	Query	Target	Query-Cov	Align-From	Align-To	DrugBank ID	Reg.Status	Mol.Name	SMILES
0	sp|P9WI81|PKNB_MYC	P9WI81	99.84	1.0	626.0	DB02930	experimental	Adenosine 5'-[gamma-thio]triphosphate	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=S)(O)O
1	sp|P9WI81|PKNB_MYC	P9WI81	99.84	1.0	626.0	DB03909	experimental	Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate	OP(=O)(O)CP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
2	sp|P9WI81|PKNB_MYC	P9WI81	99.84	1.0	626.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
3	sp|P9WHU1|PSA_MYCT	P9WHU1	99.6	1.0	248.0	DB04732	experimental	N-(4-MORPHOLINE)CARBONYL-B-(1-NAPHTHYL)-L-ALANINE-L-LEUCINE BORONIC ACID	C1COCCN1C(=O)N[C@@H](C(=O)N[C@H](B(O)O)CC(C)C)Cc(ccc2)c(c23)cccc3
4	sp|P9WG47|GYRA_MYC	P05653	97.14	4.0	818.0	DB00537	approved; investigational	Ciprofloxacin	O=C(O)c(c1=O)cn(C2CC2)c(c13)cc(c(F)c3)N4CCNCC4
5	sp|P9WG47|GYRA_MYC	P20831	97.61	7.0	825.0	DB00537	approved; investigational	Ciprofloxacin	O=C(O)c(c1=O)cn(C2CC2)c(c13)cc(c(F)c3)N4CCNCC4
6	sp|P9WG47|GYRA_MYC	P72524	97.02	5.0	818.0	DB01044	approved; investigational	Gatifloxacin	CC1CN(CCN1)c(c(F)c2)c(OC)c(c23)n(C4CC4)cc(c3=O)C(=O)O
7	sp|P9WG47|GYRA_MYC	P72524	97.02	5.0	818.0	DB06771	approved	Besifloxacin	N[C@@H]1CCCCN(C1)c(c2Cl)c(F)cc(c23)c(=O)c(C(=O)O)cn3C4CC4
8	sp|P9WG47|GYRA_MYC	P0C1U9	94.27	4.0	794.0	DB00537	approved; investigational	Ciprofloxacin	O=C(O)c(c1=O)cn(C2CC2)c(c13)cc(c(F)c3)N4CCNCC4
9	sp|P9WG47|GYRA_MYC	P72525	96.54	2.0	811.0	DB01044	approved; investigational	Gatifloxacin	CC1CN(CCN1)c(c(F)c2)c(OC)c(c23)n(C4CC4)cc(c3=O)C(=O)O
10	sp|P9WG47|GYRA_MYC	P72525	96.54	2.0	811.0	DB06771	approved	Besifloxacin	N[C@@H]1CCCCN(C1)c(c2Cl)c(F)cc(c23)c(=O)c(C(=O)O)cn3C4CC4
11	sp|P9WG47|GYRA_MYC	P43702	81.38	5.0	687.0	DB00218	approved; investigational	Moxifloxacin	N1CCC[C@H]([C@H]12)CN(C2)c(c3OC)c(F)cc(c34)c(=O)c(C(=O)O)cn4C5CC5
12	sp|P9WG47|GYRA_MYC	P43702	81.38	5.0	687.0	DB00365	approved; investigational; withdrawn	Grepafloxacin	CC1CN(CCN1)c(c2)c(F)c(C)c(c23)c(=O)c(C(=O)O)cn3C4CC4
13	sp|P9WG47|GYRA_MYC	P43702	81.38	5.0	687.0	DB00467	approved; investigational	Enoxacin	CCn1cc(C(=O)O)c(=O)c(c12)cc(F)c(n2)N3CCNCC3
14	sp|P9WG47|GYRA_MYC	P43702	81.38	5.0	687.0	DB00487	approved	Pefloxacin	CCn1cc(C(=O)O)c(=O)c(c12)cc(F)c(c2)N3CCN(C)CC3
15	sp|P9WG47|GYRA_MYC	P43702	81.38	5.0	687.0	DB00537	approved; investigational	Ciprofloxacin	O=C(O)c(c1=O)cn(C2CC2)c(c13)cc(c(F)c3)N4CCNCC4
16	sp|P9WG47|GYRA_MYC	P43702	81.38	5.0	687.0	DB00685	approved; investigational; withdrawn	Trovafloxacin	N[C@H]1[C@@H]([C@@H]12)CN(C2)c(c(F)c3)nc(c34)n(cc(c4=O)C(=O)O)-c5c(F)cc(F)cc5
17	sp|P9WG47|GYRA_MYC	P43702	81.38	5.0	687.0	DB00978	approved; investigational	Lomefloxacin	CCn1cc(C(=O)O)c(=O)c(c12)cc(F)c(c2F)N3CCNC(C)C3
18	sp|P9WG47|GYRA_MYC	P43702	81.38	5.0	687.0	DB01059	approved	Norfloxacin	CCn1cc(C(=O)O)c(=O)c(c12)cc(F)c(c2)N3CCNCC3
19	sp|P9WG47|GYRA_MYC	P43702	81.38	5.0	687.0	DB01137	approved; investigational	Levofloxacin	C1CN(C)CCN1c(c(c2n34)OC[C@@H]3C)c(F)cc2c(=O)c(c4)C(=O)O
20	sp|P9WG47|GYRA_MYC	P43702	81.38	5.0	687.0	DB01155	approved; investigational	Gemifloxacin	CO/N=C1\CN(CC1CN)c(c(F)c2)nc(c23)n(C4CC4)cc(c3=O)C(=O)O
21	sp|P9WG47|GYRA_MYC	P43702	81.38	5.0	687.0	DB01165	approved	Ofloxacin	C1CN(C)CCN1c(c(c2n34)OCC3C)c(F)cc2c(=O)c(c4)C(=O)O
22	sp|P9WG47|GYRA_MYC	P43702	81.38	5.0	687.0	DB01208	approved; investigational; withdrawn	Sparfloxacin	C[C@H]1CN(C[C@@H](C)N1)c(c2F)c(F)c(N)c(c23)c(=O)c(C(=O)O)cn3C4CC4
23	sp|P9WG47|GYRA_MYC	P43702	81.38	5.0	687.0	DB01405	withdrawn	Temafloxacin	CC1CN(CCN1)c(c2)c(F)cc(c23)c(=O)c(C(=O)O)cn3-c4c(F)cc(F)cc4
24	sp|P9WG47|GYRA_MYC	P43702	81.38	5.0	687.0	DB04576	experimental	Fleroxacin	CN1CCN(CC1)c(c2F)c(F)cc(c23)c(=O)c(C(=O)O)cn3CCF
25	sp|P9WG47|GYRA_MYC	P43702	81.38	5.0	687.0	DB06771	approved	Besifloxacin	N[C@@H]1CCCCN(C1)c(c2Cl)c(F)cc(c23)c(=O)c(C(=O)O)cn3C4CC4
26	sp|P9WG47|GYRA_MYC	P43702	81.38	5.0	687.0	DB09047	approved; investigational	Finafloxacin	O1CCN[C@H]([C@@H]12)CN(C2)c(c3C#N)c(F)cc(c34)c(=O)c(C(=O)O)cn4C5CC5
27	sp|P9WG47|GYRA_MYC	P0AFI2	85.92	5.0	725.0	DB00817	approved; investigational	Rosoxacin	CCn1cc(C(=O)O)c(=O)c(c12)ccc(c2)-c3ccncc3
28	sp|P9WG47|GYRA_MYC	P0AFI2	85.92	5.0	725.0	DB11943	approved; investigational	Delafloxacin	Fc1cc(F)c(nc1N)-n2cc(C(=O)O)c(=O)c(c23)cc(F)c(c3Cl)N4CC(O)C4
29	sp|P9WG47|GYRA_MYC	P0AFI2	85.92	5.0	725.0	DB12924	approved; investigational	Ozenoxacin	CNc1ncc(cc1C)-c(c2C)ccc(c23)c(=O)c(C(=O)O)cn3C4CC4
30	sp|P9WHT9|PSB_MYCT	P9WHT9	99.66	1.0	291.0	DB04732	experimental	N-(4-MORPHOLINE)CARBONYL-B-(1-NAPHTHYL)-L-ALANINE-L-LEUCINE BORONIC ACID	C1COCCN1C(=O)N[C@@H](C(=O)N[C@H](B(O)O)CC(C)C)Cc(ccc2)c(c23)cccc3
31	sp|P9WHT9|PSB_MYCT	P28074	73.54	40.0	254.0	DB00188	approved; investigational	Bortezomib	c1ccccc1C[C@@H](C(=O)N[C@H](B(O)O)CC(C)C)NC(=O)c2cnccn2
32	sp|P9WHT9|PSB_MYCT	P28074	73.54	40.0	254.0	DB08515	experimental	(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE	C1CCC=C[C@H]1[C@H](O)[C@@]2(C=O)NC(=O)[C@H](CCO3)[C@@]23C
33	sp|P9WHT9|PSB_MYCT	P28074	73.54	40.0	254.0	DB08889	approved; investigational	Carfilzomib	c1ccccc1C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)[C@@]2(C)CO2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCc3ccccc3)NC(=O)CN4CCOCC4
34	sp|P9WHT9|PSB_MYCT	P28062	72.16	57.0	267.0	DB08889	approved; investigational	Carfilzomib	c1ccccc1C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)[C@@]2(C)CO2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCc3ccccc3)NC(=O)CN4CCOCC4
35	sp|P9WHT9|PSB_MYCT	Q99436	72.16	13.0	223.0	DB08515	experimental	(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE	C1CCC=C[C@H]1[C@H](O)[C@@]2(C=O)NC(=O)[C@H](CCO3)[C@@]23C
36	sp|P9WHT9|PSB_MYCT	P28070	73.2	32.0	245.0	DB08515	experimental	(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE	C1CCC=C[C@H]1[C@H](O)[C@@]2(C=O)NC(=O)[C@H](CCO3)[C@@]23C
37	sp|P9WGI3|SIGF_MYC	Q18BX5	86.59	151.0	377.0	DB08874	approved	Fidaxomicin	CC(C)C(=O)O[C@H](C1(C)C)[C@H](O)[C@H](O)[C@@H](O1)O[C@@H]2[C@@H](CC)/C=C(\C)[C@@H](O)C/C=C/C=C(/C(=O)O[C@H]([C@@H](C)O)C/C=C(\C)/C=C/2C)CO[C@@H]3O[C@H](C)[C@H]([C@H](O)[C@@H]3OC)OC(=O)c4c(CC)c(Cl)c(O)c(Cl)c4O
38	sp|P9WGI3|SIGF_MYC	Q5SKW1	88.51	178.0	409.0	DB08226	experimental	Myxopyronin B	CCCC/C(C)=C/C=C(\C)C(=O)c1c(O)cc(oc1=O)CCC/C=C/NC(=O)OC
39	sp|P9WGI3|SIGF_MYC	Q5SKW1	88.51	178.0	409.0	DB08266	experimental	Methyl [(1E,5R)-5-{3-[(2E,4E)-2,5-dimethyl-2,4-octadienoyl]-2,4-dioxo-3,4-dihydro-2H-pyran-6-yl}hexylidene]carbamate	COC(=O)/N=C/CCC[C@@H](C)C1=CC(=O)C(C(=O)O1)C(=O)/C(C)=C/C=C(\C)CCC
40	sp|Q79FX8|MMAA4_MY	Q79FX8	99.67	1.0	301.0	DB07413	experimental	5'-S-[2-(decylamino)ethyl]-5'-thioadenosine	n1cnc(N)c(c12)ncn2[C@H]3[C@H](O)[C@H](O)[C@H](O3)CSCCNCCCCCCCCCC
41	sp|Q79FX8|MMAA4_MY	P9WPB7	94.35	2.0	286.0	DB01718	approved	Cetrimonium	CCCCCCCCCCCCCCCC[N+](C)(C)C
42	sp|Q79FX8|MMAA4_MY	P9WPB3	94.02	3.0	286.0	DB01752	experimental	S-adenosyl-L-homocysteine	OC(=O)[C@@H](N)CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
43	sp|Q79FX8|MMAA4_MY	Q79FX6	94.35	3.0	287.0	DB01718	approved	Cetrimonium	CCCCCCCCCCCCCCCC[N+](C)(C)C
44	sp|Q79FX8|MMAA4_MY	Q79FX6	94.35	3.0	287.0	DB01752	experimental	S-adenosyl-L-homocysteine	OC(=O)[C@@H](N)CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
45	sp|Q79FX8|MMAA4_MY	P9WPB5	98.34	6.0	302.0	DB01752	experimental	S-adenosyl-L-homocysteine	OC(=O)[C@@H](N)CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
46	sp|Q79FX8|MMAA4_MY	P9WPB5	98.34	6.0	302.0	DB04221	approved; experimental	Didecyldimethylammonium	CCCCCCCCCC[N+](C)(C)CCCCCCCCCC
47	sp|P9WIS5|KGD_MYCT	Q02218	73.03	115.0	1014.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
48	sp|P9WIS5|KGD_MYCT	Q02218	73.03	115.0	1014.0	DB00313	approved; investigational	Valproic acid	CCCC(C(=O)O)CCC
49	sp|P9WIS5|KGD_MYCT	Q02218	73.03	115.0	1014.0	DB09092	approved; withdrawn	Xanthinol	OCCN(C)CC(O)Cn1cnc(c12)n(C)c(=O)n(c2=O)C
50	sp|P9WIE5|KATG_MYC	P9WIE5	99.86	1.0	740.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
51	sp|P9WIE5|KATG_MYC	P9WIE5	99.86	1.0	740.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
52	sp|P9WIE5|KATG_MYC	Q939D2	96.49	13.0	727.0	DB08638	experimental	1-hydroperoxy-L-tryptophan	c1cccc(c12)n(OO)cc2C[C@H](N)C(=O)O
53	tr|A0A0N9DRX8|A0A0	P9WIE5	99.86	1.0	740.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
54	tr|A0A0N9DRX8|A0A0	P9WIE5	99.86	1.0	740.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
55	tr|A0A0N9DRX8|A0A0	Q939D2	96.49	13.0	727.0	DB08638	experimental	1-hydroperoxy-L-tryptophan	c1cccc(c12)n(OO)cc2C[C@H](N)C(=O)O
56	tr|A0A0N9DRW0|A0A0	P9WIE5	99.86	1.0	740.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
57	tr|A0A0N9DRW0|A0A0	P9WIE5	99.86	1.0	740.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
58	tr|A0A0N9DRW0|A0A0	Q939D2	96.49	13.0	727.0	DB08638	experimental	1-hydroperoxy-L-tryptophan	c1cccc(c12)n(OO)cc2C[C@H](N)C(=O)O
59	tr|A0A0N7EHL1|A0A0	P9WIE5	99.49	1.0	197.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
60	tr|A0A0N7EHL1|A0A0	P9WIE5	99.49	1.0	197.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
61	tr|A0A0N7EHL1|A0A0	Q939D2	85.28	13.0	181.0	DB08638	experimental	1-hydroperoxy-L-tryptophan	c1cccc(c12)n(OO)cc2C[C@H](N)C(=O)O
62	tr|A0A0N7EHL4|A0A0	P9WIE5	99.86	1.0	740.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
63	tr|A0A0N7EHL4|A0A0	P9WIE5	99.86	1.0	740.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
64	tr|A0A0N7EHL4|A0A0	Q939D2	96.49	13.0	727.0	DB08638	experimental	1-hydroperoxy-L-tryptophan	c1cccc(c12)n(OO)cc2C[C@H](N)C(=O)O
65	tr|A0A0N9DRV9|A0A0	P9WIE5	97.1	1.0	202.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
66	tr|A0A0N9DRV9|A0A0	P9WIE5	97.1	1.0	202.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
67	tr|A0A0N9DRV9|A0A0	Q939D2	82.61	13.0	184.0	DB08638	experimental	1-hydroperoxy-L-tryptophan	c1cccc(c12)n(OO)cc2C[C@H](N)C(=O)O
68	tr|A0A0N9DRZ5|A0A0	P9WIE5	99.86	1.0	740.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
69	tr|A0A0N9DRZ5|A0A0	P9WIE5	99.86	1.0	740.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
70	tr|A0A0N9DRZ5|A0A0	Q939D2	96.49	13.0	727.0	DB08638	experimental	1-hydroperoxy-L-tryptophan	c1cccc(c12)n(OO)cc2C[C@H](N)C(=O)O
71	tr|A0A0N9DS37|A0A0	P9WIE5	99.86	1.0	740.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
72	tr|A0A0N9DS37|A0A0	P9WIE5	99.86	1.0	740.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
73	tr|A0A0N9DS37|A0A0	Q939D2	96.49	13.0	727.0	DB08638	experimental	1-hydroperoxy-L-tryptophan	c1cccc(c12)n(OO)cc2C[C@H](N)C(=O)O
74	tr|A0A0N6WYQ3|A0A0	P9WIE5	99.86	1.0	740.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
75	tr|A0A0N6WYQ3|A0A0	P9WIE5	99.86	1.0	740.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
76	tr|A0A0N6WYQ3|A0A0	Q939D2	96.49	13.0	727.0	DB08638	experimental	1-hydroperoxy-L-tryptophan	c1cccc(c12)n(OO)cc2C[C@H](N)C(=O)O
77	tr|A0A0N9DQI3|A0A0	P9WIE5	99.86	1.0	740.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
78	tr|A0A0N9DQI3|A0A0	P9WIE5	99.86	1.0	740.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
79	tr|A0A0N9DQI3|A0A0	Q939D2	96.49	13.0	727.0	DB08638	experimental	1-hydroperoxy-L-tryptophan	c1cccc(c12)n(OO)cc2C[C@H](N)C(=O)O
80	tr|A0A0N9DRV6|A0A0	P9WIE5	99.86	1.0	740.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
81	tr|A0A0N9DRV6|A0A0	P9WIE5	99.86	1.0	740.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
82	tr|A0A0N9DRV6|A0A0	Q939D2	96.49	13.0	727.0	DB08638	experimental	1-hydroperoxy-L-tryptophan	c1cccc(c12)n(OO)cc2C[C@H](N)C(=O)O
83	tr|G0ZF23|G0ZF23_M	P0A8V2	99.14	477.0	592.0	DB00615	approved; investigational	Rifabutin	CC(C)CN(CC1)CCC12N=C3c4c5c6c(C)c(O)c4C(=O)C(=C3N2)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(=O)C)[C@H](C)[C@@H](OC)/C=C/O[C@](O6)(C)C5=O
84	tr|G0ZF23|G0ZF23_M	P0A8V2	99.14	477.0	592.0	DB01045	approved	Rifampicin	C[C@@]12O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(=O)C)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)Nc3c(/C=N/N4CCN(C)CC4)c(O)c5c(C1=O)c(O2)c(C)c(O)c5c3O
85	tr|G0ZF23|G0ZF23_M	P0A8V2	99.14	477.0	592.0	DB01220	approved; investigational	Rifaximin	C[C@]12O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(=O)C)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)Nc3c4c(nc5n4ccc(c5)C)c6c(c3O)c(O)c(C)c(O1)c6C2=O
86	tr|G0ZF23|G0ZF23_M	P0A8V2	99.14	477.0	592.0	DB04934	investigational	Rifalazil	C[C@]12O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(=O)C)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)Nc3c4c(c5c(c3=O)c(O)c(C)c(O1)c5C2=O)nc6c(o4)cc(cc6O)N7CCN(CC7)CC(C)C
87	tr|G0ZF23|G0ZF23_M	P0A8V2	99.14	477.0	592.0	DB11753	approved; investigational	Rifamycin	C[C@@]12O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(=O)C)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)Nc3c(O)c4c(c(c3)O)c(C1=O)c(O2)c(C)c4O
88	tr|G0ZF23|G0ZF23_M	Q8RQE9	99.14	357.0	472.0	DB04788	experimental	Tagetitoxin	OP(=O)(O)O[C@@H]([C@@]12C(=O)O)[C@@H](N)[C@@H](OC(=O)C)[C@@H](O2)[C@@](O)(SC1)C(=O)N
89	tr|G0ZF23|G0ZF23_M	Q8RQE9	99.14	357.0	472.0	DB08226	experimental	Myxopyronin B	CCCC/C(C)=C/C=C(\C)C(=O)c1c(O)cc(oc1=O)CCC/C=C/NC(=O)OC
90	tr|G0ZF23|G0ZF23_M	Q8RQE9	99.14	357.0	472.0	DB08266	experimental	Methyl [(1E,5R)-5-{3-[(2E,4E)-2,5-dimethyl-2,4-octadienoyl]-2,4-dioxo-3,4-dihydro-2H-pyran-6-yl}hexylidene]carbamate	COC(=O)/N=C/CCC[C@@H](C)C1=CC(=O)C(C(=O)O1)C(=O)/C(C)=C/C=C(\C)CCC
91	tr|I6YBX7|I6YBX7_M	P9WIE5	99.86	1.0	740.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
92	tr|I6YBX7|I6YBX7_M	P9WIE5	99.86	1.0	740.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
93	tr|I6YBX7|I6YBX7_M	Q939D2	96.49	13.0	727.0	DB08638	experimental	1-hydroperoxy-L-tryptophan	c1cccc(c12)n(OO)cc2C[C@H](N)C(=O)O
94	sp|I6YCA3|CHSE4_MY	Q72JJ3	93.75	5.0	380.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
95	sp|I6YCA3|CHSE4_MY	P11310	93.75	39.0	414.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
96	sp|I6YCA3|CHSE4_MY	P11310	93.75	39.0	414.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
97	sp|I6YCA3|CHSE4_MY	P11310	93.75	39.0	414.0	DB03415	experimental	3-thiaoctanoyl-CoA	CCCCCSCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
98	sp|I6YCA3|CHSE4_MY	P16219	93.5	33.0	407.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
99	sp|I6YCA3|CHSE4_MY	P16219	93.5	33.0	407.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
100	sp|I6YCA3|CHSE4_MY	P16219	93.5	33.0	407.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
101	sp|I6YCA3|CHSE4_MY	Q06319	95.0	2.0	382.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
102	sp|I6YCA3|CHSE4_MY	Q06319	95.0	2.0	382.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
103	sp|I6YCA3|CHSE4_MY	P26440	93.75	42.0	417.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
104	sp|I6YCA3|CHSE4_MY	P26440	93.75	42.0	417.0	DB04036	experimental	Coenzyme A persulfide	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSS
105	sp|I6YCA3|CHSE4_MY	P45954	93.0	56.0	428.0	DB00167	investigational; nutraceutical	Isoleucine	CC[C@H](C)[C@H](N)C(=O)O
106	sp|I6YCA3|CHSE4_MY	P45954	93.0	56.0	428.0	DB00313	approved; investigational	Valproic acid	CCCC(C(=O)O)CCC
107	sp|I6YCA3|CHSE4_MY	Q9UKU7	93.25	40.0	413.0	DB01675	experimental	Methacrylyl-Coenzyme A	CC(=C)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
108	sp|I6YCA3|CHSE4_MY	Q9UKU7	93.25	40.0	413.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
109	sp|I6YCA3|CHSE4_MY	Q3JP94	92.5	18.0	388.0	DB08685	experimental	1-(1,4-dimethyl-1,2,3,4-tetrahydroquinoxalin-6-yl)methanamine	CN1CCN(C)c(c12)cc(cc2)CN
110	sp|I6YCA3|CHSE4_MY	Q92947	92.5	60.0	430.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
111	sp|I6YCA3|CHSE4_MY	Q92947	92.5	60.0	430.0	DB03245	experimental	S-4-Nitrobutyryl-CoA	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCC[N+]([O-])=O
112	sp|I6YCA3|CHSE4_MY	Q9KIE5	87.25	16.0	365.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
113	sp|P9WPU1|CTPA_MYC	P03960	71.62	66.0	611.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
114	sp|P9WPY1|AROC_MYC	P0A2Y7	95.01	1.0	382.0	DB03247	approved; investigational	Flavin mononucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)COP(=O)(O)O
115	sp|P9WPY1|AROC_MYC	P0A2Y7	95.01	1.0	382.0	DB03350	experimental	Cobalt hexammine ion	[NH3+][Co-3]([NH3+])([NH3+])([NH3+])([NH3+])[NH3+]
116	sp|P9WPY1|AROC_MYC	P56122	86.03	8.0	353.0	DB03247	approved; investigational	Flavin mononucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)COP(=O)(O)O
117	sp|P9WMH3|CRPL_MYC	P22262	91.07	14.0	218.0	DB01692	experimental	Dithioerythritol	SC[C@H](O)[C@H](O)CS
118	sp|P9WMH3|CRPL_MYC	P22262	91.07	14.0	218.0	DB03654	experimental	S,S-Propylthiocysteine	O=C[C@@H](N)CSSCCC
119	sp|P9WMH3|CRPL_MYC	P22262	91.07	14.0	218.0	DB04447	experimental	1,4-Dithiothreitol	SC[C@H](O)[C@@H](O)CS
120	sp|P9WMH3|CRPL_MYC	P0ACJ8	84.82	16.0	206.0	DB02527	experimental	Cyclic adenosine monophosphate	n1cnc(N)c(c12)ncn2[C@@H]([C@@H]3O)O[C@@H]([C@H]34)COP(O4)(=O)O
121	sp|P9WQD3|ACPS_MYC	P96618	88.46	2.0	117.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
122	sp|P9WQD3|ACPS_MYC	P96618	88.46	2.0	117.0	DB04447	experimental	1,4-Dithiothreitol	SC[C@H](O)[C@@H](O)CS
123	sp|P9WQD3|ACPS_MYC	P0A2W7	86.92	2.0	115.0	DB01812	experimental	Adenosine 3',5'-diphosphate	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H](COP(=O)(O)O)[C@H]([C@H]3O)OP(=O)(O)O
124	sp|P9WQM9|ANSP1_MY	P30825	84.46	18.0	431.0	DB00123	approved; nutraceutical	L-Lysine	NCCCC[C@H](N)C(=O)O
125	sp|P9WQM9|ANSP1_MY	P30825	84.46	18.0	431.0	DB00125	investigational; nutraceutical	Arginine	OC(=O)[C@@H](N)CCCNC(N)=N
126	sp|P9WQM9|ANSP1_MY	P30825	84.46	18.0	431.0	DB00129	approved; nutraceutical	Ornithine	NCCC[C@H](N)C(=O)O
127	sp|P9WQM9|ANSP1_MY	Q9UM01	87.73	29.0	458.0	DB13146	approved	Fluciclovine (18F)	OC(=O)[C@]1(N)C[C@H]([18F])C1
128	sp|P9WQM9|ANSP1_MY	Q9UHI5	88.96	23.0	458.0	DB00120	approved; investigational; nutraceutical	Phenylalanine	OC(=O)[C@@H](N)Cc1ccccc1
129	sp|P9WQM9|ANSP1_MY	Q9UHI5	88.96	23.0	458.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
130	sp|P9WQM9|ANSP1_MY	P52569	83.23	25.0	432.0	DB00123	approved; nutraceutical	L-Lysine	NCCCC[C@H](N)C(=O)O
131	sp|P9WQM9|ANSP1_MY	P52569	83.23	25.0	432.0	DB00129	approved; nutraceutical	Ornithine	NCCC[C@H](N)C(=O)O
132	sp|P9WQM9|ANSP1_MY	Q9UPY5	88.14	35.0	466.0	DB00138	approved; nutraceutical	Cystine	OC(=O)[C@@H](N)CSSC[C@H](N)C(=O)O
133	sp|P9WQM9|ANSP1_MY	Q9UPY5	88.14	35.0	466.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
134	sp|P9WQM9|ANSP1_MY	Q9UPY5	88.14	35.0	466.0	DB00740	approved; investigational	Riluzole	Nc(s1)nc(c12)ccc(c2)OC(F)(F)F
135	sp|P9WQM9|ANSP1_MY	Q9UPY5	88.14	35.0	466.0	DB00795	approved	Sulfasalazine	OC(=O)c1cc(ccc1O)/N=N/c2ccc(cc2)S(=O)(=O)Nc3ncccc3
136	sp|P9WQM9|ANSP1_MY	Q9UPY5	88.14	35.0	466.0	DB06151	approved; investigational	Acetylcysteine	CC(=O)N[C@@H](CS)C(=O)O
137	sp|P9WQM9|ANSP1_MY	Q9UPY5	88.14	35.0	466.0	DB11590	approved	Thimerosal	CC[Hg]Sc1ccccc1C([O-])=O
138	sp|P9WQM9|ANSP1_MY	Q8WY07	83.03	22.0	428.0	DB00123	approved; nutraceutical	L-Lysine	NCCCC[C@H](N)C(=O)O
139	sp|P9WQM9|ANSP1_MY	Q8WY07	83.03	22.0	428.0	DB00125	investigational; nutraceutical	Arginine	OC(=O)[C@@H](N)CCCNC(N)=N
140	sp|P9WQM9|ANSP1_MY	Q8WY07	83.03	22.0	428.0	DB13146	approved	Fluciclovine (18F)	OC(=O)[C@]1(N)C[C@H]([18F])C1
141	sp|P9WQM9|ANSP1_MY	O43246	79.35	28.0	416.0	DB00123	approved; nutraceutical	L-Lysine	NCCCC[C@H](N)C(=O)O
142	sp|P9WQM9|ANSP1_MY	O43246	79.35	28.0	416.0	DB00125	investigational; nutraceutical	Arginine	OC(=O)[C@@H](N)CCCNC(N)=N
143	sp|P9WQM9|ANSP1_MY	P60063	87.12	2.0	428.0	DB02451	experimental	B-nonylglucoside	CCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
144	sp|P9WMD3|CHLER_MY	Q53901	88.51	23.0	254.0	DB08541	experimental	[(3S)-9-hydroxy-1-methyl-10-oxo-4,10-dihydro-3H-benzo[g]isochromen-3-yl]acetic acid	OC(=O)C[C@@H](OC=1C)CC(C12)=Cc3c(C2=O)c(O)ccc3
145	sp|P9WP87|COBH_MYC	P21638	97.12	4.0	206.0	DB02460	experimental	Hydrogenobyrinic acid	OC(=O)CC[C@](C)([C@@H](CC(=O)O)[C@@H]1[C@]23C)C(=N1)/C(C)=C4\N=C(C(C)(C)[C@@H]4CCC(=O)O)/C=C5\N=C([C@@](C)(CC(=O)O)[C@@H]5CCC(=O)O)/C(C)=C(\N2)[C@H]([C@]3(C)CC(=O)O)CCC(=O)O
146	sp|P96877|COATR_MY	P69903	100.25	2.0	397.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
147	sp|P96877|COATR_MY	O06644	103.3	2.0	409.0	DB01846	experimental	Oxidized coenzyme A	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSO
148	sp|P96877|COATR_MY	O06644	103.3	2.0	409.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
149	sp|P96877|COATR_MY	P31572	94.42	10.0	382.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
150	sp|P96877|COATR_MY	P31572	94.42	10.0	382.0	DB02516	experimental	(R)-carnitinyl-CoA betaine	C[N+](C)(C)C[C@H](O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP([O-])(=O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
151	sp|P9WPP9|CP51_MYC	P08684	101.55	40.0	498.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
152	sp|P9WPP9|CP51_MYC	P08684	101.55	40.0	498.0	DB00143	approved; investigational; nutraceutical	Glutathione	OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(=O)O
153	sp|P9WPP9|CP51_MYC	P08684	101.55	40.0	498.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
154	sp|P9WPP9|CP51_MYC	P08684	101.55	40.0	498.0	DB05478	investigational	Pradefovir mesylate	n1cnc(N)c(c12)ncn2CCOC[P@@]3(=O)OCC[C@H](O3)c4cc(Cl)ccc4
155	sp|P9WPP9|CP51_MYC	P08684	101.55	40.0	498.0	DB06634	investigational	Casopitant	FC(F)(F)c1cc(cc(c1)C(F)(F)F)[C@@H](C)N(C)C(=O)N2CC[C@H](N3CCN(CC3)C(=O)C)C[C@@H]2c4ccc(F)cc4C
156	sp|P9WPP9|CP51_MYC	P20815	101.33	40.0	497.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
157	sp|P9WPP9|CP51_MYC	P20815	101.33	40.0	497.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
158	sp|P9WPP9|CP51_MYC	P20815	101.33	40.0	497.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
159	sp|P9WPP9|CP51_MYC	P24462	101.33	40.0	497.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
160	sp|P9WPP9|CP51_MYC	P24462	101.33	40.0	497.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
161	sp|P9WPP9|CP51_MYC	P24462	101.33	40.0	497.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
162	sp|P9WPP9|CP51_MYC	Q9HB55	101.55	40.0	498.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
163	sp|P9WPP9|CP51_MYC	P33260	97.34	29.0	468.0	DB07670	experimental	N,4-Dimethyl-N-(1-phenyl-1H-pyrazol-5-yl)benzenesulfonamide	Cc1ccc(cc1)S(=O)(=O)N(C)c2ccnn2-c3ccccc3
164	sp|P9WPP9|CP51_MYC	P11712	98.45	29.0	473.0	DB03317	experimental	Ferroheme C	[Fe-2]123[N+]4=C5C=C6[N+]1=C(C(C)=C6C(C)S)C=C7[N+]2=C(C(=C7C)CCC(=O)O)C=C8[N+]3=C(C=C4C(=C5C)C(C)S)C(C)=C8CCC(=O)O
165	sp|P9WPP9|CP51_MYC	P11712	98.45	29.0	473.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
166	sp|P9WPP9|CP51_MYC	P11712	98.45	29.0	473.0	DB12319	investigational; withdrawn	Benzbromarone	c1cccc(c12)c(c(o2)CC)C(=O)c3cc(Br)c(O)c(Br)c3
167	sp|P9WPP9|CP51_MYC	P10632	98.0	29.0	471.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
168	sp|P9WPP9|CP51_MYC	P10632	98.0	29.0	471.0	DB03796	approved	Palmitic Acid	CCCCCCCCCCCCCCCC(=O)O
169	sp|P9WPP9|CP51_MYC	P10632	98.0	29.0	471.0	DB08607	experimental	(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE	O=C1NC(=O)S[C@@H]1Cc2ccc(cc2)OC[C@@](O3)(C)CCc(c34)c(C)c(O)c(C)c4C
170	sp|P9WPP9|CP51_MYC	P33261	98.45	29.0	473.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
171	sp|P9WPP9|CP51_MYC	P33261	98.45	29.0	473.0	DB12319	investigational; withdrawn	Benzbromarone	c1cccc(c12)c(c(o2)CC)C(=O)c3cc(Br)c(O)c(Br)c3
172	sp|P9WPP9|CP51_MYC	P10614	102.22	63.0	524.0	DB06890	experimental	(2R)-2-PHENYL-N-PYRIDIN-4-YLBUTANAMIDE	c1ccccc1[C@@H](CC)C(=O)Nc2ccncc2
173	sp|P9WPP9|CP51_MYC	P10614	102.22	63.0	524.0	DB07560	experimental	N-[(1S)-2-methyl-1-(pyridin-4-ylcarbamoyl)propyl]cyclohexanecarboxamide	c1cnccc1NC(=O)[C@H](C(C)C)NC(=O)C2CCCCC2
174	sp|P9WPP9|CP51_MYC	P10614	102.22	63.0	524.0	DB07568	experimental	(2S)-2-[(2,1,3-BENZOTHIADIAZOL-4-YLSULFONYL)AMINO]-2-PHENYL-N-PYRIDIN-4-YLACETAMIDE	n1snc(c12)cccc2S(=O)(=O)N[C@@H](c3ccccc3)C(=O)Nc4ccncc4
175	sp|P9WPP9|CP51_MYC	P10614	102.22	63.0	524.0	DB07569	experimental	CIS-4-METHYL-N-[(1S)-3-(METHYLSULFANYL)-1-(PYRIDIN-4-YLCARBAMOYL)PROPYL]CYCLOHEXANECARBOXAMIDE	c1cnccc1NC(=O)[C@H](CCSC)NC(=O)[C@@H]2CC[C@H](C)CC2
176	sp|P9WPP9|CP51_MYC	P10614	102.22	63.0	524.0	DB07572	experimental	3-{[(4-methylphenyl)sulfonyl]amino}propyl pyridin-4-ylcarbamate	Cc1ccc(cc1)S(=O)(=O)NCCCOC(=O)Nc2ccncc2
177	sp|P9WPP9|CP51_MYC	P10614	102.22	63.0	524.0	DB07635	experimental	4,4'-Dihydroxybenzophenone	Oc1ccc(cc1)C(=O)c2ccc(O)cc2
178	sp|P9WPP9|CP51_MYC	P50859	102.66	64.0	527.0	DB01026	approved; investigational	Ketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OCC(CO3)OC3(Cn4ccnc4)c5ccc(Cl)cc5Cl
179	sp|P9WPP9|CP51_MYC	P50859	102.66	64.0	527.0	DB01167	approved; investigational	Itraconazole	CCC(C)n1ncn(c1=O)-c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@@H](CO5)O[C@@]5(Cn6cncn6)c7ccc(Cl)cc7Cl
180	sp|P9WPP9|CP51_MYC	P50859	102.66	64.0	527.0	DB09040	approved	Efinaconazole	C=C1CCN(CC1)[C@H](C)[C@](O)(Cn2cncn2)c3c(F)cc(F)cc3
181	sp|P9WPP9|CP51_MYC	P50859	102.66	64.0	527.0	DB11633	approved; investigational	Isavuconazole	c1ncnn1C[C@](O)(c2c(F)ccc(F)c2)[C@@H](C)c3nc(cs3)-c4ccc(C#N)cc4
182	sp|P9WPP9|CP51_MYC	P11509	97.56	33.0	473.0	DB04665	experimental	Coumarin	c1cc(=O)oc(c12)cccc2
183	sp|P9WPP9|CP51_MYC	P11509	97.56	33.0	473.0	DB07609	experimental	N,N-DIMETHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	CN(C)Cc1ccc(o1)-c2cccnc2
184	sp|P9WPP9|CP51_MYC	P11509	97.56	33.0	473.0	DB07617	experimental	N-METHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	CNCc1ccc(o1)-c2cccnc2
185	sp|P9WPP9|CP51_MYC	P11509	97.56	33.0	473.0	DB07621	experimental	(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	NCc1ccc(o1)-c2cccnc2
186	sp|P9WPP9|CP51_MYC	P11509	97.56	33.0	473.0	DB07623	experimental	4,4'-DIPYRIDYL DISULFIDE	c1cnccc1SSc2ccncc2
187	sp|P9WPP9|CP51_MYC	P05181	97.56	31.0	471.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
188	sp|P9WPP9|CP51_MYC	P10613	103.99	55.0	524.0	DB00196	approved; investigational	Fluconazole	c1ncnn1CC(O)(Cn2cncn2)c3c(F)cc(F)cc3
189	sp|P9WPP9|CP51_MYC	P10613	103.99	55.0	524.0	DB00239	approved	Oxiconazole	Clc1cc(Cl)c(cc1)CO/N=C(\Cn2ccnc2)c3ccc(Cl)cc3Cl
190	sp|P9WPP9|CP51_MYC	P10613	103.99	55.0	524.0	DB00251	approved	Terconazole	CC(C)N1CCN(CC1)c2ccc(cc2)OC[C@@H](CO3)O[C@@]3(Cn4cncn4)c5c(Cl)cc(Cl)cc5
191	sp|P9WPP9|CP51_MYC	P10613	103.99	55.0	524.0	DB00257	approved; vet_approved	Clotrimazole	Clc1ccccc1C(n2ccnc2)(c3ccccc3)c4ccccc4
192	sp|P9WPP9|CP51_MYC	P10613	103.99	55.0	524.0	DB00582	approved	Voriconazole	c1ncnn1C[C@](O)(c2c(F)cc(F)cc2)[C@@H](C)c3ncncc3F
193	sp|P9WPP9|CP51_MYC	P10613	103.99	55.0	524.0	DB01007	approved	Tioconazole	c1nccn1CC(c(c(Cl)c2)ccc2Cl)OCc3c(Cl)scc3
194	sp|P9WPP9|CP51_MYC	P10613	103.99	55.0	524.0	DB01110	approved; investigational; vet_approved	Miconazole	Clc1cc(Cl)c(cc1)COC(Cn2ccnc2)c3c(Cl)cc(Cl)cc3
195	sp|P9WPP9|CP51_MYC	P10613	103.99	55.0	524.0	DB01127	approved	Econazole	Clc1ccc(cc1)COC(Cn2ccnc2)c3c(Cl)cc(Cl)cc3
196	sp|P9WPP9|CP51_MYC	P10613	103.99	55.0	524.0	DB01153	approved; investigational	Sertaconazole	Clc1cc(Cl)ccc1C(Cn2cncc2)OCc3csc(c34)c(Cl)ccc4
197	sp|P9WPP9|CP51_MYC	P10613	103.99	55.0	524.0	DB01263	approved; investigational; vet_approved	Posaconazole	C[C@H](O)[C@H](CC)n1ncn(c1=O)-c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@H](CO5)C[C@]5(Cn6cncn6)c7c(F)cc(F)cc7
198	sp|P9WPP9|CP51_MYC	P10613	103.99	55.0	524.0	DB04794	approved; investigational	Bifonazole	c1ccccc1C(n2ccnc2)c3ccc(cc3)-c4ccccc4
199	sp|P9WPP9|CP51_MYC	P10613	103.99	55.0	524.0	DB08933	approved	Luliconazole	Clc1cc(Cl)c(cc1)[C@@H]2CS/C(S2)=C(/C#N)n3ccnc3
200	sp|P9WPP9|CP51_MYC	P20813	99.78	30.0	480.0	DB02974	experimental	4-(4-Chlorophenyl)Imidazole	Clc1ccc(cc1)-c2cnc[nH]2
201	sp|P9WPP9|CP51_MYC	P20813	99.78	30.0	480.0	DB04664	experimental	Cyclohexyl-pentyl-maltoside	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@@H]2CO)OCCCCCC3CCCCC3
202	sp|P9WPP9|CP51_MYC	P20813	99.78	30.0	480.0	DB04794	approved; investigational	Bifonazole	c1ccccc1C(n2ccnc2)c3ccc(cc3)-c4ccccc4
203	sp|P9WPP9|CP51_MYC	P20813	99.78	30.0	480.0	DB08369	experimental	1-(biphenyl-4-ylmethyl)-1H-imidazole	c1cncn1Cc2ccc(cc2)-c3ccccc3
204	sp|P9WPP9|CP51_MYC	P04798	101.33	39.0	496.0	DB02342	investigational	2-Methoxyestradiol	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)c(c4)OC
205	sp|P9WPP9|CP51_MYC	P04798	101.33	39.0	496.0	DB12379	investigational	Indirubin	c1cccc(c12)NC(=O)C\2=C(C3=O)\Nc(c34)cccc4
206	sp|P9WPP9|CP51_MYC	P04798	101.33	39.0	496.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
207	sp|P9WPP9|CP51_MYC	Q16850	96.23	67.0	501.0	DB01007	approved	Tioconazole	c1nccn1CC(c(c(Cl)c2)ccc2Cl)OCc3c(Cl)scc3
208	sp|P9WPP9|CP51_MYC	Q16850	96.23	67.0	501.0	DB01167	approved; investigational	Itraconazole	CCC(C)n1ncn(c1=O)-c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@@H](CO5)O[C@@]5(Cn6cncn6)c7ccc(Cl)cc7Cl
209	sp|P9WPP9|CP51_MYC	Q16850	96.23	67.0	501.0	DB05667	investigational	Levoketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OC[C@H](CO3)O[C@]3(Cn4ccnc4)c5ccc(Cl)cc5Cl
210	sp|P9WPP9|CP51_MYC	Q16850	96.23	67.0	501.0	DB07705	experimental	(S)-econazole	Clc1ccc(cc1)CO[C@H](Cn2ccnc2)c3c(Cl)cc(Cl)cc3
211	sp|P9WPP9|CP51_MYC	O43174	97.34	41.0	480.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
212	sp|P9WPP9|CP51_MYC	O43174	97.34	41.0	480.0	DB13083	investigational	Talarozole	c1ncnn1C(C(CC)CC)c2ccc(cc2)Nc(s3)nc(c34)cccc4
213	sp|P9WPP9|CP51_MYC	P05177	103.33	41.0	507.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
214	sp|P9WPP9|CP51_MYC	P05177	103.33	41.0	507.0	DB07453	experimental	alpha-Naphthoflavone	c1ccccc1-c(cc2=O)oc(c23)c4c(cc3)cccc4
215	sp|P9WPP9|CP51_MYC	P05177	103.33	41.0	507.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
216	sp|P9WPP9|CP51_MYC	P05177	103.33	41.0	507.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
217	sp|P9WPP9|CP51_MYC	P05177	103.33	41.0	507.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
218	sp|P9WPP9|CP51_MYC	Q9NR63	98.0	47.0	489.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
219	sp|P9WPP9|CP51_MYC	Q16678	104.88	51.0	524.0	DB01645	investigational	Genistein	Oc1ccc(cc1)-c(c2=O)coc(c23)cc(O)cc3O
220	sp|P9WPP9|CP51_MYC	Q16678	104.88	51.0	524.0	DB02342	investigational	2-Methoxyestradiol	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)c(c4)OC
221	sp|P9WPP9|CP51_MYC	Q16678	104.88	51.0	524.0	DB03467	experimental	Naringenin	Oc1ccc(cc1)[C@@H](O2)CC(=O)c(c23)c(O)cc(c3)O
222	sp|P9WPP9|CP51_MYC	Q16678	104.88	51.0	524.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
223	sp|P9WPP9|CP51_MYC	Q16678	104.88	51.0	524.0	DB06732	experimental	beta-Naphthoflavone	c1cccc(c12)c3c(cc2)oc(cc3=O)-c4ccccc4
224	sp|P9WPP9|CP51_MYC	Q16678	104.88	51.0	524.0	DB07776	approved; experimental	Flavone	c1cccc(c12)oc(cc2=O)-c3ccccc3
225	sp|P9WPP9|CP51_MYC	Q16678	104.88	51.0	524.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
226	sp|P9WPP9|CP51_MYC	Q16678	104.88	51.0	524.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
227	sp|P9WPP9|CP51_MYC	Q6V0L0	101.55	45.0	503.0	DB00523	approved; investigational	Alitretinoin	OC(=O)/C=C(\C)/C=C/C=C(/C)\C=C\C(C1(C)C)=C(C)CCC1
228	sp|P9WPP9|CP51_MYC	Q6V0L0	101.55	45.0	503.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
229	sp|P9WPP9|CP51_MYC	P10635	99.11	33.0	480.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
230	sp|P9WPP9|CP51_MYC	P10635	99.11	33.0	480.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
231	sp|P9WPP9|CP51_MYC	P10635	99.11	33.0	480.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
232	sp|P9WPP9|CP51_MYC	P05093	103.99	28.0	497.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
233	sp|P9WPP9|CP51_MYC	P05093	103.99	28.0	497.0	DB00396	approved; vet_approved	Progesterone	CC(=O)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
234	sp|P9WPP9|CP51_MYC	P05093	103.99	28.0	497.0	DB00421	approved	Spironolactone	C1CC(=O)O[C@@]12[C@]3(C)[C@@H](CC2)[C@H]4[C@H](CC3)[C@]5(C)C(=CC(=O)CC5)C[C@H]4SC(=O)C
235	sp|P9WPP9|CP51_MYC	P05093	103.99	28.0	497.0	DB01026	approved; investigational	Ketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OCC(CO3)OC3(Cn4ccnc4)c5ccc(Cl)cc5Cl
236	sp|P9WPP9|CP51_MYC	P05093	103.99	28.0	497.0	DB05812	approved	Abiraterone	C1C[C@H](O)CC([C@]12C)=CC[C@@H]3[C@@H]2CC[C@@]4(C)[C@H]3CC=C4c5cccnc5
237	sp|P9WPP9|CP51_MYC	P05093	103.99	28.0	497.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
238									
239	sp|P9WPP9|CP51_MYC	P05093	103.99	28.0	497.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
240	sp|P9WPP9|CP51_MYC	P24557	107.32	49.0	533.0	DB00795	approved	Sulfasalazine	OC(=O)c1cc(ccc1O)/N=N/c2ccc(cc2)S(=O)(=O)Nc3ncccc3
241	sp|P9WPP9|CP51_MYC	P24557	107.32	49.0	533.0	DB01207	experimental	Ridogrel	OC(=O)CCCCO/N=C(/c1cnccc1)c2cc(C(F)(F)F)ccc2
242	sp|P9WPP9|CP51_MYC	P24557	107.32	49.0	533.0	DB03052	experimental	Dazoxiben	OC(=O)c1ccc(cc1)OCCn2ccnc2
243	sp|P9WPP9|CP51_MYC	P24557	107.32	49.0	533.0	DB05505	investigational	NM-702	 
244	sp|P9WPP9|CP51_MYC	P08686	95.79	51.0	483.0	DB01026	approved; investigational	Ketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OCC(CO3)OC3(Cn4ccnc4)c5ccc(Cl)cc5Cl
246	sp|P9WPP9|CP51_MYC	P14779	94.68	25.0	452.0	DB03440	experimental	N-hexadecanoylglycine	CCCCCCCCCCCCCCCC(=O)NCC(=O)O
247	sp|P9WPP9|CP51_MYC	P14779	94.68	25.0	452.0	DB04257	experimental	Palmitoleic Acid	CCCCCC/C=C\CCCCCCCC(=O)O
248	sp|P9WPP9|CP51_MYC	P14779	94.68	25.0	452.0	DB08086	experimental	N-[12-(1H-imidazol-1-yl)dodecanoyl]-L-leucine	CC(C)C[C@@H](C(=O)O)NC(=O)CCCCCCCCCCCn1ccnc1
249	sp|P9WPP9|CP51_MYC	P19099	93.35	61.0	482.0	DB00421	approved	Spironolactone	C1CC(=O)O[C@@]12[C@]3(C)[C@@H](CC2)[C@H]4[C@H](CC3)[C@]5(C)C(=CC(=O)CC5)C[C@H]4SC(=O)C
250	sp|P9WPP9|CP51_MYC	P19099	93.35	61.0	482.0	DB11837	approved; investigational	Osilodrostat	c1ncc(n12)CC[C@@H]2c3c(F)cc(C#N)cc3
251	sp|P9WPP9|CP51_MYC	P15538	92.46	65.0	482.0	DB00648	approved	Mitotane	Clc1ccc(cc1)C(C(Cl)Cl)c2ccccc2Cl
252	sp|P9WPP9|CP51_MYC	P15538	92.46	65.0	482.0	DB01011	approved; investigational	Metyrapone	c1ccncc1C(C)(C)C(=O)c2cnccc2
253	sp|P9WPP9|CP51_MYC	P15538	92.46	65.0	482.0	DB05667	investigational	Levoketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OC[C@H](CO3)O[C@]3(Cn4ccnc4)c5ccc(Cl)cc5Cl
254	sp|P9WPP9|CP51_MYC	P15538	92.46	65.0	482.0	DB11837	approved; investigational	Osilodrostat	c1ncc(n12)CC[C@@H]2c3c(F)cc(C#N)cc3
255	sp|P9WPP9|CP51_MYC	Q02928	92.24	92.0	508.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
256	sp|P9WPP9|CP51_MYC	O15528	98.45	64.0	508.0	DB01436	approved; nutraceutical	Alfacalcidol	CC(C)CCC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)/C(CCC2)=C/C=C3/C[C@@H](O)C[C@H](O)C3=C
257	sp|P9WPP9|CP51_MYC	P11511	86.25	77.0	466.0	DB00184	approved	Nicotine	CN1CCC[C@H]1c2cnccc2
258	sp|P9WPP9|CP51_MYC	P11511	86.25	77.0	466.0	DB00357	approved; investigational	Aminoglutethimide	Nc1ccc(cc1)C2(CC)CCC(=O)NC2=O
259	sp|P9WPP9|CP51_MYC	P11511	86.25	77.0	466.0	DB00655	approved	Estrone	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)cc4
260	sp|P9WPP9|CP51_MYC	P11511	86.25	77.0	466.0	DB00894	approved; investigational	Testolactone	C1=CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2CC[C@@]4(C)[C@H]3CCC(O4)=O
261	sp|P9WPP9|CP51_MYC	P11511	86.25	77.0	466.0	DB00990	approved; investigational	Exemestane	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(C(C3)=C)=CC(=O)C=C4
262	sp|P9WPP9|CP51_MYC	P11511	86.25	77.0	466.0	DB01006	approved; investigational	Letrozole	N#Cc1ccc(cc1)C(n2cncn2)c3ccc(C#N)cc3
263	sp|P9WPP9|CP51_MYC	P11511	86.25	77.0	466.0	DB01217	approved; investigational	Anastrozole	N#CC(C)(C)c1cc(C(C)(C)C#N)cc(c1)Cn2cncn2
264	sp|P9WPP9|CP51_MYC	P11511	86.25	77.0	466.0	DB02342	investigational	2-Methoxyestradiol	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)c(c4)OC
265	sp|P9WPP9|CP51_MYC	P11511	86.25	77.0	466.0	DB03467	experimental	Naringenin	Oc1ccc(cc1)[C@@H](O2)CC(=O)c(c23)c(O)cc(c3)O
266	sp|P9WPP9|CP51_MYC	P11511	86.25	77.0	466.0	DB04539	experimental	Glyphosate	OC(=O)C[NH2+]CP(=O)(O)O
267	sp|P9WPP9|CP51_MYC	P11511	86.25	77.0	466.0	DB05749	investigational	MPI-674	 
268	sp|P9WPP9|CP51_MYC	Q16647	102.66	36.0	499.0	DB00812	approved; vet_approved	Phenylbutazone	CCCCC1C(=O)N(c2ccccc2)N(C1=O)c3ccccc3
269	sp|P9WPP9|CP51_MYC	Q16647	102.66	36.0	499.0	DB01240	approved	Epoprostenol	OC(=O)CCC/C=C(C1)\O[C@H]([C@H]12)C[C@@H](O)[C@@H]2/C=C/[C@@H](O)CCCCC
270	sp|P9WPP9|CP51_MYC	Q16647	102.66	36.0	499.0	DB08675	experimental	(5Z)-7-{(1R,4S,5R,6R)-6-[(1E)-1-Octen-1-yl]-2,3-diazabicyclo[2.2.1]hept-2-en-5-yl}-5-heptenoic acid	OC(=O)CCC/C=C\C[C@@H]([C@H]12)[C@H]([C@@H](C1)N=N2)/C=C/CCCCCC
271	sp|P9WPP9|CP51_MYC	O31440	87.8	13.0	409.0	DB04257	experimental	Palmitoleic Acid	CCCCCC/C=C\CCCCCCCC(=O)O
272	sp|P9WPP9|CP51_MYC	P53554	79.38	11.0	369.0	DB04450	experimental	Heptyl 1-Thiohexopyranoside	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)SCCCCCCC
273	sp|P9WPP9|CP51_MYC	P05108	96.01	74.0	507.0	DB00357	approved; investigational	Aminoglutethimide	Nc1ccc(cc1)C2(CC)CCC(=O)NC2=O
274	sp|P9WPP9|CP51_MYC	Q83WG3	72.28	57.0	383.0	DB06955	experimental	3,4-bis(7-chloro-1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid	c1ccc(Cl)c(c12)[nH]cc2-c3c(C(=O)O)[nH]c(C(=O)O)c3-c4c[nH]c(c45)c(Cl)ccc5
275	sp|P9WPP9|CP51_MYC	Q83WG3	72.28	57.0	383.0	DB07588	experimental	3,4-DI-1H-INDOL-3-YL-1H-PYRROLE-2,5-DICARBOXYLIC ACID	c1cccc(c12)[nH]cc2-c3c(C(=O)O)[nH]c(C(=O)O)c3-c4c[nH]c(c45)cccc5
276	sp|P9WPL9|CP140_MY	P53554	75.11	65.0	394.0	DB04450	experimental	Heptyl 1-Thiohexopyranoside	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)SCCCCCCC
277	sp|P9WPL9|CP140_MY	Q83WG3	74.89	85.0	413.0	DB06955	experimental	3,4-bis(7-chloro-1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid	c1ccc(Cl)c(c12)[nH]cc2-c3c(C(=O)O)[nH]c(C(=O)O)c3-c4c[nH]c(c45)c(Cl)ccc5
278	sp|P9WPL9|CP140_MY	Q83WG3	74.89	85.0	413.0	DB07588	experimental	3,4-DI-1H-INDOL-3-YL-1H-PYRROLE-2,5-DICARBOXYLIC ACID	c1cccc(c12)[nH]cc2-c3c(C(=O)O)[nH]c(C(=O)O)c3-c4c[nH]c(c45)cccc5
279	sp|P9WPL9|CP140_MY	Q00441	72.6	85.0	403.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
280	sp|P9WPL9|CP140_MY	Q00441	72.6	85.0	403.0	DB03369	experimental	9-Aminophenanthrene	c1cccc(c12)c3c(cc2N)cccc3
281	sp|P9WPL9|CP140_MY	Q00441	72.6	85.0	403.0	DB04070	experimental	6-Deoxyerythronolide B	C[C@@H]1C[C@H](C)[C@H](O)[C@@H](C)[C@H](O)[C@@H](C)C(=O)O[C@H](CC)[C@H](C)[C@H](O)[C@@H](C)C1=O
282	sp|P9WPL9|CP140_MY	P00183	70.55	103.0	412.0	DB01011	approved; investigational	Metyrapone	c1ccncc1C(C)(C)C(=O)c2cnccc2
283	sp|P9WPL9|CP140_MY	P00183	70.55	103.0	412.0	DB01663	experimental	lambda-bis(2,2'-bipyridine)-(5-methyl-2-2'-bipyridine)-C9-adamantane ruthenium (II)	C1=CC=CN2C1=C(C=CC=C3)N3[Ru+2]245(N6C(C=CC=C6)=C7N4C=CC=C7)N8C(=C9N5C=CC(C)=C9)C=C(C=C8)CCCCCCCCC(=O)N[C@@H]([C@H]12)[C@H]3C[C@@H](C1)C[C@@H](C2)C3
284	sp|P9WPL9|CP140_MY	P00183	70.55	103.0	412.0	DB01703	experimental	N-(2-ferrocenylethyl)maleimide	O=C1C=CC(=O)N1CCC2(C3C4C5C26)[Fe]13456789C2C7C8C9C12
285	sp|P9WPL9|CP140_MY	P00183	70.55	103.0	412.0	DB01744	approved	Camphor	C[C@]12C(=O)C[C@H](C1(C)C)CC2
286	sp|P9WPL9|CP140_MY	P00183	70.55	103.0	412.0	DB01826	experimental	N-Butyl Isocyanide	CCCC[N+]#[C-]
287	sp|P9WPL9|CP140_MY	P00183	70.55	103.0	412.0	DB02125	experimental	Adamantanone	O=C([C@H]12)[C@H]3C[C@@H](C1)C[C@@H](C2)C3
288	sp|P9WPL9|CP140_MY	P00183	70.55	103.0	412.0	DB02617	experimental	1-(N-Imidazolyl)-2-Hydroxy-2-(2,3-Dichlorophenyl)Octane	CCCCCC[C@](O)(Cn1ccnc1)c2ccc(Cl)cc2Cl
289	sp|P9WPL9|CP140_MY	P00183	70.55	103.0	412.0	DB02817	experimental	5-Exo-Hydroxycamphor	C[C@]12C[C@@H](O)[C@H](CC1=O)C2(C)C
290	sp|P9WPL9|CP140_MY	P00183	70.55	103.0	412.0	DB02851	experimental	Thiocamphor	C[C@]12C(=S)C[C@H](C1(C)C)CC2
291	sp|P9WPL9|CP140_MY	P00183	70.55	103.0	412.0	DB03031	experimental	Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Octyl-Amide	CN(C)c1cccc(c12)c(ccc2)S(=O)(=O)NCCCCCCCCNC(=O)C34CC5CC(C3)CC(C5)C4
292	sp|P9WPL9|CP140_MY	P00183	70.55	103.0	412.0	DB03540	experimental	Norcamphor	[C@H]12CC[C@H](C1)C(=O)C2
293	sp|P9WPL9|CP140_MY	P00183	70.55	103.0	412.0	DB03627	experimental	Adamantane	C12CC3CC(C1)CC(C3)C2
294	sp|P9WPL9|CP140_MY	P00183	70.55	103.0	412.0	DB03836	experimental	1,3,5-trichlorobenzene	Clc1cc(Cl)cc(Cl)c1
295	sp|P9WPL9|CP140_MY	P00183	70.55	103.0	412.0	DB04032	experimental	Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Butyl-Amide	CN(C)c1cccc(c12)c(ccc2)S(=O)(=O)NCCCCNC(=O)C34CC5CC(C3)CC(C5)C4
296	sp|P9WPL9|CP140_MY	P00183	70.55	103.0	412.0	DB04501	experimental	Camphane	C[C@@]12CCC(C1(C)C)CC2
297	sp|P9WPL9|CP140_MY	Q9FCA6	71.23	92.0	404.0	DB02175	experimental	Malonic acid	OC(=O)CC(=O)O
298	sp|P9WPL9|CP140_MY	Q9FCA6	71.23	92.0	404.0	DB02521	experimental	Flaviolin	Oc1cc(O)cc(c12)C(=O)C(O)=CC2=O
299	sp|P9WPL9|CP140_MY	Q9FCA6	71.23	92.0	404.0	DB03254	experimental	4-Phenyl-1h-Imidazole	[nH]1cncc1-c2ccccc2
300	sp|P9WPL9|CP140_MY	Q9FCA6	71.23	92.0	404.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
301	sp|P9WPL9|CP140_MY	Q9NR63	74.66	137.0	464.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
302	sp|P9WPL9|CP140_MY	O43174	83.56	124.0	490.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
303	sp|P9WPL9|CP140_MY	O43174	83.56	124.0	490.0	DB13083	investigational	Talarozole	c1ncnn1C(C(CC)CC)c2ccc(cc2)Nc(s3)nc(c34)cccc4
304	sp|P9WPL9|CP140_MY	Q6V0L0	87.21	129.0	511.0	DB00523	approved; investigational	Alitretinoin	OC(=O)/C=C(\C)/C=C/C=C(/C)\C=C\C(C1(C)C)=C(C)CCC1
305	sp|P9WPL9|CP140_MY	Q6V0L0	87.21	129.0	511.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
306	sp|P9WPL9|CP140_MY	P08686	76.71	121.0	457.0	DB01026	approved; investigational	Ketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OCC(CO3)OC3(Cn4ccnc4)c5ccc(Cl)cc5Cl
307	sp|P9WPL9|CP140_MY	P08684	80.37	118.0	470.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
308	sp|P9WPL9|CP140_MY	P08684	80.37	118.0	470.0	DB00143	approved; investigational; nutraceutical	Glutathione	OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(=O)O
309	sp|P9WPL9|CP140_MY	P08684	80.37	118.0	470.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
310	sp|P9WPL9|CP140_MY	P08684	80.37	118.0	470.0	DB05478	investigational	Pradefovir mesylate	n1cnc(N)c(c12)ncn2CCOC[P@@]3(=O)OCC[C@H](O3)c4cc(Cl)ccc4
311	sp|P9WPL9|CP140_MY	P08684	80.37	118.0	470.0	DB06634	investigational	Casopitant	FC(F)(F)c1cc(cc(c1)C(F)(F)F)[C@@H](C)N(C)C(=O)N2CC[C@H](N3CCN(CC3)C(=O)C)C[C@@H]2c4ccc(F)cc4C
312	sp|P9WPL9|CP140_MY	P50859	86.53	141.0	520.0	DB01026	approved; investigational	Ketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OCC(CO3)OC3(Cn4ccnc4)c5ccc(Cl)cc5Cl
313	sp|P9WPL9|CP140_MY	P50859	86.53	141.0	520.0	DB01167	approved; investigational	Itraconazole	CCC(C)n1ncn(c1=O)-c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@@H](CO5)O[C@@]5(Cn6cncn6)c7ccc(Cl)cc7Cl
314	sp|P9WPL9|CP140_MY	P50859	86.53	141.0	520.0	DB09040	approved	Efinaconazole	C=C1CCN(CC1)[C@H](C)[C@](O)(Cn2cncn2)c3c(F)cc(F)cc3
315	sp|P9WPL9|CP140_MY	P50859	86.53	141.0	520.0	DB11633	approved; investigational	Isavuconazole	c1ncnn1C[C@](O)(c2c(F)ccc(F)c2)[C@@H](C)c3nc(cs3)-c4ccc(C#N)cc4
316	sp|P9WPL9|CP140_MY	P20813	80.59	130.0	483.0	DB02974	experimental	4-(4-Chlorophenyl)Imidazole	Clc1ccc(cc1)-c2cnc[nH]2
317	sp|P9WPL9|CP140_MY	P20813	80.59	130.0	483.0	DB04664	experimental	Cyclohexyl-pentyl-maltoside	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@@H]2CO)OCCCCCC3CCCCC3
318	sp|P9WPL9|CP140_MY	P20813	80.59	130.0	483.0	DB04794	approved; investigational	Bifonazole	c1ccccc1C(n2ccnc2)c3ccc(cc3)-c4ccccc4
319	sp|P9WPL9|CP140_MY	P20813	80.59	130.0	483.0	DB08369	experimental	1-(biphenyl-4-ylmethyl)-1H-imidazole	c1cncn1Cc2ccc(cc2)-c3ccccc3
320	sp|P9WPL9|CP140_MY	P10614	79.0	149.0	495.0	DB06890	experimental	(2R)-2-PHENYL-N-PYRIDIN-4-YLBUTANAMIDE	c1ccccc1[C@@H](CC)C(=O)Nc2ccncc2
321	sp|P9WPL9|CP140_MY	P10614	79.0	149.0	495.0	DB07560	experimental	N-[(1S)-2-methyl-1-(pyridin-4-ylcarbamoyl)propyl]cyclohexanecarboxamide	c1cnccc1NC(=O)[C@H](C(C)C)NC(=O)C2CCCCC2
322	sp|P9WPL9|CP140_MY	P10614	79.0	149.0	495.0	DB07568	experimental	(2S)-2-[(2,1,3-BENZOTHIADIAZOL-4-YLSULFONYL)AMINO]-2-PHENYL-N-PYRIDIN-4-YLACETAMIDE	n1snc(c12)cccc2S(=O)(=O)N[C@@H](c3ccccc3)C(=O)Nc4ccncc4
323	sp|P9WPL9|CP140_MY	P10614	79.0	149.0	495.0	DB07569	experimental	CIS-4-METHYL-N-[(1S)-3-(METHYLSULFANYL)-1-(PYRIDIN-4-YLCARBAMOYL)PROPYL]CYCLOHEXANECARBOXAMIDE	c1cnccc1NC(=O)[C@H](CCSC)NC(=O)[C@@H]2CC[C@H](C)CC2
324	sp|P9WPL9|CP140_MY	P10614	79.0	149.0	495.0	DB07572	experimental	3-{[(4-methylphenyl)sulfonyl]amino}propyl pyridin-4-ylcarbamate	Cc1ccc(cc1)S(=O)(=O)NCCCOC(=O)Nc2ccncc2
325	sp|P9WPL9|CP140_MY	P10614	79.0	149.0	495.0	DB07635	experimental	4,4'-Dihydroxybenzophenone	Oc1ccc(cc1)C(=O)c2ccc(O)cc2
326	sp|P9WPL9|CP140_MY	O15528	83.11	125.0	489.0	DB01436	approved; nutraceutical	Alfacalcidol	CC(C)CCC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)/C(CCC2)=C/C=C3/C[C@@H](O)C[C@H](O)C3=C
327	sp|P9WPL9|CP140_MY	Q16850	72.83	150.0	469.0	DB01007	approved	Tioconazole	c1nccn1CC(c(c(Cl)c2)ccc2Cl)OCc3c(Cl)scc3
328	sp|P9WPL9|CP140_MY	Q16850	72.83	150.0	469.0	DB01167	approved; investigational	Itraconazole	CCC(C)n1ncn(c1=O)-c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@@H](CO5)O[C@@]5(Cn6cncn6)c7ccc(Cl)cc7Cl
329	sp|P9WPL9|CP140_MY	Q16850	72.83	150.0	469.0	DB05667	investigational	Levoketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OC[C@H](CO3)O[C@]3(Cn4ccnc4)c5ccc(Cl)cc5Cl
330	sp|P9WPL9|CP140_MY	Q16850	72.83	150.0	469.0	DB07705	experimental	(S)-econazole	Clc1ccc(cc1)CO[C@H](Cn2ccnc2)c3c(Cl)cc(Cl)cc3
331	sp|P9WPL9|CP140_MY	P24557	87.67	122.0	506.0	DB00795	approved	Sulfasalazine	OC(=O)c1cc(ccc1O)/N=N/c2ccc(cc2)S(=O)(=O)Nc3ncccc3
332	sp|P9WPL9|CP140_MY	P24557	87.67	122.0	506.0	DB01207	experimental	Ridogrel	OC(=O)CCCCO/N=C(/c1cnccc1)c2cc(C(F)(F)F)ccc2
333	sp|P9WPL9|CP140_MY	P24557	87.67	122.0	506.0	DB03052	experimental	Dazoxiben	OC(=O)c1ccc(cc1)OCCn2ccnc2
334	sp|P9WPL9|CP140_MY	P24557	87.67	122.0	506.0	DB05505	investigational	NM-702	 
335	sp|P9WPL9|CP140_MY	P11511	73.52	144.0	466.0	DB00184	approved	Nicotine	CN1CCC[C@H]1c2cnccc2
336	sp|P9WPL9|CP140_MY	P11511	73.52	144.0	466.0	DB00357	approved; investigational	Aminoglutethimide	Nc1ccc(cc1)C2(CC)CCC(=O)NC2=O
337	sp|P9WPL9|CP140_MY	P11511	73.52	144.0	466.0	DB00655	approved	Estrone	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)cc4
338	sp|P9WPL9|CP140_MY	P11511	73.52	144.0	466.0	DB00894	approved; investigational	Testolactone	C1=CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2CC[C@@]4(C)[C@H]3CCC(O4)=O
339	sp|P9WPL9|CP140_MY	P11511	73.52	144.0	466.0	DB00990	approved; investigational	Exemestane	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(C(C3)=C)=CC(=O)C=C4
340	sp|P9WPL9|CP140_MY	P11511	73.52	144.0	466.0	DB01006	approved; investigational	Letrozole	N#Cc1ccc(cc1)C(n2cncn2)c3ccc(C#N)cc3
341	sp|P9WPL9|CP140_MY	P11511	73.52	144.0	466.0	DB01217	approved; investigational	Anastrozole	N#CC(C)(C)c1cc(C(C)(C)C#N)cc(c1)Cn2cncn2
342	sp|P9WPL9|CP140_MY	P11511	73.52	144.0	466.0	DB02342	investigational	2-Methoxyestradiol	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)c(c4)OC
343	sp|P9WPL9|CP140_MY	P11511	73.52	144.0	466.0	DB03467	experimental	Naringenin	Oc1ccc(cc1)[C@@H](O2)CC(=O)c(c23)c(O)cc(c3)O
344	sp|P9WPL9|CP140_MY	P11511	73.52	144.0	466.0	DB04539	experimental	Glyphosate	OC(=O)C[NH2+]CP(=O)(O)O
345	sp|P9WPL9|CP140_MY	P11511	73.52	144.0	466.0	DB05749	investigational	MPI-674	 
346	sp|P9WPN3|CP132_MY	P08684	92.62	66.0	493.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
347	sp|P9WPN3|CP132_MY	P08684	92.62	66.0	493.0	DB00143	approved; investigational; nutraceutical	Glutathione	OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(=O)O
348	sp|P9WPN3|CP132_MY	P08684	92.62	66.0	493.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
349	sp|P9WPN3|CP132_MY	P08684	92.62	66.0	493.0	DB05478	investigational	Pradefovir mesylate	n1cnc(N)c(c12)ncn2CCOC[P@@]3(=O)OCC[C@H](O3)c4cc(Cl)ccc4
350	sp|P9WPN3|CP132_MY	P08684	92.62	66.0	493.0	DB06634	investigational	Casopitant	FC(F)(F)c1cc(cc(c1)C(F)(F)F)[C@@H](C)N(C)C(=O)N2CC[C@H](N3CCN(CC3)C(=O)C)C[C@@H]2c4ccc(F)cc4C
351	sp|P9WPN3|CP132_MY	P20815	92.41	66.0	492.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
352	sp|P9WPN3|CP132_MY	P20815	92.41	66.0	492.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
353	sp|P9WPN3|CP132_MY	P20815	92.41	66.0	492.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
354	sp|P9WPN3|CP132_MY	P24462	92.62	66.0	493.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
355	sp|P9WPN3|CP132_MY	P24462	92.62	66.0	493.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
356	sp|P9WPN3|CP132_MY	P24462	92.62	66.0	493.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
357	sp|P9WPN3|CP132_MY	Q9HB55	92.41	67.0	493.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
358	sp|P9WPN3|CP132_MY	Q16678	99.78	55.0	515.0	DB01645	investigational	Genistein	Oc1ccc(cc1)-c(c2=O)coc(c23)cc(O)cc3O
359	sp|P9WPN3|CP132_MY	Q16678	99.78	55.0	515.0	DB02342	investigational	2-Methoxyestradiol	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)c(c4)OC
360	sp|P9WPN3|CP132_MY	Q16678	99.78	55.0	515.0	DB03467	experimental	Naringenin	Oc1ccc(cc1)[C@@H](O2)CC(=O)c(c23)c(O)cc(c3)O
361	sp|P9WPN3|CP132_MY	Q16678	99.78	55.0	515.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
362	sp|P9WPN3|CP132_MY	Q16678	99.78	55.0	515.0	DB06732	experimental	beta-Naphthoflavone	c1cccc(c12)c3c(cc2)oc(cc3=O)-c4ccccc4
363	sp|P9WPN3|CP132_MY	Q16678	99.78	55.0	515.0	DB07776	approved; experimental	Flavone	c1cccc(c12)oc(cc2=O)-c3ccccc3
364	sp|P9WPN3|CP132_MY	Q16678	99.78	55.0	515.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
365	sp|P9WPN3|CP132_MY	Q16678	99.78	55.0	515.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
366	sp|P9WPN3|CP132_MY	P33260	87.42	60.0	463.0	DB07670	experimental	N,4-Dimethyl-N-(1-phenyl-1H-pyrazol-5-yl)benzenesulfonamide	Cc1ccc(cc1)S(=O)(=O)N(C)c2ccnn2-c3ccccc3
367	sp|P9WPN3|CP132_MY	P11712	92.41	37.0	463.0	DB03317	experimental	Ferroheme C	[Fe-2]123[N+]4=C5C=C6[N+]1=C(C(C)=C6C(C)S)C=C7[N+]2=C(C(=C7C)CCC(=O)O)C=C8[N+]3=C(C=C4C(=C5C)C(C)S)C(C)=C8CCC(=O)O
368	sp|P9WPN3|CP132_MY	P11712	92.41	37.0	463.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
369	sp|P9WPN3|CP132_MY	P11712	92.41	37.0	463.0	DB12319	investigational; withdrawn	Benzbromarone	c1cccc(c12)c(c(o2)CC)C(=O)c3cc(Br)c(O)c(Br)c3
370	sp|P9WPN3|CP132_MY	P10632	91.97	39.0	463.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
371	sp|P9WPN3|CP132_MY	P10632	91.97	39.0	463.0	DB03796	approved	Palmitic Acid	CCCCCCCCCCCCCCCC(=O)O
372	sp|P9WPN3|CP132_MY	P10632	91.97	39.0	463.0	DB08607	experimental	(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE	O=C1NC(=O)S[C@@H]1Cc2ccc(cc2)OC[C@@](O3)(C)CCc(c34)c(C)c(O)c(C)c4C
373	sp|P9WPN3|CP132_MY	P33261	89.37	49.0	461.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
374	sp|P9WPN3|CP132_MY	P33261	89.37	49.0	461.0	DB12319	investigational; withdrawn	Benzbromarone	c1cccc(c12)c(c(o2)CC)C(=O)c3cc(Br)c(O)c(Br)c3
375	sp|P9WPN3|CP132_MY	P05177	100.65	47.0	511.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
376	sp|P9WPN3|CP132_MY	P05177	100.65	47.0	511.0	DB07453	experimental	alpha-Naphthoflavone	c1ccccc1-c(cc2=O)oc(c23)c4c(cc3)cccc4
377	sp|P9WPN3|CP132_MY	P05177	100.65	47.0	511.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
378	sp|P9WPN3|CP132_MY	P05177	100.65	47.0	511.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
379	sp|P9WPN3|CP132_MY	P05177	100.65	47.0	511.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
380	sp|P9WPN3|CP132_MY	P20813	88.94	53.0	463.0	DB02974	experimental	4-(4-Chlorophenyl)Imidazole	Clc1ccc(cc1)-c2cnc[nH]2
381	sp|P9WPN3|CP132_MY	P20813	88.94	53.0	463.0	DB04664	experimental	Cyclohexyl-pentyl-maltoside	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@@H]2CO)OCCCCCC3CCCCC3
382	sp|P9WPN3|CP132_MY	P20813	88.94	53.0	463.0	DB04794	approved; investigational	Bifonazole	c1ccccc1C(n2ccnc2)c3ccc(cc3)-c4ccccc4
383	sp|P9WPN3|CP132_MY	P20813	88.94	53.0	463.0	DB08369	experimental	1-(biphenyl-4-ylmethyl)-1H-imidazole	c1cncn1Cc2ccc(cc2)-c3ccccc3
384	sp|P9WPN3|CP132_MY	P05181	88.94	55.0	465.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
385	sp|P9WPN3|CP132_MY	P11509	88.72	58.0	467.0	DB04665	experimental	Coumarin	c1cc(=O)oc(c12)cccc2
386	sp|P9WPN3|CP132_MY	P11509	88.72	58.0	467.0	DB07609	experimental	N,N-DIMETHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	CN(C)Cc1ccc(o1)-c2cccnc2
387	sp|P9WPN3|CP132_MY	P11509	88.72	58.0	467.0	DB07617	experimental	N-METHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	CNCc1ccc(o1)-c2cccnc2
388	sp|P9WPN3|CP132_MY	P11509	88.72	58.0	467.0	DB07621	experimental	(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	NCc1ccc(o1)-c2cccnc2
389	sp|P9WPN3|CP132_MY	P11509	88.72	58.0	467.0	DB07623	experimental	4,4'-DIPYRIDYL DISULFIDE	c1cnccc1SSc2ccncc2
390	sp|P9WPN3|CP132_MY	P24557	98.92	73.0	529.0	DB00795	approved	Sulfasalazine	OC(=O)c1cc(ccc1O)/N=N/c2ccc(cc2)S(=O)(=O)Nc3ncccc3
391	sp|P9WPN3|CP132_MY	P24557	98.92	73.0	529.0	DB01207	experimental	Ridogrel	OC(=O)CCCCO/N=C(/c1cnccc1)c2cc(C(F)(F)F)ccc2
392	sp|P9WPN3|CP132_MY	P24557	98.92	73.0	529.0	DB03052	experimental	Dazoxiben	OC(=O)c1ccc(cc1)OCCn2ccnc2
393	sp|P9WPN3|CP132_MY	P24557	98.92	73.0	529.0	DB05505	investigational	NM-702	 
394	sp|P9WPN3|CP132_MY	Q02928	90.89	89.0	508.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
395	sp|P9WPN3|CP132_MY	P04798	98.92	45.0	501.0	DB02342	investigational	2-Methoxyestradiol	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)c(c4)OC
396	sp|P9WPN3|CP132_MY	P04798	98.92	45.0	501.0	DB12379	investigational	Indirubin	c1cccc(c12)NC(=O)C\2=C(C3=O)\Nc(c34)cccc4
397	sp|P9WPN3|CP132_MY	P04798	98.92	45.0	501.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
398	sp|P9WPN3|CP132_MY	P19099	91.32	75.0	496.0	DB00421	approved	Spironolactone	C1CC(=O)O[C@@]12[C@]3(C)[C@@H](CC2)[C@H]4[C@H](CC3)[C@]5(C)C(=CC(=O)CC5)C[C@H]4SC(=O)C
399	sp|P9WPN3|CP132_MY	P19099	91.32	75.0	496.0	DB11837	approved; investigational	Osilodrostat	c1ncc(n12)CC[C@@H]2c3c(F)cc(C#N)cc3
401	sp|P9WPN3|CP132_MY	P15538	90.46	75.0	492.0	DB00648	approved	Mitotane	Clc1ccc(cc1)C(C(Cl)Cl)c2ccccc2Cl
402	sp|P9WPN3|CP132_MY	P15538	90.46	75.0	492.0	DB01011	approved; investigational	Metyrapone	c1ccncc1C(C)(C)C(=O)c2cnccc2
403	sp|P9WPN3|CP132_MY	P15538	90.46	75.0	492.0	DB05667	investigational	Levoketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OC[C@H](CO3)O[C@]3(Cn4ccnc4)c5ccc(Cl)cc5Cl
404	sp|P9WPN3|CP132_MY	P15538	90.46	75.0	492.0	DB11837	approved; investigational	Osilodrostat	c1ncc(n12)CC[C@@H]2c3c(F)cc(C#N)cc3
405	sp|P9WPN3|CP132_MY	P05093	91.76	50.0	473.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
406	sp|P9WPN3|CP132_MY	P05093	91.76	50.0	473.0	DB00396	approved; vet_approved	Progesterone	CC(=O)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
407	sp|P9WPN3|CP132_MY	P05093	91.76	50.0	473.0	DB00421	approved	Spironolactone	C1CC(=O)O[C@@]12[C@]3(C)[C@@H](CC2)[C@H]4[C@H](CC3)[C@]5(C)C(=CC(=O)CC5)C[C@H]4SC(=O)C
408	sp|P9WPN3|CP132_MY	P05093	91.76	50.0	473.0	DB01026	approved; investigational	Ketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OCC(CO3)OC3(Cn4ccnc4)c5ccc(Cl)cc5Cl
409	sp|P9WPN3|CP132_MY	P05093	91.76	50.0	473.0	DB05812	approved	Abiraterone	C1C[C@H](O)CC([C@]12C)=CC[C@@H]3[C@@H]2CC[C@@]4(C)[C@H]3CC=C4c5cccnc5
410	sp|P9WPN3|CP132_MY	P05093	91.76	50.0	473.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
412	sp|P9WPN3|CP132_MY	P05093	91.76	50.0	473.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
413	sp|P9WPN3|CP132_MY	P14779	89.59	36.0	449.0	DB03440	experimental	N-hexadecanoylglycine	CCCCCCCCCCCCCCCC(=O)NCC(=O)O
414	sp|P9WPN3|CP132_MY	P14779	89.59	36.0	449.0	DB04257	experimental	Palmitoleic Acid	CCCCCC/C=C\CCCCCCCC(=O)O
415	sp|P9WPN3|CP132_MY	P14779	89.59	36.0	449.0	DB08086	experimental	N-[12-(1H-imidazol-1-yl)dodecanoyl]-L-leucine	CC(C)C[C@@H](C(=O)O)NC(=O)CCCCCCCCCCCn1ccnc1
416	sp|P9WPN3|CP132_MY	O15528	94.58	68.0	504.0	DB01436	approved; nutraceutical	Alfacalcidol	CC(C)CCC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)/C(CCC2)=C/C=C3/C[C@@H](O)C[C@H](O)C3=C
417	sp|P9WPN3|CP132_MY	O43174	90.24	70.0	486.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
418	sp|P9WPN3|CP132_MY	O43174	90.24	70.0	486.0	DB13083	investigational	Talarozole	c1ncnn1C(C(CC)CC)c2ccc(cc2)Nc(s3)nc(c34)cccc4
419	sp|P9WPN3|CP132_MY	P05108	93.06	79.0	508.0	DB00357	approved; investigational	Aminoglutethimide	Nc1ccc(cc1)C2(CC)CCC(=O)NC2=O
420	sp|P9WPN3|CP132_MY	P10635	89.59	60.0	473.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
421	sp|P9WPN3|CP132_MY	P10635	89.59	60.0	473.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
422	sp|P9WPN3|CP132_MY	P10635	89.59	60.0	473.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
423	sp|P9WPN3|CP132_MY	P08686	89.37	50.0	462.0	DB01026	approved; investigational	Ketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OCC(CO3)OC3(Cn4ccnc4)c5ccc(Cl)cc5Cl
424	sp|P9WPN3|CP132_MY	Q6V0L0	93.93	73.0	506.0	DB00523	approved; investigational	Alitretinoin	OC(=O)/C=C(\C)/C=C/C=C(/C)\C=C\C(C1(C)C)=C(C)CCC1
425	sp|P9WPN3|CP132_MY	Q6V0L0	93.93	73.0	506.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
426	sp|P9WPN3|CP132_MY	Q9NR63	90.89	70.0	489.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
427	sp|P9WPN3|CP132_MY	Q16850	96.1	58.0	501.0	DB01007	approved	Tioconazole	c1nccn1CC(c(c(Cl)c2)ccc2Cl)OCc3c(Cl)scc3
428	sp|P9WPN3|CP132_MY	Q16850	96.1	58.0	501.0	DB01167	approved; investigational	Itraconazole	CCC(C)n1ncn(c1=O)-c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@@H](CO5)O[C@@]5(Cn6cncn6)c7ccc(Cl)cc7Cl
429	sp|P9WPN3|CP132_MY	Q16850	96.1	58.0	501.0	DB05667	investigational	Levoketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OC[C@H](CO3)O[C@]3(Cn4ccnc4)c5ccc(Cl)cc5Cl
430	sp|P9WPN3|CP132_MY	Q16850	96.1	58.0	501.0	DB07705	experimental	(S)-econazole	Clc1ccc(cc1)CO[C@H](Cn2ccnc2)c3c(Cl)cc(Cl)cc3
431	sp|P9WPN3|CP132_MY	P10614	96.31	65.0	509.0	DB06890	experimental	(2R)-2-PHENYL-N-PYRIDIN-4-YLBUTANAMIDE	c1ccccc1[C@@H](CC)C(=O)Nc2ccncc2
432	sp|P9WPN3|CP132_MY	P10614	96.31	65.0	509.0	DB07560	experimental	N-[(1S)-2-methyl-1-(pyridin-4-ylcarbamoyl)propyl]cyclohexanecarboxamide	c1cnccc1NC(=O)[C@H](C(C)C)NC(=O)C2CCCCC2
433	sp|P9WPN3|CP132_MY	P10614	96.31	65.0	509.0	DB07568	experimental	(2S)-2-[(2,1,3-BENZOTHIADIAZOL-4-YLSULFONYL)AMINO]-2-PHENYL-N-PYRIDIN-4-YLACETAMIDE	n1snc(c12)cccc2S(=O)(=O)N[C@@H](c3ccccc3)C(=O)Nc4ccncc4
434	sp|P9WPN3|CP132_MY	P10614	96.31	65.0	509.0	DB07569	experimental	CIS-4-METHYL-N-[(1S)-3-(METHYLSULFANYL)-1-(PYRIDIN-4-YLCARBAMOYL)PROPYL]CYCLOHEXANECARBOXAMIDE	c1cnccc1NC(=O)[C@H](CCSC)NC(=O)[C@@H]2CC[C@H](C)CC2
435	sp|P9WPN3|CP132_MY	P10614	96.31	65.0	509.0	DB07572	experimental	3-{[(4-methylphenyl)sulfonyl]amino}propyl pyridin-4-ylcarbamate	Cc1ccc(cc1)S(=O)(=O)NCCCOC(=O)Nc2ccncc2
436	sp|P9WPN3|CP132_MY	P10614	96.31	65.0	509.0	DB07635	experimental	4,4'-Dihydroxybenzophenone	Oc1ccc(cc1)C(=O)c2ccc(O)cc2
437	sp|P9WPN3|CP132_MY	P50859	94.36	67.0	502.0	DB01026	approved; investigational	Ketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OCC(CO3)OC3(Cn4ccnc4)c5ccc(Cl)cc5Cl
438	sp|P9WPN3|CP132_MY	P50859	94.36	67.0	502.0	DB01167	approved; investigational	Itraconazole	CCC(C)n1ncn(c1=O)-c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@@H](CO5)O[C@@]5(Cn6cncn6)c7ccc(Cl)cc7Cl
439	sp|P9WPN3|CP132_MY	P50859	94.36	67.0	502.0	DB09040	approved	Efinaconazole	C=C1CCN(CC1)[C@H](C)[C@](O)(Cn2cncn2)c3c(F)cc(F)cc3
440	sp|P9WPN3|CP132_MY	P50859	94.36	67.0	502.0	DB11633	approved; investigational	Isavuconazole	c1ncnn1C[C@](O)(c2c(F)ccc(F)c2)[C@@H](C)c3nc(cs3)-c4ccc(C#N)cc4
441	sp|P9WPN3|CP132_MY	P11511	87.42	80.0	483.0	DB00184	approved	Nicotine	CN1CCC[C@H]1c2cnccc2
442	sp|P9WPN3|CP132_MY	P11511	87.42	80.0	483.0	DB00357	approved; investigational	Aminoglutethimide	Nc1ccc(cc1)C2(CC)CCC(=O)NC2=O
443	sp|P9WPN3|CP132_MY	P11511	87.42	80.0	483.0	DB00655	approved	Estrone	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)cc4
444	sp|P9WPN3|CP132_MY	P11511	87.42	80.0	483.0	DB00894	approved; investigational	Testolactone	C1=CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2CC[C@@]4(C)[C@H]3CCC(O4)=O
445	sp|P9WPN3|CP132_MY	P11511	87.42	80.0	483.0	DB00990	approved; investigational	Exemestane	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(C(C3)=C)=CC(=O)C=C4
446	sp|P9WPN3|CP132_MY	P11511	87.42	80.0	483.0	DB01006	approved; investigational	Letrozole	N#Cc1ccc(cc1)C(n2cncn2)c3ccc(C#N)cc3
447	sp|P9WPN3|CP132_MY	P11511	87.42	80.0	483.0	DB01217	approved; investigational	Anastrozole	N#CC(C)(C)c1cc(C(C)(C)C#N)cc(c1)Cn2cncn2
448	sp|P9WPN3|CP132_MY	P11511	87.42	80.0	483.0	DB02342	investigational	2-Methoxyestradiol	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)c(c4)OC
449	sp|P9WPN3|CP132_MY	P11511	87.42	80.0	483.0	DB03467	experimental	Naringenin	Oc1ccc(cc1)[C@@H](O2)CC(=O)c(c23)c(O)cc(c3)O
450	sp|P9WPN3|CP132_MY	P11511	87.42	80.0	483.0	DB04539	experimental	Glyphosate	OC(=O)C[NH2+]CP(=O)(O)O
451	sp|P9WPN3|CP132_MY	P11511	87.42	80.0	483.0	DB05749	investigational	MPI-674	 
452	sp|P9WPN3|CP132_MY	P10613	100.0	58.0	519.0	DB00196	approved; investigational	Fluconazole	c1ncnn1CC(O)(Cn2cncn2)c3c(F)cc(F)cc3
453	sp|P9WPN3|CP132_MY	P10613	100.0	58.0	519.0	DB00239	approved	Oxiconazole	Clc1cc(Cl)c(cc1)CO/N=C(\Cn2ccnc2)c3ccc(Cl)cc3Cl
454	sp|P9WPN3|CP132_MY	P10613	100.0	58.0	519.0	DB00251	approved	Terconazole	CC(C)N1CCN(CC1)c2ccc(cc2)OC[C@@H](CO3)O[C@@]3(Cn4cncn4)c5c(Cl)cc(Cl)cc5
455	sp|P9WPN3|CP132_MY	P10613	100.0	58.0	519.0	DB00257	approved; vet_approved	Clotrimazole	Clc1ccccc1C(n2ccnc2)(c3ccccc3)c4ccccc4
456	sp|P9WPN3|CP132_MY	P10613	100.0	58.0	519.0	DB00582	approved	Voriconazole	c1ncnn1C[C@](O)(c2c(F)cc(F)cc2)[C@@H](C)c3ncncc3F
457	sp|P9WPN3|CP132_MY	P10613	100.0	58.0	519.0	DB01007	approved	Tioconazole	c1nccn1CC(c(c(Cl)c2)ccc2Cl)OCc3c(Cl)scc3
458	sp|P9WPN3|CP132_MY	P10613	100.0	58.0	519.0	DB01110	approved; investigational; vet_approved	Miconazole	Clc1cc(Cl)c(cc1)COC(Cn2ccnc2)c3c(Cl)cc(Cl)cc3
459	sp|P9WPN3|CP132_MY	P10613	100.0	58.0	519.0	DB01127	approved	Econazole	Clc1ccc(cc1)COC(Cn2ccnc2)c3c(Cl)cc(Cl)cc3
460	sp|P9WPN3|CP132_MY	P10613	100.0	58.0	519.0	DB01153	approved; investigational	Sertaconazole	Clc1cc(Cl)ccc1C(Cn2cncc2)OCc3csc(c34)c(Cl)ccc4
461	sp|P9WPN3|CP132_MY	P10613	100.0	58.0	519.0	DB01263	approved; investigational; vet_approved	Posaconazole	C[C@H](O)[C@H](CC)n1ncn(c1=O)-c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@H](CO5)C[C@]5(Cn6cncn6)c7c(F)cc(F)cc7
462	sp|P9WPN3|CP132_MY	P10613	100.0	58.0	519.0	DB04794	approved; investigational	Bifonazole	c1ccccc1C(n2ccnc2)c3ccc(cc3)-c4ccccc4
463	sp|P9WPN3|CP132_MY	P10613	100.0	58.0	519.0	DB08933	approved	Luliconazole	Clc1cc(Cl)c(cc1)[C@@H]2CS/C(S2)=C(/C#N)n3ccnc3
464	sp|P9WPN3|CP132_MY	Q16647	99.78	38.0	498.0	DB00812	approved; vet_approved	Phenylbutazone	CCCCC1C(=O)N(c2ccccc2)N(C1=O)c3ccccc3
465	sp|P9WPN3|CP132_MY	Q16647	99.78	38.0	498.0	DB01240	approved	Epoprostenol	OC(=O)CCC/C=C(C1)\O[C@H]([C@H]12)C[C@@H](O)[C@@H]2/C=C/[C@@H](O)CCCCC
466	sp|P9WPN3|CP132_MY	Q16647	99.78	38.0	498.0	DB08675	experimental	(5Z)-7-{(1R,4S,5R,6R)-6-[(1E)-1-Octen-1-yl]-2,3-diazabicyclo[2.2.1]hept-2-en-5-yl}-5-heptenoic acid	OC(=O)CCC/C=C\C[C@@H]([C@H]12)[C@H]([C@@H](C1)N=N2)/C=C/CCCCCC
467	sp|P9WKZ1|ATSK_MYC	Q9WWU5	95.59	15.0	297.0	DB07518	experimental	(2R)-2-ETHYL-1-HEXANESULFONIC ACID	OS(=O)(=O)OC[C@H](CC)CCCC
468	sp|P9WKZ1|ATSK_MYC	P37610	94.24	1.0	279.0	DB01956	approved; nutraceutical	Taurine	NCCS(=O)(=O)O
469	sp|P9WPB9|CLPX_MYC	O25926	96.48	32.0	443.0	DB09275	approved; investigational	Bismuth subcitrate potassium	[O-]C(=O)CC([O-])(C([O-])=O)CC([O-])=O
470	sp|P9WQP1|A85B_MYC	P9WQN9	96.0	15.0	327.0	DB02811	experimental	Diethyl phosphonate	CCOP(=O)OCC
471	sp|P9WQP1|A85B_MYC	P9WQN9	96.0	15.0	327.0	DB08558	experimental	2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)SCCCCCCCC
472	sp|P9WPK5|CARA_MYC	P27708	94.41	2.0	357.0	DB03459	experimental	Sparfosic acid	OP(=O)(O)CC(=O)N[C@H](C(=O)O)CC(=O)O
473	sp|P9WPK5|CARA_MYC	P31327	93.88	45.0	398.0	DB06775	approved	Carglumic acid	NC(=O)N[C@H](C(=O)O)CCC(=O)O
474	sp|P9WPA5|COAD_MYC	Q9WZK0	96.89	2.0	158.0	DB03912	experimental	D-pantetheine 4'-phosphate	OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS
475	sp|P9WPA5|COAD_MYC	P0A6I8	96.27	3.0	158.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
476	sp|P9WPA5|COAD_MYC	P0A6I8	96.27	3.0	158.0	DB03170	experimental	Dephospho Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
477	sp|P9WPA5|COAD_MYC	P0A6I8	96.27	3.0	158.0	DB03912	experimental	D-pantetheine 4'-phosphate	OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS
478	sp|P9WPA5|COAD_MYC	Q72K87	96.89	2.0	158.0	DB03912	experimental	D-pantetheine 4'-phosphate	OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS
479	sp|P9WPP5|CP123_MY	P53554	96.02	7.0	393.0	DB04450	experimental	Heptyl 1-Thiohexopyranoside	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)SCCCCCCC
480	sp|P9WPP5|CP123_MY	Q83WG3	100.0	7.0	409.0	DB06955	experimental	3,4-bis(7-chloro-1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid	c1ccc(Cl)c(c12)[nH]cc2-c3c(C(=O)O)[nH]c(C(=O)O)c3-c4c[nH]c(c45)c(Cl)ccc5
481	sp|P9WPP5|CP123_MY	Q83WG3	100.0	7.0	409.0	DB07588	experimental	3,4-DI-1H-INDOL-3-YL-1H-PYRROLE-2,5-DICARBOXYLIC ACID	c1cccc(c12)[nH]cc2-c3c(C(=O)O)[nH]c(C(=O)O)c3-c4c[nH]c(c45)cccc5
482	sp|P9WPP5|CP123_MY	Q00441	98.51	6.0	402.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
483	sp|P9WPP5|CP123_MY	Q00441	98.51	6.0	402.0	DB03369	experimental	9-Aminophenanthrene	c1cccc(c12)c3c(cc2N)cccc3
484	sp|P9WPP5|CP123_MY	Q00441	98.51	6.0	402.0	DB04070	experimental	6-Deoxyerythronolide B	C[C@@H]1C[C@H](C)[C@H](O)[C@@H](C)[C@H](O)[C@@H](C)C(=O)O[C@H](CC)[C@H](C)[C@H](O)[C@@H](C)C1=O
485	sp|P9WPP5|CP123_MY	P9WPN5	97.51	11.0	403.0	DB07705	experimental	(S)-econazole	Clc1ccc(cc1)CO[C@H](Cn2ccnc2)c3c(Cl)cc(Cl)cc3
486	sp|P9WPP5|CP123_MY	P9WPN5	97.51	11.0	403.0	DB07971	experimental	5-AMINO-2-{4-[(4-AMINOPHENYL)SULFANYL]PHENYL}-1H-ISOINDOLE-1,3(2H)-DIONE	Nc1ccc(cc1)Sc2ccc(cc2)N(C3=O)C(=O)c(c34)ccc(c4)N
487	sp|P9WPP5|CP123_MY	P9WPN5	97.51	11.0	403.0	DB07972	experimental	1-(3-METHYLPHENYL)-1H-BENZIMIDAZOL-5-AMINE	Cc1cccc(c1)-n2cnc(c23)cc(N)cc3
488	sp|P9WPP5|CP123_MY	Q9FCA6	93.53	26.0	402.0	DB02175	experimental	Malonic acid	OC(=O)CC(=O)O
489	sp|P9WPP5|CP123_MY	Q9FCA6	93.53	26.0	402.0	DB02521	experimental	Flaviolin	Oc1cc(O)cc(c12)C(=O)C(O)=CC2=O
490	sp|P9WPP5|CP123_MY	Q9FCA6	93.53	26.0	402.0	DB03254	experimental	4-Phenyl-1h-Imidazole	[nH]1cncc1-c2ccccc2
491	sp|P9WPP5|CP123_MY	Q9FCA6	93.53	26.0	402.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
492	sp|P9WPP5|CP123_MY	P00183	85.82	60.0	405.0	DB01011	approved; investigational	Metyrapone	c1ccncc1C(C)(C)C(=O)c2cnccc2
493	sp|P9WPP5|CP123_MY	P00183	85.82	60.0	405.0	DB01663	experimental	lambda-bis(2,2'-bipyridine)-(5-methyl-2-2'-bipyridine)-C9-adamantane ruthenium (II)	C1=CC=CN2C1=C(C=CC=C3)N3[Ru+2]245(N6C(C=CC=C6)=C7N4C=CC=C7)N8C(=C9N5C=CC(C)=C9)C=C(C=C8)CCCCCCCCC(=O)N[C@@H]([C@H]12)[C@H]3C[C@@H](C1)C[C@@H](C2)C3
494	sp|P9WPP5|CP123_MY	P00183	85.82	60.0	405.0	DB01703	experimental	N-(2-ferrocenylethyl)maleimide	O=C1C=CC(=O)N1CCC2(C3C4C5C26)[Fe]13456789C2C7C8C9C12
495	sp|P9WPP5|CP123_MY	P00183	85.82	60.0	405.0	DB01744	approved	Camphor	C[C@]12C(=O)C[C@H](C1(C)C)CC2
496	sp|P9WPP5|CP123_MY	P00183	85.82	60.0	405.0	DB01826	experimental	N-Butyl Isocyanide	CCCC[N+]#[C-]
497	sp|P9WPP5|CP123_MY	P00183	85.82	60.0	405.0	DB02125	experimental	Adamantanone	O=C([C@H]12)[C@H]3C[C@@H](C1)C[C@@H](C2)C3
498	sp|P9WPP5|CP123_MY	P00183	85.82	60.0	405.0	DB02617	experimental	1-(N-Imidazolyl)-2-Hydroxy-2-(2,3-Dichlorophenyl)Octane	CCCCCC[C@](O)(Cn1ccnc1)c2ccc(Cl)cc2Cl
499	sp|P9WPP5|CP123_MY	P00183	85.82	60.0	405.0	DB02817	experimental	5-Exo-Hydroxycamphor	C[C@]12C[C@@H](O)[C@H](CC1=O)C2(C)C
500	sp|P9WPP5|CP123_MY	P00183	85.82	60.0	405.0	DB02851	experimental	Thiocamphor	C[C@]12C(=S)C[C@H](C1(C)C)CC2
501	sp|P9WPP5|CP123_MY	P00183	85.82	60.0	405.0	DB03031	experimental	Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Octyl-Amide	CN(C)c1cccc(c12)c(ccc2)S(=O)(=O)NCCCCCCCCNC(=O)C34CC5CC(C3)CC(C5)C4
502	sp|P9WPP5|CP123_MY	P00183	85.82	60.0	405.0	DB03540	experimental	Norcamphor	[C@H]12CC[C@H](C1)C(=O)C2
503	sp|P9WPP5|CP123_MY	P00183	85.82	60.0	405.0	DB03627	experimental	Adamantane	C12CC3CC(C1)CC(C3)C2
504	sp|P9WPP5|CP123_MY	P00183	85.82	60.0	405.0	DB03836	experimental	1,3,5-trichlorobenzene	Clc1cc(Cl)cc(Cl)c1
505	sp|P9WPP5|CP123_MY	P00183	85.82	60.0	405.0	DB04032	experimental	Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Butyl-Amide	CN(C)c1cccc(c12)c(ccc2)S(=O)(=O)NCCCCNC(=O)C34CC5CC(C3)CC(C5)C4
506	sp|P9WPP5|CP123_MY	P00183	85.82	60.0	405.0	DB04501	experimental	Camphane	C[C@@]12CCC(C1(C)C)CC2
507	sp|P9WPP5|CP123_MY	P9WPP7	92.29	23.0	394.0	DB02721	experimental	4-Iodopyrazole	Ic1c[nH]nc1
508	sp|P9WPP5|CP123_MY	P9WPP7	92.29	23.0	394.0	DB08761	experimental	(3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine-2,5-dione	Oc1ccc(cc1)C[C@@H]2NC(=O)[C@@H](NC2=O)Cc3ccc(O)cc3
509	sp|P9WPP5|CP123_MY	O31440	87.56	44.0	396.0	DB04257	experimental	Palmitoleic Acid	CCCCCC/C=C\CCCCCCCC(=O)O
510	sp|P9WPP5|CP123_MY	Q9NR63	83.58	125.0	461.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
511	sp|P9WPP5|CP123_MY	Q6V0L0	87.31	130.0	481.0	DB00523	approved; investigational	Alitretinoin	OC(=O)/C=C(\C)/C=C/C=C(/C)\C=C\C(C1(C)C)=C(C)CCC1
512	sp|P9WPP5|CP123_MY	Q6V0L0	87.31	130.0	481.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
513	sp|P9WPP5|CP123_MY	P11712	92.29	111.0	482.0	DB03317	experimental	Ferroheme C	[Fe-2]123[N+]4=C5C=C6[N+]1=C(C(C)=C6C(C)S)C=C7[N+]2=C(C(=C7C)CCC(=O)O)C=C8[N+]3=C(C=C4C(=C5C)C(C)S)C(C)=C8CCC(=O)O
514	sp|P9WPP5|CP123_MY	P11712	92.29	111.0	482.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
515	sp|P9WPP5|CP123_MY	P11712	92.29	111.0	482.0	DB12319	investigational; withdrawn	Benzbromarone	c1cccc(c12)c(c(o2)CC)C(=O)c3cc(Br)c(O)c(Br)c3
516	sp|P9WPP5|CP123_MY	P33261	92.04	112.0	482.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
517	sp|P9WPP5|CP123_MY	P33261	92.04	112.0	482.0	DB12319	investigational; withdrawn	Benzbromarone	c1cccc(c12)c(c(o2)CC)C(=O)c3cc(Br)c(O)c(Br)c3
518	sp|P9WPP5|CP123_MY	P11509	101.49	77.0	485.0	DB04665	experimental	Coumarin	c1cc(=O)oc(c12)cccc2
519	sp|P9WPP5|CP123_MY	P11509	101.49	77.0	485.0	DB07609	experimental	N,N-DIMETHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	CN(C)Cc1ccc(o1)-c2cccnc2
520	sp|P9WPP5|CP123_MY	P11509	101.49	77.0	485.0	DB07617	experimental	N-METHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	CNCc1ccc(o1)-c2cccnc2
521	sp|P9WPP5|CP123_MY	P11509	101.49	77.0	485.0	DB07621	experimental	(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	NCc1ccc(o1)-c2cccnc2
522	sp|P9WPP5|CP123_MY	P11509	101.49	77.0	485.0	DB07623	experimental	4,4'-DIPYRIDYL DISULFIDE	c1cnccc1SSc2ccncc2
523	sp|P9WPP5|CP123_MY	P33260	92.04	112.0	482.0	DB07670	experimental	N,4-Dimethyl-N-(1-phenyl-1H-pyrazol-5-yl)benzenesulfonamide	Cc1ccc(cc1)S(=O)(=O)N(C)c2ccnn2-c3ccccc3
524	sp|P9WPP5|CP123_MY	O43174	90.8	125.0	490.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
525	sp|P9WPP5|CP123_MY	O43174	90.8	125.0	490.0	DB13083	investigational	Talarozole	c1ncnn1C(C(CC)CC)c2ccc(cc2)Nc(s3)nc(c34)cccc4
526	sp|P9WPP5|CP123_MY	P20813	92.54	115.0	487.0	DB02974	experimental	4-(4-Chlorophenyl)Imidazole	Clc1ccc(cc1)-c2cnc[nH]2
527	sp|P9WPP5|CP123_MY	P20813	92.54	115.0	487.0	DB04664	experimental	Cyclohexyl-pentyl-maltoside	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@@H]2CO)OCCCCCC3CCCCC3
528	sp|P9WPP5|CP123_MY	P20813	92.54	115.0	487.0	DB04794	approved; investigational	Bifonazole	c1ccccc1C(n2ccnc2)c3ccc(cc3)-c4ccccc4
529	sp|P9WPP5|CP123_MY	P20813	92.54	115.0	487.0	DB08369	experimental	1-(biphenyl-4-ylmethyl)-1H-imidazole	c1cncn1Cc2ccc(cc2)-c3ccccc3
530	sp|P9WPP5|CP123_MY	O15528	88.81	123.0	480.0	DB01436	approved; nutraceutical	Alfacalcidol	CC(C)CCC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)/C(CCC2)=C/C=C3/C[C@@H](O)C[C@H](O)C3=C
531	sp|P9WPP5|CP123_MY	P14779	85.07	97.0	439.0	DB03440	experimental	N-hexadecanoylglycine	CCCCCCCCCCCCCCCC(=O)NCC(=O)O
532	sp|P9WPP5|CP123_MY	P14779	85.07	97.0	439.0	DB04257	experimental	Palmitoleic Acid	CCCCCC/C=C\CCCCCCCC(=O)O
533	sp|P9WPP5|CP123_MY	P14779	85.07	97.0	439.0	DB08086	experimental	N-[12-(1H-imidazol-1-yl)dodecanoyl]-L-leucine	CC(C)C[C@@H](C(=O)O)NC(=O)CCCCCCCCCCCn1ccnc1
534	sp|P9WPP5|CP123_MY	P08686	80.35	130.0	453.0	DB01026	approved; investigational	Ketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OCC(CO3)OC3(Cn4ccnc4)c5ccc(Cl)cc5Cl
535	sp|P9WPP5|CP123_MY	P10614	85.07	149.0	491.0	DB06890	experimental	(2R)-2-PHENYL-N-PYRIDIN-4-YLBUTANAMIDE	c1ccccc1[C@@H](CC)C(=O)Nc2ccncc2
536	sp|P9WPP5|CP123_MY	P10614	85.07	149.0	491.0	DB07560	experimental	N-[(1S)-2-methyl-1-(pyridin-4-ylcarbamoyl)propyl]cyclohexanecarboxamide	c1cnccc1NC(=O)[C@H](C(C)C)NC(=O)C2CCCCC2
537	sp|P9WPP5|CP123_MY	P10614	85.07	149.0	491.0	DB07568	experimental	(2S)-2-[(2,1,3-BENZOTHIADIAZOL-4-YLSULFONYL)AMINO]-2-PHENYL-N-PYRIDIN-4-YLACETAMIDE	n1snc(c12)cccc2S(=O)(=O)N[C@@H](c3ccccc3)C(=O)Nc4ccncc4
538	sp|P9WPP5|CP123_MY	P10614	85.07	149.0	491.0	DB07569	experimental	CIS-4-METHYL-N-[(1S)-3-(METHYLSULFANYL)-1-(PYRIDIN-4-YLCARBAMOYL)PROPYL]CYCLOHEXANECARBOXAMIDE	c1cnccc1NC(=O)[C@H](CCSC)NC(=O)[C@@H]2CC[C@H](C)CC2
539	sp|P9WPP5|CP123_MY	P10614	85.07	149.0	491.0	DB07572	experimental	3-{[(4-methylphenyl)sulfonyl]amino}propyl pyridin-4-ylcarbamate	Cc1ccc(cc1)S(=O)(=O)NCCCOC(=O)Nc2ccncc2
540	sp|P9WPP5|CP123_MY	P10614	85.07	149.0	491.0	DB07635	experimental	4,4'-Dihydroxybenzophenone	Oc1ccc(cc1)C(=O)c2ccc(O)cc2
541	sp|P9WPP5|CP123_MY	P50859	87.31	143.0	494.0	DB01026	approved; investigational	Ketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OCC(CO3)OC3(Cn4ccnc4)c5ccc(Cl)cc5Cl
542	sp|P9WPP5|CP123_MY	P50859	87.31	143.0	494.0	DB01167	approved; investigational	Itraconazole	CCC(C)n1ncn(c1=O)-c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@@H](CO5)O[C@@]5(Cn6cncn6)c7ccc(Cl)cc7Cl
543	sp|P9WPP5|CP123_MY	P50859	87.31	143.0	494.0	DB09040	approved	Efinaconazole	C=C1CCN(CC1)[C@H](C)[C@](O)(Cn2cncn2)c3c(F)cc(F)cc3
544	sp|P9WPP5|CP123_MY	P50859	87.31	143.0	494.0	DB11633	approved; investigational	Isavuconazole	c1ncnn1C[C@](O)(c2c(F)ccc(F)c2)[C@@H](C)c3nc(cs3)-c4ccc(C#N)cc4
545	sp|P9WPP5|CP123_MY	Q16850	79.85	149.0	470.0	DB01007	approved	Tioconazole	c1nccn1CC(c(c(Cl)c2)ccc2Cl)OCc3c(Cl)scc3
546	sp|P9WPP5|CP123_MY	Q16850	79.85	149.0	470.0	DB01167	approved; investigational	Itraconazole	CCC(C)n1ncn(c1=O)-c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@@H](CO5)O[C@@]5(Cn6cncn6)c7ccc(Cl)cc7Cl
547	sp|P9WPP5|CP123_MY	Q16850	79.85	149.0	470.0	DB05667	investigational	Levoketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OC[C@H](CO3)O[C@]3(Cn4ccnc4)c5ccc(Cl)cc5Cl
548	sp|P9WPP5|CP123_MY	Q16850	79.85	149.0	470.0	DB07705	experimental	(S)-econazole	Clc1ccc(cc1)CO[C@H](Cn2ccnc2)c3c(Cl)cc(Cl)cc3
549	sp|P9WPP5|CP123_MY	P11511	83.08	135.0	469.0	DB00184	approved	Nicotine	CN1CCC[C@H]1c2cnccc2
550	sp|P9WPP5|CP123_MY	P11511	83.08	135.0	469.0	DB00357	approved; investigational	Aminoglutethimide	Nc1ccc(cc1)C2(CC)CCC(=O)NC2=O
551	sp|P9WPP5|CP123_MY	P11511	83.08	135.0	469.0	DB00655	approved	Estrone	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)cc4
552	sp|P9WPP5|CP123_MY	P11511	83.08	135.0	469.0	DB00894	approved; investigational	Testolactone	C1=CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2CC[C@@]4(C)[C@H]3CCC(O4)=O
553	sp|P9WPP5|CP123_MY	P11511	83.08	135.0	469.0	DB00990	approved; investigational	Exemestane	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(C(C3)=C)=CC(=O)C=C4
554	sp|P9WPP5|CP123_MY	P11511	83.08	135.0	469.0	DB01006	approved; investigational	Letrozole	N#Cc1ccc(cc1)C(n2cncn2)c3ccc(C#N)cc3
555	sp|P9WPP5|CP123_MY	P11511	83.08	135.0	469.0	DB01217	approved; investigational	Anastrozole	N#CC(C)(C)c1cc(C(C)(C)C#N)cc(c1)Cn2cncn2
556	sp|P9WPP5|CP123_MY	P11511	83.08	135.0	469.0	DB02342	investigational	2-Methoxyestradiol	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)c(c4)OC
557	sp|P9WPP5|CP123_MY	P11511	83.08	135.0	469.0	DB03467	experimental	Naringenin	Oc1ccc(cc1)[C@@H](O2)CC(=O)c(c23)c(O)cc(c3)O
558	sp|P9WPP5|CP123_MY	P11511	83.08	135.0	469.0	DB04539	experimental	Glyphosate	OC(=O)C[NH2+]CP(=O)(O)O
559	sp|P9WPP5|CP123_MY	P11511	83.08	135.0	469.0	DB05749	investigational	MPI-674	 
560	sp|P9WPP5|CP123_MY	Q746J6	70.65	84.0	368.0	DB01694	experimental	D-tartaric acid	OC(=O)[C@@H](O)[C@H](O)C(=O)O
561	sp|P9WPV5|ATPF_MYC	P0ABA0	78.36	10.0	144.0	DB03091	experimental	Isoglutamine	NC(=O)[C@@H](N)CCC(=O)O
562	sp|P9WQ81|BIOA_MYC	P12995	94.74	5.0	419.0	DB02274	experimental	7-Keto-8-Aminopelargonic Acid	C[C@H](N)C(=O)CCCCCC(=O)O
563	sp|P9WQ81|BIOA_MYC	P12995	94.74	5.0	419.0	DB02725	experimental	2-Amino-4-(4-Amino-Cyclohexa-2,5-Dienyl)-Butyric Acid	OC(=O)[C@@H](N)CC[C@H]1C=CC(N)C=C1
564	sp|P9WQ81|BIOA_MYC	P12995	94.74	5.0	419.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
565	sp|P9WQ81|BIOA_MYC	Q6LFH8	87.19	28.0	409.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
566	sp|P9WQ81|BIOA_MYC	P04181	86.73	56.0	435.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
567	sp|P9WQ81|BIOA_MYC	P04181	86.73	56.0	435.0	DB00129	approved; nutraceutical	Ornithine	NCCC[C@H](N)C(=O)O
568	sp|P9WQ81|BIOA_MYC	P04181	86.73	56.0	435.0	DB02054	experimental	Gabaculine	Nc1cccc(c1)C(=O)O
569	sp|P9WQ81|BIOA_MYC	P04181	86.73	56.0	435.0	DB02821	experimental	Canaline	NOCC[C@H](N)C(=O)O
570	sp|P9WQ81|BIOA_MYC	P22256	90.62	21.0	417.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
571	sp|P9WQ81|BIOA_MYC	P22256	90.62	21.0	417.0	DB02783	experimental	4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate	Cc1ncc(COP(=O)(O)O)c(c1O)CNOCC(=O)O
572	sp|P9WQ81|BIOA_MYC	Q8IUZ5	83.3	29.0	393.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
573	sp|P9WQ81|BIOA_MYC	Q8IUZ5	83.3	29.0	393.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
574	sp|P9WQ81|BIOA_MYC	P16932	90.62	23.0	419.0	DB02038	experimental	D-[3-hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl]-N,O-cycloserylamide	Cc1ncc(COP(=O)(O)O)c(c1O)CN[C@@H]2CONC2=O
575	sp|P9WQ81|BIOA_MYC	P16932	90.62	23.0	419.0	DB02849	experimental	N-Pyridoxyl-1-Amino-Cyclopropanecarboxylic Acid-5-Monophosphate	Cc1ncc(COP(=O)(O)O)c(c1O)CNC2(CC2)C(=O)O
576	sp|P9WQ81|BIOA_MYC	P16932	90.62	23.0	419.0	DB03787	experimental	(5-Hydroxy-6-methyl-4-{[(E)-(3-oxo-1,2-oxazolidin-4-ylidene)amino]methyl}-3-pyridinyl)methyl dihydrogen phosphate	Cc1ncc(COP(=O)(O)O)c(c1O)C/N=C2\CONC2=O
577	sp|P9WQ81|BIOA_MYC	P16932	90.62	23.0	419.0	DB04241	experimental	N-Pyridoxyl-2-Methylalanine-5-Phosphate	Cc1ncc(COP(=O)(O)O)c(c1O)CNC(C)(C)C(=O)O
578	sp|P9WQ81|BIOA_MYC	Q9BYV1	95.65	77.0	495.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
579	sp|P9WQ81|BIOA_MYC	Q9BYV1	95.65	77.0	495.0	DB00119	approved; investigational; nutraceutical	Pyruvic acid	CC(=O)C(=O)O
580	sp|P9WQ81|BIOA_MYC	Q9BYV1	95.65	77.0	495.0	DB00145	approved; nutraceutical; vet_approved	Glycine	NCC(=O)O
581	sp|P9WQ81|BIOA_MYC	Q9BYV1	95.65	77.0	495.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
582	sp|P9WQ81|BIOA_MYC	P24630	72.08	34.0	349.0	DB02054	experimental	Gabaculine	Nc1cccc(c1)C(=O)O
583	sp|P9WQ81|BIOA_MYC	P24630	72.08	34.0	349.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
584	sp|P9WQ81|BIOA_MYC	P9WQ77	91.76	40.0	441.0	DB08071	experimental	(2S)-1-methyl-2-[(2S,4R)-2-methyl-4-phenylpentyl]piperidine	CN1CCCC[C@H]1C[C@@H](C)C[C@@H](C)c2ccccc2
585	sp|P9WQ81|BIOA_MYC	P80404	92.22	79.0	482.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
586	sp|P9WQ81|BIOA_MYC	P80404	92.22	79.0	482.0	DB00119	approved; investigational; nutraceutical	Pyruvic acid	CC(=O)C(=O)O
587	sp|P9WQ81|BIOA_MYC	P80404	92.22	79.0	482.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
588	sp|P9WQ81|BIOA_MYC	P80404	92.22	79.0	482.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
589	sp|P9WQ81|BIOA_MYC	P80404	92.22	79.0	482.0	DB00780	approved	Phenelzine	NNCCc1ccccc1
590	sp|P9WQ81|BIOA_MYC	P80404	92.22	79.0	482.0	DB01080	approved	Vigabatrin	C=CC(N)CCC(=O)O
591	sp|P9WQ81|BIOA_MYC	P80404	92.22	79.0	482.0	DB01699	experimental	(4e)-4-Aminohex-4-Enoic Acid	C/C=C(/N)CCC(=O)O
592	sp|P9WQ81|BIOA_MYC	P80404	92.22	79.0	482.0	DB04235	experimental	4-Amino Hexanoic Acid	CC[C@@H](N)CCC(=O)O
593	sp|P9WPH3|CDD_MYCT	P0ABF6	83.46	60.0	171.0	DB03068	experimental	Zebularine	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cccnc2=O
594	sp|P9WPH3|CDD_MYCT	P0ABF6	83.46	60.0	171.0	DB04385	experimental	3-Deazacytidine	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2ccc(N)cc2=O
595	sp|P9WPH3|CDD_MYCT	P19079	96.99	6.0	135.0	DB03562	experimental	Tetrahydrodeoxyuridine	O=C1NC(=O)N(CC1)C2C[C@H](O)[C@H](O2)CO
596	sp|P9WPH3|CDD_MYCT	P32320	92.48	21.0	144.0	DB03185	experimental	1-Beta-Ribofuranosyl-1,3-Diazepinone	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2C=CC=CNC2=O
597	sp|P9WPH3|CDD_MYCT	P0C2P0	82.71	16.0	126.0	DB04649	experimental	TETRAHEDRAL INTERMEDIATE OF BLASTICIDIN S	NC(=N)N(C)CC[C@H](N)CC(=O)N[C@H]1C=C[C@@H](O[C@@H]1C(=O)O)N(C=C2)C(=O)N[C@]2(N)O
598	sp|I6Y3Q0|CHSE5_MY	Q72JJ3	100.54	3.0	378.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
599	sp|I6Y3Q0|CHSE5_MY	Q06319	100.54	1.0	376.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
600	sp|I6Y3Q0|CHSE5_MY	Q06319	100.54	1.0	376.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
601	sp|I6Y3Q0|CHSE5_MY	P16219	100.0	33.0	406.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
602	sp|I6Y3Q0|CHSE5_MY	P16219	100.0	33.0	406.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
603	sp|I6Y3Q0|CHSE5_MY	P16219	100.0	33.0	406.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
604	sp|I6Y3Q0|CHSE5_MY	P45954	100.0	55.0	428.0	DB00167	investigational; nutraceutical	Isoleucine	CC[C@H](C)[C@H](N)C(=O)O
605	sp|I6Y3Q0|CHSE5_MY	P45954	100.0	55.0	428.0	DB00313	approved; investigational	Valproic acid	CCCC(C(=O)O)CCC
606	sp|I6Y3Q0|CHSE5_MY	Q9UKU7	99.2	41.0	411.0	DB01675	experimental	Methacrylyl-Coenzyme A	CC(=C)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
607	sp|I6Y3Q0|CHSE5_MY	Q9UKU7	99.2	41.0	411.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
608	sp|I6Y3Q0|CHSE5_MY	P11310	100.54	39.0	414.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
609	sp|I6Y3Q0|CHSE5_MY	P11310	100.54	39.0	414.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
610	sp|I6Y3Q0|CHSE5_MY	P11310	100.54	39.0	414.0	DB03415	experimental	3-thiaoctanoyl-CoA	CCCCCSCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
611	sp|I6Y3Q0|CHSE5_MY	P26440	100.54	42.0	417.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
612	sp|I6Y3Q0|CHSE5_MY	P26440	100.54	42.0	417.0	DB04036	experimental	Coenzyme A persulfide	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSS
613	sp|I6Y3Q0|CHSE5_MY	Q3JP94	100.0	14.0	387.0	DB08685	experimental	1-(1,4-dimethyl-1,2,3,4-tetrahydroquinoxalin-6-yl)methanamine	CN1CCN(C)c(c12)cc(cc2)CN
614	sp|I6Y3Q0|CHSE5_MY	Q92947	99.2	59.0	429.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
615	sp|I6Y3Q0|CHSE5_MY	Q92947	99.2	59.0	429.0	DB03245	experimental	S-4-Nitrobutyryl-CoA	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCC[N+]([O-])=O
616	sp|I6Y3Q0|CHSE5_MY	Q9KIE5	92.76	15.0	361.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
617	sp|I6Y3Q0|CHSE5_MY	Q15067	89.81	99.0	434.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
618	sp|I6Y3Q0|CHSE5_MY	Q15067	89.81	99.0	434.0	DB07930	experimental	(3R)-3-HYDROXYDODECANOIC ACID	OC(=O)C[C@H](O)CCCCCCCCC
619	sp|P9WQA3|ALF_MYCT	P0AB71	99.13	14.0	355.0	DB03026	experimental	Phosphoglycolohydroxamic Acid	ONC(=O)COP(=O)(O)O
620	sp|P9WQA3|ALF_MYCT	P0AB74	75.58	9.0	269.0	DB03026	experimental	Phosphoglycolohydroxamic Acid	ONC(=O)COP(=O)(O)O
621	sp|P9WPU9|ATPG_MYC	P36542	88.85	26.0	297.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
622	sp|P9WPU9|ATPG_MYC	P36542	88.85	26.0	297.0	DB07384	experimental	1-ACETYL-2-CARBOXYPIPERIDINE	OC(=O)[C@@H]1CCCCN1C(=O)C
623	sp|P9WPU9|ATPG_MYC	P36542	88.85	26.0	297.0	DB07394	experimental	AUROVERTIN B	C[C@@]12O[C@H](CC)[C@@](C)([C@H]1OC(=O)C)O[C@H]([C@@H]2O)/C=C/C=C/C=C/c3c(C)c(OC)cc(=O)o3
624	sp|P9WPU9|ATPG_MYC	P36542	88.85	26.0	297.0	DB08399	experimental	Piceatannol	Oc1cc(cc(O)c1)/C=C/c2ccc(O)c(O)c2
625	sp|P9WPU9|ATPG_MYC	P36542	88.85	26.0	297.0	DB08629	experimental	N1-(2-AMINO-4-METHYLPENTYL)OCTAHYDRO-PYRROLO[1,2-A] PYRIMIDINE	CC(C)C[C@H](N)CN1CCCN([C@H]12)CCC2
626	sp|P9WPQ3|BCCA_MYC	Q96RQ3	101.68	49.0	714.0	DB00121	approved; investigational; nutraceutical	Biotin	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC(=O)O
627	sp|P9WPQ3|BCCA_MYC	P05165	101.53	63.0	727.0	DB00121	approved; investigational; nutraceutical	Biotin	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC(=O)O
628	sp|P9WPQ3|BCCA_MYC	Q13085	107.03	118.0	818.0	DB00121	approved; investigational; nutraceutical	Biotin	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC(=O)O
629	sp|P9WPQ3|BCCA_MYC	O00763	107.19	260.0	961.0	DB00121	approved; investigational; nutraceutical	Biotin	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC(=O)O
630	sp|P9WPQ3|BCCA_MYC	O00763	107.19	260.0	961.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
631	sp|P9WPQ3|BCCA_MYC	O00763	107.19	260.0	961.0	DB02859	experimental	Soraphen A	CO[C@@H]([C@]12O)[C@@H](O)[C@H](C)[C@@H](O1)[C@@H](C)/C=C/[C@@H](OC)[C@@H](OC)CCCC[C@H](OC(=O)[C@H]2C)c3ccccc3
632	sp|P9WPQ3|BCCA_MYC	O00763	107.19	260.0	961.0	DB03781	experimental	2-[4-(2,4-Dichlorophenoxy)Phenoxy]Propanoic Acid	OC(=O)[C@@H](C)Oc1ccc(cc1)Oc2ccc(Cl)cc2Cl
633	sp|P9WPQ3|BCCA_MYC	O00763	107.19	260.0	961.0	DB07870	experimental	Haloxyfop-P	OC(=O)[C@@H](C)Oc1ccc(cc1)Oc2c(Cl)cc(cn2)C(F)(F)F
634	sp|P9WPQ3|BCCA_MYC	A0A0H3JRU9	70.34	4.0	464.0	DB07497	experimental	5-(HEXAHYDRO-2-OXO-1H-THIENO[3,4-D]IMIDAZOL-6-YL)PENTANAL	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC=O
635	sp|P9WPQ3|BCCA_MYC	P11498	70.18	37.0	496.0	DB00119	approved; investigational; nutraceutical	Pyruvic acid	CC(=O)C(=O)O
636	sp|P9WPQ3|BCCA_MYC	P11498	70.18	37.0	496.0	DB00121	approved; investigational; nutraceutical	Biotin	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC(=O)O
637	sp|P9WPQ3|BCCA_MYC	P11498	70.18	37.0	496.0	DB07497	experimental	5-(HEXAHYDRO-2-OXO-1H-THIENO[3,4-D]IMIDAZOL-6-YL)PENTANAL	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC=O
638	sp|P9WPK3|CARB_MYC	P31327	95.96	417.0	1487.0	DB06775	approved	Carglumic acid	NC(=O)N[C@H](C(=O)O)CCC(=O)O
639	sp|P9WPK3|CARB_MYC	P27708	93.99	394.0	1442.0	DB03459	experimental	Sparfosic acid	OP(=O)(O)CC(=O)N[C@H](C(=O)O)CC(=O)O
640	sp|P9WPD1|CLPB_MYC	Q9RA63	99.06	2.0	842.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
641	sp|P9WPN9|CP126_MY	Q83WG3	93.24	2.0	388.0	DB06955	experimental	3,4-bis(7-chloro-1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid	c1ccc(Cl)c(c12)[nH]cc2-c3c(C(=O)O)[nH]c(C(=O)O)c3-c4c[nH]c(c45)c(Cl)ccc5
642	sp|P9WPN9|CP126_MY	Q83WG3	93.24	2.0	388.0	DB07588	experimental	3,4-DI-1H-INDOL-3-YL-1H-PYRROLE-2,5-DICARBOXYLIC ACID	c1cccc(c12)[nH]cc2-c3c(C(=O)O)[nH]c(C(=O)O)c3-c4c[nH]c(c45)cccc5
643	sp|P9WPN9|CP126_MY	P53554	90.34	14.0	388.0	DB04450	experimental	Heptyl 1-Thiohexopyranoside	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)SCCCCCCC
644	sp|P9WPN9|CP126_MY	Q00441	94.2	14.0	404.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
645	sp|P9WPN9|CP126_MY	Q00441	94.2	14.0	404.0	DB03369	experimental	9-Aminophenanthrene	c1cccc(c12)c3c(cc2N)cccc3
646	sp|P9WPN9|CP126_MY	Q00441	94.2	14.0	404.0	DB04070	experimental	6-Deoxyerythronolide B	C[C@@H]1C[C@H](C)[C@H](O)[C@@H](C)[C@H](O)[C@@H](C)C(=O)O[C@H](CC)[C@H](C)[C@H](O)[C@@H](C)C1=O
647	sp|P9WPN9|CP126_MY	P9WPN5	88.16	18.0	383.0	DB07705	experimental	(S)-econazole	Clc1ccc(cc1)CO[C@H](Cn2ccnc2)c3c(Cl)cc(Cl)cc3
648	sp|P9WPN9|CP126_MY	P9WPN5	88.16	18.0	383.0	DB07971	experimental	5-AMINO-2-{4-[(4-AMINOPHENYL)SULFANYL]PHENYL}-1H-ISOINDOLE-1,3(2H)-DIONE	Nc1ccc(cc1)Sc2ccc(cc2)N(C3=O)C(=O)c(c34)ccc(c4)N
649	sp|P9WPN9|CP126_MY	P9WPN5	88.16	18.0	383.0	DB07972	experimental	1-(3-METHYLPHENYL)-1H-BENZIMIDAZOL-5-AMINE	Cc1cccc(c1)-n2cnc(c23)cc(N)cc3
650	sp|P9WPN9|CP126_MY	Q9FCA6	86.47	26.0	384.0	DB02175	experimental	Malonic acid	OC(=O)CC(=O)O
651	sp|P9WPN9|CP126_MY	Q9FCA6	86.47	26.0	384.0	DB02521	experimental	Flaviolin	Oc1cc(O)cc(c12)C(=O)C(O)=CC2=O
652	sp|P9WPN9|CP126_MY	Q9FCA6	86.47	26.0	384.0	DB03254	experimental	4-Phenyl-1h-Imidazole	[nH]1cncc1-c2ccccc2
653	sp|P9WPN9|CP126_MY	Q9FCA6	86.47	26.0	384.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
654	sp|P9WPN9|CP126_MY	P00183	83.57	59.0	405.0	DB01011	approved; investigational	Metyrapone	c1ccncc1C(C)(C)C(=O)c2cnccc2
655	sp|P9WPN9|CP126_MY	P00183	83.57	59.0	405.0	DB01663	experimental	lambda-bis(2,2'-bipyridine)-(5-methyl-2-2'-bipyridine)-C9-adamantane ruthenium (II)	C1=CC=CN2C1=C(C=CC=C3)N3[Ru+2]245(N6C(C=CC=C6)=C7N4C=CC=C7)N8C(=C9N5C=CC(C)=C9)C=C(C=C8)CCCCCCCCC(=O)N[C@@H]([C@H]12)[C@H]3C[C@@H](C1)C[C@@H](C2)C3
656	sp|P9WPN9|CP126_MY	P00183	83.57	59.0	405.0	DB01703	experimental	N-(2-ferrocenylethyl)maleimide	O=C1C=CC(=O)N1CCC2(C3C4C5C26)[Fe]13456789C2C7C8C9C12
657	sp|P9WPN9|CP126_MY	P00183	83.57	59.0	405.0	DB01744	approved	Camphor	C[C@]12C(=O)C[C@H](C1(C)C)CC2
658	sp|P9WPN9|CP126_MY	P00183	83.57	59.0	405.0	DB01826	experimental	N-Butyl Isocyanide	CCCC[N+]#[C-]
659	sp|P9WPN9|CP126_MY	P00183	83.57	59.0	405.0	DB02125	experimental	Adamantanone	O=C([C@H]12)[C@H]3C[C@@H](C1)C[C@@H](C2)C3
660	sp|P9WPN9|CP126_MY	P00183	83.57	59.0	405.0	DB02617	experimental	1-(N-Imidazolyl)-2-Hydroxy-2-(2,3-Dichlorophenyl)Octane	CCCCCC[C@](O)(Cn1ccnc1)c2ccc(Cl)cc2Cl
661	sp|P9WPN9|CP126_MY	P00183	83.57	59.0	405.0	DB02817	experimental	5-Exo-Hydroxycamphor	C[C@]12C[C@@H](O)[C@H](CC1=O)C2(C)C
662	sp|P9WPN9|CP126_MY	P00183	83.57	59.0	405.0	DB02851	experimental	Thiocamphor	C[C@]12C(=S)C[C@H](C1(C)C)CC2
663	sp|P9WPN9|CP126_MY	P00183	83.57	59.0	405.0	DB03031	experimental	Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Octyl-Amide	CN(C)c1cccc(c12)c(ccc2)S(=O)(=O)NCCCCCCCCNC(=O)C34CC5CC(C3)CC(C5)C4
664	sp|P9WPN9|CP126_MY	P00183	83.57	59.0	405.0	DB03540	experimental	Norcamphor	[C@H]12CC[C@H](C1)C(=O)C2
665	sp|P9WPN9|CP126_MY	P00183	83.57	59.0	405.0	DB03627	experimental	Adamantane	C12CC3CC(C1)CC(C3)C2
666	sp|P9WPN9|CP126_MY	P00183	83.57	59.0	405.0	DB03836	experimental	1,3,5-trichlorobenzene	Clc1cc(Cl)cc(Cl)c1
667	sp|P9WPN9|CP126_MY	P00183	83.57	59.0	405.0	DB04032	experimental	Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Butyl-Amide	CN(C)c1cccc(c12)c(ccc2)S(=O)(=O)NCCCCNC(=O)C34CC5CC(C3)CC(C5)C4
668	sp|P9WPN9|CP126_MY	P00183	83.57	59.0	405.0	DB04501	experimental	Camphane	C[C@@]12CCC(C1(C)C)CC2
669	sp|P9WPN9|CP126_MY	P9WPP7	85.27	23.0	376.0	DB02721	experimental	4-Iodopyrazole	Ic1c[nH]nc1
670	sp|P9WPN9|CP126_MY	P9WPP7	85.27	23.0	376.0	DB08761	experimental	(3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine-2,5-dione	Oc1ccc(cc1)C[C@@H]2NC(=O)[C@@H](NC2=O)Cc3ccc(O)cc3
671	sp|P9WPN9|CP126_MY	O31440	81.88	45.0	384.0	DB04257	experimental	Palmitoleic Acid	CCCCCC/C=C\CCCCCCCC(=O)O
672	sp|P9WPN9|CP126_MY	Q9NR63	89.37	120.0	490.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
673	sp|P9WPN9|CP126_MY	Q6V0L0	92.27	122.0	504.0	DB00523	approved; investigational	Alitretinoin	OC(=O)/C=C(\C)/C=C/C=C(/C)\C=C\C(C1(C)C)=C(C)CCC1
674	sp|P9WPN9|CP126_MY	Q6V0L0	92.27	122.0	504.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
675	sp|P9WPN9|CP126_MY	O43174	88.16	125.0	490.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
676	sp|P9WPN9|CP126_MY	O43174	88.16	125.0	490.0	DB13083	investigational	Talarozole	c1ncnn1C(C(CC)CC)c2ccc(cc2)Nc(s3)nc(c34)cccc4
677	sp|P9WPN9|CP126_MY	P20813	83.57	135.0	481.0	DB02974	experimental	4-(4-Chlorophenyl)Imidazole	Clc1ccc(cc1)-c2cnc[nH]2
678	sp|P9WPN9|CP126_MY	P20813	83.57	135.0	481.0	DB04664	experimental	Cyclohexyl-pentyl-maltoside	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@@H]2CO)OCCCCCC3CCCCC3
679	sp|P9WPN9|CP126_MY	P20813	83.57	135.0	481.0	DB04794	approved; investigational	Bifonazole	c1ccccc1C(n2ccnc2)c3ccc(cc3)-c4ccccc4
680	sp|P9WPN9|CP126_MY	P20813	83.57	135.0	481.0	DB08369	experimental	1-(biphenyl-4-ylmethyl)-1H-imidazole	c1cncn1Cc2ccc(cc2)-c3ccccc3
681	sp|P9WPN9|CP126_MY	Q16850	76.33	152.0	468.0	DB01007	approved	Tioconazole	c1nccn1CC(c(c(Cl)c2)ccc2Cl)OCc3c(Cl)scc3
682	sp|P9WPN9|CP126_MY	Q16850	76.33	152.0	468.0	DB01167	approved; investigational	Itraconazole	CCC(C)n1ncn(c1=O)-c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@@H](CO5)O[C@@]5(Cn6cncn6)c7ccc(Cl)cc7Cl
683	sp|P9WPN9|CP126_MY	Q16850	76.33	152.0	468.0	DB05667	investigational	Levoketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OC[C@H](CO3)O[C@]3(Cn4ccnc4)c5ccc(Cl)cc5Cl
684	sp|P9WPN9|CP126_MY	Q16850	76.33	152.0	468.0	DB07705	experimental	(S)-econazole	Clc1ccc(cc1)CO[C@H](Cn2ccnc2)c3c(Cl)cc(Cl)cc3
685	sp|P9WQB9|ADHD_MYC	P07327	99.18	9.0	374.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
686	sp|P9WQB9|ADHD_MYC	P07327	99.18	9.0	374.0	DB01213	approved; vet_approved	Fomepizole	Cc1c[nH]nc1
687	sp|P9WQB9|ADHD_MYC	P07327	99.18	9.0	374.0	DB02721	experimental	4-Iodopyrazole	Ic1c[nH]nc1
688	sp|P9WQB9|ADHD_MYC	P07327	99.18	9.0	374.0	DB04065	experimental	N-Cyclopentyl-N-Cyclobutylformamide	C1CCC1N(C=O)C2CCCC2
689	sp|P9WQB9|ADHD_MYC	P00325	98.91	9.0	373.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
690	sp|P9WQB9|ADHD_MYC	P00325	98.91	9.0	373.0	DB01213	approved; vet_approved	Fomepizole	Cc1c[nH]nc1
691	sp|P9WQB9|ADHD_MYC	P00325	98.91	9.0	373.0	DB02481	experimental	N-Benzylformamide	O=CNCc1ccccc1
692	sp|P9WQB9|ADHD_MYC	P00325	98.91	9.0	373.0	DB02721	experimental	4-Iodopyrazole	Ic1c[nH]nc1
693	sp|P9WQB9|ADHD_MYC	P00325	98.91	9.0	373.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
694	sp|P9WQB9|ADHD_MYC	P00325	98.91	9.0	373.0	DB03703	experimental	Cyclohexanol	OC1CCCCC1
695	sp|P9WQB9|ADHD_MYC	P00325	98.91	9.0	373.0	DB04105	experimental	N-Heptylformamide	CCCCCCCNC=O
696	sp|P9WQB9|ADHD_MYC	P00325	98.91	9.0	373.0	DB09462	approved; investigational	Glycerin	OCC(O)CO
697	sp|P9WQB9|ADHD_MYC	P00326	98.91	9.0	373.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
698	sp|P9WQB9|ADHD_MYC	P00326	98.91	9.0	373.0	DB01213	approved; vet_approved	Fomepizole	Cc1c[nH]nc1
699	sp|P9WQB9|ADHD_MYC	P00326	98.91	9.0	373.0	DB01711	experimental	2,3,4,5,6-Pentafluorobenzyl Alcohol	OCc1c(F)c(F)c(F)c(F)c1F
700	sp|P9WQB9|ADHD_MYC	P00326	98.91	9.0	373.0	DB02131	experimental	N-1-methylheptylformamide	O=CN[C@H](C)CCCCCC
701	sp|P9WQB9|ADHD_MYC	P00326	98.91	9.0	373.0	DB02249	experimental	2-Ethoxyethanol	CCOCCO
702	sp|P9WQB9|ADHD_MYC	P00326	98.91	9.0	373.0	DB02659	approved	Cholic Acid	OC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](C[C@@H]2O)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
703	sp|P9WQB9|ADHD_MYC	P00326	98.91	9.0	373.0	DB02721	experimental	4-Iodopyrazole	Ic1c[nH]nc1
704	sp|P9WQB9|ADHD_MYC	P00326	98.91	9.0	373.0	DB02757	experimental	Pyrazole	[nH]1cccn1
705	sp|P9WQB9|ADHD_MYC	P00326	98.91	9.0	373.0	DB02822	experimental	Para-Bromobenzyl Alcohol	OCc1ccc(Br)cc1
706	sp|P9WQB9|ADHD_MYC	P00326	98.91	9.0	373.0	DB02871	experimental	3-Butylthiolane 1-Oxide	O=[S@@]1C[C@H](CC1)CCCC
707	sp|P9WQB9|ADHD_MYC	P00326	98.91	9.0	373.0	DB03020	experimental	5-beta-D-ribofuranosylnicotinamide adenine dinucleotide	NC(=O)c1c[nH+]cc(c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
708	sp|P9WQB9|ADHD_MYC	P00326	98.91	9.0	373.0	DB03061	experimental	(R)-N-(1-Methyl-Hexyl)-Formamide	CCCCC[C@H](C)NC=O
709	sp|P9WQB9|ADHD_MYC	P00326	98.91	9.0	373.0	DB03226	experimental	Trifluoroethanol	OCC(F)(F)F
710	sp|P9WQB9|ADHD_MYC	P00326	98.91	9.0	373.0	DB03559	experimental	Cyclohexylformamide	O=CNC1CCCCC1
711	sp|P9WQB9|ADHD_MYC	P00326	98.91	9.0	373.0	DB04071	experimental	Cpad	NC(=O)c1nc(ccc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
712	sp|P9WQB9|ADHD_MYC	P00326	98.91	9.0	373.0	DB04113	experimental	N-Formylpiperidine	O=CN1CCCCC1
713	sp|P9WQB9|ADHD_MYC	P00326	98.91	9.0	373.0	DB04312	experimental	2,3-Difluorobenzyl Alcohol	OCc1cccc(F)c1F
714	sp|P9WQB9|ADHD_MYC	P00326	98.91	9.0	373.0	DB04448	experimental	2,4-Difluorobenzyl Alcohol 2,4-Difluoro-1-(Hydroxymethyl)Benzene	OCc1ccc(F)cc1F
715	sp|P9WQB9|ADHD_MYC	P40394	98.64	21.0	384.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
716	sp|P9WQB9|ADHD_MYC	P11766	99.18	7.0	372.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
717	sp|P9WQB9|ADHD_MYC	P11766	99.18	7.0	372.0	DB03017	approved; experimental	Lauric acid	CCCCCCCCCCCC(=O)O
718	sp|P9WQB9|ADHD_MYC	P11766	99.18	7.0	372.0	DB03704	experimental	12-Hydroxydodecanoic Acid	OCCCCCCCCCCCC(=O)O
719	sp|P9WQB9|ADHD_MYC	P11766	99.18	7.0	372.0	DB04153	experimental	S-Hydroxymethyl Glutathione	OC(=O)[C@@H](N)CCC(=O)N[C@@H](CSCO)C(=O)NCC(=O)O
720	sp|P9WQB9|ADHD_MYC	P08319	100.54	9.0	379.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
721	sp|P9WQB9|ADHD_MYC	P08319	100.54	9.0	379.0	DB03559	experimental	Cyclohexylformamide	O=CNC1CCCCC1
722	sp|P9WQB9|ADHD_MYC	P42328	89.4	2.0	331.0	DB03226	experimental	Trifluoroethanol	OCC(F)(F)F
723	sp|P9WQB9|ADHD_MYC	Q00796	89.13	20.0	348.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
724	sp|P9WQB9|ADHD_MYC	Q00796	89.13	20.0	348.0	DB04478	experimental	Cp-166572, 2-Hydroxymethyl-4-(4-N,N-Dimethylaminosulfonyl-1-Piperazino)-Pyrimidine	CN(C)S(=O)(=O)N1CCN(CC1)c2ccnc(n2)CO
725	sp|P9WQB9|ADHD_MYC	P14941	88.04	15.0	339.0	DB02606	experimental; investigational	2-Butanol	CC[C@@H](C)O
726	sp|P9WQB9|ADHD_MYC	P14941	88.04	15.0	339.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
727	sp|P96847|AVTA_MYC	Q56232	95.88	10.0	382.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
728	sp|P96847|AVTA_MYC	Q56232	95.88	10.0	382.0	DB04299	experimental	Maleic Acid	OC(=O)/C=C\C(=O)O
729	sp|P96847|AVTA_MYC	Q6YP21	102.84	51.0	450.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
730	sp|P96847|AVTA_MYC	Q16773	103.61	16.0	418.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
731	sp|P96847|AVTA_MYC	Q16773	103.61	16.0	418.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
732	sp|P96847|AVTA_MYC	Q16773	103.61	16.0	418.0	DB02556	experimental	D-Phenylalanine	OC(=O)[C@H](N)Cc1ccccc1
733	sp|P96847|AVTA_MYC	Q16773	103.61	16.0	418.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
734	sp|P96847|AVTA_MYC	Q16773	103.61	16.0	418.0	DB07950	experimental	Indoleacetic acid	OC(=O)Cc1c[nH]c(c12)cccc2
735	sp|P96847|AVTA_MYC	P33447	97.16	32.0	409.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
736	sp|P96847|AVTA_MYC	Q75WK2	89.18	22.0	368.0	DB02024	experimental	3-phenylpropionic acid	OC(=O)CCc1ccccc1
737	sp|P96847|AVTA_MYC	Q75WK2	89.18	22.0	368.0	DB02238	experimental	4-methylthio-2-oxobutanoic acid	CSCCC(=O)C(=O)O
738	sp|P96847|AVTA_MYC	P17735	95.62	66.0	437.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
739	sp|P96847|AVTA_MYC	P17735	95.62	66.0	437.0	DB00120	approved; investigational; nutraceutical	Phenylalanine	OC(=O)[C@@H](N)Cc1ccccc1
740	sp|P96847|AVTA_MYC	P17735	95.62	66.0	437.0	DB00135	approved; investigational; nutraceutical	Tyrosine	OC(=O)[C@@H](N)Cc1ccc(O)cc1
741	sp|P96847|AVTA_MYC	P17735	95.62	66.0	437.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
742	sp|P96847|AVTA_MYC	P24298	98.71	104.0	487.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
743	sp|P96847|AVTA_MYC	P24298	98.71	104.0	487.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
744	sp|P96847|AVTA_MYC	P24298	98.71	104.0	487.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
745	sp|P96847|AVTA_MYC	P24298	98.71	104.0	487.0	DB00780	approved	Phenelzine	NNCCc1ccccc1
746	sp|P96847|AVTA_MYC	Q8TD30	99.74	127.0	514.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
747	sp|P96847|AVTA_MYC	Q8TD30	99.74	127.0	514.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
748	sp|P96847|AVTA_MYC	Q8TD30	99.74	127.0	514.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
749	sp|P96847|AVTA_MYC	Q8TD30	99.74	127.0	514.0	DB00780	approved	Phenelzine	NNCCc1ccccc1
750	sp|P96847|AVTA_MYC	Q9X0L5	97.16	26.0	403.0	DB01942	experimental; investigational	Formic acid	OC=O
751	sp|P96847|AVTA_MYC	Q2TU84	96.65	16.0	391.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
752	sp|P96847|AVTA_MYC	Q2TU84	96.65	16.0	391.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
753	sp|P96847|AVTA_MYC	P17174	96.65	16.0	391.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
754	sp|P96847|AVTA_MYC	P17174	96.65	16.0	391.0	DB00128	approved; nutraceutical	Aspartic acid	OC(=O)[C@@H](N)CC(=O)O
755	sp|P96847|AVTA_MYC	P17174	96.65	16.0	391.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
756	sp|P96847|AVTA_MYC	P17174	96.65	16.0	391.0	DB00151	approved; nutraceutical	Cysteine	OC(=O)[C@@H](N)CS
757	sp|P96847|AVTA_MYC	P17174	96.65	16.0	391.0	DB00210	approved	Adapalene	C1C(C2)CC(C3)CC1CC23c4c(OC)ccc(c4)-c(cc5)cc(c56)ccc(c6)C(=O)O
758	sp|P96847|AVTA_MYC	P17174	96.65	16.0	391.0	DB04299	experimental	Maleic Acid	OC(=O)/C=C\C(=O)O
759	sp|P96847|AVTA_MYC	P17174	96.65	16.0	391.0	DB09130	approved; investigational	Copper	[Cu]
760	sp|P96847|AVTA_MYC	Q96QU6	98.45	96.0	478.0	DB03214	experimental	Vinylglycine	OC(=O)[C@@H](N)C=C
761	sp|P96847|AVTA_MYC	Q8N5Z0	100.0	31.0	419.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
762	sp|P96847|AVTA_MYC	Q8N5Z0	100.0	31.0	419.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
763	sp|P96847|AVTA_MYC	P00505	91.24	48.0	402.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
764	sp|P96847|AVTA_MYC	P00505	91.24	48.0	402.0	DB00128	approved; nutraceutical	Aspartic acid	OC(=O)[C@@H](N)CC(=O)O
765	sp|P96847|AVTA_MYC	P00505	91.24	48.0	402.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
766	sp|P96847|AVTA_MYC	P00505	91.24	48.0	402.0	DB00151	approved; nutraceutical	Cysteine	OC(=O)[C@@H](N)CS
767	sp|P96847|AVTA_MYC	P00505	91.24	48.0	402.0	DB02783	experimental	4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate	Cc1ncc(COP(=O)(O)O)c(c1O)CNOCC(=O)O
768	sp|P96847|AVTA_MYC	P00509	91.49	19.0	374.0	DB01639	experimental	N-Methyl-Pyridoxal-5'-Phosphate	Cc1c(O)c(C=O)c(c[n+]1C)COP(=O)(O)O
769	sp|P96847|AVTA_MYC	P00509	91.49	19.0	374.0	DB02024	experimental	3-phenylpropionic acid	OC(=O)CCc1ccccc1
770	sp|P96847|AVTA_MYC	P00509	91.49	19.0	374.0	DB02758	experimental	Indolepropionic acid	OC(=O)CCc1c[nH]c(c12)cccc2
771	sp|P96847|AVTA_MYC	P00509	91.49	19.0	374.0	DB02981	experimental	Vitamin B6 Complexed with 2-Amino-Hexanoic Acid	CCCC[C@@H](C(=O)O)NCc1c(COP(=O)(O)O)cnc(C)c1O
772	sp|P96847|AVTA_MYC	P00509	91.49	19.0	374.0	DB03553	experimental	Glutaric Acid	OC(=O)CCCC(=O)O
773	sp|P96847|AVTA_MYC	P00509	91.49	19.0	374.0	DB03629	experimental	Pyridoxal-5'-Phosphate-N-Oxide	Cc1c(O)c(C=O)c(c[n+]1[O-])COP(=O)(O)O
774	sp|P96847|AVTA_MYC	P00509	91.49	19.0	374.0	DB03662	experimental	Vitamin B6 Complexed with 2-Amino-Pentanoic Acid	CCC[C@@H](C(=O)O)NCc1c(O)c(C)ncc1COP(=O)(O)O
775	sp|P96847|AVTA_MYC	P00509	91.49	19.0	374.0	DB03750	experimental	Isovaleric Acid	CC(C)CC(=O)O
776	sp|P96847|AVTA_MYC	P00509	91.49	19.0	374.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
777	sp|P96847|AVTA_MYC	P00509	91.49	19.0	374.0	DB04299	experimental	Maleic Acid	OC(=O)/C=C\C(=O)O
778	sp|P96847|AVTA_MYC	P00509	91.49	19.0	374.0	DB04467	experimental	N-(5'-phosphopyridoxyl)-L-alanine	OC(=O)[C@H](C)NCc1c(COP(=O)(O)O)cnc(C)c1O
779	sp|P96847|AVTA_MYC	P00509	91.49	19.0	374.0	DB04762	experimental	N-PYRIDOXYL-D-GLUTAMIC ACID-5'-MONOPHOSPHATE	Cc1ncc(COP(=O)(O)O)c(c1O)CN[C@@H](C(=O)O)CCC(=O)O
780	sp|P96847|AVTA_MYC	P00509	91.49	19.0	374.0	DB04765	experimental	N-PYRIDOXYL-2-METHYL-L-GLUTAMIC ACID-5'-MONOPHOSPHATE	Cc1ncc(COP(=O)(O)O)c(c1O)CN[C@](C)(C(=O)O)CCC(=O)O
781	sp|P96847|AVTA_MYC	P00509	91.49	19.0	374.0	DB08845	experimental; investigational; nutraceutical	Oxogluric acid	OC(=O)CCC(=O)C(=O)O
782	sp|P96847|AVTA_MYC	P97084	73.2	71.0	355.0	DB02482	experimental	Phosphonothreonine	OC(=O)[C@H](N)[C@H](C)OP(=O)(O)O
783	sp|P96847|AVTA_MYC	P97084	73.2	71.0	355.0	DB03433	experimental	{3-[(3-Hydroxy-2-Methyl-5-Phosphonooxymethyl-Pyridin-4-Ylmethyl)-Amino]-2-Methyl-Propyl}-Phosphonic Acid	OP(=O)(O)O[C@H](C)CNCc1c(O)c(C)ncc1COP(=O)(O)O
784	sp|P96847|AVTA_MYC	P95468	86.08	19.0	353.0	DB02024	experimental	3-phenylpropionic acid	OC(=O)CCc1ccccc1
785	sp|P96847|AVTA_MYC	P95468	86.08	19.0	353.0	DB02242	experimental	Cyclohexanepropanoic acid	OC(=O)CCC1CCCCC1
786	sp|P96847|AVTA_MYC	P95468	86.08	19.0	353.0	DB02434	experimental	4-(2-Thienyl)Butyric Acid	OC(=O)CCCc1cccs1
787	sp|P96847|AVTA_MYC	P95468	86.08	19.0	353.0	DB02740	experimental	3-Indolebutyric Acid	OC(=O)CCCc1c[nH]c(c12)cccc2
788	sp|P96847|AVTA_MYC	P95468	86.08	19.0	353.0	DB02758	experimental	Indolepropionic acid	OC(=O)CCc1c[nH]c(c12)cccc2
789	sp|P96847|AVTA_MYC	P95468	86.08	19.0	353.0	DB03210	experimental	4-Aminohydrocinnamic Acid	Nc1ccc(cc1)CCC(=O)O
790	sp|P96847|AVTA_MYC	P95468	86.08	19.0	353.0	DB03400	experimental	3-(P-Tolyl)Propionic Acid	Cc1ccc(cc1)CCC(=O)O
791	sp|P96847|AVTA_MYC	P95468	86.08	19.0	353.0	DB04051	experimental	5-phenylpentanoic acid	OC(=O)CCCCc1ccccc1
792	sp|P96847|AVTA_MYC	P95468	86.08	19.0	353.0	DB04208	experimental	3-(3,4-dimethoxyphenyl)propanoic acid	COc1c(OC)cc(cc1)CCC(=O)O
793	sp|P96847|AVTA_MYC	P95468	86.08	19.0	353.0	DB04299	experimental	Maleic Acid	OC(=O)/C=C\C(=O)O
794	sp|P96847|AVTA_MYC	P95468	86.08	19.0	353.0	DB06819	approved; investigational	Phenylbutyric acid	OC(=O)CCCc1ccccc1
795	sp|P96847|AVTA_MYC	Q9X0D0	76.03	28.0	323.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
796	sp|P96847|AVTA_MYC	Q9X0D0	76.03	28.0	323.0	DB03997	experimental	L-histidinol phosphate	OP(=O)(O)OC[C@@H](N)Cc1c[nH]cn1
797	sp|P96847|AVTA_MYC	Q5KUI2	70.36	62.0	335.0	DB03256	experimental	(6R)-Folinic acid	Nc([nH]1)nc(=O)c(c12)N(C=O)[C@@H](CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
798	sp|P9WNH1|BPOC_MYC	P47229	99.24	24.0	284.0	DB07510	experimental	3-fluoro-6-(4-fluorophenyl)-2-hydroxy-6-oxohexa-2,4-dienoic acid	OC(=O)/C(O)=C(/F)\C=C\C(=O)c1ccc(F)cc1
799	sp|P9WNH1|BPOC_MYC	P47229	99.24	24.0	284.0	DB07516	experimental	(2Z,4E)-3-chloro-2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoic acid	OC(=O)/C(O)=C(/Cl)\C=C\C(=O)c1ccccc1
800	sp|P9WNH1|BPOC_MYC	P47229	99.24	24.0	284.0	DB07911	experimental	(3E)-2,6-DIOXO-6-PHENYLHEX-3-ENOATE	[O-]C(=O)C(=O)/C=C/CC(=O)c1ccccc1
801	sp|P9WNH1|BPOC_MYC	P47229	99.24	24.0	284.0	DB07915	experimental	(2E,4E)-2-Hydroxy-6-oxo-6-phenyl-2,4-hexadienoic acid	OC(=O)/C(O)=C\C=C\C(=O)c1ccccc1
803	sp|P9WNH1|BPOC_MYC	P34913	73.28	248.0	440.0	DB02029	experimental	N-Cyclohexyl-N'-(4-Iodophenyl)Urea	Ic1ccc(cc1)NC(=O)NC2CCCCC2
804	sp|P9WNH1|BPOC_MYC	P34913	73.28	248.0	440.0	DB03677	experimental	N-Cyclohexyl-N'-Decylurea	CCCCCCCCCCNC(=O)NC1CCCCC1
805	sp|P9WNH1|BPOC_MYC	P34913	73.28	248.0	440.0	DB04213	experimental	N-Cyclohexyl-N'-(Propyl)Phenyl Urea	C1CCCCC1NC(=O)NCCCc2ccccc2
806	sp|P9WNH1|BPOC_MYC	P34913	73.28	248.0	440.0	DB06345	investigational	AR-9281	CC(=O)N1CCC(CC1)NC(=O)NC23CC4CC(C2)CC(C4)C3
807	sp|P9WNH1|BPOC_MYC	P34913	73.28	248.0	440.0	DB08256	experimental	N-[(CYCLOHEXYLAMINO)CARBONYL]GLYCINE	OC(=O)CNC(=O)NC1CCCCC1
808	sp|P9WNH1|BPOC_MYC	P34913	73.28	248.0	440.0	DB08257	experimental	4-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}BUTANOIC ACID	OC(=O)CCCNC(=O)NC1CCCCC1
809	sp|P9WNH1|BPOC_MYC	P34913	73.28	248.0	440.0	DB08258	experimental	6-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEXANOIC ACID	OC(=O)CCCCCNC(=O)NC1CCCCC1
810	sp|P9WNH1|BPOC_MYC	P34913	73.28	248.0	440.0	DB08259	experimental	7-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEPTANOIC ACID	OC(=O)CCCCCCNC(=O)NC1CCCCC1
811	sp|P9WNH1|BPOC_MYC	P34913	73.28	248.0	440.0	DB12610	investigational	Ebselen	c1cccc(c12)[se]n(c2=O)-c3ccccc3
812	sp|P9WNH1|BPOC_MYC	O31168	100.38	14.0	277.0	DB03793	approved; investigational	Benzoic acid	OC(=O)c1ccccc1
813	sp|P9WNH1|BPOC_MYC	P96965	96.56	18.0	271.0	DB02406	experimental	N-Valeric Acid	CCCCC(=O)O
814	sp|P9WNH1|BPOC_MYC	P96965	96.56	18.0	271.0	DB02531	experimental	Isobutyric acid	CC(C)C(=O)O
815	sp|P9WNH1|BPOC_MYC	P96965	96.56	18.0	271.0	DB03568	experimental; investigational	Butyric Acid	CCCC(=O)O
816	sp|P9WNH1|BPOC_MYC	P96965	96.56	18.0	271.0	DB03741	experimental	2-Methylbutanoic Acid	CC[C@@H](C)C(=O)O
817	sp|P9WNH1|BPOC_MYC	P96965	96.56	18.0	271.0	DB03750	experimental	Isovaleric Acid	CC(C)CC(=O)O
818	sp|P9WNH1|BPOC_MYC	P96965	96.56	18.0	271.0	DB03766	approved; vet_approved	Propanoic acid	CCC(=O)O
819	sp|P9WNH1|BPOC_MYC	P96965	96.56	18.0	271.0	DB03793	approved; investigational	Benzoic acid	OC(=O)c1ccccc1
820	sp|P9WNH1|BPOC_MYC	O07015	96.95	12.0	266.0	DB02175	experimental	Malonic acid	OC(=O)CC(=O)O
821	sp|P9WNH1|BPOC_MYC	O07015	96.95	12.0	266.0	DB03297	experimental	Benzylsulfonic acid	OS(=O)(=O)Cc1ccccc1
822	sp|P9WNH1|BPOC_MYC	O07015	96.95	12.0	266.0	DB04349	experimental	(S)-propane-1,2-diol	C[C@H](O)CO
823	sp|P9WNH1|BPOC_MYC	P13001	95.42	1.0	251.0	DB03688	experimental	Hydracrylic acid	OCCC(=O)O
824	sp|P9WNH1|BPOC_MYC	Q54528	101.53	12.0	278.0	DB01806	experimental	10-decarboxymethylaclacinomycin A	c1ccc(O)c(c12)C(=O)c3c(C2=O)cc4c(c3O)[C@H](C[C@](C4)(O)CC)O[C@H]5C[C@H](N(C)C)[C@@H]([C@@H](O5)C)O[C@@H]6C[C@H](O)[C@H]([C@@H](O6)C)O[C@H]7CCC(=O)[C@H](O7)C
825	sp|P9WNH1|BPOC_MYC	Q54528	101.53	12.0	278.0	DB04131	experimental	10-(4-Dimethylamino-5-Hydroxy-6-Methyl-Tetrahydro-Pyran-2-Yloxy)-8-Ethyl-1,8,11-Trihydroxy-7,8,9,10-Tetrahydro-Naphthacene-5,12-Dione	O[C@H]1[C@@H](N(C)C)C[C@@H](O[C@H]1C)O[C@H]2C[C@](O)(CC)Cc(c23)cc4c(c3O)C(=O)c5c(C4=O)cccc5O
826	sp|P9WNH1|BPOC_MYC	Q86WA6	92.37	49.0	291.0	DB03380	experimental	L-tyrosinamide	NC(=O)[C@@H](N)Cc1ccc(O)cc1
827	sp|P9WNH1|BPOC_MYC	O07732	92.75	19.0	262.0	DB02596	experimental	alpha,beta-Methyleneadenosine 5'-triphosphate	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)CP(=O)(O)OP(=O)(O)O
828	sp|P9WNH1|BPOC_MYC	O32449	104.96	33.0	308.0	DB03833	experimental	2-Prolyl-5-Tert-Butyl-[1,3,4]Oxadiazole	C1CCN[C@@H]1C(=O)c2nnc(o2)C(C)(C)C
829	sp|P9WNH1|BPOC_MYC	O32449	104.96	33.0	308.0	DB07391	experimental	(2S)-2-AMINO-1-(5-TERT-BUTYL-1,3,4-OXADIAZOL-2-YL)PROPAN-1-ONE	C[C@H](N)C(=O)c1nnc(o1)C(C)(C)C
830	sp|P9WNH1|BPOC_MYC	O32449	104.96	33.0	308.0	DB08576	experimental	1-(5-TERT-BUTYL-1,3,4-OXADIAZOL-2-YL)-2-(METHYLAMINO)ETHANONE	CNCC(=O)c1nnc(o1)C(C)(C)C
831	sp|P9WNH1|BPOC_MYC	P51698	103.44	20.0	291.0	DB01701	experimental	1,2-Dichloro-Propane	C[C@@H](Cl)CCl
832	sp|P9WNH1|BPOC_MYC	P51698	103.44	20.0	291.0	DB02145	experimental	Butyl alcohol	CCCCO
833	sp|P9WNH1|BPOC_MYC	P51698	103.44	20.0	291.0	DB02302	experimental	Symmetric dimethylarginine	CN/C(=N/C)NCCC[C@H](N)C(=O)O
834	sp|P9WNH1|BPOC_MYC	P51698	103.44	20.0	291.0	DB02774	experimental	1,3-Propanediol	OCCCO
835	sp|P9WNH1|BPOC_MYC	P51698	103.44	20.0	291.0	DB03335	experimental	(+)-1-bromo-2-propanol	C[C@H](O)CBr
836	sp|P9WNH1|BPOC_MYC	P51698	103.44	20.0	291.0	DB03733	experimental	Ethylene Dichloride	ClCCCl
837	sp|P9WNH1|BPOC_MYC	P51698	103.44	20.0	291.0	DB04320	experimental	2-Bromo-2-Propene-1-Ol	OCC(Br)=C
838	sp|P9WP85|COBT_MYC	Q05603	92.52	10.0	344.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
839	sp|P9WP85|COBT_MYC	Q05603	92.52	10.0	344.0	DB01688	experimental	P-Cresol	Cc1ccc(O)cc1
840	sp|P9WP85|COBT_MYC	Q05603	92.52	10.0	344.0	DB01726	experimental	2-Aminophenol	Nc1ccccc1O
841	sp|P9WP85|COBT_MYC	Q05603	92.52	10.0	344.0	DB02030	experimental	Alpha-Ribazole-5'-Phosphate	Cc(c1)c(C)cc(c12)ncn2[C@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
842	sp|P9WP85|COBT_MYC	Q05603	92.52	10.0	344.0	DB02163	experimental	2,5-Xylidine	Cc1ccc(C)c(N)c1
843	sp|P9WP85|COBT_MYC	Q05603	92.52	10.0	344.0	DB02382	experimental	Namn	OP([O-])(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)[n+]2cccc(c2)C(=O)O
844	sp|P9WP85|COBT_MYC	Q05603	92.52	10.0	344.0	DB02591	experimental	5,6-Dimethylbenzimidazole	Cc(c1)c(C)cc(c12)[nH]cn2
845	sp|P9WP85|COBT_MYC	Q05603	92.52	10.0	344.0	DB02770	experimental	7-alpha-D-Ribofuranosyl-2-aminopurine-5'-phosphate	Nc(n1)ncc(c12)n(cn2)[C@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
846	sp|P9WP85|COBT_MYC	Q05603	92.52	10.0	344.0	DB02819	experimental	Mono-[3,4-Dihydroxy-5-(5-Methyl-Benzoimidazol-1-Yl)-Tetrahydor-Furan-2-Ylmethyl] Ester	OP(=O)(O)OC[C@H]1O[C@@H]([C@H](O)[C@@H]1O)n2cnc(c23)cc(C)cc3
847	sp|P9WP85|COBT_MYC	Q05603	92.52	10.0	344.0	DB02905	experimental	N7-(5'-Phospho-alpha-ribosyl)-2-hydroxypurine	OP(=O)(O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](O1)n2cnc(c23)[nH]c(=O)nc3
848	sp|P9WP85|COBT_MYC	Q05603	92.52	10.0	344.0	DB02962	experimental; investigational	Benzimidazole	[nH]1cnc(c12)cccc2
849	sp|P9WP85|COBT_MYC	Q05603	92.52	10.0	344.0	DB03018	experimental	3,4-dimethylaniline	Cc1ccc(N)cc1C
850	sp|P9WP85|COBT_MYC	Q05603	92.52	10.0	344.0	DB03079	experimental	Alpha-Ribazole-5'-Phosphate Derivative	OP(=O)(O)OC[C@H]1O[C@@H]([C@H](O)[C@@H]1O)n2cnc(c23)cccc3
851	sp|P9WP85|COBT_MYC	Q05603	92.52	10.0	344.0	DB03177	experimental	5-methylbenzimidazole	c1cc(C)cc(c12)[nH]cn2
852	sp|P9WP85|COBT_MYC	Q05603	92.52	10.0	344.0	DB03180	experimental	4,5-Dimethyl-1,2-phenylenediamine	Cc1cc(N)c(N)cc1C
853	sp|P9WP85|COBT_MYC	Q05603	92.52	10.0	344.0	DB03200	experimental	7-Alpha-D-Ribofuranosyl-Purine-5'-Phosphate	OP(=O)(O)OC[C@H]1O[C@@H]([C@H](O)[C@@H]1O)n2cnc(c23)ncnc3
854	sp|P9WP85|COBT_MYC	Q05603	92.52	10.0	344.0	DB03366	experimental; investigational	Imidazole	[nH]1ccnc1
855	sp|P9WP85|COBT_MYC	Q05603	92.52	10.0	344.0	DB03887	experimental	Alpha-Adenosine Monophosphate	OP(=O)(O)OC[C@H]1O[C@@H]([C@H](O)[C@@H]1O)n2cnc(c23)ncnc3N
856	sp|P9WP85|COBT_MYC	Q05603	92.52	10.0	344.0	DB04052	experimental	3,4-Xylenol	Cc1ccc(O)cc1C
857	sp|P9WP85|COBT_MYC	Q05603	92.52	10.0	344.0	DB04120	experimental	4-Methyl-1,2-Benzenediol	Cc1ccc(O)c(O)c1
858	sp|P9WP85|COBT_MYC	Q05603	92.52	10.0	344.0	DB04130	experimental	5-Methoxybenzimidazole	COc(cc1)cc(c12)[nH]cn2
859	sp|P9WP85|COBT_MYC	Q05603	92.52	10.0	344.0	DB04176	experimental	Phosporic Acid Mono-[3,4-Dihydroxy-5-(5-Methoxy-Benzoimidazol-1-Yl)-Tetrahydro-Furan-2-Ylmethyl] Ester	OP(=O)(O)OC[C@H]1O[C@@H]([C@H](O)[C@@H]1O)n2cnc(c23)cc(cc3)OC
860	sp|P9WP85|COBT_MYC	Q05603	92.52	10.0	344.0	DB04532	experimental	Indole	[nH]1ccc(c12)cccc2
861	sp|P9WP85|COBT_MYC	Q05603	92.52	10.0	344.0	DB04533	experimental	2-Amino-4-methylphenol	Cc1ccc(O)c(N)c1
862	tr|O86319|O86319_M	Q72JJ3	97.91	4.0	378.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
863	tr|O86319|O86319_M	P16219	97.91	32.0	406.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
864	tr|O86319|O86319_M	P16219	97.91	32.0	406.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
865	tr|O86319|O86319_M	P16219	97.91	32.0	406.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
866	tr|O86319|O86319_M	Q06319	99.48	1.0	381.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
867	tr|O86319|O86319_M	Q06319	99.48	1.0	381.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
868	tr|O86319|O86319_M	Q9UKU7	97.38	40.0	412.0	DB01675	experimental	Methacrylyl-Coenzyme A	CC(=C)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
869	tr|O86319|O86319_M	Q9UKU7	97.38	40.0	412.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
870	tr|O86319|O86319_M	P11310	98.17	39.0	414.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
871	tr|O86319|O86319_M	P11310	98.17	39.0	414.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
872	tr|O86319|O86319_M	P11310	98.17	39.0	414.0	DB03415	experimental	3-thiaoctanoyl-CoA	CCCCCSCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
873	tr|O86319|O86319_M	P45954	97.12	57.0	428.0	DB00167	investigational; nutraceutical	Isoleucine	CC[C@H](C)[C@H](N)C(=O)O
874	tr|O86319|O86319_M	P45954	97.12	57.0	428.0	DB00313	approved; investigational	Valproic acid	CCCC(C(=O)O)CCC
875	tr|O86319|O86319_M	P26440	98.43	42.0	418.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
876	tr|O86319|O86319_M	P26440	98.43	42.0	418.0	DB04036	experimental	Coenzyme A persulfide	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSS
877	tr|O86319|O86319_M	Q3JP94	96.86	17.0	387.0	DB08685	experimental	1-(1,4-dimethyl-1,2,3,4-tetrahydroquinoxalin-6-yl)methanamine	CN1CCN(C)c(c12)cc(cc2)CN
878	tr|O86319|O86319_M	Q92947	96.6	59.0	428.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
879	tr|O86319|O86319_M	Q92947	96.6	59.0	428.0	DB03245	experimental	S-4-Nitrobutyryl-CoA	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCC[N+]([O-])=O
880	tr|O86319|O86319_M	Q9KIE5	90.31	15.0	360.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
881	tr|O86319|O86319_M	Q15067	86.91	103.0	435.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
882	tr|O86319|O86319_M	Q15067	86.91	103.0	435.0	DB07930	experimental	(3R)-3-HYDROXYDODECANOIC ACID	OC(=O)C[C@H](O)CCCCCCCCC
883	tr|O07721|O07721_M	Q08257	72.16	8.0	249.0	DB00266	approved	Dicoumarol	c1cccc(c12)oc(=O)c(c2O)Cc(c(=O)o3)c(O)c(c34)cccc4
884	tr|O07721|O07721_M	Q08257	72.16	8.0	249.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
886	tr|O07721|O07721_M	Q08257	72.16	8.0	249.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
887	tr|O07721|O07721_M	P14941	74.25	17.0	265.0	DB02606	experimental; investigational	2-Butanol	CC[C@@H](C)O
888	tr|O07721|O07721_M	P14941	74.25	17.0	265.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
889	tr|O07721|O07721_M	Q8N8N7	70.06	22.0	256.0	DB00328	approved; investigational	Indomethacin	COc(cc1)cc(c12)c(CC(=O)O)c(C)n2C(=O)c3ccc(Cl)cc3
890	tr|O07721|O07721_M	Q8N8N7	70.06	22.0	256.0	DB07177	experimental	(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID	OC(=O)CCC/C=C/CC1C(C(O)CC1=O)/C=C/C(=O)CCCCC
891	tr|P96824|P96824_M	P00352	92.69	30.0	499.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
892	tr|P96824|P96824_M	P00352	92.69	30.0	499.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
893	tr|P96824|P96824_M	P00352	92.69	30.0	499.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
894	tr|P96824|P96824_M	P00352	92.69	30.0	499.0	DB04447	experimental	1,4-Dithiothreitol	SC[C@H](O)[C@@H](O)CS
895	tr|P96824|P96824_M	P47895	92.09	41.0	507.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
896	tr|P96824|P96824_M	P47895	92.09	41.0	507.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
897	tr|P96824|P96824_M	P05091	92.49	46.0	514.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
898	tr|P96824|P96824_M	P05091	92.49	46.0	514.0	DB00536	approved	Guanidine	NC(N)=N
899	tr|P96824|P96824_M	P05091	92.49	46.0	514.0	DB00822	approved	Disulfiram	CCN(CC)C(=S)SSC(=S)N(CC)CC
900	tr|P96824|P96824_M	P05091	92.49	46.0	514.0	DB02115	experimental	Daidzin	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)Oc(c2)ccc(c23)c(=O)c(co3)-c4ccc(O)cc4
901	tr|P96824|P96824_M	P05091	92.49	46.0	514.0	DB04381	experimental	Crotonaldehyde	O=C/C=C/C
902	tr|P96824|P96824_M	O94788	92.29	48.0	515.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
903	tr|P96824|P96824_M	O94788	92.29	48.0	515.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
904	tr|P96824|P96824_M	O94788	92.29	48.0	515.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
905	tr|P96824|P96824_M	P30837	92.49	46.0	514.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
906	tr|P96824|P96824_M	P30838	88.34	3.0	450.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
907	tr|P96824|P96824_M	P43353	88.34	6.0	453.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
908	tr|P96824|P96824_M	P51648	87.75	5.0	449.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
909	tr|P96824|P96824_M	P49189	91.3	25.0	487.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
910	tr|P96824|P96824_M	O75891	92.89	431.0	901.0	DB00116	nutraceutical	Tetrahydrofolic acid	Nc([nH]1)nc(=O)c(c12)NC(CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
911	tr|P96824|P96824_M	P25553	90.32	21.0	478.0	DB03619	approved	Deoxycholic acid	C1C[C@@H](O)C[C@H]([C@]12C)CC[C@@H]3[C@@H]2C[C@H](O)[C@@]4(C)[C@H]3CC[C@@H]4[C@H](C)CCC(=O)O
912	tr|P96824|P96824_M	P77674	90.51	15.0	473.0	DB04401	experimental	Betaine aldehyde	C[N+](C)(C)CC=O
913	tr|P96824|P96824_M	P51649	90.51	73.0	531.0	DB00139	approved; nutraceutical	Succinic acid	OC(=O)CCC(=O)O
914	tr|P96824|P96824_M	P51649	90.51	73.0	531.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
915	tr|P96824|P96824_M	P51649	90.51	73.0	531.0	DB00313	approved; investigational	Valproic acid	CCCC(C(=O)O)CCC
916	tr|P96824|P96824_M	P51649	90.51	73.0	531.0	DB00534	approved; withdrawn	Chlormerodrin	Cl[Hg]CC(OC)CNC(=O)N
917	tr|P96824|P96824_M	P48448	73.12	3.0	373.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
918	tr|P96824|P96824_M	P48448	73.12	3.0	373.0	DB09116	approved; withdrawn	Calcium carbimide	[N-]=C=[N-]
919	tr|P96824|P96824_M	Q59931	90.51	16.0	474.0	DB02263	experimental	Glyceraldehyde-3-Phosphate	O=C[C@H](O)COP(=O)(O)O
920	tr|P96824|P96824_M	Q59931	90.51	16.0	474.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
921	tr|P96824|P96824_M	Q02252	93.28	49.0	521.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
922	tr|P96824|P96824_M	P83849	90.71	54.0	513.0	DB03564	experimental	(4r)-2-Methylpentane-2,4-Diol	C[C@H](O)CC(C)(C)O
923	tr|P96824|P96824_M	P49419	91.5	65.0	528.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
924	tr|P96824|P96824_M	P49419	91.5	65.0	528.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
925	tr|P96824|P96824_M	P09546	87.94	656.0	1101.0	DB03051	experimental	(S)-2-Tetrahydrofuroic acid	OC(=O)[C@H]1CCCO1
926	tr|P96824|P96824_M	P09546	87.94	656.0	1101.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
927	tr|P96824|P96824_M	P09546	87.94	656.0	1101.0	DB04398	approved; vet_approved	Lactic acid	CC(O)C(=O)O
928	tr|P96824|P96824_M	P30038	87.94	88.0	533.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
929	tr|P96824|P96824_M	Q56694	82.02	22.0	437.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
930	tr|I6WZD9|I6WZD9_M	Q9BTZ2	85.82	30.0	266.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
931	tr|I6WZD9|I6WZD9_M	Q9WYS2	85.82	9.0	245.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
933	tr|I6WZD9|I6WZD9_M	P0AEK2	82.91	5.0	233.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
934	tr|I6WZD9|I6WZD9_M	Q6UWP2	89.09	11.0	256.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
935	tr|I6WZD9|I6WZD9_M	P16544	88.0	7.0	249.0	DB01942	experimental; investigational	Formic acid	OC=O
936	tr|I6WZD9|I6WZD9_M	P16544	88.0	7.0	249.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
937	tr|I6WZD9|I6WZD9_M	P16544	88.0	7.0	249.0	DB07715	investigational	Emodin	Cc(c1)cc(O)c(c12)C(=O)c3c(C2=O)cc(O)cc3O
938	tr|I6WZD9|I6WZD9_M	P0AET8	84.36	11.0	243.0	DB02123	experimental	Glycochenodeoxycholic Acid	OC(=O)CNC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
940	tr|I6WZD9|I6WZD9_M	Q92506	86.55	12.0	250.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
941	tr|I6WZD9|I6WZD9_M	Q92506	86.55	12.0	250.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
942	tr|I6WZD9|I6WZD9_M	P0CG22	86.91	30.0	269.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
943	tr|I6WZD9|I6WZD9_M	P0CG22	86.91	30.0	269.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
944	tr|I6WZD9|I6WZD9_M	P0CG22	86.91	30.0	269.0	DB03541	experimental	10-Propargyl-5,8-Dideazafolic Acid	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(CC#C)Cc(c2)ccc(c23)[nH]c(N)nc3=O
945	tr|I6WZD9|I6WZD9_M	P0CG22	86.91	30.0	269.0	DB07689	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)NCc(cn3)nc(c34)c(N)nc(n4)N
946	tr|I6WZD9|I6WZD9_M	P0CG22	86.91	30.0	269.0	DB07765	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)N(C)Cc(cn3)nc(c34)c(N)nc(n4)N
948	tr|I6WZD9|I6WZD9_M	Q84EX5	85.09	6.0	240.0	DB04619	experimental	Acetophenone	CC(=O)c1ccccc1
949	tr|I6WZD9|I6WZD9_M	Q84EX5	85.09	6.0	240.0	DB04784	experimental	(R)-1-phenylethanol	C[C@@H](O)c1ccccc1
950	tr|I6WZD9|I6WZD9_M	Q9BY49	87.27	17.0	257.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
952	tr|I6WZD9|I6WZD9_M	Q7Z4W1	82.91	4.0	232.0	DB02831	experimental	Dihydrogenphosphate	OP([O-])(=O)O
953	tr|I6WZD9|I6WZD9_M	Q7Z4W1	82.91	4.0	232.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
954	tr|I6WZD9|I6WZD9_M	Q8NBQ5	81.45	33.0	257.0	DB02854	experimental	Aetiocholanolone	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](CC3)C[C@H](O)CC4
955	tr|I6WZD9|I6WZD9_M	Q16698	85.45	58.0	293.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
956	tr|I6WZD9|I6WZD9_M	Q16698	85.45	58.0	293.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
957	tr|I6WZD9|I6WZD9_M	Q8NBN7	74.55	38.0	243.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
958	tr|I6WZD9|I6WZD9_M	P14061	81.82	2.0	227.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
959	tr|I6WZD9|I6WZD9_M	P14061	81.82	2.0	227.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
960	tr|I6WZD9|I6WZD9_M	P14061	81.82	2.0	227.0	DB01561	experimental; illicit	Androstanedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
961	tr|I6WZD9|I6WZD9_M	P14061	81.82	2.0	227.0	DB02187	experimental	Equilin	O=C1CC[C@H]([C@@]12C)C=3[C@H](CC2)c4c(CC3)cc(O)cc4
962	tr|I6WZD9|I6WZD9_M	P14061	81.82	2.0	227.0	DB02323	experimental	EM-1745	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)C[C@@H]([C@@H]4O)CCCCCCCCC(=O)OC[C@H]5O[C@H]([C@H](O)[C@@H]5O)n6cnc(c67)c(N)ncn7
963	tr|I6WZD9|I6WZD9_M	P14061	81.82	2.0	227.0	DB02901	illicit; investigational	Stanolone	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
964	tr|I6WZD9|I6WZD9_M	P14061	81.82	2.0	227.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
965	tr|I6WZD9|I6WZD9_M	P14061	81.82	2.0	227.0	DB13951	experimental	Stanolone acetate	CC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
966	tr|I6WZD9|I6WZD9_M	Q9NYR8	71.27	4.0	200.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
967	tr|I6WZD9|I6WZD9_M	Q99714	85.09	10.0	244.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
968	tr|I6WZD9|I6WZD9_M	Q99714	85.09	10.0	244.0	DB02820	experimental	1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct	C1CCCCCN1C(=O)[C@H](c2ccccc2)n(c3=S)cnc(c34)nn(c4)[C@H]5C=CN(C=C5C([O-])=N)[C@@H]6O[C@@H]([C@@H](O)[C@H]6O)COP([O-])(=O)OP(=O)(O)OC[C@H]7O[C@H]([C@H]([O-])[C@@H]7[O-])n8cnc(c89)c(N)ncn9
969	tr|I6WZD9|I6WZD9_M	Q99714	85.09	10.0	244.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
970	tr|I6WZD9|I6WZD9_M	Q9HBH5	91.64	42.0	294.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
971	tr|I6WZD9|I6WZD9_M	O75911	88.36	37.0	280.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
972	tr|I6WZD9|I6WZD9_M	Q8TC12	73.82	41.0	244.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
973	tr|I6WZD9|I6WZD9_M	Q02338	76.73	55.0	266.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
974	tr|I6WZD9|I6WZD9_M	Q96NR8	73.82	38.0	241.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
975	tr|I6WZD9|I6WZD9_M	Q7AUG5	84.36	3.0	235.0	DB04782	experimental	(S)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@H]2CO2
976	tr|I6WZD9|I6WZD9_M	Q93D82	84.36	3.0	235.0	DB04472	experimental	(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol	[N-]=[N+]=NC[C@H](O)c1ccc([N+]([O-])=O)cc1
977	tr|I6WZD9|I6WZD9_M	Q93D82	84.36	3.0	235.0	DB04499	experimental	(R)-styrene oxide	C1O[C@@H]1c2ccccc2
978	tr|I6WZD9|I6WZD9_M	Q93D82	84.36	3.0	235.0	DB04777	experimental	(R)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@@H]2CO2
979	tr|I6WZD9|I6WZD9_M	Q8I814	90.91	13.0	263.0	DB02015	experimental	Dihydrofolic Acid	O=c1[nH]c(N)nc(c12)NCC(=N2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
980	tr|I6WZD9|I6WZD9_M	Q8I814	90.91	13.0	263.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
981	tr|I6WZD9|I6WZD9_M	P0AEK4	85.45	4.0	239.0	DB01691	experimental	Indole Naphthyridinone	c1cccc(c12)n(C)cc2CN(C)C(=O)/C=C/c(c3)cnc(c34)NC(=O)CC4
982	tr|I6WZD9|I6WZD9_M	P0AEK4	85.45	4.0	239.0	DB01865	experimental	3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide	c1cccc(c12)cc(n2C)CN(C)C(=O)/C=C/c3cnc(N)cc3
983	tr|I6WZD9|I6WZD9_M	P0AEK4	85.45	4.0	239.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
984	tr|I6WZD9|I6WZD9_M	P0AEK4	85.45	4.0	239.0	DB03030	experimental	4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole	Cc1ccc(cc1)Cn2cnc(c2)-c3cccs3
985	tr|I6WZD9|I6WZD9_M	P0AEK4	85.45	4.0	239.0	DB03534	experimental	3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide	CC(=O)N(C)Cc1c(N)ccc(c1)C(=O)N(C)Cc(n2C)cc(c23)cccc3
986	tr|I6WZD9|I6WZD9_M	P0AEK4	85.45	4.0	239.0	DB04030	experimental	1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole	Oc1ccc(cc1)Cn2c(c3c(c24)cccc4)CN(CC3)C(=O)c5ccc(O)cc5
987	tr|I6WZD9|I6WZD9_M	P0AEK4	85.45	4.0	239.0	DB08265	experimental	2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL	Cc1ccc(cc1)S(=O)(=O)n(b2O)ncc(c23)cccc3
988	tr|I6WZD9|I6WZD9_M	P0AEK4	85.45	4.0	239.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
989	tr|I6WZD9|I6WZD9_M	P0AEK4	85.45	4.0	239.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
990	tr|I6WZD9|I6WZD9_M	Q92781	73.45	27.0	229.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
991	tr|I6WZD9|I6WZD9_M	Q92781	73.45	27.0	229.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
992	tr|I6WZD9|I6WZD9_M	P51659	73.82	9.0	212.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
993	tr|I6WZD9|I6WZD9_M	P51659	73.82	9.0	212.0	DB03192	experimental	(R)-3-hydroxydecanoyl-CoA	CCCCCCC[C@@H](O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
994	tr|I6WZD9|I6WZD9_M	P37058	74.55	48.0	253.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
995	tr|I6WZD9|I6WZD9_M	P28845	74.55	32.0	237.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
996	tr|I6WZD9|I6WZD9_M	P28845	74.55	32.0	237.0	DB02329	experimental	Carbenoxolone	OC(=O)CCC(=O)O[C@@H](CC1)C(C)(C)[C@@H]([C@]12C)CC[C@]3(C)[C@@H]2C(=O)C=C4[C@H]5[C@@](C)(CC[C@@]34C)CC[C@](C5)(C)C(=O)O
997	tr|I6WZD9|I6WZD9_M	P28845	74.55	32.0	237.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
998	tr|I6WZD9|I6WZD9_M	P28845	74.55	32.0	237.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
999	tr|I6WZD9|I6WZD9_M	P28845	74.55	32.0	237.0	DB04652	experimental	Corticosterone	OCC(=O)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H]([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
1000	tr|I6WZD9|I6WZD9_M	P28845	74.55	32.0	237.0	DB05064	investigational	INCB13739	 
1001	tr|I6WZD9|I6WZD9_M	P28845	74.55	32.0	237.0	DB06992	experimental	(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone	Cc1ccc(cc1F)-c2nc(ccc2)C(=O)N(CC3(C)C)CCC3
1002	tr|I6WZD9|I6WZD9_M	P28845	74.55	32.0	237.0	DB07017	experimental	(5S)-2-{[(1S)-1-(4-Fluorophenyl)ethyl]amino}-5-(2-hydroxy-2-propanyl)-5-methyl-1,3-thiazol-4(5H)-one	Fc1ccc(cc1)[C@H](C)NC(=NC2=O)S[C@@]2(C)C(C)(C)O
1003	tr|I6WZD9|I6WZD9_M	P28845	74.55	32.0	237.0	DB07049	experimental	(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine	[O-][N+](=O)c1ccc(cc1)N2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)C(C)(C)C
1004	tr|I6WZD9|I6WZD9_M	P28845	74.55	32.0	237.0	DB07056	experimental	2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide	CCN(CC)C(=O)Cc1cccc(n1)NS(=O)(=O)c2c(C)c(Cl)ccc2
1005	tr|I6WZD9|I6WZD9_M	P28845	74.55	32.0	237.0	DB07310	experimental	(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one	Fc1ccccc1[C@H](C)NC(=NC2=O)S[C@]2(C)C(F)(F)F
1006	tr|I6WZD9|I6WZD9_M	P28845	74.55	32.0	237.0	DB07316	experimental	N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)C3CCN(CC3)CC4(CC4)C(=O)N
1007	tr|I6WZD9|I6WZD9_M	P28845	74.55	32.0	237.0	DB07619	experimental	N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)[C@H]3CC[C@@H](CC3)c4cccnc4
1008	tr|I6WZD9|I6WZD9_M	P28845	74.55	32.0	237.0	DB07624	experimental	1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide	C1CC1(C(=O)N)CN2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)[C@](C)(O)C(F)(F)F
1009	tr|I6WZD9|I6WZD9_M	P28845	74.55	32.0	237.0	DB07866	experimental	(5S)-2-(Cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one	CCC[C@]1(C)SC(=NC1=O)NC2CCCCCCC2
1010	tr|I6WZD9|I6WZD9_M	P28845	74.55	32.0	237.0	DB08277	experimental	2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE	CS(=O)(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4c(Cl)cc(F)cc4
1011	tr|I6WZD9|I6WZD9_M	P28845	74.55	32.0	237.0	DB08280	experimental	(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE	NC(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4ccc(OC)cc4
1012	tr|I6WZD9|I6WZD9_M	P28845	74.55	32.0	237.0	DB08771	experimental	(5R)-2-[(2-Fluorophenyl)amino]-5-isopropyl-1,3-thiazol-4(5H)-one	CC(C)[C@H]1SC(=NC1=O)Nc2c(F)cccc2
1013	tr|I6WZD9|I6WZD9_M	P28845	74.55	32.0	237.0	DB13751	approved; experimental	Glycyrrhizic acid	C1C[C@](C)(C(=O)O)C[C@H]([C@]12C)C=3[C@@](C)(CC2)[C@@]4(C)[C@H](C(=O)C3)[C@]5(C)[C@@H](CC4)C(C)(C)[C@H](CC5)O[C@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O[C@@H]7O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]7O
1014	tr|I6WZD9|I6WZD9_M	P80365	73.09	80.0	281.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1015	tr|I6WZD9|I6WZD9_M	P80365	73.09	80.0	281.0	DB01185	approved; illicit	Fluoxymesterone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@](F)([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
1016	tr|I6WZD9|I6WZD9_M	P80365	73.09	80.0	281.0	DB01569	experimental; illicit	Formebolone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@H]([C@@H](C2)O)[C@]4(C)C(CC3)=CC(=O)C(C=O)=C4
1017	tr|I6WZD9|I6WZD9_M	P80365	73.09	80.0	281.0	DB14538	experimental; vet_approved	Hydrocortisone aceponate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CC)C(=O)COC(=O)C
1018	tr|I6WZD9|I6WZD9_M	P80365	73.09	80.0	281.0	DB14539	approved; vet_approved	Hydrocortisone acetate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)C
1019	tr|I6WZD9|I6WZD9_M	P80365	73.09	80.0	281.0	DB14540	approved; vet_approved	Hydrocortisone butyrate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCC
1020	tr|I6WZD9|I6WZD9_M	P80365	73.09	80.0	281.0	DB14541	approved; investigational; vet_approved	Hydrocortisone cypionate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)CCC5CCCC5
1021	tr|I6WZD9|I6WZD9_M	P80365	73.09	80.0	281.0	DB14542	approved; vet_approved	Hydrocortisone phosphate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COP(=O)(O)O
1022	tr|I6WZD9|I6WZD9_M	P80365	73.09	80.0	281.0	DB14543	approved; vet_approved	Hydrocortisone probutate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CCC)C(=O)COC(=O)CC
1023	tr|I6WZD9|I6WZD9_M	P80365	73.09	80.0	281.0	DB14544	approved; vet_approved	Hydrocortisone valerate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCCC
1024	tr|I6WZD9|I6WZD9_M	A0A348A0U3	86.55	6.0	244.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
1025	tr|I6WZD9|I6WZD9_M	Q6GI75	86.55	6.0	244.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
1026	tr|I6WZD9|I6WZD9_M	Q6GI75	86.55	6.0	244.0	DB11155	approved	Triclocarban	Clc1ccc(cc1)NC(=O)Nc2cc(Cl)c(Cl)cc2
1027	tr|I6WZD9|I6WZD9_M	P37059	86.18	82.0	319.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1028	tr|I6WZD9|I6WZD9_M	P37059	86.18	82.0	319.0	DB13952	approved; investigational; vet_approved	Estradiol acetate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)C
1029	tr|I6WZD9|I6WZD9_M	P37059	86.18	82.0	319.0	DB13953	approved; investigational; vet_approved	Estradiol benzoate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)c5ccccc5
1030	tr|I6WZD9|I6WZD9_M	P37059	86.18	82.0	319.0	DB13954	approved; investigational; vet_approved	Estradiol cypionate	C1CCCC1CCC(=O)O[C@H]2CC[C@H]([C@@]23C)[C@H]4[C@H](CC3)c5c(CC4)cc(O)cc5
1031	tr|I6WZD9|I6WZD9_M	P37059	86.18	82.0	319.0	DB13955	approved; investigational; vet_approved	Estradiol dienanthate	CCCCCCC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)CCCCCC
1032	tr|I6WZD9|I6WZD9_M	P37059	86.18	82.0	319.0	DB13956	approved; investigational; vet_approved	Estradiol valerate	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)CC[C@@H]4OC(=O)CCCC
1033	tr|I6WZD9|I6WZD9_M	O24990	84.73	10.0	243.0	DB04393	experimental	Soneclosan	Clc1cc(O)c(cc1)Oc2ccc(Cl)cc2
1034	tr|I6WZD9|I6WZD9_M	O24990	84.73	10.0	243.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
1035	tr|I6WZD9|I6WZD9_M	P16152	87.64	6.0	247.0	DB01698	approved; experimental; investigational	Rutin	O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O[C@H]1C)OC[C@H]2O[C@H]([C@H](O)[C@@H](O)[C@@H]2O)Oc(c3=O)c(-c4cc(O)c(O)cc4)oc(c35)cc(O)cc5O
1036	tr|I6WZD9|I6WZD9_M	P16152	87.64	6.0	247.0	DB02709	investigational	Resveratrol	Oc1ccc(cc1)/C=C/c2cc(O)cc(O)c2
1037	tr|I6WZD9|I6WZD9_M	P16152	87.64	6.0	247.0	DB03394	experimental	Heptaethylene glycol	OCCOCCOCCOCCOCCOCCOCCO
1038	tr|I6WZD9|I6WZD9_M	P16152	87.64	6.0	247.0	DB03556	experimental	2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400	CCOCCOCCOCCOCCOCCOCCOCCOCCO
1039	tr|I6WZD9|I6WZD9_M	P16152	87.64	6.0	247.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
1040	tr|I6WZD9|I6WZD9_M	P16152	87.64	6.0	247.0	DB04463	experimental	3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol	n1cnc(N)c(c12)c(nn2C(C)(C)C)-c3cccc(O)c3
1041	tr|I6WZD9|I6WZD9_M	P16152	87.64	6.0	247.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
1042	tr|I6WZD9|I6WZD9_M	P16152	87.64	6.0	247.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
1043	tr|I6WZD9|I6WZD9_M	P56937	84.36	2.0	234.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1044	tr|I6WZD9|I6WZD9_M	P35270	87.27	6.0	246.0	DB02637	experimental	Oxaloacetate Ion	OC(=O)C(=O)CC([O-])=O
1045	tr|I6WZD9|I6WZD9_M	P35270	87.27	6.0	246.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1046	tr|I6WZD9|I6WZD9_M	P35270	87.27	6.0	246.0	DB03886	experimental	Biopterin	C[C@@H](O)[C@@H](O)c(n1)cnc(c12)nc(N)[nH]c2=O
1047	tr|I6WZD9|I6WZD9_M	P35270	87.27	6.0	246.0	DB04275	experimental	N-acetylserotonin	CC(=O)NCCc1c[nH]c(c12)ccc(c2)O
1048	tr|I6WZD9|I6WZD9_M	P9WGR1	90.55	7.0	256.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
1049	tr|I6WZD9|I6WZD9_M	P9WGR1	90.55	7.0	256.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
1050	tr|I6WZD9|I6WZD9_M	P9WGR1	90.55	7.0	256.0	DB02990	experimental	S-(2-Acetamidoethyl) hexadecanethioate	CCCCCCCCCCCCCCCC(=O)SCCNC(=O)C
1051	tr|I6WZD9|I6WZD9_M	P9WGR1	90.55	7.0	256.0	DB04289	experimental	Genz-10850	[nH]1ccc(c12)cc(cc2)C(=O)N3CCN(CC3)C4c(cccc5)c5c(c46)cccc6
1052	tr|I6WZD9|I6WZD9_M	P9WGR1	90.55	7.0	256.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
1053	tr|I6WZD9|I6WZD9_M	P9WGR1	90.55	7.0	256.0	DB07090	experimental	(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cccc(c1C)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
1054	tr|I6WZD9|I6WZD9_M	P9WGR1	90.55	7.0	256.0	DB07123	experimental	N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE	Cc1ccc(cc1)C(=O)N2CCC(CC2)Cc3ccccc3
1055	tr|I6WZD9|I6WZD9_M	P9WGR1	90.55	7.0	256.0	DB07155	experimental	(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE	c1ccccc1NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
1056	tr|I6WZD9|I6WZD9_M	P9WGR1	90.55	7.0	256.0	DB07178	experimental	5-PENTYL-2-PHENOXYPHENOL	CCCCCc1cc(O)c(cc1)Oc2ccccc2
1057	tr|I6WZD9|I6WZD9_M	P9WGR1	90.55	7.0	256.0	DB07188	experimental	(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(cc(Cl)c1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
1058	tr|I6WZD9|I6WZD9_M	P9WGR1	90.55	7.0	256.0	DB07192	experimental	(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Brc1cc(ccc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
1059	tr|I6WZD9|I6WZD9_M	P9WGR1	90.55	7.0	256.0	DB07222	experimental	(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(c(C)cc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
1060	tr|I6WZD9|I6WZD9_M	P9WGR1	90.55	7.0	256.0	DB07287	experimental	2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL	c1cccnc1Cc2cc(O)c(cc2)Oc3ccc(Cl)cc3Cl
1061	tr|I6WZD9|I6WZD9_M	P9WGR1	90.55	7.0	256.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
1062	tr|I6WZD9|I6WZD9_M	Q8T8E9	70.18	3.0	196.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
1063	tr|O53612|O53612_M	P94548	79.37	9.0	159.0	DB03264	experimental	Dodecyl-Coa	CCCCCCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
1064	tr|O53612|O53612_M	P0A0N4	77.78	4.0	151.0	DB01123	approved	Proflavine	c1cc(N)cc(c12)nc3c(c2)ccc(c3)N
1065	tr|O53612|O53612_M	P0A0N4	77.78	4.0	151.0	DB03608	experimental	Diminazene	NC(=N)c1ccc(cc1)N/N=N/c2ccc(cc2)C(N)=N
1066	tr|O53612|O53612_M	P0A0N4	77.78	4.0	151.0	DB03808	experimental	Hexamidine	NC(=N)c1ccc(cc1)OCCCCCCOc2ccc(cc2)C(N)=N
1067	tr|O53612|O53612_M	P0A0N4	77.78	4.0	151.0	DB04209	approved; investigational	Dequalinium	c1cccc(c12)c(N)cc(C)[n+]2CCCCCCCCCC[n+]3c(C)cc(N)c(c34)cccc4
1068	tr|O53612|O53612_M	P0A0N5	77.78	4.0	151.0	DB03808	experimental	Hexamidine	NC(=N)c1ccc(cc1)OCCCCCCOc2ccc(cc2)C(N)=N
1069	tr|O53612|O53612_M	P0A0N5	77.78	4.0	151.0	DB03825	experimental	Rhodamine 6G	CCNc(c(C)c1)cc(c12)[o+]c3c(cc(C)c(c3)NCC)c2-c4ccccc4C(=O)OCC
1070	tr|O53612|O53612_M	P0A0N5	77.78	4.0	151.0	DB03895	experimental	Malachite Green	CN(C)c1ccc(cc1)C(c2ccccc2)=C3C=CC(C=C3)=[N+](C)C
1071	tr|O53612|O53612_M	P0A0N5	77.78	4.0	151.0	DB04115	approved; investigational	Berberine	COc1c(OC)ccc(c12)cc3[n+](c2)CCc4c3cc5c(c4)OCO5
1072	tr|P96816|P96816_M	P14060	104.41	5.0	360.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1073	tr|P96816|P96816_M	P14060	104.41	5.0	360.0	DB01108	approved; investigational; vet_approved; withdrawn	Trilostane	C1C[C@H](O)[C@@](C)(CC2)[C@@H]1[C@H](CC3)[C@H]2[C@@]([C@@]345)(C)CC(C#N)=C([C@H]4O5)O
1074	tr|P96816|P96816_M	P14060	104.41	5.0	360.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
1075	tr|P96816|P96816_M	P14060	104.41	5.0	360.0	DB14538	experimental; vet_approved	Hydrocortisone aceponate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CC)C(=O)COC(=O)C
1076	tr|P96816|P96816_M	P14060	104.41	5.0	360.0	DB14539	approved; vet_approved	Hydrocortisone acetate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)C
1077	tr|P96816|P96816_M	P14060	104.41	5.0	360.0	DB14540	approved; vet_approved	Hydrocortisone butyrate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCC
1078	tr|P96816|P96816_M	P14060	104.41	5.0	360.0	DB14541	approved; investigational; vet_approved	Hydrocortisone cypionate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)CCC5CCCC5
1079	tr|P96816|P96816_M	P14060	104.41	5.0	360.0	DB14542	approved; vet_approved	Hydrocortisone phosphate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COP(=O)(O)O
1080	tr|P96816|P96816_M	P14060	104.41	5.0	360.0	DB14543	approved; vet_approved	Hydrocortisone probutate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CCC)C(=O)COC(=O)CC
1081	tr|P96816|P96816_M	P14060	104.41	5.0	360.0	DB14544	approved; vet_approved	Hydrocortisone valerate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCCC
1082	tr|P96816|P96816_M	P26439	104.41	4.0	359.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1083	tr|P96816|P96816_M	P26439	104.41	4.0	359.0	DB01108	approved; investigational; vet_approved; withdrawn	Trilostane	C1C[C@H](O)[C@@](C)(CC2)[C@@H]1[C@H](CC3)[C@H]2[C@@]([C@@]345)(C)CC(C#N)=C([C@H]4O5)O
1084	tr|P96816|P96816_M	Q15738	97.94	39.0	372.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1085	tr|P96816|P96816_M	Q9ZGH3	91.76	3.0	315.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
1086	tr|P96816|P96816_M	P26391	98.53	2.0	337.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
1087	tr|P96816|P96816_M	P95780	93.24	7.0	324.0	DB03161	experimental	Thymidine-5'-diphospho-beta-D-xylose	O=c1[nH]c(=O)c(C)cn1[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3OC[C@@H](O)[C@H](O)[C@H]3O
1088	tr|P96816|P96816_M	P95780	93.24	7.0	324.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
1089	tr|P96816|P96816_M	O60547	98.24	26.0	360.0	DB02547	experimental	Guanosine-5'-Diphosphate-Rhamnose	O[C@H]1[C@H](O)[C@H](O)[C@H](O[C@@H]1C)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3cnc(c34)c(=O)nc([nH]4)N
1090	tr|P96816|P96816_M	O60547	98.24	26.0	360.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
1091	tr|P96816|P96816_M	Q51366	93.53	2.0	320.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
1092	tr|P96816|P96816_M	P14169	83.82	3.0	288.0	DB04555	experimental	Cytidine-5'-Diphosphate	Nc1nc(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O
1093	tr|P96816|P96816_M	Q8KN66	79.12	20.0	289.0	DB01861	experimental	Uridine diphosphate glucose	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
1094	tr|P96816|P96816_M	Q8KN66	79.12	20.0	289.0	DB02196	experimental	Uridine-Diphosphate-N-Acetylgalactosamine	CC(=O)N[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
1095	tr|P96816|P96816_M	P77398	98.24	317.0	651.0	DB03256	experimental	(6R)-Folinic acid	Nc([nH]1)nc(=O)c(c12)N(C=O)[C@@H](CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
1096	tr|P96816|P96816_M	P77398	98.24	317.0	651.0	DB03685	experimental	Uridine monophosphate	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2ccc(=O)[nH]c2=O
1097	tr|P96816|P96816_M	P09147	83.82	3.0	288.0	DB01861	experimental	Uridine diphosphate glucose	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
1098	tr|P96816|P96816_M	P09147	83.82	3.0	288.0	DB02421	experimental	Uridine-5'-diphosphate-mannose	O=c1[nH]c(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O
1099	tr|P96816|P96816_M	P09147	83.82	3.0	288.0	DB02790	experimental	Phenyl-uridine-5'-diphosphate	O=c1[nH]c(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)Oc3ccccc3
1100	tr|P96816|P96816_M	P09147	83.82	3.0	288.0	DB03397	experimental	Uridine-Diphosphate-N-Acetylglucosamine	CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
1101	tr|P96816|P96816_M	P09147	83.82	3.0	288.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
1102	tr|P96816|P96816_M	P09147	83.82	3.0	288.0	DB04097	experimental	Uridine-5'-diphosphate-4-deoxy-4-fluoro-alpha-D-galactose	O=c1[nH]c(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](F)[C@H](O)[C@H]3O
1103	tr|P96816|P96816_M	P67910	72.06	3.0	248.0	DB01774	experimental	Adenosine-5'-Monophosphate Glucopyranosyl-Monophosphate Ester	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@@](=O)(O)O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O
1104	tr|P96816|P96816_M	P67910	72.06	3.0	248.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1105	tr|P96816|P96816_M	Q14376	84.71	2.0	290.0	DB01861	experimental	Uridine diphosphate glucose	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
1106	tr|P96816|P96816_M	Q14376	84.71	2.0	290.0	DB02196	experimental	Uridine-Diphosphate-N-Acetylgalactosamine	CC(=O)N[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
1107	tr|P96816|P96816_M	Q14376	84.71	2.0	290.0	DB03041	experimental	UDP-alpha-D-glucuronic acid	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O
1108	tr|P96816|P96816_M	Q14376	84.71	2.0	290.0	DB03095	experimental	Tetramethylammonium	C[N+](C)(C)C
1109	tr|P96816|P96816_M	Q14376	84.71	2.0	290.0	DB03397	experimental	Uridine-Diphosphate-N-Acetylglucosamine	CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
1110	tr|P96816|P96816_M	Q14376	84.71	2.0	290.0	DB03501	experimental	Galactose-uridine-5'-diphosphate	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@H]1O)O[P@](=O)(O)O[P@](=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
1111	tr|P96816|P96816_M	P32055	76.76	6.0	267.0	DB02897	experimental	Acetylphosphate	CC(=O)OP(=O)(O)O
1112	tr|P96816|P96816_M	P32055	76.76	6.0	267.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1113	tr|P95208|P95208_M	Q3JP94	98.99	3.0	394.0	DB08685	experimental	1-(1,4-dimethyl-1,2,3,4-tetrahydroquinoxalin-6-yl)methanamine	CN1CCN(C)c(c12)cc(cc2)CN
1114	tr|P95208|P95208_M	Q92947	99.24	42.0	434.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
1115	tr|P95208|P95208_M	Q92947	99.24	42.0	434.0	DB03245	experimental	S-4-Nitrobutyryl-CoA	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCC[N+]([O-])=O
1116	tr|P95208|P95208_M	P11310	98.99	23.0	414.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
1117	tr|P95208|P95208_M	P11310	98.99	23.0	414.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
1118	tr|P95208|P95208_M	P11310	98.99	23.0	414.0	DB03415	experimental	3-thiaoctanoyl-CoA	CCCCCSCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
1119	tr|P95208|P95208_M	Q72JJ3	94.68	3.0	377.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
1120	tr|P95208|P95208_M	P16219	94.94	30.0	405.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1121	tr|P95208|P95208_M	P16219	94.94	30.0	405.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
1122	tr|P95208|P95208_M	P16219	94.94	30.0	405.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
1123	tr|P95208|P95208_M	Q06319	95.95	1.0	380.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
1124	tr|P95208|P95208_M	Q06319	95.95	1.0	380.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
1125	tr|P95208|P95208_M	P26440	95.7	41.0	419.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
1126	tr|P95208|P95208_M	P26440	95.7	41.0	419.0	DB04036	experimental	Coenzyme A persulfide	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSS
1127	tr|P95208|P95208_M	P45954	94.43	55.0	428.0	DB00167	investigational; nutraceutical	Isoleucine	CC[C@H](C)[C@H](N)C(=O)O
1128	tr|P95208|P95208_M	P45954	94.43	55.0	428.0	DB00313	approved; investigational	Valproic acid	CCCC(C(=O)O)CCC
1129	tr|P95208|P95208_M	Q9UKU7	94.43	38.0	411.0	DB01675	experimental	Methacrylyl-Coenzyme A	CC(=C)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
1130	tr|P95208|P95208_M	Q9UKU7	94.43	38.0	411.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
1131	tr|P95208|P95208_M	Q9KIE5	88.1	12.0	360.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
1132	tr|P95208|P95208_M	Q15067	84.05	101.0	433.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
1133	tr|P95208|P95208_M	Q15067	84.05	101.0	433.0	DB07930	experimental	(3R)-3-HYDROXYDODECANOIC ACID	OC(=O)C[C@H](O)CCCCCCCCC
1134	tr|O53622|O53622_M	Q54528	96.38	10.0	276.0	DB01806	experimental	10-decarboxymethylaclacinomycin A	c1ccc(O)c(c12)C(=O)c3c(C2=O)cc4c(c3O)[C@H](C[C@](C4)(O)CC)O[C@H]5C[C@H](N(C)C)[C@@H]([C@@H](O5)C)O[C@@H]6C[C@H](O)[C@H]([C@@H](O6)C)O[C@H]7CCC(=O)[C@H](O7)C
1135	tr|O53622|O53622_M	Q54528	96.38	10.0	276.0	DB04131	experimental	10-(4-Dimethylamino-5-Hydroxy-6-Methyl-Tetrahydro-Pyran-2-Yloxy)-8-Ethyl-1,8,11-Trihydroxy-7,8,9,10-Tetrahydro-Naphthacene-5,12-Dione	O[C@H]1[C@@H](N(C)C)C[C@@H](O[C@H]1C)O[C@H]2C[C@](O)(CC)Cc(c23)cc4c(c3O)C(=O)c5c(C4=O)cccc5O
1136	tr|O53622|O53622_M	O31168	88.77	13.0	258.0	DB03793	approved; investigational	Benzoic acid	OC(=O)c1ccccc1
1137	tr|O53622|O53622_M	P47229	91.67	21.0	274.0	DB07510	experimental	3-fluoro-6-(4-fluorophenyl)-2-hydroxy-6-oxohexa-2,4-dienoic acid	OC(=O)/C(O)=C(/F)\C=C\C(=O)c1ccc(F)cc1
1138	tr|O53622|O53622_M	P47229	91.67	21.0	274.0	DB07516	experimental	(2Z,4E)-3-chloro-2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoic acid	OC(=O)/C(O)=C(/Cl)\C=C\C(=O)c1ccccc1
1139	tr|O53622|O53622_M	P47229	91.67	21.0	274.0	DB07911	experimental	(3E)-2,6-DIOXO-6-PHENYLHEX-3-ENOATE	[O-]C(=O)C(=O)/C=C/CC(=O)c1ccccc1
1140	tr|O53622|O53622_M	P47229	91.67	21.0	274.0	DB07915	experimental	(2E,4E)-2-Hydroxy-6-oxo-6-phenyl-2,4-hexadienoic acid	OC(=O)/C(O)=C\C=C\C(=O)c1ccccc1
1142	tr|O53622|O53622_M	O07015	89.13	10.0	256.0	DB02175	experimental	Malonic acid	OC(=O)CC(=O)O
1143	tr|O53622|O53622_M	O07015	89.13	10.0	256.0	DB03297	experimental	Benzylsulfonic acid	OS(=O)(=O)Cc1ccccc1
1144	tr|O53622|O53622_M	O07015	89.13	10.0	256.0	DB04349	experimental	(S)-propane-1,2-diol	C[C@H](O)CO
1145	tr|O53622|O53622_M	O07732	82.25	51.0	278.0	DB02596	experimental	alpha,beta-Methyleneadenosine 5'-triphosphate	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)CP(=O)(O)OP(=O)(O)O
1146	tr|O53622|O53622_M	P13001	86.96	3.0	243.0	DB03688	experimental	Hydracrylic acid	OCCC(=O)O
1147	tr|I6Y4U4|I6Y4U4_M	P00390	95.39	45.0	521.0	DB00143	approved; investigational; nutraceutical	Glutathione	OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(=O)O
1148	tr|I6Y4U4|I6Y4U4_M	P00390	95.39	45.0	521.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1149	tr|I6Y4U4|I6Y4U4_M	P00390	95.39	45.0	521.0	DB00262	approved; investigational	Carmustine	ClCCNC(=O)N(N=O)CCCl
1150	tr|I6Y4U4|I6Y4U4_M	P00390	95.39	45.0	521.0	DB01644	experimental	3,6-dihydroxy-xanthene-9-propionic acid	OC(=O)CCC1c(ccc(c2)O)c2Oc(c13)cc(O)cc3
1151	tr|I6Y4U4|I6Y4U4_M	P00390	95.39	45.0	521.0	DB02153	experimental	3-sulfino-L-alanine	OC(=O)[C@@H](N)C[S@](=O)O
1152	tr|I6Y4U4|I6Y4U4_M	P00390	95.39	45.0	521.0	DB02553	experimental	Glutathionylspermidine disulfide	NCCCCNCCCNC(=O)CNC(=O)[C@@H](NC(=O)CC[C@@H](N)C(=O)O)CSSC[C@H](NC(=O)CC[C@@H](N)C(=O)O)C(=O)NCC(=O)NCCCNCCCCN
1153	tr|I6Y4U4|I6Y4U4_M	P00390	95.39	45.0	521.0	DB02895	experimental	3-(Prop-2-Ene-1-Sulfinyl)-Propene-1-Thiol	S/C=C/C[S@](=O)CC=C
1154	tr|I6Y4U4|I6Y4U4_M	P00390	95.39	45.0	521.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
1155	tr|I6Y4U4|I6Y4U4_M	P00390	95.39	45.0	521.0	DB03310	approved; experimental; investigational	Glutathione disulfide	OC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)NCC(=O)O)CSSC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@H](N)C(=O)O
1156	tr|I6Y4U4|I6Y4U4_M	P00390	95.39	45.0	521.0	DB03867	experimental	3-nitro-L-tyrosine	OC(=O)[C@@H](N)Cc1cc([N+]([O-])=O)c(O)cc1
1157	tr|I6Y4U4|I6Y4U4_M	P00390	95.39	45.0	521.0	DB07393	experimental	2-(2-PHENYL-3-PYRIDIN-2-YL-4,5,6,7-TETRAHYDRO-2H-ISOPHOSPHINDOL-1-YL)PYRIDINE	n1ccccc1-c2p(-c3ccccc3)c(c(c24)CCCC4)-c5ncccc5
1158	tr|I6Y4U4|I6Y4U4_M	P00390	95.39	45.0	521.0	DB07714	experimental	6-(3-METHYL-1,4-DIOXO-1,4-DIHYDRONAPHTHALEN-2-YL)HEXANOIC ACID	c1cccc(c12)C(=O)C(=C(C2=O)C)CCCCCC(=O)O
1159	tr|I6Y4U4|I6Y4U4_M	P00390	95.39	45.0	521.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
1160	tr|I6Y4U4|I6Y4U4_M	P00390	95.39	45.0	521.0	DB09130	approved; investigational	Copper	[Cu]
1162	tr|I6Y4U4|I6Y4U4_M	P00390	95.39	45.0	521.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
1163	tr|I6Y4U4|I6Y4U4_M	P06715	89.38	3.0	449.0	DB00336	approved; investigational; vet_approved	Nitrofural	NC(=O)N/N=C/c1ccc(o1)[N+]([O-])=O
1164	tr|I6Y4U4|I6Y4U4_M	P06715	89.38	3.0	449.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
1165	tr|I6Y4U4|I6Y4U4_M	Q16881	96.59	158.0	640.0	DB01169	approved; investigational	Arsenic trioxide	O=[As]O[As]=O
1166	tr|I6Y4U4|I6Y4U4_M	Q16881	96.59	158.0	640.0	DB02338	experimental	NADPH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1167	tr|I6Y4U4|I6Y4U4_M	Q16881	96.59	158.0	640.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
1168	tr|I6Y4U4|I6Y4U4_M	Q16881	96.59	158.0	640.0	DB03566	experimental	Spermidine	NCCCCNCCCN
1169	tr|I6Y4U4|I6Y4U4_M	Q16881	96.59	158.0	640.0	DB04106	investigational	Fotemustine	CCOP(=O)(OCC)[C@@H](C)NC(=O)N(N=O)CCCl
1170	tr|I6Y4U4|I6Y4U4_M	Q16881	96.59	158.0	640.0	DB05428	investigational	Motexafin gadolinium	CCc(c12)c(CC)c([n-]1)cc3nc(c(C)c3CCCO)cnc4c(ncc5nc(c2)c(c5C)CCCO)cc(OCCOCCOCCOC)c(c4)OCCOCCOCCOC
1171	tr|I6Y4U4|I6Y4U4_M	Q16881	96.59	158.0	640.0	DB05448	investigational	PX-12	CCC(C)SSc1ncc[nH]1
1172	tr|I6Y4U4|I6Y4U4_M	P14218	91.38	2.0	458.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
1173	tr|I6Y4U4|I6Y4U4_M	Q9NNW7	97.19	29.0	514.0	DB05428	investigational	Motexafin gadolinium	CCc(c12)c(CC)c([n-]1)cc3nc(c(C)c3CCCO)cnc4c(ncc5nc(c2)c(c5C)CCCO)cc(OCCOCCOCCOC)c(c4)OCCOCCOCCOC
1174	tr|I6Y4U4|I6Y4U4_M	P18925	91.38	2.0	458.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
1175	tr|I6Y4U4|I6Y4U4_M	P09622	90.98	40.0	494.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1176	tr|I6Y4U4|I6Y4U4_M	P09622	90.98	40.0	494.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
1177	tr|I6Y4U4|I6Y4U4_M	Q94655	98.8	3.0	496.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
1178	tr|I6Y4U4|I6Y4U4_M	P28593	94.99	3.0	477.0	DB02240	experimental	Quinacrine mustard	c1cc(Cl)cc(n2)c1c(c(c23)cc(OC)cc3)NC(C)CCCN(CCCl)CCCl
1179	tr|I6Y4U4|I6Y4U4_M	P28593	94.99	3.0	477.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
1180	tr|I6Y4U4|I6Y4U4_M	P28593	94.99	3.0	477.0	DB03470	experimental	Trypanothione	OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(=O)NCCCCNCCCNC(=O)CNC(=O)[C@H](CS)NC(=O)CC[C@H](N)C(=O)O
1181	tr|I6Y4U4|I6Y4U4_M	P28593	94.99	3.0	477.0	DB04299	experimental	Maleic Acid	OC(=O)/C=C\C(=O)O
1182	tr|I6Y4U4|I6Y4U4_M	Q51225	94.59	102.0	574.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
1183	tr|I6Y4U4|I6Y4U4_M	P09063	87.37	9.0	445.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
1185	tr|I6Y4U4|I6Y4U4_M	Q56839	91.78	39.0	497.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
1186	tr|I6Y4U4|I6Y4U4_M	Q56839	91.78	39.0	497.0	DB03163	experimental	2-oxopropyl-CoM	CC(=O)CSCCS(=O)(=O)O
1187	tr|I6Y4U4|I6Y4U4_M	P37062	70.54	66.0	418.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
1188	tr|I6Y4U4|I6Y4U4_M	P37062	70.54	66.0	418.0	DB03382	experimental	S-oxy-L-cysteine	OC(=O)[C@@H](N)CS=O
1189	tr|O05855|O05855_M	P26196	70.02	89.0	458.0	DB01694	experimental	D-tartaric acid	OC(=O)[C@@H](O)[C@H](O)C(=O)O
1190	tr|O05855|O05855_M	Q9TY94	72.87	53.0	437.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
1191	tr|P72043|P72043_M	P00325	73.48	132.0	373.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1192	tr|P72043|P72043_M	P00325	73.48	132.0	373.0	DB01213	approved; vet_approved	Fomepizole	Cc1c[nH]nc1
1193	tr|P72043|P72043_M	P00325	73.48	132.0	373.0	DB02481	experimental	N-Benzylformamide	O=CNCc1ccccc1
1194	tr|P72043|P72043_M	P00325	73.48	132.0	373.0	DB02721	experimental	4-Iodopyrazole	Ic1c[nH]nc1
1195	tr|P72043|P72043_M	P00325	73.48	132.0	373.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1196	tr|P72043|P72043_M	P00325	73.48	132.0	373.0	DB03703	experimental	Cyclohexanol	OC1CCCCC1
1197	tr|P72043|P72043_M	P00325	73.48	132.0	373.0	DB04105	experimental	N-Heptylformamide	CCCCCCCNC=O
1198	tr|P72043|P72043_M	P00325	73.48	132.0	373.0	DB09462	approved; investigational	Glycerin	OCC(O)CO
1199	tr|P72043|P72043_M	P00326	73.78	131.0	373.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1200	tr|P72043|P72043_M	P00326	73.78	131.0	373.0	DB01213	approved; vet_approved	Fomepizole	Cc1c[nH]nc1
1201	tr|P72043|P72043_M	P00326	73.78	131.0	373.0	DB01711	experimental	2,3,4,5,6-Pentafluorobenzyl Alcohol	OCc1c(F)c(F)c(F)c(F)c1F
1202	tr|P72043|P72043_M	P00326	73.78	131.0	373.0	DB02131	experimental	N-1-methylheptylformamide	O=CN[C@H](C)CCCCCC
1203	tr|P72043|P72043_M	P00326	73.78	131.0	373.0	DB02249	experimental	2-Ethoxyethanol	CCOCCO
1204	tr|P72043|P72043_M	P00326	73.78	131.0	373.0	DB02659	approved	Cholic Acid	OC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](C[C@@H]2O)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
1205	tr|P72043|P72043_M	P00326	73.78	131.0	373.0	DB02721	experimental	4-Iodopyrazole	Ic1c[nH]nc1
1206	tr|P72043|P72043_M	P00326	73.78	131.0	373.0	DB02757	experimental	Pyrazole	[nH]1cccn1
1207	tr|P72043|P72043_M	P00326	73.78	131.0	373.0	DB02822	experimental	Para-Bromobenzyl Alcohol	OCc1ccc(Br)cc1
1208	tr|P72043|P72043_M	P00326	73.78	131.0	373.0	DB02871	experimental	3-Butylthiolane 1-Oxide	O=[S@@]1C[C@H](CC1)CCCC
1209	tr|P72043|P72043_M	P00326	73.78	131.0	373.0	DB03020	experimental	5-beta-D-ribofuranosylnicotinamide adenine dinucleotide	NC(=O)c1c[nH+]cc(c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1210	tr|P72043|P72043_M	P00326	73.78	131.0	373.0	DB03061	experimental	(R)-N-(1-Methyl-Hexyl)-Formamide	CCCCC[C@H](C)NC=O
1211	tr|P72043|P72043_M	P00326	73.78	131.0	373.0	DB03226	experimental	Trifluoroethanol	OCC(F)(F)F
1212	tr|P72043|P72043_M	P00326	73.78	131.0	373.0	DB03559	experimental	Cyclohexylformamide	O=CNC1CCCCC1
1213	tr|P72043|P72043_M	P00326	73.78	131.0	373.0	DB04071	experimental	Cpad	NC(=O)c1nc(ccc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1214	tr|P72043|P72043_M	P00326	73.78	131.0	373.0	DB04113	experimental	N-Formylpiperidine	O=CN1CCCCC1
1215	tr|P72043|P72043_M	P00326	73.78	131.0	373.0	DB04312	experimental	2,3-Difluorobenzyl Alcohol	OCc1cccc(F)c1F
1216	tr|P72043|P72043_M	P00326	73.78	131.0	373.0	DB04448	experimental	2,4-Difluorobenzyl Alcohol 2,4-Difluoro-1-(Hydroxymethyl)Benzene	OCc1ccc(F)cc1F
1217	tr|P72043|P72043_M	P07327	72.56	136.0	374.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1218	tr|P72043|P72043_M	P07327	72.56	136.0	374.0	DB01213	approved; vet_approved	Fomepizole	Cc1c[nH]nc1
1219	tr|P72043|P72043_M	P07327	72.56	136.0	374.0	DB02721	experimental	4-Iodopyrazole	Ic1c[nH]nc1
1220	tr|P72043|P72043_M	P07327	72.56	136.0	374.0	DB04065	experimental	N-Cyclopentyl-N-Cyclobutylformamide	C1CCC1N(C=O)C2CCCC2
1221	tr|P72043|P72043_M	P40394	75.3	137.0	384.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1222	tr|P72043|P72043_M	P11766	75.0	126.0	372.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1223	tr|P72043|P72043_M	P11766	75.0	126.0	372.0	DB03017	approved; experimental	Lauric acid	CCCCCCCCCCCC(=O)O
1224	tr|P72043|P72043_M	P11766	75.0	126.0	372.0	DB03704	experimental	12-Hydroxydodecanoic Acid	OCCCCCCCCCCCC(=O)O
1225	tr|P72043|P72043_M	P11766	75.0	126.0	372.0	DB04153	experimental	S-Hydroxymethyl Glutathione	OC(=O)[C@@H](N)CCC(=O)N[C@@H](CSCO)C(=O)NCC(=O)O
1226	tr|P72043|P72043_M	P08319	74.09	136.0	379.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1227	tr|P72043|P72043_M	P08319	74.09	136.0	379.0	DB03559	experimental	Cyclohexylformamide	O=CNC1CCCCC1
1228	tr|P72043|P72043_M	Q08257	97.56	7.0	327.0	DB00266	approved	Dicoumarol	c1cccc(c12)oc(=O)c(c2O)Cc(c(=O)o3)c(O)c(c34)cccc4
1229	tr|P72043|P72043_M	Q08257	97.56	7.0	327.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1231	tr|P72043|P72043_M	Q08257	97.56	7.0	327.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
1232	tr|P72043|P72043_M	P49327	91.46	1556.0	1856.0	DB01034	experimental	Cerulenin	NC(=O)[C@@H]1O[C@@H]1C(=O)CC/C=C/C/C=C/C
1233	tr|P72043|P72043_M	P49327	91.46	1556.0	1856.0	DB01083	approved; investigational	Orlistat	CCCCCCCCCCC[C@H](OC(=O)[C@@H](NC=O)CC(C)C)C[C@@H]1OC(=O)[C@H]1CCCCCC
1234	tr|P72043|P72043_M	Q14914	92.38	24.0	327.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1235	tr|P72043|P72043_M	Q14914	92.38	24.0	327.0	DB04066	experimental	p-Coumaric acid	OC(=O)/C=C/c1ccc(O)cc1
1236	tr|P72043|P72043_M	Q14914	92.38	24.0	327.0	DB07177	experimental	(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID	OC(=O)CCC/C=C/CC1C(C(O)CC1=O)/C=C/C(=O)CCCCC
1237	tr|P72043|P72043_M	Q8N8N7	97.56	23.0	343.0	DB00328	approved; investigational	Indomethacin	COc(cc1)cc(c12)c(CC(=O)O)c(C)n2C(=O)c3ccc(Cl)cc3
1238	tr|P72043|P72043_M	Q8N8N7	97.56	23.0	343.0	DB07177	experimental	(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID	OC(=O)CCC/C=C/CC1C(C(O)CC1=O)/C=C/C(=O)CCCCC
1239	tr|O06806|O06806_M	Q9WXS0	89.92	2.0	225.0	DB01942	experimental; investigational	Formic acid	OC=O
1240	tr|Q79FJ2|Q79FJ2_M	P52209	97.11	2.0	473.0	DB00789	approved	Gadopentetic acid	OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC(=O)O
1241	tr|Q79FJ2|Q79FJ2_M	P52209	97.11	2.0	473.0	DB00851	approved; investigational	Dacarbazine	CN(C)/N=N/c1c(C(=O)N)nc[nH]1
1242	tr|Q79FJ2|Q79FJ2_M	P52209	97.11	2.0	473.0	DB00920	approved	Ketotifen	CN1CCC(CC1)=C2c(ccs3)c3C(=O)Cc(c24)cccc4
1243	tr|Q79FJ2|Q79FJ2_M	P52209	97.11	2.0	473.0	DB02076	experimental	6-phospho-D-gluconic acid	OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(=O)O
1244	tr|Q79FJ2|Q79FJ2_M	P52209	97.11	2.0	473.0	DB03962	experimental	Nicotinamide 8-bromo-adenine dinucleotide phosphate	NC(=O)c1c[n+](ccc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4c(Br)nc(c45)c(N)ncn5
1245	tr|O07255|O07255_M	B7JBP8	103.09	3.0	403.0	DB07640	experimental	2-decyl-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione	CCCCCCCCCCC1=C(C)C(=O)C(OC)=C(C1=O)OC
1246	tr|O07255|O07255_M	O67931	101.29	1.0	394.0	DB07640	experimental	2-decyl-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione	CCCCCCCCCCC1=C(C)C(=O)C(OC)=C(C1=O)OC
1247	tr|O07255|O07255_M	P16640	72.16	6.0	286.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
1248	tr|O07255|O07255_M	P37062	74.23	2.0	290.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
1249	tr|O07255|O07255_M	P37062	74.23	2.0	290.0	DB03382	experimental	S-oxy-L-cysteine	OC(=O)[C@@H](N)CS=O
1250	tr|O07255|O07255_M	O95831	78.61	135.0	440.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
1251	tr|O07255|O07255_M	O95831	78.61	135.0	440.0	DB05282	investigational	MCC	 
1252	tr|O50460|O50460_M	Q9BTZ2	86.59	30.0	269.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
1253	tr|O50460|O50460_M	Q84EX5	86.59	3.0	242.0	DB04619	experimental	Acetophenone	CC(=O)c1ccccc1
1254	tr|O50460|O50460_M	Q84EX5	86.59	3.0	242.0	DB04784	experimental	(R)-1-phenylethanol	C[C@@H](O)c1ccccc1
1256	tr|O50460|O50460_M	P0AEK2	85.14	2.0	237.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1257	tr|O50460|O50460_M	Q9WYS2	85.87	7.0	244.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1259	tr|O50460|O50460_M	Q92506	89.86	7.0	255.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1260	tr|O50460|O50460_M	Q92506	89.86	7.0	255.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1262	tr|O50460|O50460_M	Q6UWP2	88.41	6.0	250.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1263	tr|O50460|O50460_M	Q9BY49	88.77	16.0	261.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
1264	tr|O50460|O50460_M	P0CG22	88.04	30.0	273.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
1265	tr|O50460|O50460_M	P0CG22	88.04	30.0	273.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1266	tr|O50460|O50460_M	P0CG22	88.04	30.0	273.0	DB03541	experimental	10-Propargyl-5,8-Dideazafolic Acid	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(CC#C)Cc(c2)ccc(c23)[nH]c(N)nc3=O
1267	tr|O50460|O50460_M	P0CG22	88.04	30.0	273.0	DB07689	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)NCc(cn3)nc(c34)c(N)nc(n4)N
1268	tr|O50460|O50460_M	P0CG22	88.04	30.0	273.0	DB07765	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)N(C)Cc(cn3)nc(c34)c(N)nc(n4)N
1269	tr|O50460|O50460_M	P0AET8	86.59	8.0	247.0	DB02123	experimental	Glycochenodeoxycholic Acid	OC(=O)CNC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
1270	tr|O50460|O50460_M	P16544	89.86	2.0	250.0	DB01942	experimental; investigational	Formic acid	OC=O
1271	tr|O50460|O50460_M	P16544	89.86	2.0	250.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1272	tr|O50460|O50460_M	P16544	89.86	2.0	250.0	DB07715	investigational	Emodin	Cc(c1)cc(O)c(c12)C(=O)c3c(C2=O)cc(O)cc3O
1273	tr|O50460|O50460_M	Q8NBQ5	77.9	34.0	249.0	DB02854	experimental	Aetiocholanolone	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](CC3)C[C@H](O)CC4
1274	tr|O50460|O50460_M	Q7Z4W1	82.97	5.0	234.0	DB02831	experimental	Dihydrogenphosphate	OP([O-])(=O)O
1275	tr|O50460|O50460_M	Q7Z4W1	82.97	5.0	234.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1277	tr|O50460|O50460_M	Q16698	87.32	55.0	296.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1278	tr|O50460|O50460_M	Q16698	87.32	55.0	296.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
1279	tr|O50460|O50460_M	P14061	81.16	2.0	226.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1280	tr|O50460|O50460_M	P14061	81.16	2.0	226.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
1281	tr|O50460|O50460_M	P14061	81.16	2.0	226.0	DB01561	experimental; illicit	Androstanedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
1282	tr|O50460|O50460_M	P14061	81.16	2.0	226.0	DB02187	experimental	Equilin	O=C1CC[C@H]([C@@]12C)C=3[C@H](CC2)c4c(CC3)cc(O)cc4
1283	tr|O50460|O50460_M	P14061	81.16	2.0	226.0	DB02323	experimental	EM-1745	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)C[C@@H]([C@@H]4O)CCCCCCCCC(=O)OC[C@H]5O[C@H]([C@H](O)[C@@H]5O)n6cnc(c67)c(N)ncn7
1284	tr|O50460|O50460_M	P14061	81.16	2.0	226.0	DB02901	illicit; investigational	Stanolone	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
1285	tr|O50460|O50460_M	P14061	81.16	2.0	226.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1286	tr|O50460|O50460_M	P14061	81.16	2.0	226.0	DB13951	experimental	Stanolone acetate	CC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
1287	tr|O50460|O50460_M	O75911	70.65	35.0	230.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
1288	tr|O50460|O50460_M	Q02338	71.38	53.0	250.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1289	tr|O50460|O50460_M	Q9NYR8	70.65	5.0	200.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
1290	tr|O50460|O50460_M	Q8NBN7	74.28	36.0	241.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
1291	tr|O50460|O50460_M	Q8TC12	73.91	39.0	243.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
1292	tr|O50460|O50460_M	P37059	76.09	80.0	290.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1293	tr|O50460|O50460_M	P37059	76.09	80.0	290.0	DB13952	approved; investigational; vet_approved	Estradiol acetate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)C
1294	tr|O50460|O50460_M	P37059	76.09	80.0	290.0	DB13953	approved; investigational; vet_approved	Estradiol benzoate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)c5ccccc5
1295	tr|O50460|O50460_M	P37059	76.09	80.0	290.0	DB13954	approved; investigational; vet_approved	Estradiol cypionate	C1CCCC1CCC(=O)O[C@H]2CC[C@H]([C@@]23C)[C@H]4[C@H](CC3)c5c(CC4)cc(O)cc5
1296	tr|O50460|O50460_M	P37059	76.09	80.0	290.0	DB13955	approved; investigational; vet_approved	Estradiol dienanthate	CCCCCCC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)CCCCCC
1297	tr|O50460|O50460_M	P37059	76.09	80.0	290.0	DB13956	approved; investigational; vet_approved	Estradiol valerate	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)CC[C@@H]4OC(=O)CCCC
1298	tr|O50460|O50460_M	Q7AUG5	84.06	3.0	235.0	DB04782	experimental	(S)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@H]2CO2
1299	tr|O50460|O50460_M	Q93D82	84.06	3.0	235.0	DB04472	experimental	(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol	[N-]=[N+]=NC[C@H](O)c1ccc([N+]([O-])=O)cc1
1300	tr|O50460|O50460_M	Q93D82	84.06	3.0	235.0	DB04499	experimental	(R)-styrene oxide	C1O[C@@H]1c2ccccc2
1301	tr|O50460|O50460_M	Q93D82	84.06	3.0	235.0	DB04777	experimental	(R)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@@H]2CO2
1302	tr|O50460|O50460_M	Q96NR8	73.91	37.0	241.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
1303	tr|O50460|O50460_M	P80365	77.17	81.0	294.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1304	tr|O50460|O50460_M	P80365	77.17	81.0	294.0	DB01185	approved; illicit	Fluoxymesterone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@](F)([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
1305	tr|O50460|O50460_M	P80365	77.17	81.0	294.0	DB01569	experimental; illicit	Formebolone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@H]([C@@H](C2)O)[C@]4(C)C(CC3)=CC(=O)C(C=O)=C4
1306	tr|O50460|O50460_M	P80365	77.17	81.0	294.0	DB14538	experimental; vet_approved	Hydrocortisone aceponate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CC)C(=O)COC(=O)C
1307	tr|O50460|O50460_M	P80365	77.17	81.0	294.0	DB14539	approved; vet_approved	Hydrocortisone acetate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)C
1308	tr|O50460|O50460_M	P80365	77.17	81.0	294.0	DB14540	approved; vet_approved	Hydrocortisone butyrate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCC
1309	tr|O50460|O50460_M	P80365	77.17	81.0	294.0	DB14541	approved; investigational; vet_approved	Hydrocortisone cypionate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)CCC5CCCC5
1310	tr|O50460|O50460_M	P80365	77.17	81.0	294.0	DB14542	approved; vet_approved	Hydrocortisone phosphate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COP(=O)(O)O
1311	tr|O50460|O50460_M	P80365	77.17	81.0	294.0	DB14543	approved; vet_approved	Hydrocortisone probutate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CCC)C(=O)COC(=O)CC
1312	tr|O50460|O50460_M	P80365	77.17	81.0	294.0	DB14544	approved; vet_approved	Hydrocortisone valerate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCCC
1313	tr|O50460|O50460_M	Q99714	73.91	8.0	212.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1314	tr|O50460|O50460_M	Q99714	73.91	8.0	212.0	DB02820	experimental	1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct	C1CCCCCN1C(=O)[C@H](c2ccccc2)n(c3=S)cnc(c34)nn(c4)[C@H]5C=CN(C=C5C([O-])=N)[C@@H]6O[C@@H]([C@@H](O)[C@H]6O)COP([O-])(=O)OP(=O)(O)OC[C@H]7O[C@H]([C@H]([O-])[C@@H]7[O-])n8cnc(c89)c(N)ncn9
1315	tr|O50460|O50460_M	Q99714	73.91	8.0	212.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
1316	tr|O50460|O50460_M	P28845	71.74	30.0	228.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1317	tr|O50460|O50460_M	P28845	71.74	30.0	228.0	DB02329	experimental	Carbenoxolone	OC(=O)CCC(=O)O[C@@H](CC1)C(C)(C)[C@@H]([C@]12C)CC[C@]3(C)[C@@H]2C(=O)C=C4[C@H]5[C@@](C)(CC[C@@]34C)CC[C@](C5)(C)C(=O)O
1318	tr|O50460|O50460_M	P28845	71.74	30.0	228.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1319	tr|O50460|O50460_M	P28845	71.74	30.0	228.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
1320	tr|O50460|O50460_M	P28845	71.74	30.0	228.0	DB04652	experimental	Corticosterone	OCC(=O)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H]([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
1321	tr|O50460|O50460_M	P28845	71.74	30.0	228.0	DB05064	investigational	INCB13739	 
1322	tr|O50460|O50460_M	P28845	71.74	30.0	228.0	DB06992	experimental	(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone	Cc1ccc(cc1F)-c2nc(ccc2)C(=O)N(CC3(C)C)CCC3
1323	tr|O50460|O50460_M	P28845	71.74	30.0	228.0	DB07017	experimental	(5S)-2-{[(1S)-1-(4-Fluorophenyl)ethyl]amino}-5-(2-hydroxy-2-propanyl)-5-methyl-1,3-thiazol-4(5H)-one	Fc1ccc(cc1)[C@H](C)NC(=NC2=O)S[C@@]2(C)C(C)(C)O
1324	tr|O50460|O50460_M	P28845	71.74	30.0	228.0	DB07049	experimental	(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine	[O-][N+](=O)c1ccc(cc1)N2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)C(C)(C)C
1325	tr|O50460|O50460_M	P28845	71.74	30.0	228.0	DB07056	experimental	2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide	CCN(CC)C(=O)Cc1cccc(n1)NS(=O)(=O)c2c(C)c(Cl)ccc2
1326	tr|O50460|O50460_M	P28845	71.74	30.0	228.0	DB07310	experimental	(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one	Fc1ccccc1[C@H](C)NC(=NC2=O)S[C@]2(C)C(F)(F)F
1327	tr|O50460|O50460_M	P28845	71.74	30.0	228.0	DB07316	experimental	N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)C3CCN(CC3)CC4(CC4)C(=O)N
1328	tr|O50460|O50460_M	P28845	71.74	30.0	228.0	DB07619	experimental	N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)[C@H]3CC[C@@H](CC3)c4cccnc4
1329	tr|O50460|O50460_M	P28845	71.74	30.0	228.0	DB07624	experimental	1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide	C1CC1(C(=O)N)CN2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)[C@](C)(O)C(F)(F)F
1330	tr|O50460|O50460_M	P28845	71.74	30.0	228.0	DB07866	experimental	(5S)-2-(Cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one	CCC[C@]1(C)SC(=NC1=O)NC2CCCCCCC2
1331	tr|O50460|O50460_M	P28845	71.74	30.0	228.0	DB08277	experimental	2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE	CS(=O)(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4c(Cl)cc(F)cc4
1332	tr|O50460|O50460_M	P28845	71.74	30.0	228.0	DB08280	experimental	(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE	NC(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4ccc(OC)cc4
1333	tr|O50460|O50460_M	P28845	71.74	30.0	228.0	DB08771	experimental	(5R)-2-[(2-Fluorophenyl)amino]-5-isopropyl-1,3-thiazol-4(5H)-one	CC(C)[C@H]1SC(=NC1=O)Nc2c(F)cccc2
1334	tr|O50460|O50460_M	P28845	71.74	30.0	228.0	DB13751	approved; experimental	Glycyrrhizic acid	C1C[C@](C)(C(=O)O)C[C@H]([C@]12C)C=3[C@@](C)(CC2)[C@@]4(C)[C@H](C(=O)C3)[C@]5(C)[C@@H](CC4)C(C)(C)[C@H](CC5)O[C@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O[C@@H]7O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]7O
1335	tr|O50460|O50460_M	Q92781	72.46	28.0	228.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1336	tr|O50460|O50460_M	Q92781	72.46	28.0	228.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
1337	tr|O50460|O50460_M	P37058	71.01	48.0	244.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1338	tr|O50460|O50460_M	A0A348A0U3	89.49	1.0	248.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
1339	tr|O50460|O50460_M	Q6GI75	88.41	2.0	246.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
1340	tr|O50460|O50460_M	Q6GI75	88.41	2.0	246.0	DB11155	approved	Triclocarban	Clc1ccc(cc1)NC(=O)Nc2cc(Cl)c(Cl)cc2
1341	tr|O50460|O50460_M	Q8I814	92.03	13.0	267.0	DB02015	experimental	Dihydrofolic Acid	O=c1[nH]c(N)nc(c12)NCC(=N2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
1342	tr|O50460|O50460_M	Q8I814	92.03	13.0	267.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1343	tr|O50460|O50460_M	Q9HBH5	78.26	42.0	258.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
1344	tr|O50460|O50460_M	P0AEK4	87.68	3.0	245.0	DB01691	experimental	Indole Naphthyridinone	c1cccc(c12)n(C)cc2CN(C)C(=O)/C=C/c(c3)cnc(c34)NC(=O)CC4
1345	tr|O50460|O50460_M	P0AEK4	87.68	3.0	245.0	DB01865	experimental	3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide	c1cccc(c12)cc(n2C)CN(C)C(=O)/C=C/c3cnc(N)cc3
1346	tr|O50460|O50460_M	P0AEK4	87.68	3.0	245.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
1347	tr|O50460|O50460_M	P0AEK4	87.68	3.0	245.0	DB03030	experimental	4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole	Cc1ccc(cc1)Cn2cnc(c2)-c3cccs3
1348	tr|O50460|O50460_M	P0AEK4	87.68	3.0	245.0	DB03534	experimental	3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide	CC(=O)N(C)Cc1c(N)ccc(c1)C(=O)N(C)Cc(n2C)cc(c23)cccc3
1349	tr|O50460|O50460_M	P0AEK4	87.68	3.0	245.0	DB04030	experimental	1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole	Oc1ccc(cc1)Cn2c(c3c(c24)cccc4)CN(CC3)C(=O)c5ccc(O)cc5
1350	tr|O50460|O50460_M	P0AEK4	87.68	3.0	245.0	DB08265	experimental	2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL	Cc1ccc(cc1)S(=O)(=O)n(b2O)ncc(c23)cccc3
1351	tr|O50460|O50460_M	P0AEK4	87.68	3.0	245.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
1352	tr|O50460|O50460_M	P0AEK4	87.68	3.0	245.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
1353	tr|O50460|O50460_M	Q01782	98.19	8.0	279.0	DB02338	experimental	NADPH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1354	tr|O50460|O50460_M	Q01782	98.19	8.0	279.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
1355	tr|O50460|O50460_M	Q01782	98.19	8.0	279.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1356	tr|O50460|O50460_M	Q01782	98.19	8.0	279.0	DB04400	experimental	L-erythro-7,8-dihydrobiopterin	C[C@H](O)[C@H](O)C(CN1)=Nc(c12)c(=O)nc([nH]2)N
1357	tr|O50460|O50460_M	O24990	86.23	3.0	241.0	DB04393	experimental	Soneclosan	Clc1cc(O)c(cc1)Oc2ccc(Cl)cc2
1358	tr|O50460|O50460_M	O24990	86.23	3.0	241.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
1359	tr|O50460|O50460_M	P56937	82.97	2.0	231.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1360	tr|O50460|O50460_M	P35270	78.26	4.0	220.0	DB02637	experimental	Oxaloacetate Ion	OC(=O)C(=O)CC([O-])=O
1361	tr|O50460|O50460_M	P35270	78.26	4.0	220.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1362	tr|O50460|O50460_M	P35270	78.26	4.0	220.0	DB03886	experimental	Biopterin	C[C@@H](O)[C@@H](O)c(n1)cnc(c12)nc(N)[nH]c2=O
1363	tr|O50460|O50460_M	P35270	78.26	4.0	220.0	DB04275	experimental	N-acetylserotonin	CC(=O)NCCc1c[nH]c(c12)ccc(c2)O
1364	tr|O50460|O50460_M	P9WGR1	71.38	5.0	202.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
1365	tr|O50460|O50460_M	P9WGR1	71.38	5.0	202.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
1366	tr|O50460|O50460_M	P9WGR1	71.38	5.0	202.0	DB02990	experimental	S-(2-Acetamidoethyl) hexadecanethioate	CCCCCCCCCCCCCCCC(=O)SCCNC(=O)C
1367	tr|O50460|O50460_M	P9WGR1	71.38	5.0	202.0	DB04289	experimental	Genz-10850	[nH]1ccc(c12)cc(cc2)C(=O)N3CCN(CC3)C4c(cccc5)c5c(c46)cccc6
1368	tr|O50460|O50460_M	P9WGR1	71.38	5.0	202.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
1369	tr|O50460|O50460_M	P9WGR1	71.38	5.0	202.0	DB07090	experimental	(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cccc(c1C)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
1370	tr|O50460|O50460_M	P9WGR1	71.38	5.0	202.0	DB07123	experimental	N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE	Cc1ccc(cc1)C(=O)N2CCC(CC2)Cc3ccccc3
1371	tr|O50460|O50460_M	P9WGR1	71.38	5.0	202.0	DB07155	experimental	(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE	c1ccccc1NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
1372	tr|O50460|O50460_M	P9WGR1	71.38	5.0	202.0	DB07178	experimental	5-PENTYL-2-PHENOXYPHENOL	CCCCCc1cc(O)c(cc1)Oc2ccccc2
1373	tr|O50460|O50460_M	P9WGR1	71.38	5.0	202.0	DB07188	experimental	(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(cc(Cl)c1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
1374	tr|O50460|O50460_M	P9WGR1	71.38	5.0	202.0	DB07192	experimental	(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Brc1cc(ccc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
1375	tr|O50460|O50460_M	P9WGR1	71.38	5.0	202.0	DB07222	experimental	(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(c(C)cc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
1376	tr|O50460|O50460_M	P9WGR1	71.38	5.0	202.0	DB07287	experimental	2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL	c1cccnc1Cc2cc(O)c(cc2)Oc3ccc(Cl)cc3Cl
1377	tr|O50460|O50460_M	P9WGR1	71.38	5.0	202.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
1378	tr|O07248|O07248_M	O60701	100.23	6.0	450.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1379	tr|O07248|O07248_M	O60701	100.23	6.0	450.0	DB09130	approved; investigational	Copper	[Cu]
1380	tr|O07248|O07248_M	P0C0F4	89.84	1.0	399.0	DB01713	experimental	UDP-alpha-D-xylose	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3OC[C@@H](O)[C@H](O)[C@H]3O
1381	tr|O07248|O07248_M	P0C0F4	89.84	1.0	399.0	DB03041	experimental	UDP-alpha-D-glucuronic acid	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O
1382	tr|O07248|O07248_M	P11759	90.29	1.0	401.0	DB04023	experimental	GDP-alpha-D-mannuronic acid	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O[C@H]4O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@@H]4O
1383	tr|I6WZD7|I6WZD7_M	P07445	76.98	14.0	121.0	DB03515	experimental	Equilenin	O=C1CC[C@H]([C@@]12C)c3c(CC2)c4c(cc3)cc(O)cc4
1384	tr|I6WZD7|I6WZD7_M	P07445	76.98	14.0	121.0	DB03619	approved	Deoxycholic acid	C1C[C@@H](O)C[C@H]([C@]12C)CC[C@@H]3[C@@H]2C[C@H](O)[C@@]4(C)[C@H]3CC[C@@H]4[C@H](C)CCC(=O)O
1385	tr|I6WZD7|I6WZD7_M	P00947	77.7	9.0	117.0	DB01561	experimental; illicit	Androstanedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
1386	tr|I6WZD7|I6WZD7_M	P00947	77.7	9.0	117.0	DB03515	experimental	Equilenin	O=C1CC[C@H]([C@@]12C)c3c(CC2)c4c(cc3)cc(O)cc4
1387	tr|I6WZD7|I6WZD7_M	P00947	77.7	9.0	117.0	DB04693	experimental	Estrane-3,17-dione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@@H]4[C@@H](CC3)CC(=O)CC4
1388	tr|I6WZD7|I6WZD7_M	P00947	77.7	9.0	117.0	DB08308	experimental	SUCCINIC ACID MONO-(13-METHYL-3-OXO-2,3,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL) ESTER	OC(=O)CCC(=O)O[C@@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@@H]4C(CC3)=CC(=O)CC4
1389	tr|O86318|O86318_M	Q9HCC0	99.81	35.0	563.0	DB00121	approved; investigational; nutraceutical	Biotin	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC(=O)O
1390	tr|O86318|O86318_M	Q8GBW6	94.33	9.0	508.0	DB04045	experimental	(R)-methylmalonyl-CoA	OC(=O)[C@@H](C)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
1391	tr|O86318|O86318_M	Q8GBW6	94.33	9.0	508.0	DB04183	experimental	Methylmalonic Acid	OC(=O)C(C)C(=O)O
1392	tr|O86318|O86318_M	Q9X4K7	94.52	11.0	511.0	DB02912	experimental	Propanoyl-CoA	CCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
1393	tr|O86318|O86318_M	P05166	93.57	31.0	526.0	DB00121	approved; investigational; nutraceutical	Biotin	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC(=O)O
1394	tr|O86318|O86318_M	P05166	93.57	31.0	526.0	DB00161	approved; nutraceutical	Valine	CC(C)[C@H](N)C(=O)O
1395	tr|O86318|O86318_M	Q06700	100.95	27.0	561.0	DB01942	experimental; investigational	Formic acid	OC=O
1396	tr|O05896|O05896_M	P30825	86.46	10.0	438.0	DB00123	approved; nutraceutical	L-Lysine	NCCCC[C@H](N)C(=O)O
1397	tr|O05896|O05896_M	P30825	86.46	10.0	438.0	DB00125	investigational; nutraceutical	Arginine	OC(=O)[C@@H](N)CCCNC(N)=N
1398	tr|O05896|O05896_M	P30825	86.46	10.0	438.0	DB00129	approved; nutraceutical	Ornithine	NCCC[C@H](N)C(=O)O
1399	tr|O05896|O05896_M	Q8WY07	86.46	8.0	436.0	DB00123	approved; nutraceutical	L-Lysine	NCCCC[C@H](N)C(=O)O
1400	tr|O05896|O05896_M	Q8WY07	86.46	8.0	436.0	DB00125	investigational; nutraceutical	Arginine	OC(=O)[C@@H](N)CCCNC(N)=N
1401	tr|O05896|O05896_M	Q8WY07	86.46	8.0	436.0	DB13146	approved	Fluciclovine (18F)	OC(=O)[C@]1(N)C[C@H]([18F])C1
1402	tr|O05896|O05896_M	P52569	85.05	14.0	435.0	DB00123	approved; nutraceutical	L-Lysine	NCCCC[C@H](N)C(=O)O
1403	tr|O05896|O05896_M	P52569	85.05	14.0	435.0	DB00129	approved; nutraceutical	Ornithine	NCCC[C@H](N)C(=O)O
1404	tr|O05896|O05896_M	O43246	82.02	13.0	419.0	DB00123	approved; nutraceutical	L-Lysine	NCCCC[C@H](N)C(=O)O
1405	tr|O05896|O05896_M	O43246	82.02	13.0	419.0	DB00125	investigational; nutraceutical	Arginine	OC(=O)[C@@H](N)CCCNC(N)=N
1406	tr|O05896|O05896_M	Q9UPY5	88.08	34.0	470.0	DB00138	approved; nutraceutical	Cystine	OC(=O)[C@@H](N)CSSC[C@H](N)C(=O)O
1407	tr|O05896|O05896_M	Q9UPY5	88.08	34.0	470.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
1408	tr|O05896|O05896_M	Q9UPY5	88.08	34.0	470.0	DB00740	approved; investigational	Riluzole	Nc(s1)nc(c12)ccc(c2)OC(F)(F)F
1409	tr|O05896|O05896_M	Q9UPY5	88.08	34.0	470.0	DB00795	approved	Sulfasalazine	OC(=O)c1cc(ccc1O)/N=N/c2ccc(cc2)S(=O)(=O)Nc3ncccc3
1410	tr|O05896|O05896_M	Q9UPY5	88.08	34.0	470.0	DB06151	approved; investigational	Acetylcysteine	CC(=O)N[C@@H](CS)C(=O)O
1411	tr|O05896|O05896_M	Q9UPY5	88.08	34.0	470.0	DB11590	approved	Thimerosal	CC[Hg]Sc1ccccc1C([O-])=O
1412	tr|O05896|O05896_M	Q9UHI5	88.28	34.0	471.0	DB00120	approved; investigational; nutraceutical	Phenylalanine	OC(=O)[C@@H](N)Cc1ccccc1
1413	tr|O05896|O05896_M	Q9UHI5	88.28	34.0	471.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
1414	tr|O05896|O05896_M	Q9UM01	86.67	28.0	457.0	DB13146	approved	Fluciclovine (18F)	OC(=O)[C@]1(N)C[C@H]([18F])C1
1415	tr|O05896|O05896_M	P60063	86.06	8.0	434.0	DB02451	experimental	B-nonylglucoside	CCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
1416	tr|L0TDU1|L0TDU1_M	P11166	83.07	62.0	479.0	DB02709	investigational	Resveratrol	Oc1ccc(cc1)/C=C/c2cc(O)cc(O)c2
1417	tr|L0TDU1|L0TDU1_M	P11166	83.07	62.0	479.0	DB11059	approved; investigational	Carboxymethylcellulose	 
1418	tr|L0TDU1|L0TDU1_M	Q8TCC7	83.86	97.0	518.0	DB00493	approved	Cefotaxime	CC(=O)OCC(=C1C(=O)O)CS[C@@H](N12)[C@@H](C2=O)NC(=O)/C(=N\OC)c3csc(n3)N
1419	tr|L0TDU1|L0TDU1_M	Q8TCC7	83.86	97.0	518.0	DB01032	approved; investigational	Probenecid	CCCN(CCC)S(=O)(=O)c1ccc(cc1)C(=O)O
1420	tr|L0TDU1|L0TDU1_M	Q8TCC7	83.86	97.0	518.0	DB01053	approved; vet_approved	Benzylpenicillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)Cc3ccccc3
1421	tr|L0TDU1|L0TDU1_M	Q8TCC7	83.86	97.0	518.0	DB01212	approved	Ceftriaxone	Nc1nc(cs1)/C(=N/OC)C(=O)N[C@H](C2=O)[C@H](N23)SCC(=C3C(=O)O)CSc4nc(=O)c(=O)[nH]n4C
1422	tr|L0TDU1|L0TDU1_M	Q8TCC7	83.86	97.0	518.0	DB01241	approved	Gemfibrozil	Cc1cc(c(C)cc1)OCCCC(C)(C)C(=O)O
1423	tr|L0TDU1|L0TDU1_M	Q8TCC7	83.86	97.0	518.0	DB11995	approved; investigational	Avatrombopag	OC(=O)C1CCN(CC1)c2c(Cl)cc(cn2)C(=O)Nc3nc(-c4cc(Cl)cs4)c(s3)N5CCN(CC5)C6CCCCC6
1424	tr|L0TDU1|L0TDU1_M	Q4U2R8	83.07	111.0	528.0	DB00493	approved	Cefotaxime	CC(=O)OCC(=C1C(=O)O)CS[C@@H](N12)[C@@H](C2=O)NC(=O)/C(=N\OC)c3csc(n3)N
1425	tr|L0TDU1|L0TDU1_M	Q4U2R8	83.07	111.0	528.0	DB01032	approved; investigational	Probenecid	CCCN(CCC)S(=O)(=O)c1ccc(cc1)C(=O)O
1426	tr|L0TDU1|L0TDU1_M	Q4U2R8	83.07	111.0	528.0	DB01212	approved	Ceftriaxone	Nc1nc(cs1)/C(=N/OC)C(=O)N[C@H](C2=O)[C@H](N23)SCC(=C3C(=O)O)CSc4nc(=O)c(=O)[nH]n4C
1427	tr|L0TDU1|L0TDU1_M	O76082	82.67	122.0	537.0	DB00583	approved; investigational	Levocarnitine	C[N+](C)(C)C[C@H](O)CC([O-])=O
1428	tr|L0TDU1|L0TDU1_M	P11168	85.06	87.0	514.0	DB00428	approved; investigational	Streptozocin	O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O
1429	tr|L0TDU1|L0TDU1_M	Q9NSA0	83.07	119.0	536.0	DB00493	approved	Cefotaxime	CC(=O)OCC(=C1C(=O)O)CS[C@@H](N12)[C@@H](C2=O)NC(=O)/C(=N\OC)c3csc(n3)N
1430	tr|L0TDU1|L0TDU1_M	Q9NSA0	83.07	119.0	536.0	DB01032	approved; investigational	Probenecid	CCCN(CCC)S(=O)(=O)c1ccc(cc1)C(=O)O
1431	tr|L0TDU1|L0TDU1_M	Q9NSA0	83.07	119.0	536.0	DB01212	approved	Ceftriaxone	Nc1nc(cs1)/C(=N/OC)C(=O)N[C@H](C2=O)[C@H](N23)SCC(=C3C(=O)O)CSc4nc(=O)c(=O)[nH]n4C
1432	tr|L0TDU1|L0TDU1_M	Q9NSA0	83.07	119.0	536.0	DB11560	approved; investigational	Lesinurad	OC(=O)CSc1nnc(Br)n1-c2ccc(C3CC3)c(c24)cccc4
1433	tr|L0TDU1|L0TDU1_M	Q9H015	81.27	122.0	530.0	DB00583	approved; investigational	Levocarnitine	C[N+](C)(C)C[C@H](O)CC([O-])=O
1434	tr|L0TDU1|L0TDU1_M	Q96S37	83.07	122.0	539.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
1435	tr|L0TDU1|L0TDU1_M	Q96S37	83.07	122.0	539.0	DB11560	approved; investigational	Lesinurad	OC(=O)CSc1nnc(Br)n1-c2ccc(C3CC3)c(c24)cccc4
1436	tr|L0TDU1|L0TDU1_M	Q9Y694	82.47	118.0	532.0	DB00493	approved	Cefotaxime	CC(=O)OCC(=C1C(=O)O)CS[C@@H](N12)[C@@H](C2=O)NC(=O)/C(=N\OC)c3csc(n3)N
1437	tr|O06572|O06572_M	Q08828	75.61	865.0	989.0	DB00131	approved; investigational; nutraceutical	Adenosine phosphate	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
1438	tr|O06572|O06572_M	Q08828	75.61	865.0	989.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
1439	tr|O06572|O06572_M	Q08828	75.61	865.0	989.0	DB09121	approved; withdrawn	Aurothioglucose	OC[C@H]1O[C@H](S[Au])[C@H](O)[C@@H](O)[C@@H]1O
1440	tr|O06572|O06572_M	O95622	79.88	1058.0	1189.0	DB02587	experimental; investigational	Colforsin	O[C@H]1CCC(C)(C)[C@@H]([C@]12C)[C@H](O)[C@H](OC(=O)C)[C@]3(C)[C@]2(O)C(=O)C[C@](O3)(C)C=C
1441	tr|O06572|O06572_M	O95622	79.88	1058.0	1189.0	DB06843	experimental	2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE	OP(=O)(O)O[C@H]1C[C@@H](O[C@@H]1C)n2cnc(c23)c(N)ncn3
1442	tr|O06572|O06572_M	O95622	79.88	1058.0	1189.0	DB09121	approved; withdrawn	Aurothioglucose	OC[C@H]1O[C@H](S[Au])[C@H](O)[C@@H](O)[C@@H]1O
1443	tr|O06572|O06572_M	Q08462	78.05	883.0	1011.0	DB02587	experimental; investigational	Colforsin	O[C@H]1CCC(C)(C)[C@@H]([C@]12C)[C@H](O)[C@H](OC(=O)C)[C@]3(C)[C@]2(O)C(=O)C[C@](O3)(C)C=C
1444	tr|O06572|O06572_M	Q08462	78.05	883.0	1011.0	DB06843	experimental	2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE	OP(=O)(O)O[C@H]1C[C@@H](O[C@@H]1C)n2cnc(c23)c(N)ncn3
1445	tr|O06572|O06572_M	Q08462	78.05	883.0	1011.0	DB09121	approved; withdrawn	Aurothioglucose	OC[C@H]1O[C@H](S[Au])[C@H](O)[C@@H](O)[C@@H]1O
1446	tr|O06572|O06572_M	P94182	75.61	584.0	708.0	DB02527	experimental	Cyclic adenosine monophosphate	n1cnc(N)c(c12)ncn2[C@@H]([C@@H]3O)O[C@@H]([C@H]34)COP(O4)(=O)O
1447	tr|O06572|O06572_M	P16066	76.22	860.0	985.0	DB00325	approved; investigational	Nitroprusside	O=N[Fe-2](C#N)(C#N)(C#N)(C#N)C#N
1448	tr|O06572|O06572_M	P16066	76.22	860.0	985.0	DB00727	approved; investigational	Nitroglycerin	[O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O
1449	tr|O06572|O06572_M	P16066	76.22	860.0	985.0	DB00883	approved; investigational	Isosorbide dinitrate	[O-][N+](=O)O[C@H]1CO[C@@H]([C@@H]12)[C@@H](CO2)O[N+]([O-])=O
1450	tr|O06572|O06572_M	P16066	76.22	860.0	985.0	DB01612	approved	Amyl Nitrite	CCCCCON=O
1451	tr|O06572|O06572_M	P16066	76.22	860.0	985.0	DB01613	approved; experimental; investigational	Erythrityl tetranitrate	[O-][N+](=O)OC[C@@H](O[N+]([O-])=O)[C@@H](O[N+]([O-])=O)CO[N+]([O-])=O
1453	tr|O06572|O06572_M	P16066	76.22	860.0	985.0	DB05034	investigational	Ularitide	O=C1NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(=O)O)Cc3ccc(O)cc3)CSSC[C@@H](C(=O)N[C@@H](Cc4ccccc4)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H]1[C@@H](C)CC)CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]5CCCN5C(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O
1454	tr|O06572|O06572_M	P20594	76.22	845.0	970.0	DB01613	approved; experimental; investigational	Erythrityl tetranitrate	[O-][N+](=O)OC[C@@H](O[N+]([O-])=O)[C@@H](O[N+]([O-])=O)CO[N+]([O-])=O
1456	tr|O06572|O06572_M	P33402	71.95	509.0	627.0	DB00435	approved	Nitric Oxide	N=O
1457	tr|O06572|O06572_M	P33402	71.95	509.0	627.0	DB01020	approved	Isosorbide mononitrate	O1C[C@H](O)[C@H]([C@H]12)OC[C@H]2O[N+]([O-])=O
1458	tr|O06572|O06572_M	P33402	71.95	509.0	627.0	DB08931	approved	Riociguat	COC(=O)N(C)c1c(N)nc(nc1N)-c2nn(c(c23)nccc3)Cc4c(F)cccc4
1459	tr|O06572|O06572_M	P33402	71.95	509.0	627.0	DB09241	approved; investigational	Methylene blue	CN(C)c(cc1)cc(c12)[s+]c3c(n2)ccc(c3)N(C)C
1460	tr|O06572|O06572_M	P33402	71.95	509.0	627.0	DB09282	approved; investigational	Molsidomine	CCOC(=O)[N-]c1c[n+](no1)N2CCOCC2
1461	tr|O06572|O06572_M	P33402	71.95	509.0	627.0	DB13170	approved; investigational	Plecanatide	[C@@H]12NC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@H](C(=O)O)CC(C)C)NC(=O)CNC(=O)[C@@H](NC1=O)[C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CSSC2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CC(=O)N
1462	tr|O06572|O06572_M	O32393	73.17	1004.0	1124.0	DB02355	experimental	Adenosine-5'-Rp-Alpha-Thio-Triphosphate	OP(=O)(O)OP(=O)(O)O[P@@](=S)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
1463	tr|O06572|O06572_M	O32393	73.17	1004.0	1124.0	DB02596	experimental	alpha,beta-Methyleneadenosine 5'-triphosphate	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)CP(=O)(O)OP(=O)(O)O
1464	tr|O06572|O06572_M	O32393	73.17	1004.0	1124.0	DB07706	experimental	2-Hydroxyestradiol	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)c(c4)O
1465	tr|O53872|O53872_M	P40939	97.78	46.0	750.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1466	tr|O53872|O53872_M	P28793	96.67	7.0	703.0	DB08249	experimental	3,6,9,12,15-PENTAOXATRICOSAN-1-OL	CCCCCCCCOCCOCCOCCOCCOCCO
1467	tr|O53872|O53872_M	Q08426	93.75	6.0	681.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1468	tr|O06348|O06348_M	Q9BTZ2	79.94	23.0	274.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
1469	tr|O06348|O06348_M	Q9WYS2	78.66	6.0	253.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1470	tr|O06348|O06348_M	P0AET8	77.39	6.0	249.0	DB02123	experimental	Glycochenodeoxycholic Acid	OC(=O)CNC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
1471	tr|O06348|O06348_M	Q16698	82.48	54.0	313.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1472	tr|O06348|O06348_M	Q16698	82.48	54.0	313.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
1474	tr|O06348|O06348_M	P0AEK2	76.43	2.0	242.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1476	tr|O06348|O06348_M	Q92506	81.53	3.0	259.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1477	tr|O06348|O06348_M	Q92506	81.53	3.0	259.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1479	tr|O06348|O06348_M	Q84EX5	78.98	2.0	250.0	DB04619	experimental	Acetophenone	CC(=O)c1ccccc1
1480	tr|O06348|O06348_M	Q84EX5	78.98	2.0	250.0	DB04784	experimental	(R)-1-phenylethanol	C[C@@H](O)c1ccccc1
1481	tr|O06348|O06348_M	Q9BY49	80.57	16.0	269.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
1482	tr|O06348|O06348_M	P0CG22	80.89	23.0	277.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
1483	tr|O06348|O06348_M	P0CG22	80.89	23.0	277.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1484	tr|O06348|O06348_M	P0CG22	80.89	23.0	277.0	DB03541	experimental	10-Propargyl-5,8-Dideazafolic Acid	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(CC#C)Cc(c2)ccc(c23)[nH]c(N)nc3=O
1485	tr|O06348|O06348_M	P0CG22	80.89	23.0	277.0	DB07689	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)NCc(cn3)nc(c34)c(N)nc(n4)N
1486	tr|O06348|O06348_M	P0CG22	80.89	23.0	277.0	DB07765	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)N(C)Cc(cn3)nc(c34)c(N)nc(n4)N
1487	tr|O06348|O06348_M	Q7Z4W1	76.11	2.0	241.0	DB02831	experimental	Dihydrogenphosphate	OP([O-])(=O)O
1488	tr|O06348|O06348_M	Q7Z4W1	76.11	2.0	241.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1489	tr|O06348|O06348_M	P16544	80.57	5.0	258.0	DB01942	experimental; investigational	Formic acid	OC=O
1490	tr|O06348|O06348_M	P16544	80.57	5.0	258.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1491	tr|O06348|O06348_M	P16544	80.57	5.0	258.0	DB07715	investigational	Emodin	Cc(c1)cc(O)c(c12)C(=O)c3c(C2=O)cc(O)cc3O
1492	tr|O06348|O06348_M	A0A348A0U3	79.62	4.0	254.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
1493	tr|O06348|O06348_M	Q6GI75	79.94	2.0	253.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
1494	tr|O06348|O06348_M	Q6GI75	79.94	2.0	253.0	DB11155	approved	Triclocarban	Clc1ccc(cc1)NC(=O)Nc2cc(Cl)c(Cl)cc2
1495	tr|O06348|O06348_M	P0AEK4	80.57	4.0	257.0	DB01691	experimental	Indole Naphthyridinone	c1cccc(c12)n(C)cc2CN(C)C(=O)/C=C/c(c3)cnc(c34)NC(=O)CC4
1496	tr|O06348|O06348_M	P0AEK4	80.57	4.0	257.0	DB01865	experimental	3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide	c1cccc(c12)cc(n2C)CN(C)C(=O)/C=C/c3cnc(N)cc3
1497	tr|O06348|O06348_M	P0AEK4	80.57	4.0	257.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
1498	tr|O06348|O06348_M	P0AEK4	80.57	4.0	257.0	DB03030	experimental	4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole	Cc1ccc(cc1)Cn2cnc(c2)-c3cccs3
1499	tr|O06348|O06348_M	P0AEK4	80.57	4.0	257.0	DB03534	experimental	3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide	CC(=O)N(C)Cc1c(N)ccc(c1)C(=O)N(C)Cc(n2C)cc(c23)cccc3
1500	tr|O06348|O06348_M	P0AEK4	80.57	4.0	257.0	DB04030	experimental	1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole	Oc1ccc(cc1)Cn2c(c3c(c24)cccc4)CN(CC3)C(=O)c5ccc(O)cc5
1501	tr|O06348|O06348_M	P0AEK4	80.57	4.0	257.0	DB08265	experimental	2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL	Cc1ccc(cc1)S(=O)(=O)n(b2O)ncc(c23)cccc3
1502	tr|O06348|O06348_M	P0AEK4	80.57	4.0	257.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
1503	tr|O06348|O06348_M	P0AEK4	80.57	4.0	257.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
1504	tr|O06348|O06348_M	Q7AUG5	78.98	3.0	251.0	DB04782	experimental	(S)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@H]2CO2
1505	tr|O06348|O06348_M	Q93D82	78.98	3.0	251.0	DB04472	experimental	(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol	[N-]=[N+]=NC[C@H](O)c1ccc([N+]([O-])=O)cc1
1506	tr|O06348|O06348_M	Q93D82	78.98	3.0	251.0	DB04499	experimental	(R)-styrene oxide	C1O[C@@H]1c2ccccc2
1507	tr|O06348|O06348_M	Q93D82	78.98	3.0	251.0	DB04777	experimental	(R)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@@H]2CO2
1508	tr|O06348|O06348_M	Q99714	80.25	7.0	259.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1509	tr|O06348|O06348_M	Q99714	80.25	7.0	259.0	DB02820	experimental	1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct	C1CCCCCN1C(=O)[C@H](c2ccccc2)n(c3=S)cnc(c34)nn(c4)[C@H]5C=CN(C=C5C([O-])=N)[C@@H]6O[C@@H]([C@@H](O)[C@H]6O)COP([O-])(=O)OP(=O)(O)OC[C@H]7O[C@H]([C@H]([O-])[C@@H]7[O-])n8cnc(c89)c(N)ncn9
1510	tr|O06348|O06348_M	Q99714	80.25	7.0	259.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
1511	tr|O06348|O06348_M	Q6UWP2	77.07	8.0	250.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1513	tr|O06348|O06348_M	O24990	79.3	4.0	253.0	DB04393	experimental	Soneclosan	Clc1cc(O)c(cc1)Oc2ccc(Cl)cc2
1514	tr|O06348|O06348_M	O24990	79.3	4.0	253.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
1515	tr|O06348|O06348_M	Q8I814	83.44	13.0	275.0	DB02015	experimental	Dihydrofolic Acid	O=c1[nH]c(N)nc(c12)NCC(=N2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
1516	tr|O06348|O06348_M	Q8I814	83.44	13.0	275.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1517	tr|O06348|O06348_M	Q01782	88.85	8.0	287.0	DB02338	experimental	NADPH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1518	tr|O06348|O06348_M	Q01782	88.85	8.0	287.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
1519	tr|O06348|O06348_M	Q01782	88.85	8.0	287.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1520	tr|O06348|O06348_M	Q01782	88.85	8.0	287.0	DB04400	experimental	L-erythro-7,8-dihydrobiopterin	C[C@H](O)[C@H](O)C(CN1)=Nc(c12)c(=O)nc([nH]2)N
1521	tr|O06348|O06348_M	O75911	73.25	32.0	262.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
1522	tr|O06348|O06348_M	Q9HBH5	79.94	41.0	292.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
1523	tr|O06348|O06348_M	P9WGR1	82.8	5.0	265.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
1524	tr|O06348|O06348_M	P9WGR1	82.8	5.0	265.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
1525	tr|O06348|O06348_M	P9WGR1	82.8	5.0	265.0	DB02990	experimental	S-(2-Acetamidoethyl) hexadecanethioate	CCCCCCCCCCCCCCCC(=O)SCCNC(=O)C
1526	tr|O06348|O06348_M	P9WGR1	82.8	5.0	265.0	DB04289	experimental	Genz-10850	[nH]1ccc(c12)cc(cc2)C(=O)N3CCN(CC3)C4c(cccc5)c5c(c46)cccc6
1527	tr|O06348|O06348_M	P9WGR1	82.8	5.0	265.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
1528	tr|O06348|O06348_M	P9WGR1	82.8	5.0	265.0	DB07090	experimental	(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cccc(c1C)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
1529	tr|O06348|O06348_M	P9WGR1	82.8	5.0	265.0	DB07123	experimental	N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE	Cc1ccc(cc1)C(=O)N2CCC(CC2)Cc3ccccc3
1530	tr|O06348|O06348_M	P9WGR1	82.8	5.0	265.0	DB07155	experimental	(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE	c1ccccc1NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
1531	tr|O06348|O06348_M	P9WGR1	82.8	5.0	265.0	DB07178	experimental	5-PENTYL-2-PHENOXYPHENOL	CCCCCc1cc(O)c(cc1)Oc2ccccc2
1532	tr|O06348|O06348_M	P9WGR1	82.8	5.0	265.0	DB07188	experimental	(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(cc(Cl)c1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
1533	tr|O06348|O06348_M	P9WGR1	82.8	5.0	265.0	DB07192	experimental	(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Brc1cc(ccc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
1534	tr|O06348|O06348_M	P9WGR1	82.8	5.0	265.0	DB07222	experimental	(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(c(C)cc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
1535	tr|O06348|O06348_M	P9WGR1	82.8	5.0	265.0	DB07287	experimental	2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL	c1cccnc1Cc2cc(O)c(cc2)Oc3ccc(Cl)cc3Cl
1536	tr|O06348|O06348_M	P9WGR1	82.8	5.0	265.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
1537	tr|O06348|O06348_M	P16152	77.71	7.0	251.0	DB01698	approved; experimental; investigational	Rutin	O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O[C@H]1C)OC[C@H]2O[C@H]([C@H](O)[C@@H](O)[C@@H]2O)Oc(c3=O)c(-c4cc(O)c(O)cc4)oc(c35)cc(O)cc5O
1538	tr|O06348|O06348_M	P16152	77.71	7.0	251.0	DB02709	investigational	Resveratrol	Oc1ccc(cc1)/C=C/c2cc(O)cc(O)c2
1539	tr|O06348|O06348_M	P16152	77.71	7.0	251.0	DB03394	experimental	Heptaethylene glycol	OCCOCCOCCOCCOCCOCCOCCO
1540	tr|O06348|O06348_M	P16152	77.71	7.0	251.0	DB03556	experimental	2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400	CCOCCOCCOCCOCCOCCOCCOCCOCCO
1541	tr|O06348|O06348_M	P16152	77.71	7.0	251.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
1542	tr|O06348|O06348_M	P16152	77.71	7.0	251.0	DB04463	experimental	3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol	n1cnc(N)c(c12)c(nn2C(C)(C)C)-c3cccc(O)c3
1543	tr|O06348|O06348_M	P16152	77.71	7.0	251.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
1544	tr|O06348|O06348_M	P16152	77.71	7.0	251.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
1545	tr|O06348|O06348_M	P35270	75.16	7.0	243.0	DB02637	experimental	Oxaloacetate Ion	OC(=O)C(=O)CC([O-])=O
1546	tr|O06348|O06348_M	P35270	75.16	7.0	243.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1547	tr|O06348|O06348_M	P35270	75.16	7.0	243.0	DB03886	experimental	Biopterin	C[C@@H](O)[C@@H](O)c(n1)cnc(c12)nc(N)[nH]c2=O
1548	tr|O06348|O06348_M	P35270	75.16	7.0	243.0	DB04275	experimental	N-acetylserotonin	CC(=O)NCCc1c[nH]c(c12)ccc(c2)O
1549	tr|P71750|P71750_M	P19440	82.58	37.0	568.0	DB00143	approved; investigational; nutraceutical	Glutathione	OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(=O)O
1550	tr|I6YGX2|I6YGX2_M	Q8XJ01	74.57	61.0	665.0	DB00229	approved; investigational	Cefotiam	Nc1nc(cs1)CC(=O)N[C@H](C2=O)[C@H](N23)SCC(=C3C(=O)O)CSc4nnnn4CCN(C)C
1551	tr|I6YGX2|I6YGX2_M	Q8XJ01	74.57	61.0	665.0	DB00267	approved	Cefmenoxime	Nc1nc(cs1)/C(=N/OC)C(=O)N[C@H](C2=O)[C@H](N23)SCC(=C3C(=O)O)CSc4nnnn4C
1552	tr|I6YGX2|I6YGX2_M	Q8XJ01	74.57	61.0	665.0	DB00301	approved; investigational	Flucloxacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)c3c(C)onc3-c4c(Cl)cccc4F
1553	tr|I6YGX2|I6YGX2_M	Q8XJ01	74.57	61.0	665.0	DB00417	approved; vet_approved	Phenoxymethylpenicillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)COc3ccccc3
1554	tr|I6YGX2|I6YGX2_M	Q8XJ01	74.57	61.0	665.0	DB00447	approved; investigational; withdrawn	Loracarbef	c1ccccc1[C@@H](N)C(=O)N[C@H](C2=O)[C@H](N23)CCC(Cl)=C3C(=O)O
1555	tr|I6YGX2|I6YGX2_M	Q8XJ01	74.57	61.0	665.0	DB00456	approved; investigational; vet_approved	Cefalotin	CC(=O)OCC(CS1)=C(C(=O)O)N([C@H]12)C(=O)[C@H]2NC(=O)Cc3cccs3
1556	tr|I6YGX2|I6YGX2_M	Q8XJ01	74.57	61.0	665.0	DB00713	approved; investigational	Oxacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)c3c(C)onc3-c4ccccc4
1557	tr|I6YGX2|I6YGX2_M	Q8XJ01	74.57	61.0	665.0	DB00833	approved	Cefaclor	O=C(O)C1=C(Cl)CS[C@@H](N12)[C@@H](C2=O)NC(=O)[C@H](N)c3ccccc3
1558	tr|I6YGX2|I6YGX2_M	Q8XJ01	74.57	61.0	665.0	DB00948	approved; investigational	Mezlocillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)[C@@H](c3ccccc3)NC(=O)N4CCN(C4=O)S(=O)(=O)C
1559	tr|I6YGX2|I6YGX2_M	Q8XJ01	74.57	61.0	665.0	DB01061	approved	Azlocillin	O=C1NCCN1C(=O)N[C@H](c2ccccc2)C(=O)N[C@@H]3C(=O)N([C@@H]34)[C@H](C(S4)(C)C)C(=O)O
1560	tr|I6YGX2|I6YGX2_M	Q8XJ01	74.57	61.0	665.0	DB01066	approved; investigational	Cefditoren	Cc1ncsc1/C=C\C(=C2C(=O)O)CS[C@@H](N23)[C@@H](C3=O)NC(=O)/C(=N\OC)c4csc(n4)N
1561	tr|I6YGX2|I6YGX2_M	Q8XJ01	74.57	61.0	665.0	DB01112	approved	Cefuroxime	NC(=O)OCC(=C1C(=O)O)CS[C@@H](N12)[C@@H](C2=O)NC(=O)/C(=N\OC)c3ccco3
1562	tr|I6YGX2|I6YGX2_M	Q8XJ01	74.57	61.0	665.0	DB01139	approved; vet_approved	Cefapirin	CC(=O)OCC(=C1C(=O)O)CS[C@@H](N12)[C@@H](C2=O)NC(=O)CSc3ccncc3
1563	tr|I6YGX2|I6YGX2_M	Q8XJ01	74.57	61.0	665.0	DB01147	approved; investigational; vet_approved	Cloxacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)c3c(C)onc3-c4ccccc4Cl
1564	tr|I6YGX2|I6YGX2_M	Q8XJ01	74.57	61.0	665.0	DB01604	approved	Pivampicillin	CC(C)(C)C(=O)OCOC(=O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)[C@H](N)c3ccccc3
1565	tr|I6YGX2|I6YGX2_M	Q8XJ01	74.57	61.0	665.0	DB01605	approved	Pivmecillinam	C1CCCCCN1/C=N/[C@@H]2C(=O)N([C@@H]23)[C@H](C(S3)(C)C)C(=O)OCOC(=O)C(C)(C)C
1566	tr|I6YGX2|I6YGX2_M	Q8XJ01	74.57	61.0	665.0	DB04133	experimental	Degraded Cephaloridine	CC1=C(C(=O)O)N[C@H](SC1)[C@@H](C=O)NC(=O)Cc2cccs2
1567	tr|I6YGX2|I6YGX2_M	Q8L103	72.59	23.0	611.0	DB01060	approved; vet_approved	Amoxicillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)[C@H](N)c3ccc(O)cc3
1568	tr|I6YGX2|I6YGX2_M	A0A0H2WWQ9	73.21	35.0	628.0	DB04147	experimental	Dodecyldimethylamine N-oxide	CCCCCCCCCCCC[N+]([O-])(C)C
1569	tr|I6YGX2|I6YGX2_M	O70038	72.35	97.0	683.0	DB08401	experimental	(2E)-2-({(2S)-2-CARBOXY-2-[(PHENOXYACETYL)AMINO]ETHOXY}IMINO)PENTANEDIOIC ACID	OC(=O)CC/C(C(=O)O)=N\OC[C@@H](C(=O)O)NC(=O)COc1ccccc1
1570	tr|I6YGX2|I6YGX2_M	Q7CRA4	72.35	97.0	683.0	DB00319	approved	Piperacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)[C@@H](c3ccccc3)NC(=O)N4CCN(CC)C(=O)C4=O
1571	tr|I6YGX2|I6YGX2_M	Q7CRA4	72.35	97.0	683.0	DB00415	approved; vet_approved	Ampicillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)[C@H](N)c3ccccc3
1572	tr|I6YGX2|I6YGX2_M	Q7CRA4	72.35	97.0	683.0	DB00456	approved; investigational; vet_approved	Cefalotin	CC(=O)OCC(CS1)=C(C(=O)O)N([C@H]12)C(=O)[C@H]2NC(=O)Cc3cccs3
1573	tr|I6YGX2|I6YGX2_M	Q7CRA4	72.35	97.0	683.0	DB00485	approved; investigational; vet_approved	Dicloxacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)c3c(C)onc3-c4c(Cl)cccc4Cl
1574	tr|I6YGX2|I6YGX2_M	Q7CRA4	72.35	97.0	683.0	DB00493	approved	Cefotaxime	CC(=O)OCC(=C1C(=O)O)CS[C@@H](N12)[C@@H](C2=O)NC(=O)/C(=N\OC)c3csc(n3)N
1575	tr|I6YGX2|I6YGX2_M	Q7CRA4	72.35	97.0	683.0	DB00567	approved; investigational; vet_approved	Cephalexin	O=C(O)C1=C(C)CS[C@@H](N12)[C@@H](C2=O)NC(=O)[C@H](N)c3ccccc3
1576	tr|I6YGX2|I6YGX2_M	Q7CRA4	72.35	97.0	683.0	DB00607	approved; investigational	Nafcillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)c3c(OCC)ccc(c34)cccc4
1577	tr|I6YGX2|I6YGX2_M	Q7CRA4	72.35	97.0	683.0	DB00713	approved; investigational	Oxacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)c3c(C)onc3-c4ccccc4
1578	tr|I6YGX2|I6YGX2_M	Q7CRA4	72.35	97.0	683.0	DB00739	approved; vet_approved; withdrawn	Hetacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)N(C3(C)C)C(=O)[C@H](N3)c4ccccc4
1579	tr|I6YGX2|I6YGX2_M	Q7CRA4	72.35	97.0	683.0	DB01140	approved; vet_approved; withdrawn	Cefadroxil	O=C(O)C1=C(C)CS[C@@H](N12)[C@@H](C2=O)NC(=O)[C@H](N)c3ccc(O)cc3
1580	tr|I6YGX2|I6YGX2_M	Q7CRA4	72.35	97.0	683.0	DB01163	investigational; withdrawn	Amdinocillin	C1CCCCCN1/C=N/[C@@H]2C(=O)N([C@@H]23)[C@H](C(S3)(C)C)C(=O)O
1581	tr|I6YGX2|I6YGX2_M	Q7CRA4	72.35	97.0	683.0	DB01331	approved	Cefoxitin	NC(=O)OCC(=C1C(=O)O)CS[C@@H](N12)[C@](C2=O)(OC)NC(=O)Cc3cccs3
1582	tr|I6YGX2|I6YGX2_M	Q7CRA4	72.35	97.0	683.0	DB01603	approved; investigational	Meticillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)c3c(OC)cccc3OC
1583	tr|I6YGX2|I6YGX2_M	Q7CRA4	72.35	97.0	683.0	DB03313	experimental	Cephalosporin C	CC(=O)OCC(=C1C(=O)O)CS[C@@H](N12)[C@@H](C2=O)NC(=O)CCC[C@@H](N)C(=O)O
1584	tr|I6YGX2|I6YGX2_M	Q7CRA4	72.35	97.0	683.0	DB08508	experimental	N-BENZOYL-D-ALANINE	OC(=O)[C@@H](C)NC(=O)c1ccccc1
1585	tr|I6YGX2|I6YGX2_M	Q7CRA4	72.35	97.0	683.0	DB08795	experimental	Azidocillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)[C@H](N=[N+]=[N-])c3ccccc3
1586	tr|I6X9R9|I6X9R9_M	P47895	96.73	31.0	504.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1587	tr|I6X9R9|I6X9R9_M	P47895	96.73	31.0	504.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
1588	tr|I6X9R9|I6X9R9_M	O94788	96.73	37.0	510.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1589	tr|I6X9R9|I6X9R9_M	O94788	96.73	37.0	510.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
1590	tr|I6X9R9|I6X9R9_M	O94788	96.73	37.0	510.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
1591	tr|I6X9R9|I6X9R9_M	P05091	96.52	37.0	509.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1592	tr|I6X9R9|I6X9R9_M	P05091	96.52	37.0	509.0	DB00536	approved	Guanidine	NC(N)=N
1593	tr|I6X9R9|I6X9R9_M	P05091	96.52	37.0	509.0	DB00822	approved	Disulfiram	CCN(CC)C(=S)SSC(=S)N(CC)CC
1594	tr|I6X9R9|I6X9R9_M	P05091	96.52	37.0	509.0	DB02115	experimental	Daidzin	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)Oc(c2)ccc(c23)c(=O)c(co3)-c4ccc(O)cc4
1595	tr|I6X9R9|I6X9R9_M	P05091	96.52	37.0	509.0	DB04381	experimental	Crotonaldehyde	O=C/C=C/C
1596	tr|I6X9R9|I6X9R9_M	P00352	96.73	20.0	493.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1597	tr|I6X9R9|I6X9R9_M	P00352	96.73	20.0	493.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
1598	tr|I6X9R9|I6X9R9_M	P00352	96.73	20.0	493.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
1599	tr|I6X9R9|I6X9R9_M	P00352	96.73	20.0	493.0	DB04447	experimental	1,4-Dithiothreitol	SC[C@H](O)[C@@H](O)CS
1600	tr|I6X9R9|I6X9R9_M	P30837	96.52	37.0	509.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1601	tr|I6X9R9|I6X9R9_M	O75891	97.34	423.0	899.0	DB00116	nutraceutical	Tetrahydrofolic acid	Nc([nH]1)nc(=O)c(c12)NC(CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
1602	tr|I6X9R9|I6X9R9_M	P49189	93.87	25.0	484.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1603	tr|I6X9R9|I6X9R9_M	P25553	95.71	8.0	476.0	DB03619	approved	Deoxycholic acid	C1C[C@@H](O)C[C@H]([C@]12C)CC[C@@H]3[C@@H]2C[C@H](O)[C@@]4(C)[C@H]3CC[C@@H]4[C@H](C)CCC(=O)O
1604	tr|I6X9R9|I6X9R9_M	P77674	95.71	3.0	471.0	DB04401	experimental	Betaine aldehyde	C[N+](C)(C)CC=O
1605	tr|I6X9R9|I6X9R9_M	P51649	95.71	63.0	531.0	DB00139	approved; nutraceutical	Succinic acid	OC(=O)CCC(=O)O
1606	tr|I6X9R9|I6X9R9_M	P51649	95.71	63.0	531.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1607	tr|I6X9R9|I6X9R9_M	P51649	95.71	63.0	531.0	DB00313	approved; investigational	Valproic acid	CCCC(C(=O)O)CCC
1608	tr|I6X9R9|I6X9R9_M	P51649	95.71	63.0	531.0	DB00534	approved; withdrawn	Chlormerodrin	Cl[Hg]CC(OC)CNC(=O)N
1609	tr|I6X9R9|I6X9R9_M	P83849	96.93	39.0	513.0	DB03564	experimental	(4r)-2-Methylpentane-2,4-Diol	C[C@H](O)CC(C)(C)O
1610	tr|I6X9R9|I6X9R9_M	Q59931	94.89	7.0	471.0	DB02263	experimental	Glyceraldehyde-3-Phosphate	O=C[C@H](O)COP(=O)(O)O
1611	tr|I6X9R9|I6X9R9_M	Q59931	94.89	7.0	471.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1612	tr|I6X9R9|I6X9R9_M	P30838	87.12	3.0	429.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1613	tr|I6X9R9|I6X9R9_M	P49419	94.48	61.0	523.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1614	tr|I6X9R9|I6X9R9_M	P49419	94.48	61.0	523.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
1615	tr|I6X9R9|I6X9R9_M	Q02252	96.73	40.0	513.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1616	tr|I6X9R9|I6X9R9_M	P43353	86.5	6.0	429.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1617	tr|I6X9R9|I6X9R9_M	P51648	86.5	2.0	425.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1618	tr|I6X9R9|I6X9R9_M	P09546	90.8	657.0	1101.0	DB03051	experimental	(S)-2-Tetrahydrofuroic acid	OC(=O)[C@H]1CCCO1
1619	tr|I6X9R9|I6X9R9_M	P09546	90.8	657.0	1101.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
1620	tr|I6X9R9|I6X9R9_M	P09546	90.8	657.0	1101.0	DB04398	approved; vet_approved	Lactic acid	CC(O)C(=O)O
1621	tr|I6X9R9|I6X9R9_M	P30038	94.07	73.0	533.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1622	tr|I6X9R9|I6X9R9_M	Q56694	91.41	5.0	452.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1623	tr|P95207|P95207_M	P15555	71.39	9.0	301.0	DB00456	approved; investigational; vet_approved	Cefalotin	CC(=O)OCC(CS1)=C(C(=O)O)N([C@H]12)C(=O)[C@H]2NC(=O)Cc3cccs3
1624	tr|P95207|P95207_M	P15555	71.39	9.0	301.0	DB01786	experimental	D-Alanine	C[C@@H](N)C(=O)O
1625	tr|P95207|P95207_M	P15555	71.39	9.0	301.0	DB01868	experimental	Glycyl-L-a-Aminopimelyl-E-(D-2-Aminoethyl)Phosphonate	OP(=O)(O)[C@@H](C)/N=C(\[O-])CCCC[C@@H](C(=O)O)/N=C(\O)CN
1626	tr|P95207|P95207_M	P15555	71.39	9.0	301.0	DB02136	experimental	Cephalosporin analog	c1ccccc1CC(=O)N[C@H](C(=O)O)[C@@H]2NC(C(=O)O)=C(CS2)CC[C@H](NC(=O)CC[C@H](C(=O)O)NC(=O)C)C(=O)N[C@H](C)C(=O)N[C@H](C)C(=O)O
1627	tr|P95207|P95207_M	P15555	71.39	9.0	301.0	DB02514	experimental	(2Z)-3-{[Oxido(oxo)phosphoranyl]oxy}-2-phenylacrylate	O=P(=O)O/C=C(\C([O-])=O)c1ccccc1
1628	tr|P95207|P95207_M	P15555	71.39	9.0	301.0	DB02578	experimental	N-[(6S)-6-Carboxy-6-(glycylamino)hexanoyl]-D-alanyl-D-alanine	NCC(=O)N[C@H](C(=O)O)CCCCC(=O)N[C@H](C)C(=O)N[C@H](C)C(=O)O
1629	tr|P95207|P95207_M	P15555	71.39	9.0	301.0	DB03313	experimental	Cephalosporin C	CC(=O)OCC(=C1C(=O)O)CS[C@@H](N12)[C@@H](C2=O)NC(=O)CCC[C@@H](N)C(=O)O
1630	tr|P95207|P95207_M	P15555	71.39	9.0	301.0	DB03450	experimental	Cephalothin Group	COC(=O)CC1=C(C(=O)O)N[C@H](SC1)[C@@H](C=O)NC(=O)Cc2cccs2
1631	tr|P95207|P95207_M	P15555	71.39	9.0	301.0	DB03820	experimental	(2S,5R,6R)-6-({(6S)-6-[(Ammonioacetyl)amino]-6-carboxylatohexanoyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate	[NH3+]CC(=O)N[C@H](C([O-])=O)CCCCC(=O)N[C@@H]1C(=O)N([C@@H]12)[C@@H](C([O-])=O)C(S2)(C)C
1632	tr|P95207|P95207_M	P15555	71.39	9.0	301.0	DB03843	approved; vet_approved	Formaldehyde	C=O
1633	tr|P95207|P95207_M	P15555	71.39	9.0	301.0	DB03927	experimental	Glycyl-L-alpha-amino-epsilon-pimelyl-D-alanine	NCC(=O)N[C@H](C(=O)O)CCCCC(=O)N[C@H](C)C(=O)O
1634	tr|P95207|P95207_M	P15555	71.39	9.0	301.0	DB04340	experimental	2-[(Dioxidophosphoranyl)oxy]benzoate	[O-]C(=O)c1ccccc1OP([O-])=O
1635	tr|P95207|P95207_M	P15555	71.39	9.0	301.0	DB04488	experimental	(6S)-N-[(2S,3R,6R,7R)-3-(Acetyloxymethyl)-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]octan-7-yl]-6-[(2-aminoacetyl)amino]-7-hydroxy-7-oxoheptanimidate	CC(=O)OC[C@@H]([C@H]1C(=O)O)CS[C@@H](N12)[C@@H](C2=O)/N=C(\[O-])CCCC[C@@H](C(=O)O)NC(=O)CN
1637	tr|Q10782|Q10782_M	Q8NBQ5	92.51	31.0	278.0	DB02854	experimental	Aetiocholanolone	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](CC3)C[C@H](O)CC4
1638	tr|Q10782|Q10782_M	O75911	92.13	36.0	282.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
1639	tr|Q10782|Q10782_M	P16544	86.89	5.0	237.0	DB01942	experimental; investigational	Formic acid	OC=O
1640	tr|Q10782|Q10782_M	P16544	86.89	5.0	237.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1641	tr|Q10782|Q10782_M	P16544	86.89	5.0	237.0	DB07715	investigational	Emodin	Cc(c1)cc(O)c(c12)C(=O)c3c(C2=O)cc(O)cc3O
1642	tr|Q10782|Q10782_M	Q9BTZ2	88.39	24.0	260.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
1644	tr|Q10782|Q10782_M	P0AEK2	75.28	4.0	205.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1646	tr|Q10782|Q10782_M	Q9WYS2	88.76	8.0	245.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1647	tr|Q10782|Q10782_M	Q84EX5	86.52	5.0	236.0	DB04619	experimental	Acetophenone	CC(=O)c1ccccc1
1648	tr|Q10782|Q10782_M	Q84EX5	86.52	5.0	236.0	DB04784	experimental	(R)-1-phenylethanol	C[C@@H](O)c1ccccc1
1649	tr|Q10782|Q10782_M	Q02338	83.15	48.0	270.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1651	tr|Q10782|Q10782_M	Q6PKH6	70.41	22.0	210.0	DB04200	experimental	Matairesinol	COc1cc(ccc1O)C[C@H]2COC(=O)[C@@H]2Cc3ccc(O)c(c3)OC
1652	tr|Q10782|Q10782_M	Q6UWP2	89.89	11.0	251.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1653	tr|Q10782|Q10782_M	P0AET8	87.64	9.0	243.0	DB02123	experimental	Glycochenodeoxycholic Acid	OC(=O)CNC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
1654	tr|Q10782|Q10782_M	Q92506	86.89	9.0	241.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1655	tr|Q10782|Q10782_M	Q92506	86.89	9.0	241.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1656	tr|Q10782|Q10782_M	P0CG22	84.64	24.0	250.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
1657	tr|Q10782|Q10782_M	P0CG22	84.64	24.0	250.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1658	tr|Q10782|Q10782_M	P0CG22	84.64	24.0	250.0	DB03541	experimental	10-Propargyl-5,8-Dideazafolic Acid	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(CC#C)Cc(c2)ccc(c23)[nH]c(N)nc3=O
1659	tr|Q10782|Q10782_M	P0CG22	84.64	24.0	250.0	DB07689	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)NCc(cn3)nc(c34)c(N)nc(n4)N
1660	tr|Q10782|Q10782_M	P0CG22	84.64	24.0	250.0	DB07765	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)N(C)Cc(cn3)nc(c34)c(N)nc(n4)N
1661	tr|Q10782|Q10782_M	Q9NYR8	77.53	5.0	212.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
1662	tr|Q10782|Q10782_M	P28845	86.52	30.0	261.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1663	tr|Q10782|Q10782_M	P28845	86.52	30.0	261.0	DB02329	experimental	Carbenoxolone	OC(=O)CCC(=O)O[C@@H](CC1)C(C)(C)[C@@H]([C@]12C)CC[C@]3(C)[C@@H]2C(=O)C=C4[C@H]5[C@@](C)(CC[C@@]34C)CC[C@](C5)(C)C(=O)O
1664	tr|Q10782|Q10782_M	P28845	86.52	30.0	261.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1665	tr|Q10782|Q10782_M	P28845	86.52	30.0	261.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
1666	tr|Q10782|Q10782_M	P28845	86.52	30.0	261.0	DB04652	experimental	Corticosterone	OCC(=O)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H]([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
1667	tr|Q10782|Q10782_M	P28845	86.52	30.0	261.0	DB05064	investigational	INCB13739	 
1668	tr|Q10782|Q10782_M	P28845	86.52	30.0	261.0	DB06992	experimental	(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone	Cc1ccc(cc1F)-c2nc(ccc2)C(=O)N(CC3(C)C)CCC3
1669	tr|Q10782|Q10782_M	P28845	86.52	30.0	261.0	DB07017	experimental	(5S)-2-{[(1S)-1-(4-Fluorophenyl)ethyl]amino}-5-(2-hydroxy-2-propanyl)-5-methyl-1,3-thiazol-4(5H)-one	Fc1ccc(cc1)[C@H](C)NC(=NC2=O)S[C@@]2(C)C(C)(C)O
1670	tr|Q10782|Q10782_M	P28845	86.52	30.0	261.0	DB07049	experimental	(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine	[O-][N+](=O)c1ccc(cc1)N2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)C(C)(C)C
1671	tr|Q10782|Q10782_M	P28845	86.52	30.0	261.0	DB07056	experimental	2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide	CCN(CC)C(=O)Cc1cccc(n1)NS(=O)(=O)c2c(C)c(Cl)ccc2
1672	tr|Q10782|Q10782_M	P28845	86.52	30.0	261.0	DB07310	experimental	(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one	Fc1ccccc1[C@H](C)NC(=NC2=O)S[C@]2(C)C(F)(F)F
1673	tr|Q10782|Q10782_M	P28845	86.52	30.0	261.0	DB07316	experimental	N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)C3CCN(CC3)CC4(CC4)C(=O)N
1674	tr|Q10782|Q10782_M	P28845	86.52	30.0	261.0	DB07619	experimental	N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)[C@H]3CC[C@@H](CC3)c4cccnc4
1675	tr|Q10782|Q10782_M	P28845	86.52	30.0	261.0	DB07624	experimental	1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide	C1CC1(C(=O)N)CN2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)[C@](C)(O)C(F)(F)F
1676	tr|Q10782|Q10782_M	P28845	86.52	30.0	261.0	DB07866	experimental	(5S)-2-(Cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one	CCC[C@]1(C)SC(=NC1=O)NC2CCCCCCC2
1677	tr|Q10782|Q10782_M	P28845	86.52	30.0	261.0	DB08277	experimental	2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE	CS(=O)(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4c(Cl)cc(F)cc4
1678	tr|Q10782|Q10782_M	P28845	86.52	30.0	261.0	DB08280	experimental	(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE	NC(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4ccc(OC)cc4
1679	tr|Q10782|Q10782_M	P28845	86.52	30.0	261.0	DB08771	experimental	(5R)-2-[(2-Fluorophenyl)amino]-5-isopropyl-1,3-thiazol-4(5H)-one	CC(C)[C@H]1SC(=NC1=O)Nc2c(F)cccc2
1680	tr|Q10782|Q10782_M	P28845	86.52	30.0	261.0	DB13751	approved; experimental	Glycyrrhizic acid	C1C[C@](C)(C(=O)O)C[C@H]([C@]12C)C=3[C@@](C)(CC2)[C@@]4(C)[C@H](C(=O)C3)[C@]5(C)[C@@H](CC4)C(C)(C)[C@H](CC5)O[C@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O[C@@H]7O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]7O
1681	tr|Q10782|Q10782_M	Q7Z4W1	83.15	7.0	229.0	DB02831	experimental	Dihydrogenphosphate	OP([O-])(=O)O
1682	tr|Q10782|Q10782_M	Q7Z4W1	83.15	7.0	229.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1683	tr|Q10782|Q10782_M	P14061	73.03	2.0	197.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1684	tr|Q10782|Q10782_M	P14061	73.03	2.0	197.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
1685	tr|Q10782|Q10782_M	P14061	73.03	2.0	197.0	DB01561	experimental; illicit	Androstanedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
1686	tr|Q10782|Q10782_M	P14061	73.03	2.0	197.0	DB02187	experimental	Equilin	O=C1CC[C@H]([C@@]12C)C=3[C@H](CC2)c4c(CC3)cc(O)cc4
1687	tr|Q10782|Q10782_M	P14061	73.03	2.0	197.0	DB02323	experimental	EM-1745	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)C[C@@H]([C@@H]4O)CCCCCCCCC(=O)OC[C@H]5O[C@H]([C@H](O)[C@@H]5O)n6cnc(c67)c(N)ncn7
1688	tr|Q10782|Q10782_M	P14061	73.03	2.0	197.0	DB02901	illicit; investigational	Stanolone	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
1689	tr|Q10782|Q10782_M	P14061	73.03	2.0	197.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1690	tr|Q10782|Q10782_M	P14061	73.03	2.0	197.0	DB13951	experimental	Stanolone acetate	CC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
1691	tr|Q10782|Q10782_M	Q8TC12	77.15	41.0	247.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
1693	tr|Q10782|Q10782_M	Q8NBN7	76.03	37.0	240.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
1694	tr|Q10782|Q10782_M	P37059	84.64	79.0	305.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1695	tr|Q10782|Q10782_M	P37059	84.64	79.0	305.0	DB13952	approved; investigational; vet_approved	Estradiol acetate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)C
1696	tr|Q10782|Q10782_M	P37059	84.64	79.0	305.0	DB13953	approved; investigational; vet_approved	Estradiol benzoate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)c5ccccc5
1697	tr|Q10782|Q10782_M	P37059	84.64	79.0	305.0	DB13954	approved; investigational; vet_approved	Estradiol cypionate	C1CCCC1CCC(=O)O[C@H]2CC[C@H]([C@@]23C)[C@H]4[C@H](CC3)c5c(CC4)cc(O)cc5
1698	tr|Q10782|Q10782_M	P37059	84.64	79.0	305.0	DB13955	approved; investigational; vet_approved	Estradiol dienanthate	CCCCCCC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)CCCCCC
1699	tr|Q10782|Q10782_M	P37059	84.64	79.0	305.0	DB13956	approved; investigational; vet_approved	Estradiol valerate	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)CC[C@@H]4OC(=O)CCCC
1700	tr|Q10782|Q10782_M	P37058	76.4	48.0	252.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1701	tr|Q10782|Q10782_M	Q9BY49	72.66	16.0	210.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
1702	tr|Q10782|Q10782_M	Q96NR8	76.03	39.0	242.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
1703	tr|Q10782|Q10782_M	Q16698	91.39	54.0	298.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1704	tr|Q10782|Q10782_M	Q16698	91.39	54.0	298.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
1705	tr|Q10782|Q10782_M	P80365	80.52	79.0	294.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1706	tr|Q10782|Q10782_M	P80365	80.52	79.0	294.0	DB01185	approved; illicit	Fluoxymesterone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@](F)([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
1707	tr|Q10782|Q10782_M	P80365	80.52	79.0	294.0	DB01569	experimental; illicit	Formebolone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@H]([C@@H](C2)O)[C@]4(C)C(CC3)=CC(=O)C(C=O)=C4
1708	tr|Q10782|Q10782_M	P80365	80.52	79.0	294.0	DB14538	experimental; vet_approved	Hydrocortisone aceponate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CC)C(=O)COC(=O)C
1709	tr|Q10782|Q10782_M	P80365	80.52	79.0	294.0	DB14539	approved; vet_approved	Hydrocortisone acetate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)C
1710	tr|Q10782|Q10782_M	P80365	80.52	79.0	294.0	DB14540	approved; vet_approved	Hydrocortisone butyrate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCC
1711	tr|Q10782|Q10782_M	P80365	80.52	79.0	294.0	DB14541	approved; investigational; vet_approved	Hydrocortisone cypionate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)CCC5CCCC5
1712	tr|Q10782|Q10782_M	P80365	80.52	79.0	294.0	DB14542	approved; vet_approved	Hydrocortisone phosphate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COP(=O)(O)O
1713	tr|Q10782|Q10782_M	P80365	80.52	79.0	294.0	DB14543	approved; vet_approved	Hydrocortisone probutate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CCC)C(=O)COC(=O)CC
1714	tr|Q10782|Q10782_M	P80365	80.52	79.0	294.0	DB14544	approved; vet_approved	Hydrocortisone valerate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCCC
1715	tr|Q10782|Q10782_M	Q92781	75.66	25.0	227.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1716	tr|Q10782|Q10782_M	Q92781	75.66	25.0	227.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
1717	tr|Q10782|Q10782_M	P51659	79.78	7.0	220.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1718	tr|Q10782|Q10782_M	P51659	79.78	7.0	220.0	DB03192	experimental	(R)-3-hydroxydecanoyl-CoA	CCCCCCC[C@@H](O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
1719	tr|Q10782|Q10782_M	Q99714	76.4	6.0	210.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1720	tr|Q10782|Q10782_M	Q99714	76.4	6.0	210.0	DB02820	experimental	1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct	C1CCCCCN1C(=O)[C@H](c2ccccc2)n(c3=S)cnc(c34)nn(c4)[C@H]5C=CN(C=C5C([O-])=N)[C@@H]6O[C@@H]([C@@H](O)[C@H]6O)COP([O-])(=O)OP(=O)(O)OC[C@H]7O[C@H]([C@H]([O-])[C@@H]7[O-])n8cnc(c89)c(N)ncn9
1721	tr|Q10782|Q10782_M	Q99714	76.4	6.0	210.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
1722	tr|Q10782|Q10782_M	Q9HBH5	80.9	42.0	258.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
1723	tr|Q10782|Q10782_M	Q8I814	88.39	13.0	249.0	DB02015	experimental	Dihydrofolic Acid	O=c1[nH]c(N)nc(c12)NCC(=N2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
1724	tr|Q10782|Q10782_M	Q8I814	88.39	13.0	249.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1725	tr|Q10782|Q10782_M	Q6GI75	83.52	5.0	228.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
1726	tr|Q10782|Q10782_M	Q6GI75	83.52	5.0	228.0	DB11155	approved	Triclocarban	Clc1ccc(cc1)NC(=O)Nc2cc(Cl)c(Cl)cc2
1727	tr|Q10782|Q10782_M	P16152	88.39	6.0	242.0	DB01698	approved; experimental; investigational	Rutin	O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O[C@H]1C)OC[C@H]2O[C@H]([C@H](O)[C@@H](O)[C@@H]2O)Oc(c3=O)c(-c4cc(O)c(O)cc4)oc(c35)cc(O)cc5O
1728	tr|Q10782|Q10782_M	P16152	88.39	6.0	242.0	DB02709	investigational	Resveratrol	Oc1ccc(cc1)/C=C/c2cc(O)cc(O)c2
1729	tr|Q10782|Q10782_M	P16152	88.39	6.0	242.0	DB03394	experimental	Heptaethylene glycol	OCCOCCOCCOCCOCCOCCOCCO
1730	tr|Q10782|Q10782_M	P16152	88.39	6.0	242.0	DB03556	experimental	2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400	CCOCCOCCOCCOCCOCCOCCOCCOCCO
1731	tr|Q10782|Q10782_M	P16152	88.39	6.0	242.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
1732	tr|Q10782|Q10782_M	P16152	88.39	6.0	242.0	DB04463	experimental	3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol	n1cnc(N)c(c12)c(nn2C(C)(C)C)-c3cccc(O)c3
1733	tr|Q10782|Q10782_M	P16152	88.39	6.0	242.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
1734	tr|Q10782|Q10782_M	P16152	88.39	6.0	242.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
1735	tr|Q10782|Q10782_M	A0A348A0U3	85.02	5.0	232.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
1736	tr|Q10782|Q10782_M	O24990	89.89	6.0	246.0	DB04393	experimental	Soneclosan	Clc1cc(O)c(cc1)Oc2ccc(Cl)cc2
1737	tr|Q10782|Q10782_M	O24990	89.89	6.0	246.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
1738	tr|Q10782|Q10782_M	P35270	79.4	7.0	219.0	DB02637	experimental	Oxaloacetate Ion	OC(=O)C(=O)CC([O-])=O
1739	tr|Q10782|Q10782_M	P35270	79.4	7.0	219.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1740	tr|Q10782|Q10782_M	P35270	79.4	7.0	219.0	DB03886	experimental	Biopterin	C[C@@H](O)[C@@H](O)c(n1)cnc(c12)nc(N)[nH]c2=O
1741	tr|Q10782|Q10782_M	P35270	79.4	7.0	219.0	DB04275	experimental	N-acetylserotonin	CC(=O)NCCc1c[nH]c(c12)ccc(c2)O
1742	tr|Q10782|Q10782_M	P56937	85.77	2.0	231.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1743	tr|Q10782|Q10782_M	P0AEK4	80.15	5.0	219.0	DB01691	experimental	Indole Naphthyridinone	c1cccc(c12)n(C)cc2CN(C)C(=O)/C=C/c(c3)cnc(c34)NC(=O)CC4
1744	tr|Q10782|Q10782_M	P0AEK4	80.15	5.0	219.0	DB01865	experimental	3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide	c1cccc(c12)cc(n2C)CN(C)C(=O)/C=C/c3cnc(N)cc3
1745	tr|Q10782|Q10782_M	P0AEK4	80.15	5.0	219.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
1746	tr|Q10782|Q10782_M	P0AEK4	80.15	5.0	219.0	DB03030	experimental	4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole	Cc1ccc(cc1)Cn2cnc(c2)-c3cccs3
1747	tr|Q10782|Q10782_M	P0AEK4	80.15	5.0	219.0	DB03534	experimental	3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide	CC(=O)N(C)Cc1c(N)ccc(c1)C(=O)N(C)Cc(n2C)cc(c23)cccc3
1748	tr|Q10782|Q10782_M	P0AEK4	80.15	5.0	219.0	DB04030	experimental	1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole	Oc1ccc(cc1)Cn2c(c3c(c24)cccc4)CN(CC3)C(=O)c5ccc(O)cc5
1749	tr|Q10782|Q10782_M	P0AEK4	80.15	5.0	219.0	DB08265	experimental	2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL	Cc1ccc(cc1)S(=O)(=O)n(b2O)ncc(c23)cccc3
1750	tr|Q10782|Q10782_M	P0AEK4	80.15	5.0	219.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
1751	tr|Q10782|Q10782_M	P0AEK4	80.15	5.0	219.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
1752	tr|Q10782|Q10782_M	Q7AUG5	76.78	3.0	208.0	DB04782	experimental	(S)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@H]2CO2
1753	tr|Q10782|Q10782_M	Q93D82	76.78	3.0	208.0	DB04472	experimental	(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol	[N-]=[N+]=NC[C@H](O)c1ccc([N+]([O-])=O)cc1
1754	tr|Q10782|Q10782_M	Q93D82	76.78	3.0	208.0	DB04499	experimental	(R)-styrene oxide	C1O[C@@H]1c2ccccc2
1755	tr|Q10782|Q10782_M	Q93D82	76.78	3.0	208.0	DB04777	experimental	(R)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@@H]2CO2
1756	tr|Q10782|Q10782_M	P09417	79.78	23.0	236.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1757	tr|Q10782|Q10782_M	P09417	79.78	23.0	236.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
1758	tr|Q10782|Q10782_M	Q01782	82.02	8.0	227.0	DB02338	experimental	NADPH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1759	tr|Q10782|Q10782_M	Q01782	82.02	8.0	227.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
1760	tr|Q10782|Q10782_M	Q01782	82.02	8.0	227.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1761	tr|Q10782|Q10782_M	Q01782	82.02	8.0	227.0	DB04400	experimental	L-erythro-7,8-dihydrobiopterin	C[C@H](O)[C@H](O)C(CN1)=Nc(c12)c(=O)nc([nH]2)N
1762	tr|Q10782|Q10782_M	P9WGR1	72.66	6.0	200.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
1763	tr|Q10782|Q10782_M	P9WGR1	72.66	6.0	200.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
1764	tr|Q10782|Q10782_M	P9WGR1	72.66	6.0	200.0	DB02990	experimental	S-(2-Acetamidoethyl) hexadecanethioate	CCCCCCCCCCCCCCCC(=O)SCCNC(=O)C
1765	tr|Q10782|Q10782_M	P9WGR1	72.66	6.0	200.0	DB04289	experimental	Genz-10850	[nH]1ccc(c12)cc(cc2)C(=O)N3CCN(CC3)C4c(cccc5)c5c(c46)cccc6
1766	tr|Q10782|Q10782_M	P9WGR1	72.66	6.0	200.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
1767	tr|Q10782|Q10782_M	P9WGR1	72.66	6.0	200.0	DB07090	experimental	(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cccc(c1C)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
1768	tr|Q10782|Q10782_M	P9WGR1	72.66	6.0	200.0	DB07123	experimental	N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE	Cc1ccc(cc1)C(=O)N2CCC(CC2)Cc3ccccc3
1769	tr|Q10782|Q10782_M	P9WGR1	72.66	6.0	200.0	DB07155	experimental	(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE	c1ccccc1NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
1770	tr|Q10782|Q10782_M	P9WGR1	72.66	6.0	200.0	DB07178	experimental	5-PENTYL-2-PHENOXYPHENOL	CCCCCc1cc(O)c(cc1)Oc2ccccc2
1771	tr|Q10782|Q10782_M	P9WGR1	72.66	6.0	200.0	DB07188	experimental	(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(cc(Cl)c1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
1772	tr|Q10782|Q10782_M	P9WGR1	72.66	6.0	200.0	DB07192	experimental	(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Brc1cc(ccc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
1773	tr|Q10782|Q10782_M	P9WGR1	72.66	6.0	200.0	DB07222	experimental	(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(c(C)cc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
1774	tr|Q10782|Q10782_M	P9WGR1	72.66	6.0	200.0	DB07287	experimental	2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL	c1cccnc1Cc2cc(O)c(cc2)Oc3ccc(Cl)cc3Cl
1775	tr|Q10782|Q10782_M	P9WGR1	72.66	6.0	200.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
1776	tr|Q10782|Q10782_M	P26391	71.54	3.0	194.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
1777	tr|Q10782|Q10782_M	Q8T8E9	72.28	3.0	196.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
1778	tr|O06139|O06139_M	A0A045ISQ8	99.71	1.0	346.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
1779	tr|P71790|P71790_M	O60547	100.88	25.0	368.0	DB02547	experimental	Guanosine-5'-Diphosphate-Rhamnose	O[C@H]1[C@H](O)[C@H](O)[C@H](O[C@@H]1C)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3cnc(c34)c(=O)nc([nH]4)N
1780	tr|P71790|P71790_M	O60547	100.88	25.0	368.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
1781	tr|P71790|P71790_M	Q51366	93.53	3.0	321.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
1782	tr|P71790|P71790_M	P26391	99.12	2.0	339.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
1783	tr|P71790|P71790_M	P09147	96.18	2.0	329.0	DB01861	experimental	Uridine diphosphate glucose	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
1784	tr|P71790|P71790_M	P09147	96.18	2.0	329.0	DB02421	experimental	Uridine-5'-diphosphate-mannose	O=c1[nH]c(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O
1785	tr|P71790|P71790_M	P09147	96.18	2.0	329.0	DB02790	experimental	Phenyl-uridine-5'-diphosphate	O=c1[nH]c(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)Oc3ccccc3
1786	tr|P71790|P71790_M	P09147	96.18	2.0	329.0	DB03397	experimental	Uridine-Diphosphate-N-Acetylglucosamine	CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
1787	tr|P71790|P71790_M	P09147	96.18	2.0	329.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
1788	tr|P71790|P71790_M	P09147	96.18	2.0	329.0	DB04097	experimental	Uridine-5'-diphosphate-4-deoxy-4-fluoro-alpha-D-galactose	O=c1[nH]c(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](F)[C@H](O)[C@H]3O
1789	tr|P71790|P71790_M	P95780	94.12	5.0	325.0	DB03161	experimental	Thymidine-5'-diphospho-beta-D-xylose	O=c1[nH]c(=O)c(C)cn1[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3OC[C@@H](O)[C@H](O)[C@H]3O
1790	tr|P71790|P71790_M	P95780	94.12	5.0	325.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
1791	tr|P71790|P71790_M	Q9ZGH3	91.47	2.0	313.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
1792	tr|P71790|P71790_M	P14169	97.65	2.0	334.0	DB04555	experimental	Cytidine-5'-Diphosphate	Nc1nc(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O
1793	tr|P71790|P71790_M	Q14376	97.06	4.0	334.0	DB01861	experimental	Uridine diphosphate glucose	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
1794	tr|P71790|P71790_M	Q14376	97.06	4.0	334.0	DB02196	experimental	Uridine-Diphosphate-N-Acetylgalactosamine	CC(=O)N[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
1795	tr|P71790|P71790_M	Q14376	97.06	4.0	334.0	DB03041	experimental	UDP-alpha-D-glucuronic acid	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O
1796	tr|P71790|P71790_M	Q14376	97.06	4.0	334.0	DB03095	experimental	Tetramethylammonium	C[N+](C)(C)C
1797	tr|P71790|P71790_M	Q14376	97.06	4.0	334.0	DB03397	experimental	Uridine-Diphosphate-N-Acetylglucosamine	CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
1798	tr|P71790|P71790_M	Q14376	97.06	4.0	334.0	DB03501	experimental	Galactose-uridine-5'-diphosphate	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@H]1O)O[P@](=O)(O)O[P@](=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
1799	tr|P71790|P71790_M	P26397	97.35	10.0	341.0	DB02059	experimental	Adenosine-5-Diphosphoribose	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)CO[P@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H](O)[C@H](O)[C@@H]4O
1800	tr|P71790|P71790_M	P26397	97.35	10.0	341.0	DB03069	experimental	Cytidine-5'-diphospho-beta-D-xylose	Nc1nc(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O[C@H]3OC[C@@H](O)[C@H](O)[C@H]3O
1801	tr|P71790|P71790_M	P77398	100.59	317.0	659.0	DB03256	experimental	(6R)-Folinic acid	Nc([nH]1)nc(=O)c(c12)N(C=O)[C@@H](CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
1802	tr|P71790|P71790_M	P77398	100.59	317.0	659.0	DB03685	experimental	Uridine monophosphate	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2ccc(=O)[nH]c2=O
1803	tr|P71790|P71790_M	Q8KN66	94.12	17.0	337.0	DB01861	experimental	Uridine diphosphate glucose	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
1804	tr|P71790|P71790_M	Q8KN66	94.12	17.0	337.0	DB02196	experimental	Uridine-Diphosphate-N-Acetylgalactosamine	CC(=O)N[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
1805	tr|P71790|P71790_M	Q8T8E9	107.65	2.0	368.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
1806	tr|P71790|P71790_M	P32055	81.18	39.0	315.0	DB02897	experimental	Acetylphosphate	CC(=O)OP(=O)(O)O
1807	tr|P71790|P71790_M	P32055	81.18	39.0	315.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1808	tr|P71790|P71790_M	P67910	84.12	2.0	288.0	DB01774	experimental	Adenosine-5'-Monophosphate Glucopyranosyl-Monophosphate Ester	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@@](=O)(O)O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O
1809	tr|P71790|P71790_M	P67910	84.12	2.0	288.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1810	tr|O53816|O53816_M	P00352	93.53	21.0	498.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1811	tr|O53816|O53816_M	P00352	93.53	21.0	498.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
1812	tr|O53816|O53816_M	P00352	93.53	21.0	498.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
1813	tr|O53816|O53816_M	P00352	93.53	21.0	498.0	DB04447	experimental	1,4-Dithiothreitol	SC[C@H](O)[C@@H](O)CS
1814	tr|O53816|O53816_M	O94788	93.73	37.0	515.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1815	tr|O53816|O53816_M	O94788	93.73	37.0	515.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
1816	tr|O53816|O53816_M	O94788	93.73	37.0	515.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
1817	tr|O53816|O53816_M	P47895	93.14	32.0	507.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1818	tr|O53816|O53816_M	P47895	93.14	32.0	507.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
1819	tr|O53816|O53816_M	P30837	93.33	38.0	514.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1820	tr|O53816|O53816_M	P05091	93.33	38.0	514.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1821	tr|O53816|O53816_M	P05091	93.33	38.0	514.0	DB00536	approved	Guanidine	NC(N)=N
1822	tr|O53816|O53816_M	P05091	93.33	38.0	514.0	DB00822	approved	Disulfiram	CCN(CC)C(=S)SSC(=S)N(CC)CC
1823	tr|O53816|O53816_M	P05091	93.33	38.0	514.0	DB02115	experimental	Daidzin	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)Oc(c2)ccc(c23)c(=O)c(co3)-c4ccc(O)cc4
1824	tr|O53816|O53816_M	P05091	93.33	38.0	514.0	DB04381	experimental	Crotonaldehyde	O=C/C=C/C
1825	tr|O53816|O53816_M	Q02252	96.67	40.0	533.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1826	tr|O53816|O53816_M	P49189	91.76	20.0	488.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1827	tr|O53816|O53816_M	O75891	93.92	422.0	901.0	DB00116	nutraceutical	Tetrahydrofolic acid	Nc([nH]1)nc(=O)c(c12)NC(CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
1828	tr|O53816|O53816_M	P25553	92.55	6.0	478.0	DB03619	approved	Deoxycholic acid	C1C[C@@H](O)C[C@H]([C@]12C)CC[C@@H]3[C@@H]2C[C@H](O)[C@@]4(C)[C@H]3CC[C@@H]4[C@H](C)CCC(=O)O
1829	tr|O53816|O53816_M	P77674	92.35	2.0	473.0	DB04401	experimental	Betaine aldehyde	C[N+](C)(C)CC=O
1830	tr|O53816|O53816_M	P51649	92.16	61.0	531.0	DB00139	approved; nutraceutical	Succinic acid	OC(=O)CCC(=O)O
1831	tr|O53816|O53816_M	P51649	92.16	61.0	531.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1832	tr|O53816|O53816_M	P51649	92.16	61.0	531.0	DB00313	approved; investigational	Valproic acid	CCCC(C(=O)O)CCC
1833	tr|O53816|O53816_M	P51649	92.16	61.0	531.0	DB00534	approved; withdrawn	Chlormerodrin	Cl[Hg]CC(OC)CNC(=O)N
1834	tr|O53816|O53816_M	Q59931	92.75	1.0	474.0	DB02263	experimental	Glyceraldehyde-3-Phosphate	O=C[C@H](O)COP(=O)(O)O
1835	tr|O53816|O53816_M	Q59931	92.75	1.0	474.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1836	tr|O53816|O53816_M	P83849	93.14	38.0	513.0	DB03564	experimental	(4r)-2-Methylpentane-2,4-Diol	C[C@H](O)CC(C)(C)O
1837	tr|O53816|O53816_M	P30838	83.92	3.0	431.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1838	tr|O53816|O53816_M	P49419	91.18	63.0	528.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1839	tr|O53816|O53816_M	P49419	91.18	63.0	528.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
1840	tr|O53816|O53816_M	P43353	85.1	7.0	441.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1841	tr|O53816|O53816_M	P51648	83.14	5.0	429.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1842	tr|O53816|O53816_M	P09546	88.43	657.0	1108.0	DB03051	experimental	(S)-2-Tetrahydrofuroic acid	OC(=O)[C@H]1CCCO1
1843	tr|O53816|O53816_M	P09546	88.43	657.0	1108.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
1844	tr|O53816|O53816_M	P09546	88.43	657.0	1108.0	DB04398	approved; vet_approved	Lactic acid	CC(O)C(=O)O
1845	tr|O53816|O53816_M	P30038	93.73	69.0	547.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1846	tr|O53816|O53816_M	Q56694	92.16	5.0	475.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1847	tr|P95187|P95187_M	Q92947	85.04	18.0	416.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
1848	tr|P95187|P95187_M	Q92947	85.04	18.0	416.0	DB03245	experimental	S-4-Nitrobutyryl-CoA	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCC[N+]([O-])=O
1849	tr|P95187|P95187_M	Q72JJ3	77.78	2.0	366.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
1850	tr|P95187|P95187_M	Q06319	78.63	1.0	369.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
1851	tr|P95187|P95187_M	Q06319	78.63	1.0	369.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
1852	tr|P95187|P95187_M	P16219	77.99	29.0	394.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1853	tr|P95187|P95187_M	P16219	77.99	29.0	394.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
1854	tr|P95187|P95187_M	P16219	77.99	29.0	394.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
1855	tr|P95187|P95187_M	P11310	78.42	36.0	403.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
1856	tr|P95187|P95187_M	P11310	78.42	36.0	403.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
1857	tr|P95187|P95187_M	P11310	78.42	36.0	403.0	DB03415	experimental	3-thiaoctanoyl-CoA	CCCCCSCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
1858	tr|P95187|P95187_M	Q3JP94	79.49	4.0	376.0	DB08685	experimental	1-(1,4-dimethyl-1,2,3,4-tetrahydroquinoxalin-6-yl)methanamine	CN1CCN(C)c(c12)cc(cc2)CN
1859	tr|P95187|P95187_M	P45954	76.92	56.0	416.0	DB00167	investigational; nutraceutical	Isoleucine	CC[C@H](C)[C@H](N)C(=O)O
1860	tr|P95187|P95187_M	P45954	76.92	56.0	416.0	DB00313	approved; investigational	Valproic acid	CCCC(C(=O)O)CCC
1861	tr|P95187|P95187_M	Q9UKU7	77.35	38.0	400.0	DB01675	experimental	Methacrylyl-Coenzyme A	CC(=C)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
1862	tr|P95187|P95187_M	Q9UKU7	77.35	38.0	400.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
1863	tr|P95187|P95187_M	P26440	77.78	42.0	406.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
1864	tr|P95187|P95187_M	P26440	77.78	42.0	406.0	DB04036	experimental	Coenzyme A persulfide	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSS
1865	tr|P95187|P95187_M	Q9KIE5	71.37	15.0	349.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
1867	tr|P96831|P96831_M	Q72JJ3	84.37	39.0	379.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
1868	tr|P96831|P96831_M	P16219	83.37	75.0	411.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1869	tr|P96831|P96831_M	P16219	83.37	75.0	411.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
1870	tr|P96831|P96831_M	P16219	83.37	75.0	411.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
1871	tr|P96831|P96831_M	Q06319	78.16	67.0	382.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
1872	tr|P96831|P96831_M	Q06319	78.16	67.0	382.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
1873	tr|P96831|P96831_M	P11310	85.11	77.0	420.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
1874	tr|P96831|P96831_M	P11310	85.11	77.0	420.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
1875	tr|P96831|P96831_M	P11310	85.11	77.0	420.0	DB03415	experimental	3-thiaoctanoyl-CoA	CCCCCSCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
1876	tr|P96831|P96831_M	P45954	81.64	99.0	428.0	DB00167	investigational; nutraceutical	Isoleucine	CC[C@H](C)[C@H](N)C(=O)O
1877	tr|P96831|P96831_M	P45954	81.64	99.0	428.0	DB00313	approved; investigational	Valproic acid	CCCC(C(=O)O)CCC
1878	tr|P96831|P96831_M	Q9UKU7	83.13	78.0	413.0	DB01675	experimental	Methacrylyl-Coenzyme A	CC(=C)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
1879	tr|P96831|P96831_M	Q9UKU7	83.13	78.0	413.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
1880	tr|P96831|P96831_M	P26440	82.38	85.0	417.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
1881	tr|P96831|P96831_M	P26440	82.38	85.0	417.0	DB04036	experimental	Coenzyme A persulfide	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSS
1882	tr|P96831|P96831_M	Q3JP94	82.13	58.0	389.0	DB08685	experimental	1-(1,4-dimethyl-1,2,3,4-tetrahydroquinoxalin-6-yl)methanamine	CN1CCN(C)c(c12)cc(cc2)CN
1883	tr|P96831|P96831_M	Q92947	77.92	115.0	429.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
1884	tr|P96831|P96831_M	Q92947	77.92	115.0	429.0	DB03245	experimental	S-4-Nitrobutyryl-CoA	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCC[N+]([O-])=O
1885	tr|P96831|P96831_M	Q9KIE5	81.39	34.0	362.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
1886	tr|I6WZ71|I6WZ71_M	Q13363	90.18	56.0	350.0	DB01942	experimental; investigational	Formic acid	OC=O
1887	tr|I6WZ71|I6WZ71_M	O43175	90.8	27.0	323.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1888	tr|I6WZ71|I6WZ71_M	P9WNX3	89.57	22.0	314.0	DB01694	experimental	D-tartaric acid	OC(=O)[C@@H](O)[C@H](O)C(=O)O
1889	tr|I6WZ71|I6WZ71_M	P17584	82.82	60.0	330.0	DB03229	experimental	2-Oxo-4-Methylpentanoic Acid	CC(C)CC(=O)C(=O)O
1890	tr|I6WZ71|I6WZ71_M	P30901	86.81	47.0	330.0	DB03940	experimental	Oxamic Acid	NC(=O)C(=O)O
1891	tr|I6YB06|I6YB06_M	Q55013	74.68	60.0	119.0	DB03317	experimental	Ferroheme C	[Fe-2]123[N+]4=C5C=C6[N+]1=C(C(C)=C6C(C)S)C=C7[N+]2=C(C(=C7C)CCC(=O)O)C=C8[N+]3=C(C=C4C(=C5C)C(C)S)C(C)=C8CCC(=O)O
1892	tr|O53438|O53438_M	Q54331	98.01	112.0	260.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
1893	tr|O53438|O53438_M	Q54331	98.01	112.0	260.0	DB02467	experimental	L-methionine (S)-S-oxide	C[S@](=O)CC[C@@H](C([O-])=O)[NH3+]
1894	tr|O53438|O53438_M	Q54331	98.01	112.0	260.0	DB04282	experimental	2-deoxy-2-fluoro-α-D-glucose	O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1F
1895	tr|O53533|O53533_M	P07327	101.11	9.0	374.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1896	tr|O53533|O53533_M	P07327	101.11	9.0	374.0	DB01213	approved; vet_approved	Fomepizole	Cc1c[nH]nc1
1897	tr|O53533|O53533_M	P07327	101.11	9.0	374.0	DB02721	experimental	4-Iodopyrazole	Ic1c[nH]nc1
1898	tr|O53533|O53533_M	P07327	101.11	9.0	374.0	DB04065	experimental	N-Cyclopentyl-N-Cyclobutylformamide	C1CCC1N(C=O)C2CCCC2
1899	tr|O53533|O53533_M	P00325	100.83	9.0	373.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1900	tr|O53533|O53533_M	P00325	100.83	9.0	373.0	DB01213	approved; vet_approved	Fomepizole	Cc1c[nH]nc1
1901	tr|O53533|O53533_M	P00325	100.83	9.0	373.0	DB02481	experimental	N-Benzylformamide	O=CNCc1ccccc1
1902	tr|O53533|O53533_M	P00325	100.83	9.0	373.0	DB02721	experimental	4-Iodopyrazole	Ic1c[nH]nc1
1903	tr|O53533|O53533_M	P00325	100.83	9.0	373.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1904	tr|O53533|O53533_M	P00325	100.83	9.0	373.0	DB03703	experimental	Cyclohexanol	OC1CCCCC1
1905	tr|O53533|O53533_M	P00325	100.83	9.0	373.0	DB04105	experimental	N-Heptylformamide	CCCCCCCNC=O
1906	tr|O53533|O53533_M	P00325	100.83	9.0	373.0	DB09462	approved; investigational	Glycerin	OCC(O)CO
1907	tr|O53533|O53533_M	P00326	100.83	9.0	373.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1908	tr|O53533|O53533_M	P00326	100.83	9.0	373.0	DB01213	approved; vet_approved	Fomepizole	Cc1c[nH]nc1
1909	tr|O53533|O53533_M	P00326	100.83	9.0	373.0	DB01711	experimental	2,3,4,5,6-Pentafluorobenzyl Alcohol	OCc1c(F)c(F)c(F)c(F)c1F
1910	tr|O53533|O53533_M	P00326	100.83	9.0	373.0	DB02131	experimental	N-1-methylheptylformamide	O=CN[C@H](C)CCCCCC
1911	tr|O53533|O53533_M	P00326	100.83	9.0	373.0	DB02249	experimental	2-Ethoxyethanol	CCOCCO
1912	tr|O53533|O53533_M	P00326	100.83	9.0	373.0	DB02659	approved	Cholic Acid	OC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](C[C@@H]2O)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
1913	tr|O53533|O53533_M	P00326	100.83	9.0	373.0	DB02721	experimental	4-Iodopyrazole	Ic1c[nH]nc1
1914	tr|O53533|O53533_M	P00326	100.83	9.0	373.0	DB02757	experimental	Pyrazole	[nH]1cccn1
1915	tr|O53533|O53533_M	P00326	100.83	9.0	373.0	DB02822	experimental	Para-Bromobenzyl Alcohol	OCc1ccc(Br)cc1
1916	tr|O53533|O53533_M	P00326	100.83	9.0	373.0	DB02871	experimental	3-Butylthiolane 1-Oxide	O=[S@@]1C[C@H](CC1)CCCC
1917	tr|O53533|O53533_M	P00326	100.83	9.0	373.0	DB03020	experimental	5-beta-D-ribofuranosylnicotinamide adenine dinucleotide	NC(=O)c1c[nH+]cc(c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1918	tr|O53533|O53533_M	P00326	100.83	9.0	373.0	DB03061	experimental	(R)-N-(1-Methyl-Hexyl)-Formamide	CCCCC[C@H](C)NC=O
1919	tr|O53533|O53533_M	P00326	100.83	9.0	373.0	DB03226	experimental	Trifluoroethanol	OCC(F)(F)F
1920	tr|O53533|O53533_M	P00326	100.83	9.0	373.0	DB03559	experimental	Cyclohexylformamide	O=CNC1CCCCC1
1921	tr|O53533|O53533_M	P00326	100.83	9.0	373.0	DB04071	experimental	Cpad	NC(=O)c1nc(ccc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1922	tr|O53533|O53533_M	P00326	100.83	9.0	373.0	DB04113	experimental	N-Formylpiperidine	O=CN1CCCCC1
1923	tr|O53533|O53533_M	P00326	100.83	9.0	373.0	DB04312	experimental	2,3-Difluorobenzyl Alcohol	OCc1cccc(F)c1F
1924	tr|O53533|O53533_M	P00326	100.83	9.0	373.0	DB04448	experimental	2,4-Difluorobenzyl Alcohol 2,4-Difluoro-1-(Hydroxymethyl)Benzene	OCc1ccc(F)cc1F
1925	tr|O53533|O53533_M	P11766	101.39	7.0	373.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1926	tr|O53533|O53533_M	P11766	101.39	7.0	373.0	DB03017	approved; experimental	Lauric acid	CCCCCCCCCCCC(=O)O
1927	tr|O53533|O53533_M	P11766	101.39	7.0	373.0	DB03704	experimental	12-Hydroxydodecanoic Acid	OCCCCCCCCCCCC(=O)O
1928	tr|O53533|O53533_M	P11766	101.39	7.0	373.0	DB04153	experimental	S-Hydroxymethyl Glutathione	OC(=O)[C@@H](N)CCC(=O)N[C@@H](CSCO)C(=O)NCC(=O)O
1929	tr|O53533|O53533_M	P40394	100.55	21.0	384.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1930	tr|O53533|O53533_M	P08319	102.49	9.0	379.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1931	tr|O53533|O53533_M	P08319	102.49	9.0	379.0	DB03559	experimental	Cyclohexylformamide	O=CNC1CCCCC1
1932	tr|O53533|O53533_M	P42328	91.69	2.0	333.0	DB03226	experimental	Trifluoroethanol	OCC(F)(F)F
1933	tr|O53533|O53533_M	P14941	89.47	16.0	339.0	DB02606	experimental; investigational	2-Butanol	CC[C@@H](C)O
1934	tr|O53533|O53533_M	P14941	89.47	16.0	339.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1935	tr|O53533|O53533_M	Q00796	91.69	17.0	348.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1936	tr|O53533|O53533_M	Q00796	91.69	17.0	348.0	DB04478	experimental	Cp-166572, 2-Hydroxymethyl-4-(4-N,N-Dimethylaminosulfonyl-1-Piperazino)-Pyrimidine	CN(C)S(=O)(=O)N1CCN(CC1)c2ccnc(n2)CO
1937	tr|O06541|O06541_M	P30084	91.04	44.0	288.0	DB02563	experimental	Hexanoyl-CoA	CCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
1938	tr|O06541|O06541_M	P30084	91.04	44.0	288.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
1939	tr|O06541|O06541_M	P30084	91.04	44.0	288.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
1940	tr|O06541|O06541_M	P30084	91.04	44.0	288.0	DB04117	experimental	4-(N,N-Dimethylamino)cinnamoyl-CoA	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)/C=C/c4ccc(cc4)N(C)C
1941	tr|O06541|O06541_M	P30084	91.04	44.0	288.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
1942	tr|O06541|O06541_M	O75521	93.66	140.0	391.0	DB08231	experimental	Myristic acid	CCCCCCCCCCCCCC(=O)O
1943	tr|O06541|O06541_M	P52045	95.52	4.0	260.0	DB03117	experimental	2-carboxypropyl-coenzyme A	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC[C@H](C)C(=O)O
1944	tr|O06541|O06541_M	O68600	85.45	6.0	235.0	DB01652	experimental	4-hydroxybenzoyl-CoA	Oc1ccc(cc1)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2OP(=O)(O)O)n3cnc(c34)c(N)ncn4
1945	tr|O06541|O06541_M	P9WNP5	99.25	41.0	307.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
1946	tr|O06541|O06541_M	P9WNP5	99.25	41.0	307.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
1947	tr|O06541|O06541_M	P40939	72.01	30.0	223.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1948	tr|O06541|O06541_M	P28793	84.7	10.0	237.0	DB08249	experimental	3,6,9,12,15-PENTAOXATRICOSAN-1-OL	CCCCCCCCOCCOCCOCCOCCOCCO
1949	tr|O06541|O06541_M	P42126	89.55	56.0	296.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
1950	tr|O06541|O06541_M	P42126	89.55	56.0	296.0	DB03127	experimental	Benzamidine	NC(=[NH2+])c1ccccc1
1951	tr|O06541|O06541_M	Q08426	74.63	6.0	206.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1952	tr|O06541|O06541_M	Q93TU6	72.76	40.0	235.0	DB02906	experimental	(2s,4s)-Alpha-Campholinic Acid	CC1(C)[C@H](C)C(=O)C[C@H]1CC(O)O
1953	tr|O06541|O06541_M	Q6NVY1	72.76	43.0	238.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
1954	tr|O53863|O53863_M	P0AEK2	83.64	2.0	232.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1956	tr|O53863|O53863_M	Q9BTZ2	70.55	28.0	222.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
1957	tr|O53863|O53863_M	Q84EX5	76.36	3.0	213.0	DB04619	experimental	Acetophenone	CC(=O)c1ccccc1
1958	tr|O53863|O53863_M	Q84EX5	76.36	3.0	213.0	DB04784	experimental	(R)-1-phenylethanol	C[C@@H](O)c1ccccc1
1960	tr|O53863|O53863_M	P16544	73.09	4.0	205.0	DB01942	experimental; investigational	Formic acid	OC=O
1961	tr|O53863|O53863_M	P16544	73.09	4.0	205.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1962	tr|O53863|O53863_M	P16544	73.09	4.0	205.0	DB07715	investigational	Emodin	Cc(c1)cc(O)c(c12)C(=O)c3c(C2=O)cc(O)cc3O
1963	tr|O53863|O53863_M	Q9WYS2	70.18	7.0	200.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1964	tr|O53863|O53863_M	Q8NBQ5	72.73	34.0	234.0	DB02854	experimental	Aetiocholanolone	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](CC3)C[C@H](O)CC4
1965	tr|O53863|O53863_M	Q92506	74.55	8.0	213.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1966	tr|O53863|O53863_M	Q92506	74.55	8.0	213.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1967	tr|O53863|O53863_M	Q8NBN7	78.91	36.0	253.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
1968	tr|O53863|O53863_M	O75911	70.18	36.0	229.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
1969	tr|O53863|O53863_M	Q9BY49	70.91	16.0	211.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
1970	tr|O53863|O53863_M	P0CG22	71.64	28.0	225.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
1971	tr|O53863|O53863_M	P0CG22	71.64	28.0	225.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1972	tr|O53863|O53863_M	P0CG22	71.64	28.0	225.0	DB03541	experimental	10-Propargyl-5,8-Dideazafolic Acid	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(CC#C)Cc(c2)ccc(c23)[nH]c(N)nc3=O
1973	tr|O53863|O53863_M	P0CG22	71.64	28.0	225.0	DB07689	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)NCc(cn3)nc(c34)c(N)nc(n4)N
1974	tr|O53863|O53863_M	P0CG22	71.64	28.0	225.0	DB07765	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)N(C)Cc(cn3)nc(c34)c(N)nc(n4)N
1975	tr|O53863|O53863_M	Q8TC12	75.27	38.0	245.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
1977	tr|O53863|O53863_M	Q6UWP2	77.45	6.0	219.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1978	tr|O53863|O53863_M	Q9NYR8	73.09	6.0	207.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
1979	tr|O53863|O53863_M	Q96NR8	74.91	36.0	242.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
1980	tr|O53863|O53863_M	Q99714	76.36	8.0	218.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1981	tr|O53863|O53863_M	Q99714	76.36	8.0	218.0	DB02820	experimental	1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct	C1CCCCCN1C(=O)[C@H](c2ccccc2)n(c3=S)cnc(c34)nn(c4)[C@H]5C=CN(C=C5C([O-])=N)[C@@H]6O[C@@H]([C@@H](O)[C@H]6O)COP([O-])(=O)OP(=O)(O)OC[C@H]7O[C@H]([C@H]([O-])[C@@H]7[O-])n8cnc(c89)c(N)ncn9
1982	tr|O53863|O53863_M	Q99714	76.36	8.0	218.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
1983	tr|O53863|O53863_M	P14061	70.18	4.0	197.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1984	tr|O53863|O53863_M	P14061	70.18	4.0	197.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
1985	tr|O53863|O53863_M	P14061	70.18	4.0	197.0	DB01561	experimental; illicit	Androstanedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
1986	tr|O53863|O53863_M	P14061	70.18	4.0	197.0	DB02187	experimental	Equilin	O=C1CC[C@H]([C@@]12C)C=3[C@H](CC2)c4c(CC3)cc(O)cc4
1987	tr|O53863|O53863_M	P14061	70.18	4.0	197.0	DB02323	experimental	EM-1745	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)C[C@@H]([C@@H]4O)CCCCCCCCC(=O)OC[C@H]5O[C@H]([C@H](O)[C@@H]5O)n6cnc(c67)c(N)ncn7
1988	tr|O53863|O53863_M	P14061	70.18	4.0	197.0	DB02901	illicit; investigational	Stanolone	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
1989	tr|O53863|O53863_M	P14061	70.18	4.0	197.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1990	tr|O53863|O53863_M	P14061	70.18	4.0	197.0	DB13951	experimental	Stanolone acetate	CC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
1991	tr|O53863|O53863_M	Q9HBH5	78.91	41.0	258.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
1992	tr|O53863|O53863_M	P28845	70.55	31.0	225.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
1993	tr|O53863|O53863_M	P28845	70.55	31.0	225.0	DB02329	experimental	Carbenoxolone	OC(=O)CCC(=O)O[C@@H](CC1)C(C)(C)[C@@H]([C@]12C)CC[C@]3(C)[C@@H]2C(=O)C=C4[C@H]5[C@@](C)(CC[C@@]34C)CC[C@](C5)(C)C(=O)O
1994	tr|O53863|O53863_M	P28845	70.55	31.0	225.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
1995	tr|O53863|O53863_M	P28845	70.55	31.0	225.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
1996	tr|O53863|O53863_M	P28845	70.55	31.0	225.0	DB04652	experimental	Corticosterone	OCC(=O)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H]([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
1997	tr|O53863|O53863_M	P28845	70.55	31.0	225.0	DB05064	investigational	INCB13739	 
1998	tr|O53863|O53863_M	P28845	70.55	31.0	225.0	DB06992	experimental	(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone	Cc1ccc(cc1F)-c2nc(ccc2)C(=O)N(CC3(C)C)CCC3
1999	tr|O53863|O53863_M	P28845	70.55	31.0	225.0	DB07017	experimental	(5S)-2-{[(1S)-1-(4-Fluorophenyl)ethyl]amino}-5-(2-hydroxy-2-propanyl)-5-methyl-1,3-thiazol-4(5H)-one	Fc1ccc(cc1)[C@H](C)NC(=NC2=O)S[C@@]2(C)C(C)(C)O
2000	tr|O53863|O53863_M	P28845	70.55	31.0	225.0	DB07049	experimental	(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine	[O-][N+](=O)c1ccc(cc1)N2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)C(C)(C)C
2001	tr|O53863|O53863_M	P28845	70.55	31.0	225.0	DB07056	experimental	2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide	CCN(CC)C(=O)Cc1cccc(n1)NS(=O)(=O)c2c(C)c(Cl)ccc2
2002	tr|O53863|O53863_M	P28845	70.55	31.0	225.0	DB07310	experimental	(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one	Fc1ccccc1[C@H](C)NC(=NC2=O)S[C@]2(C)C(F)(F)F
2003	tr|O53863|O53863_M	P28845	70.55	31.0	225.0	DB07316	experimental	N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)C3CCN(CC3)CC4(CC4)C(=O)N
2004	tr|O53863|O53863_M	P28845	70.55	31.0	225.0	DB07619	experimental	N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)[C@H]3CC[C@@H](CC3)c4cccnc4
2005	tr|O53863|O53863_M	P28845	70.55	31.0	225.0	DB07624	experimental	1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide	C1CC1(C(=O)N)CN2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)[C@](C)(O)C(F)(F)F
2006	tr|O53863|O53863_M	P28845	70.55	31.0	225.0	DB07866	experimental	(5S)-2-(Cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one	CCC[C@]1(C)SC(=NC1=O)NC2CCCCCCC2
2007	tr|O53863|O53863_M	P28845	70.55	31.0	225.0	DB08277	experimental	2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE	CS(=O)(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4c(Cl)cc(F)cc4
2008	tr|O53863|O53863_M	P28845	70.55	31.0	225.0	DB08280	experimental	(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE	NC(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4ccc(OC)cc4
2009	tr|O53863|O53863_M	P28845	70.55	31.0	225.0	DB08771	experimental	(5R)-2-[(2-Fluorophenyl)amino]-5-isopropyl-1,3-thiazol-4(5H)-one	CC(C)[C@H]1SC(=NC1=O)Nc2c(F)cccc2
2010	tr|O53863|O53863_M	P28845	70.55	31.0	225.0	DB13751	approved; experimental	Glycyrrhizic acid	C1C[C@](C)(C(=O)O)C[C@H]([C@]12C)C=3[C@@](C)(CC2)[C@@]4(C)[C@H](C(=O)C3)[C@]5(C)[C@@H](CC4)C(C)(C)[C@H](CC5)O[C@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O[C@@H]7O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]7O
2011	tr|O53863|O53863_M	P37058	70.55	48.0	242.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
2012	tr|O53863|O53863_M	P37059	70.91	80.0	275.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
2013	tr|O53863|O53863_M	P37059	70.91	80.0	275.0	DB13952	approved; investigational; vet_approved	Estradiol acetate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)C
2014	tr|O53863|O53863_M	P37059	70.91	80.0	275.0	DB13953	approved; investigational; vet_approved	Estradiol benzoate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)c5ccccc5
2015	tr|O53863|O53863_M	P37059	70.91	80.0	275.0	DB13954	approved; investigational; vet_approved	Estradiol cypionate	C1CCCC1CCC(=O)O[C@H]2CC[C@H]([C@@]23C)[C@H]4[C@H](CC3)c5c(CC4)cc(O)cc5
2016	tr|O53863|O53863_M	P37059	70.91	80.0	275.0	DB13955	approved; investigational; vet_approved	Estradiol dienanthate	CCCCCCC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)CCCCCC
2017	tr|O53863|O53863_M	P37059	70.91	80.0	275.0	DB13956	approved; investigational; vet_approved	Estradiol valerate	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)CC[C@@H]4OC(=O)CCCC
2018	tr|O53863|O53863_M	P80365	70.55	81.0	275.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
2019	tr|O53863|O53863_M	P80365	70.55	81.0	275.0	DB01185	approved; illicit	Fluoxymesterone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@](F)([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
2020	tr|O53863|O53863_M	P80365	70.55	81.0	275.0	DB01569	experimental; illicit	Formebolone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@H]([C@@H](C2)O)[C@]4(C)C(CC3)=CC(=O)C(C=O)=C4
2021	tr|O53863|O53863_M	P80365	70.55	81.0	275.0	DB14538	experimental; vet_approved	Hydrocortisone aceponate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CC)C(=O)COC(=O)C
2022	tr|O53863|O53863_M	P80365	70.55	81.0	275.0	DB14539	approved; vet_approved	Hydrocortisone acetate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)C
2023	tr|O53863|O53863_M	P80365	70.55	81.0	275.0	DB14540	approved; vet_approved	Hydrocortisone butyrate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCC
2024	tr|O53863|O53863_M	P80365	70.55	81.0	275.0	DB14541	approved; investigational; vet_approved	Hydrocortisone cypionate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)CCC5CCCC5
2025	tr|O53863|O53863_M	P80365	70.55	81.0	275.0	DB14542	approved; vet_approved	Hydrocortisone phosphate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COP(=O)(O)O
2026	tr|O53863|O53863_M	P80365	70.55	81.0	275.0	DB14543	approved; vet_approved	Hydrocortisone probutate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CCC)C(=O)COC(=O)CC
2027	tr|O53863|O53863_M	P80365	70.55	81.0	275.0	DB14544	approved; vet_approved	Hydrocortisone valerate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCCC
2028	tr|O53863|O53863_M	P16152	85.82	7.0	243.0	DB01698	approved; experimental; investigational	Rutin	O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O[C@H]1C)OC[C@H]2O[C@H]([C@H](O)[C@@H](O)[C@@H]2O)Oc(c3=O)c(-c4cc(O)c(O)cc4)oc(c35)cc(O)cc5O
2029	tr|O53863|O53863_M	P16152	85.82	7.0	243.0	DB02709	investigational	Resveratrol	Oc1ccc(cc1)/C=C/c2cc(O)cc(O)c2
2030	tr|O53863|O53863_M	P16152	85.82	7.0	243.0	DB03394	experimental	Heptaethylene glycol	OCCOCCOCCOCCOCCOCCOCCO
2031	tr|O53863|O53863_M	P16152	85.82	7.0	243.0	DB03556	experimental	2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400	CCOCCOCCOCCOCCOCCOCCOCCOCCO
2032	tr|O53863|O53863_M	P16152	85.82	7.0	243.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
2033	tr|O53863|O53863_M	P16152	85.82	7.0	243.0	DB04463	experimental	3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol	n1cnc(N)c(c12)c(nn2C(C)(C)C)-c3cccc(O)c3
2034	tr|O53863|O53863_M	P16152	85.82	7.0	243.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
2035	tr|O53863|O53863_M	P16152	85.82	7.0	243.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
2036	tr|O53863|O53863_M	A0A348A0U3	72.0	1.0	199.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
2037	tr|O53863|O53863_M	Q6GI75	71.64	1.0	198.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
2038	tr|O53863|O53863_M	Q6GI75	71.64	1.0	198.0	DB11155	approved	Triclocarban	Clc1ccc(cc1)NC(=O)Nc2cc(Cl)c(Cl)cc2
2039	tr|O53863|O53863_M	O24990	70.91	1.0	196.0	DB04393	experimental	Soneclosan	Clc1cc(O)c(cc1)Oc2ccc(Cl)cc2
2040	tr|O53863|O53863_M	O24990	70.91	1.0	196.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
2041	tr|O53863|O53863_M	P56937	82.91	3.0	231.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
2042	tr|O53863|O53863_M	P0AEK4	73.45	1.0	203.0	DB01691	experimental	Indole Naphthyridinone	c1cccc(c12)n(C)cc2CN(C)C(=O)/C=C/c(c3)cnc(c34)NC(=O)CC4
2043	tr|O53863|O53863_M	P0AEK4	73.45	1.0	203.0	DB01865	experimental	3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide	c1cccc(c12)cc(n2C)CN(C)C(=O)/C=C/c3cnc(N)cc3
2044	tr|O53863|O53863_M	P0AEK4	73.45	1.0	203.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
2045	tr|O53863|O53863_M	P0AEK4	73.45	1.0	203.0	DB03030	experimental	4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole	Cc1ccc(cc1)Cn2cnc(c2)-c3cccs3
2046	tr|O53863|O53863_M	P0AEK4	73.45	1.0	203.0	DB03534	experimental	3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide	CC(=O)N(C)Cc1c(N)ccc(c1)C(=O)N(C)Cc(n2C)cc(c23)cccc3
2047	tr|O53863|O53863_M	P0AEK4	73.45	1.0	203.0	DB04030	experimental	1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole	Oc1ccc(cc1)Cn2c(c3c(c24)cccc4)CN(CC3)C(=O)c5ccc(O)cc5
2048	tr|O53863|O53863_M	P0AEK4	73.45	1.0	203.0	DB08265	experimental	2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL	Cc1ccc(cc1)S(=O)(=O)n(b2O)ncc(c23)cccc3
2049	tr|O53863|O53863_M	P0AEK4	73.45	1.0	203.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
2050	tr|O53863|O53863_M	P0AEK4	73.45	1.0	203.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
2051	tr|O53863|O53863_M	Q8I814	73.09	13.0	214.0	DB02015	experimental	Dihydrofolic Acid	O=c1[nH]c(N)nc(c12)NCC(=N2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
2052	tr|O53863|O53863_M	Q8I814	73.09	13.0	214.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
2053	tr|O53863|O53863_M	Q01782	79.27	8.0	226.0	DB02338	experimental	NADPH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
2054	tr|O53863|O53863_M	Q01782	79.27	8.0	226.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
2055	tr|O53863|O53863_M	Q01782	79.27	8.0	226.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
2056	tr|O53863|O53863_M	Q01782	79.27	8.0	226.0	DB04400	experimental	L-erythro-7,8-dihydrobiopterin	C[C@H](O)[C@H](O)C(CN1)=Nc(c12)c(=O)nc([nH]2)N
2057	tr|O53863|O53863_M	P35270	73.82	7.0	210.0	DB02637	experimental	Oxaloacetate Ion	OC(=O)C(=O)CC([O-])=O
2058	tr|O53863|O53863_M	P35270	73.82	7.0	210.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
2059	tr|O53863|O53863_M	P35270	73.82	7.0	210.0	DB03886	experimental	Biopterin	C[C@@H](O)[C@@H](O)c(n1)cnc(c12)nc(N)[nH]c2=O
2060	tr|O53863|O53863_M	P35270	73.82	7.0	210.0	DB04275	experimental	N-acetylserotonin	CC(=O)NCCc1c[nH]c(c12)ccc(c2)O
2061	tr|O53863|O53863_M	P9WGR1	70.91	5.0	200.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
2062	tr|O53863|O53863_M	P9WGR1	70.91	5.0	200.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
2063	tr|O53863|O53863_M	P9WGR1	70.91	5.0	200.0	DB02990	experimental	S-(2-Acetamidoethyl) hexadecanethioate	CCCCCCCCCCCCCCCC(=O)SCCNC(=O)C
2064	tr|O53863|O53863_M	P9WGR1	70.91	5.0	200.0	DB04289	experimental	Genz-10850	[nH]1ccc(c12)cc(cc2)C(=O)N3CCN(CC3)C4c(cccc5)c5c(c46)cccc6
2065	tr|O53863|O53863_M	P9WGR1	70.91	5.0	200.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
2066	tr|O53863|O53863_M	P9WGR1	70.91	5.0	200.0	DB07090	experimental	(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cccc(c1C)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
2067	tr|O53863|O53863_M	P9WGR1	70.91	5.0	200.0	DB07123	experimental	N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE	Cc1ccc(cc1)C(=O)N2CCC(CC2)Cc3ccccc3
2068	tr|O53863|O53863_M	P9WGR1	70.91	5.0	200.0	DB07155	experimental	(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE	c1ccccc1NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
2069	tr|O53863|O53863_M	P9WGR1	70.91	5.0	200.0	DB07178	experimental	5-PENTYL-2-PHENOXYPHENOL	CCCCCc1cc(O)c(cc1)Oc2ccccc2
2070	tr|O53863|O53863_M	P9WGR1	70.91	5.0	200.0	DB07188	experimental	(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(cc(Cl)c1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
2071	tr|O53863|O53863_M	P9WGR1	70.91	5.0	200.0	DB07192	experimental	(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Brc1cc(ccc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
2072	tr|O53863|O53863_M	P9WGR1	70.91	5.0	200.0	DB07222	experimental	(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(c(C)cc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
2073	tr|O53863|O53863_M	P9WGR1	70.91	5.0	200.0	DB07287	experimental	2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL	c1cccnc1Cc2cc(O)c(cc2)Oc3ccc(Cl)cc3Cl
2074	tr|O53863|O53863_M	P9WGR1	70.91	5.0	200.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
2075	tr|O53863|O53863_M	Q8T8E9	70.55	2.0	196.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
2076	tr|O05293|O05293_M	O32449	97.7	16.0	313.0	DB03833	experimental	2-Prolyl-5-Tert-Butyl-[1,3,4]Oxadiazole	C1CCN[C@@H]1C(=O)c2nnc(o2)C(C)(C)C
2077	tr|O05293|O05293_M	O32449	97.7	16.0	313.0	DB07391	experimental	(2S)-2-AMINO-1-(5-TERT-BUTYL-1,3,4-OXADIAZOL-2-YL)PROPAN-1-ONE	C[C@H](N)C(=O)c1nnc(o1)C(C)(C)C
2078	tr|O05293|O05293_M	O32449	97.7	16.0	313.0	DB08576	experimental	1-(5-TERT-BUTYL-1,3,4-OXADIAZOL-2-YL)-2-(METHYLAMINO)ETHANONE	CNCC(=O)c1nnc(o1)C(C)(C)C
2079	tr|O05293|O05293_M	Q54528	88.49	9.0	278.0	DB01806	experimental	10-decarboxymethylaclacinomycin A	c1ccc(O)c(c12)C(=O)c3c(C2=O)cc4c(c3O)[C@H](C[C@](C4)(O)CC)O[C@H]5C[C@H](N(C)C)[C@@H]([C@@H](O5)C)O[C@@H]6C[C@H](O)[C@H]([C@@H](O6)C)O[C@H]7CCC(=O)[C@H](O7)C
2080	tr|O05293|O05293_M	Q54528	88.49	9.0	278.0	DB04131	experimental	10-(4-Dimethylamino-5-Hydroxy-6-Methyl-Tetrahydro-Pyran-2-Yloxy)-8-Ethyl-1,8,11-Trihydroxy-7,8,9,10-Tetrahydro-Naphthacene-5,12-Dione	O[C@H]1[C@@H](N(C)C)C[C@@H](O[C@H]1C)O[C@H]2C[C@](O)(CC)Cc(c23)cc4c(c3O)C(=O)c5c(C4=O)cccc5O
2081	tr|O69652|O69652_M	P35520	85.26	101.0	396.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
2082	tr|O69652|O69652_M	P35520	85.26	101.0	396.0	DB00118	approved; investigational; nutraceutical	Ademetionine	[O-]C(=O)[C@@H](N)CC[S+](C)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
2083	tr|O69652|O69652_M	P35520	85.26	101.0	396.0	DB00133	investigational; nutraceutical	Serine	OC(=O)[C@@H](N)CO
2084	tr|O69652|O69652_M	P35520	85.26	101.0	396.0	DB00151	approved; nutraceutical	Cysteine	OC(=O)[C@@H](N)CS
2085	tr|O69652|O69652_M	Q96GA7	80.64	15.0	294.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
2086	tr|O69652|O69652_M	Q9GZT4	84.1	25.0	316.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
2087	tr|O69652|O69652_M	Q9GZT4	84.1	25.0	316.0	DB00133	investigational; nutraceutical	Serine	OC(=O)[C@@H](N)CO
2088	tr|O69652|O69652_M	P20132	80.64	8.0	287.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
2089	tr|O69652|O69652_M	P20132	80.64	8.0	287.0	DB00133	investigational; nutraceutical	Serine	OC(=O)[C@@H](N)CO
2090	tr|O69652|O69652_M	Q00740	75.72	30.0	292.0	DB01735	experimental	3-Chloroalaninate	[O-]C(=O)[C@H]([NH3+])CCl
2091	tr|O69652|O69652_M	Q00740	75.72	30.0	292.0	DB01804	experimental	2-Ammoniobut-3-Enoate, 2-Amino-3-Butenoate	[O-]C(=O)[C@H]([NH3+])C=C
2092	tr|O69652|O69652_M	Q00740	75.72	30.0	292.0	DB02085	experimental	1-Aminocyclopropanecarboxylic Acid	OC(=O)C1(N)CC1
2093	tr|O69652|O69652_M	Q00740	75.72	30.0	292.0	DB03053	experimental	1-Aminocyclopropylphosphonate	OP([O-])(=O)C1(N)CC1
2094	tr|O69652|O69652_M	Q00740	75.72	30.0	292.0	DB04212	experimental	2-Iminiopropanoate	CC(=[NH2+])C([O-])=O
2095	tr|O69652|O69652_M	Q00740	75.72	30.0	292.0	DB04553	experimental	2-Oxobutanoic Acid	CCC(=O)C(=O)O
2096	tr|O53547|O53547_M	Q16698	85.49	55.0	326.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
2097	tr|O53547|O53547_M	Q16698	85.49	55.0	326.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
2098	tr|O53547|O53547_M	Q9BTZ2	79.81	21.0	274.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
2099	tr|O53547|O53547_M	Q9WYS2	77.6	5.0	251.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
2100	tr|O53547|O53547_M	Q92506	79.5	6.0	258.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
2101	tr|O53547|O53547_M	Q92506	79.5	6.0	258.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
2102	tr|O53547|O53547_M	P0AEK2	75.71	2.0	242.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
2105	tr|O53547|O53547_M	P0AET8	76.97	7.0	251.0	DB02123	experimental	Glycochenodeoxycholic Acid	OC(=O)CNC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
2107	tr|O53547|O53547_M	Q9BY49	78.86	16.0	266.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
2108	tr|O53547|O53547_M	P16544	79.18	6.0	257.0	DB01942	experimental; investigational	Formic acid	OC=O
2109	tr|O53547|O53547_M	P16544	79.18	6.0	257.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
2110	tr|O53547|O53547_M	P16544	79.18	6.0	257.0	DB07715	investigational	Emodin	Cc(c1)cc(O)c(c12)C(=O)c3c(C2=O)cc(O)cc3O
2111	tr|O53547|O53547_M	Q84EX5	77.6	3.0	249.0	DB04619	experimental	Acetophenone	CC(=O)c1ccccc1
2112	tr|O53547|O53547_M	Q84EX5	77.6	3.0	249.0	DB04784	experimental	(R)-1-phenylethanol	C[C@@H](O)c1ccccc1
2113	tr|O53547|O53547_M	P0CG22	80.76	21.0	277.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
2114	tr|O53547|O53547_M	P0CG22	80.76	21.0	277.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
2115	tr|O53547|O53547_M	P0CG22	80.76	21.0	277.0	DB03541	experimental	10-Propargyl-5,8-Dideazafolic Acid	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(CC#C)Cc(c2)ccc(c23)[nH]c(N)nc3=O
2116	tr|O53547|O53547_M	P0CG22	80.76	21.0	277.0	DB07689	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)NCc(cn3)nc(c34)c(N)nc(n4)N
2117	tr|O53547|O53547_M	P0CG22	80.76	21.0	277.0	DB07765	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)N(C)Cc(cn3)nc(c34)c(N)nc(n4)N
2118	tr|O53547|O53547_M	Q99714	78.86	6.0	256.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
2119	tr|O53547|O53547_M	Q99714	78.86	6.0	256.0	DB02820	experimental	1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct	C1CCCCCN1C(=O)[C@H](c2ccccc2)n(c3=S)cnc(c34)nn(c4)[C@H]5C=CN(C=C5C([O-])=N)[C@@H]6O[C@@H]([C@@H](O)[C@H]6O)COP([O-])(=O)OP(=O)(O)OC[C@H]7O[C@H]([C@H]([O-])[C@@H]7[O-])n8cnc(c89)c(N)ncn9
2120	tr|O53547|O53547_M	Q99714	78.86	6.0	256.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
2121	tr|O53547|O53547_M	Q7Z4W1	74.13	5.0	240.0	DB02831	experimental	Dihydrogenphosphate	OP([O-])(=O)O
2122	tr|O53547|O53547_M	Q7Z4W1	74.13	5.0	240.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
2123	tr|O53547|O53547_M	P51659	74.45	6.0	242.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
2124	tr|O53547|O53547_M	P51659	74.45	6.0	242.0	DB03192	experimental	(R)-3-hydroxydecanoyl-CoA	CCCCCCC[C@@H](O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
2126	tr|O53547|O53547_M	Q6UWP2	75.08	11.0	249.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
2127	tr|O53547|O53547_M	Q01782	86.75	8.0	283.0	DB02338	experimental	NADPH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
2128	tr|O53547|O53547_M	Q01782	86.75	8.0	283.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
2129	tr|O53547|O53547_M	Q01782	86.75	8.0	283.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
2130	tr|O53547|O53547_M	Q01782	86.75	8.0	283.0	DB04400	experimental	L-erythro-7,8-dihydrobiopterin	C[C@H](O)[C@H](O)C(CN1)=Nc(c12)c(=O)nc([nH]2)N
2131	tr|O53547|O53547_M	A0A348A0U3	79.18	4.0	255.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
2132	tr|O53547|O53547_M	Q8NBN7	80.13	32.0	286.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
2133	tr|O53547|O53547_M	Q8I814	81.07	13.0	270.0	DB02015	experimental	Dihydrofolic Acid	O=c1[nH]c(N)nc(c12)NCC(=N2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
2134	tr|O53547|O53547_M	Q8I814	81.07	13.0	270.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
2135	tr|O53547|O53547_M	P0AEK4	77.92	4.0	251.0	DB01691	experimental	Indole Naphthyridinone	c1cccc(c12)n(C)cc2CN(C)C(=O)/C=C/c(c3)cnc(c34)NC(=O)CC4
2136	tr|O53547|O53547_M	P0AEK4	77.92	4.0	251.0	DB01865	experimental	3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide	c1cccc(c12)cc(n2C)CN(C)C(=O)/C=C/c3cnc(N)cc3
2137	tr|O53547|O53547_M	P0AEK4	77.92	4.0	251.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
2138	tr|O53547|O53547_M	P0AEK4	77.92	4.0	251.0	DB03030	experimental	4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole	Cc1ccc(cc1)Cn2cnc(c2)-c3cccs3
2139	tr|O53547|O53547_M	P0AEK4	77.92	4.0	251.0	DB03534	experimental	3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide	CC(=O)N(C)Cc1c(N)ccc(c1)C(=O)N(C)Cc(n2C)cc(c23)cccc3
2140	tr|O53547|O53547_M	P0AEK4	77.92	4.0	251.0	DB04030	experimental	1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole	Oc1ccc(cc1)Cn2c(c3c(c24)cccc4)CN(CC3)C(=O)c5ccc(O)cc5
2141	tr|O53547|O53547_M	P0AEK4	77.92	4.0	251.0	DB08265	experimental	2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL	Cc1ccc(cc1)S(=O)(=O)n(b2O)ncc(c23)cccc3
2142	tr|O53547|O53547_M	P0AEK4	77.92	4.0	251.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
2143	tr|O53547|O53547_M	P0AEK4	77.92	4.0	251.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
2144	tr|O53547|O53547_M	O24990	81.7	4.0	263.0	DB04393	experimental	Soneclosan	Clc1cc(O)c(cc1)Oc2ccc(Cl)cc2
2145	tr|O53547|O53547_M	O24990	81.7	4.0	263.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
2146	tr|O53547|O53547_M	Q6GI75	78.86	3.0	253.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
2147	tr|O53547|O53547_M	Q6GI75	78.86	3.0	253.0	DB11155	approved	Triclocarban	Clc1ccc(cc1)NC(=O)Nc2cc(Cl)c(Cl)cc2
2148	tr|O53547|O53547_M	Q9HBH5	82.65	41.0	303.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
2149	tr|O53547|O53547_M	Q7AUG5	75.39	3.0	242.0	DB04782	experimental	(S)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@H]2CO2
2150	tr|O53547|O53547_M	Q93D82	75.39	3.0	242.0	DB04472	experimental	(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol	[N-]=[N+]=NC[C@H](O)c1ccc([N+]([O-])=O)cc1
2151	tr|O53547|O53547_M	Q93D82	75.39	3.0	242.0	DB04499	experimental	(R)-styrene oxide	C1O[C@@H]1c2ccccc2
2152	tr|O53547|O53547_M	Q93D82	75.39	3.0	242.0	DB04777	experimental	(R)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@@H]2CO2
2153	tr|O53547|O53547_M	P9WGR1	82.33	5.0	266.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
2154	tr|O53547|O53547_M	P9WGR1	82.33	5.0	266.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
2155	tr|O53547|O53547_M	P9WGR1	82.33	5.0	266.0	DB02990	experimental	S-(2-Acetamidoethyl) hexadecanethioate	CCCCCCCCCCCCCCCC(=O)SCCNC(=O)C
2156	tr|O53547|O53547_M	P9WGR1	82.33	5.0	266.0	DB04289	experimental	Genz-10850	[nH]1ccc(c12)cc(cc2)C(=O)N3CCN(CC3)C4c(cccc5)c5c(c46)cccc6
2157	tr|O53547|O53547_M	P9WGR1	82.33	5.0	266.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
2158	tr|O53547|O53547_M	P9WGR1	82.33	5.0	266.0	DB07090	experimental	(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cccc(c1C)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
2159	tr|O53547|O53547_M	P9WGR1	82.33	5.0	266.0	DB07123	experimental	N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE	Cc1ccc(cc1)C(=O)N2CCC(CC2)Cc3ccccc3
2160	tr|O53547|O53547_M	P9WGR1	82.33	5.0	266.0	DB07155	experimental	(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE	c1ccccc1NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
2161	tr|O53547|O53547_M	P9WGR1	82.33	5.0	266.0	DB07178	experimental	5-PENTYL-2-PHENOXYPHENOL	CCCCCc1cc(O)c(cc1)Oc2ccccc2
2162	tr|O53547|O53547_M	P9WGR1	82.33	5.0	266.0	DB07188	experimental	(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(cc(Cl)c1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
2163	tr|O53547|O53547_M	P9WGR1	82.33	5.0	266.0	DB07192	experimental	(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Brc1cc(ccc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
2164	tr|O53547|O53547_M	P9WGR1	82.33	5.0	266.0	DB07222	experimental	(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(c(C)cc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
2165	tr|O53547|O53547_M	P9WGR1	82.33	5.0	266.0	DB07287	experimental	2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL	c1cccnc1Cc2cc(O)c(cc2)Oc3ccc(Cl)cc3Cl
2166	tr|O53547|O53547_M	P9WGR1	82.33	5.0	266.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
2167	tr|O53547|O53547_M	P16152	76.34	6.0	248.0	DB01698	approved; experimental; investigational	Rutin	O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O[C@H]1C)OC[C@H]2O[C@H]([C@H](O)[C@@H](O)[C@@H]2O)Oc(c3=O)c(-c4cc(O)c(O)cc4)oc(c35)cc(O)cc5O
2168	tr|O53547|O53547_M	P16152	76.34	6.0	248.0	DB02709	investigational	Resveratrol	Oc1ccc(cc1)/C=C/c2cc(O)cc(O)c2
2169	tr|O53547|O53547_M	P16152	76.34	6.0	248.0	DB03394	experimental	Heptaethylene glycol	OCCOCCOCCOCCOCCOCCOCCO
2170	tr|O53547|O53547_M	P16152	76.34	6.0	248.0	DB03556	experimental	2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400	CCOCCOCCOCCOCCOCCOCCOCCOCCO
2171	tr|O53547|O53547_M	P16152	76.34	6.0	248.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
2172	tr|O53547|O53547_M	P16152	76.34	6.0	248.0	DB04463	experimental	3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol	n1cnc(N)c(c12)c(nn2C(C)(C)C)-c3cccc(O)c3
2173	tr|O53547|O53547_M	P16152	76.34	6.0	248.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
2174	tr|O53547|O53547_M	P16152	76.34	6.0	248.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
2175	tr|O53547|O53547_M	P56937	72.24	2.0	231.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
2176	tr|O33203|O33203_M	Q9UM01	78.96	24.0	463.0	DB13146	approved	Fluciclovine (18F)	OC(=O)[C@]1(N)C[C@H]([18F])C1
2177	tr|O33203|O33203_M	P30825	75.36	19.0	438.0	DB00123	approved; nutraceutical	L-Lysine	NCCCC[C@H](N)C(=O)O
2178	tr|O33203|O33203_M	P30825	75.36	19.0	438.0	DB00125	investigational; nutraceutical	Arginine	OC(=O)[C@@H](N)CCCNC(N)=N
2179	tr|O33203|O33203_M	P30825	75.36	19.0	438.0	DB00129	approved; nutraceutical	Ornithine	NCCC[C@H](N)C(=O)O
2180	tr|O33203|O33203_M	Q9UHI5	78.6	32.0	469.0	DB00120	approved; investigational; nutraceutical	Phenylalanine	OC(=O)[C@@H](N)Cc1ccccc1
2181	tr|O33203|O33203_M	Q9UHI5	78.6	32.0	469.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
2182	tr|O33203|O33203_M	P52569	73.56	26.0	435.0	DB00123	approved; nutraceutical	L-Lysine	NCCCC[C@H](N)C(=O)O
2183	tr|O33203|O33203_M	P52569	73.56	26.0	435.0	DB00129	approved; nutraceutical	Ornithine	NCCC[C@H](N)C(=O)O
2184	tr|O33203|O33203_M	Q8WY07	74.82	21.0	437.0	DB00123	approved; nutraceutical	L-Lysine	NCCCC[C@H](N)C(=O)O
2185	tr|O33203|O33203_M	Q8WY07	74.82	21.0	437.0	DB00125	investigational; nutraceutical	Arginine	OC(=O)[C@@H](N)CCCNC(N)=N
2186	tr|O33203|O33203_M	Q8WY07	74.82	21.0	437.0	DB13146	approved	Fluciclovine (18F)	OC(=O)[C@]1(N)C[C@H]([18F])C1
2187	tr|O33203|O33203_M	Q9UPY5	78.24	33.0	468.0	DB00138	approved; nutraceutical	Cystine	OC(=O)[C@@H](N)CSSC[C@H](N)C(=O)O
2188	tr|O33203|O33203_M	Q9UPY5	78.24	33.0	468.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
2189	tr|O33203|O33203_M	Q9UPY5	78.24	33.0	468.0	DB00740	approved; investigational	Riluzole	Nc(s1)nc(c12)ccc(c2)OC(F)(F)F
2190	tr|O33203|O33203_M	Q9UPY5	78.24	33.0	468.0	DB00795	approved	Sulfasalazine	OC(=O)c1cc(ccc1O)/N=N/c2ccc(cc2)S(=O)(=O)Nc3ncccc3
2191	tr|O33203|O33203_M	Q9UPY5	78.24	33.0	468.0	DB06151	approved; investigational	Acetylcysteine	CC(=O)N[C@@H](CS)C(=O)O
2192	tr|O33203|O33203_M	Q9UPY5	78.24	33.0	468.0	DB11590	approved	Thimerosal	CC[Hg]Sc1ccccc1C([O-])=O
2193	tr|O33203|O33203_M	O43246	70.5	27.0	419.0	DB00123	approved; nutraceutical	L-Lysine	NCCCC[C@H](N)C(=O)O
2194	tr|O33203|O33203_M	O43246	70.5	27.0	419.0	DB00125	investigational; nutraceutical	Arginine	OC(=O)[C@@H](N)CCCNC(N)=N
2195	tr|O33203|O33203_M	P60063	74.28	9.0	422.0	DB02451	experimental	B-nonylglucoside	CCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
2196	tr|O53620|O53620_M	Q56232	92.31	22.0	382.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
2197	tr|O53620|O53620_M	Q56232	92.31	22.0	382.0	DB04299	experimental	Maleic Acid	OC(=O)/C=C\C(=O)O
2198	tr|O53620|O53620_M	Q16773	99.74	27.0	416.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
2199	tr|O53620|O53620_M	Q16773	99.74	27.0	416.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
2200	tr|O53620|O53620_M	Q16773	99.74	27.0	416.0	DB02556	experimental	D-Phenylalanine	OC(=O)[C@H](N)Cc1ccccc1
2201	tr|O53620|O53620_M	Q16773	99.74	27.0	416.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
2202	tr|O53620|O53620_M	Q16773	99.74	27.0	416.0	DB07950	experimental	Indoleacetic acid	OC(=O)Cc1c[nH]c(c12)cccc2
2203	tr|O53620|O53620_M	Q6YP21	99.23	61.0	448.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
2204	tr|O53620|O53620_M	Q75WK2	87.44	27.0	368.0	DB02024	experimental	3-phenylpropionic acid	OC(=O)CCc1ccccc1
2205	tr|O53620|O53620_M	Q75WK2	87.44	27.0	368.0	DB02238	experimental	4-methylthio-2-oxobutanoic acid	CSCCC(=O)C(=O)O
2206	tr|O53620|O53620_M	P33447	92.31	48.0	408.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
2207	tr|O53620|O53620_M	P17735	90.26	84.0	436.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
2208	tr|O53620|O53620_M	P17735	90.26	84.0	436.0	DB00120	approved; investigational; nutraceutical	Phenylalanine	OC(=O)[C@@H](N)Cc1ccccc1
2209	tr|O53620|O53620_M	P17735	90.26	84.0	436.0	DB00135	approved; investigational; nutraceutical	Tyrosine	OC(=O)[C@@H](N)Cc1ccc(O)cc1
2210	tr|O53620|O53620_M	P17735	90.26	84.0	436.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
2211	tr|O53620|O53620_M	P24298	100.26	95.0	486.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
2212	tr|O53620|O53620_M	P24298	100.26	95.0	486.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
2213	tr|O53620|O53620_M	P24298	100.26	95.0	486.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
2214	tr|O53620|O53620_M	P24298	100.26	95.0	486.0	DB00780	approved	Phenelzine	NNCCc1ccccc1
2215	tr|O53620|O53620_M	Q8TD30	100.0	123.0	513.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
2216	tr|O53620|O53620_M	Q8TD30	100.0	123.0	513.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
2217	tr|O53620|O53620_M	Q8TD30	100.0	123.0	513.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
2218	tr|O53620|O53620_M	Q8TD30	100.0	123.0	513.0	DB00780	approved	Phenelzine	NNCCc1ccccc1
2219	tr|O53620|O53620_M	Q96QU6	91.03	123.0	478.0	DB03214	experimental	Vinylglycine	OC(=O)[C@@H](N)C=C
2220	tr|O53620|O53620_M	Q9X0L5	95.64	30.0	403.0	DB01942	experimental; investigational	Formic acid	OC=O
2221	tr|O53620|O53620_M	Q2TU84	97.69	31.0	412.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
2222	tr|O53620|O53620_M	Q2TU84	97.69	31.0	412.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
2223	tr|O53620|O53620_M	P17174	97.69	31.0	412.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
2224	tr|O53620|O53620_M	P17174	97.69	31.0	412.0	DB00128	approved; nutraceutical	Aspartic acid	OC(=O)[C@@H](N)CC(=O)O
2225	tr|O53620|O53620_M	P17174	97.69	31.0	412.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
2226	tr|O53620|O53620_M	P17174	97.69	31.0	412.0	DB00151	approved; nutraceutical	Cysteine	OC(=O)[C@@H](N)CS
2227	tr|O53620|O53620_M	P17174	97.69	31.0	412.0	DB00210	approved	Adapalene	C1C(C2)CC(C3)CC1CC23c4c(OC)ccc(c4)-c(cc5)cc(c56)ccc(c6)C(=O)O
2228	tr|O53620|O53620_M	P17174	97.69	31.0	412.0	DB04299	experimental	Maleic Acid	OC(=O)/C=C\C(=O)O
2229	tr|O53620|O53620_M	P17174	97.69	31.0	412.0	DB09130	approved; investigational	Copper	[Cu]
2230	tr|O53620|O53620_M	Q8N5Z0	90.51	69.0	422.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
2231	tr|O53620|O53620_M	Q8N5Z0	90.51	69.0	422.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
2232	tr|O53620|O53620_M	Q9X0D0	76.15	10.0	307.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
2233	tr|O53620|O53620_M	Q9X0D0	76.15	10.0	307.0	DB03997	experimental	L-histidinol phosphate	OP(=O)(O)OC[C@@H](N)Cc1c[nH]cn1
2234	tr|O53620|O53620_M	P97084	73.85	44.0	332.0	DB02482	experimental	Phosphonothreonine	OC(=O)[C@H](N)[C@H](C)OP(=O)(O)O
2235	tr|O53620|O53620_M	P97084	73.85	44.0	332.0	DB03433	experimental	{3-[(3-Hydroxy-2-Methyl-5-Phosphonooxymethyl-Pyridin-4-Ylmethyl)-Amino]-2-Methyl-Propyl}-Phosphonic Acid	OP(=O)(O)O[C@H](C)CNCc1c(O)c(C)ncc1COP(=O)(O)O
2236	tr|O53620|O53620_M	P00505	82.05	82.0	402.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
2237	tr|O53620|O53620_M	P00505	82.05	82.0	402.0	DB00128	approved; nutraceutical	Aspartic acid	OC(=O)[C@@H](N)CC(=O)O
2238	tr|O53620|O53620_M	P00505	82.05	82.0	402.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
2239	tr|O53620|O53620_M	P00505	82.05	82.0	402.0	DB00151	approved; nutraceutical	Cysteine	OC(=O)[C@@H](N)CS
2240	tr|O53620|O53620_M	P00505	82.05	82.0	402.0	DB02783	experimental	4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate	Cc1ncc(COP(=O)(O)O)c(c1O)CNOCC(=O)O
2241	tr|O53620|O53620_M	P95468	77.69	43.0	346.0	DB02024	experimental	3-phenylpropionic acid	OC(=O)CCc1ccccc1
2242	tr|O53620|O53620_M	P95468	77.69	43.0	346.0	DB02242	experimental	Cyclohexanepropanoic acid	OC(=O)CCC1CCCCC1
2243	tr|O53620|O53620_M	P95468	77.69	43.0	346.0	DB02434	experimental	4-(2-Thienyl)Butyric Acid	OC(=O)CCCc1cccs1
2244	tr|O53620|O53620_M	P95468	77.69	43.0	346.0	DB02740	experimental	3-Indolebutyric Acid	OC(=O)CCCc1c[nH]c(c12)cccc2
2245	tr|O53620|O53620_M	P95468	77.69	43.0	346.0	DB02758	experimental	Indolepropionic acid	OC(=O)CCc1c[nH]c(c12)cccc2
2246	tr|O53620|O53620_M	P95468	77.69	43.0	346.0	DB03210	experimental	4-Aminohydrocinnamic Acid	Nc1ccc(cc1)CCC(=O)O
2247	tr|O53620|O53620_M	P95468	77.69	43.0	346.0	DB03400	experimental	3-(P-Tolyl)Propionic Acid	Cc1ccc(cc1)CCC(=O)O
2248	tr|O53620|O53620_M	P95468	77.69	43.0	346.0	DB04051	experimental	5-phenylpentanoic acid	OC(=O)CCCCc1ccccc1
2249	tr|O53620|O53620_M	P95468	77.69	43.0	346.0	DB04208	experimental	3-(3,4-dimethoxyphenyl)propanoic acid	COc1c(OC)cc(cc1)CCC(=O)O
2250	tr|O53620|O53620_M	P95468	77.69	43.0	346.0	DB04299	experimental	Maleic Acid	OC(=O)/C=C\C(=O)O
2251	tr|O53620|O53620_M	P95468	77.69	43.0	346.0	DB06819	approved; investigational	Phenylbutyric acid	OC(=O)CCCc1ccccc1
2252	tr|O53620|O53620_M	P00509	85.38	44.0	377.0	DB01639	experimental	N-Methyl-Pyridoxal-5'-Phosphate	Cc1c(O)c(C=O)c(c[n+]1C)COP(=O)(O)O
2253	tr|O53620|O53620_M	P00509	85.38	44.0	377.0	DB02024	experimental	3-phenylpropionic acid	OC(=O)CCc1ccccc1
2254	tr|O53620|O53620_M	P00509	85.38	44.0	377.0	DB02758	experimental	Indolepropionic acid	OC(=O)CCc1c[nH]c(c12)cccc2
2255	tr|O53620|O53620_M	P00509	85.38	44.0	377.0	DB02981	experimental	Vitamin B6 Complexed with 2-Amino-Hexanoic Acid	CCCC[C@@H](C(=O)O)NCc1c(COP(=O)(O)O)cnc(C)c1O
2256	tr|O53620|O53620_M	P00509	85.38	44.0	377.0	DB03553	experimental	Glutaric Acid	OC(=O)CCCC(=O)O
2257	tr|O53620|O53620_M	P00509	85.38	44.0	377.0	DB03629	experimental	Pyridoxal-5'-Phosphate-N-Oxide	Cc1c(O)c(C=O)c(c[n+]1[O-])COP(=O)(O)O
2258	tr|O53620|O53620_M	P00509	85.38	44.0	377.0	DB03662	experimental	Vitamin B6 Complexed with 2-Amino-Pentanoic Acid	CCC[C@@H](C(=O)O)NCc1c(O)c(C)ncc1COP(=O)(O)O
2259	tr|O53620|O53620_M	P00509	85.38	44.0	377.0	DB03750	experimental	Isovaleric Acid	CC(C)CC(=O)O
2260	tr|O53620|O53620_M	P00509	85.38	44.0	377.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
2261	tr|O53620|O53620_M	P00509	85.38	44.0	377.0	DB04299	experimental	Maleic Acid	OC(=O)/C=C\C(=O)O
2262	tr|O53620|O53620_M	P00509	85.38	44.0	377.0	DB04467	experimental	N-(5'-phosphopyridoxyl)-L-alanine	OC(=O)[C@H](C)NCc1c(COP(=O)(O)O)cnc(C)c1O
2263	tr|O53620|O53620_M	P00509	85.38	44.0	377.0	DB04762	experimental	N-PYRIDOXYL-D-GLUTAMIC ACID-5'-MONOPHOSPHATE	Cc1ncc(COP(=O)(O)O)c(c1O)CN[C@@H](C(=O)O)CCC(=O)O
2264	tr|O53620|O53620_M	P00509	85.38	44.0	377.0	DB04765	experimental	N-PYRIDOXYL-2-METHYL-L-GLUTAMIC ACID-5'-MONOPHOSPHATE	Cc1ncc(COP(=O)(O)O)c(c1O)CN[C@](C)(C(=O)O)CCC(=O)O
2265	tr|O53620|O53620_M	P00509	85.38	44.0	377.0	DB08845	experimental; investigational; nutraceutical	Oxogluric acid	OC(=O)CCC(=O)C(=O)O
2266	tr|O53620|O53620_M	Q9X266	76.92	8.0	308.0	DB02824	experimental	N-Pyridoxyl-Glycine-5-Monophosphate	Cc1ncc(COP(=O)(O)O)c(c1O)CNCC(=O)O
2267	tr|O53620|O53620_M	Q9X266	76.92	8.0	308.0	DB03576	experimental	N-Pyridoxyl-Threonine-5-Monophosphate	CC(O)C(C(=O)O)NCc1c(COP(=O)(O)O)cnc(C)c1O
2268	tr|O53620|O53620_M	Q9X266	76.92	8.0	308.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
2269	tr|O53620|O53620_M	Q5KUI2	77.18	37.0	338.0	DB03256	experimental	(6R)-Folinic acid	Nc([nH]1)nc(=O)c(c12)N(C=O)[C@@H](CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
2270	tr|O53620|O53620_M	O75600	75.9	112.0	408.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
2271	tr|O53620|O53620_M	O75600	75.9	112.0	408.0	DB00145	approved; nutraceutical; vet_approved	Glycine	NCC(=O)O
2272	tr|O53620|O53620_M	P0AB77	85.13	57.0	389.0	DB03915	experimental	2-Amino-3-Ketobutyric Acid	CC(=O)[C@H](N)C(=O)O
2273	tr|O53620|O53620_M	Q9KM65	73.08	90.0	375.0	DB08364	experimental	1-{[(1E)-(3-HYDROXY-2-METHYL-5-{[(TRIHYDROXY-LAMBDA^5^-PHOSPHANYL)OXY]METHYL}PYRIDIN-4-YL)METHYLIDENE]AMINO}UNDECAN-2-ONE	CCCCCCCCCC(=O)C/N=C/c1c(COP(O)(O)O)cnc(C)c1O
2274	tr|I6YGC8|I6YGC8_M	P40871	72.02	371.0	528.0	DB01672	experimental	2,3-Dihydroxy-Benzoic Acid	OC(=O)c1cccc(O)c1O
2275	tr|O53452|O53452_M	P06276	92.58	30.0	242.0	DB00122	approved; nutraceutical	Choline	C[N+](C)(C)CCO
2276	tr|O53452|O53452_M	P06276	92.58	30.0	242.0	DB00382	approved; investigational; withdrawn	Tacrine	c1cccc(c12)nc3c(c2N)CCCC3
2277	tr|O53452|O53452_M	P06276	92.58	30.0	242.0	DB00449	approved	Dipivefrin	CNCC(O)c1cc(OC(=O)C(C)(C)C)c(cc1)OC(=O)C(C)(C)C
2278	tr|O53452|O53452_M	P06276	92.58	30.0	242.0	DB00545	approved; investigational	Pyridostigmine	CN(C)C(=O)Oc1c[n+](C)ccc1
2279	tr|O53452|O53452_M	P06276	92.58	30.0	242.0	DB00674	approved	Galantamine	C1=C[C@H](O)C[C@@H]([C@@]123)Oc4c2c(CN(C)CC3)ccc4OC
2280	tr|O53452|O53452_M	P06276	92.58	30.0	242.0	DB00677	approved; investigational; withdrawn	Isoflurophate	CC(C)OP(F)(=O)OC(C)C
2281	tr|O53452|O53452_M	P06276	92.58	30.0	242.0	DB00733	approved; vet_approved	Pralidoxime	O/N=C/c1[n+](C)cccc1
2282	tr|O53452|O53452_M	P06276	92.58	30.0	242.0	DB00772	approved; investigational	Malathion	CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC
2283	tr|O53452|O53452_M	P06276	92.58	30.0	242.0	DB00843	approved	Donepezil	COc(c1)c(OC)cc(c12)C(=O)C(C2)CC3CCN(CC3)Cc4ccccc4
2284	tr|O53452|O53452_M	P06276	92.58	30.0	242.0	DB00941	approved	Hexafluronium	c1cccc2c1C(c(c23)cccc3)[N+](C)(C)CCCCCC[N+](C)(C)C4c(cccc5)c5c(c46)cccc6
2285	tr|O53452|O53452_M	P06276	92.58	30.0	242.0	DB00944	approved	Demecarium	C[N+](C)(C)c1cc(ccc1)OC(=O)N(C)CCCCCCCCCCN(C)C(=O)Oc2cccc(c2)[N+](C)(C)C
2286	tr|O53452|O53452_M	P06276	92.58	30.0	242.0	DB00989	approved; investigational	Rivastigmine	CCN(C)C(=O)Oc1cccc(c1)[C@H](C)N(C)C
2287	tr|O53452|O53452_M	P06276	92.58	30.0	242.0	DB01010	approved	Edrophonium	CC[N+](C)(C)c1cc(O)ccc1
2288	tr|O53452|O53452_M	P06276	92.58	30.0	242.0	DB01057	approved	Echothiophate	CCOP(=O)(OCC)SCC[N+](C)(C)C
2289	tr|O53452|O53452_M	P06276	92.58	30.0	242.0	DB01221	approved; vet_approved	Ketamine	C1CCCC(=O)C1(NC)c2ccccc2Cl
2290	tr|O53452|O53452_M	P06276	92.58	30.0	242.0	DB01226	approved	Mivacurium	COc(c1)c(OC)c(OC)cc1C[C@H](c(c23)cc(OC)c(c2)OC)[N+](C)(CC3)CCCOC(=O)CC/C=C/CCC(=O)OCCC[N+](C)(CCc(c45)cc(OC)c(c5)OC)[C@@H]4Cc6cc(OC)c(OC)c(c6)OC
2291	tr|O53452|O53452_M	P06276	92.58	30.0	242.0	DB02811	experimental	Diethyl phosphonate	CCOP(=O)OCC
2292	tr|O53452|O53452_M	P06276	92.58	30.0	242.0	DB02845	experimental	Methylphosphinic Acid	CP(=O)O
2293	tr|O53452|O53452_M	P06276	92.58	30.0	242.0	DB03568	experimental; investigational	Butyric Acid	CCCC(=O)O
2294	tr|O53452|O53452_M	P06276	92.58	30.0	242.0	DB03672	experimental	9-N-Phenylmethylamino-Tacrine	c1ccccc1CNc2c(cccc3)c3nc(c24)CCCC4
2295	tr|O53452|O53452_M	P06276	92.58	30.0	242.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
2296	tr|O53452|O53452_M	P06276	92.58	30.0	242.0	DB03822	experimental	Ethyl dihydrogen phosphate	CCOP(=O)(O)O
2297	tr|O53452|O53452_M	P06276	92.58	30.0	242.0	DB04250	experimental	Butyrylthiocholine	CCCC(=O)SCC[N+](C)(C)C
2298	tr|O53452|O53452_M	P06276	92.58	30.0	242.0	DB04892	investigational	Phenserine	C1CN(C)[C@@H]([C@@]12C)N(C)c3c2cc(cc3)OC(=O)Nc4ccccc4
2299	tr|O53452|O53452_M	P06276	92.58	30.0	242.0	DB07681	experimental	DODECANESULFONATE ION	CCCCCCCCCCCCS([O-])(=O)=O
2300	tr|O53452|O53452_M	P06276	92.58	30.0	242.0	DB07940	experimental	9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE	Ic1cccc(c1)CNc2c(CCCC3)c3nc(c24)cccc4
2301	tr|O53452|O53452_M	P06276	92.58	30.0	242.0	DB08200	experimental	(1R)-menthyl hexyl phosphonate group	CCCCCCP(=O)(O)O[C@@H]1C[C@H](C)CC[C@H]1C(C)C
2302	tr|O53452|O53452_M	P06276	92.58	30.0	242.0	DB08201	experimental	(1S)-menthyl hexyl phosphonate group	CCCCCCP(=O)(O)O[C@H]1C[C@@H](C)CC[C@@H]1C(C)C
2303	tr|O53452|O53452_M	P06276	92.58	30.0	242.0	DB08658	experimental	ETHYL HYDROGEN DIETHYLAMIDOPHOSPHATE	CCO[P@@](=O)(O)N(CC)CC
2304	tr|O53452|O53452_M	P06276	92.58	30.0	242.0	DB11397	vet_approved	Dichlorvos	COP(=O)(OC)OC=C(Cl)Cl
2305	tr|O53452|O53452_M	P06276	92.58	30.0	242.0	DB14006	approved; nutraceutical	Choline salicylate	Oc1ccccc1C([O-])=O
2306	tr|O53452|O53452_M	P23141	89.08	25.0	229.0	DB00382	approved; investigational; withdrawn	Tacrine	c1cccc(c12)nc3c(c2N)CCCC3
2307	tr|O53452|O53452_M	P23141	89.08	25.0	229.0	DB00454	approved	Meperidine	C1CN(C)CCC1(C(=O)OCC)c2ccccc2
2308	tr|O53452|O53452_M	P23141	89.08	25.0	229.0	DB00583	approved; investigational	Levocarnitine	C[N+](C)(C)C[C@H](O)CC([O-])=O
2309	tr|O53452|O53452_M	P23141	89.08	25.0	229.0	DB00647	approved; illicit; investigational; withdrawn	Dextropropoxyphene	c1ccccc1[C@@](OC(=O)CC)([C@H](C)CN(C)C)Cc2ccccc2
2310	tr|O53452|O53452_M	P23141	89.08	25.0	229.0	DB00907	approved; illicit	Cocaine	[C@@H]12CC[C@@H](N1C)[C@@H](C(=O)OC)[C@H](C2)OC(=O)c3ccccc3
2311	tr|O53452|O53452_M	P23141	89.08	25.0	229.0	DB01183	approved; vet_approved	Naloxone	[C@]123[C@H]4Oc5c1c(ccc5O)C[C@@H](N(CC2)CC=C)[C@]3(O)CCC4=O
2312	tr|O53452|O53452_M	P23141	89.08	25.0	229.0	DB01452	approved; illicit; investigational	Diamorphine	C1CN(C)[C@@H]([C@H]2[C@@]134)Cc5c3c(c(cc5)OC(=O)C)O[C@H]4[C@H](C=C2)OC(=O)C
2313	tr|O53452|O53452_M	P23141	89.08	25.0	229.0	DB01599	approved; investigational	Probucol	CC(C)(C)c1cc(cc(c1O)C(C)(C)C)SC(C)(C)Sc2cc(C(C)(C)C)c(O)c(c2)C(C)(C)C
2314	tr|O53452|O53452_M	P23141	89.08	25.0	229.0	DB02161	experimental	Hydroxy-Phenyl-Acetic Acid 8-Methyl-8-Aza-Bicyclo[3.2.1]Oct-3-Yl Ester	c1ccccc1[C@@H](O)C(=O)O[C@@H](C[C@H]23)C[C@@H](CC2)N3C
2315	tr|O53452|O53452_M	P23141	89.08	25.0	229.0	DB02659	approved	Cholic Acid	OC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](C[C@@H]2O)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
2316	tr|O53452|O53452_M	P23141	89.08	25.0	229.0	DB03056	experimental	4-Piperidino-Piperidine	C1CCCCN1C2CCNCC2
2317	tr|O53452|O53452_M	P23141	89.08	25.0	229.0	DB03721	experimental	N-acetyl-alpha-neuraminic acid	OC(=O)[C@]1(O)O[C@H]([C@@H]([C@H](C1)O)NC(=O)C)[C@H](O)[C@H](O)CO
2318	tr|O53452|O53452_M	P23141	89.08	25.0	229.0	DB04795	experimental	Thenoyltrifluoroacetone	FC(F)(F)C(=O)CC(=O)c1cccs1
2319	tr|O53452|O53452_M	P23141	89.08	25.0	229.0	DB04838	approved	Cyclandelate	CC1(C)CC(C)CC(C1)OC(=O)C(O)c2ccccc2
2320	tr|O53452|O53452_M	P23141	89.08	25.0	229.0	DB06442	investigational	Avasimibe	CC(C)c1cc(C(C)C)c(c(c1)C(C)C)CC(=O)NS(=O)(=O)Oc2c(C(C)C)cccc2C(C)C
2321	tr|O53452|O53452_M	P23141	89.08	25.0	229.0	DB07821	experimental	(1R)-1,2,2-trimethylpropyl (R)-methylphosphinate	CC(C)(C)[C@@H](C)O[P@@H](=O)C
2322	tr|O53452|O53452_M	P23141	89.08	25.0	229.0	DB08224	experimental	(1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENOL	O[C@H]1CC(=O)O[C@H](C1)CC[C@H]2[C@@H](C)C=CC([C@@H]23)=CCC[C@@H]3O
2323	tr|O53452|O53452_M	Q9UKY3	88.65	27.0	230.0	DB08612	experimental	1,1,1-TRIFLUORO-3-(OCTYLTHIO)ACETONE	CCCCCCCCSCC(=O)C(F)(F)F
2324	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB00122	approved; nutraceutical	Choline	C[N+](C)(C)CCO
2325	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB00382	approved; investigational; withdrawn	Tacrine	c1cccc(c12)nc3c(c2N)CCCC3
2326	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB00411	approved	Carbamoylcholine	C[N+](C)(C)CCOC(=O)N
2327	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB00449	approved	Dipivefrin	CNCC(O)c1cc(OC(=O)C(C)(C)C)c(cc1)OC(=O)C(C)(C)C
2328	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB00483	approved	Gallamine triethiodide	CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC
2329	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB00545	approved; investigational	Pyridostigmine	CN(C)C(=O)Oc1c[n+](C)ccc1
2330	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB00674	approved	Galantamine	C1=C[C@H](O)C[C@@H]([C@@]123)Oc4c2c(CN(C)CC3)ccc4OC
2331	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB00677	approved; investigational; withdrawn	Isoflurophate	CC(C)OP(F)(=O)OC(C)C
2332	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB00733	approved; vet_approved	Pralidoxime	O/N=C/c1[n+](C)cccc1
2333	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB00805	approved	Minaprine	c1ccccc1-c2cc(C)c(nn2)NCCN3CCOCC3
2334	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB00843	approved	Donepezil	COc(c1)c(OC)cc(c12)C(=O)C(C2)CC3CCN(CC3)Cc4ccccc4
2335	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB00863	approved; withdrawn	Ranitidine	[O-][N+](=O)/C=C(\NC)NCCSCc1ccc(o1)CN(C)C
2336	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB00944	approved	Demecarium	C[N+](C)(C)c1cc(ccc1)OC(=O)N(C)CCCCCCCCCCN(C)C(=O)Oc2cccc(c2)[N+](C)(C)C
2337	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB00981	approved; investigational	Physostigmine	C1CN(C)[C@@H]([C@@]12C)N(C)c3c2cc(cc3)OC(=O)NC
2338	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB00989	approved; investigational	Rivastigmine	CCN(C)C(=O)Oc1cccc(c1)[C@H](C)N(C)C
2339	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB01010	approved	Edrophonium	CC[N+](C)(C)c1cc(O)ccc1
2340	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB01122	approved	Ambenonium	Clc1ccccc1C[N+](CC)(CC)CCNC(=O)C(=O)NCC[N+](CC)(CC)Cc2ccccc2Cl
2341	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB01199	approved	Tubocurarine	C1CN(C)[C@H](c2c13)Cc4ccc(cc4)Oc5c6c(cc(c5O)OC)CC[N+](C)(C)[C@@H]6Cc7cc(c(O)cc7)Oc(c2)c(c3)OC
2342	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB01245	approved	Decamethonium	C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C
2343	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB01400	approved; vet_approved	Neostigmine	CN(C)C(=O)Oc1cc([N+](C)(C)C)ccc1
2344	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB01805	experimental	Monoisopropylphosphorylserine	OC(=O)[C@@H](N)COP(=O)(O)OC(C)C
2345	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB02166	experimental	Propidium	c1ccccc1-c(c(c23)cc(N)cc2)[n+](c4c3ccc(c4)N)CCC[N+](C)(CC)CC
2346	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB02226	experimental	3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium	c1c(N)ccc2c1c(-c3ccccc3)[n+](c(c24)cc(N)cc4)CCCCCCc5cn(nn5)CCNc6c(CCCC7)c7nc(c68)cccc8
2347	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB02343	experimental	3,6,9,12,15-Pentaoxaheptadecane	CCOCCOCCOCCOCCOCC
2348	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB02404	experimental	1-Deoxy-1-Thio-Heptaethylene Glycol	OCCOCCOCCOCCOCCOCCOCCS
2349	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB02673	experimental	(4aS,6R,8aS)-11-[8-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)octyl]-6-hydroxy-3-methoxy-5,6,9,10-tetrahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-11-ium	C1=C[C@H](O)C[C@@H]([C@@]123)Oc4c2c(ccc4OC)C=[N+](CC3)CCCCCCCCN(C5=O)C(=O)c(c56)cccc6
2350	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB02825	experimental	Methylphosphinate	CP([O-])=O
2351	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB02845	experimental	Methylphosphinic Acid	CP(=O)O
2352	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB03005	experimental	3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-5-Yl]Hexyl]-Phenanthridinium	c1c(N)ccc2c1c(-c3ccccc3)[n+](c(c24)cc(N)cc4)CCCCCCc5cnnn5CCNc6c(CCCC7)c7nc(c68)cccc8
2353	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB03128	approved; investigational	Acetylcholine	CC(=O)OCC[N+](C)(C)C
2354	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB03283	experimental	beta-L-fucose	C[C@@H]1O[C@H](O)[C@@H](O)[C@H](O)[C@@H]1O
2355	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB03348	investigational	Huperzine B	N1CCC[C@@H]([C@]123)[C@@H](C=C(C2)C)Cc4c3ccc(=O)[nH]4
2356	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB03359	experimental	M-(N,N,N-Trimethylammonio)-2,2,2-Trifluoro-1,1-Dihydroxyethylbenzene	C[N+](C)(C)c1cccc(c1)C(O)(O)C(F)(F)F
2357	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB03740	experimental	N-acetyl-alpha-D-glucosamine	CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O
2358	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
2359	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB04021	experimental	MF268	C[C@H]1CN(C[C@H](O1)C)CCCCCCCCNC=O
2360	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB04114	experimental	3-Chloro-9-Ethyl-6,7,8,9,10,11-Hexahydro-7,11-Methanocycloocta[B]Quinolin-12-Amine	CCC(C1)=C[C@@H](C2)Cc(c3[C@H]12)nc4c(c3N)ccc(Cl)c4
2361	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB04556	experimental	NAP-226-90	CN(C)[C@@H](C)c1cc(O)ccc1
2362	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB04614	experimental	(R)-tacrine(10)-hupyridone	c1cc(=O)[nH]c(c12)CCC[C@H]2NCCCCCCCCCCNc3c(CCCC4)c4nc(c35)cccc5
2363	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB04615	experimental	(S)-tacrine(10)-hupyridone	c1cc(=O)[nH]c(c12)CCC[C@@H]2NCCCCCCCCCCNc3c(CCCC4)c4nc(c35)cccc5
2364	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB04616	experimental	TACRINE(8)-4-AMINOQUINOLINE	c1cccc(c12)nccc2NCCCCCCCCNc3c(CCCC4)c4nc(c35)cccc5
2365	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB04617	experimental	(9S)-9-[(8-AMMONIOOCTYL)AMINO]-1,2,3,4,9,10-HEXAHYDROACRIDINIUM	[NH3+]CCCCCCCCNc1c(CCCC2)c2[nH+]c(c13)cccc3
2366	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB04859	investigational	Zanapezil	C1CCCNc(c12)cc(cc2)C(=O)CCC3CCN(CC3)Cc4ccccc4
2367	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB04864	approved; experimental	Huperzine A	C1C(C)=C[C@H](/C2=C\C)Cc(c3[C@@]12N)[nH]c(=O)cc3
2368	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB04892	investigational	Phenserine	C1CN(C)[C@@H]([C@@]12C)N(C)c3c2cc(cc3)OC(=O)Nc4ccccc4
2369	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB04924	investigational	Itopride	COc1ccc(cc1OC)C(=O)NCc2ccc(cc2)OCCN(C)C
2370	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB06525	investigational	Ganstigmine	CCc1ccccc1NC(=O)Oc(c2)ccc(c2[C@@]34C)N(C)[C@H]3ON(C)CC4
2371	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB07555	experimental	Hydroxy(oxo)(2-{(1S)-2,2,2-trifluoro-1-[2-(trimethylarsonio)ethoxy]ethyl}phenyl)ammonium	C[As+](C)(C)CCO[C@H](C(F)(F)F)c1ccccc1[N+](=O)O
2372	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB07701	experimental	1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE	COc(c1)c(OC)cc(c12)C[C@H](C2=O)CC3CCN(CC3)Cc4ccccc4
2373	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB07756	experimental	1-[3-({[(4-AMINO-5-FLUORO-2-METHYLQUINOLIN-3-YL)METHYL]THIO}METHYL)PHENYL]-2,2,2-TRIFLUOROETHANE-1,1-DIOL	c1ccc(F)c(c12)c(N)c(c(n2)C)CSCc3cc(C(O)(O)C(F)(F)F)ccc3
2374	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB07846	experimental	(3,4,8b-Trimethyl-3-oxido-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-3-ium-7-yl) N-(2-ethylphenyl)carbamate	CCc1ccccc1NC(=O)Oc(c2)ccc(c2C34C)N(C)C3[N+]([O-])(C)CC4
2375	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB08167	experimental; investigational	Methylthioninium	CN(C)c(cc1)cc(c12)[s+]c3c(n2)ccc(c3)N(C)C
2376	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB08357	experimental	Diethylene glycol diethyl ether	CCOCCOCCOCC
2377	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB08615	experimental	2-[4-(DIMETHYLAMINO)PHENYL]-6-HYDROXY-3-METHYL-1,3-BENZOTHIAZOL-3-IUM	CN(C)c1ccc(cc1)-c(s2)[n+](C)c(c23)ccc(c3)O
2378	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB08996	experimental; withdrawn	Dimetacrine	CN(C)CCCN1c(cccc2)c2C(C)(C)c(c13)cccc3
2379	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB13503	approved	Tyrothricin	 
2380	tr|O53452|O53452_M	P22303	92.14	40.0	251.0	DB14006	approved; nutraceutical	Choline salicylate	Oc1ccccc1C([O-])=O
2381	tr|O53452|O53452_M	P20261	89.96	26.0	232.0	DB02776	experimental	1-Hexadecanosulfonic Acid	CCCCCCCCCCCCCCCCS(=O)(=O)O
2382	tr|O53452|O53452_M	P32947	89.96	26.0	232.0	DB02092	experimental	Cholesteryl Linoleate	CCCCC/C=C\C/C=C\CCCCCCCC(=O)O[C@@H](CC1)CC([C@]12C)=CC[C@H]3[C@H]4[C@](C)(CC[C@H]23)[C@H](CC4)[C@H](C)CCCC(C)C
2383	tr|O53452|O53452_M	P32947	89.96	26.0	232.0	DB03500	experimental	Tricosanoic acid	CCCCCCCCCCCCCCCCCCCCCCC(=O)O
2384	tr|O53452|O53452_M	P19835	84.28	31.0	224.0	DB04348	approved; experimental	Taurocholic acid	OS(=O)(=O)CCNC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](C[C@@H]2O)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
2385	tr|O53903|O53903_M	P40871	81.16	48.0	522.0	DB01672	experimental	2,3-Dihydroxy-Benzoic Acid	OC(=O)c1cccc(O)c1O
2386	tr|O53903|O53903_M	Q96GR2	81.16	129.0	603.0	DB08326	experimental	2-(6-HYDROXY-1,3-BENZOTHIAZOL-2-YL)-1,3-THIAZOL-4(5H)-ONE	c1cc(O)cc(c12)sc(n2)C3=NC(=O)CS3
2387	tr|O53488|O53488_M	P06276	102.15	29.0	551.0	DB00122	approved; nutraceutical	Choline	C[N+](C)(C)CCO
2388	tr|O53488|O53488_M	P06276	102.15	29.0	551.0	DB00382	approved; investigational; withdrawn	Tacrine	c1cccc(c12)nc3c(c2N)CCCC3
2389	tr|O53488|O53488_M	P06276	102.15	29.0	551.0	DB00449	approved	Dipivefrin	CNCC(O)c1cc(OC(=O)C(C)(C)C)c(cc1)OC(=O)C(C)(C)C
2390	tr|O53488|O53488_M	P06276	102.15	29.0	551.0	DB00545	approved; investigational	Pyridostigmine	CN(C)C(=O)Oc1c[n+](C)ccc1
2391	tr|O53488|O53488_M	P06276	102.15	29.0	551.0	DB00674	approved	Galantamine	C1=C[C@H](O)C[C@@H]([C@@]123)Oc4c2c(CN(C)CC3)ccc4OC
2392	tr|O53488|O53488_M	P06276	102.15	29.0	551.0	DB00677	approved; investigational; withdrawn	Isoflurophate	CC(C)OP(F)(=O)OC(C)C
2393	tr|O53488|O53488_M	P06276	102.15	29.0	551.0	DB00733	approved; vet_approved	Pralidoxime	O/N=C/c1[n+](C)cccc1
2394	tr|O53488|O53488_M	P06276	102.15	29.0	551.0	DB00772	approved; investigational	Malathion	CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC
2395	tr|O53488|O53488_M	P06276	102.15	29.0	551.0	DB00843	approved	Donepezil	COc(c1)c(OC)cc(c12)C(=O)C(C2)CC3CCN(CC3)Cc4ccccc4
2396	tr|O53488|O53488_M	P06276	102.15	29.0	551.0	DB00941	approved	Hexafluronium	c1cccc2c1C(c(c23)cccc3)[N+](C)(C)CCCCCC[N+](C)(C)C4c(cccc5)c5c(c46)cccc6
2397	tr|O53488|O53488_M	P06276	102.15	29.0	551.0	DB00944	approved	Demecarium	C[N+](C)(C)c1cc(ccc1)OC(=O)N(C)CCCCCCCCCCN(C)C(=O)Oc2cccc(c2)[N+](C)(C)C
2398	tr|O53488|O53488_M	P06276	102.15	29.0	551.0	DB00989	approved; investigational	Rivastigmine	CCN(C)C(=O)Oc1cccc(c1)[C@H](C)N(C)C
2399	tr|O53488|O53488_M	P06276	102.15	29.0	551.0	DB01010	approved	Edrophonium	CC[N+](C)(C)c1cc(O)ccc1
2400	tr|O53488|O53488_M	P06276	102.15	29.0	551.0	DB01057	approved	Echothiophate	CCOP(=O)(OCC)SCC[N+](C)(C)C
2401	tr|O53488|O53488_M	P06276	102.15	29.0	551.0	DB01221	approved; vet_approved	Ketamine	C1CCCC(=O)C1(NC)c2ccccc2Cl
2402	tr|O53488|O53488_M	P06276	102.15	29.0	551.0	DB01226	approved	Mivacurium	COc(c1)c(OC)c(OC)cc1C[C@H](c(c23)cc(OC)c(c2)OC)[N+](C)(CC3)CCCOC(=O)CC/C=C/CCC(=O)OCCC[N+](C)(CCc(c45)cc(OC)c(c5)OC)[C@@H]4Cc6cc(OC)c(OC)c(c6)OC
2403	tr|O53488|O53488_M	P06276	102.15	29.0	551.0	DB02811	experimental	Diethyl phosphonate	CCOP(=O)OCC
2404	tr|O53488|O53488_M	P06276	102.15	29.0	551.0	DB02845	experimental	Methylphosphinic Acid	CP(=O)O
2405	tr|O53488|O53488_M	P06276	102.15	29.0	551.0	DB03568	experimental; investigational	Butyric Acid	CCCC(=O)O
2406	tr|O53488|O53488_M	P06276	102.15	29.0	551.0	DB03672	experimental	9-N-Phenylmethylamino-Tacrine	c1ccccc1CNc2c(cccc3)c3nc(c24)CCCC4
2407	tr|O53488|O53488_M	P06276	102.15	29.0	551.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
2408	tr|O53488|O53488_M	P06276	102.15	29.0	551.0	DB03822	experimental	Ethyl dihydrogen phosphate	CCOP(=O)(O)O
2409	tr|O53488|O53488_M	P06276	102.15	29.0	551.0	DB04250	experimental	Butyrylthiocholine	CCCC(=O)SCC[N+](C)(C)C
2410	tr|O53488|O53488_M	P06276	102.15	29.0	551.0	DB04892	investigational	Phenserine	C1CN(C)[C@@H]([C@@]12C)N(C)c3c2cc(cc3)OC(=O)Nc4ccccc4
2411	tr|O53488|O53488_M	P06276	102.15	29.0	551.0	DB07681	experimental	DODECANESULFONATE ION	CCCCCCCCCCCCS([O-])(=O)=O
2412	tr|O53488|O53488_M	P06276	102.15	29.0	551.0	DB07940	experimental	9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE	Ic1cccc(c1)CNc2c(CCCC3)c3nc(c24)cccc4
2413	tr|O53488|O53488_M	P06276	102.15	29.0	551.0	DB08200	experimental	(1R)-menthyl hexyl phosphonate group	CCCCCCP(=O)(O)O[C@@H]1C[C@H](C)CC[C@H]1C(C)C
2414	tr|O53488|O53488_M	P06276	102.15	29.0	551.0	DB08201	experimental	(1S)-menthyl hexyl phosphonate group	CCCCCCP(=O)(O)O[C@H]1C[C@@H](C)CC[C@@H]1C(C)C
2415	tr|O53488|O53488_M	P06276	102.15	29.0	551.0	DB08658	experimental	ETHYL HYDROGEN DIETHYLAMIDOPHOSPHATE	CCO[P@@](=O)(O)N(CC)CC
2416	tr|O53488|O53488_M	P06276	102.15	29.0	551.0	DB11397	vet_approved	Dichlorvos	COP(=O)(OC)OC=C(Cl)Cl
2417	tr|O53488|O53488_M	P06276	102.15	29.0	551.0	DB14006	approved; nutraceutical	Choline salicylate	Oc1ccccc1C([O-])=O
2418	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB00122	approved; nutraceutical	Choline	C[N+](C)(C)CCO
2419	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB00382	approved; investigational; withdrawn	Tacrine	c1cccc(c12)nc3c(c2N)CCCC3
2420	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB00411	approved	Carbamoylcholine	C[N+](C)(C)CCOC(=O)N
2421	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB00449	approved	Dipivefrin	CNCC(O)c1cc(OC(=O)C(C)(C)C)c(cc1)OC(=O)C(C)(C)C
2422	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB00483	approved	Gallamine triethiodide	CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC
2423	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB00545	approved; investigational	Pyridostigmine	CN(C)C(=O)Oc1c[n+](C)ccc1
2424	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB00674	approved	Galantamine	C1=C[C@H](O)C[C@@H]([C@@]123)Oc4c2c(CN(C)CC3)ccc4OC
2425	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB00677	approved; investigational; withdrawn	Isoflurophate	CC(C)OP(F)(=O)OC(C)C
2426	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB00733	approved; vet_approved	Pralidoxime	O/N=C/c1[n+](C)cccc1
2427	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB00805	approved	Minaprine	c1ccccc1-c2cc(C)c(nn2)NCCN3CCOCC3
2428	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB00843	approved	Donepezil	COc(c1)c(OC)cc(c12)C(=O)C(C2)CC3CCN(CC3)Cc4ccccc4
2429	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB00863	approved; withdrawn	Ranitidine	[O-][N+](=O)/C=C(\NC)NCCSCc1ccc(o1)CN(C)C
2430	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB00944	approved	Demecarium	C[N+](C)(C)c1cc(ccc1)OC(=O)N(C)CCCCCCCCCCN(C)C(=O)Oc2cccc(c2)[N+](C)(C)C
2431	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB00981	approved; investigational	Physostigmine	C1CN(C)[C@@H]([C@@]12C)N(C)c3c2cc(cc3)OC(=O)NC
2432	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB00989	approved; investigational	Rivastigmine	CCN(C)C(=O)Oc1cccc(c1)[C@H](C)N(C)C
2433	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB01010	approved	Edrophonium	CC[N+](C)(C)c1cc(O)ccc1
2434	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB01122	approved	Ambenonium	Clc1ccccc1C[N+](CC)(CC)CCNC(=O)C(=O)NCC[N+](CC)(CC)Cc2ccccc2Cl
2435	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB01199	approved	Tubocurarine	C1CN(C)[C@H](c2c13)Cc4ccc(cc4)Oc5c6c(cc(c5O)OC)CC[N+](C)(C)[C@@H]6Cc7cc(c(O)cc7)Oc(c2)c(c3)OC
2436	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB01245	approved	Decamethonium	C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C
2437	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB01400	approved; vet_approved	Neostigmine	CN(C)C(=O)Oc1cc([N+](C)(C)C)ccc1
2438	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB01805	experimental	Monoisopropylphosphorylserine	OC(=O)[C@@H](N)COP(=O)(O)OC(C)C
2439	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB02166	experimental	Propidium	c1ccccc1-c(c(c23)cc(N)cc2)[n+](c4c3ccc(c4)N)CCC[N+](C)(CC)CC
2440	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB02226	experimental	3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium	c1c(N)ccc2c1c(-c3ccccc3)[n+](c(c24)cc(N)cc4)CCCCCCc5cn(nn5)CCNc6c(CCCC7)c7nc(c68)cccc8
2441	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB02343	experimental	3,6,9,12,15-Pentaoxaheptadecane	CCOCCOCCOCCOCCOCC
2442	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB02404	experimental	1-Deoxy-1-Thio-Heptaethylene Glycol	OCCOCCOCCOCCOCCOCCOCCS
2443	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB02673	experimental	(4aS,6R,8aS)-11-[8-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)octyl]-6-hydroxy-3-methoxy-5,6,9,10-tetrahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-11-ium	C1=C[C@H](O)C[C@@H]([C@@]123)Oc4c2c(ccc4OC)C=[N+](CC3)CCCCCCCCN(C5=O)C(=O)c(c56)cccc6
2444	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB02825	experimental	Methylphosphinate	CP([O-])=O
2445	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB02845	experimental	Methylphosphinic Acid	CP(=O)O
2446	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB03005	experimental	3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-5-Yl]Hexyl]-Phenanthridinium	c1c(N)ccc2c1c(-c3ccccc3)[n+](c(c24)cc(N)cc4)CCCCCCc5cnnn5CCNc6c(CCCC7)c7nc(c68)cccc8
2447	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB03128	approved; investigational	Acetylcholine	CC(=O)OCC[N+](C)(C)C
2448	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB03283	experimental	beta-L-fucose	C[C@@H]1O[C@H](O)[C@@H](O)[C@H](O)[C@@H]1O
2449	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB03348	investigational	Huperzine B	N1CCC[C@@H]([C@]123)[C@@H](C=C(C2)C)Cc4c3ccc(=O)[nH]4
2450	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB03359	experimental	M-(N,N,N-Trimethylammonio)-2,2,2-Trifluoro-1,1-Dihydroxyethylbenzene	C[N+](C)(C)c1cccc(c1)C(O)(O)C(F)(F)F
2451	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB03740	experimental	N-acetyl-alpha-D-glucosamine	CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O
2452	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
2453	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB04021	experimental	MF268	C[C@H]1CN(C[C@H](O1)C)CCCCCCCCNC=O
2454	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB04114	experimental	3-Chloro-9-Ethyl-6,7,8,9,10,11-Hexahydro-7,11-Methanocycloocta[B]Quinolin-12-Amine	CCC(C1)=C[C@@H](C2)Cc(c3[C@H]12)nc4c(c3N)ccc(Cl)c4
2455	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB04556	experimental	NAP-226-90	CN(C)[C@@H](C)c1cc(O)ccc1
2456	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB04614	experimental	(R)-tacrine(10)-hupyridone	c1cc(=O)[nH]c(c12)CCC[C@H]2NCCCCCCCCCCNc3c(CCCC4)c4nc(c35)cccc5
2457	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB04615	experimental	(S)-tacrine(10)-hupyridone	c1cc(=O)[nH]c(c12)CCC[C@@H]2NCCCCCCCCCCNc3c(CCCC4)c4nc(c35)cccc5
2458	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB04616	experimental	TACRINE(8)-4-AMINOQUINOLINE	c1cccc(c12)nccc2NCCCCCCCCNc3c(CCCC4)c4nc(c35)cccc5
2459	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB04617	experimental	(9S)-9-[(8-AMMONIOOCTYL)AMINO]-1,2,3,4,9,10-HEXAHYDROACRIDINIUM	[NH3+]CCCCCCCCNc1c(CCCC2)c2[nH+]c(c13)cccc3
2460	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB04859	investigational	Zanapezil	C1CCCNc(c12)cc(cc2)C(=O)CCC3CCN(CC3)Cc4ccccc4
2461	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB04864	approved; experimental	Huperzine A	C1C(C)=C[C@H](/C2=C\C)Cc(c3[C@@]12N)[nH]c(=O)cc3
2462	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB04892	investigational	Phenserine	C1CN(C)[C@@H]([C@@]12C)N(C)c3c2cc(cc3)OC(=O)Nc4ccccc4
2463	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB04924	investigational	Itopride	COc1ccc(cc1OC)C(=O)NCc2ccc(cc2)OCCN(C)C
2464	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB06525	investigational	Ganstigmine	CCc1ccccc1NC(=O)Oc(c2)ccc(c2[C@@]34C)N(C)[C@H]3ON(C)CC4
2465	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB07555	experimental	Hydroxy(oxo)(2-{(1S)-2,2,2-trifluoro-1-[2-(trimethylarsonio)ethoxy]ethyl}phenyl)ammonium	C[As+](C)(C)CCO[C@H](C(F)(F)F)c1ccccc1[N+](=O)O
2466	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB07701	experimental	1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE	COc(c1)c(OC)cc(c12)C[C@H](C2=O)CC3CCN(CC3)Cc4ccccc4
2467	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB07756	experimental	1-[3-({[(4-AMINO-5-FLUORO-2-METHYLQUINOLIN-3-YL)METHYL]THIO}METHYL)PHENYL]-2,2,2-TRIFLUOROETHANE-1,1-DIOL	c1ccc(F)c(c12)c(N)c(c(n2)C)CSCc3cc(C(O)(O)C(F)(F)F)ccc3
2468	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB07846	experimental	(3,4,8b-Trimethyl-3-oxido-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-3-ium-7-yl) N-(2-ethylphenyl)carbamate	CCc1ccccc1NC(=O)Oc(c2)ccc(c2C34C)N(C)C3[N+]([O-])(C)CC4
2469	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB08167	experimental; investigational	Methylthioninium	CN(C)c(cc1)cc(c12)[s+]c3c(n2)ccc(c3)N(C)C
2470	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB08357	experimental	Diethylene glycol diethyl ether	CCOCCOCCOCC
2471	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB08615	experimental	2-[4-(DIMETHYLAMINO)PHENYL]-6-HYDROXY-3-METHYL-1,3-BENZOTHIAZOL-3-IUM	CN(C)c1ccc(cc1)-c(s2)[n+](C)c(c23)ccc(c3)O
2472	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB08996	experimental; withdrawn	Dimetacrine	CN(C)CCCN1c(cccc2)c2C(C)(C)c(c13)cccc3
2473	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB13503	approved	Tyrothricin	 
2474	tr|O53488|O53488_M	P22303	95.89	57.0	547.0	DB14006	approved; nutraceutical	Choline salicylate	Oc1ccccc1C([O-])=O
2475	tr|O53488|O53488_M	P23141	97.26	38.0	535.0	DB00382	approved; investigational; withdrawn	Tacrine	c1cccc(c12)nc3c(c2N)CCCC3
2476	tr|O53488|O53488_M	P23141	97.26	38.0	535.0	DB00454	approved	Meperidine	C1CN(C)CCC1(C(=O)OCC)c2ccccc2
2477	tr|O53488|O53488_M	P23141	97.26	38.0	535.0	DB00583	approved; investigational	Levocarnitine	C[N+](C)(C)C[C@H](O)CC([O-])=O
2478	tr|O53488|O53488_M	P23141	97.26	38.0	535.0	DB00647	approved; illicit; investigational; withdrawn	Dextropropoxyphene	c1ccccc1[C@@](OC(=O)CC)([C@H](C)CN(C)C)Cc2ccccc2
2479	tr|O53488|O53488_M	P23141	97.26	38.0	535.0	DB00907	approved; illicit	Cocaine	[C@@H]12CC[C@@H](N1C)[C@@H](C(=O)OC)[C@H](C2)OC(=O)c3ccccc3
2480	tr|O53488|O53488_M	P23141	97.26	38.0	535.0	DB01183	approved; vet_approved	Naloxone	[C@]123[C@H]4Oc5c1c(ccc5O)C[C@@H](N(CC2)CC=C)[C@]3(O)CCC4=O
2481	tr|O53488|O53488_M	P23141	97.26	38.0	535.0	DB01452	approved; illicit; investigational	Diamorphine	C1CN(C)[C@@H]([C@H]2[C@@]134)Cc5c3c(c(cc5)OC(=O)C)O[C@H]4[C@H](C=C2)OC(=O)C
2482	tr|O53488|O53488_M	P23141	97.26	38.0	535.0	DB01599	approved; investigational	Probucol	CC(C)(C)c1cc(cc(c1O)C(C)(C)C)SC(C)(C)Sc2cc(C(C)(C)C)c(O)c(c2)C(C)(C)C
2483	tr|O53488|O53488_M	P23141	97.26	38.0	535.0	DB02161	experimental	Hydroxy-Phenyl-Acetic Acid 8-Methyl-8-Aza-Bicyclo[3.2.1]Oct-3-Yl Ester	c1ccccc1[C@@H](O)C(=O)O[C@@H](C[C@H]23)C[C@@H](CC2)N3C
2484	tr|O53488|O53488_M	P23141	97.26	38.0	535.0	DB02659	approved	Cholic Acid	OC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](C[C@@H]2O)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
2485	tr|O53488|O53488_M	P23141	97.26	38.0	535.0	DB03056	experimental	4-Piperidino-Piperidine	C1CCCCN1C2CCNCC2
2486	tr|O53488|O53488_M	P23141	97.26	38.0	535.0	DB03721	experimental	N-acetyl-alpha-neuraminic acid	OC(=O)[C@]1(O)O[C@H]([C@@H]([C@H](C1)O)NC(=O)C)[C@H](O)[C@H](O)CO
2487	tr|O53488|O53488_M	P23141	97.26	38.0	535.0	DB04795	experimental	Thenoyltrifluoroacetone	FC(F)(F)C(=O)CC(=O)c1cccs1
2488	tr|O53488|O53488_M	P23141	97.26	38.0	535.0	DB04838	approved	Cyclandelate	CC1(C)CC(C)CC(C1)OC(=O)C(O)c2ccccc2
2489	tr|O53488|O53488_M	P23141	97.26	38.0	535.0	DB06442	investigational	Avasimibe	CC(C)c1cc(C(C)C)c(c(c1)C(C)C)CC(=O)NS(=O)(=O)Oc2c(C(C)C)cccc2C(C)C
2490	tr|O53488|O53488_M	P23141	97.26	38.0	535.0	DB07821	experimental	(1R)-1,2,2-trimethylpropyl (R)-methylphosphinate	CC(C)(C)[C@@H](C)O[P@@H](=O)C
2491	tr|O53488|O53488_M	P23141	97.26	38.0	535.0	DB08224	experimental	(1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENOL	O[C@H]1CC(=O)O[C@H](C1)CC[C@H]2[C@@H](C)C=CC([C@@H]23)=CCC[C@@H]3O
2492	tr|O53488|O53488_M	P19835	94.52	41.0	524.0	DB04348	approved; experimental	Taurocholic acid	OS(=O)(=O)CCNC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](C[C@@H]2O)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
2493	tr|O53488|O53488_M	P32947	95.89	22.0	512.0	DB02092	experimental	Cholesteryl Linoleate	CCCCC/C=C\C/C=C\CCCCCCCC(=O)O[C@@H](CC1)CC([C@]12C)=CC[C@H]3[C@H]4[C@](C)(CC[C@H]23)[C@H](CC4)[C@H](C)CCCC(C)C
2494	tr|O53488|O53488_M	P32947	95.89	22.0	512.0	DB03500	experimental	Tricosanoic acid	CCCCCCCCCCCCCCCCCCCCCCC(=O)O
2495	tr|O53488|O53488_M	P20261	96.28	20.0	512.0	DB02776	experimental	1-Hexadecanosulfonic Acid	CCCCCCCCCCCCCCCCS(=O)(=O)O
2496	tr|O33313|O33313_M	Q9FDN7	92.0	259.0	397.0	DB03247	approved; investigational	Flavin mononucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)COP(=O)(O)O
2497	tr|O33313|O33313_M	P00322	88.67	3.0	136.0	DB03247	approved; investigational	Flavin mononucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)COP(=O)(O)O
2498	tr|O33313|O33313_M	Q9F0J6	87.33	265.0	396.0	DB03247	approved; investigational	Flavin mononucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)COP(=O)(O)O
2499	tr|O33313|O33313_M	P00323	87.33	3.0	134.0	DB03247	approved; investigational	Flavin mononucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)COP(=O)(O)O
2500	tr|Q79FE8|Q79FE8_M	Q7SIG1	82.03	59.0	310.0	DB02776	experimental	1-Hexadecanosulfonic Acid	CCCCCCCCCCCCCCCCS(=O)(=O)O
2501	tr|I6Y8B5|I6Y8B5_M	P30084	87.88	43.0	246.0	DB02563	experimental	Hexanoyl-CoA	CCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
2502	tr|I6Y8B5|I6Y8B5_M	P30084	87.88	43.0	246.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
2503	tr|I6Y8B5|I6Y8B5_M	P30084	87.88	43.0	246.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
2504	tr|I6Y8B5|I6Y8B5_M	P30084	87.88	43.0	246.0	DB04117	experimental	4-(N,N-Dimethylamino)cinnamoyl-CoA	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)/C=C/c4ccc(cc4)N(C)C
2505	tr|I6Y8B5|I6Y8B5_M	P30084	87.88	43.0	246.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
2506	tr|I6Y8B5|I6Y8B5_M	O68600	94.37	1.0	219.0	DB01652	experimental	4-hydroxybenzoyl-CoA	Oc1ccc(cc1)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2OP(=O)(O)O)n3cnc(c34)c(N)ncn4
2507	tr|I6Y8B5|I6Y8B5_M	P42126	90.48	56.0	265.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
2508	tr|I6Y8B5|I6Y8B5_M	P42126	90.48	56.0	265.0	DB03127	experimental	Benzamidine	NC(=[NH2+])c1ccccc1
2509	tr|I6Y8B5|I6Y8B5_M	O75521	91.77	142.0	354.0	DB08231	experimental	Myristic acid	CCCCCCCCCCCCCC(=O)O
2510	tr|I6Y8B5|I6Y8B5_M	P9WNP5	99.13	37.0	266.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
2511	tr|I6Y8B5|I6Y8B5_M	P9WNP5	99.13	37.0	266.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
2512	tr|I6Y8B5|I6Y8B5_M	P52045	90.91	5.0	215.0	DB03117	experimental	2-carboxypropyl-coenzyme A	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC[C@H](C)C(=O)O
2513	tr|I6Y8B5|I6Y8B5_M	Q93TU6	90.04	19.0	227.0	DB02906	experimental	(2s,4s)-Alpha-Campholinic Acid	CC1(C)[C@H](C)C(=O)C[C@H]1CC(O)O
2514	tr|I6Y8B5|I6Y8B5_M	P40939	79.22	41.0	224.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
2515	tr|I6Y8B5|I6Y8B5_M	Q08426	86.58	3.0	203.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
2516	tr|I6Y8B5|I6Y8B5_M	P28793	86.15	9.0	208.0	DB08249	experimental	3,6,9,12,15-PENTAOXATRICOSAN-1-OL	CCCCCCCCOCCOCCOCCOCCOCCO
2517	tr|I6Y8B5|I6Y8B5_M	Q6NVY1	79.22	41.0	224.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
2518	tr|O50388|O50388_M	P16099	87.63	7.0	354.0	DB03247	approved; investigational	Flavin mononucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)COP(=O)(O)O
2519	tr|P71834|P71834_M	Q9X5N2	88.95	194.0	685.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
2520	tr|P71834|P71834_M	Q9X5N2	88.95	194.0	685.0	DB04033	experimental	Z-Ala Prolinal	OC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)OCc2ccccc2
2521	tr|P71834|P71834_M	P48147	90.76	206.0	707.0	DB01684	experimental	1-Hydroxy-1-Thio-Glycerol	OC[C@@H](O)CSO
2522	tr|P71834|P71834_M	P48147	90.76	206.0	707.0	DB03382	experimental	S-oxy-L-cysteine	OC(=O)[C@@H](N)CS=O
2523	tr|P71834|P71834_M	P48147	90.76	206.0	707.0	DB03535	experimental	Z-Pro-Prolinal	O=C[C@@H]1CCCN1C(=O)[C@@H]2CCCN2C(=O)OCc3ccccc3
2524	tr|P71834|P71834_M	P48147	90.76	206.0	707.0	DB03864	experimental	Monothioglycerol	OC[C@@H](O)CS
2525	tr|P71834|P71834_M	P48147	90.76	206.0	707.0	DB07148	experimental	(6S)-1-chloro-3-[(4-fluorobenzyl)oxy]-6-(pyrrolidin-1-ylcarbonyl)pyrrolo[1,2-a]pyrazin-4(6H)-one	C1CCCN1C(=O)[C@@H]2C=Cc(n23)c(Cl)nc(c3=O)OCc4ccc(F)cc4
2526	tr|P71834|P71834_M	P48147	90.76	206.0	707.0	DB08738	experimental	1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one	C1CCCN1C(=O)[C@@H]2CCCN2C(=O)CCn3c(=O)c(nc(c34)cccc4)-c5ccccc5
2527	tr|P71834|P71834_M	P48147	90.76	206.0	707.0	DB08739	experimental	2-{3-[(2S)-4,4-difluoro-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]-3-oxopropyl}-isoindole-1,3(2H)-dione	C1CCCN1C(=O)[C@H](CC2(F)F)N(C2)C(=O)CCN(C3=O)C(=O)c(c34)cccc4
2528	tr|P71834|P71834_M	Q9X6R4	86.78	199.0	678.0	DB03535	experimental	Z-Pro-Prolinal	O=C[C@@H]1CCCN1C(=O)[C@@H]2CCCN2C(=O)OCc3ccccc3
2529	tr|I6Y3U6|I6Y3U6_M	P30084	96.36	44.0	282.0	DB02563	experimental	Hexanoyl-CoA	CCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
2530	tr|I6Y3U6|I6Y3U6_M	P30084	96.36	44.0	282.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
2531	tr|I6Y3U6|I6Y3U6_M	P30084	96.36	44.0	282.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
2532	tr|I6Y3U6|I6Y3U6_M	P30084	96.36	44.0	282.0	DB04117	experimental	4-(N,N-Dimethylamino)cinnamoyl-CoA	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)/C=C/c4ccc(cc4)N(C)C
2533	tr|I6Y3U6|I6Y3U6_M	P30084	96.36	44.0	282.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
2534	tr|I6Y3U6|I6Y3U6_M	O75521	99.6	143.0	389.0	DB08231	experimental	Myristic acid	CCCCCCCCCCCCCC(=O)O
2535	tr|I6Y3U6|I6Y3U6_M	P52045	97.57	12.0	253.0	DB03117	experimental	2-carboxypropyl-coenzyme A	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC[C@H](C)C(=O)O
2536	tr|I6Y3U6|I6Y3U6_M	O68600	92.31	9.0	237.0	DB01652	experimental	4-hydroxybenzoyl-CoA	Oc1ccc(cc1)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2OP(=O)(O)O)n3cnc(c34)c(N)ncn4
2537	tr|I6Y3U6|I6Y3U6_M	P9WNP5	104.86	43.0	302.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
2538	tr|I6Y3U6|I6Y3U6_M	P9WNP5	104.86	43.0	302.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
2539	tr|I6Y3U6|I6Y3U6_M	P28793	90.69	8.0	232.0	DB08249	experimental	3,6,9,12,15-PENTAOXATRICOSAN-1-OL	CCCCCCCCOCCOCCOCCOCCOCCO
2540	tr|I6Y3U6|I6Y3U6_M	P42126	97.17	55.0	295.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
2541	tr|I6Y3U6|I6Y3U6_M	P42126	97.17	55.0	295.0	DB03127	experimental	Benzamidine	NC(=[NH2+])c1ccccc1
2542	tr|I6Y3U6|I6Y3U6_M	Q08426	81.78	7.0	209.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
2543	tr|I6Y3U6|I6Y3U6_M	Q93TU6	85.02	23.0	233.0	DB02906	experimental	(2s,4s)-Alpha-Campholinic Acid	CC1(C)[C@H](C)C(=O)C[C@H]1CC(O)O
2544	tr|I6Y3U6|I6Y3U6_M	P40939	70.85	48.0	223.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
2545	tr|I6Y3U6|I6Y3U6_M	Q6NVY1	71.66	46.0	223.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
2546	tr|O53641|O53641_M	P0A0N4	85.98	2.0	186.0	DB01123	approved	Proflavine	c1cc(N)cc(c12)nc3c(c2)ccc(c3)N
2547	tr|O53641|O53641_M	P0A0N4	85.98	2.0	186.0	DB03608	experimental	Diminazene	NC(=N)c1ccc(cc1)N/N=N/c2ccc(cc2)C(N)=N
2548	tr|O53641|O53641_M	P0A0N4	85.98	2.0	186.0	DB03808	experimental	Hexamidine	NC(=N)c1ccc(cc1)OCCCCCCOc2ccc(cc2)C(N)=N
2549	tr|O53641|O53641_M	P0A0N4	85.98	2.0	186.0	DB04209	approved; investigational	Dequalinium	c1cccc(c12)c(N)cc(C)[n+]2CCCCCCCCCC[n+]3c(C)cc(N)c(c34)cccc4
2550	tr|O53641|O53641_M	P0A0N5	85.98	2.0	186.0	DB03808	experimental	Hexamidine	NC(=N)c1ccc(cc1)OCCCCCCOc2ccc(cc2)C(N)=N
2551	tr|O53641|O53641_M	P0A0N5	85.98	2.0	186.0	DB03825	experimental	Rhodamine 6G	CCNc(c(C)c1)cc(c12)[o+]c3c(cc(C)c(c3)NCC)c2-c4ccccc4C(=O)OCC
2552	tr|O53641|O53641_M	P0A0N5	85.98	2.0	186.0	DB03895	experimental	Malachite Green	CN(C)c1ccc(cc1)C(c2ccccc2)=C3C=CC(C=C3)=[N+](C)C
2553	tr|O53641|O53641_M	P0A0N5	85.98	2.0	186.0	DB04115	approved; investigational	Berberine	COc1c(OC)ccc(c12)cc3[n+](c2)CCc4c3cc5c(c4)OCO5
2554	tr|O53641|O53641_M	Q9AIU0	78.04	2.0	169.0	DB03467	experimental	Naringenin	Oc1ccc(cc1)[C@@H](O2)CC(=O)c(c23)c(O)cc(c3)O
2555	tr|O53641|O53641_M	Q9AIU0	78.04	2.0	169.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
2556	tr|O53641|O53641_M	Q9AIU0	78.04	2.0	169.0	DB07810	experimental	Phloretin	Oc1ccc(cc1)CCC(=O)c2c(O)cc(O)cc2O
2557	tr|O06562|O06562_M	P11350	89.02	5.0	224.0	DB04464	experimental	N-Formylmethionine	O=CN[C@H](C(=O)O)CCSC
2558	tr|O06562|O06562_M	P11350	89.02	5.0	224.0	DB07349	experimental	(1S)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PENTANOYLOXY)METHYL]ETHYL OCTANOATE	OC[C@H](O)COP([O-])(=O)OC[C@@H](COC(=O)CCCC)OC(=O)CCCCCCC
2559	tr|O53240|O53240_M	O53240	99.39	1.0	163.0	DB03382	experimental	S-oxy-L-cysteine	OC(=O)[C@@H](N)CS=O
2560	tr|P95186|P95186_M	Q72JJ3	92.02	11.0	380.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
2561	tr|P95186|P95186_M	P11310	91.27	49.0	415.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
2562	tr|P95186|P95186_M	P11310	91.27	49.0	415.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
2563	tr|P95186|P95186_M	P11310	91.27	49.0	415.0	DB03415	experimental	3-thiaoctanoyl-CoA	CCCCCSCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
2564	tr|P95186|P95186_M	P16219	93.52	32.0	407.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
2565	tr|P95186|P95186_M	P16219	93.52	32.0	407.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
2566	tr|P95186|P95186_M	P16219	93.52	32.0	407.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
2567	tr|P95186|P95186_M	Q06319	81.3	56.0	382.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
2568	tr|P95186|P95186_M	Q06319	81.3	56.0	382.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
2569	tr|P95186|P95186_M	P45954	90.27	66.0	428.0	DB00167	investigational; nutraceutical	Isoleucine	CC[C@H](C)[C@H](N)C(=O)O
2570	tr|P95186|P95186_M	P45954	90.27	66.0	428.0	DB00313	approved; investigational	Valproic acid	CCCC(C(=O)O)CCC
2571	tr|P95186|P95186_M	P26440	77.81	105.0	417.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
2572	tr|P95186|P95186_M	P26440	77.81	105.0	417.0	DB04036	experimental	Coenzyme A persulfide	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSS
2573	tr|P95186|P95186_M	Q9UKU7	89.53	54.0	413.0	DB01675	experimental	Methacrylyl-Coenzyme A	CC(=C)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
2574	tr|P95186|P95186_M	Q9UKU7	89.53	54.0	413.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
2575	tr|P95186|P95186_M	Q3JP94	75.56	89.0	392.0	DB08685	experimental	1-(1,4-dimethyl-1,2,3,4-tetrahydroquinoxalin-6-yl)methanamine	CN1CCN(C)c(c12)cc(cc2)CN
2576	tr|P95186|P95186_M	Q92947	76.56	126.0	433.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
2577	tr|P95186|P95186_M	Q92947	76.56	126.0	433.0	DB03245	experimental	S-4-Nitrobutyryl-CoA	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCC[N+]([O-])=O
2578	tr|P95186|P95186_M	Q9KIE5	79.8	44.0	364.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
2579	tr|P95186|P95186_M	Q15067	79.3	118.0	436.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
2580	tr|P95186|P95186_M	Q15067	79.3	118.0	436.0	DB07930	experimental	(3R)-3-HYDROXYDODECANOIC ACID	OC(=O)C[C@H](O)CCCCCCCCC
2581	tr|Q79FY3|Q79FY3_M	P09148	97.24	162.0	338.0	DB01861	experimental	Uridine diphosphate glucose	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
2582	tr|Q79FY3|Q79FY3_M	P09148	97.24	162.0	338.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
2583	tr|Q79FY3|Q79FY3_M	P09148	97.24	162.0	338.0	DB03685	experimental	Uridine monophosphate	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2ccc(=O)[nH]c2=O
2584	tr|I6Y3V5|I6Y3V5_M	Q72JJ3	91.43	28.0	380.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
2585	tr|I6Y3V5|I6Y3V5_M	P16219	88.31	67.0	407.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
2586	tr|I6Y3V5|I6Y3V5_M	P16219	88.31	67.0	407.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
2587	tr|I6Y3V5|I6Y3V5_M	P16219	88.31	67.0	407.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
2588	tr|I6Y3V5|I6Y3V5_M	Q06319	91.95	28.0	382.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
2589	tr|I6Y3V5|I6Y3V5_M	Q06319	91.95	28.0	382.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
2590	tr|I6Y3V5|I6Y3V5_M	P26440	95.58	49.0	417.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
2591	tr|I6Y3V5|I6Y3V5_M	P26440	95.58	49.0	417.0	DB04036	experimental	Coenzyme A persulfide	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSS
2592	tr|I6Y3V5|I6Y3V5_M	P11310	87.01	79.0	414.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
2593	tr|I6Y3V5|I6Y3V5_M	P11310	87.01	79.0	414.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
2594	tr|I6Y3V5|I6Y3V5_M	P11310	87.01	79.0	414.0	DB03415	experimental	3-thiaoctanoyl-CoA	CCCCCSCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
2595	tr|I6Y3V5|I6Y3V5_M	P45954	89.61	83.0	428.0	DB00167	investigational; nutraceutical	Isoleucine	CC[C@H](C)[C@H](N)C(=O)O
2596	tr|I6Y3V5|I6Y3V5_M	P45954	89.61	83.0	428.0	DB00313	approved; investigational	Valproic acid	CCCC(C(=O)O)CCC
2597	tr|I6Y3V5|I6Y3V5_M	Q9UKU7	89.87	67.0	413.0	DB01675	experimental	Methacrylyl-Coenzyme A	CC(=C)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
2598	tr|I6Y3V5|I6Y3V5_M	Q9UKU7	89.87	67.0	413.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
2599	tr|I6Y3V5|I6Y3V5_M	Q3JP94	88.31	51.0	391.0	DB08685	experimental	1-(1,4-dimethyl-1,2,3,4-tetrahydroquinoxalin-6-yl)methanamine	CN1CCN(C)c(c12)cc(cc2)CN
2600	tr|I6Y3V5|I6Y3V5_M	Q92947	89.09	88.0	431.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
2601	tr|I6Y3V5|I6Y3V5_M	Q92947	89.09	88.0	431.0	DB03245	experimental	S-4-Nitrobutyryl-CoA	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCC[N+]([O-])=O
2602	tr|I6Y3V5|I6Y3V5_M	Q9KIE5	88.05	26.0	365.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
2603	tr|I6Y3V5|I6Y3V5_M	Q15067	85.71	103.0	433.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
2604	tr|I6Y3V5|I6Y3V5_M	Q15067	85.71	103.0	433.0	DB07930	experimental	(3R)-3-HYDROXYDODECANOIC ACID	OC(=O)C[C@H](O)CCCCCCCCC
2605	tr|I6XZC4|I6XZC4_M	Q9BTZ2	96.88	27.0	275.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
2607	tr|I6XZC4|I6XZC4_M	Q9WYS2	96.88	6.0	254.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
2608	tr|I6XZC4|I6XZC4_M	P0AEK2	93.36	2.0	241.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
2611	tr|I6XZC4|I6XZC4_M	Q92506	98.44	7.0	259.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
2612	tr|I6XZC4|I6XZC4_M	Q92506	98.44	7.0	259.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
2613	tr|I6XZC4|I6XZC4_M	P16544	98.44	6.0	258.0	DB01942	experimental; investigational	Formic acid	OC=O
2614	tr|I6XZC4|I6XZC4_M	P16544	98.44	6.0	258.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
2615	tr|I6XZC4|I6XZC4_M	P16544	98.44	6.0	258.0	DB07715	investigational	Emodin	Cc(c1)cc(O)c(c12)C(=O)c3c(C2=O)cc(O)cc3O
2616	tr|I6XZC4|I6XZC4_M	Q84EX5	96.88	3.0	251.0	DB04619	experimental	Acetophenone	CC(=O)c1ccccc1
2617	tr|I6XZC4|I6XZC4_M	Q84EX5	96.88	3.0	251.0	DB04784	experimental	(R)-1-phenylethanol	C[C@@H](O)c1ccccc1
2618	tr|I6XZC4|I6XZC4_M	P0AET8	94.92	8.0	251.0	DB02123	experimental	Glycochenodeoxycholic Acid	OC(=O)CNC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
2619	tr|I6XZC4|I6XZC4_M	P0CG22	98.05	27.0	278.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
2620	tr|I6XZC4|I6XZC4_M	P0CG22	98.05	27.0	278.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
2621	tr|I6XZC4|I6XZC4_M	P0CG22	98.05	27.0	278.0	DB03541	experimental	10-Propargyl-5,8-Dideazafolic Acid	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(CC#C)Cc(c2)ccc(c23)[nH]c(N)nc3=O
2622	tr|I6XZC4|I6XZC4_M	P0CG22	98.05	27.0	278.0	DB07689	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)NCc(cn3)nc(c34)c(N)nc(n4)N
2623	tr|I6XZC4|I6XZC4_M	P0CG22	98.05	27.0	278.0	DB07765	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)N(C)Cc(cn3)nc(c34)c(N)nc(n4)N
2624	tr|I6XZC4|I6XZC4_M	Q9BY49	97.27	16.0	265.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
2625	tr|I6XZC4|I6XZC4_M	Q7Z4W1	92.58	5.0	242.0	DB02831	experimental	Dihydrogenphosphate	OP([O-])(=O)O
2626	tr|I6XZC4|I6XZC4_M	Q7Z4W1	92.58	5.0	242.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
2627	tr|I6XZC4|I6XZC4_M	Q16698	96.48	56.0	303.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
2628	tr|I6XZC4|I6XZC4_M	Q16698	96.48	56.0	303.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
2629	tr|I6XZC4|I6XZC4_M	Q6UWP2	94.14	11.0	252.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
2630	tr|I6XZC4|I6XZC4_M	A0A348A0U3	97.27	4.0	253.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
2631	tr|I6XZC4|I6XZC4_M	Q6PKH6	74.22	25.0	215.0	DB04200	experimental	Matairesinol	COc1cc(ccc1O)C[C@H]2COC(=O)[C@@H]2Cc3ccc(O)c(c3)OC
2632	tr|I6XZC4|I6XZC4_M	Q6GI75	98.05	3.0	254.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
2633	tr|I6XZC4|I6XZC4_M	Q6GI75	98.05	3.0	254.0	DB11155	approved	Triclocarban	Clc1ccc(cc1)NC(=O)Nc2cc(Cl)c(Cl)cc2
2634	tr|I6XZC4|I6XZC4_M	P0AEK4	96.88	4.0	252.0	DB01691	experimental	Indole Naphthyridinone	c1cccc(c12)n(C)cc2CN(C)C(=O)/C=C/c(c3)cnc(c34)NC(=O)CC4
2635	tr|I6XZC4|I6XZC4_M	P0AEK4	96.88	4.0	252.0	DB01865	experimental	3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide	c1cccc(c12)cc(n2C)CN(C)C(=O)/C=C/c3cnc(N)cc3
2636	tr|I6XZC4|I6XZC4_M	P0AEK4	96.88	4.0	252.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
2637	tr|I6XZC4|I6XZC4_M	P0AEK4	96.88	4.0	252.0	DB03030	experimental	4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole	Cc1ccc(cc1)Cn2cnc(c2)-c3cccs3
2638	tr|I6XZC4|I6XZC4_M	P0AEK4	96.88	4.0	252.0	DB03534	experimental	3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide	CC(=O)N(C)Cc1c(N)ccc(c1)C(=O)N(C)Cc(n2C)cc(c23)cccc3
2639	tr|I6XZC4|I6XZC4_M	P0AEK4	96.88	4.0	252.0	DB04030	experimental	1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole	Oc1ccc(cc1)Cn2c(c3c(c24)cccc4)CN(CC3)C(=O)c5ccc(O)cc5
2640	tr|I6XZC4|I6XZC4_M	P0AEK4	96.88	4.0	252.0	DB08265	experimental	2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL	Cc1ccc(cc1)S(=O)(=O)n(b2O)ncc(c23)cccc3
2641	tr|I6XZC4|I6XZC4_M	P0AEK4	96.88	4.0	252.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
2642	tr|I6XZC4|I6XZC4_M	P0AEK4	96.88	4.0	252.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
2643	tr|I6XZC4|I6XZC4_M	Q8NBQ5	86.72	32.0	254.0	DB02854	experimental	Aetiocholanolone	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](CC3)C[C@H](O)CC4
2644	tr|I6XZC4|I6XZC4_M	Q99714	96.88	7.0	255.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
2645	tr|I6XZC4|I6XZC4_M	Q99714	96.88	7.0	255.0	DB02820	experimental	1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct	C1CCCCCN1C(=O)[C@H](c2ccccc2)n(c3=S)cnc(c34)nn(c4)[C@H]5C=CN(C=C5C([O-])=N)[C@@H]6O[C@@H]([C@@H](O)[C@H]6O)COP([O-])(=O)OP(=O)(O)OC[C@H]7O[C@H]([C@H]([O-])[C@@H]7[O-])n8cnc(c89)c(N)ncn9
2646	tr|I6XZC4|I6XZC4_M	Q99714	96.88	7.0	255.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
2648	tr|I6XZC4|I6XZC4_M	Q7AUG5	93.75	3.0	243.0	DB04782	experimental	(S)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@H]2CO2
2649	tr|I6XZC4|I6XZC4_M	Q93D82	93.75	3.0	243.0	DB04472	experimental	(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol	[N-]=[N+]=NC[C@H](O)c1ccc([N+]([O-])=O)cc1
2650	tr|I6XZC4|I6XZC4_M	Q93D82	93.75	3.0	243.0	DB04499	experimental	(R)-styrene oxide	C1O[C@@H]1c2ccccc2
2651	tr|I6XZC4|I6XZC4_M	Q93D82	93.75	3.0	243.0	DB04777	experimental	(R)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@@H]2CO2
2652	tr|I6XZC4|I6XZC4_M	P51659	92.97	6.0	244.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
2653	tr|I6XZC4|I6XZC4_M	P51659	92.97	6.0	244.0	DB03192	experimental	(R)-3-hydroxydecanoyl-CoA	CCCCCCC[C@@H](O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
2654	tr|I6XZC4|I6XZC4_M	Q8I814	100.78	14.0	272.0	DB02015	experimental	Dihydrofolic Acid	O=c1[nH]c(N)nc(c12)NCC(=N2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
2655	tr|I6XZC4|I6XZC4_M	Q8I814	100.78	14.0	272.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
2656	tr|I6XZC4|I6XZC4_M	O24990	96.48	4.0	251.0	DB04393	experimental	Soneclosan	Clc1cc(O)c(cc1)Oc2ccc(Cl)cc2
2657	tr|I6XZC4|I6XZC4_M	O24990	96.48	4.0	251.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
2658	tr|I6XZC4|I6XZC4_M	P28845	87.89	31.0	256.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
2659	tr|I6XZC4|I6XZC4_M	P28845	87.89	31.0	256.0	DB02329	experimental	Carbenoxolone	OC(=O)CCC(=O)O[C@@H](CC1)C(C)(C)[C@@H]([C@]12C)CC[C@]3(C)[C@@H]2C(=O)C=C4[C@H]5[C@@](C)(CC[C@@]34C)CC[C@](C5)(C)C(=O)O
2660	tr|I6XZC4|I6XZC4_M	P28845	87.89	31.0	256.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
2661	tr|I6XZC4|I6XZC4_M	P28845	87.89	31.0	256.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
2662	tr|I6XZC4|I6XZC4_M	P28845	87.89	31.0	256.0	DB04652	experimental	Corticosterone	OCC(=O)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H]([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
2663	tr|I6XZC4|I6XZC4_M	P28845	87.89	31.0	256.0	DB05064	investigational	INCB13739	 
2664	tr|I6XZC4|I6XZC4_M	P28845	87.89	31.0	256.0	DB06992	experimental	(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone	Cc1ccc(cc1F)-c2nc(ccc2)C(=O)N(CC3(C)C)CCC3
2665	tr|I6XZC4|I6XZC4_M	P28845	87.89	31.0	256.0	DB07017	experimental	(5S)-2-{[(1S)-1-(4-Fluorophenyl)ethyl]amino}-5-(2-hydroxy-2-propanyl)-5-methyl-1,3-thiazol-4(5H)-one	Fc1ccc(cc1)[C@H](C)NC(=NC2=O)S[C@@]2(C)C(C)(C)O
2666	tr|I6XZC4|I6XZC4_M	P28845	87.89	31.0	256.0	DB07049	experimental	(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine	[O-][N+](=O)c1ccc(cc1)N2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)C(C)(C)C
2667	tr|I6XZC4|I6XZC4_M	P28845	87.89	31.0	256.0	DB07056	experimental	2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide	CCN(CC)C(=O)Cc1cccc(n1)NS(=O)(=O)c2c(C)c(Cl)ccc2
2668	tr|I6XZC4|I6XZC4_M	P28845	87.89	31.0	256.0	DB07310	experimental	(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one	Fc1ccccc1[C@H](C)NC(=NC2=O)S[C@]2(C)C(F)(F)F
2669	tr|I6XZC4|I6XZC4_M	P28845	87.89	31.0	256.0	DB07316	experimental	N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)C3CCN(CC3)CC4(CC4)C(=O)N
2670	tr|I6XZC4|I6XZC4_M	P28845	87.89	31.0	256.0	DB07619	experimental	N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)[C@H]3CC[C@@H](CC3)c4cccnc4
2671	tr|I6XZC4|I6XZC4_M	P28845	87.89	31.0	256.0	DB07624	experimental	1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide	C1CC1(C(=O)N)CN2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)[C@](C)(O)C(F)(F)F
2672	tr|I6XZC4|I6XZC4_M	P28845	87.89	31.0	256.0	DB07866	experimental	(5S)-2-(Cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one	CCC[C@]1(C)SC(=NC1=O)NC2CCCCCCC2
2673	tr|I6XZC4|I6XZC4_M	P28845	87.89	31.0	256.0	DB08277	experimental	2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE	CS(=O)(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4c(Cl)cc(F)cc4
2674	tr|I6XZC4|I6XZC4_M	P28845	87.89	31.0	256.0	DB08280	experimental	(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE	NC(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4ccc(OC)cc4
2675	tr|I6XZC4|I6XZC4_M	P28845	87.89	31.0	256.0	DB08771	experimental	(5R)-2-[(2-Fluorophenyl)amino]-5-isopropyl-1,3-thiazol-4(5H)-one	CC(C)[C@H]1SC(=NC1=O)Nc2c(F)cccc2
2676	tr|I6XZC4|I6XZC4_M	P28845	87.89	31.0	256.0	DB13751	approved; experimental	Glycyrrhizic acid	C1C[C@](C)(C(=O)O)C[C@H]([C@]12C)C=3[C@@](C)(CC2)[C@@]4(C)[C@H](C(=O)C3)[C@]5(C)[C@@H](CC4)C(C)(C)[C@H](CC5)O[C@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O[C@@H]7O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]7O
2677	tr|I6XZC4|I6XZC4_M	O75911	87.5	35.0	259.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
2678	tr|I6XZC4|I6XZC4_M	Q8NBN7	80.47	35.0	241.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
2679	tr|I6XZC4|I6XZC4_M	Q8TC12	79.69	38.0	242.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
2680	tr|I6XZC4|I6XZC4_M	Q01782	107.81	8.0	284.0	DB02338	experimental	NADPH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
2681	tr|I6XZC4|I6XZC4_M	Q01782	107.81	8.0	284.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
2682	tr|I6XZC4|I6XZC4_M	Q01782	107.81	8.0	284.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
2683	tr|I6XZC4|I6XZC4_M	Q01782	107.81	8.0	284.0	DB04400	experimental	L-erythro-7,8-dihydrobiopterin	C[C@H](O)[C@H](O)C(CN1)=Nc(c12)c(=O)nc([nH]2)N
2684	tr|I6XZC4|I6XZC4_M	Q9NYR8	77.34	6.0	204.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
2685	tr|I6XZC4|I6XZC4_M	Q02338	80.47	52.0	258.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
2686	tr|I6XZC4|I6XZC4_M	Q96NR8	79.69	36.0	240.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
2687	tr|I6XZC4|I6XZC4_M	P14061	79.3	2.0	205.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
2688	tr|I6XZC4|I6XZC4_M	P14061	79.3	2.0	205.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
2689	tr|I6XZC4|I6XZC4_M	P14061	79.3	2.0	205.0	DB01561	experimental; illicit	Androstanedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
2690	tr|I6XZC4|I6XZC4_M	P14061	79.3	2.0	205.0	DB02187	experimental	Equilin	O=C1CC[C@H]([C@@]12C)C=3[C@H](CC2)c4c(CC3)cc(O)cc4
2691	tr|I6XZC4|I6XZC4_M	P14061	79.3	2.0	205.0	DB02323	experimental	EM-1745	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)C[C@@H]([C@@H]4O)CCCCCCCCC(=O)OC[C@H]5O[C@H]([C@H](O)[C@@H]5O)n6cnc(c67)c(N)ncn7
2692	tr|I6XZC4|I6XZC4_M	P14061	79.3	2.0	205.0	DB02901	illicit; investigational	Stanolone	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
2693	tr|I6XZC4|I6XZC4_M	P14061	79.3	2.0	205.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
2694	tr|I6XZC4|I6XZC4_M	P14061	79.3	2.0	205.0	DB13951	experimental	Stanolone acetate	CC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
2695	tr|I6XZC4|I6XZC4_M	Q92781	78.91	28.0	230.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
2696	tr|I6XZC4|I6XZC4_M	Q92781	78.91	28.0	230.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
2697	tr|I6XZC4|I6XZC4_M	Q9HBH5	97.66	41.0	291.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
2698	tr|I6XZC4|I6XZC4_M	P9WGR1	101.56	5.0	265.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
2699	tr|I6XZC4|I6XZC4_M	P9WGR1	101.56	5.0	265.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
2700	tr|I6XZC4|I6XZC4_M	P9WGR1	101.56	5.0	265.0	DB02990	experimental	S-(2-Acetamidoethyl) hexadecanethioate	CCCCCCCCCCCCCCCC(=O)SCCNC(=O)C
2701	tr|I6XZC4|I6XZC4_M	P9WGR1	101.56	5.0	265.0	DB04289	experimental	Genz-10850	[nH]1ccc(c12)cc(cc2)C(=O)N3CCN(CC3)C4c(cccc5)c5c(c46)cccc6
2702	tr|I6XZC4|I6XZC4_M	P9WGR1	101.56	5.0	265.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
2703	tr|I6XZC4|I6XZC4_M	P9WGR1	101.56	5.0	265.0	DB07090	experimental	(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cccc(c1C)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
2704	tr|I6XZC4|I6XZC4_M	P9WGR1	101.56	5.0	265.0	DB07123	experimental	N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE	Cc1ccc(cc1)C(=O)N2CCC(CC2)Cc3ccccc3
2705	tr|I6XZC4|I6XZC4_M	P9WGR1	101.56	5.0	265.0	DB07155	experimental	(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE	c1ccccc1NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
2706	tr|I6XZC4|I6XZC4_M	P9WGR1	101.56	5.0	265.0	DB07178	experimental	5-PENTYL-2-PHENOXYPHENOL	CCCCCc1cc(O)c(cc1)Oc2ccccc2
2707	tr|I6XZC4|I6XZC4_M	P9WGR1	101.56	5.0	265.0	DB07188	experimental	(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(cc(Cl)c1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
2708	tr|I6XZC4|I6XZC4_M	P9WGR1	101.56	5.0	265.0	DB07192	experimental	(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Brc1cc(ccc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
2709	tr|I6XZC4|I6XZC4_M	P9WGR1	101.56	5.0	265.0	DB07222	experimental	(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(c(C)cc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
2710	tr|I6XZC4|I6XZC4_M	P9WGR1	101.56	5.0	265.0	DB07287	experimental	2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL	c1cccnc1Cc2cc(O)c(cc2)Oc3ccc(Cl)cc3Cl
2711	tr|I6XZC4|I6XZC4_M	P9WGR1	101.56	5.0	265.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
2712	tr|I6XZC4|I6XZC4_M	P37059	78.91	80.0	282.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
2713	tr|I6XZC4|I6XZC4_M	P37059	78.91	80.0	282.0	DB13952	approved; investigational; vet_approved	Estradiol acetate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)C
2714	tr|I6XZC4|I6XZC4_M	P37059	78.91	80.0	282.0	DB13953	approved; investigational; vet_approved	Estradiol benzoate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)c5ccccc5
2715	tr|I6XZC4|I6XZC4_M	P37059	78.91	80.0	282.0	DB13954	approved; investigational; vet_approved	Estradiol cypionate	C1CCCC1CCC(=O)O[C@H]2CC[C@H]([C@@]23C)[C@H]4[C@H](CC3)c5c(CC4)cc(O)cc5
2716	tr|I6XZC4|I6XZC4_M	P37059	78.91	80.0	282.0	DB13955	approved; investigational; vet_approved	Estradiol dienanthate	CCCCCCC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)CCCCCC
2717	tr|I6XZC4|I6XZC4_M	P37059	78.91	80.0	282.0	DB13956	approved; investigational; vet_approved	Estradiol valerate	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)CC[C@@H]4OC(=O)CCCC
2718	tr|I6XZC4|I6XZC4_M	P80365	77.34	80.0	278.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
2719	tr|I6XZC4|I6XZC4_M	P80365	77.34	80.0	278.0	DB01185	approved; illicit	Fluoxymesterone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@](F)([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
2720	tr|I6XZC4|I6XZC4_M	P80365	77.34	80.0	278.0	DB01569	experimental; illicit	Formebolone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@H]([C@@H](C2)O)[C@]4(C)C(CC3)=CC(=O)C(C=O)=C4
2721	tr|I6XZC4|I6XZC4_M	P80365	77.34	80.0	278.0	DB14538	experimental; vet_approved	Hydrocortisone aceponate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CC)C(=O)COC(=O)C
2722	tr|I6XZC4|I6XZC4_M	P80365	77.34	80.0	278.0	DB14539	approved; vet_approved	Hydrocortisone acetate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)C
2723	tr|I6XZC4|I6XZC4_M	P80365	77.34	80.0	278.0	DB14540	approved; vet_approved	Hydrocortisone butyrate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCC
2724	tr|I6XZC4|I6XZC4_M	P80365	77.34	80.0	278.0	DB14541	approved; investigational; vet_approved	Hydrocortisone cypionate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)CCC5CCCC5
2725	tr|I6XZC4|I6XZC4_M	P80365	77.34	80.0	278.0	DB14542	approved; vet_approved	Hydrocortisone phosphate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COP(=O)(O)O
2726	tr|I6XZC4|I6XZC4_M	P80365	77.34	80.0	278.0	DB14543	approved; vet_approved	Hydrocortisone probutate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CCC)C(=O)COC(=O)CC
2727	tr|I6XZC4|I6XZC4_M	P80365	77.34	80.0	278.0	DB14544	approved; vet_approved	Hydrocortisone valerate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCCC
2728	tr|I6XZC4|I6XZC4_M	P37058	81.64	48.0	257.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
2729	tr|I6XZC4|I6XZC4_M	P16152	92.58	7.0	244.0	DB01698	approved; experimental; investigational	Rutin	O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O[C@H]1C)OC[C@H]2O[C@H]([C@H](O)[C@@H](O)[C@@H]2O)Oc(c3=O)c(-c4cc(O)c(O)cc4)oc(c35)cc(O)cc5O
2730	tr|I6XZC4|I6XZC4_M	P16152	92.58	7.0	244.0	DB02709	investigational	Resveratrol	Oc1ccc(cc1)/C=C/c2cc(O)cc(O)c2
2731	tr|I6XZC4|I6XZC4_M	P16152	92.58	7.0	244.0	DB03394	experimental	Heptaethylene glycol	OCCOCCOCCOCCOCCOCCOCCO
2732	tr|I6XZC4|I6XZC4_M	P16152	92.58	7.0	244.0	DB03556	experimental	2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400	CCOCCOCCOCCOCCOCCOCCOCCOCCO
2733	tr|I6XZC4|I6XZC4_M	P16152	92.58	7.0	244.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
2734	tr|I6XZC4|I6XZC4_M	P16152	92.58	7.0	244.0	DB04463	experimental	3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol	n1cnc(N)c(c12)c(nn2C(C)(C)C)-c3cccc(O)c3
2735	tr|I6XZC4|I6XZC4_M	P16152	92.58	7.0	244.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
2736	tr|I6XZC4|I6XZC4_M	P16152	92.58	7.0	244.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
2737	tr|I6XZC4|I6XZC4_M	P56937	91.02	2.0	235.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
2738	tr|I6XZC4|I6XZC4_M	P35270	84.38	5.0	221.0	DB02637	experimental	Oxaloacetate Ion	OC(=O)C(=O)CC([O-])=O
2739	tr|I6XZC4|I6XZC4_M	P35270	84.38	5.0	221.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
2740	tr|I6XZC4|I6XZC4_M	P35270	84.38	5.0	221.0	DB03886	experimental	Biopterin	C[C@@H](O)[C@@H](O)c(n1)cnc(c12)nc(N)[nH]c2=O
2741	tr|I6XZC4|I6XZC4_M	P35270	84.38	5.0	221.0	DB04275	experimental	N-acetylserotonin	CC(=O)NCCc1c[nH]c(c12)ccc(c2)O
2742	tr|I6XZC4|I6XZC4_M	P09417	73.05	11.0	198.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
2743	tr|I6XZC4|I6XZC4_M	P09417	73.05	11.0	198.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
2744	tr|I6XZC4|I6XZC4_M	Q8T8E9	75.78	2.0	196.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
2745	tr|I6XZC4|I6XZC4_M	P26391	74.61	3.0	194.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
2846	tr|O53713|O53713_M	Q9UEW3	76.71	146.0	202.0	DB09536	approved	Titanium dioxide	O=[Ti]=O
2847	tr|O53713|O53713_M	Q9UEW3	76.71	146.0	202.0	DB11132	approved	Silicon dioxide	O=[Si]=O
2848	tr|O53713|O53713_M	Q9UEW3	82.19	199.0	259.0	DB09536	approved	Titanium dioxide	O=[Ti]=O
2849	tr|O53713|O53713_M	Q9UEW3	82.19	199.0	259.0	DB11132	approved	Silicon dioxide	O=[Si]=O
2850	tr|O53713|O53713_M	Q9UEW3	86.3	259.0	322.0	DB09536	approved	Titanium dioxide	O=[Ti]=O
2851	tr|O53713|O53713_M	Q9UEW3	86.3	259.0	322.0	DB11132	approved	Silicon dioxide	O=[Si]=O
2852	tr|O53713|O53713_M	Q9UEW3	89.04	317.0	382.0	DB09536	approved	Titanium dioxide	O=[Ti]=O
2853	tr|O53713|O53713_M	Q9UEW3	89.04	317.0	382.0	DB11132	approved	Silicon dioxide	O=[Si]=O
2854	tr|O53713|O53713_M	Q9UEW3	82.19	359.0	419.0	DB09536	approved	Titanium dioxide	O=[Ti]=O
2855	tr|O53713|O53713_M	Q9UEW3	82.19	359.0	419.0	DB11132	approved	Silicon dioxide	O=[Si]=O
2856	tr|O53713|O53713_M	P35247	87.67	48.0	112.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
2857	tr|O53713|O53713_M	P35247	72.6	104.0	157.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
2858	tr|O53713|O53713_M	P35247	83.56	157.0	218.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
2868	tr|O53713|O53713_M	P02747	86.3	28.0	91.0	DB01593	approved; investigational	Zinc	[Zn]
2869	tr|O53713|O53713_M	P02747	86.3	28.0	91.0	DB09130	approved; investigational	Copper	[Cu]
2870	tr|O53713|O53713_M	P02747	86.3	28.0	91.0	DB14487	approved; investigational	Zinc acetate	CC([O-])=O
2871	tr|O53713|O53713_M	P02747	86.3	28.0	91.0	DB14533	approved; investigational	Zinc chloride	[Cl-]
2872	tr|O53713|O53713_M	P02747	86.3	28.0	91.0	DB14548	approved; experimental	Zinc sulfate, unspecified form	 
2878	tr|O53713|O53713_M	P02746	76.71	32.0	88.0	DB01593	approved; investigational	Zinc	[Zn]
2879	tr|O53713|O53713_M	P02746	76.71	32.0	88.0	DB14487	approved; investigational	Zinc acetate	CC([O-])=O
2880	tr|O53713|O53713_M	P02746	76.71	32.0	88.0	DB14533	approved; investigational	Zinc chloride	[Cl-]
2881	tr|O53713|O53713_M	P02746	76.71	32.0	88.0	DB14548	approved; experimental	Zinc sulfate, unspecified form	 
2883	tr|O53713|O53713_M	Q8IWL2	72.6	27.0	80.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
2884	tr|O53713|O53713_M	P11226	79.45	40.0	98.0	DB01818	experimental	O3-Sulfonylgalactose	O[C@@H]1O[C@H](CO)[C@H](O)[C@@H]([C@H]1O)OS(=O)(=O)O
2885	tr|O53713|O53713_M	P11226	79.45	40.0	98.0	DB01979	experimental	Methyl alpha-D-mannoside	CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O
2886	tr|O53713|O53713_M	P11226	79.45	40.0	98.0	DB02837	experimental	4-(Hydrogen sulfate)-beta-D-galactopyranose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1OS(=O)(=O)O
2887	tr|O53713|O53713_M	P11226	79.45	40.0	98.0	DB03194	experimental	Methyl beta-L-fucopyranoside	CO[C@H]1O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]1O
2888	tr|O53713|O53713_M	P11226	79.45	40.0	98.0	DB03721	experimental	N-acetyl-alpha-neuraminic acid	OC(=O)[C@]1(O)O[C@H]([C@@H]([C@H](C1)O)NC(=O)C)[C@H](O)[C@H](O)CO
2889	tr|O53713|O53713_M	P11226	79.45	40.0	98.0	DB03879	experimental	alpha-L-methyl-fucose	CO[C@@H]1O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]1O
2890	tr|O53713|O53713_M	P11226	79.45	40.0	98.0	DB04426	experimental	Alpha-Methyl-N-Acetyl-D-Glucosamine	OC[C@H]1O[C@@H](OC)[C@H](NC(=O)C)[C@@H](O)[C@@H]1O
2891	tr|I6YDN6|I6YDN6_M	P15034	71.51	165.0	431.0	DB04092	experimental	Apstatin	NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]2CCCN2C(=O)[C@@H](O)[C@H](N)Cc3ccccc3
2892	tr|P96396|P96396_M	Q8ZKF6	95.9	102.0	617.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
2893	tr|P96396|P96396_M	Q8ZKF6	95.9	102.0	617.0	DB03230	experimental	Adenosine-5'-Propylphosphate	CCCOP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
2894	tr|P96396|P96396_M	Q9NUB1	95.72	137.0	651.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
2895	tr|P96396|P96396_M	Q9NR19	100.0	132.0	669.0	DB00131	approved; investigational; nutraceutical	Adenosine phosphate	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
2896	tr|P96396|P96396_M	Q9NR19	100.0	132.0	669.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
2897	tr|P96396|P96396_M	P40871	90.88	42.0	530.0	DB01672	experimental	2,3-Dihydroxy-Benzoic Acid	OC(=O)c1cccc(O)c1O
2898	tr|P96396|P96396_M	Q8GN86	90.88	15.0	503.0	DB03728	experimental	p-Chlorobenzoic acid	OC(=O)c1ccc(Cl)cc1
2899	tr|L7N664|L7N664_M	P07237	88.62	29.0	138.0	DB01593	approved; investigational	Zinc	[Zn]
2900	tr|L7N664|L7N664_M	P07237	88.62	29.0	138.0	DB03615	approved; experimental	Ribostamycin	O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]2[C@@H](O)[C@H](N)C[C@H](N)[C@H]2O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N
2901	tr|L7N664|L7N664_M	P07237	88.62	29.0	138.0	DB09130	approved; investigational	Copper	[Cu]
2902	tr|L7N664|L7N664_M	P07237	88.62	29.0	138.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
2903	tr|L7N664|L7N664_M	P07237	88.62	29.0	138.0	DB14487	approved; investigational	Zinc acetate	CC([O-])=O
2904	tr|L7N664|L7N664_M	P07237	88.62	29.0	138.0	DB14533	approved; investigational	Zinc chloride	[Cl-]
2905	tr|L7N664|L7N664_M	P07237	88.62	29.0	138.0	DB14548	approved; experimental	Zinc sulfate, unspecified form	 
2906	tr|L7N664|L7N664_M	P07237	75.61	372.0	465.0	DB01593	approved; investigational	Zinc	[Zn]
2907	tr|L7N664|L7N664_M	P07237	75.61	372.0	465.0	DB03615	approved; experimental	Ribostamycin	O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]2[C@@H](O)[C@H](N)C[C@H](N)[C@H]2O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N
2908	tr|L7N664|L7N664_M	P07237	75.61	372.0	465.0	DB09130	approved; investigational	Copper	[Cu]
2909	tr|L7N664|L7N664_M	P07237	75.61	372.0	465.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
2910	tr|L7N664|L7N664_M	P07237	75.61	372.0	465.0	DB14487	approved; investigational	Zinc acetate	CC([O-])=O
2911	tr|L7N664|L7N664_M	P07237	75.61	372.0	465.0	DB14533	approved; investigational	Zinc chloride	[Cl-]
2912	tr|L7N664|L7N664_M	P07237	75.61	372.0	465.0	DB14548	approved; experimental	Zinc sulfate, unspecified form	 
2913	tr|L7N664|L7N664_M	P30101	86.18	29.0	135.0	DB01593	approved; investigational	Zinc	[Zn]
2914	tr|L7N664|L7N664_M	P30101	86.18	29.0	135.0	DB09130	approved; investigational	Copper	[Cu]
2915	tr|L7N664|L7N664_M	P30101	86.18	29.0	135.0	DB14487	approved; investigational	Zinc acetate	CC([O-])=O
2916	tr|L7N664|L7N664_M	P30101	86.18	29.0	135.0	DB14533	approved; investigational	Zinc chloride	[Cl-]
2917	tr|L7N664|L7N664_M	P30101	86.18	29.0	135.0	DB14548	approved; experimental	Zinc sulfate, unspecified form	 
2918	tr|L7N664|L7N664_M	P30101	82.11	381.0	482.0	DB01593	approved; investigational	Zinc	[Zn]
2919	tr|L7N664|L7N664_M	P30101	82.11	381.0	482.0	DB09130	approved; investigational	Copper	[Cu]
2920	tr|L7N664|L7N664_M	P30101	82.11	381.0	482.0	DB14487	approved; investigational	Zinc acetate	CC([O-])=O
2921	tr|L7N664|L7N664_M	P30101	82.11	381.0	482.0	DB14533	approved; investigational	Zinc chloride	[Cl-]
2922	tr|L7N664|L7N664_M	P30101	82.11	381.0	482.0	DB14548	approved; experimental	Zinc sulfate, unspecified form	 
2923	tr|L7N664|L7N664_M	C0H4Y6	81.3	34.0	134.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
2924	tr|L7N664|L7N664_M	C0H4Y6	79.67	363.0	461.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
2925	tr|L7N664|L7N664_M	P10599	78.05	8.0	104.0	DB12695	investigational	Phenethyl Isothiocyanate	S=C=NCCc1ccccc1
2926	tr|L7N664|L7N664_M	Q8IDH5	73.98	27.0	118.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
2927	tr|L7N664|L7N664_M	Q8IKL4	82.11	15.0	116.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
2928	tr|I6Y0X0|I6Y0X0_M	P40871	92.87	25.0	533.0	DB01672	experimental	2,3-Dihydroxy-Benzoic Acid	OC(=O)c1cccc(O)c1O
2929	tr|I6Y0X0|I6Y0X0_M	Q9NUB1	94.7	135.0	653.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
2930	tr|I6Y0X0|I6Y0X0_M	Q8GN86	91.41	3.0	503.0	DB03728	experimental	p-Chlorobenzoic acid	OC(=O)c1ccc(Cl)cc1
2931	tr|I6Y0X0|I6Y0X0_M	Q8ZKF6	96.89	88.0	618.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
2932	tr|I6Y0X0|I6Y0X0_M	Q8ZKF6	96.89	88.0	618.0	DB03230	experimental	Adenosine-5'-Propylphosphate	CCCOP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
2933	tr|I6Y0X0|I6Y0X0_M	Q9NR19	99.09	129.0	671.0	DB00131	approved; investigational; nutraceutical	Adenosine phosphate	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
2934	tr|I6Y0X0|I6Y0X0_M	Q9NR19	99.09	129.0	671.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
2937	tr|O50431|O50431_M	P42593	99.11	2.0	670.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
2938	tr|O50431|O50431_M	P42593	99.11	2.0	670.0	DB03247	approved; investigational	Flavin mononucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)COP(=O)(O)O
2939	tr|O50431|O50431_M	P42593	99.11	2.0	670.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
2940	tr|O50431|O50431_M	P42593	99.11	2.0	670.0	DB03698	experimental	5-Mercaptoethanol-2-decenoyl-coenzyme A	CCCCC[C@H](SCC=O)C/C=C/C(=O)SCCNC(=O)CCN[C@H](O)C(=O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)[n+]2c[nH]c(c23)c(N)ncn3
2941	tr|O50431|O50431_M	P16099	78.49	10.0	539.0	DB03247	approved; investigational	Flavin mononucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)COP(=O)(O)O
2942	tr|I6YFP0|I6YFP0_M	P50747	91.35	466.0	709.0	DB00121	approved; investigational; nutraceutical	Biotin	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC(=O)O
2943	tr|I6YFP0|I6YFP0_M	P06709	88.72	70.0	306.0	DB04651	experimental	BIOTINOL-5-AMP	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)CO[P@](=O)(O)OCCCCC[C@@H]4SC[C@@H]([C@@H]45)NC(=O)N5
2944	tr|O50444|O50444_M	P09546	97.57	251.0	572.0	DB03051	experimental	(S)-2-Tetrahydrofuroic acid	OC(=O)[C@H]1CCCO1
2945	tr|O50444|O50444_M	P09546	97.57	251.0	572.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
2946	tr|O50444|O50444_M	P09546	97.57	251.0	572.0	DB04398	approved; vet_approved	Lactic acid	CC(O)C(=O)O
2947	tr|O06338|O06338_M	O31168	96.17	27.0	278.0	DB03793	approved; investigational	Benzoic acid	OC(=O)c1ccccc1
2948	tr|O06338|O06338_M	O07015	94.64	22.0	269.0	DB02175	experimental	Malonic acid	OC(=O)CC(=O)O
2949	tr|O06338|O06338_M	O07015	94.64	22.0	269.0	DB03297	experimental	Benzylsulfonic acid	OS(=O)(=O)Cc1ccccc1
2950	tr|O06338|O06338_M	O07015	94.64	22.0	269.0	DB04349	experimental	(S)-propane-1,2-diol	C[C@H](O)CO
2951	tr|O06338|O06338_M	P96965	93.1	28.0	271.0	DB02406	experimental	N-Valeric Acid	CCCCC(=O)O
2952	tr|O06338|O06338_M	P96965	93.1	28.0	271.0	DB02531	experimental	Isobutyric acid	CC(C)C(=O)O
2953	tr|O06338|O06338_M	P96965	93.1	28.0	271.0	DB03568	experimental; investigational	Butyric Acid	CCCC(=O)O
2954	tr|O06338|O06338_M	P96965	93.1	28.0	271.0	DB03741	experimental	2-Methylbutanoic Acid	CC[C@@H](C)C(=O)O
2955	tr|O06338|O06338_M	P96965	93.1	28.0	271.0	DB03750	experimental	Isovaleric Acid	CC(C)CC(=O)O
2956	tr|O06338|O06338_M	P96965	93.1	28.0	271.0	DB03766	approved; vet_approved	Propanoic acid	CCC(=O)O
2957	tr|O06338|O06338_M	P96965	93.1	28.0	271.0	DB03793	approved; investigational	Benzoic acid	OC(=O)c1ccccc1
2958	tr|O06338|O06338_M	O32449	98.47	41.0	298.0	DB03833	experimental	2-Prolyl-5-Tert-Butyl-[1,3,4]Oxadiazole	C1CCN[C@@H]1C(=O)c2nnc(o2)C(C)(C)C
2959	tr|O06338|O06338_M	O32449	98.47	41.0	298.0	DB07391	experimental	(2S)-2-AMINO-1-(5-TERT-BUTYL-1,3,4-OXADIAZOL-2-YL)PROPAN-1-ONE	C[C@H](N)C(=O)c1nnc(o1)C(C)(C)C
2960	tr|O06338|O06338_M	O32449	98.47	41.0	298.0	DB08576	experimental	1-(5-TERT-BUTYL-1,3,4-OXADIAZOL-2-YL)-2-(METHYLAMINO)ETHANONE	CNCC(=O)c1nnc(o1)C(C)(C)C
2962	tr|O06338|O06338_M	Q54528	101.53	27.0	292.0	DB01806	experimental	10-decarboxymethylaclacinomycin A	c1ccc(O)c(c12)C(=O)c3c(C2=O)cc4c(c3O)[C@H](C[C@](C4)(O)CC)O[C@H]5C[C@H](N(C)C)[C@@H]([C@@H](O5)C)O[C@@H]6C[C@H](O)[C@H]([C@@H](O6)C)O[C@H]7CCC(=O)[C@H](O7)C
2963	tr|O06338|O06338_M	Q54528	101.53	27.0	292.0	DB04131	experimental	10-(4-Dimethylamino-5-Hydroxy-6-Methyl-Tetrahydro-Pyran-2-Yloxy)-8-Ethyl-1,8,11-Trihydroxy-7,8,9,10-Tetrahydro-Naphthacene-5,12-Dione	O[C@H]1[C@@H](N(C)C)C[C@@H](O[C@H]1C)O[C@H]2C[C@](O)(CC)Cc(c23)cc4c(c3O)C(=O)c5c(C4=O)cccc5O
2964	tr|O06338|O06338_M	P47229	95.4	36.0	285.0	DB07510	experimental	3-fluoro-6-(4-fluorophenyl)-2-hydroxy-6-oxohexa-2,4-dienoic acid	OC(=O)/C(O)=C(/F)\C=C\C(=O)c1ccc(F)cc1
2965	tr|O06338|O06338_M	P47229	95.4	36.0	285.0	DB07516	experimental	(2Z,4E)-3-chloro-2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoic acid	OC(=O)/C(O)=C(/Cl)\C=C\C(=O)c1ccccc1
2966	tr|O06338|O06338_M	P47229	95.4	36.0	285.0	DB07911	experimental	(3E)-2,6-DIOXO-6-PHENYLHEX-3-ENOATE	[O-]C(=O)C(=O)/C=C/CC(=O)c1ccccc1
2967	tr|O06338|O06338_M	P47229	95.4	36.0	285.0	DB07915	experimental	(2E,4E)-2-Hydroxy-6-oxo-6-phenyl-2,4-hexadienoic acid	OC(=O)/C(O)=C\C=C\C(=O)c1ccccc1
2968	tr|O06338|O06338_M	P13001	90.04	16.0	251.0	DB03688	experimental	Hydracrylic acid	OCCC(=O)O
2969	tr|O06338|O06338_M	O07732	86.21	57.0	282.0	DB02596	experimental	alpha,beta-Methyleneadenosine 5'-triphosphate	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)CP(=O)(O)OP(=O)(O)O
2970	tr|O53238|O53238_M	Q9WXS0	103.86	2.0	244.0	DB01942	experimental; investigational	Formic acid	OC=O
2971	tr|O33229|O33229_M	P16219	98.19	27.0	406.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
2972	tr|O33229|O33229_M	P16219	98.19	27.0	406.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
2973	tr|O33229|O33229_M	P16219	98.19	27.0	406.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
2974	tr|O33229|O33229_M	Q72JJ3	96.37	6.0	378.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
2975	tr|O33229|O33229_M	Q06319	97.41	5.0	381.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
2976	tr|O33229|O33229_M	Q06319	97.41	5.0	381.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
2977	tr|O33229|O33229_M	P26440	97.41	42.0	418.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
2978	tr|O33229|O33229_M	P26440	97.41	42.0	418.0	DB04036	experimental	Coenzyme A persulfide	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSS
2979	tr|O33229|O33229_M	P45954	96.37	56.0	428.0	DB00167	investigational; nutraceutical	Isoleucine	CC[C@H](C)[C@H](N)C(=O)O
2980	tr|O33229|O33229_M	P45954	96.37	56.0	428.0	DB00313	approved; investigational	Valproic acid	CCCC(C(=O)O)CCC
2981	tr|O33229|O33229_M	P11310	97.15	39.0	414.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
2982	tr|O33229|O33229_M	P11310	97.15	39.0	414.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
2983	tr|O33229|O33229_M	P11310	97.15	39.0	414.0	DB03415	experimental	3-thiaoctanoyl-CoA	CCCCCSCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
2984	tr|O33229|O33229_M	Q9UKU7	96.63	39.0	412.0	DB01675	experimental	Methacrylyl-Coenzyme A	CC(=C)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
2985	tr|O33229|O33229_M	Q9UKU7	96.63	39.0	412.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
2986	tr|O33229|O33229_M	Q3JP94	95.85	17.0	387.0	DB08685	experimental	1-(1,4-dimethyl-1,2,3,4-tetrahydroquinoxalin-6-yl)methanamine	CN1CCN(C)c(c12)cc(cc2)CN
2987	tr|O33229|O33229_M	Q92947	95.6	59.0	428.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
2988	tr|O33229|O33229_M	Q92947	95.6	59.0	428.0	DB03245	experimental	S-4-Nitrobutyryl-CoA	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCC[N+]([O-])=O
2989	tr|O33229|O33229_M	Q9KIE5	90.16	12.0	360.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
2990	tr|O33229|O33229_M	Q15067	86.27	101.0	434.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
2991	tr|O33229|O33229_M	Q15067	86.27	101.0	434.0	DB07930	experimental	(3R)-3-HYDROXYDODECANOIC ACID	OC(=O)C[C@H](O)CCCCCCCCC
2992	tr|I6YCB9|I6YCB9_M	P56220	71.84	93.0	218.0	DB01856	experimental	Pimelic Acid	OC(=O)CCCCCC(=O)O
2993	tr|I6YCB9|I6YCB9_M	P56220	71.84	93.0	218.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
2994	tr|I6YCB9|I6YCB9_M	P56220	71.84	93.0	218.0	DB03134	experimental	L-2-aminopimelic acid	OC(=O)[C@@H](N)CCCCC(=O)O
2995	tr|I6YCB9|I6YCB9_M	P56220	71.84	93.0	218.0	DB03699	experimental	Succinyl-Coenzyme A	OC(=O)CCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
2996	tr|I6YCB9|I6YCB9_M	P56220	71.84	93.0	218.0	DB03905	experimental	Succinamide-CoA	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCNC(=O)CCC(=O)O
2997	tr|O05307|O05307_M	Q9NR19	93.47	115.0	673.0	DB00131	approved; investigational; nutraceutical	Adenosine phosphate	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
2998	tr|O05307|O05307_M	Q9NR19	93.47	115.0	673.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
2999	tr|O05307|O05307_M	Q9NUB1	89.45	118.0	652.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
3000	tr|O05307|O05307_M	Q8ZKF6	90.45	82.0	622.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
3001	tr|O05307|O05307_M	Q8ZKF6	90.45	82.0	622.0	DB03230	experimental	Adenosine-5'-Propylphosphate	CCCOP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
3002	tr|O05307|O05307_M	P40871	84.42	24.0	528.0	DB01672	experimental	2,3-Dihydroxy-Benzoic Acid	OC(=O)c1cccc(O)c1O
3003	tr|O05307|O05307_M	Q8GN86	83.58	2.0	501.0	DB03728	experimental	p-Chlorobenzoic acid	OC(=O)c1ccc(Cl)cc1
3004	tr|Q7ARS9|Q7ARS9_M	P39662	81.54	7.0	325.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
3005	tr|Q7ARS9|Q7ARS9_M	P39662	81.54	7.0	325.0	DB03979	experimental	1-[Glycerolylphosphonyl]-2-[8-(2-Hexyl-Cyclopropyl)-Octanal-1-Yl]-3-[Hexadecanal-1-Yl]-Glycerol	CCCCCC[C@@H]1C[C@@H]1CCCCCCCC(=O)O[C@@H](COP(=O)(O)OCC(O)CO)COC(=O)CCCCCCCCCCCCCCC
3006	tr|Q7ARS9|Q7ARS9_M	P24232	94.87	17.0	387.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
3007	tr|O53453|O53453_M	P23141	88.89	396.0	548.0	DB00382	approved; investigational; withdrawn	Tacrine	c1cccc(c12)nc3c(c2N)CCCC3
3008	tr|O53453|O53453_M	P23141	88.89	396.0	548.0	DB00454	approved	Meperidine	C1CN(C)CCC1(C(=O)OCC)c2ccccc2
3009	tr|O53453|O53453_M	P23141	88.89	396.0	548.0	DB00583	approved; investigational	Levocarnitine	C[N+](C)(C)C[C@H](O)CC([O-])=O
3010	tr|O53453|O53453_M	P23141	88.89	396.0	548.0	DB00647	approved; illicit; investigational; withdrawn	Dextropropoxyphene	c1ccccc1[C@@](OC(=O)CC)([C@H](C)CN(C)C)Cc2ccccc2
3011	tr|O53453|O53453_M	P23141	88.89	396.0	548.0	DB00907	approved; illicit	Cocaine	[C@@H]12CC[C@@H](N1C)[C@@H](C(=O)OC)[C@H](C2)OC(=O)c3ccccc3
3012	tr|O53453|O53453_M	P23141	88.89	396.0	548.0	DB01183	approved; vet_approved	Naloxone	[C@]123[C@H]4Oc5c1c(ccc5O)C[C@@H](N(CC2)CC=C)[C@]3(O)CCC4=O
3013	tr|O53453|O53453_M	P23141	88.89	396.0	548.0	DB01452	approved; illicit; investigational	Diamorphine	C1CN(C)[C@@H]([C@H]2[C@@]134)Cc5c3c(c(cc5)OC(=O)C)O[C@H]4[C@H](C=C2)OC(=O)C
3014	tr|O53453|O53453_M	P23141	88.89	396.0	548.0	DB01599	approved; investigational	Probucol	CC(C)(C)c1cc(cc(c1O)C(C)(C)C)SC(C)(C)Sc2cc(C(C)(C)C)c(O)c(c2)C(C)(C)C
3015	tr|O53453|O53453_M	P23141	88.89	396.0	548.0	DB02161	experimental	Hydroxy-Phenyl-Acetic Acid 8-Methyl-8-Aza-Bicyclo[3.2.1]Oct-3-Yl Ester	c1ccccc1[C@@H](O)C(=O)O[C@@H](C[C@H]23)C[C@@H](CC2)N3C
3016	tr|O53453|O53453_M	P23141	88.89	396.0	548.0	DB02659	approved	Cholic Acid	OC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](C[C@@H]2O)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
3017	tr|O53453|O53453_M	P23141	88.89	396.0	548.0	DB03056	experimental	4-Piperidino-Piperidine	C1CCCCN1C2CCNCC2
3018	tr|O53453|O53453_M	P23141	88.89	396.0	548.0	DB03721	experimental	N-acetyl-alpha-neuraminic acid	OC(=O)[C@]1(O)O[C@H]([C@@H]([C@H](C1)O)NC(=O)C)[C@H](O)[C@H](O)CO
3019	tr|O53453|O53453_M	P23141	88.89	396.0	548.0	DB04795	experimental	Thenoyltrifluoroacetone	FC(F)(F)C(=O)CC(=O)c1cccs1
3020	tr|O53453|O53453_M	P23141	88.89	396.0	548.0	DB04838	approved	Cyclandelate	CC1(C)CC(C)CC(C1)OC(=O)C(O)c2ccccc2
3021	tr|O53453|O53453_M	P23141	88.89	396.0	548.0	DB06442	investigational	Avasimibe	CC(C)c1cc(C(C)C)c(c(c1)C(C)C)CC(=O)NS(=O)(=O)Oc2c(C(C)C)cccc2C(C)C
3022	tr|O53453|O53453_M	P23141	88.89	396.0	548.0	DB07821	experimental	(1R)-1,2,2-trimethylpropyl (R)-methylphosphinate	CC(C)(C)[C@@H](C)O[P@@H](=O)C
3023	tr|O53453|O53453_M	P23141	88.89	396.0	548.0	DB08224	experimental	(1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENOL	O[C@H]1CC(=O)O[C@H](C1)CC[C@H]2[C@@H](C)C=CC([C@@H]23)=CCC[C@@H]3O
3024	tr|O53453|O53453_M	P19835	81.87	395.0	535.0	DB04348	approved; experimental	Taurocholic acid	OS(=O)(=O)CCNC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](C[C@@H]2O)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
3025	tr|O53453|O53453_M	P06276	79.53	414.0	550.0	DB00122	approved; nutraceutical	Choline	C[N+](C)(C)CCO
3026	tr|O53453|O53453_M	P06276	79.53	414.0	550.0	DB00382	approved; investigational; withdrawn	Tacrine	c1cccc(c12)nc3c(c2N)CCCC3
3027	tr|O53453|O53453_M	P06276	79.53	414.0	550.0	DB00449	approved	Dipivefrin	CNCC(O)c1cc(OC(=O)C(C)(C)C)c(cc1)OC(=O)C(C)(C)C
3028	tr|O53453|O53453_M	P06276	79.53	414.0	550.0	DB00545	approved; investigational	Pyridostigmine	CN(C)C(=O)Oc1c[n+](C)ccc1
3029	tr|O53453|O53453_M	P06276	79.53	414.0	550.0	DB00674	approved	Galantamine	C1=C[C@H](O)C[C@@H]([C@@]123)Oc4c2c(CN(C)CC3)ccc4OC
3030	tr|O53453|O53453_M	P06276	79.53	414.0	550.0	DB00677	approved; investigational; withdrawn	Isoflurophate	CC(C)OP(F)(=O)OC(C)C
3031	tr|O53453|O53453_M	P06276	79.53	414.0	550.0	DB00733	approved; vet_approved	Pralidoxime	O/N=C/c1[n+](C)cccc1
3032	tr|O53453|O53453_M	P06276	79.53	414.0	550.0	DB00772	approved; investigational	Malathion	CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC
3033	tr|O53453|O53453_M	P06276	79.53	414.0	550.0	DB00843	approved	Donepezil	COc(c1)c(OC)cc(c12)C(=O)C(C2)CC3CCN(CC3)Cc4ccccc4
3034	tr|O53453|O53453_M	P06276	79.53	414.0	550.0	DB00941	approved	Hexafluronium	c1cccc2c1C(c(c23)cccc3)[N+](C)(C)CCCCCC[N+](C)(C)C4c(cccc5)c5c(c46)cccc6
3035	tr|O53453|O53453_M	P06276	79.53	414.0	550.0	DB00944	approved	Demecarium	C[N+](C)(C)c1cc(ccc1)OC(=O)N(C)CCCCCCCCCCN(C)C(=O)Oc2cccc(c2)[N+](C)(C)C
3036	tr|O53453|O53453_M	P06276	79.53	414.0	550.0	DB00989	approved; investigational	Rivastigmine	CCN(C)C(=O)Oc1cccc(c1)[C@H](C)N(C)C
3037	tr|O53453|O53453_M	P06276	79.53	414.0	550.0	DB01010	approved	Edrophonium	CC[N+](C)(C)c1cc(O)ccc1
3038	tr|O53453|O53453_M	P06276	79.53	414.0	550.0	DB01057	approved	Echothiophate	CCOP(=O)(OCC)SCC[N+](C)(C)C
3039	tr|O53453|O53453_M	P06276	79.53	414.0	550.0	DB01221	approved; vet_approved	Ketamine	C1CCCC(=O)C1(NC)c2ccccc2Cl
3040	tr|O53453|O53453_M	P06276	79.53	414.0	550.0	DB01226	approved	Mivacurium	COc(c1)c(OC)c(OC)cc1C[C@H](c(c23)cc(OC)c(c2)OC)[N+](C)(CC3)CCCOC(=O)CC/C=C/CCC(=O)OCCC[N+](C)(CCc(c45)cc(OC)c(c5)OC)[C@@H]4Cc6cc(OC)c(OC)c(c6)OC
3041	tr|O53453|O53453_M	P06276	79.53	414.0	550.0	DB02811	experimental	Diethyl phosphonate	CCOP(=O)OCC
3042	tr|O53453|O53453_M	P06276	79.53	414.0	550.0	DB02845	experimental	Methylphosphinic Acid	CP(=O)O
3043	tr|O53453|O53453_M	P06276	79.53	414.0	550.0	DB03568	experimental; investigational	Butyric Acid	CCCC(=O)O
3044	tr|O53453|O53453_M	P06276	79.53	414.0	550.0	DB03672	experimental	9-N-Phenylmethylamino-Tacrine	c1ccccc1CNc2c(cccc3)c3nc(c24)CCCC4
3045	tr|O53453|O53453_M	P06276	79.53	414.0	550.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
3046	tr|O53453|O53453_M	P06276	79.53	414.0	550.0	DB03822	experimental	Ethyl dihydrogen phosphate	CCOP(=O)(O)O
3047	tr|O53453|O53453_M	P06276	79.53	414.0	550.0	DB04250	experimental	Butyrylthiocholine	CCCC(=O)SCC[N+](C)(C)C
3048	tr|O53453|O53453_M	P06276	79.53	414.0	550.0	DB04892	investigational	Phenserine	C1CN(C)[C@@H]([C@@]12C)N(C)c3c2cc(cc3)OC(=O)Nc4ccccc4
3049	tr|O53453|O53453_M	P06276	79.53	414.0	550.0	DB07681	experimental	DODECANESULFONATE ION	CCCCCCCCCCCCS([O-])(=O)=O
3050	tr|O53453|O53453_M	P06276	79.53	414.0	550.0	DB07940	experimental	9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE	Ic1cccc(c1)CNc2c(CCCC3)c3nc(c24)cccc4
3051	tr|O53453|O53453_M	P06276	79.53	414.0	550.0	DB08200	experimental	(1R)-menthyl hexyl phosphonate group	CCCCCCP(=O)(O)O[C@@H]1C[C@H](C)CC[C@H]1C(C)C
3052	tr|O53453|O53453_M	P06276	79.53	414.0	550.0	DB08201	experimental	(1S)-menthyl hexyl phosphonate group	CCCCCCP(=O)(O)O[C@H]1C[C@@H](C)CC[C@@H]1C(C)C
3053	tr|O53453|O53453_M	P06276	79.53	414.0	550.0	DB08658	experimental	ETHYL HYDROGEN DIETHYLAMIDOPHOSPHATE	CCO[P@@](=O)(O)N(CC)CC
3054	tr|O53453|O53453_M	P06276	79.53	414.0	550.0	DB11397	vet_approved	Dichlorvos	COP(=O)(OC)OC=C(Cl)Cl
3055	tr|O53453|O53453_M	P06276	79.53	414.0	550.0	DB14006	approved; nutraceutical	Choline salicylate	Oc1ccccc1C([O-])=O
3056	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB00122	approved; nutraceutical	Choline	C[N+](C)(C)CCO
3057	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB00382	approved; investigational; withdrawn	Tacrine	c1cccc(c12)nc3c(c2N)CCCC3
3058	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB00411	approved	Carbamoylcholine	C[N+](C)(C)CCOC(=O)N
3059	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB00449	approved	Dipivefrin	CNCC(O)c1cc(OC(=O)C(C)(C)C)c(cc1)OC(=O)C(C)(C)C
3060	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB00483	approved	Gallamine triethiodide	CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC
3061	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB00545	approved; investigational	Pyridostigmine	CN(C)C(=O)Oc1c[n+](C)ccc1
3062	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB00674	approved	Galantamine	C1=C[C@H](O)C[C@@H]([C@@]123)Oc4c2c(CN(C)CC3)ccc4OC
3063	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB00677	approved; investigational; withdrawn	Isoflurophate	CC(C)OP(F)(=O)OC(C)C
3064	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB00733	approved; vet_approved	Pralidoxime	O/N=C/c1[n+](C)cccc1
3065	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB00805	approved	Minaprine	c1ccccc1-c2cc(C)c(nn2)NCCN3CCOCC3
3066	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB00843	approved	Donepezil	COc(c1)c(OC)cc(c12)C(=O)C(C2)CC3CCN(CC3)Cc4ccccc4
3067	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB00863	approved; withdrawn	Ranitidine	[O-][N+](=O)/C=C(\NC)NCCSCc1ccc(o1)CN(C)C
3068	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB00944	approved	Demecarium	C[N+](C)(C)c1cc(ccc1)OC(=O)N(C)CCCCCCCCCCN(C)C(=O)Oc2cccc(c2)[N+](C)(C)C
3069	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB00981	approved; investigational	Physostigmine	C1CN(C)[C@@H]([C@@]12C)N(C)c3c2cc(cc3)OC(=O)NC
3070	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB00989	approved; investigational	Rivastigmine	CCN(C)C(=O)Oc1cccc(c1)[C@H](C)N(C)C
3071	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB01010	approved	Edrophonium	CC[N+](C)(C)c1cc(O)ccc1
3072	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB01122	approved	Ambenonium	Clc1ccccc1C[N+](CC)(CC)CCNC(=O)C(=O)NCC[N+](CC)(CC)Cc2ccccc2Cl
3073	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB01199	approved	Tubocurarine	C1CN(C)[C@H](c2c13)Cc4ccc(cc4)Oc5c6c(cc(c5O)OC)CC[N+](C)(C)[C@@H]6Cc7cc(c(O)cc7)Oc(c2)c(c3)OC
3074	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB01245	approved	Decamethonium	C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C
3075	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB01400	approved; vet_approved	Neostigmine	CN(C)C(=O)Oc1cc([N+](C)(C)C)ccc1
3076	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB01805	experimental	Monoisopropylphosphorylserine	OC(=O)[C@@H](N)COP(=O)(O)OC(C)C
3077	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB02166	experimental	Propidium	c1ccccc1-c(c(c23)cc(N)cc2)[n+](c4c3ccc(c4)N)CCC[N+](C)(CC)CC
3078	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB02226	experimental	3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium	c1c(N)ccc2c1c(-c3ccccc3)[n+](c(c24)cc(N)cc4)CCCCCCc5cn(nn5)CCNc6c(CCCC7)c7nc(c68)cccc8
3079	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB02343	experimental	3,6,9,12,15-Pentaoxaheptadecane	CCOCCOCCOCCOCCOCC
3080	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB02404	experimental	1-Deoxy-1-Thio-Heptaethylene Glycol	OCCOCCOCCOCCOCCOCCOCCS
3081	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB02673	experimental	(4aS,6R,8aS)-11-[8-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)octyl]-6-hydroxy-3-methoxy-5,6,9,10-tetrahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-11-ium	C1=C[C@H](O)C[C@@H]([C@@]123)Oc4c2c(ccc4OC)C=[N+](CC3)CCCCCCCCN(C5=O)C(=O)c(c56)cccc6
3082	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB02825	experimental	Methylphosphinate	CP([O-])=O
3083	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB02845	experimental	Methylphosphinic Acid	CP(=O)O
3084	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB03005	experimental	3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-5-Yl]Hexyl]-Phenanthridinium	c1c(N)ccc2c1c(-c3ccccc3)[n+](c(c24)cc(N)cc4)CCCCCCc5cnnn5CCNc6c(CCCC7)c7nc(c68)cccc8
3085	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB03128	approved; investigational	Acetylcholine	CC(=O)OCC[N+](C)(C)C
3086	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB03283	experimental	beta-L-fucose	C[C@@H]1O[C@H](O)[C@@H](O)[C@H](O)[C@@H]1O
3087	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB03348	investigational	Huperzine B	N1CCC[C@@H]([C@]123)[C@@H](C=C(C2)C)Cc4c3ccc(=O)[nH]4
3088	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB03359	experimental	M-(N,N,N-Trimethylammonio)-2,2,2-Trifluoro-1,1-Dihydroxyethylbenzene	C[N+](C)(C)c1cccc(c1)C(O)(O)C(F)(F)F
3089	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB03740	experimental	N-acetyl-alpha-D-glucosamine	CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O
3090	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
3091	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB04021	experimental	MF268	C[C@H]1CN(C[C@H](O1)C)CCCCCCCCNC=O
3092	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB04114	experimental	3-Chloro-9-Ethyl-6,7,8,9,10,11-Hexahydro-7,11-Methanocycloocta[B]Quinolin-12-Amine	CCC(C1)=C[C@@H](C2)Cc(c3[C@H]12)nc4c(c3N)ccc(Cl)c4
3093	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB04556	experimental	NAP-226-90	CN(C)[C@@H](C)c1cc(O)ccc1
3094	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB04614	experimental	(R)-tacrine(10)-hupyridone	c1cc(=O)[nH]c(c12)CCC[C@H]2NCCCCCCCCCCNc3c(CCCC4)c4nc(c35)cccc5
3095	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB04615	experimental	(S)-tacrine(10)-hupyridone	c1cc(=O)[nH]c(c12)CCC[C@@H]2NCCCCCCCCCCNc3c(CCCC4)c4nc(c35)cccc5
3096	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB04616	experimental	TACRINE(8)-4-AMINOQUINOLINE	c1cccc(c12)nccc2NCCCCCCCCNc3c(CCCC4)c4nc(c35)cccc5
3097	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB04617	experimental	(9S)-9-[(8-AMMONIOOCTYL)AMINO]-1,2,3,4,9,10-HEXAHYDROACRIDINIUM	[NH3+]CCCCCCCCNc1c(CCCC2)c2[nH+]c(c13)cccc3
3098	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB04859	investigational	Zanapezil	C1CCCNc(c12)cc(cc2)C(=O)CCC3CCN(CC3)Cc4ccccc4
3099	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB04864	approved; experimental	Huperzine A	C1C(C)=C[C@H](/C2=C\C)Cc(c3[C@@]12N)[nH]c(=O)cc3
3100	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB04892	investigational	Phenserine	C1CN(C)[C@@H]([C@@]12C)N(C)c3c2cc(cc3)OC(=O)Nc4ccccc4
3101	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB04924	investigational	Itopride	COc1ccc(cc1OC)C(=O)NCc2ccc(cc2)OCCN(C)C
3102	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB06525	investigational	Ganstigmine	CCc1ccccc1NC(=O)Oc(c2)ccc(c2[C@@]34C)N(C)[C@H]3ON(C)CC4
3103	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB07555	experimental	Hydroxy(oxo)(2-{(1S)-2,2,2-trifluoro-1-[2-(trimethylarsonio)ethoxy]ethyl}phenyl)ammonium	C[As+](C)(C)CCO[C@H](C(F)(F)F)c1ccccc1[N+](=O)O
3104	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB07701	experimental	1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE	COc(c1)c(OC)cc(c12)C[C@H](C2=O)CC3CCN(CC3)Cc4ccccc4
3105	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB07756	experimental	1-[3-({[(4-AMINO-5-FLUORO-2-METHYLQUINOLIN-3-YL)METHYL]THIO}METHYL)PHENYL]-2,2,2-TRIFLUOROETHANE-1,1-DIOL	c1ccc(F)c(c12)c(N)c(c(n2)C)CSCc3cc(C(O)(O)C(F)(F)F)ccc3
3106	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB07846	experimental	(3,4,8b-Trimethyl-3-oxido-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-3-ium-7-yl) N-(2-ethylphenyl)carbamate	CCc1ccccc1NC(=O)Oc(c2)ccc(c2C34C)N(C)C3[N+]([O-])(C)CC4
3107	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB08167	experimental; investigational	Methylthioninium	CN(C)c(cc1)cc(c12)[s+]c3c(n2)ccc(c3)N(C)C
3108	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB08357	experimental	Diethylene glycol diethyl ether	CCOCCOCCOCC
3109	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB08615	experimental	2-[4-(DIMETHYLAMINO)PHENYL]-6-HYDROXY-3-METHYL-1,3-BENZOTHIAZOL-3-IUM	CN(C)c1ccc(cc1)-c(s2)[n+](C)c(c23)ccc(c3)O
3110	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB08996	experimental; withdrawn	Dimetacrine	CN(C)CCCN1c(cccc2)c2C(C)(C)c(c13)cccc3
3111	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB13503	approved	Tyrothricin	 
3112	tr|O53453|O53453_M	P22303	81.29	424.0	563.0	DB14006	approved; nutraceutical	Choline salicylate	Oc1ccccc1C([O-])=O
3113	tr|O53317|O53317_M	Q9AIU0	90.87	8.0	197.0	DB03467	experimental	Naringenin	Oc1ccc(cc1)[C@@H](O2)CC(=O)c(c23)c(O)cc(c3)O
3114	tr|O53317|O53317_M	Q9AIU0	90.87	8.0	197.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
3115	tr|O53317|O53317_M	Q9AIU0	90.87	8.0	197.0	DB07810	experimental	Phloretin	Oc1ccc(cc1)CCC(=O)c2c(O)cc(O)cc2O
3116	tr|O53317|O53317_M	P9WMC1	80.29	6.0	173.0	DB02425	experimental	Hexadecyl Octanoate	CCCCCCCCCCCCCCCOC(=O)CCCCCCC
3117	tr|O53317|O53317_M	P9WMC1	80.29	6.0	173.0	DB08469	experimental	tert-butyl 4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine-1-carboxylate	CC(C)(C)OC(=O)N1CCC(CC1)c2nc(no2)-c3cccs3
3118	tr|O53317|O53317_M	P9WMC1	80.29	6.0	173.0	DB08470	experimental	3-(4-fluorophenyl)-5-phenyl-4H-1,2,4-triazole	Fc1ccc(cc1)-c2nnc([nH]2)-c3ccccc3
3119	tr|O53317|O53317_M	P9WMC1	80.29	6.0	173.0	DB08471	experimental	1-(thiophen-2-ylacetyl)-4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine	c1ccsc1CC(=O)N2CCC(CC2)c3nc(no3)-c4cccs4
3120	tr|O53317|O53317_M	P94548	88.46	8.0	192.0	DB03264	experimental	Dodecyl-Coa	CCCCCCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
3121	tr|O33340|O33340_M	O94788	101.1	55.0	515.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3122	tr|O33340|O33340_M	O94788	101.1	55.0	515.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
3123	tr|O33340|O33340_M	O94788	101.1	55.0	515.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
3124	tr|O33340|O33340_M	P47895	101.1	49.0	509.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3125	tr|O33340|O33340_M	P47895	101.1	49.0	509.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
3126	tr|O33340|O33340_M	P00352	101.1	38.0	498.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3127	tr|O33340|O33340_M	P00352	101.1	38.0	498.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
3128	tr|O33340|O33340_M	P00352	101.1	38.0	498.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
3129	tr|O33340|O33340_M	P00352	101.1	38.0	498.0	DB04447	experimental	1,4-Dithiothreitol	SC[C@H](O)[C@@H](O)CS
3130	tr|O33340|O33340_M	P05091	101.32	53.0	514.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3131	tr|O33340|O33340_M	P05091	101.32	53.0	514.0	DB00536	approved	Guanidine	NC(N)=N
3132	tr|O33340|O33340_M	P05091	101.32	53.0	514.0	DB00822	approved	Disulfiram	CCN(CC)C(=S)SSC(=S)N(CC)CC
3133	tr|O33340|O33340_M	P05091	101.32	53.0	514.0	DB02115	experimental	Daidzin	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)Oc(c2)ccc(c23)c(=O)c(co3)-c4ccc(O)cc4
3134	tr|O33340|O33340_M	P05091	101.32	53.0	514.0	DB04381	experimental	Crotonaldehyde	O=C/C=C/C
3135	tr|O33340|O33340_M	P30837	101.32	53.0	514.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3136	tr|O33340|O33340_M	P49189	101.32	28.0	489.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3137	tr|O33340|O33340_M	O75891	101.76	438.0	901.0	DB00116	nutraceutical	Tetrahydrofolic acid	Nc([nH]1)nc(=O)c(c12)NC(CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
3138	tr|O33340|O33340_M	P25553	99.34	25.0	477.0	DB03619	approved	Deoxycholic acid	C1C[C@@H](O)C[C@H]([C@]12C)CC[C@@H]3[C@@H]2C[C@H](O)[C@@]4(C)[C@H]3CC[C@@H]4[C@H](C)CCC(=O)O
3139	tr|O33340|O33340_M	P77674	99.78	19.0	473.0	DB04401	experimental	Betaine aldehyde	C[N+](C)(C)CC=O
3140	tr|O33340|O33340_M	P51649	100.44	74.0	531.0	DB00139	approved; nutraceutical	Succinic acid	OC(=O)CCC(=O)O
3141	tr|O33340|O33340_M	P51649	100.44	74.0	531.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3142	tr|O33340|O33340_M	P51649	100.44	74.0	531.0	DB00313	approved; investigational	Valproic acid	CCCC(C(=O)O)CCC
3143	tr|O33340|O33340_M	P51649	100.44	74.0	531.0	DB00534	approved; withdrawn	Chlormerodrin	Cl[Hg]CC(OC)CNC(=O)N
3144	tr|O33340|O33340_M	Q59931	99.56	21.0	474.0	DB02263	experimental	Glyceraldehyde-3-Phosphate	O=C[C@H](O)COP(=O)(O)O
3145	tr|O33340|O33340_M	Q59931	99.56	21.0	474.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3146	tr|O33340|O33340_M	P30838	93.85	3.0	430.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3147	tr|O33340|O33340_M	P83849	100.44	56.0	513.0	DB03564	experimental	(4r)-2-Methylpentane-2,4-Diol	C[C@H](O)CC(C)(C)O
3148	tr|O33340|O33340_M	P49419	101.32	67.0	528.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3149	tr|O33340|O33340_M	P49419	101.32	67.0	528.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
3150	tr|O33340|O33340_M	Q02252	100.66	58.0	516.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3151	tr|O33340|O33340_M	P51648	93.41	3.0	428.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3152	tr|O33340|O33340_M	P43353	92.97	7.0	430.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3153	tr|O33340|O33340_M	P09546	96.92	661.0	1102.0	DB03051	experimental	(S)-2-Tetrahydrofuroic acid	OC(=O)[C@H]1CCCO1
3154	tr|O33340|O33340_M	P09546	96.92	661.0	1102.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
3155	tr|O33340|O33340_M	P09546	96.92	661.0	1102.0	DB04398	approved; vet_approved	Lactic acid	CC(O)C(=O)O
3156	tr|O33340|O33340_M	P30038	101.32	86.0	547.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3157	tr|O33340|O33340_M	P48448	73.41	15.0	349.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3158	tr|O33340|O33340_M	P48448	73.41	15.0	349.0	DB09116	approved; withdrawn	Calcium carbimide	[N-]=C=[N-]
3159	tr|O33340|O33340_M	Q56694	94.07	24.0	452.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3160	tr|I6WX95|I6WX95_M	P49327	70.11	2144.0	2205.0	DB01034	experimental	Cerulenin	NC(=O)[C@@H]1O[C@@H]1C(=O)CC/C=C/C/C=C/C
3161	tr|I6WX95|I6WX95_M	P49327	70.11	2144.0	2205.0	DB01083	approved; investigational	Orlistat	CCCCCCCCCCC[C@H](OC(=O)[C@@H](NC=O)CC(C)C)C[C@@H]1OC(=O)[C@H]1CCCCCC
3162	tr|O86342|O86342_M	P9WMC1	93.69	21.0	214.0	DB02425	experimental	Hexadecyl Octanoate	CCCCCCCCCCCCCCCOC(=O)CCCCCCC
3163	tr|O86342|O86342_M	P9WMC1	93.69	21.0	214.0	DB08469	experimental	tert-butyl 4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine-1-carboxylate	CC(C)(C)OC(=O)N1CCC(CC1)c2nc(no2)-c3cccs3
3164	tr|O86342|O86342_M	P9WMC1	93.69	21.0	214.0	DB08470	experimental	3-(4-fluorophenyl)-5-phenyl-4H-1,2,4-triazole	Fc1ccc(cc1)-c2nnc([nH]2)-c3ccccc3
3165	tr|O86342|O86342_M	P9WMC1	93.69	21.0	214.0	DB08471	experimental	1-(thiophen-2-ylacetyl)-4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine	c1ccsc1CC(=O)N2CCC(CC2)c3nc(no3)-c4cccs4
3166	tr|P71891|P71891_M	P04181	96.13	261.0	435.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
3167	tr|P71891|P71891_M	P04181	96.13	261.0	435.0	DB00129	approved; nutraceutical	Ornithine	NCCC[C@H](N)C(=O)O
3168	tr|P71891|P71891_M	P04181	96.13	261.0	435.0	DB02054	experimental	Gabaculine	Nc1cccc(c1)C(=O)O
3169	tr|P71891|P71891_M	P04181	96.13	261.0	435.0	DB02821	experimental	Canaline	NOCC[C@H](N)C(=O)O
3170	tr|P71891|P71891_M	Q6LFH8	95.58	231.0	404.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
3171	tr|P71891|P71891_M	Q9BYV1	103.87	318.0	506.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
3172	tr|P71891|P71891_M	Q9BYV1	103.87	318.0	506.0	DB00119	approved; investigational; nutraceutical	Pyruvic acid	CC(=O)C(=O)O
3173	tr|P71891|P71891_M	Q9BYV1	103.87	318.0	506.0	DB00145	approved; nutraceutical; vet_approved	Glycine	NCC(=O)O
3174	tr|P71891|P71891_M	Q9BYV1	103.87	318.0	506.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
3175	tr|P71891|P71891_M	P22256	103.31	236.0	423.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
3176	tr|P71891|P71891_M	P22256	103.31	236.0	423.0	DB02783	experimental	4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate	Cc1ncc(COP(=O)(O)O)c(c1O)CNOCC(=O)O
3177	tr|P71891|P71891_M	P16932	104.42	240.0	429.0	DB02038	experimental	D-[3-hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl]-N,O-cycloserylamide	Cc1ncc(COP(=O)(O)O)c(c1O)CN[C@@H]2CONC2=O
3178	tr|P71891|P71891_M	P16932	104.42	240.0	429.0	DB02849	experimental	N-Pyridoxyl-1-Amino-Cyclopropanecarboxylic Acid-5-Monophosphate	Cc1ncc(COP(=O)(O)O)c(c1O)CNC2(CC2)C(=O)O
3179	tr|P71891|P71891_M	P16932	104.42	240.0	429.0	DB03787	experimental	(5-Hydroxy-6-methyl-4-{[(E)-(3-oxo-1,2-oxazolidin-4-ylidene)amino]methyl}-3-pyridinyl)methyl dihydrogen phosphate	Cc1ncc(COP(=O)(O)O)c(c1O)C/N=C2\CONC2=O
3180	tr|P71891|P71891_M	P16932	104.42	240.0	429.0	DB04241	experimental	N-Pyridoxyl-2-Methylalanine-5-Phosphate	Cc1ncc(COP(=O)(O)O)c(c1O)CNC(C)(C)C(=O)O
3181	tr|P71891|P71891_M	P12995	98.34	242.0	420.0	DB02274	experimental	7-Keto-8-Aminopelargonic Acid	C[C@H](N)C(=O)CCCCCC(=O)O
3182	tr|P71891|P71891_M	P12995	98.34	242.0	420.0	DB02725	experimental	2-Amino-4-(4-Amino-Cyclohexa-2,5-Dienyl)-Butyric Acid	OC(=O)[C@@H](N)CC[C@H]1C=CC(N)C=C1
3183	tr|P71891|P71891_M	P12995	98.34	242.0	420.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
3184	tr|P71891|P71891_M	P9WQ77	97.79	268.0	445.0	DB08071	experimental	(2S)-1-methyl-2-[(2S,4R)-2-methyl-4-phenylpentyl]piperidine	CN1CCCC[C@H]1C[C@@H](C)C[C@@H](C)c2ccccc2
3185	tr|P71891|P71891_M	P80404	95.58	324.0	497.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
3186	tr|P71891|P71891_M	P80404	95.58	324.0	497.0	DB00119	approved; investigational; nutraceutical	Pyruvic acid	CC(=O)C(=O)O
3187	tr|P71891|P71891_M	P80404	95.58	324.0	497.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
3188	tr|P71891|P71891_M	P80404	95.58	324.0	497.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
3189	tr|P71891|P71891_M	P80404	95.58	324.0	497.0	DB00780	approved	Phenelzine	NNCCc1ccccc1
3190	tr|P71891|P71891_M	P80404	95.58	324.0	497.0	DB01080	approved	Vigabatrin	C=CC(N)CCC(=O)O
3191	tr|P71891|P71891_M	P80404	95.58	324.0	497.0	DB01699	experimental	(4e)-4-Aminohex-4-Enoic Acid	C/C=C(/N)CCC(=O)O
3192	tr|P71891|P71891_M	P80404	95.58	324.0	497.0	DB04235	experimental	4-Amino Hexanoic Acid	CC[C@@H](N)CCC(=O)O
3193	tr|P71891|P71891_M	Q8IUZ5	105.52	244.0	435.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
3194	tr|P71891|P71891_M	Q8IUZ5	105.52	244.0	435.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
3195	tr|O53371|O53371_M	P07014	87.83	3.0	234.0	DB04631	experimental	Atpenin A5	ClC[C@H](Cl)[C@@H](C)C[C@H](C)C(=O)c1c(O)c(OC)c([nH]c1=O)OC
3196	tr|O53371|O53371_M	P07014	87.83	3.0	234.0	DB07671	experimental	2-[1-METHYLHEXYL]-4,6-DINITROPHENOL	CCCCCC(C)c1c(O)c(N(=O)=O)cc(c1)N(=O)=O
3197	tr|O53371|O53371_M	P07014	87.83	3.0	234.0	DB08690	experimental	Ubiquinone Q2	COC1=C(OC)C(=O)C(=C(C)C1=O)C/C=C(\C)CCC=C(C)C
3198	tr|O53371|O53371_M	P21912	88.59	38.0	271.0	DB04141	experimental	2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol	O[C@H]1[C@@H](O)[C@@H](CO)O[C@H]([C@@H]1O)OCCCCCC
3199	tr|O53371|O53371_M	P21912	88.59	38.0	271.0	DB08689	experimental	Ubiquinone Q1	COC1=C(OC)C(=O)C(=C(C)C1=O)CC=C(C)C
3200	tr|O53371|O53371_M	P0AC47	84.41	7.0	229.0	DB07490	experimental	2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL	Clc1ccc(cc1)[C@@H](C)c2cc([N+]([O-])=O)cc([N+]([O-])=O)c2O
3201	tr|O53371|O53371_M	P0AC47	84.41	7.0	229.0	DB07918	experimental	2-heptyl-4-hydroxyquinoline N-oxide	CCCCCCCc(cc1O)[n+]([O-])c(c12)cccc2
3202	tr|O53371|O53371_M	P17596	88.21	4.0	236.0	DB07669	experimental	2,3-Dimethyl-1,4-naphthoquinone	O=C1C(C)=C(C)C(=O)c(c12)cccc2
3203	tr|O53676|O53676_M	Q05599	102.3	1.0	179.0	DB01972	experimental	Guanosine-5'-Monophosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
3204	tr|I6Y4V6|I6Y4V6_M	P22102	95.05	432.0	778.0	DB00642	approved; investigational	Pemetrexed	Nc([nH]1)nc(=O)c(c12)c(c[nH]2)CCc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
3205	tr|I6Y4V6|I6Y4V6_M	P22102	95.05	432.0	778.0	DB02236	experimental	Glycinamide Ribonucleotide	NCC(=O)NC1O[C@@H]([C@@H](O)[C@H]1O)COP(=O)(O)O
3206	tr|I6Y4V6|I6Y4V6_M	P22102	95.05	432.0	778.0	DB03546	experimental	N-({4-[(1R)-4-[(2R,4S,5S)-2,4-diamino-6-oxohexahydropyrimidin-5-yl]-1-(2,2,2-trifluoro-1,1-dihydroxyethyl)butyl]phenyl}carbonyl)-L-glutamic acid	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)[C@H](C(O)(O)C(F)(F)F)CCCC2C(O)=N[C@H](N)N[C@@H]2N
3207	tr|I6Y4E8|I6Y4E8_M	P30084	95.44	35.0	286.0	DB02563	experimental	Hexanoyl-CoA	CCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
3208	tr|I6Y4E8|I6Y4E8_M	P30084	95.44	35.0	286.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
3209	tr|I6Y4E8|I6Y4E8_M	P30084	95.44	35.0	286.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
3210	tr|I6Y4E8|I6Y4E8_M	P30084	95.44	35.0	286.0	DB04117	experimental	4-(N,N-Dimethylamino)cinnamoyl-CoA	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)/C=C/c4ccc(cc4)N(C)C
3211	tr|I6Y4E8|I6Y4E8_M	P30084	95.44	35.0	286.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
3212	tr|I6Y4E8|I6Y4E8_M	P9WNP5	101.9	44.0	312.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
3213	tr|I6Y4E8|I6Y4E8_M	P9WNP5	101.9	44.0	312.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
3214	tr|I6Y4E8|I6Y4E8_M	P52045	95.06	7.0	257.0	DB03117	experimental	2-carboxypropyl-coenzyme A	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC[C@H](C)C(=O)O
3215	tr|I6Y4E8|I6Y4E8_M	O68600	94.68	10.0	259.0	DB01652	experimental	4-hydroxybenzoyl-CoA	Oc1ccc(cc1)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2OP(=O)(O)O)n3cnc(c34)c(N)ncn4
3216	tr|I6Y4E8|I6Y4E8_M	O75521	80.61	143.0	355.0	DB08231	experimental	Myristic acid	CCCCCCCCCCCCCC(=O)O
3217	tr|I6Y4E8|I6Y4E8_M	Q93TU6	87.07	18.0	247.0	DB02906	experimental	(2s,4s)-Alpha-Campholinic Acid	CC1(C)[C@H](C)C(=O)C[C@H]1CC(O)O
3218	tr|I6Y4E8|I6Y4E8_M	P40939	84.03	46.0	267.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3219	tr|I6Y4E8|I6Y4E8_M	P28793	85.93	26.0	252.0	DB08249	experimental	3,6,9,12,15-PENTAOXATRICOSAN-1-OL	CCCCCCCCOCCOCCOCCOCCOCCO
3220	tr|I6Y4E8|I6Y4E8_M	Q08426	71.86	9.0	198.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3221	tr|I6Y4E8|I6Y4E8_M	Q6NVY1	75.67	38.0	237.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
3222	tr|I6Y4E8|I6Y4E8_M	P42126	84.03	55.0	276.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
3223	tr|I6Y4E8|I6Y4E8_M	P42126	84.03	55.0	276.0	DB03127	experimental	Benzamidine	NC(=[NH2+])c1ccccc1
3224	tr|I6YGL1|I6YGL1_M	O07015	99.22	10.0	265.0	DB02175	experimental	Malonic acid	OC(=O)CC(=O)O
3225	tr|I6YGL1|I6YGL1_M	O07015	99.22	10.0	265.0	DB03297	experimental	Benzylsulfonic acid	OS(=O)(=O)Cc1ccccc1
3226	tr|I6YGL1|I6YGL1_M	O07015	99.22	10.0	265.0	DB04349	experimental	(S)-propane-1,2-diol	C[C@H](O)CO
3227	tr|I6YGL1|I6YGL1_M	P96965	97.67	19.0	270.0	DB02406	experimental	N-Valeric Acid	CCCCC(=O)O
3228	tr|I6YGL1|I6YGL1_M	P96965	97.67	19.0	270.0	DB02531	experimental	Isobutyric acid	CC(C)C(=O)O
3229	tr|I6YGL1|I6YGL1_M	P96965	97.67	19.0	270.0	DB03568	experimental; investigational	Butyric Acid	CCCC(=O)O
3230	tr|I6YGL1|I6YGL1_M	P96965	97.67	19.0	270.0	DB03741	experimental	2-Methylbutanoic Acid	CC[C@@H](C)C(=O)O
3231	tr|I6YGL1|I6YGL1_M	P96965	97.67	19.0	270.0	DB03750	experimental	Isovaleric Acid	CC(C)CC(=O)O
3232	tr|I6YGL1|I6YGL1_M	P96965	97.67	19.0	270.0	DB03766	approved; vet_approved	Propanoic acid	CCC(=O)O
3233	tr|I6YGL1|I6YGL1_M	P96965	97.67	19.0	270.0	DB03793	approved; investigational	Benzoic acid	OC(=O)c1ccccc1
3234	tr|I6YGL1|I6YGL1_M	P47229	101.17	24.0	284.0	DB07510	experimental	3-fluoro-6-(4-fluorophenyl)-2-hydroxy-6-oxohexa-2,4-dienoic acid	OC(=O)/C(O)=C(/F)\C=C\C(=O)c1ccc(F)cc1
3235	tr|I6YGL1|I6YGL1_M	P47229	101.17	24.0	284.0	DB07516	experimental	(2Z,4E)-3-chloro-2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoic acid	OC(=O)/C(O)=C(/Cl)\C=C\C(=O)c1ccccc1
3236	tr|I6YGL1|I6YGL1_M	P47229	101.17	24.0	284.0	DB07911	experimental	(3E)-2,6-DIOXO-6-PHENYLHEX-3-ENOATE	[O-]C(=O)C(=O)/C=C/CC(=O)c1ccccc1
3237	tr|I6YGL1|I6YGL1_M	P47229	101.17	24.0	284.0	DB07915	experimental	(2E,4E)-2-Hydroxy-6-oxo-6-phenyl-2,4-hexadienoic acid	OC(=O)/C(O)=C\C=C\C(=O)c1ccccc1
3238	tr|I6YGL1|I6YGL1_M	O31168	102.33	14.0	277.0	DB03793	approved; investigational	Benzoic acid	OC(=O)c1ccccc1
3240	tr|I6YGL1|I6YGL1_M	P51698	106.23	22.0	295.0	DB01701	experimental	1,2-Dichloro-Propane	C[C@@H](Cl)CCl
3241	tr|I6YGL1|I6YGL1_M	P51698	106.23	22.0	295.0	DB02145	experimental	Butyl alcohol	CCCCO
3242	tr|I6YGL1|I6YGL1_M	P51698	106.23	22.0	295.0	DB02302	experimental	Symmetric dimethylarginine	CN/C(=N/C)NCCC[C@H](N)C(=O)O
3243	tr|I6YGL1|I6YGL1_M	P51698	106.23	22.0	295.0	DB02774	experimental	1,3-Propanediol	OCCCO
3244	tr|I6YGL1|I6YGL1_M	P51698	106.23	22.0	295.0	DB03335	experimental	(+)-1-bromo-2-propanol	C[C@H](O)CBr
3245	tr|I6YGL1|I6YGL1_M	P51698	106.23	22.0	295.0	DB03733	experimental	Ethylene Dichloride	ClCCCl
3246	tr|I6YGL1|I6YGL1_M	P51698	106.23	22.0	295.0	DB04320	experimental	2-Bromo-2-Propene-1-Ol	OCC(Br)=C
3247	tr|I6YGL1|I6YGL1_M	Q86WA6	93.39	50.0	290.0	DB03380	experimental	L-tyrosinamide	NC(=O)[C@@H](N)Cc1ccc(O)cc1
3248	tr|I6YGL1|I6YGL1_M	O07732	91.83	20.0	256.0	DB02596	experimental	alpha,beta-Methyleneadenosine 5'-triphosphate	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)CP(=O)(O)OP(=O)(O)O
3249	tr|I6YGL1|I6YGL1_M	P13001	96.11	3.0	250.0	DB03688	experimental	Hydracrylic acid	OCCC(=O)O
3250	tr|I6YGL1|I6YGL1_M	Q54528	103.5	12.0	278.0	DB01806	experimental	10-decarboxymethylaclacinomycin A	c1ccc(O)c(c12)C(=O)c3c(C2=O)cc4c(c3O)[C@H](C[C@](C4)(O)CC)O[C@H]5C[C@H](N(C)C)[C@@H]([C@@H](O5)C)O[C@@H]6C[C@H](O)[C@H]([C@@H](O6)C)O[C@H]7CCC(=O)[C@H](O7)C
3251	tr|I6YGL1|I6YGL1_M	Q54528	103.5	12.0	278.0	DB04131	experimental	10-(4-Dimethylamino-5-Hydroxy-6-Methyl-Tetrahydro-Pyran-2-Yloxy)-8-Ethyl-1,8,11-Trihydroxy-7,8,9,10-Tetrahydro-Naphthacene-5,12-Dione	O[C@H]1[C@@H](N(C)C)C[C@@H](O[C@H]1C)O[C@H]2C[C@](O)(CC)Cc(c23)cc4c(c3O)C(=O)c5c(C4=O)cccc5O
3252	tr|A0A0N7EHL6|A0A0	P9WIE5	98.58	1.0	210.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
3253	tr|A0A0N7EHL6|A0A0	P9WIE5	98.58	1.0	210.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
3254	tr|A0A0N7EHL6|A0A0	Q939D2	83.02	13.0	189.0	DB08638	experimental	1-hydroperoxy-L-tryptophan	c1cccc(c12)n(OO)cc2C[C@H](N)C(=O)O
3255	tr|A0A0N6WYR5|A0A0	P9WIE5	99.86	1.0	740.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
3256	tr|A0A0N6WYR5|A0A0	P9WIE5	99.86	1.0	740.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
3257	tr|A0A0N6WYR5|A0A0	Q939D2	96.49	13.0	727.0	DB08638	experimental	1-hydroperoxy-L-tryptophan	c1cccc(c12)n(OO)cc2C[C@H](N)C(=O)O
3258	tr|A0A0N9DS42|A0A0	P9WIE5	99.86	1.0	740.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
3259	tr|A0A0N9DS42|A0A0	P9WIE5	99.86	1.0	740.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
3260	tr|A0A0N9DS42|A0A0	Q939D2	96.49	13.0	727.0	DB08638	experimental	1-hydroperoxy-L-tryptophan	c1cccc(c12)n(OO)cc2C[C@H](N)C(=O)O
3261	tr|A0A0N9DRZ6|A0A0	P9WIE5	99.86	1.0	740.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
3262	tr|A0A0N9DRZ6|A0A0	P9WIE5	99.86	1.0	740.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
3263	tr|A0A0N9DRZ6|A0A0	Q939D2	96.49	13.0	727.0	DB08638	experimental	1-hydroperoxy-L-tryptophan	c1cccc(c12)n(OO)cc2C[C@H](N)C(=O)O
3264	tr|M4PLX9|M4PLX9_M	P9WIE5	99.25	272.0	405.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
3265	tr|M4PLX9|M4PLX9_M	P9WIE5	99.25	272.0	405.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
3266	tr|M4PLX9|M4PLX9_M	Q939D2	98.51	261.0	393.0	DB08638	experimental	1-hydroperoxy-L-tryptophan	c1cccc(c12)n(OO)cc2C[C@H](N)C(=O)O
3267	tr|A0A0N9DS32|A0A0	P9WIE5	90.84	1.0	378.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
3268	tr|A0A0N9DS32|A0A0	P9WIE5	90.84	1.0	378.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
3269	tr|A0A0N9DS32|A0A0	Q939D2	83.86	13.0	361.0	DB08638	experimental	1-hydroperoxy-L-tryptophan	c1cccc(c12)n(OO)cc2C[C@H](N)C(=O)O
3270	tr|A0A0N9DS80|A0A0	P9WIE5	99.86	1.0	740.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
3271	tr|A0A0N9DS80|A0A0	P9WIE5	99.86	1.0	740.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
3272	tr|A0A0N9DS80|A0A0	Q939D2	96.49	13.0	727.0	DB08638	experimental	1-hydroperoxy-L-tryptophan	c1cccc(c12)n(OO)cc2C[C@H](N)C(=O)O
3273	tr|A0A0N6WYR3|A0A0	P9WIE5	99.86	1.0	740.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
3274	tr|A0A0N6WYR3|A0A0	P9WIE5	99.86	1.0	740.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
3275	tr|A0A0N6WYR3|A0A0	Q939D2	96.49	13.0	727.0	DB08638	experimental	1-hydroperoxy-L-tryptophan	c1cccc(c12)n(OO)cc2C[C@H](N)C(=O)O
3276	tr|G0ZF34|G0ZF34_M	P0A8V2	98.29	477.0	592.0	DB00615	approved; investigational	Rifabutin	CC(C)CN(CC1)CCC12N=C3c4c5c6c(C)c(O)c4C(=O)C(=C3N2)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(=O)C)[C@H](C)[C@@H](OC)/C=C/O[C@](O6)(C)C5=O
3277	tr|G0ZF34|G0ZF34_M	P0A8V2	98.29	477.0	592.0	DB01045	approved	Rifampicin	C[C@@]12O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(=O)C)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)Nc3c(/C=N/N4CCN(C)CC4)c(O)c5c(C1=O)c(O2)c(C)c(O)c5c3O
3278	tr|G0ZF34|G0ZF34_M	P0A8V2	98.29	477.0	592.0	DB01220	approved; investigational	Rifaximin	C[C@]12O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(=O)C)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)Nc3c4c(nc5n4ccc(c5)C)c6c(c3O)c(O)c(C)c(O1)c6C2=O
3279	tr|G0ZF34|G0ZF34_M	P0A8V2	98.29	477.0	592.0	DB04934	investigational	Rifalazil	C[C@]12O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(=O)C)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)Nc3c4c(c5c(c3=O)c(O)c(C)c(O1)c5C2=O)nc6c(o4)cc(cc6O)N7CCN(CC7)CC(C)C
3280	tr|G0ZF34|G0ZF34_M	P0A8V2	98.29	477.0	592.0	DB11753	approved; investigational	Rifamycin	C[C@@]12O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(=O)C)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)Nc3c(O)c4c(c(c3)O)c(C1=O)c(O2)c(C)c4O
3281	tr|G0ZF34|G0ZF34_M	Q8RQE9	98.29	357.0	472.0	DB04788	experimental	Tagetitoxin	OP(=O)(O)O[C@@H]([C@@]12C(=O)O)[C@@H](N)[C@@H](OC(=O)C)[C@@H](O2)[C@@](O)(SC1)C(=O)N
3282	tr|G0ZF34|G0ZF34_M	Q8RQE9	98.29	357.0	472.0	DB08226	experimental	Myxopyronin B	CCCC/C(C)=C/C=C(\C)C(=O)c1c(O)cc(oc1=O)CCC/C=C/NC(=O)OC
3283	tr|G0ZF34|G0ZF34_M	Q8RQE9	98.29	357.0	472.0	DB08266	experimental	Methyl [(1E,5R)-5-{3-[(2E,4E)-2,5-dimethyl-2,4-octadienoyl]-2,4-dioxo-3,4-dihydro-2H-pyran-6-yl}hexylidene]carbamate	COC(=O)/N=C/CCC[C@@H](C)C1=CC(=O)C(C(=O)O1)C(=O)/C(C)=C/C=C(\C)CCC
3284	tr|G0ZF34|G0ZF34_M	Q9Z4N6	70.09	104.0	186.0	DB01942	experimental; investigational	Formic acid	OC=O
3285	tr|A0A0N9DS52|A0A0	P9WIE5	99.86	1.0	740.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
3286	tr|A0A0N9DS52|A0A0	P9WIE5	99.86	1.0	740.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
3287	tr|A0A0N9DS52|A0A0	Q939D2	96.49	13.0	727.0	DB08638	experimental	1-hydroperoxy-L-tryptophan	c1cccc(c12)n(OO)cc2C[C@H](N)C(=O)O
3288	tr|B5AFK3|B5AFK3_M	P08373	88.89	3.0	331.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
3289	tr|B5AFK3|B5AFK3_M	P08373	88.89	3.0	331.0	DB07296	experimental	(5Z)-3-(4-CHLOROPHENYL)-4-HYDROXY-5-(1-NAPHTHYLMETHYLENE)FURAN-2(5H)-ONE	Clc1ccc(cc1)C2=C(O)/C(OC2=O)=C/c3cccc(c34)cccc4
3290	tr|A0A0N9DS03|A0A0	P9WIE5	99.83	1.0	598.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
3291	tr|A0A0N9DS03|A0A0	P9WIE5	99.83	1.0	598.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
3292	tr|A0A0N9DS03|A0A0	Q939D2	95.65	13.0	585.0	DB08638	experimental	1-hydroperoxy-L-tryptophan	c1cccc(c12)n(OO)cc2C[C@H](N)C(=O)O
3293	tr|A0A0N9DRZ0|A0A0	P9WIE5	99.83	1.0	598.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
3294	tr|A0A0N9DRZ0|A0A0	P9WIE5	99.83	1.0	598.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
3295	tr|A0A0N9DRZ0|A0A0	Q939D2	95.65	13.0	585.0	DB08638	experimental	1-hydroperoxy-L-tryptophan	c1cccc(c12)n(OO)cc2C[C@H](N)C(=O)O
3296	tr|A0A0N9DS30|A0A0	P9WIE5	98.75	1.0	80.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
3297	tr|A0A0N9DS30|A0A0	P9WIE5	98.75	1.0	80.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
3298	sp|P9WFT3|SYW_MYCT	P00953	95.54	2.0	323.0	DB00150	approved; nutraceutical; withdrawn	Tryptophan	OC(=O)[C@@H](N)Cc1c[nH]c(c12)cccc2
3299	sp|P9WFT3|SYW_MYCT	P00953	95.54	2.0	323.0	DB01831	experimental	Tryptophanyl-5'amp	c1cccc(c12)[nH]cc2C[C@H](N)C(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3300	sp|P9WFT3|SYW_MYCT	P00953	95.54	2.0	323.0	DB04537	experimental	Tryptophanamide	NC(=O)[C@@H](N)Cc1c[nH]c(c12)cccc2
3301	sp|P9WFT3|SYW_MYCT	Q9UGM6	97.32	33.0	360.0	DB00150	approved; nutraceutical; withdrawn	Tryptophan	OC(=O)[C@@H](N)Cc1c[nH]c(c12)cccc2
3302	sp|P9WFT3|SYW_MYCT	Q9RVD6	97.62	18.0	346.0	DB02959	approved; investigational; nutraceutical	Oxitriptan	OC(=O)[C@@H](N)Cc1c[nH]c(c12)ccc(c2)O
3303	sp|P9WFT3|SYW_MYCT	Q5UPJ7	86.31	41.0	331.0	DB03978	experimental	Tyrosinal	O=C[C@@H](N)Cc1ccc(O)cc1
3304	sp|P9WFT3|SYW_MYCT	P23381	88.39	158.0	455.0	DB00150	approved; nutraceutical; withdrawn	Tryptophan	OC(=O)[C@@H](N)Cc1c[nH]c(c12)cccc2
3305	sp|P9WFT3|SYW_MYCT	P23381	88.39	158.0	455.0	DB01831	experimental	Tryptophanyl-5'amp	c1cccc(c12)[nH]cc2C[C@H](N)C(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3306	sp|P9WFT3|SYW_MYCT	P23381	88.39	158.0	455.0	DB04537	experimental	Tryptophanamide	NC(=O)[C@@H](N)Cc1c[nH]c(c12)cccc2
3307	sp|P9WFT3|SYW_MYCT	P54577	87.2	37.0	330.0	DB00135	approved; investigational; nutraceutical	Tyrosine	OC(=O)[C@@H](N)Cc1ccc(O)cc1
3308	sp|P9WFT3|SYW_MYCT	P54577	87.2	37.0	330.0	DB01766	experimental	Beta-(2-Naphthyl)-Alanine	OC(=O)[C@@H](N)Cc(c1)ccc(c12)cccc2
3309	sp|P9WFT3|SYW_MYCT	P54577	87.2	37.0	330.0	DB02709	investigational	Resveratrol	Oc1ccc(cc1)/C=C/c2cc(O)cc(O)c2
3310	sp|P9WFT3|SYW_MYCT	P54577	87.2	37.0	330.0	DB03978	experimental	Tyrosinal	O=C[C@@H](N)Cc1ccc(O)cc1
3311	sp|P9WFT3|SYW_MYCT	P54577	87.2	37.0	330.0	DB07205	experimental	N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(ncn3)NCCC(C)C
3312	sp|P9WFT3|SYW_MYCT	P54577	87.2	37.0	330.0	DB08371	experimental	p-Benzoyl-L-phenylalanine	OC(=O)[C@@H](N)Cc1ccc(cc1)C(=O)c2ccccc2
3313	sp|P9WFT3|SYW_MYCT	P54577	87.2	37.0	330.0	DB08617	experimental	4-(2,2,2-TRIFLUOROETHYL)-L-PHENYLALANINE	OC(=O)[C@@H](N)Cc1ccc(CC(F)(F)F)cc1
3314	sp|P9WMD1|Y1556_MY	P9WMC1	72.77	14.0	161.0	DB02425	experimental	Hexadecyl Octanoate	CCCCCCCCCCCCCCCOC(=O)CCCCCCC
3315	sp|P9WMD1|Y1556_MY	P9WMC1	72.77	14.0	161.0	DB08469	experimental	tert-butyl 4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine-1-carboxylate	CC(C)(C)OC(=O)N1CCC(CC1)c2nc(no2)-c3cccs3
3316	sp|P9WMD1|Y1556_MY	P9WMC1	72.77	14.0	161.0	DB08470	experimental	3-(4-fluorophenyl)-5-phenyl-4H-1,2,4-triazole	Fc1ccc(cc1)-c2nnc([nH]2)-c3ccccc3
3317	sp|P9WMD1|Y1556_MY	P9WMC1	72.77	14.0	161.0	DB08471	experimental	1-(thiophen-2-ylacetyl)-4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine	c1ccsc1CC(=O)N2CCC(CC2)c3nc(no3)-c4cccs4
3318	sp|P9WJJ1|Y1812_MY	P37062	77.75	2.0	313.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
3319	sp|P9WJJ1|Y1812_MY	P37062	77.75	2.0	313.0	DB03382	experimental	S-oxy-L-cysteine	OC(=O)[C@@H](N)CS=O
3320	sp|P9WJJ1|Y1812_MY	B7JBP8	75.75	1.0	304.0	DB07640	experimental	2-decyl-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione	CCCCCCCCCCC1=C(C)C(=O)C(OC)=C(C1=O)OC
3321	sp|P9WJJ1|Y1812_MY	P16640	76.0	6.0	310.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
3322	sp|P9WJJ1|Y1812_MY	P0A9P4	70.5	8.0	290.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
3323	sp|P9WH11|RMLC_MYC	P9WH11	99.5	1.0	202.0	DB04530	experimental	S,S-(2-Hydroxyethyl)Thiocysteine	OC(=O)[C@@H](N)CSSCCO
3324	sp|P9WH11|RMLC_MYC	O52806	95.54	1.0	194.0	DB01643	experimental	Thymidine monophosphate	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)O
3325	sp|P9WH11|RMLC_MYC	Q9HU21	87.13	1.0	177.0	DB01694	experimental	D-tartaric acid	OC(=O)[C@@H](O)[C@H](O)C(=O)O
3326	sp|P9WH11|RMLC_MYC	P26394	85.64	6.0	179.0	DB02549	experimental	3'-O-Acetylthymidine-5'-diphosphate	O=c1[nH]c(=O)c(C)cn1[C@H]2C[C@H](OC(=O)C)[C@H](O2)COP(=O)(O)OP(=O)(O)O
3327	sp|P9WH11|RMLC_MYC	Q8GIQ0	85.64	17.0	190.0	DB03161	experimental	Thymidine-5'-diphospho-beta-D-xylose	O=c1[nH]c(=O)c(C)cn1[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3OC[C@@H](O)[C@H](O)[C@H]3O
3328	sp|P9WH11|RMLC_MYC	Q8GIQ0	85.64	17.0	190.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
3329	sp|P9WGY1|RRF_MYCT	P0A805	98.92	1.0	184.0	DB04082	experimental	Decyloxy-Methanol	CCCCCCCCCCOCO
3330	sp|P9WGY1|RRF_MYCT	P0A808	98.92	1.0	184.0	DB04082	experimental	Decyloxy-Methanol	CCCCCCCCCCOCO
3331	sp|P9WH25|RS9_MYCT	P80374	82.12	4.0	128.0	DB08185	experimental	2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(nc(n3)SC)NCCC(C)C
3332	sp|P9WH25|RS9_MYCT	P62669	82.12	4.0	128.0	DB08185	experimental	2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(nc(n3)SC)NCCC(C)C
3333	sp|P9WH25|RS9_MYCT	P0A7X3	84.11	3.0	130.0	DB00453	experimental	Clomocycline	OCNC(=O)C(C1=O)=C(O)[C@@H](N(C)C)[C@@H]([C@@]12O)C[C@H]3C(=C2O)C(=O)c4c([C@@]3(C)O)c(Cl)ccc4O
3334	sp|P9WH25|RS9_MYCT	P0A7X3	84.11	3.0	130.0	DB00560	approved	Tigecycline	O=C1C(C(=O)N)=C(O)[C@@H](N(C)C)[C@@H]([C@@]12O)C[C@H]3C(=C2O)C(=O)c4c(C3)c(N(C)C)cc(c4O)NC(=O)CNC(C)(C)C
3335	sp|P9WH25|RS9_MYCT	P0A7X3	84.11	3.0	130.0	DB00595	approved; investigational; vet_approved	Oxytetracycline	O=C1C(C(=O)N)=C(O)[C@@H](N(C)C)[C@@H]([C@@]12O)[C@@H](O)[C@H]3C(=C2O)C(=O)c4c([C@@]3(C)O)cccc4O
3336	sp|P9WH25|RS9_MYCT	P0A7X3	84.11	3.0	130.0	DB01017	approved; investigational	Minocycline	O=C1C(C(=O)N)=C(O)[C@@H](N(C)C)[C@@H]([C@@]12O)C[C@H]3C(=C2O)C(=O)c4c(C3)c(N(C)C)ccc4O
3337	sp|P9WH25|RS9_MYCT	P0A7X3	84.11	3.0	130.0	DB01301	approved	Rolitetracycline	C1CCCN1CNC(=O)C(C2=O)=C(O)[C@@H](N(C)C)[C@@H]([C@@]23O)C[C@H]4C(=C3O)C(=O)c5c([C@@]4(C)O)cccc5O
3338	sp|P9WFU9|SYK1_MYC	Q15046	100.4	69.0	576.0	DB00123	approved; nutraceutical	L-Lysine	NCCCC[C@H](N)C(=O)O
3339	sp|P9WFU9|SYK1_MYC	P14868	89.5	44.0	496.0	DB00128	approved; nutraceutical	Aspartic acid	OC(=O)[C@@H](N)CC(=O)O
3340	sp|P9WFU9|SYK1_MYC	Q96I59	87.52	32.0	474.0	DB00174	approved; investigational; nutraceutical	Asparagine	OC(=O)[C@@H](N)CC(=O)N
3341	sp|P9WFU9|SYK1_MYC	O43776	82.77	124.0	542.0	DB00174	approved; investigational; nutraceutical	Asparagine	OC(=O)[C@@H](N)CC(=O)N
3342	sp|P9WFT1|SYY_MYCT	P0AGJ9	97.88	3.0	418.0	DB01758	experimental	3-Iodo-Tyrosine	OC(=O)[C@@H](N)Cc1ccc(O)c(I)c1
3343	sp|P9WFT1|SYY_MYCT	P0AGJ9	97.88	3.0	418.0	DB03325	experimental	Tyrosyladenylate	Oc1ccc(cc1)C[C@H](N)C(=O)NS(=O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3cnc(c34)c(N)ncn4
3344	sp|P9WFT1|SYY_MYCT	Q9Y2Z4	95.99	63.0	470.0	DB00135	approved; investigational; nutraceutical	Tyrosine	OC(=O)[C@@H](N)Cc1ccc(O)cc1
3345	sp|P9WFT1|SYY_MYCT	P83453	86.56	14.0	381.0	DB03978	experimental	Tyrosinal	O=C[C@@H](N)Cc1ccc(O)cc1
3346	sp|P9WP51|Y1077_MY	P35520	95.04	75.0	516.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
3347	sp|P9WP51|Y1077_MY	P35520	95.04	75.0	516.0	DB00118	approved; investigational; nutraceutical	Ademetionine	[O-]C(=O)[C@@H](N)CC[S+](C)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
3348	sp|P9WP51|Y1077_MY	P35520	95.04	75.0	516.0	DB00133	investigational; nutraceutical	Serine	OC(=O)[C@@H](N)CO
3349	sp|P9WP51|Y1077_MY	P35520	95.04	75.0	516.0	DB00151	approved; nutraceutical	Cysteine	OC(=O)[C@@H](N)CS
3350	sp|O07737|Y1895_MY	P07327	90.36	26.0	373.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3351	sp|O07737|Y1895_MY	P07327	90.36	26.0	373.0	DB01213	approved; vet_approved	Fomepizole	Cc1c[nH]nc1
3352	sp|O07737|Y1895_MY	P07327	90.36	26.0	373.0	DB02721	experimental	4-Iodopyrazole	Ic1c[nH]nc1
3353	sp|O07737|Y1895_MY	P07327	90.36	26.0	373.0	DB04065	experimental	N-Cyclopentyl-N-Cyclobutylformamide	C1CCC1N(C=O)C2CCCC2
3354	sp|O07737|Y1895_MY	P00325	90.36	26.0	373.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3355	sp|O07737|Y1895_MY	P00325	90.36	26.0	373.0	DB01213	approved; vet_approved	Fomepizole	Cc1c[nH]nc1
3356	sp|O07737|Y1895_MY	P00325	90.36	26.0	373.0	DB02481	experimental	N-Benzylformamide	O=CNCc1ccccc1
3357	sp|O07737|Y1895_MY	P00325	90.36	26.0	373.0	DB02721	experimental	4-Iodopyrazole	Ic1c[nH]nc1
3358	sp|O07737|Y1895_MY	P00325	90.36	26.0	373.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3359	sp|O07737|Y1895_MY	P00325	90.36	26.0	373.0	DB03703	experimental	Cyclohexanol	OC1CCCCC1
3360	sp|O07737|Y1895_MY	P00325	90.36	26.0	373.0	DB04105	experimental	N-Heptylformamide	CCCCCCCNC=O
3361	sp|O07737|Y1895_MY	P00325	90.36	26.0	373.0	DB09462	approved; investigational	Glycerin	OCC(O)CO
3362	sp|O07737|Y1895_MY	P00326	90.36	26.0	373.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3363	sp|O07737|Y1895_MY	P00326	90.36	26.0	373.0	DB01213	approved; vet_approved	Fomepizole	Cc1c[nH]nc1
3364	sp|O07737|Y1895_MY	P00326	90.36	26.0	373.0	DB01711	experimental	2,3,4,5,6-Pentafluorobenzyl Alcohol	OCc1c(F)c(F)c(F)c(F)c1F
3365	sp|O07737|Y1895_MY	P00326	90.36	26.0	373.0	DB02131	experimental	N-1-methylheptylformamide	O=CN[C@H](C)CCCCCC
3366	sp|O07737|Y1895_MY	P00326	90.36	26.0	373.0	DB02249	experimental	2-Ethoxyethanol	CCOCCO
3367	sp|O07737|Y1895_MY	P00326	90.36	26.0	373.0	DB02659	approved	Cholic Acid	OC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](C[C@@H]2O)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
3368	sp|O07737|Y1895_MY	P00326	90.36	26.0	373.0	DB02721	experimental	4-Iodopyrazole	Ic1c[nH]nc1
3369	sp|O07737|Y1895_MY	P00326	90.36	26.0	373.0	DB02757	experimental	Pyrazole	[nH]1cccn1
3370	sp|O07737|Y1895_MY	P00326	90.36	26.0	373.0	DB02822	experimental	Para-Bromobenzyl Alcohol	OCc1ccc(Br)cc1
3371	sp|O07737|Y1895_MY	P00326	90.36	26.0	373.0	DB02871	experimental	3-Butylthiolane 1-Oxide	O=[S@@]1C[C@H](CC1)CCCC
3372	sp|O07737|Y1895_MY	P00326	90.36	26.0	373.0	DB03020	experimental	5-beta-D-ribofuranosylnicotinamide adenine dinucleotide	NC(=O)c1c[nH+]cc(c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3373	sp|O07737|Y1895_MY	P00326	90.36	26.0	373.0	DB03061	experimental	(R)-N-(1-Methyl-Hexyl)-Formamide	CCCCC[C@H](C)NC=O
3374	sp|O07737|Y1895_MY	P00326	90.36	26.0	373.0	DB03226	experimental	Trifluoroethanol	OCC(F)(F)F
3375	sp|O07737|Y1895_MY	P00326	90.36	26.0	373.0	DB03559	experimental	Cyclohexylformamide	O=CNC1CCCCC1
3376	sp|O07737|Y1895_MY	P00326	90.36	26.0	373.0	DB04071	experimental	Cpad	NC(=O)c1nc(ccc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3377	sp|O07737|Y1895_MY	P00326	90.36	26.0	373.0	DB04113	experimental	N-Formylpiperidine	O=CN1CCCCC1
3378	sp|O07737|Y1895_MY	P00326	90.36	26.0	373.0	DB04312	experimental	2,3-Difluorobenzyl Alcohol	OCc1cccc(F)c1F
3379	sp|O07737|Y1895_MY	P00326	90.36	26.0	373.0	DB04448	experimental	2,4-Difluorobenzyl Alcohol 2,4-Difluoro-1-(Hydroxymethyl)Benzene	OCc1ccc(F)cc1F
3380	sp|O07737|Y1895_MY	P40394	90.1	38.0	384.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3381	sp|O07737|Y1895_MY	P11766	90.89	24.0	373.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3382	sp|O07737|Y1895_MY	P11766	90.89	24.0	373.0	DB03017	approved; experimental	Lauric acid	CCCCCCCCCCCC(=O)O
3383	sp|O07737|Y1895_MY	P11766	90.89	24.0	373.0	DB03704	experimental	12-Hydroxydodecanoic Acid	OCCCCCCCCCCCC(=O)O
3384	sp|O07737|Y1895_MY	P11766	90.89	24.0	373.0	DB04153	experimental	S-Hydroxymethyl Glutathione	OC(=O)[C@@H](N)CCC(=O)N[C@@H](CSCO)C(=O)NCC(=O)O
3385	sp|O07737|Y1895_MY	P08319	91.67	26.0	378.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3386	sp|O07737|Y1895_MY	P08319	91.67	26.0	378.0	DB03559	experimental	Cyclohexylformamide	O=CNC1CCCCC1
3387	sp|O07737|Y1895_MY	Q00796	89.32	11.0	354.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3388	sp|O07737|Y1895_MY	Q00796	89.32	11.0	354.0	DB04478	experimental	Cp-166572, 2-Hydroxymethyl-4-(4-N,N-Dimethylaminosulfonyl-1-Piperazino)-Pyrimidine	CN(C)S(=O)(=O)N1CCN(CC1)c2ccnc(n2)CO
3389	sp|O07737|Y1895_MY	P14941	84.11	18.0	341.0	DB02606	experimental; investigational	2-Butanol	CC[C@@H](C)O
3390	sp|O07737|Y1895_MY	P14941	84.11	18.0	341.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3391	sp|O07737|Y1895_MY	P42328	84.38	10.0	334.0	DB03226	experimental	Trifluoroethanol	OCC(F)(F)F
3392	sp|O07737|Y1895_MY	Q14914	71.09	54.0	327.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3393	sp|O07737|Y1895_MY	Q14914	71.09	54.0	327.0	DB04066	experimental	p-Coumaric acid	OC(=O)/C=C/c1ccc(O)cc1
3394	sp|O07737|Y1895_MY	Q14914	71.09	54.0	327.0	DB07177	experimental	(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID	OC(=O)CCC/C=C/CC1C(C(O)CC1=O)/C=C/C(=O)CCCCC
3395	sp|P9WML1|YHI2_MYC	P49773	71.53	17.0	120.0	DB00131	approved; investigational; nutraceutical	Adenosine phosphate	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
3396	sp|P9WML1|YHI2_MYC	P49773	71.53	17.0	120.0	DB01972	experimental	Guanosine-5'-Monophosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
3397	sp|P9WML1|YHI2_MYC	P49773	71.53	17.0	120.0	DB02162	experimental	5'-O-(N-Ethyl-Sulfamoyl)Adenosine	CCNS(=O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
3398	sp|P9WML1|YHI2_MYC	P49773	71.53	17.0	120.0	DB02183	experimental	Adenosine-5'-ditungstate	n1cnc(N)c(c12)ncn2C3OC(C(O)C3O)CO[W](=O)(O)O[W](=O)(O)O
3399	sp|P9WML1|YHI2_MYC	P49773	71.53	17.0	120.0	DB03349	experimental	8-Bromo-Adenosine-5'-Monophosphate	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2c(Br)nc(c23)c(N)ncn3
3400	sp|P9WH49|RS181_MY	Q5SLQ0	92.86	6.0	84.0	DB08185	experimental	2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(nc(n3)SC)NCCC(C)C
3401	sp|P9WGC7|SUCD_MYC	P53396	83.17	537.0	789.0	DB11936	approved; investigational	Bempedoic acid	OC(=O)C(C)(C)CCCCCC(O)CCCCCC(C)(C)C(=O)O
3402	sp|O69721|TYRA_MYC	O67636	77.4	26.0	276.0	DB03897	experimental	Phloretic acid	OC(=O)CCc1ccc(O)cc1
3403	sp|O69721|TYRA_MYC	O67636	77.4	26.0	276.0	DB07718	experimental	4-Hydroxyphenylpyruvic acid	OC(=O)C(=O)Cc1ccc(O)cc1
3404	sp|P9WJZ7|Y1220_MY	Q55813	95.09	6.0	219.0	DB07109	experimental	Isoferulic acid	COc1c(O)cc(cc1)/C=C/C(=O)O
3405	sp|P9WJZ7|Y1220_MY	Q55813	95.09	6.0	219.0	DB07767	experimental	Ferulic acid	COc1cc(/C=C/C(=O)O)ccc1O
3406	sp|P9WJZ7|Y1220_MY	Q86VU5	95.09	48.0	261.0	DB01752	experimental	S-adenosyl-L-homocysteine	OC(=O)[C@@H](N)CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
3407	sp|P9WJZ7|Y1220_MY	Q86VU5	95.09	48.0	261.0	DB03179	experimental	Sinapoyl coenzyme A	COc1cc(cc(OC)c1O)/C=C/C(=O)SCCNC(=O)CCNC(=O)C2(O)[C@@H](C2(C)C)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H](O)[C@@H]3OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3408	sp|P9WJZ7|Y1220_MY	Q86VU5	95.09	48.0	261.0	DB03923	experimental	Feruloyl Coenzyme A	COc1cc(cc(O)c1O)/C=C/C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2OP(=O)(O)O)n3cnc(c34)c(N)ncn4
3409	sp|P9WFX3|TRPE_MYC	P05041	83.14	21.0	450.0	DB01942	experimental; investigational	Formic acid	OC=O
3410	sp|P9WFE7|URE3_MYC	P41022	98.0	1.0	99.0	DB02899	experimental	N-Carboxymethionine	OC(=O)N[C@H](C(=O)O)CCSC
3411	sp|P9WLX9|Y1419_MY	Q7SI98	88.54	295.0	434.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
3412	sp|P9WLX9|Y1419_MY	Q7SI98	88.54	295.0	434.0	DB03389	experimental	alpha-D-Xylopyranose	O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O
3413	sp|P9WLX9|Y1419_MY	Q7SI98	88.54	295.0	434.0	DB04465	approved; experimental; investigational	Lactose	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@H]1O)O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO
3414	sp|P9WLX9|Y1419_MY	P26514	88.54	336.0	475.0	DB03366	experimental; investigational	Imidazole	[nH]1ccnc1
3415	sp|P9WLX9|Y1419_MY	P26514	88.54	336.0	475.0	DB03389	experimental	alpha-D-Xylopyranose	O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O
3416	sp|P9WLX9|Y1419_MY	P26514	88.54	336.0	475.0	DB04465	approved; experimental; investigational	Lactose	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@H]1O)O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO
3418	sp|P9WFW3|SYDND_MY	Q6PI48	98.15	49.0	632.0	DB00128	approved; nutraceutical	Aspartic acid	OC(=O)[C@@H](N)CC(=O)O
3419	sp|P9WHA5|RL2_MYCT	P20276	82.5	5.0	236.0	DB04865	approved; investigational	Omacetaxine mepesuccinate	CC(C)(O)CCC[C@@](O)(CC(=O)OC)C(=O)O[C@H](C(=C1)OC)[C@H]([C@]123)c4c(cc5c(c4)OCO5)CCN2CCC3
3420	sp|P9WHA5|RL2_MYCT	P62917	84.64	8.0	245.0	DB02494	experimental	(S)-3-phenyllactic acid	OC(=O)[C@@H](O)Cc1ccccc1
3421	sp|P9WHA5|RL2_MYCT	P62917	84.64	8.0	245.0	DB07374	experimental	Anisomycin	O[C@H]1CN[C@@H]([C@@H]1OC(=O)C)Cc2ccc(OC)cc2
3422	sp|P9WHA5|RL2_MYCT	P62917	84.64	8.0	245.0	DB08437	experimental	Puromycin	COc1ccc(cc1)C[C@H](N)C(=O)N[C@@H]2[C@@H](CO)O[C@H]([C@@H]2O)n3cnc(c34)c(ncn4)N(C)C
3423	sp|P9WHA5|RL2_MYCT	Q8I3T9	85.0	6.0	244.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
3424	sp|P9WGW5|RTCB_MYC	Q9Y3I0	101.16	68.0	505.0	DB02772	approved; experimental; investigational	Sucrose	OC[C@@H](O1)[C@@H](O)[C@H](O)[C@]1(CO)O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O
3425	sp|P9WGQ1|Y1856_MY	Q9BTZ2	107.17	35.0	274.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
3426	sp|P9WGQ1|Y1856_MY	P0AEK2	104.48	8.0	241.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3427	sp|P9WGQ1|Y1856_MY	Q9WYS2	107.62	12.0	252.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3428	sp|P9WGQ1|Y1856_MY	Q9BY49	109.42	21.0	265.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
3430	sp|P9WGQ1|Y1856_MY	P0AET8	106.73	14.0	252.0	DB02123	experimental	Glycochenodeoxycholic Acid	OC(=O)CNC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
3433	sp|P9WGQ1|Y1856_MY	P16544	111.21	9.0	257.0	DB01942	experimental; investigational	Formic acid	OC=O
3434	sp|P9WGQ1|Y1856_MY	P16544	111.21	9.0	257.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3435	sp|P9WGQ1|Y1856_MY	P16544	111.21	9.0	257.0	DB07715	investigational	Emodin	Cc(c1)cc(O)c(c12)C(=O)c3c(C2=O)cc(O)cc3O
3436	sp|P9WGQ1|Y1856_MY	P0CG22	108.52	35.0	277.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
3437	sp|P9WGQ1|Y1856_MY	P0CG22	108.52	35.0	277.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3438	sp|P9WGQ1|Y1856_MY	P0CG22	108.52	35.0	277.0	DB03541	experimental	10-Propargyl-5,8-Dideazafolic Acid	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(CC#C)Cc(c2)ccc(c23)[nH]c(N)nc3=O
3439	sp|P9WGQ1|Y1856_MY	P0CG22	108.52	35.0	277.0	DB07689	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)NCc(cn3)nc(c34)c(N)nc(n4)N
3440	sp|P9WGQ1|Y1856_MY	P0CG22	108.52	35.0	277.0	DB07765	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)N(C)Cc(cn3)nc(c34)c(N)nc(n4)N
3441	sp|P9WGQ1|Y1856_MY	Q92506	109.87	14.0	259.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3442	sp|P9WGQ1|Y1856_MY	Q92506	109.87	14.0	259.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3443	sp|P9WGQ1|Y1856_MY	Q84EX5	107.17	10.0	249.0	DB04619	experimental	Acetophenone	CC(=O)c1ccccc1
3444	sp|P9WGQ1|Y1856_MY	Q84EX5	107.17	10.0	249.0	DB04784	experimental	(R)-1-phenylethanol	C[C@@H](O)c1ccccc1
3445	sp|P9WGQ1|Y1856_MY	Q7Z4W1	103.59	9.0	240.0	DB02831	experimental	Dihydrogenphosphate	OP([O-])(=O)O
3446	sp|P9WGQ1|Y1856_MY	Q7Z4W1	103.59	9.0	240.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3447	sp|P9WGQ1|Y1856_MY	Q16698	108.07	62.0	303.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3448	sp|P9WGQ1|Y1856_MY	Q16698	108.07	62.0	303.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
3449	sp|P9WGQ1|Y1856_MY	Q8I814	115.25	14.0	271.0	DB02015	experimental	Dihydrofolic Acid	O=c1[nH]c(N)nc(c12)NCC(=N2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
3450	sp|P9WGQ1|Y1856_MY	Q8I814	115.25	14.0	271.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3451	sp|P9WGQ1|Y1856_MY	A0A348A0U3	104.93	18.0	252.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
3452	sp|P9WGQ1|Y1856_MY	Q6UWP2	105.38	14.0	249.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3453	sp|P9WGQ1|Y1856_MY	Q7AUG5	106.73	4.0	242.0	DB04782	experimental	(S)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@H]2CO2
3454	sp|P9WGQ1|Y1856_MY	Q93D82	106.73	4.0	242.0	DB04472	experimental	(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol	[N-]=[N+]=NC[C@H](O)c1ccc([N+]([O-])=O)cc1
3455	sp|P9WGQ1|Y1856_MY	Q93D82	106.73	4.0	242.0	DB04499	experimental	(R)-styrene oxide	C1O[C@@H]1c2ccccc2
3456	sp|P9WGQ1|Y1856_MY	Q93D82	106.73	4.0	242.0	DB04777	experimental	(R)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@@H]2CO2
3457	sp|P9WGQ1|Y1856_MY	Q99714	108.52	13.0	255.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3458	sp|P9WGQ1|Y1856_MY	Q99714	108.52	13.0	255.0	DB02820	experimental	1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct	C1CCCCCN1C(=O)[C@H](c2ccccc2)n(c3=S)cnc(c34)nn(c4)[C@H]5C=CN(C=C5C([O-])=N)[C@@H]6O[C@@H]([C@@H](O)[C@H]6O)COP([O-])(=O)OP(=O)(O)OC[C@H]7O[C@H]([C@H]([O-])[C@@H]7[O-])n8cnc(c89)c(N)ncn9
3459	sp|P9WGQ1|Y1856_MY	Q99714	108.52	13.0	255.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
3460	sp|P9WGQ1|Y1856_MY	P0AEK4	108.52	8.0	250.0	DB01691	experimental	Indole Naphthyridinone	c1cccc(c12)n(C)cc2CN(C)C(=O)/C=C/c(c3)cnc(c34)NC(=O)CC4
3461	sp|P9WGQ1|Y1856_MY	P0AEK4	108.52	8.0	250.0	DB01865	experimental	3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide	c1cccc(c12)cc(n2C)CN(C)C(=O)/C=C/c3cnc(N)cc3
3462	sp|P9WGQ1|Y1856_MY	P0AEK4	108.52	8.0	250.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
3463	sp|P9WGQ1|Y1856_MY	P0AEK4	108.52	8.0	250.0	DB03030	experimental	4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole	Cc1ccc(cc1)Cn2cnc(c2)-c3cccs3
3464	sp|P9WGQ1|Y1856_MY	P0AEK4	108.52	8.0	250.0	DB03534	experimental	3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide	CC(=O)N(C)Cc1c(N)ccc(c1)C(=O)N(C)Cc(n2C)cc(c23)cccc3
3465	sp|P9WGQ1|Y1856_MY	P0AEK4	108.52	8.0	250.0	DB04030	experimental	1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole	Oc1ccc(cc1)Cn2c(c3c(c24)cccc4)CN(CC3)C(=O)c5ccc(O)cc5
3466	sp|P9WGQ1|Y1856_MY	P0AEK4	108.52	8.0	250.0	DB08265	experimental	2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL	Cc1ccc(cc1)S(=O)(=O)n(b2O)ncc(c23)cccc3
3467	sp|P9WGQ1|Y1856_MY	P0AEK4	108.52	8.0	250.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
3468	sp|P9WGQ1|Y1856_MY	P0AEK4	108.52	8.0	250.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
3469	sp|P9WGQ1|Y1856_MY	Q6PKH6	78.92	33.0	209.0	DB04200	experimental	Matairesinol	COc1cc(ccc1O)C[C@H]2COC(=O)[C@@H]2Cc3ccc(O)c(c3)OC
3470	sp|P9WGQ1|Y1856_MY	Q6GI75	105.38	17.0	252.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
3471	sp|P9WGQ1|Y1856_MY	Q6GI75	105.38	17.0	252.0	DB11155	approved	Triclocarban	Clc1ccc(cc1)NC(=O)Nc2cc(Cl)c(Cl)cc2
3472	sp|P9WGQ1|Y1856_MY	P51659	103.59	12.0	243.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3473	sp|P9WGQ1|Y1856_MY	P51659	103.59	12.0	243.0	DB03192	experimental	(R)-3-hydroxydecanoyl-CoA	CCCCCCC[C@@H](O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
3474	sp|P9WGQ1|Y1856_MY	Q02338	94.17	58.0	268.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3475	sp|P9WGQ1|Y1856_MY	Q8TC12	87.0	44.0	238.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
3476	sp|P9WGQ1|Y1856_MY	P9WGR1	110.76	18.0	265.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
3477	sp|P9WGQ1|Y1856_MY	P9WGR1	110.76	18.0	265.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
3478	sp|P9WGQ1|Y1856_MY	P9WGR1	110.76	18.0	265.0	DB02990	experimental	S-(2-Acetamidoethyl) hexadecanethioate	CCCCCCCCCCCCCCCC(=O)SCCNC(=O)C
3479	sp|P9WGQ1|Y1856_MY	P9WGR1	110.76	18.0	265.0	DB04289	experimental	Genz-10850	[nH]1ccc(c12)cc(cc2)C(=O)N3CCN(CC3)C4c(cccc5)c5c(c46)cccc6
3480	sp|P9WGQ1|Y1856_MY	P9WGR1	110.76	18.0	265.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
3481	sp|P9WGQ1|Y1856_MY	P9WGR1	110.76	18.0	265.0	DB07090	experimental	(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cccc(c1C)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
3482	sp|P9WGQ1|Y1856_MY	P9WGR1	110.76	18.0	265.0	DB07123	experimental	N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE	Cc1ccc(cc1)C(=O)N2CCC(CC2)Cc3ccccc3
3483	sp|P9WGQ1|Y1856_MY	P9WGR1	110.76	18.0	265.0	DB07155	experimental	(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE	c1ccccc1NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
3484	sp|P9WGQ1|Y1856_MY	P9WGR1	110.76	18.0	265.0	DB07178	experimental	5-PENTYL-2-PHENOXYPHENOL	CCCCCc1cc(O)c(cc1)Oc2ccccc2
3485	sp|P9WGQ1|Y1856_MY	P9WGR1	110.76	18.0	265.0	DB07188	experimental	(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(cc(Cl)c1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
3486	sp|P9WGQ1|Y1856_MY	P9WGR1	110.76	18.0	265.0	DB07192	experimental	(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Brc1cc(ccc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
3487	sp|P9WGQ1|Y1856_MY	P9WGR1	110.76	18.0	265.0	DB07222	experimental	(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(c(C)cc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
3488	sp|P9WGQ1|Y1856_MY	P9WGR1	110.76	18.0	265.0	DB07287	experimental	2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL	c1cccnc1Cc2cc(O)c(cc2)Oc3ccc(Cl)cc3Cl
3489	sp|P9WGQ1|Y1856_MY	P9WGR1	110.76	18.0	265.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
3490	sp|P9WGQ1|Y1856_MY	Q01782	122.87	9.0	283.0	DB02338	experimental	NADPH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3491	sp|P9WGQ1|Y1856_MY	Q01782	122.87	9.0	283.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
3492	sp|P9WGQ1|Y1856_MY	Q01782	122.87	9.0	283.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3493	sp|P9WGQ1|Y1856_MY	Q01782	122.87	9.0	283.0	DB04400	experimental	L-erythro-7,8-dihydrobiopterin	C[C@H](O)[C@H](O)C(CN1)=Nc(c12)c(=O)nc([nH]2)N
3494	sp|P9WGQ1|Y1856_MY	Q8NBN7	87.0	41.0	235.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
3495	sp|P9WGQ1|Y1856_MY	O24990	104.48	17.0	250.0	DB04393	experimental	Soneclosan	Clc1cc(O)c(cc1)Oc2ccc(Cl)cc2
3496	sp|P9WGQ1|Y1856_MY	O24990	104.48	17.0	250.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
3497	sp|P9WGQ1|Y1856_MY	Q92781	85.65	31.0	222.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3498	sp|P9WGQ1|Y1856_MY	Q92781	85.65	31.0	222.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
3499	sp|P9WGQ1|Y1856_MY	P37059	94.62	85.0	296.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3500	sp|P9WGQ1|Y1856_MY	P37059	94.62	85.0	296.0	DB13952	approved; investigational; vet_approved	Estradiol acetate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)C
3501	sp|P9WGQ1|Y1856_MY	P37059	94.62	85.0	296.0	DB13953	approved; investigational; vet_approved	Estradiol benzoate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)c5ccccc5
3502	sp|P9WGQ1|Y1856_MY	P37059	94.62	85.0	296.0	DB13954	approved; investigational; vet_approved	Estradiol cypionate	C1CCCC1CCC(=O)O[C@H]2CC[C@H]([C@@]23C)[C@H]4[C@H](CC3)c5c(CC4)cc(O)cc5
3503	sp|P9WGQ1|Y1856_MY	P37059	94.62	85.0	296.0	DB13955	approved; investigational; vet_approved	Estradiol dienanthate	CCCCCCC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)CCCCCC
3504	sp|P9WGQ1|Y1856_MY	P37059	94.62	85.0	296.0	DB13956	approved; investigational; vet_approved	Estradiol valerate	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)CC[C@@H]4OC(=O)CCCC
3506	sp|P9WGQ1|Y1856_MY	Q9HBH5	113.9	46.0	300.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
3507	sp|P9WGQ1|Y1856_MY	Q96NR8	87.0	42.0	236.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
3508	sp|P9WGQ1|Y1856_MY	Q8NBQ5	86.55	39.0	232.0	DB02854	experimental	Aetiocholanolone	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](CC3)C[C@H](O)CC4
3509	sp|P9WGQ1|Y1856_MY	Q9NYR8	87.89	8.0	204.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
3510	sp|P9WGQ1|Y1856_MY	P80365	92.38	85.0	291.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3511	sp|P9WGQ1|Y1856_MY	P80365	92.38	85.0	291.0	DB01185	approved; illicit	Fluoxymesterone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@](F)([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
3512	sp|P9WGQ1|Y1856_MY	P80365	92.38	85.0	291.0	DB01569	experimental; illicit	Formebolone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@H]([C@@H](C2)O)[C@]4(C)C(CC3)=CC(=O)C(C=O)=C4
3513	sp|P9WGQ1|Y1856_MY	P80365	92.38	85.0	291.0	DB14538	experimental; vet_approved	Hydrocortisone aceponate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CC)C(=O)COC(=O)C
3514	sp|P9WGQ1|Y1856_MY	P80365	92.38	85.0	291.0	DB14539	approved; vet_approved	Hydrocortisone acetate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)C
3515	sp|P9WGQ1|Y1856_MY	P80365	92.38	85.0	291.0	DB14540	approved; vet_approved	Hydrocortisone butyrate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCC
3516	sp|P9WGQ1|Y1856_MY	P80365	92.38	85.0	291.0	DB14541	approved; investigational; vet_approved	Hydrocortisone cypionate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)CCC5CCCC5
3517	sp|P9WGQ1|Y1856_MY	P80365	92.38	85.0	291.0	DB14542	approved; vet_approved	Hydrocortisone phosphate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COP(=O)(O)O
3518	sp|P9WGQ1|Y1856_MY	P80365	92.38	85.0	291.0	DB14543	approved; vet_approved	Hydrocortisone probutate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CCC)C(=O)COC(=O)CC
3519	sp|P9WGQ1|Y1856_MY	P80365	92.38	85.0	291.0	DB14544	approved; vet_approved	Hydrocortisone valerate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCCC
3520	sp|P9WGQ1|Y1856_MY	P14061	92.38	6.0	212.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3521	sp|P9WGQ1|Y1856_MY	P14061	92.38	6.0	212.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
3522	sp|P9WGQ1|Y1856_MY	P14061	92.38	6.0	212.0	DB01561	experimental; illicit	Androstanedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
3523	sp|P9WGQ1|Y1856_MY	P14061	92.38	6.0	212.0	DB02187	experimental	Equilin	O=C1CC[C@H]([C@@]12C)C=3[C@H](CC2)c4c(CC3)cc(O)cc4
3524	sp|P9WGQ1|Y1856_MY	P14061	92.38	6.0	212.0	DB02323	experimental	EM-1745	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)C[C@@H]([C@@H]4O)CCCCCCCCC(=O)OC[C@H]5O[C@H]([C@H](O)[C@@H]5O)n6cnc(c67)c(N)ncn7
3525	sp|P9WGQ1|Y1856_MY	P14061	92.38	6.0	212.0	DB02901	illicit; investigational	Stanolone	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
3526	sp|P9WGQ1|Y1856_MY	P14061	92.38	6.0	212.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3527	sp|P9WGQ1|Y1856_MY	P14061	92.38	6.0	212.0	DB13951	experimental	Stanolone acetate	CC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
3528	sp|P9WGQ1|Y1856_MY	P37058	83.86	51.0	238.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3529	sp|P9WGQ1|Y1856_MY	O75911	86.55	41.0	234.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
3530	sp|P9WGQ1|Y1856_MY	P28845	84.3	36.0	224.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3531	sp|P9WGQ1|Y1856_MY	P28845	84.3	36.0	224.0	DB02329	experimental	Carbenoxolone	OC(=O)CCC(=O)O[C@@H](CC1)C(C)(C)[C@@H]([C@]12C)CC[C@]3(C)[C@@H]2C(=O)C=C4[C@H]5[C@@](C)(CC[C@@]34C)CC[C@](C5)(C)C(=O)O
3532	sp|P9WGQ1|Y1856_MY	P28845	84.3	36.0	224.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3533	sp|P9WGQ1|Y1856_MY	P28845	84.3	36.0	224.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
3534	sp|P9WGQ1|Y1856_MY	P28845	84.3	36.0	224.0	DB04652	experimental	Corticosterone	OCC(=O)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H]([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
3535	sp|P9WGQ1|Y1856_MY	P28845	84.3	36.0	224.0	DB05064	investigational	INCB13739	 
3536	sp|P9WGQ1|Y1856_MY	P28845	84.3	36.0	224.0	DB06992	experimental	(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone	Cc1ccc(cc1F)-c2nc(ccc2)C(=O)N(CC3(C)C)CCC3
3537	sp|P9WGQ1|Y1856_MY	P28845	84.3	36.0	224.0	DB07017	experimental	(5S)-2-{[(1S)-1-(4-Fluorophenyl)ethyl]amino}-5-(2-hydroxy-2-propanyl)-5-methyl-1,3-thiazol-4(5H)-one	Fc1ccc(cc1)[C@H](C)NC(=NC2=O)S[C@@]2(C)C(C)(C)O
3538	sp|P9WGQ1|Y1856_MY	P28845	84.3	36.0	224.0	DB07049	experimental	(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine	[O-][N+](=O)c1ccc(cc1)N2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)C(C)(C)C
3539	sp|P9WGQ1|Y1856_MY	P28845	84.3	36.0	224.0	DB07056	experimental	2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide	CCN(CC)C(=O)Cc1cccc(n1)NS(=O)(=O)c2c(C)c(Cl)ccc2
3540	sp|P9WGQ1|Y1856_MY	P28845	84.3	36.0	224.0	DB07310	experimental	(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one	Fc1ccccc1[C@H](C)NC(=NC2=O)S[C@]2(C)C(F)(F)F
3541	sp|P9WGQ1|Y1856_MY	P28845	84.3	36.0	224.0	DB07316	experimental	N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)C3CCN(CC3)CC4(CC4)C(=O)N
3542	sp|P9WGQ1|Y1856_MY	P28845	84.3	36.0	224.0	DB07619	experimental	N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)[C@H]3CC[C@@H](CC3)c4cccnc4
3543	sp|P9WGQ1|Y1856_MY	P28845	84.3	36.0	224.0	DB07624	experimental	1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide	C1CC1(C(=O)N)CN2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)[C@](C)(O)C(F)(F)F
3544	sp|P9WGQ1|Y1856_MY	P28845	84.3	36.0	224.0	DB07866	experimental	(5S)-2-(Cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one	CCC[C@]1(C)SC(=NC1=O)NC2CCCCCCC2
3545	sp|P9WGQ1|Y1856_MY	P28845	84.3	36.0	224.0	DB08277	experimental	2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE	CS(=O)(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4c(Cl)cc(F)cc4
3546	sp|P9WGQ1|Y1856_MY	P28845	84.3	36.0	224.0	DB08280	experimental	(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE	NC(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4ccc(OC)cc4
3547	sp|P9WGQ1|Y1856_MY	P28845	84.3	36.0	224.0	DB08771	experimental	(5R)-2-[(2-Fluorophenyl)amino]-5-isopropyl-1,3-thiazol-4(5H)-one	CC(C)[C@H]1SC(=NC1=O)Nc2c(F)cccc2
3548	sp|P9WGQ1|Y1856_MY	P28845	84.3	36.0	224.0	DB13751	approved; experimental	Glycyrrhizic acid	C1C[C@](C)(C(=O)O)C[C@H]([C@]12C)C=3[C@@](C)(CC2)[C@@]4(C)[C@H](C(=O)C3)[C@]5(C)[C@@H](CC4)C(C)(C)[C@H](CC5)O[C@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O[C@@H]7O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]7O
3549	sp|P9WGQ1|Y1856_MY	P35270	104.04	11.0	243.0	DB02637	experimental	Oxaloacetate Ion	OC(=O)C(=O)CC([O-])=O
3550	sp|P9WGQ1|Y1856_MY	P35270	104.04	11.0	243.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3551	sp|P9WGQ1|Y1856_MY	P35270	104.04	11.0	243.0	DB03886	experimental	Biopterin	C[C@@H](O)[C@@H](O)c(n1)cnc(c12)nc(N)[nH]c2=O
3552	sp|P9WGQ1|Y1856_MY	P35270	104.04	11.0	243.0	DB04275	experimental	N-acetylserotonin	CC(=O)NCCc1c[nH]c(c12)ccc(c2)O
3553	sp|P9WGQ1|Y1856_MY	Q14376	74.89	4.0	171.0	DB01861	experimental	Uridine diphosphate glucose	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
3554	sp|P9WGQ1|Y1856_MY	Q14376	74.89	4.0	171.0	DB02196	experimental	Uridine-Diphosphate-N-Acetylgalactosamine	CC(=O)N[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
3555	sp|P9WGQ1|Y1856_MY	Q14376	74.89	4.0	171.0	DB03041	experimental	UDP-alpha-D-glucuronic acid	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O
3556	sp|P9WGQ1|Y1856_MY	Q14376	74.89	4.0	171.0	DB03095	experimental	Tetramethylammonium	C[N+](C)(C)C
3557	sp|P9WGQ1|Y1856_MY	Q14376	74.89	4.0	171.0	DB03397	experimental	Uridine-Diphosphate-N-Acetylglucosamine	CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
3558	sp|P9WGQ1|Y1856_MY	Q14376	74.89	4.0	171.0	DB03501	experimental	Galactose-uridine-5'-diphosphate	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@H]1O)O[P@](=O)(O)O[P@](=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
3559	sp|P9WGQ1|Y1856_MY	P26391	86.55	1.0	194.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
3560	sp|P9WKX5|Y3679_MY	P08690	77.65	11.0	275.0	DB02453	experimental	Antimonous acid	O[Sb](O)O
3561	sp|P9WKX5|Y3679_MY	P08690	77.65	11.0	275.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
3562	sp|P9WKX5|Y3679_MY	P08690	77.65	11.0	275.0	DB04456	experimental; investigational	Arsenous acid	O[As](O)O
3563	sp|P9WKX5|Y3679_MY	O43681	72.65	36.0	283.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
3564	sp|P9WGQ5|Y927C_MY	Q9BTZ2	92.78	30.0	274.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
3565	sp|P9WGQ5|Y927C_MY	Q9WYS2	95.06	3.0	253.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3566	sp|P9WGQ5|Y927C_MY	Q9BY49	98.86	16.0	276.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
3568	sp|P9WGQ5|Y927C_MY	P0AET8	93.16	5.0	250.0	DB02123	experimental	Glycochenodeoxycholic Acid	OC(=O)CNC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
3569	sp|P9WGQ5|Y927C_MY	P0AEK2	91.25	2.0	242.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3571	sp|P9WGQ5|Y927C_MY	Q84EX5	93.92	3.0	250.0	DB04619	experimental	Acetophenone	CC(=O)c1ccccc1
3572	sp|P9WGQ5|Y927C_MY	Q84EX5	93.92	3.0	250.0	DB04784	experimental	(R)-1-phenylethanol	C[C@@H](O)c1ccccc1
3573	sp|P9WGQ5|Y927C_MY	Q92506	96.2	7.0	260.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3574	sp|P9WGQ5|Y927C_MY	Q92506	96.2	7.0	260.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3575	sp|P9WGQ5|Y927C_MY	P16544	97.34	2.0	258.0	DB01942	experimental; investigational	Formic acid	OC=O
3576	sp|P9WGQ5|Y927C_MY	P16544	97.34	2.0	258.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3577	sp|P9WGQ5|Y927C_MY	P16544	97.34	2.0	258.0	DB07715	investigational	Emodin	Cc(c1)cc(O)c(c12)C(=O)c3c(C2=O)cc(O)cc3O
3579	sp|P9WGQ5|Y927C_MY	P0CG22	93.92	30.0	277.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
3580	sp|P9WGQ5|Y927C_MY	P0CG22	93.92	30.0	277.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3581	sp|P9WGQ5|Y927C_MY	P0CG22	93.92	30.0	277.0	DB03541	experimental	10-Propargyl-5,8-Dideazafolic Acid	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(CC#C)Cc(c2)ccc(c23)[nH]c(N)nc3=O
3582	sp|P9WGQ5|Y927C_MY	P0CG22	93.92	30.0	277.0	DB07689	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)NCc(cn3)nc(c34)c(N)nc(n4)N
3583	sp|P9WGQ5|Y927C_MY	P0CG22	93.92	30.0	277.0	DB07765	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)N(C)Cc(cn3)nc(c34)c(N)nc(n4)N
3584	sp|P9WGQ5|Y927C_MY	Q16698	93.92	56.0	303.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3585	sp|P9WGQ5|Y927C_MY	Q16698	93.92	56.0	303.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
3586	sp|P9WGQ5|Y927C_MY	Q7Z4W1	89.73	5.0	241.0	DB02831	experimental	Dihydrogenphosphate	OP([O-])(=O)O
3587	sp|P9WGQ5|Y927C_MY	Q7Z4W1	89.73	5.0	241.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3588	sp|P9WGQ5|Y927C_MY	Q6GI75	95.82	1.0	253.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
3589	sp|P9WGQ5|Y927C_MY	Q6GI75	95.82	1.0	253.0	DB11155	approved	Triclocarban	Clc1ccc(cc1)NC(=O)Nc2cc(Cl)c(Cl)cc2
3590	sp|P9WGQ5|Y927C_MY	A0A348A0U3	96.2	1.0	254.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
3591	sp|P9WGQ5|Y927C_MY	P0AEK4	95.82	4.0	256.0	DB01691	experimental	Indole Naphthyridinone	c1cccc(c12)n(C)cc2CN(C)C(=O)/C=C/c(c3)cnc(c34)NC(=O)CC4
3592	sp|P9WGQ5|Y927C_MY	P0AEK4	95.82	4.0	256.0	DB01865	experimental	3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide	c1cccc(c12)cc(n2C)CN(C)C(=O)/C=C/c3cnc(N)cc3
3593	sp|P9WGQ5|Y927C_MY	P0AEK4	95.82	4.0	256.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
3594	sp|P9WGQ5|Y927C_MY	P0AEK4	95.82	4.0	256.0	DB03030	experimental	4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole	Cc1ccc(cc1)Cn2cnc(c2)-c3cccs3
3595	sp|P9WGQ5|Y927C_MY	P0AEK4	95.82	4.0	256.0	DB03534	experimental	3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide	CC(=O)N(C)Cc1c(N)ccc(c1)C(=O)N(C)Cc(n2C)cc(c23)cccc3
3596	sp|P9WGQ5|Y927C_MY	P0AEK4	95.82	4.0	256.0	DB04030	experimental	1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole	Oc1ccc(cc1)Cn2c(c3c(c24)cccc4)CN(CC3)C(=O)c5ccc(O)cc5
3597	sp|P9WGQ5|Y927C_MY	P0AEK4	95.82	4.0	256.0	DB08265	experimental	2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL	Cc1ccc(cc1)S(=O)(=O)n(b2O)ncc(c23)cccc3
3598	sp|P9WGQ5|Y927C_MY	P0AEK4	95.82	4.0	256.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
3599	sp|P9WGQ5|Y927C_MY	P0AEK4	95.82	4.0	256.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
3600	sp|P9WGQ5|Y927C_MY	Q6UWP2	91.25	6.0	246.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3601	sp|P9WGQ5|Y927C_MY	O24990	94.3	4.0	252.0	DB04393	experimental	Soneclosan	Clc1cc(O)c(cc1)Oc2ccc(Cl)cc2
3602	sp|P9WGQ5|Y927C_MY	O24990	94.3	4.0	252.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
3603	sp|P9WGQ5|Y927C_MY	O75911	86.69	34.0	262.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
3604	sp|P9WGQ5|Y927C_MY	Q99714	95.82	7.0	259.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3605	sp|P9WGQ5|Y927C_MY	Q99714	95.82	7.0	259.0	DB02820	experimental	1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct	C1CCCCCN1C(=O)[C@H](c2ccccc2)n(c3=S)cnc(c34)nn(c4)[C@H]5C=CN(C=C5C([O-])=N)[C@@H]6O[C@@H]([C@@H](O)[C@H]6O)COP([O-])(=O)OP(=O)(O)OC[C@H]7O[C@H]([C@H]([O-])[C@@H]7[O-])n8cnc(c89)c(N)ncn9
3606	sp|P9WGQ5|Y927C_MY	Q99714	95.82	7.0	259.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
3607	sp|P9WGQ5|Y927C_MY	Q8I814	99.24	13.0	274.0	DB02015	experimental	Dihydrofolic Acid	O=c1[nH]c(N)nc(c12)NCC(=N2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
3608	sp|P9WGQ5|Y927C_MY	Q8I814	99.24	13.0	274.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3610	sp|P9WGQ5|Y927C_MY	Q7AUG5	92.02	3.0	245.0	DB04782	experimental	(S)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@H]2CO2
3611	sp|P9WGQ5|Y927C_MY	Q93D82	92.02	3.0	245.0	DB04472	experimental	(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol	[N-]=[N+]=NC[C@H](O)c1ccc([N+]([O-])=O)cc1
3612	sp|P9WGQ5|Y927C_MY	Q93D82	92.02	3.0	245.0	DB04499	experimental	(R)-styrene oxide	C1O[C@@H]1c2ccccc2
3613	sp|P9WGQ5|Y927C_MY	Q93D82	92.02	3.0	245.0	DB04777	experimental	(R)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@@H]2CO2
3614	sp|P9WGQ5|Y927C_MY	Q8NBQ5	74.9	33.0	230.0	DB02854	experimental	Aetiocholanolone	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](CC3)C[C@H](O)CC4
3615	sp|P9WGQ5|Y927C_MY	Q01782	105.32	8.0	285.0	DB02338	experimental	NADPH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3616	sp|P9WGQ5|Y927C_MY	Q01782	105.32	8.0	285.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
3617	sp|P9WGQ5|Y927C_MY	Q01782	105.32	8.0	285.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3618	sp|P9WGQ5|Y927C_MY	Q01782	105.32	8.0	285.0	DB04400	experimental	L-erythro-7,8-dihydrobiopterin	C[C@H](O)[C@H](O)C(CN1)=Nc(c12)c(=O)nc([nH]2)N
3619	sp|P9WGQ5|Y927C_MY	Q9HBH5	98.86	41.0	301.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
3620	sp|P9WGQ5|Y927C_MY	Q8TC12	77.95	37.0	242.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
3621	sp|P9WGQ5|Y927C_MY	Q02338	80.61	53.0	265.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3622	sp|P9WGQ5|Y927C_MY	Q8NBN7	79.09	36.0	244.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
3623	sp|P9WGQ5|Y927C_MY	P14061	79.09	3.0	211.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3624	sp|P9WGQ5|Y927C_MY	P14061	79.09	3.0	211.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
3625	sp|P9WGQ5|Y927C_MY	P14061	79.09	3.0	211.0	DB01561	experimental; illicit	Androstanedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
3626	sp|P9WGQ5|Y927C_MY	P14061	79.09	3.0	211.0	DB02187	experimental	Equilin	O=C1CC[C@H]([C@@]12C)C=3[C@H](CC2)c4c(CC3)cc(O)cc4
3627	sp|P9WGQ5|Y927C_MY	P14061	79.09	3.0	211.0	DB02323	experimental	EM-1745	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)C[C@@H]([C@@H]4O)CCCCCCCCC(=O)OC[C@H]5O[C@H]([C@H](O)[C@@H]5O)n6cnc(c67)c(N)ncn7
3628	sp|P9WGQ5|Y927C_MY	P14061	79.09	3.0	211.0	DB02901	illicit; investigational	Stanolone	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
3629	sp|P9WGQ5|Y927C_MY	P14061	79.09	3.0	211.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3630	sp|P9WGQ5|Y927C_MY	P14061	79.09	3.0	211.0	DB13951	experimental	Stanolone acetate	CC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
3631	sp|P9WGQ5|Y927C_MY	Q9NYR8	72.62	5.0	196.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
3632	sp|P9WGQ5|Y927C_MY	Q96NR8	77.95	35.0	240.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
3633	sp|P9WGQ5|Y927C_MY	P37059	81.37	76.0	290.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3634	sp|P9WGQ5|Y927C_MY	P37059	81.37	76.0	290.0	DB13952	approved; investigational; vet_approved	Estradiol acetate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)C
3635	sp|P9WGQ5|Y927C_MY	P37059	81.37	76.0	290.0	DB13953	approved; investigational; vet_approved	Estradiol benzoate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)c5ccccc5
3636	sp|P9WGQ5|Y927C_MY	P37059	81.37	76.0	290.0	DB13954	approved; investigational; vet_approved	Estradiol cypionate	C1CCCC1CCC(=O)O[C@H]2CC[C@H]([C@@]23C)[C@H]4[C@H](CC3)c5c(CC4)cc(O)cc5
3637	sp|P9WGQ5|Y927C_MY	P37059	81.37	76.0	290.0	DB13955	approved; investigational; vet_approved	Estradiol dienanthate	CCCCCCC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)CCCCCC
3638	sp|P9WGQ5|Y927C_MY	P37059	81.37	76.0	290.0	DB13956	approved; investigational; vet_approved	Estradiol valerate	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)CC[C@@H]4OC(=O)CCCC
3639	sp|P9WGQ5|Y927C_MY	P28845	79.47	31.0	240.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3640	sp|P9WGQ5|Y927C_MY	P28845	79.47	31.0	240.0	DB02329	experimental	Carbenoxolone	OC(=O)CCC(=O)O[C@@H](CC1)C(C)(C)[C@@H]([C@]12C)CC[C@]3(C)[C@@H]2C(=O)C=C4[C@H]5[C@@](C)(CC[C@@]34C)CC[C@](C5)(C)C(=O)O
3641	sp|P9WGQ5|Y927C_MY	P28845	79.47	31.0	240.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3642	sp|P9WGQ5|Y927C_MY	P28845	79.47	31.0	240.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
3643	sp|P9WGQ5|Y927C_MY	P28845	79.47	31.0	240.0	DB04652	experimental	Corticosterone	OCC(=O)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H]([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
3644	sp|P9WGQ5|Y927C_MY	P28845	79.47	31.0	240.0	DB05064	investigational	INCB13739	 
3645	sp|P9WGQ5|Y927C_MY	P28845	79.47	31.0	240.0	DB06992	experimental	(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone	Cc1ccc(cc1F)-c2nc(ccc2)C(=O)N(CC3(C)C)CCC3
3646	sp|P9WGQ5|Y927C_MY	P28845	79.47	31.0	240.0	DB07017	experimental	(5S)-2-{[(1S)-1-(4-Fluorophenyl)ethyl]amino}-5-(2-hydroxy-2-propanyl)-5-methyl-1,3-thiazol-4(5H)-one	Fc1ccc(cc1)[C@H](C)NC(=NC2=O)S[C@@]2(C)C(C)(C)O
3647	sp|P9WGQ5|Y927C_MY	P28845	79.47	31.0	240.0	DB07049	experimental	(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine	[O-][N+](=O)c1ccc(cc1)N2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)C(C)(C)C
3648	sp|P9WGQ5|Y927C_MY	P28845	79.47	31.0	240.0	DB07056	experimental	2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide	CCN(CC)C(=O)Cc1cccc(n1)NS(=O)(=O)c2c(C)c(Cl)ccc2
3649	sp|P9WGQ5|Y927C_MY	P28845	79.47	31.0	240.0	DB07310	experimental	(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one	Fc1ccccc1[C@H](C)NC(=NC2=O)S[C@]2(C)C(F)(F)F
3650	sp|P9WGQ5|Y927C_MY	P28845	79.47	31.0	240.0	DB07316	experimental	N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)C3CCN(CC3)CC4(CC4)C(=O)N
3651	sp|P9WGQ5|Y927C_MY	P28845	79.47	31.0	240.0	DB07619	experimental	N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)[C@H]3CC[C@@H](CC3)c4cccnc4
3652	sp|P9WGQ5|Y927C_MY	P28845	79.47	31.0	240.0	DB07624	experimental	1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide	C1CC1(C(=O)N)CN2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)[C@](C)(O)C(F)(F)F
3653	sp|P9WGQ5|Y927C_MY	P28845	79.47	31.0	240.0	DB07866	experimental	(5S)-2-(Cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one	CCC[C@]1(C)SC(=NC1=O)NC2CCCCCCC2
3654	sp|P9WGQ5|Y927C_MY	P28845	79.47	31.0	240.0	DB08277	experimental	2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE	CS(=O)(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4c(Cl)cc(F)cc4
3655	sp|P9WGQ5|Y927C_MY	P28845	79.47	31.0	240.0	DB08280	experimental	(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE	NC(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4ccc(OC)cc4
3656	sp|P9WGQ5|Y927C_MY	P28845	79.47	31.0	240.0	DB08771	experimental	(5R)-2-[(2-Fluorophenyl)amino]-5-isopropyl-1,3-thiazol-4(5H)-one	CC(C)[C@H]1SC(=NC1=O)Nc2c(F)cccc2
3657	sp|P9WGQ5|Y927C_MY	P28845	79.47	31.0	240.0	DB13751	approved; experimental	Glycyrrhizic acid	C1C[C@](C)(C(=O)O)C[C@H]([C@]12C)C=3[C@@](C)(CC2)[C@@]4(C)[C@H](C(=O)C3)[C@]5(C)[C@@H](CC4)C(C)(C)[C@H](CC5)O[C@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O[C@@H]7O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]7O
3658	sp|P9WGQ5|Y927C_MY	P9WGR1	98.86	5.0	265.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
3659	sp|P9WGQ5|Y927C_MY	P9WGR1	98.86	5.0	265.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
3660	sp|P9WGQ5|Y927C_MY	P9WGR1	98.86	5.0	265.0	DB02990	experimental	S-(2-Acetamidoethyl) hexadecanethioate	CCCCCCCCCCCCCCCC(=O)SCCNC(=O)C
3661	sp|P9WGQ5|Y927C_MY	P9WGR1	98.86	5.0	265.0	DB04289	experimental	Genz-10850	[nH]1ccc(c12)cc(cc2)C(=O)N3CCN(CC3)C4c(cccc5)c5c(c46)cccc6
3662	sp|P9WGQ5|Y927C_MY	P9WGR1	98.86	5.0	265.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
3663	sp|P9WGQ5|Y927C_MY	P9WGR1	98.86	5.0	265.0	DB07090	experimental	(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cccc(c1C)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
3664	sp|P9WGQ5|Y927C_MY	P9WGR1	98.86	5.0	265.0	DB07123	experimental	N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE	Cc1ccc(cc1)C(=O)N2CCC(CC2)Cc3ccccc3
3665	sp|P9WGQ5|Y927C_MY	P9WGR1	98.86	5.0	265.0	DB07155	experimental	(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE	c1ccccc1NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
3666	sp|P9WGQ5|Y927C_MY	P9WGR1	98.86	5.0	265.0	DB07178	experimental	5-PENTYL-2-PHENOXYPHENOL	CCCCCc1cc(O)c(cc1)Oc2ccccc2
3667	sp|P9WGQ5|Y927C_MY	P9WGR1	98.86	5.0	265.0	DB07188	experimental	(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(cc(Cl)c1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
3668	sp|P9WGQ5|Y927C_MY	P9WGR1	98.86	5.0	265.0	DB07192	experimental	(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Brc1cc(ccc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
3669	sp|P9WGQ5|Y927C_MY	P9WGR1	98.86	5.0	265.0	DB07222	experimental	(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(c(C)cc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
3670	sp|P9WGQ5|Y927C_MY	P9WGR1	98.86	5.0	265.0	DB07287	experimental	2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL	c1cccnc1Cc2cc(O)c(cc2)Oc3ccc(Cl)cc3Cl
3671	sp|P9WGQ5|Y927C_MY	P9WGR1	98.86	5.0	265.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
3672	sp|P9WGQ5|Y927C_MY	P51659	77.95	5.0	210.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3673	sp|P9WGQ5|Y927C_MY	P51659	77.95	5.0	210.0	DB03192	experimental	(R)-3-hydroxydecanoyl-CoA	CCCCCCC[C@@H](O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
3674	sp|P9WGQ5|Y927C_MY	P37058	75.29	44.0	242.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3675	sp|P9WGQ5|Y927C_MY	P80365	79.47	80.0	289.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3676	sp|P9WGQ5|Y927C_MY	P80365	79.47	80.0	289.0	DB01185	approved; illicit	Fluoxymesterone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@](F)([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
3677	sp|P9WGQ5|Y927C_MY	P80365	79.47	80.0	289.0	DB01569	experimental; illicit	Formebolone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@H]([C@@H](C2)O)[C@]4(C)C(CC3)=CC(=O)C(C=O)=C4
3678	sp|P9WGQ5|Y927C_MY	P80365	79.47	80.0	289.0	DB14538	experimental; vet_approved	Hydrocortisone aceponate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CC)C(=O)COC(=O)C
3679	sp|P9WGQ5|Y927C_MY	P80365	79.47	80.0	289.0	DB14539	approved; vet_approved	Hydrocortisone acetate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)C
3680	sp|P9WGQ5|Y927C_MY	P80365	79.47	80.0	289.0	DB14540	approved; vet_approved	Hydrocortisone butyrate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCC
3681	sp|P9WGQ5|Y927C_MY	P80365	79.47	80.0	289.0	DB14541	approved; investigational; vet_approved	Hydrocortisone cypionate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)CCC5CCCC5
3682	sp|P9WGQ5|Y927C_MY	P80365	79.47	80.0	289.0	DB14542	approved; vet_approved	Hydrocortisone phosphate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COP(=O)(O)O
3683	sp|P9WGQ5|Y927C_MY	P80365	79.47	80.0	289.0	DB14543	approved; vet_approved	Hydrocortisone probutate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CCC)C(=O)COC(=O)CC
3684	sp|P9WGQ5|Y927C_MY	P80365	79.47	80.0	289.0	DB14544	approved; vet_approved	Hydrocortisone valerate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCCC
3685	sp|P9WGQ5|Y927C_MY	Q92781	77.57	26.0	230.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3686	sp|P9WGQ5|Y927C_MY	Q92781	77.57	26.0	230.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
3687	sp|P9WGQ5|Y927C_MY	P16152	88.97	7.0	241.0	DB01698	approved; experimental; investigational	Rutin	O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O[C@H]1C)OC[C@H]2O[C@H]([C@H](O)[C@@H](O)[C@@H]2O)Oc(c3=O)c(-c4cc(O)c(O)cc4)oc(c35)cc(O)cc5O
3688	sp|P9WGQ5|Y927C_MY	P16152	88.97	7.0	241.0	DB02709	investigational	Resveratrol	Oc1ccc(cc1)/C=C/c2cc(O)cc(O)c2
3689	sp|P9WGQ5|Y927C_MY	P16152	88.97	7.0	241.0	DB03394	experimental	Heptaethylene glycol	OCCOCCOCCOCCOCCOCCOCCO
3690	sp|P9WGQ5|Y927C_MY	P16152	88.97	7.0	241.0	DB03556	experimental	2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400	CCOCCOCCOCCOCCOCCOCCOCCOCCO
3691	sp|P9WGQ5|Y927C_MY	P16152	88.97	7.0	241.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
3692	sp|P9WGQ5|Y927C_MY	P16152	88.97	7.0	241.0	DB04463	experimental	3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol	n1cnc(N)c(c12)c(nn2C(C)(C)C)-c3cccc(O)c3
3693	sp|P9WGQ5|Y927C_MY	P16152	88.97	7.0	241.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
3694	sp|P9WGQ5|Y927C_MY	P16152	88.97	7.0	241.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
3695	sp|P9WGQ5|Y927C_MY	P35270	93.54	7.0	253.0	DB02637	experimental	Oxaloacetate Ion	OC(=O)C(=O)CC([O-])=O
3696	sp|P9WGQ5|Y927C_MY	P35270	93.54	7.0	253.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3697	sp|P9WGQ5|Y927C_MY	P35270	93.54	7.0	253.0	DB03886	experimental	Biopterin	C[C@@H](O)[C@@H](O)c(n1)cnc(c12)nc(N)[nH]c2=O
3698	sp|P9WGQ5|Y927C_MY	P35270	93.54	7.0	253.0	DB04275	experimental	N-acetylserotonin	CC(=O)NCCc1c[nH]c(c12)ccc(c2)O
3699	sp|P9WGQ5|Y927C_MY	P56937	87.83	2.0	233.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3700	sp|P9WGQ5|Y927C_MY	Q8T8E9	72.62	2.0	193.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
3701	sp|P9WGQ5|Y927C_MY	P26391	72.62	3.0	194.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
3702	sp|P9WLU5|Y1549_MY	Q96GR2	76.57	98.0	232.0	DB08326	experimental	2-(6-HYDROXY-1,3-BENZOTHIAZOL-2-YL)-1,3-THIAZOL-4(5H)-ONE	c1cc(O)cc(c12)sc(n2)C3=NC(=O)CS3
3703	sp|P9WLU5|Y1549_MY	P33121	72.57	87.0	214.0	DB00131	approved; investigational; nutraceutical	Adenosine phosphate	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
3704	sp|P9WLU5|Y1549_MY	P33121	72.57	87.0	214.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
3705	sp|P9WLU5|Y1549_MY	O60488	74.86	100.0	231.0	DB00159	approved; nutraceutical	Icosapent	CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O
3706	sp|P9WLU5|Y1549_MY	O60488	74.86	100.0	231.0	DB00197	approved; investigational; withdrawn	Troglitazone	Cc1c(O)c(C)c(C)c(c12)OC(C)(CC2)COc3ccc(cc3)CC4SC(=O)NC4=O
3707	sp|P9WLU5|Y1549_MY	O60488	74.86	100.0	231.0	DB00412	approved; investigational	Rosiglitazone	c1cccnc1N(C)CCOc2ccc(cc2)CC3SC(=O)NC3=O
3708	sp|P9WLU5|Y1549_MY	Q8I0X2	78.86	64.0	202.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
3709	sp|P9WLZ3|Y1367_MY	Q9KX40	85.79	28.0	372.0	DB04491	experimental	Diisopropylphosphono Group	CC(C)OP(=O)OC(C)C
3710	sp|P9WHT5|Y2782_MY	P22695	93.15	37.0	445.0	DB04141	experimental	2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol	O[C@H]1[C@@H](O)[C@@H](CO)O[C@H]([C@@H]1O)OCCCCCC
3711	sp|P9WHT5|Y2782_MY	P22695	93.15	37.0	445.0	DB04799	experimental	6-Hydroxy-5-undecyl-4,7-benzothiazoledione	CCCCCCCCCCCC(C1=O)=C(O)C(=O)c(c12)scn2
3712	sp|P9WHT5|Y2782_MY	P22695	93.15	37.0	445.0	DB07401	experimental	Azoxystrobin	CO/C=C(/C(=O)OC)c1c(cccc1)Oc2ncnc(c2)Oc3ccccc3C#N
3713	sp|P9WHT5|Y2782_MY	P22695	93.15	37.0	445.0	DB07763	experimental	(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE	Fc1cc(F)ccc1[C@]2(C)OC(=O)N(C2=O)Nc3ccccc3
3714	sp|P9WHT5|Y2782_MY	P22695	93.15	37.0	445.0	DB07778	experimental	(S)-famoxadone	c1ccccc1NN(C(=O)O2)C(=O)[C@]2(C)c3ccc(cc3)Oc4ccccc4
3715	sp|P9WHT5|Y2782_MY	P22695	93.15	37.0	445.0	DB08330	experimental	METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE	CO/C=C(/C(=O)OC)c1c(cccc1)/C=C/c2ccccc2
3716	sp|P9WHT5|Y2782_MY	P22695	93.15	37.0	445.0	DB08453	experimental	2-Nonyl-4-quinolinol 1-oxide	CCCCCCCCCc(cc1O)[n+]([O-])c(c12)cccc2
3717	sp|P9WHT5|Y2782_MY	P22695	93.15	37.0	445.0	DB08690	experimental	Ubiquinone Q2	COC1=C(OC)C(=O)C(=C(C)C1=O)C/C=C(\C)CCC=C(C)C
3718	sp|P9WHT5|Y2782_MY	P31930	95.66	48.0	467.0	DB04141	experimental	2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol	O[C@H]1[C@@H](O)[C@@H](CO)O[C@H]([C@@H]1O)OCCCCCC
3719	sp|P9WHT5|Y2782_MY	P31930	95.66	48.0	467.0	DB04741	experimental	Myxothiazol	NC(=O)/C=C(/OC)[C@H](C)[C@@H](OC)/C=C/c1csc(n1)-c2csc(n2)[C@@H](C)/C=C/C=C/C(C)C
3720	sp|P9WHT5|Y2782_MY	P31930	95.66	48.0	467.0	DB04799	experimental	6-Hydroxy-5-undecyl-4,7-benzothiazoledione	CCCCCCCCCCCC(C1=O)=C(O)C(=O)c(c12)scn2
3721	sp|P9WHT5|Y2782_MY	P31930	95.66	48.0	467.0	DB07401	experimental	Azoxystrobin	CO/C=C(/C(=O)OC)c1c(cccc1)Oc2ncnc(c2)Oc3ccccc3C#N
3722	sp|P9WHT5|Y2782_MY	P31930	95.66	48.0	467.0	DB07763	experimental	(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE	Fc1cc(F)ccc1[C@]2(C)OC(=O)N(C2=O)Nc3ccccc3
3723	sp|P9WHT5|Y2782_MY	P31930	95.66	48.0	467.0	DB07778	experimental	(S)-famoxadone	c1ccccc1NN(C(=O)O2)C(=O)[C@]2(C)c3ccc(cc3)Oc4ccccc4
3724	sp|P9WHT5|Y2782_MY	P31930	95.66	48.0	467.0	DB08330	experimental	METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE	CO/C=C(/C(=O)OC)c1c(cccc1)/C=C/c2ccccc2
3725	sp|P9WHT5|Y2782_MY	P31930	95.66	48.0	467.0	DB08453	experimental	2-Nonyl-4-quinolinol 1-oxide	CCCCCCCCCc(cc1O)[n+]([O-])c(c12)cccc2
3726	sp|P9WHT5|Y2782_MY	P31930	95.66	48.0	467.0	DB08690	experimental	Ubiquinone Q2	COC1=C(OC)C(=O)C(=C(C)C1=O)C/C=C(\C)CCC=C(C)C
3727	sp|P9WFU5|SYM_MYCT	Q6GJI1	100.0	5.0	524.0	DB05224	investigational	REP8839	 
3728	sp|P9WFU5|SYM_MYCT	Q8IJ60	95.95	224.0	722.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
3729	sp|P9WFU5|SYM_MYCT	P00959	97.11	6.0	510.0	DB02151	experimental	Methionine Phosphonate	CSCC[C@H](N)P(=O)(O)O
3730	sp|P9WFU5|SYM_MYCT	P00959	97.11	6.0	510.0	DB02229	experimental	5'-O-[(L-methionyl)-sulphamoyl]adenosine	CSCC[C@H](N)C(=O)NS(=O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2C=NC(C23)=C(N)NC=N3
3731	sp|P9WFU5|SYM_MYCT	P00959	97.11	6.0	510.0	DB03799	experimental	Trifluoromethionine	OC(=O)[C@@H](N)CCSC(F)(F)F
3732	sp|P9WFU5|SYM_MYCT	P00959	97.11	6.0	510.0	DB03816	experimental	Difluoromethionine	OC(=O)[C@@H](N)CCSC(F)F
3733	sp|P9WFU5|SYM_MYCT	P00959	97.11	6.0	510.0	DB04015	experimental	Methionine Phosphinate	CSCC[C@H](N)P(=O)O
3734	sp|P9WFU5|SYM_MYCT	P41972	74.37	397.0	783.0	DB00410	approved; investigational; vet_approved	Mupirocin	C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@H]2CO[C@H]([C@H](O)[C@@H]2O)C/C(C)=C/C(=O)OCCCCCCCCC(=O)O
3735	sp|P9WFU5|SYM_MYCT	P41252	74.95	399.0	788.0	DB00167	investigational; nutraceutical	Isoleucine	CC[C@H](C)[C@H](N)C(=O)O
3736	sp|P9WFU5|SYM_MYCT	Q9NSE4	76.88	457.0	856.0	DB00167	investigational; nutraceutical	Isoleucine	CC[C@H](C)[C@H](N)C(=O)O
3737	sp|P9WFU5|SYM_MYCT	P56690	77.65	383.0	786.0	DB01755	experimental	N-[Isoleucinyl]-N'-[adenosyl]-diaminosufone	CC[C@H](C)[C@H](N)C(=O)NS(=O)(=O)NC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
3738	sp|P9WFU5|SYM_MYCT	P26640	78.23	675.0	1081.0	DB00161	approved; nutraceutical	Valine	CC(C)[C@H](N)C(=O)O
3739	sp|P9WL55|Y2636_MY	Q56148	74.67	2.0	170.0	DB02608	experimental	N-[(1R,2R)-1,3-Dihydroxy-1-(4-nitrophenyl)-2-propanyl]acetamide	CC(=O)N[C@H](CO)[C@H](O)c1ccc([N+]([O-])=O)cc1
3740	sp|P9WL55|Y2636_MY	Q56148	74.67	2.0	170.0	DB02930	experimental	Adenosine 5'-[gamma-thio]triphosphate	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=S)(O)O
3741	sp|P9WL55|Y2636_MY	Q56148	74.67	2.0	170.0	DB04411	experimental	Alpha-N-Dichloroacetyl-P-Aminophenylserinol	ClC(Cl)C(=O)N[C@H](CO)[C@H](O)c1ccc(N)cc1
3742	sp|P9WLQ1|Y1987_MY	P07986	76.06	374.0	482.0	DB01921	experimental	Xylose-derived lactam oxime	ONC1=NC[C@@H](O)[C@H](O)[C@H]1O
3743	sp|P9WLQ1|Y1987_MY	P07986	76.06	374.0	482.0	DB02374	experimental	Xylose-Derived Imidazole	O[C@@H]1[C@@H](O)[C@H](O)Cn(c12)ccn2
3744	sp|P9WLQ1|Y1987_MY	P07986	76.06	374.0	482.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
3745	sp|P9WLQ1|Y1987_MY	P07986	76.06	374.0	482.0	DB03389	experimental	alpha-D-Xylopyranose	O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O
3746	sp|P9WLQ1|Y1987_MY	P07986	76.06	374.0	482.0	DB03717	experimental	3-Hydroxy-4-(3,4,5-trihydroxy-tetrahydro-pyran-2-yloxy)-piperidin-2-one	O[C@@H]1C(=O)NCC[C@H]1O[C@@H]2OC[C@@H](O)[C@H](O)[C@H]2O
3747	sp|P9WLQ1|Y1987_MY	P07986	76.06	374.0	482.0	DB04282	experimental	2-deoxy-2-fluoro-α-D-glucose	O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1F
3748	sp|P9WLQ1|Y1987_MY	P26221	73.94	772.0	877.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
3749	sp|P9WLQ1|Y1987_MY	Q54331	72.54	276.0	379.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
3750	sp|P9WLQ1|Y1987_MY	Q54331	72.54	276.0	379.0	DB02467	experimental	L-methionine (S)-S-oxide	C[S@](=O)CC[C@@H](C([O-])=O)[NH3+]
3751	sp|P9WLQ1|Y1987_MY	Q54331	72.54	276.0	379.0	DB04282	experimental	2-deoxy-2-fluoro-α-D-glucose	O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1F
3752	sp|P9WGR3|Y2073_MY	O75911	99.6	34.0	282.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
3753	sp|P9WGR3|Y2073_MY	Q8NBQ5	96.79	34.0	275.0	DB02854	experimental	Aetiocholanolone	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](CC3)C[C@H](O)CC4
3754	sp|P9WGR3|Y2073_MY	Q9WYS2	80.32	6.0	206.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3755	sp|P9WGR3|Y2073_MY	P16544	85.54	5.0	218.0	DB01942	experimental; investigational	Formic acid	OC=O
3756	sp|P9WGR3|Y2073_MY	P16544	85.54	5.0	218.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3757	sp|P9WGR3|Y2073_MY	P16544	85.54	5.0	218.0	DB07715	investigational	Emodin	Cc(c1)cc(O)c(c12)C(=O)c3c(C2=O)cc(O)cc3O
3759	sp|P9WGR3|Y2073_MY	P0AEK2	76.31	4.0	194.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3760	sp|P9WGR3|Y2073_MY	Q9BTZ2	79.12	29.0	226.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
3763	sp|P9WGR3|Y2073_MY	Q92506	85.54	9.0	222.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3764	sp|P9WGR3|Y2073_MY	Q92506	85.54	9.0	222.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3765	sp|P9WGR3|Y2073_MY	P0AET8	78.31	9.0	204.0	DB02123	experimental	Glycochenodeoxycholic Acid	OC(=O)CNC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
3766	sp|P9WGR3|Y2073_MY	Q6UWP2	92.37	10.0	240.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3767	sp|P9WGR3|Y2073_MY	Q6PKH6	73.49	26.0	209.0	DB04200	experimental	Matairesinol	COc1cc(ccc1O)C[C@H]2COC(=O)[C@@H]2Cc3ccc(O)c(c3)OC
3768	sp|P9WGR3|Y2073_MY	Q84EX5	77.91	5.0	199.0	DB04619	experimental	Acetophenone	CC(=O)c1ccccc1
3769	sp|P9WGR3|Y2073_MY	Q84EX5	77.91	5.0	199.0	DB04784	experimental	(R)-1-phenylethanol	C[C@@H](O)c1ccccc1
3770	sp|P9WGR3|Y2073_MY	Q8TC12	81.93	39.0	243.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
3771	sp|P9WGR3|Y2073_MY	P14061	82.73	2.0	208.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3772	sp|P9WGR3|Y2073_MY	P14061	82.73	2.0	208.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
3773	sp|P9WGR3|Y2073_MY	P14061	82.73	2.0	208.0	DB01561	experimental; illicit	Androstanedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
3774	sp|P9WGR3|Y2073_MY	P14061	82.73	2.0	208.0	DB02187	experimental	Equilin	O=C1CC[C@H]([C@@]12C)C=3[C@H](CC2)c4c(CC3)cc(O)cc4
3775	sp|P9WGR3|Y2073_MY	P14061	82.73	2.0	208.0	DB02323	experimental	EM-1745	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)C[C@@H]([C@@H]4O)CCCCCCCCC(=O)OC[C@H]5O[C@H]([C@H](O)[C@@H]5O)n6cnc(c67)c(N)ncn7
3776	sp|P9WGR3|Y2073_MY	P14061	82.73	2.0	208.0	DB02901	illicit; investigational	Stanolone	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
3777	sp|P9WGR3|Y2073_MY	P14061	82.73	2.0	208.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3778	sp|P9WGR3|Y2073_MY	P14061	82.73	2.0	208.0	DB13951	experimental	Stanolone acetate	CC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
3779	sp|P9WGR3|Y2073_MY	Q9BY49	76.71	16.0	207.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
3780	sp|P9WGR3|Y2073_MY	Q9NYR8	77.51	6.0	199.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
3782	sp|P9WGR3|Y2073_MY	Q8NBN7	81.12	38.0	240.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
3783	sp|P9WGR3|Y2073_MY	P0CG22	80.32	29.0	229.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
3784	sp|P9WGR3|Y2073_MY	P0CG22	80.32	29.0	229.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3785	sp|P9WGR3|Y2073_MY	P0CG22	80.32	29.0	229.0	DB03541	experimental	10-Propargyl-5,8-Dideazafolic Acid	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(CC#C)Cc(c2)ccc(c23)[nH]c(N)nc3=O
3786	sp|P9WGR3|Y2073_MY	P0CG22	80.32	29.0	229.0	DB07689	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)NCc(cn3)nc(c34)c(N)nc(n4)N
3787	sp|P9WGR3|Y2073_MY	P0CG22	80.32	29.0	229.0	DB07765	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)N(C)Cc(cn3)nc(c34)c(N)nc(n4)N
3788	sp|P9WGR3|Y2073_MY	Q96NR8	81.93	37.0	241.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
3789	sp|P9WGR3|Y2073_MY	Q02338	76.31	53.0	243.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3790	sp|P9WGR3|Y2073_MY	P51659	85.14	8.0	220.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3791	sp|P9WGR3|Y2073_MY	P51659	85.14	8.0	220.0	DB03192	experimental	(R)-3-hydroxydecanoyl-CoA	CCCCCCC[C@@H](O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
3792	sp|P9WGR3|Y2073_MY	Q7Z4W1	76.31	5.0	195.0	DB02831	experimental	Dihydrogenphosphate	OP([O-])(=O)O
3793	sp|P9WGR3|Y2073_MY	Q7Z4W1	76.31	5.0	195.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3794	sp|P9WGR3|Y2073_MY	P28845	89.16	32.0	254.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3795	sp|P9WGR3|Y2073_MY	P28845	89.16	32.0	254.0	DB02329	experimental	Carbenoxolone	OC(=O)CCC(=O)O[C@@H](CC1)C(C)(C)[C@@H]([C@]12C)CC[C@]3(C)[C@@H]2C(=O)C=C4[C@H]5[C@@](C)(CC[C@@]34C)CC[C@](C5)(C)C(=O)O
3796	sp|P9WGR3|Y2073_MY	P28845	89.16	32.0	254.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3797	sp|P9WGR3|Y2073_MY	P28845	89.16	32.0	254.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
3798	sp|P9WGR3|Y2073_MY	P28845	89.16	32.0	254.0	DB04652	experimental	Corticosterone	OCC(=O)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H]([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
3799	sp|P9WGR3|Y2073_MY	P28845	89.16	32.0	254.0	DB05064	investigational	INCB13739	 
3800	sp|P9WGR3|Y2073_MY	P28845	89.16	32.0	254.0	DB06992	experimental	(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone	Cc1ccc(cc1F)-c2nc(ccc2)C(=O)N(CC3(C)C)CCC3
3801	sp|P9WGR3|Y2073_MY	P28845	89.16	32.0	254.0	DB07017	experimental	(5S)-2-{[(1S)-1-(4-Fluorophenyl)ethyl]amino}-5-(2-hydroxy-2-propanyl)-5-methyl-1,3-thiazol-4(5H)-one	Fc1ccc(cc1)[C@H](C)NC(=NC2=O)S[C@@]2(C)C(C)(C)O
3802	sp|P9WGR3|Y2073_MY	P28845	89.16	32.0	254.0	DB07049	experimental	(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine	[O-][N+](=O)c1ccc(cc1)N2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)C(C)(C)C
3803	sp|P9WGR3|Y2073_MY	P28845	89.16	32.0	254.0	DB07056	experimental	2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide	CCN(CC)C(=O)Cc1cccc(n1)NS(=O)(=O)c2c(C)c(Cl)ccc2
3804	sp|P9WGR3|Y2073_MY	P28845	89.16	32.0	254.0	DB07310	experimental	(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one	Fc1ccccc1[C@H](C)NC(=NC2=O)S[C@]2(C)C(F)(F)F
3805	sp|P9WGR3|Y2073_MY	P28845	89.16	32.0	254.0	DB07316	experimental	N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)C3CCN(CC3)CC4(CC4)C(=O)N
3806	sp|P9WGR3|Y2073_MY	P28845	89.16	32.0	254.0	DB07619	experimental	N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)[C@H]3CC[C@@H](CC3)c4cccnc4
3807	sp|P9WGR3|Y2073_MY	P28845	89.16	32.0	254.0	DB07624	experimental	1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide	C1CC1(C(=O)N)CN2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)[C@](C)(O)C(F)(F)F
3808	sp|P9WGR3|Y2073_MY	P28845	89.16	32.0	254.0	DB07866	experimental	(5S)-2-(Cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one	CCC[C@]1(C)SC(=NC1=O)NC2CCCCCCC2
3809	sp|P9WGR3|Y2073_MY	P28845	89.16	32.0	254.0	DB08277	experimental	2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE	CS(=O)(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4c(Cl)cc(F)cc4
3810	sp|P9WGR3|Y2073_MY	P28845	89.16	32.0	254.0	DB08280	experimental	(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE	NC(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4ccc(OC)cc4
3811	sp|P9WGR3|Y2073_MY	P28845	89.16	32.0	254.0	DB08771	experimental	(5R)-2-[(2-Fluorophenyl)amino]-5-isopropyl-1,3-thiazol-4(5H)-one	CC(C)[C@H]1SC(=NC1=O)Nc2c(F)cccc2
3812	sp|P9WGR3|Y2073_MY	P28845	89.16	32.0	254.0	DB13751	approved; experimental	Glycyrrhizic acid	C1C[C@](C)(C(=O)O)C[C@H]([C@]12C)C=3[C@@](C)(CC2)[C@@]4(C)[C@H](C(=O)C3)[C@]5(C)[C@@H](CC4)C(C)(C)[C@H](CC5)O[C@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O[C@@H]7O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]7O
3813	sp|P9WGR3|Y2073_MY	Q99714	84.74	9.0	220.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3814	sp|P9WGR3|Y2073_MY	Q99714	84.74	9.0	220.0	DB02820	experimental	1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct	C1CCCCCN1C(=O)[C@H](c2ccccc2)n(c3=S)cnc(c34)nn(c4)[C@H]5C=CN(C=C5C([O-])=N)[C@@H]6O[C@@H]([C@@H](O)[C@H]6O)COP([O-])(=O)OP(=O)(O)OC[C@H]7O[C@H]([C@H]([O-])[C@@H]7[O-])n8cnc(c89)c(N)ncn9
3815	sp|P9WGR3|Y2073_MY	Q99714	84.74	9.0	220.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
3816	sp|P9WGR3|Y2073_MY	Q9HBH5	89.96	42.0	266.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
3817	sp|P9WGR3|Y2073_MY	P37058	82.33	48.0	253.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3818	sp|P9WGR3|Y2073_MY	Q16698	75.9	57.0	246.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3819	sp|P9WGR3|Y2073_MY	Q16698	75.9	57.0	246.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
3820	sp|P9WGR3|Y2073_MY	P37059	77.11	81.0	273.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3821	sp|P9WGR3|Y2073_MY	P37059	77.11	81.0	273.0	DB13952	approved; investigational; vet_approved	Estradiol acetate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)C
3822	sp|P9WGR3|Y2073_MY	P37059	77.11	81.0	273.0	DB13953	approved; investigational; vet_approved	Estradiol benzoate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)c5ccccc5
3823	sp|P9WGR3|Y2073_MY	P37059	77.11	81.0	273.0	DB13954	approved; investigational; vet_approved	Estradiol cypionate	C1CCCC1CCC(=O)O[C@H]2CC[C@H]([C@@]23C)[C@H]4[C@H](CC3)c5c(CC4)cc(O)cc5
3824	sp|P9WGR3|Y2073_MY	P37059	77.11	81.0	273.0	DB13955	approved; investigational; vet_approved	Estradiol dienanthate	CCCCCCC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)CCCCCC
3825	sp|P9WGR3|Y2073_MY	P37059	77.11	81.0	273.0	DB13956	approved; investigational; vet_approved	Estradiol valerate	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)CC[C@@H]4OC(=O)CCCC
3826	sp|P9WGR3|Y2073_MY	P80365	77.11	81.0	273.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3827	sp|P9WGR3|Y2073_MY	P80365	77.11	81.0	273.0	DB01185	approved; illicit	Fluoxymesterone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@](F)([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
3828	sp|P9WGR3|Y2073_MY	P80365	77.11	81.0	273.0	DB01569	experimental; illicit	Formebolone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@H]([C@@H](C2)O)[C@]4(C)C(CC3)=CC(=O)C(C=O)=C4
3829	sp|P9WGR3|Y2073_MY	P80365	77.11	81.0	273.0	DB14538	experimental; vet_approved	Hydrocortisone aceponate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CC)C(=O)COC(=O)C
3830	sp|P9WGR3|Y2073_MY	P80365	77.11	81.0	273.0	DB14539	approved; vet_approved	Hydrocortisone acetate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)C
3831	sp|P9WGR3|Y2073_MY	P80365	77.11	81.0	273.0	DB14540	approved; vet_approved	Hydrocortisone butyrate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCC
3832	sp|P9WGR3|Y2073_MY	P80365	77.11	81.0	273.0	DB14541	approved; investigational; vet_approved	Hydrocortisone cypionate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)CCC5CCCC5
3833	sp|P9WGR3|Y2073_MY	P80365	77.11	81.0	273.0	DB14542	approved; vet_approved	Hydrocortisone phosphate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COP(=O)(O)O
3834	sp|P9WGR3|Y2073_MY	P80365	77.11	81.0	273.0	DB14543	approved; vet_approved	Hydrocortisone probutate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CCC)C(=O)COC(=O)CC
3835	sp|P9WGR3|Y2073_MY	P80365	77.11	81.0	273.0	DB14544	approved; vet_approved	Hydrocortisone valerate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCCC
3836	sp|P9WGR3|Y2073_MY	Q92781	75.5	27.0	215.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3837	sp|P9WGR3|Y2073_MY	Q92781	75.5	27.0	215.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
3838	sp|P9WGR3|Y2073_MY	Q6GI75	79.52	3.0	201.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
3839	sp|P9WGR3|Y2073_MY	Q6GI75	79.52	3.0	201.0	DB11155	approved	Triclocarban	Clc1ccc(cc1)NC(=O)Nc2cc(Cl)c(Cl)cc2
3840	sp|P9WGR3|Y2073_MY	A0A348A0U3	80.32	1.0	201.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
3841	sp|P9WGR3|Y2073_MY	P56937	93.98	2.0	236.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3842	sp|P9WGR3|Y2073_MY	Q7AUG5	79.92	3.0	202.0	DB04782	experimental	(S)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@H]2CO2
3843	sp|P9WGR3|Y2073_MY	Q93D82	79.92	3.0	202.0	DB04472	experimental	(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol	[N-]=[N+]=NC[C@H](O)c1ccc([N+]([O-])=O)cc1
3844	sp|P9WGR3|Y2073_MY	Q93D82	79.92	3.0	202.0	DB04499	experimental	(R)-styrene oxide	C1O[C@@H]1c2ccccc2
3845	sp|P9WGR3|Y2073_MY	Q93D82	79.92	3.0	202.0	DB04777	experimental	(R)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@@H]2CO2
3846	sp|P9WGR3|Y2073_MY	P35270	85.14	5.0	217.0	DB02637	experimental	Oxaloacetate Ion	OC(=O)C(=O)CC([O-])=O
3847	sp|P9WGR3|Y2073_MY	P35270	85.14	5.0	217.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3848	sp|P9WGR3|Y2073_MY	P35270	85.14	5.0	217.0	DB03886	experimental	Biopterin	C[C@@H](O)[C@@H](O)c(n1)cnc(c12)nc(N)[nH]c2=O
3849	sp|P9WGR3|Y2073_MY	P35270	85.14	5.0	217.0	DB04275	experimental	N-acetylserotonin	CC(=O)NCCc1c[nH]c(c12)ccc(c2)O
3850	sp|P9WGR3|Y2073_MY	P0AEK4	78.71	4.0	200.0	DB01691	experimental	Indole Naphthyridinone	c1cccc(c12)n(C)cc2CN(C)C(=O)/C=C/c(c3)cnc(c34)NC(=O)CC4
3851	sp|P9WGR3|Y2073_MY	P0AEK4	78.71	4.0	200.0	DB01865	experimental	3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide	c1cccc(c12)cc(n2C)CN(C)C(=O)/C=C/c3cnc(N)cc3
3852	sp|P9WGR3|Y2073_MY	P0AEK4	78.71	4.0	200.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
3853	sp|P9WGR3|Y2073_MY	P0AEK4	78.71	4.0	200.0	DB03030	experimental	4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole	Cc1ccc(cc1)Cn2cnc(c2)-c3cccs3
3854	sp|P9WGR3|Y2073_MY	P0AEK4	78.71	4.0	200.0	DB03534	experimental	3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide	CC(=O)N(C)Cc1c(N)ccc(c1)C(=O)N(C)Cc(n2C)cc(c23)cccc3
3855	sp|P9WGR3|Y2073_MY	P0AEK4	78.71	4.0	200.0	DB04030	experimental	1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole	Oc1ccc(cc1)Cn2c(c3c(c24)cccc4)CN(CC3)C(=O)c5ccc(O)cc5
3856	sp|P9WGR3|Y2073_MY	P0AEK4	78.71	4.0	200.0	DB08265	experimental	2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL	Cc1ccc(cc1)S(=O)(=O)n(b2O)ncc(c23)cccc3
3857	sp|P9WGR3|Y2073_MY	P0AEK4	78.71	4.0	200.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
3858	sp|P9WGR3|Y2073_MY	P0AEK4	78.71	4.0	200.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
3859	sp|P9WGR3|Y2073_MY	Q8I814	80.72	13.0	214.0	DB02015	experimental	Dihydrofolic Acid	O=c1[nH]c(N)nc(c12)NCC(=N2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
3860	sp|P9WGR3|Y2073_MY	Q8I814	80.72	13.0	214.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3861	sp|P9WGR3|Y2073_MY	O24990	78.71	4.0	200.0	DB04393	experimental	Soneclosan	Clc1cc(O)c(cc1)Oc2ccc(Cl)cc2
3862	sp|P9WGR3|Y2073_MY	O24990	78.71	4.0	200.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
3863	sp|P9WGR3|Y2073_MY	Q01782	87.55	8.0	226.0	DB02338	experimental	NADPH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3864	sp|P9WGR3|Y2073_MY	Q01782	87.55	8.0	226.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
3865	sp|P9WGR3|Y2073_MY	Q01782	87.55	8.0	226.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
3866	sp|P9WGR3|Y2073_MY	Q01782	87.55	8.0	226.0	DB04400	experimental	L-erythro-7,8-dihydrobiopterin	C[C@H](O)[C@H](O)C(CN1)=Nc(c12)c(=O)nc([nH]2)N
3867	sp|P9WGR3|Y2073_MY	P9WGR1	77.91	5.0	199.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
3868	sp|P9WGR3|Y2073_MY	P9WGR1	77.91	5.0	199.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
3869	sp|P9WGR3|Y2073_MY	P9WGR1	77.91	5.0	199.0	DB02990	experimental	S-(2-Acetamidoethyl) hexadecanethioate	CCCCCCCCCCCCCCCC(=O)SCCNC(=O)C
3870	sp|P9WGR3|Y2073_MY	P9WGR1	77.91	5.0	199.0	DB04289	experimental	Genz-10850	[nH]1ccc(c12)cc(cc2)C(=O)N3CCN(CC3)C4c(cccc5)c5c(c46)cccc6
3871	sp|P9WGR3|Y2073_MY	P9WGR1	77.91	5.0	199.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
3872	sp|P9WGR3|Y2073_MY	P9WGR1	77.91	5.0	199.0	DB07090	experimental	(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cccc(c1C)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
3873	sp|P9WGR3|Y2073_MY	P9WGR1	77.91	5.0	199.0	DB07123	experimental	N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE	Cc1ccc(cc1)C(=O)N2CCC(CC2)Cc3ccccc3
3874	sp|P9WGR3|Y2073_MY	P9WGR1	77.91	5.0	199.0	DB07155	experimental	(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE	c1ccccc1NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
3875	sp|P9WGR3|Y2073_MY	P9WGR1	77.91	5.0	199.0	DB07178	experimental	5-PENTYL-2-PHENOXYPHENOL	CCCCCc1cc(O)c(cc1)Oc2ccccc2
3876	sp|P9WGR3|Y2073_MY	P9WGR1	77.91	5.0	199.0	DB07188	experimental	(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(cc(Cl)c1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
3877	sp|P9WGR3|Y2073_MY	P9WGR1	77.91	5.0	199.0	DB07192	experimental	(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Brc1cc(ccc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
3878	sp|P9WGR3|Y2073_MY	P9WGR1	77.91	5.0	199.0	DB07222	experimental	(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(c(C)cc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
3879	sp|P9WGR3|Y2073_MY	P9WGR1	77.91	5.0	199.0	DB07287	experimental	2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL	c1cccnc1Cc2cc(O)c(cc2)Oc3ccc(Cl)cc3Cl
3880	sp|P9WGR3|Y2073_MY	P9WGR1	77.91	5.0	199.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
3881	sp|P9WGR3|Y2073_MY	P09417	83.94	10.0	219.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
3882	sp|P9WGR3|Y2073_MY	P09417	83.94	10.0	219.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
3883	sp|P9WGR3|Y2073_MY	Q8T8E9	77.51	2.0	195.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
3884	sp|P9WGR3|Y2073_MY	P26391	76.71	3.0	194.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
3887	sp|P9WMS5|Y3376_MY	P34913	97.7	1.0	213.0	DB02029	experimental	N-Cyclohexyl-N'-(4-Iodophenyl)Urea	Ic1ccc(cc1)NC(=O)NC2CCCCC2
3888	sp|P9WMS5|Y3376_MY	P34913	97.7	1.0	213.0	DB03677	experimental	N-Cyclohexyl-N'-Decylurea	CCCCCCCCCCNC(=O)NC1CCCCC1
3889	sp|P9WMS5|Y3376_MY	P34913	97.7	1.0	213.0	DB04213	experimental	N-Cyclohexyl-N'-(Propyl)Phenyl Urea	C1CCCCC1NC(=O)NCCCc2ccccc2
3890	sp|P9WMS5|Y3376_MY	P34913	97.7	1.0	213.0	DB06345	investigational	AR-9281	CC(=O)N1CCC(CC1)NC(=O)NC23CC4CC(C2)CC(C4)C3
3891	sp|P9WMS5|Y3376_MY	P34913	97.7	1.0	213.0	DB08256	experimental	N-[(CYCLOHEXYLAMINO)CARBONYL]GLYCINE	OC(=O)CNC(=O)NC1CCCCC1
3892	sp|P9WMS5|Y3376_MY	P34913	97.7	1.0	213.0	DB08257	experimental	4-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}BUTANOIC ACID	OC(=O)CCCNC(=O)NC1CCCCC1
3893	sp|P9WMS5|Y3376_MY	P34913	97.7	1.0	213.0	DB08258	experimental	6-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEXANOIC ACID	OC(=O)CCCCCNC(=O)NC1CCCCC1
3894	sp|P9WMS5|Y3376_MY	P34913	97.7	1.0	213.0	DB08259	experimental	7-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEPTANOIC ACID	OC(=O)CCCCCCNC(=O)NC1CCCCC1
3895	sp|P9WMS5|Y3376_MY	P34913	97.7	1.0	213.0	DB12610	investigational	Ebselen	c1cccc(c12)[se]n(c2=O)-c3ccccc3
3896	sp|P9WMS5|Y3376_MY	O31156	92.17	1.0	201.0	DB03174	experimental	Phosphonoacetaldehyde	OP(=O)(O)CC=O
3897	sp|P9WMS5|Y3376_MY	O31156	92.17	1.0	201.0	DB03635	experimental	Ethanesulfonic acid	CCS(=O)(=O)O
3898	sp|P9WMS5|Y3376_MY	O31156	92.17	1.0	201.0	DB04359	experimental	Vinylsulfonic acid	OS(=O)(=O)C=C
3899	sp|P9WMS5|Y3376_MY	P71447	90.32	3.0	199.0	DB01857	experimental	Phosphoaspartate	OC(=O)[C@@H](N)CC(=O)OP(=O)(O)O
3900	sp|P9WMS5|Y3376_MY	P71447	90.32	3.0	199.0	DB02317	experimental	Alpha-D-Galactose-1-Phosphate	OC[C@H]1O[C@H](OP(=O)(O)O)[C@H](O)[C@@H](O)[C@H]1O
3901	sp|P9WMS5|Y3376_MY	P71447	90.32	3.0	199.0	DB02835	experimental	Alpha-D-Glucose 1,6-Bisphosphate	OP(=O)(O)OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O1)OP(=O)(O)O
3902	sp|P9WMS5|Y3376_MY	Q7ADF8	88.94	6.0	199.0	DB02726	experimental	2-Phosphoglycolic Acid	OC(=O)COP(=O)(O)O
3903	sp|P9WQK1|Y986_MYC	O95342	94.35	418.0	652.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
3904	sp|P9WQK1|Y986_MYC	O95342	94.35	418.0	652.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
3905	sp|P9WQK1|Y986_MYC	O95342	97.18	1073.0	1314.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
3906	sp|P9WQK1|Y986_MYC	O95342	97.18	1073.0	1314.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
3907	sp|P9WQK1|Y986_MYC	P08183	93.95	389.0	622.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
3908	sp|P9WQK1|Y986_MYC	P08183	93.95	389.0	622.0	DB00603	approved; investigational	Medroxyprogesterone acetate	CC(=O)O[C@]1(C(=O)C)CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C([C@H](C3)C)=CC(=O)CC4
3909	sp|P9WQK1|Y986_MYC	P08183	93.95	389.0	622.0	DB00778	approved; investigational; withdrawn	Roxithromycin	COCCOCO/N=C([C@H](C)[C@@H](O)[C@]1(C)O)/[C@H](C)C[C@@](C)(O)[C@@H]([C@@H](C)[C@@H]([C@@H](C)C(=O)O[C@@H]1CC)O[C@@H](C[C@@]2(C)OC)O[C@@H](C)[C@@H]2O)O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C
3910	sp|P9WQK1|Y986_MYC	P08183	93.95	389.0	622.0	DB00813	approved; illicit; investigational; vet_approved	Fentanyl	c1ccccc1N(C(=O)CC)C2CCN(CC2)CCc3ccccc3
3911	sp|P9WQK1|Y986_MYC	P08183	93.95	389.0	622.0	DB04877	experimental	Voacamine	CC[C@H]1C[C@@H](C2)CN([C@@H]1[C@@]23C(=O)OC)CCc4c3[nH]c5c4cc(OC)c(c5)[C@@H](C[C@H]67)c8c(c9c([nH]8)cccc9)C[C@H](C6C(=O)OC)N(C)CC\7=C\C
3912	sp|P9WQK1|Y986_MYC	P08183	93.95	389.0	622.0	DB04881	investigational	Elacridar	COc1cccc(c12)c(=O)c3c([nH]2)c(ccc3)C(=O)Nc4ccc(cc4)CCN(C5)CCc(c56)cc(OC)c(c6)OC
3913	sp|P9WQK1|Y986_MYC	P08183	93.95	389.0	622.0	DB04905	investigational	Tesmilifene	CCN(CC)CCOc1ccc(cc1)Cc2ccccc2
3914	sp|P9WQK1|Y986_MYC	P08183	93.95	389.0	622.0	DB05449	investigational	FM-VP4	 
3915	sp|P9WQK1|Y986_MYC	P08183	93.95	389.0	622.0	DB06191	investigational	Zosuquidar	FC1(F)[C@H]2[C@@H]1c(cccc3)c3[C@@H](c(c24)cccc4)N5CCN(CC5)C[C@@H](O)COc6cccc(c67)nccc7
3916	sp|P9WQK1|Y986_MYC	P08183	93.95	389.0	622.0	DB06240	investigational	Tariquidar	COc(c1)c(OC)cc(c12)CCN(C2)CCc3ccc(cc3)NC(=O)c4cc(OC)c(OC)cc4NC(=O)c(c5)cnc(c56)cccc6
3917	sp|P9WQK1|Y986_MYC	P08183	93.95	389.0	622.0	DB09031	approved; investigational	Miltefosine	CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C
3918	sp|P9WQK1|Y986_MYC	P08183	93.95	389.0	622.0	DB11635	approved	Tocofersolan	 
3919	sp|P9WQK1|Y986_MYC	P08183	93.95	389.0	622.0	DB14061	experimental	Hycanthone	CCN(CC)CCNc(ccc1CO)c(c12)c(=O)c3c(s2)cccc3
3920	sp|P9WQK1|Y986_MYC	P08183	93.95	389.0	622.0	DB14062	experimental	Concanamycin A	NC(=O)O[C@@H]1[C@@H](C)O[C@H](C[C@H]1O)O[C@H](C2)[C@H](C)[C@@H](/C=C/C)O[C@@]2(O)[C@@H](C)[C@H](O)[C@H](C)[C@H]3OC(=O)/C(OC)=C/C(C)=C/[C@@H](C)[C@@H](O)[C@@H](CC)[C@@H](O)[C@H](C)C/C(C)=C/C=C/[C@@H]3OC
3921	sp|P9WQK1|Y986_MYC	P08183	93.95	389.0	622.0	DB14063	experimental	Dexverapamil	COc1ccc(cc1OC)CCN(C)CCC[C@@](C#N)(C(C)C)c2cc(OC)c(OC)cc2
3922	sp|P9WQK1|Y986_MYC	P08183	93.95	389.0	622.0	DB14064	experimental	Emopamil	c1ccccc1C(C#N)(C(C)C)CCCN(C)CCc2ccccc2
3923	sp|P9WQK1|Y986_MYC	P08183	93.95	389.0	622.0	DB14065	experimental	Lomerizine	COc1ccc(c(OC)c1OC)CN2CCN(CC2)C(c3ccc(F)cc3)c4ccc(F)cc4
3924	sp|P9WQK1|Y986_MYC	P08183	93.95	389.0	622.0	DB14066	experimental	Tetrandrine	c12ccc(OC)c(c1)Oc3ccc(cc3)C[C@H]4c5c(CCN4C)cc(OC)c(c5)Oc6c7c(CCN(C)[C@H]7C2)cc(OC)c6OC
3925	sp|P9WQK1|Y986_MYC	P08183	93.95	389.0	622.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
3926	sp|P9WQK1|Y986_MYC	P08183	93.95	389.0	622.0	DB14068	experimental	Dexniguldipine	[O-][N+](=O)c1cccc(c1)[C@@H]2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCCN(CC3)CCC3(c4ccccc4)c5ccccc5
3927	sp|P9WQK1|Y986_MYC	P08183	93.95	389.0	622.0	DB14069	investigational	ONT-093	CCOC/C=C/c1ccc(cc1)-c2nc(-c3ccc(cc3)NC(C)C)c([nH]2)-c4ccc(cc4)NC(C)C
3928	sp|P9WQK1|Y986_MYC	P08183	93.95	389.0	622.0	DB14070	experimental	HM-30181	c1cccc(c12)c(=O)cc(o2)C(=O)Nc3cc(OC)c(OC)cc3-c4nn(nn4)-c5ccc(cc5)CCN(C6)CCc(c67)cc(OC)c(c7)OC
3929	sp|P9WQK1|Y986_MYC	P08183	93.95	389.0	622.0	DB14071	experimental	Desmethylsertraline	c1cccc(c12)[C@@H](CC[C@@H]2N)c3cc(Cl)c(Cl)cc3
3930	sp|P9WQK1|Y986_MYC	P08183	93.95	389.0	622.0	DB14072	experimental	Reversin 121	c1ccccc1COC(=O)C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@H](C(=O)OC(C)(C)C)CCCCNC(=O)OCc2ccccc2
3931	sp|P9WQK1|Y986_MYC	P08183	93.55	1033.0	1265.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
3932	sp|P9WQK1|Y986_MYC	P08183	93.55	1033.0	1265.0	DB00603	approved; investigational	Medroxyprogesterone acetate	CC(=O)O[C@]1(C(=O)C)CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C([C@H](C3)C)=CC(=O)CC4
3933	sp|P9WQK1|Y986_MYC	P08183	93.55	1033.0	1265.0	DB00778	approved; investigational; withdrawn	Roxithromycin	COCCOCO/N=C([C@H](C)[C@@H](O)[C@]1(C)O)/[C@H](C)C[C@@](C)(O)[C@@H]([C@@H](C)[C@@H]([C@@H](C)C(=O)O[C@@H]1CC)O[C@@H](C[C@@]2(C)OC)O[C@@H](C)[C@@H]2O)O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C
3934	sp|P9WQK1|Y986_MYC	P08183	93.55	1033.0	1265.0	DB00813	approved; illicit; investigational; vet_approved	Fentanyl	c1ccccc1N(C(=O)CC)C2CCN(CC2)CCc3ccccc3
3935	sp|P9WQK1|Y986_MYC	P08183	93.55	1033.0	1265.0	DB04877	experimental	Voacamine	CC[C@H]1C[C@@H](C2)CN([C@@H]1[C@@]23C(=O)OC)CCc4c3[nH]c5c4cc(OC)c(c5)[C@@H](C[C@H]67)c8c(c9c([nH]8)cccc9)C[C@H](C6C(=O)OC)N(C)CC\7=C\C
3936	sp|P9WQK1|Y986_MYC	P08183	93.55	1033.0	1265.0	DB04881	investigational	Elacridar	COc1cccc(c12)c(=O)c3c([nH]2)c(ccc3)C(=O)Nc4ccc(cc4)CCN(C5)CCc(c56)cc(OC)c(c6)OC
3937	sp|P9WQK1|Y986_MYC	P08183	93.55	1033.0	1265.0	DB04905	investigational	Tesmilifene	CCN(CC)CCOc1ccc(cc1)Cc2ccccc2
3938	sp|P9WQK1|Y986_MYC	P08183	93.55	1033.0	1265.0	DB05449	investigational	FM-VP4	 
3939	sp|P9WQK1|Y986_MYC	P08183	93.55	1033.0	1265.0	DB06191	investigational	Zosuquidar	FC1(F)[C@H]2[C@@H]1c(cccc3)c3[C@@H](c(c24)cccc4)N5CCN(CC5)C[C@@H](O)COc6cccc(c67)nccc7
3940	sp|P9WQK1|Y986_MYC	P08183	93.55	1033.0	1265.0	DB06240	investigational	Tariquidar	COc(c1)c(OC)cc(c12)CCN(C2)CCc3ccc(cc3)NC(=O)c4cc(OC)c(OC)cc4NC(=O)c(c5)cnc(c56)cccc6
3941	sp|P9WQK1|Y986_MYC	P08183	93.55	1033.0	1265.0	DB09031	approved; investigational	Miltefosine	CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C
3942	sp|P9WQK1|Y986_MYC	P08183	93.55	1033.0	1265.0	DB11635	approved	Tocofersolan	 
3943	sp|P9WQK1|Y986_MYC	P08183	93.55	1033.0	1265.0	DB14061	experimental	Hycanthone	CCN(CC)CCNc(ccc1CO)c(c12)c(=O)c3c(s2)cccc3
3944	sp|P9WQK1|Y986_MYC	P08183	93.55	1033.0	1265.0	DB14062	experimental	Concanamycin A	NC(=O)O[C@@H]1[C@@H](C)O[C@H](C[C@H]1O)O[C@H](C2)[C@H](C)[C@@H](/C=C/C)O[C@@]2(O)[C@@H](C)[C@H](O)[C@H](C)[C@H]3OC(=O)/C(OC)=C/C(C)=C/[C@@H](C)[C@@H](O)[C@@H](CC)[C@@H](O)[C@H](C)C/C(C)=C/C=C/[C@@H]3OC
3945	sp|P9WQK1|Y986_MYC	P08183	93.55	1033.0	1265.0	DB14063	experimental	Dexverapamil	COc1ccc(cc1OC)CCN(C)CCC[C@@](C#N)(C(C)C)c2cc(OC)c(OC)cc2
3946	sp|P9WQK1|Y986_MYC	P08183	93.55	1033.0	1265.0	DB14064	experimental	Emopamil	c1ccccc1C(C#N)(C(C)C)CCCN(C)CCc2ccccc2
3947	sp|P9WQK1|Y986_MYC	P08183	93.55	1033.0	1265.0	DB14065	experimental	Lomerizine	COc1ccc(c(OC)c1OC)CN2CCN(CC2)C(c3ccc(F)cc3)c4ccc(F)cc4
3948	sp|P9WQK1|Y986_MYC	P08183	93.55	1033.0	1265.0	DB14066	experimental	Tetrandrine	c12ccc(OC)c(c1)Oc3ccc(cc3)C[C@H]4c5c(CCN4C)cc(OC)c(c5)Oc6c7c(CCN(C)[C@H]7C2)cc(OC)c6OC
3949	sp|P9WQK1|Y986_MYC	P08183	93.55	1033.0	1265.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
3950	sp|P9WQK1|Y986_MYC	P08183	93.55	1033.0	1265.0	DB14068	experimental	Dexniguldipine	[O-][N+](=O)c1cccc(c1)[C@@H]2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCCN(CC3)CCC3(c4ccccc4)c5ccccc5
3951	sp|P9WQK1|Y986_MYC	P08183	93.55	1033.0	1265.0	DB14069	investigational	ONT-093	CCOC/C=C/c1ccc(cc1)-c2nc(-c3ccc(cc3)NC(C)C)c([nH]2)-c4ccc(cc4)NC(C)C
3952	sp|P9WQK1|Y986_MYC	P08183	93.55	1033.0	1265.0	DB14070	experimental	HM-30181	c1cccc(c12)c(=O)cc(o2)C(=O)Nc3cc(OC)c(OC)cc3-c4nn(nn4)-c5ccc(cc5)CCN(C6)CCc(c67)cc(OC)c(c7)OC
3953	sp|P9WQK1|Y986_MYC	P08183	93.55	1033.0	1265.0	DB14071	experimental	Desmethylsertraline	c1cccc(c12)[C@@H](CC[C@@H]2N)c3cc(Cl)c(Cl)cc3
3954	sp|P9WQK1|Y986_MYC	P08183	93.55	1033.0	1265.0	DB14072	experimental	Reversin 121	c1ccccc1COC(=O)C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@H](C(=O)OC(C)(C)C)CCCCNC(=O)OCc2ccccc2
3955	sp|P9WQK1|Y986_MYC	Q2M3G0	92.74	384.0	614.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
3956	sp|P9WQK1|Y986_MYC	Q2M3G0	92.74	384.0	614.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
3957	sp|P9WQK1|Y986_MYC	Q2M3G0	92.34	1013.0	1242.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
3958	sp|P9WQK1|Y986_MYC	Q2M3G0	92.34	1013.0	1242.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
3959	sp|P9WQK1|Y986_MYC	Q09428	95.16	679.0	915.0	DB00839	approved; investigational	Tolazamide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2
3960	sp|P9WQK1|Y986_MYC	Q09428	95.16	679.0	915.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
3961	sp|P9WQK1|Y986_MYC	Q09428	92.74	1341.0	1571.0	DB00839	approved; investigational	Tolazamide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2
3962	sp|P9WQK1|Y986_MYC	Q09428	92.74	1341.0	1571.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
3963	sp|P9WQK1|Y986_MYC	Q09428	95.16	679.0	915.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
3964	sp|P9WQK1|Y986_MYC	Q09428	95.16	679.0	915.0	DB00222	approved	Glimepiride	CCC1=C(C)CN(C1=O)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3
3965	sp|P9WQK1|Y986_MYC	Q09428	95.16	679.0	915.0	DB00672	approved; investigational	Chlorpropamide	CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1
3966	sp|P9WQK1|Y986_MYC	Q09428	95.16	679.0	915.0	DB00731	approved; investigational	Nateglinide	CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](C(=O)O)Cc2ccccc2
3967	sp|P9WQK1|Y986_MYC	Q09428	95.16	679.0	915.0	DB00912	approved; investigational	Repaglinide	CCOc1c(C(=O)O)ccc(c1)CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3
3968	sp|P9WQK1|Y986_MYC	Q09428	95.16	679.0	915.0	DB01067	approved; investigational	Glipizide	Cc1ncc(nc1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
3969	sp|P9WQK1|Y986_MYC	Q09428	95.16	679.0	915.0	DB01120	approved	Gliclazide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN(C2)CC(C23)CCC3
3970	sp|P9WQK1|Y986_MYC	Q09428	95.16	679.0	915.0	DB01124	approved; investigational	Tolbutamide	CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1
3971	sp|P9WQK1|Y986_MYC	Q09428	95.16	679.0	915.0	DB01251	approved; investigational	Gliquidone	COc(cc1)cc(c12)C(=O)N(C(=O)C2(C)C)CCc3ccc(cc3)S(=O)(=O)NC(=O)NC4CCCCC4
3972	sp|P9WQK1|Y986_MYC	Q09428	95.16	679.0	915.0	DB01252	investigational	Mitiglinide	c1ccccc1C[C@H](C(=O)O)CC(=O)N(C2)C[C@H]([C@H]23)CCCC3
3973	sp|P9WQK1|Y986_MYC	Q09428	95.16	679.0	915.0	DB01382	approved; investigational	Glymidine	COCCOc1cnc(nc1)NS(=O)(=O)c2ccccc2
3974	sp|P9WQK1|Y986_MYC	Q09428	92.74	1341.0	1571.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
3975	sp|P9WQK1|Y986_MYC	Q09428	92.74	1341.0	1571.0	DB00222	approved	Glimepiride	CCC1=C(C)CN(C1=O)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3
3976	sp|P9WQK1|Y986_MYC	Q09428	92.74	1341.0	1571.0	DB00672	approved; investigational	Chlorpropamide	CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1
3977	sp|P9WQK1|Y986_MYC	Q09428	92.74	1341.0	1571.0	DB00731	approved; investigational	Nateglinide	CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](C(=O)O)Cc2ccccc2
3978	sp|P9WQK1|Y986_MYC	Q09428	92.74	1341.0	1571.0	DB00912	approved; investigational	Repaglinide	CCOc1c(C(=O)O)ccc(c1)CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3
3979	sp|P9WQK1|Y986_MYC	Q09428	92.74	1341.0	1571.0	DB01067	approved; investigational	Glipizide	Cc1ncc(nc1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
3980	sp|P9WQK1|Y986_MYC	Q09428	92.74	1341.0	1571.0	DB01120	approved	Gliclazide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN(C2)CC(C23)CCC3
3981	sp|P9WQK1|Y986_MYC	Q09428	92.74	1341.0	1571.0	DB01124	approved; investigational	Tolbutamide	CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1
3982	sp|P9WQK1|Y986_MYC	Q09428	92.74	1341.0	1571.0	DB01251	approved; investigational	Gliquidone	COc(cc1)cc(c12)C(=O)N(C(=O)C2(C)C)CCc3ccc(cc3)S(=O)(=O)NC(=O)NC4CCCCC4
3983	sp|P9WQK1|Y986_MYC	Q09428	92.74	1341.0	1571.0	DB01252	investigational	Mitiglinide	c1ccccc1C[C@H](C(=O)O)CC(=O)N(C2)C[C@H]([C@H]23)CCCC3
3984	sp|P9WQK1|Y986_MYC	Q09428	92.74	1341.0	1571.0	DB01382	approved; investigational	Glymidine	COCCOc1cnc(nc1)NS(=O)(=O)c2ccccc2
3985	sp|P9WQK1|Y986_MYC	O60706	91.53	672.0	899.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
3986	sp|P9WQK1|Y986_MYC	O60706	91.53	672.0	899.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
3987	sp|P9WQK1|Y986_MYC	O60706	91.53	672.0	899.0	DB09220	approved; investigational	Nicorandil	[O-][N+](=O)OCCNC(=O)c1cccnc1
3988	sp|P9WQK1|Y986_MYC	O60706	91.53	1310.0	1537.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
3989	sp|P9WQK1|Y986_MYC	O60706	91.53	1310.0	1537.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
3990	sp|P9WQK1|Y986_MYC	O60706	91.53	1310.0	1537.0	DB09220	approved; investigational	Nicorandil	[O-][N+](=O)OCCNC(=O)c1cccnc1
3991	sp|P9WQK1|Y986_MYC	P13568	70.16	1228.0	1402.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
3992	sp|P9WQK1|Y986_MYC	P33527	87.9	643.0	861.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
3993	sp|P9WQK1|Y986_MYC	P33527	87.9	643.0	861.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
3994	sp|P9WQK1|Y986_MYC	P33527	87.9	643.0	861.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
3995	sp|P9WQK1|Y986_MYC	P33527	87.9	643.0	861.0	DB06176	approved; investigational	Romidepsin	O=C([C@H]12)N/C(=C\C)C(=O)N[C@@H](C(C)C)C(=O)O[C@@H](CC(=O)N[C@H](C(C)C)C(=O)N1)/C=C/CCSSC2
3996	sp|P9WQK1|Y986_MYC	P33527	87.9	643.0	861.0	DB08855	experimental; investigational	Leukotriene C4	CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@@H](O)CCCC(=O)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@H](N)C(=O)O
3997	sp|P9WQK1|Y986_MYC	P33527	91.53	1292.0	1519.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
3998	sp|P9WQK1|Y986_MYC	P33527	91.53	1292.0	1519.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
3999	sp|P9WQK1|Y986_MYC	P33527	91.53	1292.0	1519.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
4000	sp|P9WQK1|Y986_MYC	P33527	91.53	1292.0	1519.0	DB06176	approved; investigational	Romidepsin	O=C([C@H]12)N/C(=C\C)C(=O)N[C@@H](C(C)C)C(=O)O[C@@H](CC(=O)N[C@H](C(C)C)C(=O)N1)/C=C/CCSSC2
4001	sp|P9WQK1|Y986_MYC	P33527	91.53	1292.0	1519.0	DB08855	experimental; investigational	Leukotriene C4	CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@@H](O)CCCC(=O)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@H](N)C(=O)O
4002	sp|P9WQK1|Y986_MYC	Q92887	88.71	632.0	852.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
4003	sp|P9WQK1|Y986_MYC	Q92887	88.71	632.0	852.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
4004	sp|P9WQK1|Y986_MYC	Q92887	91.53	1298.0	1525.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
4005	sp|P9WQK1|Y986_MYC	Q92887	91.53	1298.0	1525.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
4006	sp|P9WQK1|Y986_MYC	O15440	80.24	575.0	774.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
4007	sp|P9WQK1|Y986_MYC	O15440	80.24	575.0	774.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
4008	sp|P9WQK1|Y986_MYC	O15440	90.73	1191.0	1416.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
4009	sp|P9WQK1|Y986_MYC	O15440	90.73	1191.0	1416.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
4010	sp|P9WQK1|Y986_MYC	O15439	85.48	408.0	620.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
4011	sp|P9WQK1|Y986_MYC	O15439	88.71	1040.0	1260.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
4012	sp|P9WQK1|Y986_MYC	O95255	89.52	627.0	849.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
4013	sp|P9WQK1|Y986_MYC	O95255	91.94	1263.0	1491.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
4014	sp|P9WQK1|Y986_MYC	P13569	79.03	438.0	634.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
4015	sp|P9WQK1|Y986_MYC	P13569	79.03	438.0	634.0	DB00887	approved	Bumetanide	CCCCNc1c(c(S(=O)(=O)N)cc(c1)C(=O)O)Oc2ccccc2
4016	sp|P9WQK1|Y986_MYC	P13569	79.03	438.0	634.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
4017	sp|P9WQK1|Y986_MYC	P13569	79.03	438.0	634.0	DB01050	approved	Ibuprofen	CC(C)Cc1ccc(cc1)C(C)C(=O)O
4018	sp|P9WQK1|Y986_MYC	P13569	79.03	438.0	634.0	DB02587	experimental; investigational	Colforsin	O[C@H]1CCC(C)(C)[C@@H]([C@]12C)[C@H](O)[C@H](OC(=O)C)[C@]3(C)[C@]2(O)C(=O)C[C@](O3)(C)C=C
4019	sp|P9WQK1|Y986_MYC	P13569	79.03	438.0	634.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
4020	sp|P9WQK1|Y986_MYC	P13569	79.03	438.0	634.0	DB04522	experimental	Dexfosfoserine	OC(=O)[C@@H](N)COP(=O)(O)O
4021	sp|P9WQK1|Y986_MYC	P13569	79.03	438.0	634.0	DB04941	approved	Crofelemer	 
4022	sp|P9WQK1|Y986_MYC	P13569	79.03	438.0	634.0	DB06266	investigational	Lonidamine	c1cccc(c12)n(nc2C(=O)O)Cc3c(Cl)cc(Cl)cc3
4023	sp|P9WQK1|Y986_MYC	P13569	79.03	438.0	634.0	DB08820	approved	Ivacaftor	CC(C)(C)c1cc(C(C)(C)C)c(O)cc1NC(=O)c(c2=O)c[nH]c(c23)cccc3
4024	sp|P9WQK1|Y986_MYC	P13569	79.03	438.0	634.0	DB09213	approved; investigational	Dexibuprofen	CC(C)Cc1ccc(cc1)[C@H](C)C(=O)O
4025	sp|P9WQK1|Y986_MYC	P13569	79.03	438.0	634.0	DB09280	approved	Lumacaftor	O=C(O)c1cccc(c1)-c2nc(ccc2C)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
4026	sp|P9WQK1|Y986_MYC	P13569	79.03	438.0	634.0	DB11712	approved; investigational	Tezacaftor	OC[C@H](O)Cn1c(C(C)(C)CO)cc(c12)cc(c(F)c2)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
4027	sp|P9WQK1|Y986_MYC	P13569	79.03	438.0	634.0	DB15444	approved; investigational	Elexacaftor	FC(F)(F)C(C)(C)COc1nn(cc1)-c2nc(N(C3(C)C)C[C@@H](C)C3)c(cc2)C(=O)NS(=O)(=O)c4cn(C)nc4C
4028	sp|P9WQK1|Y986_MYC	P13569	89.52	1209.0	1431.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
4029	sp|P9WQK1|Y986_MYC	P13569	89.52	1209.0	1431.0	DB00887	approved	Bumetanide	CCCCNc1c(c(S(=O)(=O)N)cc(c1)C(=O)O)Oc2ccccc2
4030	sp|P9WQK1|Y986_MYC	P13569	89.52	1209.0	1431.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
4031	sp|P9WQK1|Y986_MYC	P13569	89.52	1209.0	1431.0	DB01050	approved	Ibuprofen	CC(C)Cc1ccc(cc1)C(C)C(=O)O
4032	sp|P9WQK1|Y986_MYC	P13569	89.52	1209.0	1431.0	DB02587	experimental; investigational	Colforsin	O[C@H]1CCC(C)(C)[C@@H]([C@]12C)[C@H](O)[C@H](OC(=O)C)[C@]3(C)[C@]2(O)C(=O)C[C@](O3)(C)C=C
4033	sp|P9WQK1|Y986_MYC	P13569	89.52	1209.0	1431.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
4034	sp|P9WQK1|Y986_MYC	P13569	89.52	1209.0	1431.0	DB04522	experimental	Dexfosfoserine	OC(=O)[C@@H](N)COP(=O)(O)O
4035	sp|P9WQK1|Y986_MYC	P13569	89.52	1209.0	1431.0	DB04941	approved	Crofelemer	 
4036	sp|P9WQK1|Y986_MYC	P13569	89.52	1209.0	1431.0	DB06266	investigational	Lonidamine	c1cccc(c12)n(nc2C(=O)O)Cc3c(Cl)cc(Cl)cc3
4037	sp|P9WQK1|Y986_MYC	P13569	89.52	1209.0	1431.0	DB08820	approved	Ivacaftor	CC(C)(C)c1cc(C(C)(C)C)c(O)cc1NC(=O)c(c2=O)c[nH]c(c23)cccc3
4038	sp|P9WQK1|Y986_MYC	P13569	89.52	1209.0	1431.0	DB09213	approved; investigational	Dexibuprofen	CC(C)Cc1ccc(cc1)[C@H](C)C(=O)O
4039	sp|P9WQK1|Y986_MYC	P13569	89.52	1209.0	1431.0	DB09280	approved	Lumacaftor	O=C(O)c1cccc(c1)-c2nc(ccc2C)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
4040	sp|P9WQK1|Y986_MYC	P13569	89.52	1209.0	1431.0	DB11712	approved; investigational	Tezacaftor	OC[C@H](O)Cn1c(C(C)(C)CO)cc(c12)cc(c(F)c2)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
4041	sp|P9WQK1|Y986_MYC	P13569	89.52	1209.0	1431.0	DB15444	approved; investigational	Elexacaftor	FC(F)(F)C(C)(C)COc1nn(cc1)-c2nc(N(C3(C)C)C[C@@H](C)C3)c(cc2)C(=O)NS(=O)(=O)c4cn(C)nc4C
4042	sp|P9WQK1|Y986_MYC	O95477	86.69	899.0	1114.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
4043	sp|P9WQK1|Y986_MYC	O95477	86.69	899.0	1114.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
4044	sp|P9WQK1|Y986_MYC	O95477	86.69	899.0	1114.0	DB01599	approved; investigational	Probucol	CC(C)(C)c1cc(cc(c1O)C(C)(C)C)SC(C)(C)Sc2cc(C(C)(C)C)c(O)c(c2)C(C)(C)C
4045	sp|P9WQK1|Y986_MYC	O95477	89.11	1910.0	2131.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
4046	sp|P9WQK1|Y986_MYC	O95477	89.11	1910.0	2131.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
4047	sp|P9WQK1|Y986_MYC	O95477	89.11	1910.0	2131.0	DB01599	approved; investigational	Probucol	CC(C)(C)c1cc(cc(c1O)C(C)(C)C)SC(C)(C)Sc2cc(C(C)(C)C)c(O)c(c2)C(C)(C)C
4048	sp|P9WQK1|Y986_MYC	P45844	84.68	92.0	302.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
4049	sp|P9WQK1|Y986_MYC	Q9UNQ0	85.48	60.0	272.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
4050	sp|P9WQK1|Y986_MYC	Q9UNQ0	85.48	60.0	272.0	DB11995	approved; investigational	Avatrombopag	OC(=O)C1CCN(CC1)c2c(Cl)cc(cn2)C(=O)Nc3nc(-c4cc(Cl)cs4)c(s3)N5CCN(CC5)C6CCCCC6
4051	sp|P9WQK1|Y986_MYC	A0A0T9AZ62	85.48	222.0	434.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
4052	sp|P9WFW1|SYC_MYCT	Q9HA77	95.74	50.0	499.0	DB00151	approved; nutraceutical	Cysteine	OC(=O)[C@@H](N)CS
4053	sp|P9WG83|Y097_MYC	P37610	93.77	7.0	278.0	DB01956	approved; nutraceutical	Taurine	NCCS(=O)(=O)O
4054	sp|P9WG83|Y097_MYC	Q9WWU5	91.0	21.0	284.0	DB07518	experimental	(2R)-2-ETHYL-1-HEXANESULFONIC ACID	OS(=O)(=O)OC[C@H](CC)CCCC
4055	sp|P9WMW3|Y2581_MY	P20581	70.09	65.0	222.0	DB07418	experimental	bis(4-nitrophenyl) hydrogen phosphate	[O-][N+](=O)c1ccc(cc1)OP(=O)(O)Oc2ccc([N+]([O-])=O)cc2
4056	sp|P9WMC5|Y2250_MY	P94548	95.77	6.0	187.0	DB03264	experimental	Dodecyl-Coa	CCCCCCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
4057	sp|P9WMC5|Y2250_MY	Q9AIU0	95.24	7.0	187.0	DB03467	experimental	Naringenin	Oc1ccc(cc1)[C@@H](O2)CC(=O)c(c23)c(O)cc(c3)O
4058	sp|P9WMC5|Y2250_MY	Q9AIU0	95.24	7.0	187.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
4059	sp|P9WMC5|Y2250_MY	Q9AIU0	95.24	7.0	187.0	DB07810	experimental	Phloretin	Oc1ccc(cc1)CCC(=O)c2c(O)cc(O)cc2O
4060	sp|P9WMC5|Y2250_MY	P0A0N4	84.66	4.0	164.0	DB01123	approved	Proflavine	c1cc(N)cc(c12)nc3c(c2)ccc(c3)N
4061	sp|P9WMC5|Y2250_MY	P0A0N4	84.66	4.0	164.0	DB03608	experimental	Diminazene	NC(=N)c1ccc(cc1)N/N=N/c2ccc(cc2)C(N)=N
4062	sp|P9WMC5|Y2250_MY	P0A0N4	84.66	4.0	164.0	DB03808	experimental	Hexamidine	NC(=N)c1ccc(cc1)OCCCCCCOc2ccc(cc2)C(N)=N
4063	sp|P9WMC5|Y2250_MY	P0A0N4	84.66	4.0	164.0	DB04209	approved; investigational	Dequalinium	c1cccc(c12)c(N)cc(C)[n+]2CCCCCCCCCC[n+]3c(C)cc(N)c(c34)cccc4
4064	sp|P9WMC5|Y2250_MY	P0A0N5	84.66	4.0	164.0	DB03808	experimental	Hexamidine	NC(=N)c1ccc(cc1)OCCCCCCOc2ccc(cc2)C(N)=N
4065	sp|P9WMC5|Y2250_MY	P0A0N5	84.66	4.0	164.0	DB03825	experimental	Rhodamine 6G	CCNc(c(C)c1)cc(c12)[o+]c3c(cc(C)c(c3)NCC)c2-c4ccccc4C(=O)OCC
4066	sp|P9WMC5|Y2250_MY	P0A0N5	84.66	4.0	164.0	DB03895	experimental	Malachite Green	CN(C)c1ccc(cc1)C(c2ccccc2)=C3C=CC(C=C3)=[N+](C)C
4067	sp|P9WMC5|Y2250_MY	P0A0N5	84.66	4.0	164.0	DB04115	approved; investigational	Berberine	COc1c(OC)ccc(c12)cc3[n+](c2)CCc4c3cc5c(c4)OCO5
4068	sp|P9WMC5|Y2250_MY	P9WMC1	85.19	24.0	185.0	DB02425	experimental	Hexadecyl Octanoate	CCCCCCCCCCCCCCCOC(=O)CCCCCCC
4069	sp|P9WMC5|Y2250_MY	P9WMC1	85.19	24.0	185.0	DB08469	experimental	tert-butyl 4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine-1-carboxylate	CC(C)(C)OC(=O)N1CCC(CC1)c2nc(no2)-c3cccs3
4070	sp|P9WMC5|Y2250_MY	P9WMC1	85.19	24.0	185.0	DB08470	experimental	3-(4-fluorophenyl)-5-phenyl-4H-1,2,4-triazole	Fc1ccc(cc1)-c2nnc([nH]2)-c3ccccc3
4071	sp|P9WMC5|Y2250_MY	P9WMC1	85.19	24.0	185.0	DB08471	experimental	1-(thiophen-2-ylacetyl)-4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine	c1ccsc1CC(=O)N2CCC(CC2)c3nc(no3)-c4cccs4
4072	sp|P9WJI3|Y2287_MY	P48764	85.24	53.0	515.0	DB11761	approved; investigational	Tenapanor	Clc1cc(Cl)cc(c12)[C@@H](CN(C2)C)c3cc(ccc3)S(=O)(=O)NCCOCCOCCNC(=O)NCCCCNC(=O)NCCOCCOCCNS(=O)(=O)c4cc(ccc4)[C@@H]5CN(C)Cc(c56)c(Cl)cc(Cl)c6
4073	sp|P9WJI3|Y2287_MY	P19634	75.83	102.0	513.0	DB00594	approved	Amiloride	NC(=N)NC(=O)c1nc(Cl)c(N)nc1N
4074	sp|P9WJI3|Y2287_MY	P19634	75.83	102.0	513.0	DB02624	experimental	Homoserine Lactone	N[C@@H]1CCOC1=O
4075	sp|P9WJI3|Y2287_MY	P19634	75.83	102.0	513.0	DB06468	investigational	Cariporide	CC(C)c1ccc(cc1S(=O)(=O)C)C(=O)NC(N)=N
4076	sp|P9WGP7|Y2216_MY	P26391	91.69	2.0	278.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
4077	sp|P9WGP7|Y2216_MY	P32055	87.71	1.0	265.0	DB02897	experimental	Acetylphosphate	CC(=O)OP(=O)(O)O
4078	sp|P9WGP7|Y2216_MY	P32055	87.71	1.0	265.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
4079	sp|P9WGP7|Y2216_MY	Q9ZGH3	84.05	2.0	255.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
4080	sp|P9WGP7|Y2216_MY	P09147	94.02	2.0	285.0	DB01861	experimental	Uridine diphosphate glucose	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
4081	sp|P9WGP7|Y2216_MY	P09147	94.02	2.0	285.0	DB02421	experimental	Uridine-5'-diphosphate-mannose	O=c1[nH]c(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O
4082	sp|P9WGP7|Y2216_MY	P09147	94.02	2.0	285.0	DB02790	experimental	Phenyl-uridine-5'-diphosphate	O=c1[nH]c(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)Oc3ccccc3
4083	sp|P9WGP7|Y2216_MY	P09147	94.02	2.0	285.0	DB03397	experimental	Uridine-Diphosphate-N-Acetylglucosamine	CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
4084	sp|P9WGP7|Y2216_MY	P09147	94.02	2.0	285.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
4085	sp|P9WGP7|Y2216_MY	P09147	94.02	2.0	285.0	DB04097	experimental	Uridine-5'-diphosphate-4-deoxy-4-fluoro-alpha-D-galactose	O=c1[nH]c(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](F)[C@H](O)[C@H]3O
4086	sp|P9WGP7|Y2216_MY	P95780	88.7	7.0	274.0	DB03161	experimental	Thymidine-5'-diphospho-beta-D-xylose	O=c1[nH]c(=O)c(C)cn1[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3OC[C@@H](O)[C@H](O)[C@H]3O
4087	sp|P9WGP7|Y2216_MY	P95780	88.7	7.0	274.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
4088	sp|P9WGP7|Y2216_MY	Q8KN66	84.05	18.0	271.0	DB01861	experimental	Uridine diphosphate glucose	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
4089	sp|P9WGP7|Y2216_MY	Q8KN66	84.05	18.0	271.0	DB02196	experimental	Uridine-Diphosphate-N-Acetylgalactosamine	CC(=O)N[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
4090	sp|P9WGP7|Y2216_MY	Q14376	96.68	4.0	295.0	DB01861	experimental	Uridine diphosphate glucose	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
4091	sp|P9WGP7|Y2216_MY	Q14376	96.68	4.0	295.0	DB02196	experimental	Uridine-Diphosphate-N-Acetylgalactosamine	CC(=O)N[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
4092	sp|P9WGP7|Y2216_MY	Q14376	96.68	4.0	295.0	DB03041	experimental	UDP-alpha-D-glucuronic acid	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O
4093	sp|P9WGP7|Y2216_MY	Q14376	96.68	4.0	295.0	DB03095	experimental	Tetramethylammonium	C[N+](C)(C)C
4094	sp|P9WGP7|Y2216_MY	Q14376	96.68	4.0	295.0	DB03397	experimental	Uridine-Diphosphate-N-Acetylglucosamine	CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
4095	sp|P9WGP7|Y2216_MY	Q14376	96.68	4.0	295.0	DB03501	experimental	Galactose-uridine-5'-diphosphate	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@H]1O)O[P@](=O)(O)O[P@](=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
4096	sp|P9WGP7|Y2216_MY	Q8T8E9	79.07	91.0	329.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
4097	sp|P9WGP7|Y2216_MY	P14169	88.37	3.0	269.0	DB04555	experimental	Cytidine-5'-Diphosphate	Nc1nc(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O
4098	sp|P9WGP7|Y2216_MY	Q13630	84.39	9.0	263.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
4099	sp|P9WGP7|Y2216_MY	P67910	81.73	2.0	248.0	DB01774	experimental	Adenosine-5'-Monophosphate Glucopyranosyl-Monophosphate Ester	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@@](=O)(O)O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O
4100	sp|P9WGP7|Y2216_MY	P67910	81.73	2.0	248.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
4101	sp|P9WGP7|Y2216_MY	P26397	83.72	11.0	263.0	DB02059	experimental	Adenosine-5-Diphosphoribose	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)CO[P@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H](O)[C@H](O)[C@@H]4O
4102	sp|P9WGP7|Y2216_MY	P26397	83.72	11.0	263.0	DB03069	experimental	Cytidine-5'-diphospho-beta-D-xylose	Nc1nc(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O[C@H]3OC[C@@H](O)[C@H](O)[C@H]3O
4103	sp|P9WGP7|Y2216_MY	P77398	86.71	316.0	577.0	DB03256	experimental	(6R)-Folinic acid	Nc([nH]1)nc(=O)c(c12)N(C=O)[C@@H](CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
4104	sp|P9WGP7|Y2216_MY	P77398	86.71	316.0	577.0	DB03685	experimental	Uridine monophosphate	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2ccc(=O)[nH]c2=O
4105	sp|P9WGP7|Y2216_MY	O60547	86.71	25.0	286.0	DB02547	experimental	Guanosine-5'-Diphosphate-Rhamnose	O[C@H]1[C@H](O)[C@H](O)[C@H](O[C@@H]1C)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3cnc(c34)c(=O)nc([nH]4)N
4106	sp|P9WGP7|Y2216_MY	O60547	86.71	25.0	286.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
4107	sp|P9WGP7|Y2216_MY	Q15738	74.42	40.0	264.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
4108	sp|P9WML3|YHI1_MYC	P49773	78.2	17.0	121.0	DB00131	approved; investigational; nutraceutical	Adenosine phosphate	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
4109	sp|P9WML3|YHI1_MYC	P49773	78.2	17.0	121.0	DB01972	experimental	Guanosine-5'-Monophosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
4110	sp|P9WML3|YHI1_MYC	P49773	78.2	17.0	121.0	DB02162	experimental	5'-O-(N-Ethyl-Sulfamoyl)Adenosine	CCNS(=O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
4111	sp|P9WML3|YHI1_MYC	P49773	78.2	17.0	121.0	DB02183	experimental	Adenosine-5'-ditungstate	n1cnc(N)c(c12)ncn2C3OC(C(O)C3O)CO[W](=O)(O)O[W](=O)(O)O
4112	sp|P9WML3|YHI1_MYC	P49773	78.2	17.0	121.0	DB03349	experimental	8-Bromo-Adenosine-5'-Monophosphate	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2c(Br)nc(c23)c(N)ncn3
4113	sp|P9WFV3|SYI_MYCT	P41252	99.04	8.0	1039.0	DB00167	investigational; nutraceutical	Isoleucine	CC[C@H](C)[C@H](N)C(=O)O
4114	sp|P9WFV3|SYI_MYCT	P56690	97.12	5.0	1016.0	DB01755	experimental	N-[Isoleucinyl]-N'-[adenosyl]-diaminosufone	CC[C@H](C)[C@H](N)C(=O)NS(=O)(=O)NC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
4115	sp|P9WFV3|SYI_MYCT	P41972	81.46	19.0	867.0	DB00410	approved; investigational; vet_approved	Mupirocin	C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@H]2CO[C@H]([C@H](O)[C@@H]2O)C/C(C)=C/C(=O)OCCCCCCCCC(=O)O
4116	sp|P9WFV3|SYI_MYCT	Q9NSE4	77.52	75.0	882.0	DB00167	investigational; nutraceutical	Isoleucine	CC[C@H](C)[C@H](N)C(=O)O
4117	sp|P9WFX9|TRPB_MYC	P0A2K1	90.28	10.0	391.0	DB03171	experimental	Indole-3-Propanol Phosphate	OP(=O)(O)OCCCc1c[nH]c(c12)cccc2
4118	sp|P9WFX9|TRPB_MYC	P0A2K1	90.28	10.0	391.0	DB04143	experimental	Indole-3-Glycerol Phosphate	OP(=O)(O)OC[C@@H](O)[C@@H](O)c1c[nH]c(c12)cccc2
4119	sp|P9WFX9|TRPB_MYC	P0A2K1	90.28	10.0	391.0	DB07732	experimental	2-[(2-NAPHTHYLSULFONYL)AMINO]ETHYL DIHYDROGEN PHOSPHATE	OP(=O)(O)OCCNS(=O)(=O)c(cc1)cc(c12)cccc2
4120	sp|P9WFX9|TRPB_MYC	P0A2K1	90.28	10.0	391.0	DB07745	experimental	2-{[4-(TRIFLUOROMETHOXY)BENZOYL]AMINO}ETHYL DIHYDROGEN PHOSPHATE	OP(=O)(O)OCCNC(=O)c1ccc(OC(F)(F)F)cc1
4121	sp|P9WFX9|TRPB_MYC	P0A2K1	90.28	10.0	391.0	DB07748	experimental	2-({[4-(TRIFLUOROMETHOXY)PHENYL]SULFONYL}AMINO)ETHYL DIHYDROGEN PHOSPHATE	OP(=O)(O)OCCNS(=O)(=O)c1ccc(OC(F)(F)F)cc1
4122	sp|P9WFX9|TRPB_MYC	P0A2K1	90.28	10.0	391.0	DB07773	experimental	5-FLUOROINDOLE PROPANOL PHOSPHATE	OP(=O)(O)OCCCc1c[nH]c(c12)ccc(F)c2
4123	sp|P9WFX9|TRPB_MYC	P0A2K1	90.28	10.0	391.0	DB07890	experimental	4-(2-HYDROXYPHENYLTHIO)-1-BUTENYLPHOSPHONIC ACID	Oc1ccccc1SCC/C=C/P(=O)(O)O
4124	sp|P9WFX9|TRPB_MYC	P0A2K1	90.28	10.0	391.0	DB07894	experimental	4-(2-HYDROXY-4-FLUOROPHENYLTHIO)-BUTYLPHOSPHONIC ACID	Oc1ccc(F)cc1SCC/C=C/P(=O)(O)O
4125	sp|P9WFX9|TRPB_MYC	P0A2K1	90.28	10.0	391.0	DB07925	experimental	4-(2-HYDROXYPHENYLSULFINYL)-BUTYLPHOSPHONIC ACID	Oc1ccccc1[S@](=O)CCCCP(=O)(O)O
4126	sp|P9WFX9|TRPB_MYC	P0A2K1	90.28	10.0	391.0	DB07951	experimental	N-(indole-3-acetyl)-L-aspartic acid	OC(=O)C[C@@H](C(=O)O)NC(=O)Cc1c[nH]c(c12)cccc2
4127	sp|P9WFX9|TRPB_MYC	P0A2K1	90.28	10.0	391.0	DB07952	experimental	N-[1H-INDOL-3-YL-ACETYL]GLYCINE ACID	OC(=O)CNC(=O)Cc1c[nH]c(c12)cccc2
4128	sp|P9WFX9|TRPB_MYC	P0A2K1	90.28	10.0	391.0	DB07953	experimental	N-[1H-INDOL-3-YL-ACETYL]VALINE ACID	CC(C)[C@@H](C(=O)O)NC(=O)Cc1c[nH]c(c12)cccc2
4131	sp|P9WH65|RS11_MYC	L0LZJ6	91.37	2.0	129.0	DB12615	approved; investigational	Plazomicin	CN[C@@H]([C@@]1(C)O)[C@@H](O)[C@H](OC1)O[C@H]2[C@H](NC(=O)[C@@H](O)CCN)C[C@H](N)[C@H]([C@@H]2O)O[C@H]3OC(=CC[C@H]3N)CNCCO
4132	sp|P9WH65|RS11_MYC	P80376	87.05	5.0	126.0	DB08185	experimental	2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(nc(n3)SC)NCCC(C)C
4133	sp|P9WQD5|TESA_MYC	Q9ZGI2	80.84	1125.0	1336.0	DB07703	experimental	(3R,4S,5S,7R,9E,11R,12R)-12-ETHYL-4-HYDROXY-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE	C[C@@H]1C[C@H](C)[C@H](O)[C@@H](C)C(=O)O[C@H](CC)[C@H](C)/C=C/C1=O
4134	sp|P9WQD5|TESA_MYC	Q9ZGI2	80.84	1125.0	1336.0	DB08431	experimental	[(3R,4S)-4-HYDROXY-3-METHYL-2-OXOHEXYL]PHOSPHONIC ACID	CC[C@H](O)[C@@H](C)C(=O)C[P@@H](=O)O
4135	sp|P9WQD5|TESA_MYC	Q9ZGI2	80.84	1125.0	1336.0	DB08759	experimental	[(3R,4S,5S,7R)-4,8-DIHYDROXY-3,5,7-TRIMETHYL-2-OXOOCTYL]PHOSPHONIC ACID	OC[C@H](C)C[C@H](C)[C@H](O)[C@@H](C)C(=O)C[P@H](=O)O
4136	sp|P9WHK3|PYRR_MYC	P41007	88.08	6.0	176.0	DB01972	experimental	Guanosine-5'-Monophosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
4137	sp|P9WHK3|PYRR_MYC	P41007	88.08	6.0	176.0	DB03315	experimental	Guanosine 3'-monophosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@H](CO)[C@H]([C@H]3O)OP(=O)(O)O
4138	sp|P9WHK3|PYRR_MYC	P41007	88.08	6.0	176.0	DB03685	experimental	Uridine monophosphate	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2ccc(=O)[nH]c2=O
4139	sp|P9WHK3|PYRR_MYC	P0A9M2	73.58	8.0	150.0	DB04566	experimental	Inosinic Acid	OP(=O)(O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O1)n2cnc(c23)c(=O)[nH]cn3
4140	sp|P9WHK3|PYRR_MYC	P20035	73.58	53.0	195.0	DB02075	experimental	[(2R,3R,4S,5S)-3,4-Dihydroxy-5-(4-oxo-4,5-dihydro-1H-pyrrolo[3,2-d]pyrimidin-7-yl)-2-pyrrolidinyl]methyl dihydrogen phosphate	O=c1nc[nH]c(c12)c(c[nH]2)[C@@H]3N[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
4141	sp|P9WHK3|PYRR_MYC	P20035	73.58	53.0	195.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
4142	sp|P9WHK3|PYRR_MYC	Q27796	78.24	12.0	163.0	DB01632	approved; experimental; investigational	5-O-phosphono-alpha-D-ribofuranosyl diphosphate	OP(=O)(O)OP(=O)(O)O[C@@H]1[C@H](O)[C@H](O)[C@H](O1)COP(=O)(O)O
4143	sp|P9WHK3|PYRR_MYC	Q27796	78.24	12.0	163.0	DB01942	experimental; investigational	Formic acid	OC=O
4144	sp|P9WHK3|PYRR_MYC	Q27796	78.24	12.0	163.0	DB04198	experimental	Formycin B	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)c([nH]n2)c(c23)nc[nH]c3=O
4145	sp|P9WHK3|PYRR_MYC	Q27796	78.24	12.0	163.0	DB04566	experimental	Inosinic Acid	OP(=O)(O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O1)n2cnc(c23)c(=O)[nH]cn3
4146	sp|P9WQ73|SERC_MYC	Q9RME2	92.02	7.0	353.0	DB02327	experimental	Triethylene glycol	OCCOCCOCCO
4147	sp|P9WQ73|SERC_MYC	Q9Y617	93.88	8.0	361.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
4148	sp|P9WQ73|SERC_MYC	Q9Y617	93.88	8.0	361.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
4149	sp|P9WQ73|SERC_MYC	Q9BXA1	73.14	20.0	295.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
4150	sp|P9WQ73|SERC_MYC	P21549	73.14	50.0	325.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
4151	sp|P9WQ73|SERC_MYC	P21549	73.14	50.0	325.0	DB00133	investigational; nutraceutical	Serine	OC(=O)[C@@H](N)CO
4152	sp|P9WQ73|SERC_MYC	P21549	73.14	50.0	325.0	DB00145	approved; nutraceutical; vet_approved	Glycine	NCC(=O)O
4153	sp|P9WQ73|SERC_MYC	P21549	73.14	50.0	325.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
4154	sp|P9WQ73|SERC_MYC	P21549	73.14	50.0	325.0	DB02079	experimental	Aminooxyacetic acid	NOCC(=O)O
4155	sp|P9WQ73|SERC_MYC	P21549	73.14	50.0	325.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
4156	sp|P9WQ73|SERC_MYC	P21549	73.14	50.0	325.0	DB08060	experimental	4-(2-AMINOPHENYL)-4-OXOBUTANOIC ACID	Nc1ccccc1C(=O)CCC(=O)O
4157	sp|P9WQ73|SERC_MYC	Q55793	77.13	43.0	333.0	DB02346	experimental	3'-O-N-Octanoyl-a-D-Glucopyranosyl-B-D-Fructofuranoside	OC[C@@H](O1)[C@@H](O)[C@H](O)[C@]1(CO)O[C@H]2O[C@H](CO)[C@@H](O)[C@@H]([C@H]2O)OC(=O)CCCCCCC
4158	sp|P9WQ73|SERC_MYC	Q96EN8	71.81	92.0	362.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
4159	sp|P9WGD5|SSB_MYCT	P0AGE0	84.15	5.0	143.0	DB04243	experimental	TMP	O=c1[nH]c(=O)n(cc1C)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)O
4160	sp|P9WJ03|SIR_MYCT	P17846	91.53	47.0	555.0	DB02832	experimental	Siroheme	OC(=O)CCc(c(c1n2[Fe]345)CC(=O)O)c2C=c6n3c(c(CC(=O)O)c6CCC(=O)O)=CC=7N5C([C@@](C)(CC(=O)O)C7CCC(=O)O)=CC=8N4C(=C1)[C@@](C)(CC(=O)O)C8CCC(=O)O
4161	sp|P9WNX3|SERA_MYC	P9WNX3	99.81	1.0	528.0	DB01694	experimental	D-tartaric acid	OC(=O)[C@@H](O)[C@H](O)C(=O)O
4162	sp|P9WNX3|SERA_MYC	O43175	94.7	5.0	505.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
4164	sp|P9WFT5|SYT_MYCT	P26639	92.34	77.0	716.0	DB00156	approved; nutraceutical	Threonine	C[C@@H](O)[C@H](N)C(=O)O
4165	sp|P9WFT5|SYT_MYCT	Q9BW92	96.1	50.0	715.0	DB00156	approved; nutraceutical	Threonine	C[C@@H](O)[C@H](N)C(=O)O
4166	sp|P9WFT5|SYT_MYCT	P0A8M5	89.88	14.0	636.0	DB03355	experimental	5'-O-(L-Threonylsulfamoyl)adenosine	C[C@@H](O)[C@H](N)C(=O)NS(=O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
4167	sp|P9WFT5|SYT_MYCT	P0A8M5	89.88	14.0	636.0	DB03869	experimental	5'-O-(L-Serylsulfamoyl)adenosine	OC[C@H](N)C(=O)NS(=O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
4168	sp|P9WFT5|SYT_MYCT	P0A8M5	89.88	14.0	636.0	DB04024	experimental	Serine-3'-aminoadenosine	OC[C@H](N)C(=O)N[C@@H]1[C@@H](CO)O[C@H]([C@@H]1O)n2cnc(c23)c(N)ncn3
4169	sp|P9WFT5|SYT_MYCT	Q8NW68	92.2	3.0	641.0	DB03355	experimental	5'-O-(L-Threonylsulfamoyl)adenosine	C[C@@H](O)[C@H](N)C(=O)NS(=O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
4170	sp|P71707|PBP1A_MY	Q8DNB6	78.41	30.0	673.0	DB00319	approved	Piperacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)[C@@H](c3ccccc3)NC(=O)N4CCN(CC)C(=O)C4=O
4171	sp|P71707|PBP1A_MY	Q8DNB6	78.41	30.0	673.0	DB00415	approved; vet_approved	Ampicillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)[C@H](N)c3ccccc3
4172	sp|P71707|PBP1A_MY	Q8DNB6	78.41	30.0	673.0	DB00456	approved; investigational; vet_approved	Cefalotin	CC(=O)OCC(CS1)=C(C(=O)O)N([C@H]12)C(=O)[C@H]2NC(=O)Cc3cccs3
4173	sp|P71707|PBP1A_MY	Q8DNB6	78.41	30.0	673.0	DB00485	approved; investigational; vet_approved	Dicloxacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)c3c(C)onc3-c4c(Cl)cccc4Cl
4174	sp|P71707|PBP1A_MY	Q8DNB6	78.41	30.0	673.0	DB00493	approved	Cefotaxime	CC(=O)OCC(=C1C(=O)O)CS[C@@H](N12)[C@@H](C2=O)NC(=O)/C(=N\OC)c3csc(n3)N
4175	sp|P71707|PBP1A_MY	Q8DNB6	78.41	30.0	673.0	DB00567	approved; investigational; vet_approved	Cephalexin	O=C(O)C1=C(C)CS[C@@H](N12)[C@@H](C2=O)NC(=O)[C@H](N)c3ccccc3
4176	sp|P71707|PBP1A_MY	Q8DNB6	78.41	30.0	673.0	DB00607	approved; investigational	Nafcillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)c3c(OCC)ccc(c34)cccc4
4177	sp|P71707|PBP1A_MY	Q8DNB6	78.41	30.0	673.0	DB00713	approved; investigational	Oxacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)c3c(C)onc3-c4ccccc4
4178	sp|P71707|PBP1A_MY	Q8DNB6	78.41	30.0	673.0	DB00739	approved; vet_approved; withdrawn	Hetacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)N(C3(C)C)C(=O)[C@H](N3)c4ccccc4
4179	sp|P71707|PBP1A_MY	Q8DNB6	78.41	30.0	673.0	DB01147	approved; investigational; vet_approved	Cloxacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)c3c(C)onc3-c4ccccc4Cl
4180	sp|P71707|PBP1A_MY	Q8DNB6	78.41	30.0	673.0	DB01163	investigational; withdrawn	Amdinocillin	C1CCCCCN1/C=N/[C@@H]2C(=O)N([C@@H]23)[C@H](C(S3)(C)C)C(=O)O
4181	sp|P71707|PBP1A_MY	Q8DNB6	78.41	30.0	673.0	DB01331	approved	Cefoxitin	NC(=O)OCC(=C1C(=O)O)CS[C@@H](N12)[C@](C2=O)(OC)NC(=O)Cc3cccs3
4182	sp|P71707|PBP1A_MY	Q8DNB6	78.41	30.0	673.0	DB01603	approved; investigational	Meticillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)c3c(OC)cccc3OC
4183	sp|P71707|PBP1A_MY	Q8DNB6	78.41	30.0	673.0	DB03313	experimental	Cephalosporin C	CC(=O)OCC(=C1C(=O)O)CS[C@@H](N12)[C@@H](C2=O)NC(=O)CCC[C@@H](N)C(=O)O
4184	sp|P71707|PBP1A_MY	Q8DNB6	78.41	30.0	673.0	DB08795	experimental	Azidocillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)[C@H](N=[N+]=[N-])c3ccccc3
4185	sp|P71707|PBP1A_MY	Q04707	75.85	17.0	639.0	DB01150	approved	Cefprozil	C/C=C/C(=C1C(=O)O)CS[C@@H](N12)[C@@H](C2=O)NC(=O)[C@H](N)c3ccc(O)cc3
4186	sp|P71707|PBP1A_MY	Q04707	75.85	17.0	639.0	DB05659	investigational	Faropenem medoxomil	C1CCO[C@H]1C(S[C@@H](N23)[C@H](C3=O)[C@@H](C)O)=C2C(=O)OCc4c(C)oc(=O)o4
4187	sp|P71707|PBP1A_MY	Q8DR59	75.85	17.0	639.0	DB00415	approved; vet_approved	Ampicillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)[C@H](N)c3ccccc3
4188	sp|P71707|PBP1A_MY	Q8DR59	75.85	17.0	639.0	DB00438	approved	Ceftazidime	c1cccc[n+]1CC(=C2C([O-])=O)CS[C@@H](N23)[C@@H](C3=O)NC(=O)/C(=N\OC(C)(C)C(=O)O)c4csc(n4)N
4189	sp|P71707|PBP1A_MY	Q8DR59	75.85	17.0	639.0	DB00456	approved; investigational; vet_approved	Cefalotin	CC(=O)OCC(CS1)=C(C(=O)O)N([C@H]12)C(=O)[C@H]2NC(=O)Cc3cccs3
4190	sp|P71707|PBP1A_MY	Q8DR59	75.85	17.0	639.0	DB00485	approved; investigational; vet_approved	Dicloxacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)c3c(C)onc3-c4c(Cl)cccc4Cl
4191	sp|P71707|PBP1A_MY	Q8DR59	75.85	17.0	639.0	DB00493	approved	Cefotaxime	CC(=O)OCC(=C1C(=O)O)CS[C@@H](N12)[C@@H](C2=O)NC(=O)/C(=N\OC)c3csc(n3)N
4192	sp|P71707|PBP1A_MY	Q8DR59	75.85	17.0	639.0	DB00567	approved; investigational; vet_approved	Cephalexin	O=C(O)C1=C(C)CS[C@@H](N12)[C@@H](C2=O)NC(=O)[C@H](N)c3ccccc3
4193	sp|P71707|PBP1A_MY	Q8DR59	75.85	17.0	639.0	DB00607	approved; investigational	Nafcillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)c3c(OCC)ccc(c34)cccc4
4194	sp|P71707|PBP1A_MY	Q8DR59	75.85	17.0	639.0	DB00713	approved; investigational	Oxacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)c3c(C)onc3-c4ccccc4
4195	sp|P71707|PBP1A_MY	Q8DR59	75.85	17.0	639.0	DB00739	approved; vet_approved; withdrawn	Hetacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)N(C3(C)C)C(=O)[C@H](N3)c4ccccc4
4196	sp|P71707|PBP1A_MY	Q8DR59	75.85	17.0	639.0	DB01000	approved	Cyclacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)C3(N)CCCCC3
4197	sp|P71707|PBP1A_MY	Q8DR59	75.85	17.0	639.0	DB01140	approved; vet_approved; withdrawn	Cefadroxil	O=C(O)C1=C(C)CS[C@@H](N12)[C@@H](C2=O)NC(=O)[C@H](N)c3ccc(O)cc3
4198	sp|P71707|PBP1A_MY	Q8DR59	75.85	17.0	639.0	DB01163	investigational; withdrawn	Amdinocillin	C1CCCCCN1/C=N/[C@@H]2C(=O)N([C@@H]23)[C@H](C(S3)(C)C)C(=O)O
4199	sp|P71707|PBP1A_MY	Q8DR59	75.85	17.0	639.0	DB01331	approved	Cefoxitin	NC(=O)OCC(=C1C(=O)O)CS[C@@H](N12)[C@](C2=O)(OC)NC(=O)Cc3cccs3
4200	sp|P71707|PBP1A_MY	Q8DR59	75.85	17.0	639.0	DB01603	approved; investigational	Meticillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)c3c(OC)cccc3OC
4201	sp|P71707|PBP1A_MY	Q8DR59	75.85	17.0	639.0	DB03313	experimental	Cephalosporin C	CC(=O)OCC(=C1C(=O)O)CS[C@@H](N12)[C@@H](C2=O)NC(=O)CCC[C@@H](N)C(=O)O
4202	sp|P71707|PBP1A_MY	Q8DR59	75.85	17.0	639.0	DB08375	experimental	(2R)-2-[(1R)-1-[[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-2-oxoethyl]-5-methylidene-2H-1,3-thiazine-4-carboxylic acid	OC(=O)C1=N[C@H](SCC1=C)[C@@H](C=O)NC(=O)/C(=N\OC)c2csc(n2)N
4203	sp|P71707|PBP1A_MY	Q8DR59	75.85	17.0	639.0	DB08795	experimental	Azidocillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)[C@H](N=[N+]=[N-])c3ccccc3
4204	sp|P71707|PBP1A_MY	A0A0H2WWQ9	79.15	23.0	672.0	DB04147	experimental	Dodecyldimethylamine N-oxide	CCCCCCCCCCCC[N+]([O-])(C)C
4205	sp|P71707|PBP1A_MY	Q8L103	74.39	3.0	613.0	DB01060	approved; vet_approved	Amoxicillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)[C@H](N)c3ccc(O)cc3
4206	sp|P71707|PBP1A_MY	Q8XJ01	79.51	22.0	674.0	DB00229	approved; investigational	Cefotiam	Nc1nc(cs1)CC(=O)N[C@H](C2=O)[C@H](N23)SCC(=C3C(=O)O)CSc4nnnn4CCN(C)C
4207	sp|P71707|PBP1A_MY	Q8XJ01	79.51	22.0	674.0	DB00267	approved	Cefmenoxime	Nc1nc(cs1)/C(=N/OC)C(=O)N[C@H](C2=O)[C@H](N23)SCC(=C3C(=O)O)CSc4nnnn4C
4208	sp|P71707|PBP1A_MY	Q8XJ01	79.51	22.0	674.0	DB00301	approved; investigational	Flucloxacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)c3c(C)onc3-c4c(Cl)cccc4F
4209	sp|P71707|PBP1A_MY	Q8XJ01	79.51	22.0	674.0	DB00417	approved; vet_approved	Phenoxymethylpenicillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)COc3ccccc3
4210	sp|P71707|PBP1A_MY	Q8XJ01	79.51	22.0	674.0	DB00447	approved; investigational; withdrawn	Loracarbef	c1ccccc1[C@@H](N)C(=O)N[C@H](C2=O)[C@H](N23)CCC(Cl)=C3C(=O)O
4211	sp|P71707|PBP1A_MY	Q8XJ01	79.51	22.0	674.0	DB00456	approved; investigational; vet_approved	Cefalotin	CC(=O)OCC(CS1)=C(C(=O)O)N([C@H]12)C(=O)[C@H]2NC(=O)Cc3cccs3
4212	sp|P71707|PBP1A_MY	Q8XJ01	79.51	22.0	674.0	DB00713	approved; investigational	Oxacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)c3c(C)onc3-c4ccccc4
4213	sp|P71707|PBP1A_MY	Q8XJ01	79.51	22.0	674.0	DB00833	approved	Cefaclor	O=C(O)C1=C(Cl)CS[C@@H](N12)[C@@H](C2=O)NC(=O)[C@H](N)c3ccccc3
4214	sp|P71707|PBP1A_MY	Q8XJ01	79.51	22.0	674.0	DB00948	approved; investigational	Mezlocillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)[C@@H](c3ccccc3)NC(=O)N4CCN(C4=O)S(=O)(=O)C
4215	sp|P71707|PBP1A_MY	Q8XJ01	79.51	22.0	674.0	DB01061	approved	Azlocillin	O=C1NCCN1C(=O)N[C@H](c2ccccc2)C(=O)N[C@@H]3C(=O)N([C@@H]34)[C@H](C(S4)(C)C)C(=O)O
4216	sp|P71707|PBP1A_MY	Q8XJ01	79.51	22.0	674.0	DB01066	approved; investigational	Cefditoren	Cc1ncsc1/C=C\C(=C2C(=O)O)CS[C@@H](N23)[C@@H](C3=O)NC(=O)/C(=N\OC)c4csc(n4)N
4217	sp|P71707|PBP1A_MY	Q8XJ01	79.51	22.0	674.0	DB01112	approved	Cefuroxime	NC(=O)OCC(=C1C(=O)O)CS[C@@H](N12)[C@@H](C2=O)NC(=O)/C(=N\OC)c3ccco3
4218	sp|P71707|PBP1A_MY	Q8XJ01	79.51	22.0	674.0	DB01139	approved; vet_approved	Cefapirin	CC(=O)OCC(=C1C(=O)O)CS[C@@H](N12)[C@@H](C2=O)NC(=O)CSc3ccncc3
4219	sp|P71707|PBP1A_MY	Q8XJ01	79.51	22.0	674.0	DB01147	approved; investigational; vet_approved	Cloxacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)c3c(C)onc3-c4ccccc4Cl
4220	sp|P71707|PBP1A_MY	Q8XJ01	79.51	22.0	674.0	DB01604	approved	Pivampicillin	CC(C)(C)C(=O)OCOC(=O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)[C@H](N)c3ccccc3
4221	sp|P71707|PBP1A_MY	Q8XJ01	79.51	22.0	674.0	DB01605	approved	Pivmecillinam	C1CCCCCN1/C=N/[C@@H]2C(=O)N([C@@H]23)[C@H](C(S3)(C)C)C(=O)OCOC(=O)C(C)(C)C
4222	sp|P71707|PBP1A_MY	Q8XJ01	79.51	22.0	674.0	DB04133	experimental	Degraded Cephaloridine	CC1=C(C(=O)O)N[C@H](SC1)[C@@H](C=O)NC(=O)Cc2cccs2
4223	sp|P71707|PBP1A_MY	O70038	74.39	96.0	706.0	DB08401	experimental	(2E)-2-({(2S)-2-CARBOXY-2-[(PHENOXYACETYL)AMINO]ETHOXY}IMINO)PENTANEDIOIC ACID	OC(=O)CC/C(C(=O)O)=N\OC[C@@H](C(=O)O)NC(=O)COc1ccccc1
4224	sp|P71707|PBP1A_MY	Q7CRA4	74.39	96.0	706.0	DB00319	approved	Piperacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)[C@@H](c3ccccc3)NC(=O)N4CCN(CC)C(=O)C4=O
4225	sp|P71707|PBP1A_MY	Q7CRA4	74.39	96.0	706.0	DB00415	approved; vet_approved	Ampicillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)[C@H](N)c3ccccc3
4226	sp|P71707|PBP1A_MY	Q7CRA4	74.39	96.0	706.0	DB00456	approved; investigational; vet_approved	Cefalotin	CC(=O)OCC(CS1)=C(C(=O)O)N([C@H]12)C(=O)[C@H]2NC(=O)Cc3cccs3
4227	sp|P71707|PBP1A_MY	Q7CRA4	74.39	96.0	706.0	DB00485	approved; investigational; vet_approved	Dicloxacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)c3c(C)onc3-c4c(Cl)cccc4Cl
4228	sp|P71707|PBP1A_MY	Q7CRA4	74.39	96.0	706.0	DB00493	approved	Cefotaxime	CC(=O)OCC(=C1C(=O)O)CS[C@@H](N12)[C@@H](C2=O)NC(=O)/C(=N\OC)c3csc(n3)N
4229	sp|P71707|PBP1A_MY	Q7CRA4	74.39	96.0	706.0	DB00567	approved; investigational; vet_approved	Cephalexin	O=C(O)C1=C(C)CS[C@@H](N12)[C@@H](C2=O)NC(=O)[C@H](N)c3ccccc3
4230	sp|P71707|PBP1A_MY	Q7CRA4	74.39	96.0	706.0	DB00607	approved; investigational	Nafcillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)c3c(OCC)ccc(c34)cccc4
4231	sp|P71707|PBP1A_MY	Q7CRA4	74.39	96.0	706.0	DB00713	approved; investigational	Oxacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)c3c(C)onc3-c4ccccc4
4232	sp|P71707|PBP1A_MY	Q7CRA4	74.39	96.0	706.0	DB00739	approved; vet_approved; withdrawn	Hetacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)N(C3(C)C)C(=O)[C@H](N3)c4ccccc4
4233	sp|P71707|PBP1A_MY	Q7CRA4	74.39	96.0	706.0	DB01140	approved; vet_approved; withdrawn	Cefadroxil	O=C(O)C1=C(C)CS[C@@H](N12)[C@@H](C2=O)NC(=O)[C@H](N)c3ccc(O)cc3
4234	sp|P71707|PBP1A_MY	Q7CRA4	74.39	96.0	706.0	DB01163	investigational; withdrawn	Amdinocillin	C1CCCCCN1/C=N/[C@@H]2C(=O)N([C@@H]23)[C@H](C(S3)(C)C)C(=O)O
4235	sp|P71707|PBP1A_MY	Q7CRA4	74.39	96.0	706.0	DB01331	approved	Cefoxitin	NC(=O)OCC(=C1C(=O)O)CS[C@@H](N12)[C@](C2=O)(OC)NC(=O)Cc3cccs3
4236	sp|P71707|PBP1A_MY	Q7CRA4	74.39	96.0	706.0	DB01603	approved; investigational	Meticillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)c3c(OC)cccc3OC
4237	sp|P71707|PBP1A_MY	Q7CRA4	74.39	96.0	706.0	DB03313	experimental	Cephalosporin C	CC(=O)OCC(=C1C(=O)O)CS[C@@H](N12)[C@@H](C2=O)NC(=O)CCC[C@@H](N)C(=O)O
4238	sp|P71707|PBP1A_MY	Q7CRA4	74.39	96.0	706.0	DB08508	experimental	N-BENZOYL-D-ALANINE	OC(=O)[C@@H](C)NC(=O)c1ccccc1
4239	sp|P71707|PBP1A_MY	Q7CRA4	74.39	96.0	706.0	DB08795	experimental	Azidocillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)[C@H](N=[N+]=[N-])c3ccccc3
4240	sp|P9WN11|OTSA_MYC	P31677	88.4	16.0	458.0	DB01861	experimental	Uridine diphosphate glucose	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
4241	sp|P9WN11|OTSA_MYC	P31677	88.4	16.0	458.0	DB02007	experimental	alpha-D-glucose 6-phosphate	O[C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O)COP(=O)(O)O
4242	sp|P9WN11|OTSA_MYC	P31677	88.4	16.0	458.0	DB03366	experimental; investigational	Imidazole	[nH]1ccnc1
4243	sp|P9WN11|OTSA_MYC	P31677	88.4	16.0	458.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
4244	sp|P9WN11|OTSA_MYC	P31677	88.4	16.0	458.0	DB03488	experimental	Uridine-5'-diphosphate-2-deoxy-2-fluoro-alpha-D-galactose	OC[C@H]1O[C@@H]([C@H](F)[C@@H](O)[C@@H]1O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
4245	sp|P9WI73|PKNG_MYC	P9WI73	99.87	1.0	750.0	DB07398	experimental	2-[(CYCLOPROPYLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE	C1CCCc(c12)sc(c2C(=O)N)NC(=O)C3CC3
4246	sp|P9WH55|RS15_MYC	Q5SJ76	97.75	1.0	88.0	DB08185	experimental	2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(nc(n3)SC)NCCC(C)C
4247	sp|P9WPW5|SCOA_MYC	P55809	98.39	41.0	285.0	DB02731	experimental	Ethylmercurithiosalicylic acid	CC[Hg]Sc1ccccc1C(=O)O
4248	sp|P9WN35|TRPG_MYC	P04079	98.28	9.0	237.0	DB04272	approved; nutraceutical; vet_approved	Citric acid	OC(=O)CC(O)(C(=O)O)CC(=O)O
4249	sp|P9WN35|TRPG_MYC	P49915	90.95	28.0	239.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
4250	sp|P9WN35|TRPG_MYC	P27708	76.72	177.0	355.0	DB03459	experimental	Sparfosic acid	OP(=O)(O)CC(=O)N[C@H](C(=O)O)CC(=O)O
4251	sp|P9WN35|TRPG_MYC	P31327	82.76	219.0	411.0	DB06775	approved	Carglumic acid	NC(=O)N[C@H](C(=O)O)CCC(=O)O
4252	sp|P9WN35|TRPG_MYC	Q8IEN3	80.17	474.0	660.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
4253	sp|P9WFF1|URE1_MYC	P18314	98.09	1.0	567.0	DB00551	approved	Acetohydroxamic acid	CC(=O)NO
4254	sp|P9WFF1|URE1_MYC	P18314	98.09	1.0	567.0	DB05265	investigational	Ecabet	C1CC[C@@](C)(C(=O)O)[C@@H]([C@]12C)CCc3c2cc(S(=O)(=O)O)c(c3)C(C)C
4255	sp|P9WFF1|URE1_MYC	P41020	98.27	2.0	569.0	DB02899	experimental	N-Carboxymethionine	OC(=O)N[C@H](C(=O)O)CCSC
4256	sp|P9WGV3|SAHH_MYC	P9WGV3	99.8	1.0	495.0	DB07052	experimental	5'-S-ethyl-5'-thioadenosine	CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
4257	sp|P9WGV3|SAHH_MYC	P50250	95.76	5.0	479.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
4258	sp|P9WG43|TPIS_MYC	P36204	95.79	401.0	651.0	DB04510	experimental	3-phospho-D-glyceric acid	OC(=O)[C@H](O)COP(=O)(O)O
4259	sp|P9WG43|TPIS_MYC	P00943	94.64	2.0	249.0	DB02726	experimental	2-Phosphoglycolic Acid	OC(=O)COP(=O)(O)O
4260	sp|P9WG43|TPIS_MYC	Q07412	93.87	1.0	246.0	DB01709	experimental	2-phospho-D-glyceric acid	OC[C@H](C(=O)O)OP(=O)(O)O
4261	sp|P9WG43|TPIS_MYC	Q07412	93.87	1.0	246.0	DB01779	experimental	Glycerol 2-phosphate	OCC(CO)OP(=O)(O)O
4262	sp|P9WG43|TPIS_MYC	Q07412	93.87	1.0	246.0	DB02515	experimental	sn-glycerol 3-phosphate	OC[C@@H](O)COP(=O)(O)O
4263	sp|P9WG43|TPIS_MYC	Q07412	93.87	1.0	246.0	DB02726	experimental	2-Phosphoglycolic Acid	OC(=O)COP(=O)(O)O
4264	sp|P9WG43|TPIS_MYC	Q07412	93.87	1.0	246.0	DB02951	experimental	3-Hydroxypyruvic Acid	OCC(=O)C(=O)O
4265	sp|P9WG43|TPIS_MYC	Q07412	93.87	1.0	246.0	DB04510	experimental	3-phospho-D-glyceric acid	OC(=O)[C@H](O)COP(=O)(O)O
4266	sp|P9WG43|TPIS_MYC	P52270	92.34	6.0	247.0	DB03132	experimental	3-(2-Benzothiazolylthio)-1-Propanesulfonic Acid	OS(=O)(=O)CCCSc(s1)nc(c12)cccc2
4267	sp|P9WG43|TPIS_MYC	P50921	96.17	2.0	253.0	DB02726	experimental	2-Phosphoglycolic Acid	OC(=O)COP(=O)(O)O
4268	sp|P9WG43|TPIS_MYC	P60174	91.95	41.0	281.0	DB01593	approved; investigational	Zinc	[Zn]
4269	sp|P9WG43|TPIS_MYC	P60174	91.95	41.0	281.0	DB01695	experimental	N-Hydroxy-4-Phosphono-Butanamide	ONC(=O)CCCP([O-])([O-])=O
4270	sp|P9WG43|TPIS_MYC	P60174	91.95	41.0	281.0	DB02726	experimental	2-Phosphoglycolic Acid	OC(=O)COP(=O)(O)O
4271	sp|P9WG43|TPIS_MYC	P60174	91.95	41.0	281.0	DB03026	experimental	Phosphoglycolohydroxamic Acid	ONC(=O)COP(=O)(O)O
4272	sp|P9WG43|TPIS_MYC	P60174	91.95	41.0	281.0	DB03132	experimental	3-(2-Benzothiazolylthio)-1-Propanesulfonic Acid	OS(=O)(=O)CCCSc(s1)nc(c12)cccc2
4273	sp|P9WG43|TPIS_MYC	P60174	91.95	41.0	281.0	DB03135	experimental	[2(Formyl-Hydroxy-Amino)-Ethyl]-Phosphonic Acid	O=CN(O)CCP(=O)(O)O
4274	sp|P9WG43|TPIS_MYC	P60174	91.95	41.0	281.0	DB03314	experimental	5-fluorotryptophan	OC(=O)[C@@H](N)Cc1c[nH]c(c12)ccc(F)c2
4275	sp|P9WG43|TPIS_MYC	P60174	91.95	41.0	281.0	DB03379	experimental	2-Carboxyethylphosphonic Acid	OC(=O)CCP(=O)(O)O
4276	sp|P9WG43|TPIS_MYC	P60174	91.95	41.0	281.0	DB03900	experimental	tert-butanol	CC(C)(C)O
4277	sp|P9WG43|TPIS_MYC	P60174	91.95	41.0	281.0	DB04326	investigational	Dihydroxyacetone phosphate	OCC(=O)COP(=O)(O)O
4278	sp|P9WG43|TPIS_MYC	P60174	91.95	41.0	281.0	DB04447	experimental	1,4-Dithiothreitol	SC[C@H](O)[C@@H](O)CS
4279	sp|P9WG43|TPIS_MYC	P60174	91.95	41.0	281.0	DB04510	experimental	3-phospho-D-glyceric acid	OC(=O)[C@H](O)COP(=O)(O)O
4280	sp|P9WG43|TPIS_MYC	P60174	91.95	41.0	281.0	DB07387	experimental	3-(BUTYLSULPHONYL)-PROPANOIC ACID	CCCCS(=O)(=O)CCC(=O)O
4281	sp|P9WG43|TPIS_MYC	P60174	91.95	41.0	281.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
4282	sp|P9WG43|TPIS_MYC	P60174	91.95	41.0	281.0	DB14487	approved; investigational	Zinc acetate	CC([O-])=O
4283	sp|P9WG43|TPIS_MYC	P60174	91.95	41.0	281.0	DB14533	approved; investigational	Zinc chloride	[Cl-]
4284	sp|P9WG43|TPIS_MYC	P60174	91.95	41.0	281.0	DB14548	approved; experimental	Zinc sulfate, unspecified form	 
4285	sp|P9WFF3|UPP_MYCT	Q9WZI0	98.55	4.0	208.0	DB03685	experimental	Uridine monophosphate	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2ccc(=O)[nH]c2=O
4286	sp|P9WFF3|UPP_MYCT	Q5KUI3	99.03	3.0	208.0	DB03685	experimental	Uridine monophosphate	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2ccc(=O)[nH]c2=O
4287	sp|P9WFF3|UPP_MYCT	Q9NWZ5	98.07	329.0	532.0	DB01632	approved; experimental; investigational	5-O-phosphono-alpha-D-ribofuranosyl diphosphate	OP(=O)(O)OP(=O)(O)O[C@@H]1[C@H](O)[C@H](O)[C@H](O1)COP(=O)(O)O
4288	sp|P9WFF3|UPP_MYCT	Q9NWZ5	98.07	329.0	532.0	DB03419	experimental; investigational	Uracil	O=c1[nH]ccc(=O)[nH]1
4289	sp|P9WFF3|UPP_MYCT	Q9NWZ5	98.07	329.0	532.0	DB03685	experimental	Uridine monophosphate	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2ccc(=O)[nH]c2=O
4290	sp|P9WFF3|UPP_MYCT	Q9NWZ5	98.07	329.0	532.0	DB04137	experimental	Guanosine-5'-Triphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
4291	sp|P9WQ15|AOFH_MYC	P21397	98.9	11.0	460.0	DB00182	approved; illicit; investigational	Amphetamine	CC(N)Cc1ccccc1
4292	sp|P9WQ15|AOFH_MYC	P21397	98.9	11.0	460.0	DB00721	approved; investigational; vet_approved	Procaine	CCN(CC)CCOC(=O)c1ccc(N)cc1
4293	sp|P9WQ15|AOFH_MYC	P21397	98.9	11.0	460.0	DB01168	approved; investigational	Procarbazine	CNNCc1ccc(cc1)C(=O)NC(C)C
4294	sp|P9WQ15|AOFH_MYC	P21397	98.9	11.0	460.0	DB01171	approved; investigational	Moclobemide	Clc1ccc(cc1)C(=O)NCCN2CCOCC2
4295	sp|P9WQ15|AOFH_MYC	P21397	98.9	11.0	460.0	DB00191	approved; illicit	Phentermine	CC(C)(N)Cc1ccccc1
4296	sp|P9WQ15|AOFH_MYC	P21397	98.9	11.0	460.0	DB00752	approved; investigational	Tranylcypromine	NC1CC1c2ccccc2
4297	sp|P9WQ15|AOFH_MYC	P21397	98.9	11.0	460.0	DB00780	approved	Phenelzine	NNCCc1ccccc1
4298	sp|P9WQ15|AOFH_MYC	P21397	98.9	11.0	460.0	DB00805	approved	Minaprine	c1ccccc1-c2cc(C)c(nn2)NCCN3CCOCC3
4299	sp|P9WQ15|AOFH_MYC	P21397	98.9	11.0	460.0	DB00909	approved; investigational	Zonisamide	NS(=O)(=O)Cc1noc(c12)cccc2
4300	sp|P9WQ15|AOFH_MYC	P21397	98.9	11.0	460.0	DB01037	approved; investigational; vet_approved	Selegiline	C#CCN(C)[C@H](C)Cc1ccccc1
4302	sp|P9WQ15|AOFH_MYC	P21397	98.9	11.0	460.0	DB01247	approved	Isocarboxazid	Cc1cc(no1)C(=O)NNCc2ccccc2
4304	sp|P9WQ15|AOFH_MYC	P21397	98.9	11.0	460.0	DB01442	experimental; illicit	MMDA	O1COc(c12)cc(CC(C)N)cc2OC
4305	sp|P9WQ15|AOFH_MYC	P21397	98.9	11.0	460.0	DB01472	experimental; illicit	4-Methoxyamphetamine	COc1ccc(cc1)CC(C)N
4306	sp|P9WQ15|AOFH_MYC	P21397	98.9	11.0	460.0	DB01577	approved; illicit	Metamfetamine	CN[C@@H](C)Cc1ccccc1
4307	sp|P9WQ15|AOFH_MYC	P21397	98.9	11.0	460.0	DB01626	approved	Pargyline	C#CCN(C)Cc1ccccc1
4308	sp|P9WQ15|AOFH_MYC	P21397	98.9	11.0	460.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
4309	sp|P9WQ15|AOFH_MYC	P21397	98.9	11.0	460.0	DB04017	experimental	Clorgiline	C#CCN(C)CCCOc1ccc(Cl)cc1Cl
4310	sp|P9WQ15|AOFH_MYC	P21397	98.9	11.0	460.0	DB04820	approved; withdrawn	Nialamide	c1ccccc1CNC(=O)CCNNC(=O)c2ccncc2
4311	sp|P9WQ15|AOFH_MYC	P21397	98.9	11.0	460.0	DB04821	approved; withdrawn	Nomifensine	Nc1cccc(c12)C(CN(C2)C)c3ccccc3
4312	sp|P9WQ15|AOFH_MYC	P21397	98.9	11.0	460.0	DB04832	approved; withdrawn	Zimelidine	c1ccncc1/C(=C\CN(C)C)c2ccc(Br)cc2
4313	sp|P9WQ15|AOFH_MYC	P21397	98.9	11.0	460.0	DB04850	investigational	Posizolid	OC[C@H](O)C(=O)N1CCC(=CC1)c2c(F)cc(cc2F)N3C[C@@H](OC3=O)COc4nocc4
4314	sp|P9WQ15|AOFH_MYC	P21397	98.9	11.0	460.0	DB05205	investigational	CX157	 
4315	sp|P9WQ15|AOFH_MYC	P21397	98.9	11.0	460.0	DB07641	experimental	Decyl(dimethyl)phosphine oxide	CCCCCCCCCCP(=O)(C)C
4316	sp|P9WQ15|AOFH_MYC	P21397	98.9	11.0	460.0	DB07919	experimental	Harmine	COc(cc1)cc(c12)[nH]c3c2ccnc3C
4317	sp|P9WQ15|AOFH_MYC	P21397	98.9	11.0	460.0	DB09244	experimental	Pirlindole	Cc(c1)ccc2n(c3c4c12)CCNC3CCC4
4318	sp|P9WQ15|AOFH_MYC	P21397	98.9	11.0	460.0	DB09245	experimental	Toloxatone	Cc1cc(ccc1)N2CC(CO)OC2=O
4319	sp|P9WQ15|AOFH_MYC	P21397	98.9	11.0	460.0	DB13876	experimental	Brofaromine	Brc1cc(OC)cc(c12)cc(o2)C3CCNCC3
4320	sp|P9WQ15|AOFH_MYC	P21397	98.9	11.0	460.0	DB14914	approved; investigational	Flortaucipir F-18	[18F]c1ccc(cn1)-c(c2)ccc(c23)c4c([nH]3)ccnc4
4321	sp|P9WQ15|AOFH_MYC	P27338	98.9	2.0	451.0	DB00182	approved; illicit; investigational	Amphetamine	CC(N)Cc1ccccc1
4322	sp|P9WQ15|AOFH_MYC	P27338	98.9	2.0	451.0	DB00721	approved; investigational; vet_approved	Procaine	CCN(CC)CCOC(=O)c1ccc(N)cc1
4323	sp|P9WQ15|AOFH_MYC	P27338	98.9	2.0	451.0	DB01168	approved; investigational	Procarbazine	CNNCc1ccc(cc1)C(=O)NC(C)C
4324	sp|P9WQ15|AOFH_MYC	P27338	98.9	2.0	451.0	DB01171	approved; investigational	Moclobemide	Clc1ccc(cc1)C(=O)NCCN2CCOCC2
4326	sp|P9WQ15|AOFH_MYC	P27338	98.9	2.0	451.0	DB00191	approved; illicit	Phentermine	CC(C)(N)Cc1ccccc1
4327	sp|P9WQ15|AOFH_MYC	P27338	98.9	2.0	451.0	DB00752	approved; investigational	Tranylcypromine	NC1CC1c2ccccc2
4328	sp|P9WQ15|AOFH_MYC	P27338	98.9	2.0	451.0	DB00780	approved	Phenelzine	NNCCc1ccccc1
4329	sp|P9WQ15|AOFH_MYC	P27338	98.9	2.0	451.0	DB00909	approved; investigational	Zonisamide	NS(=O)(=O)Cc1noc(c12)cccc2
4330	sp|P9WQ15|AOFH_MYC	P27338	98.9	2.0	451.0	DB01037	approved; investigational; vet_approved	Selegiline	C#CCN(C)[C@H](C)Cc1ccccc1
4331	sp|P9WQ15|AOFH_MYC	P27338	98.9	2.0	451.0	DB01132	approved; investigational	Pioglitazone	CCc1cnc(cc1)CCOc2ccc(cc2)CC3SC(=O)NC3=O
4333	sp|P9WQ15|AOFH_MYC	P27338	98.9	2.0	451.0	DB01247	approved	Isocarboxazid	Cc1cc(no1)C(=O)NNCc2ccccc2
4335	sp|P9WQ15|AOFH_MYC	P27338	98.9	2.0	451.0	DB01367	approved	Rasagiline	C#CCN[C@@H]1CCc(c12)cccc2
4336	sp|P9WQ15|AOFH_MYC	P27338	98.9	2.0	451.0	DB01442	experimental; illicit	MMDA	O1COc(c12)cc(CC(C)N)cc2OC
4337	sp|P9WQ15|AOFH_MYC	P27338	98.9	2.0	451.0	DB01472	experimental; illicit	4-Methoxyamphetamine	COc1ccc(cc1)CC(C)N
4338	sp|P9WQ15|AOFH_MYC	P27338	98.9	2.0	451.0	DB01577	approved; illicit	Metamfetamine	CN[C@@H](C)Cc1ccccc1
4339	sp|P9WQ15|AOFH_MYC	P27338	98.9	2.0	451.0	DB01626	approved	Pargyline	C#CCN(C)Cc1ccccc1
4340	sp|P9WQ15|AOFH_MYC	P27338	98.9	2.0	451.0	DB02095	experimental	Isatin	O=C1C(=O)Nc(c12)cccc2
4341	sp|P9WQ15|AOFH_MYC	P27338	98.9	2.0	451.0	DB02211	experimental	(R)-N-methyl-N-2-propynyl-1-indanamine	C#CCN(C)[C@@H]1CCc(c12)cccc2
4342	sp|P9WQ15|AOFH_MYC	P27338	98.9	2.0	451.0	DB02509	experimental	Farnesol	CC(C)=CCC/C(C)=C\CC/C(C)=C\CO
4343	sp|P9WQ15|AOFH_MYC	P27338	98.9	2.0	451.0	DB02643	experimental	N-Dodecyl-N,N-Dimethyl-3-Ammonio-1-Propanesulfonate	CCCCCCCCCCCC[N+](C)(C)CCCS(=O)(=O)O
4344	sp|P9WQ15|AOFH_MYC	P27338	98.9	2.0	451.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
4345	sp|P9WQ15|AOFH_MYC	P27338	98.9	2.0	451.0	DB03894	experimental	N-Propargyl-1(S)-Aminoindan	C#CCN[C@H]1CCc(c12)cccc2
4346	sp|P9WQ15|AOFH_MYC	P27338	98.9	2.0	451.0	DB04147	experimental	Dodecyldimethylamine N-oxide	CCCCCCCCCCCC[N+]([O-])(C)C
4347	sp|P9WQ15|AOFH_MYC	P27338	98.9	2.0	451.0	DB04307	experimental	5-Hydroxy-N-Propargyl-1(R)-Aminoindan	C#CCN[C@@H]1CCc(c12)ccc(c2)O
4348	sp|P9WQ15|AOFH_MYC	P27338	98.9	2.0	451.0	DB04677	experimental	N-METHYL-N-[(1R)-1-METHYL-2-PHENYLETHYL]PROP-2-EN-1-AMINE	C=CCN(C)[C@H](C)Cc1ccccc1
4349	sp|P9WQ15|AOFH_MYC	P27338	98.9	2.0	451.0	DB04820	approved; withdrawn	Nialamide	c1ccccc1CNC(=O)CCNNC(=O)c2ccncc2
4350	sp|P9WQ15|AOFH_MYC	P27338	98.9	2.0	451.0	DB04821	approved; withdrawn	Nomifensine	Nc1cccc(c12)C(CN(C2)C)c3ccccc3
4351	sp|P9WQ15|AOFH_MYC	P27338	98.9	2.0	451.0	DB04832	approved; withdrawn	Zimelidine	c1ccncc1/C(=C\CN(C)C)c2ccc(Br)cc2
4352	sp|P9WQ15|AOFH_MYC	P27338	98.9	2.0	451.0	DB06654	approved; investigational	Safinamide	NC(=O)[C@H](C)NCc1ccc(cc1)OCc2cc(F)ccc2
4353	sp|P9WQ15|AOFH_MYC	P27338	98.9	2.0	451.0	DB07512	experimental	7-[(3-CHLOROBENZYL)OXY]-2-OXO-2H-CHROMENE-4-CARBALDEHYDE	Clc1cccc(c1)COc(c2)ccc(c23)c(C=O)cc(o3)=O
4354	sp|P9WQ15|AOFH_MYC	P27338	98.9	2.0	451.0	DB07513	experimental	7-[(3-CHLOROBENZYL)OXY]-4-[(METHYLAMINO)METHYL]-2H-CHROMEN-2-ONE	CNCc1cc(=O)oc(c12)cc(cc2)OCc3cccc(Cl)c3
4355	sp|P9WQ15|AOFH_MYC	P27338	98.9	2.0	451.0	DB08082	experimental	N-(2-AMINOETHYL)-P-CHLOROBENZAMIDE	OCCNC(=O)c1ccc(Cl)cc1
4356	sp|P9WQ15|AOFH_MYC	P27338	98.9	2.0	451.0	DB08176	experimental	(1Z)-4-(4-FLUOROPHENYL)-2-METHYLIDENEBUTAN-1-IMINE	N=CC(=C)CCc1ccc(F)cc1
4357	sp|P9WQ15|AOFH_MYC	P27338	98.9	2.0	451.0	DB08480	experimental	4-HYDROXY-N-PROPARGYL-1(R)-AMINOINDAN	C=C/C=N/[C@@H]1CCc(c12)c(O)ccc2
4358	sp|P9WQ15|AOFH_MYC	P27338	98.9	2.0	451.0	DB08516	experimental	(S)-(+)-2-[4-(FLUOROBENZYLOXY-BENZYLAMINO)PROPIONAMIDE]	NC(=O)[C@H](C)/N=C/c1ccc(cc1)OCc2cc(F)ccc2
4359	sp|P9WQ15|AOFH_MYC	P27338	98.9	2.0	451.0	DB14914	approved; investigational	Flortaucipir F-18	[18F]c1ccc(cn1)-c(c2)ccc(c23)c4c([nH]3)ccnc4
4360	sp|P9WQ15|AOFH_MYC	P32397	86.12	5.0	396.0	DB07338	experimental	Acifluorfen	OC(=O)c1c([N+]([O-])=O)ccc(c1)Oc2ccc(C(F)(F)F)cc2Cl
4361	sp|P9WQM7|ANSP2_MY	Q9UPY5	88.71	34.0	466.0	DB00138	approved; nutraceutical	Cystine	OC(=O)[C@@H](N)CSSC[C@H](N)C(=O)O
4362	sp|P9WQM7|ANSP2_MY	Q9UPY5	88.71	34.0	466.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
4363	sp|P9WQM7|ANSP2_MY	Q9UPY5	88.71	34.0	466.0	DB00740	approved; investigational	Riluzole	Nc(s1)nc(c12)ccc(c2)OC(F)(F)F
4364	sp|P9WQM7|ANSP2_MY	Q9UPY5	88.71	34.0	466.0	DB00795	approved	Sulfasalazine	OC(=O)c1cc(ccc1O)/N=N/c2ccc(cc2)S(=O)(=O)Nc3ncccc3
4365	sp|P9WQM7|ANSP2_MY	Q9UPY5	88.71	34.0	466.0	DB06151	approved; investigational	Acetylcysteine	CC(=O)N[C@@H](CS)C(=O)O
4366	sp|P9WQM7|ANSP2_MY	Q9UPY5	88.71	34.0	466.0	DB11590	approved	Thimerosal	CC[Hg]Sc1ccccc1C([O-])=O
4367	sp|P9WQM7|ANSP2_MY	P30825	85.83	21.0	439.0	DB00123	approved; nutraceutical	L-Lysine	NCCCC[C@H](N)C(=O)O
4368	sp|P9WQM7|ANSP2_MY	P30825	85.83	21.0	439.0	DB00125	investigational; nutraceutical	Arginine	OC(=O)[C@@H](N)CCCNC(N)=N
4369	sp|P9WQM7|ANSP2_MY	P30825	85.83	21.0	439.0	DB00129	approved; nutraceutical	Ornithine	NCCC[C@H](N)C(=O)O
4370	sp|P9WQM7|ANSP2_MY	Q9UHI5	89.12	34.0	468.0	DB00120	approved; investigational; nutraceutical	Phenylalanine	OC(=O)[C@@H](N)Cc1ccccc1
4371	sp|P9WQM7|ANSP2_MY	Q9UHI5	89.12	34.0	468.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
4372	sp|P9WQM7|ANSP2_MY	P52569	84.39	24.0	435.0	DB00123	approved; nutraceutical	L-Lysine	NCCCC[C@H](N)C(=O)O
4373	sp|P9WQM7|ANSP2_MY	P52569	84.39	24.0	435.0	DB00129	approved; nutraceutical	Ornithine	NCCC[C@H](N)C(=O)O
4374	sp|P9WQM7|ANSP2_MY	Q8WY07	83.57	24.0	431.0	DB00123	approved; nutraceutical	L-Lysine	NCCCC[C@H](N)C(=O)O
4375	sp|P9WQM7|ANSP2_MY	Q8WY07	83.57	24.0	431.0	DB00125	investigational; nutraceutical	Arginine	OC(=O)[C@@H](N)CCCNC(N)=N
4376	sp|P9WQM7|ANSP2_MY	Q8WY07	83.57	24.0	431.0	DB13146	approved	Fluciclovine (18F)	OC(=O)[C@]1(N)C[C@H]([18F])C1
4377	sp|P9WQM7|ANSP2_MY	Q9UM01	87.68	29.0	456.0	DB13146	approved	Fluciclovine (18F)	OC(=O)[C@]1(N)C[C@H]([18F])C1
4378	sp|P9WQM7|ANSP2_MY	O43246	80.08	27.0	417.0	DB00123	approved; nutraceutical	L-Lysine	NCCCC[C@H](N)C(=O)O
4379	sp|P9WQM7|ANSP2_MY	O43246	80.08	27.0	417.0	DB00125	investigational; nutraceutical	Arginine	OC(=O)[C@@H](N)CCCNC(N)=N
4380	sp|P9WQM7|ANSP2_MY	P60063	83.78	9.0	417.0	DB02451	experimental	B-nonylglucoside	CCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
4381	sp|P9WIS3|BKDA_MYC	P08559	80.65	58.0	354.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
4382	sp|P9WIS3|BKDA_MYC	P29803	80.38	57.0	352.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
4383	sp|P9WIS1|BKDB_MYC	P11177	93.97	30.0	357.0	DB00119	approved; investigational; nutraceutical	Pyruvic acid	CC(=O)C(=O)O
4384	sp|P9WIS1|BKDB_MYC	P11177	93.97	30.0	357.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
4385	sp|P9WID9|BCPB_MYC	Q06830	101.95	7.0	164.0	DB01593	approved; investigational	Zinc	[Zn]
4386	sp|P9WID9|BCPB_MYC	Q06830	101.95	7.0	164.0	DB09130	approved; investigational	Copper	[Cu]
4387	sp|P9WID9|BCPB_MYC	Q06830	101.95	7.0	164.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
4388	sp|P9WID9|BCPB_MYC	Q06830	101.95	7.0	164.0	DB14487	approved; investigational	Zinc acetate	CC([O-])=O
4389	sp|P9WID9|BCPB_MYC	Q06830	101.95	7.0	164.0	DB14533	approved; investigational	Zinc chloride	[Cl-]
4390	sp|P9WID9|BCPB_MYC	Q06830	101.95	7.0	164.0	DB14548	approved; experimental	Zinc sulfate, unspecified form	 
4391	sp|P9WID9|BCPB_MYC	P32119	101.3	7.0	163.0	DB02153	experimental	3-sulfino-L-alanine	OC(=O)[C@@H](N)C[S@](=O)O
4392	sp|P9WID9|BCPB_MYC	P32119	101.3	7.0	163.0	DB04048	experimental	N-Carbamoyl-Alanine	OC(=O)[C@@H](C)NC(=O)N
4393	sp|P9WID9|BCPB_MYC	P32119	101.3	7.0	163.0	DB09130	approved; investigational	Copper	[Cu]
4394	sp|P9WID9|BCPB_MYC	Q8IL80	101.3	5.0	161.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
4395	sp|P9WID9|BCPB_MYC	Q8P9V9	95.45	9.0	156.0	DB04640	experimental	Naphthalene-2,6-disulfonic acid	OS(=O)(=O)c(cc1)cc(c12)ccc(c2)S(=O)(=O)O
4396	sp|P9WID9|BCPB_MYC	P30041	102.6	7.0	165.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
4397	sp|P9WID9|BCPB_MYC	P30041	102.6	7.0	165.0	DB09130	approved; investigational	Copper	[Cu]
4398	sp|P9WID9|BCPB_MYC	P9WG35	94.16	20.0	165.0	DB03382	experimental	S-oxy-L-cysteine	OC(=O)[C@@H](N)CS=O
4399	sp|P9WID9|BCPB_MYC	P30044	75.32	56.0	172.0	DB00995	approved; investigational	Auranofin	CCP(CC)(CC)=[Au]S[C@@H]1O[C@H](COC(=O)C)[C@@H](OC(=O)C)[C@H](OC(=O)C)[C@H]1OC(=O)C
4400	sp|P9WID9|BCPB_MYC	P30044	75.32	56.0	172.0	DB03608	experimental	Diminazene	NC(=N)c1ccc(cc1)N/N=N/c2ccc(cc2)C(N)=N
4401	sp|P9WID9|BCPB_MYC	Q5MYR6	72.08	91.0	202.0	DB03661	experimental	L-cysteic acid	OC(=O)[C@@H](N)CS(=O)(=O)O
4402	sp|P71857|CHSE1_MY	Q72JJ3	98.82	44.0	379.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
4403	sp|P71857|CHSE1_MY	P11310	98.82	80.0	415.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
4404	sp|P71857|CHSE1_MY	P11310	98.82	80.0	415.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
4405	sp|P71857|CHSE1_MY	P11310	98.82	80.0	415.0	DB03415	experimental	3-thiaoctanoyl-CoA	CCCCCSCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
4406	sp|P71857|CHSE1_MY	Q06319	100.0	38.0	377.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
4407	sp|P71857|CHSE1_MY	Q06319	100.0	38.0	377.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
4408	sp|P71857|CHSE1_MY	P16219	99.41	70.0	407.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
4409	sp|P71857|CHSE1_MY	P16219	99.41	70.0	407.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
4410	sp|P71857|CHSE1_MY	P16219	99.41	70.0	407.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
4411	sp|P71857|CHSE1_MY	P45954	100.29	87.0	427.0	DB00167	investigational; nutraceutical	Isoleucine	CC[C@H](C)[C@H](N)C(=O)O
4412	sp|P71857|CHSE1_MY	P45954	100.29	87.0	427.0	DB00313	approved; investigational	Valproic acid	CCCC(C(=O)O)CCC
4413	sp|P71857|CHSE1_MY	Q3JP94	98.53	53.0	387.0	DB08685	experimental	1-(1,4-dimethyl-1,2,3,4-tetrahydroquinoxalin-6-yl)methanamine	CN1CCN(C)c(c12)cc(cc2)CN
4414	sp|P71857|CHSE1_MY	Q9UKU7	98.82	78.0	413.0	DB01675	experimental	Methacrylyl-Coenzyme A	CC(=C)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
4415	sp|P71857|CHSE1_MY	Q9UKU7	98.82	78.0	413.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
4416	sp|P71857|CHSE1_MY	Q92947	99.71	90.0	428.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
4417	sp|P71857|CHSE1_MY	Q92947	99.71	90.0	428.0	DB03245	experimental	S-4-Nitrobutyryl-CoA	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCC[N+]([O-])=O
4418	sp|P71857|CHSE1_MY	P26440	99.41	80.0	417.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
4419	sp|P71857|CHSE1_MY	P26440	99.41	80.0	417.0	DB04036	experimental	Coenzyme A persulfide	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSS
4420	sp|P71857|CHSE1_MY	Q9KIE5	99.41	25.0	362.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
4421	sp|P71857|CHSE1_MY	Q15067	102.06	88.0	434.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
4422	sp|P71857|CHSE1_MY	Q15067	102.06	88.0	434.0	DB07930	experimental	(3R)-3-HYDROXYDODECANOIC ACID	OC(=O)C[C@H](O)CCCCCCCCC
4423	sp|P9WG67|THIO_MYC	P30101	88.79	25.0	128.0	DB01593	approved; investigational	Zinc	[Zn]
4424	sp|P9WG67|THIO_MYC	P30101	88.79	25.0	128.0	DB09130	approved; investigational	Copper	[Cu]
4425	sp|P9WG67|THIO_MYC	P30101	88.79	25.0	128.0	DB14487	approved; investigational	Zinc acetate	CC([O-])=O
4426	sp|P9WG67|THIO_MYC	P30101	88.79	25.0	128.0	DB14533	approved; investigational	Zinc chloride	[Cl-]
4427	sp|P9WG67|THIO_MYC	P30101	88.79	25.0	128.0	DB14548	approved; experimental	Zinc sulfate, unspecified form	 
4428	sp|P9WG67|THIO_MYC	P30101	91.38	374.0	480.0	DB01593	approved; investigational	Zinc	[Zn]
4429	sp|P9WG67|THIO_MYC	P30101	91.38	374.0	480.0	DB09130	approved; investigational	Copper	[Cu]
4430	sp|P9WG67|THIO_MYC	P30101	91.38	374.0	480.0	DB14487	approved; investigational	Zinc acetate	CC([O-])=O
4431	sp|P9WG67|THIO_MYC	P30101	91.38	374.0	480.0	DB14533	approved; investigational	Zinc chloride	[Cl-]
4432	sp|P9WG67|THIO_MYC	P30101	91.38	374.0	480.0	DB14548	approved; experimental	Zinc sulfate, unspecified form	 
4433	sp|P9WG67|THIO_MYC	C0H4Y6	76.72	42.0	131.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
4434	sp|P9WG67|THIO_MYC	C0H4Y6	88.79	349.0	452.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
4435	sp|P9WG67|THIO_MYC	P07237	90.52	21.0	126.0	DB01593	approved; investigational	Zinc	[Zn]
4436	sp|P9WG67|THIO_MYC	P07237	90.52	21.0	126.0	DB03615	approved; experimental	Ribostamycin	O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]2[C@@H](O)[C@H](N)C[C@H](N)[C@H]2O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N
4437	sp|P9WG67|THIO_MYC	P07237	90.52	21.0	126.0	DB09130	approved; investigational	Copper	[Cu]
4438	sp|P9WG67|THIO_MYC	P07237	90.52	21.0	126.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
4439	sp|P9WG67|THIO_MYC	P07237	90.52	21.0	126.0	DB14487	approved; investigational	Zinc acetate	CC([O-])=O
4440	sp|P9WG67|THIO_MYC	P07237	90.52	21.0	126.0	DB14533	approved; investigational	Zinc chloride	[Cl-]
4441	sp|P9WG67|THIO_MYC	P07237	90.52	21.0	126.0	DB14548	approved; experimental	Zinc sulfate, unspecified form	 
4442	sp|P9WG67|THIO_MYC	P07237	87.07	365.0	466.0	DB01593	approved; investigational	Zinc	[Zn]
4443	sp|P9WG67|THIO_MYC	P07237	87.07	365.0	466.0	DB03615	approved; experimental	Ribostamycin	O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]2[C@@H](O)[C@H](N)C[C@H](N)[C@H]2O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N
4444	sp|P9WG67|THIO_MYC	P07237	87.07	365.0	466.0	DB09130	approved; investigational	Copper	[Cu]
4445	sp|P9WG67|THIO_MYC	P07237	87.07	365.0	466.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
4446	sp|P9WG67|THIO_MYC	P07237	87.07	365.0	466.0	DB14487	approved; investigational	Zinc acetate	CC([O-])=O
4447	sp|P9WG67|THIO_MYC	P07237	87.07	365.0	466.0	DB14533	approved; investigational	Zinc chloride	[Cl-]
4448	sp|P9WG67|THIO_MYC	P07237	87.07	365.0	466.0	DB14548	approved; experimental	Zinc sulfate, unspecified form	 
4449	sp|P9WG67|THIO_MYC	P10599	76.72	6.0	95.0	DB12695	investigational	Phenethyl Isothiocyanate	S=C=NCCc1ccccc1
4450	sp|P9WG67|THIO_MYC	Q8IDH5	76.72	23.0	112.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
4451	sp|P9WG67|THIO_MYC	Q8IKL4	84.48	5.0	103.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
4452	sp|P9WG67|THIO_MYC	Q8IB72	74.14	184.0	270.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
4453	sp|P9WFY1|TRPA_MYC	P00929	95.19	3.0	260.0	DB03171	experimental	Indole-3-Propanol Phosphate	OP(=O)(O)OCCCc1c[nH]c(c12)cccc2
4454	sp|P9WFY1|TRPA_MYC	P00929	95.19	3.0	260.0	DB04143	experimental	Indole-3-Glycerol Phosphate	OP(=O)(O)OC[C@@H](O)[C@@H](O)c1c[nH]c(c12)cccc2
4455	sp|P9WFY1|TRPA_MYC	P00929	95.19	3.0	260.0	DB07732	experimental	2-[(2-NAPHTHYLSULFONYL)AMINO]ETHYL DIHYDROGEN PHOSPHATE	OP(=O)(O)OCCNS(=O)(=O)c(cc1)cc(c12)cccc2
4456	sp|P9WFY1|TRPA_MYC	P00929	95.19	3.0	260.0	DB07745	experimental	2-{[4-(TRIFLUOROMETHOXY)BENZOYL]AMINO}ETHYL DIHYDROGEN PHOSPHATE	OP(=O)(O)OCCNC(=O)c1ccc(OC(F)(F)F)cc1
4457	sp|P9WFY1|TRPA_MYC	P00929	95.19	3.0	260.0	DB07748	experimental	2-({[4-(TRIFLUOROMETHOXY)PHENYL]SULFONYL}AMINO)ETHYL DIHYDROGEN PHOSPHATE	OP(=O)(O)OCCNS(=O)(=O)c1ccc(OC(F)(F)F)cc1
4458	sp|P9WFY1|TRPA_MYC	P00929	95.19	3.0	260.0	DB07773	experimental	5-FLUOROINDOLE PROPANOL PHOSPHATE	OP(=O)(O)OCCCc1c[nH]c(c12)ccc(F)c2
4459	sp|P9WFY1|TRPA_MYC	P00929	95.19	3.0	260.0	DB07890	experimental	4-(2-HYDROXYPHENYLTHIO)-1-BUTENYLPHOSPHONIC ACID	Oc1ccccc1SCC/C=C/P(=O)(O)O
4460	sp|P9WFY1|TRPA_MYC	P00929	95.19	3.0	260.0	DB07894	experimental	4-(2-HYDROXY-4-FLUOROPHENYLTHIO)-BUTYLPHOSPHONIC ACID	Oc1ccc(F)cc1SCC/C=C/P(=O)(O)O
4461	sp|P9WFY1|TRPA_MYC	P00929	95.19	3.0	260.0	DB07925	experimental	4-(2-HYDROXYPHENYLSULFINYL)-BUTYLPHOSPHONIC ACID	Oc1ccccc1[S@](=O)CCCCP(=O)(O)O
4462	sp|P9WFY1|TRPA_MYC	P00929	95.19	3.0	260.0	DB07951	experimental	N-(indole-3-acetyl)-L-aspartic acid	OC(=O)C[C@@H](C(=O)O)NC(=O)Cc1c[nH]c(c12)cccc2
4463	sp|P9WFY1|TRPA_MYC	P00929	95.19	3.0	260.0	DB07952	experimental	N-[1H-INDOL-3-YL-ACETYL]GLYCINE ACID	OC(=O)CNC(=O)Cc1c[nH]c(c12)cccc2
4464	sp|P9WFY1|TRPA_MYC	P00929	95.19	3.0	260.0	DB07953	experimental	N-[1H-INDOL-3-YL-ACETYL]VALINE ACID	CC(C)[C@@H](C(=O)O)NC(=O)Cc1c[nH]c(c12)cccc2
4465	sp|P9WFY1|TRPA_MYC	P16608	91.48	6.0	253.0	DB03171	experimental	Indole-3-Propanol Phosphate	OP(=O)(O)OCCCc1c[nH]c(c12)cccc2
4466	sp|P9WFX7|TRPC_MYC	P00909	92.65	3.0	255.0	DB03543	experimental	1-(O-Carboxy-Phenylamino)-1-Deoxy-D-Ribulose-5-Phosphate	OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@H](O)CNc1ccccc1C(=O)O
4467	sp|Q6MX39|UMAA_MYC	P9WPB7	98.95	4.0	287.0	DB01718	approved	Cetrimonium	CCCCCCCCCCCCCCCC[N+](C)(C)C
4468	sp|Q6MX39|UMAA_MYC	P9WPB3	98.95	4.0	287.0	DB01752	experimental	S-adenosyl-L-homocysteine	OC(=O)[C@@H](N)CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
4469	sp|Q6MX39|UMAA_MYC	Q79FX6	99.3	3.0	287.0	DB01718	approved	Cetrimonium	CCCCCCCCCCCCCCCC[N+](C)(C)C
4470	sp|Q6MX39|UMAA_MYC	Q79FX6	99.3	3.0	287.0	DB01752	experimental	S-adenosyl-L-homocysteine	OC(=O)[C@@H](N)CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
4471	sp|Q6MX39|UMAA_MYC	Q79FX8	98.95	12.0	295.0	DB07413	experimental	5'-S-[2-(decylamino)ethyl]-5'-thioadenosine	n1cnc(N)c(c12)ncn2[C@H]3[C@H](O)[C@H](O)[C@H](O3)CSCCNCCCCCCCCCC
4472	sp|Q6MX39|UMAA_MYC	P9WPB5	101.75	11.0	302.0	DB01752	experimental	S-adenosyl-L-homocysteine	OC(=O)[C@@H](N)CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
4473	sp|Q6MX39|UMAA_MYC	P9WPB5	101.75	11.0	302.0	DB04221	approved; experimental	Didecyldimethylammonium	CCCCCCCCCC[N+](C)(C)CCCCCCCCCC
4474	sp|P9WQK5|Y073_MYC	P08183	70.3	1033.0	1265.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
4475	sp|P9WQK5|Y073_MYC	P08183	70.3	1033.0	1265.0	DB00603	approved; investigational	Medroxyprogesterone acetate	CC(=O)O[C@]1(C(=O)C)CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C([C@H](C3)C)=CC(=O)CC4
4476	sp|P9WQK5|Y073_MYC	P08183	70.3	1033.0	1265.0	DB00778	approved; investigational; withdrawn	Roxithromycin	COCCOCO/N=C([C@H](C)[C@@H](O)[C@]1(C)O)/[C@H](C)C[C@@](C)(O)[C@@H]([C@@H](C)[C@@H]([C@@H](C)C(=O)O[C@@H]1CC)O[C@@H](C[C@@]2(C)OC)O[C@@H](C)[C@@H]2O)O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C
4477	sp|P9WQK5|Y073_MYC	P08183	70.3	1033.0	1265.0	DB00813	approved; illicit; investigational; vet_approved	Fentanyl	c1ccccc1N(C(=O)CC)C2CCN(CC2)CCc3ccccc3
4478	sp|P9WQK5|Y073_MYC	P08183	70.3	1033.0	1265.0	DB04877	experimental	Voacamine	CC[C@H]1C[C@@H](C2)CN([C@@H]1[C@@]23C(=O)OC)CCc4c3[nH]c5c4cc(OC)c(c5)[C@@H](C[C@H]67)c8c(c9c([nH]8)cccc9)C[C@H](C6C(=O)OC)N(C)CC\7=C\C
4479	sp|P9WQK5|Y073_MYC	P08183	70.3	1033.0	1265.0	DB04881	investigational	Elacridar	COc1cccc(c12)c(=O)c3c([nH]2)c(ccc3)C(=O)Nc4ccc(cc4)CCN(C5)CCc(c56)cc(OC)c(c6)OC
4480	sp|P9WQK5|Y073_MYC	P08183	70.3	1033.0	1265.0	DB04905	investigational	Tesmilifene	CCN(CC)CCOc1ccc(cc1)Cc2ccccc2
4481	sp|P9WQK5|Y073_MYC	P08183	70.3	1033.0	1265.0	DB05449	investigational	FM-VP4	 
4482	sp|P9WQK5|Y073_MYC	P08183	70.3	1033.0	1265.0	DB06191	investigational	Zosuquidar	FC1(F)[C@H]2[C@@H]1c(cccc3)c3[C@@H](c(c24)cccc4)N5CCN(CC5)C[C@@H](O)COc6cccc(c67)nccc7
4483	sp|P9WQK5|Y073_MYC	P08183	70.3	1033.0	1265.0	DB06240	investigational	Tariquidar	COc(c1)c(OC)cc(c12)CCN(C2)CCc3ccc(cc3)NC(=O)c4cc(OC)c(OC)cc4NC(=O)c(c5)cnc(c56)cccc6
4484	sp|P9WQK5|Y073_MYC	P08183	70.3	1033.0	1265.0	DB09031	approved; investigational	Miltefosine	CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C
4485	sp|P9WQK5|Y073_MYC	P08183	70.3	1033.0	1265.0	DB11635	approved	Tocofersolan	 
4486	sp|P9WQK5|Y073_MYC	P08183	70.3	1033.0	1265.0	DB14061	experimental	Hycanthone	CCN(CC)CCNc(ccc1CO)c(c12)c(=O)c3c(s2)cccc3
4487	sp|P9WQK5|Y073_MYC	P08183	70.3	1033.0	1265.0	DB14062	experimental	Concanamycin A	NC(=O)O[C@@H]1[C@@H](C)O[C@H](C[C@H]1O)O[C@H](C2)[C@H](C)[C@@H](/C=C/C)O[C@@]2(O)[C@@H](C)[C@H](O)[C@H](C)[C@H]3OC(=O)/C(OC)=C/C(C)=C/[C@@H](C)[C@@H](O)[C@@H](CC)[C@@H](O)[C@H](C)C/C(C)=C/C=C/[C@@H]3OC
4488	sp|P9WQK5|Y073_MYC	P08183	70.3	1033.0	1265.0	DB14063	experimental	Dexverapamil	COc1ccc(cc1OC)CCN(C)CCC[C@@](C#N)(C(C)C)c2cc(OC)c(OC)cc2
4489	sp|P9WQK5|Y073_MYC	P08183	70.3	1033.0	1265.0	DB14064	experimental	Emopamil	c1ccccc1C(C#N)(C(C)C)CCCN(C)CCc2ccccc2
4490	sp|P9WQK5|Y073_MYC	P08183	70.3	1033.0	1265.0	DB14065	experimental	Lomerizine	COc1ccc(c(OC)c1OC)CN2CCN(CC2)C(c3ccc(F)cc3)c4ccc(F)cc4
4491	sp|P9WQK5|Y073_MYC	P08183	70.3	1033.0	1265.0	DB14066	experimental	Tetrandrine	c12ccc(OC)c(c1)Oc3ccc(cc3)C[C@H]4c5c(CCN4C)cc(OC)c(c5)Oc6c7c(CCN(C)[C@H]7C2)cc(OC)c6OC
4492	sp|P9WQK5|Y073_MYC	P08183	70.3	1033.0	1265.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
4493	sp|P9WQK5|Y073_MYC	P08183	70.3	1033.0	1265.0	DB14068	experimental	Dexniguldipine	[O-][N+](=O)c1cccc(c1)[C@@H]2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCCN(CC3)CCC3(c4ccccc4)c5ccccc5
4494	sp|P9WQK5|Y073_MYC	P08183	70.3	1033.0	1265.0	DB14069	investigational	ONT-093	CCOC/C=C/c1ccc(cc1)-c2nc(-c3ccc(cc3)NC(C)C)c([nH]2)-c4ccc(cc4)NC(C)C
4495	sp|P9WQK5|Y073_MYC	P08183	70.3	1033.0	1265.0	DB14070	experimental	HM-30181	c1cccc(c12)c(=O)cc(o2)C(=O)Nc3cc(OC)c(OC)cc3-c4nn(nn4)-c5ccc(cc5)CCN(C6)CCc(c67)cc(OC)c(c7)OC
4496	sp|P9WQK5|Y073_MYC	P08183	70.3	1033.0	1265.0	DB14071	experimental	Desmethylsertraline	c1cccc(c12)[C@@H](CC[C@@H]2N)c3cc(Cl)c(Cl)cc3
4497	sp|P9WQK5|Y073_MYC	P08183	70.3	1033.0	1265.0	DB14072	experimental	Reversin 121	c1ccccc1COC(=O)C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@H](C(=O)OC(C)(C)C)CCCCNC(=O)OCc2ccccc2
4498	sp|P9WQK5|Y073_MYC	O95342	70.91	1076.0	1310.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
4499	sp|P9WQK5|Y073_MYC	O95342	70.91	1076.0	1310.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
4500	sp|P9WPZ1|Y1496_MY	Q8IVH4	100.0	80.0	414.0	DB00115	approved; nutraceutical	Cyanocobalamin	Cc(c1)c(C)cc(c12)ncn2[C@@H]3[C@H](O)[C@@H]([C@H](O3)CO)OP([O-])(=O)O[C@H](C)CNC(=O)CC[C@](C)([C@@H](CC(=O)N)[C@@H]4[C@]56C)C(=N4)/C(C)=C7\N=C(C(C)(C)[C@@H]7CCC(=O)N)/C=C8\N=C([C@@](C)(CC(=O)N)[C@@H]8CCC(=O)N)/C(C)=C(\N5[Co+]C#N)[C@@H](CCC(=O)N)[C@]6(C)CC(=O)N
4501	sp|P9WPZ1|Y1496_MY	Q8IVH4	100.0	80.0	414.0	DB00200	approved	Hydroxocobalamin	c1c(C)c(C)cc(c1[n+]2[Co-3]3456O)n(c2)[C@H]7O[C@H](CO)[C@H]([C@H]7O)OP(=O)([O-])O[C@H](C)CNC(=O)CC[C@@]8(C)C=9N3[C@H]([C@@H]8CC(=O)N)[C@]1(C)[N+]4=C([C@H]([C@]1(C)CC(=O)N)CCC(=O)N)C(C)=C1[N+]5=C([C@H]([C@]1(C)CC(=O)N)CCC(=O)N)C=C1[N+]6=C(C9C)[C@H](C1(C)C)CCC(=O)N
4502	sp|P9WNY3|Y770_MYC	P31937	71.53	38.0	249.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
4503	sp|P9WGS7|Y0687_MY	Q9BTZ2	89.45	27.0	273.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
4505	sp|P9WGS7|Y0687_MY	Q9WYS2	89.09	6.0	251.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
4506	sp|P9WGS7|Y0687_MY	P0AEK2	86.55	3.0	241.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
4508	sp|P9WGS7|Y0687_MY	Q9BY49	91.27	13.0	264.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
4510	sp|P9WGS7|Y0687_MY	P16544	91.64	5.0	257.0	DB01942	experimental; investigational	Formic acid	OC=O
4511	sp|P9WGS7|Y0687_MY	P16544	91.64	5.0	257.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
4512	sp|P9WGS7|Y0687_MY	P16544	91.64	5.0	257.0	DB07715	investigational	Emodin	Cc(c1)cc(O)c(c12)C(=O)c3c(C2=O)cc(O)cc3O
4513	sp|P9WGS7|Y0687_MY	Q92506	91.27	7.0	258.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
4514	sp|P9WGS7|Y0687_MY	Q92506	91.27	7.0	258.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
4515	sp|P9WGS7|Y0687_MY	P0AET8	87.64	8.0	249.0	DB02123	experimental	Glycochenodeoxycholic Acid	OC(=O)CNC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
4516	sp|P9WGS7|Y0687_MY	Q84EX5	89.09	3.0	248.0	DB04619	experimental	Acetophenone	CC(=O)c1ccccc1
4517	sp|P9WGS7|Y0687_MY	Q84EX5	89.09	3.0	248.0	DB04784	experimental	(R)-1-phenylethanol	C[C@@H](O)c1ccccc1
4518	sp|P9WGS7|Y0687_MY	P0CG22	90.55	27.0	276.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
4519	sp|P9WGS7|Y0687_MY	P0CG22	90.55	27.0	276.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
4520	sp|P9WGS7|Y0687_MY	P0CG22	90.55	27.0	276.0	DB03541	experimental	10-Propargyl-5,8-Dideazafolic Acid	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(CC#C)Cc(c2)ccc(c23)[nH]c(N)nc3=O
4521	sp|P9WGS7|Y0687_MY	P0CG22	90.55	27.0	276.0	DB07689	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)NCc(cn3)nc(c34)c(N)nc(n4)N
4522	sp|P9WGS7|Y0687_MY	P0CG22	90.55	27.0	276.0	DB07765	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)N(C)Cc(cn3)nc(c34)c(N)nc(n4)N
4523	sp|P9WGS7|Y0687_MY	Q7Z4W1	85.45	5.0	240.0	DB02831	experimental	Dihydrogenphosphate	OP([O-])(=O)O
4524	sp|P9WGS7|Y0687_MY	Q7Z4W1	85.45	5.0	240.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
4525	sp|P9WGS7|Y0687_MY	Q16698	89.82	55.0	302.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
4526	sp|P9WGS7|Y0687_MY	Q16698	89.82	55.0	302.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
4528	sp|P9WGS7|Y0687_MY	A0A348A0U3	90.55	2.0	251.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
4529	sp|P9WGS7|Y0687_MY	Q99714	92.36	1.0	255.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
4530	sp|P9WGS7|Y0687_MY	Q99714	92.36	1.0	255.0	DB02820	experimental	1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct	C1CCCCCN1C(=O)[C@H](c2ccccc2)n(c3=S)cnc(c34)nn(c4)[C@H]5C=CN(C=C5C([O-])=N)[C@@H]6O[C@@H]([C@@H](O)[C@H]6O)COP([O-])(=O)OP(=O)(O)OC[C@H]7O[C@H]([C@H]([O-])[C@@H]7[O-])n8cnc(c89)c(N)ncn9
4531	sp|P9WGS7|Y0687_MY	Q99714	92.36	1.0	255.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
4532	sp|P9WGS7|Y0687_MY	Q6UWP2	85.82	10.0	246.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
4533	sp|P9WGS7|Y0687_MY	P0AEK4	90.18	2.0	250.0	DB01691	experimental	Indole Naphthyridinone	c1cccc(c12)n(C)cc2CN(C)C(=O)/C=C/c(c3)cnc(c34)NC(=O)CC4
4534	sp|P9WGS7|Y0687_MY	P0AEK4	90.18	2.0	250.0	DB01865	experimental	3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide	c1cccc(c12)cc(n2C)CN(C)C(=O)/C=C/c3cnc(N)cc3
4535	sp|P9WGS7|Y0687_MY	P0AEK4	90.18	2.0	250.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
4536	sp|P9WGS7|Y0687_MY	P0AEK4	90.18	2.0	250.0	DB03030	experimental	4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole	Cc1ccc(cc1)Cn2cnc(c2)-c3cccs3
4537	sp|P9WGS7|Y0687_MY	P0AEK4	90.18	2.0	250.0	DB03534	experimental	3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide	CC(=O)N(C)Cc1c(N)ccc(c1)C(=O)N(C)Cc(n2C)cc(c23)cccc3
4538	sp|P9WGS7|Y0687_MY	P0AEK4	90.18	2.0	250.0	DB04030	experimental	1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole	Oc1ccc(cc1)Cn2c(c3c(c24)cccc4)CN(CC3)C(=O)c5ccc(O)cc5
4539	sp|P9WGS7|Y0687_MY	P0AEK4	90.18	2.0	250.0	DB08265	experimental	2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL	Cc1ccc(cc1)S(=O)(=O)n(b2O)ncc(c23)cccc3
4540	sp|P9WGS7|Y0687_MY	P0AEK4	90.18	2.0	250.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
4541	sp|P9WGS7|Y0687_MY	P0AEK4	90.18	2.0	250.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
4542	sp|P9WGS7|Y0687_MY	Q6GI75	89.82	4.0	251.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
4543	sp|P9WGS7|Y0687_MY	Q6GI75	89.82	4.0	251.0	DB11155	approved	Triclocarban	Clc1ccc(cc1)NC(=O)Nc2cc(Cl)c(Cl)cc2
4544	sp|P9WGS7|Y0687_MY	Q8I814	93.09	14.0	270.0	DB02015	experimental	Dihydrofolic Acid	O=c1[nH]c(N)nc(c12)NCC(=N2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
4545	sp|P9WGS7|Y0687_MY	Q8I814	93.09	14.0	270.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
4546	sp|P9WGS7|Y0687_MY	Q7AUG5	86.91	3.0	242.0	DB04782	experimental	(S)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@H]2CO2
4547	sp|P9WGS7|Y0687_MY	Q93D82	86.91	3.0	242.0	DB04472	experimental	(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol	[N-]=[N+]=NC[C@H](O)c1ccc([N+]([O-])=O)cc1
4548	sp|P9WGS7|Y0687_MY	Q93D82	86.91	3.0	242.0	DB04499	experimental	(R)-styrene oxide	C1O[C@@H]1c2ccccc2
4549	sp|P9WGS7|Y0687_MY	Q93D82	86.91	3.0	242.0	DB04777	experimental	(R)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@@H]2CO2
4550	sp|P9WGS7|Y0687_MY	O24990	89.82	2.0	249.0	DB04393	experimental	Soneclosan	Clc1cc(O)c(cc1)Oc2ccc(Cl)cc2
4551	sp|P9WGS7|Y0687_MY	O24990	89.82	2.0	249.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
4552	sp|P9WGS7|Y0687_MY	Q8NBQ5	72.73	31.0	231.0	DB02854	experimental	Aetiocholanolone	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](CC3)C[C@H](O)CC4
4553	sp|P9WGS7|Y0687_MY	Q01782	99.64	8.0	282.0	DB02338	experimental	NADPH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
4554	sp|P9WGS7|Y0687_MY	Q01782	99.64	8.0	282.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
4555	sp|P9WGS7|Y0687_MY	Q01782	99.64	8.0	282.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
4556	sp|P9WGS7|Y0687_MY	Q01782	99.64	8.0	282.0	DB04400	experimental	L-erythro-7,8-dihydrobiopterin	C[C@H](O)[C@H](O)C(CN1)=Nc(c12)c(=O)nc([nH]2)N
4557	sp|P9WGS7|Y0687_MY	P51659	85.82	6.0	242.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
4558	sp|P9WGS7|Y0687_MY	P51659	85.82	6.0	242.0	DB03192	experimental	(R)-3-hydroxydecanoyl-CoA	CCCCCCC[C@@H](O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
4559	sp|P9WGS7|Y0687_MY	Q8TC12	75.64	36.0	244.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
4560	sp|P9WGS7|Y0687_MY	Q8NBN7	75.64	35.0	243.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
4561	sp|P9WGS7|Y0687_MY	P14061	70.91	3.0	198.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
4562	sp|P9WGS7|Y0687_MY	P14061	70.91	3.0	198.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
4563	sp|P9WGS7|Y0687_MY	P14061	70.91	3.0	198.0	DB01561	experimental; illicit	Androstanedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
4564	sp|P9WGS7|Y0687_MY	P14061	70.91	3.0	198.0	DB02187	experimental	Equilin	O=C1CC[C@H]([C@@]12C)C=3[C@H](CC2)c4c(CC3)cc(O)cc4
4565	sp|P9WGS7|Y0687_MY	P14061	70.91	3.0	198.0	DB02323	experimental	EM-1745	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)C[C@@H]([C@@H]4O)CCCCCCCCC(=O)OC[C@H]5O[C@H]([C@H](O)[C@@H]5O)n6cnc(c67)c(N)ncn7
4566	sp|P9WGS7|Y0687_MY	P14061	70.91	3.0	198.0	DB02901	illicit; investigational	Stanolone	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
4567	sp|P9WGS7|Y0687_MY	P14061	70.91	3.0	198.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
4568	sp|P9WGS7|Y0687_MY	P14061	70.91	3.0	198.0	DB13951	experimental	Stanolone acetate	CC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
4569	sp|P9WGS7|Y0687_MY	O75911	72.73	31.0	231.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
4570	sp|P9WGS7|Y0687_MY	Q96NR8	74.91	36.0	242.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
4571	sp|P9WGS7|Y0687_MY	Q02338	80.0	49.0	269.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
4572	sp|P9WGS7|Y0687_MY	Q9HBH5	92.0	39.0	292.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
4573	sp|P9WGS7|Y0687_MY	P28845	82.55	29.0	256.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
4574	sp|P9WGS7|Y0687_MY	P28845	82.55	29.0	256.0	DB02329	experimental	Carbenoxolone	OC(=O)CCC(=O)O[C@@H](CC1)C(C)(C)[C@@H]([C@]12C)CC[C@]3(C)[C@@H]2C(=O)C=C4[C@H]5[C@@](C)(CC[C@@]34C)CC[C@](C5)(C)C(=O)O
4575	sp|P9WGS7|Y0687_MY	P28845	82.55	29.0	256.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
4576	sp|P9WGS7|Y0687_MY	P28845	82.55	29.0	256.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
4577	sp|P9WGS7|Y0687_MY	P28845	82.55	29.0	256.0	DB04652	experimental	Corticosterone	OCC(=O)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H]([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
4578	sp|P9WGS7|Y0687_MY	P28845	82.55	29.0	256.0	DB05064	investigational	INCB13739	 
4579	sp|P9WGS7|Y0687_MY	P28845	82.55	29.0	256.0	DB06992	experimental	(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone	Cc1ccc(cc1F)-c2nc(ccc2)C(=O)N(CC3(C)C)CCC3
4580	sp|P9WGS7|Y0687_MY	P28845	82.55	29.0	256.0	DB07017	experimental	(5S)-2-{[(1S)-1-(4-Fluorophenyl)ethyl]amino}-5-(2-hydroxy-2-propanyl)-5-methyl-1,3-thiazol-4(5H)-one	Fc1ccc(cc1)[C@H](C)NC(=NC2=O)S[C@@]2(C)C(C)(C)O
4581	sp|P9WGS7|Y0687_MY	P28845	82.55	29.0	256.0	DB07049	experimental	(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine	[O-][N+](=O)c1ccc(cc1)N2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)C(C)(C)C
4582	sp|P9WGS7|Y0687_MY	P28845	82.55	29.0	256.0	DB07056	experimental	2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide	CCN(CC)C(=O)Cc1cccc(n1)NS(=O)(=O)c2c(C)c(Cl)ccc2
4583	sp|P9WGS7|Y0687_MY	P28845	82.55	29.0	256.0	DB07310	experimental	(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one	Fc1ccccc1[C@H](C)NC(=NC2=O)S[C@]2(C)C(F)(F)F
4584	sp|P9WGS7|Y0687_MY	P28845	82.55	29.0	256.0	DB07316	experimental	N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)C3CCN(CC3)CC4(CC4)C(=O)N
4585	sp|P9WGS7|Y0687_MY	P28845	82.55	29.0	256.0	DB07619	experimental	N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)[C@H]3CC[C@@H](CC3)c4cccnc4
4586	sp|P9WGS7|Y0687_MY	P28845	82.55	29.0	256.0	DB07624	experimental	1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide	C1CC1(C(=O)N)CN2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)[C@](C)(O)C(F)(F)F
4587	sp|P9WGS7|Y0687_MY	P28845	82.55	29.0	256.0	DB07866	experimental	(5S)-2-(Cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one	CCC[C@]1(C)SC(=NC1=O)NC2CCCCCCC2
4588	sp|P9WGS7|Y0687_MY	P28845	82.55	29.0	256.0	DB08277	experimental	2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE	CS(=O)(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4c(Cl)cc(F)cc4
4589	sp|P9WGS7|Y0687_MY	P28845	82.55	29.0	256.0	DB08280	experimental	(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE	NC(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4ccc(OC)cc4
4590	sp|P9WGS7|Y0687_MY	P28845	82.55	29.0	256.0	DB08771	experimental	(5R)-2-[(2-Fluorophenyl)amino]-5-isopropyl-1,3-thiazol-4(5H)-one	CC(C)[C@H]1SC(=NC1=O)Nc2c(F)cccc2
4591	sp|P9WGS7|Y0687_MY	P28845	82.55	29.0	256.0	DB13751	approved; experimental	Glycyrrhizic acid	C1C[C@](C)(C(=O)O)C[C@H]([C@]12C)C=3[C@@](C)(CC2)[C@@]4(C)[C@H](C(=O)C3)[C@]5(C)[C@@H](CC4)C(C)(C)[C@H](CC5)O[C@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O[C@@H]7O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]7O
4592	sp|P9WGS7|Y0687_MY	P37059	74.18	79.0	283.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
4593	sp|P9WGS7|Y0687_MY	P37059	74.18	79.0	283.0	DB13952	approved; investigational; vet_approved	Estradiol acetate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)C
4594	sp|P9WGS7|Y0687_MY	P37059	74.18	79.0	283.0	DB13953	approved; investigational; vet_approved	Estradiol benzoate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)c5ccccc5
4595	sp|P9WGS7|Y0687_MY	P37059	74.18	79.0	283.0	DB13954	approved; investigational; vet_approved	Estradiol cypionate	C1CCCC1CCC(=O)O[C@H]2CC[C@H]([C@@]23C)[C@H]4[C@H](CC3)c5c(CC4)cc(O)cc5
4596	sp|P9WGS7|Y0687_MY	P37059	74.18	79.0	283.0	DB13955	approved; investigational; vet_approved	Estradiol dienanthate	CCCCCCC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)CCCCCC
4597	sp|P9WGS7|Y0687_MY	P37059	74.18	79.0	283.0	DB13956	approved; investigational; vet_approved	Estradiol valerate	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)CC[C@@H]4OC(=O)CCCC
4598	sp|P9WGS7|Y0687_MY	P9WGR1	94.91	2.0	263.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
4599	sp|P9WGS7|Y0687_MY	P9WGR1	94.91	2.0	263.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
4600	sp|P9WGS7|Y0687_MY	P9WGR1	94.91	2.0	263.0	DB02990	experimental	S-(2-Acetamidoethyl) hexadecanethioate	CCCCCCCCCCCCCCCC(=O)SCCNC(=O)C
4601	sp|P9WGS7|Y0687_MY	P9WGR1	94.91	2.0	263.0	DB04289	experimental	Genz-10850	[nH]1ccc(c12)cc(cc2)C(=O)N3CCN(CC3)C4c(cccc5)c5c(c46)cccc6
4602	sp|P9WGS7|Y0687_MY	P9WGR1	94.91	2.0	263.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
4603	sp|P9WGS7|Y0687_MY	P9WGR1	94.91	2.0	263.0	DB07090	experimental	(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cccc(c1C)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
4604	sp|P9WGS7|Y0687_MY	P9WGR1	94.91	2.0	263.0	DB07123	experimental	N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE	Cc1ccc(cc1)C(=O)N2CCC(CC2)Cc3ccccc3
4605	sp|P9WGS7|Y0687_MY	P9WGR1	94.91	2.0	263.0	DB07155	experimental	(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE	c1ccccc1NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
4606	sp|P9WGS7|Y0687_MY	P9WGR1	94.91	2.0	263.0	DB07178	experimental	5-PENTYL-2-PHENOXYPHENOL	CCCCCc1cc(O)c(cc1)Oc2ccccc2
4607	sp|P9WGS7|Y0687_MY	P9WGR1	94.91	2.0	263.0	DB07188	experimental	(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(cc(Cl)c1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
4608	sp|P9WGS7|Y0687_MY	P9WGR1	94.91	2.0	263.0	DB07192	experimental	(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Brc1cc(ccc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
4609	sp|P9WGS7|Y0687_MY	P9WGR1	94.91	2.0	263.0	DB07222	experimental	(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(c(C)cc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
4610	sp|P9WGS7|Y0687_MY	P9WGR1	94.91	2.0	263.0	DB07287	experimental	2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL	c1cccnc1Cc2cc(O)c(cc2)Oc3ccc(Cl)cc3Cl
4611	sp|P9WGS7|Y0687_MY	P9WGR1	94.91	2.0	263.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
4612	sp|P9WGS7|Y0687_MY	P80365	73.09	80.0	281.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
4613	sp|P9WGS7|Y0687_MY	P80365	73.09	80.0	281.0	DB01185	approved; illicit	Fluoxymesterone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@](F)([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
4614	sp|P9WGS7|Y0687_MY	P80365	73.09	80.0	281.0	DB01569	experimental; illicit	Formebolone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@H]([C@@H](C2)O)[C@]4(C)C(CC3)=CC(=O)C(C=O)=C4
4615	sp|P9WGS7|Y0687_MY	P80365	73.09	80.0	281.0	DB14538	experimental; vet_approved	Hydrocortisone aceponate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CC)C(=O)COC(=O)C
4616	sp|P9WGS7|Y0687_MY	P80365	73.09	80.0	281.0	DB14539	approved; vet_approved	Hydrocortisone acetate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)C
4617	sp|P9WGS7|Y0687_MY	P80365	73.09	80.0	281.0	DB14540	approved; vet_approved	Hydrocortisone butyrate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCC
4618	sp|P9WGS7|Y0687_MY	P80365	73.09	80.0	281.0	DB14541	approved; investigational; vet_approved	Hydrocortisone cypionate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)CCC5CCCC5
4619	sp|P9WGS7|Y0687_MY	P80365	73.09	80.0	281.0	DB14542	approved; vet_approved	Hydrocortisone phosphate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COP(=O)(O)O
4620	sp|P9WGS7|Y0687_MY	P80365	73.09	80.0	281.0	DB14543	approved; vet_approved	Hydrocortisone probutate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CCC)C(=O)COC(=O)CC
4621	sp|P9WGS7|Y0687_MY	P80365	73.09	80.0	281.0	DB14544	approved; vet_approved	Hydrocortisone valerate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCCC
4622	sp|P9WGS7|Y0687_MY	Q92781	70.91	28.0	223.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
4623	sp|P9WGS7|Y0687_MY	Q92781	70.91	28.0	223.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
4624	sp|P9WGS7|Y0687_MY	P37058	76.36	48.0	258.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
4625	sp|P9WGS7|Y0687_MY	P16152	85.09	7.0	241.0	DB01698	approved; experimental; investigational	Rutin	O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O[C@H]1C)OC[C@H]2O[C@H]([C@H](O)[C@@H](O)[C@@H]2O)Oc(c3=O)c(-c4cc(O)c(O)cc4)oc(c35)cc(O)cc5O
4626	sp|P9WGS7|Y0687_MY	P16152	85.09	7.0	241.0	DB02709	investigational	Resveratrol	Oc1ccc(cc1)/C=C/c2cc(O)cc(O)c2
4627	sp|P9WGS7|Y0687_MY	P16152	85.09	7.0	241.0	DB03394	experimental	Heptaethylene glycol	OCCOCCOCCOCCOCCOCCOCCO
4628	sp|P9WGS7|Y0687_MY	P16152	85.09	7.0	241.0	DB03556	experimental	2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400	CCOCCOCCOCCOCCOCCOCCOCCOCCO
4629	sp|P9WGS7|Y0687_MY	P16152	85.09	7.0	241.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
4630	sp|P9WGS7|Y0687_MY	P16152	85.09	7.0	241.0	DB04463	experimental	3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol	n1cnc(N)c(c12)c(nn2C(C)(C)C)-c3cccc(O)c3
4631	sp|P9WGS7|Y0687_MY	P16152	85.09	7.0	241.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
4632	sp|P9WGS7|Y0687_MY	P16152	85.09	7.0	241.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
4633	sp|P9WGS7|Y0687_MY	P56937	83.64	3.0	233.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
4634	sp|P9WGS7|Y0687_MY	P35270	85.45	5.0	240.0	DB02637	experimental	Oxaloacetate Ion	OC(=O)C(=O)CC([O-])=O
4635	sp|P9WGS7|Y0687_MY	P35270	85.45	5.0	240.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
4636	sp|P9WGS7|Y0687_MY	P35270	85.45	5.0	240.0	DB03886	experimental	Biopterin	C[C@@H](O)[C@@H](O)c(n1)cnc(c12)nc(N)[nH]c2=O
4637	sp|P9WGS7|Y0687_MY	P35270	85.45	5.0	240.0	DB04275	experimental	N-acetylserotonin	CC(=O)NCCc1c[nH]c(c12)ccc(c2)O
4638	sp|P9WGS7|Y0687_MY	Q8T8E9	70.18	3.0	196.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
4639	sp|P9WL77|Y2585_MY	P06202	74.51	97.0	512.0	DB07365	experimental	1-Naphthyl-L-alanine	OC(=O)[C@@H](N)Cc1cccc(c12)cccc2
4640	sp|P9WMC7|Y2912_MY	P9WMC1	84.1	16.0	180.0	DB02425	experimental	Hexadecyl Octanoate	CCCCCCCCCCCCCCCOC(=O)CCCCCCC
4641	sp|P9WMC7|Y2912_MY	P9WMC1	84.1	16.0	180.0	DB08469	experimental	tert-butyl 4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine-1-carboxylate	CC(C)(C)OC(=O)N1CCC(CC1)c2nc(no2)-c3cccs3
4642	sp|P9WMC7|Y2912_MY	P9WMC1	84.1	16.0	180.0	DB08470	experimental	3-(4-fluorophenyl)-5-phenyl-4H-1,2,4-triazole	Fc1ccc(cc1)-c2nnc([nH]2)-c3ccccc3
4643	sp|P9WMC7|Y2912_MY	P9WMC1	84.1	16.0	180.0	DB08471	experimental	1-(thiophen-2-ylacetyl)-4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine	c1ccsc1CC(=O)N2CCC(CC2)c3nc(no3)-c4cccs4
4644	sp|P9WGJ7|Y3402_MY	Q8ZNF3	89.81	5.0	375.0	DB02038	experimental	D-[3-hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl]-N,O-cycloserylamide	Cc1ncc(COP(=O)(O)O)c(c1O)CN[C@@H]2CONC2=O
4645	sp|P9WGJ7|Y3402_MY	Q8ZNF3	89.81	5.0	375.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
4646	sp|P9WMV1|Y891_MYC	O32393	75.79	956.0	1172.0	DB02355	experimental	Adenosine-5'-Rp-Alpha-Thio-Triphosphate	OP(=O)(O)OP(=O)(O)O[P@@](=S)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
4647	sp|P9WMV1|Y891_MYC	O32393	75.79	956.0	1172.0	DB02596	experimental	alpha,beta-Methyleneadenosine 5'-triphosphate	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)CP(=O)(O)OP(=O)(O)O
4648	sp|P9WMV1|Y891_MYC	O32393	75.79	956.0	1172.0	DB07706	experimental	2-Hydroxyestradiol	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)c(c4)O
4649	sp|P9WGR7|Y945_MYC	Q8NBQ5	96.84	32.0	277.0	DB02854	experimental	Aetiocholanolone	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](CC3)C[C@H](O)CC4
4650	sp|P9WGR7|Y945_MYC	O75911	97.23	33.0	279.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
4651	sp|P9WGR7|Y945_MYC	Q9BTZ2	78.66	30.0	229.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
4652	sp|P9WGR7|Y945_MYC	Q9WYS2	77.87	6.0	203.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
4653	sp|P9WGR7|Y945_MYC	P0AEK2	74.7	4.0	193.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
4656	sp|P9WGR7|Y945_MYC	P16544	78.66	6.0	205.0	DB01942	experimental; investigational	Formic acid	OC=O
4657	sp|P9WGR7|Y945_MYC	P16544	78.66	6.0	205.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
4658	sp|P9WGR7|Y945_MYC	P16544	78.66	6.0	205.0	DB07715	investigational	Emodin	Cc(c1)cc(O)c(c12)C(=O)c3c(C2=O)cc(O)cc3O
4660	sp|P9WGR7|Y945_MYC	Q6UWP2	90.12	12.0	240.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
4661	sp|P9WGR7|Y945_MYC	Q6PKH6	71.54	28.0	209.0	DB04200	experimental	Matairesinol	COc1cc(ccc1O)C[C@H]2COC(=O)[C@@H]2Cc3ccc(O)c(c3)OC
4662	sp|P9WGR7|Y945_MYC	P0AET8	83.4	9.0	220.0	DB02123	experimental	Glycochenodeoxycholic Acid	OC(=O)CNC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
4663	sp|P9WGR7|Y945_MYC	Q92506	81.82	9.0	216.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
4664	sp|P9WGR7|Y945_MYC	Q92506	81.82	9.0	216.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
4665	sp|P9WGR7|Y945_MYC	Q9NYR8	77.47	6.0	202.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
4666	sp|P9WGR7|Y945_MYC	Q84EX5	78.66	3.0	202.0	DB04619	experimental	Acetophenone	CC(=O)c1ccccc1
4667	sp|P9WGR7|Y945_MYC	Q84EX5	78.66	3.0	202.0	DB04784	experimental	(R)-1-phenylethanol	C[C@@H](O)c1ccccc1
4668	sp|P9WGR7|Y945_MYC	P51659	86.56	8.0	227.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
4669	sp|P9WGR7|Y945_MYC	P51659	86.56	8.0	227.0	DB03192	experimental	(R)-3-hydroxydecanoyl-CoA	CCCCCCC[C@@H](O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
4671	sp|P9WGR7|Y945_MYC	Q8TC12	81.03	38.0	243.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
4672	sp|P9WGR7|Y945_MYC	Q8NBN7	80.24	36.0	239.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
4673	sp|P9WGR7|Y945_MYC	P28845	80.63	32.0	236.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
4674	sp|P9WGR7|Y945_MYC	P28845	80.63	32.0	236.0	DB02329	experimental	Carbenoxolone	OC(=O)CCC(=O)O[C@@H](CC1)C(C)(C)[C@@H]([C@]12C)CC[C@]3(C)[C@@H]2C(=O)C=C4[C@H]5[C@@](C)(CC[C@@]34C)CC[C@](C5)(C)C(=O)O
4675	sp|P9WGR7|Y945_MYC	P28845	80.63	32.0	236.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
4676	sp|P9WGR7|Y945_MYC	P28845	80.63	32.0	236.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
4677	sp|P9WGR7|Y945_MYC	P28845	80.63	32.0	236.0	DB04652	experimental	Corticosterone	OCC(=O)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H]([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
4678	sp|P9WGR7|Y945_MYC	P28845	80.63	32.0	236.0	DB05064	investigational	INCB13739	 
4679	sp|P9WGR7|Y945_MYC	P28845	80.63	32.0	236.0	DB06992	experimental	(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone	Cc1ccc(cc1F)-c2nc(ccc2)C(=O)N(CC3(C)C)CCC3
4680	sp|P9WGR7|Y945_MYC	P28845	80.63	32.0	236.0	DB07017	experimental	(5S)-2-{[(1S)-1-(4-Fluorophenyl)ethyl]amino}-5-(2-hydroxy-2-propanyl)-5-methyl-1,3-thiazol-4(5H)-one	Fc1ccc(cc1)[C@H](C)NC(=NC2=O)S[C@@]2(C)C(C)(C)O
4681	sp|P9WGR7|Y945_MYC	P28845	80.63	32.0	236.0	DB07049	experimental	(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine	[O-][N+](=O)c1ccc(cc1)N2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)C(C)(C)C
4682	sp|P9WGR7|Y945_MYC	P28845	80.63	32.0	236.0	DB07056	experimental	2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide	CCN(CC)C(=O)Cc1cccc(n1)NS(=O)(=O)c2c(C)c(Cl)ccc2
4683	sp|P9WGR7|Y945_MYC	P28845	80.63	32.0	236.0	DB07310	experimental	(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one	Fc1ccccc1[C@H](C)NC(=NC2=O)S[C@]2(C)C(F)(F)F
4684	sp|P9WGR7|Y945_MYC	P28845	80.63	32.0	236.0	DB07316	experimental	N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)C3CCN(CC3)CC4(CC4)C(=O)N
4685	sp|P9WGR7|Y945_MYC	P28845	80.63	32.0	236.0	DB07619	experimental	N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)[C@H]3CC[C@@H](CC3)c4cccnc4
4686	sp|P9WGR7|Y945_MYC	P28845	80.63	32.0	236.0	DB07624	experimental	1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide	C1CC1(C(=O)N)CN2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)[C@](C)(O)C(F)(F)F
4687	sp|P9WGR7|Y945_MYC	P28845	80.63	32.0	236.0	DB07866	experimental	(5S)-2-(Cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one	CCC[C@]1(C)SC(=NC1=O)NC2CCCCCCC2
4688	sp|P9WGR7|Y945_MYC	P28845	80.63	32.0	236.0	DB08277	experimental	2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE	CS(=O)(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4c(Cl)cc(F)cc4
4689	sp|P9WGR7|Y945_MYC	P28845	80.63	32.0	236.0	DB08280	experimental	(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE	NC(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4ccc(OC)cc4
4690	sp|P9WGR7|Y945_MYC	P28845	80.63	32.0	236.0	DB08771	experimental	(5R)-2-[(2-Fluorophenyl)amino]-5-isopropyl-1,3-thiazol-4(5H)-one	CC(C)[C@H]1SC(=NC1=O)Nc2c(F)cccc2
4691	sp|P9WGR7|Y945_MYC	P28845	80.63	32.0	236.0	DB13751	approved; experimental	Glycyrrhizic acid	C1C[C@](C)(C(=O)O)C[C@H]([C@]12C)C=3[C@@](C)(CC2)[C@@]4(C)[C@H](C(=O)C3)[C@]5(C)[C@@H](CC4)C(C)(C)[C@H](CC5)O[C@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O[C@@H]7O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]7O
4692	sp|P9WGR7|Y945_MYC	Q02338	80.24	53.0	256.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
4693	sp|P9WGR7|Y945_MYC	Q9BY49	76.28	16.0	209.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
4694	sp|P9WGR7|Y945_MYC	Q6GI75	91.7	3.0	235.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
4695	sp|P9WGR7|Y945_MYC	Q6GI75	91.7	3.0	235.0	DB11155	approved	Triclocarban	Clc1ccc(cc1)NC(=O)Nc2cc(Cl)c(Cl)cc2
4696	sp|P9WGR7|Y945_MYC	Q96NR8	81.03	36.0	241.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
4697	sp|P9WGR7|Y945_MYC	P0CG22	79.84	30.0	232.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
4698	sp|P9WGR7|Y945_MYC	P0CG22	79.84	30.0	232.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
4699	sp|P9WGR7|Y945_MYC	P0CG22	79.84	30.0	232.0	DB03541	experimental	10-Propargyl-5,8-Dideazafolic Acid	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(CC#C)Cc(c2)ccc(c23)[nH]c(N)nc3=O
4700	sp|P9WGR7|Y945_MYC	P0CG22	79.84	30.0	232.0	DB07689	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)NCc(cn3)nc(c34)c(N)nc(n4)N
4701	sp|P9WGR7|Y945_MYC	P0CG22	79.84	30.0	232.0	DB07765	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)N(C)Cc(cn3)nc(c34)c(N)nc(n4)N
4702	sp|P9WGR7|Y945_MYC	P14061	77.47	2.0	198.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
4703	sp|P9WGR7|Y945_MYC	P14061	77.47	2.0	198.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
4704	sp|P9WGR7|Y945_MYC	P14061	77.47	2.0	198.0	DB01561	experimental; illicit	Androstanedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
4705	sp|P9WGR7|Y945_MYC	P14061	77.47	2.0	198.0	DB02187	experimental	Equilin	O=C1CC[C@H]([C@@]12C)C=3[C@H](CC2)c4c(CC3)cc(O)cc4
4706	sp|P9WGR7|Y945_MYC	P14061	77.47	2.0	198.0	DB02323	experimental	EM-1745	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)C[C@@H]([C@@H]4O)CCCCCCCCC(=O)OC[C@H]5O[C@H]([C@H](O)[C@@H]5O)n6cnc(c67)c(N)ncn7
4707	sp|P9WGR7|Y945_MYC	P14061	77.47	2.0	198.0	DB02901	illicit; investigational	Stanolone	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
4708	sp|P9WGR7|Y945_MYC	P14061	77.47	2.0	198.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
4709	sp|P9WGR7|Y945_MYC	P14061	77.47	2.0	198.0	DB13951	experimental	Stanolone acetate	CC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
4710	sp|P9WGR7|Y945_MYC	Q7Z4W1	78.26	5.0	203.0	DB02831	experimental	Dihydrogenphosphate	OP([O-])(=O)O
4711	sp|P9WGR7|Y945_MYC	Q7Z4W1	78.26	5.0	203.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
4712	sp|P9WGR7|Y945_MYC	A0A348A0U3	91.3	4.0	235.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
4713	sp|P9WGR7|Y945_MYC	Q99714	82.21	6.0	214.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
4714	sp|P9WGR7|Y945_MYC	Q99714	82.21	6.0	214.0	DB02820	experimental	1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct	C1CCCCCN1C(=O)[C@H](c2ccccc2)n(c3=S)cnc(c34)nn(c4)[C@H]5C=CN(C=C5C([O-])=N)[C@@H]6O[C@@H]([C@@H](O)[C@H]6O)COP([O-])(=O)OP(=O)(O)OC[C@H]7O[C@H]([C@H]([O-])[C@@H]7[O-])n8cnc(c89)c(N)ncn9
4715	sp|P9WGR7|Y945_MYC	Q99714	82.21	6.0	214.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
4716	sp|P9WGR7|Y945_MYC	Q16698	75.49	56.0	247.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
4717	sp|P9WGR7|Y945_MYC	Q16698	75.49	56.0	247.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
4718	sp|P9WGR7|Y945_MYC	P37058	83.0	48.0	258.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
4719	sp|P9WGR7|Y945_MYC	Q9HBH5	84.58	42.0	256.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
4720	sp|P9WGR7|Y945_MYC	P0AEK4	90.51	4.0	233.0	DB01691	experimental	Indole Naphthyridinone	c1cccc(c12)n(C)cc2CN(C)C(=O)/C=C/c(c3)cnc(c34)NC(=O)CC4
4721	sp|P9WGR7|Y945_MYC	P0AEK4	90.51	4.0	233.0	DB01865	experimental	3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide	c1cccc(c12)cc(n2C)CN(C)C(=O)/C=C/c3cnc(N)cc3
4722	sp|P9WGR7|Y945_MYC	P0AEK4	90.51	4.0	233.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
4723	sp|P9WGR7|Y945_MYC	P0AEK4	90.51	4.0	233.0	DB03030	experimental	4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole	Cc1ccc(cc1)Cn2cnc(c2)-c3cccs3
4724	sp|P9WGR7|Y945_MYC	P0AEK4	90.51	4.0	233.0	DB03534	experimental	3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide	CC(=O)N(C)Cc1c(N)ccc(c1)C(=O)N(C)Cc(n2C)cc(c23)cccc3
4725	sp|P9WGR7|Y945_MYC	P0AEK4	90.51	4.0	233.0	DB04030	experimental	1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole	Oc1ccc(cc1)Cn2c(c3c(c24)cccc4)CN(CC3)C(=O)c5ccc(O)cc5
4726	sp|P9WGR7|Y945_MYC	P0AEK4	90.51	4.0	233.0	DB08265	experimental	2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL	Cc1ccc(cc1)S(=O)(=O)n(b2O)ncc(c23)cccc3
4727	sp|P9WGR7|Y945_MYC	P0AEK4	90.51	4.0	233.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
4728	sp|P9WGR7|Y945_MYC	P0AEK4	90.51	4.0	233.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
4729	sp|P9WGR7|Y945_MYC	Q92781	74.7	28.0	217.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
4730	sp|P9WGR7|Y945_MYC	Q92781	74.7	28.0	217.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
4731	sp|P9WGR7|Y945_MYC	P37059	84.98	80.0	295.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
4732	sp|P9WGR7|Y945_MYC	P37059	84.98	80.0	295.0	DB13952	approved; investigational; vet_approved	Estradiol acetate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)C
4733	sp|P9WGR7|Y945_MYC	P37059	84.98	80.0	295.0	DB13953	approved; investigational; vet_approved	Estradiol benzoate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)c5ccccc5
4734	sp|P9WGR7|Y945_MYC	P37059	84.98	80.0	295.0	DB13954	approved; investigational; vet_approved	Estradiol cypionate	C1CCCC1CCC(=O)O[C@H]2CC[C@H]([C@@]23C)[C@H]4[C@H](CC3)c5c(CC4)cc(O)cc5
4735	sp|P9WGR7|Y945_MYC	P37059	84.98	80.0	295.0	DB13955	approved; investigational; vet_approved	Estradiol dienanthate	CCCCCCC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)CCCCCC
4736	sp|P9WGR7|Y945_MYC	P37059	84.98	80.0	295.0	DB13956	approved; investigational; vet_approved	Estradiol valerate	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)CC[C@@H]4OC(=O)CCCC
4737	sp|P9WGR7|Y945_MYC	Q7AUG5	87.75	3.0	225.0	DB04782	experimental	(S)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@H]2CO2
4738	sp|P9WGR7|Y945_MYC	Q93D82	87.75	3.0	225.0	DB04472	experimental	(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol	[N-]=[N+]=NC[C@H](O)c1ccc([N+]([O-])=O)cc1
4739	sp|P9WGR7|Y945_MYC	Q93D82	87.75	3.0	225.0	DB04499	experimental	(R)-styrene oxide	C1O[C@@H]1c2ccccc2
4740	sp|P9WGR7|Y945_MYC	Q93D82	87.75	3.0	225.0	DB04777	experimental	(R)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@@H]2CO2
4741	sp|P9WGR7|Y945_MYC	P80365	75.89	80.0	272.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
4742	sp|P9WGR7|Y945_MYC	P80365	75.89	80.0	272.0	DB01185	approved; illicit	Fluoxymesterone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@](F)([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
4743	sp|P9WGR7|Y945_MYC	P80365	75.89	80.0	272.0	DB01569	experimental; illicit	Formebolone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@H]([C@@H](C2)O)[C@]4(C)C(CC3)=CC(=O)C(C=O)=C4
4744	sp|P9WGR7|Y945_MYC	P80365	75.89	80.0	272.0	DB14538	experimental; vet_approved	Hydrocortisone aceponate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CC)C(=O)COC(=O)C
4745	sp|P9WGR7|Y945_MYC	P80365	75.89	80.0	272.0	DB14539	approved; vet_approved	Hydrocortisone acetate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)C
4746	sp|P9WGR7|Y945_MYC	P80365	75.89	80.0	272.0	DB14540	approved; vet_approved	Hydrocortisone butyrate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCC
4747	sp|P9WGR7|Y945_MYC	P80365	75.89	80.0	272.0	DB14541	approved; investigational; vet_approved	Hydrocortisone cypionate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)CCC5CCCC5
4748	sp|P9WGR7|Y945_MYC	P80365	75.89	80.0	272.0	DB14542	approved; vet_approved	Hydrocortisone phosphate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COP(=O)(O)O
4749	sp|P9WGR7|Y945_MYC	P80365	75.89	80.0	272.0	DB14543	approved; vet_approved	Hydrocortisone probutate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CCC)C(=O)COC(=O)CC
4750	sp|P9WGR7|Y945_MYC	P80365	75.89	80.0	272.0	DB14544	approved; vet_approved	Hydrocortisone valerate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCCC
4751	sp|P9WGR7|Y945_MYC	P16152	97.23	6.0	252.0	DB01698	approved; experimental; investigational	Rutin	O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O[C@H]1C)OC[C@H]2O[C@H]([C@H](O)[C@@H](O)[C@@H]2O)Oc(c3=O)c(-c4cc(O)c(O)cc4)oc(c35)cc(O)cc5O
4752	sp|P9WGR7|Y945_MYC	P16152	97.23	6.0	252.0	DB02709	investigational	Resveratrol	Oc1ccc(cc1)/C=C/c2cc(O)cc(O)c2
4753	sp|P9WGR7|Y945_MYC	P16152	97.23	6.0	252.0	DB03394	experimental	Heptaethylene glycol	OCCOCCOCCOCCOCCOCCOCCO
4754	sp|P9WGR7|Y945_MYC	P16152	97.23	6.0	252.0	DB03556	experimental	2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400	CCOCCOCCOCCOCCOCCOCCOCCOCCO
4755	sp|P9WGR7|Y945_MYC	P16152	97.23	6.0	252.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
4756	sp|P9WGR7|Y945_MYC	P16152	97.23	6.0	252.0	DB04463	experimental	3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol	n1cnc(N)c(c12)c(nn2C(C)(C)C)-c3cccc(O)c3
4757	sp|P9WGR7|Y945_MYC	P16152	97.23	6.0	252.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
4758	sp|P9WGR7|Y945_MYC	P16152	97.23	6.0	252.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
4759	sp|P9WGR7|Y945_MYC	O24990	87.75	4.0	226.0	DB04393	experimental	Soneclosan	Clc1cc(O)c(cc1)Oc2ccc(Cl)cc2
4760	sp|P9WGR7|Y945_MYC	O24990	87.75	4.0	226.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
4761	sp|P9WGR7|Y945_MYC	P56937	90.51	2.0	231.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
4762	sp|P9WGR7|Y945_MYC	P35270	88.14	4.0	227.0	DB02637	experimental	Oxaloacetate Ion	OC(=O)C(=O)CC([O-])=O
4763	sp|P9WGR7|Y945_MYC	P35270	88.14	4.0	227.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
4764	sp|P9WGR7|Y945_MYC	P35270	88.14	4.0	227.0	DB03886	experimental	Biopterin	C[C@@H](O)[C@@H](O)c(n1)cnc(c12)nc(N)[nH]c2=O
4765	sp|P9WGR7|Y945_MYC	P35270	88.14	4.0	227.0	DB04275	experimental	N-acetylserotonin	CC(=O)NCCc1c[nH]c(c12)ccc(c2)O
4766	sp|P9WGR7|Y945_MYC	Q8I814	79.05	14.0	214.0	DB02015	experimental	Dihydrofolic Acid	O=c1[nH]c(N)nc(c12)NCC(=N2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
4767	sp|P9WGR7|Y945_MYC	Q8I814	79.05	14.0	214.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
4768	sp|P9WGR7|Y945_MYC	P9WGR1	77.47	5.0	201.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
4769	sp|P9WGR7|Y945_MYC	P9WGR1	77.47	5.0	201.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
4770	sp|P9WGR7|Y945_MYC	P9WGR1	77.47	5.0	201.0	DB02990	experimental	S-(2-Acetamidoethyl) hexadecanethioate	CCCCCCCCCCCCCCCC(=O)SCCNC(=O)C
4771	sp|P9WGR7|Y945_MYC	P9WGR1	77.47	5.0	201.0	DB04289	experimental	Genz-10850	[nH]1ccc(c12)cc(cc2)C(=O)N3CCN(CC3)C4c(cccc5)c5c(c46)cccc6
4772	sp|P9WGR7|Y945_MYC	P9WGR1	77.47	5.0	201.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
4773	sp|P9WGR7|Y945_MYC	P9WGR1	77.47	5.0	201.0	DB07090	experimental	(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cccc(c1C)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
4774	sp|P9WGR7|Y945_MYC	P9WGR1	77.47	5.0	201.0	DB07123	experimental	N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE	Cc1ccc(cc1)C(=O)N2CCC(CC2)Cc3ccccc3
4775	sp|P9WGR7|Y945_MYC	P9WGR1	77.47	5.0	201.0	DB07155	experimental	(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE	c1ccccc1NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
4776	sp|P9WGR7|Y945_MYC	P9WGR1	77.47	5.0	201.0	DB07178	experimental	5-PENTYL-2-PHENOXYPHENOL	CCCCCc1cc(O)c(cc1)Oc2ccccc2
4777	sp|P9WGR7|Y945_MYC	P9WGR1	77.47	5.0	201.0	DB07188	experimental	(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(cc(Cl)c1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
4778	sp|P9WGR7|Y945_MYC	P9WGR1	77.47	5.0	201.0	DB07192	experimental	(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Brc1cc(ccc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
4779	sp|P9WGR7|Y945_MYC	P9WGR1	77.47	5.0	201.0	DB07222	experimental	(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(c(C)cc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
4780	sp|P9WGR7|Y945_MYC	P9WGR1	77.47	5.0	201.0	DB07287	experimental	2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL	c1cccnc1Cc2cc(O)c(cc2)Oc3ccc(Cl)cc3Cl
4781	sp|P9WGR7|Y945_MYC	P9WGR1	77.47	5.0	201.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
4782	sp|P9WGR7|Y945_MYC	P09417	72.33	11.0	194.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
4783	sp|P9WGR7|Y945_MYC	P09417	72.33	11.0	194.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
4784	sp|P9WGR7|Y945_MYC	P26391	75.89	2.0	194.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
4785	sp|P9WGR7|Y945_MYC	Q8T8E9	76.68	2.0	196.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
4786	sp|P9WH31|RS6_MYCT	Q5SLP8	96.88	1.0	94.0	DB08185	experimental	2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(nc(n3)SC)NCCC(C)C
4787	sp|P9WQI5|Y2564_MY	P08183	70.61	1033.0	1266.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
4788	sp|P9WQI5|Y2564_MY	P08183	70.61	1033.0	1266.0	DB00603	approved; investigational	Medroxyprogesterone acetate	CC(=O)O[C@]1(C(=O)C)CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C([C@H](C3)C)=CC(=O)CC4
4789	sp|P9WQI5|Y2564_MY	P08183	70.61	1033.0	1266.0	DB00778	approved; investigational; withdrawn	Roxithromycin	COCCOCO/N=C([C@H](C)[C@@H](O)[C@]1(C)O)/[C@H](C)C[C@@](C)(O)[C@@H]([C@@H](C)[C@@H]([C@@H](C)C(=O)O[C@@H]1CC)O[C@@H](C[C@@]2(C)OC)O[C@@H](C)[C@@H]2O)O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C
4790	sp|P9WQI5|Y2564_MY	P08183	70.61	1033.0	1266.0	DB00813	approved; illicit; investigational; vet_approved	Fentanyl	c1ccccc1N(C(=O)CC)C2CCN(CC2)CCc3ccccc3
4791	sp|P9WQI5|Y2564_MY	P08183	70.61	1033.0	1266.0	DB04877	experimental	Voacamine	CC[C@H]1C[C@@H](C2)CN([C@@H]1[C@@]23C(=O)OC)CCc4c3[nH]c5c4cc(OC)c(c5)[C@@H](C[C@H]67)c8c(c9c([nH]8)cccc9)C[C@H](C6C(=O)OC)N(C)CC\7=C\C
4792	sp|P9WQI5|Y2564_MY	P08183	70.61	1033.0	1266.0	DB04881	investigational	Elacridar	COc1cccc(c12)c(=O)c3c([nH]2)c(ccc3)C(=O)Nc4ccc(cc4)CCN(C5)CCc(c56)cc(OC)c(c6)OC
4793	sp|P9WQI5|Y2564_MY	P08183	70.61	1033.0	1266.0	DB04905	investigational	Tesmilifene	CCN(CC)CCOc1ccc(cc1)Cc2ccccc2
4794	sp|P9WQI5|Y2564_MY	P08183	70.61	1033.0	1266.0	DB05449	investigational	FM-VP4	 
4795	sp|P9WQI5|Y2564_MY	P08183	70.61	1033.0	1266.0	DB06191	investigational	Zosuquidar	FC1(F)[C@H]2[C@@H]1c(cccc3)c3[C@@H](c(c24)cccc4)N5CCN(CC5)C[C@@H](O)COc6cccc(c67)nccc7
4796	sp|P9WQI5|Y2564_MY	P08183	70.61	1033.0	1266.0	DB06240	investigational	Tariquidar	COc(c1)c(OC)cc(c12)CCN(C2)CCc3ccc(cc3)NC(=O)c4cc(OC)c(OC)cc4NC(=O)c(c5)cnc(c56)cccc6
4797	sp|P9WQI5|Y2564_MY	P08183	70.61	1033.0	1266.0	DB09031	approved; investigational	Miltefosine	CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C
4798	sp|P9WQI5|Y2564_MY	P08183	70.61	1033.0	1266.0	DB11635	approved	Tocofersolan	 
4799	sp|P9WQI5|Y2564_MY	P08183	70.61	1033.0	1266.0	DB14061	experimental	Hycanthone	CCN(CC)CCNc(ccc1CO)c(c12)c(=O)c3c(s2)cccc3
4800	sp|P9WQI5|Y2564_MY	P08183	70.61	1033.0	1266.0	DB14062	experimental	Concanamycin A	NC(=O)O[C@@H]1[C@@H](C)O[C@H](C[C@H]1O)O[C@H](C2)[C@H](C)[C@@H](/C=C/C)O[C@@]2(O)[C@@H](C)[C@H](O)[C@H](C)[C@H]3OC(=O)/C(OC)=C/C(C)=C/[C@@H](C)[C@@H](O)[C@@H](CC)[C@@H](O)[C@H](C)C/C(C)=C/C=C/[C@@H]3OC
4801	sp|P9WQI5|Y2564_MY	P08183	70.61	1033.0	1266.0	DB14063	experimental	Dexverapamil	COc1ccc(cc1OC)CCN(C)CCC[C@@](C#N)(C(C)C)c2cc(OC)c(OC)cc2
4802	sp|P9WQI5|Y2564_MY	P08183	70.61	1033.0	1266.0	DB14064	experimental	Emopamil	c1ccccc1C(C#N)(C(C)C)CCCN(C)CCc2ccccc2
4803	sp|P9WQI5|Y2564_MY	P08183	70.61	1033.0	1266.0	DB14065	experimental	Lomerizine	COc1ccc(c(OC)c1OC)CN2CCN(CC2)C(c3ccc(F)cc3)c4ccc(F)cc4
4804	sp|P9WQI5|Y2564_MY	P08183	70.61	1033.0	1266.0	DB14066	experimental	Tetrandrine	c12ccc(OC)c(c1)Oc3ccc(cc3)C[C@H]4c5c(CCN4C)cc(OC)c(c5)Oc6c7c(CCN(C)[C@H]7C2)cc(OC)c6OC
4805	sp|P9WQI5|Y2564_MY	P08183	70.61	1033.0	1266.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
4806	sp|P9WQI5|Y2564_MY	P08183	70.61	1033.0	1266.0	DB14068	experimental	Dexniguldipine	[O-][N+](=O)c1cccc(c1)[C@@H]2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCCN(CC3)CCC3(c4ccccc4)c5ccccc5
4807	sp|P9WQI5|Y2564_MY	P08183	70.61	1033.0	1266.0	DB14069	investigational	ONT-093	CCOC/C=C/c1ccc(cc1)-c2nc(-c3ccc(cc3)NC(C)C)c([nH]2)-c4ccc(cc4)NC(C)C
4808	sp|P9WQI5|Y2564_MY	P08183	70.61	1033.0	1266.0	DB14070	experimental	HM-30181	c1cccc(c12)c(=O)cc(o2)C(=O)Nc3cc(OC)c(OC)cc3-c4nn(nn4)-c5ccc(cc5)CCN(C6)CCc(c67)cc(OC)c(c7)OC
4809	sp|P9WQI5|Y2564_MY	P08183	70.61	1033.0	1266.0	DB14071	experimental	Desmethylsertraline	c1cccc(c12)[C@@H](CC[C@@H]2N)c3cc(Cl)c(Cl)cc3
4810	sp|P9WQI5|Y2564_MY	P08183	70.61	1033.0	1266.0	DB14072	experimental	Reversin 121	c1ccccc1COC(=O)C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@H](C(=O)OC(C)(C)C)CCCCNC(=O)OCc2ccccc2
4811	sp|P9WQI5|Y2564_MY	O95342	70.3	418.0	650.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
4812	sp|P9WQI5|Y2564_MY	O95342	70.3	418.0	650.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
4813	sp|P9WQI5|Y2564_MY	O95342	70.91	1076.0	1310.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
4814	sp|P9WQI5|Y2564_MY	O95342	70.91	1076.0	1310.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
4815	sp|P9WH27|RS8_MYCT	P0DOY9	103.03	2.0	138.0	DB08185	experimental	2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(nc(n3)SC)NCCC(C)C
4816	sp|P9WH27|RS8_MYCT	P0A7W7	96.97	1.0	129.0	DB00759	approved; vet_approved	Tetracycline	O=C1C(C(=O)N)=C(O)[C@@H](N(C)C)[C@@H]([C@@]12O)C[C@H]3C(=C2O)C(=O)c4c([C@@]3(C)O)cccc4O
4817	sp|P9WH27|RS8_MYCT	P0A7W7	96.97	1.0	129.0	DB09093	approved; investigational; vet_approved	Chlortetracycline	O=C1C(C(=O)N)=C(O)[C@@H](N(C)C)[C@@H]([C@@]12O)C[C@H]3C(=C2O)C(=O)c4c([C@@]3(C)O)c(Cl)ccc4O
4818	sp|P9WH27|RS8_MYCT	P0A7W7	96.97	1.0	129.0	DB12455	approved; investigational	Omadacycline	O=C1C(C(=O)N)=C(O)[C@@H](N(C)C)[C@@H]([C@@]12O)C[C@H]3C(=C2O)C(=O)c4c(C3)c(N(C)C)cc(c4O)CNCC(C)(C)C
4819	sp|P9WFV5|SYH_MYCT	P60906	98.82	3.0	421.0	DB03811	experimental	Histidinol	OC[C@@H]([NH3+])Cc1cnc[nH]1
4820	sp|P9WFV5|SYH_MYCT	P60906	98.82	3.0	421.0	DB04201	experimental	Histidyl-Adenosine Monophosphate	c1nc[nH]c1C[C@H](N)C(=O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3cnc(c34)c(N)ncn4
4821	sp|P9WFV5|SYH_MYCT	P56194	98.35	4.0	420.0	DB04201	experimental	Histidyl-Adenosine Monophosphate	c1nc[nH]c1C[C@H](N)C(=O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3cnc(c34)c(N)ncn4
4822	sp|P9WH37|RS3_MYCT	P62663	86.13	1.0	237.0	DB08185	experimental	2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(nc(n3)SC)NCCC(C)C
4823	sp|P9WH37|RS3_MYCT	P80372	86.13	1.0	237.0	DB08185	experimental	2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(nc(n3)SC)NCCC(C)C
4824	sp|P9WH37|RS3_MYCT	P0A7V3	83.94	1.0	231.0	DB00759	approved; vet_approved	Tetracycline	O=C1C(C(=O)N)=C(O)[C@@H](N(C)C)[C@@H]([C@@]12O)C[C@H]3C(=C2O)C(=O)c4c([C@@]3(C)O)cccc4O
4825	sp|P9WH37|RS3_MYCT	P0A7V3	83.94	1.0	231.0	DB09093	approved; investigational; vet_approved	Chlortetracycline	O=C1C(C(=O)N)=C(O)[C@@H](N(C)C)[C@@H]([C@@]12O)C[C@H]3C(=C2O)C(=O)c4c([C@@]3(C)O)c(Cl)ccc4O
4826	sp|P9WH37|RS3_MYCT	P0A7V3	83.94	1.0	231.0	DB12455	approved; investigational	Omadacycline	O=C1C(C(=O)N)=C(O)[C@@H](N(C)C)[C@@H]([C@@]12O)C[C@H]3C(=C2O)C(=O)c4c(C3)c(N(C)C)cc(c4O)CNCC(C)(C)C
4827	sp|P9WFW7|SYA_MYCT	P49588	105.2	6.0	957.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
4828	sp|P9WFW7|SYA_MYCT	Q5JTZ9	104.09	38.0	979.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
4829	sp|P9WFT7|SYS_MYCT	P49591	83.77	109.0	460.0	DB00133	investigational; nutraceutical	Serine	OC(=O)[C@@H](N)CO
4830	sp|P9WG75|THIE_MYC	P39594	90.99	14.0	216.0	DB01788	experimental	4-Imino-5-Methidyl-2-Methylpyrimidine	CC1=NC(=N)C(=C)C=N1
4831	sp|P9WG75|THIE_MYC	P39594	90.99	14.0	216.0	DB02254	experimental	Trifluoro-thiamin phosphate	[O-]P([O-])(=O)OCCc1c(C)[n+](cs1)Cc2cnc(C(F)(F)F)nc2N
4832	sp|P9WG75|THIE_MYC	P39594	90.99	14.0	216.0	DB02885	experimental	4-Imino-5-Methidyl-2-Trifluoromethylpyrimidine	FC(F)(F)C1=NC(=N)C(=C)C=N1
4833	sp|P9WG75|THIE_MYC	P39594	90.99	14.0	216.0	DB03145	experimental	4-Methyl-5-Hydroxyethylthiazole Phosphate	Cc1ncsc1CCOP(=O)(O)O
4834	sp|P9WG75|THIE_MYC	P39594	90.99	14.0	216.0	DB03416	experimental	Thiamine(1+) monophosphate	OP([O-])(=O)OCCc1c(C)[n+](cs1)Cc2cnc(C)nc2N
4835	sp|P9WG75|THIE_MYC	P39594	90.99	14.0	216.0	DB07782	experimental	4-AMINO-2-TRIFLUOROMETHYL-5-HYDROXYMETHYLPYRIMIDINE PYROPHOSPHATE	Nc1nc(C(F)(F)F)ncc1CO[P@](=O)(O)OP(=O)(O)O
4836	sp|P9WK03|Y089_MYC	P9WPB3	95.43	53.0	241.0	DB01752	experimental	S-adenosyl-L-homocysteine	OC(=O)[C@@H](N)CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
4837	sp|P9WK03|Y089_MYC	P9WPB7	95.43	53.0	241.0	DB01718	approved	Cetrimonium	CCCCCCCCCCCCCCCC[N+](C)(C)C
4838	sp|P9WK03|Y089_MYC	Q79FX6	94.92	53.0	240.0	DB01718	approved	Cetrimonium	CCCCCCCCCCCCCCCC[N+](C)(C)C
4839	sp|P9WK03|Y089_MYC	Q79FX6	94.92	53.0	240.0	DB01752	experimental	S-adenosyl-L-homocysteine	OC(=O)[C@@H](N)CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
4840	sp|P9WK03|Y089_MYC	Q79FX8	94.92	62.0	249.0	DB07413	experimental	5'-S-[2-(decylamino)ethyl]-5'-thioadenosine	n1cnc(N)c(c12)ncn2[C@H]3[C@H](O)[C@H](O)[C@H](O3)CSCCNCCCCCCCCCC
4841	sp|P9WK03|Y089_MYC	P9WPB5	97.97	62.0	255.0	DB01752	experimental	S-adenosyl-L-homocysteine	OC(=O)[C@@H](N)CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
4842	sp|P9WK03|Y089_MYC	P9WPB5	97.97	62.0	255.0	DB04221	approved; experimental	Didecyldimethylammonium	CCCCCCCCCC[N+](C)(C)CCCCCCCCCC
4843	sp|P9WG87|Y1250_MY	P9WJY5	70.81	52.0	462.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
4844	sp|P9WQM3|Y1999_MY	Q9UM01	96.82	28.0	454.0	DB13146	approved	Fluciclovine (18F)	OC(=O)[C@]1(N)C[C@H]([18F])C1
4845	sp|P9WQM3|Y1999_MY	P30825	96.59	16.0	441.0	DB00123	approved; nutraceutical	L-Lysine	NCCCC[C@H](N)C(=O)O
4846	sp|P9WQM3|Y1999_MY	P30825	96.59	16.0	441.0	DB00125	investigational; nutraceutical	Arginine	OC(=O)[C@@H](N)CCCNC(N)=N
4847	sp|P9WQM3|Y1999_MY	P30825	96.59	16.0	441.0	DB00129	approved; nutraceutical	Ornithine	NCCC[C@H](N)C(=O)O
4848	sp|P9WQM3|Y1999_MY	Q9UPY5	97.05	34.0	461.0	DB00138	approved; nutraceutical	Cystine	OC(=O)[C@@H](N)CSSC[C@H](N)C(=O)O
4849	sp|P9WQM3|Y1999_MY	Q9UPY5	97.05	34.0	461.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
4850	sp|P9WQM3|Y1999_MY	Q9UPY5	97.05	34.0	461.0	DB00740	approved; investigational	Riluzole	Nc(s1)nc(c12)ccc(c2)OC(F)(F)F
4851	sp|P9WQM3|Y1999_MY	Q9UPY5	97.05	34.0	461.0	DB00795	approved	Sulfasalazine	OC(=O)c1cc(ccc1O)/N=N/c2ccc(cc2)S(=O)(=O)Nc3ncccc3
4852	sp|P9WQM3|Y1999_MY	Q9UPY5	97.05	34.0	461.0	DB06151	approved; investigational	Acetylcysteine	CC(=O)N[C@@H](CS)C(=O)O
4853	sp|P9WQM3|Y1999_MY	Q9UPY5	97.05	34.0	461.0	DB11590	approved	Thimerosal	CC[Hg]Sc1ccccc1C([O-])=O
4854	sp|P9WQM3|Y1999_MY	Q9UHI5	95.91	34.0	456.0	DB00120	approved; investigational; nutraceutical	Phenylalanine	OC(=O)[C@@H](N)Cc1ccccc1
4855	sp|P9WQM3|Y1999_MY	Q9UHI5	95.91	34.0	456.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
4856	sp|P9WQM3|Y1999_MY	Q8WY07	95.91	16.0	438.0	DB00123	approved; nutraceutical	L-Lysine	NCCCC[C@H](N)C(=O)O
4857	sp|P9WQM3|Y1999_MY	Q8WY07	95.91	16.0	438.0	DB00125	investigational; nutraceutical	Arginine	OC(=O)[C@@H](N)CCCNC(N)=N
4858	sp|P9WQM3|Y1999_MY	Q8WY07	95.91	16.0	438.0	DB13146	approved	Fluciclovine (18F)	OC(=O)[C@]1(N)C[C@H]([18F])C1
4859	sp|P9WQM3|Y1999_MY	O43246	90.23	22.0	419.0	DB00123	approved; nutraceutical	L-Lysine	NCCCC[C@H](N)C(=O)O
4860	sp|P9WQM3|Y1999_MY	O43246	90.23	22.0	419.0	DB00125	investigational; nutraceutical	Arginine	OC(=O)[C@@H](N)CCCNC(N)=N
4861	sp|P9WQM3|Y1999_MY	P60063	90.0	7.0	403.0	DB02451	experimental	B-nonylglucoside	CCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
4862	sp|P9WP05|Y2417_MY	A7B6P0	99.29	54.0	332.0	DB02580	experimental	Pentaglyme	COCCOCCOCCOCCOCCOC
4863	sp|P9WP05|Y2417_MY	P83812	98.93	1.0	278.0	DB03796	approved	Palmitic Acid	CCCCCCCCCCCCCCCC(=O)O
4864	sp|P9WP05|Y2417_MY	Q9X1H9	100.71	1.0	283.0	DB03796	approved	Palmitic Acid	CCCCCCCCCCCCCCCC(=O)O
4865	sp|P9WGS1|Y1543_MY	Q02338	75.07	50.0	306.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
4866	sp|P9WGS1|Y1543_MY	Q8NBN7	72.14	33.0	279.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
4867	sp|P9WGS1|Y1543_MY	P80365	73.9	77.0	329.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
4868	sp|P9WGS1|Y1543_MY	P80365	73.9	77.0	329.0	DB01185	approved; illicit	Fluoxymesterone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@](F)([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
4869	sp|P9WGS1|Y1543_MY	P80365	73.9	77.0	329.0	DB01569	experimental; illicit	Formebolone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@H]([C@@H](C2)O)[C@]4(C)C(CC3)=CC(=O)C(C=O)=C4
4870	sp|P9WGS1|Y1543_MY	P80365	73.9	77.0	329.0	DB14538	experimental; vet_approved	Hydrocortisone aceponate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CC)C(=O)COC(=O)C
4871	sp|P9WGS1|Y1543_MY	P80365	73.9	77.0	329.0	DB14539	approved; vet_approved	Hydrocortisone acetate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)C
4872	sp|P9WGS1|Y1543_MY	P80365	73.9	77.0	329.0	DB14540	approved; vet_approved	Hydrocortisone butyrate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCC
4873	sp|P9WGS1|Y1543_MY	P80365	73.9	77.0	329.0	DB14541	approved; investigational; vet_approved	Hydrocortisone cypionate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)CCC5CCCC5
4874	sp|P9WGS1|Y1543_MY	P80365	73.9	77.0	329.0	DB14542	approved; vet_approved	Hydrocortisone phosphate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COP(=O)(O)O
4875	sp|P9WGS1|Y1543_MY	P80365	73.9	77.0	329.0	DB14543	approved; vet_approved	Hydrocortisone probutate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CCC)C(=O)COC(=O)CC
4876	sp|P9WGS1|Y1543_MY	P80365	73.9	77.0	329.0	DB14544	approved; vet_approved	Hydrocortisone valerate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCCC
4877	sp|P9WGR9|Y1350_MY	Q9BTZ2	98.79	30.0	274.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
4878	sp|P9WGR9|Y1350_MY	P0AEK2	96.76	3.0	242.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
4879	sp|P9WGR9|Y1350_MY	Q9WYS2	99.19	7.0	252.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
4882	sp|P9WGR9|Y1350_MY	Q92506	102.83	6.0	260.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
4883	sp|P9WGR9|Y1350_MY	Q92506	102.83	6.0	260.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
4884	sp|P9WGR9|Y1350_MY	Q84EX5	100.4	1.0	249.0	DB04619	experimental	Acetophenone	CC(=O)c1ccccc1
4885	sp|P9WGR9|Y1350_MY	Q84EX5	100.4	1.0	249.0	DB04784	experimental	(R)-1-phenylethanol	C[C@@H](O)c1ccccc1
4887	sp|P9WGR9|Y1350_MY	P0AET8	97.98	8.0	250.0	DB02123	experimental	Glycochenodeoxycholic Acid	OC(=O)CNC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
4888	sp|P9WGR9|Y1350_MY	P16544	102.02	6.0	258.0	DB01942	experimental; investigational	Formic acid	OC=O
4889	sp|P9WGR9|Y1350_MY	P16544	102.02	6.0	258.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
4890	sp|P9WGR9|Y1350_MY	P16544	102.02	6.0	258.0	DB07715	investigational	Emodin	Cc(c1)cc(O)c(c12)C(=O)c3c(C2=O)cc(O)cc3O
4891	sp|P9WGR9|Y1350_MY	Q9BY49	102.02	14.0	266.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
4892	sp|P9WGR9|Y1350_MY	P0CG22	100.0	30.0	277.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
4893	sp|P9WGR9|Y1350_MY	P0CG22	100.0	30.0	277.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
4894	sp|P9WGR9|Y1350_MY	P0CG22	100.0	30.0	277.0	DB03541	experimental	10-Propargyl-5,8-Dideazafolic Acid	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(CC#C)Cc(c2)ccc(c23)[nH]c(N)nc3=O
4895	sp|P9WGR9|Y1350_MY	P0CG22	100.0	30.0	277.0	DB07689	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)NCc(cn3)nc(c34)c(N)nc(n4)N
4896	sp|P9WGR9|Y1350_MY	P0CG22	100.0	30.0	277.0	DB07765	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)N(C)Cc(cn3)nc(c34)c(N)nc(n4)N
4897	sp|P9WGR9|Y1350_MY	Q7Z4W1	96.36	3.0	241.0	DB02831	experimental	Dihydrogenphosphate	OP([O-])(=O)O
4898	sp|P9WGR9|Y1350_MY	Q7Z4W1	96.36	3.0	241.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
4899	sp|P9WGR9|Y1350_MY	Q16698	100.4	55.0	303.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
4900	sp|P9WGR9|Y1350_MY	Q16698	100.4	55.0	303.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
4901	sp|P9WGR9|Y1350_MY	Q99714	100.4	7.0	255.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
4902	sp|P9WGR9|Y1350_MY	Q99714	100.4	7.0	255.0	DB02820	experimental	1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct	C1CCCCCN1C(=O)[C@H](c2ccccc2)n(c3=S)cnc(c34)nn(c4)[C@H]5C=CN(C=C5C([O-])=N)[C@@H]6O[C@@H]([C@@H](O)[C@H]6O)COP([O-])(=O)OP(=O)(O)OC[C@H]7O[C@H]([C@H]([O-])[C@@H]7[O-])n8cnc(c89)c(N)ncn9
4903	sp|P9WGR9|Y1350_MY	Q99714	100.4	7.0	255.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
4904	sp|P9WGR9|Y1350_MY	A0A348A0U3	101.62	2.0	253.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
4905	sp|P9WGR9|Y1350_MY	Q6UWP2	96.76	10.0	249.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
4906	sp|P9WGR9|Y1350_MY	Q6GI75	100.4	4.0	252.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
4907	sp|P9WGR9|Y1350_MY	Q6GI75	100.4	4.0	252.0	DB11155	approved	Triclocarban	Clc1ccc(cc1)NC(=O)Nc2cc(Cl)c(Cl)cc2
4908	sp|P9WGR9|Y1350_MY	P0AEK4	101.62	2.0	253.0	DB01691	experimental	Indole Naphthyridinone	c1cccc(c12)n(C)cc2CN(C)C(=O)/C=C/c(c3)cnc(c34)NC(=O)CC4
4909	sp|P9WGR9|Y1350_MY	P0AEK4	101.62	2.0	253.0	DB01865	experimental	3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide	c1cccc(c12)cc(n2C)CN(C)C(=O)/C=C/c3cnc(N)cc3
4910	sp|P9WGR9|Y1350_MY	P0AEK4	101.62	2.0	253.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
4911	sp|P9WGR9|Y1350_MY	P0AEK4	101.62	2.0	253.0	DB03030	experimental	4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole	Cc1ccc(cc1)Cn2cnc(c2)-c3cccs3
4912	sp|P9WGR9|Y1350_MY	P0AEK4	101.62	2.0	253.0	DB03534	experimental	3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide	CC(=O)N(C)Cc1c(N)ccc(c1)C(=O)N(C)Cc(n2C)cc(c23)cccc3
4913	sp|P9WGR9|Y1350_MY	P0AEK4	101.62	2.0	253.0	DB04030	experimental	1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole	Oc1ccc(cc1)Cn2c(c3c(c24)cccc4)CN(CC3)C(=O)c5ccc(O)cc5
4914	sp|P9WGR9|Y1350_MY	P0AEK4	101.62	2.0	253.0	DB08265	experimental	2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL	Cc1ccc(cc1)S(=O)(=O)n(b2O)ncc(c23)cccc3
4915	sp|P9WGR9|Y1350_MY	P0AEK4	101.62	2.0	253.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
4916	sp|P9WGR9|Y1350_MY	P0AEK4	101.62	2.0	253.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
4917	sp|P9WGR9|Y1350_MY	Q01782	111.74	8.0	284.0	DB02338	experimental	NADPH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
4918	sp|P9WGR9|Y1350_MY	Q01782	111.74	8.0	284.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
4919	sp|P9WGR9|Y1350_MY	Q01782	111.74	8.0	284.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
4920	sp|P9WGR9|Y1350_MY	Q01782	111.74	8.0	284.0	DB04400	experimental	L-erythro-7,8-dihydrobiopterin	C[C@H](O)[C@H](O)C(CN1)=Nc(c12)c(=O)nc([nH]2)N
4921	sp|P9WGR9|Y1350_MY	Q9HBH5	106.07	39.0	301.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
4922	sp|P9WGR9|Y1350_MY	Q8I814	104.45	14.0	272.0	DB02015	experimental	Dihydrofolic Acid	O=c1[nH]c(N)nc(c12)NCC(=N2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
4923	sp|P9WGR9|Y1350_MY	Q8I814	104.45	14.0	272.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
4924	sp|P9WGR9|Y1350_MY	Q6PKH6	74.09	28.0	211.0	DB04200	experimental	Matairesinol	COc1cc(ccc1O)C[C@H]2COC(=O)[C@@H]2Cc3ccc(O)c(c3)OC
4925	sp|P9WGR9|Y1350_MY	O24990	100.81	2.0	251.0	DB04393	experimental	Soneclosan	Clc1cc(O)c(cc1)Oc2ccc(Cl)cc2
4926	sp|P9WGR9|Y1350_MY	O24990	100.81	2.0	251.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
4928	sp|P9WGR9|Y1350_MY	Q8TC12	85.43	38.0	249.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
4929	sp|P9WGR9|Y1350_MY	Q8NBN7	83.4	36.0	242.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
4930	sp|P9WGR9|Y1350_MY	O75911	91.09	36.0	261.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
4931	sp|P9WGR9|Y1350_MY	Q8NBQ5	79.35	33.0	229.0	DB02854	experimental	Aetiocholanolone	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](CC3)C[C@H](O)CC4
4932	sp|P9WGR9|Y1350_MY	Q7AUG5	97.17	3.0	243.0	DB04782	experimental	(S)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@H]2CO2
4933	sp|P9WGR9|Y1350_MY	Q93D82	97.17	3.0	243.0	DB04472	experimental	(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol	[N-]=[N+]=NC[C@H](O)c1ccc([N+]([O-])=O)cc1
4934	sp|P9WGR9|Y1350_MY	Q93D82	97.17	3.0	243.0	DB04499	experimental	(R)-styrene oxide	C1O[C@@H]1c2ccccc2
4935	sp|P9WGR9|Y1350_MY	Q93D82	97.17	3.0	243.0	DB04777	experimental	(R)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@@H]2CO2
4936	sp|P9WGR9|Y1350_MY	P14061	96.36	2.0	240.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
4937	sp|P9WGR9|Y1350_MY	P14061	96.36	2.0	240.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
4938	sp|P9WGR9|Y1350_MY	P14061	96.36	2.0	240.0	DB01561	experimental; illicit	Androstanedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
4939	sp|P9WGR9|Y1350_MY	P14061	96.36	2.0	240.0	DB02187	experimental	Equilin	O=C1CC[C@H]([C@@]12C)C=3[C@H](CC2)c4c(CC3)cc(O)cc4
4940	sp|P9WGR9|Y1350_MY	P14061	96.36	2.0	240.0	DB02323	experimental	EM-1745	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)C[C@@H]([C@@H]4O)CCCCCCCCC(=O)OC[C@H]5O[C@H]([C@H](O)[C@@H]5O)n6cnc(c67)c(N)ncn7
4941	sp|P9WGR9|Y1350_MY	P14061	96.36	2.0	240.0	DB02901	illicit; investigational	Stanolone	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
4942	sp|P9WGR9|Y1350_MY	P14061	96.36	2.0	240.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
4943	sp|P9WGR9|Y1350_MY	P14061	96.36	2.0	240.0	DB13951	experimental	Stanolone acetate	CC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
4944	sp|P9WGR9|Y1350_MY	Q96NR8	82.59	36.0	240.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
4945	sp|P9WGR9|Y1350_MY	Q02338	86.23	52.0	265.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
4946	sp|P9WGR9|Y1350_MY	Q9NYR8	77.33	6.0	197.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
4947	sp|P9WGR9|Y1350_MY	P51659	85.83	6.0	218.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
4948	sp|P9WGR9|Y1350_MY	P51659	85.83	6.0	218.0	DB03192	experimental	(R)-3-hydroxydecanoyl-CoA	CCCCCCC[C@@H](O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
4949	sp|P9WGR9|Y1350_MY	P9WGR1	106.48	1.0	264.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
4950	sp|P9WGR9|Y1350_MY	P9WGR1	106.48	1.0	264.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
4951	sp|P9WGR9|Y1350_MY	P9WGR1	106.48	1.0	264.0	DB02990	experimental	S-(2-Acetamidoethyl) hexadecanethioate	CCCCCCCCCCCCCCCC(=O)SCCNC(=O)C
4952	sp|P9WGR9|Y1350_MY	P9WGR1	106.48	1.0	264.0	DB04289	experimental	Genz-10850	[nH]1ccc(c12)cc(cc2)C(=O)N3CCN(CC3)C4c(cccc5)c5c(c46)cccc6
4953	sp|P9WGR9|Y1350_MY	P9WGR1	106.48	1.0	264.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
4954	sp|P9WGR9|Y1350_MY	P9WGR1	106.48	1.0	264.0	DB07090	experimental	(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cccc(c1C)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
4955	sp|P9WGR9|Y1350_MY	P9WGR1	106.48	1.0	264.0	DB07123	experimental	N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE	Cc1ccc(cc1)C(=O)N2CCC(CC2)Cc3ccccc3
4956	sp|P9WGR9|Y1350_MY	P9WGR1	106.48	1.0	264.0	DB07155	experimental	(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE	c1ccccc1NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
4957	sp|P9WGR9|Y1350_MY	P9WGR1	106.48	1.0	264.0	DB07178	experimental	5-PENTYL-2-PHENOXYPHENOL	CCCCCc1cc(O)c(cc1)Oc2ccccc2
4958	sp|P9WGR9|Y1350_MY	P9WGR1	106.48	1.0	264.0	DB07188	experimental	(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(cc(Cl)c1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
4959	sp|P9WGR9|Y1350_MY	P9WGR1	106.48	1.0	264.0	DB07192	experimental	(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Brc1cc(ccc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
4960	sp|P9WGR9|Y1350_MY	P9WGR1	106.48	1.0	264.0	DB07222	experimental	(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(c(C)cc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
4961	sp|P9WGR9|Y1350_MY	P9WGR1	106.48	1.0	264.0	DB07287	experimental	2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL	c1cccnc1Cc2cc(O)c(cc2)Oc3ccc(Cl)cc3Cl
4962	sp|P9WGR9|Y1350_MY	P9WGR1	106.48	1.0	264.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
4963	sp|P9WGR9|Y1350_MY	P37059	84.21	80.0	288.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
4964	sp|P9WGR9|Y1350_MY	P37059	84.21	80.0	288.0	DB13952	approved; investigational; vet_approved	Estradiol acetate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)C
4965	sp|P9WGR9|Y1350_MY	P37059	84.21	80.0	288.0	DB13953	approved; investigational; vet_approved	Estradiol benzoate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)c5ccccc5
4966	sp|P9WGR9|Y1350_MY	P37059	84.21	80.0	288.0	DB13954	approved; investigational; vet_approved	Estradiol cypionate	C1CCCC1CCC(=O)O[C@H]2CC[C@H]([C@@]23C)[C@H]4[C@H](CC3)c5c(CC4)cc(O)cc5
4967	sp|P9WGR9|Y1350_MY	P37059	84.21	80.0	288.0	DB13955	approved; investigational; vet_approved	Estradiol dienanthate	CCCCCCC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)CCCCCC
4968	sp|P9WGR9|Y1350_MY	P37059	84.21	80.0	288.0	DB13956	approved; investigational; vet_approved	Estradiol valerate	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)CC[C@@H]4OC(=O)CCCC
4969	sp|P9WGR9|Y1350_MY	Q92781	81.78	28.0	230.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
4970	sp|P9WGR9|Y1350_MY	Q92781	81.78	28.0	230.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
4971	sp|P9WGR9|Y1350_MY	P28845	79.35	30.0	226.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
4972	sp|P9WGR9|Y1350_MY	P28845	79.35	30.0	226.0	DB02329	experimental	Carbenoxolone	OC(=O)CCC(=O)O[C@@H](CC1)C(C)(C)[C@@H]([C@]12C)CC[C@]3(C)[C@@H]2C(=O)C=C4[C@H]5[C@@](C)(CC[C@@]34C)CC[C@](C5)(C)C(=O)O
4973	sp|P9WGR9|Y1350_MY	P28845	79.35	30.0	226.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
4974	sp|P9WGR9|Y1350_MY	P28845	79.35	30.0	226.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
4975	sp|P9WGR9|Y1350_MY	P28845	79.35	30.0	226.0	DB04652	experimental	Corticosterone	OCC(=O)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H]([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
4976	sp|P9WGR9|Y1350_MY	P28845	79.35	30.0	226.0	DB05064	investigational	INCB13739	 
4977	sp|P9WGR9|Y1350_MY	P28845	79.35	30.0	226.0	DB06992	experimental	(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone	Cc1ccc(cc1F)-c2nc(ccc2)C(=O)N(CC3(C)C)CCC3
4978	sp|P9WGR9|Y1350_MY	P28845	79.35	30.0	226.0	DB07017	experimental	(5S)-2-{[(1S)-1-(4-Fluorophenyl)ethyl]amino}-5-(2-hydroxy-2-propanyl)-5-methyl-1,3-thiazol-4(5H)-one	Fc1ccc(cc1)[C@H](C)NC(=NC2=O)S[C@@]2(C)C(C)(C)O
4979	sp|P9WGR9|Y1350_MY	P28845	79.35	30.0	226.0	DB07049	experimental	(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine	[O-][N+](=O)c1ccc(cc1)N2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)C(C)(C)C
4980	sp|P9WGR9|Y1350_MY	P28845	79.35	30.0	226.0	DB07056	experimental	2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide	CCN(CC)C(=O)Cc1cccc(n1)NS(=O)(=O)c2c(C)c(Cl)ccc2
4981	sp|P9WGR9|Y1350_MY	P28845	79.35	30.0	226.0	DB07310	experimental	(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one	Fc1ccccc1[C@H](C)NC(=NC2=O)S[C@]2(C)C(F)(F)F
4982	sp|P9WGR9|Y1350_MY	P28845	79.35	30.0	226.0	DB07316	experimental	N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)C3CCN(CC3)CC4(CC4)C(=O)N
4983	sp|P9WGR9|Y1350_MY	P28845	79.35	30.0	226.0	DB07619	experimental	N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)[C@H]3CC[C@@H](CC3)c4cccnc4
4984	sp|P9WGR9|Y1350_MY	P28845	79.35	30.0	226.0	DB07624	experimental	1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide	C1CC1(C(=O)N)CN2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)[C@](C)(O)C(F)(F)F
4985	sp|P9WGR9|Y1350_MY	P28845	79.35	30.0	226.0	DB07866	experimental	(5S)-2-(Cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one	CCC[C@]1(C)SC(=NC1=O)NC2CCCCCCC2
4986	sp|P9WGR9|Y1350_MY	P28845	79.35	30.0	226.0	DB08277	experimental	2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE	CS(=O)(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4c(Cl)cc(F)cc4
4987	sp|P9WGR9|Y1350_MY	P28845	79.35	30.0	226.0	DB08280	experimental	(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE	NC(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4ccc(OC)cc4
4988	sp|P9WGR9|Y1350_MY	P28845	79.35	30.0	226.0	DB08771	experimental	(5R)-2-[(2-Fluorophenyl)amino]-5-isopropyl-1,3-thiazol-4(5H)-one	CC(C)[C@H]1SC(=NC1=O)Nc2c(F)cccc2
4989	sp|P9WGR9|Y1350_MY	P28845	79.35	30.0	226.0	DB13751	approved; experimental	Glycyrrhizic acid	C1C[C@](C)(C(=O)O)C[C@H]([C@]12C)C=3[C@@](C)(CC2)[C@@]4(C)[C@H](C(=O)C3)[C@]5(C)[C@@H](CC4)C(C)(C)[C@H](CC5)O[C@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O[C@@H]7O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]7O
4990	sp|P9WGR9|Y1350_MY	P80365	80.57	81.0	280.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
4991	sp|P9WGR9|Y1350_MY	P80365	80.57	81.0	280.0	DB01185	approved; illicit	Fluoxymesterone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@](F)([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
4992	sp|P9WGR9|Y1350_MY	P80365	80.57	81.0	280.0	DB01569	experimental; illicit	Formebolone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@H]([C@@H](C2)O)[C@]4(C)C(CC3)=CC(=O)C(C=O)=C4
4993	sp|P9WGR9|Y1350_MY	P80365	80.57	81.0	280.0	DB14538	experimental; vet_approved	Hydrocortisone aceponate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CC)C(=O)COC(=O)C
4994	sp|P9WGR9|Y1350_MY	P80365	80.57	81.0	280.0	DB14539	approved; vet_approved	Hydrocortisone acetate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)C
4995	sp|P9WGR9|Y1350_MY	P80365	80.57	81.0	280.0	DB14540	approved; vet_approved	Hydrocortisone butyrate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCC
4996	sp|P9WGR9|Y1350_MY	P80365	80.57	81.0	280.0	DB14541	approved; investigational; vet_approved	Hydrocortisone cypionate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)CCC5CCCC5
4997	sp|P9WGR9|Y1350_MY	P80365	80.57	81.0	280.0	DB14542	approved; vet_approved	Hydrocortisone phosphate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COP(=O)(O)O
4998	sp|P9WGR9|Y1350_MY	P80365	80.57	81.0	280.0	DB14543	approved; vet_approved	Hydrocortisone probutate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CCC)C(=O)COC(=O)CC
4999	sp|P9WGR9|Y1350_MY	P80365	80.57	81.0	280.0	DB14544	approved; vet_approved	Hydrocortisone valerate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCCC
5000	sp|P9WGR9|Y1350_MY	P37058	81.38	48.0	249.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
5001	sp|P9WGR9|Y1350_MY	P16152	96.76	6.0	245.0	DB01698	approved; experimental; investigational	Rutin	O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O[C@H]1C)OC[C@H]2O[C@H]([C@H](O)[C@@H](O)[C@@H]2O)Oc(c3=O)c(-c4cc(O)c(O)cc4)oc(c35)cc(O)cc5O
5002	sp|P9WGR9|Y1350_MY	P16152	96.76	6.0	245.0	DB02709	investigational	Resveratrol	Oc1ccc(cc1)/C=C/c2cc(O)cc(O)c2
5003	sp|P9WGR9|Y1350_MY	P16152	96.76	6.0	245.0	DB03394	experimental	Heptaethylene glycol	OCCOCCOCCOCCOCCOCCOCCO
5004	sp|P9WGR9|Y1350_MY	P16152	96.76	6.0	245.0	DB03556	experimental	2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400	CCOCCOCCOCCOCCOCCOCCOCCOCCO
5005	sp|P9WGR9|Y1350_MY	P16152	96.76	6.0	245.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
5006	sp|P9WGR9|Y1350_MY	P16152	96.76	6.0	245.0	DB04463	experimental	3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol	n1cnc(N)c(c12)c(nn2C(C)(C)C)-c3cccc(O)c3
5007	sp|P9WGR9|Y1350_MY	P16152	96.76	6.0	245.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
5008	sp|P9WGR9|Y1350_MY	P16152	96.76	6.0	245.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
5009	sp|P9WGR9|Y1350_MY	P56937	97.17	2.0	242.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
5010	sp|P9WGR9|Y1350_MY	P35270	98.38	1.0	244.0	DB02637	experimental	Oxaloacetate Ion	OC(=O)C(=O)CC([O-])=O
5011	sp|P9WGR9|Y1350_MY	P35270	98.38	1.0	244.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
5012	sp|P9WGR9|Y1350_MY	P35270	98.38	1.0	244.0	DB03886	experimental	Biopterin	C[C@@H](O)[C@@H](O)c(n1)cnc(c12)nc(N)[nH]c2=O
5013	sp|P9WGR9|Y1350_MY	P35270	98.38	1.0	244.0	DB04275	experimental	N-acetylserotonin	CC(=O)NCCc1c[nH]c(c12)ccc(c2)O
5014	sp|P9WGR9|Y1350_MY	P09417	77.73	10.0	202.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
5015	sp|P9WGR9|Y1350_MY	P09417	77.73	10.0	202.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
5016	sp|P9WGR9|Y1350_MY	P26391	77.33	3.0	194.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
5017	sp|P9WGR9|Y1350_MY	Q8T8E9	78.54	2.0	196.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
5018	sp|P9WGR9|Y1350_MY	P14169	71.66	3.0	180.0	DB04555	experimental	Cytidine-5'-Diphosphate	Nc1nc(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O
5019	sp|P9WGR9|Y1350_MY	P95780	70.85	5.0	180.0	DB03161	experimental	Thymidine-5'-diphospho-beta-D-xylose	O=c1[nH]c(=O)c(C)cn1[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3OC[C@@H](O)[C@H](O)[C@H]3O
5020	sp|P9WGR9|Y1350_MY	P95780	70.85	5.0	180.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
5021	sp|P9WL11|Y3073_MY	Q9WYT0	77.97	22.0	114.0	DB01903	experimental	5-Bromo-2'-deoxyuridine 5'-(dihydrogen phosphate)	OP(=O)(O)OC[C@H]1O[C@H](C[C@@H]1O)n2cc(Br)c(=O)[nH]c2=O
5022	sp|P9WL11|Y3073_MY	Q9WYT0	77.97	22.0	114.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
5023	sp|P9WL11|Y3073_MY	Q9WYT0	77.97	22.0	114.0	DB03761	experimental	5-fluoro-2'-deoxyuridine-5'-monophosphate	OP(=O)(O)OC[C@H]1O[C@H](C[C@@H]1O)n2cc(F)c(=O)[nH]c2=O
5024	sp|P9WL11|Y3073_MY	Q9WYT0	77.97	22.0	114.0	DB03800	experimental	Deoxyuridine monophosphate	OP(=O)(O)OC[C@H]1O[C@H](C[C@@H]1O)n2ccc(=O)[nH]c2=O
5025	sp|P9WJ01|Y480_MYC	P60327	92.86	31.0	291.0	DB01847	experimental	N-Carbamyl-D-Valine	CC(C)[C@H](C(=O)O)NC(=O)N
5026	sp|P9WJ01|Y480_MYC	P60327	92.86	31.0	291.0	DB03364	experimental	N-Carbamyl-D-Methionine	CSCC[C@H](C(=O)O)NC(=O)N
5027	sp|P9WJ01|Y480_MYC	P60327	92.86	31.0	291.0	DB04058	experimental	N-Carbamoylphenylalanine	NC(=O)N[C@H](C(=O)O)Cc1ccccc1
5028	sp|P9WFE9|URE2_MYC	P41021	97.12	7.0	108.0	DB02899	experimental	N-Carboxymethionine	OC(=O)N[C@H](C(=O)O)CCSC
5029	sp|P9WFQ9|UNG_MYCT	Q8X444	87.22	23.0	221.0	DB03419	experimental; investigational	Uracil	O=c1[nH]ccc(=O)[nH]1
5030	sp|P9WFQ9|UNG_MYCT	P10186	95.59	116.0	333.0	DB03419	experimental; investigational	Uracil	O=c1[nH]ccc(=O)[nH]1
5031	sp|P9WFQ9|UNG_MYCT	P13051	87.67	112.0	311.0	DB06990	experimental	4-[(1E,7E)-8-(2,6-DIOXO-1,2,3,6-TETRAHYDROPYRIMIDIN-4-YL)-3,6-DIOXA-2,7-DIAZAOCTA-1,7-DIEN-1-YL]BENZOIC ACID	OC(=O)c1ccc(cc1)/C=N/OCCO/N=C/c2cc(=O)[nH]c(=O)[nH]2
5032	sp|P9WFQ9|UNG_MYCT	P13051	87.67	112.0	311.0	DB07116	experimental	1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-4-METHYL-1H-INDOLE	OP(=O)(O)OC[C@H]1O[C@H](C[C@@H]1O)n2ccc(c23)c(C)ccc3
5033	sp|P9WFQ9|UNG_MYCT	P13051	87.67	112.0	311.0	DB07760	experimental	3-[(1E,7E)-8-(2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)-3,6-dioxa-2,7-diazaocta-1,7-dien-1-yl]benzoic acid	OC(=O)c1cccc(c1)/C=N/OCCO/N=C/c2cc(=O)[nH]c(=O)[nH]2
5034	sp|P9WHQ1|Y1711_MY	P45124	90.16	1.0	230.0	DB01955	experimental	1,4-Butanediol	OCCCCO
5035	sp|P9WHQ1|Y1711_MY	P0AA43	90.16	1.0	230.0	DB03419	experimental; investigational	Uracil	O=c1[nH]ccc(=O)[nH]1
5036	sp|P9WHQ1|Y1711_MY	P0AA43	90.16	1.0	230.0	DB03685	experimental	Uridine monophosphate	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2ccc(=O)[nH]c2=O
5037	sp|P9WQ89|Y2231_MY	P97084	87.64	24.0	343.0	DB02482	experimental	Phosphonothreonine	OC(=O)[C@H](N)[C@H](C)OP(=O)(O)O
5038	sp|P9WQ89|Y2231_MY	P97084	87.64	24.0	343.0	DB03433	experimental	{3-[(3-Hydroxy-2-Methyl-5-Phosphonooxymethyl-Pyridin-4-Ylmethyl)-Amino]-2-Methyl-Propyl}-Phosphonic Acid	OP(=O)(O)O[C@H](C)CNCc1c(O)c(C)ncc1COP(=O)(O)O
5039	sp|P9WQ89|Y2231_MY	P06986	84.34	32.0	339.0	DB01813	experimental	Pyridoxyl-Glutamic Acid-5'-Monophosphate	OC(=O)CC[C@@H](C(=O)O)NCc1c(COP(=O)(O)O)c[nH+]c(C)c1O
5040	sp|P9WQ89|Y2231_MY	P06986	84.34	32.0	339.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
5041	sp|P9WQ89|Y2231_MY	P06986	84.34	32.0	339.0	DB03997	experimental	L-histidinol phosphate	OP(=O)(O)OC[C@@H](N)Cc1c[nH]cn1
5042	sp|P9WQ89|Y2231_MY	Q6YP21	84.89	72.0	381.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
5043	sp|P9WQ89|Y2231_MY	Q75WK2	82.42	37.0	337.0	DB02024	experimental	3-phenylpropionic acid	OC(=O)CCc1ccccc1
5044	sp|P9WQ89|Y2231_MY	Q75WK2	82.42	37.0	337.0	DB02238	experimental	4-methylthio-2-oxobutanoic acid	CSCCC(=O)C(=O)O
5045	sp|P9WQ89|Y2231_MY	Q56232	87.09	45.0	362.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
5046	sp|P9WQ89|Y2231_MY	Q56232	87.09	45.0	362.0	DB04299	experimental	Maleic Acid	OC(=O)/C=C\C(=O)O
5047	sp|P9WQ89|Y2231_MY	Q9X0D0	78.02	26.0	310.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
5048	sp|P9WQ89|Y2231_MY	Q9X0D0	78.02	26.0	310.0	DB03997	experimental	L-histidinol phosphate	OP(=O)(O)OC[C@@H](N)Cc1c[nH]cn1
5049	sp|P9WQ89|Y2231_MY	Q16773	75.0	73.0	346.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
5050	sp|P9WQ89|Y2231_MY	Q16773	75.0	73.0	346.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
5051	sp|P9WQ89|Y2231_MY	Q16773	75.0	73.0	346.0	DB02556	experimental	D-Phenylalanine	OC(=O)[C@H](N)Cc1ccccc1
5052	sp|P9WQ89|Y2231_MY	Q16773	75.0	73.0	346.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
5053	sp|P9WQ89|Y2231_MY	Q16773	75.0	73.0	346.0	DB07950	experimental	Indoleacetic acid	OC(=O)Cc1c[nH]c(c12)cccc2
5054	sp|P9WQ89|Y2231_MY	P33447	77.75	101.0	384.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
5055	sp|P9WQ89|Y2231_MY	P17735	76.1	132.0	409.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
5056	sp|P9WQ89|Y2231_MY	P17735	76.1	132.0	409.0	DB00120	approved; investigational; nutraceutical	Phenylalanine	OC(=O)[C@@H](N)Cc1ccccc1
5057	sp|P9WQ89|Y2231_MY	P17735	76.1	132.0	409.0	DB00135	approved; investigational; nutraceutical	Tyrosine	OC(=O)[C@@H](N)Cc1ccc(O)cc1
5058	sp|P9WQ89|Y2231_MY	P17735	76.1	132.0	409.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
5059	sp|P9WQ89|Y2231_MY	Q96QU6	79.4	160.0	449.0	DB03214	experimental	Vinylglycine	OC(=O)[C@@H](N)C=C
5060	sp|P9WQ89|Y2231_MY	Q9X0L5	79.4	84.0	373.0	DB01942	experimental; investigational	Formic acid	OC=O
5061	sp|P9WQ89|Y2231_MY	Q8N5Z0	81.04	110.0	405.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
5062	sp|P9WQ89|Y2231_MY	Q8N5Z0	81.04	110.0	405.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
5063	sp|P9WQ89|Y2231_MY	Q8TD30	85.16	176.0	486.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
5064	sp|P9WQ89|Y2231_MY	Q8TD30	85.16	176.0	486.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
5065	sp|P9WQ89|Y2231_MY	Q8TD30	85.16	176.0	486.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
5066	sp|P9WQ89|Y2231_MY	Q8TD30	85.16	176.0	486.0	DB00780	approved	Phenelzine	NNCCc1ccccc1
5067	sp|P9WQ89|Y2231_MY	P00505	74.45	132.0	403.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
5068	sp|P9WQ89|Y2231_MY	P00505	74.45	132.0	403.0	DB00128	approved; nutraceutical	Aspartic acid	OC(=O)[C@@H](N)CC(=O)O
5069	sp|P9WQ89|Y2231_MY	P00505	74.45	132.0	403.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
5070	sp|P9WQ89|Y2231_MY	P00505	74.45	132.0	403.0	DB00151	approved; nutraceutical	Cysteine	OC(=O)[C@@H](N)CS
5071	sp|P9WQ89|Y2231_MY	P00505	74.45	132.0	403.0	DB02783	experimental	4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate	Cc1ncc(COP(=O)(O)O)c(c1O)CNOCC(=O)O
5073	sp|P9WNH3|Y2715_MY	P47229	76.54	22.0	283.0	DB07510	experimental	3-fluoro-6-(4-fluorophenyl)-2-hydroxy-6-oxohexa-2,4-dienoic acid	OC(=O)/C(O)=C(/F)\C=C\C(=O)c1ccc(F)cc1
5074	sp|P9WNH3|Y2715_MY	P47229	76.54	22.0	283.0	DB07516	experimental	(2Z,4E)-3-chloro-2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoic acid	OC(=O)/C(O)=C(/Cl)\C=C\C(=O)c1ccccc1
5075	sp|P9WNH3|Y2715_MY	P47229	76.54	22.0	283.0	DB07911	experimental	(3E)-2,6-DIOXO-6-PHENYLHEX-3-ENOATE	[O-]C(=O)C(=O)/C=C/CC(=O)c1ccccc1
5076	sp|P9WNH3|Y2715_MY	P47229	76.54	22.0	283.0	DB07915	experimental	(2E,4E)-2-Hydroxy-6-oxo-6-phenyl-2,4-hexadienoic acid	OC(=O)/C(O)=C\C=C\C(=O)c1ccccc1
5077	sp|P9WNH3|Y2715_MY	P96965	76.54	13.0	274.0	DB02406	experimental	N-Valeric Acid	CCCCC(=O)O
5078	sp|P9WNH3|Y2715_MY	P96965	76.54	13.0	274.0	DB02531	experimental	Isobutyric acid	CC(C)C(=O)O
5079	sp|P9WNH3|Y2715_MY	P96965	76.54	13.0	274.0	DB03568	experimental; investigational	Butyric Acid	CCCC(=O)O
5080	sp|P9WNH3|Y2715_MY	P96965	76.54	13.0	274.0	DB03741	experimental	2-Methylbutanoic Acid	CC[C@@H](C)C(=O)O
5081	sp|P9WNH3|Y2715_MY	P96965	76.54	13.0	274.0	DB03750	experimental	Isovaleric Acid	CC(C)CC(=O)O
5082	sp|P9WNH3|Y2715_MY	P96965	76.54	13.0	274.0	DB03766	approved; vet_approved	Propanoic acid	CCC(=O)O
5083	sp|P9WNH3|Y2715_MY	P96965	76.54	13.0	274.0	DB03793	approved; investigational	Benzoic acid	OC(=O)c1ccccc1
5084	sp|P9WH47|RS182_MY	Q5SLQ0	82.95	10.0	83.0	DB08185	experimental	2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(nc(n3)SC)NCCC(C)C
5085	sp|P9WQA7|Y2298_MY	P80874	95.67	1.0	310.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
5086	sp|P9WQA7|Y2298_MY	P46336	95.05	1.0	308.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
5087	sp|P9WQA7|Y2298_MY	Q13303	97.21	39.0	353.0	DB00228	approved; investigational; vet_approved	Enflurane	FC(F)OC(F)(F)C(F)Cl
5088	sp|P9WQA7|Y2298_MY	Q13303	97.21	39.0	353.0	DB01069	approved; investigational	Promethazine	CN(C)C(C)CN1c(cccc2)c2Sc(c13)cccc3
5089	sp|P9WQA7|Y2298_MY	Q13303	97.21	39.0	353.0	DB01110	approved; investigational; vet_approved	Miconazole	Clc1cc(Cl)c(cc1)COC(Cn2ccnc2)c3c(Cl)cc(Cl)cc3
5090	sp|P9WQA7|Y2298_MY	P42330	92.26	13.0	311.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
5091	sp|P9WQA7|Y2298_MY	P42330	92.26	13.0	311.0	DB00328	approved; investigational	Indomethacin	COc(cc1)cc(c12)c(CC(=O)O)c(C)n2C(=O)c3ccc(Cl)cc3
5092	sp|P9WQA7|Y2298_MY	P42330	92.26	13.0	311.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
5093	sp|P9WQA7|Y2298_MY	P42330	92.26	13.0	311.0	DB01698	approved; experimental; investigational	Rutin	O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O[C@H]1C)OC[C@H]2O[C@H]([C@H](O)[C@@H](O)[C@@H]2O)Oc(c3=O)c(-c4cc(O)c(O)cc4)oc(c35)cc(O)cc5O
5094	sp|P9WQA7|Y2298_MY	P42330	92.26	13.0	311.0	DB02056	investigational	Prostaglandin D2	CCCCC[C@H](O)/C=C/[C@H]1C(=O)C[C@H](O)[C@@H]1C/C=C\CCCC(=O)O
5095	sp|P9WQA7|Y2298_MY	P42330	92.26	13.0	311.0	DB02266	approved	Flufenamic acid	OC(=O)c1ccccc1Nc2cc(C(F)(F)F)ccc2
5096	sp|P9WQA7|Y2298_MY	P42330	92.26	13.0	311.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
5097	sp|P9WQA7|Y2298_MY	P42330	92.26	13.0	311.0	DB07700	experimental	3-carboxamido-1,3,5(10)-estratrien-17(R)-spiro-2'(5',5'-dimethyl-6'oxo)tetrahydropyran	C1CC(C)(C)C(=O)O[C@@]12[C@]3(C)[C@@H](CC2)[C@H]4[C@H](CC3)c5c(CC4)cc(cc5)C(=O)N
5098	sp|P9WQA7|Y2298_MY	Q14722	98.14	92.0	409.0	DB00228	approved; investigational; vet_approved	Enflurane	FC(F)OC(F)(F)C(F)Cl
5099	sp|P9WQA7|Y2298_MY	Q14722	98.14	92.0	409.0	DB01069	approved; investigational	Promethazine	CN(C)C(C)CN1c(cccc2)c2Sc(c13)cccc3
5100	sp|P9WQA7|Y2298_MY	Q14722	98.14	92.0	409.0	DB01110	approved; investigational; vet_approved	Miconazole	Clc1cc(Cl)c(cc1)COC(Cn2ccnc2)c3c(Cl)cc(Cl)cc3
5102	sp|P9WQA7|Y2298_MY	P76187	88.85	5.0	292.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
5103	sp|P9WJX3|Y1634_MY	P9WJY5	90.87	32.0	460.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
5104	sp|P9WLV1|Y1526_MY	Q9AFC7	95.31	1.0	407.0	DB04529	experimental	Desvancosaminyl vancomycin	CC(C)C[C@@H](NC)C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)c(cc2Cl)ccc2Oc(cc3[C@@H]14)c(O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)c(c3)Oc6c(Cl)cc(cc6)[C@@H](O)[C@H]7C(=O)N[C@H](C(=O)O)c8c(c(O)cc(c8)O)c9cc([C@@H](NC4=O)C(=O)N7)ccc9O
5105	sp|P9WLV1|Y1526_MY	P96558	92.49	1.0	395.0	DB04529	experimental	Desvancosaminyl vancomycin	CC(C)C[C@@H](NC)C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)c(cc2Cl)ccc2Oc(cc3[C@@H]14)c(O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)c(c3)Oc6c(Cl)cc(cc6)[C@@H](O)[C@H]7C(=O)N[C@H](C(=O)O)c8c(c(O)cc(c8)O)c9cc([C@@H](NC4=O)C(=O)N7)ccc9O
5106	sp|P9WQA5|Y2971_MY	Q9GV41	96.1	2.0	273.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
5107	sp|P9WQA5|Y2971_MY	Q9GV41	96.1	2.0	273.0	DB04272	approved; nutraceutical; vet_approved	Citric acid	OC(=O)CC(O)(C(=O)O)CC(=O)O
5108	sp|P9WQA5|Y2971_MY	P52895	107.09	5.0	307.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
5109	sp|P9WQA5|Y2971_MY	P52895	107.09	5.0	307.0	DB01586	approved; investigational	Ursodeoxycholic acid	OC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](C[C@@H]3O)C[C@H](O)CC4
5110	sp|P9WQA5|Y2971_MY	P52895	107.09	5.0	307.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
5111	sp|P9WQA5|Y2971_MY	P52895	107.09	5.0	307.0	DB06777	approved	Chenodeoxycholic acid	OC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
5112	sp|P9WQA5|Y2971_MY	P52895	107.09	5.0	307.0	DB07768	experimental	Epitestosterone	O[C@@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
5113	sp|P9WQA5|Y2971_MY	Q04828	107.09	5.0	307.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
5114	sp|P9WQA5|Y2971_MY	Q04828	107.09	5.0	307.0	DB00936	approved; investigational; vet_approved	Salicylic acid	OC(=O)c1ccccc1O
5115	sp|P9WQA5|Y2971_MY	Q04828	107.09	5.0	307.0	DB00945	approved; vet_approved	Acetylsalicylic acid	CC(=O)Oc1ccccc1C(=O)O
5116	sp|P9WQA5|Y2971_MY	Q04828	107.09	5.0	307.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
5117	sp|P9WQA5|Y2971_MY	Q04828	107.09	5.0	307.0	DB03467	experimental	Naringenin	Oc1ccc(cc1)[C@@H](O2)CC(=O)c(c23)c(O)cc(c3)O
5118	sp|P9WQA5|Y2971_MY	Q04828	107.09	5.0	307.0	DB04674	experimental	2-HYDROXY-3,5-DIIODOBENZOIC ACID	OC(=O)c1c(O)c(I)cc(I)c1
5119	sp|P9WQA5|Y2971_MY	Q04828	107.09	5.0	307.0	DB07768	experimental	Epitestosterone	O[C@@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
5120	sp|P9WQA5|Y2971_MY	Q04828	107.09	5.0	307.0	DB07931	withdrawn	Hexestrol	Oc1ccc(cc1)[C@H](CC)[C@H](CC)c2ccc(O)cc2
5121	sp|P9WQA5|Y2971_MY	P42330	107.45	4.0	307.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
5122	sp|P9WQA5|Y2971_MY	P42330	107.45	4.0	307.0	DB00328	approved; investigational	Indomethacin	COc(cc1)cc(c12)c(CC(=O)O)c(C)n2C(=O)c3ccc(Cl)cc3
5123	sp|P9WQA5|Y2971_MY	P42330	107.45	4.0	307.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
5124	sp|P9WQA5|Y2971_MY	P42330	107.45	4.0	307.0	DB01698	approved; experimental; investigational	Rutin	O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O[C@H]1C)OC[C@H]2O[C@H]([C@H](O)[C@@H](O)[C@@H]2O)Oc(c3=O)c(-c4cc(O)c(O)cc4)oc(c35)cc(O)cc5O
5125	sp|P9WQA5|Y2971_MY	P42330	107.45	4.0	307.0	DB02056	investigational	Prostaglandin D2	CCCCC[C@H](O)/C=C/[C@H]1C(=O)C[C@H](O)[C@@H]1C/C=C\CCCC(=O)O
5126	sp|P9WQA5|Y2971_MY	P42330	107.45	4.0	307.0	DB02266	approved	Flufenamic acid	OC(=O)c1ccccc1Nc2cc(C(F)(F)F)ccc2
5127	sp|P9WQA5|Y2971_MY	P42330	107.45	4.0	307.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
5128	sp|P9WQA5|Y2971_MY	P42330	107.45	4.0	307.0	DB07700	experimental	3-carboxamido-1,3,5(10)-estratrien-17(R)-spiro-2'(5',5'-dimethyl-6'oxo)tetrahydropyran	C1CC(C)(C)C(=O)O[C@@]12[C@]3(C)[C@@H](CC2)[C@H]4[C@H](CC3)c5c(CC4)cc(cc5)C(=O)N
5129	sp|P9WQA5|Y2971_MY	P17516	107.09	5.0	307.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
5130	sp|P9WQA5|Y2971_MY	P15121	105.67	2.0	300.0	DB00143	approved; investigational; nutraceutical	Glutathione	OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(=O)O
5131	sp|P9WQA5|Y2971_MY	P15121	105.67	2.0	300.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
5132	sp|P9WQA5|Y2971_MY	P15121	105.67	2.0	300.0	DB00605	approved; investigational	Sulindac	c1cc(F)cc(c12)C(CC(=O)O)=C(C)/C2=C/c3ccc(cc3)S(=O)C
5133	sp|P9WQA5|Y2971_MY	P15121	105.67	2.0	300.0	DB01689	experimental	Inhibitor Idd 384	Cc1ccccc1CC(=O)Nc2cc(C)c(c(C)c2)S(=O)(=O)NCC(=O)O
5134	sp|P9WQA5|Y2971_MY	P15121	105.67	2.0	300.0	DB02007	experimental	alpha-D-glucose 6-phosphate	O[C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O)COP(=O)(O)O
5135	sp|P9WQA5|Y2971_MY	P15121	105.67	2.0	300.0	DB02020	experimental	Alrestatin	OC(=O)CN(C1=O)C(=O)c2cccc(c2c13)ccc3
5136	sp|P9WQA5|Y2971_MY	P15121	105.67	2.0	300.0	DB02021	experimental	Fidarestat	NC(=O)[C@H](C1)Oc(ccc(F)c2)c2[C@@]13NC(=O)NC3=O
5137	sp|P9WQA5|Y2971_MY	P15121	105.67	2.0	300.0	DB02101	experimental	(S,R)-fidarestat	NC(=O)[C@H](C1)Oc(ccc(F)c2)c2[C@]13NC(=O)NC3=O
5138	sp|P9WQA5|Y2971_MY	P15121	105.67	2.0	300.0	DB02132	experimental	Zenarestat	Clc(c1)ccc(c12)c(=O)n(c(=O)n2CC(=O)O)Cc3c(F)cc(Br)cc3
5139	sp|P9WQA5|Y2971_MY	P15121	105.67	2.0	300.0	DB02383	withdrawn	Tolrestat	COc(cc1)c(C(F)(F)F)c(c12)cccc2C(=S)N(C)CC(=O)O
5140	sp|P9WQA5|Y2971_MY	P15121	105.67	2.0	300.0	DB02518	experimental	N-Acetylalanine	OC(=O)[C@H](C)NC(=O)C
5141	sp|P9WQA5|Y2971_MY	P15121	105.67	2.0	300.0	DB02712	experimental; investigational	Sorbinil	Fc(c1)ccc(OCC2)c1[C@@]23NC(=O)NC3=O
5142	sp|P9WQA5|Y2971_MY	P15121	105.67	2.0	300.0	DB02834	experimental	IDD552	OC(=O)COc1cc(F)ccc1C(=O)NCc(s2)nc(c23)c(F)c(F)cc3F
5143	sp|P9WQA5|Y2971_MY	P15121	105.67	2.0	300.0	DB02994	experimental	Cacodylic acid	C[As](=O)(C)O
5144	sp|P9WQA5|Y2971_MY	P15121	105.67	2.0	300.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
5145	sp|P9WQA5|Y2971_MY	P15121	105.67	2.0	300.0	DB04272	approved; nutraceutical; vet_approved	Citric acid	OC(=O)CC(O)(C(=O)O)CC(=O)O
5146	sp|P9WQA5|Y2971_MY	P15121	105.67	2.0	300.0	DB05327	investigational	Ranirestat	Brc1cc(F)c(cc1)CN(C2=O)C(=O)c(ccc3)n3[C@@]24CC(=O)NC4=O
5147	sp|P9WQA5|Y2971_MY	P15121	105.67	2.0	300.0	DB05383	investigational	Pimagedine	NNC(N)=N
5148	sp|P9WQA5|Y2971_MY	P15121	105.67	2.0	300.0	DB05533	investigational	QR-333	 
5149	sp|P9WQA5|Y2971_MY	P15121	105.67	2.0	300.0	DB06246	investigational	Exisulind	c1cc(F)cc(c12)C(CC(=O)O)=C(C)/C2=C/c3ccc(cc3)S(=O)(=O)C
5150	sp|P9WQA5|Y2971_MY	P15121	105.67	2.0	300.0	DB07028	experimental	(2-{[(4-BROMO-2-FLUOROBENZYL)AMINO]CARBONYL}-5-CHLOROPHENOXY)ACETIC ACID	OC(=O)COc1cc(Cl)ccc1C(=O)NCc2c(F)cc(Br)cc2
5151	sp|P9WQA5|Y2971_MY	P15121	105.67	2.0	300.0	DB07030	experimental	(5-CHLORO-2-{[(3-NITROBENZYL)AMINO]CARBONYL}PHENOXY)ACETIC ACID	OC(=O)COc1cc(Cl)ccc1C(=O)NCc2cc([N+]([O-])=O)ccc2
5152	sp|P9WQA5|Y2971_MY	P15121	105.67	2.0	300.0	DB07063	investigational	Lidorestat	c1cccc(c12)c(cn2CC(=O)O)Cc(s3)nc(c34)c(F)c(F)cc4F
5153	sp|P9WQA5|Y2971_MY	P15121	105.67	2.0	300.0	DB07093	experimental	{3-[(5-CHLORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL}ACETIC ACID	OC(=O)Cn1ccc(=O)n(c1=O)Cc(s2)nc(c23)cc(Cl)cc3
5154	sp|P9WQA5|Y2971_MY	P15121	105.67	2.0	300.0	DB07139	experimental	3-[5-(3-nitrophenyl)thiophen-2-yl]propanoic acid	OC(=O)CCc1ccc(s1)-c2cc([N+]([O-])=O)ccc2
5155	sp|P9WQA5|Y2971_MY	P15121	105.67	2.0	300.0	DB07187	experimental	CP-744809	Clc(c1)ccc(c12)oc(c2C)S(=O)(=O)c3n[nH]c(=O)cc3
5156	sp|P9WQA5|Y2971_MY	P15121	105.67	2.0	300.0	DB07450	experimental	(R)-minalrestat	O=C(C1)NC(=O)[C@]12c3c(ccc(F)c3)C(=O)N(C2=O)Cc4c(F)cc(Br)cc4
5157	sp|P9WQA5|Y2971_MY	P15121	105.67	2.0	300.0	DB07498	experimental	4-[3-(3-NITROPHENYL)-1,2,4-OXADIAZOL-5-YL]BUTANOIC ACID	OC(=O)CCCc1nc(no1)-c2cc([N+]([O-])=O)ccc2
5158	sp|P9WQA5|Y2971_MY	P15121	105.67	2.0	300.0	DB07999	experimental	{4-[(CARBOXYMETHOXY)CARBONYL]-3,3-DIOXIDO-1-OXONAPHTHO[1,2-D]ISOTHIAZOL-2(1H)-YL}ACETIC ACID	OC(=O)COC(=O)c(c1)c(S(=O)(=O)N(C2=O)CC(=O)O)c2c(c13)cccc3
5159	sp|P9WQA5|Y2971_MY	P15121	105.67	2.0	300.0	DB08000	experimental	2-(CARBOXYMETHYL)-1-OXO-1,2-DIHYDRONAPHTHO[1,2-D]ISOTHIAZOLE-4-CARBOXYLIC ACID 3,3-DIOXIDE	OC(=O)CN(S1(=O)=O)C(=O)c(c12)c3c(cc2C(=O)O)cccc3
5160	sp|P9WQA5|Y2971_MY	P15121	105.67	2.0	300.0	DB08084	experimental	IDD594	OC(=O)COc1cc(F)ccc1C(=S)NCc2ccc(Br)cc2F
5161	sp|P9WQA5|Y2971_MY	P15121	105.67	2.0	300.0	DB08098	experimental	{[5-(5-nitro-2-furyl)-1,3,4-oxadiazol-2-yl]thio}acetic acid	OC(=O)CSc1nnc(o1)-c2ccc(o2)[N+]([O-])=O
5162	sp|P9WQA5|Y2971_MY	P15121	105.67	2.0	300.0	DB08449	experimental	2-(3-((4,5,7-trifluorobenzo[d]thiazol-2-yl)methyl)-1H-pyrrolo[2,3-b]pyridin-1-yl)acetic acid	n1cccc(c12)c(cn2CC(=O)O)Cc(s3)nc(c34)c(F)c(F)cc4F
5163	sp|P9WQA5|Y2971_MY	P15121	105.67	2.0	300.0	DB08772	experimental	Zopolrestat	c1cccc(c12)c(=O)n(nc2CC(=O)O)Cc(s3)nc(c34)cc(C(F)(F)F)cc4
5164	sp|P9WQA5|Y2971_MY	O60218	105.67	2.0	300.0	DB00605	approved; investigational	Sulindac	c1cc(F)cc(c12)C(CC(=O)O)=C(C)/C2=C/c3ccc(cc3)S(=O)C
5165	sp|P9WQA5|Y2971_MY	O60218	105.67	2.0	300.0	DB02021	experimental	Fidarestat	NC(=O)[C@H](C1)Oc(ccc(F)c2)c2[C@@]13NC(=O)NC3=O
5166	sp|P9WQA5|Y2971_MY	O60218	105.67	2.0	300.0	DB02383	withdrawn	Tolrestat	COc(cc1)c(C(F)(F)F)c(c12)cccc2C(=S)N(C)CC(=O)O
5167	sp|P9WQA5|Y2971_MY	O60218	105.67	2.0	300.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
5168	sp|P9WQA5|Y2971_MY	O60218	105.67	2.0	300.0	DB06246	investigational	Exisulind	c1cc(F)cc(c12)C(CC(=O)O)=C(C)/C2=C/c3ccc(cc3)S(=O)(=O)C
5169	sp|P9WQA5|Y2971_MY	O60218	105.67	2.0	300.0	DB08772	experimental	Zopolrestat	c1cccc(c12)c(=O)n(nc2CC(=O)O)Cc(s3)nc(c34)cc(C(F)(F)F)cc4
5171	sp|P9WQA5|Y2971_MY	P51857	108.51	4.0	310.0	DB00548	approved	Azelaic acid	OC(=O)CCCCCCCC(=O)O
5172	sp|P9WQA5|Y2971_MY	P51857	108.51	4.0	310.0	DB01216	approved	Finasteride	CC(C)(C)NC(=O)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)NC(=O)C=C4
5173	sp|P9WQA5|Y2971_MY	P51857	108.51	4.0	310.0	DB07447	experimental	5beta-dihydrotestosterone	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](CC3)CC(=O)CC4
5174	sp|P9WQA5|Y2971_MY	P51857	108.51	4.0	310.0	DB07557	experimental	3,20-Pregnanedione	CC(=O)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](CC3)CC(=O)CC4
5175	sp|P9WQA5|Y2971_MY	Q9X0A2	93.62	3.0	267.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
5176	sp|P9WQA5|Y2971_MY	P06632	92.91	2.0	264.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
5177	sp|P9WQA5|Y2971_MY	Q13303	112.06	45.0	361.0	DB00228	approved; investigational; vet_approved	Enflurane	FC(F)OC(F)(F)C(F)Cl
5178	sp|P9WQA5|Y2971_MY	Q13303	112.06	45.0	361.0	DB01069	approved; investigational	Promethazine	CN(C)C(C)CN1c(cccc2)c2Sc(c13)cccc3
5179	sp|P9WQA5|Y2971_MY	Q13303	112.06	45.0	361.0	DB01110	approved; investigational; vet_approved	Miconazole	Clc1cc(Cl)c(cc1)COC(Cn2ccnc2)c3c(Cl)cc(Cl)cc3
5180	sp|P9WQA5|Y2971_MY	Q14722	112.06	97.0	413.0	DB00228	approved; investigational; vet_approved	Enflurane	FC(F)OC(F)(F)C(F)Cl
5181	sp|P9WQA5|Y2971_MY	Q14722	112.06	97.0	413.0	DB01069	approved; investigational	Promethazine	CN(C)C(C)CN1c(cccc2)c2Sc(c13)cccc3
5182	sp|P9WQA5|Y2971_MY	Q14722	112.06	97.0	413.0	DB01110	approved; investigational; vet_approved	Miconazole	Clc1cc(Cl)c(cc1)COC(Cn2ccnc2)c3c(Cl)cc(Cl)cc3
5183	sp|P9WQA5|Y2971_MY	P80874	102.84	23.0	313.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
5184	sp|P9WQA5|Y2971_MY	P46336	103.19	17.0	308.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
5185	sp|P9WQA5|Y2971_MY	P76187	92.55	27.0	288.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
5186	sp|P9WHH5|STHA_MYC	P14218	99.36	3.0	468.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
5187	sp|P9WHH5|STHA_MYC	P18925	99.36	3.0	468.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
5188	sp|P9WHH5|STHA_MYC	P09622	98.5	41.0	502.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
5189	sp|P9WHH5|STHA_MYC	P09622	98.5	41.0	502.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
5190	sp|P9WHH5|STHA_MYC	P06715	94.87	3.0	447.0	DB00336	approved; investigational; vet_approved	Nitrofural	NC(=O)N/N=C/c1ccc(o1)[N+]([O-])=O
5191	sp|P9WHH5|STHA_MYC	P06715	94.87	3.0	447.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
5192	sp|P9WHH5|STHA_MYC	P00390	97.22	64.0	519.0	DB00143	approved; investigational; nutraceutical	Glutathione	OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(=O)O
5193	sp|P9WHH5|STHA_MYC	P00390	97.22	64.0	519.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
5194	sp|P9WHH5|STHA_MYC	P00390	97.22	64.0	519.0	DB00262	approved; investigational	Carmustine	ClCCNC(=O)N(N=O)CCCl
5195	sp|P9WHH5|STHA_MYC	P00390	97.22	64.0	519.0	DB01644	experimental	3,6-dihydroxy-xanthene-9-propionic acid	OC(=O)CCC1c(ccc(c2)O)c2Oc(c13)cc(O)cc3
5196	sp|P9WHH5|STHA_MYC	P00390	97.22	64.0	519.0	DB02153	experimental	3-sulfino-L-alanine	OC(=O)[C@@H](N)C[S@](=O)O
5197	sp|P9WHH5|STHA_MYC	P00390	97.22	64.0	519.0	DB02553	experimental	Glutathionylspermidine disulfide	NCCCCNCCCNC(=O)CNC(=O)[C@@H](NC(=O)CC[C@@H](N)C(=O)O)CSSC[C@H](NC(=O)CC[C@@H](N)C(=O)O)C(=O)NCC(=O)NCCCNCCCCN
5198	sp|P9WHH5|STHA_MYC	P00390	97.22	64.0	519.0	DB02895	experimental	3-(Prop-2-Ene-1-Sulfinyl)-Propene-1-Thiol	S/C=C/C[S@](=O)CC=C
5199	sp|P9WHH5|STHA_MYC	P00390	97.22	64.0	519.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
5200	sp|P9WHH5|STHA_MYC	P00390	97.22	64.0	519.0	DB03310	approved; experimental; investigational	Glutathione disulfide	OC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)NCC(=O)O)CSSC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@H](N)C(=O)O
5201	sp|P9WHH5|STHA_MYC	P00390	97.22	64.0	519.0	DB03867	experimental	3-nitro-L-tyrosine	OC(=O)[C@@H](N)Cc1cc([N+]([O-])=O)c(O)cc1
5202	sp|P9WHH5|STHA_MYC	P00390	97.22	64.0	519.0	DB07393	experimental	2-(2-PHENYL-3-PYRIDIN-2-YL-4,5,6,7-TETRAHYDRO-2H-ISOPHOSPHINDOL-1-YL)PYRIDINE	n1ccccc1-c2p(-c3ccccc3)c(c(c24)CCCC4)-c5ncccc5
5203	sp|P9WHH5|STHA_MYC	P00390	97.22	64.0	519.0	DB07714	experimental	6-(3-METHYL-1,4-DIOXO-1,4-DIHYDRONAPHTHALEN-2-YL)HEXANOIC ACID	c1cccc(c12)C(=O)C(=C(C2=O)C)CCCCCC(=O)O
5204	sp|P9WHH5|STHA_MYC	P00390	97.22	64.0	519.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
5205	sp|P9WHH5|STHA_MYC	P00390	97.22	64.0	519.0	DB09130	approved; investigational	Copper	[Cu]
5207	sp|P9WHH5|STHA_MYC	P00390	97.22	64.0	519.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
5208	sp|P9WHH5|STHA_MYC	Q51225	99.57	117.0	583.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
5209	sp|P9WHH5|STHA_MYC	Q9NNW7	100.64	38.0	509.0	DB05428	investigational	Motexafin gadolinium	CCc(c12)c(CC)c([n-]1)cc3nc(c(C)c3CCCO)cnc4c(ncc5nc(c2)c(c5C)CCCO)cc(OCCOCCOCCOC)c(c4)OCCOCCOCCOC
5210	sp|P9WHH5|STHA_MYC	Q16881	101.07	162.0	635.0	DB01169	approved; investigational	Arsenic trioxide	O=[As]O[As]=O
5211	sp|P9WHH5|STHA_MYC	Q16881	101.07	162.0	635.0	DB02338	experimental	NADPH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
5212	sp|P9WHH5|STHA_MYC	Q16881	101.07	162.0	635.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
5213	sp|P9WHH5|STHA_MYC	Q16881	101.07	162.0	635.0	DB03566	experimental	Spermidine	NCCCCNCCCN
5214	sp|P9WHH5|STHA_MYC	Q16881	101.07	162.0	635.0	DB04106	investigational	Fotemustine	CCOP(=O)(OCC)[C@@H](C)NC(=O)N(N=O)CCCl
5215	sp|P9WHH5|STHA_MYC	Q16881	101.07	162.0	635.0	DB05428	investigational	Motexafin gadolinium	CCc(c12)c(CC)c([n-]1)cc3nc(c(C)c3CCCO)cnc4c(ncc5nc(c2)c(c5C)CCCO)cc(OCCOCCOCCOC)c(c4)OCCOCCOCCOC
5216	sp|P9WHH5|STHA_MYC	Q16881	101.07	162.0	635.0	DB05448	investigational	PX-12	CCC(C)SSc1ncc[nH]1
5217	sp|P9WHH5|STHA_MYC	Q94655	104.49	3.0	492.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
5218	sp|P9WHH5|STHA_MYC	P09063	95.09	9.0	454.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
5219	sp|P9WHH5|STHA_MYC	P28593	98.72	6.0	468.0	DB02240	experimental	Quinacrine mustard	c1cc(Cl)cc(n2)c1c(c(c23)cc(OC)cc3)NC(C)CCCN(CCCl)CCCl
5220	sp|P9WHH5|STHA_MYC	P28593	98.72	6.0	468.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
5221	sp|P9WHH5|STHA_MYC	P28593	98.72	6.0	468.0	DB03470	experimental	Trypanothione	OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(=O)NCCCCNCCCNC(=O)CNC(=O)[C@H](CS)NC(=O)CC[C@H](N)C(=O)O
5222	sp|P9WHH5|STHA_MYC	P28593	98.72	6.0	468.0	DB04299	experimental	Maleic Acid	OC(=O)/C=C\C(=O)O
5224	sp|P9WHH5|STHA_MYC	Q56839	97.22	42.0	497.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
5225	sp|P9WHH5|STHA_MYC	Q56839	97.22	42.0	497.0	DB03163	experimental	2-oxopropyl-CoM	CC(=O)CSCCS(=O)(=O)O
5226	sp|P9WHH5|STHA_MYC	P37062	77.56	57.0	420.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
5227	sp|P9WHH5|STHA_MYC	P37062	77.56	57.0	420.0	DB03382	experimental	S-oxy-L-cysteine	OC(=O)[C@@H](N)CS=O
5228	sp|P9WHF7|THT2_MYC	Q5SJI0	95.29	2.0	285.0	DB02761	experimental	S-Mercaptocysteine	OC(=O)[C@@H](N)CSS
5229	sp|P9WHF7|THT2_MYC	P31142	91.25	6.0	277.0	DB02761	experimental	S-Mercaptocysteine	OC(=O)[C@@H](N)CSS
5230	sp|P9WHF7|THT2_MYC	Q16762	92.26	9.0	283.0	DB02761	experimental	S-Mercaptocysteine	OC(=O)[C@@H](N)CSS
5231	sp|P9WHF7|THT2_MYC	P52197	87.88	8.0	269.0	DB04053	experimental	Hypophosphite	[O-]P=O
5232	sp|P9WHF7|THT2_MYC	Q7K9G0	90.91	24.0	294.0	DB02761	experimental	S-Mercaptocysteine	OC(=O)[C@@H](N)CSS
5233	sp|P9WHF7|THT2_MYC	Q7K9G0	90.91	24.0	294.0	DB03352	experimental	S-Arsonocysteine	OC(=O)[C@@H](N)CS[As](=O)(O)O
5234	sp|P9WG35|TPX_MYCT	P9WG35	99.39	1.0	165.0	DB03382	experimental	S-oxy-L-cysteine	OC(=O)[C@@H](N)CS=O
5235	sp|P9WG35|TPX_MYCT	Q8P9V9	92.12	3.0	155.0	DB04640	experimental	Naphthalene-2,6-disulfonic acid	OS(=O)(=O)c(cc1)cc(c12)ccc(c2)S(=O)(=O)O
5236	sp|P9WG35|TPX_MYCT	Q06830	90.91	7.0	157.0	DB01593	approved; investigational	Zinc	[Zn]
5237	sp|P9WG35|TPX_MYCT	Q06830	90.91	7.0	157.0	DB09130	approved; investigational	Copper	[Cu]
5238	sp|P9WG35|TPX_MYCT	Q06830	90.91	7.0	157.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
5239	sp|P9WG35|TPX_MYCT	Q06830	90.91	7.0	157.0	DB14487	approved; investigational	Zinc acetate	CC([O-])=O
5240	sp|P9WG35|TPX_MYCT	Q06830	90.91	7.0	157.0	DB14533	approved; investigational	Zinc chloride	[Cl-]
5241	sp|P9WG35|TPX_MYCT	Q06830	90.91	7.0	157.0	DB14548	approved; experimental	Zinc sulfate, unspecified form	 
5242	sp|P9WG35|TPX_MYCT	P32119	90.3	7.0	156.0	DB02153	experimental	3-sulfino-L-alanine	OC(=O)[C@@H](N)C[S@](=O)O
5243	sp|P9WG35|TPX_MYCT	P32119	90.3	7.0	156.0	DB04048	experimental	N-Carbamoyl-Alanine	OC(=O)[C@@H](C)NC(=O)N
5244	sp|P9WG35|TPX_MYCT	P32119	90.3	7.0	156.0	DB09130	approved; investigational	Copper	[Cu]
5245	sp|P9WG35|TPX_MYCT	Q8IL80	91.52	5.0	156.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
5246	sp|P9WG35|TPX_MYCT	P30041	93.33	7.0	161.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
5247	sp|P9WG35|TPX_MYCT	P30041	93.33	7.0	161.0	DB09130	approved; investigational	Copper	[Cu]
5248	sp|P9WFS1|TYPH_MYC	P07650	102.11	2.0	438.0	DB03462	experimental	Thymine	Cc1c[nH]c(=O)[nH]c1=O
5249	sp|P9WFS1|TYPH_MYC	P77836	100.23	4.0	432.0	DB03419	experimental; investigational	Uracil	O=c1[nH]ccc(=O)[nH]1
5250	sp|P9WFS1|TYPH_MYC	P19971	101.87	36.0	471.0	DB09343	approved; investigational	Tipiracil	O=c1[nH]c(=O)[nH]c(c1Cl)CN2CCCC2=N
5251	sp|P9WHH1|TRXB_MYC	P66010	89.85	5.0	306.0	DB00548	approved	Azelaic acid	OC(=O)CCCCCCCC(=O)O
5252	sp|P9WHH1|TRXB_MYC	P35340	93.13	206.0	518.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
5253	sp|P9WHH1|TRXB_MYC	P19480	92.54	207.0	517.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
5254	sp|P9WHH1|TRXB_MYC	P0A9P4	92.24	8.0	317.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
5255	sp|P9WHH1|TRXB_MYC	P09622	108.96	28.0	393.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
5256	sp|P9WHH1|TRXB_MYC	P09622	108.96	28.0	393.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
5257	sp|P9WHH1|TRXB_MYC	P18925	105.97	3.0	358.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
5258	sp|P9WHH1|TRXB_MYC	P14218	105.97	3.0	358.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
5259	sp|P9WHH1|TRXB_MYC	P00390	103.88	64.0	412.0	DB00143	approved; investigational; nutraceutical	Glutathione	OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(=O)O
5260	sp|P9WHH1|TRXB_MYC	P00390	103.88	64.0	412.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
5261	sp|P9WHH1|TRXB_MYC	P00390	103.88	64.0	412.0	DB00262	approved; investigational	Carmustine	ClCCNC(=O)N(N=O)CCCl
5262	sp|P9WHH1|TRXB_MYC	P00390	103.88	64.0	412.0	DB01644	experimental	3,6-dihydroxy-xanthene-9-propionic acid	OC(=O)CCC1c(ccc(c2)O)c2Oc(c13)cc(O)cc3
5263	sp|P9WHH1|TRXB_MYC	P00390	103.88	64.0	412.0	DB02153	experimental	3-sulfino-L-alanine	OC(=O)[C@@H](N)C[S@](=O)O
5264	sp|P9WHH1|TRXB_MYC	P00390	103.88	64.0	412.0	DB02553	experimental	Glutathionylspermidine disulfide	NCCCCNCCCNC(=O)CNC(=O)[C@@H](NC(=O)CC[C@@H](N)C(=O)O)CSSC[C@H](NC(=O)CC[C@@H](N)C(=O)O)C(=O)NCC(=O)NCCCNCCCCN
5265	sp|P9WHH1|TRXB_MYC	P00390	103.88	64.0	412.0	DB02895	experimental	3-(Prop-2-Ene-1-Sulfinyl)-Propene-1-Thiol	S/C=C/C[S@](=O)CC=C
5266	sp|P9WHH1|TRXB_MYC	P00390	103.88	64.0	412.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
5267	sp|P9WHH1|TRXB_MYC	P00390	103.88	64.0	412.0	DB03310	approved; experimental; investigational	Glutathione disulfide	OC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)NCC(=O)O)CSSC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@H](N)C(=O)O
5268	sp|P9WHH1|TRXB_MYC	P00390	103.88	64.0	412.0	DB03867	experimental	3-nitro-L-tyrosine	OC(=O)[C@@H](N)Cc1cc([N+]([O-])=O)c(O)cc1
5269	sp|P9WHH1|TRXB_MYC	P00390	103.88	64.0	412.0	DB07393	experimental	2-(2-PHENYL-3-PYRIDIN-2-YL-4,5,6,7-TETRAHYDRO-2H-ISOPHOSPHINDOL-1-YL)PYRIDINE	n1ccccc1-c2p(-c3ccccc3)c(c(c24)CCCC4)-c5ncccc5
5270	sp|P9WHH1|TRXB_MYC	P00390	103.88	64.0	412.0	DB07714	experimental	6-(3-METHYL-1,4-DIOXO-1,4-DIHYDRONAPHTHALEN-2-YL)HEXANOIC ACID	c1cccc(c12)C(=O)C(=C(C2=O)C)CCCCCC(=O)O
5271	sp|P9WHH1|TRXB_MYC	P00390	103.88	64.0	412.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
5272	sp|P9WHH1|TRXB_MYC	P00390	103.88	64.0	412.0	DB09130	approved; investigational	Copper	[Cu]
5274	sp|P9WHH1|TRXB_MYC	P00390	103.88	64.0	412.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
5275	sp|P9WHH1|TRXB_MYC	P06715	94.03	3.0	318.0	DB00336	approved; investigational; vet_approved	Nitrofural	NC(=O)N/N=C/c1ccc(o1)[N+]([O-])=O
5276	sp|P9WHH1|TRXB_MYC	P06715	94.03	3.0	318.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
5277	sp|P9WHH1|TRXB_MYC	Q51225	105.97	116.0	471.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
5278	sp|P9WHH1|TRXB_MYC	P09063	99.7	7.0	341.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
5279	sp|P9WHH1|TRXB_MYC	Q9NNW7	108.06	34.0	396.0	DB05428	investigational	Motexafin gadolinium	CCc(c12)c(CC)c([n-]1)cc3nc(c(C)c3CCCO)cnc4c(ncc5nc(c2)c(c5C)CCCO)cc(OCCOCCOCCOC)c(c4)OCCOCCOCCOC
5280	sp|P9WHH1|TRXB_MYC	Q94655	94.93	2.0	320.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
5281	sp|P9WHH1|TRXB_MYC	Q16881	105.37	159.0	512.0	DB01169	approved; investigational	Arsenic trioxide	O=[As]O[As]=O
5282	sp|P9WHH1|TRXB_MYC	Q16881	105.37	159.0	512.0	DB02338	experimental	NADPH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
5283	sp|P9WHH1|TRXB_MYC	Q16881	105.37	159.0	512.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
5284	sp|P9WHH1|TRXB_MYC	Q16881	105.37	159.0	512.0	DB03566	experimental	Spermidine	NCCCCNCCCN
5285	sp|P9WHH1|TRXB_MYC	Q16881	105.37	159.0	512.0	DB04106	investigational	Fotemustine	CCOP(=O)(OCC)[C@@H](C)NC(=O)N(N=O)CCCl
5286	sp|P9WHH1|TRXB_MYC	Q16881	105.37	159.0	512.0	DB05428	investigational	Motexafin gadolinium	CCc(c12)c(CC)c([n-]1)cc3nc(c(C)c3CCCO)cnc4c(ncc5nc(c2)c(c5C)CCCO)cc(OCCOCCOCCOC)c(c4)OCCOCCOCCOC
5287	sp|P9WHH1|TRXB_MYC	Q16881	105.37	159.0	512.0	DB05448	investigational	PX-12	CCC(C)SSc1ncc[nH]1
5288	sp|P9WHH1|TRXB_MYC	P28593	101.49	4.0	344.0	DB02240	experimental	Quinacrine mustard	c1cc(Cl)cc(n2)c1c(c(c23)cc(OC)cc3)NC(C)CCCN(CCCl)CCCl
5289	sp|P9WHH1|TRXB_MYC	P28593	101.49	4.0	344.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
5290	sp|P9WHH1|TRXB_MYC	P28593	101.49	4.0	344.0	DB03470	experimental	Trypanothione	OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(=O)NCCCCNCCCNC(=O)CNC(=O)[C@H](CS)NC(=O)CC[C@H](N)C(=O)O
5291	sp|P9WHH1|TRXB_MYC	P28593	101.49	4.0	344.0	DB04299	experimental	Maleic Acid	OC(=O)/C=C\C(=O)O
5292	sp|P9WHH1|TRXB_MYC	Q56839	100.3	40.0	376.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
5293	sp|P9WHH1|TRXB_MYC	Q56839	100.3	40.0	376.0	DB03163	experimental	2-oxopropyl-CoM	CC(=O)CSCCS(=O)(=O)O
5295	sp|P9WHH1|TRXB_MYC	P37062	87.16	3.0	295.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
5296	sp|P9WHH1|TRXB_MYC	P37062	87.16	3.0	295.0	DB03382	experimental	S-oxy-L-cysteine	OC(=O)[C@@H](N)CS=O
5297	sp|P9WHH1|TRXB_MYC	B7JBP8	89.25	2.0	301.0	DB07640	experimental	2-decyl-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione	CCCCCCCCCCC1=C(C)C(=O)C(OC)=C(C1=O)OC
5298	sp|P9WHH1|TRXB_MYC	P16640	83.88	6.0	287.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
5299	sp|P9WHH1|TRXB_MYC	Q52437	80.3	8.0	277.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
5300	sp|P9WHH1|TRXB_MYC	O95831	70.75	233.0	470.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
5301	sp|P9WHH1|TRXB_MYC	O95831	70.75	233.0	470.0	DB05282	investigational	MCC	 
5302	sp|P9WHH1|TRXB_MYC	O67931	86.87	4.0	295.0	DB07640	experimental	2-decyl-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione	CCCCCCCCCCC1=C(C)C(=O)C(OC)=C(C1=O)OC
5303	sp|O53871|Y0859_MY	Q9BWD1	97.02	5.0	396.0	DB01915	experimental	S-Hydroxycysteine	OC(=O)[C@@H](N)CSO
5304	sp|O53871|Y0859_MY	Q9BWD1	97.02	5.0	396.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
5305	sp|O53871|Y0859_MY	P07097	96.77	1.0	391.0	DB01915	experimental	S-Hydroxycysteine	OC(=O)[C@@H](N)CSO
5306	sp|O53871|Y0859_MY	P07097	96.77	1.0	391.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
5307	sp|O53871|Y0859_MY	P07097	96.77	1.0	391.0	DB02039	experimental	S-Acetyl-Cysteine	OC(=O)[C@@H](N)CSC(=O)C
5308	sp|O53871|Y0859_MY	P07097	96.77	1.0	391.0	DB02160	experimental	S-Butyryl-Cystein	OC(=O)[C@@H](N)CSC(=O)CCC
5309	sp|O53871|Y0859_MY	P07097	96.77	1.0	391.0	DB03045	experimental	Pantothenyl-Aminoethanol-Acetate Pivalic Acid	CC(=O)OCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COC(=O)C(C)(C)C
5310	sp|O53871|Y0859_MY	P07097	96.77	1.0	391.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
5311	sp|O53871|Y0859_MY	P07097	96.77	1.0	391.0	DB08328	experimental	PANTOTHENYL-AMINOETHANOL-11-PIVALIC ACID	CC(C)(C)C(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCO
5312	sp|O53871|Y0859_MY	P07097	96.77	1.0	391.0	DB08408	experimental	(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-({3-oxo-3-[(2-sulfanylethyl)amino]propyl}amino)butyl 2,2-dimethylpropanoate	CC(C)(C)C(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS
5313	sp|O53871|Y0859_MY	P28790	95.53	6.0	391.0	DB08249	experimental	3,6,9,12,15-PENTAOXATRICOSAN-1-OL	CCCCCCCCOCCOCCOCCOCCOCCO
5314	sp|O53871|Y0859_MY	P09110	95.29	36.0	420.0	DB09069	approved; investigational	Trimetazidine	COc1c(OC)c(OC)c(cc1)CN2CCNCC2
5315	sp|O53871|Y0859_MY	P24752	95.78	40.0	426.0	DB00795	approved	Sulfasalazine	OC(=O)c1cc(ccc1O)/N=N/c2ccc(cc2)S(=O)(=O)Nc3ncccc3
5316	sp|O53871|Y0859_MY	P24752	95.78	40.0	426.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
5318	sp|O53871|Y0859_MY	P24752	95.78	40.0	426.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
5319	sp|P9WIM3|Y1847_MY	Q04416	91.43	16.0	144.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
5320	sp|P9WIM3|Y1847_MY	Q04416	91.43	16.0	144.0	DB03613	experimental	4-hydroxyphenacyl coenzyme A	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSCC(=O)c4ccc(O)cc4
5321	sp|P9WIM3|Y1847_MY	Q04416	91.43	16.0	144.0	DB04067	experimental	4-hydroxybenzyl coenzyme A	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSCc4ccc(O)cc4
5322	sp|P9WIM3|Y1847_MY	Q04416	91.43	16.0	144.0	DB04242	experimental	4-hydroxybenzoic acid	OC(=O)c1ccc(O)cc1
5323	sp|P9WIM3|Y1847_MY	Q9NPJ3	82.14	18.0	133.0	DB08688	experimental	2-Undecanone	CCCCCCCCCC(=O)C
5324	sp|P9WG59|THRC_MYC	Q96GA7	83.89	16.0	318.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
5325	sp|P9WG59|THRC_MYC	P20132	83.89	7.0	309.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
5326	sp|P9WG59|THRC_MYC	P20132	83.89	7.0	309.0	DB00133	investigational; nutraceutical	Serine	OC(=O)[C@@H](N)CO
5327	sp|P9WG59|THRC_MYC	P0A2K1	91.67	56.0	386.0	DB03171	experimental	Indole-3-Propanol Phosphate	OP(=O)(O)OCCCc1c[nH]c(c12)cccc2
5328	sp|P9WG59|THRC_MYC	P0A2K1	91.67	56.0	386.0	DB04143	experimental	Indole-3-Glycerol Phosphate	OP(=O)(O)OC[C@@H](O)[C@@H](O)c1c[nH]c(c12)cccc2
5329	sp|P9WG59|THRC_MYC	P0A2K1	91.67	56.0	386.0	DB07732	experimental	2-[(2-NAPHTHYLSULFONYL)AMINO]ETHYL DIHYDROGEN PHOSPHATE	OP(=O)(O)OCCNS(=O)(=O)c(cc1)cc(c12)cccc2
5330	sp|P9WG59|THRC_MYC	P0A2K1	91.67	56.0	386.0	DB07745	experimental	2-{[4-(TRIFLUOROMETHOXY)BENZOYL]AMINO}ETHYL DIHYDROGEN PHOSPHATE	OP(=O)(O)OCCNC(=O)c1ccc(OC(F)(F)F)cc1
5331	sp|P9WG59|THRC_MYC	P0A2K1	91.67	56.0	386.0	DB07748	experimental	2-({[4-(TRIFLUOROMETHOXY)PHENYL]SULFONYL}AMINO)ETHYL DIHYDROGEN PHOSPHATE	OP(=O)(O)OCCNS(=O)(=O)c1ccc(OC(F)(F)F)cc1
5332	sp|P9WG59|THRC_MYC	P0A2K1	91.67	56.0	386.0	DB07773	experimental	5-FLUOROINDOLE PROPANOL PHOSPHATE	OP(=O)(O)OCCCc1c[nH]c(c12)ccc(F)c2
5333	sp|P9WG59|THRC_MYC	P0A2K1	91.67	56.0	386.0	DB07890	experimental	4-(2-HYDROXYPHENYLTHIO)-1-BUTENYLPHOSPHONIC ACID	Oc1ccccc1SCC/C=C/P(=O)(O)O
5334	sp|P9WG59|THRC_MYC	P0A2K1	91.67	56.0	386.0	DB07894	experimental	4-(2-HYDROXY-4-FLUOROPHENYLTHIO)-BUTYLPHOSPHONIC ACID	Oc1ccc(F)cc1SCC/C=C/P(=O)(O)O
5335	sp|P9WG59|THRC_MYC	P0A2K1	91.67	56.0	386.0	DB07925	experimental	4-(2-HYDROXYPHENYLSULFINYL)-BUTYLPHOSPHONIC ACID	Oc1ccccc1[S@](=O)CCCCP(=O)(O)O
5336	sp|P9WG59|THRC_MYC	P0A2K1	91.67	56.0	386.0	DB07951	experimental	N-(indole-3-acetyl)-L-aspartic acid	OC(=O)C[C@@H](C(=O)O)NC(=O)Cc1c[nH]c(c12)cccc2
5337	sp|P9WG59|THRC_MYC	P0A2K1	91.67	56.0	386.0	DB07952	experimental	N-[1H-INDOL-3-YL-ACETYL]GLYCINE ACID	OC(=O)CNC(=O)Cc1c[nH]c(c12)cccc2
5338	sp|P9WG59|THRC_MYC	P0A2K1	91.67	56.0	386.0	DB07953	experimental	N-[1H-INDOL-3-YL-ACETYL]VALINE ACID	CC(C)[C@@H](C(=O)O)NC(=O)Cc1c[nH]c(c12)cccc2
5339	sp|P9WG59|THRC_MYC	Q00740	86.67	11.0	323.0	DB01735	experimental	3-Chloroalaninate	[O-]C(=O)[C@H]([NH3+])CCl
5340	sp|P9WG59|THRC_MYC	Q00740	86.67	11.0	323.0	DB01804	experimental	2-Ammoniobut-3-Enoate, 2-Amino-3-Butenoate	[O-]C(=O)[C@H]([NH3+])C=C
5341	sp|P9WG59|THRC_MYC	Q00740	86.67	11.0	323.0	DB02085	experimental	1-Aminocyclopropanecarboxylic Acid	OC(=O)C1(N)CC1
5342	sp|P9WG59|THRC_MYC	Q00740	86.67	11.0	323.0	DB03053	experimental	1-Aminocyclopropylphosphonate	OP([O-])(=O)C1(N)CC1
5343	sp|P9WG59|THRC_MYC	Q00740	86.67	11.0	323.0	DB04212	experimental	2-Iminiopropanoate	CC(=[NH2+])C([O-])=O
5344	sp|P9WG59|THRC_MYC	Q00740	86.67	11.0	323.0	DB04553	experimental	2-Oxobutanoic Acid	CCC(=O)C(=O)O
5345	sp|P9WG59|THRC_MYC	Q9GZT4	81.11	25.0	317.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
5346	sp|P9WG59|THRC_MYC	Q9GZT4	81.11	25.0	317.0	DB00133	investigational; nutraceutical	Serine	OC(=O)[C@@H](N)CO
5347	sp|P9WG59|THRC_MYC	P35520	80.56	83.0	373.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
5348	sp|P9WG59|THRC_MYC	P35520	80.56	83.0	373.0	DB00118	approved; investigational; nutraceutical	Ademetionine	[O-]C(=O)[C@@H](N)CC[S+](C)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
5349	sp|P9WG59|THRC_MYC	P35520	80.56	83.0	373.0	DB00133	investigational; nutraceutical	Serine	OC(=O)[C@@H](N)CO
5350	sp|P9WG59|THRC_MYC	P35520	80.56	83.0	373.0	DB00151	approved; nutraceutical	Cysteine	OC(=O)[C@@H](N)CS
5351	sp|Q6MX01|WHB7A_MY	P02788	82.61	19.0	95.0	DB01811	experimental	3h-Indole-5,6-Diol	Oc(c1)c(O)cc(c12)cc[nH]2
5352	sp|Q6MX01|WHB7A_MY	P02788	82.61	19.0	95.0	DB03017	approved; experimental	Lauric acid	CCCCCCCCCCCC(=O)O
5353	sp|Q6MX01|WHB7A_MY	P02788	82.61	19.0	95.0	DB03040	experimental	Nitrilotriacetic acid	OC(=O)CN(CC(=O)O)CC(=O)O
5354	sp|Q6MX01|WHB7A_MY	P02788	82.61	19.0	95.0	DB03485	experimental	alpha-D-Fucopyranose	C[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O
5355	sp|Q6MX01|WHB7A_MY	P02788	82.61	19.0	95.0	DB04743	approved; investigational; withdrawn	Nimesulide	CS(=O)(=O)Nc1c(cc([N+]([O-])=O)cc1)Oc2ccccc2
5356	sp|Q6MX01|WHB7A_MY	P02788	82.61	19.0	95.0	DB06987	experimental	(R)-Atenolol	CC(C)NC[C@@H](O)COc1ccc(cc1)CC(=O)N
5357	sp|Q6MX01|WHB7A_MY	P02788	82.61	19.0	95.0	DB08439	approved	Parecoxib	CCC(=O)NS(=O)(=O)c1ccc(cc1)-c2c(C)onc2-c3ccccc3
5358	sp|Q6MX01|WHB7A_MY	P02788	72.83	356.0	423.0	DB01811	experimental	3h-Indole-5,6-Diol	Oc(c1)c(O)cc(c12)cc[nH]2
5359	sp|Q6MX01|WHB7A_MY	P02788	72.83	356.0	423.0	DB03017	approved; experimental	Lauric acid	CCCCCCCCCCCC(=O)O
5360	sp|Q6MX01|WHB7A_MY	P02788	72.83	356.0	423.0	DB03040	experimental	Nitrilotriacetic acid	OC(=O)CN(CC(=O)O)CC(=O)O
5361	sp|Q6MX01|WHB7A_MY	P02788	72.83	356.0	423.0	DB03485	experimental	alpha-D-Fucopyranose	C[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O
5362	sp|Q6MX01|WHB7A_MY	P02788	72.83	356.0	423.0	DB04743	approved; investigational; withdrawn	Nimesulide	CS(=O)(=O)Nc1c(cc([N+]([O-])=O)cc1)Oc2ccccc2
5363	sp|Q6MX01|WHB7A_MY	P02788	72.83	356.0	423.0	DB06987	experimental	(R)-Atenolol	CC(C)NC[C@@H](O)COc1ccc(cc1)CC(=O)N
5364	sp|Q6MX01|WHB7A_MY	P02788	72.83	356.0	423.0	DB08439	approved	Parecoxib	CCC(=O)NS(=O)(=O)c1ccc(cc1)-c2c(C)onc2-c3ccccc3
5365	sp|Q6MX01|WHB7A_MY	P02787	72.83	23.0	90.0	DB00515	approved	Cisplatin	[NH3+][Pt](Cl)(Cl)[NH3+]
5366	sp|Q6MX01|WHB7A_MY	P02787	72.83	23.0	90.0	DB00677	approved; investigational; withdrawn	Isoflurophate	CC(C)OP(F)(=O)OC(C)C
5367	sp|Q6MX01|WHB7A_MY	P02787	72.83	23.0	90.0	DB01370	approved; investigational	Aluminium	[Al]
5368	sp|Q6MX01|WHB7A_MY	P02787	72.83	23.0	90.0	DB01592	approved	Iron	[Fe]
5369	sp|Q6MX01|WHB7A_MY	P02787	72.83	23.0	90.0	DB01593	approved; investigational	Zinc	[Zn]
5370	sp|Q6MX01|WHB7A_MY	P02787	72.83	23.0	90.0	DB06757	approved; nutraceutical	Manganese	[Mn+2]
5371	sp|Q6MX01|WHB7A_MY	P02787	72.83	23.0	90.0	DB09130	approved; investigational	Copper	[Cu]
5372	sp|Q6MX01|WHB7A_MY	P02787	72.83	23.0	90.0	DB11397	vet_approved	Dichlorvos	COP(=O)(OC)OC=C(Cl)Cl
5373	sp|Q6MX01|WHB7A_MY	P02787	72.83	23.0	90.0	DB14487	approved; investigational	Zinc acetate	CC([O-])=O
5374	sp|Q6MX01|WHB7A_MY	P02787	72.83	23.0	90.0	DB14488	approved	Ferrous gluconate	OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O
5375	sp|Q6MX01|WHB7A_MY	P02787	72.83	23.0	90.0	DB14489	approved	Ferrous succinate	[O-]C(=O)CCC([O-])=O
5376	sp|Q6MX01|WHB7A_MY	P02787	72.83	23.0	90.0	DB14490	approved	Ferrous ascorbate	OC[C@H](O)[C@H]1OC(=O)C(O)=C1O
5377	sp|Q6MX01|WHB7A_MY	P02787	72.83	23.0	90.0	DB14491	approved	Ferrous fumarate	[O-]C(=O)/C=C/C([O-])=O
5378	sp|Q6MX01|WHB7A_MY	P02787	72.83	23.0	90.0	DB14501	approved	Ferrous glycine sulfate	NCC([O-])=O
5379	sp|Q6MX01|WHB7A_MY	P02787	72.83	23.0	90.0	DB14517	approved; investigational	Aluminium phosphate	[O-]P([O-])([O-])=O
5380	sp|Q6MX01|WHB7A_MY	P02787	72.83	23.0	90.0	DB14518	approved; investigational	Aluminum acetate	CC([O-])=O
5381	sp|Q6MX01|WHB7A_MY	P02787	72.83	23.0	90.0	DB14533	approved; investigational	Zinc chloride	[Cl-]
5382	sp|Q6MX01|WHB7A_MY	P02787	72.83	23.0	90.0	DB14548	approved; experimental	Zinc sulfate, unspecified form	 
5383	sp|Q6MX01|WHB7A_MY	P02787	77.17	349.0	420.0	DB00515	approved	Cisplatin	[NH3+][Pt](Cl)(Cl)[NH3+]
5384	sp|Q6MX01|WHB7A_MY	P02787	77.17	349.0	420.0	DB00677	approved; investigational; withdrawn	Isoflurophate	CC(C)OP(F)(=O)OC(C)C
5385	sp|Q6MX01|WHB7A_MY	P02787	77.17	349.0	420.0	DB01370	approved; investigational	Aluminium	[Al]
5386	sp|Q6MX01|WHB7A_MY	P02787	77.17	349.0	420.0	DB01592	approved	Iron	[Fe]
5387	sp|Q6MX01|WHB7A_MY	P02787	77.17	349.0	420.0	DB01593	approved; investigational	Zinc	[Zn]
5388	sp|Q6MX01|WHB7A_MY	P02787	77.17	349.0	420.0	DB06757	approved; nutraceutical	Manganese	[Mn+2]
5389	sp|Q6MX01|WHB7A_MY	P02787	77.17	349.0	420.0	DB09130	approved; investigational	Copper	[Cu]
5390	sp|Q6MX01|WHB7A_MY	P02787	77.17	349.0	420.0	DB11397	vet_approved	Dichlorvos	COP(=O)(OC)OC=C(Cl)Cl
5391	sp|Q6MX01|WHB7A_MY	P02787	77.17	349.0	420.0	DB14487	approved; investigational	Zinc acetate	CC([O-])=O
5392	sp|Q6MX01|WHB7A_MY	P02787	77.17	349.0	420.0	DB14488	approved	Ferrous gluconate	OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O
5393	sp|Q6MX01|WHB7A_MY	P02787	77.17	349.0	420.0	DB14489	approved	Ferrous succinate	[O-]C(=O)CCC([O-])=O
5394	sp|Q6MX01|WHB7A_MY	P02787	77.17	349.0	420.0	DB14490	approved	Ferrous ascorbate	OC[C@H](O)[C@H]1OC(=O)C(O)=C1O
5395	sp|Q6MX01|WHB7A_MY	P02787	77.17	349.0	420.0	DB14491	approved	Ferrous fumarate	[O-]C(=O)/C=C/C([O-])=O
5396	sp|Q6MX01|WHB7A_MY	P02787	77.17	349.0	420.0	DB14501	approved	Ferrous glycine sulfate	NCC([O-])=O
5397	sp|Q6MX01|WHB7A_MY	P02787	77.17	349.0	420.0	DB14517	approved; investigational	Aluminium phosphate	[O-]P([O-])([O-])=O
5398	sp|Q6MX01|WHB7A_MY	P02787	77.17	349.0	420.0	DB14518	approved; investigational	Aluminum acetate	CC([O-])=O
5399	sp|Q6MX01|WHB7A_MY	P02787	77.17	349.0	420.0	DB14533	approved; investigational	Zinc chloride	[Cl-]
5400	sp|Q6MX01|WHB7A_MY	P02787	77.17	349.0	420.0	DB14548	approved; experimental	Zinc sulfate, unspecified form	 
5401	sp|P9WGQ3|Y1714_MY	Q9WYS2	92.22	5.0	254.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
5402	sp|P9WGQ3|Y1714_MY	Q9BTZ2	91.85	26.0	274.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
5403	sp|P9WGQ3|Y1714_MY	P0AEK2	88.52	2.0	241.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
5407	sp|P9WGQ3|Y1714_MY	Q92506	93.7	6.0	259.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
5408	sp|P9WGQ3|Y1714_MY	Q92506	93.7	6.0	259.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
5409	sp|P9WGQ3|Y1714_MY	Q9BY49	92.59	15.0	265.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
5410	sp|P9WGQ3|Y1714_MY	Q84EX5	91.85	3.0	251.0	DB04619	experimental	Acetophenone	CC(=O)c1ccccc1
5411	sp|P9WGQ3|Y1714_MY	Q84EX5	91.85	3.0	251.0	DB04784	experimental	(R)-1-phenylethanol	C[C@@H](O)c1ccccc1
5412	sp|P9WGQ3|Y1714_MY	P16544	93.33	6.0	258.0	DB01942	experimental; investigational	Formic acid	OC=O
5413	sp|P9WGQ3|Y1714_MY	P16544	93.33	6.0	258.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
5414	sp|P9WGQ3|Y1714_MY	P16544	93.33	6.0	258.0	DB07715	investigational	Emodin	Cc(c1)cc(O)c(c12)C(=O)c3c(C2=O)cc(O)cc3O
5415	sp|P9WGQ3|Y1714_MY	Q7Z4W1	88.52	5.0	244.0	DB02831	experimental	Dihydrogenphosphate	OP([O-])(=O)O
5416	sp|P9WGQ3|Y1714_MY	Q7Z4W1	88.52	5.0	244.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
5417	sp|P9WGQ3|Y1714_MY	P0AET8	89.63	7.0	249.0	DB02123	experimental	Glycochenodeoxycholic Acid	OC(=O)CNC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
5418	sp|P9WGQ3|Y1714_MY	P0CG22	92.96	26.0	277.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
5419	sp|P9WGQ3|Y1714_MY	P0CG22	92.96	26.0	277.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
5420	sp|P9WGQ3|Y1714_MY	P0CG22	92.96	26.0	277.0	DB03541	experimental	10-Propargyl-5,8-Dideazafolic Acid	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(CC#C)Cc(c2)ccc(c23)[nH]c(N)nc3=O
5421	sp|P9WGQ3|Y1714_MY	P0CG22	92.96	26.0	277.0	DB07689	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)NCc(cn3)nc(c34)c(N)nc(n4)N
5422	sp|P9WGQ3|Y1714_MY	P0CG22	92.96	26.0	277.0	DB07765	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)N(C)Cc(cn3)nc(c34)c(N)nc(n4)N
5423	sp|P9WGQ3|Y1714_MY	Q16698	91.85	55.0	303.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
5424	sp|P9WGQ3|Y1714_MY	Q16698	91.85	55.0	303.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
5425	sp|P9WGQ3|Y1714_MY	Q6GI75	92.96	3.0	254.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
5426	sp|P9WGQ3|Y1714_MY	Q6GI75	92.96	3.0	254.0	DB11155	approved	Triclocarban	Clc1ccc(cc1)NC(=O)Nc2cc(Cl)c(Cl)cc2
5427	sp|P9WGQ3|Y1714_MY	A0A348A0U3	92.22	4.0	253.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
5428	sp|P9WGQ3|Y1714_MY	Q99714	94.07	3.0	257.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
5429	sp|P9WGQ3|Y1714_MY	Q99714	94.07	3.0	257.0	DB02820	experimental	1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct	C1CCCCCN1C(=O)[C@H](c2ccccc2)n(c3=S)cnc(c34)nn(c4)[C@H]5C=CN(C=C5C([O-])=N)[C@@H]6O[C@@H]([C@@H](O)[C@H]6O)COP([O-])(=O)OP(=O)(O)OC[C@H]7O[C@H]([C@H]([O-])[C@@H]7[O-])n8cnc(c89)c(N)ncn9
5430	sp|P9WGQ3|Y1714_MY	Q99714	94.07	3.0	257.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
5431	sp|P9WGQ3|Y1714_MY	Q6UWP2	89.63	9.0	251.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
5433	sp|P9WGQ3|Y1714_MY	P0AEK4	91.48	4.0	251.0	DB01691	experimental	Indole Naphthyridinone	c1cccc(c12)n(C)cc2CN(C)C(=O)/C=C/c(c3)cnc(c34)NC(=O)CC4
5434	sp|P9WGQ3|Y1714_MY	P0AEK4	91.48	4.0	251.0	DB01865	experimental	3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide	c1cccc(c12)cc(n2C)CN(C)C(=O)/C=C/c3cnc(N)cc3
5435	sp|P9WGQ3|Y1714_MY	P0AEK4	91.48	4.0	251.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
5436	sp|P9WGQ3|Y1714_MY	P0AEK4	91.48	4.0	251.0	DB03030	experimental	4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole	Cc1ccc(cc1)Cn2cnc(c2)-c3cccs3
5437	sp|P9WGQ3|Y1714_MY	P0AEK4	91.48	4.0	251.0	DB03534	experimental	3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide	CC(=O)N(C)Cc1c(N)ccc(c1)C(=O)N(C)Cc(n2C)cc(c23)cccc3
5438	sp|P9WGQ3|Y1714_MY	P0AEK4	91.48	4.0	251.0	DB04030	experimental	1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole	Oc1ccc(cc1)Cn2c(c3c(c24)cccc4)CN(CC3)C(=O)c5ccc(O)cc5
5439	sp|P9WGQ3|Y1714_MY	P0AEK4	91.48	4.0	251.0	DB08265	experimental	2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL	Cc1ccc(cc1)S(=O)(=O)n(b2O)ncc(c23)cccc3
5440	sp|P9WGQ3|Y1714_MY	P0AEK4	91.48	4.0	251.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
5441	sp|P9WGQ3|Y1714_MY	P0AEK4	91.48	4.0	251.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
5442	sp|P9WGQ3|Y1714_MY	Q7AUG5	88.89	3.0	243.0	DB04782	experimental	(S)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@H]2CO2
5443	sp|P9WGQ3|Y1714_MY	Q93D82	88.89	3.0	243.0	DB04472	experimental	(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol	[N-]=[N+]=NC[C@H](O)c1ccc([N+]([O-])=O)cc1
5444	sp|P9WGQ3|Y1714_MY	Q93D82	88.89	3.0	243.0	DB04499	experimental	(R)-styrene oxide	C1O[C@@H]1c2ccccc2
5445	sp|P9WGQ3|Y1714_MY	Q93D82	88.89	3.0	243.0	DB04777	experimental	(R)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@@H]2CO2
5446	sp|P9WGQ3|Y1714_MY	O24990	91.48	4.0	251.0	DB04393	experimental	Soneclosan	Clc1cc(O)c(cc1)Oc2ccc(Cl)cc2
5447	sp|P9WGQ3|Y1714_MY	O24990	91.48	4.0	251.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
5448	sp|P9WGQ3|Y1714_MY	Q8TC12	76.67	35.0	242.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
5449	sp|P9WGQ3|Y1714_MY	Q8NBQ5	73.7	30.0	229.0	DB02854	experimental	Aetiocholanolone	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](CC3)C[C@H](O)CC4
5450	sp|P9WGQ3|Y1714_MY	Q9HBH5	92.96	41.0	292.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
5451	sp|P9WGQ3|Y1714_MY	Q96NR8	77.78	29.0	239.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
5452	sp|P9WGQ3|Y1714_MY	Q01782	101.85	8.0	283.0	DB02338	experimental	NADPH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
5453	sp|P9WGQ3|Y1714_MY	Q01782	101.85	8.0	283.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
5454	sp|P9WGQ3|Y1714_MY	Q01782	101.85	8.0	283.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
5455	sp|P9WGQ3|Y1714_MY	Q01782	101.85	8.0	283.0	DB04400	experimental	L-erythro-7,8-dihydrobiopterin	C[C@H](O)[C@H](O)C(CN1)=Nc(c12)c(=O)nc([nH]2)N
5456	sp|P9WGQ3|Y1714_MY	Q8NBN7	76.67	34.0	241.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
5457	sp|P9WGQ3|Y1714_MY	Q8I814	95.19	14.0	271.0	DB02015	experimental	Dihydrofolic Acid	O=c1[nH]c(N)nc(c12)NCC(=N2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
5458	sp|P9WGQ3|Y1714_MY	Q8I814	95.19	14.0	271.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
5459	sp|P9WGQ3|Y1714_MY	Q02338	80.0	49.0	265.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
5460	sp|P9WGQ3|Y1714_MY	O75911	84.07	34.0	261.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
5461	sp|P9WGQ3|Y1714_MY	P51659	75.19	6.0	209.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
5462	sp|P9WGQ3|Y1714_MY	P51659	75.19	6.0	209.0	DB03192	experimental	(R)-3-hydroxydecanoyl-CoA	CCCCCCC[C@@H](O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
5463	sp|P9WGQ3|Y1714_MY	P28845	75.19	24.0	227.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
5464	sp|P9WGQ3|Y1714_MY	P28845	75.19	24.0	227.0	DB02329	experimental	Carbenoxolone	OC(=O)CCC(=O)O[C@@H](CC1)C(C)(C)[C@@H]([C@]12C)CC[C@]3(C)[C@@H]2C(=O)C=C4[C@H]5[C@@](C)(CC[C@@]34C)CC[C@](C5)(C)C(=O)O
5465	sp|P9WGQ3|Y1714_MY	P28845	75.19	24.0	227.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
5466	sp|P9WGQ3|Y1714_MY	P28845	75.19	24.0	227.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
5467	sp|P9WGQ3|Y1714_MY	P28845	75.19	24.0	227.0	DB04652	experimental	Corticosterone	OCC(=O)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H]([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
5468	sp|P9WGQ3|Y1714_MY	P28845	75.19	24.0	227.0	DB05064	investigational	INCB13739	 
5469	sp|P9WGQ3|Y1714_MY	P28845	75.19	24.0	227.0	DB06992	experimental	(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone	Cc1ccc(cc1F)-c2nc(ccc2)C(=O)N(CC3(C)C)CCC3
5470	sp|P9WGQ3|Y1714_MY	P28845	75.19	24.0	227.0	DB07017	experimental	(5S)-2-{[(1S)-1-(4-Fluorophenyl)ethyl]amino}-5-(2-hydroxy-2-propanyl)-5-methyl-1,3-thiazol-4(5H)-one	Fc1ccc(cc1)[C@H](C)NC(=NC2=O)S[C@@]2(C)C(C)(C)O
5471	sp|P9WGQ3|Y1714_MY	P28845	75.19	24.0	227.0	DB07049	experimental	(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine	[O-][N+](=O)c1ccc(cc1)N2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)C(C)(C)C
5472	sp|P9WGQ3|Y1714_MY	P28845	75.19	24.0	227.0	DB07056	experimental	2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide	CCN(CC)C(=O)Cc1cccc(n1)NS(=O)(=O)c2c(C)c(Cl)ccc2
5473	sp|P9WGQ3|Y1714_MY	P28845	75.19	24.0	227.0	DB07310	experimental	(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one	Fc1ccccc1[C@H](C)NC(=NC2=O)S[C@]2(C)C(F)(F)F
5474	sp|P9WGQ3|Y1714_MY	P28845	75.19	24.0	227.0	DB07316	experimental	N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)C3CCN(CC3)CC4(CC4)C(=O)N
5475	sp|P9WGQ3|Y1714_MY	P28845	75.19	24.0	227.0	DB07619	experimental	N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)[C@H]3CC[C@@H](CC3)c4cccnc4
5476	sp|P9WGQ3|Y1714_MY	P28845	75.19	24.0	227.0	DB07624	experimental	1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide	C1CC1(C(=O)N)CN2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)[C@](C)(O)C(F)(F)F
5477	sp|P9WGQ3|Y1714_MY	P28845	75.19	24.0	227.0	DB07866	experimental	(5S)-2-(Cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one	CCC[C@]1(C)SC(=NC1=O)NC2CCCCCCC2
5478	sp|P9WGQ3|Y1714_MY	P28845	75.19	24.0	227.0	DB08277	experimental	2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE	CS(=O)(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4c(Cl)cc(F)cc4
5479	sp|P9WGQ3|Y1714_MY	P28845	75.19	24.0	227.0	DB08280	experimental	(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE	NC(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4ccc(OC)cc4
5480	sp|P9WGQ3|Y1714_MY	P28845	75.19	24.0	227.0	DB08771	experimental	(5R)-2-[(2-Fluorophenyl)amino]-5-isopropyl-1,3-thiazol-4(5H)-one	CC(C)[C@H]1SC(=NC1=O)Nc2c(F)cccc2
5481	sp|P9WGQ3|Y1714_MY	P28845	75.19	24.0	227.0	DB13751	approved; experimental	Glycyrrhizic acid	C1C[C@](C)(C(=O)O)C[C@H]([C@]12C)C=3[C@@](C)(CC2)[C@@]4(C)[C@H](C(=O)C3)[C@]5(C)[C@@H](CC4)C(C)(C)[C@H](CC5)O[C@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O[C@@H]7O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]7O
5482	sp|P9WGQ3|Y1714_MY	Q9NYR8	71.11	6.0	198.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
5483	sp|P9WGQ3|Y1714_MY	P9WGR1	96.3	5.0	265.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
5484	sp|P9WGQ3|Y1714_MY	P9WGR1	96.3	5.0	265.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
5485	sp|P9WGQ3|Y1714_MY	P9WGR1	96.3	5.0	265.0	DB02990	experimental	S-(2-Acetamidoethyl) hexadecanethioate	CCCCCCCCCCCCCCCC(=O)SCCNC(=O)C
5486	sp|P9WGQ3|Y1714_MY	P9WGR1	96.3	5.0	265.0	DB04289	experimental	Genz-10850	[nH]1ccc(c12)cc(cc2)C(=O)N3CCN(CC3)C4c(cccc5)c5c(c46)cccc6
5487	sp|P9WGQ3|Y1714_MY	P9WGR1	96.3	5.0	265.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
5488	sp|P9WGQ3|Y1714_MY	P9WGR1	96.3	5.0	265.0	DB07090	experimental	(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cccc(c1C)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
5489	sp|P9WGQ3|Y1714_MY	P9WGR1	96.3	5.0	265.0	DB07123	experimental	N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE	Cc1ccc(cc1)C(=O)N2CCC(CC2)Cc3ccccc3
5490	sp|P9WGQ3|Y1714_MY	P9WGR1	96.3	5.0	265.0	DB07155	experimental	(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE	c1ccccc1NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
5491	sp|P9WGQ3|Y1714_MY	P9WGR1	96.3	5.0	265.0	DB07178	experimental	5-PENTYL-2-PHENOXYPHENOL	CCCCCc1cc(O)c(cc1)Oc2ccccc2
5492	sp|P9WGQ3|Y1714_MY	P9WGR1	96.3	5.0	265.0	DB07188	experimental	(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(cc(Cl)c1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
5493	sp|P9WGQ3|Y1714_MY	P9WGR1	96.3	5.0	265.0	DB07192	experimental	(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Brc1cc(ccc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
5494	sp|P9WGQ3|Y1714_MY	P9WGR1	96.3	5.0	265.0	DB07222	experimental	(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(c(C)cc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
5495	sp|P9WGQ3|Y1714_MY	P9WGR1	96.3	5.0	265.0	DB07287	experimental	2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL	c1cccnc1Cc2cc(O)c(cc2)Oc3ccc(Cl)cc3Cl
5496	sp|P9WGQ3|Y1714_MY	P9WGR1	96.3	5.0	265.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
5497	sp|P9WGQ3|Y1714_MY	P14061	73.7	2.0	201.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
5498	sp|P9WGQ3|Y1714_MY	P14061	73.7	2.0	201.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
5499	sp|P9WGQ3|Y1714_MY	P14061	73.7	2.0	201.0	DB01561	experimental; illicit	Androstanedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
5500	sp|P9WGQ3|Y1714_MY	P14061	73.7	2.0	201.0	DB02187	experimental	Equilin	O=C1CC[C@H]([C@@]12C)C=3[C@H](CC2)c4c(CC3)cc(O)cc4
5501	sp|P9WGQ3|Y1714_MY	P14061	73.7	2.0	201.0	DB02323	experimental	EM-1745	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)C[C@@H]([C@@H]4O)CCCCCCCCC(=O)OC[C@H]5O[C@H]([C@H](O)[C@@H]5O)n6cnc(c67)c(N)ncn7
5502	sp|P9WGQ3|Y1714_MY	P14061	73.7	2.0	201.0	DB02901	illicit; investigational	Stanolone	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
5503	sp|P9WGQ3|Y1714_MY	P14061	73.7	2.0	201.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
5504	sp|P9WGQ3|Y1714_MY	P14061	73.7	2.0	201.0	DB13951	experimental	Stanolone acetate	CC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
5505	sp|P9WGQ3|Y1714_MY	P80365	76.3	77.0	283.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
5506	sp|P9WGQ3|Y1714_MY	P80365	76.3	77.0	283.0	DB01185	approved; illicit	Fluoxymesterone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@](F)([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
5507	sp|P9WGQ3|Y1714_MY	P80365	76.3	77.0	283.0	DB01569	experimental; illicit	Formebolone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@H]([C@@H](C2)O)[C@]4(C)C(CC3)=CC(=O)C(C=O)=C4
5508	sp|P9WGQ3|Y1714_MY	P80365	76.3	77.0	283.0	DB14538	experimental; vet_approved	Hydrocortisone aceponate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CC)C(=O)COC(=O)C
5509	sp|P9WGQ3|Y1714_MY	P80365	76.3	77.0	283.0	DB14539	approved; vet_approved	Hydrocortisone acetate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)C
5510	sp|P9WGQ3|Y1714_MY	P80365	76.3	77.0	283.0	DB14540	approved; vet_approved	Hydrocortisone butyrate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCC
5511	sp|P9WGQ3|Y1714_MY	P80365	76.3	77.0	283.0	DB14541	approved; investigational; vet_approved	Hydrocortisone cypionate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)CCC5CCCC5
5512	sp|P9WGQ3|Y1714_MY	P80365	76.3	77.0	283.0	DB14542	approved; vet_approved	Hydrocortisone phosphate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COP(=O)(O)O
5513	sp|P9WGQ3|Y1714_MY	P80365	76.3	77.0	283.0	DB14543	approved; vet_approved	Hydrocortisone probutate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CCC)C(=O)COC(=O)CC
5514	sp|P9WGQ3|Y1714_MY	P80365	76.3	77.0	283.0	DB14544	approved; vet_approved	Hydrocortisone valerate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCCC
5515	sp|P9WGQ3|Y1714_MY	P37059	78.15	78.0	289.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
5516	sp|P9WGQ3|Y1714_MY	P37059	78.15	78.0	289.0	DB13952	approved; investigational; vet_approved	Estradiol acetate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)C
5517	sp|P9WGQ3|Y1714_MY	P37059	78.15	78.0	289.0	DB13953	approved; investigational; vet_approved	Estradiol benzoate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)c5ccccc5
5518	sp|P9WGQ3|Y1714_MY	P37059	78.15	78.0	289.0	DB13954	approved; investigational; vet_approved	Estradiol cypionate	C1CCCC1CCC(=O)O[C@H]2CC[C@H]([C@@]23C)[C@H]4[C@H](CC3)c5c(CC4)cc(O)cc5
5519	sp|P9WGQ3|Y1714_MY	P37059	78.15	78.0	289.0	DB13955	approved; investigational; vet_approved	Estradiol dienanthate	CCCCCCC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)CCCCCC
5520	sp|P9WGQ3|Y1714_MY	P37059	78.15	78.0	289.0	DB13956	approved; investigational; vet_approved	Estradiol valerate	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)CC[C@@H]4OC(=O)CCCC
5521	sp|P9WGQ3|Y1714_MY	P37058	72.22	48.0	243.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
5522	sp|P9WGQ3|Y1714_MY	P56937	87.04	2.0	237.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
5523	sp|P9WGQ3|Y1714_MY	P16152	88.89	7.0	247.0	DB01698	approved; experimental; investigational	Rutin	O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O[C@H]1C)OC[C@H]2O[C@H]([C@H](O)[C@@H](O)[C@@H]2O)Oc(c3=O)c(-c4cc(O)c(O)cc4)oc(c35)cc(O)cc5O
5524	sp|P9WGQ3|Y1714_MY	P16152	88.89	7.0	247.0	DB02709	investigational	Resveratrol	Oc1ccc(cc1)/C=C/c2cc(O)cc(O)c2
5525	sp|P9WGQ3|Y1714_MY	P16152	88.89	7.0	247.0	DB03394	experimental	Heptaethylene glycol	OCCOCCOCCOCCOCCOCCOCCO
5526	sp|P9WGQ3|Y1714_MY	P16152	88.89	7.0	247.0	DB03556	experimental	2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400	CCOCCOCCOCCOCCOCCOCCOCCOCCO
5527	sp|P9WGQ3|Y1714_MY	P16152	88.89	7.0	247.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
5528	sp|P9WGQ3|Y1714_MY	P16152	88.89	7.0	247.0	DB04463	experimental	3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol	n1cnc(N)c(c12)c(nn2C(C)(C)C)-c3cccc(O)c3
5529	sp|P9WGQ3|Y1714_MY	P16152	88.89	7.0	247.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
5530	sp|P9WGQ3|Y1714_MY	P16152	88.89	7.0	247.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
5531	sp|P9WGQ3|Y1714_MY	P35270	88.89	6.0	246.0	DB02637	experimental	Oxaloacetate Ion	OC(=O)C(=O)CC([O-])=O
5532	sp|P9WGQ3|Y1714_MY	P35270	88.89	6.0	246.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
5533	sp|P9WGQ3|Y1714_MY	P35270	88.89	6.0	246.0	DB03886	experimental	Biopterin	C[C@@H](O)[C@@H](O)c(n1)cnc(c12)nc(N)[nH]c2=O
5534	sp|P9WGQ3|Y1714_MY	P35270	88.89	6.0	246.0	DB04275	experimental	N-acetylserotonin	CC(=O)NCCc1c[nH]c(c12)ccc(c2)O
5535	sp|P9WGQ3|Y1714_MY	Q8T8E9	71.85	2.0	196.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
5536	sp|P9WGQ3|Y1714_MY	P26391	70.74	3.0	194.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
5537	sp|P9WKI3|Y1843_MY	P12268	95.82	24.0	483.0	DB01033	approved	Mercaptopurine	[nH]1cnc(c12)[nH]cnc2=S
5538	sp|P9WKI3|Y1843_MY	P12268	95.82	24.0	483.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
5539	sp|P9WKI3|Y1843_MY	P12268	95.82	24.0	483.0	DB00688	approved; investigational	Mycophenolate mofetil	C1OC(=O)c(c12)c(O)c(c(c2C)OC)C/C=C(\C)CCC(=O)OCCN3CCOCC3
5540	sp|P9WKI3|Y1843_MY	P12268	95.82	24.0	483.0	DB00811	approved	Ribavirin	NC(=O)c1nn(cn1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O
5541	sp|P9WKI3|Y1843_MY	P12268	95.82	24.0	483.0	DB01024	approved	Mycophenolic acid	C1OC(=O)c(c12)c(O)c(c(c2C)OC)C/C=C(\C)CCC(=O)O
5542	sp|P9WKI3|Y1843_MY	P12268	95.82	24.0	483.0	DB03070	experimental	Selenazole-4-carboxyamide-adenine dinucleotide	NC(=O)c1c[se]c(n1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
5543	sp|P9WKI3|Y1843_MY	P12268	95.82	24.0	483.0	DB03948	experimental	6-Chloropurine Riboside, 5'-Monophosphate	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(Cl)[nH+]cn3
5544	sp|P9WKI3|Y1843_MY	P12268	95.82	24.0	483.0	DB04566	experimental	Inosinic Acid	OP(=O)(O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O1)n2cnc(c23)c(=O)[nH]cn3
5545	sp|P9WKI3|Y1843_MY	P12268	95.82	24.0	483.0	DB06103	investigational	VX-148	 
5546	sp|P9WKI3|Y1843_MY	P20839	95.62	25.0	483.0	DB01033	approved	Mercaptopurine	[nH]1cnc(c12)[nH]cnc2=S
5547	sp|P9WKI3|Y1843_MY	P20839	95.62	25.0	483.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
5548	sp|P9WKI3|Y1843_MY	P20839	95.62	25.0	483.0	DB00688	approved; investigational	Mycophenolate mofetil	C1OC(=O)c(c12)c(O)c(c(c2C)OC)C/C=C(\C)CCC(=O)OCCN3CCOCC3
5549	sp|P9WKI3|Y1843_MY	P20839	95.62	25.0	483.0	DB00811	approved	Ribavirin	NC(=O)c1nn(cn1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O
5550	sp|P9WKI3|Y1843_MY	P20839	95.62	25.0	483.0	DB01024	approved	Mycophenolic acid	C1OC(=O)c(c12)c(O)c(c(c2C)OC)C/C=C(\C)CCC(=O)O
5551	sp|P9WKI3|Y1843_MY	P20839	95.62	25.0	483.0	DB03948	experimental	6-Chloropurine Riboside, 5'-Monophosphate	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(Cl)[nH+]cn3
5552	sp|P9WKI3|Y1843_MY	P20839	95.62	25.0	483.0	DB06103	investigational	VX-148	 
5553	sp|P9WKI3|Y1843_MY	P20839	95.62	25.0	483.0	DB06408	investigational	Taribavirin	NC(=N)c1nn(cn1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O
5554	sp|P9WKI3|Y1843_MY	P0C0H6	99.37	4.0	480.0	DB04566	experimental	Inosinic Acid	OP(=O)(O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O1)n2cnc(c23)c(=O)[nH]cn3
5555	sp|P9WKI3|Y1843_MY	P0C0H6	99.37	4.0	480.0	DB04862	investigational	Merimepodib	c1ncoc1-c2c(OC)cc(cc2)NC(=O)Nc3cccc(c3)CNC(=O)O[C@H]4CCOC4
5556	sp|P9WGR5|Y484_MYC	Q6UWP2	99.2	10.0	259.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
5557	sp|P9WGR5|Y484_MYC	Q9BTZ2	95.22	30.0	269.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
5558	sp|P9WGR5|Y484_MYC	Q9WYS2	96.02	5.0	246.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
5559	sp|P9WGR5|Y484_MYC	P0AEK2	92.03	2.0	233.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
5563	sp|P9WGR5|Y484_MYC	Q7Z4W1	90.44	5.0	232.0	DB02831	experimental	Dihydrogenphosphate	OP([O-])(=O)O
5564	sp|P9WGR5|Y484_MYC	Q7Z4W1	90.44	5.0	232.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
5565	sp|P9WGR5|Y484_MYC	Q92506	96.02	9.0	250.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
5566	sp|P9WGR5|Y484_MYC	Q92506	96.02	9.0	250.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
5567	sp|P9WGR5|Y484_MYC	P0AET8	94.82	6.0	244.0	DB02123	experimental	Glycochenodeoxycholic Acid	OC(=O)CNC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
5568	sp|P9WGR5|Y484_MYC	P16544	97.21	4.0	248.0	DB01942	experimental; investigational	Formic acid	OC=O
5569	sp|P9WGR5|Y484_MYC	P16544	97.21	4.0	248.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
5570	sp|P9WGR5|Y484_MYC	P16544	97.21	4.0	248.0	DB07715	investigational	Emodin	Cc(c1)cc(O)c(c12)C(=O)c3c(C2=O)cc(O)cc3O
5571	sp|P9WGR5|Y484_MYC	Q84EX5	93.63	5.0	240.0	DB04619	experimental	Acetophenone	CC(=O)c1ccccc1
5572	sp|P9WGR5|Y484_MYC	Q84EX5	93.63	5.0	240.0	DB04784	experimental	(R)-1-phenylethanol	C[C@@H](O)c1ccccc1
5573	sp|P9WGR5|Y484_MYC	Q9BY49	96.02	16.0	257.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
5574	sp|P9WGR5|Y484_MYC	P0CG22	96.41	30.0	272.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
5575	sp|P9WGR5|Y484_MYC	P0CG22	96.41	30.0	272.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
5576	sp|P9WGR5|Y484_MYC	P0CG22	96.41	30.0	272.0	DB03541	experimental	10-Propargyl-5,8-Dideazafolic Acid	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(CC#C)Cc(c2)ccc(c23)[nH]c(N)nc3=O
5577	sp|P9WGR5|Y484_MYC	P0CG22	96.41	30.0	272.0	DB07689	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)NCc(cn3)nc(c34)c(N)nc(n4)N
5578	sp|P9WGR5|Y484_MYC	P0CG22	96.41	30.0	272.0	DB07765	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)N(C)Cc(cn3)nc(c34)c(N)nc(n4)N
5579	sp|P9WGR5|Y484_MYC	Q6PKH6	75.7	28.0	218.0	DB04200	experimental	Matairesinol	COc1cc(ccc1O)C[C@H]2COC(=O)[C@@H]2Cc3ccc(O)c(c3)OC
5580	sp|P9WGR5|Y484_MYC	Q8TC12	82.07	35.0	241.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
5581	sp|P9WGR5|Y484_MYC	Q16698	92.83	58.0	291.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
5582	sp|P9WGR5|Y484_MYC	Q16698	92.83	58.0	291.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
5583	sp|P9WGR5|Y484_MYC	Q02338	86.45	55.0	272.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
5584	sp|P9WGR5|Y484_MYC	Q9NYR8	96.81	4.0	247.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
5585	sp|P9WGR5|Y484_MYC	Q96NR8	82.07	33.0	239.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
5586	sp|P9WGR5|Y484_MYC	P14061	82.07	2.0	208.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
5587	sp|P9WGR5|Y484_MYC	P14061	82.07	2.0	208.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
5588	sp|P9WGR5|Y484_MYC	P14061	82.07	2.0	208.0	DB01561	experimental; illicit	Androstanedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
5589	sp|P9WGR5|Y484_MYC	P14061	82.07	2.0	208.0	DB02187	experimental	Equilin	O=C1CC[C@H]([C@@]12C)C=3[C@H](CC2)c4c(CC3)cc(O)cc4
5590	sp|P9WGR5|Y484_MYC	P14061	82.07	2.0	208.0	DB02323	experimental	EM-1745	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)C[C@@H]([C@@H]4O)CCCCCCCCC(=O)OC[C@H]5O[C@H]([C@H](O)[C@@H]5O)n6cnc(c67)c(N)ncn7
5591	sp|P9WGR5|Y484_MYC	P14061	82.07	2.0	208.0	DB02901	illicit; investigational	Stanolone	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
5592	sp|P9WGR5|Y484_MYC	P14061	82.07	2.0	208.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
5593	sp|P9WGR5|Y484_MYC	P14061	82.07	2.0	208.0	DB13951	experimental	Stanolone acetate	CC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
5594	sp|P9WGR5|Y484_MYC	Q8I814	99.2	13.0	262.0	DB02015	experimental	Dihydrofolic Acid	O=c1[nH]c(N)nc(c12)NCC(=N2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
5595	sp|P9WGR5|Y484_MYC	Q8I814	99.2	13.0	262.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
5596	sp|P9WGR5|Y484_MYC	Q8NBQ5	76.89	35.0	228.0	DB02854	experimental	Aetiocholanolone	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](CC3)C[C@H](O)CC4
5598	sp|P9WGR5|Y484_MYC	Q8NBN7	80.88	36.0	239.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
5599	sp|P9WGR5|Y484_MYC	Q7AUG5	92.83	3.0	236.0	DB04782	experimental	(S)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@H]2CO2
5600	sp|P9WGR5|Y484_MYC	Q93D82	92.83	3.0	236.0	DB04472	experimental	(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol	[N-]=[N+]=NC[C@H](O)c1ccc([N+]([O-])=O)cc1
5601	sp|P9WGR5|Y484_MYC	Q93D82	92.83	3.0	236.0	DB04499	experimental	(R)-styrene oxide	C1O[C@@H]1c2ccccc2
5602	sp|P9WGR5|Y484_MYC	Q93D82	92.83	3.0	236.0	DB04777	experimental	(R)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@@H]2CO2
5603	sp|P9WGR5|Y484_MYC	P37059	82.07	81.0	287.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
5604	sp|P9WGR5|Y484_MYC	P37059	82.07	81.0	287.0	DB13952	approved; investigational; vet_approved	Estradiol acetate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)C
5605	sp|P9WGR5|Y484_MYC	P37059	82.07	81.0	287.0	DB13953	approved; investigational; vet_approved	Estradiol benzoate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)c5ccccc5
5606	sp|P9WGR5|Y484_MYC	P37059	82.07	81.0	287.0	DB13954	approved; investigational; vet_approved	Estradiol cypionate	C1CCCC1CCC(=O)O[C@H]2CC[C@H]([C@@]23C)[C@H]4[C@H](CC3)c5c(CC4)cc(O)cc5
5607	sp|P9WGR5|Y484_MYC	P37059	82.07	81.0	287.0	DB13955	approved; investigational; vet_approved	Estradiol dienanthate	CCCCCCC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)CCCCCC
5608	sp|P9WGR5|Y484_MYC	P37059	82.07	81.0	287.0	DB13956	approved; investigational; vet_approved	Estradiol valerate	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)CC[C@@H]4OC(=O)CCCC
5609	sp|P9WGR5|Y484_MYC	P37058	77.69	47.0	242.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
5610	sp|P9WGR5|Y484_MYC	Q99714	82.07	9.0	215.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
5611	sp|P9WGR5|Y484_MYC	Q99714	82.07	9.0	215.0	DB02820	experimental	1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct	C1CCCCCN1C(=O)[C@H](c2ccccc2)n(c3=S)cnc(c34)nn(c4)[C@H]5C=CN(C=C5C([O-])=N)[C@@H]6O[C@@H]([C@@H](O)[C@H]6O)COP([O-])(=O)OP(=O)(O)OC[C@H]7O[C@H]([C@H]([O-])[C@@H]7[O-])n8cnc(c89)c(N)ncn9
5612	sp|P9WGR5|Y484_MYC	Q99714	82.07	9.0	215.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
5613	sp|P9WGR5|Y484_MYC	Q92781	84.06	27.0	238.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
5614	sp|P9WGR5|Y484_MYC	Q92781	84.06	27.0	238.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
5615	sp|P9WGR5|Y484_MYC	Q01782	106.37	8.0	275.0	DB02338	experimental	NADPH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
5616	sp|P9WGR5|Y484_MYC	Q01782	106.37	8.0	275.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
5617	sp|P9WGR5|Y484_MYC	Q01782	106.37	8.0	275.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
5618	sp|P9WGR5|Y484_MYC	Q01782	106.37	8.0	275.0	DB04400	experimental	L-erythro-7,8-dihydrobiopterin	C[C@H](O)[C@H](O)C(CN1)=Nc(c12)c(=O)nc([nH]2)N
5619	sp|P9WGR5|Y484_MYC	P28845	79.28	32.0	231.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
5620	sp|P9WGR5|Y484_MYC	P28845	79.28	32.0	231.0	DB02329	experimental	Carbenoxolone	OC(=O)CCC(=O)O[C@@H](CC1)C(C)(C)[C@@H]([C@]12C)CC[C@]3(C)[C@@H]2C(=O)C=C4[C@H]5[C@@](C)(CC[C@@]34C)CC[C@](C5)(C)C(=O)O
5621	sp|P9WGR5|Y484_MYC	P28845	79.28	32.0	231.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
5622	sp|P9WGR5|Y484_MYC	P28845	79.28	32.0	231.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
5623	sp|P9WGR5|Y484_MYC	P28845	79.28	32.0	231.0	DB04652	experimental	Corticosterone	OCC(=O)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H]([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
5624	sp|P9WGR5|Y484_MYC	P28845	79.28	32.0	231.0	DB05064	investigational	INCB13739	 
5625	sp|P9WGR5|Y484_MYC	P28845	79.28	32.0	231.0	DB06992	experimental	(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone	Cc1ccc(cc1F)-c2nc(ccc2)C(=O)N(CC3(C)C)CCC3
5626	sp|P9WGR5|Y484_MYC	P28845	79.28	32.0	231.0	DB07017	experimental	(5S)-2-{[(1S)-1-(4-Fluorophenyl)ethyl]amino}-5-(2-hydroxy-2-propanyl)-5-methyl-1,3-thiazol-4(5H)-one	Fc1ccc(cc1)[C@H](C)NC(=NC2=O)S[C@@]2(C)C(C)(C)O
5627	sp|P9WGR5|Y484_MYC	P28845	79.28	32.0	231.0	DB07049	experimental	(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine	[O-][N+](=O)c1ccc(cc1)N2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)C(C)(C)C
5628	sp|P9WGR5|Y484_MYC	P28845	79.28	32.0	231.0	DB07056	experimental	2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide	CCN(CC)C(=O)Cc1cccc(n1)NS(=O)(=O)c2c(C)c(Cl)ccc2
5629	sp|P9WGR5|Y484_MYC	P28845	79.28	32.0	231.0	DB07310	experimental	(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one	Fc1ccccc1[C@H](C)NC(=NC2=O)S[C@]2(C)C(F)(F)F
5630	sp|P9WGR5|Y484_MYC	P28845	79.28	32.0	231.0	DB07316	experimental	N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)C3CCN(CC3)CC4(CC4)C(=O)N
5631	sp|P9WGR5|Y484_MYC	P28845	79.28	32.0	231.0	DB07619	experimental	N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)[C@H]3CC[C@@H](CC3)c4cccnc4
5632	sp|P9WGR5|Y484_MYC	P28845	79.28	32.0	231.0	DB07624	experimental	1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide	C1CC1(C(=O)N)CN2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)[C@](C)(O)C(F)(F)F
5633	sp|P9WGR5|Y484_MYC	P28845	79.28	32.0	231.0	DB07866	experimental	(5S)-2-(Cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one	CCC[C@]1(C)SC(=NC1=O)NC2CCCCCCC2
5634	sp|P9WGR5|Y484_MYC	P28845	79.28	32.0	231.0	DB08277	experimental	2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE	CS(=O)(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4c(Cl)cc(F)cc4
5635	sp|P9WGR5|Y484_MYC	P28845	79.28	32.0	231.0	DB08280	experimental	(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE	NC(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4ccc(OC)cc4
5636	sp|P9WGR5|Y484_MYC	P28845	79.28	32.0	231.0	DB08771	experimental	(5R)-2-[(2-Fluorophenyl)amino]-5-isopropyl-1,3-thiazol-4(5H)-one	CC(C)[C@H]1SC(=NC1=O)Nc2c(F)cccc2
5637	sp|P9WGR5|Y484_MYC	P28845	79.28	32.0	231.0	DB13751	approved; experimental	Glycyrrhizic acid	C1C[C@](C)(C(=O)O)C[C@H]([C@]12C)C=3[C@@](C)(CC2)[C@@]4(C)[C@H](C(=O)C3)[C@]5(C)[C@@H](CC4)C(C)(C)[C@H](CC5)O[C@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O[C@@H]7O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]7O
5638	sp|P9WGR5|Y484_MYC	P0AEK4	92.83	5.0	238.0	DB01691	experimental	Indole Naphthyridinone	c1cccc(c12)n(C)cc2CN(C)C(=O)/C=C/c(c3)cnc(c34)NC(=O)CC4
5639	sp|P9WGR5|Y484_MYC	P0AEK4	92.83	5.0	238.0	DB01865	experimental	3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide	c1cccc(c12)cc(n2C)CN(C)C(=O)/C=C/c3cnc(N)cc3
5640	sp|P9WGR5|Y484_MYC	P0AEK4	92.83	5.0	238.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
5641	sp|P9WGR5|Y484_MYC	P0AEK4	92.83	5.0	238.0	DB03030	experimental	4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole	Cc1ccc(cc1)Cn2cnc(c2)-c3cccs3
5642	sp|P9WGR5|Y484_MYC	P0AEK4	92.83	5.0	238.0	DB03534	experimental	3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide	CC(=O)N(C)Cc1c(N)ccc(c1)C(=O)N(C)Cc(n2C)cc(c23)cccc3
5643	sp|P9WGR5|Y484_MYC	P0AEK4	92.83	5.0	238.0	DB04030	experimental	1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole	Oc1ccc(cc1)Cn2c(c3c(c24)cccc4)CN(CC3)C(=O)c5ccc(O)cc5
5644	sp|P9WGR5|Y484_MYC	P0AEK4	92.83	5.0	238.0	DB08265	experimental	2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL	Cc1ccc(cc1)S(=O)(=O)n(b2O)ncc(c23)cccc3
5645	sp|P9WGR5|Y484_MYC	P0AEK4	92.83	5.0	238.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
5646	sp|P9WGR5|Y484_MYC	P0AEK4	92.83	5.0	238.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
5647	sp|P9WGR5|Y484_MYC	Q9HBH5	84.86	42.0	255.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
5648	sp|P9WGR5|Y484_MYC	O75911	76.49	36.0	228.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
5649	sp|P9WGR5|Y484_MYC	P80365	78.88	81.0	279.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
5650	sp|P9WGR5|Y484_MYC	P80365	78.88	81.0	279.0	DB01185	approved; illicit	Fluoxymesterone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@](F)([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
5651	sp|P9WGR5|Y484_MYC	P80365	78.88	81.0	279.0	DB01569	experimental; illicit	Formebolone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@H]([C@@H](C2)O)[C@]4(C)C(CC3)=CC(=O)C(C=O)=C4
5652	sp|P9WGR5|Y484_MYC	P80365	78.88	81.0	279.0	DB14538	experimental; vet_approved	Hydrocortisone aceponate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CC)C(=O)COC(=O)C
5653	sp|P9WGR5|Y484_MYC	P80365	78.88	81.0	279.0	DB14539	approved; vet_approved	Hydrocortisone acetate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)C
5654	sp|P9WGR5|Y484_MYC	P80365	78.88	81.0	279.0	DB14540	approved; vet_approved	Hydrocortisone butyrate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCC
5655	sp|P9WGR5|Y484_MYC	P80365	78.88	81.0	279.0	DB14541	approved; investigational; vet_approved	Hydrocortisone cypionate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)CCC5CCCC5
5656	sp|P9WGR5|Y484_MYC	P80365	78.88	81.0	279.0	DB14542	approved; vet_approved	Hydrocortisone phosphate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COP(=O)(O)O
5657	sp|P9WGR5|Y484_MYC	P80365	78.88	81.0	279.0	DB14543	approved; vet_approved	Hydrocortisone probutate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CCC)C(=O)COC(=O)CC
5658	sp|P9WGR5|Y484_MYC	P80365	78.88	81.0	279.0	DB14544	approved; vet_approved	Hydrocortisone valerate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCCC
5659	sp|P9WGR5|Y484_MYC	A0A348A0U3	94.42	4.0	241.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
5660	sp|P9WGR5|Y484_MYC	P51659	75.3	7.0	196.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
5661	sp|P9WGR5|Y484_MYC	P51659	75.3	7.0	196.0	DB03192	experimental	(R)-3-hydroxydecanoyl-CoA	CCCCCCC[C@@H](O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
5662	sp|P9WGR5|Y484_MYC	Q6GI75	95.22	3.0	242.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
5663	sp|P9WGR5|Y484_MYC	Q6GI75	95.22	3.0	242.0	DB11155	approved	Triclocarban	Clc1ccc(cc1)NC(=O)Nc2cc(Cl)c(Cl)cc2
5664	sp|P9WGR5|Y484_MYC	P16152	98.41	6.0	253.0	DB01698	approved; experimental; investigational	Rutin	O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O[C@H]1C)OC[C@H]2O[C@H]([C@H](O)[C@@H](O)[C@@H]2O)Oc(c3=O)c(-c4cc(O)c(O)cc4)oc(c35)cc(O)cc5O
5665	sp|P9WGR5|Y484_MYC	P16152	98.41	6.0	253.0	DB02709	investigational	Resveratrol	Oc1ccc(cc1)/C=C/c2cc(O)cc(O)c2
5666	sp|P9WGR5|Y484_MYC	P16152	98.41	6.0	253.0	DB03394	experimental	Heptaethylene glycol	OCCOCCOCCOCCOCCOCCOCCO
5667	sp|P9WGR5|Y484_MYC	P16152	98.41	6.0	253.0	DB03556	experimental	2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400	CCOCCOCCOCCOCCOCCOCCOCCOCCO
5668	sp|P9WGR5|Y484_MYC	P16152	98.41	6.0	253.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
5669	sp|P9WGR5|Y484_MYC	P16152	98.41	6.0	253.0	DB04463	experimental	3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol	n1cnc(N)c(c12)c(nn2C(C)(C)C)-c3cccc(O)c3
5670	sp|P9WGR5|Y484_MYC	P16152	98.41	6.0	253.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
5671	sp|P9WGR5|Y484_MYC	P16152	98.41	6.0	253.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
5672	sp|P9WGR5|Y484_MYC	P35270	81.67	5.0	210.0	DB02637	experimental	Oxaloacetate Ion	OC(=O)C(=O)CC([O-])=O
5673	sp|P9WGR5|Y484_MYC	P35270	81.67	5.0	210.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
5674	sp|P9WGR5|Y484_MYC	P35270	81.67	5.0	210.0	DB03886	experimental	Biopterin	C[C@@H](O)[C@@H](O)c(n1)cnc(c12)nc(N)[nH]c2=O
5675	sp|P9WGR5|Y484_MYC	P35270	81.67	5.0	210.0	DB04275	experimental	N-acetylserotonin	CC(=O)NCCc1c[nH]c(c12)ccc(c2)O
5676	sp|P9WGR5|Y484_MYC	P56937	91.24	2.0	231.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
5677	sp|P9WGR5|Y484_MYC	O24990	93.23	5.0	239.0	DB04393	experimental	Soneclosan	Clc1cc(O)c(cc1)Oc2ccc(Cl)cc2
5678	sp|P9WGR5|Y484_MYC	O24990	93.23	5.0	239.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
5679	sp|P9WGR5|Y484_MYC	P9WGR1	97.21	5.0	249.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
5680	sp|P9WGR5|Y484_MYC	P9WGR1	97.21	5.0	249.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
5681	sp|P9WGR5|Y484_MYC	P9WGR1	97.21	5.0	249.0	DB02990	experimental	S-(2-Acetamidoethyl) hexadecanethioate	CCCCCCCCCCCCCCCC(=O)SCCNC(=O)C
5682	sp|P9WGR5|Y484_MYC	P9WGR1	97.21	5.0	249.0	DB04289	experimental	Genz-10850	[nH]1ccc(c12)cc(cc2)C(=O)N3CCN(CC3)C4c(cccc5)c5c(c46)cccc6
5683	sp|P9WGR5|Y484_MYC	P9WGR1	97.21	5.0	249.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
5684	sp|P9WGR5|Y484_MYC	P9WGR1	97.21	5.0	249.0	DB07090	experimental	(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cccc(c1C)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
5685	sp|P9WGR5|Y484_MYC	P9WGR1	97.21	5.0	249.0	DB07123	experimental	N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE	Cc1ccc(cc1)C(=O)N2CCC(CC2)Cc3ccccc3
5686	sp|P9WGR5|Y484_MYC	P9WGR1	97.21	5.0	249.0	DB07155	experimental	(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE	c1ccccc1NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
5687	sp|P9WGR5|Y484_MYC	P9WGR1	97.21	5.0	249.0	DB07178	experimental	5-PENTYL-2-PHENOXYPHENOL	CCCCCc1cc(O)c(cc1)Oc2ccccc2
5688	sp|P9WGR5|Y484_MYC	P9WGR1	97.21	5.0	249.0	DB07188	experimental	(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(cc(Cl)c1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
5689	sp|P9WGR5|Y484_MYC	P9WGR1	97.21	5.0	249.0	DB07192	experimental	(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Brc1cc(ccc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
5690	sp|P9WGR5|Y484_MYC	P9WGR1	97.21	5.0	249.0	DB07222	experimental	(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(c(C)cc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
5691	sp|P9WGR5|Y484_MYC	P9WGR1	97.21	5.0	249.0	DB07287	experimental	2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL	c1cccnc1Cc2cc(O)c(cc2)Oc3ccc(Cl)cc3Cl
5692	sp|P9WGR5|Y484_MYC	P9WGR1	97.21	5.0	249.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
5693	sp|P9WGR5|Y484_MYC	P09417	74.1	10.0	196.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
5694	sp|P9WGR5|Y484_MYC	P09417	74.1	10.0	196.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
5695	sp|P9WGR5|Y484_MYC	Q8T8E9	77.29	2.0	196.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
5696	sp|P9WGR5|Y484_MYC	P26391	76.1	3.0	194.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
5697	sp|P9WH63|RS12_MYC	P0A7S3	98.39	1.0	123.0	DB00452	approved	Framycetin	NC[C@@H]1O[C@@H]([C@H](N)[C@@H](O)[C@@H]1O)O[C@@H]2[C@@H](CO)O[C@H]([C@@H]2O)O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]4O[C@H](CN)[C@@H](O)[C@H](O)[C@H]4N
5698	sp|P9WH63|RS12_MYC	P0A7S3	98.39	1.0	123.0	DB00479	approved; investigational; vet_approved	Amikacin	NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O
5699	sp|P9WH63|RS12_MYC	P0A7S3	98.39	1.0	123.0	DB00560	approved	Tigecycline	O=C1C(C(=O)N)=C(O)[C@@H](N(C)C)[C@@H]([C@@]12O)C[C@H]3C(=C2O)C(=O)c4c(C3)c(N(C)C)cc(c4O)NC(=O)CNC(C)(C)C
5700	sp|P9WH63|RS12_MYC	P0A7S3	98.39	1.0	123.0	DB00684	approved; investigational	Tobramycin	NC[C@H]1O[C@@H]([C@H](N)C[C@@H]1O)O[C@@H]2[C@@H](N)C[C@@H](N)[C@@H]([C@H]2O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O
5701	sp|P9WH63|RS12_MYC	P0A7S3	98.39	1.0	123.0	DB00798	approved; vet_approved	Gentamicin	CNC(C)C1CCC(N)C(O1)OC2C(N)CC(N)C(C2O)OC(OCC3(C)O)C(O)C3NC
5702	sp|P9WH63|RS12_MYC	P0A7S3	98.39	1.0	123.0	DB00919	approved; investigational; vet_approved	Spectinomycin	O=C1C[C@@H](C)O[C@H]([C@]12O)O[C@H]3[C@H](O2)[C@@H](NC)[C@@H](O)[C@@H](NC)[C@@H]3O
5703	sp|P9WH63|RS12_MYC	P0A7S3	98.39	1.0	123.0	DB00955	approved; investigational	Netilmicin	C[C@]1(O)CO[C@@H]([C@H](O)[C@H]1NC)O[C@@H]2[C@@H](O)[C@@H]([C@@H](N)C[C@H]2NCC)O[C@H]3OC(CN)=CC[C@H]3N
5704	sp|P9WH63|RS12_MYC	P0A7S3	98.39	1.0	123.0	DB00994	approved; vet_approved	Neomycin	 
5705	sp|P9WH63|RS12_MYC	P0A7S3	98.39	1.0	123.0	DB01082	approved; vet_approved	Streptomycin	CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@H]([C@@]2(O)C=O)[C@@H](O[C@H]2C)O[C@H]3[C@H](O)[C@@H](O)[C@H](NC(N)=N)[C@@H](O)[C@@H]3NC(N)=N
5706	sp|P9WH63|RS12_MYC	P0A7S3	98.39	1.0	123.0	DB01172	approved; investigational; vet_approved	Kanamycin	NC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)O[C@@H]2[C@@H](N)C[C@@H](N)[C@@H]([C@H]2O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O
5707	sp|P9WH63|RS12_MYC	P0A7S3	98.39	1.0	123.0	DB03615	approved; experimental	Ribostamycin	O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]2[C@@H](O)[C@H](N)C[C@H](N)[C@H]2O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N
5708	sp|P9WH63|RS12_MYC	P0A7S3	98.39	1.0	123.0	DB04729	experimental	Gentamicin C1a	CN[C@@H]([C@@]1(C)O)[C@@H](O)[C@H](OC1)O[C@H]2[C@H](N)C[C@H](N)[C@H]([C@@H]2O)O[C@H]3O[C@H](CN)CC[C@H]3N
5709	sp|P9WH63|RS12_MYC	P0A7S3	98.39	1.0	123.0	DB06696	experimental; investigational	Arbekacin	NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)CC[C@H]2N)[C@H](O)[C@H]1O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O
5710	sp|P9WH63|RS12_MYC	Q5SHN3	98.39	1.0	123.0	DB08185	experimental	2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(nc(n3)SC)NCCC(C)C
5711	sp|P9WQ67|Y3778_MY	P77444	100.0	1.0	399.0	DB02345	experimental	Selenocysteine	OC(=O)[C@@H](N)C[SeH]
5712	sp|P9WQ67|Y3778_MY	P77444	100.0	1.0	399.0	DB02761	experimental	S-Mercaptocysteine	OC(=O)[C@@H](N)CSS
5713	sp|P9WQ67|Y3778_MY	P77444	100.0	1.0	399.0	DB03049	experimental	S-Selanyl Cysteine	OC(=O)[C@@H](N)CS[SeH]
5714	sp|P9WQ67|Y3778_MY	P77444	100.0	1.0	399.0	DB04217	experimental	L-2-amino-3-butynoic acid	OC(=O)[C@@H](N)C#C
5715	sp|P9WQ67|Y3778_MY	Q55793	99.5	11.0	407.0	DB02346	experimental	3'-O-N-Octanoyl-a-D-Glucopyranosyl-B-D-Fructofuranoside	OC[C@@H](O1)[C@@H](O)[C@H](O)[C@]1(CO)O[C@H]2O[C@H](CO)[C@@H](O)[C@@H]([C@H]2O)OC(=O)CCCCCCC
5716	sp|P9WQ67|Y3778_MY	Q9Y697	91.71	57.0	422.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
5717	sp|P9WQ67|Y3778_MY	Q9Y697	91.71	57.0	422.0	DB00151	approved; nutraceutical	Cysteine	OC(=O)[C@@H](N)CS
5718	sp|P9WQ67|Y3778_MY	Q9Y697	91.71	57.0	422.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
5719	sp|P9WQ67|Y3778_MY	Q9ZHG9	92.71	19.0	388.0	DB02761	experimental	S-Mercaptocysteine	OC(=O)[C@@H](N)CSS
5720	sp|P9WQ67|Y3778_MY	Q9ZHG9	92.71	19.0	388.0	DB04467	experimental	N-(5'-phosphopyridoxyl)-L-alanine	OC(=O)[C@H](C)NCc1c(COP(=O)(O)O)cnc(C)c1O
5721	sp|P9WQ67|Y3778_MY	Q96I15	84.92	29.0	367.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
5722	sp|P9WQ67|Y3778_MY	Q96EN8	92.21	37.0	404.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
5723	sp|O53368|SDHC_MYC	Q99643	81.25	47.0	164.0	DB04141	experimental	2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol	O[C@H]1[C@@H](O)[C@@H](CO)O[C@H]([C@@H]1O)OCCCCCC
5724	sp|O53368|SDHC_MYC	Q99643	81.25	47.0	164.0	DB08689	experimental	Ubiquinone Q1	COC1=C(OC)C(=O)C(=C(C)C1=O)CC=C(C)C
5725	sp|O53368|SDHC_MYC	P69054	82.64	9.0	128.0	DB04631	experimental	Atpenin A5	ClC[C@H](Cl)[C@@H](C)C[C@H](C)C(=O)c1c(O)c(OC)c([nH]c1=O)OC
5726	sp|O53368|SDHC_MYC	P69054	82.64	9.0	128.0	DB07671	experimental	2-[1-METHYLHEXYL]-4,6-DINITROPHENOL	CCCCCC(C)c1c(O)c(N(=O)=O)cc(c1)N(=O)=O
5727	sp|O53368|SDHC_MYC	P69054	82.64	9.0	128.0	DB08690	experimental	Ubiquinone Q2	COC1=C(OC)C(=O)C(=C(C)C1=O)C/C=C(\C)CCC=C(C)C
5728	sp|O53368|SDHC_MYC	P0AC44	71.53	10.0	113.0	DB04631	experimental	Atpenin A5	ClC[C@H](Cl)[C@@H](C)C[C@H](C)C(=O)c1c(O)c(OC)c([nH]c1=O)OC
5729	sp|O53368|SDHC_MYC	P0AC44	71.53	10.0	113.0	DB07671	experimental	2-[1-METHYLHEXYL]-4,6-DINITROPHENOL	CCCCCC(C)c1c(O)c(N(=O)=O)cc(c1)N(=O)=O
5730	sp|O53368|SDHC_MYC	P0AC44	71.53	10.0	113.0	DB08690	experimental	Ubiquinone Q2	COC1=C(OC)C(=O)C(=C(C)C1=O)C/C=C(\C)CCC=C(C)C
5731	sp|O53368|SDHC_MYC	P0A8Q0	80.56	9.0	125.0	DB07490	experimental	2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL	Clc1ccc(cc1)[C@@H](C)c2cc([N+]([O-])=O)cc([N+]([O-])=O)c2O
5732	sp|O53368|SDHC_MYC	P0A8Q0	80.56	9.0	125.0	DB07918	experimental	2-heptyl-4-hydroxyquinoline N-oxide	CCCCCCCc(cc1O)[n+]([O-])c(c12)cccc2
5733	sp|P9WG25|TKT_MYCT	Q81Y15	94.57	4.0	666.0	DB02078	experimental	Triglyme	COCCOCCOCCOC
5734	sp|P9WG25|TKT_MYCT	P27302	93.71	6.0	662.0	DB01987	approved; experimental	Cocarboxylase	OP([O-])(=O)O[P@](=O)(O)OCCc1c(C)[n+](cs1)Cc2cnc(C)nc2N
5735	sp|P9WFR9|TYSY_MYC	P0A884	100.0	1.0	264.0	DB02031	experimental	(6S)-5,6,7,8-tetrahydrofolic acid	O=c1[nH]c(N)nc(c12)NC[C@@H](N2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
5736	sp|P9WFR9|TYSY_MYC	P0A884	100.0	1.0	264.0	DB02223	experimental	LY231514 tetra glu	Nc([nH]1)nc(=O)c(c12)c(c[nH]2)CCc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)N[C@H](C(=O)O)CCC(=O)N[C@H](C(=O)O)CCC(=O)NC(C(=O)O)CCC(=O)O
5737	sp|P9WFR9|TYSY_MYC	P0A884	100.0	1.0	264.0	DB02256	experimental	2'-Deoxyuridine	OC[C@H]1O[C@H](C[C@@H]1O)n2ccc(=O)[nH]c2=O
5738	sp|P9WFR9|TYSY_MYC	P0A884	100.0	1.0	264.0	DB02301	experimental	5,10-Methylene-6-Hydrofolic Acid	Nc([nH]1)nc(=O)c(c12)N3[C@H](C=N2)CN(C3)c4ccc(cc4)C(=O)N[C@@H](C(=O)O)CCC(=O)O
5739	sp|P9WFR9|TYSY_MYC	P0A884	100.0	1.0	264.0	DB02467	experimental	L-methionine (S)-S-oxide	C[S@](=O)CC[C@@H](C([O-])=O)[NH3+]
5740	sp|P9WFR9|TYSY_MYC	P0A884	100.0	1.0	264.0	DB02752	experimental	Tosyl-D-Proline	OC(=O)[C@H]1CCCN1S(=O)(=O)c2ccc(C)cc2
5741	sp|P9WFR9|TYSY_MYC	P0A884	100.0	1.0	264.0	DB02899	experimental	N-Carboxymethionine	OC(=O)N[C@H](C(=O)O)CCSC
5742	sp|P9WFR9|TYSY_MYC	P0A884	100.0	1.0	264.0	DB03038	experimental	LY341770	Nc([nH]1)nc(=O)c(c12)c(c[nH]2)CCc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCc4n[nH]nn4
5743	sp|P9WFR9|TYSY_MYC	P0A884	100.0	1.0	264.0	DB03157	experimental	N,O-Didansyl-L-Tyrosine	c1ccc(N(C)C)c(c12)cccc2S(=O)(=O)N[C@H](C(=O)O)Cc3ccc(cc3)OS(=O)(=O)c4cccc(c45)c(N(C)C)ccc5
5744	sp|P9WFR9|TYSY_MYC	P0A884	100.0	1.0	264.0	DB03274	experimental	2',5'-Dideoxyuridine	O=c1[nH]c(=O)n(cc1)[C@H]2C[C@H](O)[C@H](O2)C
5745	sp|P9WFR9|TYSY_MYC	P0A884	100.0	1.0	264.0	DB03541	experimental	10-Propargyl-5,8-Dideazafolic Acid	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(CC#C)Cc(c2)ccc(c23)[nH]c(N)nc3=O
5746	sp|P9WFR9|TYSY_MYC	P0A884	100.0	1.0	264.0	DB03558	experimental	SP-876	OC(=O)CCNC(=O)[C@H]1CCCN1S(=O)(=O)c2ccc(cc2)C(=O)N[C@H](C(=O)O)CCC(=O)O
5747	sp|P9WFR9|TYSY_MYC	P0A884	100.0	1.0	264.0	DB03761	experimental	5-fluoro-2'-deoxyuridine-5'-monophosphate	OP(=O)(O)OC[C@H]1O[C@H](C[C@@H]1O)n2cc(F)c(=O)[nH]c2=O
5748	sp|P9WFR9|TYSY_MYC	P0A884	100.0	1.0	264.0	DB03800	experimental	Deoxyuridine monophosphate	OP(=O)(O)OC[C@H]1O[C@H](C[C@@H]1O)n2ccc(=O)[nH]c2=O
5749	sp|P9WFR9|TYSY_MYC	P0A884	100.0	1.0	264.0	DB03818	experimental	N-[Tosyl-D-Prolinyl]Amino-Ethanethiol	SCCNC(=O)[C@H]1CCCN1S(=O)(=O)c2ccc(C)cc2
5750	sp|P9WFR9|TYSY_MYC	P0A884	100.0	1.0	264.0	DB04447	experimental	1,4-Dithiothreitol	SC[C@H](O)[C@@H](O)CS
5751	sp|P9WFR9|TYSY_MYC	P0A884	100.0	1.0	264.0	DB04457	experimental	2'-Deoxyguanosine-5'-Monophosphate	Nc([nH]1)nc(=O)c(c12)ncn2[C@H]3C[C@H](O)[C@H](O3)COP(=O)(O)O
5752	sp|P9WFR9|TYSY_MYC	P0A884	100.0	1.0	264.0	DB04503	experimental	Sp-722	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)S(=O)(=O)N2CCC[C@@H]2C(=O)O
5753	sp|P9WFR9|TYSY_MYC	P0A884	100.0	1.0	264.0	DB04530	experimental	S,S-(2-Hydroxyethyl)Thiocysteine	OC(=O)[C@@H](N)CSSCCO
5754	sp|P9WFR9|TYSY_MYC	P0A884	100.0	1.0	264.0	DB04586	experimental	o-Bromophenol	Oc1ccccc1Br
5755	sp|P9WFR9|TYSY_MYC	P0A884	100.0	1.0	264.0	DB04696	experimental	4-CHLORO-3',3''-DIBROMOPHENOL-1,8-NAPHTHALEIN	c1c(Br)c(O)ccc1C2(c(cc3Br)ccc3O)OC(=O)c4ccc(Cl)c(c4c25)ccc5
5756	sp|P9WFR9|TYSY_MYC	P0A884	100.0	1.0	264.0	DB08131	experimental	2-{4-[2-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYLAMINO}-3-METHYL-BUTYRIC ACID	CC(C)[C@@H](C(=O)O)NC(=O)c1ccc(cc1)CCc2c[nH]c(c23)nc(N)[nH]c3=O
5757	sp|P9WFR9|TYSY_MYC	P04818	106.84	32.0	313.0	DB00293	approved; investigational	Raltitrexed	Cc([nH]1)nc(=O)c(c12)cc(cc2)CN(C)c3ccc(s3)C(=O)N[C@H](C(=O)O)CCC(=O)O
5758	sp|P9WFR9|TYSY_MYC	P04818	106.84	32.0	313.0	DB00322	approved	Floxuridine	OC[C@H]1O[C@H](C[C@@H]1O)n2cc(F)c(=O)[nH]c2=O
5759	sp|P9WFR9|TYSY_MYC	P04818	106.84	32.0	313.0	DB00432	approved; investigational	Trifluridine	OC[C@H]1O[C@H](C[C@@H]1O)n2cc(C(F)(F)F)c(=O)[nH]c2=O
5760	sp|P9WFR9|TYSY_MYC	P04818	106.84	32.0	313.0	DB00441	approved	Gemcitabine	Nc1nc(=O)n(cc1)[C@@H](C2(F)F)O[C@H](CO)[C@H]2O
5761	sp|P9WFR9|TYSY_MYC	P04818	106.84	32.0	313.0	DB00544	approved	Fluorouracil	Fc1c[nH]c(=O)[nH]c1=O
5762	sp|P9WFR9|TYSY_MYC	P04818	106.84	32.0	313.0	DB00563	approved	Methotrexate	Nc1nc(N)nc(c12)ncc(n2)CN(C)c3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
5763	sp|P9WFR9|TYSY_MYC	P04818	106.84	32.0	313.0	DB00642	approved; investigational	Pemetrexed	Nc([nH]1)nc(=O)c(c12)c(c[nH]2)CCc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
5764	sp|P9WFR9|TYSY_MYC	P04818	106.84	32.0	313.0	DB01101	approved; investigational	Capecitabine	CCCCCOC(=O)Nc1nc(=O)n(cc1F)[C@@H]2O[C@H](C)[C@@H](O)[C@H]2O
5765	sp|P9WFR9|TYSY_MYC	P04818	106.84	32.0	313.0	DB01643	experimental	Thymidine monophosphate	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)O
5766	sp|P9WFR9|TYSY_MYC	P04818	106.84	32.0	313.0	DB03541	experimental	10-Propargyl-5,8-Dideazafolic Acid	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(CC#C)Cc(c2)ccc(c23)[nH]c(N)nc3=O
5767	sp|P9WFR9|TYSY_MYC	P04818	106.84	32.0	313.0	DB03800	experimental	Deoxyuridine monophosphate	OP(=O)(O)OC[C@H]1O[C@H](C[C@@H]1O)n2ccc(=O)[nH]c2=O
5768	sp|P9WFR9|TYSY_MYC	P04818	106.84	32.0	313.0	DB04530	experimental	S,S-(2-Hydroxyethyl)Thiocysteine	OC(=O)[C@@H](N)CSSCCO
5769	sp|P9WFR9|TYSY_MYC	P04818	106.84	32.0	313.0	DB05116	investigational	Thymectacin	c1ccccc1OP(=O)(N[C@@H](C)C(=O)OC)OC[C@H]2O[C@H](C[C@@H]2O)n3cc(/C=C/Br)c(=O)[nH]c3=O
5770	sp|P9WFR9|TYSY_MYC	P04818	106.84	32.0	313.0	DB05308	investigational	ANX-510	 
5771	sp|P9WFR9|TYSY_MYC	P04818	106.84	32.0	313.0	DB05457	investigational	OSI-7904L	 
5772	sp|P9WFR9|TYSY_MYC	P04818	106.84	32.0	313.0	DB06813	approved; investigational	Pralatrexate	Nc1nc(N)nc(c12)ncc(n2)CC(CC#C)c3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
5773	sp|P9WFR9|TYSY_MYC	P04818	106.84	32.0	313.0	DB07577	experimental	2,4-Diamino-5-phenyl-6-ethylpyrimidine	Nc1nc(CC)c(c(n1)N)-c2ccccc2
5774	sp|P9WFR9|TYSY_MYC	P04818	106.84	32.0	313.0	DB08478	experimental	N-[2-Chloro-5-(trifluoromethyl)phenyl]imidodicarbonimidic diamide	NC(N)=N/C(N)=N/c1c(Cl)ccc(c1)C(F)(F)F
5775	sp|P9WFR9|TYSY_MYC	P04818	106.84	32.0	313.0	DB08479	experimental	N-(3,5-dimethoxyphenyl)imidodicarbonimidic diamide	COc1cc(OC)cc(c1)NC(=N)NC(N)=N
5776	sp|P9WFR9|TYSY_MYC	P04818	106.84	32.0	313.0	DB08734	experimental	6,6-DIMETHYL-1-[3-(2,4,5-TRICHLOROPHENOXY)PROPOXY]-1,6-DIHYDRO-1,3,5-TRIAZINE-2,4-DIAMINE	CC1(C)N=C(N)N=C(N)N1OCCCOc2cc(Cl)c(Cl)cc2Cl
5777	sp|P9WFR9|TYSY_MYC	P04818	106.84	32.0	313.0	DB09256	approved; investigational	Tegafur	O=c1[nH]c(=O)n(cc1F)C2CCCO2
5778	sp|P9WFR9|TYSY_MYC	P04818	106.84	32.0	313.0	DB09327	approved; investigational	Tegafur-uracil	O=c1[nH]c(=O)n(cc1F)C2CCCO2
5779	sp|P9WFR9|TYSY_MYC	P00469	118.63	4.0	316.0	DB01643	experimental	Thymidine monophosphate	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)O
5780	sp|P9WFR9|TYSY_MYC	P00469	118.63	4.0	316.0	DB02301	experimental	5,10-Methylene-6-Hydrofolic Acid	Nc([nH]1)nc(=O)c(c12)N3[C@H](C=N2)CN(C3)c4ccc(cc4)C(=O)N[C@@H](C(=O)O)CCC(=O)O
5781	sp|P9WFR9|TYSY_MYC	P00469	118.63	4.0	316.0	DB03541	experimental	10-Propargyl-5,8-Dideazafolic Acid	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(CC#C)Cc(c2)ccc(c23)[nH]c(N)nc3=O
5782	sp|P9WFR9|TYSY_MYC	P00469	118.63	4.0	316.0	DB03685	experimental	Uridine monophosphate	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2ccc(=O)[nH]c2=O
5783	sp|P9WFR9|TYSY_MYC	P00469	118.63	4.0	316.0	DB03761	experimental	5-fluoro-2'-deoxyuridine-5'-monophosphate	OP(=O)(O)OC[C@H]1O[C@H](C[C@@H]1O)n2cc(F)c(=O)[nH]c2=O
5784	sp|P9WFR9|TYSY_MYC	P00469	118.63	4.0	316.0	DB03798	experimental	2'-Deoxycytidine-5'-Monophosphate	Nc1nc(=O)n(cc1)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)O
5785	sp|P9WFR9|TYSY_MYC	P00469	118.63	4.0	316.0	DB03800	experimental	Deoxyuridine monophosphate	OP(=O)(O)OC[C@H]1O[C@H](C[C@@H]1O)n2ccc(=O)[nH]c2=O
5786	sp|P9WFR9|TYSY_MYC	P00469	118.63	4.0	316.0	DB06860	experimental	2-(2-chloropyridin-4-yl)-4-methyl-1H-isoindole-1,3(2H)-dione	c1ccc(C)c(c12)C(=O)N(C2=O)c3ccnc(Cl)c3
5787	sp|P9WFR9|TYSY_MYC	P00469	118.63	4.0	316.0	DB07507	experimental	2-(4-hydroxybiphenyl-3-yl)-4-methyl-1H-isoindole-1,3(2H)-dione	c1ccc(C)c(c12)C(=O)N(C2=O)c3cc(ccc3O)-c4ccccc4
5788	sp|P9WFR9|TYSY_MYC	P00469	118.63	4.0	316.0	DB07511	experimental	4-(4-methyl-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)benzonitrile	c1ccc(C)c(c12)C(=O)N(C2=O)c3ccc(C#N)cc3
5789	sp|P9WFR9|TYSY_MYC	P00469	118.63	4.0	316.0	DB08204	experimental	3-DIPHENOL-6-NITRO-3H-BENZO[DE]ISOCHROMEN-1-ONE	c1cc(O)ccc1C2(c(cc3)ccc3O)OC(=O)c4cccc(c4c25)c([N+]([O-])=O)cc5
5790	sp|P9WFR9|TYSY_MYC	P13100	110.27	7.0	297.0	DB03541	experimental	10-Propargyl-5,8-Dideazafolic Acid	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(CC#C)Cc(c2)ccc(c23)[nH]c(N)nc3=O
5791	sp|P9WFR9|TYSY_MYC	P13100	110.27	7.0	297.0	DB03800	experimental	Deoxyuridine monophosphate	OP(=O)(O)OC[C@H]1O[C@H](C[C@@H]1O)n2ccc(=O)[nH]c2=O
5792	sp|P9WFR9|TYSY_MYC	P13922	106.46	327.0	607.0	DB00205	approved; investigational; vet_approved	Pyrimethamine	Nc1nc(CC)c(c(n1)N)-c2ccc(Cl)cc2
5793	sp|P9WFR9|TYSY_MYC	P13922	106.46	327.0	607.0	DB01131	approved	Proguanil	CC(C)NC(=N)NC(=N)Nc1ccc(Cl)cc1
5794	sp|P9WFR9|TYSY_MYC	P13922	106.46	327.0	607.0	DB01299	approved; investigational	Sulfadoxine	COc1ncnc(c1OC)NS(=O)(=O)c2ccc(N)cc2
5795	sp|P9WFR9|TYSY_MYC	P12461	115.59	11.0	315.0	DB01099	approved; investigational	Flucytosine	Nc1c(F)cnc(=O)[nH]1
5796	sp|P9WFR9|TYSY_MYC	P0CI79	103.42	7.0	279.0	DB03761	experimental	5-fluoro-2'-deoxyuridine-5'-monophosphate	OP(=O)(O)OC[C@H]1O[C@H](C[C@@H]1O)n2cc(F)c(=O)[nH]c2=O
5797	sp|P9WFR9|TYSY_MYC	P08773	74.14	27.0	222.0	DB03798	experimental	2'-Deoxycytidine-5'-Monophosphate	Nc1nc(=O)n(cc1)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)O
5799	sp|P9WGU5|Y1280_MY	P06202	72.42	96.0	524.0	DB07365	experimental	1-Naphthyl-L-alanine	OC(=O)[C@@H](N)Cc1cccc(c12)cccc2
5800	sp|P9WGU5|Y1280_MY	Q9X0V0	71.57	89.0	512.0	DB01942	experimental; investigational	Formic acid	OC=O
5801	sp|P9WGU5|Y1280_MY	P33590	71.57	83.0	506.0	DB03374	experimental	3,5-Diiodotyrosine	OC(=O)[C@@H](N)Cc1cc(I)c(O)c(I)c1
5802	sp|P9WPQ5|BIOD_MYC	P9WPQ5	99.56	1.0	226.0	DB03775	experimental	Dethiobiotin	C[C@@H]1NC(=O)N[C@@H]1CCCCCC(=O)O
5803	sp|P9WPQ5|BIOD_MYC	P13000	83.63	6.0	195.0	DB01715	experimental	7,8-Diamino-Nonanoic Acid	C[C@H](N)[C@H](N)CCCCCC(=O)O
5804	sp|P9WPQ5|BIOD_MYC	P13000	83.63	6.0	195.0	DB02927	experimental	Mixed Carbamic Phosphoric Acid Anhydride of 7,8-Diaminononanic Acid	OP(=O)(O)OC(=O)N[C@@H]([C@H](C)N)CCCCCC(=O)O
5805	sp|P9WPQ5|BIOD_MYC	P13000	83.63	6.0	195.0	DB02941	experimental	3-(1-Aminoethyl)Nonanedioic Acid	OC(=O)C[C@@H]([C@H](C)N)CCCCCC(=O)O
5806	sp|P9WPQ5|BIOD_MYC	P13000	83.63	6.0	195.0	DB03624	experimental	7-(Carboxyamino)-8-Amino-Nonanoic Acid	OC(=O)N[C@@H]([C@H](C)N)CCCCCC(=O)O
5807	sp|P9WPQ5|BIOD_MYC	P13000	83.63	6.0	195.0	DB03775	experimental	Dethiobiotin	C[C@@H]1NC(=O)N[C@@H]1CCCCCC(=O)O
5808	sp|P9WKK7|ACEA_MYC	P9WKK7	99.77	1.0	428.0	DB04343	experimental	Glyoxylic acid	OC(=O)C=O
5809	sp|P9WNV7|DNAJ2_MY	Q8IL88	89.01	26.0	366.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
5810	sp|P9WPM3|CP138_MY	P08684	101.36	39.0	486.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
5811	sp|P9WPM3|CP138_MY	P08684	101.36	39.0	486.0	DB00143	approved; investigational; nutraceutical	Glutathione	OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(=O)O
5812	sp|P9WPM3|CP138_MY	P08684	101.36	39.0	486.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
5813	sp|P9WPM3|CP138_MY	P08684	101.36	39.0	486.0	DB05478	investigational	Pradefovir mesylate	n1cnc(N)c(c12)ncn2CCOC[P@@]3(=O)OCC[C@H](O3)c4cc(Cl)ccc4
5814	sp|P9WPM3|CP138_MY	P08684	101.36	39.0	486.0	DB06634	investigational	Casopitant	FC(F)(F)c1cc(cc(c1)C(F)(F)F)[C@@H](C)N(C)C(=O)N2CC[C@H](N3CCN(CC3)C(=O)C)C[C@@H]2c4ccc(F)cc4C
5815	sp|P9WPM3|CP138_MY	P10632	98.64	28.0	463.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
5816	sp|P9WPM3|CP138_MY	P10632	98.64	28.0	463.0	DB03796	approved	Palmitic Acid	CCCCCCCCCCCCCCCC(=O)O
5817	sp|P9WPM3|CP138_MY	P10632	98.64	28.0	463.0	DB08607	experimental	(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE	O=C1NC(=O)S[C@@H]1Cc2ccc(cc2)OC[C@@](O3)(C)CCc(c34)c(C)c(O)c(C)c4C
5818	sp|P9WPM3|CP138_MY	P24462	98.64	39.0	474.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
5819	sp|P9WPM3|CP138_MY	P24462	98.64	39.0	474.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
5820	sp|P9WPM3|CP138_MY	P24462	98.64	39.0	474.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
5821	sp|P9WPM3|CP138_MY	P11712	98.64	28.0	463.0	DB03317	experimental	Ferroheme C	[Fe-2]123[N+]4=C5C=C6[N+]1=C(C(C)=C6C(C)S)C=C7[N+]2=C(C(=C7C)CCC(=O)O)C=C8[N+]3=C(C=C4C(=C5C)C(C)S)C(C)=C8CCC(=O)O
5822	sp|P9WPM3|CP138_MY	P11712	98.64	28.0	463.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
5823	sp|P9WPM3|CP138_MY	P11712	98.64	28.0	463.0	DB12319	investigational; withdrawn	Benzbromarone	c1cccc(c12)c(c(o2)CC)C(=O)c3cc(Br)c(O)c(Br)c3
5824	sp|P9WPM3|CP138_MY	P33261	98.19	28.0	461.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
5825	sp|P9WPM3|CP138_MY	P33261	98.19	28.0	461.0	DB12319	investigational; withdrawn	Benzbromarone	c1cccc(c12)c(c(o2)CC)C(=O)c3cc(Br)c(O)c(Br)c3
5826	sp|P9WPM3|CP138_MY	P20815	101.13	39.0	485.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
5827	sp|P9WPM3|CP138_MY	P20815	101.13	39.0	485.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
5828	sp|P9WPM3|CP138_MY	P20815	101.13	39.0	485.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
5829	sp|P9WPM3|CP138_MY	P33260	98.64	28.0	463.0	DB07670	experimental	N,4-Dimethyl-N-(1-phenyl-1H-pyrazol-5-yl)benzenesulfonamide	Cc1ccc(cc1)S(=O)(=O)N(C)c2ccnn2-c3ccccc3
5830	sp|P9WPM3|CP138_MY	Q9HB55	101.36	39.0	486.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
5831	sp|P9WPM3|CP138_MY	P20813	98.64	29.0	464.0	DB02974	experimental	4-(4-Chlorophenyl)Imidazole	Clc1ccc(cc1)-c2cnc[nH]2
5832	sp|P9WPM3|CP138_MY	P20813	98.64	29.0	464.0	DB04664	experimental	Cyclohexyl-pentyl-maltoside	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@@H]2CO)OCCCCCC3CCCCC3
5833	sp|P9WPM3|CP138_MY	P20813	98.64	29.0	464.0	DB04794	approved; investigational	Bifonazole	c1ccccc1C(n2ccnc2)c3ccc(cc3)-c4ccccc4
5834	sp|P9WPM3|CP138_MY	P20813	98.64	29.0	464.0	DB08369	experimental	1-(biphenyl-4-ylmethyl)-1H-imidazole	c1cncn1Cc2ccc(cc2)-c3ccccc3
5835	sp|P9WPM3|CP138_MY	P05181	98.87	29.0	465.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
5836	sp|P9WPM3|CP138_MY	P11509	100.68	32.0	476.0	DB04665	experimental	Coumarin	c1cc(=O)oc(c12)cccc2
5837	sp|P9WPM3|CP138_MY	P11509	100.68	32.0	476.0	DB07609	experimental	N,N-DIMETHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	CN(C)Cc1ccc(o1)-c2cccnc2
5838	sp|P9WPM3|CP138_MY	P11509	100.68	32.0	476.0	DB07617	experimental	N-METHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	CNCc1ccc(o1)-c2cccnc2
5839	sp|P9WPM3|CP138_MY	P11509	100.68	32.0	476.0	DB07621	experimental	(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	NCc1ccc(o1)-c2cccnc2
5840	sp|P9WPM3|CP138_MY	P11509	100.68	32.0	476.0	DB07623	experimental	4,4'-DIPYRIDYL DISULFIDE	c1cnccc1SSc2ccncc2
5841	sp|P9WPM3|CP138_MY	P04798	103.63	32.0	489.0	DB02342	investigational	2-Methoxyestradiol	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)c(c4)OC
5842	sp|P9WPM3|CP138_MY	P04798	103.63	32.0	489.0	DB12379	investigational	Indirubin	c1cccc(c12)NC(=O)C\2=C(C3=O)\Nc(c34)cccc4
5843	sp|P9WPM3|CP138_MY	P04798	103.63	32.0	489.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
5844	sp|P9WPM3|CP138_MY	O43174	100.68	40.0	484.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
5845	sp|P9WPM3|CP138_MY	O43174	100.68	40.0	484.0	DB13083	investigational	Talarozole	c1ncnn1C(C(CC)CC)c2ccc(cc2)Nc(s3)nc(c34)cccc4
5846	sp|P9WPM3|CP138_MY	Q6V0L0	104.54	45.0	506.0	DB00523	approved; investigational	Alitretinoin	OC(=O)/C=C(\C)/C=C/C=C(/C)\C=C\C(C1(C)C)=C(C)CCC1
5847	sp|P9WPM3|CP138_MY	Q6V0L0	104.54	45.0	506.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
5848	sp|P9WPM3|CP138_MY	P05177	103.85	35.0	493.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
5849	sp|P9WPM3|CP138_MY	P05177	103.85	35.0	493.0	DB07453	experimental	alpha-Naphthoflavone	c1ccccc1-c(cc2=O)oc(c23)c4c(cc3)cccc4
5850	sp|P9WPM3|CP138_MY	P05177	103.85	35.0	493.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
5851	sp|P9WPM3|CP138_MY	P05177	103.85	35.0	493.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
5852	sp|P9WPM3|CP138_MY	P05177	103.85	35.0	493.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
5853	sp|P9WPM3|CP138_MY	P10614	101.81	56.0	505.0	DB06890	experimental	(2R)-2-PHENYL-N-PYRIDIN-4-YLBUTANAMIDE	c1ccccc1[C@@H](CC)C(=O)Nc2ccncc2
5854	sp|P9WPM3|CP138_MY	P10614	101.81	56.0	505.0	DB07560	experimental	N-[(1S)-2-methyl-1-(pyridin-4-ylcarbamoyl)propyl]cyclohexanecarboxamide	c1cnccc1NC(=O)[C@H](C(C)C)NC(=O)C2CCCCC2
5855	sp|P9WPM3|CP138_MY	P10614	101.81	56.0	505.0	DB07568	experimental	(2S)-2-[(2,1,3-BENZOTHIADIAZOL-4-YLSULFONYL)AMINO]-2-PHENYL-N-PYRIDIN-4-YLACETAMIDE	n1snc(c12)cccc2S(=O)(=O)N[C@@H](c3ccccc3)C(=O)Nc4ccncc4
5856	sp|P9WPM3|CP138_MY	P10614	101.81	56.0	505.0	DB07569	experimental	CIS-4-METHYL-N-[(1S)-3-(METHYLSULFANYL)-1-(PYRIDIN-4-YLCARBAMOYL)PROPYL]CYCLOHEXANECARBOXAMIDE	c1cnccc1NC(=O)[C@H](CCSC)NC(=O)[C@@H]2CC[C@H](C)CC2
5857	sp|P9WPM3|CP138_MY	P10614	101.81	56.0	505.0	DB07572	experimental	3-{[(4-methylphenyl)sulfonyl]amino}propyl pyridin-4-ylcarbamate	Cc1ccc(cc1)S(=O)(=O)NCCCOC(=O)Nc2ccncc2
5858	sp|P9WPM3|CP138_MY	P10614	101.81	56.0	505.0	DB07635	experimental	4,4'-Dihydroxybenzophenone	Oc1ccc(cc1)C(=O)c2ccc(O)cc2
5859	sp|P9WPM3|CP138_MY	Q9NR63	100.23	45.0	487.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
5860	sp|P9WPM3|CP138_MY	P10635	102.72	31.0	484.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
5861	sp|P9WPM3|CP138_MY	P10635	102.72	31.0	484.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
5862	sp|P9WPM3|CP138_MY	P10635	102.72	31.0	484.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
5863	sp|P9WPM3|CP138_MY	Q16850	98.87	53.0	489.0	DB01007	approved	Tioconazole	c1nccn1CC(c(c(Cl)c2)ccc2Cl)OCc3c(Cl)scc3
5864	sp|P9WPM3|CP138_MY	Q16850	98.87	53.0	489.0	DB01167	approved; investigational	Itraconazole	CCC(C)n1ncn(c1=O)-c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@@H](CO5)O[C@@]5(Cn6cncn6)c7ccc(Cl)cc7Cl
5865	sp|P9WPM3|CP138_MY	Q16850	98.87	53.0	489.0	DB05667	investigational	Levoketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OC[C@H](CO3)O[C@]3(Cn4ccnc4)c5ccc(Cl)cc5Cl
5866	sp|P9WPM3|CP138_MY	Q16850	98.87	53.0	489.0	DB07705	experimental	(S)-econazole	Clc1ccc(cc1)CO[C@H](Cn2ccnc2)c3c(Cl)cc(Cl)cc3
5867	sp|P9WPM3|CP138_MY	P50859	101.59	57.0	505.0	DB01026	approved; investigational	Ketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OCC(CO3)OC3(Cn4ccnc4)c5ccc(Cl)cc5Cl
5868	sp|P9WPM3|CP138_MY	P50859	101.59	57.0	505.0	DB01167	approved; investigational	Itraconazole	CCC(C)n1ncn(c1=O)-c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@@H](CO5)O[C@@]5(Cn6cncn6)c7ccc(Cl)cc7Cl
5869	sp|P9WPM3|CP138_MY	P50859	101.59	57.0	505.0	DB09040	approved	Efinaconazole	C=C1CCN(CC1)[C@H](C)[C@](O)(Cn2cncn2)c3c(F)cc(F)cc3
5870	sp|P9WPM3|CP138_MY	P50859	101.59	57.0	505.0	DB11633	approved; investigational	Isavuconazole	c1ncnn1C[C@](O)(c2c(F)ccc(F)c2)[C@@H](C)c3nc(cs3)-c4ccc(C#N)cc4
5871	sp|P9WPM3|CP138_MY	P05093	102.95	23.0	477.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
5872	sp|P9WPM3|CP138_MY	P05093	102.95	23.0	477.0	DB00396	approved; vet_approved	Progesterone	CC(=O)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
5873	sp|P9WPM3|CP138_MY	P05093	102.95	23.0	477.0	DB00421	approved	Spironolactone	C1CC(=O)O[C@@]12[C@]3(C)[C@@H](CC2)[C@H]4[C@H](CC3)[C@]5(C)C(=CC(=O)CC5)C[C@H]4SC(=O)C
5874	sp|P9WPM3|CP138_MY	P05093	102.95	23.0	477.0	DB01026	approved; investigational	Ketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OCC(CO3)OC3(Cn4ccnc4)c5ccc(Cl)cc5Cl
5875	sp|P9WPM3|CP138_MY	P05093	102.95	23.0	477.0	DB05812	approved	Abiraterone	C1C[C@H](O)CC([C@]12C)=CC[C@@H]3[C@@H]2CC[C@@]4(C)[C@H]3CC=C4c5cccnc5
5876	sp|P9WPM3|CP138_MY	P05093	102.95	23.0	477.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
5878	sp|P9WPM3|CP138_MY	P05093	102.95	23.0	477.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
5879	sp|P9WPM3|CP138_MY	Q16678	105.44	50.0	515.0	DB01645	investigational	Genistein	Oc1ccc(cc1)-c(c2=O)coc(c23)cc(O)cc3O
5880	sp|P9WPM3|CP138_MY	Q16678	105.44	50.0	515.0	DB02342	investigational	2-Methoxyestradiol	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)c(c4)OC
5881	sp|P9WPM3|CP138_MY	Q16678	105.44	50.0	515.0	DB03467	experimental	Naringenin	Oc1ccc(cc1)[C@@H](O2)CC(=O)c(c23)c(O)cc(c3)O
5882	sp|P9WPM3|CP138_MY	Q16678	105.44	50.0	515.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
5883	sp|P9WPM3|CP138_MY	Q16678	105.44	50.0	515.0	DB06732	experimental	beta-Naphthoflavone	c1cccc(c12)c3c(cc2)oc(cc3=O)-c4ccccc4
5884	sp|P9WPM3|CP138_MY	Q16678	105.44	50.0	515.0	DB07776	approved; experimental	Flavone	c1cccc(c12)oc(cc2=O)-c3ccccc3
5885	sp|P9WPM3|CP138_MY	Q16678	105.44	50.0	515.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
5886	sp|P9WPM3|CP138_MY	Q16678	105.44	50.0	515.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
5887	sp|P9WPM3|CP138_MY	P24557	109.07	47.0	528.0	DB00795	approved	Sulfasalazine	OC(=O)c1cc(ccc1O)/N=N/c2ccc(cc2)S(=O)(=O)Nc3ncccc3
5888	sp|P9WPM3|CP138_MY	P24557	109.07	47.0	528.0	DB01207	experimental	Ridogrel	OC(=O)CCCCO/N=C(/c1cnccc1)c2cc(C(F)(F)F)ccc2
5889	sp|P9WPM3|CP138_MY	P24557	109.07	47.0	528.0	DB03052	experimental	Dazoxiben	OC(=O)c1ccc(cc1)OCCn2ccnc2
5890	sp|P9WPM3|CP138_MY	P24557	109.07	47.0	528.0	DB05505	investigational	NM-702	 
5891	sp|P9WPM3|CP138_MY	P10613	105.67	49.0	515.0	DB00196	approved; investigational	Fluconazole	c1ncnn1CC(O)(Cn2cncn2)c3c(F)cc(F)cc3
5892	sp|P9WPM3|CP138_MY	P10613	105.67	49.0	515.0	DB00239	approved	Oxiconazole	Clc1cc(Cl)c(cc1)CO/N=C(\Cn2ccnc2)c3ccc(Cl)cc3Cl
5893	sp|P9WPM3|CP138_MY	P10613	105.67	49.0	515.0	DB00251	approved	Terconazole	CC(C)N1CCN(CC1)c2ccc(cc2)OC[C@@H](CO3)O[C@@]3(Cn4cncn4)c5c(Cl)cc(Cl)cc5
5894	sp|P9WPM3|CP138_MY	P10613	105.67	49.0	515.0	DB00257	approved; vet_approved	Clotrimazole	Clc1ccccc1C(n2ccnc2)(c3ccccc3)c4ccccc4
5895	sp|P9WPM3|CP138_MY	P10613	105.67	49.0	515.0	DB00582	approved	Voriconazole	c1ncnn1C[C@](O)(c2c(F)cc(F)cc2)[C@@H](C)c3ncncc3F
5896	sp|P9WPM3|CP138_MY	P10613	105.67	49.0	515.0	DB01007	approved	Tioconazole	c1nccn1CC(c(c(Cl)c2)ccc2Cl)OCc3c(Cl)scc3
5897	sp|P9WPM3|CP138_MY	P10613	105.67	49.0	515.0	DB01110	approved; investigational; vet_approved	Miconazole	Clc1cc(Cl)c(cc1)COC(Cn2ccnc2)c3c(Cl)cc(Cl)cc3
5898	sp|P9WPM3|CP138_MY	P10613	105.67	49.0	515.0	DB01127	approved	Econazole	Clc1ccc(cc1)COC(Cn2ccnc2)c3c(Cl)cc(Cl)cc3
5899	sp|P9WPM3|CP138_MY	P10613	105.67	49.0	515.0	DB01153	approved; investigational	Sertaconazole	Clc1cc(Cl)ccc1C(Cn2cncc2)OCc3csc(c34)c(Cl)ccc4
5900	sp|P9WPM3|CP138_MY	P10613	105.67	49.0	515.0	DB01263	approved; investigational; vet_approved	Posaconazole	C[C@H](O)[C@H](CC)n1ncn(c1=O)-c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@H](CO5)C[C@]5(Cn6cncn6)c7c(F)cc(F)cc7
5901	sp|P9WPM3|CP138_MY	P10613	105.67	49.0	515.0	DB04794	approved; investigational	Bifonazole	c1ccccc1C(n2ccnc2)c3ccc(cc3)-c4ccccc4
5902	sp|P9WPM3|CP138_MY	P10613	105.67	49.0	515.0	DB08933	approved	Luliconazole	Clc1cc(Cl)c(cc1)[C@@H]2CS/C(S2)=C(/C#N)n3ccnc3
5903	sp|P9WPM3|CP138_MY	O15528	102.72	41.0	494.0	DB01436	approved; nutraceutical	Alfacalcidol	CC(C)CCC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)/C(CCC2)=C/C=C3/C[C@@H](O)C[C@H](O)C3=C
5905	sp|P9WPM3|CP138_MY	P08686	92.06	47.0	453.0	DB01026	approved; investigational	Ketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OCC(CO3)OC3(Cn4ccnc4)c5ccc(Cl)cc5Cl
5906	sp|P9WPM3|CP138_MY	Q02928	95.24	88.0	508.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
5907	sp|P9WPM3|CP138_MY	P19099	97.28	62.0	491.0	DB00421	approved	Spironolactone	C1CC(=O)O[C@@]12[C@]3(C)[C@@H](CC2)[C@H]4[C@H](CC3)[C@]5(C)C(=CC(=O)CC5)C[C@H]4SC(=O)C
5908	sp|P9WPM3|CP138_MY	P19099	97.28	62.0	491.0	DB11837	approved; investigational	Osilodrostat	c1ncc(n12)CC[C@@H]2c3c(F)cc(C#N)cc3
5909	sp|P9WPM3|CP138_MY	P14779	95.01	24.0	443.0	DB03440	experimental	N-hexadecanoylglycine	CCCCCCCCCCCCCCCC(=O)NCC(=O)O
5910	sp|P9WPM3|CP138_MY	P14779	95.01	24.0	443.0	DB04257	experimental	Palmitoleic Acid	CCCCCC/C=C\CCCCCCCC(=O)O
5911	sp|P9WPM3|CP138_MY	P14779	95.01	24.0	443.0	DB08086	experimental	N-[12-(1H-imidazol-1-yl)dodecanoyl]-L-leucine	CC(C)C[C@@H](C(=O)O)NC(=O)CCCCCCCCCCCn1ccnc1
5912	sp|P9WPM3|CP138_MY	P15538	95.92	68.0	491.0	DB00648	approved	Mitotane	Clc1ccc(cc1)C(C(Cl)Cl)c2ccccc2Cl
5913	sp|P9WPM3|CP138_MY	P15538	95.92	68.0	491.0	DB01011	approved; investigational	Metyrapone	c1ccncc1C(C)(C)C(=O)c2cnccc2
5914	sp|P9WPM3|CP138_MY	P15538	95.92	68.0	491.0	DB05667	investigational	Levoketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OC[C@H](CO3)O[C@]3(Cn4ccnc4)c5ccc(Cl)cc5Cl
5915	sp|P9WPM3|CP138_MY	P15538	95.92	68.0	491.0	DB11837	approved; investigational	Osilodrostat	c1ncc(n12)CC[C@@H]2c3c(F)cc(C#N)cc3
5916	sp|P9WPM3|CP138_MY	P05108	93.65	76.0	489.0	DB00357	approved; investigational	Aminoglutethimide	Nc1ccc(cc1)C2(CC)CCC(=O)NC2=O
5917	sp|P9WPM3|CP138_MY	P11511	94.56	58.0	475.0	DB00184	approved	Nicotine	CN1CCC[C@H]1c2cnccc2
5918	sp|P9WPM3|CP138_MY	P11511	94.56	58.0	475.0	DB00357	approved; investigational	Aminoglutethimide	Nc1ccc(cc1)C2(CC)CCC(=O)NC2=O
5919	sp|P9WPM3|CP138_MY	P11511	94.56	58.0	475.0	DB00655	approved	Estrone	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)cc4
5920	sp|P9WPM3|CP138_MY	P11511	94.56	58.0	475.0	DB00894	approved; investigational	Testolactone	C1=CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2CC[C@@]4(C)[C@H]3CCC(O4)=O
5921	sp|P9WPM3|CP138_MY	P11511	94.56	58.0	475.0	DB00990	approved; investigational	Exemestane	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(C(C3)=C)=CC(=O)C=C4
5922	sp|P9WPM3|CP138_MY	P11511	94.56	58.0	475.0	DB01006	approved; investigational	Letrozole	N#Cc1ccc(cc1)C(n2cncn2)c3ccc(C#N)cc3
5923	sp|P9WPM3|CP138_MY	P11511	94.56	58.0	475.0	DB01217	approved; investigational	Anastrozole	N#CC(C)(C)c1cc(C(C)(C)C#N)cc(c1)Cn2cncn2
5924	sp|P9WPM3|CP138_MY	P11511	94.56	58.0	475.0	DB02342	investigational	2-Methoxyestradiol	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)c(c4)OC
5925	sp|P9WPM3|CP138_MY	P11511	94.56	58.0	475.0	DB03467	experimental	Naringenin	Oc1ccc(cc1)[C@@H](O2)CC(=O)c(c23)c(O)cc(c3)O
5926	sp|P9WPM3|CP138_MY	P11511	94.56	58.0	475.0	DB04539	experimental	Glyphosate	OC(=O)C[NH2+]CP(=O)(O)O
5927	sp|P9WPM3|CP138_MY	P11511	94.56	58.0	475.0	DB05749	investigational	MPI-674	 
5928	sp|P9WPM3|CP138_MY	O31440	87.53	13.0	399.0	DB04257	experimental	Palmitoleic Acid	CCCCCC/C=C\CCCCCCCC(=O)O
5929	sp|P9WPM3|CP138_MY	P53554	80.5	11.0	366.0	DB04450	experimental	Heptyl 1-Thiohexopyranoside	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)SCCCCCCC
5930	sp|P9WPM3|CP138_MY	Q16647	99.55	30.0	469.0	DB00812	approved; vet_approved	Phenylbutazone	CCCCC1C(=O)N(c2ccccc2)N(C1=O)c3ccccc3
5931	sp|P9WPM3|CP138_MY	Q16647	99.55	30.0	469.0	DB01240	approved	Epoprostenol	OC(=O)CCC/C=C(C1)\O[C@H]([C@H]12)C[C@@H](O)[C@@H]2/C=C/[C@@H](O)CCCCC
5932	sp|P9WPM3|CP138_MY	Q16647	99.55	30.0	469.0	DB08675	experimental	(5Z)-7-{(1R,4S,5R,6R)-6-[(1E)-1-Octen-1-yl]-2,3-diazabicyclo[2.2.1]hept-2-en-5-yl}-5-heptenoic acid	OC(=O)CCC/C=C\C[C@@H]([C@H]12)[C@H]([C@@H](C1)N=N2)/C=C/CCCCCC
5933	sp|P9WPM3|CP138_MY	Q83WG3	73.47	59.0	383.0	DB06955	experimental	3,4-bis(7-chloro-1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid	c1ccc(Cl)c(c12)[nH]cc2-c3c(C(=O)O)[nH]c(C(=O)O)c3-c4c[nH]c(c45)c(Cl)ccc5
5934	sp|P9WPM3|CP138_MY	Q83WG3	73.47	59.0	383.0	DB07588	experimental	3,4-DI-1H-INDOL-3-YL-1H-PYRROLE-2,5-DICARBOXYLIC ACID	c1cccc(c12)[nH]cc2-c3c(C(=O)O)[nH]c(C(=O)O)c3-c4c[nH]c(c45)cccc5
5935	sp|P9WPM3|CP138_MY	Q9FCA6	76.42	37.0	374.0	DB02175	experimental	Malonic acid	OC(=O)CC(=O)O
5936	sp|P9WPM3|CP138_MY	Q9FCA6	76.42	37.0	374.0	DB02521	experimental	Flaviolin	Oc1cc(O)cc(c12)C(=O)C(O)=CC2=O
5937	sp|P9WPM3|CP138_MY	Q9FCA6	76.42	37.0	374.0	DB03254	experimental	4-Phenyl-1h-Imidazole	[nH]1cncc1-c2ccccc2
5938	sp|P9WPM3|CP138_MY	Q9FCA6	76.42	37.0	374.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
5939	sp|P9WPS9|CTPF_MYC	P16615	108.95	3.0	989.0	DB06157	investigational	Istaroxime	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](C(=O)C3)C/C(CC4)=N/OCCN
5940	sp|P9WPS9|CTPF_MYC	P16615	108.95	3.0	989.0	DB01189	approved	Desflurane	FC(F)OC(F)C(F)(F)F
5941	sp|P9WPS9|CTPF_MYC	P98194	97.46	21.0	903.0	DB00228	approved; investigational; vet_approved	Enflurane	FC(F)OC(F)(F)C(F)Cl
5942	sp|P9WPS9|CTPF_MYC	P98194	97.46	21.0	903.0	DB00753	approved; vet_approved	Isoflurane	FC(F)OC(Cl)C(F)(F)F
5943	sp|P9WPS9|CTPF_MYC	P98194	97.46	21.0	903.0	DB01028	approved; investigational; vet_approved	Methoxyflurane	COC(F)(F)C(Cl)Cl
5944	sp|P9WPS9|CTPF_MYC	P98194	97.46	21.0	903.0	DB01236	approved; vet_approved	Sevoflurane	FCOC(C(F)(F)F)C(F)(F)F
5945	sp|P9WPS9|CTPF_MYC	P98194	97.46	21.0	903.0	DB01373	nutraceutical	Calcium	[Ca]
5946	sp|P9WPS9|CTPF_MYC	P98194	97.46	21.0	903.0	DB01189	approved	Desflurane	FC(F)OC(F)C(F)(F)F
5947	sp|P9WPS9|CTPF_MYC	O14983	109.06	3.0	990.0	DB00228	approved; investigational; vet_approved	Enflurane	FC(F)OC(F)(F)C(F)Cl
5948	sp|P9WPS9|CTPF_MYC	O14983	109.06	3.0	990.0	DB03909	experimental	Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate	OP(=O)(O)CP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
5949	sp|P9WPS9|CTPF_MYC	O14983	109.06	3.0	990.0	DB04444	experimental	Tetrafluoroaluminate Ion	F[Al-](F)(F)F
5950	sp|P9WPS9|CTPF_MYC	O14983	109.06	3.0	990.0	DB04638	experimental	2,5-di-tert-butylhydroquinone	CC(C)(C)c1cc(O)c(C(C)(C)C)cc1O
5951	sp|P9WPS9|CTPF_MYC	O14983	109.06	3.0	990.0	DB07604	experimental	(6AR,11AS,11BR)-10-ACETYL-9-HYDROXY-7,7-DIMETHYL-2,6,6A,7,11A,11B-HEXAHYDRO-11H-PYRROLO[1',2':2,3]ISOINDOLO[4,5,6-CD]INDOL-11-ONE	CC(=O)C(=C1O)C(=O)[C@@H](N12)[C@@H]3[C@H](C2(C)C)Cc4c5c3c[nH]c5ccc4
5952	sp|P9WPS9|CTPF_MYC	O14983	109.06	3.0	990.0	DB01189	approved	Desflurane	FC(F)OC(F)C(F)(F)F
5953	sp|P9WPS9|CTPF_MYC	P50993	107.29	36.0	1007.0	DB01092	approved	Ouabain	O=C1OCC(=C1)[C@H]2CC[C@@](O)([C@@]23C)[C@H]4[C@H]([C@@H](C3)O)[C@]5(CO)[C@](O)(CC4)C[C@H](C[C@H]5O)O[C@@H]6O[C@@H](C)[C@H](O)[C@@H](O)[C@H]6O
5954	sp|P9WPS9|CTPF_MYC	P13637	107.4	28.0	1000.0	DB01092	approved	Ouabain	O=C1OCC(=C1)[C@H]2CC[C@@](O)([C@@]23C)[C@H]4[C@H]([C@@H](C3)O)[C@]5(CO)[C@](O)(CC4)C[C@H](C[C@H]5O)O[C@@H]6O[C@@H](C)[C@H](O)[C@@H](O)[C@H]6O
5955	sp|P9WPS9|CTPF_MYC	P05023	107.62	38.0	1012.0	DB00390	approved	Digoxin	O=C1OCC(=C1)[C@@H](CC2)[C@](C)([C@]23O)[C@H](O)C[C@H]4[C@H]3CC[C@H]5[C@]4(C)CC[C@@H](C5)O[C@H]6C[C@H](O)[C@@H]([C@H](O6)C)O[C@H]7C[C@H](O)[C@@H]([C@H](O7)C)O[C@H]8C[C@H](O)[C@H](O)[C@H](O8)C
5956	sp|P9WPS9|CTPF_MYC	P05023	107.62	38.0	1012.0	DB00511	approved	Acetyldigitoxin	O=C1OCC(=C1)[C@H]2CC[C@@](O)([C@@]23C)[C@H]4[C@H](CC3)[C@]5(C)[C@H](CC4)C[C@H](CC5)O[C@H]6C[C@H](O)[C@@H]([C@H](O6)C)O[C@H]7C[C@H](O)[C@@H]([C@H](O7)C)O[C@H]8C[C@H](OC(=O)C)[C@H](O)[C@H](O8)C
5957	sp|P9WPS9|CTPF_MYC	P05023	107.62	38.0	1012.0	DB00774	approved; investigational; withdrawn	Hydroflumethiazide	FC(F)(F)c(c1)c(S(=O)(=O)N)cc(c12)S(=O)(=O)NCN2
5958	sp|P9WPS9|CTPF_MYC	P05023	107.62	38.0	1012.0	DB00903	approved; investigational	Etacrynic acid	CCC(=C)C(=O)c1c(Cl)c(Cl)c(cc1)OCC(=O)O
5959	sp|P9WPS9|CTPF_MYC	P05023	107.62	38.0	1012.0	DB01021	approved; vet_approved	Trichlormethiazide	NS(=O)(=O)c(c1)c(Cl)cc(c12)NC(C(Cl)Cl)NS2(=O)=O
5960	sp|P9WPS9|CTPF_MYC	P05023	107.62	38.0	1012.0	DB01078	approved	Deslanoside	O=C1OCC(=C1)[C@@H](CC2)[C@](C)([C@]23O)[C@H](O)C[C@H]4[C@H]3CC[C@H]5[C@]4(C)CC[C@@H](C5)O[C@@H]6O[C@H](C)[C@H]([C@H](C6)O)O[C@H]7C[C@H](O)[C@@H]([C@H](O7)C)O[C@H]8C[C@H](O)[C@@H]([C@H](O8)C)O[C@@H]9O[C@H](CO)[C@@H](O)[C@H](O)[C@H]9O
5961	sp|P9WPS9|CTPF_MYC	P05023	107.62	38.0	1012.0	DB01092	approved	Ouabain	O=C1OCC(=C1)[C@H]2CC[C@@](O)([C@@]23C)[C@H]4[C@H]([C@@H](C3)O)[C@]5(CO)[C@](O)(CC4)C[C@H](C[C@H]5O)O[C@@H]6O[C@@H](C)[C@H](O)[C@@H](O)[C@H]6O
5962	sp|P9WPS9|CTPF_MYC	P05023	107.62	38.0	1012.0	DB01119	approved	Diazoxide	CC(N1)=NS(=O)(=O)c(c12)cc(Cl)cc2
5963	sp|P9WPS9|CTPF_MYC	P05023	107.62	38.0	1012.0	DB01158	approved	Bretylium	CC[N+](C)(C)Cc1ccccc1Br
5964	sp|P9WPS9|CTPF_MYC	P05023	107.62	38.0	1012.0	DB01188	approved; investigational	Ciclopirox	Cc1cc(=O)n(O)c(c1)C2CCCCC2
5965	sp|P9WPS9|CTPF_MYC	P05023	107.62	38.0	1012.0	DB01244	approved; withdrawn	Bepridil	CC(C)COCC(N1CCCC1)CN(c2ccccc2)Cc3ccccc3
5966	sp|P9WPS9|CTPF_MYC	P05023	107.62	38.0	1012.0	DB01345	approved; investigational	Potassium cation	[K+]
5967	sp|P9WPS9|CTPF_MYC	P05023	107.62	38.0	1012.0	DB01370	approved; investigational	Aluminium	[Al]
5968	sp|P9WPS9|CTPF_MYC	P05023	107.62	38.0	1012.0	DB01378	approved; nutraceutical	Magnesium cation	[Mg+2]
5969	sp|P9WPS9|CTPF_MYC	P05023	107.62	38.0	1012.0	DB01396	approved; investigational	Digitoxin	O=C1OCC(=C1)[C@H]2CC[C@@](O)([C@@]23C)[C@H]4[C@H](CC3)[C@]5(C)[C@H](CC4)C[C@H](CC5)O[C@H]6C[C@H](O)[C@@H]([C@H](O6)C)O[C@H]7C[C@H](O)[C@@H]([C@H](O7)C)O[C@H]8C[C@H](O)[C@H](O)[C@H](O8)C
5970	sp|P9WPS9|CTPF_MYC	P05023	107.62	38.0	1012.0	DB01430	approved	Almitrine	c1cc(F)ccc1C(c(cc2)ccc2F)N3CCN(CC3)c4nc(NCC=C)nc(n4)NCC=C
5971	sp|P9WPS9|CTPF_MYC	P05023	107.62	38.0	1012.0	DB06157	investigational	Istaroxime	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](C(=O)C3)C/C(CC4)=N/OCCN
5972	sp|P9WPS9|CTPF_MYC	P05023	107.62	38.0	1012.0	DB13996	approved	Magnesium acetate	CC([O-])=O
5973	sp|P9WPS9|CTPF_MYC	P05023	107.62	38.0	1012.0	DB14498	approved; investigational	Potassium acetate	CC([O-])=O
5974	sp|P9WPS9|CTPF_MYC	P05023	107.62	38.0	1012.0	DB14499	approved; investigational	Potassium sulfate	[O-]S([O-])(=O)=O
5975	sp|P9WPS9|CTPF_MYC	P05023	107.62	38.0	1012.0	DB14500	approved; experimental	Potassium	[KH]
5976	sp|P9WPS9|CTPF_MYC	P05023	107.62	38.0	1012.0	DB14514	nutraceutical	Magnesium levulinate	CC(=O)CCC([O-])=O
5977	sp|P9WPS9|CTPF_MYC	P05023	107.62	38.0	1012.0	DB14515	nutraceutical	Magnesium lactate	CC(O)C([O-])=O
5978	sp|P9WPS9|CTPF_MYC	P05023	107.62	38.0	1012.0	DB14517	approved; investigational	Aluminium phosphate	[O-]P([O-])([O-])=O
5979	sp|P9WPS9|CTPF_MYC	P05023	107.62	38.0	1012.0	DB14518	approved; investigational	Aluminum acetate	CC([O-])=O
5980	sp|P9WPS9|CTPF_MYC	Q16720	78.45	348.0	1058.0	DB01159	approved; vet_approved	Halothane	ClC(Br)C(F)(F)F
5981	sp|P9WPS9|CTPF_MYC	Q16720	78.45	348.0	1058.0	DB01189	approved	Desflurane	FC(F)OC(F)C(F)(F)F
5982	sp|P9WPS9|CTPF_MYC	Q01814	78.56	374.0	1085.0	DB01159	approved; vet_approved	Halothane	ClC(Br)C(F)(F)F
5983	sp|P9WPS9|CTPF_MYC	Q01814	78.56	374.0	1085.0	DB01189	approved	Desflurane	FC(F)OC(F)C(F)(F)F
5984	sp|P9WPS9|CTPF_MYC	P23634	77.57	340.0	1042.0	DB01159	approved; vet_approved	Halothane	ClC(Br)C(F)(F)F
5985	sp|P9WPS9|CTPF_MYC	P23634	77.57	340.0	1042.0	DB01189	approved	Desflurane	FC(F)OC(F)C(F)(F)F
5986	sp|P9WPS9|CTPF_MYC	P20020	78.12	352.0	1059.0	DB01159	approved; vet_approved	Halothane	ClC(Br)C(F)(F)F
5987	sp|P9WPS9|CTPF_MYC	P20020	78.12	352.0	1059.0	DB01189	approved	Desflurane	FC(F)OC(F)C(F)(F)F
5988	sp|P9WPS9|CTPF_MYC	O75185	96.91	55.0	932.0	DB01189	approved	Desflurane	FC(F)OC(F)C(F)(F)F
5989	sp|P9WPS9|CTPF_MYC	P20648	107.18	51.0	1021.0	DB00213	approved	Pantoprazole	COc1c(OC)c(ncc1)CS(=O)c([nH]2)nc(c23)ccc(c3)OC(F)F
5990	sp|P9WPS9|CTPF_MYC	P20648	107.18	51.0	1021.0	DB00338	approved; investigational; vet_approved	Omeprazole	COc(cc1)cc(c12)[nH]c(n2)S(=O)Cc3ncc(C)c(OC)c3C
5991	sp|P9WPS9|CTPF_MYC	P20648	107.18	51.0	1021.0	DB00448	approved; investigational	Lansoprazole	FC(F)(F)COc1c(C)c(ncc1)CS(=O)c([nH]2)nc(c23)cccc3
5992	sp|P9WPS9|CTPF_MYC	P20648	107.18	51.0	1021.0	DB00736	approved; investigational	Esomeprazole	COc(cc1)cc(c12)nc([nH]2)[S@@](=O)Cc3ncc(C)c(OC)c3C
5993	sp|P9WPS9|CTPF_MYC	P20648	107.18	51.0	1021.0	DB01129	approved; investigational	Rabeprazole	COCCCOc1c(C)c(ncc1)CS(=O)c([nH]2)nc(c23)cccc3
5994	sp|P9WPS9|CTPF_MYC	P20648	107.18	51.0	1021.0	DB05351	approved; investigational	Dexlansoprazole	FC(F)(F)COc1c(C)c(ncc1)C[S@@](=O)c([nH]2)nc(c23)cccc3
5995	sp|P9WPS9|CTPF_MYC	A0A143ZZK9	125.08	122.0	1254.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
5996	sp|P9WNX1|DYR_MYCT	P9WNX1	99.38	1.0	161.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
5997	sp|P9WNX1|DYR_MYCT	P9WNX1	99.38	1.0	161.0	DB04007	experimental	Bromo-WR99210	CC1(C)N=C(N)N=C(N)N1OCCCOc2ccc(Br)cc2
5998	sp|P9WNX1|DYR_MYCT	Q81R22	92.55	2.0	151.0	DB08234	experimental	5-[3-(2,5-dimethoxyphenyl)prop-1-yn-1-yl]-6-ethylpyrimidine-2,4-diamine	CCc1nc(N)nc(N)c1C#CCc2cc(OC)ccc2OC
5999	sp|P9WNX1|DYR_MYCT	P0ABQ4	86.34	1.0	140.0	DB00440	approved; vet_approved	Trimethoprim	COc1c(OC)cc(cc1OC)Cc2cnc(N)nc2N
6000	sp|P9WNX1|DYR_MYCT	P0ABQ4	86.34	1.0	140.0	DB02015	experimental	Dihydrofolic Acid	O=c1[nH]c(N)nc(c12)NCC(=N2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
6001	sp|P9WNX1|DYR_MYCT	P0ABQ4	86.34	1.0	140.0	DB02363	experimental	2'-Monophosphoadenosine-5'-Diphosphate	OP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@@H]([C@@H]1O)OP(=O)(O)O)n2cnc(c23)c(N)ncn3
6002	sp|P9WNX1|DYR_MYCT	P0ABQ4	86.34	1.0	140.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
6003	sp|P9WNX1|DYR_MYCT	P0ABQ4	86.34	1.0	140.0	DB07262	experimental	1-{[N-(1-Imino-guanidino-methyl)]sulfanylmethyl}-3-trifluoromethyl-benzene	NC(=N)NC(=N)SCc1cccc(c1)C(F)(F)F
6004	sp|P9WNX1|DYR_MYCT	P0ABQ4	86.34	1.0	140.0	DB12769	investigational	Lometrexol	Nc([nH]1)nc(=O)c(c12)C[C@H](CN2)CCc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
6005	sp|P9WNX1|DYR_MYCT	P0A017	77.64	3.0	128.0	DB07938	experimental	(S)-iclaprim	C1CC1[C@@H](C=C2)Oc(c23)c(OC)c(OC)cc3Cc4cnc(N)nc4N
6006	sp|P9WNX1|DYR_MYCT	P0A017	77.64	3.0	128.0	DB08234	experimental	5-[3-(2,5-dimethoxyphenyl)prop-1-yn-1-yl]-6-ethylpyrimidine-2,4-diamine	CCc1nc(N)nc(N)c1C#CCc2cc(OC)ccc2OC
6007	sp|P9WNX1|DYR_MYCT	P0A017	77.64	3.0	128.0	DB08741	experimental	5-[[(2R)-2-cyclopropyl-7,8-dimethoxy-2H-chromen-5-yl]methyl]pyrimidine-2,4-diamine	C1CC1[C@H](C=C2)Oc(c23)c(OC)c(OC)cc3Cc4c(N)nc(N)nc4
6008	sp|P9WNX1|DYR_MYCT	A0A0M3KKX1	77.02	3.0	127.0	DB06847	experimental	5-[(3S)-3-(2-methoxybiphenyl-4-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine	Cc1nc(N)nc(N)c1C#C[C@@H](C)c2cc(OC)c(cc2)-c3ccccc3
6009	sp|P9WNX1|DYR_MYCT	A0A0M3KKX1	77.02	3.0	127.0	DB07140	experimental	5-[(3R)-3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine	Nc1nc(N)nc(C)c1C#C[C@H](C)c2cc(OC)cc(c2)-c3ccccc3
6010	sp|P9WNX1|DYR_MYCT	A0A0M3KKX1	77.02	3.0	127.0	DB07142	experimental	5-[(3R)-3-(5-methoxy-3',5'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine	Nc1nc(N)nc(C)c1C#C[C@H](C)c2cc(OC)cc(c2)-c3cc(C)cc(C)c3
6011	sp|P9WNX1|DYR_MYCT	A0A0M3KKX1	77.02	3.0	127.0	DB07153	experimental	6-methyl-5-[3-methyl-3-(3,4,5-trimethoxyphenyl)but-1-yn-1-yl]pyrimidine-2,4-diamine	COc1c(OC)cc(cc1OC)C(C)(C)C#Cc2c(C)nc(N)nc2N
6012	sp|P9WNX1|DYR_MYCT	A0A0M3KKX1	77.02	3.0	127.0	DB08234	experimental	5-[3-(2,5-dimethoxyphenyl)prop-1-yn-1-yl]-6-ethylpyrimidine-2,4-diamine	CCc1nc(N)nc(N)c1C#CCc2cc(OC)ccc2OC
6013	sp|P9WNX1|DYR_MYCT	P00374	92.55	6.0	155.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
6014	sp|P9WNX1|DYR_MYCT	P00374	92.55	6.0	155.0	DB00205	approved; investigational; vet_approved	Pyrimethamine	Nc1nc(CC)c(c(n1)N)-c2ccc(Cl)cc2
6015	sp|P9WNX1|DYR_MYCT	P00374	92.55	6.0	155.0	DB00563	approved	Methotrexate	Nc1nc(N)nc(c12)ncc(n2)CN(C)c3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
6016	sp|P9WNX1|DYR_MYCT	P00374	92.55	6.0	155.0	DB00642	approved; investigational	Pemetrexed	Nc([nH]1)nc(=O)c(c12)c(c[nH]2)CCc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
6017	sp|P9WNX1|DYR_MYCT	P00374	92.55	6.0	155.0	DB00798	approved; vet_approved	Gentamicin	CNC(C)C1CCC(N)C(O1)OC2C(N)CC(N)C(C2O)OC(OCC3(C)O)C(O)C3NC
6018	sp|P9WNX1|DYR_MYCT	P00374	92.55	6.0	155.0	DB01131	approved	Proguanil	CC(C)NC(=N)NC(=N)Nc1ccc(Cl)cc1
6019	sp|P9WNX1|DYR_MYCT	P00374	92.55	6.0	155.0	DB01157	approved; investigational	Trimetrexate	COc1c(OC)cc(cc1OC)NCc(cc2)c(C)c(c23)c(N)nc(n3)N
6020	sp|P9WNX1|DYR_MYCT	P00374	92.55	6.0	155.0	DB02104	experimental	2,4-Diamino-5-Methyl-6-[(3,4,5-Trimethoxy-N-Methylanilino)Methyl]Pyrido[2,3-D]Pyrimidine	COc1c(OC)cc(cc1OC)N(C)Cc(cn2)c(C)c(c23)c(N)nc(n3)N
6021	sp|P9WNX1|DYR_MYCT	P00374	92.55	6.0	155.0	DB02427	experimental	2,4-Diamino-6-[N-(2',5'-Dimethoxybenzyl)-N-Methylamino]Quinazoline	COc1cc(c(OC)cc1)CN(C)c(c2)ccc(c23)nc(N)nc3N
6022	sp|P9WNX1|DYR_MYCT	P00374	92.55	6.0	155.0	DB02559	experimental	6-(Octahydro-1h-Indol-1-Ylmethyl)Decahydroquinazoline-2,4-Diamine	C1CCC[C@@H]([C@H]12)CCN2C[C@H](C3)CC[C@@H]([C@@H]34)N[C@@H](N)N[C@H]4N
6023	sp|P9WNX1|DYR_MYCT	P00374	92.55	6.0	155.0	DB02583	experimental	N6-(2,5-Dimethoxy-Benzyl)-N6-Methyl-Pyrido[2,3-D]Pyrimidine-2,4,6-Triamine	COc1cc(c(OC)cc1)CN(C)c(cn2)cc(c23)c(N)nc(n3)N
6024	sp|P9WNX1|DYR_MYCT	P00374	92.55	6.0	155.0	DB02919	experimental	2,4-Diamino-6-[N-(3',4',5'-Trimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine	COc1c(OC)cc(cc1OC)CN(C)c(c2)cnc(c23)nc(N)nc3N
6025	sp|P9WNX1|DYR_MYCT	P00374	92.55	6.0	155.0	DB03060	experimental	Sri-9662	COc1cc(c(OC)cc1)/C=C\c(cn2)c(C)c(c23)c(N)nc(n3)N
6026	sp|P9WNX1|DYR_MYCT	P00374	92.55	6.0	155.0	DB03125	experimental	2,4-Diamino-5-(3,4,5-Trimethoxy-Benzyl)-Pyrimidin-1-Ium	COc1c(OC)cc(cc1OC)Cc2c[nH+]c(N)nc2N
6027	sp|P9WNX1|DYR_MYCT	P00374	92.55	6.0	155.0	DB03351	experimental	Sri-9439	Nc1nc(N)nc(c12)ncc(c2C)CNc3cccc(c34)nccc4
6028	sp|P9WNX1|DYR_MYCT	P00374	92.55	6.0	155.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
6029	sp|P9WNX1|DYR_MYCT	P00374	92.55	6.0	155.0	DB03695	investigational	Piritrexim	COc1cc(c(OC)cc1)Cc(cn2)c(C)c(c23)c(N)nc(n3)N
6030	sp|P9WNX1|DYR_MYCT	P00374	92.55	6.0	155.0	DB03886	experimental	Biopterin	C[C@@H](O)[C@@H](O)c(n1)cnc(c12)nc(N)[nH]c2=O
6031	sp|P9WNX1|DYR_MYCT	P00374	92.55	6.0	155.0	DB03987	experimental	2,4-Diamino-6-[N-(3',5'-Dimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine	COc1cc(OC)cc(c1)CN(C)c(c2)cnc(c23)nc(N)nc3N
6032	sp|P9WNX1|DYR_MYCT	P00374	92.55	6.0	155.0	DB06358	investigational	Iclaprim	C1CC1C(O2)C=Cc(c23)c(cc(OC)c3OC)Cc4cnc(N)nc4N
6033	sp|P9WNX1|DYR_MYCT	P00374	92.55	6.0	155.0	DB06813	approved; investigational	Pralatrexate	Nc1nc(N)nc(c12)ncc(n2)CC(CC#C)c3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
6034	sp|P9WNX1|DYR_MYCT	P00374	92.55	6.0	155.0	DB07140	experimental	5-[(3R)-3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine	Nc1nc(N)nc(C)c1C#C[C@H](C)c2cc(OC)cc(c2)-c3ccccc3
6035	sp|P9WNX1|DYR_MYCT	P00374	92.55	6.0	155.0	DB07141	experimental	5-[(3R)-3-(5-methoxy-4'-methylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine	Nc1nc(N)nc(C)c1C#C[C@H](C)c2cc(OC)cc(c2)-c3ccc(C)cc3
6036	sp|P9WNX1|DYR_MYCT	P00374	92.55	6.0	155.0	DB07142	experimental	5-[(3R)-3-(5-methoxy-3',5'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine	Nc1nc(N)nc(C)c1C#C[C@H](C)c2cc(OC)cc(c2)-c3cc(C)cc(C)c3
6037	sp|P9WNX1|DYR_MYCT	P00374	92.55	6.0	155.0	DB07144	experimental	5-[(3R)-3-(5-methoxy-2',6'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine	Cc1nc(N)nc(N)c1C#C[C@H](C)c2cc(OC)cc(c2)-c3c(C)cccc3C
6038	sp|P9WNX1|DYR_MYCT	P00374	92.55	6.0	155.0	DB08234	experimental	5-[3-(2,5-dimethoxyphenyl)prop-1-yn-1-yl]-6-ethylpyrimidine-2,4-diamine	CCc1nc(N)nc(N)c1C#CCc2cc(OC)ccc2OC
6039	sp|P9WNX1|DYR_MYCT	P00374	92.55	6.0	155.0	DB08406	experimental	[N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]-DIBENZ[B,F]AZEPINE	Nc1nc(N)nc(c12)ncc(n2)CN3c(cccc4)c4C=Cc(c35)cccc5
6040	sp|P9WNX1|DYR_MYCT	P00374	92.55	6.0	155.0	DB08448	experimental	(4aS)-5-[(2,4-diaminopteridin-6-yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin-8-ol	c1cc(O)cc(C=C2)c1N([C@H](C23)C=CCC=3)Cc(cn4)nc(c45)c(N)nc(n5)N
6041	sp|P9WNX1|DYR_MYCT	P00374	92.55	6.0	155.0	DB08642	experimental	(2R,6S)-6-{[methyl(3,4,5-trimethoxyphenyl)amino]methyl}-1,2,5,6,7,8-hexahydroquinazoline-2,4-diamine	NC1=N[C@H](N)NC(=C12)CC[C@@H](C2)CN(C)c3cc(OC)c(OC)c(c3)OC
6042	sp|P9WNX1|DYR_MYCT	P00378	91.3	7.0	154.0	DB03904	approved; investigational	Urea	NC(=O)N
6043	sp|P9WNX1|DYR_MYCT	P00381	78.88	1.0	128.0	DB02809	experimental	Brodimoprim-4,6-Dicarboxylate	Nc1nc(N)[nH+]cc1Cc2cc(OC)c(Br)c(c2)OCCC[C@H](C([O-])=O)CCC([O-])=O
6044	sp|P9WNX1|DYR_MYCT	P00381	78.88	1.0	128.0	DB03125	experimental	2,4-Diamino-5-(3,4,5-Trimethoxy-Benzyl)-Pyrimidin-1-Ium	COc1c(OC)cc(cc1OC)Cc2c[nH+]c(N)nc2N
6045	sp|P9WNX1|DYR_MYCT	Q86XF0	92.55	5.0	154.0	DB01929	experimental	5-Chloryl-2,4,6-Quinazolinetriamine	C1=CC2=C(C(=C1N)Cl(=O)=O)C(=NC(=N2)N)N
6046	sp|P9WNX1|DYR_MYCT	Q86XF0	92.55	5.0	154.0	DB01958	experimental	5-[4-Tert-Butylphenylsulfanyl]-2,4-Quinazolinediamine	CC(C)(C)c1ccc(cc1)Sc2cccc(c23)nc(N)nc3N
6047	sp|P9WNX1|DYR_MYCT	Q86XF0	92.55	5.0	154.0	DB02001	experimental	5-(4-Morpholin-4-Yl-Phenylsulfanyl)-2,4-Quinazolinediamine	Nc1nc(N)nc(c12)cccc2Sc3ccc(cc3)N4CCOCC4
6048	sp|P9WNX1|DYR_MYCT	Q86XF0	92.55	5.0	154.0	DB02402	experimental	5-(4-Methoxyphenoxy)-2,4-Quinazolinediamine	COc1ccc(cc1)Oc2cccc(c23)nc(N)nc3N
6049	sp|P9WNX1|DYR_MYCT	Q86XF0	92.55	5.0	154.0	DB04163	experimental	5-Phenylsulfanyl-2,4-Quinazolinediamine	Nc1nc(N)nc(c12)cccc2Sc3ccccc3
6050	sp|P9WNX1|DYR_MYCT	Q86XF0	92.55	5.0	154.0	DB04306	experimental	5-[(4-Methylphenyl)Sulfanyl]-2,4-Quinazolinediamine	Cc1ccc(cc1)Sc2cccc(c23)nc(N)nc3N
6051	sp|P9WNX1|DYR_MYCT	Q86XF0	92.55	5.0	154.0	DB07862	experimental	7-(1-ETHYL-PROPYL)-7H-PYRROLO-[3,2-F]QUINAZOLINE-1,3-DIAMINE	CCC(CC)n1ccc(c12)c3c(cc2)nc(N)nc3N
6052	sp|P9WNX1|DYR_MYCT	Q86XF0	92.55	5.0	154.0	DB08203	experimental	7-[2-METHOXY-1-(METHOXYMETHYL)ETHYL]-7H-PYRROLO[3,2-F] QUINAZOLINE-1,3-DIAMINE	COCC(COC)n1ccc(c12)c3c(cc2)nc(N)nc3N
6053	sp|P9WNX1|DYR_MYCT	Q86XF0	92.55	5.0	154.0	DB12116	investigational	Epigallocatechin gallate	Oc(c1)c(O)c(O)cc1[C@@H](O2)[C@@H](Cc(c23)c(O)cc(O)c3)OC(=O)c4cc(O)c(O)c(O)c4
6054	sp|P9WNX1|DYR_MYCT	P22906	88.2	9.0	151.0	DB01929	experimental	5-Chloryl-2,4,6-Quinazolinetriamine	C1=CC2=C(C(=C1N)Cl(=O)=O)C(=NC(=N2)N)N
6055	sp|P9WNX1|DYR_MYCT	P22906	88.2	9.0	151.0	DB01958	experimental	5-[4-Tert-Butylphenylsulfanyl]-2,4-Quinazolinediamine	CC(C)(C)c1ccc(cc1)Sc2cccc(c23)nc(N)nc3N
6056	sp|P9WNX1|DYR_MYCT	P22906	88.2	9.0	151.0	DB02001	experimental	5-(4-Morpholin-4-Yl-Phenylsulfanyl)-2,4-Quinazolinediamine	Nc1nc(N)nc(c12)cccc2Sc3ccc(cc3)N4CCOCC4
6057	sp|P9WNX1|DYR_MYCT	P22906	88.2	9.0	151.0	DB02402	experimental	5-(4-Methoxyphenoxy)-2,4-Quinazolinediamine	COc1ccc(cc1)Oc2cccc(c23)nc(N)nc3N
6058	sp|P9WNX1|DYR_MYCT	P22906	88.2	9.0	151.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
6059	sp|P9WNX1|DYR_MYCT	P22906	88.2	9.0	151.0	DB04163	experimental	5-Phenylsulfanyl-2,4-Quinazolinediamine	Nc1nc(N)nc(c12)cccc2Sc3ccccc3
6060	sp|P9WNX1|DYR_MYCT	P22906	88.2	9.0	151.0	DB04306	experimental	5-[(4-Methylphenyl)Sulfanyl]-2,4-Quinazolinediamine	Cc1ccc(cc1)Sc2cccc(c23)nc(N)nc3N
6061	sp|P9WNX1|DYR_MYCT	P16184	98.76	7.0	166.0	DB02026	experimental	Furo[2,3d]Pyrimidine Antifolate	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(C)Cc2coc(c23)nc(N)nc3N
6062	sp|P9WNX1|DYR_MYCT	P16184	98.76	7.0	166.0	DB02427	experimental	2,4-Diamino-6-[N-(2',5'-Dimethoxybenzyl)-N-Methylamino]Quinazoline	COc1cc(c(OC)cc1)CN(C)c(c2)ccc(c23)nc(N)nc3N
6063	sp|P9WNX1|DYR_MYCT	P16184	98.76	7.0	166.0	DB02559	experimental	6-(Octahydro-1h-Indol-1-Ylmethyl)Decahydroquinazoline-2,4-Diamine	C1CCC[C@@H]([C@H]12)CCN2C[C@H](C3)CC[C@@H]([C@@H]34)N[C@@H](N)N[C@H]4N
6064	sp|P9WNX1|DYR_MYCT	P16184	98.76	7.0	166.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
6065	sp|P9WNX1|DYR_MYCT	P16184	98.76	7.0	166.0	DB03987	experimental	2,4-Diamino-6-[N-(3',5'-Dimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine	COc1cc(OC)cc(c1)CN(C)c(c2)cnc(c23)nc(N)nc3N
6066	sp|P9WNX1|DYR_MYCT	P13922	102.48	38.0	203.0	DB00205	approved; investigational; vet_approved	Pyrimethamine	Nc1nc(CC)c(c(n1)N)-c2ccc(Cl)cc2
6067	sp|P9WNX1|DYR_MYCT	P13922	102.48	38.0	203.0	DB01131	approved	Proguanil	CC(C)NC(=N)NC(=N)Nc1ccc(Cl)cc1
6068	sp|P9WNX1|DYR_MYCT	P13922	102.48	38.0	203.0	DB01299	approved; investigational	Sulfadoxine	COc1ncnc(c1OC)NS(=O)(=O)c2ccc(N)cc2
6069	sp|P9WNL7|EMBB_MYC	P9WNL7	99.91	1.0	1098.0	DB00330	approved	Ethambutol	CC[C@@H](CO)NCCN[C@@H](CC)CO
6070	sp|P9WNL7|EMBB_MYC	P9WNL5	98.45	13.0	1094.0	DB00330	approved	Ethambutol	CC[C@@H](CO)NCCN[C@@H](CC)CO
6071	sp|P9WNL7|EMBB_MYC	P9WNL9	98.72	8.0	1092.0	DB00330	approved	Ethambutol	CC[C@@H](CO)NCCN[C@@H](CC)CO
6072	sp|P9WG69|FADA4_MY	P07097	98.2	7.0	389.0	DB01915	experimental	S-Hydroxycysteine	OC(=O)[C@@H](N)CSO
6073	sp|P9WG69|FADA4_MY	P07097	98.2	7.0	389.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
6074	sp|P9WG69|FADA4_MY	P07097	98.2	7.0	389.0	DB02039	experimental	S-Acetyl-Cysteine	OC(=O)[C@@H](N)CSC(=O)C
6075	sp|P9WG69|FADA4_MY	P07097	98.2	7.0	389.0	DB02160	experimental	S-Butyryl-Cystein	OC(=O)[C@@H](N)CSC(=O)CCC
6076	sp|P9WG69|FADA4_MY	P07097	98.2	7.0	389.0	DB03045	experimental	Pantothenyl-Aminoethanol-Acetate Pivalic Acid	CC(=O)OCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COC(=O)C(C)(C)C
6077	sp|P9WG69|FADA4_MY	P07097	98.2	7.0	389.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
6078	sp|P9WG69|FADA4_MY	P07097	98.2	7.0	389.0	DB08328	experimental	PANTOTHENYL-AMINOETHANOL-11-PIVALIC ACID	CC(C)(C)C(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCO
6079	sp|P9WG69|FADA4_MY	P07097	98.2	7.0	389.0	DB08408	experimental	(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-({3-oxo-3-[(2-sulfanylethyl)amino]propyl}amino)butyl 2,2-dimethylpropanoate	CC(C)(C)C(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS
6080	sp|P9WG69|FADA4_MY	Q9BWD1	98.71	10.0	394.0	DB01915	experimental	S-Hydroxycysteine	OC(=O)[C@@H](N)CSO
6081	sp|P9WG69|FADA4_MY	Q9BWD1	98.71	10.0	394.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
6082	sp|P9WG69|FADA4_MY	P24752	97.69	44.0	424.0	DB00795	approved	Sulfasalazine	OC(=O)c1cc(ccc1O)/N=N/c2ccc(cc2)S(=O)(=O)Nc3ncccc3
6083	sp|P9WG69|FADA4_MY	P24752	97.69	44.0	424.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
6085	sp|P9WG69|FADA4_MY	P24752	97.69	44.0	424.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
6086	sp|P9WG69|FADA4_MY	P28790	97.17	10.0	388.0	DB08249	experimental	3,6,9,12,15-PENTAOXATRICOSAN-1-OL	CCCCCCCCOCCOCCOCCOCCOCCO
6087	sp|P9WG69|FADA4_MY	P09110	97.43	40.0	419.0	DB09069	approved; investigational	Trimetazidine	COc1c(OC)c(OC)c(cc1)CN2CCNCC2
6088	sp|P9WQG3|ACDC_MYC	Q72JJ3	96.91	4.0	380.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
6089	sp|P9WQG3|ACDC_MYC	P16219	97.16	31.0	408.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
6090	sp|P9WQG3|ACDC_MYC	P16219	97.16	31.0	408.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
6091	sp|P9WQG3|ACDC_MYC	P16219	97.16	31.0	408.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
6092	sp|P9WQG3|ACDC_MYC	P11310	97.16	38.0	415.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
6093	sp|P9WQG3|ACDC_MYC	P11310	97.16	38.0	415.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
6094	sp|P9WQG3|ACDC_MYC	P11310	97.16	38.0	415.0	DB03415	experimental	3-thiaoctanoyl-CoA	CCCCCSCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
6095	sp|P9WQG3|ACDC_MYC	P45954	95.62	57.0	428.0	DB00167	investigational; nutraceutical	Isoleucine	CC[C@H](C)[C@H](N)C(=O)O
6096	sp|P9WQG3|ACDC_MYC	P45954	95.62	57.0	428.0	DB00313	approved; investigational	Valproic acid	CCCC(C(=O)O)CCC
6097	sp|P9WQG3|ACDC_MYC	Q9UKU7	97.16	36.0	413.0	DB01675	experimental	Methacrylyl-Coenzyme A	CC(=C)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
6098	sp|P9WQG3|ACDC_MYC	Q9UKU7	97.16	36.0	413.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
6099	sp|P9WQG3|ACDC_MYC	Q06319	97.16	3.0	380.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
6100	sp|P9WQG3|ACDC_MYC	Q06319	97.16	3.0	380.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
6101	sp|P9WQG3|ACDC_MYC	P26440	97.16	40.0	417.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
6102	sp|P9WQG3|ACDC_MYC	P26440	97.16	40.0	417.0	DB04036	experimental	Coenzyme A persulfide	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSS
6103	sp|P9WQG3|ACDC_MYC	Q3JP94	95.36	18.0	388.0	DB08685	experimental	1-(1,4-dimethyl-1,2,3,4-tetrahydroquinoxalin-6-yl)methanamine	CN1CCN(C)c(c12)cc(cc2)CN
6104	sp|P9WQG3|ACDC_MYC	Q92947	94.85	62.0	430.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
6105	sp|P9WQG3|ACDC_MYC	Q92947	94.85	62.0	430.0	DB03245	experimental	S-4-Nitrobutyryl-CoA	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCC[N+]([O-])=O
6106	sp|P9WQG3|ACDC_MYC	Q9KIE5	90.72	13.0	365.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
6107	sp|P9WQA9|ALR_MYCT	Q9L888	99.22	1.0	384.0	DB00260	approved	Cycloserine	N[C@@H]1CONC1=O
6108	sp|P9WQA9|ALR_MYCT	P10724	92.75	10.0	368.0	DB01993	experimental	N-(5'-Phosphopyridoxyl)-D-Alanine	OC(=O)[C@@H](C)NCc1c(O)c(C)ncc1COP(=O)(O)O
6109	sp|P9WQA9|ALR_MYCT	P10724	92.75	10.0	368.0	DB02038	experimental	D-[3-hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl]-N,O-cycloserylamide	Cc1ncc(COP(=O)(O)O)c(c1O)CN[C@@H]2CONC2=O
6110	sp|P9WQA9|ALR_MYCT	P10724	92.75	10.0	368.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
6111	sp|P9WQA9|ALR_MYCT	P10724	92.75	10.0	368.0	DB03097	experimental	PMP-hydroxyisoxazole, pyridoxamine-5-phosphate-hydroxyisoxazole	O=c1[nH]occ1NCc2c(O)c(C)ncc2COP(=O)(O)O
6112	sp|P9WQA9|ALR_MYCT	P10724	92.75	10.0	368.0	DB03327	experimental	{1-[(3-Hydroxy-Methyl-5-Phosphonooxy-Methyl-Pyridin-4-Ylmethyl)-Amino]-Ethyl}-Phosphonic Acid	OP(=O)(O)[C@H](C)NCc1c(COP(=O)(O)O)cnc(C)c1O
6113	sp|P9WQA9|ALR_MYCT	P10724	92.75	10.0	368.0	DB03766	approved; vet_approved	Propanoic acid	CCC(=O)O
6114	sp|P9WQA9|ALR_MYCT	P10724	92.75	10.0	368.0	DB03801	experimental	Lysine Nz-Carboxylic Acid	OC(=O)[C@@H](N)CCCCNC(=O)O
6115	sp|P9WQA9|ALR_MYCT	P10724	92.75	10.0	368.0	DB04467	experimental	N-(5'-phosphopyridoxyl)-L-alanine	OC(=O)[C@H](C)NCc1c(COP(=O)(O)O)cnc(C)c1O
6116	sp|P9WQA9|ALR_MYCT	Q9HTQ2	90.93	4.0	355.0	DB03252	experimental	D-Lysine	OC(=O)[C@H](N)CCCCN
6117	sp|P9WQA9|ALR_MYCT	Q9HTQ2	90.93	4.0	355.0	DB03801	experimental	Lysine Nz-Carboxylic Acid	OC(=O)[C@@H](N)CCCCNC(=O)O
6118	sp|P9WMJ9|DNAK_MYC	P11142	84.96	104.0	635.0	DB01254	approved; investigational	Dasatinib	OCCN1CCN(CC1)c2nc(C)nc(c2)Nc3ncc(s3)C(=O)Nc4c(C)cccc4Cl
6119	sp|P9WMJ9|DNAK_MYC	P11142	84.96	104.0	635.0	DB07045	experimental	(2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol	OC[C@@H](O1)[C@@H](O)[C@@H](O)[C@@H]1n2c(nc(c23)c(N)ncn3)NCc4ccc(Cl)c(Cl)c4
6120	sp|P9WMJ9|DNAK_MYC	P11142	84.96	104.0	635.0	DB09130	approved; investigational	Copper	[Cu]
6121	sp|P9WMJ9|DNAK_MYC	P11142	84.96	104.0	635.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
6122	sp|P9WMJ9|DNAK_MYC	P54652	84.64	106.0	635.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
6124	sp|P9WMJ9|DNAK_MYC	P11021	80.32	135.0	637.0	DB00945	approved; vet_approved	Acetylsalicylic acid	CC(=O)Oc1ccccc1C(=O)O
6125	sp|P9WMJ9|DNAK_MYC	P11021	80.32	135.0	637.0	DB09130	approved; investigational	Copper	[Cu]
6128	sp|P9WMJ9|DNAK_MYC	P34932	76.48	98.0	576.0	DB12695	investigational	Phenethyl Isothiocyanate	S=C=NCCc1ccccc1
6129	sp|P9WMJ9|DNAK_MYC	Q92598	76.0	100.0	575.0	DB12695	investigational	Phenethyl Isothiocyanate	S=C=NCCc1ccccc1
6130	sp|P9WMJ9|DNAK_MYC	C0H5H0	80.48	146.0	649.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
6131	sp|P9WPW7|ASSY_MYC	P00966	99.25	6.0	401.0	DB00125	investigational; nutraceutical	Arginine	OC(=O)[C@@H](N)CCCNC(N)=N
6132	sp|P9WPW7|ASSY_MYC	P00966	99.25	6.0	401.0	DB00128	approved; nutraceutical	Aspartic acid	OC(=O)[C@@H](N)CC(=O)O
6133	sp|P9WPW7|ASSY_MYC	P00966	99.25	6.0	401.0	DB00155	approved; investigational; nutraceutical	Citrulline	OC(=O)[C@@H](N)CCCNC(=O)N
6134	sp|P9WPW7|ASSY_MYC	P00966	99.25	6.0	401.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
6135	sp|P9WPW7|ASSY_MYC	Q5T6L4	99.25	6.0	401.0	DB00128	approved; nutraceutical	Aspartic acid	OC(=O)[C@@H](N)CC(=O)O
6136	sp|P9WPW7|ASSY_MYC	Q5T6L4	99.25	6.0	401.0	DB00155	approved; investigational; nutraceutical	Citrulline	OC(=O)[C@@H](N)CCCNC(=O)N
6137	sp|P9WPW7|ASSY_MYC	P59846	97.74	2.0	391.0	DB02267	experimental	Argininosuccinate	OC(=O)[C@@H](N)CCC/N=C(\N)N[C@@H](C(=O)O)CC(=O)O
6138	sp|P9WPW7|ASSY_MYC	P59846	97.74	2.0	391.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
6139	sp|O06159|BKDC_MYC	P10802	105.6	223.0	638.0	DB01846	experimental	Oxidized coenzyme A	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSO
6140	sp|O06159|BKDC_MYC	P10802	105.6	223.0	638.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
6141	sp|O06159|BKDC_MYC	P10802	105.6	223.0	638.0	DB08120	experimental	6,8-DIMERCAPTO-OCTANOIC ACID AMIDE	SCC[C@H](S)CCCCC(=O)N
6142	sp|O06159|BKDC_MYC	P10515	108.91	219.0	647.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
6143	sp|O06159|BKDC_MYC	P10515	108.91	219.0	647.0	DB03758	experimental	Radicicol	Oc1cc(O)c(Cl)c(c12)CC(=O)/C=C/C=C\[C@@H]3[C@H](O3)C[C@@H](C)OC2=O
6144	sp|O06159|BKDC_MYC	P10515	108.91	219.0	647.0	DB03760	experimental	Dihydrolipoic Acid	SCC[C@H](S)CCCCC(=O)O
6145	sp|P9WPE5|CH10_MYC	P61604	90.0	8.0	98.0	DB12695	investigational	Phenethyl Isothiocyanate	S=C=NCCc1ccccc1
6146	sp|O06543|AMACR_MY	P31572	94.17	10.0	349.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
6147	sp|O06543|AMACR_MY	P31572	94.17	10.0	349.0	DB02516	experimental	(R)-carnitinyl-CoA betaine	C[N+](C)(C)C[C@H](O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP([O-])(=O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
6148	sp|P9WPX5|ASPG_MYC	Q88K39	100.0	35.0	350.0	DB02571	experimental	Allysine	O=CCCC[C@H](N)C(=O)O
6149	sp|P9WPX5|ASPG_MYC	Q88K39	100.0	35.0	350.0	DB04388	experimental	4-Carboxy-4-Aminobutanal	OC(=O)[C@@H](N)CCC=O
6150	sp|P9WPX5|ASPG_MYC	P00805	98.73	25.0	336.0	DB01817	experimental	Threonine-Aspartic Ester	OC(=O)[C@@H](N)C[C@H](O)O[C@H](C)[C@H](N)C(=O)O
6151	sp|P9WPX5|ASPG_MYC	P06608	98.41	27.0	337.0	DB02233	experimental	6-hydroxy-D-norleucine	OC(=O)[C@H](N)CCCCO
6152	sp|P9WPX5|ASPG_MYC	P06608	98.41	27.0	337.0	DB02655	experimental	D-Aspartic Acid	OC(=O)[C@H](N)CC(=O)O
6153	sp|P9WPX5|ASPG_MYC	P06608	98.41	27.0	337.0	DB03412	experimental	6-hydroxynorleucine	OC(=O)[C@@H](N)CCCCO
6154	sp|P9WPX5|ASPG_MYC	Q86U10	75.87	83.0	322.0	DB00721	approved; investigational; vet_approved	Procaine	CCN(CC)CCOC(=O)c1ccc(N)cc1
6155	sp|P9WQ69|CSD_MYCT	Q55793	96.64	10.0	413.0	DB02346	experimental	3'-O-N-Octanoyl-a-D-Glucopyranosyl-B-D-Fructofuranoside	OC[C@@H](O1)[C@@H](O)[C@H](O)[C@]1(CO)O[C@H]2O[C@H](CO)[C@@H](O)[C@@H]([C@H]2O)OC(=O)CCCCCCC
6156	sp|P9WQ69|CSD_MYCT	P77444	96.4	4.0	406.0	DB02345	experimental	Selenocysteine	OC(=O)[C@@H](N)C[SeH]
6157	sp|P9WQ69|CSD_MYCT	P77444	96.4	4.0	406.0	DB02761	experimental	S-Mercaptocysteine	OC(=O)[C@@H](N)CSS
6158	sp|P9WQ69|CSD_MYCT	P77444	96.4	4.0	406.0	DB03049	experimental	S-Selanyl Cysteine	OC(=O)[C@@H](N)CS[SeH]
6159	sp|P9WQ69|CSD_MYCT	P77444	96.4	4.0	406.0	DB04217	experimental	L-2-amino-3-butynoic acid	OC(=O)[C@@H](N)C#C
6160	sp|P9WQ69|CSD_MYCT	Q9Y697	89.93	58.0	433.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
6161	sp|P9WQ69|CSD_MYCT	Q9Y697	89.93	58.0	433.0	DB00151	approved; nutraceutical	Cysteine	OC(=O)[C@@H](N)CS
6162	sp|P9WQ69|CSD_MYCT	Q9Y697	89.93	58.0	433.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
6163	sp|P9WQ69|CSD_MYCT	Q96I15	97.12	32.0	437.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
6164	sp|P9WQ69|CSD_MYCT	Q9ZHG9	87.53	21.0	386.0	DB02761	experimental	S-Mercaptocysteine	OC(=O)[C@@H](N)CSS
6165	sp|P9WQ69|CSD_MYCT	Q9ZHG9	87.53	21.0	386.0	DB04467	experimental	N-(5'-phosphopyridoxyl)-L-alanine	OC(=O)[C@H](C)NCc1c(COP(=O)(O)O)cnc(C)c1O
6166	sp|P9WQ69|CSD_MYCT	P83788	82.01	22.0	364.0	DB02343	experimental	3,6,9,12,15-Pentaoxaheptadecane	CCOCCOCCOCCOCCOCC
6167	sp|P9WQ69|CSD_MYCT	Q96EN8	93.29	47.0	436.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
6168	sp|P9WQ69|CSD_MYCT	Q16719	74.1	116.0	425.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
6169	sp|P9WQ69|CSD_MYCT	Q16719	74.1	116.0	425.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
6170	sp|P9WQ69|CSD_MYCT	Q16719	74.1	116.0	425.0	DB07069	experimental	m-Hydroxyhippuric acid	OC(=O)CNC(=O)c1cc(O)ccc1
6171	sp|P9WQ69|CSD_MYCT	Q9RME2	74.82	10.0	322.0	DB02327	experimental	Triethylene glycol	OCCOCCOCCO
6172	sp|P9WPL1|CP144_MY	P53554	89.63	4.0	393.0	DB04450	experimental	Heptyl 1-Thiohexopyranoside	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)SCCCCCCC
6173	sp|P9WPL1|CP144_MY	Q00441	89.63	11.0	400.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
6174	sp|P9WPL1|CP144_MY	Q00441	89.63	11.0	400.0	DB03369	experimental	9-Aminophenanthrene	c1cccc(c12)c3c(cc2N)cccc3
6175	sp|P9WPL1|CP144_MY	Q00441	89.63	11.0	400.0	DB04070	experimental	6-Deoxyerythronolide B	C[C@@H]1C[C@H](C)[C@H](O)[C@@H](C)[C@H](O)[C@@H](C)C(=O)O[C@H](CC)[C@H](C)[C@H](O)[C@@H](C)C1=O
6176	sp|P9WPL1|CP144_MY	Q83WG3	90.32	17.0	409.0	DB06955	experimental	3,4-bis(7-chloro-1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid	c1ccc(Cl)c(c12)[nH]cc2-c3c(C(=O)O)[nH]c(C(=O)O)c3-c4c[nH]c(c45)c(Cl)ccc5
6177	sp|P9WPL1|CP144_MY	Q83WG3	90.32	17.0	409.0	DB07588	experimental	3,4-DI-1H-INDOL-3-YL-1H-PYRROLE-2,5-DICARBOXYLIC ACID	c1cccc(c12)[nH]cc2-c3c(C(=O)O)[nH]c(C(=O)O)c3-c4c[nH]c(c45)cccc5
6178	sp|P9WPL1|CP144_MY	P9WPN5	90.09	9.0	400.0	DB07705	experimental	(S)-econazole	Clc1ccc(cc1)CO[C@H](Cn2ccnc2)c3c(Cl)cc(Cl)cc3
6179	sp|P9WPL1|CP144_MY	P9WPN5	90.09	9.0	400.0	DB07971	experimental	5-AMINO-2-{4-[(4-AMINOPHENYL)SULFANYL]PHENYL}-1H-ISOINDOLE-1,3(2H)-DIONE	Nc1ccc(cc1)Sc2ccc(cc2)N(C3=O)C(=O)c(c34)ccc(c4)N
6180	sp|P9WPL1|CP144_MY	P9WPN5	90.09	9.0	400.0	DB07972	experimental	1-(3-METHYLPHENYL)-1H-BENZIMIDAZOL-5-AMINE	Cc1cccc(c1)-n2cnc(c23)cc(N)cc3
6181	sp|P9WPL1|CP144_MY	Q9FCA6	85.48	32.0	403.0	DB02175	experimental	Malonic acid	OC(=O)CC(=O)O
6182	sp|P9WPL1|CP144_MY	Q9FCA6	85.48	32.0	403.0	DB02521	experimental	Flaviolin	Oc1cc(O)cc(c12)C(=O)C(O)=CC2=O
6183	sp|P9WPL1|CP144_MY	Q9FCA6	85.48	32.0	403.0	DB03254	experimental	4-Phenyl-1h-Imidazole	[nH]1cncc1-c2ccccc2
6184	sp|P9WPL1|CP144_MY	Q9FCA6	85.48	32.0	403.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
6185	sp|P9WPL1|CP144_MY	P9WPP7	85.25	24.0	394.0	DB02721	experimental	4-Iodopyrazole	Ic1c[nH]nc1
6186	sp|P9WPL1|CP144_MY	P9WPP7	85.25	24.0	394.0	DB08761	experimental	(3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine-2,5-dione	Oc1ccc(cc1)C[C@@H]2NC(=O)[C@@H](NC2=O)Cc3ccc(O)cc3
6187	sp|P9WPL1|CP144_MY	Q9NR63	81.8	115.0	470.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
6188	sp|P9WPL1|CP144_MY	Q6V0L0	85.25	118.0	488.0	DB00523	approved; investigational	Alitretinoin	OC(=O)/C=C(\C)/C=C/C=C(/C)\C=C\C(C1(C)C)=C(C)CCC1
6189	sp|P9WPL1|CP144_MY	Q6V0L0	85.25	118.0	488.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
6190	sp|P9WPL1|CP144_MY	Q9HB55	80.41	116.0	465.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
6191	sp|P9WPL1|CP144_MY	O43174	83.87	123.0	487.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
6192	sp|P9WPL1|CP144_MY	O43174	83.87	123.0	487.0	DB13083	investigational	Talarozole	c1ncnn1C(C(CC)CC)c2ccc(cc2)Nc(s3)nc(c34)cccc4
6193	sp|P9WPL1|CP144_MY	P11509	91.01	67.0	462.0	DB04665	experimental	Coumarin	c1cc(=O)oc(c12)cccc2
6194	sp|P9WPL1|CP144_MY	P11509	91.01	67.0	462.0	DB07609	experimental	N,N-DIMETHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	CN(C)Cc1ccc(o1)-c2cccnc2
6195	sp|P9WPL1|CP144_MY	P11509	91.01	67.0	462.0	DB07617	experimental	N-METHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	CNCc1ccc(o1)-c2cccnc2
6196	sp|P9WPL1|CP144_MY	P11509	91.01	67.0	462.0	DB07621	experimental	(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	NCc1ccc(o1)-c2cccnc2
6197	sp|P9WPL1|CP144_MY	P11509	91.01	67.0	462.0	DB07623	experimental	4,4'-DIPYRIDYL DISULFIDE	c1cnccc1SSc2ccncc2
6198	sp|P9WPL1|CP144_MY	P05177	70.28	176.0	481.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
6199	sp|P9WPL1|CP144_MY	P05177	70.28	176.0	481.0	DB07453	experimental	alpha-Naphthoflavone	c1ccccc1-c(cc2=O)oc(c23)c4c(cc3)cccc4
6200	sp|P9WPL1|CP144_MY	P05177	70.28	176.0	481.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
6201	sp|P9WPL1|CP144_MY	P05177	70.28	176.0	481.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
6202	sp|P9WPL1|CP144_MY	P05177	70.28	176.0	481.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
6203	sp|P9WPL1|CP144_MY	O31440	73.73	70.0	390.0	DB04257	experimental	Palmitoleic Acid	CCCCCC/C=C\CCCCCCCC(=O)O
6204	sp|P9WP53|CYSM_MYC	P35520	94.12	79.0	383.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
6205	sp|P9WP53|CYSM_MYC	P35520	94.12	79.0	383.0	DB00118	approved; investigational; nutraceutical	Ademetionine	[O-]C(=O)[C@@H](N)CC[S+](C)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
6206	sp|P9WP53|CYSM_MYC	P35520	94.12	79.0	383.0	DB00133	investigational; nutraceutical	Serine	OC(=O)[C@@H](N)CO
6207	sp|P9WP53|CYSM_MYC	P35520	94.12	79.0	383.0	DB00151	approved; nutraceutical	Cysteine	OC(=O)[C@@H](N)CS
6208	sp|P9WP53|CYSM_MYC	P20132	80.8	25.0	286.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
6209	sp|P9WP53|CYSM_MYC	P20132	80.8	25.0	286.0	DB00133	investigational; nutraceutical	Serine	OC(=O)[C@@H](N)CO
6210	sp|P9WP53|CYSM_MYC	Q96GA7	80.8	32.0	293.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
6211	sp|P9WP53|CYSM_MYC	P0A2K1	96.59	62.0	374.0	DB03171	experimental	Indole-3-Propanol Phosphate	OP(=O)(O)OCCCc1c[nH]c(c12)cccc2
6212	sp|P9WP53|CYSM_MYC	P0A2K1	96.59	62.0	374.0	DB04143	experimental	Indole-3-Glycerol Phosphate	OP(=O)(O)OC[C@@H](O)[C@@H](O)c1c[nH]c(c12)cccc2
6213	sp|P9WP53|CYSM_MYC	P0A2K1	96.59	62.0	374.0	DB07732	experimental	2-[(2-NAPHTHYLSULFONYL)AMINO]ETHYL DIHYDROGEN PHOSPHATE	OP(=O)(O)OCCNS(=O)(=O)c(cc1)cc(c12)cccc2
6214	sp|P9WP53|CYSM_MYC	P0A2K1	96.59	62.0	374.0	DB07745	experimental	2-{[4-(TRIFLUOROMETHOXY)BENZOYL]AMINO}ETHYL DIHYDROGEN PHOSPHATE	OP(=O)(O)OCCNC(=O)c1ccc(OC(F)(F)F)cc1
6215	sp|P9WP53|CYSM_MYC	P0A2K1	96.59	62.0	374.0	DB07748	experimental	2-({[4-(TRIFLUOROMETHOXY)PHENYL]SULFONYL}AMINO)ETHYL DIHYDROGEN PHOSPHATE	OP(=O)(O)OCCNS(=O)(=O)c1ccc(OC(F)(F)F)cc1
6216	sp|P9WP53|CYSM_MYC	P0A2K1	96.59	62.0	374.0	DB07773	experimental	5-FLUOROINDOLE PROPANOL PHOSPHATE	OP(=O)(O)OCCCc1c[nH]c(c12)ccc(F)c2
6217	sp|P9WP53|CYSM_MYC	P0A2K1	96.59	62.0	374.0	DB07890	experimental	4-(2-HYDROXYPHENYLTHIO)-1-BUTENYLPHOSPHONIC ACID	Oc1ccccc1SCC/C=C/P(=O)(O)O
6218	sp|P9WP53|CYSM_MYC	P0A2K1	96.59	62.0	374.0	DB07894	experimental	4-(2-HYDROXY-4-FLUOROPHENYLTHIO)-BUTYLPHOSPHONIC ACID	Oc1ccc(F)cc1SCC/C=C/P(=O)(O)O
6219	sp|P9WP53|CYSM_MYC	P0A2K1	96.59	62.0	374.0	DB07925	experimental	4-(2-HYDROXYPHENYLSULFINYL)-BUTYLPHOSPHONIC ACID	Oc1ccccc1[S@](=O)CCCCP(=O)(O)O
6220	sp|P9WP53|CYSM_MYC	P0A2K1	96.59	62.0	374.0	DB07951	experimental	N-(indole-3-acetyl)-L-aspartic acid	OC(=O)C[C@@H](C(=O)O)NC(=O)Cc1c[nH]c(c12)cccc2
6221	sp|P9WP53|CYSM_MYC	P0A2K1	96.59	62.0	374.0	DB07952	experimental	N-[1H-INDOL-3-YL-ACETYL]GLYCINE ACID	OC(=O)CNC(=O)Cc1c[nH]c(c12)cccc2
6222	sp|P9WP53|CYSM_MYC	P0A2K1	96.59	62.0	374.0	DB07953	experimental	N-[1H-INDOL-3-YL-ACETYL]VALINE ACID	CC(C)[C@@H](C(=O)O)NC(=O)Cc1c[nH]c(c12)cccc2
6223	sp|P9WP53|CYSM_MYC	Q00740	93.81	13.0	316.0	DB01735	experimental	3-Chloroalaninate	[O-]C(=O)[C@H]([NH3+])CCl
6224	sp|P9WP53|CYSM_MYC	Q00740	93.81	13.0	316.0	DB01804	experimental	2-Ammoniobut-3-Enoate, 2-Amino-3-Butenoate	[O-]C(=O)[C@H]([NH3+])C=C
6225	sp|P9WP53|CYSM_MYC	Q00740	93.81	13.0	316.0	DB02085	experimental	1-Aminocyclopropanecarboxylic Acid	OC(=O)C1(N)CC1
6226	sp|P9WP53|CYSM_MYC	Q00740	93.81	13.0	316.0	DB03053	experimental	1-Aminocyclopropylphosphonate	OP([O-])(=O)C1(N)CC1
6227	sp|P9WP53|CYSM_MYC	Q00740	93.81	13.0	316.0	DB04212	experimental	2-Iminiopropanoate	CC(=[NH2+])C([O-])=O
6228	sp|P9WP53|CYSM_MYC	Q00740	93.81	13.0	316.0	DB04553	experimental	2-Oxobutanoic Acid	CCC(=O)C(=O)O
6229	sp|P9WNV1|DNLJ_MYC	Q837V6	95.95	8.0	671.0	DB03227	experimental	Nicotinamide Mononucleotide	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@H]([C@H](O)[C@H]2O)COP(=O)(O)O
6230	sp|P9WNV1|DNLJ_MYC	Q837V6	95.95	8.0	671.0	DB07040	experimental	2-amino-7-fluoro-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxamide	NC(=O)c(c1)c(N)nc(c12)oc3c(c2=O)cc(F)cc3
6231	sp|P9WNV1|DNLJ_MYC	Q837V6	95.95	8.0	671.0	DB07041	experimental	N-[2-(2,4-diaminopyrido[2,3-d]pyrimidin-7-yl)-2-methylpropyl]-4-phenoxybenzamide	Nc1nc(N)nc(c12)nc(cc2)C(C)(C)CNC(=O)c3ccc(cc3)Oc4ccccc4
6232	sp|P9WNV1|DNLJ_MYC	Q837V6	95.95	8.0	671.0	DB07042	experimental	7-amino-2-tert-butyl-4-{[2-(1H-imidazol-4-yl)ethyl]amino}pyrido[2,3-d]pyrimidine-6-carboxamide	O=C(N)c(c1)c(N)nc(c12)nc(C(C)(C)C)nc2NCCc3c[nH]cn3
6233	sp|P9WNV1|DNLJ_MYC	Q837V6	95.95	8.0	671.0	DB07043	experimental	7-amino-2-tert-butyl-4-(4-pyrimidin-2-ylpiperazin-1-yl)pyrido[2,3-d]pyrimidine-6-carboxamide	NC(=O)c(c(n1)N)cc(c12)c(nc(n2)C(C)(C)C)N3CCN(CC3)c4ncccn4
6234	sp|P9WNV1|DNLJ_MYC	P43813	95.95	3.0	666.0	DB07041	experimental	N-[2-(2,4-diaminopyrido[2,3-d]pyrimidin-7-yl)-2-methylpropyl]-4-phenoxybenzamide	Nc1nc(N)nc(c12)nc(cc2)C(C)(C)CNC(=O)c3ccc(cc3)Oc4ccccc4
6235	sp|P9WMS1|DHMA2_MY	P51698	98.25	6.0	287.0	DB01701	experimental	1,2-Dichloro-Propane	C[C@@H](Cl)CCl
6236	sp|P9WMS1|DHMA2_MY	P51698	98.25	6.0	287.0	DB02145	experimental	Butyl alcohol	CCCCO
6237	sp|P9WMS1|DHMA2_MY	P51698	98.25	6.0	287.0	DB02302	experimental	Symmetric dimethylarginine	CN/C(=N/C)NCCC[C@H](N)C(=O)O
6238	sp|P9WMS1|DHMA2_MY	P51698	98.25	6.0	287.0	DB02774	experimental	1,3-Propanediol	OCCCO
6239	sp|P9WMS1|DHMA2_MY	P51698	98.25	6.0	287.0	DB03335	experimental	(+)-1-bromo-2-propanol	C[C@H](O)CBr
6240	sp|P9WMS1|DHMA2_MY	P51698	98.25	6.0	287.0	DB03733	experimental	Ethylene Dichloride	ClCCCl
6241	sp|P9WMS1|DHMA2_MY	P51698	98.25	6.0	287.0	DB04320	experimental	2-Bromo-2-Propene-1-Ol	OCC(Br)=C
6243	sp|P9WMS1|DHMA2_MY	P47229	90.56	21.0	280.0	DB07510	experimental	3-fluoro-6-(4-fluorophenyl)-2-hydroxy-6-oxohexa-2,4-dienoic acid	OC(=O)/C(O)=C(/F)\C=C\C(=O)c1ccc(F)cc1
6244	sp|P9WMS1|DHMA2_MY	P47229	90.56	21.0	280.0	DB07516	experimental	(2Z,4E)-3-chloro-2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoic acid	OC(=O)/C(O)=C(/Cl)\C=C\C(=O)c1ccccc1
6245	sp|P9WMS1|DHMA2_MY	P47229	90.56	21.0	280.0	DB07911	experimental	(3E)-2,6-DIOXO-6-PHENYLHEX-3-ENOATE	[O-]C(=O)C(=O)/C=C/CC(=O)c1ccccc1
6246	sp|P9WMS1|DHMA2_MY	P47229	90.56	21.0	280.0	DB07915	experimental	(2E,4E)-2-Hydroxy-6-oxo-6-phenyl-2,4-hexadienoic acid	OC(=O)/C(O)=C\C=C\C(=O)c1ccccc1
6247	sp|P9WMS1|DHMA2_MY	P96965	88.81	16.0	270.0	DB02406	experimental	N-Valeric Acid	CCCCC(=O)O
6248	sp|P9WMS1|DHMA2_MY	P96965	88.81	16.0	270.0	DB02531	experimental	Isobutyric acid	CC(C)C(=O)O
6249	sp|P9WMS1|DHMA2_MY	P96965	88.81	16.0	270.0	DB03568	experimental; investigational	Butyric Acid	CCCC(=O)O
6250	sp|P9WMS1|DHMA2_MY	P96965	88.81	16.0	270.0	DB03741	experimental	2-Methylbutanoic Acid	CC[C@@H](C)C(=O)O
6251	sp|P9WMS1|DHMA2_MY	P96965	88.81	16.0	270.0	DB03750	experimental	Isovaleric Acid	CC(C)CC(=O)O
6252	sp|P9WMS1|DHMA2_MY	P96965	88.81	16.0	270.0	DB03766	approved; vet_approved	Propanoic acid	CCC(=O)O
6253	sp|P9WMS1|DHMA2_MY	P96965	88.81	16.0	270.0	DB03793	approved; investigational	Benzoic acid	OC(=O)c1ccccc1
6254	sp|P9WMS1|DHMA2_MY	O31168	90.91	11.0	271.0	DB03793	approved; investigational	Benzoic acid	OC(=O)c1ccccc1
6255	sp|P9WMS1|DHMA2_MY	P25275	79.37	54.0	281.0	DB03999	experimental	Butylphosphonate	CCCCP(=O)(O)O
6256	sp|P9WQL9|DRRA_MYC	O95477	74.62	898.0	1145.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
6257	sp|P9WQL9|DRRA_MYC	O95477	74.62	898.0	1145.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
6258	sp|P9WQL9|DRRA_MYC	O95477	74.62	898.0	1145.0	DB01599	approved; investigational	Probucol	CC(C)(C)c1cc(cc(c1O)C(C)(C)C)SC(C)(C)Sc2cc(C(C)(C)C)c(O)c(c2)C(C)(C)C
6259	sp|P9WQL9|DRRA_MYC	O95477	96.37	1911.0	2230.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
6260	sp|P9WQL9|DRRA_MYC	O95477	96.37	1911.0	2230.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
6261	sp|P9WQL9|DRRA_MYC	O95477	96.37	1911.0	2230.0	DB01599	approved; investigational	Probucol	CC(C)(C)c1cc(cc(c1O)C(C)(C)C)SC(C)(C)Sc2cc(C(C)(C)C)c(O)c(c2)C(C)(C)C
6262	sp|P9WQL9|DRRA_MYC	Q2M3G0	78.85	385.0	646.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
6263	sp|P9WQL9|DRRA_MYC	Q2M3G0	78.85	385.0	646.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
6264	sp|P9WQL9|DRRA_MYC	Q2M3G0	72.21	1015.0	1254.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
6265	sp|P9WQL9|DRRA_MYC	Q2M3G0	72.21	1015.0	1254.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
6266	sp|P9WQL9|DRRA_MYC	P33527	80.97	643.0	911.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
6267	sp|P9WQL9|DRRA_MYC	P33527	80.97	643.0	911.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
6268	sp|P9WQL9|DRRA_MYC	P33527	80.97	643.0	911.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
6269	sp|P9WQL9|DRRA_MYC	P33527	80.97	643.0	911.0	DB06176	approved; investigational	Romidepsin	O=C([C@H]12)N/C(=C\C)C(=O)N[C@@H](C(C)C)C(=O)O[C@@H](CC(=O)N[C@H](C(C)C)C(=O)N1)/C=C/CCSSC2
6270	sp|P9WQL9|DRRA_MYC	P33527	80.97	643.0	911.0	DB08855	experimental; investigational	Leukotriene C4	CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@@H](O)CCCC(=O)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@H](N)C(=O)O
6271	sp|P9WQL9|DRRA_MYC	P08183	82.78	392.0	666.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
6272	sp|P9WQL9|DRRA_MYC	P08183	82.78	392.0	666.0	DB00603	approved; investigational	Medroxyprogesterone acetate	CC(=O)O[C@]1(C(=O)C)CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C([C@H](C3)C)=CC(=O)CC4
6273	sp|P9WQL9|DRRA_MYC	P08183	82.78	392.0	666.0	DB00778	approved; investigational; withdrawn	Roxithromycin	COCCOCO/N=C([C@H](C)[C@@H](O)[C@]1(C)O)/[C@H](C)C[C@@](C)(O)[C@@H]([C@@H](C)[C@@H]([C@@H](C)C(=O)O[C@@H]1CC)O[C@@H](C[C@@]2(C)OC)O[C@@H](C)[C@@H]2O)O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C
6274	sp|P9WQL9|DRRA_MYC	P08183	82.78	392.0	666.0	DB00813	approved; illicit; investigational; vet_approved	Fentanyl	c1ccccc1N(C(=O)CC)C2CCN(CC2)CCc3ccccc3
6275	sp|P9WQL9|DRRA_MYC	P08183	82.78	392.0	666.0	DB04877	experimental	Voacamine	CC[C@H]1C[C@@H](C2)CN([C@@H]1[C@@]23C(=O)OC)CCc4c3[nH]c5c4cc(OC)c(c5)[C@@H](C[C@H]67)c8c(c9c([nH]8)cccc9)C[C@H](C6C(=O)OC)N(C)CC\7=C\C
6276	sp|P9WQL9|DRRA_MYC	P08183	82.78	392.0	666.0	DB04881	investigational	Elacridar	COc1cccc(c12)c(=O)c3c([nH]2)c(ccc3)C(=O)Nc4ccc(cc4)CCN(C5)CCc(c56)cc(OC)c(c6)OC
6277	sp|P9WQL9|DRRA_MYC	P08183	82.78	392.0	666.0	DB04905	investigational	Tesmilifene	CCN(CC)CCOc1ccc(cc1)Cc2ccccc2
6278	sp|P9WQL9|DRRA_MYC	P08183	82.78	392.0	666.0	DB05449	investigational	FM-VP4	 
6279	sp|P9WQL9|DRRA_MYC	P08183	82.78	392.0	666.0	DB06191	investigational	Zosuquidar	FC1(F)[C@H]2[C@@H]1c(cccc3)c3[C@@H](c(c24)cccc4)N5CCN(CC5)C[C@@H](O)COc6cccc(c67)nccc7
6280	sp|P9WQL9|DRRA_MYC	P08183	82.78	392.0	666.0	DB06240	investigational	Tariquidar	COc(c1)c(OC)cc(c12)CCN(C2)CCc3ccc(cc3)NC(=O)c4cc(OC)c(OC)cc4NC(=O)c(c5)cnc(c56)cccc6
6281	sp|P9WQL9|DRRA_MYC	P08183	82.78	392.0	666.0	DB09031	approved; investigational	Miltefosine	CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C
6282	sp|P9WQL9|DRRA_MYC	P08183	82.78	392.0	666.0	DB11635	approved	Tocofersolan	 
6283	sp|P9WQL9|DRRA_MYC	P08183	82.78	392.0	666.0	DB14061	experimental	Hycanthone	CCN(CC)CCNc(ccc1CO)c(c12)c(=O)c3c(s2)cccc3
6284	sp|P9WQL9|DRRA_MYC	P08183	82.78	392.0	666.0	DB14062	experimental	Concanamycin A	NC(=O)O[C@@H]1[C@@H](C)O[C@H](C[C@H]1O)O[C@H](C2)[C@H](C)[C@@H](/C=C/C)O[C@@]2(O)[C@@H](C)[C@H](O)[C@H](C)[C@H]3OC(=O)/C(OC)=C/C(C)=C/[C@@H](C)[C@@H](O)[C@@H](CC)[C@@H](O)[C@H](C)C/C(C)=C/C=C/[C@@H]3OC
6285	sp|P9WQL9|DRRA_MYC	P08183	82.78	392.0	666.0	DB14063	experimental	Dexverapamil	COc1ccc(cc1OC)CCN(C)CCC[C@@](C#N)(C(C)C)c2cc(OC)c(OC)cc2
6286	sp|P9WQL9|DRRA_MYC	P08183	82.78	392.0	666.0	DB14064	experimental	Emopamil	c1ccccc1C(C#N)(C(C)C)CCCN(C)CCc2ccccc2
6287	sp|P9WQL9|DRRA_MYC	P08183	82.78	392.0	666.0	DB14065	experimental	Lomerizine	COc1ccc(c(OC)c1OC)CN2CCN(CC2)C(c3ccc(F)cc3)c4ccc(F)cc4
6288	sp|P9WQL9|DRRA_MYC	P08183	82.78	392.0	666.0	DB14066	experimental	Tetrandrine	c12ccc(OC)c(c1)Oc3ccc(cc3)C[C@H]4c5c(CCN4C)cc(OC)c(c5)Oc6c7c(CCN(C)[C@H]7C2)cc(OC)c6OC
6289	sp|P9WQL9|DRRA_MYC	P08183	82.78	392.0	666.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
6290	sp|P9WQL9|DRRA_MYC	P08183	82.78	392.0	666.0	DB14068	experimental	Dexniguldipine	[O-][N+](=O)c1cccc(c1)[C@@H]2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCCN(CC3)CCC3(c4ccccc4)c5ccccc5
6291	sp|P9WQL9|DRRA_MYC	P08183	82.78	392.0	666.0	DB14069	investigational	ONT-093	CCOC/C=C/c1ccc(cc1)-c2nc(-c3ccc(cc3)NC(C)C)c([nH]2)-c4ccc(cc4)NC(C)C
6292	sp|P9WQL9|DRRA_MYC	P08183	82.78	392.0	666.0	DB14070	experimental	HM-30181	c1cccc(c12)c(=O)cc(o2)C(=O)Nc3cc(OC)c(OC)cc3-c4nn(nn4)-c5ccc(cc5)CCN(C6)CCc(c67)cc(OC)c(c7)OC
6293	sp|P9WQL9|DRRA_MYC	P08183	82.78	392.0	666.0	DB14071	experimental	Desmethylsertraline	c1cccc(c12)[C@@H](CC[C@@H]2N)c3cc(Cl)c(Cl)cc3
6294	sp|P9WQL9|DRRA_MYC	P08183	82.78	392.0	666.0	DB14072	experimental	Reversin 121	c1ccccc1COC(=O)C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@H](C(=O)OC(C)(C)C)CCCCNC(=O)OCc2ccccc2
6295	sp|P9WQL9|DRRA_MYC	P08183	71.9	1034.0	1272.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
6296	sp|P9WQL9|DRRA_MYC	P08183	71.9	1034.0	1272.0	DB00603	approved; investigational	Medroxyprogesterone acetate	CC(=O)O[C@]1(C(=O)C)CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C([C@H](C3)C)=CC(=O)CC4
6297	sp|P9WQL9|DRRA_MYC	P08183	71.9	1034.0	1272.0	DB00778	approved; investigational; withdrawn	Roxithromycin	COCCOCO/N=C([C@H](C)[C@@H](O)[C@]1(C)O)/[C@H](C)C[C@@](C)(O)[C@@H]([C@@H](C)[C@@H]([C@@H](C)C(=O)O[C@@H]1CC)O[C@@H](C[C@@]2(C)OC)O[C@@H](C)[C@@H]2O)O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C
6298	sp|P9WQL9|DRRA_MYC	P08183	71.9	1034.0	1272.0	DB00813	approved; illicit; investigational; vet_approved	Fentanyl	c1ccccc1N(C(=O)CC)C2CCN(CC2)CCc3ccccc3
6299	sp|P9WQL9|DRRA_MYC	P08183	71.9	1034.0	1272.0	DB04877	experimental	Voacamine	CC[C@H]1C[C@@H](C2)CN([C@@H]1[C@@]23C(=O)OC)CCc4c3[nH]c5c4cc(OC)c(c5)[C@@H](C[C@H]67)c8c(c9c([nH]8)cccc9)C[C@H](C6C(=O)OC)N(C)CC\7=C\C
6300	sp|P9WQL9|DRRA_MYC	P08183	71.9	1034.0	1272.0	DB04881	investigational	Elacridar	COc1cccc(c12)c(=O)c3c([nH]2)c(ccc3)C(=O)Nc4ccc(cc4)CCN(C5)CCc(c56)cc(OC)c(c6)OC
6301	sp|P9WQL9|DRRA_MYC	P08183	71.9	1034.0	1272.0	DB04905	investigational	Tesmilifene	CCN(CC)CCOc1ccc(cc1)Cc2ccccc2
6302	sp|P9WQL9|DRRA_MYC	P08183	71.9	1034.0	1272.0	DB05449	investigational	FM-VP4	 
6303	sp|P9WQL9|DRRA_MYC	P08183	71.9	1034.0	1272.0	DB06191	investigational	Zosuquidar	FC1(F)[C@H]2[C@@H]1c(cccc3)c3[C@@H](c(c24)cccc4)N5CCN(CC5)C[C@@H](O)COc6cccc(c67)nccc7
6304	sp|P9WQL9|DRRA_MYC	P08183	71.9	1034.0	1272.0	DB06240	investigational	Tariquidar	COc(c1)c(OC)cc(c12)CCN(C2)CCc3ccc(cc3)NC(=O)c4cc(OC)c(OC)cc4NC(=O)c(c5)cnc(c56)cccc6
6305	sp|P9WQL9|DRRA_MYC	P08183	71.9	1034.0	1272.0	DB09031	approved; investigational	Miltefosine	CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C
6306	sp|P9WQL9|DRRA_MYC	P08183	71.9	1034.0	1272.0	DB11635	approved	Tocofersolan	 
6307	sp|P9WQL9|DRRA_MYC	P08183	71.9	1034.0	1272.0	DB14061	experimental	Hycanthone	CCN(CC)CCNc(ccc1CO)c(c12)c(=O)c3c(s2)cccc3
6308	sp|P9WQL9|DRRA_MYC	P08183	71.9	1034.0	1272.0	DB14062	experimental	Concanamycin A	NC(=O)O[C@@H]1[C@@H](C)O[C@H](C[C@H]1O)O[C@H](C2)[C@H](C)[C@@H](/C=C/C)O[C@@]2(O)[C@@H](C)[C@H](O)[C@H](C)[C@H]3OC(=O)/C(OC)=C/C(C)=C/[C@@H](C)[C@@H](O)[C@@H](CC)[C@@H](O)[C@H](C)C/C(C)=C/C=C/[C@@H]3OC
6309	sp|P9WQL9|DRRA_MYC	P08183	71.9	1034.0	1272.0	DB14063	experimental	Dexverapamil	COc1ccc(cc1OC)CCN(C)CCC[C@@](C#N)(C(C)C)c2cc(OC)c(OC)cc2
6310	sp|P9WQL9|DRRA_MYC	P08183	71.9	1034.0	1272.0	DB14064	experimental	Emopamil	c1ccccc1C(C#N)(C(C)C)CCCN(C)CCc2ccccc2
6311	sp|P9WQL9|DRRA_MYC	P08183	71.9	1034.0	1272.0	DB14065	experimental	Lomerizine	COc1ccc(c(OC)c1OC)CN2CCN(CC2)C(c3ccc(F)cc3)c4ccc(F)cc4
6312	sp|P9WQL9|DRRA_MYC	P08183	71.9	1034.0	1272.0	DB14066	experimental	Tetrandrine	c12ccc(OC)c(c1)Oc3ccc(cc3)C[C@H]4c5c(CCN4C)cc(OC)c(c5)Oc6c7c(CCN(C)[C@H]7C2)cc(OC)c6OC
6313	sp|P9WQL9|DRRA_MYC	P08183	71.9	1034.0	1272.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
6314	sp|P9WQL9|DRRA_MYC	P08183	71.9	1034.0	1272.0	DB14068	experimental	Dexniguldipine	[O-][N+](=O)c1cccc(c1)[C@@H]2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCCN(CC3)CCC3(c4ccccc4)c5ccccc5
6315	sp|P9WQL9|DRRA_MYC	P08183	71.9	1034.0	1272.0	DB14069	investigational	ONT-093	CCOC/C=C/c1ccc(cc1)-c2nc(-c3ccc(cc3)NC(C)C)c([nH]2)-c4ccc(cc4)NC(C)C
6316	sp|P9WQL9|DRRA_MYC	P08183	71.9	1034.0	1272.0	DB14070	experimental	HM-30181	c1cccc(c12)c(=O)cc(o2)C(=O)Nc3cc(OC)c(OC)cc3-c4nn(nn4)-c5ccc(cc5)CCN(C6)CCc(c67)cc(OC)c(c7)OC
6317	sp|P9WQL9|DRRA_MYC	P08183	71.9	1034.0	1272.0	DB14071	experimental	Desmethylsertraline	c1cccc(c12)[C@@H](CC[C@@H]2N)c3cc(Cl)c(Cl)cc3
6318	sp|P9WQL9|DRRA_MYC	P08183	71.9	1034.0	1272.0	DB14072	experimental	Reversin 121	c1ccccc1COC(=O)C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@H](C(=O)OC(C)(C)C)CCCCNC(=O)OCc2ccccc2
6319	sp|P9WQL9|DRRA_MYC	O95342	76.44	420.0	673.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
6320	sp|P9WQL9|DRRA_MYC	O95342	76.44	420.0	673.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
6321	sp|P9WQL9|DRRA_MYC	O95342	71.9	1077.0	1315.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
6322	sp|P9WQL9|DRRA_MYC	O95342	71.9	1077.0	1315.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
6323	sp|P9WQL9|DRRA_MYC	Q09428	81.27	675.0	944.0	DB00839	approved; investigational	Tolazamide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2
6324	sp|P9WQL9|DRRA_MYC	Q09428	81.27	675.0	944.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
6325	sp|P9WQL9|DRRA_MYC	Q09428	72.21	1341.0	1580.0	DB00839	approved; investigational	Tolazamide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2
6326	sp|P9WQL9|DRRA_MYC	Q09428	72.21	1341.0	1580.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
6327	sp|P9WQL9|DRRA_MYC	Q09428	81.27	675.0	944.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
6328	sp|P9WQL9|DRRA_MYC	Q09428	81.27	675.0	944.0	DB00222	approved	Glimepiride	CCC1=C(C)CN(C1=O)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3
6329	sp|P9WQL9|DRRA_MYC	Q09428	81.27	675.0	944.0	DB00672	approved; investigational	Chlorpropamide	CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1
6330	sp|P9WQL9|DRRA_MYC	Q09428	81.27	675.0	944.0	DB00731	approved; investigational	Nateglinide	CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](C(=O)O)Cc2ccccc2
6331	sp|P9WQL9|DRRA_MYC	Q09428	81.27	675.0	944.0	DB00912	approved; investigational	Repaglinide	CCOc1c(C(=O)O)ccc(c1)CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3
6332	sp|P9WQL9|DRRA_MYC	Q09428	81.27	675.0	944.0	DB01067	approved; investigational	Glipizide	Cc1ncc(nc1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
6333	sp|P9WQL9|DRRA_MYC	Q09428	81.27	675.0	944.0	DB01120	approved	Gliclazide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN(C2)CC(C23)CCC3
6334	sp|P9WQL9|DRRA_MYC	Q09428	81.27	675.0	944.0	DB01124	approved; investigational	Tolbutamide	CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1
6335	sp|P9WQL9|DRRA_MYC	Q09428	81.27	675.0	944.0	DB01251	approved; investigational	Gliquidone	COc(cc1)cc(c12)C(=O)N(C(=O)C2(C)C)CCc3ccc(cc3)S(=O)(=O)NC(=O)NC4CCCCC4
6336	sp|P9WQL9|DRRA_MYC	Q09428	81.27	675.0	944.0	DB01252	investigational	Mitiglinide	c1ccccc1C[C@H](C(=O)O)CC(=O)N(C2)C[C@H]([C@H]23)CCCC3
6337	sp|P9WQL9|DRRA_MYC	Q09428	81.27	675.0	944.0	DB01382	approved; investigational	Glymidine	COCCOc1cnc(nc1)NS(=O)(=O)c2ccccc2
6338	sp|P9WQL9|DRRA_MYC	Q09428	72.21	1341.0	1580.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
6339	sp|P9WQL9|DRRA_MYC	Q09428	72.21	1341.0	1580.0	DB00222	approved	Glimepiride	CCC1=C(C)CN(C1=O)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3
6340	sp|P9WQL9|DRRA_MYC	Q09428	72.21	1341.0	1580.0	DB00672	approved; investigational	Chlorpropamide	CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1
6341	sp|P9WQL9|DRRA_MYC	Q09428	72.21	1341.0	1580.0	DB00731	approved; investigational	Nateglinide	CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](C(=O)O)Cc2ccccc2
6342	sp|P9WQL9|DRRA_MYC	Q09428	72.21	1341.0	1580.0	DB00912	approved; investigational	Repaglinide	CCOc1c(C(=O)O)ccc(c1)CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3
6343	sp|P9WQL9|DRRA_MYC	Q09428	72.21	1341.0	1580.0	DB01067	approved; investigational	Glipizide	Cc1ncc(nc1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
6344	sp|P9WQL9|DRRA_MYC	Q09428	72.21	1341.0	1580.0	DB01120	approved	Gliclazide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN(C2)CC(C23)CCC3
6345	sp|P9WQL9|DRRA_MYC	Q09428	72.21	1341.0	1580.0	DB01124	approved; investigational	Tolbutamide	CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1
6346	sp|P9WQL9|DRRA_MYC	Q09428	72.21	1341.0	1580.0	DB01251	approved; investigational	Gliquidone	COc(cc1)cc(c12)C(=O)N(C(=O)C2(C)C)CCc3ccc(cc3)S(=O)(=O)NC(=O)NC4CCCCC4
6347	sp|P9WQL9|DRRA_MYC	Q09428	72.21	1341.0	1580.0	DB01252	investigational	Mitiglinide	c1ccccc1C[C@H](C(=O)O)CC(=O)N(C2)C[C@H]([C@H]23)CCCC3
6348	sp|P9WQL9|DRRA_MYC	Q09428	72.21	1341.0	1580.0	DB01382	approved; investigational	Glymidine	COCCOc1cnc(nc1)NS(=O)(=O)c2ccccc2
6349	sp|P9WQL9|DRRA_MYC	O60706	83.69	667.0	944.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
6350	sp|P9WQL9|DRRA_MYC	O60706	83.69	667.0	944.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
6351	sp|P9WQL9|DRRA_MYC	O60706	83.69	667.0	944.0	DB09220	approved; investigational	Nicorandil	[O-][N+](=O)OCCNC(=O)c1cccnc1
6352	sp|P9WQL9|DRRA_MYC	O60706	71.3	1311.0	1547.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
6353	sp|P9WQL9|DRRA_MYC	O60706	71.3	1311.0	1547.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
6354	sp|P9WQL9|DRRA_MYC	O60706	71.3	1311.0	1547.0	DB09220	approved; investigational	Nicorandil	[O-][N+](=O)OCCNC(=O)c1cccnc1
6355	sp|P9WQL9|DRRA_MYC	Q92887	70.69	1299.0	1533.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
6356	sp|P9WQL9|DRRA_MYC	Q92887	70.69	1299.0	1533.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
6357	sp|P9WQL9|DRRA_MYC	O15439	71.6	1041.0	1278.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
6358	sp|P9WQL9|DRRA_MYC	O15440	71.0	1192.0	1427.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
6359	sp|P9WQL9|DRRA_MYC	O15440	71.0	1192.0	1427.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
6360	sp|P9WQL9|DRRA_MYC	P13569	71.6	438.0	675.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
6361	sp|P9WQL9|DRRA_MYC	P13569	71.6	438.0	675.0	DB00887	approved	Bumetanide	CCCCNc1c(c(S(=O)(=O)N)cc(c1)C(=O)O)Oc2ccccc2
6362	sp|P9WQL9|DRRA_MYC	P13569	71.6	438.0	675.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
6363	sp|P9WQL9|DRRA_MYC	P13569	71.6	438.0	675.0	DB01050	approved	Ibuprofen	CC(C)Cc1ccc(cc1)C(C)C(=O)O
6364	sp|P9WQL9|DRRA_MYC	P13569	71.6	438.0	675.0	DB02587	experimental; investigational	Colforsin	O[C@H]1CCC(C)(C)[C@@H]([C@]12C)[C@H](O)[C@H](OC(=O)C)[C@]3(C)[C@]2(O)C(=O)C[C@](O3)(C)C=C
6365	sp|P9WQL9|DRRA_MYC	P13569	71.6	438.0	675.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
6366	sp|P9WQL9|DRRA_MYC	P13569	71.6	438.0	675.0	DB04522	experimental	Dexfosfoserine	OC(=O)[C@@H](N)COP(=O)(O)O
6367	sp|P9WQL9|DRRA_MYC	P13569	71.6	438.0	675.0	DB04941	approved	Crofelemer	 
6368	sp|P9WQL9|DRRA_MYC	P13569	71.6	438.0	675.0	DB06266	investigational	Lonidamine	c1cccc(c12)n(nc2C(=O)O)Cc3c(Cl)cc(Cl)cc3
6369	sp|P9WQL9|DRRA_MYC	P13569	71.6	438.0	675.0	DB08820	approved	Ivacaftor	CC(C)(C)c1cc(C(C)(C)C)c(O)cc1NC(=O)c(c2=O)c[nH]c(c23)cccc3
6370	sp|P9WQL9|DRRA_MYC	P13569	71.6	438.0	675.0	DB09213	approved; investigational	Dexibuprofen	CC(C)Cc1ccc(cc1)[C@H](C)C(=O)O
6371	sp|P9WQL9|DRRA_MYC	P13569	71.6	438.0	675.0	DB09280	approved	Lumacaftor	O=C(O)c1cccc(c1)-c2nc(ccc2C)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
6372	sp|P9WQL9|DRRA_MYC	P13569	71.6	438.0	675.0	DB11712	approved; investigational	Tezacaftor	OC[C@H](O)Cn1c(C(C)(C)CO)cc(c12)cc(c(F)c2)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
6373	sp|P9WQL9|DRRA_MYC	P13569	71.6	438.0	675.0	DB15444	approved; investigational	Elexacaftor	FC(F)(F)C(C)(C)COc1nn(cc1)-c2nc(N(C3(C)C)C[C@@H](C)C3)c(cc2)C(=O)NS(=O)(=O)c4cn(C)nc4C
6374	sp|P9WQL9|DRRA_MYC	P13569	71.6	1210.0	1447.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
6375	sp|P9WQL9|DRRA_MYC	P13569	71.6	1210.0	1447.0	DB00887	approved	Bumetanide	CCCCNc1c(c(S(=O)(=O)N)cc(c1)C(=O)O)Oc2ccccc2
6376	sp|P9WQL9|DRRA_MYC	P13569	71.6	1210.0	1447.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
6377	sp|P9WQL9|DRRA_MYC	P13569	71.6	1210.0	1447.0	DB01050	approved	Ibuprofen	CC(C)Cc1ccc(cc1)C(C)C(=O)O
6378	sp|P9WQL9|DRRA_MYC	P13569	71.6	1210.0	1447.0	DB02587	experimental; investigational	Colforsin	O[C@H]1CCC(C)(C)[C@@H]([C@]12C)[C@H](O)[C@H](OC(=O)C)[C@]3(C)[C@]2(O)C(=O)C[C@](O3)(C)C=C
6379	sp|P9WQL9|DRRA_MYC	P13569	71.6	1210.0	1447.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
6380	sp|P9WQL9|DRRA_MYC	P13569	71.6	1210.0	1447.0	DB04522	experimental	Dexfosfoserine	OC(=O)[C@@H](N)COP(=O)(O)O
6381	sp|P9WQL9|DRRA_MYC	P13569	71.6	1210.0	1447.0	DB04941	approved	Crofelemer	 
6382	sp|P9WQL9|DRRA_MYC	P13569	71.6	1210.0	1447.0	DB06266	investigational	Lonidamine	c1cccc(c12)n(nc2C(=O)O)Cc3c(Cl)cc(Cl)cc3
6383	sp|P9WQL9|DRRA_MYC	P13569	71.6	1210.0	1447.0	DB08820	approved	Ivacaftor	CC(C)(C)c1cc(C(C)(C)C)c(O)cc1NC(=O)c(c2=O)c[nH]c(c23)cccc3
6384	sp|P9WQL9|DRRA_MYC	P13569	71.6	1210.0	1447.0	DB09213	approved; investigational	Dexibuprofen	CC(C)Cc1ccc(cc1)[C@H](C)C(=O)O
6385	sp|P9WQL9|DRRA_MYC	P13569	71.6	1210.0	1447.0	DB09280	approved	Lumacaftor	O=C(O)c1cccc(c1)-c2nc(ccc2C)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
6386	sp|P9WQL9|DRRA_MYC	P13569	71.6	1210.0	1447.0	DB11712	approved; investigational	Tezacaftor	OC[C@H](O)Cn1c(C(C)(C)CO)cc(c12)cc(c(F)c2)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
6387	sp|P9WQL9|DRRA_MYC	P13569	71.6	1210.0	1447.0	DB15444	approved; investigational	Elexacaftor	FC(F)(F)C(C)(C)COc1nn(cc1)-c2nc(N(C3(C)C)C[C@@H](C)C3)c(cc2)C(=O)NS(=O)(=O)c4cn(C)nc4C
6388	sp|P9WNL9|EMBA_MYC	P9WNL9	99.91	1.0	1094.0	DB00330	approved	Ethambutol	CC[C@@H](CO)NCCN[C@@H](CC)CO
6389	sp|P9WNL9|EMBA_MYC	P9WNL7	98.26	21.0	1096.0	DB00330	approved	Ethambutol	CC[C@@H](CO)NCCN[C@@H](CC)CO
6390	sp|P9WNL9|EMBA_MYC	P9WNL5	97.62	24.0	1092.0	DB00330	approved	Ethambutol	CC[C@@H](CO)NCCN[C@@H](CC)CO
6391	sp|P9WQ37|FAC13_MY	Q8GN86	99.8	1.0	503.0	DB03728	experimental	p-Chlorobenzoic acid	OC(=O)c1ccc(Cl)cc1
6392	sp|P9WQ37|FAC13_MY	P40871	100.2	26.0	530.0	DB01672	experimental	2,3-Dihydroxy-Benzoic Acid	OC(=O)c1cccc(O)c1O
6393	sp|P9WQ37|FAC13_MY	Q9NR19	107.55	128.0	669.0	DB00131	approved; investigational; nutraceutical	Adenosine phosphate	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
6394	sp|P9WQ37|FAC13_MY	Q9NR19	107.55	128.0	669.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
6395	sp|P9WQ37|FAC13_MY	Q8ZKF6	102.58	102.0	618.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
6396	sp|P9WQ37|FAC13_MY	Q8ZKF6	102.58	102.0	618.0	DB03230	experimental	Adenosine-5'-Propylphosphate	CCCOP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
6397	sp|P9WQ37|FAC13_MY	Q9NUB1	106.96	115.0	653.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
6398	sp|P9WP31|DDL_MYCT	P0A6J8	94.1	3.0	354.0	DB00260	approved	Cycloserine	N[C@@H]1CONC1=O
6399	sp|P9WP31|DDL_MYCT	Q5HEB7	91.69	3.0	345.0	DB07805	experimental	3-CHLORO-2,2-DIMETHYL-N-[4-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE	ClCC(C)(C)C(=O)Nc1ccc(C(F)(F)F)cc1
6400	sp|P9WNM9|EFGL_MYC	P13551	95.38	9.0	690.0	DB02703	approved; investigational	Fusidic acid	CC(C)=CCC/C(C(=O)O)=C(/[C@H](C1)OC(=O)C)[C@@H]([C@]12C)C[C@@H](O)[C@@H]3[C@]2(C)CC[C@@H]4[C@]3(C)CC[C@@H](O)[C@H]4C
6401	sp|P9WNM9|EFGL_MYC	P13551	95.38	9.0	690.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
6402	sp|P9WMP1|CGOX_MYC	P32397	101.55	6.0	465.0	DB07338	experimental	Acifluorfen	OC(=O)c1c([N+]([O-])=O)ccc(c1)Oc2ccc(C(F)(F)F)cc2Cl
6403	sp|P9WMP1|CGOX_MYC	P56601	100.66	8.0	463.0	DB07338	experimental	Acifluorfen	OC(=O)c1c([N+]([O-])=O)ccc(c1)Oc2ccc(C(F)(F)F)cc2Cl
6404	sp|P9WP55|CYSK_MYC	P35520	99.35	76.0	384.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
6405	sp|P9WP55|CYSK_MYC	P35520	99.35	76.0	384.0	DB00118	approved; investigational; nutraceutical	Ademetionine	[O-]C(=O)[C@@H](N)CC[S+](C)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
6406	sp|P9WP55|CYSK_MYC	P35520	99.35	76.0	384.0	DB00133	investigational; nutraceutical	Serine	OC(=O)[C@@H](N)CO
6407	sp|P9WP55|CYSK_MYC	P35520	99.35	76.0	384.0	DB00151	approved; nutraceutical	Cysteine	OC(=O)[C@@H](N)CS
6408	sp|P9WP55|CYSK_MYC	Q9GZT4	97.74	18.0	321.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
6409	sp|P9WP55|CYSK_MYC	Q9GZT4	97.74	18.0	321.0	DB00133	investigational; nutraceutical	Serine	OC(=O)[C@@H](N)CO
6410	sp|P9WP55|CYSK_MYC	P0A2K1	107.42	53.0	386.0	DB03171	experimental	Indole-3-Propanol Phosphate	OP(=O)(O)OCCCc1c[nH]c(c12)cccc2
6411	sp|P9WP55|CYSK_MYC	P0A2K1	107.42	53.0	386.0	DB04143	experimental	Indole-3-Glycerol Phosphate	OP(=O)(O)OC[C@@H](O)[C@@H](O)c1c[nH]c(c12)cccc2
6412	sp|P9WP55|CYSK_MYC	P0A2K1	107.42	53.0	386.0	DB07732	experimental	2-[(2-NAPHTHYLSULFONYL)AMINO]ETHYL DIHYDROGEN PHOSPHATE	OP(=O)(O)OCCNS(=O)(=O)c(cc1)cc(c12)cccc2
6413	sp|P9WP55|CYSK_MYC	P0A2K1	107.42	53.0	386.0	DB07745	experimental	2-{[4-(TRIFLUOROMETHOXY)BENZOYL]AMINO}ETHYL DIHYDROGEN PHOSPHATE	OP(=O)(O)OCCNC(=O)c1ccc(OC(F)(F)F)cc1
6414	sp|P9WP55|CYSK_MYC	P0A2K1	107.42	53.0	386.0	DB07748	experimental	2-({[4-(TRIFLUOROMETHOXY)PHENYL]SULFONYL}AMINO)ETHYL DIHYDROGEN PHOSPHATE	OP(=O)(O)OCCNS(=O)(=O)c1ccc(OC(F)(F)F)cc1
6415	sp|P9WP55|CYSK_MYC	P0A2K1	107.42	53.0	386.0	DB07773	experimental	5-FLUOROINDOLE PROPANOL PHOSPHATE	OP(=O)(O)OCCCc1c[nH]c(c12)ccc(F)c2
6416	sp|P9WP55|CYSK_MYC	P0A2K1	107.42	53.0	386.0	DB07890	experimental	4-(2-HYDROXYPHENYLTHIO)-1-BUTENYLPHOSPHONIC ACID	Oc1ccccc1SCC/C=C/P(=O)(O)O
6417	sp|P9WP55|CYSK_MYC	P0A2K1	107.42	53.0	386.0	DB07894	experimental	4-(2-HYDROXY-4-FLUOROPHENYLTHIO)-BUTYLPHOSPHONIC ACID	Oc1ccc(F)cc1SCC/C=C/P(=O)(O)O
6418	sp|P9WP55|CYSK_MYC	P0A2K1	107.42	53.0	386.0	DB07925	experimental	4-(2-HYDROXYPHENYLSULFINYL)-BUTYLPHOSPHONIC ACID	Oc1ccccc1[S@](=O)CCCCP(=O)(O)O
6419	sp|P9WP55|CYSK_MYC	P0A2K1	107.42	53.0	386.0	DB07951	experimental	N-(indole-3-acetyl)-L-aspartic acid	OC(=O)C[C@@H](C(=O)O)NC(=O)Cc1c[nH]c(c12)cccc2
6420	sp|P9WP55|CYSK_MYC	P0A2K1	107.42	53.0	386.0	DB07952	experimental	N-[1H-INDOL-3-YL-ACETYL]GLYCINE ACID	OC(=O)CNC(=O)Cc1c[nH]c(c12)cccc2
6421	sp|P9WP55|CYSK_MYC	P0A2K1	107.42	53.0	386.0	DB07953	experimental	N-[1H-INDOL-3-YL-ACETYL]VALINE ACID	CC(C)[C@@H](C(=O)O)NC(=O)Cc1c[nH]c(c12)cccc2
6422	sp|P9WP55|CYSK_MYC	Q96GA7	90.65	14.0	295.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
6423	sp|P9WP55|CYSK_MYC	P20132	90.32	10.0	290.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
6424	sp|P9WP55|CYSK_MYC	P20132	90.32	10.0	290.0	DB00133	investigational; nutraceutical	Serine	OC(=O)[C@@H](N)CO
6425	sp|P9WP55|CYSK_MYC	Q00740	90.0	13.0	292.0	DB01735	experimental	3-Chloroalaninate	[O-]C(=O)[C@H]([NH3+])CCl
6426	sp|P9WP55|CYSK_MYC	Q00740	90.0	13.0	292.0	DB01804	experimental	2-Ammoniobut-3-Enoate, 2-Amino-3-Butenoate	[O-]C(=O)[C@H]([NH3+])C=C
6427	sp|P9WP55|CYSK_MYC	Q00740	90.0	13.0	292.0	DB02085	experimental	1-Aminocyclopropanecarboxylic Acid	OC(=O)C1(N)CC1
6428	sp|P9WP55|CYSK_MYC	Q00740	90.0	13.0	292.0	DB03053	experimental	1-Aminocyclopropylphosphonate	OP([O-])(=O)C1(N)CC1
6429	sp|P9WP55|CYSK_MYC	Q00740	90.0	13.0	292.0	DB04212	experimental	2-Iminiopropanoate	CC(=[NH2+])C([O-])=O
6430	sp|P9WP55|CYSK_MYC	Q00740	90.0	13.0	292.0	DB04553	experimental	2-Oxobutanoic Acid	CCC(=O)C(=O)O
6431	sp|P9WH05|DEAD_MYC	Q9TY94	71.23	51.0	452.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
6432	sp|P9WQG1|ACDP_MYC	Q72JJ3	96.14	5.0	379.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
6433	sp|P9WQG1|ACDP_MYC	P16219	97.94	27.0	408.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
6434	sp|P9WQG1|ACDP_MYC	P16219	97.94	27.0	408.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
6435	sp|P9WQG1|ACDP_MYC	P16219	97.94	27.0	408.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
6436	sp|P9WQG1|ACDP_MYC	Q06319	97.69	3.0	383.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
6437	sp|P9WQG1|ACDP_MYC	Q06319	97.69	3.0	383.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
6438	sp|P9WQG1|ACDP_MYC	P11310	96.66	38.0	414.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
6439	sp|P9WQG1|ACDP_MYC	P11310	96.66	38.0	414.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
6440	sp|P9WQG1|ACDP_MYC	P11310	96.66	38.0	414.0	DB03415	experimental	3-thiaoctanoyl-CoA	CCCCCSCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
6441	sp|P9WQG1|ACDP_MYC	P45954	96.14	54.0	428.0	DB00167	investigational; nutraceutical	Isoleucine	CC[C@H](C)[C@H](N)C(=O)O
6442	sp|P9WQG1|ACDP_MYC	P45954	96.14	54.0	428.0	DB00313	approved; investigational	Valproic acid	CCCC(C(=O)O)CCC
6443	sp|P9WQG1|ACDP_MYC	Q9UKU7	96.66	37.0	413.0	DB01675	experimental	Methacrylyl-Coenzyme A	CC(=C)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
6444	sp|P9WQG1|ACDP_MYC	Q9UKU7	96.66	37.0	413.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
6445	sp|P9WQG1|ACDP_MYC	P26440	96.66	41.0	417.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
6446	sp|P9WQG1|ACDP_MYC	P26440	96.66	41.0	417.0	DB04036	experimental	Coenzyme A persulfide	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSS
6447	sp|P9WQG1|ACDP_MYC	Q3JP94	96.66	11.0	387.0	DB08685	experimental	1-(1,4-dimethyl-1,2,3,4-tetrahydroquinoxalin-6-yl)methanamine	CN1CCN(C)c(c12)cc(cc2)CN
6448	sp|P9WQG1|ACDP_MYC	Q92947	95.37	57.0	428.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
6449	sp|P9WQG1|ACDP_MYC	Q92947	95.37	57.0	428.0	DB03245	experimental	S-4-Nitrobutyryl-CoA	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCC[N+]([O-])=O
6450	sp|P9WQG1|ACDP_MYC	Q9KIE5	90.75	9.0	362.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
6451	sp|P9WQG1|ACDP_MYC	Q15067	85.09	105.0	436.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
6452	sp|P9WQG1|ACDP_MYC	Q15067	85.09	105.0	436.0	DB07930	experimental	(3R)-3-HYDROXYDODECANOIC ACID	OC(=O)C[C@H](O)CCCCCCCCC
6453	sp|P9WQ87|BIOF1_MY	P13196	95.85	216.0	586.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
6454	sp|P9WQ87|BIOF1_MY	P13196	95.85	216.0	586.0	DB00145	approved; nutraceutical; vet_approved	Glycine	NCC(=O)O
6455	sp|P9WQ87|BIOF1_MY	Q5JAM2	95.85	216.0	586.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
6456	sp|P9WQ87|BIOF1_MY	P22557	96.37	162.0	534.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
6457	sp|P9WQ87|BIOF1_MY	P22557	96.37	162.0	534.0	DB00145	approved; nutraceutical; vet_approved	Glycine	NCC(=O)O
6458	sp|P9WQ87|BIOF1_MY	O15270	101.04	138.0	528.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
6459	sp|P9WQ87|BIOF1_MY	O15270	101.04	138.0	528.0	DB00133	investigational; nutraceutical	Serine	OC(=O)[C@@H](N)CO
6460	sp|P9WQ87|BIOF1_MY	Q9NUV7	101.04	130.0	520.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
6461	sp|P9WQ87|BIOF1_MY	P0AB77	89.38	43.0	388.0	DB03915	experimental	2-Amino-3-Ketobutyric Acid	CC(=O)[C@H](N)C(=O)O
6462	sp|P9WQ87|BIOF1_MY	O75600	90.67	58.0	408.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
6463	sp|P9WQ87|BIOF1_MY	O75600	90.67	58.0	408.0	DB00145	approved; nutraceutical; vet_approved	Glycine	NCC(=O)O
6464	sp|P9WQ87|BIOF1_MY	Q9KM65	90.93	30.0	381.0	DB08364	experimental	1-{[(1E)-(3-HYDROXY-2-METHYL-5-{[(TRIHYDROXY-LAMBDA^5^-PHOSPHANYL)OXY]METHYL}PYRIDIN-4-YL)METHYLIDENE]AMINO}UNDECAN-2-ONE	CCCCCCCCCC(=O)C/N=C/c1c(COP(O)(O)O)cnc(C)c1O
6465	sp|P9WQ87|BIOF1_MY	P12998	88.08	40.0	380.0	DB03160	experimental	N-Pyridoxyl-7-Keto-8-Aminopelargonic Acid-5'-Monophosphate	OC(=O)CCCCCC(=O)[C@H](C)NCc1c(COP(=O)(O)O)cnc(C)c1O
6466	sp|P9WQ87|BIOF1_MY	O15269	95.34	98.0	466.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
6467	sp|P9WQ87|BIOF1_MY	O15269	95.34	98.0	466.0	DB00133	investigational; nutraceutical	Serine	OC(=O)[C@@H](N)CO
6468	sp|P9WQ87|BIOF1_MY	P0A827	88.08	28.0	368.0	DB02824	experimental	N-Pyridoxyl-Glycine-5-Monophosphate	Cc1ncc(COP(=O)(O)O)c(c1O)CNCC(=O)O
6469	sp|P9WQ87|BIOF1_MY	P0A827	88.08	28.0	368.0	DB11596	approved; investigational	Levoleucovorin	Nc([nH]1)nc(=O)c(c12)N(C=O)[C@H](CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
6470	sp|P9WQ87|BIOF1_MY	Q5KUI2	85.23	38.0	367.0	DB03256	experimental	(6R)-Folinic acid	Nc([nH]1)nc(=O)c(c12)N(C=O)[C@@H](CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
6471	sp|P9WQ87|BIOF1_MY	Q9X266	79.02	29.0	334.0	DB02824	experimental	N-Pyridoxyl-Glycine-5-Monophosphate	Cc1ncc(COP(=O)(O)O)c(c1O)CNCC(=O)O
6472	sp|P9WQ87|BIOF1_MY	Q9X266	79.02	29.0	334.0	DB03576	experimental	N-Pyridoxyl-Threonine-5-Monophosphate	CC(O)C(C(=O)O)NCc1c(COP(=O)(O)O)cnc(C)c1O
6473	sp|P9WQ87|BIOF1_MY	Q9X266	79.02	29.0	334.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
6474	sp|P9WQ87|BIOF1_MY	Q53ET4	83.16	94.0	415.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
6475	sp|P9WQ87|BIOF1_MY	Q53ET4	83.16	94.0	415.0	DB00116	nutraceutical	Tetrahydrofolic acid	Nc([nH]1)nc(=O)c(c12)NC(CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
6476	sp|P9WQ87|BIOF1_MY	Q53ET4	83.16	94.0	415.0	DB00145	approved; nutraceutical; vet_approved	Glycine	NCC(=O)O
6477	sp|P9WQ87|BIOF1_MY	P34897	83.16	94.0	415.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
6478	sp|P9WQ87|BIOF1_MY	P34897	83.16	94.0	415.0	DB00116	nutraceutical	Tetrahydrofolic acid	Nc([nH]1)nc(=O)c(c12)NC(CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
6479	sp|P9WQ87|BIOF1_MY	P34897	83.16	94.0	415.0	DB00145	approved; nutraceutical; vet_approved	Glycine	NCC(=O)O
6480	sp|P9WQ87|BIOF1_MY	P34897	83.16	94.0	415.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
6481	sp|P9WQ87|BIOF1_MY	P34896	89.64	70.0	416.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
6482	sp|P9WQ87|BIOF1_MY	P34896	89.64	70.0	416.0	DB00116	nutraceutical	Tetrahydrofolic acid	Nc([nH]1)nc(=O)c(c12)NC(CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
6483	sp|P9WQ87|BIOF1_MY	P34896	89.64	70.0	416.0	DB00145	approved; nutraceutical; vet_approved	Glycine	NCC(=O)O
6484	sp|P9WQ87|BIOF1_MY	P34896	89.64	70.0	416.0	DB01055	experimental	Mimosine	OC(=O)[C@@H](N)Cn1ccc(=O)c(O)c1
6485	sp|P9WQ87|BIOF1_MY	P34896	89.64	70.0	416.0	DB02067	experimental	Triglu-5-formyl-tetrahydrofolate	Nc([nH]1)nc(=O)c(c12)N(C=O)[C@H](CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)N[C@H](C(=O)O)CCC(=O)N[C@H](C(=O)O)CCC(=O)O
6486	sp|P9WQ87|BIOF1_MY	P34896	89.64	70.0	416.0	DB02800	experimental	5-hydroxymethyl-5,6-dihydrofolic acid	O=c1[nH]c(N)nc(c12)N=C[C@@H](N2CO)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
6487	sp|P9WQ87|BIOF1_MY	P34896	89.64	70.0	416.0	DB02824	experimental	N-Pyridoxyl-Glycine-5-Monophosphate	Cc1ncc(COP(=O)(O)O)c(c1O)CNCC(=O)O
6488	sp|P9WPE7|CH602_MY	P10809	99.44	27.0	564.0	DB09130	approved; investigational	Copper	[Cu]
6489	sp|P9WPT3|CTPD_MYC	P03960	80.06	46.0	572.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
6490	sp|P9WNP1|ECHA6_MY	P30084	100.82	43.0	288.0	DB02563	experimental	Hexanoyl-CoA	CCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
6491	sp|P9WNP1|ECHA6_MY	P30084	100.82	43.0	288.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
6492	sp|P9WNP1|ECHA6_MY	P30084	100.82	43.0	288.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
6493	sp|P9WNP1|ECHA6_MY	P30084	100.82	43.0	288.0	DB04117	experimental	4-(N,N-Dimethylamino)cinnamoyl-CoA	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)/C=C/c4ccc(cc4)N(C)C
6494	sp|P9WNP1|ECHA6_MY	P30084	100.82	43.0	288.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
6495	sp|P9WNP1|ECHA6_MY	P52045	104.53	6.0	260.0	DB03117	experimental	2-carboxypropyl-coenzyme A	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC[C@H](C)C(=O)O
6496	sp|P9WNP1|ECHA6_MY	O75521	102.06	143.0	391.0	DB08231	experimental	Myristic acid	CCCCCCCCCCCCCC(=O)O
6497	sp|P9WNP1|ECHA6_MY	P9WNP5	108.64	43.0	307.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
6498	sp|P9WNP1|ECHA6_MY	P9WNP5	108.64	43.0	307.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
6499	sp|P9WNP1|ECHA6_MY	O68600	88.48	5.0	220.0	DB01652	experimental	4-hydroxybenzoyl-CoA	Oc1ccc(cc1)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2OP(=O)(O)O)n3cnc(c34)c(N)ncn4
6500	sp|P9WNP1|ECHA6_MY	Q08426	83.54	7.0	210.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
6501	sp|P9WNP1|ECHA6_MY	Q6NVY1	85.19	46.0	253.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
6502	sp|P9WNP1|ECHA6_MY	P42126	98.77	56.0	296.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
6503	sp|P9WNP1|ECHA6_MY	P42126	98.77	56.0	296.0	DB03127	experimental	Benzamidine	NC(=[NH2+])c1ccccc1
6504	sp|P9WNP1|ECHA6_MY	P40939	73.25	45.0	223.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
6505	sp|P9WNP1|ECHA6_MY	P28793	78.6	14.0	205.0	DB08249	experimental	3,6,9,12,15-PENTAOXATRICOSAN-1-OL	CCCCCCCCOCCOCCOCCOCCOCCO
6506	sp|P9WNP1|ECHA6_MY	Q93TU6	77.37	41.0	229.0	DB02906	experimental	(2s,4s)-Alpha-Campholinic Acid	CC1(C)[C@H](C)C(=O)C[C@H]1CC(O)O
6507	tr|Q3HKR4|Q3HKR4_M	P9WNL7	99.43	300.0	474.0	DB00330	approved	Ethambutol	CC[C@@H](CO)NCCN[C@@H](CC)CO
6508	tr|Q3HKR4|Q3HKR4_M	P9WNL5	99.43	294.0	468.0	DB00330	approved	Ethambutol	CC[C@@H](CO)NCCN[C@@H](CC)CO
6509	tr|Q3HKR4|Q3HKR4_M	P9WNL9	98.86	274.0	447.0	DB00330	approved	Ethambutol	CC[C@@H](CO)NCCN[C@@H](CC)CO
6510	tr|A0A2Z3DKC1|A0A2	P9WIE5	99.5	266.0	467.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
6511	tr|A0A2Z3DKC1|A0A2	P9WIE5	99.5	266.0	467.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
6512	tr|A0A2Z3DKC1|A0A2	Q939D2	99.01	255.0	455.0	DB08638	experimental	1-hydroperoxy-L-tryptophan	c1cccc(c12)n(OO)cc2C[C@H](N)C(=O)O
6513	tr|A6ZI23|A6ZI23_M	P0A8V2	95.83	481.0	550.0	DB00615	approved; investigational	Rifabutin	CC(C)CN(CC1)CCC12N=C3c4c5c6c(C)c(O)c4C(=O)C(=C3N2)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(=O)C)[C@H](C)[C@@H](OC)/C=C/O[C@](O6)(C)C5=O
6514	tr|A6ZI23|A6ZI23_M	P0A8V2	95.83	481.0	550.0	DB01045	approved	Rifampicin	C[C@@]12O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(=O)C)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)Nc3c(/C=N/N4CCN(C)CC4)c(O)c5c(C1=O)c(O2)c(C)c(O)c5c3O
6515	tr|A6ZI23|A6ZI23_M	P0A8V2	95.83	481.0	550.0	DB01220	approved; investigational	Rifaximin	C[C@]12O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(=O)C)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)Nc3c4c(nc5n4ccc(c5)C)c6c(c3O)c(O)c(C)c(O1)c6C2=O
6516	tr|A6ZI23|A6ZI23_M	P0A8V2	95.83	481.0	550.0	DB04934	investigational	Rifalazil	C[C@]12O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(=O)C)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)Nc3c4c(c5c(c3=O)c(O)c(C)c(O1)c5C2=O)nc6c(o4)cc(cc6O)N7CCN(CC7)CC(C)C
6517	tr|A6ZI23|A6ZI23_M	P0A8V2	95.83	481.0	550.0	DB11753	approved; investigational	Rifamycin	C[C@@]12O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(=O)C)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)Nc3c(O)c4c(c(c3)O)c(C1=O)c(O2)c(C)c4O
6518	tr|A6ZI23|A6ZI23_M	Q8RQE9	93.06	363.0	430.0	DB04788	experimental	Tagetitoxin	OP(=O)(O)O[C@@H]([C@@]12C(=O)O)[C@@H](N)[C@@H](OC(=O)C)[C@@H](O2)[C@@](O)(SC1)C(=O)N
6519	tr|A6ZI23|A6ZI23_M	Q8RQE9	93.06	363.0	430.0	DB08226	experimental	Myxopyronin B	CCCC/C(C)=C/C=C(\C)C(=O)c1c(O)cc(oc1=O)CCC/C=C/NC(=O)OC
6520	tr|A6ZI23|A6ZI23_M	Q8RQE9	93.06	363.0	430.0	DB08266	experimental	Methyl [(1E,5R)-5-{3-[(2E,4E)-2,5-dimethyl-2,4-octadienoyl]-2,4-dioxo-3,4-dihydro-2H-pyran-6-yl}hexylidene]carbamate	COC(=O)/N=C/CCC[C@@H](C)C1=CC(=O)C(C(=O)O1)C(=O)/C(C)=C/C=C(\C)CCC
6521	tr|A0A0N9DS11|A0A0	P9WIE5	99.86	1.0	740.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
6522	tr|A0A0N9DS11|A0A0	P9WIE5	99.86	1.0	740.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
6523	tr|A0A0N9DS11|A0A0	Q939D2	96.49	13.0	727.0	DB08638	experimental	1-hydroperoxy-L-tryptophan	c1cccc(c12)n(OO)cc2C[C@H](N)C(=O)O
6524	tr|D9YMC3|D9YMC3_M	Q8RQE9	92.98	71.0	177.0	DB04788	experimental	Tagetitoxin	OP(=O)(O)O[C@@H]([C@@]12C(=O)O)[C@@H](N)[C@@H](OC(=O)C)[C@@H](O2)[C@@](O)(SC1)C(=O)N
6525	tr|D9YMC3|D9YMC3_M	Q8RQE9	92.98	71.0	177.0	DB08226	experimental	Myxopyronin B	CCCC/C(C)=C/C=C(\C)C(=O)c1c(O)cc(oc1=O)CCC/C=C/NC(=O)OC
6526	tr|D9YMC3|D9YMC3_M	Q8RQE9	92.98	71.0	177.0	DB08266	experimental	Methyl [(1E,5R)-5-{3-[(2E,4E)-2,5-dimethyl-2,4-octadienoyl]-2,4-dioxo-3,4-dihydro-2H-pyran-6-yl}hexylidene]carbamate	COC(=O)/N=C/CCC[C@@H](C)C1=CC(=O)C(C(=O)O1)C(=O)/C(C)=C/C=C(\C)CCC
6527	tr|D9YMC3|D9YMC3_M	P0A8V2	101.75	73.0	189.0	DB00615	approved; investigational	Rifabutin	CC(C)CN(CC1)CCC12N=C3c4c5c6c(C)c(O)c4C(=O)C(=C3N2)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(=O)C)[C@H](C)[C@@H](OC)/C=C/O[C@](O6)(C)C5=O
6528	tr|D9YMC3|D9YMC3_M	P0A8V2	101.75	73.0	189.0	DB01045	approved	Rifampicin	C[C@@]12O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(=O)C)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)Nc3c(/C=N/N4CCN(C)CC4)c(O)c5c(C1=O)c(O2)c(C)c(O)c5c3O
6529	tr|D9YMC3|D9YMC3_M	P0A8V2	101.75	73.0	189.0	DB01220	approved; investigational	Rifaximin	C[C@]12O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(=O)C)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)Nc3c4c(nc5n4ccc(c5)C)c6c(c3O)c(O)c(C)c(O1)c6C2=O
6530	tr|D9YMC3|D9YMC3_M	P0A8V2	101.75	73.0	189.0	DB04934	investigational	Rifalazil	C[C@]12O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(=O)C)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)Nc3c4c(c5c(c3=O)c(O)c(C)c(O1)c5C2=O)nc6c(o4)cc(cc6O)N7CCN(CC7)CC(C)C
6531	tr|D9YMC3|D9YMC3_M	P0A8V2	101.75	73.0	189.0	DB11753	approved; investigational	Rifamycin	C[C@@]12O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(=O)C)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)Nc3c(O)c4c(c(c3)O)c(C1=O)c(O2)c(C)c4O
6532	tr|A0A0N9DS19|A0A0	P9WIE5	99.06	1.0	106.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
6533	tr|A0A0N9DS19|A0A0	P9WIE5	99.06	1.0	106.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
6534	tr|A0A0N9DS19|A0A0	Q939D2	72.64	13.0	90.0	DB08638	experimental	1-hydroperoxy-L-tryptophan	c1cccc(c12)n(OO)cc2C[C@H](N)C(=O)O
6535	tr|A0A0N9DS93|A0A0	P9WIE5	98.58	1.0	210.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
6536	tr|A0A0N9DS93|A0A0	P9WIE5	98.58	1.0	210.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
6537	tr|A0A0N9DS93|A0A0	Q939D2	83.02	13.0	189.0	DB08638	experimental	1-hydroperoxy-L-tryptophan	c1cccc(c12)n(OO)cc2C[C@H](N)C(=O)O
6538	tr|A0A0N9DRY5|A0A0	P9WIE5	99.86	1.0	740.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
6539	tr|A0A0N9DRY5|A0A0	P9WIE5	99.86	1.0	740.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
6540	tr|A0A0N9DRY5|A0A0	Q939D2	96.49	13.0	727.0	DB08638	experimental	1-hydroperoxy-L-tryptophan	c1cccc(c12)n(OO)cc2C[C@H](N)C(=O)O
6541	tr|A0A0N9DS09|A0A0	P9WIE5	87.12	1.0	143.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
6542	tr|A0A0N9DS09|A0A0	P9WIE5	87.12	1.0	143.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
6543	tr|A0A0N9DS09|A0A0	Q939D2	70.55	12.0	127.0	DB08638	experimental	1-hydroperoxy-L-tryptophan	c1cccc(c12)n(OO)cc2C[C@H](N)C(=O)O
6544	tr|A0A0N6WYQ2|A0A0	P9WIE5	94.21	1.0	440.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
6545	tr|A0A0N6WYQ2|A0A0	P9WIE5	94.21	1.0	440.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
6546	tr|A0A0N6WYQ2|A0A0	Q939D2	88.84	13.0	427.0	DB08638	experimental	1-hydroperoxy-L-tryptophan	c1cccc(c12)n(OO)cc2C[C@H](N)C(=O)O
6547	tr|F2X2D5|F2X2D5_M	P0A4L9	97.44	435.0	473.0	DB01044	approved; investigational	Gatifloxacin	CC1CN(CCN1)c(c(F)c2)c(OC)c(c23)n(C4CC4)cc(c3=O)C(=O)O
6548	tr|F2X2D5|F2X2D5_M	Q59961	97.44	435.0	473.0	DB01044	approved; investigational	Gatifloxacin	CC1CN(CCN1)c(c(F)c2)c(OC)c(c23)n(C4CC4)cc(c3=O)C(=O)O
6549	tr|F2X2D5|F2X2D5_M	Q59192	97.44	431.0	469.0	DB00537	approved; investigational	Ciprofloxacin	O=C(O)c(c1=O)cn(C2CC2)c(c13)cc(c(F)c3)N4CCNCC4
6550	tr|F2X2D5|F2X2D5_M	Q5SHZ4	97.44	424.0	462.0	DB01942	experimental; investigational	Formic acid	OC=O
6551	tr|F2X2D5|F2X2D5_M	P0A0K8	97.44	437.0	475.0	DB01051	approved; investigational; vet_approved	Novobiocin	CO[C@@H](C1(C)C)[C@@H](OC(=O)N)[C@@H](O)[C@@H](O1)Oc(cc2)c(C)c(c23)oc(=O)c(c3O)NC(=O)c4ccc(O)c(c4)CC=C(C)C
6552	tr|F2X2D5|F2X2D5_M	P0AES6	94.87	426.0	463.0	DB00817	approved; investigational	Rosoxacin	CCn1cc(C(=O)O)c(=O)c(c12)ccc(c2)-c3ccncc3
6553	tr|F2X2D5|F2X2D5_M	P0AES6	94.87	426.0	463.0	DB03966	experimental	Clorobiocin	Cc1[nH]c(cc1)C(=O)O[C@H]([C@@H](OC)C2(C)C)[C@@H](O)[C@@H](O2)Oc(cc3)c(Cl)c(c34)oc(=O)c(c4O)NC(=O)c5cc(c(O)cc5)CC=C(C)C
6554	tr|F2X2D5|F2X2D5_M	P0AES6	94.87	426.0	463.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
6555	tr|F2X2D5|F2X2D5_M	P0AES6	94.87	426.0	463.0	DB05488	investigational	Technetium Tc-99m ciprofloxacin	 
6556	tr|F2X2D5|F2X2D5_M	P20083	94.87	420.0	457.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
6557	tr|A0A0N9DS13|A0A0	P9WIE5	99.86	1.0	740.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
6558	tr|A0A0N9DS13|A0A0	P9WIE5	99.86	1.0	740.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
6559	tr|A0A0N9DS13|A0A0	Q939D2	96.49	13.0	727.0	DB08638	experimental	1-hydroperoxy-L-tryptophan	c1cccc(c12)n(OO)cc2C[C@H](N)C(=O)O
6560	tr|A0A0N9DS04|A0A0	P9WIE5	97.64	1.0	539.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
6561	tr|A0A0N9DS04|A0A0	P9WIE5	97.64	1.0	539.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
6562	tr|A0A0N9DS04|A0A0	Q939D2	93.47	11.0	526.0	DB08638	experimental	1-hydroperoxy-L-tryptophan	c1cccc(c12)n(OO)cc2C[C@H](N)C(=O)O
6563	tr|G0ZF28|G0ZF28_M	P0A8V2	99.14	477.0	592.0	DB00615	approved; investigational	Rifabutin	CC(C)CN(CC1)CCC12N=C3c4c5c6c(C)c(O)c4C(=O)C(=C3N2)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(=O)C)[C@H](C)[C@@H](OC)/C=C/O[C@](O6)(C)C5=O
6564	tr|G0ZF28|G0ZF28_M	P0A8V2	99.14	477.0	592.0	DB01045	approved	Rifampicin	C[C@@]12O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(=O)C)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)Nc3c(/C=N/N4CCN(C)CC4)c(O)c5c(C1=O)c(O2)c(C)c(O)c5c3O
6565	tr|G0ZF28|G0ZF28_M	P0A8V2	99.14	477.0	592.0	DB01220	approved; investigational	Rifaximin	C[C@]12O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(=O)C)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)Nc3c4c(nc5n4ccc(c5)C)c6c(c3O)c(O)c(C)c(O1)c6C2=O
6566	tr|G0ZF28|G0ZF28_M	P0A8V2	99.14	477.0	592.0	DB04934	investigational	Rifalazil	C[C@]12O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(=O)C)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)Nc3c4c(c5c(c3=O)c(O)c(C)c(O1)c5C2=O)nc6c(o4)cc(cc6O)N7CCN(CC7)CC(C)C
6567	tr|G0ZF28|G0ZF28_M	P0A8V2	99.14	477.0	592.0	DB11753	approved; investigational	Rifamycin	C[C@@]12O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(=O)C)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)Nc3c(O)c4c(c(c3)O)c(C1=O)c(O2)c(C)c4O
6568	tr|G0ZF28|G0ZF28_M	Q8RQE9	99.14	357.0	472.0	DB04788	experimental	Tagetitoxin	OP(=O)(O)O[C@@H]([C@@]12C(=O)O)[C@@H](N)[C@@H](OC(=O)C)[C@@H](O2)[C@@](O)(SC1)C(=O)N
6569	tr|G0ZF28|G0ZF28_M	Q8RQE9	99.14	357.0	472.0	DB08226	experimental	Myxopyronin B	CCCC/C(C)=C/C=C(\C)C(=O)c1c(O)cc(oc1=O)CCC/C=C/NC(=O)OC
6570	tr|G0ZF28|G0ZF28_M	Q8RQE9	99.14	357.0	472.0	DB08266	experimental	Methyl [(1E,5R)-5-{3-[(2E,4E)-2,5-dimethyl-2,4-octadienoyl]-2,4-dioxo-3,4-dihydro-2H-pyran-6-yl}hexylidene]carbamate	COC(=O)/N=C/CCC[C@@H](C)C1=CC(=O)C(C(=O)O1)C(=O)/C(C)=C/C=C(\C)CCC
6571	tr|A0A0N9DS48|A0A0	P9WIE5	94.55	1.0	53.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
6572	tr|A0A0N9DS48|A0A0	P9WIE5	94.55	1.0	53.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
6573	tr|A0A2Z3DFG4|A0A2	P05653	96.07	6.0	226.0	DB00537	approved; investigational	Ciprofloxacin	O=C(O)c(c1=O)cn(C2CC2)c(c13)cc(c(F)c3)N4CCNCC4
6574	tr|A0A2Z3DFG4|A0A2	P20831	95.63	7.0	226.0	DB00537	approved; investigational	Ciprofloxacin	O=C(O)c(c1=O)cn(C2CC2)c(c13)cc(c(F)c3)N4CCNCC4
6575	tr|A0A2Z3DFG4|A0A2	P0AES4	96.07	5.0	225.0	DB00537	approved; investigational	Ciprofloxacin	O=C(O)c(c1=O)cn(C2CC2)c(c13)cc(c(F)c3)N4CCNCC4
6576	tr|A0A2Z3DFG4|A0A2	P0AES4	96.07	5.0	225.0	DB11943	approved; investigational	Delafloxacin	Fc1cc(F)c(nc1N)-n2cc(C(=O)O)c(=O)c(c23)cc(F)c(c3Cl)N4CC(O)C4
6577	tr|A0A2Z3DFG4|A0A2	P72524	95.2	5.0	223.0	DB01044	approved; investigational	Gatifloxacin	CC1CN(CCN1)c(c(F)c2)c(OC)c(c23)n(C4CC4)cc(c3=O)C(=O)O
6578	tr|A0A2Z3DFG4|A0A2	P72524	95.2	5.0	223.0	DB06771	approved	Besifloxacin	N[C@@H]1CCCCN(C1)c(c2Cl)c(F)cc(c23)c(=O)c(C(=O)O)cn3C4CC4
6579	tr|A0A2Z3DFG4|A0A2	P43700	96.07	6.0	226.0	DB00218	approved; investigational	Moxifloxacin	N1CCC[C@H]([C@H]12)CN(C2)c(c3OC)c(F)cc(c34)c(=O)c(C(=O)O)cn4C5CC5
6580	tr|A0A2Z3DFG4|A0A2	P43700	96.07	6.0	226.0	DB00365	approved; investigational; withdrawn	Grepafloxacin	CC1CN(CCN1)c(c2)c(F)c(C)c(c23)c(=O)c(C(=O)O)cn3C4CC4
6581	tr|A0A2Z3DFG4|A0A2	P43700	96.07	6.0	226.0	DB00467	approved; investigational	Enoxacin	CCn1cc(C(=O)O)c(=O)c(c12)cc(F)c(n2)N3CCNCC3
6582	tr|A0A2Z3DFG4|A0A2	P43700	96.07	6.0	226.0	DB00487	approved	Pefloxacin	CCn1cc(C(=O)O)c(=O)c(c12)cc(F)c(c2)N3CCN(C)CC3
6583	tr|A0A2Z3DFG4|A0A2	P43700	96.07	6.0	226.0	DB00537	approved; investigational	Ciprofloxacin	O=C(O)c(c1=O)cn(C2CC2)c(c13)cc(c(F)c3)N4CCNCC4
6584	tr|A0A2Z3DFG4|A0A2	P43700	96.07	6.0	226.0	DB00685	approved; investigational; withdrawn	Trovafloxacin	N[C@H]1[C@@H]([C@@H]12)CN(C2)c(c(F)c3)nc(c34)n(cc(c4=O)C(=O)O)-c5c(F)cc(F)cc5
6585	tr|A0A2Z3DFG4|A0A2	P43700	96.07	6.0	226.0	DB00827	approved; investigational; withdrawn	Cinoxacin	CCn1nc(C(=O)O)c(=O)c(c12)cc3c(c2)OCO3
6586	tr|A0A2Z3DFG4|A0A2	P43700	96.07	6.0	226.0	DB00978	approved; investigational	Lomefloxacin	CCn1cc(C(=O)O)c(=O)c(c12)cc(F)c(c2F)N3CCNC(C)C3
6587	tr|A0A2Z3DFG4|A0A2	P43700	96.07	6.0	226.0	DB01059	approved	Norfloxacin	CCn1cc(C(=O)O)c(=O)c(c12)cc(F)c(c2)N3CCNCC3
6588	tr|A0A2Z3DFG4|A0A2	P43700	96.07	6.0	226.0	DB01137	approved; investigational	Levofloxacin	C1CN(C)CCN1c(c(c2n34)OC[C@@H]3C)c(F)cc2c(=O)c(c4)C(=O)O
6589	tr|A0A2Z3DFG4|A0A2	P43700	96.07	6.0	226.0	DB01155	approved; investigational	Gemifloxacin	CO/N=C1\CN(CC1CN)c(c(F)c2)nc(c23)n(C4CC4)cc(c3=O)C(=O)O
6590	tr|A0A2Z3DFG4|A0A2	P43700	96.07	6.0	226.0	DB01165	approved	Ofloxacin	C1CN(C)CCN1c(c(c2n34)OCC3C)c(F)cc2c(=O)c(c4)C(=O)O
6591	tr|A0A2Z3DFG4|A0A2	P43700	96.07	6.0	226.0	DB01208	approved; investigational; withdrawn	Sparfloxacin	C[C@H]1CN(C[C@@H](C)N1)c(c2F)c(F)c(N)c(c23)c(=O)c(C(=O)O)cn3C4CC4
6592	tr|A0A2Z3DFG4|A0A2	P43700	96.07	6.0	226.0	DB01405	withdrawn	Temafloxacin	CC1CN(CCN1)c(c2)c(F)cc(c23)c(=O)c(C(=O)O)cn3-c4c(F)cc(F)cc4
6593	tr|A0A2Z3DFG4|A0A2	P43700	96.07	6.0	226.0	DB04576	experimental	Fleroxacin	CN1CCN(CC1)c(c2F)c(F)cc(c23)c(=O)c(C(=O)O)cn3CCF
6594	tr|A0A2Z3DFG4|A0A2	P43700	96.07	6.0	226.0	DB06771	approved	Besifloxacin	N[C@@H]1CCCCN(C1)c(c2Cl)c(F)cc(c23)c(=O)c(C(=O)O)cn3C4CC4
6595	tr|A0A2Z3DFG4|A0A2	P43700	96.07	6.0	226.0	DB09047	approved; investigational	Finafloxacin	O1CCN[C@H]([C@@H]12)CN(C2)c(c3C#N)c(F)cc(c34)c(=O)c(C(=O)O)cn4C5CC5
6596	tr|A0A2Z3DFG4|A0A2	P43700	96.07	6.0	226.0	DB12924	approved; investigational	Ozenoxacin	CNc1ncc(cc1C)-c(c2C)ccc(c23)c(=O)c(C(=O)O)cn3C4CC4
6597	tr|A0A2Z3DFG4|A0A2	P72525	95.63	2.0	221.0	DB01044	approved; investigational	Gatifloxacin	CC1CN(CCN1)c(c(F)c2)c(OC)c(c23)n(C4CC4)cc(c3=O)C(=O)O
6598	tr|A0A2Z3DFG4|A0A2	P72525	95.63	2.0	221.0	DB06771	approved	Besifloxacin	N[C@@H]1CCCCN(C1)c(c2Cl)c(F)cc(c23)c(=O)c(C(=O)O)cn3C4CC4
6599	tr|A0A2Z3DFG4|A0A2	P0C1U9	95.2	4.0	222.0	DB00537	approved; investigational	Ciprofloxacin	O=C(O)c(c1=O)cn(C2CC2)c(c13)cc(c(F)c3)N4CCNCC4
6600	tr|A0A2Z3DFG4|A0A2	P43702	96.07	6.0	226.0	DB00218	approved; investigational	Moxifloxacin	N1CCC[C@H]([C@H]12)CN(C2)c(c3OC)c(F)cc(c34)c(=O)c(C(=O)O)cn4C5CC5
6601	tr|A0A2Z3DFG4|A0A2	P43702	96.07	6.0	226.0	DB00365	approved; investigational; withdrawn	Grepafloxacin	CC1CN(CCN1)c(c2)c(F)c(C)c(c23)c(=O)c(C(=O)O)cn3C4CC4
6602	tr|A0A2Z3DFG4|A0A2	P43702	96.07	6.0	226.0	DB00467	approved; investigational	Enoxacin	CCn1cc(C(=O)O)c(=O)c(c12)cc(F)c(n2)N3CCNCC3
6603	tr|A0A2Z3DFG4|A0A2	P43702	96.07	6.0	226.0	DB00487	approved	Pefloxacin	CCn1cc(C(=O)O)c(=O)c(c12)cc(F)c(c2)N3CCN(C)CC3
6604	tr|A0A2Z3DFG4|A0A2	P43702	96.07	6.0	226.0	DB00537	approved; investigational	Ciprofloxacin	O=C(O)c(c1=O)cn(C2CC2)c(c13)cc(c(F)c3)N4CCNCC4
6605	tr|A0A2Z3DFG4|A0A2	P43702	96.07	6.0	226.0	DB00685	approved; investigational; withdrawn	Trovafloxacin	N[C@H]1[C@@H]([C@@H]12)CN(C2)c(c(F)c3)nc(c34)n(cc(c4=O)C(=O)O)-c5c(F)cc(F)cc5
6606	tr|A0A2Z3DFG4|A0A2	P43702	96.07	6.0	226.0	DB00978	approved; investigational	Lomefloxacin	CCn1cc(C(=O)O)c(=O)c(c12)cc(F)c(c2F)N3CCNC(C)C3
6607	tr|A0A2Z3DFG4|A0A2	P43702	96.07	6.0	226.0	DB01059	approved	Norfloxacin	CCn1cc(C(=O)O)c(=O)c(c12)cc(F)c(c2)N3CCNCC3
6608	tr|A0A2Z3DFG4|A0A2	P43702	96.07	6.0	226.0	DB01137	approved; investigational	Levofloxacin	C1CN(C)CCN1c(c(c2n34)OC[C@@H]3C)c(F)cc2c(=O)c(c4)C(=O)O
6609	tr|A0A2Z3DFG4|A0A2	P43702	96.07	6.0	226.0	DB01155	approved; investigational	Gemifloxacin	CO/N=C1\CN(CC1CN)c(c(F)c2)nc(c23)n(C4CC4)cc(c3=O)C(=O)O
6610	tr|A0A2Z3DFG4|A0A2	P43702	96.07	6.0	226.0	DB01165	approved	Ofloxacin	C1CN(C)CCN1c(c(c2n34)OCC3C)c(F)cc2c(=O)c(c4)C(=O)O
6611	tr|A0A2Z3DFG4|A0A2	P43702	96.07	6.0	226.0	DB01208	approved; investigational; withdrawn	Sparfloxacin	C[C@H]1CN(C[C@@H](C)N1)c(c2F)c(F)c(N)c(c23)c(=O)c(C(=O)O)cn3C4CC4
6612	tr|A0A2Z3DFG4|A0A2	P43702	96.07	6.0	226.0	DB01405	withdrawn	Temafloxacin	CC1CN(CCN1)c(c2)c(F)cc(c23)c(=O)c(C(=O)O)cn3-c4c(F)cc(F)cc4
6613	tr|A0A2Z3DFG4|A0A2	P43702	96.07	6.0	226.0	DB04576	experimental	Fleroxacin	CN1CCN(CC1)c(c2F)c(F)cc(c23)c(=O)c(C(=O)O)cn3CCF
6614	tr|A0A2Z3DFG4|A0A2	P43702	96.07	6.0	226.0	DB06771	approved	Besifloxacin	N[C@@H]1CCCCN(C1)c(c2Cl)c(F)cc(c23)c(=O)c(C(=O)O)cn3C4CC4
6615	tr|A0A2Z3DFG4|A0A2	P43702	96.07	6.0	226.0	DB09047	approved; investigational	Finafloxacin	O1CCN[C@H]([C@@H]12)CN(C2)c(c3C#N)c(F)cc(c34)c(=O)c(C(=O)O)cn4C5CC5
6616	tr|A0A2Z3DFG4|A0A2	P0AFI2	94.76	5.0	222.0	DB00817	approved; investigational	Rosoxacin	CCn1cc(C(=O)O)c(=O)c(c12)ccc(c2)-c3ccncc3
6617	tr|A0A2Z3DFG4|A0A2	P0AFI2	94.76	5.0	222.0	DB11943	approved; investigational	Delafloxacin	Fc1cc(F)c(nc1N)-n2cc(C(=O)O)c(=O)c(c23)cc(F)c(c3Cl)N4CC(O)C4
6618	tr|A0A2Z3DFG4|A0A2	P0AFI2	94.76	5.0	222.0	DB12924	approved; investigational	Ozenoxacin	CNc1ncc(cc1C)-c(c2C)ccc(c23)c(=O)c(C(=O)O)cn3C4CC4
6619	tr|A0A2Z3DFG4|A0A2	P11388	75.11	711.0	883.0	DB00218	approved; investigational	Moxifloxacin	N1CCC[C@H]([C@H]12)CN(C2)c(c3OC)c(F)cc(c34)c(=O)c(C(=O)O)cn4C5CC5
6620	tr|A0A2Z3DFG4|A0A2	P11388	75.11	711.0	883.0	DB00276	approved; investigational	Amsacrine	CS(=O)(=O)Nc1cc(OC)c(cc1)Nc2c(cccc3)c3nc(c24)cccc4
6621	tr|A0A2Z3DFG4|A0A2	P11388	75.11	711.0	883.0	DB00380	approved; withdrawn	Dexrazoxane	O=C1CN(CC(=O)N1)[C@@H](C)CN2CC(=O)NC(=O)C2
6622	tr|A0A2Z3DFG4|A0A2	P11388	75.11	711.0	883.0	DB00385	approved	Valrubicin	FC(F)(F)C(=O)N[C@H]([C@H](O)[C@@H](O1)C)C[C@@H]1O[C@H]2C[C@](O)(C(=O)COC(=O)CCCC)Cc(c23)c(O)c4c(c3O)C(=O)c5c(C4=O)cccc5OC
6623	tr|A0A2Z3DFG4|A0A2	P11388	75.11	711.0	883.0	DB00444	approved	Teniposide	COc1cc(cc(c1O)OC)[C@@H]2c(cc3c(c4)OCO3)c4[C@H]([C@H]([C@@H]25)COC5=O)O[C@@H]([C@H](O)[C@H]6O)O[C@@H]([C@H]67)CO[C@H](O7)c8cccs8
6624	tr|A0A2Z3DFG4|A0A2	P11388	75.11	711.0	883.0	DB00445	approved	Epirubicin	COc1cccc(c12)C(=O)c3c(C2=O)c(O)c4c(c3O)C[C@@](O)(C(=O)CO)C[C@@H]4O[C@H]5C[C@H](N)[C@@H](O)[C@@H](O5)C
6625	tr|A0A2Z3DFG4|A0A2	P11388	75.11	711.0	883.0	DB00467	approved; investigational	Enoxacin	CCn1cc(C(=O)O)c(=O)c(c12)cc(F)c(n2)N3CCNCC3
6626	tr|A0A2Z3DFG4|A0A2	P11388	75.11	711.0	883.0	DB00487	approved	Pefloxacin	CCn1cc(C(=O)O)c(=O)c(c12)cc(F)c(c2)N3CCN(C)CC3
6627	tr|A0A2Z3DFG4|A0A2	P11388	75.11	711.0	883.0	DB00537	approved; investigational	Ciprofloxacin	O=C(O)c(c1=O)cn(C2CC2)c(c13)cc(c(F)c3)N4CCNCC4
6628	tr|A0A2Z3DFG4|A0A2	P11388	75.11	711.0	883.0	DB00685	approved; investigational; withdrawn	Trovafloxacin	N[C@H]1[C@@H]([C@@H]12)CN(C2)c(c(F)c3)nc(c34)n(cc(c4=O)C(=O)O)-c5c(F)cc(F)cc5
6629	tr|A0A2Z3DFG4|A0A2	P11388	75.11	711.0	883.0	DB00694	approved	Daunorubicin	COc1cccc(c12)C(=O)c3c(C2=O)c(O)c4c(c3O)C[C@@](O)(C(=O)C)C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@@H](O5)C
6630	tr|A0A2Z3DFG4|A0A2	P11388	75.11	711.0	883.0	DB00773	approved	Etoposide	COc1cc(cc(c1O)OC)[C@@H]2c(cc3c(c4)OCO3)c4[C@H]([C@H]([C@@H]25)COC5=O)O[C@@H]([C@H](O)[C@H]6O)O[C@@H]([C@H]67)CO[C@H](O7)C
6631	tr|A0A2Z3DFG4|A0A2	P11388	75.11	711.0	883.0	DB00978	approved; investigational	Lomefloxacin	CCn1cc(C(=O)O)c(=O)c(c12)cc(F)c(c2F)N3CCNC(C)C3
6632	tr|A0A2Z3DFG4|A0A2	P11388	75.11	711.0	883.0	DB00997	approved; investigational	Doxorubicin	COc1cccc(c12)C(=O)c3c(C2=O)c(O)c4c(c3O)C[C@@](O)(C(=O)CO)C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@@H](O5)C
6633	tr|A0A2Z3DFG4|A0A2	P11388	75.11	711.0	883.0	DB01059	approved	Norfloxacin	CCn1cc(C(=O)O)c(=O)c(c12)cc(F)c(c2)N3CCNCC3
6634	tr|A0A2Z3DFG4|A0A2	P11388	75.11	711.0	883.0	DB01165	approved	Ofloxacin	C1CN(C)CCN1c(c(c2n34)OCC3C)c(F)cc2c(=O)c(c4)C(=O)O
6635	tr|A0A2Z3DFG4|A0A2	P11388	75.11	711.0	883.0	DB01177	approved	Idarubicin	O[C@H]1[C@@H](N)C[C@@H](O[C@H]1C)O[C@H]2C[C@](O)(C(=O)C)Cc(c23)c(O)c4c(c3O)C(=O)c5c(C4=O)cccc5
6636	tr|A0A2Z3DFG4|A0A2	P11388	75.11	711.0	883.0	DB01179	approved	Podofilox	COc1c(OC)cc(cc1OC)[C@@H]2c(cc3c(c4)OCO3)c4[C@H](O)[C@H]([C@@H]25)COC5=O
6637	tr|A0A2Z3DFG4|A0A2	P11388	75.11	711.0	883.0	DB01204	approved; investigational	Mitoxantrone	Oc1ccc(O)c(c12)C(=O)c3c(C2=O)c(NCCNCCO)ccc3NCCNCCO
6638	tr|A0A2Z3DFG4|A0A2	P11388	75.11	711.0	883.0	DB01208	approved; investigational; withdrawn	Sparfloxacin	C[C@H]1CN(C[C@@H](C)N1)c(c2F)c(F)c(N)c(c23)c(=O)c(C(=O)O)cn3C4CC4
6639	tr|A0A2Z3DFG4|A0A2	P11388	75.11	711.0	883.0	DB01645	investigational	Genistein	Oc1ccc(cc1)-c(c2=O)coc(c23)cc(O)cc3O
6640	tr|A0A2Z3DFG4|A0A2	P11388	75.11	711.0	883.0	DB04576	experimental	Fleroxacin	CN1CCN(CC1)c(c2F)c(F)cc(c23)c(=O)c(C(=O)O)cn3CCF
6641	tr|A0A2Z3DFG4|A0A2	P11388	75.11	711.0	883.0	DB04967	investigational	Lucanthone	CCN(CC)CCNc(ccc1C)c(c12)c(=O)c3c(s2)cccc3
6642	tr|A0A2Z3DFG4|A0A2	P11388	75.11	711.0	883.0	DB04975	investigational	Banoxantrone	[O-][N+](C)(C)CCNc1ccc(NCC[N+]([O-])(C)C)c(c12)C(=O)c3c(C2=O)c(O)ccc3O
6643	tr|A0A2Z3DFG4|A0A2	P11388	75.11	711.0	883.0	DB04978	investigational	SP1049C	 
6644	tr|A0A2Z3DFG4|A0A2	P11388	75.11	711.0	883.0	DB05022	investigational	Amonafide	CN(C)CCN(C1=O)C(=O)c2cccc(c2c13)cc(c3)N
6645	tr|A0A2Z3DFG4|A0A2	P11388	75.11	711.0	883.0	DB05129	investigational	Elsamitrucin	CO[C@@H]1[C@@H](N)[C@H](O[C@H](C)[C@@H]1O)O[C@H]([C@@]2(C)O)[C@@H](O[C@H](C)[C@@H]2O)Oc3cccc(c34)c(O)c5c6c4oc(=O)c7c6c(oc5=O)ccc7C
6646	tr|A0A2Z3DFG4|A0A2	P11388	75.11	711.0	883.0	DB05706	investigational	13-deoxydoxorubicin	c1ccc(OC)c(c12)C(=O)c3c(C2=O)c(O)c4c(c3O)[C@H](C[C@](C4)(O)CCO)O[C@H]5C[C@H](N)[C@H](O)[C@@H](O5)C
6647	tr|A0A2Z3DFG4|A0A2	P11388	75.11	711.0	883.0	DB05920	investigational	RTA 744	 
6648	tr|A0A2Z3DFG4|A0A2	P11388	75.11	711.0	883.0	DB06013	investigational	Aldoxorubicin	c1ccc(OC)c(c12)C(=O)c3c(C2=O)c(O)c4c(c3O)[C@@H](O[C@H]5C[C@H](N)[C@H](O)[C@@H](O5)C)C[C@](C4)(O)/C(CO)=N/NC(=O)CCCCCN6C(=O)C=CC6=O
6649	tr|A0A2Z3DFG4|A0A2	P11388	75.11	711.0	883.0	DB06042	investigational	ZEN-012	 
6650	tr|A0A2Z3DFG4|A0A2	P11388	75.11	711.0	883.0	DB06263	investigational	Amrubicin	O[C@@H]1CO[C@H](C[C@@H]1O)O[C@H]2C[C@](N)(C(=O)C)Cc(c23)c(O)c4c(c3O)C(=O)c5c(C4=O)cccc5
6651	tr|A0A2Z3DFG4|A0A2	P11388	75.11	711.0	883.0	DB06362	investigational	Becatecarin	CCN(CC)CCN(C1=O)C(=O)c(c12)c3c([nH]c4c3cccc4Cl)c5c2c6c(c(Cl)ccc6)n5[C@@H]7O[C@H](CO)[C@@H](OC)[C@H](O)[C@H]7O
6652	tr|A0A2Z3DFG4|A0A2	P11388	75.11	711.0	883.0	DB06420	investigational	Annamycin	O[C@@H]1[C@@H](O)[C@@H](I)[C@@H](O[C@H]1C)O[C@H]2C[C@](O)(C(=O)CO)Cc(c23)c(O)c4c(c3O)C(=O)c5c(C4=O)cccc5
6653	tr|A0A2Z3DFG4|A0A2	P11388	75.11	711.0	883.0	DB06421	investigational	Declopramide	CCN(CC)CCNC(=O)c1ccc(N)c(Cl)c1
6654	tr|A0A2Z3DFG4|A0A2	P11388	75.11	711.0	883.0	DB09047	approved; investigational	Finafloxacin	O1CCN[C@H]([C@@H]12)CN(C2)c(c3C#N)c(F)cc(c34)c(=O)c(C(=O)O)cn4C5CC5
6655	tr|A0A2Z3DFG4|A0A2	P11388	75.11	711.0	883.0	DB00970	approved; investigational	Dactinomycin	C1CC[C@H](N12)C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@H](C)[C@@H](C(=O)N[C@@H](C2=O)C(C)C)NC(=O)c(ccc3C)c(c34)nc5c(o4)c(C)c(=O)c(N)c5C(=O)N[C@H](C(=O)N[C@@H](C6=O)C(C)C)[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H](N67)CCC7
6656	tr|A0A2Z3DFG4|A0A2	Q02880	75.11	732.0	904.0	DB00380	approved; withdrawn	Dexrazoxane	O=C1CN(CC(=O)N1)[C@@H](C)CN2CC(=O)NC(=O)C2
6657	tr|A0A2Z3DFG4|A0A2	Q02880	75.11	732.0	904.0	DB00694	approved	Daunorubicin	COc1cccc(c12)C(=O)c3c(C2=O)c(O)c4c(c3O)C[C@@](O)(C(=O)C)C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@@H](O5)C
6658	tr|A0A2Z3DFG4|A0A2	Q02880	75.11	732.0	904.0	DB00773	approved	Etoposide	COc1cc(cc(c1O)OC)[C@@H]2c(cc3c(c4)OCO3)c4[C@H]([C@H]([C@@H]25)COC5=O)O[C@@H]([C@H](O)[C@H]6O)O[C@@H]([C@H]67)CO[C@H](O7)C
6659	tr|A0A2Z3DFG4|A0A2	Q02880	75.11	732.0	904.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
6660	tr|A0A2Z3DFG4|A0A2	Q02880	75.11	732.0	904.0	DB05022	investigational	Amonafide	CN(C)CCN(C1=O)C(=O)c2cccc(c2c13)cc(c3)N
6661	tr|A0A2Z3DFG4|A0A2	Q02880	75.11	732.0	904.0	DB05488	investigational	Technetium Tc-99m ciprofloxacin	 
6662	tr|A0A2Z3DFG4|A0A2	Q02880	75.11	732.0	904.0	DB06042	investigational	ZEN-012	 
6663	tr|A0A2Z3DFG4|A0A2	Q02880	75.11	732.0	904.0	DB06362	investigational	Becatecarin	CCN(CC)CCN(C1=O)C(=O)c(c12)c3c([nH]c4c3cccc4Cl)c5c2c6c(c(Cl)ccc6)n5[C@@H]7O[C@H](CO)[C@@H](OC)[C@H](O)[C@H]7O
6664	tr|A0A2Z3DFG4|A0A2	Q02880	75.11	732.0	904.0	DB06421	investigational	Declopramide	CCN(CC)CCNC(=O)c1ccc(N)c(Cl)c1
6665	tr|A0A2Z3DFG4|A0A2	Q02880	75.11	732.0	904.0	DB08651	experimental	3'-THIO-THYMIDINE-5'-PHOSPHATE	OP(=O)(O)OC[C@H]1O[C@H](C[C@@H]1S)n2cc(C)c(=O)[nH]c2=O
6666	tr|A0A2Z3DFG4|A0A2	Q02880	75.11	732.0	904.0	DB00970	approved; investigational	Dactinomycin	C1CC[C@H](N12)C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@H](C)[C@@H](C(=O)N[C@@H](C2=O)C(C)C)NC(=O)c(ccc3C)c(c34)nc5c(o4)c(C)c(=O)c(N)c5C(=O)N[C@H](C(=O)N[C@@H](C6=O)C(C)C)[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H](N67)CCC7
6667	tr|A0A0N9DRZ8|A0A0	P9WIE5	99.86	1.0	740.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
6668	tr|A0A0N9DRZ8|A0A0	P9WIE5	99.86	1.0	740.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
6669	tr|A0A0N9DRZ8|A0A0	Q939D2	96.49	13.0	727.0	DB08638	experimental	1-hydroperoxy-L-tryptophan	c1cccc(c12)n(OO)cc2C[C@H](N)C(=O)O
6670	tr|A0A0N7EHL7|A0A0	P9WIE5	76.83	1.0	127.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
6671	tr|A0A0N7EHL7|A0A0	P9WIE5	76.83	1.0	127.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
6672	tr|E5G958|E5G958_M	P0A0K8	97.26	321.0	392.0	DB01051	approved; investigational; vet_approved	Novobiocin	CO[C@@H](C1(C)C)[C@@H](OC(=O)N)[C@@H](O)[C@@H](O1)Oc(cc2)c(C)c(c23)oc(=O)c(c3O)NC(=O)c4ccc(O)c(c4)CC=C(C)C
6673	tr|E5G958|E5G958_M	P0A4L9	98.63	318.0	390.0	DB01044	approved; investigational	Gatifloxacin	CC1CN(CCN1)c(c(F)c2)c(OC)c(c23)n(C4CC4)cc(c3=O)C(=O)O
6674	tr|E5G958|E5G958_M	Q59192	101.37	310.0	384.0	DB00537	approved; investigational	Ciprofloxacin	O=C(O)c(c1=O)cn(C2CC2)c(c13)cc(c(F)c3)N4CCNCC4
6675	tr|E5G958|E5G958_M	P0AES6	97.26	310.0	381.0	DB00817	approved; investigational	Rosoxacin	CCn1cc(C(=O)O)c(=O)c(c12)ccc(c2)-c3ccncc3
6676	tr|E5G958|E5G958_M	P0AES6	97.26	310.0	381.0	DB03966	experimental	Clorobiocin	Cc1[nH]c(cc1)C(=O)O[C@H]([C@@H](OC)C2(C)C)[C@@H](O)[C@@H](O2)Oc(cc3)c(Cl)c(c34)oc(=O)c(c4O)NC(=O)c5cc(c(O)cc5)CC=C(C)C
6677	tr|E5G958|E5G958_M	P0AES6	97.26	310.0	381.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
6678	tr|E5G958|E5G958_M	P0AES6	97.26	310.0	381.0	DB05488	investigational	Technetium Tc-99m ciprofloxacin	 
6679	tr|E5G958|E5G958_M	Q5SHZ4	95.89	309.0	379.0	DB01942	experimental; investigational	Formic acid	OC=O
6680	tr|E5G958|E5G958_M	P20083	95.89	307.0	377.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
6681	tr|E5G958|E5G958_M	Q59961	98.63	314.0	386.0	DB01044	approved; investigational	Gatifloxacin	CC1CN(CCN1)c(c(F)c2)c(OC)c(c23)n(C4CC4)cc(c3=O)C(=O)O
6682	tr|G0ZF27|G0ZF27_M	P0A8V2	99.14	477.0	592.0	DB00615	approved; investigational	Rifabutin	CC(C)CN(CC1)CCC12N=C3c4c5c6c(C)c(O)c4C(=O)C(=C3N2)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(=O)C)[C@H](C)[C@@H](OC)/C=C/O[C@](O6)(C)C5=O
6683	tr|G0ZF27|G0ZF27_M	P0A8V2	99.14	477.0	592.0	DB01045	approved	Rifampicin	C[C@@]12O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(=O)C)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)Nc3c(/C=N/N4CCN(C)CC4)c(O)c5c(C1=O)c(O2)c(C)c(O)c5c3O
6684	tr|G0ZF27|G0ZF27_M	P0A8V2	99.14	477.0	592.0	DB01220	approved; investigational	Rifaximin	C[C@]12O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(=O)C)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)Nc3c4c(nc5n4ccc(c5)C)c6c(c3O)c(O)c(C)c(O1)c6C2=O
6685	tr|G0ZF27|G0ZF27_M	P0A8V2	99.14	477.0	592.0	DB04934	investigational	Rifalazil	C[C@]12O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(=O)C)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)Nc3c4c(c5c(c3=O)c(O)c(C)c(O1)c5C2=O)nc6c(o4)cc(cc6O)N7CCN(CC7)CC(C)C
6686	tr|G0ZF27|G0ZF27_M	P0A8V2	99.14	477.0	592.0	DB11753	approved; investigational	Rifamycin	C[C@@]12O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(=O)C)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)Nc3c(O)c4c(c(c3)O)c(C1=O)c(O2)c(C)c4O
6687	tr|G0ZF27|G0ZF27_M	Q8RQE9	99.14	357.0	472.0	DB04788	experimental	Tagetitoxin	OP(=O)(O)O[C@@H]([C@@]12C(=O)O)[C@@H](N)[C@@H](OC(=O)C)[C@@H](O2)[C@@](O)(SC1)C(=O)N
6688	tr|G0ZF27|G0ZF27_M	Q8RQE9	99.14	357.0	472.0	DB08226	experimental	Myxopyronin B	CCCC/C(C)=C/C=C(\C)C(=O)c1c(O)cc(oc1=O)CCC/C=C/NC(=O)OC
6689	tr|G0ZF27|G0ZF27_M	Q8RQE9	99.14	357.0	472.0	DB08266	experimental	Methyl [(1E,5R)-5-{3-[(2E,4E)-2,5-dimethyl-2,4-octadienoyl]-2,4-dioxo-3,4-dihydro-2H-pyran-6-yl}hexylidene]carbamate	COC(=O)/N=C/CCC[C@@H](C)C1=CC(=O)C(C(=O)O1)C(=O)/C(C)=C/C=C(\C)CCC
6690	tr|A0A0N9DQW1|A0A0	P9WIE5	94.7	1.0	126.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
6691	tr|A0A0N9DQW1|A0A0	P9WIE5	94.7	1.0	126.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
6692	tr|A0A0N9DQW1|A0A0	Q939D2	73.48	13.0	110.0	DB08638	experimental	1-hydroperoxy-L-tryptophan	c1cccc(c12)n(OO)cc2C[C@H](N)C(=O)O
6693	tr|A0A0N9DS10|A0A0	P9WIE5	97.3	1.0	37.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
6694	tr|A0A0N9DS10|A0A0	P9WIE5	97.3	1.0	37.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
6695	tr|G0ZF36|G0ZF36_M	P0A8V2	99.14	477.0	592.0	DB00615	approved; investigational	Rifabutin	CC(C)CN(CC1)CCC12N=C3c4c5c6c(C)c(O)c4C(=O)C(=C3N2)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(=O)C)[C@H](C)[C@@H](OC)/C=C/O[C@](O6)(C)C5=O
6696	tr|G0ZF36|G0ZF36_M	P0A8V2	99.14	477.0	592.0	DB01045	approved	Rifampicin	C[C@@]12O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(=O)C)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)Nc3c(/C=N/N4CCN(C)CC4)c(O)c5c(C1=O)c(O2)c(C)c(O)c5c3O
6697	tr|G0ZF36|G0ZF36_M	P0A8V2	99.14	477.0	592.0	DB01220	approved; investigational	Rifaximin	C[C@]12O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(=O)C)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)Nc3c4c(nc5n4ccc(c5)C)c6c(c3O)c(O)c(C)c(O1)c6C2=O
6698	tr|G0ZF36|G0ZF36_M	P0A8V2	99.14	477.0	592.0	DB04934	investigational	Rifalazil	C[C@]12O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(=O)C)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)Nc3c4c(c5c(c3=O)c(O)c(C)c(O1)c5C2=O)nc6c(o4)cc(cc6O)N7CCN(CC7)CC(C)C
6699	tr|G0ZF36|G0ZF36_M	P0A8V2	99.14	477.0	592.0	DB11753	approved; investigational	Rifamycin	C[C@@]12O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(=O)C)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)Nc3c(O)c4c(c(c3)O)c(C1=O)c(O2)c(C)c4O
6700	tr|G0ZF36|G0ZF36_M	Q8RQE9	99.14	357.0	472.0	DB04788	experimental	Tagetitoxin	OP(=O)(O)O[C@@H]([C@@]12C(=O)O)[C@@H](N)[C@@H](OC(=O)C)[C@@H](O2)[C@@](O)(SC1)C(=O)N
6701	tr|G0ZF36|G0ZF36_M	Q8RQE9	99.14	357.0	472.0	DB08226	experimental	Myxopyronin B	CCCC/C(C)=C/C=C(\C)C(=O)c1c(O)cc(oc1=O)CCC/C=C/NC(=O)OC
6702	tr|G0ZF36|G0ZF36_M	Q8RQE9	99.14	357.0	472.0	DB08266	experimental	Methyl [(1E,5R)-5-{3-[(2E,4E)-2,5-dimethyl-2,4-octadienoyl]-2,4-dioxo-3,4-dihydro-2H-pyran-6-yl}hexylidene]carbamate	COC(=O)/N=C/CCC[C@@H](C)C1=CC(=O)C(C(=O)O1)C(=O)/C(C)=C/C=C(\C)CCC
6703	tr|M4PJD1|M4PJD1_M	P0A8V2	98.75	441.0	599.0	DB00615	approved; investigational	Rifabutin	CC(C)CN(CC1)CCC12N=C3c4c5c6c(C)c(O)c4C(=O)C(=C3N2)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(=O)C)[C@H](C)[C@@H](OC)/C=C/O[C@](O6)(C)C5=O
6704	tr|M4PJD1|M4PJD1_M	P0A8V2	98.75	441.0	599.0	DB01045	approved	Rifampicin	C[C@@]12O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(=O)C)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)Nc3c(/C=N/N4CCN(C)CC4)c(O)c5c(C1=O)c(O2)c(C)c(O)c5c3O
6705	tr|M4PJD1|M4PJD1_M	P0A8V2	98.75	441.0	599.0	DB01220	approved; investigational	Rifaximin	C[C@]12O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(=O)C)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)Nc3c4c(nc5n4ccc(c5)C)c6c(c3O)c(O)c(C)c(O1)c6C2=O
6706	tr|M4PJD1|M4PJD1_M	P0A8V2	98.75	441.0	599.0	DB04934	investigational	Rifalazil	C[C@]12O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(=O)C)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)Nc3c4c(c5c(c3=O)c(O)c(C)c(O1)c5C2=O)nc6c(o4)cc(cc6O)N7CCN(CC7)CC(C)C
6707	tr|M4PJD1|M4PJD1_M	P0A8V2	98.75	441.0	599.0	DB11753	approved; investigational	Rifamycin	C[C@@]12O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(=O)C)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)Nc3c(O)c4c(c(c3)O)c(C1=O)c(O2)c(C)c4O
6708	tr|M4PJD1|M4PJD1_M	Q8RQE9	98.75	321.0	479.0	DB04788	experimental	Tagetitoxin	OP(=O)(O)O[C@@H]([C@@]12C(=O)O)[C@@H](N)[C@@H](OC(=O)C)[C@@H](O2)[C@@](O)(SC1)C(=O)N
6709	tr|M4PJD1|M4PJD1_M	Q8RQE9	98.75	321.0	479.0	DB08226	experimental	Myxopyronin B	CCCC/C(C)=C/C=C(\C)C(=O)c1c(O)cc(oc1=O)CCC/C=C/NC(=O)OC
6710	tr|M4PJD1|M4PJD1_M	Q8RQE9	98.75	321.0	479.0	DB08266	experimental	Methyl [(1E,5R)-5-{3-[(2E,4E)-2,5-dimethyl-2,4-octadienoyl]-2,4-dioxo-3,4-dihydro-2H-pyran-6-yl}hexylidene]carbamate	COC(=O)/N=C/CCC[C@@H](C)C1=CC(=O)C(C(=O)O1)C(=O)/C(C)=C/C=C(\C)CCC
6711	tr|A0A0N9DS08|A0A0	P9WIE5	92.44	1.0	576.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
6712	tr|A0A0N9DS08|A0A0	P9WIE5	92.44	1.0	576.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
6713	tr|A0A0N9DS08|A0A0	Q939D2	88.26	13.0	562.0	DB08638	experimental	1-hydroperoxy-L-tryptophan	c1cccc(c12)n(OO)cc2C[C@H](N)C(=O)O
6714	tr|A0A2Z3DFA7|A0A2	P0A8V2	93.15	395.0	599.0	DB00615	approved; investigational	Rifabutin	CC(C)CN(CC1)CCC12N=C3c4c5c6c(C)c(O)c4C(=O)C(=C3N2)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(=O)C)[C@H](C)[C@@H](OC)/C=C/O[C@](O6)(C)C5=O
6715	tr|A0A2Z3DFA7|A0A2	P0A8V2	93.15	395.0	599.0	DB01045	approved	Rifampicin	C[C@@]12O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(=O)C)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)Nc3c(/C=N/N4CCN(C)CC4)c(O)c5c(C1=O)c(O2)c(C)c(O)c5c3O
6716	tr|A0A2Z3DFA7|A0A2	P0A8V2	93.15	395.0	599.0	DB01220	approved; investigational	Rifaximin	C[C@]12O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(=O)C)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)Nc3c4c(nc5n4ccc(c5)C)c6c(c3O)c(O)c(C)c(O1)c6C2=O
6717	tr|A0A2Z3DFA7|A0A2	P0A8V2	93.15	395.0	599.0	DB04934	investigational	Rifalazil	C[C@]12O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(=O)C)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)Nc3c4c(c5c(c3=O)c(O)c(C)c(O1)c5C2=O)nc6c(o4)cc(cc6O)N7CCN(CC7)CC(C)C
6718	tr|A0A2Z3DFA7|A0A2	P0A8V2	93.15	395.0	599.0	DB11753	approved; investigational	Rifamycin	C[C@@]12O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(=O)C)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)Nc3c(O)c4c(c(c3)O)c(C1=O)c(O2)c(C)c4O
6719	tr|A0A2Z3DFA7|A0A2	Q8RQE9	96.8	267.0	479.0	DB04788	experimental	Tagetitoxin	OP(=O)(O)O[C@@H]([C@@]12C(=O)O)[C@@H](N)[C@@H](OC(=O)C)[C@@H](O2)[C@@](O)(SC1)C(=O)N
6720	tr|A0A2Z3DFA7|A0A2	Q8RQE9	96.8	267.0	479.0	DB08226	experimental	Myxopyronin B	CCCC/C(C)=C/C=C(\C)C(=O)c1c(O)cc(oc1=O)CCC/C=C/NC(=O)OC
6721	tr|A0A2Z3DFA7|A0A2	Q8RQE9	96.8	267.0	479.0	DB08266	experimental	Methyl [(1E,5R)-5-{3-[(2E,4E)-2,5-dimethyl-2,4-octadienoyl]-2,4-dioxo-3,4-dihydro-2H-pyran-6-yl}hexylidene]carbamate	COC(=O)/N=C/CCC[C@@H](C)C1=CC(=O)C(C(=O)O1)C(=O)/C(C)=C/C=C(\C)CCC
6722	tr|F2X2D0|F2X2D0_M	P20831	97.5	68.0	107.0	DB00537	approved; investigational	Ciprofloxacin	O=C(O)c(c1=O)cn(C2CC2)c(c13)cc(c(F)c3)N4CCNCC4
6723	tr|F2X2D0|F2X2D0_M	P72524	95.0	65.0	103.0	DB01044	approved; investigational	Gatifloxacin	CC1CN(CCN1)c(c(F)c2)c(OC)c(c23)n(C4CC4)cc(c3=O)C(=O)O
6724	tr|F2X2D0|F2X2D0_M	P72524	95.0	65.0	103.0	DB06771	approved	Besifloxacin	N[C@@H]1CCCCN(C1)c(c2Cl)c(F)cc(c23)c(=O)c(C(=O)O)cn3C4CC4
6725	tr|F2X2D0|F2X2D0_M	P0AFI2	97.5	64.0	103.0	DB00817	approved; investigational	Rosoxacin	CCn1cc(C(=O)O)c(=O)c(c12)ccc(c2)-c3ccncc3
6726	tr|F2X2D0|F2X2D0_M	P0AFI2	97.5	64.0	103.0	DB11943	approved; investigational	Delafloxacin	Fc1cc(F)c(nc1N)-n2cc(C(=O)O)c(=O)c(c23)cc(F)c(c3Cl)N4CC(O)C4
6727	tr|F2X2D0|F2X2D0_M	P0AFI2	97.5	64.0	103.0	DB12924	approved; investigational	Ozenoxacin	CNc1ncc(cc1C)-c(c2C)ccc(c23)c(=O)c(C(=O)O)cn3C4CC4
6728	tr|F2X2D0|F2X2D0_M	P0AES4	97.5	67.0	106.0	DB00537	approved; investigational	Ciprofloxacin	O=C(O)c(c1=O)cn(C2CC2)c(c13)cc(c(F)c3)N4CCNCC4
6729	tr|F2X2D0|F2X2D0_M	P0AES4	97.5	67.0	106.0	DB11943	approved; investigational	Delafloxacin	Fc1cc(F)c(nc1N)-n2cc(C(=O)O)c(=O)c(c23)cc(F)c(c3Cl)N4CC(O)C4
6730	tr|F2X2D0|F2X2D0_M	P43700	97.5	68.0	107.0	DB00218	approved; investigational	Moxifloxacin	N1CCC[C@H]([C@H]12)CN(C2)c(c3OC)c(F)cc(c34)c(=O)c(C(=O)O)cn4C5CC5
6731	tr|F2X2D0|F2X2D0_M	P43700	97.5	68.0	107.0	DB00365	approved; investigational; withdrawn	Grepafloxacin	CC1CN(CCN1)c(c2)c(F)c(C)c(c23)c(=O)c(C(=O)O)cn3C4CC4
6732	tr|F2X2D0|F2X2D0_M	P43700	97.5	68.0	107.0	DB00467	approved; investigational	Enoxacin	CCn1cc(C(=O)O)c(=O)c(c12)cc(F)c(n2)N3CCNCC3
6733	tr|F2X2D0|F2X2D0_M	P43700	97.5	68.0	107.0	DB00487	approved	Pefloxacin	CCn1cc(C(=O)O)c(=O)c(c12)cc(F)c(c2)N3CCN(C)CC3
6734	tr|F2X2D0|F2X2D0_M	P43700	97.5	68.0	107.0	DB00537	approved; investigational	Ciprofloxacin	O=C(O)c(c1=O)cn(C2CC2)c(c13)cc(c(F)c3)N4CCNCC4
6735	tr|F2X2D0|F2X2D0_M	P43700	97.5	68.0	107.0	DB00685	approved; investigational; withdrawn	Trovafloxacin	N[C@H]1[C@@H]([C@@H]12)CN(C2)c(c(F)c3)nc(c34)n(cc(c4=O)C(=O)O)-c5c(F)cc(F)cc5
6736	tr|F2X2D0|F2X2D0_M	P43700	97.5	68.0	107.0	DB00827	approved; investigational; withdrawn	Cinoxacin	CCn1nc(C(=O)O)c(=O)c(c12)cc3c(c2)OCO3
6737	tr|F2X2D0|F2X2D0_M	P43700	97.5	68.0	107.0	DB00978	approved; investigational	Lomefloxacin	CCn1cc(C(=O)O)c(=O)c(c12)cc(F)c(c2F)N3CCNC(C)C3
6738	tr|F2X2D0|F2X2D0_M	P43700	97.5	68.0	107.0	DB01059	approved	Norfloxacin	CCn1cc(C(=O)O)c(=O)c(c12)cc(F)c(c2)N3CCNCC3
6739	tr|F2X2D0|F2X2D0_M	P43700	97.5	68.0	107.0	DB01137	approved; investigational	Levofloxacin	C1CN(C)CCN1c(c(c2n34)OC[C@@H]3C)c(F)cc2c(=O)c(c4)C(=O)O
6740	tr|F2X2D0|F2X2D0_M	P43700	97.5	68.0	107.0	DB01155	approved; investigational	Gemifloxacin	CO/N=C1\CN(CC1CN)c(c(F)c2)nc(c23)n(C4CC4)cc(c3=O)C(=O)O
6741	tr|F2X2D0|F2X2D0_M	P43700	97.5	68.0	107.0	DB01165	approved	Ofloxacin	C1CN(C)CCN1c(c(c2n34)OCC3C)c(F)cc2c(=O)c(c4)C(=O)O
6742	tr|F2X2D0|F2X2D0_M	P43700	97.5	68.0	107.0	DB01208	approved; investigational; withdrawn	Sparfloxacin	C[C@H]1CN(C[C@@H](C)N1)c(c2F)c(F)c(N)c(c23)c(=O)c(C(=O)O)cn3C4CC4
6743	tr|F2X2D0|F2X2D0_M	P43700	97.5	68.0	107.0	DB01405	withdrawn	Temafloxacin	CC1CN(CCN1)c(c2)c(F)cc(c23)c(=O)c(C(=O)O)cn3-c4c(F)cc(F)cc4
6744	tr|F2X2D0|F2X2D0_M	P43700	97.5	68.0	107.0	DB04576	experimental	Fleroxacin	CN1CCN(CC1)c(c2F)c(F)cc(c23)c(=O)c(C(=O)O)cn3CCF
6745	tr|F2X2D0|F2X2D0_M	P43700	97.5	68.0	107.0	DB06771	approved	Besifloxacin	N[C@@H]1CCCCN(C1)c(c2Cl)c(F)cc(c23)c(=O)c(C(=O)O)cn3C4CC4
6746	tr|F2X2D0|F2X2D0_M	P43700	97.5	68.0	107.0	DB09047	approved; investigational	Finafloxacin	O1CCN[C@H]([C@@H]12)CN(C2)c(c3C#N)c(F)cc(c34)c(=O)c(C(=O)O)cn4C5CC5
6747	tr|F2X2D0|F2X2D0_M	P43700	97.5	68.0	107.0	DB12924	approved; investigational	Ozenoxacin	CNc1ncc(cc1C)-c(c2C)ccc(c23)c(=O)c(C(=O)O)cn3C4CC4
6748	tr|F2X2D0|F2X2D0_M	P43702	97.5	68.0	107.0	DB00218	approved; investigational	Moxifloxacin	N1CCC[C@H]([C@H]12)CN(C2)c(c3OC)c(F)cc(c34)c(=O)c(C(=O)O)cn4C5CC5
6749	tr|F2X2D0|F2X2D0_M	P43702	97.5	68.0	107.0	DB00365	approved; investigational; withdrawn	Grepafloxacin	CC1CN(CCN1)c(c2)c(F)c(C)c(c23)c(=O)c(C(=O)O)cn3C4CC4
6750	tr|F2X2D0|F2X2D0_M	P43702	97.5	68.0	107.0	DB00467	approved; investigational	Enoxacin	CCn1cc(C(=O)O)c(=O)c(c12)cc(F)c(n2)N3CCNCC3
6751	tr|F2X2D0|F2X2D0_M	P43702	97.5	68.0	107.0	DB00487	approved	Pefloxacin	CCn1cc(C(=O)O)c(=O)c(c12)cc(F)c(c2)N3CCN(C)CC3
6752	tr|F2X2D0|F2X2D0_M	P43702	97.5	68.0	107.0	DB00537	approved; investigational	Ciprofloxacin	O=C(O)c(c1=O)cn(C2CC2)c(c13)cc(c(F)c3)N4CCNCC4
6753	tr|F2X2D0|F2X2D0_M	P43702	97.5	68.0	107.0	DB00685	approved; investigational; withdrawn	Trovafloxacin	N[C@H]1[C@@H]([C@@H]12)CN(C2)c(c(F)c3)nc(c34)n(cc(c4=O)C(=O)O)-c5c(F)cc(F)cc5
6754	tr|F2X2D0|F2X2D0_M	P43702	97.5	68.0	107.0	DB00978	approved; investigational	Lomefloxacin	CCn1cc(C(=O)O)c(=O)c(c12)cc(F)c(c2F)N3CCNC(C)C3
6755	tr|F2X2D0|F2X2D0_M	P43702	97.5	68.0	107.0	DB01059	approved	Norfloxacin	CCn1cc(C(=O)O)c(=O)c(c12)cc(F)c(c2)N3CCNCC3
6756	tr|F2X2D0|F2X2D0_M	P43702	97.5	68.0	107.0	DB01137	approved; investigational	Levofloxacin	C1CN(C)CCN1c(c(c2n34)OC[C@@H]3C)c(F)cc2c(=O)c(c4)C(=O)O
6757	tr|F2X2D0|F2X2D0_M	P43702	97.5	68.0	107.0	DB01155	approved; investigational	Gemifloxacin	CO/N=C1\CN(CC1CN)c(c(F)c2)nc(c23)n(C4CC4)cc(c3=O)C(=O)O
6758	tr|F2X2D0|F2X2D0_M	P43702	97.5	68.0	107.0	DB01165	approved	Ofloxacin	C1CN(C)CCN1c(c(c2n34)OCC3C)c(F)cc2c(=O)c(c4)C(=O)O
6759	tr|F2X2D0|F2X2D0_M	P43702	97.5	68.0	107.0	DB01208	approved; investigational; withdrawn	Sparfloxacin	C[C@H]1CN(C[C@@H](C)N1)c(c2F)c(F)c(N)c(c23)c(=O)c(C(=O)O)cn3C4CC4
6760	tr|F2X2D0|F2X2D0_M	P43702	97.5	68.0	107.0	DB01405	withdrawn	Temafloxacin	CC1CN(CCN1)c(c2)c(F)cc(c23)c(=O)c(C(=O)O)cn3-c4c(F)cc(F)cc4
6761	tr|F2X2D0|F2X2D0_M	P43702	97.5	68.0	107.0	DB04576	experimental	Fleroxacin	CN1CCN(CC1)c(c2F)c(F)cc(c23)c(=O)c(C(=O)O)cn3CCF
6762	tr|F2X2D0|F2X2D0_M	P43702	97.5	68.0	107.0	DB06771	approved	Besifloxacin	N[C@@H]1CCCCN(C1)c(c2Cl)c(F)cc(c23)c(=O)c(C(=O)O)cn3C4CC4
6763	tr|F2X2D0|F2X2D0_M	P43702	97.5	68.0	107.0	DB09047	approved; investigational	Finafloxacin	O1CCN[C@H]([C@@H]12)CN(C2)c(c3C#N)c(F)cc(c34)c(=O)c(C(=O)O)cn4C5CC5
6764	tr|F2X2D0|F2X2D0_M	P05653	95.0	68.0	106.0	DB00537	approved; investigational	Ciprofloxacin	O=C(O)c(c1=O)cn(C2CC2)c(c13)cc(c(F)c3)N4CCNCC4
6765	tr|F2X2D0|F2X2D0_M	P72525	92.5	63.0	100.0	DB01044	approved; investigational	Gatifloxacin	CC1CN(CCN1)c(c(F)c2)c(OC)c(c23)n(C4CC4)cc(c3=O)C(=O)O
6766	tr|F2X2D0|F2X2D0_M	P72525	92.5	63.0	100.0	DB06771	approved	Besifloxacin	N[C@@H]1CCCCN(C1)c(c2Cl)c(F)cc(c23)c(=O)c(C(=O)O)cn3C4CC4
6767	tr|F2X2D0|F2X2D0_M	P0C1U9	92.5	64.0	101.0	DB00537	approved; investigational	Ciprofloxacin	O=C(O)c(c1=O)cn(C2CC2)c(c13)cc(c(F)c3)N4CCNCC4
6768	tr|A0A2Z3DI51|A0A2	P0A8V2	102.13	608.0	848.0	DB00615	approved; investigational	Rifabutin	CC(C)CN(CC1)CCC12N=C3c4c5c6c(C)c(O)c4C(=O)C(=C3N2)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(=O)C)[C@H](C)[C@@H](OC)/C=C/O[C@](O6)(C)C5=O
6769	tr|A0A2Z3DI51|A0A2	P0A8V2	102.13	608.0	848.0	DB01045	approved	Rifampicin	C[C@@]12O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(=O)C)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)Nc3c(/C=N/N4CCN(C)CC4)c(O)c5c(C1=O)c(O2)c(C)c(O)c5c3O
6770	tr|A0A2Z3DI51|A0A2	P0A8V2	102.13	608.0	848.0	DB01220	approved; investigational	Rifaximin	C[C@]12O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(=O)C)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)Nc3c4c(nc5n4ccc(c5)C)c6c(c3O)c(O)c(C)c(O1)c6C2=O
6771	tr|A0A2Z3DI51|A0A2	P0A8V2	102.13	608.0	848.0	DB04934	investigational	Rifalazil	C[C@]12O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(=O)C)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)Nc3c4c(c5c(c3=O)c(O)c(C)c(O1)c5C2=O)nc6c(o4)cc(cc6O)N7CCN(CC7)CC(C)C
6772	tr|A0A2Z3DI51|A0A2	P0A8V2	102.13	608.0	848.0	DB11753	approved; investigational	Rifamycin	C[C@@]12O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(=O)C)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)Nc3c(O)c4c(c(c3)O)c(C1=O)c(O2)c(C)c4O
6773	tr|A0A2Z3DI51|A0A2	Q8RQE9	98.72	488.0	720.0	DB04788	experimental	Tagetitoxin	OP(=O)(O)O[C@@H]([C@@]12C(=O)O)[C@@H](N)[C@@H](OC(=O)C)[C@@H](O2)[C@@](O)(SC1)C(=O)N
6774	tr|A0A2Z3DI51|A0A2	Q8RQE9	98.72	488.0	720.0	DB08226	experimental	Myxopyronin B	CCCC/C(C)=C/C=C(\C)C(=O)c1c(O)cc(oc1=O)CCC/C=C/NC(=O)OC
6775	tr|A0A2Z3DI51|A0A2	Q8RQE9	98.72	488.0	720.0	DB08266	experimental	Methyl [(1E,5R)-5-{3-[(2E,4E)-2,5-dimethyl-2,4-octadienoyl]-2,4-dioxo-3,4-dihydro-2H-pyran-6-yl}hexylidene]carbamate	COC(=O)/N=C/CCC[C@@H](C)C1=CC(=O)C(C(=O)O1)C(=O)/C(C)=C/C=C(\C)CCC
6776	tr|A0A0N6WYR6|A0A0	P9WIE5	99.86	1.0	740.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
6777	tr|A0A0N6WYR6|A0A0	P9WIE5	99.86	1.0	740.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
6778	tr|A0A0N6WYR6|A0A0	Q939D2	96.49	13.0	727.0	DB08638	experimental	1-hydroperoxy-L-tryptophan	c1cccc(c12)n(OO)cc2C[C@H](N)C(=O)O
6779	tr|M4PN16|M4PN16_M	P05653	96.0	5.0	125.0	DB00537	approved; investigational	Ciprofloxacin	O=C(O)c(c1=O)cn(C2CC2)c(c13)cc(c(F)c3)N4CCNCC4
6780	tr|M4PN16|M4PN16_M	P20831	94.4	7.0	125.0	DB00537	approved; investigational	Ciprofloxacin	O=C(O)c(c1=O)cn(C2CC2)c(c13)cc(c(F)c3)N4CCNCC4
6781	tr|M4PN16|M4PN16_M	P0AES4	96.0	4.0	124.0	DB00537	approved; investigational	Ciprofloxacin	O=C(O)c(c1=O)cn(C2CC2)c(c13)cc(c(F)c3)N4CCNCC4
6782	tr|M4PN16|M4PN16_M	P0AES4	96.0	4.0	124.0	DB11943	approved; investigational	Delafloxacin	Fc1cc(F)c(nc1N)-n2cc(C(=O)O)c(=O)c(c23)cc(F)c(c3Cl)N4CC(O)C4
6783	tr|M4PN16|M4PN16_M	P43700	96.0	5.0	125.0	DB00218	approved; investigational	Moxifloxacin	N1CCC[C@H]([C@H]12)CN(C2)c(c3OC)c(F)cc(c34)c(=O)c(C(=O)O)cn4C5CC5
6784	tr|M4PN16|M4PN16_M	P43700	96.0	5.0	125.0	DB00365	approved; investigational; withdrawn	Grepafloxacin	CC1CN(CCN1)c(c2)c(F)c(C)c(c23)c(=O)c(C(=O)O)cn3C4CC4
6785	tr|M4PN16|M4PN16_M	P43700	96.0	5.0	125.0	DB00467	approved; investigational	Enoxacin	CCn1cc(C(=O)O)c(=O)c(c12)cc(F)c(n2)N3CCNCC3
6786	tr|M4PN16|M4PN16_M	P43700	96.0	5.0	125.0	DB00487	approved	Pefloxacin	CCn1cc(C(=O)O)c(=O)c(c12)cc(F)c(c2)N3CCN(C)CC3
6787	tr|M4PN16|M4PN16_M	P43700	96.0	5.0	125.0	DB00537	approved; investigational	Ciprofloxacin	O=C(O)c(c1=O)cn(C2CC2)c(c13)cc(c(F)c3)N4CCNCC4
6788	tr|M4PN16|M4PN16_M	P43700	96.0	5.0	125.0	DB00685	approved; investigational; withdrawn	Trovafloxacin	N[C@H]1[C@@H]([C@@H]12)CN(C2)c(c(F)c3)nc(c34)n(cc(c4=O)C(=O)O)-c5c(F)cc(F)cc5
6789	tr|M4PN16|M4PN16_M	P43700	96.0	5.0	125.0	DB00827	approved; investigational; withdrawn	Cinoxacin	CCn1nc(C(=O)O)c(=O)c(c12)cc3c(c2)OCO3
6790	tr|M4PN16|M4PN16_M	P43700	96.0	5.0	125.0	DB00978	approved; investigational	Lomefloxacin	CCn1cc(C(=O)O)c(=O)c(c12)cc(F)c(c2F)N3CCNC(C)C3
6791	tr|M4PN16|M4PN16_M	P43700	96.0	5.0	125.0	DB01059	approved	Norfloxacin	CCn1cc(C(=O)O)c(=O)c(c12)cc(F)c(c2)N3CCNCC3
6792	tr|M4PN16|M4PN16_M	P43700	96.0	5.0	125.0	DB01137	approved; investigational	Levofloxacin	C1CN(C)CCN1c(c(c2n34)OC[C@@H]3C)c(F)cc2c(=O)c(c4)C(=O)O
6793	tr|M4PN16|M4PN16_M	P43700	96.0	5.0	125.0	DB01155	approved; investigational	Gemifloxacin	CO/N=C1\CN(CC1CN)c(c(F)c2)nc(c23)n(C4CC4)cc(c3=O)C(=O)O
6794	tr|M4PN16|M4PN16_M	P43700	96.0	5.0	125.0	DB01165	approved	Ofloxacin	C1CN(C)CCN1c(c(c2n34)OCC3C)c(F)cc2c(=O)c(c4)C(=O)O
6795	tr|M4PN16|M4PN16_M	P43700	96.0	5.0	125.0	DB01208	approved; investigational; withdrawn	Sparfloxacin	C[C@H]1CN(C[C@@H](C)N1)c(c2F)c(F)c(N)c(c23)c(=O)c(C(=O)O)cn3C4CC4
6796	tr|M4PN16|M4PN16_M	P43700	96.0	5.0	125.0	DB01405	withdrawn	Temafloxacin	CC1CN(CCN1)c(c2)c(F)cc(c23)c(=O)c(C(=O)O)cn3-c4c(F)cc(F)cc4
6797	tr|M4PN16|M4PN16_M	P43700	96.0	5.0	125.0	DB04576	experimental	Fleroxacin	CN1CCN(CC1)c(c2F)c(F)cc(c23)c(=O)c(C(=O)O)cn3CCF
6798	tr|M4PN16|M4PN16_M	P43700	96.0	5.0	125.0	DB06771	approved	Besifloxacin	N[C@@H]1CCCCN(C1)c(c2Cl)c(F)cc(c23)c(=O)c(C(=O)O)cn3C4CC4
6799	tr|M4PN16|M4PN16_M	P43700	96.0	5.0	125.0	DB09047	approved; investigational	Finafloxacin	O1CCN[C@H]([C@@H]12)CN(C2)c(c3C#N)c(F)cc(c34)c(=O)c(C(=O)O)cn4C5CC5
6800	tr|M4PN16|M4PN16_M	P43700	96.0	5.0	125.0	DB12924	approved; investigational	Ozenoxacin	CNc1ncc(cc1C)-c(c2C)ccc(c23)c(=O)c(C(=O)O)cn3C4CC4
6801	tr|M4PN16|M4PN16_M	P72524	93.6	5.0	122.0	DB01044	approved; investigational	Gatifloxacin	CC1CN(CCN1)c(c(F)c2)c(OC)c(c23)n(C4CC4)cc(c3=O)C(=O)O
6802	tr|M4PN16|M4PN16_M	P72524	93.6	5.0	122.0	DB06771	approved	Besifloxacin	N[C@@H]1CCCCN(C1)c(c2Cl)c(F)cc(c23)c(=O)c(C(=O)O)cn3C4CC4
6803	tr|M4PN16|M4PN16_M	P72525	94.4	2.0	120.0	DB01044	approved; investigational	Gatifloxacin	CC1CN(CCN1)c(c(F)c2)c(OC)c(c23)n(C4CC4)cc(c3=O)C(=O)O
6804	tr|M4PN16|M4PN16_M	P72525	94.4	2.0	120.0	DB06771	approved	Besifloxacin	N[C@@H]1CCCCN(C1)c(c2Cl)c(F)cc(c23)c(=O)c(C(=O)O)cn3C4CC4
6805	tr|M4PN16|M4PN16_M	P0C1U9	93.6	4.0	121.0	DB00537	approved; investigational	Ciprofloxacin	O=C(O)c(c1=O)cn(C2CC2)c(c13)cc(c(F)c3)N4CCNCC4
6806	tr|M4PN16|M4PN16_M	P43702	96.0	6.0	126.0	DB00218	approved; investigational	Moxifloxacin	N1CCC[C@H]([C@H]12)CN(C2)c(c3OC)c(F)cc(c34)c(=O)c(C(=O)O)cn4C5CC5
6807	tr|M4PN16|M4PN16_M	P43702	96.0	6.0	126.0	DB00365	approved; investigational; withdrawn	Grepafloxacin	CC1CN(CCN1)c(c2)c(F)c(C)c(c23)c(=O)c(C(=O)O)cn3C4CC4
6808	tr|M4PN16|M4PN16_M	P43702	96.0	6.0	126.0	DB00467	approved; investigational	Enoxacin	CCn1cc(C(=O)O)c(=O)c(c12)cc(F)c(n2)N3CCNCC3
6809	tr|M4PN16|M4PN16_M	P43702	96.0	6.0	126.0	DB00487	approved	Pefloxacin	CCn1cc(C(=O)O)c(=O)c(c12)cc(F)c(c2)N3CCN(C)CC3
6810	tr|M4PN16|M4PN16_M	P43702	96.0	6.0	126.0	DB00537	approved; investigational	Ciprofloxacin	O=C(O)c(c1=O)cn(C2CC2)c(c13)cc(c(F)c3)N4CCNCC4
6811	tr|M4PN16|M4PN16_M	P43702	96.0	6.0	126.0	DB00685	approved; investigational; withdrawn	Trovafloxacin	N[C@H]1[C@@H]([C@@H]12)CN(C2)c(c(F)c3)nc(c34)n(cc(c4=O)C(=O)O)-c5c(F)cc(F)cc5
6812	tr|M4PN16|M4PN16_M	P43702	96.0	6.0	126.0	DB00978	approved; investigational	Lomefloxacin	CCn1cc(C(=O)O)c(=O)c(c12)cc(F)c(c2F)N3CCNC(C)C3
6813	tr|M4PN16|M4PN16_M	P43702	96.0	6.0	126.0	DB01059	approved	Norfloxacin	CCn1cc(C(=O)O)c(=O)c(c12)cc(F)c(c2)N3CCNCC3
6814	tr|M4PN16|M4PN16_M	P43702	96.0	6.0	126.0	DB01137	approved; investigational	Levofloxacin	C1CN(C)CCN1c(c(c2n34)OC[C@@H]3C)c(F)cc2c(=O)c(c4)C(=O)O
6815	tr|M4PN16|M4PN16_M	P43702	96.0	6.0	126.0	DB01155	approved; investigational	Gemifloxacin	CO/N=C1\CN(CC1CN)c(c(F)c2)nc(c23)n(C4CC4)cc(c3=O)C(=O)O
6816	tr|M4PN16|M4PN16_M	P43702	96.0	6.0	126.0	DB01165	approved	Ofloxacin	C1CN(C)CCN1c(c(c2n34)OCC3C)c(F)cc2c(=O)c(c4)C(=O)O
6817	tr|M4PN16|M4PN16_M	P43702	96.0	6.0	126.0	DB01208	approved; investigational; withdrawn	Sparfloxacin	C[C@H]1CN(C[C@@H](C)N1)c(c2F)c(F)c(N)c(c23)c(=O)c(C(=O)O)cn3C4CC4
6818	tr|M4PN16|M4PN16_M	P43702	96.0	6.0	126.0	DB01405	withdrawn	Temafloxacin	CC1CN(CCN1)c(c2)c(F)cc(c23)c(=O)c(C(=O)O)cn3-c4c(F)cc(F)cc4
6819	tr|M4PN16|M4PN16_M	P43702	96.0	6.0	126.0	DB04576	experimental	Fleroxacin	CN1CCN(CC1)c(c2F)c(F)cc(c23)c(=O)c(C(=O)O)cn3CCF
6820	tr|M4PN16|M4PN16_M	P43702	96.0	6.0	126.0	DB06771	approved	Besifloxacin	N[C@@H]1CCCCN(C1)c(c2Cl)c(F)cc(c23)c(=O)c(C(=O)O)cn3C4CC4
6821	tr|M4PN16|M4PN16_M	P43702	96.0	6.0	126.0	DB09047	approved; investigational	Finafloxacin	O1CCN[C@H]([C@@H]12)CN(C2)c(c3C#N)c(F)cc(c34)c(=O)c(C(=O)O)cn4C5CC5
6822	tr|M4PN16|M4PN16_M	P0AFI2	93.6	5.0	122.0	DB00817	approved; investigational	Rosoxacin	CCn1cc(C(=O)O)c(=O)c(c12)ccc(c2)-c3ccncc3
6823	tr|M4PN16|M4PN16_M	P0AFI2	93.6	5.0	122.0	DB11943	approved; investigational	Delafloxacin	Fc1cc(F)c(nc1N)-n2cc(C(=O)O)c(=O)c(c23)cc(F)c(c3Cl)N4CC(O)C4
6824	tr|M4PN16|M4PN16_M	P0AFI2	93.6	5.0	122.0	DB12924	approved; investigational	Ozenoxacin	CNc1ncc(cc1C)-c(c2C)ccc(c23)c(=O)c(C(=O)O)cn3C4CC4
6825	tr|M4PN16|M4PN16_M	P11388	75.2	711.0	805.0	DB00970	approved; investigational	Dactinomycin	C1CC[C@H](N12)C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@H](C)[C@@H](C(=O)N[C@@H](C2=O)C(C)C)NC(=O)c(ccc3C)c(c34)nc5c(o4)c(C)c(=O)c(N)c5C(=O)N[C@H](C(=O)N[C@@H](C6=O)C(C)C)[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H](N67)CCC7
6826	tr|M4PN16|M4PN16_M	P11388	75.2	711.0	805.0	DB00218	approved; investigational	Moxifloxacin	N1CCC[C@H]([C@H]12)CN(C2)c(c3OC)c(F)cc(c34)c(=O)c(C(=O)O)cn4C5CC5
6827	tr|M4PN16|M4PN16_M	P11388	75.2	711.0	805.0	DB00276	approved; investigational	Amsacrine	CS(=O)(=O)Nc1cc(OC)c(cc1)Nc2c(cccc3)c3nc(c24)cccc4
6828	tr|M4PN16|M4PN16_M	P11388	75.2	711.0	805.0	DB00380	approved; withdrawn	Dexrazoxane	O=C1CN(CC(=O)N1)[C@@H](C)CN2CC(=O)NC(=O)C2
6829	tr|M4PN16|M4PN16_M	P11388	75.2	711.0	805.0	DB00385	approved	Valrubicin	FC(F)(F)C(=O)N[C@H]([C@H](O)[C@@H](O1)C)C[C@@H]1O[C@H]2C[C@](O)(C(=O)COC(=O)CCCC)Cc(c23)c(O)c4c(c3O)C(=O)c5c(C4=O)cccc5OC
6830	tr|M4PN16|M4PN16_M	P11388	75.2	711.0	805.0	DB00444	approved	Teniposide	COc1cc(cc(c1O)OC)[C@@H]2c(cc3c(c4)OCO3)c4[C@H]([C@H]([C@@H]25)COC5=O)O[C@@H]([C@H](O)[C@H]6O)O[C@@H]([C@H]67)CO[C@H](O7)c8cccs8
6831	tr|M4PN16|M4PN16_M	P11388	75.2	711.0	805.0	DB00445	approved	Epirubicin	COc1cccc(c12)C(=O)c3c(C2=O)c(O)c4c(c3O)C[C@@](O)(C(=O)CO)C[C@@H]4O[C@H]5C[C@H](N)[C@@H](O)[C@@H](O5)C
6832	tr|M4PN16|M4PN16_M	P11388	75.2	711.0	805.0	DB00467	approved; investigational	Enoxacin	CCn1cc(C(=O)O)c(=O)c(c12)cc(F)c(n2)N3CCNCC3
6833	tr|M4PN16|M4PN16_M	P11388	75.2	711.0	805.0	DB00487	approved	Pefloxacin	CCn1cc(C(=O)O)c(=O)c(c12)cc(F)c(c2)N3CCN(C)CC3
6834	tr|M4PN16|M4PN16_M	P11388	75.2	711.0	805.0	DB00537	approved; investigational	Ciprofloxacin	O=C(O)c(c1=O)cn(C2CC2)c(c13)cc(c(F)c3)N4CCNCC4
6835	tr|M4PN16|M4PN16_M	P11388	75.2	711.0	805.0	DB00685	approved; investigational; withdrawn	Trovafloxacin	N[C@H]1[C@@H]([C@@H]12)CN(C2)c(c(F)c3)nc(c34)n(cc(c4=O)C(=O)O)-c5c(F)cc(F)cc5
6836	tr|M4PN16|M4PN16_M	P11388	75.2	711.0	805.0	DB00694	approved	Daunorubicin	COc1cccc(c12)C(=O)c3c(C2=O)c(O)c4c(c3O)C[C@@](O)(C(=O)C)C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@@H](O5)C
6837	tr|M4PN16|M4PN16_M	P11388	75.2	711.0	805.0	DB00773	approved	Etoposide	COc1cc(cc(c1O)OC)[C@@H]2c(cc3c(c4)OCO3)c4[C@H]([C@H]([C@@H]25)COC5=O)O[C@@H]([C@H](O)[C@H]6O)O[C@@H]([C@H]67)CO[C@H](O7)C
6838	tr|M4PN16|M4PN16_M	P11388	75.2	711.0	805.0	DB00978	approved; investigational	Lomefloxacin	CCn1cc(C(=O)O)c(=O)c(c12)cc(F)c(c2F)N3CCNC(C)C3
6839	tr|M4PN16|M4PN16_M	P11388	75.2	711.0	805.0	DB00997	approved; investigational	Doxorubicin	COc1cccc(c12)C(=O)c3c(C2=O)c(O)c4c(c3O)C[C@@](O)(C(=O)CO)C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@@H](O5)C
6840	tr|M4PN16|M4PN16_M	P11388	75.2	711.0	805.0	DB01059	approved	Norfloxacin	CCn1cc(C(=O)O)c(=O)c(c12)cc(F)c(c2)N3CCNCC3
6841	tr|M4PN16|M4PN16_M	P11388	75.2	711.0	805.0	DB01165	approved	Ofloxacin	C1CN(C)CCN1c(c(c2n34)OCC3C)c(F)cc2c(=O)c(c4)C(=O)O
6842	tr|M4PN16|M4PN16_M	P11388	75.2	711.0	805.0	DB01177	approved	Idarubicin	O[C@H]1[C@@H](N)C[C@@H](O[C@H]1C)O[C@H]2C[C@](O)(C(=O)C)Cc(c23)c(O)c4c(c3O)C(=O)c5c(C4=O)cccc5
6843	tr|M4PN16|M4PN16_M	P11388	75.2	711.0	805.0	DB01179	approved	Podofilox	COc1c(OC)cc(cc1OC)[C@@H]2c(cc3c(c4)OCO3)c4[C@H](O)[C@H]([C@@H]25)COC5=O
6844	tr|M4PN16|M4PN16_M	P11388	75.2	711.0	805.0	DB01204	approved; investigational	Mitoxantrone	Oc1ccc(O)c(c12)C(=O)c3c(C2=O)c(NCCNCCO)ccc3NCCNCCO
6845	tr|M4PN16|M4PN16_M	P11388	75.2	711.0	805.0	DB01208	approved; investigational; withdrawn	Sparfloxacin	C[C@H]1CN(C[C@@H](C)N1)c(c2F)c(F)c(N)c(c23)c(=O)c(C(=O)O)cn3C4CC4
6846	tr|M4PN16|M4PN16_M	P11388	75.2	711.0	805.0	DB01645	investigational	Genistein	Oc1ccc(cc1)-c(c2=O)coc(c23)cc(O)cc3O
6847	tr|M4PN16|M4PN16_M	P11388	75.2	711.0	805.0	DB04576	experimental	Fleroxacin	CN1CCN(CC1)c(c2F)c(F)cc(c23)c(=O)c(C(=O)O)cn3CCF
6848	tr|M4PN16|M4PN16_M	P11388	75.2	711.0	805.0	DB04967	investigational	Lucanthone	CCN(CC)CCNc(ccc1C)c(c12)c(=O)c3c(s2)cccc3
6849	tr|M4PN16|M4PN16_M	P11388	75.2	711.0	805.0	DB04975	investigational	Banoxantrone	[O-][N+](C)(C)CCNc1ccc(NCC[N+]([O-])(C)C)c(c12)C(=O)c3c(C2=O)c(O)ccc3O
6850	tr|M4PN16|M4PN16_M	P11388	75.2	711.0	805.0	DB04978	investigational	SP1049C	 
6851	tr|M4PN16|M4PN16_M	P11388	75.2	711.0	805.0	DB05022	investigational	Amonafide	CN(C)CCN(C1=O)C(=O)c2cccc(c2c13)cc(c3)N
6852	tr|M4PN16|M4PN16_M	P11388	75.2	711.0	805.0	DB05129	investigational	Elsamitrucin	CO[C@@H]1[C@@H](N)[C@H](O[C@H](C)[C@@H]1O)O[C@H]([C@@]2(C)O)[C@@H](O[C@H](C)[C@@H]2O)Oc3cccc(c34)c(O)c5c6c4oc(=O)c7c6c(oc5=O)ccc7C
6853	tr|M4PN16|M4PN16_M	P11388	75.2	711.0	805.0	DB05706	investigational	13-deoxydoxorubicin	c1ccc(OC)c(c12)C(=O)c3c(C2=O)c(O)c4c(c3O)[C@H](C[C@](C4)(O)CCO)O[C@H]5C[C@H](N)[C@H](O)[C@@H](O5)C
6854	tr|M4PN16|M4PN16_M	P11388	75.2	711.0	805.0	DB05920	investigational	RTA 744	 
6855	tr|M4PN16|M4PN16_M	P11388	75.2	711.0	805.0	DB06013	investigational	Aldoxorubicin	c1ccc(OC)c(c12)C(=O)c3c(C2=O)c(O)c4c(c3O)[C@@H](O[C@H]5C[C@H](N)[C@H](O)[C@@H](O5)C)C[C@](C4)(O)/C(CO)=N/NC(=O)CCCCCN6C(=O)C=CC6=O
6856	tr|M4PN16|M4PN16_M	P11388	75.2	711.0	805.0	DB06042	investigational	ZEN-012	 
6857	tr|M4PN16|M4PN16_M	P11388	75.2	711.0	805.0	DB06263	investigational	Amrubicin	O[C@@H]1CO[C@H](C[C@@H]1O)O[C@H]2C[C@](N)(C(=O)C)Cc(c23)c(O)c4c(c3O)C(=O)c5c(C4=O)cccc5
6858	tr|M4PN16|M4PN16_M	P11388	75.2	711.0	805.0	DB06362	investigational	Becatecarin	CCN(CC)CCN(C1=O)C(=O)c(c12)c3c([nH]c4c3cccc4Cl)c5c2c6c(c(Cl)ccc6)n5[C@@H]7O[C@H](CO)[C@@H](OC)[C@H](O)[C@H]7O
6859	tr|M4PN16|M4PN16_M	P11388	75.2	711.0	805.0	DB06420	investigational	Annamycin	O[C@@H]1[C@@H](O)[C@@H](I)[C@@H](O[C@H]1C)O[C@H]2C[C@](O)(C(=O)CO)Cc(c23)c(O)c4c(c3O)C(=O)c5c(C4=O)cccc5
6860	tr|M4PN16|M4PN16_M	P11388	75.2	711.0	805.0	DB06421	investigational	Declopramide	CCN(CC)CCNC(=O)c1ccc(N)c(Cl)c1
6861	tr|M4PN16|M4PN16_M	P11388	75.2	711.0	805.0	DB09047	approved; investigational	Finafloxacin	O1CCN[C@H]([C@@H]12)CN(C2)c(c3C#N)c(F)cc(c34)c(=O)c(C(=O)O)cn4C5CC5
6862	tr|M4PN16|M4PN16_M	Q02880	75.2	732.0	826.0	DB00380	approved; withdrawn	Dexrazoxane	O=C1CN(CC(=O)N1)[C@@H](C)CN2CC(=O)NC(=O)C2
6863	tr|M4PN16|M4PN16_M	Q02880	75.2	732.0	826.0	DB00694	approved	Daunorubicin	COc1cccc(c12)C(=O)c3c(C2=O)c(O)c4c(c3O)C[C@@](O)(C(=O)C)C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@@H](O5)C
6864	tr|M4PN16|M4PN16_M	Q02880	75.2	732.0	826.0	DB00773	approved	Etoposide	COc1cc(cc(c1O)OC)[C@@H]2c(cc3c(c4)OCO3)c4[C@H]([C@H]([C@@H]25)COC5=O)O[C@@H]([C@H](O)[C@H]6O)O[C@@H]([C@H]67)CO[C@H](O7)C
6865	tr|M4PN16|M4PN16_M	Q02880	75.2	732.0	826.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
6866	tr|M4PN16|M4PN16_M	Q02880	75.2	732.0	826.0	DB05022	investigational	Amonafide	CN(C)CCN(C1=O)C(=O)c2cccc(c2c13)cc(c3)N
6867	tr|M4PN16|M4PN16_M	Q02880	75.2	732.0	826.0	DB05488	investigational	Technetium Tc-99m ciprofloxacin	 
6868	tr|M4PN16|M4PN16_M	Q02880	75.2	732.0	826.0	DB06042	investigational	ZEN-012	 
6869	tr|M4PN16|M4PN16_M	Q02880	75.2	732.0	826.0	DB06362	investigational	Becatecarin	CCN(CC)CCN(C1=O)C(=O)c(c12)c3c([nH]c4c3cccc4Cl)c5c2c6c(c(Cl)ccc6)n5[C@@H]7O[C@H](CO)[C@@H](OC)[C@H](O)[C@H]7O
6870	tr|M4PN16|M4PN16_M	Q02880	75.2	732.0	826.0	DB06421	investigational	Declopramide	CCN(CC)CCNC(=O)c1ccc(N)c(Cl)c1
6871	tr|M4PN16|M4PN16_M	Q02880	75.2	732.0	826.0	DB08651	experimental	3'-THIO-THYMIDINE-5'-PHOSPHATE	OP(=O)(O)OC[C@H]1O[C@H](C[C@@H]1S)n2cc(C)c(=O)[nH]c2=O
6872	tr|M4PN16|M4PN16_M	Q02880	75.2	732.0	826.0	DB00970	approved; investigational	Dactinomycin	C1CC[C@H](N12)C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@H](C)[C@@H](C(=O)N[C@@H](C2=O)C(C)C)NC(=O)c(ccc3C)c(c34)nc5c(o4)c(C)c(=O)c(N)c5C(=O)N[C@H](C(=O)N[C@@H](C6=O)C(C)C)[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H](N67)CCC7
6873	tr|A0A0N9DSA1|A0A0	P9WIE5	99.86	1.0	740.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
6874	tr|A0A0N9DSA1|A0A0	P9WIE5	99.86	1.0	740.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
6875	tr|A0A0N9DSA1|A0A0	Q939D2	96.49	13.0	727.0	DB08638	experimental	1-hydroperoxy-L-tryptophan	c1cccc(c12)n(OO)cc2C[C@H](N)C(=O)O
6876	tr|A0A0N7EHL5|A0A0	P9WIE5	99.86	1.0	740.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
6877	tr|A0A0N7EHL5|A0A0	P9WIE5	99.86	1.0	740.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
6878	tr|A0A0N7EHL5|A0A0	Q939D2	96.49	13.0	727.0	DB08638	experimental	1-hydroperoxy-L-tryptophan	c1cccc(c12)n(OO)cc2C[C@H](N)C(=O)O
6879	tr|A0A0N7EHL2|A0A0	P9WIE5	99.86	1.0	740.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
6880	tr|A0A0N7EHL2|A0A0	P9WIE5	99.86	1.0	740.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
6881	tr|A0A0N7EHL2|A0A0	Q939D2	96.49	13.0	727.0	DB08638	experimental	1-hydroperoxy-L-tryptophan	c1cccc(c12)n(OO)cc2C[C@H](N)C(=O)O
6882	tr|A9X5B9|A9X5B9_M	P0A4L9	92.92	109.0	503.0	DB01044	approved; investigational	Gatifloxacin	CC1CN(CCN1)c(c(F)c2)c(OC)c(c23)n(C4CC4)cc(c3=O)C(=O)O
6883	tr|A9X5B9|A9X5B9_M	P0A0K8	93.16	110.0	505.0	DB01051	approved; investigational; vet_approved	Novobiocin	CO[C@@H](C1(C)C)[C@@H](OC(=O)N)[C@@H](O)[C@@H](O1)Oc(cc2)c(C)c(c23)oc(=O)c(c3O)NC(=O)c4ccc(O)c(c4)CC=C(C)C
6884	tr|A9X5B9|A9X5B9_M	P0AES6	92.69	102.0	495.0	DB00817	approved; investigational	Rosoxacin	CCn1cc(C(=O)O)c(=O)c(c12)ccc(c2)-c3ccncc3
6885	tr|A9X5B9|A9X5B9_M	P0AES6	92.69	102.0	495.0	DB03966	experimental	Clorobiocin	Cc1[nH]c(cc1)C(=O)O[C@H]([C@@H](OC)C2(C)C)[C@@H](O)[C@@H](O2)Oc(cc3)c(Cl)c(c34)oc(=O)c(c4O)NC(=O)c5cc(c(O)cc5)CC=C(C)C
6886	tr|A9X5B9|A9X5B9_M	P0AES6	92.69	102.0	495.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
6887	tr|A9X5B9|A9X5B9_M	P0AES6	92.69	102.0	495.0	DB05488	investigational	Technetium Tc-99m ciprofloxacin	 
6888	tr|A9X5B9|A9X5B9_M	Q59192	93.16	104.0	499.0	DB00537	approved; investigational	Ciprofloxacin	O=C(O)c(c1=O)cn(C2CC2)c(c13)cc(c(F)c3)N4CCNCC4
6889	tr|A9X5B9|A9X5B9_M	Q59961	93.63	106.0	503.0	DB01044	approved; investigational	Gatifloxacin	CC1CN(CCN1)c(c(F)c2)c(OC)c(c23)n(C4CC4)cc(c3=O)C(=O)O
6890	tr|A9X5B9|A9X5B9_M	Q5SHZ4	93.63	99.0	496.0	DB01942	experimental; investigational	Formic acid	OC=O
6891	tr|A9X5B9|A9X5B9_M	P20083	91.75	98.0	487.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
6892	sp|P9WPE9|CH601_MY	P10809	97.96	27.0	555.0	DB09130	approved; investigational	Copper	[Cu]
6893	sp|V5QRX7|3098A_MY	P96622	103.77	2.0	112.0	DB02042	experimental	2-(2-{2-[2-(2-Methoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol	COCCOCCOCCOCCOCCO
6894	sp|P9WQ93|AMI4_MYC	Q9ZIV5	77.26	36.0	403.0	DB02153	experimental	3-sulfino-L-alanine	OC(=O)[C@@H](N)C[S@](=O)O
6895	sp|P9WQ93|AMI4_MYC	Q9ZIV5	77.26	36.0	403.0	DB02175	experimental	Malonic acid	OC(=O)CC(=O)O
6896	sp|P9WQ93|AMI4_MYC	Q9ZIV5	77.26	36.0	403.0	DB02649	experimental	3-Amino-3-Oxopropanoic Acid	NC(=O)CC(=O)O
6897	sp|P9WQ93|AMI4_MYC	Q8RJN5	100.84	48.0	527.0	DB01683	experimental	Chymostatin	c1ccccc1C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C2CCNC(=N)N2)NC(=O)N[C@H](C(=O)O)Cc3ccccc3
6898	sp|P9WNY1|ALDH_MYC	O94788	94.87	35.0	516.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
6899	sp|P9WNY1|ALDH_MYC	O94788	94.87	35.0	516.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
6900	sp|P9WNY1|ALDH_MYC	O94788	94.87	35.0	516.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
6901	sp|P9WNY1|ALDH_MYC	P00352	94.87	18.0	499.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
6902	sp|P9WNY1|ALDH_MYC	P00352	94.87	18.0	499.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
6903	sp|P9WNY1|ALDH_MYC	P00352	94.87	18.0	499.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
6904	sp|P9WNY1|ALDH_MYC	P00352	94.87	18.0	499.0	DB04447	experimental	1,4-Dithiothreitol	SC[C@H](O)[C@@H](O)CS
6905	sp|P9WNY1|ALDH_MYC	P47895	94.87	29.0	510.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
6906	sp|P9WNY1|ALDH_MYC	P47895	94.87	29.0	510.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
6907	sp|P9WNY1|ALDH_MYC	P05091	94.28	37.0	515.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
6908	sp|P9WNY1|ALDH_MYC	P05091	94.28	37.0	515.0	DB00536	approved	Guanidine	NC(N)=N
6909	sp|P9WNY1|ALDH_MYC	P05091	94.28	37.0	515.0	DB00822	approved	Disulfiram	CCN(CC)C(=S)SSC(=S)N(CC)CC
6910	sp|P9WNY1|ALDH_MYC	P05091	94.28	37.0	515.0	DB02115	experimental	Daidzin	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)Oc(c2)ccc(c23)c(=O)c(co3)-c4ccc(O)cc4
6911	sp|P9WNY1|ALDH_MYC	P05091	94.28	37.0	515.0	DB04381	experimental	Crotonaldehyde	O=C/C=C/C
6912	sp|P9WNY1|ALDH_MYC	P30837	95.07	33.0	515.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
6913	sp|P9WNY1|ALDH_MYC	P49189	95.46	7.0	491.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
6914	sp|P9WNY1|ALDH_MYC	O75891	95.46	417.0	901.0	DB00116	nutraceutical	Tetrahydrofolic acid	Nc([nH]1)nc(=O)c(c12)NC(CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
6915	sp|P9WNY1|ALDH_MYC	P25553	94.08	1.0	478.0	DB03619	approved	Deoxycholic acid	C1C[C@@H](O)C[C@H]([C@]12C)CC[C@@H]3[C@@H]2C[C@H](O)[C@@]4(C)[C@H]3CC[C@@H]4[C@H](C)CCC(=O)O
6916	sp|P9WNY1|ALDH_MYC	P77674	92.9	2.0	473.0	DB04401	experimental	Betaine aldehyde	C[N+](C)(C)CC=O
6917	sp|P9WNY1|ALDH_MYC	P51649	95.46	48.0	532.0	DB00139	approved; nutraceutical	Succinic acid	OC(=O)CCC(=O)O
6918	sp|P9WNY1|ALDH_MYC	P51649	95.46	48.0	532.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
6919	sp|P9WNY1|ALDH_MYC	P51649	95.46	48.0	532.0	DB00313	approved; investigational	Valproic acid	CCCC(C(=O)O)CCC
6920	sp|P9WNY1|ALDH_MYC	P51649	95.46	48.0	532.0	DB00534	approved; withdrawn	Chlormerodrin	Cl[Hg]CC(OC)CNC(=O)N
6921	sp|P9WNY1|ALDH_MYC	Q02252	96.06	29.0	516.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
6922	sp|P9WNY1|ALDH_MYC	Q59931	92.9	2.0	473.0	DB02263	experimental	Glyceraldehyde-3-Phosphate	O=C[C@H](O)COP(=O)(O)O
6923	sp|P9WNY1|ALDH_MYC	Q59931	92.9	2.0	473.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
6924	sp|P9WNY1|ALDH_MYC	P83849	94.08	36.0	513.0	DB03564	experimental	(4r)-2-Methylpentane-2,4-Diol	C[C@H](O)CC(C)(C)O
6925	sp|P9WNY1|ALDH_MYC	P30838	84.42	3.0	431.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
6926	sp|P9WNY1|ALDH_MYC	P49419	93.29	55.0	528.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
6927	sp|P9WNY1|ALDH_MYC	P49419	93.29	55.0	528.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
6928	sp|P9WNY1|ALDH_MYC	P51648	83.63	4.0	428.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
6929	sp|P9WNY1|ALDH_MYC	P43353	83.23	9.0	431.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
6930	sp|P9WNY1|ALDH_MYC	P09546	87.77	656.0	1101.0	DB03051	experimental	(S)-2-Tetrahydrofuroic acid	OC(=O)[C@H]1CCCO1
6931	sp|P9WNY1|ALDH_MYC	P09546	87.77	656.0	1101.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
6932	sp|P9WNY1|ALDH_MYC	P09546	87.77	656.0	1101.0	DB04398	approved; vet_approved	Lactic acid	CC(O)C(=O)O
6933	sp|P9WNY1|ALDH_MYC	P30038	89.74	78.0	533.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
6934	sp|P9WNY1|ALDH_MYC	Q56694	86.39	2.0	440.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
6936	sp|P9WGB1|COBM_MYC	P21631	94.82	16.0	254.0	DB01752	experimental	S-adenosyl-L-homocysteine	OC(=O)[C@@H](N)CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
6937	sp|P9WGB1|COBM_MYC	P25924	91.63	218.0	448.0	DB01752	experimental	S-adenosyl-L-homocysteine	OC(=O)[C@@H](N)CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
6938	sp|P9WGB1|COBM_MYC	P25924	91.63	218.0	448.0	DB04522	experimental	Dexfosfoserine	OC(=O)[C@@H](N)COP(=O)(O)O
6939	sp|P9WGB1|COBM_MYC	Q5SKH6	88.05	4.0	225.0	DB01752	experimental	S-adenosyl-L-homocysteine	OC(=O)[C@@H](N)CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
6940	sp|P95280|ACD17_MY	Q72JJ3	91.69	4.0	379.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
6941	sp|P95280|ACD17_MY	P16219	91.69	32.0	407.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
6942	sp|P95280|ACD17_MY	P16219	91.69	32.0	407.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
6943	sp|P95280|ACD17_MY	P16219	91.69	32.0	407.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
6944	sp|P95280|ACD17_MY	P11310	91.69	39.0	414.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
6945	sp|P95280|ACD17_MY	P11310	91.69	39.0	414.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
6946	sp|P95280|ACD17_MY	P11310	91.69	39.0	414.0	DB03415	experimental	3-thiaoctanoyl-CoA	CCCCCSCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
6947	sp|P95280|ACD17_MY	P26440	91.44	42.0	416.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
6948	sp|P95280|ACD17_MY	P26440	91.44	42.0	416.0	DB04036	experimental	Coenzyme A persulfide	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSS
6949	sp|P95280|ACD17_MY	P45954	90.71	57.0	428.0	DB00167	investigational; nutraceutical	Isoleucine	CC[C@H](C)[C@H](N)C(=O)O
6950	sp|P95280|ACD17_MY	P45954	90.71	57.0	428.0	DB00313	approved; investigational	Valproic acid	CCCC(C(=O)O)CCC
6951	sp|P95280|ACD17_MY	Q06319	93.15	1.0	382.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
6952	sp|P95280|ACD17_MY	Q06319	93.15	1.0	382.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
6953	sp|P95280|ACD17_MY	Q9UKU7	91.2	40.0	413.0	DB01675	experimental	Methacrylyl-Coenzyme A	CC(=C)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
6954	sp|P95280|ACD17_MY	Q9UKU7	91.2	40.0	413.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
6955	sp|P95280|ACD17_MY	Q3JP94	90.95	15.0	387.0	DB08685	experimental	1-(1,4-dimethyl-1,2,3,4-tetrahydroquinoxalin-6-yl)methanamine	CN1CCN(C)c(c12)cc(cc2)CN
6956	sp|P95280|ACD17_MY	Q92947	90.46	61.0	431.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
6957	sp|P95280|ACD17_MY	Q92947	90.46	61.0	431.0	DB03245	experimental	S-4-Nitrobutyryl-CoA	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCC[N+]([O-])=O
6958	sp|P95280|ACD17_MY	Q9KIE5	85.33	16.0	365.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
6959	sp|P9WQC1|ADHA_MYC	P00325	102.02	20.0	373.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
6960	sp|P9WQC1|ADHA_MYC	P00325	102.02	20.0	373.0	DB01213	approved; vet_approved	Fomepizole	Cc1c[nH]nc1
6961	sp|P9WQC1|ADHA_MYC	P00325	102.02	20.0	373.0	DB02481	experimental	N-Benzylformamide	O=CNCc1ccccc1
6962	sp|P9WQC1|ADHA_MYC	P00325	102.02	20.0	373.0	DB02721	experimental	4-Iodopyrazole	Ic1c[nH]nc1
6963	sp|P9WQC1|ADHA_MYC	P00325	102.02	20.0	373.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
6964	sp|P9WQC1|ADHA_MYC	P00325	102.02	20.0	373.0	DB03703	experimental	Cyclohexanol	OC1CCCCC1
6965	sp|P9WQC1|ADHA_MYC	P00325	102.02	20.0	373.0	DB04105	experimental	N-Heptylformamide	CCCCCCCNC=O
6966	sp|P9WQC1|ADHA_MYC	P00325	102.02	20.0	373.0	DB09462	approved; investigational	Glycerin	OCC(O)CO
6967	sp|P9WQC1|ADHA_MYC	P00326	102.02	20.0	373.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
6968	sp|P9WQC1|ADHA_MYC	P00326	102.02	20.0	373.0	DB01213	approved; vet_approved	Fomepizole	Cc1c[nH]nc1
6969	sp|P9WQC1|ADHA_MYC	P00326	102.02	20.0	373.0	DB01711	experimental	2,3,4,5,6-Pentafluorobenzyl Alcohol	OCc1c(F)c(F)c(F)c(F)c1F
6970	sp|P9WQC1|ADHA_MYC	P00326	102.02	20.0	373.0	DB02131	experimental	N-1-methylheptylformamide	O=CN[C@H](C)CCCCCC
6971	sp|P9WQC1|ADHA_MYC	P00326	102.02	20.0	373.0	DB02249	experimental	2-Ethoxyethanol	CCOCCO
6972	sp|P9WQC1|ADHA_MYC	P00326	102.02	20.0	373.0	DB02659	approved	Cholic Acid	OC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](C[C@@H]2O)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
6973	sp|P9WQC1|ADHA_MYC	P00326	102.02	20.0	373.0	DB02721	experimental	4-Iodopyrazole	Ic1c[nH]nc1
6974	sp|P9WQC1|ADHA_MYC	P00326	102.02	20.0	373.0	DB02757	experimental	Pyrazole	[nH]1cccn1
6975	sp|P9WQC1|ADHA_MYC	P00326	102.02	20.0	373.0	DB02822	experimental	Para-Bromobenzyl Alcohol	OCc1ccc(Br)cc1
6976	sp|P9WQC1|ADHA_MYC	P00326	102.02	20.0	373.0	DB02871	experimental	3-Butylthiolane 1-Oxide	O=[S@@]1C[C@H](CC1)CCCC
6977	sp|P9WQC1|ADHA_MYC	P00326	102.02	20.0	373.0	DB03020	experimental	5-beta-D-ribofuranosylnicotinamide adenine dinucleotide	NC(=O)c1c[nH+]cc(c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
6978	sp|P9WQC1|ADHA_MYC	P00326	102.02	20.0	373.0	DB03061	experimental	(R)-N-(1-Methyl-Hexyl)-Formamide	CCCCC[C@H](C)NC=O
6979	sp|P9WQC1|ADHA_MYC	P00326	102.02	20.0	373.0	DB03226	experimental	Trifluoroethanol	OCC(F)(F)F
6980	sp|P9WQC1|ADHA_MYC	P00326	102.02	20.0	373.0	DB03559	experimental	Cyclohexylformamide	O=CNC1CCCCC1
6981	sp|P9WQC1|ADHA_MYC	P00326	102.02	20.0	373.0	DB04071	experimental	Cpad	NC(=O)c1nc(ccc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
6982	sp|P9WQC1|ADHA_MYC	P00326	102.02	20.0	373.0	DB04113	experimental	N-Formylpiperidine	O=CN1CCCCC1
6983	sp|P9WQC1|ADHA_MYC	P00326	102.02	20.0	373.0	DB04312	experimental	2,3-Difluorobenzyl Alcohol	OCc1cccc(F)c1F
6984	sp|P9WQC1|ADHA_MYC	P00326	102.02	20.0	373.0	DB04448	experimental	2,4-Difluorobenzyl Alcohol 2,4-Difluoro-1-(Hydroxymethyl)Benzene	OCc1ccc(F)cc1F
6985	sp|P9WQC1|ADHA_MYC	P07327	102.02	20.0	373.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
6986	sp|P9WQC1|ADHA_MYC	P07327	102.02	20.0	373.0	DB01213	approved; vet_approved	Fomepizole	Cc1c[nH]nc1
6987	sp|P9WQC1|ADHA_MYC	P07327	102.02	20.0	373.0	DB02721	experimental	4-Iodopyrazole	Ic1c[nH]nc1
6988	sp|P9WQC1|ADHA_MYC	P07327	102.02	20.0	373.0	DB04065	experimental	N-Cyclopentyl-N-Cyclobutylformamide	C1CCC1N(C=O)C2CCCC2
6989	sp|P9WQC1|ADHA_MYC	P42328	93.64	11.0	335.0	DB03226	experimental	Trifluoroethanol	OCC(F)(F)F
6990	sp|P9WQC1|ADHA_MYC	P40394	102.02	31.0	384.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
6991	sp|P9WQC1|ADHA_MYC	P08319	103.47	20.0	378.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
6992	sp|P9WQC1|ADHA_MYC	P08319	103.47	20.0	378.0	DB03559	experimental	Cyclohexylformamide	O=CNC1CCCCC1
6993	sp|P9WQC1|ADHA_MYC	P11766	101.73	18.0	370.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
6994	sp|P9WQC1|ADHA_MYC	P11766	101.73	18.0	370.0	DB03017	approved; experimental	Lauric acid	CCCCCCCCCCCC(=O)O
6995	sp|P9WQC1|ADHA_MYC	P11766	101.73	18.0	370.0	DB03704	experimental	12-Hydroxydodecanoic Acid	OCCCCCCCCCCCC(=O)O
6996	sp|P9WQC1|ADHA_MYC	P11766	101.73	18.0	370.0	DB04153	experimental	S-Hydroxymethyl Glutathione	OC(=O)[C@@H](N)CCC(=O)N[C@@H](CSCO)C(=O)NCC(=O)O
6997	sp|P9WQC1|ADHA_MYC	Q00796	93.93	18.0	343.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
6998	sp|P9WQC1|ADHA_MYC	Q00796	93.93	18.0	343.0	DB04478	experimental	Cp-166572, 2-Hydroxymethyl-4-(4-N,N-Dimethylaminosulfonyl-1-Piperazino)-Pyrimidine	CN(C)S(=O)(=O)N1CCN(CC1)c2ccnc(n2)CO
6999	sp|P9WQC1|ADHA_MYC	P14941	95.66	7.0	338.0	DB02606	experimental; investigational	2-Butanol	CC[C@@H](C)O
7000	sp|P9WQC1|ADHA_MYC	P14941	95.66	7.0	338.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
7001	sp|P9WQC1|ADHA_MYC	P49327	70.81	1609.0	1854.0	DB01034	experimental	Cerulenin	NC(=O)[C@@H]1O[C@@H]1C(=O)CC/C=C/C/C=C/C
7002	sp|P9WQC1|ADHA_MYC	P49327	70.81	1609.0	1854.0	DB01083	approved; investigational	Orlistat	CCCCCCCCCCC[C@H](OC(=O)[C@@H](NC=O)CC(C)C)C[C@@H]1OC(=O)[C@H]1CCCCCC
7003	sp|P9WPY7|ARLY_MYC	P04424	96.6	1.0	455.0	DB00125	investigational; nutraceutical	Arginine	OC(=O)[C@@H](N)CCCNC(N)=N
7004	sp|P9WPY7|ARLY_MYC	P04424	96.6	1.0	455.0	DB02267	experimental	Argininosuccinate	OC(=O)[C@@H](N)CCC/N=C(\N)N[C@@H](C(=O)O)CC(=O)O
7005	sp|P9WPY7|ARLY_MYC	P04424	96.6	1.0	455.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
7006	sp|P9WKD3|BLAC_MYC	P00808	94.14	11.0	300.0	DB04261	experimental	Carbamic Acid	NC(=O)O
7007	sp|P9WKD3|BLAC_MYC	P00808	94.14	11.0	300.0	DB04272	approved; nutraceutical; vet_approved	Citric acid	OC(=O)CC(O)(C(=O)O)CC(=O)O
7008	sp|P9WKD3|BLAC_MYC	Q9L5C7	85.02	27.0	288.0	DB02772	approved; experimental; investigational	Sucrose	OC[C@@H](O1)[C@@H](O)[C@H](O)[C@]1(CO)O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O
7009	sp|P9WKD3|BLAC_MYC	Q9L5C7	85.02	27.0	288.0	DB04035	experimental	Ceftazidime BATSI	OB(O)CNC(=O)C(\c(cs1)nc1N)=N/OC(C)(C)C(=O)O
7010	sp|P9WKD3|BLAC_MYC	Q9L5C7	85.02	27.0	288.0	DB09060	approved	Avibactam	[C@@H]12CC[C@@H](C(=O)N)N(C1)C(=O)N2OS(=O)(=O)O
7011	sp|P9WKD3|BLAC_MYC	Q9L5C7	85.02	27.0	288.0	DB12107	approved; investigational	Vaborbactam	OB1O[C@H](CC(=O)O)CC[C@@H]1NC(=O)Cc2cccs2
7012	sp|P9WKD3|BLAC_MYC	Q9L5C7	85.02	27.0	288.0	DB12377	approved; investigational	Relebactam	OS(=O)(=O)ON([C@@H]12)C(=O)N(C1)[C@@H](CC2)C(=O)NC3CCNCC3
7013	sp|P9WKD3|BLAC_MYC	Q840M4	85.02	27.0	288.0	DB02772	approved; experimental; investigational	Sucrose	OC[C@@H](O1)[C@@H](O)[C@H](O)[C@]1(CO)O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O
7014	sp|P9WKD3|BLAC_MYC	Q840M4	85.02	27.0	288.0	DB04035	experimental	Ceftazidime BATSI	OB(O)CNC(=O)C(\c(cs1)nc1N)=N/OC(C)(C)C(=O)O
7015	sp|P9WKD3|BLAC_MYC	Q840M4	85.02	27.0	288.0	DB09060	approved	Avibactam	[C@@H]12CC[C@@H](C(=O)N)N(C1)C(=O)N2OS(=O)(=O)O
7016	sp|P9WKD3|BLAC_MYC	Q840M4	85.02	27.0	288.0	DB12107	approved; investigational	Vaborbactam	OB1O[C@H](CC(=O)O)CC[C@@H]1NC(=O)Cc2cccs2
7017	sp|P9WKD3|BLAC_MYC	Q840M4	85.02	27.0	288.0	DB12377	approved; investigational	Relebactam	OS(=O)(=O)ON([C@@H]12)C(=O)N(C1)[C@@H](CC2)C(=O)NC3CCNCC3
7018	sp|P9WKD3|BLAC_MYC	Q9L5C8	85.02	27.0	288.0	DB02772	approved; experimental; investigational	Sucrose	OC[C@@H](O1)[C@@H](O)[C@H](O)[C@]1(CO)O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O
7019	sp|P9WKD3|BLAC_MYC	Q9L5C8	85.02	27.0	288.0	DB02841	experimental	[(2-Ethoxy-1-Naphthoyl)Amino]Methylboronic Acid	OB(O)CNC(=O)c(c(cc1)OCC)c(c12)cccc2
7020	sp|P9WKD3|BLAC_MYC	Q9L5C8	85.02	27.0	288.0	DB06889	experimental	3-(1H-tetrazol-5-ylmethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one	C1CCCc(c12)c3c(s2)ncn(c3=O)Cc4nnn[nH]4
7021	sp|P9WKD3|BLAC_MYC	Q9L5C8	85.02	27.0	288.0	DB07055	experimental	2-[2-(1H-tetrazol-5-yl)ethyl]-1H-isoindole-1,3(2H)-dione	c1cccc(c12)C(=O)N(C2=O)CCc3nnn[nH]3
7022	sp|P9WKD3|BLAC_MYC	Q9L5C8	85.02	27.0	288.0	DB07729	experimental	3-fluoro-N-[3-(1H-tetrazol-5-yl)phenyl]benzamide	Fc1cc(ccc1)C(=O)Nc2cccc(c2)-c3nnn[nH]3
7023	sp|P9WKD3|BLAC_MYC	Q9L5C8	85.02	27.0	288.0	DB07808	experimental	(1S,2R)-2-[(2,5-difluorophenyl)carbamoyl]cyclopropanecarboxylic acid	OC(=O)[C@H]1C[C@H]1C(=O)Nc2cc(F)ccc2F
7024	sp|P9WKD3|BLAC_MYC	Q9L5C8	85.02	27.0	288.0	DB07823	experimental	(2S)-2-[(3aR,4R,7S,7aS)-1,3-dioxooctahydro-2H-4,7-methanoisoindol-2-yl]propanoic acid	OC(=O)[C@H](C)N(C1=O)C(=O)[C@H]2[C@@H](CC3)C[C@@H]3[C@@H]12
7025	sp|P9WKD3|BLAC_MYC	Q9L5C8	85.02	27.0	288.0	DB07824	experimental	4-ethyl-5-methyl-2-(1H-tetrazol-5-yl)-1,2-dihydro-3H-pyrazol-3-one	CCc1c(C)[nH]n(c1=O)-c2nnn[nH]2
7026	sp|P9WKD3|BLAC_MYC	Q9L5C8	85.02	27.0	288.0	DB07865	experimental	3-(1H-tetrazol-5-ylamino)cyclohex-2-en-1-one	O=C1CCCC(=C1)Nc2nnn[nH]2
7027	sp|P9WKD3|BLAC_MYC	Q9L5C8	85.02	27.0	288.0	DB08551	experimental	3-{(R)-(Dihydroxyboryl)[(2-thienylacetyl)amino]methyl}benzoic acid	O=C(O)c1cccc(c1)[C@@H](B(O)O)NC(=O)Cc2cccs2
7028	sp|P9WKD3|BLAC_MYC	Q939N4	85.02	27.0	288.0	DB02772	approved; experimental; investigational	Sucrose	OC[C@@H](O1)[C@@H](O)[C@H](O)[C@]1(CO)O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O
7029	sp|P9WKD3|BLAC_MYC	Q939N4	85.02	27.0	288.0	DB04035	experimental	Ceftazidime BATSI	OB(O)CNC(=O)C(\c(cs1)nc1N)=N/OC(C)(C)C(=O)O
7030	sp|P9WKD3|BLAC_MYC	Q939N4	85.02	27.0	288.0	DB09060	approved	Avibactam	[C@@H]12CC[C@@H](C(=O)N)N(C1)C(=O)N2OS(=O)(=O)O
7031	sp|P9WKD3|BLAC_MYC	Q939N4	85.02	27.0	288.0	DB12107	approved; investigational	Vaborbactam	OB1O[C@H](CC(=O)O)CC[C@@H]1NC(=O)Cc2cccs2
7032	sp|P9WKD3|BLAC_MYC	Q939N4	85.02	27.0	288.0	DB12377	approved; investigational	Relebactam	OS(=O)(=O)ON([C@@H]12)C(=O)N(C1)[C@@H](CC2)C(=O)NC3CCNCC3
7033	sp|P9WKD3|BLAC_MYC	Q47066	86.32	23.0	288.0	DB03450	experimental	Cephalothin Group	COC(=O)CC1=C(C(=O)O)N[C@H](SC1)[C@@H](C=O)NC(=O)Cc2cccs2
7034	sp|P9WKD3|BLAC_MYC	Q47066	86.32	23.0	288.0	DB08375	experimental	(2R)-2-[(1R)-1-[[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-2-oxoethyl]-5-methylidene-2H-1,3-thiazine-4-carboxylic acid	OC(=O)C1=N[C@H](SCC1=C)[C@@H](C=O)NC(=O)/C(=N\OC)c2csc(n2)N
7035	sp|P9WKD3|BLAC_MYC	Q9EXV5	84.69	28.0	288.0	DB09060	approved	Avibactam	[C@@H]12CC[C@@H](C(=O)N)N(C1)C(=O)N2OS(=O)(=O)O
7036	sp|P9WKD3|BLAC_MYC	P52664	84.36	31.0	290.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
7037	sp|P9WKD3|BLAC_MYC	Q93LQ9	84.69	23.0	283.0	DB12107	approved; investigational	Vaborbactam	OB1O[C@H](CC(=O)O)CC[C@@H]1NC(=O)Cc2cccs2
7038	sp|P9WKD3|BLAC_MYC	Q93LQ9	84.69	23.0	283.0	DB12377	approved; investigational	Relebactam	OS(=O)(=O)ON([C@@H]12)C(=O)N(C1)[C@@H](CC2)C(=O)NC3CCNCC3
7039	sp|P9WKD3|BLAC_MYC	Q9F663	84.69	23.0	283.0	DB09060	approved	Avibactam	[C@@H]12CC[C@@H](C(=O)N)N(C1)C(=O)N2OS(=O)(=O)O
7040	sp|P9WKD3|BLAC_MYC	Q9F663	84.69	23.0	283.0	DB12107	approved; investigational	Vaborbactam	OB1O[C@H](CC(=O)O)CC[C@@H]1NC(=O)Cc2cccs2
7041	sp|P9WKD3|BLAC_MYC	P0AD63	82.08	26.0	278.0	DB01606	approved	Tazobactam	O=C1C[C@H](N12)S(=O)(=O)[C@](C)([C@@H]2C(=O)O)Cn3ccnn3
7042	sp|P9WKD3|BLAC_MYC	P0AD63	82.08	26.0	278.0	DB02579	experimental	Acrylic Acid	OC(=O)C=C
7043	sp|P9WKD3|BLAC_MYC	P0AD63	82.08	26.0	278.0	DB03057	experimental	Malonaldehyde	O=CCC=O
7044	sp|P9WKD3|BLAC_MYC	P0AD63	82.08	26.0	278.0	DB03445	experimental	(3S)-3-(dioxidosulfanyl)-N-[(1E)-3-oxoprop-1-en-1-yl]-4-(1H-1,2,3-triazol-1-yl)-D-valine	O=C/C=C/N[C@@H](C(=O)O)C(C)(S(=O)=O)Cn1ccnn1
7045	sp|P9WKD3|BLAC_MYC	P0AD63	82.08	26.0	278.0	DB03472	experimental	Cyclohexyl-Hexyl-Beta-D-Maltoside	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)O[C@@H]2[C@@H](CO)O[C@H]([C@H](O)[C@H]2O)OCCCCCCC3CCCCC3
7046	sp|P9WKD3|BLAC_MYC	P0AD63	82.08	26.0	278.0	DB03834	experimental	(3S)-3-(dioxidosulfanyl)-N-[(1Z)-3-oxoprop-1-en-1-yl]-4-(1H-1,2,3-triazol-1-yl)-D-valine	O=C/C=C\N[C@@H](C(=O)O)C(C)(S([O-])=O)Cn1ccnn1
7047	sp|P9WKD3|BLAC_MYC	P0AD63	82.08	26.0	278.0	DB03970	experimental	(7R)-7-(6,7-Dihydro-5H-cyclopenta[d]imidazo[2,1-b][1,3]thiazol-2-yl)-2,7-dihydro-1,4-thiazepine-3,6-dicarboxylic acid	OC(=O)C1=CN=C(C(=O)O)CS[C@H]1c(n2)cn(c23)c4c(s3)CCC4
7048	sp|P9WKD3|BLAC_MYC	P0AD63	82.08	26.0	278.0	DB09060	approved	Avibactam	[C@@H]12CC[C@@H](C(=O)N)N(C1)C(=O)N2OS(=O)(=O)O
7049	sp|P9WKD3|BLAC_MYC	P0AD63	82.08	26.0	278.0	DB12377	approved; investigational	Relebactam	OS(=O)(=O)ON([C@@H]12)C(=O)N(C1)[C@@H](CC2)C(=O)NC3CCNCC3
7050	sp|P9WKD3|BLAC_MYC	P0AD64	82.08	26.0	278.0	DB03970	experimental	(7R)-7-(6,7-Dihydro-5H-cyclopenta[d]imidazo[2,1-b][1,3]thiazol-2-yl)-2,7-dihydro-1,4-thiazepine-3,6-dicarboxylic acid	OC(=O)C1=CN=C(C(=O)O)CS[C@H]1c(n2)cn(c23)c4c(s3)CCC4
7051	sp|P9WKD3|BLAC_MYC	P0AD64	82.08	26.0	278.0	DB08116	experimental	(3R)-4-{[(3,4-dihydroxyphenyl)acetyl]oxy}-N-(2-formylindolizin-3-yl)-3-sulfino-D-valine	c1cccc(n12)cc(C=O)c2N[C@@H](C(=O)O)[C@@](C)([S@@](=O)O)COC(=O)Cc3cc(O)c(O)cc3
7052	sp|P9WKD3|BLAC_MYC	P0AD64	82.08	26.0	278.0	DB09060	approved	Avibactam	[C@@H]12CC[C@@H](C(=O)N)N(C1)C(=O)N2OS(=O)(=O)O
7053	sp|P9WKD3|BLAC_MYC	P0AD64	82.08	26.0	278.0	DB12107	approved; investigational	Vaborbactam	OB1O[C@H](CC(=O)O)CC[C@@H]1NC(=O)Cc2cccs2
7054	sp|P9WKD3|BLAC_MYC	P0A9Z7	82.08	26.0	278.0	DB03472	experimental	Cyclohexyl-Hexyl-Beta-D-Maltoside	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)O[C@@H]2[C@@H](CO)O[C@H]([C@H](O)[C@H]2O)OCCCCCCC3CCCCC3
7055	sp|P9WKD3|BLAC_MYC	P0A9Z7	82.08	26.0	278.0	DB09060	approved	Avibactam	[C@@H]12CC[C@@H](C(=O)N)N(C1)C(=O)N2OS(=O)(=O)O
7056	sp|P9WKD3|BLAC_MYC	P18251	81.43	27.0	277.0	DB01606	approved	Tazobactam	O=C1C[C@H](N12)S(=O)(=O)[C@](C)([C@@H]2C(=O)O)Cn3ccnn3
7057	sp|P9WKD3|BLAC_MYC	P62593	81.11	30.0	279.0	DB02614	experimental	1(R)-1-Acetamido-2-(3-Carboxyphenyl)Ethyl Boronic Acid	CC(=O)N[C@H](B(O)O)Cc1cccc(c1)C(=O)O
7058	sp|P9WKD3|BLAC_MYC	P62593	81.11	30.0	279.0	DB02642	experimental	[[N-(Benzyloxycarbonyl)Amino]Methyl]Phosphate	OP(=O)(O)CNC(=O)OCc1ccccc1
7059	sp|P9WKD3|BLAC_MYC	P62593	81.11	30.0	279.0	DB02841	experimental	[(2-Ethoxy-1-Naphthoyl)Amino]Methylboronic Acid	OB(O)CNC(=O)c(c(cc1)OCC)c(c12)cccc2
7060	sp|P9WKD3|BLAC_MYC	P62593	81.11	30.0	279.0	DB04035	experimental	Ceftazidime BATSI	OB(O)CNC(=O)C(\c(cs1)nc1N)=N/OC(C)(C)C(=O)O
7061	sp|P9WKD3|BLAC_MYC	P62593	81.11	30.0	279.0	DB04037	experimental	N,N-Bis(4-Chlorobenzyl)-1h-1,2,3,4-Tetraazol-5-Amine	Clc1ccc(cc1)CN(c2n[nH]nn2)Cc3ccc(Cl)cc3
7062	sp|P9WKD3|BLAC_MYC	P62593	81.11	30.0	279.0	DB04430	experimental	3-(4-Phenylamino-Phenylamino)-2-(1h-Tetrazol-5-Yl)-Acrylonitrile	n1[nH]nnc1/C(C#N)=C\Nc2ccc(cc2)Nc3ccccc3
7063	sp|P9WKD3|BLAC_MYC	P62593	81.11	30.0	279.0	DB07464	experimental	1(R)-1-ACETAMIDO-2-(3-CARBOXY-2-HYDROXYPHENYL)ETHYL BORONIC ACID	CC(=O)N[C@H](B(O)O)Cc1cccc(C(=O)O)c1O
7064	sp|P9WKD3|BLAC_MYC	P62593	81.11	30.0	279.0	DB07466	experimental	(1R)-2-PHENYLACETAMIDO-2-(3-CARBOXYPHENYL)ETHYL BORONIC ACID	OC(=O)c1cc(ccc1)C[C@@H](B(O)O)NC(=O)Cc2ccccc2
7065	sp|P9WKD3|BLAC_MYC	P62593	81.11	30.0	279.0	DB07599	experimental	[(2-AMINO-ALPHA-METHOXYIMINO-4-THIAZOLYLACETYL)AMINO]METHYLBORONIC ACID	Nc1nc(cs1)/C(=N/OC)C(=O)NCB(O)O
7066	sp|P9WKD3|BLAC_MYC	P62593	81.11	30.0	279.0	DB08551	experimental	3-{(R)-(Dihydroxyboryl)[(2-thienylacetyl)amino]methyl}benzoic acid	O=C(O)c1cccc(c1)[C@@H](B(O)O)NC(=O)Cc2cccs2
7067	sp|P9WKD3|BLAC_MYC	P62593	81.11	30.0	279.0	DB09060	approved	Avibactam	[C@@H]12CC[C@@H](C(=O)N)N(C1)C(=O)N2OS(=O)(=O)O
7068	sp|P9WKD3|BLAC_MYC	P62593	81.11	30.0	279.0	DB12107	approved; investigational	Vaborbactam	OB1O[C@H](CC(=O)O)CC[C@@H]1NC(=O)Cc2cccs2
7069	sp|P9WKD3|BLAC_MYC	P62593	81.11	30.0	279.0	DB12377	approved; investigational	Relebactam	OS(=O)(=O)ON([C@@H]12)C(=O)N(C1)[C@@H](CC2)C(=O)NC3CCNCC3
7070	sp|P9WKD3|BLAC_MYC	P62594	81.11	30.0	279.0	DB01606	approved	Tazobactam	O=C1C[C@H](N12)S(=O)(=O)[C@](C)([C@@H]2C(=O)O)Cn3ccnn3
7071	sp|P9WKD3|BLAC_MYC	P62594	81.11	30.0	279.0	DB02614	experimental	1(R)-1-Acetamido-2-(3-Carboxyphenyl)Ethyl Boronic Acid	CC(=O)N[C@H](B(O)O)Cc1cccc(c1)C(=O)O
7072	sp|P9WKD3|BLAC_MYC	P62594	81.11	30.0	279.0	DB02642	experimental	[[N-(Benzyloxycarbonyl)Amino]Methyl]Phosphate	OP(=O)(O)CNC(=O)OCc1ccccc1
7073	sp|P9WKD3|BLAC_MYC	P62594	81.11	30.0	279.0	DB02841	experimental	[(2-Ethoxy-1-Naphthoyl)Amino]Methylboronic Acid	OB(O)CNC(=O)c(c(cc1)OCC)c(c12)cccc2
7074	sp|P9WKD3|BLAC_MYC	P62594	81.11	30.0	279.0	DB03640	experimental	Beta-Hydroxyaspartic Acid	OC(=O)[C@@H](N)[C@@H](O)C(=O)O
7075	sp|P9WKD3|BLAC_MYC	P62594	81.11	30.0	279.0	DB04037	experimental	N,N-Bis(4-Chlorobenzyl)-1h-1,2,3,4-Tetraazol-5-Amine	Clc1ccc(cc1)CN(c2n[nH]nn2)Cc3ccc(Cl)cc3
7076	sp|P9WKD3|BLAC_MYC	P62594	81.11	30.0	279.0	DB04430	experimental	3-(4-Phenylamino-Phenylamino)-2-(1h-Tetrazol-5-Yl)-Acrylonitrile	n1[nH]nnc1/C(C#N)=C\Nc2ccc(cc2)Nc3ccccc3
7077	sp|P9WKD3|BLAC_MYC	P00807	84.69	18.0	278.0	DB02642	experimental	[[N-(Benzyloxycarbonyl)Amino]Methyl]Phosphate	OP(=O)(O)CNC(=O)OCc1ccccc1
7078	sp|P9WKD3|BLAC_MYC	P00807	84.69	18.0	278.0	DB04133	experimental	Degraded Cephaloridine	CC1=C(C(=O)O)N[C@H](SC1)[C@@H](C=O)NC(=O)Cc2cccs2
7079	sp|P9WKD3|BLAC_MYC	P00807	84.69	18.0	278.0	DB09324	approved	Sulbactam	O=C1C[C@H](N12)S(=O)(=O)C(C)(C)[C@@H]2C(=O)O
7080	sp|P9WKD3|BLAC_MYC	P37321	87.95	23.0	293.0	DB09060	approved	Avibactam	[C@@H]12CC[C@@H](C(=O)N)N(C1)C(=O)N2OS(=O)(=O)O
7081	sp|P9WMH5|CMR_MYCT	P0ACJ8	78.28	13.0	204.0	DB02527	experimental	Cyclic adenosine monophosphate	n1cnc(N)c(c12)ncn2[C@@H]([C@@H]3O)O[C@@H]([C@H]34)COP(O4)(=O)O
7082	sp|P9WPB5|CMAS2_MY	P9WPB5	99.67	1.0	302.0	DB01752	experimental	S-adenosyl-L-homocysteine	OC(=O)[C@@H](N)CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
7083	sp|P9WPB5|CMAS2_MY	P9WPB5	99.67	1.0	302.0	DB04221	approved; experimental	Didecyldimethylammonium	CCCCCCCCCC[N+](C)(C)CCCCCCCCCC
7084	sp|P9WPB5|CMAS2_MY	P9WPB7	94.37	2.0	287.0	DB01718	approved	Cetrimonium	CCCCCCCCCCCCCCCC[N+](C)(C)C
7085	sp|P9WPB5|CMAS2_MY	P9WPB3	94.37	2.0	287.0	DB01752	experimental	S-adenosyl-L-homocysteine	OC(=O)[C@@H](N)CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
7086	sp|P9WPB5|CMAS2_MY	Q79FX6	94.04	3.0	287.0	DB01718	approved	Cetrimonium	CCCCCCCCCCCCCCCC[N+](C)(C)C
7087	sp|P9WPB5|CMAS2_MY	Q79FX6	94.04	3.0	287.0	DB01752	experimental	S-adenosyl-L-homocysteine	OC(=O)[C@@H](N)CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
7088	sp|P9WPB5|CMAS2_MY	Q79FX8	95.7	7.0	296.0	DB07413	experimental	5'-S-[2-(decylamino)ethyl]-5'-thioadenosine	n1cnc(N)c(c12)ncn2[C@H]3[C@H](O)[C@H](O)[C@H](O3)CSCCNCCCCCCCCCC
7089	tr|G0ZF12|G0ZF12_M	P0A8V2	99.14	477.0	592.0	DB00615	approved; investigational	Rifabutin	CC(C)CN(CC1)CCC12N=C3c4c5c6c(C)c(O)c4C(=O)C(=C3N2)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(=O)C)[C@H](C)[C@@H](OC)/C=C/O[C@](O6)(C)C5=O
7090	tr|G0ZF12|G0ZF12_M	P0A8V2	99.14	477.0	592.0	DB01045	approved	Rifampicin	C[C@@]12O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(=O)C)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)Nc3c(/C=N/N4CCN(C)CC4)c(O)c5c(C1=O)c(O2)c(C)c(O)c5c3O
7091	tr|G0ZF12|G0ZF12_M	P0A8V2	99.14	477.0	592.0	DB01220	approved; investigational	Rifaximin	C[C@]12O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(=O)C)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)Nc3c4c(nc5n4ccc(c5)C)c6c(c3O)c(O)c(C)c(O1)c6C2=O
7092	tr|G0ZF12|G0ZF12_M	P0A8V2	99.14	477.0	592.0	DB04934	investigational	Rifalazil	C[C@]12O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(=O)C)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)Nc3c4c(c5c(c3=O)c(O)c(C)c(O1)c5C2=O)nc6c(o4)cc(cc6O)N7CCN(CC7)CC(C)C
7093	tr|G0ZF12|G0ZF12_M	P0A8V2	99.14	477.0	592.0	DB11753	approved; investigational	Rifamycin	C[C@@]12O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(=O)C)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)Nc3c(O)c4c(c(c3)O)c(C1=O)c(O2)c(C)c4O
7094	tr|G0ZF12|G0ZF12_M	Q8RQE9	99.14	357.0	472.0	DB04788	experimental	Tagetitoxin	OP(=O)(O)O[C@@H]([C@@]12C(=O)O)[C@@H](N)[C@@H](OC(=O)C)[C@@H](O2)[C@@](O)(SC1)C(=O)N
7095	tr|G0ZF12|G0ZF12_M	Q8RQE9	99.14	357.0	472.0	DB08226	experimental	Myxopyronin B	CCCC/C(C)=C/C=C(\C)C(=O)c1c(O)cc(oc1=O)CCC/C=C/NC(=O)OC
7096	tr|G0ZF12|G0ZF12_M	Q8RQE9	99.14	357.0	472.0	DB08266	experimental	Methyl [(1E,5R)-5-{3-[(2E,4E)-2,5-dimethyl-2,4-octadienoyl]-2,4-dioxo-3,4-dihydro-2H-pyran-6-yl}hexylidene]carbamate	COC(=O)/N=C/CCC[C@@H](C)C1=CC(=O)C(C(=O)O1)C(=O)/C(C)=C/C=C(\C)CCC
7097	tr|I6X8R2|I6X8R2_M	P08473	102.56	70.0	750.0	DB00616	experimental	Candoxatril	C1CCc(c12)cc(cc2)OC(=O)[C@H](COCCOC)CC3(CCCC3)C(=O)N[C@H]4CC[C@H](CC4)C(=O)O
7098	tr|I6X8R2|I6X8R2_M	P08473	102.56	70.0	750.0	DB00886	investigational	Omapatrilat	O=C(O)[C@@H]1CCC[C@@H](N12)SCC[C@@H](C2=O)NC(=O)[C@@H](S)Cc3ccccc3
7099	tr|I6X8R2|I6X8R2_M	P08473	102.56	70.0	750.0	DB02062	experimental	N-[3-[(1-Aminoethyl)(Hydroxy)Phosphoryl]-2-(1,1'-Biphenyl-4-Ylmethyl)Propanoyl]Alanine	OC(=O)[C@H](C)NC(=O)[C@@H](C[P@](=O)(O)[C@H](C)N)Cc1ccc(cc1)-c2ccccc2
7100	tr|I6X8R2|I6X8R2_M	P08473	102.56	70.0	750.0	DB02557	experimental	Phosphoramidon	c1cccc(c12)[nH]cc2C[C@@H](C(=O)O)NC(=O)[C@H](CC(C)C)NP(=O)(O)O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O
7101	tr|I6X8R2|I6X8R2_M	P08473	102.56	70.0	750.0	DB02558	experimental	N-(3-Phenyl-2-Sulfanylpropanoyl)Phenylalanylalanine	c1ccccc1C[C@@H](C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](S)Cc2ccccc2
7102	tr|I6X8R2|I6X8R2_M	P08473	102.56	70.0	750.0	DB02597	experimental	[2(R,S)-2-Sulfanylheptanoyl]-Phe-Ala	c1ccccc1C[C@@H](C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@@H](S)CCCCC
7103	tr|I6X8R2|I6X8R2_M	P08473	102.56	70.0	750.0	DB05796	investigational	Daglutril	c1ccccc1CC[C@@H](C(=O)OCC)CC2(CCCC2)C(=O)N[C@H](C(=O)N3CC(=O)O)CCc(c34)cccc4
7104	tr|I6X8R2|I6X8R2_M	P08473	102.56	70.0	750.0	DB08575	experimental	2-[(1S)-1-BENZYL-2-SULFANYLETHYL]-1H-IMIDAZO[4,5-C]PYRIDIN-5-IUM	c1c[nH+]cc(c12)nc([nH]2)[C@@H](CS)Cc3ccccc3
7105	tr|I6X8R2|I6X8R2_M	P08473	102.56	70.0	750.0	DB08626	experimental	Thiorphan	OC(=O)CNC(=O)[C@@H](CS)Cc1ccccc1
7106	tr|I6X8R2|I6X8R2_M	P08473	102.56	70.0	750.0	DB09292	approved	Sacubitril	CCOC(=O)[C@H](C)C[C@H](NC(=O)CCC(=O)O)Cc1ccc(cc1)-c2ccccc2
7107	tr|I6X8R2|I6X8R2_M	P08473	102.56	70.0	750.0	DB11623	experimental	Candoxatrilat	COCCOC[C@@H](C(=O)O)CC1(CCCC1)C(=O)N[C@H]2CC[C@H](CC2)C(=O)O
7108	tr|I6X8R2|I6X8R2_M	P42892	100.15	106.0	770.0	DB07171	experimental	5-(2-hydroxyethyl)nonane-1,9-diol	OCCCCC(CCO)CCCCO
7109	tr|I6X8R2|I6X8R2_M	P23276	96.23	94.0	732.0	DB02557	experimental	Phosphoramidon	c1cccc(c12)[nH]cc2C[C@@H](C(=O)O)NC(=O)[C@H](CC(C)C)NP(=O)(O)O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O
7110	tr|Q79FW0|Q79FW0_M	P0AB80	91.35	11.0	275.0	DB01813	experimental	Pyridoxyl-Glutamic Acid-5'-Monophosphate	OC(=O)CC[C@@H](C(=O)O)NCc1c(COP(=O)(O)O)c[nH+]c(C)c1O
7111	tr|Q79FW0|Q79FW0_M	P0AB80	91.35	11.0	275.0	DB03553	experimental	Glutaric Acid	OC(=O)CCCC(=O)O
7112	tr|Q79FW0|Q79FW0_M	P0AB80	91.35	11.0	275.0	DB03993	experimental	Isocaproic acid	CC(C)CCC(=O)O
7113	tr|Q79FW0|Q79FW0_M	P0AB80	91.35	11.0	275.0	DB04063	experimental	alpha-Methylleucine	CC(C)C[C@](C)(N)C(=O)O
7114	tr|Q79FW0|Q79FW0_M	P19938	88.93	7.0	264.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
7115	tr|Q79FW0|Q79FW0_M	P28305	86.16	10.0	259.0	DB02038	experimental	D-[3-hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl]-N,O-cycloserylamide	Cc1ncc(COP(=O)(O)O)c(c1O)CN[C@@H]2CONC2=O
7116	tr|Q79FW0|Q79FW0_M	P54687	91.0	80.0	343.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
7117	tr|Q79FW0|Q79FW0_M	P54687	91.0	80.0	343.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
7118	tr|Q79FW0|Q79FW0_M	P54687	91.0	80.0	343.0	DB00149	investigational; nutraceutical	Leucine	CC(C)C[C@H](N)C(=O)O
7119	tr|Q79FW0|Q79FW0_M	P54687	91.0	80.0	343.0	DB00161	approved; nutraceutical	Valine	CC(C)[C@H](N)C(=O)O
7120	tr|Q79FW0|Q79FW0_M	P54687	91.0	80.0	343.0	DB00167	investigational; nutraceutical	Isoleucine	CC[C@H](C)[C@H](N)C(=O)O
7121	tr|Q79FW0|Q79FW0_M	P54687	91.0	80.0	343.0	DB07544	experimental	N'-(5-CHLOROBENZOFURAN-2-CARBONYL)-2-(TRIFLUOROMETHYL)BENZENESULFONOHYDRAZIDE	FC(F)(F)c1ccccc1S(=O)(=O)NNC(=O)c(o2)cc(c23)cc(Cl)cc3
7122	tr|Q79FW0|Q79FW0_M	O15382	91.0	87.0	350.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
7123	tr|Q79FW0|Q79FW0_M	O15382	91.0	87.0	350.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
7124	tr|Q79FW0|Q79FW0_M	O15382	91.0	87.0	350.0	DB00149	investigational; nutraceutical	Leucine	CC(C)C[C@H](N)C(=O)O
7125	tr|Q79FW0|Q79FW0_M	O15382	91.0	87.0	350.0	DB00167	investigational; nutraceutical	Isoleucine	CC[C@H](C)[C@H](N)C(=O)O
7126	tr|Q79FW0|Q79FW0_M	O15382	91.0	87.0	350.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
7127	tr|Q79FW0|Q79FW0_M	O15382	91.0	87.0	350.0	DB02635	experimental	N-[O-Phosphono-Pyridoxyl]-Isoleucine	CC[C@H](C)[C@H](C(=O)O)NCc1c(COP(=O)(O)O)cnc(C)c1O
7128	tr|Q79FW0|Q79FW0_M	O15382	91.0	87.0	350.0	DB04074	experimental	alpha-Ketoisovalerate	CC(C)C(=O)C(=O)O
7129	tr|O69692|O69692_M	P09147	81.23	1.0	252.0	DB01861	experimental	Uridine diphosphate glucose	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
7130	tr|O69692|O69692_M	P09147	81.23	1.0	252.0	DB02421	experimental	Uridine-5'-diphosphate-mannose	O=c1[nH]c(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O
7131	tr|O69692|O69692_M	P09147	81.23	1.0	252.0	DB02790	experimental	Phenyl-uridine-5'-diphosphate	O=c1[nH]c(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)Oc3ccccc3
7132	tr|O69692|O69692_M	P09147	81.23	1.0	252.0	DB03397	experimental	Uridine-Diphosphate-N-Acetylglucosamine	CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
7133	tr|O69692|O69692_M	P09147	81.23	1.0	252.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
7134	tr|O69692|O69692_M	P09147	81.23	1.0	252.0	DB04097	experimental	Uridine-5'-diphosphate-4-deoxy-4-fluoro-alpha-D-galactose	O=c1[nH]c(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](F)[C@H](O)[C@H]3O
7135	tr|O69692|O69692_M	Q15738	74.76	34.0	265.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
7136	tr|O69692|O69692_M	Q14376	83.5	2.0	260.0	DB01861	experimental	Uridine diphosphate glucose	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
7137	tr|O69692|O69692_M	Q14376	83.5	2.0	260.0	DB02196	experimental	Uridine-Diphosphate-N-Acetylgalactosamine	CC(=O)N[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
7138	tr|O69692|O69692_M	Q14376	83.5	2.0	260.0	DB03041	experimental	UDP-alpha-D-glucuronic acid	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O
7139	tr|O69692|O69692_M	Q14376	83.5	2.0	260.0	DB03095	experimental	Tetramethylammonium	C[N+](C)(C)C
7140	tr|O69692|O69692_M	Q14376	83.5	2.0	260.0	DB03397	experimental	Uridine-Diphosphate-N-Acetylglucosamine	CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
7141	tr|O69692|O69692_M	Q14376	83.5	2.0	260.0	DB03501	experimental	Galactose-uridine-5'-diphosphate	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@H]1O)O[P@](=O)(O)O[P@](=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
7142	tr|O69692|O69692_M	P26391	84.47	1.0	262.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
7143	tr|O69692|O69692_M	Q9ZGH3	82.85	1.0	257.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
7144	tr|O69692|O69692_M	P95780	80.58	4.0	253.0	DB03161	experimental	Thymidine-5'-diphospho-beta-D-xylose	O=c1[nH]c(=O)c(C)cn1[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3OC[C@@H](O)[C@H](O)[C@H]3O
7145	tr|O69692|O69692_M	P95780	80.58	4.0	253.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
7146	tr|O69692|O69692_M	Q8T8E9	76.38	1.0	237.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
7147	tr|O69692|O69692_M	P14169	87.06	1.0	270.0	DB04555	experimental	Cytidine-5'-Diphosphate	Nc1nc(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O
7148	tr|O69692|O69692_M	P56937	71.84	3.0	225.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
7149	tr|P96261|P96261_M	O31616	100.0	6.0	346.0	DB02713	experimental	Acetylamino-Acetic Acid	CC(=O)NCC(=O)O
7150	tr|P96261|P96261_M	O31616	100.0	6.0	346.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
7151	tr|P71890|P71890_M	Q6LFH8	95.93	9.0	221.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
7152	tr|P71890|P71890_M	P04181	93.67	42.0	249.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
7153	tr|P71890|P71890_M	P04181	93.67	42.0	249.0	DB00129	approved; nutraceutical	Ornithine	NCCC[C@H](N)C(=O)O
7154	tr|P71890|P71890_M	P04181	93.67	42.0	249.0	DB02054	experimental	Gabaculine	Nc1cccc(c1)C(=O)O
7155	tr|P71890|P71890_M	P04181	93.67	42.0	249.0	DB02821	experimental	Canaline	NOCC[C@H](N)C(=O)O
7156	tr|P71890|P71890_M	Q8IUZ5	101.36	9.0	233.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
7157	tr|P71890|P71890_M	Q8IUZ5	101.36	9.0	233.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
7158	tr|P71890|P71890_M	P12995	103.62	2.0	231.0	DB02274	experimental	7-Keto-8-Aminopelargonic Acid	C[C@H](N)C(=O)CCCCCC(=O)O
7159	tr|P71890|P71890_M	P12995	103.62	2.0	231.0	DB02725	experimental	2-Amino-4-(4-Amino-Cyclohexa-2,5-Dienyl)-Butyric Acid	OC(=O)[C@@H](N)CC[C@H]1C=CC(N)C=C1
7160	tr|P71890|P71890_M	P12995	103.62	2.0	231.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
7161	tr|P71890|P71890_M	P24630	86.88	39.0	231.0	DB02054	experimental	Gabaculine	Nc1cccc(c1)C(=O)O
7162	tr|P71890|P71890_M	P24630	86.88	39.0	231.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
7163	tr|P71890|P71890_M	P22256	92.31	21.0	225.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
7164	tr|P71890|P71890_M	P22256	92.31	21.0	225.0	DB02783	experimental	4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate	Cc1ncc(COP(=O)(O)O)c(c1O)CNOCC(=O)O
7165	tr|P71890|P71890_M	Q9BYV1	102.71	78.0	305.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
7166	tr|P71890|P71890_M	Q9BYV1	102.71	78.0	305.0	DB00119	approved; investigational; nutraceutical	Pyruvic acid	CC(=O)C(=O)O
7167	tr|P71890|P71890_M	Q9BYV1	102.71	78.0	305.0	DB00145	approved; nutraceutical; vet_approved	Glycine	NCC(=O)O
7168	tr|P71890|P71890_M	Q9BYV1	102.71	78.0	305.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
7169	tr|P71890|P71890_M	P16932	94.57	20.0	229.0	DB02038	experimental	D-[3-hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl]-N,O-cycloserylamide	Cc1ncc(COP(=O)(O)O)c(c1O)CN[C@@H]2CONC2=O
7170	tr|P71890|P71890_M	P16932	94.57	20.0	229.0	DB02849	experimental	N-Pyridoxyl-1-Amino-Cyclopropanecarboxylic Acid-5-Monophosphate	Cc1ncc(COP(=O)(O)O)c(c1O)CNC2(CC2)C(=O)O
7171	tr|P71890|P71890_M	P16932	94.57	20.0	229.0	DB03787	experimental	(5-Hydroxy-6-methyl-4-{[(E)-(3-oxo-1,2-oxazolidin-4-ylidene)amino]methyl}-3-pyridinyl)methyl dihydrogen phosphate	Cc1ncc(COP(=O)(O)O)c(c1O)C/N=C2\CONC2=O
7172	tr|P71890|P71890_M	P16932	94.57	20.0	229.0	DB04241	experimental	N-Pyridoxyl-2-Methylalanine-5-Phosphate	Cc1ncc(COP(=O)(O)O)c(c1O)CNC(C)(C)C(=O)O
7173	tr|P71890|P71890_M	P9WQ77	97.29	39.0	254.0	DB08071	experimental	(2S)-1-methyl-2-[(2S,4R)-2-methyl-4-phenylpentyl]piperidine	CN1CCCC[C@H]1C[C@@H](C)C[C@@H](C)c2ccccc2
7174	tr|P71890|P71890_M	P80404	105.88	78.0	312.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
7175	tr|P71890|P71890_M	P80404	105.88	78.0	312.0	DB00119	approved; investigational; nutraceutical	Pyruvic acid	CC(=O)C(=O)O
7176	tr|P71890|P71890_M	P80404	105.88	78.0	312.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
7177	tr|P71890|P71890_M	P80404	105.88	78.0	312.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
7178	tr|P71890|P71890_M	P80404	105.88	78.0	312.0	DB00780	approved	Phenelzine	NNCCc1ccccc1
7179	tr|P71890|P71890_M	P80404	105.88	78.0	312.0	DB01080	approved	Vigabatrin	C=CC(N)CCC(=O)O
7180	tr|P71890|P71890_M	P80404	105.88	78.0	312.0	DB01699	experimental	(4e)-4-Aminohex-4-Enoic Acid	C/C=C(/N)CCC(=O)O
7181	tr|P71890|P71890_M	P80404	105.88	78.0	312.0	DB04235	experimental	4-Amino Hexanoic Acid	CC[C@@H](N)CCC(=O)O
7182	tr|O05295|O05295_M	Q8GN86	74.63	147.0	500.0	DB03728	experimental	p-Chlorobenzoic acid	OC(=O)c1ccc(Cl)cc1
7183	tr|O05295|O05295_M	P40871	74.21	174.0	525.0	DB01672	experimental	2,3-Dihydroxy-Benzoic Acid	OC(=O)c1cccc(O)c1O
7184	tr|O05295|O05295_M	Q8ZKF6	77.8	247.0	615.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
7185	tr|O05295|O05295_M	Q8ZKF6	77.8	247.0	615.0	DB03230	experimental	Adenosine-5'-Propylphosphate	CCCOP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
7186	tr|O05295|O05295_M	Q9NR19	76.53	305.0	667.0	DB00131	approved; investigational; nutraceutical	Adenosine phosphate	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
7187	tr|O05295|O05295_M	Q9NR19	76.53	305.0	667.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
7188	tr|O05295|O05295_M	Q9NUB1	77.17	283.0	648.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
7189	tr|P95197|P95197_M	P31327	95.23	417.0	816.0	DB06775	approved	Carglumic acid	NC(=O)N[C@H](C(=O)O)CCC(=O)O
7190	tr|P95197|P95197_M	P31327	83.29	1000.0	1349.0	DB06775	approved	Carglumic acid	NC(=O)N[C@H](C(=O)O)CCC(=O)O
7191	tr|P95197|P95197_M	P27708	93.08	394.0	784.0	DB03459	experimental	Sparfosic acid	OP(=O)(O)CC(=O)N[C@H](C(=O)O)CC(=O)O
7192	tr|P95197|P95197_M	P27708	81.86	959.0	1302.0	DB03459	experimental	Sparfosic acid	OP(=O)(O)CC(=O)N[C@H](C(=O)O)CC(=O)O
7193	tr|P95197|P95197_M	Q8IEN3	87.83	700.0	1068.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
7194	tr|P95197|P95197_M	P33221	90.93	9.0	390.0	DB02236	experimental	Glycinamide Ribonucleotide	NCC(=O)NC1O[C@@H]([C@@H](O)[C@H]1O)COP(=O)(O)O
7195	tr|P95197|P95197_M	P33221	90.93	9.0	390.0	DB02930	experimental	Adenosine 5'-[gamma-thio]triphosphate	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=S)(O)O
7196	tr|P95197|P95197_M	P33221	90.93	9.0	390.0	DB03434	experimental	3-(N-morpholino)propanesulfonic acid	OS(=O)(=O)CCCN1CCOCC1
7197	tr|P95197|P95197_M	P33221	90.93	9.0	390.0	DB03909	experimental	Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate	OP(=O)(O)CP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
7198	tr|P95197|P95197_M	P33221	90.93	9.0	390.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
7199	tr|P95197|P95197_M	Q96RQ3	78.04	42.0	369.0	DB00121	approved; investigational; nutraceutical	Biotin	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC(=O)O
7200	tr|P95197|P95197_M	P05165	76.85	63.0	385.0	DB00121	approved; investigational; nutraceutical	Biotin	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC(=O)O
7201	tr|P95197|P95197_M	P11498	78.28	35.0	363.0	DB00119	approved; investigational; nutraceutical	Pyruvic acid	CC(=O)C(=O)O
7202	tr|P95197|P95197_M	P11498	78.28	35.0	363.0	DB00121	approved; investigational; nutraceutical	Biotin	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC(=O)O
7203	tr|P95197|P95197_M	P11498	78.28	35.0	363.0	DB07497	experimental	5-(HEXAHYDRO-2-OXO-1H-THIENO[3,4-D]IMIDAZOL-6-YL)PENTANAL	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC=O
7204	tr|P95197|P95197_M	P24182	76.13	4.0	323.0	DB08074	experimental	3-(3-Methyl-2-buten-1-yl)-3H-purin-6-amine	CC(C)=CCn1cnc(N)c(c12)ncn2
7205	tr|P95197|P95197_M	P24182	76.13	4.0	323.0	DB08075	experimental	4-(2-amino-1,3-thiazol-4-yl)pyrimidin-2-amine	Nc1nc(cs1)-c2nc(N)ncc2
7206	tr|P95197|P95197_M	P24182	76.13	4.0	323.0	DB08076	experimental	4-[1-(2,6-dichlorobenzyl)-2-methyl-1H-imidazol-4-yl]pyrimidin-2-amine	Nc1nccc(n1)-c2nc(C)n(c2)Cc3c(Cl)cccc3Cl
7207	tr|P95197|P95197_M	P24182	76.13	4.0	323.0	DB08144	experimental	6-(2,6-dibromophenyl)pyrido[2,3-d]pyrimidine-2,7-diamine	c1nc(N)nc(c12)nc(N)c(c2)-c3c(Br)cccc3Br
7208	tr|P95197|P95197_M	P24182	76.13	4.0	323.0	DB08145	experimental	6-(2,6-DIMETHOXYPHENYL)PYRIDO[2,3-D]PYRIMIDINE-2,7-DIAMINE	COc1cccc(OC)c1-c(c(n2)N)cc(c23)cnc(n3)N
7209	tr|P95197|P95197_M	P24182	76.13	4.0	323.0	DB08146	experimental	7-(2,5-dihydropyrrol-1-yl)-6-phenyl-pyrido[6,5-d]pyrimidin-2-amine	c1nc(N)nc(c12)nc(N3CC=CC3)c(c2)-c4ccccc4
7210	tr|P95197|P95197_M	P24182	76.13	4.0	323.0	DB08314	experimental	(2-AMINO-1,3-OXAZOL-5-YL)-(3-BROMOPHENYL)METHANONE	Nc1ncc(o1)C(=O)c2cc(Br)ccc2
7211	tr|P95197|P95197_M	P24182	76.13	4.0	323.0	DB08315	experimental	2-AMINO-N,N-BIS(PHENYLMETHYL)-1,3-OXAZOLE-5-CARBOXAMIDE	c1ccccc1CN(C(=O)c2oc(N)nc2)Cc3ccccc3
7212	tr|P95197|P95197_M	P24182	76.13	4.0	323.0	DB08316	experimental	4-amino-7,7-dimethyl-7,8-dihydroquinazolin-5(6H)-one	CC(C)(C1)CC(=O)c(c12)c(N)ncn2
7213	tr|P95197|P95197_M	P24182	76.13	4.0	323.0	DB08317	experimental	5-methyl-6-phenylquinazoline-2,4-diamine	Nc1nc(N)nc(c12)ccc(c2C)-c3ccccc3
7214	tr|P95197|P95197_M	P24182	76.13	4.0	323.0	DB08318	experimental	6-(2-phenoxyethoxy)-1,3,5-triazine-2,4-diamine	Nc1nc(nc(n1)N)OCCOc2ccccc2
7215	tr|P95197|P95197_M	A0A0H3JRU9	77.09	2.0	325.0	DB07497	experimental	5-(HEXAHYDRO-2-OXO-1H-THIENO[3,4-D]IMIDAZOL-6-YL)PENTANAL	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC=O
7216	tr|P95197|P95197_M	Q13085	84.73	118.0	473.0	DB00121	approved; investigational; nutraceutical	Biotin	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC(=O)O
7217	tr|P95197|P95197_M	O00763	85.2	259.0	616.0	DB00121	approved; investigational; nutraceutical	Biotin	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC(=O)O
7218	tr|P95197|P95197_M	O00763	85.2	259.0	616.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
7219	tr|P95197|P95197_M	O00763	85.2	259.0	616.0	DB02859	experimental	Soraphen A	CO[C@@H]([C@]12O)[C@@H](O)[C@H](C)[C@@H](O1)[C@@H](C)/C=C/[C@@H](OC)[C@@H](OC)CCCC[C@H](OC(=O)[C@H]2C)c3ccccc3
7220	tr|P95197|P95197_M	O00763	85.2	259.0	616.0	DB03781	experimental	2-[4-(2,4-Dichlorophenoxy)Phenoxy]Propanoic Acid	OC(=O)[C@@H](C)Oc1ccc(cc1)Oc2ccc(Cl)cc2Cl
7221	tr|P95197|P95197_M	O00763	85.2	259.0	616.0	DB07870	experimental	Haloxyfop-P	OC(=O)[C@@H](C)Oc1ccc(cc1)Oc2c(Cl)cc(cn2)C(F)(F)F
7222	tr|O07252|O07252_M	Q9AIU0	89.0	8.0	186.0	DB03467	experimental	Naringenin	Oc1ccc(cc1)[C@@H](O2)CC(=O)c(c23)c(O)cc(c3)O
7223	tr|O07252|O07252_M	Q9AIU0	89.0	8.0	186.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
7224	tr|O07252|O07252_M	Q9AIU0	89.0	8.0	186.0	DB07810	experimental	Phloretin	Oc1ccc(cc1)CCC(=O)c2c(O)cc(O)cc2O
7225	tr|O53419|O53419_M	Q6NVY1	102.03	32.0	384.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
7226	tr|O53419|O53419_M	P28793	72.75	11.0	262.0	DB08249	experimental	3,6,9,12,15-PENTAOXATRICOSAN-1-OL	CCCCCCCCOCCOCCOCCOCCOCCO
7227	tr|O07179|O07179_M	P30084	84.87	31.0	289.0	DB02563	experimental	Hexanoyl-CoA	CCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
7228	tr|O07179|O07179_M	P30084	84.87	31.0	289.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
7229	tr|O07179|O07179_M	P30084	84.87	31.0	289.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
7230	tr|O07179|O07179_M	P30084	84.87	31.0	289.0	DB04117	experimental	4-(N,N-Dimethylamino)cinnamoyl-CoA	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)/C=C/c4ccc(cc4)N(C)C
7231	tr|O07179|O07179_M	P30084	84.87	31.0	289.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
7232	tr|O07179|O07179_M	P9WNP5	85.86	43.0	304.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
7233	tr|O07179|O07179_M	P9WNP5	85.86	43.0	304.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
7234	tr|O07179|O07179_M	O68600	70.72	2.0	217.0	DB01652	experimental	4-hydroxybenzoyl-CoA	Oc1ccc(cc1)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2OP(=O)(O)O)n3cnc(c34)c(N)ncn4
7235	tr|O07179|O07179_M	O75521	71.38	137.0	354.0	DB08231	experimental	Myristic acid	CCCCCCCCCCCCCC(=O)O
7236	tr|O07179|O07179_M	P52045	84.21	2.0	258.0	DB03117	experimental	2-carboxypropyl-coenzyme A	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC[C@H](C)C(=O)O
7237	tr|O07179|O07179_M	P28793	73.68	14.0	238.0	DB08249	experimental	3,6,9,12,15-PENTAOXATRICOSAN-1-OL	CCCCCCCCOCCOCCOCCOCCOCCO
7238	tr|O07179|O07179_M	Q93TU6	70.39	14.0	228.0	DB02906	experimental	(2s,4s)-Alpha-Campholinic Acid	CC1(C)[C@H](C)C(=O)C[C@H]1CC(O)O
7239	tr|O07179|O07179_M	Q08426	70.07	8.0	221.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
7240	tr|O07169|O07169_M	Q9NUB1	102.29	115.0	652.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
7241	tr|O07169|O07169_M	P40871	96.0	26.0	530.0	DB01672	experimental	2,3-Dihydroxy-Benzoic Acid	OC(=O)c1cccc(O)c1O
7242	tr|O07169|O07169_M	Q8GN86	94.86	4.0	502.0	DB03728	experimental	p-Chlorobenzoic acid	OC(=O)c1ccc(Cl)cc1
7243	tr|O07169|O07169_M	Q9NR19	105.33	116.0	669.0	DB00131	approved; investigational; nutraceutical	Adenosine phosphate	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
7244	tr|O07169|O07169_M	Q9NR19	105.33	116.0	669.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
7245	tr|O07169|O07169_M	Q8ZKF6	101.52	84.0	617.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
7246	tr|O07169|O07169_M	Q8ZKF6	101.52	84.0	617.0	DB03230	experimental	Adenosine-5'-Propylphosphate	CCCOP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
7247	tr|O06536|O06536_M	P30084	95.58	49.0	157.0	DB02563	experimental	Hexanoyl-CoA	CCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
7248	tr|O06536|O06536_M	P30084	95.58	49.0	157.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
7249	tr|O06536|O06536_M	P30084	95.58	49.0	157.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
7250	tr|O06536|O06536_M	P30084	95.58	49.0	157.0	DB04117	experimental	4-(N,N-Dimethylamino)cinnamoyl-CoA	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)/C=C/c4ccc(cc4)N(C)C
7251	tr|O06536|O06536_M	P30084	95.58	49.0	157.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
7252	tr|O06536|O06536_M	Q6NVY1	100.88	48.0	162.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
7253	tr|O06536|O06536_M	O68600	100.0	16.0	129.0	DB01652	experimental	4-hydroxybenzoyl-CoA	Oc1ccc(cc1)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2OP(=O)(O)O)n3cnc(c34)c(N)ncn4
7254	tr|O06536|O06536_M	P52045	96.46	16.0	125.0	DB03117	experimental	2-carboxypropyl-coenzyme A	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC[C@H](C)C(=O)O
7255	tr|O06536|O06536_M	P40939	98.23	51.0	162.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
7256	tr|O06536|O06536_M	P9WNP5	110.62	50.0	175.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
7257	tr|O06536|O06536_M	P9WNP5	110.62	50.0	175.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
7258	tr|O06536|O06536_M	O75521	98.23	153.0	264.0	DB08231	experimental	Myristic acid	CCCCCCCCCCCCCC(=O)O
7259	tr|O06536|O06536_M	P42126	89.38	67.0	168.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
7260	tr|O06536|O06536_M	P42126	89.38	67.0	168.0	DB03127	experimental	Benzamidine	NC(=[NH2+])c1ccccc1
7261	tr|O06536|O06536_M	P28793	93.81	26.0	132.0	DB08249	experimental	3,6,9,12,15-PENTAOXATRICOSAN-1-OL	CCCCCCCCOCCOCCOCCOCCOCCO
7262	tr|O06536|O06536_M	Q08426	83.19	21.0	115.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
7263	tr|O06536|O06536_M	Q93TU6	83.19	42.0	136.0	DB02906	experimental	(2s,4s)-Alpha-Campholinic Acid	CC1(C)[C@H](C)C(=O)C[C@H]1CC(O)O
7265	tr|O06428|O06428_M	P14324	70.75	114.0	351.0	DB00282	approved	Pamidronic acid	NCCC(O)(P(=O)(O)O)P(=O)(O)O
7266	tr|O06428|O06428_M	P14324	70.75	114.0	351.0	DB00399	approved	Zoledronic acid	OP(=O)(O)C(O)(P(=O)(O)O)Cn1ccnc1
7267	tr|O06428|O06428_M	P14324	70.75	114.0	351.0	DB00630	approved	Alendronic acid	NCCCC(O)(P(=O)(O)O)P(=O)(O)O
7268	tr|O06428|O06428_M	P14324	70.75	114.0	351.0	DB00710	approved; investigational	Ibandronate	CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
7269	tr|O06428|O06428_M	P14324	70.75	114.0	351.0	DB00884	approved; investigational	Risedronic acid	OP(=O)(O)C(O)(P(=O)(O)O)Cc1cnccc1
7270	tr|O06428|O06428_M	P14324	70.75	114.0	351.0	DB01785	experimental	Dimethylallyl Diphosphate	CC(C)=CCO[P@@](=O)(O)OP(=O)(O)O
7271	tr|O06428|O06428_M	P14324	70.75	114.0	351.0	DB02508	experimental	Isopentyl Pyrophosphate	CC(C)CCO[P@@](=O)(O)OP(=O)(O)O
7272	tr|O06428|O06428_M	P14324	70.75	114.0	351.0	DB02552	experimental	Geranyl Diphosphate	CC(C)=CCC/C(C)=C/CO[P@@](=O)(O)OP(=O)(O)O
7273	tr|O06428|O06428_M	P14324	70.75	114.0	351.0	DB04714	experimental	ISOPENTENYL PYROPHOSPHATE	CC(=C)CCO[P@@](=O)(O)OP(=O)(O)O
7274	tr|O06428|O06428_M	P14324	70.75	114.0	351.0	DB06255	experimental	Incadronic acid	OP(=O)(O)C(P(=O)(O)O)NC1CCCCCC1
7275	tr|O06428|O06428_M	P14324	70.75	114.0	351.0	DB06548	investigational	Minodronic acid	OP(=O)(O)C(O)(P(=O)(O)O)Cc1cnc(n12)cccc2
7276	tr|O06428|O06428_M	P14324	70.75	114.0	351.0	DB07780	experimental	Farnesyl diphosphate	CC(C)=CCC/C(C)=C/CC/C(C)=C/COP(=O)(O)OP(=O)(O)O
7277	tr|O06428|O06428_M	P14324	70.75	114.0	351.0	DB07841	experimental	Geranylgeranyl diphosphate	CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C(C)=C/COP(=O)(O)OP(=O)(O)O
7278	tr|I6WY86|I6WY86_M	P43889	73.6	1.0	146.0	DB08344	experimental	4-chloro-N-(3-methoxypropyl)-N-[(3S)-1-(2-phenylethyl)piperidin-3-yl]benzamide	Clc1ccc(cc1)C(=O)N(CCCOC)[C@H]2CCCN(C2)CCc3ccccc3
7279	tr|I6WY86|I6WY86_M	Q97R46	72.59	5.0	148.0	DB03397	experimental	Uridine-Diphosphate-N-Acetylglucosamine	CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
7280	tr|I6WY86|I6WY86_M	P0ACC7	73.6	1.0	146.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
7281	tr|I6WY86|I6WY86_M	P0ACC7	73.6	1.0	146.0	DB03397	experimental	Uridine-Diphosphate-N-Acetylglucosamine	CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
7282	tr|I6WY86|I6WY86_M	P0ACC7	73.6	1.0	146.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
7283	tr|I6WY86|I6WY86_M	P26393	75.13	5.0	153.0	DB01861	experimental	Uridine diphosphate glucose	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
7284	tr|I6WY86|I6WY86_M	P26393	75.13	5.0	153.0	DB02452	experimental	Thymidine 5'-triphosphate	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
7285	tr|I6YFL7|I6YFL7_M	P00269	81.67	2.0	51.0	DB04464	experimental	N-Formylmethionine	O=CN[C@H](C(=O)O)CCSC
7286	tr|P71616|P71616_M	C3T8E2	95.22	7.0	425.0	DB00537	approved; investigational	Ciprofloxacin	O=C(O)c(c1=O)cn(C2CC2)c(c13)cc(c(F)c3)N4CCNCC4
7287	tr|I6Y8Y0|I6Y8Y0_M	P31572	92.76	7.0	340.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
7288	tr|I6Y8Y0|I6Y8Y0_M	P31572	92.76	7.0	340.0	DB02516	experimental	(R)-carnitinyl-CoA betaine	C[N+](C)(C)C[C@H](O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP([O-])(=O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
7289	tr|O50443|O50443_M	P30038	97.79	31.0	562.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
7290	tr|O50443|O50443_M	P47895	87.29	30.0	504.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
7291	tr|O50443|O50443_M	P47895	87.29	30.0	504.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
7292	tr|O50443|O50443_M	P00352	87.66	18.0	494.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
7293	tr|O50443|O50443_M	P00352	87.66	18.0	494.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
7294	tr|O50443|O50443_M	P00352	87.66	18.0	494.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
7295	tr|O50443|O50443_M	P00352	87.66	18.0	494.0	DB04447	experimental	1,4-Dithiothreitol	SC[C@H](O)[C@@H](O)CS
7296	tr|O50443|O50443_M	O94788	87.29	36.0	510.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
7297	tr|O50443|O50443_M	O94788	87.29	36.0	510.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
7298	tr|O50443|O50443_M	O94788	87.29	36.0	510.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
7299	tr|O50443|O50443_M	P05091	86.74	38.0	509.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
7300	tr|O50443|O50443_M	P05091	86.74	38.0	509.0	DB00536	approved	Guanidine	NC(N)=N
7301	tr|O50443|O50443_M	P05091	86.74	38.0	509.0	DB00822	approved	Disulfiram	CCN(CC)C(=S)SSC(=S)N(CC)CC
7302	tr|O50443|O50443_M	P05091	86.74	38.0	509.0	DB02115	experimental	Daidzin	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)Oc(c2)ccc(c23)c(=O)c(co3)-c4ccc(O)cc4
7303	tr|O50443|O50443_M	P05091	86.74	38.0	509.0	DB04381	experimental	Crotonaldehyde	O=C/C=C/C
7304	tr|O50443|O50443_M	P30837	86.92	37.0	509.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
7305	tr|O50443|O50443_M	P83849	94.29	4.0	516.0	DB03564	experimental	(4r)-2-Methylpentane-2,4-Diol	C[C@H](O)CC(C)(C)O
7306	tr|O50443|O50443_M	O75891	89.5	413.0	899.0	DB00116	nutraceutical	Tetrahydrofolic acid	Nc([nH]1)nc(=O)c(c12)NC(CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
7307	tr|O50443|O50443_M	P77674	86.19	2.0	470.0	DB04401	experimental	Betaine aldehyde	C[N+](C)(C)CC=O
7308	tr|O50443|O50443_M	P25553	86.74	4.0	475.0	DB03619	approved	Deoxycholic acid	C1C[C@@H](O)C[C@H]([C@]12C)CC[C@@H]3[C@@H]2C[C@H](O)[C@@]4(C)[C@H]3CC[C@@H]4[C@H](C)CCC(=O)O
7309	tr|O50443|O50443_M	P49189	84.53	28.0	487.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
7310	tr|O50443|O50443_M	P51649	88.58	49.0	530.0	DB00139	approved; nutraceutical	Succinic acid	OC(=O)CCC(=O)O
7311	tr|O50443|O50443_M	P51649	88.58	49.0	530.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
7312	tr|O50443|O50443_M	P51649	88.58	49.0	530.0	DB00313	approved; investigational	Valproic acid	CCCC(C(=O)O)CCC
7313	tr|O50443|O50443_M	P51649	88.58	49.0	530.0	DB00534	approved; withdrawn	Chlormerodrin	Cl[Hg]CC(OC)CNC(=O)N
7314	tr|O50443|O50443_M	Q59931	86.19	2.0	470.0	DB02263	experimental	Glyceraldehyde-3-Phosphate	O=C[C@H](O)COP(=O)(O)O
7315	tr|O50443|O50443_M	Q59931	86.19	2.0	470.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
7316	tr|O50443|O50443_M	Q02252	88.58	36.0	517.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
7317	tr|O50443|O50443_M	P09546	84.35	656.0	1114.0	DB03051	experimental	(S)-2-Tetrahydrofuroic acid	OC(=O)[C@H]1CCCO1
7318	tr|O50443|O50443_M	P09546	84.35	656.0	1114.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
7319	tr|O50443|O50443_M	P09546	84.35	656.0	1114.0	DB04398	approved; vet_approved	Lactic acid	CC(O)C(=O)O
7320	tr|O50443|O50443_M	P49419	86.37	51.0	520.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
7321	tr|O50443|O50443_M	P49419	86.37	51.0	520.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
7322	tr|O50443|O50443_M	P30838	78.08	3.0	427.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
7323	tr|O50443|O50443_M	P43353	76.8	10.0	427.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
7324	tr|O50443|O50443_M	P51648	77.16	5.0	424.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
7325	tr|O65936|O65936_M	P20586	73.26	2.0	339.0	DB02839	experimental	2,4-Dihydroxybenzoic Acid	OC(=O)c1ccc(O)cc1O
7326	tr|O65936|O65936_M	P20586	73.26	2.0	339.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
7327	tr|O65936|O65936_M	P20586	73.26	2.0	339.0	DB03482	experimental	8-demethyl-8-dimethylamino-flavin-adenine-dinucleotide	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)Cn4c(cc(c(c5)C)N(C)C)c5nc(c46)c(=O)[nH]c(n6)=O
7328	tr|O65936|O65936_M	P20586	73.26	2.0	339.0	DB04242	experimental	4-hydroxybenzoic acid	OC(=O)c1ccc(O)cc1
7329	tr|O65936|O65936_M	P20586	73.26	2.0	339.0	DB02362	approved; experimental	Aminobenzoic acid	Nc1ccc(cc1)C(=O)O
7330	tr|O65936|O65936_M	P00438	73.26	2.0	339.0	DB02059	experimental	Adenosine-5-Diphosphoribose	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)CO[P@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H](O)[C@H](O)[C@@H]4O
7331	tr|O65936|O65936_M	P00438	73.26	2.0	339.0	DB02839	experimental	2,4-Dihydroxybenzoic Acid	OC(=O)c1ccc(O)cc1O
7332	tr|O65936|O65936_M	P00438	73.26	2.0	339.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
7333	tr|O65936|O65936_M	P00438	73.26	2.0	339.0	DB04242	experimental	4-hydroxybenzoic acid	OC(=O)c1ccc(O)cc1
7334	tr|O65936|O65936_M	P00438	73.26	2.0	339.0	DB02362	approved; experimental	Aminobenzoic acid	Nc1ccc(cc1)C(=O)O
7335	tr|O65936|O65936_M	Q92206	85.0	4.0	395.0	DB00525	approved; investigational; vet_approved	Tolnaftate	Cc1cc(ccc1)N(C)C(=S)Oc(cc2)cc(c23)cccc3
7336	tr|O65936|O65936_M	Q92206	85.0	4.0	395.0	DB00857	approved; investigational; vet_approved	Terbinafine	c1cccc(c12)cccc2CN(C)C/C=C/C#CC(C)(C)C
7337	tr|O65936|O65936_M	Q14534	75.0	117.0	462.0	DB00735	approved	Naftifine	c1cccc(c12)cccc2CN(C)C/C=C/c3ccccc3
7338	tr|O65936|O65936_M	Q14534	75.0	117.0	462.0	DB00857	approved; investigational; vet_approved	Terbinafine	c1cccc(c12)cccc2CN(C)C/C=C/C#CC(C)(C)C
7339	tr|O65936|O65936_M	Q14534	75.0	117.0	462.0	DB01091	approved	Butenafine	c1cccc(c12)cccc2CN(C)Cc3ccc(cc3)C(C)(C)C
7340	tr|O65936|O65936_M	Q14534	75.0	117.0	462.0	DB08846	investigational	Ellagic acid	Oc(c1)c(O)c(c2c13)oc(=O)c4c2c(oc3=O)c(O)c(c4)O
7341	tr|O65936|O65936_M	Q8KI25	77.39	6.0	362.0	DB07241	experimental	7-carboxy-5-hydroxy-12,13-dihydro-6H-indolo[2,3-a]pyrrolo[3,4-c]carbazole	c1cccc2c1[nH]c(c2c(c34)c(C(=O)O)[nH]c3O)c5c4c6c([nH]5)cccc6
7342	tr|O65936|O65936_M	Q8KI25	77.39	6.0	362.0	DB08036	experimental	6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one	c1cccc(c12)c3c4c(CNC4=O)c5c(c3[nH]2)[nH]c6c5cccc6
7343	tr|O53632|O53632_M	P09391	79.52	77.0	275.0	DB02451	experimental	B-nonylglucoside	CCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
7344	tr|O53632|O53632_M	P09391	79.52	77.0	275.0	DB04147	experimental	Dodecyldimethylamine N-oxide	CCCCCCCCCCCC[N+]([O-])(C)C
7345	tr|O53537|O53537_M	Q8TC12	89.59	31.0	315.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
7346	tr|O53537|O53537_M	Q8NBN7	93.06	30.0	325.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
7347	tr|O53537|O53537_M	Q96NR8	89.91	29.0	314.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
7348	tr|O53537|O53537_M	Q9HBH5	92.43	41.0	334.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
7349	tr|O53537|O53537_M	P56937	72.24	2.0	231.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
7350	tr|Q10881|Q10881_M	P03886	85.13	31.0	300.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
7351	tr|Q10881|Q10881_M	P03886	85.13	31.0	300.0	DB01028	approved; investigational; vet_approved	Methoxyflurane	COC(F)(F)C(Cl)Cl
7352	tr|Q10881|Q10881_M	P03886	85.13	31.0	300.0	DB01159	approved; vet_approved	Halothane	ClC(Br)C(F)(F)F
7353	tr|Q10881|Q10881_M	P03886	85.13	31.0	300.0	DB01189	approved	Desflurane	FC(F)OC(F)C(F)(F)F
7354	tr|Q10881|Q10881_M	P03886	85.13	31.0	300.0	DB01236	approved; vet_approved	Sevoflurane	FCOC(C(F)(F)F)C(F)(F)F
7355	tr|Q10881|Q10881_M	P03886	85.13	31.0	300.0	DB04464	experimental	N-Formylmethionine	O=CN[C@H](C(=O)O)CCSC
7356	tr|Q10881|Q10881_M	P03886	85.13	31.0	300.0	DB12695	investigational	Phenethyl Isothiocyanate	S=C=NCCc1ccccc1
7357	tr|P72050|P72050_M	P26391	104.91	1.0	343.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
7358	tr|P72050|P72050_M	P95780	99.08	6.0	329.0	DB03161	experimental	Thymidine-5'-diphospho-beta-D-xylose	O=c1[nH]c(=O)c(C)cn1[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3OC[C@@H](O)[C@H](O)[C@H]3O
7359	tr|P72050|P72050_M	P95780	99.08	6.0	329.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
7360	tr|P72050|P72050_M	Q9ZGH3	96.63	1.0	316.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
7361	tr|P72050|P72050_M	P09147	102.15	1.0	334.0	DB01861	experimental	Uridine diphosphate glucose	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
7362	tr|P72050|P72050_M	P09147	102.15	1.0	334.0	DB02421	experimental	Uridine-5'-diphosphate-mannose	O=c1[nH]c(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O
7363	tr|P72050|P72050_M	P09147	102.15	1.0	334.0	DB02790	experimental	Phenyl-uridine-5'-diphosphate	O=c1[nH]c(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)Oc3ccccc3
7364	tr|P72050|P72050_M	P09147	102.15	1.0	334.0	DB03397	experimental	Uridine-Diphosphate-N-Acetylglucosamine	CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
7365	tr|P72050|P72050_M	P09147	102.15	1.0	334.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
7366	tr|P72050|P72050_M	P09147	102.15	1.0	334.0	DB04097	experimental	Uridine-5'-diphosphate-4-deoxy-4-fluoro-alpha-D-galactose	O=c1[nH]c(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](F)[C@H](O)[C@H]3O
7367	tr|P72050|P72050_M	P14169	102.76	1.0	336.0	DB04555	experimental	Cytidine-5'-Diphosphate	Nc1nc(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O
7368	tr|P72050|P72050_M	Q14376	103.68	4.0	342.0	DB01861	experimental	Uridine diphosphate glucose	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
7369	tr|P72050|P72050_M	Q14376	103.68	4.0	342.0	DB02196	experimental	Uridine-Diphosphate-N-Acetylgalactosamine	CC(=O)N[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
7370	tr|P72050|P72050_M	Q14376	103.68	4.0	342.0	DB03041	experimental	UDP-alpha-D-glucuronic acid	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O
7371	tr|P72050|P72050_M	Q14376	103.68	4.0	342.0	DB03095	experimental	Tetramethylammonium	C[N+](C)(C)C
7372	tr|P72050|P72050_M	Q14376	103.68	4.0	342.0	DB03397	experimental	Uridine-Diphosphate-N-Acetylglucosamine	CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
7373	tr|P72050|P72050_M	Q14376	103.68	4.0	342.0	DB03501	experimental	Galactose-uridine-5'-diphosphate	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@H]1O)O[P@](=O)(O)O[P@](=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
7374	tr|P72050|P72050_M	Q8KN66	96.93	20.0	336.0	DB01861	experimental	Uridine diphosphate glucose	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
7375	tr|P72050|P72050_M	Q8KN66	96.93	20.0	336.0	DB02196	experimental	Uridine-Diphosphate-N-Acetylgalactosamine	CC(=O)N[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
7376	tr|P72050|P72050_M	Q8T8E9	115.64	1.0	378.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
7377	tr|P72050|P72050_M	Q51366	94.48	6.0	314.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
7378	tr|P72050|P72050_M	P77398	102.45	317.0	651.0	DB03256	experimental	(6R)-Folinic acid	Nc([nH]1)nc(=O)c(c12)N(C=O)[C@@H](CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
7379	tr|P72050|P72050_M	P77398	102.45	317.0	651.0	DB03685	experimental	Uridine monophosphate	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2ccc(=O)[nH]c2=O
7380	tr|P72050|P72050_M	O60547	102.15	27.0	360.0	DB02547	experimental	Guanosine-5'-Diphosphate-Rhamnose	O[C@H]1[C@H](O)[C@H](O)[C@H](O[C@@H]1C)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3cnc(c34)c(=O)nc([nH]4)N
7381	tr|P72050|P72050_M	O60547	102.15	27.0	360.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
7382	tr|P72050|P72050_M	P26397	99.69	11.0	336.0	DB02059	experimental	Adenosine-5-Diphosphoribose	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)CO[P@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H](O)[C@H](O)[C@@H]4O
7383	tr|P72050|P72050_M	P26397	99.69	11.0	336.0	DB03069	experimental	Cytidine-5'-diphospho-beta-D-xylose	Nc1nc(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O[C@H]3OC[C@@H](O)[C@H](O)[C@H]3O
7384	tr|P72050|P72050_M	P32055	85.28	42.0	320.0	DB02897	experimental	Acetylphosphate	CC(=O)OP(=O)(O)O
7385	tr|P72050|P72050_M	P32055	85.28	42.0	320.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
7386	tr|P72050|P72050_M	P14060	86.2	6.0	287.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
7387	tr|P72050|P72050_M	P14060	86.2	6.0	287.0	DB01108	approved; investigational; vet_approved; withdrawn	Trilostane	C1C[C@H](O)[C@@](C)(CC2)[C@@H]1[C@H](CC3)[C@H]2[C@@]([C@@]345)(C)CC(C#N)=C([C@H]4O5)O
7388	tr|P72050|P72050_M	P14060	86.2	6.0	287.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
7389	tr|P72050|P72050_M	P14060	86.2	6.0	287.0	DB14538	experimental; vet_approved	Hydrocortisone aceponate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CC)C(=O)COC(=O)C
7390	tr|P72050|P72050_M	P14060	86.2	6.0	287.0	DB14539	approved; vet_approved	Hydrocortisone acetate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)C
7391	tr|P72050|P72050_M	P14060	86.2	6.0	287.0	DB14540	approved; vet_approved	Hydrocortisone butyrate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCC
7392	tr|P72050|P72050_M	P14060	86.2	6.0	287.0	DB14541	approved; investigational; vet_approved	Hydrocortisone cypionate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)CCC5CCCC5
7393	tr|P72050|P72050_M	P14060	86.2	6.0	287.0	DB14542	approved; vet_approved	Hydrocortisone phosphate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COP(=O)(O)O
7394	tr|P72050|P72050_M	P14060	86.2	6.0	287.0	DB14543	approved; vet_approved	Hydrocortisone probutate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CCC)C(=O)COC(=O)CC
7395	tr|P72050|P72050_M	P14060	86.2	6.0	287.0	DB14544	approved; vet_approved	Hydrocortisone valerate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCCC
7396	tr|P72050|P72050_M	P26439	86.2	5.0	286.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
7397	tr|P72050|P72050_M	P26439	86.2	5.0	286.0	DB01108	approved; investigational; vet_approved; withdrawn	Trilostane	C1C[C@H](O)[C@@](C)(CC2)[C@@H]1[C@H](CC3)[C@H]2[C@@]([C@@]345)(C)CC(C#N)=C([C@H]4O5)O
7398	tr|P72050|P72050_M	Q13630	95.09	8.0	318.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
7399	tr|P72050|P72050_M	P67910	93.87	2.0	308.0	DB01774	experimental	Adenosine-5'-Monophosphate Glucopyranosyl-Monophosphate Ester	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@@](=O)(O)O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O
7400	tr|P72050|P72050_M	P67910	93.87	2.0	308.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
7401	tr|P72050|P72050_M	Q15738	71.17	39.0	271.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
7403	tr|O53422|O53422_M	P07097	95.56	5.0	392.0	DB01915	experimental	S-Hydroxycysteine	OC(=O)[C@@H](N)CSO
7404	tr|O53422|O53422_M	P07097	95.56	5.0	392.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
7405	tr|O53422|O53422_M	P07097	95.56	5.0	392.0	DB02039	experimental	S-Acetyl-Cysteine	OC(=O)[C@@H](N)CSC(=O)C
7406	tr|O53422|O53422_M	P07097	95.56	5.0	392.0	DB02160	experimental	S-Butyryl-Cystein	OC(=O)[C@@H](N)CSC(=O)CCC
7407	tr|O53422|O53422_M	P07097	95.56	5.0	392.0	DB03045	experimental	Pantothenyl-Aminoethanol-Acetate Pivalic Acid	CC(=O)OCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COC(=O)C(C)(C)C
7408	tr|O53422|O53422_M	P07097	95.56	5.0	392.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
7409	tr|O53422|O53422_M	P07097	95.56	5.0	392.0	DB08328	experimental	PANTOTHENYL-AMINOETHANOL-11-PIVALIC ACID	CC(C)(C)C(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCO
7410	tr|O53422|O53422_M	P07097	95.56	5.0	392.0	DB08408	experimental	(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-({3-oxo-3-[(2-sulfanylethyl)amino]propyl}amino)butyl 2,2-dimethylpropanoate	CC(C)(C)C(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS
7411	tr|O53422|O53422_M	Q9BWD1	95.8	8.0	396.0	DB01915	experimental	S-Hydroxycysteine	OC(=O)[C@@H](N)CSO
7412	tr|O53422|O53422_M	Q9BWD1	95.8	8.0	396.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
7413	tr|O53422|O53422_M	P28790	94.81	6.0	390.0	DB08249	experimental	3,6,9,12,15-PENTAOXATRICOSAN-1-OL	CCCCCCCCOCCOCCOCCOCCOCCO
7414	tr|O53422|O53422_M	P24752	95.56	40.0	427.0	DB00795	approved	Sulfasalazine	OC(=O)c1cc(ccc1O)/N=N/c2ccc(cc2)S(=O)(=O)Nc3ncccc3
7415	tr|O53422|O53422_M	P24752	95.56	40.0	427.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
7417	tr|O53422|O53422_M	P24752	95.56	40.0	427.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
7418	tr|O53422|O53422_M	P09110	94.57	37.0	420.0	DB09069	approved; investigational	Trimetazidine	COc1c(OC)c(OC)c(cc1)CN2CCNCC2
7419	tr|O53327|O53327_M	P47229	98.25	2.0	283.0	DB07510	experimental	3-fluoro-6-(4-fluorophenyl)-2-hydroxy-6-oxohexa-2,4-dienoic acid	OC(=O)/C(O)=C(/F)\C=C\C(=O)c1ccc(F)cc1
7420	tr|O53327|O53327_M	P47229	98.25	2.0	283.0	DB07516	experimental	(2Z,4E)-3-chloro-2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoic acid	OC(=O)/C(O)=C(/Cl)\C=C\C(=O)c1ccccc1
7421	tr|O53327|O53327_M	P47229	98.25	2.0	283.0	DB07911	experimental	(3E)-2,6-DIOXO-6-PHENYLHEX-3-ENOATE	[O-]C(=O)C(=O)/C=C/CC(=O)c1ccccc1
7422	tr|O53327|O53327_M	P47229	98.25	2.0	283.0	DB07915	experimental	(2E,4E)-2-Hydroxy-6-oxo-6-phenyl-2,4-hexadienoic acid	OC(=O)/C(O)=C\C=C\C(=O)c1ccccc1
7423	tr|O53327|O53327_M	Q86WA6	91.61	28.0	290.0	DB03380	experimental	L-tyrosinamide	NC(=O)[C@@H](N)Cc1ccc(O)cc1
7425	tr|O53327|O53327_M	P96965	91.61	8.0	270.0	DB02406	experimental	N-Valeric Acid	CCCCC(=O)O
7426	tr|O53327|O53327_M	P96965	91.61	8.0	270.0	DB02531	experimental	Isobutyric acid	CC(C)C(=O)O
7427	tr|O53327|O53327_M	P96965	91.61	8.0	270.0	DB03568	experimental; investigational	Butyric Acid	CCCC(=O)O
7428	tr|O53327|O53327_M	P96965	91.61	8.0	270.0	DB03741	experimental	2-Methylbutanoic Acid	CC[C@@H](C)C(=O)O
7429	tr|O53327|O53327_M	P96965	91.61	8.0	270.0	DB03750	experimental	Isovaleric Acid	CC(C)CC(=O)O
7430	tr|O53327|O53327_M	P96965	91.61	8.0	270.0	DB03766	approved; vet_approved	Propanoic acid	CCC(=O)O
7431	tr|O53327|O53327_M	P96965	91.61	8.0	270.0	DB03793	approved; investigational	Benzoic acid	OC(=O)c1ccccc1
7432	tr|O53327|O53327_M	O31168	91.96	13.0	276.0	DB03793	approved; investigational	Benzoic acid	OC(=O)c1ccccc1
7433	tr|O53327|O53327_M	O07015	87.76	14.0	265.0	DB02175	experimental	Malonic acid	OC(=O)CC(=O)O
7434	tr|O53327|O53327_M	O07015	87.76	14.0	265.0	DB03297	experimental	Benzylsulfonic acid	OS(=O)(=O)Cc1ccccc1
7435	tr|O53327|O53327_M	O07015	87.76	14.0	265.0	DB04349	experimental	(S)-propane-1,2-diol	C[C@H](O)CO
7436	tr|O53327|O53327_M	P13001	86.71	3.0	251.0	DB03688	experimental	Hydracrylic acid	OCCC(=O)O
7437	tr|O53327|O53327_M	O07732	86.01	15.0	261.0	DB02596	experimental	alpha,beta-Methyleneadenosine 5'-triphosphate	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)CP(=O)(O)OP(=O)(O)O
7438	tr|L0T6V0|L0T6V0_M	Q8ZNF3	96.48	3.0	195.0	DB02038	experimental	D-[3-hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl]-N,O-cycloserylamide	Cc1ncc(COP(=O)(O)O)c(c1O)CN[C@@H]2CONC2=O
7439	tr|L0T6V0|L0T6V0_M	Q8ZNF3	96.48	3.0	195.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
7440	tr|L0T6V0|L0T6V0_M	P13254	77.89	64.0	219.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
7441	tr|L0T6V0|L0T6V0_M	P22557	79.4	225.0	383.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
7442	tr|L0T6V0|L0T6V0_M	P22557	79.4	225.0	383.0	DB00145	approved; nutraceutical; vet_approved	Glycine	NCC(=O)O
7443	tr|L0T6V0|L0T6V0_M	P32929	73.37	65.0	211.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
7444	tr|L0T6V0|L0T6V0_M	P32929	73.37	65.0	211.0	DB00151	approved; nutraceutical	Cysteine	OC(=O)[C@@H](N)CS
7445	tr|L0T6V0|L0T6V0_M	P32929	73.37	65.0	211.0	DB02328	experimental	2-[(3-Hydroxy-2-Methyl-5-Phosphonooxymethyl-Pyridin-4-Ylmethyl)-Imino]-5-Phosphono-Pent-3-Enoic Acid	OP(=O)(O)C/C=C/C(C(=O)O)=N\Cc1c(COP(=O)(O)O)cnc(C)c1O
7446	tr|L0T6V0|L0T6V0_M	P32929	73.37	65.0	211.0	DB03928	experimental	Carboxymethylthio-3-(3-Chlorophenyl)-1,2,4-Oxadiazol	OC(=O)CSc1nc(no1)-c2cccc(Cl)c2
7447	tr|L0T6V0|L0T6V0_M	P32929	73.37	65.0	211.0	DB04217	experimental	L-2-amino-3-butynoic acid	OC(=O)[C@@H](N)C#C
7448	tr|L0T6V0|L0T6V0_M	Q9X266	79.9	18.0	177.0	DB02824	experimental	N-Pyridoxyl-Glycine-5-Monophosphate	Cc1ncc(COP(=O)(O)O)c(c1O)CNCC(=O)O
7449	tr|L0T6V0|L0T6V0_M	Q9X266	79.9	18.0	177.0	DB03576	experimental	N-Pyridoxyl-Threonine-5-Monophosphate	CC(O)C(C(=O)O)NCc1c(COP(=O)(O)O)cnc(C)c1O
7450	tr|L0T6V0|L0T6V0_M	Q9X266	79.9	18.0	177.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
7451	tr|L0T6V0|L0T6V0_M	P0AB77	70.35	77.0	217.0	DB03915	experimental	2-Amino-3-Ketobutyric Acid	CC(=O)[C@H](N)C(=O)O
7452	tr|L0T6V0|L0T6V0_M	Q6YP21	71.86	120.0	263.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
7453	tr|L0T6V0|L0T6V0_M	P13196	75.38	279.0	429.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
7454	tr|L0T6V0|L0T6V0_M	P13196	75.38	279.0	429.0	DB00145	approved; nutraceutical; vet_approved	Glycine	NCC(=O)O
7455	tr|L0T6V0|L0T6V0_M	Q5JAM2	75.38	279.0	429.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
7456	tr|L0T6V0|L0T6V0_M	Q96QU6	71.36	163.0	305.0	DB03214	experimental	Vinylglycine	OC(=O)[C@@H](N)C=C
7457	tr|L0T6V0|L0T6V0_M	P00935	72.86	51.0	196.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
7458	tr|L0T6V0|L0T6V0_M	Q9NUV7	74.37	195.0	343.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
7459	tr|L0T6V0|L0T6V0_M	O15270	74.87	202.0	351.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
7460	tr|L0T6V0|L0T6V0_M	O15270	74.87	202.0	351.0	DB00133	investigational; nutraceutical	Serine	OC(=O)[C@@H](N)CO
7462	tr|L0T6V0|L0T6V0_M	P31013	72.86	79.0	224.0	DB03897	experimental	Phloretic acid	OC(=O)CCc1ccc(O)cc1
7463	tr|L0T6V0|L0T6V0_M	O15269	70.35	137.0	277.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
7464	tr|L0T6V0|L0T6V0_M	O15269	70.35	137.0	277.0	DB00133	investigational; nutraceutical	Serine	OC(=O)[C@@H](N)CO
7465	tr|L0T6V0|L0T6V0_M	P31012	72.86	79.0	224.0	DB03897	experimental	Phloretic acid	OC(=O)CCc1ccc(O)cc1
7466	tr|L0T6V0|L0T6V0_M	Q6LFH8	73.37	94.0	240.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
7467	tr|O33332|O33332_M	P09110	96.51	32.0	419.0	DB09069	approved; investigational	Trimetazidine	COc1c(OC)c(OC)c(cc1)CN2CCNCC2
7468	tr|O33332|O33332_M	P28790	95.26	6.0	388.0	DB08249	experimental	3,6,9,12,15-PENTAOXATRICOSAN-1-OL	CCCCCCCCOCCOCCOCCOCCOCCO
7469	tr|O33332|O33332_M	Q9BWD1	97.51	3.0	394.0	DB01915	experimental	S-Hydroxycysteine	OC(=O)[C@@H](N)CSO
7470	tr|O33332|O33332_M	Q9BWD1	97.51	3.0	394.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
7471	tr|O33332|O33332_M	P07097	95.76	6.0	390.0	DB01915	experimental	S-Hydroxycysteine	OC(=O)[C@@H](N)CSO
7472	tr|O33332|O33332_M	P07097	95.76	6.0	390.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
7473	tr|O33332|O33332_M	P07097	95.76	6.0	390.0	DB02039	experimental	S-Acetyl-Cysteine	OC(=O)[C@@H](N)CSC(=O)C
7474	tr|O33332|O33332_M	P07097	95.76	6.0	390.0	DB02160	experimental	S-Butyryl-Cystein	OC(=O)[C@@H](N)CSC(=O)CCC
7475	tr|O33332|O33332_M	P07097	95.76	6.0	390.0	DB03045	experimental	Pantothenyl-Aminoethanol-Acetate Pivalic Acid	CC(=O)OCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COC(=O)C(C)(C)C
7476	tr|O33332|O33332_M	P07097	95.76	6.0	390.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
7477	tr|O33332|O33332_M	P07097	95.76	6.0	390.0	DB08328	experimental	PANTOTHENYL-AMINOETHANOL-11-PIVALIC ACID	CC(C)(C)C(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCO
7478	tr|O33332|O33332_M	P07097	95.76	6.0	390.0	DB08408	experimental	(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-({3-oxo-3-[(2-sulfanylethyl)amino]propyl}amino)butyl 2,2-dimethylpropanoate	CC(C)(C)C(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS
7479	tr|P71835|P71835_M	Q9X6R4	73.73	8.0	182.0	DB03535	experimental	Z-Pro-Prolinal	O=C[C@@H]1CCCN1C(=O)[C@@H]2CCCN2C(=O)OCc3ccccc3
7480	tr|P71835|P71835_M	P48147	77.54	4.0	187.0	DB01684	experimental	1-Hydroxy-1-Thio-Glycerol	OC[C@@H](O)CSO
7481	tr|P71835|P71835_M	P48147	77.54	4.0	187.0	DB03382	experimental	S-oxy-L-cysteine	OC(=O)[C@@H](N)CS=O
7482	tr|P71835|P71835_M	P48147	77.54	4.0	187.0	DB03535	experimental	Z-Pro-Prolinal	O=C[C@@H]1CCCN1C(=O)[C@@H]2CCCN2C(=O)OCc3ccccc3
7483	tr|P71835|P71835_M	P48147	77.54	4.0	187.0	DB03864	experimental	Monothioglycerol	OC[C@@H](O)CS
7484	tr|P71835|P71835_M	P48147	77.54	4.0	187.0	DB07148	experimental	(6S)-1-chloro-3-[(4-fluorobenzyl)oxy]-6-(pyrrolidin-1-ylcarbonyl)pyrrolo[1,2-a]pyrazin-4(6H)-one	C1CCCN1C(=O)[C@@H]2C=Cc(n23)c(Cl)nc(c3=O)OCc4ccc(F)cc4
7485	tr|P71835|P71835_M	P48147	77.54	4.0	187.0	DB08738	experimental	1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one	C1CCCN1C(=O)[C@@H]2CCCN2C(=O)CCn3c(=O)c(nc(c34)cccc4)-c5ccccc5
7486	tr|P71835|P71835_M	P48147	77.54	4.0	187.0	DB08739	experimental	2-{3-[(2S)-4,4-difluoro-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]-3-oxopropyl}-isoindole-1,3(2H)-dione	C1CCCN1C(=O)[C@H](CC2(F)F)N(C2)C(=O)CCN(C3=O)C(=O)c(c34)cccc4
7487	tr|P71835|P71835_M	Q9X5N2	75.42	2.0	180.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
7488	tr|P71835|P71835_M	Q9X5N2	75.42	2.0	180.0	DB04033	experimental	Z-Ala Prolinal	OC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)OCc2ccccc2
7489	tr|I6YDK7|I6YDK7_M	Q9HCC0	97.73	46.0	563.0	DB00121	approved; investigational; nutraceutical	Biotin	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC(=O)O
7490	tr|I6YDK7|I6YDK7_M	Q8GBW6	94.52	9.0	509.0	DB04045	experimental	(R)-methylmalonyl-CoA	OC(=O)[C@@H](C)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
7491	tr|I6YDK7|I6YDK7_M	Q8GBW6	94.52	9.0	509.0	DB04183	experimental	Methylmalonic Acid	OC(=O)C(C)C(=O)O
7492	tr|I6YDK7|I6YDK7_M	Q9X4K7	93.19	17.0	510.0	DB02912	experimental	Propanoyl-CoA	CCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
7493	tr|I6YDK7|I6YDK7_M	P05166	93.19	25.0	518.0	DB00121	approved; investigational; nutraceutical	Biotin	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC(=O)O
7494	tr|I6YDK7|I6YDK7_M	P05166	93.19	25.0	518.0	DB00161	approved; nutraceutical	Valine	CC(C)[C@H](N)C(=O)O
7495	tr|I6Y0W5|I6Y0W5_M	P16219	95.69	29.0	406.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
7496	tr|I6Y0W5|I6Y0W5_M	P16219	95.69	29.0	406.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
7497	tr|I6Y0W5|I6Y0W5_M	P16219	95.69	29.0	406.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
7498	tr|I6Y0W5|I6Y0W5_M	Q72JJ3	94.42	6.0	378.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
7499	tr|I6Y0W5|I6Y0W5_M	Q06319	95.43	5.0	381.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
7500	tr|I6Y0W5|I6Y0W5_M	Q06319	95.43	5.0	381.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
7501	tr|I6Y0W5|I6Y0W5_M	P11310	94.92	40.0	414.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
7502	tr|I6Y0W5|I6Y0W5_M	P11310	94.92	40.0	414.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
7503	tr|I6Y0W5|I6Y0W5_M	P11310	94.92	40.0	414.0	DB03415	experimental	3-thiaoctanoyl-CoA	CCCCCSCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
7504	tr|I6Y0W5|I6Y0W5_M	P26440	95.69	41.0	418.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
7505	tr|I6Y0W5|I6Y0W5_M	P26440	95.69	41.0	418.0	DB04036	experimental	Coenzyme A persulfide	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSS
7506	tr|I6Y0W5|I6Y0W5_M	P45954	94.16	57.0	428.0	DB00167	investigational; nutraceutical	Isoleucine	CC[C@H](C)[C@H](N)C(=O)O
7507	tr|I6Y0W5|I6Y0W5_M	P45954	94.16	57.0	428.0	DB00313	approved; investigational	Valproic acid	CCCC(C(=O)O)CCC
7508	tr|I6Y0W5|I6Y0W5_M	Q9UKU7	94.42	40.0	412.0	DB01675	experimental	Methacrylyl-Coenzyme A	CC(=C)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
7509	tr|I6Y0W5|I6Y0W5_M	Q9UKU7	94.42	40.0	412.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
7510	tr|I6Y0W5|I6Y0W5_M	Q3JP94	94.16	16.0	387.0	DB08685	experimental	1-(1,4-dimethyl-1,2,3,4-tetrahydroquinoxalin-6-yl)methanamine	CN1CCN(C)c(c12)cc(cc2)CN
7511	tr|I6Y0W5|I6Y0W5_M	Q92947	93.65	59.0	428.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
7512	tr|I6Y0W5|I6Y0W5_M	Q92947	93.65	59.0	428.0	DB03245	experimental	S-4-Nitrobutyryl-CoA	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCC[N+]([O-])=O
7513	tr|I6Y0W5|I6Y0W5_M	Q9KIE5	88.32	12.0	360.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
7514	tr|I6Y0W5|I6Y0W5_M	Q15067	83.76	103.0	433.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
7515	tr|I6Y0W5|I6Y0W5_M	Q15067	83.76	103.0	433.0	DB07930	experimental	(3R)-3-HYDROXYDODECANOIC ACID	OC(=O)C[C@H](O)CCCCCCCCC
7516	tr|P71538|P71538_M	Q96RQ3	101.35	48.0	724.0	DB00121	approved; investigational; nutraceutical	Biotin	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC(=O)O
7517	tr|P71538|P71538_M	P05165	99.55	64.0	728.0	DB00121	approved; investigational; nutraceutical	Biotin	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC(=O)O
7518	tr|P71538|P71538_M	Q13085	106.0	118.0	825.0	DB00121	approved; investigational; nutraceutical	Biotin	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC(=O)O
7519	tr|P71538|P71538_M	O00763	106.15	260.0	968.0	DB00121	approved; investigational; nutraceutical	Biotin	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC(=O)O
7520	tr|P71538|P71538_M	O00763	106.15	260.0	968.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
7521	tr|P71538|P71538_M	O00763	106.15	260.0	968.0	DB02859	experimental	Soraphen A	CO[C@@H]([C@]12O)[C@@H](O)[C@H](C)[C@@H](O1)[C@@H](C)/C=C/[C@@H](OC)[C@@H](OC)CCCC[C@H](OC(=O)[C@H]2C)c3ccccc3
7522	tr|P71538|P71538_M	O00763	106.15	260.0	968.0	DB03781	experimental	2-[4-(2,4-Dichlorophenoxy)Phenoxy]Propanoic Acid	OC(=O)[C@@H](C)Oc1ccc(cc1)Oc2ccc(Cl)cc2Cl
7523	tr|P71538|P71538_M	O00763	106.15	260.0	968.0	DB07870	experimental	Haloxyfop-P	OC(=O)[C@@H](C)Oc1ccc(cc1)Oc2c(Cl)cc(cn2)C(F)(F)F
7524	tr|P71538|P71538_M	A0A0H3JRU9	70.91	3.0	476.0	DB07497	experimental	5-(HEXAHYDRO-2-OXO-1H-THIENO[3,4-D]IMIDAZOL-6-YL)PENTANAL	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC=O
7525	tr|P71538|P71538_M	P11498	70.61	37.0	508.0	DB00119	approved; investigational; nutraceutical	Pyruvic acid	CC(=O)C(=O)O
7526	tr|P71538|P71538_M	P11498	70.61	37.0	508.0	DB00121	approved; investigational; nutraceutical	Biotin	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC(=O)O
7527	tr|P71538|P71538_M	P11498	70.61	37.0	508.0	DB07497	experimental	5-(HEXAHYDRO-2-OXO-1H-THIENO[3,4-D]IMIDAZOL-6-YL)PENTANAL	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC=O
7528	tr|P72047|P72047_M	P08183	80.22	406.0	625.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
7529	tr|P72047|P72047_M	P08183	80.22	406.0	625.0	DB00603	approved; investigational	Medroxyprogesterone acetate	CC(=O)O[C@]1(C(=O)C)CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C([C@H](C3)C)=CC(=O)CC4
7530	tr|P72047|P72047_M	P08183	80.22	406.0	625.0	DB00778	approved; investigational; withdrawn	Roxithromycin	COCCOCO/N=C([C@H](C)[C@@H](O)[C@]1(C)O)/[C@H](C)C[C@@](C)(O)[C@@H]([C@@H](C)[C@@H]([C@@H](C)C(=O)O[C@@H]1CC)O[C@@H](C[C@@]2(C)OC)O[C@@H](C)[C@@H]2O)O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C
7531	tr|P72047|P72047_M	P08183	80.22	406.0	625.0	DB00813	approved; illicit; investigational; vet_approved	Fentanyl	c1ccccc1N(C(=O)CC)C2CCN(CC2)CCc3ccccc3
7532	tr|P72047|P72047_M	P08183	80.22	406.0	625.0	DB04877	experimental	Voacamine	CC[C@H]1C[C@@H](C2)CN([C@@H]1[C@@]23C(=O)OC)CCc4c3[nH]c5c4cc(OC)c(c5)[C@@H](C[C@H]67)c8c(c9c([nH]8)cccc9)C[C@H](C6C(=O)OC)N(C)CC\7=C\C
7533	tr|P72047|P72047_M	P08183	80.22	406.0	625.0	DB04881	investigational	Elacridar	COc1cccc(c12)c(=O)c3c([nH]2)c(ccc3)C(=O)Nc4ccc(cc4)CCN(C5)CCc(c56)cc(OC)c(c6)OC
7534	tr|P72047|P72047_M	P08183	80.22	406.0	625.0	DB04905	investigational	Tesmilifene	CCN(CC)CCOc1ccc(cc1)Cc2ccccc2
7535	tr|P72047|P72047_M	P08183	80.22	406.0	625.0	DB05449	investigational	FM-VP4	 
7536	tr|P72047|P72047_M	P08183	80.22	406.0	625.0	DB06191	investigational	Zosuquidar	FC1(F)[C@H]2[C@@H]1c(cccc3)c3[C@@H](c(c24)cccc4)N5CCN(CC5)C[C@@H](O)COc6cccc(c67)nccc7
7537	tr|P72047|P72047_M	P08183	80.22	406.0	625.0	DB06240	investigational	Tariquidar	COc(c1)c(OC)cc(c12)CCN(C2)CCc3ccc(cc3)NC(=O)c4cc(OC)c(OC)cc4NC(=O)c(c5)cnc(c56)cccc6
7538	tr|P72047|P72047_M	P08183	80.22	406.0	625.0	DB09031	approved; investigational	Miltefosine	CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C
7539	tr|P72047|P72047_M	P08183	80.22	406.0	625.0	DB11635	approved	Tocofersolan	 
7540	tr|P72047|P72047_M	P08183	80.22	406.0	625.0	DB14061	experimental	Hycanthone	CCN(CC)CCNc(ccc1CO)c(c12)c(=O)c3c(s2)cccc3
7541	tr|P72047|P72047_M	P08183	80.22	406.0	625.0	DB14062	experimental	Concanamycin A	NC(=O)O[C@@H]1[C@@H](C)O[C@H](C[C@H]1O)O[C@H](C2)[C@H](C)[C@@H](/C=C/C)O[C@@]2(O)[C@@H](C)[C@H](O)[C@H](C)[C@H]3OC(=O)/C(OC)=C/C(C)=C/[C@@H](C)[C@@H](O)[C@@H](CC)[C@@H](O)[C@H](C)C/C(C)=C/C=C/[C@@H]3OC
7542	tr|P72047|P72047_M	P08183	80.22	406.0	625.0	DB14063	experimental	Dexverapamil	COc1ccc(cc1OC)CCN(C)CCC[C@@](C#N)(C(C)C)c2cc(OC)c(OC)cc2
7543	tr|P72047|P72047_M	P08183	80.22	406.0	625.0	DB14064	experimental	Emopamil	c1ccccc1C(C#N)(C(C)C)CCCN(C)CCc2ccccc2
7544	tr|P72047|P72047_M	P08183	80.22	406.0	625.0	DB14065	experimental	Lomerizine	COc1ccc(c(OC)c1OC)CN2CCN(CC2)C(c3ccc(F)cc3)c4ccc(F)cc4
7545	tr|P72047|P72047_M	P08183	80.22	406.0	625.0	DB14066	experimental	Tetrandrine	c12ccc(OC)c(c1)Oc3ccc(cc3)C[C@H]4c5c(CCN4C)cc(OC)c(c5)Oc6c7c(CCN(C)[C@H]7C2)cc(OC)c6OC
7546	tr|P72047|P72047_M	P08183	80.22	406.0	625.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
7547	tr|P72047|P72047_M	P08183	80.22	406.0	625.0	DB14068	experimental	Dexniguldipine	[O-][N+](=O)c1cccc(c1)[C@@H]2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCCN(CC3)CCC3(c4ccccc4)c5ccccc5
7548	tr|P72047|P72047_M	P08183	80.22	406.0	625.0	DB14069	investigational	ONT-093	CCOC/C=C/c1ccc(cc1)-c2nc(-c3ccc(cc3)NC(C)C)c([nH]2)-c4ccc(cc4)NC(C)C
7549	tr|P72047|P72047_M	P08183	80.22	406.0	625.0	DB14070	experimental	HM-30181	c1cccc(c12)c(=O)cc(o2)C(=O)Nc3cc(OC)c(OC)cc3-c4nn(nn4)-c5ccc(cc5)CCN(C6)CCc(c67)cc(OC)c(c7)OC
7550	tr|P72047|P72047_M	P08183	80.22	406.0	625.0	DB14071	experimental	Desmethylsertraline	c1cccc(c12)[C@@H](CC[C@@H]2N)c3cc(Cl)c(Cl)cc3
7551	tr|P72047|P72047_M	P08183	80.22	406.0	625.0	DB14072	experimental	Reversin 121	c1ccccc1COC(=O)C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@H](C(=O)OC(C)(C)C)CCCCNC(=O)OCc2ccccc2
7552	tr|P72047|P72047_M	P08183	79.85	1049.0	1267.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
7553	tr|P72047|P72047_M	P08183	79.85	1049.0	1267.0	DB00603	approved; investigational	Medroxyprogesterone acetate	CC(=O)O[C@]1(C(=O)C)CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C([C@H](C3)C)=CC(=O)CC4
7554	tr|P72047|P72047_M	P08183	79.85	1049.0	1267.0	DB00778	approved; investigational; withdrawn	Roxithromycin	COCCOCO/N=C([C@H](C)[C@@H](O)[C@]1(C)O)/[C@H](C)C[C@@](C)(O)[C@@H]([C@@H](C)[C@@H]([C@@H](C)C(=O)O[C@@H]1CC)O[C@@H](C[C@@]2(C)OC)O[C@@H](C)[C@@H]2O)O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C
7555	tr|P72047|P72047_M	P08183	79.85	1049.0	1267.0	DB00813	approved; illicit; investigational; vet_approved	Fentanyl	c1ccccc1N(C(=O)CC)C2CCN(CC2)CCc3ccccc3
7556	tr|P72047|P72047_M	P08183	79.85	1049.0	1267.0	DB04877	experimental	Voacamine	CC[C@H]1C[C@@H](C2)CN([C@@H]1[C@@]23C(=O)OC)CCc4c3[nH]c5c4cc(OC)c(c5)[C@@H](C[C@H]67)c8c(c9c([nH]8)cccc9)C[C@H](C6C(=O)OC)N(C)CC\7=C\C
7557	tr|P72047|P72047_M	P08183	79.85	1049.0	1267.0	DB04881	investigational	Elacridar	COc1cccc(c12)c(=O)c3c([nH]2)c(ccc3)C(=O)Nc4ccc(cc4)CCN(C5)CCc(c56)cc(OC)c(c6)OC
7558	tr|P72047|P72047_M	P08183	79.85	1049.0	1267.0	DB04905	investigational	Tesmilifene	CCN(CC)CCOc1ccc(cc1)Cc2ccccc2
7559	tr|P72047|P72047_M	P08183	79.85	1049.0	1267.0	DB05449	investigational	FM-VP4	 
7560	tr|P72047|P72047_M	P08183	79.85	1049.0	1267.0	DB06191	investigational	Zosuquidar	FC1(F)[C@H]2[C@@H]1c(cccc3)c3[C@@H](c(c24)cccc4)N5CCN(CC5)C[C@@H](O)COc6cccc(c67)nccc7
7561	tr|P72047|P72047_M	P08183	79.85	1049.0	1267.0	DB06240	investigational	Tariquidar	COc(c1)c(OC)cc(c12)CCN(C2)CCc3ccc(cc3)NC(=O)c4cc(OC)c(OC)cc4NC(=O)c(c5)cnc(c56)cccc6
7562	tr|P72047|P72047_M	P08183	79.85	1049.0	1267.0	DB09031	approved; investigational	Miltefosine	CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C
7563	tr|P72047|P72047_M	P08183	79.85	1049.0	1267.0	DB11635	approved	Tocofersolan	 
7564	tr|P72047|P72047_M	P08183	79.85	1049.0	1267.0	DB14061	experimental	Hycanthone	CCN(CC)CCNc(ccc1CO)c(c12)c(=O)c3c(s2)cccc3
7565	tr|P72047|P72047_M	P08183	79.85	1049.0	1267.0	DB14062	experimental	Concanamycin A	NC(=O)O[C@@H]1[C@@H](C)O[C@H](C[C@H]1O)O[C@H](C2)[C@H](C)[C@@H](/C=C/C)O[C@@]2(O)[C@@H](C)[C@H](O)[C@H](C)[C@H]3OC(=O)/C(OC)=C/C(C)=C/[C@@H](C)[C@@H](O)[C@@H](CC)[C@@H](O)[C@H](C)C/C(C)=C/C=C/[C@@H]3OC
7566	tr|P72047|P72047_M	P08183	79.85	1049.0	1267.0	DB14063	experimental	Dexverapamil	COc1ccc(cc1OC)CCN(C)CCC[C@@](C#N)(C(C)C)c2cc(OC)c(OC)cc2
7567	tr|P72047|P72047_M	P08183	79.85	1049.0	1267.0	DB14064	experimental	Emopamil	c1ccccc1C(C#N)(C(C)C)CCCN(C)CCc2ccccc2
7568	tr|P72047|P72047_M	P08183	79.85	1049.0	1267.0	DB14065	experimental	Lomerizine	COc1ccc(c(OC)c1OC)CN2CCN(CC2)C(c3ccc(F)cc3)c4ccc(F)cc4
7569	tr|P72047|P72047_M	P08183	79.85	1049.0	1267.0	DB14066	experimental	Tetrandrine	c12ccc(OC)c(c1)Oc3ccc(cc3)C[C@H]4c5c(CCN4C)cc(OC)c(c5)Oc6c7c(CCN(C)[C@H]7C2)cc(OC)c6OC
7570	tr|P72047|P72047_M	P08183	79.85	1049.0	1267.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
7571	tr|P72047|P72047_M	P08183	79.85	1049.0	1267.0	DB14068	experimental	Dexniguldipine	[O-][N+](=O)c1cccc(c1)[C@@H]2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCCN(CC3)CCC3(c4ccccc4)c5ccccc5
7572	tr|P72047|P72047_M	P08183	79.85	1049.0	1267.0	DB14069	investigational	ONT-093	CCOC/C=C/c1ccc(cc1)-c2nc(-c3ccc(cc3)NC(C)C)c([nH]2)-c4ccc(cc4)NC(C)C
7573	tr|P72047|P72047_M	P08183	79.85	1049.0	1267.0	DB14070	experimental	HM-30181	c1cccc(c12)c(=O)cc(o2)C(=O)Nc3cc(OC)c(OC)cc3-c4nn(nn4)-c5ccc(cc5)CCN(C6)CCc(c67)cc(OC)c(c7)OC
7574	tr|P72047|P72047_M	P08183	79.85	1049.0	1267.0	DB14071	experimental	Desmethylsertraline	c1cccc(c12)[C@@H](CC[C@@H]2N)c3cc(Cl)c(Cl)cc3
7575	tr|P72047|P72047_M	P08183	79.85	1049.0	1267.0	DB14072	experimental	Reversin 121	c1ccccc1COC(=O)C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@H](C(=O)OC(C)(C)C)CCCCNC(=O)OCc2ccccc2
7576	tr|P72047|P72047_M	O95342	79.12	434.0	650.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
7577	tr|P72047|P72047_M	O95342	79.12	434.0	650.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
7578	tr|P72047|P72047_M	O95342	79.12	1094.0	1310.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
7579	tr|P72047|P72047_M	O95342	79.12	1094.0	1310.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
7580	tr|P72047|P72047_M	Q92887	78.39	653.0	867.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
7581	tr|P72047|P72047_M	Q92887	78.39	653.0	867.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
7582	tr|P72047|P72047_M	Q92887	75.82	1316.0	1523.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
7583	tr|P72047|P72047_M	Q92887	75.82	1316.0	1523.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
7584	tr|P72047|P72047_M	Q2M3G0	79.85	398.0	616.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
7585	tr|P72047|P72047_M	Q2M3G0	79.85	398.0	616.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
7586	tr|P72047|P72047_M	Q2M3G0	78.75	1030.0	1245.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
7587	tr|P72047|P72047_M	Q2M3G0	78.75	1030.0	1245.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
7588	tr|P72047|P72047_M	P33527	78.75	659.0	874.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
7589	tr|P72047|P72047_M	P33527	78.75	659.0	874.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
7590	tr|P72047|P72047_M	P33527	78.75	659.0	874.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
7591	tr|P72047|P72047_M	P33527	78.75	659.0	874.0	DB06176	approved; investigational	Romidepsin	O=C([C@H]12)N/C(=C\C)C(=O)N[C@@H](C(C)C)C(=O)O[C@@H](CC(=O)N[C@H](C(C)C)C(=O)N1)/C=C/CCSSC2
7592	tr|P72047|P72047_M	P33527	78.75	659.0	874.0	DB08855	experimental; investigational	Leukotriene C4	CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@@H](O)CCCC(=O)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@H](N)C(=O)O
7593	tr|P72047|P72047_M	P33527	77.29	1309.0	1520.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
7594	tr|P72047|P72047_M	P33527	77.29	1309.0	1520.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
7595	tr|P72047|P72047_M	P33527	77.29	1309.0	1520.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
7596	tr|P72047|P72047_M	P33527	77.29	1309.0	1520.0	DB06176	approved; investigational	Romidepsin	O=C([C@H]12)N/C(=C\C)C(=O)N[C@@H](C(C)C)C(=O)O[C@@H](CC(=O)N[C@H](C(C)C)C(=O)N1)/C=C/CCSSC2
7597	tr|P72047|P72047_M	P33527	77.29	1309.0	1520.0	DB08855	experimental; investigational	Leukotriene C4	CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@@H](O)CCCC(=O)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@H](N)C(=O)O
7598	tr|P72047|P72047_M	O15440	78.02	576.0	789.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
7599	tr|P72047|P72047_M	O15440	78.02	576.0	789.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
7600	tr|P72047|P72047_M	O15440	78.39	1209.0	1423.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
7601	tr|P72047|P72047_M	O15440	78.39	1209.0	1423.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
7602	tr|P72047|P72047_M	P13569	78.75	428.0	643.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
7603	tr|P72047|P72047_M	P13569	78.75	428.0	643.0	DB00887	approved	Bumetanide	CCCCNc1c(c(S(=O)(=O)N)cc(c1)C(=O)O)Oc2ccccc2
7604	tr|P72047|P72047_M	P13569	78.75	428.0	643.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
7605	tr|P72047|P72047_M	P13569	78.75	428.0	643.0	DB01050	approved	Ibuprofen	CC(C)Cc1ccc(cc1)C(C)C(=O)O
7606	tr|P72047|P72047_M	P13569	78.75	428.0	643.0	DB02587	experimental; investigational	Colforsin	O[C@H]1CCC(C)(C)[C@@H]([C@]12C)[C@H](O)[C@H](OC(=O)C)[C@]3(C)[C@]2(O)C(=O)C[C@](O3)(C)C=C
7607	tr|P72047|P72047_M	P13569	78.75	428.0	643.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
7608	tr|P72047|P72047_M	P13569	78.75	428.0	643.0	DB04522	experimental	Dexfosfoserine	OC(=O)[C@@H](N)COP(=O)(O)O
7609	tr|P72047|P72047_M	P13569	78.75	428.0	643.0	DB04941	approved	Crofelemer	 
7610	tr|P72047|P72047_M	P13569	78.75	428.0	643.0	DB06266	investigational	Lonidamine	c1cccc(c12)n(nc2C(=O)O)Cc3c(Cl)cc(Cl)cc3
7611	tr|P72047|P72047_M	P13569	78.75	428.0	643.0	DB08820	approved	Ivacaftor	CC(C)(C)c1cc(C(C)(C)C)c(O)cc1NC(=O)c(c2=O)c[nH]c(c23)cccc3
7612	tr|P72047|P72047_M	P13569	78.75	428.0	643.0	DB09213	approved; investigational	Dexibuprofen	CC(C)Cc1ccc(cc1)[C@H](C)C(=O)O
7613	tr|P72047|P72047_M	P13569	78.75	428.0	643.0	DB09280	approved	Lumacaftor	O=C(O)c1cccc(c1)-c2nc(ccc2C)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
7614	tr|P72047|P72047_M	P13569	78.75	428.0	643.0	DB11712	approved; investigational	Tezacaftor	OC[C@H](O)Cn1c(C(C)(C)CO)cc(c12)cc(c(F)c2)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
7615	tr|P72047|P72047_M	P13569	78.75	428.0	643.0	DB15444	approved; investigational	Elexacaftor	FC(F)(F)C(C)(C)COc1nn(cc1)-c2nc(N(C3(C)C)C[C@@H](C)C3)c(cc2)C(=O)NS(=O)(=O)c4cn(C)nc4C
7616	tr|P72047|P72047_M	P13569	76.56	1225.0	1434.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
7617	tr|P72047|P72047_M	P13569	76.56	1225.0	1434.0	DB00887	approved	Bumetanide	CCCCNc1c(c(S(=O)(=O)N)cc(c1)C(=O)O)Oc2ccccc2
7618	tr|P72047|P72047_M	P13569	76.56	1225.0	1434.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
7619	tr|P72047|P72047_M	P13569	76.56	1225.0	1434.0	DB01050	approved	Ibuprofen	CC(C)Cc1ccc(cc1)C(C)C(=O)O
7620	tr|P72047|P72047_M	P13569	76.56	1225.0	1434.0	DB02587	experimental; investigational	Colforsin	O[C@H]1CCC(C)(C)[C@@H]([C@]12C)[C@H](O)[C@H](OC(=O)C)[C@]3(C)[C@]2(O)C(=O)C[C@](O3)(C)C=C
7621	tr|P72047|P72047_M	P13569	76.56	1225.0	1434.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
7622	tr|P72047|P72047_M	P13569	76.56	1225.0	1434.0	DB04522	experimental	Dexfosfoserine	OC(=O)[C@@H](N)COP(=O)(O)O
7623	tr|P72047|P72047_M	P13569	76.56	1225.0	1434.0	DB04941	approved	Crofelemer	 
7624	tr|P72047|P72047_M	P13569	76.56	1225.0	1434.0	DB06266	investigational	Lonidamine	c1cccc(c12)n(nc2C(=O)O)Cc3c(Cl)cc(Cl)cc3
7625	tr|P72047|P72047_M	P13569	76.56	1225.0	1434.0	DB08820	approved	Ivacaftor	CC(C)(C)c1cc(C(C)(C)C)c(O)cc1NC(=O)c(c2=O)c[nH]c(c23)cccc3
7626	tr|P72047|P72047_M	P13569	76.56	1225.0	1434.0	DB09213	approved; investigational	Dexibuprofen	CC(C)Cc1ccc(cc1)[C@H](C)C(=O)O
7627	tr|P72047|P72047_M	P13569	76.56	1225.0	1434.0	DB09280	approved	Lumacaftor	O=C(O)c1cccc(c1)-c2nc(ccc2C)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
7628	tr|P72047|P72047_M	P13569	76.56	1225.0	1434.0	DB11712	approved; investigational	Tezacaftor	OC[C@H](O)Cn1c(C(C)(C)CO)cc(c12)cc(c(F)c2)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
7629	tr|P72047|P72047_M	P13569	76.56	1225.0	1434.0	DB15444	approved; investigational	Elexacaftor	FC(F)(F)C(C)(C)COc1nn(cc1)-c2nc(N(C3(C)C)C[C@@H](C)C3)c(cc2)C(=O)NS(=O)(=O)c4cn(C)nc4C
7630	tr|P72047|P72047_M	O60706	83.88	685.0	914.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
7631	tr|P72047|P72047_M	O60706	83.88	685.0	914.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
7632	tr|P72047|P72047_M	O60706	83.88	685.0	914.0	DB09220	approved; investigational	Nicorandil	[O-][N+](=O)OCCNC(=O)c1cccnc1
7633	tr|P72047|P72047_M	O60706	78.75	1327.0	1542.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
7634	tr|P72047|P72047_M	O60706	78.75	1327.0	1542.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
7635	tr|P72047|P72047_M	O60706	78.75	1327.0	1542.0	DB09220	approved; investigational	Nicorandil	[O-][N+](=O)OCCNC(=O)c1cccnc1
7636	tr|P72047|P72047_M	Q09428	87.18	692.0	930.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
7637	tr|P72047|P72047_M	Q09428	87.18	692.0	930.0	DB00222	approved	Glimepiride	CCC1=C(C)CN(C1=O)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3
7638	tr|P72047|P72047_M	Q09428	87.18	692.0	930.0	DB00672	approved; investigational	Chlorpropamide	CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1
7639	tr|P72047|P72047_M	Q09428	87.18	692.0	930.0	DB00731	approved; investigational	Nateglinide	CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](C(=O)O)Cc2ccccc2
7640	tr|P72047|P72047_M	Q09428	87.18	692.0	930.0	DB00912	approved; investigational	Repaglinide	CCOc1c(C(=O)O)ccc(c1)CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3
7641	tr|P72047|P72047_M	Q09428	87.18	692.0	930.0	DB01067	approved; investigational	Glipizide	Cc1ncc(nc1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
7642	tr|P72047|P72047_M	Q09428	87.18	692.0	930.0	DB01120	approved	Gliclazide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN(C2)CC(C23)CCC3
7643	tr|P72047|P72047_M	Q09428	87.18	692.0	930.0	DB01124	approved; investigational	Tolbutamide	CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1
7644	tr|P72047|P72047_M	Q09428	87.18	692.0	930.0	DB01251	approved; investigational	Gliquidone	COc(cc1)cc(c12)C(=O)N(C(=O)C2(C)C)CCc3ccc(cc3)S(=O)(=O)NC(=O)NC4CCCCC4
7645	tr|P72047|P72047_M	Q09428	87.18	692.0	930.0	DB01252	investigational	Mitiglinide	c1ccccc1C[C@H](C(=O)O)CC(=O)N(C2)C[C@H]([C@H]23)CCCC3
7646	tr|P72047|P72047_M	Q09428	87.18	692.0	930.0	DB01382	approved; investigational	Glymidine	COCCOc1cnc(nc1)NS(=O)(=O)c2ccccc2
7647	tr|P72047|P72047_M	Q09428	80.22	1359.0	1578.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
7648	tr|P72047|P72047_M	Q09428	80.22	1359.0	1578.0	DB00222	approved	Glimepiride	CCC1=C(C)CN(C1=O)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3
7649	tr|P72047|P72047_M	Q09428	80.22	1359.0	1578.0	DB00672	approved; investigational	Chlorpropamide	CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1
7650	tr|P72047|P72047_M	Q09428	80.22	1359.0	1578.0	DB00731	approved; investigational	Nateglinide	CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](C(=O)O)Cc2ccccc2
7651	tr|P72047|P72047_M	Q09428	80.22	1359.0	1578.0	DB00912	approved; investigational	Repaglinide	CCOc1c(C(=O)O)ccc(c1)CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3
7652	tr|P72047|P72047_M	Q09428	80.22	1359.0	1578.0	DB01067	approved; investigational	Glipizide	Cc1ncc(nc1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
7653	tr|P72047|P72047_M	Q09428	80.22	1359.0	1578.0	DB01120	approved	Gliclazide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN(C2)CC(C23)CCC3
7654	tr|P72047|P72047_M	Q09428	80.22	1359.0	1578.0	DB01124	approved; investigational	Tolbutamide	CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1
7655	tr|P72047|P72047_M	Q09428	80.22	1359.0	1578.0	DB01251	approved; investigational	Gliquidone	COc(cc1)cc(c12)C(=O)N(C(=O)C2(C)C)CCc3ccc(cc3)S(=O)(=O)NC(=O)NC4CCCCC4
7656	tr|P72047|P72047_M	Q09428	80.22	1359.0	1578.0	DB01252	investigational	Mitiglinide	c1ccccc1C[C@H](C(=O)O)CC(=O)N(C2)C[C@H]([C@H]23)CCCC3
7657	tr|P72047|P72047_M	Q09428	80.22	1359.0	1578.0	DB01382	approved; investigational	Glymidine	COCCOc1cnc(nc1)NS(=O)(=O)c2ccccc2
7658	tr|P72047|P72047_M	Q09428	87.18	692.0	930.0	DB00839	approved; investigational	Tolazamide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2
7659	tr|P72047|P72047_M	Q09428	87.18	692.0	930.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
7660	tr|P72047|P72047_M	Q09428	80.22	1359.0	1578.0	DB00839	approved; investigational	Tolazamide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2
7661	tr|P72047|P72047_M	Q09428	80.22	1359.0	1578.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
7662	tr|P72047|P72047_M	O95255	73.99	644.0	846.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
7663	tr|P72047|P72047_M	O95255	77.66	1281.0	1493.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
7664	tr|P72047|P72047_M	O15439	72.89	425.0	624.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
7665	tr|P72047|P72047_M	O15439	77.66	1057.0	1269.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
7666	tr|P72047|P72047_M	P13568	89.38	393.0	637.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
7667	tr|P72047|P72047_M	O95477	74.73	915.0	1119.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
7668	tr|P72047|P72047_M	O95477	74.73	915.0	1119.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
7669	tr|P72047|P72047_M	O95477	74.73	915.0	1119.0	DB01599	approved; investigational	Probucol	CC(C)(C)c1cc(cc(c1O)C(C)(C)C)SC(C)(C)Sc2cc(C(C)(C)C)c(O)c(c2)C(C)(C)C
7670	tr|P72047|P72047_M	O95477	76.56	1927.0	2136.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
7671	tr|P72047|P72047_M	O95477	76.56	1927.0	2136.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
7672	tr|P72047|P72047_M	O95477	76.56	1927.0	2136.0	DB01599	approved; investigational	Probucol	CC(C)(C)c1cc(cc(c1O)C(C)(C)C)SC(C)(C)Sc2cc(C(C)(C)C)c(O)c(c2)C(C)(C)C
7673	tr|P72047|P72047_M	P45844	75.46	100.0	306.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
7674	tr|P72047|P72047_M	Q9UNQ0	79.49	61.0	278.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
7675	tr|P72047|P72047_M	Q9UNQ0	79.49	61.0	278.0	DB11995	approved; investigational	Avatrombopag	OC(=O)C1CCN(CC1)c2c(Cl)cc(cn2)C(=O)Nc3nc(-c4cc(Cl)cs4)c(s3)N5CCN(CC5)C6CCCCC6
7676	tr|P72047|P72047_M	A0A0T9AZ62	74.73	222.0	426.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
7677	tr|O53764|O53764_M	P46597	95.28	13.0	336.0	DB01065	approved; nutraceutical; vet_approved	Melatonin	COc(cc1)cc(c12)c(c[nH]2)CCNC(=O)C
7678	tr|O53764|O53764_M	Q06528	93.22	19.0	335.0	DB01752	experimental	S-adenosyl-L-homocysteine	OC(=O)[C@@H](N)CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
7679	tr|O53764|O53764_M	Q06528	93.22	19.0	335.0	DB03199	experimental	4-Methoxy-E-Rhodomycin T	O[C@H]1[C@@H](N(C)C)C[C@@H](O[C@H]1C)O[C@H]2C[C@](O)(CC)[C@H](C(=O)OC)c(c23)c(O)c4c(c3O)C(=O)c5c(C4=O)cccc5OC
7680	tr|O53764|O53764_M	Q54527	91.45	22.0	332.0	DB01752	experimental	S-adenosyl-L-homocysteine	OC(=O)[C@@H](N)CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
7681	tr|O53764|O53764_M	Q54527	91.45	22.0	332.0	DB01910	experimental	Sinefungin	OC(=O)[C@@H](N)CC[C@H](N)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
7682	tr|O53764|O53764_M	Q54527	91.45	22.0	332.0	DB03219	experimental	11-Deoxy-Beta-Rhodomycin	O=C1CC[C@@H](O[C@@H]1C)O[C@H]2[C@H](C)O[C@H](C[C@@H]2O)O[C@@H]3[C@H](C)O[C@H](C[C@@H]3N(C)C)O[C@H]4C[C@](O)(CC)[C@H](O)c(c45)cc6c(c5O)C(=O)c7c(C6=O)cccc7O
7683	tr|P71913|P71913_M	P0A9J6	100.33	4.0	309.0	DB01936	experimental; investigational	alpha-D-arabinofuranose	OC[C@H]1O[C@H](O)[C@@H](O)[C@@H]1O
7684	tr|P71913|P71913_M	P0A9J6	100.33	4.0	309.0	DB03909	experimental	Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate	OP(=O)(O)CP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
7685	tr|P71913|P71913_M	P0A9J6	100.33	4.0	309.0	DB04444	experimental	Tetrafluoroaluminate Ion	F[Al-](F)(F)F
7686	tr|P71913|P71913_M	P55263	82.89	101.0	353.0	DB00131	approved; investigational; nutraceutical	Adenosine phosphate	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
7687	tr|P71913|P71913_M	P55263	82.89	101.0	353.0	DB07173	experimental	7-(5-DEOXY-BETA-D-RIBOFURANOSYL)-5-IODO-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE	C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cc(I)c(c23)c(N)ncn3
7688	tr|P71913|P71913_M	P55263	82.89	101.0	353.0	DB07280	experimental	5-[4-(DIMETHYLAMINO)PHENYL]-6-[(6-MORPHOLIN-4-YLPYRIDIN-3-YL)ETHYNYL]PYRIMIDIN-4-AMINE	CN(C)c1ccc(cc1)-c2c(ncnc2N)C#Cc3ccc(nc3)N4CCOCC4
7689	tr|P71913|P71913_M	Q8ZKR2	95.07	21.0	310.0	DB03909	experimental	Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate	OP(=O)(O)CP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
7690	tr|P71913|P71913_M	Q8ZKR2	95.07	21.0	310.0	DB04568	experimental	5-Aminoimidazole Ribonucleoside	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cncc2N
7691	tr|O86353|O86353_M	P0A115	93.25	5.0	226.0	DB01973	experimental	O-Benzylsulfonyl-Serine	OC(=O)[C@@H](N)COS(=O)(=O)Cc1ccccc1
7692	tr|O86353|O86353_M	P0A115	93.25	5.0	226.0	DB02153	experimental	3-sulfino-L-alanine	OC(=O)[C@@H](N)C[S@](=O)O
7693	tr|L7N6B9|L7N6B9_M	P30825	93.09	40.0	444.0	DB00123	approved; nutraceutical	L-Lysine	NCCCC[C@H](N)C(=O)O
7694	tr|L7N6B9|L7N6B9_M	P30825	93.09	40.0	444.0	DB00125	investigational; nutraceutical	Arginine	OC(=O)[C@@H](N)CCCNC(N)=N
7695	tr|L7N6B9|L7N6B9_M	P30825	93.09	40.0	444.0	DB00129	approved; nutraceutical	Ornithine	NCCC[C@H](N)C(=O)O
7696	tr|L7N6B9|L7N6B9_M	P52569	90.78	42.0	436.0	DB00123	approved; nutraceutical	L-Lysine	NCCCC[C@H](N)C(=O)O
7697	tr|L7N6B9|L7N6B9_M	P52569	90.78	42.0	436.0	DB00129	approved; nutraceutical	Ornithine	NCCC[C@H](N)C(=O)O
7698	tr|L7N6B9|L7N6B9_M	Q8WY07	91.24	40.0	436.0	DB00123	approved; nutraceutical	L-Lysine	NCCCC[C@H](N)C(=O)O
7699	tr|L7N6B9|L7N6B9_M	Q8WY07	91.24	40.0	436.0	DB00125	investigational; nutraceutical	Arginine	OC(=O)[C@@H](N)CCCNC(N)=N
7700	tr|L7N6B9|L7N6B9_M	Q8WY07	91.24	40.0	436.0	DB13146	approved	Fluciclovine (18F)	OC(=O)[C@]1(N)C[C@H]([18F])C1
7701	tr|L7N6B9|L7N6B9_M	Q9UPY5	89.63	52.0	441.0	DB00138	approved; nutraceutical	Cystine	OC(=O)[C@@H](N)CSSC[C@H](N)C(=O)O
7702	tr|L7N6B9|L7N6B9_M	Q9UPY5	89.63	52.0	441.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
7703	tr|L7N6B9|L7N6B9_M	Q9UPY5	89.63	52.0	441.0	DB00740	approved; investigational	Riluzole	Nc(s1)nc(c12)ccc(c2)OC(F)(F)F
7704	tr|L7N6B9|L7N6B9_M	Q9UPY5	89.63	52.0	441.0	DB00795	approved	Sulfasalazine	OC(=O)c1cc(ccc1O)/N=N/c2ccc(cc2)S(=O)(=O)Nc3ncccc3
7705	tr|L7N6B9|L7N6B9_M	Q9UPY5	89.63	52.0	441.0	DB06151	approved; investigational	Acetylcysteine	CC(=O)N[C@@H](CS)C(=O)O
7706	tr|L7N6B9|L7N6B9_M	Q9UPY5	89.63	52.0	441.0	DB11590	approved	Thimerosal	CC[Hg]Sc1ccccc1C([O-])=O
7707	tr|L7N6B9|L7N6B9_M	Q9UHI5	88.25	48.0	431.0	DB00120	approved; investigational; nutraceutical	Phenylalanine	OC(=O)[C@@H](N)Cc1ccccc1
7708	tr|L7N6B9|L7N6B9_M	Q9UHI5	88.25	48.0	431.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
7709	tr|L7N6B9|L7N6B9_M	Q9UM01	89.63	45.0	434.0	DB13146	approved	Fluciclovine (18F)	OC(=O)[C@]1(N)C[C@H]([18F])C1
7710	tr|L7N6B9|L7N6B9_M	O43246	86.64	44.0	420.0	DB00123	approved; nutraceutical	L-Lysine	NCCCC[C@H](N)C(=O)O
7711	tr|L7N6B9|L7N6B9_M	O43246	86.64	44.0	420.0	DB00125	investigational; nutraceutical	Arginine	OC(=O)[C@@H](N)CCCNC(N)=N
7712	tr|L7N6B9|L7N6B9_M	P60063	88.02	17.0	399.0	DB02451	experimental	B-nonylglucoside	CCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
7713	tr|I6XFT2|I6XFT2_M	P06632	80.36	218.0	263.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
7714	tr|I6XFT2|I6XFT2_M	O60218	71.43	249.0	289.0	DB00605	approved; investigational	Sulindac	c1cc(F)cc(c12)C(CC(=O)O)=C(C)/C2=C/c3ccc(cc3)S(=O)C
7715	tr|I6XFT2|I6XFT2_M	O60218	71.43	249.0	289.0	DB02021	experimental	Fidarestat	NC(=O)[C@H](C1)Oc(ccc(F)c2)c2[C@@]13NC(=O)NC3=O
7716	tr|I6XFT2|I6XFT2_M	O60218	71.43	249.0	289.0	DB02383	withdrawn	Tolrestat	COc(cc1)c(C(F)(F)F)c(c12)cccc2C(=S)N(C)CC(=O)O
7717	tr|I6XFT2|I6XFT2_M	O60218	71.43	249.0	289.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
7718	tr|I6XFT2|I6XFT2_M	O60218	71.43	249.0	289.0	DB06246	investigational	Exisulind	c1cc(F)cc(c12)C(CC(=O)O)=C(C)/C2=C/c3ccc(cc3)S(=O)(=O)C
7719	tr|I6XFT2|I6XFT2_M	O60218	71.43	249.0	289.0	DB08772	experimental	Zopolrestat	c1cccc(c12)c(=O)n(nc2CC(=O)O)Cc(s3)nc(c34)cc(C(F)(F)F)cc4
7720	tr|I6XFT2|I6XFT2_M	P51857	73.21	259.0	300.0	DB00548	approved	Azelaic acid	OC(=O)CCCCCCCC(=O)O
7721	tr|I6XFT2|I6XFT2_M	P51857	73.21	259.0	300.0	DB01216	approved	Finasteride	CC(C)(C)NC(=O)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)NC(=O)C=C4
7722	tr|I6XFT2|I6XFT2_M	P51857	73.21	259.0	300.0	DB07447	experimental	5beta-dihydrotestosterone	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](CC3)CC(=O)CC4
7723	tr|I6XFT2|I6XFT2_M	P51857	73.21	259.0	300.0	DB07557	experimental	3,20-Pregnanedione	CC(=O)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](CC3)CC(=O)CC4
7724	tr|I6XFT2|I6XFT2_M	Q04828	71.43	257.0	297.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
7725	tr|I6XFT2|I6XFT2_M	Q04828	71.43	257.0	297.0	DB00936	approved; investigational; vet_approved	Salicylic acid	OC(=O)c1ccccc1O
7726	tr|I6XFT2|I6XFT2_M	Q04828	71.43	257.0	297.0	DB00945	approved; vet_approved	Acetylsalicylic acid	CC(=O)Oc1ccccc1C(=O)O
7727	tr|I6XFT2|I6XFT2_M	Q04828	71.43	257.0	297.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
7728	tr|I6XFT2|I6XFT2_M	Q04828	71.43	257.0	297.0	DB03467	experimental	Naringenin	Oc1ccc(cc1)[C@@H](O2)CC(=O)c(c23)c(O)cc(c3)O
7729	tr|I6XFT2|I6XFT2_M	Q04828	71.43	257.0	297.0	DB04674	experimental	2-HYDROXY-3,5-DIIODOBENZOIC ACID	OC(=O)c1c(O)c(I)cc(I)c1
7730	tr|I6XFT2|I6XFT2_M	Q04828	71.43	257.0	297.0	DB07768	experimental	Epitestosterone	O[C@@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
7731	tr|I6XFT2|I6XFT2_M	Q04828	71.43	257.0	297.0	DB07931	withdrawn	Hexestrol	Oc1ccc(cc1)[C@H](CC)[C@H](CC)c2ccc(O)cc2
7732	tr|I6XFT2|I6XFT2_M	P52895	71.43	257.0	297.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
7733	tr|I6XFT2|I6XFT2_M	P52895	71.43	257.0	297.0	DB01586	approved; investigational	Ursodeoxycholic acid	OC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](C[C@@H]3O)C[C@H](O)CC4
7734	tr|I6XFT2|I6XFT2_M	P52895	71.43	257.0	297.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
7735	tr|I6XFT2|I6XFT2_M	P52895	71.43	257.0	297.0	DB06777	approved	Chenodeoxycholic acid	OC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
7736	tr|I6XFT2|I6XFT2_M	P52895	71.43	257.0	297.0	DB07768	experimental	Epitestosterone	O[C@@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
7737	tr|I6XFT2|I6XFT2_M	P42330	71.43	257.0	297.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
7738	tr|I6XFT2|I6XFT2_M	P42330	71.43	257.0	297.0	DB00328	approved; investigational	Indomethacin	COc(cc1)cc(c12)c(CC(=O)O)c(C)n2C(=O)c3ccc(Cl)cc3
7739	tr|I6XFT2|I6XFT2_M	P42330	71.43	257.0	297.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
7740	tr|I6XFT2|I6XFT2_M	P42330	71.43	257.0	297.0	DB01698	approved; experimental; investigational	Rutin	O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O[C@H]1C)OC[C@H]2O[C@H]([C@H](O)[C@@H](O)[C@@H]2O)Oc(c3=O)c(-c4cc(O)c(O)cc4)oc(c35)cc(O)cc5O
7741	tr|I6XFT2|I6XFT2_M	P42330	71.43	257.0	297.0	DB02056	investigational	Prostaglandin D2	CCCCC[C@H](O)/C=C/[C@H]1C(=O)C[C@H](O)[C@@H]1C/C=C\CCCC(=O)O
7742	tr|I6XFT2|I6XFT2_M	P42330	71.43	257.0	297.0	DB02266	approved	Flufenamic acid	OC(=O)c1ccccc1Nc2cc(C(F)(F)F)ccc2
7743	tr|I6XFT2|I6XFT2_M	P42330	71.43	257.0	297.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
7744	tr|I6XFT2|I6XFT2_M	P42330	71.43	257.0	297.0	DB07700	experimental	3-carboxamido-1,3,5(10)-estratrien-17(R)-spiro-2'(5',5'-dimethyl-6'oxo)tetrahydropyran	C1CC(C)(C)C(=O)O[C@@]12[C@]3(C)[C@@H](CC2)[C@H]4[C@H](CC3)c5c(CC4)cc(cc5)C(=O)N
7745	tr|I6XFT2|I6XFT2_M	Q9GV41	73.21	216.0	257.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
7746	tr|I6XFT2|I6XFT2_M	Q9GV41	73.21	216.0	257.0	DB04272	approved; nutraceutical; vet_approved	Citric acid	OC(=O)CC(O)(C(=O)O)CC(=O)O
7747	tr|O53926|O53926_M	Q72JJ3	94.91	24.0	378.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
7748	tr|O53926|O53926_M	P11310	95.44	58.0	414.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
7749	tr|O53926|O53926_M	P11310	95.44	58.0	414.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
7750	tr|O53926|O53926_M	P11310	95.44	58.0	414.0	DB03415	experimental	3-thiaoctanoyl-CoA	CCCCCSCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
7751	tr|O53926|O53926_M	P16219	93.3	57.0	405.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
7752	tr|O53926|O53926_M	P16219	93.3	57.0	405.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
7753	tr|O53926|O53926_M	P16219	93.3	57.0	405.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
7754	tr|O53926|O53926_M	Q9UKU7	93.83	61.0	411.0	DB01675	experimental	Methacrylyl-Coenzyme A	CC(=C)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
7755	tr|O53926|O53926_M	Q9UKU7	93.83	61.0	411.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
7756	tr|O53926|O53926_M	Q06319	94.91	26.0	380.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
7757	tr|O53926|O53926_M	Q06319	94.91	26.0	380.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
7758	tr|O53926|O53926_M	P26440	95.71	61.0	418.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
7759	tr|O53926|O53926_M	P26440	95.71	61.0	418.0	DB04036	experimental	Coenzyme A persulfide	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSS
7760	tr|O53926|O53926_M	P45954	94.1	77.0	428.0	DB00167	investigational; nutraceutical	Isoleucine	CC[C@H](C)[C@H](N)C(=O)O
7761	tr|O53926|O53926_M	P45954	94.1	77.0	428.0	DB00313	approved; investigational	Valproic acid	CCCC(C(=O)O)CCC
7762	tr|O53926|O53926_M	Q3JP94	94.64	41.0	394.0	DB08685	experimental	1-(1,4-dimethyl-1,2,3,4-tetrahydroquinoxalin-6-yl)methanamine	CN1CCN(C)c(c12)cc(cc2)CN
7763	tr|O53926|O53926_M	Q92947	93.03	87.0	434.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
7764	tr|O53926|O53926_M	Q92947	93.03	87.0	434.0	DB03245	experimental	S-4-Nitrobutyryl-CoA	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCC[N+]([O-])=O
7765	tr|O53926|O53926_M	Q9KIE5	94.64	9.0	362.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
7766	tr|O53926|O53926_M	Q15067	88.47	103.0	433.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
7767	tr|O53926|O53926_M	Q15067	88.47	103.0	433.0	DB07930	experimental	(3R)-3-HYDROXYDODECANOIC ACID	OC(=O)C[C@H](O)CCCCCCCCC
7768	tr|O53670|O53670_M	P00363	86.38	5.0	563.0	DB00730	approved; vet_approved	Thiabendazole	c1scnc1-c(n2)[nH]c(c23)cccc3
7769	tr|O53670|O53670_M	P00363	86.38	5.0	563.0	DB07490	experimental	2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL	Clc1ccc(cc1)[C@@H](C)c2cc([N+]([O-])=O)cc([N+]([O-])=O)c2O
7770	tr|O53670|O53670_M	P00363	86.38	5.0	563.0	DB07918	experimental	2-heptyl-4-hydroxyquinoline N-oxide	CCCCCCCc(cc1O)[n+]([O-])c(c12)cccc2
7771	tr|O53670|O53670_M	P17412	87.31	2.0	566.0	DB07669	experimental	2,3-Dimethyl-1,4-naphthoquinone	O=C1C(C)=C(C)C(=O)c(c12)cccc2
7772	tr|I6Y4R2|I6Y4R2_M	Q72JJ3	95.64	5.0	378.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
7773	tr|I6Y4R2|I6Y4R2_M	Q9UKU7	95.13	40.0	411.0	DB01675	experimental	Methacrylyl-Coenzyme A	CC(=C)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
7774	tr|I6Y4R2|I6Y4R2_M	Q9UKU7	95.13	40.0	411.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
7775	tr|I6Y4R2|I6Y4R2_M	P11310	97.69	39.0	420.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
7776	tr|I6Y4R2|I6Y4R2_M	P11310	97.69	39.0	420.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
7777	tr|I6Y4R2|I6Y4R2_M	P11310	97.69	39.0	420.0	DB03415	experimental	3-thiaoctanoyl-CoA	CCCCCSCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
7778	tr|I6Y4R2|I6Y4R2_M	Q06319	96.67	3.0	380.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
7779	tr|I6Y4R2|I6Y4R2_M	Q06319	96.67	3.0	380.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
7780	tr|I6Y4R2|I6Y4R2_M	P16219	96.41	34.0	410.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
7781	tr|I6Y4R2|I6Y4R2_M	P16219	96.41	34.0	410.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
7782	tr|I6Y4R2|I6Y4R2_M	P16219	96.41	34.0	410.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
7783	tr|I6Y4R2|I6Y4R2_M	P45954	96.41	56.0	432.0	DB00167	investigational; nutraceutical	Isoleucine	CC[C@H](C)[C@H](N)C(=O)O
7784	tr|I6Y4R2|I6Y4R2_M	P45954	96.41	56.0	432.0	DB00313	approved; investigational	Valproic acid	CCCC(C(=O)O)CCC
7785	tr|I6Y4R2|I6Y4R2_M	P26440	97.44	42.0	422.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
7786	tr|I6Y4R2|I6Y4R2_M	P26440	97.44	42.0	422.0	DB04036	experimental	Coenzyme A persulfide	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSS
7787	tr|I6Y4R2|I6Y4R2_M	Q3JP94	95.13	18.0	389.0	DB08685	experimental	1-(1,4-dimethyl-1,2,3,4-tetrahydroquinoxalin-6-yl)methanamine	CN1CCN(C)c(c12)cc(cc2)CN
7788	tr|I6Y4R2|I6Y4R2_M	Q92947	94.62	60.0	429.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
7789	tr|I6Y4R2|I6Y4R2_M	Q92947	94.62	60.0	429.0	DB03245	experimental	S-4-Nitrobutyryl-CoA	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCC[N+]([O-])=O
7790	tr|I6Y4R2|I6Y4R2_M	Q9KIE5	89.49	12.0	361.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
7791	tr|I6Y4R2|I6Y4R2_M	Q15067	92.31	78.0	438.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
7792	tr|I6Y4R2|I6Y4R2_M	Q15067	92.31	78.0	438.0	DB07930	experimental	(3R)-3-HYDROXYDODECANOIC ACID	OC(=O)C[C@H](O)CCCCCCCCC
7793	tr|P96397|P96397_M	Q72JJ3	96.64	7.0	352.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
7794	tr|P96397|P96397_M	P16219	97.2	33.0	380.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
7795	tr|P96397|P96397_M	P16219	97.2	33.0	380.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
7796	tr|P96397|P96397_M	P16219	97.2	33.0	380.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
7797	tr|P96397|P96397_M	Q06319	98.32	4.0	355.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
7798	tr|P96397|P96397_M	Q06319	98.32	4.0	355.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
7799	tr|P96397|P96397_M	P11310	97.76	40.0	389.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
7800	tr|P96397|P96397_M	P11310	97.76	40.0	389.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
7801	tr|P96397|P96397_M	P11310	97.76	40.0	389.0	DB03415	experimental	3-thiaoctanoyl-CoA	CCCCCSCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
7802	tr|P96397|P96397_M	P45954	96.92	56.0	402.0	DB00167	investigational; nutraceutical	Isoleucine	CC[C@H](C)[C@H](N)C(=O)O
7803	tr|P96397|P96397_M	P45954	96.92	56.0	402.0	DB00313	approved; investigational	Valproic acid	CCCC(C(=O)O)CCC
7804	tr|P96397|P96397_M	P26440	98.6	40.0	392.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
7805	tr|P96397|P96397_M	P26440	98.6	40.0	392.0	DB04036	experimental	Coenzyme A persulfide	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSS
7806	tr|P96397|P96397_M	Q9UKU7	96.92	40.0	386.0	DB01675	experimental	Methacrylyl-Coenzyme A	CC(=C)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
7807	tr|P96397|P96397_M	Q9UKU7	96.92	40.0	386.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
7808	tr|P96397|P96397_M	Q3JP94	96.92	16.0	362.0	DB08685	experimental	1-(1,4-dimethyl-1,2,3,4-tetrahydroquinoxalin-6-yl)methanamine	CN1CCN(C)c(c12)cc(cc2)CN
7809	tr|P96397|P96397_M	Q92947	96.36	58.0	402.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
7810	tr|P96397|P96397_M	Q92947	96.36	58.0	402.0	DB03245	experimental	S-4-Nitrobutyryl-CoA	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCC[N+]([O-])=O
7811	tr|P96397|P96397_M	Q9KIE5	89.64	15.0	335.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
7812	tr|O33189|O33189_M	P08183	85.1	404.0	621.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
7813	tr|O33189|O33189_M	P08183	85.1	404.0	621.0	DB00603	approved; investigational	Medroxyprogesterone acetate	CC(=O)O[C@]1(C(=O)C)CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C([C@H](C3)C)=CC(=O)CC4
7814	tr|O33189|O33189_M	P08183	85.1	404.0	621.0	DB00778	approved; investigational; withdrawn	Roxithromycin	COCCOCO/N=C([C@H](C)[C@@H](O)[C@]1(C)O)/[C@H](C)C[C@@](C)(O)[C@@H]([C@@H](C)[C@@H]([C@@H](C)C(=O)O[C@@H]1CC)O[C@@H](C[C@@]2(C)OC)O[C@@H](C)[C@@H]2O)O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C
7815	tr|O33189|O33189_M	P08183	85.1	404.0	621.0	DB00813	approved; illicit; investigational; vet_approved	Fentanyl	c1ccccc1N(C(=O)CC)C2CCN(CC2)CCc3ccccc3
7816	tr|O33189|O33189_M	P08183	85.1	404.0	621.0	DB04877	experimental	Voacamine	CC[C@H]1C[C@@H](C2)CN([C@@H]1[C@@]23C(=O)OC)CCc4c3[nH]c5c4cc(OC)c(c5)[C@@H](C[C@H]67)c8c(c9c([nH]8)cccc9)C[C@H](C6C(=O)OC)N(C)CC\7=C\C
7817	tr|O33189|O33189_M	P08183	85.1	404.0	621.0	DB04881	investigational	Elacridar	COc1cccc(c12)c(=O)c3c([nH]2)c(ccc3)C(=O)Nc4ccc(cc4)CCN(C5)CCc(c56)cc(OC)c(c6)OC
7818	tr|O33189|O33189_M	P08183	85.1	404.0	621.0	DB04905	investigational	Tesmilifene	CCN(CC)CCOc1ccc(cc1)Cc2ccccc2
7819	tr|O33189|O33189_M	P08183	85.1	404.0	621.0	DB05449	investigational	FM-VP4	 
7820	tr|O33189|O33189_M	P08183	85.1	404.0	621.0	DB06191	investigational	Zosuquidar	FC1(F)[C@H]2[C@@H]1c(cccc3)c3[C@@H](c(c24)cccc4)N5CCN(CC5)C[C@@H](O)COc6cccc(c67)nccc7
7821	tr|O33189|O33189_M	P08183	85.1	404.0	621.0	DB06240	investigational	Tariquidar	COc(c1)c(OC)cc(c12)CCN(C2)CCc3ccc(cc3)NC(=O)c4cc(OC)c(OC)cc4NC(=O)c(c5)cnc(c56)cccc6
7822	tr|O33189|O33189_M	P08183	85.1	404.0	621.0	DB09031	approved; investigational	Miltefosine	CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C
7823	tr|O33189|O33189_M	P08183	85.1	404.0	621.0	DB11635	approved	Tocofersolan	 
7824	tr|O33189|O33189_M	P08183	85.1	404.0	621.0	DB14061	experimental	Hycanthone	CCN(CC)CCNc(ccc1CO)c(c12)c(=O)c3c(s2)cccc3
7825	tr|O33189|O33189_M	P08183	85.1	404.0	621.0	DB14062	experimental	Concanamycin A	NC(=O)O[C@@H]1[C@@H](C)O[C@H](C[C@H]1O)O[C@H](C2)[C@H](C)[C@@H](/C=C/C)O[C@@]2(O)[C@@H](C)[C@H](O)[C@H](C)[C@H]3OC(=O)/C(OC)=C/C(C)=C/[C@@H](C)[C@@H](O)[C@@H](CC)[C@@H](O)[C@H](C)C/C(C)=C/C=C/[C@@H]3OC
7826	tr|O33189|O33189_M	P08183	85.1	404.0	621.0	DB14063	experimental	Dexverapamil	COc1ccc(cc1OC)CCN(C)CCC[C@@](C#N)(C(C)C)c2cc(OC)c(OC)cc2
7827	tr|O33189|O33189_M	P08183	85.1	404.0	621.0	DB14064	experimental	Emopamil	c1ccccc1C(C#N)(C(C)C)CCCN(C)CCc2ccccc2
7828	tr|O33189|O33189_M	P08183	85.1	404.0	621.0	DB14065	experimental	Lomerizine	COc1ccc(c(OC)c1OC)CN2CCN(CC2)C(c3ccc(F)cc3)c4ccc(F)cc4
7829	tr|O33189|O33189_M	P08183	85.1	404.0	621.0	DB14066	experimental	Tetrandrine	c12ccc(OC)c(c1)Oc3ccc(cc3)C[C@H]4c5c(CCN4C)cc(OC)c(c5)Oc6c7c(CCN(C)[C@H]7C2)cc(OC)c6OC
7830	tr|O33189|O33189_M	P08183	85.1	404.0	621.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
7831	tr|O33189|O33189_M	P08183	85.1	404.0	621.0	DB14068	experimental	Dexniguldipine	[O-][N+](=O)c1cccc(c1)[C@@H]2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCCN(CC3)CCC3(c4ccccc4)c5ccccc5
7832	tr|O33189|O33189_M	P08183	85.1	404.0	621.0	DB14069	investigational	ONT-093	CCOC/C=C/c1ccc(cc1)-c2nc(-c3ccc(cc3)NC(C)C)c([nH]2)-c4ccc(cc4)NC(C)C
7833	tr|O33189|O33189_M	P08183	85.1	404.0	621.0	DB14070	experimental	HM-30181	c1cccc(c12)c(=O)cc(o2)C(=O)Nc3cc(OC)c(OC)cc3-c4nn(nn4)-c5ccc(cc5)CCN(C6)CCc(c67)cc(OC)c(c7)OC
7834	tr|O33189|O33189_M	P08183	85.1	404.0	621.0	DB14071	experimental	Desmethylsertraline	c1cccc(c12)[C@@H](CC[C@@H]2N)c3cc(Cl)c(Cl)cc3
7835	tr|O33189|O33189_M	P08183	85.1	404.0	621.0	DB14072	experimental	Reversin 121	c1ccccc1COC(=O)C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@H](C(=O)OC(C)(C)C)CCCCNC(=O)OCc2ccccc2
7836	tr|O33189|O33189_M	P08183	85.88	1051.0	1270.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
7837	tr|O33189|O33189_M	P08183	85.88	1051.0	1270.0	DB00603	approved; investigational	Medroxyprogesterone acetate	CC(=O)O[C@]1(C(=O)C)CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C([C@H](C3)C)=CC(=O)CC4
7838	tr|O33189|O33189_M	P08183	85.88	1051.0	1270.0	DB00778	approved; investigational; withdrawn	Roxithromycin	COCCOCO/N=C([C@H](C)[C@@H](O)[C@]1(C)O)/[C@H](C)C[C@@](C)(O)[C@@H]([C@@H](C)[C@@H]([C@@H](C)C(=O)O[C@@H]1CC)O[C@@H](C[C@@]2(C)OC)O[C@@H](C)[C@@H]2O)O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C
7839	tr|O33189|O33189_M	P08183	85.88	1051.0	1270.0	DB00813	approved; illicit; investigational; vet_approved	Fentanyl	c1ccccc1N(C(=O)CC)C2CCN(CC2)CCc3ccccc3
7840	tr|O33189|O33189_M	P08183	85.88	1051.0	1270.0	DB04877	experimental	Voacamine	CC[C@H]1C[C@@H](C2)CN([C@@H]1[C@@]23C(=O)OC)CCc4c3[nH]c5c4cc(OC)c(c5)[C@@H](C[C@H]67)c8c(c9c([nH]8)cccc9)C[C@H](C6C(=O)OC)N(C)CC\7=C\C
7841	tr|O33189|O33189_M	P08183	85.88	1051.0	1270.0	DB04881	investigational	Elacridar	COc1cccc(c12)c(=O)c3c([nH]2)c(ccc3)C(=O)Nc4ccc(cc4)CCN(C5)CCc(c56)cc(OC)c(c6)OC
7842	tr|O33189|O33189_M	P08183	85.88	1051.0	1270.0	DB04905	investigational	Tesmilifene	CCN(CC)CCOc1ccc(cc1)Cc2ccccc2
7843	tr|O33189|O33189_M	P08183	85.88	1051.0	1270.0	DB05449	investigational	FM-VP4	 
7844	tr|O33189|O33189_M	P08183	85.88	1051.0	1270.0	DB06191	investigational	Zosuquidar	FC1(F)[C@H]2[C@@H]1c(cccc3)c3[C@@H](c(c24)cccc4)N5CCN(CC5)C[C@@H](O)COc6cccc(c67)nccc7
7845	tr|O33189|O33189_M	P08183	85.88	1051.0	1270.0	DB06240	investigational	Tariquidar	COc(c1)c(OC)cc(c12)CCN(C2)CCc3ccc(cc3)NC(=O)c4cc(OC)c(OC)cc4NC(=O)c(c5)cnc(c56)cccc6
7846	tr|O33189|O33189_M	P08183	85.88	1051.0	1270.0	DB09031	approved; investigational	Miltefosine	CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C
7847	tr|O33189|O33189_M	P08183	85.88	1051.0	1270.0	DB11635	approved	Tocofersolan	 
7848	tr|O33189|O33189_M	P08183	85.88	1051.0	1270.0	DB14061	experimental	Hycanthone	CCN(CC)CCNc(ccc1CO)c(c12)c(=O)c3c(s2)cccc3
7849	tr|O33189|O33189_M	P08183	85.88	1051.0	1270.0	DB14062	experimental	Concanamycin A	NC(=O)O[C@@H]1[C@@H](C)O[C@H](C[C@H]1O)O[C@H](C2)[C@H](C)[C@@H](/C=C/C)O[C@@]2(O)[C@@H](C)[C@H](O)[C@H](C)[C@H]3OC(=O)/C(OC)=C/C(C)=C/[C@@H](C)[C@@H](O)[C@@H](CC)[C@@H](O)[C@H](C)C/C(C)=C/C=C/[C@@H]3OC
7850	tr|O33189|O33189_M	P08183	85.88	1051.0	1270.0	DB14063	experimental	Dexverapamil	COc1ccc(cc1OC)CCN(C)CCC[C@@](C#N)(C(C)C)c2cc(OC)c(OC)cc2
7851	tr|O33189|O33189_M	P08183	85.88	1051.0	1270.0	DB14064	experimental	Emopamil	c1ccccc1C(C#N)(C(C)C)CCCN(C)CCc2ccccc2
7852	tr|O33189|O33189_M	P08183	85.88	1051.0	1270.0	DB14065	experimental	Lomerizine	COc1ccc(c(OC)c1OC)CN2CCN(CC2)C(c3ccc(F)cc3)c4ccc(F)cc4
7853	tr|O33189|O33189_M	P08183	85.88	1051.0	1270.0	DB14066	experimental	Tetrandrine	c12ccc(OC)c(c1)Oc3ccc(cc3)C[C@H]4c5c(CCN4C)cc(OC)c(c5)Oc6c7c(CCN(C)[C@H]7C2)cc(OC)c6OC
7854	tr|O33189|O33189_M	P08183	85.88	1051.0	1270.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
7855	tr|O33189|O33189_M	P08183	85.88	1051.0	1270.0	DB14068	experimental	Dexniguldipine	[O-][N+](=O)c1cccc(c1)[C@@H]2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCCN(CC3)CCC3(c4ccccc4)c5ccccc5
7856	tr|O33189|O33189_M	P08183	85.88	1051.0	1270.0	DB14069	investigational	ONT-093	CCOC/C=C/c1ccc(cc1)-c2nc(-c3ccc(cc3)NC(C)C)c([nH]2)-c4ccc(cc4)NC(C)C
7857	tr|O33189|O33189_M	P08183	85.88	1051.0	1270.0	DB14070	experimental	HM-30181	c1cccc(c12)c(=O)cc(o2)C(=O)Nc3cc(OC)c(OC)cc3-c4nn(nn4)-c5ccc(cc5)CCN(C6)CCc(c67)cc(OC)c(c7)OC
7858	tr|O33189|O33189_M	P08183	85.88	1051.0	1270.0	DB14071	experimental	Desmethylsertraline	c1cccc(c12)[C@@H](CC[C@@H]2N)c3cc(Cl)c(Cl)cc3
7859	tr|O33189|O33189_M	P08183	85.88	1051.0	1270.0	DB14072	experimental	Reversin 121	c1ccccc1COC(=O)C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@H](C(=O)OC(C)(C)C)CCCCNC(=O)OCc2ccccc2
7860	tr|O33189|O33189_M	O95342	84.31	434.0	649.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
7861	tr|O33189|O33189_M	O95342	84.31	434.0	649.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
7862	tr|O33189|O33189_M	O95342	85.49	1091.0	1309.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
7863	tr|O33189|O33189_M	O95342	85.49	1091.0	1309.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
7864	tr|O33189|O33189_M	Q2M3G0	83.92	401.0	615.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
7865	tr|O33189|O33189_M	Q2M3G0	83.92	401.0	615.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
7866	tr|O33189|O33189_M	Q2M3G0	84.31	1031.0	1246.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
7867	tr|O33189|O33189_M	Q2M3G0	84.31	1031.0	1246.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
7868	tr|O33189|O33189_M	O15440	78.82	574.0	775.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
7869	tr|O33189|O33189_M	O15440	78.82	574.0	775.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
7870	tr|O33189|O33189_M	O15440	86.67	1198.0	1419.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
7871	tr|O33189|O33189_M	O15440	86.67	1198.0	1419.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
7872	tr|O33189|O33189_M	P33527	85.1	649.0	866.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
7873	tr|O33189|O33189_M	P33527	85.1	649.0	866.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
7874	tr|O33189|O33189_M	P33527	85.1	649.0	866.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
7875	tr|O33189|O33189_M	P33527	85.1	649.0	866.0	DB06176	approved; investigational	Romidepsin	O=C([C@H]12)N/C(=C\C)C(=O)N[C@@H](C(C)C)C(=O)O[C@@H](CC(=O)N[C@H](C(C)C)C(=O)N1)/C=C/CCSSC2
7876	tr|O33189|O33189_M	P33527	85.1	649.0	866.0	DB08855	experimental; investigational	Leukotriene C4	CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@@H](O)CCCC(=O)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@H](N)C(=O)O
7877	tr|O33189|O33189_M	P33527	87.84	1300.0	1524.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
7878	tr|O33189|O33189_M	P33527	87.84	1300.0	1524.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
7879	tr|O33189|O33189_M	P33527	87.84	1300.0	1524.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
7880	tr|O33189|O33189_M	P33527	87.84	1300.0	1524.0	DB06176	approved; investigational	Romidepsin	O=C([C@H]12)N/C(=C\C)C(=O)N[C@@H](C(C)C)C(=O)O[C@@H](CC(=O)N[C@H](C(C)C)C(=O)N1)/C=C/CCSSC2
7881	tr|O33189|O33189_M	P33527	87.84	1300.0	1524.0	DB08855	experimental; investigational	Leukotriene C4	CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@@H](O)CCCC(=O)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@H](N)C(=O)O
7882	tr|O33189|O33189_M	Q09428	89.8	694.0	923.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
7883	tr|O33189|O33189_M	Q09428	89.8	694.0	923.0	DB00222	approved	Glimepiride	CCC1=C(C)CN(C1=O)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3
7884	tr|O33189|O33189_M	Q09428	89.8	694.0	923.0	DB00672	approved; investigational	Chlorpropamide	CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1
7885	tr|O33189|O33189_M	Q09428	89.8	694.0	923.0	DB00731	approved; investigational	Nateglinide	CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](C(=O)O)Cc2ccccc2
7886	tr|O33189|O33189_M	Q09428	89.8	694.0	923.0	DB00912	approved; investigational	Repaglinide	CCOc1c(C(=O)O)ccc(c1)CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3
7887	tr|O33189|O33189_M	Q09428	89.8	694.0	923.0	DB01067	approved; investigational	Glipizide	Cc1ncc(nc1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
7888	tr|O33189|O33189_M	Q09428	89.8	694.0	923.0	DB01120	approved	Gliclazide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN(C2)CC(C23)CCC3
7889	tr|O33189|O33189_M	Q09428	89.8	694.0	923.0	DB01124	approved; investigational	Tolbutamide	CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1
7890	tr|O33189|O33189_M	Q09428	89.8	694.0	923.0	DB01251	approved; investigational	Gliquidone	COc(cc1)cc(c12)C(=O)N(C(=O)C2(C)C)CCc3ccc(cc3)S(=O)(=O)NC(=O)NC4CCCCC4
7891	tr|O33189|O33189_M	Q09428	89.8	694.0	923.0	DB01252	investigational	Mitiglinide	c1ccccc1C[C@H](C(=O)O)CC(=O)N(C2)C[C@H]([C@H]23)CCCC3
7892	tr|O33189|O33189_M	Q09428	89.8	694.0	923.0	DB01382	approved; investigational	Glymidine	COCCOc1cnc(nc1)NS(=O)(=O)c2ccccc2
7893	tr|O33189|O33189_M	Q09428	90.59	1348.0	1579.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
7894	tr|O33189|O33189_M	Q09428	90.59	1348.0	1579.0	DB00222	approved	Glimepiride	CCC1=C(C)CN(C1=O)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3
7895	tr|O33189|O33189_M	Q09428	90.59	1348.0	1579.0	DB00672	approved; investigational	Chlorpropamide	CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1
7896	tr|O33189|O33189_M	Q09428	90.59	1348.0	1579.0	DB00731	approved; investigational	Nateglinide	CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](C(=O)O)Cc2ccccc2
7897	tr|O33189|O33189_M	Q09428	90.59	1348.0	1579.0	DB00912	approved; investigational	Repaglinide	CCOc1c(C(=O)O)ccc(c1)CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3
7898	tr|O33189|O33189_M	Q09428	90.59	1348.0	1579.0	DB01067	approved; investigational	Glipizide	Cc1ncc(nc1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
7899	tr|O33189|O33189_M	Q09428	90.59	1348.0	1579.0	DB01120	approved	Gliclazide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN(C2)CC(C23)CCC3
7900	tr|O33189|O33189_M	Q09428	90.59	1348.0	1579.0	DB01124	approved; investigational	Tolbutamide	CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1
7901	tr|O33189|O33189_M	Q09428	90.59	1348.0	1579.0	DB01251	approved; investigational	Gliquidone	COc(cc1)cc(c12)C(=O)N(C(=O)C2(C)C)CCc3ccc(cc3)S(=O)(=O)NC(=O)NC4CCCCC4
7902	tr|O33189|O33189_M	Q09428	90.59	1348.0	1579.0	DB01252	investigational	Mitiglinide	c1ccccc1C[C@H](C(=O)O)CC(=O)N(C2)C[C@H]([C@H]23)CCCC3
7903	tr|O33189|O33189_M	Q09428	90.59	1348.0	1579.0	DB01382	approved; investigational	Glymidine	COCCOc1cnc(nc1)NS(=O)(=O)c2ccccc2
7904	tr|O33189|O33189_M	Q09428	89.8	694.0	923.0	DB00839	approved; investigational	Tolazamide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2
7905	tr|O33189|O33189_M	Q09428	89.8	694.0	923.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
7906	tr|O33189|O33189_M	Q09428	90.59	1348.0	1579.0	DB00839	approved; investigational	Tolazamide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2
7907	tr|O33189|O33189_M	Q09428	90.59	1348.0	1579.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
7908	tr|O33189|O33189_M	O60706	86.67	686.0	907.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
7909	tr|O33189|O33189_M	O60706	86.67	686.0	907.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
7910	tr|O33189|O33189_M	O60706	86.67	686.0	907.0	DB09220	approved; investigational	Nicorandil	[O-][N+](=O)OCCNC(=O)c1cccnc1
7911	tr|O33189|O33189_M	O60706	86.27	1318.0	1538.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
7912	tr|O33189|O33189_M	O60706	86.27	1318.0	1538.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
7913	tr|O33189|O33189_M	O60706	86.27	1318.0	1538.0	DB09220	approved; investigational	Nicorandil	[O-][N+](=O)OCCNC(=O)c1cccnc1
7914	tr|O33189|O33189_M	Q92887	81.18	647.0	854.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
7915	tr|O33189|O33189_M	Q92887	81.18	647.0	854.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
7916	tr|O33189|O33189_M	Q92887	86.67	1305.0	1526.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
7917	tr|O33189|O33189_M	Q92887	86.67	1305.0	1526.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
7918	tr|O33189|O33189_M	O15439	85.49	405.0	623.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
7919	tr|O33189|O33189_M	O15439	92.16	1040.0	1275.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
7920	tr|O33189|O33189_M	O95255	86.67	625.0	846.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
7921	tr|O33189|O33189_M	O95255	86.27	1272.0	1492.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
7922	tr|O33189|O33189_M	P13569	77.65	438.0	636.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
7923	tr|O33189|O33189_M	P13569	77.65	438.0	636.0	DB00887	approved	Bumetanide	CCCCNc1c(c(S(=O)(=O)N)cc(c1)C(=O)O)Oc2ccccc2
7924	tr|O33189|O33189_M	P13569	77.65	438.0	636.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
7925	tr|O33189|O33189_M	P13569	77.65	438.0	636.0	DB01050	approved	Ibuprofen	CC(C)Cc1ccc(cc1)C(C)C(=O)O
7926	tr|O33189|O33189_M	P13569	77.65	438.0	636.0	DB02587	experimental; investigational	Colforsin	O[C@H]1CCC(C)(C)[C@@H]([C@]12C)[C@H](O)[C@H](OC(=O)C)[C@]3(C)[C@]2(O)C(=O)C[C@](O3)(C)C=C
7927	tr|O33189|O33189_M	P13569	77.65	438.0	636.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
7928	tr|O33189|O33189_M	P13569	77.65	438.0	636.0	DB04522	experimental	Dexfosfoserine	OC(=O)[C@@H](N)COP(=O)(O)O
7929	tr|O33189|O33189_M	P13569	77.65	438.0	636.0	DB04941	approved	Crofelemer	 
7930	tr|O33189|O33189_M	P13569	77.65	438.0	636.0	DB06266	investigational	Lonidamine	c1cccc(c12)n(nc2C(=O)O)Cc3c(Cl)cc(Cl)cc3
7931	tr|O33189|O33189_M	P13569	77.65	438.0	636.0	DB08820	approved	Ivacaftor	CC(C)(C)c1cc(C(C)(C)C)c(O)cc1NC(=O)c(c2=O)c[nH]c(c23)cccc3
7932	tr|O33189|O33189_M	P13569	77.65	438.0	636.0	DB09213	approved; investigational	Dexibuprofen	CC(C)Cc1ccc(cc1)[C@H](C)C(=O)O
7933	tr|O33189|O33189_M	P13569	77.65	438.0	636.0	DB09280	approved	Lumacaftor	O=C(O)c1cccc(c1)-c2nc(ccc2C)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
7934	tr|O33189|O33189_M	P13569	77.65	438.0	636.0	DB11712	approved; investigational	Tezacaftor	OC[C@H](O)Cn1c(C(C)(C)CO)cc(c12)cc(c(F)c2)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
7935	tr|O33189|O33189_M	P13569	77.65	438.0	636.0	DB15444	approved; investigational	Elexacaftor	FC(F)(F)C(C)(C)COc1nn(cc1)-c2nc(N(C3(C)C)C[C@@H](C)C3)c(cc2)C(=O)NS(=O)(=O)c4cn(C)nc4C
7936	tr|O33189|O33189_M	P13569	92.16	1201.0	1436.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
7937	tr|O33189|O33189_M	P13569	92.16	1201.0	1436.0	DB00887	approved	Bumetanide	CCCCNc1c(c(S(=O)(=O)N)cc(c1)C(=O)O)Oc2ccccc2
7938	tr|O33189|O33189_M	P13569	92.16	1201.0	1436.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
7939	tr|O33189|O33189_M	P13569	92.16	1201.0	1436.0	DB01050	approved	Ibuprofen	CC(C)Cc1ccc(cc1)C(C)C(=O)O
7940	tr|O33189|O33189_M	P13569	92.16	1201.0	1436.0	DB02587	experimental; investigational	Colforsin	O[C@H]1CCC(C)(C)[C@@H]([C@]12C)[C@H](O)[C@H](OC(=O)C)[C@]3(C)[C@]2(O)C(=O)C[C@](O3)(C)C=C
7941	tr|O33189|O33189_M	P13569	92.16	1201.0	1436.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
7942	tr|O33189|O33189_M	P13569	92.16	1201.0	1436.0	DB04522	experimental	Dexfosfoserine	OC(=O)[C@@H](N)COP(=O)(O)O
7943	tr|O33189|O33189_M	P13569	92.16	1201.0	1436.0	DB04941	approved	Crofelemer	 
7944	tr|O33189|O33189_M	P13569	92.16	1201.0	1436.0	DB06266	investigational	Lonidamine	c1cccc(c12)n(nc2C(=O)O)Cc3c(Cl)cc(Cl)cc3
7945	tr|O33189|O33189_M	P13569	92.16	1201.0	1436.0	DB08820	approved	Ivacaftor	CC(C)(C)c1cc(C(C)(C)C)c(O)cc1NC(=O)c(c2=O)c[nH]c(c23)cccc3
7946	tr|O33189|O33189_M	P13569	92.16	1201.0	1436.0	DB09213	approved; investigational	Dexibuprofen	CC(C)Cc1ccc(cc1)[C@H](C)C(=O)O
7947	tr|O33189|O33189_M	P13569	92.16	1201.0	1436.0	DB09280	approved	Lumacaftor	O=C(O)c1cccc(c1)-c2nc(ccc2C)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
7948	tr|O33189|O33189_M	P13569	92.16	1201.0	1436.0	DB11712	approved; investigational	Tezacaftor	OC[C@H](O)Cn1c(C(C)(C)CO)cc(c12)cc(c(F)c2)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
7949	tr|O33189|O33189_M	P13569	92.16	1201.0	1436.0	DB15444	approved; investigational	Elexacaftor	FC(F)(F)C(C)(C)COc1nn(cc1)-c2nc(N(C3(C)C)C[C@@H](C)C3)c(cc2)C(=O)NS(=O)(=O)c4cn(C)nc4C
7950	tr|O33189|O33189_M	O95477	90.98	900.0	1132.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
7951	tr|O33189|O33189_M	O95477	90.98	900.0	1132.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
7952	tr|O33189|O33189_M	O95477	90.98	900.0	1132.0	DB01599	approved; investigational	Probucol	CC(C)(C)c1cc(cc(c1O)C(C)(C)C)SC(C)(C)Sc2cc(C(C)(C)C)c(O)c(c2)C(C)(C)C
7953	tr|O33189|O33189_M	O95477	92.16	1909.0	2144.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
7954	tr|O33189|O33189_M	O95477	92.16	1909.0	2144.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
7955	tr|O33189|O33189_M	O95477	92.16	1909.0	2144.0	DB01599	approved; investigational	Probucol	CC(C)(C)c1cc(cc(c1O)C(C)(C)C)SC(C)(C)Sc2cc(C(C)(C)C)c(O)c(c2)C(C)(C)C
7956	tr|O33189|O33189_M	P13568	97.65	390.0	639.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
7957	tr|O33189|O33189_M	P13568	70.59	1228.0	1408.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
7958	tr|O33189|O33189_M	P45844	81.96	95.0	304.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
7959	tr|O33189|O33189_M	Q9UNQ0	83.14	60.0	272.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
7960	tr|O33189|O33189_M	Q9UNQ0	83.14	60.0	272.0	DB11995	approved; investigational	Avatrombopag	OC(=O)C1CCN(CC1)c2c(Cl)cc(cn2)C(=O)Nc3nc(-c4cc(Cl)cs4)c(s3)N5CCN(CC5)C6CCCCC6
7961	tr|O33189|O33189_M	A0A0T9AZ62	80.39	222.0	427.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
7962	tr|O07233|O07233_M	Q6PHW0	84.3	90.0	278.0	DB03374	experimental	3,5-Diiodotyrosine	OC(=O)[C@@H](N)Cc1cc(I)c(O)c(I)c1
7963	tr|O07233|O07233_M	Q81EW9	80.72	6.0	186.0	DB03247	approved; investigational	Flavin mononucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)COP(=O)(O)O
7964	tr|O07233|O07233_M	Q60049	79.37	12.0	189.0	DB03247	approved; investigational	Flavin mononucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)COP(=O)(O)O
7965	tr|O07233|O07233_M	O25608	81.17	10.0	191.0	DB00916	approved	Metronidazole	Cc1ncc([N+]([O-])=O)n1CCO
7966	tr|O07233|O07233_M	P17117	73.54	6.0	170.0	DB00698	approved; vet_approved	Nitrofurantoin	[O-][N+](=O)c1ccc(o1)/C=N/N2CC(=O)NC2=O
7967	tr|O07233|O07233_M	P17117	73.54	6.0	170.0	DB03247	approved; investigational	Flavin mononucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)COP(=O)(O)O
7968	tr|O07233|O07233_M	Q8DW21	79.37	3.0	180.0	DB03247	approved; investigational	Flavin mononucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)COP(=O)(O)O
7970	tr|O07233|O07233_M	Q56691	73.54	5.0	169.0	DB03247	approved; investigational	Flavin mononucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)COP(=O)(O)O
7974	tr|P95291|P95291_M	P15555	98.65	2.0	368.0	DB00456	approved; investigational; vet_approved	Cefalotin	CC(=O)OCC(CS1)=C(C(=O)O)N([C@H]12)C(=O)[C@H]2NC(=O)Cc3cccs3
7975	tr|P95291|P95291_M	P15555	98.65	2.0	368.0	DB01786	experimental	D-Alanine	C[C@@H](N)C(=O)O
7976	tr|P95291|P95291_M	P15555	98.65	2.0	368.0	DB01868	experimental	Glycyl-L-a-Aminopimelyl-E-(D-2-Aminoethyl)Phosphonate	OP(=O)(O)[C@@H](C)/N=C(\[O-])CCCC[C@@H](C(=O)O)/N=C(\O)CN
7977	tr|P95291|P95291_M	P15555	98.65	2.0	368.0	DB02136	experimental	Cephalosporin analog	c1ccccc1CC(=O)N[C@H](C(=O)O)[C@@H]2NC(C(=O)O)=C(CS2)CC[C@H](NC(=O)CC[C@H](C(=O)O)NC(=O)C)C(=O)N[C@H](C)C(=O)N[C@H](C)C(=O)O
7978	tr|P95291|P95291_M	P15555	98.65	2.0	368.0	DB02514	experimental	(2Z)-3-{[Oxido(oxo)phosphoranyl]oxy}-2-phenylacrylate	O=P(=O)O/C=C(\C([O-])=O)c1ccccc1
7979	tr|P95291|P95291_M	P15555	98.65	2.0	368.0	DB02578	experimental	N-[(6S)-6-Carboxy-6-(glycylamino)hexanoyl]-D-alanyl-D-alanine	NCC(=O)N[C@H](C(=O)O)CCCCC(=O)N[C@H](C)C(=O)N[C@H](C)C(=O)O
7980	tr|P95291|P95291_M	P15555	98.65	2.0	368.0	DB03313	experimental	Cephalosporin C	CC(=O)OCC(=C1C(=O)O)CS[C@@H](N12)[C@@H](C2=O)NC(=O)CCC[C@@H](N)C(=O)O
7981	tr|P95291|P95291_M	P15555	98.65	2.0	368.0	DB03450	experimental	Cephalothin Group	COC(=O)CC1=C(C(=O)O)N[C@H](SC1)[C@@H](C=O)NC(=O)Cc2cccs2
7982	tr|P95291|P95291_M	P15555	98.65	2.0	368.0	DB03820	experimental	(2S,5R,6R)-6-({(6S)-6-[(Ammonioacetyl)amino]-6-carboxylatohexanoyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate	[NH3+]CC(=O)N[C@H](C([O-])=O)CCCCC(=O)N[C@@H]1C(=O)N([C@@H]12)[C@@H](C([O-])=O)C(S2)(C)C
7983	tr|P95291|P95291_M	P15555	98.65	2.0	368.0	DB03843	approved; vet_approved	Formaldehyde	C=O
7984	tr|P95291|P95291_M	P15555	98.65	2.0	368.0	DB03927	experimental	Glycyl-L-alpha-amino-epsilon-pimelyl-D-alanine	NCC(=O)N[C@H](C(=O)O)CCCCC(=O)N[C@H](C)C(=O)O
7985	tr|P95291|P95291_M	P15555	98.65	2.0	368.0	DB04340	experimental	2-[(Dioxidophosphoranyl)oxy]benzoate	[O-]C(=O)c1ccccc1OP([O-])=O
7986	tr|P95291|P95291_M	P15555	98.65	2.0	368.0	DB04488	experimental	(6S)-N-[(2S,3R,6R,7R)-3-(Acetyloxymethyl)-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]octan-7-yl]-6-[(2-aminoacetyl)amino]-7-hydroxy-7-oxoheptanimidate	CC(=O)OC[C@@H]([C@H]1C(=O)O)CS[C@@H](N12)[C@@H](C2=O)/N=C(\[O-])CCCC[C@@H](C(=O)O)NC(=O)CN
7987	tr|P95291|P95291_M	P05193	71.7	12.0	278.0	DB00355	approved	Aztreonam	[O-]S(=O)(=O)N1C(=O)[C@H]([C@@H]1C)NC(=O)/C(=N\OC(C)(C)C(=O)O)c2csc(n2)[NH3+]
7988	tr|P95291|P95291_M	P00811	70.89	12.0	275.0	DB00456	approved; investigational; vet_approved	Cefalotin	CC(=O)OCC(CS1)=C(C(=O)O)N([C@H]12)C(=O)[C@H]2NC(=O)Cc3cccs3
7989	tr|P95291|P95291_M	P00811	70.89	12.0	275.0	DB01147	approved; investigational; vet_approved	Cloxacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)c3c(C)onc3-c4ccccc4Cl
7990	tr|P95291|P95291_M	P00811	70.89	12.0	275.0	DB01896	experimental	M-Aminophenylboronic Acid	Nc1cccc(c1)B(O)O
7991	tr|P95291|P95291_M	P00811	70.89	12.0	275.0	DB02094	experimental	N-2-Thiophen-2-Yl-Acetamide Boronic Acid	OB(O)CNC(=O)Cc1cccs1
7992	tr|P95291|P95291_M	P00811	70.89	12.0	275.0	DB02247	experimental	Hydrolyzed Cephalothin	CC1=C(C(=O)O)N[C@@H](SC1)[C@@H](C(=O)O)NC(=O)Cc2cccs2
7993	tr|P95291|P95291_M	P00811	70.89	12.0	275.0	DB02503	experimental	4-(Carboxyvin-2-Yl)Phenylboronic Acid	OB(O)c1ccc(cc1)/C=C/C(=O)O
7994	tr|P95291|P95291_M	P00811	70.89	12.0	275.0	DB02588	experimental	(2R)-2-[(1R)-1-{[(2S)-2-Carboxy-2-(4-hydroxyphenyl)acetyl]amino}-1-methoxy-2-oxoethyl]-5-methylene-5,6-dihydro-2H-1,3-oxazine-4-carboxylic acid	OC(=O)C1=N[C@H](OCC1=C)C(C=O)(OC)NC(=O)[C@@H](C(=O)O)c2ccc(O)cc2
7995	tr|P95291|P95291_M	P00811	70.89	12.0	275.0	DB02627	experimental	4,4'-Biphenyldiboronic Acid	OB(O)c1ccc(cc1)-c2ccc(cc2)B(O)O
7996	tr|P95291|P95291_M	P00811	70.89	12.0	275.0	DB02772	approved; experimental; investigational	Sucrose	OC[C@@H](O1)[C@@H](O)[C@H](O)[C@]1(CO)O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O
7997	tr|P95291|P95291_M	P00811	70.89	12.0	275.0	DB02797	experimental	3-Nitrophenylboronic Acid	OB(O)c1cccc(c1)[N+]([O-])=O
7998	tr|P95291|P95291_M	P00811	70.89	12.0	275.0	DB02858	experimental	3-(4-Benzenesulfonyl-Thiophene-2-Sulfonylamino)-Phenylboronic Acid	OB(O)c1cc(ccc1)NS(=O)(=O)c2cc(cs2)S(=O)(=O)c3ccccc3
7999	tr|P95291|P95291_M	P00811	70.89	12.0	275.0	DB03140	experimental	4-Carboxyphenylboronic Acid	OB(O)c1ccc(cc1)C(=O)O
8000	tr|P95291|P95291_M	P00811	70.89	12.0	275.0	DB03437	experimental	(2R,4S)-2-[(1R)-1-{[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid	Nc1nc(cs1)/C(=N/OC)C(=O)N[C@H](C=O)[C@@H](SC2(C)C)N[C@H]2C(=O)O
8001	tr|P95291|P95291_M	P00811	70.89	12.0	275.0	DB03530	experimental	Acylated ceftazidime	OC(=O)C(C)(C)O/N=C(/c1csc(n1)N)C(=O)N[C@H](C=O)[C@H]2SCC(=C)C(=N2)C(=O)O
8002	tr|P95291|P95291_M	P00811	70.89	12.0	275.0	DB03658	experimental	(2R,4S)-2-[(1R)-1-{[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino}-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid	Oc1ccc(cc1)[C@@H](N)C(=O)N[C@H](C=O)[C@@H](SC2(C)C)N[C@H]2C(=O)O
8003	tr|P95291|P95291_M	P00811	70.89	12.0	275.0	DB04035	experimental	Ceftazidime BATSI	OB(O)CNC(=O)C(\c(cs1)nc1N)=N/OC(C)(C)C(=O)O
8004	tr|P95291|P95291_M	P00811	70.89	12.0	275.0	DB04293	experimental	7-(2-Amino-2-Phenyl-Acetylamino)-3-Chloro-8-Oxo-1-Aza-Bicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid	c1ccccc1[C@@H](N)C(=O)N[C@@H](C2=O)[C@H](N23)CCC(Cl)=C3C(=O)O
8005	tr|P95291|P95291_M	P00811	70.89	12.0	275.0	DB04360	experimental	Benzo[B]Thiophene-2-Boronic Acid	OB(O)c(s1)cc(c12)cccc2
8006	tr|P95291|P95291_M	P00811	70.89	12.0	275.0	DB06922	experimental	2-[(1R)-1-carboxy-2-naphthalen-1-ylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid	O=C(O)c(c1)ccc(c12)C(=O)N(C2=O)[C@@H](C(=O)O)Cc3cccc(c34)cccc4
8007	tr|P95291|P95291_M	P00811	70.89	12.0	275.0	DB07057	experimental	(3S)-1-(2-hydroxyphenyl)-5-oxopyrrolidine-3-carboxylic acid	OC(=O)[C@@H]1CN(C(=O)C1)c2c(O)cccc2
8008	tr|P95291|P95291_M	P00811	70.89	12.0	275.0	DB07114	experimental	4-[(METHYLSULFONYL)AMINO]BENZOIC ACID	CS(=O)(=O)Nc1ccc(cc1)C(=O)O
8009	tr|P95291|P95291_M	P00811	70.89	12.0	275.0	DB07541	experimental	4-(dihydroxyboranyl)-2-({[4-(phenylsulfonyl)thiophen-2-yl]sulfonyl}amino)benzoic acid	OB(O)c1cc(c(cc1)C(=O)O)NS(=O)(=O)c2cc(cs2)S(=O)(=O)c3ccccc3
8010	tr|P95291|P95291_M	P00811	70.89	12.0	275.0	DB07663	experimental	2-[(1R)-1-CARBOXY-2-(4-HYDROXYPHENYL)ETHYL]-1,3-DIOXOISOINDOLINE-5-CARBOXYLIC ACID	O=C(O)c(c1)ccc(c12)C(=O)N(C2=O)[C@@H](C(=O)O)Cc3ccc(O)cc3
8011	tr|P95291|P95291_M	P00811	70.89	12.0	275.0	DB07803	experimental	2-phenyl-1H-imidazole-4-carboxylic acid	OC(=O)c1c[nH]c(n1)-c2ccccc2
8012	tr|P95291|P95291_M	P00811	70.89	12.0	275.0	DB07823	experimental	(2S)-2-[(3aR,4R,7S,7aS)-1,3-dioxooctahydro-2H-4,7-methanoisoindol-2-yl]propanoic acid	OC(=O)[C@H](C)N(C1=O)C(=O)[C@H]2[C@@H](CC3)C[C@@H]3[C@@H]12
8013	tr|P95291|P95291_M	P00811	70.89	12.0	275.0	DB07824	experimental	4-ethyl-5-methyl-2-(1H-tetrazol-5-yl)-1,2-dihydro-3H-pyrazol-3-one	CCc1c(C)[nH]n(c1=O)-c2nnn[nH]2
8014	tr|P95291|P95291_M	P00811	70.89	12.0	275.0	DB07825	experimental	(3S)-1-(4-acetylphenyl)-5-oxopyrrolidine-3-carboxylic acid	OC(=O)[C@@H]1CN(C(=O)C1)c2ccc(cc2)C(=O)C
8015	tr|P95291|P95291_M	P00811	70.89	12.0	275.0	DB07850	experimental	(1R,2S)-2-(5-thioxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)cyclohexanecarboxylic acid	OC(=O)[C@@H]1CCCC[C@@H]1c2n[nH]c(=S)[nH]2
8016	tr|P95291|P95291_M	P00811	70.89	12.0	275.0	DB07927	experimental	3-[(4-Carboxy-2-hydroxyphenyl)sulfamoyl]-2-thiophenecarboxylic acid	OC(=O)c1c(ccs1)S(=O)(=O)Nc2c(O)cc(cc2)C(=O)O
8017	tr|P95291|P95291_M	P00811	70.89	12.0	275.0	DB08306	experimental	3-[(3-Nitrophenyl)sulfamoyl]-2-thiophenecarboxylic acid	O=C(O)c1sccc1S(=O)(=O)Nc2cc([N+]([O-])=O)ccc2
8018	tr|P95291|P95291_M	P00811	70.89	12.0	275.0	DB08336	experimental	2-Methyl-2-propanyl [(1R)-2-methyl-1-(1,3,4-oxadiazol-2-yl)propyl]carbamate	CC(C)(C)OC(=O)N[C@H](C(C)C)c1nnco1
8019	tr|P95291|P95291_M	P00811	70.89	12.0	275.0	DB08337	experimental	2-Methyl-2-propanyl [(1S)-2-methyl-1-(1,3,4-oxadiazol-2-yl)propyl]carbamate	CC(C)(C)OC(=O)N[C@@H](C(C)C)c1nnco1
8020	tr|P95291|P95291_M	P00811	70.89	12.0	275.0	DB08375	experimental	(2R)-2-[(1R)-1-[[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-2-oxoethyl]-5-methylidene-2H-1,3-thiazine-4-carboxylic acid	OC(=O)C1=N[C@H](SCC1=C)[C@@H](C=O)NC(=O)/C(=N\OC)c2csc(n2)N
8021	tr|P95291|P95291_M	P00811	70.89	12.0	275.0	DB08551	experimental	3-{(R)-(Dihydroxyboryl)[(2-thienylacetyl)amino]methyl}benzoic acid	O=C(O)c1cccc(c1)[C@@H](B(O)O)NC(=O)Cc2cccs2
8022	tr|P95291|P95291_M	P00811	70.89	12.0	275.0	DB08552	experimental	(1R)-1-(2-thienylacetylamino)-1-phenylmethylboronic acid	c1ccccc1[C@@H](B(O)O)NC(=O)Cc2cccs2
8023	tr|P95291|P95291_M	P00811	70.89	12.0	275.0	DB08573	experimental	3-[(4-CHLOROANILINO)SULFONYL]THIOPHENE-2-CARBOXYLIC ACID	OC(=O)c1c(ccs1)S(=O)(=O)Nc2ccc(Cl)cc2
8024	tr|P95291|P95291_M	P00811	70.89	12.0	275.0	DB08623	experimental	2-[CARBOXY-(2-THIOPHEN-2-YL-ACETYLAMINO)-METHYL]-5-METHYLENE-5,6-DIHYDRO-2H-[1,3]THIAZINE-4-CARBOXYLIC ACID	C=C1CSC(=N[C@@H]1C(=O)O)[C@@H](C(=O)O)NC(=O)Cc2cccs2
8025	tr|P95291|P95291_M	P00811	70.89	12.0	275.0	DB08731	experimental	2-[(1R)-2-carboxy-1-(naphthalen-1-ylmethyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid	O=C(O)c(c1)ccc(c12)C(=O)N(C2=O)[C@@H](CC(=O)O)Cc3cccc(c34)cccc4
8026	tr|P95291|P95291_M	Q9X757	71.43	14.0	279.0	DB12107	approved; investigational	Vaborbactam	OB1O[C@H](CC(=O)O)CC[C@@H]1NC(=O)Cc2cccs2
8027	tr|O50391|O50391_M	Q92930	73.58	31.0	173.0	DB02082	experimental	Phosphoaminophosphonic acid guanylate ester	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)NP(=O)(O)O
8028	tr|O50391|O50391_M	Q92930	73.58	31.0	173.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
8029	tr|O50391|O50391_M	P51149	85.49	10.0	175.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
8030	tr|O50391|O50391_M	P01116	77.72	13.0	163.0	DB07771	experimental	[(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACID	CC(C)=CCC/C(C)=C/CC/C(C)=C/CONC(=O)CP(=O)(O)O
8031	tr|O50391|O50391_M	P01116	77.72	13.0	163.0	DB07780	experimental	Farnesyl diphosphate	CC(C)=CCC/C(C)=C/CC/C(C)=C/COP(=O)(O)OP(=O)(O)O
8032	tr|O50391|O50391_M	P01116	77.72	13.0	163.0	DB15568	investigational	MRTX849	 
8033	tr|O50391|O50391_M	P01116	77.72	13.0	163.0	DB15569	investigational	AMG-510	Fc1cccc(O)c1-c(n2)c(F)cc(c23)c(N4CCN(C[C@@H]4C)C(=O)C=C)nc(=O)n3-c5c(C)ccnc5C(C)C
8034	tr|O50391|O50391_M	P01112	77.72	13.0	163.0	DB02210	experimental	Hexane-1,6-Diol	OCCCCCCO
8035	tr|O50391|O50391_M	P01112	77.72	13.0	163.0	DB03226	experimental	Trifluoroethanol	OCC(F)(F)F
8036	tr|O50391|O50391_M	P01112	77.72	13.0	163.0	DB04137	experimental	Guanosine-5'-Triphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8037	tr|O50391|O50391_M	P01112	77.72	13.0	163.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
8038	tr|O50391|O50391_M	P01112	77.72	13.0	163.0	DB08751	experimental	N,N'-DIMETHYL-N-(ACETYL)-N'-(7-NITROBENZ-2-OXA-1,3-DIAZOL-4-YL)ETHYLENEDIAMINE	CC(=O)N(C)CCN(C)c1ccc([N+]([O-])=O)c(c12)non2
8039	tr|O50391|O50391_M	P51151	74.61	31.0	175.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
8040	tr|O50391|O50391_M	P11233	78.24	24.0	175.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
8041	tr|O50391|O50391_M	Q5S007	76.68	1335.0	1483.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
8042	tr|O50391|O50391_M	P20339	70.47	44.0	180.0	DB02467	experimental	L-methionine (S)-S-oxide	C[S@](=O)CC[C@@H](C([O-])=O)[NH3+]
8043	tr|O50391|O50391_M	P20339	70.47	44.0	180.0	DB04137	experimental	Guanosine-5'-Triphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8044	tr|O50391|O50391_M	P20339	70.47	44.0	180.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
8046	tr|O50391|O50391_M	P10114	78.24	13.0	164.0	DB04137	experimental	Guanosine-5'-Triphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8047	tr|O50391|O50391_M	P10114	78.24	13.0	164.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
8048	tr|O50391|O50391_M	Q15382	76.17	17.0	164.0	DB04137	experimental	Guanosine-5'-Triphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8049	tr|O50391|O50391_M	Q15382	76.17	17.0	164.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
8050	tr|O50391|O50391_M	P62826	81.35	11.0	168.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
8051	tr|O50391|O50391_M	P38545	80.31	11.0	166.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
8052	tr|O50391|O50391_M	P61586	91.19	4.0	180.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
8054	tr|O50391|O50391_M	P40616	83.94	13.0	175.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
8055	tr|O50391|O50391_M	P63000	77.72	26.0	176.0	DB00993	approved	Azathioprine	Cn1cnc([N+]([O-])=O)c1Sc2ncnc(c23)nc[nH]3
8056	tr|O50391|O50391_M	P63000	77.72	26.0	176.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
8057	tr|O50391|O50391_M	P63000	77.72	26.0	176.0	DB00514	approved	Dextromethorphan	C1CCC[C@@H]([C@]123)[C@@H](N(C)CC2)Cc4c3cc(OC)cc4
8058	tr|O50391|O50391_M	P60953	79.27	26.0	179.0	DB02623	experimental	Aminophosphonic acid-guanylate ester	Nc([nH]1)nc(=O)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)N
8059	tr|O50391|O50391_M	P60953	79.27	26.0	179.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
8060	tr|O50391|O50391_M	P15153	78.24	26.0	177.0	DB00514	approved	Dextromethorphan	C1CCC[C@@H]([C@]123)[C@@H](N(C)CC2)Cc4c3cc(OC)cc4
8061	tr|O50391|O50391_M	P36405	70.47	41.0	177.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
8062	tr|O50391|O50391_M	P36405	70.47	41.0	177.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
8063	tr|O50391|O50391_M	Q8I4W4	70.98	65.0	202.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
8064	tr|O50391|O50391_M	P61587	86.53	24.0	191.0	DB04137	experimental	Guanosine-5'-Triphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8065	tr|O50391|O50391_M	Q8IKW5	71.5	20.0	158.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
8066	tr|O50391|O50391_M	P13639	74.09	20.0	163.0	DB02059	experimental	Adenosine-5-Diphosphoribose	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)CO[P@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H](O)[C@H](O)[C@@H]4O
8067	tr|O50391|O50391_M	P13639	74.09	20.0	163.0	DB03223	experimental	Diphthamide	C[N+](C)(C)[C@H](C(=O)N)CCc1nc(c[nH]1)C[C@H](N)C(=O)O
8068	tr|O50391|O50391_M	P13639	74.09	20.0	163.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
8069	tr|O50391|O50391_M	P13639	74.09	20.0	163.0	DB08348	experimental	N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE	CN(C)CC(=O)Nc(cc1)cc(c12)c3c(c(=O)[nH]2)cccc3
8070	tr|O50391|O50391_M	P13639	74.09	20.0	163.0	DB11823	approved; investigational	Esketamine	C1CCCC(=O)[C@@]1(NC)c2ccccc2Cl
8072	tr|O50391|O50391_M	Q00080	81.35	9.0	166.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
8073	tr|O50391|O50391_M	Q9X1F8	81.35	5.0	162.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
8074	tr|O50391|O50391_M	P68104	80.31	9.0	164.0	DB01593	approved; investigational	Zinc	[Zn]
8075	tr|O50391|O50391_M	P68104	80.31	9.0	164.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
8076	tr|O50391|O50391_M	P68104	80.31	9.0	164.0	DB09130	approved; investigational	Copper	[Cu]
8077	tr|O50391|O50391_M	P68104	80.31	9.0	164.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
8078	tr|O50391|O50391_M	P68104	80.31	9.0	164.0	DB14487	approved; investigational	Zinc acetate	CC([O-])=O
8079	tr|O50391|O50391_M	P68104	80.31	9.0	164.0	DB14533	approved; investigational	Zinc chloride	[Cl-]
8080	tr|O50391|O50391_M	P68104	80.31	9.0	164.0	DB14548	approved; experimental	Zinc sulfate, unspecified form	 
8081	tr|O50391|O50391_M	P15170	87.56	76.0	245.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
8082	tr|I6YF11|I6YF11_M	P08183	86.76	376.0	625.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8083	tr|I6YF11|I6YF11_M	P08183	86.76	376.0	625.0	DB00603	approved; investigational	Medroxyprogesterone acetate	CC(=O)O[C@]1(C(=O)C)CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C([C@H](C3)C)=CC(=O)CC4
8084	tr|I6YF11|I6YF11_M	P08183	86.76	376.0	625.0	DB00778	approved; investigational; withdrawn	Roxithromycin	COCCOCO/N=C([C@H](C)[C@@H](O)[C@]1(C)O)/[C@H](C)C[C@@](C)(O)[C@@H]([C@@H](C)[C@@H]([C@@H](C)C(=O)O[C@@H]1CC)O[C@@H](C[C@@]2(C)OC)O[C@@H](C)[C@@H]2O)O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C
8085	tr|I6YF11|I6YF11_M	P08183	86.76	376.0	625.0	DB00813	approved; illicit; investigational; vet_approved	Fentanyl	c1ccccc1N(C(=O)CC)C2CCN(CC2)CCc3ccccc3
8086	tr|I6YF11|I6YF11_M	P08183	86.76	376.0	625.0	DB04877	experimental	Voacamine	CC[C@H]1C[C@@H](C2)CN([C@@H]1[C@@]23C(=O)OC)CCc4c3[nH]c5c4cc(OC)c(c5)[C@@H](C[C@H]67)c8c(c9c([nH]8)cccc9)C[C@H](C6C(=O)OC)N(C)CC\7=C\C
8087	tr|I6YF11|I6YF11_M	P08183	86.76	376.0	625.0	DB04881	investigational	Elacridar	COc1cccc(c12)c(=O)c3c([nH]2)c(ccc3)C(=O)Nc4ccc(cc4)CCN(C5)CCc(c56)cc(OC)c(c6)OC
8088	tr|I6YF11|I6YF11_M	P08183	86.76	376.0	625.0	DB04905	investigational	Tesmilifene	CCN(CC)CCOc1ccc(cc1)Cc2ccccc2
8089	tr|I6YF11|I6YF11_M	P08183	86.76	376.0	625.0	DB05449	investigational	FM-VP4	 
8090	tr|I6YF11|I6YF11_M	P08183	86.76	376.0	625.0	DB06191	investigational	Zosuquidar	FC1(F)[C@H]2[C@@H]1c(cccc3)c3[C@@H](c(c24)cccc4)N5CCN(CC5)C[C@@H](O)COc6cccc(c67)nccc7
8091	tr|I6YF11|I6YF11_M	P08183	86.76	376.0	625.0	DB06240	investigational	Tariquidar	COc(c1)c(OC)cc(c12)CCN(C2)CCc3ccc(cc3)NC(=O)c4cc(OC)c(OC)cc4NC(=O)c(c5)cnc(c56)cccc6
8092	tr|I6YF11|I6YF11_M	P08183	86.76	376.0	625.0	DB09031	approved; investigational	Miltefosine	CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C
8093	tr|I6YF11|I6YF11_M	P08183	86.76	376.0	625.0	DB11635	approved	Tocofersolan	 
8094	tr|I6YF11|I6YF11_M	P08183	86.76	376.0	625.0	DB14061	experimental	Hycanthone	CCN(CC)CCNc(ccc1CO)c(c12)c(=O)c3c(s2)cccc3
8095	tr|I6YF11|I6YF11_M	P08183	86.76	376.0	625.0	DB14062	experimental	Concanamycin A	NC(=O)O[C@@H]1[C@@H](C)O[C@H](C[C@H]1O)O[C@H](C2)[C@H](C)[C@@H](/C=C/C)O[C@@]2(O)[C@@H](C)[C@H](O)[C@H](C)[C@H]3OC(=O)/C(OC)=C/C(C)=C/[C@@H](C)[C@@H](O)[C@@H](CC)[C@@H](O)[C@H](C)C/C(C)=C/C=C/[C@@H]3OC
8096	tr|I6YF11|I6YF11_M	P08183	86.76	376.0	625.0	DB14063	experimental	Dexverapamil	COc1ccc(cc1OC)CCN(C)CCC[C@@](C#N)(C(C)C)c2cc(OC)c(OC)cc2
8097	tr|I6YF11|I6YF11_M	P08183	86.76	376.0	625.0	DB14064	experimental	Emopamil	c1ccccc1C(C#N)(C(C)C)CCCN(C)CCc2ccccc2
8098	tr|I6YF11|I6YF11_M	P08183	86.76	376.0	625.0	DB14065	experimental	Lomerizine	COc1ccc(c(OC)c1OC)CN2CCN(CC2)C(c3ccc(F)cc3)c4ccc(F)cc4
8099	tr|I6YF11|I6YF11_M	P08183	86.76	376.0	625.0	DB14066	experimental	Tetrandrine	c12ccc(OC)c(c1)Oc3ccc(cc3)C[C@H]4c5c(CCN4C)cc(OC)c(c5)Oc6c7c(CCN(C)[C@H]7C2)cc(OC)c6OC
8100	tr|I6YF11|I6YF11_M	P08183	86.76	376.0	625.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
8101	tr|I6YF11|I6YF11_M	P08183	86.76	376.0	625.0	DB14068	experimental	Dexniguldipine	[O-][N+](=O)c1cccc(c1)[C@@H]2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCCN(CC3)CCC3(c4ccccc4)c5ccccc5
8102	tr|I6YF11|I6YF11_M	P08183	86.76	376.0	625.0	DB14069	investigational	ONT-093	CCOC/C=C/c1ccc(cc1)-c2nc(-c3ccc(cc3)NC(C)C)c([nH]2)-c4ccc(cc4)NC(C)C
8103	tr|I6YF11|I6YF11_M	P08183	86.76	376.0	625.0	DB14070	experimental	HM-30181	c1cccc(c12)c(=O)cc(o2)C(=O)Nc3cc(OC)c(OC)cc3-c4nn(nn4)-c5ccc(cc5)CCN(C6)CCc(c67)cc(OC)c(c7)OC
8104	tr|I6YF11|I6YF11_M	P08183	86.76	376.0	625.0	DB14071	experimental	Desmethylsertraline	c1cccc(c12)[C@@H](CC[C@@H]2N)c3cc(Cl)c(Cl)cc3
8105	tr|I6YF11|I6YF11_M	P08183	86.76	376.0	625.0	DB14072	experimental	Reversin 121	c1ccccc1COC(=O)C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@H](C(=O)OC(C)(C)C)CCCCNC(=O)OCc2ccccc2
8106	tr|I6YF11|I6YF11_M	P08183	87.46	1019.0	1270.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8107	tr|I6YF11|I6YF11_M	P08183	87.46	1019.0	1270.0	DB00603	approved; investigational	Medroxyprogesterone acetate	CC(=O)O[C@]1(C(=O)C)CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C([C@H](C3)C)=CC(=O)CC4
8108	tr|I6YF11|I6YF11_M	P08183	87.46	1019.0	1270.0	DB00778	approved; investigational; withdrawn	Roxithromycin	COCCOCO/N=C([C@H](C)[C@@H](O)[C@]1(C)O)/[C@H](C)C[C@@](C)(O)[C@@H]([C@@H](C)[C@@H]([C@@H](C)C(=O)O[C@@H]1CC)O[C@@H](C[C@@]2(C)OC)O[C@@H](C)[C@@H]2O)O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C
8109	tr|I6YF11|I6YF11_M	P08183	87.46	1019.0	1270.0	DB00813	approved; illicit; investigational; vet_approved	Fentanyl	c1ccccc1N(C(=O)CC)C2CCN(CC2)CCc3ccccc3
8110	tr|I6YF11|I6YF11_M	P08183	87.46	1019.0	1270.0	DB04877	experimental	Voacamine	CC[C@H]1C[C@@H](C2)CN([C@@H]1[C@@]23C(=O)OC)CCc4c3[nH]c5c4cc(OC)c(c5)[C@@H](C[C@H]67)c8c(c9c([nH]8)cccc9)C[C@H](C6C(=O)OC)N(C)CC\7=C\C
8111	tr|I6YF11|I6YF11_M	P08183	87.46	1019.0	1270.0	DB04881	investigational	Elacridar	COc1cccc(c12)c(=O)c3c([nH]2)c(ccc3)C(=O)Nc4ccc(cc4)CCN(C5)CCc(c56)cc(OC)c(c6)OC
8112	tr|I6YF11|I6YF11_M	P08183	87.46	1019.0	1270.0	DB04905	investigational	Tesmilifene	CCN(CC)CCOc1ccc(cc1)Cc2ccccc2
8113	tr|I6YF11|I6YF11_M	P08183	87.46	1019.0	1270.0	DB05449	investigational	FM-VP4	 
8114	tr|I6YF11|I6YF11_M	P08183	87.46	1019.0	1270.0	DB06191	investigational	Zosuquidar	FC1(F)[C@H]2[C@@H]1c(cccc3)c3[C@@H](c(c24)cccc4)N5CCN(CC5)C[C@@H](O)COc6cccc(c67)nccc7
8115	tr|I6YF11|I6YF11_M	P08183	87.46	1019.0	1270.0	DB06240	investigational	Tariquidar	COc(c1)c(OC)cc(c12)CCN(C2)CCc3ccc(cc3)NC(=O)c4cc(OC)c(OC)cc4NC(=O)c(c5)cnc(c56)cccc6
8116	tr|I6YF11|I6YF11_M	P08183	87.46	1019.0	1270.0	DB09031	approved; investigational	Miltefosine	CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C
8117	tr|I6YF11|I6YF11_M	P08183	87.46	1019.0	1270.0	DB11635	approved	Tocofersolan	 
8118	tr|I6YF11|I6YF11_M	P08183	87.46	1019.0	1270.0	DB14061	experimental	Hycanthone	CCN(CC)CCNc(ccc1CO)c(c12)c(=O)c3c(s2)cccc3
8119	tr|I6YF11|I6YF11_M	P08183	87.46	1019.0	1270.0	DB14062	experimental	Concanamycin A	NC(=O)O[C@@H]1[C@@H](C)O[C@H](C[C@H]1O)O[C@H](C2)[C@H](C)[C@@H](/C=C/C)O[C@@]2(O)[C@@H](C)[C@H](O)[C@H](C)[C@H]3OC(=O)/C(OC)=C/C(C)=C/[C@@H](C)[C@@H](O)[C@@H](CC)[C@@H](O)[C@H](C)C/C(C)=C/C=C/[C@@H]3OC
8120	tr|I6YF11|I6YF11_M	P08183	87.46	1019.0	1270.0	DB14063	experimental	Dexverapamil	COc1ccc(cc1OC)CCN(C)CCC[C@@](C#N)(C(C)C)c2cc(OC)c(OC)cc2
8121	tr|I6YF11|I6YF11_M	P08183	87.46	1019.0	1270.0	DB14064	experimental	Emopamil	c1ccccc1C(C#N)(C(C)C)CCCN(C)CCc2ccccc2
8122	tr|I6YF11|I6YF11_M	P08183	87.46	1019.0	1270.0	DB14065	experimental	Lomerizine	COc1ccc(c(OC)c1OC)CN2CCN(CC2)C(c3ccc(F)cc3)c4ccc(F)cc4
8123	tr|I6YF11|I6YF11_M	P08183	87.46	1019.0	1270.0	DB14066	experimental	Tetrandrine	c12ccc(OC)c(c1)Oc3ccc(cc3)C[C@H]4c5c(CCN4C)cc(OC)c(c5)Oc6c7c(CCN(C)[C@H]7C2)cc(OC)c6OC
8124	tr|I6YF11|I6YF11_M	P08183	87.46	1019.0	1270.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
8125	tr|I6YF11|I6YF11_M	P08183	87.46	1019.0	1270.0	DB14068	experimental	Dexniguldipine	[O-][N+](=O)c1cccc(c1)[C@@H]2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCCN(CC3)CCC3(c4ccccc4)c5ccccc5
8126	tr|I6YF11|I6YF11_M	P08183	87.46	1019.0	1270.0	DB14069	investigational	ONT-093	CCOC/C=C/c1ccc(cc1)-c2nc(-c3ccc(cc3)NC(C)C)c([nH]2)-c4ccc(cc4)NC(C)C
8127	tr|I6YF11|I6YF11_M	P08183	87.46	1019.0	1270.0	DB14070	experimental	HM-30181	c1cccc(c12)c(=O)cc(o2)C(=O)Nc3cc(OC)c(OC)cc3-c4nn(nn4)-c5ccc(cc5)CCN(C6)CCc(c67)cc(OC)c(c7)OC
8128	tr|I6YF11|I6YF11_M	P08183	87.46	1019.0	1270.0	DB14071	experimental	Desmethylsertraline	c1cccc(c12)[C@@H](CC[C@@H]2N)c3cc(Cl)c(Cl)cc3
8129	tr|I6YF11|I6YF11_M	P08183	87.46	1019.0	1270.0	DB14072	experimental	Reversin 121	c1ccccc1COC(=O)C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@H](C(=O)OC(C)(C)C)CCCCNC(=O)OCc2ccccc2
8130	tr|I6YF11|I6YF11_M	Q2M3G0	87.46	381.0	632.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
8131	tr|I6YF11|I6YF11_M	Q2M3G0	87.46	381.0	632.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
8132	tr|I6YF11|I6YF11_M	Q2M3G0	87.46	999.0	1250.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
8133	tr|I6YF11|I6YF11_M	Q2M3G0	87.46	999.0	1250.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
8134	tr|I6YF11|I6YF11_M	O95342	82.93	415.0	653.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8135	tr|I6YF11|I6YF11_M	O95342	82.93	415.0	653.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
8136	tr|I6YF11|I6YF11_M	O95342	85.71	1067.0	1313.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8137	tr|I6YF11|I6YF11_M	O95342	85.71	1067.0	1313.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
8138	tr|I6YF11|I6YF11_M	P33527	81.18	633.0	866.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8139	tr|I6YF11|I6YF11_M	P33527	81.18	633.0	866.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
8140	tr|I6YF11|I6YF11_M	P33527	81.18	633.0	866.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
8141	tr|I6YF11|I6YF11_M	P33527	81.18	633.0	866.0	DB06176	approved; investigational	Romidepsin	O=C([C@H]12)N/C(=C\C)C(=O)N[C@@H](C(C)C)C(=O)O[C@@H](CC(=O)N[C@H](C(C)C)C(=O)N1)/C=C/CCSSC2
8142	tr|I6YF11|I6YF11_M	P33527	81.18	633.0	866.0	DB08855	experimental; investigational	Leukotriene C4	CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@@H](O)CCCC(=O)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@H](N)C(=O)O
8143	tr|I6YF11|I6YF11_M	P33527	86.76	1278.0	1527.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8144	tr|I6YF11|I6YF11_M	P33527	86.76	1278.0	1527.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
8145	tr|I6YF11|I6YF11_M	P33527	86.76	1278.0	1527.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
8146	tr|I6YF11|I6YF11_M	P33527	86.76	1278.0	1527.0	DB06176	approved; investigational	Romidepsin	O=C([C@H]12)N/C(=C\C)C(=O)N[C@@H](C(C)C)C(=O)O[C@@H](CC(=O)N[C@H](C(C)C)C(=O)N1)/C=C/CCSSC2
8147	tr|I6YF11|I6YF11_M	P33527	86.76	1278.0	1527.0	DB08855	experimental; investigational	Leukotriene C4	CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@@H](O)CCCC(=O)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@H](N)C(=O)O
8148	tr|I6YF11|I6YF11_M	O60706	82.23	667.0	903.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8149	tr|I6YF11|I6YF11_M	O60706	82.23	667.0	903.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
8150	tr|I6YF11|I6YF11_M	O60706	82.23	667.0	903.0	DB09220	approved; investigational	Nicorandil	[O-][N+](=O)OCCNC(=O)c1cccnc1
8151	tr|I6YF11|I6YF11_M	O60706	81.88	1303.0	1538.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8152	tr|I6YF11|I6YF11_M	O60706	81.88	1303.0	1538.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
8153	tr|I6YF11|I6YF11_M	O60706	81.88	1303.0	1538.0	DB09220	approved; investigational	Nicorandil	[O-][N+](=O)OCCNC(=O)c1cccnc1
8154	tr|I6YF11|I6YF11_M	P13569	86.41	413.0	661.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8155	tr|I6YF11|I6YF11_M	P13569	86.41	413.0	661.0	DB00887	approved	Bumetanide	CCCCNc1c(c(S(=O)(=O)N)cc(c1)C(=O)O)Oc2ccccc2
8156	tr|I6YF11|I6YF11_M	P13569	86.41	413.0	661.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
8157	tr|I6YF11|I6YF11_M	P13569	86.41	413.0	661.0	DB01050	approved	Ibuprofen	CC(C)Cc1ccc(cc1)C(C)C(=O)O
8158	tr|I6YF11|I6YF11_M	P13569	86.41	413.0	661.0	DB02587	experimental; investigational	Colforsin	O[C@H]1CCC(C)(C)[C@@H]([C@]12C)[C@H](O)[C@H](OC(=O)C)[C@]3(C)[C@]2(O)C(=O)C[C@](O3)(C)C=C
8159	tr|I6YF11|I6YF11_M	P13569	86.41	413.0	661.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
8160	tr|I6YF11|I6YF11_M	P13569	86.41	413.0	661.0	DB04522	experimental	Dexfosfoserine	OC(=O)[C@@H](N)COP(=O)(O)O
8161	tr|I6YF11|I6YF11_M	P13569	86.41	413.0	661.0	DB04941	approved	Crofelemer	 
8162	tr|I6YF11|I6YF11_M	P13569	86.41	413.0	661.0	DB06266	investigational	Lonidamine	c1cccc(c12)n(nc2C(=O)O)Cc3c(Cl)cc(Cl)cc3
8163	tr|I6YF11|I6YF11_M	P13569	86.41	413.0	661.0	DB08820	approved	Ivacaftor	CC(C)(C)c1cc(C(C)(C)C)c(O)cc1NC(=O)c(c2=O)c[nH]c(c23)cccc3
8164	tr|I6YF11|I6YF11_M	P13569	86.41	413.0	661.0	DB09213	approved; investigational	Dexibuprofen	CC(C)Cc1ccc(cc1)[C@H](C)C(=O)O
8165	tr|I6YF11|I6YF11_M	P13569	86.41	413.0	661.0	DB09280	approved	Lumacaftor	O=C(O)c1cccc(c1)-c2nc(ccc2C)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
8166	tr|I6YF11|I6YF11_M	P13569	86.41	413.0	661.0	DB11712	approved; investigational	Tezacaftor	OC[C@H](O)Cn1c(C(C)(C)CO)cc(c12)cc(c(F)c2)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
8167	tr|I6YF11|I6YF11_M	P13569	86.41	413.0	661.0	DB15444	approved; investigational	Elexacaftor	FC(F)(F)C(C)(C)COc1nn(cc1)-c2nc(N(C3(C)C)C[C@@H](C)C3)c(cc2)C(=O)NS(=O)(=O)c4cn(C)nc4C
8168	tr|I6YF11|I6YF11_M	P13569	82.93	1207.0	1445.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8169	tr|I6YF11|I6YF11_M	P13569	82.93	1207.0	1445.0	DB00887	approved	Bumetanide	CCCCNc1c(c(S(=O)(=O)N)cc(c1)C(=O)O)Oc2ccccc2
8170	tr|I6YF11|I6YF11_M	P13569	82.93	1207.0	1445.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
8171	tr|I6YF11|I6YF11_M	P13569	82.93	1207.0	1445.0	DB01050	approved	Ibuprofen	CC(C)Cc1ccc(cc1)C(C)C(=O)O
8172	tr|I6YF11|I6YF11_M	P13569	82.93	1207.0	1445.0	DB02587	experimental; investigational	Colforsin	O[C@H]1CCC(C)(C)[C@@H]([C@]12C)[C@H](O)[C@H](OC(=O)C)[C@]3(C)[C@]2(O)C(=O)C[C@](O3)(C)C=C
8173	tr|I6YF11|I6YF11_M	P13569	82.93	1207.0	1445.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
8174	tr|I6YF11|I6YF11_M	P13569	82.93	1207.0	1445.0	DB04522	experimental	Dexfosfoserine	OC(=O)[C@@H](N)COP(=O)(O)O
8175	tr|I6YF11|I6YF11_M	P13569	82.93	1207.0	1445.0	DB04941	approved	Crofelemer	 
8176	tr|I6YF11|I6YF11_M	P13569	82.93	1207.0	1445.0	DB06266	investigational	Lonidamine	c1cccc(c12)n(nc2C(=O)O)Cc3c(Cl)cc(Cl)cc3
8177	tr|I6YF11|I6YF11_M	P13569	82.93	1207.0	1445.0	DB08820	approved	Ivacaftor	CC(C)(C)c1cc(C(C)(C)C)c(O)cc1NC(=O)c(c2=O)c[nH]c(c23)cccc3
8178	tr|I6YF11|I6YF11_M	P13569	82.93	1207.0	1445.0	DB09213	approved; investigational	Dexibuprofen	CC(C)Cc1ccc(cc1)[C@H](C)C(=O)O
8179	tr|I6YF11|I6YF11_M	P13569	82.93	1207.0	1445.0	DB09280	approved	Lumacaftor	O=C(O)c1cccc(c1)-c2nc(ccc2C)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
8180	tr|I6YF11|I6YF11_M	P13569	82.93	1207.0	1445.0	DB11712	approved; investigational	Tezacaftor	OC[C@H](O)Cn1c(C(C)(C)CO)cc(c12)cc(c(F)c2)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
8181	tr|I6YF11|I6YF11_M	P13569	82.93	1207.0	1445.0	DB15444	approved; investigational	Elexacaftor	FC(F)(F)C(C)(C)COc1nn(cc1)-c2nc(N(C3(C)C)C[C@@H](C)C3)c(cc2)C(=O)NS(=O)(=O)c4cn(C)nc4C
8182	tr|I6YF11|I6YF11_M	Q09428	80.49	689.0	920.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8183	tr|I6YF11|I6YF11_M	Q09428	80.49	689.0	920.0	DB00222	approved	Glimepiride	CCC1=C(C)CN(C1=O)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3
8184	tr|I6YF11|I6YF11_M	Q09428	80.49	689.0	920.0	DB00672	approved; investigational	Chlorpropamide	CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1
8185	tr|I6YF11|I6YF11_M	Q09428	80.49	689.0	920.0	DB00731	approved; investigational	Nateglinide	CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](C(=O)O)Cc2ccccc2
8186	tr|I6YF11|I6YF11_M	Q09428	80.49	689.0	920.0	DB00912	approved; investigational	Repaglinide	CCOc1c(C(=O)O)ccc(c1)CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3
8187	tr|I6YF11|I6YF11_M	Q09428	80.49	689.0	920.0	DB01067	approved; investigational	Glipizide	Cc1ncc(nc1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
8188	tr|I6YF11|I6YF11_M	Q09428	80.49	689.0	920.0	DB01120	approved	Gliclazide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN(C2)CC(C23)CCC3
8189	tr|I6YF11|I6YF11_M	Q09428	80.49	689.0	920.0	DB01124	approved; investigational	Tolbutamide	CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1
8190	tr|I6YF11|I6YF11_M	Q09428	80.49	689.0	920.0	DB01251	approved; investigational	Gliquidone	COc(cc1)cc(c12)C(=O)N(C(=O)C2(C)C)CCc3ccc(cc3)S(=O)(=O)NC(=O)NC4CCCCC4
8191	tr|I6YF11|I6YF11_M	Q09428	80.49	689.0	920.0	DB01252	investigational	Mitiglinide	c1ccccc1C[C@H](C(=O)O)CC(=O)N(C2)C[C@H]([C@H]23)CCCC3
8192	tr|I6YF11|I6YF11_M	Q09428	80.49	689.0	920.0	DB01382	approved; investigational	Glymidine	COCCOc1cnc(nc1)NS(=O)(=O)c2ccccc2
8193	tr|I6YF11|I6YF11_M	Q09428	81.53	1336.0	1570.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8194	tr|I6YF11|I6YF11_M	Q09428	81.53	1336.0	1570.0	DB00222	approved	Glimepiride	CCC1=C(C)CN(C1=O)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3
8195	tr|I6YF11|I6YF11_M	Q09428	81.53	1336.0	1570.0	DB00672	approved; investigational	Chlorpropamide	CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1
8196	tr|I6YF11|I6YF11_M	Q09428	81.53	1336.0	1570.0	DB00731	approved; investigational	Nateglinide	CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](C(=O)O)Cc2ccccc2
8197	tr|I6YF11|I6YF11_M	Q09428	81.53	1336.0	1570.0	DB00912	approved; investigational	Repaglinide	CCOc1c(C(=O)O)ccc(c1)CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3
8198	tr|I6YF11|I6YF11_M	Q09428	81.53	1336.0	1570.0	DB01067	approved; investigational	Glipizide	Cc1ncc(nc1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
8199	tr|I6YF11|I6YF11_M	Q09428	81.53	1336.0	1570.0	DB01120	approved	Gliclazide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN(C2)CC(C23)CCC3
8200	tr|I6YF11|I6YF11_M	Q09428	81.53	1336.0	1570.0	DB01124	approved; investigational	Tolbutamide	CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1
8201	tr|I6YF11|I6YF11_M	Q09428	81.53	1336.0	1570.0	DB01251	approved; investigational	Gliquidone	COc(cc1)cc(c12)C(=O)N(C(=O)C2(C)C)CCc3ccc(cc3)S(=O)(=O)NC(=O)NC4CCCCC4
8202	tr|I6YF11|I6YF11_M	Q09428	81.53	1336.0	1570.0	DB01252	investigational	Mitiglinide	c1ccccc1C[C@H](C(=O)O)CC(=O)N(C2)C[C@H]([C@H]23)CCCC3
8203	tr|I6YF11|I6YF11_M	Q09428	81.53	1336.0	1570.0	DB01382	approved; investigational	Glymidine	COCCOc1cnc(nc1)NS(=O)(=O)c2ccccc2
8204	tr|I6YF11|I6YF11_M	Q09428	80.49	689.0	920.0	DB00839	approved; investigational	Tolazamide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2
8205	tr|I6YF11|I6YF11_M	Q09428	80.49	689.0	920.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
8206	tr|I6YF11|I6YF11_M	Q09428	81.53	1336.0	1570.0	DB00839	approved; investigational	Tolazamide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2
8207	tr|I6YF11|I6YF11_M	Q09428	81.53	1336.0	1570.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
8208	tr|I6YF11|I6YF11_M	O95255	80.84	614.0	846.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8209	tr|I6YF11|I6YF11_M	O95255	82.58	1263.0	1500.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8210	tr|I6YF11|I6YF11_M	Q92887	80.14	628.0	858.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8211	tr|I6YF11|I6YF11_M	Q92887	80.14	628.0	858.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
8212	tr|I6YF11|I6YF11_M	Q92887	83.62	1286.0	1526.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8213	tr|I6YF11|I6YF11_M	Q92887	83.62	1286.0	1526.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
8214	tr|I6YF11|I6YF11_M	O15439	79.44	401.0	629.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8215	tr|I6YF11|I6YF11_M	O15439	83.62	1037.0	1277.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8216	tr|I6YF11|I6YF11_M	O15440	85.02	1177.0	1421.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
8217	tr|I6YF11|I6YF11_M	O15440	85.02	1177.0	1421.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
8218	tr|I6YF11|I6YF11_M	O95477	78.4	898.0	1123.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8219	tr|I6YF11|I6YF11_M	O95477	78.4	898.0	1123.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
8220	tr|I6YF11|I6YF11_M	O95477	78.4	898.0	1123.0	DB01599	approved; investigational	Probucol	CC(C)(C)c1cc(cc(c1O)C(C)(C)C)SC(C)(C)Sc2cc(C(C)(C)C)c(O)c(c2)C(C)(C)C
8221	tr|I6YF11|I6YF11_M	O95477	84.32	1897.0	2139.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8222	tr|I6YF11|I6YF11_M	O95477	84.32	1897.0	2139.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
8223	tr|I6YF11|I6YF11_M	O95477	84.32	1897.0	2139.0	DB01599	approved; investigational	Probucol	CC(C)(C)c1cc(cc(c1O)C(C)(C)C)SC(C)(C)Sc2cc(C(C)(C)C)c(O)c(c2)C(C)(C)C
8224	tr|I6YF11|I6YF11_M	P45844	80.49	74.0	305.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8225	tr|I6YF11|I6YF11_M	A0A0T9AZ62	71.08	222.0	426.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
8226	tr|I6YF11|I6YF11_M	Q9UNQ0	82.58	37.0	274.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
8227	tr|I6YF11|I6YF11_M	Q9UNQ0	82.58	37.0	274.0	DB11995	approved; investigational	Avatrombopag	OC(=O)C1CCN(CC1)c2c(Cl)cc(cn2)C(=O)Nc3nc(-c4cc(Cl)cs4)c(s3)N5CCN(CC5)C6CCCCC6
8228	tr|O06796|O06796_M	O06796	99.21	1.0	127.0	DB08217	experimental	S-[(1-Hydroxy-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate	CC1(C)C=C(C(C)(C)N1O)CSS(=O)(=O)C
8230	tr|P95223|P95223_M	O14841	103.39	7.0	1257.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
8231	tr|O53324|O53324_M	P0AEK2	90.21	3.0	215.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
8232	tr|O53324|O53324_M	Q9BTZ2	92.34	30.0	247.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
8233	tr|O53324|O53324_M	Q9WYS2	92.34	6.0	223.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
8234	tr|O53324|O53324_M	P37059	94.89	80.0	303.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
8235	tr|O53324|O53324_M	P37059	94.89	80.0	303.0	DB13952	approved; investigational; vet_approved	Estradiol acetate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)C
8236	tr|O53324|O53324_M	P37059	94.89	80.0	303.0	DB13953	approved; investigational; vet_approved	Estradiol benzoate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)c5ccccc5
8237	tr|O53324|O53324_M	P37059	94.89	80.0	303.0	DB13954	approved; investigational; vet_approved	Estradiol cypionate	C1CCCC1CCC(=O)O[C@H]2CC[C@H]([C@@]23C)[C@H]4[C@H](CC3)c5c(CC4)cc(O)cc5
8238	tr|O53324|O53324_M	P37059	94.89	80.0	303.0	DB13955	approved; investigational; vet_approved	Estradiol dienanthate	CCCCCCC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)CCCCCC
8239	tr|O53324|O53324_M	P37059	94.89	80.0	303.0	DB13956	approved; investigational; vet_approved	Estradiol valerate	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)CC[C@@H]4OC(=O)CCCC
8240	tr|O53324|O53324_M	Q92506	96.17	7.0	233.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
8241	tr|O53324|O53324_M	Q92506	96.17	7.0	233.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
8242	tr|O53324|O53324_M	P16544	88.94	1.0	210.0	DB01942	experimental; investigational	Formic acid	OC=O
8243	tr|O53324|O53324_M	P16544	88.94	1.0	210.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
8244	tr|O53324|O53324_M	P16544	88.94	1.0	210.0	DB07715	investigational	Emodin	Cc(c1)cc(O)c(c12)C(=O)c3c(C2=O)cc(O)cc3O
8247	tr|O53324|O53324_M	Q7Z4W1	88.09	5.0	212.0	DB02831	experimental	Dihydrogenphosphate	OP([O-])(=O)O
8248	tr|O53324|O53324_M	Q7Z4W1	88.09	5.0	212.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
8250	tr|O53324|O53324_M	Q8NBQ5	95.74	32.0	257.0	DB02854	experimental	Aetiocholanolone	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](CC3)C[C@H](O)CC4
8251	tr|O53324|O53324_M	Q9NYR8	84.26	4.0	202.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
8252	tr|O53324|O53324_M	Q6UWP2	96.17	6.0	232.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
8253	tr|O53324|O53324_M	P0AET8	91.91	8.0	224.0	DB02123	experimental	Glycochenodeoxycholic Acid	OC(=O)CNC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
8254	tr|O53324|O53324_M	P0CG22	94.47	30.0	252.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
8255	tr|O53324|O53324_M	P0CG22	94.47	30.0	252.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
8256	tr|O53324|O53324_M	P0CG22	94.47	30.0	252.0	DB03541	experimental	10-Propargyl-5,8-Dideazafolic Acid	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(CC#C)Cc(c2)ccc(c23)[nH]c(N)nc3=O
8257	tr|O53324|O53324_M	P0CG22	94.47	30.0	252.0	DB07689	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)NCc(cn3)nc(c34)c(N)nc(n4)N
8258	tr|O53324|O53324_M	P0CG22	94.47	30.0	252.0	DB07765	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)N(C)Cc(cn3)nc(c34)c(N)nc(n4)N
8259	tr|O53324|O53324_M	P14061	85.53	2.0	203.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
8260	tr|O53324|O53324_M	P14061	85.53	2.0	203.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
8261	tr|O53324|O53324_M	P14061	85.53	2.0	203.0	DB01561	experimental; illicit	Androstanedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
8262	tr|O53324|O53324_M	P14061	85.53	2.0	203.0	DB02187	experimental	Equilin	O=C1CC[C@H]([C@@]12C)C=3[C@H](CC2)c4c(CC3)cc(O)cc4
8263	tr|O53324|O53324_M	P14061	85.53	2.0	203.0	DB02323	experimental	EM-1745	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)C[C@@H]([C@@H]4O)CCCCCCCCC(=O)OC[C@H]5O[C@H]([C@H](O)[C@@H]5O)n6cnc(c67)c(N)ncn7
8264	tr|O53324|O53324_M	P14061	85.53	2.0	203.0	DB02901	illicit; investigational	Stanolone	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
8265	tr|O53324|O53324_M	P14061	85.53	2.0	203.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
8266	tr|O53324|O53324_M	P14061	85.53	2.0	203.0	DB13951	experimental	Stanolone acetate	CC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
8267	tr|O53324|O53324_M	Q6PKH6	77.45	28.0	210.0	DB04200	experimental	Matairesinol	COc1cc(ccc1O)C[C@H]2COC(=O)[C@@H]2Cc3ccc(O)c(c3)OC
8268	tr|O53324|O53324_M	P80365	92.77	80.0	298.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
8269	tr|O53324|O53324_M	P80365	92.77	80.0	298.0	DB01185	approved; illicit	Fluoxymesterone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@](F)([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
8270	tr|O53324|O53324_M	P80365	92.77	80.0	298.0	DB01569	experimental; illicit	Formebolone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@H]([C@@H](C2)O)[C@]4(C)C(CC3)=CC(=O)C(C=O)=C4
8271	tr|O53324|O53324_M	P80365	92.77	80.0	298.0	DB14538	experimental; vet_approved	Hydrocortisone aceponate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CC)C(=O)COC(=O)C
8272	tr|O53324|O53324_M	P80365	92.77	80.0	298.0	DB14539	approved; vet_approved	Hydrocortisone acetate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)C
8273	tr|O53324|O53324_M	P80365	92.77	80.0	298.0	DB14540	approved; vet_approved	Hydrocortisone butyrate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCC
8274	tr|O53324|O53324_M	P80365	92.77	80.0	298.0	DB14541	approved; investigational; vet_approved	Hydrocortisone cypionate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)CCC5CCCC5
8275	tr|O53324|O53324_M	P80365	92.77	80.0	298.0	DB14542	approved; vet_approved	Hydrocortisone phosphate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COP(=O)(O)O
8276	tr|O53324|O53324_M	P80365	92.77	80.0	298.0	DB14543	approved; vet_approved	Hydrocortisone probutate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CCC)C(=O)COC(=O)CC
8277	tr|O53324|O53324_M	P80365	92.77	80.0	298.0	DB14544	approved; vet_approved	Hydrocortisone valerate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCCC
8278	tr|O53324|O53324_M	Q9BY49	82.13	16.0	209.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
8279	tr|O53324|O53324_M	Q8TC12	87.23	38.0	243.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
8280	tr|O53324|O53324_M	Q84EX5	87.23	3.0	208.0	DB04619	experimental	Acetophenone	CC(=O)c1ccccc1
8281	tr|O53324|O53324_M	Q84EX5	87.23	3.0	208.0	DB04784	experimental	(R)-1-phenylethanol	C[C@@H](O)c1ccccc1
8282	tr|O53324|O53324_M	Q92781	79.15	28.0	214.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
8283	tr|O53324|O53324_M	Q92781	79.15	28.0	214.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
8284	tr|O53324|O53324_M	Q96NR8	87.23	36.0	241.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
8286	tr|O53324|O53324_M	Q8NBN7	87.23	36.0	241.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
8287	tr|O53324|O53324_M	P37058	92.34	48.0	265.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
8288	tr|O53324|O53324_M	Q02338	79.15	55.0	241.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
8289	tr|O53324|O53324_M	O75911	83.83	34.0	231.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
8290	tr|O53324|O53324_M	Q9HBH5	92.77	41.0	259.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
8291	tr|O53324|O53324_M	P28845	95.32	32.0	256.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
8292	tr|O53324|O53324_M	P28845	95.32	32.0	256.0	DB02329	experimental	Carbenoxolone	OC(=O)CCC(=O)O[C@@H](CC1)C(C)(C)[C@@H]([C@]12C)CC[C@]3(C)[C@@H]2C(=O)C=C4[C@H]5[C@@](C)(CC[C@@]34C)CC[C@](C5)(C)C(=O)O
8293	tr|O53324|O53324_M	P28845	95.32	32.0	256.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
8294	tr|O53324|O53324_M	P28845	95.32	32.0	256.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
8295	tr|O53324|O53324_M	P28845	95.32	32.0	256.0	DB04652	experimental	Corticosterone	OCC(=O)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H]([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
8296	tr|O53324|O53324_M	P28845	95.32	32.0	256.0	DB05064	investigational	INCB13739	 
8297	tr|O53324|O53324_M	P28845	95.32	32.0	256.0	DB06992	experimental	(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone	Cc1ccc(cc1F)-c2nc(ccc2)C(=O)N(CC3(C)C)CCC3
8298	tr|O53324|O53324_M	P28845	95.32	32.0	256.0	DB07017	experimental	(5S)-2-{[(1S)-1-(4-Fluorophenyl)ethyl]amino}-5-(2-hydroxy-2-propanyl)-5-methyl-1,3-thiazol-4(5H)-one	Fc1ccc(cc1)[C@H](C)NC(=NC2=O)S[C@@]2(C)C(C)(C)O
8299	tr|O53324|O53324_M	P28845	95.32	32.0	256.0	DB07049	experimental	(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine	[O-][N+](=O)c1ccc(cc1)N2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)C(C)(C)C
8300	tr|O53324|O53324_M	P28845	95.32	32.0	256.0	DB07056	experimental	2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide	CCN(CC)C(=O)Cc1cccc(n1)NS(=O)(=O)c2c(C)c(Cl)ccc2
8301	tr|O53324|O53324_M	P28845	95.32	32.0	256.0	DB07310	experimental	(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one	Fc1ccccc1[C@H](C)NC(=NC2=O)S[C@]2(C)C(F)(F)F
8302	tr|O53324|O53324_M	P28845	95.32	32.0	256.0	DB07316	experimental	N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)C3CCN(CC3)CC4(CC4)C(=O)N
8303	tr|O53324|O53324_M	P28845	95.32	32.0	256.0	DB07619	experimental	N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)[C@H]3CC[C@@H](CC3)c4cccnc4
8304	tr|O53324|O53324_M	P28845	95.32	32.0	256.0	DB07624	experimental	1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide	C1CC1(C(=O)N)CN2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)[C@](C)(O)C(F)(F)F
8305	tr|O53324|O53324_M	P28845	95.32	32.0	256.0	DB07866	experimental	(5S)-2-(Cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one	CCC[C@]1(C)SC(=NC1=O)NC2CCCCCCC2
8306	tr|O53324|O53324_M	P28845	95.32	32.0	256.0	DB08277	experimental	2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE	CS(=O)(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4c(Cl)cc(F)cc4
8307	tr|O53324|O53324_M	P28845	95.32	32.0	256.0	DB08280	experimental	(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE	NC(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4ccc(OC)cc4
8308	tr|O53324|O53324_M	P28845	95.32	32.0	256.0	DB08771	experimental	(5R)-2-[(2-Fluorophenyl)amino]-5-isopropyl-1,3-thiazol-4(5H)-one	CC(C)[C@H]1SC(=NC1=O)Nc2c(F)cccc2
8309	tr|O53324|O53324_M	P28845	95.32	32.0	256.0	DB13751	approved; experimental	Glycyrrhizic acid	C1C[C@](C)(C(=O)O)C[C@H]([C@]12C)C=3[C@@](C)(CC2)[C@@]4(C)[C@H](C(=O)C3)[C@]5(C)[C@@H](CC4)C(C)(C)[C@H](CC5)O[C@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O[C@@H]7O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]7O
8310	tr|O53324|O53324_M	Q99714	87.66	6.0	212.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
8311	tr|O53324|O53324_M	Q99714	87.66	6.0	212.0	DB02820	experimental	1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct	C1CCCCCN1C(=O)[C@H](c2ccccc2)n(c3=S)cnc(c34)nn(c4)[C@H]5C=CN(C=C5C([O-])=N)[C@@H]6O[C@@H]([C@@H](O)[C@H]6O)COP([O-])(=O)OP(=O)(O)OC[C@H]7O[C@H]([C@H]([O-])[C@@H]7[O-])n8cnc(c89)c(N)ncn9
8312	tr|O53324|O53324_M	Q99714	87.66	6.0	212.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
8313	tr|O53324|O53324_M	P51659	80.85	6.0	196.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
8314	tr|O53324|O53324_M	P51659	80.85	6.0	196.0	DB03192	experimental	(R)-3-hydroxydecanoyl-CoA	CCCCCCC[C@@H](O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
8315	tr|O53324|O53324_M	Q16698	85.11	55.0	255.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
8316	tr|O53324|O53324_M	Q16698	85.11	55.0	255.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
8317	tr|O53324|O53324_M	P0AEK4	92.34	1.0	218.0	DB01691	experimental	Indole Naphthyridinone	c1cccc(c12)n(C)cc2CN(C)C(=O)/C=C/c(c3)cnc(c34)NC(=O)CC4
8318	tr|O53324|O53324_M	P0AEK4	92.34	1.0	218.0	DB01865	experimental	3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide	c1cccc(c12)cc(n2C)CN(C)C(=O)/C=C/c3cnc(N)cc3
8319	tr|O53324|O53324_M	P0AEK4	92.34	1.0	218.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
8320	tr|O53324|O53324_M	P0AEK4	92.34	1.0	218.0	DB03030	experimental	4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole	Cc1ccc(cc1)Cn2cnc(c2)-c3cccs3
8321	tr|O53324|O53324_M	P0AEK4	92.34	1.0	218.0	DB03534	experimental	3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide	CC(=O)N(C)Cc1c(N)ccc(c1)C(=O)N(C)Cc(n2C)cc(c23)cccc3
8322	tr|O53324|O53324_M	P0AEK4	92.34	1.0	218.0	DB04030	experimental	1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole	Oc1ccc(cc1)Cn2c(c3c(c24)cccc4)CN(CC3)C(=O)c5ccc(O)cc5
8323	tr|O53324|O53324_M	P0AEK4	92.34	1.0	218.0	DB08265	experimental	2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL	Cc1ccc(cc1)S(=O)(=O)n(b2O)ncc(c23)cccc3
8324	tr|O53324|O53324_M	P0AEK4	92.34	1.0	218.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
8325	tr|O53324|O53324_M	P0AEK4	92.34	1.0	218.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
8326	tr|O53324|O53324_M	P16152	98.3	7.0	238.0	DB01698	approved; experimental; investigational	Rutin	O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O[C@H]1C)OC[C@H]2O[C@H]([C@H](O)[C@@H](O)[C@@H]2O)Oc(c3=O)c(-c4cc(O)c(O)cc4)oc(c35)cc(O)cc5O
8327	tr|O53324|O53324_M	P16152	98.3	7.0	238.0	DB02709	investigational	Resveratrol	Oc1ccc(cc1)/C=C/c2cc(O)cc(O)c2
8328	tr|O53324|O53324_M	P16152	98.3	7.0	238.0	DB03394	experimental	Heptaethylene glycol	OCCOCCOCCOCCOCCOCCOCCO
8329	tr|O53324|O53324_M	P16152	98.3	7.0	238.0	DB03556	experimental	2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400	CCOCCOCCOCCOCCOCCOCCOCCOCCO
8330	tr|O53324|O53324_M	P16152	98.3	7.0	238.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
8331	tr|O53324|O53324_M	P16152	98.3	7.0	238.0	DB04463	experimental	3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol	n1cnc(N)c(c12)c(nn2C(C)(C)C)-c3cccc(O)c3
8332	tr|O53324|O53324_M	P16152	98.3	7.0	238.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
8333	tr|O53324|O53324_M	P16152	98.3	7.0	238.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
8334	tr|O53324|O53324_M	A0A348A0U3	95.74	1.0	226.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
8335	tr|O53324|O53324_M	P56937	97.45	2.0	231.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
8336	tr|O53324|O53324_M	Q6GI75	95.74	1.0	226.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
8337	tr|O53324|O53324_M	Q6GI75	95.74	1.0	226.0	DB11155	approved	Triclocarban	Clc1ccc(cc1)NC(=O)Nc2cc(Cl)c(Cl)cc2
8338	tr|O53324|O53324_M	Q8I814	85.53	13.0	214.0	DB02015	experimental	Dihydrofolic Acid	O=c1[nH]c(N)nc(c12)NCC(=N2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
8339	tr|O53324|O53324_M	Q8I814	85.53	13.0	214.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
8340	tr|O53324|O53324_M	Q01782	92.77	8.0	226.0	DB02338	experimental	NADPH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
8341	tr|O53324|O53324_M	Q01782	92.77	8.0	226.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
8342	tr|O53324|O53324_M	Q01782	92.77	8.0	226.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
8343	tr|O53324|O53324_M	Q01782	92.77	8.0	226.0	DB04400	experimental	L-erythro-7,8-dihydrobiopterin	C[C@H](O)[C@H](O)C(CN1)=Nc(c12)c(=O)nc([nH]2)N
8344	tr|O53324|O53324_M	P35270	90.21	6.0	218.0	DB02637	experimental	Oxaloacetate Ion	OC(=O)C(=O)CC([O-])=O
8345	tr|O53324|O53324_M	P35270	90.21	6.0	218.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
8346	tr|O53324|O53324_M	P35270	90.21	6.0	218.0	DB03886	experimental	Biopterin	C[C@@H](O)[C@@H](O)c(n1)cnc(c12)nc(N)[nH]c2=O
8347	tr|O53324|O53324_M	P35270	90.21	6.0	218.0	DB04275	experimental	N-acetylserotonin	CC(=O)NCCc1c[nH]c(c12)ccc(c2)O
8348	tr|O53324|O53324_M	Q7AUG5	71.49	13.0	181.0	DB04782	experimental	(S)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@H]2CO2
8349	tr|O53324|O53324_M	Q93D82	71.49	13.0	181.0	DB04472	experimental	(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol	[N-]=[N+]=NC[C@H](O)c1ccc([N+]([O-])=O)cc1
8350	tr|O53324|O53324_M	Q93D82	71.49	13.0	181.0	DB04499	experimental	(R)-styrene oxide	C1O[C@@H]1c2ccccc2
8351	tr|O53324|O53324_M	Q93D82	71.49	13.0	181.0	DB04777	experimental	(R)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@@H]2CO2
8352	tr|O53324|O53324_M	P9WGR1	83.4	5.0	201.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
8353	tr|O53324|O53324_M	P9WGR1	83.4	5.0	201.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
8354	tr|O53324|O53324_M	P9WGR1	83.4	5.0	201.0	DB02990	experimental	S-(2-Acetamidoethyl) hexadecanethioate	CCCCCCCCCCCCCCCC(=O)SCCNC(=O)C
8355	tr|O53324|O53324_M	P9WGR1	83.4	5.0	201.0	DB04289	experimental	Genz-10850	[nH]1ccc(c12)cc(cc2)C(=O)N3CCN(CC3)C4c(cccc5)c5c(c46)cccc6
8356	tr|O53324|O53324_M	P9WGR1	83.4	5.0	201.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
8357	tr|O53324|O53324_M	P9WGR1	83.4	5.0	201.0	DB07090	experimental	(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cccc(c1C)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
8358	tr|O53324|O53324_M	P9WGR1	83.4	5.0	201.0	DB07123	experimental	N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE	Cc1ccc(cc1)C(=O)N2CCC(CC2)Cc3ccccc3
8359	tr|O53324|O53324_M	P9WGR1	83.4	5.0	201.0	DB07155	experimental	(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE	c1ccccc1NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
8360	tr|O53324|O53324_M	P9WGR1	83.4	5.0	201.0	DB07178	experimental	5-PENTYL-2-PHENOXYPHENOL	CCCCCc1cc(O)c(cc1)Oc2ccccc2
8361	tr|O53324|O53324_M	P9WGR1	83.4	5.0	201.0	DB07188	experimental	(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(cc(Cl)c1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
8362	tr|O53324|O53324_M	P9WGR1	83.4	5.0	201.0	DB07192	experimental	(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Brc1cc(ccc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
8363	tr|O53324|O53324_M	P9WGR1	83.4	5.0	201.0	DB07222	experimental	(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(c(C)cc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
8364	tr|O53324|O53324_M	P9WGR1	83.4	5.0	201.0	DB07287	experimental	2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL	c1cccnc1Cc2cc(O)c(cc2)Oc3ccc(Cl)cc3Cl
8365	tr|O53324|O53324_M	P9WGR1	83.4	5.0	201.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
8366	tr|O53324|O53324_M	O24990	84.26	1.0	199.0	DB04393	experimental	Soneclosan	Clc1cc(O)c(cc1)Oc2ccc(Cl)cc2
8367	tr|O53324|O53324_M	O24990	84.26	1.0	199.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
8368	tr|O53324|O53324_M	P49327	71.49	1884.0	2052.0	DB01034	experimental	Cerulenin	NC(=O)[C@@H]1O[C@@H]1C(=O)CC/C=C/C/C=C/C
8369	tr|O53324|O53324_M	P49327	71.49	1884.0	2052.0	DB01083	approved; investigational	Orlistat	CCCCCCCCCCC[C@H](OC(=O)[C@@H](NC=O)CC(C)C)C[C@@H]1OC(=O)[C@H]1CCCCCC
8370	tr|O53324|O53324_M	P09417	77.87	10.0	193.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
8371	tr|O53324|O53324_M	P09417	77.87	10.0	193.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
8372	tr|O53324|O53324_M	Q14376	71.06	3.0	170.0	DB01861	experimental	Uridine diphosphate glucose	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
8373	tr|O53324|O53324_M	Q14376	71.06	3.0	170.0	DB02196	experimental	Uridine-Diphosphate-N-Acetylgalactosamine	CC(=O)N[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
8374	tr|O53324|O53324_M	Q14376	71.06	3.0	170.0	DB03041	experimental	UDP-alpha-D-glucuronic acid	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O
8375	tr|O53324|O53324_M	Q14376	71.06	3.0	170.0	DB03095	experimental	Tetramethylammonium	C[N+](C)(C)C
8376	tr|O53324|O53324_M	Q14376	71.06	3.0	170.0	DB03397	experimental	Uridine-Diphosphate-N-Acetylglucosamine	CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
8377	tr|O53324|O53324_M	Q14376	71.06	3.0	170.0	DB03501	experimental	Galactose-uridine-5'-diphosphate	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@H]1O)O[P@](=O)(O)O[P@](=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
8378	tr|O53324|O53324_M	P26391	81.28	3.0	194.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
8379	tr|O53324|O53324_M	Q9ZGH3	70.64	3.0	169.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
8380	tr|O53324|O53324_M	Q8T8E9	82.55	2.0	196.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
8381	tr|O86335|O86335_M	Q9ZGI2	95.22	3.0	1338.0	DB07703	experimental	(3R,4S,5S,7R,9E,11R,12R)-12-ETHYL-4-HYDROXY-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE	C[C@@H]1C[C@H](C)[C@H](O)[C@@H](C)C(=O)O[C@H](CC)[C@H](C)/C=C/C1=O
8382	tr|O86335|O86335_M	Q9ZGI2	95.22	3.0	1338.0	DB08431	experimental	[(3R,4S)-4-HYDROXY-3-METHYL-2-OXOHEXYL]PHOSPHONIC ACID	CC[C@H](O)[C@@H](C)C(=O)C[P@@H](=O)O
8383	tr|O86335|O86335_M	Q9ZGI2	95.22	3.0	1338.0	DB08759	experimental	[(3R,4S,5S,7R)-4,8-DIHYDROXY-3,5,7-TRIMETHYL-2-OXOOCTYL]PHOSPHONIC ACID	OC[C@H](C)C[C@H](C)[C@H](O)[C@@H](C)C(=O)C[P@H](=O)O
8384	tr|O53561|O53561_M	P30084	96.96	34.0	289.0	DB02563	experimental	Hexanoyl-CoA	CCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
8385	tr|O53561|O53561_M	P30084	96.96	34.0	289.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
8386	tr|O53561|O53561_M	P30084	96.96	34.0	289.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
8387	tr|O53561|O53561_M	P30084	96.96	34.0	289.0	DB04117	experimental	4-(N,N-Dimethylamino)cinnamoyl-CoA	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)/C=C/c4ccc(cc4)N(C)C
8388	tr|O53561|O53561_M	P30084	96.96	34.0	289.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
8389	tr|O53561|O53561_M	Q6NVY1	93.54	33.0	279.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
8390	tr|O53561|O53561_M	P52045	93.54	13.0	259.0	DB03117	experimental	2-carboxypropyl-coenzyme A	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC[C@H](C)C(=O)O
8391	tr|O53561|O53561_M	O75521	93.92	144.0	391.0	DB08231	experimental	Myristic acid	CCCCCCCCCCCCCC(=O)O
8392	tr|O53561|O53561_M	P9WNP5	99.24	46.0	307.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
8393	tr|O53561|O53561_M	P9WNP5	99.24	46.0	307.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
8394	tr|O53561|O53561_M	O68600	84.03	12.0	233.0	DB01652	experimental	4-hydroxybenzoyl-CoA	Oc1ccc(cc1)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2OP(=O)(O)O)n3cnc(c34)c(N)ncn4
8395	tr|O53561|O53561_M	P42126	90.49	45.0	283.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
8396	tr|O53561|O53561_M	P42126	90.49	45.0	283.0	DB03127	experimental	Benzamidine	NC(=[NH2+])c1ccccc1
8397	tr|O53561|O53561_M	Q93TU6	80.23	16.0	227.0	DB02906	experimental	(2s,4s)-Alpha-Campholinic Acid	CC1(C)[C@H](C)C(=O)C[C@H]1CC(O)O
8398	tr|O53561|O53561_M	Q08426	75.67	11.0	210.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
8399	tr|O53561|O53561_M	P28793	79.85	25.0	235.0	DB08249	experimental	3,6,9,12,15-PENTAOXATRICOSAN-1-OL	CCCCCCCCOCCOCCOCCOCCOCCO
8400	tr|O07732|O07732_M	O07732	99.78	1.0	462.0	DB02596	experimental	alpha,beta-Methyleneadenosine 5'-triphosphate	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)CP(=O)(O)OP(=O)(O)O
8401	tr|O53154|O53154_M	P08183	86.84	392.0	623.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8402	tr|O53154|O53154_M	P08183	86.84	392.0	623.0	DB00603	approved; investigational	Medroxyprogesterone acetate	CC(=O)O[C@]1(C(=O)C)CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C([C@H](C3)C)=CC(=O)CC4
8403	tr|O53154|O53154_M	P08183	86.84	392.0	623.0	DB00778	approved; investigational; withdrawn	Roxithromycin	COCCOCO/N=C([C@H](C)[C@@H](O)[C@]1(C)O)/[C@H](C)C[C@@](C)(O)[C@@H]([C@@H](C)[C@@H]([C@@H](C)C(=O)O[C@@H]1CC)O[C@@H](C[C@@]2(C)OC)O[C@@H](C)[C@@H]2O)O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C
8404	tr|O53154|O53154_M	P08183	86.84	392.0	623.0	DB00813	approved; illicit; investigational; vet_approved	Fentanyl	c1ccccc1N(C(=O)CC)C2CCN(CC2)CCc3ccccc3
8405	tr|O53154|O53154_M	P08183	86.84	392.0	623.0	DB04877	experimental	Voacamine	CC[C@H]1C[C@@H](C2)CN([C@@H]1[C@@]23C(=O)OC)CCc4c3[nH]c5c4cc(OC)c(c5)[C@@H](C[C@H]67)c8c(c9c([nH]8)cccc9)C[C@H](C6C(=O)OC)N(C)CC\7=C\C
8406	tr|O53154|O53154_M	P08183	86.84	392.0	623.0	DB04881	investigational	Elacridar	COc1cccc(c12)c(=O)c3c([nH]2)c(ccc3)C(=O)Nc4ccc(cc4)CCN(C5)CCc(c56)cc(OC)c(c6)OC
8407	tr|O53154|O53154_M	P08183	86.84	392.0	623.0	DB04905	investigational	Tesmilifene	CCN(CC)CCOc1ccc(cc1)Cc2ccccc2
8408	tr|O53154|O53154_M	P08183	86.84	392.0	623.0	DB05449	investigational	FM-VP4	 
8409	tr|O53154|O53154_M	P08183	86.84	392.0	623.0	DB06191	investigational	Zosuquidar	FC1(F)[C@H]2[C@@H]1c(cccc3)c3[C@@H](c(c24)cccc4)N5CCN(CC5)C[C@@H](O)COc6cccc(c67)nccc7
8410	tr|O53154|O53154_M	P08183	86.84	392.0	623.0	DB06240	investigational	Tariquidar	COc(c1)c(OC)cc(c12)CCN(C2)CCc3ccc(cc3)NC(=O)c4cc(OC)c(OC)cc4NC(=O)c(c5)cnc(c56)cccc6
8411	tr|O53154|O53154_M	P08183	86.84	392.0	623.0	DB09031	approved; investigational	Miltefosine	CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C
8412	tr|O53154|O53154_M	P08183	86.84	392.0	623.0	DB11635	approved	Tocofersolan	 
8413	tr|O53154|O53154_M	P08183	86.84	392.0	623.0	DB14061	experimental	Hycanthone	CCN(CC)CCNc(ccc1CO)c(c12)c(=O)c3c(s2)cccc3
8414	tr|O53154|O53154_M	P08183	86.84	392.0	623.0	DB14062	experimental	Concanamycin A	NC(=O)O[C@@H]1[C@@H](C)O[C@H](C[C@H]1O)O[C@H](C2)[C@H](C)[C@@H](/C=C/C)O[C@@]2(O)[C@@H](C)[C@H](O)[C@H](C)[C@H]3OC(=O)/C(OC)=C/C(C)=C/[C@@H](C)[C@@H](O)[C@@H](CC)[C@@H](O)[C@H](C)C/C(C)=C/C=C/[C@@H]3OC
8415	tr|O53154|O53154_M	P08183	86.84	392.0	623.0	DB14063	experimental	Dexverapamil	COc1ccc(cc1OC)CCN(C)CCC[C@@](C#N)(C(C)C)c2cc(OC)c(OC)cc2
8416	tr|O53154|O53154_M	P08183	86.84	392.0	623.0	DB14064	experimental	Emopamil	c1ccccc1C(C#N)(C(C)C)CCCN(C)CCc2ccccc2
8417	tr|O53154|O53154_M	P08183	86.84	392.0	623.0	DB14065	experimental	Lomerizine	COc1ccc(c(OC)c1OC)CN2CCN(CC2)C(c3ccc(F)cc3)c4ccc(F)cc4
8418	tr|O53154|O53154_M	P08183	86.84	392.0	623.0	DB14066	experimental	Tetrandrine	c12ccc(OC)c(c1)Oc3ccc(cc3)C[C@H]4c5c(CCN4C)cc(OC)c(c5)Oc6c7c(CCN(C)[C@H]7C2)cc(OC)c6OC
8419	tr|O53154|O53154_M	P08183	86.84	392.0	623.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
8420	tr|O53154|O53154_M	P08183	86.84	392.0	623.0	DB14068	experimental	Dexniguldipine	[O-][N+](=O)c1cccc(c1)[C@@H]2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCCN(CC3)CCC3(c4ccccc4)c5ccccc5
8421	tr|O53154|O53154_M	P08183	86.84	392.0	623.0	DB14069	investigational	ONT-093	CCOC/C=C/c1ccc(cc1)-c2nc(-c3ccc(cc3)NC(C)C)c([nH]2)-c4ccc(cc4)NC(C)C
8422	tr|O53154|O53154_M	P08183	86.84	392.0	623.0	DB14070	experimental	HM-30181	c1cccc(c12)c(=O)cc(o2)C(=O)Nc3cc(OC)c(OC)cc3-c4nn(nn4)-c5ccc(cc5)CCN(C6)CCc(c67)cc(OC)c(c7)OC
8423	tr|O53154|O53154_M	P08183	86.84	392.0	623.0	DB14071	experimental	Desmethylsertraline	c1cccc(c12)[C@@H](CC[C@@H]2N)c3cc(Cl)c(Cl)cc3
8424	tr|O53154|O53154_M	P08183	86.84	392.0	623.0	DB14072	experimental	Reversin 121	c1ccccc1COC(=O)C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@H](C(=O)OC(C)(C)C)CCCCNC(=O)OCc2ccccc2
8425	tr|O53154|O53154_M	P08183	87.97	1037.0	1271.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8426	tr|O53154|O53154_M	P08183	87.97	1037.0	1271.0	DB00603	approved; investigational	Medroxyprogesterone acetate	CC(=O)O[C@]1(C(=O)C)CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C([C@H](C3)C)=CC(=O)CC4
8427	tr|O53154|O53154_M	P08183	87.97	1037.0	1271.0	DB00778	approved; investigational; withdrawn	Roxithromycin	COCCOCO/N=C([C@H](C)[C@@H](O)[C@]1(C)O)/[C@H](C)C[C@@](C)(O)[C@@H]([C@@H](C)[C@@H]([C@@H](C)C(=O)O[C@@H]1CC)O[C@@H](C[C@@]2(C)OC)O[C@@H](C)[C@@H]2O)O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C
8428	tr|O53154|O53154_M	P08183	87.97	1037.0	1271.0	DB00813	approved; illicit; investigational; vet_approved	Fentanyl	c1ccccc1N(C(=O)CC)C2CCN(CC2)CCc3ccccc3
8429	tr|O53154|O53154_M	P08183	87.97	1037.0	1271.0	DB04877	experimental	Voacamine	CC[C@H]1C[C@@H](C2)CN([C@@H]1[C@@]23C(=O)OC)CCc4c3[nH]c5c4cc(OC)c(c5)[C@@H](C[C@H]67)c8c(c9c([nH]8)cccc9)C[C@H](C6C(=O)OC)N(C)CC\7=C\C
8430	tr|O53154|O53154_M	P08183	87.97	1037.0	1271.0	DB04881	investigational	Elacridar	COc1cccc(c12)c(=O)c3c([nH]2)c(ccc3)C(=O)Nc4ccc(cc4)CCN(C5)CCc(c56)cc(OC)c(c6)OC
8431	tr|O53154|O53154_M	P08183	87.97	1037.0	1271.0	DB04905	investigational	Tesmilifene	CCN(CC)CCOc1ccc(cc1)Cc2ccccc2
8432	tr|O53154|O53154_M	P08183	87.97	1037.0	1271.0	DB05449	investigational	FM-VP4	 
8433	tr|O53154|O53154_M	P08183	87.97	1037.0	1271.0	DB06191	investigational	Zosuquidar	FC1(F)[C@H]2[C@@H]1c(cccc3)c3[C@@H](c(c24)cccc4)N5CCN(CC5)C[C@@H](O)COc6cccc(c67)nccc7
8434	tr|O53154|O53154_M	P08183	87.97	1037.0	1271.0	DB06240	investigational	Tariquidar	COc(c1)c(OC)cc(c12)CCN(C2)CCc3ccc(cc3)NC(=O)c4cc(OC)c(OC)cc4NC(=O)c(c5)cnc(c56)cccc6
8435	tr|O53154|O53154_M	P08183	87.97	1037.0	1271.0	DB09031	approved; investigational	Miltefosine	CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C
8436	tr|O53154|O53154_M	P08183	87.97	1037.0	1271.0	DB11635	approved	Tocofersolan	 
8437	tr|O53154|O53154_M	P08183	87.97	1037.0	1271.0	DB14061	experimental	Hycanthone	CCN(CC)CCNc(ccc1CO)c(c12)c(=O)c3c(s2)cccc3
8438	tr|O53154|O53154_M	P08183	87.97	1037.0	1271.0	DB14062	experimental	Concanamycin A	NC(=O)O[C@@H]1[C@@H](C)O[C@H](C[C@H]1O)O[C@H](C2)[C@H](C)[C@@H](/C=C/C)O[C@@]2(O)[C@@H](C)[C@H](O)[C@H](C)[C@H]3OC(=O)/C(OC)=C/C(C)=C/[C@@H](C)[C@@H](O)[C@@H](CC)[C@@H](O)[C@H](C)C/C(C)=C/C=C/[C@@H]3OC
8439	tr|O53154|O53154_M	P08183	87.97	1037.0	1271.0	DB14063	experimental	Dexverapamil	COc1ccc(cc1OC)CCN(C)CCC[C@@](C#N)(C(C)C)c2cc(OC)c(OC)cc2
8440	tr|O53154|O53154_M	P08183	87.97	1037.0	1271.0	DB14064	experimental	Emopamil	c1ccccc1C(C#N)(C(C)C)CCCN(C)CCc2ccccc2
8441	tr|O53154|O53154_M	P08183	87.97	1037.0	1271.0	DB14065	experimental	Lomerizine	COc1ccc(c(OC)c1OC)CN2CCN(CC2)C(c3ccc(F)cc3)c4ccc(F)cc4
8442	tr|O53154|O53154_M	P08183	87.97	1037.0	1271.0	DB14066	experimental	Tetrandrine	c12ccc(OC)c(c1)Oc3ccc(cc3)C[C@H]4c5c(CCN4C)cc(OC)c(c5)Oc6c7c(CCN(C)[C@H]7C2)cc(OC)c6OC
8443	tr|O53154|O53154_M	P08183	87.97	1037.0	1271.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
8444	tr|O53154|O53154_M	P08183	87.97	1037.0	1271.0	DB14068	experimental	Dexniguldipine	[O-][N+](=O)c1cccc(c1)[C@@H]2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCCN(CC3)CCC3(c4ccccc4)c5ccccc5
8445	tr|O53154|O53154_M	P08183	87.97	1037.0	1271.0	DB14069	investigational	ONT-093	CCOC/C=C/c1ccc(cc1)-c2nc(-c3ccc(cc3)NC(C)C)c([nH]2)-c4ccc(cc4)NC(C)C
8446	tr|O53154|O53154_M	P08183	87.97	1037.0	1271.0	DB14070	experimental	HM-30181	c1cccc(c12)c(=O)cc(o2)C(=O)Nc3cc(OC)c(OC)cc3-c4nn(nn4)-c5ccc(cc5)CCN(C6)CCc(c67)cc(OC)c(c7)OC
8447	tr|O53154|O53154_M	P08183	87.97	1037.0	1271.0	DB14071	experimental	Desmethylsertraline	c1cccc(c12)[C@@H](CC[C@@H]2N)c3cc(Cl)c(Cl)cc3
8448	tr|O53154|O53154_M	P08183	87.97	1037.0	1271.0	DB14072	experimental	Reversin 121	c1ccccc1COC(=O)C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@H](C(=O)OC(C)(C)C)CCCCNC(=O)OCc2ccccc2
8449	tr|O53154|O53154_M	Q2M3G0	86.47	386.0	616.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
8450	tr|O53154|O53154_M	Q2M3G0	86.47	386.0	616.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
8451	tr|O53154|O53154_M	Q2M3G0	87.59	1015.0	1248.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
8452	tr|O53154|O53154_M	Q2M3G0	87.59	1015.0	1248.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
8453	tr|O53154|O53154_M	O95342	86.84	420.0	651.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8454	tr|O53154|O53154_M	O95342	86.84	420.0	651.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
8455	tr|O53154|O53154_M	O95342	87.59	1078.0	1311.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8456	tr|O53154|O53154_M	O95342	87.59	1078.0	1311.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
8457	tr|O53154|O53154_M	O60706	87.97	666.0	900.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8458	tr|O53154|O53154_M	O60706	87.97	666.0	900.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
8459	tr|O53154|O53154_M	O60706	87.97	666.0	900.0	DB09220	approved; investigational	Nicorandil	[O-][N+](=O)OCCNC(=O)c1cccnc1
8460	tr|O53154|O53154_M	O60706	83.08	1312.0	1533.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8461	tr|O53154|O53154_M	O60706	83.08	1312.0	1533.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
8462	tr|O53154|O53154_M	O60706	83.08	1312.0	1533.0	DB09220	approved; investigational	Nicorandil	[O-][N+](=O)OCCNC(=O)c1cccnc1
8463	tr|O53154|O53154_M	Q09428	85.71	686.0	914.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8464	tr|O53154|O53154_M	Q09428	85.71	686.0	914.0	DB00222	approved	Glimepiride	CCC1=C(C)CN(C1=O)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3
8465	tr|O53154|O53154_M	Q09428	85.71	686.0	914.0	DB00672	approved; investigational	Chlorpropamide	CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1
8466	tr|O53154|O53154_M	Q09428	85.71	686.0	914.0	DB00731	approved; investigational	Nateglinide	CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](C(=O)O)Cc2ccccc2
8467	tr|O53154|O53154_M	Q09428	85.71	686.0	914.0	DB00912	approved; investigational	Repaglinide	CCOc1c(C(=O)O)ccc(c1)CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3
8468	tr|O53154|O53154_M	Q09428	85.71	686.0	914.0	DB01067	approved; investigational	Glipizide	Cc1ncc(nc1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
8469	tr|O53154|O53154_M	Q09428	85.71	686.0	914.0	DB01120	approved	Gliclazide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN(C2)CC(C23)CCC3
8470	tr|O53154|O53154_M	Q09428	85.71	686.0	914.0	DB01124	approved; investigational	Tolbutamide	CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1
8471	tr|O53154|O53154_M	Q09428	85.71	686.0	914.0	DB01251	approved; investigational	Gliquidone	COc(cc1)cc(c12)C(=O)N(C(=O)C2(C)C)CCc3ccc(cc3)S(=O)(=O)NC(=O)NC4CCCCC4
8472	tr|O53154|O53154_M	Q09428	85.71	686.0	914.0	DB01252	investigational	Mitiglinide	c1ccccc1C[C@H](C(=O)O)CC(=O)N(C2)C[C@H]([C@H]23)CCCC3
8473	tr|O53154|O53154_M	Q09428	85.71	686.0	914.0	DB01382	approved; investigational	Glymidine	COCCOc1cnc(nc1)NS(=O)(=O)c2ccccc2
8474	tr|O53154|O53154_M	Q09428	84.96	1344.0	1570.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8475	tr|O53154|O53154_M	Q09428	84.96	1344.0	1570.0	DB00222	approved	Glimepiride	CCC1=C(C)CN(C1=O)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3
8476	tr|O53154|O53154_M	Q09428	84.96	1344.0	1570.0	DB00672	approved; investigational	Chlorpropamide	CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1
8477	tr|O53154|O53154_M	Q09428	84.96	1344.0	1570.0	DB00731	approved; investigational	Nateglinide	CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](C(=O)O)Cc2ccccc2
8478	tr|O53154|O53154_M	Q09428	84.96	1344.0	1570.0	DB00912	approved; investigational	Repaglinide	CCOc1c(C(=O)O)ccc(c1)CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3
8479	tr|O53154|O53154_M	Q09428	84.96	1344.0	1570.0	DB01067	approved; investigational	Glipizide	Cc1ncc(nc1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
8480	tr|O53154|O53154_M	Q09428	84.96	1344.0	1570.0	DB01120	approved	Gliclazide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN(C2)CC(C23)CCC3
8481	tr|O53154|O53154_M	Q09428	84.96	1344.0	1570.0	DB01124	approved; investigational	Tolbutamide	CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1
8482	tr|O53154|O53154_M	Q09428	84.96	1344.0	1570.0	DB01251	approved; investigational	Gliquidone	COc(cc1)cc(c12)C(=O)N(C(=O)C2(C)C)CCc3ccc(cc3)S(=O)(=O)NC(=O)NC4CCCCC4
8483	tr|O53154|O53154_M	Q09428	84.96	1344.0	1570.0	DB01252	investigational	Mitiglinide	c1ccccc1C[C@H](C(=O)O)CC(=O)N(C2)C[C@H]([C@H]23)CCCC3
8484	tr|O53154|O53154_M	Q09428	84.96	1344.0	1570.0	DB01382	approved; investigational	Glymidine	COCCOc1cnc(nc1)NS(=O)(=O)c2ccccc2
8485	tr|O53154|O53154_M	Q09428	85.71	686.0	914.0	DB00839	approved; investigational	Tolazamide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2
8486	tr|O53154|O53154_M	Q09428	85.71	686.0	914.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
8487	tr|O53154|O53154_M	Q09428	84.96	1344.0	1570.0	DB00839	approved; investigational	Tolazamide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2
8488	tr|O53154|O53154_M	Q09428	84.96	1344.0	1570.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
8489	tr|O53154|O53154_M	P33527	81.2	644.0	860.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8490	tr|O53154|O53154_M	P33527	81.2	644.0	860.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
8491	tr|O53154|O53154_M	P33527	81.2	644.0	860.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
8492	tr|O53154|O53154_M	P33527	81.2	644.0	860.0	DB06176	approved; investigational	Romidepsin	O=C([C@H]12)N/C(=C\C)C(=O)N[C@@H](C(C)C)C(=O)O[C@@H](CC(=O)N[C@H](C(C)C)C(=O)N1)/C=C/CCSSC2
8493	tr|O53154|O53154_M	P33527	81.2	644.0	860.0	DB08855	experimental; investigational	Leukotriene C4	CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@@H](O)CCCC(=O)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@H](N)C(=O)O
8494	tr|O53154|O53154_M	P33527	85.71	1293.0	1521.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8495	tr|O53154|O53154_M	P33527	85.71	1293.0	1521.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
8496	tr|O53154|O53154_M	P33527	85.71	1293.0	1521.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
8497	tr|O53154|O53154_M	P33527	85.71	1293.0	1521.0	DB06176	approved; investigational	Romidepsin	O=C([C@H]12)N/C(=C\C)C(=O)N[C@@H](C(C)C)C(=O)O[C@@H](CC(=O)N[C@H](C(C)C)C(=O)N1)/C=C/CCSSC2
8498	tr|O53154|O53154_M	P33527	85.71	1293.0	1521.0	DB08855	experimental; investigational	Leukotriene C4	CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@@H](O)CCCC(=O)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@H](N)C(=O)O
8499	tr|O53154|O53154_M	O95255	81.2	631.0	847.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8500	tr|O53154|O53154_M	O95255	88.72	1265.0	1501.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8501	tr|O53154|O53154_M	O15440	76.32	576.0	779.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
8502	tr|O53154|O53154_M	O15440	76.32	576.0	779.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
8503	tr|O53154|O53154_M	O15440	87.22	1194.0	1426.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
8504	tr|O53154|O53154_M	O15440	87.22	1194.0	1426.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
8505	tr|O53154|O53154_M	Q92887	81.2	637.0	853.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8506	tr|O53154|O53154_M	Q92887	81.2	637.0	853.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
8507	tr|O53154|O53154_M	Q92887	83.08	1301.0	1522.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8508	tr|O53154|O53154_M	Q92887	83.08	1301.0	1522.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
8509	tr|O53154|O53154_M	O15439	76.69	415.0	619.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8510	tr|O53154|O53154_M	O15439	83.83	1043.0	1266.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8511	tr|O53154|O53154_M	O95477	84.59	901.0	1126.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8512	tr|O53154|O53154_M	O95477	84.59	901.0	1126.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
8513	tr|O53154|O53154_M	O95477	84.59	901.0	1126.0	DB01599	approved; investigational	Probucol	CC(C)(C)c1cc(cc(c1O)C(C)(C)C)SC(C)(C)Sc2cc(C(C)(C)C)c(O)c(c2)C(C)(C)C
8514	tr|O53154|O53154_M	O95477	90.23	1911.0	2151.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8515	tr|O53154|O53154_M	O95477	90.23	1911.0	2151.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
8516	tr|O53154|O53154_M	O95477	90.23	1911.0	2151.0	DB01599	approved; investigational	Probucol	CC(C)(C)c1cc(cc(c1O)C(C)(C)C)SC(C)(C)Sc2cc(C(C)(C)C)c(O)c(c2)C(C)(C)C
8517	tr|O53154|O53154_M	P13569	75.19	437.0	637.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8518	tr|O53154|O53154_M	P13569	75.19	437.0	637.0	DB00887	approved	Bumetanide	CCCCNc1c(c(S(=O)(=O)N)cc(c1)C(=O)O)Oc2ccccc2
8519	tr|O53154|O53154_M	P13569	75.19	437.0	637.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
8520	tr|O53154|O53154_M	P13569	75.19	437.0	637.0	DB01050	approved	Ibuprofen	CC(C)Cc1ccc(cc1)C(C)C(=O)O
8521	tr|O53154|O53154_M	P13569	75.19	437.0	637.0	DB02587	experimental; investigational	Colforsin	O[C@H]1CCC(C)(C)[C@@H]([C@]12C)[C@H](O)[C@H](OC(=O)C)[C@]3(C)[C@]2(O)C(=O)C[C@](O3)(C)C=C
8522	tr|O53154|O53154_M	P13569	75.19	437.0	637.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
8523	tr|O53154|O53154_M	P13569	75.19	437.0	637.0	DB04522	experimental	Dexfosfoserine	OC(=O)[C@@H](N)COP(=O)(O)O
8524	tr|O53154|O53154_M	P13569	75.19	437.0	637.0	DB04941	approved	Crofelemer	 
8525	tr|O53154|O53154_M	P13569	75.19	437.0	637.0	DB06266	investigational	Lonidamine	c1cccc(c12)n(nc2C(=O)O)Cc3c(Cl)cc(Cl)cc3
8526	tr|O53154|O53154_M	P13569	75.19	437.0	637.0	DB08820	approved	Ivacaftor	CC(C)(C)c1cc(C(C)(C)C)c(O)cc1NC(=O)c(c2=O)c[nH]c(c23)cccc3
8527	tr|O53154|O53154_M	P13569	75.19	437.0	637.0	DB09213	approved; investigational	Dexibuprofen	CC(C)Cc1ccc(cc1)[C@H](C)C(=O)O
8528	tr|O53154|O53154_M	P13569	75.19	437.0	637.0	DB09280	approved	Lumacaftor	O=C(O)c1cccc(c1)-c2nc(ccc2C)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
8529	tr|O53154|O53154_M	P13569	75.19	437.0	637.0	DB11712	approved; investigational	Tezacaftor	OC[C@H](O)Cn1c(C(C)(C)CO)cc(c12)cc(c(F)c2)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
8530	tr|O53154|O53154_M	P13569	75.19	437.0	637.0	DB15444	approved; investigational	Elexacaftor	FC(F)(F)C(C)(C)COc1nn(cc1)-c2nc(N(C3(C)C)C[C@@H](C)C3)c(cc2)C(=O)NS(=O)(=O)c4cn(C)nc4C
8531	tr|O53154|O53154_M	P13569	83.46	1212.0	1434.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8532	tr|O53154|O53154_M	P13569	83.46	1212.0	1434.0	DB00887	approved	Bumetanide	CCCCNc1c(c(S(=O)(=O)N)cc(c1)C(=O)O)Oc2ccccc2
8533	tr|O53154|O53154_M	P13569	83.46	1212.0	1434.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
8534	tr|O53154|O53154_M	P13569	83.46	1212.0	1434.0	DB01050	approved	Ibuprofen	CC(C)Cc1ccc(cc1)C(C)C(=O)O
8535	tr|O53154|O53154_M	P13569	83.46	1212.0	1434.0	DB02587	experimental; investigational	Colforsin	O[C@H]1CCC(C)(C)[C@@H]([C@]12C)[C@H](O)[C@H](OC(=O)C)[C@]3(C)[C@]2(O)C(=O)C[C@](O3)(C)C=C
8536	tr|O53154|O53154_M	P13569	83.46	1212.0	1434.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
8537	tr|O53154|O53154_M	P13569	83.46	1212.0	1434.0	DB04522	experimental	Dexfosfoserine	OC(=O)[C@@H](N)COP(=O)(O)O
8538	tr|O53154|O53154_M	P13569	83.46	1212.0	1434.0	DB04941	approved	Crofelemer	 
8539	tr|O53154|O53154_M	P13569	83.46	1212.0	1434.0	DB06266	investigational	Lonidamine	c1cccc(c12)n(nc2C(=O)O)Cc3c(Cl)cc(Cl)cc3
8540	tr|O53154|O53154_M	P13569	83.46	1212.0	1434.0	DB08820	approved	Ivacaftor	CC(C)(C)c1cc(C(C)(C)C)c(O)cc1NC(=O)c(c2=O)c[nH]c(c23)cccc3
8541	tr|O53154|O53154_M	P13569	83.46	1212.0	1434.0	DB09213	approved; investigational	Dexibuprofen	CC(C)Cc1ccc(cc1)[C@H](C)C(=O)O
8542	tr|O53154|O53154_M	P13569	83.46	1212.0	1434.0	DB09280	approved	Lumacaftor	O=C(O)c1cccc(c1)-c2nc(ccc2C)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
8543	tr|O53154|O53154_M	P13569	83.46	1212.0	1434.0	DB11712	approved; investigational	Tezacaftor	OC[C@H](O)Cn1c(C(C)(C)CO)cc(c12)cc(c(F)c2)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
8544	tr|O53154|O53154_M	P13569	83.46	1212.0	1434.0	DB15444	approved; investigational	Elexacaftor	FC(F)(F)C(C)(C)COc1nn(cc1)-c2nc(N(C3(C)C)C[C@@H](C)C3)c(cc2)C(=O)NS(=O)(=O)c4cn(C)nc4C
8545	tr|O53154|O53154_M	P45844	84.21	77.0	301.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8546	tr|O53154|O53154_M	Q9UNQ0	88.35	37.0	272.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
8547	tr|O53154|O53154_M	Q9UNQ0	88.35	37.0	272.0	DB11995	approved; investigational	Avatrombopag	OC(=O)C1CCN(CC1)c2c(Cl)cc(cn2)C(=O)Nc3nc(-c4cc(Cl)cs4)c(s3)N5CCN(CC5)C6CCCCC6
8548	tr|O53154|O53154_M	A0A0T9AZ62	78.2	222.0	430.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
8549	tr|O53154|O53154_M	Q56313	73.31	52.0	247.0	DB02210	experimental	Hexane-1,6-Diol	OCCCCCCO
8550	tr|O06542|O06542_M	P30084	90.67	44.0	287.0	DB02563	experimental	Hexanoyl-CoA	CCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
8551	tr|O06542|O06542_M	P30084	90.67	44.0	287.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
8552	tr|O06542|O06542_M	P30084	90.67	44.0	287.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
8553	tr|O06542|O06542_M	P30084	90.67	44.0	287.0	DB04117	experimental	4-(N,N-Dimethylamino)cinnamoyl-CoA	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)/C=C/c4ccc(cc4)N(C)C
8554	tr|O06542|O06542_M	P30084	90.67	44.0	287.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
8555	tr|O06542|O06542_M	O75521	94.78	137.0	391.0	DB08231	experimental	Myristic acid	CCCCCCCCCCCCCC(=O)O
8556	tr|O06542|O06542_M	P9WNP5	98.51	43.0	307.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
8557	tr|O06542|O06542_M	P9WNP5	98.51	43.0	307.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
8558	tr|O06542|O06542_M	P52045	94.03	8.0	260.0	DB03117	experimental	2-carboxypropyl-coenzyme A	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC[C@H](C)C(=O)O
8559	tr|O06542|O06542_M	P42126	89.55	56.0	296.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
8560	tr|O06542|O06542_M	P42126	89.55	56.0	296.0	DB03127	experimental	Benzamidine	NC(=[NH2+])c1ccccc1
8561	tr|O06542|O06542_M	O68600	87.31	6.0	240.0	DB01652	experimental	4-hydroxybenzoyl-CoA	Oc1ccc(cc1)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2OP(=O)(O)O)n3cnc(c34)c(N)ncn4
8562	tr|O06542|O06542_M	P28793	81.72	10.0	229.0	DB08249	experimental	3,6,9,12,15-PENTAOXATRICOSAN-1-OL	CCCCCCCCOCCOCCOCCOCCOCCO
8563	tr|O06542|O06542_M	Q93TU6	76.87	22.0	228.0	DB02906	experimental	(2s,4s)-Alpha-Campholinic Acid	CC1(C)[C@H](C)C(=O)C[C@H]1CC(O)O
8564	tr|O06542|O06542_M	Q08426	74.25	7.0	206.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
8565	tr|I6Y9I3|I6Y9I3_M	Q02338	98.88	51.0	316.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
8566	tr|I6Y9I3|I6Y9I3_M	P37059	97.39	78.0	339.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
8567	tr|I6Y9I3|I6Y9I3_M	P37059	97.39	78.0	339.0	DB13952	approved; investigational; vet_approved	Estradiol acetate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)C
8568	tr|I6Y9I3|I6Y9I3_M	P37059	97.39	78.0	339.0	DB13953	approved; investigational; vet_approved	Estradiol benzoate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)c5ccccc5
8569	tr|I6Y9I3|I6Y9I3_M	P37059	97.39	78.0	339.0	DB13954	approved; investigational; vet_approved	Estradiol cypionate	C1CCCC1CCC(=O)O[C@H]2CC[C@H]([C@@]23C)[C@H]4[C@H](CC3)c5c(CC4)cc(O)cc5
8570	tr|I6Y9I3|I6Y9I3_M	P37059	97.39	78.0	339.0	DB13955	approved; investigational; vet_approved	Estradiol dienanthate	CCCCCCC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)CCCCCC
8571	tr|I6Y9I3|I6Y9I3_M	P37059	97.39	78.0	339.0	DB13956	approved; investigational; vet_approved	Estradiol valerate	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)CC[C@@H]4OC(=O)CCCC
8572	tr|I6Y9I3|I6Y9I3_M	Q92781	96.64	23.0	282.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
8573	tr|I6Y9I3|I6Y9I3_M	Q92781	96.64	23.0	282.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
8574	tr|I6Y9I3|I6Y9I3_M	P80365	98.51	75.0	339.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
8575	tr|I6Y9I3|I6Y9I3_M	P80365	98.51	75.0	339.0	DB01185	approved; illicit	Fluoxymesterone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@](F)([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
8576	tr|I6Y9I3|I6Y9I3_M	P80365	98.51	75.0	339.0	DB01569	experimental; illicit	Formebolone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@H]([C@@H](C2)O)[C@]4(C)C(CC3)=CC(=O)C(C=O)=C4
8577	tr|I6Y9I3|I6Y9I3_M	P80365	98.51	75.0	339.0	DB14538	experimental; vet_approved	Hydrocortisone aceponate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CC)C(=O)COC(=O)C
8578	tr|I6Y9I3|I6Y9I3_M	P80365	98.51	75.0	339.0	DB14539	approved; vet_approved	Hydrocortisone acetate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)C
8579	tr|I6Y9I3|I6Y9I3_M	P80365	98.51	75.0	339.0	DB14540	approved; vet_approved	Hydrocortisone butyrate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCC
8580	tr|I6Y9I3|I6Y9I3_M	P80365	98.51	75.0	339.0	DB14541	approved; investigational; vet_approved	Hydrocortisone cypionate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)CCC5CCCC5
8581	tr|I6Y9I3|I6Y9I3_M	P80365	98.51	75.0	339.0	DB14542	approved; vet_approved	Hydrocortisone phosphate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COP(=O)(O)O
8582	tr|I6Y9I3|I6Y9I3_M	P80365	98.51	75.0	339.0	DB14543	approved; vet_approved	Hydrocortisone probutate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CCC)C(=O)COC(=O)CC
8583	tr|I6Y9I3|I6Y9I3_M	P80365	98.51	75.0	339.0	DB14544	approved; vet_approved	Hydrocortisone valerate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCCC
8584	tr|I6Y9I3|I6Y9I3_M	O75911	92.91	36.0	285.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
8586	tr|I6Y9I3|I6Y9I3_M	Q9BTZ2	78.73	25.0	236.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
8587	tr|I6Y9I3|I6Y9I3_M	Q9WYS2	72.39	7.0	201.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
8588	tr|I6Y9I3|I6Y9I3_M	P0AEK2	71.64	3.0	195.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
8589	tr|I6Y9I3|I6Y9I3_M	P16544	74.63	3.0	203.0	DB01942	experimental; investigational	Formic acid	OC=O
8590	tr|I6Y9I3|I6Y9I3_M	P16544	74.63	3.0	203.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
8591	tr|I6Y9I3|I6Y9I3_M	P16544	74.63	3.0	203.0	DB07715	investigational	Emodin	Cc(c1)cc(O)c(c12)C(=O)c3c(C2=O)cc(O)cc3O
8592	tr|I6Y9I3|I6Y9I3_M	Q8TC12	89.93	37.0	278.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
8594	tr|I6Y9I3|I6Y9I3_M	Q9NYR8	76.49	3.0	208.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
8595	tr|I6Y9I3|I6Y9I3_M	Q96NR8	84.7	35.0	262.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
8596	tr|I6Y9I3|I6Y9I3_M	Q8NBQ5	79.1	31.0	243.0	DB02854	experimental	Aetiocholanolone	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](CC3)C[C@H](O)CC4
8597	tr|I6Y9I3|I6Y9I3_M	P0AET8	77.24	9.0	216.0	DB02123	experimental	Glycochenodeoxycholic Acid	OC(=O)CNC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
8598	tr|I6Y9I3|I6Y9I3_M	Q8NBN7	78.36	31.0	241.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
8600	tr|I6Y9I3|I6Y9I3_M	Q92506	77.61	10.0	218.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
8601	tr|I6Y9I3|I6Y9I3_M	Q92506	77.61	10.0	218.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
8602	tr|I6Y9I3|I6Y9I3_M	P14061	72.76	3.0	198.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
8603	tr|I6Y9I3|I6Y9I3_M	P14061	72.76	3.0	198.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
8604	tr|I6Y9I3|I6Y9I3_M	P14061	72.76	3.0	198.0	DB01561	experimental; illicit	Androstanedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
8605	tr|I6Y9I3|I6Y9I3_M	P14061	72.76	3.0	198.0	DB02187	experimental	Equilin	O=C1CC[C@H]([C@@]12C)C=3[C@H](CC2)c4c(CC3)cc(O)cc4
8606	tr|I6Y9I3|I6Y9I3_M	P14061	72.76	3.0	198.0	DB02323	experimental	EM-1745	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)C[C@@H]([C@@H]4O)CCCCCCCCC(=O)OC[C@H]5O[C@H]([C@H](O)[C@@H]5O)n6cnc(c67)c(N)ncn7
8607	tr|I6Y9I3|I6Y9I3_M	P14061	72.76	3.0	198.0	DB02901	illicit; investigational	Stanolone	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
8608	tr|I6Y9I3|I6Y9I3_M	P14061	72.76	3.0	198.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
8609	tr|I6Y9I3|I6Y9I3_M	P14061	72.76	3.0	198.0	DB13951	experimental	Stanolone acetate	CC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
8610	tr|I6Y9I3|I6Y9I3_M	P37058	78.73	46.0	257.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
8611	tr|I6Y9I3|I6Y9I3_M	Q6UWP2	77.99	10.0	219.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
8612	tr|I6Y9I3|I6Y9I3_M	Q84EX5	72.76	5.0	200.0	DB04619	experimental	Acetophenone	CC(=O)c1ccccc1
8613	tr|I6Y9I3|I6Y9I3_M	Q84EX5	72.76	5.0	200.0	DB04784	experimental	(R)-1-phenylethanol	C[C@@H](O)c1ccccc1
8614	tr|I6Y9I3|I6Y9I3_M	Q7Z4W1	74.63	5.0	205.0	DB02831	experimental	Dihydrogenphosphate	OP([O-])(=O)O
8615	tr|I6Y9I3|I6Y9I3_M	Q7Z4W1	74.63	5.0	205.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
8617	tr|I6Y9I3|I6Y9I3_M	Q9BY49	71.64	16.0	208.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
8618	tr|I6Y9I3|I6Y9I3_M	Q16698	71.64	54.0	246.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
8619	tr|I6Y9I3|I6Y9I3_M	Q16698	71.64	54.0	246.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
8620	tr|I6Y9I3|I6Y9I3_M	Q9HBH5	83.58	41.0	265.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
8621	tr|I6Y9I3|I6Y9I3_M	P0CG22	80.22	25.0	240.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
8622	tr|I6Y9I3|I6Y9I3_M	P0CG22	80.22	25.0	240.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
8623	tr|I6Y9I3|I6Y9I3_M	P0CG22	80.22	25.0	240.0	DB03541	experimental	10-Propargyl-5,8-Dideazafolic Acid	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(CC#C)Cc(c2)ccc(c23)[nH]c(N)nc3=O
8624	tr|I6Y9I3|I6Y9I3_M	P0CG22	80.22	25.0	240.0	DB07689	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)NCc(cn3)nc(c34)c(N)nc(n4)N
8625	tr|I6Y9I3|I6Y9I3_M	P0CG22	80.22	25.0	240.0	DB07765	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)N(C)Cc(cn3)nc(c34)c(N)nc(n4)N
8626	tr|I6Y9I3|I6Y9I3_M	P51659	84.33	3.0	229.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
8627	tr|I6Y9I3|I6Y9I3_M	P51659	84.33	3.0	229.0	DB03192	experimental	(R)-3-hydroxydecanoyl-CoA	CCCCCCC[C@@H](O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
8628	tr|I6Y9I3|I6Y9I3_M	P28845	72.39	31.0	225.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
8629	tr|I6Y9I3|I6Y9I3_M	P28845	72.39	31.0	225.0	DB02329	experimental	Carbenoxolone	OC(=O)CCC(=O)O[C@@H](CC1)C(C)(C)[C@@H]([C@]12C)CC[C@]3(C)[C@@H]2C(=O)C=C4[C@H]5[C@@](C)(CC[C@@]34C)CC[C@](C5)(C)C(=O)O
8630	tr|I6Y9I3|I6Y9I3_M	P28845	72.39	31.0	225.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
8631	tr|I6Y9I3|I6Y9I3_M	P28845	72.39	31.0	225.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
8632	tr|I6Y9I3|I6Y9I3_M	P28845	72.39	31.0	225.0	DB04652	experimental	Corticosterone	OCC(=O)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H]([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
8633	tr|I6Y9I3|I6Y9I3_M	P28845	72.39	31.0	225.0	DB05064	investigational	INCB13739	 
8634	tr|I6Y9I3|I6Y9I3_M	P28845	72.39	31.0	225.0	DB06992	experimental	(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone	Cc1ccc(cc1F)-c2nc(ccc2)C(=O)N(CC3(C)C)CCC3
8635	tr|I6Y9I3|I6Y9I3_M	P28845	72.39	31.0	225.0	DB07017	experimental	(5S)-2-{[(1S)-1-(4-Fluorophenyl)ethyl]amino}-5-(2-hydroxy-2-propanyl)-5-methyl-1,3-thiazol-4(5H)-one	Fc1ccc(cc1)[C@H](C)NC(=NC2=O)S[C@@]2(C)C(C)(C)O
8636	tr|I6Y9I3|I6Y9I3_M	P28845	72.39	31.0	225.0	DB07049	experimental	(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine	[O-][N+](=O)c1ccc(cc1)N2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)C(C)(C)C
8637	tr|I6Y9I3|I6Y9I3_M	P28845	72.39	31.0	225.0	DB07056	experimental	2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide	CCN(CC)C(=O)Cc1cccc(n1)NS(=O)(=O)c2c(C)c(Cl)ccc2
8638	tr|I6Y9I3|I6Y9I3_M	P28845	72.39	31.0	225.0	DB07310	experimental	(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one	Fc1ccccc1[C@H](C)NC(=NC2=O)S[C@]2(C)C(F)(F)F
8639	tr|I6Y9I3|I6Y9I3_M	P28845	72.39	31.0	225.0	DB07316	experimental	N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)C3CCN(CC3)CC4(CC4)C(=O)N
8640	tr|I6Y9I3|I6Y9I3_M	P28845	72.39	31.0	225.0	DB07619	experimental	N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)[C@H]3CC[C@@H](CC3)c4cccnc4
8641	tr|I6Y9I3|I6Y9I3_M	P28845	72.39	31.0	225.0	DB07624	experimental	1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide	C1CC1(C(=O)N)CN2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)[C@](C)(O)C(F)(F)F
8642	tr|I6Y9I3|I6Y9I3_M	P28845	72.39	31.0	225.0	DB07866	experimental	(5S)-2-(Cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one	CCC[C@]1(C)SC(=NC1=O)NC2CCCCCCC2
8643	tr|I6Y9I3|I6Y9I3_M	P28845	72.39	31.0	225.0	DB08277	experimental	2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE	CS(=O)(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4c(Cl)cc(F)cc4
8644	tr|I6Y9I3|I6Y9I3_M	P28845	72.39	31.0	225.0	DB08280	experimental	(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE	NC(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4ccc(OC)cc4
8645	tr|I6Y9I3|I6Y9I3_M	P28845	72.39	31.0	225.0	DB08771	experimental	(5R)-2-[(2-Fluorophenyl)amino]-5-isopropyl-1,3-thiazol-4(5H)-one	CC(C)[C@H]1SC(=NC1=O)Nc2c(F)cccc2
8646	tr|I6Y9I3|I6Y9I3_M	P28845	72.39	31.0	225.0	DB13751	approved; experimental	Glycyrrhizic acid	C1C[C@](C)(C(=O)O)C[C@H]([C@]12C)C=3[C@@](C)(CC2)[C@@]4(C)[C@H](C(=O)C3)[C@]5(C)[C@@H](CC4)C(C)(C)[C@H](CC5)O[C@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O[C@@H]7O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]7O
8647	tr|I6Y9I3|I6Y9I3_M	Q99714	79.48	7.0	220.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
8648	tr|I6Y9I3|I6Y9I3_M	Q99714	79.48	7.0	220.0	DB02820	experimental	1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct	C1CCCCCN1C(=O)[C@H](c2ccccc2)n(c3=S)cnc(c34)nn(c4)[C@H]5C=CN(C=C5C([O-])=N)[C@@H]6O[C@@H]([C@@H](O)[C@H]6O)COP([O-])(=O)OP(=O)(O)OC[C@H]7O[C@H]([C@H]([O-])[C@@H]7[O-])n8cnc(c89)c(N)ncn9
8649	tr|I6Y9I3|I6Y9I3_M	Q99714	79.48	7.0	220.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
8650	tr|I6Y9I3|I6Y9I3_M	Q7AUG5	79.1	3.0	215.0	DB04782	experimental	(S)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@H]2CO2
8651	tr|I6Y9I3|I6Y9I3_M	Q93D82	79.1	3.0	215.0	DB04472	experimental	(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol	[N-]=[N+]=NC[C@H](O)c1ccc([N+]([O-])=O)cc1
8652	tr|I6Y9I3|I6Y9I3_M	Q93D82	79.1	3.0	215.0	DB04499	experimental	(R)-styrene oxide	C1O[C@@H]1c2ccccc2
8653	tr|I6Y9I3|I6Y9I3_M	Q93D82	79.1	3.0	215.0	DB04777	experimental	(R)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@@H]2CO2
8654	tr|I6Y9I3|I6Y9I3_M	P16152	89.93	6.0	247.0	DB01698	approved; experimental; investigational	Rutin	O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O[C@H]1C)OC[C@H]2O[C@H]([C@H](O)[C@@H](O)[C@@H]2O)Oc(c3=O)c(-c4cc(O)c(O)cc4)oc(c35)cc(O)cc5O
8655	tr|I6Y9I3|I6Y9I3_M	P16152	89.93	6.0	247.0	DB02709	investigational	Resveratrol	Oc1ccc(cc1)/C=C/c2cc(O)cc(O)c2
8656	tr|I6Y9I3|I6Y9I3_M	P16152	89.93	6.0	247.0	DB03394	experimental	Heptaethylene glycol	OCCOCCOCCOCCOCCOCCOCCO
8657	tr|I6Y9I3|I6Y9I3_M	P16152	89.93	6.0	247.0	DB03556	experimental	2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400	CCOCCOCCOCCOCCOCCOCCOCCOCCO
8658	tr|I6Y9I3|I6Y9I3_M	P16152	89.93	6.0	247.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
8659	tr|I6Y9I3|I6Y9I3_M	P16152	89.93	6.0	247.0	DB04463	experimental	3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol	n1cnc(N)c(c12)c(nn2C(C)(C)C)-c3cccc(O)c3
8660	tr|I6Y9I3|I6Y9I3_M	P16152	89.93	6.0	247.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
8661	tr|I6Y9I3|I6Y9I3_M	P16152	89.93	6.0	247.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
8662	tr|I6Y9I3|I6Y9I3_M	P56937	90.67	2.0	245.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
8663	tr|I6Y9I3|I6Y9I3_M	Q8I814	80.97	13.0	230.0	DB02015	experimental	Dihydrofolic Acid	O=c1[nH]c(N)nc(c12)NCC(=N2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
8664	tr|I6Y9I3|I6Y9I3_M	Q8I814	80.97	13.0	230.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
8665	tr|I6Y9I3|I6Y9I3_M	Q6GI75	80.97	4.0	221.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
8666	tr|I6Y9I3|I6Y9I3_M	Q6GI75	80.97	4.0	221.0	DB11155	approved	Triclocarban	Clc1ccc(cc1)NC(=O)Nc2cc(Cl)c(Cl)cc2
8667	tr|I6Y9I3|I6Y9I3_M	P35270	82.09	7.0	227.0	DB02637	experimental	Oxaloacetate Ion	OC(=O)C(=O)CC([O-])=O
8668	tr|I6Y9I3|I6Y9I3_M	P35270	82.09	7.0	227.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
8669	tr|I6Y9I3|I6Y9I3_M	P35270	82.09	7.0	227.0	DB03886	experimental	Biopterin	C[C@@H](O)[C@@H](O)c(n1)cnc(c12)nc(N)[nH]c2=O
8670	tr|I6Y9I3|I6Y9I3_M	P35270	82.09	7.0	227.0	DB04275	experimental	N-acetylserotonin	CC(=O)NCCc1c[nH]c(c12)ccc(c2)O
8671	tr|I6Y9I3|I6Y9I3_M	A0A348A0U3	80.6	4.0	220.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
8672	tr|I6Y9I3|I6Y9I3_M	P0AEK4	79.1	5.0	217.0	DB01691	experimental	Indole Naphthyridinone	c1cccc(c12)n(C)cc2CN(C)C(=O)/C=C/c(c3)cnc(c34)NC(=O)CC4
8673	tr|I6Y9I3|I6Y9I3_M	P0AEK4	79.1	5.0	217.0	DB01865	experimental	3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide	c1cccc(c12)cc(n2C)CN(C)C(=O)/C=C/c3cnc(N)cc3
8674	tr|I6Y9I3|I6Y9I3_M	P0AEK4	79.1	5.0	217.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
8675	tr|I6Y9I3|I6Y9I3_M	P0AEK4	79.1	5.0	217.0	DB03030	experimental	4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole	Cc1ccc(cc1)Cn2cnc(c2)-c3cccs3
8676	tr|I6Y9I3|I6Y9I3_M	P0AEK4	79.1	5.0	217.0	DB03534	experimental	3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide	CC(=O)N(C)Cc1c(N)ccc(c1)C(=O)N(C)Cc(n2C)cc(c23)cccc3
8677	tr|I6Y9I3|I6Y9I3_M	P0AEK4	79.1	5.0	217.0	DB04030	experimental	1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole	Oc1ccc(cc1)Cn2c(c3c(c24)cccc4)CN(CC3)C(=O)c5ccc(O)cc5
8678	tr|I6Y9I3|I6Y9I3_M	P0AEK4	79.1	5.0	217.0	DB08265	experimental	2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL	Cc1ccc(cc1)S(=O)(=O)n(b2O)ncc(c23)cccc3
8679	tr|I6Y9I3|I6Y9I3_M	P0AEK4	79.1	5.0	217.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
8680	tr|I6Y9I3|I6Y9I3_M	P0AEK4	79.1	5.0	217.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
8681	tr|I6Y9I3|I6Y9I3_M	Q01782	81.34	8.0	226.0	DB02338	experimental	NADPH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
8682	tr|I6Y9I3|I6Y9I3_M	Q01782	81.34	8.0	226.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
8683	tr|I6Y9I3|I6Y9I3_M	Q01782	81.34	8.0	226.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
8684	tr|I6Y9I3|I6Y9I3_M	Q01782	81.34	8.0	226.0	DB04400	experimental	L-erythro-7,8-dihydrobiopterin	C[C@H](O)[C@H](O)C(CN1)=Nc(c12)c(=O)nc([nH]2)N
8685	tr|I6Y9I3|I6Y9I3_M	O24990	74.25	5.0	204.0	DB04393	experimental	Soneclosan	Clc1cc(O)c(cc1)Oc2ccc(Cl)cc2
8686	tr|I6Y9I3|I6Y9I3_M	O24990	74.25	5.0	204.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
8687	tr|I6Y9I3|I6Y9I3_M	P9WGR1	73.13	5.0	201.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
8688	tr|I6Y9I3|I6Y9I3_M	P9WGR1	73.13	5.0	201.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
8689	tr|I6Y9I3|I6Y9I3_M	P9WGR1	73.13	5.0	201.0	DB02990	experimental	S-(2-Acetamidoethyl) hexadecanethioate	CCCCCCCCCCCCCCCC(=O)SCCNC(=O)C
8690	tr|I6Y9I3|I6Y9I3_M	P9WGR1	73.13	5.0	201.0	DB04289	experimental	Genz-10850	[nH]1ccc(c12)cc(cc2)C(=O)N3CCN(CC3)C4c(cccc5)c5c(c46)cccc6
8691	tr|I6Y9I3|I6Y9I3_M	P9WGR1	73.13	5.0	201.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
8692	tr|I6Y9I3|I6Y9I3_M	P9WGR1	73.13	5.0	201.0	DB07090	experimental	(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cccc(c1C)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
8693	tr|I6Y9I3|I6Y9I3_M	P9WGR1	73.13	5.0	201.0	DB07123	experimental	N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE	Cc1ccc(cc1)C(=O)N2CCC(CC2)Cc3ccccc3
8694	tr|I6Y9I3|I6Y9I3_M	P9WGR1	73.13	5.0	201.0	DB07155	experimental	(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE	c1ccccc1NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
8695	tr|I6Y9I3|I6Y9I3_M	P9WGR1	73.13	5.0	201.0	DB07178	experimental	5-PENTYL-2-PHENOXYPHENOL	CCCCCc1cc(O)c(cc1)Oc2ccccc2
8696	tr|I6Y9I3|I6Y9I3_M	P9WGR1	73.13	5.0	201.0	DB07188	experimental	(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(cc(Cl)c1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
8697	tr|I6Y9I3|I6Y9I3_M	P9WGR1	73.13	5.0	201.0	DB07192	experimental	(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Brc1cc(ccc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
8698	tr|I6Y9I3|I6Y9I3_M	P9WGR1	73.13	5.0	201.0	DB07222	experimental	(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(c(C)cc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
8699	tr|I6Y9I3|I6Y9I3_M	P9WGR1	73.13	5.0	201.0	DB07287	experimental	2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL	c1cccnc1Cc2cc(O)c(cc2)Oc3ccc(Cl)cc3Cl
8700	tr|I6Y9I3|I6Y9I3_M	P9WGR1	73.13	5.0	201.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
8701	tr|I6Y9I3|I6Y9I3_M	P09417	70.52	7.0	196.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
8702	tr|I6Y9I3|I6Y9I3_M	P09417	70.52	7.0	196.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
8703	tr|I6Y9I3|I6Y9I3_M	Q8T8E9	72.39	2.0	196.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
8704	tr|I6Y9I3|I6Y9I3_M	P26391	71.27	3.0	194.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
8705	tr|O50434|O50434_M	Q56232	99.72	17.0	378.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
8706	tr|O50434|O50434_M	Q56232	99.72	17.0	378.0	DB04299	experimental	Maleic Acid	OC(=O)/C=C\C(=O)O
8707	tr|O50434|O50434_M	Q16773	108.56	22.0	415.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
8708	tr|O50434|O50434_M	Q16773	108.56	22.0	415.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
8709	tr|O50434|O50434_M	Q16773	108.56	22.0	415.0	DB02556	experimental	D-Phenylalanine	OC(=O)[C@H](N)Cc1ccccc1
8710	tr|O50434|O50434_M	Q16773	108.56	22.0	415.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
8711	tr|O50434|O50434_M	Q16773	108.56	22.0	415.0	DB07950	experimental	Indoleacetic acid	OC(=O)Cc1c[nH]c(c12)cccc2
8712	tr|O50434|O50434_M	P33447	108.29	14.0	406.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
8713	tr|O50434|O50434_M	Q75WK2	94.75	21.0	364.0	DB02024	experimental	3-phenylpropionic acid	OC(=O)CCc1ccccc1
8714	tr|O50434|O50434_M	Q75WK2	94.75	21.0	364.0	DB02238	experimental	4-methylthio-2-oxobutanoic acid	CSCCC(=O)C(=O)O
8715	tr|O50434|O50434_M	Q6YP21	106.08	58.0	442.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
8716	tr|O50434|O50434_M	P17735	104.97	54.0	434.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
8717	tr|O50434|O50434_M	P17735	104.97	54.0	434.0	DB00120	approved; investigational; nutraceutical	Phenylalanine	OC(=O)[C@@H](N)Cc1ccccc1
8718	tr|O50434|O50434_M	P17735	104.97	54.0	434.0	DB00135	approved; investigational; nutraceutical	Tyrosine	OC(=O)[C@@H](N)Cc1ccc(O)cc1
8719	tr|O50434|O50434_M	P17735	104.97	54.0	434.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
8720	tr|O50434|O50434_M	Q8TD30	103.87	135.0	511.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
8721	tr|O50434|O50434_M	Q8TD30	103.87	135.0	511.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
8722	tr|O50434|O50434_M	Q8TD30	103.87	135.0	511.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
8723	tr|O50434|O50434_M	Q8TD30	103.87	135.0	511.0	DB00780	approved	Phenelzine	NNCCc1ccccc1
8724	tr|O50434|O50434_M	P24298	104.97	104.0	484.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
8725	tr|O50434|O50434_M	P24298	104.97	104.0	484.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
8726	tr|O50434|O50434_M	P24298	104.97	104.0	484.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
8727	tr|O50434|O50434_M	P24298	104.97	104.0	484.0	DB00780	approved	Phenelzine	NNCCc1ccccc1
8728	tr|O50434|O50434_M	Q9X0L5	102.49	28.0	399.0	DB01942	experimental; investigational	Formic acid	OC=O
8729	tr|O50434|O50434_M	Q96QU6	104.7	95.0	474.0	DB03214	experimental	Vinylglycine	OC(=O)[C@@H](N)C=C
8730	tr|O50434|O50434_M	Q8N5Z0	110.22	17.0	416.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
8731	tr|O50434|O50434_M	Q8N5Z0	110.22	17.0	416.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
8732	tr|O50434|O50434_M	P00505	97.79	49.0	403.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
8733	tr|O50434|O50434_M	P00505	97.79	49.0	403.0	DB00128	approved; nutraceutical	Aspartic acid	OC(=O)[C@@H](N)CC(=O)O
8734	tr|O50434|O50434_M	P00505	97.79	49.0	403.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
8735	tr|O50434|O50434_M	P00505	97.79	49.0	403.0	DB00151	approved; nutraceutical	Cysteine	OC(=O)[C@@H](N)CS
8736	tr|O50434|O50434_M	P00505	97.79	49.0	403.0	DB02783	experimental	4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate	Cc1ncc(COP(=O)(O)O)c(c1O)CNOCC(=O)O
8737	tr|O50434|O50434_M	Q2TU84	98.9	29.0	387.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
8738	tr|O50434|O50434_M	Q2TU84	98.9	29.0	387.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
8739	tr|O50434|O50434_M	P17174	98.9	29.0	387.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
8740	tr|O50434|O50434_M	P17174	98.9	29.0	387.0	DB00128	approved; nutraceutical	Aspartic acid	OC(=O)[C@@H](N)CC(=O)O
8741	tr|O50434|O50434_M	P17174	98.9	29.0	387.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
8742	tr|O50434|O50434_M	P17174	98.9	29.0	387.0	DB00151	approved; nutraceutical	Cysteine	OC(=O)[C@@H](N)CS
8743	tr|O50434|O50434_M	P17174	98.9	29.0	387.0	DB00210	approved	Adapalene	C1C(C2)CC(C3)CC1CC23c4c(OC)ccc(c4)-c(cc5)cc(c56)ccc(c6)C(=O)O
8744	tr|O50434|O50434_M	P17174	98.9	29.0	387.0	DB04299	experimental	Maleic Acid	OC(=O)/C=C\C(=O)O
8745	tr|O50434|O50434_M	P17174	98.9	29.0	387.0	DB09130	approved; investigational	Copper	[Cu]
8746	tr|O50434|O50434_M	P97084	77.9	72.0	354.0	DB02482	experimental	Phosphonothreonine	OC(=O)[C@H](N)[C@H](C)OP(=O)(O)O
8747	tr|O50434|O50434_M	P97084	77.9	72.0	354.0	DB03433	experimental	{3-[(3-Hydroxy-2-Methyl-5-Phosphonooxymethyl-Pyridin-4-Ylmethyl)-Amino]-2-Methyl-Propyl}-Phosphonic Acid	OP(=O)(O)O[C@H](C)CNCc1c(O)c(C)ncc1COP(=O)(O)O
8748	tr|O50434|O50434_M	P95468	94.75	24.0	367.0	DB02024	experimental	3-phenylpropionic acid	OC(=O)CCc1ccccc1
8749	tr|O50434|O50434_M	P95468	94.75	24.0	367.0	DB02242	experimental	Cyclohexanepropanoic acid	OC(=O)CCC1CCCCC1
8750	tr|O50434|O50434_M	P95468	94.75	24.0	367.0	DB02434	experimental	4-(2-Thienyl)Butyric Acid	OC(=O)CCCc1cccs1
8751	tr|O50434|O50434_M	P95468	94.75	24.0	367.0	DB02740	experimental	3-Indolebutyric Acid	OC(=O)CCCc1c[nH]c(c12)cccc2
8752	tr|O50434|O50434_M	P95468	94.75	24.0	367.0	DB02758	experimental	Indolepropionic acid	OC(=O)CCc1c[nH]c(c12)cccc2
8753	tr|O50434|O50434_M	P95468	94.75	24.0	367.0	DB03210	experimental	4-Aminohydrocinnamic Acid	Nc1ccc(cc1)CCC(=O)O
8754	tr|O50434|O50434_M	P95468	94.75	24.0	367.0	DB03400	experimental	3-(P-Tolyl)Propionic Acid	Cc1ccc(cc1)CCC(=O)O
8755	tr|O50434|O50434_M	P95468	94.75	24.0	367.0	DB04051	experimental	5-phenylpentanoic acid	OC(=O)CCCCc1ccccc1
8756	tr|O50434|O50434_M	P95468	94.75	24.0	367.0	DB04208	experimental	3-(3,4-dimethoxyphenyl)propanoic acid	COc1c(OC)cc(cc1)CCC(=O)O
8757	tr|O50434|O50434_M	P95468	94.75	24.0	367.0	DB04299	experimental	Maleic Acid	OC(=O)/C=C\C(=O)O
8758	tr|O50434|O50434_M	P95468	94.75	24.0	367.0	DB06819	approved; investigational	Phenylbutyric acid	OC(=O)CCCc1ccccc1
8759	tr|O50434|O50434_M	P00509	98.62	16.0	373.0	DB01639	experimental	N-Methyl-Pyridoxal-5'-Phosphate	Cc1c(O)c(C=O)c(c[n+]1C)COP(=O)(O)O
8760	tr|O50434|O50434_M	P00509	98.62	16.0	373.0	DB02024	experimental	3-phenylpropionic acid	OC(=O)CCc1ccccc1
8761	tr|O50434|O50434_M	P00509	98.62	16.0	373.0	DB02758	experimental	Indolepropionic acid	OC(=O)CCc1c[nH]c(c12)cccc2
8762	tr|O50434|O50434_M	P00509	98.62	16.0	373.0	DB02981	experimental	Vitamin B6 Complexed with 2-Amino-Hexanoic Acid	CCCC[C@@H](C(=O)O)NCc1c(COP(=O)(O)O)cnc(C)c1O
8763	tr|O50434|O50434_M	P00509	98.62	16.0	373.0	DB03553	experimental	Glutaric Acid	OC(=O)CCCC(=O)O
8764	tr|O50434|O50434_M	P00509	98.62	16.0	373.0	DB03629	experimental	Pyridoxal-5'-Phosphate-N-Oxide	Cc1c(O)c(C=O)c(c[n+]1[O-])COP(=O)(O)O
8765	tr|O50434|O50434_M	P00509	98.62	16.0	373.0	DB03662	experimental	Vitamin B6 Complexed with 2-Amino-Pentanoic Acid	CCC[C@@H](C(=O)O)NCc1c(O)c(C)ncc1COP(=O)(O)O
8766	tr|O50434|O50434_M	P00509	98.62	16.0	373.0	DB03750	experimental	Isovaleric Acid	CC(C)CC(=O)O
8767	tr|O50434|O50434_M	P00509	98.62	16.0	373.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
8768	tr|O50434|O50434_M	P00509	98.62	16.0	373.0	DB04299	experimental	Maleic Acid	OC(=O)/C=C\C(=O)O
8769	tr|O50434|O50434_M	P00509	98.62	16.0	373.0	DB04467	experimental	N-(5'-phosphopyridoxyl)-L-alanine	OC(=O)[C@H](C)NCc1c(COP(=O)(O)O)cnc(C)c1O
8770	tr|O50434|O50434_M	P00509	98.62	16.0	373.0	DB04762	experimental	N-PYRIDOXYL-D-GLUTAMIC ACID-5'-MONOPHOSPHATE	Cc1ncc(COP(=O)(O)O)c(c1O)CN[C@@H](C(=O)O)CCC(=O)O
8771	tr|O50434|O50434_M	P00509	98.62	16.0	373.0	DB04765	experimental	N-PYRIDOXYL-2-METHYL-L-GLUTAMIC ACID-5'-MONOPHOSPHATE	Cc1ncc(COP(=O)(O)O)c(c1O)CN[C@](C)(C(=O)O)CCC(=O)O
8772	tr|O50434|O50434_M	P00509	98.62	16.0	373.0	DB08845	experimental; investigational; nutraceutical	Oxogluric acid	OC(=O)CCC(=O)C(=O)O
8773	tr|O50434|O50434_M	P06986	71.82	61.0	321.0	DB01813	experimental	Pyridoxyl-Glutamic Acid-5'-Monophosphate	OC(=O)CC[C@@H](C(=O)O)NCc1c(COP(=O)(O)O)c[nH+]c(C)c1O
8774	tr|O50434|O50434_M	P06986	71.82	61.0	321.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
8775	tr|O50434|O50434_M	P06986	71.82	61.0	321.0	DB03997	experimental	L-histidinol phosphate	OP(=O)(O)OC[C@@H](N)Cc1c[nH]cn1
8776	tr|O50434|O50434_M	O75600	82.87	107.0	407.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
8777	tr|O50434|O50434_M	O75600	82.87	107.0	407.0	DB00145	approved; nutraceutical; vet_approved	Glycine	NCC(=O)O
8778	tr|O50434|O50434_M	P0AB77	83.15	86.0	387.0	DB03915	experimental	2-Amino-3-Ketobutyric Acid	CC(=O)[C@H](N)C(=O)O
8779	tr|O50434|O50434_M	Q9KM65	89.78	49.0	374.0	DB08364	experimental	1-{[(1E)-(3-HYDROXY-2-METHYL-5-{[(TRIHYDROXY-LAMBDA^5^-PHOSPHANYL)OXY]METHYL}PYRIDIN-4-YL)METHYLIDENE]AMINO}UNDECAN-2-ONE	CCCCCCCCCC(=O)C/N=C/c1c(COP(O)(O)O)cnc(C)c1O
8780	tr|O50434|O50434_M	Q9X266	73.48	41.0	307.0	DB02824	experimental	N-Pyridoxyl-Glycine-5-Monophosphate	Cc1ncc(COP(=O)(O)O)c(c1O)CNCC(=O)O
8781	tr|O50434|O50434_M	Q9X266	73.48	41.0	307.0	DB03576	experimental	N-Pyridoxyl-Threonine-5-Monophosphate	CC(O)C(C(=O)O)NCc1c(COP(=O)(O)O)cnc(C)c1O
8782	tr|O50434|O50434_M	Q9X266	73.48	41.0	307.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
8784	tr|O07411|O07411_M	Q8ZKF6	97.29	79.0	618.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
8785	tr|O07411|O07411_M	Q8ZKF6	97.29	79.0	618.0	DB03230	experimental	Adenosine-5'-Propylphosphate	CCCOP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
8786	tr|O07411|O07411_M	P40871	89.53	31.0	527.0	DB01672	experimental	2,3-Dihydroxy-Benzoic Acid	OC(=O)c1cccc(O)c1O
8787	tr|O07411|O07411_M	Q9NR19	101.81	105.0	669.0	DB00131	approved; investigational; nutraceutical	Adenosine phosphate	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
8788	tr|O07411|O07411_M	Q9NR19	101.81	105.0	669.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8789	tr|O07411|O07411_M	Q8GN86	89.53	3.0	499.0	DB03728	experimental	p-Chlorobenzoic acid	OC(=O)c1ccc(Cl)cc1
8790	tr|O07411|O07411_M	Q9NUB1	97.29	111.0	650.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
8791	tr|P71540|P71540_M	P30084	89.96	46.0	288.0	DB02563	experimental	Hexanoyl-CoA	CCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
8792	tr|P71540|P71540_M	P30084	89.96	46.0	288.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
8793	tr|P71540|P71540_M	P30084	89.96	46.0	288.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
8794	tr|P71540|P71540_M	P30084	89.96	46.0	288.0	DB04117	experimental	4-(N,N-Dimethylamino)cinnamoyl-CoA	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)/C=C/c4ccc(cc4)N(C)C
8795	tr|P71540|P71540_M	P30084	89.96	46.0	288.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
8796	tr|P71540|P71540_M	P52045	91.45	13.0	259.0	DB03117	experimental	2-carboxypropyl-coenzyme A	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC[C@H](C)C(=O)O
8797	tr|P71540|P71540_M	P9WNP5	97.03	47.0	308.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
8798	tr|P71540|P71540_M	P9WNP5	97.03	47.0	308.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
8799	tr|P71540|P71540_M	Q6NVY1	80.67	46.0	263.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
8800	tr|P71540|P71540_M	O68600	77.32	12.0	220.0	DB01652	experimental	4-hydroxybenzoyl-CoA	Oc1ccc(cc1)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2OP(=O)(O)O)n3cnc(c34)c(N)ncn4
8801	tr|P71540|P71540_M	O75521	78.81	149.0	361.0	DB08231	experimental	Myristic acid	CCCCCCCCCCCCCC(=O)O
8802	tr|P71540|P71540_M	P42126	74.72	53.0	254.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
8803	tr|P71540|P71540_M	P42126	74.72	53.0	254.0	DB03127	experimental	Benzamidine	NC(=[NH2+])c1ccccc1
8804	tr|P71540|P71540_M	Q93TU6	72.12	42.0	236.0	DB02906	experimental	(2s,4s)-Alpha-Campholinic Acid	CC1(C)[C@H](C)C(=O)C[C@H]1CC(O)O
8805	tr|O53639|O53639_M	P27696	92.78	5.0	545.0	DB01987	approved; experimental	Cocarboxylase	OP([O-])(=O)O[P@](=O)(O)OCCc1c(C)[n+](cs1)Cc2cnc(C)nc2N
8806	tr|O53639|O53639_M	P27696	92.78	5.0	545.0	DB02327	experimental	Triethylene glycol	OCCOCCOCCO
8807	tr|O53639|O53639_M	P27696	92.78	5.0	545.0	DB03361	experimental	2-{(9as)-9a-[(1s)-1-Hydroxyethyl]-2,7-Dimethyl-9a,10-Dihydro-5h-Pyrimido[4,5-D][1,3]Thiazolo[3,2-a]Pyrimidin-8-Yl}Ethyl Trihydrogen Diphosphate	c1nc(C)nc(N2)c1CN([C@]23[C@H](C)O)C(C)=C(S3)CCOP(=O)(O)OP(=O)(O)O
8809	tr|O53639|O53639_M	P37063	91.92	13.0	548.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
8810	tr|O53639|O53639_M	P51852	90.72	4.0	532.0	DB03884	experimental	Phenylpyruvic acid	OC(=O)C(=O)Cc1ccccc1
8811	tr|O53639|O53639_M	P51852	90.72	4.0	532.0	DB08050	experimental	5-phenyl-2-keto-valeric acid	OC(=O)C(=O)CCCc1ccccc1
8812	tr|O53639|O53639_M	P20906	87.8	10.0	521.0	DB02280	experimental	(R)-Mandelic acid	OC(=O)[C@H](O)c1ccccc1
8813	tr|O53639|O53639_M	P06672	92.96	6.0	547.0	DB04272	approved; nutraceutical; vet_approved	Citric acid	OC(=O)CC(O)(C(=O)O)CC(=O)O
8814	tr|O53639|O53639_M	P23234	90.38	8.0	534.0	DB01987	approved; experimental	Cocarboxylase	OP([O-])(=O)O[P@](=O)(O)OCCc1c(C)[n+](cs1)Cc2cnc(C)nc2N
8815	tr|P72036|P72036_M	Q15075	82.22	1261.0	1335.0	DB02942	experimental	Inositol 1,3-Bisphosphate	O[C@H]1[C@H](O)[C@@H](OP(=O)(O)O)[C@@H](O)[C@H]([C@@H]1O)OP(=O)(O)O
8816	tr|L7N650|L7N650_M	P00352	94.13	33.0	498.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
8817	tr|L7N650|L7N650_M	P00352	94.13	33.0	498.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
8818	tr|L7N650|L7N650_M	P00352	94.13	33.0	498.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
8819	tr|L7N650|L7N650_M	P00352	94.13	33.0	498.0	DB04447	experimental	1,4-Dithiothreitol	SC[C@H](O)[C@@H](O)CS
8820	tr|L7N650|L7N650_M	O94788	93.93	49.0	513.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
8821	tr|L7N650|L7N650_M	O94788	93.93	49.0	513.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
8822	tr|L7N650|L7N650_M	O94788	93.93	49.0	513.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
8823	tr|L7N650|L7N650_M	P47895	94.33	43.0	509.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
8824	tr|L7N650|L7N650_M	P47895	94.33	43.0	509.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
8825	tr|L7N650|L7N650_M	P30837	93.72	49.0	512.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
8826	tr|L7N650|L7N650_M	P05091	93.93	48.0	512.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
8827	tr|L7N650|L7N650_M	P05091	93.93	48.0	512.0	DB00536	approved	Guanidine	NC(N)=N
8828	tr|L7N650|L7N650_M	P05091	93.93	48.0	512.0	DB00822	approved	Disulfiram	CCN(CC)C(=S)SSC(=S)N(CC)CC
8829	tr|L7N650|L7N650_M	P05091	93.93	48.0	512.0	DB02115	experimental	Daidzin	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)Oc(c2)ccc(c23)c(=O)c(co3)-c4ccc(O)cc4
8830	tr|L7N650|L7N650_M	P05091	93.93	48.0	512.0	DB04381	experimental	Crotonaldehyde	O=C/C=C/C
8831	tr|L7N650|L7N650_M	P49419	96.15	63.0	538.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
8832	tr|L7N650|L7N650_M	P49419	96.15	63.0	538.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
8833	tr|L7N650|L7N650_M	P49189	93.72	25.0	488.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
8834	tr|L7N650|L7N650_M	O75891	95.14	432.0	902.0	DB00116	nutraceutical	Tetrahydrofolic acid	Nc([nH]1)nc(=O)c(c12)NC(CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
8835	tr|L7N650|L7N650_M	P25553	92.91	19.0	478.0	DB03619	approved	Deoxycholic acid	C1C[C@@H](O)C[C@H]([C@]12C)CC[C@@H]3[C@@H]2C[C@H](O)[C@@]4(C)[C@H]3CC[C@@H]4[C@H](C)CCC(=O)O
8836	tr|L7N650|L7N650_M	P77674	92.71	15.0	473.0	DB04401	experimental	Betaine aldehyde	C[N+](C)(C)CC=O
8837	tr|L7N650|L7N650_M	P51649	93.12	71.0	531.0	DB00139	approved; nutraceutical	Succinic acid	OC(=O)CCC(=O)O
8838	tr|L7N650|L7N650_M	P51649	93.12	71.0	531.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
8839	tr|L7N650|L7N650_M	P51649	93.12	71.0	531.0	DB00313	approved; investigational	Valproic acid	CCCC(C(=O)O)CCC
8840	tr|L7N650|L7N650_M	P51649	93.12	71.0	531.0	DB00534	approved; withdrawn	Chlormerodrin	Cl[Hg]CC(OC)CNC(=O)N
8841	tr|L7N650|L7N650_M	Q02252	94.94	50.0	519.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
8842	tr|L7N650|L7N650_M	P83849	93.32	51.0	512.0	DB03564	experimental	(4r)-2-Methylpentane-2,4-Diol	C[C@H](O)CC(C)(C)O
8843	tr|L7N650|L7N650_M	Q59931	92.91	15.0	474.0	DB02263	experimental	Glyceraldehyde-3-Phosphate	O=C[C@H](O)COP(=O)(O)O
8844	tr|L7N650|L7N650_M	Q59931	92.91	15.0	474.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
8845	tr|L7N650|L7N650_M	P30838	86.64	3.0	431.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
8846	tr|L7N650|L7N650_M	P51648	85.83	5.0	429.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
8847	tr|L7N650|L7N650_M	P43353	85.83	7.0	431.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
8848	tr|L7N650|L7N650_M	P09546	90.28	657.0	1103.0	DB03051	experimental	(S)-2-Tetrahydrofuroic acid	OC(=O)[C@H]1CCCO1
8849	tr|L7N650|L7N650_M	P09546	90.28	657.0	1103.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
8850	tr|L7N650|L7N650_M	P09546	90.28	657.0	1103.0	DB04398	approved; vet_approved	Lactic acid	CC(O)C(=O)O
8851	tr|L7N650|L7N650_M	P30038	92.71	77.0	535.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
8852	tr|L7N650|L7N650_M	Q56694	90.69	4.0	452.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
8853	tr|O06169|O06169_M	P94548	86.98	2.0	189.0	DB03264	experimental	Dodecyl-Coa	CCCCCCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
8854	tr|O06169|O06169_M	P0A0N4	76.28	5.0	169.0	DB01123	approved	Proflavine	c1cc(N)cc(c12)nc3c(c2)ccc(c3)N
8855	tr|O06169|O06169_M	P0A0N4	76.28	5.0	169.0	DB03608	experimental	Diminazene	NC(=N)c1ccc(cc1)N/N=N/c2ccc(cc2)C(N)=N
8856	tr|O06169|O06169_M	P0A0N4	76.28	5.0	169.0	DB03808	experimental	Hexamidine	NC(=N)c1ccc(cc1)OCCCCCCOc2ccc(cc2)C(N)=N
8857	tr|O06169|O06169_M	P0A0N4	76.28	5.0	169.0	DB04209	approved; investigational	Dequalinium	c1cccc(c12)c(N)cc(C)[n+]2CCCCCCCCCC[n+]3c(C)cc(N)c(c34)cccc4
8858	tr|O06169|O06169_M	P0A0N5	76.28	5.0	169.0	DB03808	experimental	Hexamidine	NC(=N)c1ccc(cc1)OCCCCCCOc2ccc(cc2)C(N)=N
8859	tr|O06169|O06169_M	P0A0N5	76.28	5.0	169.0	DB03825	experimental	Rhodamine 6G	CCNc(c(C)c1)cc(c12)[o+]c3c(cc(C)c(c3)NCC)c2-c4ccccc4C(=O)OCC
8860	tr|O06169|O06169_M	P0A0N5	76.28	5.0	169.0	DB03895	experimental	Malachite Green	CN(C)c1ccc(cc1)C(c2ccccc2)=C3C=CC(C=C3)=[N+](C)C
8861	tr|O06169|O06169_M	P0A0N5	76.28	5.0	169.0	DB04115	approved; investigational	Berberine	COc1c(OC)ccc(c12)cc3[n+](c2)CCc4c3cc5c(c4)OCO5
8862	tr|P96857|P96857_M	P03023	91.92	2.0	332.0	DB01862	experimental	Isopropyl beta-D-thiogalactopyranoside	CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O
8863	tr|P96857|P96857_M	P03023	91.92	2.0	332.0	DB08297	experimental	ORTHONITROPHENYL-BETA-D-FUCOPYRANOSIDE	O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O[C@@H]1C)Oc2ccccc2[N+]([O-])=O
8864	tr|P96857|P96857_M	P46828	87.19	2.0	315.0	DB02283	experimental	2-Phenylamino-Ethanesulfonic Acid	OS(=O)(=O)CCNc1ccccc1
8865	tr|P96857|P96857_M	P36673	82.45	2.0	298.0	DB02430	experimental	Trehalose-6-Phosphate	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)O[C@H]2O[C@H](COP(=O)(O)O)[C@@H](O)[C@H](O)[C@H]2O
8866	tr|P96857|P96857_M	P02925	74.65	25.0	293.0	DB04286	experimental	beta-D-Ribopyranose	O[C@@H]1CO[C@@H](O)[C@H](O)[C@@H]1O
8867	tr|P96857|P96857_M	P0AEE5	73.26	25.0	288.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
8868	tr|P96857|P96857_M	P23905	73.82	25.0	290.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
8869	tr|P96857|P96857_M	P39265	72.98	28.0	290.0	DB03989	experimental	D-Allopyranose	OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@@H]1O
8870	tr|P71718|P71718_M	Q9ZGI2	99.55	34.0	476.0	DB07703	experimental	(3R,4S,5S,7R,9E,11R,12R)-12-ETHYL-4-HYDROXY-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE	C[C@@H]1C[C@H](C)[C@H](O)[C@@H](C)C(=O)O[C@H](CC)[C@H](C)/C=C/C1=O
8871	tr|P71718|P71718_M	Q9ZGI2	99.55	34.0	476.0	DB08431	experimental	[(3R,4S)-4-HYDROXY-3-METHYL-2-OXOHEXYL]PHOSPHONIC ACID	CC[C@H](O)[C@@H](C)C(=O)C[P@@H](=O)O
8872	tr|P71718|P71718_M	Q9ZGI2	99.55	34.0	476.0	DB08759	experimental	[(3R,4S,5S,7R)-4,8-DIHYDROXY-3,5,7-TRIMETHYL-2-OXOOCTYL]PHOSPHONIC ACID	OC[C@H](C)C[C@H](C)[C@H](O)[C@@H](C)C(=O)C[P@H](=O)O
8873	tr|P71718|P71718_M	P49327	93.69	2.0	418.0	DB01034	experimental	Cerulenin	NC(=O)[C@@H]1O[C@@H]1C(=O)CC/C=C/C/C=C/C
8874	tr|P71718|P71718_M	P49327	93.69	2.0	418.0	DB01083	approved; investigational	Orlistat	CCCCCCCCCCC[C@H](OC(=O)[C@@H](NC=O)CC(C)C)C[C@@H]1OC(=O)[C@H]1CCCCCC
8876	tr|P71718|P71718_M	P0AAI5	91.44	5.0	411.0	DB01034	experimental	Cerulenin	NC(=O)[C@@H]1O[C@@H]1C(=O)CC/C=C/C/C=C/C
8877	tr|P71718|P71718_M	P0AAI5	91.44	5.0	411.0	DB03017	approved; experimental	Lauric acid	CCCCCCCCCCCC(=O)O
8878	tr|P71718|P71718_M	P0AAI5	91.44	5.0	411.0	DB08366	experimental	3-({3-[(1S,4aS,6S,7S,9S,9aR)-1,6-dimethyl-2-oxodecahydro-6,9-epoxy-4a,7-methanobenzo[7]annulen-1-yl]propanoyl}amino)-2,4-dihydroxybenzoic acid	C1[C@@H](C2)[C@](C)(C3)O[C@@H]2[C@H]([C@@]134)[C@@](C)(C(=O)CC4)CCC(=O)Nc5c(O)ccc(C(=O)O)c5O
8879	tr|P71718|P71718_M	P0AAI5	91.44	5.0	411.0	DB08407	experimental	Platensimycin	C1[C@@H](C2)[C@](C)(C3)O[C@@H]2[C@H]([C@@]134)[C@@](C)(C(=O)C=C4)CCC(=O)Nc5c(O)c(C(=O)O)ccc5O
8880	tr|P71718|P71718_M	P0A953	77.03	60.0	402.0	DB01034	experimental	Cerulenin	NC(=O)[C@@H]1O[C@@H]1C(=O)CC/C=C/C/C=C/C
8881	tr|P71718|P71718_M	P0A953	77.03	60.0	402.0	DB03017	approved; experimental	Lauric acid	CCCCCCCCCCCC(=O)O
8882	tr|P71718|P71718_M	P0A953	77.03	60.0	402.0	DB03600	experimental	Capric acid	CCCCCCCCCC(=O)O
8883	tr|P71718|P71718_M	P0A953	77.03	60.0	402.0	DB04302	experimental	4-Hydroxy-3,5-Dimethyl-5-(2-Methyl-Buta-1,3-Dienyl)-5h-Thiophen-2-One	C=C/C(C)=C/[C@@]1(C)SC(=O)C(C)=C1O
8884	tr|P71718|P71718_M	P0A953	77.03	60.0	402.0	DB04519	investigational	Caprylic acid	CCCCCCCC(=O)O
8885	tr|P71718|P71718_M	P0A953	77.03	60.0	402.0	DB08359	experimental	2-PHENYLAMINO-4-METHYL-5-ACETYL THIAZOLE	CC(=O)c1c(C)nc(s1)Nc2ccccc2
8886	tr|P71718|P71718_M	P0A953	77.03	60.0	402.0	DB08627	experimental	(5R)-4-HYDROXY-3,5-DIMETHYL-5-[(1E,3E)-2-METHYLPENTA-1,3-DIENYL]THIOPHEN-2(5H)-ONE	C/C=C/C(C)=C/[C@@]1(C)SC(=O)C(C)=C1O
8887	tr|P71718|P71718_M	P0A953	77.03	60.0	402.0	DB08628	experimental	(5R)-5-[(1E)-BUTA-1,3-DIENYL]-4-HYDROXY-3,5-DIMETHYLTHIOPHEN-2(5H)-ONE	OC1=C(C)C(=O)S[C@]1(C)/C=C/C=C
8888	tr|P71718|P71718_M	P9WQD9	70.05	102.0	413.0	DB04302	experimental	4-Hydroxy-3,5-Dimethyl-5-(2-Methyl-Buta-1,3-Dienyl)-5h-Thiophen-2-One	C=C/C(C)=C/[C@@]1(C)SC(=O)C(C)=C1O
8889	tr|I6Y3S9|I6Y3S9_M	Q9BTZ2	93.46	30.0	273.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
8891	tr|I6Y3S9|I6Y3S9_M	P16544	96.54	6.0	257.0	DB01942	experimental; investigational	Formic acid	OC=O
8892	tr|I6Y3S9|I6Y3S9_M	P16544	96.54	6.0	257.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
8893	tr|I6Y3S9|I6Y3S9_M	P16544	96.54	6.0	257.0	DB07715	investigational	Emodin	Cc(c1)cc(O)c(c12)C(=O)c3c(C2=O)cc(O)cc3O
8894	tr|I6Y3S9|I6Y3S9_M	Q9WYS2	93.85	7.0	251.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
8895	tr|I6Y3S9|I6Y3S9_M	P0AEK2	91.92	3.0	242.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
8896	tr|I6Y3S9|I6Y3S9_M	P0AET8	92.69	8.0	249.0	DB02123	experimental	Glycochenodeoxycholic Acid	OC(=O)CNC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
8898	tr|I6Y3S9|I6Y3S9_M	Q9BY49	96.15	14.0	264.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
8899	tr|I6Y3S9|I6Y3S9_M	Q84EX5	95.38	1.0	249.0	DB04619	experimental	Acetophenone	CC(=O)c1ccccc1
8900	tr|I6Y3S9|I6Y3S9_M	Q84EX5	95.38	1.0	249.0	DB04784	experimental	(R)-1-phenylethanol	C[C@@H](O)c1ccccc1
8902	tr|I6Y3S9|I6Y3S9_M	Q92506	96.92	6.0	258.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
8903	tr|I6Y3S9|I6Y3S9_M	Q92506	96.92	6.0	258.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
8904	tr|I6Y3S9|I6Y3S9_M	P0CG22	94.62	30.0	276.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
8905	tr|I6Y3S9|I6Y3S9_M	P0CG22	94.62	30.0	276.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
8906	tr|I6Y3S9|I6Y3S9_M	P0CG22	94.62	30.0	276.0	DB03541	experimental	10-Propargyl-5,8-Dideazafolic Acid	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(CC#C)Cc(c2)ccc(c23)[nH]c(N)nc3=O
8907	tr|I6Y3S9|I6Y3S9_M	P0CG22	94.62	30.0	276.0	DB07689	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)NCc(cn3)nc(c34)c(N)nc(n4)N
8908	tr|I6Y3S9|I6Y3S9_M	P0CG22	94.62	30.0	276.0	DB07765	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)N(C)Cc(cn3)nc(c34)c(N)nc(n4)N
8909	tr|I6Y3S9|I6Y3S9_M	Q7Z4W1	91.92	1.0	240.0	DB02831	experimental	Dihydrogenphosphate	OP([O-])(=O)O
8910	tr|I6Y3S9|I6Y3S9_M	Q7Z4W1	91.92	1.0	240.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
8911	tr|I6Y3S9|I6Y3S9_M	Q16698	94.62	56.0	302.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
8912	tr|I6Y3S9|I6Y3S9_M	Q16698	94.62	56.0	302.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
8913	tr|I6Y3S9|I6Y3S9_M	A0A348A0U3	96.15	3.0	253.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
8914	tr|I6Y3S9|I6Y3S9_M	Q6GI75	95.77	4.0	253.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
8915	tr|I6Y3S9|I6Y3S9_M	Q6GI75	95.77	4.0	253.0	DB11155	approved	Triclocarban	Clc1ccc(cc1)NC(=O)Nc2cc(Cl)c(Cl)cc2
8916	tr|I6Y3S9|I6Y3S9_M	P0AEK4	95.38	2.0	250.0	DB01691	experimental	Indole Naphthyridinone	c1cccc(c12)n(C)cc2CN(C)C(=O)/C=C/c(c3)cnc(c34)NC(=O)CC4
8917	tr|I6Y3S9|I6Y3S9_M	P0AEK4	95.38	2.0	250.0	DB01865	experimental	3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide	c1cccc(c12)cc(n2C)CN(C)C(=O)/C=C/c3cnc(N)cc3
8918	tr|I6Y3S9|I6Y3S9_M	P0AEK4	95.38	2.0	250.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
8919	tr|I6Y3S9|I6Y3S9_M	P0AEK4	95.38	2.0	250.0	DB03030	experimental	4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole	Cc1ccc(cc1)Cn2cnc(c2)-c3cccs3
8920	tr|I6Y3S9|I6Y3S9_M	P0AEK4	95.38	2.0	250.0	DB03534	experimental	3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide	CC(=O)N(C)Cc1c(N)ccc(c1)C(=O)N(C)Cc(n2C)cc(c23)cccc3
8921	tr|I6Y3S9|I6Y3S9_M	P0AEK4	95.38	2.0	250.0	DB04030	experimental	1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole	Oc1ccc(cc1)Cn2c(c3c(c24)cccc4)CN(CC3)C(=O)c5ccc(O)cc5
8922	tr|I6Y3S9|I6Y3S9_M	P0AEK4	95.38	2.0	250.0	DB08265	experimental	2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL	Cc1ccc(cc1)S(=O)(=O)n(b2O)ncc(c23)cccc3
8923	tr|I6Y3S9|I6Y3S9_M	P0AEK4	95.38	2.0	250.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
8924	tr|I6Y3S9|I6Y3S9_M	P0AEK4	95.38	2.0	250.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
8925	tr|I6Y3S9|I6Y3S9_M	O24990	95.77	2.0	251.0	DB04393	experimental	Soneclosan	Clc1cc(O)c(cc1)Oc2ccc(Cl)cc2
8926	tr|I6Y3S9|I6Y3S9_M	O24990	95.77	2.0	251.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
8927	tr|I6Y3S9|I6Y3S9_M	Q7AUG5	91.92	3.0	242.0	DB04782	experimental	(S)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@H]2CO2
8928	tr|I6Y3S9|I6Y3S9_M	Q93D82	91.92	3.0	242.0	DB04472	experimental	(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol	[N-]=[N+]=NC[C@H](O)c1ccc([N+]([O-])=O)cc1
8929	tr|I6Y3S9|I6Y3S9_M	Q93D82	91.92	3.0	242.0	DB04499	experimental	(R)-styrene oxide	C1O[C@@H]1c2ccccc2
8930	tr|I6Y3S9|I6Y3S9_M	Q93D82	91.92	3.0	242.0	DB04777	experimental	(R)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@@H]2CO2
8931	tr|I6Y3S9|I6Y3S9_M	Q02338	91.15	55.0	292.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
8932	tr|I6Y3S9|I6Y3S9_M	P9WGR1	101.54	1.0	265.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
8933	tr|I6Y3S9|I6Y3S9_M	P9WGR1	101.54	1.0	265.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
8934	tr|I6Y3S9|I6Y3S9_M	P9WGR1	101.54	1.0	265.0	DB02990	experimental	S-(2-Acetamidoethyl) hexadecanethioate	CCCCCCCCCCCCCCCC(=O)SCCNC(=O)C
8935	tr|I6Y3S9|I6Y3S9_M	P9WGR1	101.54	1.0	265.0	DB04289	experimental	Genz-10850	[nH]1ccc(c12)cc(cc2)C(=O)N3CCN(CC3)C4c(cccc5)c5c(c46)cccc6
8936	tr|I6Y3S9|I6Y3S9_M	P9WGR1	101.54	1.0	265.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
8937	tr|I6Y3S9|I6Y3S9_M	P9WGR1	101.54	1.0	265.0	DB07090	experimental	(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cccc(c1C)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
8938	tr|I6Y3S9|I6Y3S9_M	P9WGR1	101.54	1.0	265.0	DB07123	experimental	N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE	Cc1ccc(cc1)C(=O)N2CCC(CC2)Cc3ccccc3
8939	tr|I6Y3S9|I6Y3S9_M	P9WGR1	101.54	1.0	265.0	DB07155	experimental	(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE	c1ccccc1NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
8940	tr|I6Y3S9|I6Y3S9_M	P9WGR1	101.54	1.0	265.0	DB07178	experimental	5-PENTYL-2-PHENOXYPHENOL	CCCCCc1cc(O)c(cc1)Oc2ccccc2
8941	tr|I6Y3S9|I6Y3S9_M	P9WGR1	101.54	1.0	265.0	DB07188	experimental	(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(cc(Cl)c1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
8942	tr|I6Y3S9|I6Y3S9_M	P9WGR1	101.54	1.0	265.0	DB07192	experimental	(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Brc1cc(ccc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
8943	tr|I6Y3S9|I6Y3S9_M	P9WGR1	101.54	1.0	265.0	DB07222	experimental	(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(c(C)cc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
8944	tr|I6Y3S9|I6Y3S9_M	P9WGR1	101.54	1.0	265.0	DB07287	experimental	2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL	c1cccnc1Cc2cc(O)c(cc2)Oc3ccc(Cl)cc3Cl
8945	tr|I6Y3S9|I6Y3S9_M	P9WGR1	101.54	1.0	265.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
8946	tr|I6Y3S9|I6Y3S9_M	Q6UWP2	91.15	12.0	249.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
8947	tr|I6Y3S9|I6Y3S9_M	Q8NBN7	86.54	36.0	261.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
8949	tr|I6Y3S9|I6Y3S9_M	O75911	86.92	36.0	262.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
8950	tr|I6Y3S9|I6Y3S9_M	Q8NBQ5	74.62	34.0	228.0	DB02854	experimental	Aetiocholanolone	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](CC3)C[C@H](O)CC4
8951	tr|I6Y3S9|I6Y3S9_M	Q8I814	98.46	14.0	270.0	DB02015	experimental	Dihydrofolic Acid	O=c1[nH]c(N)nc(c12)NCC(=N2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
8952	tr|I6Y3S9|I6Y3S9_M	Q8I814	98.46	14.0	270.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
8953	tr|I6Y3S9|I6Y3S9_M	Q01782	105.77	8.0	283.0	DB02338	experimental	NADPH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
8954	tr|I6Y3S9|I6Y3S9_M	Q01782	105.77	8.0	283.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
8955	tr|I6Y3S9|I6Y3S9_M	Q01782	105.77	8.0	283.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
8956	tr|I6Y3S9|I6Y3S9_M	Q01782	105.77	8.0	283.0	DB04400	experimental	L-erythro-7,8-dihydrobiopterin	C[C@H](O)[C@H](O)C(CN1)=Nc(c12)c(=O)nc([nH]2)N
8957	tr|I6Y3S9|I6Y3S9_M	Q8TC12	78.85	38.0	243.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
8958	tr|I6Y3S9|I6Y3S9_M	P28845	80.77	31.0	241.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
8959	tr|I6Y3S9|I6Y3S9_M	P28845	80.77	31.0	241.0	DB02329	experimental	Carbenoxolone	OC(=O)CCC(=O)O[C@@H](CC1)C(C)(C)[C@@H]([C@]12C)CC[C@]3(C)[C@@H]2C(=O)C=C4[C@H]5[C@@](C)(CC[C@@]34C)CC[C@](C5)(C)C(=O)O
8960	tr|I6Y3S9|I6Y3S9_M	P28845	80.77	31.0	241.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
8961	tr|I6Y3S9|I6Y3S9_M	P28845	80.77	31.0	241.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
8962	tr|I6Y3S9|I6Y3S9_M	P28845	80.77	31.0	241.0	DB04652	experimental	Corticosterone	OCC(=O)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H]([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
8963	tr|I6Y3S9|I6Y3S9_M	P28845	80.77	31.0	241.0	DB05064	investigational	INCB13739	 
8964	tr|I6Y3S9|I6Y3S9_M	P28845	80.77	31.0	241.0	DB06992	experimental	(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone	Cc1ccc(cc1F)-c2nc(ccc2)C(=O)N(CC3(C)C)CCC3
8965	tr|I6Y3S9|I6Y3S9_M	P28845	80.77	31.0	241.0	DB07017	experimental	(5S)-2-{[(1S)-1-(4-Fluorophenyl)ethyl]amino}-5-(2-hydroxy-2-propanyl)-5-methyl-1,3-thiazol-4(5H)-one	Fc1ccc(cc1)[C@H](C)NC(=NC2=O)S[C@@]2(C)C(C)(C)O
8966	tr|I6Y3S9|I6Y3S9_M	P28845	80.77	31.0	241.0	DB07049	experimental	(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine	[O-][N+](=O)c1ccc(cc1)N2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)C(C)(C)C
8967	tr|I6Y3S9|I6Y3S9_M	P28845	80.77	31.0	241.0	DB07056	experimental	2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide	CCN(CC)C(=O)Cc1cccc(n1)NS(=O)(=O)c2c(C)c(Cl)ccc2
8968	tr|I6Y3S9|I6Y3S9_M	P28845	80.77	31.0	241.0	DB07310	experimental	(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one	Fc1ccccc1[C@H](C)NC(=NC2=O)S[C@]2(C)C(F)(F)F
8969	tr|I6Y3S9|I6Y3S9_M	P28845	80.77	31.0	241.0	DB07316	experimental	N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)C3CCN(CC3)CC4(CC4)C(=O)N
8970	tr|I6Y3S9|I6Y3S9_M	P28845	80.77	31.0	241.0	DB07619	experimental	N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)[C@H]3CC[C@@H](CC3)c4cccnc4
8971	tr|I6Y3S9|I6Y3S9_M	P28845	80.77	31.0	241.0	DB07624	experimental	1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide	C1CC1(C(=O)N)CN2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)[C@](C)(O)C(F)(F)F
8972	tr|I6Y3S9|I6Y3S9_M	P28845	80.77	31.0	241.0	DB07866	experimental	(5S)-2-(Cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one	CCC[C@]1(C)SC(=NC1=O)NC2CCCCCCC2
8973	tr|I6Y3S9|I6Y3S9_M	P28845	80.77	31.0	241.0	DB08277	experimental	2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE	CS(=O)(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4c(Cl)cc(F)cc4
8974	tr|I6Y3S9|I6Y3S9_M	P28845	80.77	31.0	241.0	DB08280	experimental	(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE	NC(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4ccc(OC)cc4
8975	tr|I6Y3S9|I6Y3S9_M	P28845	80.77	31.0	241.0	DB08771	experimental	(5R)-2-[(2-Fluorophenyl)amino]-5-isopropyl-1,3-thiazol-4(5H)-one	CC(C)[C@H]1SC(=NC1=O)Nc2c(F)cccc2
8976	tr|I6Y3S9|I6Y3S9_M	P28845	80.77	31.0	241.0	DB13751	approved; experimental	Glycyrrhizic acid	C1C[C@](C)(C(=O)O)C[C@H]([C@]12C)C=3[C@@](C)(CC2)[C@@]4(C)[C@H](C(=O)C3)[C@]5(C)[C@@H](CC4)C(C)(C)[C@H](CC5)O[C@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O[C@@H]7O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]7O
8977	tr|I6Y3S9|I6Y3S9_M	Q9NYR8	74.23	6.0	199.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
8978	tr|I6Y3S9|I6Y3S9_M	Q96NR8	78.85	36.0	241.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
8979	tr|I6Y3S9|I6Y3S9_M	Q99714	95.0	8.0	255.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
8980	tr|I6Y3S9|I6Y3S9_M	Q99714	95.0	8.0	255.0	DB02820	experimental	1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct	C1CCCCCN1C(=O)[C@H](c2ccccc2)n(c3=S)cnc(c34)nn(c4)[C@H]5C=CN(C=C5C([O-])=N)[C@@H]6O[C@@H]([C@@H](O)[C@H]6O)COP([O-])(=O)OP(=O)(O)OC[C@H]7O[C@H]([C@H]([O-])[C@@H]7[O-])n8cnc(c89)c(N)ncn9
8981	tr|I6Y3S9|I6Y3S9_M	Q99714	95.0	8.0	255.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
8982	tr|I6Y3S9|I6Y3S9_M	P14061	77.31	2.0	203.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
8983	tr|I6Y3S9|I6Y3S9_M	P14061	77.31	2.0	203.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
8984	tr|I6Y3S9|I6Y3S9_M	P14061	77.31	2.0	203.0	DB01561	experimental; illicit	Androstanedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
8985	tr|I6Y3S9|I6Y3S9_M	P14061	77.31	2.0	203.0	DB02187	experimental	Equilin	O=C1CC[C@H]([C@@]12C)C=3[C@H](CC2)c4c(CC3)cc(O)cc4
8986	tr|I6Y3S9|I6Y3S9_M	P14061	77.31	2.0	203.0	DB02323	experimental	EM-1745	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)C[C@@H]([C@@H]4O)CCCCCCCCC(=O)OC[C@H]5O[C@H]([C@H](O)[C@@H]5O)n6cnc(c67)c(N)ncn7
8987	tr|I6Y3S9|I6Y3S9_M	P14061	77.31	2.0	203.0	DB02901	illicit; investigational	Stanolone	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
8988	tr|I6Y3S9|I6Y3S9_M	P14061	77.31	2.0	203.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
8989	tr|I6Y3S9|I6Y3S9_M	P14061	77.31	2.0	203.0	DB13951	experimental	Stanolone acetate	CC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
8990	tr|I6Y3S9|I6Y3S9_M	P37058	77.31	48.0	249.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
8991	tr|I6Y3S9|I6Y3S9_M	Q9HBH5	85.0	39.0	260.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
8992	tr|I6Y3S9|I6Y3S9_M	P37059	79.23	81.0	287.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
8993	tr|I6Y3S9|I6Y3S9_M	P37059	79.23	81.0	287.0	DB13952	approved; investigational; vet_approved	Estradiol acetate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)C
8994	tr|I6Y3S9|I6Y3S9_M	P37059	79.23	81.0	287.0	DB13953	approved; investigational; vet_approved	Estradiol benzoate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)c5ccccc5
8995	tr|I6Y3S9|I6Y3S9_M	P37059	79.23	81.0	287.0	DB13954	approved; investigational; vet_approved	Estradiol cypionate	C1CCCC1CCC(=O)O[C@H]2CC[C@H]([C@@]23C)[C@H]4[C@H](CC3)c5c(CC4)cc(O)cc5
8996	tr|I6Y3S9|I6Y3S9_M	P37059	79.23	81.0	287.0	DB13955	approved; investigational; vet_approved	Estradiol dienanthate	CCCCCCC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)CCCCCC
8997	tr|I6Y3S9|I6Y3S9_M	P37059	79.23	81.0	287.0	DB13956	approved; investigational; vet_approved	Estradiol valerate	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)CC[C@@H]4OC(=O)CCCC
8998	tr|I6Y3S9|I6Y3S9_M	P51659	77.31	7.0	208.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
8999	tr|I6Y3S9|I6Y3S9_M	P51659	77.31	7.0	208.0	DB03192	experimental	(R)-3-hydroxydecanoyl-CoA	CCCCCCC[C@@H](O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
9000	tr|I6Y3S9|I6Y3S9_M	Q92781	71.15	29.0	214.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9001	tr|I6Y3S9|I6Y3S9_M	Q92781	71.15	29.0	214.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
9002	tr|I6Y3S9|I6Y3S9_M	P80365	74.62	83.0	277.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9003	tr|I6Y3S9|I6Y3S9_M	P80365	74.62	83.0	277.0	DB01185	approved; illicit	Fluoxymesterone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@](F)([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
9004	tr|I6Y3S9|I6Y3S9_M	P80365	74.62	83.0	277.0	DB01569	experimental; illicit	Formebolone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@H]([C@@H](C2)O)[C@]4(C)C(CC3)=CC(=O)C(C=O)=C4
9005	tr|I6Y3S9|I6Y3S9_M	P80365	74.62	83.0	277.0	DB14538	experimental; vet_approved	Hydrocortisone aceponate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CC)C(=O)COC(=O)C
9006	tr|I6Y3S9|I6Y3S9_M	P80365	74.62	83.0	277.0	DB14539	approved; vet_approved	Hydrocortisone acetate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)C
9007	tr|I6Y3S9|I6Y3S9_M	P80365	74.62	83.0	277.0	DB14540	approved; vet_approved	Hydrocortisone butyrate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCC
9008	tr|I6Y3S9|I6Y3S9_M	P80365	74.62	83.0	277.0	DB14541	approved; investigational; vet_approved	Hydrocortisone cypionate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)CCC5CCCC5
9009	tr|I6Y3S9|I6Y3S9_M	P80365	74.62	83.0	277.0	DB14542	approved; vet_approved	Hydrocortisone phosphate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COP(=O)(O)O
9010	tr|I6Y3S9|I6Y3S9_M	P80365	74.62	83.0	277.0	DB14543	approved; vet_approved	Hydrocortisone probutate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CCC)C(=O)COC(=O)CC
9011	tr|I6Y3S9|I6Y3S9_M	P80365	74.62	83.0	277.0	DB14544	approved; vet_approved	Hydrocortisone valerate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCCC
9012	tr|I6Y3S9|I6Y3S9_M	P16152	93.46	7.0	250.0	DB01698	approved; experimental; investigational	Rutin	O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O[C@H]1C)OC[C@H]2O[C@H]([C@H](O)[C@@H](O)[C@@H]2O)Oc(c3=O)c(-c4cc(O)c(O)cc4)oc(c35)cc(O)cc5O
9013	tr|I6Y3S9|I6Y3S9_M	P16152	93.46	7.0	250.0	DB02709	investigational	Resveratrol	Oc1ccc(cc1)/C=C/c2cc(O)cc(O)c2
9014	tr|I6Y3S9|I6Y3S9_M	P16152	93.46	7.0	250.0	DB03394	experimental	Heptaethylene glycol	OCCOCCOCCOCCOCCOCCOCCO
9015	tr|I6Y3S9|I6Y3S9_M	P16152	93.46	7.0	250.0	DB03556	experimental	2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400	CCOCCOCCOCCOCCOCCOCCOCCOCCO
9016	tr|I6Y3S9|I6Y3S9_M	P16152	93.46	7.0	250.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
9017	tr|I6Y3S9|I6Y3S9_M	P16152	93.46	7.0	250.0	DB04463	experimental	3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol	n1cnc(N)c(c12)c(nn2C(C)(C)C)-c3cccc(O)c3
9018	tr|I6Y3S9|I6Y3S9_M	P16152	93.46	7.0	250.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
9019	tr|I6Y3S9|I6Y3S9_M	P16152	93.46	7.0	250.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
9020	tr|I6Y3S9|I6Y3S9_M	P56937	89.23	2.0	234.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9021	tr|I6Y3S9|I6Y3S9_M	P35270	83.08	1.0	217.0	DB02637	experimental	Oxaloacetate Ion	OC(=O)C(=O)CC([O-])=O
9022	tr|I6Y3S9|I6Y3S9_M	P35270	83.08	1.0	217.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9023	tr|I6Y3S9|I6Y3S9_M	P35270	83.08	1.0	217.0	DB03886	experimental	Biopterin	C[C@@H](O)[C@@H](O)c(n1)cnc(c12)nc(N)[nH]c2=O
9024	tr|I6Y3S9|I6Y3S9_M	P35270	83.08	1.0	217.0	DB04275	experimental	N-acetylserotonin	CC(=O)NCCc1c[nH]c(c12)ccc(c2)O
9025	tr|I6Y3S9|I6Y3S9_M	P09417	71.54	11.0	197.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9026	tr|I6Y3S9|I6Y3S9_M	P09417	71.54	11.0	197.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
9027	tr|I6Y3S9|I6Y3S9_M	Q8T8E9	74.62	2.0	196.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
9028	tr|I6Y3S9|I6Y3S9_M	P26391	73.46	3.0	194.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
9029	tr|I6Y3S9|I6Y3S9_M	P26397	72.31	6.0	194.0	DB02059	experimental	Adenosine-5-Diphosphoribose	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)CO[P@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H](O)[C@H](O)[C@@H]4O
9030	tr|I6Y3S9|I6Y3S9_M	P26397	72.31	6.0	194.0	DB03069	experimental	Cytidine-5'-diphospho-beta-D-xylose	Nc1nc(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O[C@H]3OC[C@@H](O)[C@H](O)[C@H]3O
9031	tr|Q6MWW2|Q6MWW2_M	P51659	98.6	325.0	607.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9032	tr|Q6MWW2|Q6MWW2_M	P51659	98.6	325.0	607.0	DB03192	experimental	(R)-3-hydroxydecanoyl-CoA	CCCCCCC[C@@H](O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
9033	tr|O06413|O06413_M	Q96NR8	79.59	6.0	240.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
9034	tr|O06413|O06413_M	P16544	72.79	6.0	220.0	DB01942	experimental; investigational	Formic acid	OC=O
9035	tr|O06413|O06413_M	P16544	72.79	6.0	220.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9036	tr|O06413|O06413_M	P16544	72.79	6.0	220.0	DB07715	investigational	Emodin	Cc(c1)cc(O)c(c12)C(=O)c3c(C2=O)cc(O)cc3O
9037	tr|O06413|O06413_M	Q8TC12	76.87	16.0	242.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
9038	tr|O06413|O06413_M	P28845	73.81	24.0	241.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9039	tr|O06413|O06413_M	P28845	73.81	24.0	241.0	DB02329	experimental	Carbenoxolone	OC(=O)CCC(=O)O[C@@H](CC1)C(C)(C)[C@@H]([C@]12C)CC[C@]3(C)[C@@H]2C(=O)C=C4[C@H]5[C@@](C)(CC[C@@]34C)CC[C@](C5)(C)C(=O)O
9040	tr|O06413|O06413_M	P28845	73.81	24.0	241.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9041	tr|O06413|O06413_M	P28845	73.81	24.0	241.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
9042	tr|O06413|O06413_M	P28845	73.81	24.0	241.0	DB04652	experimental	Corticosterone	OCC(=O)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H]([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
9043	tr|O06413|O06413_M	P28845	73.81	24.0	241.0	DB05064	investigational	INCB13739	 
9044	tr|O06413|O06413_M	P28845	73.81	24.0	241.0	DB06992	experimental	(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone	Cc1ccc(cc1F)-c2nc(ccc2)C(=O)N(CC3(C)C)CCC3
9045	tr|O06413|O06413_M	P28845	73.81	24.0	241.0	DB07017	experimental	(5S)-2-{[(1S)-1-(4-Fluorophenyl)ethyl]amino}-5-(2-hydroxy-2-propanyl)-5-methyl-1,3-thiazol-4(5H)-one	Fc1ccc(cc1)[C@H](C)NC(=NC2=O)S[C@@]2(C)C(C)(C)O
9046	tr|O06413|O06413_M	P28845	73.81	24.0	241.0	DB07049	experimental	(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine	[O-][N+](=O)c1ccc(cc1)N2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)C(C)(C)C
9047	tr|O06413|O06413_M	P28845	73.81	24.0	241.0	DB07056	experimental	2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide	CCN(CC)C(=O)Cc1cccc(n1)NS(=O)(=O)c2c(C)c(Cl)ccc2
9048	tr|O06413|O06413_M	P28845	73.81	24.0	241.0	DB07310	experimental	(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one	Fc1ccccc1[C@H](C)NC(=NC2=O)S[C@]2(C)C(F)(F)F
9049	tr|O06413|O06413_M	P28845	73.81	24.0	241.0	DB07316	experimental	N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)C3CCN(CC3)CC4(CC4)C(=O)N
9050	tr|O06413|O06413_M	P28845	73.81	24.0	241.0	DB07619	experimental	N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)[C@H]3CC[C@@H](CC3)c4cccnc4
9051	tr|O06413|O06413_M	P28845	73.81	24.0	241.0	DB07624	experimental	1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide	C1CC1(C(=O)N)CN2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)[C@](C)(O)C(F)(F)F
9052	tr|O06413|O06413_M	P28845	73.81	24.0	241.0	DB07866	experimental	(5S)-2-(Cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one	CCC[C@]1(C)SC(=NC1=O)NC2CCCCCCC2
9053	tr|O06413|O06413_M	P28845	73.81	24.0	241.0	DB08277	experimental	2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE	CS(=O)(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4c(Cl)cc(F)cc4
9054	tr|O06413|O06413_M	P28845	73.81	24.0	241.0	DB08280	experimental	(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE	NC(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4ccc(OC)cc4
9055	tr|O06413|O06413_M	P28845	73.81	24.0	241.0	DB08771	experimental	(5R)-2-[(2-Fluorophenyl)amino]-5-isopropyl-1,3-thiazol-4(5H)-one	CC(C)[C@H]1SC(=NC1=O)Nc2c(F)cccc2
9056	tr|O06413|O06413_M	P28845	73.81	24.0	241.0	DB13751	approved; experimental	Glycyrrhizic acid	C1C[C@](C)(C(=O)O)C[C@H]([C@]12C)C=3[C@@](C)(CC2)[C@@]4(C)[C@H](C(=O)C3)[C@]5(C)[C@@H](CC4)C(C)(C)[C@H](CC5)O[C@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O[C@@H]7O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]7O
9057	tr|O06413|O06413_M	Q8NBN7	73.13	27.0	242.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
9058	tr|O06413|O06413_M	Q6UWP2	72.79	10.0	224.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9059	tr|O06413|O06413_M	Q9HBH5	79.93	21.0	256.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
9060	tr|O06413|O06413_M	Q92506	73.13	6.0	221.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9061	tr|O06413|O06413_M	Q92506	73.13	6.0	221.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9062	tr|O06413|O06413_M	P80365	71.43	76.0	286.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9063	tr|O06413|O06413_M	P80365	71.43	76.0	286.0	DB01185	approved; illicit	Fluoxymesterone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@](F)([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
9064	tr|O06413|O06413_M	P80365	71.43	76.0	286.0	DB01569	experimental; illicit	Formebolone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@H]([C@@H](C2)O)[C@]4(C)C(CC3)=CC(=O)C(C=O)=C4
9065	tr|O06413|O06413_M	P80365	71.43	76.0	286.0	DB14538	experimental; vet_approved	Hydrocortisone aceponate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CC)C(=O)COC(=O)C
9066	tr|O06413|O06413_M	P80365	71.43	76.0	286.0	DB14539	approved; vet_approved	Hydrocortisone acetate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)C
9067	tr|O06413|O06413_M	P80365	71.43	76.0	286.0	DB14540	approved; vet_approved	Hydrocortisone butyrate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCC
9068	tr|O06413|O06413_M	P80365	71.43	76.0	286.0	DB14541	approved; investigational; vet_approved	Hydrocortisone cypionate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)CCC5CCCC5
9069	tr|O06413|O06413_M	P80365	71.43	76.0	286.0	DB14542	approved; vet_approved	Hydrocortisone phosphate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COP(=O)(O)O
9070	tr|O06413|O06413_M	P80365	71.43	76.0	286.0	DB14543	approved; vet_approved	Hydrocortisone probutate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CCC)C(=O)COC(=O)CC
9071	tr|O06413|O06413_M	P80365	71.43	76.0	286.0	DB14544	approved; vet_approved	Hydrocortisone valerate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCCC
9072	tr|O06413|O06413_M	P16152	78.91	7.0	239.0	DB01698	approved; experimental; investigational	Rutin	O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O[C@H]1C)OC[C@H]2O[C@H]([C@H](O)[C@@H](O)[C@@H]2O)Oc(c3=O)c(-c4cc(O)c(O)cc4)oc(c35)cc(O)cc5O
9073	tr|O06413|O06413_M	P16152	78.91	7.0	239.0	DB02709	investigational	Resveratrol	Oc1ccc(cc1)/C=C/c2cc(O)cc(O)c2
9074	tr|O06413|O06413_M	P16152	78.91	7.0	239.0	DB03394	experimental	Heptaethylene glycol	OCCOCCOCCOCCOCCOCCOCCO
9075	tr|O06413|O06413_M	P16152	78.91	7.0	239.0	DB03556	experimental	2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400	CCOCCOCCOCCOCCOCCOCCOCCOCCO
9076	tr|O06413|O06413_M	P16152	78.91	7.0	239.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
9077	tr|O06413|O06413_M	P16152	78.91	7.0	239.0	DB04463	experimental	3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol	n1cnc(N)c(c12)c(nn2C(C)(C)C)-c3cccc(O)c3
9078	tr|O06413|O06413_M	P16152	78.91	7.0	239.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
9079	tr|O06413|O06413_M	P16152	78.91	7.0	239.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
9080	tr|O06413|O06413_M	Q8I814	72.45	13.0	226.0	DB02015	experimental	Dihydrofolic Acid	O=c1[nH]c(N)nc(c12)NCC(=N2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
9081	tr|O06413|O06413_M	Q8I814	72.45	13.0	226.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9082	tr|O06413|O06413_M	P56937	77.89	2.0	231.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9083	tr|O06413|O06413_M	P35270	72.79	5.0	219.0	DB02637	experimental	Oxaloacetate Ion	OC(=O)C(=O)CC([O-])=O
9084	tr|O06413|O06413_M	P35270	72.79	5.0	219.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9085	tr|O06413|O06413_M	P35270	72.79	5.0	219.0	DB03886	experimental	Biopterin	C[C@@H](O)[C@@H](O)c(n1)cnc(c12)nc(N)[nH]c2=O
9086	tr|O06413|O06413_M	P35270	72.79	5.0	219.0	DB04275	experimental	N-acetylserotonin	CC(=O)NCCc1c[nH]c(c12)ccc(c2)O
9087	tr|I6X5Z8|I6X5Z8_M	O95477	74.89	903.0	1067.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
9088	tr|I6X5Z8|I6X5Z8_M	O95477	74.89	903.0	1067.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
9089	tr|I6X5Z8|I6X5Z8_M	O95477	74.89	903.0	1067.0	DB01599	approved; investigational	Probucol	CC(C)(C)c1cc(cc(c1O)C(C)(C)C)SC(C)(C)Sc2cc(C(C)(C)C)c(O)c(c2)C(C)(C)C
9090	tr|I6X5Z8|I6X5Z8_M	O95477	75.34	1916.0	2081.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
9091	tr|I6X5Z8|I6X5Z8_M	O95477	75.34	1916.0	2081.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
9092	tr|I6X5Z8|I6X5Z8_M	O95477	75.34	1916.0	2081.0	DB01599	approved; investigational	Probucol	CC(C)(C)c1cc(cc(c1O)C(C)(C)C)SC(C)(C)Sc2cc(C(C)(C)C)c(O)c(c2)C(C)(C)C
9093	tr|I6X5Z8|I6X5Z8_M	O60706	79.91	1326.0	1501.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
9094	tr|I6X5Z8|I6X5Z8_M	O60706	79.91	1326.0	1501.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
9095	tr|I6X5Z8|I6X5Z8_M	O60706	79.91	1326.0	1501.0	DB09220	approved; investigational	Nicorandil	[O-][N+](=O)OCCNC(=O)c1cccnc1
9096	tr|I6X5Z8|I6X5Z8_M	Q09428	76.26	691.0	858.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
9097	tr|I6X5Z8|I6X5Z8_M	Q09428	76.26	691.0	858.0	DB00222	approved	Glimepiride	CCC1=C(C)CN(C1=O)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3
9098	tr|I6X5Z8|I6X5Z8_M	Q09428	76.26	691.0	858.0	DB00672	approved; investigational	Chlorpropamide	CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1
9099	tr|I6X5Z8|I6X5Z8_M	Q09428	76.26	691.0	858.0	DB00731	approved; investigational	Nateglinide	CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](C(=O)O)Cc2ccccc2
9100	tr|I6X5Z8|I6X5Z8_M	Q09428	76.26	691.0	858.0	DB00912	approved; investigational	Repaglinide	CCOc1c(C(=O)O)ccc(c1)CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3
9101	tr|I6X5Z8|I6X5Z8_M	Q09428	76.26	691.0	858.0	DB01067	approved; investigational	Glipizide	Cc1ncc(nc1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
9102	tr|I6X5Z8|I6X5Z8_M	Q09428	76.26	691.0	858.0	DB01120	approved	Gliclazide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN(C2)CC(C23)CCC3
9103	tr|I6X5Z8|I6X5Z8_M	Q09428	76.26	691.0	858.0	DB01124	approved; investigational	Tolbutamide	CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1
9104	tr|I6X5Z8|I6X5Z8_M	Q09428	76.26	691.0	858.0	DB01251	approved; investigational	Gliquidone	COc(cc1)cc(c12)C(=O)N(C(=O)C2(C)C)CCc3ccc(cc3)S(=O)(=O)NC(=O)NC4CCCCC4
9105	tr|I6X5Z8|I6X5Z8_M	Q09428	76.26	691.0	858.0	DB01252	investigational	Mitiglinide	c1ccccc1C[C@H](C(=O)O)CC(=O)N(C2)C[C@H]([C@H]23)CCCC3
9106	tr|I6X5Z8|I6X5Z8_M	Q09428	76.26	691.0	858.0	DB01382	approved; investigational	Glymidine	COCCOc1cnc(nc1)NS(=O)(=O)c2ccccc2
9107	tr|I6X5Z8|I6X5Z8_M	Q09428	76.26	691.0	858.0	DB00839	approved; investigational	Tolazamide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2
9108	tr|I6X5Z8|I6X5Z8_M	Q09428	76.26	691.0	858.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
9109	tr|I6X5Z8|I6X5Z8_M	O95255	78.08	1274.0	1445.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
9110	tr|I6X5Z8|I6X5Z8_M	O15439	70.32	1057.0	1211.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
9111	tr|I6X5Z8|I6X5Z8_M	P13569	77.17	1224.0	1393.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
9112	tr|I6X5Z8|I6X5Z8_M	P13569	77.17	1224.0	1393.0	DB00887	approved	Bumetanide	CCCCNc1c(c(S(=O)(=O)N)cc(c1)C(=O)O)Oc2ccccc2
9113	tr|I6X5Z8|I6X5Z8_M	P13569	77.17	1224.0	1393.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
9114	tr|I6X5Z8|I6X5Z8_M	P13569	77.17	1224.0	1393.0	DB01050	approved	Ibuprofen	CC(C)Cc1ccc(cc1)C(C)C(=O)O
9115	tr|I6X5Z8|I6X5Z8_M	P13569	77.17	1224.0	1393.0	DB02587	experimental; investigational	Colforsin	O[C@H]1CCC(C)(C)[C@@H]([C@]12C)[C@H](O)[C@H](OC(=O)C)[C@]3(C)[C@]2(O)C(=O)C[C@](O3)(C)C=C
9116	tr|I6X5Z8|I6X5Z8_M	P13569	77.17	1224.0	1393.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
9117	tr|I6X5Z8|I6X5Z8_M	P13569	77.17	1224.0	1393.0	DB04522	experimental	Dexfosfoserine	OC(=O)[C@@H](N)COP(=O)(O)O
9118	tr|I6X5Z8|I6X5Z8_M	P13569	77.17	1224.0	1393.0	DB04941	approved	Crofelemer	 
9119	tr|I6X5Z8|I6X5Z8_M	P13569	77.17	1224.0	1393.0	DB06266	investigational	Lonidamine	c1cccc(c12)n(nc2C(=O)O)Cc3c(Cl)cc(Cl)cc3
9120	tr|I6X5Z8|I6X5Z8_M	P13569	77.17	1224.0	1393.0	DB08820	approved	Ivacaftor	CC(C)(C)c1cc(C(C)(C)C)c(O)cc1NC(=O)c(c2=O)c[nH]c(c23)cccc3
9121	tr|I6X5Z8|I6X5Z8_M	P13569	77.17	1224.0	1393.0	DB09213	approved; investigational	Dexibuprofen	CC(C)Cc1ccc(cc1)[C@H](C)C(=O)O
9122	tr|I6X5Z8|I6X5Z8_M	P13569	77.17	1224.0	1393.0	DB09280	approved	Lumacaftor	O=C(O)c1cccc(c1)-c2nc(ccc2C)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
9123	tr|I6X5Z8|I6X5Z8_M	P13569	77.17	1224.0	1393.0	DB11712	approved; investigational	Tezacaftor	OC[C@H](O)Cn1c(C(C)(C)CO)cc(c12)cc(c(F)c2)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
9124	tr|I6X5Z8|I6X5Z8_M	P13569	77.17	1224.0	1393.0	DB15444	approved; investigational	Elexacaftor	FC(F)(F)C(C)(C)COc1nn(cc1)-c2nc(N(C3(C)C)C[C@@H](C)C3)c(cc2)C(=O)NS(=O)(=O)c4cn(C)nc4C
9125	tr|I6X5Z8|I6X5Z8_M	P45844	73.52	98.0	259.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
9126	tr|I6X5Z8|I6X5Z8_M	Q9UNQ0	72.15	60.0	218.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
9127	tr|I6X5Z8|I6X5Z8_M	Q9UNQ0	72.15	60.0	218.0	DB11995	approved; investigational	Avatrombopag	OC(=O)C1CCN(CC1)c2c(Cl)cc(cn2)C(=O)Nc3nc(-c4cc(Cl)cs4)c(s3)N5CCN(CC5)C6CCCCC6
9128	tr|I6X5C9|I6X5C9_M	Q9WZW1	84.29	2.0	281.0	DB03247	approved; investigational	Flavin mononucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)COP(=O)(O)O
9129	tr|I6X5C9|I6X5C9_M	Q9WZW1	84.29	2.0	281.0	DB04272	approved; nutraceutical; vet_approved	Citric acid	OC(=O)CC(O)(C(=O)O)CC(=O)O
9130	tr|I6X5C9|I6X5C9_M	Q9WZW1	84.29	2.0	281.0	DB04345	experimental	Lumichrome	Cc(c1)c(C)cc(c12)nc3c(n2)c(=O)[nH]c(=O)[nH]3
9131	tr|L0TAD5|L0TAD5_M	P21964	92.35	76.0	257.0	DB00118	approved; investigational; nutraceutical	Ademetionine	[O-]C(=O)[C@@H](N)CC[S+](C)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
9132	tr|L0TAD5|L0TAD5_M	P21964	92.35	76.0	257.0	DB00323	approved; withdrawn	Tolcapone	Cc1ccc(cc1)C(=O)c2cc([N+]([O-])=O)c(O)c(O)c2
9133	tr|L0TAD5|L0TAD5_M	P21964	92.35	76.0	257.0	DB00494	approved; investigational	Entacapone	CCN(CC)C(=O)/C(C#N)=C/c1cc([N+]([O-])=O)c(O)c(O)c1
9134	tr|L0TAD5|L0TAD5_M	P21964	92.35	76.0	257.0	DB02105	experimental	3,5-Dinitrocatechol	Oc1cc([N+]([O-])=O)cc([N+]([O-])=O)c1O
9135	tr|L0TAD5|L0TAD5_M	P21964	92.35	76.0	257.0	DB02342	investigational	2-Methoxyestradiol	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)c(c4)OC
9136	tr|L0TAD5|L0TAD5_M	P21964	92.35	76.0	257.0	DB03336	experimental	BIA	Oc1c([N+]([O-])=O)cc(cc1O)C(=O)CCN2CCN(CC2)c3cc(C(F)(F)F)ccc3
9137	tr|L0TAD5|L0TAD5_M	P21964	92.35	76.0	257.0	DB03907	experimental	N-[(E)-3-[(2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]prop-2-enyl]-2,3-dihydroxy-5-nitrobenzamide	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)/C=C/CNC(=O)c4c(O)c(O)cc(c4)[N+]([O-])=O
9138	tr|L0TAD5|L0TAD5_M	P21964	92.35	76.0	257.0	DB04820	approved; withdrawn	Nialamide	c1ccccc1CNC(=O)CCNNC(=O)c2ccncc2
9139	tr|L0TAD5|L0TAD5_M	P21964	92.35	76.0	257.0	DB07462	experimental	(3,4-DIHYDROXY-2-NITROPHENYL)(PHENYL)METHANONE	Oc1ccc(c([N+]([O-])=O)c1O)C(=O)c2ccccc2
9140	tr|L0TAD5|L0TAD5_M	P21964	92.35	76.0	257.0	DB08049	experimental	7,8-dihydroxy-4-phenyl-2H-chromen-2-one	Oc1c(O)ccc(c12)c(cc(o2)=O)-c3ccccc3
9141	tr|L0TAD5|L0TAD5_M	P21964	92.35	76.0	257.0	DB11632	approved; investigational	Opicapone	Clc1c(C)[n+]([O-])c(Cl)c(c1C)-c2noc(n2)-c3cc([N+]([O-])=O)c(O)c(O)c3
9142	tr|I6YEE6|I6YEE6_M	Q9L9D7	99.64	8.0	555.0	DB01795	experimental	Phenylboronic acid	OB(O)c1ccccc1
9143	tr|I6YEE6|I6YEE6_M	Q9L9D7	99.64	8.0	555.0	DB03793	approved; investigational	Benzoic acid	OC(=O)c1ccccc1
9144	tr|O53726|O53726_M	Q8TC12	90.35	34.0	315.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
9145	tr|O53726|O53726_M	Q96NR8	90.03	34.0	314.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
9146	tr|O53726|O53726_M	Q8NBN7	91.64	34.0	319.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
9147	tr|O53726|O53726_M	Q9HBH5	94.21	41.0	334.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
9148	tr|O53726|O53726_M	P56937	78.78	2.0	247.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9149	tr|P95103|P95103_M	Q9AIU0	80.88	6.0	171.0	DB03467	experimental	Naringenin	Oc1ccc(cc1)[C@@H](O2)CC(=O)c(c23)c(O)cc(c3)O
9150	tr|P95103|P95103_M	Q9AIU0	80.88	6.0	171.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
9151	tr|P95103|P95103_M	Q9AIU0	80.88	6.0	171.0	DB07810	experimental	Phloretin	Oc1ccc(cc1)CCC(=O)c2c(O)cc(O)cc2O
9152	tr|O05842|O05842_M	Q9WYS2	85.82	6.0	248.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9153	tr|O05842|O05842_M	Q9BTZ2	84.75	30.0	269.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
9154	tr|O05842|O05842_M	P0AET8	84.4	8.0	246.0	DB02123	experimental	Glycochenodeoxycholic Acid	OC(=O)CNC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
9155	tr|O05842|O05842_M	P0AEK2	83.69	1.0	237.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9156	tr|O05842|O05842_M	Q16698	91.49	56.0	314.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9157	tr|O05842|O05842_M	Q16698	91.49	56.0	314.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
9160	tr|O05842|O05842_M	Q9BY49	86.52	16.0	260.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
9162	tr|O05842|O05842_M	Q92506	86.88	9.0	254.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9163	tr|O05842|O05842_M	Q92506	86.88	9.0	254.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9164	tr|O05842|O05842_M	P16544	87.59	6.0	253.0	DB01942	experimental; investigational	Formic acid	OC=O
9165	tr|O05842|O05842_M	P16544	87.59	6.0	253.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9166	tr|O05842|O05842_M	P16544	87.59	6.0	253.0	DB07715	investigational	Emodin	Cc(c1)cc(O)c(c12)C(=O)c3c(C2=O)cc(O)cc3O
9167	tr|O05842|O05842_M	P0CG22	86.17	30.0	273.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
9168	tr|O05842|O05842_M	P0CG22	86.17	30.0	273.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9169	tr|O05842|O05842_M	P0CG22	86.17	30.0	273.0	DB03541	experimental	10-Propargyl-5,8-Dideazafolic Acid	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(CC#C)Cc(c2)ccc(c23)[nH]c(N)nc3=O
9170	tr|O05842|O05842_M	P0CG22	86.17	30.0	273.0	DB07689	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)NCc(cn3)nc(c34)c(N)nc(n4)N
9171	tr|O05842|O05842_M	P0CG22	86.17	30.0	273.0	DB07765	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)N(C)Cc(cn3)nc(c34)c(N)nc(n4)N
9172	tr|O05842|O05842_M	Q84EX5	85.11	4.0	244.0	DB04619	experimental	Acetophenone	CC(=O)c1ccccc1
9173	tr|O05842|O05842_M	Q84EX5	85.11	4.0	244.0	DB04784	experimental	(R)-1-phenylethanol	C[C@@H](O)c1ccccc1
9174	tr|O05842|O05842_M	Q7Z4W1	82.62	5.0	238.0	DB02831	experimental	Dihydrogenphosphate	OP([O-])(=O)O
9175	tr|O05842|O05842_M	Q7Z4W1	82.62	5.0	238.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9176	tr|O05842|O05842_M	Q6UWP2	85.11	11.0	251.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9177	tr|O05842|O05842_M	P51659	81.21	6.0	235.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9178	tr|O05842|O05842_M	P51659	81.21	6.0	235.0	DB03192	experimental	(R)-3-hydroxydecanoyl-CoA	CCCCCCC[C@@H](O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
9179	tr|O05842|O05842_M	A0A348A0U3	87.23	4.0	250.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
9181	tr|O05842|O05842_M	Q8NBQ5	74.82	33.0	244.0	DB02854	experimental	Aetiocholanolone	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](CC3)C[C@H](O)CC4
9182	tr|O05842|O05842_M	P14061	73.05	3.0	209.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9183	tr|O05842|O05842_M	P14061	73.05	3.0	209.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
9184	tr|O05842|O05842_M	P14061	73.05	3.0	209.0	DB01561	experimental; illicit	Androstanedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
9185	tr|O05842|O05842_M	P14061	73.05	3.0	209.0	DB02187	experimental	Equilin	O=C1CC[C@H]([C@@]12C)C=3[C@H](CC2)c4c(CC3)cc(O)cc4
9186	tr|O05842|O05842_M	P14061	73.05	3.0	209.0	DB02323	experimental	EM-1745	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)C[C@@H]([C@@H]4O)CCCCCCCCC(=O)OC[C@H]5O[C@H]([C@H](O)[C@@H]5O)n6cnc(c67)c(N)ncn7
9187	tr|O05842|O05842_M	P14061	73.05	3.0	209.0	DB02901	illicit; investigational	Stanolone	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
9188	tr|O05842|O05842_M	P14061	73.05	3.0	209.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9189	tr|O05842|O05842_M	P14061	73.05	3.0	209.0	DB13951	experimental	Stanolone acetate	CC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
9190	tr|O05842|O05842_M	O75911	75.18	36.0	248.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
9191	tr|O05842|O05842_M	Q8I814	91.13	14.0	271.0	DB02015	experimental	Dihydrofolic Acid	O=c1[nH]c(N)nc(c12)NCC(=N2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
9192	tr|O05842|O05842_M	Q8I814	91.13	14.0	271.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9193	tr|O05842|O05842_M	Q6GI75	88.3	3.0	252.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
9194	tr|O05842|O05842_M	Q6GI75	88.3	3.0	252.0	DB11155	approved	Triclocarban	Clc1ccc(cc1)NC(=O)Nc2cc(Cl)c(Cl)cc2
9195	tr|O05842|O05842_M	P0AEK4	86.52	4.0	248.0	DB01691	experimental	Indole Naphthyridinone	c1cccc(c12)n(C)cc2CN(C)C(=O)/C=C/c(c3)cnc(c34)NC(=O)CC4
9196	tr|O05842|O05842_M	P0AEK4	86.52	4.0	248.0	DB01865	experimental	3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide	c1cccc(c12)cc(n2C)CN(C)C(=O)/C=C/c3cnc(N)cc3
9197	tr|O05842|O05842_M	P0AEK4	86.52	4.0	248.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
9198	tr|O05842|O05842_M	P0AEK4	86.52	4.0	248.0	DB03030	experimental	4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole	Cc1ccc(cc1)Cn2cnc(c2)-c3cccs3
9199	tr|O05842|O05842_M	P0AEK4	86.52	4.0	248.0	DB03534	experimental	3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide	CC(=O)N(C)Cc1c(N)ccc(c1)C(=O)N(C)Cc(n2C)cc(c23)cccc3
9200	tr|O05842|O05842_M	P0AEK4	86.52	4.0	248.0	DB04030	experimental	1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole	Oc1ccc(cc1)Cn2c(c3c(c24)cccc4)CN(CC3)C(=O)c5ccc(O)cc5
9201	tr|O05842|O05842_M	P0AEK4	86.52	4.0	248.0	DB08265	experimental	2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL	Cc1ccc(cc1)S(=O)(=O)n(b2O)ncc(c23)cccc3
9202	tr|O05842|O05842_M	P0AEK4	86.52	4.0	248.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
9203	tr|O05842|O05842_M	P0AEK4	86.52	4.0	248.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
9204	tr|O05842|O05842_M	Q8TC12	71.99	38.0	241.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
9205	tr|O05842|O05842_M	Q8NBN7	71.28	36.0	237.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
9206	tr|O05842|O05842_M	Q99714	83.69	7.0	243.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9207	tr|O05842|O05842_M	Q99714	83.69	7.0	243.0	DB02820	experimental	1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct	C1CCCCCN1C(=O)[C@H](c2ccccc2)n(c3=S)cnc(c34)nn(c4)[C@H]5C=CN(C=C5C([O-])=N)[C@@H]6O[C@@H]([C@@H](O)[C@H]6O)COP([O-])(=O)OP(=O)(O)OC[C@H]7O[C@H]([C@H]([O-])[C@@H]7[O-])n8cnc(c89)c(N)ncn9
9208	tr|O05842|O05842_M	Q99714	83.69	7.0	243.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
9209	tr|O05842|O05842_M	Q96NR8	72.34	36.0	240.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
9210	tr|O05842|O05842_M	O24990	85.11	4.0	244.0	DB04393	experimental	Soneclosan	Clc1cc(O)c(cc1)Oc2ccc(Cl)cc2
9211	tr|O05842|O05842_M	O24990	85.11	4.0	244.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
9212	tr|O05842|O05842_M	Q01782	96.45	8.0	280.0	DB02338	experimental	NADPH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9213	tr|O05842|O05842_M	Q01782	96.45	8.0	280.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
9214	tr|O05842|O05842_M	Q01782	96.45	8.0	280.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9215	tr|O05842|O05842_M	Q01782	96.45	8.0	280.0	DB04400	experimental	L-erythro-7,8-dihydrobiopterin	C[C@H](O)[C@H](O)C(CN1)=Nc(c12)c(=O)nc([nH]2)N
9216	tr|O05842|O05842_M	Q9HBH5	76.6	41.0	257.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
9217	tr|O05842|O05842_M	Q02338	71.28	55.0	256.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9218	tr|O05842|O05842_M	Q7AUG5	82.62	3.0	236.0	DB04782	experimental	(S)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@H]2CO2
9219	tr|O05842|O05842_M	Q93D82	82.62	3.0	236.0	DB04472	experimental	(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol	[N-]=[N+]=NC[C@H](O)c1ccc([N+]([O-])=O)cc1
9220	tr|O05842|O05842_M	Q93D82	82.62	3.0	236.0	DB04499	experimental	(R)-styrene oxide	C1O[C@@H]1c2ccccc2
9221	tr|O05842|O05842_M	Q93D82	82.62	3.0	236.0	DB04777	experimental	(R)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@@H]2CO2
9222	tr|O05842|O05842_M	P56937	80.14	2.0	228.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9223	tr|O05842|O05842_M	P16152	81.56	7.0	237.0	DB01698	approved; experimental; investigational	Rutin	O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O[C@H]1C)OC[C@H]2O[C@H]([C@H](O)[C@@H](O)[C@@H]2O)Oc(c3=O)c(-c4cc(O)c(O)cc4)oc(c35)cc(O)cc5O
9224	tr|O05842|O05842_M	P16152	81.56	7.0	237.0	DB02709	investigational	Resveratrol	Oc1ccc(cc1)/C=C/c2cc(O)cc(O)c2
9225	tr|O05842|O05842_M	P16152	81.56	7.0	237.0	DB03394	experimental	Heptaethylene glycol	OCCOCCOCCOCCOCCOCCOCCO
9226	tr|O05842|O05842_M	P16152	81.56	7.0	237.0	DB03556	experimental	2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400	CCOCCOCCOCCOCCOCCOCCOCCOCCO
9227	tr|O05842|O05842_M	P16152	81.56	7.0	237.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
9228	tr|O05842|O05842_M	P16152	81.56	7.0	237.0	DB04463	experimental	3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol	n1cnc(N)c(c12)c(nn2C(C)(C)C)-c3cccc(O)c3
9229	tr|O05842|O05842_M	P16152	81.56	7.0	237.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
9230	tr|O05842|O05842_M	P16152	81.56	7.0	237.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
9231	tr|O05842|O05842_M	P9WGR1	90.07	5.0	259.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
9232	tr|O05842|O05842_M	P9WGR1	90.07	5.0	259.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
9233	tr|O05842|O05842_M	P9WGR1	90.07	5.0	259.0	DB02990	experimental	S-(2-Acetamidoethyl) hexadecanethioate	CCCCCCCCCCCCCCCC(=O)SCCNC(=O)C
9234	tr|O05842|O05842_M	P9WGR1	90.07	5.0	259.0	DB04289	experimental	Genz-10850	[nH]1ccc(c12)cc(cc2)C(=O)N3CCN(CC3)C4c(cccc5)c5c(c46)cccc6
9235	tr|O05842|O05842_M	P9WGR1	90.07	5.0	259.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
9236	tr|O05842|O05842_M	P9WGR1	90.07	5.0	259.0	DB07090	experimental	(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cccc(c1C)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
9237	tr|O05842|O05842_M	P9WGR1	90.07	5.0	259.0	DB07123	experimental	N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE	Cc1ccc(cc1)C(=O)N2CCC(CC2)Cc3ccccc3
9238	tr|O05842|O05842_M	P9WGR1	90.07	5.0	259.0	DB07155	experimental	(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE	c1ccccc1NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
9239	tr|O05842|O05842_M	P9WGR1	90.07	5.0	259.0	DB07178	experimental	5-PENTYL-2-PHENOXYPHENOL	CCCCCc1cc(O)c(cc1)Oc2ccccc2
9240	tr|O05842|O05842_M	P9WGR1	90.07	5.0	259.0	DB07188	experimental	(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(cc(Cl)c1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
9241	tr|O05842|O05842_M	P9WGR1	90.07	5.0	259.0	DB07192	experimental	(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Brc1cc(ccc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
9242	tr|O05842|O05842_M	P9WGR1	90.07	5.0	259.0	DB07222	experimental	(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(c(C)cc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
9243	tr|O05842|O05842_M	P9WGR1	90.07	5.0	259.0	DB07287	experimental	2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL	c1cccnc1Cc2cc(O)c(cc2)Oc3ccc(Cl)cc3Cl
9244	tr|O05842|O05842_M	P9WGR1	90.07	5.0	259.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
9245	tr|O05842|O05842_M	P35270	72.34	7.0	211.0	DB02637	experimental	Oxaloacetate Ion	OC(=O)C(=O)CC([O-])=O
9246	tr|O05842|O05842_M	P35270	72.34	7.0	211.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9247	tr|O05842|O05842_M	P35270	72.34	7.0	211.0	DB03886	experimental	Biopterin	C[C@@H](O)[C@@H](O)c(n1)cnc(c12)nc(N)[nH]c2=O
9248	tr|O05842|O05842_M	P35270	72.34	7.0	211.0	DB04275	experimental	N-acetylserotonin	CC(=O)NCCc1c[nH]c(c12)ccc(c2)O
9249	tr|P75019|P75019_M	P30084	93.8	30.0	287.0	DB02563	experimental	Hexanoyl-CoA	CCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
9250	tr|P75019|P75019_M	P30084	93.8	30.0	287.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
9251	tr|P75019|P75019_M	P30084	93.8	30.0	287.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
9252	tr|P75019|P75019_M	P30084	93.8	30.0	287.0	DB04117	experimental	4-(N,N-Dimethylamino)cinnamoyl-CoA	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)/C=C/c4ccc(cc4)N(C)C
9253	tr|P75019|P75019_M	P30084	93.8	30.0	287.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
9254	tr|P75019|P75019_M	P52045	94.16	2.0	260.0	DB03117	experimental	2-carboxypropyl-coenzyme A	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC[C@H](C)C(=O)O
9255	tr|P75019|P75019_M	P9WNP5	96.72	42.0	307.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
9256	tr|P75019|P75019_M	P9WNP5	96.72	42.0	307.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
9257	tr|P75019|P75019_M	O68600	87.59	2.0	242.0	DB01652	experimental	4-hydroxybenzoyl-CoA	Oc1ccc(cc1)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2OP(=O)(O)O)n3cnc(c34)c(N)ncn4
9258	tr|P75019|P75019_M	P42126	88.69	55.0	298.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
9259	tr|P75019|P75019_M	P42126	88.69	55.0	298.0	DB03127	experimental	Benzamidine	NC(=[NH2+])c1ccccc1
9260	tr|P75019|P75019_M	O75521	91.61	139.0	390.0	DB08231	experimental	Myristic acid	CCCCCCCCCCCCCC(=O)O
9261	tr|P75019|P75019_M	Q93TU6	83.58	13.0	242.0	DB02906	experimental	(2s,4s)-Alpha-Campholinic Acid	CC1(C)[C@H](C)C(=O)C[C@H]1CC(O)O
9262	tr|P75019|P75019_M	Q08426	84.67	8.0	240.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9263	tr|P75019|P75019_M	P28793	71.17	10.0	205.0	DB08249	experimental	3,6,9,12,15-PENTAOXATRICOSAN-1-OL	CCCCCCCCOCCOCCOCCOCCOCCO
9264	tr|I6YB11|I6YB11_M	Q9BTZ2	84.32	28.0	270.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
9266	tr|I6YB11|I6YB11_M	Q92506	87.11	7.0	257.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9267	tr|I6YB11|I6YB11_M	Q92506	87.11	7.0	257.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9268	tr|I6YB11|I6YB11_M	P0AEK2	82.93	2.0	240.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9269	tr|I6YB11|I6YB11_M	Q9WYS2	85.37	7.0	252.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9270	tr|I6YB11|I6YB11_M	P16544	86.41	6.0	254.0	DB01942	experimental; investigational	Formic acid	OC=O
9271	tr|I6YB11|I6YB11_M	P16544	86.41	6.0	254.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9272	tr|I6YB11|I6YB11_M	P16544	86.41	6.0	254.0	DB07715	investigational	Emodin	Cc(c1)cc(O)c(c12)C(=O)c3c(C2=O)cc(O)cc3O
9273	tr|I6YB11|I6YB11_M	Q9BY49	89.2	12.0	268.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
9274	tr|I6YB11|I6YB11_M	Q84EX5	86.06	3.0	250.0	DB04619	experimental	Acetophenone	CC(=O)c1ccccc1
9275	tr|I6YB11|I6YB11_M	Q84EX5	86.06	3.0	250.0	DB04784	experimental	(R)-1-phenylethanol	C[C@@H](O)c1ccccc1
9277	tr|I6YB11|I6YB11_M	P0CG22	85.37	28.0	273.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
9278	tr|I6YB11|I6YB11_M	P0CG22	85.37	28.0	273.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9279	tr|I6YB11|I6YB11_M	P0CG22	85.37	28.0	273.0	DB03541	experimental	10-Propargyl-5,8-Dideazafolic Acid	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(CC#C)Cc(c2)ccc(c23)[nH]c(N)nc3=O
9280	tr|I6YB11|I6YB11_M	P0CG22	85.37	28.0	273.0	DB07689	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)NCc(cn3)nc(c34)c(N)nc(n4)N
9281	tr|I6YB11|I6YB11_M	P0CG22	85.37	28.0	273.0	DB07765	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)N(C)Cc(cn3)nc(c34)c(N)nc(n4)N
9282	tr|I6YB11|I6YB11_M	P0AET8	83.62	7.0	247.0	DB02123	experimental	Glycochenodeoxycholic Acid	OC(=O)CNC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
9284	tr|I6YB11|I6YB11_M	Q7Z4W1	82.58	4.0	241.0	DB02831	experimental	Dihydrogenphosphate	OP([O-])(=O)O
9285	tr|I6YB11|I6YB11_M	Q7Z4W1	82.58	4.0	241.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9286	tr|I6YB11|I6YB11_M	Q6UWP2	83.62	6.0	246.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9287	tr|I6YB11|I6YB11_M	Q99714	87.46	3.0	254.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9288	tr|I6YB11|I6YB11_M	Q99714	87.46	3.0	254.0	DB02820	experimental	1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct	C1CCCCCN1C(=O)[C@H](c2ccccc2)n(c3=S)cnc(c34)nn(c4)[C@H]5C=CN(C=C5C([O-])=N)[C@@H]6O[C@@H]([C@@H](O)[C@H]6O)COP([O-])(=O)OP(=O)(O)OC[C@H]7O[C@H]([C@H]([O-])[C@@H]7[O-])n8cnc(c89)c(N)ncn9
9289	tr|I6YB11|I6YB11_M	Q99714	87.46	3.0	254.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
9290	tr|I6YB11|I6YB11_M	Q01782	97.21	8.0	287.0	DB02338	experimental	NADPH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9291	tr|I6YB11|I6YB11_M	Q01782	97.21	8.0	287.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
9292	tr|I6YB11|I6YB11_M	Q01782	97.21	8.0	287.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9293	tr|I6YB11|I6YB11_M	Q01782	97.21	8.0	287.0	DB04400	experimental	L-erythro-7,8-dihydrobiopterin	C[C@H](O)[C@H](O)C(CN1)=Nc(c12)c(=O)nc([nH]2)N
9294	tr|I6YB11|I6YB11_M	Q8I814	91.29	13.0	275.0	DB02015	experimental	Dihydrofolic Acid	O=c1[nH]c(N)nc(c12)NCC(=N2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
9295	tr|I6YB11|I6YB11_M	Q8I814	91.29	13.0	275.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9296	tr|I6YB11|I6YB11_M	Q16698	85.71	54.0	300.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9297	tr|I6YB11|I6YB11_M	Q16698	85.71	54.0	300.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
9298	tr|I6YB11|I6YB11_M	Q02338	82.93	49.0	287.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9300	tr|I6YB11|I6YB11_M	Q8TC12	71.78	36.0	242.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
9301	tr|I6YB11|I6YB11_M	Q8NBN7	74.56	35.0	249.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
9302	tr|I6YB11|I6YB11_M	P14061	73.17	2.0	212.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9303	tr|I6YB11|I6YB11_M	P14061	73.17	2.0	212.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
9304	tr|I6YB11|I6YB11_M	P14061	73.17	2.0	212.0	DB01561	experimental; illicit	Androstanedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
9305	tr|I6YB11|I6YB11_M	P14061	73.17	2.0	212.0	DB02187	experimental	Equilin	O=C1CC[C@H]([C@@]12C)C=3[C@H](CC2)c4c(CC3)cc(O)cc4
9306	tr|I6YB11|I6YB11_M	P14061	73.17	2.0	212.0	DB02323	experimental	EM-1745	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)C[C@@H]([C@@H]4O)CCCCCCCCC(=O)OC[C@H]5O[C@H]([C@H](O)[C@@H]5O)n6cnc(c67)c(N)ncn7
9307	tr|I6YB11|I6YB11_M	P14061	73.17	2.0	212.0	DB02901	illicit; investigational	Stanolone	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
9308	tr|I6YB11|I6YB11_M	P14061	73.17	2.0	212.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9309	tr|I6YB11|I6YB11_M	P14061	73.17	2.0	212.0	DB13951	experimental	Stanolone acetate	CC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
9310	tr|I6YB11|I6YB11_M	P28845	76.66	29.0	249.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9311	tr|I6YB11|I6YB11_M	P28845	76.66	29.0	249.0	DB02329	experimental	Carbenoxolone	OC(=O)CCC(=O)O[C@@H](CC1)C(C)(C)[C@@H]([C@]12C)CC[C@]3(C)[C@@H]2C(=O)C=C4[C@H]5[C@@](C)(CC[C@@]34C)CC[C@](C5)(C)C(=O)O
9312	tr|I6YB11|I6YB11_M	P28845	76.66	29.0	249.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9313	tr|I6YB11|I6YB11_M	P28845	76.66	29.0	249.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
9314	tr|I6YB11|I6YB11_M	P28845	76.66	29.0	249.0	DB04652	experimental	Corticosterone	OCC(=O)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H]([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
9315	tr|I6YB11|I6YB11_M	P28845	76.66	29.0	249.0	DB05064	investigational	INCB13739	 
9316	tr|I6YB11|I6YB11_M	P28845	76.66	29.0	249.0	DB06992	experimental	(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone	Cc1ccc(cc1F)-c2nc(ccc2)C(=O)N(CC3(C)C)CCC3
9317	tr|I6YB11|I6YB11_M	P28845	76.66	29.0	249.0	DB07017	experimental	(5S)-2-{[(1S)-1-(4-Fluorophenyl)ethyl]amino}-5-(2-hydroxy-2-propanyl)-5-methyl-1,3-thiazol-4(5H)-one	Fc1ccc(cc1)[C@H](C)NC(=NC2=O)S[C@@]2(C)C(C)(C)O
9318	tr|I6YB11|I6YB11_M	P28845	76.66	29.0	249.0	DB07049	experimental	(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine	[O-][N+](=O)c1ccc(cc1)N2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)C(C)(C)C
9319	tr|I6YB11|I6YB11_M	P28845	76.66	29.0	249.0	DB07056	experimental	2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide	CCN(CC)C(=O)Cc1cccc(n1)NS(=O)(=O)c2c(C)c(Cl)ccc2
9320	tr|I6YB11|I6YB11_M	P28845	76.66	29.0	249.0	DB07310	experimental	(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one	Fc1ccccc1[C@H](C)NC(=NC2=O)S[C@]2(C)C(F)(F)F
9321	tr|I6YB11|I6YB11_M	P28845	76.66	29.0	249.0	DB07316	experimental	N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)C3CCN(CC3)CC4(CC4)C(=O)N
9322	tr|I6YB11|I6YB11_M	P28845	76.66	29.0	249.0	DB07619	experimental	N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)[C@H]3CC[C@@H](CC3)c4cccnc4
9323	tr|I6YB11|I6YB11_M	P28845	76.66	29.0	249.0	DB07624	experimental	1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide	C1CC1(C(=O)N)CN2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)[C@](C)(O)C(F)(F)F
9324	tr|I6YB11|I6YB11_M	P28845	76.66	29.0	249.0	DB07866	experimental	(5S)-2-(Cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one	CCC[C@]1(C)SC(=NC1=O)NC2CCCCCCC2
9325	tr|I6YB11|I6YB11_M	P28845	76.66	29.0	249.0	DB08277	experimental	2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE	CS(=O)(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4c(Cl)cc(F)cc4
9326	tr|I6YB11|I6YB11_M	P28845	76.66	29.0	249.0	DB08280	experimental	(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE	NC(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4ccc(OC)cc4
9327	tr|I6YB11|I6YB11_M	P28845	76.66	29.0	249.0	DB08771	experimental	(5R)-2-[(2-Fluorophenyl)amino]-5-isopropyl-1,3-thiazol-4(5H)-one	CC(C)[C@H]1SC(=NC1=O)Nc2c(F)cccc2
9328	tr|I6YB11|I6YB11_M	P28845	76.66	29.0	249.0	DB13751	approved; experimental	Glycyrrhizic acid	C1C[C@](C)(C(=O)O)C[C@H]([C@]12C)C=3[C@@](C)(CC2)[C@@]4(C)[C@H](C(=O)C3)[C@]5(C)[C@@H](CC4)C(C)(C)[C@H](CC5)O[C@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O[C@@H]7O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]7O
9329	tr|I6YB11|I6YB11_M	Q96NR8	71.43	35.0	240.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
9330	tr|I6YB11|I6YB11_M	Q9HBH5	78.4	36.0	261.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
9331	tr|I6YB11|I6YB11_M	P51659	71.78	3.0	209.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9332	tr|I6YB11|I6YB11_M	P51659	71.78	3.0	209.0	DB03192	experimental	(R)-3-hydroxydecanoyl-CoA	CCCCCCC[C@@H](O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
9333	tr|I6YB11|I6YB11_M	P35270	87.11	7.0	257.0	DB02637	experimental	Oxaloacetate Ion	OC(=O)C(=O)CC([O-])=O
9334	tr|I6YB11|I6YB11_M	P35270	87.11	7.0	257.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9335	tr|I6YB11|I6YB11_M	P35270	87.11	7.0	257.0	DB03886	experimental	Biopterin	C[C@@H](O)[C@@H](O)c(n1)cnc(c12)nc(N)[nH]c2=O
9336	tr|I6YB11|I6YB11_M	P35270	87.11	7.0	257.0	DB04275	experimental	N-acetylserotonin	CC(=O)NCCc1c[nH]c(c12)ccc(c2)O
9337	tr|I6YB11|I6YB11_M	A0A348A0U3	87.46	2.0	253.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
9338	tr|I6YB11|I6YB11_M	P80365	70.38	76.0	278.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9339	tr|I6YB11|I6YB11_M	P80365	70.38	76.0	278.0	DB01185	approved; illicit	Fluoxymesterone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@](F)([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
9340	tr|I6YB11|I6YB11_M	P80365	70.38	76.0	278.0	DB01569	experimental; illicit	Formebolone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@H]([C@@H](C2)O)[C@]4(C)C(CC3)=CC(=O)C(C=O)=C4
9341	tr|I6YB11|I6YB11_M	P80365	70.38	76.0	278.0	DB14538	experimental; vet_approved	Hydrocortisone aceponate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CC)C(=O)COC(=O)C
9342	tr|I6YB11|I6YB11_M	P80365	70.38	76.0	278.0	DB14539	approved; vet_approved	Hydrocortisone acetate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)C
9343	tr|I6YB11|I6YB11_M	P80365	70.38	76.0	278.0	DB14540	approved; vet_approved	Hydrocortisone butyrate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCC
9344	tr|I6YB11|I6YB11_M	P80365	70.38	76.0	278.0	DB14541	approved; investigational; vet_approved	Hydrocortisone cypionate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)CCC5CCCC5
9345	tr|I6YB11|I6YB11_M	P80365	70.38	76.0	278.0	DB14542	approved; vet_approved	Hydrocortisone phosphate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COP(=O)(O)O
9346	tr|I6YB11|I6YB11_M	P80365	70.38	76.0	278.0	DB14543	approved; vet_approved	Hydrocortisone probutate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CCC)C(=O)COC(=O)CC
9347	tr|I6YB11|I6YB11_M	P80365	70.38	76.0	278.0	DB14544	approved; vet_approved	Hydrocortisone valerate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCCC
9348	tr|I6YB11|I6YB11_M	P0AEK4	87.11	3.0	253.0	DB01691	experimental	Indole Naphthyridinone	c1cccc(c12)n(C)cc2CN(C)C(=O)/C=C/c(c3)cnc(c34)NC(=O)CC4
9349	tr|I6YB11|I6YB11_M	P0AEK4	87.11	3.0	253.0	DB01865	experimental	3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide	c1cccc(c12)cc(n2C)CN(C)C(=O)/C=C/c3cnc(N)cc3
9350	tr|I6YB11|I6YB11_M	P0AEK4	87.11	3.0	253.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
9351	tr|I6YB11|I6YB11_M	P0AEK4	87.11	3.0	253.0	DB03030	experimental	4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole	Cc1ccc(cc1)Cn2cnc(c2)-c3cccs3
9352	tr|I6YB11|I6YB11_M	P0AEK4	87.11	3.0	253.0	DB03534	experimental	3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide	CC(=O)N(C)Cc1c(N)ccc(c1)C(=O)N(C)Cc(n2C)cc(c23)cccc3
9353	tr|I6YB11|I6YB11_M	P0AEK4	87.11	3.0	253.0	DB04030	experimental	1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole	Oc1ccc(cc1)Cn2c(c3c(c24)cccc4)CN(CC3)C(=O)c5ccc(O)cc5
9354	tr|I6YB11|I6YB11_M	P0AEK4	87.11	3.0	253.0	DB08265	experimental	2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL	Cc1ccc(cc1)S(=O)(=O)n(b2O)ncc(c23)cccc3
9355	tr|I6YB11|I6YB11_M	P0AEK4	87.11	3.0	253.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
9356	tr|I6YB11|I6YB11_M	P0AEK4	87.11	3.0	253.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
9357	tr|I6YB11|I6YB11_M	Q6GI75	86.41	4.0	252.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
9358	tr|I6YB11|I6YB11_M	Q6GI75	86.41	4.0	252.0	DB11155	approved	Triclocarban	Clc1ccc(cc1)NC(=O)Nc2cc(Cl)c(Cl)cc2
9359	tr|I6YB11|I6YB11_M	P16152	80.49	7.0	238.0	DB01698	approved; experimental; investigational	Rutin	O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O[C@H]1C)OC[C@H]2O[C@H]([C@H](O)[C@@H](O)[C@@H]2O)Oc(c3=O)c(-c4cc(O)c(O)cc4)oc(c35)cc(O)cc5O
9360	tr|I6YB11|I6YB11_M	P16152	80.49	7.0	238.0	DB02709	investigational	Resveratrol	Oc1ccc(cc1)/C=C/c2cc(O)cc(O)c2
9361	tr|I6YB11|I6YB11_M	P16152	80.49	7.0	238.0	DB03394	experimental	Heptaethylene glycol	OCCOCCOCCOCCOCCOCCOCCO
9362	tr|I6YB11|I6YB11_M	P16152	80.49	7.0	238.0	DB03556	experimental	2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400	CCOCCOCCOCCOCCOCCOCCOCCOCCO
9363	tr|I6YB11|I6YB11_M	P16152	80.49	7.0	238.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
9364	tr|I6YB11|I6YB11_M	P16152	80.49	7.0	238.0	DB04463	experimental	3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol	n1cnc(N)c(c12)c(nn2C(C)(C)C)-c3cccc(O)c3
9365	tr|I6YB11|I6YB11_M	P16152	80.49	7.0	238.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
9366	tr|I6YB11|I6YB11_M	P16152	80.49	7.0	238.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
9367	tr|I6YB11|I6YB11_M	Q7AUG5	82.23	3.0	239.0	DB04782	experimental	(S)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@H]2CO2
9368	tr|I6YB11|I6YB11_M	Q93D82	82.23	3.0	239.0	DB04472	experimental	(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol	[N-]=[N+]=NC[C@H](O)c1ccc([N+]([O-])=O)cc1
9369	tr|I6YB11|I6YB11_M	Q93D82	82.23	3.0	239.0	DB04499	experimental	(R)-styrene oxide	C1O[C@@H]1c2ccccc2
9370	tr|I6YB11|I6YB11_M	Q93D82	82.23	3.0	239.0	DB04777	experimental	(R)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@@H]2CO2
9371	tr|I6YB11|I6YB11_M	O24990	86.41	3.0	251.0	DB04393	experimental	Soneclosan	Clc1cc(O)c(cc1)Oc2ccc(Cl)cc2
9372	tr|I6YB11|I6YB11_M	O24990	86.41	3.0	251.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
9373	tr|I6YB11|I6YB11_M	P56937	79.44	3.0	231.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9374	tr|I6YB11|I6YB11_M	P9WGR1	84.67	4.0	247.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
9375	tr|I6YB11|I6YB11_M	P9WGR1	84.67	4.0	247.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
9376	tr|I6YB11|I6YB11_M	P9WGR1	84.67	4.0	247.0	DB02990	experimental	S-(2-Acetamidoethyl) hexadecanethioate	CCCCCCCCCCCCCCCC(=O)SCCNC(=O)C
9377	tr|I6YB11|I6YB11_M	P9WGR1	84.67	4.0	247.0	DB04289	experimental	Genz-10850	[nH]1ccc(c12)cc(cc2)C(=O)N3CCN(CC3)C4c(cccc5)c5c(c46)cccc6
9378	tr|I6YB11|I6YB11_M	P9WGR1	84.67	4.0	247.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
9379	tr|I6YB11|I6YB11_M	P9WGR1	84.67	4.0	247.0	DB07090	experimental	(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cccc(c1C)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
9380	tr|I6YB11|I6YB11_M	P9WGR1	84.67	4.0	247.0	DB07123	experimental	N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE	Cc1ccc(cc1)C(=O)N2CCC(CC2)Cc3ccccc3
9381	tr|I6YB11|I6YB11_M	P9WGR1	84.67	4.0	247.0	DB07155	experimental	(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE	c1ccccc1NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
9382	tr|I6YB11|I6YB11_M	P9WGR1	84.67	4.0	247.0	DB07178	experimental	5-PENTYL-2-PHENOXYPHENOL	CCCCCc1cc(O)c(cc1)Oc2ccccc2
9383	tr|I6YB11|I6YB11_M	P9WGR1	84.67	4.0	247.0	DB07188	experimental	(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(cc(Cl)c1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
9384	tr|I6YB11|I6YB11_M	P9WGR1	84.67	4.0	247.0	DB07192	experimental	(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Brc1cc(ccc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
9385	tr|I6YB11|I6YB11_M	P9WGR1	84.67	4.0	247.0	DB07222	experimental	(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(c(C)cc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
9386	tr|I6YB11|I6YB11_M	P9WGR1	84.67	4.0	247.0	DB07287	experimental	2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL	c1cccnc1Cc2cc(O)c(cc2)Oc3ccc(Cl)cc3Cl
9387	tr|I6YB11|I6YB11_M	P9WGR1	84.67	4.0	247.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
9388	tr|O53709|O53709_M	Q46509	96.23	3.0	156.0	DB02137	experimental	Molybdenum cofactor	O=c1[nH]c(N)nc(c12)N[C@H]3[C@@H](N2)C([S-])=C([S-])[C@H](O3)COP([O-])([O-])=O
9389	tr|O53709|O53709_M	Q9REC4	94.97	4.0	155.0	DB03300	experimental	Pterin Cytosine Dinucleotide	Nc(n1)[nH]c(=O)c(c12)N[C@@H]3[C@H](N2)O[C@@H](C(S)=C3S)COP(=O)(O)OP(=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5ccc(N)nc5=O
9390	tr|O53709|O53709_M	Q06278	98.74	9.0	166.0	DB00924	approved	Cyclobenzaprine	CN(C)CCC=C1c(cccc2)c2C=Cc(c13)cccc3
9391	tr|O53709|O53709_M	Q06278	98.74	9.0	166.0	DB03516	investigational	Eniluracil	O=c1[nH]cc(C#C)c(=O)[nH]1
9392	tr|O53709|O53709_M	P47989	99.37	6.0	164.0	DB00437	approved	Allopurinol	c1n[nH]c(c12)ncnc2O
9393	tr|O53709|O53709_M	P47989	99.37	6.0	164.0	DB00583	approved; investigational	Levocarnitine	C[N+](C)(C)C[C@H](O)CC([O-])=O
9394	tr|O53709|O53709_M	P47989	99.37	6.0	164.0	DB01685	experimental	Topiroxostat	N#Cc1nccc(c1)-c2n[nH]c(n2)-c3ccncc3
9395	tr|O53709|O53709_M	P47989	99.37	6.0	164.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
9396	tr|O53709|O53709_M	P47989	99.37	6.0	164.0	DB03328	experimental	Dioxo(sulfanyl)molybdenum	S[Mo](=O)=O
9397	tr|O53709|O53709_M	P47989	99.37	6.0	164.0	DB03516	investigational	Eniluracil	O=c1[nH]cc(C#C)c(=O)[nH]1
9398	tr|O53709|O53709_M	P47989	99.37	6.0	164.0	DB03841	experimental	Niraxostat	CC(C)(C)COc1c(C#N)cc(cc1)-n2cc(cn2)C(=O)O
9399	tr|O53709|O53709_M	P47989	99.37	6.0	164.0	DB04854	approved	Febuxostat	CC(C)COc1c(C#N)cc(cc1)-c2nc(C)c(s2)C(=O)O
9400	tr|O53709|O53709_M	P47989	99.37	6.0	164.0	DB05262	investigational	Oxypurinol	O=c1[nH]c(=O)[nH]c(c12)[nH]nc2
9401	tr|O06417|O06417_M	Q9NUB1	90.37	138.0	654.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
9402	tr|O06417|O06417_M	Q8ZKF6	90.37	106.0	622.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
9403	tr|O06417|O06417_M	Q8ZKF6	90.37	106.0	622.0	DB03230	experimental	Adenosine-5'-Propylphosphate	CCCOP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
9404	tr|O06417|O06417_M	P40871	88.09	28.0	531.0	DB01672	experimental	2,3-Dihydroxy-Benzoic Acid	OC(=O)c1cccc(O)c1O
9405	tr|O06417|O06417_M	Q9NR19	94.22	133.0	671.0	DB00131	approved; investigational; nutraceutical	Adenosine phosphate	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
9406	tr|O06417|O06417_M	Q9NR19	94.22	133.0	671.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
9407	tr|O06417|O06417_M	Q8GN86	86.16	10.0	502.0	DB03728	experimental	p-Chlorobenzoic acid	OC(=O)c1ccc(Cl)cc1
9408	tr|I6Y8V2|I6Y8V2_M	P30101	75.0	17.0	122.0	DB01593	approved; investigational	Zinc	[Zn]
9409	tr|I6Y8V2|I6Y8V2_M	P30101	75.0	17.0	122.0	DB09130	approved; investigational	Copper	[Cu]
9410	tr|I6Y8V2|I6Y8V2_M	P30101	75.0	17.0	122.0	DB14487	approved; investigational	Zinc acetate	CC([O-])=O
9411	tr|I6Y8V2|I6Y8V2_M	P30101	75.0	17.0	122.0	DB14533	approved; investigational	Zinc chloride	[Cl-]
9412	tr|I6Y8V2|I6Y8V2_M	P30101	75.0	17.0	122.0	DB14548	approved; experimental	Zinc sulfate, unspecified form	 
9413	tr|P95146|P95146_M	P16640	100.0	1.0	412.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
9414	tr|P95146|P95146_M	Q52437	96.35	7.0	403.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
9415	tr|P95146|P95146_M	P37062	77.37	2.0	320.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
9416	tr|P95146|P95146_M	P37062	77.37	2.0	320.0	DB03382	experimental	S-oxy-L-cysteine	OC(=O)[C@@H](N)CS=O
9417	tr|P95146|P95146_M	P66010	72.99	7.0	307.0	DB00548	approved	Azelaic acid	OC(=O)CCCCCCCC(=O)O
9418	tr|P95146|P95146_M	P14218	83.94	2.0	347.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
9419	tr|P96238|P96238_M	P24752	81.02	196.0	307.0	DB00795	approved	Sulfasalazine	OC(=O)c1cc(ccc1O)/N=N/c2ccc(cc2)S(=O)(=O)Nc3ncccc3
9420	tr|P96238|P96238_M	P24752	81.02	196.0	307.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
9422	tr|P96238|P96238_M	P24752	81.02	196.0	307.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
9423	tr|I6Y8F2|I6Y8F2_M	P9WNP5	82.37	23.0	280.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
9424	tr|I6Y8F2|I6Y8F2_M	P9WNP5	82.37	23.0	280.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
9425	tr|O53406|O53406_M	Q8ZKF6	100.92	81.0	629.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
9426	tr|O53406|O53406_M	Q8ZKF6	100.92	81.0	629.0	DB03230	experimental	Adenosine-5'-Propylphosphate	CCCOP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
9427	tr|O53406|O53406_M	Q9NR19	104.24	115.0	681.0	DB00131	approved; investigational; nutraceutical	Adenosine phosphate	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
9428	tr|O53406|O53406_M	Q9NR19	104.24	115.0	681.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
9429	tr|O53406|O53406_M	Q9NUB1	100.74	115.0	662.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
9430	tr|O53406|O53406_M	P40871	93.0	26.0	531.0	DB01672	experimental	2,3-Dihydroxy-Benzoic Acid	OC(=O)c1cccc(O)c1O
9431	tr|O53406|O53406_M	Q8GN86	92.08	3.0	503.0	DB03728	experimental	p-Chlorobenzoic acid	OC(=O)c1ccc(Cl)cc1
9432	tr|O33221|O33221_M	Q96GD0	98.91	19.0	292.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
9433	tr|O53254|O53254_M	Q9LAG2	70.1	3.0	146.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
9434	tr|O86374|O86374_M	P26276	93.98	11.0	448.0	DB02007	experimental	alpha-D-glucose 6-phosphate	O[C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O)COP(=O)(O)O
9435	tr|O86374|O86374_M	P26276	93.98	11.0	448.0	DB02843	experimental	alpha-D-glucose-1-phosphate	OC[C@H]1O[C@H](OP(=O)(O)O)[C@H](O)[C@@H](O)[C@@H]1O
9436	tr|O86374|O86374_M	P26276	93.98	11.0	448.0	DB02867	experimental	D-Mannose 1-Phosphate	OC[C@H]1OC(OP(=O)(O)O)[C@@H](O)[C@@H](O)[C@@H]1O
9437	tr|O86374|O86374_M	P26276	93.98	11.0	448.0	DB02900	experimental	alpha-D-mannose 6-phosphate	O[C@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O)COP(=O)(O)O
9438	tr|O86374|O86374_M	P26276	93.98	11.0	448.0	DB04522	experimental	Dexfosfoserine	OC(=O)[C@@H](N)COP(=O)(O)O
9439	tr|O86374|O86374_M	P36871	78.92	49.0	416.0	DB02835	experimental	Alpha-D-Glucose 1,6-Bisphosphate	OP(=O)(O)OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O1)OP(=O)(O)O
9440	tr|O86374|O86374_M	P36871	78.92	49.0	416.0	DB04397	experimental	Alpha-D-Glucose-1-Phosphate-6-Vanadate	O[V](=O)(=O)OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O1)OP(=O)(O)O
9441	tr|O07230|O07230_M	Q8TC12	90.07	41.0	313.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
9442	tr|O07230|O07230_M	Q8NBN7	92.38	38.0	317.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
9443	tr|O07230|O07230_M	Q96NR8	90.07	39.0	311.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
9444	tr|O07230|O07230_M	Q9HBH5	96.36	41.0	332.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
9445	tr|O07230|O07230_M	P16152	76.16	6.0	236.0	DB01698	approved; experimental; investigational	Rutin	O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O[C@H]1C)OC[C@H]2O[C@H]([C@H](O)[C@@H](O)[C@@H]2O)Oc(c3=O)c(-c4cc(O)c(O)cc4)oc(c35)cc(O)cc5O
9446	tr|O07230|O07230_M	P16152	76.16	6.0	236.0	DB02709	investigational	Resveratrol	Oc1ccc(cc1)/C=C/c2cc(O)cc(O)c2
9447	tr|O07230|O07230_M	P16152	76.16	6.0	236.0	DB03394	experimental	Heptaethylene glycol	OCCOCCOCCOCCOCCOCCOCCO
9448	tr|O07230|O07230_M	P16152	76.16	6.0	236.0	DB03556	experimental	2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400	CCOCCOCCOCCOCCOCCOCCOCCOCCO
9449	tr|O07230|O07230_M	P16152	76.16	6.0	236.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
9450	tr|O07230|O07230_M	P16152	76.16	6.0	236.0	DB04463	experimental	3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol	n1cnc(N)c(c12)c(nn2C(C)(C)C)-c3cccc(O)c3
9451	tr|O07230|O07230_M	P16152	76.16	6.0	236.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
9452	tr|O07230|O07230_M	P16152	76.16	6.0	236.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
9453	tr|O07230|O07230_M	Q01782	72.19	8.0	226.0	DB02338	experimental	NADPH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9454	tr|O07230|O07230_M	Q01782	72.19	8.0	226.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
9455	tr|O07230|O07230_M	Q01782	72.19	8.0	226.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9456	tr|O07230|O07230_M	Q01782	72.19	8.0	226.0	DB04400	experimental	L-erythro-7,8-dihydrobiopterin	C[C@H](O)[C@H](O)C(CN1)=Nc(c12)c(=O)nc([nH]2)N
9457	tr|L0T8G4|L0T8G4_M	Q8ZNF3	78.57	233.0	376.0	DB02038	experimental	D-[3-hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl]-N,O-cycloserylamide	Cc1ncc(COP(=O)(O)O)c(c1O)CN[C@@H]2CONC2=O
9458	tr|L0T8G4|L0T8G4_M	Q8ZNF3	78.57	233.0	376.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
9459	tr|P71853|P71853_M	Q9WYS2	80.92	7.0	253.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9462	tr|P71853|P71853_M	Q9BTZ2	80.26	30.0	274.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
9463	tr|P71853|P71853_M	P0AEK2	78.95	3.0	243.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9464	tr|P71853|P71853_M	Q92506	82.24	9.0	259.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9465	tr|P71853|P71853_M	Q92506	82.24	9.0	259.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9466	tr|P71853|P71853_M	Q9BY49	87.5	14.0	280.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
9468	tr|P71853|P71853_M	P16544	84.54	1.0	258.0	DB01942	experimental; investigational	Formic acid	OC=O
9469	tr|P71853|P71853_M	P16544	84.54	1.0	258.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9470	tr|P71853|P71853_M	P16544	84.54	1.0	258.0	DB07715	investigational	Emodin	Cc(c1)cc(O)c(c12)C(=O)c3c(C2=O)cc(O)cc3O
9471	tr|P71853|P71853_M	P0AET8	79.61	9.0	251.0	DB02123	experimental	Glycochenodeoxycholic Acid	OC(=O)CNC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
9472	tr|P71853|P71853_M	Q84EX5	80.92	4.0	250.0	DB04619	experimental	Acetophenone	CC(=O)c1ccccc1
9473	tr|P71853|P71853_M	Q84EX5	80.92	4.0	250.0	DB04784	experimental	(R)-1-phenylethanol	C[C@@H](O)c1ccccc1
9474	tr|P71853|P71853_M	P51659	77.96	7.0	244.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9475	tr|P71853|P71853_M	P51659	77.96	7.0	244.0	DB03192	experimental	(R)-3-hydroxydecanoyl-CoA	CCCCCCC[C@@H](O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
9476	tr|P71853|P71853_M	P0CG22	81.25	30.0	277.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
9477	tr|P71853|P71853_M	P0CG22	81.25	30.0	277.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9478	tr|P71853|P71853_M	P0CG22	81.25	30.0	277.0	DB03541	experimental	10-Propargyl-5,8-Dideazafolic Acid	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(CC#C)Cc(c2)ccc(c23)[nH]c(N)nc3=O
9479	tr|P71853|P71853_M	P0CG22	81.25	30.0	277.0	DB07689	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)NCc(cn3)nc(c34)c(N)nc(n4)N
9480	tr|P71853|P71853_M	P0CG22	81.25	30.0	277.0	DB07765	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)N(C)Cc(cn3)nc(c34)c(N)nc(n4)N
9481	tr|P71853|P71853_M	Q7Z4W1	78.29	4.0	242.0	DB02831	experimental	Dihydrogenphosphate	OP([O-])(=O)O
9482	tr|P71853|P71853_M	Q7Z4W1	78.29	4.0	242.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9483	tr|P71853|P71853_M	Q16698	83.88	57.0	312.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9484	tr|P71853|P71853_M	Q16698	83.88	57.0	312.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
9485	tr|P71853|P71853_M	Q99714	82.57	8.0	259.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9486	tr|P71853|P71853_M	Q99714	82.57	8.0	259.0	DB02820	experimental	1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct	C1CCCCCN1C(=O)[C@H](c2ccccc2)n(c3=S)cnc(c34)nn(c4)[C@H]5C=CN(C=C5C([O-])=N)[C@@H]6O[C@@H]([C@@H](O)[C@H]6O)COP([O-])(=O)OP(=O)(O)OC[C@H]7O[C@H]([C@H]([O-])[C@@H]7[O-])n8cnc(c89)c(N)ncn9
9487	tr|P71853|P71853_M	Q99714	82.57	8.0	259.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
9488	tr|P71853|P71853_M	Q6UWP2	79.93	6.0	249.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9489	tr|P71853|P71853_M	A0A348A0U3	82.89	1.0	253.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
9490	tr|P71853|P71853_M	O24990	88.49	1.0	270.0	DB04393	experimental	Soneclosan	Clc1cc(O)c(cc1)Oc2ccc(Cl)cc2
9491	tr|P71853|P71853_M	O24990	88.49	1.0	270.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
9492	tr|P71853|P71853_M	Q8I814	84.87	14.0	272.0	DB02015	experimental	Dihydrofolic Acid	O=c1[nH]c(N)nc(c12)NCC(=N2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
9493	tr|P71853|P71853_M	Q8I814	84.87	14.0	272.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9494	tr|P71853|P71853_M	Q8NBN7	82.89	36.0	288.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
9495	tr|P71853|P71853_M	P0AEK4	83.22	1.0	254.0	DB01691	experimental	Indole Naphthyridinone	c1cccc(c12)n(C)cc2CN(C)C(=O)/C=C/c(c3)cnc(c34)NC(=O)CC4
9496	tr|P71853|P71853_M	P0AEK4	83.22	1.0	254.0	DB01865	experimental	3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide	c1cccc(c12)cc(n2C)CN(C)C(=O)/C=C/c3cnc(N)cc3
9497	tr|P71853|P71853_M	P0AEK4	83.22	1.0	254.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
9498	tr|P71853|P71853_M	P0AEK4	83.22	1.0	254.0	DB03030	experimental	4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole	Cc1ccc(cc1)Cn2cnc(c2)-c3cccs3
9499	tr|P71853|P71853_M	P0AEK4	83.22	1.0	254.0	DB03534	experimental	3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide	CC(=O)N(C)Cc1c(N)ccc(c1)C(=O)N(C)Cc(n2C)cc(c23)cccc3
9500	tr|P71853|P71853_M	P0AEK4	83.22	1.0	254.0	DB04030	experimental	1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole	Oc1ccc(cc1)Cn2c(c3c(c24)cccc4)CN(CC3)C(=O)c5ccc(O)cc5
9501	tr|P71853|P71853_M	P0AEK4	83.22	1.0	254.0	DB08265	experimental	2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL	Cc1ccc(cc1)S(=O)(=O)n(b2O)ncc(c23)cccc3
9502	tr|P71853|P71853_M	P0AEK4	83.22	1.0	254.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
9503	tr|P71853|P71853_M	P0AEK4	83.22	1.0	254.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
9505	tr|P71853|P71853_M	Q6GI75	82.57	3.0	254.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
9506	tr|P71853|P71853_M	Q6GI75	82.57	3.0	254.0	DB11155	approved	Triclocarban	Clc1ccc(cc1)NC(=O)Nc2cc(Cl)c(Cl)cc2
9507	tr|P71853|P71853_M	Q01782	90.79	8.0	284.0	DB02338	experimental	NADPH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9508	tr|P71853|P71853_M	Q01782	90.79	8.0	284.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
9509	tr|P71853|P71853_M	Q01782	90.79	8.0	284.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9510	tr|P71853|P71853_M	Q01782	90.79	8.0	284.0	DB04400	experimental	L-erythro-7,8-dihydrobiopterin	C[C@H](O)[C@H](O)C(CN1)=Nc(c12)c(=O)nc([nH]2)N
9511	tr|P71853|P71853_M	Q9HBH5	86.84	39.0	303.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
9512	tr|P71853|P71853_M	Q7AUG5	81.25	3.0	250.0	DB04782	experimental	(S)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@H]2CO2
9513	tr|P71853|P71853_M	Q93D82	81.25	3.0	250.0	DB04472	experimental	(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol	[N-]=[N+]=NC[C@H](O)c1ccc([N+]([O-])=O)cc1
9514	tr|P71853|P71853_M	Q93D82	81.25	3.0	250.0	DB04499	experimental	(R)-styrene oxide	C1O[C@@H]1c2ccccc2
9515	tr|P71853|P71853_M	Q93D82	81.25	3.0	250.0	DB04777	experimental	(R)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@@H]2CO2
9516	tr|P71853|P71853_M	Q02338	70.39	54.0	268.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9517	tr|P71853|P71853_M	Q9NYR8	78.95	6.0	246.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
9518	tr|P71853|P71853_M	P37059	71.05	80.0	296.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9519	tr|P71853|P71853_M	P37059	71.05	80.0	296.0	DB13952	approved; investigational; vet_approved	Estradiol acetate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)C
9520	tr|P71853|P71853_M	P37059	71.05	80.0	296.0	DB13953	approved; investigational; vet_approved	Estradiol benzoate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)c5ccccc5
9521	tr|P71853|P71853_M	P37059	71.05	80.0	296.0	DB13954	approved; investigational; vet_approved	Estradiol cypionate	C1CCCC1CCC(=O)O[C@H]2CC[C@H]([C@@]23C)[C@H]4[C@H](CC3)c5c(CC4)cc(O)cc5
9522	tr|P71853|P71853_M	P37059	71.05	80.0	296.0	DB13955	approved; investigational; vet_approved	Estradiol dienanthate	CCCCCCC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)CCCCCC
9523	tr|P71853|P71853_M	P37059	71.05	80.0	296.0	DB13956	approved; investigational; vet_approved	Estradiol valerate	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)CC[C@@H]4OC(=O)CCCC
9524	tr|P71853|P71853_M	P9WGR1	86.18	3.0	265.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
9525	tr|P71853|P71853_M	P9WGR1	86.18	3.0	265.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
9526	tr|P71853|P71853_M	P9WGR1	86.18	3.0	265.0	DB02990	experimental	S-(2-Acetamidoethyl) hexadecanethioate	CCCCCCCCCCCCCCCC(=O)SCCNC(=O)C
9527	tr|P71853|P71853_M	P9WGR1	86.18	3.0	265.0	DB04289	experimental	Genz-10850	[nH]1ccc(c12)cc(cc2)C(=O)N3CCN(CC3)C4c(cccc5)c5c(c46)cccc6
9528	tr|P71853|P71853_M	P9WGR1	86.18	3.0	265.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
9529	tr|P71853|P71853_M	P9WGR1	86.18	3.0	265.0	DB07090	experimental	(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cccc(c1C)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
9530	tr|P71853|P71853_M	P9WGR1	86.18	3.0	265.0	DB07123	experimental	N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE	Cc1ccc(cc1)C(=O)N2CCC(CC2)Cc3ccccc3
9531	tr|P71853|P71853_M	P9WGR1	86.18	3.0	265.0	DB07155	experimental	(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE	c1ccccc1NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
9532	tr|P71853|P71853_M	P9WGR1	86.18	3.0	265.0	DB07178	experimental	5-PENTYL-2-PHENOXYPHENOL	CCCCCc1cc(O)c(cc1)Oc2ccccc2
9533	tr|P71853|P71853_M	P9WGR1	86.18	3.0	265.0	DB07188	experimental	(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(cc(Cl)c1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
9534	tr|P71853|P71853_M	P9WGR1	86.18	3.0	265.0	DB07192	experimental	(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Brc1cc(ccc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
9535	tr|P71853|P71853_M	P9WGR1	86.18	3.0	265.0	DB07222	experimental	(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(c(C)cc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
9536	tr|P71853|P71853_M	P9WGR1	86.18	3.0	265.0	DB07287	experimental	2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL	c1cccnc1Cc2cc(O)c(cc2)Oc3ccc(Cl)cc3Cl
9537	tr|P71853|P71853_M	P9WGR1	86.18	3.0	265.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
9538	tr|P71853|P71853_M	P16152	75.66	7.0	237.0	DB01698	approved; experimental; investigational	Rutin	O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O[C@H]1C)OC[C@H]2O[C@H]([C@H](O)[C@@H](O)[C@@H]2O)Oc(c3=O)c(-c4cc(O)c(O)cc4)oc(c35)cc(O)cc5O
9539	tr|P71853|P71853_M	P16152	75.66	7.0	237.0	DB02709	investigational	Resveratrol	Oc1ccc(cc1)/C=C/c2cc(O)cc(O)c2
9540	tr|P71853|P71853_M	P16152	75.66	7.0	237.0	DB03394	experimental	Heptaethylene glycol	OCCOCCOCCOCCOCCOCCOCCO
9541	tr|P71853|P71853_M	P16152	75.66	7.0	237.0	DB03556	experimental	2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400	CCOCCOCCOCCOCCOCCOCCOCCOCCO
9542	tr|P71853|P71853_M	P16152	75.66	7.0	237.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
9543	tr|P71853|P71853_M	P16152	75.66	7.0	237.0	DB04463	experimental	3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol	n1cnc(N)c(c12)c(nn2C(C)(C)C)-c3cccc(O)c3
9544	tr|P71853|P71853_M	P16152	75.66	7.0	237.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
9545	tr|P71853|P71853_M	P16152	75.66	7.0	237.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
9546	tr|P71853|P71853_M	P56937	76.64	3.0	236.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9547	tr|P71853|P71853_M	P35270	78.29	8.0	246.0	DB02637	experimental	Oxaloacetate Ion	OC(=O)C(=O)CC([O-])=O
9548	tr|P71853|P71853_M	P35270	78.29	8.0	246.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9549	tr|P71853|P71853_M	P35270	78.29	8.0	246.0	DB03886	experimental	Biopterin	C[C@@H](O)[C@@H](O)c(n1)cnc(c12)nc(N)[nH]c2=O
9550	tr|P71853|P71853_M	P35270	78.29	8.0	246.0	DB04275	experimental	N-acetylserotonin	CC(=O)NCCc1c[nH]c(c12)ccc(c2)O
9551	tr|I6Y8Y8|I6Y8Y8_M	Q9NQX3	93.75	19.0	169.0	DB01942	experimental; investigational	Formic acid	OC=O
9552	tr|I6Y8Y8|I6Y8Y8_M	Q9NQX3	93.75	19.0	169.0	DB03366	experimental; investigational	Imidazole	[nH]1ccnc1
9553	tr|I6Y8Y8|I6Y8Y8_M	Q9NQX3	93.75	19.0	169.0	DB03766	approved; vet_approved	Propanoic acid	CCC(=O)O
9554	tr|I6Y8Y8|I6Y8Y8_M	Q9NQX3	75.0	523.0	643.0	DB01942	experimental; investigational	Formic acid	OC=O
9555	tr|I6Y8Y8|I6Y8Y8_M	Q9NQX3	75.0	523.0	643.0	DB03366	experimental; investigational	Imidazole	[nH]1ccnc1
9556	tr|I6Y8Y8|I6Y8Y8_M	Q9NQX3	75.0	523.0	643.0	DB03766	approved; vet_approved	Propanoic acid	CCC(=O)O
9557	tr|I6Y8Y8|I6Y8Y8_M	Q816R0	90.62	16.0	161.0	DB03366	experimental; investigational	Imidazole	[nH]1ccnc1
9559	tr|O05572|O05572_M	P22939	72.31	32.0	267.0	DB02270	experimental	Dimethylallyl S-Thiolodiphosphate	CC(C)CCS[P@@](=O)(O)OP(=O)(O)O
9560	tr|O05572|O05572_M	P22939	72.31	32.0	267.0	DB02508	experimental	Isopentyl Pyrophosphate	CC(C)CCO[P@@](=O)(O)OP(=O)(O)O
9561	tr|O05572|O05572_M	P22939	72.31	32.0	267.0	DB04160	approved; experimental	Pyrophosphoric acid	OP(=O)(O)OP(=O)(O)O
9562	tr|O05572|O05572_M	P14324	81.85	103.0	369.0	DB00282	approved	Pamidronic acid	NCCC(O)(P(=O)(O)O)P(=O)(O)O
9563	tr|O05572|O05572_M	P14324	81.85	103.0	369.0	DB00399	approved	Zoledronic acid	OP(=O)(O)C(O)(P(=O)(O)O)Cn1ccnc1
9564	tr|O05572|O05572_M	P14324	81.85	103.0	369.0	DB00630	approved	Alendronic acid	NCCCC(O)(P(=O)(O)O)P(=O)(O)O
9565	tr|O05572|O05572_M	P14324	81.85	103.0	369.0	DB00710	approved; investigational	Ibandronate	CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
9566	tr|O05572|O05572_M	P14324	81.85	103.0	369.0	DB00884	approved; investigational	Risedronic acid	OP(=O)(O)C(O)(P(=O)(O)O)Cc1cnccc1
9567	tr|O05572|O05572_M	P14324	81.85	103.0	369.0	DB01785	experimental	Dimethylallyl Diphosphate	CC(C)=CCO[P@@](=O)(O)OP(=O)(O)O
9568	tr|O05572|O05572_M	P14324	81.85	103.0	369.0	DB02508	experimental	Isopentyl Pyrophosphate	CC(C)CCO[P@@](=O)(O)OP(=O)(O)O
9569	tr|O05572|O05572_M	P14324	81.85	103.0	369.0	DB02552	experimental	Geranyl Diphosphate	CC(C)=CCC/C(C)=C/CO[P@@](=O)(O)OP(=O)(O)O
9570	tr|O05572|O05572_M	P14324	81.85	103.0	369.0	DB04714	experimental	ISOPENTENYL PYROPHOSPHATE	CC(=C)CCO[P@@](=O)(O)OP(=O)(O)O
9571	tr|O05572|O05572_M	P14324	81.85	103.0	369.0	DB06255	experimental	Incadronic acid	OP(=O)(O)C(P(=O)(O)O)NC1CCCCCC1
9572	tr|O05572|O05572_M	P14324	81.85	103.0	369.0	DB06548	investigational	Minodronic acid	OP(=O)(O)C(O)(P(=O)(O)O)Cc1cnc(n12)cccc2
9573	tr|O05572|O05572_M	P14324	81.85	103.0	369.0	DB07780	experimental	Farnesyl diphosphate	CC(C)=CCC/C(C)=C/CC/C(C)=C/COP(=O)(O)OP(=O)(O)O
9574	tr|O05572|O05572_M	P14324	81.85	103.0	369.0	DB07841	experimental	Geranylgeranyl diphosphate	CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C(C)=C/COP(=O)(O)OP(=O)(O)O
9575	tr|O06817|O06817_M	Q57366	100.39	51.0	820.0	DB02153	experimental	3-sulfino-L-alanine	OC(=O)[C@@H](N)C[S@](=O)O
9576	tr|O06817|O06817_M	Q57366	100.39	51.0	820.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
9577	tr|O06817|O06817_M	P07658	83.16	21.0	658.0	DB02345	experimental	Selenocysteine	OC(=O)[C@@H](N)C[SeH]
9578	tr|O06817|O06817_M	Q72LA4	85.25	45.0	698.0	DB08689	experimental	Ubiquinone Q1	COC1=C(OC)C(=O)C(=C(C)C1=O)CC=C(C)C
9579	tr|O06831|O06831_M	Q9NUB1	100.56	116.0	654.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
9580	tr|O06831|O06831_M	Q8ZKF6	99.81	84.0	618.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
9581	tr|O06831|O06831_M	Q8ZKF6	99.81	84.0	618.0	DB03230	experimental	Adenosine-5'-Propylphosphate	CCCOP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
9582	tr|O06831|O06831_M	Q9NR19	103.74	115.0	670.0	DB00131	approved; investigational; nutraceutical	Adenosine phosphate	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
9583	tr|O06831|O06831_M	Q9NR19	103.74	115.0	670.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
9584	tr|O06831|O06831_M	P40871	94.02	27.0	530.0	DB01672	experimental	2,3-Dihydroxy-Benzoic Acid	OC(=O)c1cccc(O)c1O
9585	tr|O06831|O06831_M	Q8GN86	92.52	9.0	504.0	DB03728	experimental	p-Chlorobenzoic acid	OC(=O)c1ccc(Cl)cc1
9587	tr|O07749|O07749_M	P16544	82.31	8.0	236.0	DB01942	experimental; investigational	Formic acid	OC=O
9588	tr|O07749|O07749_M	P16544	82.31	8.0	236.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9589	tr|O07749|O07749_M	P16544	82.31	8.0	236.0	DB07715	investigational	Emodin	Cc(c1)cc(O)c(c12)C(=O)c3c(C2=O)cc(O)cc3O
9590	tr|O07749|O07749_M	P14061	88.09	5.0	249.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9591	tr|O07749|O07749_M	P14061	88.09	5.0	249.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
9592	tr|O07749|O07749_M	P14061	88.09	5.0	249.0	DB01561	experimental; illicit	Androstanedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
9593	tr|O07749|O07749_M	P14061	88.09	5.0	249.0	DB02187	experimental	Equilin	O=C1CC[C@H]([C@@]12C)C=3[C@H](CC2)c4c(CC3)cc(O)cc4
9594	tr|O07749|O07749_M	P14061	88.09	5.0	249.0	DB02323	experimental	EM-1745	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)C[C@@H]([C@@H]4O)CCCCCCCCC(=O)OC[C@H]5O[C@H]([C@H](O)[C@@H]5O)n6cnc(c67)c(N)ncn7
9595	tr|O07749|O07749_M	P14061	88.09	5.0	249.0	DB02901	illicit; investigational	Stanolone	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
9596	tr|O07749|O07749_M	P14061	88.09	5.0	249.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9597	tr|O07749|O07749_M	P14061	88.09	5.0	249.0	DB13951	experimental	Stanolone acetate	CC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
9598	tr|O07749|O07749_M	Q9BTZ2	75.45	33.0	242.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
9599	tr|O07749|O07749_M	P0AEK2	70.04	6.0	200.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9601	tr|O07749|O07749_M	Q9WYS2	72.56	10.0	211.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9603	tr|O07749|O07749_M	Q92506	73.65	14.0	218.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9604	tr|O07749|O07749_M	Q92506	73.65	14.0	218.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9605	tr|O07749|O07749_M	P0AET8	71.48	12.0	210.0	DB02123	experimental	Glycochenodeoxycholic Acid	OC(=O)CNC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
9606	tr|O07749|O07749_M	Q9NYR8	70.76	6.0	202.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
9607	tr|O07749|O07749_M	Q6UWP2	78.7	12.0	230.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9608	tr|O07749|O07749_M	P0CG22	76.53	33.0	245.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
9609	tr|O07749|O07749_M	P0CG22	76.53	33.0	245.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9610	tr|O07749|O07749_M	P0CG22	76.53	33.0	245.0	DB03541	experimental	10-Propargyl-5,8-Dideazafolic Acid	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(CC#C)Cc(c2)ccc(c23)[nH]c(N)nc3=O
9611	tr|O07749|O07749_M	P0CG22	76.53	33.0	245.0	DB07689	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)NCc(cn3)nc(c34)c(N)nc(n4)N
9612	tr|O07749|O07749_M	P0CG22	76.53	33.0	245.0	DB07765	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)N(C)Cc(cn3)nc(c34)c(N)nc(n4)N
9613	tr|O07749|O07749_M	Q84EX5	70.76	8.0	204.0	DB04619	experimental	Acetophenone	CC(=O)c1ccccc1
9614	tr|O07749|O07749_M	Q84EX5	70.76	8.0	204.0	DB04784	experimental	(R)-1-phenylethanol	C[C@@H](O)c1ccccc1
9615	tr|O07749|O07749_M	Q8NBN7	74.73	39.0	246.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
9616	tr|O07749|O07749_M	Q8TC12	72.2	42.0	242.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
9617	tr|O07749|O07749_M	P37059	70.4	83.0	278.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9618	tr|O07749|O07749_M	P37059	70.4	83.0	278.0	DB13952	approved; investigational; vet_approved	Estradiol acetate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)C
9619	tr|O07749|O07749_M	P37059	70.4	83.0	278.0	DB13953	approved; investigational; vet_approved	Estradiol benzoate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)c5ccccc5
9620	tr|O07749|O07749_M	P37059	70.4	83.0	278.0	DB13954	approved; investigational; vet_approved	Estradiol cypionate	C1CCCC1CCC(=O)O[C@H]2CC[C@H]([C@@]23C)[C@H]4[C@H](CC3)c5c(CC4)cc(O)cc5
9621	tr|O07749|O07749_M	P37059	70.4	83.0	278.0	DB13955	approved; investigational; vet_approved	Estradiol dienanthate	CCCCCCC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)CCCCCC
9622	tr|O07749|O07749_M	P37059	70.4	83.0	278.0	DB13956	approved; investigational; vet_approved	Estradiol valerate	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)CC[C@@H]4OC(=O)CCCC
9623	tr|O07749|O07749_M	P80365	71.48	83.0	281.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9624	tr|O07749|O07749_M	P80365	71.48	83.0	281.0	DB01185	approved; illicit	Fluoxymesterone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@](F)([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
9625	tr|O07749|O07749_M	P80365	71.48	83.0	281.0	DB01569	experimental; illicit	Formebolone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@H]([C@@H](C2)O)[C@]4(C)C(CC3)=CC(=O)C(C=O)=C4
9626	tr|O07749|O07749_M	P80365	71.48	83.0	281.0	DB14538	experimental; vet_approved	Hydrocortisone aceponate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CC)C(=O)COC(=O)C
9627	tr|O07749|O07749_M	P80365	71.48	83.0	281.0	DB14539	approved; vet_approved	Hydrocortisone acetate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)C
9628	tr|O07749|O07749_M	P80365	71.48	83.0	281.0	DB14540	approved; vet_approved	Hydrocortisone butyrate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCC
9629	tr|O07749|O07749_M	P80365	71.48	83.0	281.0	DB14541	approved; investigational; vet_approved	Hydrocortisone cypionate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)CCC5CCCC5
9630	tr|O07749|O07749_M	P80365	71.48	83.0	281.0	DB14542	approved; vet_approved	Hydrocortisone phosphate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COP(=O)(O)O
9631	tr|O07749|O07749_M	P80365	71.48	83.0	281.0	DB14543	approved; vet_approved	Hydrocortisone probutate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CCC)C(=O)COC(=O)CC
9632	tr|O07749|O07749_M	P80365	71.48	83.0	281.0	DB14544	approved; vet_approved	Hydrocortisone valerate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCCC
9633	tr|O07749|O07749_M	Q99714	72.2	12.0	212.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9634	tr|O07749|O07749_M	Q99714	72.2	12.0	212.0	DB02820	experimental	1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct	C1CCCCCN1C(=O)[C@H](c2ccccc2)n(c3=S)cnc(c34)nn(c4)[C@H]5C=CN(C=C5C([O-])=N)[C@@H]6O[C@@H]([C@@H](O)[C@H]6O)COP([O-])(=O)OP(=O)(O)OC[C@H]7O[C@H]([C@H]([O-])[C@@H]7[O-])n8cnc(c89)c(N)ncn9
9635	tr|O07749|O07749_M	Q99714	72.2	12.0	212.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
9636	tr|O07749|O07749_M	Q96NR8	72.2	40.0	240.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
9637	tr|O07749|O07749_M	P37058	70.04	51.0	245.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9638	tr|O07749|O07749_M	Q9HBH5	77.26	44.0	258.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
9639	tr|O07749|O07749_M	Q8I814	84.12	13.0	246.0	DB02015	experimental	Dihydrofolic Acid	O=c1[nH]c(N)nc(c12)NCC(=N2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
9640	tr|O07749|O07749_M	Q8I814	84.12	13.0	246.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9641	tr|O07749|O07749_M	P16152	86.64	6.0	246.0	DB01698	approved; experimental; investigational	Rutin	O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O[C@H]1C)OC[C@H]2O[C@H]([C@H](O)[C@@H](O)[C@@H]2O)Oc(c3=O)c(-c4cc(O)c(O)cc4)oc(c35)cc(O)cc5O
9642	tr|O07749|O07749_M	P16152	86.64	6.0	246.0	DB02709	investigational	Resveratrol	Oc1ccc(cc1)/C=C/c2cc(O)cc(O)c2
9643	tr|O07749|O07749_M	P16152	86.64	6.0	246.0	DB03394	experimental	Heptaethylene glycol	OCCOCCOCCOCCOCCOCCOCCO
9644	tr|O07749|O07749_M	P16152	86.64	6.0	246.0	DB03556	experimental	2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400	CCOCCOCCOCCOCCOCCOCCOCCOCCO
9645	tr|O07749|O07749_M	P16152	86.64	6.0	246.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
9646	tr|O07749|O07749_M	P16152	86.64	6.0	246.0	DB04463	experimental	3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol	n1cnc(N)c(c12)c(nn2C(C)(C)C)-c3cccc(O)c3
9647	tr|O07749|O07749_M	P16152	86.64	6.0	246.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
9648	tr|O07749|O07749_M	P16152	86.64	6.0	246.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
9649	tr|O07749|O07749_M	P0AEK4	70.4	7.0	202.0	DB01691	experimental	Indole Naphthyridinone	c1cccc(c12)n(C)cc2CN(C)C(=O)/C=C/c(c3)cnc(c34)NC(=O)CC4
9650	tr|O07749|O07749_M	P0AEK4	70.4	7.0	202.0	DB01865	experimental	3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide	c1cccc(c12)cc(n2C)CN(C)C(=O)/C=C/c3cnc(N)cc3
9651	tr|O07749|O07749_M	P0AEK4	70.4	7.0	202.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
9652	tr|O07749|O07749_M	P0AEK4	70.4	7.0	202.0	DB03030	experimental	4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole	Cc1ccc(cc1)Cn2cnc(c2)-c3cccs3
9653	tr|O07749|O07749_M	P0AEK4	70.4	7.0	202.0	DB03534	experimental	3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide	CC(=O)N(C)Cc1c(N)ccc(c1)C(=O)N(C)Cc(n2C)cc(c23)cccc3
9654	tr|O07749|O07749_M	P0AEK4	70.4	7.0	202.0	DB04030	experimental	1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole	Oc1ccc(cc1)Cn2c(c3c(c24)cccc4)CN(CC3)C(=O)c5ccc(O)cc5
9655	tr|O07749|O07749_M	P0AEK4	70.4	7.0	202.0	DB08265	experimental	2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL	Cc1ccc(cc1)S(=O)(=O)n(b2O)ncc(c23)cccc3
9656	tr|O07749|O07749_M	P0AEK4	70.4	7.0	202.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
9657	tr|O07749|O07749_M	P0AEK4	70.4	7.0	202.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
9658	tr|O07749|O07749_M	P56937	82.31	3.0	231.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9659	tr|O07749|O07749_M	P35270	77.62	9.0	224.0	DB02637	experimental	Oxaloacetate Ion	OC(=O)C(=O)CC([O-])=O
9660	tr|O07749|O07749_M	P35270	77.62	9.0	224.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9661	tr|O07749|O07749_M	P35270	77.62	9.0	224.0	DB03886	experimental	Biopterin	C[C@@H](O)[C@@H](O)c(n1)cnc(c12)nc(N)[nH]c2=O
9662	tr|O07749|O07749_M	P35270	77.62	9.0	224.0	DB04275	experimental	N-acetylserotonin	CC(=O)NCCc1c[nH]c(c12)ccc(c2)O
9663	tr|O07749|O07749_M	Q01782	78.7	8.0	226.0	DB02338	experimental	NADPH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9664	tr|O07749|O07749_M	Q01782	78.7	8.0	226.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
9665	tr|O07749|O07749_M	Q01782	78.7	8.0	226.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9666	tr|O07749|O07749_M	Q01782	78.7	8.0	226.0	DB04400	experimental	L-erythro-7,8-dihydrobiopterin	C[C@H](O)[C@H](O)C(CN1)=Nc(c12)c(=O)nc([nH]2)N
9667	tr|O07749|O07749_M	P9WGR1	70.04	8.0	202.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
9668	tr|O07749|O07749_M	P9WGR1	70.04	8.0	202.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
9669	tr|O07749|O07749_M	P9WGR1	70.04	8.0	202.0	DB02990	experimental	S-(2-Acetamidoethyl) hexadecanethioate	CCCCCCCCCCCCCCCC(=O)SCCNC(=O)C
9670	tr|O07749|O07749_M	P9WGR1	70.04	8.0	202.0	DB04289	experimental	Genz-10850	[nH]1ccc(c12)cc(cc2)C(=O)N3CCN(CC3)C4c(cccc5)c5c(c46)cccc6
9671	tr|O07749|O07749_M	P9WGR1	70.04	8.0	202.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
9672	tr|O07749|O07749_M	P9WGR1	70.04	8.0	202.0	DB07090	experimental	(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cccc(c1C)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
9673	tr|O07749|O07749_M	P9WGR1	70.04	8.0	202.0	DB07123	experimental	N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE	Cc1ccc(cc1)C(=O)N2CCC(CC2)Cc3ccccc3
9674	tr|O07749|O07749_M	P9WGR1	70.04	8.0	202.0	DB07155	experimental	(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE	c1ccccc1NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
9675	tr|O07749|O07749_M	P9WGR1	70.04	8.0	202.0	DB07178	experimental	5-PENTYL-2-PHENOXYPHENOL	CCCCCc1cc(O)c(cc1)Oc2ccccc2
9676	tr|O07749|O07749_M	P9WGR1	70.04	8.0	202.0	DB07188	experimental	(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(cc(Cl)c1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
9677	tr|O07749|O07749_M	P9WGR1	70.04	8.0	202.0	DB07192	experimental	(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Brc1cc(ccc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
9678	tr|O07749|O07749_M	P9WGR1	70.04	8.0	202.0	DB07222	experimental	(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(c(C)cc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
9679	tr|O07749|O07749_M	P9WGR1	70.04	8.0	202.0	DB07287	experimental	2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL	c1cccnc1Cc2cc(O)c(cc2)Oc3ccc(Cl)cc3Cl
9680	tr|O07749|O07749_M	P9WGR1	70.04	8.0	202.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
9681	tr|O07749|O07749_M	Q7AUG5	75.45	1.0	210.0	DB04782	experimental	(S)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@H]2CO2
9682	tr|O07749|O07749_M	Q93D82	75.45	1.0	210.0	DB04472	experimental	(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol	[N-]=[N+]=NC[C@H](O)c1ccc([N+]([O-])=O)cc1
9683	tr|O07749|O07749_M	Q93D82	75.45	1.0	210.0	DB04499	experimental	(R)-styrene oxide	C1O[C@@H]1c2ccccc2
9684	tr|O07749|O07749_M	Q93D82	75.45	1.0	210.0	DB04777	experimental	(R)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@@H]2CO2
9685	tr|O07749|O07749_M	Q8T8E9	70.04	2.0	196.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
9686	tr|Q50616|Q50616_M	P83223	93.84	137.0	594.0	DB00518	approved; vet_approved	Albendazole	CCCSc(cc1)cc(c12)[nH]c(n2)NC(=O)OC
9687	tr|Q50616|Q50616_M	P83223	93.84	137.0	594.0	DB01677	experimental; investigational	Fumaric Acid	OC(=O)/C=C/C(=O)O
9688	tr|Q50616|Q50616_M	P83223	93.84	137.0	594.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
9689	tr|Q50616|Q50616_M	P0C278	93.02	116.0	569.0	DB01677	experimental; investigational	Fumaric Acid	OC(=O)/C=C/C(=O)O
9690	tr|Q50616|Q50616_M	P0C278	93.02	116.0	569.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
9691	tr|Q50616|Q50616_M	P0C278	93.02	116.0	569.0	DB03343	experimental	Malate Like Intermediate	[O-]C(=O)[C@H](O)C=C([O-])O
9692	tr|Q50616|Q50616_M	P0C278	93.02	116.0	569.0	DB04734	experimental	Citraconic acid	OC(=O)/C(C)=C\C(=O)O
9693	tr|Q50616|Q50616_M	Q9Z4P0	92.61	134.0	585.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
9694	tr|O53149|O53149_M	P08183	78.59	384.0	630.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
9695	tr|O53149|O53149_M	P08183	78.59	384.0	630.0	DB00603	approved; investigational	Medroxyprogesterone acetate	CC(=O)O[C@]1(C(=O)C)CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C([C@H](C3)C)=CC(=O)CC4
9696	tr|O53149|O53149_M	P08183	78.59	384.0	630.0	DB00778	approved; investigational; withdrawn	Roxithromycin	COCCOCO/N=C([C@H](C)[C@@H](O)[C@]1(C)O)/[C@H](C)C[C@@](C)(O)[C@@H]([C@@H](C)[C@@H]([C@@H](C)C(=O)O[C@@H]1CC)O[C@@H](C[C@@]2(C)OC)O[C@@H](C)[C@@H]2O)O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C
9697	tr|O53149|O53149_M	P08183	78.59	384.0	630.0	DB00813	approved; illicit; investigational; vet_approved	Fentanyl	c1ccccc1N(C(=O)CC)C2CCN(CC2)CCc3ccccc3
9698	tr|O53149|O53149_M	P08183	78.59	384.0	630.0	DB04877	experimental	Voacamine	CC[C@H]1C[C@@H](C2)CN([C@@H]1[C@@]23C(=O)OC)CCc4c3[nH]c5c4cc(OC)c(c5)[C@@H](C[C@H]67)c8c(c9c([nH]8)cccc9)C[C@H](C6C(=O)OC)N(C)CC\7=C\C
9699	tr|O53149|O53149_M	P08183	78.59	384.0	630.0	DB04881	investigational	Elacridar	COc1cccc(c12)c(=O)c3c([nH]2)c(ccc3)C(=O)Nc4ccc(cc4)CCN(C5)CCc(c56)cc(OC)c(c6)OC
9700	tr|O53149|O53149_M	P08183	78.59	384.0	630.0	DB04905	investigational	Tesmilifene	CCN(CC)CCOc1ccc(cc1)Cc2ccccc2
9701	tr|O53149|O53149_M	P08183	78.59	384.0	630.0	DB05449	investigational	FM-VP4	 
9702	tr|O53149|O53149_M	P08183	78.59	384.0	630.0	DB06191	investigational	Zosuquidar	FC1(F)[C@H]2[C@@H]1c(cccc3)c3[C@@H](c(c24)cccc4)N5CCN(CC5)C[C@@H](O)COc6cccc(c67)nccc7
9703	tr|O53149|O53149_M	P08183	78.59	384.0	630.0	DB06240	investigational	Tariquidar	COc(c1)c(OC)cc(c12)CCN(C2)CCc3ccc(cc3)NC(=O)c4cc(OC)c(OC)cc4NC(=O)c(c5)cnc(c56)cccc6
9704	tr|O53149|O53149_M	P08183	78.59	384.0	630.0	DB09031	approved; investigational	Miltefosine	CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C
9705	tr|O53149|O53149_M	P08183	78.59	384.0	630.0	DB11635	approved	Tocofersolan	 
9706	tr|O53149|O53149_M	P08183	78.59	384.0	630.0	DB14061	experimental	Hycanthone	CCN(CC)CCNc(ccc1CO)c(c12)c(=O)c3c(s2)cccc3
9707	tr|O53149|O53149_M	P08183	78.59	384.0	630.0	DB14062	experimental	Concanamycin A	NC(=O)O[C@@H]1[C@@H](C)O[C@H](C[C@H]1O)O[C@H](C2)[C@H](C)[C@@H](/C=C/C)O[C@@]2(O)[C@@H](C)[C@H](O)[C@H](C)[C@H]3OC(=O)/C(OC)=C/C(C)=C/[C@@H](C)[C@@H](O)[C@@H](CC)[C@@H](O)[C@H](C)C/C(C)=C/C=C/[C@@H]3OC
9708	tr|O53149|O53149_M	P08183	78.59	384.0	630.0	DB14063	experimental	Dexverapamil	COc1ccc(cc1OC)CCN(C)CCC[C@@](C#N)(C(C)C)c2cc(OC)c(OC)cc2
9709	tr|O53149|O53149_M	P08183	78.59	384.0	630.0	DB14064	experimental	Emopamil	c1ccccc1C(C#N)(C(C)C)CCCN(C)CCc2ccccc2
9710	tr|O53149|O53149_M	P08183	78.59	384.0	630.0	DB14065	experimental	Lomerizine	COc1ccc(c(OC)c1OC)CN2CCN(CC2)C(c3ccc(F)cc3)c4ccc(F)cc4
9711	tr|O53149|O53149_M	P08183	78.59	384.0	630.0	DB14066	experimental	Tetrandrine	c12ccc(OC)c(c1)Oc3ccc(cc3)C[C@H]4c5c(CCN4C)cc(OC)c(c5)Oc6c7c(CCN(C)[C@H]7C2)cc(OC)c6OC
9712	tr|O53149|O53149_M	P08183	78.59	384.0	630.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
9713	tr|O53149|O53149_M	P08183	78.59	384.0	630.0	DB14068	experimental	Dexniguldipine	[O-][N+](=O)c1cccc(c1)[C@@H]2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCCN(CC3)CCC3(c4ccccc4)c5ccccc5
9714	tr|O53149|O53149_M	P08183	78.59	384.0	630.0	DB14069	investigational	ONT-093	CCOC/C=C/c1ccc(cc1)-c2nc(-c3ccc(cc3)NC(C)C)c([nH]2)-c4ccc(cc4)NC(C)C
9715	tr|O53149|O53149_M	P08183	78.59	384.0	630.0	DB14070	experimental	HM-30181	c1cccc(c12)c(=O)cc(o2)C(=O)Nc3cc(OC)c(OC)cc3-c4nn(nn4)-c5ccc(cc5)CCN(C6)CCc(c67)cc(OC)c(c7)OC
9716	tr|O53149|O53149_M	P08183	78.59	384.0	630.0	DB14071	experimental	Desmethylsertraline	c1cccc(c12)[C@@H](CC[C@@H]2N)c3cc(Cl)c(Cl)cc3
9717	tr|O53149|O53149_M	P08183	78.59	384.0	630.0	DB14072	experimental	Reversin 121	c1ccccc1COC(=O)C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@H](C(=O)OC(C)(C)C)CCCCNC(=O)OCc2ccccc2
9718	tr|O53149|O53149_M	P08183	77.64	1028.0	1271.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
9719	tr|O53149|O53149_M	P08183	77.64	1028.0	1271.0	DB00603	approved; investigational	Medroxyprogesterone acetate	CC(=O)O[C@]1(C(=O)C)CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C([C@H](C3)C)=CC(=O)CC4
9720	tr|O53149|O53149_M	P08183	77.64	1028.0	1271.0	DB00778	approved; investigational; withdrawn	Roxithromycin	COCCOCO/N=C([C@H](C)[C@@H](O)[C@]1(C)O)/[C@H](C)C[C@@](C)(O)[C@@H]([C@@H](C)[C@@H]([C@@H](C)C(=O)O[C@@H]1CC)O[C@@H](C[C@@]2(C)OC)O[C@@H](C)[C@@H]2O)O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C
9721	tr|O53149|O53149_M	P08183	77.64	1028.0	1271.0	DB00813	approved; illicit; investigational; vet_approved	Fentanyl	c1ccccc1N(C(=O)CC)C2CCN(CC2)CCc3ccccc3
9722	tr|O53149|O53149_M	P08183	77.64	1028.0	1271.0	DB04877	experimental	Voacamine	CC[C@H]1C[C@@H](C2)CN([C@@H]1[C@@]23C(=O)OC)CCc4c3[nH]c5c4cc(OC)c(c5)[C@@H](C[C@H]67)c8c(c9c([nH]8)cccc9)C[C@H](C6C(=O)OC)N(C)CC\7=C\C
9723	tr|O53149|O53149_M	P08183	77.64	1028.0	1271.0	DB04881	investigational	Elacridar	COc1cccc(c12)c(=O)c3c([nH]2)c(ccc3)C(=O)Nc4ccc(cc4)CCN(C5)CCc(c56)cc(OC)c(c6)OC
9724	tr|O53149|O53149_M	P08183	77.64	1028.0	1271.0	DB04905	investigational	Tesmilifene	CCN(CC)CCOc1ccc(cc1)Cc2ccccc2
9725	tr|O53149|O53149_M	P08183	77.64	1028.0	1271.0	DB05449	investigational	FM-VP4	 
9726	tr|O53149|O53149_M	P08183	77.64	1028.0	1271.0	DB06191	investigational	Zosuquidar	FC1(F)[C@H]2[C@@H]1c(cccc3)c3[C@@H](c(c24)cccc4)N5CCN(CC5)C[C@@H](O)COc6cccc(c67)nccc7
9727	tr|O53149|O53149_M	P08183	77.64	1028.0	1271.0	DB06240	investigational	Tariquidar	COc(c1)c(OC)cc(c12)CCN(C2)CCc3ccc(cc3)NC(=O)c4cc(OC)c(OC)cc4NC(=O)c(c5)cnc(c56)cccc6
9728	tr|O53149|O53149_M	P08183	77.64	1028.0	1271.0	DB09031	approved; investigational	Miltefosine	CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C
9729	tr|O53149|O53149_M	P08183	77.64	1028.0	1271.0	DB11635	approved	Tocofersolan	 
9730	tr|O53149|O53149_M	P08183	77.64	1028.0	1271.0	DB14061	experimental	Hycanthone	CCN(CC)CCNc(ccc1CO)c(c12)c(=O)c3c(s2)cccc3
9731	tr|O53149|O53149_M	P08183	77.64	1028.0	1271.0	DB14062	experimental	Concanamycin A	NC(=O)O[C@@H]1[C@@H](C)O[C@H](C[C@H]1O)O[C@H](C2)[C@H](C)[C@@H](/C=C/C)O[C@@]2(O)[C@@H](C)[C@H](O)[C@H](C)[C@H]3OC(=O)/C(OC)=C/C(C)=C/[C@@H](C)[C@@H](O)[C@@H](CC)[C@@H](O)[C@H](C)C/C(C)=C/C=C/[C@@H]3OC
9732	tr|O53149|O53149_M	P08183	77.64	1028.0	1271.0	DB14063	experimental	Dexverapamil	COc1ccc(cc1OC)CCN(C)CCC[C@@](C#N)(C(C)C)c2cc(OC)c(OC)cc2
9733	tr|O53149|O53149_M	P08183	77.64	1028.0	1271.0	DB14064	experimental	Emopamil	c1ccccc1C(C#N)(C(C)C)CCCN(C)CCc2ccccc2
9734	tr|O53149|O53149_M	P08183	77.64	1028.0	1271.0	DB14065	experimental	Lomerizine	COc1ccc(c(OC)c1OC)CN2CCN(CC2)C(c3ccc(F)cc3)c4ccc(F)cc4
9735	tr|O53149|O53149_M	P08183	77.64	1028.0	1271.0	DB14066	experimental	Tetrandrine	c12ccc(OC)c(c1)Oc3ccc(cc3)C[C@H]4c5c(CCN4C)cc(OC)c(c5)Oc6c7c(CCN(C)[C@H]7C2)cc(OC)c6OC
9736	tr|O53149|O53149_M	P08183	77.64	1028.0	1271.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
9737	tr|O53149|O53149_M	P08183	77.64	1028.0	1271.0	DB14068	experimental	Dexniguldipine	[O-][N+](=O)c1cccc(c1)[C@@H]2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCCN(CC3)CCC3(c4ccccc4)c5ccccc5
9738	tr|O53149|O53149_M	P08183	77.64	1028.0	1271.0	DB14069	investigational	ONT-093	CCOC/C=C/c1ccc(cc1)-c2nc(-c3ccc(cc3)NC(C)C)c([nH]2)-c4ccc(cc4)NC(C)C
9739	tr|O53149|O53149_M	P08183	77.64	1028.0	1271.0	DB14070	experimental	HM-30181	c1cccc(c12)c(=O)cc(o2)C(=O)Nc3cc(OC)c(OC)cc3-c4nn(nn4)-c5ccc(cc5)CCN(C6)CCc(c67)cc(OC)c(c7)OC
9740	tr|O53149|O53149_M	P08183	77.64	1028.0	1271.0	DB14071	experimental	Desmethylsertraline	c1cccc(c12)[C@@H](CC[C@@H]2N)c3cc(Cl)c(Cl)cc3
9741	tr|O53149|O53149_M	P08183	77.64	1028.0	1271.0	DB14072	experimental	Reversin 121	c1ccccc1COC(=O)C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@H](C(=O)OC(C)(C)C)CCCCNC(=O)OCc2ccccc2
9742	tr|O53149|O53149_M	Q2M3G0	77.96	378.0	622.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
9743	tr|O53149|O53149_M	Q2M3G0	77.96	378.0	622.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
9744	tr|O53149|O53149_M	Q2M3G0	78.27	1006.0	1251.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
9745	tr|O53149|O53149_M	Q2M3G0	78.27	1006.0	1251.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
9746	tr|O53149|O53149_M	O95342	77.32	414.0	656.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
9747	tr|O53149|O53149_M	O95342	77.32	414.0	656.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
9748	tr|O53149|O53149_M	O95342	78.91	1072.0	1319.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
9749	tr|O53149|O53149_M	O95342	78.91	1072.0	1319.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
9750	tr|O53149|O53149_M	O60706	76.68	664.0	904.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
9751	tr|O53149|O53149_M	O60706	76.68	664.0	904.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
9752	tr|O53149|O53149_M	O60706	76.68	664.0	904.0	DB09220	approved; investigational	Nicorandil	[O-][N+](=O)OCCNC(=O)c1cccnc1
9753	tr|O53149|O53149_M	O60706	76.36	1308.0	1547.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
9754	tr|O53149|O53149_M	O60706	76.36	1308.0	1547.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
9755	tr|O53149|O53149_M	O60706	76.36	1308.0	1547.0	DB09220	approved; investigational	Nicorandil	[O-][N+](=O)OCCNC(=O)c1cccnc1
9756	tr|O53149|O53149_M	P33527	71.25	643.0	866.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
9757	tr|O53149|O53149_M	P33527	71.25	643.0	866.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
9758	tr|O53149|O53149_M	P33527	71.25	643.0	866.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
9759	tr|O53149|O53149_M	P33527	71.25	643.0	866.0	DB06176	approved; investigational	Romidepsin	O=C([C@H]12)N/C(=C\C)C(=O)N[C@@H](C(C)C)C(=O)O[C@@H](CC(=O)N[C@H](C(C)C)C(=O)N1)/C=C/CCSSC2
9760	tr|O53149|O53149_M	P33527	71.25	643.0	866.0	DB08855	experimental; investigational	Leukotriene C4	CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@@H](O)CCCC(=O)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@H](N)C(=O)O
9761	tr|O53149|O53149_M	P33527	74.44	1291.0	1524.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
9762	tr|O53149|O53149_M	P33527	74.44	1291.0	1524.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
9763	tr|O53149|O53149_M	P33527	74.44	1291.0	1524.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
9764	tr|O53149|O53149_M	P33527	74.44	1291.0	1524.0	DB06176	approved; investigational	Romidepsin	O=C([C@H]12)N/C(=C\C)C(=O)N[C@@H](C(C)C)C(=O)O[C@@H](CC(=O)N[C@H](C(C)C)C(=O)N1)/C=C/CCSSC2
9765	tr|O53149|O53149_M	P33527	74.44	1291.0	1524.0	DB08855	experimental; investigational	Leukotriene C4	CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@@H](O)CCCC(=O)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@H](N)C(=O)O
9766	tr|O53149|O53149_M	Q92887	70.61	634.0	855.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
9767	tr|O53149|O53149_M	Q92887	70.61	634.0	855.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
9768	tr|O53149|O53149_M	Q92887	72.2	1297.0	1523.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
9769	tr|O53149|O53149_M	Q92887	72.2	1297.0	1523.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
9770	tr|O53149|O53149_M	Q09428	78.91	673.0	920.0	DB00839	approved; investigational	Tolazamide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2
9771	tr|O53149|O53149_M	Q09428	78.91	673.0	920.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
9772	tr|O53149|O53149_M	Q09428	72.84	1341.0	1569.0	DB00839	approved; investigational	Tolazamide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2
9773	tr|O53149|O53149_M	Q09428	72.84	1341.0	1569.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
9774	tr|O53149|O53149_M	Q09428	78.91	673.0	920.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
9775	tr|O53149|O53149_M	Q09428	78.91	673.0	920.0	DB00222	approved	Glimepiride	CCC1=C(C)CN(C1=O)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3
9776	tr|O53149|O53149_M	Q09428	78.91	673.0	920.0	DB00672	approved; investigational	Chlorpropamide	CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1
9777	tr|O53149|O53149_M	Q09428	78.91	673.0	920.0	DB00731	approved; investigational	Nateglinide	CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](C(=O)O)Cc2ccccc2
9778	tr|O53149|O53149_M	Q09428	78.91	673.0	920.0	DB00912	approved; investigational	Repaglinide	CCOc1c(C(=O)O)ccc(c1)CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3
9779	tr|O53149|O53149_M	Q09428	78.91	673.0	920.0	DB01067	approved; investigational	Glipizide	Cc1ncc(nc1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
9780	tr|O53149|O53149_M	Q09428	78.91	673.0	920.0	DB01120	approved	Gliclazide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN(C2)CC(C23)CCC3
9781	tr|O53149|O53149_M	Q09428	78.91	673.0	920.0	DB01124	approved; investigational	Tolbutamide	CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1
9782	tr|O53149|O53149_M	Q09428	78.91	673.0	920.0	DB01251	approved; investigational	Gliquidone	COc(cc1)cc(c12)C(=O)N(C(=O)C2(C)C)CCc3ccc(cc3)S(=O)(=O)NC(=O)NC4CCCCC4
9783	tr|O53149|O53149_M	Q09428	78.91	673.0	920.0	DB01252	investigational	Mitiglinide	c1ccccc1C[C@H](C(=O)O)CC(=O)N(C2)C[C@H]([C@H]23)CCCC3
9784	tr|O53149|O53149_M	Q09428	78.91	673.0	920.0	DB01382	approved; investigational	Glymidine	COCCOc1cnc(nc1)NS(=O)(=O)c2ccccc2
9785	tr|O53149|O53149_M	Q09428	72.84	1341.0	1569.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
9786	tr|O53149|O53149_M	Q09428	72.84	1341.0	1569.0	DB00222	approved	Glimepiride	CCC1=C(C)CN(C1=O)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3
9787	tr|O53149|O53149_M	Q09428	72.84	1341.0	1569.0	DB00672	approved; investigational	Chlorpropamide	CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1
9788	tr|O53149|O53149_M	Q09428	72.84	1341.0	1569.0	DB00731	approved; investigational	Nateglinide	CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](C(=O)O)Cc2ccccc2
9789	tr|O53149|O53149_M	Q09428	72.84	1341.0	1569.0	DB00912	approved; investigational	Repaglinide	CCOc1c(C(=O)O)ccc(c1)CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3
9790	tr|O53149|O53149_M	Q09428	72.84	1341.0	1569.0	DB01067	approved; investigational	Glipizide	Cc1ncc(nc1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
9791	tr|O53149|O53149_M	Q09428	72.84	1341.0	1569.0	DB01120	approved	Gliclazide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN(C2)CC(C23)CCC3
9792	tr|O53149|O53149_M	Q09428	72.84	1341.0	1569.0	DB01124	approved; investigational	Tolbutamide	CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1
9793	tr|O53149|O53149_M	Q09428	72.84	1341.0	1569.0	DB01251	approved; investigational	Gliquidone	COc(cc1)cc(c12)C(=O)N(C(=O)C2(C)C)CCc3ccc(cc3)S(=O)(=O)NC(=O)NC4CCCCC4
9794	tr|O53149|O53149_M	Q09428	72.84	1341.0	1569.0	DB01252	investigational	Mitiglinide	c1ccccc1C[C@H](C(=O)O)CC(=O)N(C2)C[C@H]([C@H]23)CCCC3
9795	tr|O53149|O53149_M	Q09428	72.84	1341.0	1569.0	DB01382	approved; investigational	Glymidine	COCCOc1cnc(nc1)NS(=O)(=O)c2ccccc2
9796	tr|O53149|O53149_M	O15440	74.44	1186.0	1419.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
9797	tr|O53149|O53149_M	O15440	74.44	1186.0	1419.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
9798	tr|O53149|O53149_M	O95255	70.93	628.0	850.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
9799	tr|O53149|O53149_M	O95255	74.76	1263.0	1497.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
9800	tr|O53149|O53149_M	P13568	83.39	376.0	637.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
9801	tr|O53149|O53149_M	O15439	70.93	403.0	625.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
9802	tr|O53149|O53149_M	O15439	74.44	1037.0	1270.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
9803	tr|O53149|O53149_M	O95477	73.8	889.0	1120.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
9804	tr|O53149|O53149_M	O95477	73.8	889.0	1120.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
9805	tr|O53149|O53149_M	O95477	73.8	889.0	1120.0	DB01599	approved; investigational	Probucol	CC(C)(C)c1cc(cc(c1O)C(C)(C)C)SC(C)(C)Sc2cc(C(C)(C)C)c(O)c(c2)C(C)(C)C
9806	tr|O53149|O53149_M	O95477	71.57	1910.0	2134.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
9807	tr|O53149|O53149_M	O95477	71.57	1910.0	2134.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
9808	tr|O53149|O53149_M	O95477	71.57	1910.0	2134.0	DB01599	approved; investigational	Probucol	CC(C)(C)c1cc(cc(c1O)C(C)(C)C)SC(C)(C)Sc2cc(C(C)(C)C)c(O)c(c2)C(C)(C)C
9809	tr|O53149|O53149_M	P13569	73.48	1208.0	1438.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
9810	tr|O53149|O53149_M	P13569	73.48	1208.0	1438.0	DB00887	approved	Bumetanide	CCCCNc1c(c(S(=O)(=O)N)cc(c1)C(=O)O)Oc2ccccc2
9811	tr|O53149|O53149_M	P13569	73.48	1208.0	1438.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
9812	tr|O53149|O53149_M	P13569	73.48	1208.0	1438.0	DB01050	approved	Ibuprofen	CC(C)Cc1ccc(cc1)C(C)C(=O)O
9813	tr|O53149|O53149_M	P13569	73.48	1208.0	1438.0	DB02587	experimental; investigational	Colforsin	O[C@H]1CCC(C)(C)[C@@H]([C@]12C)[C@H](O)[C@H](OC(=O)C)[C@]3(C)[C@]2(O)C(=O)C[C@](O3)(C)C=C
9814	tr|O53149|O53149_M	P13569	73.48	1208.0	1438.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
9815	tr|O53149|O53149_M	P13569	73.48	1208.0	1438.0	DB04522	experimental	Dexfosfoserine	OC(=O)[C@@H](N)COP(=O)(O)O
9816	tr|O53149|O53149_M	P13569	73.48	1208.0	1438.0	DB04941	approved	Crofelemer	 
9817	tr|O53149|O53149_M	P13569	73.48	1208.0	1438.0	DB06266	investigational	Lonidamine	c1cccc(c12)n(nc2C(=O)O)Cc3c(Cl)cc(Cl)cc3
9818	tr|O53149|O53149_M	P13569	73.48	1208.0	1438.0	DB08820	approved	Ivacaftor	CC(C)(C)c1cc(C(C)(C)C)c(O)cc1NC(=O)c(c2=O)c[nH]c(c23)cccc3
9819	tr|O53149|O53149_M	P13569	73.48	1208.0	1438.0	DB09213	approved; investigational	Dexibuprofen	CC(C)Cc1ccc(cc1)[C@H](C)C(=O)O
9820	tr|O53149|O53149_M	P13569	73.48	1208.0	1438.0	DB09280	approved	Lumacaftor	O=C(O)c1cccc(c1)-c2nc(ccc2C)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
9821	tr|O53149|O53149_M	P13569	73.48	1208.0	1438.0	DB11712	approved; investigational	Tezacaftor	OC[C@H](O)Cn1c(C(C)(C)CO)cc(c12)cc(c(F)c2)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
9822	tr|O53149|O53149_M	P13569	73.48	1208.0	1438.0	DB15444	approved; investigational	Elexacaftor	FC(F)(F)C(C)(C)COc1nn(cc1)-c2nc(N(C3(C)C)C[C@@H](C)C3)c(cc2)C(=O)NS(=O)(=O)c4cn(C)nc4C
9823	tr|O53149|O53149_M	P45844	73.48	75.0	305.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
9824	tr|O53149|O53149_M	Q9UNQ0	76.04	36.0	274.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
9825	tr|O53149|O53149_M	Q9UNQ0	76.04	36.0	274.0	DB11995	approved; investigational	Avatrombopag	OC(=O)C1CCN(CC1)c2c(Cl)cc(cn2)C(=O)Nc3nc(-c4cc(Cl)cs4)c(s3)N5CCN(CC5)C6CCCCC6
9826	tr|P71791|P71791_M	P32055	98.14	3.0	319.0	DB02897	experimental	Acetylphosphate	CC(=O)OP(=O)(O)O
9827	tr|P71791|P71791_M	P32055	98.14	3.0	319.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9828	tr|P71791|P71791_M	Q13630	98.76	2.0	320.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9829	tr|P71791|P71791_M	P26391	104.97	1.0	339.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
9830	tr|P71791|P71791_M	Q14376	104.97	2.0	340.0	DB01861	experimental	Uridine diphosphate glucose	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
9831	tr|P71791|P71791_M	Q14376	104.97	2.0	340.0	DB02196	experimental	Uridine-Diphosphate-N-Acetylgalactosamine	CC(=O)N[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
9832	tr|P71791|P71791_M	Q14376	104.97	2.0	340.0	DB03041	experimental	UDP-alpha-D-glucuronic acid	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O
9833	tr|P71791|P71791_M	Q14376	104.97	2.0	340.0	DB03095	experimental	Tetramethylammonium	C[N+](C)(C)C
9834	tr|P71791|P71791_M	Q14376	104.97	2.0	340.0	DB03397	experimental	Uridine-Diphosphate-N-Acetylglucosamine	CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
9835	tr|P71791|P71791_M	Q14376	104.97	2.0	340.0	DB03501	experimental	Galactose-uridine-5'-diphosphate	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@H]1O)O[P@](=O)(O)O[P@](=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
9836	tr|P71791|P71791_M	P09147	102.8	1.0	332.0	DB01861	experimental	Uridine diphosphate glucose	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
9837	tr|P71791|P71791_M	P09147	102.8	1.0	332.0	DB02421	experimental	Uridine-5'-diphosphate-mannose	O=c1[nH]c(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O
9838	tr|P71791|P71791_M	P09147	102.8	1.0	332.0	DB02790	experimental	Phenyl-uridine-5'-diphosphate	O=c1[nH]c(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)Oc3ccccc3
9839	tr|P71791|P71791_M	P09147	102.8	1.0	332.0	DB03397	experimental	Uridine-Diphosphate-N-Acetylglucosamine	CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
9840	tr|P71791|P71791_M	P09147	102.8	1.0	332.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
9841	tr|P71791|P71791_M	P09147	102.8	1.0	332.0	DB04097	experimental	Uridine-5'-diphosphate-4-deoxy-4-fluoro-alpha-D-galactose	O=c1[nH]c(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](F)[C@H](O)[C@H]3O
9842	tr|P71791|P71791_M	P14169	104.04	1.0	336.0	DB04555	experimental	Cytidine-5'-Diphosphate	Nc1nc(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O
9843	tr|P71791|P71791_M	Q9ZGH3	97.52	1.0	315.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
9844	tr|P71791|P71791_M	P26397	101.55	8.0	335.0	DB02059	experimental	Adenosine-5-Diphosphoribose	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)CO[P@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H](O)[C@H](O)[C@@H]4O
9845	tr|P71791|P71791_M	P26397	101.55	8.0	335.0	DB03069	experimental	Cytidine-5'-diphospho-beta-D-xylose	Nc1nc(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O[C@H]3OC[C@@H](O)[C@H](O)[C@H]3O
9846	tr|P71791|P71791_M	P95780	100.31	4.0	327.0	DB03161	experimental	Thymidine-5'-diphospho-beta-D-xylose	O=c1[nH]c(=O)c(C)cn1[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3OC[C@@H](O)[C@H](O)[C@H]3O
9847	tr|P71791|P71791_M	P95780	100.31	4.0	327.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
9848	tr|P71791|P71791_M	P67910	95.34	2.0	309.0	DB01774	experimental	Adenosine-5'-Monophosphate Glucopyranosyl-Monophosphate Ester	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@@](=O)(O)O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O
9849	tr|P71791|P71791_M	P67910	95.34	2.0	309.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9850	tr|P71791|P71791_M	Q8T8E9	116.46	1.0	376.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
9851	tr|P71791|P71791_M	Q51366	95.65	6.0	314.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
9852	tr|P71791|P71791_M	Q8KN66	98.14	20.0	336.0	DB01861	experimental	Uridine diphosphate glucose	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
9853	tr|P71791|P71791_M	Q8KN66	98.14	20.0	336.0	DB02196	experimental	Uridine-Diphosphate-N-Acetylgalactosamine	CC(=O)N[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
9854	tr|P71791|P71791_M	O60547	103.42	27.0	360.0	DB02547	experimental	Guanosine-5'-Diphosphate-Rhamnose	O[C@H]1[C@H](O)[C@H](O)[C@H](O[C@@H]1C)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3cnc(c34)c(=O)nc([nH]4)N
9855	tr|P71791|P71791_M	O60547	103.42	27.0	360.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
9856	tr|P71791|P71791_M	Q15738	72.36	26.0	259.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9857	tr|P71791|P71791_M	P77398	104.97	313.0	651.0	DB03256	experimental	(6R)-Folinic acid	Nc([nH]1)nc(=O)c(c12)N(C=O)[C@@H](CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
9858	tr|P71791|P71791_M	P77398	104.97	313.0	651.0	DB03685	experimental	Uridine monophosphate	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2ccc(=O)[nH]c2=O
9859	tr|P71791|P71791_M	P26439	73.29	5.0	241.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9860	tr|P71791|P71791_M	P26439	73.29	5.0	241.0	DB01108	approved; investigational; vet_approved; withdrawn	Trilostane	C1C[C@H](O)[C@@](C)(CC2)[C@@H]1[C@H](CC3)[C@H]2[C@@]([C@@]345)(C)CC(C#N)=C([C@H]4O5)O
9861	tr|P71791|P71791_M	P14060	73.29	6.0	242.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9862	tr|P71791|P71791_M	P14060	73.29	6.0	242.0	DB01108	approved; investigational; vet_approved; withdrawn	Trilostane	C1C[C@H](O)[C@@](C)(CC2)[C@@H]1[C@H](CC3)[C@H]2[C@@]([C@@]345)(C)CC(C#N)=C([C@H]4O5)O
9863	tr|P71791|P71791_M	P14060	73.29	6.0	242.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
9864	tr|P71791|P71791_M	P14060	73.29	6.0	242.0	DB14538	experimental; vet_approved	Hydrocortisone aceponate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CC)C(=O)COC(=O)C
9865	tr|P71791|P71791_M	P14060	73.29	6.0	242.0	DB14539	approved; vet_approved	Hydrocortisone acetate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)C
9866	tr|P71791|P71791_M	P14060	73.29	6.0	242.0	DB14540	approved; vet_approved	Hydrocortisone butyrate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCC
9867	tr|P71791|P71791_M	P14060	73.29	6.0	242.0	DB14541	approved; investigational; vet_approved	Hydrocortisone cypionate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)CCC5CCCC5
9868	tr|P71791|P71791_M	P14060	73.29	6.0	242.0	DB14542	approved; vet_approved	Hydrocortisone phosphate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COP(=O)(O)O
9869	tr|P71791|P71791_M	P14060	73.29	6.0	242.0	DB14543	approved; vet_approved	Hydrocortisone probutate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CCC)C(=O)COC(=O)CC
9870	tr|P71791|P71791_M	P14060	73.29	6.0	242.0	DB14544	approved; vet_approved	Hydrocortisone valerate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCCC
9871	tr|Q10838|Q10838_M	P13956	90.5	19.0	181.0	DB01752	experimental	S-adenosyl-L-homocysteine	OC(=O)[C@@H](N)CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
9872	tr|Q10838|Q10838_M	P13956	90.5	19.0	181.0	DB01910	experimental	Sinefungin	OC(=O)[C@@H](N)CC[C@H](N)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
9873	tr|O86331|O86331_M	Q734I1	84.01	12.0	238.0	DB02078	experimental	Triglyme	COCCOCCOCCOC
9874	tr|O50402|O50402_M	P30084	75.59	43.0	204.0	DB02563	experimental	Hexanoyl-CoA	CCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
9875	tr|O50402|O50402_M	P30084	75.59	43.0	204.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
9876	tr|O50402|O50402_M	P30084	75.59	43.0	204.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
9877	tr|O50402|O50402_M	P30084	75.59	43.0	204.0	DB04117	experimental	4-(N,N-Dimethylamino)cinnamoyl-CoA	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)/C=C/c4ccc(cc4)N(C)C
9878	tr|O50402|O50402_M	P30084	75.59	43.0	204.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
9879	tr|O50402|O50402_M	O68600	82.63	3.0	179.0	DB01652	experimental	4-hydroxybenzoyl-CoA	Oc1ccc(cc1)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2OP(=O)(O)O)n3cnc(c34)c(N)ncn4
9880	tr|O50402|O50402_M	O75521	81.22	139.0	312.0	DB08231	experimental	Myristic acid	CCCCCCCCCCCCCC(=O)O
9881	tr|O50402|O50402_M	P40939	80.75	41.0	213.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9882	tr|O50402|O50402_M	Q6NVY1	73.24	34.0	190.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
9883	tr|O50402|O50402_M	P52045	78.4	6.0	173.0	DB03117	experimental	2-carboxypropyl-coenzyme A	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC[C@H](C)C(=O)O
9884	tr|O50402|O50402_M	Q08426	73.71	7.0	164.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9885	tr|O50402|O50402_M	P28793	72.77	25.0	180.0	DB08249	experimental	3,6,9,12,15-PENTAOXATRICOSAN-1-OL	CCCCCCCCOCCOCCOCCOCCOCCO
9886	tr|O50402|O50402_M	P42126	76.53	55.0	218.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
9887	tr|O50402|O50402_M	P42126	76.53	55.0	218.0	DB03127	experimental	Benzamidine	NC(=[NH2+])c1ccccc1
9888	tr|O50402|O50402_M	P9WNP5	88.26	35.0	223.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
9889	tr|O50402|O50402_M	P9WNP5	88.26	35.0	223.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
9890	tr|O50402|O50402_M	Q93TU6	80.75	14.0	186.0	DB02906	experimental	(2s,4s)-Alpha-Campholinic Acid	CC1(C)[C@H](C)C(=O)C[C@H]1CC(O)O
9891	tr|O53161|O53161_M	P30101	86.29	29.0	136.0	DB01593	approved; investigational	Zinc	[Zn]
9892	tr|O53161|O53161_M	P30101	86.29	29.0	136.0	DB09130	approved; investigational	Copper	[Cu]
9893	tr|O53161|O53161_M	P30101	86.29	29.0	136.0	DB14487	approved; investigational	Zinc acetate	CC([O-])=O
9894	tr|O53161|O53161_M	P30101	86.29	29.0	136.0	DB14533	approved; investigational	Zinc chloride	[Cl-]
9895	tr|O53161|O53161_M	P30101	86.29	29.0	136.0	DB14548	approved; experimental	Zinc sulfate, unspecified form	 
9896	tr|O53161|O53161_M	P30101	86.29	381.0	488.0	DB01593	approved; investigational	Zinc	[Zn]
9897	tr|O53161|O53161_M	P30101	86.29	381.0	488.0	DB09130	approved; investigational	Copper	[Cu]
9898	tr|O53161|O53161_M	P30101	86.29	381.0	488.0	DB14487	approved; investigational	Zinc acetate	CC([O-])=O
9899	tr|O53161|O53161_M	P30101	86.29	381.0	488.0	DB14533	approved; investigational	Zinc chloride	[Cl-]
9900	tr|O53161|O53161_M	P30101	86.29	381.0	488.0	DB14548	approved; experimental	Zinc sulfate, unspecified form	 
9901	tr|O53161|O53161_M	P07237	92.74	29.0	144.0	DB01593	approved; investigational	Zinc	[Zn]
9902	tr|O53161|O53161_M	P07237	92.74	29.0	144.0	DB03615	approved; experimental	Ribostamycin	O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]2[C@@H](O)[C@H](N)C[C@H](N)[C@H]2O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N
9903	tr|O53161|O53161_M	P07237	92.74	29.0	144.0	DB09130	approved; investigational	Copper	[Cu]
9904	tr|O53161|O53161_M	P07237	92.74	29.0	144.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
9905	tr|O53161|O53161_M	P07237	92.74	29.0	144.0	DB14487	approved; investigational	Zinc acetate	CC([O-])=O
9906	tr|O53161|O53161_M	P07237	92.74	29.0	144.0	DB14533	approved; investigational	Zinc chloride	[Cl-]
9907	tr|O53161|O53161_M	P07237	92.74	29.0	144.0	DB14548	approved; experimental	Zinc sulfate, unspecified form	 
9908	tr|O53161|O53161_M	C0H4Y6	82.26	34.0	136.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
9909	tr|O53161|O53161_M	C0H4Y6	84.68	361.0	466.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
9910	tr|O53161|O53161_M	P10599	77.42	8.0	104.0	DB12695	investigational	Phenethyl Isothiocyanate	S=C=NCCc1ccccc1
9911	tr|O53161|O53161_M	Q8IDH5	84.68	27.0	132.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
9912	tr|O53161|O53161_M	Q8IKL4	80.65	15.0	115.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
9913	tr|L7N662|L7N662_M	A0A045KKX4	99.79	1.0	485.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
9914	tr|P96935|P96935_M	P47229	88.04	21.0	286.0	DB07510	experimental	3-fluoro-6-(4-fluorophenyl)-2-hydroxy-6-oxohexa-2,4-dienoic acid	OC(=O)/C(O)=C(/F)\C=C\C(=O)c1ccc(F)cc1
9915	tr|P96935|P96935_M	P47229	88.04	21.0	286.0	DB07516	experimental	(2Z,4E)-3-chloro-2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoic acid	OC(=O)/C(O)=C(/Cl)\C=C\C(=O)c1ccccc1
9916	tr|P96935|P96935_M	P47229	88.04	21.0	286.0	DB07911	experimental	(3E)-2,6-DIOXO-6-PHENYLHEX-3-ENOATE	[O-]C(=O)C(=O)/C=C/CC(=O)c1ccccc1
9917	tr|P96935|P96935_M	P47229	88.04	21.0	286.0	DB07915	experimental	(2E,4E)-2-Hydroxy-6-oxo-6-phenyl-2,4-hexadienoic acid	OC(=O)/C(O)=C\C=C\C(=O)c1ccccc1
9918	tr|P96935|P96935_M	P96965	86.05	14.0	273.0	DB02406	experimental	N-Valeric Acid	CCCCC(=O)O
9919	tr|P96935|P96935_M	P96965	86.05	14.0	273.0	DB02531	experimental	Isobutyric acid	CC(C)C(=O)O
9920	tr|P96935|P96935_M	P96965	86.05	14.0	273.0	DB03568	experimental; investigational	Butyric Acid	CCCC(=O)O
9921	tr|P96935|P96935_M	P96965	86.05	14.0	273.0	DB03741	experimental	2-Methylbutanoic Acid	CC[C@@H](C)C(=O)O
9922	tr|P96935|P96935_M	P96965	86.05	14.0	273.0	DB03750	experimental	Isovaleric Acid	CC(C)CC(=O)O
9923	tr|P96935|P96935_M	P96965	86.05	14.0	273.0	DB03766	approved; vet_approved	Propanoic acid	CCC(=O)O
9924	tr|P96935|P96935_M	P96965	86.05	14.0	273.0	DB03793	approved; investigational	Benzoic acid	OC(=O)c1ccccc1
9926	tr|P96935|P96935_M	O31168	90.37	4.0	276.0	DB03793	approved; investigational	Benzoic acid	OC(=O)c1ccccc1
9927	tr|P96935|P96935_M	Q54528	91.69	7.0	283.0	DB01806	experimental	10-decarboxymethylaclacinomycin A	c1ccc(O)c(c12)C(=O)c3c(C2=O)cc4c(c3O)[C@H](C[C@](C4)(O)CC)O[C@H]5C[C@H](N(C)C)[C@@H]([C@@H](O5)C)O[C@@H]6C[C@H](O)[C@H]([C@@H](O6)C)O[C@H]7CCC(=O)[C@H](O7)C
9928	tr|P96935|P96935_M	Q54528	91.69	7.0	283.0	DB04131	experimental	10-(4-Dimethylamino-5-Hydroxy-6-Methyl-Tetrahydro-Pyran-2-Yloxy)-8-Ethyl-1,8,11-Trihydroxy-7,8,9,10-Tetrahydro-Naphthacene-5,12-Dione	O[C@H]1[C@@H](N(C)C)C[C@@H](O[C@H]1C)O[C@H]2C[C@](O)(CC)Cc(c23)cc4c(c3O)C(=O)c5c(C4=O)cccc5O
9929	tr|P96935|P96935_M	P34913	99.34	244.0	543.0	DB02029	experimental	N-Cyclohexyl-N'-(4-Iodophenyl)Urea	Ic1ccc(cc1)NC(=O)NC2CCCCC2
9930	tr|P96935|P96935_M	P34913	99.34	244.0	543.0	DB03677	experimental	N-Cyclohexyl-N'-Decylurea	CCCCCCCCCCNC(=O)NC1CCCCC1
9931	tr|P96935|P96935_M	P34913	99.34	244.0	543.0	DB04213	experimental	N-Cyclohexyl-N'-(Propyl)Phenyl Urea	C1CCCCC1NC(=O)NCCCc2ccccc2
9932	tr|P96935|P96935_M	P34913	99.34	244.0	543.0	DB06345	investigational	AR-9281	CC(=O)N1CCC(CC1)NC(=O)NC23CC4CC(C2)CC(C4)C3
9933	tr|P96935|P96935_M	P34913	99.34	244.0	543.0	DB08256	experimental	N-[(CYCLOHEXYLAMINO)CARBONYL]GLYCINE	OC(=O)CNC(=O)NC1CCCCC1
9934	tr|P96935|P96935_M	P34913	99.34	244.0	543.0	DB08257	experimental	4-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}BUTANOIC ACID	OC(=O)CCCNC(=O)NC1CCCCC1
9935	tr|P96935|P96935_M	P34913	99.34	244.0	543.0	DB08258	experimental	6-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEXANOIC ACID	OC(=O)CCCCCNC(=O)NC1CCCCC1
9936	tr|P96935|P96935_M	P34913	99.34	244.0	543.0	DB08259	experimental	7-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEPTANOIC ACID	OC(=O)CCCCCCNC(=O)NC1CCCCC1
9937	tr|P96935|P96935_M	P34913	99.34	244.0	543.0	DB12610	investigational	Ebselen	c1cccc(c12)[se]n(c2=O)-c3ccccc3
9938	tr|P96935|P96935_M	O07732	83.39	11.0	262.0	DB02596	experimental	alpha,beta-Methyleneadenosine 5'-triphosphate	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)CP(=O)(O)OP(=O)(O)O
9939	tr|P96935|P96935_M	O32449	90.37	26.0	298.0	DB03833	experimental	2-Prolyl-5-Tert-Butyl-[1,3,4]Oxadiazole	C1CCN[C@@H]1C(=O)c2nnc(o2)C(C)(C)C
9940	tr|P96935|P96935_M	O32449	90.37	26.0	298.0	DB07391	experimental	(2S)-2-AMINO-1-(5-TERT-BUTYL-1,3,4-OXADIAZOL-2-YL)PROPAN-1-ONE	C[C@H](N)C(=O)c1nnc(o1)C(C)(C)C
9941	tr|P96935|P96935_M	O32449	90.37	26.0	298.0	DB08576	experimental	1-(5-TERT-BUTYL-1,3,4-OXADIAZOL-2-YL)-2-(METHYLAMINO)ETHANONE	CNCC(=O)c1nnc(o1)C(C)(C)C
9942	tr|P96935|P96935_M	O07015	82.06	19.0	266.0	DB02175	experimental	Malonic acid	OC(=O)CC(=O)O
9943	tr|P96935|P96935_M	O07015	82.06	19.0	266.0	DB03297	experimental	Benzylsulfonic acid	OS(=O)(=O)Cc1ccccc1
9944	tr|P96935|P96935_M	O07015	82.06	19.0	266.0	DB04349	experimental	(S)-propane-1,2-diol	C[C@H](O)CO
9945	tr|P96935|P96935_M	P13001	82.39	3.0	251.0	DB03688	experimental	Hydracrylic acid	OCCC(=O)O
9946	tr|P95185|P95185_M	P00325	74.3	132.0	372.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9947	tr|P95185|P95185_M	P00325	74.3	132.0	372.0	DB01213	approved; vet_approved	Fomepizole	Cc1c[nH]nc1
9948	tr|P95185|P95185_M	P00325	74.3	132.0	372.0	DB02481	experimental	N-Benzylformamide	O=CNCc1ccccc1
9949	tr|P95185|P95185_M	P00325	74.3	132.0	372.0	DB02721	experimental	4-Iodopyrazole	Ic1c[nH]nc1
9950	tr|P95185|P95185_M	P00325	74.3	132.0	372.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9951	tr|P95185|P95185_M	P00325	74.3	132.0	372.0	DB03703	experimental	Cyclohexanol	OC1CCCCC1
9952	tr|P95185|P95185_M	P00325	74.3	132.0	372.0	DB04105	experimental	N-Heptylformamide	CCCCCCCNC=O
9953	tr|P95185|P95185_M	P00325	74.3	132.0	372.0	DB09462	approved; investigational	Glycerin	OCC(O)CO
9954	tr|P95185|P95185_M	P07327	72.76	138.0	373.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9955	tr|P95185|P95185_M	P07327	72.76	138.0	373.0	DB01213	approved; vet_approved	Fomepizole	Cc1c[nH]nc1
9956	tr|P95185|P95185_M	P07327	72.76	138.0	373.0	DB02721	experimental	4-Iodopyrazole	Ic1c[nH]nc1
9957	tr|P95185|P95185_M	P07327	72.76	138.0	373.0	DB04065	experimental	N-Cyclopentyl-N-Cyclobutylformamide	C1CCC1N(C=O)C2CCCC2
9958	tr|P95185|P95185_M	P00326	74.3	132.0	372.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9959	tr|P95185|P95185_M	P00326	74.3	132.0	372.0	DB01213	approved; vet_approved	Fomepizole	Cc1c[nH]nc1
9960	tr|P95185|P95185_M	P00326	74.3	132.0	372.0	DB01711	experimental	2,3,4,5,6-Pentafluorobenzyl Alcohol	OCc1c(F)c(F)c(F)c(F)c1F
9961	tr|P95185|P95185_M	P00326	74.3	132.0	372.0	DB02131	experimental	N-1-methylheptylformamide	O=CN[C@H](C)CCCCCC
9962	tr|P95185|P95185_M	P00326	74.3	132.0	372.0	DB02249	experimental	2-Ethoxyethanol	CCOCCO
9963	tr|P95185|P95185_M	P00326	74.3	132.0	372.0	DB02659	approved	Cholic Acid	OC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](C[C@@H]2O)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
9964	tr|P95185|P95185_M	P00326	74.3	132.0	372.0	DB02721	experimental	4-Iodopyrazole	Ic1c[nH]nc1
9965	tr|P95185|P95185_M	P00326	74.3	132.0	372.0	DB02757	experimental	Pyrazole	[nH]1cccn1
9966	tr|P95185|P95185_M	P00326	74.3	132.0	372.0	DB02822	experimental	Para-Bromobenzyl Alcohol	OCc1ccc(Br)cc1
9967	tr|P95185|P95185_M	P00326	74.3	132.0	372.0	DB02871	experimental	3-Butylthiolane 1-Oxide	O=[S@@]1C[C@H](CC1)CCCC
9968	tr|P95185|P95185_M	P00326	74.3	132.0	372.0	DB03020	experimental	5-beta-D-ribofuranosylnicotinamide adenine dinucleotide	NC(=O)c1c[nH+]cc(c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9969	tr|P95185|P95185_M	P00326	74.3	132.0	372.0	DB03061	experimental	(R)-N-(1-Methyl-Hexyl)-Formamide	CCCCC[C@H](C)NC=O
9970	tr|P95185|P95185_M	P00326	74.3	132.0	372.0	DB03226	experimental	Trifluoroethanol	OCC(F)(F)F
9971	tr|P95185|P95185_M	P00326	74.3	132.0	372.0	DB03559	experimental	Cyclohexylformamide	O=CNC1CCCCC1
9972	tr|P95185|P95185_M	P00326	74.3	132.0	372.0	DB04071	experimental	Cpad	NC(=O)c1nc(ccc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9973	tr|P95185|P95185_M	P00326	74.3	132.0	372.0	DB04113	experimental	N-Formylpiperidine	O=CN1CCCCC1
9974	tr|P95185|P95185_M	P00326	74.3	132.0	372.0	DB04312	experimental	2,3-Difluorobenzyl Alcohol	OCc1cccc(F)c1F
9975	tr|P95185|P95185_M	P00326	74.3	132.0	372.0	DB04448	experimental	2,4-Difluorobenzyl Alcohol 2,4-Difluoro-1-(Hydroxymethyl)Benzene	OCc1ccc(F)cc1F
9976	tr|P95185|P95185_M	P40394	75.85	138.0	383.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9977	tr|P95185|P95185_M	P11766	74.61	131.0	372.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9978	tr|P95185|P95185_M	P11766	74.61	131.0	372.0	DB03017	approved; experimental	Lauric acid	CCCCCCCCCCCC(=O)O
9979	tr|P95185|P95185_M	P11766	74.61	131.0	372.0	DB03704	experimental	12-Hydroxydodecanoic Acid	OCCCCCCCCCCCC(=O)O
9980	tr|P95185|P95185_M	P11766	74.61	131.0	372.0	DB04153	experimental	S-Hydroxymethyl Glutathione	OC(=O)[C@@H](N)CCC(=O)N[C@@H](CSCO)C(=O)NCC(=O)O
9981	tr|P95185|P95185_M	P08319	74.61	137.0	378.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
9982	tr|P95185|P95185_M	P08319	74.61	137.0	378.0	DB03559	experimental	Cyclohexylformamide	O=CNC1CCCCC1
9983	tr|P95185|P95185_M	Q08257	99.07	8.0	328.0	DB00266	approved	Dicoumarol	c1cccc(c12)oc(=O)c(c2O)Cc(c(=O)o3)c(O)c(c34)cccc4
9984	tr|P95185|P95185_M	Q08257	99.07	8.0	328.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9986	tr|P95185|P95185_M	Q08257	99.07	8.0	328.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
9987	tr|P95185|P95185_M	P49327	93.5	1554.0	1856.0	DB01034	experimental	Cerulenin	NC(=O)[C@@H]1O[C@@H]1C(=O)CC/C=C/C/C=C/C
9988	tr|P95185|P95185_M	P49327	93.5	1554.0	1856.0	DB01083	approved; investigational	Orlistat	CCCCCCCCCCC[C@H](OC(=O)[C@@H](NC=O)CC(C)C)C[C@@H]1OC(=O)[C@H]1CCCCCC
9989	tr|P95185|P95185_M	Q8N8N7	85.14	70.0	345.0	DB00328	approved; investigational	Indomethacin	COc(cc1)cc(c12)c(CC(=O)O)c(C)n2C(=O)c3ccc(Cl)cc3
9990	tr|P95185|P95185_M	Q8N8N7	85.14	70.0	345.0	DB07177	experimental	(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID	OC(=O)CCC/C=C/CC1C(C(O)CC1=O)/C=C/C(=O)CCCCC
9991	tr|P95185|P95185_M	Q14914	77.4	78.0	328.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
9992	tr|P95185|P95185_M	Q14914	77.4	78.0	328.0	DB04066	experimental	p-Coumaric acid	OC(=O)/C=C/c1ccc(O)cc1
9993	tr|P95185|P95185_M	Q14914	77.4	78.0	328.0	DB07177	experimental	(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID	OC(=O)CCC/C=C/CC1C(C(O)CC1=O)/C=C/C(=O)CCCCC
9994	tr|O05894|O05894_M	P00269	89.09	1.0	50.0	DB04464	experimental	N-Formylmethionine	O=CN[C@H](C(=O)O)CCSC
9995	tr|O06135|O06135_M	P0AGG2	92.67	5.0	283.0	DB04147	experimental	Dodecyldimethylamine N-oxide	CCCCCCCCCCCC[N+]([O-])(C)C
9996	tr|O07810|O07810_M	Q8IJ74	96.34	22.0	285.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
9997	tr|O07810|O07810_M	P75792	94.14	4.0	261.0	DB04156	experimental	Aspartate Beryllium Trifluoride	[Be+2].C(C(C(=O)O)N)C(O)[O-].[F-].[F-].[F-]
9999	tr|O06575|O06575_M	O31168	84.11	22.0	276.0	DB03793	approved; investigational	Benzoic acid	OC(=O)c1ccccc1
10000	tr|O06575|O06575_M	O07015	83.11	15.0	266.0	DB02175	experimental	Malonic acid	OC(=O)CC(=O)O
10001	tr|O06575|O06575_M	O07015	83.11	15.0	266.0	DB03297	experimental	Benzylsulfonic acid	OS(=O)(=O)Cc1ccccc1
10002	tr|O06575|O06575_M	O07015	83.11	15.0	266.0	DB04349	experimental	(S)-propane-1,2-diol	C[C@H](O)CO
10003	tr|O06575|O06575_M	P47229	84.77	29.0	285.0	DB07510	experimental	3-fluoro-6-(4-fluorophenyl)-2-hydroxy-6-oxohexa-2,4-dienoic acid	OC(=O)/C(O)=C(/F)\C=C\C(=O)c1ccc(F)cc1
10004	tr|O06575|O06575_M	P47229	84.77	29.0	285.0	DB07516	experimental	(2Z,4E)-3-chloro-2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoic acid	OC(=O)/C(O)=C(/Cl)\C=C\C(=O)c1ccccc1
10005	tr|O06575|O06575_M	P47229	84.77	29.0	285.0	DB07911	experimental	(3E)-2,6-DIOXO-6-PHENYLHEX-3-ENOATE	[O-]C(=O)C(=O)/C=C/CC(=O)c1ccccc1
10006	tr|O06575|O06575_M	P47229	84.77	29.0	285.0	DB07915	experimental	(2E,4E)-2-Hydroxy-6-oxo-6-phenyl-2,4-hexadienoic acid	OC(=O)/C(O)=C\C=C\C(=O)c1ccccc1
10007	tr|O06575|O06575_M	P96965	85.43	12.0	270.0	DB02406	experimental	N-Valeric Acid	CCCCC(=O)O
10008	tr|O06575|O06575_M	P96965	85.43	12.0	270.0	DB02531	experimental	Isobutyric acid	CC(C)C(=O)O
10009	tr|O06575|O06575_M	P96965	85.43	12.0	270.0	DB03568	experimental; investigational	Butyric Acid	CCCC(=O)O
10010	tr|O06575|O06575_M	P96965	85.43	12.0	270.0	DB03741	experimental	2-Methylbutanoic Acid	CC[C@@H](C)C(=O)O
10011	tr|O06575|O06575_M	P96965	85.43	12.0	270.0	DB03750	experimental	Isovaleric Acid	CC(C)CC(=O)O
10012	tr|O06575|O06575_M	P96965	85.43	12.0	270.0	DB03766	approved; vet_approved	Propanoic acid	CCC(=O)O
10013	tr|O06575|O06575_M	P96965	85.43	12.0	270.0	DB03793	approved; investigational	Benzoic acid	OC(=O)c1ccccc1
10014	tr|O06575|O06575_M	P13001	79.14	11.0	250.0	DB03688	experimental	Hydracrylic acid	OCCC(=O)O
10015	tr|O06575|O06575_M	O07732	70.2	50.0	262.0	DB02596	experimental	alpha,beta-Methyleneadenosine 5'-triphosphate	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)CP(=O)(O)OP(=O)(O)O
10016	tr|P95281|P95281_M	Q72JJ3	102.75	4.0	377.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
10017	tr|P95281|P95281_M	Q06319	104.13	1.0	379.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
10018	tr|P95281|P95281_M	Q06319	104.13	1.0	379.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
10019	tr|P95281|P95281_M	P16219	102.48	33.0	405.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10020	tr|P95281|P95281_M	P16219	102.48	33.0	405.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
10021	tr|P95281|P95281_M	P16219	102.48	33.0	405.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
10022	tr|P95281|P95281_M	P11310	103.31	38.0	413.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
10023	tr|P95281|P95281_M	P11310	103.31	38.0	413.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
10024	tr|P95281|P95281_M	P11310	103.31	38.0	413.0	DB03415	experimental	3-thiaoctanoyl-CoA	CCCCCSCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
10025	tr|P95281|P95281_M	P45954	101.93	57.0	427.0	DB00167	investigational; nutraceutical	Isoleucine	CC[C@H](C)[C@H](N)C(=O)O
10026	tr|P95281|P95281_M	P45954	101.93	57.0	427.0	DB00313	approved; investigational	Valproic acid	CCCC(C(=O)O)CCC
10027	tr|P95281|P95281_M	P26440	103.03	42.0	416.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
10028	tr|P95281|P95281_M	P26440	103.03	42.0	416.0	DB04036	experimental	Coenzyme A persulfide	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSS
10029	tr|P95281|P95281_M	Q3JP94	102.2	16.0	387.0	DB08685	experimental	1-(1,4-dimethyl-1,2,3,4-tetrahydroquinoxalin-6-yl)methanamine	CN1CCN(C)c(c12)cc(cc2)CN
10030	tr|P95281|P95281_M	Q9UKU7	101.65	41.0	410.0	DB01675	experimental	Methacrylyl-Coenzyme A	CC(=C)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
10031	tr|P95281|P95281_M	Q9UKU7	101.65	41.0	410.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
10032	tr|P95281|P95281_M	Q92947	101.38	59.0	427.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
10033	tr|P95281|P95281_M	Q92947	101.38	59.0	427.0	DB03245	experimental	S-4-Nitrobutyryl-CoA	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCC[N+]([O-])=O
10034	tr|P95281|P95281_M	Q9KIE5	95.04	16.0	361.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
10035	tr|P95281|P95281_M	Q15067	88.98	105.0	428.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
10036	tr|P95281|P95281_M	Q15067	88.98	105.0	428.0	DB07930	experimental	(3R)-3-HYDROXYDODECANOIC ACID	OC(=O)C[C@H](O)CCCCCCCCC
10037	tr|O53388|O53388_M	O07732	90.65	88.0	282.0	DB02596	experimental	alpha,beta-Methyleneadenosine 5'-triphosphate	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)CP(=O)(O)OP(=O)(O)O
10038	tr|O05311|O05311_M	P05100	90.2	3.0	187.0	DB04104	experimental	3-Methyladenine	n1cnc(c12)c(N)ncn2C
10039	tr|P71892|P71892_M	P30825	90.55	7.0	438.0	DB00123	approved; nutraceutical	L-Lysine	NCCCC[C@H](N)C(=O)O
10040	tr|P71892|P71892_M	P30825	90.55	7.0	438.0	DB00125	investigational; nutraceutical	Arginine	OC(=O)[C@@H](N)CCCNC(N)=N
10041	tr|P71892|P71892_M	P30825	90.55	7.0	438.0	DB00129	approved; nutraceutical	Ornithine	NCCC[C@H](N)C(=O)O
10042	tr|P71892|P71892_M	Q8WY07	89.5	9.0	435.0	DB00123	approved; nutraceutical	L-Lysine	NCCCC[C@H](N)C(=O)O
10043	tr|P71892|P71892_M	Q8WY07	89.5	9.0	435.0	DB00125	investigational; nutraceutical	Arginine	OC(=O)[C@@H](N)CCCNC(N)=N
10044	tr|P71892|P71892_M	Q8WY07	89.5	9.0	435.0	DB13146	approved	Fluciclovine (18F)	OC(=O)[C@]1(N)C[C@H]([18F])C1
10045	tr|P71892|P71892_M	P52569	90.34	6.0	436.0	DB00123	approved; nutraceutical	L-Lysine	NCCCC[C@H](N)C(=O)O
10046	tr|P71892|P71892_M	P52569	90.34	6.0	436.0	DB00129	approved; nutraceutical	Ornithine	NCCC[C@H](N)C(=O)O
10047	tr|P71892|P71892_M	O43246	85.5	13.0	420.0	DB00123	approved; nutraceutical	L-Lysine	NCCCC[C@H](N)C(=O)O
10048	tr|P71892|P71892_M	O43246	85.5	13.0	420.0	DB00125	investigational; nutraceutical	Arginine	OC(=O)[C@@H](N)CCCNC(N)=N
10049	tr|P71892|P71892_M	Q9UHI5	91.18	30.0	464.0	DB00120	approved; investigational; nutraceutical	Phenylalanine	OC(=O)[C@@H](N)Cc1ccccc1
10050	tr|P71892|P71892_M	Q9UHI5	91.18	30.0	464.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
10051	tr|P71892|P71892_M	Q9UM01	90.55	27.0	458.0	DB13146	approved	Fluciclovine (18F)	OC(=O)[C@]1(N)C[C@H]([18F])C1
10052	tr|P71892|P71892_M	Q9UPY5	91.6	34.0	470.0	DB00138	approved; nutraceutical	Cystine	OC(=O)[C@@H](N)CSSC[C@H](N)C(=O)O
10053	tr|P71892|P71892_M	Q9UPY5	91.6	34.0	470.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
10054	tr|P71892|P71892_M	Q9UPY5	91.6	34.0	470.0	DB00740	approved; investigational	Riluzole	Nc(s1)nc(c12)ccc(c2)OC(F)(F)F
10055	tr|P71892|P71892_M	Q9UPY5	91.6	34.0	470.0	DB00795	approved	Sulfasalazine	OC(=O)c1cc(ccc1O)/N=N/c2ccc(cc2)S(=O)(=O)Nc3ncccc3
10056	tr|P71892|P71892_M	Q9UPY5	91.6	34.0	470.0	DB06151	approved; investigational	Acetylcysteine	CC(=O)N[C@@H](CS)C(=O)O
10057	tr|P71892|P71892_M	Q9UPY5	91.6	34.0	470.0	DB11590	approved	Thimerosal	CC[Hg]Sc1ccccc1C([O-])=O
10058	tr|P71892|P71892_M	Q9UP95	111.76	117.0	649.0	DB00761	approved; withdrawn	Potassium chloride	[Cl-]
10059	tr|P71892|P71892_M	Q9UP95	111.76	117.0	649.0	DB00887	approved	Bumetanide	CCCCNc1c(c(S(=O)(=O)N)cc(c1)C(=O)O)Oc2ccccc2
10060	tr|P71892|P71892_M	Q9UHW9	111.34	184.0	714.0	DB00761	approved; withdrawn	Potassium chloride	[Cl-]
10061	tr|P71892|P71892_M	Q9Y666	111.76	117.0	649.0	DB00761	approved; withdrawn	Potassium chloride	[Cl-]
10062	tr|P71892|P71892_M	Q9H2X9	111.97	119.0	652.0	DB00761	approved; withdrawn	Potassium chloride	[Cl-]
10063	tr|P71892|P71892_M	Q9H2X9	111.97	119.0	652.0	DB00887	approved	Bumetanide	CCCCNc1c(c(S(=O)(=O)N)cc(c1)C(=O)O)Oc2ccccc2
10064	tr|P71892|P71892_M	P60063	89.29	7.0	432.0	DB02451	experimental	B-nonylglucoside	CCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
10065	tr|O53382|O53382_M	O34450	97.65	8.0	382.0	DB02657	experimental	Glucosamine 6-Phosphate	N[C@H]1[C@@H](O)O[C@@H]([C@@H](O)[C@@H]1O)COP(=O)(O)O
10066	tr|O53611|O53611_M	P16100	98.79	2.0	738.0	DB01727	experimental	Isocitric Acid	OC(=O)[C@@H](O)[C@@H](C(=O)O)CC(=O)O
10067	tr|O53611|O53611_M	P16100	98.79	2.0	738.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10068	tr|I6XHY3|I6XHY3_M	P52700	82.58	28.0	246.0	DB02032	experimental	Epicaptopril	SC[C@H](C)C(=O)N1CCC[C@H]1C(=O)O
10069	tr|I6XHY3|I6XHY3_M	P52700	82.58	28.0	246.0	DB02365	experimental	1,10-Phenanthroline	n1cccc(c12)ccc3c2nccc3
10070	tr|I6XHY3|I6XHY3_M	P52700	82.58	28.0	246.0	DB04740	experimental	Moxalactam (hydrolyzed)	OC(=O)C1=N[C@H](OCC1=C)C(OC)(C(=O)O)NC(=O)[C@@H](C(=O)O)c2ccc(O)cc2
10071	tr|I6XHY3|I6XHY3_M	P52700	82.58	28.0	246.0	DB07939	experimental	N-(3-MERCAPTOPROPANOYL)-D-ALANINE	OC(=O)[C@@H](C)NC(=O)CCS
10072	tr|I6XHY3|I6XHY3_M	P52700	82.58	28.0	246.0	DB08069	experimental	4-AMINO-5-(2-METHYLPHENYL)-2,4-DIHYDRO-3H-1,2,4-TRIAZOLE-3-THIONE	Cc1ccccc1-c2n[nH]c(=S)n2N
10073	tr|I6XHY3|I6XHY3_M	P52700	82.58	28.0	246.0	DB08199	experimental	N-[(BENZYLOXY)CARBONYL]-L-CYSTEINYLGLYCINE	OC(=O)CNC(=O)[C@H](CS)NC(=O)OCc1ccccc1
10074	tr|I6XHY3|I6XHY3_M	P52700	82.58	28.0	246.0	DB08702	experimental	2,5-DIPHENYLFURAN-3,4-DICARBOXYLIC ACID	c1ccccc1-c2c(C(=O)O)c(C(=O)O)c(o2)-c3ccccc3
10075	tr|I6XHY3|I6XHY3_M	P20581	71.97	35.0	225.0	DB07418	experimental	bis(4-nitrophenyl) hydrogen phosphate	[O-][N+](=O)c1ccc(cc1)OP(=O)(O)Oc2ccc([N+]([O-])=O)cc2
10076	tr|O06574|O06574_M	P52209	91.47	5.0	316.0	DB00789	approved	Gadopentetic acid	OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC(=O)O
10077	tr|O06574|O06574_M	P52209	91.47	5.0	316.0	DB00851	approved; investigational	Dacarbazine	CN(C)/N=N/c1c(C(=O)N)nc[nH]1
10078	tr|O06574|O06574_M	P52209	91.47	5.0	316.0	DB00920	approved	Ketotifen	CN1CCC(CC1)=C2c(ccs3)c3C(=O)Cc(c24)cccc4
10079	tr|O06574|O06574_M	P52209	91.47	5.0	316.0	DB02076	experimental	6-phospho-D-gluconic acid	OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(=O)O
10080	tr|O06574|O06574_M	P52209	91.47	5.0	316.0	DB03962	experimental	Nicotinamide 8-bromo-adenine dinucleotide phosphate	NC(=O)c1c[n+](ccc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4c(Br)nc(c45)c(N)ncn5
10081	tr|O53198|O53198_M	P30920	76.56	31.0	449.0	DB01719	experimental	Thio-Maltopentaose	S[C@H]1O[C@H](CO)[C@H]([C@H](O)[C@H]1O)O[C@H]2O[C@H](CO)[C@H]([C@H](O)[C@H]2O)S[C@H]3O[C@H](CO)[C@H]([C@H](O)[C@H]3O)O[C@H]4O[C@H](CO)[C@H]([C@H](O)[C@H]4O)S[C@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O
10082	tr|O53198|O53198_M	P30920	76.56	31.0	449.0	DB01789	experimental	1-Amino-2,3-Dihydroxy-5-Hydroxymethyl Cyclohex-5-Ene	N[C@H]1C=C(CO)C[C@H](O)[C@H]1O
10083	tr|O53198|O53198_M	P30920	76.56	31.0	449.0	DB01841	experimental	4,6-Dideoxyglucose	C[C@@H]1C[C@H](O)[C@@H](O)[C@H](O1)O
10084	tr|O53198|O53198_M	P30920	76.56	31.0	449.0	DB01909	experimental	Alpha-Cyclodextrin (Cyclohexa-Amylose)	OC[C@@H](O[C@@H]12)[C@H]([C@H](O)[C@H]1O)O[C@H]3O[C@H](CO)[C@H]([C@H](O)[C@H]3O)O[C@H]4O[C@H](CO)[C@H]([C@H](O)[C@H]4O)O[C@H]5O[C@H](CO)[C@H]([C@H](O)[C@H]5O)O[C@H]6O[C@H](CO)[C@H]([C@H](O)[C@H]6O)O[C@H]7O[C@H](CO)[C@@H](O2)[C@H](O)[C@H]7O
10085	tr|O53198|O53198_M	P30920	76.56	31.0	449.0	DB02120	experimental	6-Amino-4-Hydroxymethyl-Cyclohex-4-Ene-1,2,3-Triol	N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O
10086	tr|O53198|O53198_M	P30920	76.56	31.0	449.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
10087	tr|O53198|O53198_M	P30920	76.56	31.0	449.0	DB02394	experimental	Oxiranpseudoglucose	OC[C@]12[C@H](O1)C[C@H](O)[C@@H](O)[C@@H]2O
10088	tr|O53198|O53198_M	P30920	76.56	31.0	449.0	DB02469	experimental	4,6-dideoxy-4-amino-beta-D-glucopyranoside	C[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1N
10089	tr|O53198|O53198_M	P30920	76.56	31.0	449.0	DB02670	experimental	4-Deoxy-Alpha-D-Glucose	O[C@H]1C[C@@H](CO)O[C@H](O)[C@@H]1O
10090	tr|O53198|O53198_M	P30920	76.56	31.0	449.0	DB03198	experimental	Thio-Maltohexaose	O[C@H]1O[C@H](CO)[C@H]([C@H](O)[C@H]1O)S[C@H]2O[C@H](CO)[C@H]([C@H](O)[C@H]2O)O[C@H]3O[C@H](CO)[C@H]([C@H](O)[C@H]3O)S[C@H]4O[C@H](CO)[C@H]([C@H](O)[C@H]4O)O[C@H]5O[C@H](CO)[C@H]([C@H](O)[C@H]5O)S[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O
10091	tr|O53198|O53198_M	P30920	76.56	31.0	449.0	DB03323	experimental; investigational	Maltose	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO
10092	tr|O53198|O53198_M	P30920	76.56	31.0	449.0	DB03773	experimental	alpha-D-quinovopyranose	C[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O
10093	tr|O53198|O53198_M	Q60053	75.09	169.0	579.0	DB01841	experimental	4,6-Dideoxyglucose	C[C@@H]1C[C@H](O)[C@@H](O)[C@H](O1)O
10094	tr|O53198|O53198_M	Q60053	75.09	169.0	579.0	DB02120	experimental	6-Amino-4-Hydroxymethyl-Cyclohex-4-Ene-1,2,3-Triol	N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O
10095	tr|O53198|O53198_M	Q60053	75.09	169.0	579.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
10097	tr|L7N6A3|L7N6A3_M	Q84EX5	81.98	3.0	94.0	DB04619	experimental	Acetophenone	CC(=O)c1ccccc1
10098	tr|L7N6A3|L7N6A3_M	Q84EX5	81.98	3.0	94.0	DB04784	experimental	(R)-1-phenylethanol	C[C@@H](O)c1ccccc1
10100	tr|L7N6A3|L7N6A3_M	Q9WYS2	76.58	6.0	91.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10102	tr|L7N6A3|L7N6A3_M	Q9BY49	82.88	15.0	107.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
10103	tr|L7N6A3|L7N6A3_M	P0AEK2	72.07	3.0	83.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10104	tr|L7N6A3|L7N6A3_M	P16544	72.07	2.0	82.0	DB01942	experimental; investigational	Formic acid	OC=O
10105	tr|L7N6A3|L7N6A3_M	P16544	72.07	2.0	82.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10106	tr|L7N6A3|L7N6A3_M	P16544	72.07	2.0	82.0	DB07715	investigational	Emodin	Cc(c1)cc(O)c(c12)C(=O)c3c(C2=O)cc(O)cc3O
10107	tr|L7N6A3|L7N6A3_M	Q99714	72.07	8.0	88.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10108	tr|L7N6A3|L7N6A3_M	Q99714	72.07	8.0	88.0	DB02820	experimental	1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct	C1CCCCCN1C(=O)[C@H](c2ccccc2)n(c3=S)cnc(c34)nn(c4)[C@H]5C=CN(C=C5C([O-])=N)[C@@H]6O[C@@H]([C@@H](O)[C@H]6O)COP([O-])(=O)OP(=O)(O)OC[C@H]7O[C@H]([C@H]([O-])[C@@H]7[O-])n8cnc(c89)c(N)ncn9
10109	tr|L7N6A3|L7N6A3_M	Q99714	72.07	8.0	88.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
10110	tr|L7N6A3|L7N6A3_M	P51659	81.98	6.0	97.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10111	tr|L7N6A3|L7N6A3_M	P51659	81.98	6.0	97.0	DB03192	experimental	(R)-3-hydroxydecanoyl-CoA	CCCCCCC[C@@H](O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
10112	tr|L7N6A3|L7N6A3_M	A0A348A0U3	81.08	1.0	91.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
10113	tr|O06137|O06137_M	A0A0T9AZ62	75.87	1.0	438.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
10116	tr|I6Y1W3|I6Y1W3_M	Q9BTZ2	96.12	27.0	275.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
10117	tr|I6Y1W3|I6Y1W3_M	Q9WYS2	95.74	6.0	253.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10118	tr|I6Y1W3|I6Y1W3_M	P0AEK2	92.64	3.0	242.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10121	tr|I6Y1W3|I6Y1W3_M	Q92506	98.84	4.0	259.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10122	tr|I6Y1W3|I6Y1W3_M	Q92506	98.84	4.0	259.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10124	tr|I6Y1W3|I6Y1W3_M	P0AET8	93.41	8.0	249.0	DB02123	experimental	Glycochenodeoxycholic Acid	OC(=O)CNC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
10125	tr|I6Y1W3|I6Y1W3_M	Q84EX5	96.51	1.0	250.0	DB04619	experimental	Acetophenone	CC(=O)c1ccccc1
10126	tr|I6Y1W3|I6Y1W3_M	Q84EX5	96.51	1.0	250.0	DB04784	experimental	(R)-1-phenylethanol	C[C@@H](O)c1ccccc1
10127	tr|I6Y1W3|I6Y1W3_M	P16544	98.45	5.0	259.0	DB01942	experimental; investigational	Formic acid	OC=O
10128	tr|I6Y1W3|I6Y1W3_M	P16544	98.45	5.0	259.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10129	tr|I6Y1W3|I6Y1W3_M	P16544	98.45	5.0	259.0	DB07715	investigational	Emodin	Cc(c1)cc(O)c(c12)C(=O)c3c(C2=O)cc(O)cc3O
10130	tr|I6Y1W3|I6Y1W3_M	P0CG22	97.29	27.0	278.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
10131	tr|I6Y1W3|I6Y1W3_M	P0CG22	97.29	27.0	278.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10132	tr|I6Y1W3|I6Y1W3_M	P0CG22	97.29	27.0	278.0	DB03541	experimental	10-Propargyl-5,8-Dideazafolic Acid	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(CC#C)Cc(c2)ccc(c23)[nH]c(N)nc3=O
10133	tr|I6Y1W3|I6Y1W3_M	P0CG22	97.29	27.0	278.0	DB07689	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)NCc(cn3)nc(c34)c(N)nc(n4)N
10134	tr|I6Y1W3|I6Y1W3_M	P0CG22	97.29	27.0	278.0	DB07765	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)N(C)Cc(cn3)nc(c34)c(N)nc(n4)N
10135	tr|I6Y1W3|I6Y1W3_M	Q9BY49	97.29	16.0	267.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
10136	tr|I6Y1W3|I6Y1W3_M	Q7Z4W1	91.86	5.0	242.0	DB02831	experimental	Dihydrogenphosphate	OP([O-])(=O)O
10137	tr|I6Y1W3|I6Y1W3_M	Q7Z4W1	91.86	5.0	242.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10138	tr|I6Y1W3|I6Y1W3_M	P0AEK4	98.45	4.0	258.0	DB01691	experimental	Indole Naphthyridinone	c1cccc(c12)n(C)cc2CN(C)C(=O)/C=C/c(c3)cnc(c34)NC(=O)CC4
10139	tr|I6Y1W3|I6Y1W3_M	P0AEK4	98.45	4.0	258.0	DB01865	experimental	3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide	c1cccc(c12)cc(n2C)CN(C)C(=O)/C=C/c3cnc(N)cc3
10140	tr|I6Y1W3|I6Y1W3_M	P0AEK4	98.45	4.0	258.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
10141	tr|I6Y1W3|I6Y1W3_M	P0AEK4	98.45	4.0	258.0	DB03030	experimental	4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole	Cc1ccc(cc1)Cn2cnc(c2)-c3cccs3
10142	tr|I6Y1W3|I6Y1W3_M	P0AEK4	98.45	4.0	258.0	DB03534	experimental	3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide	CC(=O)N(C)Cc1c(N)ccc(c1)C(=O)N(C)Cc(n2C)cc(c23)cccc3
10143	tr|I6Y1W3|I6Y1W3_M	P0AEK4	98.45	4.0	258.0	DB04030	experimental	1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole	Oc1ccc(cc1)Cn2c(c3c(c24)cccc4)CN(CC3)C(=O)c5ccc(O)cc5
10144	tr|I6Y1W3|I6Y1W3_M	P0AEK4	98.45	4.0	258.0	DB08265	experimental	2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL	Cc1ccc(cc1)S(=O)(=O)n(b2O)ncc(c23)cccc3
10145	tr|I6Y1W3|I6Y1W3_M	P0AEK4	98.45	4.0	258.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
10146	tr|I6Y1W3|I6Y1W3_M	P0AEK4	98.45	4.0	258.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
10147	tr|I6Y1W3|I6Y1W3_M	Q16698	96.51	55.0	304.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10148	tr|I6Y1W3|I6Y1W3_M	Q16698	96.51	55.0	304.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
10149	tr|I6Y1W3|I6Y1W3_M	A0A348A0U3	96.9	4.0	254.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
10150	tr|I6Y1W3|I6Y1W3_M	Q99714	97.67	6.0	258.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10151	tr|I6Y1W3|I6Y1W3_M	Q99714	97.67	6.0	258.0	DB02820	experimental	1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct	C1CCCCCN1C(=O)[C@H](c2ccccc2)n(c3=S)cnc(c34)nn(c4)[C@H]5C=CN(C=C5C([O-])=N)[C@@H]6O[C@@H]([C@@H](O)[C@H]6O)COP([O-])(=O)OP(=O)(O)OC[C@H]7O[C@H]([C@H]([O-])[C@@H]7[O-])n8cnc(c89)c(N)ncn9
10152	tr|I6Y1W3|I6Y1W3_M	Q99714	97.67	6.0	258.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
10153	tr|I6Y1W3|I6Y1W3_M	Q6GI75	97.29	3.0	254.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
10154	tr|I6Y1W3|I6Y1W3_M	Q6GI75	97.29	3.0	254.0	DB11155	approved	Triclocarban	Clc1ccc(cc1)NC(=O)Nc2cc(Cl)c(Cl)cc2
10155	tr|I6Y1W3|I6Y1W3_M	Q6UWP2	93.02	7.0	247.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10156	tr|I6Y1W3|I6Y1W3_M	Q7AUG5	93.8	3.0	245.0	DB04782	experimental	(S)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@H]2CO2
10157	tr|I6Y1W3|I6Y1W3_M	Q93D82	93.8	3.0	245.0	DB04472	experimental	(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol	[N-]=[N+]=NC[C@H](O)c1ccc([N+]([O-])=O)cc1
10158	tr|I6Y1W3|I6Y1W3_M	Q93D82	93.8	3.0	245.0	DB04499	experimental	(R)-styrene oxide	C1O[C@@H]1c2ccccc2
10159	tr|I6Y1W3|I6Y1W3_M	Q93D82	93.8	3.0	245.0	DB04777	experimental	(R)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@@H]2CO2
10160	tr|I6Y1W3|I6Y1W3_M	O24990	96.9	4.0	254.0	DB04393	experimental	Soneclosan	Clc1cc(O)c(cc1)Oc2ccc(Cl)cc2
10161	tr|I6Y1W3|I6Y1W3_M	O24990	96.9	4.0	254.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
10162	tr|I6Y1W3|I6Y1W3_M	Q6PKH6	71.71	24.0	209.0	DB04200	experimental	Matairesinol	COc1cc(ccc1O)C[C@H]2COC(=O)[C@@H]2Cc3ccc(O)c(c3)OC
10163	tr|I6Y1W3|I6Y1W3_M	Q9HBH5	100.39	42.0	301.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
10164	tr|I6Y1W3|I6Y1W3_M	O75911	87.98	35.0	262.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
10165	tr|I6Y1W3|I6Y1W3_M	Q8I814	101.16	13.0	274.0	DB02015	experimental	Dihydrofolic Acid	O=c1[nH]c(N)nc(c12)NCC(=N2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
10166	tr|I6Y1W3|I6Y1W3_M	Q8I814	101.16	13.0	274.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10167	tr|I6Y1W3|I6Y1W3_M	Q8TC12	79.46	38.0	243.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
10168	tr|I6Y1W3|I6Y1W3_M	Q8NBN7	80.23	35.0	242.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
10170	tr|I6Y1W3|I6Y1W3_M	Q8NBQ5	78.29	31.0	233.0	DB02854	experimental	Aetiocholanolone	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](CC3)C[C@H](O)CC4
10171	tr|I6Y1W3|I6Y1W3_M	Q96NR8	79.07	36.0	240.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
10172	tr|I6Y1W3|I6Y1W3_M	Q01782	107.36	8.0	285.0	DB02338	experimental	NADPH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10173	tr|I6Y1W3|I6Y1W3_M	Q01782	107.36	8.0	285.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
10174	tr|I6Y1W3|I6Y1W3_M	Q01782	107.36	8.0	285.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10175	tr|I6Y1W3|I6Y1W3_M	Q01782	107.36	8.0	285.0	DB04400	experimental	L-erythro-7,8-dihydrobiopterin	C[C@H](O)[C@H](O)C(CN1)=Nc(c12)c(=O)nc([nH]2)N
10176	tr|I6Y1W3|I6Y1W3_M	Q02338	82.17	51.0	263.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10177	tr|I6Y1W3|I6Y1W3_M	P14061	81.4	2.0	212.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10178	tr|I6Y1W3|I6Y1W3_M	P14061	81.4	2.0	212.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
10179	tr|I6Y1W3|I6Y1W3_M	P14061	81.4	2.0	212.0	DB01561	experimental; illicit	Androstanedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
10180	tr|I6Y1W3|I6Y1W3_M	P14061	81.4	2.0	212.0	DB02187	experimental	Equilin	O=C1CC[C@H]([C@@]12C)C=3[C@H](CC2)c4c(CC3)cc(O)cc4
10181	tr|I6Y1W3|I6Y1W3_M	P14061	81.4	2.0	212.0	DB02323	experimental	EM-1745	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)C[C@@H]([C@@H]4O)CCCCCCCCC(=O)OC[C@H]5O[C@H]([C@H](O)[C@@H]5O)n6cnc(c67)c(N)ncn7
10182	tr|I6Y1W3|I6Y1W3_M	P14061	81.4	2.0	212.0	DB02901	illicit; investigational	Stanolone	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
10183	tr|I6Y1W3|I6Y1W3_M	P14061	81.4	2.0	212.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10184	tr|I6Y1W3|I6Y1W3_M	P14061	81.4	2.0	212.0	DB13951	experimental	Stanolone acetate	CC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
10185	tr|I6Y1W3|I6Y1W3_M	Q9NYR8	76.36	4.0	201.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
10186	tr|I6Y1W3|I6Y1W3_M	P51659	80.23	6.0	213.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10187	tr|I6Y1W3|I6Y1W3_M	P51659	80.23	6.0	213.0	DB03192	experimental	(R)-3-hydroxydecanoyl-CoA	CCCCCCC[C@@H](O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
10188	tr|I6Y1W3|I6Y1W3_M	P9WGR1	101.55	4.0	266.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
10189	tr|I6Y1W3|I6Y1W3_M	P9WGR1	101.55	4.0	266.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
10190	tr|I6Y1W3|I6Y1W3_M	P9WGR1	101.55	4.0	266.0	DB02990	experimental	S-(2-Acetamidoethyl) hexadecanethioate	CCCCCCCCCCCCCCCC(=O)SCCNC(=O)C
10191	tr|I6Y1W3|I6Y1W3_M	P9WGR1	101.55	4.0	266.0	DB04289	experimental	Genz-10850	[nH]1ccc(c12)cc(cc2)C(=O)N3CCN(CC3)C4c(cccc5)c5c(c46)cccc6
10192	tr|I6Y1W3|I6Y1W3_M	P9WGR1	101.55	4.0	266.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
10193	tr|I6Y1W3|I6Y1W3_M	P9WGR1	101.55	4.0	266.0	DB07090	experimental	(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cccc(c1C)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
10194	tr|I6Y1W3|I6Y1W3_M	P9WGR1	101.55	4.0	266.0	DB07123	experimental	N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE	Cc1ccc(cc1)C(=O)N2CCC(CC2)Cc3ccccc3
10195	tr|I6Y1W3|I6Y1W3_M	P9WGR1	101.55	4.0	266.0	DB07155	experimental	(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE	c1ccccc1NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
10196	tr|I6Y1W3|I6Y1W3_M	P9WGR1	101.55	4.0	266.0	DB07178	experimental	5-PENTYL-2-PHENOXYPHENOL	CCCCCc1cc(O)c(cc1)Oc2ccccc2
10197	tr|I6Y1W3|I6Y1W3_M	P9WGR1	101.55	4.0	266.0	DB07188	experimental	(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(cc(Cl)c1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
10198	tr|I6Y1W3|I6Y1W3_M	P9WGR1	101.55	4.0	266.0	DB07192	experimental	(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Brc1cc(ccc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
10199	tr|I6Y1W3|I6Y1W3_M	P9WGR1	101.55	4.0	266.0	DB07222	experimental	(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(c(C)cc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
10200	tr|I6Y1W3|I6Y1W3_M	P9WGR1	101.55	4.0	266.0	DB07287	experimental	2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL	c1cccnc1Cc2cc(O)c(cc2)Oc3ccc(Cl)cc3Cl
10201	tr|I6Y1W3|I6Y1W3_M	P9WGR1	101.55	4.0	266.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
10202	tr|I6Y1W3|I6Y1W3_M	Q92781	72.87	26.0	214.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10203	tr|I6Y1W3|I6Y1W3_M	Q92781	72.87	26.0	214.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
10204	tr|I6Y1W3|I6Y1W3_M	P37058	79.46	45.0	250.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10205	tr|I6Y1W3|I6Y1W3_M	P37059	81.4	79.0	289.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10206	tr|I6Y1W3|I6Y1W3_M	P37059	81.4	79.0	289.0	DB13952	approved; investigational; vet_approved	Estradiol acetate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)C
10207	tr|I6Y1W3|I6Y1W3_M	P37059	81.4	79.0	289.0	DB13953	approved; investigational; vet_approved	Estradiol benzoate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)c5ccccc5
10208	tr|I6Y1W3|I6Y1W3_M	P37059	81.4	79.0	289.0	DB13954	approved; investigational; vet_approved	Estradiol cypionate	C1CCCC1CCC(=O)O[C@H]2CC[C@H]([C@@]23C)[C@H]4[C@H](CC3)c5c(CC4)cc(O)cc5
10209	tr|I6Y1W3|I6Y1W3_M	P37059	81.4	79.0	289.0	DB13955	approved; investigational; vet_approved	Estradiol dienanthate	CCCCCCC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)CCCCCC
10210	tr|I6Y1W3|I6Y1W3_M	P37059	81.4	79.0	289.0	DB13956	approved; investigational; vet_approved	Estradiol valerate	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)CC[C@@H]4OC(=O)CCCC
10211	tr|I6Y1W3|I6Y1W3_M	P28845	76.74	30.0	228.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10212	tr|I6Y1W3|I6Y1W3_M	P28845	76.74	30.0	228.0	DB02329	experimental	Carbenoxolone	OC(=O)CCC(=O)O[C@@H](CC1)C(C)(C)[C@@H]([C@]12C)CC[C@]3(C)[C@@H]2C(=O)C=C4[C@H]5[C@@](C)(CC[C@@]34C)CC[C@](C5)(C)C(=O)O
10213	tr|I6Y1W3|I6Y1W3_M	P28845	76.74	30.0	228.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10214	tr|I6Y1W3|I6Y1W3_M	P28845	76.74	30.0	228.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
10215	tr|I6Y1W3|I6Y1W3_M	P28845	76.74	30.0	228.0	DB04652	experimental	Corticosterone	OCC(=O)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H]([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
10216	tr|I6Y1W3|I6Y1W3_M	P28845	76.74	30.0	228.0	DB05064	investigational	INCB13739	 
10217	tr|I6Y1W3|I6Y1W3_M	P28845	76.74	30.0	228.0	DB06992	experimental	(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone	Cc1ccc(cc1F)-c2nc(ccc2)C(=O)N(CC3(C)C)CCC3
10218	tr|I6Y1W3|I6Y1W3_M	P28845	76.74	30.0	228.0	DB07017	experimental	(5S)-2-{[(1S)-1-(4-Fluorophenyl)ethyl]amino}-5-(2-hydroxy-2-propanyl)-5-methyl-1,3-thiazol-4(5H)-one	Fc1ccc(cc1)[C@H](C)NC(=NC2=O)S[C@@]2(C)C(C)(C)O
10219	tr|I6Y1W3|I6Y1W3_M	P28845	76.74	30.0	228.0	DB07049	experimental	(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine	[O-][N+](=O)c1ccc(cc1)N2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)C(C)(C)C
10220	tr|I6Y1W3|I6Y1W3_M	P28845	76.74	30.0	228.0	DB07056	experimental	2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide	CCN(CC)C(=O)Cc1cccc(n1)NS(=O)(=O)c2c(C)c(Cl)ccc2
10221	tr|I6Y1W3|I6Y1W3_M	P28845	76.74	30.0	228.0	DB07310	experimental	(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one	Fc1ccccc1[C@H](C)NC(=NC2=O)S[C@]2(C)C(F)(F)F
10222	tr|I6Y1W3|I6Y1W3_M	P28845	76.74	30.0	228.0	DB07316	experimental	N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)C3CCN(CC3)CC4(CC4)C(=O)N
10223	tr|I6Y1W3|I6Y1W3_M	P28845	76.74	30.0	228.0	DB07619	experimental	N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)[C@H]3CC[C@@H](CC3)c4cccnc4
10224	tr|I6Y1W3|I6Y1W3_M	P28845	76.74	30.0	228.0	DB07624	experimental	1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide	C1CC1(C(=O)N)CN2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)[C@](C)(O)C(F)(F)F
10225	tr|I6Y1W3|I6Y1W3_M	P28845	76.74	30.0	228.0	DB07866	experimental	(5S)-2-(Cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one	CCC[C@]1(C)SC(=NC1=O)NC2CCCCCCC2
10226	tr|I6Y1W3|I6Y1W3_M	P28845	76.74	30.0	228.0	DB08277	experimental	2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE	CS(=O)(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4c(Cl)cc(F)cc4
10227	tr|I6Y1W3|I6Y1W3_M	P28845	76.74	30.0	228.0	DB08280	experimental	(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE	NC(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4ccc(OC)cc4
10228	tr|I6Y1W3|I6Y1W3_M	P28845	76.74	30.0	228.0	DB08771	experimental	(5R)-2-[(2-Fluorophenyl)amino]-5-isopropyl-1,3-thiazol-4(5H)-one	CC(C)[C@H]1SC(=NC1=O)Nc2c(F)cccc2
10229	tr|I6Y1W3|I6Y1W3_M	P28845	76.74	30.0	228.0	DB13751	approved; experimental	Glycyrrhizic acid	C1C[C@](C)(C(=O)O)C[C@H]([C@]12C)C=3[C@@](C)(CC2)[C@@]4(C)[C@H](C(=O)C3)[C@]5(C)[C@@H](CC4)C(C)(C)[C@H](CC5)O[C@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O[C@@H]7O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]7O
10230	tr|I6Y1W3|I6Y1W3_M	P80365	77.13	79.0	278.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10231	tr|I6Y1W3|I6Y1W3_M	P80365	77.13	79.0	278.0	DB01185	approved; illicit	Fluoxymesterone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@](F)([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
10232	tr|I6Y1W3|I6Y1W3_M	P80365	77.13	79.0	278.0	DB01569	experimental; illicit	Formebolone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@H]([C@@H](C2)O)[C@]4(C)C(CC3)=CC(=O)C(C=O)=C4
10233	tr|I6Y1W3|I6Y1W3_M	P80365	77.13	79.0	278.0	DB14538	experimental; vet_approved	Hydrocortisone aceponate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CC)C(=O)COC(=O)C
10234	tr|I6Y1W3|I6Y1W3_M	P80365	77.13	79.0	278.0	DB14539	approved; vet_approved	Hydrocortisone acetate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)C
10235	tr|I6Y1W3|I6Y1W3_M	P80365	77.13	79.0	278.0	DB14540	approved; vet_approved	Hydrocortisone butyrate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCC
10236	tr|I6Y1W3|I6Y1W3_M	P80365	77.13	79.0	278.0	DB14541	approved; investigational; vet_approved	Hydrocortisone cypionate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)CCC5CCCC5
10237	tr|I6Y1W3|I6Y1W3_M	P80365	77.13	79.0	278.0	DB14542	approved; vet_approved	Hydrocortisone phosphate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COP(=O)(O)O
10238	tr|I6Y1W3|I6Y1W3_M	P80365	77.13	79.0	278.0	DB14543	approved; vet_approved	Hydrocortisone probutate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CCC)C(=O)COC(=O)CC
10239	tr|I6Y1W3|I6Y1W3_M	P80365	77.13	79.0	278.0	DB14544	approved; vet_approved	Hydrocortisone valerate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCCC
10240	tr|I6Y1W3|I6Y1W3_M	P16152	94.57	6.0	250.0	DB01698	approved; experimental; investigational	Rutin	O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O[C@H]1C)OC[C@H]2O[C@H]([C@H](O)[C@@H](O)[C@@H]2O)Oc(c3=O)c(-c4cc(O)c(O)cc4)oc(c35)cc(O)cc5O
10241	tr|I6Y1W3|I6Y1W3_M	P16152	94.57	6.0	250.0	DB02709	investigational	Resveratrol	Oc1ccc(cc1)/C=C/c2cc(O)cc(O)c2
10242	tr|I6Y1W3|I6Y1W3_M	P16152	94.57	6.0	250.0	DB03394	experimental	Heptaethylene glycol	OCCOCCOCCOCCOCCOCCOCCO
10243	tr|I6Y1W3|I6Y1W3_M	P16152	94.57	6.0	250.0	DB03556	experimental	2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400	CCOCCOCCOCCOCCOCCOCCOCCOCCO
10244	tr|I6Y1W3|I6Y1W3_M	P16152	94.57	6.0	250.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
10245	tr|I6Y1W3|I6Y1W3_M	P16152	94.57	6.0	250.0	DB04463	experimental	3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol	n1cnc(N)c(c12)c(nn2C(C)(C)C)-c3cccc(O)c3
10246	tr|I6Y1W3|I6Y1W3_M	P16152	94.57	6.0	250.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
10247	tr|I6Y1W3|I6Y1W3_M	P16152	94.57	6.0	250.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
10248	tr|I6Y1W3|I6Y1W3_M	P56937	90.31	2.0	235.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10249	tr|I6Y1W3|I6Y1W3_M	P35270	80.23	5.0	212.0	DB02637	experimental	Oxaloacetate Ion	OC(=O)C(=O)CC([O-])=O
10250	tr|I6Y1W3|I6Y1W3_M	P35270	80.23	5.0	212.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10251	tr|I6Y1W3|I6Y1W3_M	P35270	80.23	5.0	212.0	DB03886	experimental	Biopterin	C[C@@H](O)[C@@H](O)c(n1)cnc(c12)nc(N)[nH]c2=O
10252	tr|I6Y1W3|I6Y1W3_M	P35270	80.23	5.0	212.0	DB04275	experimental	N-acetylserotonin	CC(=O)NCCc1c[nH]c(c12)ccc(c2)O
10253	tr|I6Y1W3|I6Y1W3_M	P09417	71.71	10.0	195.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10254	tr|I6Y1W3|I6Y1W3_M	P09417	71.71	10.0	195.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
10255	tr|I6Y1W3|I6Y1W3_M	Q8T8E9	75.19	2.0	196.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
10256	tr|I6Y1W3|I6Y1W3_M	P26391	74.03	3.0	194.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
10257	tr|P96808|P96808_M	P16219	87.47	20.0	411.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10258	tr|P96808|P96808_M	P16219	87.47	20.0	411.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
10259	tr|P96808|P96808_M	P16219	87.47	20.0	411.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
10260	tr|P96808|P96808_M	Q72JJ3	84.34	4.0	381.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
10261	tr|P96808|P96808_M	Q06319	85.01	2.0	382.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
10262	tr|P96808|P96808_M	Q06319	85.01	2.0	382.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
10263	tr|P96808|P96808_M	P11310	85.68	37.0	420.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
10264	tr|P96808|P96808_M	P11310	85.68	37.0	420.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
10265	tr|P96808|P96808_M	P11310	85.68	37.0	420.0	DB03415	experimental	3-thiaoctanoyl-CoA	CCCCCSCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
10266	tr|P96808|P96808_M	P45954	84.12	56.0	432.0	DB00167	investigational; nutraceutical	Isoleucine	CC[C@H](C)[C@H](N)C(=O)O
10267	tr|P96808|P96808_M	P45954	84.12	56.0	432.0	DB00313	approved; investigational	Valproic acid	CCCC(C(=O)O)CCC
10268	tr|P96808|P96808_M	P26440	85.23	41.0	422.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
10269	tr|P96808|P96808_M	P26440	85.23	41.0	422.0	DB04036	experimental	Coenzyme A persulfide	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSS
10270	tr|P96808|P96808_M	Q9UKU7	84.12	39.0	415.0	DB01675	experimental	Methacrylyl-Coenzyme A	CC(=C)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
10271	tr|P96808|P96808_M	Q9UKU7	84.12	39.0	415.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
10272	tr|P96808|P96808_M	Q3JP94	84.12	12.0	388.0	DB08685	experimental	1-(1,4-dimethyl-1,2,3,4-tetrahydroquinoxalin-6-yl)methanamine	CN1CCN(C)c(c12)cc(cc2)CN
10273	tr|P96808|P96808_M	Q92947	84.12	53.0	429.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
10274	tr|P96808|P96808_M	Q92947	84.12	53.0	429.0	DB03245	experimental	S-4-Nitrobutyryl-CoA	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCC[N+]([O-])=O
10275	tr|P96808|P96808_M	Q9KIE5	77.4	16.0	362.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
10276	tr|P96808|P96808_M	Q15067	76.51	101.0	443.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
10277	tr|P96808|P96808_M	Q15067	76.51	101.0	443.0	DB07930	experimental	(3R)-3-HYDROXYDODECANOIC ACID	OC(=O)C[C@H](O)CCCCCCCCC
10279	tr|I6YGH7|I6YGH7_M	Q72JJ3	99.73	4.0	380.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
10280	tr|I6YGH7|I6YGH7_M	Q06319	101.33	1.0	383.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
10281	tr|I6YGH7|I6YGH7_M	Q06319	101.33	1.0	383.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
10282	tr|I6YGH7|I6YGH7_M	P16219	99.73	33.0	409.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10283	tr|I6YGH7|I6YGH7_M	P16219	99.73	33.0	409.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
10284	tr|I6YGH7|I6YGH7_M	P16219	99.73	33.0	409.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
10285	tr|I6YGH7|I6YGH7_M	P11310	99.73	39.0	415.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
10286	tr|I6YGH7|I6YGH7_M	P11310	99.73	39.0	415.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
10287	tr|I6YGH7|I6YGH7_M	P11310	99.73	39.0	415.0	DB03415	experimental	3-thiaoctanoyl-CoA	CCCCCSCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
10288	tr|I6YGH7|I6YGH7_M	P26440	99.47	42.0	417.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
10289	tr|I6YGH7|I6YGH7_M	P26440	99.47	42.0	417.0	DB04036	experimental	Coenzyme A persulfide	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSS
10290	tr|I6YGH7|I6YGH7_M	P45954	98.67	56.0	428.0	DB00167	investigational; nutraceutical	Isoleucine	CC[C@H](C)[C@H](N)C(=O)O
10291	tr|I6YGH7|I6YGH7_M	P45954	98.67	56.0	428.0	DB00313	approved; investigational	Valproic acid	CCCC(C(=O)O)CCC
10292	tr|I6YGH7|I6YGH7_M	Q9UKU7	99.2	40.0	414.0	DB01675	experimental	Methacrylyl-Coenzyme A	CC(=C)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
10293	tr|I6YGH7|I6YGH7_M	Q9UKU7	99.2	40.0	414.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
10294	tr|I6YGH7|I6YGH7_M	Q3JP94	98.94	15.0	388.0	DB08685	experimental	1-(1,4-dimethyl-1,2,3,4-tetrahydroquinoxalin-6-yl)methanamine	CN1CCN(C)c(c12)cc(cc2)CN
10295	tr|I6YGH7|I6YGH7_M	Q92947	98.41	59.0	430.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
10296	tr|I6YGH7|I6YGH7_M	Q92947	98.41	59.0	430.0	DB03245	experimental	S-4-Nitrobutyryl-CoA	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCC[N+]([O-])=O
10297	tr|I6YGH7|I6YGH7_M	Q9KIE5	92.84	15.0	365.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
10298	tr|I6YGH7|I6YGH7_M	Q15067	88.59	103.0	437.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
10299	tr|I6YGH7|I6YGH7_M	Q15067	88.59	103.0	437.0	DB07930	experimental	(3R)-3-HYDROXYDODECANOIC ACID	OC(=O)C[C@H](O)CCCCCCCCC
10300	tr|O53534|O53534_M	O08498	89.1	37.0	225.0	DB02032	experimental	Epicaptopril	SC[C@H](C)C(=O)N1CCC[C@H]1C(=O)O
10301	tr|O53534|O53534_M	P04190	90.52	54.0	245.0	DB02133	experimental	Chlorophyll A	CCc(c(c12)C)c(n1)cc3c(C)c4c([n-]3)c([C@H](C4=O)C(=O)OC)c5nc(cc6[n-]c(c2)c(C=C)c6C)[C@@H](C)[C@@H]5CCC(=O)OC/C=C(\C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C
10302	tr|O53534|O53534_M	P04190	90.52	54.0	245.0	DB02153	experimental	3-sulfino-L-alanine	OC(=O)[C@@H](N)C[S@](=O)O
10303	tr|O53534|O53534_M	P04190	90.52	54.0	245.0	DB04272	approved; nutraceutical; vet_approved	Citric acid	OC(=O)CC(O)(C(=O)O)CC(=O)O
10304	tr|O53534|O53534_M	P25910	96.68	35.0	239.0	DB02593	experimental	7,8-Dihydroxy-1-Methoxy-3-Methyl-10-Oxo-4,10-Dihydro-1h,3h-Pyrano[4,3-B]Chromene-9-Carboxylic Acid	CO[C@@H]1O[C@@H](C)Cc(c12)oc3c(c2=O)c(C(=O)O)c(O)c(c3)O
10305	tr|O53534|O53534_M	P26918	95.73	46.0	248.0	DB02032	experimental	Epicaptopril	SC[C@H](C)C(=O)N1CCC[C@H]1C(=O)O
10306	tr|O53534|O53534_M	Q16775	86.26	43.0	225.0	DB00143	approved; investigational; nutraceutical	Glutathione	OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(=O)O
10307	tr|O53534|O53534_M	Q16775	86.26	43.0	225.0	DB03889	experimental	S-(N-hydroxy-N-bromophenylcarbamoyl)glutathione	OC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)NCC(=O)O)CS[C@H](O)N(O)c1ccc(Br)cc1
10308	tr|O53534|O53534_M	P52699	87.2	32.0	216.0	DB02154	experimental	2,3-Bis-Benzo[1,3]Dioxol-5-Ylmethyl-Succinic Acid	O1COc(c12)ccc(c2)C[C@H](C(=O)O)[C@@H](C(=O)O)Cc(c3)ccc(c34)OCO4
10309	tr|O53534|O53534_M	P52699	87.2	32.0	216.0	DB02450	experimental	2-Benzo[1,3]Dioxol-5-Ylmethyl-3-Benzyl-Succinic Acid	c1ccccc1C[C@H](C(=O)O)[C@@H](C(=O)O)Cc(cc2)cc(c23)OCO3
10310	tr|O53534|O53534_M	P52699	87.2	32.0	216.0	DB02706	experimental	Mercaptocarboxylate Inhibitor	c1ccccc1CC[C@H](CS)C(=O)/N=C(\C(=O)O)c2ccc(s2)Cn3cnnn3
10311	tr|O53534|O53534_M	P52699	87.2	32.0	216.0	DB04749	experimental	2-(3-OXO-PROPYLSULFANYLCARBONYL)-ETHANETHIOLATE	[S-]CCC(=O)SCCC=O
10312	tr|O53534|O53534_M	P52699	87.2	32.0	216.0	DB07526	experimental	N-[4-({[5-(DIMETHYLAMINO)-1-NAPHTHYL]SULFONYL}AMINO)BUTYL]-3-SULFANYLPROPANAMIDE	c1ccc(N(C)C)c(c12)cccc2S(=O)(=O)NCCCCNC(=O)CCS
10313	tr|O53534|O53534_M	Q79MP6	87.2	32.0	216.0	DB02154	experimental	2,3-Bis-Benzo[1,3]Dioxol-5-Ylmethyl-Succinic Acid	O1COc(c12)ccc(c2)C[C@H](C(=O)O)[C@@H](C(=O)O)Cc(c3)ccc(c34)OCO4
10314	tr|O53534|O53534_M	Q79MP6	87.2	32.0	216.0	DB02450	experimental	2-Benzo[1,3]Dioxol-5-Ylmethyl-3-Benzyl-Succinic Acid	c1ccccc1C[C@H](C(=O)O)[C@@H](C(=O)O)Cc(cc2)cc(c23)OCO3
10315	tr|O53534|O53534_M	Q7BJM5	90.05	52.0	242.0	DB08161	experimental	(S)-2-(MERCAPTOMETHYL)-5-PHENYLPENTANOIC ACID	SC[C@H](C(=O)O)CCCc1ccccc1
10316	tr|O53534|O53534_M	Q9K2N0	90.05	52.0	242.0	DB03661	experimental	L-cysteic acid	OC(=O)[C@@H](N)CS(=O)(=O)O
10317	tr|O53534|O53534_M	P52700	88.15	60.0	246.0	DB02032	experimental	Epicaptopril	SC[C@H](C)C(=O)N1CCC[C@H]1C(=O)O
10318	tr|O53534|O53534_M	P52700	88.15	60.0	246.0	DB02365	experimental	1,10-Phenanthroline	n1cccc(c12)ccc3c2nccc3
10319	tr|O53534|O53534_M	P52700	88.15	60.0	246.0	DB04740	experimental	Moxalactam (hydrolyzed)	OC(=O)C1=N[C@H](OCC1=C)C(OC)(C(=O)O)NC(=O)[C@@H](C(=O)O)c2ccc(O)cc2
10320	tr|O53534|O53534_M	P52700	88.15	60.0	246.0	DB07939	experimental	N-(3-MERCAPTOPROPANOYL)-D-ALANINE	OC(=O)[C@@H](C)NC(=O)CCS
10321	tr|O53534|O53534_M	P52700	88.15	60.0	246.0	DB08069	experimental	4-AMINO-5-(2-METHYLPHENYL)-2,4-DIHYDRO-3H-1,2,4-TRIAZOLE-3-THIONE	Cc1ccccc1-c2n[nH]c(=S)n2N
10322	tr|O53534|O53534_M	P52700	88.15	60.0	246.0	DB08199	experimental	N-[(BENZYLOXY)CARBONYL]-L-CYSTEINYLGLYCINE	OC(=O)CNC(=O)[C@H](CS)NC(=O)OCc1ccccc1
10323	tr|O53534|O53534_M	P52700	88.15	60.0	246.0	DB08702	experimental	2,5-DIPHENYLFURAN-3,4-DICARBOXYLIC ACID	c1ccccc1-c2c(C(=O)O)c(C(=O)O)c(o2)-c3ccccc3
10324	tr|O53534|O53534_M	C7C422	91.47	58.0	251.0	DB04272	approved; nutraceutical; vet_approved	Citric acid	OC(=O)CC(O)(C(=O)O)CC(=O)O
10325	tr|O53534|O53534_M	P20581	89.1	34.0	222.0	DB07418	experimental	bis(4-nitrophenyl) hydrogen phosphate	[O-][N+](=O)c1ccc(cc1)OP(=O)(O)Oc2ccc([N+]([O-])=O)cc2
10326	tr|O53534|O53534_M	Q9K578	77.73	70.0	234.0	DB02032	experimental	Epicaptopril	SC[C@H](C)C(=O)N1CCC[C@H]1C(=O)O
10327	tr|I6Y551|I6Y551_M	P74334	92.83	22.0	488.0	DB02253	experimental	(1r)-4-[(1e,3e,5e,7z,9e,11z,13e,15e)-17-Hydroxy-3,7,12,16-Tetramethylheptadeca-1,3,5,7,9,11,13,15-Octaen-1-Yl]-3,5,5-Trimethylcyclohex-3-En-1-Ol	OC/C(C)=C/C=C/C(C)=C\C=C\C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)C[C@@H](O)C1
10328	tr|I6Y551|I6Y551_M	P74334	92.83	22.0	488.0	DB04233	experimental	(Hydroxyethyloxy)Tri(Ethyloxy)Octane	CCCCCCCCOCCOCCOCCOCCO
10329	tr|L7N6A5|L7N6A5_M	P0ACC7	94.99	1.0	342.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
10330	tr|L7N6A5|L7N6A5_M	P0ACC7	94.99	1.0	342.0	DB03397	experimental	Uridine-Diphosphate-N-Acetylglucosamine	CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
10331	tr|L7N6A5|L7N6A5_M	P0ACC7	94.99	1.0	342.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
10332	tr|L7N6A5|L7N6A5_M	P43889	94.15	1.0	339.0	DB08344	experimental	4-chloro-N-(3-methoxypropyl)-N-[(3S)-1-(2-phenylethyl)piperidin-3-yl]benzamide	Clc1ccc(cc1)C(=O)N(CCCOC)[C@H]2CCCN(C2)CCc3ccccc3
10333	tr|L7N6A5|L7N6A5_M	Q97R46	92.48	5.0	337.0	DB03397	experimental	Uridine-Diphosphate-N-Acetylglucosamine	CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
10334	tr|L7N6A5|L7N6A5_M	P26393	71.31	5.0	261.0	DB01861	experimental	Uridine diphosphate glucose	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
10335	tr|L7N6A5|L7N6A5_M	P26393	71.31	5.0	261.0	DB02452	experimental	Thymidine 5'-triphosphate	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
10336	tr|L7N6B3|L7N6B3_M	P07327	94.26	14.0	375.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10337	tr|L7N6B3|L7N6B3_M	P07327	94.26	14.0	375.0	DB01213	approved; vet_approved	Fomepizole	Cc1c[nH]nc1
10338	tr|L7N6B3|L7N6B3_M	P07327	94.26	14.0	375.0	DB02721	experimental	4-Iodopyrazole	Ic1c[nH]nc1
10339	tr|L7N6B3|L7N6B3_M	P07327	94.26	14.0	375.0	DB04065	experimental	N-Cyclopentyl-N-Cyclobutylformamide	C1CCC1N(C=O)C2CCCC2
10340	tr|L7N6B3|L7N6B3_M	P00326	94.26	14.0	375.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10341	tr|L7N6B3|L7N6B3_M	P00326	94.26	14.0	375.0	DB01213	approved; vet_approved	Fomepizole	Cc1c[nH]nc1
10342	tr|L7N6B3|L7N6B3_M	P00326	94.26	14.0	375.0	DB01711	experimental	2,3,4,5,6-Pentafluorobenzyl Alcohol	OCc1c(F)c(F)c(F)c(F)c1F
10343	tr|L7N6B3|L7N6B3_M	P00326	94.26	14.0	375.0	DB02131	experimental	N-1-methylheptylformamide	O=CN[C@H](C)CCCCCC
10344	tr|L7N6B3|L7N6B3_M	P00326	94.26	14.0	375.0	DB02249	experimental	2-Ethoxyethanol	CCOCCO
10345	tr|L7N6B3|L7N6B3_M	P00326	94.26	14.0	375.0	DB02659	approved	Cholic Acid	OC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](C[C@@H]2O)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
10346	tr|L7N6B3|L7N6B3_M	P00326	94.26	14.0	375.0	DB02721	experimental	4-Iodopyrazole	Ic1c[nH]nc1
10347	tr|L7N6B3|L7N6B3_M	P00326	94.26	14.0	375.0	DB02757	experimental	Pyrazole	[nH]1cccn1
10348	tr|L7N6B3|L7N6B3_M	P00326	94.26	14.0	375.0	DB02822	experimental	Para-Bromobenzyl Alcohol	OCc1ccc(Br)cc1
10349	tr|L7N6B3|L7N6B3_M	P00326	94.26	14.0	375.0	DB02871	experimental	3-Butylthiolane 1-Oxide	O=[S@@]1C[C@H](CC1)CCCC
10350	tr|L7N6B3|L7N6B3_M	P00326	94.26	14.0	375.0	DB03020	experimental	5-beta-D-ribofuranosylnicotinamide adenine dinucleotide	NC(=O)c1c[nH+]cc(c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10351	tr|L7N6B3|L7N6B3_M	P00326	94.26	14.0	375.0	DB03061	experimental	(R)-N-(1-Methyl-Hexyl)-Formamide	CCCCC[C@H](C)NC=O
10352	tr|L7N6B3|L7N6B3_M	P00326	94.26	14.0	375.0	DB03226	experimental	Trifluoroethanol	OCC(F)(F)F
10353	tr|L7N6B3|L7N6B3_M	P00326	94.26	14.0	375.0	DB03559	experimental	Cyclohexylformamide	O=CNC1CCCCC1
10354	tr|L7N6B3|L7N6B3_M	P00326	94.26	14.0	375.0	DB04071	experimental	Cpad	NC(=O)c1nc(ccc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10355	tr|L7N6B3|L7N6B3_M	P00326	94.26	14.0	375.0	DB04113	experimental	N-Formylpiperidine	O=CN1CCCCC1
10356	tr|L7N6B3|L7N6B3_M	P00326	94.26	14.0	375.0	DB04312	experimental	2,3-Difluorobenzyl Alcohol	OCc1cccc(F)c1F
10357	tr|L7N6B3|L7N6B3_M	P00326	94.26	14.0	375.0	DB04448	experimental	2,4-Difluorobenzyl Alcohol 2,4-Difluoro-1-(Hydroxymethyl)Benzene	OCc1ccc(F)cc1F
10358	tr|L7N6B3|L7N6B3_M	P00325	94.26	14.0	375.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10359	tr|L7N6B3|L7N6B3_M	P00325	94.26	14.0	375.0	DB01213	approved; vet_approved	Fomepizole	Cc1c[nH]nc1
10360	tr|L7N6B3|L7N6B3_M	P00325	94.26	14.0	375.0	DB02481	experimental	N-Benzylformamide	O=CNCc1ccccc1
10361	tr|L7N6B3|L7N6B3_M	P00325	94.26	14.0	375.0	DB02721	experimental	4-Iodopyrazole	Ic1c[nH]nc1
10362	tr|L7N6B3|L7N6B3_M	P00325	94.26	14.0	375.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10363	tr|L7N6B3|L7N6B3_M	P00325	94.26	14.0	375.0	DB03703	experimental	Cyclohexanol	OC1CCCCC1
10364	tr|L7N6B3|L7N6B3_M	P00325	94.26	14.0	375.0	DB04105	experimental	N-Heptylformamide	CCCCCCCNC=O
10365	tr|L7N6B3|L7N6B3_M	P00325	94.26	14.0	375.0	DB09462	approved; investigational	Glycerin	OCC(O)CO
10366	tr|L7N6B3|L7N6B3_M	P40394	94.26	25.0	386.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10367	tr|L7N6B3|L7N6B3_M	P11766	94.26	12.0	373.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10368	tr|L7N6B3|L7N6B3_M	P11766	94.26	12.0	373.0	DB03017	approved; experimental	Lauric acid	CCCCCCCCCCCC(=O)O
10369	tr|L7N6B3|L7N6B3_M	P11766	94.26	12.0	373.0	DB03704	experimental	12-Hydroxydodecanoic Acid	OCCCCCCCCCCCC(=O)O
10370	tr|L7N6B3|L7N6B3_M	P11766	94.26	12.0	373.0	DB04153	experimental	S-Hydroxymethyl Glutathione	OC(=O)[C@@H](N)CCC(=O)N[C@@H](CSCO)C(=O)NCC(=O)O
10371	tr|L7N6B3|L7N6B3_M	P08319	95.56	14.0	380.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10372	tr|L7N6B3|L7N6B3_M	P08319	95.56	14.0	380.0	DB03559	experimental	Cyclohexylformamide	O=CNC1CCCCC1
10373	tr|L7N6B3|L7N6B3_M	P42328	84.6	10.0	334.0	DB03226	experimental	Trifluoroethanol	OCC(F)(F)F
10374	tr|L7N6B3|L7N6B3_M	P14941	84.33	16.0	339.0	DB02606	experimental; investigational	2-Butanol	CC[C@@H](C)O
10375	tr|L7N6B3|L7N6B3_M	P14941	84.33	16.0	339.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10376	tr|I6XFA9|I6XFA9_M	Q06319	79.51	56.0	382.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
10377	tr|I6XFA9|I6XFA9_M	Q06319	79.51	56.0	382.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
10378	tr|I6XFA9|I6XFA9_M	P16219	90.98	35.0	408.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10379	tr|I6XFA9|I6XFA9_M	P16219	90.98	35.0	408.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
10380	tr|I6XFA9|I6XFA9_M	P16219	90.98	35.0	408.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
10381	tr|I6XFA9|I6XFA9_M	Q72JJ3	78.05	61.0	381.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
10382	tr|I6XFA9|I6XFA9_M	P45954	90.98	57.0	430.0	DB00167	investigational; nutraceutical	Isoleucine	CC[C@H](C)[C@H](N)C(=O)O
10383	tr|I6XFA9|I6XFA9_M	P45954	90.98	57.0	430.0	DB00313	approved; investigational	Valproic acid	CCCC(C(=O)O)CCC
10384	tr|I6XFA9|I6XFA9_M	P11310	78.05	95.0	415.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
10385	tr|I6XFA9|I6XFA9_M	P11310	78.05	95.0	415.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
10386	tr|I6XFA9|I6XFA9_M	P11310	78.05	95.0	415.0	DB03415	experimental	3-thiaoctanoyl-CoA	CCCCCSCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
10387	tr|I6XFA9|I6XFA9_M	P26440	77.8	99.0	418.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
10388	tr|I6XFA9|I6XFA9_M	P26440	77.8	99.0	418.0	DB04036	experimental	Coenzyme A persulfide	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSS
10389	tr|I6XFA9|I6XFA9_M	Q9UKU7	77.8	96.0	415.0	DB01675	experimental	Methacrylyl-Coenzyme A	CC(=C)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
10390	tr|I6XFA9|I6XFA9_M	Q9UKU7	77.8	96.0	415.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
10391	tr|I6XFA9|I6XFA9_M	Q92947	78.29	112.0	433.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
10392	tr|I6XFA9|I6XFA9_M	Q92947	78.29	112.0	433.0	DB03245	experimental	S-4-Nitrobutyryl-CoA	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCC[N+]([O-])=O
10393	tr|I6XFA9|I6XFA9_M	Q3JP94	77.8	72.0	391.0	DB08685	experimental	1-(1,4-dimethyl-1,2,3,4-tetrahydroquinoxalin-6-yl)methanamine	CN1CCN(C)c(c12)cc(cc2)CN
10394	tr|I6XFA9|I6XFA9_M	Q9KIE5	73.41	65.0	366.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
10395	tr|I6XFA9|I6XFA9_M	Q15067	83.41	94.0	436.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
10396	tr|I6XFA9|I6XFA9_M	Q15067	83.41	94.0	436.0	DB07930	experimental	(3R)-3-HYDROXYDODECANOIC ACID	OC(=O)C[C@H](O)CCCCCCCCC
10397	tr|O53491|O53491_M	P9WPX7	79.73	36.0	95.0	DB02801	experimental	2,3-Anhydro-quinic acid	O=C(O)[C@]1(O)C=C[C@@H](O)[C@H](O)C1
10398	tr|O53491|O53491_M	P9WPX7	79.73	36.0	95.0	DB03739	experimental	3-Hydroxyimino Quinic Acid	OC(=O)[C@@]1(O)C[C@@H](O)[C@H](O)/C(C1)=N/O
10399	tr|I6YCE1|I6YCE1_M	Q9BTZ2	95.37	27.0	274.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
10400	tr|I6YCE1|I6YCE1_M	Q9WYS2	96.14	5.0	254.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10401	tr|I6YCE1|I6YCE1_M	P0AEK2	92.28	2.0	241.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10404	tr|I6YCE1|I6YCE1_M	P0AET8	94.98	4.0	250.0	DB02123	experimental	Glycochenodeoxycholic Acid	OC(=O)CNC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
10405	tr|I6YCE1|I6YCE1_M	Q92506	98.46	3.0	258.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10406	tr|I6YCE1|I6YCE1_M	Q92506	98.46	3.0	258.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10407	tr|I6YCE1|I6YCE1_M	P16544	97.3	6.0	258.0	DB01942	experimental; investigational	Formic acid	OC=O
10408	tr|I6YCE1|I6YCE1_M	P16544	97.3	6.0	258.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10409	tr|I6YCE1|I6YCE1_M	P16544	97.3	6.0	258.0	DB07715	investigational	Emodin	Cc(c1)cc(O)c(c12)C(=O)c3c(C2=O)cc(O)cc3O
10411	tr|I6YCE1|I6YCE1_M	Q84EX5	95.75	3.0	251.0	DB04619	experimental	Acetophenone	CC(=O)c1ccccc1
10412	tr|I6YCE1|I6YCE1_M	Q84EX5	95.75	3.0	251.0	DB04784	experimental	(R)-1-phenylethanol	C[C@@H](O)c1ccccc1
10413	tr|I6YCE1|I6YCE1_M	P0CG22	98.07	23.0	277.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
10414	tr|I6YCE1|I6YCE1_M	P0CG22	98.07	23.0	277.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10415	tr|I6YCE1|I6YCE1_M	P0CG22	98.07	23.0	277.0	DB03541	experimental	10-Propargyl-5,8-Dideazafolic Acid	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(CC#C)Cc(c2)ccc(c23)[nH]c(N)nc3=O
10416	tr|I6YCE1|I6YCE1_M	P0CG22	98.07	23.0	277.0	DB07689	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)NCc(cn3)nc(c34)c(N)nc(n4)N
10417	tr|I6YCE1|I6YCE1_M	P0CG22	98.07	23.0	277.0	DB07765	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)N(C)Cc(cn3)nc(c34)c(N)nc(n4)N
10418	tr|I6YCE1|I6YCE1_M	Q9BY49	96.14	16.0	265.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
10419	tr|I6YCE1|I6YCE1_M	Q7Z4W1	91.89	2.0	240.0	DB02831	experimental	Dihydrogenphosphate	OP([O-])(=O)O
10420	tr|I6YCE1|I6YCE1_M	Q7Z4W1	91.89	2.0	240.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10421	tr|I6YCE1|I6YCE1_M	Q16698	95.75	56.0	304.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10422	tr|I6YCE1|I6YCE1_M	Q16698	95.75	56.0	304.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
10423	tr|I6YCE1|I6YCE1_M	A0A348A0U3	96.14	4.0	253.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
10424	tr|I6YCE1|I6YCE1_M	Q6GI75	96.91	2.0	253.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
10425	tr|I6YCE1|I6YCE1_M	Q6GI75	96.91	2.0	253.0	DB11155	approved	Triclocarban	Clc1ccc(cc1)NC(=O)Nc2cc(Cl)c(Cl)cc2
10426	tr|I6YCE1|I6YCE1_M	P0AEK4	95.75	4.0	252.0	DB01691	experimental	Indole Naphthyridinone	c1cccc(c12)n(C)cc2CN(C)C(=O)/C=C/c(c3)cnc(c34)NC(=O)CC4
10427	tr|I6YCE1|I6YCE1_M	P0AEK4	95.75	4.0	252.0	DB01865	experimental	3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide	c1cccc(c12)cc(n2C)CN(C)C(=O)/C=C/c3cnc(N)cc3
10428	tr|I6YCE1|I6YCE1_M	P0AEK4	95.75	4.0	252.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
10429	tr|I6YCE1|I6YCE1_M	P0AEK4	95.75	4.0	252.0	DB03030	experimental	4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole	Cc1ccc(cc1)Cn2cnc(c2)-c3cccs3
10430	tr|I6YCE1|I6YCE1_M	P0AEK4	95.75	4.0	252.0	DB03534	experimental	3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide	CC(=O)N(C)Cc1c(N)ccc(c1)C(=O)N(C)Cc(n2C)cc(c23)cccc3
10431	tr|I6YCE1|I6YCE1_M	P0AEK4	95.75	4.0	252.0	DB04030	experimental	1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole	Oc1ccc(cc1)Cn2c(c3c(c24)cccc4)CN(CC3)C(=O)c5ccc(O)cc5
10432	tr|I6YCE1|I6YCE1_M	P0AEK4	95.75	4.0	252.0	DB08265	experimental	2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL	Cc1ccc(cc1)S(=O)(=O)n(b2O)ncc(c23)cccc3
10433	tr|I6YCE1|I6YCE1_M	P0AEK4	95.75	4.0	252.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
10434	tr|I6YCE1|I6YCE1_M	P0AEK4	95.75	4.0	252.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
10435	tr|I6YCE1|I6YCE1_M	Q6UWP2	90.73	11.0	246.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10436	tr|I6YCE1|I6YCE1_M	Q7AUG5	92.66	3.0	243.0	DB04782	experimental	(S)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@H]2CO2
10437	tr|I6YCE1|I6YCE1_M	Q93D82	92.66	3.0	243.0	DB04472	experimental	(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol	[N-]=[N+]=NC[C@H](O)c1ccc([N+]([O-])=O)cc1
10438	tr|I6YCE1|I6YCE1_M	Q93D82	92.66	3.0	243.0	DB04499	experimental	(R)-styrene oxide	C1O[C@@H]1c2ccccc2
10439	tr|I6YCE1|I6YCE1_M	Q93D82	92.66	3.0	243.0	DB04777	experimental	(R)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@@H]2CO2
10440	tr|I6YCE1|I6YCE1_M	Q6PKH6	74.13	23.0	215.0	DB04200	experimental	Matairesinol	COc1cc(ccc1O)C[C@H]2COC(=O)[C@@H]2Cc3ccc(O)c(c3)OC
10441	tr|I6YCE1|I6YCE1_M	Q99714	96.53	7.0	257.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10442	tr|I6YCE1|I6YCE1_M	Q99714	96.53	7.0	257.0	DB02820	experimental	1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct	C1CCCCCN1C(=O)[C@H](c2ccccc2)n(c3=S)cnc(c34)nn(c4)[C@H]5C=CN(C=C5C([O-])=N)[C@@H]6O[C@@H]([C@@H](O)[C@H]6O)COP([O-])(=O)OP(=O)(O)OC[C@H]7O[C@H]([C@H]([O-])[C@@H]7[O-])n8cnc(c89)c(N)ncn9
10443	tr|I6YCE1|I6YCE1_M	Q99714	96.53	7.0	257.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
10444	tr|I6YCE1|I6YCE1_M	O24990	95.75	4.0	252.0	DB04393	experimental	Soneclosan	Clc1cc(O)c(cc1)Oc2ccc(Cl)cc2
10445	tr|I6YCE1|I6YCE1_M	O24990	95.75	4.0	252.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
10446	tr|I6YCE1|I6YCE1_M	Q8I814	98.84	14.0	270.0	DB02015	experimental	Dihydrofolic Acid	O=c1[nH]c(N)nc(c12)NCC(=N2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
10447	tr|I6YCE1|I6YCE1_M	Q8I814	98.84	14.0	270.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10448	tr|I6YCE1|I6YCE1_M	Q9HBH5	100.39	41.0	301.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
10450	tr|I6YCE1|I6YCE1_M	Q01782	106.56	8.0	284.0	DB02338	experimental	NADPH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10451	tr|I6YCE1|I6YCE1_M	Q01782	106.56	8.0	284.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
10452	tr|I6YCE1|I6YCE1_M	Q01782	106.56	8.0	284.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10453	tr|I6YCE1|I6YCE1_M	Q01782	106.56	8.0	284.0	DB04400	experimental	L-erythro-7,8-dihydrobiopterin	C[C@H](O)[C@H](O)C(CN1)=Nc(c12)c(=O)nc([nH]2)N
10454	tr|I6YCE1|I6YCE1_M	Q8TC12	80.31	34.0	242.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
10455	tr|I6YCE1|I6YCE1_M	O75911	87.64	35.0	262.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
10456	tr|I6YCE1|I6YCE1_M	P14061	78.76	2.0	206.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10457	tr|I6YCE1|I6YCE1_M	P14061	78.76	2.0	206.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
10458	tr|I6YCE1|I6YCE1_M	P14061	78.76	2.0	206.0	DB01561	experimental; illicit	Androstanedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
10459	tr|I6YCE1|I6YCE1_M	P14061	78.76	2.0	206.0	DB02187	experimental	Equilin	O=C1CC[C@H]([C@@]12C)C=3[C@H](CC2)c4c(CC3)cc(O)cc4
10460	tr|I6YCE1|I6YCE1_M	P14061	78.76	2.0	206.0	DB02323	experimental	EM-1745	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)C[C@@H]([C@@H]4O)CCCCCCCCC(=O)OC[C@H]5O[C@H]([C@H](O)[C@@H]5O)n6cnc(c67)c(N)ncn7
10461	tr|I6YCE1|I6YCE1_M	P14061	78.76	2.0	206.0	DB02901	illicit; investigational	Stanolone	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
10462	tr|I6YCE1|I6YCE1_M	P14061	78.76	2.0	206.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10463	tr|I6YCE1|I6YCE1_M	P14061	78.76	2.0	206.0	DB13951	experimental	Stanolone acetate	CC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
10464	tr|I6YCE1|I6YCE1_M	Q96NR8	80.69	31.0	240.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
10465	tr|I6YCE1|I6YCE1_M	Q8NBN7	80.31	33.0	241.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
10466	tr|I6YCE1|I6YCE1_M	Q9NYR8	74.52	5.0	198.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
10467	tr|I6YCE1|I6YCE1_M	Q02338	79.54	53.0	259.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10468	tr|I6YCE1|I6YCE1_M	Q8NBQ5	75.29	33.0	228.0	DB02854	experimental	Aetiocholanolone	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](CC3)C[C@H](O)CC4
10469	tr|I6YCE1|I6YCE1_M	P9WGR1	100.77	5.0	266.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
10470	tr|I6YCE1|I6YCE1_M	P9WGR1	100.77	5.0	266.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
10471	tr|I6YCE1|I6YCE1_M	P9WGR1	100.77	5.0	266.0	DB02990	experimental	S-(2-Acetamidoethyl) hexadecanethioate	CCCCCCCCCCCCCCCC(=O)SCCNC(=O)C
10472	tr|I6YCE1|I6YCE1_M	P9WGR1	100.77	5.0	266.0	DB04289	experimental	Genz-10850	[nH]1ccc(c12)cc(cc2)C(=O)N3CCN(CC3)C4c(cccc5)c5c(c46)cccc6
10473	tr|I6YCE1|I6YCE1_M	P9WGR1	100.77	5.0	266.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
10474	tr|I6YCE1|I6YCE1_M	P9WGR1	100.77	5.0	266.0	DB07090	experimental	(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cccc(c1C)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
10475	tr|I6YCE1|I6YCE1_M	P9WGR1	100.77	5.0	266.0	DB07123	experimental	N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE	Cc1ccc(cc1)C(=O)N2CCC(CC2)Cc3ccccc3
10476	tr|I6YCE1|I6YCE1_M	P9WGR1	100.77	5.0	266.0	DB07155	experimental	(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE	c1ccccc1NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
10477	tr|I6YCE1|I6YCE1_M	P9WGR1	100.77	5.0	266.0	DB07178	experimental	5-PENTYL-2-PHENOXYPHENOL	CCCCCc1cc(O)c(cc1)Oc2ccccc2
10478	tr|I6YCE1|I6YCE1_M	P9WGR1	100.77	5.0	266.0	DB07188	experimental	(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(cc(Cl)c1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
10479	tr|I6YCE1|I6YCE1_M	P9WGR1	100.77	5.0	266.0	DB07192	experimental	(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Brc1cc(ccc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
10480	tr|I6YCE1|I6YCE1_M	P9WGR1	100.77	5.0	266.0	DB07222	experimental	(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(c(C)cc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
10481	tr|I6YCE1|I6YCE1_M	P9WGR1	100.77	5.0	266.0	DB07287	experimental	2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL	c1cccnc1Cc2cc(O)c(cc2)Oc3ccc(Cl)cc3Cl
10482	tr|I6YCE1|I6YCE1_M	P9WGR1	100.77	5.0	266.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
10483	tr|I6YCE1|I6YCE1_M	P80365	84.94	69.0	289.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10484	tr|I6YCE1|I6YCE1_M	P80365	84.94	69.0	289.0	DB01185	approved; illicit	Fluoxymesterone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@](F)([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
10485	tr|I6YCE1|I6YCE1_M	P80365	84.94	69.0	289.0	DB01569	experimental; illicit	Formebolone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@H]([C@@H](C2)O)[C@]4(C)C(CC3)=CC(=O)C(C=O)=C4
10486	tr|I6YCE1|I6YCE1_M	P80365	84.94	69.0	289.0	DB14538	experimental; vet_approved	Hydrocortisone aceponate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CC)C(=O)COC(=O)C
10487	tr|I6YCE1|I6YCE1_M	P80365	84.94	69.0	289.0	DB14539	approved; vet_approved	Hydrocortisone acetate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)C
10488	tr|I6YCE1|I6YCE1_M	P80365	84.94	69.0	289.0	DB14540	approved; vet_approved	Hydrocortisone butyrate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCC
10489	tr|I6YCE1|I6YCE1_M	P80365	84.94	69.0	289.0	DB14541	approved; investigational; vet_approved	Hydrocortisone cypionate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)CCC5CCCC5
10490	tr|I6YCE1|I6YCE1_M	P80365	84.94	69.0	289.0	DB14542	approved; vet_approved	Hydrocortisone phosphate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COP(=O)(O)O
10491	tr|I6YCE1|I6YCE1_M	P80365	84.94	69.0	289.0	DB14543	approved; vet_approved	Hydrocortisone probutate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CCC)C(=O)COC(=O)CC
10492	tr|I6YCE1|I6YCE1_M	P80365	84.94	69.0	289.0	DB14544	approved; vet_approved	Hydrocortisone valerate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCCC
10493	tr|I6YCE1|I6YCE1_M	P28845	76.06	31.0	228.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10494	tr|I6YCE1|I6YCE1_M	P28845	76.06	31.0	228.0	DB02329	experimental	Carbenoxolone	OC(=O)CCC(=O)O[C@@H](CC1)C(C)(C)[C@@H]([C@]12C)CC[C@]3(C)[C@@H]2C(=O)C=C4[C@H]5[C@@](C)(CC[C@@]34C)CC[C@](C5)(C)C(=O)O
10495	tr|I6YCE1|I6YCE1_M	P28845	76.06	31.0	228.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10496	tr|I6YCE1|I6YCE1_M	P28845	76.06	31.0	228.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
10497	tr|I6YCE1|I6YCE1_M	P28845	76.06	31.0	228.0	DB04652	experimental	Corticosterone	OCC(=O)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H]([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
10498	tr|I6YCE1|I6YCE1_M	P28845	76.06	31.0	228.0	DB05064	investigational	INCB13739	 
10499	tr|I6YCE1|I6YCE1_M	P28845	76.06	31.0	228.0	DB06992	experimental	(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone	Cc1ccc(cc1F)-c2nc(ccc2)C(=O)N(CC3(C)C)CCC3
10500	tr|I6YCE1|I6YCE1_M	P28845	76.06	31.0	228.0	DB07017	experimental	(5S)-2-{[(1S)-1-(4-Fluorophenyl)ethyl]amino}-5-(2-hydroxy-2-propanyl)-5-methyl-1,3-thiazol-4(5H)-one	Fc1ccc(cc1)[C@H](C)NC(=NC2=O)S[C@@]2(C)C(C)(C)O
10501	tr|I6YCE1|I6YCE1_M	P28845	76.06	31.0	228.0	DB07049	experimental	(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine	[O-][N+](=O)c1ccc(cc1)N2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)C(C)(C)C
10502	tr|I6YCE1|I6YCE1_M	P28845	76.06	31.0	228.0	DB07056	experimental	2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide	CCN(CC)C(=O)Cc1cccc(n1)NS(=O)(=O)c2c(C)c(Cl)ccc2
10503	tr|I6YCE1|I6YCE1_M	P28845	76.06	31.0	228.0	DB07310	experimental	(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one	Fc1ccccc1[C@H](C)NC(=NC2=O)S[C@]2(C)C(F)(F)F
10504	tr|I6YCE1|I6YCE1_M	P28845	76.06	31.0	228.0	DB07316	experimental	N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)C3CCN(CC3)CC4(CC4)C(=O)N
10505	tr|I6YCE1|I6YCE1_M	P28845	76.06	31.0	228.0	DB07619	experimental	N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)[C@H]3CC[C@@H](CC3)c4cccnc4
10506	tr|I6YCE1|I6YCE1_M	P28845	76.06	31.0	228.0	DB07624	experimental	1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide	C1CC1(C(=O)N)CN2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)[C@](C)(O)C(F)(F)F
10507	tr|I6YCE1|I6YCE1_M	P28845	76.06	31.0	228.0	DB07866	experimental	(5S)-2-(Cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one	CCC[C@]1(C)SC(=NC1=O)NC2CCCCCCC2
10508	tr|I6YCE1|I6YCE1_M	P28845	76.06	31.0	228.0	DB08277	experimental	2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE	CS(=O)(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4c(Cl)cc(F)cc4
10509	tr|I6YCE1|I6YCE1_M	P28845	76.06	31.0	228.0	DB08280	experimental	(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE	NC(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4ccc(OC)cc4
10510	tr|I6YCE1|I6YCE1_M	P28845	76.06	31.0	228.0	DB08771	experimental	(5R)-2-[(2-Fluorophenyl)amino]-5-isopropyl-1,3-thiazol-4(5H)-one	CC(C)[C@H]1SC(=NC1=O)Nc2c(F)cccc2
10511	tr|I6YCE1|I6YCE1_M	P28845	76.06	31.0	228.0	DB13751	approved; experimental	Glycyrrhizic acid	C1C[C@](C)(C(=O)O)C[C@H]([C@]12C)C=3[C@@](C)(CC2)[C@@]4(C)[C@H](C(=O)C3)[C@]5(C)[C@@H](CC4)C(C)(C)[C@H](CC5)O[C@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O[C@@H]7O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]7O
10512	tr|I6YCE1|I6YCE1_M	Q92781	80.69	21.0	230.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10513	tr|I6YCE1|I6YCE1_M	Q92781	80.69	21.0	230.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
10514	tr|I6YCE1|I6YCE1_M	P51659	73.75	5.0	196.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10515	tr|I6YCE1|I6YCE1_M	P51659	73.75	5.0	196.0	DB03192	experimental	(R)-3-hydroxydecanoyl-CoA	CCCCCCC[C@@H](O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
10516	tr|I6YCE1|I6YCE1_M	P37059	81.47	78.0	289.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10517	tr|I6YCE1|I6YCE1_M	P37059	81.47	78.0	289.0	DB13952	approved; investigational; vet_approved	Estradiol acetate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)C
10518	tr|I6YCE1|I6YCE1_M	P37059	81.47	78.0	289.0	DB13953	approved; investigational; vet_approved	Estradiol benzoate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)c5ccccc5
10519	tr|I6YCE1|I6YCE1_M	P37059	81.47	78.0	289.0	DB13954	approved; investigational; vet_approved	Estradiol cypionate	C1CCCC1CCC(=O)O[C@H]2CC[C@H]([C@@]23C)[C@H]4[C@H](CC3)c5c(CC4)cc(O)cc5
10520	tr|I6YCE1|I6YCE1_M	P37059	81.47	78.0	289.0	DB13955	approved; investigational; vet_approved	Estradiol dienanthate	CCCCCCC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)CCCCCC
10521	tr|I6YCE1|I6YCE1_M	P37059	81.47	78.0	289.0	DB13956	approved; investigational; vet_approved	Estradiol valerate	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)CC[C@@H]4OC(=O)CCCC
10522	tr|I6YCE1|I6YCE1_M	P37058	74.13	48.0	240.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10523	tr|I6YCE1|I6YCE1_M	P56937	88.8	2.0	232.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10524	tr|I6YCE1|I6YCE1_M	P16152	91.89	7.0	245.0	DB01698	approved; experimental; investigational	Rutin	O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O[C@H]1C)OC[C@H]2O[C@H]([C@H](O)[C@@H](O)[C@@H]2O)Oc(c3=O)c(-c4cc(O)c(O)cc4)oc(c35)cc(O)cc5O
10525	tr|I6YCE1|I6YCE1_M	P16152	91.89	7.0	245.0	DB02709	investigational	Resveratrol	Oc1ccc(cc1)/C=C/c2cc(O)cc(O)c2
10526	tr|I6YCE1|I6YCE1_M	P16152	91.89	7.0	245.0	DB03394	experimental	Heptaethylene glycol	OCCOCCOCCOCCOCCOCCOCCO
10527	tr|I6YCE1|I6YCE1_M	P16152	91.89	7.0	245.0	DB03556	experimental	2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400	CCOCCOCCOCCOCCOCCOCCOCCOCCO
10528	tr|I6YCE1|I6YCE1_M	P16152	91.89	7.0	245.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
10529	tr|I6YCE1|I6YCE1_M	P16152	91.89	7.0	245.0	DB04463	experimental	3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol	n1cnc(N)c(c12)c(nn2C(C)(C)C)-c3cccc(O)c3
10530	tr|I6YCE1|I6YCE1_M	P16152	91.89	7.0	245.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
10531	tr|I6YCE1|I6YCE1_M	P16152	91.89	7.0	245.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
10532	tr|I6YCE1|I6YCE1_M	P35270	91.89	5.0	243.0	DB02637	experimental	Oxaloacetate Ion	OC(=O)C(=O)CC([O-])=O
10533	tr|I6YCE1|I6YCE1_M	P35270	91.89	5.0	243.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10534	tr|I6YCE1|I6YCE1_M	P35270	91.89	5.0	243.0	DB03886	experimental	Biopterin	C[C@@H](O)[C@@H](O)c(n1)cnc(c12)nc(N)[nH]c2=O
10535	tr|I6YCE1|I6YCE1_M	P35270	91.89	5.0	243.0	DB04275	experimental	N-acetylserotonin	CC(=O)NCCc1c[nH]c(c12)ccc(c2)O
10536	tr|I6YCE1|I6YCE1_M	P09417	74.13	10.0	202.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10537	tr|I6YCE1|I6YCE1_M	P09417	74.13	10.0	202.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
10538	tr|I6YCE1|I6YCE1_M	Q8T8E9	74.9	2.0	196.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
10539	tr|I6YCE1|I6YCE1_M	P26391	73.75	3.0	194.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
10540	tr|O33365|O33365_M	Q06528	77.59	215.0	305.0	DB01752	experimental	S-adenosyl-L-homocysteine	OC(=O)[C@@H](N)CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
10541	tr|O33365|O33365_M	Q06528	77.59	215.0	305.0	DB03199	experimental	4-Methoxy-E-Rhodomycin T	O[C@H]1[C@@H](N(C)C)C[C@@H](O[C@H]1C)O[C@H]2C[C@](O)(CC)[C@H](C(=O)OC)c(c23)c(O)c4c(c3O)C(=O)c5c(C4=O)cccc5OC
10542	tr|O33365|O33365_M	P46597	73.28	203.0	288.0	DB01065	approved; nutraceutical; vet_approved	Melatonin	COc(cc1)cc(c12)c(c[nH]2)CCNC(=O)C
10545	tr|O53708|O53708_M	Q06278	93.49	574.0	1321.0	DB00924	approved	Cyclobenzaprine	CN(C)CCC=C1c(cccc2)c2C=Cc(c13)cccc3
10546	tr|O53708|O53708_M	Q06278	93.49	574.0	1321.0	DB03516	investigational	Eniluracil	O=c1[nH]cc(C#C)c(=O)[nH]1
10547	tr|O53708|O53708_M	Q9REC4	90.61	181.0	905.0	DB03300	experimental	Pterin Cytosine Dinucleotide	Nc(n1)[nH]c(=O)c(c12)N[C@@H]3[C@H](N2)O[C@@H](C(S)=C3S)COP(=O)(O)OP(=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5ccc(N)nc5=O
10548	tr|O53708|O53708_M	Q46509	90.11	186.0	906.0	DB02137	experimental	Molybdenum cofactor	O=c1[nH]c(N)nc(c12)N[C@H]3[C@@H](N2)C([S-])=C([S-])[C@H](O3)COP([O-])([O-])=O
10549	tr|O53708|O53708_M	P47989	93.24	570.0	1315.0	DB00437	approved	Allopurinol	c1n[nH]c(c12)ncnc2O
10550	tr|O53708|O53708_M	P47989	93.24	570.0	1315.0	DB00583	approved; investigational	Levocarnitine	C[N+](C)(C)C[C@H](O)CC([O-])=O
10551	tr|O53708|O53708_M	P47989	93.24	570.0	1315.0	DB01685	experimental	Topiroxostat	N#Cc1nccc(c1)-c2n[nH]c(n2)-c3ccncc3
10552	tr|O53708|O53708_M	P47989	93.24	570.0	1315.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
10553	tr|O53708|O53708_M	P47989	93.24	570.0	1315.0	DB03328	experimental	Dioxo(sulfanyl)molybdenum	S[Mo](=O)=O
10554	tr|O53708|O53708_M	P47989	93.24	570.0	1315.0	DB03516	investigational	Eniluracil	O=c1[nH]cc(C#C)c(=O)[nH]1
10555	tr|O53708|O53708_M	P47989	93.24	570.0	1315.0	DB03841	experimental	Niraxostat	CC(C)(C)COc1c(C#N)cc(cc1)-n2cc(cn2)C(=O)O
10556	tr|O53708|O53708_M	P47989	93.24	570.0	1315.0	DB04854	approved	Febuxostat	CC(C)COc1c(C#N)cc(cc1)-c2nc(C)c(s2)C(=O)O
10557	tr|O53708|O53708_M	P47989	93.24	570.0	1315.0	DB05262	investigational	Oxypurinol	O=c1[nH]c(=O)[nH]c(c12)[nH]nc2
10558	tr|I6XF92|I6XF92_M	P0A115	84.9	9.0	217.0	DB01973	experimental	O-Benzylsulfonyl-Serine	OC(=O)[C@@H](N)COS(=O)(=O)Cc1ccccc1
10559	tr|I6XF92|I6XF92_M	P0A115	84.9	9.0	217.0	DB02153	experimental	3-sulfino-L-alanine	OC(=O)[C@@H](N)C[S@](=O)O
10560	tr|P95100|P95100_M	P9WMC1	93.98	11.0	214.0	DB02425	experimental	Hexadecyl Octanoate	CCCCCCCCCCCCCCCOC(=O)CCCCCCC
10561	tr|P95100|P95100_M	P9WMC1	93.98	11.0	214.0	DB08469	experimental	tert-butyl 4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine-1-carboxylate	CC(C)(C)OC(=O)N1CCC(CC1)c2nc(no2)-c3cccs3
10562	tr|P95100|P95100_M	P9WMC1	93.98	11.0	214.0	DB08470	experimental	3-(4-fluorophenyl)-5-phenyl-4H-1,2,4-triazole	Fc1ccc(cc1)-c2nnc([nH]2)-c3ccccc3
10563	tr|P95100|P95100_M	P9WMC1	93.98	11.0	214.0	DB08471	experimental	1-(thiophen-2-ylacetyl)-4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine	c1ccsc1CC(=O)N2CCC(CC2)c3nc(no3)-c4cccs4
10564	tr|O53369|O53369_M	P17413	78.47	115.0	228.0	DB07669	experimental	2,3-Dimethyl-1,4-naphthoquinone	O=C1C(C)=C(C)C(=O)c(c12)cccc2
10565	tr|L7N6B1|L7N6B1_M	O52791	72.37	6.0	116.0	DB07896	experimental	(2S)-hydroxy(4-hydroxyphenyl)ethanoic acid	OC(=O)[C@@H](O)c1ccc(O)cc1
10566	tr|L7N6B1|L7N6B1_M	O52791	75.0	155.0	269.0	DB07896	experimental	(2S)-hydroxy(4-hydroxyphenyl)ethanoic acid	OC(=O)[C@@H](O)c1ccc(O)cc1
10567	tr|L7N6B1|L7N6B1_M	Q53586	71.71	20.0	129.0	DB08307	experimental	2-{HYDROXY[2-NITRO-4-(TRIFLUOROMETHYL)PHENYL]METHYLENE}CYCLOHEXANE-1,3-DIONE	O=C1CCCC(=O)C1=C(O)c2ccc(C(F)(F)F)cc2[N+]([O-])=O
10568	tr|L7N6B1|L7N6B1_M	Q53586	76.97	179.0	296.0	DB08307	experimental	2-{HYDROXY[2-NITRO-4-(TRIFLUOROMETHYL)PHENYL]METHYLENE}CYCLOHEXANE-1,3-DIONE	O=C1CCCC(=O)C1=C(O)c2ccc(C(F)(F)F)cc2[N+]([O-])=O
10569	tr|L7N6B1|L7N6B1_M	P32754	74.34	20.0	133.0	DB00348	approved; investigational	Nitisinone	FC(F)(F)c1cc([N+]([O-])=O)c(cc1)C(=O)C2C(=O)CCCC2=O
10570	tr|L7N6B1|L7N6B1_M	P32754	74.34	20.0	133.0	DB02850	experimental	DAS869	COc1ccc(cc1)-c2c(C)c(ccc2S(=O)(=O)C)C(=O)c3c(O)n(nc3)C(C)(C)C
10571	tr|L7N6B1|L7N6B1_M	P32754	77.63	175.0	293.0	DB00348	approved; investigational	Nitisinone	FC(F)(F)c1cc([N+]([O-])=O)c(cc1)C(=O)C2C(=O)CCCC2=O
10572	tr|L7N6B1|L7N6B1_M	P32754	77.63	175.0	293.0	DB02850	experimental	DAS869	COc1ccc(cc1)-c2c(C)c(ccc2S(=O)(=O)C)C(=O)c3c(O)n(nc3)C(C)(C)C
10573	tr|L7N6B1|L7N6B1_M	Q81F54	94.74	1.0	145.0	DB01942	experimental; investigational	Formic acid	OC=O
10574	tr|L7N6B1|L7N6B1_M	Q81F54	94.74	1.0	145.0	DB04272	approved; nutraceutical; vet_approved	Citric acid	OC(=O)CC(O)(C(=O)O)CC(=O)O
10575	tr|L7N6B1|L7N6B1_M	Q04760	94.08	34.0	177.0	DB00143	approved; investigational; nutraceutical	Glutathione	OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(=O)O
10576	tr|L7N6B1|L7N6B1_M	Q04760	94.08	34.0	177.0	DB00328	approved; investigational	Indomethacin	COc(cc1)cc(c12)c(CC(=O)O)c(C)n2C(=O)c3ccc(Cl)cc3
10577	tr|L7N6B1|L7N6B1_M	Q04760	94.08	34.0	177.0	DB03130	experimental	S-P-Nitrobenzyloxycarbonylglutathione	OC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)NCC(=O)O)CSC(O)OCc1ccc([N+]([O-])=O)cc1
10578	tr|L7N6B1|L7N6B1_M	Q04760	94.08	34.0	177.0	DB03330	experimental	S-(N-hydroxy-N-iodophenylcarbamoyl)glutathione	OC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)NCC(=O)O)CS[C@@H](O)N(O)c1ccc(I)cc1
10579	tr|L7N6B1|L7N6B1_M	Q04760	94.08	34.0	177.0	DB03345	experimental	Mercaptoethanol	OCCS
10580	tr|L7N6B1|L7N6B1_M	Q04760	94.08	34.0	177.0	DB03602	experimental	S-benzylglutathione	OC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)NCC(=O)O)CSCc1ccccc1
10581	tr|L7N6B1|L7N6B1_M	Q04760	94.08	34.0	177.0	DB04132	experimental	S-Hexylglutathione	CCCCCCSC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@H](N)C(=O)O
10582	tr|L7N6B1|L7N6B1_M	Q04760	94.08	34.0	177.0	DB08179	experimental	methyl 4-(2,3-dihydroxy-5-methylphenoxy)-2-hydroxy-6-methylbenzoate	COC(=O)c1c(C)cc(cc1O)Oc2c(O)c(O)cc(C)c2
10583	tr|I6YEB6|I6YEB6_M	Q9BTZ2	93.85	30.0	274.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
10584	tr|I6YEB6|I6YEB6_M	P0AEK2	92.31	2.0	242.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10586	tr|I6YEB6|I6YEB6_M	Q9WYS2	95.77	5.0	254.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10589	tr|I6YEB6|I6YEB6_M	P0AET8	93.85	6.0	250.0	DB02123	experimental	Glycochenodeoxycholic Acid	OC(=O)CNC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
10590	tr|I6YEB6|I6YEB6_M	Q92506	96.92	8.0	260.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10591	tr|I6YEB6|I6YEB6_M	Q92506	96.92	8.0	260.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10592	tr|I6YEB6|I6YEB6_M	Q84EX5	94.62	4.0	250.0	DB04619	experimental	Acetophenone	CC(=O)c1ccccc1
10593	tr|I6YEB6|I6YEB6_M	Q84EX5	94.62	4.0	250.0	DB04784	experimental	(R)-1-phenylethanol	C[C@@H](O)c1ccccc1
10594	tr|I6YEB6|I6YEB6_M	P0CG22	95.38	29.0	277.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
10595	tr|I6YEB6|I6YEB6_M	P0CG22	95.38	29.0	277.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10596	tr|I6YEB6|I6YEB6_M	P0CG22	95.38	29.0	277.0	DB03541	experimental	10-Propargyl-5,8-Dideazafolic Acid	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(CC#C)Cc(c2)ccc(c23)[nH]c(N)nc3=O
10597	tr|I6YEB6|I6YEB6_M	P0CG22	95.38	29.0	277.0	DB07689	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)NCc(cn3)nc(c34)c(N)nc(n4)N
10598	tr|I6YEB6|I6YEB6_M	P0CG22	95.38	29.0	277.0	DB07765	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)N(C)Cc(cn3)nc(c34)c(N)nc(n4)N
10599	tr|I6YEB6|I6YEB6_M	Q9BY49	96.54	16.0	267.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
10600	tr|I6YEB6|I6YEB6_M	P16544	97.31	5.0	258.0	DB01942	experimental; investigational	Formic acid	OC=O
10601	tr|I6YEB6|I6YEB6_M	P16544	97.31	5.0	258.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10602	tr|I6YEB6|I6YEB6_M	P16544	97.31	5.0	258.0	DB07715	investigational	Emodin	Cc(c1)cc(O)c(c12)C(=O)c3c(C2=O)cc(O)cc3O
10603	tr|I6YEB6|I6YEB6_M	Q7Z4W1	92.31	2.0	242.0	DB02831	experimental	Dihydrogenphosphate	OP([O-])(=O)O
10604	tr|I6YEB6|I6YEB6_M	Q7Z4W1	92.31	2.0	242.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10605	tr|I6YEB6|I6YEB6_M	Q16698	95.38	57.0	305.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10606	tr|I6YEB6|I6YEB6_M	Q16698	95.38	57.0	305.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
10607	tr|I6YEB6|I6YEB6_M	Q6GI75	96.92	2.0	254.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
10608	tr|I6YEB6|I6YEB6_M	Q6GI75	96.92	2.0	254.0	DB11155	approved	Triclocarban	Clc1ccc(cc1)NC(=O)Nc2cc(Cl)c(Cl)cc2
10609	tr|I6YEB6|I6YEB6_M	Q6UWP2	91.54	11.0	249.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10610	tr|I6YEB6|I6YEB6_M	Q99714	96.15	8.0	258.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10611	tr|I6YEB6|I6YEB6_M	Q99714	96.15	8.0	258.0	DB02820	experimental	1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct	C1CCCCCN1C(=O)[C@H](c2ccccc2)n(c3=S)cnc(c34)nn(c4)[C@H]5C=CN(C=C5C([O-])=N)[C@@H]6O[C@@H]([C@@H](O)[C@H]6O)COP([O-])(=O)OP(=O)(O)OC[C@H]7O[C@H]([C@H]([O-])[C@@H]7[O-])n8cnc(c89)c(N)ncn9
10612	tr|I6YEB6|I6YEB6_M	Q99714	96.15	8.0	258.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
10614	tr|I6YEB6|I6YEB6_M	A0A348A0U3	96.15	4.0	254.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
10615	tr|I6YEB6|I6YEB6_M	P0AEK4	96.54	4.0	255.0	DB01691	experimental	Indole Naphthyridinone	c1cccc(c12)n(C)cc2CN(C)C(=O)/C=C/c(c3)cnc(c34)NC(=O)CC4
10616	tr|I6YEB6|I6YEB6_M	P0AEK4	96.54	4.0	255.0	DB01865	experimental	3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide	c1cccc(c12)cc(n2C)CN(C)C(=O)/C=C/c3cnc(N)cc3
10617	tr|I6YEB6|I6YEB6_M	P0AEK4	96.54	4.0	255.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
10618	tr|I6YEB6|I6YEB6_M	P0AEK4	96.54	4.0	255.0	DB03030	experimental	4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole	Cc1ccc(cc1)Cn2cnc(c2)-c3cccs3
10619	tr|I6YEB6|I6YEB6_M	P0AEK4	96.54	4.0	255.0	DB03534	experimental	3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide	CC(=O)N(C)Cc1c(N)ccc(c1)C(=O)N(C)Cc(n2C)cc(c23)cccc3
10620	tr|I6YEB6|I6YEB6_M	P0AEK4	96.54	4.0	255.0	DB04030	experimental	1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole	Oc1ccc(cc1)Cn2c(c3c(c24)cccc4)CN(CC3)C(=O)c5ccc(O)cc5
10621	tr|I6YEB6|I6YEB6_M	P0AEK4	96.54	4.0	255.0	DB08265	experimental	2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL	Cc1ccc(cc1)S(=O)(=O)n(b2O)ncc(c23)cccc3
10622	tr|I6YEB6|I6YEB6_M	P0AEK4	96.54	4.0	255.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
10623	tr|I6YEB6|I6YEB6_M	P0AEK4	96.54	4.0	255.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
10624	tr|I6YEB6|I6YEB6_M	Q8I814	100.77	14.0	276.0	DB02015	experimental	Dihydrofolic Acid	O=c1[nH]c(N)nc(c12)NCC(=N2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
10625	tr|I6YEB6|I6YEB6_M	Q8I814	100.77	14.0	276.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10626	tr|I6YEB6|I6YEB6_M	Q7AUG5	92.69	3.0	244.0	DB04782	experimental	(S)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@H]2CO2
10627	tr|I6YEB6|I6YEB6_M	Q93D82	92.69	3.0	244.0	DB04472	experimental	(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol	[N-]=[N+]=NC[C@H](O)c1ccc([N+]([O-])=O)cc1
10628	tr|I6YEB6|I6YEB6_M	Q93D82	92.69	3.0	244.0	DB04499	experimental	(R)-styrene oxide	C1O[C@@H]1c2ccccc2
10629	tr|I6YEB6|I6YEB6_M	Q93D82	92.69	3.0	244.0	DB04777	experimental	(R)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@@H]2CO2
10630	tr|I6YEB6|I6YEB6_M	Q01782	107.69	8.0	288.0	DB02338	experimental	NADPH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10631	tr|I6YEB6|I6YEB6_M	Q01782	107.69	8.0	288.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
10632	tr|I6YEB6|I6YEB6_M	Q01782	107.69	8.0	288.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10633	tr|I6YEB6|I6YEB6_M	Q01782	107.69	8.0	288.0	DB04400	experimental	L-erythro-7,8-dihydrobiopterin	C[C@H](O)[C@H](O)C(CN1)=Nc(c12)c(=O)nc([nH]2)N
10634	tr|I6YEB6|I6YEB6_M	O24990	95.38	4.0	252.0	DB04393	experimental	Soneclosan	Clc1cc(O)c(cc1)Oc2ccc(Cl)cc2
10635	tr|I6YEB6|I6YEB6_M	O24990	95.38	4.0	252.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
10636	tr|I6YEB6|I6YEB6_M	Q8NBQ5	75.77	34.0	231.0	DB02854	experimental	Aetiocholanolone	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](CC3)C[C@H](O)CC4
10637	tr|I6YEB6|I6YEB6_M	Q8TC12	79.23	36.0	242.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
10638	tr|I6YEB6|I6YEB6_M	Q9HBH5	99.62	41.0	300.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
10639	tr|I6YEB6|I6YEB6_M	Q8NBN7	79.23	36.0	242.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
10640	tr|I6YEB6|I6YEB6_M	Q96NR8	79.62	33.0	240.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
10641	tr|I6YEB6|I6YEB6_M	O75911	87.69	35.0	263.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
10642	tr|I6YEB6|I6YEB6_M	P51659	91.92	5.0	244.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10643	tr|I6YEB6|I6YEB6_M	P51659	91.92	5.0	244.0	DB03192	experimental	(R)-3-hydroxydecanoyl-CoA	CCCCCCC[C@@H](O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
10644	tr|I6YEB6|I6YEB6_M	Q9NYR8	74.62	4.0	198.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
10645	tr|I6YEB6|I6YEB6_M	P14061	79.23	2.0	208.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10646	tr|I6YEB6|I6YEB6_M	P14061	79.23	2.0	208.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
10647	tr|I6YEB6|I6YEB6_M	P14061	79.23	2.0	208.0	DB01561	experimental; illicit	Androstanedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
10648	tr|I6YEB6|I6YEB6_M	P14061	79.23	2.0	208.0	DB02187	experimental	Equilin	O=C1CC[C@H]([C@@]12C)C=3[C@H](CC2)c4c(CC3)cc(O)cc4
10649	tr|I6YEB6|I6YEB6_M	P14061	79.23	2.0	208.0	DB02323	experimental	EM-1745	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)C[C@@H]([C@@H]4O)CCCCCCCCC(=O)OC[C@H]5O[C@H]([C@H](O)[C@@H]5O)n6cnc(c67)c(N)ncn7
10650	tr|I6YEB6|I6YEB6_M	P14061	79.23	2.0	208.0	DB02901	illicit; investigational	Stanolone	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
10651	tr|I6YEB6|I6YEB6_M	P14061	79.23	2.0	208.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10652	tr|I6YEB6|I6YEB6_M	P14061	79.23	2.0	208.0	DB13951	experimental	Stanolone acetate	CC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
10653	tr|I6YEB6|I6YEB6_M	Q02338	74.23	54.0	247.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10654	tr|I6YEB6|I6YEB6_M	P80365	80.77	78.0	288.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10655	tr|I6YEB6|I6YEB6_M	P80365	80.77	78.0	288.0	DB01185	approved; illicit	Fluoxymesterone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@](F)([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
10656	tr|I6YEB6|I6YEB6_M	P80365	80.77	78.0	288.0	DB01569	experimental; illicit	Formebolone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@H]([C@@H](C2)O)[C@]4(C)C(CC3)=CC(=O)C(C=O)=C4
10657	tr|I6YEB6|I6YEB6_M	P80365	80.77	78.0	288.0	DB14538	experimental; vet_approved	Hydrocortisone aceponate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CC)C(=O)COC(=O)C
10658	tr|I6YEB6|I6YEB6_M	P80365	80.77	78.0	288.0	DB14539	approved; vet_approved	Hydrocortisone acetate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)C
10659	tr|I6YEB6|I6YEB6_M	P80365	80.77	78.0	288.0	DB14540	approved; vet_approved	Hydrocortisone butyrate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCC
10660	tr|I6YEB6|I6YEB6_M	P80365	80.77	78.0	288.0	DB14541	approved; investigational; vet_approved	Hydrocortisone cypionate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)CCC5CCCC5
10661	tr|I6YEB6|I6YEB6_M	P80365	80.77	78.0	288.0	DB14542	approved; vet_approved	Hydrocortisone phosphate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COP(=O)(O)O
10662	tr|I6YEB6|I6YEB6_M	P80365	80.77	78.0	288.0	DB14543	approved; vet_approved	Hydrocortisone probutate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CCC)C(=O)COC(=O)CC
10663	tr|I6YEB6|I6YEB6_M	P80365	80.77	78.0	288.0	DB14544	approved; vet_approved	Hydrocortisone valerate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCCC
10664	tr|I6YEB6|I6YEB6_M	Q92781	75.77	23.0	220.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10665	tr|I6YEB6|I6YEB6_M	Q92781	75.77	23.0	220.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
10666	tr|I6YEB6|I6YEB6_M	P28845	75.38	31.0	227.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10667	tr|I6YEB6|I6YEB6_M	P28845	75.38	31.0	227.0	DB02329	experimental	Carbenoxolone	OC(=O)CCC(=O)O[C@@H](CC1)C(C)(C)[C@@H]([C@]12C)CC[C@]3(C)[C@@H]2C(=O)C=C4[C@H]5[C@@](C)(CC[C@@]34C)CC[C@](C5)(C)C(=O)O
10668	tr|I6YEB6|I6YEB6_M	P28845	75.38	31.0	227.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10669	tr|I6YEB6|I6YEB6_M	P28845	75.38	31.0	227.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
10670	tr|I6YEB6|I6YEB6_M	P28845	75.38	31.0	227.0	DB04652	experimental	Corticosterone	OCC(=O)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H]([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
10671	tr|I6YEB6|I6YEB6_M	P28845	75.38	31.0	227.0	DB05064	investigational	INCB13739	 
10672	tr|I6YEB6|I6YEB6_M	P28845	75.38	31.0	227.0	DB06992	experimental	(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone	Cc1ccc(cc1F)-c2nc(ccc2)C(=O)N(CC3(C)C)CCC3
10673	tr|I6YEB6|I6YEB6_M	P28845	75.38	31.0	227.0	DB07017	experimental	(5S)-2-{[(1S)-1-(4-Fluorophenyl)ethyl]amino}-5-(2-hydroxy-2-propanyl)-5-methyl-1,3-thiazol-4(5H)-one	Fc1ccc(cc1)[C@H](C)NC(=NC2=O)S[C@@]2(C)C(C)(C)O
10674	tr|I6YEB6|I6YEB6_M	P28845	75.38	31.0	227.0	DB07049	experimental	(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine	[O-][N+](=O)c1ccc(cc1)N2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)C(C)(C)C
10675	tr|I6YEB6|I6YEB6_M	P28845	75.38	31.0	227.0	DB07056	experimental	2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide	CCN(CC)C(=O)Cc1cccc(n1)NS(=O)(=O)c2c(C)c(Cl)ccc2
10676	tr|I6YEB6|I6YEB6_M	P28845	75.38	31.0	227.0	DB07310	experimental	(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one	Fc1ccccc1[C@H](C)NC(=NC2=O)S[C@]2(C)C(F)(F)F
10677	tr|I6YEB6|I6YEB6_M	P28845	75.38	31.0	227.0	DB07316	experimental	N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)C3CCN(CC3)CC4(CC4)C(=O)N
10678	tr|I6YEB6|I6YEB6_M	P28845	75.38	31.0	227.0	DB07619	experimental	N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)[C@H]3CC[C@@H](CC3)c4cccnc4
10679	tr|I6YEB6|I6YEB6_M	P28845	75.38	31.0	227.0	DB07624	experimental	1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide	C1CC1(C(=O)N)CN2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)[C@](C)(O)C(F)(F)F
10680	tr|I6YEB6|I6YEB6_M	P28845	75.38	31.0	227.0	DB07866	experimental	(5S)-2-(Cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one	CCC[C@]1(C)SC(=NC1=O)NC2CCCCCCC2
10681	tr|I6YEB6|I6YEB6_M	P28845	75.38	31.0	227.0	DB08277	experimental	2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE	CS(=O)(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4c(Cl)cc(F)cc4
10682	tr|I6YEB6|I6YEB6_M	P28845	75.38	31.0	227.0	DB08280	experimental	(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE	NC(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4ccc(OC)cc4
10683	tr|I6YEB6|I6YEB6_M	P28845	75.38	31.0	227.0	DB08771	experimental	(5R)-2-[(2-Fluorophenyl)amino]-5-isopropyl-1,3-thiazol-4(5H)-one	CC(C)[C@H]1SC(=NC1=O)Nc2c(F)cccc2
10684	tr|I6YEB6|I6YEB6_M	P28845	75.38	31.0	227.0	DB13751	approved; experimental	Glycyrrhizic acid	C1C[C@](C)(C(=O)O)C[C@H]([C@]12C)C=3[C@@](C)(CC2)[C@@]4(C)[C@H](C(=O)C3)[C@]5(C)[C@@H](CC4)C(C)(C)[C@H](CC5)O[C@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O[C@@H]7O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]7O
10685	tr|I6YEB6|I6YEB6_M	P37059	81.15	78.0	289.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10686	tr|I6YEB6|I6YEB6_M	P37059	81.15	78.0	289.0	DB13952	approved; investigational; vet_approved	Estradiol acetate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)C
10687	tr|I6YEB6|I6YEB6_M	P37059	81.15	78.0	289.0	DB13953	approved; investigational; vet_approved	Estradiol benzoate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)c5ccccc5
10688	tr|I6YEB6|I6YEB6_M	P37059	81.15	78.0	289.0	DB13954	approved; investigational; vet_approved	Estradiol cypionate	C1CCCC1CCC(=O)O[C@H]2CC[C@H]([C@@]23C)[C@H]4[C@H](CC3)c5c(CC4)cc(O)cc5
10689	tr|I6YEB6|I6YEB6_M	P37059	81.15	78.0	289.0	DB13955	approved; investigational; vet_approved	Estradiol dienanthate	CCCCCCC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)CCCCCC
10690	tr|I6YEB6|I6YEB6_M	P37059	81.15	78.0	289.0	DB13956	approved; investigational; vet_approved	Estradiol valerate	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)CC[C@@H]4OC(=O)CCCC
10691	tr|I6YEB6|I6YEB6_M	P9WGR1	100.38	5.0	266.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
10692	tr|I6YEB6|I6YEB6_M	P9WGR1	100.38	5.0	266.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
10693	tr|I6YEB6|I6YEB6_M	P9WGR1	100.38	5.0	266.0	DB02990	experimental	S-(2-Acetamidoethyl) hexadecanethioate	CCCCCCCCCCCCCCCC(=O)SCCNC(=O)C
10694	tr|I6YEB6|I6YEB6_M	P9WGR1	100.38	5.0	266.0	DB04289	experimental	Genz-10850	[nH]1ccc(c12)cc(cc2)C(=O)N3CCN(CC3)C4c(cccc5)c5c(c46)cccc6
10695	tr|I6YEB6|I6YEB6_M	P9WGR1	100.38	5.0	266.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
10696	tr|I6YEB6|I6YEB6_M	P9WGR1	100.38	5.0	266.0	DB07090	experimental	(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cccc(c1C)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
10697	tr|I6YEB6|I6YEB6_M	P9WGR1	100.38	5.0	266.0	DB07123	experimental	N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE	Cc1ccc(cc1)C(=O)N2CCC(CC2)Cc3ccccc3
10698	tr|I6YEB6|I6YEB6_M	P9WGR1	100.38	5.0	266.0	DB07155	experimental	(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE	c1ccccc1NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
10699	tr|I6YEB6|I6YEB6_M	P9WGR1	100.38	5.0	266.0	DB07178	experimental	5-PENTYL-2-PHENOXYPHENOL	CCCCCc1cc(O)c(cc1)Oc2ccccc2
10700	tr|I6YEB6|I6YEB6_M	P9WGR1	100.38	5.0	266.0	DB07188	experimental	(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(cc(Cl)c1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
10701	tr|I6YEB6|I6YEB6_M	P9WGR1	100.38	5.0	266.0	DB07192	experimental	(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Brc1cc(ccc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
10702	tr|I6YEB6|I6YEB6_M	P9WGR1	100.38	5.0	266.0	DB07222	experimental	(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(c(C)cc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
10703	tr|I6YEB6|I6YEB6_M	P9WGR1	100.38	5.0	266.0	DB07287	experimental	2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL	c1cccnc1Cc2cc(O)c(cc2)Oc3ccc(Cl)cc3Cl
10704	tr|I6YEB6|I6YEB6_M	P9WGR1	100.38	5.0	266.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
10705	tr|I6YEB6|I6YEB6_M	P37058	76.15	44.0	242.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10706	tr|I6YEB6|I6YEB6_M	P35270	90.77	7.0	243.0	DB02637	experimental	Oxaloacetate Ion	OC(=O)C(=O)CC([O-])=O
10707	tr|I6YEB6|I6YEB6_M	P35270	90.77	7.0	243.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10708	tr|I6YEB6|I6YEB6_M	P35270	90.77	7.0	243.0	DB03886	experimental	Biopterin	C[C@@H](O)[C@@H](O)c(n1)cnc(c12)nc(N)[nH]c2=O
10709	tr|I6YEB6|I6YEB6_M	P35270	90.77	7.0	243.0	DB04275	experimental	N-acetylserotonin	CC(=O)NCCc1c[nH]c(c12)ccc(c2)O
10710	tr|I6YEB6|I6YEB6_M	P16152	91.92	7.0	246.0	DB01698	approved; experimental; investigational	Rutin	O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O[C@H]1C)OC[C@H]2O[C@H]([C@H](O)[C@@H](O)[C@@H]2O)Oc(c3=O)c(-c4cc(O)c(O)cc4)oc(c35)cc(O)cc5O
10711	tr|I6YEB6|I6YEB6_M	P16152	91.92	7.0	246.0	DB02709	investigational	Resveratrol	Oc1ccc(cc1)/C=C/c2cc(O)cc(O)c2
10712	tr|I6YEB6|I6YEB6_M	P16152	91.92	7.0	246.0	DB03394	experimental	Heptaethylene glycol	OCCOCCOCCOCCOCCOCCOCCO
10713	tr|I6YEB6|I6YEB6_M	P16152	91.92	7.0	246.0	DB03556	experimental	2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400	CCOCCOCCOCCOCCOCCOCCOCCOCCO
10714	tr|I6YEB6|I6YEB6_M	P16152	91.92	7.0	246.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
10715	tr|I6YEB6|I6YEB6_M	P16152	91.92	7.0	246.0	DB04463	experimental	3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol	n1cnc(N)c(c12)c(nn2C(C)(C)C)-c3cccc(O)c3
10716	tr|I6YEB6|I6YEB6_M	P16152	91.92	7.0	246.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
10717	tr|I6YEB6|I6YEB6_M	P16152	91.92	7.0	246.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
10718	tr|I6YEB6|I6YEB6_M	P56937	89.23	2.0	234.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10719	tr|I6YEB6|I6YEB6_M	P09417	71.15	11.0	196.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10720	tr|I6YEB6|I6YEB6_M	P09417	71.15	11.0	196.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
10721	tr|I6YEB6|I6YEB6_M	Q8T8E9	74.62	2.0	196.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
10722	tr|I6YEB6|I6YEB6_M	P26391	73.46	3.0	194.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
10723	tr|O07720|O07720_M	Q7BJM5	76.4	72.0	263.0	DB08161	experimental	(S)-2-(MERCAPTOMETHYL)-5-PHENYLPENTANOIC ACID	SC[C@H](C(=O)O)CCCc1ccccc1
10724	tr|O07720|O07720_M	Q9K2N0	76.4	72.0	263.0	DB03661	experimental	L-cysteic acid	OC(=O)[C@@H](N)CS(=O)(=O)O
10725	tr|O07720|O07720_M	P25910	73.6	57.0	241.0	DB02593	experimental	7,8-Dihydroxy-1-Methoxy-3-Methyl-10-Oxo-4,10-Dihydro-1h,3h-Pyrano[4,3-B]Chromene-9-Carboxylic Acid	CO[C@@H]1O[C@@H](C)Cc(c12)oc3c(c2=O)c(C(=O)O)c(O)c(c3)O
10726	tr|O07720|O07720_M	O08498	76.8	52.0	244.0	DB02032	experimental	Epicaptopril	SC[C@H](C)C(=O)N1CCC[C@H]1C(=O)O
10727	tr|O07720|O07720_M	P04190	72.0	76.0	256.0	DB02133	experimental	Chlorophyll A	CCc(c(c12)C)c(n1)cc3c(C)c4c([n-]3)c([C@H](C4=O)C(=O)OC)c5nc(cc6[n-]c(c2)c(C=C)c6C)[C@@H](C)[C@@H]5CCC(=O)OC/C=C(\C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C
10728	tr|O07720|O07720_M	P04190	72.0	76.0	256.0	DB02153	experimental	3-sulfino-L-alanine	OC(=O)[C@@H](N)C[S@](=O)O
10729	tr|O07720|O07720_M	P04190	72.0	76.0	256.0	DB04272	approved; nutraceutical; vet_approved	Citric acid	OC(=O)CC(O)(C(=O)O)CC(=O)O
10730	tr|O07720|O07720_M	C7C422	74.0	78.0	263.0	DB04272	approved; nutraceutical; vet_approved	Citric acid	OC(=O)CC(O)(C(=O)O)CC(=O)O
10731	tr|O07720|O07720_M	P26918	77.6	56.0	250.0	DB02032	experimental	Epicaptopril	SC[C@H](C)C(=O)N1CCC[C@H]1C(=O)O
10732	tr|O07720|O07720_M	P20581	83.2	15.0	223.0	DB07418	experimental	bis(4-nitrophenyl) hydrogen phosphate	[O-][N+](=O)c1ccc(cc1)OP(=O)(O)Oc2ccc([N+]([O-])=O)cc2
10733	tr|O53485|O53485_M	Q9RHZ6	78.13	45.0	388.0	DB03277	experimental	alpha-maltotriose	O[C@H]1O[C@H](CO)[C@H]([C@H](O)[C@H]1O)O[C@H]2O[C@H](CO)[C@H]([C@H](O)[C@H]2O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
10734	tr|O53485|O53485_M	Q9RHZ6	78.13	45.0	388.0	DB03323	experimental; investigational	Maltose	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO
10735	tr|P96826|P96826_M	P00326	75.78	129.0	373.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10736	tr|P96826|P96826_M	P00326	75.78	129.0	373.0	DB01213	approved; vet_approved	Fomepizole	Cc1c[nH]nc1
10737	tr|P96826|P96826_M	P00326	75.78	129.0	373.0	DB01711	experimental	2,3,4,5,6-Pentafluorobenzyl Alcohol	OCc1c(F)c(F)c(F)c(F)c1F
10738	tr|P96826|P96826_M	P00326	75.78	129.0	373.0	DB02131	experimental	N-1-methylheptylformamide	O=CN[C@H](C)CCCCCC
10739	tr|P96826|P96826_M	P00326	75.78	129.0	373.0	DB02249	experimental	2-Ethoxyethanol	CCOCCO
10740	tr|P96826|P96826_M	P00326	75.78	129.0	373.0	DB02659	approved	Cholic Acid	OC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](C[C@@H]2O)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
10741	tr|P96826|P96826_M	P00326	75.78	129.0	373.0	DB02721	experimental	4-Iodopyrazole	Ic1c[nH]nc1
10742	tr|P96826|P96826_M	P00326	75.78	129.0	373.0	DB02757	experimental	Pyrazole	[nH]1cccn1
10743	tr|P96826|P96826_M	P00326	75.78	129.0	373.0	DB02822	experimental	Para-Bromobenzyl Alcohol	OCc1ccc(Br)cc1
10744	tr|P96826|P96826_M	P00326	75.78	129.0	373.0	DB02871	experimental	3-Butylthiolane 1-Oxide	O=[S@@]1C[C@H](CC1)CCCC
10745	tr|P96826|P96826_M	P00326	75.78	129.0	373.0	DB03020	experimental	5-beta-D-ribofuranosylnicotinamide adenine dinucleotide	NC(=O)c1c[nH+]cc(c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10746	tr|P96826|P96826_M	P00326	75.78	129.0	373.0	DB03061	experimental	(R)-N-(1-Methyl-Hexyl)-Formamide	CCCCC[C@H](C)NC=O
10747	tr|P96826|P96826_M	P00326	75.78	129.0	373.0	DB03226	experimental	Trifluoroethanol	OCC(F)(F)F
10748	tr|P96826|P96826_M	P00326	75.78	129.0	373.0	DB03559	experimental	Cyclohexylformamide	O=CNC1CCCCC1
10749	tr|P96826|P96826_M	P00326	75.78	129.0	373.0	DB04071	experimental	Cpad	NC(=O)c1nc(ccc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10750	tr|P96826|P96826_M	P00326	75.78	129.0	373.0	DB04113	experimental	N-Formylpiperidine	O=CN1CCCCC1
10751	tr|P96826|P96826_M	P00326	75.78	129.0	373.0	DB04312	experimental	2,3-Difluorobenzyl Alcohol	OCc1cccc(F)c1F
10752	tr|P96826|P96826_M	P00326	75.78	129.0	373.0	DB04448	experimental	2,4-Difluorobenzyl Alcohol 2,4-Difluoro-1-(Hydroxymethyl)Benzene	OCc1ccc(F)cc1F
10753	tr|P96826|P96826_M	P00325	75.78	129.0	373.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10754	tr|P96826|P96826_M	P00325	75.78	129.0	373.0	DB01213	approved; vet_approved	Fomepizole	Cc1c[nH]nc1
10755	tr|P96826|P96826_M	P00325	75.78	129.0	373.0	DB02481	experimental	N-Benzylformamide	O=CNCc1ccccc1
10756	tr|P96826|P96826_M	P00325	75.78	129.0	373.0	DB02721	experimental	4-Iodopyrazole	Ic1c[nH]nc1
10757	tr|P96826|P96826_M	P00325	75.78	129.0	373.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10758	tr|P96826|P96826_M	P00325	75.78	129.0	373.0	DB03703	experimental	Cyclohexanol	OC1CCCCC1
10759	tr|P96826|P96826_M	P00325	75.78	129.0	373.0	DB04105	experimental	N-Heptylformamide	CCCCCCCNC=O
10760	tr|P96826|P96826_M	P00325	75.78	129.0	373.0	DB09462	approved; investigational	Glycerin	OCC(O)CO
10761	tr|P96826|P96826_M	P07327	74.22	133.0	372.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10762	tr|P96826|P96826_M	P07327	74.22	133.0	372.0	DB01213	approved; vet_approved	Fomepizole	Cc1c[nH]nc1
10763	tr|P96826|P96826_M	P07327	74.22	133.0	372.0	DB02721	experimental	4-Iodopyrazole	Ic1c[nH]nc1
10764	tr|P96826|P96826_M	P07327	74.22	133.0	372.0	DB04065	experimental	N-Cyclopentyl-N-Cyclobutylformamide	C1CCC1N(C=O)C2CCCC2
10765	tr|P96826|P96826_M	P08319	77.64	127.0	377.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10766	tr|P96826|P96826_M	P08319	77.64	127.0	377.0	DB03559	experimental	Cyclohexylformamide	O=CNC1CCCCC1
10767	tr|P96826|P96826_M	P40394	76.71	137.0	384.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10768	tr|P96826|P96826_M	P11766	76.4	126.0	372.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10769	tr|P96826|P96826_M	P11766	76.4	126.0	372.0	DB03017	approved; experimental	Lauric acid	CCCCCCCCCCCC(=O)O
10770	tr|P96826|P96826_M	P11766	76.4	126.0	372.0	DB03704	experimental	12-Hydroxydodecanoic Acid	OCCCCCCCCCCCC(=O)O
10771	tr|P96826|P96826_M	P11766	76.4	126.0	372.0	DB04153	experimental	S-Hydroxymethyl Glutathione	OC(=O)[C@@H](N)CCC(=O)N[C@@H](CSCO)C(=O)NCC(=O)O
10772	tr|P96826|P96826_M	Q08257	99.07	8.0	327.0	DB00266	approved	Dicoumarol	c1cccc(c12)oc(=O)c(c2O)Cc(c(=O)o3)c(O)c(c34)cccc4
10773	tr|P96826|P96826_M	Q08257	99.07	8.0	327.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10775	tr|P96826|P96826_M	Q08257	99.07	8.0	327.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
10776	tr|P96826|P96826_M	P49327	91.61	1559.0	1854.0	DB01034	experimental	Cerulenin	NC(=O)[C@@H]1O[C@@H]1C(=O)CC/C=C/C/C=C/C
10777	tr|P96826|P96826_M	P49327	91.61	1559.0	1854.0	DB01083	approved; investigational	Orlistat	CCCCCCCCCCC[C@H](OC(=O)[C@@H](NC=O)CC(C)C)C[C@@H]1OC(=O)[C@H]1CCCCCC
10778	tr|P96826|P96826_M	P14941	79.19	84.0	339.0	DB02606	experimental; investigational	2-Butanol	CC[C@@H](C)O
10779	tr|P96826|P96826_M	P14941	79.19	84.0	339.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10780	tr|P96826|P96826_M	Q8N8N7	84.47	71.0	343.0	DB00328	approved; investigational	Indomethacin	COc(cc1)cc(c12)c(CC(=O)O)c(C)n2C(=O)c3ccc(Cl)cc3
10781	tr|P96826|P96826_M	Q8N8N7	84.47	71.0	343.0	DB07177	experimental	(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID	OC(=O)CCC/C=C/CC1C(C(O)CC1=O)/C=C/C(=O)CCCCC
10782	tr|P96826|P96826_M	Q14914	92.24	30.0	327.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10783	tr|P96826|P96826_M	Q14914	92.24	30.0	327.0	DB04066	experimental	p-Coumaric acid	OC(=O)/C=C/c1ccc(O)cc1
10784	tr|P96826|P96826_M	Q14914	92.24	30.0	327.0	DB07177	experimental	(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID	OC(=O)CCC/C=C/CC1C(C(O)CC1=O)/C=C/C(=O)CCCCC
10785	tr|P95075|P95075_M	P0AB87	85.78	9.0	196.0	DB03026	experimental	Phosphoglycolohydroxamic Acid	ONC(=O)COP(=O)(O)O
10786	tr|P95075|P95075_M	P0AB87	85.78	9.0	196.0	DB04326	investigational	Dihydroxyacetone phosphate	OCC(=O)COP(=O)(O)O
10787	tr|P95075|P95075_M	P32169	71.1	91.0	246.0	DB03026	experimental	Phosphoglycolohydroxamic Acid	ONC(=O)COP(=O)(O)O
10788	tr|O06178|O06178_M	Q9NPJ3	90.97	6.0	137.0	DB08688	experimental	2-Undecanone	CCCCCCCCCC(=O)C
10789	tr|O06178|O06178_M	Q04416	79.17	27.0	141.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
10790	tr|O06178|O06178_M	Q04416	79.17	27.0	141.0	DB03613	experimental	4-hydroxyphenacyl coenzyme A	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSCC(=O)c4ccc(O)cc4
10791	tr|O06178|O06178_M	Q04416	79.17	27.0	141.0	DB04067	experimental	4-hydroxybenzyl coenzyme A	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSCc4ccc(O)cc4
10792	tr|O06178|O06178_M	Q04416	79.17	27.0	141.0	DB04242	experimental	4-hydroxybenzoic acid	OC(=O)c1ccc(O)cc1
10793	tr|O53667|O53667_M	Q9LAG2	90.74	4.0	151.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
10794	tr|P95275|P95275_M	Q9LAG2	87.72	1.0	151.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
10795	tr|O33263|O33263_M	Q9WYS2	79.52	6.0	239.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10796	tr|O33263|O33263_M	Q9BTZ2	77.82	30.0	258.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
10797	tr|O33263|O33263_M	P0AEK2	76.45	2.0	226.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10798	tr|O33263|O33263_M	P16544	81.57	1.0	240.0	DB01942	experimental; investigational	Formic acid	OC=O
10799	tr|O33263|O33263_M	P16544	81.57	1.0	240.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10800	tr|O33263|O33263_M	P16544	81.57	1.0	240.0	DB07715	investigational	Emodin	Cc(c1)cc(O)c(c12)C(=O)c3c(C2=O)cc(O)cc3O
10801	tr|O33263|O33263_M	P0AET8	76.45	8.0	232.0	DB02123	experimental	Glycochenodeoxycholic Acid	OC(=O)CNC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
10803	tr|O33263|O33263_M	Q92506	80.55	7.0	243.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10804	tr|O33263|O33263_M	Q92506	80.55	7.0	243.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10805	tr|O33263|O33263_M	Q84EX5	79.18	3.0	235.0	DB04619	experimental	Acetophenone	CC(=O)c1ccccc1
10806	tr|O33263|O33263_M	Q84EX5	79.18	3.0	235.0	DB04784	experimental	(R)-1-phenylethanol	C[C@@H](O)c1ccccc1
10807	tr|O33263|O33263_M	Q9BY49	78.5	16.0	246.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
10808	tr|O33263|O33263_M	Q7Z4W1	74.06	5.0	222.0	DB02831	experimental	Dihydrogenphosphate	OP([O-])(=O)O
10809	tr|O33263|O33263_M	Q7Z4W1	74.06	5.0	222.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10810	tr|O33263|O33263_M	P0CG22	78.5	30.0	260.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
10811	tr|O33263|O33263_M	P0CG22	78.5	30.0	260.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10812	tr|O33263|O33263_M	P0CG22	78.5	30.0	260.0	DB03541	experimental	10-Propargyl-5,8-Dideazafolic Acid	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(CC#C)Cc(c2)ccc(c23)[nH]c(N)nc3=O
10813	tr|O33263|O33263_M	P0CG22	78.5	30.0	260.0	DB07689	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)NCc(cn3)nc(c34)c(N)nc(n4)N
10814	tr|O33263|O33263_M	P0CG22	78.5	30.0	260.0	DB07765	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)N(C)Cc(cn3)nc(c34)c(N)nc(n4)N
10815	tr|O33263|O33263_M	Q16698	78.5	55.0	285.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10816	tr|O33263|O33263_M	Q16698	78.5	55.0	285.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
10817	tr|O33263|O33263_M	A0A348A0U3	79.52	1.0	234.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
10818	tr|O33263|O33263_M	Q02338	72.35	55.0	267.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10819	tr|O33263|O33263_M	Q6UWP2	78.84	6.0	237.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10820	tr|O33263|O33263_M	Q6GI75	79.52	1.0	234.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
10821	tr|O33263|O33263_M	Q6GI75	79.52	1.0	234.0	DB11155	approved	Triclocarban	Clc1ccc(cc1)NC(=O)Nc2cc(Cl)c(Cl)cc2
10822	tr|O33263|O33263_M	Q8NBN7	79.52	36.0	269.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
10823	tr|O33263|O33263_M	Q99714	74.4	7.0	225.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10824	tr|O33263|O33263_M	Q99714	74.4	7.0	225.0	DB02820	experimental	1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct	C1CCCCCN1C(=O)[C@H](c2ccccc2)n(c3=S)cnc(c34)nn(c4)[C@H]5C=CN(C=C5C([O-])=N)[C@@H]6O[C@@H]([C@@H](O)[C@H]6O)COP([O-])(=O)OP(=O)(O)OC[C@H]7O[C@H]([C@H]([O-])[C@@H]7[O-])n8cnc(c89)c(N)ncn9
10825	tr|O33263|O33263_M	Q99714	74.4	7.0	225.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
10826	tr|O33263|O33263_M	Q9HBH5	85.32	41.0	291.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
10827	tr|O33263|O33263_M	P80365	72.35	81.0	293.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10828	tr|O33263|O33263_M	P80365	72.35	81.0	293.0	DB01185	approved; illicit	Fluoxymesterone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@](F)([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
10829	tr|O33263|O33263_M	P80365	72.35	81.0	293.0	DB01569	experimental; illicit	Formebolone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@H]([C@@H](C2)O)[C@]4(C)C(CC3)=CC(=O)C(C=O)=C4
10830	tr|O33263|O33263_M	P80365	72.35	81.0	293.0	DB14538	experimental; vet_approved	Hydrocortisone aceponate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CC)C(=O)COC(=O)C
10831	tr|O33263|O33263_M	P80365	72.35	81.0	293.0	DB14539	approved; vet_approved	Hydrocortisone acetate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)C
10832	tr|O33263|O33263_M	P80365	72.35	81.0	293.0	DB14540	approved; vet_approved	Hydrocortisone butyrate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCC
10833	tr|O33263|O33263_M	P80365	72.35	81.0	293.0	DB14541	approved; investigational; vet_approved	Hydrocortisone cypionate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)CCC5CCCC5
10834	tr|O33263|O33263_M	P80365	72.35	81.0	293.0	DB14542	approved; vet_approved	Hydrocortisone phosphate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COP(=O)(O)O
10835	tr|O33263|O33263_M	P80365	72.35	81.0	293.0	DB14543	approved; vet_approved	Hydrocortisone probutate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CCC)C(=O)COC(=O)CC
10836	tr|O33263|O33263_M	P80365	72.35	81.0	293.0	DB14544	approved; vet_approved	Hydrocortisone valerate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCCC
10837	tr|O33263|O33263_M	P0AEK4	79.18	1.0	233.0	DB01691	experimental	Indole Naphthyridinone	c1cccc(c12)n(C)cc2CN(C)C(=O)/C=C/c(c3)cnc(c34)NC(=O)CC4
10838	tr|O33263|O33263_M	P0AEK4	79.18	1.0	233.0	DB01865	experimental	3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide	c1cccc(c12)cc(n2C)CN(C)C(=O)/C=C/c3cnc(N)cc3
10839	tr|O33263|O33263_M	P0AEK4	79.18	1.0	233.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
10840	tr|O33263|O33263_M	P0AEK4	79.18	1.0	233.0	DB03030	experimental	4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole	Cc1ccc(cc1)Cn2cnc(c2)-c3cccs3
10841	tr|O33263|O33263_M	P0AEK4	79.18	1.0	233.0	DB03534	experimental	3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide	CC(=O)N(C)Cc1c(N)ccc(c1)C(=O)N(C)Cc(n2C)cc(c23)cccc3
10842	tr|O33263|O33263_M	P0AEK4	79.18	1.0	233.0	DB04030	experimental	1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole	Oc1ccc(cc1)Cn2c(c3c(c24)cccc4)CN(CC3)C(=O)c5ccc(O)cc5
10843	tr|O33263|O33263_M	P0AEK4	79.18	1.0	233.0	DB08265	experimental	2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL	Cc1ccc(cc1)S(=O)(=O)n(b2O)ncc(c23)cccc3
10844	tr|O33263|O33263_M	P0AEK4	79.18	1.0	233.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
10845	tr|O33263|O33263_M	P0AEK4	79.18	1.0	233.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
10846	tr|O33263|O33263_M	P37059	72.7	80.0	293.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10847	tr|O33263|O33263_M	P37059	72.7	80.0	293.0	DB13952	approved; investigational; vet_approved	Estradiol acetate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)C
10848	tr|O33263|O33263_M	P37059	72.7	80.0	293.0	DB13953	approved; investigational; vet_approved	Estradiol benzoate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)c5ccccc5
10849	tr|O33263|O33263_M	P37059	72.7	80.0	293.0	DB13954	approved; investigational; vet_approved	Estradiol cypionate	C1CCCC1CCC(=O)O[C@H]2CC[C@H]([C@@]23C)[C@H]4[C@H](CC3)c5c(CC4)cc(O)cc5
10850	tr|O33263|O33263_M	P37059	72.7	80.0	293.0	DB13955	approved; investigational; vet_approved	Estradiol dienanthate	CCCCCCC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)CCCCCC
10851	tr|O33263|O33263_M	P37059	72.7	80.0	293.0	DB13956	approved; investigational; vet_approved	Estradiol valerate	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)CC[C@@H]4OC(=O)CCCC
10852	tr|O33263|O33263_M	O24990	78.5	1.0	231.0	DB04393	experimental	Soneclosan	Clc1cc(O)c(cc1)Oc2ccc(Cl)cc2
10853	tr|O33263|O33263_M	O24990	78.5	1.0	231.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
10854	tr|O33263|O33263_M	P56937	78.16	2.0	231.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10855	tr|O33263|O33263_M	Q7AUG5	76.11	3.0	226.0	DB04782	experimental	(S)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@H]2CO2
10856	tr|O33263|O33263_M	Q93D82	76.11	3.0	226.0	DB04472	experimental	(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol	[N-]=[N+]=NC[C@H](O)c1ccc([N+]([O-])=O)cc1
10857	tr|O33263|O33263_M	Q93D82	76.11	3.0	226.0	DB04499	experimental	(R)-styrene oxide	C1O[C@@H]1c2ccccc2
10858	tr|O33263|O33263_M	Q93D82	76.11	3.0	226.0	DB04777	experimental	(R)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@@H]2CO2
10859	tr|O33263|O33263_M	Q01782	74.74	7.0	226.0	DB02338	experimental	NADPH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10860	tr|O33263|O33263_M	Q01782	74.74	7.0	226.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
10861	tr|O33263|O33263_M	Q01782	74.74	7.0	226.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10862	tr|O33263|O33263_M	Q01782	74.74	7.0	226.0	DB04400	experimental	L-erythro-7,8-dihydrobiopterin	C[C@H](O)[C@H](O)C(CN1)=Nc(c12)c(=O)nc([nH]2)N
10863	tr|O05773|O05773_M	Q72JJ3	97.87	11.0	379.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
10864	tr|O05773|O05773_M	Q9UKU7	98.94	42.0	414.0	DB01675	experimental	Methacrylyl-Coenzyme A	CC(=C)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
10865	tr|O05773|O05773_M	Q9UKU7	98.94	42.0	414.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
10866	tr|O05773|O05773_M	P16219	96.54	44.0	407.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10867	tr|O05773|O05773_M	P16219	96.54	44.0	407.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
10868	tr|O05773|O05773_M	P16219	96.54	44.0	407.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
10869	tr|O05773|O05773_M	P11310	99.47	44.0	418.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
10870	tr|O05773|O05773_M	P11310	99.47	44.0	418.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
10871	tr|O05773|O05773_M	P11310	99.47	44.0	418.0	DB03415	experimental	3-thiaoctanoyl-CoA	CCCCCSCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
10872	tr|O05773|O05773_M	P45954	97.61	61.0	428.0	DB00167	investigational; nutraceutical	Isoleucine	CC[C@H](C)[C@H](N)C(=O)O
10873	tr|O05773|O05773_M	P45954	97.61	61.0	428.0	DB00313	approved; investigational	Valproic acid	CCCC(C(=O)O)CCC
10874	tr|O05773|O05773_M	Q06319	97.61	15.0	382.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
10875	tr|O05773|O05773_M	Q06319	97.61	15.0	382.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
10876	tr|O05773|O05773_M	Q3JP94	94.95	30.0	387.0	DB08685	experimental	1-(1,4-dimethyl-1,2,3,4-tetrahydroquinoxalin-6-yl)methanamine	CN1CCN(C)c(c12)cc(cc2)CN
10877	tr|O05773|O05773_M	Q92947	92.29	81.0	428.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
10878	tr|O05773|O05773_M	Q92947	92.29	81.0	428.0	DB03245	experimental	S-4-Nitrobutyryl-CoA	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCC[N+]([O-])=O
10879	tr|O05773|O05773_M	P26440	97.87	50.0	418.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
10880	tr|O05773|O05773_M	P26440	97.87	50.0	418.0	DB04036	experimental	Coenzyme A persulfide	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSS
10881	tr|O05773|O05773_M	Q9KIE5	93.62	14.0	366.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
10882	tr|O53613|O53613_M	Q8TC12	92.74	35.0	316.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
10883	tr|O53613|O53613_M	Q96NR8	91.75	35.0	313.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
10884	tr|O53613|O53613_M	Q8NBN7	94.72	35.0	322.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
10885	tr|O53613|O53613_M	Q9HBH5	96.7	41.0	334.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
10886	tr|O53613|O53613_M	P0AET8	78.88	6.0	245.0	DB02123	experimental	Glycochenodeoxycholic Acid	OC(=O)CNC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
10887	tr|O53613|O53613_M	Q6UWP2	77.56	9.0	244.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10888	tr|O53613|O53613_M	P0AEK2	74.59	2.0	228.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10889	tr|O53613|O53613_M	Q9BTZ2	73.27	30.0	252.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
10891	tr|O53613|O53613_M	Q84EX5	76.24	4.0	235.0	DB04619	experimental	Acetophenone	CC(=O)c1ccccc1
10892	tr|O53613|O53613_M	Q84EX5	76.24	4.0	235.0	DB04784	experimental	(R)-1-phenylethanol	C[C@@H](O)c1ccccc1
10894	tr|O53613|O53613_M	O75911	73.6	31.0	254.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
10895	tr|O53613|O53613_M	P56937	81.19	2.0	248.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10896	tr|O53613|O53613_M	Q99714	76.9	2.0	235.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10897	tr|O53613|O53613_M	Q99714	76.9	2.0	235.0	DB02820	experimental	1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct	C1CCCCCN1C(=O)[C@H](c2ccccc2)n(c3=S)cnc(c34)nn(c4)[C@H]5C=CN(C=C5C([O-])=N)[C@@H]6O[C@@H]([C@@H](O)[C@H]6O)COP([O-])(=O)OP(=O)(O)OC[C@H]7O[C@H]([C@H]([O-])[C@@H]7[O-])n8cnc(c89)c(N)ncn9
10898	tr|O53613|O53613_M	Q99714	76.9	2.0	235.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
10899	tr|O53613|O53613_M	Q92506	77.56	8.0	243.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10900	tr|O53613|O53613_M	Q92506	77.56	8.0	243.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10901	tr|O53613|O53613_M	P14061	84.82	2.0	259.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10902	tr|O53613|O53613_M	P14061	84.82	2.0	259.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
10903	tr|O53613|O53613_M	P14061	84.82	2.0	259.0	DB01561	experimental; illicit	Androstanedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
10904	tr|O53613|O53613_M	P14061	84.82	2.0	259.0	DB02187	experimental	Equilin	O=C1CC[C@H]([C@@]12C)C=3[C@H](CC2)c4c(CC3)cc(O)cc4
10905	tr|O53613|O53613_M	P14061	84.82	2.0	259.0	DB02323	experimental	EM-1745	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)C[C@@H]([C@@H]4O)CCCCCCCCC(=O)OC[C@H]5O[C@H]([C@H](O)[C@@H]5O)n6cnc(c67)c(N)ncn7
10906	tr|O53613|O53613_M	P14061	84.82	2.0	259.0	DB02901	illicit; investigational	Stanolone	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
10907	tr|O53613|O53613_M	P14061	84.82	2.0	259.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
10908	tr|O53613|O53613_M	P14061	84.82	2.0	259.0	DB13951	experimental	Stanolone acetate	CC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
10909	tr|O53613|O53613_M	O24990	87.79	4.0	270.0	DB04393	experimental	Soneclosan	Clc1cc(O)c(cc1)Oc2ccc(Cl)cc2
10910	tr|O53613|O53613_M	O24990	87.79	4.0	270.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
10911	tr|I6X4S7|I6X4S7_M	P0AGG2	97.86	9.0	284.0	DB04147	experimental	Dodecyldimethylamine N-oxide	CCCCCCCCCCCC[N+]([O-])(C)C
10912	tr|O06586|O06586_M	Q9ZGI2	91.45	96.0	1026.0	DB07703	experimental	(3R,4S,5S,7R,9E,11R,12R)-12-ETHYL-4-HYDROXY-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE	C[C@@H]1C[C@H](C)[C@H](O)[C@@H](C)C(=O)O[C@H](CC)[C@H](C)/C=C/C1=O
10913	tr|O06586|O06586_M	Q9ZGI2	91.45	96.0	1026.0	DB08431	experimental	[(3R,4S)-4-HYDROXY-3-METHYL-2-OXOHEXYL]PHOSPHONIC ACID	CC[C@H](O)[C@@H](C)C(=O)C[P@@H](=O)O
10914	tr|O06586|O06586_M	Q9ZGI2	91.45	96.0	1026.0	DB08759	experimental	[(3R,4S,5S,7R)-4,8-DIHYDROXY-3,5,7-TRIMETHYL-2-OXOOCTYL]PHOSPHONIC ACID	OC[C@H](C)C[C@H](C)[C@H](O)[C@@H](C)C(=O)C[P@H](=O)O
10915	tr|O06586|O06586_M	P49327	75.61	50.0	819.0	DB01034	experimental	Cerulenin	NC(=O)[C@@H]1O[C@@H]1C(=O)CC/C=C/C/C=C/C
10916	tr|O06586|O06586_M	P49327	75.61	50.0	819.0	DB01083	approved; investigational	Orlistat	CCCCCCCCCCC[C@H](OC(=O)[C@@H](NC=O)CC(C)C)C[C@@H]1OC(=O)[C@H]1CCCCCC
10917	tr|I6YEH6|I6YEH6_M	P30084	97.99	43.0	287.0	DB02563	experimental	Hexanoyl-CoA	CCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
10918	tr|I6YEH6|I6YEH6_M	P30084	97.99	43.0	287.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
10919	tr|I6YEH6|I6YEH6_M	P30084	97.99	43.0	287.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
10920	tr|I6YEH6|I6YEH6_M	P30084	97.99	43.0	287.0	DB04117	experimental	4-(N,N-Dimethylamino)cinnamoyl-CoA	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)/C=C/c4ccc(cc4)N(C)C
10921	tr|I6YEH6|I6YEH6_M	P30084	97.99	43.0	287.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
10922	tr|I6YEH6|I6YEH6_M	P52045	101.61	4.0	257.0	DB03117	experimental	2-carboxypropyl-coenzyme A	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC[C@H](C)C(=O)O
10923	tr|I6YEH6|I6YEH6_M	O75521	100.8	140.0	391.0	DB08231	experimental	Myristic acid	CCCCCCCCCCCCCC(=O)O
10924	tr|I6YEH6|I6YEH6_M	P9WNP5	104.82	42.0	303.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
10925	tr|I6YEH6|I6YEH6_M	P9WNP5	104.82	42.0	303.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
10926	tr|I6YEH6|I6YEH6_M	O68600	90.36	9.0	234.0	DB01652	experimental	4-hydroxybenzoyl-CoA	Oc1ccc(cc1)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2OP(=O)(O)O)n3cnc(c34)c(N)ncn4
10927	tr|I6YEH6|I6YEH6_M	Q93TU6	95.58	18.0	256.0	DB02906	experimental	(2s,4s)-Alpha-Campholinic Acid	CC1(C)[C@H](C)C(=O)C[C@H]1CC(O)O
10928	tr|I6YEH6|I6YEH6_M	P42126	98.39	53.0	298.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
10929	tr|I6YEH6|I6YEH6_M	P42126	98.39	53.0	298.0	DB03127	experimental	Benzamidine	NC(=[NH2+])c1ccccc1
10930	tr|I6YEH6|I6YEH6_M	Q6NVY1	99.6	36.0	284.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
10931	tr|I6YEH6|I6YEH6_M	Q08426	86.35	8.0	223.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10932	tr|I6YEH6|I6YEH6_M	P28793	81.12	12.0	214.0	DB08249	experimental	3,6,9,12,15-PENTAOXATRICOSAN-1-OL	CCCCCCCCOCCOCCOCCOCCOCCO
10933	tr|I6YEH6|I6YEH6_M	P40939	71.49	45.0	223.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
10934	tr|L7N699|L7N699_M	Q9NUB1	90.57	140.0	649.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
10935	tr|L7N699|L7N699_M	Q8ZKF6	94.84	103.0	636.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
10936	tr|L7N699|L7N699_M	Q8ZKF6	94.84	103.0	636.0	DB03230	experimental	Adenosine-5'-Propylphosphate	CCCOP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
10937	tr|L7N699|L7N699_M	Q9NR19	98.04	131.0	682.0	DB00131	approved; investigational; nutraceutical	Adenosine phosphate	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
10938	tr|L7N699|L7N699_M	Q9NR19	98.04	131.0	682.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
10939	tr|L7N699|L7N699_M	P40871	87.19	40.0	530.0	DB01672	experimental	2,3-Dihydroxy-Benzoic Acid	OC(=O)c1cccc(O)c1O
10940	tr|L7N699|L7N699_M	Q8GN86	72.24	30.0	436.0	DB03728	experimental	p-Chlorobenzoic acid	OC(=O)c1ccc(Cl)cc1
10941	tr|P71977|P71977_M	Q9WXS0	86.49	3.0	227.0	DB01942	experimental; investigational	Formic acid	OC=O
10942	tr|O69728|O69728_M	Q9I5I9	100.64	22.0	652.0	DB06893	experimental	Decylsulfonic acid	CCCCCCCCCCS(=O)(=O)O
10943	tr|O69728|O69728_M	Q9I5I9	100.64	22.0	652.0	DB06894	experimental	1-Dodecanol	CCCCCCCCCCCCO
10944	tr|O06138|O06138_M	Q2M3G0	78.94	182.0	598.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
10945	tr|O06138|O06138_M	Q2M3G0	78.94	182.0	598.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
10946	tr|O06138|O06138_M	Q2M3G0	77.23	822.0	1229.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
10947	tr|O06138|O06138_M	Q2M3G0	77.23	822.0	1229.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
10948	tr|O06138|O06138_M	P08183	77.8	194.0	604.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
10949	tr|O06138|O06138_M	P08183	77.8	194.0	604.0	DB00603	approved; investigational	Medroxyprogesterone acetate	CC(=O)O[C@]1(C(=O)C)CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C([C@H](C3)C)=CC(=O)CC4
10950	tr|O06138|O06138_M	P08183	77.8	194.0	604.0	DB00778	approved; investigational; withdrawn	Roxithromycin	COCCOCO/N=C([C@H](C)[C@@H](O)[C@]1(C)O)/[C@H](C)C[C@@](C)(O)[C@@H]([C@@H](C)[C@@H]([C@@H](C)C(=O)O[C@@H]1CC)O[C@@H](C[C@@]2(C)OC)O[C@@H](C)[C@@H]2O)O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C
10951	tr|O06138|O06138_M	P08183	77.8	194.0	604.0	DB00813	approved; illicit; investigational; vet_approved	Fentanyl	c1ccccc1N(C(=O)CC)C2CCN(CC2)CCc3ccccc3
10952	tr|O06138|O06138_M	P08183	77.8	194.0	604.0	DB04877	experimental	Voacamine	CC[C@H]1C[C@@H](C2)CN([C@@H]1[C@@]23C(=O)OC)CCc4c3[nH]c5c4cc(OC)c(c5)[C@@H](C[C@H]67)c8c(c9c([nH]8)cccc9)C[C@H](C6C(=O)OC)N(C)CC\7=C\C
10953	tr|O06138|O06138_M	P08183	77.8	194.0	604.0	DB04881	investigational	Elacridar	COc1cccc(c12)c(=O)c3c([nH]2)c(ccc3)C(=O)Nc4ccc(cc4)CCN(C5)CCc(c56)cc(OC)c(c6)OC
10954	tr|O06138|O06138_M	P08183	77.8	194.0	604.0	DB04905	investigational	Tesmilifene	CCN(CC)CCOc1ccc(cc1)Cc2ccccc2
10955	tr|O06138|O06138_M	P08183	77.8	194.0	604.0	DB05449	investigational	FM-VP4	 
10956	tr|O06138|O06138_M	P08183	77.8	194.0	604.0	DB06191	investigational	Zosuquidar	FC1(F)[C@H]2[C@@H]1c(cccc3)c3[C@@H](c(c24)cccc4)N5CCN(CC5)C[C@@H](O)COc6cccc(c67)nccc7
10957	tr|O06138|O06138_M	P08183	77.8	194.0	604.0	DB06240	investigational	Tariquidar	COc(c1)c(OC)cc(c12)CCN(C2)CCc3ccc(cc3)NC(=O)c4cc(OC)c(OC)cc4NC(=O)c(c5)cnc(c56)cccc6
10958	tr|O06138|O06138_M	P08183	77.8	194.0	604.0	DB09031	approved; investigational	Miltefosine	CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C
10959	tr|O06138|O06138_M	P08183	77.8	194.0	604.0	DB11635	approved	Tocofersolan	 
10960	tr|O06138|O06138_M	P08183	77.8	194.0	604.0	DB14061	experimental	Hycanthone	CCN(CC)CCNc(ccc1CO)c(c12)c(=O)c3c(s2)cccc3
10961	tr|O06138|O06138_M	P08183	77.8	194.0	604.0	DB14062	experimental	Concanamycin A	NC(=O)O[C@@H]1[C@@H](C)O[C@H](C[C@H]1O)O[C@H](C2)[C@H](C)[C@@H](/C=C/C)O[C@@]2(O)[C@@H](C)[C@H](O)[C@H](C)[C@H]3OC(=O)/C(OC)=C/C(C)=C/[C@@H](C)[C@@H](O)[C@@H](CC)[C@@H](O)[C@H](C)C/C(C)=C/C=C/[C@@H]3OC
10962	tr|O06138|O06138_M	P08183	77.8	194.0	604.0	DB14063	experimental	Dexverapamil	COc1ccc(cc1OC)CCN(C)CCC[C@@](C#N)(C(C)C)c2cc(OC)c(OC)cc2
10963	tr|O06138|O06138_M	P08183	77.8	194.0	604.0	DB14064	experimental	Emopamil	c1ccccc1C(C#N)(C(C)C)CCCN(C)CCc2ccccc2
10964	tr|O06138|O06138_M	P08183	77.8	194.0	604.0	DB14065	experimental	Lomerizine	COc1ccc(c(OC)c1OC)CN2CCN(CC2)C(c3ccc(F)cc3)c4ccc(F)cc4
10965	tr|O06138|O06138_M	P08183	77.8	194.0	604.0	DB14066	experimental	Tetrandrine	c12ccc(OC)c(c1)Oc3ccc(cc3)C[C@H]4c5c(CCN4C)cc(OC)c(c5)Oc6c7c(CCN(C)[C@H]7C2)cc(OC)c6OC
10966	tr|O06138|O06138_M	P08183	77.8	194.0	604.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
10967	tr|O06138|O06138_M	P08183	77.8	194.0	604.0	DB14068	experimental	Dexniguldipine	[O-][N+](=O)c1cccc(c1)[C@@H]2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCCN(CC3)CCC3(c4ccccc4)c5ccccc5
10968	tr|O06138|O06138_M	P08183	77.8	194.0	604.0	DB14069	investigational	ONT-093	CCOC/C=C/c1ccc(cc1)-c2nc(-c3ccc(cc3)NC(C)C)c([nH]2)-c4ccc(cc4)NC(C)C
10969	tr|O06138|O06138_M	P08183	77.8	194.0	604.0	DB14070	experimental	HM-30181	c1cccc(c12)c(=O)cc(o2)C(=O)Nc3cc(OC)c(OC)cc3-c4nn(nn4)-c5ccc(cc5)CCN(C6)CCc(c67)cc(OC)c(c7)OC
10970	tr|O06138|O06138_M	P08183	77.8	194.0	604.0	DB14071	experimental	Desmethylsertraline	c1cccc(c12)[C@@H](CC[C@@H]2N)c3cc(Cl)c(Cl)cc3
10971	tr|O06138|O06138_M	P08183	77.8	194.0	604.0	DB14072	experimental	Reversin 121	c1ccccc1COC(=O)C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@H](C(=O)OC(C)(C)C)CCCCNC(=O)OCc2ccccc2
10972	tr|O06138|O06138_M	P08183	78.75	834.0	1249.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
10973	tr|O06138|O06138_M	P08183	78.75	834.0	1249.0	DB00603	approved; investigational	Medroxyprogesterone acetate	CC(=O)O[C@]1(C(=O)C)CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C([C@H](C3)C)=CC(=O)CC4
10974	tr|O06138|O06138_M	P08183	78.75	834.0	1249.0	DB00778	approved; investigational; withdrawn	Roxithromycin	COCCOCO/N=C([C@H](C)[C@@H](O)[C@]1(C)O)/[C@H](C)C[C@@](C)(O)[C@@H]([C@@H](C)[C@@H]([C@@H](C)C(=O)O[C@@H]1CC)O[C@@H](C[C@@]2(C)OC)O[C@@H](C)[C@@H]2O)O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C
10975	tr|O06138|O06138_M	P08183	78.75	834.0	1249.0	DB00813	approved; illicit; investigational; vet_approved	Fentanyl	c1ccccc1N(C(=O)CC)C2CCN(CC2)CCc3ccccc3
10976	tr|O06138|O06138_M	P08183	78.75	834.0	1249.0	DB04877	experimental	Voacamine	CC[C@H]1C[C@@H](C2)CN([C@@H]1[C@@]23C(=O)OC)CCc4c3[nH]c5c4cc(OC)c(c5)[C@@H](C[C@H]67)c8c(c9c([nH]8)cccc9)C[C@H](C6C(=O)OC)N(C)CC\7=C\C
10977	tr|O06138|O06138_M	P08183	78.75	834.0	1249.0	DB04881	investigational	Elacridar	COc1cccc(c12)c(=O)c3c([nH]2)c(ccc3)C(=O)Nc4ccc(cc4)CCN(C5)CCc(c56)cc(OC)c(c6)OC
10978	tr|O06138|O06138_M	P08183	78.75	834.0	1249.0	DB04905	investigational	Tesmilifene	CCN(CC)CCOc1ccc(cc1)Cc2ccccc2
10979	tr|O06138|O06138_M	P08183	78.75	834.0	1249.0	DB05449	investigational	FM-VP4	 
10980	tr|O06138|O06138_M	P08183	78.75	834.0	1249.0	DB06191	investigational	Zosuquidar	FC1(F)[C@H]2[C@@H]1c(cccc3)c3[C@@H](c(c24)cccc4)N5CCN(CC5)C[C@@H](O)COc6cccc(c67)nccc7
10981	tr|O06138|O06138_M	P08183	78.75	834.0	1249.0	DB06240	investigational	Tariquidar	COc(c1)c(OC)cc(c12)CCN(C2)CCc3ccc(cc3)NC(=O)c4cc(OC)c(OC)cc4NC(=O)c(c5)cnc(c56)cccc6
10982	tr|O06138|O06138_M	P08183	78.75	834.0	1249.0	DB09031	approved; investigational	Miltefosine	CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C
10983	tr|O06138|O06138_M	P08183	78.75	834.0	1249.0	DB11635	approved	Tocofersolan	 
10984	tr|O06138|O06138_M	P08183	78.75	834.0	1249.0	DB14061	experimental	Hycanthone	CCN(CC)CCNc(ccc1CO)c(c12)c(=O)c3c(s2)cccc3
10985	tr|O06138|O06138_M	P08183	78.75	834.0	1249.0	DB14062	experimental	Concanamycin A	NC(=O)O[C@@H]1[C@@H](C)O[C@H](C[C@H]1O)O[C@H](C2)[C@H](C)[C@@H](/C=C/C)O[C@@]2(O)[C@@H](C)[C@H](O)[C@H](C)[C@H]3OC(=O)/C(OC)=C/C(C)=C/[C@@H](C)[C@@H](O)[C@@H](CC)[C@@H](O)[C@H](C)C/C(C)=C/C=C/[C@@H]3OC
10986	tr|O06138|O06138_M	P08183	78.75	834.0	1249.0	DB14063	experimental	Dexverapamil	COc1ccc(cc1OC)CCN(C)CCC[C@@](C#N)(C(C)C)c2cc(OC)c(OC)cc2
10987	tr|O06138|O06138_M	P08183	78.75	834.0	1249.0	DB14064	experimental	Emopamil	c1ccccc1C(C#N)(C(C)C)CCCN(C)CCc2ccccc2
10988	tr|O06138|O06138_M	P08183	78.75	834.0	1249.0	DB14065	experimental	Lomerizine	COc1ccc(c(OC)c1OC)CN2CCN(CC2)C(c3ccc(F)cc3)c4ccc(F)cc4
10989	tr|O06138|O06138_M	P08183	78.75	834.0	1249.0	DB14066	experimental	Tetrandrine	c12ccc(OC)c(c1)Oc3ccc(cc3)C[C@H]4c5c(CCN4C)cc(OC)c(c5)Oc6c7c(CCN(C)[C@H]7C2)cc(OC)c6OC
10990	tr|O06138|O06138_M	P08183	78.75	834.0	1249.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
10991	tr|O06138|O06138_M	P08183	78.75	834.0	1249.0	DB14068	experimental	Dexniguldipine	[O-][N+](=O)c1cccc(c1)[C@@H]2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCCN(CC3)CCC3(c4ccccc4)c5ccccc5
10992	tr|O06138|O06138_M	P08183	78.75	834.0	1249.0	DB14069	investigational	ONT-093	CCOC/C=C/c1ccc(cc1)-c2nc(-c3ccc(cc3)NC(C)C)c([nH]2)-c4ccc(cc4)NC(C)C
10993	tr|O06138|O06138_M	P08183	78.75	834.0	1249.0	DB14070	experimental	HM-30181	c1cccc(c12)c(=O)cc(o2)C(=O)Nc3cc(OC)c(OC)cc3-c4nn(nn4)-c5ccc(cc5)CCN(C6)CCc(c67)cc(OC)c(c7)OC
10994	tr|O06138|O06138_M	P08183	78.75	834.0	1249.0	DB14071	experimental	Desmethylsertraline	c1cccc(c12)[C@@H](CC[C@@H]2N)c3cc(Cl)c(Cl)cc3
10995	tr|O06138|O06138_M	P08183	78.75	834.0	1249.0	DB14072	experimental	Reversin 121	c1ccccc1COC(=O)C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@H](C(=O)OC(C)(C)C)CCCCNC(=O)OCc2ccccc2
10996	tr|O06138|O06138_M	O95342	77.99	219.0	630.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
10997	tr|O06138|O06138_M	O95342	77.99	219.0	630.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
10998	tr|O06138|O06138_M	O95342	77.61	882.0	1291.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
10999	tr|O06138|O06138_M	O95342	77.61	882.0	1291.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
11000	tr|O06138|O06138_M	Q92887	75.33	438.0	835.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
11001	tr|O06138|O06138_M	Q92887	75.33	438.0	835.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
11002	tr|O06138|O06138_M	Q92887	76.28	1107.0	1509.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
11003	tr|O06138|O06138_M	Q92887	76.28	1107.0	1509.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
11004	tr|O06138|O06138_M	Q09428	88.05	441.0	905.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
11005	tr|O06138|O06138_M	Q09428	88.05	441.0	905.0	DB00222	approved	Glimepiride	CCC1=C(C)CN(C1=O)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3
11006	tr|O06138|O06138_M	Q09428	88.05	441.0	905.0	DB00672	approved; investigational	Chlorpropamide	CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1
11007	tr|O06138|O06138_M	Q09428	88.05	441.0	905.0	DB00731	approved; investigational	Nateglinide	CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](C(=O)O)Cc2ccccc2
11008	tr|O06138|O06138_M	Q09428	88.05	441.0	905.0	DB00912	approved; investigational	Repaglinide	CCOc1c(C(=O)O)ccc(c1)CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3
11009	tr|O06138|O06138_M	Q09428	88.05	441.0	905.0	DB01067	approved; investigational	Glipizide	Cc1ncc(nc1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
11010	tr|O06138|O06138_M	Q09428	88.05	441.0	905.0	DB01120	approved	Gliclazide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN(C2)CC(C23)CCC3
11011	tr|O06138|O06138_M	Q09428	88.05	441.0	905.0	DB01124	approved; investigational	Tolbutamide	CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1
11012	tr|O06138|O06138_M	Q09428	88.05	441.0	905.0	DB01251	approved; investigational	Gliquidone	COc(cc1)cc(c12)C(=O)N(C(=O)C2(C)C)CCc3ccc(cc3)S(=O)(=O)NC(=O)NC4CCCCC4
11013	tr|O06138|O06138_M	Q09428	88.05	441.0	905.0	DB01252	investigational	Mitiglinide	c1ccccc1C[C@H](C(=O)O)CC(=O)N(C2)C[C@H]([C@H]23)CCCC3
11014	tr|O06138|O06138_M	Q09428	88.05	441.0	905.0	DB01382	approved; investigational	Glymidine	COCCOc1cnc(nc1)NS(=O)(=O)c2ccccc2
11015	tr|O06138|O06138_M	Q09428	77.8	1142.0	1552.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
11016	tr|O06138|O06138_M	Q09428	77.8	1142.0	1552.0	DB00222	approved	Glimepiride	CCC1=C(C)CN(C1=O)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3
11017	tr|O06138|O06138_M	Q09428	77.8	1142.0	1552.0	DB00672	approved; investigational	Chlorpropamide	CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1
11018	tr|O06138|O06138_M	Q09428	77.8	1142.0	1552.0	DB00731	approved; investigational	Nateglinide	CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](C(=O)O)Cc2ccccc2
11019	tr|O06138|O06138_M	Q09428	77.8	1142.0	1552.0	DB00912	approved; investigational	Repaglinide	CCOc1c(C(=O)O)ccc(c1)CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3
11020	tr|O06138|O06138_M	Q09428	77.8	1142.0	1552.0	DB01067	approved; investigational	Glipizide	Cc1ncc(nc1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
11021	tr|O06138|O06138_M	Q09428	77.8	1142.0	1552.0	DB01120	approved	Gliclazide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN(C2)CC(C23)CCC3
11022	tr|O06138|O06138_M	Q09428	77.8	1142.0	1552.0	DB01124	approved; investigational	Tolbutamide	CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1
11023	tr|O06138|O06138_M	Q09428	77.8	1142.0	1552.0	DB01251	approved; investigational	Gliquidone	COc(cc1)cc(c12)C(=O)N(C(=O)C2(C)C)CCc3ccc(cc3)S(=O)(=O)NC(=O)NC4CCCCC4
11024	tr|O06138|O06138_M	Q09428	77.8	1142.0	1552.0	DB01252	investigational	Mitiglinide	c1ccccc1C[C@H](C(=O)O)CC(=O)N(C2)C[C@H]([C@H]23)CCCC3
11025	tr|O06138|O06138_M	Q09428	77.8	1142.0	1552.0	DB01382	approved; investigational	Glymidine	COCCOc1cnc(nc1)NS(=O)(=O)c2ccccc2
11026	tr|O06138|O06138_M	Q09428	88.05	441.0	905.0	DB00839	approved; investigational	Tolazamide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2
11027	tr|O06138|O06138_M	Q09428	88.05	441.0	905.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
11028	tr|O06138|O06138_M	Q09428	77.8	1142.0	1552.0	DB00839	approved; investigational	Tolazamide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2
11029	tr|O06138|O06138_M	Q09428	77.8	1142.0	1552.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
11030	tr|O06138|O06138_M	O60706	85.77	436.0	888.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
11031	tr|O06138|O06138_M	O60706	85.77	436.0	888.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
11032	tr|O06138|O06138_M	O60706	85.77	436.0	888.0	DB09220	approved; investigational	Nicorandil	[O-][N+](=O)OCCNC(=O)c1cccnc1
11033	tr|O06138|O06138_M	O60706	77.42	1114.0	1522.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
11034	tr|O06138|O06138_M	O60706	77.42	1114.0	1522.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
11035	tr|O06138|O06138_M	O60706	77.42	1114.0	1522.0	DB09220	approved; investigational	Nicorandil	[O-][N+](=O)OCCNC(=O)c1cccnc1
11036	tr|O06138|O06138_M	P33527	81.4	413.0	842.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
11037	tr|O06138|O06138_M	P33527	81.4	413.0	842.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
11038	tr|O06138|O06138_M	P33527	81.4	413.0	842.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
11039	tr|O06138|O06138_M	P33527	81.4	413.0	842.0	DB06176	approved; investigational	Romidepsin	O=C([C@H]12)N/C(=C\C)C(=O)N[C@@H](C(C)C)C(=O)O[C@@H](CC(=O)N[C@H](C(C)C)C(=O)N1)/C=C/CCSSC2
11040	tr|O06138|O06138_M	P33527	81.4	413.0	842.0	DB08855	experimental; investigational	Leukotriene C4	CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@@H](O)CCCC(=O)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@H](N)C(=O)O
11041	tr|O06138|O06138_M	P33527	77.04	1096.0	1502.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
11042	tr|O06138|O06138_M	P33527	77.04	1096.0	1502.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
11043	tr|O06138|O06138_M	P33527	77.04	1096.0	1502.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
11044	tr|O06138|O06138_M	P33527	77.04	1096.0	1502.0	DB06176	approved; investigational	Romidepsin	O=C([C@H]12)N/C(=C\C)C(=O)N[C@@H](C(C)C)C(=O)O[C@@H](CC(=O)N[C@H](C(C)C)C(=O)N1)/C=C/CCSSC2
11045	tr|O06138|O06138_M	P33527	77.04	1096.0	1502.0	DB08855	experimental; investigational	Leukotriene C4	CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@@H](O)CCCC(=O)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@H](N)C(=O)O
11046	tr|O06138|O06138_M	O95255	76.66	425.0	829.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
11047	tr|O06138|O06138_M	O95255	76.47	1071.0	1474.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
11048	tr|O06138|O06138_M	O15439	74.76	215.0	609.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
11049	tr|O06138|O06138_M	O15439	76.66	845.0	1249.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
11050	tr|O06138|O06138_M	O15440	76.28	999.0	1401.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
11051	tr|O06138|O06138_M	O15440	76.28	999.0	1401.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
11052	tr|O06138|O06138_M	P13569	79.7	202.0	622.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
11053	tr|O06138|O06138_M	P13569	79.7	202.0	622.0	DB00887	approved	Bumetanide	CCCCNc1c(c(S(=O)(=O)N)cc(c1)C(=O)O)Oc2ccccc2
11054	tr|O06138|O06138_M	P13569	79.7	202.0	622.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
11055	tr|O06138|O06138_M	P13569	79.7	202.0	622.0	DB01050	approved	Ibuprofen	CC(C)Cc1ccc(cc1)C(C)C(=O)O
11056	tr|O06138|O06138_M	P13569	79.7	202.0	622.0	DB02587	experimental; investigational	Colforsin	O[C@H]1CCC(C)(C)[C@@H]([C@]12C)[C@H](O)[C@H](OC(=O)C)[C@]3(C)[C@]2(O)C(=O)C[C@](O3)(C)C=C
11057	tr|O06138|O06138_M	P13569	79.7	202.0	622.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
11058	tr|O06138|O06138_M	P13569	79.7	202.0	622.0	DB04522	experimental	Dexfosfoserine	OC(=O)[C@@H](N)COP(=O)(O)O
11059	tr|O06138|O06138_M	P13569	79.7	202.0	622.0	DB04941	approved	Crofelemer	 
11060	tr|O06138|O06138_M	P13569	79.7	202.0	622.0	DB06266	investigational	Lonidamine	c1cccc(c12)n(nc2C(=O)O)Cc3c(Cl)cc(Cl)cc3
11061	tr|O06138|O06138_M	P13569	79.7	202.0	622.0	DB08820	approved	Ivacaftor	CC(C)(C)c1cc(C(C)(C)C)c(O)cc1NC(=O)c(c2=O)c[nH]c(c23)cccc3
11062	tr|O06138|O06138_M	P13569	79.7	202.0	622.0	DB09213	approved; investigational	Dexibuprofen	CC(C)Cc1ccc(cc1)[C@H](C)C(=O)O
11063	tr|O06138|O06138_M	P13569	79.7	202.0	622.0	DB09280	approved	Lumacaftor	O=C(O)c1cccc(c1)-c2nc(ccc2C)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
11064	tr|O06138|O06138_M	P13569	79.7	202.0	622.0	DB11712	approved; investigational	Tezacaftor	OC[C@H](O)Cn1c(C(C)(C)CO)cc(c12)cc(c(F)c2)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
11065	tr|O06138|O06138_M	P13569	79.7	202.0	622.0	DB15444	approved; investigational	Elexacaftor	FC(F)(F)C(C)(C)COc1nn(cc1)-c2nc(N(C3(C)C)C[C@@H](C)C3)c(cc2)C(=O)NS(=O)(=O)c4cn(C)nc4C
11066	tr|O06138|O06138_M	P13569	80.27	997.0	1420.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
11067	tr|O06138|O06138_M	P13569	80.27	997.0	1420.0	DB00887	approved	Bumetanide	CCCCNc1c(c(S(=O)(=O)N)cc(c1)C(=O)O)Oc2ccccc2
11068	tr|O06138|O06138_M	P13569	80.27	997.0	1420.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
11069	tr|O06138|O06138_M	P13569	80.27	997.0	1420.0	DB01050	approved	Ibuprofen	CC(C)Cc1ccc(cc1)C(C)C(=O)O
11070	tr|O06138|O06138_M	P13569	80.27	997.0	1420.0	DB02587	experimental; investigational	Colforsin	O[C@H]1CCC(C)(C)[C@@H]([C@]12C)[C@H](O)[C@H](OC(=O)C)[C@]3(C)[C@]2(O)C(=O)C[C@](O3)(C)C=C
11071	tr|O06138|O06138_M	P13569	80.27	997.0	1420.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
11072	tr|O06138|O06138_M	P13569	80.27	997.0	1420.0	DB04522	experimental	Dexfosfoserine	OC(=O)[C@@H](N)COP(=O)(O)O
11073	tr|O06138|O06138_M	P13569	80.27	997.0	1420.0	DB04941	approved	Crofelemer	 
11074	tr|O06138|O06138_M	P13569	80.27	997.0	1420.0	DB06266	investigational	Lonidamine	c1cccc(c12)n(nc2C(=O)O)Cc3c(Cl)cc(Cl)cc3
11075	tr|O06138|O06138_M	P13569	80.27	997.0	1420.0	DB08820	approved	Ivacaftor	CC(C)(C)c1cc(C(C)(C)C)c(O)cc1NC(=O)c(c2=O)c[nH]c(c23)cccc3
11076	tr|O06138|O06138_M	P13569	80.27	997.0	1420.0	DB09213	approved; investigational	Dexibuprofen	CC(C)Cc1ccc(cc1)[C@H](C)C(=O)O
11077	tr|O06138|O06138_M	P13569	80.27	997.0	1420.0	DB09280	approved	Lumacaftor	O=C(O)c1cccc(c1)-c2nc(ccc2C)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
11078	tr|O06138|O06138_M	P13569	80.27	997.0	1420.0	DB11712	approved; investigational	Tezacaftor	OC[C@H](O)Cn1c(C(C)(C)CO)cc(c12)cc(c(F)c2)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
11079	tr|O06138|O06138_M	P13569	80.27	997.0	1420.0	DB15444	approved; investigational	Elexacaftor	FC(F)(F)C(C)(C)COc1nn(cc1)-c2nc(N(C3(C)C)C[C@@H](C)C3)c(cc2)C(=O)NS(=O)(=O)c4cn(C)nc4C
11080	tr|O06138|O06138_M	A0A0T9AZ62	75.52	6.0	404.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
11081	tr|O86361|O86361_M	Q9BWD1	88.18	6.0	394.0	DB01915	experimental	S-Hydroxycysteine	OC(=O)[C@@H](N)CSO
11082	tr|O86361|O86361_M	Q9BWD1	88.18	6.0	394.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
11083	tr|O86361|O86361_M	P07097	87.5	5.0	390.0	DB01915	experimental	S-Hydroxycysteine	OC(=O)[C@@H](N)CSO
11084	tr|O86361|O86361_M	P07097	87.5	5.0	390.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
11085	tr|O86361|O86361_M	P07097	87.5	5.0	390.0	DB02039	experimental	S-Acetyl-Cysteine	OC(=O)[C@@H](N)CSC(=O)C
11086	tr|O86361|O86361_M	P07097	87.5	5.0	390.0	DB02160	experimental	S-Butyryl-Cystein	OC(=O)[C@@H](N)CSC(=O)CCC
11087	tr|O86361|O86361_M	P07097	87.5	5.0	390.0	DB03045	experimental	Pantothenyl-Aminoethanol-Acetate Pivalic Acid	CC(=O)OCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COC(=O)C(C)(C)C
11088	tr|O86361|O86361_M	P07097	87.5	5.0	390.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
11089	tr|O86361|O86361_M	P07097	87.5	5.0	390.0	DB08328	experimental	PANTOTHENYL-AMINOETHANOL-11-PIVALIC ACID	CC(C)(C)C(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCO
11090	tr|O86361|O86361_M	P07097	87.5	5.0	390.0	DB08408	experimental	(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-({3-oxo-3-[(2-sulfanylethyl)amino]propyl}amino)butyl 2,2-dimethylpropanoate	CC(C)(C)C(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS
11091	tr|O86361|O86361_M	P24752	88.41	35.0	424.0	DB00795	approved	Sulfasalazine	OC(=O)c1cc(ccc1O)/N=N/c2ccc(cc2)S(=O)(=O)Nc3ncccc3
11092	tr|O86361|O86361_M	P24752	88.41	35.0	424.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
11094	tr|O86361|O86361_M	P24752	88.41	35.0	424.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
11095	tr|P96404|P96404_M	P30084	93.51	43.0	288.0	DB02563	experimental	Hexanoyl-CoA	CCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
11096	tr|P96404|P96404_M	P30084	93.51	43.0	288.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
11097	tr|P96404|P96404_M	P30084	93.51	43.0	288.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
11098	tr|P96404|P96404_M	P30084	93.51	43.0	288.0	DB04117	experimental	4-(N,N-Dimethylamino)cinnamoyl-CoA	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)/C=C/c4ccc(cc4)N(C)C
11099	tr|P96404|P96404_M	P30084	93.51	43.0	288.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
11100	tr|P96404|P96404_M	O75521	98.85	132.0	391.0	DB08231	experimental	Myristic acid	CCCCCCCCCCCCCC(=O)O
11101	tr|P96404|P96404_M	P52045	96.95	6.0	260.0	DB03117	experimental	2-carboxypropyl-coenzyme A	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC[C@H](C)C(=O)O
11102	tr|P96404|P96404_M	P42126	95.8	47.0	298.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
11103	tr|P96404|P96404_M	P42126	95.8	47.0	298.0	DB03127	experimental	Benzamidine	NC(=[NH2+])c1ccccc1
11104	tr|P96404|P96404_M	P9WNP5	101.15	43.0	308.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
11105	tr|P96404|P96404_M	P9WNP5	101.15	43.0	308.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
11106	tr|P96404|P96404_M	O68600	87.4	9.0	238.0	DB01652	experimental	4-hydroxybenzoyl-CoA	Oc1ccc(cc1)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2OP(=O)(O)O)n3cnc(c34)c(N)ncn4
11107	tr|P96404|P96404_M	Q6NVY1	95.42	28.0	278.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
11108	tr|P96404|P96404_M	Q93TU6	82.82	15.0	232.0	DB02906	experimental	(2s,4s)-Alpha-Campholinic Acid	CC1(C)[C@H](C)C(=O)C[C@H]1CC(O)O
11109	tr|P96404|P96404_M	Q08426	75.95	8.0	207.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11110	tr|P96404|P96404_M	P28793	72.52	17.0	207.0	DB08249	experimental	3,6,9,12,15-PENTAOXATRICOSAN-1-OL	CCCCCCCCOCCOCCOCCOCCOCCO
11112	tr|I6YA03|I6YA03_M	P30084	90.22	40.0	289.0	DB02563	experimental	Hexanoyl-CoA	CCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
11113	tr|I6YA03|I6YA03_M	P30084	90.22	40.0	289.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
11114	tr|I6YA03|I6YA03_M	P30084	90.22	40.0	289.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
11115	tr|I6YA03|I6YA03_M	P30084	90.22	40.0	289.0	DB04117	experimental	4-(N,N-Dimethylamino)cinnamoyl-CoA	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)/C=C/c4ccc(cc4)N(C)C
11116	tr|I6YA03|I6YA03_M	P30084	90.22	40.0	289.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
11117	tr|I6YA03|I6YA03_M	P9WNP5	100.72	29.0	307.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
11118	tr|I6YA03|I6YA03_M	P9WNP5	100.72	29.0	307.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
11119	tr|I6YA03|I6YA03_M	P52045	88.41	14.0	258.0	DB03117	experimental	2-carboxypropyl-coenzyme A	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC[C@H](C)C(=O)O
11120	tr|I6YA03|I6YA03_M	P28793	92.03	14.0	268.0	DB08249	experimental	3,6,9,12,15-PENTAOXATRICOSAN-1-OL	CCCCCCCCOCCOCCOCCOCCOCCO
11121	tr|I6YA03|I6YA03_M	O68600	76.81	7.0	219.0	DB01652	experimental	4-hydroxybenzoyl-CoA	Oc1ccc(cc1)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2OP(=O)(O)O)n3cnc(c34)c(N)ncn4
11122	tr|I6YA03|I6YA03_M	O75521	79.71	145.0	365.0	DB08231	experimental	Myristic acid	CCCCCCCCCCCCCC(=O)O
11123	tr|I6YA03|I6YA03_M	Q93TU6	81.88	23.0	249.0	DB02906	experimental	(2s,4s)-Alpha-Campholinic Acid	CC1(C)[C@H](C)C(=O)C[C@H]1CC(O)O
11124	tr|I6YA03|I6YA03_M	Q08426	77.9	8.0	223.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11125	tr|I6YA03|I6YA03_M	P42126	82.97	52.0	281.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
11126	tr|I6YA03|I6YA03_M	P42126	82.97	52.0	281.0	DB03127	experimental	Benzamidine	NC(=[NH2+])c1ccccc1
11127	tr|O86348|O86348_M	P51698	94.18	17.0	292.0	DB01701	experimental	1,2-Dichloro-Propane	C[C@@H](Cl)CCl
11128	tr|O86348|O86348_M	P51698	94.18	17.0	292.0	DB02145	experimental	Butyl alcohol	CCCCO
11129	tr|O86348|O86348_M	P51698	94.18	17.0	292.0	DB02302	experimental	Symmetric dimethylarginine	CN/C(=N/C)NCCC[C@H](N)C(=O)O
11130	tr|O86348|O86348_M	P51698	94.18	17.0	292.0	DB02774	experimental	1,3-Propanediol	OCCCO
11131	tr|O86348|O86348_M	P51698	94.18	17.0	292.0	DB03335	experimental	(+)-1-bromo-2-propanol	C[C@H](O)CBr
11132	tr|O86348|O86348_M	P51698	94.18	17.0	292.0	DB03733	experimental	Ethylene Dichloride	ClCCCl
11133	tr|O86348|O86348_M	P51698	94.18	17.0	292.0	DB04320	experimental	2-Bromo-2-Propene-1-Ol	OCC(Br)=C
11134	tr|O86348|O86348_M	O31168	89.38	15.0	276.0	DB03793	approved; investigational	Benzoic acid	OC(=O)c1ccccc1
11135	tr|O86348|O86348_M	P47229	89.04	23.0	283.0	DB07510	experimental	3-fluoro-6-(4-fluorophenyl)-2-hydroxy-6-oxohexa-2,4-dienoic acid	OC(=O)/C(O)=C(/F)\C=C\C(=O)c1ccc(F)cc1
11136	tr|O86348|O86348_M	P47229	89.04	23.0	283.0	DB07516	experimental	(2Z,4E)-3-chloro-2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoic acid	OC(=O)/C(O)=C(/Cl)\C=C\C(=O)c1ccccc1
11137	tr|O86348|O86348_M	P47229	89.04	23.0	283.0	DB07911	experimental	(3E)-2,6-DIOXO-6-PHENYLHEX-3-ENOATE	[O-]C(=O)C(=O)/C=C/CC(=O)c1ccccc1
11138	tr|O86348|O86348_M	P47229	89.04	23.0	283.0	DB07915	experimental	(2E,4E)-2-Hydroxy-6-oxo-6-phenyl-2,4-hexadienoic acid	OC(=O)/C(O)=C\C=C\C(=O)c1ccccc1
11139	tr|O08377|O08377_M	P9WMC1	79.56	7.0	186.0	DB02425	experimental	Hexadecyl Octanoate	CCCCCCCCCCCCCCCOC(=O)CCCCCCC
11140	tr|O08377|O08377_M	P9WMC1	79.56	7.0	186.0	DB08469	experimental	tert-butyl 4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine-1-carboxylate	CC(C)(C)OC(=O)N1CCC(CC1)c2nc(no2)-c3cccs3
11141	tr|O08377|O08377_M	P9WMC1	79.56	7.0	186.0	DB08470	experimental	3-(4-fluorophenyl)-5-phenyl-4H-1,2,4-triazole	Fc1ccc(cc1)-c2nnc([nH]2)-c3ccccc3
11142	tr|O08377|O08377_M	P9WMC1	79.56	7.0	186.0	DB08471	experimental	1-(thiophen-2-ylacetyl)-4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine	c1ccsc1CC(=O)N2CCC(CC2)c3nc(no3)-c4cccs4
11143	tr|O08377|O08377_M	P0A0N4	73.78	4.0	170.0	DB01123	approved	Proflavine	c1cc(N)cc(c12)nc3c(c2)ccc(c3)N
11144	tr|O08377|O08377_M	P0A0N4	73.78	4.0	170.0	DB03608	experimental	Diminazene	NC(=N)c1ccc(cc1)N/N=N/c2ccc(cc2)C(N)=N
11145	tr|O08377|O08377_M	P0A0N4	73.78	4.0	170.0	DB03808	experimental	Hexamidine	NC(=N)c1ccc(cc1)OCCCCCCOc2ccc(cc2)C(N)=N
11146	tr|O08377|O08377_M	P0A0N4	73.78	4.0	170.0	DB04209	approved; investigational	Dequalinium	c1cccc(c12)c(N)cc(C)[n+]2CCCCCCCCCC[n+]3c(C)cc(N)c(c34)cccc4
11147	tr|O08377|O08377_M	P0A0N5	73.78	4.0	170.0	DB03808	experimental	Hexamidine	NC(=N)c1ccc(cc1)OCCCCCCOc2ccc(cc2)C(N)=N
11148	tr|O08377|O08377_M	P0A0N5	73.78	4.0	170.0	DB03825	experimental	Rhodamine 6G	CCNc(c(C)c1)cc(c12)[o+]c3c(cc(C)c(c3)NCC)c2-c4ccccc4C(=O)OCC
11149	tr|O08377|O08377_M	P0A0N5	73.78	4.0	170.0	DB03895	experimental	Malachite Green	CN(C)c1ccc(cc1)C(c2ccccc2)=C3C=CC(C=C3)=[N+](C)C
11150	tr|O08377|O08377_M	P0A0N5	73.78	4.0	170.0	DB04115	approved; investigational	Berberine	COc1c(OC)ccc(c12)cc3[n+](c2)CCc4c3cc5c(c4)OCO5
11151	tr|O08377|O08377_M	P94548	84.0	2.0	191.0	DB03264	experimental	Dodecyl-Coa	CCCCCCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
11152	tr|O06560|O06560_M	P11349	86.74	1.0	485.0	DB04464	experimental	N-Formylmethionine	O=CN[C@H](C(=O)O)CCSC
11153	tr|O06560|O06560_M	P11349	86.74	1.0	485.0	DB07349	experimental	(1S)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PENTANOYLOXY)METHYL]ETHYL OCTANOATE	OC[C@H](O)COP([O-])(=O)OC[C@@H](COC(=O)CCCC)OC(=O)CCCCCCC
11154	tr|P96890|P96890_M	P05165	74.5	61.0	508.0	DB00121	approved; investigational; nutraceutical	Biotin	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC(=O)O
11155	tr|P96890|P96890_M	Q96RQ3	74.67	47.0	495.0	DB00121	approved; investigational; nutraceutical	Biotin	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC(=O)O
11156	tr|P96890|P96890_M	A0A0H3JRU9	75.83	2.0	457.0	DB07497	experimental	5-(HEXAHYDRO-2-OXO-1H-THIENO[3,4-D]IMIDAZOL-6-YL)PENTANAL	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC=O
11157	tr|P96890|P96890_M	P11498	74.83	35.0	484.0	DB00119	approved; investigational; nutraceutical	Pyruvic acid	CC(=O)C(=O)O
11158	tr|P96890|P96890_M	P11498	74.83	35.0	484.0	DB00121	approved; investigational; nutraceutical	Biotin	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC(=O)O
11159	tr|P96890|P96890_M	P11498	74.83	35.0	484.0	DB07497	experimental	5-(HEXAHYDRO-2-OXO-1H-THIENO[3,4-D]IMIDAZOL-6-YL)PENTANAL	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC=O
11160	tr|P96890|P96890_M	P24182	73.33	2.0	442.0	DB08074	experimental	3-(3-Methyl-2-buten-1-yl)-3H-purin-6-amine	CC(C)=CCn1cnc(N)c(c12)ncn2
11161	tr|P96890|P96890_M	P24182	73.33	2.0	442.0	DB08075	experimental	4-(2-amino-1,3-thiazol-4-yl)pyrimidin-2-amine	Nc1nc(cs1)-c2nc(N)ncc2
11162	tr|P96890|P96890_M	P24182	73.33	2.0	442.0	DB08076	experimental	4-[1-(2,6-dichlorobenzyl)-2-methyl-1H-imidazol-4-yl]pyrimidin-2-amine	Nc1nccc(n1)-c2nc(C)n(c2)Cc3c(Cl)cccc3Cl
11163	tr|P96890|P96890_M	P24182	73.33	2.0	442.0	DB08144	experimental	6-(2,6-dibromophenyl)pyrido[2,3-d]pyrimidine-2,7-diamine	c1nc(N)nc(c12)nc(N)c(c2)-c3c(Br)cccc3Br
11164	tr|P96890|P96890_M	P24182	73.33	2.0	442.0	DB08145	experimental	6-(2,6-DIMETHOXYPHENYL)PYRIDO[2,3-D]PYRIMIDINE-2,7-DIAMINE	COc1cccc(OC)c1-c(c(n2)N)cc(c23)cnc(n3)N
11165	tr|P96890|P96890_M	P24182	73.33	2.0	442.0	DB08146	experimental	7-(2,5-dihydropyrrol-1-yl)-6-phenyl-pyrido[6,5-d]pyrimidin-2-amine	c1nc(N)nc(c12)nc(N3CC=CC3)c(c2)-c4ccccc4
11166	tr|P96890|P96890_M	P24182	73.33	2.0	442.0	DB08314	experimental	(2-AMINO-1,3-OXAZOL-5-YL)-(3-BROMOPHENYL)METHANONE	Nc1ncc(o1)C(=O)c2cc(Br)ccc2
11167	tr|P96890|P96890_M	P24182	73.33	2.0	442.0	DB08315	experimental	2-AMINO-N,N-BIS(PHENYLMETHYL)-1,3-OXAZOLE-5-CARBOXAMIDE	c1ccccc1CN(C(=O)c2oc(N)nc2)Cc3ccccc3
11168	tr|P96890|P96890_M	P24182	73.33	2.0	442.0	DB08316	experimental	4-amino-7,7-dimethyl-7,8-dihydroquinazolin-5(6H)-one	CC(C)(C1)CC(=O)c(c12)c(N)ncn2
11169	tr|P96890|P96890_M	P24182	73.33	2.0	442.0	DB08317	experimental	5-methyl-6-phenylquinazoline-2,4-diamine	Nc1nc(N)nc(c12)ccc(c2C)-c3ccccc3
11170	tr|P96890|P96890_M	P24182	73.33	2.0	442.0	DB08318	experimental	6-(2-phenoxyethoxy)-1,3,5-triazine-2,4-diamine	Nc1nc(nc(n1)N)OCCOc2ccccc2
11171	tr|Q79FS6|Q79FS6_M	Q54331	73.53	85.0	110.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
11172	tr|Q79FS6|Q79FS6_M	Q54331	73.53	85.0	110.0	DB02467	experimental	L-methionine (S)-S-oxide	C[S@](=O)CC[C@@H](C([O-])=O)[NH3+]
11173	tr|Q79FS6|Q79FS6_M	Q54331	73.53	85.0	110.0	DB04282	experimental	2-deoxy-2-fluoro-α-D-glucose	O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1F
11174	tr|I6YA21|I6YA21_M	P0AF93	79.58	12.0	125.0	DB03544	experimental	S-Phosphocysteine	OC(=O)[C@@H](N)CSP(=O)(O)O
11175	tr|O86347|O86347_M	P07771	72.17	123.0	346.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
11176	tr|O86347|O86347_M	P24232	74.43	165.0	395.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
11177	tr|O86347|O86347_M	P39662	78.32	157.0	399.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
11178	tr|O86347|O86347_M	P39662	78.32	157.0	399.0	DB03979	experimental	1-[Glycerolylphosphonyl]-2-[8-(2-Hexyl-Cyclopropyl)-Octanal-1-Yl]-3-[Hexadecanal-1-Yl]-Glycerol	CCCCCC[C@@H]1C[C@@H]1CCCCCCCC(=O)O[C@@H](COP(=O)(O)OCC(O)CO)COC(=O)CCCCCCCCCCCCCCC
11179	tr|O86347|O86347_M	P28861	73.46	9.0	236.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
11180	tr|O86347|O86347_M	P58558	74.11	186.0	415.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
11181	tr|O86347|O86347_M	P58558	74.11	186.0	415.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11182	tr|O86347|O86347_M	P21890	74.11	186.0	415.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
11183	tr|O86347|O86347_M	P21890	74.11	186.0	415.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11184	tr|O86347|O86347_M	P00387	78.32	48.0	290.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11185	tr|O86347|O86347_M	P00387	78.32	48.0	290.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
11186	tr|O86347|O86347_M	P00387	78.32	48.0	290.0	DB09130	approved; investigational	Copper	[Cu]
11187	tr|O86347|O86347_M	P04839	82.2	291.0	545.0	DB00514	approved	Dextromethorphan	C1CCC[C@@H]([C@]123)[C@@H](N(C)CC2)Cc4c3cc(OC)cc4
11188	tr|O86347|O86347_M	Q9L6V3	71.2	21.0	241.0	DB04450	experimental	Heptyl 1-Thiohexopyranoside	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)SCCCCCCC
11189	tr|I6X8S7|I6X8S7_M	P00352	99.38	14.0	498.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11190	tr|I6X8S7|I6X8S7_M	P00352	99.38	14.0	498.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
11191	tr|I6X8S7|I6X8S7_M	P00352	99.38	14.0	498.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
11192	tr|I6X8S7|I6X8S7_M	P00352	99.38	14.0	498.0	DB04447	experimental	1,4-Dithiothreitol	SC[C@H](O)[C@@H](O)CS
11193	tr|I6X8S7|I6X8S7_M	P47895	99.18	26.0	509.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11194	tr|I6X8S7|I6X8S7_M	P47895	99.18	26.0	509.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
11195	tr|I6X8S7|I6X8S7_M	O94788	98.56	33.0	513.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11196	tr|I6X8S7|I6X8S7_M	O94788	98.56	33.0	513.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
11197	tr|I6X8S7|I6X8S7_M	O94788	98.56	33.0	513.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
11198	tr|I6X8S7|I6X8S7_M	P05091	98.15	34.0	512.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11199	tr|I6X8S7|I6X8S7_M	P05091	98.15	34.0	512.0	DB00536	approved	Guanidine	NC(N)=N
11200	tr|I6X8S7|I6X8S7_M	P05091	98.15	34.0	512.0	DB00822	approved	Disulfiram	CCN(CC)C(=S)SSC(=S)N(CC)CC
11201	tr|I6X8S7|I6X8S7_M	P05091	98.15	34.0	512.0	DB02115	experimental	Daidzin	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)Oc(c2)ccc(c23)c(=O)c(co3)-c4ccc(O)cc4
11202	tr|I6X8S7|I6X8S7_M	P05091	98.15	34.0	512.0	DB04381	experimental	Crotonaldehyde	O=C/C=C/C
11203	tr|I6X8S7|I6X8S7_M	P30837	98.36	33.0	512.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11204	tr|I6X8S7|I6X8S7_M	O75891	98.15	422.0	900.0	DB00116	nutraceutical	Tetrahydrofolic acid	Nc([nH]1)nc(=O)c(c12)NC(CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
11205	tr|I6X8S7|I6X8S7_M	P49189	97.74	13.0	489.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11206	tr|I6X8S7|I6X8S7_M	P25553	96.71	6.0	477.0	DB03619	approved	Deoxycholic acid	C1C[C@@H](O)C[C@H]([C@]12C)CC[C@@H]3[C@@H]2C[C@H](O)[C@@]4(C)[C@H]3CC[C@@H]4[C@H](C)CCC(=O)O
11207	tr|I6X8S7|I6X8S7_M	P77674	96.71	2.0	473.0	DB04401	experimental	Betaine aldehyde	C[N+](C)(C)CC=O
11208	tr|I6X8S7|I6X8S7_M	P51649	96.51	61.0	531.0	DB00139	approved; nutraceutical	Succinic acid	OC(=O)CCC(=O)O
11209	tr|I6X8S7|I6X8S7_M	P51649	96.51	61.0	531.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11210	tr|I6X8S7|I6X8S7_M	P51649	96.51	61.0	531.0	DB00313	approved; investigational	Valproic acid	CCCC(C(=O)O)CCC
11211	tr|I6X8S7|I6X8S7_M	P51649	96.51	61.0	531.0	DB00534	approved; withdrawn	Chlormerodrin	Cl[Hg]CC(OC)CNC(=O)N
11212	tr|I6X8S7|I6X8S7_M	Q59931	96.92	2.0	474.0	DB02263	experimental	Glyceraldehyde-3-Phosphate	O=C[C@H](O)COP(=O)(O)O
11213	tr|I6X8S7|I6X8S7_M	Q59931	96.92	2.0	474.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11214	tr|I6X8S7|I6X8S7_M	Q02252	98.15	35.0	513.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11215	tr|I6X8S7|I6X8S7_M	P83849	97.54	37.0	512.0	DB03564	experimental	(4r)-2-Methylpentane-2,4-Diol	C[C@H](O)CC(C)(C)O
11216	tr|I6X8S7|I6X8S7_M	P30838	87.68	3.0	430.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11217	tr|I6X8S7|I6X8S7_M	P49419	96.71	55.0	526.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11218	tr|I6X8S7|I6X8S7_M	P49419	96.71	55.0	526.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
11219	tr|I6X8S7|I6X8S7_M	P51648	86.86	5.0	428.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11220	tr|I6X8S7|I6X8S7_M	P43353	86.86	7.0	430.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11221	tr|I6X8S7|I6X8S7_M	P30038	97.13	74.0	547.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11222	tr|I6X8S7|I6X8S7_M	P09546	91.17	657.0	1101.0	DB03051	experimental	(S)-2-Tetrahydrofuroic acid	OC(=O)[C@H]1CCCO1
11223	tr|I6X8S7|I6X8S7_M	P09546	91.17	657.0	1101.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
11224	tr|I6X8S7|I6X8S7_M	P09546	91.17	657.0	1101.0	DB04398	approved; vet_approved	Lactic acid	CC(O)C(=O)O
11225	tr|I6X8S7|I6X8S7_M	Q56694	89.73	3.0	440.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11226	tr|L7N649|L7N649_M	Q9RHZ6	89.9	8.0	97.0	DB03277	experimental	alpha-maltotriose	O[C@H]1O[C@H](CO)[C@H]([C@H](O)[C@H]1O)O[C@H]2O[C@H](CO)[C@H]([C@H](O)[C@H]2O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
11227	tr|L7N649|L7N649_M	Q9RHZ6	89.9	8.0	97.0	DB03323	experimental; investigational	Maltose	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO
11228	tr|O53669|O53669_M	P21912	89.52	53.0	275.0	DB04141	experimental	2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol	O[C@H]1[C@@H](O)[C@@H](CO)O[C@H]([C@@H]1O)OCCCCCC
11229	tr|O53669|O53669_M	P21912	89.52	53.0	275.0	DB08689	experimental	Ubiquinone Q1	COC1=C(OC)C(=O)C(=C(C)C1=O)CC=C(C)C
11230	tr|O53669|O53669_M	P07014	89.52	14.0	236.0	DB04631	experimental	Atpenin A5	ClC[C@H](Cl)[C@@H](C)C[C@H](C)C(=O)c1c(O)c(OC)c([nH]c1=O)OC
11231	tr|O53669|O53669_M	P07014	89.52	14.0	236.0	DB07671	experimental	2-[1-METHYLHEXYL]-4,6-DINITROPHENOL	CCCCCC(C)c1c(O)c(N(=O)=O)cc(c1)N(=O)=O
11232	tr|O53669|O53669_M	P07014	89.52	14.0	236.0	DB08690	experimental	Ubiquinone Q2	COC1=C(OC)C(=O)C(=C(C)C1=O)C/C=C(\C)CCC=C(C)C
11233	tr|O53669|O53669_M	P0AC47	84.68	18.0	228.0	DB07490	experimental	2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL	Clc1ccc(cc1)[C@@H](C)c2cc([N+]([O-])=O)cc([N+]([O-])=O)c2O
11234	tr|O53669|O53669_M	P0AC47	84.68	18.0	228.0	DB07918	experimental	2-heptyl-4-hydroxyquinoline N-oxide	CCCCCCCc(cc1O)[n+]([O-])c(c12)cccc2
11235	tr|O53669|O53669_M	P17596	89.11	16.0	237.0	DB07669	experimental	2,3-Dimethyl-1,4-naphthoquinone	O=C1C(C)=C(C)C(=O)c(c12)cccc2
11236	tr|P72007|P72007_M	P40871	94.55	25.0	528.0	DB01672	experimental	2,3-Dihydroxy-Benzoic Acid	OC(=O)c1cccc(O)c1O
11237	tr|P72007|P72007_M	Q9NUB1	99.62	138.0	668.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
11238	tr|P72007|P72007_M	Q9NR19	102.82	133.0	680.0	DB00131	approved; investigational; nutraceutical	Adenosine phosphate	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
11239	tr|P72007|P72007_M	Q9NR19	102.82	133.0	680.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
11240	tr|P72007|P72007_M	Q8GN86	93.61	3.0	501.0	DB03728	experimental	p-Chlorobenzoic acid	OC(=O)c1ccc(Cl)cc1
11241	tr|P72007|P72007_M	Q8ZKF6	99.62	105.0	635.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
11242	tr|P72007|P72007_M	Q8ZKF6	99.62	105.0	635.0	DB03230	experimental	Adenosine-5'-Propylphosphate	CCCOP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
11244	tr|O53634|O53634_M	P26391	105.03	1.0	335.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
11245	tr|O53634|O53634_M	P14169	105.35	1.0	336.0	DB04555	experimental	Cytidine-5'-Diphosphate	Nc1nc(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O
11246	tr|O53634|O53634_M	Q9ZGH3	98.11	1.0	313.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
11247	tr|O53634|O53634_M	P09147	103.46	1.0	330.0	DB01861	experimental	Uridine diphosphate glucose	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
11248	tr|O53634|O53634_M	P09147	103.46	1.0	330.0	DB02421	experimental	Uridine-5'-diphosphate-mannose	O=c1[nH]c(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O
11249	tr|O53634|O53634_M	P09147	103.46	1.0	330.0	DB02790	experimental	Phenyl-uridine-5'-diphosphate	O=c1[nH]c(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)Oc3ccccc3
11250	tr|O53634|O53634_M	P09147	103.46	1.0	330.0	DB03397	experimental	Uridine-Diphosphate-N-Acetylglucosamine	CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
11251	tr|O53634|O53634_M	P09147	103.46	1.0	330.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
11252	tr|O53634|O53634_M	P09147	103.46	1.0	330.0	DB04097	experimental	Uridine-5'-diphosphate-4-deoxy-4-fluoro-alpha-D-galactose	O=c1[nH]c(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](F)[C@H](O)[C@H]3O
11253	tr|O53634|O53634_M	P95780	99.69	7.0	324.0	DB03161	experimental	Thymidine-5'-diphospho-beta-D-xylose	O=c1[nH]c(=O)c(C)cn1[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3OC[C@@H](O)[C@H](O)[C@H]3O
11254	tr|O53634|O53634_M	P95780	99.69	7.0	324.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
11255	tr|O53634|O53634_M	Q14376	105.35	4.0	339.0	DB01861	experimental	Uridine diphosphate glucose	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
11256	tr|O53634|O53634_M	Q14376	105.35	4.0	339.0	DB02196	experimental	Uridine-Diphosphate-N-Acetylgalactosamine	CC(=O)N[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
11257	tr|O53634|O53634_M	Q14376	105.35	4.0	339.0	DB03041	experimental	UDP-alpha-D-glucuronic acid	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O
11258	tr|O53634|O53634_M	Q14376	105.35	4.0	339.0	DB03095	experimental	Tetramethylammonium	C[N+](C)(C)C
11259	tr|O53634|O53634_M	Q14376	105.35	4.0	339.0	DB03397	experimental	Uridine-Diphosphate-N-Acetylglucosamine	CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
11260	tr|O53634|O53634_M	Q14376	105.35	4.0	339.0	DB03501	experimental	Galactose-uridine-5'-diphosphate	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@H]1O)O[P@](=O)(O)O[P@](=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
11261	tr|O53634|O53634_M	Q51366	96.86	6.0	314.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
11262	tr|O53634|O53634_M	O60547	104.72	27.0	360.0	DB02547	experimental	Guanosine-5'-Diphosphate-Rhamnose	O[C@H]1[C@H](O)[C@H](O)[C@H](O[C@@H]1C)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3cnc(c34)c(=O)nc([nH]4)N
11263	tr|O53634|O53634_M	O60547	104.72	27.0	360.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
11264	tr|O53634|O53634_M	Q8T8E9	116.98	1.0	373.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
11265	tr|O53634|O53634_M	Q8KN66	100.0	18.0	336.0	DB01861	experimental	Uridine diphosphate glucose	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
11266	tr|O53634|O53634_M	Q8KN66	100.0	18.0	336.0	DB02196	experimental	Uridine-Diphosphate-N-Acetylgalactosamine	CC(=O)N[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
11267	tr|O53634|O53634_M	P26397	101.57	11.0	334.0	DB02059	experimental	Adenosine-5-Diphosphoribose	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)CO[P@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H](O)[C@H](O)[C@@H]4O
11268	tr|O53634|O53634_M	P26397	101.57	11.0	334.0	DB03069	experimental	Cytidine-5'-diphospho-beta-D-xylose	Nc1nc(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O[C@H]3OC[C@@H](O)[C@H](O)[C@H]3O
11269	tr|O53634|O53634_M	P77398	104.72	317.0	650.0	DB03256	experimental	(6R)-Folinic acid	Nc([nH]1)nc(=O)c(c12)N(C=O)[C@@H](CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
11270	tr|O53634|O53634_M	P77398	104.72	317.0	650.0	DB03685	experimental	Uridine monophosphate	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2ccc(=O)[nH]c2=O
11271	tr|O53634|O53634_M	P67910	95.6	2.0	306.0	DB01774	experimental	Adenosine-5'-Monophosphate Glucopyranosyl-Monophosphate Ester	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@@](=O)(O)O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O
11272	tr|O53634|O53634_M	P67910	95.6	2.0	306.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11273	tr|O53634|O53634_M	P32055	97.17	5.0	314.0	DB02897	experimental	Acetylphosphate	CC(=O)OP(=O)(O)O
11274	tr|O53634|O53634_M	P32055	97.17	5.0	314.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11275	tr|O53634|O53634_M	Q13630	97.17	8.0	317.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11276	tr|O53634|O53634_M	Q15738	102.83	39.0	366.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11277	tr|O53634|O53634_M	P14060	78.62	6.0	256.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11278	tr|O53634|O53634_M	P14060	78.62	6.0	256.0	DB01108	approved; investigational; vet_approved; withdrawn	Trilostane	C1C[C@H](O)[C@@](C)(CC2)[C@@H]1[C@H](CC3)[C@H]2[C@@]([C@@]345)(C)CC(C#N)=C([C@H]4O5)O
11279	tr|O53634|O53634_M	P14060	78.62	6.0	256.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
11280	tr|O53634|O53634_M	P14060	78.62	6.0	256.0	DB14538	experimental; vet_approved	Hydrocortisone aceponate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CC)C(=O)COC(=O)C
11281	tr|O53634|O53634_M	P14060	78.62	6.0	256.0	DB14539	approved; vet_approved	Hydrocortisone acetate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)C
11282	tr|O53634|O53634_M	P14060	78.62	6.0	256.0	DB14540	approved; vet_approved	Hydrocortisone butyrate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCC
11283	tr|O53634|O53634_M	P14060	78.62	6.0	256.0	DB14541	approved; investigational; vet_approved	Hydrocortisone cypionate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)CCC5CCCC5
11284	tr|O53634|O53634_M	P14060	78.62	6.0	256.0	DB14542	approved; vet_approved	Hydrocortisone phosphate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COP(=O)(O)O
11285	tr|O53634|O53634_M	P14060	78.62	6.0	256.0	DB14543	approved; vet_approved	Hydrocortisone probutate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CCC)C(=O)COC(=O)CC
11286	tr|O53634|O53634_M	P14060	78.62	6.0	256.0	DB14544	approved; vet_approved	Hydrocortisone valerate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCCC
11287	tr|O53634|O53634_M	P26439	78.93	5.0	256.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11288	tr|O53634|O53634_M	P26439	78.93	5.0	256.0	DB01108	approved; investigational; vet_approved; withdrawn	Trilostane	C1C[C@H](O)[C@@](C)(CC2)[C@@H]1[C@H](CC3)[C@H]2[C@@]([C@@]345)(C)CC(C#N)=C([C@H]4O5)O
11289	tr|I6YG46|I6YG46_M	P69908	94.78	16.0	452.0	DB03553	experimental	Glutaric Acid	OC(=O)CCCC(=O)O
11290	tr|I6YG46|I6YG46_M	O95470	74.78	170.0	514.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
11291	tr|I6XWE5|I6XWE5_M	P29803	89.22	60.0	358.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11292	tr|I6XWE5|I6XWE5_M	P08559	89.52	60.0	359.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11293	tr|P96399|P96399_M	Q7SIG1	83.77	57.0	310.0	DB02776	experimental	1-Hexadecanosulfonic Acid	CCCCCCCCCCCCCCCCS(=O)(=O)O
11294	tr|P95150|P95150_M	O75911	91.26	30.0	291.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
11295	tr|P95150|P95150_M	Q8NBQ5	88.46	29.0	282.0	DB02854	experimental	Aetiocholanolone	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](CC3)C[C@H](O)CC4
11297	tr|P95150|P95150_M	Q9BTZ2	72.38	20.0	227.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
11299	tr|P95150|P95150_M	Q6UWP2	82.52	7.0	243.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11300	tr|P95150|P95150_M	P28845	80.77	30.0	261.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11301	tr|P95150|P95150_M	P28845	80.77	30.0	261.0	DB02329	experimental	Carbenoxolone	OC(=O)CCC(=O)O[C@@H](CC1)C(C)(C)[C@@H]([C@]12C)CC[C@]3(C)[C@@H]2C(=O)C=C4[C@H]5[C@@](C)(CC[C@@]34C)CC[C@](C5)(C)C(=O)O
11302	tr|P95150|P95150_M	P28845	80.77	30.0	261.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11303	tr|P95150|P95150_M	P28845	80.77	30.0	261.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
11304	tr|P95150|P95150_M	P28845	80.77	30.0	261.0	DB04652	experimental	Corticosterone	OCC(=O)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H]([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
11305	tr|P95150|P95150_M	P28845	80.77	30.0	261.0	DB05064	investigational	INCB13739	 
11306	tr|P95150|P95150_M	P28845	80.77	30.0	261.0	DB06992	experimental	(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone	Cc1ccc(cc1F)-c2nc(ccc2)C(=O)N(CC3(C)C)CCC3
11307	tr|P95150|P95150_M	P28845	80.77	30.0	261.0	DB07017	experimental	(5S)-2-{[(1S)-1-(4-Fluorophenyl)ethyl]amino}-5-(2-hydroxy-2-propanyl)-5-methyl-1,3-thiazol-4(5H)-one	Fc1ccc(cc1)[C@H](C)NC(=NC2=O)S[C@@]2(C)C(C)(C)O
11308	tr|P95150|P95150_M	P28845	80.77	30.0	261.0	DB07049	experimental	(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine	[O-][N+](=O)c1ccc(cc1)N2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)C(C)(C)C
11309	tr|P95150|P95150_M	P28845	80.77	30.0	261.0	DB07056	experimental	2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide	CCN(CC)C(=O)Cc1cccc(n1)NS(=O)(=O)c2c(C)c(Cl)ccc2
11310	tr|P95150|P95150_M	P28845	80.77	30.0	261.0	DB07310	experimental	(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one	Fc1ccccc1[C@H](C)NC(=NC2=O)S[C@]2(C)C(F)(F)F
11311	tr|P95150|P95150_M	P28845	80.77	30.0	261.0	DB07316	experimental	N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)C3CCN(CC3)CC4(CC4)C(=O)N
11312	tr|P95150|P95150_M	P28845	80.77	30.0	261.0	DB07619	experimental	N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)[C@H]3CC[C@@H](CC3)c4cccnc4
11313	tr|P95150|P95150_M	P28845	80.77	30.0	261.0	DB07624	experimental	1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide	C1CC1(C(=O)N)CN2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)[C@](C)(O)C(F)(F)F
11314	tr|P95150|P95150_M	P28845	80.77	30.0	261.0	DB07866	experimental	(5S)-2-(Cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one	CCC[C@]1(C)SC(=NC1=O)NC2CCCCCCC2
11315	tr|P95150|P95150_M	P28845	80.77	30.0	261.0	DB08277	experimental	2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE	CS(=O)(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4c(Cl)cc(F)cc4
11316	tr|P95150|P95150_M	P28845	80.77	30.0	261.0	DB08280	experimental	(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE	NC(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4ccc(OC)cc4
11317	tr|P95150|P95150_M	P28845	80.77	30.0	261.0	DB08771	experimental	(5R)-2-[(2-Fluorophenyl)amino]-5-isopropyl-1,3-thiazol-4(5H)-one	CC(C)[C@H]1SC(=NC1=O)Nc2c(F)cccc2
11318	tr|P95150|P95150_M	P28845	80.77	30.0	261.0	DB13751	approved; experimental	Glycyrrhizic acid	C1C[C@](C)(C(=O)O)C[C@H]([C@]12C)C=3[C@@](C)(CC2)[C@@]4(C)[C@H](C(=O)C3)[C@]5(C)[C@@H](CC4)C(C)(C)[C@H](CC5)O[C@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O[C@@H]7O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]7O
11319	tr|P95150|P95150_M	Q92506	81.47	4.0	237.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11320	tr|P95150|P95150_M	Q92506	81.47	4.0	237.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11321	tr|P95150|P95150_M	Q84EX5	80.07	3.0	232.0	DB04619	experimental	Acetophenone	CC(=O)c1ccccc1
11322	tr|P95150|P95150_M	Q84EX5	80.07	3.0	232.0	DB04784	experimental	(R)-1-phenylethanol	C[C@@H](O)c1ccccc1
11323	tr|P95150|P95150_M	P0CG22	72.03	20.0	226.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
11324	tr|P95150|P95150_M	P0CG22	72.03	20.0	226.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11325	tr|P95150|P95150_M	P0CG22	72.03	20.0	226.0	DB03541	experimental	10-Propargyl-5,8-Dideazafolic Acid	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(CC#C)Cc(c2)ccc(c23)[nH]c(N)nc3=O
11326	tr|P95150|P95150_M	P0CG22	72.03	20.0	226.0	DB07689	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)NCc(cn3)nc(c34)c(N)nc(n4)N
11327	tr|P95150|P95150_M	P0CG22	72.03	20.0	226.0	DB07765	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)N(C)Cc(cn3)nc(c34)c(N)nc(n4)N
11328	tr|P95150|P95150_M	P0AET8	76.57	8.0	227.0	DB02123	experimental	Glycochenodeoxycholic Acid	OC(=O)CNC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
11329	tr|P95150|P95150_M	Q8TC12	72.38	37.0	244.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
11330	tr|P95150|P95150_M	Q8NBN7	73.43	34.0	244.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
11331	tr|P95150|P95150_M	Q96NR8	72.38	35.0	242.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
11332	tr|P95150|P95150_M	Q9BY49	70.28	16.0	217.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
11333	tr|P95150|P95150_M	Q9NYR8	86.36	6.0	253.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
11334	tr|P95150|P95150_M	Q99714	70.98	7.0	210.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11335	tr|P95150|P95150_M	Q99714	70.98	7.0	210.0	DB02820	experimental	1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct	C1CCCCCN1C(=O)[C@H](c2ccccc2)n(c3=S)cnc(c34)nn(c4)[C@H]5C=CN(C=C5C([O-])=N)[C@@H]6O[C@@H]([C@@H](O)[C@H]6O)COP([O-])(=O)OP(=O)(O)OC[C@H]7O[C@H]([C@H]([O-])[C@@H]7[O-])n8cnc(c89)c(N)ncn9
11336	tr|P95150|P95150_M	Q99714	70.98	7.0	210.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
11337	tr|P95150|P95150_M	P80365	71.68	77.0	282.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11338	tr|P95150|P95150_M	P80365	71.68	77.0	282.0	DB01185	approved; illicit	Fluoxymesterone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@](F)([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
11339	tr|P95150|P95150_M	P80365	71.68	77.0	282.0	DB01569	experimental; illicit	Formebolone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@H]([C@@H](C2)O)[C@]4(C)C(CC3)=CC(=O)C(C=O)=C4
11340	tr|P95150|P95150_M	P80365	71.68	77.0	282.0	DB14538	experimental; vet_approved	Hydrocortisone aceponate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CC)C(=O)COC(=O)C
11341	tr|P95150|P95150_M	P80365	71.68	77.0	282.0	DB14539	approved; vet_approved	Hydrocortisone acetate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)C
11342	tr|P95150|P95150_M	P80365	71.68	77.0	282.0	DB14540	approved; vet_approved	Hydrocortisone butyrate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCC
11343	tr|P95150|P95150_M	P80365	71.68	77.0	282.0	DB14541	approved; investigational; vet_approved	Hydrocortisone cypionate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)CCC5CCCC5
11344	tr|P95150|P95150_M	P80365	71.68	77.0	282.0	DB14542	approved; vet_approved	Hydrocortisone phosphate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COP(=O)(O)O
11345	tr|P95150|P95150_M	P80365	71.68	77.0	282.0	DB14543	approved; vet_approved	Hydrocortisone probutate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CCC)C(=O)COC(=O)CC
11346	tr|P95150|P95150_M	P80365	71.68	77.0	282.0	DB14544	approved; vet_approved	Hydrocortisone valerate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCCC
11347	tr|P95150|P95150_M	Q9HBH5	76.57	41.0	260.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
11348	tr|P95150|P95150_M	P51659	75.52	7.0	223.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11349	tr|P95150|P95150_M	P51659	75.52	7.0	223.0	DB03192	experimental	(R)-3-hydroxydecanoyl-CoA	CCCCCCC[C@@H](O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
11350	tr|P95150|P95150_M	P37058	70.28	47.0	248.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11351	tr|P95150|P95150_M	A0A348A0U3	70.63	3.0	205.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
11352	tr|P95150|P95150_M	Q6GI75	70.63	4.0	206.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
11353	tr|P95150|P95150_M	Q6GI75	70.63	4.0	206.0	DB11155	approved	Triclocarban	Clc1ccc(cc1)NC(=O)Nc2cc(Cl)c(Cl)cc2
11354	tr|P95150|P95150_M	P0AEK4	70.28	4.0	205.0	DB01691	experimental	Indole Naphthyridinone	c1cccc(c12)n(C)cc2CN(C)C(=O)/C=C/c(c3)cnc(c34)NC(=O)CC4
11355	tr|P95150|P95150_M	P0AEK4	70.28	4.0	205.0	DB01865	experimental	3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide	c1cccc(c12)cc(n2C)CN(C)C(=O)/C=C/c3cnc(N)cc3
11356	tr|P95150|P95150_M	P0AEK4	70.28	4.0	205.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
11357	tr|P95150|P95150_M	P0AEK4	70.28	4.0	205.0	DB03030	experimental	4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole	Cc1ccc(cc1)Cn2cnc(c2)-c3cccs3
11358	tr|P95150|P95150_M	P0AEK4	70.28	4.0	205.0	DB03534	experimental	3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide	CC(=O)N(C)Cc1c(N)ccc(c1)C(=O)N(C)Cc(n2C)cc(c23)cccc3
11359	tr|P95150|P95150_M	P0AEK4	70.28	4.0	205.0	DB04030	experimental	1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole	Oc1ccc(cc1)Cn2c(c3c(c24)cccc4)CN(CC3)C(=O)c5ccc(O)cc5
11360	tr|P95150|P95150_M	P0AEK4	70.28	4.0	205.0	DB08265	experimental	2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL	Cc1ccc(cc1)S(=O)(=O)n(b2O)ncc(c23)cccc3
11361	tr|P95150|P95150_M	P0AEK4	70.28	4.0	205.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
11362	tr|P95150|P95150_M	P0AEK4	70.28	4.0	205.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
11363	tr|P95150|P95150_M	Q8I814	70.28	13.0	214.0	DB02015	experimental	Dihydrofolic Acid	O=c1[nH]c(N)nc(c12)NCC(=N2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
11364	tr|P95150|P95150_M	Q8I814	70.28	13.0	214.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11365	tr|P95150|P95150_M	P16152	82.17	6.0	241.0	DB01698	approved; experimental; investigational	Rutin	O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O[C@H]1C)OC[C@H]2O[C@H]([C@H](O)[C@@H](O)[C@@H]2O)Oc(c3=O)c(-c4cc(O)c(O)cc4)oc(c35)cc(O)cc5O
11366	tr|P95150|P95150_M	P16152	82.17	6.0	241.0	DB02709	investigational	Resveratrol	Oc1ccc(cc1)/C=C/c2cc(O)cc(O)c2
11367	tr|P95150|P95150_M	P16152	82.17	6.0	241.0	DB03394	experimental	Heptaethylene glycol	OCCOCCOCCOCCOCCOCCOCCO
11368	tr|P95150|P95150_M	P16152	82.17	6.0	241.0	DB03556	experimental	2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400	CCOCCOCCOCCOCCOCCOCCOCCOCCO
11369	tr|P95150|P95150_M	P16152	82.17	6.0	241.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
11370	tr|P95150|P95150_M	P16152	82.17	6.0	241.0	DB04463	experimental	3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol	n1cnc(N)c(c12)c(nn2C(C)(C)C)-c3cccc(O)c3
11371	tr|P95150|P95150_M	P16152	82.17	6.0	241.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
11372	tr|P95150|P95150_M	P16152	82.17	6.0	241.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
11373	tr|P95150|P95150_M	P56937	80.07	3.0	232.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11374	tr|P95150|P95150_M	Q01782	76.22	8.0	226.0	DB02338	experimental	NADPH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11375	tr|P95150|P95150_M	Q01782	76.22	8.0	226.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
11376	tr|P95150|P95150_M	Q01782	76.22	8.0	226.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11377	tr|P95150|P95150_M	Q01782	76.22	8.0	226.0	DB04400	experimental	L-erythro-7,8-dihydrobiopterin	C[C@H](O)[C@H](O)C(CN1)=Nc(c12)c(=O)nc([nH]2)N
11378	tr|P95150|P95150_M	P35270	70.63	8.0	210.0	DB02637	experimental	Oxaloacetate Ion	OC(=O)C(=O)CC([O-])=O
11379	tr|P95150|P95150_M	P35270	70.63	8.0	210.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11380	tr|P95150|P95150_M	P35270	70.63	8.0	210.0	DB03886	experimental	Biopterin	C[C@@H](O)[C@@H](O)c(n1)cnc(c12)nc(N)[nH]c2=O
11381	tr|P95150|P95150_M	P35270	70.63	8.0	210.0	DB04275	experimental	N-acetylserotonin	CC(=O)NCCc1c[nH]c(c12)ccc(c2)O
11382	tr|O53398|O53398_M	Q8NBQ5	85.05	31.0	287.0	DB02854	experimental	Aetiocholanolone	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](CC3)C[C@H](O)CC4
11383	tr|O53398|O53398_M	O75911	81.06	35.0	279.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
11384	tr|O53398|O53398_M	Q9WYS2	70.1	7.0	218.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11385	tr|O53398|O53398_M	Q6UWP2	77.08	6.0	238.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11386	tr|O53398|O53398_M	Q8NBN7	73.75	35.0	257.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
11387	tr|O53398|O53398_M	Q92506	72.76	6.0	225.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11388	tr|O53398|O53398_M	Q92506	72.76	6.0	225.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11389	tr|O53398|O53398_M	Q84EX5	70.43	3.0	215.0	DB04619	experimental	Acetophenone	CC(=O)c1ccccc1
11390	tr|O53398|O53398_M	Q84EX5	70.43	3.0	215.0	DB04784	experimental	(R)-1-phenylethanol	C[C@@H](O)c1ccccc1
11391	tr|O53398|O53398_M	Q99714	73.09	5.0	225.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11392	tr|O53398|O53398_M	Q99714	73.09	5.0	225.0	DB02820	experimental	1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct	C1CCCCCN1C(=O)[C@H](c2ccccc2)n(c3=S)cnc(c34)nn(c4)[C@H]5C=CN(C=C5C([O-])=N)[C@@H]6O[C@@H]([C@@H](O)[C@H]6O)COP([O-])(=O)OP(=O)(O)OC[C@H]7O[C@H]([C@H]([O-])[C@@H]7[O-])n8cnc(c89)c(N)ncn9
11393	tr|O53398|O53398_M	Q99714	73.09	5.0	225.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
11394	tr|O53398|O53398_M	Q7Z4W1	71.1	5.0	219.0	DB02831	experimental	Dihydrogenphosphate	OP([O-])(=O)O
11395	tr|O53398|O53398_M	Q7Z4W1	71.1	5.0	219.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11396	tr|O53398|O53398_M	Q9HBH5	72.76	41.0	260.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
11397	tr|O53398|O53398_M	P28845	74.42	31.0	255.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11398	tr|O53398|O53398_M	P28845	74.42	31.0	255.0	DB02329	experimental	Carbenoxolone	OC(=O)CCC(=O)O[C@@H](CC1)C(C)(C)[C@@H]([C@]12C)CC[C@]3(C)[C@@H]2C(=O)C=C4[C@H]5[C@@](C)(CC[C@@]34C)CC[C@](C5)(C)C(=O)O
11399	tr|O53398|O53398_M	P28845	74.42	31.0	255.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11400	tr|O53398|O53398_M	P28845	74.42	31.0	255.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
11401	tr|O53398|O53398_M	P28845	74.42	31.0	255.0	DB04652	experimental	Corticosterone	OCC(=O)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H]([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
11402	tr|O53398|O53398_M	P28845	74.42	31.0	255.0	DB05064	investigational	INCB13739	 
11403	tr|O53398|O53398_M	P28845	74.42	31.0	255.0	DB06992	experimental	(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone	Cc1ccc(cc1F)-c2nc(ccc2)C(=O)N(CC3(C)C)CCC3
11404	tr|O53398|O53398_M	P28845	74.42	31.0	255.0	DB07017	experimental	(5S)-2-{[(1S)-1-(4-Fluorophenyl)ethyl]amino}-5-(2-hydroxy-2-propanyl)-5-methyl-1,3-thiazol-4(5H)-one	Fc1ccc(cc1)[C@H](C)NC(=NC2=O)S[C@@]2(C)C(C)(C)O
11405	tr|O53398|O53398_M	P28845	74.42	31.0	255.0	DB07049	experimental	(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine	[O-][N+](=O)c1ccc(cc1)N2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)C(C)(C)C
11406	tr|O53398|O53398_M	P28845	74.42	31.0	255.0	DB07056	experimental	2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide	CCN(CC)C(=O)Cc1cccc(n1)NS(=O)(=O)c2c(C)c(Cl)ccc2
11407	tr|O53398|O53398_M	P28845	74.42	31.0	255.0	DB07310	experimental	(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one	Fc1ccccc1[C@H](C)NC(=NC2=O)S[C@]2(C)C(F)(F)F
11408	tr|O53398|O53398_M	P28845	74.42	31.0	255.0	DB07316	experimental	N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)C3CCN(CC3)CC4(CC4)C(=O)N
11409	tr|O53398|O53398_M	P28845	74.42	31.0	255.0	DB07619	experimental	N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)[C@H]3CC[C@@H](CC3)c4cccnc4
11410	tr|O53398|O53398_M	P28845	74.42	31.0	255.0	DB07624	experimental	1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide	C1CC1(C(=O)N)CN2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)[C@](C)(O)C(F)(F)F
11411	tr|O53398|O53398_M	P28845	74.42	31.0	255.0	DB07866	experimental	(5S)-2-(Cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one	CCC[C@]1(C)SC(=NC1=O)NC2CCCCCCC2
11412	tr|O53398|O53398_M	P28845	74.42	31.0	255.0	DB08277	experimental	2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE	CS(=O)(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4c(Cl)cc(F)cc4
11413	tr|O53398|O53398_M	P28845	74.42	31.0	255.0	DB08280	experimental	(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE	NC(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4ccc(OC)cc4
11414	tr|O53398|O53398_M	P28845	74.42	31.0	255.0	DB08771	experimental	(5R)-2-[(2-Fluorophenyl)amino]-5-isopropyl-1,3-thiazol-4(5H)-one	CC(C)[C@H]1SC(=NC1=O)Nc2c(F)cccc2
11415	tr|O53398|O53398_M	P28845	74.42	31.0	255.0	DB13751	approved; experimental	Glycyrrhizic acid	C1C[C@](C)(C(=O)O)C[C@H]([C@]12C)C=3[C@@](C)(CC2)[C@@]4(C)[C@H](C(=O)C3)[C@]5(C)[C@@H](CC4)C(C)(C)[C@H](CC5)O[C@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O[C@@H]7O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]7O
11416	tr|O53398|O53398_M	Q8I814	78.41	13.0	249.0	DB02015	experimental	Dihydrofolic Acid	O=c1[nH]c(N)nc(c12)NCC(=N2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
11417	tr|O53398|O53398_M	Q8I814	78.41	13.0	249.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11418	tr|O53398|O53398_M	P37059	70.43	80.0	292.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11419	tr|O53398|O53398_M	P37059	70.43	80.0	292.0	DB13952	approved; investigational; vet_approved	Estradiol acetate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)C
11420	tr|O53398|O53398_M	P37059	70.43	80.0	292.0	DB13953	approved; investigational; vet_approved	Estradiol benzoate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)c5ccccc5
11421	tr|O53398|O53398_M	P37059	70.43	80.0	292.0	DB13954	approved; investigational; vet_approved	Estradiol cypionate	C1CCCC1CCC(=O)O[C@H]2CC[C@H]([C@@]23C)[C@H]4[C@H](CC3)c5c(CC4)cc(O)cc5
11422	tr|O53398|O53398_M	P37059	70.43	80.0	292.0	DB13955	approved; investigational; vet_approved	Estradiol dienanthate	CCCCCCC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)CCCCCC
11423	tr|O53398|O53398_M	P37059	70.43	80.0	292.0	DB13956	approved; investigational; vet_approved	Estradiol valerate	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)CC[C@@H]4OC(=O)CCCC
11424	tr|O53398|O53398_M	A0A348A0U3	72.09	3.0	220.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
11425	tr|O53398|O53398_M	Q6GI75	71.43	3.0	218.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
11426	tr|O53398|O53398_M	Q6GI75	71.43	3.0	218.0	DB11155	approved	Triclocarban	Clc1ccc(cc1)NC(=O)Nc2cc(Cl)c(Cl)cc2
11427	tr|O53398|O53398_M	P16152	78.41	7.0	243.0	DB01698	approved; experimental; investigational	Rutin	O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O[C@H]1C)OC[C@H]2O[C@H]([C@H](O)[C@@H](O)[C@@H]2O)Oc(c3=O)c(-c4cc(O)c(O)cc4)oc(c35)cc(O)cc5O
11428	tr|O53398|O53398_M	P16152	78.41	7.0	243.0	DB02709	investigational	Resveratrol	Oc1ccc(cc1)/C=C/c2cc(O)cc(O)c2
11429	tr|O53398|O53398_M	P16152	78.41	7.0	243.0	DB03394	experimental	Heptaethylene glycol	OCCOCCOCCOCCOCCOCCOCCO
11430	tr|O53398|O53398_M	P16152	78.41	7.0	243.0	DB03556	experimental	2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400	CCOCCOCCOCCOCCOCCOCCOCCOCCO
11431	tr|O53398|O53398_M	P16152	78.41	7.0	243.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
11432	tr|O53398|O53398_M	P16152	78.41	7.0	243.0	DB04463	experimental	3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol	n1cnc(N)c(c12)c(nn2C(C)(C)C)-c3cccc(O)c3
11433	tr|O53398|O53398_M	P16152	78.41	7.0	243.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
11434	tr|O53398|O53398_M	P16152	78.41	7.0	243.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
11435	tr|O53398|O53398_M	Q01782	84.05	8.0	261.0	DB02338	experimental	NADPH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11436	tr|O53398|O53398_M	Q01782	84.05	8.0	261.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
11437	tr|O53398|O53398_M	Q01782	84.05	8.0	261.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11438	tr|O53398|O53398_M	Q01782	84.05	8.0	261.0	DB04400	experimental	L-erythro-7,8-dihydrobiopterin	C[C@H](O)[C@H](O)C(CN1)=Nc(c12)c(=O)nc([nH]2)N
11439	tr|O53398|O53398_M	P56937	77.08	2.0	234.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11440	tr|O53398|O53398_M	P0AEK4	71.43	4.0	219.0	DB01691	experimental	Indole Naphthyridinone	c1cccc(c12)n(C)cc2CN(C)C(=O)/C=C/c(c3)cnc(c34)NC(=O)CC4
11441	tr|O53398|O53398_M	P0AEK4	71.43	4.0	219.0	DB01865	experimental	3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide	c1cccc(c12)cc(n2C)CN(C)C(=O)/C=C/c3cnc(N)cc3
11442	tr|O53398|O53398_M	P0AEK4	71.43	4.0	219.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
11443	tr|O53398|O53398_M	P0AEK4	71.43	4.0	219.0	DB03030	experimental	4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole	Cc1ccc(cc1)Cn2cnc(c2)-c3cccs3
11444	tr|O53398|O53398_M	P0AEK4	71.43	4.0	219.0	DB03534	experimental	3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide	CC(=O)N(C)Cc1c(N)ccc(c1)C(=O)N(C)Cc(n2C)cc(c23)cccc3
11445	tr|O53398|O53398_M	P0AEK4	71.43	4.0	219.0	DB04030	experimental	1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole	Oc1ccc(cc1)Cn2c(c3c(c24)cccc4)CN(CC3)C(=O)c5ccc(O)cc5
11446	tr|O53398|O53398_M	P0AEK4	71.43	4.0	219.0	DB08265	experimental	2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL	Cc1ccc(cc1)S(=O)(=O)n(b2O)ncc(c23)cccc3
11447	tr|O53398|O53398_M	P0AEK4	71.43	4.0	219.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
11448	tr|O53398|O53398_M	P0AEK4	71.43	4.0	219.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
11449	tr|O53398|O53398_M	P35270	70.76	7.0	220.0	DB02637	experimental	Oxaloacetate Ion	OC(=O)C(=O)CC([O-])=O
11450	tr|O53398|O53398_M	P35270	70.76	7.0	220.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11451	tr|O53398|O53398_M	P35270	70.76	7.0	220.0	DB03886	experimental	Biopterin	C[C@@H](O)[C@@H](O)c(n1)cnc(c12)nc(N)[nH]c2=O
11452	tr|O53398|O53398_M	P35270	70.76	7.0	220.0	DB04275	experimental	N-acetylserotonin	CC(=O)NCCc1c[nH]c(c12)ccc(c2)O
11453	tr|P71737|P71737_M	P54619	86.62	126.0	249.0	DB00131	approved; investigational; nutraceutical	Adenosine phosphate	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
11454	tr|P71737|P71737_M	P54619	86.62	126.0	249.0	DB00945	approved; vet_approved	Acetylsalicylic acid	CC(=O)Oc1ccccc1C(=O)O
11455	tr|P71737|P71737_M	P54619	86.62	126.0	249.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
11456	tr|P71737|P71737_M	Q9UGJ0	88.03	359.0	484.0	DB00131	approved; investigational; nutraceutical	Adenosine phosphate	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
11457	tr|P71737|P71737_M	Q9UGJ0	88.03	359.0	484.0	DB00945	approved; vet_approved	Acetylsalicylic acid	CC(=O)Oc1ccccc1C(=O)O
11458	tr|P71737|P71737_M	Q9UGJ0	88.03	359.0	484.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
11459	tr|P71737|P71737_M	Q9UGI9	84.51	283.0	403.0	DB00131	approved; investigational; nutraceutical	Adenosine phosphate	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
11460	tr|P71737|P71737_M	Q9UGI9	84.51	283.0	403.0	DB00945	approved; vet_approved	Acetylsalicylic acid	CC(=O)Oc1ccccc1C(=O)O
11461	tr|P71737|P71737_M	Q9UGI9	84.51	283.0	403.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
11462	tr|P71737|P71737_M	P0C0H6	73.24	104.0	208.0	DB04566	experimental	Inosinic Acid	OP(=O)(O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O1)n2cnc(c23)c(=O)[nH]cn3
11463	tr|P71737|P71737_M	P0C0H6	73.24	104.0	208.0	DB04862	investigational	Merimepodib	c1ncoc1-c2c(OC)cc(cc2)NC(=O)Nc3cccc(c3)CNC(=O)O[C@H]4CCOC4
11464	tr|O53370|O53370_M	P0AC41	98.64	5.0	587.0	DB04631	experimental	Atpenin A5	ClC[C@H](Cl)[C@@H](C)C[C@H](C)C(=O)c1c(O)c(OC)c([nH]c1=O)OC
11465	tr|O53370|O53370_M	P0AC41	98.64	5.0	587.0	DB07671	experimental	2-[1-METHYLHEXYL]-4,6-DINITROPHENOL	CCCCCC(C)c1c(O)c(N(=O)=O)cc(c1)N(=O)=O
11466	tr|O53370|O53370_M	P0AC41	98.64	5.0	587.0	DB08690	experimental	Ubiquinone Q2	COC1=C(OC)C(=O)C(=C(C)C1=O)C/C=C(\C)CCC=C(C)C
11467	tr|O53370|O53370_M	P31040	93.39	57.0	608.0	DB04141	experimental	2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol	O[C@H]1[C@@H](O)[C@@H](CO)O[C@H]([C@@H]1O)OCCCCCC
11468	tr|O53370|O53370_M	P31040	93.39	57.0	608.0	DB04657	approved; experimental	Carboxin	S1CCOC(C)=C1C(=O)Nc2ccccc2
11469	tr|O53370|O53370_M	P31040	93.39	57.0	608.0	DB04795	experimental	Thenoyltrifluoroacetone	FC(F)(F)C(=O)CC(=O)c1cccs1
11470	tr|O53370|O53370_M	P31040	93.39	57.0	608.0	DB08689	experimental	Ubiquinone Q1	COC1=C(OC)C(=O)C(=C(C)C1=O)CC=C(C)C
11471	tr|O53370|O53370_M	P31040	93.39	57.0	608.0	DB09270	approved; investigational; nutraceutical	Ubidecarenone	COC1=C(OC)C(=O)C(=C(C)C1=O)C/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CCC=C(C)C
11472	tr|O53370|O53370_M	P00363	97.97	4.0	582.0	DB00730	approved; vet_approved	Thiabendazole	c1scnc1-c(n2)[nH]c(c23)cccc3
11473	tr|O53370|O53370_M	P00363	97.97	4.0	582.0	DB07490	experimental	2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL	Clc1ccc(cc1)[C@@H](C)c2cc([N+]([O-])=O)cc([N+]([O-])=O)c2O
11474	tr|O53370|O53370_M	P00363	97.97	4.0	582.0	DB07918	experimental	2-heptyl-4-hydroxyquinoline N-oxide	CCCCCCCc(cc1O)[n+]([O-])c(c12)cccc2
11475	tr|O53370|O53370_M	P17412	95.08	5.0	566.0	DB07669	experimental	2,3-Dimethyl-1,4-naphthoquinone	O=C1C(C)=C(C)C(=O)c(c12)cccc2
11476	tr|O53370|O53370_M	P10902	87.63	4.0	521.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
11477	tr|P95034|P95034_M	P16640	96.06	2.0	392.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
11478	tr|P95034|P95034_M	Q52437	93.35	6.0	385.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
11479	tr|P95034|P95034_M	P37062	78.33	2.0	320.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
11480	tr|P95034|P95034_M	P37062	78.33	2.0	320.0	DB03382	experimental	S-oxy-L-cysteine	OC(=O)[C@@H](N)CS=O
11481	tr|P95034|P95034_M	P19480	70.94	204.0	492.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
11482	tr|P95034|P95034_M	P35340	70.69	205.0	492.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
11483	tr|P95034|P95034_M	B7JBP8	75.12	2.0	307.0	DB07640	experimental	2-decyl-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione	CCCCCCCCCCC1=C(C)C(=O)C(OC)=C(C1=O)OC
11484	tr|P95034|P95034_M	O67931	72.66	3.0	298.0	DB07640	experimental	2-decyl-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione	CCCCCCCCCCC1=C(C)C(=O)C(OC)=C(C1=O)OC
11485	tr|L7N688|L7N688_M	P28793	98.36	311.0	610.0	DB08249	experimental	3,6,9,12,15-PENTAOXATRICOSAN-1-OL	CCCCCCCCOCCOCCOCCOCCOCCO
11486	tr|L7N688|L7N688_M	Q08426	95.39	294.0	584.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11487	tr|L7N688|L7N688_M	P40939	99.67	358.0	661.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11488	tr|L7N688|L7N688_M	Q16836	94.41	27.0	314.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11489	tr|L7N688|L7N688_M	Q16836	94.41	27.0	314.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
11490	tr|L7N688|L7N688_M	Q16836	94.41	27.0	314.0	DB03612	experimental	3-Hydroxybutyryl-Coenzyme A	CC(O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
11491	tr|L7N688|L7N688_M	Q16836	94.41	27.0	314.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
11492	tr|O53578|O53578_M	Q9X4K7	99.81	8.0	529.0	DB02912	experimental	Propanoyl-CoA	CCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
11493	tr|O53578|O53578_M	Q8GBW6	98.08	11.0	523.0	DB04045	experimental	(R)-methylmalonyl-CoA	OC(=O)[C@@H](C)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
11494	tr|O53578|O53578_M	Q8GBW6	98.08	11.0	523.0	DB04183	experimental	Methylmalonic Acid	OC(=O)C(C)C(=O)O
11495	tr|O53578|O53578_M	P05166	95.98	37.0	538.0	DB00121	approved; investigational; nutraceutical	Biotin	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC(=O)O
11496	tr|O53578|O53578_M	P05166	95.98	37.0	538.0	DB00161	approved; nutraceutical	Valine	CC(C)[C@H](N)C(=O)O
11497	tr|O53578|O53578_M	Q9HCC0	95.98	45.0	546.0	DB00121	approved; investigational; nutraceutical	Biotin	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC(=O)O
11498	tr|O53578|O53578_M	Q06700	100.77	27.0	553.0	DB01942	experimental; investigational	Formic acid	OC=O
11499	tr|L7N6A4|L7N6A4_M	Q96Q83	84.88	101.0	275.0	DB00126	approved; nutraceutical	Ascorbic acid	OC[C@H](O)[C@H]1OC(=O)C(O)=C1O
11500	tr|I6X9S5|I6X9S5_M	P19440	102.54	42.0	567.0	DB00143	approved; investigational; nutraceutical	Glutathione	OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(=O)O
11501	tr|I6YGW9|I6YGW9_M	A9CJ63	98.01	6.0	154.0	DB02078	experimental	Triglyme	COCCOCCOCCOC
11502	tr|I6YGW9|I6YGW9_M	P0AF93	76.82	8.0	124.0	DB03544	experimental	S-Phosphocysteine	OC(=O)[C@@H](N)CSP(=O)(O)O
11503	tr|O53185|O53185_M	Q9WYA5	92.72	9.0	289.0	DB04422	experimental	Homocysteine	OC(=O)[C@@H](N)CCS
11504	tr|O53185|O53185_M	Q99707	91.72	67.0	344.0	DB00115	approved; nutraceutical	Cyanocobalamin	Cc(c1)c(C)cc(c12)ncn2[C@@H]3[C@H](O)[C@@H]([C@H](O3)CO)OP([O-])(=O)O[C@H](C)CNC(=O)CC[C@](C)([C@@H](CC(=O)N)[C@@H]4[C@]56C)C(=N4)/C(C)=C7\N=C(C(C)(C)[C@@H]7CCC(=O)N)/C=C8\N=C([C@@](C)(CC(=O)N)[C@@H]8CCC(=O)N)/C(C)=C(\N5[Co+]C#N)[C@@H](CCC(=O)N)[C@]6(C)CC(=O)N
11505	tr|O53185|O53185_M	Q99707	91.72	67.0	344.0	DB00116	nutraceutical	Tetrahydrofolic acid	Nc([nH]1)nc(=O)c(c12)NC(CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
11506	tr|O53185|O53185_M	Q99707	91.72	67.0	344.0	DB00134	approved; nutraceutical	Methionine	CSCC[C@H](N)C(=O)O
11507	tr|O53185|O53185_M	Q99707	91.72	67.0	344.0	DB00200	approved	Hydroxocobalamin	c1c(C)c(C)cc(c1[n+]2[Co-3]3456O)n(c2)[C@H]7O[C@H](CO)[C@H]([C@H]7O)OP(=O)([O-])O[C@H](C)CNC(=O)CC[C@@]8(C)C=9N3[C@H]([C@@H]8CC(=O)N)[C@]1(C)[N+]4=C([C@H]([C@]1(C)CC(=O)N)CCC(=O)N)C(C)=C1[N+]5=C([C@H]([C@]1(C)CC(=O)N)CCC(=O)N)C=C1[N+]6=C(C9C)[C@H](C1(C)C)CCC(=O)N
11508	tr|O53185|O53185_M	Q99707	91.72	67.0	344.0	DB03614	approved; investigational	Mecobalamin	Cc(c1)c(C)cc(c1[n+]2[Co-3]3456C)n(c2)[C@@H]7[C@H](O)[C@@H]([C@H](O7)CO)OP([O-])(=O)O[C@H](C)CNC(=O)CC[C@@]8(C)C=9N3[C@H]([C@@H]8CC(=O)N)[C@]1(C)[N+]4=C([C@H]([C@]1(C)CC(=O)N)CCC(=O)N)C(C)=C1[N+]6=C([C@H]([C@]1(C)CC(=O)N)CCC(=O)N)C=C1[N+]5=C(C9C)[C@H](C1(C)C)CCC(=O)N
11509	tr|O53185|O53185_M	Q99707	91.72	67.0	344.0	DB11590	approved	Thimerosal	CC[Hg]Sc1ccccc1C([O-])=O
11510	tr|O53185|O53185_M	Q93088	100.0	17.0	319.0	DB00134	approved; nutraceutical	Methionine	CSCC[C@H](N)C(=O)O
11511	tr|O53185|O53185_M	Q93088	100.0	17.0	319.0	DB02337	experimental	S-(D-Carboxybutyl)-L-Homocysteine	OC(=O)[C@@H](N)CCSCCCCC(=O)O
11512	tr|O53185|O53185_M	Q9H2M3	97.35	16.0	310.0	DB00134	approved; nutraceutical	Methionine	CSCC[C@H](N)C(=O)O
11513	tr|O53146|O53146_M	Q08257	97.56	8.0	328.0	DB00266	approved	Dicoumarol	c1cccc(c12)oc(=O)c(c2O)Cc(c(=O)o3)c(O)c(c34)cccc4
11514	tr|O53146|O53146_M	Q08257	97.56	8.0	328.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11516	tr|O53146|O53146_M	Q08257	97.56	8.0	328.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
11517	tr|O53146|O53146_M	P00325	75.61	123.0	371.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11518	tr|O53146|O53146_M	P00325	75.61	123.0	371.0	DB01213	approved; vet_approved	Fomepizole	Cc1c[nH]nc1
11519	tr|O53146|O53146_M	P00325	75.61	123.0	371.0	DB02481	experimental	N-Benzylformamide	O=CNCc1ccccc1
11520	tr|O53146|O53146_M	P00325	75.61	123.0	371.0	DB02721	experimental	4-Iodopyrazole	Ic1c[nH]nc1
11521	tr|O53146|O53146_M	P00325	75.61	123.0	371.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11522	tr|O53146|O53146_M	P00325	75.61	123.0	371.0	DB03703	experimental	Cyclohexanol	OC1CCCCC1
11523	tr|O53146|O53146_M	P00325	75.61	123.0	371.0	DB04105	experimental	N-Heptylformamide	CCCCCCCNC=O
11524	tr|O53146|O53146_M	P00325	75.61	123.0	371.0	DB09462	approved; investigational	Glycerin	OCC(O)CO
11525	tr|O53146|O53146_M	P00326	75.61	123.0	371.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11526	tr|O53146|O53146_M	P00326	75.61	123.0	371.0	DB01213	approved; vet_approved	Fomepizole	Cc1c[nH]nc1
11527	tr|O53146|O53146_M	P00326	75.61	123.0	371.0	DB01711	experimental	2,3,4,5,6-Pentafluorobenzyl Alcohol	OCc1c(F)c(F)c(F)c(F)c1F
11528	tr|O53146|O53146_M	P00326	75.61	123.0	371.0	DB02131	experimental	N-1-methylheptylformamide	O=CN[C@H](C)CCCCCC
11529	tr|O53146|O53146_M	P00326	75.61	123.0	371.0	DB02249	experimental	2-Ethoxyethanol	CCOCCO
11530	tr|O53146|O53146_M	P00326	75.61	123.0	371.0	DB02659	approved	Cholic Acid	OC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](C[C@@H]2O)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
11531	tr|O53146|O53146_M	P00326	75.61	123.0	371.0	DB02721	experimental	4-Iodopyrazole	Ic1c[nH]nc1
11532	tr|O53146|O53146_M	P00326	75.61	123.0	371.0	DB02757	experimental	Pyrazole	[nH]1cccn1
11533	tr|O53146|O53146_M	P00326	75.61	123.0	371.0	DB02822	experimental	Para-Bromobenzyl Alcohol	OCc1ccc(Br)cc1
11534	tr|O53146|O53146_M	P00326	75.61	123.0	371.0	DB02871	experimental	3-Butylthiolane 1-Oxide	O=[S@@]1C[C@H](CC1)CCCC
11535	tr|O53146|O53146_M	P00326	75.61	123.0	371.0	DB03020	experimental	5-beta-D-ribofuranosylnicotinamide adenine dinucleotide	NC(=O)c1c[nH+]cc(c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11536	tr|O53146|O53146_M	P00326	75.61	123.0	371.0	DB03061	experimental	(R)-N-(1-Methyl-Hexyl)-Formamide	CCCCC[C@H](C)NC=O
11537	tr|O53146|O53146_M	P00326	75.61	123.0	371.0	DB03226	experimental	Trifluoroethanol	OCC(F)(F)F
11538	tr|O53146|O53146_M	P00326	75.61	123.0	371.0	DB03559	experimental	Cyclohexylformamide	O=CNC1CCCCC1
11539	tr|O53146|O53146_M	P00326	75.61	123.0	371.0	DB04071	experimental	Cpad	NC(=O)c1nc(ccc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11540	tr|O53146|O53146_M	P00326	75.61	123.0	371.0	DB04113	experimental	N-Formylpiperidine	O=CN1CCCCC1
11541	tr|O53146|O53146_M	P00326	75.61	123.0	371.0	DB04312	experimental	2,3-Difluorobenzyl Alcohol	OCc1cccc(F)c1F
11542	tr|O53146|O53146_M	P00326	75.61	123.0	371.0	DB04448	experimental	2,4-Difluorobenzyl Alcohol 2,4-Difluoro-1-(Hydroxymethyl)Benzene	OCc1ccc(F)cc1F
11543	tr|O53146|O53146_M	P07327	75.61	123.0	371.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11544	tr|O53146|O53146_M	P07327	75.61	123.0	371.0	DB01213	approved; vet_approved	Fomepizole	Cc1c[nH]nc1
11545	tr|O53146|O53146_M	P07327	75.61	123.0	371.0	DB02721	experimental	4-Iodopyrazole	Ic1c[nH]nc1
11546	tr|O53146|O53146_M	P07327	75.61	123.0	371.0	DB04065	experimental	N-Cyclopentyl-N-Cyclobutylformamide	C1CCC1N(C=O)C2CCCC2
11547	tr|O53146|O53146_M	P08319	73.17	136.0	376.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11548	tr|O53146|O53146_M	P08319	73.17	136.0	376.0	DB03559	experimental	Cyclohexylformamide	O=CNC1CCCCC1
11549	tr|O53146|O53146_M	P40394	76.52	129.0	380.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11550	tr|O53146|O53146_M	P11766	77.13	119.0	372.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11551	tr|O53146|O53146_M	P11766	77.13	119.0	372.0	DB03017	approved; experimental	Lauric acid	CCCCCCCCCCCC(=O)O
11552	tr|O53146|O53146_M	P11766	77.13	119.0	372.0	DB03704	experimental	12-Hydroxydodecanoic Acid	OCCCCCCCCCCCC(=O)O
11553	tr|O53146|O53146_M	P11766	77.13	119.0	372.0	DB04153	experimental	S-Hydroxymethyl Glutathione	OC(=O)[C@@H](N)CCC(=O)N[C@@H](CSCO)C(=O)NCC(=O)O
11554	tr|O53146|O53146_M	P49327	74.7	1609.0	1854.0	DB01034	experimental	Cerulenin	NC(=O)[C@@H]1O[C@@H]1C(=O)CC/C=C/C/C=C/C
11555	tr|O53146|O53146_M	P49327	74.7	1609.0	1854.0	DB01083	approved; investigational	Orlistat	CCCCCCCCCCC[C@H](OC(=O)[C@@H](NC=O)CC(C)C)C[C@@H]1OC(=O)[C@H]1CCCCCC
11556	tr|O53146|O53146_M	Q8N8N7	80.18	80.0	343.0	DB00328	approved; investigational	Indomethacin	COc(cc1)cc(c12)c(CC(=O)O)c(C)n2C(=O)c3ccc(Cl)cc3
11557	tr|O53146|O53146_M	Q8N8N7	80.18	80.0	343.0	DB07177	experimental	(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID	OC(=O)CCC/C=C/CC1C(C(O)CC1=O)/C=C/C(=O)CCCCC
11558	tr|O53146|O53146_M	Q14914	82.01	58.0	327.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11559	tr|O53146|O53146_M	Q14914	82.01	58.0	327.0	DB04066	experimental	p-Coumaric acid	OC(=O)/C=C/c1ccc(O)cc1
11560	tr|O53146|O53146_M	Q14914	82.01	58.0	327.0	DB07177	experimental	(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID	OC(=O)CCC/C=C/CC1C(C(O)CC1=O)/C=C/C(=O)CCCCC
11561	tr|P95286|P95286_M	Q9WYS2	98.82	2.0	254.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11562	tr|P95286|P95286_M	Q9BTZ2	96.08	29.0	274.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
11564	tr|P95286|P95286_M	P0AEK2	93.73	2.0	241.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11565	tr|P95286|P95286_M	P0AET8	96.08	4.0	249.0	DB02123	experimental	Glycochenodeoxycholic Acid	OC(=O)CNC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
11566	tr|P95286|P95286_M	Q84EX5	96.86	4.0	251.0	DB04619	experimental	Acetophenone	CC(=O)c1ccccc1
11567	tr|P95286|P95286_M	Q84EX5	96.86	4.0	251.0	DB04784	experimental	(R)-1-phenylethanol	C[C@@H](O)c1ccccc1
11570	tr|P95286|P95286_M	Q92506	98.82	7.0	259.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11571	tr|P95286|P95286_M	Q92506	98.82	7.0	259.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11572	tr|P95286|P95286_M	P16544	99.22	5.0	258.0	DB01942	experimental; investigational	Formic acid	OC=O
11573	tr|P95286|P95286_M	P16544	99.22	5.0	258.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11574	tr|P95286|P95286_M	P16544	99.22	5.0	258.0	DB07715	investigational	Emodin	Cc(c1)cc(O)c(c12)C(=O)c3c(C2=O)cc(O)cc3O
11575	tr|P95286|P95286_M	Q9BY49	98.04	16.0	266.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
11576	tr|P95286|P95286_M	Q7Z4W1	92.55	5.0	241.0	DB02831	experimental	Dihydrogenphosphate	OP([O-])(=O)O
11577	tr|P95286|P95286_M	Q7Z4W1	92.55	5.0	241.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11578	tr|P95286|P95286_M	P0CG22	97.25	29.0	277.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
11579	tr|P95286|P95286_M	P0CG22	97.25	29.0	277.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11580	tr|P95286|P95286_M	P0CG22	97.25	29.0	277.0	DB03541	experimental	10-Propargyl-5,8-Dideazafolic Acid	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(CC#C)Cc(c2)ccc(c23)[nH]c(N)nc3=O
11581	tr|P95286|P95286_M	P0CG22	97.25	29.0	277.0	DB07689	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)NCc(cn3)nc(c34)c(N)nc(n4)N
11582	tr|P95286|P95286_M	P0CG22	97.25	29.0	277.0	DB07765	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)N(C)Cc(cn3)nc(c34)c(N)nc(n4)N
11583	tr|P95286|P95286_M	Q16698	96.86	56.0	303.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11584	tr|P95286|P95286_M	Q16698	96.86	56.0	303.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
11585	tr|P95286|P95286_M	A0A348A0U3	97.65	4.0	253.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
11586	tr|P95286|P95286_M	Q6GI75	98.43	2.0	253.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
11587	tr|P95286|P95286_M	Q6GI75	98.43	2.0	253.0	DB11155	approved	Triclocarban	Clc1ccc(cc1)NC(=O)Nc2cc(Cl)c(Cl)cc2
11588	tr|P95286|P95286_M	Q6UWP2	92.16	11.0	246.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11589	tr|P95286|P95286_M	P0AEK4	97.65	4.0	253.0	DB01691	experimental	Indole Naphthyridinone	c1cccc(c12)n(C)cc2CN(C)C(=O)/C=C/c(c3)cnc(c34)NC(=O)CC4
11590	tr|P95286|P95286_M	P0AEK4	97.65	4.0	253.0	DB01865	experimental	3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide	c1cccc(c12)cc(n2C)CN(C)C(=O)/C=C/c3cnc(N)cc3
11591	tr|P95286|P95286_M	P0AEK4	97.65	4.0	253.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
11592	tr|P95286|P95286_M	P0AEK4	97.65	4.0	253.0	DB03030	experimental	4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole	Cc1ccc(cc1)Cn2cnc(c2)-c3cccs3
11593	tr|P95286|P95286_M	P0AEK4	97.65	4.0	253.0	DB03534	experimental	3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide	CC(=O)N(C)Cc1c(N)ccc(c1)C(=O)N(C)Cc(n2C)cc(c23)cccc3
11594	tr|P95286|P95286_M	P0AEK4	97.65	4.0	253.0	DB04030	experimental	1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole	Oc1ccc(cc1)Cn2c(c3c(c24)cccc4)CN(CC3)C(=O)c5ccc(O)cc5
11595	tr|P95286|P95286_M	P0AEK4	97.65	4.0	253.0	DB08265	experimental	2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL	Cc1ccc(cc1)S(=O)(=O)n(b2O)ncc(c23)cccc3
11596	tr|P95286|P95286_M	P0AEK4	97.65	4.0	253.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
11597	tr|P95286|P95286_M	P0AEK4	97.65	4.0	253.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
11598	tr|P95286|P95286_M	Q96NR8	93.33	33.0	271.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
11599	tr|P95286|P95286_M	Q8TC12	85.1	35.0	252.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
11600	tr|P95286|P95286_M	Q99714	97.65	6.0	255.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11601	tr|P95286|P95286_M	Q99714	97.65	6.0	255.0	DB02820	experimental	1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct	C1CCCCCN1C(=O)[C@H](c2ccccc2)n(c3=S)cnc(c34)nn(c4)[C@H]5C=CN(C=C5C([O-])=N)[C@@H]6O[C@@H]([C@@H](O)[C@H]6O)COP([O-])(=O)OP(=O)(O)OC[C@H]7O[C@H]([C@H]([O-])[C@@H]7[O-])n8cnc(c89)c(N)ncn9
11602	tr|P95286|P95286_M	Q99714	97.65	6.0	255.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
11603	tr|P95286|P95286_M	O24990	96.86	4.0	251.0	DB04393	experimental	Soneclosan	Clc1cc(O)c(cc1)Oc2ccc(Cl)cc2
11604	tr|P95286|P95286_M	O24990	96.86	4.0	251.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
11605	tr|P95286|P95286_M	Q8NBQ5	84.31	33.0	248.0	DB02854	experimental	Aetiocholanolone	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](CC3)C[C@H](O)CC4
11606	tr|P95286|P95286_M	Q6PKH6	71.37	27.0	209.0	DB04200	experimental	Matairesinol	COc1cc(ccc1O)C[C@H]2COC(=O)[C@@H]2Cc3ccc(O)c(c3)OC
11607	tr|P95286|P95286_M	Q8NBN7	83.14	35.0	247.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
11608	tr|P95286|P95286_M	O75911	90.59	32.0	263.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
11609	tr|P95286|P95286_M	Q9HBH5	101.96	41.0	301.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
11610	tr|P95286|P95286_M	Q01782	108.24	8.0	284.0	DB02338	experimental	NADPH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11611	tr|P95286|P95286_M	Q01782	108.24	8.0	284.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
11612	tr|P95286|P95286_M	Q01782	108.24	8.0	284.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11613	tr|P95286|P95286_M	Q01782	108.24	8.0	284.0	DB04400	experimental	L-erythro-7,8-dihydrobiopterin	C[C@H](O)[C@H](O)C(CN1)=Nc(c12)c(=O)nc([nH]2)N
11614	tr|P95286|P95286_M	Q8I814	100.78	14.0	271.0	DB02015	experimental	Dihydrofolic Acid	O=c1[nH]c(N)nc(c12)NCC(=N2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
11615	tr|P95286|P95286_M	Q8I814	100.78	14.0	271.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11617	tr|P95286|P95286_M	Q7AUG5	94.12	3.0	243.0	DB04782	experimental	(S)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@H]2CO2
11618	tr|P95286|P95286_M	Q93D82	94.12	3.0	243.0	DB04472	experimental	(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol	[N-]=[N+]=NC[C@H](O)c1ccc([N+]([O-])=O)cc1
11619	tr|P95286|P95286_M	Q93D82	94.12	3.0	243.0	DB04499	experimental	(R)-styrene oxide	C1O[C@@H]1c2ccccc2
11620	tr|P95286|P95286_M	Q93D82	94.12	3.0	243.0	DB04777	experimental	(R)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@@H]2CO2
11621	tr|P95286|P95286_M	Q02338	77.25	53.0	250.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11622	tr|P95286|P95286_M	Q9NYR8	74.51	6.0	196.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
11623	tr|P95286|P95286_M	P14061	81.96	2.0	211.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11624	tr|P95286|P95286_M	P14061	81.96	2.0	211.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
11625	tr|P95286|P95286_M	P14061	81.96	2.0	211.0	DB01561	experimental; illicit	Androstanedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
11626	tr|P95286|P95286_M	P14061	81.96	2.0	211.0	DB02187	experimental	Equilin	O=C1CC[C@H]([C@@]12C)C=3[C@H](CC2)c4c(CC3)cc(O)cc4
11627	tr|P95286|P95286_M	P14061	81.96	2.0	211.0	DB02323	experimental	EM-1745	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)C[C@@H]([C@@H]4O)CCCCCCCCC(=O)OC[C@H]5O[C@H]([C@H](O)[C@@H]5O)n6cnc(c67)c(N)ncn7
11628	tr|P95286|P95286_M	P14061	81.96	2.0	211.0	DB02901	illicit; investigational	Stanolone	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
11629	tr|P95286|P95286_M	P14061	81.96	2.0	211.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11630	tr|P95286|P95286_M	P14061	81.96	2.0	211.0	DB13951	experimental	Stanolone acetate	CC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
11631	tr|P95286|P95286_M	P37059	81.18	73.0	280.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11632	tr|P95286|P95286_M	P37059	81.18	73.0	280.0	DB13952	approved; investigational; vet_approved	Estradiol acetate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)C
11633	tr|P95286|P95286_M	P37059	81.18	73.0	280.0	DB13953	approved; investigational; vet_approved	Estradiol benzoate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)c5ccccc5
11634	tr|P95286|P95286_M	P37059	81.18	73.0	280.0	DB13954	approved; investigational; vet_approved	Estradiol cypionate	C1CCCC1CCC(=O)O[C@H]2CC[C@H]([C@@]23C)[C@H]4[C@H](CC3)c5c(CC4)cc(O)cc5
11635	tr|P95286|P95286_M	P37059	81.18	73.0	280.0	DB13955	approved; investigational; vet_approved	Estradiol dienanthate	CCCCCCC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)CCCCCC
11636	tr|P95286|P95286_M	P37059	81.18	73.0	280.0	DB13956	approved; investigational; vet_approved	Estradiol valerate	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)CC[C@@H]4OC(=O)CCCC
11637	tr|P95286|P95286_M	P51659	78.82	5.0	206.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11638	tr|P95286|P95286_M	P51659	78.82	5.0	206.0	DB03192	experimental	(R)-3-hydroxydecanoyl-CoA	CCCCCCC[C@@H](O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
11639	tr|P95286|P95286_M	P28845	75.69	32.0	225.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11640	tr|P95286|P95286_M	P28845	75.69	32.0	225.0	DB02329	experimental	Carbenoxolone	OC(=O)CCC(=O)O[C@@H](CC1)C(C)(C)[C@@H]([C@]12C)CC[C@]3(C)[C@@H]2C(=O)C=C4[C@H]5[C@@](C)(CC[C@@]34C)CC[C@](C5)(C)C(=O)O
11641	tr|P95286|P95286_M	P28845	75.69	32.0	225.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11642	tr|P95286|P95286_M	P28845	75.69	32.0	225.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
11643	tr|P95286|P95286_M	P28845	75.69	32.0	225.0	DB04652	experimental	Corticosterone	OCC(=O)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H]([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
11644	tr|P95286|P95286_M	P28845	75.69	32.0	225.0	DB05064	investigational	INCB13739	 
11645	tr|P95286|P95286_M	P28845	75.69	32.0	225.0	DB06992	experimental	(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone	Cc1ccc(cc1F)-c2nc(ccc2)C(=O)N(CC3(C)C)CCC3
11646	tr|P95286|P95286_M	P28845	75.69	32.0	225.0	DB07017	experimental	(5S)-2-{[(1S)-1-(4-Fluorophenyl)ethyl]amino}-5-(2-hydroxy-2-propanyl)-5-methyl-1,3-thiazol-4(5H)-one	Fc1ccc(cc1)[C@H](C)NC(=NC2=O)S[C@@]2(C)C(C)(C)O
11647	tr|P95286|P95286_M	P28845	75.69	32.0	225.0	DB07049	experimental	(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine	[O-][N+](=O)c1ccc(cc1)N2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)C(C)(C)C
11648	tr|P95286|P95286_M	P28845	75.69	32.0	225.0	DB07056	experimental	2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide	CCN(CC)C(=O)Cc1cccc(n1)NS(=O)(=O)c2c(C)c(Cl)ccc2
11649	tr|P95286|P95286_M	P28845	75.69	32.0	225.0	DB07310	experimental	(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one	Fc1ccccc1[C@H](C)NC(=NC2=O)S[C@]2(C)C(F)(F)F
11650	tr|P95286|P95286_M	P28845	75.69	32.0	225.0	DB07316	experimental	N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)C3CCN(CC3)CC4(CC4)C(=O)N
11651	tr|P95286|P95286_M	P28845	75.69	32.0	225.0	DB07619	experimental	N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)[C@H]3CC[C@@H](CC3)c4cccnc4
11652	tr|P95286|P95286_M	P28845	75.69	32.0	225.0	DB07624	experimental	1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide	C1CC1(C(=O)N)CN2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)[C@](C)(O)C(F)(F)F
11653	tr|P95286|P95286_M	P28845	75.69	32.0	225.0	DB07866	experimental	(5S)-2-(Cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one	CCC[C@]1(C)SC(=NC1=O)NC2CCCCCCC2
11654	tr|P95286|P95286_M	P28845	75.69	32.0	225.0	DB08277	experimental	2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE	CS(=O)(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4c(Cl)cc(F)cc4
11655	tr|P95286|P95286_M	P28845	75.69	32.0	225.0	DB08280	experimental	(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE	NC(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4ccc(OC)cc4
11656	tr|P95286|P95286_M	P28845	75.69	32.0	225.0	DB08771	experimental	(5R)-2-[(2-Fluorophenyl)amino]-5-isopropyl-1,3-thiazol-4(5H)-one	CC(C)[C@H]1SC(=NC1=O)Nc2c(F)cccc2
11657	tr|P95286|P95286_M	P28845	75.69	32.0	225.0	DB13751	approved; experimental	Glycyrrhizic acid	C1C[C@](C)(C(=O)O)C[C@H]([C@]12C)C=3[C@@](C)(CC2)[C@@]4(C)[C@H](C(=O)C3)[C@]5(C)[C@@H](CC4)C(C)(C)[C@H](CC5)O[C@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O[C@@H]7O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]7O
11658	tr|P95286|P95286_M	Q92781	75.29	25.0	217.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11659	tr|P95286|P95286_M	Q92781	75.29	25.0	217.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
11660	tr|P95286|P95286_M	P80365	79.22	77.0	279.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11661	tr|P95286|P95286_M	P80365	79.22	77.0	279.0	DB01185	approved; illicit	Fluoxymesterone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@](F)([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
11662	tr|P95286|P95286_M	P80365	79.22	77.0	279.0	DB01569	experimental; illicit	Formebolone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@H]([C@@H](C2)O)[C@]4(C)C(CC3)=CC(=O)C(C=O)=C4
11663	tr|P95286|P95286_M	P80365	79.22	77.0	279.0	DB14538	experimental; vet_approved	Hydrocortisone aceponate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CC)C(=O)COC(=O)C
11664	tr|P95286|P95286_M	P80365	79.22	77.0	279.0	DB14539	approved; vet_approved	Hydrocortisone acetate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)C
11665	tr|P95286|P95286_M	P80365	79.22	77.0	279.0	DB14540	approved; vet_approved	Hydrocortisone butyrate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCC
11666	tr|P95286|P95286_M	P80365	79.22	77.0	279.0	DB14541	approved; investigational; vet_approved	Hydrocortisone cypionate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)CCC5CCCC5
11667	tr|P95286|P95286_M	P80365	79.22	77.0	279.0	DB14542	approved; vet_approved	Hydrocortisone phosphate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COP(=O)(O)O
11668	tr|P95286|P95286_M	P80365	79.22	77.0	279.0	DB14543	approved; vet_approved	Hydrocortisone probutate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CCC)C(=O)COC(=O)CC
11669	tr|P95286|P95286_M	P80365	79.22	77.0	279.0	DB14544	approved; vet_approved	Hydrocortisone valerate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCCC
11670	tr|P95286|P95286_M	P9WGR1	101.57	5.0	264.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
11671	tr|P95286|P95286_M	P9WGR1	101.57	5.0	264.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
11672	tr|P95286|P95286_M	P9WGR1	101.57	5.0	264.0	DB02990	experimental	S-(2-Acetamidoethyl) hexadecanethioate	CCCCCCCCCCCCCCCC(=O)SCCNC(=O)C
11673	tr|P95286|P95286_M	P9WGR1	101.57	5.0	264.0	DB04289	experimental	Genz-10850	[nH]1ccc(c12)cc(cc2)C(=O)N3CCN(CC3)C4c(cccc5)c5c(c46)cccc6
11674	tr|P95286|P95286_M	P9WGR1	101.57	5.0	264.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
11675	tr|P95286|P95286_M	P9WGR1	101.57	5.0	264.0	DB07090	experimental	(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cccc(c1C)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
11676	tr|P95286|P95286_M	P9WGR1	101.57	5.0	264.0	DB07123	experimental	N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE	Cc1ccc(cc1)C(=O)N2CCC(CC2)Cc3ccccc3
11677	tr|P95286|P95286_M	P9WGR1	101.57	5.0	264.0	DB07155	experimental	(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE	c1ccccc1NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
11678	tr|P95286|P95286_M	P9WGR1	101.57	5.0	264.0	DB07178	experimental	5-PENTYL-2-PHENOXYPHENOL	CCCCCc1cc(O)c(cc1)Oc2ccccc2
11679	tr|P95286|P95286_M	P9WGR1	101.57	5.0	264.0	DB07188	experimental	(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(cc(Cl)c1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
11680	tr|P95286|P95286_M	P9WGR1	101.57	5.0	264.0	DB07192	experimental	(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Brc1cc(ccc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
11681	tr|P95286|P95286_M	P9WGR1	101.57	5.0	264.0	DB07222	experimental	(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(c(C)cc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
11682	tr|P95286|P95286_M	P9WGR1	101.57	5.0	264.0	DB07287	experimental	2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL	c1cccnc1Cc2cc(O)c(cc2)Oc3ccc(Cl)cc3Cl
11683	tr|P95286|P95286_M	P9WGR1	101.57	5.0	264.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
11684	tr|P95286|P95286_M	P37058	75.69	48.0	241.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11685	tr|P95286|P95286_M	P16152	96.08	7.0	252.0	DB01698	approved; experimental; investigational	Rutin	O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O[C@H]1C)OC[C@H]2O[C@H]([C@H](O)[C@@H](O)[C@@H]2O)Oc(c3=O)c(-c4cc(O)c(O)cc4)oc(c35)cc(O)cc5O
11686	tr|P95286|P95286_M	P16152	96.08	7.0	252.0	DB02709	investigational	Resveratrol	Oc1ccc(cc1)/C=C/c2cc(O)cc(O)c2
11687	tr|P95286|P95286_M	P16152	96.08	7.0	252.0	DB03394	experimental	Heptaethylene glycol	OCCOCCOCCOCCOCCOCCOCCO
11688	tr|P95286|P95286_M	P16152	96.08	7.0	252.0	DB03556	experimental	2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400	CCOCCOCCOCCOCCOCCOCCOCCOCCO
11689	tr|P95286|P95286_M	P16152	96.08	7.0	252.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
11690	tr|P95286|P95286_M	P16152	96.08	7.0	252.0	DB04463	experimental	3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol	n1cnc(N)c(c12)c(nn2C(C)(C)C)-c3cccc(O)c3
11691	tr|P95286|P95286_M	P16152	96.08	7.0	252.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
11692	tr|P95286|P95286_M	P16152	96.08	7.0	252.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
11693	tr|P95286|P95286_M	P56937	89.8	2.0	231.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11694	tr|P95286|P95286_M	P35270	81.18	6.0	213.0	DB02637	experimental	Oxaloacetate Ion	OC(=O)C(=O)CC([O-])=O
11695	tr|P95286|P95286_M	P35270	81.18	6.0	213.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11696	tr|P95286|P95286_M	P35270	81.18	6.0	213.0	DB03886	experimental	Biopterin	C[C@@H](O)[C@@H](O)c(n1)cnc(c12)nc(N)[nH]c2=O
11697	tr|P95286|P95286_M	P35270	81.18	6.0	213.0	DB04275	experimental	N-acetylserotonin	CC(=O)NCCc1c[nH]c(c12)ccc(c2)O
11698	tr|P95286|P95286_M	P26391	74.9	3.0	194.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
11699	tr|P95286|P95286_M	P09417	71.37	11.0	193.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11700	tr|P95286|P95286_M	P09417	71.37	11.0	193.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
11701	tr|P95286|P95286_M	Q8T8E9	76.08	2.0	196.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
11702	tr|P95286|P95286_M	P26397	72.94	8.0	194.0	DB02059	experimental	Adenosine-5-Diphosphoribose	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)CO[P@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H](O)[C@H](O)[C@@H]4O
11703	tr|P95286|P95286_M	P26397	72.94	8.0	194.0	DB03069	experimental	Cytidine-5'-diphospho-beta-D-xylose	Nc1nc(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O[C@H]3OC[C@@H](O)[C@H](O)[C@H]3O
11704	tr|I6XHJ3|I6XHJ3_M	Q9BWD1	100.78	7.0	396.0	DB01915	experimental	S-Hydroxycysteine	OC(=O)[C@@H](N)CSO
11705	tr|I6XHJ3|I6XHJ3_M	Q9BWD1	100.78	7.0	396.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
11706	tr|I6XHJ3|I6XHJ3_M	P07097	100.78	3.0	392.0	DB01915	experimental	S-Hydroxycysteine	OC(=O)[C@@H](N)CSO
11707	tr|I6XHJ3|I6XHJ3_M	P07097	100.78	3.0	392.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
11708	tr|I6XHJ3|I6XHJ3_M	P07097	100.78	3.0	392.0	DB02039	experimental	S-Acetyl-Cysteine	OC(=O)[C@@H](N)CSC(=O)C
11709	tr|I6XHJ3|I6XHJ3_M	P07097	100.78	3.0	392.0	DB02160	experimental	S-Butyryl-Cystein	OC(=O)[C@@H](N)CSC(=O)CCC
11710	tr|I6XHJ3|I6XHJ3_M	P07097	100.78	3.0	392.0	DB03045	experimental	Pantothenyl-Aminoethanol-Acetate Pivalic Acid	CC(=O)OCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COC(=O)C(C)(C)C
11711	tr|I6XHJ3|I6XHJ3_M	P07097	100.78	3.0	392.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
11712	tr|I6XHJ3|I6XHJ3_M	P07097	100.78	3.0	392.0	DB08328	experimental	PANTOTHENYL-AMINOETHANOL-11-PIVALIC ACID	CC(C)(C)C(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCO
11713	tr|I6XHJ3|I6XHJ3_M	P07097	100.78	3.0	392.0	DB08408	experimental	(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-({3-oxo-3-[(2-sulfanylethyl)amino]propyl}amino)butyl 2,2-dimethylpropanoate	CC(C)(C)C(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS
11714	tr|I6XHJ3|I6XHJ3_M	P24752	100.26	40.0	427.0	DB00795	approved	Sulfasalazine	OC(=O)c1cc(ccc1O)/N=N/c2ccc(cc2)S(=O)(=O)Nc3ncccc3
11715	tr|I6XHJ3|I6XHJ3_M	P24752	100.26	40.0	427.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
11717	tr|I6XHJ3|I6XHJ3_M	P24752	100.26	40.0	427.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
11718	tr|I6XHJ3|I6XHJ3_M	P28790	99.22	7.0	390.0	DB08249	experimental	3,6,9,12,15-PENTAOXATRICOSAN-1-OL	CCCCCCCCOCCOCCOCCOCCOCCO
11719	tr|I6XHJ3|I6XHJ3_M	P09110	99.22	37.0	420.0	DB09069	approved; investigational	Trimetazidine	COc1c(OC)c(OC)c(cc1)CN2CCNCC2
11720	tr|O53897|O53897_M	Q816R0	82.87	4.0	154.0	DB03366	experimental; investigational	Imidazole	[nH]1ccnc1
11721	tr|O53897|O53897_M	Q9NQX3	80.11	15.0	160.0	DB01942	experimental; investigational	Formic acid	OC=O
11722	tr|O53897|O53897_M	Q9NQX3	80.11	15.0	160.0	DB03366	experimental; investigational	Imidazole	[nH]1ccnc1
11723	tr|O53897|O53897_M	Q9NQX3	80.11	15.0	160.0	DB03766	approved; vet_approved	Propanoic acid	CCC(=O)O
11724	tr|I6X811|I6X811_M	P06202	92.61	12.0	513.0	DB07365	experimental	1-Naphthyl-L-alanine	OC(=O)[C@@H](N)Cc1cccc(c12)cccc2
11725	tr|I6X811|I6X811_M	P33590	91.68	2.0	498.0	DB03374	experimental	3,5-Diiodotyrosine	OC(=O)[C@@H](N)Cc1cc(I)c(O)c(I)c1
11726	tr|I6YCF0|I6YCF0_M	Q9BTZ2	96.56	18.0	271.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
11727	tr|I6YCF0|I6YCF0_M	Q9WYS2	92.75	6.0	249.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11729	tr|I6YCF0|I6YCF0_M	P0AEK2	89.69	3.0	238.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11730	tr|I6YCF0|I6YCF0_M	P0CG22	97.71	18.0	274.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
11731	tr|I6YCF0|I6YCF0_M	P0CG22	97.71	18.0	274.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11732	tr|I6YCF0|I6YCF0_M	P0CG22	97.71	18.0	274.0	DB03541	experimental	10-Propargyl-5,8-Dideazafolic Acid	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(CC#C)Cc(c2)ccc(c23)[nH]c(N)nc3=O
11733	tr|I6YCF0|I6YCF0_M	P0CG22	97.71	18.0	274.0	DB07689	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)NCc(cn3)nc(c34)c(N)nc(n4)N
11734	tr|I6YCF0|I6YCF0_M	P0CG22	97.71	18.0	274.0	DB07765	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)N(C)Cc(cn3)nc(c34)c(N)nc(n4)N
11735	tr|I6YCF0|I6YCF0_M	P0AET8	91.22	8.0	247.0	DB02123	experimental	Glycochenodeoxycholic Acid	OC(=O)CNC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
11736	tr|I6YCF0|I6YCF0_M	Q92506	95.42	6.0	256.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11737	tr|I6YCF0|I6YCF0_M	Q92506	95.42	6.0	256.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11739	tr|I6YCF0|I6YCF0_M	Q84EX5	92.75	3.0	246.0	DB04619	experimental	Acetophenone	CC(=O)c1ccccc1
11740	tr|I6YCF0|I6YCF0_M	Q84EX5	92.75	3.0	246.0	DB04784	experimental	(R)-1-phenylethanol	C[C@@H](O)c1ccccc1
11741	tr|I6YCF0|I6YCF0_M	Q9BY49	96.18	10.0	262.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
11742	tr|I6YCF0|I6YCF0_M	P16544	95.42	5.0	255.0	DB01942	experimental; investigational	Formic acid	OC=O
11743	tr|I6YCF0|I6YCF0_M	P16544	95.42	5.0	255.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11744	tr|I6YCF0|I6YCF0_M	P16544	95.42	5.0	255.0	DB07715	investigational	Emodin	Cc(c1)cc(O)c(c12)C(=O)c3c(C2=O)cc(O)cc3O
11746	tr|I6YCF0|I6YCF0_M	Q16698	96.18	48.0	300.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11747	tr|I6YCF0|I6YCF0_M	Q16698	96.18	48.0	300.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
11748	tr|I6YCF0|I6YCF0_M	Q7Z4W1	89.31	4.0	238.0	DB02831	experimental	Dihydrogenphosphate	OP([O-])(=O)O
11749	tr|I6YCF0|I6YCF0_M	Q7Z4W1	89.31	4.0	238.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11750	tr|I6YCF0|I6YCF0_M	Q6PKH6	74.81	16.0	212.0	DB04200	experimental	Matairesinol	COc1cc(ccc1O)C[C@H]2COC(=O)[C@@H]2Cc3ccc(O)c(c3)OC
11751	tr|I6YCF0|I6YCF0_M	A0A348A0U3	94.27	2.0	249.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
11752	tr|I6YCF0|I6YCF0_M	Q6GI75	93.51	4.0	249.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
11753	tr|I6YCF0|I6YCF0_M	Q6GI75	93.51	4.0	249.0	DB11155	approved	Triclocarban	Clc1ccc(cc1)NC(=O)Nc2cc(Cl)c(Cl)cc2
11755	tr|I6YCF0|I6YCF0_M	Q6UWP2	90.84	8.0	246.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11756	tr|I6YCF0|I6YCF0_M	P0AEK4	93.89	2.0	248.0	DB01691	experimental	Indole Naphthyridinone	c1cccc(c12)n(C)cc2CN(C)C(=O)/C=C/c(c3)cnc(c34)NC(=O)CC4
11757	tr|I6YCF0|I6YCF0_M	P0AEK4	93.89	2.0	248.0	DB01865	experimental	3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide	c1cccc(c12)cc(n2C)CN(C)C(=O)/C=C/c3cnc(N)cc3
11758	tr|I6YCF0|I6YCF0_M	P0AEK4	93.89	2.0	248.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
11759	tr|I6YCF0|I6YCF0_M	P0AEK4	93.89	2.0	248.0	DB03030	experimental	4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole	Cc1ccc(cc1)Cn2cnc(c2)-c3cccs3
11760	tr|I6YCF0|I6YCF0_M	P0AEK4	93.89	2.0	248.0	DB03534	experimental	3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide	CC(=O)N(C)Cc1c(N)ccc(c1)C(=O)N(C)Cc(n2C)cc(c23)cccc3
11761	tr|I6YCF0|I6YCF0_M	P0AEK4	93.89	2.0	248.0	DB04030	experimental	1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole	Oc1ccc(cc1)Cn2c(c3c(c24)cccc4)CN(CC3)C(=O)c5ccc(O)cc5
11762	tr|I6YCF0|I6YCF0_M	P0AEK4	93.89	2.0	248.0	DB08265	experimental	2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL	Cc1ccc(cc1)S(=O)(=O)n(b2O)ncc(c23)cccc3
11763	tr|I6YCF0|I6YCF0_M	P0AEK4	93.89	2.0	248.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
11764	tr|I6YCF0|I6YCF0_M	P0AEK4	93.89	2.0	248.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
11765	tr|I6YCF0|I6YCF0_M	Q99714	94.66	6.0	254.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11766	tr|I6YCF0|I6YCF0_M	Q99714	94.66	6.0	254.0	DB02820	experimental	1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct	C1CCCCCN1C(=O)[C@H](c2ccccc2)n(c3=S)cnc(c34)nn(c4)[C@H]5C=CN(C=C5C([O-])=N)[C@@H]6O[C@@H]([C@@H](O)[C@H]6O)COP([O-])(=O)OP(=O)(O)OC[C@H]7O[C@H]([C@H]([O-])[C@@H]7[O-])n8cnc(c89)c(N)ncn9
11767	tr|I6YCF0|I6YCF0_M	Q99714	94.66	6.0	254.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
11768	tr|I6YCF0|I6YCF0_M	Q9HBH5	97.71	36.0	292.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
11769	tr|I6YCF0|I6YCF0_M	Q8NBQ5	87.79	30.0	260.0	DB02854	experimental	Aetiocholanolone	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](CC3)C[C@H](O)CC4
11770	tr|I6YCF0|I6YCF0_M	O24990	93.51	2.0	247.0	DB04393	experimental	Soneclosan	Clc1cc(O)c(cc1)Oc2ccc(Cl)cc2
11771	tr|I6YCF0|I6YCF0_M	O24990	93.51	2.0	247.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
11772	tr|I6YCF0|I6YCF0_M	Q8I814	97.33	13.0	268.0	DB02015	experimental	Dihydrofolic Acid	O=c1[nH]c(N)nc(c12)NCC(=N2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
11773	tr|I6YCF0|I6YCF0_M	Q8I814	97.33	13.0	268.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11774	tr|I6YCF0|I6YCF0_M	Q01782	103.82	8.0	280.0	DB02338	experimental	NADPH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11775	tr|I6YCF0|I6YCF0_M	Q01782	103.82	8.0	280.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
11776	tr|I6YCF0|I6YCF0_M	Q01782	103.82	8.0	280.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11777	tr|I6YCF0|I6YCF0_M	Q01782	103.82	8.0	280.0	DB04400	experimental	L-erythro-7,8-dihydrobiopterin	C[C@H](O)[C@H](O)C(CN1)=Nc(c12)c(=O)nc([nH]2)N
11778	tr|I6YCF0|I6YCF0_M	Q8NBN7	80.15	33.0	243.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
11779	tr|I6YCF0|I6YCF0_M	O75911	86.64	36.0	263.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
11780	tr|I6YCF0|I6YCF0_M	Q8TC12	80.15	33.0	243.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
11781	tr|I6YCF0|I6YCF0_M	Q02338	81.68	50.0	264.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11782	tr|I6YCF0|I6YCF0_M	Q96NR8	78.63	34.0	240.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
11783	tr|I6YCF0|I6YCF0_M	P28845	83.21	24.0	242.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11784	tr|I6YCF0|I6YCF0_M	P28845	83.21	24.0	242.0	DB02329	experimental	Carbenoxolone	OC(=O)CCC(=O)O[C@@H](CC1)C(C)(C)[C@@H]([C@]12C)CC[C@]3(C)[C@@H]2C(=O)C=C4[C@H]5[C@@](C)(CC[C@@]34C)CC[C@](C5)(C)C(=O)O
11785	tr|I6YCF0|I6YCF0_M	P28845	83.21	24.0	242.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11786	tr|I6YCF0|I6YCF0_M	P28845	83.21	24.0	242.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
11787	tr|I6YCF0|I6YCF0_M	P28845	83.21	24.0	242.0	DB04652	experimental	Corticosterone	OCC(=O)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H]([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
11788	tr|I6YCF0|I6YCF0_M	P28845	83.21	24.0	242.0	DB05064	investigational	INCB13739	 
11789	tr|I6YCF0|I6YCF0_M	P28845	83.21	24.0	242.0	DB06992	experimental	(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone	Cc1ccc(cc1F)-c2nc(ccc2)C(=O)N(CC3(C)C)CCC3
11790	tr|I6YCF0|I6YCF0_M	P28845	83.21	24.0	242.0	DB07017	experimental	(5S)-2-{[(1S)-1-(4-Fluorophenyl)ethyl]amino}-5-(2-hydroxy-2-propanyl)-5-methyl-1,3-thiazol-4(5H)-one	Fc1ccc(cc1)[C@H](C)NC(=NC2=O)S[C@@]2(C)C(C)(C)O
11791	tr|I6YCF0|I6YCF0_M	P28845	83.21	24.0	242.0	DB07049	experimental	(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine	[O-][N+](=O)c1ccc(cc1)N2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)C(C)(C)C
11792	tr|I6YCF0|I6YCF0_M	P28845	83.21	24.0	242.0	DB07056	experimental	2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide	CCN(CC)C(=O)Cc1cccc(n1)NS(=O)(=O)c2c(C)c(Cl)ccc2
11793	tr|I6YCF0|I6YCF0_M	P28845	83.21	24.0	242.0	DB07310	experimental	(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one	Fc1ccccc1[C@H](C)NC(=NC2=O)S[C@]2(C)C(F)(F)F
11794	tr|I6YCF0|I6YCF0_M	P28845	83.21	24.0	242.0	DB07316	experimental	N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)C3CCN(CC3)CC4(CC4)C(=O)N
11795	tr|I6YCF0|I6YCF0_M	P28845	83.21	24.0	242.0	DB07619	experimental	N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)[C@H]3CC[C@@H](CC3)c4cccnc4
11796	tr|I6YCF0|I6YCF0_M	P28845	83.21	24.0	242.0	DB07624	experimental	1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide	C1CC1(C(=O)N)CN2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)[C@](C)(O)C(F)(F)F
11797	tr|I6YCF0|I6YCF0_M	P28845	83.21	24.0	242.0	DB07866	experimental	(5S)-2-(Cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one	CCC[C@]1(C)SC(=NC1=O)NC2CCCCCCC2
11798	tr|I6YCF0|I6YCF0_M	P28845	83.21	24.0	242.0	DB08277	experimental	2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE	CS(=O)(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4c(Cl)cc(F)cc4
11799	tr|I6YCF0|I6YCF0_M	P28845	83.21	24.0	242.0	DB08280	experimental	(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE	NC(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4ccc(OC)cc4
11800	tr|I6YCF0|I6YCF0_M	P28845	83.21	24.0	242.0	DB08771	experimental	(5R)-2-[(2-Fluorophenyl)amino]-5-isopropyl-1,3-thiazol-4(5H)-one	CC(C)[C@H]1SC(=NC1=O)Nc2c(F)cccc2
11801	tr|I6YCF0|I6YCF0_M	P28845	83.21	24.0	242.0	DB13751	approved; experimental	Glycyrrhizic acid	C1C[C@](C)(C(=O)O)C[C@H]([C@]12C)C=3[C@@](C)(CC2)[C@@]4(C)[C@H](C(=O)C3)[C@]5(C)[C@@H](CC4)C(C)(C)[C@H](CC5)O[C@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O[C@@H]7O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]7O
11802	tr|I6YCF0|I6YCF0_M	P14061	78.24	3.0	208.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11803	tr|I6YCF0|I6YCF0_M	P14061	78.24	3.0	208.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
11804	tr|I6YCF0|I6YCF0_M	P14061	78.24	3.0	208.0	DB01561	experimental; illicit	Androstanedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
11805	tr|I6YCF0|I6YCF0_M	P14061	78.24	3.0	208.0	DB02187	experimental	Equilin	O=C1CC[C@H]([C@@]12C)C=3[C@H](CC2)c4c(CC3)cc(O)cc4
11806	tr|I6YCF0|I6YCF0_M	P14061	78.24	3.0	208.0	DB02323	experimental	EM-1745	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)C[C@@H]([C@@H]4O)CCCCCCCCC(=O)OC[C@H]5O[C@H]([C@H](O)[C@@H]5O)n6cnc(c67)c(N)ncn7
11807	tr|I6YCF0|I6YCF0_M	P14061	78.24	3.0	208.0	DB02901	illicit; investigational	Stanolone	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
11808	tr|I6YCF0|I6YCF0_M	P14061	78.24	3.0	208.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11809	tr|I6YCF0|I6YCF0_M	P14061	78.24	3.0	208.0	DB13951	experimental	Stanolone acetate	CC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
11810	tr|I6YCF0|I6YCF0_M	Q9NYR8	72.9	6.0	197.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
11811	tr|I6YCF0|I6YCF0_M	P51659	81.3	3.0	216.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11812	tr|I6YCF0|I6YCF0_M	P51659	81.3	3.0	216.0	DB03192	experimental	(R)-3-hydroxydecanoyl-CoA	CCCCCCC[C@@H](O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
11813	tr|I6YCF0|I6YCF0_M	Q7AUG5	89.31	3.0	237.0	DB04782	experimental	(S)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@H]2CO2
11814	tr|I6YCF0|I6YCF0_M	Q93D82	89.31	3.0	237.0	DB04472	experimental	(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol	[N-]=[N+]=NC[C@H](O)c1ccc([N+]([O-])=O)cc1
11815	tr|I6YCF0|I6YCF0_M	Q93D82	89.31	3.0	237.0	DB04499	experimental	(R)-styrene oxide	C1O[C@@H]1c2ccccc2
11816	tr|I6YCF0|I6YCF0_M	Q93D82	89.31	3.0	237.0	DB04777	experimental	(R)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@@H]2CO2
11817	tr|I6YCF0|I6YCF0_M	P37058	75.95	48.0	247.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11818	tr|I6YCF0|I6YCF0_M	P37059	79.77	79.0	288.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11819	tr|I6YCF0|I6YCF0_M	P37059	79.77	79.0	288.0	DB13952	approved; investigational; vet_approved	Estradiol acetate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)C
11820	tr|I6YCF0|I6YCF0_M	P37059	79.77	79.0	288.0	DB13953	approved; investigational; vet_approved	Estradiol benzoate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)c5ccccc5
11821	tr|I6YCF0|I6YCF0_M	P37059	79.77	79.0	288.0	DB13954	approved; investigational; vet_approved	Estradiol cypionate	C1CCCC1CCC(=O)O[C@H]2CC[C@H]([C@@]23C)[C@H]4[C@H](CC3)c5c(CC4)cc(O)cc5
11822	tr|I6YCF0|I6YCF0_M	P37059	79.77	79.0	288.0	DB13955	approved; investigational; vet_approved	Estradiol dienanthate	CCCCCCC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)CCCCCC
11823	tr|I6YCF0|I6YCF0_M	P37059	79.77	79.0	288.0	DB13956	approved; investigational; vet_approved	Estradiol valerate	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)CC[C@@H]4OC(=O)CCCC
11824	tr|I6YCF0|I6YCF0_M	P80365	77.86	78.0	282.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11825	tr|I6YCF0|I6YCF0_M	P80365	77.86	78.0	282.0	DB01185	approved; illicit	Fluoxymesterone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@](F)([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
11826	tr|I6YCF0|I6YCF0_M	P80365	77.86	78.0	282.0	DB01569	experimental; illicit	Formebolone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@H]([C@@H](C2)O)[C@]4(C)C(CC3)=CC(=O)C(C=O)=C4
11827	tr|I6YCF0|I6YCF0_M	P80365	77.86	78.0	282.0	DB14538	experimental; vet_approved	Hydrocortisone aceponate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CC)C(=O)COC(=O)C
11828	tr|I6YCF0|I6YCF0_M	P80365	77.86	78.0	282.0	DB14539	approved; vet_approved	Hydrocortisone acetate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)C
11829	tr|I6YCF0|I6YCF0_M	P80365	77.86	78.0	282.0	DB14540	approved; vet_approved	Hydrocortisone butyrate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCC
11830	tr|I6YCF0|I6YCF0_M	P80365	77.86	78.0	282.0	DB14541	approved; investigational; vet_approved	Hydrocortisone cypionate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)CCC5CCCC5
11831	tr|I6YCF0|I6YCF0_M	P80365	77.86	78.0	282.0	DB14542	approved; vet_approved	Hydrocortisone phosphate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COP(=O)(O)O
11832	tr|I6YCF0|I6YCF0_M	P80365	77.86	78.0	282.0	DB14543	approved; vet_approved	Hydrocortisone probutate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CCC)C(=O)COC(=O)CC
11833	tr|I6YCF0|I6YCF0_M	P80365	77.86	78.0	282.0	DB14544	approved; vet_approved	Hydrocortisone valerate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCCC
11834	tr|I6YCF0|I6YCF0_M	Q92781	74.81	27.0	223.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11835	tr|I6YCF0|I6YCF0_M	Q92781	74.81	27.0	223.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
11836	tr|I6YCF0|I6YCF0_M	P9WGR1	98.09	2.0	259.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
11837	tr|I6YCF0|I6YCF0_M	P9WGR1	98.09	2.0	259.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
11838	tr|I6YCF0|I6YCF0_M	P9WGR1	98.09	2.0	259.0	DB02990	experimental	S-(2-Acetamidoethyl) hexadecanethioate	CCCCCCCCCCCCCCCC(=O)SCCNC(=O)C
11839	tr|I6YCF0|I6YCF0_M	P9WGR1	98.09	2.0	259.0	DB04289	experimental	Genz-10850	[nH]1ccc(c12)cc(cc2)C(=O)N3CCN(CC3)C4c(cccc5)c5c(c46)cccc6
11840	tr|I6YCF0|I6YCF0_M	P9WGR1	98.09	2.0	259.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
11841	tr|I6YCF0|I6YCF0_M	P9WGR1	98.09	2.0	259.0	DB07090	experimental	(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cccc(c1C)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
11842	tr|I6YCF0|I6YCF0_M	P9WGR1	98.09	2.0	259.0	DB07123	experimental	N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE	Cc1ccc(cc1)C(=O)N2CCC(CC2)Cc3ccccc3
11843	tr|I6YCF0|I6YCF0_M	P9WGR1	98.09	2.0	259.0	DB07155	experimental	(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE	c1ccccc1NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
11844	tr|I6YCF0|I6YCF0_M	P9WGR1	98.09	2.0	259.0	DB07178	experimental	5-PENTYL-2-PHENOXYPHENOL	CCCCCc1cc(O)c(cc1)Oc2ccccc2
11845	tr|I6YCF0|I6YCF0_M	P9WGR1	98.09	2.0	259.0	DB07188	experimental	(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(cc(Cl)c1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
11846	tr|I6YCF0|I6YCF0_M	P9WGR1	98.09	2.0	259.0	DB07192	experimental	(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Brc1cc(ccc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
11847	tr|I6YCF0|I6YCF0_M	P9WGR1	98.09	2.0	259.0	DB07222	experimental	(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(c(C)cc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
11848	tr|I6YCF0|I6YCF0_M	P9WGR1	98.09	2.0	259.0	DB07287	experimental	2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL	c1cccnc1Cc2cc(O)c(cc2)Oc3ccc(Cl)cc3Cl
11849	tr|I6YCF0|I6YCF0_M	P9WGR1	98.09	2.0	259.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
11850	tr|I6YCF0|I6YCF0_M	P56937	88.93	2.0	235.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
11851	tr|I6YCF0|I6YCF0_M	P35270	91.98	6.0	247.0	DB02637	experimental	Oxaloacetate Ion	OC(=O)C(=O)CC([O-])=O
11852	tr|I6YCF0|I6YCF0_M	P35270	91.98	6.0	247.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
11853	tr|I6YCF0|I6YCF0_M	P35270	91.98	6.0	247.0	DB03886	experimental	Biopterin	C[C@@H](O)[C@@H](O)c(n1)cnc(c12)nc(N)[nH]c2=O
11854	tr|I6YCF0|I6YCF0_M	P35270	91.98	6.0	247.0	DB04275	experimental	N-acetylserotonin	CC(=O)NCCc1c[nH]c(c12)ccc(c2)O
11855	tr|I6YCF0|I6YCF0_M	P26391	72.9	3.0	194.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
11856	tr|Q79FZ8|Q79FZ8_M	P06307	74.0	3.0	77.0	DB13729	experimental	Camostat	CN(C)C(=O)COC(=O)Cc1ccc(cc1)OC(=O)c2ccc(cc2)NC(N)=N
11857	tr|O33282|O33282_M	Q9AFC7	75.26	96.0	388.0	DB04529	experimental	Desvancosaminyl vancomycin	CC(C)C[C@@H](NC)C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)c(cc2Cl)ccc2Oc(cc3[C@@H]14)c(O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)c(c3)Oc6c(Cl)cc(cc6)[C@@H](O)[C@H]7C(=O)N[C@H](C(=O)O)c8c(c(O)cc(c8)O)c9cc([C@@H](NC4=O)C(=O)N7)ccc9O
11858	tr|O33282|O33282_M	P96558	76.29	92.0	388.0	DB04529	experimental	Desvancosaminyl vancomycin	CC(C)C[C@@H](NC)C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)c(cc2Cl)ccc2Oc(cc3[C@@H]14)c(O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)c(c3)Oc6c(Cl)cc(cc6)[C@@H](O)[C@H]7C(=O)N[C@H](C(=O)O)c8c(c(O)cc(c8)O)c9cc([C@@H](NC4=O)C(=O)N7)ccc9O
11859	tr|I6YEU0|I6YEU0_M	A0A0H3JRU9	101.24	4.0	1145.0	DB07497	experimental	5-(HEXAHYDRO-2-OXO-1H-THIENO[3,4-D]IMIDAZOL-6-YL)PENTANAL	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC=O
11860	tr|I6YEU0|I6YEU0_M	P11498	101.15	37.0	1177.0	DB00119	approved; investigational; nutraceutical	Pyruvic acid	CC(=O)C(=O)O
11861	tr|I6YEU0|I6YEU0_M	P11498	101.15	37.0	1177.0	DB00121	approved; investigational; nutraceutical	Biotin	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC(=O)O
11862	tr|I6YEU0|I6YEU0_M	P11498	101.15	37.0	1177.0	DB07497	experimental	5-(HEXAHYDRO-2-OXO-1H-THIENO[3,4-D]IMIDAZOL-6-YL)PENTANAL	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC=O
11863	tr|O53623|O53623_M	P94548	92.54	7.0	193.0	DB03264	experimental	Dodecyl-Coa	CCCCCCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
11864	tr|O53623|O53623_M	Q9AIU0	92.04	2.0	187.0	DB03467	experimental	Naringenin	Oc1ccc(cc1)[C@@H](O2)CC(=O)c(c23)c(O)cc(c3)O
11865	tr|O53623|O53623_M	Q9AIU0	92.04	2.0	187.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
11866	tr|O53623|O53623_M	Q9AIU0	92.04	2.0	187.0	DB07810	experimental	Phloretin	Oc1ccc(cc1)CCC(=O)c2c(O)cc(O)cc2O
11867	tr|P95227|P95227_M	Q9NR19	99.46	113.0	670.0	DB00131	approved; investigational; nutraceutical	Adenosine phosphate	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
11868	tr|P95227|P95227_M	Q9NR19	99.46	113.0	670.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
11869	tr|P95227|P95227_M	Q8ZKF6	95.71	82.0	618.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
11870	tr|P95227|P95227_M	Q8ZKF6	95.71	82.0	618.0	DB03230	experimental	Adenosine-5'-Propylphosphate	CCCOP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
11871	tr|P95227|P95227_M	Q9NUB1	95.71	115.0	651.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
11872	tr|P95227|P95227_M	P40871	89.46	26.0	527.0	DB01672	experimental	2,3-Dihydroxy-Benzoic Acid	OC(=O)c1cccc(O)c1O
11873	tr|P95227|P95227_M	Q8GN86	88.21	4.0	498.0	DB03728	experimental	p-Chlorobenzoic acid	OC(=O)c1ccc(Cl)cc1
11874	tr|I6YF40|I6YF40_M	Q9RUZ0	83.39	3.0	259.0	DB02637	experimental	Oxaloacetate Ion	OC(=O)C(=O)CC([O-])=O
11875	tr|I6YF40|I6YF40_M	P9WPE1	78.18	9.0	249.0	DB01942	experimental; investigational	Formic acid	OC=O
11876	sp|P9WJW5|OGT_MYCT	P16455	101.21	8.0	175.0	DB00151	approved; nutraceutical	Cysteine	OC(=O)[C@@H](N)CS
11877	sp|P9WJW5|OGT_MYCT	P16455	101.21	8.0	175.0	DB01593	approved; investigational	Zinc	[Zn]
11878	sp|P9WJW5|OGT_MYCT	P16455	101.21	8.0	175.0	DB02216	experimental	S-Methylcysteine	CSC[C@H](N)C(=O)O
11879	sp|P9WJW5|OGT_MYCT	P16455	101.21	8.0	175.0	DB04531	experimental	S-Benzylcysteine	OC(=O)[C@@H](N)CSCc1ccccc1
11880	sp|P9WJW5|OGT_MYCT	P16455	101.21	8.0	175.0	DB11831	investigational	Dinitrochlorobenzene	Clc1c(N(=O)=O)cc(N(=O)=O)cc1
11881	sp|P9WJW5|OGT_MYCT	P16455	101.21	8.0	175.0	DB14487	approved; investigational	Zinc acetate	CC([O-])=O
11882	sp|P9WJW5|OGT_MYCT	P16455	101.21	8.0	175.0	DB14533	approved; investigational	Zinc chloride	[Cl-]
11883	sp|P9WJW5|OGT_MYCT	P16455	101.21	8.0	175.0	DB14548	approved; experimental	Zinc sulfate, unspecified form	 
11884	sp|P9WKD5|PURNU_MY	P33644	90.4	16.0	242.0	DB04272	approved; nutraceutical; vet_approved	Citric acid	OC(=O)CC(O)(C(=O)O)CC(=O)O
11885	sp|P9WHK9|PYRE_MYC	P11172	91.62	15.0	179.0	DB02890	experimental	6-hydroxyuridine-5'-phosphate	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2c(=O)[nH]c(=O)cc2O
11886	sp|P9WHK9|PYRE_MYC	P08870	97.77	12.0	187.0	DB01632	approved; experimental; investigational	5-O-phosphono-alpha-D-ribofuranosyl diphosphate	OP(=O)(O)OP(=O)(O)O[C@@H]1[C@H](O)[C@H](O)[C@H](O1)COP(=O)(O)O
11887	sp|P9WHK9|PYRE_MYC	P08870	97.77	12.0	187.0	DB02262	investigational	Orotic acid	OC(=O)c1cc(=O)[nH]c(=O)[nH]1
11888	sp|P9WHK9|PYRE_MYC	P37551	85.47	102.0	255.0	DB03942	experimental	Carboxylic PRPP	OP(=O)(O)OP(=O)(O)O[C@@H]1[C@H](O)[C@H](O)[C@H](C1)COP(=O)(O)O
11889	sp|P9WHK9|PYRE_MYC	P42085	72.63	51.0	181.0	DB04022	experimental	Guanosine tetraphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)O)[C@H]([C@H]3O)OP(=O)(O)OP(=O)(O)O
11890	sp|P9WHK9|PYRE_MYC	P41007	71.51	12.0	140.0	DB01972	experimental	Guanosine-5'-Monophosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
11891	sp|P9WHK9|PYRE_MYC	P41007	71.51	12.0	140.0	DB03315	experimental	Guanosine 3'-monophosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@H](CO)[C@H]([C@H]3O)OP(=O)(O)O
11892	sp|P9WHK9|PYRE_MYC	P41007	71.51	12.0	140.0	DB03685	experimental	Uridine monophosphate	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2ccc(=O)[nH]c2=O
11893	sp|P9WIB9|SCMU_MYC	P9WIB9	99.5	1.0	199.0	DB08648	experimental	(1R,3S,5S,8R)-8-Hydroxy-2-oxabicyclo[3.3.1]non-6-ene-3,5-dicarboxylic acid	OC(=O)[C@@]12C=C[C@@H](O)[C@@H](C1)O[C@@H](C2)C(=O)O
11894	sp|P9WGD7|SRP54_MY	O07347	81.52	1.0	429.0	DB01942	experimental; investigational	Formic acid	OC=O
11895	sp|P9WGD7|SRP54_MY	O07347	81.52	1.0	429.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
11896	sp|P9WPW3|SCOB_MYC	P55809	93.12	301.0	504.0	DB02731	experimental	Ethylmercurithiosalicylic acid	CC[Hg]Sc1ccccc1C(=O)O
11897	sp|P9WGY3|RRAAH_MY	P9WGY3	99.36	1.0	157.0	DB04343	experimental	Glyoxylic acid	OC(=O)C=O
11898	sp|P9WQ23|TREZ_MYC	Q9RX51	92.41	37.0	573.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
11899	sp|P9WQ23|TREZ_MYC	Q9RX51	92.41	37.0	573.0	DB03323	experimental; investigational	Maltose	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO
11900	sp|P9WFE3|UREG_MYC	Q8IVH4	79.46	130.0	308.0	DB00115	approved; nutraceutical	Cyanocobalamin	Cc(c1)c(C)cc(c12)ncn2[C@@H]3[C@H](O)[C@@H]([C@H](O3)CO)OP([O-])(=O)O[C@H](C)CNC(=O)CC[C@](C)([C@@H](CC(=O)N)[C@@H]4[C@]56C)C(=N4)/C(C)=C7\N=C(C(C)(C)[C@@H]7CCC(=O)N)/C=C8\N=C([C@@](C)(CC(=O)N)[C@@H]8CCC(=O)N)/C(C)=C(\N5[Co+]C#N)[C@@H](CCC(=O)N)[C@]6(C)CC(=O)N
11901	sp|P9WFE3|UREG_MYC	Q8IVH4	79.46	130.0	308.0	DB00200	approved	Hydroxocobalamin	c1c(C)c(C)cc(c1[n+]2[Co-3]3456O)n(c2)[C@H]7O[C@H](CO)[C@H]([C@H]7O)OP(=O)([O-])O[C@H](C)CNC(=O)CC[C@@]8(C)C=9N3[C@H]([C@@H]8CC(=O)N)[C@]1(C)[N+]4=C([C@H]([C@]1(C)CC(=O)N)CCC(=O)N)C(C)=C1[N+]5=C([C@H]([C@]1(C)CC(=O)N)CCC(=O)N)C=C1[N+]6=C(C9C)[C@H](C1(C)C)CCC(=O)N
11902	sp|P9WFE3|UREG_MYC	O07347	70.54	102.0	260.0	DB01942	experimental; investigational	Formic acid	OC=O
11903	sp|P9WFE3|UREG_MYC	O07347	70.54	102.0	260.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
11904	sp|P9WH45|RS19_MYC	P62660	97.85	1.0	92.0	DB08185	experimental	2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(nc(n3)SC)NCCC(C)C
11905	sp|P9WH45|RS19_MYC	Q5SHP2	97.85	1.0	92.0	DB08185	experimental	2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(nc(n3)SC)NCCC(C)C
11906	sp|P9WH45|RS19_MYC	P0A7U3	97.85	1.0	92.0	DB00560	approved	Tigecycline	O=C1C(C(=O)N)=C(O)[C@@H](N(C)C)[C@@H]([C@@]12O)C[C@H]3C(=C2O)C(=O)c4c(C3)c(N(C)C)cc(c4O)NC(=O)CNC(C)(C)C
11907	sp|P9WH45|RS19_MYC	P0A7U3	97.85	1.0	92.0	DB00759	approved; vet_approved	Tetracycline	O=C1C(C(=O)N)=C(O)[C@@H](N(C)C)[C@@H]([C@@]12O)C[C@H]3C(=C2O)C(=O)c4c([C@@]3(C)O)cccc4O
11908	sp|P9WH45|RS19_MYC	P0A7U3	97.85	1.0	92.0	DB09093	approved; investigational; vet_approved	Chlortetracycline	O=C1C(C(=O)N)=C(O)[C@@H](N(C)C)[C@@H]([C@@]12O)C[C@H]3C(=C2O)C(=O)c4c([C@@]3(C)O)c(Cl)ccc4O
11909	sp|P9WH45|RS19_MYC	P0A7U3	97.85	1.0	92.0	DB12455	approved; investigational	Omadacycline	O=C1C(C(=O)N)=C(O)[C@@H](N(C)C)[C@@H]([C@@]12O)C[C@H]3C(=C2O)C(=O)c4c(C3)c(N(C)C)cc(c4O)CNCC(C)(C)C
11910	sp|P9WH45|RS19_MYC	C0H5C2	80.65	55.0	130.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
11911	sp|O06775|VAPB8_MY	P22413	72.22	1.0	66.0	DB06408	investigational	Taribavirin	NC(=N)c1nn(cn1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O
11912	sp|O06775|VAPB8_MY	P22413	72.22	1.0	66.0	DB11077	approved	Polyethylene glycol 400	 
11913	sp|P9WQG7|Y802_MYC	Q9HYX1	72.02	29.0	186.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
11914	sp|P9WQM5|Y1979_MY	P60063	88.98	5.0	433.0	DB02451	experimental	B-nonylglucoside	CCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
11915	sp|P9WQM5|Y1979_MY	P30825	83.58	29.0	431.0	DB00123	approved; nutraceutical	L-Lysine	NCCCC[C@H](N)C(=O)O
11916	sp|P9WQM5|Y1979_MY	P30825	83.58	29.0	431.0	DB00125	investigational; nutraceutical	Arginine	OC(=O)[C@@H](N)CCCNC(N)=N
11917	sp|P9WQM5|Y1979_MY	P30825	83.58	29.0	431.0	DB00129	approved; nutraceutical	Ornithine	NCCC[C@H](N)C(=O)O
11918	sp|P9WQM5|Y1979_MY	Q8WY07	82.95	29.0	428.0	DB00123	approved; nutraceutical	L-Lysine	NCCCC[C@H](N)C(=O)O
11919	sp|P9WQM5|Y1979_MY	Q8WY07	82.95	29.0	428.0	DB00125	investigational; nutraceutical	Arginine	OC(=O)[C@@H](N)CCCNC(N)=N
11920	sp|P9WQM5|Y1979_MY	Q8WY07	82.95	29.0	428.0	DB13146	approved	Fluciclovine (18F)	OC(=O)[C@]1(N)C[C@H]([18F])C1
11921	sp|P9WQM5|Y1979_MY	P52569	83.37	31.0	432.0	DB00123	approved; nutraceutical	L-Lysine	NCCCC[C@H](N)C(=O)O
11922	sp|P9WQM5|Y1979_MY	P52569	83.37	31.0	432.0	DB00129	approved; nutraceutical	Ornithine	NCCC[C@H](N)C(=O)O
11923	sp|P9WQM5|Y1979_MY	Q9UHI5	78.17	33.0	409.0	DB00120	approved; investigational; nutraceutical	Phenylalanine	OC(=O)[C@@H](N)Cc1ccccc1
11924	sp|P9WQM5|Y1979_MY	Q9UHI5	78.17	33.0	409.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
11925	sp|P9WQM5|Y1979_MY	Q9UM01	88.98	35.0	463.0	DB13146	approved	Fluciclovine (18F)	OC(=O)[C@]1(N)C[C@H]([18F])C1
11926	sp|P9WQM5|Y1979_MY	Q9UPY5	87.73	42.0	464.0	DB00138	approved; nutraceutical	Cystine	OC(=O)[C@@H](N)CSSC[C@H](N)C(=O)O
11927	sp|P9WQM5|Y1979_MY	Q9UPY5	87.73	42.0	464.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
11928	sp|P9WQM5|Y1979_MY	Q9UPY5	87.73	42.0	464.0	DB00740	approved; investigational	Riluzole	Nc(s1)nc(c12)ccc(c2)OC(F)(F)F
11929	sp|P9WQM5|Y1979_MY	Q9UPY5	87.73	42.0	464.0	DB00795	approved	Sulfasalazine	OC(=O)c1cc(ccc1O)/N=N/c2ccc(cc2)S(=O)(=O)Nc3ncccc3
11930	sp|P9WQM5|Y1979_MY	Q9UPY5	87.73	42.0	464.0	DB06151	approved; investigational	Acetylcysteine	CC(=O)N[C@@H](CS)C(=O)O
11931	sp|P9WQM5|Y1979_MY	Q9UPY5	87.73	42.0	464.0	DB11590	approved	Thimerosal	CC[Hg]Sc1ccccc1C([O-])=O
11932	sp|P9WQM5|Y1979_MY	O43246	78.59	35.0	413.0	DB00123	approved; nutraceutical	L-Lysine	NCCCC[C@H](N)C(=O)O
11933	sp|P9WQM5|Y1979_MY	O43246	78.59	35.0	413.0	DB00125	investigational; nutraceutical	Arginine	OC(=O)[C@@H](N)CCCNC(N)=N
11934	sp|P9WH57|RS14Z_MY	P0DOY6	98.36	1.0	61.0	DB08185	experimental	2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(nc(n3)SC)NCCC(C)C
11935	sp|P9WH57|RS14Z_MY	P0AG59	72.13	57.0	101.0	DB00560	approved	Tigecycline	O=C1C(C(=O)N)=C(O)[C@@H](N(C)C)[C@@H]([C@@]12O)C[C@H]3C(=C2O)C(=O)c4c(C3)c(N(C)C)cc(c4O)NC(=O)CNC(C)(C)C
11936	sp|P9WH57|RS14Z_MY	P0AG59	72.13	57.0	101.0	DB00759	approved; vet_approved	Tetracycline	O=C1C(C(=O)N)=C(O)[C@@H](N(C)C)[C@@H]([C@@]12O)C[C@H]3C(=C2O)C(=O)c4c([C@@]3(C)O)cccc4O
11937	sp|P9WH57|RS14Z_MY	P0AG59	72.13	57.0	101.0	DB09093	approved; investigational; vet_approved	Chlortetracycline	O=C1C(C(=O)N)=C(O)[C@@H](N(C)C)[C@@H]([C@@]12O)C[C@H]3C(=C2O)C(=O)c4c([C@@]3(C)O)c(Cl)ccc4O
11938	sp|P9WH57|RS14Z_MY	P0AG59	72.13	57.0	101.0	DB12455	approved; investigational	Omadacycline	O=C1C(C(=O)N)=C(O)[C@@H](N(C)C)[C@@H]([C@@]12O)C[C@H]3C(=C2O)C(=O)c4c(C3)c(N(C)C)cc(c4O)CNCC(C)(C)C
11939	sp|P9WH57|RS14Z_MY	P0AG59	72.13	57.0	101.0	DB12615	approved; investigational	Plazomicin	CN[C@@H]([C@@]1(C)O)[C@@H](O)[C@H](OC1)O[C@H]2[C@H](NC(=O)[C@@H](O)CCN)C[C@H](N)[C@H]([C@@H]2O)O[C@H]3OC(=CC[C@H]3N)CNCCO
11940	sp|P9WHF9|THTR_MYC	Q5SJI0	100.72	4.0	283.0	DB02761	experimental	S-Mercaptocysteine	OC(=O)[C@@H](N)CSS
11941	sp|P9WHF9|THTR_MYC	P31142	98.19	6.0	278.0	DB02761	experimental	S-Mercaptocysteine	OC(=O)[C@@H](N)CSS
11942	sp|P9WHF9|THTR_MYC	Q16762	98.92	9.0	283.0	DB02761	experimental	S-Mercaptocysteine	OC(=O)[C@@H](N)CSS
11943	sp|P9WHF9|THTR_MYC	P52197	91.7	16.0	270.0	DB04053	experimental	Hypophosphite	[O-]P=O
11944	sp|P9WHF9|THTR_MYC	Q7K9G0	96.75	26.0	294.0	DB02761	experimental	S-Mercaptocysteine	OC(=O)[C@@H](N)CSS
11945	sp|P9WHF9|THTR_MYC	Q7K9G0	96.75	26.0	294.0	DB03352	experimental	S-Arsonocysteine	OC(=O)[C@@H](N)CS[As](=O)(O)O
11946	sp|P9WFX5|TRPD_MYC	Q8VP84	80.27	12.0	309.0	DB01632	approved; experimental; investigational	5-O-phosphono-alpha-D-ribofuranosyl diphosphate	OP(=O)(O)OP(=O)(O)O[C@@H]1[C@H](O)[C@H](O)[C@H](O1)COP(=O)(O)O
11947	sp|P9WN25|TRHBN_MY	P9WN25	99.26	1.0	136.0	DB01826	experimental	N-Butyl Isocyanide	CCCC[N+]#[C-]
11948	sp|P9WN25|TRHBN_MY	P9WN25	99.26	1.0	136.0	DB03317	experimental	Ferroheme C	[Fe-2]123[N+]4=C5C=C6[N+]1=C(C(C)=C6C(C)S)C=C7[N+]2=C(C(=C7C)CCC(=O)O)C=C8[N+]3=C(C=C4C(=C5C)C(C)S)C(C)=C8CCC(=O)O
11949	sp|P9WKD7|RPIB_MYC	P9WKD7	99.38	1.0	162.0	DB03108	experimental	4-phospho-D-erythronic acid	OC(=O)[C@H](O)[C@H](O)COP(=O)(O)O
11950	sp|P9WKD7|RPIB_MYC	P9WKD7	99.38	1.0	162.0	DB04496	experimental	4-Phospho-D-erythronohydroxamic acid	ONC(=O)[C@H](O)[C@H](O)COP(=O)(O)O
11951	sp|P9WKD7|RPIB_MYC	Q9X0G9	87.04	1.0	142.0	DB03661	experimental	L-cysteic acid	OC(=O)[C@@H](N)CS(=O)(=O)O
11952	sp|P9WGI5|SIGB_MYC	Q5SKW1	82.66	155.0	422.0	DB08226	experimental	Myxopyronin B	CCCC/C(C)=C/C=C(\C)C(=O)c1c(O)cc(oc1=O)CCC/C=C/NC(=O)OC
11953	sp|P9WGI5|SIGB_MYC	Q5SKW1	82.66	155.0	422.0	DB08266	experimental	Methyl [(1E,5R)-5-{3-[(2E,4E)-2,5-dimethyl-2,4-octadienoyl]-2,4-dioxo-3,4-dihydro-2H-pyran-6-yl}hexylidene]carbamate	COC(=O)/N=C/CCC[C@@H](C)C1=CC(=O)C(C(=O)O1)C(=O)/C(C)=C/C=C(\C)CCC
11954	sp|P9WGI5|SIGB_MYC	Q18BX5	73.99	150.0	389.0	DB08874	approved	Fidaxomicin	CC(C)C(=O)O[C@H](C1(C)C)[C@H](O)[C@H](O)[C@@H](O1)O[C@@H]2[C@@H](CC)/C=C(\C)[C@@H](O)C/C=C/C=C(/C(=O)O[C@H]([C@@H](C)O)C/C=C(\C)/C=C/2C)CO[C@@H]3O[C@H](C)[C@H]([C@H](O)[C@@H]3OC)OC(=O)c4c(CC)c(Cl)c(O)c(Cl)c4O
11955	sp|Q6MWZ7|SUGPH_MY	Q16877	77.83	247.0	405.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
11956	sp|Q6MWZ7|SUGPH_MY	Q16877	77.83	247.0	405.0	DB04493	experimental	Fructose-6-phosphate	OCC(=O)[C@@H](O)[C@H](O)[C@H](O)COP(=O)(O)O
11957	sp|Q6MWZ7|SUGPH_MY	P16118	78.33	249.0	408.0	DB02393	experimental	D-Gluco-2,5-Anhydro-1-Deoxy-1-Phosphonohexitol-6-Phosphate	O[C@H]1[C@H](O)[C@H](CP(=O)(O)O)O[C@@H]1COP(=O)(O)O
11958	sp|Q6MWZ7|SUGPH_MY	P16118	78.33	249.0	408.0	DB02515	experimental	sn-glycerol 3-phosphate	OC[C@@H](O)COP(=O)(O)O
11959	sp|Q6MWZ7|SUGPH_MY	P16118	78.33	249.0	408.0	DB02930	experimental	Adenosine 5'-[gamma-thio]triphosphate	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=S)(O)O
11960	sp|Q6MWZ7|SUGPH_MY	P16118	78.33	249.0	408.0	DB04137	experimental	Guanosine-5'-Triphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
11961	sp|Q6MWZ7|SUGPH_MY	P16118	78.33	249.0	408.0	DB04493	experimental	Fructose-6-phosphate	OCC(=O)[C@@H](O)[C@H](O)[C@H](O)COP(=O)(O)O
11962	sp|P9WFU1|SYFB_MYC	Q4L5E4	96.15	1.0	800.0	DB07817	experimental	1-{3-[(4-pyridin-2-ylpiperazin-1-yl)sulfonyl]phenyl}-3-(1,3-thiazol-2-yl)urea	n1ccsc1NC(=O)Nc2cc(ccc2)S(=O)(=O)N3CCN(CC3)c4ccccn4
11963	sp|P9WQJ1|Y1273_MY	P08183	91.58	98.0	631.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
11964	sp|P9WQJ1|Y1273_MY	P08183	91.58	98.0	631.0	DB00603	approved; investigational	Medroxyprogesterone acetate	CC(=O)O[C@]1(C(=O)C)CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C([C@H](C3)C)=CC(=O)CC4
11965	sp|P9WQJ1|Y1273_MY	P08183	91.58	98.0	631.0	DB00778	approved; investigational; withdrawn	Roxithromycin	COCCOCO/N=C([C@H](C)[C@@H](O)[C@]1(C)O)/[C@H](C)C[C@@](C)(O)[C@@H]([C@@H](C)[C@@H]([C@@H](C)C(=O)O[C@@H]1CC)O[C@@H](C[C@@]2(C)OC)O[C@@H](C)[C@@H]2O)O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C
11966	sp|P9WQJ1|Y1273_MY	P08183	91.58	98.0	631.0	DB00813	approved; illicit; investigational; vet_approved	Fentanyl	c1ccccc1N(C(=O)CC)C2CCN(CC2)CCc3ccccc3
11967	sp|P9WQJ1|Y1273_MY	P08183	91.58	98.0	631.0	DB04877	experimental	Voacamine	CC[C@H]1C[C@@H](C2)CN([C@@H]1[C@@]23C(=O)OC)CCc4c3[nH]c5c4cc(OC)c(c5)[C@@H](C[C@H]67)c8c(c9c([nH]8)cccc9)C[C@H](C6C(=O)OC)N(C)CC\7=C\C
11968	sp|P9WQJ1|Y1273_MY	P08183	91.58	98.0	631.0	DB04881	investigational	Elacridar	COc1cccc(c12)c(=O)c3c([nH]2)c(ccc3)C(=O)Nc4ccc(cc4)CCN(C5)CCc(c56)cc(OC)c(c6)OC
11969	sp|P9WQJ1|Y1273_MY	P08183	91.58	98.0	631.0	DB04905	investigational	Tesmilifene	CCN(CC)CCOc1ccc(cc1)Cc2ccccc2
11970	sp|P9WQJ1|Y1273_MY	P08183	91.58	98.0	631.0	DB05449	investigational	FM-VP4	 
11971	sp|P9WQJ1|Y1273_MY	P08183	91.58	98.0	631.0	DB06191	investigational	Zosuquidar	FC1(F)[C@H]2[C@@H]1c(cccc3)c3[C@@H](c(c24)cccc4)N5CCN(CC5)C[C@@H](O)COc6cccc(c67)nccc7
11972	sp|P9WQJ1|Y1273_MY	P08183	91.58	98.0	631.0	DB06240	investigational	Tariquidar	COc(c1)c(OC)cc(c12)CCN(C2)CCc3ccc(cc3)NC(=O)c4cc(OC)c(OC)cc4NC(=O)c(c5)cnc(c56)cccc6
11973	sp|P9WQJ1|Y1273_MY	P08183	91.58	98.0	631.0	DB09031	approved; investigational	Miltefosine	CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C
11974	sp|P9WQJ1|Y1273_MY	P08183	91.58	98.0	631.0	DB11635	approved	Tocofersolan	 
11975	sp|P9WQJ1|Y1273_MY	P08183	91.58	98.0	631.0	DB14061	experimental	Hycanthone	CCN(CC)CCNc(ccc1CO)c(c12)c(=O)c3c(s2)cccc3
11976	sp|P9WQJ1|Y1273_MY	P08183	91.58	98.0	631.0	DB14062	experimental	Concanamycin A	NC(=O)O[C@@H]1[C@@H](C)O[C@H](C[C@H]1O)O[C@H](C2)[C@H](C)[C@@H](/C=C/C)O[C@@]2(O)[C@@H](C)[C@H](O)[C@H](C)[C@H]3OC(=O)/C(OC)=C/C(C)=C/[C@@H](C)[C@@H](O)[C@@H](CC)[C@@H](O)[C@H](C)C/C(C)=C/C=C/[C@@H]3OC
11977	sp|P9WQJ1|Y1273_MY	P08183	91.58	98.0	631.0	DB14063	experimental	Dexverapamil	COc1ccc(cc1OC)CCN(C)CCC[C@@](C#N)(C(C)C)c2cc(OC)c(OC)cc2
11978	sp|P9WQJ1|Y1273_MY	P08183	91.58	98.0	631.0	DB14064	experimental	Emopamil	c1ccccc1C(C#N)(C(C)C)CCCN(C)CCc2ccccc2
11979	sp|P9WQJ1|Y1273_MY	P08183	91.58	98.0	631.0	DB14065	experimental	Lomerizine	COc1ccc(c(OC)c1OC)CN2CCN(CC2)C(c3ccc(F)cc3)c4ccc(F)cc4
11980	sp|P9WQJ1|Y1273_MY	P08183	91.58	98.0	631.0	DB14066	experimental	Tetrandrine	c12ccc(OC)c(c1)Oc3ccc(cc3)C[C@H]4c5c(CCN4C)cc(OC)c(c5)Oc6c7c(CCN(C)[C@H]7C2)cc(OC)c6OC
11981	sp|P9WQJ1|Y1273_MY	P08183	91.58	98.0	631.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
11982	sp|P9WQJ1|Y1273_MY	P08183	91.58	98.0	631.0	DB14068	experimental	Dexniguldipine	[O-][N+](=O)c1cccc(c1)[C@@H]2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCCN(CC3)CCC3(c4ccccc4)c5ccccc5
11983	sp|P9WQJ1|Y1273_MY	P08183	91.58	98.0	631.0	DB14069	investigational	ONT-093	CCOC/C=C/c1ccc(cc1)-c2nc(-c3ccc(cc3)NC(C)C)c([nH]2)-c4ccc(cc4)NC(C)C
11984	sp|P9WQJ1|Y1273_MY	P08183	91.58	98.0	631.0	DB14070	experimental	HM-30181	c1cccc(c12)c(=O)cc(o2)C(=O)Nc3cc(OC)c(OC)cc3-c4nn(nn4)-c5ccc(cc5)CCN(C6)CCc(c67)cc(OC)c(c7)OC
11985	sp|P9WQJ1|Y1273_MY	P08183	91.58	98.0	631.0	DB14071	experimental	Desmethylsertraline	c1cccc(c12)[C@@H](CC[C@@H]2N)c3cc(Cl)c(Cl)cc3
11986	sp|P9WQJ1|Y1273_MY	P08183	91.58	98.0	631.0	DB14072	experimental	Reversin 121	c1ccccc1COC(=O)C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@H](C(=O)OC(C)(C)C)CCCCNC(=O)OCc2ccccc2
11987	sp|P9WQJ1|Y1273_MY	P08183	91.58	741.0	1274.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
11988	sp|P9WQJ1|Y1273_MY	P08183	91.58	741.0	1274.0	DB00603	approved; investigational	Medroxyprogesterone acetate	CC(=O)O[C@]1(C(=O)C)CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C([C@H](C3)C)=CC(=O)CC4
11989	sp|P9WQJ1|Y1273_MY	P08183	91.58	741.0	1274.0	DB00778	approved; investigational; withdrawn	Roxithromycin	COCCOCO/N=C([C@H](C)[C@@H](O)[C@]1(C)O)/[C@H](C)C[C@@](C)(O)[C@@H]([C@@H](C)[C@@H]([C@@H](C)C(=O)O[C@@H]1CC)O[C@@H](C[C@@]2(C)OC)O[C@@H](C)[C@@H]2O)O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C
11990	sp|P9WQJ1|Y1273_MY	P08183	91.58	741.0	1274.0	DB00813	approved; illicit; investigational; vet_approved	Fentanyl	c1ccccc1N(C(=O)CC)C2CCN(CC2)CCc3ccccc3
11991	sp|P9WQJ1|Y1273_MY	P08183	91.58	741.0	1274.0	DB04877	experimental	Voacamine	CC[C@H]1C[C@@H](C2)CN([C@@H]1[C@@]23C(=O)OC)CCc4c3[nH]c5c4cc(OC)c(c5)[C@@H](C[C@H]67)c8c(c9c([nH]8)cccc9)C[C@H](C6C(=O)OC)N(C)CC\7=C\C
11992	sp|P9WQJ1|Y1273_MY	P08183	91.58	741.0	1274.0	DB04881	investigational	Elacridar	COc1cccc(c12)c(=O)c3c([nH]2)c(ccc3)C(=O)Nc4ccc(cc4)CCN(C5)CCc(c56)cc(OC)c(c6)OC
11993	sp|P9WQJ1|Y1273_MY	P08183	91.58	741.0	1274.0	DB04905	investigational	Tesmilifene	CCN(CC)CCOc1ccc(cc1)Cc2ccccc2
11994	sp|P9WQJ1|Y1273_MY	P08183	91.58	741.0	1274.0	DB05449	investigational	FM-VP4	 
11995	sp|P9WQJ1|Y1273_MY	P08183	91.58	741.0	1274.0	DB06191	investigational	Zosuquidar	FC1(F)[C@H]2[C@@H]1c(cccc3)c3[C@@H](c(c24)cccc4)N5CCN(CC5)C[C@@H](O)COc6cccc(c67)nccc7
11996	sp|P9WQJ1|Y1273_MY	P08183	91.58	741.0	1274.0	DB06240	investigational	Tariquidar	COc(c1)c(OC)cc(c12)CCN(C2)CCc3ccc(cc3)NC(=O)c4cc(OC)c(OC)cc4NC(=O)c(c5)cnc(c56)cccc6
11997	sp|P9WQJ1|Y1273_MY	P08183	91.58	741.0	1274.0	DB09031	approved; investigational	Miltefosine	CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C
11998	sp|P9WQJ1|Y1273_MY	P08183	91.58	741.0	1274.0	DB11635	approved	Tocofersolan	 
11999	sp|P9WQJ1|Y1273_MY	P08183	91.58	741.0	1274.0	DB14061	experimental	Hycanthone	CCN(CC)CCNc(ccc1CO)c(c12)c(=O)c3c(s2)cccc3
12000	sp|P9WQJ1|Y1273_MY	P08183	91.58	741.0	1274.0	DB14062	experimental	Concanamycin A	NC(=O)O[C@@H]1[C@@H](C)O[C@H](C[C@H]1O)O[C@H](C2)[C@H](C)[C@@H](/C=C/C)O[C@@]2(O)[C@@H](C)[C@H](O)[C@H](C)[C@H]3OC(=O)/C(OC)=C/C(C)=C/[C@@H](C)[C@@H](O)[C@@H](CC)[C@@H](O)[C@H](C)C/C(C)=C/C=C/[C@@H]3OC
12001	sp|P9WQJ1|Y1273_MY	P08183	91.58	741.0	1274.0	DB14063	experimental	Dexverapamil	COc1ccc(cc1OC)CCN(C)CCC[C@@](C#N)(C(C)C)c2cc(OC)c(OC)cc2
12002	sp|P9WQJ1|Y1273_MY	P08183	91.58	741.0	1274.0	DB14064	experimental	Emopamil	c1ccccc1C(C#N)(C(C)C)CCCN(C)CCc2ccccc2
12003	sp|P9WQJ1|Y1273_MY	P08183	91.58	741.0	1274.0	DB14065	experimental	Lomerizine	COc1ccc(c(OC)c1OC)CN2CCN(CC2)C(c3ccc(F)cc3)c4ccc(F)cc4
12004	sp|P9WQJ1|Y1273_MY	P08183	91.58	741.0	1274.0	DB14066	experimental	Tetrandrine	c12ccc(OC)c(c1)Oc3ccc(cc3)C[C@H]4c5c(CCN4C)cc(OC)c(c5)Oc6c7c(CCN(C)[C@H]7C2)cc(OC)c6OC
12005	sp|P9WQJ1|Y1273_MY	P08183	91.58	741.0	1274.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
12006	sp|P9WQJ1|Y1273_MY	P08183	91.58	741.0	1274.0	DB14068	experimental	Dexniguldipine	[O-][N+](=O)c1cccc(c1)[C@@H]2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCCN(CC3)CCC3(c4ccccc4)c5ccccc5
12007	sp|P9WQJ1|Y1273_MY	P08183	91.58	741.0	1274.0	DB14069	investigational	ONT-093	CCOC/C=C/c1ccc(cc1)-c2nc(-c3ccc(cc3)NC(C)C)c([nH]2)-c4ccc(cc4)NC(C)C
12008	sp|P9WQJ1|Y1273_MY	P08183	91.58	741.0	1274.0	DB14070	experimental	HM-30181	c1cccc(c12)c(=O)cc(o2)C(=O)Nc3cc(OC)c(OC)cc3-c4nn(nn4)-c5ccc(cc5)CCN(C6)CCc(c67)cc(OC)c(c7)OC
12009	sp|P9WQJ1|Y1273_MY	P08183	91.58	741.0	1274.0	DB14071	experimental	Desmethylsertraline	c1cccc(c12)[C@@H](CC[C@@H]2N)c3cc(Cl)c(Cl)cc3
12010	sp|P9WQJ1|Y1273_MY	P08183	91.58	741.0	1274.0	DB14072	experimental	Reversin 121	c1ccccc1COC(=O)C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@H](C(=O)OC(C)(C)C)CCCCNC(=O)OCc2ccccc2
12011	sp|P9WQJ1|Y1273_MY	Q2M3G0	93.47	81.0	625.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
12012	sp|P9WQJ1|Y1273_MY	Q2M3G0	93.47	81.0	625.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
12013	sp|P9WQJ1|Y1273_MY	Q2M3G0	91.75	722.0	1256.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
12014	sp|P9WQJ1|Y1273_MY	Q2M3G0	91.75	722.0	1256.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
12015	sp|P9WQJ1|Y1273_MY	P33527	86.6	364.0	868.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
12016	sp|P9WQJ1|Y1273_MY	P33527	86.6	364.0	868.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
12017	sp|P9WQJ1|Y1273_MY	P33527	86.6	364.0	868.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
12018	sp|P9WQJ1|Y1273_MY	P33527	86.6	364.0	868.0	DB06176	approved; investigational	Romidepsin	O=C([C@H]12)N/C(=C\C)C(=O)N[C@@H](C(C)C)C(=O)O[C@@H](CC(=O)N[C@H](C(C)C)C(=O)N1)/C=C/CCSSC2
12019	sp|P9WQJ1|Y1273_MY	P33527	86.6	364.0	868.0	DB08855	experimental; investigational	Leukotriene C4	CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@@H](O)CCCC(=O)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@H](N)C(=O)O
12020	sp|P9WQJ1|Y1273_MY	P33527	95.36	972.0	1527.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
12021	sp|P9WQJ1|Y1273_MY	P33527	95.36	972.0	1527.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
12022	sp|P9WQJ1|Y1273_MY	P33527	95.36	972.0	1527.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
12023	sp|P9WQJ1|Y1273_MY	P33527	95.36	972.0	1527.0	DB06176	approved; investigational	Romidepsin	O=C([C@H]12)N/C(=C\C)C(=O)N[C@@H](C(C)C)C(=O)O[C@@H](CC(=O)N[C@H](C(C)C)C(=O)N1)/C=C/CCSSC2
12024	sp|P9WQJ1|Y1273_MY	P33527	95.36	972.0	1527.0	DB08855	experimental; investigational	Leukotriene C4	CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@@H](O)CCCC(=O)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@H](N)C(=O)O
12025	sp|P9WQJ1|Y1273_MY	O95342	93.3	116.0	659.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
12026	sp|P9WQJ1|Y1273_MY	O95342	93.3	116.0	659.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
12027	sp|P9WQJ1|Y1273_MY	O95342	91.41	784.0	1316.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
12028	sp|P9WQJ1|Y1273_MY	O95342	91.41	784.0	1316.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
12029	sp|P9WQJ1|Y1273_MY	Q92887	91.24	327.0	858.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
12030	sp|P9WQJ1|Y1273_MY	Q92887	91.24	327.0	858.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
12031	sp|P9WQJ1|Y1273_MY	Q92887	96.91	970.0	1534.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
12032	sp|P9WQJ1|Y1273_MY	Q92887	96.91	970.0	1534.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
12033	sp|P9WQJ1|Y1273_MY	Q09428	98.11	1009.0	1580.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
12034	sp|P9WQJ1|Y1273_MY	Q09428	98.11	1009.0	1580.0	DB00222	approved	Glimepiride	CCC1=C(C)CN(C1=O)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3
12035	sp|P9WQJ1|Y1273_MY	Q09428	98.11	1009.0	1580.0	DB00672	approved; investigational	Chlorpropamide	CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1
12036	sp|P9WQJ1|Y1273_MY	Q09428	98.11	1009.0	1580.0	DB00731	approved; investigational	Nateglinide	CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](C(=O)O)Cc2ccccc2
12037	sp|P9WQJ1|Y1273_MY	Q09428	98.11	1009.0	1580.0	DB00912	approved; investigational	Repaglinide	CCOc1c(C(=O)O)ccc(c1)CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3
12038	sp|P9WQJ1|Y1273_MY	Q09428	98.11	1009.0	1580.0	DB01067	approved; investigational	Glipizide	Cc1ncc(nc1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
12039	sp|P9WQJ1|Y1273_MY	Q09428	98.11	1009.0	1580.0	DB01120	approved	Gliclazide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN(C2)CC(C23)CCC3
12040	sp|P9WQJ1|Y1273_MY	Q09428	98.11	1009.0	1580.0	DB01124	approved; investigational	Tolbutamide	CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1
12041	sp|P9WQJ1|Y1273_MY	Q09428	98.11	1009.0	1580.0	DB01251	approved; investigational	Gliquidone	COc(cc1)cc(c12)C(=O)N(C(=O)C2(C)C)CCc3ccc(cc3)S(=O)(=O)NC(=O)NC4CCCCC4
12042	sp|P9WQJ1|Y1273_MY	Q09428	98.11	1009.0	1580.0	DB01252	investigational	Mitiglinide	c1ccccc1C[C@H](C(=O)O)CC(=O)N(C2)C[C@H]([C@H]23)CCCC3
12043	sp|P9WQJ1|Y1273_MY	Q09428	98.11	1009.0	1580.0	DB01382	approved; investigational	Glymidine	COCCOc1cnc(nc1)NS(=O)(=O)c2ccccc2
12044	sp|P9WQJ1|Y1273_MY	Q09428	98.11	1009.0	1580.0	DB00839	approved; investigational	Tolazamide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2
12045	sp|P9WQJ1|Y1273_MY	Q09428	98.11	1009.0	1580.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
12046	sp|P9WQJ1|Y1273_MY	O95255	86.43	350.0	853.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
12047	sp|P9WQJ1|Y1273_MY	O95255	96.74	936.0	1499.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
12048	sp|P9WQJ1|Y1273_MY	O60706	97.77	336.0	905.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
12049	sp|P9WQJ1|Y1273_MY	O60706	97.77	336.0	905.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
12050	sp|P9WQJ1|Y1273_MY	O60706	97.77	336.0	905.0	DB09220	approved; investigational	Nicorandil	[O-][N+](=O)OCCNC(=O)c1cccnc1
12051	sp|P9WQJ1|Y1273_MY	O60706	94.85	995.0	1547.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
12052	sp|P9WQJ1|Y1273_MY	O60706	94.85	995.0	1547.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
12053	sp|P9WQJ1|Y1273_MY	O60706	94.85	995.0	1547.0	DB09220	approved; investigational	Nicorandil	[O-][N+](=O)OCCNC(=O)c1cccnc1
12054	sp|P9WQJ1|Y1273_MY	O15439	87.8	124.0	635.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
12055	sp|P9WQJ1|Y1273_MY	O15439	96.05	716.0	1275.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
12056	sp|P9WQJ1|Y1273_MY	O15440	100.86	849.0	1436.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
12057	sp|P9WQJ1|Y1273_MY	O15440	100.86	849.0	1436.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
12058	sp|P9WQJ1|Y1273_MY	P13568	73.2	53.0	479.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
12059	sp|P9WQJ1|Y1273_MY	P13569	91.58	109.0	642.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
12060	sp|P9WQJ1|Y1273_MY	P13569	91.58	109.0	642.0	DB00887	approved	Bumetanide	CCCCNc1c(c(S(=O)(=O)N)cc(c1)C(=O)O)Oc2ccccc2
12061	sp|P9WQJ1|Y1273_MY	P13569	91.58	109.0	642.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
12062	sp|P9WQJ1|Y1273_MY	P13569	91.58	109.0	642.0	DB01050	approved	Ibuprofen	CC(C)Cc1ccc(cc1)C(C)C(=O)O
12063	sp|P9WQJ1|Y1273_MY	P13569	91.58	109.0	642.0	DB02587	experimental; investigational	Colforsin	O[C@H]1CCC(C)(C)[C@@H]([C@]12C)[C@H](O)[C@H](OC(=O)C)[C@]3(C)[C@]2(O)C(=O)C[C@](O3)(C)C=C
12064	sp|P9WQJ1|Y1273_MY	P13569	91.58	109.0	642.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
12065	sp|P9WQJ1|Y1273_MY	P13569	91.58	109.0	642.0	DB04522	experimental	Dexfosfoserine	OC(=O)[C@@H](N)COP(=O)(O)O
12066	sp|P9WQJ1|Y1273_MY	P13569	91.58	109.0	642.0	DB04941	approved	Crofelemer	 
12067	sp|P9WQJ1|Y1273_MY	P13569	91.58	109.0	642.0	DB06266	investigational	Lonidamine	c1cccc(c12)n(nc2C(=O)O)Cc3c(Cl)cc(Cl)cc3
12068	sp|P9WQJ1|Y1273_MY	P13569	91.58	109.0	642.0	DB08820	approved	Ivacaftor	CC(C)(C)c1cc(C(C)(C)C)c(O)cc1NC(=O)c(c2=O)c[nH]c(c23)cccc3
12069	sp|P9WQJ1|Y1273_MY	P13569	91.58	109.0	642.0	DB09213	approved; investigational	Dexibuprofen	CC(C)Cc1ccc(cc1)[C@H](C)C(=O)O
12070	sp|P9WQJ1|Y1273_MY	P13569	91.58	109.0	642.0	DB09280	approved	Lumacaftor	O=C(O)c1cccc(c1)-c2nc(ccc2C)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
12071	sp|P9WQJ1|Y1273_MY	P13569	91.58	109.0	642.0	DB11712	approved; investigational	Tezacaftor	OC[C@H](O)Cn1c(C(C)(C)CO)cc(c12)cc(c(F)c2)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
12072	sp|P9WQJ1|Y1273_MY	P13569	91.58	109.0	642.0	DB15444	approved; investigational	Elexacaftor	FC(F)(F)C(C)(C)COc1nn(cc1)-c2nc(N(C3(C)C)C[C@@H](C)C3)c(cc2)C(=O)NS(=O)(=O)c4cn(C)nc4C
12073	sp|P9WQJ1|Y1273_MY	P13569	98.8	866.0	1441.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
12074	sp|P9WQJ1|Y1273_MY	P13569	98.8	866.0	1441.0	DB00887	approved	Bumetanide	CCCCNc1c(c(S(=O)(=O)N)cc(c1)C(=O)O)Oc2ccccc2
12075	sp|P9WQJ1|Y1273_MY	P13569	98.8	866.0	1441.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
12076	sp|P9WQJ1|Y1273_MY	P13569	98.8	866.0	1441.0	DB01050	approved	Ibuprofen	CC(C)Cc1ccc(cc1)C(C)C(=O)O
12077	sp|P9WQJ1|Y1273_MY	P13569	98.8	866.0	1441.0	DB02587	experimental; investigational	Colforsin	O[C@H]1CCC(C)(C)[C@@H]([C@]12C)[C@H](O)[C@H](OC(=O)C)[C@]3(C)[C@]2(O)C(=O)C[C@](O3)(C)C=C
12078	sp|P9WQJ1|Y1273_MY	P13569	98.8	866.0	1441.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
12079	sp|P9WQJ1|Y1273_MY	P13569	98.8	866.0	1441.0	DB04522	experimental	Dexfosfoserine	OC(=O)[C@@H](N)COP(=O)(O)O
12080	sp|P9WQJ1|Y1273_MY	P13569	98.8	866.0	1441.0	DB04941	approved	Crofelemer	 
12081	sp|P9WQJ1|Y1273_MY	P13569	98.8	866.0	1441.0	DB06266	investigational	Lonidamine	c1cccc(c12)n(nc2C(=O)O)Cc3c(Cl)cc(Cl)cc3
12082	sp|P9WQJ1|Y1273_MY	P13569	98.8	866.0	1441.0	DB08820	approved	Ivacaftor	CC(C)(C)c1cc(C(C)(C)C)c(O)cc1NC(=O)c(c2=O)c[nH]c(c23)cccc3
12083	sp|P9WQJ1|Y1273_MY	P13569	98.8	866.0	1441.0	DB09213	approved; investigational	Dexibuprofen	CC(C)Cc1ccc(cc1)[C@H](C)C(=O)O
12084	sp|P9WQJ1|Y1273_MY	P13569	98.8	866.0	1441.0	DB09280	approved	Lumacaftor	O=C(O)c1cccc(c1)-c2nc(ccc2C)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
12085	sp|P9WQJ1|Y1273_MY	P13569	98.8	866.0	1441.0	DB11712	approved; investigational	Tezacaftor	OC[C@H](O)Cn1c(C(C)(C)CO)cc(c12)cc(c(F)c2)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
12086	sp|P9WQJ1|Y1273_MY	P13569	98.8	866.0	1441.0	DB15444	approved; investigational	Elexacaftor	FC(F)(F)C(C)(C)COc1nn(cc1)-c2nc(N(C3(C)C)C[C@@H](C)C3)c(cc2)C(=O)NS(=O)(=O)c4cn(C)nc4C
12087	sp|P9WQJ1|Y1273_MY	A0A0T9AZ62	71.31	12.0	427.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
12088	sp|P9WKZ7|Y3400_MY	P71447	72.9	3.0	194.0	DB01857	experimental	Phosphoaspartate	OC(=O)[C@@H](N)CC(=O)OP(=O)(O)O
12089	sp|P9WKZ7|Y3400_MY	P71447	72.9	3.0	194.0	DB02317	experimental	Alpha-D-Galactose-1-Phosphate	OC[C@H]1O[C@H](OP(=O)(O)O)[C@H](O)[C@@H](O)[C@H]1O
12090	sp|P9WKZ7|Y3400_MY	P71447	72.9	3.0	194.0	DB02835	experimental	Alpha-D-Glucose 1,6-Bisphosphate	OP(=O)(O)OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O1)OP(=O)(O)O
12091	sp|P9WKT3|Y501_MYC	O60547	91.76	11.0	356.0	DB02547	experimental	Guanosine-5'-Diphosphate-Rhamnose	O[C@H]1[C@H](O)[C@H](O)[C@H](O[C@@H]1C)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3cnc(c34)c(=O)nc([nH]4)N
12092	sp|P9WKT3|Y501_MYC	O60547	91.76	11.0	356.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
12093	sp|P9WKT3|Y501_MYC	P26391	85.64	2.0	324.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
12094	sp|P9WKT3|Y501_MYC	P95780	81.65	5.0	312.0	DB03161	experimental	Thymidine-5'-diphospho-beta-D-xylose	O=c1[nH]c(=O)c(C)cn1[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3OC[C@@H](O)[C@H](O)[C@H]3O
12095	sp|P9WKT3|Y501_MYC	P95780	81.65	5.0	312.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
12096	sp|P9WKT3|Y501_MYC	Q9ZGH3	79.26	2.0	300.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
12097	sp|P9WKT3|Y501_MYC	P26397	84.57	8.0	326.0	DB02059	experimental	Adenosine-5-Diphosphoribose	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)CO[P@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H](O)[C@H](O)[C@@H]4O
12098	sp|P9WKT3|Y501_MYC	P26397	84.57	8.0	326.0	DB03069	experimental	Cytidine-5'-diphospho-beta-D-xylose	Nc1nc(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O[C@H]3OC[C@@H](O)[C@H](O)[C@H]3O
12099	sp|P9WKT3|Y501_MYC	P09147	84.57	2.0	320.0	DB01861	experimental	Uridine diphosphate glucose	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
12100	sp|P9WKT3|Y501_MYC	P09147	84.57	2.0	320.0	DB02421	experimental	Uridine-5'-diphosphate-mannose	O=c1[nH]c(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O
12101	sp|P9WKT3|Y501_MYC	P09147	84.57	2.0	320.0	DB02790	experimental	Phenyl-uridine-5'-diphosphate	O=c1[nH]c(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)Oc3ccccc3
12102	sp|P9WKT3|Y501_MYC	P09147	84.57	2.0	320.0	DB03397	experimental	Uridine-Diphosphate-N-Acetylglucosamine	CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
12103	sp|P9WKT3|Y501_MYC	P09147	84.57	2.0	320.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
12104	sp|P9WKT3|Y501_MYC	P09147	84.57	2.0	320.0	DB04097	experimental	Uridine-5'-diphosphate-4-deoxy-4-fluoro-alpha-D-galactose	O=c1[nH]c(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](F)[C@H](O)[C@H]3O
12105	sp|P9WKT3|Y501_MYC	Q8KN66	83.24	10.0	323.0	DB01861	experimental	Uridine diphosphate glucose	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
12106	sp|P9WKT3|Y501_MYC	Q8KN66	83.24	10.0	323.0	DB02196	experimental	Uridine-Diphosphate-N-Acetylgalactosamine	CC(=O)N[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
12107	sp|P9WKT3|Y501_MYC	Q14376	77.93	2.0	295.0	DB01861	experimental	Uridine diphosphate glucose	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
12108	sp|P9WKT3|Y501_MYC	Q14376	77.93	2.0	295.0	DB02196	experimental	Uridine-Diphosphate-N-Acetylgalactosamine	CC(=O)N[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
12109	sp|P9WKT3|Y501_MYC	Q14376	77.93	2.0	295.0	DB03041	experimental	UDP-alpha-D-glucuronic acid	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O
12110	sp|P9WKT3|Y501_MYC	Q14376	77.93	2.0	295.0	DB03095	experimental	Tetramethylammonium	C[N+](C)(C)C
12111	sp|P9WKT3|Y501_MYC	Q14376	77.93	2.0	295.0	DB03397	experimental	Uridine-Diphosphate-N-Acetylglucosamine	CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
12112	sp|P9WKT3|Y501_MYC	Q14376	77.93	2.0	295.0	DB03501	experimental	Galactose-uridine-5'-diphosphate	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@H]1O)O[P@](=O)(O)O[P@](=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
12113	sp|P9WKT3|Y501_MYC	Q51366	71.01	3.0	270.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
12114	sp|P9WKT3|Y501_MYC	P14169	75.53	2.0	286.0	DB04555	experimental	Cytidine-5'-Diphosphate	Nc1nc(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O
12115	sp|P9WKT3|Y501_MYC	Q8T8E9	96.54	2.0	365.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
12116	sp|P9WGS5|Y2750_MY	Q9BTZ2	90.07	29.0	274.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
12118	sp|P9WGS5|Y2750_MY	Q9WYS2	90.81	6.0	253.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12119	sp|P9WGS5|Y2750_MY	Q92506	92.65	7.0	259.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
12120	sp|P9WGS5|Y2750_MY	Q92506	92.65	7.0	259.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12121	sp|P9WGS5|Y2750_MY	P0AEK2	87.5	3.0	241.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12122	sp|P9WGS5|Y2750_MY	P16544	92.65	6.0	258.0	DB01942	experimental; investigational	Formic acid	OC=O
12123	sp|P9WGS5|Y2750_MY	P16544	92.65	6.0	258.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12124	sp|P9WGS5|Y2750_MY	P16544	92.65	6.0	258.0	DB07715	investigational	Emodin	Cc(c1)cc(O)c(c12)C(=O)c3c(C2=O)cc(O)cc3O
12125	sp|P9WGS5|Y2750_MY	P0AET8	89.34	8.0	251.0	DB02123	experimental	Glycochenodeoxycholic Acid	OC(=O)CNC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
12128	sp|P9WGS5|Y2750_MY	Q9BY49	91.18	16.0	264.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
12129	sp|P9WGS5|Y2750_MY	Q84EX5	90.81	3.0	250.0	DB04619	experimental	Acetophenone	CC(=O)c1ccccc1
12130	sp|P9WGS5|Y2750_MY	Q84EX5	90.81	3.0	250.0	DB04784	experimental	(R)-1-phenylethanol	C[C@@H](O)c1ccccc1
12131	sp|P9WGS5|Y2750_MY	P0CG22	91.18	29.0	277.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
12132	sp|P9WGS5|Y2750_MY	P0CG22	91.18	29.0	277.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12133	sp|P9WGS5|Y2750_MY	P0CG22	91.18	29.0	277.0	DB03541	experimental	10-Propargyl-5,8-Dideazafolic Acid	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(CC#C)Cc(c2)ccc(c23)[nH]c(N)nc3=O
12134	sp|P9WGS5|Y2750_MY	P0CG22	91.18	29.0	277.0	DB07689	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)NCc(cn3)nc(c34)c(N)nc(n4)N
12135	sp|P9WGS5|Y2750_MY	P0CG22	91.18	29.0	277.0	DB07765	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)N(C)Cc(cn3)nc(c34)c(N)nc(n4)N
12136	sp|P9WGS5|Y2750_MY	Q7Z4W1	86.76	5.0	241.0	DB02831	experimental	Dihydrogenphosphate	OP([O-])(=O)O
12137	sp|P9WGS5|Y2750_MY	Q7Z4W1	86.76	5.0	241.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12139	sp|P9WGS5|Y2750_MY	Q16698	90.44	56.0	302.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12140	sp|P9WGS5|Y2750_MY	Q16698	90.44	56.0	302.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
12141	sp|P9WGS5|Y2750_MY	Q99714	91.54	6.0	255.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
12142	sp|P9WGS5|Y2750_MY	Q99714	91.54	6.0	255.0	DB02820	experimental	1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct	C1CCCCCN1C(=O)[C@H](c2ccccc2)n(c3=S)cnc(c34)nn(c4)[C@H]5C=CN(C=C5C([O-])=N)[C@@H]6O[C@@H]([C@@H](O)[C@H]6O)COP([O-])(=O)OP(=O)(O)OC[C@H]7O[C@H]([C@H]([O-])[C@@H]7[O-])n8cnc(c89)c(N)ncn9
12143	sp|P9WGS5|Y2750_MY	Q99714	91.54	6.0	255.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
12144	sp|P9WGS5|Y2750_MY	Q6UWP2	87.13	11.0	248.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12145	sp|P9WGS5|Y2750_MY	A0A348A0U3	91.18	4.0	252.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
12146	sp|P9WGS5|Y2750_MY	P51659	87.5	6.0	244.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
12147	sp|P9WGS5|Y2750_MY	P51659	87.5	6.0	244.0	DB03192	experimental	(R)-3-hydroxydecanoyl-CoA	CCCCCCC[C@@H](O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
12148	sp|P9WGS5|Y2750_MY	Q7AUG5	88.24	3.0	243.0	DB04782	experimental	(S)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@H]2CO2
12149	sp|P9WGS5|Y2750_MY	Q93D82	88.24	3.0	243.0	DB04472	experimental	(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol	[N-]=[N+]=NC[C@H](O)c1ccc([N+]([O-])=O)cc1
12150	sp|P9WGS5|Y2750_MY	Q93D82	88.24	3.0	243.0	DB04499	experimental	(R)-styrene oxide	C1O[C@@H]1c2ccccc2
12151	sp|P9WGS5|Y2750_MY	Q93D82	88.24	3.0	243.0	DB04777	experimental	(R)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@@H]2CO2
12152	sp|P9WGS5|Y2750_MY	Q8TC12	77.94	38.0	250.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
12153	sp|P9WGS5|Y2750_MY	Q6GI75	91.18	4.0	252.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
12154	sp|P9WGS5|Y2750_MY	Q6GI75	91.18	4.0	252.0	DB11155	approved	Triclocarban	Clc1ccc(cc1)NC(=O)Nc2cc(Cl)c(Cl)cc2
12155	sp|P9WGS5|Y2750_MY	P0AEK4	90.81	4.0	251.0	DB01691	experimental	Indole Naphthyridinone	c1cccc(c12)n(C)cc2CN(C)C(=O)/C=C/c(c3)cnc(c34)NC(=O)CC4
12156	sp|P9WGS5|Y2750_MY	P0AEK4	90.81	4.0	251.0	DB01865	experimental	3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide	c1cccc(c12)cc(n2C)CN(C)C(=O)/C=C/c3cnc(N)cc3
12157	sp|P9WGS5|Y2750_MY	P0AEK4	90.81	4.0	251.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
12158	sp|P9WGS5|Y2750_MY	P0AEK4	90.81	4.0	251.0	DB03030	experimental	4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole	Cc1ccc(cc1)Cn2cnc(c2)-c3cccs3
12159	sp|P9WGS5|Y2750_MY	P0AEK4	90.81	4.0	251.0	DB03534	experimental	3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide	CC(=O)N(C)Cc1c(N)ccc(c1)C(=O)N(C)Cc(n2C)cc(c23)cccc3
12160	sp|P9WGS5|Y2750_MY	P0AEK4	90.81	4.0	251.0	DB04030	experimental	1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole	Oc1ccc(cc1)Cn2c(c3c(c24)cccc4)CN(CC3)C(=O)c5ccc(O)cc5
12161	sp|P9WGS5|Y2750_MY	P0AEK4	90.81	4.0	251.0	DB08265	experimental	2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL	Cc1ccc(cc1)S(=O)(=O)n(b2O)ncc(c23)cccc3
12162	sp|P9WGS5|Y2750_MY	P0AEK4	90.81	4.0	251.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
12163	sp|P9WGS5|Y2750_MY	P0AEK4	90.81	4.0	251.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
12164	sp|P9WGS5|Y2750_MY	P14061	81.25	3.0	224.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
12165	sp|P9WGS5|Y2750_MY	P14061	81.25	3.0	224.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
12166	sp|P9WGS5|Y2750_MY	P14061	81.25	3.0	224.0	DB01561	experimental; illicit	Androstanedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
12167	sp|P9WGS5|Y2750_MY	P14061	81.25	3.0	224.0	DB02187	experimental	Equilin	O=C1CC[C@H]([C@@]12C)C=3[C@H](CC2)c4c(CC3)cc(O)cc4
12168	sp|P9WGS5|Y2750_MY	P14061	81.25	3.0	224.0	DB02323	experimental	EM-1745	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)C[C@@H]([C@@H]4O)CCCCCCCCC(=O)OC[C@H]5O[C@H]([C@H](O)[C@@H]5O)n6cnc(c67)c(N)ncn7
12169	sp|P9WGS5|Y2750_MY	P14061	81.25	3.0	224.0	DB02901	illicit; investigational	Stanolone	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
12170	sp|P9WGS5|Y2750_MY	P14061	81.25	3.0	224.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12171	sp|P9WGS5|Y2750_MY	P14061	81.25	3.0	224.0	DB13951	experimental	Stanolone acetate	CC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
12172	sp|P9WGS5|Y2750_MY	Q8I814	95.22	13.0	272.0	DB02015	experimental	Dihydrofolic Acid	O=c1[nH]c(N)nc(c12)NCC(=N2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
12173	sp|P9WGS5|Y2750_MY	Q8I814	95.22	13.0	272.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12174	sp|P9WGS5|Y2750_MY	Q8NBQ5	78.68	33.0	247.0	DB02854	experimental	Aetiocholanolone	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](CC3)C[C@H](O)CC4
12175	sp|P9WGS5|Y2750_MY	Q01782	101.1	8.0	283.0	DB02338	experimental	NADPH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12176	sp|P9WGS5|Y2750_MY	Q01782	101.1	8.0	283.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
12177	sp|P9WGS5|Y2750_MY	Q01782	101.1	8.0	283.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12178	sp|P9WGS5|Y2750_MY	Q01782	101.1	8.0	283.0	DB04400	experimental	L-erythro-7,8-dihydrobiopterin	C[C@H](O)[C@H](O)C(CN1)=Nc(c12)c(=O)nc([nH]2)N
12179	sp|P9WGS5|Y2750_MY	Q96NR8	75.37	35.0	240.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
12180	sp|P9WGS5|Y2750_MY	Q8NBN7	75.0	36.0	240.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
12181	sp|P9WGS5|Y2750_MY	Q9HBH5	92.28	41.0	292.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
12182	sp|P9WGS5|Y2750_MY	O75911	72.43	34.0	231.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
12183	sp|P9WGS5|Y2750_MY	O24990	90.44	4.0	250.0	DB04393	experimental	Soneclosan	Clc1cc(O)c(cc1)Oc2ccc(Cl)cc2
12184	sp|P9WGS5|Y2750_MY	O24990	90.44	4.0	250.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
12185	sp|P9WGS5|Y2750_MY	Q02338	80.15	52.0	270.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
12186	sp|P9WGS5|Y2750_MY	P28845	82.72	31.0	256.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
12187	sp|P9WGS5|Y2750_MY	P28845	82.72	31.0	256.0	DB02329	experimental	Carbenoxolone	OC(=O)CCC(=O)O[C@@H](CC1)C(C)(C)[C@@H]([C@]12C)CC[C@]3(C)[C@@H]2C(=O)C=C4[C@H]5[C@@](C)(CC[C@@]34C)CC[C@](C5)(C)C(=O)O
12188	sp|P9WGS5|Y2750_MY	P28845	82.72	31.0	256.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12189	sp|P9WGS5|Y2750_MY	P28845	82.72	31.0	256.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
12190	sp|P9WGS5|Y2750_MY	P28845	82.72	31.0	256.0	DB04652	experimental	Corticosterone	OCC(=O)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H]([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
12191	sp|P9WGS5|Y2750_MY	P28845	82.72	31.0	256.0	DB05064	investigational	INCB13739	 
12192	sp|P9WGS5|Y2750_MY	P28845	82.72	31.0	256.0	DB06992	experimental	(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone	Cc1ccc(cc1F)-c2nc(ccc2)C(=O)N(CC3(C)C)CCC3
12193	sp|P9WGS5|Y2750_MY	P28845	82.72	31.0	256.0	DB07017	experimental	(5S)-2-{[(1S)-1-(4-Fluorophenyl)ethyl]amino}-5-(2-hydroxy-2-propanyl)-5-methyl-1,3-thiazol-4(5H)-one	Fc1ccc(cc1)[C@H](C)NC(=NC2=O)S[C@@]2(C)C(C)(C)O
12194	sp|P9WGS5|Y2750_MY	P28845	82.72	31.0	256.0	DB07049	experimental	(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine	[O-][N+](=O)c1ccc(cc1)N2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)C(C)(C)C
12195	sp|P9WGS5|Y2750_MY	P28845	82.72	31.0	256.0	DB07056	experimental	2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide	CCN(CC)C(=O)Cc1cccc(n1)NS(=O)(=O)c2c(C)c(Cl)ccc2
12196	sp|P9WGS5|Y2750_MY	P28845	82.72	31.0	256.0	DB07310	experimental	(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one	Fc1ccccc1[C@H](C)NC(=NC2=O)S[C@]2(C)C(F)(F)F
12197	sp|P9WGS5|Y2750_MY	P28845	82.72	31.0	256.0	DB07316	experimental	N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)C3CCN(CC3)CC4(CC4)C(=O)N
12198	sp|P9WGS5|Y2750_MY	P28845	82.72	31.0	256.0	DB07619	experimental	N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)[C@H]3CC[C@@H](CC3)c4cccnc4
12199	sp|P9WGS5|Y2750_MY	P28845	82.72	31.0	256.0	DB07624	experimental	1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide	C1CC1(C(=O)N)CN2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)[C@](C)(O)C(F)(F)F
12200	sp|P9WGS5|Y2750_MY	P28845	82.72	31.0	256.0	DB07866	experimental	(5S)-2-(Cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one	CCC[C@]1(C)SC(=NC1=O)NC2CCCCCCC2
12201	sp|P9WGS5|Y2750_MY	P28845	82.72	31.0	256.0	DB08277	experimental	2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE	CS(=O)(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4c(Cl)cc(F)cc4
12202	sp|P9WGS5|Y2750_MY	P28845	82.72	31.0	256.0	DB08280	experimental	(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE	NC(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4ccc(OC)cc4
12203	sp|P9WGS5|Y2750_MY	P28845	82.72	31.0	256.0	DB08771	experimental	(5R)-2-[(2-Fluorophenyl)amino]-5-isopropyl-1,3-thiazol-4(5H)-one	CC(C)[C@H]1SC(=NC1=O)Nc2c(F)cccc2
12204	sp|P9WGS5|Y2750_MY	P28845	82.72	31.0	256.0	DB13751	approved; experimental	Glycyrrhizic acid	C1C[C@](C)(C(=O)O)C[C@H]([C@]12C)C=3[C@@](C)(CC2)[C@@]4(C)[C@H](C(=O)C3)[C@]5(C)[C@@H](CC4)C(C)(C)[C@H](CC5)O[C@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O[C@@H]7O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]7O
12205	sp|P9WGS5|Y2750_MY	P37058	76.84	48.0	257.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
12206	sp|P9WGS5|Y2750_MY	Q92781	74.26	28.0	230.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
12207	sp|P9WGS5|Y2750_MY	Q92781	74.26	28.0	230.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
12208	sp|P9WGS5|Y2750_MY	P37059	76.84	79.0	288.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
12209	sp|P9WGS5|Y2750_MY	P37059	76.84	79.0	288.0	DB13952	approved; investigational; vet_approved	Estradiol acetate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)C
12210	sp|P9WGS5|Y2750_MY	P37059	76.84	79.0	288.0	DB13953	approved; investigational; vet_approved	Estradiol benzoate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)c5ccccc5
12211	sp|P9WGS5|Y2750_MY	P37059	76.84	79.0	288.0	DB13954	approved; investigational; vet_approved	Estradiol cypionate	C1CCCC1CCC(=O)O[C@H]2CC[C@H]([C@@]23C)[C@H]4[C@H](CC3)c5c(CC4)cc(O)cc5
12212	sp|P9WGS5|Y2750_MY	P37059	76.84	79.0	288.0	DB13955	approved; investigational; vet_approved	Estradiol dienanthate	CCCCCCC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)CCCCCC
12213	sp|P9WGS5|Y2750_MY	P37059	76.84	79.0	288.0	DB13956	approved; investigational; vet_approved	Estradiol valerate	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)CC[C@@H]4OC(=O)CCCC
12214	sp|P9WGS5|Y2750_MY	P9WGR1	95.22	5.0	264.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
12215	sp|P9WGS5|Y2750_MY	P9WGR1	95.22	5.0	264.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
12216	sp|P9WGS5|Y2750_MY	P9WGR1	95.22	5.0	264.0	DB02990	experimental	S-(2-Acetamidoethyl) hexadecanethioate	CCCCCCCCCCCCCCCC(=O)SCCNC(=O)C
12217	sp|P9WGS5|Y2750_MY	P9WGR1	95.22	5.0	264.0	DB04289	experimental	Genz-10850	[nH]1ccc(c12)cc(cc2)C(=O)N3CCN(CC3)C4c(cccc5)c5c(c46)cccc6
12218	sp|P9WGS5|Y2750_MY	P9WGR1	95.22	5.0	264.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
12219	sp|P9WGS5|Y2750_MY	P9WGR1	95.22	5.0	264.0	DB07090	experimental	(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cccc(c1C)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
12220	sp|P9WGS5|Y2750_MY	P9WGR1	95.22	5.0	264.0	DB07123	experimental	N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE	Cc1ccc(cc1)C(=O)N2CCC(CC2)Cc3ccccc3
12221	sp|P9WGS5|Y2750_MY	P9WGR1	95.22	5.0	264.0	DB07155	experimental	(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE	c1ccccc1NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
12222	sp|P9WGS5|Y2750_MY	P9WGR1	95.22	5.0	264.0	DB07178	experimental	5-PENTYL-2-PHENOXYPHENOL	CCCCCc1cc(O)c(cc1)Oc2ccccc2
12223	sp|P9WGS5|Y2750_MY	P9WGR1	95.22	5.0	264.0	DB07188	experimental	(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(cc(Cl)c1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
12224	sp|P9WGS5|Y2750_MY	P9WGR1	95.22	5.0	264.0	DB07192	experimental	(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Brc1cc(ccc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
12225	sp|P9WGS5|Y2750_MY	P9WGR1	95.22	5.0	264.0	DB07222	experimental	(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(c(C)cc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
12226	sp|P9WGS5|Y2750_MY	P9WGR1	95.22	5.0	264.0	DB07287	experimental	2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL	c1cccnc1Cc2cc(O)c(cc2)Oc3ccc(Cl)cc3Cl
12227	sp|P9WGS5|Y2750_MY	P9WGR1	95.22	5.0	264.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
12228	sp|P9WGS5|Y2750_MY	P80365	73.9	79.0	280.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
12229	sp|P9WGS5|Y2750_MY	P80365	73.9	79.0	280.0	DB01185	approved; illicit	Fluoxymesterone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@](F)([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
12230	sp|P9WGS5|Y2750_MY	P80365	73.9	79.0	280.0	DB01569	experimental; illicit	Formebolone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@H]([C@@H](C2)O)[C@]4(C)C(CC3)=CC(=O)C(C=O)=C4
12231	sp|P9WGS5|Y2750_MY	P80365	73.9	79.0	280.0	DB14538	experimental; vet_approved	Hydrocortisone aceponate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CC)C(=O)COC(=O)C
12232	sp|P9WGS5|Y2750_MY	P80365	73.9	79.0	280.0	DB14539	approved; vet_approved	Hydrocortisone acetate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)C
12233	sp|P9WGS5|Y2750_MY	P80365	73.9	79.0	280.0	DB14540	approved; vet_approved	Hydrocortisone butyrate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCC
12234	sp|P9WGS5|Y2750_MY	P80365	73.9	79.0	280.0	DB14541	approved; investigational; vet_approved	Hydrocortisone cypionate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)CCC5CCCC5
12235	sp|P9WGS5|Y2750_MY	P80365	73.9	79.0	280.0	DB14542	approved; vet_approved	Hydrocortisone phosphate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COP(=O)(O)O
12236	sp|P9WGS5|Y2750_MY	P80365	73.9	79.0	280.0	DB14543	approved; vet_approved	Hydrocortisone probutate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CCC)C(=O)COC(=O)CC
12237	sp|P9WGS5|Y2750_MY	P80365	73.9	79.0	280.0	DB14544	approved; vet_approved	Hydrocortisone valerate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCCC
12238	sp|P9WGS5|Y2750_MY	P16152	86.76	7.0	243.0	DB01698	approved; experimental; investigational	Rutin	O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O[C@H]1C)OC[C@H]2O[C@H]([C@H](O)[C@@H](O)[C@@H]2O)Oc(c3=O)c(-c4cc(O)c(O)cc4)oc(c35)cc(O)cc5O
12239	sp|P9WGS5|Y2750_MY	P16152	86.76	7.0	243.0	DB02709	investigational	Resveratrol	Oc1ccc(cc1)/C=C/c2cc(O)cc(O)c2
12240	sp|P9WGS5|Y2750_MY	P16152	86.76	7.0	243.0	DB03394	experimental	Heptaethylene glycol	OCCOCCOCCOCCOCCOCCOCCO
12241	sp|P9WGS5|Y2750_MY	P16152	86.76	7.0	243.0	DB03556	experimental	2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400	CCOCCOCCOCCOCCOCCOCCOCCOCCO
12242	sp|P9WGS5|Y2750_MY	P16152	86.76	7.0	243.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
12243	sp|P9WGS5|Y2750_MY	P16152	86.76	7.0	243.0	DB04463	experimental	3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol	n1cnc(N)c(c12)c(nn2C(C)(C)C)-c3cccc(O)c3
12244	sp|P9WGS5|Y2750_MY	P16152	86.76	7.0	243.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
12245	sp|P9WGS5|Y2750_MY	P16152	86.76	7.0	243.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
12246	sp|P9WGS5|Y2750_MY	P56937	84.19	2.0	231.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
12247	sp|P9WGS5|Y2750_MY	P35270	87.87	7.0	246.0	DB02637	experimental	Oxaloacetate Ion	OC(=O)C(=O)CC([O-])=O
12248	sp|P9WGS5|Y2750_MY	P35270	87.87	7.0	246.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12249	sp|P9WGS5|Y2750_MY	P35270	87.87	7.0	246.0	DB03886	experimental	Biopterin	C[C@@H](O)[C@@H](O)c(n1)cnc(c12)nc(N)[nH]c2=O
12250	sp|P9WGS5|Y2750_MY	P35270	87.87	7.0	246.0	DB04275	experimental	N-acetylserotonin	CC(=O)NCCc1c[nH]c(c12)ccc(c2)O
12251	sp|P9WGS5|Y2750_MY	Q8T8E9	71.69	2.0	197.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
12252	sp|P9WGS5|Y2750_MY	P26391	70.22	3.0	194.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
12253	sp|P9WJP1|RSMH_MYC	Q9WZX6	73.23	6.0	296.0	DB01752	experimental	S-adenosyl-L-homocysteine	OC(=O)[C@@H](N)CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
12254	sp|P9WKI9|SUHB_MYC	O14732	85.17	34.0	281.0	DB01356	experimental	Lithium cation	[Li+]
12255	sp|P9WKI9|SUHB_MYC	O14732	85.17	34.0	281.0	DB14507	approved	Lithium citrate	[O-]C(=O)CC(O)(C([O-])=O)CC([O-])=O
12256	sp|P9WKI9|SUHB_MYC	O14732	85.17	34.0	281.0	DB14508	experimental	Lithium succinate	[O-]C(=O)CCC([O-])=O
12257	sp|P9WKI9|SUHB_MYC	O14732	85.17	34.0	281.0	DB14509	approved	Lithium carbonate	[O-]C([O-])=O
12258	sp|P9WKI9|SUHB_MYC	P29218	84.14	23.0	267.0	DB01356	experimental	Lithium cation	[Li+]
12259	sp|P9WKI9|SUHB_MYC	P29218	84.14	23.0	267.0	DB03542	experimental	L-Myo-Inositol-1-Phosphate	O[C@H]1[C@H](O)[C@H](O)[C@H](OP([O-])([O-])=O)[C@@H](O)[C@@H]1O
12260	sp|P9WKI9|SUHB_MYC	P29218	84.14	23.0	267.0	DB14507	approved	Lithium citrate	[O-]C(=O)CC(O)(C([O-])=O)CC([O-])=O
12261	sp|P9WKI9|SUHB_MYC	P29218	84.14	23.0	267.0	DB14508	experimental	Lithium succinate	[O-]C(=O)CCC([O-])=O
12262	sp|P9WKI9|SUHB_MYC	P29218	84.14	23.0	267.0	DB14509	approved	Lithium carbonate	[O-]C([O-])=O
12263	sp|P9WG77|THID_MYC	P55882	97.36	4.0	262.0	DB02022	experimental	4-Amino-5-Hydroxymethyl-2-Methylpyrimidine	Cc1ncc(CO)c(n1)N
12264	sp|P9WH29|RS7_MYCT	P17291	99.36	1.0	156.0	DB08185	experimental	2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(nc(n3)SC)NCCC(C)C
12265	sp|P9WH29|RS7_MYCT	P02359	99.36	1.0	156.0	DB00759	approved; vet_approved	Tetracycline	O=C1C(C(=O)N)=C(O)[C@@H](N(C)C)[C@@H]([C@@]12O)C[C@H]3C(=C2O)C(=O)c4c([C@@]3(C)O)cccc4O
12266	sp|P9WH29|RS7_MYCT	P02359	99.36	1.0	156.0	DB09093	approved; investigational; vet_approved	Chlortetracycline	O=C1C(C(=O)N)=C(O)[C@@H](N(C)C)[C@@H]([C@@]12O)C[C@H]3C(=C2O)C(=O)c4c([C@@]3(C)O)c(Cl)ccc4O
12267	sp|P9WH29|RS7_MYCT	P02359	99.36	1.0	156.0	DB12455	approved; investigational	Omadacycline	O=C1C(C(=O)N)=C(O)[C@@H](N(C)C)[C@@H]([C@@]12O)C[C@H]3C(=C2O)C(=O)c4c(C3)c(N(C)C)cc(c4O)CNCC(C)(C)C
12268	sp|P9WH29|RS7_MYCT	P02359	99.36	1.0	156.0	DB13092	investigational	Meclocycline	O=C1C(C(=O)N)=C(O)[C@@H](N(C)C)[C@@H]([C@@]12O)[C@@H](O)[C@H]3C(=C2O)C(=O)c4c(C3=C)c(Cl)ccc4O
12269	sp|P9WH29|RS7_MYCT	Q8IBN5	87.18	59.0	195.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
12270	sp|P9WH29|RS7_MYCT	P46782	87.18	68.0	204.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
12271	sp|P9WGC5|SUCC_MYC	Q96I99	100.26	38.0	426.0	DB12695	investigational	Phenethyl Isothiocyanate	S=C=NCCc1ccccc1
12272	sp|P9WGC5|SUCC_MYC	P53396	89.41	51.0	397.0	DB11936	approved; investigational	Bempedoic acid	OC(=O)C(C)(C)CCCCCC(O)CCCCCC(C)(C)C(=O)O
12274	sp|P9WFF5|ZFPP_MYC	P9WFF7	87.4	65.0	294.0	DB02552	experimental	Geranyl Diphosphate	CC(C)=CCC/C(C)=C/CO[P@@](=O)(O)OP(=O)(O)O
12275	sp|P9WFF5|ZFPP_MYC	P9WFF7	87.4	65.0	294.0	DB04714	experimental	ISOPENTENYL PYROPHOSPHATE	CC(=C)CCO[P@@](=O)(O)OP(=O)(O)O
12276	sp|P9WFF5|ZFPP_MYC	P60472	86.26	18.0	244.0	DB15690	approved	Fluoroestradiol F-18	O[C@H]1[C@H]([18F])C[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)cc4
12277	sp|P96825|Y0148_MY	P51659	96.15	7.0	282.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
12278	sp|P96825|Y0148_MY	P51659	96.15	7.0	282.0	DB03192	experimental	(R)-3-hydroxydecanoyl-CoA	CCCCCCC[C@@H](O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
12279	sp|P96825|Y0148_MY	Q9BTZ2	86.71	30.0	278.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
12281	sp|P96825|Y0148_MY	Q9WYS2	86.36	6.0	253.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12283	sp|P96825|Y0148_MY	P0AEK2	83.22	3.0	241.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12284	sp|P96825|Y0148_MY	P0AET8	85.66	9.0	254.0	DB02123	experimental	Glycochenodeoxycholic Acid	OC(=O)CNC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
12285	sp|P96825|Y0148_MY	Q92506	87.41	9.0	259.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
12286	sp|P96825|Y0148_MY	Q92506	87.41	9.0	259.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12288	sp|P96825|Y0148_MY	P16544	88.46	5.0	258.0	DB01942	experimental; investigational	Formic acid	OC=O
12289	sp|P96825|Y0148_MY	P16544	88.46	5.0	258.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12290	sp|P96825|Y0148_MY	P16544	88.46	5.0	258.0	DB07715	investigational	Emodin	Cc(c1)cc(O)c(c12)C(=O)c3c(C2=O)cc(O)cc3O
12291	sp|P96825|Y0148_MY	Q84EX5	86.01	4.0	250.0	DB04619	experimental	Acetophenone	CC(=O)c1ccccc1
12292	sp|P96825|Y0148_MY	Q84EX5	86.01	4.0	250.0	DB04784	experimental	(R)-1-phenylethanol	C[C@@H](O)c1ccccc1
12293	sp|P96825|Y0148_MY	Q9BY49	87.06	16.0	265.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
12294	sp|P96825|Y0148_MY	P0CG22	87.76	30.0	281.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
12295	sp|P96825|Y0148_MY	P0CG22	87.76	30.0	281.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12296	sp|P96825|Y0148_MY	P0CG22	87.76	30.0	281.0	DB03541	experimental	10-Propargyl-5,8-Dideazafolic Acid	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(CC#C)Cc(c2)ccc(c23)[nH]c(N)nc3=O
12297	sp|P96825|Y0148_MY	P0CG22	87.76	30.0	281.0	DB07689	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)NCc(cn3)nc(c34)c(N)nc(n4)N
12298	sp|P96825|Y0148_MY	P0CG22	87.76	30.0	281.0	DB07765	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)N(C)Cc(cn3)nc(c34)c(N)nc(n4)N
12299	sp|P96825|Y0148_MY	Q7Z4W1	82.52	5.0	241.0	DB02831	experimental	Dihydrogenphosphate	OP([O-])(=O)O
12300	sp|P96825|Y0148_MY	Q7Z4W1	82.52	5.0	241.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12301	sp|P96825|Y0148_MY	Q16698	86.71	56.0	304.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12302	sp|P96825|Y0148_MY	Q16698	86.71	56.0	304.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
12304	sp|P96825|Y0148_MY	Q8NBQ5	73.78	33.0	244.0	DB02854	experimental	Aetiocholanolone	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](CC3)C[C@H](O)CC4
12305	sp|P96825|Y0148_MY	Q6UWP2	82.17	10.0	245.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12306	sp|P96825|Y0148_MY	O75911	74.48	35.0	248.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
12307	sp|P96825|Y0148_MY	Q02338	81.82	53.0	287.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
12308	sp|P96825|Y0148_MY	Q99714	86.71	7.0	255.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
12309	sp|P96825|Y0148_MY	Q99714	86.71	7.0	255.0	DB02820	experimental	1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct	C1CCCCCN1C(=O)[C@H](c2ccccc2)n(c3=S)cnc(c34)nn(c4)[C@H]5C=CN(C=C5C([O-])=N)[C@@H]6O[C@@H]([C@@H](O)[C@H]6O)COP([O-])(=O)OP(=O)(O)OC[C@H]7O[C@H]([C@H]([O-])[C@@H]7[O-])n8cnc(c89)c(N)ncn9
12310	sp|P96825|Y0148_MY	Q99714	86.71	7.0	255.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
12311	sp|P96825|Y0148_MY	P14061	77.27	3.0	224.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
12312	sp|P96825|Y0148_MY	P14061	77.27	3.0	224.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
12313	sp|P96825|Y0148_MY	P14061	77.27	3.0	224.0	DB01561	experimental; illicit	Androstanedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
12314	sp|P96825|Y0148_MY	P14061	77.27	3.0	224.0	DB02187	experimental	Equilin	O=C1CC[C@H]([C@@]12C)C=3[C@H](CC2)c4c(CC3)cc(O)cc4
12315	sp|P96825|Y0148_MY	P14061	77.27	3.0	224.0	DB02323	experimental	EM-1745	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)C[C@@H]([C@@H]4O)CCCCCCCCC(=O)OC[C@H]5O[C@H]([C@H](O)[C@@H]5O)n6cnc(c67)c(N)ncn7
12316	sp|P96825|Y0148_MY	P14061	77.27	3.0	224.0	DB02901	illicit; investigational	Stanolone	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
12317	sp|P96825|Y0148_MY	P14061	77.27	3.0	224.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12318	sp|P96825|Y0148_MY	P14061	77.27	3.0	224.0	DB13951	experimental	Stanolone acetate	CC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
12319	sp|P96825|Y0148_MY	Q8I814	90.21	14.0	272.0	DB02015	experimental	Dihydrofolic Acid	O=c1[nH]c(N)nc(c12)NCC(=N2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
12320	sp|P96825|Y0148_MY	Q8I814	90.21	14.0	272.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12321	sp|P96825|Y0148_MY	Q8TC12	71.33	39.0	243.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
12322	sp|P96825|Y0148_MY	Q9NYR8	71.68	6.0	211.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
12323	sp|P96825|Y0148_MY	Q9HBH5	87.76	41.0	292.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
12324	sp|P96825|Y0148_MY	Q8NBN7	83.92	36.0	276.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
12325	sp|P96825|Y0148_MY	Q01782	96.15	8.0	283.0	DB02338	experimental	NADPH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12326	sp|P96825|Y0148_MY	Q01782	96.15	8.0	283.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
12327	sp|P96825|Y0148_MY	Q01782	96.15	8.0	283.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12328	sp|P96825|Y0148_MY	Q01782	96.15	8.0	283.0	DB04400	experimental	L-erythro-7,8-dihydrobiopterin	C[C@H](O)[C@H](O)C(CN1)=Nc(c12)c(=O)nc([nH]2)N
12329	sp|P96825|Y0148_MY	Q6GI75	87.06	3.0	252.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
12330	sp|P96825|Y0148_MY	Q6GI75	87.06	3.0	252.0	DB11155	approved	Triclocarban	Clc1ccc(cc1)NC(=O)Nc2cc(Cl)c(Cl)cc2
12331	sp|P96825|Y0148_MY	P37058	74.13	48.0	260.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
12332	sp|P96825|Y0148_MY	Q7AUG5	84.27	3.0	244.0	DB04782	experimental	(S)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@H]2CO2
12333	sp|P96825|Y0148_MY	Q93D82	84.27	3.0	244.0	DB04472	experimental	(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol	[N-]=[N+]=NC[C@H](O)c1ccc([N+]([O-])=O)cc1
12334	sp|P96825|Y0148_MY	Q93D82	84.27	3.0	244.0	DB04499	experimental	(R)-styrene oxide	C1O[C@@H]1c2ccccc2
12335	sp|P96825|Y0148_MY	Q93D82	84.27	3.0	244.0	DB04777	experimental	(R)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@@H]2CO2
12336	sp|P96825|Y0148_MY	Q96NR8	70.63	37.0	239.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
12337	sp|P96825|Y0148_MY	A0A348A0U3	87.06	3.0	252.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
12338	sp|P96825|Y0148_MY	P0AEK4	86.71	4.0	252.0	DB01691	experimental	Indole Naphthyridinone	c1cccc(c12)n(C)cc2CN(C)C(=O)/C=C/c(c3)cnc(c34)NC(=O)CC4
12339	sp|P96825|Y0148_MY	P0AEK4	86.71	4.0	252.0	DB01865	experimental	3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide	c1cccc(c12)cc(n2C)CN(C)C(=O)/C=C/c3cnc(N)cc3
12340	sp|P96825|Y0148_MY	P0AEK4	86.71	4.0	252.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
12341	sp|P96825|Y0148_MY	P0AEK4	86.71	4.0	252.0	DB03030	experimental	4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole	Cc1ccc(cc1)Cn2cnc(c2)-c3cccs3
12342	sp|P96825|Y0148_MY	P0AEK4	86.71	4.0	252.0	DB03534	experimental	3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide	CC(=O)N(C)Cc1c(N)ccc(c1)C(=O)N(C)Cc(n2C)cc(c23)cccc3
12343	sp|P96825|Y0148_MY	P0AEK4	86.71	4.0	252.0	DB04030	experimental	1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole	Oc1ccc(cc1)Cn2c(c3c(c24)cccc4)CN(CC3)C(=O)c5ccc(O)cc5
12344	sp|P96825|Y0148_MY	P0AEK4	86.71	4.0	252.0	DB08265	experimental	2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL	Cc1ccc(cc1)S(=O)(=O)n(b2O)ncc(c23)cccc3
12345	sp|P96825|Y0148_MY	P0AEK4	86.71	4.0	252.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
12346	sp|P96825|Y0148_MY	P0AEK4	86.71	4.0	252.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
12347	sp|P96825|Y0148_MY	P37059	70.28	80.0	281.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
12348	sp|P96825|Y0148_MY	P37059	70.28	80.0	281.0	DB13952	approved; investigational; vet_approved	Estradiol acetate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)C
12349	sp|P96825|Y0148_MY	P37059	70.28	80.0	281.0	DB13953	approved; investigational; vet_approved	Estradiol benzoate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)c5ccccc5
12350	sp|P96825|Y0148_MY	P37059	70.28	80.0	281.0	DB13954	approved; investigational; vet_approved	Estradiol cypionate	C1CCCC1CCC(=O)O[C@H]2CC[C@H]([C@@]23C)[C@H]4[C@H](CC3)c5c(CC4)cc(O)cc5
12351	sp|P96825|Y0148_MY	P37059	70.28	80.0	281.0	DB13955	approved; investigational; vet_approved	Estradiol dienanthate	CCCCCCC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)CCCCCC
12352	sp|P96825|Y0148_MY	P37059	70.28	80.0	281.0	DB13956	approved; investigational; vet_approved	Estradiol valerate	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)CC[C@@H]4OC(=O)CCCC
12353	sp|P96825|Y0148_MY	P80365	70.63	80.0	282.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
12354	sp|P96825|Y0148_MY	P80365	70.63	80.0	282.0	DB01185	approved; illicit	Fluoxymesterone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@](F)([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
12355	sp|P96825|Y0148_MY	P80365	70.63	80.0	282.0	DB01569	experimental; illicit	Formebolone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@H]([C@@H](C2)O)[C@]4(C)C(CC3)=CC(=O)C(C=O)=C4
12356	sp|P96825|Y0148_MY	P80365	70.63	80.0	282.0	DB14538	experimental; vet_approved	Hydrocortisone aceponate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CC)C(=O)COC(=O)C
12357	sp|P96825|Y0148_MY	P80365	70.63	80.0	282.0	DB14539	approved; vet_approved	Hydrocortisone acetate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)C
12358	sp|P96825|Y0148_MY	P80365	70.63	80.0	282.0	DB14540	approved; vet_approved	Hydrocortisone butyrate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCC
12359	sp|P96825|Y0148_MY	P80365	70.63	80.0	282.0	DB14541	approved; investigational; vet_approved	Hydrocortisone cypionate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)CCC5CCCC5
12360	sp|P96825|Y0148_MY	P80365	70.63	80.0	282.0	DB14542	approved; vet_approved	Hydrocortisone phosphate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COP(=O)(O)O
12361	sp|P96825|Y0148_MY	P80365	70.63	80.0	282.0	DB14543	approved; vet_approved	Hydrocortisone probutate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CCC)C(=O)COC(=O)CC
12362	sp|P96825|Y0148_MY	P80365	70.63	80.0	282.0	DB14544	approved; vet_approved	Hydrocortisone valerate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCCC
12363	sp|P96825|Y0148_MY	O24990	88.46	4.0	257.0	DB04393	experimental	Soneclosan	Clc1cc(O)c(cc1)Oc2ccc(Cl)cc2
12364	sp|P96825|Y0148_MY	O24990	88.46	4.0	257.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
12365	sp|P96825|Y0148_MY	P56937	95.45	2.0	275.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
12366	sp|P96825|Y0148_MY	P16152	81.12	7.0	239.0	DB01698	approved; experimental; investigational	Rutin	O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O[C@H]1C)OC[C@H]2O[C@H]([C@H](O)[C@@H](O)[C@@H]2O)Oc(c3=O)c(-c4cc(O)c(O)cc4)oc(c35)cc(O)cc5O
12367	sp|P96825|Y0148_MY	P16152	81.12	7.0	239.0	DB02709	investigational	Resveratrol	Oc1ccc(cc1)/C=C/c2cc(O)cc(O)c2
12368	sp|P96825|Y0148_MY	P16152	81.12	7.0	239.0	DB03394	experimental	Heptaethylene glycol	OCCOCCOCCOCCOCCOCCOCCO
12369	sp|P96825|Y0148_MY	P16152	81.12	7.0	239.0	DB03556	experimental	2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400	CCOCCOCCOCCOCCOCCOCCOCCOCCO
12370	sp|P96825|Y0148_MY	P16152	81.12	7.0	239.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
12371	sp|P96825|Y0148_MY	P16152	81.12	7.0	239.0	DB04463	experimental	3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol	n1cnc(N)c(c12)c(nn2C(C)(C)C)-c3cccc(O)c3
12372	sp|P96825|Y0148_MY	P16152	81.12	7.0	239.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
12373	sp|P96825|Y0148_MY	P16152	81.12	7.0	239.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
12374	sp|P96825|Y0148_MY	P09417	76.57	11.0	230.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
12375	sp|P96825|Y0148_MY	P09417	76.57	11.0	230.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
12376	sp|P96825|Y0148_MY	P9WGR1	91.61	5.0	267.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
12377	sp|P96825|Y0148_MY	P9WGR1	91.61	5.0	267.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
12378	sp|P96825|Y0148_MY	P9WGR1	91.61	5.0	267.0	DB02990	experimental	S-(2-Acetamidoethyl) hexadecanethioate	CCCCCCCCCCCCCCCC(=O)SCCNC(=O)C
12379	sp|P96825|Y0148_MY	P9WGR1	91.61	5.0	267.0	DB04289	experimental	Genz-10850	[nH]1ccc(c12)cc(cc2)C(=O)N3CCN(CC3)C4c(cccc5)c5c(c46)cccc6
12380	sp|P96825|Y0148_MY	P9WGR1	91.61	5.0	267.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
12381	sp|P96825|Y0148_MY	P9WGR1	91.61	5.0	267.0	DB07090	experimental	(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cccc(c1C)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
12382	sp|P96825|Y0148_MY	P9WGR1	91.61	5.0	267.0	DB07123	experimental	N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE	Cc1ccc(cc1)C(=O)N2CCC(CC2)Cc3ccccc3
12383	sp|P96825|Y0148_MY	P9WGR1	91.61	5.0	267.0	DB07155	experimental	(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE	c1ccccc1NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
12384	sp|P96825|Y0148_MY	P9WGR1	91.61	5.0	267.0	DB07178	experimental	5-PENTYL-2-PHENOXYPHENOL	CCCCCc1cc(O)c(cc1)Oc2ccccc2
12385	sp|P96825|Y0148_MY	P9WGR1	91.61	5.0	267.0	DB07188	experimental	(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(cc(Cl)c1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
12386	sp|P96825|Y0148_MY	P9WGR1	91.61	5.0	267.0	DB07192	experimental	(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Brc1cc(ccc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
12387	sp|P96825|Y0148_MY	P9WGR1	91.61	5.0	267.0	DB07222	experimental	(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(c(C)cc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
12388	sp|P96825|Y0148_MY	P9WGR1	91.61	5.0	267.0	DB07287	experimental	2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL	c1cccnc1Cc2cc(O)c(cc2)Oc3ccc(Cl)cc3Cl
12389	sp|P96825|Y0148_MY	P9WGR1	91.61	5.0	267.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
12390	sp|P96825|Y0148_MY	P35270	72.73	5.0	213.0	DB02637	experimental	Oxaloacetate Ion	OC(=O)C(=O)CC([O-])=O
12391	sp|P96825|Y0148_MY	P35270	72.73	5.0	213.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12392	sp|P96825|Y0148_MY	P35270	72.73	5.0	213.0	DB03886	experimental	Biopterin	C[C@@H](O)[C@@H](O)c(n1)cnc(c12)nc(N)[nH]c2=O
12393	sp|P96825|Y0148_MY	P35270	72.73	5.0	213.0	DB04275	experimental	N-acetylserotonin	CC(=O)NCCc1c[nH]c(c12)ccc(c2)O
12394	sp|P9WGQ7|Y1144_MY	P0AEK2	96.0	3.0	243.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12395	sp|P9WGQ7|Y1144_MY	Q9BTZ2	97.2	31.0	274.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
12396	sp|P9WGQ7|Y1144_MY	Q99714	101.2	8.0	261.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
12397	sp|P9WGQ7|Y1144_MY	Q99714	101.2	8.0	261.0	DB02820	experimental	1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct	C1CCCCCN1C(=O)[C@H](c2ccccc2)n(c3=S)cnc(c34)nn(c4)[C@H]5C=CN(C=C5C([O-])=N)[C@@H]6O[C@@H]([C@@H](O)[C@H]6O)COP([O-])(=O)OP(=O)(O)OC[C@H]7O[C@H]([C@H]([O-])[C@@H]7[O-])n8cnc(c89)c(N)ncn9
12398	sp|P9WGQ7|Y1144_MY	Q99714	101.2	8.0	261.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
12399	sp|P9WGQ7|Y1144_MY	Q9WYS2	98.4	7.0	253.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12401	sp|P9WGQ7|Y1144_MY	Q92506	100.4	10.0	261.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
12402	sp|P9WGQ7|Y1144_MY	Q92506	100.4	10.0	261.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12404	sp|P9WGQ7|Y1144_MY	P0AET8	96.0	9.0	249.0	DB02123	experimental	Glycochenodeoxycholic Acid	OC(=O)CNC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
12406	sp|P9WGQ7|Y1144_MY	Q84EX5	98.0	5.0	250.0	DB04619	experimental	Acetophenone	CC(=O)c1ccccc1
12407	sp|P9WGQ7|Y1144_MY	Q84EX5	98.0	5.0	250.0	DB04784	experimental	(R)-1-phenylethanol	C[C@@H](O)c1ccccc1
12408	sp|P9WGQ7|Y1144_MY	P16544	100.8	6.0	258.0	DB01942	experimental; investigational	Formic acid	OC=O
12409	sp|P9WGQ7|Y1144_MY	P16544	100.8	6.0	258.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12410	sp|P9WGQ7|Y1144_MY	P16544	100.8	6.0	258.0	DB07715	investigational	Emodin	Cc(c1)cc(O)c(c12)C(=O)c3c(C2=O)cc(O)cc3O
12411	sp|P9WGQ7|Y1144_MY	Q9BY49	99.2	17.0	265.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
12412	sp|P9WGQ7|Y1144_MY	P0CG22	98.4	31.0	277.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
12413	sp|P9WGQ7|Y1144_MY	P0CG22	98.4	31.0	277.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12414	sp|P9WGQ7|Y1144_MY	P0CG22	98.4	31.0	277.0	DB03541	experimental	10-Propargyl-5,8-Dideazafolic Acid	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(CC#C)Cc(c2)ccc(c23)[nH]c(N)nc3=O
12415	sp|P9WGQ7|Y1144_MY	P0CG22	98.4	31.0	277.0	DB07689	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)NCc(cn3)nc(c34)c(N)nc(n4)N
12416	sp|P9WGQ7|Y1144_MY	P0CG22	98.4	31.0	277.0	DB07765	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)N(C)Cc(cn3)nc(c34)c(N)nc(n4)N
12417	sp|P9WGQ7|Y1144_MY	Q7Z4W1	94.0	6.0	241.0	DB02831	experimental	Dihydrogenphosphate	OP([O-])(=O)O
12418	sp|P9WGQ7|Y1144_MY	Q7Z4W1	94.0	6.0	241.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12420	sp|P9WGQ7|Y1144_MY	Q8I814	104.0	13.0	273.0	DB02015	experimental	Dihydrofolic Acid	O=c1[nH]c(N)nc(c12)NCC(=N2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
12421	sp|P9WGQ7|Y1144_MY	Q8I814	104.0	13.0	273.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12422	sp|P9WGQ7|Y1144_MY	Q16698	97.6	58.0	302.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12423	sp|P9WGQ7|Y1144_MY	Q16698	97.6	58.0	302.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
12424	sp|P9WGQ7|Y1144_MY	Q01782	110.8	8.0	285.0	DB02338	experimental	NADPH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12425	sp|P9WGQ7|Y1144_MY	Q01782	110.8	8.0	285.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
12426	sp|P9WGQ7|Y1144_MY	Q01782	110.8	8.0	285.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12427	sp|P9WGQ7|Y1144_MY	Q01782	110.8	8.0	285.0	DB04400	experimental	L-erythro-7,8-dihydrobiopterin	C[C@H](O)[C@H](O)C(CN1)=Nc(c12)c(=O)nc([nH]2)N
12428	sp|P9WGQ7|Y1144_MY	Q6UWP2	93.6	10.0	244.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12429	sp|P9WGQ7|Y1144_MY	P0AEK4	99.6	5.0	254.0	DB01691	experimental	Indole Naphthyridinone	c1cccc(c12)n(C)cc2CN(C)C(=O)/C=C/c(c3)cnc(c34)NC(=O)CC4
12430	sp|P9WGQ7|Y1144_MY	P0AEK4	99.6	5.0	254.0	DB01865	experimental	3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide	c1cccc(c12)cc(n2C)CN(C)C(=O)/C=C/c3cnc(N)cc3
12431	sp|P9WGQ7|Y1144_MY	P0AEK4	99.6	5.0	254.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
12432	sp|P9WGQ7|Y1144_MY	P0AEK4	99.6	5.0	254.0	DB03030	experimental	4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole	Cc1ccc(cc1)Cn2cnc(c2)-c3cccs3
12433	sp|P9WGQ7|Y1144_MY	P0AEK4	99.6	5.0	254.0	DB03534	experimental	3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide	CC(=O)N(C)Cc1c(N)ccc(c1)C(=O)N(C)Cc(n2C)cc(c23)cccc3
12434	sp|P9WGQ7|Y1144_MY	P0AEK4	99.6	5.0	254.0	DB04030	experimental	1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole	Oc1ccc(cc1)Cn2c(c3c(c24)cccc4)CN(CC3)C(=O)c5ccc(O)cc5
12435	sp|P9WGQ7|Y1144_MY	P0AEK4	99.6	5.0	254.0	DB08265	experimental	2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL	Cc1ccc(cc1)S(=O)(=O)n(b2O)ncc(c23)cccc3
12436	sp|P9WGQ7|Y1144_MY	P0AEK4	99.6	5.0	254.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
12437	sp|P9WGQ7|Y1144_MY	P0AEK4	99.6	5.0	254.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
12438	sp|P9WGQ7|Y1144_MY	A0A348A0U3	99.2	5.0	253.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
12439	sp|P9WGQ7|Y1144_MY	Q6GI75	94.0	17.0	252.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
12440	sp|P9WGQ7|Y1144_MY	Q6GI75	94.0	17.0	252.0	DB11155	approved	Triclocarban	Clc1ccc(cc1)NC(=O)Nc2cc(Cl)c(Cl)cc2
12441	sp|P9WGQ7|Y1144_MY	Q7AUG5	96.8	3.0	245.0	DB04782	experimental	(S)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@H]2CO2
12442	sp|P9WGQ7|Y1144_MY	Q93D82	96.8	3.0	245.0	DB04472	experimental	(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol	[N-]=[N+]=NC[C@H](O)c1ccc([N+]([O-])=O)cc1
12443	sp|P9WGQ7|Y1144_MY	Q93D82	96.8	3.0	245.0	DB04499	experimental	(R)-styrene oxide	C1O[C@@H]1c2ccccc2
12444	sp|P9WGQ7|Y1144_MY	Q93D82	96.8	3.0	245.0	DB04777	experimental	(R)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@@H]2CO2
12445	sp|P9WGQ7|Y1144_MY	Q6PKH6	72.0	29.0	209.0	DB04200	experimental	Matairesinol	COc1cc(ccc1O)C[C@H]2COC(=O)[C@@H]2Cc3ccc(O)c(c3)OC
12446	sp|P9WGQ7|Y1144_MY	Q8NBQ5	78.8	34.0	231.0	DB02854	experimental	Aetiocholanolone	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](CC3)C[C@H](O)CC4
12447	sp|P9WGQ7|Y1144_MY	Q9NYR8	77.2	6.0	199.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
12448	sp|P9WGQ7|Y1144_MY	O24990	98.4	5.0	251.0	DB04393	experimental	Soneclosan	Clc1cc(O)c(cc1)Oc2ccc(Cl)cc2
12449	sp|P9WGQ7|Y1144_MY	O24990	98.4	5.0	251.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
12450	sp|P9WGQ7|Y1144_MY	P14061	80.8	4.0	206.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
12451	sp|P9WGQ7|Y1144_MY	P14061	80.8	4.0	206.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
12452	sp|P9WGQ7|Y1144_MY	P14061	80.8	4.0	206.0	DB01561	experimental; illicit	Androstanedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
12453	sp|P9WGQ7|Y1144_MY	P14061	80.8	4.0	206.0	DB02187	experimental	Equilin	O=C1CC[C@H]([C@@]12C)C=3[C@H](CC2)c4c(CC3)cc(O)cc4
12454	sp|P9WGQ7|Y1144_MY	P14061	80.8	4.0	206.0	DB02323	experimental	EM-1745	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)C[C@@H]([C@@H]4O)CCCCCCCCC(=O)OC[C@H]5O[C@H]([C@H](O)[C@@H]5O)n6cnc(c67)c(N)ncn7
12455	sp|P9WGQ7|Y1144_MY	P14061	80.8	4.0	206.0	DB02901	illicit; investigational	Stanolone	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
12456	sp|P9WGQ7|Y1144_MY	P14061	80.8	4.0	206.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12457	sp|P9WGQ7|Y1144_MY	P14061	80.8	4.0	206.0	DB13951	experimental	Stanolone acetate	CC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
12458	sp|P9WGQ7|Y1144_MY	Q8TC12	80.8	40.0	242.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
12459	sp|P9WGQ7|Y1144_MY	Q02338	84.0	55.0	265.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
12460	sp|P9WGQ7|Y1144_MY	P37059	81.2	80.0	283.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
12461	sp|P9WGQ7|Y1144_MY	P37059	81.2	80.0	283.0	DB13952	approved; investigational; vet_approved	Estradiol acetate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)C
12462	sp|P9WGQ7|Y1144_MY	P37059	81.2	80.0	283.0	DB13953	approved; investigational; vet_approved	Estradiol benzoate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)c5ccccc5
12463	sp|P9WGQ7|Y1144_MY	P37059	81.2	80.0	283.0	DB13954	approved; investigational; vet_approved	Estradiol cypionate	C1CCCC1CCC(=O)O[C@H]2CC[C@H]([C@@]23C)[C@H]4[C@H](CC3)c5c(CC4)cc(O)cc5
12464	sp|P9WGQ7|Y1144_MY	P37059	81.2	80.0	283.0	DB13955	approved; investigational; vet_approved	Estradiol dienanthate	CCCCCCC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)CCCCCC
12465	sp|P9WGQ7|Y1144_MY	P37059	81.2	80.0	283.0	DB13956	approved; investigational; vet_approved	Estradiol valerate	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)CC[C@@H]4OC(=O)CCCC
12466	sp|P9WGQ7|Y1144_MY	Q8NBN7	81.6	37.0	241.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
12467	sp|P9WGQ7|Y1144_MY	Q92781	80.0	28.0	228.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
12468	sp|P9WGQ7|Y1144_MY	Q92781	80.0	28.0	228.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
12469	sp|P9WGQ7|Y1144_MY	P80365	79.2	82.0	280.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
12470	sp|P9WGQ7|Y1144_MY	P80365	79.2	82.0	280.0	DB01185	approved; illicit	Fluoxymesterone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@](F)([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
12471	sp|P9WGQ7|Y1144_MY	P80365	79.2	82.0	280.0	DB01569	experimental; illicit	Formebolone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@H]([C@@H](C2)O)[C@]4(C)C(CC3)=CC(=O)C(C=O)=C4
12472	sp|P9WGQ7|Y1144_MY	P80365	79.2	82.0	280.0	DB14538	experimental; vet_approved	Hydrocortisone aceponate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CC)C(=O)COC(=O)C
12473	sp|P9WGQ7|Y1144_MY	P80365	79.2	82.0	280.0	DB14539	approved; vet_approved	Hydrocortisone acetate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)C
12474	sp|P9WGQ7|Y1144_MY	P80365	79.2	82.0	280.0	DB14540	approved; vet_approved	Hydrocortisone butyrate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCC
12475	sp|P9WGQ7|Y1144_MY	P80365	79.2	82.0	280.0	DB14541	approved; investigational; vet_approved	Hydrocortisone cypionate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)CCC5CCCC5
12476	sp|P9WGQ7|Y1144_MY	P80365	79.2	82.0	280.0	DB14542	approved; vet_approved	Hydrocortisone phosphate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COP(=O)(O)O
12477	sp|P9WGQ7|Y1144_MY	P80365	79.2	82.0	280.0	DB14543	approved; vet_approved	Hydrocortisone probutate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CCC)C(=O)COC(=O)CC
12478	sp|P9WGQ7|Y1144_MY	P80365	79.2	82.0	280.0	DB14544	approved; vet_approved	Hydrocortisone valerate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCCC
12479	sp|P9WGQ7|Y1144_MY	P51659	81.2	8.0	211.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
12480	sp|P9WGQ7|Y1144_MY	P51659	81.2	8.0	211.0	DB03192	experimental	(R)-3-hydroxydecanoyl-CoA	CCCCCCC[C@@H](O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
12481	sp|P9WGQ7|Y1144_MY	Q96NR8	80.8	38.0	240.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
12482	sp|P9WGQ7|Y1144_MY	P37058	80.0	47.0	247.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
12483	sp|P9WGQ7|Y1144_MY	O75911	88.4	40.0	261.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
12484	sp|P9WGQ7|Y1144_MY	Q9HBH5	103.6	42.0	301.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
12485	sp|P9WGQ7|Y1144_MY	P9WGR1	103.2	6.0	264.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
12486	sp|P9WGQ7|Y1144_MY	P9WGR1	103.2	6.0	264.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
12487	sp|P9WGQ7|Y1144_MY	P9WGR1	103.2	6.0	264.0	DB02990	experimental	S-(2-Acetamidoethyl) hexadecanethioate	CCCCCCCCCCCCCCCC(=O)SCCNC(=O)C
12488	sp|P9WGQ7|Y1144_MY	P9WGR1	103.2	6.0	264.0	DB04289	experimental	Genz-10850	[nH]1ccc(c12)cc(cc2)C(=O)N3CCN(CC3)C4c(cccc5)c5c(c46)cccc6
12489	sp|P9WGQ7|Y1144_MY	P9WGR1	103.2	6.0	264.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
12490	sp|P9WGQ7|Y1144_MY	P9WGR1	103.2	6.0	264.0	DB07090	experimental	(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cccc(c1C)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
12491	sp|P9WGQ7|Y1144_MY	P9WGR1	103.2	6.0	264.0	DB07123	experimental	N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE	Cc1ccc(cc1)C(=O)N2CCC(CC2)Cc3ccccc3
12492	sp|P9WGQ7|Y1144_MY	P9WGR1	103.2	6.0	264.0	DB07155	experimental	(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE	c1ccccc1NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
12493	sp|P9WGQ7|Y1144_MY	P9WGR1	103.2	6.0	264.0	DB07178	experimental	5-PENTYL-2-PHENOXYPHENOL	CCCCCc1cc(O)c(cc1)Oc2ccccc2
12494	sp|P9WGQ7|Y1144_MY	P9WGR1	103.2	6.0	264.0	DB07188	experimental	(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(cc(Cl)c1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
12495	sp|P9WGQ7|Y1144_MY	P9WGR1	103.2	6.0	264.0	DB07192	experimental	(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Brc1cc(ccc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
12496	sp|P9WGQ7|Y1144_MY	P9WGR1	103.2	6.0	264.0	DB07222	experimental	(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(c(C)cc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
12497	sp|P9WGQ7|Y1144_MY	P9WGR1	103.2	6.0	264.0	DB07287	experimental	2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL	c1cccnc1Cc2cc(O)c(cc2)Oc3ccc(Cl)cc3Cl
12498	sp|P9WGQ7|Y1144_MY	P9WGR1	103.2	6.0	264.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
12499	sp|P9WGQ7|Y1144_MY	P35270	99.6	8.0	257.0	DB02637	experimental	Oxaloacetate Ion	OC(=O)C(=O)CC([O-])=O
12500	sp|P9WGQ7|Y1144_MY	P35270	99.6	8.0	257.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12501	sp|P9WGQ7|Y1144_MY	P35270	99.6	8.0	257.0	DB03886	experimental	Biopterin	C[C@@H](O)[C@@H](O)c(n1)cnc(c12)nc(N)[nH]c2=O
12502	sp|P9WGQ7|Y1144_MY	P35270	99.6	8.0	257.0	DB04275	experimental	N-acetylserotonin	CC(=O)NCCc1c[nH]c(c12)ccc(c2)O
12503	sp|P9WGQ7|Y1144_MY	P28845	76.8	33.0	225.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
12504	sp|P9WGQ7|Y1144_MY	P28845	76.8	33.0	225.0	DB02329	experimental	Carbenoxolone	OC(=O)CCC(=O)O[C@@H](CC1)C(C)(C)[C@@H]([C@]12C)CC[C@]3(C)[C@@H]2C(=O)C=C4[C@H]5[C@@](C)(CC[C@@]34C)CC[C@](C5)(C)C(=O)O
12505	sp|P9WGQ7|Y1144_MY	P28845	76.8	33.0	225.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12506	sp|P9WGQ7|Y1144_MY	P28845	76.8	33.0	225.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
12507	sp|P9WGQ7|Y1144_MY	P28845	76.8	33.0	225.0	DB04652	experimental	Corticosterone	OCC(=O)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H]([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
12508	sp|P9WGQ7|Y1144_MY	P28845	76.8	33.0	225.0	DB05064	investigational	INCB13739	 
12509	sp|P9WGQ7|Y1144_MY	P28845	76.8	33.0	225.0	DB06992	experimental	(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone	Cc1ccc(cc1F)-c2nc(ccc2)C(=O)N(CC3(C)C)CCC3
12510	sp|P9WGQ7|Y1144_MY	P28845	76.8	33.0	225.0	DB07017	experimental	(5S)-2-{[(1S)-1-(4-Fluorophenyl)ethyl]amino}-5-(2-hydroxy-2-propanyl)-5-methyl-1,3-thiazol-4(5H)-one	Fc1ccc(cc1)[C@H](C)NC(=NC2=O)S[C@@]2(C)C(C)(C)O
12511	sp|P9WGQ7|Y1144_MY	P28845	76.8	33.0	225.0	DB07049	experimental	(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine	[O-][N+](=O)c1ccc(cc1)N2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)C(C)(C)C
12512	sp|P9WGQ7|Y1144_MY	P28845	76.8	33.0	225.0	DB07056	experimental	2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide	CCN(CC)C(=O)Cc1cccc(n1)NS(=O)(=O)c2c(C)c(Cl)ccc2
12513	sp|P9WGQ7|Y1144_MY	P28845	76.8	33.0	225.0	DB07310	experimental	(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one	Fc1ccccc1[C@H](C)NC(=NC2=O)S[C@]2(C)C(F)(F)F
12514	sp|P9WGQ7|Y1144_MY	P28845	76.8	33.0	225.0	DB07316	experimental	N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)C3CCN(CC3)CC4(CC4)C(=O)N
12515	sp|P9WGQ7|Y1144_MY	P28845	76.8	33.0	225.0	DB07619	experimental	N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)[C@H]3CC[C@@H](CC3)c4cccnc4
12516	sp|P9WGQ7|Y1144_MY	P28845	76.8	33.0	225.0	DB07624	experimental	1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide	C1CC1(C(=O)N)CN2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)[C@](C)(O)C(F)(F)F
12517	sp|P9WGQ7|Y1144_MY	P28845	76.8	33.0	225.0	DB07866	experimental	(5S)-2-(Cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one	CCC[C@]1(C)SC(=NC1=O)NC2CCCCCCC2
12518	sp|P9WGQ7|Y1144_MY	P28845	76.8	33.0	225.0	DB08277	experimental	2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE	CS(=O)(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4c(Cl)cc(F)cc4
12519	sp|P9WGQ7|Y1144_MY	P28845	76.8	33.0	225.0	DB08280	experimental	(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE	NC(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4ccc(OC)cc4
12520	sp|P9WGQ7|Y1144_MY	P28845	76.8	33.0	225.0	DB08771	experimental	(5R)-2-[(2-Fluorophenyl)amino]-5-isopropyl-1,3-thiazol-4(5H)-one	CC(C)[C@H]1SC(=NC1=O)Nc2c(F)cccc2
12521	sp|P9WGQ7|Y1144_MY	P28845	76.8	33.0	225.0	DB13751	approved; experimental	Glycyrrhizic acid	C1C[C@](C)(C(=O)O)C[C@H]([C@]12C)C=3[C@@](C)(CC2)[C@@]4(C)[C@H](C(=O)C3)[C@]5(C)[C@@H](CC4)C(C)(C)[C@H](CC5)O[C@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O[C@@H]7O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]7O
12522	sp|P9WGQ7|Y1144_MY	P56937	95.2	3.0	241.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
12523	sp|P9WGQ7|Y1144_MY	P16152	98.4	6.0	252.0	DB01698	approved; experimental; investigational	Rutin	O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O[C@H]1C)OC[C@H]2O[C@H]([C@H](O)[C@@H](O)[C@@H]2O)Oc(c3=O)c(-c4cc(O)c(O)cc4)oc(c35)cc(O)cc5O
12524	sp|P9WGQ7|Y1144_MY	P16152	98.4	6.0	252.0	DB02709	investigational	Resveratrol	Oc1ccc(cc1)/C=C/c2cc(O)cc(O)c2
12525	sp|P9WGQ7|Y1144_MY	P16152	98.4	6.0	252.0	DB03394	experimental	Heptaethylene glycol	OCCOCCOCCOCCOCCOCCOCCO
12526	sp|P9WGQ7|Y1144_MY	P16152	98.4	6.0	252.0	DB03556	experimental	2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400	CCOCCOCCOCCOCCOCCOCCOCCOCCO
12527	sp|P9WGQ7|Y1144_MY	P16152	98.4	6.0	252.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
12528	sp|P9WGQ7|Y1144_MY	P16152	98.4	6.0	252.0	DB04463	experimental	3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol	n1cnc(N)c(c12)c(nn2C(C)(C)C)-c3cccc(O)c3
12529	sp|P9WGQ7|Y1144_MY	P16152	98.4	6.0	252.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
12530	sp|P9WGQ7|Y1144_MY	P16152	98.4	6.0	252.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
12531	sp|P9WGQ7|Y1144_MY	P09417	74.4	11.0	197.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
12532	sp|P9WGQ7|Y1144_MY	P09417	74.4	11.0	197.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
12533	sp|P9WGQ7|Y1144_MY	P26391	76.4	3.0	194.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
12534	sp|P9WGQ7|Y1144_MY	Q8T8E9	77.2	3.0	196.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
12535	sp|O53379|Y3329_MY	Q9BYV1	99.36	47.0	510.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
12536	sp|O53379|Y3329_MY	Q9BYV1	99.36	47.0	510.0	DB00119	approved; investigational; nutraceutical	Pyruvic acid	CC(=O)C(=O)O
12537	sp|O53379|Y3329_MY	Q9BYV1	99.36	47.0	510.0	DB00145	approved; nutraceutical; vet_approved	Glycine	NCC(=O)O
12538	sp|O53379|Y3329_MY	Q9BYV1	99.36	47.0	510.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
12539	sp|O53379|Y3329_MY	Q8IUZ5	87.77	30.0	439.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
12540	sp|O53379|Y3329_MY	Q8IUZ5	87.77	30.0	439.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
12541	sp|O53379|Y3329_MY	P16932	88.63	7.0	420.0	DB02038	experimental	D-[3-hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl]-N,O-cycloserylamide	Cc1ncc(COP(=O)(O)O)c(c1O)CN[C@@H]2CONC2=O
12542	sp|O53379|Y3329_MY	P16932	88.63	7.0	420.0	DB02849	experimental	N-Pyridoxyl-1-Amino-Cyclopropanecarboxylic Acid-5-Monophosphate	Cc1ncc(COP(=O)(O)O)c(c1O)CNC2(CC2)C(=O)O
12543	sp|O53379|Y3329_MY	P16932	88.63	7.0	420.0	DB03787	experimental	(5-Hydroxy-6-methyl-4-{[(E)-(3-oxo-1,2-oxazolidin-4-ylidene)amino]methyl}-3-pyridinyl)methyl dihydrogen phosphate	Cc1ncc(COP(=O)(O)O)c(c1O)C/N=C2\CONC2=O
12544	sp|O53379|Y3329_MY	P16932	88.63	7.0	420.0	DB04241	experimental	N-Pyridoxyl-2-Methylalanine-5-Phosphate	Cc1ncc(COP(=O)(O)O)c(c1O)CNC(C)(C)C(=O)O
12545	sp|O53379|Y3329_MY	P04181	85.62	38.0	437.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
12546	sp|O53379|Y3329_MY	P04181	85.62	38.0	437.0	DB00129	approved; nutraceutical	Ornithine	NCCC[C@H](N)C(=O)O
12547	sp|O53379|Y3329_MY	P04181	85.62	38.0	437.0	DB02054	experimental	Gabaculine	Nc1cccc(c1)C(=O)O
12548	sp|O53379|Y3329_MY	P04181	85.62	38.0	437.0	DB02821	experimental	Canaline	NOCC[C@H](N)C(=O)O
12549	sp|O53379|Y3329_MY	P22256	87.12	11.0	417.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
12550	sp|O53379|Y3329_MY	P22256	87.12	11.0	417.0	DB02783	experimental	4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate	Cc1ncc(COP(=O)(O)O)c(c1O)CNOCC(=O)O
12551	sp|O53379|Y3329_MY	P12995	88.2	10.0	421.0	DB02274	experimental	7-Keto-8-Aminopelargonic Acid	C[C@H](N)C(=O)CCCCCC(=O)O
12552	sp|O53379|Y3329_MY	P12995	88.2	10.0	421.0	DB02725	experimental	2-Amino-4-(4-Amino-Cyclohexa-2,5-Dienyl)-Butyric Acid	OC(=O)[C@@H](N)CC[C@H]1C=CC(N)C=C1
12553	sp|O53379|Y3329_MY	P12995	88.2	10.0	421.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
12554	sp|O53379|Y3329_MY	Q6LFH8	83.05	19.0	406.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
12555	sp|O53379|Y3329_MY	P24630	78.11	38.0	402.0	DB02054	experimental	Gabaculine	Nc1cccc(c1)C(=O)O
12556	sp|O53379|Y3329_MY	P24630	78.11	38.0	402.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
12557	sp|O53379|Y3329_MY	P9WQ77	87.12	39.0	445.0	DB08071	experimental	(2S)-1-methyl-2-[(2S,4R)-2-methyl-4-phenylpentyl]piperidine	CN1CCCC[C@H]1C[C@@H](C)C[C@@H](C)c2ccccc2
12558	sp|O53379|Y3329_MY	P80404	90.13	78.0	498.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
12559	sp|O53379|Y3329_MY	P80404	90.13	78.0	498.0	DB00119	approved; investigational; nutraceutical	Pyruvic acid	CC(=O)C(=O)O
12560	sp|O53379|Y3329_MY	P80404	90.13	78.0	498.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
12561	sp|O53379|Y3329_MY	P80404	90.13	78.0	498.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
12562	sp|O53379|Y3329_MY	P80404	90.13	78.0	498.0	DB00780	approved	Phenelzine	NNCCc1ccccc1
12563	sp|O53379|Y3329_MY	P80404	90.13	78.0	498.0	DB01080	approved	Vigabatrin	C=CC(N)CCC(=O)O
12564	sp|O53379|Y3329_MY	P80404	90.13	78.0	498.0	DB01699	experimental	(4e)-4-Aminohex-4-Enoic Acid	C/C=C(/N)CCC(=O)O
12565	sp|O53379|Y3329_MY	P80404	90.13	78.0	498.0	DB04235	experimental	4-Amino Hexanoic Acid	CC[C@@H](N)CCC(=O)O
12566	sp|P9WGQ9|Y769_MYC	Q9BTZ2	98.39	30.0	274.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
12567	sp|P9WGQ9|Y769_MYC	Q9WYS2	99.19	7.0	253.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12569	sp|P9WGQ9|Y769_MYC	P0AEK2	96.37	3.0	242.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12570	sp|P9WGQ9|Y769_MYC	P0AET8	97.18	9.0	250.0	DB02123	experimental	Glycochenodeoxycholic Acid	OC(=O)CNC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
12573	sp|P9WGQ9|Y769_MYC	Q92506	100.4	10.0	259.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
12574	sp|P9WGQ9|Y769_MYC	Q92506	100.4	10.0	259.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12575	sp|P9WGQ9|Y769_MYC	P16544	102.02	5.0	258.0	DB01942	experimental; investigational	Formic acid	OC=O
12576	sp|P9WGQ9|Y769_MYC	P16544	102.02	5.0	258.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12577	sp|P9WGQ9|Y769_MYC	P16544	102.02	5.0	258.0	DB07715	investigational	Emodin	Cc(c1)cc(O)c(c12)C(=O)c3c(C2=O)cc(O)cc3O
12578	sp|P9WGQ9|Y769_MYC	Q84EX5	98.79	5.0	250.0	DB04619	experimental	Acetophenone	CC(=O)c1ccccc1
12579	sp|P9WGQ9|Y769_MYC	Q84EX5	98.79	5.0	250.0	DB04784	experimental	(R)-1-phenylethanol	C[C@@H](O)c1ccccc1
12580	sp|P9WGQ9|Y769_MYC	Q9BY49	101.21	16.0	267.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
12581	sp|P9WGQ9|Y769_MYC	P0CG22	99.6	30.0	277.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
12582	sp|P9WGQ9|Y769_MYC	P0CG22	99.6	30.0	277.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12583	sp|P9WGQ9|Y769_MYC	P0CG22	99.6	30.0	277.0	DB03541	experimental	10-Propargyl-5,8-Dideazafolic Acid	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(CC#C)Cc(c2)ccc(c23)[nH]c(N)nc3=O
12584	sp|P9WGQ9|Y769_MYC	P0CG22	99.6	30.0	277.0	DB07689	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)NCc(cn3)nc(c34)c(N)nc(n4)N
12585	sp|P9WGQ9|Y769_MYC	P0CG22	99.6	30.0	277.0	DB07765	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)N(C)Cc(cn3)nc(c34)c(N)nc(n4)N
12586	sp|P9WGQ9|Y769_MYC	Q7Z4W1	95.16	5.0	241.0	DB02831	experimental	Dihydrogenphosphate	OP([O-])(=O)O
12587	sp|P9WGQ9|Y769_MYC	Q7Z4W1	95.16	5.0	241.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12588	sp|P9WGQ9|Y769_MYC	Q16698	99.6	57.0	304.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12589	sp|P9WGQ9|Y769_MYC	Q16698	99.6	57.0	304.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
12590	sp|P9WGQ9|Y769_MYC	A0A348A0U3	100.81	4.0	254.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
12591	sp|P9WGQ9|Y769_MYC	P0AEK4	100.4	4.0	253.0	DB01691	experimental	Indole Naphthyridinone	c1cccc(c12)n(C)cc2CN(C)C(=O)/C=C/c(c3)cnc(c34)NC(=O)CC4
12592	sp|P9WGQ9|Y769_MYC	P0AEK4	100.4	4.0	253.0	DB01865	experimental	3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide	c1cccc(c12)cc(n2C)CN(C)C(=O)/C=C/c3cnc(N)cc3
12593	sp|P9WGQ9|Y769_MYC	P0AEK4	100.4	4.0	253.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
12594	sp|P9WGQ9|Y769_MYC	P0AEK4	100.4	4.0	253.0	DB03030	experimental	4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole	Cc1ccc(cc1)Cn2cnc(c2)-c3cccs3
12595	sp|P9WGQ9|Y769_MYC	P0AEK4	100.4	4.0	253.0	DB03534	experimental	3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide	CC(=O)N(C)Cc1c(N)ccc(c1)C(=O)N(C)Cc(n2C)cc(c23)cccc3
12596	sp|P9WGQ9|Y769_MYC	P0AEK4	100.4	4.0	253.0	DB04030	experimental	1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole	Oc1ccc(cc1)Cn2c(c3c(c24)cccc4)CN(CC3)C(=O)c5ccc(O)cc5
12597	sp|P9WGQ9|Y769_MYC	P0AEK4	100.4	4.0	253.0	DB08265	experimental	2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL	Cc1ccc(cc1)S(=O)(=O)n(b2O)ncc(c23)cccc3
12598	sp|P9WGQ9|Y769_MYC	P0AEK4	100.4	4.0	253.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
12599	sp|P9WGQ9|Y769_MYC	P0AEK4	100.4	4.0	253.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
12600	sp|P9WGQ9|Y769_MYC	Q6GI75	100.4	4.0	253.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
12601	sp|P9WGQ9|Y769_MYC	Q6GI75	100.4	4.0	253.0	DB11155	approved	Triclocarban	Clc1ccc(cc1)NC(=O)Nc2cc(Cl)c(Cl)cc2
12602	sp|P9WGQ9|Y769_MYC	Q6UWP2	95.97	11.0	249.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12603	sp|P9WGQ9|Y769_MYC	Q99714	100.4	9.0	258.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
12604	sp|P9WGQ9|Y769_MYC	Q99714	100.4	9.0	258.0	DB02820	experimental	1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct	C1CCCCCN1C(=O)[C@H](c2ccccc2)n(c3=S)cnc(c34)nn(c4)[C@H]5C=CN(C=C5C([O-])=N)[C@@H]6O[C@@H]([C@@H](O)[C@H]6O)COP([O-])(=O)OP(=O)(O)OC[C@H]7O[C@H]([C@H]([O-])[C@@H]7[O-])n8cnc(c89)c(N)ncn9
12605	sp|P9WGQ9|Y769_MYC	Q99714	100.4	9.0	258.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
12607	sp|P9WGQ9|Y769_MYC	Q9HBH5	105.65	41.0	303.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
12608	sp|P9WGQ9|Y769_MYC	O24990	100.0	4.0	252.0	DB04393	experimental	Soneclosan	Clc1cc(O)c(cc1)Oc2ccc(Cl)cc2
12609	sp|P9WGQ9|Y769_MYC	O24990	100.0	4.0	252.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
12610	sp|P9WGQ9|Y769_MYC	Q6PKH6	73.39	28.0	210.0	DB04200	experimental	Matairesinol	COc1cc(ccc1O)C[C@H]2COC(=O)[C@@H]2Cc3ccc(O)c(c3)OC
12611	sp|P9WGQ9|Y769_MYC	P51659	95.56	7.0	244.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
12612	sp|P9WGQ9|Y769_MYC	P51659	95.56	7.0	244.0	DB03192	experimental	(R)-3-hydroxydecanoyl-CoA	CCCCCCC[C@@H](O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
12613	sp|P9WGQ9|Y769_MYC	Q7AUG5	97.18	3.0	244.0	DB04782	experimental	(S)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@H]2CO2
12614	sp|P9WGQ9|Y769_MYC	Q93D82	97.18	3.0	244.0	DB04472	experimental	(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol	[N-]=[N+]=NC[C@H](O)c1ccc([N+]([O-])=O)cc1
12615	sp|P9WGQ9|Y769_MYC	Q93D82	97.18	3.0	244.0	DB04499	experimental	(R)-styrene oxide	C1O[C@@H]1c2ccccc2
12616	sp|P9WGQ9|Y769_MYC	Q93D82	97.18	3.0	244.0	DB04777	experimental	(R)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@@H]2CO2
12617	sp|P9WGQ9|Y769_MYC	Q8NBN7	82.66	37.0	242.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
12618	sp|P9WGQ9|Y769_MYC	Q8I814	104.44	14.0	273.0	DB02015	experimental	Dihydrofolic Acid	O=c1[nH]c(N)nc(c12)NCC(=N2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
12619	sp|P9WGQ9|Y769_MYC	Q8I814	104.44	14.0	273.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12620	sp|P9WGQ9|Y769_MYC	Q8TC12	82.26	39.0	243.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
12621	sp|P9WGQ9|Y769_MYC	Q01782	111.69	8.0	285.0	DB02338	experimental	NADPH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12622	sp|P9WGQ9|Y769_MYC	Q01782	111.69	8.0	285.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
12623	sp|P9WGQ9|Y769_MYC	Q01782	111.69	8.0	285.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12624	sp|P9WGQ9|Y769_MYC	Q01782	111.69	8.0	285.0	DB04400	experimental	L-erythro-7,8-dihydrobiopterin	C[C@H](O)[C@H](O)C(CN1)=Nc(c12)c(=O)nc([nH]2)N
12625	sp|P9WGQ9|Y769_MYC	Q8NBQ5	77.82	35.0	228.0	DB02854	experimental	Aetiocholanolone	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](CC3)C[C@H](O)CC4
12626	sp|P9WGQ9|Y769_MYC	O75911	90.73	38.0	263.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
12627	sp|P9WGQ9|Y769_MYC	Q96NR8	82.26	37.0	241.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
12628	sp|P9WGQ9|Y769_MYC	P14061	81.85	4.0	207.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
12629	sp|P9WGQ9|Y769_MYC	P14061	81.85	4.0	207.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
12630	sp|P9WGQ9|Y769_MYC	P14061	81.85	4.0	207.0	DB01561	experimental; illicit	Androstanedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
12631	sp|P9WGQ9|Y769_MYC	P14061	81.85	4.0	207.0	DB02187	experimental	Equilin	O=C1CC[C@H]([C@@]12C)C=3[C@H](CC2)c4c(CC3)cc(O)cc4
12632	sp|P9WGQ9|Y769_MYC	P14061	81.85	4.0	207.0	DB02323	experimental	EM-1745	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)C[C@@H]([C@@H]4O)CCCCCCCCC(=O)OC[C@H]5O[C@H]([C@H](O)[C@@H]5O)n6cnc(c67)c(N)ncn7
12633	sp|P9WGQ9|Y769_MYC	P14061	81.85	4.0	207.0	DB02901	illicit; investigational	Stanolone	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
12634	sp|P9WGQ9|Y769_MYC	P14061	81.85	4.0	207.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12635	sp|P9WGQ9|Y769_MYC	P14061	81.85	4.0	207.0	DB13951	experimental	Stanolone acetate	CC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
12636	sp|P9WGQ9|Y769_MYC	Q9NYR8	76.61	6.0	196.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
12637	sp|P9WGQ9|Y769_MYC	Q02338	84.68	55.0	265.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
12638	sp|P9WGQ9|Y769_MYC	P9WGR1	104.84	5.0	265.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
12639	sp|P9WGQ9|Y769_MYC	P9WGR1	104.84	5.0	265.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
12640	sp|P9WGQ9|Y769_MYC	P9WGR1	104.84	5.0	265.0	DB02990	experimental	S-(2-Acetamidoethyl) hexadecanethioate	CCCCCCCCCCCCCCCC(=O)SCCNC(=O)C
12641	sp|P9WGQ9|Y769_MYC	P9WGR1	104.84	5.0	265.0	DB04289	experimental	Genz-10850	[nH]1ccc(c12)cc(cc2)C(=O)N3CCN(CC3)C4c(cccc5)c5c(c46)cccc6
12642	sp|P9WGQ9|Y769_MYC	P9WGR1	104.84	5.0	265.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
12643	sp|P9WGQ9|Y769_MYC	P9WGR1	104.84	5.0	265.0	DB07090	experimental	(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cccc(c1C)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
12644	sp|P9WGQ9|Y769_MYC	P9WGR1	104.84	5.0	265.0	DB07123	experimental	N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE	Cc1ccc(cc1)C(=O)N2CCC(CC2)Cc3ccccc3
12645	sp|P9WGQ9|Y769_MYC	P9WGR1	104.84	5.0	265.0	DB07155	experimental	(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE	c1ccccc1NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
12646	sp|P9WGQ9|Y769_MYC	P9WGR1	104.84	5.0	265.0	DB07178	experimental	5-PENTYL-2-PHENOXYPHENOL	CCCCCc1cc(O)c(cc1)Oc2ccccc2
12647	sp|P9WGQ9|Y769_MYC	P9WGR1	104.84	5.0	265.0	DB07188	experimental	(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(cc(Cl)c1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
12648	sp|P9WGQ9|Y769_MYC	P9WGR1	104.84	5.0	265.0	DB07192	experimental	(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Brc1cc(ccc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
12649	sp|P9WGQ9|Y769_MYC	P9WGR1	104.84	5.0	265.0	DB07222	experimental	(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(c(C)cc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
12650	sp|P9WGQ9|Y769_MYC	P9WGR1	104.84	5.0	265.0	DB07287	experimental	2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL	c1cccnc1Cc2cc(O)c(cc2)Oc3ccc(Cl)cc3Cl
12651	sp|P9WGQ9|Y769_MYC	P9WGR1	104.84	5.0	265.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
12652	sp|P9WGQ9|Y769_MYC	P28845	79.03	31.0	227.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
12653	sp|P9WGQ9|Y769_MYC	P28845	79.03	31.0	227.0	DB02329	experimental	Carbenoxolone	OC(=O)CCC(=O)O[C@@H](CC1)C(C)(C)[C@@H]([C@]12C)CC[C@]3(C)[C@@H]2C(=O)C=C4[C@H]5[C@@](C)(CC[C@@]34C)CC[C@](C5)(C)C(=O)O
12654	sp|P9WGQ9|Y769_MYC	P28845	79.03	31.0	227.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12655	sp|P9WGQ9|Y769_MYC	P28845	79.03	31.0	227.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
12656	sp|P9WGQ9|Y769_MYC	P28845	79.03	31.0	227.0	DB04652	experimental	Corticosterone	OCC(=O)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H]([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
12657	sp|P9WGQ9|Y769_MYC	P28845	79.03	31.0	227.0	DB05064	investigational	INCB13739	 
12658	sp|P9WGQ9|Y769_MYC	P28845	79.03	31.0	227.0	DB06992	experimental	(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone	Cc1ccc(cc1F)-c2nc(ccc2)C(=O)N(CC3(C)C)CCC3
12659	sp|P9WGQ9|Y769_MYC	P28845	79.03	31.0	227.0	DB07017	experimental	(5S)-2-{[(1S)-1-(4-Fluorophenyl)ethyl]amino}-5-(2-hydroxy-2-propanyl)-5-methyl-1,3-thiazol-4(5H)-one	Fc1ccc(cc1)[C@H](C)NC(=NC2=O)S[C@@]2(C)C(C)(C)O
12660	sp|P9WGQ9|Y769_MYC	P28845	79.03	31.0	227.0	DB07049	experimental	(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine	[O-][N+](=O)c1ccc(cc1)N2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)C(C)(C)C
12661	sp|P9WGQ9|Y769_MYC	P28845	79.03	31.0	227.0	DB07056	experimental	2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide	CCN(CC)C(=O)Cc1cccc(n1)NS(=O)(=O)c2c(C)c(Cl)ccc2
12662	sp|P9WGQ9|Y769_MYC	P28845	79.03	31.0	227.0	DB07310	experimental	(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one	Fc1ccccc1[C@H](C)NC(=NC2=O)S[C@]2(C)C(F)(F)F
12663	sp|P9WGQ9|Y769_MYC	P28845	79.03	31.0	227.0	DB07316	experimental	N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)C3CCN(CC3)CC4(CC4)C(=O)N
12664	sp|P9WGQ9|Y769_MYC	P28845	79.03	31.0	227.0	DB07619	experimental	N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)[C@H]3CC[C@@H](CC3)c4cccnc4
12665	sp|P9WGQ9|Y769_MYC	P28845	79.03	31.0	227.0	DB07624	experimental	1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide	C1CC1(C(=O)N)CN2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)[C@](C)(O)C(F)(F)F
12666	sp|P9WGQ9|Y769_MYC	P28845	79.03	31.0	227.0	DB07866	experimental	(5S)-2-(Cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one	CCC[C@]1(C)SC(=NC1=O)NC2CCCCCCC2
12667	sp|P9WGQ9|Y769_MYC	P28845	79.03	31.0	227.0	DB08277	experimental	2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE	CS(=O)(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4c(Cl)cc(F)cc4
12668	sp|P9WGQ9|Y769_MYC	P28845	79.03	31.0	227.0	DB08280	experimental	(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE	NC(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4ccc(OC)cc4
12669	sp|P9WGQ9|Y769_MYC	P28845	79.03	31.0	227.0	DB08771	experimental	(5R)-2-[(2-Fluorophenyl)amino]-5-isopropyl-1,3-thiazol-4(5H)-one	CC(C)[C@H]1SC(=NC1=O)Nc2c(F)cccc2
12670	sp|P9WGQ9|Y769_MYC	P28845	79.03	31.0	227.0	DB13751	approved; experimental	Glycyrrhizic acid	C1C[C@](C)(C(=O)O)C[C@H]([C@]12C)C=3[C@@](C)(CC2)[C@@]4(C)[C@H](C(=O)C3)[C@]5(C)[C@@H](CC4)C(C)(C)[C@H](CC5)O[C@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O[C@@H]7O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]7O
12671	sp|P9WGQ9|Y769_MYC	P37058	81.45	48.0	250.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
12672	sp|P9WGQ9|Y769_MYC	P37059	83.87	81.0	289.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
12673	sp|P9WGQ9|Y769_MYC	P37059	83.87	81.0	289.0	DB13952	approved; investigational; vet_approved	Estradiol acetate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)C
12674	sp|P9WGQ9|Y769_MYC	P37059	83.87	81.0	289.0	DB13953	approved; investigational; vet_approved	Estradiol benzoate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)c5ccccc5
12675	sp|P9WGQ9|Y769_MYC	P37059	83.87	81.0	289.0	DB13954	approved; investigational; vet_approved	Estradiol cypionate	C1CCCC1CCC(=O)O[C@H]2CC[C@H]([C@@]23C)[C@H]4[C@H](CC3)c5c(CC4)cc(O)cc5
12676	sp|P9WGQ9|Y769_MYC	P37059	83.87	81.0	289.0	DB13955	approved; investigational; vet_approved	Estradiol dienanthate	CCCCCCC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)CCCCCC
12677	sp|P9WGQ9|Y769_MYC	P37059	83.87	81.0	289.0	DB13956	approved; investigational; vet_approved	Estradiol valerate	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)CC[C@@H]4OC(=O)CCCC
12678	sp|P9WGQ9|Y769_MYC	Q92781	81.05	29.0	230.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
12679	sp|P9WGQ9|Y769_MYC	Q92781	81.05	29.0	230.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
12680	sp|P9WGQ9|Y769_MYC	P80365	80.65	82.0	282.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
12681	sp|P9WGQ9|Y769_MYC	P80365	80.65	82.0	282.0	DB01185	approved; illicit	Fluoxymesterone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@](F)([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
12682	sp|P9WGQ9|Y769_MYC	P80365	80.65	82.0	282.0	DB01569	experimental; illicit	Formebolone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@H]([C@@H](C2)O)[C@]4(C)C(CC3)=CC(=O)C(C=O)=C4
12683	sp|P9WGQ9|Y769_MYC	P80365	80.65	82.0	282.0	DB14538	experimental; vet_approved	Hydrocortisone aceponate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CC)C(=O)COC(=O)C
12684	sp|P9WGQ9|Y769_MYC	P80365	80.65	82.0	282.0	DB14539	approved; vet_approved	Hydrocortisone acetate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)C
12685	sp|P9WGQ9|Y769_MYC	P80365	80.65	82.0	282.0	DB14540	approved; vet_approved	Hydrocortisone butyrate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCC
12686	sp|P9WGQ9|Y769_MYC	P80365	80.65	82.0	282.0	DB14541	approved; investigational; vet_approved	Hydrocortisone cypionate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)CCC5CCCC5
12687	sp|P9WGQ9|Y769_MYC	P80365	80.65	82.0	282.0	DB14542	approved; vet_approved	Hydrocortisone phosphate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COP(=O)(O)O
12688	sp|P9WGQ9|Y769_MYC	P80365	80.65	82.0	282.0	DB14543	approved; vet_approved	Hydrocortisone probutate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CCC)C(=O)COC(=O)CC
12689	sp|P9WGQ9|Y769_MYC	P80365	80.65	82.0	282.0	DB14544	approved; vet_approved	Hydrocortisone valerate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCCC
12690	sp|P9WGQ9|Y769_MYC	P16152	97.18	7.0	248.0	DB01698	approved; experimental; investigational	Rutin	O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O[C@H]1C)OC[C@H]2O[C@H]([C@H](O)[C@@H](O)[C@@H]2O)Oc(c3=O)c(-c4cc(O)c(O)cc4)oc(c35)cc(O)cc5O
12691	sp|P9WGQ9|Y769_MYC	P16152	97.18	7.0	248.0	DB02709	investigational	Resveratrol	Oc1ccc(cc1)/C=C/c2cc(O)cc(O)c2
12692	sp|P9WGQ9|Y769_MYC	P16152	97.18	7.0	248.0	DB03394	experimental	Heptaethylene glycol	OCCOCCOCCOCCOCCOCCOCCO
12693	sp|P9WGQ9|Y769_MYC	P16152	97.18	7.0	248.0	DB03556	experimental	2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400	CCOCCOCCOCCOCCOCCOCCOCCOCCO
12694	sp|P9WGQ9|Y769_MYC	P16152	97.18	7.0	248.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
12695	sp|P9WGQ9|Y769_MYC	P16152	97.18	7.0	248.0	DB04463	experimental	3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol	n1cnc(N)c(c12)c(nn2C(C)(C)C)-c3cccc(O)c3
12696	sp|P9WGQ9|Y769_MYC	P16152	97.18	7.0	248.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
12697	sp|P9WGQ9|Y769_MYC	P16152	97.18	7.0	248.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
12698	sp|P9WGQ9|Y769_MYC	P56937	94.35	3.0	237.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
12699	sp|P9WGQ9|Y769_MYC	P35270	94.76	8.0	243.0	DB02637	experimental	Oxaloacetate Ion	OC(=O)C(=O)CC([O-])=O
12700	sp|P9WGQ9|Y769_MYC	P35270	94.76	8.0	243.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
12701	sp|P9WGQ9|Y769_MYC	P35270	94.76	8.0	243.0	DB03886	experimental	Biopterin	C[C@@H](O)[C@@H](O)c(n1)cnc(c12)nc(N)[nH]c2=O
12702	sp|P9WGQ9|Y769_MYC	P35270	94.76	8.0	243.0	DB04275	experimental	N-acetylserotonin	CC(=O)NCCc1c[nH]c(c12)ccc(c2)O
12703	sp|P9WGQ9|Y769_MYC	Q8T8E9	78.63	2.0	197.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
12704	sp|P9WGQ9|Y769_MYC	P09417	77.02	11.0	202.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
12705	sp|P9WGQ9|Y769_MYC	P09417	77.02	11.0	202.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
12706	sp|P9WGQ9|Y769_MYC	P26391	77.02	3.0	194.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
12707	sp|P9WGQ9|Y769_MYC	P14169	71.37	3.0	180.0	DB04555	experimental	Cytidine-5'-Diphosphate	Nc1nc(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O
12708	sp|P9WGQ9|Y769_MYC	P95780	70.56	4.0	179.0	DB03161	experimental	Thymidine-5'-diphospho-beta-D-xylose	O=c1[nH]c(=O)c(C)cn1[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3OC[C@@H](O)[C@H](O)[C@H]3O
12709	sp|P9WGQ9|Y769_MYC	P95780	70.56	4.0	179.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
12710	sp|P9WPX9|AROB_MYC	Q6GGU4	87.02	11.0	326.0	DB02592	experimental	Carbaphosphonate	OC(=O)[C@@]1(O)C[C@@H](O)[C@H](O)[C@H](C1)CP(=O)(O)O
12711	sp|P95231|CYSE_MYC	P43886	77.73	74.0	252.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
12712	sp|P95231|CYSE_MYC	A0A384KMH6	77.73	77.0	255.0	DB02078	experimental	Triglyme	COCCOCCOCCOC
12713	sp|P9WPB3|CMAS3_MY	P9WPB3	99.65	1.0	287.0	DB01752	experimental	S-adenosyl-L-homocysteine	OC(=O)[C@@H](N)CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
12714	sp|P9WPB3|CMAS3_MY	P9WPB7	98.95	3.0	287.0	DB01718	approved	Cetrimonium	CCCCCCCCCCCCCCCC[N+](C)(C)C
12715	sp|P9WPB3|CMAS3_MY	Q79FX6	99.65	1.0	287.0	DB01718	approved	Cetrimonium	CCCCCCCCCCCCCCCC[N+](C)(C)C
12716	sp|P9WPB3|CMAS3_MY	Q79FX6	99.65	1.0	287.0	DB01752	experimental	S-adenosyl-L-homocysteine	OC(=O)[C@@H](N)CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
12717	sp|P9WPB3|CMAS3_MY	Q79FX8	98.95	12.0	296.0	DB07413	experimental	5'-S-[2-(decylamino)ethyl]-5'-thioadenosine	n1cnc(N)c(c12)ncn2[C@H]3[C@H](O)[C@H](O)[C@H](O3)CSCCNCCCCCCCCCC
12718	sp|P9WPB3|CMAS3_MY	P9WPB5	101.39	11.0	302.0	DB01752	experimental	S-adenosyl-L-homocysteine	OC(=O)[C@@H](N)CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
12719	sp|P9WPB3|CMAS3_MY	P9WPB5	101.39	11.0	302.0	DB04221	approved; experimental	Didecyldimethylammonium	CCCCCCCCCC[N+](C)(C)CCCCCCCCCC
12720	sp|P9WQB7|AHPC_MYC	Q06830	88.72	14.0	187.0	DB01593	approved; investigational	Zinc	[Zn]
12721	sp|P9WQB7|AHPC_MYC	Q06830	88.72	14.0	187.0	DB09130	approved; investigational	Copper	[Cu]
12722	sp|P9WQB7|AHPC_MYC	Q06830	88.72	14.0	187.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
12723	sp|P9WQB7|AHPC_MYC	Q06830	88.72	14.0	187.0	DB14487	approved; investigational	Zinc acetate	CC([O-])=O
12724	sp|P9WQB7|AHPC_MYC	Q06830	88.72	14.0	187.0	DB14533	approved; investigational	Zinc chloride	[Cl-]
12725	sp|P9WQB7|AHPC_MYC	Q06830	88.72	14.0	187.0	DB14548	approved; experimental	Zinc sulfate, unspecified form	 
12726	sp|P9WQB7|AHPC_MYC	Q8IL80	89.23	11.0	185.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
12727	sp|P9WQB7|AHPC_MYC	P32119	87.69	15.0	186.0	DB02153	experimental	3-sulfino-L-alanine	OC(=O)[C@@H](N)C[S@](=O)O
12728	sp|P9WQB7|AHPC_MYC	P32119	87.69	15.0	186.0	DB04048	experimental	N-Carbamoyl-Alanine	OC(=O)[C@@H](C)NC(=O)N
12729	sp|P9WQB7|AHPC_MYC	P32119	87.69	15.0	186.0	DB09130	approved; investigational	Copper	[Cu]
12730	sp|P9WQB7|AHPC_MYC	P30041	88.21	16.0	188.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
12731	sp|P9WQB7|AHPC_MYC	P30041	88.21	16.0	188.0	DB09130	approved; investigational	Copper	[Cu]
12732	sp|P9WQB7|AHPC_MYC	P30044	70.26	57.0	194.0	DB00995	approved; investigational	Auranofin	CCP(CC)(CC)=[Au]S[C@@H]1O[C@H](COC(=O)C)[C@@H](OC(=O)C)[C@H](OC(=O)C)[C@H]1OC(=O)C
12733	sp|P9WQB7|AHPC_MYC	P30044	70.26	57.0	194.0	DB03608	experimental	Diminazene	NC(=N)c1ccc(cc1)N/N=N/c2ccc(cc2)C(N)=N
12734	sp|P9WPT5|CTPC_MYC	P03960	74.37	71.0	605.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
12735	sp|P9WPS3|CTPV_MYC	P03960	73.38	38.0	603.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
12736	sp|P9WPC5|CLPP1_MY	Q16740	90.5	72.0	253.0	DB04464	experimental	N-Formylmethionine	O=CN[C@H](C(=O)O)CCSC
12737	sp|P9WPC5|CLPP1_MY	P0A6G7	88.0	29.0	205.0	DB07571	experimental	N~2~-[(BENZYLOXY)CARBONYL]-N-[(1S,2S)-2-HYDROXY-1-(4-HYDROXYBENZYL)PROPYL]-L-LEUCINAMIDE	Oc1ccc(cc1)C[C@@H]([C@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)OCc2ccccc2
12738	sp|P9WP25|DAPA_MYC	Q9X1K9	97.0	2.0	293.0	DB02370	experimental	Nz-(1-Carboxyethyl)-Lysine	OC(=O)[C@@H](C)NCCCC[C@H](N)C(=O)O
12739	sp|P9WP25|DAPA_MYC	P0A6L6	95.0	2.0	287.0	DB02951	experimental	3-Hydroxypyruvic Acid	OCC(=O)C(=O)O
12740	sp|P9WQP3|A85A_MYC	P9WQN9	98.82	5.0	339.0	DB02811	experimental	Diethyl phosphonate	CCOP(=O)OCC
12741	sp|P9WQP3|A85A_MYC	P9WQN9	98.82	5.0	339.0	DB08558	experimental	2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)SCCCCCCCC
12742	sp|P9WNE5|BFRB_MYC	P02794	83.43	15.0	166.0	DB00893	approved; vet_approved	Iron Dextran	 
12743	sp|P9WNE5|BFRB_MYC	P02794	83.43	15.0	166.0	DB01592	approved	Iron	[Fe]
12744	sp|P9WNE5|BFRB_MYC	P02794	83.43	15.0	166.0	DB13995	approved; investigational	Ferric pyrophosphate citrate	[O-]C(=O)CC(O)(C([O-])=O)CC([O-])=O
12745	sp|P9WNE5|BFRB_MYC	P02794	83.43	15.0	166.0	DB14488	approved	Ferrous gluconate	OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O
12746	sp|P9WNE5|BFRB_MYC	P02794	83.43	15.0	166.0	DB14489	approved	Ferrous succinate	[O-]C(=O)CCC([O-])=O
12747	sp|P9WNE5|BFRB_MYC	P02794	83.43	15.0	166.0	DB14490	approved	Ferrous ascorbate	OC[C@H](O)[C@H]1OC(=O)C(O)=C1O
12748	sp|P9WNE5|BFRB_MYC	P02794	83.43	15.0	166.0	DB14491	approved	Ferrous fumarate	[O-]C(=O)/C=C/C([O-])=O
12749	sp|P9WNE5|BFRB_MYC	P02794	83.43	15.0	166.0	DB14501	approved	Ferrous glycine sulfate	NCC([O-])=O
12750	sp|P9WNE5|BFRB_MYC	P02792	83.43	9.0	160.0	DB00893	approved; vet_approved	Iron Dextran	 
12751	sp|P9WNE5|BFRB_MYC	P02792	83.43	9.0	160.0	DB02285	experimental	Protoporphyrin	OC(=O)CCc(c12)c(C)c([nH]1)cc3nc(c(C)c3C=C)cc4c(C=C)c(C)c([nH]4)cc5nc(c2)c(c5C)CCC(=O)O
12752	sp|P9WNE5|BFRB_MYC	P02792	83.43	9.0	160.0	DB09147	experimental	Ferric pyrophosphate	[O-]P([O-])(=O)OP([O-])([O-])=O
12753	sp|P9WNE5|BFRB_MYC	P02792	83.43	9.0	160.0	DB09517	approved	Sodium ferric gluconate complex	OC[C@@H](O1)[C@@H](O)[C@H](O)[C@]1(CO)O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O
12754	sp|P9WNE5|BFRB_MYC	P02792	83.43	9.0	160.0	DB13995	approved; investigational	Ferric pyrophosphate citrate	[O-]C(=O)CC(O)(C([O-])=O)CC([O-])=O
12755	sp|P9WQ83|CBL_MYCT	Q56232	88.94	20.0	382.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
12756	sp|P9WQ83|CBL_MYCT	Q56232	88.94	20.0	382.0	DB04299	experimental	Maleic Acid	OC(=O)/C=C\C(=O)O
12757	sp|P9WQ83|CBL_MYCT	P17735	86.98	45.0	399.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
12758	sp|P9WQ83|CBL_MYCT	P17735	86.98	45.0	399.0	DB00120	approved; investigational; nutraceutical	Phenylalanine	OC(=O)[C@@H](N)Cc1ccccc1
12759	sp|P9WQ83|CBL_MYCT	P17735	86.98	45.0	399.0	DB00135	approved; investigational; nutraceutical	Tyrosine	OC(=O)[C@@H](N)Cc1ccc(O)cc1
12760	sp|P9WQ83|CBL_MYCT	P17735	86.98	45.0	399.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
12761	sp|P9WQ83|CBL_MYCT	P33447	96.81	12.0	406.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
12762	sp|P9WQ83|CBL_MYCT	Q16773	78.87	25.0	346.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
12763	sp|P9WQ83|CBL_MYCT	Q16773	78.87	25.0	346.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
12764	sp|P9WQ83|CBL_MYCT	Q16773	78.87	25.0	346.0	DB02556	experimental	D-Phenylalanine	OC(=O)[C@H](N)Cc1ccccc1
12765	sp|P9WQ83|CBL_MYCT	Q16773	78.87	25.0	346.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
12766	sp|P9WQ83|CBL_MYCT	Q16773	78.87	25.0	346.0	DB07950	experimental	Indoleacetic acid	OC(=O)Cc1c[nH]c(c12)cccc2
12767	sp|P9WQ83|CBL_MYCT	Q6YP21	80.1	63.0	389.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
12768	sp|P9WQ83|CBL_MYCT	Q75WK2	83.78	27.0	368.0	DB02024	experimental	3-phenylpropionic acid	OC(=O)CCc1ccccc1
12769	sp|P9WQ83|CBL_MYCT	Q75WK2	83.78	27.0	368.0	DB02238	experimental	4-methylthio-2-oxobutanoic acid	CSCCC(=O)C(=O)O
12770	sp|P9WQ83|CBL_MYCT	Q8TD30	90.91	126.0	496.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
12771	sp|P9WQ83|CBL_MYCT	Q8TD30	90.91	126.0	496.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
12772	sp|P9WQ83|CBL_MYCT	Q8TD30	90.91	126.0	496.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
12773	sp|P9WQ83|CBL_MYCT	Q8TD30	90.91	126.0	496.0	DB00780	approved	Phenelzine	NNCCc1ccccc1
12774	sp|P9WQ83|CBL_MYCT	Q9X0L5	81.08	29.0	359.0	DB01942	experimental; investigational	Formic acid	OC=O
12775	sp|P9WQ83|CBL_MYCT	P24298	98.53	85.0	486.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
12776	sp|P9WQ83|CBL_MYCT	P24298	98.53	85.0	486.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
12777	sp|P9WQ83|CBL_MYCT	P24298	98.53	85.0	486.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
12778	sp|P9WQ83|CBL_MYCT	P24298	98.53	85.0	486.0	DB00780	approved	Phenelzine	NNCCc1ccccc1
12779	sp|P9WQ83|CBL_MYCT	P00509	76.9	42.0	355.0	DB01639	experimental	N-Methyl-Pyridoxal-5'-Phosphate	Cc1c(O)c(C=O)c(c[n+]1C)COP(=O)(O)O
12780	sp|P9WQ83|CBL_MYCT	P00509	76.9	42.0	355.0	DB02024	experimental	3-phenylpropionic acid	OC(=O)CCc1ccccc1
12781	sp|P9WQ83|CBL_MYCT	P00509	76.9	42.0	355.0	DB02758	experimental	Indolepropionic acid	OC(=O)CCc1c[nH]c(c12)cccc2
12782	sp|P9WQ83|CBL_MYCT	P00509	76.9	42.0	355.0	DB02981	experimental	Vitamin B6 Complexed with 2-Amino-Hexanoic Acid	CCCC[C@@H](C(=O)O)NCc1c(COP(=O)(O)O)cnc(C)c1O
12783	sp|P9WQ83|CBL_MYCT	P00509	76.9	42.0	355.0	DB03553	experimental	Glutaric Acid	OC(=O)CCCC(=O)O
12784	sp|P9WQ83|CBL_MYCT	P00509	76.9	42.0	355.0	DB03629	experimental	Pyridoxal-5'-Phosphate-N-Oxide	Cc1c(O)c(C=O)c(c[n+]1[O-])COP(=O)(O)O
12785	sp|P9WQ83|CBL_MYCT	P00509	76.9	42.0	355.0	DB03662	experimental	Vitamin B6 Complexed with 2-Amino-Pentanoic Acid	CCC[C@@H](C(=O)O)NCc1c(O)c(C)ncc1COP(=O)(O)O
12786	sp|P9WQ83|CBL_MYCT	P00509	76.9	42.0	355.0	DB03750	experimental	Isovaleric Acid	CC(C)CC(=O)O
12787	sp|P9WQ83|CBL_MYCT	P00509	76.9	42.0	355.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
12788	sp|P9WQ83|CBL_MYCT	P00509	76.9	42.0	355.0	DB04299	experimental	Maleic Acid	OC(=O)/C=C\C(=O)O
12789	sp|P9WQ83|CBL_MYCT	P00509	76.9	42.0	355.0	DB04467	experimental	N-(5'-phosphopyridoxyl)-L-alanine	OC(=O)[C@H](C)NCc1c(COP(=O)(O)O)cnc(C)c1O
12790	sp|P9WQ83|CBL_MYCT	P00509	76.9	42.0	355.0	DB04762	experimental	N-PYRIDOXYL-D-GLUTAMIC ACID-5'-MONOPHOSPHATE	Cc1ncc(COP(=O)(O)O)c(c1O)CN[C@@H](C(=O)O)CCC(=O)O
12791	sp|P9WQ83|CBL_MYCT	P00509	76.9	42.0	355.0	DB04765	experimental	N-PYRIDOXYL-2-METHYL-L-GLUTAMIC ACID-5'-MONOPHOSPHATE	Cc1ncc(COP(=O)(O)O)c(c1O)CN[C@](C)(C(=O)O)CCC(=O)O
12792	sp|P9WQ83|CBL_MYCT	P00509	76.9	42.0	355.0	DB08845	experimental; investigational; nutraceutical	Oxogluric acid	OC(=O)CCC(=O)C(=O)O
12793	sp|P9WQ83|CBL_MYCT	P95468	73.96	29.0	330.0	DB02024	experimental	3-phenylpropionic acid	OC(=O)CCc1ccccc1
12794	sp|P9WQ83|CBL_MYCT	P95468	73.96	29.0	330.0	DB02242	experimental	Cyclohexanepropanoic acid	OC(=O)CCC1CCCCC1
12795	sp|P9WQ83|CBL_MYCT	P95468	73.96	29.0	330.0	DB02434	experimental	4-(2-Thienyl)Butyric Acid	OC(=O)CCCc1cccs1
12796	sp|P9WQ83|CBL_MYCT	P95468	73.96	29.0	330.0	DB02740	experimental	3-Indolebutyric Acid	OC(=O)CCCc1c[nH]c(c12)cccc2
12797	sp|P9WQ83|CBL_MYCT	P95468	73.96	29.0	330.0	DB02758	experimental	Indolepropionic acid	OC(=O)CCc1c[nH]c(c12)cccc2
12798	sp|P9WQ83|CBL_MYCT	P95468	73.96	29.0	330.0	DB03210	experimental	4-Aminohydrocinnamic Acid	Nc1ccc(cc1)CCC(=O)O
12799	sp|P9WQ83|CBL_MYCT	P95468	73.96	29.0	330.0	DB03400	experimental	3-(P-Tolyl)Propionic Acid	Cc1ccc(cc1)CCC(=O)O
12800	sp|P9WQ83|CBL_MYCT	P95468	73.96	29.0	330.0	DB04051	experimental	5-phenylpentanoic acid	OC(=O)CCCCc1ccccc1
12801	sp|P9WQ83|CBL_MYCT	P95468	73.96	29.0	330.0	DB04208	experimental	3-(3,4-dimethoxyphenyl)propanoic acid	COc1c(OC)cc(cc1)CCC(=O)O
12802	sp|P9WQ83|CBL_MYCT	P95468	73.96	29.0	330.0	DB04299	experimental	Maleic Acid	OC(=O)/C=C\C(=O)O
12803	sp|P9WQ83|CBL_MYCT	P95468	73.96	29.0	330.0	DB06819	approved; investigational	Phenylbutyric acid	OC(=O)CCCc1ccccc1
12804	sp|P9WQ83|CBL_MYCT	Q96QU6	82.31	143.0	478.0	DB03214	experimental	Vinylglycine	OC(=O)[C@@H](N)C=C
12805	sp|P9WQ83|CBL_MYCT	P00505	76.66	78.0	390.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
12806	sp|P9WQ83|CBL_MYCT	P00505	76.66	78.0	390.0	DB00128	approved; nutraceutical	Aspartic acid	OC(=O)[C@@H](N)CC(=O)O
12807	sp|P9WQ83|CBL_MYCT	P00505	76.66	78.0	390.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
12808	sp|P9WQ83|CBL_MYCT	P00505	76.66	78.0	390.0	DB00151	approved; nutraceutical	Cysteine	OC(=O)[C@@H](N)CS
12809	sp|P9WQ83|CBL_MYCT	P00505	76.66	78.0	390.0	DB02783	experimental	4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate	Cc1ncc(COP(=O)(O)O)c(c1O)CNOCC(=O)O
12810	sp|P9WQ83|CBL_MYCT	Q2TU84	77.15	52.0	366.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
12811	sp|P9WQ83|CBL_MYCT	Q2TU84	77.15	52.0	366.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
12812	sp|P9WQ83|CBL_MYCT	P17174	77.15	52.0	366.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
12813	sp|P9WQ83|CBL_MYCT	P17174	77.15	52.0	366.0	DB00128	approved; nutraceutical	Aspartic acid	OC(=O)[C@@H](N)CC(=O)O
12814	sp|P9WQ83|CBL_MYCT	P17174	77.15	52.0	366.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
12815	sp|P9WQ83|CBL_MYCT	P17174	77.15	52.0	366.0	DB00151	approved; nutraceutical	Cysteine	OC(=O)[C@@H](N)CS
12816	sp|P9WQ83|CBL_MYCT	P17174	77.15	52.0	366.0	DB00210	approved	Adapalene	C1C(C2)CC(C3)CC1CC23c4c(OC)ccc(c4)-c(cc5)cc(c56)ccc(c6)C(=O)O
12817	sp|P9WQ83|CBL_MYCT	P17174	77.15	52.0	366.0	DB04299	experimental	Maleic Acid	OC(=O)/C=C\C(=O)O
12818	sp|P9WQ83|CBL_MYCT	P17174	77.15	52.0	366.0	DB09130	approved; investigational	Copper	[Cu]
12819	sp|P9WPM5|CP137_MY	P04798	100.21	14.0	491.0	DB02342	investigational	2-Methoxyestradiol	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)c(c4)OC
12820	sp|P9WPM5|CP137_MY	P04798	100.21	14.0	491.0	DB12379	investigational	Indirubin	c1cccc(c12)NC(=O)C\2=C(C3=O)\Nc(c34)cccc4
12821	sp|P9WPM5|CP137_MY	P04798	100.21	14.0	491.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
12822	sp|P9WPM5|CP137_MY	P08684	95.17	39.0	492.0	DB00143	approved; investigational; nutraceutical	Glutathione	OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(=O)O
12823	sp|P9WPM5|CP137_MY	P08684	95.17	39.0	492.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
12824	sp|P9WPM5|CP137_MY	P08684	95.17	39.0	492.0	DB05478	investigational	Pradefovir mesylate	n1cnc(N)c(c12)ncn2CCOC[P@@]3(=O)OCC[C@H](O3)c4cc(Cl)ccc4
12825	sp|P9WPM5|CP137_MY	P08684	95.17	39.0	492.0	DB06634	investigational	Casopitant	FC(F)(F)c1cc(cc(c1)C(F)(F)F)[C@@H](C)N(C)C(=O)N2CC[C@H](N3CCN(CC3)C(=O)C)C[C@@H]2c4ccc(F)cc4C
12826	sp|P9WPM5|CP137_MY	P08684	95.17	39.0	492.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
12827	sp|P9WPM5|CP137_MY	P20815	94.96	39.0	491.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
12828	sp|P9WPM5|CP137_MY	P20815	94.96	39.0	491.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
12829	sp|P9WPM5|CP137_MY	P20815	94.96	39.0	491.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
12830	sp|P9WPM5|CP137_MY	P05177	100.0	16.0	492.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
12831	sp|P9WPM5|CP137_MY	P05177	100.0	16.0	492.0	DB07453	experimental	alpha-Naphthoflavone	c1ccccc1-c(cc2=O)oc(c23)c4c(cc3)cccc4
12832	sp|P9WPM5|CP137_MY	P05177	100.0	16.0	492.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
12833	sp|P9WPM5|CP137_MY	P05177	100.0	16.0	492.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
12834	sp|P9WPM5|CP137_MY	P05177	100.0	16.0	492.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
12835	sp|P9WPM5|CP137_MY	P24462	94.96	39.0	491.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
12836	sp|P9WPM5|CP137_MY	P24462	94.96	39.0	491.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
12837	sp|P9WPM5|CP137_MY	P24462	94.96	39.0	491.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
12838	sp|P9WPM5|CP137_MY	P33260	91.39	28.0	463.0	DB07670	experimental	N,4-Dimethyl-N-(1-phenyl-1H-pyrazol-5-yl)benzenesulfonamide	Cc1ccc(cc1)S(=O)(=O)N(C)c2ccnn2-c3ccccc3
12839	sp|P9WPM5|CP137_MY	Q9HB55	95.17	39.0	492.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
12840	sp|P9WPM5|CP137_MY	P11712	91.39	28.0	463.0	DB03317	experimental	Ferroheme C	[Fe-2]123[N+]4=C5C=C6[N+]1=C(C(C)=C6C(C)S)C=C7[N+]2=C(C(=C7C)CCC(=O)O)C=C8[N+]3=C(C=C4C(=C5C)C(C)S)C(C)=C8CCC(=O)O
12841	sp|P9WPM5|CP137_MY	P11712	91.39	28.0	463.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
12842	sp|P9WPM5|CP137_MY	P11712	91.39	28.0	463.0	DB12319	investigational; withdrawn	Benzbromarone	c1cccc(c12)c(c(o2)CC)C(=O)c3cc(Br)c(O)c(Br)c3
12843	sp|P9WPM5|CP137_MY	P10632	92.02	27.0	465.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
12844	sp|P9WPM5|CP137_MY	P10632	92.02	27.0	465.0	DB03796	approved	Palmitic Acid	CCCCCCCCCCCCCCCC(=O)O
12845	sp|P9WPM5|CP137_MY	P10632	92.02	27.0	465.0	DB08607	experimental	(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE	O=C1NC(=O)S[C@@H]1Cc2ccc(cc2)OC[C@@](O3)(C)CCc(c34)c(C)c(O)c(C)c4C
12846	sp|P9WPM5|CP137_MY	P33261	91.39	28.0	463.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
12847	sp|P9WPM5|CP137_MY	P33261	91.39	28.0	463.0	DB12319	investigational; withdrawn	Benzbromarone	c1cccc(c12)c(c(o2)CC)C(=O)c3cc(Br)c(O)c(Br)c3
12848	sp|P9WPM5|CP137_MY	O43174	94.75	39.0	490.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
12849	sp|P9WPM5|CP137_MY	O43174	94.75	39.0	490.0	DB13083	investigational	Talarozole	c1ncnn1C(C(CC)CC)c2ccc(cc2)Nc(s3)nc(c34)cccc4
12850	sp|P9WPM5|CP137_MY	Q6V0L0	97.69	45.0	510.0	DB00523	approved; investigational	Alitretinoin	OC(=O)/C=C(\C)/C=C/C=C(/C)\C=C\C(C1(C)C)=C(C)CCC1
12851	sp|P9WPM5|CP137_MY	Q6V0L0	97.69	45.0	510.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
12852	sp|P9WPM5|CP137_MY	Q16850	95.8	41.0	497.0	DB01007	approved	Tioconazole	c1nccn1CC(c(c(Cl)c2)ccc2Cl)OCc3c(Cl)scc3
12853	sp|P9WPM5|CP137_MY	Q16850	95.8	41.0	497.0	DB01167	approved; investigational	Itraconazole	CCC(C)n1ncn(c1=O)-c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@@H](CO5)O[C@@]5(Cn6cncn6)c7ccc(Cl)cc7Cl
12854	sp|P9WPM5|CP137_MY	Q16850	95.8	41.0	497.0	DB05667	investigational	Levoketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OC[C@H](CO3)O[C@]3(Cn4ccnc4)c5ccc(Cl)cc5Cl
12855	sp|P9WPM5|CP137_MY	Q16850	95.8	41.0	497.0	DB07705	experimental	(S)-econazole	Clc1ccc(cc1)CO[C@H](Cn2ccnc2)c3c(Cl)cc(Cl)cc3
12856	sp|P9WPM5|CP137_MY	P20813	92.23	29.0	468.0	DB02974	experimental	4-(4-Chlorophenyl)Imidazole	Clc1ccc(cc1)-c2cnc[nH]2
12857	sp|P9WPM5|CP137_MY	P20813	92.23	29.0	468.0	DB04664	experimental	Cyclohexyl-pentyl-maltoside	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@@H]2CO)OCCCCCC3CCCCC3
12858	sp|P9WPM5|CP137_MY	P20813	92.23	29.0	468.0	DB04794	approved; investigational	Bifonazole	c1ccccc1C(n2ccnc2)c3ccc(cc3)-c4ccccc4
12859	sp|P9WPM5|CP137_MY	P20813	92.23	29.0	468.0	DB08369	experimental	1-(biphenyl-4-ylmethyl)-1H-imidazole	c1cncn1Cc2ccc(cc2)-c3ccccc3
12860	sp|P9WPM5|CP137_MY	P11509	97.9	3.0	469.0	DB04665	experimental	Coumarin	c1cc(=O)oc(c12)cccc2
12861	sp|P9WPM5|CP137_MY	P11509	97.9	3.0	469.0	DB07609	experimental	N,N-DIMETHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	CN(C)Cc1ccc(o1)-c2cccnc2
12862	sp|P9WPM5|CP137_MY	P11509	97.9	3.0	469.0	DB07617	experimental	N-METHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	CNCc1ccc(o1)-c2cccnc2
12863	sp|P9WPM5|CP137_MY	P11509	97.9	3.0	469.0	DB07621	experimental	(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	NCc1ccc(o1)-c2cccnc2
12864	sp|P9WPM5|CP137_MY	P11509	97.9	3.0	469.0	DB07623	experimental	4,4'-DIPYRIDYL DISULFIDE	c1cnccc1SSc2ccncc2
12865	sp|P9WPM5|CP137_MY	P05181	92.02	30.0	468.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
12866	sp|P9WPM5|CP137_MY	Q9NR63	93.7	44.0	490.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
12867	sp|P9WPM5|CP137_MY	P10614	96.01	57.0	514.0	DB06890	experimental	(2R)-2-PHENYL-N-PYRIDIN-4-YLBUTANAMIDE	c1ccccc1[C@@H](CC)C(=O)Nc2ccncc2
12868	sp|P9WPM5|CP137_MY	P10614	96.01	57.0	514.0	DB07560	experimental	N-[(1S)-2-methyl-1-(pyridin-4-ylcarbamoyl)propyl]cyclohexanecarboxamide	c1cnccc1NC(=O)[C@H](C(C)C)NC(=O)C2CCCCC2
12869	sp|P9WPM5|CP137_MY	P10614	96.01	57.0	514.0	DB07568	experimental	(2S)-2-[(2,1,3-BENZOTHIADIAZOL-4-YLSULFONYL)AMINO]-2-PHENYL-N-PYRIDIN-4-YLACETAMIDE	n1snc(c12)cccc2S(=O)(=O)N[C@@H](c3ccccc3)C(=O)Nc4ccncc4
12870	sp|P9WPM5|CP137_MY	P10614	96.01	57.0	514.0	DB07569	experimental	CIS-4-METHYL-N-[(1S)-3-(METHYLSULFANYL)-1-(PYRIDIN-4-YLCARBAMOYL)PROPYL]CYCLOHEXANECARBOXAMIDE	c1cnccc1NC(=O)[C@H](CCSC)NC(=O)[C@@H]2CC[C@H](C)CC2
12871	sp|P9WPM5|CP137_MY	P10614	96.01	57.0	514.0	DB07572	experimental	3-{[(4-methylphenyl)sulfonyl]amino}propyl pyridin-4-ylcarbamate	Cc1ccc(cc1)S(=O)(=O)NCCCOC(=O)Nc2ccncc2
12872	sp|P9WPM5|CP137_MY	P10614	96.01	57.0	514.0	DB07635	experimental	4,4'-Dihydroxybenzophenone	Oc1ccc(cc1)C(=O)c2ccc(O)cc2
12873	sp|P9WPM5|CP137_MY	P50859	96.22	58.0	516.0	DB01026	approved; investigational	Ketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OCC(CO3)OC3(Cn4ccnc4)c5ccc(Cl)cc5Cl
12874	sp|P9WPM5|CP137_MY	P50859	96.22	58.0	516.0	DB01167	approved; investigational	Itraconazole	CCC(C)n1ncn(c1=O)-c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@@H](CO5)O[C@@]5(Cn6cncn6)c7ccc(Cl)cc7Cl
12875	sp|P9WPM5|CP137_MY	P50859	96.22	58.0	516.0	DB09040	approved	Efinaconazole	C=C1CCN(CC1)[C@H](C)[C@](O)(Cn2cncn2)c3c(F)cc(F)cc3
12876	sp|P9WPM5|CP137_MY	P50859	96.22	58.0	516.0	DB11633	approved; investigational	Isavuconazole	c1ncnn1C[C@](O)(c2c(F)ccc(F)c2)[C@@H](C)c3nc(cs3)-c4ccc(C#N)cc4
12877	sp|P9WPM5|CP137_MY	P10613	98.32	47.0	515.0	DB00196	approved; investigational	Fluconazole	c1ncnn1CC(O)(Cn2cncn2)c3c(F)cc(F)cc3
12878	sp|P9WPM5|CP137_MY	P10613	98.32	47.0	515.0	DB00239	approved	Oxiconazole	Clc1cc(Cl)c(cc1)CO/N=C(\Cn2ccnc2)c3ccc(Cl)cc3Cl
12879	sp|P9WPM5|CP137_MY	P10613	98.32	47.0	515.0	DB00251	approved	Terconazole	CC(C)N1CCN(CC1)c2ccc(cc2)OC[C@@H](CO3)O[C@@]3(Cn4cncn4)c5c(Cl)cc(Cl)cc5
12880	sp|P9WPM5|CP137_MY	P10613	98.32	47.0	515.0	DB00257	approved; vet_approved	Clotrimazole	Clc1ccccc1C(n2ccnc2)(c3ccccc3)c4ccccc4
12881	sp|P9WPM5|CP137_MY	P10613	98.32	47.0	515.0	DB00582	approved	Voriconazole	c1ncnn1C[C@](O)(c2c(F)cc(F)cc2)[C@@H](C)c3ncncc3F
12882	sp|P9WPM5|CP137_MY	P10613	98.32	47.0	515.0	DB01007	approved	Tioconazole	c1nccn1CC(c(c(Cl)c2)ccc2Cl)OCc3c(Cl)scc3
12883	sp|P9WPM5|CP137_MY	P10613	98.32	47.0	515.0	DB01110	approved; investigational; vet_approved	Miconazole	Clc1cc(Cl)c(cc1)COC(Cn2ccnc2)c3c(Cl)cc(Cl)cc3
12884	sp|P9WPM5|CP137_MY	P10613	98.32	47.0	515.0	DB01127	approved	Econazole	Clc1ccc(cc1)COC(Cn2ccnc2)c3c(Cl)cc(Cl)cc3
12885	sp|P9WPM5|CP137_MY	P10613	98.32	47.0	515.0	DB01153	approved; investigational	Sertaconazole	Clc1cc(Cl)ccc1C(Cn2cncc2)OCc3csc(c34)c(Cl)ccc4
12886	sp|P9WPM5|CP137_MY	P10613	98.32	47.0	515.0	DB01263	approved; investigational; vet_approved	Posaconazole	C[C@H](O)[C@H](CC)n1ncn(c1=O)-c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@H](CO5)C[C@]5(Cn6cncn6)c7c(F)cc(F)cc7
12887	sp|P9WPM5|CP137_MY	P10613	98.32	47.0	515.0	DB04794	approved; investigational	Bifonazole	c1ccccc1C(n2ccnc2)c3ccc(cc3)-c4ccccc4
12888	sp|P9WPM5|CP137_MY	P10613	98.32	47.0	515.0	DB08933	approved	Luliconazole	Clc1cc(Cl)c(cc1)[C@@H]2CS/C(S2)=C(/C#N)n3ccnc3
12889	sp|P9WPM5|CP137_MY	P24557	101.47	46.0	529.0	DB00795	approved	Sulfasalazine	OC(=O)c1cc(ccc1O)/N=N/c2ccc(cc2)S(=O)(=O)Nc3ncccc3
12890	sp|P9WPM5|CP137_MY	P24557	101.47	46.0	529.0	DB01207	experimental	Ridogrel	OC(=O)CCCCO/N=C(/c1cnccc1)c2cc(C(F)(F)F)ccc2
12891	sp|P9WPM5|CP137_MY	P24557	101.47	46.0	529.0	DB03052	experimental	Dazoxiben	OC(=O)c1ccc(cc1)OCCn2ccnc2
12892	sp|P9WPM5|CP137_MY	P24557	101.47	46.0	529.0	DB05505	investigational	NM-702	 
12893	sp|P9WPM5|CP137_MY	Q16678	97.9	49.0	515.0	DB01645	investigational	Genistein	Oc1ccc(cc1)-c(c2=O)coc(c23)cc(O)cc3O
12894	sp|P9WPM5|CP137_MY	Q16678	97.9	49.0	515.0	DB02342	investigational	2-Methoxyestradiol	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)c(c4)OC
12895	sp|P9WPM5|CP137_MY	Q16678	97.9	49.0	515.0	DB03467	experimental	Naringenin	Oc1ccc(cc1)[C@@H](O2)CC(=O)c(c23)c(O)cc(c3)O
12896	sp|P9WPM5|CP137_MY	Q16678	97.9	49.0	515.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
12897	sp|P9WPM5|CP137_MY	Q16678	97.9	49.0	515.0	DB06732	experimental	beta-Naphthoflavone	c1cccc(c12)c3c(cc2)oc(cc3=O)-c4ccccc4
12898	sp|P9WPM5|CP137_MY	Q16678	97.9	49.0	515.0	DB07776	approved; experimental	Flavone	c1cccc(c12)oc(cc2=O)-c3ccccc3
12899	sp|P9WPM5|CP137_MY	Q16678	97.9	49.0	515.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
12900	sp|P9WPM5|CP137_MY	Q16678	97.9	49.0	515.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
12902	sp|P9WPM5|CP137_MY	P05093	95.17	23.0	476.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
12903	sp|P9WPM5|CP137_MY	P05093	95.17	23.0	476.0	DB00396	approved; vet_approved	Progesterone	CC(=O)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
12904	sp|P9WPM5|CP137_MY	P05093	95.17	23.0	476.0	DB00421	approved	Spironolactone	C1CC(=O)O[C@@]12[C@]3(C)[C@@H](CC2)[C@H]4[C@H](CC3)[C@]5(C)C(=CC(=O)CC5)C[C@H]4SC(=O)C
12905	sp|P9WPM5|CP137_MY	P05093	95.17	23.0	476.0	DB01026	approved; investigational	Ketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OCC(CO3)OC3(Cn4ccnc4)c5ccc(Cl)cc5Cl
12906	sp|P9WPM5|CP137_MY	P05093	95.17	23.0	476.0	DB05812	approved	Abiraterone	C1C[C@H](O)CC([C@]12C)=CC[C@@H]3[C@@H]2CC[C@@]4(C)[C@H]3CC=C4c5cccnc5
12907	sp|P9WPM5|CP137_MY	P05093	95.17	23.0	476.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
12909	sp|P9WPM5|CP137_MY	P05093	95.17	23.0	476.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
12910	sp|P9WPM5|CP137_MY	P10635	94.12	30.0	478.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
12911	sp|P9WPM5|CP137_MY	P10635	94.12	30.0	478.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
12912	sp|P9WPM5|CP137_MY	P10635	94.12	30.0	478.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
12913	sp|P9WPM5|CP137_MY	P08686	85.29	48.0	454.0	DB01026	approved; investigational	Ketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OCC(CO3)OC3(Cn4ccnc4)c5ccc(Cl)cc5Cl
12914	sp|P9WPM5|CP137_MY	P14779	88.03	25.0	444.0	DB03440	experimental	N-hexadecanoylglycine	CCCCCCCCCCCCCCCC(=O)NCC(=O)O
12915	sp|P9WPM5|CP137_MY	P14779	88.03	25.0	444.0	DB04257	experimental	Palmitoleic Acid	CCCCCC/C=C\CCCCCCCC(=O)O
12916	sp|P9WPM5|CP137_MY	P14779	88.03	25.0	444.0	DB08086	experimental	N-[12-(1H-imidazol-1-yl)dodecanoyl]-L-leucine	CC(C)C[C@@H](C(=O)O)NC(=O)CCCCCCCCCCCn1ccnc1
12917	sp|P9WPM5|CP137_MY	P15538	91.6	65.0	501.0	DB00648	approved	Mitotane	Clc1ccc(cc1)C(C(Cl)Cl)c2ccccc2Cl
12918	sp|P9WPM5|CP137_MY	P15538	91.6	65.0	501.0	DB01011	approved; investigational	Metyrapone	c1ccncc1C(C)(C)C(=O)c2cnccc2
12919	sp|P9WPM5|CP137_MY	P15538	91.6	65.0	501.0	DB05667	investigational	Levoketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OC[C@H](CO3)O[C@]3(Cn4ccnc4)c5ccc(Cl)cc5Cl
12920	sp|P9WPM5|CP137_MY	P15538	91.6	65.0	501.0	DB11837	approved; investigational	Osilodrostat	c1ncc(n12)CC[C@@H]2c3c(F)cc(C#N)cc3
12921	sp|P9WPM5|CP137_MY	P05108	92.44	73.0	513.0	DB00357	approved; investigational	Aminoglutethimide	Nc1ccc(cc1)C2(CC)CCC(=O)NC2=O
12922	sp|P9WPM5|CP137_MY	P19099	91.81	64.0	501.0	DB00421	approved	Spironolactone	C1CC(=O)O[C@@]12[C@]3(C)[C@@H](CC2)[C@H]4[C@H](CC3)[C@]5(C)C(=CC(=O)CC5)C[C@H]4SC(=O)C
12923	sp|P9WPM5|CP137_MY	P19099	91.81	64.0	501.0	DB11837	approved; investigational	Osilodrostat	c1ncc(n12)CC[C@@H]2c3c(F)cc(C#N)cc3
12924	sp|P9WPM5|CP137_MY	O15528	93.07	62.0	505.0	DB01436	approved; nutraceutical	Alfacalcidol	CC(C)CCC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)/C(CCC2)=C/C=C3/C[C@@H](O)C[C@H](O)C3=C
12925	sp|P9WPM5|CP137_MY	Q02928	86.13	97.0	507.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
12926	sp|P9WPM5|CP137_MY	P11511	91.81	45.0	482.0	DB00184	approved	Nicotine	CN1CCC[C@H]1c2cnccc2
12927	sp|P9WPM5|CP137_MY	P11511	91.81	45.0	482.0	DB00357	approved; investigational	Aminoglutethimide	Nc1ccc(cc1)C2(CC)CCC(=O)NC2=O
12928	sp|P9WPM5|CP137_MY	P11511	91.81	45.0	482.0	DB00655	approved	Estrone	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)cc4
12929	sp|P9WPM5|CP137_MY	P11511	91.81	45.0	482.0	DB00894	approved; investigational	Testolactone	C1=CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2CC[C@@]4(C)[C@H]3CCC(O4)=O
12930	sp|P9WPM5|CP137_MY	P11511	91.81	45.0	482.0	DB00990	approved; investigational	Exemestane	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(C(C3)=C)=CC(=O)C=C4
12931	sp|P9WPM5|CP137_MY	P11511	91.81	45.0	482.0	DB01006	approved; investigational	Letrozole	N#Cc1ccc(cc1)C(n2cncn2)c3ccc(C#N)cc3
12932	sp|P9WPM5|CP137_MY	P11511	91.81	45.0	482.0	DB01217	approved; investigational	Anastrozole	N#CC(C)(C)c1cc(C(C)(C)C#N)cc(c1)Cn2cncn2
12933	sp|P9WPM5|CP137_MY	P11511	91.81	45.0	482.0	DB02342	investigational	2-Methoxyestradiol	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)c(c4)OC
12934	sp|P9WPM5|CP137_MY	P11511	91.81	45.0	482.0	DB03467	experimental	Naringenin	Oc1ccc(cc1)[C@@H](O2)CC(=O)c(c23)c(O)cc(c3)O
12935	sp|P9WPM5|CP137_MY	P11511	91.81	45.0	482.0	DB04539	experimental	Glyphosate	OC(=O)C[NH2+]CP(=O)(O)O
12936	sp|P9WPM5|CP137_MY	P11511	91.81	45.0	482.0	DB05749	investigational	MPI-674	 
12937	sp|P9WPM5|CP137_MY	O31440	79.41	13.0	391.0	DB04257	experimental	Palmitoleic Acid	CCCCCC/C=C\CCCCCCCC(=O)O
12938	sp|P9WPM5|CP137_MY	P53554	74.37	12.0	366.0	DB04450	experimental	Heptyl 1-Thiohexopyranoside	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)SCCCCCCC
12939	sp|P9WPM5|CP137_MY	P9WPN5	70.59	47.0	383.0	DB07705	experimental	(S)-econazole	Clc1ccc(cc1)CO[C@H](Cn2ccnc2)c3c(Cl)cc(Cl)cc3
12940	sp|P9WPM5|CP137_MY	P9WPN5	70.59	47.0	383.0	DB07971	experimental	5-AMINO-2-{4-[(4-AMINOPHENYL)SULFANYL]PHENYL}-1H-ISOINDOLE-1,3(2H)-DIONE	Nc1ccc(cc1)Sc2ccc(cc2)N(C3=O)C(=O)c(c34)ccc(c4)N
12941	sp|P9WPM5|CP137_MY	P9WPN5	70.59	47.0	383.0	DB07972	experimental	1-(3-METHYLPHENYL)-1H-BENZIMIDAZOL-5-AMINE	Cc1cccc(c1)-n2cnc(c23)cc(N)cc3
12942	sp|P9WPM5|CP137_MY	Q9FCA6	71.43	55.0	395.0	DB02175	experimental	Malonic acid	OC(=O)CC(=O)O
12943	sp|P9WPM5|CP137_MY	Q9FCA6	71.43	55.0	395.0	DB02521	experimental	Flaviolin	Oc1cc(O)cc(c12)C(=O)C(O)=CC2=O
12944	sp|P9WPM5|CP137_MY	Q9FCA6	71.43	55.0	395.0	DB03254	experimental	4-Phenyl-1h-Imidazole	[nH]1cncc1-c2ccccc2
12945	sp|P9WPM5|CP137_MY	Q9FCA6	71.43	55.0	395.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
12946	sp|P9WPM5|CP137_MY	Q16647	97.9	31.0	497.0	DB00812	approved; vet_approved	Phenylbutazone	CCCCC1C(=O)N(c2ccccc2)N(C1=O)c3ccccc3
12947	sp|P9WPM5|CP137_MY	Q16647	97.9	31.0	497.0	DB01240	approved	Epoprostenol	OC(=O)CCC/C=C(C1)\O[C@H]([C@H]12)C[C@@H](O)[C@@H]2/C=C/[C@@H](O)CCCCC
12948	sp|P9WPM5|CP137_MY	Q16647	97.9	31.0	497.0	DB08675	experimental	(5Z)-7-{(1R,4S,5R,6R)-6-[(1E)-1-Octen-1-yl]-2,3-diazabicyclo[2.2.1]hept-2-en-5-yl}-5-heptenoic acid	OC(=O)CCC/C=C\C[C@@H]([C@H]12)[C@H]([C@@H](C1)N=N2)/C=C/CCCCCC
12949	sp|P9WPM1|CP139_MY	P33260	95.81	50.0	462.0	DB07670	experimental	N,4-Dimethyl-N-(1-phenyl-1H-pyrazol-5-yl)benzenesulfonamide	Cc1ccc(cc1)S(=O)(=O)N(C)c2ccnn2-c3ccccc3
12950	sp|P9WPM1|CP139_MY	P11712	95.58	50.0	461.0	DB03317	experimental	Ferroheme C	[Fe-2]123[N+]4=C5C=C6[N+]1=C(C(C)=C6C(C)S)C=C7[N+]2=C(C(=C7C)CCC(=O)O)C=C8[N+]3=C(C=C4C(=C5C)C(C)S)C(C)=C8CCC(=O)O
12951	sp|P9WPM1|CP139_MY	P11712	95.58	50.0	461.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
12952	sp|P9WPM1|CP139_MY	P11712	95.58	50.0	461.0	DB12319	investigational; withdrawn	Benzbromarone	c1cccc(c12)c(c(o2)CC)C(=O)c3cc(Br)c(O)c(Br)c3
12953	sp|P9WPM1|CP139_MY	P10632	96.05	50.0	463.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
12954	sp|P9WPM1|CP139_MY	P10632	96.05	50.0	463.0	DB03796	approved	Palmitic Acid	CCCCCCCCCCCCCCCC(=O)O
12955	sp|P9WPM1|CP139_MY	P10632	96.05	50.0	463.0	DB08607	experimental	(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE	O=C1NC(=O)S[C@@H]1Cc2ccc(cc2)OC[C@@](O3)(C)CCc(c34)c(C)c(O)c(C)c4C
12956	sp|P9WPM1|CP139_MY	P33261	95.58	50.0	461.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
12957	sp|P9WPM1|CP139_MY	P33261	95.58	50.0	461.0	DB12319	investigational; withdrawn	Benzbromarone	c1cccc(c12)c(c(o2)CC)C(=O)c3cc(Br)c(O)c(Br)c3
12958	sp|P9WPM1|CP139_MY	P08684	100.23	62.0	493.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
12959	sp|P9WPM1|CP139_MY	P08684	100.23	62.0	493.0	DB00143	approved; investigational; nutraceutical	Glutathione	OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(=O)O
12960	sp|P9WPM1|CP139_MY	P08684	100.23	62.0	493.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
12961	sp|P9WPM1|CP139_MY	P08684	100.23	62.0	493.0	DB05478	investigational	Pradefovir mesylate	n1cnc(N)c(c12)ncn2CCOC[P@@]3(=O)OCC[C@H](O3)c4cc(Cl)ccc4
12962	sp|P9WPM1|CP139_MY	P08684	100.23	62.0	493.0	DB06634	investigational	Casopitant	FC(F)(F)c1cc(cc(c1)C(F)(F)F)[C@@H](C)N(C)C(=O)N2CC[C@H](N3CCN(CC3)C(=O)C)C[C@@H]2c4ccc(F)cc4C
12963	sp|P9WPM1|CP139_MY	P20815	100.7	59.0	492.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
12964	sp|P9WPM1|CP139_MY	P20815	100.7	59.0	492.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
12965	sp|P9WPM1|CP139_MY	P20815	100.7	59.0	492.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
12966	sp|P9WPM1|CP139_MY	Q9HB55	100.0	63.0	493.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
12967	sp|P9WPM1|CP139_MY	P20813	95.81	51.0	463.0	DB02974	experimental	4-(4-Chlorophenyl)Imidazole	Clc1ccc(cc1)-c2cnc[nH]2
12968	sp|P9WPM1|CP139_MY	P20813	95.81	51.0	463.0	DB04664	experimental	Cyclohexyl-pentyl-maltoside	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@@H]2CO)OCCCCCC3CCCCC3
12969	sp|P9WPM1|CP139_MY	P20813	95.81	51.0	463.0	DB04794	approved; investigational	Bifonazole	c1ccccc1C(n2ccnc2)c3ccc(cc3)-c4ccccc4
12970	sp|P9WPM1|CP139_MY	P20813	95.81	51.0	463.0	DB08369	experimental	1-(biphenyl-4-ylmethyl)-1H-imidazole	c1cncn1Cc2ccc(cc2)-c3ccccc3
12971	sp|P9WPM1|CP139_MY	P05181	95.58	54.0	465.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
12972	sp|P9WPM1|CP139_MY	P24462	100.23	62.0	493.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
12973	sp|P9WPM1|CP139_MY	P24462	100.23	62.0	493.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
12974	sp|P9WPM1|CP139_MY	P24462	100.23	62.0	493.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
12975	sp|P9WPM1|CP139_MY	P11509	96.74	56.0	472.0	DB04665	experimental	Coumarin	c1cc(=O)oc(c12)cccc2
12976	sp|P9WPM1|CP139_MY	P11509	96.74	56.0	472.0	DB07609	experimental	N,N-DIMETHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	CN(C)Cc1ccc(o1)-c2cccnc2
12977	sp|P9WPM1|CP139_MY	P11509	96.74	56.0	472.0	DB07617	experimental	N-METHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	CNCc1ccc(o1)-c2cccnc2
12978	sp|P9WPM1|CP139_MY	P11509	96.74	56.0	472.0	DB07621	experimental	(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	NCc1ccc(o1)-c2cccnc2
12979	sp|P9WPM1|CP139_MY	P11509	96.74	56.0	472.0	DB07623	experimental	4,4'-DIPYRIDYL DISULFIDE	c1cnccc1SSc2ccncc2
12980	sp|P9WPM1|CP139_MY	P04798	101.63	62.0	499.0	DB02342	investigational	2-Methoxyestradiol	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)c(c4)OC
12981	sp|P9WPM1|CP139_MY	P04798	101.63	62.0	499.0	DB12379	investigational	Indirubin	c1cccc(c12)NC(=O)C\2=C(C3=O)\Nc(c34)cccc4
12982	sp|P9WPM1|CP139_MY	P04798	101.63	62.0	499.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
12983	sp|P9WPM1|CP139_MY	P05177	102.09	64.0	503.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
12984	sp|P9WPM1|CP139_MY	P05177	102.09	64.0	503.0	DB07453	experimental	alpha-Naphthoflavone	c1ccccc1-c(cc2=O)oc(c23)c4c(cc3)cccc4
12985	sp|P9WPM1|CP139_MY	P05177	102.09	64.0	503.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
12986	sp|P9WPM1|CP139_MY	P05177	102.09	64.0	503.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
12987	sp|P9WPM1|CP139_MY	P05177	102.09	64.0	503.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
12988	sp|P9WPM1|CP139_MY	Q16850	96.05	83.0	496.0	DB01007	approved	Tioconazole	c1nccn1CC(c(c(Cl)c2)ccc2Cl)OCc3c(Cl)scc3
12989	sp|P9WPM1|CP139_MY	Q16850	96.05	83.0	496.0	DB01167	approved; investigational	Itraconazole	CCC(C)n1ncn(c1=O)-c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@@H](CO5)O[C@@]5(Cn6cncn6)c7ccc(Cl)cc7Cl
12990	sp|P9WPM1|CP139_MY	Q16850	96.05	83.0	496.0	DB05667	investigational	Levoketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OC[C@H](CO3)O[C@]3(Cn4ccnc4)c5ccc(Cl)cc5Cl
12991	sp|P9WPM1|CP139_MY	Q16850	96.05	83.0	496.0	DB07705	experimental	(S)-econazole	Clc1ccc(cc1)CO[C@H](Cn2ccnc2)c3c(Cl)cc(Cl)cc3
12992	sp|P9WPM1|CP139_MY	P50859	98.14	79.0	501.0	DB01026	approved; investigational	Ketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OCC(CO3)OC3(Cn4ccnc4)c5ccc(Cl)cc5Cl
12993	sp|P9WPM1|CP139_MY	P50859	98.14	79.0	501.0	DB01167	approved; investigational	Itraconazole	CCC(C)n1ncn(c1=O)-c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@@H](CO5)O[C@@]5(Cn6cncn6)c7ccc(Cl)cc7Cl
12994	sp|P9WPM1|CP139_MY	P50859	98.14	79.0	501.0	DB09040	approved	Efinaconazole	C=C1CCN(CC1)[C@H](C)[C@](O)(Cn2cncn2)c3c(F)cc(F)cc3
12995	sp|P9WPM1|CP139_MY	P50859	98.14	79.0	501.0	DB11633	approved; investigational	Isavuconazole	c1ncnn1C[C@](O)(c2c(F)ccc(F)c2)[C@@H](C)c3nc(cs3)-c4ccc(C#N)cc4
12996	sp|P9WPM1|CP139_MY	P10614	98.37	78.0	501.0	DB06890	experimental	(2R)-2-PHENYL-N-PYRIDIN-4-YLBUTANAMIDE	c1ccccc1[C@@H](CC)C(=O)Nc2ccncc2
12997	sp|P9WPM1|CP139_MY	P10614	98.37	78.0	501.0	DB07560	experimental	N-[(1S)-2-methyl-1-(pyridin-4-ylcarbamoyl)propyl]cyclohexanecarboxamide	c1cnccc1NC(=O)[C@H](C(C)C)NC(=O)C2CCCCC2
12998	sp|P9WPM1|CP139_MY	P10614	98.37	78.0	501.0	DB07568	experimental	(2S)-2-[(2,1,3-BENZOTHIADIAZOL-4-YLSULFONYL)AMINO]-2-PHENYL-N-PYRIDIN-4-YLACETAMIDE	n1snc(c12)cccc2S(=O)(=O)N[C@@H](c3ccccc3)C(=O)Nc4ccncc4
12999	sp|P9WPM1|CP139_MY	P10614	98.37	78.0	501.0	DB07569	experimental	CIS-4-METHYL-N-[(1S)-3-(METHYLSULFANYL)-1-(PYRIDIN-4-YLCARBAMOYL)PROPYL]CYCLOHEXANECARBOXAMIDE	c1cnccc1NC(=O)[C@H](CCSC)NC(=O)[C@@H]2CC[C@H](C)CC2
13000	sp|P9WPM1|CP139_MY	P10614	98.37	78.0	501.0	DB07572	experimental	3-{[(4-methylphenyl)sulfonyl]amino}propyl pyridin-4-ylcarbamate	Cc1ccc(cc1)S(=O)(=O)NCCCOC(=O)Nc2ccncc2
13001	sp|P9WPM1|CP139_MY	P10614	98.37	78.0	501.0	DB07635	experimental	4,4'-Dihydroxybenzophenone	Oc1ccc(cc1)C(=O)c2ccc(O)cc2
13002	sp|P9WPM1|CP139_MY	Q9NR63	96.74	73.0	489.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
13003	sp|P9WPM1|CP139_MY	P24557	108.37	64.0	530.0	DB00795	approved	Sulfasalazine	OC(=O)c1cc(ccc1O)/N=N/c2ccc(cc2)S(=O)(=O)Nc3ncccc3
13004	sp|P9WPM1|CP139_MY	P24557	108.37	64.0	530.0	DB01207	experimental	Ridogrel	OC(=O)CCCCO/N=C(/c1cnccc1)c2cc(C(F)(F)F)ccc2
13005	sp|P9WPM1|CP139_MY	P24557	108.37	64.0	530.0	DB03052	experimental	Dazoxiben	OC(=O)c1ccc(cc1)OCCn2ccnc2
13006	sp|P9WPM1|CP139_MY	P24557	108.37	64.0	530.0	DB05505	investigational	NM-702	 
13007	sp|P9WPM1|CP139_MY	P05093	98.14	51.0	473.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
13008	sp|P9WPM1|CP139_MY	P05093	98.14	51.0	473.0	DB00396	approved; vet_approved	Progesterone	CC(=O)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
13009	sp|P9WPM1|CP139_MY	P05093	98.14	51.0	473.0	DB00421	approved	Spironolactone	C1CC(=O)O[C@@]12[C@]3(C)[C@@H](CC2)[C@H]4[C@H](CC3)[C@]5(C)C(=CC(=O)CC5)C[C@H]4SC(=O)C
13010	sp|P9WPM1|CP139_MY	P05093	98.14	51.0	473.0	DB01026	approved; investigational	Ketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OCC(CO3)OC3(Cn4ccnc4)c5ccc(Cl)cc5Cl
13011	sp|P9WPM1|CP139_MY	P05093	98.14	51.0	473.0	DB05812	approved	Abiraterone	C1C[C@H](O)CC([C@]12C)=CC[C@@H]3[C@@H]2CC[C@@]4(C)[C@H]3CC=C4c5cccnc5
13012	sp|P9WPM1|CP139_MY	P05093	98.14	51.0	473.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
13014	sp|P9WPM1|CP139_MY	P05093	98.14	51.0	473.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
13015	sp|P9WPM1|CP139_MY	O43174	98.37	66.0	489.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
13016	sp|P9WPM1|CP139_MY	O43174	98.37	66.0	489.0	DB13083	investigational	Talarozole	c1ncnn1C(C(CC)CC)c2ccc(cc2)Nc(s3)nc(c34)cccc4
13017	sp|P9WPM1|CP139_MY	Q16678	103.49	73.0	518.0	DB01645	investigational	Genistein	Oc1ccc(cc1)-c(c2=O)coc(c23)cc(O)cc3O
13018	sp|P9WPM1|CP139_MY	Q16678	103.49	73.0	518.0	DB02342	investigational	2-Methoxyestradiol	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)c(c4)OC
13019	sp|P9WPM1|CP139_MY	Q16678	103.49	73.0	518.0	DB03467	experimental	Naringenin	Oc1ccc(cc1)[C@@H](O2)CC(=O)c(c23)c(O)cc(c3)O
13020	sp|P9WPM1|CP139_MY	Q16678	103.49	73.0	518.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
13021	sp|P9WPM1|CP139_MY	Q16678	103.49	73.0	518.0	DB06732	experimental	beta-Naphthoflavone	c1cccc(c12)c3c(cc2)oc(cc3=O)-c4ccccc4
13022	sp|P9WPM1|CP139_MY	Q16678	103.49	73.0	518.0	DB07776	approved; experimental	Flavone	c1cccc(c12)oc(cc2=O)-c3ccccc3
13023	sp|P9WPM1|CP139_MY	Q16678	103.49	73.0	518.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
13024	sp|P9WPM1|CP139_MY	Q16678	103.49	73.0	518.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
13025	sp|P9WPM1|CP139_MY	P10613	101.86	70.0	508.0	DB00196	approved; investigational	Fluconazole	c1ncnn1CC(O)(Cn2cncn2)c3c(F)cc(F)cc3
13026	sp|P9WPM1|CP139_MY	P10613	101.86	70.0	508.0	DB00239	approved	Oxiconazole	Clc1cc(Cl)c(cc1)CO/N=C(\Cn2ccnc2)c3ccc(Cl)cc3Cl
13027	sp|P9WPM1|CP139_MY	P10613	101.86	70.0	508.0	DB00251	approved	Terconazole	CC(C)N1CCN(CC1)c2ccc(cc2)OC[C@@H](CO3)O[C@@]3(Cn4cncn4)c5c(Cl)cc(Cl)cc5
13028	sp|P9WPM1|CP139_MY	P10613	101.86	70.0	508.0	DB00257	approved; vet_approved	Clotrimazole	Clc1ccccc1C(n2ccnc2)(c3ccccc3)c4ccccc4
13029	sp|P9WPM1|CP139_MY	P10613	101.86	70.0	508.0	DB00582	approved	Voriconazole	c1ncnn1C[C@](O)(c2c(F)cc(F)cc2)[C@@H](C)c3ncncc3F
13030	sp|P9WPM1|CP139_MY	P10613	101.86	70.0	508.0	DB01007	approved	Tioconazole	c1nccn1CC(c(c(Cl)c2)ccc2Cl)OCc3c(Cl)scc3
13031	sp|P9WPM1|CP139_MY	P10613	101.86	70.0	508.0	DB01110	approved; investigational; vet_approved	Miconazole	Clc1cc(Cl)c(cc1)COC(Cn2ccnc2)c3c(Cl)cc(Cl)cc3
13032	sp|P9WPM1|CP139_MY	P10613	101.86	70.0	508.0	DB01127	approved	Econazole	Clc1ccc(cc1)COC(Cn2ccnc2)c3c(Cl)cc(Cl)cc3
13033	sp|P9WPM1|CP139_MY	P10613	101.86	70.0	508.0	DB01153	approved; investigational	Sertaconazole	Clc1cc(Cl)ccc1C(Cn2cncc2)OCc3csc(c34)c(Cl)ccc4
13034	sp|P9WPM1|CP139_MY	P10613	101.86	70.0	508.0	DB01263	approved; investigational; vet_approved	Posaconazole	C[C@H](O)[C@H](CC)n1ncn(c1=O)-c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@H](CO5)C[C@]5(Cn6cncn6)c7c(F)cc(F)cc7
13035	sp|P9WPM1|CP139_MY	P10613	101.86	70.0	508.0	DB04794	approved; investigational	Bifonazole	c1ccccc1C(n2ccnc2)c3ccc(cc3)-c4ccccc4
13036	sp|P9WPM1|CP139_MY	P10613	101.86	70.0	508.0	DB08933	approved	Luliconazole	Clc1cc(Cl)c(cc1)[C@@H]2CS/C(S2)=C(/C#N)n3ccnc3
13037	sp|P9WPM1|CP139_MY	Q6V0L0	100.47	74.0	506.0	DB00523	approved; investigational	Alitretinoin	OC(=O)/C=C(\C)/C=C/C=C(/C)\C=C\C(C1(C)C)=C(C)CCC1
13038	sp|P9WPM1|CP139_MY	Q6V0L0	100.47	74.0	506.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
13039	sp|P9WPM1|CP139_MY	P15538	98.14	70.0	492.0	DB00648	approved	Mitotane	Clc1ccc(cc1)C(C(Cl)Cl)c2ccccc2Cl
13040	sp|P9WPM1|CP139_MY	P15538	98.14	70.0	492.0	DB01011	approved; investigational	Metyrapone	c1ccncc1C(C)(C)C(=O)c2cnccc2
13041	sp|P9WPM1|CP139_MY	P15538	98.14	70.0	492.0	DB05667	investigational	Levoketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OC[C@H](CO3)O[C@]3(Cn4ccnc4)c5ccc(Cl)cc5Cl
13042	sp|P9WPM1|CP139_MY	P15538	98.14	70.0	492.0	DB11837	approved; investigational	Osilodrostat	c1ncc(n12)CC[C@@H]2c3c(F)cc(C#N)cc3
13043	sp|P9WPM1|CP139_MY	P19099	98.37	69.0	492.0	DB00421	approved	Spironolactone	C1CC(=O)O[C@@]12[C@]3(C)[C@@H](CC2)[C@H]4[C@H](CC3)[C@]5(C)C(=CC(=O)CC5)C[C@H]4SC(=O)C
13044	sp|P9WPM1|CP139_MY	P19099	98.37	69.0	492.0	DB11837	approved; investigational	Osilodrostat	c1ncc(n12)CC[C@@H]2c3c(F)cc(C#N)cc3
13045	sp|P9WPM1|CP139_MY	Q02928	96.74	92.0	508.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
13047	sp|P9WPM1|CP139_MY	O15528	101.4	68.0	504.0	DB01436	approved; nutraceutical	Alfacalcidol	CC(C)CCC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)/C(CCC2)=C/C=C3/C[C@@H](O)C[C@H](O)C3=C
13048	sp|P9WPM1|CP139_MY	P10635	96.98	58.0	475.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
13049	sp|P9WPM1|CP139_MY	P10635	96.98	58.0	475.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
13050	sp|P9WPM1|CP139_MY	P10635	96.98	58.0	475.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
13051	sp|P9WPM1|CP139_MY	P14779	97.91	28.0	449.0	DB03440	experimental	N-hexadecanoylglycine	CCCCCCCCCCCCCCCC(=O)NCC(=O)O
13052	sp|P9WPM1|CP139_MY	P14779	97.91	28.0	449.0	DB04257	experimental	Palmitoleic Acid	CCCCCC/C=C\CCCCCCCC(=O)O
13053	sp|P9WPM1|CP139_MY	P14779	97.91	28.0	449.0	DB08086	experimental	N-[12-(1H-imidazol-1-yl)dodecanoyl]-L-leucine	CC(C)C[C@@H](C(=O)O)NC(=O)CCCCCCCCCCCn1ccnc1
13054	sp|P9WPM1|CP139_MY	P08686	95.58	48.0	459.0	DB01026	approved; investigational	Ketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OCC(CO3)OC3(Cn4ccnc4)c5ccc(Cl)cc5Cl
13055	sp|P9WPM1|CP139_MY	P05108	99.77	80.0	509.0	DB00357	approved; investigational	Aminoglutethimide	Nc1ccc(cc1)C2(CC)CCC(=O)NC2=O
13056	sp|P9WPM1|CP139_MY	P11511	94.65	76.0	483.0	DB00184	approved	Nicotine	CN1CCC[C@H]1c2cnccc2
13057	sp|P9WPM1|CP139_MY	P11511	94.65	76.0	483.0	DB00357	approved; investigational	Aminoglutethimide	Nc1ccc(cc1)C2(CC)CCC(=O)NC2=O
13058	sp|P9WPM1|CP139_MY	P11511	94.65	76.0	483.0	DB00655	approved	Estrone	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)cc4
13059	sp|P9WPM1|CP139_MY	P11511	94.65	76.0	483.0	DB00894	approved; investigational	Testolactone	C1=CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2CC[C@@]4(C)[C@H]3CCC(O4)=O
13060	sp|P9WPM1|CP139_MY	P11511	94.65	76.0	483.0	DB00990	approved; investigational	Exemestane	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(C(C3)=C)=CC(=O)C=C4
13061	sp|P9WPM1|CP139_MY	P11511	94.65	76.0	483.0	DB01006	approved; investigational	Letrozole	N#Cc1ccc(cc1)C(n2cncn2)c3ccc(C#N)cc3
13062	sp|P9WPM1|CP139_MY	P11511	94.65	76.0	483.0	DB01217	approved; investigational	Anastrozole	N#CC(C)(C)c1cc(C(C)(C)C#N)cc(c1)Cn2cncn2
13063	sp|P9WPM1|CP139_MY	P11511	94.65	76.0	483.0	DB02342	investigational	2-Methoxyestradiol	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)c(c4)OC
13064	sp|P9WPM1|CP139_MY	P11511	94.65	76.0	483.0	DB03467	experimental	Naringenin	Oc1ccc(cc1)[C@@H](O2)CC(=O)c(c23)c(O)cc(c3)O
13065	sp|P9WPM1|CP139_MY	P11511	94.65	76.0	483.0	DB04539	experimental	Glyphosate	OC(=O)C[NH2+]CP(=O)(O)O
13066	sp|P9WPM1|CP139_MY	P11511	94.65	76.0	483.0	DB05749	investigational	MPI-674	 
13067	sp|P9WPM1|CP139_MY	O31440	86.05	28.0	398.0	DB04257	experimental	Palmitoleic Acid	CCCCCC/C=C\CCCCCCCC(=O)O
13068	sp|P9WPM1|CP139_MY	P53554	79.53	24.0	366.0	DB04450	experimental	Heptyl 1-Thiohexopyranoside	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)SCCCCCCC
13069	sp|P9WPM1|CP139_MY	Q00441	87.21	26.0	401.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
13070	sp|P9WPM1|CP139_MY	Q00441	87.21	26.0	401.0	DB03369	experimental	9-Aminophenanthrene	c1cccc(c12)c3c(cc2N)cccc3
13071	sp|P9WPM1|CP139_MY	Q00441	87.21	26.0	401.0	DB04070	experimental	6-Deoxyerythronolide B	C[C@@H]1C[C@H](C)[C@H](O)[C@@H](C)[C@H](O)[C@@H](C)C(=O)O[C@H](CC)[C@H](C)[C@H](O)[C@@H](C)C1=O
13072	sp|P9WPM1|CP139_MY	Q9FCA6	74.88	52.0	374.0	DB02175	experimental	Malonic acid	OC(=O)CC(=O)O
13073	sp|P9WPM1|CP139_MY	Q9FCA6	74.88	52.0	374.0	DB02521	experimental	Flaviolin	Oc1cc(O)cc(c12)C(=O)C(O)=CC2=O
13074	sp|P9WPM1|CP139_MY	Q9FCA6	74.88	52.0	374.0	DB03254	experimental	4-Phenyl-1h-Imidazole	[nH]1cncc1-c2ccccc2
13075	sp|P9WPM1|CP139_MY	Q9FCA6	74.88	52.0	374.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
13076	sp|P9WPM1|CP139_MY	Q16647	103.02	52.0	495.0	DB00812	approved; vet_approved	Phenylbutazone	CCCCC1C(=O)N(c2ccccc2)N(C1=O)c3ccccc3
13077	sp|P9WPM1|CP139_MY	Q16647	103.02	52.0	495.0	DB01240	approved	Epoprostenol	OC(=O)CCC/C=C(C1)\O[C@H]([C@H]12)C[C@@H](O)[C@@H]2/C=C/[C@@H](O)CCCCC
13078	sp|P9WPM1|CP139_MY	Q16647	103.02	52.0	495.0	DB08675	experimental	(5Z)-7-{(1R,4S,5R,6R)-6-[(1E)-1-Octen-1-yl]-2,3-diazabicyclo[2.2.1]hept-2-en-5-yl}-5-heptenoic acid	OC(=O)CCC/C=C\C[C@@H]([C@H]12)[C@H]([C@@H](C1)N=N2)/C=C/CCCCCC
13079	sp|P9WQ05|ARCA_MYC	P13981	101.99	6.0	416.0	DB04671	experimental	[(1S)-4-[[Amino-[(2R)-2-amino-2-carboxyethyl]sulfanylmethylidene]amino]-1-carboxybutyl]azanium	OC(=O)[C@@H](N)CS/C(N)=N/CCC[C@H]([NH3+])C(=O)O
13080	sp|P9WPB7|CMAS1_MY	P9WPB7	99.65	1.0	287.0	DB01718	approved	Cetrimonium	CCCCCCCCCCCCCCCC[N+](C)(C)C
13081	sp|P9WPB7|CMAS1_MY	P9WPB3	99.65	1.0	287.0	DB01752	experimental	S-adenosyl-L-homocysteine	OC(=O)[C@@H](N)CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
13082	sp|P9WPB7|CMAS1_MY	Q79FX6	99.65	1.0	287.0	DB01718	approved	Cetrimonium	CCCCCCCCCCCCCCCC[N+](C)(C)C
13083	sp|P9WPB7|CMAS1_MY	Q79FX6	99.65	1.0	287.0	DB01752	experimental	S-adenosyl-L-homocysteine	OC(=O)[C@@H](N)CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
13084	sp|P9WPB7|CMAS1_MY	Q79FX8	99.3	11.0	296.0	DB07413	experimental	5'-S-[2-(decylamino)ethyl]-5'-thioadenosine	n1cnc(N)c(c12)ncn2[C@H]3[C@H](O)[C@H](O)[C@H](O3)CSCCNCCCCCCCCCC
13085	sp|P9WPB7|CMAS1_MY	P9WPB5	101.39	11.0	302.0	DB01752	experimental	S-adenosyl-L-homocysteine	OC(=O)[C@@H](N)CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
13086	sp|P9WPB7|CMAS1_MY	P9WPB5	101.39	11.0	302.0	DB04221	approved; experimental	Didecyldimethylammonium	CCCCCCCCCC[N+](C)(C)CCCCCCCCCC
13087	sp|O53380|DACB1_MY	P08506	70.86	26.0	313.0	DB00578	approved; investigational	Carbenicillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)C(C(=O)O)c3ccccc3
13088	sp|O53380|DACB1_MY	P08506	70.86	26.0	313.0	DB01000	approved	Cyclacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)C3(N)CCCCC3
13089	sp|O53380|DACB1_MY	P08506	70.86	26.0	313.0	DB01602	approved; investigational	Bacampicillin	CCOC(=O)OC(C)OC(=O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)[C@H](N)c3ccccc3
13090	sp|O53380|DACB1_MY	P08506	70.86	26.0	313.0	DB09050	approved; investigational	Ceftolozane	NCCNC(=O)Nc1c(N)n(C)[n+](c1)CC(CS2)=C(C([O-])=O)N([C@H]23)C(=O)[C@H]3NC(=O)/C(=N\OC(C)(C)C(=O)O)c4nsc(n4)N
13091	sp|O53380|DACB1_MY	P08506	70.86	26.0	313.0	DB09319	approved; investigational	Carindacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)C(c3ccccc3)C(=O)Oc(cc4)cc(c45)CCC5
13092	sp|O53380|DACB1_MY	P08506	70.86	26.0	313.0	DB00274	approved; investigational	Cefmetazole	N#CCSCC(=O)N[C@@](C1=O)(OC)[C@H](N12)SCC(=C2C(=O)O)CSc3nnnn3C
13093	sp|O53380|DACB1_MY	P08506	70.86	26.0	313.0	DB00303	approved; investigational	Ertapenem	C[C@@H](O)[C@@H](C1=O)[C@H](N12)[C@@H](C)C(=C2C(=O)O)S[C@@H]3CN[C@@H](C3)C(=O)Nc4cccc(c4)C(=O)O
13094	sp|O53380|DACB1_MY	P08506	70.86	26.0	313.0	DB00430	approved	Cefpiramide	Cn1nnnc1SCC(=C2C(=O)O)CS[C@@H](N23)[C@@H](C3=O)NC(=O)[C@@H](c4ccc(O)cc4)NC(=O)c5c(O)cc(C)nc5
13095	sp|O53380|DACB1_MY	P08506	70.86	26.0	313.0	DB01329	approved; investigational	Cefoperazone	Cn1nnnc1SCC(=C2C(=O)O)CS[C@@H](N23)[C@@H](C3=O)NC(=O)[C@@H](c4ccc(O)cc4)NC(=O)N5CCN(CC)C(=O)C5=O
13096	sp|O53380|DACB1_MY	P08506	70.86	26.0	313.0	DB01331	approved	Cefoxitin	NC(=O)OCC(=C1C(=O)O)CS[C@@H](N12)[C@](C2=O)(OC)NC(=O)Cc3cccs3
13097	sp|O53380|DACB1_MY	P08506	70.86	26.0	313.0	DB01332	approved; withdrawn	Ceftizoxime	O=C(O)C1=CCS[C@@H](N12)[C@@H](C2=O)NC(=O)/C(=N\OC)c3csc(n3)N
13098	sp|P71858|CHSE2_MY	Q72JJ3	96.9	5.0	380.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
13099	sp|P71858|CHSE2_MY	P16219	97.16	32.0	408.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
13100	sp|P71858|CHSE2_MY	P16219	97.16	32.0	408.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
13101	sp|P71858|CHSE2_MY	P16219	97.16	32.0	408.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
13102	sp|P71858|CHSE2_MY	Q06319	97.93	3.0	382.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
13103	sp|P71858|CHSE2_MY	Q06319	97.93	3.0	382.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
13104	sp|P71858|CHSE2_MY	P26440	96.64	42.0	416.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
13105	sp|P71858|CHSE2_MY	P26440	96.64	42.0	416.0	DB04036	experimental	Coenzyme A persulfide	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSS
13106	sp|P71858|CHSE2_MY	P11310	97.16	39.0	415.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
13107	sp|P71858|CHSE2_MY	P11310	97.16	39.0	415.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
13108	sp|P71858|CHSE2_MY	P11310	97.16	39.0	415.0	DB03415	experimental	3-thiaoctanoyl-CoA	CCCCCSCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
13109	sp|P71858|CHSE2_MY	P45954	95.87	56.0	427.0	DB00167	investigational; nutraceutical	Isoleucine	CC[C@H](C)[C@H](N)C(=O)O
13110	sp|P71858|CHSE2_MY	P45954	95.87	56.0	427.0	DB00313	approved; investigational	Valproic acid	CCCC(C(=O)O)CCC
13111	sp|P71858|CHSE2_MY	Q9UKU7	96.64	40.0	414.0	DB01675	experimental	Methacrylyl-Coenzyme A	CC(=C)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
13112	sp|P71858|CHSE2_MY	Q9UKU7	96.64	40.0	414.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
13113	sp|P71858|CHSE2_MY	Q3JP94	95.61	17.0	387.0	DB08685	experimental	1-(1,4-dimethyl-1,2,3,4-tetrahydroquinoxalin-6-yl)methanamine	CN1CCN(C)c(c12)cc(cc2)CN
13114	sp|P71858|CHSE2_MY	Q92947	95.09	59.0	427.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
13115	sp|P71858|CHSE2_MY	Q92947	95.09	59.0	427.0	DB03245	experimental	S-4-Nitrobutyryl-CoA	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCC[N+]([O-])=O
13116	sp|P71858|CHSE2_MY	Q9KIE5	90.18	16.0	365.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
13117	sp|P9WP17|DCDB_MYC	P28248	98.95	1.0	189.0	DB02333	experimental	Deoxyuridine-5'-Triphosphate	O=c1[nH]c(=O)ccn1[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
13118	sp|P9WP17|DCDB_MYC	P28248	98.95	1.0	189.0	DB03258	experimental	2'-Deoxycytidine 5'-triphosphate	Nc1nc(=O)n(cc1)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
13119	sp|P9WK17|MASZ_MYC	P9WK17	99.87	1.0	741.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
13120	sp|P9WK17|MASZ_MYC	P9WK17	99.87	1.0	741.0	DB03499	experimental	D-Malic acid	OC(=O)[C@H](O)CC(=O)O
13121	sp|P9WK17|MASZ_MYC	P9WK17	99.87	1.0	741.0	DB04343	experimental	Glyoxylic acid	OC(=O)C=O
13122	sp|P9WK17|MASZ_MYC	P37330	96.76	1.0	718.0	DB04343	experimental	Glyoxylic acid	OC(=O)C=O
13123	sp|P9WQF9|MBTN_MYC	Q72JJ3	94.04	15.0	378.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
13124	sp|P9WQF9|MBTN_MYC	P26440	96.89	47.0	421.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
13125	sp|P9WQF9|MBTN_MYC	P26440	96.89	47.0	421.0	DB04036	experimental	Coenzyme A persulfide	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSS
13126	sp|P9WQF9|MBTN_MYC	P16219	94.04	43.0	406.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
13127	sp|P9WQF9|MBTN_MYC	P16219	94.04	43.0	406.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
13128	sp|P9WQF9|MBTN_MYC	P16219	94.04	43.0	406.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
13129	sp|P9WQF9|MBTN_MYC	Q06319	95.08	11.0	378.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
13130	sp|P9WQF9|MBTN_MYC	Q06319	95.08	11.0	378.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
13131	sp|P9WQF9|MBTN_MYC	P11310	95.34	46.0	414.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
13132	sp|P9WQF9|MBTN_MYC	P11310	95.34	46.0	414.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
13133	sp|P9WQF9|MBTN_MYC	P11310	95.34	46.0	414.0	DB03415	experimental	3-thiaoctanoyl-CoA	CCCCCSCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
13134	sp|P9WQF9|MBTN_MYC	P45954	94.82	64.0	430.0	DB00167	investigational; nutraceutical	Isoleucine	CC[C@H](C)[C@H](N)C(=O)O
13135	sp|P9WQF9|MBTN_MYC	P45954	94.82	64.0	430.0	DB00313	approved; investigational	Valproic acid	CCCC(C(=O)O)CCC
13136	sp|P9WQF9|MBTN_MYC	Q9UKU7	94.04	49.0	412.0	DB01675	experimental	Methacrylyl-Coenzyme A	CC(=C)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
13137	sp|P9WQF9|MBTN_MYC	Q9UKU7	94.04	49.0	412.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
13138	sp|P9WQF9|MBTN_MYC	Q3JP94	94.04	25.0	388.0	DB08685	experimental	1-(1,4-dimethyl-1,2,3,4-tetrahydroquinoxalin-6-yl)methanamine	CN1CCN(C)c(c12)cc(cc2)CN
13139	sp|P9WQF9|MBTN_MYC	Q92947	93.78	67.0	429.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
13140	sp|P9WQF9|MBTN_MYC	Q92947	93.78	67.0	429.0	DB03245	experimental	S-4-Nitrobutyryl-CoA	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCC[N+]([O-])=O
13141	sp|P9WQF9|MBTN_MYC	Q9KIE5	89.38	15.0	360.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
13142	sp|P9WQF9|MBTN_MYC	Q15067	86.27	105.0	438.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
13143	sp|P9WQF9|MBTN_MYC	Q15067	86.27	105.0	438.0	DB07930	experimental	(3R)-3-HYDROXYDODECANOIC ACID	OC(=O)C[C@H](O)CCCCCCCCC
13144	sp|P9WQH5|PCC6_MYC	Q9X4K7	102.33	46.0	530.0	DB02912	experimental	Propanoyl-CoA	CCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
13145	sp|P9WQH5|PCC6_MYC	Q8GBW6	98.73	46.0	513.0	DB04045	experimental	(R)-methylmalonyl-CoA	OC(=O)[C@@H](C)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
13146	sp|P9WQH5|PCC6_MYC	Q8GBW6	98.73	46.0	513.0	DB04183	experimental	Methylmalonic Acid	OC(=O)C(C)C(=O)O
13147	sp|P9WQH5|PCC6_MYC	P05166	100.42	64.0	539.0	DB00121	approved; investigational; nutraceutical	Biotin	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC(=O)O
13148	sp|P9WQH5|PCC6_MYC	P05166	100.42	64.0	539.0	DB00161	approved; nutraceutical	Valine	CC(C)[C@H](N)C(=O)O
13149	sp|P9WQH5|PCC6_MYC	Q9HCC0	97.25	81.0	541.0	DB00121	approved; investigational; nutraceutical	Biotin	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC(=O)O
13150	sp|P9WQH5|PCC6_MYC	Q13085	71.46	1793.0	2131.0	DB00121	approved; investigational; nutraceutical	Biotin	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC(=O)O
13151	sp|P9WQH5|PCC6_MYC	O00763	71.46	1904.0	2242.0	DB00121	approved; investigational; nutraceutical	Biotin	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC(=O)O
13152	sp|P9WQH5|PCC6_MYC	O00763	71.46	1904.0	2242.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
13153	sp|P9WQH5|PCC6_MYC	O00763	71.46	1904.0	2242.0	DB02859	experimental	Soraphen A	CO[C@@H]([C@]12O)[C@@H](O)[C@H](C)[C@@H](O1)[C@@H](C)/C=C/[C@@H](OC)[C@@H](OC)CCCC[C@H](OC(=O)[C@H]2C)c3ccccc3
13154	sp|P9WQH5|PCC6_MYC	O00763	71.46	1904.0	2242.0	DB03781	experimental	2-[4-(2,4-Dichlorophenoxy)Phenoxy]Propanoic Acid	OC(=O)[C@@H](C)Oc1ccc(cc1)Oc2ccc(Cl)cc2Cl
13155	sp|P9WQH5|PCC6_MYC	O00763	71.46	1904.0	2242.0	DB07870	experimental	Haloxyfop-P	OC(=O)[C@@H](C)Oc1ccc(cc1)Oc2c(Cl)cc(cn2)C(F)(F)F
13156	sp|P9WH09|RMLD_MYC	P26392	95.07	2.0	291.0	DB03723	experimental	2'-Deoxy-Thymidine-Beta-L-Rhamnose	O[C@@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]1C)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H](C[C@@H]2O)n3cc(C)c(=O)[nH]c3=O
13157	sp|P9WH09|RMLD_MYC	P14060	86.18	6.0	268.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
13158	sp|P9WH09|RMLD_MYC	P14060	86.18	6.0	268.0	DB01108	approved; investigational; vet_approved; withdrawn	Trilostane	C1C[C@H](O)[C@@](C)(CC2)[C@@H]1[C@H](CC3)[C@H]2[C@@]([C@@]345)(C)CC(C#N)=C([C@H]4O5)O
13159	sp|P9WH09|RMLD_MYC	P14060	86.18	6.0	268.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
13160	sp|P9WH09|RMLD_MYC	P14060	86.18	6.0	268.0	DB14538	experimental; vet_approved	Hydrocortisone aceponate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CC)C(=O)COC(=O)C
13161	sp|P9WH09|RMLD_MYC	P14060	86.18	6.0	268.0	DB14539	approved; vet_approved	Hydrocortisone acetate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)C
13162	sp|P9WH09|RMLD_MYC	P14060	86.18	6.0	268.0	DB14540	approved; vet_approved	Hydrocortisone butyrate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCC
13163	sp|P9WH09|RMLD_MYC	P14060	86.18	6.0	268.0	DB14541	approved; investigational; vet_approved	Hydrocortisone cypionate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)CCC5CCCC5
13164	sp|P9WH09|RMLD_MYC	P14060	86.18	6.0	268.0	DB14542	approved; vet_approved	Hydrocortisone phosphate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COP(=O)(O)O
13165	sp|P9WH09|RMLD_MYC	P14060	86.18	6.0	268.0	DB14543	approved; vet_approved	Hydrocortisone probutate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CCC)C(=O)COC(=O)CC
13166	sp|P9WH09|RMLD_MYC	P14060	86.18	6.0	268.0	DB14544	approved; vet_approved	Hydrocortisone valerate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCCC
13167	sp|P9WH09|RMLD_MYC	P26439	87.17	5.0	270.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
13168	sp|P9WH09|RMLD_MYC	P26439	87.17	5.0	270.0	DB01108	approved; investigational; vet_approved; withdrawn	Trilostane	C1C[C@H](O)[C@@](C)(CC2)[C@@H]1[C@H](CC3)[C@H]2[C@@]([C@@]345)(C)CC(C#N)=C([C@H]4O5)O
13169	sp|P9WH09|RMLD_MYC	Q15738	77.63	36.0	272.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
13170	sp|P9WH09|RMLD_MYC	P67910	78.62	2.0	241.0	DB01774	experimental	Adenosine-5'-Monophosphate Glucopyranosyl-Monophosphate Ester	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@@](=O)(O)O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O
13171	sp|P9WH09|RMLD_MYC	P67910	78.62	2.0	241.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
13172	sp|P9WH09|RMLD_MYC	P09147	80.92	1.0	247.0	DB01861	experimental	Uridine diphosphate glucose	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
13173	sp|P9WH09|RMLD_MYC	P09147	80.92	1.0	247.0	DB02421	experimental	Uridine-5'-diphosphate-mannose	O=c1[nH]c(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O
13174	sp|P9WH09|RMLD_MYC	P09147	80.92	1.0	247.0	DB02790	experimental	Phenyl-uridine-5'-diphosphate	O=c1[nH]c(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)Oc3ccccc3
13175	sp|P9WH09|RMLD_MYC	P09147	80.92	1.0	247.0	DB03397	experimental	Uridine-Diphosphate-N-Acetylglucosamine	CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
13176	sp|P9WH09|RMLD_MYC	P09147	80.92	1.0	247.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
13177	sp|P9WH09|RMLD_MYC	P09147	80.92	1.0	247.0	DB04097	experimental	Uridine-5'-diphosphate-4-deoxy-4-fluoro-alpha-D-galactose	O=c1[nH]c(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](F)[C@H](O)[C@H]3O
13178	sp|P9WH09|RMLD_MYC	P14169	86.84	2.0	266.0	DB04555	experimental	Cytidine-5'-Diphosphate	Nc1nc(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O
13179	sp|P9WH09|RMLD_MYC	P26391	89.14	1.0	272.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
13180	sp|P9WH09|RMLD_MYC	Q9ZGH3	89.14	1.0	272.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
13181	sp|P9WH09|RMLD_MYC	Q14376	90.46	2.0	277.0	DB01861	experimental	Uridine diphosphate glucose	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
13182	sp|P9WH09|RMLD_MYC	Q14376	90.46	2.0	277.0	DB02196	experimental	Uridine-Diphosphate-N-Acetylgalactosamine	CC(=O)N[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
13183	sp|P9WH09|RMLD_MYC	Q14376	90.46	2.0	277.0	DB03041	experimental	UDP-alpha-D-glucuronic acid	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O
13184	sp|P9WH09|RMLD_MYC	Q14376	90.46	2.0	277.0	DB03095	experimental	Tetramethylammonium	C[N+](C)(C)C
13185	sp|P9WH09|RMLD_MYC	Q14376	90.46	2.0	277.0	DB03397	experimental	Uridine-Diphosphate-N-Acetylglucosamine	CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
13186	sp|P9WH09|RMLD_MYC	Q14376	90.46	2.0	277.0	DB03501	experimental	Galactose-uridine-5'-diphosphate	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@H]1O)O[P@](=O)(O)O[P@](=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
13187	sp|P9WH09|RMLD_MYC	Q8KN66	82.24	20.0	270.0	DB01861	experimental	Uridine diphosphate glucose	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
13188	sp|P9WH09|RMLD_MYC	Q8KN66	82.24	20.0	270.0	DB02196	experimental	Uridine-Diphosphate-N-Acetylgalactosamine	CC(=O)N[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
13189	sp|P9WH09|RMLD_MYC	Q13630	84.21	7.0	263.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
13190	sp|P9WH09|RMLD_MYC	Q51366	90.13	6.0	280.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
13191	sp|P9WGG3|NPD_MYCT	Q9NXA8	105.06	52.0	301.0	DB02059	experimental	Adenosine-5-Diphosphoribose	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)CO[P@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H](O)[C@H](O)[C@@H]4O
13192	sp|P9WGG3|NPD_MYCT	Q9NXA8	105.06	52.0	301.0	DB02701	approved; investigational	Nicotinamide	NC(=O)c1cccnc1
13193	sp|P9WGG3|NPD_MYCT	Q9NXA8	105.06	52.0	301.0	DB03478	experimental	2'-O-Acetyl Adenosine-5-Diphosphoribose	CC(=O)O[C@@H]1[C@H](O)[C@H](O[C@@H]1O)COP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3cnc(c34)c(N)ncn4
13194	sp|P9WGG3|NPD_MYCT	Q9NXA8	105.06	52.0	301.0	DB04786	investigational	Suramin	O=S(=O)(O)c(c1)cc(S(=O)(=O)O)c(c12)c(ccc2S(=O)(=O)O)NC(=O)c3ccc(C)c(c3)NC(=O)c4cc(ccc4)NC(=O)Nc5cccc(c5)C(=O)Nc6c(C)ccc(c6)C(=O)Nc(ccc7S(=O)(=O)O)c(c78)c(S(=O)(=O)O)cc(c8)S(=O)(=O)O
13195	sp|P9WGG3|NPD_MYCT	Q9NXA8	105.06	52.0	301.0	DB15493	experimental	Cambinol	c1cccc(c12)c(c(O)cc2)Cc3c([nH]c(=S)[nH]c3=O)-c4ccccc4
13196	sp|P9WGG3|NPD_MYCT	Q8IXJ6	91.98	78.0	296.0	DB15493	experimental	Cambinol	c1cccc(c12)c(c(O)cc2)Cc3c([nH]c(=S)[nH]c3=O)-c4ccccc4
13197	sp|P9WGG3|NPD_MYCT	Q96EB6	100.42	255.0	493.0	DB02709	investigational	Resveratrol	Oc1ccc(cc1)/C=C/c2cc(O)cc(O)c2
13198	sp|P9WGG3|NPD_MYCT	Q96EB6	100.42	255.0	493.0	DB13978	experimental	Selisistat	O=C(N)C1CCCc(c12)c3c([nH]2)ccc(Cl)c3
13199	sp|P9WGG3|NPD_MYCT	Q96EB6	100.42	255.0	493.0	DB15493	experimental	Cambinol	c1cccc(c12)c(c(O)cc2)Cc3c([nH]c(=S)[nH]c3=O)-c4ccccc4
13200	sp|P9WGG3|NPD_MYCT	Q9NTG7	88.61	139.0	349.0	DB02059	experimental	Adenosine-5-Diphosphoribose	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)CO[P@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H](O)[C@H](O)[C@@H]4O
13201	sp|P9WPF1|PKS18_MY	P9WPF1	99.75	1.0	393.0	DB08231	experimental	Myristic acid	CCCCCCCCCCCCCC(=O)O
13202	sp|P9WPF1|PKS18_MY	P0A6R0	77.35	10.0	314.0	DB01034	experimental	Cerulenin	NC(=O)[C@@H]1O[C@@H]1C(=O)CC/C=C/C/C=C/C
13203	sp|P9WPF1|PKS18_MY	P0A6R0	77.35	10.0	314.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
13204	sp|P9WPF1|PKS18_MY	P0A6R0	77.35	10.0	314.0	DB02039	experimental	S-Acetyl-Cysteine	OC(=O)[C@@H](N)CSC(=O)C
13205	sp|P9WPF1|PKS18_MY	P0A6R0	77.35	10.0	314.0	DB02316	experimental	1-(5-Carboxypentyl)-5-[(2,6-Dichlorobenzyl)Oxy]-1 H-Indole-2-Carboxylic Acid	OC(=O)CCCCCn1c(C(=O)O)cc(c12)cc(cc2)OCc3c(Cl)cccc3Cl
13206	sp|P9WPF1|PKS18_MY	P0A6R0	77.35	10.0	314.0	DB03661	experimental	L-cysteic acid	OC(=O)[C@@H](N)CS(=O)(=O)O
13207	sp|P9WPF1|PKS18_MY	P0A6R0	77.35	10.0	314.0	DB04524	experimental	Malonyl-CoA	OC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
13208	sp|P9WPF1|PKS18_MY	P9WNG3	78.63	20.0	329.0	DB03017	approved; experimental	Lauric acid	CCCCCCCCCCCC(=O)O
13209	sp|P9WPF1|PKS18_MY	P9WNG3	78.63	20.0	329.0	DB03264	experimental	Dodecyl-Coa	CCCCCCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
13210	sp|P9WPF1|PKS18_MY	P9WNG3	78.63	20.0	329.0	DB07611	experimental	DECANE-1-THIOL	CCCCCCCCCCS
13211	sp|P9WPF1|PKS18_MY	P9WNG3	78.63	20.0	329.0	DB07650	experimental	Decyl formate	CCCCCCCCCCOC=O
13212	sp|P9WPF1|PKS18_MY	P9WNG3	78.63	20.0	329.0	DB08171	experimental	11-MERCAPTOUNDECANOIC ACID	OC(=O)CCCCCCCCCCS
13213	sp|P9WPF1|PKS18_MY	P9WNG3	78.63	20.0	329.0	DB08684	experimental	O-Decyl Hydrogen Thiocarbonate	CCCCCCCCCCOC(=O)S
13214	sp|P9WPF1|PKS18_MY	P9WNG3	78.63	20.0	329.0	DB08712	experimental	11-[(MERCAPTOCARBONYL)OXY]UNDECANOIC ACID	OC(=O)CCCCCCCCCCOC(=O)S
13215	sp|P9WPF1|PKS18_MY	Q820T1	78.63	10.0	319.0	DB07429	experimental	2-({[4-bromo-3-(diethylsulfamoyl)phenyl]carbonyl}amino)benzoic acid	CCN(CC)S(=O)(=O)c1cc(ccc1Br)C(=O)Nc2ccccc2C(=O)O
13216	sp|P9WPF1|PKS18_MY	Q9F6D4	78.37	19.0	327.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
13217	sp|P9WHZ7|PPE40_MY	Q9P2E9	70.24	165.0	597.0	DB12339	investigational	Radezolid	CC(=O)NC[C@H]1CN(C(=O)O1)c2ccc(c(F)c2)-c3ccc(cc3)CNCc4cnn[nH]4
13218	sp|P9WIT7|PYRB_MYC	P0A786	93.42	7.0	305.0	DB05540	investigational	Alanosine	OC(=O)[C@@H](N)CN(O)N=O
13219	sp|P9WIT7|PYRB_MYC	P0A789	93.42	7.0	305.0	DB03459	experimental	Sparfosic acid	OP(=O)(O)CC(=O)N[C@H](C(=O)O)CC(=O)O
13220	sp|P9WIT7|PYRB_MYC	P27708	93.42	1924.0	2222.0	DB03459	experimental	Sparfosic acid	OP(=O)(O)CC(=O)N[C@H](C(=O)O)CC(=O)O
13221	sp|P9WIT7|PYRB_MYC	Q8IDP8	98.75	56.0	371.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
13222	sp|P9WIT7|PYRB_MYC	Q8P8J2	104.7	1.0	335.0	DB02368	experimental	N-Acetyl-L-Citrulline	CC(=O)N[C@H](C(=O)O)CCCNC(=O)N
13223	sp|P9WIT7|PYRB_MYC	Q8P8J2	104.7	1.0	335.0	DB08554	experimental	N-(3-carboxypropanoyl)-L-norvaline	CCC[C@@H](C(=O)O)NC(=O)CCC(=O)O
13224	sp|P9WIT7|PYRB_MYC	P04391	86.52	6.0	282.0	DB02965	experimental	Ndelta-(N'-Sulphodiaminophosphinyl)-L-Ornithine	OC(=O)[C@@H](N)CCCN[P@](=O)(N)NS(=O)(=O)O
13225	sp|P9WIT7|PYRB_MYC	P00480	94.67	40.0	342.0	DB00129	approved; nutraceutical	Ornithine	NCCC[C@H](N)C(=O)O
13226	sp|P9WIT7|PYRB_MYC	P00480	94.67	40.0	342.0	DB00155	approved; investigational; nutraceutical	Citrulline	OC(=O)[C@@H](N)CCCNC(=O)N
13227	sp|P9WIT7|PYRB_MYC	P00480	94.67	40.0	342.0	DB02011	experimental	N-(Phosphonoacetyl)-L-Ornithine	OC(=O)[C@@H](N)CCCNC(=O)CP(=O)(O)O
13228	sp|P9WIT7|PYRB_MYC	P00480	94.67	40.0	342.0	DB04185	experimental	Norvaline	CCC[C@H](N)C(=O)O
13229	sp|P9WIT7|PYRB_MYC	Q5LI27	89.34	18.0	303.0	DB08554	experimental	N-(3-carboxypropanoyl)-L-norvaline	CCC[C@@H](C(=O)O)NC(=O)CCC(=O)O
13230	sp|P9WH75|RIR1_MYC	Q08698	96.83	12.0	714.0	DB02452	experimental	Thymidine 5'-triphosphate	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
13231	sp|P9WH75|RIR1_MYC	Q08698	96.83	12.0	714.0	DB03222	experimental	dATP	Nc1ncnc(c12)n(cn2)[C@H]3C[C@H](O)[C@H](O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
13232	sp|P9WH75|RIR1_MYC	Q08698	96.83	12.0	714.0	DB03258	experimental	2'-Deoxycytidine 5'-triphosphate	Nc1nc(=O)n(cc1)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
13233	sp|P9WH75|RIR1_MYC	P23921	70.21	136.0	645.0	DB00242	approved; investigational	Cladribine	Clc(n1)nc(N)c(c12)ncn2[C@H]3C[C@H](O)[C@H](O3)CO
13234	sp|P9WH75|RIR1_MYC	P23921	70.21	136.0	645.0	DB00441	approved	Gemcitabine	Nc1nc(=O)n(cc1)[C@@H](C2(F)F)O[C@H](CO)[C@H]2O
13235	sp|P9WH75|RIR1_MYC	P23921	70.21	136.0	645.0	DB00631	approved; investigational	Clofarabine	F[C@H]1[C@H](O)[C@@H](CO)O[C@H]1n2cnc(c23)c(N)nc(n3)Cl
13236	sp|P9WH75|RIR1_MYC	P23921	70.21	136.0	645.0	DB01005	approved	Hydroxyurea	NC(=O)NO
13237	sp|P9WH75|RIR1_MYC	P23921	70.21	136.0	645.0	DB01073	approved	Fludarabine	Nc1nc(F)nc(c12)n(cn2)[C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3O
13238	sp|P9WH75|RIR1_MYC	P23921	70.21	136.0	645.0	DB05003	investigational	Imexon	N12C(C1)C(N)=NC2=O
13239	sp|P9WH75|RIR1_MYC	P23921	70.21	136.0	645.0	DB05420	investigational	Gallium maltolate	Cc1c([O-])c(=O)cco1
13240	sp|P9WH75|RIR1_MYC	P23921	70.21	136.0	645.0	DB06433	investigational	Tezacitabine	Nc1nc(=O)n(cc1)[C@@H]2O[C@H](CO)[C@@H](O)C\2=C/F
13241	sp|P9WHA7|RL29_MYC	P42766	79.22	4.0	65.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
13242	sp|P9WGB5|METZ_MYC	P13254	91.13	24.0	394.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
13243	sp|P9WGB5|METZ_MYC	P00935	92.12	4.0	378.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
13244	sp|P9WGB5|METZ_MYC	P32929	85.22	48.0	394.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
13245	sp|P9WGB5|METZ_MYC	P32929	85.22	48.0	394.0	DB00151	approved; nutraceutical	Cysteine	OC(=O)[C@@H](N)CS
13246	sp|P9WGB5|METZ_MYC	P32929	85.22	48.0	394.0	DB02328	experimental	2-[(3-Hydroxy-2-Methyl-5-Phosphonooxymethyl-Pyridin-4-Ylmethyl)-Imino]-5-Phosphono-Pent-3-Enoic Acid	OP(=O)(O)C/C=C/C(C(=O)O)=N\Cc1c(COP(=O)(O)O)cnc(C)c1O
13247	sp|P9WGB5|METZ_MYC	P32929	85.22	48.0	394.0	DB03928	experimental	Carboxymethylthio-3-(3-Chlorophenyl)-1,2,4-Oxadiazol	OC(=O)CSc1nc(no1)-c2cccc(Cl)c2
13248	sp|P9WGB5|METZ_MYC	P32929	85.22	48.0	394.0	DB04217	experimental	L-2-amino-3-butynoic acid	OC(=O)[C@@H](N)C#C
13249	sp|P9WK07|METE_MYC	Q9X112	95.65	3.0	729.0	DB04422	experimental	Homocysteine	OC(=O)[C@@H](N)CCS
13250	sp|P9WK07|METE_MYC	Q9X112	95.65	3.0	729.0	DB04481	experimental	Erythritol	OC[C@H](O)[C@H](O)CO
13251	sp|P9WJL5|MURD_MYC	P14900	75.6	5.0	380.0	DB01673	experimental	Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine	OC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)O[C@@H]([C@@H]1NC(=O)C)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
13252	sp|P9WJL5|MURD_MYC	P14900	75.6	5.0	380.0	DB02314	experimental	Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine-D-Glutamate	OC(=O)CC[C@H](C(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)O[C@@H]([C@@H]1NC(=O)C)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
13253	sp|P9WJL5|MURD_MYC	P14900	75.6	5.0	380.0	DB03801	experimental	Lysine Nz-Carboxylic Acid	OC(=O)[C@@H](N)CCCCNC(=O)O
13254	sp|P9WJL5|MURD_MYC	P14900	75.6	5.0	380.0	DB08105	experimental	N-[(6-butoxynaphthalen-2-yl)sulfonyl]-L-glutamic acid	CCCCOc(cc1)cc(c12)ccc(c2)S(=O)(=O)N[C@H](C(=O)O)CCC(=O)O
13255	sp|P9WJL5|MURD_MYC	P14900	75.6	5.0	380.0	DB08106	experimental	N-[(6-butoxynaphthalen-2-yl)sulfonyl]-D-glutamic acid	CCCCOc(cc1)cc(c12)ccc(c2)S(=O)(=O)N[C@@H](C(=O)O)CCC(=O)O
13256	sp|P9WJL5|MURD_MYC	P14900	75.6	5.0	380.0	DB08107	experimental	N-{[6-(PENTYLOXY)NAPHTHALEN-2-YL]SULFONYL}-D-GLUTAMIC ACID	OC(=O)CC[C@H](C(=O)O)NS(=O)(=O)c(cc1)cc(c12)ccc(c2)OCCCCC
13257	sp|P9WJL5|MURD_MYC	P14900	75.6	5.0	380.0	DB08108	experimental	N-({6-[(4-CYANOBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID	OC(=O)CC[C@H](C(=O)O)NS(=O)(=O)c(cc1)cc(c12)ccc(c2)OCc3ccc(C#N)cc3
13258	sp|P9WJL5|MURD_MYC	P14900	75.6	5.0	380.0	DB08112	experimental	N-({6-[(4-CYANO-2-FLUOROBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID	OC(=O)CC[C@H](C(=O)O)NS(=O)(=O)c(cc1)cc(c12)ccc(c2)OCc3c(F)cc(C#N)cc3
13259	sp|I6Y9Q3|PRPC_MYC	O34002	95.67	3.0	379.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
13260	sp|I6Y9Q3|PRPC_MYC	O34002	95.67	3.0	379.0	DB04272	approved; nutraceutical; vet_approved	Citric acid	OC(=O)CC(O)(C(=O)O)CC(=O)O
13261	sp|I6Y9Q3|PRPC_MYC	Q9LCX9	92.37	2.0	365.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
13262	sp|I6Y9Q3|PRPC_MYC	Q9LCX9	92.37	2.0	365.0	DB04272	approved; nutraceutical; vet_approved	Citric acid	OC(=O)CC(O)(C(=O)O)CC(=O)O
13263	sp|I6Y9Q3|PRPC_MYC	O75390	96.69	72.0	452.0	DB01969	experimental	Trifluoroacetonyl coenzyme A	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSCC(=O)C(F)(F)F
13264	sp|I6Y9Q3|PRPC_MYC	O75390	96.69	72.0	452.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
13265	sp|I6Y9Q3|PRPC_MYC	O75390	96.69	72.0	452.0	DB02637	experimental	Oxaloacetate Ion	OC(=O)C(=O)CC([O-])=O
13266	sp|I6Y9Q3|PRPC_MYC	O75390	96.69	72.0	452.0	DB03182	experimental	alpha-Fluoro-carboxymethyldethia coenzyme A complex	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCC[C@@H](F)C(=O)O
13267	sp|I6Y9Q3|PRPC_MYC	O75390	96.69	72.0	452.0	DB03499	experimental	D-Malic acid	OC(=O)[C@H](O)CC(=O)O
13268	sp|I6Y9Q3|PRPC_MYC	O75390	96.69	72.0	452.0	DB04230	experimental	Nitromethyldethia coenzyme A	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCC[N+]([O-])=O
13269	sp|I6Y9Q3|PRPC_MYC	O75390	96.69	72.0	452.0	DB04272	approved; nutraceutical; vet_approved	Citric acid	OC(=O)CC(O)(C(=O)O)CC(=O)O
13270	sp|P9WHM9|PUR2_MYC	P22102	99.76	4.0	425.0	DB00642	approved; investigational	Pemetrexed	Nc([nH]1)nc(=O)c(c12)c(c[nH]2)CCc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
13271	sp|P9WHM9|PUR2_MYC	P22102	99.76	4.0	425.0	DB02236	experimental	Glycinamide Ribonucleotide	NCC(=O)NC1O[C@@H]([C@@H](O)[C@H]1O)COP(=O)(O)O
13272	sp|P9WHM9|PUR2_MYC	P22102	99.76	4.0	425.0	DB03546	experimental	N-({4-[(1R)-4-[(2R,4S,5S)-2,4-diamino-6-oxohexahydropyrimidin-5-yl]-1-(2,2,2-trifluoro-1,1-dihydroxyethyl)butyl]phenyl}carbonyl)-L-glutamic acid	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)[C@H](C(O)(O)C(F)(F)F)CCCC2C(O)=N[C@H](N)N[C@@H]2N
13273	sp|P9WH69|RIR2H_MY	P9WH69	99.68	1.0	314.0	DB08231	experimental	Myristic acid	CCCCCCCCCCCCCC(=O)O
13274	sp|L7N6B4|MOAD_MYC	P54646	72.29	285.0	345.0	DB00131	approved; investigational; nutraceutical	Adenosine phosphate	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
13275	sp|L7N6B4|MOAD_MYC	P54646	72.29	285.0	345.0	DB00945	approved; vet_approved	Acetylsalicylic acid	CC(=O)Oc1ccccc1C(=O)O
13276	sp|L7N6B4|MOAD_MYC	P54646	72.29	285.0	345.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
13277	sp|L7N6B4|MOAD_MYC	Q13131	71.08	297.0	356.0	DB00131	approved; investigational; nutraceutical	Adenosine phosphate	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
13278	sp|L7N6B4|MOAD_MYC	Q13131	71.08	297.0	356.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
13279	sp|L7N6B4|MOAD_MYC	Q13131	71.08	297.0	356.0	DB00914	approved; investigational; withdrawn	Phenformin	NC(=N)NC(=N)NCCc1ccccc1
13280	sp|L7N6B4|MOAD_MYC	Q13131	71.08	297.0	356.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
13282	sp|L7N6B4|MOAD_MYC	Q13131	71.08	297.0	356.0	DB00945	approved; vet_approved	Acetylsalicylic acid	CC(=O)Oc1ccccc1C(=O)O
13284	sp|P9WHN1|PUR7_MYC	P22234	74.07	11.0	231.0	DB00128	approved; nutraceutical	Aspartic acid	OC(=O)[C@@H](N)CC(=O)O
13285	sp|P9WHC7|RL1_MYCT	Q2G0P0	96.17	1.0	227.0	DB01190	approved; vet_approved	Clindamycin	CCC[C@@H]1C[C@H](N(C)C1)C(=O)NC(C(Cl)C)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O
13286	sp|P9WIY1|MUTT2_MY	P08337	89.36	2.0	128.0	DB02023	experimental	8-oxo-dGMP	O=c1[nH]c(N)nc(c12)n(c(=O)[nH]2)[C@H]3C[C@H](O)[C@H](O3)COP(=O)(O)O
13287	sp|P9WIY1|MUTT2_MY	P32056	86.52	22.0	144.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
13288	sp|P9WIY1|MUTT2_MY	Q84CU3	73.05	36.0	139.0	DB02053	experimental	Ribose-5-phosphate	O=C[C@H](O)[C@H](O)[C@H](O)COP(=O)(O)O
13289	sp|P9WIY1|MUTT2_MY	Q84CU3	73.05	36.0	139.0	DB02059	experimental	Adenosine-5-Diphosphoribose	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)CO[P@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H](O)[C@H](O)[C@@H]4O
13290	sp|P9WIY1|MUTT2_MY	Q46822	78.72	44.0	155.0	DB01799	experimental	4-Hydroxy-3-Methyl Butyl Diphosphate	OC[C@@H](C)CCO[P@@](=O)(O)OP(=O)(O)O
13291	sp|P9WIY1|MUTT2_MY	Q46822	78.72	44.0	155.0	DB02480	experimental	(S)-4-bromo-3-hydroxy-3-methylbutyl diphosphate	BrC[C@@](C)(O)CCOP(=O)(O)OP(=O)(O)O
13292	sp|P9WIY1|MUTT2_MY	Q46822	78.72	44.0	155.0	DB03165	experimental	2-Dimethylamino-Ethyl-Diphosphate	CN(C)CCO[P@@](=O)(O)OP(=O)(O)O
13293	sp|P9WIY1|MUTT2_MY	Q46822	78.72	44.0	155.0	DB03366	experimental; investigational	Imidazole	[nH]1ccnc1
13294	sp|P9WIY1|MUTT2_MY	Q46822	78.72	44.0	155.0	DB04170	experimental	4-bromo-3-hydroxy-3-methyl butyl diphosphate	BrC[C@](C)(O)CCO[P@@](=O)(O)OP(=O)(O)O
13295	sp|P9WK27|NTPP_MYC	Q02169	77.48	5.0	177.0	DB02333	experimental	Deoxyuridine-5'-Triphosphate	O=c1[nH]c(=O)ccn1[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
13296	sp|P9WID7|PFKA_MYC	P00512	89.8	3.0	311.0	DB02726	experimental	2-Phosphoglycolic Acid	OC(=O)COP(=O)(O)O
13297	sp|P9WID7|PFKA_MYC	P00512	89.8	3.0	311.0	DB04493	experimental	Fructose-6-phosphate	OCC(=O)[C@@H](O)[C@H](O)[C@H](O)COP(=O)(O)O
13298	sp|P9WGT7|PSTS3_MY	P0AG82	83.78	22.0	332.0	DB02799	experimental	N-[2-(1-Maleimidyl)Ethyl]-7-Diethylaminocoumarin-3-Carboxamide	CCN(CC)c(cc1)cc(c12)oc(=O)c(c2)C(=O)N/C=C\N3C(=O)CCC3=O
13299	sp|P9WGT7|PSTS3_MY	P0AG82	83.78	22.0	332.0	DB02831	experimental	Dihydrogenphosphate	OP([O-])(=O)O
13300	sp|P9WP01|PUNA_MYC	P9WP01	99.63	1.0	268.0	DB03411	experimental	2-Hydroxymethyl-Pyrrolidine-3,4-Diol	OC[C@@H]1NC[C@H](O)[C@H]1O
13301	sp|P9WP01|PUNA_MYC	P9WP01	99.63	1.0	268.0	DB03551	experimental	(3R,4R)-3-Hydroxy-4-(hydroxymethyl)-1-[(4-oxo-4,4a,5,7a-tetrahydro-3H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]pyrrolidinium	O=C1NC=NC(C12)C(=CN2)C[NH+]3C[C@H](O)[C@H](C3)CO
13302	sp|P9WP01|PUNA_MYC	P9WP01	99.63	1.0	268.0	DB04095	experimental	9-Deazahypoxanthine	[nH]1ccc(c12)nc[nH]c2=O
13303	sp|P9WP01|PUNA_MYC	P81989	100.75	12.0	282.0	DB02985	experimental	8-iodo-guanine	Nc([nH]1)nc(=O)c(c12)[nH]c(n2)I
13304	sp|P9WP01|PUNA_MYC	Q9X1T2	94.78	7.0	261.0	DB02377	experimental	Guanine	Nc([nH]1)nc(=O)c(c12)[nH]cn2
13305	sp|P9WP01|PUNA_MYC	P00491	95.15	24.0	279.0	DB00242	approved; investigational	Cladribine	Clc(n1)nc(N)c(c12)ncn2[C@H]3C[C@H](O)[C@H](O3)CO
13306	sp|P9WP01|PUNA_MYC	P00491	95.15	24.0	279.0	DB00900	approved	Didanosine	OC[C@@H]1CC[C@@H](O1)n2cnc(c23)c(=O)nc[nH]3
13307	sp|P9WP01|PUNA_MYC	P00491	95.15	24.0	279.0	DB01667	experimental	8-azaguanine	O=c1[nH]c(N)nc(c12)[nH]nn2
13308	sp|P9WP01|PUNA_MYC	P00491	95.15	24.0	279.0	DB02222	experimental	2,6-Diamino-(S)-9-[2-(Phosphonomethoxy)Propyl]Purine	[O-]P([O-])(=O)CO[C@@H](C)Cn1cnc(c12)c(N)nc(n2)N
13309	sp|P9WP01|PUNA_MYC	P00491	95.15	24.0	279.0	DB02230	experimental	Immucillin-G	O=c1[nH]c(N)nc(c12)c(c[nH]2)[C@@H]3N[C@H](CO)[C@@H](O)[C@H]3O
13310	sp|P9WP01|PUNA_MYC	P00491	95.15	24.0	279.0	DB02377	experimental	Guanine	Nc([nH]1)nc(=O)c(c12)[nH]cn2
13311	sp|P9WP01|PUNA_MYC	P00491	95.15	24.0	279.0	DB02391	experimental	2-Amino-7-[2-(2-Hydroxy-1-Hydroxymethyl-Ethylamino)-Ethyl]-1,7-Dihydro-Purin-6-One	O=c1[nH]c(N)nc(c12)ncn2CCNC(CO)CO
13312	sp|P9WP01|PUNA_MYC	P00491	95.15	24.0	279.0	DB02568	investigational	Peldesine	Nc([nH]1)nc(=O)c(c12)[nH]cc2Cc3cnccc3
13313	sp|P9WP01|PUNA_MYC	P00491	95.15	24.0	279.0	DB02796	experimental	9-deazainosine	O=c1nc[nH]c(c12)c(c[nH]2)[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O
13314	sp|P9WP01|PUNA_MYC	P00491	95.15	24.0	279.0	DB02857	experimental; investigational	Guanosine	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O
13315	sp|P9WP01|PUNA_MYC	P00491	95.15	24.0	279.0	DB03101	experimental	Ribose-1-Phosphate	OC[C@H]1O[C@H](OP(=O)(O)O)[C@H](O)[C@@H]1O
13316	sp|P9WP01|PUNA_MYC	P00491	95.15	24.0	279.0	DB03551	experimental	(3R,4R)-3-Hydroxy-4-(hydroxymethyl)-1-[(4-oxo-4,4a,5,7a-tetrahydro-3H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]pyrrolidinium	O=C1NC=NC(C12)C(=CN2)C[NH+]3C[C@H](O)[C@H](C3)CO
13317	sp|P9WP01|PUNA_MYC	P00491	95.15	24.0	279.0	DB03609	experimental	3'-deoxyguanosine	Nc([nH]1)nc(=O)c(c12)ncn2[C@@H]3O[C@H](CO)C[C@H]3O
13318	sp|P9WP01|PUNA_MYC	P00491	95.15	24.0	279.0	DB03881	experimental	(2S,3R,4S,5S)-3,4-Dihydroxy-2-[(methylsulfanyl)methyl]-5-(4-oxo-4,5-dihydro-1H-pyrrolo[3,2-d]pyrimidin-7-yl)pyrrolidinium	O=c1nc[nH]c(c12)c(c[nH]2)[C@H]3[C@H](O)[C@H](O)[C@H]([NH2+]3)CSC
13319	sp|P9WP01|PUNA_MYC	P00491	95.15	24.0	279.0	DB04076	experimental	Hypoxanthine	[nH]1cnc(c12)[nH]cnc2=O
13320	sp|P9WP01|PUNA_MYC	P00491	95.15	24.0	279.0	DB04260	experimental	9-(5,5-Difluoro-5-Phosphonopentyl)Guanine	O=c1[nH]c(N)nc(c12)n(cn2)CCCCC(F)(F)P(=O)(O)O
13321	sp|P9WP01|PUNA_MYC	P00491	95.15	24.0	279.0	DB04335	experimental; investigational	Inosine	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(=O)nc[nH]3
13322	sp|P9WP01|PUNA_MYC	P00491	95.15	24.0	279.0	DB04753	experimental	9-DEAZAINOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE	OP(=O)(O)C[C@H](O1)O[C@H]([C@H]12)[C@@H](O[C@@H]2CO)c3c[nH]c(c34)c(=O)nc[nH]4
13323	sp|P9WP01|PUNA_MYC	P00491	95.15	24.0	279.0	DB04754	experimental	GUANOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE	Nc([nH]1)nc(=O)c(c12)ncn2[C@@H]3O[C@H](CO)[C@H]([C@H]34)O[C@H](O4)CP(=O)(O)O
13324	sp|P9WP01|PUNA_MYC	P00491	95.15	24.0	279.0	DB04757	experimental	GUANOSINE-2',3'-O-METHYLIDENEPHOSPHONATE	Nc([nH]1)nc(=O)c(c12)ncn2[C@@H]3O[C@H](CO)[C@H]([C@H]34)O[C@@H](O4)P(=O)(O)O
13325	sp|P9WP01|PUNA_MYC	P00491	95.15	24.0	279.0	DB06185	investigational	Forodesine	OC[C@H]1N[C@H]([C@H](O)[C@@H]1O)c2c[nH]c(c23)c(=O)[nH]cn3
13326	sp|P9WP01|PUNA_MYC	P45563	91.04	26.0	270.0	DB02134	experimental	Xanthine	O=c1[nH]c(=O)[nH]c(c12)nc[nH]2
13327	sp|P9WP01|PUNA_MYC	P45563	91.04	26.0	270.0	DB02377	experimental	Guanine	Nc([nH]1)nc(=O)c(c12)[nH]cn2
13328	sp|P9WP01|PUNA_MYC	Q13126	77.61	44.0	252.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
13329	sp|P9WP01|PUNA_MYC	Q13126	77.61	44.0	252.0	DB02158	experimental	(2S,3S,4R,5S)-2-(4-Amino-4,5-dihydro-1H-pyrrolo[3,2-d]pyrimidin-7-yl)-5-[(methylsulfanyl)methyl]-3,4-pyrrolidinediol	CSC[C@H]1N[C@H]([C@H](O)[C@@H]1O)c2c[nH]c(c23)C(N)NC=N3
13330	sp|P9WP01|PUNA_MYC	Q13126	77.61	44.0	252.0	DB02281	experimental	Formycin	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)c([nH]n2)c(c23)ncnc3N
13331	sp|P9WP01|PUNA_MYC	Q13126	77.61	44.0	252.0	DB02282	experimental	5'-S-methyl-5'-thioadenosine	CSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
13332	sp|P9WP01|PUNA_MYC	Q13126	77.61	44.0	252.0	DB02933	experimental	5'-Deoxy-5'-(Methylthio)-Tubercidin	CSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2ccc(c23)c(N)ncn3
13333	sp|P9WPY5|AROA_MYC	P0A6D3	91.78	10.0	423.0	DB01942	experimental; investigational	Formic acid	OC=O
13334	sp|P9WPY5|AROA_MYC	P0A6D3	91.78	10.0	423.0	DB03116	experimental	5-(1-Carboxy-1-Phosphonooxy-Ethoxyl)-Shikimate-3-Phosphate	OP(=O)(O)O[C@@](C)(C(=O)O)O[C@@H]1CC(C(=O)O)=C[C@H]([C@H]1O)OP(=O)(O)O
13335	sp|P9WPY5|AROA_MYC	P0A6D3	91.78	10.0	423.0	DB04328	experimental	Shikimate-3-Phosphate	O[C@@H]1CC(C(=O)O)=C[C@H]([C@H]1O)OP(=O)(O)O
13336	sp|P9WPY5|AROA_MYC	P0A6D3	91.78	10.0	423.0	DB04539	experimental	Glyphosate	OC(=O)C[NH2+]CP(=O)(O)O
13337	sp|P9WPY5|AROA_MYC	Q9S400	92.67	5.0	422.0	DB04328	experimental	Shikimate-3-Phosphate	O[C@@H]1CC(C(=O)O)=C[C@H]([C@H]1O)OP(=O)(O)O
13338	sp|P9WPY5|AROA_MYC	Q9S400	92.67	5.0	422.0	DB04539	experimental	Glyphosate	OC(=O)C[NH2+]CP(=O)(O)O
13339	sp|P9WHQ9|HGPRT_MY	Q27796	90.1	8.0	190.0	DB01632	approved; experimental; investigational	5-O-phosphono-alpha-D-ribofuranosyl diphosphate	OP(=O)(O)OP(=O)(O)O[C@@H]1[C@H](O)[C@H](O)[C@H](O1)COP(=O)(O)O
13340	sp|P9WHQ9|HGPRT_MY	Q27796	90.1	8.0	190.0	DB01942	experimental; investigational	Formic acid	OC=O
13341	sp|P9WHQ9|HGPRT_MY	Q27796	90.1	8.0	190.0	DB04198	experimental	Formycin B	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)c([nH]n2)c(c23)nc[nH]c3=O
13342	sp|P9WHQ9|HGPRT_MY	Q27796	90.1	8.0	190.0	DB04566	experimental	Inosinic Acid	OP(=O)(O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O1)n2cnc(c23)c(=O)[nH]cn3
13343	sp|P9WHQ9|HGPRT_MY	P0A9M2	83.17	5.0	173.0	DB04566	experimental	Inosinic Acid	OP(=O)(O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O1)n2cnc(c23)c(=O)[nH]cn3
13344	sp|P9WHQ9|HGPRT_MY	P00492	90.59	26.0	209.0	DB01033	approved	Mercaptopurine	[nH]1cnc(c12)[nH]cnc2=S
13345	sp|P9WHQ9|HGPRT_MY	P00492	90.59	26.0	209.0	DB01632	approved; experimental; investigational	5-O-phosphono-alpha-D-ribofuranosyl diphosphate	OP(=O)(O)OP(=O)(O)O[C@@H]1[C@H](O)[C@H](O)[C@H](O1)COP(=O)(O)O
13346	sp|P9WHQ9|HGPRT_MY	P00492	90.59	26.0	209.0	DB02309	experimental	5-monophosphate-9-beta-D-ribofuranosyl xanthine	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)[n+]2c[nH]c(c23)c(=O)[nH]c(=O)[nH]3
13347	sp|P9WHQ9|HGPRT_MY	P00492	90.59	26.0	209.0	DB03153	experimental	3H-pyrazolo[4,3-d]pyrimidin-7-ol	N1=NCc(c12)ncnc2O
13348	sp|P9WHQ9|HGPRT_MY	P00492	90.59	26.0	209.0	DB04356	experimental	9-Deazaguanine	O=c1[nH]c(N)nc(c12)cc[nH]2
13349	sp|P9WHQ9|HGPRT_MY	P20035	92.08	34.0	220.0	DB02075	experimental	[(2R,3R,4S,5S)-3,4-Dihydroxy-5-(4-oxo-4,5-dihydro-1H-pyrrolo[3,2-d]pyrimidin-7-yl)-2-pyrrolidinyl]methyl dihydrogen phosphate	O=c1nc[nH]c(c12)c(c[nH]2)[C@@H]3N[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
13350	sp|P9WHQ9|HGPRT_MY	P20035	92.08	34.0	220.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
13351	sp|P9WHQ9|HGPRT_MY	P41007	75.25	3.0	155.0	DB01972	experimental	Guanosine-5'-Monophosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
13352	sp|P9WHQ9|HGPRT_MY	P41007	75.25	3.0	155.0	DB03315	experimental	Guanosine 3'-monophosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@H](CO)[C@H]([C@H]3O)OP(=O)(O)O
13353	sp|P9WHQ9|HGPRT_MY	P41007	75.25	3.0	155.0	DB03685	experimental	Uridine monophosphate	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2ccc(=O)[nH]c2=O
13354	sp|P9WKG9|ISPD_MYC	Q9X1B3	92.21	3.0	216.0	DB02431	experimental	Cytidine-5'-Triphosphate	Nc1nc(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
13355	sp|P9WKG9|ISPD_MYC	Q46893	95.24	5.0	225.0	DB02431	experimental	Cytidine-5'-Triphosphate	Nc1nc(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
13356	sp|P9WKG9|ISPD_MYC	Q46893	95.24	5.0	225.0	DB03687	experimental	4-(Cytidine 5'-diphospho)-2-C-methyl-D-erythritol	OC[C@](C)(O)[C@H](O)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2ccc(N)nc2=O
13357	sp|P9WKG9|ISPD_MYC	Q46893	95.24	5.0	225.0	DB03854	experimental	Cadaverine	NCCCCCN
13358	sp|P9WKG9|ISPD_MYC	Q9PM68	85.28	2.0	199.0	DB02552	experimental	Geranyl Diphosphate	CC(C)=CCC/C(C)=C/CO[P@@](=O)(O)OP(=O)(O)O
13359	sp|P9WKG9|ISPD_MYC	Q9PM68	85.28	2.0	199.0	DB03403	experimental	Cytidine-5'-Monophosphate	Nc1nc(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)O
13360	sp|P9WJM5|MSRA_MYC	P0A745	86.26	44.0	201.0	DB03963	experimental	S-(Dimethylarsenic)Cysteine	OC(=O)[C@@H](N)CS[As](C)C
13361	sp|P9WJM5|MSRA_MYC	Q9UJ68	86.26	65.0	222.0	DB04447	experimental	1,4-Dithiothreitol	SC[C@H](O)[C@@H](O)CS
13362	sp|P9WGB7|METB_MYC	P32929	97.68	15.0	394.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
13363	sp|P9WGB7|METB_MYC	P32929	97.68	15.0	394.0	DB00151	approved; nutraceutical	Cysteine	OC(=O)[C@@H](N)CS
13364	sp|P9WGB7|METB_MYC	P32929	97.68	15.0	394.0	DB02328	experimental	2-[(3-Hydroxy-2-Methyl-5-Phosphonooxymethyl-Pyridin-4-Ylmethyl)-Imino]-5-Phosphono-Pent-3-Enoic Acid	OP(=O)(O)C/C=C/C(C(=O)O)=N\Cc1c(COP(=O)(O)O)cnc(C)c1O
13365	sp|P9WGB7|METB_MYC	P32929	97.68	15.0	394.0	DB03928	experimental	Carboxymethylthio-3-(3-Chlorophenyl)-1,2,4-Oxadiazol	OC(=O)CSc1nc(no1)-c2cccc(Cl)c2
13366	sp|P9WGB7|METB_MYC	P32929	97.68	15.0	394.0	DB04217	experimental	L-2-amino-3-butynoic acid	OC(=O)[C@@H](N)C#C
13367	sp|P9WGB7|METB_MYC	P13254	100.77	3.0	394.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
13368	sp|P9WGB7|METB_MYC	P00935	96.39	4.0	378.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
13369	sp|P9WJR1|MOAE2_MY	P30749	92.91	7.0	138.0	DB01942	experimental; investigational	Formic acid	OC=O
13371	sp|P0CL62|MAZF7_MY	P96622	80.15	4.0	113.0	DB02042	experimental	2-(2-{2-[2-(2-Methoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol	COCCOCCOCCOCCOCCO
13372	sp|P9WJY3|MFS55_MY	P9WJY5	78.19	53.0	458.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
13373	sp|O33259|METH_MYC	Q99707	101.93	15.0	1230.0	DB00115	approved; nutraceutical	Cyanocobalamin	Cc(c1)c(C)cc(c12)ncn2[C@@H]3[C@H](O)[C@@H]([C@H](O3)CO)OP([O-])(=O)O[C@H](C)CNC(=O)CC[C@](C)([C@@H](CC(=O)N)[C@@H]4[C@]56C)C(=N4)/C(C)=C7\N=C(C(C)(C)[C@@H]7CCC(=O)N)/C=C8\N=C([C@@](C)(CC(=O)N)[C@@H]8CCC(=O)N)/C(C)=C(\N5[Co+]C#N)[C@@H](CCC(=O)N)[C@]6(C)CC(=O)N
13374	sp|O33259|METH_MYC	Q99707	101.93	15.0	1230.0	DB00116	nutraceutical	Tetrahydrofolic acid	Nc([nH]1)nc(=O)c(c12)NC(CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
13375	sp|O33259|METH_MYC	Q99707	101.93	15.0	1230.0	DB00134	approved; nutraceutical	Methionine	CSCC[C@H](N)C(=O)O
13376	sp|O33259|METH_MYC	Q99707	101.93	15.0	1230.0	DB00200	approved	Hydroxocobalamin	c1c(C)c(C)cc(c1[n+]2[Co-3]3456O)n(c2)[C@H]7O[C@H](CO)[C@H]([C@H]7O)OP(=O)([O-])O[C@H](C)CNC(=O)CC[C@@]8(C)C=9N3[C@H]([C@@H]8CC(=O)N)[C@]1(C)[N+]4=C([C@H]([C@]1(C)CC(=O)N)CCC(=O)N)C(C)=C1[N+]5=C([C@H]([C@]1(C)CC(=O)N)CCC(=O)N)C=C1[N+]6=C(C9C)[C@H](C1(C)C)CCC(=O)N
13377	sp|O33259|METH_MYC	Q99707	101.93	15.0	1230.0	DB03614	approved; investigational	Mecobalamin	Cc(c1)c(C)cc(c1[n+]2[Co-3]3456C)n(c2)[C@@H]7[C@H](O)[C@@H]([C@H](O7)CO)OP([O-])(=O)O[C@H](C)CNC(=O)CC[C@@]8(C)C=9N3[C@H]([C@@H]8CC(=O)N)[C@]1(C)[N+]4=C([C@H]([C@]1(C)CC(=O)N)CCC(=O)N)C(C)=C1[N+]6=C([C@H]([C@]1(C)CC(=O)N)CCC(=O)N)C=C1[N+]5=C(C9C)[C@H](C1(C)C)CCC(=O)N
13378	sp|O33259|METH_MYC	Q99707	101.93	15.0	1230.0	DB11590	approved	Thimerosal	CC[Hg]Sc1ccccc1C([O-])=O
13415	sp|Q6MWV0|PG61_MYC	Q9UEW3	74.87	147.0	293.0	DB09536	approved	Titanium dioxide	O=[Ti]=O
13416	sp|Q6MWV0|PG61_MYC	Q9UEW3	74.87	147.0	293.0	DB11132	approved	Silicon dioxide	O=[Si]=O
13417	sp|Q6MWV0|PG61_MYC	P35247	85.13	47.0	213.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
13418	sp|P9WHM7|PUR9_MYC	P31939	87.95	2.0	462.0	DB00116	nutraceutical	Tetrahydrofolic acid	Nc([nH]1)nc(=O)c(c12)NC(CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
13419	sp|P9WHM7|PUR9_MYC	P31939	87.95	2.0	462.0	DB00563	approved	Methotrexate	Nc1nc(N)nc(c12)ncc(n2)CN(C)c3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
13420	sp|P9WHM7|PUR9_MYC	P31939	87.95	2.0	462.0	DB00642	approved; investigational	Pemetrexed	Nc([nH]1)nc(=O)c(c12)c(c[nH]2)CCc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
13421	sp|P9WHM7|PUR9_MYC	P31939	87.95	2.0	462.0	DB01700	experimental; investigational	AICA ribonucleotide	NC(=O)c1c(N)n(cn1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)O
13422	sp|P9WHM7|PUR9_MYC	P31939	87.95	2.0	462.0	DB01972	experimental	Guanosine-5'-Monophosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
13423	sp|P9WHM7|PUR9_MYC	P31939	87.95	2.0	462.0	DB02309	experimental	5-monophosphate-9-beta-D-ribofuranosyl xanthine	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)[n+]2c[nH]c(c23)c(=O)[nH]c(=O)[nH]3
13424	sp|P9WHM7|PUR9_MYC	P31939	87.95	2.0	462.0	DB03442	experimental	Acid yellow 54 free acid	O=S(=O)(O)c1ccc(c(c1)C)-n2nc(C)c(c2O)/N=N/c3cc(S(=O)(=O)O)ccc3C(=O)O
13425	sp|P9WHM7|PUR9_MYC	P31939	87.95	2.0	462.0	DB04057	experimental	N-[4-([(2-Amino-4-oxo-1,4-dihydropyrido[3,2-d]pyrimidin-6-yl)methyl]{(2E)-3-[4-carbamoyl-1-(5-O-phosphono-beta-D-ribofuranosyl)-1H-imidazol-5-yl]-2-propenoyl}amino)benzoyl]-L-glutamic acid	OP(=O)(O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O1)n2cnc(C(=O)N)c2/C=C/C(=O)N(Cc(cc3)nc(c34)c(=O)nc([nH]4)N)c5ccc(cc5)C(=O)N[C@H](C(=O)O)CCC(=O)O
13426	sp|P9WHE9|RISB_MYC	P9WHE9	99.38	1.0	160.0	DB01692	experimental	Dithioerythritol	SC[C@H](O)[C@H](O)CS
13427	sp|P9WHE9|RISB_MYC	P9WHE9	99.38	1.0	160.0	DB02135	experimental	1-deoxy-1-{2,6,8-trioxo-7-[4-(phosphonooxy)butyl]-1,2,3,6,7,8-hexahydro-9H-purin-9-yl}-D-arabinitol	OP(=O)(O)OCCCCn1c(=O)n(c(c12)[nH]c(=O)[nH]c2=O)C[C@@H](O)[C@H](O)[C@H](O)CO
13428	sp|P9WHE9|RISB_MYC	P9WHE9	99.38	1.0	160.0	DB02184	experimental	D-1,4-dithiothreitol	SC[C@@H](O)[C@H](O)CS
13429	sp|P9WHE9|RISB_MYC	P9WHE9	99.38	1.0	160.0	DB02290	experimental	3-{2,6,8-trioxo-9-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate	OP(=O)(O)OCCCn1c(=O)n(c(c12)[nH]c(=O)[nH]c2=O)C[C@H](O)[C@H](O)[C@H](O)CO
13430	sp|P9WHE9|RISB_MYC	P9WHE9	99.38	1.0	160.0	DB02693	experimental	(4S,5S)-1,2-dithiane-4,5-diol	O[C@@H]1CSSC[C@H]1O
13431	sp|P9WHE9|RISB_MYC	P9WHE9	99.38	1.0	160.0	DB02711	experimental	4-{2,6,8-Trioxo-9-[(2S,3R,4R)-2,3,4,5-Tetrahydroxypentyl]-1,2,3,6,8,9-Hexahydro-7h-Purin-7-Yl}Butyl Dihydrogen Phosphate	OC[C@@H](O)[C@H](O)[C@@H](O)Cn1c(=O)n(c(c12)c(=O)[nH]c(=O)[nH]2)CCCCOP(=O)(O)O
13432	sp|P9WHE9|RISB_MYC	P9WHE9	99.38	1.0	160.0	DB03022	experimental	3-[2,6,8-Trioxo-9-[(2R,3S,4R)-2,3,4,5-tetrahydroxypentyl]-3H-purin-7-yl]propyl dihydrogen phosphate	OP(=O)(O)OCCCn1c(=O)n(c(c12)[nH]c(=O)[nH]c2=O)C[C@@H](O)[C@H](O)[C@H](O)CO
13433	sp|P9WHE9|RISB_MYC	P9WHE9	99.38	1.0	160.0	DB03812	experimental	3-{2,6,8-trioxo-9-[(2S,3R,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate	OC[C@@H](O)[C@H](O)[C@@H](O)Cn1c(=O)n(c(c12)c(=O)[nH]c(=O)[nH]2)CCCOP(=O)(O)O
13434	sp|P9WHE9|RISB_MYC	P9WHE9	99.38	1.0	160.0	DB03973	experimental	3-[2,6,8-Trioxo-9-[(2R,3R,4R)-2,3,4,5-tetrahydroxypentyl]-3H-purin-7-yl]propyl dihydrogen phosphate	OP(=O)(O)OCCCn1c(=O)n(c(c12)[nH]c(=O)[nH]c2=O)C[C@@H](O)[C@@H](O)[C@H](O)CO
13435	sp|P9WHE9|RISB_MYC	P9WHE9	99.38	1.0	160.0	DB08016	experimental	4-(6-CHLORO-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL) BUTYL PHOSPHATE	OP(=O)(O)OCCCCc1c(Cl)[nH]c(=O)[nH]c1=O
13436	sp|P9WHE9|RISB_MYC	O66529	91.88	7.0	154.0	DB02214	experimental	6,7-dioxo-5H-8-ribitylaminolumazine	O=c1[nH]c(=O)[nH]c(c12)n(c(=O)c(=O)[nH]2)C[C@H](O)[C@H](O)[C@H](O)CO
13437	sp|P9WHE9|RISB_MYC	O66529	91.88	7.0	154.0	DB04128	experimental	5-Nitroso-6-ribityl-amino-2,4(1H,3H)-pyrimidinedione	O=c1[nH]c(c(N=O)c(=O)[nH]1)NC[C@H](O)[C@H](O)[C@H](O)CO
13438	sp|P9WHE9|RISB_MYC	O66529	91.88	7.0	154.0	DB04262	experimental	3-(7-hydroxy-8-ribityllumazine-6-yl) propionic acid	OC[C@@H](O)[C@@H](O)[C@@H](O)Cn1c(O)c(CCC(=O)O)nc(c12)c(O)nc(n2)=O
13439	sp|P9WHE9|RISB_MYC	P11998	90.62	7.0	152.0	DB04162	experimental	5-Nitro-6-ribityl-amino-2,4(1H,3H)-pyrimidinedione	O=c1[nH]c(c([N+]([O-])=O)c(=O)[nH]1)NC[C@H](O)[C@H](O)[C@H](O)CO
13440	sp|P9WHE9|RISB_MYC	P61713	87.5	8.0	148.0	DB04162	experimental	5-Nitro-6-ribityl-amino-2,4(1H,3H)-pyrimidinedione	O=c1[nH]c(c([N+]([O-])=O)c(=O)[nH]1)NC[C@H](O)[C@H](O)[C@H](O)CO
13441	sp|P9WPU3|KDPB_MYC	P03960	95.49	4.0	681.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
13442	sp|P9WK83|LIPB_MYC	P9WK83	99.57	1.0	230.0	DB03600	experimental	Capric acid	CCCCCCCCCC(=O)O
13443	sp|P9WJH1|NUOB_MYC	O75251	78.8	58.0	203.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
13444	sp|P9WJH3|NUOC_MYC	O75489	84.75	11.0	211.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
13445	sp|P9WID5|ADOK_MYC	P55263	97.53	36.0	352.0	DB00131	approved; investigational; nutraceutical	Adenosine phosphate	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
13446	sp|P9WID5|ADOK_MYC	P55263	97.53	36.0	352.0	DB07173	experimental	7-(5-DEOXY-BETA-D-RIBOFURANOSYL)-5-IODO-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE	C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cc(I)c(c23)c(N)ncn3
13447	sp|P9WID5|ADOK_MYC	P55263	97.53	36.0	352.0	DB07280	experimental	5-[4-(DIMETHYLAMINO)PHENYL]-6-[(6-MORPHOLIN-4-YLPYRIDIN-3-YL)ETHYNYL]PYRIMIDIN-4-AMINE	CN(C)c1ccc(cc1)-c2c(ncnc2N)C#Cc3ccc(nc3)N4CCOCC4
13448	sp|P9WID5|ADOK_MYC	Q746L7	80.56	28.0	289.0	DB03489	experimental	2-Keto-3-Deoxygluconate	OC[C@H](O)[C@@H](O)CC(=O)C(=O)O
13449	sp|P9WID5|ADOK_MYC	P0A9J6	79.63	35.0	293.0	DB01936	experimental; investigational	alpha-D-arabinofuranose	OC[C@H]1O[C@H](O)[C@@H](O)[C@@H]1O
13450	sp|P9WID5|ADOK_MYC	P0A9J6	79.63	35.0	293.0	DB03909	experimental	Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate	OP(=O)(O)CP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
13451	sp|P9WID5|ADOK_MYC	P0A9J6	79.63	35.0	293.0	DB04444	experimental	Tetrafluoroaluminate Ion	F[Al-](F)(F)F
13452	sp|P9WID5|ADOK_MYC	Q8ZKR2	81.79	28.0	293.0	DB03909	experimental	Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate	OP(=O)(O)CP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
13453	sp|P9WID5|ADOK_MYC	Q8ZKR2	81.79	28.0	293.0	DB04568	experimental	5-Aminoimidazole Ribonucleoside	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cncc2N
13455	sp|P95189|HISN_MYC	O14732	90.0	21.0	255.0	DB01356	experimental	Lithium cation	[Li+]
13456	sp|P95189|HISN_MYC	O14732	90.0	21.0	255.0	DB14507	approved	Lithium citrate	[O-]C(=O)CC(O)(C([O-])=O)CC([O-])=O
13457	sp|P95189|HISN_MYC	O14732	90.0	21.0	255.0	DB14508	experimental	Lithium succinate	[O-]C(=O)CCC([O-])=O
13458	sp|P95189|HISN_MYC	O14732	90.0	21.0	255.0	DB14509	approved	Lithium carbonate	[O-]C([O-])=O
13459	sp|P95189|HISN_MYC	P29218	89.62	11.0	244.0	DB01356	experimental	Lithium cation	[Li+]
13460	sp|P95189|HISN_MYC	P29218	89.62	11.0	244.0	DB03542	experimental	L-Myo-Inositol-1-Phosphate	O[C@H]1[C@H](O)[C@H](O)[C@H](OP([O-])([O-])=O)[C@@H](O)[C@@H]1O
13461	sp|P95189|HISN_MYC	P29218	89.62	11.0	244.0	DB14507	approved	Lithium citrate	[O-]C(=O)CC(O)(C([O-])=O)CC([O-])=O
13462	sp|P95189|HISN_MYC	P29218	89.62	11.0	244.0	DB14508	experimental	Lithium succinate	[O-]C(=O)CCC([O-])=O
13463	sp|P95189|HISN_MYC	P29218	89.62	11.0	244.0	DB14509	approved	Lithium carbonate	[O-]C([O-])=O
13464	sp|P9WQC7|ADHB_MYC	P07327	97.33	9.0	374.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
13465	sp|P9WQC7|ADHB_MYC	P07327	97.33	9.0	374.0	DB01213	approved; vet_approved	Fomepizole	Cc1c[nH]nc1
13466	sp|P9WQC7|ADHB_MYC	P07327	97.33	9.0	374.0	DB02721	experimental	4-Iodopyrazole	Ic1c[nH]nc1
13467	sp|P9WQC7|ADHB_MYC	P07327	97.33	9.0	374.0	DB04065	experimental	N-Cyclopentyl-N-Cyclobutylformamide	C1CCC1N(C=O)C2CCCC2
13468	sp|P9WQC7|ADHB_MYC	P00325	97.33	9.0	374.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
13469	sp|P9WQC7|ADHB_MYC	P00325	97.33	9.0	374.0	DB01213	approved; vet_approved	Fomepizole	Cc1c[nH]nc1
13470	sp|P9WQC7|ADHB_MYC	P00325	97.33	9.0	374.0	DB02481	experimental	N-Benzylformamide	O=CNCc1ccccc1
13471	sp|P9WQC7|ADHB_MYC	P00325	97.33	9.0	374.0	DB02721	experimental	4-Iodopyrazole	Ic1c[nH]nc1
13472	sp|P9WQC7|ADHB_MYC	P00325	97.33	9.0	374.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
13473	sp|P9WQC7|ADHB_MYC	P00325	97.33	9.0	374.0	DB03703	experimental	Cyclohexanol	OC1CCCCC1
13474	sp|P9WQC7|ADHB_MYC	P00325	97.33	9.0	374.0	DB04105	experimental	N-Heptylformamide	CCCCCCCNC=O
13475	sp|P9WQC7|ADHB_MYC	P00325	97.33	9.0	374.0	DB09462	approved; investigational	Glycerin	OCC(O)CO
13476	sp|P9WQC7|ADHB_MYC	P00326	97.33	9.0	374.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
13477	sp|P9WQC7|ADHB_MYC	P00326	97.33	9.0	374.0	DB01213	approved; vet_approved	Fomepizole	Cc1c[nH]nc1
13478	sp|P9WQC7|ADHB_MYC	P00326	97.33	9.0	374.0	DB01711	experimental	2,3,4,5,6-Pentafluorobenzyl Alcohol	OCc1c(F)c(F)c(F)c(F)c1F
13479	sp|P9WQC7|ADHB_MYC	P00326	97.33	9.0	374.0	DB02131	experimental	N-1-methylheptylformamide	O=CN[C@H](C)CCCCCC
13480	sp|P9WQC7|ADHB_MYC	P00326	97.33	9.0	374.0	DB02249	experimental	2-Ethoxyethanol	CCOCCO
13481	sp|P9WQC7|ADHB_MYC	P00326	97.33	9.0	374.0	DB02659	approved	Cholic Acid	OC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](C[C@@H]2O)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
13482	sp|P9WQC7|ADHB_MYC	P00326	97.33	9.0	374.0	DB02721	experimental	4-Iodopyrazole	Ic1c[nH]nc1
13483	sp|P9WQC7|ADHB_MYC	P00326	97.33	9.0	374.0	DB02757	experimental	Pyrazole	[nH]1cccn1
13484	sp|P9WQC7|ADHB_MYC	P00326	97.33	9.0	374.0	DB02822	experimental	Para-Bromobenzyl Alcohol	OCc1ccc(Br)cc1
13485	sp|P9WQC7|ADHB_MYC	P00326	97.33	9.0	374.0	DB02871	experimental	3-Butylthiolane 1-Oxide	O=[S@@]1C[C@H](CC1)CCCC
13486	sp|P9WQC7|ADHB_MYC	P00326	97.33	9.0	374.0	DB03020	experimental	5-beta-D-ribofuranosylnicotinamide adenine dinucleotide	NC(=O)c1c[nH+]cc(c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
13487	sp|P9WQC7|ADHB_MYC	P00326	97.33	9.0	374.0	DB03061	experimental	(R)-N-(1-Methyl-Hexyl)-Formamide	CCCCC[C@H](C)NC=O
13488	sp|P9WQC7|ADHB_MYC	P00326	97.33	9.0	374.0	DB03226	experimental	Trifluoroethanol	OCC(F)(F)F
13489	sp|P9WQC7|ADHB_MYC	P00326	97.33	9.0	374.0	DB03559	experimental	Cyclohexylformamide	O=CNC1CCCCC1
13490	sp|P9WQC7|ADHB_MYC	P00326	97.33	9.0	374.0	DB04071	experimental	Cpad	NC(=O)c1nc(ccc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
13491	sp|P9WQC7|ADHB_MYC	P00326	97.33	9.0	374.0	DB04113	experimental	N-Formylpiperidine	O=CN1CCCCC1
13492	sp|P9WQC7|ADHB_MYC	P00326	97.33	9.0	374.0	DB04312	experimental	2,3-Difluorobenzyl Alcohol	OCc1cccc(F)c1F
13493	sp|P9WQC7|ADHB_MYC	P00326	97.33	9.0	374.0	DB04448	experimental	2,4-Difluorobenzyl Alcohol 2,4-Difluoro-1-(Hydroxymethyl)Benzene	OCc1ccc(F)cc1F
13494	sp|P9WQC7|ADHB_MYC	P40394	97.07	21.0	385.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
13495	sp|P9WQC7|ADHB_MYC	P11766	97.6	7.0	373.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
13496	sp|P9WQC7|ADHB_MYC	P11766	97.6	7.0	373.0	DB03017	approved; experimental	Lauric acid	CCCCCCCCCCCC(=O)O
13497	sp|P9WQC7|ADHB_MYC	P11766	97.6	7.0	373.0	DB03704	experimental	12-Hydroxydodecanoic Acid	OCCCCCCCCCCCC(=O)O
13498	sp|P9WQC7|ADHB_MYC	P11766	97.6	7.0	373.0	DB04153	experimental	S-Hydroxymethyl Glutathione	OC(=O)[C@@H](N)CCC(=O)N[C@@H](CSCO)C(=O)NCC(=O)O
13499	sp|P9WQC7|ADHB_MYC	P08319	98.67	9.0	379.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
13500	sp|P9WQC7|ADHB_MYC	P08319	98.67	9.0	379.0	DB03559	experimental	Cyclohexylformamide	O=CNC1CCCCC1
13501	sp|P9WQC7|ADHB_MYC	P42328	89.6	2.0	338.0	DB03226	experimental	Trifluoroethanol	OCC(F)(F)F
13502	sp|P9WQC7|ADHB_MYC	Q00796	87.73	20.0	349.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
13503	sp|P9WQC7|ADHB_MYC	Q00796	87.73	20.0	349.0	DB04478	experimental	Cp-166572, 2-Hydroxymethyl-4-(4-N,N-Dimethylaminosulfonyl-1-Piperazino)-Pyrimidine	CN(C)S(=O)(=O)N1CCN(CC1)c2ccnc(n2)CO
13504	sp|P9WQC7|ADHB_MYC	P14941	85.87	16.0	338.0	DB02606	experimental; investigational	2-Butanol	CC[C@@H](C)O
13505	sp|P9WQC7|ADHB_MYC	P14941	85.87	16.0	338.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
13506	sp|O53554|ILVX_MYC	P20906	99.81	11.0	525.0	DB02280	experimental	(R)-Mandelic acid	OC(=O)[C@H](O)c1ccccc1
13507	sp|O53554|ILVX_MYC	P27696	102.72	12.0	541.0	DB01987	approved; experimental	Cocarboxylase	OP([O-])(=O)O[P@](=O)(O)OCCc1c(C)[n+](cs1)Cc2cnc(C)nc2N
13508	sp|O53554|ILVX_MYC	P27696	102.72	12.0	541.0	DB02327	experimental	Triethylene glycol	OCCOCCOCCO
13509	sp|O53554|ILVX_MYC	P27696	102.72	12.0	541.0	DB03361	experimental	2-{(9as)-9a-[(1s)-1-Hydroxyethyl]-2,7-Dimethyl-9a,10-Dihydro-5h-Pyrimido[4,5-D][1,3]Thiazolo[3,2-a]Pyrimidin-8-Yl}Ethyl Trihydrogen Diphosphate	c1nc(C)nc(N2)c1CN([C@]23[C@H](C)O)C(C)=C(S3)CCOP(=O)(O)OP(=O)(O)O
13510	sp|O53554|ILVX_MYC	P37063	102.91	14.0	544.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
13511	sp|O53554|ILVX_MYC	P23234	101.75	7.0	531.0	DB01987	approved; experimental	Cocarboxylase	OP([O-])(=O)O[P@](=O)(O)OCCc1c(C)[n+](cs1)Cc2cnc(C)nc2N
13512	sp|O53554|ILVX_MYC	P06672	103.11	8.0	539.0	DB04272	approved; nutraceutical; vet_approved	Citric acid	OC(=O)CC(O)(C(=O)O)CC(=O)O
13513	sp|O53554|ILVX_MYC	P51852	101.17	1.0	522.0	DB03884	experimental	Phenylpyruvic acid	OC(=O)C(=O)Cc1ccccc1
13514	sp|O53554|ILVX_MYC	P51852	101.17	1.0	522.0	DB08050	experimental	5-phenyl-2-keto-valeric acid	OC(=O)C(=O)CCCc1ccccc1
13515	sp|P9WMB9|KSTR2_MY	P94548	83.0	3.0	169.0	DB03264	experimental	Dodecyl-Coa	CCCCCCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
13516	sp|P9WMB9|KSTR2_MY	P0A0N4	79.0	4.0	162.0	DB01123	approved	Proflavine	c1cc(N)cc(c12)nc3c(c2)ccc(c3)N
13517	sp|P9WMB9|KSTR2_MY	P0A0N4	79.0	4.0	162.0	DB03608	experimental	Diminazene	NC(=N)c1ccc(cc1)N/N=N/c2ccc(cc2)C(N)=N
13518	sp|P9WMB9|KSTR2_MY	P0A0N4	79.0	4.0	162.0	DB03808	experimental	Hexamidine	NC(=N)c1ccc(cc1)OCCCCCCOc2ccc(cc2)C(N)=N
13519	sp|P9WMB9|KSTR2_MY	P0A0N4	79.0	4.0	162.0	DB04209	approved; investigational	Dequalinium	c1cccc(c12)c(N)cc(C)[n+]2CCCCCCCCCC[n+]3c(C)cc(N)c(c34)cccc4
13520	sp|P9WMB9|KSTR2_MY	P0A0N5	79.0	4.0	162.0	DB03808	experimental	Hexamidine	NC(=N)c1ccc(cc1)OCCCCCCOc2ccc(cc2)C(N)=N
13521	sp|P9WMB9|KSTR2_MY	P0A0N5	79.0	4.0	162.0	DB03825	experimental	Rhodamine 6G	CCNc(c(C)c1)cc(c12)[o+]c3c(cc(C)c(c3)NCC)c2-c4ccccc4C(=O)OCC
13522	sp|P9WMB9|KSTR2_MY	P0A0N5	79.0	4.0	162.0	DB03895	experimental	Malachite Green	CN(C)c1ccc(cc1)C(c2ccccc2)=C3C=CC(C=C3)=[N+](C)C
13523	sp|P9WMB9|KSTR2_MY	P0A0N5	79.0	4.0	162.0	DB04115	approved; investigational	Berberine	COc1c(OC)ccc(c12)cc3[n+](c2)CCc4c3cc5c(c4)OCO5
13524	sp|P9WJK7|MUTA_MYC	P22033	77.72	52.0	530.0	DB00115	approved; nutraceutical	Cyanocobalamin	Cc(c1)c(C)cc(c12)ncn2[C@@H]3[C@H](O)[C@@H]([C@H](O3)CO)OP([O-])(=O)O[C@H](C)CNC(=O)CC[C@](C)([C@@H](CC(=O)N)[C@@H]4[C@]56C)C(=N4)/C(C)=C7\N=C(C(C)(C)[C@@H]7CCC(=O)N)/C=C8\N=C([C@@](C)(CC(=O)N)[C@@H]8CCC(=O)N)/C(C)=C(\N5[Co+]C#N)[C@@H](CCC(=O)N)[C@]6(C)CC(=O)N
13525	sp|P9WJK7|MUTA_MYC	P22033	77.72	52.0	530.0	DB00200	approved	Hydroxocobalamin	c1c(C)c(C)cc(c1[n+]2[Co-3]3456O)n(c2)[C@H]7O[C@H](CO)[C@H]([C@H]7O)OP(=O)([O-])O[C@H](C)CNC(=O)CC[C@@]8(C)C=9N3[C@H]([C@@H]8CC(=O)N)[C@]1(C)[N+]4=C([C@H]([C@]1(C)CC(=O)N)CCC(=O)N)C(C)=C1[N+]5=C([C@H]([C@]1(C)CC(=O)N)CCC(=O)N)C=C1[N+]6=C(C9C)[C@H](C1(C)C)CCC(=O)N
13526	sp|P9WJH7|NDK_MYCT	P22392	95.59	5.0	135.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
13527	sp|P9WJH7|NDK_MYCT	P15531	96.32	4.0	135.0	DB01593	approved; investigational	Zinc	[Zn]
13528	sp|P9WJH7|NDK_MYCT	P15531	96.32	4.0	135.0	DB02181	experimental	2'-Deoxyguanosine-5'-Triphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@H]3C[C@H](O)[C@H](O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
13529	sp|P9WJH7|NDK_MYCT	P15531	96.32	4.0	135.0	DB02345	experimental	Selenocysteine	OC(=O)[C@@H](N)C[SeH]
13530	sp|P9WJH7|NDK_MYCT	P15531	96.32	4.0	135.0	DB02569	experimental	2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Diphosphate	O=c1[nH]c(=O)n(cc1C)[C@@H]2O[C@@H](C=C2)CO[P@](=O)(O)OP(=O)(O)O
13531	sp|P9WJH7|NDK_MYCT	P15531	96.32	4.0	135.0	DB02607	experimental	Adenosine Phosphonoacetic Acid	OP(=O)(O)CC(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
13532	sp|P9WJH7|NDK_MYCT	P15531	96.32	4.0	135.0	DB02887	experimental	Stavudine triphosphate	O=c1[nH]c(=O)n(cc1C)[C@@H]2O[C@@H](C=C2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
13533	sp|P9WJH7|NDK_MYCT	P15531	96.32	4.0	135.0	DB03103	experimental	Thymidine-5'- Diphosphate	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
13534	sp|P9WJH7|NDK_MYCT	P15531	96.32	4.0	135.0	DB03491	experimental	2'-Deoxyguanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@H]3C[C@H](O)[C@H](O3)COP(=O)(O)OP(=O)(O)O
13535	sp|P9WJH7|NDK_MYCT	P15531	96.32	4.0	135.0	DB04068	experimental	2',3'-dideoxy-3'-fluoro-urididine-5'-diphosphate	O=c1[nH]c(=O)n(cc1)[C@H]2C[C@H](F)[C@H](O2)COP(=O)(O)OP(=O)(O)O
13536	sp|P9WJH7|NDK_MYCT	P15531	96.32	4.0	135.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
13537	sp|P9WJH7|NDK_MYCT	P15531	96.32	4.0	135.0	DB04366	experimental	3'-Deoxy 3'-Amino Adenosine-5'-Diphosphate	OP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1N)n2cnc(c23)c(N)ncn3
13538	sp|P9WJH7|NDK_MYCT	P15531	96.32	4.0	135.0	DB04542	experimental	Zidovudine diphosphate	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](N=[N+]=[N-])[C@H](O2)COP(=O)(O)OP(=O)(O)O
13539	sp|P9WJH7|NDK_MYCT	P15531	96.32	4.0	135.0	DB09130	approved; investigational	Copper	[Cu]
13540	sp|P9WJH7|NDK_MYCT	P15531	96.32	4.0	135.0	DB14487	approved; investigational	Zinc acetate	CC([O-])=O
13541	sp|P9WJH7|NDK_MYCT	P15531	96.32	4.0	135.0	DB14533	approved; investigational	Zinc chloride	[Cl-]
13542	sp|P9WJH7|NDK_MYCT	P15531	96.32	4.0	135.0	DB14548	approved; experimental	Zinc sulfate, unspecified form	 
13543	sp|P9WHV3|PRMC_MYC	P0ACC1	86.18	9.0	271.0	DB01752	experimental	S-adenosyl-L-homocysteine	OC(=O)[C@@H](N)CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
13544	sp|P9WHV3|PRMC_MYC	Q9WYV8	70.39	64.0	278.0	DB01752	experimental	S-adenosyl-L-homocysteine	OC(=O)[C@@H](N)CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
13545	sp|P9WHV3|PRMC_MYC	Q9WYV8	70.39	64.0	278.0	DB03473	experimental	N5-Methylglutamine	CNC(=O)CC[C@H](N)C(=O)O
13546	sp|P9WJW1|MIAA_MYC	P16384	95.22	11.0	310.0	DB02270	experimental	Dimethylallyl S-Thiolodiphosphate	CC(C)CCS[P@@](=O)(O)OP(=O)(O)O
13547	sp|P9WHH3|MTR_MYCT	P00390	98.91	64.0	518.0	DB00143	approved; investigational; nutraceutical	Glutathione	OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(=O)O
13548	sp|P9WHH3|MTR_MYCT	P00390	98.91	64.0	518.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
13549	sp|P9WHH3|MTR_MYCT	P00390	98.91	64.0	518.0	DB00262	approved; investigational	Carmustine	ClCCNC(=O)N(N=O)CCCl
13550	sp|P9WHH3|MTR_MYCT	P00390	98.91	64.0	518.0	DB01644	experimental	3,6-dihydroxy-xanthene-9-propionic acid	OC(=O)CCC1c(ccc(c2)O)c2Oc(c13)cc(O)cc3
13551	sp|P9WHH3|MTR_MYCT	P00390	98.91	64.0	518.0	DB02153	experimental	3-sulfino-L-alanine	OC(=O)[C@@H](N)C[S@](=O)O
13552	sp|P9WHH3|MTR_MYCT	P00390	98.91	64.0	518.0	DB02553	experimental	Glutathionylspermidine disulfide	NCCCCNCCCNC(=O)CNC(=O)[C@@H](NC(=O)CC[C@@H](N)C(=O)O)CSSC[C@H](NC(=O)CC[C@@H](N)C(=O)O)C(=O)NCC(=O)NCCCNCCCCN
13553	sp|P9WHH3|MTR_MYCT	P00390	98.91	64.0	518.0	DB02895	experimental	3-(Prop-2-Ene-1-Sulfinyl)-Propene-1-Thiol	S/C=C/C[S@](=O)CC=C
13554	sp|P9WHH3|MTR_MYCT	P00390	98.91	64.0	518.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
13555	sp|P9WHH3|MTR_MYCT	P00390	98.91	64.0	518.0	DB03310	approved; experimental; investigational	Glutathione disulfide	OC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)NCC(=O)O)CSSC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@H](N)C(=O)O
13556	sp|P9WHH3|MTR_MYCT	P00390	98.91	64.0	518.0	DB03867	experimental	3-nitro-L-tyrosine	OC(=O)[C@@H](N)Cc1cc([N+]([O-])=O)c(O)cc1
13557	sp|P9WHH3|MTR_MYCT	P00390	98.91	64.0	518.0	DB07393	experimental	2-(2-PHENYL-3-PYRIDIN-2-YL-4,5,6,7-TETRAHYDRO-2H-ISOPHOSPHINDOL-1-YL)PYRIDINE	n1ccccc1-c2p(-c3ccccc3)c(c(c24)CCCC4)-c5ncccc5
13558	sp|P9WHH3|MTR_MYCT	P00390	98.91	64.0	518.0	DB07714	experimental	6-(3-METHYL-1,4-DIOXO-1,4-DIHYDRONAPHTHALEN-2-YL)HEXANOIC ACID	c1cccc(c12)C(=O)C(=C(C2=O)C)CCCCCC(=O)O
13559	sp|P9WHH3|MTR_MYCT	P00390	98.91	64.0	518.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
13560	sp|P9WHH3|MTR_MYCT	P00390	98.91	64.0	518.0	DB09130	approved; investigational	Copper	[Cu]
13562	sp|P9WHH3|MTR_MYCT	P00390	98.91	64.0	518.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
13563	sp|P9WHH3|MTR_MYCT	P06715	96.3	4.0	446.0	DB00336	approved; investigational; vet_approved	Nitrofural	NC(=O)N/N=C/c1ccc(o1)[N+]([O-])=O
13564	sp|P9WHH3|MTR_MYCT	P06715	96.3	4.0	446.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
13565	sp|P9WHH3|MTR_MYCT	P14218	100.44	4.0	465.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
13566	sp|P9WHH3|MTR_MYCT	P18925	100.44	4.0	465.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
13567	sp|P9WHH3|MTR_MYCT	P09622	99.56	43.0	500.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
13568	sp|P9WHH3|MTR_MYCT	P09622	99.56	43.0	500.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
13569	sp|P9WHH3|MTR_MYCT	Q16881	101.96	162.0	630.0	DB01169	approved; investigational	Arsenic trioxide	O=[As]O[As]=O
13570	sp|P9WHH3|MTR_MYCT	Q16881	101.96	162.0	630.0	DB02338	experimental	NADPH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
13571	sp|P9WHH3|MTR_MYCT	Q16881	101.96	162.0	630.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
13572	sp|P9WHH3|MTR_MYCT	Q16881	101.96	162.0	630.0	DB03566	experimental	Spermidine	NCCCCNCCCN
13573	sp|P9WHH3|MTR_MYCT	Q16881	101.96	162.0	630.0	DB04106	investigational	Fotemustine	CCOP(=O)(OCC)[C@@H](C)NC(=O)N(N=O)CCCl
13574	sp|P9WHH3|MTR_MYCT	Q16881	101.96	162.0	630.0	DB05428	investigational	Motexafin gadolinium	CCc(c12)c(CC)c([n-]1)cc3nc(c(C)c3CCCO)cnc4c(ncc5nc(c2)c(c5C)CCCO)cc(OCCOCCOCCOC)c(c4)OCCOCCOCCOC
13575	sp|P9WHH3|MTR_MYCT	Q16881	101.96	162.0	630.0	DB05448	investigational	PX-12	CCC(C)SSc1ncc[nH]1
13576	sp|P9WHH3|MTR_MYCT	Q9NNW7	101.31	39.0	504.0	DB05428	investigational	Motexafin gadolinium	CCc(c12)c(CC)c([n-]1)cc3nc(c(C)c3CCCO)cnc4c(ncc5nc(c2)c(c5C)CCCO)cc(OCCOCCOCCOC)c(c4)OCCOCCOCCOC
13577	sp|P9WHH3|MTR_MYCT	Q51225	100.44	117.0	578.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
13578	sp|P9WHH3|MTR_MYCT	P28593	100.65	6.0	468.0	DB02240	experimental	Quinacrine mustard	c1cc(Cl)cc(n2)c1c(c(c23)cc(OC)cc3)NC(C)CCCN(CCCl)CCCl
13579	sp|P9WHH3|MTR_MYCT	P28593	100.65	6.0	468.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
13580	sp|P9WHH3|MTR_MYCT	P28593	100.65	6.0	468.0	DB03470	experimental	Trypanothione	OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(=O)NCCCCNCCCNC(=O)CNC(=O)[C@H](CS)NC(=O)CC[C@H](N)C(=O)O
13581	sp|P9WHH3|MTR_MYCT	P28593	100.65	6.0	468.0	DB04299	experimental	Maleic Acid	OC(=O)/C=C\C(=O)O
13582	sp|P9WHH3|MTR_MYCT	P09063	96.08	9.0	450.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
13584	sp|P9WHH3|MTR_MYCT	Q56839	100.65	43.0	505.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
13585	sp|P9WHH3|MTR_MYCT	Q56839	100.65	43.0	505.0	DB03163	experimental	2-oxopropyl-CoM	CC(=O)CSCCS(=O)(=O)O
13586	sp|P9WHH3|MTR_MYCT	P37062	81.26	55.0	428.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
13587	sp|P9WHH3|MTR_MYCT	P37062	81.26	55.0	428.0	DB03382	experimental	S-oxy-L-cysteine	OC(=O)[C@@H](N)CS=O
13588	sp|P9WJM1|MURA_MYC	P0A749	99.04	2.0	416.0	DB00828	approved	Fosfomycin	C[C@@H]1O[C@@H]1P(=O)(O)O
13589	sp|P9WJM1|MURA_MYC	P0A751	99.04	2.0	416.0	DB03397	experimental	Uridine-Diphosphate-N-Acetylglucosamine	CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
13590	sp|P9WJM1|MURA_MYC	P33038	99.04	2.0	416.0	DB01879	experimental	(S)-2-{Methyl-[2-(Naphthalene-2-Sulfonylamino)-5-(Naphthalene-2-Sulfonyloxy)-Benzoyl]-Amino}-Succinicacid	c1cccc(c12)cc(cc2)S(=O)(=O)Nc3c(C(=O)N(C)[C@H](C(=O)O)CC(=O)O)cc(cc3)OS(=O)(=O)c(cc4)cc(c45)cccc5
13591	sp|P9WJM1|MURA_MYC	P33038	99.04	2.0	416.0	DB02435	experimental	Aminomethylcyclohexane	[NH3+]CC1CCCCC1
13592	sp|P9WJM1|MURA_MYC	P33038	99.04	2.0	416.0	DB02995	experimental	Cyclohexylammonium Ion	[NH3+]C1CCCCC1
13593	sp|P9WJM1|MURA_MYC	P33038	99.04	2.0	416.0	DB04174	experimental	3'-1-carboxy-1-phosphonooxy-ethoxy-uridine-diphosphate-N-acetylglucosamine	OP(=O)(O)OC(C)(C(=O)O)O[C@H]1[C@H](O)[C@@H](CO)O[C@@H]([C@@H]1NC(=O)C)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
13594	sp|P9WJM1|MURA_MYC	P33038	99.04	2.0	416.0	DB04474	experimental	8-anilinonaphthalene-1-sulfonic acid	O=S(=O)(O)c1cccc(c12)cccc2Nc3ccccc3
13595	sp|P9WJM1|MURA_MYC	Q9S400	99.52	8.0	424.0	DB04328	experimental	Shikimate-3-Phosphate	O[C@@H]1CC(C(=O)O)=C[C@H]([C@H]1O)OP(=O)(O)O
13596	sp|P9WJM1|MURA_MYC	Q9S400	99.52	8.0	424.0	DB04539	experimental	Glyphosate	OC(=O)C[NH2+]CP(=O)(O)O
13597	sp|P9WGR1|INHA_MYC	P9WGR1	99.63	1.0	269.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
13598	sp|P9WGR1|INHA_MYC	P9WGR1	99.63	1.0	269.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
13599	sp|P9WGR1|INHA_MYC	P9WGR1	99.63	1.0	269.0	DB02990	experimental	S-(2-Acetamidoethyl) hexadecanethioate	CCCCCCCCCCCCCCCC(=O)SCCNC(=O)C
13600	sp|P9WGR1|INHA_MYC	P9WGR1	99.63	1.0	269.0	DB04289	experimental	Genz-10850	[nH]1ccc(c12)cc(cc2)C(=O)N3CCN(CC3)C4c(cccc5)c5c(c46)cccc6
13601	sp|P9WGR1|INHA_MYC	P9WGR1	99.63	1.0	269.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
13602	sp|P9WGR1|INHA_MYC	P9WGR1	99.63	1.0	269.0	DB07090	experimental	(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cccc(c1C)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
13603	sp|P9WGR1|INHA_MYC	P9WGR1	99.63	1.0	269.0	DB07123	experimental	N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE	Cc1ccc(cc1)C(=O)N2CCC(CC2)Cc3ccccc3
13604	sp|P9WGR1|INHA_MYC	P9WGR1	99.63	1.0	269.0	DB07155	experimental	(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE	c1ccccc1NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
13605	sp|P9WGR1|INHA_MYC	P9WGR1	99.63	1.0	269.0	DB07178	experimental	5-PENTYL-2-PHENOXYPHENOL	CCCCCc1cc(O)c(cc1)Oc2ccccc2
13606	sp|P9WGR1|INHA_MYC	P9WGR1	99.63	1.0	269.0	DB07188	experimental	(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(cc(Cl)c1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
13607	sp|P9WGR1|INHA_MYC	P9WGR1	99.63	1.0	269.0	DB07192	experimental	(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Brc1cc(ccc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
13608	sp|P9WGR1|INHA_MYC	P9WGR1	99.63	1.0	269.0	DB07222	experimental	(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(c(C)cc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
13609	sp|P9WGR1|INHA_MYC	P9WGR1	99.63	1.0	269.0	DB07287	experimental	2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL	c1cccnc1Cc2cc(O)c(cc2)Oc3ccc(Cl)cc3Cl
13610	sp|P9WGR1|INHA_MYC	P9WGR1	99.63	1.0	269.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
13611	sp|P9WGR1|INHA_MYC	Q9WYS2	91.45	7.0	253.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
13613	sp|P9WGR1|INHA_MYC	Q9BTZ2	90.71	30.0	274.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
13614	sp|P9WGR1|INHA_MYC	P0AEK2	88.48	4.0	242.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
13616	sp|P9WGR1|INHA_MYC	P16544	93.31	7.0	258.0	DB01942	experimental; investigational	Formic acid	OC=O
13617	sp|P9WGR1|INHA_MYC	P16544	93.31	7.0	258.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
13618	sp|P9WGR1|INHA_MYC	P16544	93.31	7.0	258.0	DB07715	investigational	Emodin	Cc(c1)cc(O)c(c12)C(=O)c3c(C2=O)cc(O)cc3O
13619	sp|P9WGR1|INHA_MYC	A0A348A0U3	92.94	3.0	253.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
13620	sp|P9WGR1|INHA_MYC	P0AET8	89.59	9.0	250.0	DB02123	experimental	Glycochenodeoxycholic Acid	OC(=O)CNC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
13622	sp|P9WGR1|INHA_MYC	Q84EX5	92.94	2.0	252.0	DB04619	experimental	Acetophenone	CC(=O)c1ccccc1
13623	sp|P9WGR1|INHA_MYC	Q84EX5	92.94	2.0	252.0	DB04784	experimental	(R)-1-phenylethanol	C[C@@H](O)c1ccccc1
13624	sp|P9WGR1|INHA_MYC	Q9BY49	93.31	14.0	265.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
13625	sp|P9WGR1|INHA_MYC	Q6GI75	92.57	4.0	253.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
13626	sp|P9WGR1|INHA_MYC	Q6GI75	92.57	4.0	253.0	DB11155	approved	Triclocarban	Clc1ccc(cc1)NC(=O)Nc2cc(Cl)c(Cl)cc2
13627	sp|P9WGR1|INHA_MYC	Q92506	91.82	12.0	259.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
13628	sp|P9WGR1|INHA_MYC	Q92506	91.82	12.0	259.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
13629	sp|P9WGR1|INHA_MYC	O24990	92.94	2.0	252.0	DB04393	experimental	Soneclosan	Clc1cc(O)c(cc1)Oc2ccc(Cl)cc2
13630	sp|P9WGR1|INHA_MYC	O24990	92.94	2.0	252.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
13631	sp|P9WGR1|INHA_MYC	P0CG22	91.82	30.0	277.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
13632	sp|P9WGR1|INHA_MYC	P0CG22	91.82	30.0	277.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
13633	sp|P9WGR1|INHA_MYC	P0CG22	91.82	30.0	277.0	DB03541	experimental	10-Propargyl-5,8-Dideazafolic Acid	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(CC#C)Cc(c2)ccc(c23)[nH]c(N)nc3=O
13634	sp|P9WGR1|INHA_MYC	P0CG22	91.82	30.0	277.0	DB07689	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)NCc(cn3)nc(c34)c(N)nc(n4)N
13635	sp|P9WGR1|INHA_MYC	P0CG22	91.82	30.0	277.0	DB07765	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)N(C)Cc(cn3)nc(c34)c(N)nc(n4)N
13636	sp|P9WGR1|INHA_MYC	P0AEK4	92.57	2.0	251.0	DB01691	experimental	Indole Naphthyridinone	c1cccc(c12)n(C)cc2CN(C)C(=O)/C=C/c(c3)cnc(c34)NC(=O)CC4
13637	sp|P9WGR1|INHA_MYC	P0AEK4	92.57	2.0	251.0	DB01865	experimental	3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide	c1cccc(c12)cc(n2C)CN(C)C(=O)/C=C/c3cnc(N)cc3
13638	sp|P9WGR1|INHA_MYC	P0AEK4	92.57	2.0	251.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
13639	sp|P9WGR1|INHA_MYC	P0AEK4	92.57	2.0	251.0	DB03030	experimental	4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole	Cc1ccc(cc1)Cn2cnc(c2)-c3cccs3
13640	sp|P9WGR1|INHA_MYC	P0AEK4	92.57	2.0	251.0	DB03534	experimental	3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide	CC(=O)N(C)Cc1c(N)ccc(c1)C(=O)N(C)Cc(n2C)cc(c23)cccc3
13641	sp|P9WGR1|INHA_MYC	P0AEK4	92.57	2.0	251.0	DB04030	experimental	1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole	Oc1ccc(cc1)Cn2c(c3c(c24)cccc4)CN(CC3)C(=O)c5ccc(O)cc5
13642	sp|P9WGR1|INHA_MYC	P0AEK4	92.57	2.0	251.0	DB08265	experimental	2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL	Cc1ccc(cc1)S(=O)(=O)n(b2O)ncc(c23)cccc3
13643	sp|P9WGR1|INHA_MYC	P0AEK4	92.57	2.0	251.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
13644	sp|P9WGR1|INHA_MYC	P0AEK4	92.57	2.0	251.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
13645	sp|P9WGR1|INHA_MYC	Q7Z4W1	88.48	4.0	242.0	DB02831	experimental	Dihydrogenphosphate	OP([O-])(=O)O
13646	sp|P9WGR1|INHA_MYC	Q7Z4W1	88.48	4.0	242.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
13647	sp|P9WGR1|INHA_MYC	Q16698	91.08	58.0	303.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
13648	sp|P9WGR1|INHA_MYC	Q16698	91.08	58.0	303.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
13649	sp|P9WGR1|INHA_MYC	Q99714	92.19	9.0	257.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
13650	sp|P9WGR1|INHA_MYC	Q99714	92.19	9.0	257.0	DB02820	experimental	1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct	C1CCCCCN1C(=O)[C@H](c2ccccc2)n(c3=S)cnc(c34)nn(c4)[C@H]5C=CN(C=C5C([O-])=N)[C@@H]6O[C@@H]([C@@H](O)[C@H]6O)COP([O-])(=O)OP(=O)(O)OC[C@H]7O[C@H]([C@H]([O-])[C@@H]7[O-])n8cnc(c89)c(N)ncn9
13651	sp|P9WGR1|INHA_MYC	Q99714	92.19	9.0	257.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
13652	sp|P9WGR1|INHA_MYC	Q8I814	95.54	14.0	271.0	DB02015	experimental	Dihydrofolic Acid	O=c1[nH]c(N)nc(c12)NCC(=N2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
13653	sp|P9WGR1|INHA_MYC	Q8I814	95.54	14.0	271.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
13654	sp|P9WGR1|INHA_MYC	Q7AUG5	88.85	4.0	243.0	DB04782	experimental	(S)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@H]2CO2
13655	sp|P9WGR1|INHA_MYC	Q93D82	88.85	4.0	243.0	DB04472	experimental	(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol	[N-]=[N+]=NC[C@H](O)c1ccc([N+]([O-])=O)cc1
13656	sp|P9WGR1|INHA_MYC	Q93D82	88.85	4.0	243.0	DB04499	experimental	(R)-styrene oxide	C1O[C@@H]1c2ccccc2
13657	sp|P9WGR1|INHA_MYC	Q93D82	88.85	4.0	243.0	DB04777	experimental	(R)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@@H]2CO2
13658	sp|P9WGR1|INHA_MYC	Q6UWP2	88.85	12.0	251.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
13659	sp|P9WGR1|INHA_MYC	Q01782	102.23	8.0	283.0	DB02338	experimental	NADPH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
13660	sp|P9WGR1|INHA_MYC	Q01782	102.23	8.0	283.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
13661	sp|P9WGR1|INHA_MYC	Q01782	102.23	8.0	283.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
13662	sp|P9WGR1|INHA_MYC	Q01782	102.23	8.0	283.0	DB04400	experimental	L-erythro-7,8-dihydrobiopterin	C[C@H](O)[C@H](O)C(CN1)=Nc(c12)c(=O)nc([nH]2)N
13664	sp|P9WGR1|INHA_MYC	Q8NBQ5	71.75	35.0	228.0	DB02854	experimental	Aetiocholanolone	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](CC3)C[C@H](O)CC4
13665	sp|P9WGR1|INHA_MYC	Q9NYR8	76.58	6.0	212.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
13666	sp|P9WGR1|INHA_MYC	Q02338	77.7	56.0	265.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
13667	sp|P9WGR1|INHA_MYC	P14061	78.81	5.0	217.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
13668	sp|P9WGR1|INHA_MYC	P14061	78.81	5.0	217.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
13669	sp|P9WGR1|INHA_MYC	P14061	78.81	5.0	217.0	DB01561	experimental; illicit	Androstanedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
13670	sp|P9WGR1|INHA_MYC	P14061	78.81	5.0	217.0	DB02187	experimental	Equilin	O=C1CC[C@H]([C@@]12C)C=3[C@H](CC2)c4c(CC3)cc(O)cc4
13671	sp|P9WGR1|INHA_MYC	P14061	78.81	5.0	217.0	DB02323	experimental	EM-1745	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)C[C@@H]([C@@H]4O)CCCCCCCCC(=O)OC[C@H]5O[C@H]([C@H](O)[C@@H]5O)n6cnc(c67)c(N)ncn7
13672	sp|P9WGR1|INHA_MYC	P14061	78.81	5.0	217.0	DB02901	illicit; investigational	Stanolone	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
13673	sp|P9WGR1|INHA_MYC	P14061	78.81	5.0	217.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
13674	sp|P9WGR1|INHA_MYC	P14061	78.81	5.0	217.0	DB13951	experimental	Stanolone acetate	CC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
13675	sp|P9WGR1|INHA_MYC	Q8TC12	75.46	39.0	242.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
13676	sp|P9WGR1|INHA_MYC	P37059	77.32	81.0	289.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
13677	sp|P9WGR1|INHA_MYC	P37059	77.32	81.0	289.0	DB13952	approved; investigational; vet_approved	Estradiol acetate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)C
13678	sp|P9WGR1|INHA_MYC	P37059	77.32	81.0	289.0	DB13953	approved; investigational; vet_approved	Estradiol benzoate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)c5ccccc5
13679	sp|P9WGR1|INHA_MYC	P37059	77.32	81.0	289.0	DB13954	approved; investigational; vet_approved	Estradiol cypionate	C1CCCC1CCC(=O)O[C@H]2CC[C@H]([C@@]23C)[C@H]4[C@H](CC3)c5c(CC4)cc(O)cc5
13680	sp|P9WGR1|INHA_MYC	P37059	77.32	81.0	289.0	DB13955	approved; investigational; vet_approved	Estradiol dienanthate	CCCCCCC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)CCCCCC
13681	sp|P9WGR1|INHA_MYC	P37059	77.32	81.0	289.0	DB13956	approved; investigational; vet_approved	Estradiol valerate	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)CC[C@@H]4OC(=O)CCCC
13682	sp|P9WGR1|INHA_MYC	Q9HBH5	94.05	39.0	292.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
13683	sp|P9WGR1|INHA_MYC	P80365	72.12	83.0	277.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
13684	sp|P9WGR1|INHA_MYC	P80365	72.12	83.0	277.0	DB01185	approved; illicit	Fluoxymesterone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@](F)([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
13685	sp|P9WGR1|INHA_MYC	P80365	72.12	83.0	277.0	DB01569	experimental; illicit	Formebolone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@H]([C@@H](C2)O)[C@]4(C)C(CC3)=CC(=O)C(C=O)=C4
13686	sp|P9WGR1|INHA_MYC	P80365	72.12	83.0	277.0	DB14538	experimental; vet_approved	Hydrocortisone aceponate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CC)C(=O)COC(=O)C
13687	sp|P9WGR1|INHA_MYC	P80365	72.12	83.0	277.0	DB14539	approved; vet_approved	Hydrocortisone acetate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)C
13688	sp|P9WGR1|INHA_MYC	P80365	72.12	83.0	277.0	DB14540	approved; vet_approved	Hydrocortisone butyrate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCC
13689	sp|P9WGR1|INHA_MYC	P80365	72.12	83.0	277.0	DB14541	approved; investigational; vet_approved	Hydrocortisone cypionate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)CCC5CCCC5
13690	sp|P9WGR1|INHA_MYC	P80365	72.12	83.0	277.0	DB14542	approved; vet_approved	Hydrocortisone phosphate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COP(=O)(O)O
13691	sp|P9WGR1|INHA_MYC	P80365	72.12	83.0	277.0	DB14543	approved; vet_approved	Hydrocortisone probutate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CCC)C(=O)COC(=O)CC
13692	sp|P9WGR1|INHA_MYC	P80365	72.12	83.0	277.0	DB14544	approved; vet_approved	Hydrocortisone valerate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCCC
13693	sp|P9WGR1|INHA_MYC	Q8NBN7	76.21	36.0	241.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
13694	sp|P9WGR1|INHA_MYC	P37058	79.55	48.0	262.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
13695	sp|P9WGR1|INHA_MYC	Q96NR8	75.09	37.0	239.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
13696	sp|P9WGR1|INHA_MYC	O75911	71.0	39.0	230.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
13697	sp|P9WGR1|INHA_MYC	P51659	75.84	8.0	212.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
13698	sp|P9WGR1|INHA_MYC	P51659	75.84	8.0	212.0	DB03192	experimental	(R)-3-hydroxydecanoyl-CoA	CCCCCCC[C@@H](O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
13699	sp|P9WGR1|INHA_MYC	P28845	74.35	31.0	231.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
13700	sp|P9WGR1|INHA_MYC	P28845	74.35	31.0	231.0	DB02329	experimental	Carbenoxolone	OC(=O)CCC(=O)O[C@@H](CC1)C(C)(C)[C@@H]([C@]12C)CC[C@]3(C)[C@@H]2C(=O)C=C4[C@H]5[C@@](C)(CC[C@@]34C)CC[C@](C5)(C)C(=O)O
13701	sp|P9WGR1|INHA_MYC	P28845	74.35	31.0	231.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
13702	sp|P9WGR1|INHA_MYC	P28845	74.35	31.0	231.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
13703	sp|P9WGR1|INHA_MYC	P28845	74.35	31.0	231.0	DB04652	experimental	Corticosterone	OCC(=O)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H]([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
13704	sp|P9WGR1|INHA_MYC	P28845	74.35	31.0	231.0	DB05064	investigational	INCB13739	 
13705	sp|P9WGR1|INHA_MYC	P28845	74.35	31.0	231.0	DB06992	experimental	(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone	Cc1ccc(cc1F)-c2nc(ccc2)C(=O)N(CC3(C)C)CCC3
13706	sp|P9WGR1|INHA_MYC	P28845	74.35	31.0	231.0	DB07017	experimental	(5S)-2-{[(1S)-1-(4-Fluorophenyl)ethyl]amino}-5-(2-hydroxy-2-propanyl)-5-methyl-1,3-thiazol-4(5H)-one	Fc1ccc(cc1)[C@H](C)NC(=NC2=O)S[C@@]2(C)C(C)(C)O
13707	sp|P9WGR1|INHA_MYC	P28845	74.35	31.0	231.0	DB07049	experimental	(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine	[O-][N+](=O)c1ccc(cc1)N2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)C(C)(C)C
13708	sp|P9WGR1|INHA_MYC	P28845	74.35	31.0	231.0	DB07056	experimental	2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide	CCN(CC)C(=O)Cc1cccc(n1)NS(=O)(=O)c2c(C)c(Cl)ccc2
13709	sp|P9WGR1|INHA_MYC	P28845	74.35	31.0	231.0	DB07310	experimental	(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one	Fc1ccccc1[C@H](C)NC(=NC2=O)S[C@]2(C)C(F)(F)F
13710	sp|P9WGR1|INHA_MYC	P28845	74.35	31.0	231.0	DB07316	experimental	N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)C3CCN(CC3)CC4(CC4)C(=O)N
13711	sp|P9WGR1|INHA_MYC	P28845	74.35	31.0	231.0	DB07619	experimental	N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)[C@H]3CC[C@@H](CC3)c4cccnc4
13712	sp|P9WGR1|INHA_MYC	P28845	74.35	31.0	231.0	DB07624	experimental	1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide	C1CC1(C(=O)N)CN2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)[C@](C)(O)C(F)(F)F
13713	sp|P9WGR1|INHA_MYC	P28845	74.35	31.0	231.0	DB07866	experimental	(5S)-2-(Cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one	CCC[C@]1(C)SC(=NC1=O)NC2CCCCCCC2
13714	sp|P9WGR1|INHA_MYC	P28845	74.35	31.0	231.0	DB08277	experimental	2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE	CS(=O)(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4c(Cl)cc(F)cc4
13715	sp|P9WGR1|INHA_MYC	P28845	74.35	31.0	231.0	DB08280	experimental	(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE	NC(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4ccc(OC)cc4
13716	sp|P9WGR1|INHA_MYC	P28845	74.35	31.0	231.0	DB08771	experimental	(5R)-2-[(2-Fluorophenyl)amino]-5-isopropyl-1,3-thiazol-4(5H)-one	CC(C)[C@H]1SC(=NC1=O)Nc2c(F)cccc2
13717	sp|P9WGR1|INHA_MYC	P28845	74.35	31.0	231.0	DB13751	approved; experimental	Glycyrrhizic acid	C1C[C@](C)(C(=O)O)C[C@H]([C@]12C)C=3[C@@](C)(CC2)[C@@]4(C)[C@H](C(=O)C3)[C@]5(C)[C@@H](CC4)C(C)(C)[C@H](CC5)O[C@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O[C@@H]7O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]7O
13718	sp|P9WGR1|INHA_MYC	P56937	86.25	3.0	235.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
13719	sp|P9WGR1|INHA_MYC	P35270	77.7	5.0	214.0	DB02637	experimental	Oxaloacetate Ion	OC(=O)C(=O)CC([O-])=O
13720	sp|P9WGR1|INHA_MYC	P35270	77.7	5.0	214.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
13721	sp|P9WGR1|INHA_MYC	P35270	77.7	5.0	214.0	DB03886	experimental	Biopterin	C[C@@H](O)[C@@H](O)c(n1)cnc(c12)nc(N)[nH]c2=O
13722	sp|P9WGR1|INHA_MYC	P35270	77.7	5.0	214.0	DB04275	experimental	N-acetylserotonin	CC(=O)NCCc1c[nH]c(c12)ccc(c2)O
13723	sp|P9WGR1|INHA_MYC	P26391	71.0	3.0	194.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
13724	sp|P9WQN7|MPT51_MY	P9WQN9	100.67	24.0	325.0	DB02811	experimental	Diethyl phosphonate	CCOP(=O)OCC
13725	sp|P9WQN7|MPT51_MY	P9WQN9	100.67	24.0	325.0	DB08558	experimental	2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)SCCCCCCCC
13726	sp|P9WJQ3|NARG_MYC	P09152	99.59	2.0	1229.0	DB04464	experimental	N-Formylmethionine	O=CN[C@H](C(=O)O)CCSC
13727	sp|P9WJQ3|NARG_MYC	P09152	99.59	2.0	1229.0	DB07349	experimental	(1S)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PENTANOYLOXY)METHYL]ETHYL OCTANOATE	OC[C@H](O)COP([O-])(=O)OC[C@@H](COC(=O)CCCC)OC(=O)CCCCCCC
13728	sp|P9WK85|LIPR_MYC	Q7SIG1	80.19	62.0	309.0	DB02776	experimental	1-Hexadecanosulfonic Acid	CCCCCCCCCCCCCCCCS(=O)(=O)O
13729	sp|P9WJK5|MUTB_MYC	P22033	94.53	35.0	744.0	DB00115	approved; nutraceutical	Cyanocobalamin	Cc(c1)c(C)cc(c12)ncn2[C@@H]3[C@H](O)[C@@H]([C@H](O3)CO)OP([O-])(=O)O[C@H](C)CNC(=O)CC[C@](C)([C@@H](CC(=O)N)[C@@H]4[C@]56C)C(=N4)/C(C)=C7\N=C(C(C)(C)[C@@H]7CCC(=O)N)/C=C8\N=C([C@@](C)(CC(=O)N)[C@@H]8CCC(=O)N)/C(C)=C(\N5[Co+]C#N)[C@@H](CCC(=O)N)[C@]6(C)CC(=O)N
13730	sp|P9WJK5|MUTB_MYC	P22033	94.53	35.0	744.0	DB00200	approved	Hydroxocobalamin	c1c(C)c(C)cc(c1[n+]2[Co-3]3456O)n(c2)[C@H]7O[C@H](CO)[C@H]([C@H]7O)OP(=O)([O-])O[C@H](C)CNC(=O)CC[C@@]8(C)C=9N3[C@H]([C@@H]8CC(=O)N)[C@]1(C)[N+]4=C([C@H]([C@]1(C)CC(=O)N)CCC(=O)N)C(C)=C1[N+]5=C([C@H]([C@]1(C)CC(=O)N)CCC(=O)N)C=C1[N+]6=C(C9C)[C@H](C1(C)C)CCC(=O)N
13731	sp|P9WIN1|PPGK_MYC	Q7WT42	92.08	14.0	258.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
13732	sp|P9WNM5|CYSNC_MY	P68104	73.78	6.0	459.0	DB01593	approved; investigational	Zinc	[Zn]
13733	sp|P9WNM5|CYSNC_MY	P68104	73.78	6.0	459.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
13734	sp|P9WNM5|CYSNC_MY	P68104	73.78	6.0	459.0	DB09130	approved; investigational	Copper	[Cu]
13735	sp|P9WNM5|CYSNC_MY	P68104	73.78	6.0	459.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
13736	sp|P9WNM5|CYSNC_MY	P68104	73.78	6.0	459.0	DB14487	approved; investigational	Zinc acetate	CC([O-])=O
13737	sp|P9WNM5|CYSNC_MY	P68104	73.78	6.0	459.0	DB14533	approved; investigational	Zinc chloride	[Cl-]
13738	sp|P9WNM5|CYSNC_MY	P68104	73.78	6.0	459.0	DB14548	approved; experimental	Zinc sulfate, unspecified form	 
13739	sp|P9WNS1|DXR_MYCT	P45568	95.64	3.0	398.0	DB02496	experimental	1-Deoxy-D-xylulose 5-phosphate	CC(=O)[C@@H](O)[C@H](O)COP(=O)(O)O
13740	sp|P9WNS1|DXR_MYCT	P45568	95.64	3.0	398.0	DB02948	experimental; investigational	Fosmidomycin	O=CN(O)CCCP(=O)(O)O
13741	sp|P9WNS1|DXR_MYCT	P45568	95.64	3.0	398.0	DB03649	experimental	[{(5-Chloro-2-Pyridinyl)Amino} Methylene]-1,1-Bisphosphonate	OP(=O)(O)C(P(=O)(O)O)Nc1ccc(Cl)cn1
13742	sp|P9WKE5|KPYK_MYC	P14618	102.97	42.0	528.0	DB00119	approved; investigational; nutraceutical	Pyruvic acid	CC(=O)C(=O)O
13743	sp|P9WKE5|KPYK_MYC	P14618	102.97	42.0	528.0	DB01733	experimental	L-Phospholactate	OC(=O)[C@@H](C)OP(=O)(O)O
13744	sp|P9WKE5|KPYK_MYC	P14618	102.97	42.0	528.0	DB02726	experimental	2-Phosphoglycolic Acid	OC(=O)COP(=O)(O)O
13745	sp|P9WKE5|KPYK_MYC	P14618	102.97	42.0	528.0	DB07628	experimental	6-(2-fluorobenzyl)-2,4-dimethyl-4,6-dihydro-5H-thieno[2',3':4,5]pyrrolo[2,3-d]pyridazin-5-one	Cc(s1)cc(c12)n(C)c3c2cnn(c3=O)Cc4ccccc4F
13746	sp|P9WKE5|KPYK_MYC	P14618	102.97	42.0	528.0	DB07692	experimental	1-[(2,6-difluorophenyl)sulfonyl]-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine	Fc1cccc(F)c1S(=O)(=O)N2CCN(CC2)S(=O)(=O)c(c3)ccc(c34)OCCO4
13747	sp|P9WKE5|KPYK_MYC	P14618	102.97	42.0	528.0	DB07697	experimental	1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-[(4-methoxyphenyl)sulfonyl]piperazine	COc1ccc(cc1)S(=O)(=O)N2CCN(CC2)S(=O)(=O)c(c3)ccc(c34)OCCO4
13748	sp|P9WKE5|KPYK_MYC	P14618	102.97	42.0	528.0	DB09130	approved; investigational	Copper	[Cu]
13749	sp|P9WKE5|KPYK_MYC	P14618	102.97	42.0	528.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
13750	sp|P9WKE5|KPYK_MYC	C6KTA4	100.42	36.0	510.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
13751	sp|P9WKE5|KPYK_MYC	P30613	103.39	85.0	573.0	DB00119	approved; investigational; nutraceutical	Pyruvic acid	CC(=O)C(=O)O
13752	sp|P9WKE5|KPYK_MYC	P30613	103.39	85.0	573.0	DB02726	experimental	2-Phosphoglycolic Acid	OC(=O)COP(=O)(O)O
13753	sp|P9WKE5|KPYK_MYC	P30613	103.39	85.0	573.0	DB04551	experimental	beta-D-fructofuranose 1,6-bisphosphate	OP(=O)(O)OC[C@H]([C@@H](O)[C@@H]1O)O[C@]1(O)COP(=O)(O)O
13754	sp|O86311|MEATP_MY	O95342	95.5	414.0	711.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
13755	sp|O86311|MEATP_MY	O95342	95.5	414.0	711.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
13756	sp|O86311|MEATP_MY	O95342	79.42	1072.0	1319.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
13757	sp|O86311|MEATP_MY	O95342	79.42	1072.0	1319.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
13758	sp|O86311|MEATP_MY	P08183	90.68	386.0	668.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
13759	sp|O86311|MEATP_MY	P08183	90.68	386.0	668.0	DB00603	approved; investigational	Medroxyprogesterone acetate	CC(=O)O[C@]1(C(=O)C)CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C([C@H](C3)C)=CC(=O)CC4
13760	sp|O86311|MEATP_MY	P08183	90.68	386.0	668.0	DB00778	approved; investigational; withdrawn	Roxithromycin	COCCOCO/N=C([C@H](C)[C@@H](O)[C@]1(C)O)/[C@H](C)C[C@@](C)(O)[C@@H]([C@@H](C)[C@@H]([C@@H](C)C(=O)O[C@@H]1CC)O[C@@H](C[C@@]2(C)OC)O[C@@H](C)[C@@H]2O)O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C
13761	sp|O86311|MEATP_MY	P08183	90.68	386.0	668.0	DB00813	approved; illicit; investigational; vet_approved	Fentanyl	c1ccccc1N(C(=O)CC)C2CCN(CC2)CCc3ccccc3
13762	sp|O86311|MEATP_MY	P08183	90.68	386.0	668.0	DB04877	experimental	Voacamine	CC[C@H]1C[C@@H](C2)CN([C@@H]1[C@@]23C(=O)OC)CCc4c3[nH]c5c4cc(OC)c(c5)[C@@H](C[C@H]67)c8c(c9c([nH]8)cccc9)C[C@H](C6C(=O)OC)N(C)CC\7=C\C
13763	sp|O86311|MEATP_MY	P08183	90.68	386.0	668.0	DB04881	investigational	Elacridar	COc1cccc(c12)c(=O)c3c([nH]2)c(ccc3)C(=O)Nc4ccc(cc4)CCN(C5)CCc(c56)cc(OC)c(c6)OC
13764	sp|O86311|MEATP_MY	P08183	90.68	386.0	668.0	DB04905	investigational	Tesmilifene	CCN(CC)CCOc1ccc(cc1)Cc2ccccc2
13765	sp|O86311|MEATP_MY	P08183	90.68	386.0	668.0	DB05449	investigational	FM-VP4	 
13766	sp|O86311|MEATP_MY	P08183	90.68	386.0	668.0	DB06191	investigational	Zosuquidar	FC1(F)[C@H]2[C@@H]1c(cccc3)c3[C@@H](c(c24)cccc4)N5CCN(CC5)C[C@@H](O)COc6cccc(c67)nccc7
13767	sp|O86311|MEATP_MY	P08183	90.68	386.0	668.0	DB06240	investigational	Tariquidar	COc(c1)c(OC)cc(c12)CCN(C2)CCc3ccc(cc3)NC(=O)c4cc(OC)c(OC)cc4NC(=O)c(c5)cnc(c56)cccc6
13768	sp|O86311|MEATP_MY	P08183	90.68	386.0	668.0	DB09031	approved; investigational	Miltefosine	CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C
13769	sp|O86311|MEATP_MY	P08183	90.68	386.0	668.0	DB11635	approved	Tocofersolan	 
13770	sp|O86311|MEATP_MY	P08183	90.68	386.0	668.0	DB14061	experimental	Hycanthone	CCN(CC)CCNc(ccc1CO)c(c12)c(=O)c3c(s2)cccc3
13771	sp|O86311|MEATP_MY	P08183	90.68	386.0	668.0	DB14062	experimental	Concanamycin A	NC(=O)O[C@@H]1[C@@H](C)O[C@H](C[C@H]1O)O[C@H](C2)[C@H](C)[C@@H](/C=C/C)O[C@@]2(O)[C@@H](C)[C@H](O)[C@H](C)[C@H]3OC(=O)/C(OC)=C/C(C)=C/[C@@H](C)[C@@H](O)[C@@H](CC)[C@@H](O)[C@H](C)C/C(C)=C/C=C/[C@@H]3OC
13772	sp|O86311|MEATP_MY	P08183	90.68	386.0	668.0	DB14063	experimental	Dexverapamil	COc1ccc(cc1OC)CCN(C)CCC[C@@](C#N)(C(C)C)c2cc(OC)c(OC)cc2
13773	sp|O86311|MEATP_MY	P08183	90.68	386.0	668.0	DB14064	experimental	Emopamil	c1ccccc1C(C#N)(C(C)C)CCCN(C)CCc2ccccc2
13774	sp|O86311|MEATP_MY	P08183	90.68	386.0	668.0	DB14065	experimental	Lomerizine	COc1ccc(c(OC)c1OC)CN2CCN(CC2)C(c3ccc(F)cc3)c4ccc(F)cc4
13775	sp|O86311|MEATP_MY	P08183	90.68	386.0	668.0	DB14066	experimental	Tetrandrine	c12ccc(OC)c(c1)Oc3ccc(cc3)C[C@H]4c5c(CCN4C)cc(OC)c(c5)Oc6c7c(CCN(C)[C@H]7C2)cc(OC)c6OC
13776	sp|O86311|MEATP_MY	P08183	90.68	386.0	668.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
13777	sp|O86311|MEATP_MY	P08183	90.68	386.0	668.0	DB14068	experimental	Dexniguldipine	[O-][N+](=O)c1cccc(c1)[C@@H]2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCCN(CC3)CCC3(c4ccccc4)c5ccccc5
13778	sp|O86311|MEATP_MY	P08183	90.68	386.0	668.0	DB14069	investigational	ONT-093	CCOC/C=C/c1ccc(cc1)-c2nc(-c3ccc(cc3)NC(C)C)c([nH]2)-c4ccc(cc4)NC(C)C
13779	sp|O86311|MEATP_MY	P08183	90.68	386.0	668.0	DB14070	experimental	HM-30181	c1cccc(c12)c(=O)cc(o2)C(=O)Nc3cc(OC)c(OC)cc3-c4nn(nn4)-c5ccc(cc5)CCN(C6)CCc(c67)cc(OC)c(c7)OC
13780	sp|O86311|MEATP_MY	P08183	90.68	386.0	668.0	DB14071	experimental	Desmethylsertraline	c1cccc(c12)[C@@H](CC[C@@H]2N)c3cc(Cl)c(Cl)cc3
13781	sp|O86311|MEATP_MY	P08183	90.68	386.0	668.0	DB14072	experimental	Reversin 121	c1ccccc1COC(=O)C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@H](C(=O)OC(C)(C)C)CCCCNC(=O)OCc2ccccc2
13782	sp|O86311|MEATP_MY	P08183	78.14	1031.0	1274.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
13783	sp|O86311|MEATP_MY	P08183	78.14	1031.0	1274.0	DB00603	approved; investigational	Medroxyprogesterone acetate	CC(=O)O[C@]1(C(=O)C)CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C([C@H](C3)C)=CC(=O)CC4
13784	sp|O86311|MEATP_MY	P08183	78.14	1031.0	1274.0	DB00778	approved; investigational; withdrawn	Roxithromycin	COCCOCO/N=C([C@H](C)[C@@H](O)[C@]1(C)O)/[C@H](C)C[C@@](C)(O)[C@@H]([C@@H](C)[C@@H]([C@@H](C)C(=O)O[C@@H]1CC)O[C@@H](C[C@@]2(C)OC)O[C@@H](C)[C@@H]2O)O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C
13785	sp|O86311|MEATP_MY	P08183	78.14	1031.0	1274.0	DB00813	approved; illicit; investigational; vet_approved	Fentanyl	c1ccccc1N(C(=O)CC)C2CCN(CC2)CCc3ccccc3
13786	sp|O86311|MEATP_MY	P08183	78.14	1031.0	1274.0	DB04877	experimental	Voacamine	CC[C@H]1C[C@@H](C2)CN([C@@H]1[C@@]23C(=O)OC)CCc4c3[nH]c5c4cc(OC)c(c5)[C@@H](C[C@H]67)c8c(c9c([nH]8)cccc9)C[C@H](C6C(=O)OC)N(C)CC\7=C\C
13787	sp|O86311|MEATP_MY	P08183	78.14	1031.0	1274.0	DB04881	investigational	Elacridar	COc1cccc(c12)c(=O)c3c([nH]2)c(ccc3)C(=O)Nc4ccc(cc4)CCN(C5)CCc(c56)cc(OC)c(c6)OC
13788	sp|O86311|MEATP_MY	P08183	78.14	1031.0	1274.0	DB04905	investigational	Tesmilifene	CCN(CC)CCOc1ccc(cc1)Cc2ccccc2
13789	sp|O86311|MEATP_MY	P08183	78.14	1031.0	1274.0	DB05449	investigational	FM-VP4	 
13790	sp|O86311|MEATP_MY	P08183	78.14	1031.0	1274.0	DB06191	investigational	Zosuquidar	FC1(F)[C@H]2[C@@H]1c(cccc3)c3[C@@H](c(c24)cccc4)N5CCN(CC5)C[C@@H](O)COc6cccc(c67)nccc7
13791	sp|O86311|MEATP_MY	P08183	78.14	1031.0	1274.0	DB06240	investigational	Tariquidar	COc(c1)c(OC)cc(c12)CCN(C2)CCc3ccc(cc3)NC(=O)c4cc(OC)c(OC)cc4NC(=O)c(c5)cnc(c56)cccc6
13792	sp|O86311|MEATP_MY	P08183	78.14	1031.0	1274.0	DB09031	approved; investigational	Miltefosine	CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C
13793	sp|O86311|MEATP_MY	P08183	78.14	1031.0	1274.0	DB11635	approved	Tocofersolan	 
13794	sp|O86311|MEATP_MY	P08183	78.14	1031.0	1274.0	DB14061	experimental	Hycanthone	CCN(CC)CCNc(ccc1CO)c(c12)c(=O)c3c(s2)cccc3
13795	sp|O86311|MEATP_MY	P08183	78.14	1031.0	1274.0	DB14062	experimental	Concanamycin A	NC(=O)O[C@@H]1[C@@H](C)O[C@H](C[C@H]1O)O[C@H](C2)[C@H](C)[C@@H](/C=C/C)O[C@@]2(O)[C@@H](C)[C@H](O)[C@H](C)[C@H]3OC(=O)/C(OC)=C/C(C)=C/[C@@H](C)[C@@H](O)[C@@H](CC)[C@@H](O)[C@H](C)C/C(C)=C/C=C/[C@@H]3OC
13796	sp|O86311|MEATP_MY	P08183	78.14	1031.0	1274.0	DB14063	experimental	Dexverapamil	COc1ccc(cc1OC)CCN(C)CCC[C@@](C#N)(C(C)C)c2cc(OC)c(OC)cc2
13797	sp|O86311|MEATP_MY	P08183	78.14	1031.0	1274.0	DB14064	experimental	Emopamil	c1ccccc1C(C#N)(C(C)C)CCCN(C)CCc2ccccc2
13798	sp|O86311|MEATP_MY	P08183	78.14	1031.0	1274.0	DB14065	experimental	Lomerizine	COc1ccc(c(OC)c1OC)CN2CCN(CC2)C(c3ccc(F)cc3)c4ccc(F)cc4
13799	sp|O86311|MEATP_MY	P08183	78.14	1031.0	1274.0	DB14066	experimental	Tetrandrine	c12ccc(OC)c(c1)Oc3ccc(cc3)C[C@H]4c5c(CCN4C)cc(OC)c(c5)Oc6c7c(CCN(C)[C@H]7C2)cc(OC)c6OC
13800	sp|O86311|MEATP_MY	P08183	78.14	1031.0	1274.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
13801	sp|O86311|MEATP_MY	P08183	78.14	1031.0	1274.0	DB14068	experimental	Dexniguldipine	[O-][N+](=O)c1cccc(c1)[C@@H]2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCCN(CC3)CCC3(c4ccccc4)c5ccccc5
13802	sp|O86311|MEATP_MY	P08183	78.14	1031.0	1274.0	DB14069	investigational	ONT-093	CCOC/C=C/c1ccc(cc1)-c2nc(-c3ccc(cc3)NC(C)C)c([nH]2)-c4ccc(cc4)NC(C)C
13803	sp|O86311|MEATP_MY	P08183	78.14	1031.0	1274.0	DB14070	experimental	HM-30181	c1cccc(c12)c(=O)cc(o2)C(=O)Nc3cc(OC)c(OC)cc3-c4nn(nn4)-c5ccc(cc5)CCN(C6)CCc(c67)cc(OC)c(c7)OC
13804	sp|O86311|MEATP_MY	P08183	78.14	1031.0	1274.0	DB14071	experimental	Desmethylsertraline	c1cccc(c12)[C@@H](CC[C@@H]2N)c3cc(Cl)c(Cl)cc3
13805	sp|O86311|MEATP_MY	P08183	78.14	1031.0	1274.0	DB14072	experimental	Reversin 121	c1ccccc1COC(=O)C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@H](C(=O)OC(C)(C)C)CCCCNC(=O)OCc2ccccc2
13806	sp|O86311|MEATP_MY	Q2M3G0	83.6	381.0	641.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
13807	sp|O86311|MEATP_MY	Q2M3G0	83.6	381.0	641.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
13808	sp|O86311|MEATP_MY	Q2M3G0	78.78	1009.0	1254.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
13809	sp|O86311|MEATP_MY	Q2M3G0	78.78	1009.0	1254.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
13810	sp|O86311|MEATP_MY	O60706	91.32	667.0	951.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
13811	sp|O86311|MEATP_MY	O60706	91.32	667.0	951.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
13812	sp|O86311|MEATP_MY	O60706	91.32	667.0	951.0	DB09220	approved; investigational	Nicorandil	[O-][N+](=O)OCCNC(=O)c1cccnc1
13813	sp|O86311|MEATP_MY	O60706	76.21	1309.0	1546.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
13814	sp|O86311|MEATP_MY	O60706	76.21	1309.0	1546.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
13815	sp|O86311|MEATP_MY	O60706	76.21	1309.0	1546.0	DB09220	approved; investigational	Nicorandil	[O-][N+](=O)OCCNC(=O)c1cccnc1
13816	sp|O86311|MEATP_MY	P33527	79.74	643.0	891.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
13817	sp|O86311|MEATP_MY	P33527	79.74	643.0	891.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
13818	sp|O86311|MEATP_MY	P33527	79.74	643.0	891.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
13819	sp|O86311|MEATP_MY	P33527	79.74	643.0	891.0	DB06176	approved; investigational	Romidepsin	O=C([C@H]12)N/C(=C\C)C(=O)N[C@@H](C(C)C)C(=O)O[C@@H](CC(=O)N[C@H](C(C)C)C(=O)N1)/C=C/CCSSC2
13820	sp|O86311|MEATP_MY	P33527	79.74	643.0	891.0	DB08855	experimental; investigational	Leukotriene C4	CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@@H](O)CCCC(=O)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@H](N)C(=O)O
13821	sp|O86311|MEATP_MY	P33527	74.92	1291.0	1524.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
13822	sp|O86311|MEATP_MY	P33527	74.92	1291.0	1524.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
13823	sp|O86311|MEATP_MY	P33527	74.92	1291.0	1524.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
13824	sp|O86311|MEATP_MY	P33527	74.92	1291.0	1524.0	DB06176	approved; investigational	Romidepsin	O=C([C@H]12)N/C(=C\C)C(=O)N[C@@H](C(C)C)C(=O)O[C@@H](CC(=O)N[C@H](C(C)C)C(=O)N1)/C=C/CCSSC2
13825	sp|O86311|MEATP_MY	P33527	74.92	1291.0	1524.0	DB08855	experimental; investigational	Leukotriene C4	CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@@H](O)CCCC(=O)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@H](N)C(=O)O
13826	sp|O86311|MEATP_MY	Q09428	87.46	673.0	945.0	DB00839	approved; investigational	Tolazamide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2
13827	sp|O86311|MEATP_MY	Q09428	87.46	673.0	945.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
13828	sp|O86311|MEATP_MY	Q09428	74.6	1341.0	1573.0	DB00839	approved; investigational	Tolazamide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2
13829	sp|O86311|MEATP_MY	Q09428	74.6	1341.0	1573.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
13830	sp|O86311|MEATP_MY	Q09428	87.46	673.0	945.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
13831	sp|O86311|MEATP_MY	Q09428	87.46	673.0	945.0	DB00222	approved	Glimepiride	CCC1=C(C)CN(C1=O)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3
13832	sp|O86311|MEATP_MY	Q09428	87.46	673.0	945.0	DB00672	approved; investigational	Chlorpropamide	CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1
13833	sp|O86311|MEATP_MY	Q09428	87.46	673.0	945.0	DB00731	approved; investigational	Nateglinide	CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](C(=O)O)Cc2ccccc2
13834	sp|O86311|MEATP_MY	Q09428	87.46	673.0	945.0	DB00912	approved; investigational	Repaglinide	CCOc1c(C(=O)O)ccc(c1)CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3
13835	sp|O86311|MEATP_MY	Q09428	87.46	673.0	945.0	DB01067	approved; investigational	Glipizide	Cc1ncc(nc1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
13836	sp|O86311|MEATP_MY	Q09428	87.46	673.0	945.0	DB01120	approved	Gliclazide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN(C2)CC(C23)CCC3
13837	sp|O86311|MEATP_MY	Q09428	87.46	673.0	945.0	DB01124	approved; investigational	Tolbutamide	CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1
13838	sp|O86311|MEATP_MY	Q09428	87.46	673.0	945.0	DB01251	approved; investigational	Gliquidone	COc(cc1)cc(c12)C(=O)N(C(=O)C2(C)C)CCc3ccc(cc3)S(=O)(=O)NC(=O)NC4CCCCC4
13839	sp|O86311|MEATP_MY	Q09428	87.46	673.0	945.0	DB01252	investigational	Mitiglinide	c1ccccc1C[C@H](C(=O)O)CC(=O)N(C2)C[C@H]([C@H]23)CCCC3
13840	sp|O86311|MEATP_MY	Q09428	87.46	673.0	945.0	DB01382	approved; investigational	Glymidine	COCCOc1cnc(nc1)NS(=O)(=O)c2ccccc2
13841	sp|O86311|MEATP_MY	Q09428	74.6	1341.0	1573.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
13842	sp|O86311|MEATP_MY	Q09428	74.6	1341.0	1573.0	DB00222	approved	Glimepiride	CCC1=C(C)CN(C1=O)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3
13843	sp|O86311|MEATP_MY	Q09428	74.6	1341.0	1573.0	DB00672	approved; investigational	Chlorpropamide	CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1
13844	sp|O86311|MEATP_MY	Q09428	74.6	1341.0	1573.0	DB00731	approved; investigational	Nateglinide	CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](C(=O)O)Cc2ccccc2
13845	sp|O86311|MEATP_MY	Q09428	74.6	1341.0	1573.0	DB00912	approved; investigational	Repaglinide	CCOc1c(C(=O)O)ccc(c1)CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3
13846	sp|O86311|MEATP_MY	Q09428	74.6	1341.0	1573.0	DB01067	approved; investigational	Glipizide	Cc1ncc(nc1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
13847	sp|O86311|MEATP_MY	Q09428	74.6	1341.0	1573.0	DB01120	approved	Gliclazide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN(C2)CC(C23)CCC3
13848	sp|O86311|MEATP_MY	Q09428	74.6	1341.0	1573.0	DB01124	approved; investigational	Tolbutamide	CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1
13849	sp|O86311|MEATP_MY	Q09428	74.6	1341.0	1573.0	DB01251	approved; investigational	Gliquidone	COc(cc1)cc(c12)C(=O)N(C(=O)C2(C)C)CCc3ccc(cc3)S(=O)(=O)NC(=O)NC4CCCCC4
13850	sp|O86311|MEATP_MY	Q09428	74.6	1341.0	1573.0	DB01252	investigational	Mitiglinide	c1ccccc1C[C@H](C(=O)O)CC(=O)N(C2)C[C@H]([C@H]23)CCCC3
13851	sp|O86311|MEATP_MY	Q09428	74.6	1341.0	1573.0	DB01382	approved; investigational	Glymidine	COCCOc1cnc(nc1)NS(=O)(=O)c2ccccc2
13852	sp|O86311|MEATP_MY	O15440	72.99	552.0	779.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
13853	sp|O86311|MEATP_MY	O15440	72.99	552.0	779.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
13854	sp|O86311|MEATP_MY	O15440	76.85	1190.0	1429.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
13855	sp|O86311|MEATP_MY	O15440	76.85	1190.0	1429.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
13856	sp|O86311|MEATP_MY	O95255	74.92	629.0	862.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
13857	sp|O86311|MEATP_MY	O95255	74.92	1263.0	1496.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
13858	sp|O86311|MEATP_MY	Q92887	76.53	633.0	871.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
13859	sp|O86311|MEATP_MY	Q92887	76.53	633.0	871.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
13860	sp|O86311|MEATP_MY	Q92887	74.92	1297.0	1530.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
13861	sp|O86311|MEATP_MY	Q92887	74.92	1297.0	1530.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
13862	sp|O86311|MEATP_MY	O95477	82.32	898.0	1154.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
13863	sp|O86311|MEATP_MY	O95477	82.32	898.0	1154.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
13864	sp|O86311|MEATP_MY	O95477	82.32	898.0	1154.0	DB01599	approved; investigational	Probucol	CC(C)(C)c1cc(cc(c1O)C(C)(C)C)SC(C)(C)Sc2cc(C(C)(C)C)c(O)c(c2)C(C)(C)C
13865	sp|O86311|MEATP_MY	O95477	89.07	1912.0	2189.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
13866	sp|O86311|MEATP_MY	O95477	89.07	1912.0	2189.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
13867	sp|O86311|MEATP_MY	O95477	89.07	1912.0	2189.0	DB01599	approved; investigational	Probucol	CC(C)(C)c1cc(cc(c1O)C(C)(C)C)SC(C)(C)Sc2cc(C(C)(C)C)c(O)c(c2)C(C)(C)C
13868	sp|O86311|MEATP_MY	O15439	77.49	1037.0	1278.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
13869	sp|O86311|MEATP_MY	P13569	73.95	1208.0	1438.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
13870	sp|O86311|MEATP_MY	P13569	73.95	1208.0	1438.0	DB00887	approved	Bumetanide	CCCCNc1c(c(S(=O)(=O)N)cc(c1)C(=O)O)Oc2ccccc2
13871	sp|O86311|MEATP_MY	P13569	73.95	1208.0	1438.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
13872	sp|O86311|MEATP_MY	P13569	73.95	1208.0	1438.0	DB01050	approved	Ibuprofen	CC(C)Cc1ccc(cc1)C(C)C(=O)O
13873	sp|O86311|MEATP_MY	P13569	73.95	1208.0	1438.0	DB02587	experimental; investigational	Colforsin	O[C@H]1CCC(C)(C)[C@@H]([C@]12C)[C@H](O)[C@H](OC(=O)C)[C@]3(C)[C@]2(O)C(=O)C[C@](O3)(C)C=C
13874	sp|O86311|MEATP_MY	P13569	73.95	1208.0	1438.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
13875	sp|O86311|MEATP_MY	P13569	73.95	1208.0	1438.0	DB04522	experimental	Dexfosfoserine	OC(=O)[C@@H](N)COP(=O)(O)O
13876	sp|O86311|MEATP_MY	P13569	73.95	1208.0	1438.0	DB04941	approved	Crofelemer	 
13877	sp|O86311|MEATP_MY	P13569	73.95	1208.0	1438.0	DB06266	investigational	Lonidamine	c1cccc(c12)n(nc2C(=O)O)Cc3c(Cl)cc(Cl)cc3
13878	sp|O86311|MEATP_MY	P13569	73.95	1208.0	1438.0	DB08820	approved	Ivacaftor	CC(C)(C)c1cc(C(C)(C)C)c(O)cc1NC(=O)c(c2=O)c[nH]c(c23)cccc3
13879	sp|O86311|MEATP_MY	P13569	73.95	1208.0	1438.0	DB09213	approved; investigational	Dexibuprofen	CC(C)Cc1ccc(cc1)[C@H](C)C(=O)O
13880	sp|O86311|MEATP_MY	P13569	73.95	1208.0	1438.0	DB09280	approved	Lumacaftor	O=C(O)c1cccc(c1)-c2nc(ccc2C)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
13881	sp|O86311|MEATP_MY	P13569	73.95	1208.0	1438.0	DB11712	approved; investigational	Tezacaftor	OC[C@H](O)Cn1c(C(C)(C)CO)cc(c12)cc(c(F)c2)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
13882	sp|O86311|MEATP_MY	P13569	73.95	1208.0	1438.0	DB15444	approved; investigational	Elexacaftor	FC(F)(F)C(C)(C)COc1nn(cc1)-c2nc(N(C3(C)C)C[C@@H](C)C3)c(cc2)C(=O)NS(=O)(=O)c4cn(C)nc4C
13883	sp|O86311|MEATP_MY	P45844	80.71	74.0	325.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
13884	sp|O86311|MEATP_MY	Q9UNQ0	74.28	61.0	292.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
13885	sp|O86311|MEATP_MY	Q9UNQ0	74.28	61.0	292.0	DB11995	approved; investigational	Avatrombopag	OC(=O)C1CCN(CC1)c2c(Cl)cc(cn2)C(=O)Nc3nc(-c4cc(Cl)cs4)c(s3)N5CCN(CC5)C6CCCCC6
13886	sp|P9WGS9|DPRE2_MY	Q8NBQ5	95.67	36.0	279.0	DB02854	experimental	Aetiocholanolone	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](CC3)C[C@H](O)CC4
13887	sp|P9WGS9|DPRE2_MY	O75911	96.06	38.0	282.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
13888	sp|P9WGS9|DPRE2_MY	P28845	92.13	33.0	267.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
13889	sp|P9WGS9|DPRE2_MY	P28845	92.13	33.0	267.0	DB02329	experimental	Carbenoxolone	OC(=O)CCC(=O)O[C@@H](CC1)C(C)(C)[C@@H]([C@]12C)CC[C@]3(C)[C@@H]2C(=O)C=C4[C@H]5[C@@](C)(CC[C@@]34C)CC[C@](C5)(C)C(=O)O
13890	sp|P9WGS9|DPRE2_MY	P28845	92.13	33.0	267.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
13891	sp|P9WGS9|DPRE2_MY	P28845	92.13	33.0	267.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
13892	sp|P9WGS9|DPRE2_MY	P28845	92.13	33.0	267.0	DB04652	experimental	Corticosterone	OCC(=O)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H]([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
13893	sp|P9WGS9|DPRE2_MY	P28845	92.13	33.0	267.0	DB05064	investigational	INCB13739	 
13894	sp|P9WGS9|DPRE2_MY	P28845	92.13	33.0	267.0	DB06992	experimental	(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone	Cc1ccc(cc1F)-c2nc(ccc2)C(=O)N(CC3(C)C)CCC3
13895	sp|P9WGS9|DPRE2_MY	P28845	92.13	33.0	267.0	DB07017	experimental	(5S)-2-{[(1S)-1-(4-Fluorophenyl)ethyl]amino}-5-(2-hydroxy-2-propanyl)-5-methyl-1,3-thiazol-4(5H)-one	Fc1ccc(cc1)[C@H](C)NC(=NC2=O)S[C@@]2(C)C(C)(C)O
13896	sp|P9WGS9|DPRE2_MY	P28845	92.13	33.0	267.0	DB07049	experimental	(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine	[O-][N+](=O)c1ccc(cc1)N2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)C(C)(C)C
13897	sp|P9WGS9|DPRE2_MY	P28845	92.13	33.0	267.0	DB07056	experimental	2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide	CCN(CC)C(=O)Cc1cccc(n1)NS(=O)(=O)c2c(C)c(Cl)ccc2
13898	sp|P9WGS9|DPRE2_MY	P28845	92.13	33.0	267.0	DB07310	experimental	(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one	Fc1ccccc1[C@H](C)NC(=NC2=O)S[C@]2(C)C(F)(F)F
13899	sp|P9WGS9|DPRE2_MY	P28845	92.13	33.0	267.0	DB07316	experimental	N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)C3CCN(CC3)CC4(CC4)C(=O)N
13900	sp|P9WGS9|DPRE2_MY	P28845	92.13	33.0	267.0	DB07619	experimental	N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)[C@H]3CC[C@@H](CC3)c4cccnc4
13901	sp|P9WGS9|DPRE2_MY	P28845	92.13	33.0	267.0	DB07624	experimental	1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide	C1CC1(C(=O)N)CN2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)[C@](C)(O)C(F)(F)F
13902	sp|P9WGS9|DPRE2_MY	P28845	92.13	33.0	267.0	DB07866	experimental	(5S)-2-(Cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one	CCC[C@]1(C)SC(=NC1=O)NC2CCCCCCC2
13903	sp|P9WGS9|DPRE2_MY	P28845	92.13	33.0	267.0	DB08277	experimental	2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE	CS(=O)(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4c(Cl)cc(F)cc4
13904	sp|P9WGS9|DPRE2_MY	P28845	92.13	33.0	267.0	DB08280	experimental	(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE	NC(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4ccc(OC)cc4
13905	sp|P9WGS9|DPRE2_MY	P28845	92.13	33.0	267.0	DB08771	experimental	(5R)-2-[(2-Fluorophenyl)amino]-5-isopropyl-1,3-thiazol-4(5H)-one	CC(C)[C@H]1SC(=NC1=O)Nc2c(F)cccc2
13906	sp|P9WGS9|DPRE2_MY	P28845	92.13	33.0	267.0	DB13751	approved; experimental	Glycyrrhizic acid	C1C[C@](C)(C(=O)O)C[C@H]([C@]12C)C=3[C@@](C)(CC2)[C@@]4(C)[C@H](C(=O)C3)[C@]5(C)[C@@H](CC4)C(C)(C)[C@H](CC5)O[C@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O[C@@H]7O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]7O
13907	sp|P9WGS9|DPRE2_MY	Q9BTZ2	78.74	31.0	231.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
13909	sp|P9WGS9|DPRE2_MY	P16544	82.28	2.0	211.0	DB01942	experimental; investigational	Formic acid	OC=O
13910	sp|P9WGS9|DPRE2_MY	P16544	82.28	2.0	211.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
13911	sp|P9WGS9|DPRE2_MY	P16544	82.28	2.0	211.0	DB07715	investigational	Emodin	Cc(c1)cc(O)c(c12)C(=O)c3c(C2=O)cc(O)cc3O
13912	sp|P9WGS9|DPRE2_MY	P0AEK2	75.2	4.0	195.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
13913	sp|P9WGS9|DPRE2_MY	Q9WYS2	78.74	9.0	209.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
13917	sp|P9WGS9|DPRE2_MY	P0AET8	80.71	10.0	215.0	DB02123	experimental	Glycochenodeoxycholic Acid	OC(=O)CNC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
13918	sp|P9WGS9|DPRE2_MY	Q02338	81.1	54.0	260.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
13919	sp|P9WGS9|DPRE2_MY	Q9NYR8	77.17	3.0	199.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
13920	sp|P9WGS9|DPRE2_MY	Q6PKH6	70.47	30.0	209.0	DB04200	experimental	Matairesinol	COc1cc(ccc1O)C[C@H]2COC(=O)[C@@H]2Cc3ccc(O)c(c3)OC
13921	sp|P9WGS9|DPRE2_MY	Q84EX5	78.35	6.0	205.0	DB04619	experimental	Acetophenone	CC(=O)c1ccccc1
13922	sp|P9WGS9|DPRE2_MY	Q84EX5	78.35	6.0	205.0	DB04784	experimental	(R)-1-phenylethanol	C[C@@H](O)c1ccccc1
13923	sp|P9WGS9|DPRE2_MY	Q8TC12	79.92	41.0	244.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
13924	sp|P9WGS9|DPRE2_MY	Q6UWP2	81.1	12.0	218.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
13925	sp|P9WGS9|DPRE2_MY	Q8NBN7	79.92	38.0	241.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
13926	sp|P9WGS9|DPRE2_MY	Q92506	81.1	13.0	219.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
13927	sp|P9WGS9|DPRE2_MY	Q92506	81.1	13.0	219.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
13928	sp|P9WGS9|DPRE2_MY	P0CG22	79.53	32.0	234.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
13929	sp|P9WGS9|DPRE2_MY	P0CG22	79.53	32.0	234.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
13930	sp|P9WGS9|DPRE2_MY	P0CG22	79.53	32.0	234.0	DB03541	experimental	10-Propargyl-5,8-Dideazafolic Acid	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(CC#C)Cc(c2)ccc(c23)[nH]c(N)nc3=O
13931	sp|P9WGS9|DPRE2_MY	P0CG22	79.53	32.0	234.0	DB07689	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)NCc(cn3)nc(c34)c(N)nc(n4)N
13932	sp|P9WGS9|DPRE2_MY	P0CG22	79.53	32.0	234.0	DB07765	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)N(C)Cc(cn3)nc(c34)c(N)nc(n4)N
13933	sp|P9WGS9|DPRE2_MY	P14061	78.35	4.0	203.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
13934	sp|P9WGS9|DPRE2_MY	P14061	78.35	4.0	203.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
13935	sp|P9WGS9|DPRE2_MY	P14061	78.35	4.0	203.0	DB01561	experimental; illicit	Androstanedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
13936	sp|P9WGS9|DPRE2_MY	P14061	78.35	4.0	203.0	DB02187	experimental	Equilin	O=C1CC[C@H]([C@@]12C)C=3[C@H](CC2)c4c(CC3)cc(O)cc4
13937	sp|P9WGS9|DPRE2_MY	P14061	78.35	4.0	203.0	DB02323	experimental	EM-1745	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)C[C@@H]([C@@H]4O)CCCCCCCCC(=O)OC[C@H]5O[C@H]([C@H](O)[C@@H]5O)n6cnc(c67)c(N)ncn7
13938	sp|P9WGS9|DPRE2_MY	P14061	78.35	4.0	203.0	DB02901	illicit; investigational	Stanolone	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
13939	sp|P9WGS9|DPRE2_MY	P14061	78.35	4.0	203.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
13940	sp|P9WGS9|DPRE2_MY	P14061	78.35	4.0	203.0	DB13951	experimental	Stanolone acetate	CC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
13941	sp|P9WGS9|DPRE2_MY	P37058	81.1	48.0	254.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
13942	sp|P9WGS9|DPRE2_MY	Q7Z4W1	75.2	7.0	198.0	DB02831	experimental	Dihydrogenphosphate	OP([O-])(=O)O
13943	sp|P9WGS9|DPRE2_MY	Q7Z4W1	75.2	7.0	198.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
13944	sp|P9WGS9|DPRE2_MY	Q96NR8	79.53	39.0	241.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
13945	sp|P9WGS9|DPRE2_MY	P37059	87.4	81.0	303.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
13946	sp|P9WGS9|DPRE2_MY	P37059	87.4	81.0	303.0	DB13952	approved; investigational; vet_approved	Estradiol acetate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)C
13947	sp|P9WGS9|DPRE2_MY	P37059	87.4	81.0	303.0	DB13953	approved; investigational; vet_approved	Estradiol benzoate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)c5ccccc5
13948	sp|P9WGS9|DPRE2_MY	P37059	87.4	81.0	303.0	DB13954	approved; investigational; vet_approved	Estradiol cypionate	C1CCCC1CCC(=O)O[C@H]2CC[C@H]([C@@]23C)[C@H]4[C@H](CC3)c5c(CC4)cc(O)cc5
13949	sp|P9WGS9|DPRE2_MY	P37059	87.4	81.0	303.0	DB13955	approved; investigational; vet_approved	Estradiol dienanthate	CCCCCCC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)CCCCCC
13950	sp|P9WGS9|DPRE2_MY	P37059	87.4	81.0	303.0	DB13956	approved; investigational; vet_approved	Estradiol valerate	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)CC[C@@H]4OC(=O)CCCC
13951	sp|P9WGS9|DPRE2_MY	P51659	84.25	8.0	222.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
13952	sp|P9WGS9|DPRE2_MY	P51659	84.25	8.0	222.0	DB03192	experimental	(R)-3-hydroxydecanoyl-CoA	CCCCCCC[C@@H](O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
13953	sp|P9WGS9|DPRE2_MY	Q9BY49	75.59	17.0	209.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
13954	sp|P9WGS9|DPRE2_MY	Q16698	81.89	58.0	266.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
13955	sp|P9WGS9|DPRE2_MY	Q16698	81.89	58.0	266.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
13956	sp|P9WGS9|DPRE2_MY	Q9HBH5	85.43	42.0	259.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
13957	sp|P9WGS9|DPRE2_MY	Q99714	79.13	12.0	213.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
13958	sp|P9WGS9|DPRE2_MY	Q99714	79.13	12.0	213.0	DB02820	experimental	1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct	C1CCCCCN1C(=O)[C@H](c2ccccc2)n(c3=S)cnc(c34)nn(c4)[C@H]5C=CN(C=C5C([O-])=N)[C@@H]6O[C@@H]([C@@H](O)[C@H]6O)COP([O-])(=O)OP(=O)(O)OC[C@H]7O[C@H]([C@H]([O-])[C@@H]7[O-])n8cnc(c89)c(N)ncn9
13959	sp|P9WGS9|DPRE2_MY	Q99714	79.13	12.0	213.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
13960	sp|P9WGS9|DPRE2_MY	P80365	77.17	82.0	278.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
13961	sp|P9WGS9|DPRE2_MY	P80365	77.17	82.0	278.0	DB01185	approved; illicit	Fluoxymesterone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@](F)([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
13962	sp|P9WGS9|DPRE2_MY	P80365	77.17	82.0	278.0	DB01569	experimental; illicit	Formebolone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@H]([C@@H](C2)O)[C@]4(C)C(CC3)=CC(=O)C(C=O)=C4
13963	sp|P9WGS9|DPRE2_MY	P80365	77.17	82.0	278.0	DB14538	experimental; vet_approved	Hydrocortisone aceponate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CC)C(=O)COC(=O)C
13964	sp|P9WGS9|DPRE2_MY	P80365	77.17	82.0	278.0	DB14539	approved; vet_approved	Hydrocortisone acetate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)C
13965	sp|P9WGS9|DPRE2_MY	P80365	77.17	82.0	278.0	DB14540	approved; vet_approved	Hydrocortisone butyrate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCC
13966	sp|P9WGS9|DPRE2_MY	P80365	77.17	82.0	278.0	DB14541	approved; investigational; vet_approved	Hydrocortisone cypionate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)CCC5CCCC5
13967	sp|P9WGS9|DPRE2_MY	P80365	77.17	82.0	278.0	DB14542	approved; vet_approved	Hydrocortisone phosphate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COP(=O)(O)O
13968	sp|P9WGS9|DPRE2_MY	P80365	77.17	82.0	278.0	DB14543	approved; vet_approved	Hydrocortisone probutate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CCC)C(=O)COC(=O)CC
13969	sp|P9WGS9|DPRE2_MY	P80365	77.17	82.0	278.0	DB14544	approved; vet_approved	Hydrocortisone valerate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCCC
13970	sp|P9WGS9|DPRE2_MY	Q92781	72.83	29.0	214.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
13971	sp|P9WGS9|DPRE2_MY	Q92781	72.83	29.0	214.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
13972	sp|P9WGS9|DPRE2_MY	Q6GI75	80.71	5.0	210.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
13973	sp|P9WGS9|DPRE2_MY	Q6GI75	80.71	5.0	210.0	DB11155	approved	Triclocarban	Clc1ccc(cc1)NC(=O)Nc2cc(Cl)c(Cl)cc2
13974	sp|P9WGS9|DPRE2_MY	P56937	90.94	2.0	233.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
13975	sp|P9WGS9|DPRE2_MY	A0A348A0U3	77.56	6.0	203.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
13976	sp|P9WGS9|DPRE2_MY	Q8I814	79.13	13.0	214.0	DB02015	experimental	Dihydrofolic Acid	O=c1[nH]c(N)nc(c12)NCC(=N2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
13977	sp|P9WGS9|DPRE2_MY	Q8I814	79.13	13.0	214.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
13978	sp|P9WGS9|DPRE2_MY	P0AEK4	78.35	6.0	205.0	DB01691	experimental	Indole Naphthyridinone	c1cccc(c12)n(C)cc2CN(C)C(=O)/C=C/c(c3)cnc(c34)NC(=O)CC4
13979	sp|P9WGS9|DPRE2_MY	P0AEK4	78.35	6.0	205.0	DB01865	experimental	3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide	c1cccc(c12)cc(n2C)CN(C)C(=O)/C=C/c3cnc(N)cc3
13980	sp|P9WGS9|DPRE2_MY	P0AEK4	78.35	6.0	205.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
13981	sp|P9WGS9|DPRE2_MY	P0AEK4	78.35	6.0	205.0	DB03030	experimental	4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole	Cc1ccc(cc1)Cn2cnc(c2)-c3cccs3
13982	sp|P9WGS9|DPRE2_MY	P0AEK4	78.35	6.0	205.0	DB03534	experimental	3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide	CC(=O)N(C)Cc1c(N)ccc(c1)C(=O)N(C)Cc(n2C)cc(c23)cccc3
13983	sp|P9WGS9|DPRE2_MY	P0AEK4	78.35	6.0	205.0	DB04030	experimental	1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole	Oc1ccc(cc1)Cn2c(c3c(c24)cccc4)CN(CC3)C(=O)c5ccc(O)cc5
13984	sp|P9WGS9|DPRE2_MY	P0AEK4	78.35	6.0	205.0	DB08265	experimental	2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL	Cc1ccc(cc1)S(=O)(=O)n(b2O)ncc(c23)cccc3
13985	sp|P9WGS9|DPRE2_MY	P0AEK4	78.35	6.0	205.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
13986	sp|P9WGS9|DPRE2_MY	P0AEK4	78.35	6.0	205.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
13987	sp|P9WGS9|DPRE2_MY	Q7AUG5	70.47	30.0	209.0	DB04782	experimental	(S)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@H]2CO2
13988	sp|P9WGS9|DPRE2_MY	Q93D82	70.47	30.0	209.0	DB04472	experimental	(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol	[N-]=[N+]=NC[C@H](O)c1ccc([N+]([O-])=O)cc1
13989	sp|P9WGS9|DPRE2_MY	Q93D82	70.47	30.0	209.0	DB04499	experimental	(R)-styrene oxide	C1O[C@@H]1c2ccccc2
13990	sp|P9WGS9|DPRE2_MY	Q93D82	70.47	30.0	209.0	DB04777	experimental	(R)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@@H]2CO2
13991	sp|P9WGS9|DPRE2_MY	P35270	80.71	9.0	214.0	DB02637	experimental	Oxaloacetate Ion	OC(=O)C(=O)CC([O-])=O
13992	sp|P9WGS9|DPRE2_MY	P35270	80.71	9.0	214.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
13993	sp|P9WGS9|DPRE2_MY	P35270	80.71	9.0	214.0	DB03886	experimental	Biopterin	C[C@@H](O)[C@@H](O)c(n1)cnc(c12)nc(N)[nH]c2=O
13994	sp|P9WGS9|DPRE2_MY	P35270	80.71	9.0	214.0	DB04275	experimental	N-acetylserotonin	CC(=O)NCCc1c[nH]c(c12)ccc(c2)O
13995	sp|P9WGS9|DPRE2_MY	O24990	75.59	10.0	202.0	DB04393	experimental	Soneclosan	Clc1cc(O)c(cc1)Oc2ccc(Cl)cc2
13996	sp|P9WGS9|DPRE2_MY	O24990	75.59	10.0	202.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
13997	sp|P9WGS9|DPRE2_MY	Q01782	85.83	8.0	226.0	DB02338	experimental	NADPH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
13998	sp|P9WGS9|DPRE2_MY	Q01782	85.83	8.0	226.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
13999	sp|P9WGS9|DPRE2_MY	Q01782	85.83	8.0	226.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
14000	sp|P9WGS9|DPRE2_MY	Q01782	85.83	8.0	226.0	DB04400	experimental	L-erythro-7,8-dihydrobiopterin	C[C@H](O)[C@H](O)C(CN1)=Nc(c12)c(=O)nc([nH]2)N
14001	sp|P9WGS9|DPRE2_MY	P9WGR1	77.17	6.0	202.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
14002	sp|P9WGS9|DPRE2_MY	P9WGR1	77.17	6.0	202.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
14003	sp|P9WGS9|DPRE2_MY	P9WGR1	77.17	6.0	202.0	DB02990	experimental	S-(2-Acetamidoethyl) hexadecanethioate	CCCCCCCCCCCCCCCC(=O)SCCNC(=O)C
14004	sp|P9WGS9|DPRE2_MY	P9WGR1	77.17	6.0	202.0	DB04289	experimental	Genz-10850	[nH]1ccc(c12)cc(cc2)C(=O)N3CCN(CC3)C4c(cccc5)c5c(c46)cccc6
14005	sp|P9WGS9|DPRE2_MY	P9WGR1	77.17	6.0	202.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
14006	sp|P9WGS9|DPRE2_MY	P9WGR1	77.17	6.0	202.0	DB07090	experimental	(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cccc(c1C)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
14007	sp|P9WGS9|DPRE2_MY	P9WGR1	77.17	6.0	202.0	DB07123	experimental	N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE	Cc1ccc(cc1)C(=O)N2CCC(CC2)Cc3ccccc3
14008	sp|P9WGS9|DPRE2_MY	P9WGR1	77.17	6.0	202.0	DB07155	experimental	(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE	c1ccccc1NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
14009	sp|P9WGS9|DPRE2_MY	P9WGR1	77.17	6.0	202.0	DB07178	experimental	5-PENTYL-2-PHENOXYPHENOL	CCCCCc1cc(O)c(cc1)Oc2ccccc2
14010	sp|P9WGS9|DPRE2_MY	P9WGR1	77.17	6.0	202.0	DB07188	experimental	(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(cc(Cl)c1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
14011	sp|P9WGS9|DPRE2_MY	P9WGR1	77.17	6.0	202.0	DB07192	experimental	(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Brc1cc(ccc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
14012	sp|P9WGS9|DPRE2_MY	P9WGR1	77.17	6.0	202.0	DB07222	experimental	(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(c(C)cc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
14013	sp|P9WGS9|DPRE2_MY	P9WGR1	77.17	6.0	202.0	DB07287	experimental	2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL	c1cccnc1Cc2cc(O)c(cc2)Oc3ccc(Cl)cc3Cl
14014	sp|P9WGS9|DPRE2_MY	P9WGR1	77.17	6.0	202.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
14015	sp|P9WGS9|DPRE2_MY	P09417	74.02	6.0	194.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
14016	sp|P9WGS9|DPRE2_MY	P09417	74.02	6.0	194.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
14017	sp|P9WGS9|DPRE2_MY	Q8T8E9	76.38	2.0	196.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
14018	sp|P9WGS9|DPRE2_MY	P26391	75.2	3.0	194.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
14019	sp|P9WKL1|IDH_MYCT	P48735	99.76	41.0	449.0	DB01727	experimental	Isocitric Acid	OC(=O)[C@@H](O)[C@@H](C(=O)O)CC(=O)O
14020	sp|P9WKL1|IDH_MYCT	P48735	99.76	41.0	449.0	DB13874	approved; investigational	Enasidenib	CC(C)(O)CNc1nc(-c2nc(C(F)(F)F)ccc2)nc(n1)Nc3cc(C(F)(F)F)ncc3
14021	sp|P9WKL1|IDH_MYCT	O75874	99.02	5.0	410.0	DB01727	experimental	Isocitric Acid	OC(=O)[C@@H](O)[C@@H](C(=O)O)CC(=O)O
14022	sp|P9WKL1|IDH_MYCT	O75874	99.02	5.0	410.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
14023	sp|P9WKL1|IDH_MYCT	O75874	99.02	5.0	410.0	DB14568	approved; investigational	Ivosidenib	FC1(F)CC(C1)NC(=O)[C@H](c2c(Cl)cccc2)N(c3cc(F)cnc3)C(=O)[C@@H]4CCC(=O)N4c5nccc(c5)C#N
14024	sp|P9WQJ7|IRTB_MYC	Q92887	89.46	343.0	861.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
14025	sp|P9WQJ7|IRTB_MYC	Q92887	89.46	343.0	861.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
14026	sp|P9WQJ7|IRTB_MYC	Q92887	73.58	1108.0	1534.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
14027	sp|P9WQJ7|IRTB_MYC	Q92887	73.58	1108.0	1534.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
14028	sp|P9WQJ7|IRTB_MYC	P33527	87.91	361.0	870.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
14029	sp|P9WQJ7|IRTB_MYC	P33527	87.91	361.0	870.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
14030	sp|P9WQJ7|IRTB_MYC	P33527	87.91	361.0	870.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
14031	sp|P9WQJ7|IRTB_MYC	P33527	87.91	361.0	870.0	DB06176	approved; investigational	Romidepsin	O=C([C@H]12)N/C(=C\C)C(=O)N[C@@H](C(C)C)C(=O)O[C@@H](CC(=O)N[C@H](C(C)C)C(=O)N1)/C=C/CCSSC2
14032	sp|P9WQJ7|IRTB_MYC	P33527	87.91	361.0	870.0	DB08855	experimental; investigational	Leukotriene C4	CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@@H](O)CCCC(=O)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@H](N)C(=O)O
14033	sp|P9WQJ7|IRTB_MYC	P33527	75.3	1090.0	1526.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
14034	sp|P9WQJ7|IRTB_MYC	P33527	75.3	1090.0	1526.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
14035	sp|P9WQJ7|IRTB_MYC	P33527	75.3	1090.0	1526.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
14036	sp|P9WQJ7|IRTB_MYC	P33527	75.3	1090.0	1526.0	DB06176	approved; investigational	Romidepsin	O=C([C@H]12)N/C(=C\C)C(=O)N[C@@H](C(C)C)C(=O)O[C@@H](CC(=O)N[C@H](C(C)C)C(=O)N1)/C=C/CCSSC2
14037	sp|P9WQJ7|IRTB_MYC	P33527	75.3	1090.0	1526.0	DB08855	experimental; investigational	Leukotriene C4	CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@@H](O)CCCC(=O)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@H](N)C(=O)O
14038	sp|P9WQJ7|IRTB_MYC	P08183	79.79	173.0	635.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
14039	sp|P9WQJ7|IRTB_MYC	P08183	79.79	173.0	635.0	DB00603	approved; investigational	Medroxyprogesterone acetate	CC(=O)O[C@]1(C(=O)C)CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C([C@H](C3)C)=CC(=O)CC4
14040	sp|P9WQJ7|IRTB_MYC	P08183	79.79	173.0	635.0	DB00778	approved; investigational; withdrawn	Roxithromycin	COCCOCO/N=C([C@H](C)[C@@H](O)[C@]1(C)O)/[C@H](C)C[C@@](C)(O)[C@@H]([C@@H](C)[C@@H]([C@@H](C)C(=O)O[C@@H]1CC)O[C@@H](C[C@@]2(C)OC)O[C@@H](C)[C@@H]2O)O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C
14041	sp|P9WQJ7|IRTB_MYC	P08183	79.79	173.0	635.0	DB00813	approved; illicit; investigational; vet_approved	Fentanyl	c1ccccc1N(C(=O)CC)C2CCN(CC2)CCc3ccccc3
14042	sp|P9WQJ7|IRTB_MYC	P08183	79.79	173.0	635.0	DB04877	experimental	Voacamine	CC[C@H]1C[C@@H](C2)CN([C@@H]1[C@@]23C(=O)OC)CCc4c3[nH]c5c4cc(OC)c(c5)[C@@H](C[C@H]67)c8c(c9c([nH]8)cccc9)C[C@H](C6C(=O)OC)N(C)CC\7=C\C
14043	sp|P9WQJ7|IRTB_MYC	P08183	79.79	173.0	635.0	DB04881	investigational	Elacridar	COc1cccc(c12)c(=O)c3c([nH]2)c(ccc3)C(=O)Nc4ccc(cc4)CCN(C5)CCc(c56)cc(OC)c(c6)OC
14044	sp|P9WQJ7|IRTB_MYC	P08183	79.79	173.0	635.0	DB04905	investigational	Tesmilifene	CCN(CC)CCOc1ccc(cc1)Cc2ccccc2
14045	sp|P9WQJ7|IRTB_MYC	P08183	79.79	173.0	635.0	DB05449	investigational	FM-VP4	 
14046	sp|P9WQJ7|IRTB_MYC	P08183	79.79	173.0	635.0	DB06191	investigational	Zosuquidar	FC1(F)[C@H]2[C@@H]1c(cccc3)c3[C@@H](c(c24)cccc4)N5CCN(CC5)C[C@@H](O)COc6cccc(c67)nccc7
14047	sp|P9WQJ7|IRTB_MYC	P08183	79.79	173.0	635.0	DB06240	investigational	Tariquidar	COc(c1)c(OC)cc(c12)CCN(C2)CCc3ccc(cc3)NC(=O)c4cc(OC)c(OC)cc4NC(=O)c(c5)cnc(c56)cccc6
14048	sp|P9WQJ7|IRTB_MYC	P08183	79.79	173.0	635.0	DB09031	approved; investigational	Miltefosine	CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C
14049	sp|P9WQJ7|IRTB_MYC	P08183	79.79	173.0	635.0	DB11635	approved	Tocofersolan	 
14050	sp|P9WQJ7|IRTB_MYC	P08183	79.79	173.0	635.0	DB14061	experimental	Hycanthone	CCN(CC)CCNc(ccc1CO)c(c12)c(=O)c3c(s2)cccc3
14051	sp|P9WQJ7|IRTB_MYC	P08183	79.79	173.0	635.0	DB14062	experimental	Concanamycin A	NC(=O)O[C@@H]1[C@@H](C)O[C@H](C[C@H]1O)O[C@H](C2)[C@H](C)[C@@H](/C=C/C)O[C@@]2(O)[C@@H](C)[C@H](O)[C@H](C)[C@H]3OC(=O)/C(OC)=C/C(C)=C/[C@@H](C)[C@@H](O)[C@@H](CC)[C@@H](O)[C@H](C)C/C(C)=C/C=C/[C@@H]3OC
14052	sp|P9WQJ7|IRTB_MYC	P08183	79.79	173.0	635.0	DB14063	experimental	Dexverapamil	COc1ccc(cc1OC)CCN(C)CCC[C@@](C#N)(C(C)C)c2cc(OC)c(OC)cc2
14053	sp|P9WQJ7|IRTB_MYC	P08183	79.79	173.0	635.0	DB14064	experimental	Emopamil	c1ccccc1C(C#N)(C(C)C)CCCN(C)CCc2ccccc2
14054	sp|P9WQJ7|IRTB_MYC	P08183	79.79	173.0	635.0	DB14065	experimental	Lomerizine	COc1ccc(c(OC)c1OC)CN2CCN(CC2)C(c3ccc(F)cc3)c4ccc(F)cc4
14055	sp|P9WQJ7|IRTB_MYC	P08183	79.79	173.0	635.0	DB14066	experimental	Tetrandrine	c12ccc(OC)c(c1)Oc3ccc(cc3)C[C@H]4c5c(CCN4C)cc(OC)c(c5)Oc6c7c(CCN(C)[C@H]7C2)cc(OC)c6OC
14056	sp|P9WQJ7|IRTB_MYC	P08183	79.79	173.0	635.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
14057	sp|P9WQJ7|IRTB_MYC	P08183	79.79	173.0	635.0	DB14068	experimental	Dexniguldipine	[O-][N+](=O)c1cccc(c1)[C@@H]2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCCN(CC3)CCC3(c4ccccc4)c5ccccc5
14058	sp|P9WQJ7|IRTB_MYC	P08183	79.79	173.0	635.0	DB14069	investigational	ONT-093	CCOC/C=C/c1ccc(cc1)-c2nc(-c3ccc(cc3)NC(C)C)c([nH]2)-c4ccc(cc4)NC(C)C
14059	sp|P9WQJ7|IRTB_MYC	P08183	79.79	173.0	635.0	DB14070	experimental	HM-30181	c1cccc(c12)c(=O)cc(o2)C(=O)Nc3cc(OC)c(OC)cc3-c4nn(nn4)-c5ccc(cc5)CCN(C6)CCc(c67)cc(OC)c(c7)OC
14060	sp|P9WQJ7|IRTB_MYC	P08183	79.79	173.0	635.0	DB14071	experimental	Desmethylsertraline	c1cccc(c12)[C@@H](CC[C@@H]2N)c3cc(Cl)c(Cl)cc3
14061	sp|P9WQJ7|IRTB_MYC	P08183	79.79	173.0	635.0	DB14072	experimental	Reversin 121	c1ccccc1COC(=O)C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@H](C(=O)OC(C)(C)C)CCCCNC(=O)OCc2ccccc2
14062	sp|P9WQJ7|IRTB_MYC	P08183	79.45	814.0	1274.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
14063	sp|P9WQJ7|IRTB_MYC	P08183	79.45	814.0	1274.0	DB00603	approved; investigational	Medroxyprogesterone acetate	CC(=O)O[C@]1(C(=O)C)CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C([C@H](C3)C)=CC(=O)CC4
14064	sp|P9WQJ7|IRTB_MYC	P08183	79.45	814.0	1274.0	DB00778	approved; investigational; withdrawn	Roxithromycin	COCCOCO/N=C([C@H](C)[C@@H](O)[C@]1(C)O)/[C@H](C)C[C@@](C)(O)[C@@H]([C@@H](C)[C@@H]([C@@H](C)C(=O)O[C@@H]1CC)O[C@@H](C[C@@]2(C)OC)O[C@@H](C)[C@@H]2O)O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C
14065	sp|P9WQJ7|IRTB_MYC	P08183	79.45	814.0	1274.0	DB00813	approved; illicit; investigational; vet_approved	Fentanyl	c1ccccc1N(C(=O)CC)C2CCN(CC2)CCc3ccccc3
14066	sp|P9WQJ7|IRTB_MYC	P08183	79.45	814.0	1274.0	DB04877	experimental	Voacamine	CC[C@H]1C[C@@H](C2)CN([C@@H]1[C@@]23C(=O)OC)CCc4c3[nH]c5c4cc(OC)c(c5)[C@@H](C[C@H]67)c8c(c9c([nH]8)cccc9)C[C@H](C6C(=O)OC)N(C)CC\7=C\C
14067	sp|P9WQJ7|IRTB_MYC	P08183	79.45	814.0	1274.0	DB04881	investigational	Elacridar	COc1cccc(c12)c(=O)c3c([nH]2)c(ccc3)C(=O)Nc4ccc(cc4)CCN(C5)CCc(c56)cc(OC)c(c6)OC
14068	sp|P9WQJ7|IRTB_MYC	P08183	79.45	814.0	1274.0	DB04905	investigational	Tesmilifene	CCN(CC)CCOc1ccc(cc1)Cc2ccccc2
14069	sp|P9WQJ7|IRTB_MYC	P08183	79.45	814.0	1274.0	DB05449	investigational	FM-VP4	 
14070	sp|P9WQJ7|IRTB_MYC	P08183	79.45	814.0	1274.0	DB06191	investigational	Zosuquidar	FC1(F)[C@H]2[C@@H]1c(cccc3)c3[C@@H](c(c24)cccc4)N5CCN(CC5)C[C@@H](O)COc6cccc(c67)nccc7
14071	sp|P9WQJ7|IRTB_MYC	P08183	79.45	814.0	1274.0	DB06240	investigational	Tariquidar	COc(c1)c(OC)cc(c12)CCN(C2)CCc3ccc(cc3)NC(=O)c4cc(OC)c(OC)cc4NC(=O)c(c5)cnc(c56)cccc6
14072	sp|P9WQJ7|IRTB_MYC	P08183	79.45	814.0	1274.0	DB09031	approved; investigational	Miltefosine	CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C
14073	sp|P9WQJ7|IRTB_MYC	P08183	79.45	814.0	1274.0	DB11635	approved	Tocofersolan	 
14074	sp|P9WQJ7|IRTB_MYC	P08183	79.45	814.0	1274.0	DB14061	experimental	Hycanthone	CCN(CC)CCNc(ccc1CO)c(c12)c(=O)c3c(s2)cccc3
14075	sp|P9WQJ7|IRTB_MYC	P08183	79.45	814.0	1274.0	DB14062	experimental	Concanamycin A	NC(=O)O[C@@H]1[C@@H](C)O[C@H](C[C@H]1O)O[C@H](C2)[C@H](C)[C@@H](/C=C/C)O[C@@]2(O)[C@@H](C)[C@H](O)[C@H](C)[C@H]3OC(=O)/C(OC)=C/C(C)=C/[C@@H](C)[C@@H](O)[C@@H](CC)[C@@H](O)[C@H](C)C/C(C)=C/C=C/[C@@H]3OC
14076	sp|P9WQJ7|IRTB_MYC	P08183	79.45	814.0	1274.0	DB14063	experimental	Dexverapamil	COc1ccc(cc1OC)CCN(C)CCC[C@@](C#N)(C(C)C)c2cc(OC)c(OC)cc2
14077	sp|P9WQJ7|IRTB_MYC	P08183	79.45	814.0	1274.0	DB14064	experimental	Emopamil	c1ccccc1C(C#N)(C(C)C)CCCN(C)CCc2ccccc2
14078	sp|P9WQJ7|IRTB_MYC	P08183	79.45	814.0	1274.0	DB14065	experimental	Lomerizine	COc1ccc(c(OC)c1OC)CN2CCN(CC2)C(c3ccc(F)cc3)c4ccc(F)cc4
14079	sp|P9WQJ7|IRTB_MYC	P08183	79.45	814.0	1274.0	DB14066	experimental	Tetrandrine	c12ccc(OC)c(c1)Oc3ccc(cc3)C[C@H]4c5c(CCN4C)cc(OC)c(c5)Oc6c7c(CCN(C)[C@H]7C2)cc(OC)c6OC
14080	sp|P9WQJ7|IRTB_MYC	P08183	79.45	814.0	1274.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
14081	sp|P9WQJ7|IRTB_MYC	P08183	79.45	814.0	1274.0	DB14068	experimental	Dexniguldipine	[O-][N+](=O)c1cccc(c1)[C@@H]2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCCN(CC3)CCC3(c4ccccc4)c5ccccc5
14082	sp|P9WQJ7|IRTB_MYC	P08183	79.45	814.0	1274.0	DB14069	investigational	ONT-093	CCOC/C=C/c1ccc(cc1)-c2nc(-c3ccc(cc3)NC(C)C)c([nH]2)-c4ccc(cc4)NC(C)C
14083	sp|P9WQJ7|IRTB_MYC	P08183	79.45	814.0	1274.0	DB14070	experimental	HM-30181	c1cccc(c12)c(=O)cc(o2)C(=O)Nc3cc(OC)c(OC)cc3-c4nn(nn4)-c5ccc(cc5)CCN(C6)CCc(c67)cc(OC)c(c7)OC
14084	sp|P9WQJ7|IRTB_MYC	P08183	79.45	814.0	1274.0	DB14071	experimental	Desmethylsertraline	c1cccc(c12)[C@@H](CC[C@@H]2N)c3cc(Cl)c(Cl)cc3
14085	sp|P9WQJ7|IRTB_MYC	P08183	79.45	814.0	1274.0	DB14072	experimental	Reversin 121	c1ccccc1COC(=O)C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@H](C(=O)OC(C)(C)C)CCCCNC(=O)OCc2ccccc2
14086	sp|P9WQJ7|IRTB_MYC	Q2M3G0	74.61	192.0	624.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
14087	sp|P9WQJ7|IRTB_MYC	Q2M3G0	74.61	192.0	624.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
14088	sp|P9WQJ7|IRTB_MYC	Q2M3G0	78.58	799.0	1254.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
14089	sp|P9WQJ7|IRTB_MYC	Q2M3G0	78.58	799.0	1254.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
14090	sp|P9WQJ7|IRTB_MYC	O95342	76.51	216.0	659.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
14091	sp|P9WQJ7|IRTB_MYC	O95342	76.51	216.0	659.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
14092	sp|P9WQJ7|IRTB_MYC	O95342	79.1	858.0	1316.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
14093	sp|P9WQJ7|IRTB_MYC	O95342	79.1	858.0	1316.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
14094	sp|P9WQJ7|IRTB_MYC	Q09428	97.41	366.0	930.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
14095	sp|P9WQJ7|IRTB_MYC	Q09428	97.41	366.0	930.0	DB00222	approved	Glimepiride	CCC1=C(C)CN(C1=O)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3
14096	sp|P9WQJ7|IRTB_MYC	Q09428	97.41	366.0	930.0	DB00672	approved; investigational	Chlorpropamide	CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1
14097	sp|P9WQJ7|IRTB_MYC	Q09428	97.41	366.0	930.0	DB00731	approved; investigational	Nateglinide	CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](C(=O)O)Cc2ccccc2
14098	sp|P9WQJ7|IRTB_MYC	Q09428	97.41	366.0	930.0	DB00912	approved; investigational	Repaglinide	CCOc1c(C(=O)O)ccc(c1)CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3
14099	sp|P9WQJ7|IRTB_MYC	Q09428	97.41	366.0	930.0	DB01067	approved; investigational	Glipizide	Cc1ncc(nc1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
14100	sp|P9WQJ7|IRTB_MYC	Q09428	97.41	366.0	930.0	DB01120	approved	Gliclazide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN(C2)CC(C23)CCC3
14101	sp|P9WQJ7|IRTB_MYC	Q09428	97.41	366.0	930.0	DB01124	approved; investigational	Tolbutamide	CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1
14102	sp|P9WQJ7|IRTB_MYC	Q09428	97.41	366.0	930.0	DB01251	approved; investigational	Gliquidone	COc(cc1)cc(c12)C(=O)N(C(=O)C2(C)C)CCc3ccc(cc3)S(=O)(=O)NC(=O)NC4CCCCC4
14103	sp|P9WQJ7|IRTB_MYC	Q09428	97.41	366.0	930.0	DB01252	investigational	Mitiglinide	c1ccccc1C[C@H](C(=O)O)CC(=O)N(C2)C[C@H]([C@H]23)CCCC3
14104	sp|P9WQJ7|IRTB_MYC	Q09428	97.41	366.0	930.0	DB01382	approved; investigational	Glymidine	COCCOc1cnc(nc1)NS(=O)(=O)c2ccccc2
14105	sp|P9WQJ7|IRTB_MYC	Q09428	76.17	1139.0	1580.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
14106	sp|P9WQJ7|IRTB_MYC	Q09428	76.17	1139.0	1580.0	DB00222	approved	Glimepiride	CCC1=C(C)CN(C1=O)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3
14107	sp|P9WQJ7|IRTB_MYC	Q09428	76.17	1139.0	1580.0	DB00672	approved; investigational	Chlorpropamide	CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1
14108	sp|P9WQJ7|IRTB_MYC	Q09428	76.17	1139.0	1580.0	DB00731	approved; investigational	Nateglinide	CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](C(=O)O)Cc2ccccc2
14109	sp|P9WQJ7|IRTB_MYC	Q09428	76.17	1139.0	1580.0	DB00912	approved; investigational	Repaglinide	CCOc1c(C(=O)O)ccc(c1)CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3
14110	sp|P9WQJ7|IRTB_MYC	Q09428	76.17	1139.0	1580.0	DB01067	approved; investigational	Glipizide	Cc1ncc(nc1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
14111	sp|P9WQJ7|IRTB_MYC	Q09428	76.17	1139.0	1580.0	DB01120	approved	Gliclazide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN(C2)CC(C23)CCC3
14112	sp|P9WQJ7|IRTB_MYC	Q09428	76.17	1139.0	1580.0	DB01124	approved; investigational	Tolbutamide	CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1
14113	sp|P9WQJ7|IRTB_MYC	Q09428	76.17	1139.0	1580.0	DB01251	approved; investigational	Gliquidone	COc(cc1)cc(c12)C(=O)N(C(=O)C2(C)C)CCc3ccc(cc3)S(=O)(=O)NC(=O)NC4CCCCC4
14114	sp|P9WQJ7|IRTB_MYC	Q09428	76.17	1139.0	1580.0	DB01252	investigational	Mitiglinide	c1ccccc1C[C@H](C(=O)O)CC(=O)N(C2)C[C@H]([C@H]23)CCCC3
14115	sp|P9WQJ7|IRTB_MYC	Q09428	76.17	1139.0	1580.0	DB01382	approved; investigational	Glymidine	COCCOc1cnc(nc1)NS(=O)(=O)c2ccccc2
14116	sp|P9WQJ7|IRTB_MYC	Q09428	97.41	366.0	930.0	DB00839	approved; investigational	Tolazamide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2
14117	sp|P9WQJ7|IRTB_MYC	Q09428	97.41	366.0	930.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
14118	sp|P9WQJ7|IRTB_MYC	Q09428	76.17	1139.0	1580.0	DB00839	approved; investigational	Tolazamide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2
14119	sp|P9WQJ7|IRTB_MYC	Q09428	76.17	1139.0	1580.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
14120	sp|P9WQJ7|IRTB_MYC	O15439	82.38	162.0	639.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
14121	sp|P9WQJ7|IRTB_MYC	O15439	76.51	843.0	1286.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
14122	sp|P9WQJ7|IRTB_MYC	O60706	95.16	362.0	913.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
14123	sp|P9WQJ7|IRTB_MYC	O60706	95.16	362.0	913.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
14124	sp|P9WQJ7|IRTB_MYC	O60706	95.16	362.0	913.0	DB09220	approved; investigational	Nicorandil	[O-][N+](=O)OCCNC(=O)c1cccnc1
14125	sp|P9WQJ7|IRTB_MYC	O60706	75.65	1109.0	1547.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
14126	sp|P9WQJ7|IRTB_MYC	O60706	75.65	1109.0	1547.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
14127	sp|P9WQJ7|IRTB_MYC	O60706	75.65	1109.0	1547.0	DB09220	approved; investigational	Nicorandil	[O-][N+](=O)OCCNC(=O)c1cccnc1
14128	sp|P9WQJ7|IRTB_MYC	O95255	87.74	346.0	854.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
14129	sp|P9WQJ7|IRTB_MYC	O95255	72.71	1077.0	1498.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
14130	sp|P9WQJ7|IRTB_MYC	O15440	75.13	995.0	1430.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
14131	sp|P9WQJ7|IRTB_MYC	O15440	75.13	995.0	1430.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
14132	sp|P9WQJ7|IRTB_MYC	P13569	95.34	91.0	643.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
14133	sp|P9WQJ7|IRTB_MYC	P13569	95.34	91.0	643.0	DB00887	approved	Bumetanide	CCCCNc1c(c(S(=O)(=O)N)cc(c1)C(=O)O)Oc2ccccc2
14134	sp|P9WQJ7|IRTB_MYC	P13569	95.34	91.0	643.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
14135	sp|P9WQJ7|IRTB_MYC	P13569	95.34	91.0	643.0	DB01050	approved	Ibuprofen	CC(C)Cc1ccc(cc1)C(C)C(=O)O
14136	sp|P9WQJ7|IRTB_MYC	P13569	95.34	91.0	643.0	DB02587	experimental; investigational	Colforsin	O[C@H]1CCC(C)(C)[C@@H]([C@]12C)[C@H](O)[C@H](OC(=O)C)[C@]3(C)[C@]2(O)C(=O)C[C@](O3)(C)C=C
14137	sp|P9WQJ7|IRTB_MYC	P13569	95.34	91.0	643.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
14138	sp|P9WQJ7|IRTB_MYC	P13569	95.34	91.0	643.0	DB04522	experimental	Dexfosfoserine	OC(=O)[C@@H](N)COP(=O)(O)O
14139	sp|P9WQJ7|IRTB_MYC	P13569	95.34	91.0	643.0	DB04941	approved	Crofelemer	 
14140	sp|P9WQJ7|IRTB_MYC	P13569	95.34	91.0	643.0	DB06266	investigational	Lonidamine	c1cccc(c12)n(nc2C(=O)O)Cc3c(Cl)cc(Cl)cc3
14141	sp|P9WQJ7|IRTB_MYC	P13569	95.34	91.0	643.0	DB08820	approved	Ivacaftor	CC(C)(C)c1cc(C(C)(C)C)c(O)cc1NC(=O)c(c2=O)c[nH]c(c23)cccc3
14142	sp|P9WQJ7|IRTB_MYC	P13569	95.34	91.0	643.0	DB09213	approved; investigational	Dexibuprofen	CC(C)Cc1ccc(cc1)[C@H](C)C(=O)O
14143	sp|P9WQJ7|IRTB_MYC	P13569	95.34	91.0	643.0	DB09280	approved	Lumacaftor	O=C(O)c1cccc(c1)-c2nc(ccc2C)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
14144	sp|P9WQJ7|IRTB_MYC	P13569	95.34	91.0	643.0	DB11712	approved; investigational	Tezacaftor	OC[C@H](O)Cn1c(C(C)(C)CO)cc(c12)cc(c(F)c2)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
14145	sp|P9WQJ7|IRTB_MYC	P13569	95.34	91.0	643.0	DB15444	approved; investigational	Elexacaftor	FC(F)(F)C(C)(C)COc1nn(cc1)-c2nc(N(C3(C)C)C[C@@H](C)C3)c(cc2)C(=O)NS(=O)(=O)c4cn(C)nc4C
14146	sp|P9WQJ7|IRTB_MYC	P13569	77.03	995.0	1441.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
14147	sp|P9WQJ7|IRTB_MYC	P13569	77.03	995.0	1441.0	DB00887	approved	Bumetanide	CCCCNc1c(c(S(=O)(=O)N)cc(c1)C(=O)O)Oc2ccccc2
14148	sp|P9WQJ7|IRTB_MYC	P13569	77.03	995.0	1441.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
14149	sp|P9WQJ7|IRTB_MYC	P13569	77.03	995.0	1441.0	DB01050	approved	Ibuprofen	CC(C)Cc1ccc(cc1)C(C)C(=O)O
14150	sp|P9WQJ7|IRTB_MYC	P13569	77.03	995.0	1441.0	DB02587	experimental; investigational	Colforsin	O[C@H]1CCC(C)(C)[C@@H]([C@]12C)[C@H](O)[C@H](OC(=O)C)[C@]3(C)[C@]2(O)C(=O)C[C@](O3)(C)C=C
14151	sp|P9WQJ7|IRTB_MYC	P13569	77.03	995.0	1441.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
14152	sp|P9WQJ7|IRTB_MYC	P13569	77.03	995.0	1441.0	DB04522	experimental	Dexfosfoserine	OC(=O)[C@@H](N)COP(=O)(O)O
14153	sp|P9WQJ7|IRTB_MYC	P13569	77.03	995.0	1441.0	DB04941	approved	Crofelemer	 
14154	sp|P9WQJ7|IRTB_MYC	P13569	77.03	995.0	1441.0	DB06266	investigational	Lonidamine	c1cccc(c12)n(nc2C(=O)O)Cc3c(Cl)cc(Cl)cc3
14155	sp|P9WQJ7|IRTB_MYC	P13569	77.03	995.0	1441.0	DB08820	approved	Ivacaftor	CC(C)(C)c1cc(C(C)(C)C)c(O)cc1NC(=O)c(c2=O)c[nH]c(c23)cccc3
14156	sp|P9WQJ7|IRTB_MYC	P13569	77.03	995.0	1441.0	DB09213	approved; investigational	Dexibuprofen	CC(C)Cc1ccc(cc1)[C@H](C)C(=O)O
14157	sp|P9WQJ7|IRTB_MYC	P13569	77.03	995.0	1441.0	DB09280	approved	Lumacaftor	O=C(O)c1cccc(c1)-c2nc(ccc2C)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
14158	sp|P9WQJ7|IRTB_MYC	P13569	77.03	995.0	1441.0	DB11712	approved; investigational	Tezacaftor	OC[C@H](O)Cn1c(C(C)(C)CO)cc(c12)cc(c(F)c2)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
14159	sp|P9WQJ7|IRTB_MYC	P13569	77.03	995.0	1441.0	DB15444	approved; investigational	Elexacaftor	FC(F)(F)C(C)(C)COc1nn(cc1)-c2nc(N(C3(C)C)C[C@@H](C)C3)c(cc2)C(=O)NS(=O)(=O)c4cn(C)nc4C
14160	sp|P9WQJ7|IRTB_MYC	A0A0T9AZ62	73.4	2.0	427.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
14161	sp|P96374|PPX2_MYC	O67040	74.29	8.0	245.0	DB03382	experimental	S-oxy-L-cysteine	OC(=O)[C@@H](N)CS=O
14162	sp|P71668|LIPI_MYC	Q7SIG1	95.62	3.0	309.0	DB02776	experimental	1-Hexadecanosulfonic Acid	CCCCCCCCCCCCCCCCS(=O)(=O)O
14163	sp|P9WI63|PKNL_MYC	Q15418	73.43	413.0	706.0	DB04751	experimental	Purvalanol A	CC(C)n1cnc(c12)c(nc(n2)N[C@@H](CO)C(C)C)Nc3cccc(Cl)c3
14164	sp|P9WI63|PKNL_MYC	Q15418	73.43	413.0	706.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14165	sp|P9WI63|PKNL_MYC	O60674	72.18	842.0	1130.0	DB04716	experimental	2-tert-butyl-9-fluoro-1,6-dihydrobenzo[h]imidazo[4,5-f]isoquinolin-7-one	CC(C)(C)c([nH]1)nc2c(cc[nH]c3=O)c3c(c4c12)cc(F)cc4
14166	sp|P9WI63|PKNL_MYC	O60674	72.18	842.0	1130.0	DB05243	investigational	XL019	 
14167	sp|P9WI63|PKNL_MYC	O60674	72.18	842.0	1130.0	DB07161	experimental	5-phenyl-1H-indazol-3-amine	Nc1n[nH]c(c12)ccc(c2)-c3ccccc3
14168	sp|P9WI63|PKNL_MYC	O60674	72.18	842.0	1130.0	DB07162	experimental	4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide	CC(C)(C)NS(=O)(=O)c1ccc(cc1)-c(cc2)cc(c23)c(N)n[nH]3
14169	sp|P9WI63|PKNL_MYC	O60674	72.18	842.0	1130.0	DB08067	experimental	4-[(2-{4-[(CYCLOPROPYLCARBAMOYL)AMINO]-1H-PYRAZOL-3-YL}-1H-BENZIMIDAZOL-6-YL)METHYL]MORPHOLIN-4-IUM	C1CC1NC(=O)Nc2c[nH]nc2-c([nH]3)nc(c34)ccc(c4)C[NH+]5CCOCC5
14170	sp|P9WI63|PKNL_MYC	O60674	72.18	842.0	1130.0	DB08877	approved	Ruxolitinib	C1CCCC1[C@@H](CC#N)n2cc(cn2)-c(ncn3)c(c34)cc[nH]4
14171	sp|P9WI63|PKNL_MYC	O60674	72.18	842.0	1130.0	DB08895	approved; investigational	Tofacitinib	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c2ncnc(c23)[nH]cc3
14172	sp|P9WI63|PKNL_MYC	O60674	72.18	842.0	1130.0	DB11817	approved; investigational	Baricitinib	CCS(=O)(=O)N(C1)CC1(CC#N)n2cc(cn2)-c(ncn3)c(c34)cc[nH]4
14173	sp|P9WI63|PKNL_MYC	O60674	72.18	842.0	1130.0	DB11986	approved; investigational	Entrectinib	CN1CCN(CC1)c2ccc(c(c2)NC3CCOCC3)C(=O)Nc4n[nH]c(c45)ccc(c5)Cc6cc(F)cc(F)c6
14174	sp|P9WI63|PKNL_MYC	O60674	72.18	842.0	1130.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14175	sp|P9WI63|PKNL_MYC	O60674	72.18	842.0	1130.0	DB12500	approved; investigational	Fedratinib	CC(C)(C)NS(=O)(=O)c1cc(ccc1)Nc2nc(ncc2C)Nc3ccc(cc3)OCCN4CCCC4
14176	sp|P9WI63|PKNL_MYC	O60674	72.18	842.0	1130.0	DB15035	approved; investigational	Zanubrutinib	C=CC(=O)N1CCC(CC1)[C@@H]2CCNc(n23)c(C(=O)N)c(n3)-c4ccc(cc4)Oc5ccccc5
14177	sp|P9WI63|PKNL_MYC	P52333	72.43	819.0	1108.0	DB04716	experimental	2-tert-butyl-9-fluoro-1,6-dihydrobenzo[h]imidazo[4,5-f]isoquinolin-7-one	CC(C)(C)c([nH]1)nc2c(cc[nH]c3=O)c3c(c4c12)cc(F)cc4
14178	sp|P9WI63|PKNL_MYC	P52333	72.43	819.0	1108.0	DB06321	investigational	R-348	CCC(=O)NS(=O)(=O)c1cc(ccc1C)Nc2ncc(F)c(n2)Nc3ccc(cc3)OCC#C
14179	sp|P9WI63|PKNL_MYC	P52333	72.43	819.0	1108.0	DB08895	approved; investigational	Tofacitinib	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c2ncnc(c23)[nH]cc3
14180	sp|P9WI63|PKNL_MYC	P52333	72.43	819.0	1108.0	DB11817	approved; investigational	Baricitinib	CCS(=O)(=O)N(C1)CC1(CC#N)n2cc(cn2)-c(ncn3)c(c34)cc[nH]4
14181	sp|P9WI63|PKNL_MYC	P52333	72.43	819.0	1108.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14182	sp|P9WI63|PKNL_MYC	P52333	72.43	819.0	1108.0	DB15035	approved; investigational	Zanubrutinib	C=CC(=O)N1CCC(CC1)[C@@H]2CCNc(n23)c(C(=O)N)c(n3)-c4ccc(cc4)Oc5ccccc5
14183	sp|P9WI63|PKNL_MYC	P29597	71.68	891.0	1177.0	DB04716	experimental	2-tert-butyl-9-fluoro-1,6-dihydrobenzo[h]imidazo[4,5-f]isoquinolin-7-one	CC(C)(C)c([nH]1)nc2c(cc[nH]c3=O)c3c(c4c12)cc(F)cc4
14184	sp|P9WI63|PKNL_MYC	P29597	71.68	891.0	1177.0	DB08895	approved; investigational	Tofacitinib	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c2ncnc(c23)[nH]cc3
14185	sp|P9WI63|PKNL_MYC	P29597	71.68	891.0	1177.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14186	sp|P9WI63|PKNL_MYC	P15056	81.7	440.0	766.0	DB00398	approved; investigational	Sorafenib	CNC(=O)c1nccc(c1)Oc2ccc(cc2)NC(=O)Nc3cc(C(F)(F)F)c(Cl)cc3
14187	sp|P9WI63|PKNL_MYC	P15056	81.7	440.0	766.0	DB05190	investigational	XL281	 
14188	sp|P9WI63|PKNL_MYC	P15056	81.7	440.0	766.0	DB05984	investigational	RAF-265	FC(F)(F)c1ccc(cc1)Nc(n2C)nc(c23)cc(cc3)Oc4ccnc(c4)-c5ncc([nH]5)C(F)(F)F
14189	sp|P9WI63|PKNL_MYC	P15056	81.7	440.0	766.0	DB06999	experimental	PLX-4720	CCCS(=O)(=O)Nc1ccc(F)c(c1F)C(=O)c2c[nH]c(c23)ncc(Cl)c3
14190	sp|P9WI63|PKNL_MYC	P15056	81.7	440.0	766.0	DB07000	experimental	N-{2,4-difluoro-3-[(5-pyridin-3-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]phenyl}ethanesulfonamide	CCS(=O)(=O)Nc1ccc(F)c(c1F)C(=O)c2c[nH]c(c23)ncc(c3)-c4cnccc4
14191	sp|P9WI63|PKNL_MYC	P15056	81.7	440.0	766.0	DB08553	experimental	(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime	O/N=C1\CCc(c12)cc(cc2)-c3cn(C4CCNCC4)nc3-c5ccncc5
14192	sp|P9WI63|PKNL_MYC	P15056	81.7	440.0	766.0	DB08881	approved	Vemurafenib	CCCS(=O)(=O)Nc1c(F)c(c(F)cc1)C(=O)c2c[nH]c(c23)ncc(c3)-c4ccc(Cl)cc4
14193	sp|P9WI63|PKNL_MYC	P15056	81.7	440.0	766.0	DB08896	approved	Regorafenib	CNC(=O)c1cc(ccn1)Oc2cc(F)c(cc2)NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F
14194	sp|P9WI63|PKNL_MYC	P15056	81.7	440.0	766.0	DB08912	approved; investigational	Dabrafenib	Nc1nccc(n1)-c2sc(C(C)(C)C)nc2-c3c(F)c(ccc3)NS(=O)(=O)c4c(F)cccc4F
14195	sp|P9WI63|PKNL_MYC	P15056	81.7	440.0	766.0	DB11718	approved; investigational	Encorafenib	COC(=O)N[C@@H](C)CNc1nccc(n1)-c2cn(C(C)C)nc2-c3cc(Cl)cc(c3F)NS(=O)(=O)C
14196	sp|P9WI63|PKNL_MYC	P15056	81.7	440.0	766.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14197	sp|P9WI63|PKNL_MYC	P15056	81.7	440.0	766.0	DB14840	approved	Ripretinib	CNc(c1)ncc(c12)cc(c(=O)n2CC)-c3c(Br)cc(F)c(c3)NC(=O)Nc4ccccc4
14198	sp|P9WI63|PKNL_MYC	Q14012	73.43	13.0	306.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14199	sp|P9WI63|PKNL_MYC	P62344	71.68	52.0	338.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14200	sp|P9WI63|PKNL_MYC	P04049	75.94	334.0	637.0	DB00398	approved; investigational	Sorafenib	CNC(=O)c1nccc(c1)Oc2ccc(cc2)NC(=O)Nc3cc(C(F)(F)F)c(Cl)cc3
14202	sp|P9WI63|PKNL_MYC	P04049	75.94	334.0	637.0	DB05190	investigational	XL281	 
14203	sp|P9WI63|PKNL_MYC	P04049	75.94	334.0	637.0	DB05268	investigational	iCo-007	 
14204	sp|P9WI63|PKNL_MYC	P04049	75.94	334.0	637.0	DB08862	approved; investigational	Cholecystokinin	 
14205	sp|P9WI63|PKNL_MYC	P04049	75.94	334.0	637.0	DB08896	approved	Regorafenib	CNC(=O)c1cc(ccn1)Oc2cc(F)c(cc2)NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F
14206	sp|P9WI63|PKNL_MYC	P04049	75.94	334.0	637.0	DB08912	approved; investigational	Dabrafenib	Nc1nccc(n1)-c2sc(C(C)(C)C)nc2-c3c(F)c(ccc3)NS(=O)(=O)c4c(F)cccc4F
14207	sp|P9WI63|PKNL_MYC	P04049	75.94	334.0	637.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14208	sp|P9WI63|PKNL_MYC	Q8N568	75.69	384.0	686.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14209	sp|P9WI63|PKNL_MYC	Q8IBS5	70.18	63.0	343.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
14210	sp|P9WI63|PKNL_MYC	Q96NX5	72.68	15.0	305.0	DB08009	experimental	SU-11652	CCN(CC)CCNC(=O)c1c(C)[nH]c(c1C)/C=C2\C(=O)Nc(c23)ccc(Cl)c3
14211	sp|P9WI63|PKNL_MYC	Q96NX5	72.68	15.0	305.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14212	sp|P9WI63|PKNL_MYC	O00444	72.43	10.0	299.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14213	sp|P9WI63|PKNL_MYC	Q16566	78.45	37.0	350.0	DB07664	experimental	K-00546	O=S(=O)(N)c1ccc(cc1)Nc2nc(N)n(n2)C(=S)Nc3c(F)cccc3F
14214	sp|P9WI63|PKNL_MYC	Q16566	78.45	37.0	350.0	DB07676	experimental	3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one	OC[C@@H](O)CCONc1c([nH]c(c12)cccc2)C(C(=O)N=3)=c(c34)cccc4
14216	sp|P9WI63|PKNL_MYC	Q05397	70.43	414.0	695.0	DB07248	experimental	7-PYRIDIN-2-YL-N-(3,4,5-TRIMETHOXYPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-2-AMINE	COc1c(OC)cc(cc1OC)Nc(n2)ncc(c23)ccn3-c4ccccn4
14217	sp|P9WI63|PKNL_MYC	Q05397	70.43	414.0	695.0	DB07460	experimental	2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN-4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-N-METHYLBENZAMIDE	CNC(=O)c1c(cccc1)Nc2nc(ncc2Cl)Nc3ccc(cc3OC)N4CCOCC4
14218	sp|P9WI63|PKNL_MYC	Q05397	70.43	414.0	695.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14219	sp|P9WI63|PKNL_MYC	Q16620	70.68	530.0	812.0	DB00321	approved	Amitriptyline	CN(C)CCC=C1c(cccc2)c2CCc(c13)cccc3
14220	sp|P9WI63|PKNL_MYC	Q16620	70.68	530.0	812.0	DB11823	approved; investigational	Esketamine	C1CCCC(=O)[C@@]1(NC)c2ccccc2Cl
14221	sp|P9WI63|PKNL_MYC	Q16620	70.68	530.0	812.0	DB11986	approved; investigational	Entrectinib	CN1CCN(CC1)c2ccc(c(c2)NC3CCOCC3)C(=O)Nc4n[nH]c(c45)ccc(c5)Cc6cc(F)cc(F)c6
14222	sp|P9WI63|PKNL_MYC	Q16620	70.68	530.0	812.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14223	sp|P9WI63|PKNL_MYC	Q16620	70.68	530.0	812.0	DB14723	approved; investigational	Larotrectinib	O[C@H]1CCN(C1)C(=O)Nc(cn2)c(n23)nc(cc3)N4CCC[C@@H]4c5c(F)ccc(F)c5
14225	sp|P9WI63|PKNL_MYC	P11362	73.18	472.0	764.0	DB00398	approved; investigational	Sorafenib	CNC(=O)c1nccc(c1)Oc2ccc(cc2)NC(=O)Nc3cc(C(F)(F)F)c(Cl)cc3
14226	sp|P9WI63|PKNL_MYC	P11362	73.18	472.0	764.0	DB01109	approved; investigational	Heparin	 
14227	sp|P9WI63|PKNL_MYC	P11362	73.18	472.0	764.0	DB02058	experimental	3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone	c1cccc(c12)C(C(=O)N2)Cc3ccc(cc3)N4CCN(C=O)CC4
14228	sp|P9WI63|PKNL_MYC	P11362	73.18	472.0	764.0	DB05014	investigational	XL999	 
14229	sp|P9WI63|PKNL_MYC	P11362	73.18	472.0	764.0	DB07525	experimental	3-(3-methoxybenzyl)-1H-pyrrolo[2,3-b]pyridine	COc1cccc(c1)Cc2c[nH]c(c23)nccc3
14230	sp|P9WI63|PKNL_MYC	P11362	73.18	472.0	764.0	DB07840	experimental	(E)-[4-(3,5-Difluorophenyl)-3H-pyrrolo[2,3-b]pyridin-3-ylidene](3-methoxyphenyl)methanol	COc1cccc(c1)C(=O)c2c[nH]c(c23)nccc3-c4cc(F)cc(F)c4
14231	sp|P9WI63|PKNL_MYC	P11362	73.18	472.0	764.0	DB08577	experimental	3-[(3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-YL)METHYLENE]-2-INDOLINONE	OC(=O)CCc1c([nH]cc1C)/C=C2\C(=O)Nc(c23)cccc3
14232	sp|P9WI63|PKNL_MYC	P11362	73.18	472.0	764.0	DB08896	approved	Regorafenib	CNC(=O)c1cc(ccn1)Oc2cc(F)c(cc2)NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F
14233	sp|P9WI63|PKNL_MYC	P11362	73.18	472.0	764.0	DB08901	approved; investigational	Ponatinib	CN1CCN(CC1)Cc2ccc(cc2C(F)(F)F)NC(=O)c3cc(c(C)cc3)C#Cc4cnc(n45)cccn5
14234	sp|P9WI63|PKNL_MYC	P11362	73.18	472.0	764.0	DB09078	approved; investigational	Lenvatinib	COc(c1)c(C(=O)N)cc(c12)c(ccn2)Oc3ccc(c(Cl)c3)NC(=O)NC4CC4
14235	sp|P9WI63|PKNL_MYC	P11362	73.18	472.0	764.0	DB09079	approved	Nintedanib	COC(=O)c(c1)ccc(c12)/C(C(=O)N2)=C(\c3ccccc3)Nc4ccc(cc4)N(C)C(=O)CN5CCN(C)CC5
14236	sp|P9WI63|PKNL_MYC	P11362	73.18	472.0	764.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14237	sp|P9WI63|PKNL_MYC	P11362	73.18	472.0	764.0	DB12147	approved; investigational	Erdafitinib	COc1cc(cc(c1)OC)N(CCNC(C)C)c(c2)ccc(c23)ncc(n3)-c4cn(C)nc4
14238	sp|P9WI63|PKNL_MYC	P11362	73.18	472.0	764.0	DB15102	approved; investigational	Pemigatinib	COc1c(F)c(c(F)c(c1)OC)N(C(=O)N2CC)Cc(c23)cnc4c3cc([nH]4)CN5CCOCC5
14239	sp|P9WI63|PKNL_MYC	P11362	73.18	472.0	764.0	DB15685	approved; investigational	Selpercatinib	COc1ncc(cc1)CN(C23)C(C2)CN(C3)c4ccc(cn4)-c5cc(OCC(C)(C)O)cn(c56)ncc6C#N
14240	sp|P9WI63|PKNL_MYC	P10398	70.93	304.0	587.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
14241	sp|P9WI63|PKNL_MYC	O95747	73.43	11.0	304.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14242	sp|P9WI63|PKNL_MYC	Q13188	70.93	22.0	305.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14243	sp|P9WI63|PKNL_MYC	Q15139	70.68	586.0	868.0	DB11752	investigational	Bryostatin 1	 
14244	sp|P9WI63|PKNL_MYC	Q15139	70.68	586.0	868.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14246	sp|P9WI63|PKNL_MYC	P21802	73.18	475.0	767.0	DB01041	approved; investigational; withdrawn	Thalidomide	c1cccc(c12)C(=O)N(C2=O)C3CCC(=O)NC3=O
14247	sp|P9WI63|PKNL_MYC	P21802	73.18	475.0	767.0	DB01109	approved; investigational	Heparin	 
14248	sp|P9WI63|PKNL_MYC	P21802	73.18	475.0	767.0	DB01901	experimental	Sucrosofate	O=S(=O)(O)OC[C@@H](O1)[C@@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)[C@]1(COS(=O)(=O)O)O[C@H]2O[C@H](COS(=O)(=O)O)[C@@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)[C@H]2OS(=O)(=O)O
14249	sp|P9WI63|PKNL_MYC	P21802	73.18	475.0	767.0	DB02058	experimental	3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone	c1cccc(c12)C(C(=O)N2)Cc3ccc(cc3)N4CCN(C=O)CC4
14250	sp|P9WI63|PKNL_MYC	P21802	73.18	475.0	767.0	DB02491	experimental	4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine	CC(C)(N)c1ccc(cc1)-c2nc(ncc2Cl)Nc3ccc(cc3)CCN4CCOCC4
14251	sp|P9WI63|PKNL_MYC	P21802	73.18	475.0	767.0	DB08896	approved	Regorafenib	CNC(=O)c1cc(ccn1)Oc2cc(F)c(cc2)NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F
14252	sp|P9WI63|PKNL_MYC	P21802	73.18	475.0	767.0	DB08901	approved; investigational	Ponatinib	CN1CCN(CC1)Cc2ccc(cc2C(F)(F)F)NC(=O)c3cc(c(C)cc3)C#Cc4cnc(n45)cccn5
14253	sp|P9WI63|PKNL_MYC	P21802	73.18	475.0	767.0	DB09078	approved; investigational	Lenvatinib	COc(c1)c(C(=O)N)cc(c12)c(ccn2)Oc3ccc(c(Cl)c3)NC(=O)NC4CC4
14254	sp|P9WI63|PKNL_MYC	P21802	73.18	475.0	767.0	DB09079	approved	Nintedanib	COC(=O)c(c1)ccc(c12)/C(C(=O)N2)=C(\c3ccccc3)Nc4ccc(cc4)N(C)C(=O)CN5CCN(C)CC5
14257	sp|P9WI63|PKNL_MYC	P21802	73.18	475.0	767.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14258	sp|P9WI63|PKNL_MYC	P21802	73.18	475.0	767.0	DB12147	approved; investigational	Erdafitinib	COc1cc(cc(c1)OC)N(CCNC(C)C)c(c2)ccc(c23)ncc(n3)-c4cn(C)nc4
14259	sp|P9WI63|PKNL_MYC	P21802	73.18	475.0	767.0	DB15102	approved; investigational	Pemigatinib	COc1c(F)c(c(F)c(c1)OC)N(C(=O)N2CC)Cc(c23)cnc4c3cc([nH]4)CN5CCOCC5
14260	sp|P9WI63|PKNL_MYC	P21802	73.18	475.0	767.0	DB15685	approved; investigational	Selpercatinib	COc1ncc(cc1)CN(C23)C(C2)CN(C3)c4ccc(cn4)-c5cc(OCC(C)(C)O)cn(c56)ncc6C#N
14262	sp|P9WI63|PKNL_MYC	P22607	72.68	466.0	756.0	DB05014	investigational	XL999	 
14263	sp|P9WI63|PKNL_MYC	P22607	72.68	466.0	756.0	DB06589	approved	Pazopanib	Cc1n(C)nc(c12)cc(cc2)N(C)c3ccnc(n3)Nc4ccc(C)c(c4)S(=O)(=O)N
14264	sp|P9WI63|PKNL_MYC	P22607	72.68	466.0	756.0	DB08901	approved; investigational	Ponatinib	CN1CCN(CC1)Cc2ccc(cc2C(F)(F)F)NC(=O)c3cc(c(C)cc3)C#Cc4cnc(n45)cccn5
14265	sp|P9WI63|PKNL_MYC	P22607	72.68	466.0	756.0	DB09078	approved; investigational	Lenvatinib	COc(c1)c(C(=O)N)cc(c12)c(ccn2)Oc3ccc(c(Cl)c3)NC(=O)NC4CC4
14266	sp|P9WI63|PKNL_MYC	P22607	72.68	466.0	756.0	DB09079	approved	Nintedanib	COC(=O)c(c1)ccc(c12)/C(C(=O)N2)=C(\c3ccccc3)Nc4ccc(cc4)N(C)C(=O)CN5CCN(C)CC5
14267	sp|P9WI63|PKNL_MYC	P22607	72.68	466.0	756.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14268	sp|P9WI63|PKNL_MYC	P22607	72.68	466.0	756.0	DB12147	approved; investigational	Erdafitinib	COc1cc(cc(c1)OC)N(CCNC(C)C)c(c2)ccc(c23)ncc(n3)-c4cn(C)nc4
14269	sp|P9WI63|PKNL_MYC	P22607	72.68	466.0	756.0	DB15102	approved; investigational	Pemigatinib	COc1c(F)c(c(F)c(c1)OC)N(C(=O)N2CC)Cc(c23)cnc4c3cc([nH]4)CN5CCOCC5
14270	sp|P9WI63|PKNL_MYC	P22607	72.68	466.0	756.0	DB15685	approved; investigational	Selpercatinib	COc1ncc(cc1)CN(C23)C(C2)CN(C3)c4ccc(cn4)-c5cc(OCC(C)(C)O)cn(c56)ncc6C#N
14271	sp|P9WI63|PKNL_MYC	P07949	73.18	718.0	1010.0	DB00398	approved; investigational	Sorafenib	CNC(=O)c1nccc(c1)Oc2ccc(cc2)NC(=O)Nc3cc(C(F)(F)F)c(Cl)cc3
14272	sp|P9WI63|PKNL_MYC	P07949	73.18	718.0	1010.0	DB01809	experimental	1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine	Cc1ccc(cc1)-c2nn(C(C)(C)C)c(c23)ncnc3N
14273	sp|P9WI63|PKNL_MYC	P07949	73.18	718.0	1010.0	DB05294	approved	Vandetanib	CN1CCC(CC1)COc(c(c2)OC)cc(c23)ncnc3Nc4c(F)cc(Br)cc4
14274	sp|P9WI63|PKNL_MYC	P07949	73.18	718.0	1010.0	DB08875	approved; investigational	Cabozantinib	COc(c1)c(OC)cc(c12)nccc2Oc3ccc(cc3)NC(=O)C4(CC4)C(=O)Nc5ccc(F)cc5
14275	sp|P9WI63|PKNL_MYC	P07949	73.18	718.0	1010.0	DB08896	approved	Regorafenib	CNC(=O)c1cc(ccn1)Oc2cc(F)c(cc2)NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F
14276	sp|P9WI63|PKNL_MYC	P07949	73.18	718.0	1010.0	DB08901	approved; investigational	Ponatinib	CN1CCN(CC1)Cc2ccc(cc2C(F)(F)F)NC(=O)c3cc(c(C)cc3)C#Cc4cnc(n45)cccn5
14277	sp|P9WI63|PKNL_MYC	P07949	73.18	718.0	1010.0	DB09078	approved; investigational	Lenvatinib	COc(c1)c(C(=O)N)cc(c12)c(ccn2)Oc3ccc(c(Cl)c3)NC(=O)NC4CC4
14278	sp|P9WI63|PKNL_MYC	P07949	73.18	718.0	1010.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14279	sp|P9WI63|PKNL_MYC	P07949	73.18	718.0	1010.0	DB12742	investigational	Amuvatinib	O1COc(c12)ccc(c2)CNC(=S)N3CCN(CC3)c4ncnc(c45)c6c(o5)cccc6
14280	sp|P9WI63|PKNL_MYC	P07949	73.18	718.0	1010.0	DB15685	approved; investigational	Selpercatinib	COc1ncc(cc1)CN(C23)C(C2)CN(C3)c4ccc(cn4)-c5cc(OCC(C)(C)O)cn(c56)ncc6C#N
14281	sp|P9WI63|PKNL_MYC	Q9UEW8	70.18	58.0	338.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14290	sp|P9WI63|PKNL_MYC	P08069	70.43	989.0	1270.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
14291	sp|P9WI63|PKNL_MYC	P08069	70.43	989.0	1270.0	DB05023	investigational	ATL1101	 
14292	sp|P9WI63|PKNL_MYC	P08069	70.43	989.0	1270.0	DB05184	investigational	XL228	 
14293	sp|P9WI63|PKNL_MYC	P08069	70.43	989.0	1270.0	DB05897	investigational	rhIGFBP-3	 
14294	sp|P9WI63|PKNL_MYC	P08069	70.43	989.0	1270.0	DB06075	investigational	Linsitinib	C[C@]1(O)C[C@H](C1)c2nc(c(n23)c(N)ncc3)-c(c4)ccc(c45)ccc(n5)-c6ccccc6
14296	sp|P9WI63|PKNL_MYC	P08069	70.43	989.0	1270.0	DB07156	experimental	(4Z)-6-bromo-4-({[4-(pyrrolidin-1-ylmethyl)phenyl]amino}methylidene)isoquinoline-1,3(2H,4H)-dione	Brc(c1)ccc(c12)C(=O)NC(=O)C\2=C/Nc3ccc(cc3)CN4CCCC4
14297	sp|P9WI63|PKNL_MYC	P08069	70.43	989.0	1270.0	DB07474	experimental	3-[5-(1H-IMIDAZOL-1-YL)-7-METHYL-1H-BENZIMIDAZOL-2-YL]-4-[(PYRIDIN-2-YLMETHYL)AMINO]PYRIDIN-2(1H)-ONE	c1cncn1-c(cc2C)cc(c23)[nH]c(n3)-c4c(cc[nH]c4=O)NCc5ncccc5
14301	sp|P9WI63|PKNL_MYC	P08069	70.43	989.0	1270.0	DB12267	approved; investigational	Brigatinib	CN1CCN(CC1)C2CCN(CC2)c3cc(OC)c(cc3)Nc4ncc(Cl)c(n4)Nc5ccccc5P(=O)(C)C
14303	sp|P9WI63|PKNL_MYC	P04629	70.93	503.0	786.0	DB00321	approved	Amitriptyline	CN(C)CCC=C1c(cccc2)c2CCc(c13)cccc3
14304	sp|P9WI63|PKNL_MYC	P04629	70.93	503.0	786.0	DB00619	approved	Imatinib	CN1CCN(CC1)Cc2ccc(cc2)C(=O)Nc3cc(c(C)cc3)Nc4nccc(n4)-c5cnccc5
14305	sp|P9WI63|PKNL_MYC	P04629	70.93	503.0	786.0	DB08896	approved	Regorafenib	CNC(=O)c1cc(ccn1)Oc2cc(F)c(cc2)NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F
14306	sp|P9WI63|PKNL_MYC	P04629	70.93	503.0	786.0	DB11986	approved; investigational	Entrectinib	CN1CCN(CC1)c2ccc(c(c2)NC3CCOCC3)C(=O)Nc4n[nH]c(c45)ccc(c5)Cc6cc(F)cc(F)c6
14307	sp|P9WI63|PKNL_MYC	P04629	70.93	503.0	786.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14309	sp|P9WI63|PKNL_MYC	P04629	70.93	503.0	786.0	DB14723	approved; investigational	Larotrectinib	O[C@H]1CCN(C1)C(=O)Nc(cn2)c(n23)nc(cc3)N4CCC[C@@H]4c5c(F)ccc(F)c5
14311	sp|P9WI63|PKNL_MYC	P22455	71.18	463.0	747.0	DB01109	approved; investigational	Heparin	 
14312	sp|P9WI63|PKNL_MYC	P22455	71.18	463.0	747.0	DB08901	approved; investigational	Ponatinib	CN1CCN(CC1)Cc2ccc(cc2C(F)(F)F)NC(=O)c3cc(c(C)cc3)C#Cc4cnc(n45)cccn5
14313	sp|P9WI63|PKNL_MYC	P22455	71.18	463.0	747.0	DB09078	approved; investigational	Lenvatinib	COc(c1)c(C(=O)N)cc(c12)c(ccn2)Oc3ccc(c(Cl)c3)NC(=O)NC4CC4
14314	sp|P9WI63|PKNL_MYC	P22455	71.18	463.0	747.0	DB12147	approved; investigational	Erdafitinib	COc1cc(cc(c1)OC)N(CCNC(C)C)c(c2)ccc(c23)ncc(n3)-c4cn(C)nc4
14315	sp|P9WI63|PKNL_MYC	P22455	71.18	463.0	747.0	DB15102	approved; investigational	Pemigatinib	COc1c(F)c(c(F)c(c1)OC)N(C(=O)N2CC)Cc(c23)cnc4c3cc([nH]4)CN5CCOCC5
14316	sp|P9WI63|PKNL_MYC	O15146	72.93	571.0	862.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14317	sp|P9WI63|PKNL_MYC	P08922	70.18	1939.0	2219.0	DB11986	approved; investigational	Entrectinib	CN1CCN(CC1)c2ccc(c(c2)NC3CCOCC3)C(=O)Nc4n[nH]c(c45)ccc(c5)Cc6cc(F)cc(F)c6
14318	sp|P9WI63|PKNL_MYC	P08922	70.18	1939.0	2219.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14319	sp|P9WI63|PKNL_MYC	Q16288	74.94	528.0	827.0	DB11986	approved; investigational	Entrectinib	CN1CCN(CC1)c2ccc(c(c2)NC3CCOCC3)C(=O)Nc4n[nH]c(c45)ccc(c5)Cc6cc(F)cc(F)c6
14320	sp|P9WI63|PKNL_MYC	Q16288	74.94	528.0	827.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14321	sp|P9WI63|PKNL_MYC	Q16288	74.94	528.0	827.0	DB14723	approved; investigational	Larotrectinib	O[C@H]1CCN(C1)C(=O)Nc(cn2)c(n23)nc(cc3)N4CCC[C@@H]4c5c(F)ccc(F)c5
14322	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB01888	experimental	4-[5-(Trans-4-Aminocyclohexylamino)-3-Isopropylpyrazolo[1,5-a]Pyrimidin-7-Ylamino]-N,N-Dimethylbenzenesulfonamide	CN(C)S(=O)(=O)c1ccc(cc1)Nc2cc(nc(n23)c(cn3)C(C)C)N[C@H]4CC[C@H](N)CC4
14323	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB02010	experimental	Staurosporine	CO[C@@H]1[C@H](NC)C[C@@H](O2)n(c3c4n5[C@]12C)c6c(cccc6)c3c7c(CNC7=O)c4c8c5cccc8
14324	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB02052	experimental	Indirubin-3'-monoxime	c1cccc(c12)NC(\C\2=N\O)=C3/C(=O)Nc(c34)cccc4
14325	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB02091	experimental	4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine	Cc1nc(C)c(s1)-c2nc(N)ncc2
14326	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB02116	experimental	Olomoucine	OCCNc(n1)nc(c(c12)ncn2C)NCc3ccccc3
14327	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB02197	experimental	4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide	NS(=O)(=O)c1ccc(cc1)Nc2nc(ccn2)-c3cnc(n34)cccc4
14328	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB02297	experimental	2-Amino-6-Chloropyrazine	Nc1cncc(Cl)n1
14329	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB02407	experimental	6-O-Cyclohexylmethyl Guanine	[nH]1cnc(c12)c(nc(n2)N)OCC3CCCCC3
14330	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB02538	experimental	N-[4-(2-Methylimidazo[1,2-a]Pyridin-3-Yl)-2-Pyrimidinyl]Acetamide	CC(=O)Nc1nc(ccn1)-c2c(C)nc(n23)cccc3
14331	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB02603	experimental	1-Amino-6-Cyclohex-3-Enylmethyloxypurine	[nH]1cnc(c12)c(nc(c2)N)OCC3CCCCC3
14332	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB02647	experimental	N-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide	c1ccccc1C(=O)Nc2cc(n[nH]2)C3CC3
14333	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB02733	experimental	Purvalanol	n1cn(C(C)C)c(c12)nc(N[C@@H](CO)C(C)C)nc2Nc3ccc(C(=O)O)c(Cl)c3
14334	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB02833	experimental	[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine	Nc1nc(C)c(s1)-c2nc(ncc2)Nc3cccc(c3)[N+]([O-])=O
14335	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB02898	experimental	(5R)-5-{[(2-Amino-3H-purin-6-yl)oxy]methyl}-2-pyrrolidinone	n1c[nH]c(c12)nc(N)nc2OC[C@H]3CCC(=O)N3
14336	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB02915	experimental	4-(2,4-Dimethyl-1,3-thiazol-5-yl)-N-[4-(trifluoromethyl)phenyl]-2-pyrimidinamine	Cc1nc(C)c(s1)-c2ccnc(n2)Nc3ccc(C(F)(F)F)cc3
14337	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB02950	experimental	Hymenialdisine	O=C1NCC[C@@H]([C@@H](C12)C=C(Br)N=2)C3=NC(N)=NC3=O
14338	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB02963	experimental	(5-Chloropyrazolo[1,5-a]Pyrimidin-7-Yl)-(4-Methanesulfonylphenyl)Amine	CS(=O)(=O)c1ccc(cc1)Nc2cc(Cl)nc(n23)ccn3
14339	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB02973	experimental	4-(5-Bromo-2-Oxo-2h-Indol-3-Ylazo)-Benzenesulfonamide	NS(=O)(=O)c1ccc(cc1)/N=N/C(C(=O)N=2)=c(c23)cc(Br)cc3
14340	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB03019	experimental	4-(2,5-Dichloro-Thiophen-3-Yl)-Pyrimidin-2-Ylamine	Nc1nccc(n1)-c2c(Cl)sc(Cl)c2
14341	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB03307	experimental	4-[(6-Amino-4-Pyrimidinyl)Amino]Benzenesulfonamide	Nc1ncnc(c1)Nc2ccc(cc2)S(=O)(=O)N
14342	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB03365	experimental	4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline	COc(c1)c(OC)cc(c12)ncnc2Nc3cc(O)ccc3
14343	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB03428	experimental	SU9516	COc(c1)ccc(c12)NC(=O)C\2=C/c3cnc[nH]3
14344	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB03490	experimental	3-Pyridin-4-Yl-2,4-Dihydro-Indeno[1,2-.C.]Pyrazole	c1cccc(c12)Cc3c2n[nH]c3-c4ccncc4
14345	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB03496	experimental; investigational	Alvocidib	CN1CC[C@@H]([C@H](O)C1)c2c(O)cc(O)c(c23)c(=O)cc(o3)-c4ccccc4Cl
14346	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB03583	experimental	(2E,3S)-3-hydroxy-5'-[(4-hydroxypiperidin-1-yl)sulfonyl]-3-methyl-1,3-dihydro-2,3'-biindol-2'(1'H)-one	c1cccc(c12)NC(\[C@@]2(C)O)=C(/C(=O)N3)c(c34)cc(cc4)S(=O)(=O)N5CCC(O)CC5
14347	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB03663	experimental	1-[(2-Amino-6,9-Dihydro-1h-Purin-6-Yl)Oxy]-3-Methyl-2-Butanol	CC(C)C(=O)COc1nc(N)nc(c12)nc[nH]2
14348	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB03737	experimental	4-((3r,4s,5r)-4-Amino-3,5-Dihydroxy-Hex-1-Ynyl)-5-Fluoro-3-[1-(3-Methoxy-1h-Pyrrol-2-Yl)-Meth-(Z)-Ylidene]-1,3-Dihydro-Indol-2-One	C[C@@H](O)[C@H](N)[C@H](O)C#Cc1c(F)ccc(c12)NC(=O)C\2=C/c3c(OC)cc[nH]3
14349	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB03801	experimental	Lysine Nz-Carboxylic Acid	OC(=O)[C@@H](N)CCCCNC(=O)O
14350	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB04006	experimental	[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone	c1ccccc1C(=O)c(c(n2)N)n(c23)cc(cc3)C(=O)c4c(F)cccc4F
14351	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB04101	experimental	N'-[4-(2,4-Dimethyl-1,3-thiazol-5-yl)-2-pyrimidinyl]-N-hydroxyimidoformamide	Cc1nc(C)c(s1)-c2nc(ncc2)/N=C/NO
14352	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB04186	experimental	N'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea	C1CC[C@@H](N12)c3c(C2=O)cccc3NC(=O)Nc4ccccn4
14353	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB04288	experimental	2-[Trans-(4-Aminocyclohexyl)Amino]-6-(Benzyl-Amino)-9-Cyclopentylpurine	C1CCCC1n2cnc(c23)c(NCc4ccccc4)nc(n3)N[C@@H]5CC[C@@H](N)CC5
14354	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB04407	experimental	4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol	CNc1nc(C)c(s1)-c2ccnc(n2)Nc3ccc(O)cc3
14355	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB04518	experimental	3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol	Cc1nc(C)c(s1)-c2nc(ncc2)Nc3cccc(O)c3
14356	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB04607	experimental	PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE	NS(=O)(=O)c1ccc(cc1)Nc(n2)cn(c23)cc(cc3)C(=O)c4c(Cl)cccc4Cl
14357	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB04662	experimental	OLOMOUCINE II	n1cn(C(C)C)c(c12)nc(N[C@H](CC)CO)nc2NCc3ccccc3O
14358	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB04669	experimental	TRIAZOLOPYRIMIDINE	Brc1cccc(c1)-c(nc([n+]23)nc[nH]3)cc2NCc4ccncc4
14359	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB06195	investigational	Seliciclib	CC(C)n1cnc(c12)c(nc(n2)N[C@H](CC)CO)NCc3ccccc3
14360	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB06616	approved	Bosutinib	COc1cc(c(Cl)cc1Cl)Nc2c(C#N)cnc(c23)cc(c(c3)OC)OCCCN4CCN(C)CC4
14361	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB06844	experimental	4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE	n1csc(c12)c=3c(cc2)=NC(=O)C3CNc4ccc(cc4)S(=O)(=O)Nc5ccccn5
14362	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB06888	experimental	(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE	[C@@H]12CN([C@H](C)C1)CCn3[nH]c4c(cccc4c3=O)c5nc6c([nH]c5=O)cccc6O2
14363	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB06944	experimental	N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide	C1CC1c2n[nH]c(c2)NC(=O)Cc(cc3)cc(c34)cccc4
14364	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB06948	experimental	2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE	C1CCCCC1COc(c(c23)[nH]cn3)nc(n2)Nc4ccccc4
14365	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB06976	experimental	1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA	C1CCN[C@@H]1c2cc(n[nH]2)NC(=O)Nc3cccc(c34)C(=O)N5[C@H]4CCC5
14366	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB06983	experimental	(5-phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol	c1ccccc1-c(nc(n23)c(cn3)CO)cc2NCc4cnccc4
14367	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB07024	experimental	2-(3,4-DIHYDROXYPHENYL)-8-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-3-HYDROXY-6-METHYL-4H-CHROMEN-4-ONE	O=S1(=O)CCCN1c(cc(C)c2)c(c23)oc(c(c3=O)O)-c4ccc(O)c(O)c4
14368	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB07054	experimental	(2R)-1-(DIMETHYLAMINO)-3-{4-[(6-{[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-4-YL)AMINO]PHENOXY}PROPAN-2-OL	CN(C)C[C@@H](O)COc1ccc(cc1)Nc2ncnc(c2)Nc3c(F)ccc(c3)C(F)(F)F
14369	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB07065	experimental	5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)-3-thiocyanatopyrazolo[1,5-a]pyrimidin-7-amine	N#CSc(cn1)c(n12)nc(-c3c(Cl)c(Cl)ccc3)cc2NCc4ccncc4
14370	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB07126	experimental	O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE	NS(=O)(=O)c1ccc(cc1)Nc(n2)nc(c(c23)nc[nH]3)OCC4CCCCC4
14371	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB07137	experimental	(2S)-N-[(3E)-5-Cyclopropyl-3H-pyrazol-3-ylidene]-2-[4-(2-oxo-1-imidazolidinyl)phenyl]propanamide	C1CC1C2=CC(\N=N2)=N/C(=O)[C@@H](C)c3ccc(cc3)N4CCNC4=O
14372	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB07163	experimental	5-[(2-AMINOETHYL)AMINO]-6-FLUORO-3-(1H-PYRROL-2-YL)BENZO[CD]INDOL-2(1H)-ONE	NCCNc1cc(-c2[nH]ccc2)c3C(=O)Nc(c3c14)ccc4F
14373	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB07164	experimental	N-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine	C1CC1Nc2nc(ccn2)-c(cn3)c(n34)cccn4
14374	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB07179	experimental	3-((3-bromo-5-o-tolylpyrazolo[1,5-a]pyrimidin-7-ylamino)methyl)pyridine 1-oxide	Cc1ccccc1-c(nc(n23)c(Br)cn3)cc2NCc4c[n+]([O-])ccc4
14375	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB07203	experimental	6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE	Clc1cccc(c1)Nc(n2)nc(c(c23)[nH]cn3)OCC4CCCCC4
14376	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB07210	experimental	3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine	c1ccccc1-c(nc(n23)c(Br)cn3)cc2NCc4ccncc4
14377	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB07220	experimental	N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE	O=S1(=O)CCCN1c(c2)ccc(c23)[nH]nc3NC(=O)Cc4ccc(cc4)N5CCCCC5
14378	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB07431	experimental	(3R)-3-(aminomethyl)-9-methoxy-1,2,3,4-tetrahydro-5H-[1]benzothieno[3,2-e][1,4]diazepin-5-one	O=C1N[C@H](CN)CNc(c12)c3c(s2)ccc(c3)OC
14379	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB07471	experimental	5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE	Clc1ccccc1[C@@H](C)Oc2c(C(=O)N)sc(c2)-n3cnc(c34)cc(OC)c(c4)OC
14380	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB07493	experimental	5-Bromoindirubin	c1cc(Br)cc(c12)/C(C(=O)N2)=C(C3=O)/Nc(c34)cccc4
14381	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB07501	experimental	(2S)-1-{4-[(4-Anilino-5-bromo-2-pyrimidinyl)amino]phenoxy}-3-(dimethylamino)-2-propanol	CN(C)C[C@H](O)COc1ccc(cc1)Nc2ncc(Br)c(n2)Nc3ccccc3
14382	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB07504	experimental	(2R)-1-{4-[(4-Anilino-5-bromo-2-pyrimidinyl)amino]phenoxy}-3-(dimethylamino)-2-propanol	CN(C)C[C@@H](O)COc1ccc(cc1)Nc2ncc(Br)c(n2)Nc3ccccc3
14383	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB07529	experimental	(5E)-2-Amino-5-(2-pyridinylmethylene)-1,3-thiazol-4(5H)-one	N=C1NC(=O)/C(S1)=C\c2ccccn2
14384	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB07531	experimental	4-{5-[(Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE	NS(=O)(=O)c1ccc(cc1)-c2ccc(o2)/C=C3\SC(=O)NC3=O
14385	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB07533	experimental	4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE	CNS(=O)(=O)c1ccc(cc1)-c2ccc(o2)/C=C3\SC(=N)NC3=O
14386	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB07534	experimental	4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE	NS(=O)(=O)c1ccc(cc1)-c2ccc(o2)/C=C3\SC(=N)NC3=O
14387	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB07538	experimental	4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE	NS(=O)(=O)c1ccc(cc1C(F)(F)F)-c2ccc(o2)/C=C3\SC(=N)NC3=O
14388	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB07539	experimental	4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID	OC(=O)c1ccc(cc1)-c2ccc(o2)/C=C3\SC(=N)NC3=O
14389	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB07540	experimental	4-{5-[(1Z)-1-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)ETHYL]-2-FURYL}BENZENESULFONAMIDE	O=C1NC(=N)SC\1=C(\C)c2ccc(o2)-c3ccc(cc3)S(=O)(=O)N
14390	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB07562	experimental	N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE	CN(C)c1ccc(cc1)Nc2nc(ccn2)-c3c(C)nc(s3)C
14391	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB07595	experimental	(5Z)-5-(3-BROMOCYCLOHEXA-2,5-DIEN-1-YLIDENE)-N-(PYRIDIN-4-YLMETHYL)-1,5-DIHYDROPYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE	Brc1cccc(c1)-c(nc([n+]23)cc[nH]3)cc2NCc4ccncc4
14392	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB07606	experimental	6-(3,4-DIHYDROXYBENZYL)-3-ETHYL-1-(2,4,6-TRICHLOROPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4(5H)-ONE	Clc1cc(Cl)cc(Cl)c1-n(nc2CC)c(c23)nc([nH]c3=O)Cc4cc(O)c(O)cc4
14393	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB07612	experimental	6-(3-AMINOPHENYL)-N-(TERT-BUTYL)-2-(TRIFLUOROMETHYL)QUINAZOLIN-4-AMINE	CC(C)(C)Nc1nc(C(F)(F)F)nc(c12)ccc(c2)-c3cccc(N)c3
14394	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB07618	experimental	2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE	NCC1CCN(CC1)CC(=O)Nc2cccc(c23)c4c(C3=O)c([nH]n4)C5CCCCC5
14395	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB07622	experimental	1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA	CN1CCN(CC1)NC(=O)Nc2cccc(c23)c4c(C3=O)c([nH]n4)-c5c(C)nc(s5)C
14396	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB07685	experimental	4-{[5-(CYCLOHEXYLMETHOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE	NS(=O)(=O)c1ccc(cc1)Nc2cc(nc(n23)ncn3)OCC4CCCCC4
14397	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB07686	experimental	4-{[5-(CYCLOHEXYLAMINO)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE	NS(=O)(=O)c1ccc(cc1)Nc2cc(nc(n23)ncn3)NC4CCCCC4
14398	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB07687	experimental	4-({5-[(4-AMINOCYCLOHEXYL)AMINO][1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL}AMINO)BENZENESULFONAMIDE	N[C@H]1CC[C@@H](CC1)Nc(nc(n23)ncn3)cc2Nc4ccc(cc4)S(=O)(=O)N
14399	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB07688	experimental	4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE	NS(=O)(=O)c1ccc(cc1)Nc2cc(nc(n23)ncn3)OC4CCCCC4
14400	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB07731	experimental	CAN-508	Nc1n[nH]c(N)c1/N=N/c2ccc(O)cc2
14401	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB07750	experimental	(2R)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol	CN(C)C[C@@H](O)COc1ccc(cc1)Nc2nccc(n2)Nc3c(Cl)ccc(Cl)c3
14402	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB07751	experimental	(2S)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol	CN(C)C[C@H](O)COc1ccc(cc1)Nc2cc(ncn2)Nc3c(F)cccc3F
14403	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB07755	experimental	(2S)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol	CN(C)C[C@H](O)COc1ccc(cc1)Nc2nccc(n2)Nc3c(Cl)ccc(Cl)c3
14404	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB07761	experimental	(2R)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol	CN(C)C[C@@H](O)COc1ccc(cc1)Nc2cc(ncn2)Nc3c(F)cccc3F
14405	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB07790	experimental	N-(2-METHOXYETHYL)-4-({4-[2-METHYL-1-(1-METHYLETHYL)-1H-IMIDAZOL-5-YL]PYRIMIDIN-2-YL}AMINO)BENZENESULFONAMIDE	COCCNS(=O)(=O)c1ccc(cc1)Nc2nc(ccn2)-c3cnc(C)n3C(C)C
14406	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB07791	experimental	4-{[4-(1-CYCLOPROPYL-2-METHYL-1H-IMIDAZOL-5-YL)PYRIMIDIN-2-YL]AMINO}-N-METHYLBENZENESULFONAMIDE	CNS(=O)(=O)c1ccc(cc1)Nc2nc(ccn2)-c3cnc(C)n3C4CC4
14407	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB07852	experimental	1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID	Cc1nc(C(=O)O)nn1-c2cc(Cl)cc(Cl)c2
14408	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB07889	experimental	(2S)-1-(Dimethylamino)-3-(4-{[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-2-pyrimidinyl]amino}phenoxy)-2-propanol	CN(C)C[C@H](O)COc1ccc(cc1)Nc2nccc(n2)-c3c(C)nc(n34)cccc4
14409	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB07936	experimental	N-(4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]carbonyl}phenyl)-5-fluoro-4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-amine	CN(C)[C@H]1CCN(C1)C(=O)c2ccc(cc2)Nc3nc(c(F)cn3)-c4cnc(C)n4C(C)C
14410	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB07982	experimental	2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol	CC(C)n1c(C)ncc1-c2nc(ncc2)Nc3ccc(cc3)N4CCN(CC4)C(=O)CO
14411	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB08066	experimental	N-[3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YL]BENZAMIDE	c1ccccc1C(=O)Nc2c[nH]nc2-c([nH]3)nc(c34)cccc4
14412	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB08094	investigational	RO-4584820	COc1ccc(F)c(F)c1C(=O)c2cnc(nc2N)NC3CCN(CC3)S(=O)(=O)C
14413	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB08122	experimental	N-Methyl-4-{[(2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]amino}benzenesulfonamide	c1cccc(c12)NC(=O)C\2=C/Nc3ccc(cc3)S(=O)(=O)NC
14414	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB08123	experimental	N-methyl-{4-[2-(7-oxo-6,7-dihydro-8H-[1,3]thiazolo[5,4-e]indol-8-ylidene)hydrazino]phenyl}methanesulfonamide	CNS(=O)(=O)Cc1ccc(cc1)N/N=C2\C(=O)Nc(c23)ccc4c3scn4
14415	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB08124	experimental	3-{[(2,2-dioxido-1,3-dihydro-2-benzothien-5-yl)amino]methylene}-5-(1,3-oxazol-5-yl)-1,3-dihydro-2H-indol-2-one	c1ncoc1-c(c2)ccc(c23)NC(=O)C\3=C/Nc(cc4)cc(c45)CS(=O)(=O)C5
14416	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB08125	experimental	4-{[(2-Oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]amino}-N-(1,3-thiazol-2-yl)benzenesulfonamide	c1cccc(c12)NC(=O)C\2=C/Nc3ccc(cc3)S(=O)(=O)Nc4nccs4
14417	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB08126	experimental	3-{[4-([amino(imino)methyl]aminosulfonyl)anilino]methylene}-2-oxo-2,3-dihydro-1H-indole	NC(=N)NS(=O)(=O)c1ccc(cc1)N/C=C2\C(=O)Nc(c23)cccc3
14418	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB08132	experimental	5-hydroxynaphthalene-1-sulfonamide	c1ccc(S(=O)(=O)N)c(c12)cccc2O
14419	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB08133	experimental	N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide	NS(=O)(=O)c1ccc(cc1)NC(=O)c2n[nH]c(c23)cccc3
14420	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB08134	experimental	4-[(6-chloropyrazin-2-yl)amino]benzenesulfonamide	NS(=O)(=O)c1ccc(cc1)Nc2nc(Cl)cnc2
14421	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB08135	experimental	N-phenyl-1H-pyrazole-3-carboxamide	n1[nH]ccc1C(=O)Nc2ccccc2
14422	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB08136	experimental	4-(acetylamino)-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide	CC(=O)Nc1c[nH]nc1C(=O)Nc2ccc(F)cc2
14423	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB08137	experimental	(4E)-N-(4-fluorophenyl)-4-[(phenylcarbonyl)imino]-4H-pyrazole-3-carboxamide	Fc1ccc(cc1)NC(=O)c2n[nH]cc2NC(=O)c3ccccc3
14424	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB08138	experimental	{[(2,6-difluorophenyl)carbonyl]amino}-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide	Fc1ccc(cc1)NC(=O)c2n[nH]cc2NC(=O)c3c(F)cccc3F
14425	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB08139	experimental	5-chloro-7-[(1-methylethyl)amino]pyrazolo[1,5-a]pyrimidine-3-carbonitrile	CC(C)Nc1cc(Cl)nc(n12)c(cn2)C#N
14426	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB08140	experimental	5-[(4-AMINOCYCLOHEXYL)AMINO]-7-(PROPAN-2-YLAMINO)PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBONITRILE	N[C@H]1CC[C@@H](CC1)Nc(nc(n23)c(cn3)C#N)cc2NC(C)C
14427	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB08141	experimental	4-{[(2,6-difluorophenyl)carbonyl]amino}-N-[(3S)-piperidin-3-yl]-1H-pyrazole-3-carboxamide	C1CCNC[C@H]1NC(=O)c2n[nH]cc2NC(=O)c3c(F)cccc3F
14428	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB08142	investigational	AT-7519	Clc1cccc(Cl)c1C(=O)Nc2c[nH]nc2C(=O)NC3CCNCC3
14429	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB08178	experimental	4-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine	n1ccc(OC)c(c12)c(c[nH]2)-c3nc(N)ncc3
14430	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB08182	experimental	4-(4-propoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine	CCCOc(ccn1)c(c12)c(c[nH]2)-c3nc(N)ncc3
14431	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB08218	experimental	HYDROXY(OXO)(3-{[(2Z)-4-[3-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]PYRIMIDIN-2(5H)-YLIDENE]AMINO}PHENYL)AMMONIUM	O=N(=O)c1cccc(c1)/N=C2/N=CCC(=N2)c3cccc(c3)Cn4cncn4
14432	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB08219	experimental	4-Methyl-5-[(2Z)-2-{[4-(4-morpholinyl)phenyl]imino}-2,5-dihydro-4-pyrimidinyl]-1,3-thiazol-2-amine	Nc1nc(C)c(s1)C2=N/C(N=CC2)=N\c3ccc(cc3)N4CCOCC4
14433	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB08233	experimental	6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE	Oc1ccc(cc1)Nc(n2)nc(c(c23)nc[nH]3)OCC4CCCCC4
14434	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB08241	experimental	4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE	NC(=O)c1ccc(cc1)Nc(n2)nc(c(c23)nc[nH]3)OCC4CCCCC4
14435	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB08247	experimental	6-(CYCLOHEXYLMETHOXY)-8-ISOPROPYL-9H-PURIN-2-AMINE	CC(C)c([nH]1)nc(c12)c(nc(n2)N)OCC3CCCCC3
14436	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB08248	experimental	3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE	NS(=O)(=O)c1cccc(c1)Nc(n2)nc(c(c23)nc[nH]3)OCC4CCCCC4
14437	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB08285	experimental	(2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol	n1cc(C(C)C)c(n12)nc(N[C@H](CC)CO)nc2NCc3ccccc3
14438	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB08309	experimental	3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL	OCCCNCCS(=O)(=O)c1ccc(cc1)Nc(n2)nc(c(c23)nc[nH]3)OCC4CCCCC4
14439	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB08312	experimental	6-CYCLOHEXYLMETHYLOXY-5-NITROSO-PYRIMIDINE-2,4-DIAMINE	Nc1nc(N)c(N=O)c(n1)OCC2CCCCC2
14440	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB08355	experimental	1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid	Cn1nc(C(=O)O)c(c12)CCc3c2nc(nc3)Nc4ccccc4
14441	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB08441	experimental	6-BROMO-13-THIA-2,4,8,12,19-PENTAAZATRICYCLO[12.3.1.1~3,7~]NONADECA-1(18),3(19),4,6,14,16-HEXAENE 13,13-DIOXIDE	Brc(c12)cnc(n1)Nc3cccc(c3)S(=O)(=O)NCCCN2
14442	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB08463	experimental	(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol	n1cn(C(C)C)c(c12)nc(N[C@H](CC)CO)nc2NCc3ccc(cc3)-c4ccccn4
14443	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB08527	experimental	1-[4-(AMINOSULFONYL)PHENYL]-1,6-DIHYDROPYRAZOLO[3,4-E]INDAZOLE-3-CARBOXAMIDE	O=S(=O)(N)c1ccc(cc1)-n(nc2C(=O)N)c(c23)c4c(cc3)[nH]nc4
14444	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB08531	experimental	5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine	Clc1cccc(c1Cl)-c(nc(n23)ccn3)cc2NCc4ccncc4
14445	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB08532	experimental	6-(2-fluorophenyl)-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine	Fc1ccccc1-c(cn(c23)ccn3)nc2NCc4cccnc4
14446	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB08533	experimental	3-methyl-N-(pyridin-4-ylmethyl)imidazo[1,2-a]pyrazin-8-amine	Cc1cnc(n12)c(ncc2)NCc3ccncc3
14447	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB08534	experimental	5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine	Fc1ccccc1-c(nc(n23)ccn3)cc2NCc4ccncc4
14448	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB08535	experimental	3-bromo-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine	c1ccccc1-c(nc(n23)c(Br)cn3)cc2NCc4cccnc4
14449	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB08536	experimental	3-bromo-5-phenyl-N-(pyrimidin-5-ylmethyl)pyrazolo[1,5-a]pyridin-7-amine	c1ccccc1-c(cc(n23)c(Br)cn3)cc2NCc4cncnc4
14450	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB08537	experimental	3-bromo-6-phenyl-N-(pyrimidin-5-ylmethyl)imidazo[1,2-a]pyridin-8-amine	c1ccccc1-c(c2)cc(c(n23)ncc3Br)NCc4cncnc4
14451	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB08538	experimental	N-((2-aminopyrimidin-5-yl)methyl)-5-(2,6-difluorophenyl)-3-ethylpyrazolo[1,5-a]pyrimidin-7-amine	Nc1ncc(cn1)CNc2cc(nc(n23)c(cn3)CC)-c4c(F)cccc4F
14452	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB08539	experimental	3-cyclopropyl-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine	c1ncccc1CNc2cc(nc(n23)c(cn3)C4CC4)-c5ccccc5
14453	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB08572	experimental	4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE	NC(=O)c1ccc(cc1)Nc2nc(c(N=O)c(n2)N)OCC3CCCCC3
14454	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB08673	experimental	4-[(5-ISOPROPYL-1,3-THIAZOL-2-YL)AMINO]BENZENESULFONAMIDE	CC(C)c1cnc(s1)Nc2ccc(cc2)S(=O)(=O)N
14455	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB08677	experimental	N-(5-Isopropyl-thiazol-2-YL)-2-pyridin-3-YL-acetamide	CC(C)c1sc(nc1)NC(=O)Cc2cnccc2
14456	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB08694	experimental	Variolin B	Nc1nccc(n1)-c2c(ccnc3N)n3c(c24)nccc4O
14457	sp|P9WI63|PKNL_MYC	P24941	70.18	2.0	282.0	DB08768	experimental	N(6)-dimethylallyladenine	CC(C)=CCNc1ncnc(c12)[nH]cn2
14458	sp|P9WI63|PKNL_MYC	Q92772	72.43	2.0	291.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14459	sp|P9WI63|PKNL_MYC	Q00532	75.19	3.0	303.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14460	sp|P9WI63|PKNL_MYC	O94768	71.43	33.0	318.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
14461	sp|P9WI63|PKNL_MYC	O94768	71.43	33.0	318.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14462	sp|P9WI63|PKNL_MYC	Q06418	72.43	506.0	795.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14463	sp|P9WI63|PKNL_MYC	Q12866	73.43	574.0	867.0	DB08325	experimental	2-({6-[(3-Chlorophenyl)amino]-9-isopropyl-9H-purin-2-yl}amino)ethanol	CC(C)n1cnc(c12)c(nc(n2)NCCO)Nc3cc(Cl)ccc3
14464	sp|P9WI63|PKNL_MYC	Q12866	73.43	574.0	867.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14465	sp|P9WI63|PKNL_MYC	O15264	71.43	22.0	307.0	DB05157	investigational	KC706	 
14466	sp|P9WI63|PKNL_MYC	O15264	71.43	22.0	307.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14467	sp|P9WI63|PKNL_MYC	O15264	71.43	22.0	307.0	DB01017	approved; investigational	Minocycline	O=C1C(C(=O)N)=C(O)[C@@H](N(C)C)[C@@H]([C@@]12O)C[C@H]3C(=C2O)C(=O)c4c(C3)c(N(C)C)ccc4O
14468	sp|P9WI63|PKNL_MYC	Q86UE8	70.68	453.0	735.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14469	sp|P9WI63|PKNL_MYC	Q8TD19	71.18	51.0	335.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14470	sp|P9WI63|PKNL_MYC	Q16832	73.68	552.0	846.0	DB08896	approved	Regorafenib	CNC(=O)c1cc(ccn1)Oc2cc(F)c(cc2)NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F
14471	sp|P9WI63|PKNL_MYC	Q16832	73.68	552.0	846.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14472	sp|P9WI63|PKNL_MYC	Q16644	72.43	30.0	319.0	DB07728	experimental	2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE	Fc1ccccc1-c2cc(ccn2)-c([nH]3)cc(c34)C(=O)NCC4
14473	sp|P9WI63|PKNL_MYC	Q16644	72.43	30.0	319.0	DB08358	experimental	2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE	O=C1NCCc(c12)[nH]c(c2)-c3cc(ncc3)-c(cn4)cc(c45)cccc5
14474	sp|P9WI63|PKNL_MYC	O95835	73.68	702.0	996.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14475	sp|P9WI63|PKNL_MYC	Q08345	74.19	606.0	902.0	DB00619	approved	Imatinib	CN1CCN(CC1)Cc2ccc(cc2)C(=O)Nc3cc(c(C)cc3)Nc4nccc(n4)-c5cnccc5
14476	sp|P9WI63|PKNL_MYC	Q08345	74.19	606.0	902.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14477	sp|P9WI63|PKNL_MYC	Q9HBH9	81.95	79.0	406.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14478	sp|P9WI63|PKNL_MYC	Q9UM73	70.93	1109.0	1392.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
14479	sp|P9WI63|PKNL_MYC	Q9UM73	70.93	1109.0	1392.0	DB08865	approved	Crizotinib	Clc1c(F)ccc(Cl)c1[C@@H](C)Oc2cc(cnc2N)-c3cn(nc3)C4CCNCC4
14480	sp|P9WI63|PKNL_MYC	Q9UM73	70.93	1109.0	1392.0	DB09063	approved	Ceritinib	C1CNCCC1c2cc(OC(C)C)c(cc2C)Nc3ncc(Cl)/c([nH]3)=N\c4ccccc4S(=O)(=O)C(C)C
14481	sp|P9WI63|PKNL_MYC	Q9UM73	70.93	1109.0	1392.0	DB11363	approved; investigational	Alectinib	C1COCCN1C2CCN(CC2)c(c3)c(CC)cc(c34)C(=O)c5c(C4(C)C)[nH]c6c5ccc(c6)C#N
14482	sp|P9WI63|PKNL_MYC	Q9UM73	70.93	1109.0	1392.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14483	sp|P9WI63|PKNL_MYC	Q9UM73	70.93	1109.0	1392.0	DB12130	approved; investigational	Lorlatinib	Fc(c1)ccc(c12)C(=O)N(C)Cc3c(c(C#N)n(n3)C)c4cc(O[C@@H]2C)c(N)nc4
14484	sp|P9WI63|PKNL_MYC	Q9UM73	70.93	1109.0	1392.0	DB12141	approved; investigational	Gilteritinib	C1COCCC1Nc2c(CC)nc(C(=O)N)c(n2)Nc3ccc(c(c3)OC)N4CCC(CC4)N5CCN(C)CC5
14485	sp|P9WI63|PKNL_MYC	Q9UM73	70.93	1109.0	1392.0	DB12267	approved; investigational	Brigatinib	CN1CCN(CC1)C2CCN(CC2)c3cc(OC)c(cc3)Nc4ncc(Cl)c(n4)Nc5ccccc5P(=O)(C)C
14486	sp|P9WI63|PKNL_MYC	Q9UKI8	70.43	447.0	728.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14487	sp|P9WI63|PKNL_MYC	Q13546	77.69	13.0	323.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14488	sp|P9WI63|PKNL_MYC	P49137	71.18	56.0	340.0	DB02010	experimental	Staurosporine	CO[C@@H]1[C@H](NC)C[C@@H](O2)n(c3c4n5[C@]12C)c6c(cccc6)c3c7c(CNC7=O)c4c8c5cccc8
14489	sp|P9WI63|PKNL_MYC	P49137	71.18	56.0	340.0	DB07234	experimental	3-{[(1R)-1-phenylethyl]amino}-4-(pyridin-4-ylamino)cyclobut-3-ene-1,2-dione	c1ccccc1[C@@H](C)Nc2c(c(=O)c2=O)Nc3ccncc3
14490	sp|P9WI63|PKNL_MYC	P49137	71.18	56.0	340.0	DB07406	experimental	(4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMINO}CARBONYL)-1,3-THIAZOL-2-YL]-4-METHYL-1-OXO-2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE-6-CARBOXAMIDE	C[C@H]1CNC(=O)c(c12)[nH]c3c2cc(cc3)C(=O)Nc4nc(cs4)C(=O)NCCN(C)C
14491	sp|P9WI63|PKNL_MYC	P49137	71.18	56.0	340.0	DB07430	experimental	(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one	O=C1N[C@H](C)CNc(c12)c3c(s2)ccc4c3ccc(n4)-c5cnc(C)cc5
14492	sp|P9WI63|PKNL_MYC	P49137	71.18	56.0	340.0	DB07431	experimental	(3R)-3-(aminomethyl)-9-methoxy-1,2,3,4-tetrahydro-5H-[1]benzothieno[3,2-e][1,4]diazepin-5-one	O=C1N[C@H](CN)CNc(c12)c3c(s2)ccc(c3)OC
14493	sp|P9WI63|PKNL_MYC	P49137	71.18	56.0	340.0	DB07728	experimental	2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE	Fc1ccccc1-c2cc(ccn2)-c([nH]3)cc(c34)C(=O)NCC4
14494	sp|P9WI63|PKNL_MYC	P49137	71.18	56.0	340.0	DB08358	experimental	2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE	O=C1NCCc(c12)[nH]c(c2)-c3cc(ncc3)-c(cn4)cc(c45)cccc5
14495	sp|P9WI63|PKNL_MYC	Q00534	75.44	9.0	310.0	DB03496	experimental; investigational	Alvocidib	CN1CC[C@@H]([C@H](O)C1)c2c(O)cc(O)c(c23)c(=O)cc(o3)-c4ccccc4Cl
14496	sp|P9WI63|PKNL_MYC	Q00534	75.44	9.0	310.0	DB07379	experimental	(2S)-2-({6-[(3-Amino-5-chlorophenyl)amino]-9-isopropyl-9H-purin-2-yl}amino)-3-methyl-1-butanol	n1cn(C(C)C)c(c12)nc(N[C@H](CO)C(C)C)nc2Nc3cc(Cl)cc(N)c3
14497	sp|P9WI63|PKNL_MYC	Q00534	75.44	9.0	310.0	DB07795	experimental	Fisetin	c1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
14498	sp|P9WI63|PKNL_MYC	Q00534	75.44	9.0	310.0	DB09073	approved; investigational	Palbociclib	C1CCCC1n2c(=O)c(C(=O)C)c(C)c(c23)cnc(n3)Nc4ncc(cc4)N5CCNCC5
14499	sp|P9WI63|PKNL_MYC	Q00534	75.44	9.0	310.0	DB11730	approved; investigational	Ribociclib	C1CCCC1n2c(C(=O)N(C)C)cc(c23)cnc(n3)Nc4ccc(cn4)N5CCNCC5
14500	sp|P9WI63|PKNL_MYC	Q00534	75.44	9.0	310.0	DB12001	approved; investigational	Abemaciclib	CCN1CCN(CC1)Cc2ccc(nc2)Nc3ncc(F)c(n3)-c(c4)cc(F)c(c45)nc(C)n5C(C)C
14501	sp|P9WI63|PKNL_MYC	Q8TD08	72.68	11.0	301.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14502	sp|P9WI63|PKNL_MYC	Q8TD08	72.68	11.0	301.0	DB00945	approved; vet_approved	Acetylsalicylic acid	CC(=O)Oc1ccccc1C(=O)O
14503	sp|P9WI63|PKNL_MYC	Q8TD08	72.68	11.0	301.0	DB01017	approved; investigational	Minocycline	O=C1C(C(=O)N)=C(O)[C@@H](N(C)C)[C@@H]([C@@]12O)C[C@H]3C(=C2O)C(=O)c4c(C3)c(N(C)C)ccc4O
14504	sp|P9WI63|PKNL_MYC	P28482	71.68	23.0	309.0	DB00945	approved; vet_approved	Acetylsalicylic acid	CC(=O)Oc1ccccc1C(=O)O
14505	sp|P9WI63|PKNL_MYC	P28482	71.68	23.0	309.0	DB01064	approved; investigational	Isoprenaline	CC(C)NCC(O)c1cc(O)c(O)cc1
14506	sp|P9WI63|PKNL_MYC	P28482	71.68	23.0	309.0	DB01169	approved; investigational	Arsenic trioxide	O=[As]O[As]=O
14507	sp|P9WI63|PKNL_MYC	P28482	71.68	23.0	309.0	DB02116	experimental	Olomoucine	OCCNc(n1)nc(c(c12)ncn2C)NCc3ccccc3
14508	sp|P9WI63|PKNL_MYC	P28482	71.68	23.0	309.0	DB02482	experimental	Phosphonothreonine	OC(=O)[C@H](N)[C@H](C)OP(=O)(O)O
14509	sp|P9WI63|PKNL_MYC	P28482	71.68	23.0	309.0	DB02733	experimental	Purvalanol	n1cn(C(C)C)c(c12)nc(N[C@@H](CO)C(C)C)nc2Nc3ccc(C(=O)O)c(Cl)c3
14510	sp|P9WI63|PKNL_MYC	P28482	71.68	23.0	309.0	DB04338	experimental	SB220025	Nc1nccc(n1)-c2c(-c3ccc(F)cc3)ncn2C4CCNCC4
14511	sp|P9WI63|PKNL_MYC	P28482	71.68	23.0	309.0	DB06195	investigational	Seliciclib	CC(C)n1cnc(c12)c(nc(n2)N[C@H](CC)CO)NCc3ccccc3
14512	sp|P9WI63|PKNL_MYC	P28482	71.68	23.0	309.0	DB06641	investigational	Perifosine	CCCCCCCCCCCCCCCCCCOP([O-])(=O)OC(CC1)CC[N+]1(C)C
14513	sp|P9WI63|PKNL_MYC	P28482	71.68	23.0	309.0	DB06877	experimental	N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE	CN(C)C(=O)c1cc(c[nH]1)-c2n[nH]cc2-c3ccccc3
14514	sp|P9WI63|PKNL_MYC	P28482	71.68	23.0	309.0	DB07010	experimental	N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE	Clc1cc(ccc1)-c2c[nH]nc2-c3c[nH]c(c3)C(=O)NCc4ccccc4
14515	sp|P9WI63|PKNL_MYC	P28482	71.68	23.0	309.0	DB07264	experimental	(S)-N-(1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL)-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE	Fc1ccc(cc1Cl)[C@@H](CO)NC(=O)c2cc(c[nH]2)-c3n[nH]cc3-c4cccc(Cl)c4
14516	sp|P9WI63|PKNL_MYC	P28482	71.68	23.0	309.0	DB07788	experimental	(3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE	Oc1cc(OC)cc(c12)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@@H](C)OC2=O
14517	sp|P9WI63|PKNL_MYC	P28482	71.68	23.0	309.0	DB07794	experimental	5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE	Nc1n[nH]c(c12)nnc(c2)-c(c(n34)cccc4)c(n3)-c5ccccc5
14518	sp|P9WI63|PKNL_MYC	P28482	71.68	23.0	309.0	DB07905	experimental	(1aR,8S,13S,14S,15aR)-5,13,14-trihydroxy-3-methoxy-8-methyl-8,9,13,14,15,15a-hexahydro-6H-oxireno[k][2]benzoxacyclotetradecine-6,12(1aH)-dione	Oc1cc(OC)cc(c12)[C@@H]3[C@H](O3)C[C@H](O)[C@H](O)C(=O)\C=C\C[C@H](C)OC2=O
14519	sp|P9WI63|PKNL_MYC	P28482	71.68	23.0	309.0	DB08513	experimental	[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID	Cc1cc(ccc1)Nc2nc(ncc2C(=O)N)Nc3ccc(cc3)CC(=O)O
14520	sp|P9WI63|PKNL_MYC	P28482	71.68	23.0	309.0	DB08521	experimental	4-[4-(4-Fluorophenyl)-2-[4-[(R)-methylsulfinyl]phenyl]-1H-imidazol-5-yl]pyridine	C[S@@](=O)c1ccc(cc1)-c2nc(-c3ccc(F)cc3)c([nH]2)-c4ccncc4
14521	sp|P9WI63|PKNL_MYC	P28482	71.68	23.0	309.0	DB11120	approved; experimental	Turpentine	 
14522	sp|P9WI63|PKNL_MYC	P28482	71.68	23.0	309.0	DB13930	investigational	Ulixertinib	Clc1cccc(c1)[C@@H](CO)NC(=O)c2cc(c[nH]2)-c3cc(ncc3Cl)NC(C)C
14523	sp|P9WI63|PKNL_MYC	P28482	71.68	23.0	309.0	DB01017	approved; investigational	Minocycline	O=C1C(C(=O)N)=C(O)[C@@H](N(C)C)[C@@H]([C@@]12O)C[C@H]3C(=C2O)C(=O)c4c(C3)c(N(C)C)ccc4O
14524	sp|P9WI63|PKNL_MYC	Q15569	71.68	52.0	338.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14525	sp|P9WI63|PKNL_MYC	P11802	72.68	3.0	293.0	DB02733	experimental	Purvalanol	n1cn(C(C)C)c(c12)nc(N[C@@H](CO)C(C)C)nc2Nc3ccc(C(=O)O)c(Cl)c3
14526	sp|P9WI63|PKNL_MYC	P11802	72.68	3.0	293.0	DB03496	experimental; investigational	Alvocidib	CN1CC[C@@H]([C@H](O)C1)c2c(O)cc(O)c(c23)c(=O)cc(o3)-c4ccccc4Cl
14527	sp|P9WI63|PKNL_MYC	P11802	72.68	3.0	293.0	DB09073	approved; investigational	Palbociclib	C1CCCC1n2c(=O)c(C(=O)C)c(C)c(c23)cnc(n3)Nc4ncc(cc4)N5CCNCC5
14528	sp|P9WI63|PKNL_MYC	P11802	72.68	3.0	293.0	DB11730	approved; investigational	Ribociclib	C1CCCC1n2c(C(=O)N(C)C)cc(c23)cnc(n3)Nc4ccc(cn4)N5CCNCC5
14529	sp|P9WI63|PKNL_MYC	P11802	72.68	3.0	293.0	DB12001	approved; investigational	Abemaciclib	CCN1CCN(CC1)Cc2ccc(nc2)Nc3ncc(F)c(n3)-c(c4)cc(F)c(c45)nc(C)n5C(C)C
14530	sp|P9WI63|PKNL_MYC	P11802	72.68	3.0	293.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14531	sp|P9WI63|PKNL_MYC	Q8NFD2	70.93	27.0	310.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14532	sp|P9WI63|PKNL_MYC	Q8IW41	73.18	17.0	309.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14533	sp|P9WI63|PKNL_MYC	P19525	70.43	265.0	546.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14534	sp|P9WI63|PKNL_MYC	Q16659	74.19	16.0	312.0	DB00945	approved; vet_approved	Acetylsalicylic acid	CC(=O)Oc1ccccc1C(=O)O
14535	sp|P9WI63|PKNL_MYC	Q16659	74.19	16.0	312.0	DB01017	approved; investigational	Minocycline	O=C1C(C(=O)N)=C(O)[C@@H](N(C)C)[C@@H]([C@@]12O)C[C@H]3C(=C2O)C(=O)c4c(C3)c(N(C)C)ccc4O
14536	sp|P9WI63|PKNL_MYC	O43353	76.69	21.0	327.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14537	sp|P9WI63|PKNL_MYC	O14976	70.93	37.0	320.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14538	sp|P9WI63|PKNL_MYC	Q5S007	73.93	1884.0	2179.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14539	sp|P9WI63|PKNL_MYC	Q8TDR2	82.71	199.0	529.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14540	sp|P9WI63|PKNL_MYC	Q04771	75.94	202.0	505.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
14541	sp|P9WI63|PKNL_MYC	Q04771	75.94	202.0	505.0	DB08597	experimental	Dorsomorphin	C1CCCCN1CCOc2ccc(cc2)-c(cn3)cn(c34)ncc4-c5ccncc5
14542	sp|P9WI63|PKNL_MYC	Q04771	75.94	202.0	505.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14543	sp|P9WI63|PKNL_MYC	Q2M2I8	70.93	43.0	326.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14544	sp|P9WI63|PKNL_MYC	O00238	75.19	198.0	498.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14546	sp|P9WI63|PKNL_MYC	P36897	74.94	199.0	498.0	DB03921	experimental	4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline	n1ccccc1-c2n[nH]cc2-c(ccn3)c(c34)cccc4
14547	sp|P9WI63|PKNL_MYC	P36897	74.94	199.0	498.0	DB04434	experimental	Naphthyridine Inhibitor	Cc1cccc(n1)C2=C(CNN2)c(n3)ccc(c34)nccc4
14548	sp|P9WI63|PKNL_MYC	P36897	74.94	199.0	498.0	DB04480	experimental	3-(4-Fluorophenyl)-2-(6-Methylpyridin-2-Yl)-5,6-Dihydro-4h-Pyrrolo[1,2-B]Pyrazole	C1CCn(c12)nc(-c(nc3C)ccc3)c2-c4ccc(F)cc4
14549	sp|P9WI63|PKNL_MYC	P36897	74.94	199.0	498.0	DB07152	experimental	N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide	Fc1ccc(nc1C)-c2nc(NC(=O)C)[nH]c2-c(c3)ccc(c34)nccn4
14550	sp|P9WI63|PKNL_MYC	P36897	74.94	199.0	498.0	DB07267	experimental	2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine	Cc1cccc(n1)-c(n2)nc(c(c23)cccc3)Nc4ccncc4
14551	sp|P9WI63|PKNL_MYC	P36897	74.94	199.0	498.0	DB08450	experimental	N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine	Cc1cccc(n1)-c(n2)nc(c(c23)cccc3)Nc(c4)ccc(c45)[nH]nc5
14552	sp|P9WI63|PKNL_MYC	P36897	74.94	199.0	498.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14553	sp|P9WI63|PKNL_MYC	P37023	75.94	196.0	499.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
14554	sp|P9WI63|PKNL_MYC	P30291	74.19	293.0	589.0	DB04608	experimental	9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE	c1cc(O)cc(c12)c3c([nH]2)cc(c4c3C(=O)NC4=O)-c5ccccc5
14555	sp|P9WI63|PKNL_MYC	P30291	74.19	293.0	589.0	DB07006	experimental	9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE	COc1ccccc1-c2cc(c3c(c24)C(=O)NC4=O)n(CCCO)c5c3cc(O)cc5
14556	sp|P9WI63|PKNL_MYC	P30291	74.19	293.0	589.0	DB07226	experimental	N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE	Clc1ccccc1-c2cc(c3c(c24)C(=O)NC4=O)[nH]c5c3cc(cc5)NC=O
14557	sp|P9WI63|PKNL_MYC	P30291	74.19	293.0	589.0	DB07257	experimental	4-(2-chlorophenyl)-8-(2-hydroxyethyl)-6-methylpyrrolo[3,4-e]indole-1,3(2H,6H)-dione	OCCc(cn1C)c(c12)c3c(C(=O)NC3=O)c(c2)-c4ccccc4Cl
14558	sp|P9WI63|PKNL_MYC	P30291	74.19	293.0	589.0	DB07265	experimental	3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID	Oc(c1)ccc(c12)n(CCC(=O)O)c3c2c4c(C(=O)NC4=O)c(c3)-c5ccccc5
14559	sp|P9WI63|PKNL_MYC	P30291	74.19	293.0	589.0	DB08365	experimental	8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide	OCCNC(=O)c(c1Br)n(C)c(c12)cc(c3c2C(=O)NC3=O)-c4c(Cl)cccc4
14560	sp|P9WI63|PKNL_MYC	P30291	74.19	293.0	589.0	DB11740	investigational	MK-1775	CN1CCN(CC1)c2ccc(cc2)Nc(n3)ncc(c34)c(=O)n(CC=C)n4-c5nc(C(C)(C)O)ccc5
14561	sp|P9WI63|PKNL_MYC	P30291	74.19	293.0	589.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14562	sp|P9WI63|PKNL_MYC	P36896	74.44	201.0	498.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
14563	sp|P9WI63|PKNL_MYC	P36896	74.44	201.0	498.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14565	sp|P9WI63|PKNL_MYC	Q13873	81.95	193.0	520.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14566	sp|P9WI63|PKNL_MYC	Q9Y616	71.68	165.0	451.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14570	sp|P9WI63|PKNL_MYC	P37173	74.44	244.0	541.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
14571	sp|P9WI63|PKNL_MYC	Q16671	77.94	204.0	515.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
14572	sp|O07434|RICR_MYC	Q8GMG0	84.38	86.0	167.0	DB06946	experimental	(2S,3S)-3-(4-fluorophenyl)-2,3-dihydroxypropanoic acid	OC(=O)[C@@H](O)[C@@H](O)c1ccc(F)cc1
14573	sp|O07434|RICR_MYC	P42357	84.38	187.0	268.0	DB00117	investigational; nutraceutical	Histidine	OC(=O)[C@@H](N)Cc1c[nH]cn1
14574	sp|O07434|RICR_MYC	Q3IWB0	82.29	84.0	163.0	DB01880	experimental; investigational	3,4-Dihydroxycinnamic Acid	OC(=O)/C=C/c1cc(O)c(O)cc1
14575	sp|O07434|RICR_MYC	Q3IWB0	82.29	84.0	163.0	DB04066	experimental	p-Coumaric acid	OC(=O)/C=C/c1ccc(O)cc1
14576	sp|P9WH71|RIR2B_MY	Q9CBQ2	99.69	2.0	325.0	DB04272	approved; nutraceutical; vet_approved	Citric acid	OC(=O)CC(O)(C(=O)O)CC(=O)O
14577	sp|P9WH71|RIR2B_MY	Q7LG56	78.4	54.0	308.0	DB00242	approved; investigational	Cladribine	Clc(n1)nc(N)c(c12)ncn2[C@H]3C[C@H](O)[C@H](O3)CO
14578	sp|P9WH71|RIR2B_MY	P31350	78.09	92.0	345.0	DB00242	approved; investigational	Cladribine	Clc(n1)nc(N)c(c12)ncn2[C@H]3C[C@H](O)[C@H](O3)CO
14579	sp|P9WH71|RIR2B_MY	P31350	78.09	92.0	345.0	DB05003	investigational	Imexon	N12C(C1)C(N)=NC2=O
14580	sp|P9WH71|RIR2B_MY	P31350	78.09	92.0	345.0	DB05260	approved; investigational	Gallium nitrate	[O-][N+]([O-])=O
14581	sp|P9WH71|RIR2B_MY	P31350	78.09	92.0	345.0	DB05428	investigational	Motexafin gadolinium	CCc(c12)c(CC)c([n-]1)cc3nc(c(C)c3CCCO)cnc4c(ncc5nc(c2)c(c5C)CCCO)cc(OCCOCCOCCOC)c(c4)OCCOCCOCCOC
14582	sp|P9WH71|RIR2B_MY	P31350	78.09	92.0	345.0	DB05801	investigational	GTI 2040	 
14583	sp|P9WH71|RIR2B_MY	P9WH69	78.4	21.0	275.0	DB08231	experimental	Myristic acid	CCCCCCCCCCCCCC(=O)O
14584	sp|P9WII3|MAZF6_MY	P96622	97.37	1.0	112.0	DB02042	experimental	2-(2-{2-[2-(2-Methoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol	COCCOCCOCCOCCOCCO
14585	sp|O07427|MGLL_MYC	P47229	92.47	23.0	281.0	DB07510	experimental	3-fluoro-6-(4-fluorophenyl)-2-hydroxy-6-oxohexa-2,4-dienoic acid	OC(=O)/C(O)=C(/F)\C=C\C(=O)c1ccc(F)cc1
14586	sp|O07427|MGLL_MYC	P47229	92.47	23.0	281.0	DB07516	experimental	(2Z,4E)-3-chloro-2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoic acid	OC(=O)/C(O)=C(/Cl)\C=C\C(=O)c1ccccc1
14587	sp|O07427|MGLL_MYC	P47229	92.47	23.0	281.0	DB07911	experimental	(3E)-2,6-DIOXO-6-PHENYLHEX-3-ENOATE	[O-]C(=O)C(=O)/C=C/CC(=O)c1ccccc1
14588	sp|O07427|MGLL_MYC	P47229	92.47	23.0	281.0	DB07915	experimental	(2E,4E)-2-Hydroxy-6-oxo-6-phenyl-2,4-hexadienoic acid	OC(=O)/C(O)=C\C=C\C(=O)c1ccccc1
14590	sp|O07427|MGLL_MYC	P96965	88.17	19.0	265.0	DB02406	experimental	N-Valeric Acid	CCCCC(=O)O
14591	sp|O07427|MGLL_MYC	P96965	88.17	19.0	265.0	DB02531	experimental	Isobutyric acid	CC(C)C(=O)O
14592	sp|O07427|MGLL_MYC	P96965	88.17	19.0	265.0	DB03568	experimental; investigational	Butyric Acid	CCCC(=O)O
14593	sp|O07427|MGLL_MYC	P96965	88.17	19.0	265.0	DB03741	experimental	2-Methylbutanoic Acid	CC[C@@H](C)C(=O)O
14594	sp|O07427|MGLL_MYC	P96965	88.17	19.0	265.0	DB03750	experimental	Isovaleric Acid	CC(C)CC(=O)O
14595	sp|O07427|MGLL_MYC	P96965	88.17	19.0	265.0	DB03766	approved; vet_approved	Propanoic acid	CCC(=O)O
14596	sp|O07427|MGLL_MYC	P96965	88.17	19.0	265.0	DB03793	approved; investigational	Benzoic acid	OC(=O)c1ccccc1
14597	sp|O07427|MGLL_MYC	O31168	94.98	12.0	277.0	DB03793	approved; investigational	Benzoic acid	OC(=O)c1ccccc1
14598	sp|O07427|MGLL_MYC	O07732	73.84	50.0	256.0	DB02596	experimental	alpha,beta-Methyleneadenosine 5'-triphosphate	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)CP(=O)(O)OP(=O)(O)O
14599	sp|O07427|MGLL_MYC	Q06174	81.36	14.0	241.0	DB01670	experimental	Propyl acetate	CCCOC(=O)C
14600	sp|O07427|MGLL_MYC	Q86WA6	85.3	50.0	288.0	DB03380	experimental	L-tyrosinamide	NC(=O)[C@@H](N)Cc1ccc(O)cc1
14601	sp|O07427|MGLL_MYC	O32449	96.42	27.0	296.0	DB03833	experimental	2-Prolyl-5-Tert-Butyl-[1,3,4]Oxadiazole	C1CCN[C@@H]1C(=O)c2nnc(o2)C(C)(C)C
14602	sp|O07427|MGLL_MYC	O32449	96.42	27.0	296.0	DB07391	experimental	(2S)-2-AMINO-1-(5-TERT-BUTYL-1,3,4-OXADIAZOL-2-YL)PROPAN-1-ONE	C[C@H](N)C(=O)c1nnc(o1)C(C)(C)C
14603	sp|O07427|MGLL_MYC	O32449	96.42	27.0	296.0	DB08576	experimental	1-(5-TERT-BUTYL-1,3,4-OXADIAZOL-2-YL)-2-(METHYLAMINO)ETHANONE	CNCC(=O)c1nnc(o1)C(C)(C)C
14604	sp|O07427|MGLL_MYC	O07015	89.25	14.0	263.0	DB02175	experimental	Malonic acid	OC(=O)CC(=O)O
14605	sp|O07427|MGLL_MYC	O07015	89.25	14.0	263.0	DB03297	experimental	Benzylsulfonic acid	OS(=O)(=O)Cc1ccccc1
14606	sp|O07427|MGLL_MYC	O07015	89.25	14.0	263.0	DB04349	experimental	(S)-propane-1,2-diol	C[C@H](O)CO
14607	sp|L0T911|PBPB_MYC	P0AD68	80.85	17.0	566.0	DB00267	approved	Cefmenoxime	Nc1nc(cs1)/C(=N/OC)C(=O)N[C@H](C2=O)[C@H](N23)SCC(=C3C(=O)O)CSc4nnnn4C
14608	sp|L0T911|PBPB_MYC	P0AD68	80.85	17.0	566.0	DB00274	approved; investigational	Cefmetazole	N#CCSCC(=O)N[C@@](C1=O)(OC)[C@H](N12)SCC(=C2C(=O)O)CSc3nnnn3C
14609	sp|L0T911|PBPB_MYC	P0AD68	80.85	17.0	566.0	DB00303	approved; investigational	Ertapenem	C[C@@H](O)[C@@H](C1=O)[C@H](N12)[C@@H](C)C(=C2C(=O)O)S[C@@H]3CN[C@@H](C3)C(=O)Nc4cccc(c4)C(=O)O
14610	sp|L0T911|PBPB_MYC	P0AD68	80.85	17.0	566.0	DB00430	approved	Cefpiramide	Cn1nnnc1SCC(=C2C(=O)O)CS[C@@H](N23)[C@@H](C3=O)NC(=O)[C@@H](c4ccc(O)cc4)NC(=O)c5c(O)cc(C)nc5
14611	sp|L0T911|PBPB_MYC	P0AD68	80.85	17.0	566.0	DB00438	approved	Ceftazidime	c1cccc[n+]1CC(=C2C([O-])=O)CS[C@@H](N23)[C@@H](C3=O)NC(=O)/C(=N\OC(C)(C)C(=O)O)c4csc(n4)N
14612	sp|L0T911|PBPB_MYC	P0AD68	80.85	17.0	566.0	DB01327	approved	Cefazolin	Cc1sc(nn1)SCC(=C2C(=O)O)CS[C@@H](N23)[C@@H](C3=O)NC(=O)Cn4cnnn4
14613	sp|L0T911|PBPB_MYC	P0AD68	80.85	17.0	566.0	DB01328	approved; investigational	Cefonicid	c1ccccc1[C@@H](O)C(=O)N[C@H](C2=O)[C@H](N23)SCC(=C3C(=O)O)CSc4nnnn4CS(=O)(=O)O
14614	sp|L0T911|PBPB_MYC	P0AD68	80.85	17.0	566.0	DB01329	approved; investigational	Cefoperazone	Cn1nnnc1SCC(=C2C(=O)O)CS[C@@H](N23)[C@@H](C3=O)NC(=O)[C@@H](c4ccc(O)cc4)NC(=O)N5CCN(CC)C(=O)C5=O
14615	sp|L0T911|PBPB_MYC	P0AD68	80.85	17.0	566.0	DB01331	approved	Cefoxitin	NC(=O)OCC(=C1C(=O)O)CS[C@@H](N12)[C@](C2=O)(OC)NC(=O)Cc3cccs3
14616	sp|L0T911|PBPB_MYC	P0AD68	80.85	17.0	566.0	DB01413	approved; investigational	Cefepime	Nc1nc(cs1)/C(=N/OC)C(=O)N[C@@H]2C(=O)N([C@@H]23)C(C([O-])=O)=C(CS3)C[N+]4(C)CCCC4
14617	sp|L0T911|PBPB_MYC	P0AD68	80.85	17.0	566.0	DB01415	approved; investigational	Ceftibuten	O=C(O)C1=CCS[C@@H](N12)[C@@H](C2=O)NC(=O)/C(=C\CC(=O)O)c3csc(n3)N
14618	sp|L0T911|PBPB_MYC	P0AD68	80.85	17.0	566.0	DB01416	approved; vet_approved	Cefpodoxime	COCC(=C1C(=O)O)CS[C@@H](N12)[C@@H](C2=O)NC(=O)/C(=N\OC)c3csc(n3)N
14619	sp|L0T911|PBPB_MYC	P0AD68	80.85	17.0	566.0	DB04918	approved; investigational	Ceftobiprole	Nc1nc(ns1)/C(=N/O)C(=O)N[C@@H]2C(=O)N([C@@H]23)C(C(=O)O)=C(CS3)/C=C4\CCN(C4=O)[C@@H]5CCNC5
14620	sp|L0T911|PBPB_MYC	P0AD68	80.85	17.0	566.0	DB00578	approved; investigational	Carbenicillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)C(C(=O)O)c3ccccc3
14621	sp|L0T911|PBPB_MYC	P0AD68	80.85	17.0	566.0	DB01000	approved	Cyclacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)C3(N)CCCCC3
14622	sp|L0T911|PBPB_MYC	P0AD68	80.85	17.0	566.0	DB01602	approved; investigational	Bacampicillin	CCOC(=O)OC(C)OC(=O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)[C@H](N)c3ccccc3
14623	sp|L0T911|PBPB_MYC	P0AD68	80.85	17.0	566.0	DB09050	approved; investigational	Ceftolozane	NCCNC(=O)Nc1c(N)n(C)[n+](c1)CC(CS2)=C(C([O-])=O)N([C@H]23)C(=O)[C@H]3NC(=O)/C(=N\OC(C)(C)C(=O)O)c4nsc(n4)N
14624	sp|L0T911|PBPB_MYC	P0AD68	80.85	17.0	566.0	DB09319	approved; investigational	Carindacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)C(c3ccccc3)C(=O)Oc(cc4)cc(c45)CCC5
14625	sp|L0T911|PBPB_MYC	P0AD69	80.85	17.0	566.0	DB05659	investigational	Faropenem medoxomil	C1CCO[C@H]1C(S[C@@H](N23)[C@H](C3=O)[C@@H](C)O)=C2C(=O)OCc4c(C)oc(=O)o4
14626	sp|L0T911|PBPB_MYC	Q51504	81.59	7.0	561.0	DB01147	approved; investigational; vet_approved	Cloxacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)c3c(C)onc3-c4ccccc4Cl
14627	sp|L0T911|PBPB_MYC	Q51504	81.59	7.0	561.0	DB01413	approved; investigational	Cefepime	Nc1nc(cs1)/C(=N/OC)C(=O)N[C@@H]2C(=O)N([C@@H]23)C(C([O-])=O)=C(CS3)C[N+]4(C)CCCC4
14628	sp|L0T911|PBPB_MYC	Q51504	81.59	7.0	561.0	DB06211	approved; investigational	Doripenem	C[C@@H](O)[C@@H](C1=O)[C@H](N12)[C@@H](C)C(=C2C(=O)O)S[C@@H]3CN[C@@H](C3)CNS(=O)(=O)N
14629	sp|L0T911|PBPB_MYC	Q51504	81.59	7.0	561.0	DB09050	approved; investigational	Ceftolozane	NCCNC(=O)Nc1c(N)n(C)[n+](c1)CC(CS2)=C(C([O-])=O)N([C@H]23)C(=O)[C@H]3NC(=O)/C(=N\OC(C)(C)C(=O)O)c4nsc(n4)N
14630	sp|L0T911|PBPB_MYC	Q51504	81.59	7.0	561.0	DB14879	approved; investigational	Cefiderocol	OC(=O)C(C)(C)O/N=C(/c1csc(n1)N)C(=O)N[C@H](C2=O)[C@H](N23)SCC(=C3C([O-])=O)C[N+]4(CCCC4)CCNC(=O)c5c(Cl)c(O)c(O)cc5
14631	sp|L0T911|PBPB_MYC	P45059	80.12	42.0	586.0	DB00303	approved; investigational	Ertapenem	C[C@@H](O)[C@@H](C1=O)[C@H](N12)[C@@H](C)C(=C2C(=O)O)S[C@@H]3CN[C@@H](C3)C(=O)Nc4cccc(c4)C(=O)O
14632	sp|L0T911|PBPB_MYC	Q60FT7	80.12	42.0	586.0	DB00535	approved	Cefdinir	O=C(O)C1=C(C=C)CS[C@@H](N12)[C@@H](C2=O)NC(=O)/C(=N\O)c3csc(n3)N
14633	sp|L0T911|PBPB_MYC	P08149	79.53	34.0	574.0	DB00535	approved	Cefdinir	O=C(O)C1=C(C=C)CS[C@@H](N12)[C@@H](C2=O)NC(=O)/C(=N\O)c3csc(n3)N
14634	sp|L0T911|PBPB_MYC	P0AD65	89.1	9.0	614.0	DB00578	approved; investigational	Carbenicillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)C(C(=O)O)c3ccccc3
14635	sp|L0T911|PBPB_MYC	P0AD65	89.1	9.0	614.0	DB01000	approved	Cyclacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)C3(N)CCCCC3
14636	sp|L0T911|PBPB_MYC	P0AD65	89.1	9.0	614.0	DB01602	approved; investigational	Bacampicillin	CCOC(=O)OC(C)OC(=O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)[C@H](N)c3ccccc3
14637	sp|L0T911|PBPB_MYC	P0AD65	89.1	9.0	614.0	DB09050	approved; investigational	Ceftolozane	NCCNC(=O)Nc1c(N)n(C)[n+](c1)CC(CS2)=C(C([O-])=O)N([C@H]23)C(=O)[C@H]3NC(=O)/C(=N\OC(C)(C)C(=O)O)c4nsc(n4)N
14638	sp|L0T911|PBPB_MYC	P0AD65	89.1	9.0	614.0	DB09319	approved; investigational	Carindacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)C(c3ccccc3)C(=O)Oc(cc4)cc(c45)CCC5
14639	sp|L0T911|PBPB_MYC	P0AD65	89.1	9.0	614.0	DB00303	approved; investigational	Ertapenem	C[C@@H](O)[C@@H](C1=O)[C@H](N12)[C@@H](C)C(=C2C(=O)O)S[C@@H]3CN[C@@H](C3)C(=O)Nc4cccc(c4)C(=O)O
14640	sp|L0T911|PBPB_MYC	P0AD65	89.1	9.0	614.0	DB00438	approved	Ceftazidime	c1cccc[n+]1CC(=C2C([O-])=O)CS[C@@H](N23)[C@@H](C3=O)NC(=O)/C(=N\OC(C)(C)C(=O)O)c4csc(n4)N
14641	sp|L0T911|PBPB_MYC	P0AD65	89.1	9.0	614.0	DB00948	approved; investigational	Mezlocillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)[C@@H](c3ccccc3)NC(=O)N4CCN(C4=O)S(=O)(=O)C
14642	sp|L0T911|PBPB_MYC	P0AD65	89.1	9.0	614.0	DB01163	investigational; withdrawn	Amdinocillin	C1CCCCCN1/C=N/[C@@H]2C(=O)N([C@@H]23)[C@H](C(S3)(C)C)C(=O)O
14643	sp|L0T911|PBPB_MYC	P0AD65	89.1	9.0	614.0	DB01327	approved	Cefazolin	Cc1sc(nn1)SCC(=C2C(=O)O)CS[C@@H](N23)[C@@H](C3=O)NC(=O)Cn4cnnn4
14644	sp|L0T911|PBPB_MYC	P0AD65	89.1	9.0	614.0	DB01328	approved; investigational	Cefonicid	c1ccccc1[C@@H](O)C(=O)N[C@H](C2=O)[C@H](N23)SCC(=C3C(=O)O)CSc4nnnn4CS(=O)(=O)O
14645	sp|L0T911|PBPB_MYC	P0AD65	89.1	9.0	614.0	DB01329	approved; investigational	Cefoperazone	Cn1nnnc1SCC(=C2C(=O)O)CS[C@@H](N23)[C@@H](C3=O)NC(=O)[C@@H](c4ccc(O)cc4)NC(=O)N5CCN(CC)C(=O)C5=O
14646	sp|L0T911|PBPB_MYC	P0AD65	89.1	9.0	614.0	DB01413	approved; investigational	Cefepime	Nc1nc(cs1)/C(=N/OC)C(=O)N[C@@H]2C(=O)N([C@@H]23)C(C([O-])=O)=C(CS3)C[N+]4(C)CCCC4
14647	sp|L0T911|PBPB_MYC	P0AD65	89.1	9.0	614.0	DB01415	approved; investigational	Ceftibuten	O=C(O)C1=CCS[C@@H](N12)[C@@H](C2=O)NC(=O)/C(=C\CC(=O)O)c3csc(n3)N
14648	sp|L0T911|PBPB_MYC	P0AD65	89.1	9.0	614.0	DB01598	approved	Imipenem	C[C@@H](O)[C@@H](C1=O)[C@H](N12)CC(=C2C(=O)O)SCC/N=C/N
14649	sp|L0T911|PBPB_MYC	P0AD65	89.1	9.0	614.0	DB06211	approved; investigational	Doripenem	C[C@@H](O)[C@@H](C1=O)[C@H](N12)[C@@H](C)C(=C2C(=O)O)S[C@@H]3CN[C@@H](C3)CNS(=O)(=O)N
14651	sp|L0T911|PBPB_MYC	Q9X6V3	88.07	13.0	611.0	DB00438	approved	Ceftazidime	c1cccc[n+]1CC(=C2C([O-])=O)CS[C@@H](N23)[C@@H](C3=O)NC(=O)/C(=N\OC(C)(C)C(=O)O)c4csc(n4)N
14652	sp|L0T911|PBPB_MYC	Q9X6V3	88.07	13.0	611.0	DB01413	approved; investigational	Cefepime	Nc1nc(cs1)/C(=N/OC)C(=O)N[C@@H]2C(=O)N([C@@H]23)C(C([O-])=O)=C(CS3)C[N+]4(C)CCCC4
14653	sp|L0T911|PBPB_MYC	Q9X6V3	88.07	13.0	611.0	DB14879	approved; investigational	Cefiderocol	OC(=O)C(C)(C)O/N=C(/c1csc(n1)N)C(=O)N[C@H](C2=O)[C@H](N23)SCC(=C3C([O-])=O)C[N+]4(CCCC4)CCNC(=O)c5c(Cl)c(O)c(O)cc5
14654	sp|L0T911|PBPB_MYC	P44469	89.25	19.0	625.0	DB00303	approved; investigational	Ertapenem	C[C@@H](O)[C@@H](C1=O)[C@H](N12)[C@@H](C)C(=C2C(=O)O)S[C@@H]3CN[C@@H](C3)C(=O)Nc4cccc(c4)C(=O)O
14655	sp|L0T911|PBPB_MYC	P44469	89.25	19.0	625.0	DB00671	approved; investigational	Cefixime	O=C(O)C1=C(C=C)CS[C@@H](N12)[C@@H](C2=O)NC(=O)/C(=N\OCC(=O)O)c3csc(n3)N
14656	sp|L0T911|PBPB_MYC	P59676	87.48	17.0	611.0	DB03190	experimental	6-o-Capryloylsucrose	O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@]2(CO)O[C@@H]([C@@H](O)[C@@H]2O)COC(=O)CCCCCCC
14657	sp|L0T911|PBPB_MYC	P14677	87.48	17.0	611.0	DB01150	approved	Cefprozil	C/C=C/C(=C1C(=O)O)CS[C@@H](N12)[C@@H](C2=O)NC(=O)[C@H](N)c3ccc(O)cc3
14658	sp|L0T911|PBPB_MYC	P14677	87.48	17.0	611.0	DB04918	approved; investigational	Ceftobiprole	Nc1nc(ns1)/C(=N/O)C(=O)N[C@@H]2C(=O)N([C@@H]23)C(C(=O)O)=C(CS3)/C=C4\CCN(C4=O)[C@@H]5CCNC5
14659	sp|L0T911|PBPB_MYC	Q7DHH4	76.14	137.0	654.0	DB04918	approved; investigational	Ceftobiprole	Nc1nc(ns1)/C(=N/O)C(=O)N[C@@H]2C(=O)N([C@@H]23)C(C(=O)O)=C(CS3)/C=C4\CCN(C4=O)[C@@H]5CCNC5
14660	sp|L0T911|PBPB_MYC	Q70KI2	86.89	7.0	597.0	DB00923	approved	Ceforanide	OC(=O)Cn1nnnc1SCC(=C2C(=O)O)CS[C@@H](N23)[C@@H](C3=O)NC(=O)Cc4ccccc4CN
14661	sp|L0T911|PBPB_MYC	Q70KI2	86.89	7.0	597.0	DB01326	approved; experimental	Cefamandole	Cn1nnnc1SCC(=C2C(=O)O)CS[C@@H](N23)[C@@H](C3=O)NC(=O)[C@H](O)c4ccccc4
14663	sp|L0T911|PBPB_MYC	P07944	76.44	137.0	656.0	DB02443	experimental	Methicillin Acyl-Serine	[O-]C(=O)[C@@H](N)COC(=O)[C@H]([C@@H](SC1(C)C)N[C@H]1C(=O)O)/N=C(\[O-])c2c(OC)cccc2OC
14664	sp|L0T911|PBPB_MYC	P07944	76.44	137.0	656.0	DB02968	experimental	Penicillin G Acyl-Serine	[O-]C(=O)[C@@H](N)COC(=O)[C@H]([C@@H](SC1(C)C)N[C@H]1C(=O)O)/N=C(\[O-])Cc2ccccc2
14665	sp|L0T911|PBPB_MYC	P07944	76.44	137.0	656.0	DB04041	experimental	Nitrocefin Acyl-Serine	O=N(=O)c1ccc(c(c1)N(=O)=O)/C=C/C2=C(C(=O)O)N[C@H](SC2)[C@@H](C(=O)OC[C@H](N)C([O-])=O)/N=C(\[O-])Cc3cccs3
14666	sp|L0T911|PBPB_MYC	P42971	74.52	146.0	652.0	DB00355	approved	Aztreonam	[O-]S(=O)(=O)N1C(=O)[C@H]([C@@H]1C)NC(=O)/C(=N\OC(C)(C)C(=O)O)c2csc(n2)[NH3+]
14667	sp|L0T911|PBPB_MYC	P42971	74.52	146.0	652.0	DB00493	approved	Cefotaxime	CC(=O)OCC(=C1C(=O)O)CS[C@@H](N12)[C@@H](C2=O)NC(=O)/C(=N\OC)c3csc(n3)N
14668	sp|L0T911|PBPB_MYC	P42971	74.52	146.0	652.0	DB01598	approved	Imipenem	C[C@@H](O)[C@@H](C1=O)[C@H](N12)CC(=C2C(=O)O)SCC/N=C/N
14669	sp|L0T911|PBPB_MYC	P42971	74.52	146.0	652.0	DB04570	approved; investigational	Latamoxef	Cn1nnnc1SCC(=C2C(=O)O)CO[C@@H](N23)[C@](C3=O)(OC)NC(=O)C(C(=O)O)c4ccc(O)cc4
14670	sp|L0T911|PBPB_MYC	A0A0H2XJ39	73.34	158.0	656.0	DB01053	approved; vet_approved	Benzylpenicillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)Cc3ccccc3
14671	sp|L0T911|PBPB_MYC	A0A0E1R3H3	73.2	171.0	668.0	DB00485	approved; investigational; vet_approved	Dicloxacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)c3c(C)onc3-c4c(Cl)cccc4Cl
14672	sp|P9WII5|MAZF4_MY	P96622	102.86	5.0	113.0	DB02042	experimental	2-(2-{2-[2-(2-Methoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol	COCCOCCOCCOCCOCCO
14674	sp|P9WII5|MAZF4_MY	P11021	80.95	512.0	597.0	DB00945	approved; vet_approved	Acetylsalicylic acid	CC(=O)Oc1ccccc1C(=O)O
14675	sp|P9WII5|MAZF4_MY	P11021	80.95	512.0	597.0	DB09130	approved; investigational	Copper	[Cu]
14678	sp|P9WII5|MAZF4_MY	P54652	83.81	490.0	578.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
14679	sp|P9WII5|MAZF4_MY	P11142	83.81	488.0	576.0	DB01254	approved; investigational	Dasatinib	OCCN1CCN(CC1)c2nc(C)nc(c2)Nc3ncc(s3)C(=O)Nc4c(C)cccc4Cl
14680	sp|P9WII5|MAZF4_MY	P11142	83.81	488.0	576.0	DB07045	experimental	(2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol	OC[C@@H](O1)[C@@H](O)[C@@H](O)[C@@H]1n2c(nc(c23)c(N)ncn3)NCc4ccc(Cl)c(Cl)c4
14681	sp|P9WII5|MAZF4_MY	P11142	83.81	488.0	576.0	DB09130	approved; investigational	Copper	[Cu]
14682	sp|P9WII5|MAZF4_MY	P11142	83.81	488.0	576.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
14683	sp|P9WGV1|METK_MYC	Q00266	93.8	14.0	392.0	DB00118	approved; investigational; nutraceutical	Ademetionine	[O-]C(=O)[C@@H](N)CC[S+](C)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
14684	sp|P9WGV1|METK_MYC	Q00266	93.8	14.0	392.0	DB03191	experimental	3-Oxiran-2ylalanine	OC(=O)[C@@H](N)C[C@H]1CO1
14685	sp|P9WGV1|METK_MYC	Q00266	93.8	14.0	392.0	DB03611	experimental	L-2-amino-4-methoxy-cis-but-3-enoic acid	CO/C=C\[C@H](N)C(=O)O
14686	sp|P9WGV1|METK_MYC	P31153	93.8	15.0	393.0	DB00118	approved; investigational; nutraceutical	Ademetionine	[O-]C(=O)[C@@H](N)CC[S+](C)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
14687	sp|P9WGV1|METK_MYC	Q7K6A4	96.77	9.0	399.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
14688	sp|P9WGV1|METK_MYC	P0A820	93.3	3.0	379.0	DB03075	experimental	(Diphosphono)Aminophosphonic Acid	OP(=O)(O)N[P@@](=O)(O)OP(=O)(O)O
14689	sp|P9WGV1|METK_MYC	P0A820	93.3	3.0	379.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
14690	sp|P9WGV1|METK_MYC	P0A820	93.3	3.0	379.0	DB04554	experimental	8-Bromoadenosine-5'-Diphosphate	OP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2c(Br)nc(c23)c(N)ncn3
14691	sp|P9WJL3|MURE_MYC	P22188	88.6	19.0	493.0	DB02314	experimental	Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine-D-Glutamate	OC(=O)CC[C@H](C(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)O[C@@H]([C@@H]1NC(=O)C)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
14692	sp|P9WJL3|MURE_MYC	P22188	88.6	19.0	493.0	DB03590	experimental	2,6-Diaminopimelic Acid	OC(=O)[C@@H](N)CCC[C@H](N)C(=O)O
14693	sp|P9WJL3|MURE_MYC	P22188	88.6	19.0	493.0	DB03801	experimental	Lysine Nz-Carboxylic Acid	OC(=O)[C@@H](N)CCCCNC(=O)O
14694	sp|P9WJL7|MURC_MYC	P45066	92.71	9.0	467.0	DB01673	experimental	Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine	OC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)O[C@@H]([C@@H]1NC(=O)C)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
14695	sp|P9WJL7|MURC_MYC	P45066	92.71	9.0	467.0	DB03909	experimental	Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate	OP(=O)(O)CP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
14696	sp|P9WJL7|MURC_MYC	P45066	92.71	9.0	467.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
14697	sp|P9WJL7|MURC_MYC	P22188	70.24	28.0	375.0	DB02314	experimental	Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine-D-Glutamate	OC(=O)CC[C@H](C(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)O[C@@H]([C@@H]1NC(=O)C)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
14698	sp|P9WJL7|MURC_MYC	P22188	70.24	28.0	375.0	DB03590	experimental	2,6-Diaminopimelic Acid	OC(=O)[C@@H](N)CCC[C@H](N)C(=O)O
14699	sp|P9WJL7|MURC_MYC	P22188	70.24	28.0	375.0	DB03801	experimental	Lysine Nz-Carboxylic Acid	OC(=O)[C@@H](N)CCCCNC(=O)O
14700	sp|P9WII9|PDXS_MYC	C6KT50	92.98	3.0	281.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
14701	sp|P9WI93|PHS_MYCT	P61457	95.74	8.0	98.0	DB04400	experimental	L-erythro-7,8-dihydrobiopterin	C[C@H](O)[C@H](O)C(CN1)=Nc(c12)c(=O)nc([nH]2)N
14702	sp|P9WPF5|PKS10_MY	P9WPF1	100.57	33.0	388.0	DB08231	experimental	Myristic acid	CCCCCCCCCCCCCC(=O)O
14703	sp|P9WPF5|PKS10_MY	P0A6R0	83.0	23.0	316.0	DB01034	experimental	Cerulenin	NC(=O)[C@@H]1O[C@@H]1C(=O)CC/C=C/C/C=C/C
14704	sp|P9WPF5|PKS10_MY	P0A6R0	83.0	23.0	316.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
14705	sp|P9WPF5|PKS10_MY	P0A6R0	83.0	23.0	316.0	DB02039	experimental	S-Acetyl-Cysteine	OC(=O)[C@@H](N)CSC(=O)C
14706	sp|P9WPF5|PKS10_MY	P0A6R0	83.0	23.0	316.0	DB02316	experimental	1-(5-Carboxypentyl)-5-[(2,6-Dichlorobenzyl)Oxy]-1 H-Indole-2-Carboxylic Acid	OC(=O)CCCCCn1c(C(=O)O)cc(c12)cc(cc2)OCc3c(Cl)cccc3Cl
14707	sp|P9WPF5|PKS10_MY	P0A6R0	83.0	23.0	316.0	DB03661	experimental	L-cysteic acid	OC(=O)[C@@H](N)CS(=O)(=O)O
14708	sp|P9WPF5|PKS10_MY	P0A6R0	83.0	23.0	316.0	DB04524	experimental	Malonyl-CoA	OC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
14709	sp|P9WPF5|PKS10_MY	Q820T1	83.0	26.0	319.0	DB07429	experimental	2-({[4-bromo-3-(diethylsulfamoyl)phenyl]carbonyl}amino)benzoic acid	CCN(CC)S(=O)(=O)c1cc(ccc1Br)C(=O)Nc2ccccc2C(=O)O
14710	sp|P9WPF5|PKS10_MY	P9WNG3	83.57	36.0	331.0	DB03017	approved; experimental	Lauric acid	CCCCCCCCCCCC(=O)O
14711	sp|P9WPF5|PKS10_MY	P9WNG3	83.57	36.0	331.0	DB03264	experimental	Dodecyl-Coa	CCCCCCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
14712	sp|P9WPF5|PKS10_MY	P9WNG3	83.57	36.0	331.0	DB07611	experimental	DECANE-1-THIOL	CCCCCCCCCCS
14713	sp|P9WPF5|PKS10_MY	P9WNG3	83.57	36.0	331.0	DB07650	experimental	Decyl formate	CCCCCCCCCCOC=O
14714	sp|P9WPF5|PKS10_MY	P9WNG3	83.57	36.0	331.0	DB08171	experimental	11-MERCAPTOUNDECANOIC ACID	OC(=O)CCCCCCCCCCS
14715	sp|P9WPF5|PKS10_MY	P9WNG3	83.57	36.0	331.0	DB08684	experimental	O-Decyl Hydrogen Thiocarbonate	CCCCCCCCCCOC(=O)S
14716	sp|P9WPF5|PKS10_MY	P9WNG3	83.57	36.0	331.0	DB08712	experimental	11-[(MERCAPTOCARBONYL)OXY]UNDECANOIC ACID	OC(=O)CCCCCCCCCCOC(=O)S
14717	sp|P9WPF5|PKS10_MY	Q9F6D4	82.44	35.0	326.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
14718	sp|P9WN49|GLMS_MYC	P17169	97.44	1.0	609.0	DB02007	experimental	alpha-D-glucose 6-phosphate	O[C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O)COP(=O)(O)O
14719	sp|P9WN49|GLMS_MYC	P17169	97.44	1.0	609.0	DB02445	experimental	2-Deoxy-2-Amino Glucitol-6-Phosphate	OC[C@H](N)[C@@H](O)[C@H](O)[C@H](O)COP(=O)(O)O
14720	sp|P9WN49|GLMS_MYC	P17169	97.44	1.0	609.0	DB02446	experimental	Glutamine hydroxamate	OC(=O)[C@@H](N)CCC(=O)NO
14721	sp|P9WN49|GLMS_MYC	P17169	97.44	1.0	609.0	DB02657	experimental	Glucosamine 6-Phosphate	N[C@H]1[C@@H](O)O[C@@H]([C@@H](O)[C@@H]1O)COP(=O)(O)O
14722	sp|P9WN49|GLMS_MYC	P17169	97.44	1.0	609.0	DB03581	experimental	Glucose-6-Phosphate	OP(=O)(O)OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C=O
14723	sp|P9WN49|GLMS_MYC	P17169	97.44	1.0	609.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
14724	sp|P9WMN3|GLMU_MYC	P43889	90.3	4.0	451.0	DB08344	experimental	4-chloro-N-(3-methoxypropyl)-N-[(3S)-1-(2-phenylethyl)piperidin-3-yl]benzamide	Clc1ccc(cc1)C(=O)N(CCCOC)[C@H]2CCCN(C2)CCc3ccccc3
14725	sp|P9WMN3|GLMU_MYC	P0ACC7	90.3	4.0	451.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
14726	sp|P9WMN3|GLMU_MYC	P0ACC7	90.3	4.0	451.0	DB03397	experimental	Uridine-Diphosphate-N-Acetylglucosamine	CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
14727	sp|P9WMN3|GLMU_MYC	P0ACC7	90.3	4.0	451.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
14728	sp|P9WMN3|GLMU_MYC	Q97R46	91.52	5.0	458.0	DB03397	experimental	Uridine-Diphosphate-N-Acetylglucosamine	CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
14730	sp|P9WMP3|HEM3_MYC	P06983	97.09	6.0	306.0	DB04517	experimental	Dipyrromethane Cofactor	OC(=O)Cc1c(C)[nH]c(c1CCC(=O)O)Cc2c(CC(=O)O)c(c[nH]2)CCC(=O)O
14731	sp|P9WQ75|ILVE_MYC	P54687	95.38	31.0	382.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
14732	sp|P9WQ75|ILVE_MYC	P54687	95.38	31.0	382.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
14733	sp|P9WQ75|ILVE_MYC	P54687	95.38	31.0	382.0	DB00149	investigational; nutraceutical	Leucine	CC(C)C[C@H](N)C(=O)O
14734	sp|P9WQ75|ILVE_MYC	P54687	95.38	31.0	382.0	DB00161	approved; nutraceutical	Valine	CC(C)[C@H](N)C(=O)O
14735	sp|P9WQ75|ILVE_MYC	P54687	95.38	31.0	382.0	DB00167	investigational; nutraceutical	Isoleucine	CC[C@H](C)[C@H](N)C(=O)O
14736	sp|P9WQ75|ILVE_MYC	P54687	95.38	31.0	382.0	DB07544	experimental	N'-(5-CHLOROBENZOFURAN-2-CARBONYL)-2-(TRIFLUOROMETHYL)BENZENESULFONOHYDRAZIDE	FC(F)(F)c1ccccc1S(=O)(=O)NNC(=O)c(o2)cc(c23)cc(Cl)cc3
14737	sp|P9WQ75|ILVE_MYC	O15382	91.85	51.0	389.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
14738	sp|P9WQ75|ILVE_MYC	O15382	91.85	51.0	389.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
14739	sp|P9WQ75|ILVE_MYC	O15382	91.85	51.0	389.0	DB00149	investigational; nutraceutical	Leucine	CC(C)C[C@H](N)C(=O)O
14740	sp|P9WQ75|ILVE_MYC	O15382	91.85	51.0	389.0	DB00167	investigational; nutraceutical	Isoleucine	CC[C@H](C)[C@H](N)C(=O)O
14741	sp|P9WQ75|ILVE_MYC	O15382	91.85	51.0	389.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
14742	sp|P9WQ75|ILVE_MYC	O15382	91.85	51.0	389.0	DB02635	experimental	N-[O-Phosphono-Pyridoxyl]-Isoleucine	CC[C@H](C)[C@H](C(=O)O)NCc1c(COP(=O)(O)O)cnc(C)c1O
14743	sp|P9WQ75|ILVE_MYC	O15382	91.85	51.0	389.0	DB04074	experimental	alpha-Ketoisovalerate	CC(C)C(=O)C(=O)O
14744	sp|P9WQ75|ILVE_MYC	P0AB80	81.79	6.0	307.0	DB01813	experimental	Pyridoxyl-Glutamic Acid-5'-Monophosphate	OC(=O)CC[C@@H](C(=O)O)NCc1c(COP(=O)(O)O)c[nH+]c(C)c1O
14745	sp|P9WQ75|ILVE_MYC	P0AB80	81.79	6.0	307.0	DB03553	experimental	Glutaric Acid	OC(=O)CCCC(=O)O
14746	sp|P9WQ75|ILVE_MYC	P0AB80	81.79	6.0	307.0	DB03993	experimental	Isocaproic acid	CC(C)CCC(=O)O
14747	sp|P9WQ75|ILVE_MYC	P0AB80	81.79	6.0	307.0	DB04063	experimental	alpha-Methylleucine	CC(C)C[C@](C)(N)C(=O)O
14748	sp|P9WK09|MYMT_MYC	Q02155	71.7	234.0	272.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
14749	sp|P9WIS7|ODP2_MYC	P10802	78.84	195.0	631.0	DB01846	experimental	Oxidized coenzyme A	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSO
14750	sp|P9WIS7|ODP2_MYC	P10802	78.84	195.0	631.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
14751	sp|P9WIS7|ODP2_MYC	P10802	78.84	195.0	631.0	DB08120	experimental	6,8-DIMERCAPTO-OCTANOIC ACID AMIDE	SCC[C@H](S)CCCCC(=O)N
14752	sp|P9WIS7|ODP2_MYC	P10515	99.1	93.0	641.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
14753	sp|P9WIS7|ODP2_MYC	P10515	99.1	93.0	641.0	DB03758	experimental	Radicicol	Oc1cc(O)c(Cl)c(c12)CC(=O)/C=C/C=C\[C@@H]3[C@H](O3)C[C@@H](C)OC2=O
14754	sp|P9WIS7|ODP2_MYC	P10515	99.1	93.0	641.0	DB03760	experimental	Dihydrolipoic Acid	SCC[C@H](S)CCCCC(=O)O
14755	sp|P9WIL7|PANB_MYC	Q9JZW6	92.17	2.0	261.0	DB04074	experimental	alpha-Ketoisovalerate	CC(C)C(=O)C(=O)O
14756	sp|P9WIL7|PANB_MYC	P31057	91.46	6.0	263.0	DB03795	experimental	2-Dehydropantoate	OCC(C)(C)C(=O)C(=O)O
14757	sp|P9WPF3|PKS11_MY	P9WPF1	100.28	33.0	387.0	DB08231	experimental	Myristic acid	CCCCCCCCCCCCCC(=O)O
14758	sp|P9WPF3|PKS11_MY	Q820T1	80.45	35.0	319.0	DB07429	experimental	2-({[4-bromo-3-(diethylsulfamoyl)phenyl]carbonyl}amino)benzoic acid	CCN(CC)S(=O)(=O)c1cc(ccc1Br)C(=O)Nc2ccccc2C(=O)O
14759	sp|P9WPF3|PKS11_MY	P0A6R0	83.0	24.0	317.0	DB01034	experimental	Cerulenin	NC(=O)[C@@H]1O[C@@H]1C(=O)CC/C=C/C/C=C/C
14760	sp|P9WPF3|PKS11_MY	P0A6R0	83.0	24.0	317.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
14761	sp|P9WPF3|PKS11_MY	P0A6R0	83.0	24.0	317.0	DB02039	experimental	S-Acetyl-Cysteine	OC(=O)[C@@H](N)CSC(=O)C
14762	sp|P9WPF3|PKS11_MY	P0A6R0	83.0	24.0	317.0	DB02316	experimental	1-(5-Carboxypentyl)-5-[(2,6-Dichlorobenzyl)Oxy]-1 H-Indole-2-Carboxylic Acid	OC(=O)CCCCCn1c(C(=O)O)cc(c12)cc(cc2)OCc3c(Cl)cccc3Cl
14763	sp|P9WPF3|PKS11_MY	P0A6R0	83.0	24.0	317.0	DB03661	experimental	L-cysteic acid	OC(=O)[C@@H](N)CS(=O)(=O)O
14764	sp|P9WPF3|PKS11_MY	P0A6R0	83.0	24.0	317.0	DB04524	experimental	Malonyl-CoA	OC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
14765	sp|P9WPF3|PKS11_MY	P9WNG3	81.3	44.0	331.0	DB03017	approved; experimental	Lauric acid	CCCCCCCCCCCC(=O)O
14766	sp|P9WPF3|PKS11_MY	P9WNG3	81.3	44.0	331.0	DB03264	experimental	Dodecyl-Coa	CCCCCCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
14767	sp|P9WPF3|PKS11_MY	P9WNG3	81.3	44.0	331.0	DB07611	experimental	DECANE-1-THIOL	CCCCCCCCCCS
14768	sp|P9WPF3|PKS11_MY	P9WNG3	81.3	44.0	331.0	DB07650	experimental	Decyl formate	CCCCCCCCCCOC=O
14769	sp|P9WPF3|PKS11_MY	P9WNG3	81.3	44.0	331.0	DB08171	experimental	11-MERCAPTOUNDECANOIC ACID	OC(=O)CCCCCCCCCCS
14770	sp|P9WPF3|PKS11_MY	P9WNG3	81.3	44.0	331.0	DB08684	experimental	O-Decyl Hydrogen Thiocarbonate	CCCCCCCCCCOC(=O)S
14771	sp|P9WPF3|PKS11_MY	P9WNG3	81.3	44.0	331.0	DB08712	experimental	11-[(MERCAPTOCARBONYL)OXY]UNDECANOIC ACID	OC(=O)CCCCCCCCCCOC(=O)S
14772	sp|P9WPF3|PKS11_MY	Q9F6D4	80.45	44.0	328.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
14773	sp|P9WH61|RS13_MYC	P80377	98.39	1.0	123.0	DB08185	experimental	2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(nc(n3)SC)NCCC(C)C
14774	sp|P9WH61|RS13_MYC	P0A7S9	92.74	1.0	116.0	DB00560	approved	Tigecycline	O=C1C(C(=O)N)=C(O)[C@@H](N(C)C)[C@@H]([C@@]12O)C[C@H]3C(=C2O)C(=O)c4c(C3)c(N(C)C)cc(c4O)NC(=O)CNC(C)(C)C
14775	sp|P9WJM7|MSHD_MYC	P9WJM7	99.68	1.0	315.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
14776	sp|P9WHU7|P5CR_MYC	Q96C36	90.17	3.0	269.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
14777	sp|P9WHU7|P5CR_MYC	Q96C36	90.17	3.0	269.0	DB00172	nutraceutical	Proline	OC(=O)[C@@H]1CCCN1
14778	sp|P9WHU7|P5CR_MYC	P32322	90.17	3.0	269.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
14779	sp|P9WHU7|P5CR_MYC	P32322	90.17	3.0	269.0	DB00172	nutraceutical	Proline	OC(=O)[C@@H]1CCCN1
14780	sp|P9WHU7|P5CR_MYC	Q53H96	88.81	10.0	272.0	DB00172	nutraceutical	Proline	OC(=O)[C@@H]1CCCN1
14781	sp|P9WHU7|P5CR_MYC	Q4W8W1	89.83	3.0	268.0	DB00172	nutraceutical	Proline	OC(=O)[C@@H]1CCCN1
14782	sp|P9WGM3|PDTAR_MY	O32393	70.73	835.0	980.0	DB02355	experimental	Adenosine-5'-Rp-Alpha-Thio-Triphosphate	OP(=O)(O)OP(=O)(O)O[P@@](=S)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
14783	sp|P9WGM3|PDTAR_MY	O32393	70.73	835.0	980.0	DB02596	experimental	alpha,beta-Methyleneadenosine 5'-triphosphate	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)CP(=O)(O)OP(=O)(O)O
14784	sp|P9WGM3|PDTAR_MY	O32393	70.73	835.0	980.0	DB07706	experimental	2-Hydroxyestradiol	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)c(c4)O
14785	sp|P9WH73|RIR2A_MY	Q9CBQ2	98.76	7.0	325.0	DB04272	approved; nutraceutical; vet_approved	Citric acid	OC(=O)CC(O)(C(=O)O)CC(=O)O
14786	sp|P9WH73|RIR2A_MY	P31350	77.64	92.0	342.0	DB00242	approved; investigational	Cladribine	Clc(n1)nc(N)c(c12)ncn2[C@H]3C[C@H](O)[C@H](O3)CO
14787	sp|P9WH73|RIR2A_MY	P31350	77.64	92.0	342.0	DB05003	investigational	Imexon	N12C(C1)C(N)=NC2=O
14788	sp|P9WH73|RIR2A_MY	P31350	77.64	92.0	342.0	DB05260	approved; investigational	Gallium nitrate	[O-][N+]([O-])=O
14789	sp|P9WH73|RIR2A_MY	P31350	77.64	92.0	342.0	DB05428	investigational	Motexafin gadolinium	CCc(c12)c(CC)c([n-]1)cc3nc(c(C)c3CCCO)cnc4c(ncc5nc(c2)c(c5C)CCCO)cc(OCCOCCOCCOC)c(c4)OCCOCCOCCOC
14790	sp|P9WH73|RIR2A_MY	P31350	77.64	92.0	342.0	DB05801	investigational	GTI 2040	 
14791	sp|P9WH73|RIR2A_MY	Q7LG56	78.26	54.0	306.0	DB00242	approved; investigational	Cladribine	Clc(n1)nc(N)c(c12)ncn2[C@H]3C[C@H](O)[C@H](O3)CO
14792	sp|P9WH73|RIR2A_MY	P9WH69	79.19	20.0	275.0	DB08231	experimental	Myristic acid	CCCCCCCCCCCCCC(=O)O
14793	sp|P9WJJ9|NADB_MYC	P31040	106.07	56.0	615.0	DB04141	experimental	2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol	O[C@H]1[C@@H](O)[C@@H](CO)O[C@H]([C@@H]1O)OCCCCCC
14794	sp|P9WJJ9|NADB_MYC	P31040	106.07	56.0	615.0	DB04657	approved; experimental	Carboxin	S1CCOC(C)=C1C(=O)Nc2ccccc2
14795	sp|P9WJJ9|NADB_MYC	P31040	106.07	56.0	615.0	DB04795	experimental	Thenoyltrifluoroacetone	FC(F)(F)C(=O)CC(=O)c1cccs1
14796	sp|P9WJJ9|NADB_MYC	P31040	106.07	56.0	615.0	DB08689	experimental	Ubiquinone Q1	COC1=C(OC)C(=O)C(=C(C)C1=O)CC=C(C)C
14797	sp|P9WJJ9|NADB_MYC	P31040	106.07	56.0	615.0	DB09270	approved; investigational; nutraceutical	Ubidecarenone	COC1=C(OC)C(=O)C(=C(C)C1=O)C/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CCC=C(C)C
14798	sp|P9WJJ9|NADB_MYC	P0AC41	103.8	6.0	553.0	DB04631	experimental	Atpenin A5	ClC[C@H](Cl)[C@@H](C)C[C@H](C)C(=O)c1c(O)c(OC)c([nH]c1=O)OC
14799	sp|P9WJJ9|NADB_MYC	P0AC41	103.8	6.0	553.0	DB07671	experimental	2-[1-METHYLHEXYL]-4,6-DINITROPHENOL	CCCCCC(C)c1c(O)c(N(=O)=O)cc(c1)N(=O)=O
14800	sp|P9WJJ9|NADB_MYC	P0AC41	103.8	6.0	553.0	DB08690	experimental	Ubiquinone Q2	COC1=C(OC)C(=O)C(=C(C)C1=O)C/C=C(\C)CCC=C(C)C
14801	sp|P9WJJ9|NADB_MYC	P10902	100.38	6.0	535.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
14802	sp|P9WJJ9|NADB_MYC	P00363	102.66	5.0	546.0	DB00730	approved; vet_approved	Thiabendazole	c1scnc1-c(n2)[nH]c(c23)cccc3
14803	sp|P9WJJ9|NADB_MYC	P00363	102.66	5.0	546.0	DB07490	experimental	2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL	Clc1ccc(cc1)[C@@H](C)c2cc([N+]([O-])=O)cc([N+]([O-])=O)c2O
14804	sp|P9WJJ9|NADB_MYC	P00363	102.66	5.0	546.0	DB07918	experimental	2-heptyl-4-hydroxyquinoline N-oxide	CCCCCCCc(cc1O)[n+]([O-])c(c12)cccc2
14805	sp|P9WJJ9|NADB_MYC	P17412	104.93	4.0	557.0	DB07669	experimental	2,3-Dimethyl-1,4-naphthoquinone	O=C1C(C)=C(C)C(=O)c(c12)cccc2
14806	sp|P9WIW7|NUOA_MYC	P03897	87.5	1.0	113.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
14807	sp|P9WIW7|NUOA_MYC	Q34522	77.34	17.0	116.0	DB12245	approved; investigational	Triclabendazole	CSc([nH]1)nc(c12)cc(c(Cl)c2)Oc3cccc(Cl)c3Cl
14808	sp|P9WIX3|NUOK_MYC	P03901	94.95	3.0	97.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
14809	sp|P9WHE7|RL10_MYC	P0A7J6	80.34	6.0	149.0	DB00778	approved; investigational; withdrawn	Roxithromycin	COCCOCO/N=C([C@H](C)[C@@H](O)[C@]1(C)O)/[C@H](C)C[C@@](C)(O)[C@@H]([C@@H](C)[C@@H]([C@@H](C)C(=O)O[C@@H]1CC)O[C@@H](C[C@@]2(C)OC)O[C@@H](C)[C@@H]2O)O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C
14810	sp|P9WHE7|RL10_MYC	P0A7J6	80.34	6.0	149.0	DB01211	approved	Clarithromycin	C[C@]1(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(OC)[C@@H]([C@@H](C)[C@@H]([C@@H](C)C(=O)O[C@@H]1CC)O[C@@H](C[C@@]2(C)OC)O[C@@H](C)[C@@H]2O)O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C
14811	sp|P9WHE7|RL10_MYC	P0A7J6	80.34	6.0	149.0	DB01369	approved	Quinupristin	Oc1cccnc1C(=O)N[C@H](C(=O)N[C@@H](C2=O)CC)[C@@H](C)OC(=O)[C@H](c3ccccc3)NC(=O)[C@H](CC(=O)[C@@H](C4)CS[C@H](CN56)C(CC5)CC6)N4C(=O)[C@@H](N(C)C(=O)[C@@H](N27)CCC7)Cc8ccc(cc8)N(C)C
14812	sp|P9WHE7|RL10_MYC	P0A7J6	80.34	6.0	149.0	DB01627	approved; vet_approved	Lincomycin	CCC[C@H]1CN(C)[C@@H](C1)C(=O)N[C@H]([C@@H](C)O)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O
14813	sp|P9WIL3|PAND_MYC	P0A793	81.29	1.0	114.0	DB02175	experimental	Malonic acid	OC(=O)CC(=O)O
14814	sp|P9WIL3|PAND_MYC	P0A793	81.29	1.0	114.0	DB03382	experimental	S-oxy-L-cysteine	OC(=O)[C@@H](N)CS=O
14815	sp|P9WIJ1|PDXH_MYC	P0AFI7	89.73	6.0	207.0	DB03247	approved; investigational	Flavin mononucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)COP(=O)(O)O
14816	sp|P9WIJ1|PDXH_MYC	P0AFI7	89.73	6.0	207.0	DB03345	experimental	Mercaptoethanol	OCCS
14817	sp|P9WIJ1|PDXH_MYC	Q9NVS9	90.18	33.0	235.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
14818	sp|P9WIJ1|PDXH_MYC	Q9NVS9	90.18	33.0	235.0	DB03247	approved; investigational	Flavin mononucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)COP(=O)(O)O
14819	sp|P9WIJ1|PDXH_MYC	Q9NVS9	90.18	33.0	235.0	DB03345	experimental	Mercaptoethanol	OCCS
14820	sp|P9WIJ1|PDXH_MYC	O69755	81.25	21.0	203.0	DB03247	approved; investigational	Flavin mononucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)COP(=O)(O)O
14821	sp|P9WIJ1|PDXH_MYC	Q51793	81.25	29.0	211.0	DB03247	approved; investigational	Flavin mononucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)COP(=O)(O)O
14822	sp|P9WIL5|PANC_MYC	P9WIL5	99.68	1.0	309.0	DB01930	experimental	2,4-Dihydroxy-3,3-Dimethyl-Butyrate	OCC(C)(C)[C@@H](O)C([O-])=O
14823	sp|P9WIL5|PANC_MYC	P9WIL5	99.68	1.0	309.0	DB02596	experimental	alpha,beta-Methyleneadenosine 5'-triphosphate	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)CP(=O)(O)OP(=O)(O)O
14824	sp|P9WIL5|PANC_MYC	P9WIL5	99.68	1.0	309.0	DB02694	experimental	Pantoyl Adenylate	OCC(C)(C)[C@@H](O)C(=O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
14825	sp|P9WIL5|PANC_MYC	P9WIL5	99.68	1.0	309.0	DB03107	experimental	beta-Alanine	NCCC(=O)O
14826	sp|P9WIL5|PANC_MYC	Q5SHF5	87.06	5.0	274.0	DB03570	experimental	Tris-Hydroxymethyl-Methyl-Ammonium	OC[N+](C)(CO)CO
14827	sp|P9WHN9|PHP_MYCT	P0A433	98.77	36.0	358.0	DB02127	experimental	Diisopropyl methylphosphonate	CC(C)OP(=O)(C)OC(C)C
14828	sp|P9WHN9|PHP_MYCT	P0A433	98.77	36.0	358.0	DB02138	experimental	Diethyl 4-Methylbenzylphosphonate	CCOP(=O)(OCC)Cc1ccc(C)cc1
14829	sp|P9WHN9|PHP_MYCT	P0A433	98.77	36.0	358.0	DB02192	experimental	Phenylethyl alcohol	OCCc1ccccc1
14830	sp|P9WHN9|PHP_MYCT	P0A433	98.77	36.0	358.0	DB02437	experimental	(5r)-5-Amino-6-Hydroxyhexylcarbamic Acid	OC[C@@H](N)CCCCNC(=O)O
14831	sp|P9WHN9|PHP_MYCT	P0A433	98.77	36.0	358.0	DB03347	experimental	Triethyl phosphate	CCOP(=O)(OCC)OCC
14832	sp|P9WHN9|PHP_MYCT	P0A433	98.77	36.0	358.0	DB03801	experimental	Lysine Nz-Carboxylic Acid	OC(=O)[C@@H](N)CCCCNC(=O)O
14833	sp|P9WHN9|PHP_MYCT	P0A433	98.77	36.0	358.0	DB03822	experimental	Ethyl dihydrogen phosphate	CCOP(=O)(O)O
14834	sp|P9WHN9|PHP_MYCT	P0A434	98.77	36.0	358.0	DB02127	experimental	Diisopropyl methylphosphonate	CC(C)OP(=O)(C)OC(C)C
14835	sp|P9WHN9|PHP_MYCT	P0A434	98.77	36.0	358.0	DB02138	experimental	Diethyl 4-Methylbenzylphosphonate	CCOP(=O)(OCC)Cc1ccc(C)cc1
14836	sp|P9WHN9|PHP_MYCT	P0A434	98.77	36.0	358.0	DB03347	experimental	Triethyl phosphate	CCOP(=O)(OCC)OCC
14837	sp|P9WHN9|PHP_MYCT	Q93LD7	98.47	36.0	357.0	DB04687	experimental	DIMETHYL THIOPHOSPHATE	COP(=S)(O)OC
14838	sp|P9WHN9|PHP_MYCT	Q93LD7	98.47	36.0	357.0	DB07674	experimental	O,O-DIETHYL HYDROGEN THIOPHOSPHATE	CCOP(=S)(O)OCC
14839	sp|P9WHN9|PHP_MYCT	Q93LD7	98.47	36.0	357.0	DB07721	experimental	DIETHYL 4-METHOXYPHENYL PHOSPHATE	CCOP(=O)(OCC)Oc1ccc(OC)cc1
14840	sp|P9WH41|RS20_MYC	P80380	93.02	11.0	91.0	DB08185	experimental	2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(nc(n3)SC)NCCC(C)C
14841	sp|P9WH41|RS20_MYC	P62661	93.02	11.0	91.0	DB08185	experimental	2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(nc(n3)SC)NCCC(C)C
14842	sp|P9WK87|NLHH_MYC	Q7SIG1	95.92	3.0	309.0	DB02776	experimental	1-Hexadecanosulfonic Acid	CCCCCCCCCCCCCCCCS(=O)(=O)O
14843	sp|P9WML5|PATR_MYC	Q56232	98.3	33.0	380.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
14844	sp|P9WML5|PATR_MYC	Q56232	98.3	33.0	380.0	DB04299	experimental	Maleic Acid	OC(=O)/C=C\C(=O)O
14845	sp|P9WML5|PATR_MYC	Q9X0D0	86.69	24.0	330.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
14846	sp|P9WML5|PATR_MYC	Q9X0D0	86.69	24.0	330.0	DB03997	experimental	L-histidinol phosphate	OP(=O)(O)OC[C@@H](N)Cc1c[nH]cn1
14847	sp|P9WML5|PATR_MYC	P97084	93.77	20.0	351.0	DB02482	experimental	Phosphonothreonine	OC(=O)[C@H](N)[C@H](C)OP(=O)(O)O
14848	sp|P9WML5|PATR_MYC	P97084	93.77	20.0	351.0	DB03433	experimental	{3-[(3-Hydroxy-2-Methyl-5-Phosphonooxymethyl-Pyridin-4-Ylmethyl)-Amino]-2-Methyl-Propyl}-Phosphonic Acid	OP(=O)(O)O[C@H](C)CNCc1c(O)c(C)ncc1COP(=O)(O)O
14849	sp|P9WML5|PATR_MYC	Q16773	90.65	27.0	347.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
14850	sp|P9WML5|PATR_MYC	Q16773	90.65	27.0	347.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
14851	sp|P9WML5|PATR_MYC	Q16773	90.65	27.0	347.0	DB02556	experimental	D-Phenylalanine	OC(=O)[C@H](N)Cc1ccccc1
14852	sp|P9WML5|PATR_MYC	Q16773	90.65	27.0	347.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
14853	sp|P9WML5|PATR_MYC	Q16773	90.65	27.0	347.0	DB07950	experimental	Indoleacetic acid	OC(=O)Cc1c[nH]c(c12)cccc2
14854	sp|P9WML5|PATR_MYC	Q6YP21	91.78	61.0	385.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
14855	sp|P9WML5|PATR_MYC	Q75WK2	96.32	24.0	364.0	DB02024	experimental	3-phenylpropionic acid	OC(=O)CCc1ccccc1
14856	sp|P9WML5|PATR_MYC	Q75WK2	96.32	24.0	364.0	DB02238	experimental	4-methylthio-2-oxobutanoic acid	CSCCC(=O)C(=O)O
14857	sp|P9WML5|PATR_MYC	P06986	86.12	44.0	348.0	DB01813	experimental	Pyridoxyl-Glutamic Acid-5'-Monophosphate	OC(=O)CC[C@@H](C(=O)O)NCc1c(COP(=O)(O)O)c[nH+]c(C)c1O
14858	sp|P9WML5|PATR_MYC	P06986	86.12	44.0	348.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
14859	sp|P9WML5|PATR_MYC	P06986	86.12	44.0	348.0	DB03997	experimental	L-histidinol phosphate	OP(=O)(O)OC[C@@H](N)Cc1c[nH]cn1
14860	sp|P9WML5|PATR_MYC	P33447	100.28	52.0	406.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
14861	sp|P9WML5|PATR_MYC	P17735	99.72	72.0	424.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
14862	sp|P9WML5|PATR_MYC	P17735	99.72	72.0	424.0	DB00120	approved; investigational; nutraceutical	Phenylalanine	OC(=O)[C@@H](N)Cc1ccccc1
14863	sp|P9WML5|PATR_MYC	P17735	99.72	72.0	424.0	DB00135	approved; investigational; nutraceutical	Tyrosine	OC(=O)[C@@H](N)Cc1ccc(O)cc1
14864	sp|P9WML5|PATR_MYC	P17735	99.72	72.0	424.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
14865	sp|P9WML5|PATR_MYC	Q96QU6	94.33	89.0	422.0	DB03214	experimental	Vinylglycine	OC(=O)[C@@H](N)C=C
14866	sp|P9WML5|PATR_MYC	Q9X0L5	94.9	33.0	368.0	DB01942	experimental; investigational	Formic acid	OC=O
14867	sp|P9WML5|PATR_MYC	Q9X266	90.08	7.0	325.0	DB02824	experimental	N-Pyridoxyl-Glycine-5-Monophosphate	Cc1ncc(COP(=O)(O)O)c(c1O)CNCC(=O)O
14868	sp|P9WML5|PATR_MYC	Q9X266	90.08	7.0	325.0	DB03576	experimental	N-Pyridoxyl-Threonine-5-Monophosphate	CC(O)C(C(=O)O)NCc1c(COP(=O)(O)O)cnc(C)c1O
14869	sp|P9WML5|PATR_MYC	Q9X266	90.08	7.0	325.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
14870	sp|P9WML5|PATR_MYC	P00509	97.73	25.0	370.0	DB01639	experimental	N-Methyl-Pyridoxal-5'-Phosphate	Cc1c(O)c(C=O)c(c[n+]1C)COP(=O)(O)O
14871	sp|P9WML5|PATR_MYC	P00509	97.73	25.0	370.0	DB02024	experimental	3-phenylpropionic acid	OC(=O)CCc1ccccc1
14872	sp|P9WML5|PATR_MYC	P00509	97.73	25.0	370.0	DB02758	experimental	Indolepropionic acid	OC(=O)CCc1c[nH]c(c12)cccc2
14873	sp|P9WML5|PATR_MYC	P00509	97.73	25.0	370.0	DB02981	experimental	Vitamin B6 Complexed with 2-Amino-Hexanoic Acid	CCCC[C@@H](C(=O)O)NCc1c(COP(=O)(O)O)cnc(C)c1O
14874	sp|P9WML5|PATR_MYC	P00509	97.73	25.0	370.0	DB03553	experimental	Glutaric Acid	OC(=O)CCCC(=O)O
14875	sp|P9WML5|PATR_MYC	P00509	97.73	25.0	370.0	DB03629	experimental	Pyridoxal-5'-Phosphate-N-Oxide	Cc1c(O)c(C=O)c(c[n+]1[O-])COP(=O)(O)O
14876	sp|P9WML5|PATR_MYC	P00509	97.73	25.0	370.0	DB03662	experimental	Vitamin B6 Complexed with 2-Amino-Pentanoic Acid	CCC[C@@H](C(=O)O)NCc1c(O)c(C)ncc1COP(=O)(O)O
14877	sp|P9WML5|PATR_MYC	P00509	97.73	25.0	370.0	DB03750	experimental	Isovaleric Acid	CC(C)CC(=O)O
14878	sp|P9WML5|PATR_MYC	P00509	97.73	25.0	370.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
14879	sp|P9WML5|PATR_MYC	P00509	97.73	25.0	370.0	DB04299	experimental	Maleic Acid	OC(=O)/C=C\C(=O)O
14880	sp|P9WML5|PATR_MYC	P00509	97.73	25.0	370.0	DB04467	experimental	N-(5'-phosphopyridoxyl)-L-alanine	OC(=O)[C@H](C)NCc1c(COP(=O)(O)O)cnc(C)c1O
14881	sp|P9WML5|PATR_MYC	P00509	97.73	25.0	370.0	DB04762	experimental	N-PYRIDOXYL-D-GLUTAMIC ACID-5'-MONOPHOSPHATE	Cc1ncc(COP(=O)(O)O)c(c1O)CN[C@@H](C(=O)O)CCC(=O)O
14882	sp|P9WML5|PATR_MYC	P00509	97.73	25.0	370.0	DB04765	experimental	N-PYRIDOXYL-2-METHYL-L-GLUTAMIC ACID-5'-MONOPHOSPHATE	Cc1ncc(COP(=O)(O)O)c(c1O)CN[C@](C)(C(=O)O)CCC(=O)O
14883	sp|P9WML5|PATR_MYC	P00509	97.73	25.0	370.0	DB08845	experimental; investigational; nutraceutical	Oxogluric acid	OC(=O)CCC(=O)C(=O)O
14884	sp|P9WML5|PATR_MYC	P00505	87.54	93.0	402.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
14885	sp|P9WML5|PATR_MYC	P00505	87.54	93.0	402.0	DB00128	approved; nutraceutical	Aspartic acid	OC(=O)[C@@H](N)CC(=O)O
14886	sp|P9WML5|PATR_MYC	P00505	87.54	93.0	402.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
14887	sp|P9WML5|PATR_MYC	P00505	87.54	93.0	402.0	DB00151	approved; nutraceutical	Cysteine	OC(=O)[C@@H](N)CS
14888	sp|P9WML5|PATR_MYC	P00505	87.54	93.0	402.0	DB02783	experimental	4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate	Cc1ncc(COP(=O)(O)O)c(c1O)CNOCC(=O)O
14889	sp|P9WML5|PATR_MYC	Q8N5Z0	89.24	68.0	383.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
14890	sp|P9WML5|PATR_MYC	Q8N5Z0	89.24	68.0	383.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
14891	sp|P9WML5|PATR_MYC	Q2TU84	79.6	108.0	389.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
14892	sp|P9WML5|PATR_MYC	Q2TU84	79.6	108.0	389.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
14893	sp|P9WML5|PATR_MYC	P17174	73.65	129.0	389.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
14894	sp|P9WML5|PATR_MYC	P17174	73.65	129.0	389.0	DB00128	approved; nutraceutical	Aspartic acid	OC(=O)[C@@H](N)CC(=O)O
14895	sp|P9WML5|PATR_MYC	P17174	73.65	129.0	389.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
14896	sp|P9WML5|PATR_MYC	P17174	73.65	129.0	389.0	DB00151	approved; nutraceutical	Cysteine	OC(=O)[C@@H](N)CS
14897	sp|P9WML5|PATR_MYC	P17174	73.65	129.0	389.0	DB00210	approved	Adapalene	C1C(C2)CC(C3)CC1CC23c4c(OC)ccc(c4)-c(cc5)cc(c56)ccc(c6)C(=O)O
14898	sp|P9WML5|PATR_MYC	P17174	73.65	129.0	389.0	DB04299	experimental	Maleic Acid	OC(=O)/C=C\C(=O)O
14899	sp|P9WML5|PATR_MYC	P17174	73.65	129.0	389.0	DB09130	approved; investigational	Copper	[Cu]
14900	sp|P9WML5|PATR_MYC	Q8TD30	81.3	127.0	414.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
14901	sp|P9WML5|PATR_MYC	Q8TD30	81.3	127.0	414.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
14902	sp|P9WML5|PATR_MYC	Q8TD30	81.3	127.0	414.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
14903	sp|P9WML5|PATR_MYC	Q8TD30	81.3	127.0	414.0	DB00780	approved	Phenelzine	NNCCc1ccccc1
14904	sp|P9WML5|PATR_MYC	P24298	105.38	101.0	473.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
14905	sp|P9WML5|PATR_MYC	P24298	105.38	101.0	473.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
14906	sp|P9WML5|PATR_MYC	P24298	105.38	101.0	473.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
14907	sp|P9WML5|PATR_MYC	P24298	105.38	101.0	473.0	DB00780	approved	Phenelzine	NNCCc1ccccc1
14908	sp|P9WML5|PATR_MYC	P0AB77	75.64	88.0	355.0	DB03915	experimental	2-Amino-3-Ketobutyric Acid	CC(=O)[C@H](N)C(=O)O
14909	sp|P9WML5|PATR_MYC	O75600	82.44	112.0	403.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
14910	sp|P9WML5|PATR_MYC	O75600	82.44	112.0	403.0	DB00145	approved; nutraceutical; vet_approved	Glycine	NCC(=O)O
14911	sp|P9WML5|PATR_MYC	P95468	81.02	43.0	329.0	DB02024	experimental	3-phenylpropionic acid	OC(=O)CCc1ccccc1
14912	sp|P9WML5|PATR_MYC	P95468	81.02	43.0	329.0	DB02242	experimental	Cyclohexanepropanoic acid	OC(=O)CCC1CCCCC1
14913	sp|P9WML5|PATR_MYC	P95468	81.02	43.0	329.0	DB02434	experimental	4-(2-Thienyl)Butyric Acid	OC(=O)CCCc1cccs1
14914	sp|P9WML5|PATR_MYC	P95468	81.02	43.0	329.0	DB02740	experimental	3-Indolebutyric Acid	OC(=O)CCCc1c[nH]c(c12)cccc2
14915	sp|P9WML5|PATR_MYC	P95468	81.02	43.0	329.0	DB02758	experimental	Indolepropionic acid	OC(=O)CCc1c[nH]c(c12)cccc2
14916	sp|P9WML5|PATR_MYC	P95468	81.02	43.0	329.0	DB03210	experimental	4-Aminohydrocinnamic Acid	Nc1ccc(cc1)CCC(=O)O
14917	sp|P9WML5|PATR_MYC	P95468	81.02	43.0	329.0	DB03400	experimental	3-(P-Tolyl)Propionic Acid	Cc1ccc(cc1)CCC(=O)O
14918	sp|P9WML5|PATR_MYC	P95468	81.02	43.0	329.0	DB04051	experimental	5-phenylpentanoic acid	OC(=O)CCCCc1ccccc1
14919	sp|P9WML5|PATR_MYC	P95468	81.02	43.0	329.0	DB04208	experimental	3-(3,4-dimethoxyphenyl)propanoic acid	COc1c(OC)cc(cc1)CCC(=O)O
14920	sp|P9WML5|PATR_MYC	P95468	81.02	43.0	329.0	DB04299	experimental	Maleic Acid	OC(=O)/C=C\C(=O)O
14921	sp|P9WML5|PATR_MYC	P95468	81.02	43.0	329.0	DB06819	approved; investigational	Phenylbutyric acid	OC(=O)CCCc1ccccc1
14922	sp|P9WML5|PATR_MYC	Q5KUI2	85.55	59.0	361.0	DB03256	experimental	(6R)-Folinic acid	Nc([nH]1)nc(=O)c(c12)N(C=O)[C@@H](CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
14923	sp|P9WML5|PATR_MYC	P0A827	80.45	62.0	346.0	DB02824	experimental	N-Pyridoxyl-Glycine-5-Monophosphate	Cc1ncc(COP(=O)(O)O)c(c1O)CNCC(=O)O
14924	sp|P9WML5|PATR_MYC	P0A827	80.45	62.0	346.0	DB11596	approved; investigational	Levoleucovorin	Nc([nH]1)nc(=O)c(c12)N(C=O)[C@H](CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
14925	sp|P9WML5|PATR_MYC	P12998	81.87	86.0	375.0	DB03160	experimental	N-Pyridoxyl-7-Keto-8-Aminopelargonic Acid-5'-Monophosphate	OC(=O)CCCCCC(=O)[C@H](C)NCc1c(COP(=O)(O)O)cnc(C)c1O
14926	sp|P9WML5|PATR_MYC	Q9KM65	75.35	101.0	367.0	DB08364	experimental	1-{[(1E)-(3-HYDROXY-2-METHYL-5-{[(TRIHYDROXY-LAMBDA^5^-PHOSPHANYL)OXY]METHYL}PYRIDIN-4-YL)METHYLIDENE]AMINO}UNDECAN-2-ONE	CCCCCCCCCC(=O)C/N=C/c1c(COP(O)(O)O)cnc(C)c1O
14927	sp|P9WHL3|PYRC_MYC	Q45515	102.33	2.0	442.0	DB03801	experimental	Lysine Nz-Carboxylic Acid	OC(=O)[C@@H](N)CCCCNC(=O)O
14928	sp|P9WHL3|PYRC_MYC	Q7SIE9	101.86	2.0	440.0	DB03801	experimental	Lysine Nz-Carboxylic Acid	OC(=O)[C@@H](N)CCCCNC(=O)O
14929	sp|P9WHL3|PYRC_MYC	Q16555	102.79	17.0	459.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
14930	sp|P9WHL3|PYRC_MYC	Q8VTT5	101.86	1.0	439.0	DB03801	experimental	Lysine Nz-Carboxylic Acid	OC(=O)[C@@H](N)CCCCNC(=O)O
14931	sp|P9WHL3|PYRC_MYC	P81006	101.16	4.0	439.0	DB03801	experimental	Lysine Nz-Carboxylic Acid	OC(=O)[C@@H](N)CCCCNC(=O)O
14932	sp|P9WHE1|RL13_MYC	P40429	76.87	14.0	127.0	DB02494	experimental	(S)-3-phenyllactic acid	OC(=O)[C@@H](O)Cc1ccccc1
14933	sp|P9WHE1|RL13_MYC	P40429	76.87	14.0	127.0	DB07374	experimental	Anisomycin	O[C@H]1CN[C@@H]([C@@H]1OC(=O)C)Cc2ccc(OC)cc2
14934	sp|P9WHE1|RL13_MYC	P40429	76.87	14.0	127.0	DB08437	experimental	Puromycin	COc1ccc(cc1)C[C@H](N)C(=O)N[C@@H]2[C@@H](CO)O[C@H]([C@@H]2O)n3cnc(c34)c(ncn4)N(C)C
14935	sp|P9WN65|RMLB_MYC	P95780	101.51	7.0	343.0	DB03161	experimental	Thymidine-5'-diphospho-beta-D-xylose	O=c1[nH]c(=O)c(C)cn1[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3OC[C@@H](O)[C@H](O)[C@H]3O
14936	sp|P9WN65|RMLB_MYC	P95780	101.51	7.0	343.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
14937	sp|P9WN65|RMLB_MYC	P26391	106.65	1.0	354.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
14938	sp|P9WN65|RMLB_MYC	Q9ZGH3	98.19	1.0	326.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
14939	sp|P9WN65|RMLB_MYC	P09147	100.0	1.0	332.0	DB01861	experimental	Uridine diphosphate glucose	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
14940	sp|P9WN65|RMLB_MYC	P09147	100.0	1.0	332.0	DB02421	experimental	Uridine-5'-diphosphate-mannose	O=c1[nH]c(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O
14941	sp|P9WN65|RMLB_MYC	P09147	100.0	1.0	332.0	DB02790	experimental	Phenyl-uridine-5'-diphosphate	O=c1[nH]c(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)Oc3ccccc3
14942	sp|P9WN65|RMLB_MYC	P09147	100.0	1.0	332.0	DB03397	experimental	Uridine-Diphosphate-N-Acetylglucosamine	CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
14943	sp|P9WN65|RMLB_MYC	P09147	100.0	1.0	332.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
14944	sp|P9WN65|RMLB_MYC	P09147	100.0	1.0	332.0	DB04097	experimental	Uridine-5'-diphosphate-4-deoxy-4-fluoro-alpha-D-galactose	O=c1[nH]c(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](F)[C@H](O)[C@H]3O
14945	sp|P9WN65|RMLB_MYC	P14169	100.91	1.0	335.0	DB04555	experimental	Cytidine-5'-Diphosphate	Nc1nc(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O
14946	sp|P9WN65|RMLB_MYC	Q14376	101.51	4.0	340.0	DB01861	experimental	Uridine diphosphate glucose	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
14947	sp|P9WN65|RMLB_MYC	Q14376	101.51	4.0	340.0	DB02196	experimental	Uridine-Diphosphate-N-Acetylgalactosamine	CC(=O)N[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
14948	sp|P9WN65|RMLB_MYC	Q14376	101.51	4.0	340.0	DB03041	experimental	UDP-alpha-D-glucuronic acid	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O
14949	sp|P9WN65|RMLB_MYC	Q14376	101.51	4.0	340.0	DB03095	experimental	Tetramethylammonium	C[N+](C)(C)C
14950	sp|P9WN65|RMLB_MYC	Q14376	101.51	4.0	340.0	DB03397	experimental	Uridine-Diphosphate-N-Acetylglucosamine	CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
14951	sp|P9WN65|RMLB_MYC	Q14376	101.51	4.0	340.0	DB03501	experimental	Galactose-uridine-5'-diphosphate	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@H]1O)O[P@](=O)(O)O[P@](=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
14952	sp|P9WN65|RMLB_MYC	Q8KN66	95.47	20.0	336.0	DB01861	experimental	Uridine diphosphate glucose	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
14953	sp|P9WN65|RMLB_MYC	Q8KN66	95.47	20.0	336.0	DB02196	experimental	Uridine-Diphosphate-N-Acetylgalactosamine	CC(=O)N[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
14954	sp|P9WN65|RMLB_MYC	P26397	99.09	11.0	339.0	DB02059	experimental	Adenosine-5-Diphosphoribose	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)CO[P@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H](O)[C@H](O)[C@@H]4O
14955	sp|P9WN65|RMLB_MYC	P26397	99.09	11.0	339.0	DB03069	experimental	Cytidine-5'-diphospho-beta-D-xylose	Nc1nc(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O[C@H]3OC[C@@H](O)[C@H](O)[C@H]3O
14956	sp|P9WN65|RMLB_MYC	Q51366	93.05	6.0	314.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
14957	sp|P9WN65|RMLB_MYC	P77398	100.91	317.0	651.0	DB03256	experimental	(6R)-Folinic acid	Nc([nH]1)nc(=O)c(c12)N(C=O)[C@@H](CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
14958	sp|P9WN65|RMLB_MYC	P77398	100.91	317.0	651.0	DB03685	experimental	Uridine monophosphate	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2ccc(=O)[nH]c2=O
14959	sp|P9WN65|RMLB_MYC	Q8T8E9	112.39	1.0	373.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
14960	sp|P9WN65|RMLB_MYC	O60547	100.6	27.0	360.0	DB02547	experimental	Guanosine-5'-Diphosphate-Rhamnose	O[C@H]1[C@H](O)[C@H](O)[C@H](O[C@@H]1C)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3cnc(c34)c(=O)nc([nH]4)N
14961	sp|P9WN65|RMLB_MYC	O60547	100.6	27.0	360.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
14962	sp|P9WN65|RMLB_MYC	P67910	92.15	2.0	307.0	DB01774	experimental	Adenosine-5'-Monophosphate Glucopyranosyl-Monophosphate Ester	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@@](=O)(O)O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O
14963	sp|P9WN65|RMLB_MYC	P67910	92.15	2.0	307.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
14964	sp|P9WN65|RMLB_MYC	Q13630	94.26	8.0	320.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
14965	sp|P9WN65|RMLB_MYC	P32055	88.22	28.0	320.0	DB02897	experimental	Acetylphosphate	CC(=O)OP(=O)(O)O
14966	sp|P9WN65|RMLB_MYC	P32055	88.22	28.0	320.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
14967	sp|P9WN65|RMLB_MYC	P14060	71.0	6.0	241.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
14968	sp|P9WN65|RMLB_MYC	P14060	71.0	6.0	241.0	DB01108	approved; investigational; vet_approved; withdrawn	Trilostane	C1C[C@H](O)[C@@](C)(CC2)[C@@H]1[C@H](CC3)[C@H]2[C@@]([C@@]345)(C)CC(C#N)=C([C@H]4O5)O
14969	sp|P9WN65|RMLB_MYC	P14060	71.0	6.0	241.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
14970	sp|P9WN65|RMLB_MYC	P14060	71.0	6.0	241.0	DB14538	experimental; vet_approved	Hydrocortisone aceponate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CC)C(=O)COC(=O)C
14971	sp|P9WN65|RMLB_MYC	P14060	71.0	6.0	241.0	DB14539	approved; vet_approved	Hydrocortisone acetate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)C
14972	sp|P9WN65|RMLB_MYC	P14060	71.0	6.0	241.0	DB14540	approved; vet_approved	Hydrocortisone butyrate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCC
14973	sp|P9WN65|RMLB_MYC	P14060	71.0	6.0	241.0	DB14541	approved; investigational; vet_approved	Hydrocortisone cypionate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)CCC5CCCC5
14974	sp|P9WN65|RMLB_MYC	P14060	71.0	6.0	241.0	DB14542	approved; vet_approved	Hydrocortisone phosphate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COP(=O)(O)O
14975	sp|P9WN65|RMLB_MYC	P14060	71.0	6.0	241.0	DB14543	approved; vet_approved	Hydrocortisone probutate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CCC)C(=O)COC(=O)CC
14976	sp|P9WN65|RMLB_MYC	P14060	71.0	6.0	241.0	DB14544	approved; vet_approved	Hydrocortisone valerate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCCC
14977	sp|P9WN65|RMLB_MYC	P26439	109.06	5.0	366.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
14978	sp|P9WN65|RMLB_MYC	P26439	109.06	5.0	366.0	DB01108	approved; investigational; vet_approved; withdrawn	Trilostane	C1C[C@H](O)[C@@](C)(CC2)[C@@H]1[C@H](CC3)[C@H]2[C@@]([C@@]345)(C)CC(C#N)=C([C@H]4O5)O
14979	sp|P9WN65|RMLB_MYC	Q15738	99.09	39.0	367.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
14980	sp|P9WGZ7|RNPH_MYC	P50597	91.12	2.0	238.0	DB03309	experimental	N-cyclohexyltaurine	OS(=O)(=O)CCNC1CCCCC1
14981	sp|P9WGY9|RPOB_MYC	Q8RQE9	94.23	4.0	1114.0	DB04788	experimental	Tagetitoxin	OP(=O)(O)O[C@@H]([C@@]12C(=O)O)[C@@H](N)[C@@H](OC(=O)C)[C@@H](O2)[C@@](O)(SC1)C(=O)N
14982	sp|P9WGY9|RPOB_MYC	Q8RQE9	94.23	4.0	1114.0	DB08226	experimental	Myxopyronin B	CCCC/C(C)=C/C=C(\C)C(=O)c1c(O)cc(oc1=O)CCC/C=C/NC(=O)OC
14983	sp|P9WGY9|RPOB_MYC	Q8RQE9	94.23	4.0	1114.0	DB08266	experimental	Methyl [(1E,5R)-5-{3-[(2E,4E)-2,5-dimethyl-2,4-octadienoyl]-2,4-dioxo-3,4-dihydro-2H-pyran-6-yl}hexylidene]carbamate	COC(=O)/N=C/CCC[C@@H](C)C1=CC(=O)C(C(=O)O1)C(=O)/C(C)=C/C=C(\C)CCC
14984	sp|P9WHM1|PURE_MYC	Q2QJL3	85.63	18.0	167.0	DB04272	approved; nutraceutical; vet_approved	Citric acid	OC(=O)CC(O)(C(=O)O)CC(=O)O
14985	sp|P9WHM1|PURE_MYC	P22234	81.61	263.0	405.0	DB00128	approved; nutraceutical	Aspartic acid	OC(=O)[C@@H](N)CC(=O)O
14986	sp|P9WH85|RL4_MYCT	P60723	83.41	8.0	194.0	DB13179	approved	Troleandomycin	O1C[C@]12C(=O)[C@H](C)[C@@H](OC(=O)C)[C@@H](C)[C@@H](C)OC(=O)[C@H](C)[C@@H](O[C@H]3C[C@H](OC)[C@H]([C@@H](O3)C)OC(=O)C)[C@H](C)[C@H]([C@@H](C)C2)O[C@@H]4O[C@H](C)C[C@H](N(C)C)[C@H]4OC(=O)C
14987	sp|P9WH85|RL4_MYCT	P44345	82.51	9.0	193.0	DB01321	investigational	Josamycin	CO[C@H]1[C@H](OC(=O)C)CC(=O)O[C@H](C)C/C=C/C=C/[C@H](O)[C@H](C)C[C@H](CC=O)[C@@H]1O[C@@H]2O[C@H](C)[C@H]([C@@H]([C@H]2O)N(C)C)O[C@@H](C[C@@]3(C)O)O[C@@H](C)[C@@H]3OC(=O)CC(C)C
14988	sp|P9WH85|RL4_MYCT	P38516	82.51	3.0	187.0	DB04272	approved; nutraceutical; vet_approved	Citric acid	OC(=O)CC(O)(C(=O)O)CC(=O)O
14989	sp|P9WGY7|RPOC_MYC	P9WGY7	99.92	1.0	1316.0	DB01201	approved; investigational	Rifapentine	C[C@@]12O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(=O)C)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)Nc3c(O)c4c(c(C1=O)c(O2)c(C)c4O)c(O)c3/C=N/N5CCN(CC5)C6CCCC6
14990	sp|P9WGY7|RPOC_MYC	Q8RQE8	80.55	435.0	1495.0	DB04788	experimental	Tagetitoxin	OP(=O)(O)O[C@@H]([C@@]12C(=O)O)[C@@H](N)[C@@H](OC(=O)C)[C@@H](O2)[C@@](O)(SC1)C(=O)N
14991	sp|P9WGY7|RPOC_MYC	Q8RQE8	80.55	435.0	1495.0	DB08226	experimental	Myxopyronin B	CCCC/C(C)=C/C=C(\C)C(=O)c1c(O)cc(oc1=O)CCC/C=C/NC(=O)OC
14992	sp|P9WGY7|RPOC_MYC	Q8RQE8	80.55	435.0	1495.0	DB08266	experimental	Methyl [(1E,5R)-5-{3-[(2E,4E)-2,5-dimethyl-2,4-octadienoyl]-2,4-dioxo-3,4-dihydro-2H-pyran-6-yl}hexylidene]carbamate	COC(=O)/N=C/CCC[C@@H](C)C1=CC(=O)C(C(=O)O1)C(=O)/C(C)=C/C=C(\C)CCC
14993	sp|P9WIZ3|NRDI_MYC	P50618	71.33	4.0	111.0	DB03247	approved; investigational	Flavin mononucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)COP(=O)(O)O
14994	sp|P9WQH7|PCC5_MYC	Q9X4K7	95.99	4.0	530.0	DB02912	experimental	Propanoyl-CoA	CCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
14995	sp|P9WQH7|PCC5_MYC	Q8GBW6	93.8	10.0	524.0	DB04045	experimental	(R)-methylmalonyl-CoA	OC(=O)[C@@H](C)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
14996	sp|P9WQH7|PCC5_MYC	Q8GBW6	93.8	10.0	524.0	DB04183	experimental	Methylmalonic Acid	OC(=O)C(C)C(=O)O
14997	sp|P9WQH7|PCC5_MYC	P05166	92.34	33.0	539.0	DB00121	approved; investigational; nutraceutical	Biotin	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC(=O)O
14998	sp|P9WQH7|PCC5_MYC	P05166	92.34	33.0	539.0	DB00161	approved; nutraceutical	Valine	CC(C)[C@H](N)C(=O)O
14999	sp|P9WQH7|PCC5_MYC	Q9HCC0	92.34	40.0	546.0	DB00121	approved; investigational; nutraceutical	Biotin	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC(=O)O
15000	sp|P9WQH7|PCC5_MYC	Q06700	97.26	21.0	554.0	DB01942	experimental; investigational	Formic acid	OC=O
15001	sp|P9WID1|PGK_MYCT	P00558	100.49	1.0	415.0	DB03909	experimental	Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate	OP(=O)(O)CP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
15002	sp|P9WID1|PGK_MYCT	P00558	100.49	1.0	415.0	DB04510	experimental	3-phospho-D-glyceric acid	OC(=O)[C@H](O)COP(=O)(O)O
15003	sp|P9WID1|PGK_MYCT	P00558	100.49	1.0	415.0	DB09130	approved; investigational	Copper	[Cu]
15004	sp|P9WID1|PGK_MYCT	P00558	100.49	1.0	415.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
15005	sp|P9WID1|PGK_MYCT	P36204	95.87	3.0	398.0	DB04510	experimental	3-phospho-D-glyceric acid	OC(=O)[C@H](O)COP(=O)(O)O
15006	sp|P9WHL7|PURL_MYC	O15067	88.64	303.0	982.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
15007	sp|P9WHB3|RL27_MYC	P60493	84.88	1.0	74.0	DB04447	experimental	1,4-Dithiothreitol	SC[C@H](O)[C@@H](O)CS
15008	sp|P9WGP9|SADH_MYC	Q9BTZ2	80.8	30.0	253.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
15009	sp|P9WGP9|SADH_MYC	P16544	78.99	1.0	219.0	DB01942	experimental; investigational	Formic acid	OC=O
15010	sp|P9WGP9|SADH_MYC	P16544	78.99	1.0	219.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
15011	sp|P9WGP9|SADH_MYC	P16544	78.99	1.0	219.0	DB07715	investigational	Emodin	Cc(c1)cc(O)c(c12)C(=O)c3c(C2=O)cc(O)cc3O
15012	sp|P9WGP9|SADH_MYC	Q6UWP2	84.42	6.0	239.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
15013	sp|P9WGP9|SADH_MYC	Q92506	83.33	8.0	238.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
15014	sp|P9WGP9|SADH_MYC	Q92506	83.33	8.0	238.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
15015	sp|P9WGP9|SADH_MYC	P0AEK2	71.01	2.0	198.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
15017	sp|P9WGP9|SADH_MYC	P0AET8	79.35	8.0	227.0	DB02123	experimental	Glycochenodeoxycholic Acid	OC(=O)CNC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
15019	sp|P9WGP9|SADH_MYC	Q9WYS2	80.8	6.0	229.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
15020	sp|P9WGP9|SADH_MYC	Q84EX5	81.88	3.0	229.0	DB04619	experimental	Acetophenone	CC(=O)c1ccccc1
15021	sp|P9WGP9|SADH_MYC	Q84EX5	81.88	3.0	229.0	DB04784	experimental	(R)-1-phenylethanol	C[C@@H](O)c1ccccc1
15022	sp|P9WGP9|SADH_MYC	Q8NBQ5	71.74	33.0	231.0	DB02854	experimental	Aetiocholanolone	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](CC3)C[C@H](O)CC4
15023	sp|P9WGP9|SADH_MYC	P0CG22	81.52	30.0	255.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
15024	sp|P9WGP9|SADH_MYC	P0CG22	81.52	30.0	255.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
15025	sp|P9WGP9|SADH_MYC	P0CG22	81.52	30.0	255.0	DB03541	experimental	10-Propargyl-5,8-Dideazafolic Acid	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(CC#C)Cc(c2)ccc(c23)[nH]c(N)nc3=O
15026	sp|P9WGP9|SADH_MYC	P0CG22	81.52	30.0	255.0	DB07689	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)NCc(cn3)nc(c34)c(N)nc(n4)N
15027	sp|P9WGP9|SADH_MYC	P0CG22	81.52	30.0	255.0	DB07765	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)N(C)Cc(cn3)nc(c34)c(N)nc(n4)N
15028	sp|P9WGP9|SADH_MYC	Q8NBN7	84.78	36.0	270.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
15030	sp|P9WGP9|SADH_MYC	P14061	81.52	3.0	228.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
15031	sp|P9WGP9|SADH_MYC	P14061	81.52	3.0	228.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
15032	sp|P9WGP9|SADH_MYC	P14061	81.52	3.0	228.0	DB01561	experimental; illicit	Androstanedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
15033	sp|P9WGP9|SADH_MYC	P14061	81.52	3.0	228.0	DB02187	experimental	Equilin	O=C1CC[C@H]([C@@]12C)C=3[C@H](CC2)c4c(CC3)cc(O)cc4
15034	sp|P9WGP9|SADH_MYC	P14061	81.52	3.0	228.0	DB02323	experimental	EM-1745	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)C[C@@H]([C@@H]4O)CCCCCCCCC(=O)OC[C@H]5O[C@H]([C@H](O)[C@@H]5O)n6cnc(c67)c(N)ncn7
15035	sp|P9WGP9|SADH_MYC	P14061	81.52	3.0	228.0	DB02901	illicit; investigational	Stanolone	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
15036	sp|P9WGP9|SADH_MYC	P14061	81.52	3.0	228.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
15037	sp|P9WGP9|SADH_MYC	P14061	81.52	3.0	228.0	DB13951	experimental	Stanolone acetate	CC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
15038	sp|P9WGP9|SADH_MYC	O75911	81.16	35.0	259.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
15039	sp|P9WGP9|SADH_MYC	Q02338	70.29	55.0	249.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
15040	sp|P9WGP9|SADH_MYC	Q9BY49	71.38	16.0	213.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
15041	sp|P9WGP9|SADH_MYC	Q8TC12	74.64	39.0	245.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
15042	sp|P9WGP9|SADH_MYC	Q7Z4W1	73.19	5.0	207.0	DB02831	experimental	Dihydrogenphosphate	OP([O-])(=O)O
15043	sp|P9WGP9|SADH_MYC	Q7Z4W1	73.19	5.0	207.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
15044	sp|P9WGP9|SADH_MYC	Q96NR8	74.28	37.0	242.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
15045	sp|P9WGP9|SADH_MYC	Q99714	80.8	7.0	230.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
15046	sp|P9WGP9|SADH_MYC	Q99714	80.8	7.0	230.0	DB02820	experimental	1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct	C1CCCCCN1C(=O)[C@H](c2ccccc2)n(c3=S)cnc(c34)nn(c4)[C@H]5C=CN(C=C5C([O-])=N)[C@@H]6O[C@@H]([C@@H](O)[C@H]6O)COP([O-])(=O)OP(=O)(O)OC[C@H]7O[C@H]([C@H]([O-])[C@@H]7[O-])n8cnc(c89)c(N)ncn9
15047	sp|P9WGP9|SADH_MYC	Q99714	80.8	7.0	230.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
15048	sp|P9WGP9|SADH_MYC	P28845	70.65	32.0	227.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
15049	sp|P9WGP9|SADH_MYC	P28845	70.65	32.0	227.0	DB02329	experimental	Carbenoxolone	OC(=O)CCC(=O)O[C@@H](CC1)C(C)(C)[C@@H]([C@]12C)CC[C@]3(C)[C@@H]2C(=O)C=C4[C@H]5[C@@](C)(CC[C@@]34C)CC[C@](C5)(C)C(=O)O
15050	sp|P9WGP9|SADH_MYC	P28845	70.65	32.0	227.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
15051	sp|P9WGP9|SADH_MYC	P28845	70.65	32.0	227.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
15052	sp|P9WGP9|SADH_MYC	P28845	70.65	32.0	227.0	DB04652	experimental	Corticosterone	OCC(=O)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H]([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
15053	sp|P9WGP9|SADH_MYC	P28845	70.65	32.0	227.0	DB05064	investigational	INCB13739	 
15054	sp|P9WGP9|SADH_MYC	P28845	70.65	32.0	227.0	DB06992	experimental	(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone	Cc1ccc(cc1F)-c2nc(ccc2)C(=O)N(CC3(C)C)CCC3
15055	sp|P9WGP9|SADH_MYC	P28845	70.65	32.0	227.0	DB07017	experimental	(5S)-2-{[(1S)-1-(4-Fluorophenyl)ethyl]amino}-5-(2-hydroxy-2-propanyl)-5-methyl-1,3-thiazol-4(5H)-one	Fc1ccc(cc1)[C@H](C)NC(=NC2=O)S[C@@]2(C)C(C)(C)O
15056	sp|P9WGP9|SADH_MYC	P28845	70.65	32.0	227.0	DB07049	experimental	(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine	[O-][N+](=O)c1ccc(cc1)N2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)C(C)(C)C
15057	sp|P9WGP9|SADH_MYC	P28845	70.65	32.0	227.0	DB07056	experimental	2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide	CCN(CC)C(=O)Cc1cccc(n1)NS(=O)(=O)c2c(C)c(Cl)ccc2
15058	sp|P9WGP9|SADH_MYC	P28845	70.65	32.0	227.0	DB07310	experimental	(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one	Fc1ccccc1[C@H](C)NC(=NC2=O)S[C@]2(C)C(F)(F)F
15059	sp|P9WGP9|SADH_MYC	P28845	70.65	32.0	227.0	DB07316	experimental	N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)C3CCN(CC3)CC4(CC4)C(=O)N
15060	sp|P9WGP9|SADH_MYC	P28845	70.65	32.0	227.0	DB07619	experimental	N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)[C@H]3CC[C@@H](CC3)c4cccnc4
15061	sp|P9WGP9|SADH_MYC	P28845	70.65	32.0	227.0	DB07624	experimental	1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide	C1CC1(C(=O)N)CN2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)[C@](C)(O)C(F)(F)F
15062	sp|P9WGP9|SADH_MYC	P28845	70.65	32.0	227.0	DB07866	experimental	(5S)-2-(Cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one	CCC[C@]1(C)SC(=NC1=O)NC2CCCCCCC2
15063	sp|P9WGP9|SADH_MYC	P28845	70.65	32.0	227.0	DB08277	experimental	2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE	CS(=O)(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4c(Cl)cc(F)cc4
15064	sp|P9WGP9|SADH_MYC	P28845	70.65	32.0	227.0	DB08280	experimental	(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE	NC(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4ccc(OC)cc4
15065	sp|P9WGP9|SADH_MYC	P28845	70.65	32.0	227.0	DB08771	experimental	(5R)-2-[(2-Fluorophenyl)amino]-5-isopropyl-1,3-thiazol-4(5H)-one	CC(C)[C@H]1SC(=NC1=O)Nc2c(F)cccc2
15066	sp|P9WGP9|SADH_MYC	P28845	70.65	32.0	227.0	DB13751	approved; experimental	Glycyrrhizic acid	C1C[C@](C)(C(=O)O)C[C@H]([C@]12C)C=3[C@@](C)(CC2)[C@@]4(C)[C@H](C(=O)C3)[C@]5(C)[C@@H](CC4)C(C)(C)[C@H](CC5)O[C@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O[C@@H]7O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]7O
15067	sp|P9WGP9|SADH_MYC	P37058	74.64	48.0	254.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
15068	sp|P9WGP9|SADH_MYC	Q16698	70.65	55.0	250.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
15069	sp|P9WGP9|SADH_MYC	Q16698	70.65	55.0	250.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
15070	sp|P9WGP9|SADH_MYC	P37059	71.38	80.0	277.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
15071	sp|P9WGP9|SADH_MYC	P37059	71.38	80.0	277.0	DB13952	approved; investigational; vet_approved	Estradiol acetate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)C
15072	sp|P9WGP9|SADH_MYC	P37059	71.38	80.0	277.0	DB13953	approved; investigational; vet_approved	Estradiol benzoate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)c5ccccc5
15073	sp|P9WGP9|SADH_MYC	P37059	71.38	80.0	277.0	DB13954	approved; investigational; vet_approved	Estradiol cypionate	C1CCCC1CCC(=O)O[C@H]2CC[C@H]([C@@]23C)[C@H]4[C@H](CC3)c5c(CC4)cc(O)cc5
15074	sp|P9WGP9|SADH_MYC	P37059	71.38	80.0	277.0	DB13955	approved; investigational; vet_approved	Estradiol dienanthate	CCCCCCC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)CCCCCC
15075	sp|P9WGP9|SADH_MYC	P37059	71.38	80.0	277.0	DB13956	approved; investigational; vet_approved	Estradiol valerate	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)CC[C@@H]4OC(=O)CCCC
15076	sp|P9WGP9|SADH_MYC	P80365	74.28	82.0	287.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
15077	sp|P9WGP9|SADH_MYC	P80365	74.28	82.0	287.0	DB01185	approved; illicit	Fluoxymesterone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@](F)([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
15078	sp|P9WGP9|SADH_MYC	P80365	74.28	82.0	287.0	DB01569	experimental; illicit	Formebolone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@H]([C@@H](C2)O)[C@]4(C)C(CC3)=CC(=O)C(C=O)=C4
15079	sp|P9WGP9|SADH_MYC	P80365	74.28	82.0	287.0	DB14538	experimental; vet_approved	Hydrocortisone aceponate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CC)C(=O)COC(=O)C
15080	sp|P9WGP9|SADH_MYC	P80365	74.28	82.0	287.0	DB14539	approved; vet_approved	Hydrocortisone acetate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)C
15081	sp|P9WGP9|SADH_MYC	P80365	74.28	82.0	287.0	DB14540	approved; vet_approved	Hydrocortisone butyrate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCC
15082	sp|P9WGP9|SADH_MYC	P80365	74.28	82.0	287.0	DB14541	approved; investigational; vet_approved	Hydrocortisone cypionate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)CCC5CCCC5
15083	sp|P9WGP9|SADH_MYC	P80365	74.28	82.0	287.0	DB14542	approved; vet_approved	Hydrocortisone phosphate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COP(=O)(O)O
15084	sp|P9WGP9|SADH_MYC	P80365	74.28	82.0	287.0	DB14543	approved; vet_approved	Hydrocortisone probutate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CCC)C(=O)COC(=O)CC
15085	sp|P9WGP9|SADH_MYC	P80365	74.28	82.0	287.0	DB14544	approved; vet_approved	Hydrocortisone valerate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCCC
15086	sp|P9WGP9|SADH_MYC	Q9HBH5	78.99	41.0	259.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
15087	sp|P9WGP9|SADH_MYC	Q6GI75	72.83	1.0	202.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
15088	sp|P9WGP9|SADH_MYC	Q6GI75	72.83	1.0	202.0	DB11155	approved	Triclocarban	Clc1ccc(cc1)NC(=O)Nc2cc(Cl)c(Cl)cc2
15089	sp|P9WGP9|SADH_MYC	A0A348A0U3	72.83	1.0	202.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
15090	sp|P9WGP9|SADH_MYC	P49327	81.52	1885.0	2110.0	DB01034	experimental	Cerulenin	NC(=O)[C@@H]1O[C@@H]1C(=O)CC/C=C/C/C=C/C
15091	sp|P9WGP9|SADH_MYC	P49327	81.52	1885.0	2110.0	DB01083	approved; investigational	Orlistat	CCCCCCCCCCC[C@H](OC(=O)[C@@H](NC=O)CC(C)C)C[C@@H]1OC(=O)[C@H]1CCCCCC
15092	sp|P9WGP9|SADH_MYC	P56937	82.61	3.0	231.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
15093	sp|P9WGP9|SADH_MYC	P0AEK4	71.74	3.0	201.0	DB01691	experimental	Indole Naphthyridinone	c1cccc(c12)n(C)cc2CN(C)C(=O)/C=C/c(c3)cnc(c34)NC(=O)CC4
15094	sp|P9WGP9|SADH_MYC	P0AEK4	71.74	3.0	201.0	DB01865	experimental	3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide	c1cccc(c12)cc(n2C)CN(C)C(=O)/C=C/c3cnc(N)cc3
15095	sp|P9WGP9|SADH_MYC	P0AEK4	71.74	3.0	201.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
15096	sp|P9WGP9|SADH_MYC	P0AEK4	71.74	3.0	201.0	DB03030	experimental	4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole	Cc1ccc(cc1)Cn2cnc(c2)-c3cccs3
15097	sp|P9WGP9|SADH_MYC	P0AEK4	71.74	3.0	201.0	DB03534	experimental	3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide	CC(=O)N(C)Cc1c(N)ccc(c1)C(=O)N(C)Cc(n2C)cc(c23)cccc3
15098	sp|P9WGP9|SADH_MYC	P0AEK4	71.74	3.0	201.0	DB04030	experimental	1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole	Oc1ccc(cc1)Cn2c(c3c(c24)cccc4)CN(CC3)C(=O)c5ccc(O)cc5
15099	sp|P9WGP9|SADH_MYC	P0AEK4	71.74	3.0	201.0	DB08265	experimental	2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL	Cc1ccc(cc1)S(=O)(=O)n(b2O)ncc(c23)cccc3
15100	sp|P9WGP9|SADH_MYC	P0AEK4	71.74	3.0	201.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
15101	sp|P9WGP9|SADH_MYC	P0AEK4	71.74	3.0	201.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
15102	sp|P9WGP9|SADH_MYC	Q8I814	73.19	13.0	215.0	DB02015	experimental	Dihydrofolic Acid	O=c1[nH]c(N)nc(c12)NCC(=N2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
15103	sp|P9WGP9|SADH_MYC	Q8I814	73.19	13.0	215.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
15104	sp|P9WGP9|SADH_MYC	Q01782	78.99	8.0	226.0	DB02338	experimental	NADPH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
15105	sp|P9WGP9|SADH_MYC	Q01782	78.99	8.0	226.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
15106	sp|P9WGP9|SADH_MYC	Q01782	78.99	8.0	226.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
15107	sp|P9WGP9|SADH_MYC	Q01782	78.99	8.0	226.0	DB04400	experimental	L-erythro-7,8-dihydrobiopterin	C[C@H](O)[C@H](O)C(CN1)=Nc(c12)c(=O)nc([nH]2)N
15108	sp|P9WGP9|SADH_MYC	P35270	73.55	8.0	211.0	DB02637	experimental	Oxaloacetate Ion	OC(=O)C(=O)CC([O-])=O
15109	sp|P9WGP9|SADH_MYC	P35270	73.55	8.0	211.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
15110	sp|P9WGP9|SADH_MYC	P35270	73.55	8.0	211.0	DB03886	experimental	Biopterin	C[C@@H](O)[C@@H](O)c(n1)cnc(c12)nc(N)[nH]c2=O
15111	sp|P9WGP9|SADH_MYC	P35270	73.55	8.0	211.0	DB04275	experimental	N-acetylserotonin	CC(=O)NCCc1c[nH]c(c12)ccc(c2)O
15112	sp|P9WGP9|SADH_MYC	P9WGR1	71.01	5.0	201.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
15113	sp|P9WGP9|SADH_MYC	P9WGR1	71.01	5.0	201.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
15114	sp|P9WGP9|SADH_MYC	P9WGR1	71.01	5.0	201.0	DB02990	experimental	S-(2-Acetamidoethyl) hexadecanethioate	CCCCCCCCCCCCCCCC(=O)SCCNC(=O)C
15115	sp|P9WGP9|SADH_MYC	P9WGR1	71.01	5.0	201.0	DB04289	experimental	Genz-10850	[nH]1ccc(c12)cc(cc2)C(=O)N3CCN(CC3)C4c(cccc5)c5c(c46)cccc6
15116	sp|P9WGP9|SADH_MYC	P9WGR1	71.01	5.0	201.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
15117	sp|P9WGP9|SADH_MYC	P9WGR1	71.01	5.0	201.0	DB07090	experimental	(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cccc(c1C)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
15118	sp|P9WGP9|SADH_MYC	P9WGR1	71.01	5.0	201.0	DB07123	experimental	N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE	Cc1ccc(cc1)C(=O)N2CCC(CC2)Cc3ccccc3
15119	sp|P9WGP9|SADH_MYC	P9WGR1	71.01	5.0	201.0	DB07155	experimental	(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE	c1ccccc1NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
15120	sp|P9WGP9|SADH_MYC	P9WGR1	71.01	5.0	201.0	DB07178	experimental	5-PENTYL-2-PHENOXYPHENOL	CCCCCc1cc(O)c(cc1)Oc2ccccc2
15121	sp|P9WGP9|SADH_MYC	P9WGR1	71.01	5.0	201.0	DB07188	experimental	(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(cc(Cl)c1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
15122	sp|P9WGP9|SADH_MYC	P9WGR1	71.01	5.0	201.0	DB07192	experimental	(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Brc1cc(ccc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
15123	sp|P9WGP9|SADH_MYC	P9WGR1	71.01	5.0	201.0	DB07222	experimental	(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(c(C)cc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
15124	sp|P9WGP9|SADH_MYC	P9WGR1	71.01	5.0	201.0	DB07287	experimental	2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL	c1cccnc1Cc2cc(O)c(cc2)Oc3ccc(Cl)cc3Cl
15125	sp|P9WGP9|SADH_MYC	P9WGR1	71.01	5.0	201.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
15126	sp|P9WI83|PKNA_MYC	Q9UK32	71.69	421.0	730.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
15127	sp|P9WI83|PKNA_MYC	P00521	72.16	126.0	437.0	DB02567	experimental	PD173955	CSc1cccc(c1)Nc(n2)ncc(c23)cc(c(=O)n3C)-c4c(Cl)cccc4Cl
15128	sp|P9WI83|PKNA_MYC	P00521	72.16	126.0	437.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
15129	sp|P9WI83|PKNA_MYC	P00521	72.16	126.0	437.0	DB03878	experimental	N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide	c1ccncc1C(=O)Nc2ccc(C)c(c2)Nc3nccc(n3)-c4cccnc4
15130	sp|P9WI83|PKNA_MYC	P00521	72.16	126.0	437.0	DB05489	investigational	ACA 125	 
15131	sp|P9WI83|PKNA_MYC	Q9BYT3	72.85	109.0	423.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
15132	sp|P9WI83|PKNA_MYC	P00519	70.3	240.0	543.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
15133	sp|P9WI83|PKNA_MYC	P00519	70.3	240.0	543.0	DB00619	approved	Imatinib	CN1CCN(CC1)Cc2ccc(cc2)C(=O)Nc3cc(c(C)cc3)Nc4nccc(n4)-c5cnccc5
15134	sp|P9WI83|PKNA_MYC	P00519	70.3	240.0	543.0	DB01254	approved; investigational	Dasatinib	OCCN1CCN(CC1)c2nc(C)nc(c2)Nc3ncc(s3)C(=O)Nc4c(C)cccc4Cl
15135	sp|P9WI83|PKNA_MYC	P00519	70.3	240.0	543.0	DB03878	experimental	N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide	c1ccncc1C(=O)Nc2ccc(C)c(c2)Nc3nccc(n3)-c4cccnc4
15136	sp|P9WI83|PKNA_MYC	P00519	70.3	240.0	543.0	DB04868	approved; investigational	Nilotinib	Cc1cn(cn1)-c2cc(cc(c2)C(F)(F)F)NC(=O)c3ccc(C)c(c3)Nc4nccc(n4)-c5cnccc5
15137	sp|P9WI83|PKNA_MYC	P00519	70.3	240.0	543.0	DB05184	investigational	XL228	 
15138	sp|P9WI83|PKNA_MYC	P00519	70.3	240.0	543.0	DB06616	approved	Bosutinib	COc1cc(c(Cl)cc1Cl)Nc2c(C#N)cnc(c23)cc(c(c3)OC)OCCCN4CCN(C)CC4
15139	sp|P9WI83|PKNA_MYC	P00519	70.3	240.0	543.0	DB07831	experimental	2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE	CCCc1ccc(cc1C(F)(F)F)NC(=O)c2ccccc2NCc3c[nH]c(=O)cc3
15140	sp|P9WI83|PKNA_MYC	P00519	70.3	240.0	543.0	DB08043	experimental	1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA	FC(F)(F)c1cc(ccc1)NC(=O)Nc2ccc(cc2)Oc3ccncc3
15141	sp|P9WI83|PKNA_MYC	P00519	70.3	240.0	543.0	DB08231	experimental	Myristic acid	CCCCCCCCCCCCCC(=O)O
15142	sp|P9WI83|PKNA_MYC	P00519	70.3	240.0	543.0	DB08339	experimental	PD-166326	Clc1cccc(Cl)c1-c(c(=O)n2C)cc(c23)cnc(n3)Nc4cccc(c4)CO
15143	sp|P9WI83|PKNA_MYC	P00519	70.3	240.0	543.0	DB08350	experimental	5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE	COc1ccccc1-c2c[nH]c(c23)ncc(c3)-c4cc(cnc4)C(=O)N(C)C
15144	sp|P9WI83|PKNA_MYC	P00519	70.3	240.0	543.0	DB08583	experimental	2-amino-5-[3-(1-ethyl-1H-pyrazol-5-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-N,N-dimethylbenzamide	CCn1nccc1-c2c[nH]c(c23)ncc(c3)-c4cc(C(=O)N(C)C)c(N)cc4
15145	sp|P9WI83|PKNA_MYC	P00519	70.3	240.0	543.0	DB08896	approved	Regorafenib	CNC(=O)c1cc(ccn1)Oc2cc(F)c(cc2)NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F
15146	sp|P9WI83|PKNA_MYC	P00519	70.3	240.0	543.0	DB08901	approved; investigational	Ponatinib	CN1CCN(CC1)Cc2ccc(cc2C(F)(F)F)NC(=O)c3cc(c(C)cc3)C#Cc4cnc(n45)cccn5
15147	sp|P9WI83|PKNA_MYC	P00519	70.3	240.0	543.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
15148	sp|P9WI83|PKNA_MYC	P00519	70.3	240.0	543.0	DB12267	approved; investigational	Brigatinib	CN1CCN(CC1)C2CCN(CC2)c3cc(OC)c(cc3)Nc4ncc(Cl)c(n4)Nc5ccccc5P(=O)(C)C
15149	sp|P9WI83|PKNA_MYC	P00519	70.3	240.0	543.0	DB12323	investigational	Radotinib	Cc1cn(cn1)-c2cc(cc(c2)C(F)(F)F)NC(=O)c3ccc(C)c(c3)Nc4nccc(n4)-c5cnccn5
15150	sp|P9WI83|PKNA_MYC	O75385	70.77	15.0	320.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
15151	sp|P9WI83|PKNA_MYC	Q16566	71.46	40.0	348.0	DB07664	experimental	K-00546	O=S(=O)(N)c1ccc(cc1)Nc2nc(N)n(n2)C(=S)Nc3c(F)cccc3F
15152	sp|P9WI83|PKNA_MYC	Q16566	71.46	40.0	348.0	DB07676	experimental	3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one	OC[C@@H](O)CCONc1c([nH]c(c12)cccc2)C(C(=O)N=3)=c(c34)cccc4
15153	sp|P9WI83|PKNA_MYC	Q96NX5	74.71	16.0	338.0	DB08009	experimental	SU-11652	CCN(CC)CCNC(=O)c1c(C)[nH]c(c1C)/C=C2\C(=O)Nc(c23)ccc(Cl)c3
15154	sp|P9WI83|PKNA_MYC	Q96NX5	74.71	16.0	338.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
15155	sp|P9WI83|PKNA_MYC	Q13554	70.77	8.0	313.0	DB07168	experimental	[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-(methylamino)pyrimidin-2-yl}amino)phenyl]acetonitrile	N#CCc1ccc(cc1)Nc2nc(NC)cc(n2)Nc3n[nH]c(c3)C4CC4
15156	sp|P9WI83|PKNA_MYC	Q13554	70.77	8.0	313.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
15157	sp|P9WI83|PKNA_MYC	P53355	71.93	6.0	316.0	DB04069	experimental	5,6-Dihydro-Benzo[H]Cinnolin-3-Ylamine	Nc(c1)nnc(c12)c3c(CC2)cccc3
15158	sp|P9WI83|PKNA_MYC	P53355	71.93	6.0	316.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
15159	sp|P9WI83|PKNA_MYC	P53355	71.93	6.0	316.0	DB07444	experimental	6-(3-AMINOPROPYL)-4,9-DIMETHYLPYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE	c1cc(C)cc(c12)c3c(n2CCCN)cc(C)c4c3C(=O)NC4=O
15160	sp|P9WI83|PKNA_MYC	P53355	71.93	6.0	316.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
15161	sp|P9WI83|PKNA_MYC	O96017	74.94	215.0	538.0	DB05149	investigational	XL844	 
15162	sp|P9WI83|PKNA_MYC	O96017	74.94	215.0	538.0	DB06486	investigational	Enzastaurin	c1cccc(c12)c(cn2C)C3=C(C(=O)NC3=O)c4cn(c(c45)cccc5)C6CCN(CC6)Cc7ccccn7
15163	sp|P9WI83|PKNA_MYC	O96017	74.94	215.0	538.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
15164	sp|P9WI83|PKNA_MYC	Q8N568	70.77	388.0	693.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
15165	sp|P9WI83|PKNA_MYC	P53778	70.07	22.0	324.0	DB02482	experimental	Phosphonothreonine	OC(=O)[C@H](N)[C@H](C)OP(=O)(O)O
15166	sp|P9WI83|PKNA_MYC	P53778	70.07	22.0	324.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
15167	sp|P9WI83|PKNA_MYC	P53778	70.07	22.0	324.0	DB05157	investigational	KC706	 
15168	sp|P9WI83|PKNA_MYC	P53778	70.07	22.0	324.0	DB05403	investigational	CEP-1347	COOC(=O)[C@H]1C[C@H](O2)n(c3c4n5[C@]12C)c6c(cc(cc6)CSCC)c3c7c(CNC7=O)c4c8c5ccc(c8)CSCC
15169	sp|P9WI83|PKNA_MYC	P53778	70.07	22.0	324.0	DB01017	approved; investigational	Minocycline	O=C1C(C(=O)N)=C(O)[C@@H](N(C)C)[C@@H]([C@@]12O)C[C@H]3C(=C2O)C(=O)c4c(C3)c(N(C)C)ccc4O
15170	sp|P9WI83|PKNA_MYC	Q92772	74.71	2.0	324.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
15171	sp|P9WI83|PKNA_MYC	Q00532	71.0	2.0	308.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
15172	sp|P9WI83|PKNA_MYC	Q00534	72.39	9.0	321.0	DB03496	experimental; investigational	Alvocidib	CN1CC[C@@H]([C@H](O)C1)c2c(O)cc(O)c(c23)c(=O)cc(o3)-c4ccccc4Cl
15173	sp|P9WI83|PKNA_MYC	Q00534	72.39	9.0	321.0	DB07379	experimental	(2S)-2-({6-[(3-Amino-5-chlorophenyl)amino]-9-isopropyl-9H-purin-2-yl}amino)-3-methyl-1-butanol	n1cn(C(C)C)c(c12)nc(N[C@H](CO)C(C)C)nc2Nc3cc(Cl)cc(N)c3
15174	sp|P9WI83|PKNA_MYC	Q00534	72.39	9.0	321.0	DB07795	experimental	Fisetin	c1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
15175	sp|P9WI83|PKNA_MYC	Q00534	72.39	9.0	321.0	DB09073	approved; investigational	Palbociclib	C1CCCC1n2c(=O)c(C(=O)C)c(C)c(c23)cnc(n3)Nc4ncc(cc4)N5CCNCC5
15176	sp|P9WI83|PKNA_MYC	Q00534	72.39	9.0	321.0	DB11730	approved; investigational	Ribociclib	C1CCCC1n2c(C(=O)N(C)C)cc(c23)cnc(n3)Nc4ccc(cn4)N5CCNCC5
15177	sp|P9WI83|PKNA_MYC	Q00534	72.39	9.0	321.0	DB12001	approved; investigational	Abemaciclib	CCN1CCN(CC1)Cc2ccc(nc2)Nc3ncc(F)c(n3)-c(c4)cc(F)c(c45)nc(C)n5C(C)C
15178	sp|P9WI83|PKNA_MYC	O95382	72.62	653.0	966.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
15179	sp|P9WI83|PKNA_MYC	Q9UPZ9	70.07	2.0	304.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
15180	sp|P9WI83|PKNA_MYC	Q2M2I8	77.49	43.0	377.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
15181	sp|P9WI83|PKNA_MYC	Q52WX2	74.01	47.0	366.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
15182	sp|P9WI83|PKNA_MYC	Q9NSY1	76.57	47.0	377.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
15183	sp|P9WI83|PKNA_MYC	Q9HBH9	78.89	79.0	419.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
15184	sp|P9WI83|PKNA_MYC	Q13546	71.46	5.0	313.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
15185	sp|P9WI83|PKNA_MYC	Q8IW41	74.25	22.0	342.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
15186	sp|P9WI83|PKNA_MYC	Q16659	70.53	13.0	317.0	DB01017	approved; investigational	Minocycline	O=C1C(C(=O)N)=C(O)[C@@H](N(C)C)[C@@H]([C@@]12O)C[C@H]3C(=C2O)C(=O)c4c(C3)c(N(C)C)ccc4O
15187	sp|P9WI83|PKNA_MYC	Q16659	70.53	13.0	317.0	DB00945	approved; vet_approved	Acetylsalicylic acid	CC(=O)Oc1ccccc1C(=O)O
15188	sp|P9WI83|PKNA_MYC	P68400	70.77	35.0	340.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
15189	sp|P9WI83|PKNA_MYC	P68400	70.77	35.0	340.0	DB01765	experimental	(5-hydroxyindolo[1,2-a]quinazolin-7-yl)acetic acid	c1cccc(c12)n3c(c2CC(=O)O)[nH]c(=O)c4c3cccc4
15190	sp|P9WI83|PKNA_MYC	P68400	70.77	35.0	340.0	DB02170	experimental	1,8-Di-Hydroxy-4-Nitro-Xanthen-9-One	Oc1ccc([N+]([O-])=O)c(c12)oc3c(c2=O)c(O)ccc3
15191	sp|P9WI83|PKNA_MYC	P68400	70.77	35.0	340.0	DB02709	investigational	Resveratrol	Oc1ccc(cc1)/C=C/c2cc(O)cc(O)c2
15192	sp|P9WI83|PKNA_MYC	P68400	70.77	35.0	340.0	DB03035	experimental	1,8-Di-Hydroxy-4-Nitro-Anthraquinone	Oc1cccc(c12)C(=O)c3c(C2=O)c(O)ccc3[N+]([O-])=O
15193	sp|P9WI83|PKNA_MYC	P68400	70.77	35.0	340.0	DB03127	experimental	Benzamidine	NC(=[NH2+])c1ccccc1
15194	sp|P9WI83|PKNA_MYC	P68400	70.77	35.0	340.0	DB03924	experimental	5,8-Di-Amino-1,4-Dihydroxy-Anthraquinone	Nc1ccc(N)c(c12)C(=O)c3c(C2=O)c(O)ccc3O
15195	sp|P9WI83|PKNA_MYC	P68400	70.77	35.0	340.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
15196	sp|P9WI83|PKNA_MYC	P68400	70.77	35.0	340.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
15197	sp|P9WI83|PKNA_MYC	P68400	70.77	35.0	340.0	DB04462	experimental	Tetrabromo-2-Benzotriazole	n1[nH]nc(c12)c(Br)c(Br)c(Br)c2Br
15198	sp|P9WI83|PKNA_MYC	P68400	70.77	35.0	340.0	DB04719	experimental	DIMETHYL-(4,5,6,7-TETRABROMO-1H-BENZOIMIDAZOL-2-YL)-AMINE	CN(C)c([nH]1)nc(c12)c(Br)c(Br)c(Br)c2Br
15199	sp|P9WI83|PKNA_MYC	P68400	70.77	35.0	340.0	DB04720	experimental	S-METHYL-4,5,6,7-TETRABROMO-BENZIMIDAZOLE	CSc([nH]1)nc(c12)c(Br)c(Br)c(Br)c2Br
15200	sp|P9WI83|PKNA_MYC	P68400	70.77	35.0	340.0	DB04721	experimental	N1,N2-ETHYLENE-2-METHYLAMINO-4,5,6,7-TETRABROMO-BENZIMIDAZOLE	CN1CCn(c12)c3c(n2)c(Br)c(Br)c(Br)c3Br
15201	sp|P9WI83|PKNA_MYC	P68400	70.77	35.0	340.0	DB07715	investigational	Emodin	Cc(c1)cc(O)c(c12)C(=O)c3c(C2=O)cc(O)cc3O
15202	sp|P9WI83|PKNA_MYC	P68400	70.77	35.0	340.0	DB07802	experimental	3,8-DIBROMO-7-HYDROXY-4-METHYL-2H-CHROMEN-2-ONE	Cc1c(Br)c(=O)oc(c12)c(Br)c(O)cc2
15203	sp|P9WI83|PKNA_MYC	P68400	70.77	35.0	340.0	DB08338	experimental	19-(cyclopropylamino)-4,6,7,15-tetrahydro-5H-16,1-(azenometheno)-10,14-(metheno)pyrazolo[4,3-o][1,3,9]triazacyclohexadecin-8(9H)-one	O=C(N1)CCCCc2cnn(c(n3)NC4CC4)c2nc3Nc(c5)cccc15
15204	sp|P9WI83|PKNA_MYC	P68400	70.77	35.0	340.0	DB08340	experimental	N,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE-2,4-DIAMINE	c1ccccc1Nc(nc(n23)ccn3)nc2Nc4ccccc4
15205	sp|P9WI83|PKNA_MYC	P68400	70.77	35.0	340.0	DB08345	experimental	4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE	c1nc[nH]c1CCNc2nc(nc(n23)c(cn3)C#N)Nc4ccccc4
15206	sp|P9WI83|PKNA_MYC	P68400	70.77	35.0	340.0	DB08353	experimental	2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE	c1ccccc1Nc2nc(nc(n23)c(cn3)C#N)NCC4CCCCC4
15207	sp|P9WI83|PKNA_MYC	P68400	70.77	35.0	340.0	DB08354	experimental	2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE	Clc1ccc(cc1)CNc(nc(n23)c(cn3)C#N)nc2Nc4ccccc4
15208	sp|P9WI83|PKNA_MYC	P68400	70.77	35.0	340.0	DB08360	experimental	2-(4-ETHYLPIPERAZIN-1-YL)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE	CCN1CCN(CC1)c(nc(n23)c(cn3)C#N)nc2Nc4ccccc4
15209	sp|P9WI83|PKNA_MYC	P68400	70.77	35.0	340.0	DB08362	experimental	N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE	CC(=O)Nc1cccc(c1)Nc(nc(n23)c(cn3)C#N)nc2Nc4ccccc4
15210	sp|P9WI83|PKNA_MYC	P68400	70.77	35.0	340.0	DB08473	experimental	Dichlororibofuranosylbenzimidazole	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)cc(Cl)c(Cl)c3
15211	sp|P9WI83|PKNA_MYC	P68400	70.77	35.0	340.0	DB08660	experimental	Quinalizarin	Oc1ccc(O)c(c12)C(=O)c3c(C2=O)ccc(O)c3O
15212	sp|P9WI83|PKNA_MYC	P68400	70.77	35.0	340.0	DB08846	investigational	Ellagic acid	Oc(c1)c(O)c(c2c13)oc(=O)c4c2c(oc3=O)c(O)c(c4)O
15213	sp|P9WI83|PKNA_MYC	P68400	70.77	35.0	340.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
15214	sp|P9WI83|PKNA_MYC	P30291	78.19	292.0	629.0	DB04608	experimental	9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE	c1cc(O)cc(c12)c3c([nH]2)cc(c4c3C(=O)NC4=O)-c5ccccc5
15215	sp|P9WI83|PKNA_MYC	P30291	78.19	292.0	629.0	DB07006	experimental	9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE	COc1ccccc1-c2cc(c3c(c24)C(=O)NC4=O)n(CCCO)c5c3cc(O)cc5
15216	sp|P9WI83|PKNA_MYC	P30291	78.19	292.0	629.0	DB07226	experimental	N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE	Clc1ccccc1-c2cc(c3c(c24)C(=O)NC4=O)[nH]c5c3cc(cc5)NC=O
15217	sp|P9WI83|PKNA_MYC	P30291	78.19	292.0	629.0	DB07257	experimental	4-(2-chlorophenyl)-8-(2-hydroxyethyl)-6-methylpyrrolo[3,4-e]indole-1,3(2H,6H)-dione	OCCc(cn1C)c(c12)c3c(C(=O)NC3=O)c(c2)-c4ccccc4Cl
15218	sp|P9WI83|PKNA_MYC	P30291	78.19	292.0	629.0	DB07265	experimental	3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID	Oc(c1)ccc(c12)n(CCC(=O)O)c3c2c4c(C(=O)NC4=O)c(c3)-c5ccccc5
15219	sp|P9WI83|PKNA_MYC	P30291	78.19	292.0	629.0	DB08365	experimental	8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide	OCCNC(=O)c(c1Br)n(C)c(c12)cc(c3c2C(=O)NC3=O)-c4c(Cl)cccc4
15220	sp|P9WI83|PKNA_MYC	P30291	78.19	292.0	629.0	DB11740	investigational	MK-1775	CN1CCN(CC1)c2ccc(cc2)Nc(n3)ncc(c34)c(=O)n(CC=C)n4-c5nc(C(C)(C)O)ccc5
15221	sp|P9WI83|PKNA_MYC	P30291	78.19	292.0	629.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
15223	sp|P9WI83|PKNA_MYC	Q13873	75.41	202.0	527.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
15224	sp|P9WI83|PKNA_MYC	P48729	73.32	10.0	326.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
15225	sp|P9WI83|PKNA_MYC	Q16671	72.85	205.0	519.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
15226	sp|P9WFQ7|PLPHP_MY	O94903	92.64	13.0	252.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
15227	sp|P9WFQ7|PLPHP_MY	O94903	92.64	13.0	252.0	DB00172	nutraceutical	Proline	OC(=O)[C@@H]1CCCN1
15228	sp|P9WHU9|PROB_MYC	P54886	77.93	62.0	355.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
15229	sp|P9WGW1|RUVB_MYC	Q56313	94.19	5.0	329.0	DB02210	experimental	Hexane-1,6-Diol	OCCCCCCO
15230	sp|P9WGW1|RUVB_MYC	Q5SL87	92.15	3.0	320.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
15231	sp|P9WGE7|SODF_MYC	P04179	94.2	25.0	220.0	DB03297	experimental	Benzylsulfonic acid	OS(=O)(=O)Cc1ccccc1
15232	sp|P9WGE7|SODF_MYC	P04179	94.2	25.0	220.0	DB04436	experimental	3-Fluoro-L-tyrosine	OC(=O)[C@@H](N)Cc1cc(F)c(O)cc1
15233	sp|P9WHV1|PROA_MYC	P54886	98.31	362.0	770.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
15234	sp|P9WHV1|PROA_MYC	P00352	95.66	64.0	461.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
15235	sp|P9WHV1|PROA_MYC	P00352	95.66	64.0	461.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
15236	sp|P9WHV1|PROA_MYC	P00352	95.66	64.0	461.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
15237	sp|P9WHV1|PROA_MYC	P00352	95.66	64.0	461.0	DB04447	experimental	1,4-Dithiothreitol	SC[C@H](O)[C@@H](O)CS
15238	sp|P9WHV1|PROA_MYC	P47895	95.66	75.0	472.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
15239	sp|P9WHV1|PROA_MYC	P47895	95.66	75.0	472.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
15240	sp|P9WHV1|PROA_MYC	O94788	97.83	77.0	483.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
15241	sp|P9WHV1|PROA_MYC	O94788	97.83	77.0	483.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
15242	sp|P9WHV1|PROA_MYC	O94788	97.83	77.0	483.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
15243	sp|P9WHV1|PROA_MYC	O75891	96.14	464.0	863.0	DB00116	nutraceutical	Tetrahydrofolic acid	Nc([nH]1)nc(=O)c(c12)NC(CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
15244	sp|P9WHV1|PROA_MYC	P30837	97.11	80.0	483.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
15245	sp|P9WHV1|PROA_MYC	P05091	97.35	79.0	483.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
15246	sp|P9WHV1|PROA_MYC	P05091	97.35	79.0	483.0	DB00536	approved	Guanidine	NC(N)=N
15247	sp|P9WHV1|PROA_MYC	P05091	97.35	79.0	483.0	DB00822	approved	Disulfiram	CCN(CC)C(=S)SSC(=S)N(CC)CC
15248	sp|P9WHV1|PROA_MYC	P05091	97.35	79.0	483.0	DB02115	experimental	Daidzin	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)Oc(c2)ccc(c23)c(=O)c(co3)-c4ccc(O)cc4
15249	sp|P9WHV1|PROA_MYC	P05091	97.35	79.0	483.0	DB04381	experimental	Crotonaldehyde	O=C/C=C/C
15250	sp|P9WHV1|PROA_MYC	Q59931	97.83	35.0	441.0	DB02263	experimental	Glyceraldehyde-3-Phosphate	O=C[C@H](O)COP(=O)(O)O
15251	sp|P9WHV1|PROA_MYC	Q59931	97.83	35.0	441.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
15252	sp|P9WHV1|PROA_MYC	P51648	70.36	94.0	386.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
15253	sp|P9WHV1|PROA_MYC	P30838	85.78	4.0	360.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
15254	sp|P9WHV1|PROA_MYC	P25553	90.6	49.0	425.0	DB03619	approved	Deoxycholic acid	C1C[C@@H](O)C[C@H]([C@]12C)CC[C@@H]3[C@@H]2C[C@H](O)[C@@]4(C)[C@H]3CC[C@@H]4[C@H](C)CCC(=O)O
15255	sp|P9WHV1|PROA_MYC	P49189	96.39	48.0	448.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
15256	sp|P9WHV1|PROA_MYC	P77674	95.18	39.0	434.0	DB04401	experimental	Betaine aldehyde	C[N+](C)(C)CC=O
15257	sp|P9WHV1|PROA_MYC	P49419	92.05	89.0	471.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
15258	sp|P9WHV1|PROA_MYC	P49419	92.05	89.0	471.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
15259	sp|P9WHV1|PROA_MYC	P43353	79.28	29.0	358.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
15260	sp|P9WHV1|PROA_MYC	P09546	91.81	682.0	1063.0	DB03051	experimental	(S)-2-Tetrahydrofuroic acid	OC(=O)[C@H]1CCCO1
15261	sp|P9WHV1|PROA_MYC	P09546	91.81	682.0	1063.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
15262	sp|P9WHV1|PROA_MYC	P09546	91.81	682.0	1063.0	DB04398	approved; vet_approved	Lactic acid	CC(O)C(=O)O
15263	sp|P9WHV1|PROA_MYC	Q02252	80.24	139.0	472.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
15264	sp|P9WHV1|PROA_MYC	P83849	88.92	74.0	443.0	DB03564	experimental	(4r)-2-Methylpentane-2,4-Diol	C[C@H](O)CC(C)(C)O
15265	sp|P9WHV1|PROA_MYC	P30038	94.7	108.0	501.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
15266	sp|P9WGT9|PSTS2_MY	P0AG82	83.24	25.0	333.0	DB02799	experimental	N-[2-(1-Maleimidyl)Ethyl]-7-Diethylaminocoumarin-3-Carboxamide	CCN(CC)c(cc1)cc(c12)oc(=O)c(c2)C(=O)N/C=C\N3C(=O)CCC3=O
15267	sp|P9WGT9|PSTS2_MY	P0AG82	83.24	25.0	333.0	DB02831	experimental	Dihydrogenphosphate	OP([O-])(=O)O
15268	sp|P9WHL9|PURK_MYC	P33221	87.18	11.0	385.0	DB02236	experimental	Glycinamide Ribonucleotide	NCC(=O)NC1O[C@@H]([C@@H](O)[C@H]1O)COP(=O)(O)O
15269	sp|P9WHL9|PURK_MYC	P33221	87.18	11.0	385.0	DB02930	experimental	Adenosine 5'-[gamma-thio]triphosphate	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=S)(O)O
15270	sp|P9WHL9|PURK_MYC	P33221	87.18	11.0	385.0	DB03434	experimental	3-(N-morpholino)propanesulfonic acid	OS(=O)(=O)CCCN1CCOCC1
15271	sp|P9WHL9|PURK_MYC	P33221	87.18	11.0	385.0	DB03909	experimental	Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate	OP(=O)(O)CP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
15272	sp|P9WHL9|PURK_MYC	P33221	87.18	11.0	385.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
15273	sp|P9WHL9|PURK_MYC	Q96RQ3	76.92	44.0	374.0	DB00121	approved; investigational; nutraceutical	Biotin	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC(=O)O
15274	sp|P9WHL9|PURK_MYC	P05165	74.83	65.0	386.0	DB00121	approved; investigational; nutraceutical	Biotin	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC(=O)O
15275	sp|P9WHL9|PURK_MYC	P24182	75.99	4.0	330.0	DB08074	experimental	3-(3-Methyl-2-buten-1-yl)-3H-purin-6-amine	CC(C)=CCn1cnc(N)c(c12)ncn2
15276	sp|P9WHL9|PURK_MYC	P24182	75.99	4.0	330.0	DB08075	experimental	4-(2-amino-1,3-thiazol-4-yl)pyrimidin-2-amine	Nc1nc(cs1)-c2nc(N)ncc2
15277	sp|P9WHL9|PURK_MYC	P24182	75.99	4.0	330.0	DB08076	experimental	4-[1-(2,6-dichlorobenzyl)-2-methyl-1H-imidazol-4-yl]pyrimidin-2-amine	Nc1nccc(n1)-c2nc(C)n(c2)Cc3c(Cl)cccc3Cl
15278	sp|P9WHL9|PURK_MYC	P24182	75.99	4.0	330.0	DB08144	experimental	6-(2,6-dibromophenyl)pyrido[2,3-d]pyrimidine-2,7-diamine	c1nc(N)nc(c12)nc(N)c(c2)-c3c(Br)cccc3Br
15279	sp|P9WHL9|PURK_MYC	P24182	75.99	4.0	330.0	DB08145	experimental	6-(2,6-DIMETHOXYPHENYL)PYRIDO[2,3-D]PYRIMIDINE-2,7-DIAMINE	COc1cccc(OC)c1-c(c(n2)N)cc(c23)cnc(n3)N
15280	sp|P9WHL9|PURK_MYC	P24182	75.99	4.0	330.0	DB08146	experimental	7-(2,5-dihydropyrrol-1-yl)-6-phenyl-pyrido[6,5-d]pyrimidin-2-amine	c1nc(N)nc(c12)nc(N3CC=CC3)c(c2)-c4ccccc4
15281	sp|P9WHL9|PURK_MYC	P24182	75.99	4.0	330.0	DB08314	experimental	(2-AMINO-1,3-OXAZOL-5-YL)-(3-BROMOPHENYL)METHANONE	Nc1ncc(o1)C(=O)c2cc(Br)ccc2
15282	sp|P9WHL9|PURK_MYC	P24182	75.99	4.0	330.0	DB08315	experimental	2-AMINO-N,N-BIS(PHENYLMETHYL)-1,3-OXAZOLE-5-CARBOXAMIDE	c1ccccc1CN(C(=O)c2oc(N)nc2)Cc3ccccc3
15283	sp|P9WHL9|PURK_MYC	P24182	75.99	4.0	330.0	DB08316	experimental	4-amino-7,7-dimethyl-7,8-dihydroquinazolin-5(6H)-one	CC(C)(C1)CC(=O)c(c12)c(N)ncn2
15284	sp|P9WHL9|PURK_MYC	P24182	75.99	4.0	330.0	DB08317	experimental	5-methyl-6-phenylquinazoline-2,4-diamine	Nc1nc(N)nc(c12)ccc(c2C)-c3ccccc3
15285	sp|P9WHL9|PURK_MYC	P24182	75.99	4.0	330.0	DB08318	experimental	6-(2-phenoxyethoxy)-1,3,5-triazine-2,4-diamine	Nc1nc(nc(n1)N)OCCOc2ccccc2
15286	sp|P9WHL9|PURK_MYC	P11498	75.06	37.0	359.0	DB00119	approved; investigational; nutraceutical	Pyruvic acid	CC(=O)C(=O)O
15287	sp|P9WHL9|PURK_MYC	P11498	75.06	37.0	359.0	DB00121	approved; investigational; nutraceutical	Biotin	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC(=O)O
15288	sp|P9WHL9|PURK_MYC	P11498	75.06	37.0	359.0	DB07497	experimental	5-(HEXAHYDRO-2-OXO-1H-THIENO[3,4-D]IMIDAZOL-6-YL)PENTANAL	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC=O
15289	sp|P9WHL9|PURK_MYC	A0A0H3JRU9	74.36	5.0	324.0	DB07497	experimental	5-(HEXAHYDRO-2-OXO-1H-THIENO[3,4-D]IMIDAZOL-6-YL)PENTANAL	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC=O
15290	sp|P9WQP5|6PGL_MYC	Q9KL51	93.93	5.0	237.0	DB03556	experimental	2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400	CCOCCOCCOCCOCCOCCOCCOCCOCCO
15291	sp|P9WQP5|6PGL_MYC	O95479	92.31	560.0	788.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
15292	sp|P9WQP5|6PGL_MYC	Q9X0N8	81.38	17.0	218.0	DB01942	experimental; investigational	Formic acid	OC=O
15293	sp|P9WQP5|6PGL_MYC	Q9X0N8	81.38	17.0	218.0	DB04272	approved; nutraceutical; vet_approved	Citric acid	OC(=O)CC(O)(C(=O)O)CC(=O)O
15294	sp|P9WQP5|6PGL_MYC	P0A759	96.76	8.0	247.0	DB02445	experimental	2-Deoxy-2-Amino Glucitol-6-Phosphate	OC[C@H](N)[C@@H](O)[C@H](O)[C@H](O)COP(=O)(O)O
15295	sp|P9WQP5|6PGL_MYC	P0A759	96.76	8.0	247.0	DB03951	experimental	N-acetyl-D-glucosamine-6-phosphate	CC(=O)N[C@H]1C(O)O[C@@H]([C@@H](O)[C@@H]1O)COP(=O)(O)O
15296	sp|P9WQP5|6PGL_MYC	P46926	85.83	35.0	247.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
15297	sp|P9WQP5|6PGL_MYC	P46926	85.83	35.0	247.0	DB02445	experimental	2-Deoxy-2-Amino Glucitol-6-Phosphate	OC[C@H](N)[C@@H](O)[C@H](O)[C@H](O)COP(=O)(O)O
15298	sp|P9WQP5|6PGL_MYC	P46926	85.83	35.0	247.0	DB03951	experimental	N-acetyl-D-glucosamine-6-phosphate	CC(=O)N[C@H]1C(O)O[C@@H]([C@@H](O)[C@@H]1O)COP(=O)(O)O
15299	sp|P9WQP5|6PGL_MYC	O35000	88.26	22.0	240.0	DB02726	experimental	2-Phosphoglycolic Acid	OC(=O)COP(=O)(O)O
15300	sp|P9WQP5|6PGL_MYC	O35000	88.26	22.0	240.0	DB04277	experimental	Fructose -6-Phosphate	OCC(=O)[C@@H](O)[C@@H](O)[C@H](O)COP(=O)(O)O
15301	sp|I6X235|ADPP_MYC	O33199	99.52	1.0	207.0	DB01975	experimental	AMPCPR	O[C@H]1O[C@@H]([C@@H](O)[C@H]1O)COP(=O)(O)CP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3cnc(c34)c(N)ncn4
15302	sp|I6X235|ADPP_MYC	O33199	99.52	1.0	207.0	DB02059	experimental	Adenosine-5-Diphosphoribose	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)CO[P@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H](O)[C@H](O)[C@@H]4O
15303	sp|I6X235|ADPP_MYC	O33199	99.52	1.0	207.0	DB03148	experimental	Adenosine 5'-methylenediphosphate	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)CP(=O)(O)O
15304	sp|I6X235|ADPP_MYC	P83844	87.44	13.0	194.0	DB01975	experimental	AMPCPR	O[C@H]1O[C@@H]([C@@H](O)[C@H]1O)COP(=O)(O)CP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3cnc(c34)c(N)ncn4
15305	sp|I6X235|ADPP_MYC	P83844	87.44	13.0	194.0	DB02059	experimental	Adenosine-5-Diphosphoribose	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)CO[P@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H](O)[C@H](O)[C@@H]4O
15306	sp|I6X235|ADPP_MYC	Q84CU3	75.36	13.0	169.0	DB02053	experimental	Ribose-5-phosphate	O=C[C@H](O)[C@H](O)[C@H](O)COP(=O)(O)O
15307	sp|I6X235|ADPP_MYC	Q84CU3	75.36	13.0	169.0	DB02059	experimental	Adenosine-5-Diphosphoribose	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)CO[P@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H](O)[C@H](O)[C@@H]4O
15308	sp|P9WQ91|ALAA_MYC	Q56232	87.18	8.0	382.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
15309	sp|P9WQ91|ALAA_MYC	Q56232	87.18	8.0	382.0	DB04299	experimental	Maleic Acid	OC(=O)/C=C\C(=O)O
15310	sp|P9WQ91|ALAA_MYC	Q16773	91.84	27.0	421.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
15311	sp|P9WQ91|ALAA_MYC	Q16773	91.84	27.0	421.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
15312	sp|P9WQ91|ALAA_MYC	Q16773	91.84	27.0	421.0	DB02556	experimental	D-Phenylalanine	OC(=O)[C@H](N)Cc1ccccc1
15313	sp|P9WQ91|ALAA_MYC	Q16773	91.84	27.0	421.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
15314	sp|P9WQ91|ALAA_MYC	Q16773	91.84	27.0	421.0	DB07950	experimental	Indoleacetic acid	OC(=O)Cc1c[nH]c(c12)cccc2
15315	sp|P9WQ91|ALAA_MYC	P17735	89.28	54.0	437.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
15316	sp|P9WQ91|ALAA_MYC	P17735	89.28	54.0	437.0	DB00120	approved; investigational; nutraceutical	Phenylalanine	OC(=O)[C@@H](N)Cc1ccccc1
15317	sp|P9WQ91|ALAA_MYC	P17735	89.28	54.0	437.0	DB00135	approved; investigational; nutraceutical	Tyrosine	OC(=O)[C@@H](N)Cc1ccc(O)cc1
15318	sp|P9WQ91|ALAA_MYC	P17735	89.28	54.0	437.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
15319	sp|P9WQ91|ALAA_MYC	Q6YP21	93.01	52.0	451.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
15320	sp|P9WQ91|ALAA_MYC	P33447	88.58	29.0	409.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
15321	sp|P9WQ91|ALAA_MYC	Q8TD30	90.91	128.0	518.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
15322	sp|P9WQ91|ALAA_MYC	Q8TD30	90.91	128.0	518.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
15323	sp|P9WQ91|ALAA_MYC	Q8TD30	90.91	128.0	518.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
15324	sp|P9WQ91|ALAA_MYC	Q8TD30	90.91	128.0	518.0	DB00780	approved	Phenelzine	NNCCc1ccccc1
15325	sp|P9WQ91|ALAA_MYC	P24298	91.14	100.0	491.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
15326	sp|P9WQ91|ALAA_MYC	P24298	91.14	100.0	491.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
15327	sp|P9WQ91|ALAA_MYC	P24298	91.14	100.0	491.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
15328	sp|P9WQ91|ALAA_MYC	P24298	91.14	100.0	491.0	DB00780	approved	Phenelzine	NNCCc1ccccc1
15329	sp|P9WQ91|ALAA_MYC	Q75WK2	81.82	17.0	368.0	DB02024	experimental	3-phenylpropionic acid	OC(=O)CCc1ccccc1
15330	sp|P9WQ91|ALAA_MYC	Q75WK2	81.82	17.0	368.0	DB02238	experimental	4-methylthio-2-oxobutanoic acid	CSCCC(=O)C(=O)O
15331	sp|P9WQ91|ALAA_MYC	Q8N5Z0	93.94	17.0	420.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
15332	sp|P9WQ91|ALAA_MYC	Q8N5Z0	93.94	17.0	420.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
15333	sp|P9WQ91|ALAA_MYC	Q9X0L5	87.88	29.0	406.0	DB01942	experimental; investigational	Formic acid	OC=O
15334	sp|P9WQ91|ALAA_MYC	Q96QU6	86.01	109.0	478.0	DB03214	experimental	Vinylglycine	OC(=O)[C@@H](N)C=C
15335	sp|P9WQ91|ALAA_MYC	Q2TU84	79.95	31.0	374.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
15336	sp|P9WQ91|ALAA_MYC	Q2TU84	79.95	31.0	374.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
15337	sp|P9WQ91|ALAA_MYC	P17174	79.95	31.0	374.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
15338	sp|P9WQ91|ALAA_MYC	P17174	79.95	31.0	374.0	DB00128	approved; nutraceutical	Aspartic acid	OC(=O)[C@@H](N)CC(=O)O
15339	sp|P9WQ91|ALAA_MYC	P17174	79.95	31.0	374.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
15340	sp|P9WQ91|ALAA_MYC	P17174	79.95	31.0	374.0	DB00151	approved; nutraceutical	Cysteine	OC(=O)[C@@H](N)CS
15341	sp|P9WQ91|ALAA_MYC	P17174	79.95	31.0	374.0	DB00210	approved	Adapalene	C1C(C2)CC(C3)CC1CC23c4c(OC)ccc(c4)-c(cc5)cc(c56)ccc(c6)C(=O)O
15342	sp|P9WQ91|ALAA_MYC	P17174	79.95	31.0	374.0	DB04299	experimental	Maleic Acid	OC(=O)/C=C\C(=O)O
15343	sp|P9WQ91|ALAA_MYC	P17174	79.95	31.0	374.0	DB09130	approved; investigational	Copper	[Cu]
15344	sp|P9WQ91|ALAA_MYC	P00505	81.82	59.0	410.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
15345	sp|P9WQ91|ALAA_MYC	P00505	81.82	59.0	410.0	DB00128	approved; nutraceutical	Aspartic acid	OC(=O)[C@@H](N)CC(=O)O
15346	sp|P9WQ91|ALAA_MYC	P00505	81.82	59.0	410.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
15347	sp|P9WQ91|ALAA_MYC	P00505	81.82	59.0	410.0	DB00151	approved; nutraceutical	Cysteine	OC(=O)[C@@H](N)CS
15348	sp|P9WQ91|ALAA_MYC	P00505	81.82	59.0	410.0	DB02783	experimental	4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate	Cc1ncc(COP(=O)(O)O)c(c1O)CNOCC(=O)O
15349	sp|P9WQ91|ALAA_MYC	P00509	78.79	20.0	358.0	DB01639	experimental	N-Methyl-Pyridoxal-5'-Phosphate	Cc1c(O)c(C=O)c(c[n+]1C)COP(=O)(O)O
15350	sp|P9WQ91|ALAA_MYC	P00509	78.79	20.0	358.0	DB02024	experimental	3-phenylpropionic acid	OC(=O)CCc1ccccc1
15351	sp|P9WQ91|ALAA_MYC	P00509	78.79	20.0	358.0	DB02758	experimental	Indolepropionic acid	OC(=O)CCc1c[nH]c(c12)cccc2
15352	sp|P9WQ91|ALAA_MYC	P00509	78.79	20.0	358.0	DB02981	experimental	Vitamin B6 Complexed with 2-Amino-Hexanoic Acid	CCCC[C@@H](C(=O)O)NCc1c(COP(=O)(O)O)cnc(C)c1O
15353	sp|P9WQ91|ALAA_MYC	P00509	78.79	20.0	358.0	DB03553	experimental	Glutaric Acid	OC(=O)CCCC(=O)O
15354	sp|P9WQ91|ALAA_MYC	P00509	78.79	20.0	358.0	DB03629	experimental	Pyridoxal-5'-Phosphate-N-Oxide	Cc1c(O)c(C=O)c(c[n+]1[O-])COP(=O)(O)O
15355	sp|P9WQ91|ALAA_MYC	P00509	78.79	20.0	358.0	DB03662	experimental	Vitamin B6 Complexed with 2-Amino-Pentanoic Acid	CCC[C@@H](C(=O)O)NCc1c(O)c(C)ncc1COP(=O)(O)O
15356	sp|P9WQ91|ALAA_MYC	P00509	78.79	20.0	358.0	DB03750	experimental	Isovaleric Acid	CC(C)CC(=O)O
15357	sp|P9WQ91|ALAA_MYC	P00509	78.79	20.0	358.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
15358	sp|P9WQ91|ALAA_MYC	P00509	78.79	20.0	358.0	DB04299	experimental	Maleic Acid	OC(=O)/C=C\C(=O)O
15359	sp|P9WQ91|ALAA_MYC	P00509	78.79	20.0	358.0	DB04467	experimental	N-(5'-phosphopyridoxyl)-L-alanine	OC(=O)[C@H](C)NCc1c(COP(=O)(O)O)cnc(C)c1O
15360	sp|P9WQ91|ALAA_MYC	P00509	78.79	20.0	358.0	DB04762	experimental	N-PYRIDOXYL-D-GLUTAMIC ACID-5'-MONOPHOSPHATE	Cc1ncc(COP(=O)(O)O)c(c1O)CN[C@@H](C(=O)O)CCC(=O)O
15361	sp|P9WQ91|ALAA_MYC	P00509	78.79	20.0	358.0	DB04765	experimental	N-PYRIDOXYL-2-METHYL-L-GLUTAMIC ACID-5'-MONOPHOSPHATE	Cc1ncc(COP(=O)(O)O)c(c1O)CN[C@](C)(C(=O)O)CCC(=O)O
15362	sp|P9WQ91|ALAA_MYC	P00509	78.79	20.0	358.0	DB08845	experimental; investigational; nutraceutical	Oxogluric acid	OC(=O)CCC(=O)C(=O)O
15363	sp|P9WQ91|ALAA_MYC	P95468	76.69	31.0	360.0	DB02024	experimental	3-phenylpropionic acid	OC(=O)CCc1ccccc1
15364	sp|P9WQ91|ALAA_MYC	P95468	76.69	31.0	360.0	DB02242	experimental	Cyclohexanepropanoic acid	OC(=O)CCC1CCCCC1
15365	sp|P9WQ91|ALAA_MYC	P95468	76.69	31.0	360.0	DB02434	experimental	4-(2-Thienyl)Butyric Acid	OC(=O)CCCc1cccs1
15366	sp|P9WQ91|ALAA_MYC	P95468	76.69	31.0	360.0	DB02740	experimental	3-Indolebutyric Acid	OC(=O)CCCc1c[nH]c(c12)cccc2
15367	sp|P9WQ91|ALAA_MYC	P95468	76.69	31.0	360.0	DB02758	experimental	Indolepropionic acid	OC(=O)CCc1c[nH]c(c12)cccc2
15368	sp|P9WQ91|ALAA_MYC	P95468	76.69	31.0	360.0	DB03210	experimental	4-Aminohydrocinnamic Acid	Nc1ccc(cc1)CCC(=O)O
15369	sp|P9WQ91|ALAA_MYC	P95468	76.69	31.0	360.0	DB03400	experimental	3-(P-Tolyl)Propionic Acid	Cc1ccc(cc1)CCC(=O)O
15370	sp|P9WQ91|ALAA_MYC	P95468	76.69	31.0	360.0	DB04051	experimental	5-phenylpentanoic acid	OC(=O)CCCCc1ccccc1
15371	sp|P9WQ91|ALAA_MYC	P95468	76.69	31.0	360.0	DB04208	experimental	3-(3,4-dimethoxyphenyl)propanoic acid	COc1c(OC)cc(cc1)CCC(=O)O
15372	sp|P9WQ91|ALAA_MYC	P95468	76.69	31.0	360.0	DB04299	experimental	Maleic Acid	OC(=O)/C=C\C(=O)O
15373	sp|P9WQ91|ALAA_MYC	P95468	76.69	31.0	360.0	DB06819	approved; investigational	Phenylbutyric acid	OC(=O)CCCc1ccccc1
15375	sp|P9WND5|LLDD_MYC	Q9UJM8	86.23	4.0	361.0	DB02164	experimental	N-sulfo-flavin mononucleotide	O=c1[nH]c(=O)nc(c12)n(c3c([n+]2S([O-])(=O)=O)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)COP(=O)(O)O
15376	sp|P9WND5|LLDD_MYC	Q9UJM8	86.23	4.0	361.0	DB02279	experimental	Benzoylformic Acid	OC(=O)C(=O)c1ccccc1
15377	sp|P9WND5|LLDD_MYC	Q9UJM8	86.23	4.0	361.0	DB03064	experimental	3-Decyl-2,5-Dioxo-4-Hydroxy-3-Pyrroline	CCCCCCCCCCC1=C(O)C(=O)NC1=O
15378	sp|P9WND5|LLDD_MYC	Q9UJM8	86.23	4.0	361.0	DB03247	approved; investigational	Flavin mononucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)COP(=O)(O)O
15379	sp|P9WND5|LLDD_MYC	Q9UJM8	86.23	4.0	361.0	DB03884	experimental	Phenylpyruvic acid	OC(=O)C(=O)Cc1ccccc1
15380	sp|P9WND5|LLDD_MYC	Q9UJM8	86.23	4.0	361.0	DB04374	experimental	4-Carboxy-5-(1-Pentyl)Hexylsulfanyl-1,2,3-Triazole	CCCCCC(CCCCC)Sc1c(C(=O)O)nn[nH]1
15381	sp|P9WND5|LLDD_MYC	Q9UJM8	86.23	4.0	361.0	DB06979	experimental	5-(dodecylthio)-1H-1,2,3-triazole-4-carboxylic acid	CCCCCCCCCCCCSc1c(C(=O)O)nn[nH]1
15382	sp|P9WND5|LLDD_MYC	Q9UJM8	86.23	4.0	361.0	DB07060	experimental	3-(INDOL-3-YL) LACTATE	OC(=O)[C@@H](O)Cc1c[nH]c(c12)cccc2
15383	sp|P9WND5|LLDD_MYC	Q9UJM8	86.23	4.0	361.0	DB07907	experimental	(2S)-2-HYDROXYOCTANOIC ACID	OC(=O)[C@@H](O)CCCCCC
15384	sp|P9WJS1|MOAA2_MY	P65389	85.28	3.0	310.0	DB04447	experimental	1,4-Dithiothreitol	SC[C@H](O)[C@@H](O)CS
15385	sp|P9WJJ7|NADC_MYC	P9WJJ7	99.65	1.0	285.0	DB01796	experimental	Quinolinic Acid	OC(=O)c1cccnc1C(=O)O
15386	sp|P9WJJ7|NADC_MYC	P9WJJ7	99.65	1.0	285.0	DB02382	experimental	Namn	OP([O-])(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)[n+]2cccc(c2)C(=O)O
15387	sp|P9WJJ7|NADC_MYC	P9WJJ7	99.65	1.0	285.0	DB02746	experimental	Phthalic Acid	OC(=O)c1ccccc1C(=O)O
15388	sp|P9WJJ7|NADC_MYC	P9WJJ7	99.65	1.0	285.0	DB04294	experimental	5-Phosphoribosyl-1-(Beta-Methylene) Pyrophosphate	OP(=O)(O)CP(=O)(O)O[C@@H]1[C@H](O)[C@H](O)[C@H](O1)COP(=O)(O)O
15389	sp|P9WJJ7|NADC_MYC	P30012	95.44	23.0	295.0	DB01796	experimental	Quinolinic Acid	OC(=O)c1cccnc1C(=O)O
15390	sp|P9WJJ7|NADC_MYC	Q15274	94.04	16.0	284.0	DB00627	approved; investigational; nutraceutical	Niacin	OC(=O)c1cnccc1
15391	sp|P9WIV7|NUOF_MYC	P49821	89.21	51.0	448.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
15392	sp|P9WKH3|MHUD_MYC	Q81C15	74.29	9.0	87.0	DB01942	experimental; investigational	Formic acid	OC=O
15393	sp|P9WJL1|MURF_MYC	Q8DNV6	77.45	2.0	397.0	DB06970	experimental	2-CHLORO-N-(3-CYANO-5,6-DIHYDRO-4H-CYCLOPENTA[B]THIOPHEN-2-YL)-5-DIETHYLSULFAMOYL-BENZAMIDE	CCN(CC)S(=O)(=O)c1ccc(Cl)c(c1)C(=O)Nc(s2)c(C#N)c(c23)CCC3
15394	sp|P9WJL1|MURF_MYC	P22188	72.35	16.0	385.0	DB02314	experimental	Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine-D-Glutamate	OC(=O)CC[C@H](C(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)O[C@@H]([C@@H]1NC(=O)C)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
15395	sp|P9WJL1|MURF_MYC	P22188	72.35	16.0	385.0	DB03590	experimental	2,6-Diaminopimelic Acid	OC(=O)[C@@H](N)CCC[C@H](N)C(=O)O
15396	sp|P9WJL1|MURF_MYC	P22188	72.35	16.0	385.0	DB03801	experimental	Lysine Nz-Carboxylic Acid	OC(=O)[C@@H](N)CCCCNC(=O)O
15397	sp|P9WJJ5|NADD_MYC	P0A753	96.21	9.0	212.0	DB04272	approved; nutraceutical; vet_approved	Citric acid	OC(=O)CC(O)(C(=O)O)CC(=O)O
15398	sp|P9WJJ5|NADD_MYC	P54455	84.83	8.0	187.0	DB04099	experimental	Deamido-Nad+	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)[n+]5cccc(c5)C(=O)O
15399	sp|P9WIH3|PCKG_MYC	P35558	98.18	24.0	619.0	DB01819	experimental	Phosphoenolpyruvate	OC(=O)C(=C)OP(=O)(O)O
15400	sp|P9WIH3|PCKG_MYC	P35558	98.18	24.0	619.0	DB02008	experimental	1-(2-Fluorobenzyl)-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine	Fc1ccccc1Cn(c2=O)c(=O)n(CCCC)c(c23)nc([nH]3)Cc4ccc(cc4)NC(=O)C
15401	sp|P9WIH3|PCKG_MYC	P35558	98.18	24.0	619.0	DB03267	experimental	1-Allyl-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine	C=CCn(c1=O)c(=O)n(CCCC)c(c12)nc([nH]2)Cc3ccc(cc3)NC(=O)C
15402	sp|P9WIH3|PCKG_MYC	P35558	98.18	24.0	619.0	DB03725	experimental	5'-Guanylylmethylenebisphosphonate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)CP(=O)(O)O
15403	sp|P9WIC3|PHEA_MYC	P0A9J8	87.23	104.0	384.0	DB08648	experimental	(1R,3S,5S,8R)-8-Hydroxy-2-oxabicyclo[3.3.1]non-6-ene-3,5-dicarboxylic acid	OC(=O)[C@@]12C=C[C@@H](O)[C@@H](C1)O[C@@H](C2)C(=O)O
15404	sp|P9WIC3|PHEA_MYC	A1A2B5	88.16	5.0	288.0	DB03884	experimental	Phenylpyruvic acid	OC(=O)C(=O)Cc1ccccc1
15405	sp|P96284|PKS15_MY	Q9ZGI2	95.77	3.0	478.0	DB07703	experimental	(3R,4S,5S,7R,9E,11R,12R)-12-ETHYL-4-HYDROXY-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE	C[C@@H]1C[C@H](C)[C@H](O)[C@@H](C)C(=O)O[C@H](CC)[C@H](C)/C=C/C1=O
15406	sp|P96284|PKS15_MY	Q9ZGI2	95.77	3.0	478.0	DB08431	experimental	[(3R,4S)-4-HYDROXY-3-METHYL-2-OXOHEXYL]PHOSPHONIC ACID	CC[C@H](O)[C@@H](C)C(=O)C[P@@H](=O)O
15407	sp|P96284|PKS15_MY	Q9ZGI2	95.77	3.0	478.0	DB08759	experimental	[(3R,4S,5S,7R)-4,8-DIHYDROXY-3,5,7-TRIMETHYL-2-OXOOCTYL]PHOSPHONIC ACID	OC[C@H](C)C[C@H](C)[C@H](O)[C@@H](C)C(=O)C[P@H](=O)O
15408	sp|P96284|PKS15_MY	P49327	83.87	2.0	418.0	DB01034	experimental	Cerulenin	NC(=O)[C@@H]1O[C@@H]1C(=O)CC/C=C/C/C=C/C
15409	sp|P96284|PKS15_MY	P49327	83.87	2.0	418.0	DB01083	approved; investigational	Orlistat	CCCCCCCCCCC[C@H](OC(=O)[C@@H](NC=O)CC(C)C)C[C@@H]1OC(=O)[C@H]1CCCCCC
15410	sp|P96284|PKS15_MY	P0AAI5	72.98	49.0	411.0	DB01034	experimental	Cerulenin	NC(=O)[C@@H]1O[C@@H]1C(=O)CC/C=C/C/C=C/C
15411	sp|P96284|PKS15_MY	P0AAI5	72.98	49.0	411.0	DB03017	approved; experimental	Lauric acid	CCCCCCCCCCCC(=O)O
15412	sp|P96284|PKS15_MY	P0AAI5	72.98	49.0	411.0	DB08366	experimental	3-({3-[(1S,4aS,6S,7S,9S,9aR)-1,6-dimethyl-2-oxodecahydro-6,9-epoxy-4a,7-methanobenzo[7]annulen-1-yl]propanoyl}amino)-2,4-dihydroxybenzoic acid	C1[C@@H](C2)[C@](C)(C3)O[C@@H]2[C@H]([C@@]134)[C@@](C)(C(=O)CC4)CCC(=O)Nc5c(O)ccc(C(=O)O)c5O
15413	sp|P96284|PKS15_MY	P0AAI5	72.98	49.0	411.0	DB08407	experimental	Platensimycin	C1[C@@H](C2)[C@](C)(C3)O[C@@H]2[C@H]([C@@]134)[C@@](C)(C(=O)C=C4)CCC(=O)Nc5c(O)c(C(=O)O)ccc5O
15415	sp|P96284|PKS15_MY	P0A953	80.04	5.0	402.0	DB01034	experimental	Cerulenin	NC(=O)[C@@H]1O[C@@H]1C(=O)CC/C=C/C/C=C/C
15416	sp|P96284|PKS15_MY	P0A953	80.04	5.0	402.0	DB03017	approved; experimental	Lauric acid	CCCCCCCCCCCC(=O)O
15417	sp|P96284|PKS15_MY	P0A953	80.04	5.0	402.0	DB03600	experimental	Capric acid	CCCCCCCCCC(=O)O
15418	sp|P96284|PKS15_MY	P0A953	80.04	5.0	402.0	DB04302	experimental	4-Hydroxy-3,5-Dimethyl-5-(2-Methyl-Buta-1,3-Dienyl)-5h-Thiophen-2-One	C=C/C(C)=C/[C@@]1(C)SC(=O)C(C)=C1O
15419	sp|P96284|PKS15_MY	P0A953	80.04	5.0	402.0	DB04519	investigational	Caprylic acid	CCCCCCCC(=O)O
15420	sp|P96284|PKS15_MY	P0A953	80.04	5.0	402.0	DB08359	experimental	2-PHENYLAMINO-4-METHYL-5-ACETYL THIAZOLE	CC(=O)c1c(C)nc(s1)Nc2ccccc2
15421	sp|P96284|PKS15_MY	P0A953	80.04	5.0	402.0	DB08627	experimental	(5R)-4-HYDROXY-3,5-DIMETHYL-5-[(1E,3E)-2-METHYLPENTA-1,3-DIENYL]THIOPHEN-2(5H)-ONE	C/C=C/C(C)=C/[C@@]1(C)SC(=O)C(C)=C1O
15422	sp|P96284|PKS15_MY	P0A953	80.04	5.0	402.0	DB08628	experimental	(5R)-5-[(1E)-BUTA-1,3-DIENYL]-4-HYDROXY-3,5-DIMETHYLTHIOPHEN-2(5H)-ONE	OC1=C(C)C(=O)S[C@]1(C)/C=C/C=C
15423	sp|P9WN51|GCST_MYC	Q9WY54	96.46	3.0	357.0	DB03256	experimental	(6R)-Folinic acid	Nc([nH]1)nc(=O)c(c12)N(C=O)[C@@H](CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
15424	sp|P9WN51|GCST_MYC	Q9WY54	96.46	3.0	357.0	DB03760	experimental	Dihydrolipoic Acid	SCC[C@H](S)CCCCC(=O)O
15425	sp|P9WN51|GCST_MYC	P48728	98.91	33.0	396.0	DB00116	nutraceutical	Tetrahydrofolic acid	Nc([nH]1)nc(=O)c(c12)NC(CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
15426	sp|P9WN51|GCST_MYC	P48728	98.91	33.0	396.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
15427	sp|P9WN51|GCST_MYC	P48728	98.91	33.0	396.0	DB04789	investigational; nutraceutical	5-methyltetrahydrofolic acid	O=c1nc(N)[nH]c(c12)NCC(N2C)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
15428	sp|P9WN51|GCST_MYC	Q9AGP8	90.74	489.0	822.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
15429	sp|P9WN51|GCST_MYC	Q9AGP8	90.74	489.0	822.0	DB03256	experimental	(6R)-Folinic acid	Nc([nH]1)nc(=O)c(c12)N(C=O)[C@@H](CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
15430	sp|P9WMN1|HIS1_MYC	P60757	101.41	7.0	295.0	DB01661	experimental	1-(5-phospho-D-ribosyl)-ATP	OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O1)n2cnc(c23)c(=N)n(cn3)C4O[C@@H]([C@@H](O)[C@H]4O)COP(=O)(O)O
15431	sp|P9WMT1|OBG_MYCT	P20964	88.52	2.0	426.0	DB04022	experimental	Guanosine tetraphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)O)[C@H]([C@H]3O)OP(=O)(O)OP(=O)(O)O
15432	sp|P9WPZ7|ARGD_MYC	P04181	98.0	44.0	436.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
15433	sp|P9WPZ7|ARGD_MYC	P04181	98.0	44.0	436.0	DB00129	approved; nutraceutical	Ornithine	NCCC[C@H](N)C(=O)O
15434	sp|P9WPZ7|ARGD_MYC	P04181	98.0	44.0	436.0	DB02054	experimental	Gabaculine	Nc1cccc(c1)C(=O)O
15435	sp|P9WPZ7|ARGD_MYC	P04181	98.0	44.0	436.0	DB02821	experimental	Canaline	NOCC[C@H](N)C(=O)O
15436	sp|P9WPZ7|ARGD_MYC	Q6LFH8	97.75	16.0	407.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
15437	sp|P9WPZ7|ARGD_MYC	P22256	105.25	3.0	424.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
15438	sp|P9WPZ7|ARGD_MYC	P22256	105.25	3.0	424.0	DB02783	experimental	4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate	Cc1ncc(COP(=O)(O)O)c(c1O)CNOCC(=O)O
15439	sp|P9WPZ7|ARGD_MYC	Q9BYV1	109.25	70.0	507.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
15440	sp|P9WPZ7|ARGD_MYC	Q9BYV1	109.25	70.0	507.0	DB00119	approved; investigational; nutraceutical	Pyruvic acid	CC(=O)C(=O)O
15441	sp|P9WPZ7|ARGD_MYC	Q9BYV1	109.25	70.0	507.0	DB00145	approved; nutraceutical; vet_approved	Glycine	NCC(=O)O
15442	sp|P9WPZ7|ARGD_MYC	Q9BYV1	109.25	70.0	507.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
15443	sp|P9WPZ7|ARGD_MYC	P12995	103.0	10.0	422.0	DB02274	experimental	7-Keto-8-Aminopelargonic Acid	C[C@H](N)C(=O)CCCCCC(=O)O
15444	sp|P9WPZ7|ARGD_MYC	P12995	103.0	10.0	422.0	DB02725	experimental	2-Amino-4-(4-Amino-Cyclohexa-2,5-Dienyl)-Butyric Acid	OC(=O)[C@@H](N)CC[C@H]1C=CC(N)C=C1
15445	sp|P9WPZ7|ARGD_MYC	P12995	103.0	10.0	422.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
15446	sp|P9WPZ7|ARGD_MYC	Q8IUZ5	106.25	9.0	434.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
15447	sp|P9WPZ7|ARGD_MYC	Q8IUZ5	106.25	9.0	434.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
15448	sp|P9WPZ7|ARGD_MYC	P16932	105.25	11.0	432.0	DB02038	experimental	D-[3-hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl]-N,O-cycloserylamide	Cc1ncc(COP(=O)(O)O)c(c1O)CN[C@@H]2CONC2=O
15449	sp|P9WPZ7|ARGD_MYC	P16932	105.25	11.0	432.0	DB02849	experimental	N-Pyridoxyl-1-Amino-Cyclopropanecarboxylic Acid-5-Monophosphate	Cc1ncc(COP(=O)(O)O)c(c1O)CNC2(CC2)C(=O)O
15450	sp|P9WPZ7|ARGD_MYC	P16932	105.25	11.0	432.0	DB03787	experimental	(5-Hydroxy-6-methyl-4-{[(E)-(3-oxo-1,2-oxazolidin-4-ylidene)amino]methyl}-3-pyridinyl)methyl dihydrogen phosphate	Cc1ncc(COP(=O)(O)O)c(c1O)C/N=C2\CONC2=O
15451	sp|P9WPZ7|ARGD_MYC	P16932	105.25	11.0	432.0	DB04241	experimental	N-Pyridoxyl-2-Methylalanine-5-Phosphate	Cc1ncc(COP(=O)(O)O)c(c1O)CNC(C)(C)C(=O)O
15452	sp|P9WPZ7|ARGD_MYC	P9WQ77	101.5	39.0	445.0	DB08071	experimental	(2S)-1-methyl-2-[(2S,4R)-2-methyl-4-phenylpentyl]piperidine	CN1CCCC[C@H]1C[C@@H](C)C[C@@H](C)c2ccccc2
15453	sp|P9WPZ7|ARGD_MYC	P80404	104.75	77.0	496.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
15454	sp|P9WPZ7|ARGD_MYC	P80404	104.75	77.0	496.0	DB00119	approved; investigational; nutraceutical	Pyruvic acid	CC(=O)C(=O)O
15455	sp|P9WPZ7|ARGD_MYC	P80404	104.75	77.0	496.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
15456	sp|P9WPZ7|ARGD_MYC	P80404	104.75	77.0	496.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
15457	sp|P9WPZ7|ARGD_MYC	P80404	104.75	77.0	496.0	DB00780	approved	Phenelzine	NNCCc1ccccc1
15458	sp|P9WPZ7|ARGD_MYC	P80404	104.75	77.0	496.0	DB01080	approved	Vigabatrin	C=CC(N)CCC(=O)O
15459	sp|P9WPZ7|ARGD_MYC	P80404	104.75	77.0	496.0	DB01699	experimental	(4e)-4-Aminohex-4-Enoic Acid	C/C=C(/N)CCC(=O)O
15460	sp|P9WPZ7|ARGD_MYC	P80404	104.75	77.0	496.0	DB04235	experimental	4-Amino Hexanoic Acid	CC[C@@H](N)CCC(=O)O
15461	sp|P9WPZ7|ARGD_MYC	P24630	78.75	35.0	350.0	DB02054	experimental	Gabaculine	Nc1cccc(c1)C(=O)O
15462	sp|P9WPZ7|ARGD_MYC	P24630	78.75	35.0	350.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
15463	sp|P9WPZ7|ARGD_MYC	Q9X266	80.75	16.0	339.0	DB02824	experimental	N-Pyridoxyl-Glycine-5-Monophosphate	Cc1ncc(COP(=O)(O)O)c(c1O)CNCC(=O)O
15464	sp|P9WPZ7|ARGD_MYC	Q9X266	80.75	16.0	339.0	DB03576	experimental	N-Pyridoxyl-Threonine-5-Monophosphate	CC(O)C(C(=O)O)NCc1c(COP(=O)(O)O)cnc(C)c1O
15465	sp|P9WPZ7|ARGD_MYC	Q9X266	80.75	16.0	339.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
15466	sp|P9WMR9|DHAA_MYC	P51698	98.0	2.0	296.0	DB01701	experimental	1,2-Dichloro-Propane	C[C@@H](Cl)CCl
15467	sp|P9WMR9|DHAA_MYC	P51698	98.0	2.0	296.0	DB02145	experimental	Butyl alcohol	CCCCO
15468	sp|P9WMR9|DHAA_MYC	P51698	98.0	2.0	296.0	DB02302	experimental	Symmetric dimethylarginine	CN/C(=N/C)NCCC[C@H](N)C(=O)O
15469	sp|P9WMR9|DHAA_MYC	P51698	98.0	2.0	296.0	DB02774	experimental	1,3-Propanediol	OCCCO
15470	sp|P9WMR9|DHAA_MYC	P51698	98.0	2.0	296.0	DB03335	experimental	(+)-1-bromo-2-propanol	C[C@H](O)CBr
15471	sp|P9WMR9|DHAA_MYC	P51698	98.0	2.0	296.0	DB03733	experimental	Ethylene Dichloride	ClCCCl
15472	sp|P9WMR9|DHAA_MYC	P51698	98.0	2.0	296.0	DB04320	experimental	2-Bromo-2-Propene-1-Ol	OCC(Br)=C
15473	sp|Q7D9K1|HK12_MYC	Q9X2W8	77.72	590.0	883.0	DB04066	experimental	p-Coumaric acid	OC(=O)/C=C/c1ccc(O)cc1
15474	sp|O06350|LIPF_MYC	Q7SIG1	85.2	74.0	310.0	DB02776	experimental	1-Hexadecanosulfonic Acid	CCCCCCCCCCCCCCCCS(=O)(=O)O
15475	sp|P9WJQ5|MOEA2_MY	Q9NQX3	97.28	326.0	720.0	DB01942	experimental; investigational	Formic acid	OC=O
15476	sp|P9WJQ5|MOEA2_MY	Q9NQX3	97.28	326.0	720.0	DB03366	experimental; investigational	Imidazole	[nH]1ccnc1
15477	sp|P9WJQ5|MOEA2_MY	Q9NQX3	97.28	326.0	720.0	DB03766	approved; vet_approved	Propanoic acid	CCC(=O)O
15478	sp|P9WIX1|NUOH_MYC	P03886	72.68	4.0	302.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
15479	sp|P9WIX1|NUOH_MYC	P03886	72.68	4.0	302.0	DB01028	approved; investigational; vet_approved	Methoxyflurane	COC(F)(F)C(Cl)Cl
15480	sp|P9WIX1|NUOH_MYC	P03886	72.68	4.0	302.0	DB01159	approved; vet_approved	Halothane	ClC(Br)C(F)(F)F
15481	sp|P9WIX1|NUOH_MYC	P03886	72.68	4.0	302.0	DB01189	approved	Desflurane	FC(F)OC(F)C(F)(F)F
15482	sp|P9WIX1|NUOH_MYC	P03886	72.68	4.0	302.0	DB01236	approved; vet_approved	Sevoflurane	FCOC(C(F)(F)F)C(F)(F)F
15483	sp|P9WIX1|NUOH_MYC	P03886	72.68	4.0	302.0	DB04464	experimental	N-Formylmethionine	O=CN[C@H](C(=O)O)CCSC
15484	sp|P9WIX1|NUOH_MYC	P03886	72.68	4.0	302.0	DB12695	investigational	Phenethyl Isothiocyanate	S=C=NCCc1ccccc1
15485	sp|P9WNU5|DPO1_MYC	P52026	96.57	2.0	875.0	DB07435	experimental	1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE	O[C@H]1[C@H](O)[C@H](O)Cc(c12)c3c4c(c2)ccc5c4c(cc3)ccc5
15486	sp|P9WNU5|DPO1_MYC	P00582	101.88	6.0	927.0	DB00548	approved	Azelaic acid	OC(=O)CCCCCCCC(=O)O
15487	sp|P9WNU5|DPO1_MYC	P00582	101.88	6.0	927.0	DB08432	experimental	THYMIDINE-5'-THIOPHOSPHATE	OP(=S)(O)OC[C@H]1O[C@H](C[C@@H]1O)n2cc(C)c(=O)[nH]c2=O
15488	sp|P9WML7|HIS8_MYC	P06986	91.84	3.0	352.0	DB01813	experimental	Pyridoxyl-Glutamic Acid-5'-Monophosphate	OC(=O)CC[C@@H](C(=O)O)NCc1c(COP(=O)(O)O)c[nH+]c(C)c1O
15489	sp|P9WML7|HIS8_MYC	P06986	91.84	3.0	352.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
15490	sp|P9WML7|HIS8_MYC	P06986	91.84	3.0	352.0	DB03997	experimental	L-histidinol phosphate	OP(=O)(O)OC[C@@H](N)Cc1c[nH]cn1
15491	sp|P9WML7|HIS8_MYC	Q9X0D0	83.95	13.0	332.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
15492	sp|P9WML7|HIS8_MYC	Q9X0D0	83.95	13.0	332.0	DB03997	experimental	L-histidinol phosphate	OP(=O)(O)OC[C@@H](N)Cc1c[nH]cn1
15493	sp|P9WML7|HIS8_MYC	P97084	87.11	31.0	362.0	DB02482	experimental	Phosphonothreonine	OC(=O)[C@H](N)[C@H](C)OP(=O)(O)O
15494	sp|P9WML7|HIS8_MYC	P97084	87.11	31.0	362.0	DB03433	experimental	{3-[(3-Hydroxy-2-Methyl-5-Phosphonooxymethyl-Pyridin-4-Ylmethyl)-Amino]-2-Methyl-Propyl}-Phosphonic Acid	OP(=O)(O)O[C@H](C)CNCc1c(O)c(C)ncc1COP(=O)(O)O
15495	sp|P9WML7|HIS8_MYC	Q56232	90.53	33.0	377.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
15496	sp|P9WML7|HIS8_MYC	Q56232	90.53	33.0	377.0	DB04299	experimental	Maleic Acid	OC(=O)/C=C\C(=O)O
15497	sp|P9WML7|HIS8_MYC	Q75WK2	85.79	37.0	363.0	DB02024	experimental	3-phenylpropionic acid	OC(=O)CCc1ccccc1
15498	sp|P9WML7|HIS8_MYC	Q75WK2	85.79	37.0	363.0	DB02238	experimental	4-methylthio-2-oxobutanoic acid	CSCCC(=O)C(=O)O
15499	sp|P9WML7|HIS8_MYC	P17735	85.79	107.0	433.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
15500	sp|P9WML7|HIS8_MYC	P17735	85.79	107.0	433.0	DB00120	approved; investigational; nutraceutical	Phenylalanine	OC(=O)[C@@H](N)Cc1ccccc1
15501	sp|P9WML7|HIS8_MYC	P17735	85.79	107.0	433.0	DB00135	approved; investigational; nutraceutical	Tyrosine	OC(=O)[C@@H](N)Cc1ccc(O)cc1
15502	sp|P9WML7|HIS8_MYC	P17735	85.79	107.0	433.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
15503	sp|P9WML7|HIS8_MYC	Q16773	81.32	40.0	349.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
15504	sp|P9WML7|HIS8_MYC	Q16773	81.32	40.0	349.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
15505	sp|P9WML7|HIS8_MYC	Q16773	81.32	40.0	349.0	DB02556	experimental	D-Phenylalanine	OC(=O)[C@H](N)Cc1ccccc1
15506	sp|P9WML7|HIS8_MYC	Q16773	81.32	40.0	349.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
15507	sp|P9WML7|HIS8_MYC	Q16773	81.32	40.0	349.0	DB07950	experimental	Indoleacetic acid	OC(=O)Cc1c[nH]c(c12)cccc2
15508	sp|P9WML7|HIS8_MYC	P33447	88.42	60.0	396.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
15509	sp|P9WML7|HIS8_MYC	Q96QU6	87.37	130.0	462.0	DB03214	experimental	Vinylglycine	OC(=O)[C@@H](N)C=C
15510	sp|P9WML7|HIS8_MYC	Q9X0L5	81.84	43.0	354.0	DB01942	experimental; investigational	Formic acid	OC=O
15511	sp|P9WML7|HIS8_MYC	Q6YP21	72.37	101.0	376.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
15512	sp|P9WML7|HIS8_MYC	P0AB77	77.11	90.0	383.0	DB03915	experimental	2-Amino-3-Ketobutyric Acid	CC(=O)[C@H](N)C(=O)O
15513	sp|P9WML7|HIS8_MYC	Q55793	77.11	39.0	332.0	DB02346	experimental	3'-O-N-Octanoyl-a-D-Glucopyranosyl-B-D-Fructofuranoside	OC[C@@H](O1)[C@@H](O)[C@H](O)[C@]1(CO)O[C@H]2O[C@H](CO)[C@@H](O)[C@@H]([C@H]2O)OC(=O)CCCCCCC
15514	sp|P9WML7|HIS8_MYC	O75600	77.11	115.0	408.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
15515	sp|P9WML7|HIS8_MYC	O75600	77.11	115.0	408.0	DB00145	approved; nutraceutical; vet_approved	Glycine	NCC(=O)O
15516	sp|P9WML7|HIS8_MYC	Q5KUI2	78.42	60.0	358.0	DB03256	experimental	(6R)-Folinic acid	Nc([nH]1)nc(=O)c(c12)N(C=O)[C@@H](CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
15517	sp|P9WML7|HIS8_MYC	P22557	73.16	239.0	517.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
15518	sp|P9WML7|HIS8_MYC	P22557	73.16	239.0	517.0	DB00145	approved; nutraceutical; vet_approved	Glycine	NCC(=O)O
15519	sp|P9WML7|HIS8_MYC	P95468	73.95	49.0	330.0	DB02024	experimental	3-phenylpropionic acid	OC(=O)CCc1ccccc1
15520	sp|P9WML7|HIS8_MYC	P95468	73.95	49.0	330.0	DB02242	experimental	Cyclohexanepropanoic acid	OC(=O)CCC1CCCCC1
15521	sp|P9WML7|HIS8_MYC	P95468	73.95	49.0	330.0	DB02434	experimental	4-(2-Thienyl)Butyric Acid	OC(=O)CCCc1cccs1
15522	sp|P9WML7|HIS8_MYC	P95468	73.95	49.0	330.0	DB02740	experimental	3-Indolebutyric Acid	OC(=O)CCCc1c[nH]c(c12)cccc2
15523	sp|P9WML7|HIS8_MYC	P95468	73.95	49.0	330.0	DB02758	experimental	Indolepropionic acid	OC(=O)CCc1c[nH]c(c12)cccc2
15524	sp|P9WML7|HIS8_MYC	P95468	73.95	49.0	330.0	DB03210	experimental	4-Aminohydrocinnamic Acid	Nc1ccc(cc1)CCC(=O)O
15525	sp|P9WML7|HIS8_MYC	P95468	73.95	49.0	330.0	DB03400	experimental	3-(P-Tolyl)Propionic Acid	Cc1ccc(cc1)CCC(=O)O
15526	sp|P9WML7|HIS8_MYC	P95468	73.95	49.0	330.0	DB04051	experimental	5-phenylpentanoic acid	OC(=O)CCCCc1ccccc1
15527	sp|P9WML7|HIS8_MYC	P95468	73.95	49.0	330.0	DB04208	experimental	3-(3,4-dimethoxyphenyl)propanoic acid	COc1c(OC)cc(cc1)CCC(=O)O
15528	sp|P9WML7|HIS8_MYC	P95468	73.95	49.0	330.0	DB04299	experimental	Maleic Acid	OC(=O)/C=C\C(=O)O
15529	sp|P9WML7|HIS8_MYC	P95468	73.95	49.0	330.0	DB06819	approved; investigational	Phenylbutyric acid	OC(=O)CCCc1ccccc1
15530	sp|P9WML7|HIS8_MYC	P0A827	72.63	68.0	344.0	DB02824	experimental	N-Pyridoxyl-Glycine-5-Monophosphate	Cc1ncc(COP(=O)(O)O)c(c1O)CNCC(=O)O
15531	sp|P9WML7|HIS8_MYC	P0A827	72.63	68.0	344.0	DB11596	approved; investigational	Levoleucovorin	Nc([nH]1)nc(=O)c(c12)N(C=O)[C@H](CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
15532	sp|P9WML7|HIS8_MYC	P24630	89.47	91.0	431.0	DB02054	experimental	Gabaculine	Nc1cccc(c1)C(=O)O
15533	sp|P9WML7|HIS8_MYC	P24630	89.47	91.0	431.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
15534	sp|P9WKE9|KGUA_MYC	P9WKE9	99.52	1.0	208.0	DB01942	experimental; investigational	Formic acid	OC=O
15535	sp|P9WKE9|KGUA_MYC	Q16774	87.02	5.0	186.0	DB01972	experimental	Guanosine-5'-Monophosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
15536	sp|P9WKE9|KGUA_MYC	O14936	88.46	733.0	917.0	DB01942	experimental; investigational	Formic acid	OC=O
15537	sp|P9WKE9|KGUA_MYC	O14936	88.46	733.0	917.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
15538	sp|P9WKE9|KGUA_MYC	P78352	84.13	532.0	707.0	DB00536	approved	Guanidine	NC(N)=N
15539	sp|P9WKE9|KGUA_MYC	P78352	84.13	532.0	707.0	DB01972	experimental	Guanosine-5'-Monophosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
15540	sp|P9WJQ9|MOBA_MYC	P32173	90.55	5.0	187.0	DB04137	experimental	Guanosine-5'-Triphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
15541	sp|P9WJR3|MOAE1_MY	P30749	91.16	6.0	140.0	DB01942	experimental; investigational	Formic acid	OC=O
15542	sp|P9WJL9|MURB_MYC	P08373	88.89	3.0	331.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
15543	sp|P9WJL9|MURB_MYC	P08373	88.89	3.0	331.0	DB07296	experimental	(5Z)-3-(4-CHLOROPHENYL)-4-HYDROXY-5-(1-NAPHTHYLMETHYLENE)FURAN-2(5H)-ONE	Clc1ccc(cc1)C2=C(O)/C(OC2=O)=C/c3cccc(c34)cccc4
15544	sp|P9WIT9|OTC_MYCT	P0A786	97.39	8.0	307.0	DB05540	investigational	Alanosine	OC(=O)[C@@H](N)CN(O)N=O
15545	sp|P9WIT9|OTC_MYCT	P0A789	97.39	8.0	307.0	DB03459	experimental	Sparfosic acid	OP(=O)(O)CC(=O)N[C@H](C(=O)O)CC(=O)O
15546	sp|P9WIT9|OTC_MYCT	P00480	98.37	40.0	342.0	DB00129	approved; nutraceutical	Ornithine	NCCC[C@H](N)C(=O)O
15547	sp|P9WIT9|OTC_MYCT	P00480	98.37	40.0	342.0	DB00155	approved; investigational; nutraceutical	Citrulline	OC(=O)[C@@H](N)CCCNC(=O)N
15548	sp|P9WIT9|OTC_MYCT	P00480	98.37	40.0	342.0	DB02011	experimental	N-(Phosphonoacetyl)-L-Ornithine	OC(=O)[C@@H](N)CCCNC(=O)CP(=O)(O)O
15549	sp|P9WIT9|OTC_MYCT	P00480	98.37	40.0	342.0	DB04185	experimental	Norvaline	CCC[C@H](N)C(=O)O
15550	sp|P9WIT9|OTC_MYCT	P04391	90.23	7.0	284.0	DB02965	experimental	Ndelta-(N'-Sulphodiaminophosphinyl)-L-Ornithine	OC(=O)[C@@H](N)CCCN[P@](=O)(N)NS(=O)(=O)O
15551	sp|P9WIT9|OTC_MYCT	P27708	97.72	1924.0	2224.0	DB03459	experimental	Sparfosic acid	OP(=O)(O)CC(=O)N[C@H](C(=O)O)CC(=O)O
15552	sp|P9WIT9|OTC_MYCT	Q8IDP8	101.95	58.0	371.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
15553	sp|P9WIT9|OTC_MYCT	Q8P8J2	108.14	3.0	335.0	DB02368	experimental	N-Acetyl-L-Citrulline	CC(=O)N[C@H](C(=O)O)CCCNC(=O)N
15554	sp|P9WIT9|OTC_MYCT	Q8P8J2	108.14	3.0	335.0	DB08554	experimental	N-(3-carboxypropanoyl)-L-norvaline	CCC[C@@H](C(=O)O)NC(=O)CCC(=O)O
15555	sp|P9WIT9|OTC_MYCT	Q5LI27	99.02	11.0	315.0	DB08554	experimental	N-(3-carboxypropanoyl)-L-norvaline	CCC[C@@H](C(=O)O)NC(=O)CCC(=O)O
15556	sp|O53165|ACNR_MYC	Q9AIU0	72.73	1.0	137.0	DB03467	experimental	Naringenin	Oc1ccc(cc1)[C@@H](O2)CC(=O)c(c23)c(O)cc(c3)O
15557	sp|O53165|ACNR_MYC	Q9AIU0	72.73	1.0	137.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
15558	sp|O53165|ACNR_MYC	Q9AIU0	72.73	1.0	137.0	DB07810	experimental	Phloretin	Oc1ccc(cc1)CCC(=O)c2c(O)cc(O)cc2O
15559	sp|P9WQN9|A85C_MYC	P9WQN9	99.71	1.0	340.0	DB02811	experimental	Diethyl phosphonate	CCOP(=O)OCC
15560	sp|P9WQN9|A85C_MYC	P9WQN9	99.71	1.0	340.0	DB08558	experimental	2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)SCCCCCCCC
15561	sp|P9WPQ7|BIOB_MYC	P12996	86.25	10.0	311.0	DB03775	experimental	Dethiobiotin	C[C@@H]1NC(=O)N[C@@H]1CCCCCC(=O)O
15562	sp|O07431|CAMT_MYC	Q55813	98.18	2.0	218.0	DB07109	experimental	Isoferulic acid	COc1c(O)cc(cc1)/C=C/C(=O)O
15563	sp|O07431|CAMT_MYC	Q55813	98.18	2.0	218.0	DB07767	experimental	Ferulic acid	COc1cc(/C=C/C(=O)O)ccc1O
15564	sp|O07431|CAMT_MYC	Q86VU5	87.73	53.0	246.0	DB01752	experimental	S-adenosyl-L-homocysteine	OC(=O)[C@@H](N)CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
15565	sp|O07431|CAMT_MYC	Q86VU5	87.73	53.0	246.0	DB03179	experimental	Sinapoyl coenzyme A	COc1cc(cc(OC)c1O)/C=C/C(=O)SCCNC(=O)CCNC(=O)C2(O)[C@@H](C2(C)C)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H](O)[C@@H]3OP(=O)(O)O)n4cnc(c45)c(N)ncn5
15566	sp|O07431|CAMT_MYC	Q86VU5	87.73	53.0	246.0	DB03923	experimental	Feruloyl Coenzyme A	COc1cc(cc(O)c1O)/C=C/C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2OP(=O)(O)O)n3cnc(c34)c(N)ncn4
15567	sp|P9WPA9|KCY_MYCT	P0A6I0	95.22	4.0	223.0	DB02456	experimental	Aracytidine 5'-monophosphate	Nc1nc(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@@H]2O)COP(=O)(O)O
15568	sp|P9WPA9|KCY_MYCT	P0A6I0	95.22	4.0	223.0	DB02883	experimental	2',3'-Dideoxycytidine-5'-Monophosphate	Nc1nc(=O)n(cc1)[C@H]2CC[C@H](O2)COP(=O)(O)O
15569	sp|P9WPA9|KCY_MYCT	P0A6I0	95.22	4.0	223.0	DB03403	experimental	Cytidine-5'-Monophosphate	Nc1nc(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)O
15570	sp|P9WPA9|KCY_MYCT	P0A6I0	95.22	4.0	223.0	DB04555	experimental	Cytidine-5'-Diphosphate	Nc1nc(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O
15571	sp|P9WIP7|LSR2_MYC	P9WIP7	99.11	1.0	112.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
15572	sp|P9WJP3|MENC_MYC	Q47Q21	92.94	5.0	308.0	DB02251	experimental	O-Succinylbenzoate	OC(=O)CCC(=O)c1c(C(=O)O)cccc1
15573	sp|P9WJP3|MENC_MYC	Q9RYA6	73.62	110.0	350.0	DB04167	experimental	Aceglutamide	CC(=O)N[C@H](C(=O)O)CCC(=O)N
15574	sp|P9WJP3|MENC_MYC	Q44244	70.25	113.0	342.0	DB01646	experimental	N-Acetylmethionine	CSCC[C@@H](C(=O)O)NC(=O)C
15575	sp|P9WJP3|MENC_MYC	Q44244	70.25	113.0	342.0	DB02251	experimental	O-Succinylbenzoate	OC(=O)CCC(=O)c1c(C(=O)O)cccc1
15576	sp|P9WJP3|MENC_MYC	Q44244	70.25	113.0	342.0	DB03299	experimental	N-Succinyl Phenylglycine	c1ccccc1[C@H](C(=O)O)NC(=O)CCC(=O)O
15577	sp|P9WJP3|MENC_MYC	Q44244	70.25	113.0	342.0	DB04511	experimental	N-Succinyl Methionine	CSCC[C@H](C(=O)O)NC(=O)CCC(=O)O
15578	sp|P9WII1|MAZF2_MY	P96622	102.94	5.0	110.0	DB02042	experimental	2-(2-{2-[2-(2-Methoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol	COCCOCCOCCOCCOCCO
15579	sp|P9WK21|MAP11_MY	P53582	94.36	121.0	372.0	DB04324	experimental	Ovalicin	CC(C)=CC[C@@H](O1)[C@@]1(C)[C@@]2(O)[C@H](OC)C(=O)CC[C@@]2(C)O
15580	sp|P9WK21|MAP11_MY	P53582	94.36	121.0	372.0	DB07901	experimental	5-CHLORO-6-METHYL-N-(2-PHENYLETHYL)-2-PYRIDIN-2-YLPYRIMIDIN-4-AMINE	n1ccccc1-c2nc(C)c(Cl)c(n2)NCCc3ccccc3
15581	sp|P9WK21|MAP11_MY	P53582	94.36	121.0	372.0	DB07902	experimental	TERT-BUTYL {2-[(1,3-THIAZOL-2-YLAMINO)CARBONYL]PYRIDIN-3-YL}CARBAMATE	CC(C)(C)OC(=O)Nc1c(nccc1)C(=O)Nc2nccs2
15582	sp|P9WK21|MAP11_MY	P53582	94.36	121.0	372.0	DB07903	experimental	3-[(2,2-DIMETHYLPROPANOYL)AMINO]-N-1,3-THIAZOL-2-YLPYRIDINE-2-CARBOXAMIDE	CC(C)(C)C(=O)Nc1c(nccc1)C(=O)Nc2nccs2
15583	sp|P9WK21|MAP11_MY	P0AE18	92.86	3.0	250.0	DB02088	experimental	Norleucine Phosphonate	CCCC[C@H](N)P(=O)(O)O
15584	sp|P9WK21|MAP11_MY	P0AE18	92.86	3.0	250.0	DB02151	experimental	Methionine Phosphonate	CSCC[C@H](N)P(=O)(O)O
15585	sp|P9WK21|MAP11_MY	P0AE18	92.86	3.0	250.0	DB02909	experimental	5-(2-Chlorophenyl)Furan-2-Carboxylic Acid	OC(=O)c1ccc(o1)-c2ccccc2Cl
15586	sp|P9WK21|MAP11_MY	P0AE18	92.86	3.0	250.0	DB03799	experimental	Trifluoromethionine	OC(=O)[C@@H](N)CCSC(F)(F)F
15587	sp|P9WK21|MAP11_MY	P0AE18	92.86	3.0	250.0	DB04015	experimental	Methionine Phosphinate	CSCC[C@H](N)P(=O)O
15588	sp|P9WK21|MAP11_MY	P0AE18	92.86	3.0	250.0	DB07304	experimental	5-[2-(TRIFLUOROMETHOXY)PHENYL]-2-FUROIC ACID	OC(=O)c1ccc(o1)-c2c(OC(F)(F)F)cccc2
15589	sp|P9WK21|MAP11_MY	P0AE18	92.86	3.0	250.0	DB07305	experimental	5-(2-CHLORO-4-NITROPHENYL)-2-FUROIC ACID	OC(=O)c1ccc(o1)-c2ccc([N+]([O-])=O)cc2Cl
15590	sp|P9WK21|MAP11_MY	P0AE18	92.86	3.0	250.0	DB07308	experimental	5-(2-CHLOROBENZYL)-2-FUROIC ACID	OC(=O)c1ccc(o1)Cc2ccccc2Cl
15591	sp|P9WK21|MAP11_MY	P0AE18	92.86	3.0	250.0	DB07407	experimental	5-(2-METHOXYPHENYL)-2-FUROIC ACID	COc1ccccc1-c2ccc(o2)C(=O)O
15592	sp|P9WK21|MAP11_MY	P0AE18	92.86	3.0	250.0	DB07408	experimental	5-(2-NITROPHENYL)-2-FUROIC ACID	OC(=O)c1ccc(o1)-c2c([N+]([O-])=O)cccc2
15593	sp|P9WK21|MAP11_MY	P0AE18	92.86	3.0	250.0	DB07591	experimental	N1-CYCLOPENTYL-N2-(THIAZOL-2-YL)OXALAMIDE	C1CCCC1NC(=O)C(=O)Nc2nccs2
15594	sp|P9WK21|MAP11_MY	P0AE18	92.86	3.0	250.0	DB07758	experimental	5-(2,5-DICHLOROPHENYL)-2-FUROIC ACID	OC(=O)c1ccc(o1)-c2cc(Cl)ccc2Cl
15595	sp|P9WK21|MAP11_MY	P0AE18	92.86	3.0	250.0	DB07759	experimental	5-[2-(TRIFLUOROMETHYL)PHENYL]-2-FUROIC ACID	OC(=O)c1ccc(o1)-c2ccccc2C(F)(F)F
15596	sp|P9WK21|MAP11_MY	P0AE18	92.86	3.0	250.0	DB08451	experimental	N-(QUINOLIN-8-YL)METHANESULFONAMIDE	CS(=O)(=O)Nc1cccc(c12)cccn2
15597	sp|P9WK21|MAP11_MY	P0AE18	92.86	3.0	250.0	DB08666	experimental	5-imino-4-(3-trifluoromethyl-phenylazo)-5H-pyrazol-3-ylamine	FC(F)(F)c1cc(ccc1)NN=c2c(=N)nnc2=N
15598	sp|P9WK21|MAP11_MY	P0AE18	92.86	3.0	250.0	DB08667	experimental	4-(4-fluoro-phenylazo)-5-imino-5H-pyrazol-3-ylamine	Fc1ccc(cc1)NN=c2c(=N)nnc2=N
15599	sp|P9WK21|MAP11_MY	P0AE18	92.86	3.0	250.0	DB08668	experimental	3-(5-Amino-3-imino-3H-pyrazol-4-ylazo)-benzoic acid	OC(=O)c1cc(ccc1)NN=c2c(=N)nnc2=N
15600	sp|P9WK21|MAP11_MY	P0AE18	92.86	3.0	250.0	DB08669	experimental	METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY-3-(4-METHYLPHENYL)PROPANOYL]-D-ALANYL-D-LEUCINATE	CC(C)C[C@H](C(=O)OC)NC(=O)[C@H](C)NC(=O)[C@@H](O)[C@H](N)c1ccc(C)cc1
15601	sp|P9WK21|MAP11_MY	P0AE18	92.86	3.0	250.0	DB08670	experimental	METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY-3-(4-ISOPROPYLPHENYL)PROPANOYL]-D-ALANYL-D-LEUCINATE	CC(C)C[C@H](C(=O)OC)NC(=O)[C@H](C)NC(=O)[C@@H](O)[C@H](N)c1ccc(cc1)C(C)C
15602	sp|P9WK21|MAP11_MY	P0AE18	92.86	3.0	250.0	DB08671	experimental	5-Imino-4-(2-trifluoromethyl-phenylazo)-5H-pyrazol-3-ylamine	FC(F)(F)c1ccccc1NN=c2c(=N)nnc2=N
15603	sp|P9WK21|MAP11_MY	P0AE18	92.86	3.0	250.0	DB08718	experimental	4-(3-ethylthiophen-2-yl)benzene-1,2-diol	CCc1c(scc1)-c2cc(O)c(O)cc2
15604	sp|P9WK21|MAP11_MY	P0AE18	92.86	3.0	250.0	DB08757	experimental	5-(2-chlorophenyl)furan-2-carbohydrazide	NNC(=O)c1ccc(o1)-c2ccccc2Cl
15605	sp|P9WK21|MAP11_MY	P0AE18	92.86	3.0	250.0	DB08758	experimental	IMIDAZO[2,1-A]ISOQUINOLINE-2-CARBOHYDRAZIDE	NNC(=O)c(n1)cn(c12)ccc3c2cccc3
15606	sp|P9WK21|MAP11_MY	P9WK19	90.6	42.0	283.0	DB02909	experimental	5-(2-Chlorophenyl)Furan-2-Carboxylic Acid	OC(=O)c1ccc(o1)-c2ccccc2Cl
15607	sp|P9WK21|MAP11_MY	P0A078	91.35	4.0	247.0	DB01882	experimental	(2s)-2-Amino-4-(Methylsulfanyl)-1-Pyridin-2-Ylbutane-1,1-Diol	CSCC[C@H](N)C(O)(O)c1ccccn1
15608	sp|P9WK21|MAP11_MY	P0A078	91.35	4.0	247.0	DB02408	experimental	(3s)-3-Amino-1-(Cyclopropylamino)Heptane-2,2-Diol	CCCC[C@H](N)C(O)(O)CNC1CC1
15609	sp|P9WK21|MAP11_MY	P0A078	91.35	4.0	247.0	DB08160	experimental	(2S)-2-AMINO-4-(METHYLSULFANYL)-1-(1,3-THIAZOL-2-YL)BUTANE-1,1-DIOL	CSCC[C@H](N)C(O)(O)c1nccs1
15610	sp|P9WK21|MAP11_MY	P0A079	91.35	4.0	247.0	DB01882	experimental	(2s)-2-Amino-4-(Methylsulfanyl)-1-Pyridin-2-Ylbutane-1,1-Diol	CSCC[C@H](N)C(O)(O)c1ccccn1
15611	sp|P9WK21|MAP11_MY	P0A079	91.35	4.0	247.0	DB02408	experimental	(3s)-3-Amino-1-(Cyclopropylamino)Heptane-2,2-Diol	CCCC[C@H](N)C(O)(O)CNC1CC1
15612	sp|P9WK21|MAP11_MY	P50579	83.46	155.0	377.0	DB00134	approved; nutraceutical	Methionine	CSCC[C@H](N)C(=O)O
15613	sp|P9WK21|MAP11_MY	P50579	83.46	155.0	377.0	DB01422	experimental	Nitroxoline	c1ccnc(c12)c(O)ccc2[N+]([O-])=O
15614	sp|P9WK21|MAP11_MY	P50579	83.46	155.0	377.0	DB02310	experimental	3,5,6,8-Tetramethyl-N-Methyl Phenanthrolinium	Cc(c1)cnc(c12)c3c(c(C)c2C)cc(C)c[n+]3C
15615	sp|P9WK21|MAP11_MY	P50579	83.46	155.0	377.0	DB02640	experimental	Fumagillin	CC(C)=CC[C@@H](O1)[C@@]1(C)[C@H]([C@@]23CO3)[C@H](OC)[C@@H](CC2)OC(=O)/C=C/C=C/C=C/C=C/C(=O)O
15616	sp|P9WK21|MAP11_MY	P50579	83.46	155.0	377.0	DB02893	approved; experimental; investigational	D-Methionine	CSCC[C@@H](N)C(=O)O
15617	sp|P9WK21|MAP11_MY	P50579	83.46	155.0	377.0	DB03086	experimental	N'-(2s,3r)-3-Amino-4-Cyclohexyl-2-Hydroxy-Butano-N-(4-Methylphenyl)Hydrazide	C1CCCCC1C[C@@H](N)[C@H](O)C(=O)NNc2ccc(C)cc2
15618	sp|P9WK21|MAP11_MY	P50579	83.46	155.0	377.0	DB03396	experimental	(2R,3R,4S,5R,6E)-3,4,5-Trihydroxy-N-[(3S,6R)-6-hydroxy-2-oxo-3-azepanyl]-2-methoxy-8,8-dimethyl-6-nonenamide	O=C1NC[C@H](O)CC[C@@H]1NC(=O)[C@H](OC)[C@H](O)[C@@H](O)[C@H](O)/C=C/C(C)(C)C
15619	sp|P9WK21|MAP11_MY	P50579	83.46	155.0	377.0	DB03900	experimental	tert-butanol	CC(C)(C)O
15620	sp|P9WK21|MAP11_MY	P50579	83.46	155.0	377.0	DB04108	experimental	(2s,3r)-3-Amino-2-Hydroxy-5-(Ethylsulfanyl)Pentanoyl-((S)-(-)-(1-Naphthyl)Ethyl)Amide	CCSCC[C@H](N)[C@H](O)C(=O)N[C@@H](C)c(ccc1)c(c12)cccc2
15621	sp|P9WK21|MAP11_MY	P50579	83.46	155.0	377.0	DB04324	experimental	Ovalicin	CC(C)=CC[C@@H](O1)[C@@]1(C)[C@@]2(O)[C@H](OC)C(=O)CC[C@@]2(C)O
15622	sp|P9WK21|MAP11_MY	P50579	83.46	155.0	377.0	DB05864	investigational	PPI-2458	CC(C)=CC[C@@H](O1)[C@@]1(C)[C@H]([C@]23CO2)[C@H](OC)[C@@H](CC3)OC(=O)N[C@H](C(C)C)C(=O)N
15623	sp|P9WK21|MAP11_MY	P50579	83.46	155.0	377.0	DB07309	experimental	5-BROMO-2-{[(4-CHLOROPHENYL)SULFONYL]AMINO}BENZOIC ACID	Brc1cc(C(=O)O)c(cc1)NS(=O)(=O)c2ccc(Cl)cc2
15624	sp|P9WK21|MAP11_MY	P50579	83.46	155.0	377.0	DB07313	experimental	5-METHYL-2-[(PHENYLSULFONYL)AMINO]BENZOIC ACID	Cc1ccc(c(c1)C(=O)O)NS(=O)(=O)c2ccccc2
15625	sp|P9WK21|MAP11_MY	P50579	83.46	155.0	377.0	DB07322	experimental	2-[(PHENYLSULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID	C1CCCc(c12)c(C(=O)O)c(cc2)NS(=O)(=O)c3ccccc3
15626	sp|P9WK21|MAP11_MY	P50579	83.46	155.0	377.0	DB07323	experimental	2-[({2-[(1Z)-3-(DIMETHYLAMINO)PROP-1-ENYL]-4-FLUOROPHENYL}SULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID	CN(C)C/C=C\c1cc(F)ccc1S(=O)(=O)Nc(c2C(=O)O)ccc(c23)CCCC3
15627	sp|P9WK21|MAP11_MY	P50579	83.46	155.0	377.0	DB07377	experimental	N'-((2S,3R)-3-AMINO-2-HYDROXY-5-(ISOPROPYLSULFANYL)PENTANOYL)-N-3-CHLOROBENZOYL HYDRAZIDE	CC(C)SCC[C@@H](N)[C@H](O)C(=O)NNC(=O)c1cc(Cl)ccc1
15628	sp|P9WK21|MAP11_MY	P50579	83.46	155.0	377.0	DB07746	experimental	3-ETHYL-6-{[(4-FLUOROPHENYL)SULFONYL]AMINO}-2-METHYLBENZOIC ACID	CCc1ccc(c(C(=O)O)c1C)NS(=O)(=O)c2ccc(F)cc2
15629	sp|P9WK21|MAP11_MY	P50579	83.46	155.0	377.0	DB08633	investigational	TNP-470	CC(C)=CC[C@@H](O1)[C@@]1(C)[C@H]([C@]23CO2)[C@H](OC)[C@@H](CC3)OC(=O)NC(=O)CCl
15630	sp|P9WK21|MAP11_MY	P15034	91.73	176.0	420.0	DB04092	experimental	Apstatin	NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]2CCCN2C(=O)[C@@H](O)[C@H](N)Cc3ccccc3
15631	sp|P9WJM9|MSHC_MYC	Q9HA77	91.55	47.0	426.0	DB00151	approved; nutraceutical	Cysteine	OC(=O)[C@@H](N)CS
15632	sp|P9WJM9|MSHC_MYC	P49589	74.4	220.0	528.0	DB00151	approved; nutraceutical	Cysteine	OC(=O)[C@@H](N)CS
15633	sp|P9WQC5|ADHC_MYC	P00326	105.2	10.0	374.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
15634	sp|P9WQC5|ADHC_MYC	P00326	105.2	10.0	374.0	DB01213	approved; vet_approved	Fomepizole	Cc1c[nH]nc1
15635	sp|P9WQC5|ADHC_MYC	P00326	105.2	10.0	374.0	DB01711	experimental	2,3,4,5,6-Pentafluorobenzyl Alcohol	OCc1c(F)c(F)c(F)c(F)c1F
15636	sp|P9WQC5|ADHC_MYC	P00326	105.2	10.0	374.0	DB02131	experimental	N-1-methylheptylformamide	O=CN[C@H](C)CCCCCC
15637	sp|P9WQC5|ADHC_MYC	P00326	105.2	10.0	374.0	DB02249	experimental	2-Ethoxyethanol	CCOCCO
15638	sp|P9WQC5|ADHC_MYC	P00326	105.2	10.0	374.0	DB02659	approved	Cholic Acid	OC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](C[C@@H]2O)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
15639	sp|P9WQC5|ADHC_MYC	P00326	105.2	10.0	374.0	DB02721	experimental	4-Iodopyrazole	Ic1c[nH]nc1
15640	sp|P9WQC5|ADHC_MYC	P00326	105.2	10.0	374.0	DB02757	experimental	Pyrazole	[nH]1cccn1
15641	sp|P9WQC5|ADHC_MYC	P00326	105.2	10.0	374.0	DB02822	experimental	Para-Bromobenzyl Alcohol	OCc1ccc(Br)cc1
15642	sp|P9WQC5|ADHC_MYC	P00326	105.2	10.0	374.0	DB02871	experimental	3-Butylthiolane 1-Oxide	O=[S@@]1C[C@H](CC1)CCCC
15643	sp|P9WQC5|ADHC_MYC	P00326	105.2	10.0	374.0	DB03020	experimental	5-beta-D-ribofuranosylnicotinamide adenine dinucleotide	NC(=O)c1c[nH+]cc(c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
15644	sp|P9WQC5|ADHC_MYC	P00326	105.2	10.0	374.0	DB03061	experimental	(R)-N-(1-Methyl-Hexyl)-Formamide	CCCCC[C@H](C)NC=O
15645	sp|P9WQC5|ADHC_MYC	P00326	105.2	10.0	374.0	DB03226	experimental	Trifluoroethanol	OCC(F)(F)F
15646	sp|P9WQC5|ADHC_MYC	P00326	105.2	10.0	374.0	DB03559	experimental	Cyclohexylformamide	O=CNC1CCCCC1
15647	sp|P9WQC5|ADHC_MYC	P00326	105.2	10.0	374.0	DB04071	experimental	Cpad	NC(=O)c1nc(ccc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
15648	sp|P9WQC5|ADHC_MYC	P00326	105.2	10.0	374.0	DB04113	experimental	N-Formylpiperidine	O=CN1CCCCC1
15649	sp|P9WQC5|ADHC_MYC	P00326	105.2	10.0	374.0	DB04312	experimental	2,3-Difluorobenzyl Alcohol	OCc1cccc(F)c1F
15650	sp|P9WQC5|ADHC_MYC	P00326	105.2	10.0	374.0	DB04448	experimental	2,4-Difluorobenzyl Alcohol 2,4-Difluoro-1-(Hydroxymethyl)Benzene	OCc1ccc(F)cc1F
15651	sp|P9WQC5|ADHC_MYC	P07327	104.91	10.0	373.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
15652	sp|P9WQC5|ADHC_MYC	P07327	104.91	10.0	373.0	DB01213	approved; vet_approved	Fomepizole	Cc1c[nH]nc1
15653	sp|P9WQC5|ADHC_MYC	P07327	104.91	10.0	373.0	DB02721	experimental	4-Iodopyrazole	Ic1c[nH]nc1
15654	sp|P9WQC5|ADHC_MYC	P07327	104.91	10.0	373.0	DB04065	experimental	N-Cyclopentyl-N-Cyclobutylformamide	C1CCC1N(C=O)C2CCCC2
15655	sp|P9WQC5|ADHC_MYC	P00325	105.2	10.0	374.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
15656	sp|P9WQC5|ADHC_MYC	P00325	105.2	10.0	374.0	DB01213	approved; vet_approved	Fomepizole	Cc1c[nH]nc1
15657	sp|P9WQC5|ADHC_MYC	P00325	105.2	10.0	374.0	DB02481	experimental	N-Benzylformamide	O=CNCc1ccccc1
15658	sp|P9WQC5|ADHC_MYC	P00325	105.2	10.0	374.0	DB02721	experimental	4-Iodopyrazole	Ic1c[nH]nc1
15659	sp|P9WQC5|ADHC_MYC	P00325	105.2	10.0	374.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
15660	sp|P9WQC5|ADHC_MYC	P00325	105.2	10.0	374.0	DB03703	experimental	Cyclohexanol	OC1CCCCC1
15661	sp|P9WQC5|ADHC_MYC	P00325	105.2	10.0	374.0	DB04105	experimental	N-Heptylformamide	CCCCCCCNC=O
15662	sp|P9WQC5|ADHC_MYC	P00325	105.2	10.0	374.0	DB09462	approved; investigational	Glycerin	OCC(O)CO
15663	sp|P9WQC5|ADHC_MYC	P11766	105.78	8.0	374.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
15664	sp|P9WQC5|ADHC_MYC	P11766	105.78	8.0	374.0	DB03017	approved; experimental	Lauric acid	CCCCCCCCCCCC(=O)O
15665	sp|P9WQC5|ADHC_MYC	P11766	105.78	8.0	374.0	DB03704	experimental	12-Hydroxydodecanoic Acid	OCCCCCCCCCCCC(=O)O
15666	sp|P9WQC5|ADHC_MYC	P11766	105.78	8.0	374.0	DB04153	experimental	S-Hydroxymethyl Glutathione	OC(=O)[C@@H](N)CCC(=O)N[C@@H](CSCO)C(=O)NCC(=O)O
15667	sp|P9WQC5|ADHC_MYC	P40394	104.91	22.0	385.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
15668	sp|P9WQC5|ADHC_MYC	P08319	106.36	10.0	378.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
15669	sp|P9WQC5|ADHC_MYC	P08319	106.36	10.0	378.0	DB03559	experimental	Cyclohexylformamide	O=CNC1CCCCC1
15670	sp|P9WQC5|ADHC_MYC	P42328	96.53	2.0	336.0	DB03226	experimental	Trifluoroethanol	OCC(F)(F)F
15671	sp|P9WQC5|ADHC_MYC	Q00796	92.49	21.0	341.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
15672	sp|P9WQC5|ADHC_MYC	Q00796	92.49	21.0	341.0	DB04478	experimental	Cp-166572, 2-Hydroxymethyl-4-(4-N,N-Dimethylaminosulfonyl-1-Piperazino)-Pyrimidine	CN(C)S(=O)(=O)N1CCN(CC1)c2ccnc(n2)CO
15673	sp|P9WQC5|ADHC_MYC	P14941	92.77	18.0	339.0	DB02606	experimental; investigational	2-Butanol	CC[C@@H](C)O
15674	sp|P9WQC5|ADHC_MYC	P14941	92.77	18.0	339.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
15675	sp|P9WQC5|ADHC_MYC	P49327	93.35	1533.0	1856.0	DB01034	experimental	Cerulenin	NC(=O)[C@@H]1O[C@@H]1C(=O)CC/C=C/C/C=C/C
15676	sp|P9WQC5|ADHC_MYC	P49327	93.35	1533.0	1856.0	DB01083	approved; investigational	Orlistat	CCCCCCCCCCC[C@H](OC(=O)[C@@H](NC=O)CC(C)C)C[C@@H]1OC(=O)[C@H]1CCCCCC
15677	sp|P9WPS1|ATPL_MYC	P9WPS1	98.77	1.0	81.0	DB08903	approved	Bedaquiline	Brc(c1)ccc(c12)nc(OC)c(c2)[C@@H](c3ccccc3)[C@@](O)(CCN(C)C)c4cccc(c45)cccc5
15678	sp|P9WPS1|ATPL_MYC	Q99437	75.31	50.0	111.0	DB01133	approved; investigational; vet_approved	Tiludronic acid	OP(=O)(O)C(P(=O)(O)O)Sc1ccc(Cl)cc1
15679	sp|P9WPS1|ATPL_MYC	Q99437	74.07	136.0	196.0	DB01133	approved; investigational; vet_approved	Tiludronic acid	OP(=O)(O)C(P(=O)(O)O)Sc1ccc(Cl)cc1
15680	sp|P9WPS1|ATPL_MYC	P43457	77.78	15.0	78.0	DB02043	experimental	1,2-Dipalmitoyl-Phosphatidyl-Glycerole	CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)CO)OC(=O)CCCCCCCCCCCCCCC
15681	sp|P9WPS1|ATPL_MYC	P43457	77.78	15.0	78.0	DB02686	experimental	Undecyl-Beta-D-Maltopyranoside	O[C@H]1[C@H](O)[C@@H](CO)O[C@@H]([C@@H]1O)O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@@H]2CO)OCCCCCCCCCCC
15682	sp|P9WPS1|ATPL_MYC	P43457	81.48	87.0	153.0	DB02043	experimental	1,2-Dipalmitoyl-Phosphatidyl-Glycerole	CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)CO)OC(=O)CCCCCCCCCCCCCCC
15683	sp|P9WPS1|ATPL_MYC	P43457	81.48	87.0	153.0	DB02686	experimental	Undecyl-Beta-D-Maltopyranoside	O[C@H]1[C@H](O)[C@@H](CO)O[C@@H]([C@@H]1O)O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@@H]2CO)OCCCCCCCCCCC
15684	sp|P9WPS1|ATPL_MYC	A5HEI4	91.36	6.0	80.0	DB04464	experimental	N-Formylmethionine	O=CN[C@H](C(=O)O)CCSC
15685	sp|P9WPS1|ATPL_MYC	P21905	91.36	9.0	83.0	DB03143	experimental	Nonan-1-Ol	CCCCCCCCCO
15686	sp|P9WPS1|ATPL_MYC	P27449	77.78	15.0	78.0	DB01133	approved; investigational; vet_approved	Tiludronic acid	OP(=O)(O)C(P(=O)(O)O)Sc1ccc(Cl)cc1
15687	sp|P9WPS1|ATPL_MYC	P27449	72.84	93.0	152.0	DB01133	approved; investigational; vet_approved	Tiludronic acid	OP(=O)(O)C(P(=O)(O)O)Sc1ccc(Cl)cc1
15688	sp|P9WQ41|MBTM_MYC	Q8ZKF6	72.55	239.0	617.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
15689	sp|P9WQ41|MBTM_MYC	Q8ZKF6	72.55	239.0	617.0	DB03230	experimental	Adenosine-5'-Propylphosphate	CCCOP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
15690	sp|P9WNP5|MENB_MYC	P9WNP5	99.68	1.0	314.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
15691	sp|P9WNP5|MENB_MYC	P9WNP5	99.68	1.0	314.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
15692	sp|P9WNP5|MENB_MYC	P30084	85.67	18.0	287.0	DB02563	experimental	Hexanoyl-CoA	CCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
15693	sp|P9WNP5|MENB_MYC	P30084	85.67	18.0	287.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
15694	sp|P9WNP5|MENB_MYC	P30084	85.67	18.0	287.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
15695	sp|P9WNP5|MENB_MYC	P30084	85.67	18.0	287.0	DB04117	experimental	4-(N,N-Dimethylamino)cinnamoyl-CoA	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)/C=C/c4ccc(cc4)N(C)C
15696	sp|P9WNP5|MENB_MYC	P30084	85.67	18.0	287.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
15697	sp|P9WNP5|MENB_MYC	P52045	78.34	12.0	258.0	DB03117	experimental	2-carboxypropyl-coenzyme A	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC[C@H](C)C(=O)O
15698	sp|P9WNP5|MENB_MYC	O68600	81.21	4.0	259.0	DB01652	experimental	4-hydroxybenzoyl-CoA	Oc1ccc(cc1)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2OP(=O)(O)O)n3cnc(c34)c(N)ncn4
15699	sp|P9WNP5|MENB_MYC	O75521	78.34	145.0	391.0	DB08231	experimental	Myristic acid	CCCCCCCCCCCCCC(=O)O
15700	sp|P9WNP5|MENB_MYC	P42126	77.39	56.0	299.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
15701	sp|P9WNP5|MENB_MYC	P42126	77.39	56.0	299.0	DB03127	experimental	Benzamidine	NC(=[NH2+])c1ccccc1
15702	sp|P9WNP5|MENB_MYC	P28793	70.38	12.0	233.0	DB08249	experimental	3,6,9,12,15-PENTAOXATRICOSAN-1-OL	CCCCCCCCOCCOCCOCCOCCOCCO
15703	sp|P9WNW7|HSAC_MYC	P9WNW7	99.67	1.0	300.0	DB08542	experimental	3,4-dihydroxy-9,10-secoandrosta-1(10),2,4-triene-9,17-dione	O=C1CC[C@H]([C@@]12C)[C@@H](C(=O)CC2)CCc3c(O)c(O)ccc3C
15704	sp|P9WNW7|HSAC_MYC	P47228	96.67	1.0	291.0	DB01925	experimental	2'-Chloro-Biphenyl-2,3-Diol	Oc1cccc(c1O)-c2c(Cl)cccc2
15705	sp|P9WNW7|HSAC_MYC	P47228	96.67	1.0	291.0	DB02232	experimental	1,2-Dihydroxybenzene	Oc1ccccc1O
15706	sp|P9WNW7|HSAC_MYC	P47228	96.67	1.0	291.0	DB02923	experimental	Biphenyl-2,3-Diol	Oc1c(O)c(ccc1)-c2ccccc2
15707	sp|P9WNW7|HSAC_MYC	P47228	96.67	1.0	291.0	DB03259	experimental	2',6'-Dichloro-Biphenyl-2,6-Diol	Oc1cccc(c1O)-c2c(Cl)cccc2Cl
15708	sp|P9WNW7|HSAC_MYC	P47228	96.67	1.0	291.0	DB03454	experimental	3-methyl-benzene-1,2-diol	Cc1cccc(O)c1O
15709	sp|P9WNW7|HSAC_MYC	P47228	96.67	1.0	291.0	DB03900	experimental	tert-butanol	CC(C)(C)O
15710	sp|P9WNW7|HSAC_MYC	P17297	97.33	1.0	293.0	DB02923	experimental	Biphenyl-2,3-Diol	Oc1c(O)c(ccc1)-c2ccccc2
15711	sp|P9WNW7|HSAC_MYC	P0A108	93.67	6.0	287.0	DB02923	experimental	Biphenyl-2,3-Diol	Oc1c(O)c(ccc1)-c2ccccc2
15712	sp|P9WNW7|HSAC_MYC	P0A108	93.67	6.0	287.0	DB07478	experimental	3,4-Biphenyldiol	Oc1c(O)cc(cc1)-c2ccccc2
15713	sp|P9WNW7|HSAC_MYC	P0A108	93.67	6.0	287.0	DB07610	experimental	1,2-Dihydroxynaphthalene	c1cc(O)c(O)c(c12)cccc2
15714	sp|P9WNW7|HSAC_MYC	Q45135	85.33	15.0	271.0	DB01702	experimental	2-(3,4-Dihydroxyphenyl)Acetic Acid	OC(=O)Cc1cc(O)c(O)cc1
15715	sp|P9WNW7|HSAC_MYC	Q44048	84.67	15.0	269.0	DB01702	experimental	2-(3,4-Dihydroxyphenyl)Acetic Acid	OC(=O)Cc1cc(O)c(O)cc1
15716	sp|P9WNW7|HSAC_MYC	Q0S9X1	84.33	16.0	269.0	DB07914	experimental	2-hydroxy-6-oxo-6-phenyl-2,4-hexadienoic acid	OC(=O)/C(O)=C/C=C/C(=O)c1ccccc1
15717	sp|P9WJW9|JEFA_MYC	P9WJY5	79.92	54.0	460.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
15718	sp|P9WIQ1|GLF_MYCT	P9WIQ1	99.75	1.0	399.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
15719	sp|P9WIQ1|GLF_MYCT	P9WIQ1	99.75	1.0	399.0	DB03709	experimental	Bicine	OCCN(CCO)CC(=O)O
15720	sp|P9WIQ1|GLF_MYCT	P37747	91.23	1.0	365.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
15721	sp|P9WG45|GYRB_MYC	P0A0K8	94.07	8.0	643.0	DB01051	approved; investigational; vet_approved	Novobiocin	CO[C@@H](C1(C)C)[C@@H](OC(=O)N)[C@@H](O)[C@@H](O1)Oc(cc2)c(C)c(c23)oc(=O)c(c3O)NC(=O)c4ccc(O)c(c4)CC=C(C)C
15722	sp|P9WG45|GYRB_MYC	P0A4L9	94.96	6.0	647.0	DB01044	approved; investigational	Gatifloxacin	CC1CN(CCN1)c(c(F)c2)c(OC)c(c23)n(C4CC4)cc(c3=O)C(=O)O
15723	sp|P9WG45|GYRB_MYC	Q59192	93.33	3.0	633.0	DB00537	approved; investigational	Ciprofloxacin	O=C(O)c(c1=O)cn(C2CC2)c(c13)cc(c(F)c3)N4CCNCC4
15724	sp|P9WG45|GYRB_MYC	Q59961	94.07	3.0	638.0	DB01044	approved; investigational	Gatifloxacin	CC1CN(CCN1)c(c(F)c2)c(OC)c(c23)n(C4CC4)cc(c3=O)C(=O)O
15725	sp|P9WG45|GYRB_MYC	P0AES6	81.63	3.0	554.0	DB00817	approved; investigational	Rosoxacin	CCn1cc(C(=O)O)c(=O)c(c12)ccc(c2)-c3ccncc3
15726	sp|P9WG45|GYRB_MYC	P0AES6	81.63	3.0	554.0	DB03966	experimental	Clorobiocin	Cc1[nH]c(cc1)C(=O)O[C@H]([C@@H](OC)C2(C)C)[C@@H](O)[C@@H](O2)Oc(cc3)c(Cl)c(c34)oc(=O)c(c4O)NC(=O)c5cc(c(O)cc5)CC=C(C)C
15727	sp|P9WG45|GYRB_MYC	P0AES6	81.63	3.0	554.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
15728	sp|P9WG45|GYRB_MYC	P0AES6	81.63	3.0	554.0	DB05488	investigational	Technetium Tc-99m ciprofloxacin	 
15729	sp|P9WG45|GYRB_MYC	Q5SHZ4	93.48	2.0	633.0	DB01942	experimental; investigational	Formic acid	OC=O
15730	sp|P9WG45|GYRB_MYC	P20083	92.3	2.0	625.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
15731	sp|P9WG45|GYRB_MYC	Q02880	88.89	94.0	694.0	DB00380	approved; withdrawn	Dexrazoxane	O=C1CN(CC(=O)N1)[C@@H](C)CN2CC(=O)NC(=O)C2
15732	sp|P9WG45|GYRB_MYC	Q02880	88.89	94.0	694.0	DB00694	approved	Daunorubicin	COc1cccc(c12)C(=O)c3c(C2=O)c(O)c4c(c3O)C[C@@](O)(C(=O)C)C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@@H](O5)C
15733	sp|P9WG45|GYRB_MYC	Q02880	88.89	94.0	694.0	DB00773	approved	Etoposide	COc1cc(cc(c1O)OC)[C@@H]2c(cc3c(c4)OCO3)c4[C@H]([C@H]([C@@H]25)COC5=O)O[C@@H]([C@H](O)[C@H]6O)O[C@@H]([C@H]67)CO[C@H](O7)C
15734	sp|P9WG45|GYRB_MYC	Q02880	88.89	94.0	694.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
15735	sp|P9WG45|GYRB_MYC	Q02880	88.89	94.0	694.0	DB05022	investigational	Amonafide	CN(C)CCN(C1=O)C(=O)c2cccc(c2c13)cc(c3)N
15736	sp|P9WG45|GYRB_MYC	Q02880	88.89	94.0	694.0	DB05488	investigational	Technetium Tc-99m ciprofloxacin	 
15737	sp|P9WG45|GYRB_MYC	Q02880	88.89	94.0	694.0	DB06042	investigational	ZEN-012	 
15738	sp|P9WG45|GYRB_MYC	Q02880	88.89	94.0	694.0	DB06362	investigational	Becatecarin	CCN(CC)CCN(C1=O)C(=O)c(c12)c3c([nH]c4c3cccc4Cl)c5c2c6c(c(Cl)ccc6)n5[C@@H]7O[C@H](CO)[C@@H](OC)[C@H](O)[C@H]7O
15739	sp|P9WG45|GYRB_MYC	Q02880	88.89	94.0	694.0	DB06421	investigational	Declopramide	CCN(CC)CCNC(=O)c1ccc(N)c(Cl)c1
15740	sp|P9WG45|GYRB_MYC	Q02880	88.89	94.0	694.0	DB08651	experimental	3'-THIO-THYMIDINE-5'-PHOSPHATE	OP(=O)(O)OC[C@H]1O[C@H](C[C@@H]1S)n2cc(C)c(=O)[nH]c2=O
15741	sp|P9WG45|GYRB_MYC	Q02880	88.89	94.0	694.0	DB00970	approved; investigational	Dactinomycin	C1CC[C@H](N12)C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@H](C)[C@@H](C(=O)N[C@@H](C2=O)C(C)C)NC(=O)c(ccc3C)c(c34)nc5c(o4)c(C)c(=O)c(N)c5C(=O)N[C@H](C(=O)N[C@@H](C6=O)C(C)C)[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H](N67)CCC7
15742	sp|P9WKE1|KTHY_MYC	P9WKE1	99.53	1.0	214.0	DB01643	experimental	Thymidine monophosphate	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)O
15743	sp|P9WKE1|KTHY_MYC	P9WKE1	99.53	1.0	214.0	DB02452	experimental	Thymidine 5'-triphosphate	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
15744	sp|P9WKE1|KTHY_MYC	P9WKE1	99.53	1.0	214.0	DB03280	experimental	p1-(5'-adenosyl)p5-(5'-thymidyl)pentaphosphate	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]4O[C@H](C[C@@H]4O)n5cc(C)c(=O)[nH]c5=O
15745	sp|P9WKE1|KTHY_MYC	P9WKE1	99.53	1.0	214.0	DB03666	experimental	Zidovudine monophosphate	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](N=[N+]=[N-])[C@H](O2)COP(=O)(O)O
15746	sp|P9WKE1|KTHY_MYC	P9WKE1	99.53	1.0	214.0	DB03846	experimental	2'-deoxy-5-(hydroxymethyl)uridine 5'-(dihydrogen phosphate)	O=c1[nH]c(=O)c(CO)cn1[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)O
15747	sp|P9WKE1|KTHY_MYC	P9WKE1	99.53	1.0	214.0	DB04485	experimental; investigational	Thymidine	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)CO
15748	sp|P9WKE1|KTHY_MYC	P0A721	82.24	6.0	182.0	DB03280	experimental	p1-(5'-adenosyl)p5-(5'-thymidyl)pentaphosphate	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]4O[C@H](C[C@@H]4O)n5cc(C)c(=O)[nH]c5=O
15749	sp|P9WKE1|KTHY_MYC	P23919	74.3	8.0	167.0	DB01643	experimental	Thymidine monophosphate	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)O
15750	sp|P9WKE1|KTHY_MYC	P23919	74.3	8.0	167.0	DB03150	experimental	2',3'-Dideoxythymidine-5'-Monophosphate	O=c1[nH]c(=O)n(cc1C)[C@H]2CC[C@H](O2)COP(=O)(O)O
15751	sp|P9WKE1|KTHY_MYC	P23919	74.3	8.0	167.0	DB03195	experimental	3'-Fluoro-3'-deoxythymidine 5'-monophosphate	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](F)[C@H](O2)COP(=O)(O)O
15752	sp|P9WKE1|KTHY_MYC	P23919	74.3	8.0	167.0	DB03233	experimental	3'-deoxy-3'-aminothymidine monophosphate	OP(=O)(O)OC[C@H]1O[C@H](C[C@@H]1N)n2cc(C)c(=O)[nH]c2=O
15753	sp|P9WKE1|KTHY_MYC	P23919	74.3	8.0	167.0	DB03280	experimental	p1-(5'-adenosyl)p5-(5'-thymidyl)pentaphosphate	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]4O[C@H](C[C@@H]4O)n5cc(C)c(=O)[nH]c5=O
15754	sp|P9WKE1|KTHY_MYC	P23919	74.3	8.0	167.0	DB03666	experimental	Zidovudine monophosphate	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](N=[N+]=[N-])[C@H](O2)COP(=O)(O)O
15755	sp|P9WKE1|KTHY_MYC	P23919	74.3	8.0	167.0	DB03845	experimental	P1-(5'-Adenosyl)P5-(5'-(3'azido-3'-Deoxythymidyl))Pentaphosphate	O=c1nc([O-])c(C)cn1[C@H]2C[C@H](N=[N+]=[N-])[C@H](O2)COP([O-])(=O)OP([O-])(=O)OP(=O)(O)OP([O-])(=O)OP([O-])(=O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
15756	sp|P9WKE1|KTHY_MYC	P23919	74.3	8.0	167.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
15757	sp|P71716|MBTA_MYC	P40871	93.27	2.0	529.0	DB01672	experimental	2,3-Dihydroxy-Benzoic Acid	OC(=O)c1cccc(O)c1O
15758	sp|P71716|MBTA_MYC	Q8ZKF6	96.11	79.0	622.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
15759	sp|P71716|MBTA_MYC	Q8ZKF6	96.11	79.0	622.0	DB03230	experimental	Adenosine-5'-Propylphosphate	CCCOP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
15760	sp|P71716|MBTA_MYC	Q9NR19	100.0	105.0	670.0	DB00131	approved; investigational; nutraceutical	Adenosine phosphate	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
15761	sp|P71716|MBTA_MYC	Q9NR19	100.0	105.0	670.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
15762	sp|P71716|MBTA_MYC	Q9NUB1	95.58	113.0	653.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
15763	sp|P71716|MBTA_MYC	Q8GN86	88.5	2.0	502.0	DB03728	experimental	p-Chlorobenzoic acid	OC(=O)c1ccc(Cl)cc1
15764	sp|P9WK25|MAOX_MYC	Q16798	96.9	54.0	585.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
15765	sp|P9WK25|MAOX_MYC	Q16798	96.9	54.0	585.0	DB03680	experimental	Tartronate	[O-]C(=O)C(O)C([O-])=O
15766	sp|P9WK25|MAOX_MYC	P48163	96.72	20.0	550.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
15767	sp|P9WK25|MAOX_MYC	P48163	96.72	20.0	550.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
15768	sp|P9WK25|MAOX_MYC	P23368	97.45	29.0	563.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
15769	sp|P9WK25|MAOX_MYC	P23368	97.45	29.0	563.0	DB01677	experimental; investigational	Fumaric Acid	OC(=O)/C=C/C(=O)O
15770	sp|P9WK25|MAOX_MYC	P23368	97.45	29.0	563.0	DB03499	experimental	D-Malic acid	OC(=O)[C@H](O)CC(=O)O
15771	sp|P9WK25|MAOX_MYC	P23368	97.45	29.0	563.0	DB03589	experimental	Mesoxalic acid	OC(=O)C(=O)C(=O)O
15772	sp|P9WK25|MAOX_MYC	P23368	97.45	29.0	563.0	DB03680	experimental	Tartronate	[O-]C(=O)C(O)C([O-])=O
15773	sp|P9WJH5|NUOD_MYC	O75306	87.73	77.0	463.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
15774	sp|P9WN83|G3P_MYCT	P0A9B2	97.35	1.0	331.0	DB02263	experimental	Glyceraldehyde-3-Phosphate	O=C[C@H](O)COP(=O)(O)O
15775	sp|P9WN83|G3P_MYCT	P0A9B2	97.35	1.0	331.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
15776	sp|P9WN83|G3P_MYCT	P04406	96.76	4.0	332.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
15777	sp|P9WN83|G3P_MYCT	P04406	96.76	4.0	332.0	DB02059	experimental	Adenosine-5-Diphosphoribose	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)CO[P@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H](O)[C@H](O)[C@@H]4O
15778	sp|P9WN83|G3P_MYCT	P04406	96.76	4.0	332.0	DB03893	experimental	Thionicotinamide-Adenine-Dinucleotide	n1cnc(N)c(c12)ncn2[C@H]3[C@H](O)[C@H](O)[C@H](O3)COP(=O)(O)OP(=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)[n+]5cccc(c5)C([S-])=N
15779	sp|P9WN83|G3P_MYCT	P04406	96.76	4.0	332.0	DB07347	experimental	4-(2-Aminoethyl)Benzenesulfonyl Fluoride	NCCc1ccc(S(F)(=O)=O)cc1
15780	sp|P9WN83|G3P_MYCT	P04406	96.76	4.0	332.0	DB09092	approved; withdrawn	Xanthinol	OCCN(C)CC(O)Cn1cnc(c12)n(C)c(=O)n(c2=O)C
15781	sp|P9WN83|G3P_MYCT	P04406	96.76	4.0	332.0	DB09130	approved; investigational	Copper	[Cu]
15782	sp|P9WN83|G3P_MYCT	P04406	96.76	4.0	332.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
15783	sp|P9WN83|G3P_MYCT	Q8IKK7	97.64	4.0	335.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
15784	sp|P9WN83|G3P_MYCT	O14556	96.46	76.0	403.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
15785	sp|P9WN83|G3P_MYCT	O14556	96.46	76.0	403.0	DB01593	approved; investigational	Zinc	[Zn]
15786	sp|P9WN83|G3P_MYCT	O14556	96.46	76.0	403.0	DB02205	experimental	(+)-Rutamarin alcohol	CC(C)(O)[C@@H](O1)Cc(c12)cc3c(c2)oc(=O)c(c3)C(C)(C)C=C
15787	sp|P9WN83|G3P_MYCT	O14556	96.46	76.0	403.0	DB03331	experimental	N-naphthalen-1-ylmethyl-2'-[3,5-dimethoxybenzamido]-2'-deoxy-adenosine	c1cccc(c12)cccc2CNc(ncn3)c(c34)ncn4[C@@H]5O[C@H](CO)[C@@H](O)[C@H]5NC(=O)c6cc(OC)cc(c6)OC
15788	sp|P9WN83|G3P_MYCT	O14556	96.46	76.0	403.0	DB04477	experimental	2'-Deoxy-2'-[(3,5-dimethoxybenzoyl)amino]-N-[(1R)-1,2,3,4-tetrahydro-1-naphthalenyl]adenosine	COc1cc(cc(c1)OC)C(=O)N[C@@H]2[C@H](O)[C@@H](CO)O[C@H]2n3cnc(c34)c(ncn4)N[C@@H]5CCCc(c56)cccc6
15789	sp|P9WN83|G3P_MYCT	O14556	96.46	76.0	403.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
15790	sp|P9WN83|G3P_MYCT	O14556	96.46	76.0	403.0	DB14487	approved; investigational	Zinc acetate	CC([O-])=O
15791	sp|P9WN83|G3P_MYCT	O14556	96.46	76.0	403.0	DB14533	approved; investigational	Zinc chloride	[Cl-]
15792	sp|P9WN83|G3P_MYCT	O14556	96.46	76.0	403.0	DB14548	approved; experimental	Zinc sulfate, unspecified form	 
15793	sp|P9WN83|G3P_MYCT	P00362	97.35	1.0	331.0	DB02263	experimental	Glyceraldehyde-3-Phosphate	O=C[C@H](O)COP(=O)(O)O
15794	sp|P9WN83|G3P_MYCT	P22513	103.24	1.0	351.0	DB02205	experimental	(+)-Rutamarin alcohol	CC(C)(O)[C@@H](O1)Cc(c12)cc3c(c2)oc(=O)c(c3)C(C)(C)C=C
15795	sp|P9WN83|G3P_MYCT	P22513	103.24	1.0	351.0	DB03211	experimental	(3-Formyl-but-3-Enyl)-Phosphonic Acid	OP(=O)(O)CCC(=C)C=O
15796	sp|P9WN89|FRDB_MYC	P0AC47	93.93	4.0	236.0	DB07490	experimental	2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL	Clc1ccc(cc1)[C@@H](C)c2cc([N+]([O-])=O)cc([N+]([O-])=O)c2O
15797	sp|P9WN89|FRDB_MYC	P0AC47	93.93	4.0	236.0	DB07918	experimental	2-heptyl-4-hydroxyquinoline N-oxide	CCCCCCCc(cc1O)[n+]([O-])c(c12)cccc2
15798	sp|P9WN89|FRDB_MYC	P21912	95.55	41.0	277.0	DB04141	experimental	2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol	O[C@H]1[C@@H](O)[C@@H](CO)O[C@H]([C@@H]1O)OCCCCCC
15799	sp|P9WN89|FRDB_MYC	P21912	95.55	41.0	277.0	DB08689	experimental	Ubiquinone Q1	COC1=C(OC)C(=O)C(=C(C)C1=O)CC=C(C)C
15800	sp|P9WN89|FRDB_MYC	P07014	93.12	2.0	232.0	DB04631	experimental	Atpenin A5	ClC[C@H](Cl)[C@@H](C)C[C@H](C)C(=O)c1c(O)c(OC)c([nH]c1=O)OC
15801	sp|P9WN89|FRDB_MYC	P07014	93.12	2.0	232.0	DB07671	experimental	2-[1-METHYLHEXYL]-4,6-DINITROPHENOL	CCCCCC(C)c1c(O)c(N(=O)=O)cc(c1)N(=O)=O
15802	sp|P9WN89|FRDB_MYC	P07014	93.12	2.0	232.0	DB08690	experimental	Ubiquinone Q2	COC1=C(OC)C(=O)C(=C(C)C1=O)C/C=C(\C)CCC=C(C)C
15803	sp|P9WN89|FRDB_MYC	P17596	94.33	3.0	236.0	DB07669	experimental	2,3-Dimethyl-1,4-naphthoquinone	O=C1C(C)=C(C)C(=O)c(c12)cccc2
15804	sp|P9WI55|IPYR_MYC	Q3JUV5	98.15	15.0	174.0	DB06851	experimental	N-(pyridin-3-ylmethyl)aniline	c1ccncc1CNc2ccccc2
15805	sp|P9WI55|IPYR_MYC	Q3JUV5	98.15	15.0	174.0	DB07291	experimental	5-amino-1-(4-chlorophenyl)-1H-pyrazole-4-carbonitrile	Nc1c(C#N)cnn1-c2ccc(Cl)cc2
15806	sp|P9WK91|LIPA_MYC	O43766	92.6	73.0	361.0	DB00166	approved; investigational; nutraceutical	Lipoic acid	OC(=O)CCCC[C@@H]1CCSS1
15807	sp|P9WPW9|MURI_MYC	Q836J0	96.68	4.0	266.0	DB07937	experimental	2-butoxy-9-(2,6-difluorobenzyl)-N-(2-morpholin-4-ylethyl)-9H-purin-6-amine	Fc1cccc(F)c1Cn2cnc(c23)c(nc(n3)OCCCC)NCCN4CCOCC4
15808	sp|P9WPW9|MURI_MYC	Q8Y7N7	94.1	3.0	258.0	DB02343	experimental	3,6,9,12,15-Pentaoxaheptadecane	CCOCCOCCOCCOCCOCC
15809	sp|P9WPW9|MURI_MYC	Q9A1B7	93.36	3.0	256.0	DB08272	experimental	(4S)-4-(2-NAPHTHYLMETHYL)-D-GLUTAMIC ACID	OC(=O)[C@H](N)C[C@@H](C(=O)O)Cc(cc1)cc(c12)cccc2
15810	sp|P9WPW9|MURI_MYC	P56868	74.91	2.0	205.0	DB02174	experimental	D-Glutamine	OC(=O)[C@H](N)CCC(=O)N
15811	sp|P9WPW9|MURI_MYC	Q9ZLT0	92.62	2.0	253.0	DB08698	experimental	1-[(3S)-5-PHENYL-3-THIOPHEN-2-YL-3H-1,4-BENZODIAZEPIN-2-YL]AZETIDIN-3-OL	c1ccccc1C(c(c23)cccc2)=N[C@H](c4cccs4)C(=N3)N5CC(O)C5
15812	sp|P9WJM3|MTNN_MYC	P0AF12	89.02	2.0	229.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
15813	sp|P9WJM3|MTNN_MYC	P0AF12	89.02	2.0	229.0	DB02158	experimental	(2S,3S,4R,5S)-2-(4-Amino-4,5-dihydro-1H-pyrrolo[3,2-d]pyrimidin-7-yl)-5-[(methylsulfanyl)methyl]-3,4-pyrrolidinediol	CSC[C@H]1N[C@H]([C@H](O)[C@@H]1O)c2c[nH]c(c23)C(N)NC=N3
15814	sp|P9WJM3|MTNN_MYC	P0AF12	89.02	2.0	229.0	DB02281	experimental	Formycin	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)c([nH]n2)c(c23)ncnc3N
15815	sp|P9WJM3|MTNN_MYC	P0AF12	89.02	2.0	229.0	DB02933	experimental	5'-Deoxy-5'-(Methylthio)-Tubercidin	CSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2ccc(c23)c(N)ncn3
15816	sp|P9WJM3|MTNN_MYC	P0AF12	89.02	2.0	229.0	DB08606	experimental	(3R,4S)-1-[(4-AMINO-5H-PYRROLO[3,2-D]PYRIMIDIN-7-YL)METHYL]-4-[(METHYLSULFANYL)METHYL]PYRROLIDIN-3-OL	CSC[C@H]1CN(C[C@@H]1O)Cc2c[nH]c(c23)c(N)ncn3
15817	sp|P9WJM3|MTNN_MYC	P0AF14	89.02	2.0	229.0	DB07649	experimental	(3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-[(benzylsulfanyl)methyl]pyrrolidin-3-ol	n1cnc(N)c(c12)[nH]cc2CN3C[C@H](O)[C@H](C3)CSCc4ccccc4
15818	sp|P9WJM3|MTNN_MYC	Q9KPI8	89.41	2.0	230.0	DB07463	experimental	(3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-[(butylsulfanyl)methyl]pyrrolidin-3-ol	CCCCSC[C@H]1CN(C[C@@H]1O)Cc2c[nH]c(c23)c(N)ncn3
15819	sp|P9WIV5|NUOE_MYC	P19404	72.22	39.0	221.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
15820	sp|P9WHT3|AMPA_MYC	P28838	81.17	94.0	512.0	DB02386	experimental	Leucine Phosphonic Acid	CC(C)C[C@H](N)P(=O)(O)O
15821	sp|P9WHT3|AMPA_MYC	P28838	81.17	94.0	512.0	DB07448	experimental	(2S)-3-[(R)-[(1S)-1-amino-3-phenylpropyl](hydroxy)phosphoryl]-2-benzylpropanoic acid	c1ccccc1C[C@@H](C(=O)O)C[P@@](=O)(O)[C@H](N)CCc2ccccc2
15822	sp|P9WHT3|AMPA_MYC	P28838	81.17	94.0	512.0	DB08766	experimental	Zofenoprilat	SC[C@@H](C)C(=O)N1C[C@H](C[C@H]1C(=O)O)Sc2ccccc2
15823	sp|P9WN67|GALE_MYC	Q9ZGH3	99.68	1.0	314.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
15824	sp|P9WN67|GALE_MYC	P09147	105.1	1.0	331.0	DB01861	experimental	Uridine diphosphate glucose	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
15825	sp|P9WN67|GALE_MYC	P09147	105.1	1.0	331.0	DB02421	experimental	Uridine-5'-diphosphate-mannose	O=c1[nH]c(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O
15826	sp|P9WN67|GALE_MYC	P09147	105.1	1.0	331.0	DB02790	experimental	Phenyl-uridine-5'-diphosphate	O=c1[nH]c(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)Oc3ccccc3
15827	sp|P9WN67|GALE_MYC	P09147	105.1	1.0	331.0	DB03397	experimental	Uridine-Diphosphate-N-Acetylglucosamine	CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
15828	sp|P9WN67|GALE_MYC	P09147	105.1	1.0	331.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
15829	sp|P9WN67|GALE_MYC	P09147	105.1	1.0	331.0	DB04097	experimental	Uridine-5'-diphosphate-4-deoxy-4-fluoro-alpha-D-galactose	O=c1[nH]c(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](F)[C@H](O)[C@H]3O
15830	sp|P9WN67|GALE_MYC	P26391	107.01	1.0	337.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
15831	sp|P9WN67|GALE_MYC	P14169	106.37	1.0	335.0	DB04555	experimental	Cytidine-5'-Diphosphate	Nc1nc(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O
15832	sp|P9WN67|GALE_MYC	Q14376	107.01	4.0	340.0	DB01861	experimental	Uridine diphosphate glucose	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
15833	sp|P9WN67|GALE_MYC	Q14376	107.01	4.0	340.0	DB02196	experimental	Uridine-Diphosphate-N-Acetylgalactosamine	CC(=O)N[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
15834	sp|P9WN67|GALE_MYC	Q14376	107.01	4.0	340.0	DB03041	experimental	UDP-alpha-D-glucuronic acid	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O
15835	sp|P9WN67|GALE_MYC	Q14376	107.01	4.0	340.0	DB03095	experimental	Tetramethylammonium	C[N+](C)(C)C
15836	sp|P9WN67|GALE_MYC	Q14376	107.01	4.0	340.0	DB03397	experimental	Uridine-Diphosphate-N-Acetylglucosamine	CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
15837	sp|P9WN67|GALE_MYC	Q14376	107.01	4.0	340.0	DB03501	experimental	Galactose-uridine-5'-diphosphate	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@H]1O)O[P@](=O)(O)O[P@](=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
15838	sp|P9WN67|GALE_MYC	P95780	101.27	7.0	325.0	DB03161	experimental	Thymidine-5'-diphospho-beta-D-xylose	O=c1[nH]c(=O)c(C)cn1[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3OC[C@@H](O)[C@H](O)[C@H]3O
15839	sp|P9WN67|GALE_MYC	P95780	101.27	7.0	325.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
15840	sp|P9WN67|GALE_MYC	Q8T8E9	119.43	1.0	376.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
15841	sp|P9WN67|GALE_MYC	Q8KN66	100.64	20.0	336.0	DB01861	experimental	Uridine diphosphate glucose	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
15842	sp|P9WN67|GALE_MYC	Q8KN66	100.64	20.0	336.0	DB02196	experimental	Uridine-Diphosphate-N-Acetylgalactosamine	CC(=O)N[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
15843	sp|P9WN67|GALE_MYC	O60547	106.37	26.0	360.0	DB02547	experimental	Guanosine-5'-Diphosphate-Rhamnose	O[C@H]1[C@H](O)[C@H](O)[C@H](O[C@@H]1C)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3cnc(c34)c(=O)nc([nH]4)N
15844	sp|P9WN67|GALE_MYC	O60547	106.37	26.0	360.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
15845	sp|P9WN67|GALE_MYC	Q51366	98.41	5.0	314.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
15846	sp|P9WN67|GALE_MYC	P77398	106.69	317.0	652.0	DB03256	experimental	(6R)-Folinic acid	Nc([nH]1)nc(=O)c(c12)N(C=O)[C@@H](CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
15847	sp|P9WN67|GALE_MYC	P77398	106.69	317.0	652.0	DB03685	experimental	Uridine monophosphate	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2ccc(=O)[nH]c2=O
15848	sp|P9WN67|GALE_MYC	P26397	102.87	11.0	334.0	DB02059	experimental	Adenosine-5-Diphosphoribose	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)CO[P@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H](O)[C@H](O)[C@@H]4O
15849	sp|P9WN67|GALE_MYC	P26397	102.87	11.0	334.0	DB03069	experimental	Cytidine-5'-diphospho-beta-D-xylose	Nc1nc(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O[C@H]3OC[C@@H](O)[C@H](O)[C@H]3O
15850	sp|P9WN67|GALE_MYC	Q13630	97.77	8.0	315.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
15851	sp|P9WN67|GALE_MYC	P67910	97.45	2.0	308.0	DB01774	experimental	Adenosine-5'-Monophosphate Glucopyranosyl-Monophosphate Ester	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@@](=O)(O)O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O
15852	sp|P9WN67|GALE_MYC	P67910	97.45	2.0	308.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
15853	sp|P9WN67|GALE_MYC	P32055	98.73	5.0	315.0	DB02897	experimental	Acetylphosphate	CC(=O)OP(=O)(O)O
15854	sp|P9WN67|GALE_MYC	P32055	98.73	5.0	315.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
15855	sp|P9WN67|GALE_MYC	P26439	111.46	5.0	355.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
15856	sp|P9WN67|GALE_MYC	P26439	111.46	5.0	355.0	DB01108	approved; investigational; vet_approved; withdrawn	Trilostane	C1C[C@H](O)[C@@](C)(CC2)[C@@H]1[C@H](CC3)[C@H]2[C@@]([C@@]345)(C)CC(C#N)=C([C@H]4O5)O
15857	sp|P9WN67|GALE_MYC	P14060	111.46	6.0	356.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
15858	sp|P9WN67|GALE_MYC	P14060	111.46	6.0	356.0	DB01108	approved; investigational; vet_approved; withdrawn	Trilostane	C1C[C@H](O)[C@@](C)(CC2)[C@@H]1[C@H](CC3)[C@H]2[C@@]([C@@]345)(C)CC(C#N)=C([C@H]4O5)O
15859	sp|P9WN67|GALE_MYC	P14060	111.46	6.0	356.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
15860	sp|P9WN67|GALE_MYC	P14060	111.46	6.0	356.0	DB14538	experimental; vet_approved	Hydrocortisone aceponate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CC)C(=O)COC(=O)C
15861	sp|P9WN67|GALE_MYC	P14060	111.46	6.0	356.0	DB14539	approved; vet_approved	Hydrocortisone acetate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)C
15862	sp|P9WN67|GALE_MYC	P14060	111.46	6.0	356.0	DB14540	approved; vet_approved	Hydrocortisone butyrate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCC
15863	sp|P9WN67|GALE_MYC	P14060	111.46	6.0	356.0	DB14541	approved; investigational; vet_approved	Hydrocortisone cypionate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)CCC5CCCC5
15864	sp|P9WN67|GALE_MYC	P14060	111.46	6.0	356.0	DB14542	approved; vet_approved	Hydrocortisone phosphate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COP(=O)(O)O
15865	sp|P9WN67|GALE_MYC	P14060	111.46	6.0	356.0	DB14543	approved; vet_approved	Hydrocortisone probutate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CCC)C(=O)COC(=O)CC
15866	sp|P9WN67|GALE_MYC	P14060	111.46	6.0	356.0	DB14544	approved; vet_approved	Hydrocortisone valerate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCCC
15867	sp|P9WN67|GALE_MYC	Q15738	104.78	39.0	368.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
15868	sp|P9WIH9|MAZF3_MY	P96622	87.38	15.0	105.0	DB02042	experimental	2-(2-{2-[2-(2-Methoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol	COCCOCCOCCOCCOCCO
15869	sp|P9WNY5|MMSB_MYC	P31937	99.32	40.0	332.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
15870	sp|P9WNY5|MMSB_MYC	P52209	72.45	5.0	218.0	DB00789	approved	Gadopentetic acid	OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC(=O)O
15871	sp|P9WNY5|MMSB_MYC	P52209	72.45	5.0	218.0	DB00851	approved; investigational	Dacarbazine	CN(C)/N=N/c1c(C(=O)N)nc[nH]1
15872	sp|P9WNY5|MMSB_MYC	P52209	72.45	5.0	218.0	DB00920	approved	Ketotifen	CN1CCC(CC1)=C2c(ccs3)c3C(=O)Cc(c24)cccc4
15873	sp|P9WNY5|MMSB_MYC	P52209	72.45	5.0	218.0	DB02076	experimental	6-phospho-D-gluconic acid	OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(=O)O
15874	sp|P9WNY5|MMSB_MYC	P52209	72.45	5.0	218.0	DB03962	experimental	Nicotinamide 8-bromo-adenine dinucleotide phosphate	NC(=O)c1c[n+](ccc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4c(Br)nc(c45)c(N)ncn5
15875	sp|P9WJI5|NAT_MYCT	P9WJI5	99.65	1.0	283.0	DB00244	approved	Mesalazine	Nc1cc(C(=O)O)c(O)cc1
15876	sp|P9WQ99|AMIA2_MY	Q9ZIV5	78.1	29.0	407.0	DB02153	experimental	3-sulfino-L-alanine	OC(=O)[C@@H](N)C[S@](=O)O
15877	sp|P9WQ99|AMIA2_MY	Q9ZIV5	78.1	29.0	407.0	DB02175	experimental	Malonic acid	OC(=O)CC(=O)O
15878	sp|P9WQ99|AMIA2_MY	Q9ZIV5	78.1	29.0	407.0	DB02649	experimental	3-Amino-3-Oxopropanoic Acid	NC(=O)CC(=O)O
15879	sp|P63907|ADD_MYCT	P00813	93.42	9.0	350.0	DB00552	approved; investigational	Pentostatin	OC[C@H]1O[C@H](C[C@@H]1O)n2cnc(c23)[C@H](O)CNC=N3
15880	sp|P63907|ADD_MYCT	P00813	93.42	9.0	350.0	DB00975	approved	Dipyridamole	C1CCCCN1c2nc(N(CCO)CCO)nc(c23)c(nc(n3)N(CCO)CCO)N4CCCCC4
15881	sp|P63907|ADD_MYCT	P00813	93.42	9.0	350.0	DB02096	experimental	FR221647	NC(=O)c1cn(cn1)[C@@H](CO)CCc2ccccc2
15882	sp|P63907|ADD_MYCT	P00813	93.42	9.0	350.0	DB02472	experimental	7,8-dihydroinosine	O=c1nc[nH]c(c12)N(CN2)[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O
15883	sp|P63907|ADD_MYCT	P00813	93.42	9.0	350.0	DB02616	experimental	FR117016	NC(N)=Nc1nc(cs1)-c2ccc(s2)CNc([nH]3)nc(c34)cccc4
15884	sp|P63907|ADD_MYCT	P00813	93.42	9.0	350.0	DB02830	experimental	FR236913	NC(=O)c1cn(cn1)[C@@H](CO)CCn2ccc(c23)ccc(c3)NC(=O)NCc4ccccc4
15885	sp|P63907|ADD_MYCT	P00813	93.42	9.0	350.0	DB03015	experimental	6-hydroxy-1,6-dihydro purine nucleoside	O[C@@H]1N=CNc(c12)[n+](c[nH]2)[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O
15886	sp|P63907|ADD_MYCT	P00813	93.42	9.0	350.0	DB03220	experimental	FR-234938	NC(=O)c1cn(cn1)[C@@H]([C@H](C)O)CCc(ccc2)c(c23)cccc3
15887	sp|P63907|ADD_MYCT	P00813	93.42	9.0	350.0	DB03370	experimental	FR239087	NC(=O)c1cn(cn1)[C@@H]([C@H](C)O)CCc2cccc(Cl)c2Cl
15888	sp|P63907|ADD_MYCT	P00813	93.42	9.0	350.0	DB03572	experimental	FR230513	NC(=O)c1cn(cn1)[C@@H](CO)CCc2cccc(c23)cccc3
15889	sp|P63907|ADD_MYCT	P00813	93.42	9.0	350.0	DB04218	experimental	1-Deaza-Adenosine	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ccn3
15890	sp|P63907|ADD_MYCT	P00813	93.42	9.0	350.0	DB04440	experimental	Nebularine	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)cncn3
15891	sp|P63907|ADD_MYCT	P00813	93.42	9.0	350.0	DB07711	experimental	(2S,3R)-3-(6-amino-9H-purin-9-yl)nonan-2-ol	CCCCCC[C@H]([C@H](C)O)n1cnc(c12)c(N)ncn2
15892	sp|P63907|ADD_MYCT	P00813	93.42	9.0	350.0	DB07783	experimental	1-((1R)-1-(HYDROXYMETHYL)-3-{6-[(3-PHENYLPROPANOYL)AMINO]-1H-INDOL-1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE	NC(=O)c1cn(cn1)[C@@H](CO)CCn2ccc(c23)ccc(c3)NC(=O)CCc4ccccc4
15893	sp|P63907|ADD_MYCT	P00813	93.42	9.0	350.0	DB07785	experimental	1-{(1R,2S)-2-HYDROXY-1-[2-(2-NAPHTHYLOXY)ETHYL]PROPYL}-1H-IMIDAZONE-4-CARBOXAMIDE	NC(=O)c1cn(cn1)[C@@H]([C@H](C)O)CCOc(cc2)cc(c23)cccc3
15894	sp|P63907|ADD_MYCT	P00813	93.42	9.0	350.0	DB07786	experimental	1-((1R,2S)-1-{2-[2-(4-CHLOROPHENYL)-1,3-BENZOXAZOL-7-YL]ETHYL}-2-HYDROXYPROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE	NC(=O)c1cn(cn1)[C@H]([C@H](C)O)CCc2cccc(c23)nc(o3)-c4ccc(Cl)cc4
15895	sp|P63907|ADD_MYCT	Q8IJA9	89.59	38.0	365.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
15896	sp|P9WQD1|ACSA_MYC	Q8ZKF6	95.55	19.0	641.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
15897	sp|P9WQD1|ACSA_MYC	Q8ZKF6	95.55	19.0	641.0	DB03230	experimental	Adenosine-5'-Propylphosphate	CCCOP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
15898	sp|P9WQD1|ACSA_MYC	Q9NR19	100.92	35.0	692.0	DB00131	approved; investigational; nutraceutical	Adenosine phosphate	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
15899	sp|P9WQD1|ACSA_MYC	Q9NR19	100.92	35.0	692.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
15900	sp|P9WQD1|ACSA_MYC	Q9NUB1	97.54	39.0	674.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
15901	sp|P9WQD1|ACSA_MYC	P40871	77.11	32.0	534.0	DB01672	experimental	2,3-Dihydroxy-Benzoic Acid	OC(=O)c1cccc(O)c1O
15902	sp|P9WPX7|AROQ_MYC	P9WPX7	99.32	1.0	147.0	DB02801	experimental	2,3-Anhydro-quinic acid	O=C(O)[C@]1(O)C=C[C@@H](O)[C@H](O)C1
15903	sp|P9WPX7|AROQ_MYC	P9WPX7	99.32	1.0	147.0	DB03739	experimental	3-Hydroxyimino Quinic Acid	OC(=O)[C@@]1(O)C[C@@H](O)[C@H](O)/C(C1)=N/O
15904	sp|P9WPX7|AROQ_MYC	P15474	96.6	9.0	151.0	DB02786	experimental	2-Anhydro-3-Fluoro-Quinic Acid	O=C(O)[C@]1(O)C=C(F)[C@@H](O)[C@H](O)C1
15905	sp|P9WPX7|AROQ_MYC	P15474	96.6	9.0	151.0	DB02801	experimental	2,3-Anhydro-quinic acid	O=C(O)[C@]1(O)C=C[C@@H](O)[C@H](O)C1
15906	sp|P9WPX7|AROQ_MYC	P15474	96.6	9.0	151.0	DB04347	experimental	3-Dehydroshikimate	O[C@@H]1CC(C(=O)O)=CC(=O)[C@H]1O
15907	sp|P9WPX7|AROQ_MYC	P15474	96.6	9.0	151.0	DB04656	experimental	1,3,4-TRIHYDROXY-5-(3-PHENOXYPROPYL)-CYCLOHEXANE-1-CARBOXYLIC A CID	OC(=O)[C@@]1(O)C[C@@H](O)[C@H](O)[C@H](C1)CCCOc2ccccc2
15908	sp|P9WPX7|AROQ_MYC	P15474	96.6	9.0	151.0	DB08485	experimental	(1S,4S,5S)-1,4,5-TRIHYDROXY-3-[3-(PHENYLTHIO)PHENYL]CYCLOHEX-2-ENE-1-CARBOXYLIC ACID	OC(=O)[C@@]1(O)C[C@@H](O)[C@H](O)C(=C1)c2cccc(c2)Sc3ccccc3
15909	sp|P9WPX7|AROQ_MYC	Q48255	95.24	3.0	143.0	DB03868	experimental	3-Dehydroquinic Acid	O=C(O)[C@]1(O)CC(=O)[C@@H](O)[C@H](O)C1
15910	sp|P9WPX7|AROQ_MYC	Q48255	95.24	3.0	143.0	DB04698	experimental	N-(1,4-dihydro-5H-tetrazol-5-ylidene)-9-oxo-9H-xanthene-2-sulfonamide	n1[nH]nnc1NS(=O)(=O)c(cc2)cc(c23)c(=O)c4c(o3)cccc4
15911	sp|O53907|IMPA_MYC	P29218	83.33	35.0	260.0	DB01356	experimental	Lithium cation	[Li+]
15912	sp|O53907|IMPA_MYC	P29218	83.33	35.0	260.0	DB03542	experimental	L-Myo-Inositol-1-Phosphate	O[C@H]1[C@H](O)[C@H](O)[C@H](OP([O-])([O-])=O)[C@@H](O)[C@@H]1O
15913	sp|O53907|IMPA_MYC	P29218	83.33	35.0	260.0	DB14507	approved	Lithium citrate	[O-]C(=O)CC(O)(C([O-])=O)CC([O-])=O
15914	sp|O53907|IMPA_MYC	P29218	83.33	35.0	260.0	DB14508	experimental	Lithium succinate	[O-]C(=O)CCC([O-])=O
15915	sp|O53907|IMPA_MYC	P29218	83.33	35.0	260.0	DB14509	approved	Lithium carbonate	[O-]C([O-])=O
15916	sp|O53907|IMPA_MYC	O14732	84.07	46.0	273.0	DB01356	experimental	Lithium cation	[Li+]
15917	sp|O53907|IMPA_MYC	O14732	84.07	46.0	273.0	DB14507	approved	Lithium citrate	[O-]C(=O)CC(O)(C([O-])=O)CC([O-])=O
15918	sp|O53907|IMPA_MYC	O14732	84.07	46.0	273.0	DB14508	experimental	Lithium succinate	[O-]C(=O)CCC([O-])=O
15919	sp|O53907|IMPA_MYC	O14732	84.07	46.0	273.0	DB14509	approved	Lithium carbonate	[O-]C([O-])=O
15920	sp|P9WQ39|MENE_MYC	Q9NUB1	100.81	284.0	657.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
15921	sp|P9WQ39|MENE_MYC	Q9NR19	99.73	307.0	676.0	DB00131	approved; investigational; nutraceutical	Adenosine phosphate	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
15922	sp|P9WQ39|MENE_MYC	Q9NR19	99.73	307.0	676.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
15923	sp|P9WQ39|MENE_MYC	Q8GN86	95.68	149.0	503.0	DB03728	experimental	p-Chlorobenzoic acid	OC(=O)c1ccc(Cl)cc1
15924	sp|P9WQ39|MENE_MYC	P40871	96.49	173.0	530.0	DB01672	experimental	2,3-Dihydroxy-Benzoic Acid	OC(=O)c1cccc(O)c1O
15925	sp|P9WQ39|MENE_MYC	Q8ZKF6	99.73	254.0	623.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
15926	sp|P9WQ39|MENE_MYC	Q8ZKF6	99.73	254.0	623.0	DB03230	experimental	Adenosine-5'-Propylphosphate	CCCOP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
15927	sp|P9WNF5|MP70_MYC	Q8WWQ8	88.6	332.0	503.0	DB08818	approved; vet_approved	Hyaluronic acid	CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@@H]2O[C@H](C(=O)O)[C@H]([C@H](O)[C@H]2O)O[C@@H]3O[C@H](CO)[C@@H](O)C([C@H]3NC(=O)C)O[C@@H]4O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]4O
15928	sp|P9WNF5|MP70_MYC	Q8WWQ8	85.49	964.0	1129.0	DB08818	approved; vet_approved	Hyaluronic acid	CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@@H]2O[C@H](C(=O)O)[C@H]([C@H](O)[C@H]2O)O[C@@H]3O[C@H](CO)[C@@H](O)C([C@H]3NC(=O)C)O[C@@H]4O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]4O
15929	sp|P9WNF5|MP70_MYC	Q8WWQ8	83.94	1564.0	1726.0	DB08818	approved; vet_approved	Hyaluronic acid	CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@@H]2O[C@H](C(=O)O)[C@H]([C@H](O)[C@H]2O)O[C@@H]3O[C@H](CO)[C@@H](O)C([C@H]3NC(=O)C)O[C@@H]4O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]4O
15930	sp|P9WPQ1|BTB7_MYC	P10802	84.51	13.0	73.0	DB01846	experimental	Oxidized coenzyme A	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSO
15931	sp|P9WPQ1|BTB7_MYC	P10802	84.51	13.0	73.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
15932	sp|P9WPQ1|BTB7_MYC	P10802	84.51	13.0	73.0	DB08120	experimental	6,8-DIMERCAPTO-OCTANOIC ACID AMIDE	SCC[C@H](S)CCCCC(=O)N
15933	sp|P9WPQ1|BTB7_MYC	P10802	92.96	124.0	190.0	DB01846	experimental	Oxidized coenzyme A	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSO
15934	sp|P9WPQ1|BTB7_MYC	P10802	92.96	124.0	190.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
15935	sp|P9WPQ1|BTB7_MYC	P10802	92.96	124.0	190.0	DB08120	experimental	6,8-DIMERCAPTO-OCTANOIC ACID AMIDE	SCC[C@H](S)CCCCC(=O)N
15936	sp|P9WPQ1|BTB7_MYC	P10802	92.96	229.0	295.0	DB01846	experimental	Oxidized coenzyme A	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSO
15937	sp|P9WPQ1|BTB7_MYC	P10802	92.96	229.0	295.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
15938	sp|P9WPQ1|BTB7_MYC	P10802	92.96	229.0	295.0	DB08120	experimental	6,8-DIMERCAPTO-OCTANOIC ACID AMIDE	SCC[C@H](S)CCCCC(=O)N
15939	sp|P9WPQ1|BTB7_MYC	C0H419	91.55	3.0	68.0	DB07497	experimental	5-(HEXAHYDRO-2-OXO-1H-THIENO[3,4-D]IMIDAZOL-6-YL)PENTANAL	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC=O
15940	sp|P9WPQ1|BTB7_MYC	A0A0H3JRU9	92.96	1079.0	1145.0	DB07497	experimental	5-(HEXAHYDRO-2-OXO-1H-THIENO[3,4-D]IMIDAZOL-6-YL)PENTANAL	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC=O
15941	sp|P9WPQ1|BTB7_MYC	P11498	92.96	1111.0	1177.0	DB00119	approved; investigational; nutraceutical	Pyruvic acid	CC(=O)C(=O)O
15942	sp|P9WPQ1|BTB7_MYC	P11498	92.96	1111.0	1177.0	DB00121	approved; investigational; nutraceutical	Biotin	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC(=O)O
15943	sp|P9WPQ1|BTB7_MYC	P11498	92.96	1111.0	1177.0	DB07497	experimental	5-(HEXAHYDRO-2-OXO-1H-THIENO[3,4-D]IMIDAZOL-6-YL)PENTANAL	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC=O
15944	sp|P9WPQ1|BTB7_MYC	P05165	91.55	662.0	727.0	DB00121	approved; investigational; nutraceutical	Biotin	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC(=O)O
15945	sp|P9WPQ1|BTB7_MYC	Q51225	92.96	10.0	76.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
15946	sp|P9WPQ1|BTB7_MYC	Q96RQ3	80.28	651.0	708.0	DB00121	approved; investigational; nutraceutical	Biotin	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC(=O)O
15947	sp|P9WPQ1|BTB7_MYC	Q13085	88.73	754.0	817.0	DB00121	approved; investigational; nutraceutical	Biotin	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC(=O)O
15948	sp|P9WPQ1|BTB7_MYC	O00763	88.73	897.0	960.0	DB00121	approved; investigational; nutraceutical	Biotin	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC(=O)O
15949	sp|P9WPQ1|BTB7_MYC	O00763	88.73	897.0	960.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
15950	sp|P9WPQ1|BTB7_MYC	O00763	88.73	897.0	960.0	DB02859	experimental	Soraphen A	CO[C@@H]([C@]12O)[C@@H](O)[C@H](C)[C@@H](O1)[C@@H](C)/C=C/[C@@H](OC)[C@@H](OC)CCCC[C@H](OC(=O)[C@H]2C)c3ccccc3
15951	sp|P9WPQ1|BTB7_MYC	O00763	88.73	897.0	960.0	DB03781	experimental	2-[4-(2,4-Dichlorophenoxy)Phenoxy]Propanoic Acid	OC(=O)[C@@H](C)Oc1ccc(cc1)Oc2ccc(Cl)cc2Cl
15952	sp|P9WPQ1|BTB7_MYC	O00763	88.73	897.0	960.0	DB07870	experimental	Haloxyfop-P	OC(=O)[C@@H](C)Oc1ccc(cc1)Oc2c(Cl)cc(cn2)C(F)(F)F
15953	sp|P9WIE1|BCP_MYCT	Q8P9V9	92.36	6.0	151.0	DB04640	experimental	Naphthalene-2,6-disulfonic acid	OS(=O)(=O)c(cc1)cc(c12)ccc(c2)S(=O)(=O)O
15954	sp|P9WIE1|BCP_MYCT	Q06830	85.99	9.0	144.0	DB01593	approved; investigational	Zinc	[Zn]
15955	sp|P9WIE1|BCP_MYCT	Q06830	85.99	9.0	144.0	DB09130	approved; investigational	Copper	[Cu]
15956	sp|P9WIE1|BCP_MYCT	Q06830	85.99	9.0	144.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
15957	sp|P9WIE1|BCP_MYCT	Q06830	85.99	9.0	144.0	DB14487	approved; investigational	Zinc acetate	CC([O-])=O
15958	sp|P9WIE1|BCP_MYCT	Q06830	85.99	9.0	144.0	DB14533	approved; investigational	Zinc chloride	[Cl-]
15959	sp|P9WIE1|BCP_MYCT	Q06830	85.99	9.0	144.0	DB14548	approved; experimental	Zinc sulfate, unspecified form	 
15960	sp|P9WIE1|BCP_MYCT	P32119	84.71	10.0	143.0	DB02153	experimental	3-sulfino-L-alanine	OC(=O)[C@@H](N)C[S@](=O)O
15961	sp|P9WIE1|BCP_MYCT	P32119	84.71	10.0	143.0	DB04048	experimental	N-Carbamoyl-Alanine	OC(=O)[C@@H](C)NC(=O)N
15962	sp|P9WIE1|BCP_MYCT	P32119	84.71	10.0	143.0	DB09130	approved; investigational	Copper	[Cu]
15963	sp|P9WIE1|BCP_MYCT	Q8IL80	89.81	6.0	147.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
15964	sp|P9WIE1|BCP_MYCT	P30041	91.72	6.0	150.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
15965	sp|P9WIE1|BCP_MYCT	P30041	91.72	6.0	150.0	DB09130	approved; investigational	Copper	[Cu]
15966	sp|P9WIE1|BCP_MYCT	P9WG35	80.25	18.0	144.0	DB03382	experimental	S-oxy-L-cysteine	OC(=O)[C@@H](N)CS=O
15967	sp|P9WIE1|BCP_MYCT	P30044	71.34	56.0	168.0	DB00995	approved; investigational	Auranofin	CCP(CC)(CC)=[Au]S[C@@H]1O[C@H](COC(=O)C)[C@@H](OC(=O)C)[C@H](OC(=O)C)[C@H]1OC(=O)C
15968	sp|P9WIE1|BCP_MYCT	P30044	71.34	56.0	168.0	DB03608	experimental	Diminazene	NC(=N)c1ccc(cc1)N/N=N/c2ccc(cc2)C(N)=N
15969	sp|P9WIU7|DCDA_MYC	P00861	90.16	16.0	419.0	DB03252	experimental	D-Lysine	OC(=O)[C@H](N)CCCCN
15970	sp|P9WIU7|DCDA_MYC	P00861	90.16	16.0	419.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
15971	sp|P9WIU7|DCDA_MYC	P11926	79.19	64.0	418.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
15972	sp|P9WIU7|DCDA_MYC	P11926	79.19	64.0	418.0	DB00127	experimental; nutraceutical	Spermine	NCCCNCCCCNCCCN
15973	sp|P9WIU7|DCDA_MYC	P11926	79.19	64.0	418.0	DB01917	experimental	Putrescine	NCCCCN
15974	sp|P9WIU7|DCDA_MYC	P11926	79.19	64.0	418.0	DB02209	experimental	Pyridoxine phosphate	Cc1ncc(c(CO)c1O)COP(=O)(O)O
15975	sp|P9WIU7|DCDA_MYC	P11926	79.19	64.0	418.0	DB02824	experimental	N-Pyridoxyl-Glycine-5-Monophosphate	Cc1ncc(COP(=O)(O)O)c(c1O)CNCC(=O)O
15976	sp|P9WIU7|DCDA_MYC	P11926	79.19	64.0	418.0	DB03856	experimental; investigational	L-Eflornithine	NCCC[C@@](N)(C(F)F)C(=O)O
15977	sp|P9WIU7|DCDA_MYC	P11926	79.19	64.0	418.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
15978	sp|P9WIU7|DCDA_MYC	P11926	79.19	64.0	418.0	DB04263	experimental	Geneticin	C[C@@H](O)[C@H]1O[C@@H]([C@H](N)[C@@H](O)[C@@H]1O)O[C@@H]2[C@@H](N)C[C@@H](N)[C@@H]([C@H]2O)O[C@@H](OC[C@]3(C)O)[C@H](O)[C@H]3NC
15979	sp|P9WIU7|DCDA_MYC	P11926	79.19	64.0	418.0	DB06243	approved; withdrawn	Eflornithine	NCCCC(N)(C(F)F)C(=O)O
15980	sp|P9WIU7|DCDA_MYC	Q96A70	79.64	66.0	422.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
15981	sp|P9WIU7|DCDA_MYC	Q96A70	79.64	66.0	422.0	DB00125	investigational; nutraceutical	Arginine	OC(=O)[C@@H](N)CCCNC(N)=N
15982	sp|P9WP23|DAPB_MYC	P9WP23	99.59	1.0	245.0	DB04267	experimental	Dipicolinic acid	OC(=O)c1cccc(n1)C(=O)O
15983	sp|P9WP23|DAPB_MYC	P04036	82.04	69.0	270.0	DB03363	experimental	3-Acetylpyridine Adenine Dinucleotide	n1cnc(N)c(c12)ncn2[C@H]3[C@H](O)[C@H](O)[C@H](O3)COP([O-])(=O)OP(=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)[n+]5cccc(c5)C(=O)C
15984	sp|P9WP23|DAPB_MYC	P04036	82.04	69.0	270.0	DB04267	experimental	Dipicolinic acid	OC(=O)c1cccc(n1)C(=O)O
15985	sp|L0TDE1|LIGC_MYC	P18858	98.04	538.0	889.0	DB00290	approved; investigational	Bleomycin	NC(=O)OC1C(O)C(OC(C1O)CO)OC2C(O)C(O)C(CO)OC2O[C@@H](c3c[nH]cn3)[C@H](NC(=O)c4nc(nc(N)c4C)[C@H](CC(=O)N)NC[C@H](N)C(=O)N)C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCc5nc(cs5)-c6nc(cs6)C(=O)NCCC[S+](C)C
15986	sp|L0TDE1|LIGC_MYC	P49916	96.65	474.0	820.0	DB00290	approved; investigational	Bleomycin	NC(=O)OC1C(O)C(OC(C1O)CO)OC2C(O)C(O)C(CO)OC2O[C@@H](c3c[nH]cn3)[C@H](NC(=O)c4nc(nc(N)c4C)[C@H](CC(=O)N)NC[C@H](N)C(=O)N)C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCc5nc(cs5)-c6nc(cs6)C(=O)NCCC[S+](C)C
15987	sp|P9WIX7|MUTT4_MY	O33199	71.77	21.0	199.0	DB01975	experimental	AMPCPR	O[C@H]1O[C@@H]([C@@H](O)[C@H]1O)COP(=O)(O)CP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3cnc(c34)c(N)ncn4
15988	sp|P9WIX7|MUTT4_MY	O33199	71.77	21.0	199.0	DB02059	experimental	Adenosine-5-Diphosphoribose	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)CO[P@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H](O)[C@H](O)[C@@H]4O
15989	sp|P9WIX7|MUTT4_MY	O33199	71.77	21.0	199.0	DB03148	experimental	Adenosine 5'-methylenediphosphate	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)CP(=O)(O)O
15990	sp|P9WKK5|IDI_MYCT	Q46822	80.3	3.0	166.0	DB01799	experimental	4-Hydroxy-3-Methyl Butyl Diphosphate	OC[C@@H](C)CCO[P@@](=O)(O)OP(=O)(O)O
15991	sp|P9WKK5|IDI_MYCT	Q46822	80.3	3.0	166.0	DB02480	experimental	(S)-4-bromo-3-hydroxy-3-methylbutyl diphosphate	BrC[C@@](C)(O)CCOP(=O)(O)OP(=O)(O)O
15992	sp|P9WKK5|IDI_MYCT	Q46822	80.3	3.0	166.0	DB03165	experimental	2-Dimethylamino-Ethyl-Diphosphate	CN(C)CCO[P@@](=O)(O)OP(=O)(O)O
15993	sp|P9WKK5|IDI_MYCT	Q46822	80.3	3.0	166.0	DB03366	experimental; investigational	Imidazole	[nH]1ccnc1
15994	sp|P9WKK5|IDI_MYCT	Q46822	80.3	3.0	166.0	DB04170	experimental	4-bromo-3-hydroxy-3-methyl butyl diphosphate	BrC[C@](C)(O)CCO[P@@](=O)(O)OP(=O)(O)O
15995	sp|P9WKK5|IDI_MYCT	Q13907	89.16	18.0	199.0	DB01785	experimental	Dimethylallyl Diphosphate	CC(C)=CCO[P@@](=O)(O)OP(=O)(O)O
15996	sp|O06335|ILVB2_MY	P27696	96.38	14.0	546.0	DB01987	approved; experimental	Cocarboxylase	OP([O-])(=O)O[P@](=O)(O)OCCc1c(C)[n+](cs1)Cc2cnc(C)nc2N
15997	sp|O06335|ILVB2_MY	P27696	96.38	14.0	546.0	DB02327	experimental	Triethylene glycol	OCCOCCOCCO
15998	sp|O06335|ILVB2_MY	P27696	96.38	14.0	546.0	DB03361	experimental	2-{(9as)-9a-[(1s)-1-Hydroxyethyl]-2,7-Dimethyl-9a,10-Dihydro-5h-Pyrimido[4,5-D][1,3]Thiazolo[3,2-a]Pyrimidin-8-Yl}Ethyl Trihydrogen Diphosphate	c1nc(C)nc(N2)c1CN([C@]23[C@H](C)O)C(C)=C(S3)CCOP(=O)(O)OP(=O)(O)O
16000	sp|O06335|ILVB2_MY	P37063	96.38	13.0	545.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
16001	sp|O06335|ILVB2_MY	P23234	94.93	7.0	531.0	DB01987	approved; experimental	Cocarboxylase	OP([O-])(=O)O[P@](=O)(O)OCCc1c(C)[n+](cs1)Cc2cnc(C)nc2N
16002	sp|O06335|ILVB2_MY	P06672	97.64	4.0	543.0	DB04272	approved; nutraceutical; vet_approved	Citric acid	OC(=O)CC(O)(C(=O)O)CC(=O)O
16003	sp|O06335|ILVB2_MY	P20906	92.75	10.0	522.0	DB02280	experimental	(R)-Mandelic acid	OC(=O)[C@H](O)c1ccccc1
16004	sp|O06335|ILVB2_MY	P51852	93.66	2.0	519.0	DB03884	experimental	Phenylpyruvic acid	OC(=O)C(=O)Cc1ccccc1
16005	sp|O06335|ILVB2_MY	P51852	93.66	2.0	519.0	DB08050	experimental	5-phenyl-2-keto-valeric acid	OC(=O)C(=O)CCCc1ccccc1
16006	sp|P9WKK9|LEU3_MYC	P50213	93.45	34.0	348.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
16007	sp|P9WKK9|LEU3_MYC	P50213	93.45	34.0	348.0	DB06757	approved; nutraceutical	Manganese	[Mn+2]
16008	sp|P9WKK9|LEU3_MYC	P50213	93.45	34.0	348.0	DB09092	approved; withdrawn	Xanthinol	OCCN(C)CC(O)Cn1cnc(c12)n(C)c(=O)n(c2=O)C
16009	sp|P9WKK9|LEU3_MYC	P50213	93.45	34.0	348.0	DB09130	approved; investigational	Copper	[Cu]
16010	sp|P9WKK9|LEU3_MYC	O43837	93.45	51.0	365.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
16011	sp|P9WKK9|LEU3_MYC	P51553	92.86	57.0	369.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
16012	sp|P9WKK9|LEU3_MYC	P51553	92.86	57.0	369.0	DB06757	approved; nutraceutical	Manganese	[Mn+2]
16013	sp|P9WKK9|LEU3_MYC	P39126	112.2	22.0	399.0	DB02159	experimental	(R)-Propylene glycol	C[C@@H](O)CO
16014	sp|P9WKK9|LEU3_MYC	P39126	112.2	22.0	399.0	DB04272	approved; nutraceutical; vet_approved	Citric acid	OC(=O)CC(O)(C(=O)O)CC(=O)O
16015	sp|P9WKK9|LEU3_MYC	P39126	112.2	22.0	399.0	DB04349	experimental	(S)-propane-1,2-diol	C[C@H](O)CO
16016	sp|P9WKK9|LEU3_MYC	P39126	112.2	22.0	399.0	DB04530	experimental	S,S-(2-Hydroxyethyl)Thiocysteine	OC(=O)[C@@H](N)CSSCCO
16017	sp|P9WKK9|LEU3_MYC	Q56268	98.51	3.0	334.0	DB04279	experimental	3-Isopropylmalic Acid	CC(C)C(C(=O)O)C(O)C(=O)O
16018	sp|P9WKK9|LEU3_MYC	P08200	106.85	29.0	388.0	DB01727	experimental	Isocitric Acid	OC(=O)[C@@H](O)[C@@H](C(=O)O)CC(=O)O
16019	sp|P9WKK9|LEU3_MYC	P08200	106.85	29.0	388.0	DB02190	experimental	(S)-oxalosuccinic acid	OC(=O)C(=O)[C@@H](C(=O)O)CC(=O)O
16020	sp|P9WKK9|LEU3_MYC	P08200	106.85	29.0	388.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
16021	sp|P9WKK9|LEU3_MYC	P08200	106.85	29.0	388.0	DB04279	experimental	3-Isopropylmalic Acid	CC(C)C(C(=O)O)C(O)C(=O)O
16022	sp|P0CH91|MMAA3_MY	P9WPB7	96.59	4.0	287.0	DB01718	approved	Cetrimonium	CCCCCCCCCCCCCCCC[N+](C)(C)C
16023	sp|P0CH91|MMAA3_MY	P9WPB3	97.27	2.0	287.0	DB01752	experimental	S-adenosyl-L-homocysteine	OC(=O)[C@@H](N)CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
16024	sp|P0CH91|MMAA3_MY	Q79FX6	96.59	4.0	287.0	DB01718	approved	Cetrimonium	CCCCCCCCCCCCCCCC[N+](C)(C)C
16025	sp|P0CH91|MMAA3_MY	Q79FX6	96.59	4.0	287.0	DB01752	experimental	S-adenosyl-L-homocysteine	OC(=O)[C@@H](N)CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
16026	sp|P0CH91|MMAA3_MY	Q79FX8	99.66	4.0	296.0	DB07413	experimental	5'-S-[2-(decylamino)ethyl]-5'-thioadenosine	n1cnc(N)c(c12)ncn2[C@H]3[C@H](O)[C@H](O)[C@H](O3)CSCCNCCCCCCCCCC
16027	sp|P0CH91|MMAA3_MY	P9WPB5	101.02	6.0	302.0	DB01752	experimental	S-adenosyl-L-homocysteine	OC(=O)[C@@H](N)CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
16028	sp|P0CH91|MMAA3_MY	P9WPB5	101.02	6.0	302.0	DB04221	approved; experimental	Didecyldimethylammonium	CCCCCCCCCC[N+](C)(C)CCCCCCCCCC
16030	sp|P9WNS7|DUS_MYCT	Q9WXV1	73.52	4.0	290.0	DB03247	approved; investigational	Flavin mononucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)COP(=O)(O)O
16032	sp|P9WIZ5|MNTH_MYC	P49281	101.64	64.0	499.0	DB15598	approved	Ferric maltol	Cc1c([O-])c(=O)cco1
16033	sp|P9WJS3|MOAA1_MY	P65389	89.14	4.0	324.0	DB04447	experimental	1,4-Dithiothreitol	SC[C@H](O)[C@@H](O)CS
16034	sp|P9WJY5|EFPA_MYC	P9WJY5	99.81	1.0	530.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
16035	sp|P9WNG5|FABD_MYC	Q8IVS2	102.98	64.0	375.0	DB07344	experimental	3,6,9,12,15-PENTAOXAHEPTADECAN-1-OL	CCOCCOCCOCCOCCOCCO
16036	sp|P9WNG5|FABD_MYC	P49327	95.03	494.0	781.0	DB01034	experimental	Cerulenin	NC(=O)[C@@H]1O[C@@H]1C(=O)CC/C=C/C/C=C/C
16037	sp|P9WNG5|FABD_MYC	P49327	95.03	494.0	781.0	DB01083	approved; investigational	Orlistat	CCCCCCCCCCC[C@H](OC(=O)[C@@H](NC=O)CC(C)C)C[C@@H]1OC(=O)[C@H]1CCCCCC
16038	sp|P9WNG5|FABD_MYC	Q9ZGI2	94.7	560.0	846.0	DB07703	experimental	(3R,4S,5S,7R,9E,11R,12R)-12-ETHYL-4-HYDROXY-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE	C[C@@H]1C[C@H](C)[C@H](O)[C@@H](C)C(=O)O[C@H](CC)[C@H](C)/C=C/C1=O
16039	sp|P9WNG5|FABD_MYC	Q9ZGI2	94.7	560.0	846.0	DB08431	experimental	[(3R,4S)-4-HYDROXY-3-METHYL-2-OXOHEXYL]PHOSPHONIC ACID	CC[C@H](O)[C@@H](C)C(=O)C[P@@H](=O)O
16040	sp|P9WNG5|FABD_MYC	Q9ZGI2	94.7	560.0	846.0	DB08759	experimental	[(3R,4S,5S,7R)-4,8-DIHYDROXY-3,5,7-TRIMETHYL-2-OXOOCTYL]PHOSPHONIC ACID	OC[C@H](C)C[C@H](C)[C@H](O)[C@@H](C)C(=O)C[P@H](=O)O
16041	sp|P96843|FAD3_MYC	Q8ZKF6	107.1	75.0	618.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
16042	sp|P96843|FAD3_MYC	Q8ZKF6	107.1	75.0	618.0	DB03230	experimental	Adenosine-5'-Propylphosphate	CCCOP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
16043	sp|P96843|FAD3_MYC	Q9NUB1	107.1	108.0	651.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16044	sp|P96843|FAD3_MYC	Q9NR19	111.83	103.0	670.0	DB00131	approved; investigational; nutraceutical	Adenosine phosphate	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
16045	sp|P96843|FAD3_MYC	Q9NR19	111.83	103.0	670.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16046	sp|P96843|FAD3_MYC	P40871	98.82	26.0	527.0	DB01672	experimental	2,3-Dihydroxy-Benzoic Acid	OC(=O)c1cccc(O)c1O
16047	sp|P96843|FAD3_MYC	Q8GN86	98.03	1.0	498.0	DB03728	experimental	p-Chlorobenzoic acid	OC(=O)c1ccc(Cl)cc1
16048	sp|P9WQD7|FAB2_MYC	P9WQD9	98.08	7.0	416.0	DB04302	experimental	4-Hydroxy-3,5-Dimethyl-5-(2-Methyl-Buta-1,3-Dienyl)-5h-Thiophen-2-One	C=C/C(C)=C/[C@@]1(C)SC(=O)C(C)=C1O
16049	sp|P9WQD7|FAB2_MYC	P0AAI5	97.6	5.0	412.0	DB01034	experimental	Cerulenin	NC(=O)[C@@H]1O[C@@H]1C(=O)CC/C=C/C/C=C/C
16050	sp|P9WQD7|FAB2_MYC	P0AAI5	97.6	5.0	412.0	DB03017	approved; experimental	Lauric acid	CCCCCCCCCCCC(=O)O
16051	sp|P9WQD7|FAB2_MYC	P0AAI5	97.6	5.0	412.0	DB08366	experimental	3-({3-[(1S,4aS,6S,7S,9S,9aR)-1,6-dimethyl-2-oxodecahydro-6,9-epoxy-4a,7-methanobenzo[7]annulen-1-yl]propanoyl}amino)-2,4-dihydroxybenzoic acid	C1[C@@H](C2)[C@](C)(C3)O[C@@H]2[C@H]([C@@]134)[C@@](C)(C(=O)CC4)CCC(=O)Nc5c(O)ccc(C(=O)O)c5O
16052	sp|P9WQD7|FAB2_MYC	P0AAI5	97.6	5.0	412.0	DB08407	experimental	Platensimycin	C1[C@@H](C2)[C@](C)(C3)O[C@@H]2[C@H]([C@@]134)[C@@](C)(C(=O)C=C4)CCC(=O)Nc5c(O)c(C(=O)O)ccc5O
16053	sp|P9WQD7|FAB2_MYC	P0A953	95.92	3.0	403.0	DB01034	experimental	Cerulenin	NC(=O)[C@@H]1O[C@@H]1C(=O)CC/C=C/C/C=C/C
16054	sp|P9WQD7|FAB2_MYC	P0A953	95.92	3.0	403.0	DB03017	approved; experimental	Lauric acid	CCCCCCCCCCCC(=O)O
16055	sp|P9WQD7|FAB2_MYC	P0A953	95.92	3.0	403.0	DB03600	experimental	Capric acid	CCCCCCCCCC(=O)O
16056	sp|P9WQD7|FAB2_MYC	P0A953	95.92	3.0	403.0	DB04302	experimental	4-Hydroxy-3,5-Dimethyl-5-(2-Methyl-Buta-1,3-Dienyl)-5h-Thiophen-2-One	C=C/C(C)=C/[C@@]1(C)SC(=O)C(C)=C1O
16057	sp|P9WQD7|FAB2_MYC	P0A953	95.92	3.0	403.0	DB04519	investigational	Caprylic acid	CCCCCCCC(=O)O
16058	sp|P9WQD7|FAB2_MYC	P0A953	95.92	3.0	403.0	DB08359	experimental	2-PHENYLAMINO-4-METHYL-5-ACETYL THIAZOLE	CC(=O)c1c(C)nc(s1)Nc2ccccc2
16059	sp|P9WQD7|FAB2_MYC	P0A953	95.92	3.0	403.0	DB08627	experimental	(5R)-4-HYDROXY-3,5-DIMETHYL-5-[(1E,3E)-2-METHYLPENTA-1,3-DIENYL]THIOPHEN-2(5H)-ONE	C/C=C/C(C)=C/[C@@]1(C)SC(=O)C(C)=C1O
16060	sp|P9WQD7|FAB2_MYC	P0A953	95.92	3.0	403.0	DB08628	experimental	(5R)-5-[(1E)-BUTA-1,3-DIENYL]-4-HYDROXY-3,5-DIMETHYLTHIOPHEN-2(5H)-ONE	OC1=C(C)C(=O)S[C@]1(C)/C=C/C=C
16062	sp|P9WQD7|FAB2_MYC	Q9ZGI2	79.62	128.0	460.0	DB07703	experimental	(3R,4S,5S,7R,9E,11R,12R)-12-ETHYL-4-HYDROXY-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE	C[C@@H]1C[C@H](C)[C@H](O)[C@@H](C)C(=O)O[C@H](CC)[C@H](C)/C=C/C1=O
16063	sp|P9WQD7|FAB2_MYC	Q9ZGI2	79.62	128.0	460.0	DB08431	experimental	[(3R,4S)-4-HYDROXY-3-METHYL-2-OXOHEXYL]PHOSPHONIC ACID	CC[C@H](O)[C@@H](C)C(=O)C[P@@H](=O)O
16064	sp|P9WQD7|FAB2_MYC	Q9ZGI2	79.62	128.0	460.0	DB08759	experimental	[(3R,4S,5S,7R)-4,8-DIHYDROXY-3,5,7-TRIMETHYL-2-OXOOCTYL]PHOSPHONIC ACID	OC[C@H](C)C[C@H](C)[C@H](O)[C@@H](C)C(=O)C[P@H](=O)O
16065	sp|P9WQL7|FLQE1_MY	P08183	76.08	392.0	621.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16066	sp|P9WQL7|FLQE1_MY	P08183	76.08	392.0	621.0	DB00603	approved; investigational	Medroxyprogesterone acetate	CC(=O)O[C@]1(C(=O)C)CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C([C@H](C3)C)=CC(=O)CC4
16067	sp|P9WQL7|FLQE1_MY	P08183	76.08	392.0	621.0	DB00778	approved; investigational; withdrawn	Roxithromycin	COCCOCO/N=C([C@H](C)[C@@H](O)[C@]1(C)O)/[C@H](C)C[C@@](C)(O)[C@@H]([C@@H](C)[C@@H]([C@@H](C)C(=O)O[C@@H]1CC)O[C@@H](C[C@@]2(C)OC)O[C@@H](C)[C@@H]2O)O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C
16068	sp|P9WQL7|FLQE1_MY	P08183	76.08	392.0	621.0	DB00813	approved; illicit; investigational; vet_approved	Fentanyl	c1ccccc1N(C(=O)CC)C2CCN(CC2)CCc3ccccc3
16069	sp|P9WQL7|FLQE1_MY	P08183	76.08	392.0	621.0	DB04877	experimental	Voacamine	CC[C@H]1C[C@@H](C2)CN([C@@H]1[C@@]23C(=O)OC)CCc4c3[nH]c5c4cc(OC)c(c5)[C@@H](C[C@H]67)c8c(c9c([nH]8)cccc9)C[C@H](C6C(=O)OC)N(C)CC\7=C\C
16070	sp|P9WQL7|FLQE1_MY	P08183	76.08	392.0	621.0	DB04881	investigational	Elacridar	COc1cccc(c12)c(=O)c3c([nH]2)c(ccc3)C(=O)Nc4ccc(cc4)CCN(C5)CCc(c56)cc(OC)c(c6)OC
16071	sp|P9WQL7|FLQE1_MY	P08183	76.08	392.0	621.0	DB04905	investigational	Tesmilifene	CCN(CC)CCOc1ccc(cc1)Cc2ccccc2
16072	sp|P9WQL7|FLQE1_MY	P08183	76.08	392.0	621.0	DB05449	investigational	FM-VP4	 
16073	sp|P9WQL7|FLQE1_MY	P08183	76.08	392.0	621.0	DB06191	investigational	Zosuquidar	FC1(F)[C@H]2[C@@H]1c(cccc3)c3[C@@H](c(c24)cccc4)N5CCN(CC5)C[C@@H](O)COc6cccc(c67)nccc7
16074	sp|P9WQL7|FLQE1_MY	P08183	76.08	392.0	621.0	DB06240	investigational	Tariquidar	COc(c1)c(OC)cc(c12)CCN(C2)CCc3ccc(cc3)NC(=O)c4cc(OC)c(OC)cc4NC(=O)c(c5)cnc(c56)cccc6
16075	sp|P9WQL7|FLQE1_MY	P08183	76.08	392.0	621.0	DB09031	approved; investigational	Miltefosine	CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C
16076	sp|P9WQL7|FLQE1_MY	P08183	76.08	392.0	621.0	DB11635	approved	Tocofersolan	 
16077	sp|P9WQL7|FLQE1_MY	P08183	76.08	392.0	621.0	DB14061	experimental	Hycanthone	CCN(CC)CCNc(ccc1CO)c(c12)c(=O)c3c(s2)cccc3
16078	sp|P9WQL7|FLQE1_MY	P08183	76.08	392.0	621.0	DB14062	experimental	Concanamycin A	NC(=O)O[C@@H]1[C@@H](C)O[C@H](C[C@H]1O)O[C@H](C2)[C@H](C)[C@@H](/C=C/C)O[C@@]2(O)[C@@H](C)[C@H](O)[C@H](C)[C@H]3OC(=O)/C(OC)=C/C(C)=C/[C@@H](C)[C@@H](O)[C@@H](CC)[C@@H](O)[C@H](C)C/C(C)=C/C=C/[C@@H]3OC
16079	sp|P9WQL7|FLQE1_MY	P08183	76.08	392.0	621.0	DB14063	experimental	Dexverapamil	COc1ccc(cc1OC)CCN(C)CCC[C@@](C#N)(C(C)C)c2cc(OC)c(OC)cc2
16080	sp|P9WQL7|FLQE1_MY	P08183	76.08	392.0	621.0	DB14064	experimental	Emopamil	c1ccccc1C(C#N)(C(C)C)CCCN(C)CCc2ccccc2
16081	sp|P9WQL7|FLQE1_MY	P08183	76.08	392.0	621.0	DB14065	experimental	Lomerizine	COc1ccc(c(OC)c1OC)CN2CCN(CC2)C(c3ccc(F)cc3)c4ccc(F)cc4
16082	sp|P9WQL7|FLQE1_MY	P08183	76.08	392.0	621.0	DB14066	experimental	Tetrandrine	c12ccc(OC)c(c1)Oc3ccc(cc3)C[C@H]4c5c(CCN4C)cc(OC)c(c5)Oc6c7c(CCN(C)[C@H]7C2)cc(OC)c6OC
16083	sp|P9WQL7|FLQE1_MY	P08183	76.08	392.0	621.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
16084	sp|P9WQL7|FLQE1_MY	P08183	76.08	392.0	621.0	DB14068	experimental	Dexniguldipine	[O-][N+](=O)c1cccc(c1)[C@@H]2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCCN(CC3)CCC3(c4ccccc4)c5ccccc5
16085	sp|P9WQL7|FLQE1_MY	P08183	76.08	392.0	621.0	DB14069	investigational	ONT-093	CCOC/C=C/c1ccc(cc1)-c2nc(-c3ccc(cc3)NC(C)C)c([nH]2)-c4ccc(cc4)NC(C)C
16086	sp|P9WQL7|FLQE1_MY	P08183	76.08	392.0	621.0	DB14070	experimental	HM-30181	c1cccc(c12)c(=O)cc(o2)C(=O)Nc3cc(OC)c(OC)cc3-c4nn(nn4)-c5ccc(cc5)CCN(C6)CCc(c67)cc(OC)c(c7)OC
16087	sp|P9WQL7|FLQE1_MY	P08183	76.08	392.0	621.0	DB14071	experimental	Desmethylsertraline	c1cccc(c12)[C@@H](CC[C@@H]2N)c3cc(Cl)c(Cl)cc3
16088	sp|P9WQL7|FLQE1_MY	P08183	76.08	392.0	621.0	DB14072	experimental	Reversin 121	c1ccccc1COC(=O)C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@H](C(=O)OC(C)(C)C)CCCCNC(=O)OCc2ccccc2
16089	sp|P9WQL7|FLQE1_MY	P08183	76.08	1035.0	1264.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16090	sp|P9WQL7|FLQE1_MY	P08183	76.08	1035.0	1264.0	DB00603	approved; investigational	Medroxyprogesterone acetate	CC(=O)O[C@]1(C(=O)C)CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C([C@H](C3)C)=CC(=O)CC4
16091	sp|P9WQL7|FLQE1_MY	P08183	76.08	1035.0	1264.0	DB00778	approved; investigational; withdrawn	Roxithromycin	COCCOCO/N=C([C@H](C)[C@@H](O)[C@]1(C)O)/[C@H](C)C[C@@](C)(O)[C@@H]([C@@H](C)[C@@H]([C@@H](C)C(=O)O[C@@H]1CC)O[C@@H](C[C@@]2(C)OC)O[C@@H](C)[C@@H]2O)O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C
16092	sp|P9WQL7|FLQE1_MY	P08183	76.08	1035.0	1264.0	DB00813	approved; illicit; investigational; vet_approved	Fentanyl	c1ccccc1N(C(=O)CC)C2CCN(CC2)CCc3ccccc3
16093	sp|P9WQL7|FLQE1_MY	P08183	76.08	1035.0	1264.0	DB04877	experimental	Voacamine	CC[C@H]1C[C@@H](C2)CN([C@@H]1[C@@]23C(=O)OC)CCc4c3[nH]c5c4cc(OC)c(c5)[C@@H](C[C@H]67)c8c(c9c([nH]8)cccc9)C[C@H](C6C(=O)OC)N(C)CC\7=C\C
16094	sp|P9WQL7|FLQE1_MY	P08183	76.08	1035.0	1264.0	DB04881	investigational	Elacridar	COc1cccc(c12)c(=O)c3c([nH]2)c(ccc3)C(=O)Nc4ccc(cc4)CCN(C5)CCc(c56)cc(OC)c(c6)OC
16095	sp|P9WQL7|FLQE1_MY	P08183	76.08	1035.0	1264.0	DB04905	investigational	Tesmilifene	CCN(CC)CCOc1ccc(cc1)Cc2ccccc2
16096	sp|P9WQL7|FLQE1_MY	P08183	76.08	1035.0	1264.0	DB05449	investigational	FM-VP4	 
16097	sp|P9WQL7|FLQE1_MY	P08183	76.08	1035.0	1264.0	DB06191	investigational	Zosuquidar	FC1(F)[C@H]2[C@@H]1c(cccc3)c3[C@@H](c(c24)cccc4)N5CCN(CC5)C[C@@H](O)COc6cccc(c67)nccc7
16098	sp|P9WQL7|FLQE1_MY	P08183	76.08	1035.0	1264.0	DB06240	investigational	Tariquidar	COc(c1)c(OC)cc(c12)CCN(C2)CCc3ccc(cc3)NC(=O)c4cc(OC)c(OC)cc4NC(=O)c(c5)cnc(c56)cccc6
16099	sp|P9WQL7|FLQE1_MY	P08183	76.08	1035.0	1264.0	DB09031	approved; investigational	Miltefosine	CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C
16100	sp|P9WQL7|FLQE1_MY	P08183	76.08	1035.0	1264.0	DB11635	approved	Tocofersolan	 
16101	sp|P9WQL7|FLQE1_MY	P08183	76.08	1035.0	1264.0	DB14061	experimental	Hycanthone	CCN(CC)CCNc(ccc1CO)c(c12)c(=O)c3c(s2)cccc3
16102	sp|P9WQL7|FLQE1_MY	P08183	76.08	1035.0	1264.0	DB14062	experimental	Concanamycin A	NC(=O)O[C@@H]1[C@@H](C)O[C@H](C[C@H]1O)O[C@H](C2)[C@H](C)[C@@H](/C=C/C)O[C@@]2(O)[C@@H](C)[C@H](O)[C@H](C)[C@H]3OC(=O)/C(OC)=C/C(C)=C/[C@@H](C)[C@@H](O)[C@@H](CC)[C@@H](O)[C@H](C)C/C(C)=C/C=C/[C@@H]3OC
16103	sp|P9WQL7|FLQE1_MY	P08183	76.08	1035.0	1264.0	DB14063	experimental	Dexverapamil	COc1ccc(cc1OC)CCN(C)CCC[C@@](C#N)(C(C)C)c2cc(OC)c(OC)cc2
16104	sp|P9WQL7|FLQE1_MY	P08183	76.08	1035.0	1264.0	DB14064	experimental	Emopamil	c1ccccc1C(C#N)(C(C)C)CCCN(C)CCc2ccccc2
16105	sp|P9WQL7|FLQE1_MY	P08183	76.08	1035.0	1264.0	DB14065	experimental	Lomerizine	COc1ccc(c(OC)c1OC)CN2CCN(CC2)C(c3ccc(F)cc3)c4ccc(F)cc4
16106	sp|P9WQL7|FLQE1_MY	P08183	76.08	1035.0	1264.0	DB14066	experimental	Tetrandrine	c12ccc(OC)c(c1)Oc3ccc(cc3)C[C@H]4c5c(CCN4C)cc(OC)c(c5)Oc6c7c(CCN(C)[C@H]7C2)cc(OC)c6OC
16107	sp|P9WQL7|FLQE1_MY	P08183	76.08	1035.0	1264.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
16108	sp|P9WQL7|FLQE1_MY	P08183	76.08	1035.0	1264.0	DB14068	experimental	Dexniguldipine	[O-][N+](=O)c1cccc(c1)[C@@H]2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCCN(CC3)CCC3(c4ccccc4)c5ccccc5
16109	sp|P9WQL7|FLQE1_MY	P08183	76.08	1035.0	1264.0	DB14069	investigational	ONT-093	CCOC/C=C/c1ccc(cc1)-c2nc(-c3ccc(cc3)NC(C)C)c([nH]2)-c4ccc(cc4)NC(C)C
16110	sp|P9WQL7|FLQE1_MY	P08183	76.08	1035.0	1264.0	DB14070	experimental	HM-30181	c1cccc(c12)c(=O)cc(o2)C(=O)Nc3cc(OC)c(OC)cc3-c4nn(nn4)-c5ccc(cc5)CCN(C6)CCc(c67)cc(OC)c(c7)OC
16111	sp|P9WQL7|FLQE1_MY	P08183	76.08	1035.0	1264.0	DB14071	experimental	Desmethylsertraline	c1cccc(c12)[C@@H](CC[C@@H]2N)c3cc(Cl)c(Cl)cc3
16112	sp|P9WQL7|FLQE1_MY	P08183	76.08	1035.0	1264.0	DB14072	experimental	Reversin 121	c1ccccc1COC(=O)C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@H](C(=O)OC(C)(C)C)CCCCNC(=O)OCc2ccccc2
16113	sp|P9WQL7|FLQE1_MY	O95342	75.75	419.0	647.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16114	sp|P9WQL7|FLQE1_MY	O95342	75.75	419.0	647.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
16115	sp|P9WQL7|FLQE1_MY	O95342	76.41	1077.0	1307.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16116	sp|P9WQL7|FLQE1_MY	O95342	76.41	1077.0	1307.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
16117	sp|P9WQL7|FLQE1_MY	Q2M3G0	76.08	385.0	614.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
16118	sp|P9WQL7|FLQE1_MY	Q2M3G0	76.08	385.0	614.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
16119	sp|P9WQL7|FLQE1_MY	Q2M3G0	76.08	1015.0	1244.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
16120	sp|P9WQL7|FLQE1_MY	Q2M3G0	76.08	1015.0	1244.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
16121	sp|P9WQL7|FLQE1_MY	P33527	73.09	638.0	858.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16122	sp|P9WQL7|FLQE1_MY	P33527	73.09	638.0	858.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
16123	sp|P9WQL7|FLQE1_MY	P33527	73.09	638.0	858.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
16124	sp|P9WQL7|FLQE1_MY	P33527	73.09	638.0	858.0	DB06176	approved; investigational	Romidepsin	O=C([C@H]12)N/C(=C\C)C(=O)N[C@@H](C(C)C)C(=O)O[C@@H](CC(=O)N[C@H](C(C)C)C(=O)N1)/C=C/CCSSC2
16125	sp|P9WQL7|FLQE1_MY	P33527	73.09	638.0	858.0	DB08855	experimental; investigational	Leukotriene C4	CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@@H](O)CCCC(=O)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@H](N)C(=O)O
16126	sp|P9WQL7|FLQE1_MY	P33527	75.42	1292.0	1519.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16127	sp|P9WQL7|FLQE1_MY	P33527	75.42	1292.0	1519.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
16128	sp|P9WQL7|FLQE1_MY	P33527	75.42	1292.0	1519.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
16129	sp|P9WQL7|FLQE1_MY	P33527	75.42	1292.0	1519.0	DB06176	approved; investigational	Romidepsin	O=C([C@H]12)N/C(=C\C)C(=O)N[C@@H](C(C)C)C(=O)O[C@@H](CC(=O)N[C@H](C(C)C)C(=O)N1)/C=C/CCSSC2
16130	sp|P9WQL7|FLQE1_MY	P33527	75.42	1292.0	1519.0	DB08855	experimental; investigational	Leukotriene C4	CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@@H](O)CCCC(=O)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@H](N)C(=O)O
16131	sp|P9WQL7|FLQE1_MY	Q92887	72.43	635.0	853.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16132	sp|P9WQL7|FLQE1_MY	Q92887	72.43	635.0	853.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
16133	sp|P9WQL7|FLQE1_MY	Q92887	74.42	1299.0	1523.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16134	sp|P9WQL7|FLQE1_MY	Q92887	74.42	1299.0	1523.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
16135	sp|P9WQL7|FLQE1_MY	O95255	75.08	618.0	844.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16136	sp|P9WQL7|FLQE1_MY	O95255	75.42	1264.0	1491.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16137	sp|P9WQL7|FLQE1_MY	Q09428	82.72	670.0	919.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16138	sp|P9WQL7|FLQE1_MY	Q09428	82.72	670.0	919.0	DB00222	approved	Glimepiride	CCC1=C(C)CN(C1=O)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3
16139	sp|P9WQL7|FLQE1_MY	Q09428	82.72	670.0	919.0	DB00672	approved; investigational	Chlorpropamide	CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1
16140	sp|P9WQL7|FLQE1_MY	Q09428	82.72	670.0	919.0	DB00731	approved; investigational	Nateglinide	CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](C(=O)O)Cc2ccccc2
16141	sp|P9WQL7|FLQE1_MY	Q09428	82.72	670.0	919.0	DB00912	approved; investigational	Repaglinide	CCOc1c(C(=O)O)ccc(c1)CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3
16142	sp|P9WQL7|FLQE1_MY	Q09428	82.72	670.0	919.0	DB01067	approved; investigational	Glipizide	Cc1ncc(nc1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
16143	sp|P9WQL7|FLQE1_MY	Q09428	82.72	670.0	919.0	DB01120	approved	Gliclazide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN(C2)CC(C23)CCC3
16144	sp|P9WQL7|FLQE1_MY	Q09428	82.72	670.0	919.0	DB01124	approved; investigational	Tolbutamide	CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1
16145	sp|P9WQL7|FLQE1_MY	Q09428	82.72	670.0	919.0	DB01251	approved; investigational	Gliquidone	COc(cc1)cc(c12)C(=O)N(C(=O)C2(C)C)CCc3ccc(cc3)S(=O)(=O)NC(=O)NC4CCCCC4
16146	sp|P9WQL7|FLQE1_MY	Q09428	82.72	670.0	919.0	DB01252	investigational	Mitiglinide	c1ccccc1C[C@H](C(=O)O)CC(=O)N(C2)C[C@H]([C@H]23)CCCC3
16147	sp|P9WQL7|FLQE1_MY	Q09428	82.72	670.0	919.0	DB01382	approved; investigational	Glymidine	COCCOc1cnc(nc1)NS(=O)(=O)c2ccccc2
16148	sp|P9WQL7|FLQE1_MY	Q09428	75.08	1342.0	1568.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16149	sp|P9WQL7|FLQE1_MY	Q09428	75.08	1342.0	1568.0	DB00222	approved	Glimepiride	CCC1=C(C)CN(C1=O)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3
16150	sp|P9WQL7|FLQE1_MY	Q09428	75.08	1342.0	1568.0	DB00672	approved; investigational	Chlorpropamide	CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1
16151	sp|P9WQL7|FLQE1_MY	Q09428	75.08	1342.0	1568.0	DB00731	approved; investigational	Nateglinide	CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](C(=O)O)Cc2ccccc2
16152	sp|P9WQL7|FLQE1_MY	Q09428	75.08	1342.0	1568.0	DB00912	approved; investigational	Repaglinide	CCOc1c(C(=O)O)ccc(c1)CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3
16153	sp|P9WQL7|FLQE1_MY	Q09428	75.08	1342.0	1568.0	DB01067	approved; investigational	Glipizide	Cc1ncc(nc1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
16154	sp|P9WQL7|FLQE1_MY	Q09428	75.08	1342.0	1568.0	DB01120	approved	Gliclazide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN(C2)CC(C23)CCC3
16155	sp|P9WQL7|FLQE1_MY	Q09428	75.08	1342.0	1568.0	DB01124	approved; investigational	Tolbutamide	CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1
16156	sp|P9WQL7|FLQE1_MY	Q09428	75.08	1342.0	1568.0	DB01251	approved; investigational	Gliquidone	COc(cc1)cc(c12)C(=O)N(C(=O)C2(C)C)CCc3ccc(cc3)S(=O)(=O)NC(=O)NC4CCCCC4
16157	sp|P9WQL7|FLQE1_MY	Q09428	75.08	1342.0	1568.0	DB01252	investigational	Mitiglinide	c1ccccc1C[C@H](C(=O)O)CC(=O)N(C2)C[C@H]([C@H]23)CCCC3
16158	sp|P9WQL7|FLQE1_MY	Q09428	75.08	1342.0	1568.0	DB01382	approved; investigational	Glymidine	COCCOc1cnc(nc1)NS(=O)(=O)c2ccccc2
16159	sp|P9WQL7|FLQE1_MY	Q09428	82.72	670.0	919.0	DB00839	approved; investigational	Tolazamide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2
16160	sp|P9WQL7|FLQE1_MY	Q09428	82.72	670.0	919.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
16161	sp|P9WQL7|FLQE1_MY	Q09428	75.08	1342.0	1568.0	DB00839	approved; investigational	Tolazamide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2
16162	sp|P9WQL7|FLQE1_MY	Q09428	75.08	1342.0	1568.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
16163	sp|P9WQL7|FLQE1_MY	O15439	72.43	404.0	622.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16164	sp|P9WQL7|FLQE1_MY	O15439	75.08	1039.0	1265.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16165	sp|P9WQL7|FLQE1_MY	O15440	76.08	1192.0	1421.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
16166	sp|P9WQL7|FLQE1_MY	O15440	76.08	1192.0	1421.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
16167	sp|P9WQL7|FLQE1_MY	O95477	73.75	899.0	1121.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16168	sp|P9WQL7|FLQE1_MY	O95477	73.75	899.0	1121.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
16169	sp|P9WQL7|FLQE1_MY	O95477	73.75	899.0	1121.0	DB01599	approved; investigational	Probucol	CC(C)(C)c1cc(cc(c1O)C(C)(C)C)SC(C)(C)Sc2cc(C(C)(C)C)c(O)c(c2)C(C)(C)C
16170	sp|P9WQL7|FLQE1_MY	O95477	75.08	1908.0	2134.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16171	sp|P9WQL7|FLQE1_MY	O95477	75.08	1908.0	2134.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
16172	sp|P9WQL7|FLQE1_MY	O95477	75.08	1908.0	2134.0	DB01599	approved; investigational	Probucol	CC(C)(C)c1cc(cc(c1O)C(C)(C)C)SC(C)(C)Sc2cc(C(C)(C)C)c(O)c(c2)C(C)(C)C
16173	sp|P9WQL7|FLQE1_MY	O60706	78.74	665.0	902.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16174	sp|P9WQL7|FLQE1_MY	O60706	78.74	665.0	902.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
16175	sp|P9WQL7|FLQE1_MY	O60706	78.74	665.0	902.0	DB09220	approved; investigational	Nicorandil	[O-][N+](=O)OCCNC(=O)c1cccnc1
16176	sp|P9WQL7|FLQE1_MY	O60706	75.08	1311.0	1537.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16177	sp|P9WQL7|FLQE1_MY	O60706	75.08	1311.0	1537.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
16178	sp|P9WQL7|FLQE1_MY	O60706	75.08	1311.0	1537.0	DB09220	approved; investigational	Nicorandil	[O-][N+](=O)OCCNC(=O)c1cccnc1
16179	sp|P9WQL7|FLQE1_MY	P13569	75.75	1210.0	1438.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16180	sp|P9WQL7|FLQE1_MY	P13569	75.75	1210.0	1438.0	DB00887	approved	Bumetanide	CCCCNc1c(c(S(=O)(=O)N)cc(c1)C(=O)O)Oc2ccccc2
16181	sp|P9WQL7|FLQE1_MY	P13569	75.75	1210.0	1438.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
16182	sp|P9WQL7|FLQE1_MY	P13569	75.75	1210.0	1438.0	DB01050	approved	Ibuprofen	CC(C)Cc1ccc(cc1)C(C)C(=O)O
16183	sp|P9WQL7|FLQE1_MY	P13569	75.75	1210.0	1438.0	DB02587	experimental; investigational	Colforsin	O[C@H]1CCC(C)(C)[C@@H]([C@]12C)[C@H](O)[C@H](OC(=O)C)[C@]3(C)[C@]2(O)C(=O)C[C@](O3)(C)C=C
16184	sp|P9WQL7|FLQE1_MY	P13569	75.75	1210.0	1438.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
16185	sp|P9WQL7|FLQE1_MY	P13569	75.75	1210.0	1438.0	DB04522	experimental	Dexfosfoserine	OC(=O)[C@@H](N)COP(=O)(O)O
16186	sp|P9WQL7|FLQE1_MY	P13569	75.75	1210.0	1438.0	DB04941	approved	Crofelemer	 
16187	sp|P9WQL7|FLQE1_MY	P13569	75.75	1210.0	1438.0	DB06266	investigational	Lonidamine	c1cccc(c12)n(nc2C(=O)O)Cc3c(Cl)cc(Cl)cc3
16188	sp|P9WQL7|FLQE1_MY	P13569	75.75	1210.0	1438.0	DB08820	approved	Ivacaftor	CC(C)(C)c1cc(C(C)(C)C)c(O)cc1NC(=O)c(c2=O)c[nH]c(c23)cccc3
16189	sp|P9WQL7|FLQE1_MY	P13569	75.75	1210.0	1438.0	DB09213	approved; investigational	Dexibuprofen	CC(C)Cc1ccc(cc1)[C@H](C)C(=O)O
16190	sp|P9WQL7|FLQE1_MY	P13569	75.75	1210.0	1438.0	DB09280	approved	Lumacaftor	O=C(O)c1cccc(c1)-c2nc(ccc2C)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
16191	sp|P9WQL7|FLQE1_MY	P13569	75.75	1210.0	1438.0	DB11712	approved; investigational	Tezacaftor	OC[C@H](O)Cn1c(C(C)(C)CO)cc(c12)cc(c(F)c2)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
16192	sp|P9WQL7|FLQE1_MY	P13569	75.75	1210.0	1438.0	DB15444	approved; investigational	Elexacaftor	FC(F)(F)C(C)(C)COc1nn(cc1)-c2nc(N(C3(C)C)C[C@@H](C)C3)c(cc2)C(=O)NS(=O)(=O)c4cn(C)nc4C
16193	sp|P9WQL7|FLQE1_MY	Q9UNQ0	70.43	60.0	272.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
16194	sp|P9WQL7|FLQE1_MY	Q9UNQ0	70.43	60.0	272.0	DB11995	approved; investigational	Avatrombopag	OC(=O)C1CCN(CC1)c2c(Cl)cc(cn2)C(=O)Nc3nc(-c4cc(Cl)cs4)c(s3)N5CCN(CC5)C6CCCCC6
16195	sp|P9WPB1|MMAA1_MY	P9WPB7	98.95	4.0	287.0	DB01718	approved	Cetrimonium	CCCCCCCCCCCCCCCC[N+](C)(C)C
16196	sp|P9WPB1|MMAA1_MY	P9WPB3	98.95	4.0	287.0	DB01752	experimental	S-adenosyl-L-homocysteine	OC(=O)[C@@H](N)CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
16197	sp|P9WPB1|MMAA1_MY	Q79FX6	98.95	4.0	287.0	DB01718	approved	Cetrimonium	CCCCCCCCCCCCCCCC[N+](C)(C)C
16198	sp|P9WPB1|MMAA1_MY	Q79FX6	98.95	4.0	287.0	DB01752	experimental	S-adenosyl-L-homocysteine	OC(=O)[C@@H](N)CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
16199	sp|P9WPB1|MMAA1_MY	Q79FX8	98.95	13.0	296.0	DB07413	experimental	5'-S-[2-(decylamino)ethyl]-5'-thioadenosine	n1cnc(N)c(c12)ncn2[C@H]3[C@H](O)[C@H](O)[C@H](O3)CSCCNCCCCCCCCCC
16200	sp|P9WPB1|MMAA1_MY	P9WPB5	101.4	12.0	302.0	DB01752	experimental	S-adenosyl-L-homocysteine	OC(=O)[C@@H](N)CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
16201	sp|P9WPB1|MMAA1_MY	P9WPB5	101.4	12.0	302.0	DB04221	approved; experimental	Didecyldimethylammonium	CCCCCCCCCC[N+](C)(C)CCCCCCCCCC
16202	sp|P95272|MAZF5_MY	P96622	98.17	4.0	111.0	DB02042	experimental	2-(2-{2-[2-(2-Methoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol	COCCOCCOCCOCCOCCO
16203	sp|O06401|MTAP_MYC	Q13126	95.08	10.0	261.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
16204	sp|O06401|MTAP_MYC	Q13126	95.08	10.0	261.0	DB02158	experimental	(2S,3S,4R,5S)-2-(4-Amino-4,5-dihydro-1H-pyrrolo[3,2-d]pyrimidin-7-yl)-5-[(methylsulfanyl)methyl]-3,4-pyrrolidinediol	CSC[C@H]1N[C@H]([C@H](O)[C@@H]1O)c2c[nH]c(c23)C(N)NC=N3
16205	sp|O06401|MTAP_MYC	Q13126	95.08	10.0	261.0	DB02281	experimental	Formycin	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)c([nH]n2)c(c23)ncnc3N
16206	sp|O06401|MTAP_MYC	Q13126	95.08	10.0	261.0	DB02282	experimental	5'-S-methyl-5'-thioadenosine	CSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
16207	sp|O06401|MTAP_MYC	Q13126	95.08	10.0	261.0	DB02933	experimental	5'-Deoxy-5'-(Methylthio)-Tubercidin	CSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2ccc(c23)c(N)ncn3
16208	sp|O06401|MTAP_MYC	Q9X1T2	82.2	46.0	263.0	DB02377	experimental	Guanine	Nc([nH]1)nc(=O)c(c12)[nH]cn2
16209	sp|O06401|MTAP_MYC	P9WP01	72.35	76.0	267.0	DB03411	experimental	2-Hydroxymethyl-Pyrrolidine-3,4-Diol	OC[C@@H]1NC[C@H](O)[C@H]1O
16210	sp|O06401|MTAP_MYC	P9WP01	72.35	76.0	267.0	DB03551	experimental	(3R,4R)-3-Hydroxy-4-(hydroxymethyl)-1-[(4-oxo-4,4a,5,7a-tetrahydro-3H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]pyrrolidinium	O=C1NC=NC(C12)C(=CN2)C[NH+]3C[C@H](O)[C@H](C3)CO
16211	sp|O06401|MTAP_MYC	P9WP01	72.35	76.0	267.0	DB04095	experimental	9-Deazahypoxanthine	[nH]1ccc(c12)nc[nH]c2=O
16212	sp|O06401|MTAP_MYC	P45563	76.52	68.0	270.0	DB02134	experimental	Xanthine	O=c1[nH]c(=O)[nH]c(c12)nc[nH]2
16213	sp|O06401|MTAP_MYC	P45563	76.52	68.0	270.0	DB02377	experimental	Guanine	Nc([nH]1)nc(=O)c(c12)[nH]cn2
16214	sp|O06401|MTAP_MYC	P00491	79.55	67.0	277.0	DB00242	approved; investigational	Cladribine	Clc(n1)nc(N)c(c12)ncn2[C@H]3C[C@H](O)[C@H](O3)CO
16215	sp|O06401|MTAP_MYC	P00491	79.55	67.0	277.0	DB00900	approved	Didanosine	OC[C@@H]1CC[C@@H](O1)n2cnc(c23)c(=O)nc[nH]3
16216	sp|O06401|MTAP_MYC	P00491	79.55	67.0	277.0	DB01667	experimental	8-azaguanine	O=c1[nH]c(N)nc(c12)[nH]nn2
16217	sp|O06401|MTAP_MYC	P00491	79.55	67.0	277.0	DB02222	experimental	2,6-Diamino-(S)-9-[2-(Phosphonomethoxy)Propyl]Purine	[O-]P([O-])(=O)CO[C@@H](C)Cn1cnc(c12)c(N)nc(n2)N
16218	sp|O06401|MTAP_MYC	P00491	79.55	67.0	277.0	DB02230	experimental	Immucillin-G	O=c1[nH]c(N)nc(c12)c(c[nH]2)[C@@H]3N[C@H](CO)[C@@H](O)[C@H]3O
16219	sp|O06401|MTAP_MYC	P00491	79.55	67.0	277.0	DB02377	experimental	Guanine	Nc([nH]1)nc(=O)c(c12)[nH]cn2
16220	sp|O06401|MTAP_MYC	P00491	79.55	67.0	277.0	DB02391	experimental	2-Amino-7-[2-(2-Hydroxy-1-Hydroxymethyl-Ethylamino)-Ethyl]-1,7-Dihydro-Purin-6-One	O=c1[nH]c(N)nc(c12)ncn2CCNC(CO)CO
16221	sp|O06401|MTAP_MYC	P00491	79.55	67.0	277.0	DB02568	investigational	Peldesine	Nc([nH]1)nc(=O)c(c12)[nH]cc2Cc3cnccc3
16222	sp|O06401|MTAP_MYC	P00491	79.55	67.0	277.0	DB02796	experimental	9-deazainosine	O=c1nc[nH]c(c12)c(c[nH]2)[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O
16223	sp|O06401|MTAP_MYC	P00491	79.55	67.0	277.0	DB02857	experimental; investigational	Guanosine	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O
16224	sp|O06401|MTAP_MYC	P00491	79.55	67.0	277.0	DB03101	experimental	Ribose-1-Phosphate	OC[C@H]1O[C@H](OP(=O)(O)O)[C@H](O)[C@@H]1O
16225	sp|O06401|MTAP_MYC	P00491	79.55	67.0	277.0	DB03551	experimental	(3R,4R)-3-Hydroxy-4-(hydroxymethyl)-1-[(4-oxo-4,4a,5,7a-tetrahydro-3H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]pyrrolidinium	O=C1NC=NC(C12)C(=CN2)C[NH+]3C[C@H](O)[C@H](C3)CO
16226	sp|O06401|MTAP_MYC	P00491	79.55	67.0	277.0	DB03609	experimental	3'-deoxyguanosine	Nc([nH]1)nc(=O)c(c12)ncn2[C@@H]3O[C@H](CO)C[C@H]3O
16227	sp|O06401|MTAP_MYC	P00491	79.55	67.0	277.0	DB03881	experimental	(2S,3R,4S,5S)-3,4-Dihydroxy-2-[(methylsulfanyl)methyl]-5-(4-oxo-4,5-dihydro-1H-pyrrolo[3,2-d]pyrimidin-7-yl)pyrrolidinium	O=c1nc[nH]c(c12)c(c[nH]2)[C@H]3[C@H](O)[C@H](O)[C@H]([NH2+]3)CSC
16228	sp|O06401|MTAP_MYC	P00491	79.55	67.0	277.0	DB04076	experimental	Hypoxanthine	[nH]1cnc(c12)[nH]cnc2=O
16229	sp|O06401|MTAP_MYC	P00491	79.55	67.0	277.0	DB04260	experimental	9-(5,5-Difluoro-5-Phosphonopentyl)Guanine	O=c1[nH]c(N)nc(c12)n(cn2)CCCCC(F)(F)P(=O)(O)O
16230	sp|O06401|MTAP_MYC	P00491	79.55	67.0	277.0	DB04335	experimental; investigational	Inosine	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(=O)nc[nH]3
16231	sp|O06401|MTAP_MYC	P00491	79.55	67.0	277.0	DB04753	experimental	9-DEAZAINOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE	OP(=O)(O)C[C@H](O1)O[C@H]([C@H]12)[C@@H](O[C@@H]2CO)c3c[nH]c(c34)c(=O)nc[nH]4
16232	sp|O06401|MTAP_MYC	P00491	79.55	67.0	277.0	DB04754	experimental	GUANOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE	Nc([nH]1)nc(=O)c(c12)ncn2[C@@H]3O[C@H](CO)[C@H]([C@H]34)O[C@H](O4)CP(=O)(O)O
16233	sp|O06401|MTAP_MYC	P00491	79.55	67.0	277.0	DB04757	experimental	GUANOSINE-2',3'-O-METHYLIDENEPHOSPHONATE	Nc([nH]1)nc(=O)c(c12)ncn2[C@@H]3O[C@H](CO)[C@H]([C@H]34)O[C@@H](O4)P(=O)(O)O
16234	sp|O06401|MTAP_MYC	P00491	79.55	67.0	277.0	DB06185	investigational	Forodesine	OC[C@H]1N[C@H]([C@H](O)[C@@H]1O)c2c[nH]c(c23)c(=O)[nH]cn3
16235	sp|I6Y204|DACB2_MY	P0AEB2	96.22	11.0	291.0	DB00274	approved; investigational	Cefmetazole	N#CCSCC(=O)N[C@@](C1=O)(OC)[C@H](N12)SCC(=C2C(=O)O)CSc3nnnn3C
16236	sp|I6Y204|DACB2_MY	P0AEB2	96.22	11.0	291.0	DB01329	approved; investigational	Cefoperazone	Cn1nnnc1SCC(=C2C(=O)O)CS[C@@H](N23)[C@@H](C3=O)NC(=O)[C@@H](c4ccc(O)cc4)NC(=O)N5CCN(CC)C(=O)C5=O
16237	sp|I6Y204|DACB2_MY	P0AEB2	96.22	11.0	291.0	DB01331	approved	Cefoxitin	NC(=O)OCC(=C1C(=O)O)CS[C@@H](N12)[C@](C2=O)(OC)NC(=O)Cc3cccs3
16238	sp|I6Y204|DACB2_MY	P0AEB2	96.22	11.0	291.0	DB04647	experimental	BOC-GAMMA-D-GLU-L-LYS(CBZ)-D-BOROALA	CC(C)(C)OC(=O)N[C@H](C(=O)O)CCC(=O)N[C@H](C(=O)N[C@H](C)B(O)O)CCCCNC(=O)OCc1ccccc1
16239	sp|I6Y204|DACB2_MY	P0AEB2	96.22	11.0	291.0	DB00578	approved; investigational	Carbenicillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)C(C(=O)O)c3ccccc3
16240	sp|I6Y204|DACB2_MY	P0AEB2	96.22	11.0	291.0	DB01000	approved	Cyclacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)C3(N)CCCCC3
16241	sp|I6Y204|DACB2_MY	P0AEB2	96.22	11.0	291.0	DB01602	approved; investigational	Bacampicillin	CCOC(=O)OC(C)OC(=O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)[C@H](N)c3ccccc3
16242	sp|I6Y204|DACB2_MY	P0AEB2	96.22	11.0	291.0	DB09050	approved; investigational	Ceftolozane	NCCNC(=O)Nc1c(N)n(C)[n+](c1)CC(CS2)=C(C([O-])=O)N([C@H]23)C(=O)[C@H]3NC(=O)/C(=N\OC(C)(C)C(=O)O)c4nsc(n4)N
16243	sp|I6Y204|DACB2_MY	P0AEB2	96.22	11.0	291.0	DB09319	approved; investigational	Carindacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)C(c3ccccc3)C(=O)Oc(cc4)cc(c45)CCC5
16244	sp|I6Y204|DACB2_MY	P0AEB3	96.22	11.0	291.0	DB01147	approved; investigational; vet_approved	Cloxacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)c3c(C)onc3-c4ccccc4Cl
16245	sp|I6Y204|DACB2_MY	P0AEB3	96.22	11.0	291.0	DB04647	experimental	BOC-GAMMA-D-GLU-L-LYS(CBZ)-D-BOROALA	CC(C)(C)OC(=O)N[C@H](C(=O)O)CCC(=O)N[C@H](C(=O)N[C@H](C)B(O)O)CCCCNC(=O)OCc1ccccc1
16246	sp|I6Y204|DACB2_MY	P08506	93.47	12.0	284.0	DB00274	approved; investigational	Cefmetazole	N#CCSCC(=O)N[C@@](C1=O)(OC)[C@H](N12)SCC(=C2C(=O)O)CSc3nnnn3C
16247	sp|I6Y204|DACB2_MY	P08506	93.47	12.0	284.0	DB00303	approved; investigational	Ertapenem	C[C@@H](O)[C@@H](C1=O)[C@H](N12)[C@@H](C)C(=C2C(=O)O)S[C@@H]3CN[C@@H](C3)C(=O)Nc4cccc(c4)C(=O)O
16248	sp|I6Y204|DACB2_MY	P08506	93.47	12.0	284.0	DB00430	approved	Cefpiramide	Cn1nnnc1SCC(=C2C(=O)O)CS[C@@H](N23)[C@@H](C3=O)NC(=O)[C@@H](c4ccc(O)cc4)NC(=O)c5c(O)cc(C)nc5
16249	sp|I6Y204|DACB2_MY	P08506	93.47	12.0	284.0	DB01329	approved; investigational	Cefoperazone	Cn1nnnc1SCC(=C2C(=O)O)CS[C@@H](N23)[C@@H](C3=O)NC(=O)[C@@H](c4ccc(O)cc4)NC(=O)N5CCN(CC)C(=O)C5=O
16250	sp|I6Y204|DACB2_MY	P08506	93.47	12.0	284.0	DB01331	approved	Cefoxitin	NC(=O)OCC(=C1C(=O)O)CS[C@@H](N12)[C@](C2=O)(OC)NC(=O)Cc3cccs3
16251	sp|I6Y204|DACB2_MY	P08506	93.47	12.0	284.0	DB01332	approved; withdrawn	Ceftizoxime	O=C(O)C1=CCS[C@@H](N12)[C@@H](C2=O)NC(=O)/C(=N\OC)c3csc(n3)N
16252	sp|I6Y204|DACB2_MY	P08506	93.47	12.0	284.0	DB00578	approved; investigational	Carbenicillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)C(C(=O)O)c3ccccc3
16253	sp|I6Y204|DACB2_MY	P08506	93.47	12.0	284.0	DB01000	approved	Cyclacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)C3(N)CCCCC3
16254	sp|I6Y204|DACB2_MY	P08506	93.47	12.0	284.0	DB01602	approved; investigational	Bacampicillin	CCOC(=O)OC(C)OC(=O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)[C@H](N)c3ccccc3
16255	sp|I6Y204|DACB2_MY	P08506	93.47	12.0	284.0	DB09050	approved; investigational	Ceftolozane	NCCNC(=O)Nc1c(N)n(C)[n+](c1)CC(CS2)=C(C([O-])=O)N([C@H]23)C(=O)[C@H]3NC(=O)/C(=N\OC(C)(C)C(=O)O)c4nsc(n4)N
16256	sp|I6Y204|DACB2_MY	P08506	93.47	12.0	284.0	DB09319	approved; investigational	Carindacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)C(c3ccccc3)C(=O)Oc(cc4)cc(c45)CCC5
16257	sp|I6Y204|DACB2_MY	P72161	92.1	7.0	275.0	DB00438	approved	Ceftazidime	c1cccc[n+]1CC(=C2C([O-])=O)CS[C@@H](N23)[C@@H](C3=O)NC(=O)/C(=N\OC(C)(C)C(=O)O)c4csc(n4)N
16258	sp|I6Y204|DACB2_MY	P0AFI5	92.78	6.0	276.0	DB01331	approved	Cefoxitin	NC(=O)OCC(=C1C(=O)O)CS[C@@H](N12)[C@](C2=O)(OC)NC(=O)Cc3cccs3
16259	sp|I6Y204|DACB2_MY	Q75Y35	92.78	18.0	288.0	DB00319	approved	Piperacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)[C@@H](c3ccccc3)NC(=O)N4CCN(CC)C(=O)C4=O
16260	sp|I6Y204|DACB2_MY	Q75Y35	92.78	18.0	288.0	DB00415	approved; vet_approved	Ampicillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)[C@H](N)c3ccccc3
16261	sp|I6Y204|DACB2_MY	Q75Y35	92.78	18.0	288.0	DB00438	approved	Ceftazidime	c1cccc[n+]1CC(=C2C([O-])=O)CS[C@@H](N23)[C@@H](C3=O)NC(=O)/C(=N\OC(C)(C)C(=O)O)c4csc(n4)N
16262	sp|I6Y204|DACB2_MY	Q75Y35	92.78	18.0	288.0	DB00447	approved; investigational; withdrawn	Loracarbef	c1ccccc1[C@@H](N)C(=O)N[C@H](C2=O)[C@H](N23)CCC(Cl)=C3C(=O)O
16263	sp|I6Y204|DACB2_MY	Q75Y35	92.78	18.0	288.0	DB00456	approved; investigational; vet_approved	Cefalotin	CC(=O)OCC(CS1)=C(C(=O)O)N([C@H]12)C(=O)[C@H]2NC(=O)Cc3cccs3
16264	sp|I6Y204|DACB2_MY	Q75Y35	92.78	18.0	288.0	DB00485	approved; investigational; vet_approved	Dicloxacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)c3c(C)onc3-c4c(Cl)cccc4Cl
16265	sp|I6Y204|DACB2_MY	Q75Y35	92.78	18.0	288.0	DB00567	approved; investigational; vet_approved	Cephalexin	O=C(O)C1=C(C)CS[C@@H](N12)[C@@H](C2=O)NC(=O)[C@H](N)c3ccccc3
16266	sp|I6Y204|DACB2_MY	Q75Y35	92.78	18.0	288.0	DB00607	approved; investigational	Nafcillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)c3c(OCC)ccc(c34)cccc4
16267	sp|I6Y204|DACB2_MY	Q75Y35	92.78	18.0	288.0	DB00713	approved; investigational	Oxacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)c3c(C)onc3-c4ccccc4
16268	sp|I6Y204|DACB2_MY	Q75Y35	92.78	18.0	288.0	DB00739	approved; vet_approved; withdrawn	Hetacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)N(C3(C)C)C(=O)[C@H](N3)c4ccccc4
16269	sp|I6Y204|DACB2_MY	Q75Y35	92.78	18.0	288.0	DB00833	approved	Cefaclor	O=C(O)C1=C(Cl)CS[C@@H](N12)[C@@H](C2=O)NC(=O)[C@H](N)c3ccccc3
16270	sp|I6Y204|DACB2_MY	Q75Y35	92.78	18.0	288.0	DB00948	approved; investigational	Mezlocillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)[C@@H](c3ccccc3)NC(=O)N4CCN(C4=O)S(=O)(=O)C
16271	sp|I6Y204|DACB2_MY	Q75Y35	92.78	18.0	288.0	DB01000	approved	Cyclacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)C3(N)CCCCC3
16272	sp|I6Y204|DACB2_MY	Q75Y35	92.78	18.0	288.0	DB01140	approved; vet_approved; withdrawn	Cefadroxil	O=C(O)C1=C(C)CS[C@@H](N12)[C@@H](C2=O)NC(=O)[C@H](N)c3ccc(O)cc3
16273	sp|I6Y204|DACB2_MY	Q75Y35	92.78	18.0	288.0	DB01163	investigational; withdrawn	Amdinocillin	C1CCCCCN1/C=N/[C@@H]2C(=O)N([C@@H]23)[C@H](C(S3)(C)C)C(=O)O
16274	sp|I6Y204|DACB2_MY	Q75Y35	92.78	18.0	288.0	DB01330	approved	Cefotetan	NC(=O)C(C(=O)O)=C1SC(S1)C(=O)N[C@@](C2=O)(OC)[C@H](N23)SCC(=C3C(=O)O)CSc4nnnn4C
16275	sp|I6Y204|DACB2_MY	Q75Y35	92.78	18.0	288.0	DB01331	approved	Cefoxitin	NC(=O)OCC(=C1C(=O)O)CS[C@@H](N12)[C@](C2=O)(OC)NC(=O)Cc3cccs3
16276	sp|I6Y204|DACB2_MY	Q75Y35	92.78	18.0	288.0	DB01603	approved; investigational	Meticillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)c3c(OC)cccc3OC
16277	sp|I6Y204|DACB2_MY	Q75Y35	92.78	18.0	288.0	DB03313	experimental	Cephalosporin C	CC(=O)OCC(=C1C(=O)O)CS[C@@H](N12)[C@@H](C2=O)NC(=O)CCC[C@@H](N)C(=O)O
16278	sp|I6Y204|DACB2_MY	Q75Y35	92.78	18.0	288.0	DB08795	experimental	Azidocillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)[C@H](N=[N+]=[N-])c3ccccc3
16279	sp|I6Y204|DACB2_MY	P72355	97.25	10.0	293.0	DB01598	approved	Imipenem	C[C@@H](O)[C@@H](C1=O)[C@H](N12)CC(=C2C(=O)O)SCC/N=C/N
16280	sp|I6Y204|DACB2_MY	P72355	97.25	10.0	293.0	DB06211	approved; investigational	Doripenem	C[C@@H](O)[C@@H](C1=O)[C@H](N12)[C@@H](C)C(=C2C(=O)O)S[C@@H]3CN[C@@H](C3)CNS(=O)(=O)N
16281	sp|I6Y204|DACB2_MY	Q9L5C7	89.69	7.0	268.0	DB02772	approved; experimental; investigational	Sucrose	OC[C@@H](O1)[C@@H](O)[C@H](O)[C@]1(CO)O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O
16282	sp|I6Y204|DACB2_MY	Q9L5C7	89.69	7.0	268.0	DB04035	experimental	Ceftazidime BATSI	OB(O)CNC(=O)C(\c(cs1)nc1N)=N/OC(C)(C)C(=O)O
16283	sp|I6Y204|DACB2_MY	Q9L5C7	89.69	7.0	268.0	DB09060	approved	Avibactam	[C@@H]12CC[C@@H](C(=O)N)N(C1)C(=O)N2OS(=O)(=O)O
16284	sp|I6Y204|DACB2_MY	Q9L5C7	89.69	7.0	268.0	DB12107	approved; investigational	Vaborbactam	OB1O[C@H](CC(=O)O)CC[C@@H]1NC(=O)Cc2cccs2
16285	sp|I6Y204|DACB2_MY	Q9L5C7	89.69	7.0	268.0	DB12377	approved; investigational	Relebactam	OS(=O)(=O)ON([C@@H]12)C(=O)N(C1)[C@@H](CC2)C(=O)NC3CCNCC3
16286	sp|I6Y204|DACB2_MY	Q9L5C8	89.69	7.0	268.0	DB02772	approved; experimental; investigational	Sucrose	OC[C@@H](O1)[C@@H](O)[C@H](O)[C@]1(CO)O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O
16287	sp|I6Y204|DACB2_MY	Q9L5C8	89.69	7.0	268.0	DB02841	experimental	[(2-Ethoxy-1-Naphthoyl)Amino]Methylboronic Acid	OB(O)CNC(=O)c(c(cc1)OCC)c(c12)cccc2
16288	sp|I6Y204|DACB2_MY	Q9L5C8	89.69	7.0	268.0	DB06889	experimental	3-(1H-tetrazol-5-ylmethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one	C1CCCc(c12)c3c(s2)ncn(c3=O)Cc4nnn[nH]4
16289	sp|I6Y204|DACB2_MY	Q9L5C8	89.69	7.0	268.0	DB07055	experimental	2-[2-(1H-tetrazol-5-yl)ethyl]-1H-isoindole-1,3(2H)-dione	c1cccc(c12)C(=O)N(C2=O)CCc3nnn[nH]3
16290	sp|I6Y204|DACB2_MY	Q9L5C8	89.69	7.0	268.0	DB07729	experimental	3-fluoro-N-[3-(1H-tetrazol-5-yl)phenyl]benzamide	Fc1cc(ccc1)C(=O)Nc2cccc(c2)-c3nnn[nH]3
16291	sp|I6Y204|DACB2_MY	Q9L5C8	89.69	7.0	268.0	DB07808	experimental	(1S,2R)-2-[(2,5-difluorophenyl)carbamoyl]cyclopropanecarboxylic acid	OC(=O)[C@H]1C[C@H]1C(=O)Nc2cc(F)ccc2F
16292	sp|I6Y204|DACB2_MY	Q9L5C8	89.69	7.0	268.0	DB07823	experimental	(2S)-2-[(3aR,4R,7S,7aS)-1,3-dioxooctahydro-2H-4,7-methanoisoindol-2-yl]propanoic acid	OC(=O)[C@H](C)N(C1=O)C(=O)[C@H]2[C@@H](CC3)C[C@@H]3[C@@H]12
16293	sp|I6Y204|DACB2_MY	Q9L5C8	89.69	7.0	268.0	DB07824	experimental	4-ethyl-5-methyl-2-(1H-tetrazol-5-yl)-1,2-dihydro-3H-pyrazol-3-one	CCc1c(C)[nH]n(c1=O)-c2nnn[nH]2
16294	sp|I6Y204|DACB2_MY	Q9L5C8	89.69	7.0	268.0	DB07865	experimental	3-(1H-tetrazol-5-ylamino)cyclohex-2-en-1-one	O=C1CCCC(=C1)Nc2nnn[nH]2
16295	sp|I6Y204|DACB2_MY	Q9L5C8	89.69	7.0	268.0	DB08551	experimental	3-{(R)-(Dihydroxyboryl)[(2-thienylacetyl)amino]methyl}benzoic acid	O=C(O)c1cccc(c1)[C@@H](B(O)O)NC(=O)Cc2cccs2
16296	sp|I6Y204|DACB2_MY	Q840M4	89.69	7.0	268.0	DB02772	approved; experimental; investigational	Sucrose	OC[C@@H](O1)[C@@H](O)[C@H](O)[C@]1(CO)O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O
16297	sp|I6Y204|DACB2_MY	Q840M4	89.69	7.0	268.0	DB04035	experimental	Ceftazidime BATSI	OB(O)CNC(=O)C(\c(cs1)nc1N)=N/OC(C)(C)C(=O)O
16298	sp|I6Y204|DACB2_MY	Q840M4	89.69	7.0	268.0	DB09060	approved	Avibactam	[C@@H]12CC[C@@H](C(=O)N)N(C1)C(=O)N2OS(=O)(=O)O
16299	sp|I6Y204|DACB2_MY	Q840M4	89.69	7.0	268.0	DB12107	approved; investigational	Vaborbactam	OB1O[C@H](CC(=O)O)CC[C@@H]1NC(=O)Cc2cccs2
16300	sp|I6Y204|DACB2_MY	Q840M4	89.69	7.0	268.0	DB12377	approved; investigational	Relebactam	OS(=O)(=O)ON([C@@H]12)C(=O)N(C1)[C@@H](CC2)C(=O)NC3CCNCC3
16301	sp|I6Y204|DACB2_MY	Q939N4	89.69	7.0	268.0	DB02772	approved; experimental; investigational	Sucrose	OC[C@@H](O1)[C@@H](O)[C@H](O)[C@]1(CO)O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O
16302	sp|I6Y204|DACB2_MY	Q939N4	89.69	7.0	268.0	DB04035	experimental	Ceftazidime BATSI	OB(O)CNC(=O)C(\c(cs1)nc1N)=N/OC(C)(C)C(=O)O
16303	sp|I6Y204|DACB2_MY	Q939N4	89.69	7.0	268.0	DB09060	approved	Avibactam	[C@@H]12CC[C@@H](C(=O)N)N(C1)C(=O)N2OS(=O)(=O)O
16304	sp|I6Y204|DACB2_MY	Q939N4	89.69	7.0	268.0	DB12107	approved; investigational	Vaborbactam	OB1O[C@H](CC(=O)O)CC[C@@H]1NC(=O)Cc2cccs2
16305	sp|I6Y204|DACB2_MY	Q939N4	89.69	7.0	268.0	DB12377	approved; investigational	Relebactam	OS(=O)(=O)ON([C@@H]12)C(=O)N(C1)[C@@H](CC2)C(=O)NC3CCNCC3
16306	sp|I6Y204|DACB2_MY	P00808	81.44	51.0	288.0	DB04261	experimental	Carbamic Acid	NC(=O)O
16307	sp|I6Y204|DACB2_MY	P00808	81.44	51.0	288.0	DB04272	approved; nutraceutical; vet_approved	Citric acid	OC(=O)CC(O)(C(=O)O)CC(=O)O
16308	sp|I6Y204|DACB2_MY	P0A9Z7	87.63	5.0	260.0	DB03472	experimental	Cyclohexyl-Hexyl-Beta-D-Maltoside	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)O[C@@H]2[C@@H](CO)O[C@H]([C@H](O)[C@H]2O)OCCCCCCC3CCCCC3
16309	sp|I6Y204|DACB2_MY	P0A9Z7	87.63	5.0	260.0	DB09060	approved	Avibactam	[C@@H]12CC[C@@H](C(=O)N)N(C1)C(=O)N2OS(=O)(=O)O
16310	sp|I6Y204|DACB2_MY	P0AD63	87.63	5.0	260.0	DB01606	approved	Tazobactam	O=C1C[C@H](N12)S(=O)(=O)[C@](C)([C@@H]2C(=O)O)Cn3ccnn3
16311	sp|I6Y204|DACB2_MY	P0AD63	87.63	5.0	260.0	DB02579	experimental	Acrylic Acid	OC(=O)C=C
16312	sp|I6Y204|DACB2_MY	P0AD63	87.63	5.0	260.0	DB03057	experimental	Malonaldehyde	O=CCC=O
16313	sp|I6Y204|DACB2_MY	P0AD63	87.63	5.0	260.0	DB03445	experimental	(3S)-3-(dioxidosulfanyl)-N-[(1E)-3-oxoprop-1-en-1-yl]-4-(1H-1,2,3-triazol-1-yl)-D-valine	O=C/C=C/N[C@@H](C(=O)O)C(C)(S(=O)=O)Cn1ccnn1
16314	sp|I6Y204|DACB2_MY	P0AD63	87.63	5.0	260.0	DB03472	experimental	Cyclohexyl-Hexyl-Beta-D-Maltoside	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)O[C@@H]2[C@@H](CO)O[C@H]([C@H](O)[C@H]2O)OCCCCCCC3CCCCC3
16315	sp|I6Y204|DACB2_MY	P0AD63	87.63	5.0	260.0	DB03834	experimental	(3S)-3-(dioxidosulfanyl)-N-[(1Z)-3-oxoprop-1-en-1-yl]-4-(1H-1,2,3-triazol-1-yl)-D-valine	O=C/C=C\N[C@@H](C(=O)O)C(C)(S([O-])=O)Cn1ccnn1
16316	sp|I6Y204|DACB2_MY	P0AD63	87.63	5.0	260.0	DB03970	experimental	(7R)-7-(6,7-Dihydro-5H-cyclopenta[d]imidazo[2,1-b][1,3]thiazol-2-yl)-2,7-dihydro-1,4-thiazepine-3,6-dicarboxylic acid	OC(=O)C1=CN=C(C(=O)O)CS[C@H]1c(n2)cn(c23)c4c(s3)CCC4
16317	sp|I6Y204|DACB2_MY	P0AD63	87.63	5.0	260.0	DB09060	approved	Avibactam	[C@@H]12CC[C@@H](C(=O)N)N(C1)C(=O)N2OS(=O)(=O)O
16318	sp|I6Y204|DACB2_MY	P0AD63	87.63	5.0	260.0	DB12377	approved; investigational	Relebactam	OS(=O)(=O)ON([C@@H]12)C(=O)N(C1)[C@@H](CC2)C(=O)NC3CCNCC3
16319	sp|I6Y204|DACB2_MY	P0AD64	87.63	5.0	260.0	DB03970	experimental	(7R)-7-(6,7-Dihydro-5H-cyclopenta[d]imidazo[2,1-b][1,3]thiazol-2-yl)-2,7-dihydro-1,4-thiazepine-3,6-dicarboxylic acid	OC(=O)C1=CN=C(C(=O)O)CS[C@H]1c(n2)cn(c23)c4c(s3)CCC4
16320	sp|I6Y204|DACB2_MY	P0AD64	87.63	5.0	260.0	DB08116	experimental	(3R)-4-{[(3,4-dihydroxyphenyl)acetyl]oxy}-N-(2-formylindolizin-3-yl)-3-sulfino-D-valine	c1cccc(n12)cc(C=O)c2N[C@@H](C(=O)O)[C@@](C)([S@@](=O)O)COC(=O)Cc3cc(O)c(O)cc3
16321	sp|I6Y204|DACB2_MY	P0AD64	87.63	5.0	260.0	DB09060	approved	Avibactam	[C@@H]12CC[C@@H](C(=O)N)N(C1)C(=O)N2OS(=O)(=O)O
16322	sp|I6Y204|DACB2_MY	P0AD64	87.63	5.0	260.0	DB12107	approved; investigational	Vaborbactam	OB1O[C@H](CC(=O)O)CC[C@@H]1NC(=O)Cc2cccs2
16323	sp|I6Y204|DACB2_MY	P37321	93.47	10.0	282.0	DB09060	approved	Avibactam	[C@@H]12CC[C@@H](C(=O)N)N(C1)C(=O)N2OS(=O)(=O)O
16324	sp|I6Y204|DACB2_MY	Q47066	97.25	8.0	291.0	DB03450	experimental	Cephalothin Group	COC(=O)CC1=C(C(=O)O)N[C@H](SC1)[C@@H](C=O)NC(=O)Cc2cccs2
16325	sp|I6Y204|DACB2_MY	Q47066	97.25	8.0	291.0	DB08375	experimental	(2R)-2-[(1R)-1-[[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-2-oxoethyl]-5-methylidene-2H-1,3-thiazine-4-carboxylic acid	OC(=O)C1=N[C@H](SCC1=C)[C@@H](C=O)NC(=O)/C(=N\OC)c2csc(n2)N
16326	sp|I6Y204|DACB2_MY	P18251	87.29	6.0	260.0	DB01606	approved	Tazobactam	O=C1C[C@H](N12)S(=O)(=O)[C@](C)([C@@H]2C(=O)O)Cn3ccnn3
16327	sp|I6Y204|DACB2_MY	P52664	90.03	10.0	272.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
16328	sp|I6Y204|DACB2_MY	Q9EXV5	86.94	10.0	263.0	DB09060	approved	Avibactam	[C@@H]12CC[C@@H](C(=O)N)N(C1)C(=O)N2OS(=O)(=O)O
16329	sp|I6Y204|DACB2_MY	P62593	83.16	23.0	265.0	DB02614	experimental	1(R)-1-Acetamido-2-(3-Carboxyphenyl)Ethyl Boronic Acid	CC(=O)N[C@H](B(O)O)Cc1cccc(c1)C(=O)O
16330	sp|I6Y204|DACB2_MY	P62593	83.16	23.0	265.0	DB02642	experimental	[[N-(Benzyloxycarbonyl)Amino]Methyl]Phosphate	OP(=O)(O)CNC(=O)OCc1ccccc1
16331	sp|I6Y204|DACB2_MY	P62593	83.16	23.0	265.0	DB02841	experimental	[(2-Ethoxy-1-Naphthoyl)Amino]Methylboronic Acid	OB(O)CNC(=O)c(c(cc1)OCC)c(c12)cccc2
16332	sp|I6Y204|DACB2_MY	P62593	83.16	23.0	265.0	DB04035	experimental	Ceftazidime BATSI	OB(O)CNC(=O)C(\c(cs1)nc1N)=N/OC(C)(C)C(=O)O
16333	sp|I6Y204|DACB2_MY	P62593	83.16	23.0	265.0	DB04037	experimental	N,N-Bis(4-Chlorobenzyl)-1h-1,2,3,4-Tetraazol-5-Amine	Clc1ccc(cc1)CN(c2n[nH]nn2)Cc3ccc(Cl)cc3
16334	sp|I6Y204|DACB2_MY	P62593	83.16	23.0	265.0	DB04430	experimental	3-(4-Phenylamino-Phenylamino)-2-(1h-Tetrazol-5-Yl)-Acrylonitrile	n1[nH]nnc1/C(C#N)=C\Nc2ccc(cc2)Nc3ccccc3
16335	sp|I6Y204|DACB2_MY	P62593	83.16	23.0	265.0	DB07464	experimental	1(R)-1-ACETAMIDO-2-(3-CARBOXY-2-HYDROXYPHENYL)ETHYL BORONIC ACID	CC(=O)N[C@H](B(O)O)Cc1cccc(C(=O)O)c1O
16336	sp|I6Y204|DACB2_MY	P62593	83.16	23.0	265.0	DB07466	experimental	(1R)-2-PHENYLACETAMIDO-2-(3-CARBOXYPHENYL)ETHYL BORONIC ACID	OC(=O)c1cc(ccc1)C[C@@H](B(O)O)NC(=O)Cc2ccccc2
16337	sp|I6Y204|DACB2_MY	P62593	83.16	23.0	265.0	DB07599	experimental	[(2-AMINO-ALPHA-METHOXYIMINO-4-THIAZOLYLACETYL)AMINO]METHYLBORONIC ACID	Nc1nc(cs1)/C(=N/OC)C(=O)NCB(O)O
16338	sp|I6Y204|DACB2_MY	P62593	83.16	23.0	265.0	DB08551	experimental	3-{(R)-(Dihydroxyboryl)[(2-thienylacetyl)amino]methyl}benzoic acid	O=C(O)c1cccc(c1)[C@@H](B(O)O)NC(=O)Cc2cccs2
16339	sp|I6Y204|DACB2_MY	P62593	83.16	23.0	265.0	DB09060	approved	Avibactam	[C@@H]12CC[C@@H](C(=O)N)N(C1)C(=O)N2OS(=O)(=O)O
16340	sp|I6Y204|DACB2_MY	P62593	83.16	23.0	265.0	DB12107	approved; investigational	Vaborbactam	OB1O[C@H](CC(=O)O)CC[C@@H]1NC(=O)Cc2cccs2
16341	sp|I6Y204|DACB2_MY	P62593	83.16	23.0	265.0	DB12377	approved; investigational	Relebactam	OS(=O)(=O)ON([C@@H]12)C(=O)N(C1)[C@@H](CC2)C(=O)NC3CCNCC3
16342	sp|I6Y204|DACB2_MY	P62594	83.16	23.0	265.0	DB01606	approved	Tazobactam	O=C1C[C@H](N12)S(=O)(=O)[C@](C)([C@@H]2C(=O)O)Cn3ccnn3
16343	sp|I6Y204|DACB2_MY	P62594	83.16	23.0	265.0	DB02614	experimental	1(R)-1-Acetamido-2-(3-Carboxyphenyl)Ethyl Boronic Acid	CC(=O)N[C@H](B(O)O)Cc1cccc(c1)C(=O)O
16344	sp|I6Y204|DACB2_MY	P62594	83.16	23.0	265.0	DB02642	experimental	[[N-(Benzyloxycarbonyl)Amino]Methyl]Phosphate	OP(=O)(O)CNC(=O)OCc1ccccc1
16345	sp|I6Y204|DACB2_MY	P62594	83.16	23.0	265.0	DB02841	experimental	[(2-Ethoxy-1-Naphthoyl)Amino]Methylboronic Acid	OB(O)CNC(=O)c(c(cc1)OCC)c(c12)cccc2
16346	sp|I6Y204|DACB2_MY	P62594	83.16	23.0	265.0	DB03640	experimental	Beta-Hydroxyaspartic Acid	OC(=O)[C@@H](N)[C@@H](O)C(=O)O
16347	sp|I6Y204|DACB2_MY	P62594	83.16	23.0	265.0	DB04037	experimental	N,N-Bis(4-Chlorobenzyl)-1h-1,2,3,4-Tetraazol-5-Amine	Clc1ccc(cc1)CN(c2n[nH]nn2)Cc3ccc(Cl)cc3
16348	sp|I6Y204|DACB2_MY	P62594	83.16	23.0	265.0	DB04430	experimental	3-(4-Phenylamino-Phenylamino)-2-(1h-Tetrazol-5-Yl)-Acrylonitrile	n1[nH]nnc1/C(C#N)=C\Nc2ccc(cc2)Nc3ccccc3
16349	sp|I6Y204|DACB2_MY	Q93LQ9	95.19	6.0	283.0	DB12107	approved; investigational	Vaborbactam	OB1O[C@H](CC(=O)O)CC[C@@H]1NC(=O)Cc2cccs2
16350	sp|I6Y204|DACB2_MY	Q93LQ9	95.19	6.0	283.0	DB12377	approved; investigational	Relebactam	OS(=O)(=O)ON([C@@H]12)C(=O)N(C1)[C@@H](CC2)C(=O)NC3CCNCC3
16351	sp|I6Y204|DACB2_MY	Q9F663	95.19	6.0	283.0	DB09060	approved	Avibactam	[C@@H]12CC[C@@H](C(=O)N)N(C1)C(=O)N2OS(=O)(=O)O
16352	sp|I6Y204|DACB2_MY	Q9F663	95.19	6.0	283.0	DB12107	approved; investigational	Vaborbactam	OB1O[C@H](CC(=O)O)CC[C@@H]1NC(=O)Cc2cccs2
16353	sp|I6Y204|DACB2_MY	P00807	87.97	7.0	263.0	DB02642	experimental	[[N-(Benzyloxycarbonyl)Amino]Methyl]Phosphate	OP(=O)(O)CNC(=O)OCc1ccccc1
16354	sp|I6Y204|DACB2_MY	P00807	87.97	7.0	263.0	DB04133	experimental	Degraded Cephaloridine	CC1=C(C(=O)O)N[C@H](SC1)[C@@H](C=O)NC(=O)Cc2cccs2
16355	sp|I6Y204|DACB2_MY	P00807	87.97	7.0	263.0	DB09324	approved	Sulbactam	O=C1C[C@H](N12)S(=O)(=O)C(C)(C)[C@@H]2C(=O)O
16356	sp|P9WPZ5|DAPC_MYC	Q6YP21	101.26	43.0	445.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
16357	sp|P9WPZ5|DAPC_MYC	Q16773	102.77	8.0	416.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
16358	sp|P9WPZ5|DAPC_MYC	Q16773	102.77	8.0	416.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
16359	sp|P9WPZ5|DAPC_MYC	Q16773	102.77	8.0	416.0	DB02556	experimental	D-Phenylalanine	OC(=O)[C@H](N)Cc1ccccc1
16360	sp|P9WPZ5|DAPC_MYC	Q16773	102.77	8.0	416.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
16361	sp|P9WPZ5|DAPC_MYC	Q16773	102.77	8.0	416.0	DB07950	experimental	Indoleacetic acid	OC(=O)Cc1c[nH]c(c12)cccc2
16362	sp|P9WPZ5|DAPC_MYC	Q75WK2	91.94	6.0	371.0	DB02024	experimental	3-phenylpropionic acid	OC(=O)CCc1ccccc1
16363	sp|P9WPZ5|DAPC_MYC	Q75WK2	91.94	6.0	371.0	DB02238	experimental	4-methylthio-2-oxobutanoic acid	CSCCC(=O)C(=O)O
16364	sp|P9WPZ5|DAPC_MYC	Q56232	94.71	8.0	384.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
16365	sp|P9WPZ5|DAPC_MYC	Q56232	94.71	8.0	384.0	DB04299	experimental	Maleic Acid	OC(=O)/C=C\C(=O)O
16366	sp|P9WPZ5|DAPC_MYC	Q9X0L5	97.98	14.0	403.0	DB01942	experimental; investigational	Formic acid	OC=O
16367	sp|P9WPZ5|DAPC_MYC	Q8N5Z0	102.02	17.0	422.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
16368	sp|P9WPZ5|DAPC_MYC	Q8N5Z0	102.02	17.0	422.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
16369	sp|P9WPZ5|DAPC_MYC	P17735	92.19	70.0	436.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
16370	sp|P9WPZ5|DAPC_MYC	P17735	92.19	70.0	436.0	DB00120	approved; investigational; nutraceutical	Phenylalanine	OC(=O)[C@@H](N)Cc1ccccc1
16371	sp|P9WPZ5|DAPC_MYC	P17735	92.19	70.0	436.0	DB00135	approved; investigational; nutraceutical	Tyrosine	OC(=O)[C@@H](N)Cc1ccc(O)cc1
16372	sp|P9WPZ5|DAPC_MYC	P17735	92.19	70.0	436.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
16373	sp|P9WPZ5|DAPC_MYC	P24298	102.27	81.0	487.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
16374	sp|P9WPZ5|DAPC_MYC	P24298	102.27	81.0	487.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
16375	sp|P9WPZ5|DAPC_MYC	P24298	102.27	81.0	487.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
16376	sp|P9WPZ5|DAPC_MYC	P24298	102.27	81.0	487.0	DB00780	approved	Phenelzine	NNCCc1ccccc1
16377	sp|P9WPZ5|DAPC_MYC	P33447	94.21	36.0	410.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
16378	sp|P9WPZ5|DAPC_MYC	Q8TD30	101.26	107.0	509.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
16379	sp|P9WPZ5|DAPC_MYC	Q8TD30	101.26	107.0	509.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
16380	sp|P9WPZ5|DAPC_MYC	Q8TD30	101.26	107.0	509.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
16381	sp|P9WPZ5|DAPC_MYC	Q8TD30	101.26	107.0	509.0	DB00780	approved	Phenelzine	NNCCc1ccccc1
16382	sp|P9WPZ5|DAPC_MYC	Q2TU84	89.42	30.0	385.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
16383	sp|P9WPZ5|DAPC_MYC	Q2TU84	89.42	30.0	385.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
16384	sp|P9WPZ5|DAPC_MYC	P17174	89.42	30.0	385.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
16385	sp|P9WPZ5|DAPC_MYC	P17174	89.42	30.0	385.0	DB00128	approved; nutraceutical	Aspartic acid	OC(=O)[C@@H](N)CC(=O)O
16386	sp|P9WPZ5|DAPC_MYC	P17174	89.42	30.0	385.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
16387	sp|P9WPZ5|DAPC_MYC	P17174	89.42	30.0	385.0	DB00151	approved; nutraceutical	Cysteine	OC(=O)[C@@H](N)CS
16388	sp|P9WPZ5|DAPC_MYC	P17174	89.42	30.0	385.0	DB00210	approved	Adapalene	C1C(C2)CC(C3)CC1CC23c4c(OC)ccc(c4)-c(cc5)cc(c56)ccc(c6)C(=O)O
16389	sp|P9WPZ5|DAPC_MYC	P17174	89.42	30.0	385.0	DB04299	experimental	Maleic Acid	OC(=O)/C=C\C(=O)O
16390	sp|P9WPZ5|DAPC_MYC	P17174	89.42	30.0	385.0	DB09130	approved; investigational	Copper	[Cu]
16391	sp|P9WPZ5|DAPC_MYC	P00509	86.9	24.0	369.0	DB01639	experimental	N-Methyl-Pyridoxal-5'-Phosphate	Cc1c(O)c(C=O)c(c[n+]1C)COP(=O)(O)O
16392	sp|P9WPZ5|DAPC_MYC	P00509	86.9	24.0	369.0	DB02024	experimental	3-phenylpropionic acid	OC(=O)CCc1ccccc1
16393	sp|P9WPZ5|DAPC_MYC	P00509	86.9	24.0	369.0	DB02758	experimental	Indolepropionic acid	OC(=O)CCc1c[nH]c(c12)cccc2
16394	sp|P9WPZ5|DAPC_MYC	P00509	86.9	24.0	369.0	DB02981	experimental	Vitamin B6 Complexed with 2-Amino-Hexanoic Acid	CCCC[C@@H](C(=O)O)NCc1c(COP(=O)(O)O)cnc(C)c1O
16395	sp|P9WPZ5|DAPC_MYC	P00509	86.9	24.0	369.0	DB03553	experimental	Glutaric Acid	OC(=O)CCCC(=O)O
16396	sp|P9WPZ5|DAPC_MYC	P00509	86.9	24.0	369.0	DB03629	experimental	Pyridoxal-5'-Phosphate-N-Oxide	Cc1c(O)c(C=O)c(c[n+]1[O-])COP(=O)(O)O
16397	sp|P9WPZ5|DAPC_MYC	P00509	86.9	24.0	369.0	DB03662	experimental	Vitamin B6 Complexed with 2-Amino-Pentanoic Acid	CCC[C@@H](C(=O)O)NCc1c(O)c(C)ncc1COP(=O)(O)O
16398	sp|P9WPZ5|DAPC_MYC	P00509	86.9	24.0	369.0	DB03750	experimental	Isovaleric Acid	CC(C)CC(=O)O
16399	sp|P9WPZ5|DAPC_MYC	P00509	86.9	24.0	369.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
16400	sp|P9WPZ5|DAPC_MYC	P00509	86.9	24.0	369.0	DB04299	experimental	Maleic Acid	OC(=O)/C=C\C(=O)O
16401	sp|P9WPZ5|DAPC_MYC	P00509	86.9	24.0	369.0	DB04467	experimental	N-(5'-phosphopyridoxyl)-L-alanine	OC(=O)[C@H](C)NCc1c(COP(=O)(O)O)cnc(C)c1O
16402	sp|P9WPZ5|DAPC_MYC	P00509	86.9	24.0	369.0	DB04762	experimental	N-PYRIDOXYL-D-GLUTAMIC ACID-5'-MONOPHOSPHATE	Cc1ncc(COP(=O)(O)O)c(c1O)CN[C@@H](C(=O)O)CCC(=O)O
16403	sp|P9WPZ5|DAPC_MYC	P00509	86.9	24.0	369.0	DB04765	experimental	N-PYRIDOXYL-2-METHYL-L-GLUTAMIC ACID-5'-MONOPHOSPHATE	Cc1ncc(COP(=O)(O)O)c(c1O)CN[C@](C)(C(=O)O)CCC(=O)O
16404	sp|P9WPZ5|DAPC_MYC	P00509	86.9	24.0	369.0	DB08845	experimental; investigational; nutraceutical	Oxogluric acid	OC(=O)CCC(=O)C(=O)O
16405	sp|P9WPZ5|DAPC_MYC	P00505	90.18	52.0	410.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
16406	sp|P9WPZ5|DAPC_MYC	P00505	90.18	52.0	410.0	DB00128	approved; nutraceutical	Aspartic acid	OC(=O)[C@@H](N)CC(=O)O
16407	sp|P9WPZ5|DAPC_MYC	P00505	90.18	52.0	410.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
16408	sp|P9WPZ5|DAPC_MYC	P00505	90.18	52.0	410.0	DB00151	approved; nutraceutical	Cysteine	OC(=O)[C@@H](N)CS
16409	sp|P9WPZ5|DAPC_MYC	P00505	90.18	52.0	410.0	DB02783	experimental	4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate	Cc1ncc(COP(=O)(O)O)c(c1O)CNOCC(=O)O
16410	sp|P9WPZ5|DAPC_MYC	Q96QU6	90.18	120.0	478.0	DB03214	experimental	Vinylglycine	OC(=O)[C@@H](N)C=C
16411	sp|P9WPZ5|DAPC_MYC	P95468	87.41	25.0	372.0	DB02024	experimental	3-phenylpropionic acid	OC(=O)CCc1ccccc1
16412	sp|P9WPZ5|DAPC_MYC	P95468	87.41	25.0	372.0	DB02242	experimental	Cyclohexanepropanoic acid	OC(=O)CCC1CCCCC1
16413	sp|P9WPZ5|DAPC_MYC	P95468	87.41	25.0	372.0	DB02434	experimental	4-(2-Thienyl)Butyric Acid	OC(=O)CCCc1cccs1
16414	sp|P9WPZ5|DAPC_MYC	P95468	87.41	25.0	372.0	DB02740	experimental	3-Indolebutyric Acid	OC(=O)CCCc1c[nH]c(c12)cccc2
16415	sp|P9WPZ5|DAPC_MYC	P95468	87.41	25.0	372.0	DB02758	experimental	Indolepropionic acid	OC(=O)CCc1c[nH]c(c12)cccc2
16416	sp|P9WPZ5|DAPC_MYC	P95468	87.41	25.0	372.0	DB03210	experimental	4-Aminohydrocinnamic Acid	Nc1ccc(cc1)CCC(=O)O
16417	sp|P9WPZ5|DAPC_MYC	P95468	87.41	25.0	372.0	DB03400	experimental	3-(P-Tolyl)Propionic Acid	Cc1ccc(cc1)CCC(=O)O
16418	sp|P9WPZ5|DAPC_MYC	P95468	87.41	25.0	372.0	DB04051	experimental	5-phenylpentanoic acid	OC(=O)CCCCc1ccccc1
16419	sp|P9WPZ5|DAPC_MYC	P95468	87.41	25.0	372.0	DB04208	experimental	3-(3,4-dimethoxyphenyl)propanoic acid	COc1c(OC)cc(cc1)CCC(=O)O
16420	sp|P9WPZ5|DAPC_MYC	P95468	87.41	25.0	372.0	DB04299	experimental	Maleic Acid	OC(=O)/C=C\C(=O)O
16421	sp|P9WPZ5|DAPC_MYC	P95468	87.41	25.0	372.0	DB06819	approved; investigational	Phenylbutyric acid	OC(=O)CCCc1ccccc1
16422	sp|P9WPZ5|DAPC_MYC	Q5KUI2	70.28	59.0	338.0	DB03256	experimental	(6R)-Folinic acid	Nc([nH]1)nc(=O)c(c12)N(C=O)[C@@H](CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
16423	sp|P9WPZ5|DAPC_MYC	Q9KM65	72.8	92.0	381.0	DB08364	experimental	1-{[(1E)-(3-HYDROXY-2-METHYL-5-{[(TRIHYDROXY-LAMBDA^5^-PHOSPHANYL)OXY]METHYL}PYRIDIN-4-YL)METHYLIDENE]AMINO}UNDECAN-2-ONE	CCCCCCCCCC(=O)C/N=C/c1c(COP(O)(O)O)cnc(C)c1O
16424	sp|P9WNN3|ECH17_MY	P30084	92.13	36.0	270.0	DB02563	experimental	Hexanoyl-CoA	CCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
16425	sp|P9WNN3|ECH17_MY	P30084	92.13	36.0	270.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
16426	sp|P9WNN3|ECH17_MY	P30084	92.13	36.0	270.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
16427	sp|P9WNN3|ECH17_MY	P30084	92.13	36.0	270.0	DB04117	experimental	4-(N,N-Dimethylamino)cinnamoyl-CoA	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)/C=C/c4ccc(cc4)N(C)C
16428	sp|P9WNN3|ECH17_MY	P30084	92.13	36.0	270.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
16429	sp|P9WNN3|ECH17_MY	P42126	91.34	47.0	279.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
16430	sp|P9WNN3|ECH17_MY	P42126	91.34	47.0	279.0	DB03127	experimental	Benzamidine	NC(=[NH2+])c1ccccc1
16431	sp|P9WNN3|ECH17_MY	O68600	82.28	10.0	219.0	DB01652	experimental	4-hydroxybenzoyl-CoA	Oc1ccc(cc1)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2OP(=O)(O)O)n3cnc(c34)c(N)ncn4
16432	sp|P9WNN3|ECH17_MY	O75521	81.89	146.0	354.0	DB08231	experimental	Myristic acid	CCCCCCCCCCCCCC(=O)O
16433	sp|P9WNN3|ECH17_MY	P52045	82.28	6.0	215.0	DB03117	experimental	2-carboxypropyl-coenzyme A	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC[C@H](C)C(=O)O
16434	sp|P9WNN3|ECH17_MY	Q08426	76.77	8.0	203.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
16435	sp|P9WNN3|ECH17_MY	P28793	90.94	15.0	246.0	DB08249	experimental	3,6,9,12,15-PENTAOXATRICOSAN-1-OL	CCCCCCCCOCCOCCOCCOCCOCCO
16436	sp|P9WNN3|ECH17_MY	P9WNP5	86.22	44.0	263.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
16437	sp|P9WNN3|ECH17_MY	P9WNP5	86.22	44.0	263.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
16438	sp|P9WNN3|ECH17_MY	Q93TU6	72.83	42.0	227.0	DB02906	experimental	(2s,4s)-Alpha-Campholinic Acid	CC1(C)[C@H](C)C(=O)C[C@H]1CC(O)O
16439	sp|P9WNN3|ECH17_MY	Q6NVY1	70.08	46.0	224.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
16440	sp|P9WKF9|ISPH1_MY	P62623	93.62	2.0	310.0	DB01785	experimental	Dimethylallyl Diphosphate	CC(C)=CCO[P@@](=O)(O)OP(=O)(O)O
16441	sp|P9WKF9|ISPH1_MY	P62623	93.62	2.0	310.0	DB04714	experimental	ISOPENTENYL PYROPHOSPHATE	CC(=C)CCO[P@@](=O)(O)OP(=O)(O)O
16442	sp|P9WQ71|ISCSL_MY	Q9Y697	95.42	60.0	435.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
16443	sp|P9WQ71|ISCSL_MY	Q9Y697	95.42	60.0	435.0	DB00151	approved; nutraceutical	Cysteine	OC(=O)[C@@H](N)CS
16444	sp|P9WQ71|ISCSL_MY	Q9Y697	95.42	60.0	435.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
16445	sp|P9WQ71|ISCSL_MY	Q96I15	104.58	32.0	443.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
16446	sp|P9WQ71|ISCSL_MY	Q55793	96.95	29.0	410.0	DB02346	experimental	3'-O-N-Octanoyl-a-D-Glucopyranosyl-B-D-Fructofuranoside	OC[C@@H](O1)[C@@H](O)[C@H](O)[C@]1(CO)O[C@H]2O[C@H](CO)[C@@H](O)[C@@H]([C@H]2O)OC(=O)CCCCCCC
16447	sp|P9WQ71|ISCSL_MY	P77444	96.69	24.0	404.0	DB02345	experimental	Selenocysteine	OC(=O)[C@@H](N)C[SeH]
16448	sp|P9WQ71|ISCSL_MY	P77444	96.69	24.0	404.0	DB02761	experimental	S-Mercaptocysteine	OC(=O)[C@@H](N)CSS
16449	sp|P9WQ71|ISCSL_MY	P77444	96.69	24.0	404.0	DB03049	experimental	S-Selanyl Cysteine	OC(=O)[C@@H](N)CS[SeH]
16450	sp|P9WQ71|ISCSL_MY	P77444	96.69	24.0	404.0	DB04217	experimental	L-2-amino-3-butynoic acid	OC(=O)[C@@H](N)C#C
16451	sp|P9WQ71|ISCSL_MY	Q96EN8	98.47	50.0	437.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
16452	sp|P9WQ71|ISCSL_MY	Q9ZHG9	85.24	26.0	361.0	DB02761	experimental	S-Mercaptocysteine	OC(=O)[C@@H](N)CSS
16453	sp|P9WQ71|ISCSL_MY	Q9ZHG9	85.24	26.0	361.0	DB04467	experimental	N-(5'-phosphopyridoxyl)-L-alanine	OC(=O)[C@H](C)NCc1c(COP(=O)(O)O)cnc(C)c1O
16454	sp|P9WQ71|ISCSL_MY	P83788	84.99	30.0	364.0	DB02343	experimental	3,6,9,12,15-Pentaoxaheptadecane	CCOCCOCCOCCOCCOCC
16455	sp|P9WQ71|ISCSL_MY	Q16719	72.77	120.0	406.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
16456	sp|P9WQ71|ISCSL_MY	Q16719	72.77	120.0	406.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
16457	sp|P9WQ71|ISCSL_MY	Q16719	72.77	120.0	406.0	DB07069	experimental	m-Hydroxyhippuric acid	OC(=O)CNC(=O)c1cc(O)ccc1
16458	sp|P9WQ71|ISCSL_MY	P13254	74.81	101.0	395.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
16459	sp|Q79FX6|MMAA2_MY	Q79FX6	99.65	1.0	287.0	DB01718	approved	Cetrimonium	CCCCCCCCCCCCCCCC[N+](C)(C)C
16460	sp|Q79FX6|MMAA2_MY	Q79FX6	99.65	1.0	287.0	DB01752	experimental	S-adenosyl-L-homocysteine	OC(=O)[C@@H](N)CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
16461	sp|Q79FX6|MMAA2_MY	P9WPB7	99.65	1.0	287.0	DB01718	approved	Cetrimonium	CCCCCCCCCCCCCCCC[N+](C)(C)C
16462	sp|Q79FX6|MMAA2_MY	P9WPB3	99.65	1.0	287.0	DB01752	experimental	S-adenosyl-L-homocysteine	OC(=O)[C@@H](N)CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
16463	sp|Q79FX6|MMAA2_MY	Q79FX8	98.61	13.0	296.0	DB07413	experimental	5'-S-[2-(decylamino)ethyl]-5'-thioadenosine	n1cnc(N)c(c12)ncn2[C@H]3[C@H](O)[C@H](O)[C@H](O3)CSCCNCCCCCCCCCC
16464	sp|Q79FX6|MMAA2_MY	P9WPB5	101.39	11.0	302.0	DB01752	experimental	S-adenosyl-L-homocysteine	OC(=O)[C@@H](N)CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
16465	sp|Q79FX6|MMAA2_MY	P9WPB5	101.39	11.0	302.0	DB04221	approved; experimental	Didecyldimethylammonium	CCCCCCCCCC[N+](C)(C)CCCCCCCCCC
16466	sp|P9WGF1|MMR_MYCT	Q9Y487	73.83	728.0	807.0	DB01133	approved; investigational; vet_approved	Tiludronic acid	OP(=O)(O)C(P(=O)(O)O)Sc1ccc(Cl)cc1
16467	sp|P9WGF1|MMR_MYCT	Q13488	78.5	706.0	790.0	DB01133	approved; investigational; vet_approved	Tiludronic acid	OP(=O)(O)C(P(=O)(O)O)Sc1ccc(Cl)cc1
16468	sp|P9WMR7|IXTPA_MY	Q9BY32	90.69	8.0	193.0	DB04272	approved; nutraceutical; vet_approved	Citric acid	OC(=O)CC(O)(C(=O)O)CC(=O)O
16469	sp|P9WQ77|LAT_MYCT	P9WQ77	99.78	1.0	449.0	DB08071	experimental	(2S)-1-methyl-2-[(2S,4R)-2-methyl-4-phenylpentyl]piperidine	CN1CCCC[C@H]1C[C@@H](C)C[C@@H](C)c2ccccc2
16470	sp|P9WQ77|LAT_MYCT	P80404	94.43	69.0	493.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
16471	sp|P9WQ77|LAT_MYCT	P80404	94.43	69.0	493.0	DB00119	approved; investigational; nutraceutical	Pyruvic acid	CC(=O)C(=O)O
16472	sp|P9WQ77|LAT_MYCT	P80404	94.43	69.0	493.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
16473	sp|P9WQ77|LAT_MYCT	P80404	94.43	69.0	493.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
16474	sp|P9WQ77|LAT_MYCT	P80404	94.43	69.0	493.0	DB00780	approved	Phenelzine	NNCCc1ccccc1
16475	sp|P9WQ77|LAT_MYCT	P80404	94.43	69.0	493.0	DB01080	approved	Vigabatrin	C=CC(N)CCC(=O)O
16476	sp|P9WQ77|LAT_MYCT	P80404	94.43	69.0	493.0	DB01699	experimental	(4e)-4-Aminohex-4-Enoic Acid	C/C=C(/N)CCC(=O)O
16477	sp|P9WQ77|LAT_MYCT	P80404	94.43	69.0	493.0	DB04235	experimental	4-Amino Hexanoic Acid	CC[C@@H](N)CCC(=O)O
16478	sp|P9WQ77|LAT_MYCT	P04181	88.42	38.0	435.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
16479	sp|P9WQ77|LAT_MYCT	P04181	88.42	38.0	435.0	DB00129	approved; nutraceutical	Ornithine	NCCC[C@H](N)C(=O)O
16480	sp|P9WQ77|LAT_MYCT	P04181	88.42	38.0	435.0	DB02054	experimental	Gabaculine	Nc1cccc(c1)C(=O)O
16481	sp|P9WQ77|LAT_MYCT	P04181	88.42	38.0	435.0	DB02821	experimental	Canaline	NOCC[C@H](N)C(=O)O
16482	sp|P9WQ77|LAT_MYCT	P22256	86.86	30.0	420.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
16483	sp|P9WQ77|LAT_MYCT	P22256	86.86	30.0	420.0	DB02783	experimental	4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate	Cc1ncc(COP(=O)(O)O)c(c1O)CNOCC(=O)O
16484	sp|P9WQ77|LAT_MYCT	Q9BYV1	93.54	85.0	505.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
16485	sp|P9WQ77|LAT_MYCT	Q9BYV1	93.54	85.0	505.0	DB00119	approved; investigational; nutraceutical	Pyruvic acid	CC(=O)C(=O)O
16486	sp|P9WQ77|LAT_MYCT	Q9BYV1	93.54	85.0	505.0	DB00145	approved; nutraceutical; vet_approved	Glycine	NCC(=O)O
16487	sp|P9WQ77|LAT_MYCT	Q9BYV1	93.54	85.0	505.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
16488	sp|P9WQ77|LAT_MYCT	P12995	84.63	41.0	421.0	DB02274	experimental	7-Keto-8-Aminopelargonic Acid	C[C@H](N)C(=O)CCCCCC(=O)O
16489	sp|P9WQ77|LAT_MYCT	P12995	84.63	41.0	421.0	DB02725	experimental	2-Amino-4-(4-Amino-Cyclohexa-2,5-Dienyl)-Butyric Acid	OC(=O)[C@@H](N)CC[C@H]1C=CC(N)C=C1
16490	sp|P9WQ77|LAT_MYCT	P12995	84.63	41.0	421.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
16491	sp|P9WQ77|LAT_MYCT	Q6LFH8	84.19	28.0	406.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
16492	sp|P9WQ77|LAT_MYCT	Q8IUZ5	88.86	31.0	430.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
16493	sp|P9WQ77|LAT_MYCT	Q8IUZ5	88.86	31.0	430.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
16494	sp|P9WQ77|LAT_MYCT	P16932	89.53	27.0	429.0	DB02038	experimental	D-[3-hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl]-N,O-cycloserylamide	Cc1ncc(COP(=O)(O)O)c(c1O)CN[C@@H]2CONC2=O
16495	sp|P9WQ77|LAT_MYCT	P16932	89.53	27.0	429.0	DB02849	experimental	N-Pyridoxyl-1-Amino-Cyclopropanecarboxylic Acid-5-Monophosphate	Cc1ncc(COP(=O)(O)O)c(c1O)CNC2(CC2)C(=O)O
16496	sp|P9WQ77|LAT_MYCT	P16932	89.53	27.0	429.0	DB03787	experimental	(5-Hydroxy-6-methyl-4-{[(E)-(3-oxo-1,2-oxazolidin-4-ylidene)amino]methyl}-3-pyridinyl)methyl dihydrogen phosphate	Cc1ncc(COP(=O)(O)O)c(c1O)C/N=C2\CONC2=O
16497	sp|P9WQ77|LAT_MYCT	P16932	89.53	27.0	429.0	DB04241	experimental	N-Pyridoxyl-2-Methylalanine-5-Phosphate	Cc1ncc(COP(=O)(O)O)c(c1O)CNC(C)(C)C(=O)O
16498	sp|P95125|LIPN_MYC	Q7SIG1	71.28	41.0	309.0	DB02776	experimental	1-Hexadecanosulfonic Acid	CCCCCCCCCCCCCCCCS(=O)(=O)O
16499	sp|P9WQL5|MKL_MYCT	O15440	71.03	574.0	829.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
16500	sp|P9WQL5|MKL_MYCT	O15440	71.03	574.0	829.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
16501	sp|P9WQL5|MKL_MYCT	O15440	71.03	1171.0	1426.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
16502	sp|P9WQL5|MKL_MYCT	O15440	71.03	1171.0	1426.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
16503	sp|P9WQL5|MKL_MYCT	P08183	72.14	387.0	646.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16504	sp|P9WQL5|MKL_MYCT	P08183	72.14	387.0	646.0	DB00603	approved; investigational	Medroxyprogesterone acetate	CC(=O)O[C@]1(C(=O)C)CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C([C@H](C3)C)=CC(=O)CC4
16505	sp|P9WQL5|MKL_MYCT	P08183	72.14	387.0	646.0	DB00778	approved; investigational; withdrawn	Roxithromycin	COCCOCO/N=C([C@H](C)[C@@H](O)[C@]1(C)O)/[C@H](C)C[C@@](C)(O)[C@@H]([C@@H](C)[C@@H]([C@@H](C)C(=O)O[C@@H]1CC)O[C@@H](C[C@@]2(C)OC)O[C@@H](C)[C@@H]2O)O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C
16506	sp|P9WQL5|MKL_MYCT	P08183	72.14	387.0	646.0	DB00813	approved; illicit; investigational; vet_approved	Fentanyl	c1ccccc1N(C(=O)CC)C2CCN(CC2)CCc3ccccc3
16507	sp|P9WQL5|MKL_MYCT	P08183	72.14	387.0	646.0	DB04877	experimental	Voacamine	CC[C@H]1C[C@@H](C2)CN([C@@H]1[C@@]23C(=O)OC)CCc4c3[nH]c5c4cc(OC)c(c5)[C@@H](C[C@H]67)c8c(c9c([nH]8)cccc9)C[C@H](C6C(=O)OC)N(C)CC\7=C\C
16508	sp|P9WQL5|MKL_MYCT	P08183	72.14	387.0	646.0	DB04881	investigational	Elacridar	COc1cccc(c12)c(=O)c3c([nH]2)c(ccc3)C(=O)Nc4ccc(cc4)CCN(C5)CCc(c56)cc(OC)c(c6)OC
16509	sp|P9WQL5|MKL_MYCT	P08183	72.14	387.0	646.0	DB04905	investigational	Tesmilifene	CCN(CC)CCOc1ccc(cc1)Cc2ccccc2
16510	sp|P9WQL5|MKL_MYCT	P08183	72.14	387.0	646.0	DB05449	investigational	FM-VP4	 
16511	sp|P9WQL5|MKL_MYCT	P08183	72.14	387.0	646.0	DB06191	investigational	Zosuquidar	FC1(F)[C@H]2[C@@H]1c(cccc3)c3[C@@H](c(c24)cccc4)N5CCN(CC5)C[C@@H](O)COc6cccc(c67)nccc7
16512	sp|P9WQL5|MKL_MYCT	P08183	72.14	387.0	646.0	DB06240	investigational	Tariquidar	COc(c1)c(OC)cc(c12)CCN(C2)CCc3ccc(cc3)NC(=O)c4cc(OC)c(OC)cc4NC(=O)c(c5)cnc(c56)cccc6
16513	sp|P9WQL5|MKL_MYCT	P08183	72.14	387.0	646.0	DB09031	approved; investigational	Miltefosine	CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C
16514	sp|P9WQL5|MKL_MYCT	P08183	72.14	387.0	646.0	DB11635	approved	Tocofersolan	 
16515	sp|P9WQL5|MKL_MYCT	P08183	72.14	387.0	646.0	DB14061	experimental	Hycanthone	CCN(CC)CCNc(ccc1CO)c(c12)c(=O)c3c(s2)cccc3
16516	sp|P9WQL5|MKL_MYCT	P08183	72.14	387.0	646.0	DB14062	experimental	Concanamycin A	NC(=O)O[C@@H]1[C@@H](C)O[C@H](C[C@H]1O)O[C@H](C2)[C@H](C)[C@@H](/C=C/C)O[C@@]2(O)[C@@H](C)[C@H](O)[C@H](C)[C@H]3OC(=O)/C(OC)=C/C(C)=C/[C@@H](C)[C@@H](O)[C@@H](CC)[C@@H](O)[C@H](C)C/C(C)=C/C=C/[C@@H]3OC
16517	sp|P9WQL5|MKL_MYCT	P08183	72.14	387.0	646.0	DB14063	experimental	Dexverapamil	COc1ccc(cc1OC)CCN(C)CCC[C@@](C#N)(C(C)C)c2cc(OC)c(OC)cc2
16518	sp|P9WQL5|MKL_MYCT	P08183	72.14	387.0	646.0	DB14064	experimental	Emopamil	c1ccccc1C(C#N)(C(C)C)CCCN(C)CCc2ccccc2
16519	sp|P9WQL5|MKL_MYCT	P08183	72.14	387.0	646.0	DB14065	experimental	Lomerizine	COc1ccc(c(OC)c1OC)CN2CCN(CC2)C(c3ccc(F)cc3)c4ccc(F)cc4
16520	sp|P9WQL5|MKL_MYCT	P08183	72.14	387.0	646.0	DB14066	experimental	Tetrandrine	c12ccc(OC)c(c1)Oc3ccc(cc3)C[C@H]4c5c(CCN4C)cc(OC)c(c5)Oc6c7c(CCN(C)[C@H]7C2)cc(OC)c6OC
16521	sp|P9WQL5|MKL_MYCT	P08183	72.14	387.0	646.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
16522	sp|P9WQL5|MKL_MYCT	P08183	72.14	387.0	646.0	DB14068	experimental	Dexniguldipine	[O-][N+](=O)c1cccc(c1)[C@@H]2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCCN(CC3)CCC3(c4ccccc4)c5ccccc5
16523	sp|P9WQL5|MKL_MYCT	P08183	72.14	387.0	646.0	DB14069	investigational	ONT-093	CCOC/C=C/c1ccc(cc1)-c2nc(-c3ccc(cc3)NC(C)C)c([nH]2)-c4ccc(cc4)NC(C)C
16524	sp|P9WQL5|MKL_MYCT	P08183	72.14	387.0	646.0	DB14070	experimental	HM-30181	c1cccc(c12)c(=O)cc(o2)C(=O)Nc3cc(OC)c(OC)cc3-c4nn(nn4)-c5ccc(cc5)CCN(C6)CCc(c67)cc(OC)c(c7)OC
16525	sp|P9WQL5|MKL_MYCT	P08183	72.14	387.0	646.0	DB14071	experimental	Desmethylsertraline	c1cccc(c12)[C@@H](CC[C@@H]2N)c3cc(Cl)c(Cl)cc3
16526	sp|P9WQL5|MKL_MYCT	P08183	72.14	387.0	646.0	DB14072	experimental	Reversin 121	c1ccccc1COC(=O)C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@H](C(=O)OC(C)(C)C)CCCCNC(=O)OCc2ccccc2
16527	sp|P9WQL5|MKL_MYCT	P08183	70.47	1019.0	1272.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16528	sp|P9WQL5|MKL_MYCT	P08183	70.47	1019.0	1272.0	DB00603	approved; investigational	Medroxyprogesterone acetate	CC(=O)O[C@]1(C(=O)C)CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C([C@H](C3)C)=CC(=O)CC4
16529	sp|P9WQL5|MKL_MYCT	P08183	70.47	1019.0	1272.0	DB00778	approved; investigational; withdrawn	Roxithromycin	COCCOCO/N=C([C@H](C)[C@@H](O)[C@]1(C)O)/[C@H](C)C[C@@](C)(O)[C@@H]([C@@H](C)[C@@H]([C@@H](C)C(=O)O[C@@H]1CC)O[C@@H](C[C@@]2(C)OC)O[C@@H](C)[C@@H]2O)O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C
16530	sp|P9WQL5|MKL_MYCT	P08183	70.47	1019.0	1272.0	DB00813	approved; illicit; investigational; vet_approved	Fentanyl	c1ccccc1N(C(=O)CC)C2CCN(CC2)CCc3ccccc3
16531	sp|P9WQL5|MKL_MYCT	P08183	70.47	1019.0	1272.0	DB04877	experimental	Voacamine	CC[C@H]1C[C@@H](C2)CN([C@@H]1[C@@]23C(=O)OC)CCc4c3[nH]c5c4cc(OC)c(c5)[C@@H](C[C@H]67)c8c(c9c([nH]8)cccc9)C[C@H](C6C(=O)OC)N(C)CC\7=C\C
16532	sp|P9WQL5|MKL_MYCT	P08183	70.47	1019.0	1272.0	DB04881	investigational	Elacridar	COc1cccc(c12)c(=O)c3c([nH]2)c(ccc3)C(=O)Nc4ccc(cc4)CCN(C5)CCc(c56)cc(OC)c(c6)OC
16533	sp|P9WQL5|MKL_MYCT	P08183	70.47	1019.0	1272.0	DB04905	investigational	Tesmilifene	CCN(CC)CCOc1ccc(cc1)Cc2ccccc2
16534	sp|P9WQL5|MKL_MYCT	P08183	70.47	1019.0	1272.0	DB05449	investigational	FM-VP4	 
16535	sp|P9WQL5|MKL_MYCT	P08183	70.47	1019.0	1272.0	DB06191	investigational	Zosuquidar	FC1(F)[C@H]2[C@@H]1c(cccc3)c3[C@@H](c(c24)cccc4)N5CCN(CC5)C[C@@H](O)COc6cccc(c67)nccc7
16536	sp|P9WQL5|MKL_MYCT	P08183	70.47	1019.0	1272.0	DB06240	investigational	Tariquidar	COc(c1)c(OC)cc(c12)CCN(C2)CCc3ccc(cc3)NC(=O)c4cc(OC)c(OC)cc4NC(=O)c(c5)cnc(c56)cccc6
16537	sp|P9WQL5|MKL_MYCT	P08183	70.47	1019.0	1272.0	DB09031	approved; investigational	Miltefosine	CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C
16538	sp|P9WQL5|MKL_MYCT	P08183	70.47	1019.0	1272.0	DB11635	approved	Tocofersolan	 
16539	sp|P9WQL5|MKL_MYCT	P08183	70.47	1019.0	1272.0	DB14061	experimental	Hycanthone	CCN(CC)CCNc(ccc1CO)c(c12)c(=O)c3c(s2)cccc3
16540	sp|P9WQL5|MKL_MYCT	P08183	70.47	1019.0	1272.0	DB14062	experimental	Concanamycin A	NC(=O)O[C@@H]1[C@@H](C)O[C@H](C[C@H]1O)O[C@H](C2)[C@H](C)[C@@H](/C=C/C)O[C@@]2(O)[C@@H](C)[C@H](O)[C@H](C)[C@H]3OC(=O)/C(OC)=C/C(C)=C/[C@@H](C)[C@@H](O)[C@@H](CC)[C@@H](O)[C@H](C)C/C(C)=C/C=C/[C@@H]3OC
16541	sp|P9WQL5|MKL_MYCT	P08183	70.47	1019.0	1272.0	DB14063	experimental	Dexverapamil	COc1ccc(cc1OC)CCN(C)CCC[C@@](C#N)(C(C)C)c2cc(OC)c(OC)cc2
16542	sp|P9WQL5|MKL_MYCT	P08183	70.47	1019.0	1272.0	DB14064	experimental	Emopamil	c1ccccc1C(C#N)(C(C)C)CCCN(C)CCc2ccccc2
16543	sp|P9WQL5|MKL_MYCT	P08183	70.47	1019.0	1272.0	DB14065	experimental	Lomerizine	COc1ccc(c(OC)c1OC)CN2CCN(CC2)C(c3ccc(F)cc3)c4ccc(F)cc4
16544	sp|P9WQL5|MKL_MYCT	P08183	70.47	1019.0	1272.0	DB14066	experimental	Tetrandrine	c12ccc(OC)c(c1)Oc3ccc(cc3)C[C@H]4c5c(CCN4C)cc(OC)c(c5)Oc6c7c(CCN(C)[C@H]7C2)cc(OC)c6OC
16545	sp|P9WQL5|MKL_MYCT	P08183	70.47	1019.0	1272.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
16546	sp|P9WQL5|MKL_MYCT	P08183	70.47	1019.0	1272.0	DB14068	experimental	Dexniguldipine	[O-][N+](=O)c1cccc(c1)[C@@H]2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCCN(CC3)CCC3(c4ccccc4)c5ccccc5
16547	sp|P9WQL5|MKL_MYCT	P08183	70.47	1019.0	1272.0	DB14069	investigational	ONT-093	CCOC/C=C/c1ccc(cc1)-c2nc(-c3ccc(cc3)NC(C)C)c([nH]2)-c4ccc(cc4)NC(C)C
16548	sp|P9WQL5|MKL_MYCT	P08183	70.47	1019.0	1272.0	DB14070	experimental	HM-30181	c1cccc(c12)c(=O)cc(o2)C(=O)Nc3cc(OC)c(OC)cc3-c4nn(nn4)-c5ccc(cc5)CCN(C6)CCc(c67)cc(OC)c(c7)OC
16549	sp|P9WQL5|MKL_MYCT	P08183	70.47	1019.0	1272.0	DB14071	experimental	Desmethylsertraline	c1cccc(c12)[C@@H](CC[C@@H]2N)c3cc(Cl)c(Cl)cc3
16550	sp|P9WQL5|MKL_MYCT	P08183	70.47	1019.0	1272.0	DB14072	experimental	Reversin 121	c1ccccc1COC(=O)C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@H](C(=O)OC(C)(C)C)CCCCNC(=O)OCc2ccccc2
16551	sp|P9WQL5|MKL_MYCT	O60706	78.27	652.0	933.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16552	sp|P9WQL5|MKL_MYCT	O60706	78.27	652.0	933.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
16553	sp|P9WQL5|MKL_MYCT	O60706	78.27	652.0	933.0	DB09220	approved; investigational	Nicorandil	[O-][N+](=O)OCCNC(=O)c1cccnc1
16554	sp|P9WQL5|MKL_MYCT	O60706	71.59	1289.0	1546.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16555	sp|P9WQL5|MKL_MYCT	O60706	71.59	1289.0	1546.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
16556	sp|P9WQL5|MKL_MYCT	O60706	71.59	1289.0	1546.0	DB09220	approved; investigational	Nicorandil	[O-][N+](=O)OCCNC(=O)c1cccnc1
16557	sp|P9WQL5|MKL_MYCT	O95342	71.03	417.0	672.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16558	sp|P9WQL5|MKL_MYCT	O95342	71.03	417.0	672.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
16559	sp|P9WQL5|MKL_MYCT	Q2M3G0	72.7	383.0	644.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
16560	sp|P9WQL5|MKL_MYCT	Q2M3G0	72.7	383.0	644.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
16561	sp|P9WQL5|MKL_MYCT	Q92887	78.27	624.0	905.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16562	sp|P9WQL5|MKL_MYCT	Q92887	78.27	624.0	905.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
16563	sp|P9WQL5|MKL_MYCT	Q09428	75.49	675.0	946.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16564	sp|P9WQL5|MKL_MYCT	Q09428	75.49	675.0	946.0	DB00222	approved	Glimepiride	CCC1=C(C)CN(C1=O)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3
16565	sp|P9WQL5|MKL_MYCT	Q09428	75.49	675.0	946.0	DB00672	approved; investigational	Chlorpropamide	CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1
16566	sp|P9WQL5|MKL_MYCT	Q09428	75.49	675.0	946.0	DB00731	approved; investigational	Nateglinide	CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](C(=O)O)Cc2ccccc2
16567	sp|P9WQL5|MKL_MYCT	Q09428	75.49	675.0	946.0	DB00912	approved; investigational	Repaglinide	CCOc1c(C(=O)O)ccc(c1)CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3
16568	sp|P9WQL5|MKL_MYCT	Q09428	75.49	675.0	946.0	DB01067	approved; investigational	Glipizide	Cc1ncc(nc1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
16569	sp|P9WQL5|MKL_MYCT	Q09428	75.49	675.0	946.0	DB01120	approved	Gliclazide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN(C2)CC(C23)CCC3
16570	sp|P9WQL5|MKL_MYCT	Q09428	75.49	675.0	946.0	DB01124	approved; investigational	Tolbutamide	CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1
16571	sp|P9WQL5|MKL_MYCT	Q09428	75.49	675.0	946.0	DB01251	approved; investigational	Gliquidone	COc(cc1)cc(c12)C(=O)N(C(=O)C2(C)C)CCc3ccc(cc3)S(=O)(=O)NC(=O)NC4CCCCC4
16572	sp|P9WQL5|MKL_MYCT	Q09428	75.49	675.0	946.0	DB01252	investigational	Mitiglinide	c1ccccc1C[C@H](C(=O)O)CC(=O)N(C2)C[C@H]([C@H]23)CCCC3
16573	sp|P9WQL5|MKL_MYCT	Q09428	75.49	675.0	946.0	DB01382	approved; investigational	Glymidine	COCCOc1cnc(nc1)NS(=O)(=O)c2ccccc2
16574	sp|P9WQL5|MKL_MYCT	Q09428	71.03	1323.0	1578.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16575	sp|P9WQL5|MKL_MYCT	Q09428	71.03	1323.0	1578.0	DB00222	approved	Glimepiride	CCC1=C(C)CN(C1=O)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3
16576	sp|P9WQL5|MKL_MYCT	Q09428	71.03	1323.0	1578.0	DB00672	approved; investigational	Chlorpropamide	CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1
16577	sp|P9WQL5|MKL_MYCT	Q09428	71.03	1323.0	1578.0	DB00731	approved; investigational	Nateglinide	CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](C(=O)O)Cc2ccccc2
16578	sp|P9WQL5|MKL_MYCT	Q09428	71.03	1323.0	1578.0	DB00912	approved; investigational	Repaglinide	CCOc1c(C(=O)O)ccc(c1)CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3
16579	sp|P9WQL5|MKL_MYCT	Q09428	71.03	1323.0	1578.0	DB01067	approved; investigational	Glipizide	Cc1ncc(nc1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
16580	sp|P9WQL5|MKL_MYCT	Q09428	71.03	1323.0	1578.0	DB01120	approved	Gliclazide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN(C2)CC(C23)CCC3
16581	sp|P9WQL5|MKL_MYCT	Q09428	71.03	1323.0	1578.0	DB01124	approved; investigational	Tolbutamide	CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1
16582	sp|P9WQL5|MKL_MYCT	Q09428	71.03	1323.0	1578.0	DB01251	approved; investigational	Gliquidone	COc(cc1)cc(c12)C(=O)N(C(=O)C2(C)C)CCc3ccc(cc3)S(=O)(=O)NC(=O)NC4CCCCC4
16583	sp|P9WQL5|MKL_MYCT	Q09428	71.03	1323.0	1578.0	DB01252	investigational	Mitiglinide	c1ccccc1C[C@H](C(=O)O)CC(=O)N(C2)C[C@H]([C@H]23)CCCC3
16584	sp|P9WQL5|MKL_MYCT	Q09428	71.03	1323.0	1578.0	DB01382	approved; investigational	Glymidine	COCCOc1cnc(nc1)NS(=O)(=O)c2ccccc2
16585	sp|P9WQL5|MKL_MYCT	Q09428	75.49	675.0	946.0	DB00839	approved; investigational	Tolazamide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2
16586	sp|P9WQL5|MKL_MYCT	Q09428	75.49	675.0	946.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
16587	sp|P9WQL5|MKL_MYCT	Q09428	71.03	1323.0	1578.0	DB00839	approved; investigational	Tolazamide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2
16588	sp|P9WQL5|MKL_MYCT	Q09428	71.03	1323.0	1578.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
16589	sp|P9WQL5|MKL_MYCT	O15439	72.14	1024.0	1283.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16590	sp|P9WQL5|MKL_MYCT	O95255	71.59	623.0	880.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16591	sp|P9WQL5|MKL_MYCT	O95477	70.19	895.0	1147.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16592	sp|P9WQL5|MKL_MYCT	O95477	70.19	895.0	1147.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
16593	sp|P9WQL5|MKL_MYCT	O95477	70.19	895.0	1147.0	DB01599	approved; investigational	Probucol	CC(C)(C)c1cc(cc(c1O)C(C)(C)C)SC(C)(C)Sc2cc(C(C)(C)C)c(O)c(c2)C(C)(C)C
16594	sp|O06769|NCASE_MY	Q9I596	99.53	31.0	665.0	DB06960	experimental	N-[(1R,2R,3E)-2-hydroxy-1-(hydroxymethyl)heptadec-3-en-1-yl]acetamide	CC(=O)N[C@H](CO)[C@H](O)/C=C/CCCCCCCCCCCCC
16595	sp|P9WIS9|ODP1_MYC	P0AFG8	94.73	4.0	885.0	DB01987	approved; experimental	Cocarboxylase	OP([O-])(=O)O[P@](=O)(O)OCCc1c(C)[n+](cs1)Cc2cnc(C)nc2N
16596	sp|P9WQL1|PSTB1_MY	P08183	89.53	391.0	622.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16597	sp|P9WQL1|PSTB1_MY	P08183	89.53	391.0	622.0	DB00603	approved; investigational	Medroxyprogesterone acetate	CC(=O)O[C@]1(C(=O)C)CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C([C@H](C3)C)=CC(=O)CC4
16598	sp|P9WQL1|PSTB1_MY	P08183	89.53	391.0	622.0	DB00778	approved; investigational; withdrawn	Roxithromycin	COCCOCO/N=C([C@H](C)[C@@H](O)[C@]1(C)O)/[C@H](C)C[C@@](C)(O)[C@@H]([C@@H](C)[C@@H]([C@@H](C)C(=O)O[C@@H]1CC)O[C@@H](C[C@@]2(C)OC)O[C@@H](C)[C@@H]2O)O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C
16599	sp|P9WQL1|PSTB1_MY	P08183	89.53	391.0	622.0	DB00813	approved; illicit; investigational; vet_approved	Fentanyl	c1ccccc1N(C(=O)CC)C2CCN(CC2)CCc3ccccc3
16600	sp|P9WQL1|PSTB1_MY	P08183	89.53	391.0	622.0	DB04877	experimental	Voacamine	CC[C@H]1C[C@@H](C2)CN([C@@H]1[C@@]23C(=O)OC)CCc4c3[nH]c5c4cc(OC)c(c5)[C@@H](C[C@H]67)c8c(c9c([nH]8)cccc9)C[C@H](C6C(=O)OC)N(C)CC\7=C\C
16601	sp|P9WQL1|PSTB1_MY	P08183	89.53	391.0	622.0	DB04881	investigational	Elacridar	COc1cccc(c12)c(=O)c3c([nH]2)c(ccc3)C(=O)Nc4ccc(cc4)CCN(C5)CCc(c56)cc(OC)c(c6)OC
16602	sp|P9WQL1|PSTB1_MY	P08183	89.53	391.0	622.0	DB04905	investigational	Tesmilifene	CCN(CC)CCOc1ccc(cc1)Cc2ccccc2
16603	sp|P9WQL1|PSTB1_MY	P08183	89.53	391.0	622.0	DB05449	investigational	FM-VP4	 
16604	sp|P9WQL1|PSTB1_MY	P08183	89.53	391.0	622.0	DB06191	investigational	Zosuquidar	FC1(F)[C@H]2[C@@H]1c(cccc3)c3[C@@H](c(c24)cccc4)N5CCN(CC5)C[C@@H](O)COc6cccc(c67)nccc7
16605	sp|P9WQL1|PSTB1_MY	P08183	89.53	391.0	622.0	DB06240	investigational	Tariquidar	COc(c1)c(OC)cc(c12)CCN(C2)CCc3ccc(cc3)NC(=O)c4cc(OC)c(OC)cc4NC(=O)c(c5)cnc(c56)cccc6
16606	sp|P9WQL1|PSTB1_MY	P08183	89.53	391.0	622.0	DB09031	approved; investigational	Miltefosine	CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C
16607	sp|P9WQL1|PSTB1_MY	P08183	89.53	391.0	622.0	DB11635	approved	Tocofersolan	 
16608	sp|P9WQL1|PSTB1_MY	P08183	89.53	391.0	622.0	DB14061	experimental	Hycanthone	CCN(CC)CCNc(ccc1CO)c(c12)c(=O)c3c(s2)cccc3
16609	sp|P9WQL1|PSTB1_MY	P08183	89.53	391.0	622.0	DB14062	experimental	Concanamycin A	NC(=O)O[C@@H]1[C@@H](C)O[C@H](C[C@H]1O)O[C@H](C2)[C@H](C)[C@@H](/C=C/C)O[C@@]2(O)[C@@H](C)[C@H](O)[C@H](C)[C@H]3OC(=O)/C(OC)=C/C(C)=C/[C@@H](C)[C@@H](O)[C@@H](CC)[C@@H](O)[C@H](C)C/C(C)=C/C=C/[C@@H]3OC
16610	sp|P9WQL1|PSTB1_MY	P08183	89.53	391.0	622.0	DB14063	experimental	Dexverapamil	COc1ccc(cc1OC)CCN(C)CCC[C@@](C#N)(C(C)C)c2cc(OC)c(OC)cc2
16611	sp|P9WQL1|PSTB1_MY	P08183	89.53	391.0	622.0	DB14064	experimental	Emopamil	c1ccccc1C(C#N)(C(C)C)CCCN(C)CCc2ccccc2
16612	sp|P9WQL1|PSTB1_MY	P08183	89.53	391.0	622.0	DB14065	experimental	Lomerizine	COc1ccc(c(OC)c1OC)CN2CCN(CC2)C(c3ccc(F)cc3)c4ccc(F)cc4
16613	sp|P9WQL1|PSTB1_MY	P08183	89.53	391.0	622.0	DB14066	experimental	Tetrandrine	c12ccc(OC)c(c1)Oc3ccc(cc3)C[C@H]4c5c(CCN4C)cc(OC)c(c5)Oc6c7c(CCN(C)[C@H]7C2)cc(OC)c6OC
16614	sp|P9WQL1|PSTB1_MY	P08183	89.53	391.0	622.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
16615	sp|P9WQL1|PSTB1_MY	P08183	89.53	391.0	622.0	DB14068	experimental	Dexniguldipine	[O-][N+](=O)c1cccc(c1)[C@@H]2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCCN(CC3)CCC3(c4ccccc4)c5ccccc5
16616	sp|P9WQL1|PSTB1_MY	P08183	89.53	391.0	622.0	DB14069	investigational	ONT-093	CCOC/C=C/c1ccc(cc1)-c2nc(-c3ccc(cc3)NC(C)C)c([nH]2)-c4ccc(cc4)NC(C)C
16617	sp|P9WQL1|PSTB1_MY	P08183	89.53	391.0	622.0	DB14070	experimental	HM-30181	c1cccc(c12)c(=O)cc(o2)C(=O)Nc3cc(OC)c(OC)cc3-c4nn(nn4)-c5ccc(cc5)CCN(C6)CCc(c67)cc(OC)c(c7)OC
16618	sp|P9WQL1|PSTB1_MY	P08183	89.53	391.0	622.0	DB14071	experimental	Desmethylsertraline	c1cccc(c12)[C@@H](CC[C@@H]2N)c3cc(Cl)c(Cl)cc3
16619	sp|P9WQL1|PSTB1_MY	P08183	89.53	391.0	622.0	DB14072	experimental	Reversin 121	c1ccccc1COC(=O)C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@H](C(=O)OC(C)(C)C)CCCCNC(=O)OCc2ccccc2
16620	sp|P9WQL1|PSTB1_MY	P08183	90.31	1034.0	1267.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16621	sp|P9WQL1|PSTB1_MY	P08183	90.31	1034.0	1267.0	DB00603	approved; investigational	Medroxyprogesterone acetate	CC(=O)O[C@]1(C(=O)C)CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C([C@H](C3)C)=CC(=O)CC4
16622	sp|P9WQL1|PSTB1_MY	P08183	90.31	1034.0	1267.0	DB00778	approved; investigational; withdrawn	Roxithromycin	COCCOCO/N=C([C@H](C)[C@@H](O)[C@]1(C)O)/[C@H](C)C[C@@](C)(O)[C@@H]([C@@H](C)[C@@H]([C@@H](C)C(=O)O[C@@H]1CC)O[C@@H](C[C@@]2(C)OC)O[C@@H](C)[C@@H]2O)O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C
16623	sp|P9WQL1|PSTB1_MY	P08183	90.31	1034.0	1267.0	DB00813	approved; illicit; investigational; vet_approved	Fentanyl	c1ccccc1N(C(=O)CC)C2CCN(CC2)CCc3ccccc3
16624	sp|P9WQL1|PSTB1_MY	P08183	90.31	1034.0	1267.0	DB04877	experimental	Voacamine	CC[C@H]1C[C@@H](C2)CN([C@@H]1[C@@]23C(=O)OC)CCc4c3[nH]c5c4cc(OC)c(c5)[C@@H](C[C@H]67)c8c(c9c([nH]8)cccc9)C[C@H](C6C(=O)OC)N(C)CC\7=C\C
16625	sp|P9WQL1|PSTB1_MY	P08183	90.31	1034.0	1267.0	DB04881	investigational	Elacridar	COc1cccc(c12)c(=O)c3c([nH]2)c(ccc3)C(=O)Nc4ccc(cc4)CCN(C5)CCc(c56)cc(OC)c(c6)OC
16626	sp|P9WQL1|PSTB1_MY	P08183	90.31	1034.0	1267.0	DB04905	investigational	Tesmilifene	CCN(CC)CCOc1ccc(cc1)Cc2ccccc2
16627	sp|P9WQL1|PSTB1_MY	P08183	90.31	1034.0	1267.0	DB05449	investigational	FM-VP4	 
16628	sp|P9WQL1|PSTB1_MY	P08183	90.31	1034.0	1267.0	DB06191	investigational	Zosuquidar	FC1(F)[C@H]2[C@@H]1c(cccc3)c3[C@@H](c(c24)cccc4)N5CCN(CC5)C[C@@H](O)COc6cccc(c67)nccc7
16629	sp|P9WQL1|PSTB1_MY	P08183	90.31	1034.0	1267.0	DB06240	investigational	Tariquidar	COc(c1)c(OC)cc(c12)CCN(C2)CCc3ccc(cc3)NC(=O)c4cc(OC)c(OC)cc4NC(=O)c(c5)cnc(c56)cccc6
16630	sp|P9WQL1|PSTB1_MY	P08183	90.31	1034.0	1267.0	DB09031	approved; investigational	Miltefosine	CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C
16631	sp|P9WQL1|PSTB1_MY	P08183	90.31	1034.0	1267.0	DB11635	approved	Tocofersolan	 
16632	sp|P9WQL1|PSTB1_MY	P08183	90.31	1034.0	1267.0	DB14061	experimental	Hycanthone	CCN(CC)CCNc(ccc1CO)c(c12)c(=O)c3c(s2)cccc3
16633	sp|P9WQL1|PSTB1_MY	P08183	90.31	1034.0	1267.0	DB14062	experimental	Concanamycin A	NC(=O)O[C@@H]1[C@@H](C)O[C@H](C[C@H]1O)O[C@H](C2)[C@H](C)[C@@H](/C=C/C)O[C@@]2(O)[C@@H](C)[C@H](O)[C@H](C)[C@H]3OC(=O)/C(OC)=C/C(C)=C/[C@@H](C)[C@@H](O)[C@@H](CC)[C@@H](O)[C@H](C)C/C(C)=C/C=C/[C@@H]3OC
16634	sp|P9WQL1|PSTB1_MY	P08183	90.31	1034.0	1267.0	DB14063	experimental	Dexverapamil	COc1ccc(cc1OC)CCN(C)CCC[C@@](C#N)(C(C)C)c2cc(OC)c(OC)cc2
16635	sp|P9WQL1|PSTB1_MY	P08183	90.31	1034.0	1267.0	DB14064	experimental	Emopamil	c1ccccc1C(C#N)(C(C)C)CCCN(C)CCc2ccccc2
16636	sp|P9WQL1|PSTB1_MY	P08183	90.31	1034.0	1267.0	DB14065	experimental	Lomerizine	COc1ccc(c(OC)c1OC)CN2CCN(CC2)C(c3ccc(F)cc3)c4ccc(F)cc4
16637	sp|P9WQL1|PSTB1_MY	P08183	90.31	1034.0	1267.0	DB14066	experimental	Tetrandrine	c12ccc(OC)c(c1)Oc3ccc(cc3)C[C@H]4c5c(CCN4C)cc(OC)c(c5)Oc6c7c(CCN(C)[C@H]7C2)cc(OC)c6OC
16638	sp|P9WQL1|PSTB1_MY	P08183	90.31	1034.0	1267.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
16639	sp|P9WQL1|PSTB1_MY	P08183	90.31	1034.0	1267.0	DB14068	experimental	Dexniguldipine	[O-][N+](=O)c1cccc(c1)[C@@H]2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCCN(CC3)CCC3(c4ccccc4)c5ccccc5
16640	sp|P9WQL1|PSTB1_MY	P08183	90.31	1034.0	1267.0	DB14069	investigational	ONT-093	CCOC/C=C/c1ccc(cc1)-c2nc(-c3ccc(cc3)NC(C)C)c([nH]2)-c4ccc(cc4)NC(C)C
16641	sp|P9WQL1|PSTB1_MY	P08183	90.31	1034.0	1267.0	DB14070	experimental	HM-30181	c1cccc(c12)c(=O)cc(o2)C(=O)Nc3cc(OC)c(OC)cc3-c4nn(nn4)-c5ccc(cc5)CCN(C6)CCc(c67)cc(OC)c(c7)OC
16642	sp|P9WQL1|PSTB1_MY	P08183	90.31	1034.0	1267.0	DB14071	experimental	Desmethylsertraline	c1cccc(c12)[C@@H](CC[C@@H]2N)c3cc(Cl)c(Cl)cc3
16643	sp|P9WQL1|PSTB1_MY	P08183	90.31	1034.0	1267.0	DB14072	experimental	Reversin 121	c1ccccc1COC(=O)C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@H](C(=O)OC(C)(C)C)CCCCNC(=O)OCc2ccccc2
16644	sp|P9WQL1|PSTB1_MY	O95342	89.15	419.0	649.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16645	sp|P9WQL1|PSTB1_MY	O95342	89.15	419.0	649.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
16646	sp|P9WQL1|PSTB1_MY	O95342	89.53	1077.0	1308.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16647	sp|P9WQL1|PSTB1_MY	O95342	89.53	1077.0	1308.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
16648	sp|P9WQL1|PSTB1_MY	Q2M3G0	89.15	386.0	616.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
16649	sp|P9WQL1|PSTB1_MY	Q2M3G0	89.15	386.0	616.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
16650	sp|P9WQL1|PSTB1_MY	Q2M3G0	90.31	1014.0	1247.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
16651	sp|P9WQL1|PSTB1_MY	Q2M3G0	90.31	1014.0	1247.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
16652	sp|P9WQL1|PSTB1_MY	P13568	70.16	1227.0	1408.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
16653	sp|P9WQL1|PSTB1_MY	O60706	89.92	672.0	904.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16654	sp|P9WQL1|PSTB1_MY	O60706	89.92	672.0	904.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
16655	sp|P9WQL1|PSTB1_MY	O60706	89.92	672.0	904.0	DB09220	approved; investigational	Nicorandil	[O-][N+](=O)OCCNC(=O)c1cccnc1
16656	sp|P9WQL1|PSTB1_MY	O60706	87.98	1311.0	1538.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16657	sp|P9WQL1|PSTB1_MY	O60706	87.98	1311.0	1538.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
16658	sp|P9WQL1|PSTB1_MY	O60706	87.98	1311.0	1538.0	DB09220	approved; investigational	Nicorandil	[O-][N+](=O)OCCNC(=O)c1cccnc1
16659	sp|P9WQL1|PSTB1_MY	Q09428	91.47	687.0	923.0	DB00839	approved; investigational	Tolazamide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2
16660	sp|P9WQL1|PSTB1_MY	Q09428	91.47	687.0	923.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
16661	sp|P9WQL1|PSTB1_MY	Q09428	88.37	1343.0	1571.0	DB00839	approved; investigational	Tolazamide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2
16662	sp|P9WQL1|PSTB1_MY	Q09428	88.37	1343.0	1571.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
16663	sp|P9WQL1|PSTB1_MY	Q09428	91.47	687.0	923.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16664	sp|P9WQL1|PSTB1_MY	Q09428	91.47	687.0	923.0	DB00222	approved	Glimepiride	CCC1=C(C)CN(C1=O)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3
16665	sp|P9WQL1|PSTB1_MY	Q09428	91.47	687.0	923.0	DB00672	approved; investigational	Chlorpropamide	CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1
16666	sp|P9WQL1|PSTB1_MY	Q09428	91.47	687.0	923.0	DB00731	approved; investigational	Nateglinide	CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](C(=O)O)Cc2ccccc2
16667	sp|P9WQL1|PSTB1_MY	Q09428	91.47	687.0	923.0	DB00912	approved; investigational	Repaglinide	CCOc1c(C(=O)O)ccc(c1)CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3
16668	sp|P9WQL1|PSTB1_MY	Q09428	91.47	687.0	923.0	DB01067	approved; investigational	Glipizide	Cc1ncc(nc1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
16669	sp|P9WQL1|PSTB1_MY	Q09428	91.47	687.0	923.0	DB01120	approved	Gliclazide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN(C2)CC(C23)CCC3
16670	sp|P9WQL1|PSTB1_MY	Q09428	91.47	687.0	923.0	DB01124	approved; investigational	Tolbutamide	CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1
16671	sp|P9WQL1|PSTB1_MY	Q09428	91.47	687.0	923.0	DB01251	approved; investigational	Gliquidone	COc(cc1)cc(c12)C(=O)N(C(=O)C2(C)C)CCc3ccc(cc3)S(=O)(=O)NC(=O)NC4CCCCC4
16672	sp|P9WQL1|PSTB1_MY	Q09428	91.47	687.0	923.0	DB01252	investigational	Mitiglinide	c1ccccc1C[C@H](C(=O)O)CC(=O)N(C2)C[C@H]([C@H]23)CCCC3
16673	sp|P9WQL1|PSTB1_MY	Q09428	91.47	687.0	923.0	DB01382	approved; investigational	Glymidine	COCCOc1cnc(nc1)NS(=O)(=O)c2ccccc2
16674	sp|P9WQL1|PSTB1_MY	Q09428	88.37	1343.0	1571.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16675	sp|P9WQL1|PSTB1_MY	Q09428	88.37	1343.0	1571.0	DB00222	approved	Glimepiride	CCC1=C(C)CN(C1=O)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3
16676	sp|P9WQL1|PSTB1_MY	Q09428	88.37	1343.0	1571.0	DB00672	approved; investigational	Chlorpropamide	CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1
16677	sp|P9WQL1|PSTB1_MY	Q09428	88.37	1343.0	1571.0	DB00731	approved; investigational	Nateglinide	CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](C(=O)O)Cc2ccccc2
16678	sp|P9WQL1|PSTB1_MY	Q09428	88.37	1343.0	1571.0	DB00912	approved; investigational	Repaglinide	CCOc1c(C(=O)O)ccc(c1)CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3
16679	sp|P9WQL1|PSTB1_MY	Q09428	88.37	1343.0	1571.0	DB01067	approved; investigational	Glipizide	Cc1ncc(nc1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
16680	sp|P9WQL1|PSTB1_MY	Q09428	88.37	1343.0	1571.0	DB01120	approved	Gliclazide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN(C2)CC(C23)CCC3
16681	sp|P9WQL1|PSTB1_MY	Q09428	88.37	1343.0	1571.0	DB01124	approved; investigational	Tolbutamide	CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1
16682	sp|P9WQL1|PSTB1_MY	Q09428	88.37	1343.0	1571.0	DB01251	approved; investigational	Gliquidone	COc(cc1)cc(c12)C(=O)N(C(=O)C2(C)C)CCc3ccc(cc3)S(=O)(=O)NC(=O)NC4CCCCC4
16683	sp|P9WQL1|PSTB1_MY	Q09428	88.37	1343.0	1571.0	DB01252	investigational	Mitiglinide	c1ccccc1C[C@H](C(=O)O)CC(=O)N(C2)C[C@H]([C@H]23)CCCC3
16684	sp|P9WQL1|PSTB1_MY	Q09428	88.37	1343.0	1571.0	DB01382	approved; investigational	Glymidine	COCCOc1cnc(nc1)NS(=O)(=O)c2ccccc2
16685	sp|P9WQL1|PSTB1_MY	O15440	76.74	575.0	773.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
16686	sp|P9WQL1|PSTB1_MY	O15440	76.74	575.0	773.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
16687	sp|P9WQL1|PSTB1_MY	O15440	88.76	1192.0	1421.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
16688	sp|P9WQL1|PSTB1_MY	O15440	88.76	1192.0	1421.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
16689	sp|P9WQL1|PSTB1_MY	P33527	84.11	644.0	861.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16690	sp|P9WQL1|PSTB1_MY	P33527	84.11	644.0	861.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
16691	sp|P9WQL1|PSTB1_MY	P33527	84.11	644.0	861.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
16692	sp|P9WQL1|PSTB1_MY	P33527	84.11	644.0	861.0	DB06176	approved; investigational	Romidepsin	O=C([C@H]12)N/C(=C\C)C(=O)N[C@@H](C(C)C)C(=O)O[C@@H](CC(=O)N[C@H](C(C)C)C(=O)N1)/C=C/CCSSC2
16693	sp|P9WQL1|PSTB1_MY	P33527	84.11	644.0	861.0	DB08855	experimental; investigational	Leukotriene C4	CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@@H](O)CCCC(=O)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@H](N)C(=O)O
16694	sp|P9WQL1|PSTB1_MY	P33527	88.37	1292.0	1520.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16695	sp|P9WQL1|PSTB1_MY	P33527	88.37	1292.0	1520.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
16696	sp|P9WQL1|PSTB1_MY	P33527	88.37	1292.0	1520.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
16697	sp|P9WQL1|PSTB1_MY	P33527	88.37	1292.0	1520.0	DB06176	approved; investigational	Romidepsin	O=C([C@H]12)N/C(=C\C)C(=O)N[C@@H](C(C)C)C(=O)O[C@@H](CC(=O)N[C@H](C(C)C)C(=O)N1)/C=C/CCSSC2
16698	sp|P9WQL1|PSTB1_MY	P33527	88.37	1292.0	1520.0	DB08855	experimental; investigational	Leukotriene C4	CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@@H](O)CCCC(=O)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@H](N)C(=O)O
16699	sp|P9WQL1|PSTB1_MY	Q92887	86.05	635.0	857.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16700	sp|P9WQL1|PSTB1_MY	Q92887	86.05	635.0	857.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
16701	sp|P9WQL1|PSTB1_MY	Q92887	86.43	1299.0	1522.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16702	sp|P9WQL1|PSTB1_MY	Q92887	86.43	1299.0	1522.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
16703	sp|P9WQL1|PSTB1_MY	O15439	82.56	410.0	623.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16704	sp|P9WQL1|PSTB1_MY	O15439	86.82	1042.0	1266.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16705	sp|P9WQL1|PSTB1_MY	O95255	83.33	629.0	844.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16706	sp|P9WQL1|PSTB1_MY	O95255	89.15	1264.0	1494.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16707	sp|P9WQL1|PSTB1_MY	P13569	77.91	437.0	638.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16708	sp|P9WQL1|PSTB1_MY	P13569	77.91	437.0	638.0	DB00887	approved	Bumetanide	CCCCNc1c(c(S(=O)(=O)N)cc(c1)C(=O)O)Oc2ccccc2
16709	sp|P9WQL1|PSTB1_MY	P13569	77.91	437.0	638.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
16710	sp|P9WQL1|PSTB1_MY	P13569	77.91	437.0	638.0	DB01050	approved	Ibuprofen	CC(C)Cc1ccc(cc1)C(C)C(=O)O
16711	sp|P9WQL1|PSTB1_MY	P13569	77.91	437.0	638.0	DB02587	experimental; investigational	Colforsin	O[C@H]1CCC(C)(C)[C@@H]([C@]12C)[C@H](O)[C@H](OC(=O)C)[C@]3(C)[C@]2(O)C(=O)C[C@](O3)(C)C=C
16712	sp|P9WQL1|PSTB1_MY	P13569	77.91	437.0	638.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
16713	sp|P9WQL1|PSTB1_MY	P13569	77.91	437.0	638.0	DB04522	experimental	Dexfosfoserine	OC(=O)[C@@H](N)COP(=O)(O)O
16714	sp|P9WQL1|PSTB1_MY	P13569	77.91	437.0	638.0	DB04941	approved	Crofelemer	 
16715	sp|P9WQL1|PSTB1_MY	P13569	77.91	437.0	638.0	DB06266	investigational	Lonidamine	c1cccc(c12)n(nc2C(=O)O)Cc3c(Cl)cc(Cl)cc3
16716	sp|P9WQL1|PSTB1_MY	P13569	77.91	437.0	638.0	DB08820	approved	Ivacaftor	CC(C)(C)c1cc(C(C)(C)C)c(O)cc1NC(=O)c(c2=O)c[nH]c(c23)cccc3
16717	sp|P9WQL1|PSTB1_MY	P13569	77.91	437.0	638.0	DB09213	approved; investigational	Dexibuprofen	CC(C)Cc1ccc(cc1)[C@H](C)C(=O)O
16718	sp|P9WQL1|PSTB1_MY	P13569	77.91	437.0	638.0	DB09280	approved	Lumacaftor	O=C(O)c1cccc(c1)-c2nc(ccc2C)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
16719	sp|P9WQL1|PSTB1_MY	P13569	77.91	437.0	638.0	DB11712	approved; investigational	Tezacaftor	OC[C@H](O)Cn1c(C(C)(C)CO)cc(c12)cc(c(F)c2)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
16720	sp|P9WQL1|PSTB1_MY	P13569	77.91	437.0	638.0	DB15444	approved; investigational	Elexacaftor	FC(F)(F)C(C)(C)COc1nn(cc1)-c2nc(N(C3(C)C)C[C@@H](C)C3)c(cc2)C(=O)NS(=O)(=O)c4cn(C)nc4C
16721	sp|P9WQL1|PSTB1_MY	P13569	87.98	1211.0	1438.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16722	sp|P9WQL1|PSTB1_MY	P13569	87.98	1211.0	1438.0	DB00887	approved	Bumetanide	CCCCNc1c(c(S(=O)(=O)N)cc(c1)C(=O)O)Oc2ccccc2
16723	sp|P9WQL1|PSTB1_MY	P13569	87.98	1211.0	1438.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
16724	sp|P9WQL1|PSTB1_MY	P13569	87.98	1211.0	1438.0	DB01050	approved	Ibuprofen	CC(C)Cc1ccc(cc1)C(C)C(=O)O
16725	sp|P9WQL1|PSTB1_MY	P13569	87.98	1211.0	1438.0	DB02587	experimental; investigational	Colforsin	O[C@H]1CCC(C)(C)[C@@H]([C@]12C)[C@H](O)[C@H](OC(=O)C)[C@]3(C)[C@]2(O)C(=O)C[C@](O3)(C)C=C
16726	sp|P9WQL1|PSTB1_MY	P13569	87.98	1211.0	1438.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
16727	sp|P9WQL1|PSTB1_MY	P13569	87.98	1211.0	1438.0	DB04522	experimental	Dexfosfoserine	OC(=O)[C@@H](N)COP(=O)(O)O
16728	sp|P9WQL1|PSTB1_MY	P13569	87.98	1211.0	1438.0	DB04941	approved	Crofelemer	 
16729	sp|P9WQL1|PSTB1_MY	P13569	87.98	1211.0	1438.0	DB06266	investigational	Lonidamine	c1cccc(c12)n(nc2C(=O)O)Cc3c(Cl)cc(Cl)cc3
16730	sp|P9WQL1|PSTB1_MY	P13569	87.98	1211.0	1438.0	DB08820	approved	Ivacaftor	CC(C)(C)c1cc(C(C)(C)C)c(O)cc1NC(=O)c(c2=O)c[nH]c(c23)cccc3
16731	sp|P9WQL1|PSTB1_MY	P13569	87.98	1211.0	1438.0	DB09213	approved; investigational	Dexibuprofen	CC(C)Cc1ccc(cc1)[C@H](C)C(=O)O
16732	sp|P9WQL1|PSTB1_MY	P13569	87.98	1211.0	1438.0	DB09280	approved	Lumacaftor	O=C(O)c1cccc(c1)-c2nc(ccc2C)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
16733	sp|P9WQL1|PSTB1_MY	P13569	87.98	1211.0	1438.0	DB11712	approved; investigational	Tezacaftor	OC[C@H](O)Cn1c(C(C)(C)CO)cc(c12)cc(c(F)c2)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
16734	sp|P9WQL1|PSTB1_MY	P13569	87.98	1211.0	1438.0	DB15444	approved; investigational	Elexacaftor	FC(F)(F)C(C)(C)COc1nn(cc1)-c2nc(N(C3(C)C)C[C@@H](C)C3)c(cc2)C(=O)NS(=O)(=O)c4cn(C)nc4C
16735	sp|P9WQL1|PSTB1_MY	O95477	81.4	902.0	1112.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16736	sp|P9WQL1|PSTB1_MY	O95477	81.4	902.0	1112.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
16737	sp|P9WQL1|PSTB1_MY	O95477	81.4	902.0	1112.0	DB01599	approved; investigational	Probucol	CC(C)(C)c1cc(cc(c1O)C(C)(C)C)SC(C)(C)Sc2cc(C(C)(C)C)c(O)c(c2)C(C)(C)C
16738	sp|P9WQL1|PSTB1_MY	O95477	84.5	1913.0	2131.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16739	sp|P9WQL1|PSTB1_MY	O95477	84.5	1913.0	2131.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
16740	sp|P9WQL1|PSTB1_MY	O95477	84.5	1913.0	2131.0	DB01599	approved; investigational	Probucol	CC(C)(C)c1cc(cc(c1O)C(C)(C)C)SC(C)(C)Sc2cc(C(C)(C)C)c(O)c(c2)C(C)(C)C
16741	sp|P9WQL1|PSTB1_MY	P45844	76.74	98.0	296.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16742	sp|P9WQL1|PSTB1_MY	A0A0T9AZ62	79.46	222.0	427.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
16743	sp|P9WQL1|PSTB1_MY	Q9UNQ0	77.91	63.0	264.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
16744	sp|P9WQL1|PSTB1_MY	Q9UNQ0	77.91	63.0	264.0	DB11995	approved; investigational	Avatrombopag	OC(=O)C1CCN(CC1)c2c(Cl)cc(cn2)C(=O)Nc3nc(-c4cc(Cl)cs4)c(s3)N5CCN(CC5)C6CCCCC6
16745	sp|P9WK35|RISA_MYC	P0AFU8	95.02	1.0	192.0	DB00140	approved; investigational; nutraceutical; vet_approved	Riboflavin	OC[C@@H](O)[C@@H](O)[C@@H](O)Cn(c(c12)cc(C)c(C)c1)c3c(n2)c(=O)[nH]c(n3)=O
16746	sp|P9WH13|RMLA_MYC	P26393	98.96	5.0	290.0	DB01861	experimental	Uridine diphosphate glucose	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
16747	sp|P9WH13|RMLA_MYC	P26393	98.96	5.0	290.0	DB02452	experimental	Thymidine 5'-triphosphate	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16748	sp|P9WH13|RMLA_MYC	Q9HU22	98.96	4.0	289.0	DB01643	experimental	Thymidine monophosphate	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)O
16749	sp|P9WH13|RMLA_MYC	Q9HU22	98.96	4.0	289.0	DB02452	experimental	Thymidine 5'-triphosphate	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16750	sp|P9WH13|RMLA_MYC	Q9HU22	98.96	4.0	289.0	DB02843	experimental	alpha-D-glucose-1-phosphate	OC[C@H]1O[C@H](OP(=O)(O)O)[C@H](O)[C@@H](O)[C@@H]1O
16751	sp|P9WH13|RMLA_MYC	Q9HU22	98.96	4.0	289.0	DB03723	experimental	2'-Deoxy-Thymidine-Beta-L-Rhamnose	O[C@@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]1C)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H](C[C@@H]2O)n3cc(C)c(=O)[nH]c3=O
16752	sp|P9WH13|RMLA_MYC	Q9HU22	98.96	4.0	289.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
16753	sp|P9WH13|RMLA_MYC	Q9HU22	98.96	4.0	289.0	DB04272	approved; nutraceutical; vet_approved	Citric acid	OC(=O)CC(O)(C(=O)O)CC(=O)O
16754	sp|P9WH13|RMLA_MYC	Q9HU22	98.96	4.0	289.0	DB04485	experimental; investigational	Thymidine	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)CO
16755	sp|P9WH13|RMLA_MYC	P61888	99.31	1.0	287.0	DB02452	experimental	Thymidine 5'-triphosphate	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16756	sp|P9WH13|RMLA_MYC	P43889	85.07	7.0	252.0	DB08344	experimental	4-chloro-N-(3-methoxypropyl)-N-[(3S)-1-(2-phenylethyl)piperidin-3-yl]benzamide	Clc1ccc(cc1)C(=O)N(CCCOC)[C@H]2CCCN(C2)CCc3ccccc3
16757	sp|P9WH13|RMLA_MYC	P0ACC7	86.46	6.0	255.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
16758	sp|P9WH13|RMLA_MYC	P0ACC7	86.46	6.0	255.0	DB03397	experimental	Uridine-Diphosphate-N-Acetylglucosamine	CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
16759	sp|P9WH13|RMLA_MYC	P0ACC7	86.46	6.0	255.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
16760	sp|P9WH13|RMLA_MYC	Q97R46	86.81	5.0	255.0	DB03397	experimental	Uridine-Diphosphate-N-Acetylglucosamine	CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
16761	sp|P9WH59|RS14_MYC	P0AG59	99.01	1.0	101.0	DB00560	approved	Tigecycline	O=C1C(C(=O)N)=C(O)[C@@H](N(C)C)[C@@H]([C@@]12O)C[C@H]3C(=C2O)C(=O)c4c(C3)c(N(C)C)cc(c4O)NC(=O)CNC(C)(C)C
16762	sp|P9WH59|RS14_MYC	P0AG59	99.01	1.0	101.0	DB00759	approved; vet_approved	Tetracycline	O=C1C(C(=O)N)=C(O)[C@@H](N(C)C)[C@@H]([C@@]12O)C[C@H]3C(=C2O)C(=O)c4c([C@@]3(C)O)cccc4O
16763	sp|P9WH59|RS14_MYC	P0AG59	99.01	1.0	101.0	DB09093	approved; investigational; vet_approved	Chlortetracycline	O=C1C(C(=O)N)=C(O)[C@@H](N(C)C)[C@@H]([C@@]12O)C[C@H]3C(=C2O)C(=O)c4c([C@@]3(C)O)c(Cl)ccc4O
16764	sp|P9WH59|RS14_MYC	P0AG59	99.01	1.0	101.0	DB12455	approved; investigational	Omadacycline	O=C1C(C(=O)N)=C(O)[C@@H](N(C)C)[C@@H]([C@@]12O)C[C@H]3C(=C2O)C(=O)c4c(C3)c(N(C)C)cc(c4O)CNCC(C)(C)C
16765	sp|P9WH59|RS14_MYC	P0AG59	99.01	1.0	101.0	DB12615	approved; investigational	Plazomicin	CN[C@@H]([C@@]1(C)O)[C@@H](O)[C@H](OC1)O[C@H]2[C@H](NC(=O)[C@@H](O)CCN)C[C@H](N)[C@H]([C@@H]2O)O[C@H]3OC(=CC[C@H]3N)CNCCO
16766	sp|P9WHK7|PYRG_MYC	P17812	93.34	2.0	549.0	DB00130	approved; investigational; nutraceutical	L-Glutamine	OC(=O)[C@@H](N)CCC(=O)N
16768	sp|P9WHD5|RL16_MYC	P0ADY7	95.65	1.0	133.0	DB00446	approved; vet_approved	Chloramphenicol	ClC(Cl)C(=O)N[C@H](CO)[C@H](O)c1ccc([N+]([O-])=O)cc1
16769	sp|P9WHD5|RL16_MYC	Q8ILV2	90.58	43.0	168.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
16770	sp|P9WHD5|RL16_MYC	P27635	84.78	51.0	168.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
16771	sp|P9WHD5|RL16_MYC	Q96L21	84.78	51.0	168.0	DB02494	experimental	(S)-3-phenyllactic acid	OC(=O)[C@@H](O)Cc1ccccc1
16772	sp|P9WHD5|RL16_MYC	Q96L21	84.78	51.0	168.0	DB07374	experimental	Anisomycin	O[C@H]1CN[C@@H]([C@@H]1OC(=O)C)Cc2ccc(OC)cc2
16773	sp|P9WHD5|RL16_MYC	Q96L21	84.78	51.0	168.0	DB08437	experimental	Puromycin	COc1ccc(cc1)C[C@H](N)C(=O)N[C@@H]2[C@@H](CO)O[C@H]([C@@H]2O)n3cnc(c34)c(ncn4)N(C)C
16774	sp|P9WG91|STP_MYCT	P9WJY5	76.54	49.0	460.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
16775	sp|P9WKD1|PBPA_MYC	Q9X6V3	92.26	157.0	610.0	DB00438	approved	Ceftazidime	c1cccc[n+]1CC(=C2C([O-])=O)CS[C@@H](N23)[C@@H](C3=O)NC(=O)/C(=N\OC(C)(C)C(=O)O)c4csc(n4)N
16776	sp|P9WKD1|PBPA_MYC	Q9X6V3	92.26	157.0	610.0	DB01413	approved; investigational	Cefepime	Nc1nc(cs1)/C(=N/OC)C(=O)N[C@@H]2C(=O)N([C@@H]23)C(C([O-])=O)=C(CS3)C[N+]4(C)CCCC4
16777	sp|P9WKD1|PBPA_MYC	Q9X6V3	92.26	157.0	610.0	DB14879	approved; investigational	Cefiderocol	OC(=O)C(C)(C)O/N=C(/c1csc(n1)N)C(=O)N[C@H](C2=O)[C@H](N23)SCC(=C3C([O-])=O)C[N+]4(CCCC4)CCNC(=O)c5c(Cl)c(O)c(O)cc5
16778	sp|P9WKD1|PBPA_MYC	P0AD68	80.86	162.0	559.0	DB00267	approved	Cefmenoxime	Nc1nc(cs1)/C(=N/OC)C(=O)N[C@H](C2=O)[C@H](N23)SCC(=C3C(=O)O)CSc4nnnn4C
16779	sp|P9WKD1|PBPA_MYC	P0AD68	80.86	162.0	559.0	DB00274	approved; investigational	Cefmetazole	N#CCSCC(=O)N[C@@](C1=O)(OC)[C@H](N12)SCC(=C2C(=O)O)CSc3nnnn3C
16780	sp|P9WKD1|PBPA_MYC	P0AD68	80.86	162.0	559.0	DB00303	approved; investigational	Ertapenem	C[C@@H](O)[C@@H](C1=O)[C@H](N12)[C@@H](C)C(=C2C(=O)O)S[C@@H]3CN[C@@H](C3)C(=O)Nc4cccc(c4)C(=O)O
16781	sp|P9WKD1|PBPA_MYC	P0AD68	80.86	162.0	559.0	DB00430	approved	Cefpiramide	Cn1nnnc1SCC(=C2C(=O)O)CS[C@@H](N23)[C@@H](C3=O)NC(=O)[C@@H](c4ccc(O)cc4)NC(=O)c5c(O)cc(C)nc5
16782	sp|P9WKD1|PBPA_MYC	P0AD68	80.86	162.0	559.0	DB00438	approved	Ceftazidime	c1cccc[n+]1CC(=C2C([O-])=O)CS[C@@H](N23)[C@@H](C3=O)NC(=O)/C(=N\OC(C)(C)C(=O)O)c4csc(n4)N
16783	sp|P9WKD1|PBPA_MYC	P0AD68	80.86	162.0	559.0	DB01327	approved	Cefazolin	Cc1sc(nn1)SCC(=C2C(=O)O)CS[C@@H](N23)[C@@H](C3=O)NC(=O)Cn4cnnn4
16784	sp|P9WKD1|PBPA_MYC	P0AD68	80.86	162.0	559.0	DB01328	approved; investigational	Cefonicid	c1ccccc1[C@@H](O)C(=O)N[C@H](C2=O)[C@H](N23)SCC(=C3C(=O)O)CSc4nnnn4CS(=O)(=O)O
16785	sp|P9WKD1|PBPA_MYC	P0AD68	80.86	162.0	559.0	DB01329	approved; investigational	Cefoperazone	Cn1nnnc1SCC(=C2C(=O)O)CS[C@@H](N23)[C@@H](C3=O)NC(=O)[C@@H](c4ccc(O)cc4)NC(=O)N5CCN(CC)C(=O)C5=O
16786	sp|P9WKD1|PBPA_MYC	P0AD68	80.86	162.0	559.0	DB01331	approved	Cefoxitin	NC(=O)OCC(=C1C(=O)O)CS[C@@H](N12)[C@](C2=O)(OC)NC(=O)Cc3cccs3
16787	sp|P9WKD1|PBPA_MYC	P0AD68	80.86	162.0	559.0	DB01413	approved; investigational	Cefepime	Nc1nc(cs1)/C(=N/OC)C(=O)N[C@@H]2C(=O)N([C@@H]23)C(C([O-])=O)=C(CS3)C[N+]4(C)CCCC4
16788	sp|P9WKD1|PBPA_MYC	P0AD68	80.86	162.0	559.0	DB01415	approved; investigational	Ceftibuten	O=C(O)C1=CCS[C@@H](N12)[C@@H](C2=O)NC(=O)/C(=C\CC(=O)O)c3csc(n3)N
16789	sp|P9WKD1|PBPA_MYC	P0AD68	80.86	162.0	559.0	DB01416	approved; vet_approved	Cefpodoxime	COCC(=C1C(=O)O)CS[C@@H](N12)[C@@H](C2=O)NC(=O)/C(=N\OC)c3csc(n3)N
16790	sp|P9WKD1|PBPA_MYC	P0AD68	80.86	162.0	559.0	DB04918	approved; investigational	Ceftobiprole	Nc1nc(ns1)/C(=N/O)C(=O)N[C@@H]2C(=O)N([C@@H]23)C(C(=O)O)=C(CS3)/C=C4\CCN(C4=O)[C@@H]5CCNC5
16791	sp|P9WKD1|PBPA_MYC	P0AD68	80.86	162.0	559.0	DB00578	approved; investigational	Carbenicillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)C(C(=O)O)c3ccccc3
16792	sp|P9WKD1|PBPA_MYC	P0AD68	80.86	162.0	559.0	DB01000	approved	Cyclacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)C3(N)CCCCC3
16793	sp|P9WKD1|PBPA_MYC	P0AD68	80.86	162.0	559.0	DB01602	approved; investigational	Bacampicillin	CCOC(=O)OC(C)OC(=O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)[C@H](N)c3ccccc3
16794	sp|P9WKD1|PBPA_MYC	P0AD68	80.86	162.0	559.0	DB09050	approved; investigational	Ceftolozane	NCCNC(=O)Nc1c(N)n(C)[n+](c1)CC(CS2)=C(C([O-])=O)N([C@H]23)C(=O)[C@H]3NC(=O)/C(=N\OC(C)(C)C(=O)O)c4nsc(n4)N
16795	sp|P9WKD1|PBPA_MYC	P0AD68	80.86	162.0	559.0	DB09319	approved; investigational	Carindacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)C(c3ccccc3)C(=O)Oc(cc4)cc(c45)CCC5
16796	sp|P9WKD1|PBPA_MYC	P0AD69	80.86	162.0	559.0	DB05659	investigational	Faropenem medoxomil	C1CCO[C@H]1C(S[C@@H](N23)[C@H](C3=O)[C@@H](C)O)=C2C(=O)OCc4c(C)oc(=O)o4
16797	sp|P9WKD1|PBPA_MYC	P44469	93.28	165.0	623.0	DB00303	approved; investigational	Ertapenem	C[C@@H](O)[C@@H](C1=O)[C@H](N12)[C@@H](C)C(=C2C(=O)O)S[C@@H]3CN[C@@H](C3)C(=O)Nc4cccc(c4)C(=O)O
16798	sp|P9WKD1|PBPA_MYC	P44469	93.28	165.0	623.0	DB00671	approved; investigational	Cefixime	O=C(O)C1=C(C=C)CS[C@@H](N12)[C@@H](C2=O)NC(=O)/C(=N\OCC(=O)O)c3csc(n3)N
16799	sp|P9WKD1|PBPA_MYC	P45059	80.24	183.0	577.0	DB00303	approved; investigational	Ertapenem	C[C@@H](O)[C@@H](C1=O)[C@H](N12)[C@@H](C)C(=C2C(=O)O)S[C@@H]3CN[C@@H](C3)C(=O)Nc4cccc(c4)C(=O)O
16800	sp|P9WKD1|PBPA_MYC	Q60FT7	80.24	183.0	577.0	DB00535	approved	Cefdinir	O=C(O)C1=C(C=C)CS[C@@H](N12)[C@@H](C2=O)NC(=O)/C(=N\O)c3csc(n3)N
16801	sp|P9WKD1|PBPA_MYC	P0AD65	91.65	162.0	612.0	DB00578	approved; investigational	Carbenicillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)C(C(=O)O)c3ccccc3
16802	sp|P9WKD1|PBPA_MYC	P0AD65	91.65	162.0	612.0	DB01000	approved	Cyclacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)C3(N)CCCCC3
16803	sp|P9WKD1|PBPA_MYC	P0AD65	91.65	162.0	612.0	DB01602	approved; investigational	Bacampicillin	CCOC(=O)OC(C)OC(=O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)[C@H](N)c3ccccc3
16804	sp|P9WKD1|PBPA_MYC	P0AD65	91.65	162.0	612.0	DB09050	approved; investigational	Ceftolozane	NCCNC(=O)Nc1c(N)n(C)[n+](c1)CC(CS2)=C(C([O-])=O)N([C@H]23)C(=O)[C@H]3NC(=O)/C(=N\OC(C)(C)C(=O)O)c4nsc(n4)N
16805	sp|P9WKD1|PBPA_MYC	P0AD65	91.65	162.0	612.0	DB09319	approved; investigational	Carindacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)C(c3ccccc3)C(=O)Oc(cc4)cc(c45)CCC5
16806	sp|P9WKD1|PBPA_MYC	P0AD65	91.65	162.0	612.0	DB00303	approved; investigational	Ertapenem	C[C@@H](O)[C@@H](C1=O)[C@H](N12)[C@@H](C)C(=C2C(=O)O)S[C@@H]3CN[C@@H](C3)C(=O)Nc4cccc(c4)C(=O)O
16807	sp|P9WKD1|PBPA_MYC	P0AD65	91.65	162.0	612.0	DB00438	approved	Ceftazidime	c1cccc[n+]1CC(=C2C([O-])=O)CS[C@@H](N23)[C@@H](C3=O)NC(=O)/C(=N\OC(C)(C)C(=O)O)c4csc(n4)N
16808	sp|P9WKD1|PBPA_MYC	P0AD65	91.65	162.0	612.0	DB00948	approved; investigational	Mezlocillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)[C@@H](c3ccccc3)NC(=O)N4CCN(C4=O)S(=O)(=O)C
16809	sp|P9WKD1|PBPA_MYC	P0AD65	91.65	162.0	612.0	DB01163	investigational; withdrawn	Amdinocillin	C1CCCCCN1/C=N/[C@@H]2C(=O)N([C@@H]23)[C@H](C(S3)(C)C)C(=O)O
16810	sp|P9WKD1|PBPA_MYC	P0AD65	91.65	162.0	612.0	DB01327	approved	Cefazolin	Cc1sc(nn1)SCC(=C2C(=O)O)CS[C@@H](N23)[C@@H](C3=O)NC(=O)Cn4cnnn4
16811	sp|P9WKD1|PBPA_MYC	P0AD65	91.65	162.0	612.0	DB01328	approved; investigational	Cefonicid	c1ccccc1[C@@H](O)C(=O)N[C@H](C2=O)[C@H](N23)SCC(=C3C(=O)O)CSc4nnnn4CS(=O)(=O)O
16812	sp|P9WKD1|PBPA_MYC	P0AD65	91.65	162.0	612.0	DB01329	approved; investigational	Cefoperazone	Cn1nnnc1SCC(=C2C(=O)O)CS[C@@H](N23)[C@@H](C3=O)NC(=O)[C@@H](c4ccc(O)cc4)NC(=O)N5CCN(CC)C(=O)C5=O
16813	sp|P9WKD1|PBPA_MYC	P0AD65	91.65	162.0	612.0	DB01413	approved; investigational	Cefepime	Nc1nc(cs1)/C(=N/OC)C(=O)N[C@@H]2C(=O)N([C@@H]23)C(C([O-])=O)=C(CS3)C[N+]4(C)CCCC4
16814	sp|P9WKD1|PBPA_MYC	P0AD65	91.65	162.0	612.0	DB01415	approved; investigational	Ceftibuten	O=C(O)C1=CCS[C@@H](N12)[C@@H](C2=O)NC(=O)/C(=C\CC(=O)O)c3csc(n3)N
16815	sp|P9WKD1|PBPA_MYC	P0AD65	91.65	162.0	612.0	DB01598	approved	Imipenem	C[C@@H](O)[C@@H](C1=O)[C@H](N12)CC(=C2C(=O)O)SCC/N=C/N
16816	sp|P9WKD1|PBPA_MYC	P0AD65	91.65	162.0	612.0	DB06211	approved; investigational	Doripenem	C[C@@H](O)[C@@H](C1=O)[C@H](N12)[C@@H](C)C(=C2C(=O)O)S[C@@H]3CN[C@@H](C3)CNS(=O)(=O)N
16818	sp|P9WKD1|PBPA_MYC	Q7DHH4	84.73	237.0	653.0	DB04918	approved; investigational	Ceftobiprole	Nc1nc(ns1)/C(=N/O)C(=O)N[C@@H]2C(=O)N([C@@H]23)C(C(=O)O)=C(CS3)/C=C4\CCN(C4=O)[C@@H]5CCNC5
16819	sp|P9WKD1|PBPA_MYC	P07944	85.13	237.0	655.0	DB02443	experimental	Methicillin Acyl-Serine	[O-]C(=O)[C@@H](N)COC(=O)[C@H]([C@@H](SC1(C)C)N[C@H]1C(=O)O)/N=C(\[O-])c2c(OC)cccc2OC
16820	sp|P9WKD1|PBPA_MYC	P07944	85.13	237.0	655.0	DB02968	experimental	Penicillin G Acyl-Serine	[O-]C(=O)[C@@H](N)COC(=O)[C@H]([C@@H](SC1(C)C)N[C@H]1C(=O)O)/N=C(\[O-])Cc2ccccc2
16821	sp|P9WKD1|PBPA_MYC	P07944	85.13	237.0	655.0	DB04041	experimental	Nitrocefin Acyl-Serine	O=N(=O)c1ccc(c(c1)N(=O)=O)/C=C/C2=C(C(=O)O)N[C@H](SC2)[C@@H](C(=O)OC[C@H](N)C([O-])=O)/N=C(\[O-])Cc3cccs3
16823	sp|P9WKD1|PBPA_MYC	Q51504	82.08	148.0	551.0	DB01147	approved; investigational; vet_approved	Cloxacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)c3c(C)onc3-c4ccccc4Cl
16824	sp|P9WKD1|PBPA_MYC	Q51504	82.08	148.0	551.0	DB01413	approved; investigational	Cefepime	Nc1nc(cs1)/C(=N/OC)C(=O)N[C@@H]2C(=O)N([C@@H]23)C(C([O-])=O)=C(CS3)C[N+]4(C)CCCC4
16825	sp|P9WKD1|PBPA_MYC	Q51504	82.08	148.0	551.0	DB06211	approved; investigational	Doripenem	C[C@@H](O)[C@@H](C1=O)[C@H](N12)[C@@H](C)C(=C2C(=O)O)S[C@@H]3CN[C@@H](C3)CNS(=O)(=O)N
16826	sp|P9WKD1|PBPA_MYC	Q51504	82.08	148.0	551.0	DB09050	approved; investigational	Ceftolozane	NCCNC(=O)Nc1c(N)n(C)[n+](c1)CC(CS2)=C(C([O-])=O)N([C@H]23)C(=O)[C@H]3NC(=O)/C(=N\OC(C)(C)C(=O)O)c4nsc(n4)N
16827	sp|P9WKD1|PBPA_MYC	Q51504	82.08	148.0	551.0	DB14879	approved; investigational	Cefiderocol	OC(=O)C(C)(C)O/N=C(/c1csc(n1)N)C(=O)N[C@H](C2=O)[C@H](N23)SCC(=C3C([O-])=O)C[N+]4(CCCC4)CCNC(=O)c5c(Cl)c(O)c(O)cc5
16828	sp|P9WKD1|PBPA_MYC	P42971	81.87	251.0	653.0	DB00355	approved	Aztreonam	[O-]S(=O)(=O)N1C(=O)[C@H]([C@@H]1C)NC(=O)/C(=N\OC(C)(C)C(=O)O)c2csc(n2)[NH3+]
16829	sp|P9WKD1|PBPA_MYC	P42971	81.87	251.0	653.0	DB00493	approved	Cefotaxime	CC(=O)OCC(=C1C(=O)O)CS[C@@H](N12)[C@@H](C2=O)NC(=O)/C(=N\OC)c3csc(n3)N
16830	sp|P9WKD1|PBPA_MYC	P42971	81.87	251.0	653.0	DB01598	approved	Imipenem	C[C@@H](O)[C@@H](C1=O)[C@H](N12)CC(=C2C(=O)O)SCC/N=C/N
16831	sp|P9WKD1|PBPA_MYC	P42971	81.87	251.0	653.0	DB04570	approved; investigational	Latamoxef	Cn1nnnc1SCC(=C2C(=O)O)CO[C@@H](N23)[C@](C3=O)(OC)NC(=O)C(C(=O)O)c4ccc(O)cc4
16832	sp|P9WKD1|PBPA_MYC	A0A0E1R3H3	82.08	265.0	668.0	DB00485	approved; investigational; vet_approved	Dicloxacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)c3c(C)onc3-c4c(Cl)cccc4Cl
16833	sp|P9WKD1|PBPA_MYC	C1KC03	76.17	109.0	483.0	DB00274	approved; investigational	Cefmetazole	N#CCSCC(=O)N[C@@](C1=O)(OC)[C@H](N12)SCC(=C2C(=O)O)CSc3nnnn3C
16834	sp|P9WKD1|PBPA_MYC	C1KC03	76.17	109.0	483.0	DB00430	approved	Cefpiramide	Cn1nnnc1SCC(=C2C(=O)O)CS[C@@H](N23)[C@@H](C3=O)NC(=O)[C@@H](c4ccc(O)cc4)NC(=O)c5c(O)cc(C)nc5
16835	sp|P9WKD1|PBPA_MYC	C1KC03	76.17	109.0	483.0	DB01000	approved	Cyclacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)C3(N)CCCCC3
16836	sp|P9WKD1|PBPA_MYC	C1KC03	76.17	109.0	483.0	DB01607	approved; investigational; vet_approved	Ticarcillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)[C@H](C(=O)O)c3cscc3
16837	sp|P9WKD1|PBPA_MYC	P08149	81.26	163.0	562.0	DB00535	approved	Cefdinir	O=C(O)C1=C(C=C)CS[C@@H](N12)[C@@H](C2=O)NC(=O)/C(=N\O)c3csc(n3)N
16838	sp|P9WKD1|PBPA_MYC	P14677	87.78	179.0	610.0	DB01150	approved	Cefprozil	C/C=C/C(=C1C(=O)O)CS[C@@H](N12)[C@@H](C2=O)NC(=O)[C@H](N)c3ccc(O)cc3
16839	sp|P9WKD1|PBPA_MYC	P14677	87.78	179.0	610.0	DB04918	approved; investigational	Ceftobiprole	Nc1nc(ns1)/C(=N/O)C(=O)N[C@@H]2C(=O)N([C@@H]23)C(C(=O)O)=C(CS3)/C=C4\CCN(C4=O)[C@@H]5CCNC5
16840	sp|P9WKD1|PBPA_MYC	P59676	87.78	179.0	610.0	DB03190	experimental	6-o-Capryloylsucrose	O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@]2(CO)O[C@@H]([C@@H](O)[C@@H]2O)COC(=O)CCCCCCC
16841	sp|P9WKD1|PBPA_MYC	Q70KI2	87.58	164.0	594.0	DB00923	approved	Ceforanide	OC(=O)Cn1nnnc1SCC(=C2C(=O)O)CS[C@@H](N23)[C@@H](C3=O)NC(=O)Cc4ccccc4CN
16842	sp|P9WKD1|PBPA_MYC	Q70KI2	87.58	164.0	594.0	DB01326	approved; experimental	Cefamandole	Cn1nnnc1SCC(=C2C(=O)O)CS[C@@H](N23)[C@@H](C3=O)NC(=O)[C@H](O)c4ccccc4
16843	sp|P9WKD1|PBPA_MYC	P0A3M5	86.76	245.0	671.0	DB01147	approved; investigational; vet_approved	Cloxacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)c3c(C)onc3-c4ccccc4Cl
16844	sp|P9WKD1|PBPA_MYC	P0A3M5	86.76	245.0	671.0	DB01150	approved	Cefprozil	C/C=C/C(=C1C(=O)O)CS[C@@H](N12)[C@@H](C2=O)NC(=O)[C@H](N)c3ccc(O)cc3
16845	sp|P9WKD1|PBPA_MYC	P0A3M5	86.76	245.0	671.0	DB05659	investigational	Faropenem medoxomil	C1CCO[C@H]1C(S[C@@H](N23)[C@H](C3=O)[C@@H](C)O)=C2C(=O)OCc4c(C)oc(=O)o4
16846	sp|P9WKD1|PBPA_MYC	P0A3M6	86.76	245.0	671.0	DB00319	approved	Piperacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)[C@@H](c3ccccc3)NC(=O)N4CCN(CC)C(=O)C4=O
16847	sp|P9WKD1|PBPA_MYC	P0A3M6	86.76	245.0	671.0	DB00415	approved; vet_approved	Ampicillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)[C@H](N)c3ccccc3
16848	sp|P9WKD1|PBPA_MYC	P0A3M6	86.76	245.0	671.0	DB00456	approved; investigational; vet_approved	Cefalotin	CC(=O)OCC(CS1)=C(C(=O)O)N([C@H]12)C(=O)[C@H]2NC(=O)Cc3cccs3
16849	sp|P9WKD1|PBPA_MYC	P0A3M6	86.76	245.0	671.0	DB00485	approved; investigational; vet_approved	Dicloxacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)c3c(C)onc3-c4c(Cl)cccc4Cl
16850	sp|P9WKD1|PBPA_MYC	P0A3M6	86.76	245.0	671.0	DB00493	approved	Cefotaxime	CC(=O)OCC(=C1C(=O)O)CS[C@@H](N12)[C@@H](C2=O)NC(=O)/C(=N\OC)c3csc(n3)N
16851	sp|P9WKD1|PBPA_MYC	P0A3M6	86.76	245.0	671.0	DB00567	approved; investigational; vet_approved	Cephalexin	O=C(O)C1=C(C)CS[C@@H](N12)[C@@H](C2=O)NC(=O)[C@H](N)c3ccccc3
16852	sp|P9WKD1|PBPA_MYC	P0A3M6	86.76	245.0	671.0	DB00607	approved; investigational	Nafcillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)c3c(OCC)ccc(c34)cccc4
16853	sp|P9WKD1|PBPA_MYC	P0A3M6	86.76	245.0	671.0	DB00713	approved; investigational	Oxacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)c3c(C)onc3-c4ccccc4
16854	sp|P9WKD1|PBPA_MYC	P0A3M6	86.76	245.0	671.0	DB00739	approved; vet_approved; withdrawn	Hetacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)N(C3(C)C)C(=O)[C@H](N3)c4ccccc4
16855	sp|P9WKD1|PBPA_MYC	P0A3M6	86.76	245.0	671.0	DB01066	approved; investigational	Cefditoren	Cc1ncsc1/C=C\C(=C2C(=O)O)CS[C@@H](N23)[C@@H](C3=O)NC(=O)/C(=N\OC)c4csc(n4)N
16856	sp|P9WKD1|PBPA_MYC	P0A3M6	86.76	245.0	671.0	DB01140	approved; vet_approved; withdrawn	Cefadroxil	O=C(O)C1=C(C)CS[C@@H](N12)[C@@H](C2=O)NC(=O)[C@H](N)c3ccc(O)cc3
16857	sp|P9WKD1|PBPA_MYC	P0A3M6	86.76	245.0	671.0	DB01163	investigational; withdrawn	Amdinocillin	C1CCCCCN1/C=N/[C@@H]2C(=O)N([C@@H]23)[C@H](C(S3)(C)C)C(=O)O
16858	sp|P9WKD1|PBPA_MYC	P0A3M6	86.76	245.0	671.0	DB01212	approved	Ceftriaxone	Nc1nc(cs1)/C(=N/OC)C(=O)N[C@H](C2=O)[C@H](N23)SCC(=C3C(=O)O)CSc4nc(=O)c(=O)[nH]n4C
16859	sp|P9WKD1|PBPA_MYC	P0A3M6	86.76	245.0	671.0	DB01331	approved	Cefoxitin	NC(=O)OCC(=C1C(=O)O)CS[C@@H](N12)[C@](C2=O)(OC)NC(=O)Cc3cccs3
16860	sp|P9WKD1|PBPA_MYC	P0A3M6	86.76	245.0	671.0	DB01603	approved; investigational	Meticillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)c3c(OC)cccc3OC
16861	sp|P9WKD1|PBPA_MYC	P0A3M6	86.76	245.0	671.0	DB03313	experimental	Cephalosporin C	CC(=O)OCC(=C1C(=O)O)CS[C@@H](N12)[C@@H](C2=O)NC(=O)CCC[C@@H](N)C(=O)O
16862	sp|P9WKD1|PBPA_MYC	P0A3M6	86.76	245.0	671.0	DB08795	experimental	Azidocillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)[C@H](N=[N+]=[N-])c3ccccc3
16863	sp|P9WKD1|PBPA_MYC	A0A0H2XJ39	92.06	224.0	676.0	DB01053	approved; vet_approved	Benzylpenicillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)Cc3ccccc3
16864	sp|P9WKD1|PBPA_MYC	Q8L103	71.08	265.0	614.0	DB01060	approved; vet_approved	Amoxicillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)[C@H](N)c3ccc(O)cc3
16865	sp|P9WKD1|PBPA_MYC	Q8DNB6	76.99	274.0	652.0	DB00319	approved	Piperacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)[C@@H](c3ccccc3)NC(=O)N4CCN(CC)C(=O)C4=O
16866	sp|P9WKD1|PBPA_MYC	Q8DNB6	76.99	274.0	652.0	DB00415	approved; vet_approved	Ampicillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)[C@H](N)c3ccccc3
16867	sp|P9WKD1|PBPA_MYC	Q8DNB6	76.99	274.0	652.0	DB00456	approved; investigational; vet_approved	Cefalotin	CC(=O)OCC(CS1)=C(C(=O)O)N([C@H]12)C(=O)[C@H]2NC(=O)Cc3cccs3
16868	sp|P9WKD1|PBPA_MYC	Q8DNB6	76.99	274.0	652.0	DB00485	approved; investigational; vet_approved	Dicloxacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)c3c(C)onc3-c4c(Cl)cccc4Cl
16869	sp|P9WKD1|PBPA_MYC	Q8DNB6	76.99	274.0	652.0	DB00493	approved	Cefotaxime	CC(=O)OCC(=C1C(=O)O)CS[C@@H](N12)[C@@H](C2=O)NC(=O)/C(=N\OC)c3csc(n3)N
16870	sp|P9WKD1|PBPA_MYC	Q8DNB6	76.99	274.0	652.0	DB00567	approved; investigational; vet_approved	Cephalexin	O=C(O)C1=C(C)CS[C@@H](N12)[C@@H](C2=O)NC(=O)[C@H](N)c3ccccc3
16871	sp|P9WKD1|PBPA_MYC	Q8DNB6	76.99	274.0	652.0	DB00607	approved; investigational	Nafcillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)c3c(OCC)ccc(c34)cccc4
16872	sp|P9WKD1|PBPA_MYC	Q8DNB6	76.99	274.0	652.0	DB00713	approved; investigational	Oxacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)c3c(C)onc3-c4ccccc4
16873	sp|P9WKD1|PBPA_MYC	Q8DNB6	76.99	274.0	652.0	DB00739	approved; vet_approved; withdrawn	Hetacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)N(C3(C)C)C(=O)[C@H](N3)c4ccccc4
16874	sp|P9WKD1|PBPA_MYC	Q8DNB6	76.99	274.0	652.0	DB01147	approved; investigational; vet_approved	Cloxacillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)c3c(C)onc3-c4ccccc4Cl
16875	sp|P9WKD1|PBPA_MYC	Q8DNB6	76.99	274.0	652.0	DB01163	investigational; withdrawn	Amdinocillin	C1CCCCCN1/C=N/[C@@H]2C(=O)N([C@@H]23)[C@H](C(S3)(C)C)C(=O)O
16876	sp|P9WKD1|PBPA_MYC	Q8DNB6	76.99	274.0	652.0	DB01331	approved	Cefoxitin	NC(=O)OCC(=C1C(=O)O)CS[C@@H](N12)[C@](C2=O)(OC)NC(=O)Cc3cccs3
16877	sp|P9WKD1|PBPA_MYC	Q8DNB6	76.99	274.0	652.0	DB01603	approved; investigational	Meticillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)c3c(OC)cccc3OC
16878	sp|P9WKD1|PBPA_MYC	Q8DNB6	76.99	274.0	652.0	DB03313	experimental	Cephalosporin C	CC(=O)OCC(=C1C(=O)O)CS[C@@H](N12)[C@@H](C2=O)NC(=O)CCC[C@@H](N)C(=O)O
16879	sp|P9WKD1|PBPA_MYC	Q8DNB6	76.99	274.0	652.0	DB08795	experimental	Azidocillin	O=C(O)[C@H]1C(C)(C)S[C@@H](N12)[C@@H](C2=O)NC(=O)[C@H](N=[N+]=[N-])c3ccccc3
16880	sp|P9WHD9|RL14_MYC	P62829	88.52	25.0	133.0	DB02494	experimental	(S)-3-phenyllactic acid	OC(=O)[C@@H](O)Cc1ccccc1
16881	sp|P9WHD9|RL14_MYC	P62829	88.52	25.0	133.0	DB07374	experimental	Anisomycin	O[C@H]1CN[C@@H]([C@@H]1OC(=O)C)Cc2ccc(OC)cc2
16882	sp|P9WHD9|RL14_MYC	P62829	88.52	25.0	133.0	DB08437	experimental	Puromycin	COc1ccc(cc1)C[C@H](N)C(=O)N[C@@H]2[C@@H](CO)O[C@H]([C@@H]2O)n3cnc(c34)c(ncn4)N(C)C
16883	sp|P9WGZ1|RPOA_MYC	P0A7Z4	90.2	14.0	327.0	DB00615	approved; investigational	Rifabutin	CC(C)CN(CC1)CCC12N=C3c4c5c6c(C)c(O)c4C(=O)C(=C3N2)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(=O)C)[C@H](C)[C@@H](OC)/C=C/O[C@](O6)(C)C5=O
16884	sp|P9WGZ1|RPOA_MYC	P0A7Z4	90.2	14.0	327.0	DB11753	approved; investigational	Rifamycin	C[C@@]12O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(=O)C)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)Nc3c(O)c4c(c(c3)O)c(C1=O)c(O2)c(C)c4O
16885	sp|P9WGZ1|RPOA_MYC	Q5SHR6	88.18	9.0	315.0	DB08266	experimental	Methyl [(1E,5R)-5-{3-[(2E,4E)-2,5-dimethyl-2,4-octadienoyl]-2,4-dioxo-3,4-dihydro-2H-pyran-6-yl}hexylidene]carbamate	COC(=O)/N=C/CCC[C@@H](C)C1=CC(=O)C(C(=O)O1)C(=O)/C(C)=C/C=C(\C)CCC
16886	sp|P9WGZ1|RPOA_MYC	Q9Z9H6	88.18	9.0	315.0	DB08226	experimental	Myxopyronin B	CCCC/C(C)=C/C=C(\C)C(=O)c1c(O)cc(oc1=O)CCC/C=C/NC(=O)OC
16887	sp|P9WH67|RS10_MYC	P0A7R5	98.02	1.0	100.0	DB00698	approved; vet_approved	Nitrofurantoin	[O-][N+](=O)c1ccc(o1)/C=N/N2CC(=O)NC2=O
16888	sp|P9WH67|RS10_MYC	Q5SHN7	94.06	3.0	98.0	DB01421	approved; investigational	Paromomycin	NC[C@@H]1O[C@@H]([C@H](N)[C@@H](O)[C@@H]1O)O[C@@H]2[C@@H](CO)O[C@H]([C@@H]2O)O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4N
16889	sp|P9WH67|RS10_MYC	Q5SHN7	94.06	3.0	98.0	DB08185	experimental	2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(nc(n3)SC)NCCC(C)C
16890	sp|P9WQK9|PSTB2_MY	Q2M3G0	83.33	399.0	629.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
16891	sp|P9WQK9|PSTB2_MY	Q2M3G0	83.33	399.0	629.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
16892	sp|P9WQK9|PSTB2_MY	Q2M3G0	77.17	1031.0	1244.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
16893	sp|P9WQK9|PSTB2_MY	Q2M3G0	77.17	1031.0	1244.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
16894	sp|P9WQK9|PSTB2_MY	P08183	80.07	398.0	619.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16895	sp|P9WQK9|PSTB2_MY	P08183	80.07	398.0	619.0	DB00603	approved; investigational	Medroxyprogesterone acetate	CC(=O)O[C@]1(C(=O)C)CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C([C@H](C3)C)=CC(=O)CC4
16896	sp|P9WQK9|PSTB2_MY	P08183	80.07	398.0	619.0	DB00778	approved; investigational; withdrawn	Roxithromycin	COCCOCO/N=C([C@H](C)[C@@H](O)[C@]1(C)O)/[C@H](C)C[C@@](C)(O)[C@@H]([C@@H](C)[C@@H]([C@@H](C)C(=O)O[C@@H]1CC)O[C@@H](C[C@@]2(C)OC)O[C@@H](C)[C@@H]2O)O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C
16897	sp|P9WQK9|PSTB2_MY	P08183	80.07	398.0	619.0	DB00813	approved; illicit; investigational; vet_approved	Fentanyl	c1ccccc1N(C(=O)CC)C2CCN(CC2)CCc3ccccc3
16898	sp|P9WQK9|PSTB2_MY	P08183	80.07	398.0	619.0	DB04877	experimental	Voacamine	CC[C@H]1C[C@@H](C2)CN([C@@H]1[C@@]23C(=O)OC)CCc4c3[nH]c5c4cc(OC)c(c5)[C@@H](C[C@H]67)c8c(c9c([nH]8)cccc9)C[C@H](C6C(=O)OC)N(C)CC\7=C\C
16899	sp|P9WQK9|PSTB2_MY	P08183	80.07	398.0	619.0	DB04881	investigational	Elacridar	COc1cccc(c12)c(=O)c3c([nH]2)c(ccc3)C(=O)Nc4ccc(cc4)CCN(C5)CCc(c56)cc(OC)c(c6)OC
16900	sp|P9WQK9|PSTB2_MY	P08183	80.07	398.0	619.0	DB04905	investigational	Tesmilifene	CCN(CC)CCOc1ccc(cc1)Cc2ccccc2
16901	sp|P9WQK9|PSTB2_MY	P08183	80.07	398.0	619.0	DB05449	investigational	FM-VP4	 
16902	sp|P9WQK9|PSTB2_MY	P08183	80.07	398.0	619.0	DB06191	investigational	Zosuquidar	FC1(F)[C@H]2[C@@H]1c(cccc3)c3[C@@H](c(c24)cccc4)N5CCN(CC5)C[C@@H](O)COc6cccc(c67)nccc7
16903	sp|P9WQK9|PSTB2_MY	P08183	80.07	398.0	619.0	DB06240	investigational	Tariquidar	COc(c1)c(OC)cc(c12)CCN(C2)CCc3ccc(cc3)NC(=O)c4cc(OC)c(OC)cc4NC(=O)c(c5)cnc(c56)cccc6
16904	sp|P9WQK9|PSTB2_MY	P08183	80.07	398.0	619.0	DB09031	approved; investigational	Miltefosine	CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C
16905	sp|P9WQK9|PSTB2_MY	P08183	80.07	398.0	619.0	DB11635	approved	Tocofersolan	 
16906	sp|P9WQK9|PSTB2_MY	P08183	80.07	398.0	619.0	DB14061	experimental	Hycanthone	CCN(CC)CCNc(ccc1CO)c(c12)c(=O)c3c(s2)cccc3
16907	sp|P9WQK9|PSTB2_MY	P08183	80.07	398.0	619.0	DB14062	experimental	Concanamycin A	NC(=O)O[C@@H]1[C@@H](C)O[C@H](C[C@H]1O)O[C@H](C2)[C@H](C)[C@@H](/C=C/C)O[C@@]2(O)[C@@H](C)[C@H](O)[C@H](C)[C@H]3OC(=O)/C(OC)=C/C(C)=C/[C@@H](C)[C@@H](O)[C@@H](CC)[C@@H](O)[C@H](C)C/C(C)=C/C=C/[C@@H]3OC
16908	sp|P9WQK9|PSTB2_MY	P08183	80.07	398.0	619.0	DB14063	experimental	Dexverapamil	COc1ccc(cc1OC)CCN(C)CCC[C@@](C#N)(C(C)C)c2cc(OC)c(OC)cc2
16909	sp|P9WQK9|PSTB2_MY	P08183	80.07	398.0	619.0	DB14064	experimental	Emopamil	c1ccccc1C(C#N)(C(C)C)CCCN(C)CCc2ccccc2
16910	sp|P9WQK9|PSTB2_MY	P08183	80.07	398.0	619.0	DB14065	experimental	Lomerizine	COc1ccc(c(OC)c1OC)CN2CCN(CC2)C(c3ccc(F)cc3)c4ccc(F)cc4
16911	sp|P9WQK9|PSTB2_MY	P08183	80.07	398.0	619.0	DB14066	experimental	Tetrandrine	c12ccc(OC)c(c1)Oc3ccc(cc3)C[C@H]4c5c(CCN4C)cc(OC)c(c5)Oc6c7c(CCN(C)[C@H]7C2)cc(OC)c6OC
16912	sp|P9WQK9|PSTB2_MY	P08183	80.07	398.0	619.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
16913	sp|P9WQK9|PSTB2_MY	P08183	80.07	398.0	619.0	DB14068	experimental	Dexniguldipine	[O-][N+](=O)c1cccc(c1)[C@@H]2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCCN(CC3)CCC3(c4ccccc4)c5ccccc5
16914	sp|P9WQK9|PSTB2_MY	P08183	80.07	398.0	619.0	DB14069	investigational	ONT-093	CCOC/C=C/c1ccc(cc1)-c2nc(-c3ccc(cc3)NC(C)C)c([nH]2)-c4ccc(cc4)NC(C)C
16915	sp|P9WQK9|PSTB2_MY	P08183	80.07	398.0	619.0	DB14070	experimental	HM-30181	c1cccc(c12)c(=O)cc(o2)C(=O)Nc3cc(OC)c(OC)cc3-c4nn(nn4)-c5ccc(cc5)CCN(C6)CCc(c67)cc(OC)c(c7)OC
16916	sp|P9WQK9|PSTB2_MY	P08183	80.07	398.0	619.0	DB14071	experimental	Desmethylsertraline	c1cccc(c12)[C@@H](CC[C@@H]2N)c3cc(Cl)c(Cl)cc3
16917	sp|P9WQK9|PSTB2_MY	P08183	80.07	398.0	619.0	DB14072	experimental	Reversin 121	c1ccccc1COC(=O)C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@H](C(=O)OC(C)(C)C)CCCCNC(=O)OCc2ccccc2
16918	sp|P9WQK9|PSTB2_MY	P08183	79.71	1049.0	1269.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16919	sp|P9WQK9|PSTB2_MY	P08183	79.71	1049.0	1269.0	DB00603	approved; investigational	Medroxyprogesterone acetate	CC(=O)O[C@]1(C(=O)C)CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C([C@H](C3)C)=CC(=O)CC4
16920	sp|P9WQK9|PSTB2_MY	P08183	79.71	1049.0	1269.0	DB00778	approved; investigational; withdrawn	Roxithromycin	COCCOCO/N=C([C@H](C)[C@@H](O)[C@]1(C)O)/[C@H](C)C[C@@](C)(O)[C@@H]([C@@H](C)[C@@H]([C@@H](C)C(=O)O[C@@H]1CC)O[C@@H](C[C@@]2(C)OC)O[C@@H](C)[C@@H]2O)O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C
16921	sp|P9WQK9|PSTB2_MY	P08183	79.71	1049.0	1269.0	DB00813	approved; illicit; investigational; vet_approved	Fentanyl	c1ccccc1N(C(=O)CC)C2CCN(CC2)CCc3ccccc3
16922	sp|P9WQK9|PSTB2_MY	P08183	79.71	1049.0	1269.0	DB04877	experimental	Voacamine	CC[C@H]1C[C@@H](C2)CN([C@@H]1[C@@]23C(=O)OC)CCc4c3[nH]c5c4cc(OC)c(c5)[C@@H](C[C@H]67)c8c(c9c([nH]8)cccc9)C[C@H](C6C(=O)OC)N(C)CC\7=C\C
16923	sp|P9WQK9|PSTB2_MY	P08183	79.71	1049.0	1269.0	DB04881	investigational	Elacridar	COc1cccc(c12)c(=O)c3c([nH]2)c(ccc3)C(=O)Nc4ccc(cc4)CCN(C5)CCc(c56)cc(OC)c(c6)OC
16924	sp|P9WQK9|PSTB2_MY	P08183	79.71	1049.0	1269.0	DB04905	investigational	Tesmilifene	CCN(CC)CCOc1ccc(cc1)Cc2ccccc2
16925	sp|P9WQK9|PSTB2_MY	P08183	79.71	1049.0	1269.0	DB05449	investigational	FM-VP4	 
16926	sp|P9WQK9|PSTB2_MY	P08183	79.71	1049.0	1269.0	DB06191	investigational	Zosuquidar	FC1(F)[C@H]2[C@@H]1c(cccc3)c3[C@@H](c(c24)cccc4)N5CCN(CC5)C[C@@H](O)COc6cccc(c67)nccc7
16927	sp|P9WQK9|PSTB2_MY	P08183	79.71	1049.0	1269.0	DB06240	investigational	Tariquidar	COc(c1)c(OC)cc(c12)CCN(C2)CCc3ccc(cc3)NC(=O)c4cc(OC)c(OC)cc4NC(=O)c(c5)cnc(c56)cccc6
16928	sp|P9WQK9|PSTB2_MY	P08183	79.71	1049.0	1269.0	DB09031	approved; investigational	Miltefosine	CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C
16929	sp|P9WQK9|PSTB2_MY	P08183	79.71	1049.0	1269.0	DB11635	approved	Tocofersolan	 
16930	sp|P9WQK9|PSTB2_MY	P08183	79.71	1049.0	1269.0	DB14061	experimental	Hycanthone	CCN(CC)CCNc(ccc1CO)c(c12)c(=O)c3c(s2)cccc3
16931	sp|P9WQK9|PSTB2_MY	P08183	79.71	1049.0	1269.0	DB14062	experimental	Concanamycin A	NC(=O)O[C@@H]1[C@@H](C)O[C@H](C[C@H]1O)O[C@H](C2)[C@H](C)[C@@H](/C=C/C)O[C@@]2(O)[C@@H](C)[C@H](O)[C@H](C)[C@H]3OC(=O)/C(OC)=C/C(C)=C/[C@@H](C)[C@@H](O)[C@@H](CC)[C@@H](O)[C@H](C)C/C(C)=C/C=C/[C@@H]3OC
16932	sp|P9WQK9|PSTB2_MY	P08183	79.71	1049.0	1269.0	DB14063	experimental	Dexverapamil	COc1ccc(cc1OC)CCN(C)CCC[C@@](C#N)(C(C)C)c2cc(OC)c(OC)cc2
16933	sp|P9WQK9|PSTB2_MY	P08183	79.71	1049.0	1269.0	DB14064	experimental	Emopamil	c1ccccc1C(C#N)(C(C)C)CCCN(C)CCc2ccccc2
16934	sp|P9WQK9|PSTB2_MY	P08183	79.71	1049.0	1269.0	DB14065	experimental	Lomerizine	COc1ccc(c(OC)c1OC)CN2CCN(CC2)C(c3ccc(F)cc3)c4ccc(F)cc4
16935	sp|P9WQK9|PSTB2_MY	P08183	79.71	1049.0	1269.0	DB14066	experimental	Tetrandrine	c12ccc(OC)c(c1)Oc3ccc(cc3)C[C@H]4c5c(CCN4C)cc(OC)c(c5)Oc6c7c(CCN(C)[C@H]7C2)cc(OC)c6OC
16936	sp|P9WQK9|PSTB2_MY	P08183	79.71	1049.0	1269.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
16937	sp|P9WQK9|PSTB2_MY	P08183	79.71	1049.0	1269.0	DB14068	experimental	Dexniguldipine	[O-][N+](=O)c1cccc(c1)[C@@H]2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCCN(CC3)CCC3(c4ccccc4)c5ccccc5
16938	sp|P9WQK9|PSTB2_MY	P08183	79.71	1049.0	1269.0	DB14069	investigational	ONT-093	CCOC/C=C/c1ccc(cc1)-c2nc(-c3ccc(cc3)NC(C)C)c([nH]2)-c4ccc(cc4)NC(C)C
16939	sp|P9WQK9|PSTB2_MY	P08183	79.71	1049.0	1269.0	DB14070	experimental	HM-30181	c1cccc(c12)c(=O)cc(o2)C(=O)Nc3cc(OC)c(OC)cc3-c4nn(nn4)-c5ccc(cc5)CCN(C6)CCc(c67)cc(OC)c(c7)OC
16940	sp|P9WQK9|PSTB2_MY	P08183	79.71	1049.0	1269.0	DB14071	experimental	Desmethylsertraline	c1cccc(c12)[C@@H](CC[C@@H]2N)c3cc(Cl)c(Cl)cc3
16941	sp|P9WQK9|PSTB2_MY	P08183	79.71	1049.0	1269.0	DB14072	experimental	Reversin 121	c1ccccc1COC(=O)C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@H](C(=O)OC(C)(C)C)CCCCNC(=O)OCc2ccccc2
16942	sp|P9WQK9|PSTB2_MY	O95342	82.97	423.0	652.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16943	sp|P9WQK9|PSTB2_MY	O95342	82.97	423.0	652.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
16944	sp|P9WQK9|PSTB2_MY	O95342	83.7	1083.0	1314.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16945	sp|P9WQK9|PSTB2_MY	O95342	83.7	1083.0	1314.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
16946	sp|P9WQK9|PSTB2_MY	Q09428	90.22	670.0	919.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16947	sp|P9WQK9|PSTB2_MY	Q09428	90.22	670.0	919.0	DB00222	approved	Glimepiride	CCC1=C(C)CN(C1=O)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3
16948	sp|P9WQK9|PSTB2_MY	Q09428	90.22	670.0	919.0	DB00672	approved; investigational	Chlorpropamide	CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1
16949	sp|P9WQK9|PSTB2_MY	Q09428	90.22	670.0	919.0	DB00731	approved; investigational	Nateglinide	CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](C(=O)O)Cc2ccccc2
16950	sp|P9WQK9|PSTB2_MY	Q09428	90.22	670.0	919.0	DB00912	approved; investigational	Repaglinide	CCOc1c(C(=O)O)ccc(c1)CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3
16951	sp|P9WQK9|PSTB2_MY	Q09428	90.22	670.0	919.0	DB01067	approved; investigational	Glipizide	Cc1ncc(nc1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
16952	sp|P9WQK9|PSTB2_MY	Q09428	90.22	670.0	919.0	DB01120	approved	Gliclazide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN(C2)CC(C23)CCC3
16953	sp|P9WQK9|PSTB2_MY	Q09428	90.22	670.0	919.0	DB01124	approved; investigational	Tolbutamide	CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1
16954	sp|P9WQK9|PSTB2_MY	Q09428	90.22	670.0	919.0	DB01251	approved; investigational	Gliquidone	COc(cc1)cc(c12)C(=O)N(C(=O)C2(C)C)CCc3ccc(cc3)S(=O)(=O)NC(=O)NC4CCCCC4
16955	sp|P9WQK9|PSTB2_MY	Q09428	90.22	670.0	919.0	DB01252	investigational	Mitiglinide	c1ccccc1C[C@H](C(=O)O)CC(=O)N(C2)C[C@H]([C@H]23)CCCC3
16956	sp|P9WQK9|PSTB2_MY	Q09428	90.22	670.0	919.0	DB01382	approved; investigational	Glymidine	COCCOc1cnc(nc1)NS(=O)(=O)c2ccccc2
16957	sp|P9WQK9|PSTB2_MY	Q09428	84.78	1343.0	1577.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16958	sp|P9WQK9|PSTB2_MY	Q09428	84.78	1343.0	1577.0	DB00222	approved	Glimepiride	CCC1=C(C)CN(C1=O)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3
16959	sp|P9WQK9|PSTB2_MY	Q09428	84.78	1343.0	1577.0	DB00672	approved; investigational	Chlorpropamide	CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1
16960	sp|P9WQK9|PSTB2_MY	Q09428	84.78	1343.0	1577.0	DB00731	approved; investigational	Nateglinide	CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](C(=O)O)Cc2ccccc2
16961	sp|P9WQK9|PSTB2_MY	Q09428	84.78	1343.0	1577.0	DB00912	approved; investigational	Repaglinide	CCOc1c(C(=O)O)ccc(c1)CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3
16962	sp|P9WQK9|PSTB2_MY	Q09428	84.78	1343.0	1577.0	DB01067	approved; investigational	Glipizide	Cc1ncc(nc1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
16963	sp|P9WQK9|PSTB2_MY	Q09428	84.78	1343.0	1577.0	DB01120	approved	Gliclazide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN(C2)CC(C23)CCC3
16964	sp|P9WQK9|PSTB2_MY	Q09428	84.78	1343.0	1577.0	DB01124	approved; investigational	Tolbutamide	CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1
16965	sp|P9WQK9|PSTB2_MY	Q09428	84.78	1343.0	1577.0	DB01251	approved; investigational	Gliquidone	COc(cc1)cc(c12)C(=O)N(C(=O)C2(C)C)CCc3ccc(cc3)S(=O)(=O)NC(=O)NC4CCCCC4
16966	sp|P9WQK9|PSTB2_MY	Q09428	84.78	1343.0	1577.0	DB01252	investigational	Mitiglinide	c1ccccc1C[C@H](C(=O)O)CC(=O)N(C2)C[C@H]([C@H]23)CCCC3
16967	sp|P9WQK9|PSTB2_MY	Q09428	84.78	1343.0	1577.0	DB01382	approved; investigational	Glymidine	COCCOc1cnc(nc1)NS(=O)(=O)c2ccccc2
16968	sp|P9WQK9|PSTB2_MY	Q09428	90.22	670.0	919.0	DB00839	approved; investigational	Tolazamide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2
16969	sp|P9WQK9|PSTB2_MY	Q09428	90.22	670.0	919.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
16970	sp|P9WQK9|PSTB2_MY	Q09428	84.78	1343.0	1577.0	DB00839	approved; investigational	Tolazamide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2
16971	sp|P9WQK9|PSTB2_MY	Q09428	84.78	1343.0	1577.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
16972	sp|P9WQK9|PSTB2_MY	O60706	86.96	665.0	905.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16973	sp|P9WQK9|PSTB2_MY	O60706	86.96	665.0	905.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
16974	sp|P9WQK9|PSTB2_MY	O60706	86.96	665.0	905.0	DB09220	approved; investigational	Nicorandil	[O-][N+](=O)OCCNC(=O)c1cccnc1
16975	sp|P9WQK9|PSTB2_MY	O60706	79.35	1319.0	1538.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16976	sp|P9WQK9|PSTB2_MY	O60706	79.35	1319.0	1538.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
16977	sp|P9WQK9|PSTB2_MY	O60706	79.35	1319.0	1538.0	DB09220	approved; investigational	Nicorandil	[O-][N+](=O)OCCNC(=O)c1cccnc1
16978	sp|P9WQK9|PSTB2_MY	P33527	79.71	645.0	865.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16979	sp|P9WQK9|PSTB2_MY	P33527	79.71	645.0	865.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
16980	sp|P9WQK9|PSTB2_MY	P33527	79.71	645.0	865.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
16981	sp|P9WQK9|PSTB2_MY	P33527	79.71	645.0	865.0	DB06176	approved; investigational	Romidepsin	O=C([C@H]12)N/C(=C\C)C(=O)N[C@@H](C(C)C)C(=O)O[C@@H](CC(=O)N[C@H](C(C)C)C(=O)N1)/C=C/CCSSC2
16982	sp|P9WQK9|PSTB2_MY	P33527	79.71	645.0	865.0	DB08855	experimental; investigational	Leukotriene C4	CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@@H](O)CCCC(=O)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@H](N)C(=O)O
16983	sp|P9WQK9|PSTB2_MY	P33527	78.62	1300.0	1517.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16984	sp|P9WQK9|PSTB2_MY	P33527	78.62	1300.0	1517.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
16985	sp|P9WQK9|PSTB2_MY	P33527	78.62	1300.0	1517.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
16986	sp|P9WQK9|PSTB2_MY	P33527	78.62	1300.0	1517.0	DB06176	approved; investigational	Romidepsin	O=C([C@H]12)N/C(=C\C)C(=O)N[C@@H](C(C)C)C(=O)O[C@@H](CC(=O)N[C@H](C(C)C)C(=O)N1)/C=C/CCSSC2
16987	sp|P9WQK9|PSTB2_MY	P33527	78.62	1300.0	1517.0	DB08855	experimental; investigational	Leukotriene C4	CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@@H](O)CCCC(=O)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@H](N)C(=O)O
16988	sp|P9WQK9|PSTB2_MY	Q92887	80.07	636.0	857.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16989	sp|P9WQK9|PSTB2_MY	Q92887	80.07	636.0	857.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
16990	sp|P9WQK9|PSTB2_MY	Q92887	80.43	1302.0	1524.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16991	sp|P9WQK9|PSTB2_MY	Q92887	80.43	1302.0	1524.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
16992	sp|P9WQK9|PSTB2_MY	O15439	77.54	420.0	634.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16993	sp|P9WQK9|PSTB2_MY	O15439	81.52	1045.0	1270.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16994	sp|P9WQK9|PSTB2_MY	O15440	72.46	573.0	773.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
16995	sp|P9WQK9|PSTB2_MY	O15440	72.46	573.0	773.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
16996	sp|P9WQK9|PSTB2_MY	O15440	82.97	1197.0	1426.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
16997	sp|P9WQK9|PSTB2_MY	O15440	82.97	1197.0	1426.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
16998	sp|P9WQK9|PSTB2_MY	O95255	80.07	623.0	844.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
16999	sp|P9WQK9|PSTB2_MY	O95255	78.62	1273.0	1490.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
17000	sp|P9WQK9|PSTB2_MY	P13569	72.46	435.0	635.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
17001	sp|P9WQK9|PSTB2_MY	P13569	72.46	435.0	635.0	DB00887	approved	Bumetanide	CCCCNc1c(c(S(=O)(=O)N)cc(c1)C(=O)O)Oc2ccccc2
17002	sp|P9WQK9|PSTB2_MY	P13569	72.46	435.0	635.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
17003	sp|P9WQK9|PSTB2_MY	P13569	72.46	435.0	635.0	DB01050	approved	Ibuprofen	CC(C)Cc1ccc(cc1)C(C)C(=O)O
17004	sp|P9WQK9|PSTB2_MY	P13569	72.46	435.0	635.0	DB02587	experimental; investigational	Colforsin	O[C@H]1CCC(C)(C)[C@@H]([C@]12C)[C@H](O)[C@H](OC(=O)C)[C@]3(C)[C@]2(O)C(=O)C[C@](O3)(C)C=C
17005	sp|P9WQK9|PSTB2_MY	P13569	72.46	435.0	635.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
17006	sp|P9WQK9|PSTB2_MY	P13569	72.46	435.0	635.0	DB04522	experimental	Dexfosfoserine	OC(=O)[C@@H](N)COP(=O)(O)O
17007	sp|P9WQK9|PSTB2_MY	P13569	72.46	435.0	635.0	DB04941	approved	Crofelemer	 
17008	sp|P9WQK9|PSTB2_MY	P13569	72.46	435.0	635.0	DB06266	investigational	Lonidamine	c1cccc(c12)n(nc2C(=O)O)Cc3c(Cl)cc(Cl)cc3
17009	sp|P9WQK9|PSTB2_MY	P13569	72.46	435.0	635.0	DB08820	approved	Ivacaftor	CC(C)(C)c1cc(C(C)(C)C)c(O)cc1NC(=O)c(c2=O)c[nH]c(c23)cccc3
17010	sp|P9WQK9|PSTB2_MY	P13569	72.46	435.0	635.0	DB09213	approved; investigational	Dexibuprofen	CC(C)Cc1ccc(cc1)[C@H](C)C(=O)O
17011	sp|P9WQK9|PSTB2_MY	P13569	72.46	435.0	635.0	DB09280	approved	Lumacaftor	O=C(O)c1cccc(c1)-c2nc(ccc2C)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
17012	sp|P9WQK9|PSTB2_MY	P13569	72.46	435.0	635.0	DB11712	approved; investigational	Tezacaftor	OC[C@H](O)Cn1c(C(C)(C)CO)cc(c12)cc(c(F)c2)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
17013	sp|P9WQK9|PSTB2_MY	P13569	72.46	435.0	635.0	DB15444	approved; investigational	Elexacaftor	FC(F)(F)C(C)(C)COc1nn(cc1)-c2nc(N(C3(C)C)C[C@@H](C)C3)c(cc2)C(=O)NS(=O)(=O)c4cn(C)nc4C
17014	sp|P9WQK9|PSTB2_MY	P13569	84.06	1202.0	1434.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
17015	sp|P9WQK9|PSTB2_MY	P13569	84.06	1202.0	1434.0	DB00887	approved	Bumetanide	CCCCNc1c(c(S(=O)(=O)N)cc(c1)C(=O)O)Oc2ccccc2
17016	sp|P9WQK9|PSTB2_MY	P13569	84.06	1202.0	1434.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
17017	sp|P9WQK9|PSTB2_MY	P13569	84.06	1202.0	1434.0	DB01050	approved	Ibuprofen	CC(C)Cc1ccc(cc1)C(C)C(=O)O
17018	sp|P9WQK9|PSTB2_MY	P13569	84.06	1202.0	1434.0	DB02587	experimental; investigational	Colforsin	O[C@H]1CCC(C)(C)[C@@H]([C@]12C)[C@H](O)[C@H](OC(=O)C)[C@]3(C)[C@]2(O)C(=O)C[C@](O3)(C)C=C
17019	sp|P9WQK9|PSTB2_MY	P13569	84.06	1202.0	1434.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
17020	sp|P9WQK9|PSTB2_MY	P13569	84.06	1202.0	1434.0	DB04522	experimental	Dexfosfoserine	OC(=O)[C@@H](N)COP(=O)(O)O
17021	sp|P9WQK9|PSTB2_MY	P13569	84.06	1202.0	1434.0	DB04941	approved	Crofelemer	 
17022	sp|P9WQK9|PSTB2_MY	P13569	84.06	1202.0	1434.0	DB06266	investigational	Lonidamine	c1cccc(c12)n(nc2C(=O)O)Cc3c(Cl)cc(Cl)cc3
17023	sp|P9WQK9|PSTB2_MY	P13569	84.06	1202.0	1434.0	DB08820	approved	Ivacaftor	CC(C)(C)c1cc(C(C)(C)C)c(O)cc1NC(=O)c(c2=O)c[nH]c(c23)cccc3
17024	sp|P9WQK9|PSTB2_MY	P13569	84.06	1202.0	1434.0	DB09213	approved; investigational	Dexibuprofen	CC(C)Cc1ccc(cc1)[C@H](C)C(=O)O
17025	sp|P9WQK9|PSTB2_MY	P13569	84.06	1202.0	1434.0	DB09280	approved	Lumacaftor	O=C(O)c1cccc(c1)-c2nc(ccc2C)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
17026	sp|P9WQK9|PSTB2_MY	P13569	84.06	1202.0	1434.0	DB11712	approved; investigational	Tezacaftor	OC[C@H](O)Cn1c(C(C)(C)CO)cc(c12)cc(c(F)c2)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
17027	sp|P9WQK9|PSTB2_MY	P13569	84.06	1202.0	1434.0	DB15444	approved; investigational	Elexacaftor	FC(F)(F)C(C)(C)COc1nn(cc1)-c2nc(N(C3(C)C)C[C@@H](C)C3)c(cc2)C(=O)NS(=O)(=O)c4cn(C)nc4C
17028	sp|P9WQK9|PSTB2_MY	O95477	82.97	908.0	1137.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
17029	sp|P9WQK9|PSTB2_MY	O95477	82.97	908.0	1137.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
17030	sp|P9WQK9|PSTB2_MY	O95477	82.97	908.0	1137.0	DB01599	approved; investigational	Probucol	CC(C)(C)c1cc(cc(c1O)C(C)(C)C)SC(C)(C)Sc2cc(C(C)(C)C)c(O)c(c2)C(C)(C)C
17031	sp|P9WQK9|PSTB2_MY	O95477	78.26	1918.0	2134.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
17032	sp|P9WQK9|PSTB2_MY	O95477	78.26	1918.0	2134.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
17033	sp|P9WQK9|PSTB2_MY	O95477	78.26	1918.0	2134.0	DB01599	approved; investigational	Probucol	CC(C)(C)c1cc(cc(c1O)C(C)(C)C)SC(C)(C)Sc2cc(C(C)(C)C)c(O)c(c2)C(C)(C)C
17034	sp|P9WQK9|PSTB2_MY	P45844	76.09	95.0	305.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
17035	sp|P9WQK9|PSTB2_MY	Q9UNQ0	80.8	59.0	282.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
17036	sp|P9WQK9|PSTB2_MY	Q9UNQ0	80.8	59.0	282.0	DB11995	approved; investigational	Avatrombopag	OC(=O)C1CCN(CC1)c2c(Cl)cc(cn2)C(=O)Nc3nc(-c4cc(Cl)cs4)c(s3)N5CCN(CC5)C6CCCCC6
17037	sp|P9WQK9|PSTB2_MY	A0A0T9AZ62	74.28	222.0	427.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
17038	sp|P9WHI3|RECR_MYC	Q9ZNA2	94.09	5.0	196.0	DB03366	experimental; investigational	Imidazole	[nH]1ccnc1
17039	sp|P9WHM5|PUR3_MYC	P22102	90.7	806.0	1001.0	DB00642	approved; investigational	Pemetrexed	Nc([nH]1)nc(=O)c(c12)c(c[nH]2)CCc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
17040	sp|P9WHM5|PUR3_MYC	P22102	90.7	806.0	1001.0	DB02236	experimental	Glycinamide Ribonucleotide	NCC(=O)NC1O[C@@H]([C@@H](O)[C@H]1O)COP(=O)(O)O
17041	sp|P9WHM5|PUR3_MYC	P22102	90.7	806.0	1001.0	DB03546	experimental	N-({4-[(1R)-4-[(2R,4S,5S)-2,4-diamino-6-oxohexahydropyrimidin-5-yl]-1-(2,2,2-trifluoro-1,1-dihydroxyethyl)butyl]phenyl}carbonyl)-L-glutamic acid	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)[C@H](C(O)(O)C(F)(F)F)CCCC2C(O)=N[C@H](N)N[C@@H]2N
17042	sp|P9WHM5|PUR3_MYC	P08179	86.05	3.0	188.0	DB02236	experimental	Glycinamide Ribonucleotide	NCC(=O)NC1O[C@@H]([C@@H](O)[C@H]1O)COP(=O)(O)O
17043	sp|P9WHM5|PUR3_MYC	P08179	86.05	3.0	188.0	DB02540	experimental	10-formyl-5,8,10-trideazafolic acid	Nc([nH]1)nc(=O)c(c12)cc(cc2)C[C@H](C(=O)O)c3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
17044	sp|P9WHM5|PUR3_MYC	P08179	86.05	3.0	188.0	DB02794	experimental	(2S)-2-({4-[(2S)-1-(2-Amino-4-oxo-1,4-dihydro-6-quinazolinyl)-3-{[2-({(2R,3R,4S,5R)-3,4-dihydroxy-5-[(phosphonooxy)methyl]tetrahydro-2-furanyl}amino)-2-oxoethyl]amino}-2-hydroxy-2-propanyl]benzoyl}ami no)pentanedioic acid	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)C(O)(Cc(cc2)cc(c23)c(=O)nc([nH]3)N)CNCC(=O)N[C@@H]4O[C@@H]([C@@H](O)[C@H]4O)COP(=O)(O)O
17045	sp|P9WHM5|PUR3_MYC	P08179	86.05	3.0	188.0	DB04264	experimental	(10R)-10-formyl-5,8,10-trideazafolic acid	Nc([nH]1)nc(=O)c(c12)cc(cc2)C[C@@H](C(=O)O)c3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
17046	sp|P9WIA1|PTPA_MYC	P24666	84.05	8.0	145.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
17047	sp|P9WIA1|PTPA_MYC	P24666	84.05	8.0	145.0	DB04214	experimental	4-Nitrophenyl Phosphate	OP(=O)(O)Oc1ccc([N+]([O-])=O)cc1
17048	sp|P9WHW3|PPIA_MYC	P23284	79.67	55.0	200.0	DB00172	nutraceutical	Proline	OC(=O)[C@@H]1CCCN1
17049	sp|P9WHW3|PPIA_MYC	P23284	79.67	55.0	200.0	DB04447	experimental	1,4-Dithiothreitol	SC[C@H](O)[C@@H](O)CS
17050	sp|P9WHW3|PPIA_MYC	Q13427	86.81	15.0	173.0	DB00172	nutraceutical	Proline	OC(=O)[C@@H]1CCCN1
17051	sp|P9WHW3|PPIA_MYC	Q76NN7	84.07	12.0	165.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
17052	sp|P9WHW3|PPIA_MYC	O43447	82.97	21.0	172.0	DB00172	nutraceutical	Proline	OC(=O)[C@@H]1CCCN1
17053	sp|P9WHW3|PPIA_MYC	P45877	79.67	48.0	193.0	DB00172	nutraceutical	Proline	OC(=O)[C@@H]1CCCN1
17054	sp|P9WHW3|PPIA_MYC	P62937	77.47	16.0	157.0	DB00091	approved; investigational; vet_approved	Cyclosporine	C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C
17055	sp|P9WHW3|PPIA_MYC	P62937	77.47	16.0	157.0	DB00172	nutraceutical	Proline	OC(=O)[C@@H]1CCCN1
17056	sp|P9WHW3|PPIA_MYC	P62937	77.47	16.0	157.0	DB01742	experimental	(3r)-1-Acetyl-3-Methylpiperidine	C[C@@H]1CCCN(C1)C(=O)C
17057	sp|P9WHW3|PPIA_MYC	P62937	77.47	16.0	157.0	DB02419	experimental	Ethyl Oxo(Piperidin-1-Yl)Acetate	CCOC(=O)C(=O)N1CCCCC1
17058	sp|P9WHW3|PPIA_MYC	P62937	77.47	16.0	157.0	DB03393	experimental	Sanglifehrin A	Oc1cccc(c1)C[C@@H](C(=O)N23)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(=O)C)[C@H](O)[C@@H](C)[C@@H](O)/C=C/C=C/C[C@H](OC(=O)[C@@H](N2)CCC3)/C(C)=C/C=C/CC[C@H](C)[C@@H](O)C[C@H](O4)[C@H](C)[C@H](O)[C@H](C)[C@]45NC(=O)[C@@H](CC)C[C@@H]5C
17059	sp|P9WHW3|PPIA_MYC	P62937	77.47	16.0	157.0	DB09130	approved; investigational	Copper	[Cu]
17060	sp|P9WHW3|PPIA_MYC	P62937	77.47	16.0	157.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
17061	sp|P9WHW3|PPIA_MYC	P30405	79.12	57.0	201.0	DB00091	approved; investigational; vet_approved	Cyclosporine	C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C
17062	sp|P9WHW3|PPIA_MYC	P30405	79.12	57.0	201.0	DB00172	nutraceutical	Proline	OC(=O)[C@@H]1CCCN1
17063	sp|P9WHW3|PPIA_MYC	P30405	79.12	57.0	201.0	DB02078	experimental	Triglyme	COCCOCCOCCOC
17064	sp|P9WHW3|PPIA_MYC	P30405	79.12	57.0	201.0	DB08168	experimental	Coumarin 120	Cc1cc(=O)oc(c12)cc(N)cc2
17065	sp|P9WHW3|PPIA_MYC	P0AFL3	74.73	50.0	186.0	DB08168	experimental	Coumarin 120	Cc1cc(=O)oc(c12)cc(N)cc2
17066	sp|P9WHQ7|PUR1_MYC	P00497	89.37	4.0	475.0	DB01972	experimental	Guanosine-5'-Monophosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
17067	sp|P9WHQ7|PUR1_MYC	Q06203	96.96	4.0	515.0	DB00130	approved; investigational; nutraceutical	L-Glutamine	OC(=O)[C@@H](N)CCC(=O)N
17068	sp|P9WHQ7|PUR1_MYC	Q06203	96.96	4.0	515.0	DB01033	approved	Mercaptopurine	[nH]1cnc(c12)[nH]cnc2=S
17069	sp|P9WHQ7|PUR1_MYC	Q06203	96.96	4.0	515.0	DB01254	approved; investigational	Dasatinib	OCCN1CCN(CC1)c2nc(C)nc(c2)Nc3ncc(s3)C(=O)Nc4c(C)cccc4Cl
17070	sp|P9WHQ7|PUR1_MYC	P0AG16	88.61	2.0	469.0	DB01972	experimental	Guanosine-5'-Monophosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
17071	sp|P9WHQ7|PUR1_MYC	P0AG16	88.61	2.0	469.0	DB03942	experimental	Carboxylic PRPP	OP(=O)(O)OP(=O)(O)O[C@@H]1[C@H](O)[C@H](O)[C@H](C1)COP(=O)(O)O
17072	sp|P9WHQ7|PUR1_MYC	P0AG16	88.61	2.0	469.0	DB04296	experimental	5-Oxo-L-Norleucine	OC(=O)[C@@H](N)CCC(=O)C
17073	sp|P9WHV5|PPX1_MYC	O67040	87.21	9.0	309.0	DB03382	experimental	S-oxy-L-cysteine	OC(=O)[C@@H](N)CS=O
17079	sp|P9WFU3|SYFA_MYC	Q4L5E3	99.12	6.0	344.0	DB07817	experimental	1-{3-[(4-pyridin-2-ylpiperazin-1-yl)sulfonyl]phenyl}-3-(1,3-thiazol-2-yl)urea	n1ccsc1NC(=O)Nc2cc(ccc2)S(=O)(=O)N3CCN(CC3)c4ccccn4
17080	sp|P9WHF5|THT3_MYC	Q16762	94.37	16.0	284.0	DB02761	experimental	S-Mercaptocysteine	OC(=O)[C@@H](N)CSS
17081	sp|P9WHF5|THT3_MYC	P31142	91.55	17.0	277.0	DB02761	experimental	S-Mercaptocysteine	OC(=O)[C@@H](N)CSS
17082	sp|P9WHF5|THT3_MYC	Q5SJI0	90.49	26.0	283.0	DB02761	experimental	S-Mercaptocysteine	OC(=O)[C@@H](N)CSS
17083	sp|P9WHF5|THT3_MYC	Q7K9G0	94.72	26.0	295.0	DB02761	experimental	S-Mercaptocysteine	OC(=O)[C@@H](N)CSS
17084	sp|P9WHF5|THT3_MYC	Q7K9G0	94.72	26.0	295.0	DB03352	experimental	S-Arsonocysteine	OC(=O)[C@@H](N)CS[As](=O)(O)O
17085	sp|P9WHF5|THT3_MYC	P52197	83.45	32.0	269.0	DB04053	experimental	Hypophosphite	[O-]P=O
17086	sp|P9WHM3|PURU_MYC	P22102	70.32	787.0	1005.0	DB00642	approved; investigational	Pemetrexed	Nc([nH]1)nc(=O)c(c12)c(c[nH]2)CCc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
17087	sp|P9WHM3|PURU_MYC	P22102	70.32	787.0	1005.0	DB02236	experimental	Glycinamide Ribonucleotide	NCC(=O)NC1O[C@@H]([C@@H](O)[C@H]1O)COP(=O)(O)O
17088	sp|P9WHM3|PURU_MYC	P22102	70.32	787.0	1005.0	DB03546	experimental	N-({4-[(1R)-4-[(2R,4S,5S)-2,4-diamino-6-oxohexahydropyrimidin-5-yl]-1-(2,2,2-trifluoro-1,1-dihydroxyethyl)butyl]phenyl}carbonyl)-L-glutamic acid	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)[C@H](C(O)(O)C(F)(F)F)CCCC2C(O)=N[C@H](N)N[C@@H]2N
17089	sp|P9WHB7|RL24_MYC	Q9UNX3	82.86	47.0	134.0	DB02494	experimental	(S)-3-phenyllactic acid	OC(=O)[C@@H](O)Cc1ccccc1
17090	sp|P9WHB7|RL24_MYC	Q9UNX3	82.86	47.0	134.0	DB07374	experimental	Anisomycin	O[C@H]1CN[C@@H]([C@@H]1OC(=O)C)Cc2ccc(OC)cc2
17091	sp|P9WHB7|RL24_MYC	Q9UNX3	82.86	47.0	134.0	DB08437	experimental	Puromycin	COc1ccc(cc1)C[C@H](N)C(=O)N[C@@H]2[C@@H](CO)O[C@H]([C@@H]2O)n3cnc(c34)c(ncn4)N(C)C
17092	sp|P9WH39|RS2_MYCT	P62662	83.62	5.0	245.0	DB08185	experimental	2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(nc(n3)SC)NCCC(C)C
17093	sp|P9WH39|RS2_MYCT	P80371	83.62	5.0	245.0	DB08185	experimental	2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(nc(n3)SC)NCCC(C)C
17094	sp|P9WHN3|PURA_MYC	P0A7D4	98.61	4.0	430.0	DB02109	experimental	Hadacidin	O=CN(O)CC(=O)O
17095	sp|P9WHN3|PURA_MYC	P0A7D4	98.61	4.0	430.0	DB02493	experimental	Hydantocidin-5'-phosphate	O=C(N1)NC(=O)[C@]12O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)O
17096	sp|P9WHN3|PURA_MYC	P0A7D4	98.61	4.0	430.0	DB02666	experimental	(C8-R)-hydantocidin 5'-phosphate	OP(=O)(O)OC[C@@H](O1)[C@@H](O)[C@@H](O)[C@]12NC(=O)N(C2=O)CCC[C@H](C(=O)O)N(O)CO
17097	sp|P9WHN3|PURA_MYC	P0A7D4	98.61	4.0	430.0	DB02836	experimental	Guanosine 5'-diphosphate 2':3'-cyclic monophosphate	Nc([nH]1)nc(=O)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]34)O[P@@](O4)(=O)O)COP(=O)(O)OP(=O)(O)O
17098	sp|P9WHN3|PURA_MYC	P0A7D4	98.61	4.0	430.0	DB02954	experimental	(Carboxyhydroxyamino)Ethanoic Acid	OC(=O)N(O)CC(=O)O
17099	sp|P9WHN3|PURA_MYC	P0A7D4	98.61	4.0	430.0	DB03146	experimental	2-deazo-6-thiophosphate guanosine-5'-monophosphate	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(nc[nH+]3)SP(=O)(O)O
17100	sp|P9WHN3|PURA_MYC	P0A7D4	98.61	4.0	430.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
17101	sp|P9WHN3|PURA_MYC	P0A7D4	98.61	4.0	430.0	DB04460	experimental	(C8-S)-Hydantocidin 5'-phosphate	OP(=O)(O)OC[C@@H](O1)[C@@H](O)[C@@H](O)[C@]12NC(=O)N(C2=O)CCC[C@@H](C(=O)O)N(O)CO
17102	sp|P9WHN3|PURA_MYC	P0A7D4	98.61	4.0	430.0	DB04566	experimental	Inosinic Acid	OP(=O)(O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O1)n2cnc(c23)c(=O)[nH]cn3
17103	sp|P9WHN3|PURA_MYC	Q83P33	98.61	4.0	430.0	DB02954	experimental	(Carboxyhydroxyamino)Ethanoic Acid	OC(=O)N(O)CC(=O)O
17104	sp|P9WHN3|PURA_MYC	Q83P33	98.61	4.0	430.0	DB04566	experimental	Inosinic Acid	OP(=O)(O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O1)n2cnc(c23)c(=O)[nH]cn3
17105	sp|P9WHN3|PURA_MYC	Q8ZIV7	98.61	4.0	430.0	DB02580	experimental	Pentaglyme	COCCOCCOCCOCCOCCOC
17106	sp|P9WHN3|PURA_MYC	P30520	97.69	31.0	453.0	DB00128	approved; nutraceutical	Aspartic acid	OC(=O)[C@@H](N)CC(=O)O
17108	sp|P9WHN3|PURA_MYC	P30520	97.69	31.0	453.0	DB05540	investigational	Alanosine	OC(=O)[C@@H](N)CN(O)N=O
17109	sp|P9WHN3|PURA_MYC	Q8N142	97.22	34.0	454.0	DB00128	approved; nutraceutical	Aspartic acid	OC(=O)[C@@H](N)CC(=O)O
17110	sp|P9WHN3|PURA_MYC	Q8N142	97.22	34.0	454.0	DB02109	experimental	Hadacidin	O=CN(O)CC(=O)O
17111	sp|P9WHN3|PURA_MYC	Q8N142	97.22	34.0	454.0	DB03510	experimental	6-O-Phosphoryl Inosine Monophosphate	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(ncn3)OP(=O)(O)O
17112	sp|P9WHN3|PURA_MYC	Q8N142	97.22	34.0	454.0	DB04137	experimental	Guanosine-5'-Triphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
17113	sp|P9WHN3|PURA_MYC	Q8N142	97.22	34.0	454.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
17114	sp|P9WHN3|PURA_MYC	Q8N142	97.22	34.0	454.0	DB04418	experimental	Adenylosuccinic acid	OP(=O)(O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O1)n2cnc(c23)c(ncn3)N[C@H](C(=O)O)CC(=O)O
17115	sp|P9WHN3|PURA_MYC	Q8N142	97.22	34.0	454.0	DB04566	experimental	Inosinic Acid	OP(=O)(O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O1)n2cnc(c23)c(=O)[nH]cn3
17116	sp|P9WHN3|PURA_MYC	Q8N142	97.22	34.0	454.0	DB05540	investigational	Alanosine	OC(=O)[C@@H](N)CN(O)N=O
17117	sp|P9WHN3|PURA_MYC	Q9U8D3	97.69	16.0	438.0	DB02109	experimental	Hadacidin	O=CN(O)CC(=O)O
17118	sp|P9WHN3|PURA_MYC	Q9U8D3	97.69	16.0	438.0	DB03510	experimental	6-O-Phosphoryl Inosine Monophosphate	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(ncn3)OP(=O)(O)O
17119	sp|P9WHN3|PURA_MYC	Q9U8D3	97.69	16.0	438.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
17120	sp|P9WGU1|PSTS1_MY	P0AG82	83.16	19.0	330.0	DB02799	experimental	N-[2-(1-Maleimidyl)Ethyl]-7-Diethylaminocoumarin-3-Carboxamide	CCN(CC)c(cc1)cc(c12)oc(=O)c(c2)C(=O)N/C=C\N3C(=O)CCC3=O
17121	sp|P9WGU1|PSTS1_MY	P0AG82	83.16	19.0	330.0	DB02831	experimental	Dihydrogenphosphate	OP([O-])(=O)O
17122	sp|P9WHE5|RL11_MYC	P29395	96.48	2.0	139.0	DB02566	experimental	8-Hydroxy-4-(1-Hydroxyethyl)Quinoline-2-Carboxylic Acid	C[C@H](O)c1cc(C(=O)O)nc(c12)[C@@H](O)CC=C2
17123	sp|P9WHE5|RL11_MYC	P29395	96.48	2.0	139.0	DB02940	experimental	(4s)-2-[(1e)-1-Aminoprop-1-Enyl]-4,5-Dihydro-1,3-Thiazole-4-Carboxylic Acid	OC(=O)[C@H]1CSC(=N1)/C(N)=C/C
17124	sp|P9WH87|RL3_MYCT	Q9A1X4	94.01	2.0	206.0	DB01256	approved	Retapamulin	C1CC(=O)[C@H]([C@]123)[C@@](C)([C@H](C)CC2)[C@@H](C[C@@](C)(C=C)[C@@H](O)[C@@H]3C)OC(=O)CS[C@@H](C[C@H]45)C[C@@H](CC4)N5C
17125	sp|P9WH87|RL3_MYCT	Q9A1X4	94.01	2.0	206.0	DB06145	approved	Spiramycin	CO[C@H]1[C@H](O)CC(=O)O[C@H](C)C/C=C/C=C/[C@H](O[C@H]2CC[C@@H]([C@@H](O2)C)N(C)C)[C@H](C)C[C@H](CC=O)[C@@H]1O[C@@H]3O[C@H](C)[C@H]([C@@H]([C@H]3O)N(C)C)O[C@@H](C[C@@]4(C)O)O[C@@H](C)[C@@H]4O
17126	sp|P9WH35|RS4_MYCT	P80373	103.48	1.0	209.0	DB08185	experimental	2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(nc(n3)SC)NCCC(C)C
17127	sp|P9WH35|RS4_MYCT	P0A7V8	101.99	1.0	206.0	DB00256	approved; investigational	Lymecycline	Oc1cccc([C@@]2(C)O)c1C(=O)C(=C3O)[C@@H]2C[C@H]([C@]34O)[C@H](N(C)C)C(O)=C(C4=O)C(=O)NCNCCCC[C@H](N)C(=O)O
17128	sp|P9WH35|RS4_MYCT	P0A7V8	101.99	1.0	206.0	DB00453	experimental	Clomocycline	OCNC(=O)C(C1=O)=C(O)[C@@H](N(C)C)[C@@H]([C@@]12O)C[C@H]3C(=C2O)C(=O)c4c([C@@]3(C)O)c(Cl)ccc4O
17129	sp|P9WH35|RS4_MYCT	P0A7V8	101.99	1.0	206.0	DB00595	approved; investigational; vet_approved	Oxytetracycline	O=C1C(C(=O)N)=C(O)[C@@H](N(C)C)[C@@H]([C@@]12O)[C@@H](O)[C@H]3C(=C2O)C(=O)c4c([C@@]3(C)O)cccc4O
17130	sp|P9WH35|RS4_MYCT	P0A7V8	101.99	1.0	206.0	DB01017	approved; investigational	Minocycline	O=C1C(C(=O)N)=C(O)[C@@H](N(C)C)[C@@H]([C@@]12O)C[C@H]3C(=C2O)C(=O)c4c(C3)c(N(C)C)ccc4O
17131	sp|P9WH35|RS4_MYCT	P0A7V8	101.99	1.0	206.0	DB12329	approved; investigational	Eravacycline	O=C1C(C(=O)N)=C(O)[C@@H](N(C)C)[C@@H]([C@@]12O)C[C@H]3C(=C2O)C(=O)c4c(C3)c(F)cc(c4O)NC(=O)CN5CCCC5
17132	sp|P9WQ07|APT_MYCT	P07741	82.08	2.0	176.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
17133	sp|P9WQ07|APT_MYCT	P07741	82.08	2.0	176.0	DB01632	approved; experimental; investigational	5-O-phosphono-alpha-D-ribofuranosyl diphosphate	OP(=O)(O)OP(=O)(O)O[C@@H]1[C@H](O)[C@H](O)[C@H](O1)COP(=O)(O)O
17134	sp|P9WQ07|APT_MYCT	P07741	82.08	2.0	176.0	DB03506	experimental	9-Deazaadenine	[nH]1ccc(c12)ncnc2N
17135	sp|P9WQ07|APT_MYCT	P07741	82.08	2.0	176.0	DB04272	approved; nutraceutical; vet_approved	Citric acid	OC(=O)CC(O)(C(=O)O)CC(=O)O
17136	sp|P9WG39|ILVG_MYC	P27696	97.44	9.0	542.0	DB01987	approved; experimental	Cocarboxylase	OP([O-])(=O)O[P@](=O)(O)OCCc1c(C)[n+](cs1)Cc2cnc(C)nc2N
17137	sp|P9WG39|ILVG_MYC	P27696	97.44	9.0	542.0	DB02327	experimental	Triethylene glycol	OCCOCCOCCO
17138	sp|P9WG39|ILVG_MYC	P27696	97.44	9.0	542.0	DB03361	experimental	2-{(9as)-9a-[(1s)-1-Hydroxyethyl]-2,7-Dimethyl-9a,10-Dihydro-5h-Pyrimido[4,5-D][1,3]Thiazolo[3,2-a]Pyrimidin-8-Yl}Ethyl Trihydrogen Diphosphate	c1nc(C)nc(N2)c1CN([C@]23[C@H](C)O)C(C)=C(S3)CCOP(=O)(O)OP(=O)(O)O
17139	sp|P9WG39|ILVG_MYC	P37063	97.99	8.0	544.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
17141	sp|P9WG39|ILVG_MYC	P23234	95.8	7.0	531.0	DB01987	approved; experimental	Cocarboxylase	OP([O-])(=O)O[P@](=O)(O)OCCc1c(C)[n+](cs1)Cc2cnc(C)nc2N
17142	sp|P9WG39|ILVG_MYC	P20906	93.78	10.0	523.0	DB02280	experimental	(R)-Mandelic acid	OC(=O)[C@H](O)c1ccccc1
17143	sp|P9WG39|ILVG_MYC	P06672	97.99	3.0	539.0	DB04272	approved; nutraceutical; vet_approved	Citric acid	OC(=O)CC(O)(C(=O)O)CC(=O)O
17144	sp|P9WG39|ILVG_MYC	P51852	94.88	1.0	520.0	DB03884	experimental	Phenylpyruvic acid	OC(=O)C(=O)Cc1ccccc1
17145	sp|P9WG39|ILVG_MYC	P51852	94.88	1.0	520.0	DB08050	experimental	5-phenyl-2-keto-valeric acid	OC(=O)C(=O)CCCc1ccccc1
17146	sp|P9WK19|MAP12_MY	P9WK19	99.65	1.0	285.0	DB02909	experimental	5-(2-Chlorophenyl)Furan-2-Carboxylic Acid	OC(=O)c1ccc(o1)-c2ccccc2Cl
17147	sp|P9WK19|MAP12_MY	P53582	97.89	93.0	372.0	DB04324	experimental	Ovalicin	CC(C)=CC[C@@H](O1)[C@@]1(C)[C@@]2(O)[C@H](OC)C(=O)CC[C@@]2(C)O
17148	sp|P9WK19|MAP12_MY	P53582	97.89	93.0	372.0	DB07901	experimental	5-CHLORO-6-METHYL-N-(2-PHENYLETHYL)-2-PYRIDIN-2-YLPYRIMIDIN-4-AMINE	n1ccccc1-c2nc(C)c(Cl)c(n2)NCCc3ccccc3
17149	sp|P9WK19|MAP12_MY	P53582	97.89	93.0	372.0	DB07902	experimental	TERT-BUTYL {2-[(1,3-THIAZOL-2-YLAMINO)CARBONYL]PYRIDIN-3-YL}CARBAMATE	CC(C)(C)OC(=O)Nc1c(nccc1)C(=O)Nc2nccs2
17150	sp|P9WK19|MAP12_MY	P53582	97.89	93.0	372.0	DB07903	experimental	3-[(2,2-DIMETHYLPROPANOYL)AMINO]-N-1,3-THIAZOL-2-YLPYRIDINE-2-CARBOXAMIDE	CC(C)(C)C(=O)Nc1c(nccc1)C(=O)Nc2nccs2
17151	sp|P9WK19|MAP12_MY	P0AE18	85.96	4.0	249.0	DB02088	experimental	Norleucine Phosphonate	CCCC[C@H](N)P(=O)(O)O
17152	sp|P9WK19|MAP12_MY	P0AE18	85.96	4.0	249.0	DB02151	experimental	Methionine Phosphonate	CSCC[C@H](N)P(=O)(O)O
17153	sp|P9WK19|MAP12_MY	P0AE18	85.96	4.0	249.0	DB02909	experimental	5-(2-Chlorophenyl)Furan-2-Carboxylic Acid	OC(=O)c1ccc(o1)-c2ccccc2Cl
17154	sp|P9WK19|MAP12_MY	P0AE18	85.96	4.0	249.0	DB03799	experimental	Trifluoromethionine	OC(=O)[C@@H](N)CCSC(F)(F)F
17155	sp|P9WK19|MAP12_MY	P0AE18	85.96	4.0	249.0	DB04015	experimental	Methionine Phosphinate	CSCC[C@H](N)P(=O)O
17156	sp|P9WK19|MAP12_MY	P0AE18	85.96	4.0	249.0	DB07304	experimental	5-[2-(TRIFLUOROMETHOXY)PHENYL]-2-FUROIC ACID	OC(=O)c1ccc(o1)-c2c(OC(F)(F)F)cccc2
17157	sp|P9WK19|MAP12_MY	P0AE18	85.96	4.0	249.0	DB07305	experimental	5-(2-CHLORO-4-NITROPHENYL)-2-FUROIC ACID	OC(=O)c1ccc(o1)-c2ccc([N+]([O-])=O)cc2Cl
17158	sp|P9WK19|MAP12_MY	P0AE18	85.96	4.0	249.0	DB07308	experimental	5-(2-CHLOROBENZYL)-2-FUROIC ACID	OC(=O)c1ccc(o1)Cc2ccccc2Cl
17159	sp|P9WK19|MAP12_MY	P0AE18	85.96	4.0	249.0	DB07407	experimental	5-(2-METHOXYPHENYL)-2-FUROIC ACID	COc1ccccc1-c2ccc(o2)C(=O)O
17160	sp|P9WK19|MAP12_MY	P0AE18	85.96	4.0	249.0	DB07408	experimental	5-(2-NITROPHENYL)-2-FUROIC ACID	OC(=O)c1ccc(o1)-c2c([N+]([O-])=O)cccc2
17161	sp|P9WK19|MAP12_MY	P0AE18	85.96	4.0	249.0	DB07591	experimental	N1-CYCLOPENTYL-N2-(THIAZOL-2-YL)OXALAMIDE	C1CCCC1NC(=O)C(=O)Nc2nccs2
17162	sp|P9WK19|MAP12_MY	P0AE18	85.96	4.0	249.0	DB07758	experimental	5-(2,5-DICHLOROPHENYL)-2-FUROIC ACID	OC(=O)c1ccc(o1)-c2cc(Cl)ccc2Cl
17163	sp|P9WK19|MAP12_MY	P0AE18	85.96	4.0	249.0	DB07759	experimental	5-[2-(TRIFLUOROMETHYL)PHENYL]-2-FUROIC ACID	OC(=O)c1ccc(o1)-c2ccccc2C(F)(F)F
17164	sp|P9WK19|MAP12_MY	P0AE18	85.96	4.0	249.0	DB08451	experimental	N-(QUINOLIN-8-YL)METHANESULFONAMIDE	CS(=O)(=O)Nc1cccc(c12)cccn2
17165	sp|P9WK19|MAP12_MY	P0AE18	85.96	4.0	249.0	DB08666	experimental	5-imino-4-(3-trifluoromethyl-phenylazo)-5H-pyrazol-3-ylamine	FC(F)(F)c1cc(ccc1)NN=c2c(=N)nnc2=N
17166	sp|P9WK19|MAP12_MY	P0AE18	85.96	4.0	249.0	DB08667	experimental	4-(4-fluoro-phenylazo)-5-imino-5H-pyrazol-3-ylamine	Fc1ccc(cc1)NN=c2c(=N)nnc2=N
17167	sp|P9WK19|MAP12_MY	P0AE18	85.96	4.0	249.0	DB08668	experimental	3-(5-Amino-3-imino-3H-pyrazol-4-ylazo)-benzoic acid	OC(=O)c1cc(ccc1)NN=c2c(=N)nnc2=N
17168	sp|P9WK19|MAP12_MY	P0AE18	85.96	4.0	249.0	DB08669	experimental	METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY-3-(4-METHYLPHENYL)PROPANOYL]-D-ALANYL-D-LEUCINATE	CC(C)C[C@H](C(=O)OC)NC(=O)[C@H](C)NC(=O)[C@@H](O)[C@H](N)c1ccc(C)cc1
17169	sp|P9WK19|MAP12_MY	P0AE18	85.96	4.0	249.0	DB08670	experimental	METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY-3-(4-ISOPROPYLPHENYL)PROPANOYL]-D-ALANYL-D-LEUCINATE	CC(C)C[C@H](C(=O)OC)NC(=O)[C@H](C)NC(=O)[C@@H](O)[C@H](N)c1ccc(cc1)C(C)C
17170	sp|P9WK19|MAP12_MY	P0AE18	85.96	4.0	249.0	DB08671	experimental	5-Imino-4-(2-trifluoromethyl-phenylazo)-5H-pyrazol-3-ylamine	FC(F)(F)c1ccccc1NN=c2c(=N)nnc2=N
17171	sp|P9WK19|MAP12_MY	P0AE18	85.96	4.0	249.0	DB08718	experimental	4-(3-ethylthiophen-2-yl)benzene-1,2-diol	CCc1c(scc1)-c2cc(O)c(O)cc2
17172	sp|P9WK19|MAP12_MY	P0AE18	85.96	4.0	249.0	DB08757	experimental	5-(2-chlorophenyl)furan-2-carbohydrazide	NNC(=O)c1ccc(o1)-c2ccccc2Cl
17173	sp|P9WK19|MAP12_MY	P0AE18	85.96	4.0	249.0	DB08758	experimental	IMIDAZO[2,1-A]ISOQUINOLINE-2-CARBOHYDRAZIDE	NNC(=O)c(n1)cn(c12)ccc3c2cccc3
17174	sp|P9WK19|MAP12_MY	P0A078	85.96	2.0	247.0	DB01882	experimental	(2s)-2-Amino-4-(Methylsulfanyl)-1-Pyridin-2-Ylbutane-1,1-Diol	CSCC[C@H](N)C(O)(O)c1ccccn1
17175	sp|P9WK19|MAP12_MY	P0A078	85.96	2.0	247.0	DB02408	experimental	(3s)-3-Amino-1-(Cyclopropylamino)Heptane-2,2-Diol	CCCC[C@H](N)C(O)(O)CNC1CC1
17176	sp|P9WK19|MAP12_MY	P0A078	85.96	2.0	247.0	DB08160	experimental	(2S)-2-AMINO-4-(METHYLSULFANYL)-1-(1,3-THIAZOL-2-YL)BUTANE-1,1-DIOL	CSCC[C@H](N)C(O)(O)c1nccs1
17177	sp|P9WK19|MAP12_MY	P0A079	85.96	2.0	247.0	DB01882	experimental	(2s)-2-Amino-4-(Methylsulfanyl)-1-Pyridin-2-Ylbutane-1,1-Diol	CSCC[C@H](N)C(O)(O)c1ccccn1
17178	sp|P9WK19|MAP12_MY	P0A079	85.96	2.0	247.0	DB02408	experimental	(3s)-3-Amino-1-(Cyclopropylamino)Heptane-2,2-Diol	CCCC[C@H](N)C(O)(O)CNC1CC1
17179	sp|P9WK19|MAP12_MY	P15034	86.32	175.0	421.0	DB04092	experimental	Apstatin	NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]2CCCN2C(=O)[C@@H](O)[C@H](N)Cc3ccccc3
17180	sp|P9WK19|MAP12_MY	P50579	75.44	156.0	371.0	DB00134	approved; nutraceutical	Methionine	CSCC[C@H](N)C(=O)O
17181	sp|P9WK19|MAP12_MY	P50579	75.44	156.0	371.0	DB01422	experimental	Nitroxoline	c1ccnc(c12)c(O)ccc2[N+]([O-])=O
17182	sp|P9WK19|MAP12_MY	P50579	75.44	156.0	371.0	DB02310	experimental	3,5,6,8-Tetramethyl-N-Methyl Phenanthrolinium	Cc(c1)cnc(c12)c3c(c(C)c2C)cc(C)c[n+]3C
17183	sp|P9WK19|MAP12_MY	P50579	75.44	156.0	371.0	DB02640	experimental	Fumagillin	CC(C)=CC[C@@H](O1)[C@@]1(C)[C@H]([C@@]23CO3)[C@H](OC)[C@@H](CC2)OC(=O)/C=C/C=C/C=C/C=C/C(=O)O
17184	sp|P9WK19|MAP12_MY	P50579	75.44	156.0	371.0	DB02893	approved; experimental; investigational	D-Methionine	CSCC[C@@H](N)C(=O)O
17185	sp|P9WK19|MAP12_MY	P50579	75.44	156.0	371.0	DB03086	experimental	N'-(2s,3r)-3-Amino-4-Cyclohexyl-2-Hydroxy-Butano-N-(4-Methylphenyl)Hydrazide	C1CCCCC1C[C@@H](N)[C@H](O)C(=O)NNc2ccc(C)cc2
17186	sp|P9WK19|MAP12_MY	P50579	75.44	156.0	371.0	DB03396	experimental	(2R,3R,4S,5R,6E)-3,4,5-Trihydroxy-N-[(3S,6R)-6-hydroxy-2-oxo-3-azepanyl]-2-methoxy-8,8-dimethyl-6-nonenamide	O=C1NC[C@H](O)CC[C@@H]1NC(=O)[C@H](OC)[C@H](O)[C@@H](O)[C@H](O)/C=C/C(C)(C)C
17187	sp|P9WK19|MAP12_MY	P50579	75.44	156.0	371.0	DB03900	experimental	tert-butanol	CC(C)(C)O
17188	sp|P9WK19|MAP12_MY	P50579	75.44	156.0	371.0	DB04108	experimental	(2s,3r)-3-Amino-2-Hydroxy-5-(Ethylsulfanyl)Pentanoyl-((S)-(-)-(1-Naphthyl)Ethyl)Amide	CCSCC[C@H](N)[C@H](O)C(=O)N[C@@H](C)c(ccc1)c(c12)cccc2
17189	sp|P9WK19|MAP12_MY	P50579	75.44	156.0	371.0	DB04324	experimental	Ovalicin	CC(C)=CC[C@@H](O1)[C@@]1(C)[C@@]2(O)[C@H](OC)C(=O)CC[C@@]2(C)O
17190	sp|P9WK19|MAP12_MY	P50579	75.44	156.0	371.0	DB05864	investigational	PPI-2458	CC(C)=CC[C@@H](O1)[C@@]1(C)[C@H]([C@]23CO2)[C@H](OC)[C@@H](CC3)OC(=O)N[C@H](C(C)C)C(=O)N
17191	sp|P9WK19|MAP12_MY	P50579	75.44	156.0	371.0	DB07309	experimental	5-BROMO-2-{[(4-CHLOROPHENYL)SULFONYL]AMINO}BENZOIC ACID	Brc1cc(C(=O)O)c(cc1)NS(=O)(=O)c2ccc(Cl)cc2
17192	sp|P9WK19|MAP12_MY	P50579	75.44	156.0	371.0	DB07313	experimental	5-METHYL-2-[(PHENYLSULFONYL)AMINO]BENZOIC ACID	Cc1ccc(c(c1)C(=O)O)NS(=O)(=O)c2ccccc2
17193	sp|P9WK19|MAP12_MY	P50579	75.44	156.0	371.0	DB07322	experimental	2-[(PHENYLSULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID	C1CCCc(c12)c(C(=O)O)c(cc2)NS(=O)(=O)c3ccccc3
17194	sp|P9WK19|MAP12_MY	P50579	75.44	156.0	371.0	DB07323	experimental	2-[({2-[(1Z)-3-(DIMETHYLAMINO)PROP-1-ENYL]-4-FLUOROPHENYL}SULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID	CN(C)C/C=C\c1cc(F)ccc1S(=O)(=O)Nc(c2C(=O)O)ccc(c23)CCCC3
17195	sp|P9WK19|MAP12_MY	P50579	75.44	156.0	371.0	DB07377	experimental	N'-((2S,3R)-3-AMINO-2-HYDROXY-5-(ISOPROPYLSULFANYL)PENTANOYL)-N-3-CHLOROBENZOYL HYDRAZIDE	CC(C)SCC[C@@H](N)[C@H](O)C(=O)NNC(=O)c1cc(Cl)ccc1
17196	sp|P9WK19|MAP12_MY	P50579	75.44	156.0	371.0	DB07746	experimental	3-ETHYL-6-{[(4-FLUOROPHENYL)SULFONYL]AMINO}-2-METHYLBENZOIC ACID	CCc1ccc(c(C(=O)O)c1C)NS(=O)(=O)c2ccc(F)cc2
17197	sp|P9WK19|MAP12_MY	P50579	75.44	156.0	371.0	DB08633	investigational	TNP-470	CC(C)=CC[C@@H](O1)[C@@]1(C)[C@H]([C@]23CO2)[C@H](OC)[C@@H](CC3)OC(=O)NC(=O)CCl
17198	sp|P71650|MAZF9_MY	P96622	93.22	3.0	113.0	DB02042	experimental	2-(2-{2-[2-(2-Methoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol	COCCOCCOCCOCCOCCO
17199	sp|P9WND3|FMT_MYCT	P23882	96.15	5.0	305.0	DB04464	experimental	N-Formylmethionine	O=CN[C@H](C(=O)O)CCSC
17200	sp|P9WND3|FMT_MYCT	P77398	94.87	9.0	305.0	DB03256	experimental	(6R)-Folinic acid	Nc([nH]1)nc(=O)c(c12)N(C=O)[C@@H](CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
17201	sp|P9WND3|FMT_MYCT	P77398	94.87	9.0	305.0	DB03685	experimental	Uridine monophosphate	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2ccc(=O)[nH]c2=O
17202	sp|P9WND3|FMT_MYCT	O75891	93.27	19.0	310.0	DB00116	nutraceutical	Tetrahydrofolic acid	Nc([nH]1)nc(=O)c(c12)NC(CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
17203	sp|P9WND3|FMT_MYCT	Q96DP5	85.58	49.0	316.0	DB00116	nutraceutical	Tetrahydrofolic acid	Nc([nH]1)nc(=O)c(c12)NC(CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
17204	sp|P9WJQ7|MOEA1_MY	Q9NQX3	91.08	345.0	733.0	DB01942	experimental; investigational	Formic acid	OC=O
17205	sp|P9WJQ7|MOEA1_MY	Q9NQX3	91.08	345.0	733.0	DB03366	experimental; investigational	Imidazole	[nH]1ccnc1
17206	sp|P9WJQ7|MOEA1_MY	Q9NQX3	91.08	345.0	733.0	DB03766	approved; vet_approved	Propanoic acid	CCC(=O)O
17207	sp|P9WQ65|AMT_MYCT	P69681	84.28	25.0	427.0	DB01828	experimental	Methylamine	CN
17208	sp|P9WQ65|AMT_MYCT	P69681	84.28	25.0	427.0	DB04147	experimental	Dodecyldimethylamine N-oxide	CCCCCCCCCCCC[N+]([O-])(C)C
17209	sp|P9WNW9|HISX_MYC	P06988	93.06	11.0	427.0	DB03366	experimental; investigational	Imidazole	[nH]1ccnc1
17210	sp|P9WNW9|HISX_MYC	P06988	93.06	11.0	427.0	DB03811	experimental	Histidinol	OC[C@@H]([NH3+])Cc1cnc[nH]1
17211	sp|P9WNW9|HISX_MYC	P06988	93.06	11.0	427.0	DB04447	experimental	1,4-Dithiothreitol	SC[C@H](O)[C@@H](O)CS
17212	sp|P9WKI7|IMDH_MYC	P20839	90.74	4.0	484.0	DB01033	approved	Mercaptopurine	[nH]1cnc(c12)[nH]cnc2=S
17213	sp|P9WKI7|IMDH_MYC	P20839	90.74	4.0	484.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
17214	sp|P9WKI7|IMDH_MYC	P20839	90.74	4.0	484.0	DB00688	approved; investigational	Mycophenolate mofetil	C1OC(=O)c(c12)c(O)c(c(c2C)OC)C/C=C(\C)CCC(=O)OCCN3CCOCC3
17215	sp|P9WKI7|IMDH_MYC	P20839	90.74	4.0	484.0	DB00811	approved	Ribavirin	NC(=O)c1nn(cn1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O
17216	sp|P9WKI7|IMDH_MYC	P20839	90.74	4.0	484.0	DB01024	approved	Mycophenolic acid	C1OC(=O)c(c12)c(O)c(c(c2C)OC)C/C=C(\C)CCC(=O)O
17217	sp|P9WKI7|IMDH_MYC	P20839	90.74	4.0	484.0	DB03948	experimental	6-Chloropurine Riboside, 5'-Monophosphate	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(Cl)[nH+]cn3
17218	sp|P9WKI7|IMDH_MYC	P20839	90.74	4.0	484.0	DB06103	investigational	VX-148	 
17219	sp|P9WKI7|IMDH_MYC	P20839	90.74	4.0	484.0	DB06408	investigational	Taribavirin	NC(=N)c1nn(cn1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O
17220	sp|P9WKI7|IMDH_MYC	P0C0H6	91.68	6.0	491.0	DB04566	experimental	Inosinic Acid	OP(=O)(O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O1)n2cnc(c23)c(=O)[nH]cn3
17221	sp|P9WKI7|IMDH_MYC	P0C0H6	91.68	6.0	491.0	DB04862	investigational	Merimepodib	c1ncoc1-c2c(OC)cc(cc2)NC(=O)Nc3cccc(c3)CNC(=O)O[C@H]4CCOC4
17222	sp|P9WKI7|IMDH_MYC	P12268	90.93	3.0	484.0	DB01033	approved	Mercaptopurine	[nH]1cnc(c12)[nH]cnc2=S
17223	sp|P9WKI7|IMDH_MYC	P12268	90.93	3.0	484.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
17224	sp|P9WKI7|IMDH_MYC	P12268	90.93	3.0	484.0	DB00688	approved; investigational	Mycophenolate mofetil	C1OC(=O)c(c12)c(O)c(c(c2C)OC)C/C=C(\C)CCC(=O)OCCN3CCOCC3
17225	sp|P9WKI7|IMDH_MYC	P12268	90.93	3.0	484.0	DB00811	approved	Ribavirin	NC(=O)c1nn(cn1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O
17226	sp|P9WKI7|IMDH_MYC	P12268	90.93	3.0	484.0	DB01024	approved	Mycophenolic acid	C1OC(=O)c(c12)c(O)c(c(c2C)OC)C/C=C(\C)CCC(=O)O
17227	sp|P9WKI7|IMDH_MYC	P12268	90.93	3.0	484.0	DB03070	experimental	Selenazole-4-carboxyamide-adenine dinucleotide	NC(=O)c1c[se]c(n1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
17228	sp|P9WKI7|IMDH_MYC	P12268	90.93	3.0	484.0	DB03948	experimental	6-Chloropurine Riboside, 5'-Monophosphate	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(Cl)[nH+]cn3
17229	sp|P9WKI7|IMDH_MYC	P12268	90.93	3.0	484.0	DB04566	experimental	Inosinic Acid	OP(=O)(O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O1)n2cnc(c23)c(=O)[nH]cn3
17230	sp|P9WKI7|IMDH_MYC	P12268	90.93	3.0	484.0	DB06103	investigational	VX-148	 
17231	sp|O53424|LIPU_MYC	Q7SIG1	83.5	60.0	308.0	DB02776	experimental	1-Hexadecanosulfonic Acid	CCCCCCCCCCCCCCCCS(=O)(=O)O
17232	sp|P9WGI7|GLYA2_MY	P0A827	96.47	6.0	416.0	DB02824	experimental	N-Pyridoxyl-Glycine-5-Monophosphate	Cc1ncc(COP(=O)(O)O)c(c1O)CNCC(=O)O
17233	sp|P9WGI7|GLYA2_MY	P0A827	96.47	6.0	416.0	DB11596	approved; investigational	Levoleucovorin	Nc([nH]1)nc(=O)c(c12)N(C=O)[C@H](CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
17234	sp|P9WGI7|GLYA2_MY	Q5KUI2	96.24	2.0	411.0	DB03256	experimental	(6R)-Folinic acid	Nc([nH]1)nc(=O)c(c12)N(C=O)[C@@H](CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
17235	sp|P9WGI7|GLYA2_MY	Q53ET4	99.06	44.0	465.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
17236	sp|P9WGI7|GLYA2_MY	Q53ET4	99.06	44.0	465.0	DB00116	nutraceutical	Tetrahydrofolic acid	Nc([nH]1)nc(=O)c(c12)NC(CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
17237	sp|P9WGI7|GLYA2_MY	Q53ET4	99.06	44.0	465.0	DB00145	approved; nutraceutical; vet_approved	Glycine	NCC(=O)O
17238	sp|P9WGI7|GLYA2_MY	P34896	101.18	22.0	452.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
17239	sp|P9WGI7|GLYA2_MY	P34896	101.18	22.0	452.0	DB00116	nutraceutical	Tetrahydrofolic acid	Nc([nH]1)nc(=O)c(c12)NC(CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
17240	sp|P9WGI7|GLYA2_MY	P34896	101.18	22.0	452.0	DB00145	approved; nutraceutical; vet_approved	Glycine	NCC(=O)O
17241	sp|P9WGI7|GLYA2_MY	P34896	101.18	22.0	452.0	DB01055	experimental	Mimosine	OC(=O)[C@@H](N)Cn1ccc(=O)c(O)c1
17242	sp|P9WGI7|GLYA2_MY	P34896	101.18	22.0	452.0	DB02067	experimental	Triglu-5-formyl-tetrahydrofolate	Nc([nH]1)nc(=O)c(c12)N(C=O)[C@H](CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)N[C@H](C(=O)O)CCC(=O)N[C@H](C(=O)O)CCC(=O)O
17243	sp|P9WGI7|GLYA2_MY	P34896	101.18	22.0	452.0	DB02800	experimental	5-hydroxymethyl-5,6-dihydrofolic acid	O=c1[nH]c(N)nc(c12)N=C[C@@H](N2CO)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
17244	sp|P9WGI7|GLYA2_MY	P34896	101.18	22.0	452.0	DB02824	experimental	N-Pyridoxyl-Glycine-5-Monophosphate	Cc1ncc(COP(=O)(O)O)c(c1O)CNCC(=O)O
17245	sp|P9WGI7|GLYA2_MY	P34897	99.06	44.0	465.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
17246	sp|P9WGI7|GLYA2_MY	P34897	99.06	44.0	465.0	DB00116	nutraceutical	Tetrahydrofolic acid	Nc([nH]1)nc(=O)c(c12)NC(CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
17247	sp|P9WGI7|GLYA2_MY	P34897	99.06	44.0	465.0	DB00145	approved; nutraceutical; vet_approved	Glycine	NCC(=O)O
17248	sp|P9WGI7|GLYA2_MY	P34897	99.06	44.0	465.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
17249	sp|P9WGI7|GLYA2_MY	P13196	71.53	261.0	565.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
17250	sp|P9WGI7|GLYA2_MY	P13196	71.53	261.0	565.0	DB00145	approved; nutraceutical; vet_approved	Glycine	NCC(=O)O
17251	sp|P9WGI7|GLYA2_MY	Q5JAM2	71.53	261.0	565.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
17252	sp|P9WGI7|GLYA2_MY	P22557	71.76	206.0	511.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
17253	sp|P9WGI7|GLYA2_MY	P22557	71.76	206.0	511.0	DB00145	approved; nutraceutical; vet_approved	Glycine	NCC(=O)O
17254	sp|P9WGI7|GLYA2_MY	O15270	79.53	190.0	528.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
17255	sp|P9WGI7|GLYA2_MY	O15270	79.53	190.0	528.0	DB00133	investigational; nutraceutical	Serine	OC(=O)[C@@H](N)CO
17256	sp|P9WGI7|GLYA2_MY	Q9NUV7	78.35	181.0	514.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
17257	sp|P9WGI7|GLYA2_MY	O75600	73.65	82.0	395.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
17258	sp|P9WGI7|GLYA2_MY	O75600	73.65	82.0	395.0	DB00145	approved; nutraceutical; vet_approved	Glycine	NCC(=O)O
17259	sp|P9WMP5|HEM2_MYC	Q59334	96.35	10.0	327.0	DB04560	experimental	4,7-Dioxosebacic Acid	OC(=O)CCC(=O)CCC(=O)CCC(=O)O
17260	sp|P9WMP5|HEM2_MYC	Q59643	98.78	8.0	333.0	DB01942	experimental; investigational	Formic acid	OC=O
17261	sp|P9WMP5|HEM2_MYC	Q59643	98.78	8.0	333.0	DB02828	experimental	5-Fluorolevulinic Acid	OC(=O)CCC(=O)CF
17262	sp|P9WMP5|HEM2_MYC	P0ACB2	95.44	5.0	319.0	DB02260	experimental	4-Oxosebacic Acid	OC(=O)CCCCCC(=O)CCC(=O)O
17263	sp|P9WMP5|HEM2_MYC	P0ACB2	95.44	5.0	319.0	DB04530	experimental	S,S-(2-Hydroxyethyl)Thiocysteine	OC(=O)[C@@H](N)CSSCCO
17264	sp|P9WMP5|HEM2_MYC	P0ACB2	95.44	5.0	319.0	DB04560	experimental	4,7-Dioxosebacic Acid	OC(=O)CCC(=O)CCC(=O)CCC(=O)O
17265	sp|P9WMP5|HEM2_MYC	P13716	93.01	21.0	327.0	DB00855	approved	Aminolevulinic acid	NCC(=O)CCC(=O)O
17266	sp|P9WMP5|HEM2_MYC	P13716	93.01	21.0	327.0	DB02068	experimental	Delta-Amino Valeric Acid	[NH3+]CCCCC(=O)O
17267	sp|P9WMP5|HEM2_MYC	P13716	93.01	21.0	327.0	DB02239	experimental	Laevulinic Acid	CC(=O)CCC(=O)O
17268	sp|P9WMP5|HEM2_MYC	P13716	93.01	21.0	327.0	DB02260	experimental	4-Oxosebacic Acid	OC(=O)CCCCCC(=O)CCC(=O)O
17269	sp|P9WMP5|HEM2_MYC	P13716	93.01	21.0	327.0	DB02272	experimental	Porphobilinogen	NCc1c(CC(=O)O)c(c[nH]1)CCC(=O)O
17270	sp|P9WMP5|HEM2_MYC	P13716	93.01	21.0	327.0	DB02878	experimental	3-(2-Aminoethyl)-4-(Aminomethyl)Heptanedioic Acid	NCC[C@H](CC(=O)O)[C@@H](CN)CCC(=O)O
17271	sp|P9WMP5|HEM2_MYC	P13716	93.01	21.0	327.0	DB04560	experimental	4,7-Dioxosebacic Acid	OC(=O)CCC(=O)CCC(=O)CCC(=O)O
17272	sp|P9WMP5|HEM2_MYC	P13716	93.01	21.0	327.0	DB04781	experimental	5-hydroxyvaleric acid	OCCCCC(=O)O
17273	sp|P9WMJ7|HTPG_MYC	P14625	103.86	72.0	744.0	DB00615	approved; investigational	Rifabutin	CC(C)CN(CC1)CCC12N=C3c4c5c6c(C)c(O)c4C(=O)C(=C3N2)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(=O)C)[C@H](C)[C@@H](OC)/C=C/O[C@](O6)(C)C5=O
17274	sp|P9WMJ7|HTPG_MYC	P14625	103.86	72.0	744.0	DB02103	experimental	2-Chlorodideoxyadenosine	OC[C@@H]1CC[C@@H](O1)n2cnc(c23)c(N)nc(n3)Cl
17275	sp|P9WMJ7|HTPG_MYC	P14625	103.86	72.0	744.0	DB02424	experimental; investigational	Geldanamycin	C12=CC(=O)C(OC)=C(C2=O)C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(=O)N)[C@@H](OC)/C=C\C=C(/C)C(=O)N1
17276	sp|P9WMJ7|HTPG_MYC	P14625	103.86	72.0	744.0	DB02935	experimental	Diglyme	COCCOCCOC
17277	sp|P9WMJ7|HTPG_MYC	P14625	103.86	72.0	744.0	DB03719	experimental	N-Ethyl-5'-Carboxamido Adenosine	CCNC(=O)[C@@H]1O[C@H]([C@H](O)[C@H]1O)n2cnc(c23)c(N)ncn3
17278	sp|P9WMJ7|HTPG_MYC	P14625	103.86	72.0	744.0	DB03758	experimental	Radicicol	Oc1cc(O)c(Cl)c(c12)CC(=O)/C=C/C=C\[C@@H]3[C@H](O3)C[C@@H](C)OC2=O
17279	sp|P9WMJ7|HTPG_MYC	P14625	103.86	72.0	744.0	DB08464	experimental	METHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL)AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE	Oc1cc(O)c(Cl)c(c1C(=O)OC)CCC(=O)Nc2c(O)cc(OC)c(O)c2
17280	sp|P9WMJ7|HTPG_MYC	P14625	103.86	72.0	744.0	DB08465	experimental	2-(3-AMINO-2,5,6-TRIMETHOXYPHENYL)ETHYL 5-CHLORO-2,4-DIHYDROXYBENZOATE	COc1cc(N)c(OC)c(c1OC)CCOC(=O)c2c(O)cc(O)c(Cl)c2
17281	sp|P9WMJ7|HTPG_MYC	P14625	103.86	72.0	744.0	DB09130	approved; investigational	Copper	[Cu]
17283	sp|P9WGT1|HSD_MYCT	Q16698	103.46	55.0	324.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
17284	sp|P9WGT1|HSD_MYCT	Q16698	103.46	55.0	324.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
17285	sp|P9WGT1|HSD_MYCT	Q9BTZ2	95.38	30.0	278.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
17287	sp|P9WGT1|HSD_MYCT	P0AEK2	91.92	3.0	242.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
17288	sp|P9WGT1|HSD_MYCT	Q9WYS2	95.0	7.0	254.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
17290	sp|P9WGT1|HSD_MYCT	Q84EX5	96.15	1.0	251.0	DB04619	experimental	Acetophenone	CC(=O)c1ccccc1
17291	sp|P9WGT1|HSD_MYCT	Q84EX5	96.15	1.0	251.0	DB04784	experimental	(R)-1-phenylethanol	C[C@@H](O)c1ccccc1
17292	sp|P9WGT1|HSD_MYCT	Q92506	97.31	6.0	259.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
17293	sp|P9WGT1|HSD_MYCT	Q92506	97.31	6.0	259.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
17294	sp|P9WGT1|HSD_MYCT	P0AET8	94.62	8.0	254.0	DB02123	experimental	Glycochenodeoxycholic Acid	OC(=O)CNC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
17295	sp|P9WGT1|HSD_MYCT	Q9BY49	96.92	14.0	266.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
17296	sp|P9WGT1|HSD_MYCT	P16544	97.31	5.0	258.0	DB01942	experimental; investigational	Formic acid	OC=O
17297	sp|P9WGT1|HSD_MYCT	P16544	97.31	5.0	258.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
17298	sp|P9WGT1|HSD_MYCT	P16544	97.31	5.0	258.0	DB07715	investigational	Emodin	Cc(c1)cc(O)c(c12)C(=O)c3c(C2=O)cc(O)cc3O
17299	sp|P9WGT1|HSD_MYCT	P0CG22	96.54	30.0	281.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
17300	sp|P9WGT1|HSD_MYCT	P0CG22	96.54	30.0	281.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
17301	sp|P9WGT1|HSD_MYCT	P0CG22	96.54	30.0	281.0	DB03541	experimental	10-Propargyl-5,8-Dideazafolic Acid	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(CC#C)Cc(c2)ccc(c23)[nH]c(N)nc3=O
17302	sp|P9WGT1|HSD_MYCT	P0CG22	96.54	30.0	281.0	DB07689	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)NCc(cn3)nc(c34)c(N)nc(n4)N
17303	sp|P9WGT1|HSD_MYCT	P0CG22	96.54	30.0	281.0	DB07765	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)N(C)Cc(cn3)nc(c34)c(N)nc(n4)N
17304	sp|P9WGT1|HSD_MYCT	Q7Z4W1	91.54	4.0	242.0	DB02831	experimental	Dihydrogenphosphate	OP([O-])(=O)O
17305	sp|P9WGT1|HSD_MYCT	Q7Z4W1	91.54	4.0	242.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
17306	sp|P9WGT1|HSD_MYCT	Q99714	95.38	7.0	255.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
17307	sp|P9WGT1|HSD_MYCT	Q99714	95.38	7.0	255.0	DB02820	experimental	1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct	C1CCCCCN1C(=O)[C@H](c2ccccc2)n(c3=S)cnc(c34)nn(c4)[C@H]5C=CN(C=C5C([O-])=N)[C@@H]6O[C@@H]([C@@H](O)[C@H]6O)COP([O-])(=O)OP(=O)(O)OC[C@H]7O[C@H]([C@H]([O-])[C@@H]7[O-])n8cnc(c89)c(N)ncn9
17308	sp|P9WGT1|HSD_MYCT	Q99714	95.38	7.0	255.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
17309	sp|P9WGT1|HSD_MYCT	P51659	92.69	6.0	247.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
17310	sp|P9WGT1|HSD_MYCT	P51659	92.69	6.0	247.0	DB03192	experimental	(R)-3-hydroxydecanoyl-CoA	CCCCCCC[C@@H](O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
17311	sp|P9WGT1|HSD_MYCT	Q6UWP2	92.69	8.0	249.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
17312	sp|P9WGT1|HSD_MYCT	Q6PKH6	71.54	28.0	214.0	DB04200	experimental	Matairesinol	COc1cc(ccc1O)C[C@H]2COC(=O)[C@@H]2Cc3ccc(O)c(c3)OC
17313	sp|P9WGT1|HSD_MYCT	A0A348A0U3	96.15	3.0	253.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
17314	sp|P9WGT1|HSD_MYCT	P0AEK4	96.54	2.0	253.0	DB01691	experimental	Indole Naphthyridinone	c1cccc(c12)n(C)cc2CN(C)C(=O)/C=C/c(c3)cnc(c34)NC(=O)CC4
17315	sp|P9WGT1|HSD_MYCT	P0AEK4	96.54	2.0	253.0	DB01865	experimental	3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide	c1cccc(c12)cc(n2C)CN(C)C(=O)/C=C/c3cnc(N)cc3
17316	sp|P9WGT1|HSD_MYCT	P0AEK4	96.54	2.0	253.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
17317	sp|P9WGT1|HSD_MYCT	P0AEK4	96.54	2.0	253.0	DB03030	experimental	4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole	Cc1ccc(cc1)Cn2cnc(c2)-c3cccs3
17318	sp|P9WGT1|HSD_MYCT	P0AEK4	96.54	2.0	253.0	DB03534	experimental	3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide	CC(=O)N(C)Cc1c(N)ccc(c1)C(=O)N(C)Cc(n2C)cc(c23)cccc3
17319	sp|P9WGT1|HSD_MYCT	P0AEK4	96.54	2.0	253.0	DB04030	experimental	1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole	Oc1ccc(cc1)Cn2c(c3c(c24)cccc4)CN(CC3)C(=O)c5ccc(O)cc5
17320	sp|P9WGT1|HSD_MYCT	P0AEK4	96.54	2.0	253.0	DB08265	experimental	2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL	Cc1ccc(cc1)S(=O)(=O)n(b2O)ncc(c23)cccc3
17321	sp|P9WGT1|HSD_MYCT	P0AEK4	96.54	2.0	253.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
17322	sp|P9WGT1|HSD_MYCT	P0AEK4	96.54	2.0	253.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
17323	sp|P9WGT1|HSD_MYCT	Q6GI75	96.15	4.0	254.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
17324	sp|P9WGT1|HSD_MYCT	Q6GI75	96.15	4.0	254.0	DB11155	approved	Triclocarban	Clc1ccc(cc1)NC(=O)Nc2cc(Cl)c(Cl)cc2
17325	sp|P9WGT1|HSD_MYCT	Q9HBH5	101.15	39.0	302.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
17326	sp|P9WGT1|HSD_MYCT	Q8NBQ5	81.15	33.0	244.0	DB02854	experimental	Aetiocholanolone	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](CC3)C[C@H](O)CC4
17327	sp|P9WGT1|HSD_MYCT	Q7AUG5	92.69	3.0	244.0	DB04782	experimental	(S)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@H]2CO2
17328	sp|P9WGT1|HSD_MYCT	Q93D82	92.69	3.0	244.0	DB04472	experimental	(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol	[N-]=[N+]=NC[C@H](O)c1ccc([N+]([O-])=O)cc1
17329	sp|P9WGT1|HSD_MYCT	Q93D82	92.69	3.0	244.0	DB04499	experimental	(R)-styrene oxide	C1O[C@@H]1c2ccccc2
17330	sp|P9WGT1|HSD_MYCT	Q93D82	92.69	3.0	244.0	DB04777	experimental	(R)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@@H]2CO2
17331	sp|P9WGT1|HSD_MYCT	Q8TC12	79.23	38.0	244.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
17333	sp|P9WGT1|HSD_MYCT	Q8I814	99.62	13.0	272.0	DB02015	experimental	Dihydrofolic Acid	O=c1[nH]c(N)nc(c12)NCC(=N2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
17334	sp|P9WGT1|HSD_MYCT	Q8I814	99.62	13.0	272.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
17335	sp|P9WGT1|HSD_MYCT	Q8NBN7	91.54	36.0	274.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
17336	sp|P9WGT1|HSD_MYCT	Q01782	106.15	8.0	284.0	DB02338	experimental	NADPH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
17337	sp|P9WGT1|HSD_MYCT	Q01782	106.15	8.0	284.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
17338	sp|P9WGT1|HSD_MYCT	Q01782	106.15	8.0	284.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
17339	sp|P9WGT1|HSD_MYCT	Q01782	106.15	8.0	284.0	DB04400	experimental	L-erythro-7,8-dihydrobiopterin	C[C@H](O)[C@H](O)C(CN1)=Nc(c12)c(=O)nc([nH]2)N
17340	sp|P9WGT1|HSD_MYCT	O24990	96.15	2.0	252.0	DB04393	experimental	Soneclosan	Clc1cc(O)c(cc1)Oc2ccc(Cl)cc2
17341	sp|P9WGT1|HSD_MYCT	O24990	96.15	2.0	252.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
17342	sp|P9WGT1|HSD_MYCT	Q02338	80.38	54.0	263.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
17343	sp|P9WGT1|HSD_MYCT	O75911	86.92	36.0	262.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
17344	sp|P9WGT1|HSD_MYCT	Q96NR8	78.85	36.0	241.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
17345	sp|P9WGT1|HSD_MYCT	P14061	77.69	3.0	205.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
17346	sp|P9WGT1|HSD_MYCT	P14061	77.69	3.0	205.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
17347	sp|P9WGT1|HSD_MYCT	P14061	77.69	3.0	205.0	DB01561	experimental; illicit	Androstanedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
17348	sp|P9WGT1|HSD_MYCT	P14061	77.69	3.0	205.0	DB02187	experimental	Equilin	O=C1CC[C@H]([C@@]12C)C=3[C@H](CC2)c4c(CC3)cc(O)cc4
17349	sp|P9WGT1|HSD_MYCT	P14061	77.69	3.0	205.0	DB02323	experimental	EM-1745	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)C[C@@H]([C@@H]4O)CCCCCCCCC(=O)OC[C@H]5O[C@H]([C@H](O)[C@@H]5O)n6cnc(c67)c(N)ncn7
17350	sp|P9WGT1|HSD_MYCT	P14061	77.69	3.0	205.0	DB02901	illicit; investigational	Stanolone	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
17351	sp|P9WGT1|HSD_MYCT	P14061	77.69	3.0	205.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
17352	sp|P9WGT1|HSD_MYCT	P14061	77.69	3.0	205.0	DB13951	experimental	Stanolone acetate	CC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
17353	sp|P9WGT1|HSD_MYCT	Q9NYR8	74.23	6.0	199.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
17354	sp|P9WGT1|HSD_MYCT	P9WGR1	102.69	1.0	268.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
17355	sp|P9WGT1|HSD_MYCT	P9WGR1	102.69	1.0	268.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
17356	sp|P9WGT1|HSD_MYCT	P9WGR1	102.69	1.0	268.0	DB02990	experimental	S-(2-Acetamidoethyl) hexadecanethioate	CCCCCCCCCCCCCCCC(=O)SCCNC(=O)C
17357	sp|P9WGT1|HSD_MYCT	P9WGR1	102.69	1.0	268.0	DB04289	experimental	Genz-10850	[nH]1ccc(c12)cc(cc2)C(=O)N3CCN(CC3)C4c(cccc5)c5c(c46)cccc6
17358	sp|P9WGT1|HSD_MYCT	P9WGR1	102.69	1.0	268.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
17359	sp|P9WGT1|HSD_MYCT	P9WGR1	102.69	1.0	268.0	DB07090	experimental	(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cccc(c1C)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
17360	sp|P9WGT1|HSD_MYCT	P9WGR1	102.69	1.0	268.0	DB07123	experimental	N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE	Cc1ccc(cc1)C(=O)N2CCC(CC2)Cc3ccccc3
17361	sp|P9WGT1|HSD_MYCT	P9WGR1	102.69	1.0	268.0	DB07155	experimental	(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE	c1ccccc1NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
17362	sp|P9WGT1|HSD_MYCT	P9WGR1	102.69	1.0	268.0	DB07178	experimental	5-PENTYL-2-PHENOXYPHENOL	CCCCCc1cc(O)c(cc1)Oc2ccccc2
17363	sp|P9WGT1|HSD_MYCT	P9WGR1	102.69	1.0	268.0	DB07188	experimental	(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(cc(Cl)c1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
17364	sp|P9WGT1|HSD_MYCT	P9WGR1	102.69	1.0	268.0	DB07192	experimental	(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Brc1cc(ccc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
17365	sp|P9WGT1|HSD_MYCT	P9WGR1	102.69	1.0	268.0	DB07222	experimental	(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(c(C)cc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
17366	sp|P9WGT1|HSD_MYCT	P9WGR1	102.69	1.0	268.0	DB07287	experimental	2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL	c1cccnc1Cc2cc(O)c(cc2)Oc3ccc(Cl)cc3Cl
17367	sp|P9WGT1|HSD_MYCT	P9WGR1	102.69	1.0	268.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
17368	sp|P9WGT1|HSD_MYCT	P28845	75.0	31.0	226.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
17369	sp|P9WGT1|HSD_MYCT	P28845	75.0	31.0	226.0	DB02329	experimental	Carbenoxolone	OC(=O)CCC(=O)O[C@@H](CC1)C(C)(C)[C@@H]([C@]12C)CC[C@]3(C)[C@@H]2C(=O)C=C4[C@H]5[C@@](C)(CC[C@@]34C)CC[C@](C5)(C)C(=O)O
17370	sp|P9WGT1|HSD_MYCT	P28845	75.0	31.0	226.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
17371	sp|P9WGT1|HSD_MYCT	P28845	75.0	31.0	226.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
17372	sp|P9WGT1|HSD_MYCT	P28845	75.0	31.0	226.0	DB04652	experimental	Corticosterone	OCC(=O)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H]([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
17373	sp|P9WGT1|HSD_MYCT	P28845	75.0	31.0	226.0	DB05064	investigational	INCB13739	 
17374	sp|P9WGT1|HSD_MYCT	P28845	75.0	31.0	226.0	DB06992	experimental	(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone	Cc1ccc(cc1F)-c2nc(ccc2)C(=O)N(CC3(C)C)CCC3
17375	sp|P9WGT1|HSD_MYCT	P28845	75.0	31.0	226.0	DB07017	experimental	(5S)-2-{[(1S)-1-(4-Fluorophenyl)ethyl]amino}-5-(2-hydroxy-2-propanyl)-5-methyl-1,3-thiazol-4(5H)-one	Fc1ccc(cc1)[C@H](C)NC(=NC2=O)S[C@@]2(C)C(C)(C)O
17376	sp|P9WGT1|HSD_MYCT	P28845	75.0	31.0	226.0	DB07049	experimental	(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine	[O-][N+](=O)c1ccc(cc1)N2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)C(C)(C)C
17377	sp|P9WGT1|HSD_MYCT	P28845	75.0	31.0	226.0	DB07056	experimental	2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide	CCN(CC)C(=O)Cc1cccc(n1)NS(=O)(=O)c2c(C)c(Cl)ccc2
17378	sp|P9WGT1|HSD_MYCT	P28845	75.0	31.0	226.0	DB07310	experimental	(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one	Fc1ccccc1[C@H](C)NC(=NC2=O)S[C@]2(C)C(F)(F)F
17379	sp|P9WGT1|HSD_MYCT	P28845	75.0	31.0	226.0	DB07316	experimental	N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)C3CCN(CC3)CC4(CC4)C(=O)N
17380	sp|P9WGT1|HSD_MYCT	P28845	75.0	31.0	226.0	DB07619	experimental	N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)[C@H]3CC[C@@H](CC3)c4cccnc4
17381	sp|P9WGT1|HSD_MYCT	P28845	75.0	31.0	226.0	DB07624	experimental	1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide	C1CC1(C(=O)N)CN2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)[C@](C)(O)C(F)(F)F
17382	sp|P9WGT1|HSD_MYCT	P28845	75.0	31.0	226.0	DB07866	experimental	(5S)-2-(Cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one	CCC[C@]1(C)SC(=NC1=O)NC2CCCCCCC2
17383	sp|P9WGT1|HSD_MYCT	P28845	75.0	31.0	226.0	DB08277	experimental	2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE	CS(=O)(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4c(Cl)cc(F)cc4
17384	sp|P9WGT1|HSD_MYCT	P28845	75.0	31.0	226.0	DB08280	experimental	(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE	NC(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4ccc(OC)cc4
17385	sp|P9WGT1|HSD_MYCT	P28845	75.0	31.0	226.0	DB08771	experimental	(5R)-2-[(2-Fluorophenyl)amino]-5-isopropyl-1,3-thiazol-4(5H)-one	CC(C)[C@H]1SC(=NC1=O)Nc2c(F)cccc2
17386	sp|P9WGT1|HSD_MYCT	P28845	75.0	31.0	226.0	DB13751	approved; experimental	Glycyrrhizic acid	C1C[C@](C)(C(=O)O)C[C@H]([C@]12C)C=3[C@@](C)(CC2)[C@@]4(C)[C@H](C(=O)C3)[C@]5(C)[C@@H](CC4)C(C)(C)[C@H](CC5)O[C@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O[C@@H]7O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]7O
17387	sp|P9WGT1|HSD_MYCT	Q92781	81.92	28.0	241.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
17388	sp|P9WGT1|HSD_MYCT	Q92781	81.92	28.0	241.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
17389	sp|P9WGT1|HSD_MYCT	P37058	75.77	46.0	243.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
17390	sp|P9WGT1|HSD_MYCT	P37059	79.62	80.0	287.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
17391	sp|P9WGT1|HSD_MYCT	P37059	79.62	80.0	287.0	DB13952	approved; investigational; vet_approved	Estradiol acetate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)C
17392	sp|P9WGT1|HSD_MYCT	P37059	79.62	80.0	287.0	DB13953	approved; investigational; vet_approved	Estradiol benzoate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)c5ccccc5
17393	sp|P9WGT1|HSD_MYCT	P37059	79.62	80.0	287.0	DB13954	approved; investigational; vet_approved	Estradiol cypionate	C1CCCC1CCC(=O)O[C@H]2CC[C@H]([C@@]23C)[C@H]4[C@H](CC3)c5c(CC4)cc(O)cc5
17394	sp|P9WGT1|HSD_MYCT	P37059	79.62	80.0	287.0	DB13955	approved; investigational; vet_approved	Estradiol dienanthate	CCCCCCC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)CCCCCC
17395	sp|P9WGT1|HSD_MYCT	P37059	79.62	80.0	287.0	DB13956	approved; investigational; vet_approved	Estradiol valerate	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)CC[C@@H]4OC(=O)CCCC
17396	sp|P9WGT1|HSD_MYCT	P80365	78.46	82.0	286.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
17397	sp|P9WGT1|HSD_MYCT	P80365	78.46	82.0	286.0	DB01185	approved; illicit	Fluoxymesterone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@](F)([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
17398	sp|P9WGT1|HSD_MYCT	P80365	78.46	82.0	286.0	DB01569	experimental; illicit	Formebolone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@H]([C@@H](C2)O)[C@]4(C)C(CC3)=CC(=O)C(C=O)=C4
17399	sp|P9WGT1|HSD_MYCT	P80365	78.46	82.0	286.0	DB14538	experimental; vet_approved	Hydrocortisone aceponate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CC)C(=O)COC(=O)C
17400	sp|P9WGT1|HSD_MYCT	P80365	78.46	82.0	286.0	DB14539	approved; vet_approved	Hydrocortisone acetate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)C
17401	sp|P9WGT1|HSD_MYCT	P80365	78.46	82.0	286.0	DB14540	approved; vet_approved	Hydrocortisone butyrate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCC
17402	sp|P9WGT1|HSD_MYCT	P80365	78.46	82.0	286.0	DB14541	approved; investigational; vet_approved	Hydrocortisone cypionate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)CCC5CCCC5
17403	sp|P9WGT1|HSD_MYCT	P80365	78.46	82.0	286.0	DB14542	approved; vet_approved	Hydrocortisone phosphate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COP(=O)(O)O
17404	sp|P9WGT1|HSD_MYCT	P80365	78.46	82.0	286.0	DB14543	approved; vet_approved	Hydrocortisone probutate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CCC)C(=O)COC(=O)CC
17405	sp|P9WGT1|HSD_MYCT	P80365	78.46	82.0	286.0	DB14544	approved; vet_approved	Hydrocortisone valerate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCCC
17406	sp|P9WGT1|HSD_MYCT	P16152	94.23	7.0	252.0	DB01698	approved; experimental; investigational	Rutin	O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O[C@H]1C)OC[C@H]2O[C@H]([C@H](O)[C@@H](O)[C@@H]2O)Oc(c3=O)c(-c4cc(O)c(O)cc4)oc(c35)cc(O)cc5O
17407	sp|P9WGT1|HSD_MYCT	P16152	94.23	7.0	252.0	DB02709	investigational	Resveratrol	Oc1ccc(cc1)/C=C/c2cc(O)cc(O)c2
17408	sp|P9WGT1|HSD_MYCT	P16152	94.23	7.0	252.0	DB03394	experimental	Heptaethylene glycol	OCCOCCOCCOCCOCCOCCOCCO
17409	sp|P9WGT1|HSD_MYCT	P16152	94.23	7.0	252.0	DB03556	experimental	2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400	CCOCCOCCOCCOCCOCCOCCOCCOCCO
17410	sp|P9WGT1|HSD_MYCT	P16152	94.23	7.0	252.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
17411	sp|P9WGT1|HSD_MYCT	P16152	94.23	7.0	252.0	DB04463	experimental	3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol	n1cnc(N)c(c12)c(nn2C(C)(C)C)-c3cccc(O)c3
17412	sp|P9WGT1|HSD_MYCT	P16152	94.23	7.0	252.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
17413	sp|P9WGT1|HSD_MYCT	P16152	94.23	7.0	252.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
17414	sp|P9WGT1|HSD_MYCT	P56937	91.54	2.0	240.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
17415	sp|P9WGT1|HSD_MYCT	P35270	81.92	1.0	214.0	DB02637	experimental	Oxaloacetate Ion	OC(=O)C(=O)CC([O-])=O
17416	sp|P9WGT1|HSD_MYCT	P35270	81.92	1.0	214.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
17417	sp|P9WGT1|HSD_MYCT	P35270	81.92	1.0	214.0	DB03886	experimental	Biopterin	C[C@@H](O)[C@@H](O)c(n1)cnc(c12)nc(N)[nH]c2=O
17418	sp|P9WGT1|HSD_MYCT	P35270	81.92	1.0	214.0	DB04275	experimental	N-acetylserotonin	CC(=O)NCCc1c[nH]c(c12)ccc(c2)O
17419	sp|P9WGT1|HSD_MYCT	P09417	75.77	11.0	208.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
17420	sp|P9WGT1|HSD_MYCT	P09417	75.77	11.0	208.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
17421	sp|P9WGT1|HSD_MYCT	Q8T8E9	74.62	2.0	196.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
17422	sp|P9WGT1|HSD_MYCT	P26391	73.46	3.0	194.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
17423	sp|P9WG41|ILVB1_MY	P37063	87.38	10.0	550.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
17424	sp|P9WG41|ILVB1_MY	P27696	86.57	8.0	543.0	DB01987	approved; experimental	Cocarboxylase	OP([O-])(=O)O[P@](=O)(O)OCCc1c(C)[n+](cs1)Cc2cnc(C)nc2N
17425	sp|P9WG41|ILVB1_MY	P27696	86.57	8.0	543.0	DB02327	experimental	Triethylene glycol	OCCOCCOCCO
17426	sp|P9WG41|ILVB1_MY	P27696	86.57	8.0	543.0	DB03361	experimental	2-{(9as)-9a-[(1s)-1-Hydroxyethyl]-2,7-Dimethyl-9a,10-Dihydro-5h-Pyrimido[4,5-D][1,3]Thiazolo[3,2-a]Pyrimidin-8-Yl}Ethyl Trihydrogen Diphosphate	c1nc(C)nc(N2)c1CN([C@]23[C@H](C)O)C(C)=C(S3)CCOP(=O)(O)OP(=O)(O)O
17428	sp|P9WG41|ILVB1_MY	P23234	85.92	8.0	539.0	DB01987	approved; experimental	Cocarboxylase	OP([O-])(=O)O[P@](=O)(O)OCCc1c(C)[n+](cs1)Cc2cnc(C)nc2N
17429	sp|P9WG41|ILVB1_MY	P20906	82.52	11.0	521.0	DB02280	experimental	(R)-Mandelic acid	OC(=O)[C@H](O)c1ccccc1
17430	sp|P9WG41|ILVB1_MY	P51852	83.5	4.0	520.0	DB03884	experimental	Phenylpyruvic acid	OC(=O)C(=O)Cc1ccccc1
17431	sp|P9WG41|ILVB1_MY	P51852	83.5	4.0	520.0	DB08050	experimental	5-phenyl-2-keto-valeric acid	OC(=O)C(=O)CCCc1ccccc1
17432	sp|P9WG41|ILVB1_MY	P06672	86.73	7.0	543.0	DB04272	approved; nutraceutical; vet_approved	Citric acid	OC(=O)CC(O)(C(=O)O)CC(=O)O
17433	sp|P9WK13|MDH_MYCT	Q9ZF99	99.09	1.0	327.0	DB02637	experimental	Oxaloacetate Ion	OC(=O)C(=O)CC([O-])=O
17434	sp|P9WK13|MDH_MYCT	P40925	99.39	2.0	329.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
17435	sp|P9WK13|MDH_MYCT	P40925	99.39	2.0	329.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
17436	sp|P9WK13|MDH_MYCT	P40925	99.39	2.0	329.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
17437	sp|P9WK13|MDH_MYCT	P07195	94.22	23.0	333.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
17438	sp|P9WK13|MDH_MYCT	P07195	94.22	23.0	333.0	DB02401	experimental	4-Hydroxy-1,2,5-oxadiazole-3-carboxylic acid	OC(=O)c1nonc1O
17439	sp|P9WK13|MDH_MYCT	P07195	94.22	23.0	333.0	DB03940	experimental	Oxamic Acid	NC(=O)C(=O)O
17440	sp|P9WK13|MDH_MYCT	P07195	94.22	23.0	333.0	DB09118	approved	Stiripentol	CC(C)(C)C(O)/C=C/c(cc1)cc(c12)OCO2
17441	sp|P9WK13|MDH_MYCT	P07195	94.22	23.0	333.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
17442	sp|P9WK13|MDH_MYCT	P00338	92.1	25.0	328.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
17443	sp|P9WK13|MDH_MYCT	P00338	92.1	25.0	328.0	DB02483	experimental	Etheno-NAD	NC(=O)c1c[n+](ccc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c6n(cn5)ccn6
17444	sp|P9WK13|MDH_MYCT	P00338	92.1	25.0	328.0	DB02701	approved; investigational	Nicotinamide	NC(=O)c1cccnc1
17445	sp|P9WK13|MDH_MYCT	P00338	92.1	25.0	328.0	DB03940	experimental	Oxamic Acid	NC(=O)C(=O)O
17446	sp|P9WK13|MDH_MYCT	P00338	92.1	25.0	328.0	DB09118	approved	Stiripentol	CC(C)(C)C(O)/C=C/c(cc1)cc(c12)OCO2
17447	sp|P9WK13|MDH_MYCT	P00338	92.1	25.0	328.0	DB09130	approved; investigational	Copper	[Cu]
17448	sp|P9WK13|MDH_MYCT	P00338	92.1	25.0	328.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
17449	sp|P9WK13|MDH_MYCT	P07864	91.19	28.0	328.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
17450	sp|P9WK13|MDH_MYCT	Q9BYZ2	91.19	78.0	378.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
17451	sp|P9WK13|MDH_MYCT	Q6ZMR3	89.06	35.0	328.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
17452	sp|P9WK13|MDH_MYCT	P16115	90.27	9.0	306.0	DB03940	experimental	Oxamic Acid	NC(=O)C(=O)O
17453	sp|P9WK13|MDH_MYCT	Q27743	87.54	23.0	311.0	DB02111	experimental	3-hydroxyisoxazole-4-carboxylic acid	OC(=O)c1conc1O
17454	sp|P9WK13|MDH_MYCT	Q27743	87.54	23.0	311.0	DB02401	experimental	4-Hydroxy-1,2,5-oxadiazole-3-carboxylic acid	OC(=O)c1nonc1O
17455	sp|P9WK13|MDH_MYCT	Q27743	87.54	23.0	311.0	DB03162	experimental	4-oxo-4,5-dihydro-1,2,5-thiadiazole-3-carboxylic acid	OC(=O)c1nsnc1O
17456	sp|P9WK13|MDH_MYCT	Q27743	87.54	23.0	311.0	DB03940	experimental	Oxamic Acid	NC(=O)C(=O)O
17457	sp|P9WK13|MDH_MYCT	Q27743	87.54	23.0	311.0	DB04640	experimental	Naphthalene-2,6-disulfonic acid	OS(=O)(=O)c(cc1)cc(c12)ccc(c2)S(=O)(=O)O
17458	sp|P9WK13|MDH_MYCT	Q27743	87.54	23.0	311.0	DB04641	experimental	3,7-DIHYDROXYNAPHTHALENE-2-CARBOXYLIC ACID	OC(=O)c(c1)c(O)cc(c12)ccc(c2)O
17459	sp|P9WK13|MDH_MYCT	Q27743	87.54	23.0	311.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
17460	sp|P9WK13|MDH_MYCT	P80040	82.07	29.0	299.0	DB01677	experimental; investigational	Fumaric Acid	OC(=O)/C=C/C(=O)O
17461	sp|P9WK13|MDH_MYCT	P40926	91.79	21.0	323.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
17462	sp|P9WK13|MDH_MYCT	P40926	91.79	21.0	323.0	DB04272	approved; nutraceutical; vet_approved	Citric acid	OC(=O)CC(O)(C(=O)O)CC(=O)O
17463	sp|P9WK13|MDH_MYCT	P40926	91.79	21.0	323.0	DB09092	approved; withdrawn	Xanthinol	OCCN(C)CC(O)Cn1cnc(c12)n(C)c(=O)n(c2=O)C
17464	sp|P9WNN5|ECH14_MY	O68600	96.48	2.0	249.0	DB01652	experimental	4-hydroxybenzoyl-CoA	Oc1ccc(cc1)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2OP(=O)(O)O)n3cnc(c34)c(N)ncn4
17465	sp|P9WNN5|ECH14_MY	P30084	80.47	42.0	248.0	DB02563	experimental	Hexanoyl-CoA	CCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
17466	sp|P9WNN5|ECH14_MY	P30084	80.47	42.0	248.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
17467	sp|P9WNN5|ECH14_MY	P30084	80.47	42.0	248.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
17468	sp|P9WNN5|ECH14_MY	P30084	80.47	42.0	248.0	DB04117	experimental	4-(N,N-Dimethylamino)cinnamoyl-CoA	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)/C=C/c4ccc(cc4)N(C)C
17469	sp|P9WNN5|ECH14_MY	P30084	80.47	42.0	248.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
17470	sp|P9WNN5|ECH14_MY	O75521	89.45	139.0	368.0	DB08231	experimental	Myristic acid	CCCCCCCCCCCCCC(=O)O
17471	sp|P9WNN5|ECH14_MY	Q93TU6	82.81	14.0	226.0	DB02906	experimental	(2s,4s)-Alpha-Campholinic Acid	CC1(C)[C@H](C)C(=O)C[C@H]1CC(O)O
17472	sp|P9WNN5|ECH14_MY	P52045	85.94	3.0	223.0	DB03117	experimental	2-carboxypropyl-coenzyme A	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC[C@H](C)C(=O)O
17473	sp|P9WNN5|ECH14_MY	P42126	81.64	55.0	264.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
17474	sp|P9WNN5|ECH14_MY	P42126	81.64	55.0	264.0	DB03127	experimental	Benzamidine	NC(=[NH2+])c1ccccc1
17475	sp|P9WNN5|ECH14_MY	Q6NVY1	79.3	36.0	239.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
17476	sp|P9WNN5|ECH14_MY	Q08426	77.73	7.0	206.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
17477	sp|P9WNN5|ECH14_MY	P9WNP5	87.5	42.0	266.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
17478	sp|P9WNN5|ECH14_MY	P9WNP5	87.5	42.0	266.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
17479	sp|P9WNN5|ECH14_MY	P40939	71.48	40.0	223.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
17480	sp|P9WNN5|ECH14_MY	P28793	74.22	17.0	207.0	DB08249	experimental	3,6,9,12,15-PENTAOXATRICOSAN-1-OL	CCCCCCCCOCCOCCOCCOCCOCCO
17481	sp|P9WQ47|FAC23_MY	Q96GR2	90.75	106.0	636.0	DB08326	experimental	2-(6-HYDROXY-1,3-BENZOTHIAZOL-2-YL)-1,3-THIAZOL-4(5H)-ONE	c1cc(O)cc(c12)sc(n2)C3=NC(=O)CS3
17483	sp|O07778|HK1_MYCT	P0DM80	87.5	340.0	487.0	DB03758	experimental	Radicicol	Oc1cc(O)c(Cl)c(c12)CC(=O)/C=C/C=C\[C@@H]3[C@H](O3)C[C@@H](C)OC2=O
17484	sp|O07778|HK1_MYCT	P23837	86.9	339.0	485.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
17488	sp|O07778|HK1_MYCT	P0AEJ4	83.33	302.0	442.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
17489	sp|O07778|HK1_MYCT	O32393	77.38	651.0	781.0	DB02355	experimental	Adenosine-5'-Rp-Alpha-Thio-Triphosphate	OP(=O)(O)OP(=O)(O)O[P@@](=S)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
17490	sp|O07778|HK1_MYCT	O32393	77.38	651.0	781.0	DB02596	experimental	alpha,beta-Methyleneadenosine 5'-triphosphate	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)CP(=O)(O)OP(=O)(O)O
17491	sp|O07778|HK1_MYCT	O32393	77.38	651.0	781.0	DB07706	experimental	2-Hydroxyestradiol	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)c(c4)O
17492	sp|O07778|HK1_MYCT	P23222	75.6	375.0	502.0	DB02671	experimental	1-Methylimidazole	Cn1cc[nH+]c1
17493	sp|O07778|HK1_MYCT	P23222	75.6	375.0	502.0	DB03366	experimental; investigational	Imidazole	[nH]1ccnc1
17494	sp|O07778|HK1_MYCT	Q9X2W8	77.98	752.0	883.0	DB04066	experimental	p-Coumaric acid	OC(=O)/C=C/c1ccc(O)cc1
17495	sp|O07778|HK1_MYCT	P52687	71.43	426.0	546.0	DB04414	experimental	Heptamolybdate	[OH-]
17496	sp|O07778|HK1_MYCT	P52687	71.43	426.0	546.0	DB04494	experimental	Dihydroxy(oxo)molybdenum(6+)	O[Mo+6](=O)O
17497	sp|O07778|HK1_MYCT	Q9X180	70.83	631.0	750.0	DB02731	experimental	Ethylmercurithiosalicylic acid	CC[Hg]Sc1ccccc1C(=O)O
17498	sp|O07778|HK1_MYCT	O14874	80.36	267.0	402.0	DB02930	experimental	Adenosine 5'-[gamma-thio]triphosphate	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=S)(O)O
17499	sp|L7N6B0|LPQI_MYC	P40406	82.99	71.0	393.0	DB08357	experimental	Diethylene glycol diethyl ether	CCOCCOCCOCC
17500	sp|L7N6B0|LPQI_MYC	Q9KU37	72.16	6.0	286.0	DB07432	experimental	[[(3R,4R,5S,6R)-3-(butanoylamino)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-ylidene]amino] N-phenylcarbamate	CCCC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC\1=N/OC(=O)Nc2ccccc2
17501	sp|L7N6B0|LPQI_MYC	Q9KU37	72.16	6.0	286.0	DB08704	experimental	[[(3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(pentanoylamino)oxan-2-ylidene]amino] N-phenylcarbamate	CCCCC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC\1=N/OC(=O)Nc2ccccc2
17502	sp|P9WQA1|GATA_MYC	Q8RJN5	95.75	47.0	520.0	DB01683	experimental	Chymostatin	c1ccccc1C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C2CCNC(=N)N2)NC(=O)N[C@H](C(=O)O)Cc3ccccc3
17504	sp|P9WNH5|HSAD_MYC	P47229	96.56	3.0	284.0	DB07510	experimental	3-fluoro-6-(4-fluorophenyl)-2-hydroxy-6-oxohexa-2,4-dienoic acid	OC(=O)/C(O)=C(/F)\C=C\C(=O)c1ccc(F)cc1
17505	sp|P9WNH5|HSAD_MYC	P47229	96.56	3.0	284.0	DB07516	experimental	(2Z,4E)-3-chloro-2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoic acid	OC(=O)/C(O)=C(/Cl)\C=C\C(=O)c1ccccc1
17506	sp|P9WNH5|HSAD_MYC	P47229	96.56	3.0	284.0	DB07911	experimental	(3E)-2,6-DIOXO-6-PHENYLHEX-3-ENOATE	[O-]C(=O)C(=O)/C=C/CC(=O)c1ccccc1
17507	sp|P9WNH5|HSAD_MYC	P47229	96.56	3.0	284.0	DB07915	experimental	(2E,4E)-2-Hydroxy-6-oxo-6-phenyl-2,4-hexadienoic acid	OC(=O)/C(O)=C\C=C\C(=O)c1ccccc1
17508	sp|P9WNH5|HSAD_MYC	P96965	88.32	14.0	271.0	DB02406	experimental	N-Valeric Acid	CCCCC(=O)O
17509	sp|P9WNH5|HSAD_MYC	P96965	88.32	14.0	271.0	DB02531	experimental	Isobutyric acid	CC(C)C(=O)O
17510	sp|P9WNH5|HSAD_MYC	P96965	88.32	14.0	271.0	DB03568	experimental; investigational	Butyric Acid	CCCC(=O)O
17511	sp|P9WNH5|HSAD_MYC	P96965	88.32	14.0	271.0	DB03741	experimental	2-Methylbutanoic Acid	CC[C@@H](C)C(=O)O
17512	sp|P9WNH5|HSAD_MYC	P96965	88.32	14.0	271.0	DB03750	experimental	Isovaleric Acid	CC(C)CC(=O)O
17513	sp|P9WNH5|HSAD_MYC	P96965	88.32	14.0	271.0	DB03766	approved; vet_approved	Propanoic acid	CCC(=O)O
17514	sp|P9WNH5|HSAD_MYC	P96965	88.32	14.0	271.0	DB03793	approved; investigational	Benzoic acid	OC(=O)c1ccccc1
17515	sp|P9WNH5|HSAD_MYC	O07015	87.97	10.0	266.0	DB02175	experimental	Malonic acid	OC(=O)CC(=O)O
17516	sp|P9WNH5|HSAD_MYC	O07015	87.97	10.0	266.0	DB03297	experimental	Benzylsulfonic acid	OS(=O)(=O)Cc1ccccc1
17517	sp|P9WNH5|HSAD_MYC	O07015	87.97	10.0	266.0	DB04349	experimental	(S)-propane-1,2-diol	C[C@H](O)CO
17518	sp|P9WNH5|HSAD_MYC	O31168	91.41	10.0	276.0	DB03793	approved; investigational	Benzoic acid	OC(=O)c1ccccc1
17519	sp|P9WNH5|HSAD_MYC	P13001	84.88	3.0	250.0	DB03688	experimental	Hydracrylic acid	OCCC(=O)O
17520	sp|P9WNH5|HSAD_MYC	O07732	85.22	13.0	261.0	DB02596	experimental	alpha,beta-Methyleneadenosine 5'-triphosphate	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)CP(=O)(O)OP(=O)(O)O
17521	sp|P9WNH5|HSAD_MYC	O32449	94.16	23.0	297.0	DB03833	experimental	2-Prolyl-5-Tert-Butyl-[1,3,4]Oxadiazole	C1CCN[C@@H]1C(=O)c2nnc(o2)C(C)(C)C
17522	sp|P9WNH5|HSAD_MYC	O32449	94.16	23.0	297.0	DB07391	experimental	(2S)-2-AMINO-1-(5-TERT-BUTYL-1,3,4-OXADIAZOL-2-YL)PROPAN-1-ONE	C[C@H](N)C(=O)c1nnc(o1)C(C)(C)C
17523	sp|P9WNH5|HSAD_MYC	O32449	94.16	23.0	297.0	DB08576	experimental	1-(5-TERT-BUTYL-1,3,4-OXADIAZOL-2-YL)-2-(METHYLAMINO)ETHANONE	CNCC(=O)c1nnc(o1)C(C)(C)C
17524	sp|P9WG37|KDC_MYCT	P23234	96.79	4.0	546.0	DB01987	approved; experimental	Cocarboxylase	OP([O-])(=O)O[P@](=O)(O)OCCc1c(C)[n+](cs1)Cc2cnc(C)nc2N
17525	sp|P9WG37|KDC_MYCT	P06672	98.93	2.0	556.0	DB04272	approved; nutraceutical; vet_approved	Citric acid	OC(=O)CC(O)(C(=O)O)CC(=O)O
17526	sp|P9WG37|KDC_MYCT	P51852	94.64	4.0	534.0	DB03884	experimental	Phenylpyruvic acid	OC(=O)C(=O)Cc1ccccc1
17527	sp|P9WG37|KDC_MYCT	P51852	94.64	4.0	534.0	DB08050	experimental	5-phenyl-2-keto-valeric acid	OC(=O)C(=O)CCCc1ccccc1
17528	sp|P9WG37|KDC_MYCT	P37063	95.18	12.0	545.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
17530	sp|P9WG37|KDC_MYCT	P27696	96.25	14.0	553.0	DB01987	approved; experimental	Cocarboxylase	OP([O-])(=O)O[P@](=O)(O)OCCc1c(C)[n+](cs1)Cc2cnc(C)nc2N
17531	sp|P9WG37|KDC_MYCT	P27696	96.25	14.0	553.0	DB02327	experimental	Triethylene glycol	OCCOCCOCCO
17532	sp|P9WG37|KDC_MYCT	P27696	96.25	14.0	553.0	DB03361	experimental	2-{(9as)-9a-[(1s)-1-Hydroxyethyl]-2,7-Dimethyl-9a,10-Dihydro-5h-Pyrimido[4,5-D][1,3]Thiazolo[3,2-a]Pyrimidin-8-Yl}Ethyl Trihydrogen Diphosphate	c1nc(C)nc(N2)c1CN([C@]23[C@H](C)O)C(C)=C(S3)CCOP(=O)(O)OP(=O)(O)O
17533	sp|P9WG37|KDC_MYCT	P20906	91.25	10.0	521.0	DB02280	experimental	(R)-Mandelic acid	OC(=O)[C@H](O)c1ccccc1
17534	sp|P9WQF1|MBTL_MYC	O14561	86.9	78.0	151.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
17535	sp|P9WQF1|MBTL_MYC	P0A6A8	84.52	2.0	73.0	DB04450	experimental	Heptyl 1-Thiohexopyranoside	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)SCCCCCCC
17536	sp|P9WQF1|MBTL_MYC	P0A6A8	84.52	2.0	73.0	DB08404	experimental	S-(2-{[N-(2-HYDROXY-4-{[HYDROXY(OXIDO)PHOSPHINO]OXY}-3,3-DIMETHYLBUTANOYL)-BETA-ALANYL]AMINO}ETHYL) HEXANETHIOATE	O[P@H](=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCCCC
17537	sp|P9WQF1|MBTL_MYC	P0A6A8	84.52	2.0	73.0	DB08405	experimental	S-(2-{[N-(2-HYDROXY-4-{[HYDROXY(OXIDO)PHOSPHINO]OXY}-3,3-DIMETHYLBUTANOYL)-BETA-ALANYL]AMINO}ETHYL) HEPTANETHIOATE	O[P@H](=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCCCCC
17538	sp|P9WQF1|MBTL_MYC	P0A6B1	84.52	2.0	73.0	DB03366	experimental; investigational	Imidazole	[nH]1ccnc1
17539	sp|P9WQF1|MBTL_MYC	Q02054	78.57	12.0	78.0	DB08585	experimental	S-[2-({N-[(2S)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] hexanethioate	OP(=O)(O)OCC(C)(C)[C@H](O)C(=O)NCCC(=O)NCCSC(=O)CCCCC
17540	sp|P9WQF1|MBTL_MYC	Q02054	78.57	12.0	78.0	DB08586	experimental	S-[2-({N-[(2S)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] octanethioate	OP(=O)(O)OCC(C)(C)[C@H](O)C(=O)NCCC(=O)NCCSC(=O)CCCCCCC
17541	sp|P9WQF1|MBTL_MYC	P49327	72.62	2127.0	2188.0	DB01034	experimental	Cerulenin	NC(=O)[C@@H]1O[C@@H]1C(=O)CC/C=C/C/C=C/C
17542	sp|P9WQF1|MBTL_MYC	P49327	72.62	2127.0	2188.0	DB01083	approved; investigational	Orlistat	CCCCCCCCCCC[C@H](OC(=O)[C@@H](NC=O)CC(C)C)C[C@@H]1OC(=O)[C@H]1CCCCCC
17543	sp|P9WQP7|3BHS_MYC	P14060	98.92	6.0	372.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
17544	sp|P9WQP7|3BHS_MYC	P14060	98.92	6.0	372.0	DB01108	approved; investigational; vet_approved; withdrawn	Trilostane	C1C[C@H](O)[C@@](C)(CC2)[C@@H]1[C@H](CC3)[C@H]2[C@@]([C@@]345)(C)CC(C#N)=C([C@H]4O5)O
17545	sp|P9WQP7|3BHS_MYC	P14060	98.92	6.0	372.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
17546	sp|P9WQP7|3BHS_MYC	P14060	98.92	6.0	372.0	DB14538	experimental; vet_approved	Hydrocortisone aceponate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CC)C(=O)COC(=O)C
17547	sp|P9WQP7|3BHS_MYC	P14060	98.92	6.0	372.0	DB14539	approved; vet_approved	Hydrocortisone acetate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)C
17548	sp|P9WQP7|3BHS_MYC	P14060	98.92	6.0	372.0	DB14540	approved; vet_approved	Hydrocortisone butyrate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCC
17549	sp|P9WQP7|3BHS_MYC	P14060	98.92	6.0	372.0	DB14541	approved; investigational; vet_approved	Hydrocortisone cypionate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)CCC5CCCC5
17550	sp|P9WQP7|3BHS_MYC	P14060	98.92	6.0	372.0	DB14542	approved; vet_approved	Hydrocortisone phosphate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COP(=O)(O)O
17551	sp|P9WQP7|3BHS_MYC	P14060	98.92	6.0	372.0	DB14543	approved; vet_approved	Hydrocortisone probutate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CCC)C(=O)COC(=O)CC
17552	sp|P9WQP7|3BHS_MYC	P14060	98.92	6.0	372.0	DB14544	approved; vet_approved	Hydrocortisone valerate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCCC
17553	sp|P9WQP7|3BHS_MYC	P26439	98.92	5.0	371.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
17554	sp|P9WQP7|3BHS_MYC	P26439	98.92	5.0	371.0	DB01108	approved; investigational; vet_approved; withdrawn	Trilostane	C1C[C@H](O)[C@@](C)(CC2)[C@@H]1[C@H](CC3)[C@H]2[C@@]([C@@]345)(C)CC(C#N)=C([C@H]4O5)O
17555	sp|P9WQP7|3BHS_MYC	Q15738	89.73	35.0	367.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
17556	sp|P9WQP7|3BHS_MYC	O60547	95.41	14.0	367.0	DB02547	experimental	Guanosine-5'-Diphosphate-Rhamnose	O[C@H]1[C@H](O)[C@H](O)[C@H](O[C@@H]1C)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3cnc(c34)c(=O)nc([nH]4)N
17557	sp|P9WQP7|3BHS_MYC	O60547	95.41	14.0	367.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
17558	sp|P9WQP7|3BHS_MYC	P26391	76.49	2.0	285.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
17559	sp|P9WQP7|3BHS_MYC	Q9ZGH3	72.16	2.0	269.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
17560	sp|P9WQP7|3BHS_MYC	P09147	77.03	2.0	287.0	DB01861	experimental	Uridine diphosphate glucose	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
17561	sp|P9WQP7|3BHS_MYC	P09147	77.03	2.0	287.0	DB02421	experimental	Uridine-5'-diphosphate-mannose	O=c1[nH]c(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O
17562	sp|P9WQP7|3BHS_MYC	P09147	77.03	2.0	287.0	DB02790	experimental	Phenyl-uridine-5'-diphosphate	O=c1[nH]c(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)Oc3ccccc3
17563	sp|P9WQP7|3BHS_MYC	P09147	77.03	2.0	287.0	DB03397	experimental	Uridine-Diphosphate-N-Acetylglucosamine	CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
17564	sp|P9WQP7|3BHS_MYC	P09147	77.03	2.0	287.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
17565	sp|P9WQP7|3BHS_MYC	P09147	77.03	2.0	287.0	DB04097	experimental	Uridine-5'-diphosphate-4-deoxy-4-fluoro-alpha-D-galactose	O=c1[nH]c(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](F)[C@H](O)[C@H]3O
17566	sp|P9WQP7|3BHS_MYC	Q14376	80.27	2.0	299.0	DB01861	experimental	Uridine diphosphate glucose	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
17567	sp|P9WQP7|3BHS_MYC	Q14376	80.27	2.0	299.0	DB02196	experimental	Uridine-Diphosphate-N-Acetylgalactosamine	CC(=O)N[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
17568	sp|P9WQP7|3BHS_MYC	Q14376	80.27	2.0	299.0	DB03041	experimental	UDP-alpha-D-glucuronic acid	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O
17569	sp|P9WQP7|3BHS_MYC	Q14376	80.27	2.0	299.0	DB03095	experimental	Tetramethylammonium	C[N+](C)(C)C
17570	sp|P9WQP7|3BHS_MYC	Q14376	80.27	2.0	299.0	DB03397	experimental	Uridine-Diphosphate-N-Acetylglucosamine	CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
17571	sp|P9WQP7|3BHS_MYC	Q14376	80.27	2.0	299.0	DB03501	experimental	Galactose-uridine-5'-diphosphate	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@H]1O)O[P@](=O)(O)O[P@](=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc(=O)[nH]c3=O
17572	sp|P9WQP7|3BHS_MYC	P95780	73.51	1.0	273.0	DB03161	experimental	Thymidine-5'-diphospho-beta-D-xylose	O=c1[nH]c(=O)c(C)cn1[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3OC[C@@H](O)[C@H](O)[C@H]3O
17573	sp|P9WQP7|3BHS_MYC	P95780	73.51	1.0	273.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
17574	sp|P9WQP7|3BHS_MYC	P14169	72.7	2.0	271.0	DB04555	experimental	Cytidine-5'-Diphosphate	Nc1nc(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O
17575	sp|P9WQP7|3BHS_MYC	P77398	75.41	309.0	588.0	DB03256	experimental	(6R)-Folinic acid	Nc([nH]1)nc(=O)c(c12)N(C=O)[C@@H](CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
17576	sp|P9WQP7|3BHS_MYC	P77398	75.41	309.0	588.0	DB03685	experimental	Uridine monophosphate	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2ccc(=O)[nH]c2=O
17577	sp|P9WQP7|3BHS_MYC	Q51366	71.08	3.0	266.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
17578	sp|P9WQP7|3BHS_MYC	Q8T8E9	88.11	2.0	328.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
17579	sp|P9WQP7|3BHS_MYC	P26397	71.89	8.0	274.0	DB02059	experimental	Adenosine-5-Diphosphoribose	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)CO[P@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H](O)[C@H](O)[C@@H]4O
17580	sp|P9WQP7|3BHS_MYC	P26397	71.89	8.0	274.0	DB03069	experimental	Cytidine-5'-diphospho-beta-D-xylose	Nc1nc(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O[C@H]3OC[C@@H](O)[C@H](O)[C@H]3O
17581	sp|P9WQP7|3BHS_MYC	P32055	71.08	3.0	266.0	DB02897	experimental	Acetylphosphate	CC(=O)OP(=O)(O)O
17582	sp|P9WQP7|3BHS_MYC	P32055	71.08	3.0	266.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
17583	sp|P9WNM7|EFG_MYCT	P13551	97.57	4.0	688.0	DB02703	approved; investigational	Fusidic acid	CC(C)=CCC/C(C(=O)O)=C(/[C@H](C1)OC(=O)C)[C@@H]([C@]12C)C[C@@H](O)[C@@H]3[C@]2(C)CC[C@@H]4[C@]3(C)CC[C@@H](O)[C@H]4C
17584	sp|P9WNM7|EFG_MYCT	P13551	97.57	4.0	688.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
17585	sp|P9WQF5|LEUC_MYC	Q99798	74.84	152.0	506.0	DB01727	experimental	Isocitric Acid	OC(=O)[C@@H](O)[C@@H](C(=O)O)CC(=O)O
17586	sp|P9WQF5|LEUC_MYC	Q99798	74.84	152.0	506.0	DB03964	experimental	4-Hydroxy-Aconitate Ion	[O-]C(=O)/C=C(/C([O-])=O)[C@@H](O)C([O-])=O
17587	sp|P9WQF5|LEUC_MYC	Q99798	74.84	152.0	506.0	DB04072	experimental	Alpha-Methylisocitric Acid	OC(=O)[C@](C)(O)[C@@H](C(=O)O)CC(=O)O
17588	sp|P9WQF5|LEUC_MYC	Q99798	74.84	152.0	506.0	DB04351	experimental	Aconitate Ion	[O-]C(=O)C/C(C([O-])=O)=C/C([O-])=O
17589	sp|P9WQF5|LEUC_MYC	Q99798	74.84	152.0	506.0	DB04562	experimental	Tricarballylic acid	OC(=O)CC(C(=O)O)CC(=O)O
17590	sp|P9WQH9|ACCD_MYC	Q8GBW6	95.35	45.0	517.0	DB04045	experimental	(R)-methylmalonyl-CoA	OC(=O)[C@@H](C)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
17591	sp|P9WQH9|ACCD_MYC	Q8GBW6	95.35	45.0	517.0	DB04183	experimental	Methylmalonic Acid	OC(=O)C(C)C(=O)O
17592	sp|P9WQH9|ACCD_MYC	P05166	94.95	63.0	533.0	DB00121	approved; investigational; nutraceutical	Biotin	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC(=O)O
17593	sp|P9WQH9|ACCD_MYC	P05166	94.95	63.0	533.0	DB00161	approved; nutraceutical	Valine	CC(C)[C@H](N)C(=O)O
17594	sp|P9WQH9|ACCD_MYC	Q9X4K7	96.16	45.0	521.0	DB02912	experimental	Propanoyl-CoA	CCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
17595	sp|P9WQH9|ACCD_MYC	Q9HCC0	92.32	83.0	540.0	DB00121	approved; investigational; nutraceutical	Biotin	O=C(N1)N[C@H]([C@H]12)CS[C@H]2CCCCC(=O)O
17596	sp|P9WQH9|ACCD_MYC	Q06700	93.94	88.0	553.0	DB01942	experimental; investigational	Formic acid	OC=O
17597	sp|P9WNC5|FOLB_MYC	P56740	89.47	1.0	120.0	DB01778	experimental	8-Aminotheophylline	[nH]1c(=N)[nH]c(c12)n(C)c(=O)n(C)c2=O
17598	sp|P9WNC5|FOLB_MYC	P56740	89.47	1.0	120.0	DB01906	experimental	3-(5-amino-7-hydroxy-(1,2,3)triazolo(4,5-d)pyrimidin-2-yl)benzoic acid	Oc1nc(N)nc(c12)nn(n2)-c3cc(C(=O)O)ccc3
17599	sp|P9WNC5|FOLB_MYC	P56740	89.47	1.0	120.0	DB02119	experimental	6-Hydroxymethyl-7,8-Dihydropterin	O=c1[nH]c(N)nc(c12)NCC(=N2)CO
17600	sp|P9WNC5|FOLB_MYC	P56740	89.47	1.0	120.0	DB02489	experimental	9-Methylguanine	Cn1cnc(c12)c(=O)[nH]c(n2)N
17601	sp|P9WNC5|FOLB_MYC	P56740	89.47	1.0	120.0	DB03231	experimental	3-(5-Amino-7-oxo-3,7-dihydro-2H-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(2-{[2-(hydroxymethyl)phenyl]sulfanyl}benzyl)benzamide	Nc(n1)nc(=O)c(c12)nn([nH]2)-c3cccc(c3)C(=O)NCc4ccccc4Sc5ccccc5CO
17602	sp|P9WNC5|FOLB_MYC	P56740	89.47	1.0	120.0	DB03571	experimental	3-(5-amino-7-hydroxy-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(3,5-dichlorobenzyl)-benzamide	Oc1nc(N)nc(c12)nn(n2)-c3cc(ccc3)C(=O)NCc4cc(Cl)cc(Cl)c4
17603	sp|P9WNC5|FOLB_MYC	P56740	89.47	1.0	120.0	DB04168	experimental	Bropirimine	Nc1nc(=O)c(Br)c([nH]1)-c2ccccc2
17604	sp|P9WNC5|FOLB_MYC	P56740	89.47	1.0	120.0	DB04400	experimental	L-erythro-7,8-dihydrobiopterin	C[C@H](O)[C@H](O)C(CN1)=Nc(c12)c(=O)nc([nH]2)N
17605	sp|P9WNC5|FOLB_MYC	P56740	89.47	1.0	120.0	DB04425	experimental	7,8-Dihydroneopterin	O=c1[nH]c(N)nc(c12)NCC(=N2)[C@H](O)[C@H](O)CO
17606	sp|P9WNC5|FOLB_MYC	P56740	89.47	1.0	120.0	DB06906	experimental	ethyl 2-amino-4-hydroxypyrimidine-5-carboxylate	CCOC(=O)c1cnc(N)nc1O
17607	sp|P9WNC5|FOLB_MYC	P53848	89.47	20.0	139.0	DB00634	approved	Sulfacetamide	CC(=O)NS(=O)(=O)c1ccc(N)cc1
17608	sp|P9WQ79|GABT_MYC	P22256	92.65	3.0	419.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
17609	sp|P9WQ79|GABT_MYC	P22256	92.65	3.0	419.0	DB02783	experimental	4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate	Cc1ncc(COP(=O)(O)O)c(c1O)CNOCC(=O)O
17610	sp|P9WQ79|GABT_MYC	P80404	100.89	45.0	498.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
17611	sp|P9WQ79|GABT_MYC	P80404	100.89	45.0	498.0	DB00119	approved; investigational; nutraceutical	Pyruvic acid	CC(=O)C(=O)O
17612	sp|P9WQ79|GABT_MYC	P80404	100.89	45.0	498.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
17613	sp|P9WQ79|GABT_MYC	P80404	100.89	45.0	498.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
17614	sp|P9WQ79|GABT_MYC	P80404	100.89	45.0	498.0	DB00780	approved	Phenelzine	NNCCc1ccccc1
17615	sp|P9WQ79|GABT_MYC	P80404	100.89	45.0	498.0	DB01080	approved	Vigabatrin	C=CC(N)CCC(=O)O
17616	sp|P9WQ79|GABT_MYC	P80404	100.89	45.0	498.0	DB01699	experimental	(4e)-4-Aminohex-4-Enoic Acid	C/C=C(/N)CCC(=O)O
17617	sp|P9WQ79|GABT_MYC	P80404	100.89	45.0	498.0	DB04235	experimental	4-Amino Hexanoic Acid	CC[C@@H](N)CCC(=O)O
17618	sp|P9WQ79|GABT_MYC	Q9BYV1	94.65	81.0	506.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
17619	sp|P9WQ79|GABT_MYC	Q9BYV1	94.65	81.0	506.0	DB00119	approved; investigational; nutraceutical	Pyruvic acid	CC(=O)C(=O)O
17620	sp|P9WQ79|GABT_MYC	Q9BYV1	94.65	81.0	506.0	DB00145	approved; nutraceutical; vet_approved	Glycine	NCC(=O)O
17621	sp|P9WQ79|GABT_MYC	Q9BYV1	94.65	81.0	506.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
17622	sp|P9WQ79|GABT_MYC	Q8IUZ5	90.65	28.0	435.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
17623	sp|P9WQ79|GABT_MYC	Q8IUZ5	90.65	28.0	435.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
17624	sp|P9WQ79|GABT_MYC	P16932	91.76	15.0	427.0	DB02038	experimental	D-[3-hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl]-N,O-cycloserylamide	Cc1ncc(COP(=O)(O)O)c(c1O)CN[C@@H]2CONC2=O
17625	sp|P9WQ79|GABT_MYC	P16932	91.76	15.0	427.0	DB02849	experimental	N-Pyridoxyl-1-Amino-Cyclopropanecarboxylic Acid-5-Monophosphate	Cc1ncc(COP(=O)(O)O)c(c1O)CNC2(CC2)C(=O)O
17626	sp|P9WQ79|GABT_MYC	P16932	91.76	15.0	427.0	DB03787	experimental	(5-Hydroxy-6-methyl-4-{[(E)-(3-oxo-1,2-oxazolidin-4-ylidene)amino]methyl}-3-pyridinyl)methyl dihydrogen phosphate	Cc1ncc(COP(=O)(O)O)c(c1O)C/N=C2\CONC2=O
17627	sp|P9WQ79|GABT_MYC	P16932	91.76	15.0	427.0	DB04241	experimental	N-Pyridoxyl-2-Methylalanine-5-Phosphate	Cc1ncc(COP(=O)(O)O)c(c1O)CNC(C)(C)C(=O)O
17628	sp|P9WQ79|GABT_MYC	Q6LFH8	85.3	22.0	405.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
17629	sp|P9WQ79|GABT_MYC	P04181	89.31	33.0	434.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
17630	sp|P9WQ79|GABT_MYC	P04181	89.31	33.0	434.0	DB00129	approved; nutraceutical	Ornithine	NCCC[C@H](N)C(=O)O
17631	sp|P9WQ79|GABT_MYC	P04181	89.31	33.0	434.0	DB02054	experimental	Gabaculine	Nc1cccc(c1)C(=O)O
17632	sp|P9WQ79|GABT_MYC	P04181	89.31	33.0	434.0	DB02821	experimental	Canaline	NOCC[C@H](N)C(=O)O
17633	sp|P9WQ79|GABT_MYC	P12995	89.09	21.0	421.0	DB02274	experimental	7-Keto-8-Aminopelargonic Acid	C[C@H](N)C(=O)CCCCCC(=O)O
17634	sp|P9WQ79|GABT_MYC	P12995	89.09	21.0	421.0	DB02725	experimental	2-Amino-4-(4-Amino-Cyclohexa-2,5-Dienyl)-Butyric Acid	OC(=O)[C@@H](N)CC[C@H]1C=CC(N)C=C1
17635	sp|P9WQ79|GABT_MYC	P12995	89.09	21.0	421.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
17636	sp|P9WQ79|GABT_MYC	P9WQ77	91.76	31.0	443.0	DB08071	experimental	(2S)-1-methyl-2-[(2S,4R)-2-methyl-4-phenylpentyl]piperidine	CN1CCCC[C@H]1C[C@@H](C)C[C@@H](C)c2ccccc2
17637	sp|P9WN57|GCH1_MYC	P30793	88.12	70.0	248.0	DB02377	experimental	Guanine	Nc([nH]1)nc(=O)c(c12)[nH]cn2
17638	sp|P9WN57|GCH1_MYC	P0A6T8	88.12	40.0	218.0	DB04137	experimental	Guanosine-5'-Triphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
17639	sp|P9WMN9|GSA_MYCT	P24630	90.04	11.0	427.0	DB02054	experimental	Gabaculine	Nc1cccc(c1)C(=O)O
17640	sp|P9WMN9|GSA_MYCT	P24630	90.04	11.0	427.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
17641	sp|P9WMN9|GSA_MYCT	Q8IUZ5	75.32	29.0	377.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
17642	sp|P9WMN9|GSA_MYCT	Q8IUZ5	75.32	29.0	377.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
17643	sp|P9WMN9|GSA_MYCT	Q9BYV1	79.87	78.0	447.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
17644	sp|P9WMN9|GSA_MYCT	Q9BYV1	79.87	78.0	447.0	DB00119	approved; investigational; nutraceutical	Pyruvic acid	CC(=O)C(=O)O
17645	sp|P9WMN9|GSA_MYCT	Q9BYV1	79.87	78.0	447.0	DB00145	approved; nutraceutical; vet_approved	Glycine	NCC(=O)O
17646	sp|P9WMN9|GSA_MYCT	Q9BYV1	79.87	78.0	447.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
17647	sp|P9WMN9|GSA_MYCT	P04181	71.43	55.0	385.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
17648	sp|P9WMN9|GSA_MYCT	P04181	71.43	55.0	385.0	DB00129	approved; nutraceutical	Ornithine	NCCC[C@H](N)C(=O)O
17649	sp|P9WMN9|GSA_MYCT	P04181	71.43	55.0	385.0	DB02054	experimental	Gabaculine	Nc1cccc(c1)C(=O)O
17650	sp|P9WMN9|GSA_MYCT	P04181	71.43	55.0	385.0	DB02821	experimental	Canaline	NOCC[C@H](N)C(=O)O
17651	sp|P9WMN9|GSA_MYCT	P22256	76.41	19.0	372.0	DB02142	experimental	Pyridoxamine-5'-Phosphate	Cc1ncc(c(CN)c1O)COP(=O)(O)O
17652	sp|P9WMN9|GSA_MYCT	P22256	76.41	19.0	372.0	DB02783	experimental	4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate	Cc1ncc(COP(=O)(O)O)c(c1O)CNOCC(=O)O
17653	sp|P9WMN9|GSA_MYCT	Q6LFH8	71.86	28.0	360.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
17654	sp|P9WMN9|GSA_MYCT	P16932	75.32	20.0	368.0	DB02038	experimental	D-[3-hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl]-N,O-cycloserylamide	Cc1ncc(COP(=O)(O)O)c(c1O)CN[C@@H]2CONC2=O
17655	sp|P9WMN9|GSA_MYCT	P16932	75.32	20.0	368.0	DB02849	experimental	N-Pyridoxyl-1-Amino-Cyclopropanecarboxylic Acid-5-Monophosphate	Cc1ncc(COP(=O)(O)O)c(c1O)CNC2(CC2)C(=O)O
17656	sp|P9WMN9|GSA_MYCT	P16932	75.32	20.0	368.0	DB03787	experimental	(5-Hydroxy-6-methyl-4-{[(E)-(3-oxo-1,2-oxazolidin-4-ylidene)amino]methyl}-3-pyridinyl)methyl dihydrogen phosphate	Cc1ncc(COP(=O)(O)O)c(c1O)C/N=C2\CONC2=O
17657	sp|P9WMN9|GSA_MYCT	P16932	75.32	20.0	368.0	DB04241	experimental	N-Pyridoxyl-2-Methylalanine-5-Phosphate	Cc1ncc(COP(=O)(O)O)c(c1O)CNC(C)(C)C(=O)O
17658	sp|P9WMN9|GSA_MYCT	P12995	74.89	29.0	375.0	DB02274	experimental	7-Keto-8-Aminopelargonic Acid	C[C@H](N)C(=O)CCCCCC(=O)O
17659	sp|P9WMN9|GSA_MYCT	P12995	74.89	29.0	375.0	DB02725	experimental	2-Amino-4-(4-Amino-Cyclohexa-2,5-Dienyl)-Butyric Acid	OC(=O)[C@@H](N)CC[C@H]1C=CC(N)C=C1
17660	sp|P9WMN9|GSA_MYCT	P12995	74.89	29.0	375.0	DB04083	experimental	N(6)-(pyridoxal phosphate)-L-lysine	Cc1ncc(COP(=O)(O)O)c(c1O)/C=N/CCCC[C@H](N)C(=O)O
17661	sp|P9WMN9|GSA_MYCT	P80404	80.52	78.0	450.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
17662	sp|P9WMN9|GSA_MYCT	P80404	80.52	78.0	450.0	DB00119	approved; investigational; nutraceutical	Pyruvic acid	CC(=O)C(=O)O
17663	sp|P9WMN9|GSA_MYCT	P80404	80.52	78.0	450.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
17664	sp|P9WMN9|GSA_MYCT	P80404	80.52	78.0	450.0	DB00160	nutraceutical	Alanine	C[C@H](N)C(=O)O
17665	sp|P9WMN9|GSA_MYCT	P80404	80.52	78.0	450.0	DB00780	approved	Phenelzine	NNCCc1ccccc1
17666	sp|P9WMN9|GSA_MYCT	P80404	80.52	78.0	450.0	DB01080	approved	Vigabatrin	C=CC(N)CCC(=O)O
17667	sp|P9WMN9|GSA_MYCT	P80404	80.52	78.0	450.0	DB01699	experimental	(4e)-4-Aminohex-4-Enoic Acid	C/C=C(/N)CCC(=O)O
17668	sp|P9WMN9|GSA_MYCT	P80404	80.52	78.0	450.0	DB04235	experimental	4-Amino Hexanoic Acid	CC[C@@H](N)CCC(=O)O
17669	sp|P9WMN9|GSA_MYCT	P9WQ77	78.35	39.0	401.0	DB08071	experimental	(2S)-1-methyl-2-[(2S,4R)-2-methyl-4-phenylpentyl]piperidine	CN1CCCC[C@H]1C[C@@H](C)C[C@@H](C)c2ccccc2
17671	sp|P9WHH7|LPDA_MYC	P14218	93.91	5.0	468.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
17672	sp|P9WHH7|LPDA_MYC	P18925	93.91	5.0	468.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
17673	sp|P9WHH7|LPDA_MYC	P09622	93.1	43.0	502.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
17674	sp|P9WHH7|LPDA_MYC	P09622	93.1	43.0	502.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
17675	sp|P9WHH7|LPDA_MYC	P00390	92.49	65.0	521.0	DB00143	approved; investigational; nutraceutical	Glutathione	OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(=O)O
17676	sp|P9WHH7|LPDA_MYC	P00390	92.49	65.0	521.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
17677	sp|P9WHH7|LPDA_MYC	P00390	92.49	65.0	521.0	DB00262	approved; investigational	Carmustine	ClCCNC(=O)N(N=O)CCCl
17678	sp|P9WHH7|LPDA_MYC	P00390	92.49	65.0	521.0	DB01644	experimental	3,6-dihydroxy-xanthene-9-propionic acid	OC(=O)CCC1c(ccc(c2)O)c2Oc(c13)cc(O)cc3
17679	sp|P9WHH7|LPDA_MYC	P00390	92.49	65.0	521.0	DB02153	experimental	3-sulfino-L-alanine	OC(=O)[C@@H](N)C[S@](=O)O
17680	sp|P9WHH7|LPDA_MYC	P00390	92.49	65.0	521.0	DB02553	experimental	Glutathionylspermidine disulfide	NCCCCNCCCNC(=O)CNC(=O)[C@@H](NC(=O)CC[C@@H](N)C(=O)O)CSSC[C@H](NC(=O)CC[C@@H](N)C(=O)O)C(=O)NCC(=O)NCCCNCCCCN
17681	sp|P9WHH7|LPDA_MYC	P00390	92.49	65.0	521.0	DB02895	experimental	3-(Prop-2-Ene-1-Sulfinyl)-Propene-1-Thiol	S/C=C/C[S@](=O)CC=C
17682	sp|P9WHH7|LPDA_MYC	P00390	92.49	65.0	521.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
17683	sp|P9WHH7|LPDA_MYC	P00390	92.49	65.0	521.0	DB03310	approved; experimental; investigational	Glutathione disulfide	OC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)NCC(=O)O)CSSC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@H](N)C(=O)O
17684	sp|P9WHH7|LPDA_MYC	P00390	92.49	65.0	521.0	DB03867	experimental	3-nitro-L-tyrosine	OC(=O)[C@@H](N)Cc1cc([N+]([O-])=O)c(O)cc1
17685	sp|P9WHH7|LPDA_MYC	P00390	92.49	65.0	521.0	DB07393	experimental	2-(2-PHENYL-3-PYRIDIN-2-YL-4,5,6,7-TETRAHYDRO-2H-ISOPHOSPHINDOL-1-YL)PYRIDINE	n1ccccc1-c2p(-c3ccccc3)c(c(c24)CCCC4)-c5ncccc5
17686	sp|P9WHH7|LPDA_MYC	P00390	92.49	65.0	521.0	DB07714	experimental	6-(3-METHYL-1,4-DIOXO-1,4-DIHYDRONAPHTHALEN-2-YL)HEXANOIC ACID	c1cccc(c12)C(=O)C(=C(C2=O)C)CCCCCC(=O)O
17687	sp|P9WHH7|LPDA_MYC	P00390	92.49	65.0	521.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
17688	sp|P9WHH7|LPDA_MYC	P00390	92.49	65.0	521.0	DB09130	approved; investigational	Copper	[Cu]
17690	sp|P9WHH7|LPDA_MYC	P00390	92.49	65.0	521.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
17691	sp|P9WHH7|LPDA_MYC	Q51225	94.93	118.0	586.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
17692	sp|P9WHH7|LPDA_MYC	P06715	89.86	5.0	448.0	DB00336	approved; investigational; vet_approved	Nitrofural	NC(=O)N/N=C/c1ccc(o1)[N+]([O-])=O
17693	sp|P9WHH7|LPDA_MYC	P06715	89.86	5.0	448.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
17694	sp|P9WHH7|LPDA_MYC	Q9NNW7	97.16	40.0	519.0	DB05428	investigational	Motexafin gadolinium	CCc(c12)c(CC)c([n-]1)cc3nc(c(C)c3CCCO)cnc4c(ncc5nc(c2)c(c5C)CCCO)cc(OCCOCCOCCOC)c(c4)OCCOCCOCCOC
17695	sp|P9WHH7|LPDA_MYC	Q94655	100.0	1.0	494.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
17696	sp|P9WHH7|LPDA_MYC	P28593	94.32	5.0	470.0	DB02240	experimental	Quinacrine mustard	c1cc(Cl)cc(n2)c1c(c(c23)cc(OC)cc3)NC(C)CCCN(CCCl)CCCl
17697	sp|P9WHH7|LPDA_MYC	P28593	94.32	5.0	470.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
17698	sp|P9WHH7|LPDA_MYC	P28593	94.32	5.0	470.0	DB03470	experimental	Trypanothione	OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(=O)NCCCCNCCCNC(=O)CNC(=O)[C@H](CS)NC(=O)CC[C@H](N)C(=O)O
17699	sp|P9WHH7|LPDA_MYC	P28593	94.32	5.0	470.0	DB04299	experimental	Maleic Acid	OC(=O)/C=C\C(=O)O
17700	sp|P9WHH7|LPDA_MYC	Q16881	96.15	163.0	637.0	DB01169	approved; investigational	Arsenic trioxide	O=[As]O[As]=O
17701	sp|P9WHH7|LPDA_MYC	Q16881	96.15	163.0	637.0	DB02338	experimental	NADPH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
17702	sp|P9WHH7|LPDA_MYC	Q16881	96.15	163.0	637.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
17703	sp|P9WHH7|LPDA_MYC	Q16881	96.15	163.0	637.0	DB03566	experimental	Spermidine	NCCCCNCCCN
17704	sp|P9WHH7|LPDA_MYC	Q16881	96.15	163.0	637.0	DB04106	investigational	Fotemustine	CCOP(=O)(OCC)[C@@H](C)NC(=O)N(N=O)CCCl
17705	sp|P9WHH7|LPDA_MYC	Q16881	96.15	163.0	637.0	DB05428	investigational	Motexafin gadolinium	CCc(c12)c(CC)c([n-]1)cc3nc(c(C)c3CCCO)cnc4c(ncc5nc(c2)c(c5C)CCCO)cc(OCCOCCOCCOC)c(c4)OCCOCCOCCOC
17706	sp|P9WHH7|LPDA_MYC	Q16881	96.15	163.0	637.0	DB05448	investigational	PX-12	CCC(C)SSc1ncc[nH]1
17707	sp|P9WHH7|LPDA_MYC	P09063	90.87	7.0	455.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
17708	sp|P9WHH7|LPDA_MYC	Q56839	91.89	44.0	497.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
17709	sp|P9WHH7|LPDA_MYC	Q56839	91.89	44.0	497.0	DB03163	experimental	2-oxopropyl-CoM	CC(=O)CSCCS(=O)(=O)O
17710	sp|P9WHH7|LPDA_MYC	P37062	71.2	67.0	418.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
17711	sp|P9WHH7|LPDA_MYC	P37062	71.2	67.0	418.0	DB03382	experimental	S-oxy-L-cysteine	OC(=O)[C@@H](N)CS=O
17713	sp|P9WP03|DEOC_MYC	Q5SJ28	94.2	2.0	213.0	DB04087	experimental	Open Form of 2'-Deoxy-Ribofuranose-5'-Phosphate	OCC[C@H](O)[C@H](O)COP(=O)(O)O
17714	sp|P9WP03|DEOC_MYC	P0A6L0	94.64	10.0	222.0	DB04087	experimental	Open Form of 2'-Deoxy-Ribofuranose-5'-Phosphate	OCC[C@H](O)[C@H](O)COP(=O)(O)O
17715	sp|P9WP27|DAO_MYCT	P14920	102.81	2.0	331.0	DB02838	experimental	3,4-Dihydro-2h-Pyrrolium-5-Carboxylate	[O-]C(=O)C1=[NH+]CCC1
17716	sp|P9WP27|DAO_MYCT	P14920	102.81	2.0	331.0	DB02988	experimental	Imino-Tryptophan	OC(=O)C(=N)Cc1c[nH]c(c12)cccc2
17717	sp|P9WP27|DAO_MYCT	P14920	102.81	2.0	331.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
17718	sp|P9WP27|DAO_MYCT	P14920	102.81	2.0	331.0	DB03225	experimental	D-Tryptophan	OC(=O)[C@H](N)Cc1c[nH]c(c12)cccc2
17719	sp|P9WP27|DAO_MYCT	P14920	102.81	2.0	331.0	DB03531	experimental	Flavin-adenine dinucleotide-N5-isobutyl ketone	CC(C)C(=O)N1c(cc(C)c(c2)C)c2N(c(c13)[nH]c(=O)nc3[O-])C[C@H](O)[C@H](O)[C@H](O)COP(=O)(O)OP(=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)[N+]5=CN=C(C5=6)C(=N)N=CN6
17720	sp|P9WP27|DAO_MYCT	P14920	102.81	2.0	331.0	DB03793	approved; investigational	Benzoic acid	OC(=O)c1ccccc1
17721	sp|P9WP27|DAO_MYCT	P14920	102.81	2.0	331.0	DB04166	experimental	Anthranilic acid	Nc1ccccc1C(=O)O
17722	sp|P9WP27|DAO_MYCT	P14920	102.81	2.0	331.0	DB07979	experimental	(2E)-3-(3,4-DIHYDROXYPHENYL)-2-IMINOPROPANOIC ACID	OC(=O)C(=N)Cc1cc(O)c(O)cc1
17724	sp|P9WNL1|ENO_MYCT	P09104	99.07	3.0	428.0	DB02726	experimental	2-Phosphoglycolic Acid	OC(=O)COP(=O)(O)O
17725	sp|P9WNL1|ENO_MYCT	P06733	99.07	3.0	428.0	DB01593	approved; investigational	Zinc	[Zn]
17726	sp|P9WNL1|ENO_MYCT	P06733	99.07	3.0	428.0	DB09130	approved; investigational	Copper	[Cu]
17727	sp|P9WNL1|ENO_MYCT	P06733	99.07	3.0	428.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
17728	sp|P9WNL1|ENO_MYCT	P06733	99.07	3.0	428.0	DB14487	approved; investigational	Zinc acetate	CC([O-])=O
17729	sp|P9WNL1|ENO_MYCT	P06733	99.07	3.0	428.0	DB14533	approved; investigational	Zinc chloride	[Cl-]
17730	sp|P9WNL1|ENO_MYCT	P06733	99.07	3.0	428.0	DB14548	approved; experimental	Zinc sulfate, unspecified form	 
17731	sp|P9WNL1|ENO_MYCT	P13929	99.07	3.0	428.0	DB01709	experimental	2-phospho-D-glyceric acid	OC[C@H](C(=O)O)OP(=O)(O)O
17732	sp|P9WNL1|ENO_MYCT	P13929	99.07	3.0	428.0	DB01819	experimental	Phosphoenolpyruvate	OC(=O)C(=C)OP(=O)(O)O
17733	sp|P9WNL1|ENO_MYCT	P13929	99.07	3.0	428.0	DB02726	experimental	2-Phosphoglycolic Acid	OC(=O)COP(=O)(O)O
17734	sp|P9WNL1|ENO_MYCT	P13929	99.07	3.0	428.0	DB03645	experimental	Phosphonoacetohydroxamic Acid	ONC(=O)CP(=O)(O)O
17735	sp|P9WNL1|ENO_MYCT	Q27655	99.3	3.0	429.0	DB12245	approved; investigational	Triclabendazole	CSc([nH]1)nc(c12)cc(c(Cl)c2)Oc3cccc(Cl)c3Cl
17736	sp|P9WNL1|ENO_MYCT	Q8IJN7	101.86	4.0	441.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
17737	sp|P9WNU3|EX53_MYC	P52026	89.94	1.0	287.0	DB07435	experimental	1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE	O[C@H]1[C@H](O)[C@H](O)Cc(c12)c3c4c(c2)ccc5c4c(cc3)ccc5
17738	sp|P9WNU3|EX53_MYC	P00582	89.62	6.0	291.0	DB00548	approved	Azelaic acid	OC(=O)CCCCCCCC(=O)O
17739	sp|P9WNU3|EX53_MYC	P00582	89.62	6.0	291.0	DB08432	experimental	THYMIDINE-5'-THIOPHOSPHATE	OP(=S)(O)OC[C@H]1O[C@H](C[C@@H]1O)n2cc(C)c(=O)[nH]c2=O
17740	sp|P9WNU3|EX53_MYC	P19821	86.16	11.0	285.0	DB03152	experimental	B-2-Octylglucoside	O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1OCCCCCCCC
17741	sp|P9WNU3|EX53_MYC	P19821	86.16	11.0	285.0	DB03258	experimental	2'-Deoxycytidine 5'-triphosphate	Nc1nc(=O)n(cc1)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
17742	sp|P9WNU3|EX53_MYC	P39748	74.21	31.0	267.0	DB01592	approved	Iron	[Fe]
17743	sp|P9WNU3|EX53_MYC	P39748	74.21	31.0	267.0	DB14488	approved	Ferrous gluconate	OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O
17744	sp|P9WNU3|EX53_MYC	P39748	74.21	31.0	267.0	DB14489	approved	Ferrous succinate	[O-]C(=O)CCC([O-])=O
17745	sp|P9WNU3|EX53_MYC	P39748	74.21	31.0	267.0	DB14490	approved	Ferrous ascorbate	OC[C@H](O)[C@H]1OC(=O)C(O)=C1O
17746	sp|P9WNU3|EX53_MYC	P39748	74.21	31.0	267.0	DB14491	approved	Ferrous fumarate	[O-]C(=O)/C=C/C([O-])=O
17747	sp|P9WNU3|EX53_MYC	P39748	74.21	31.0	267.0	DB14501	approved	Ferrous glycine sulfate	NCC([O-])=O
17748	sp|P9WQ53|FAD11_MY	Q96GR2	79.86	265.0	721.0	DB08326	experimental	2-(6-HYDROXY-1,3-BENZOTHIAZOL-2-YL)-1,3-THIAZOL-4(5H)-ONE	c1cc(O)cc(c12)sc(n2)C3=NC(=O)CS3
17749	sp|P9WQ53|FAD11_MY	P33121	75.83	262.0	695.0	DB00131	approved; investigational; nutraceutical	Adenosine phosphate	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
17750	sp|P9WQ53|FAD11_MY	P33121	75.83	262.0	695.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
17751	sp|P9WQ53|FAD11_MY	O60488	77.23	268.0	709.0	DB00159	approved; nutraceutical	Icosapent	CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O
17752	sp|P9WQ53|FAD11_MY	O60488	77.23	268.0	709.0	DB00197	approved; investigational; withdrawn	Troglitazone	Cc1c(O)c(C)c(C)c(c12)OC(C)(CC2)COc3ccc(cc3)CC4SC(=O)NC4=O
17753	sp|P9WQ53|FAD11_MY	O60488	77.23	268.0	709.0	DB00412	approved; investigational	Rosiglitazone	c1cccnc1N(C)CCOc2ccc(cc2)CC3SC(=O)NC3=O
17754	sp|P9WQ53|FAD11_MY	Q8I0X2	80.04	292.0	749.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
17755	sp|P9WPK1|GLPK_MYC	P0A6F3	95.94	3.0	499.0	DB02937	experimental	Gamma-Arsono-Beta, Gamma-Methyleneadenosine-5'-Diphosphate	O[As](=O)(O)CP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
17756	sp|P9WPK1|GLPK_MYC	P0A6F3	95.94	3.0	499.0	DB04551	experimental	beta-D-fructofuranose 1,6-bisphosphate	OP(=O)(O)OC[C@H]([C@@H](O)[C@@H]1O)O[C@]1(O)COP(=O)(O)O
17757	sp|P9WIC9|GPMA_MYC	P15259	100.0	2.0	251.0	DB01681	experimental	Benzene Hexacarboxylic Acid	OC(=O)c1c(C(=O)O)c(C(=O)O)c(C(=O)O)c(C(=O)O)c1C(=O)O
17758	sp|P9WIC9|GPMA_MYC	P15259	100.0	2.0	251.0	DB04510	experimental	3-phospho-D-glyceric acid	OC(=O)[C@H](O)COP(=O)(O)O
17759	sp|P9WIC9|GPMA_MYC	P18669	99.2	4.0	251.0	DB09130	approved; investigational	Copper	[Cu]
17760	sp|P9WIC9|GPMA_MYC	P18669	99.2	4.0	251.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
17761	sp|P9WIC9|GPMA_MYC	Q3JWH7	97.59	3.0	246.0	DB02580	experimental	Pentaglyme	COCCOCCOCCOCCOCCOC
17762	sp|P9WQB3|LEU1_MYC	P9WQB3	99.84	1.0	644.0	DB04074	experimental	alpha-Ketoisovalerate	CC(C)C(=O)C(=O)O
17763	sp|P9WNP7|FADB2_MY	P28793	98.25	311.0	592.0	DB08249	experimental	3,6,9,12,15-PENTAOXATRICOSAN-1-OL	CCCCCCCCOCCOCCOCCOCCOCCO
17764	sp|P9WNP7|FADB2_MY	Q08426	100.0	296.0	582.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
17765	sp|P9WNP7|FADB2_MY	P40939	97.9	359.0	639.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
17766	sp|P9WNP7|FADB2_MY	Q16836	100.35	26.0	313.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
17767	sp|P9WNP7|FADB2_MY	Q16836	100.35	26.0	313.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
17768	sp|P9WNP7|FADB2_MY	Q16836	100.35	26.0	313.0	DB03612	experimental	3-Hydroxybutyryl-Coenzyme A	CC(O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
17769	sp|P9WNP7|FADB2_MY	Q16836	100.35	26.0	313.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
17770	sp|P9WMC1|ETHR_MYC	P9WMC1	99.54	1.0	216.0	DB02425	experimental	Hexadecyl Octanoate	CCCCCCCCCCCCCCCOC(=O)CCCCCCC
17771	sp|P9WMC1|ETHR_MYC	P9WMC1	99.54	1.0	216.0	DB08469	experimental	tert-butyl 4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine-1-carboxylate	CC(C)(C)OC(=O)N1CCC(CC1)c2nc(no2)-c3cccs3
17772	sp|P9WMC1|ETHR_MYC	P9WMC1	99.54	1.0	216.0	DB08470	experimental	3-(4-fluorophenyl)-5-phenyl-4H-1,2,4-triazole	Fc1ccc(cc1)-c2nnc([nH]2)-c3ccccc3
17773	sp|P9WMC1|ETHR_MYC	P9WMC1	99.54	1.0	216.0	DB08471	experimental	1-(thiophen-2-ylacetyl)-4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine	c1ccsc1CC(=O)N2CCC(CC2)c3nc(no3)-c4cccs4
17774	sp|P9WG95|ILVA_MYC	Q96GA7	74.36	8.0	327.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
17775	sp|P9WG95|ILVA_MYC	P20132	73.43	5.0	320.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
17776	sp|P9WG95|ILVA_MYC	P20132	73.43	5.0	320.0	DB00133	investigational; nutraceutical	Serine	OC(=O)[C@@H](N)CO
17777	sp|P9WG95|ILVA_MYC	Q9GZT4	75.06	3.0	325.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
17778	sp|P9WG95|ILVA_MYC	Q9GZT4	75.06	3.0	325.0	DB00133	investigational; nutraceutical	Serine	OC(=O)[C@@H](N)CO
17779	sp|P9WG95|ILVA_MYC	P35520	73.89	57.0	374.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
17780	sp|P9WG95|ILVA_MYC	P35520	73.89	57.0	374.0	DB00118	approved; investigational; nutraceutical	Ademetionine	[O-]C(=O)[C@@H](N)CC[S+](C)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
17781	sp|P9WG95|ILVA_MYC	P35520	73.89	57.0	374.0	DB00133	investigational; nutraceutical	Serine	OC(=O)[C@@H](N)CO
17782	sp|P9WG95|ILVA_MYC	P35520	73.89	57.0	374.0	DB00151	approved; nutraceutical	Cysteine	OC(=O)[C@@H](N)CS
17783	sp|P9WPM9|C135B_MY	P08684	97.88	35.0	497.0	DB00143	approved; investigational; nutraceutical	Glutathione	OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(=O)O
17784	sp|P9WPM9|C135B_MY	P08684	97.88	35.0	497.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
17785	sp|P9WPM9|C135B_MY	P08684	97.88	35.0	497.0	DB05478	investigational	Pradefovir mesylate	n1cnc(N)c(c12)ncn2CCOC[P@@]3(=O)OCC[C@H](O3)c4cc(Cl)ccc4
17786	sp|P9WPM9|C135B_MY	P08684	97.88	35.0	497.0	DB06634	investigational	Casopitant	FC(F)(F)c1cc(cc(c1)C(F)(F)F)[C@@H](C)N(C)C(=O)N2CC[C@H](N3CCN(CC3)C(=O)C)C[C@@H]2c4ccc(F)cc4C
17787	sp|P9WPM9|C135B_MY	P08684	97.88	35.0	497.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
17788	sp|P9WPM9|C135B_MY	P20815	97.46	36.0	496.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
17789	sp|P9WPM9|C135B_MY	P20815	97.46	36.0	496.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
17790	sp|P9WPM9|C135B_MY	P20815	97.46	36.0	496.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
17791	sp|P9WPM9|C135B_MY	P24462	97.88	35.0	497.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
17792	sp|P9WPM9|C135B_MY	P24462	97.88	35.0	497.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
17793	sp|P9WPM9|C135B_MY	P24462	97.88	35.0	497.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
17794	sp|P9WPM9|C135B_MY	Q9HB55	97.67	35.0	496.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
17795	sp|P9WPM9|C135B_MY	P11712	93.22	27.0	467.0	DB03317	experimental	Ferroheme C	[Fe-2]123[N+]4=C5C=C6[N+]1=C(C(C)=C6C(C)S)C=C7[N+]2=C(C(=C7C)CCC(=O)O)C=C8[N+]3=C(C=C4C(=C5C)C(C)S)C(C)=C8CCC(=O)O
17796	sp|P9WPM9|C135B_MY	P11712	93.22	27.0	467.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
17797	sp|P9WPM9|C135B_MY	P11712	93.22	27.0	467.0	DB12319	investigational; withdrawn	Benzbromarone	c1cccc(c12)c(c(o2)CC)C(=O)c3cc(Br)c(O)c(Br)c3
17798	sp|P9WPM9|C135B_MY	P33260	91.95	28.0	462.0	DB07670	experimental	N,4-Dimethyl-N-(1-phenyl-1H-pyrazol-5-yl)benzenesulfonamide	Cc1ccc(cc1)S(=O)(=O)N(C)c2ccnn2-c3ccccc3
17799	sp|P9WPM9|C135B_MY	P10632	93.43	28.0	469.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
17800	sp|P9WPM9|C135B_MY	P10632	93.43	28.0	469.0	DB03796	approved	Palmitic Acid	CCCCCCCCCCCCCCCC(=O)O
17801	sp|P9WPM9|C135B_MY	P10632	93.43	28.0	469.0	DB08607	experimental	(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE	O=C1NC(=O)S[C@@H]1Cc2ccc(cc2)OC[C@@](O3)(C)CCc(c34)c(C)c(O)c(C)c4C
17802	sp|P9WPM9|C135B_MY	P33261	92.16	27.0	462.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
17803	sp|P9WPM9|C135B_MY	P33261	92.16	27.0	462.0	DB12319	investigational; withdrawn	Benzbromarone	c1cccc(c12)c(c(o2)CC)C(=O)c3cc(Br)c(O)c(Br)c3
17804	sp|P9WPM9|C135B_MY	P05181	92.37	28.0	464.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
17805	sp|P9WPM9|C135B_MY	P11509	92.8	29.0	467.0	DB04665	experimental	Coumarin	c1cc(=O)oc(c12)cccc2
17806	sp|P9WPM9|C135B_MY	P11509	92.8	29.0	467.0	DB07609	experimental	N,N-DIMETHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	CN(C)Cc1ccc(o1)-c2cccnc2
17807	sp|P9WPM9|C135B_MY	P11509	92.8	29.0	467.0	DB07617	experimental	N-METHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	CNCc1ccc(o1)-c2cccnc2
17808	sp|P9WPM9|C135B_MY	P11509	92.8	29.0	467.0	DB07621	experimental	(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	NCc1ccc(o1)-c2cccnc2
17809	sp|P9WPM9|C135B_MY	P11509	92.8	29.0	467.0	DB07623	experimental	4,4'-DIPYRIDYL DISULFIDE	c1cnccc1SSc2ccncc2
17810	sp|P9WPM9|C135B_MY	P20813	91.95	29.0	463.0	DB02974	experimental	4-(4-Chlorophenyl)Imidazole	Clc1ccc(cc1)-c2cnc[nH]2
17811	sp|P9WPM9|C135B_MY	P20813	91.95	29.0	463.0	DB04664	experimental	Cyclohexyl-pentyl-maltoside	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@@H]2CO)OCCCCCC3CCCCC3
17812	sp|P9WPM9|C135B_MY	P20813	91.95	29.0	463.0	DB04794	approved; investigational	Bifonazole	c1ccccc1C(n2ccnc2)c3ccc(cc3)-c4ccccc4
17813	sp|P9WPM9|C135B_MY	P20813	91.95	29.0	463.0	DB08369	experimental	1-(biphenyl-4-ylmethyl)-1H-imidazole	c1cncn1Cc2ccc(cc2)-c3ccccc3
17814	sp|P9WPM9|C135B_MY	P05177	99.79	39.0	510.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
17815	sp|P9WPM9|C135B_MY	P05177	99.79	39.0	510.0	DB07453	experimental	alpha-Naphthoflavone	c1ccccc1-c(cc2=O)oc(c23)c4c(cc3)cccc4
17816	sp|P9WPM9|C135B_MY	P05177	99.79	39.0	510.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
17817	sp|P9WPM9|C135B_MY	P05177	99.79	39.0	510.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
17818	sp|P9WPM9|C135B_MY	P05177	99.79	39.0	510.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
17819	sp|P9WPM9|C135B_MY	P04798	99.36	37.0	506.0	DB02342	investigational	2-Methoxyestradiol	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)c(c4)OC
17820	sp|P9WPM9|C135B_MY	P04798	99.36	37.0	506.0	DB12379	investigational	Indirubin	c1cccc(c12)NC(=O)C\2=C(C3=O)\Nc(c34)cccc4
17821	sp|P9WPM9|C135B_MY	P04798	99.36	37.0	506.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
17822	sp|P9WPM9|C135B_MY	O43174	94.92	39.0	487.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
17823	sp|P9WPM9|C135B_MY	O43174	94.92	39.0	487.0	DB13083	investigational	Talarozole	c1ncnn1C(C(CC)CC)c2ccc(cc2)Nc(s3)nc(c34)cccc4
17824	sp|P9WPM9|C135B_MY	P10614	96.82	62.0	519.0	DB06890	experimental	(2R)-2-PHENYL-N-PYRIDIN-4-YLBUTANAMIDE	c1ccccc1[C@@H](CC)C(=O)Nc2ccncc2
17825	sp|P9WPM9|C135B_MY	P10614	96.82	62.0	519.0	DB07560	experimental	N-[(1S)-2-methyl-1-(pyridin-4-ylcarbamoyl)propyl]cyclohexanecarboxamide	c1cnccc1NC(=O)[C@H](C(C)C)NC(=O)C2CCCCC2
17826	sp|P9WPM9|C135B_MY	P10614	96.82	62.0	519.0	DB07568	experimental	(2S)-2-[(2,1,3-BENZOTHIADIAZOL-4-YLSULFONYL)AMINO]-2-PHENYL-N-PYRIDIN-4-YLACETAMIDE	n1snc(c12)cccc2S(=O)(=O)N[C@@H](c3ccccc3)C(=O)Nc4ccncc4
17827	sp|P9WPM9|C135B_MY	P10614	96.82	62.0	519.0	DB07569	experimental	CIS-4-METHYL-N-[(1S)-3-(METHYLSULFANYL)-1-(PYRIDIN-4-YLCARBAMOYL)PROPYL]CYCLOHEXANECARBOXAMIDE	c1cnccc1NC(=O)[C@H](CCSC)NC(=O)[C@@H]2CC[C@H](C)CC2
17828	sp|P9WPM9|C135B_MY	P10614	96.82	62.0	519.0	DB07572	experimental	3-{[(4-methylphenyl)sulfonyl]amino}propyl pyridin-4-ylcarbamate	Cc1ccc(cc1)S(=O)(=O)NCCCOC(=O)Nc2ccncc2
17829	sp|P9WPM9|C135B_MY	P10614	96.82	62.0	519.0	DB07635	experimental	4,4'-Dihydroxybenzophenone	Oc1ccc(cc1)C(=O)c2ccc(O)cc2
17830	sp|P9WPM9|C135B_MY	P50859	97.25	63.0	522.0	DB01026	approved; investigational	Ketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OCC(CO3)OC3(Cn4ccnc4)c5ccc(Cl)cc5Cl
17831	sp|P9WPM9|C135B_MY	P50859	97.25	63.0	522.0	DB01167	approved; investigational	Itraconazole	CCC(C)n1ncn(c1=O)-c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@@H](CO5)O[C@@]5(Cn6cncn6)c7ccc(Cl)cc7Cl
17832	sp|P9WPM9|C135B_MY	P50859	97.25	63.0	522.0	DB09040	approved	Efinaconazole	C=C1CCN(CC1)[C@H](C)[C@](O)(Cn2cncn2)c3c(F)cc(F)cc3
17833	sp|P9WPM9|C135B_MY	P50859	97.25	63.0	522.0	DB11633	approved; investigational	Isavuconazole	c1ncnn1C[C@](O)(c2c(F)ccc(F)c2)[C@@H](C)c3nc(cs3)-c4ccc(C#N)cc4
17834	sp|P9WPM9|C135B_MY	Q9NR63	94.49	44.0	490.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
17835	sp|P9WPM9|C135B_MY	P10613	98.31	54.0	518.0	DB00196	approved; investigational	Fluconazole	c1ncnn1CC(O)(Cn2cncn2)c3c(F)cc(F)cc3
17836	sp|P9WPM9|C135B_MY	P10613	98.31	54.0	518.0	DB00239	approved	Oxiconazole	Clc1cc(Cl)c(cc1)CO/N=C(\Cn2ccnc2)c3ccc(Cl)cc3Cl
17837	sp|P9WPM9|C135B_MY	P10613	98.31	54.0	518.0	DB00251	approved	Terconazole	CC(C)N1CCN(CC1)c2ccc(cc2)OC[C@@H](CO3)O[C@@]3(Cn4cncn4)c5c(Cl)cc(Cl)cc5
17838	sp|P9WPM9|C135B_MY	P10613	98.31	54.0	518.0	DB00257	approved; vet_approved	Clotrimazole	Clc1ccccc1C(n2ccnc2)(c3ccccc3)c4ccccc4
17839	sp|P9WPM9|C135B_MY	P10613	98.31	54.0	518.0	DB00582	approved	Voriconazole	c1ncnn1C[C@](O)(c2c(F)cc(F)cc2)[C@@H](C)c3ncncc3F
17840	sp|P9WPM9|C135B_MY	P10613	98.31	54.0	518.0	DB01007	approved	Tioconazole	c1nccn1CC(c(c(Cl)c2)ccc2Cl)OCc3c(Cl)scc3
17841	sp|P9WPM9|C135B_MY	P10613	98.31	54.0	518.0	DB01110	approved; investigational; vet_approved	Miconazole	Clc1cc(Cl)c(cc1)COC(Cn2ccnc2)c3c(Cl)cc(Cl)cc3
17842	sp|P9WPM9|C135B_MY	P10613	98.31	54.0	518.0	DB01127	approved	Econazole	Clc1ccc(cc1)COC(Cn2ccnc2)c3c(Cl)cc(Cl)cc3
17843	sp|P9WPM9|C135B_MY	P10613	98.31	54.0	518.0	DB01153	approved; investigational	Sertaconazole	Clc1cc(Cl)ccc1C(Cn2cncc2)OCc3csc(c34)c(Cl)ccc4
17844	sp|P9WPM9|C135B_MY	P10613	98.31	54.0	518.0	DB01263	approved; investigational; vet_approved	Posaconazole	C[C@H](O)[C@H](CC)n1ncn(c1=O)-c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@H](CO5)C[C@]5(Cn6cncn6)c7c(F)cc(F)cc7
17845	sp|P9WPM9|C135B_MY	P10613	98.31	54.0	518.0	DB04794	approved; investigational	Bifonazole	c1ccccc1C(n2ccnc2)c3ccc(cc3)-c4ccccc4
17846	sp|P9WPM9|C135B_MY	P10613	98.31	54.0	518.0	DB08933	approved	Luliconazole	Clc1cc(Cl)c(cc1)[C@@H]2CS/C(S2)=C(/C#N)n3ccnc3
17847	sp|P9WPM9|C135B_MY	P24557	103.18	43.0	530.0	DB00795	approved	Sulfasalazine	OC(=O)c1cc(ccc1O)/N=N/c2ccc(cc2)S(=O)(=O)Nc3ncccc3
17848	sp|P9WPM9|C135B_MY	P24557	103.18	43.0	530.0	DB01207	experimental	Ridogrel	OC(=O)CCCCO/N=C(/c1cnccc1)c2cc(C(F)(F)F)ccc2
17849	sp|P9WPM9|C135B_MY	P24557	103.18	43.0	530.0	DB03052	experimental	Dazoxiben	OC(=O)c1ccc(cc1)OCCn2ccnc2
17850	sp|P9WPM9|C135B_MY	P24557	103.18	43.0	530.0	DB05505	investigational	NM-702	 
17851	sp|P9WPM9|C135B_MY	P10635	94.92	32.0	480.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
17852	sp|P9WPM9|C135B_MY	P10635	94.92	32.0	480.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
17853	sp|P9WPM9|C135B_MY	P10635	94.92	32.0	480.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
17854	sp|P9WPM9|C135B_MY	Q6V0L0	97.67	44.0	505.0	DB00523	approved; investigational	Alitretinoin	OC(=O)/C=C(\C)/C=C/C=C(/C)\C=C\C(C1(C)C)=C(C)CCC1
17855	sp|P9WPM9|C135B_MY	Q6V0L0	97.67	44.0	505.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
17856	sp|P9WPM9|C135B_MY	Q16850	90.04	66.0	491.0	DB01007	approved	Tioconazole	c1nccn1CC(c(c(Cl)c2)ccc2Cl)OCc3c(Cl)scc3
17857	sp|P9WPM9|C135B_MY	Q16850	90.04	66.0	491.0	DB01167	approved; investigational	Itraconazole	CCC(C)n1ncn(c1=O)-c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@@H](CO5)O[C@@]5(Cn6cncn6)c7ccc(Cl)cc7Cl
17858	sp|P9WPM9|C135B_MY	Q16850	90.04	66.0	491.0	DB05667	investigational	Levoketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OC[C@H](CO3)O[C@]3(Cn4ccnc4)c5ccc(Cl)cc5Cl
17859	sp|P9WPM9|C135B_MY	Q16850	90.04	66.0	491.0	DB07705	experimental	(S)-econazole	Clc1ccc(cc1)CO[C@H](Cn2ccnc2)c3c(Cl)cc(Cl)cc3
17861	sp|P9WPM9|C135B_MY	P05093	101.06	27.0	504.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
17862	sp|P9WPM9|C135B_MY	P05093	101.06	27.0	504.0	DB00396	approved; vet_approved	Progesterone	CC(=O)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
17863	sp|P9WPM9|C135B_MY	P05093	101.06	27.0	504.0	DB00421	approved	Spironolactone	C1CC(=O)O[C@@]12[C@]3(C)[C@@H](CC2)[C@H]4[C@H](CC3)[C@]5(C)C(=CC(=O)CC5)C[C@H]4SC(=O)C
17864	sp|P9WPM9|C135B_MY	P05093	101.06	27.0	504.0	DB01026	approved; investigational	Ketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OCC(CO3)OC3(Cn4ccnc4)c5ccc(Cl)cc5Cl
17865	sp|P9WPM9|C135B_MY	P05093	101.06	27.0	504.0	DB05812	approved	Abiraterone	C1C[C@H](O)CC([C@]12C)=CC[C@@H]3[C@@H]2CC[C@@]4(C)[C@H]3CC=C4c5cccnc5
17866	sp|P9WPM9|C135B_MY	P05093	101.06	27.0	504.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
17868	sp|P9WPM9|C135B_MY	P05093	101.06	27.0	504.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
17869	sp|P9WPM9|C135B_MY	Q16678	99.79	50.0	521.0	DB01645	investigational	Genistein	Oc1ccc(cc1)-c(c2=O)coc(c23)cc(O)cc3O
17870	sp|P9WPM9|C135B_MY	Q16678	99.79	50.0	521.0	DB02342	investigational	2-Methoxyestradiol	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)c(c4)OC
17871	sp|P9WPM9|C135B_MY	Q16678	99.79	50.0	521.0	DB03467	experimental	Naringenin	Oc1ccc(cc1)[C@@H](O2)CC(=O)c(c23)c(O)cc(c3)O
17872	sp|P9WPM9|C135B_MY	Q16678	99.79	50.0	521.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
17873	sp|P9WPM9|C135B_MY	Q16678	99.79	50.0	521.0	DB06732	experimental	beta-Naphthoflavone	c1cccc(c12)c3c(cc2)oc(cc3=O)-c4ccccc4
17874	sp|P9WPM9|C135B_MY	Q16678	99.79	50.0	521.0	DB07776	approved; experimental	Flavone	c1cccc(c12)oc(cc2=O)-c3ccccc3
17875	sp|P9WPM9|C135B_MY	Q16678	99.79	50.0	521.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
17876	sp|P9WPM9|C135B_MY	Q16678	99.79	50.0	521.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
17877	sp|P9WPM9|C135B_MY	Q02928	96.61	51.0	507.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
17878	sp|P9WPM9|C135B_MY	P14779	93.86	7.0	450.0	DB03440	experimental	N-hexadecanoylglycine	CCCCCCCCCCCCCCCC(=O)NCC(=O)O
17879	sp|P9WPM9|C135B_MY	P14779	93.86	7.0	450.0	DB04257	experimental	Palmitoleic Acid	CCCCCC/C=C\CCCCCCCC(=O)O
17880	sp|P9WPM9|C135B_MY	P14779	93.86	7.0	450.0	DB08086	experimental	N-[12-(1H-imidazol-1-yl)dodecanoyl]-L-leucine	CC(C)C[C@@H](C(=O)O)NC(=O)CCCCCCCCCCCn1ccnc1
17881	sp|P9WPM9|C135B_MY	P19099	96.82	44.0	501.0	DB00421	approved	Spironolactone	C1CC(=O)O[C@@]12[C@]3(C)[C@@H](CC2)[C@H]4[C@H](CC3)[C@]5(C)C(=CC(=O)CC5)C[C@H]4SC(=O)C
17882	sp|P9WPM9|C135B_MY	P19099	96.82	44.0	501.0	DB11837	approved; investigational	Osilodrostat	c1ncc(n12)CC[C@@H]2c3c(F)cc(C#N)cc3
17883	sp|P9WPM9|C135B_MY	O15528	98.73	39.0	505.0	DB01436	approved; nutraceutical	Alfacalcidol	CC(C)CCC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)/C(CCC2)=C/C=C3/C[C@@H](O)C[C@H](O)C3=C
17884	sp|P9WPM9|C135B_MY	P08686	91.74	47.0	480.0	DB01026	approved; investigational	Ketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OCC(CO3)OC3(Cn4ccnc4)c5ccc(Cl)cc5Cl
17885	sp|P9WPM9|C135B_MY	P15538	96.4	45.0	500.0	DB00648	approved	Mitotane	Clc1ccc(cc1)C(C(Cl)Cl)c2ccccc2Cl
17886	sp|P9WPM9|C135B_MY	P15538	96.4	45.0	500.0	DB01011	approved; investigational	Metyrapone	c1ccncc1C(C)(C)C(=O)c2cnccc2
17887	sp|P9WPM9|C135B_MY	P15538	96.4	45.0	500.0	DB05667	investigational	Levoketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OC[C@H](CO3)O[C@]3(Cn4ccnc4)c5ccc(Cl)cc5Cl
17888	sp|P9WPM9|C135B_MY	P15538	96.4	45.0	500.0	DB11837	approved; investigational	Osilodrostat	c1ncc(n12)CC[C@@H]2c3c(F)cc(C#N)cc3
17889	sp|P9WPM9|C135B_MY	P05108	91.95	75.0	509.0	DB00357	approved; investigational	Aminoglutethimide	Nc1ccc(cc1)C2(CC)CCC(=O)NC2=O
17890	sp|P9WPM9|C135B_MY	P11511	91.95	47.0	481.0	DB00184	approved	Nicotine	CN1CCC[C@H]1c2cnccc2
17891	sp|P9WPM9|C135B_MY	P11511	91.95	47.0	481.0	DB00357	approved; investigational	Aminoglutethimide	Nc1ccc(cc1)C2(CC)CCC(=O)NC2=O
17892	sp|P9WPM9|C135B_MY	P11511	91.95	47.0	481.0	DB00655	approved	Estrone	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)cc4
17893	sp|P9WPM9|C135B_MY	P11511	91.95	47.0	481.0	DB00894	approved; investigational	Testolactone	C1=CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2CC[C@@]4(C)[C@H]3CCC(O4)=O
17894	sp|P9WPM9|C135B_MY	P11511	91.95	47.0	481.0	DB00990	approved; investigational	Exemestane	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(C(C3)=C)=CC(=O)C=C4
17895	sp|P9WPM9|C135B_MY	P11511	91.95	47.0	481.0	DB01006	approved; investigational	Letrozole	N#Cc1ccc(cc1)C(n2cncn2)c3ccc(C#N)cc3
17896	sp|P9WPM9|C135B_MY	P11511	91.95	47.0	481.0	DB01217	approved; investigational	Anastrozole	N#CC(C)(C)c1cc(C(C)(C)C#N)cc(c1)Cn2cncn2
17897	sp|P9WPM9|C135B_MY	P11511	91.95	47.0	481.0	DB02342	investigational	2-Methoxyestradiol	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)c(c4)OC
17898	sp|P9WPM9|C135B_MY	P11511	91.95	47.0	481.0	DB03467	experimental	Naringenin	Oc1ccc(cc1)[C@@H](O2)CC(=O)c(c23)c(O)cc(c3)O
17899	sp|P9WPM9|C135B_MY	P11511	91.95	47.0	481.0	DB04539	experimental	Glyphosate	OC(=O)C[NH2+]CP(=O)(O)O
17900	sp|P9WPM9|C135B_MY	P11511	91.95	47.0	481.0	DB05749	investigational	MPI-674	 
17901	sp|P9WPM9|C135B_MY	O31440	79.87	15.0	392.0	DB04257	experimental	Palmitoleic Acid	CCCCCC/C=C\CCCCCCCC(=O)O
17902	sp|P9WPM9|C135B_MY	Q16647	97.46	37.0	497.0	DB00812	approved; vet_approved	Phenylbutazone	CCCCC1C(=O)N(c2ccccc2)N(C1=O)c3ccccc3
17903	sp|P9WPM9|C135B_MY	Q16647	97.46	37.0	497.0	DB01240	approved	Epoprostenol	OC(=O)CCC/C=C(C1)\O[C@H]([C@H]12)C[C@@H](O)[C@@H]2/C=C/[C@@H](O)CCCCC
17904	sp|P9WPM9|C135B_MY	Q16647	97.46	37.0	497.0	DB08675	experimental	(5Z)-7-{(1R,4S,5R,6R)-6-[(1E)-1-Octen-1-yl]-2,3-diazabicyclo[2.2.1]hept-2-en-5-yl}-5-heptenoic acid	OC(=O)CCC/C=C\C[C@@H]([C@H]12)[C@H]([C@@H](C1)N=N2)/C=C/CCCCCC
17905	sp|P9WQD9|FAB1_MYC	P9WQD9	99.76	1.0	416.0	DB04302	experimental	4-Hydroxy-3,5-Dimethyl-5-(2-Methyl-Buta-1,3-Dienyl)-5h-Thiophen-2-One	C=C/C(C)=C/[C@@]1(C)SC(=O)C(C)=C1O
17906	sp|P9WQD9|FAB1_MYC	P0AAI5	97.84	5.0	412.0	DB01034	experimental	Cerulenin	NC(=O)[C@@H]1O[C@@H]1C(=O)CC/C=C/C/C=C/C
17907	sp|P9WQD9|FAB1_MYC	P0AAI5	97.84	5.0	412.0	DB03017	approved; experimental	Lauric acid	CCCCCCCCCCCC(=O)O
17908	sp|P9WQD9|FAB1_MYC	P0AAI5	97.84	5.0	412.0	DB08366	experimental	3-({3-[(1S,4aS,6S,7S,9S,9aR)-1,6-dimethyl-2-oxodecahydro-6,9-epoxy-4a,7-methanobenzo[7]annulen-1-yl]propanoyl}amino)-2,4-dihydroxybenzoic acid	C1[C@@H](C2)[C@](C)(C3)O[C@@H]2[C@H]([C@@]134)[C@@](C)(C(=O)CC4)CCC(=O)Nc5c(O)ccc(C(=O)O)c5O
17909	sp|P9WQD9|FAB1_MYC	P0AAI5	97.84	5.0	412.0	DB08407	experimental	Platensimycin	C1[C@@H](C2)[C@](C)(C3)O[C@@H]2[C@H]([C@@]134)[C@@](C)(C(=O)C=C4)CCC(=O)Nc5c(O)c(C(=O)O)ccc5O
17910	sp|P9WQD9|FAB1_MYC	P0A953	96.39	2.0	403.0	DB01034	experimental	Cerulenin	NC(=O)[C@@H]1O[C@@H]1C(=O)CC/C=C/C/C=C/C
17911	sp|P9WQD9|FAB1_MYC	P0A953	96.39	2.0	403.0	DB03017	approved; experimental	Lauric acid	CCCCCCCCCCCC(=O)O
17912	sp|P9WQD9|FAB1_MYC	P0A953	96.39	2.0	403.0	DB03600	experimental	Capric acid	CCCCCCCCCC(=O)O
17913	sp|P9WQD9|FAB1_MYC	P0A953	96.39	2.0	403.0	DB04302	experimental	4-Hydroxy-3,5-Dimethyl-5-(2-Methyl-Buta-1,3-Dienyl)-5h-Thiophen-2-One	C=C/C(C)=C/[C@@]1(C)SC(=O)C(C)=C1O
17914	sp|P9WQD9|FAB1_MYC	P0A953	96.39	2.0	403.0	DB04519	investigational	Caprylic acid	CCCCCCCC(=O)O
17915	sp|P9WQD9|FAB1_MYC	P0A953	96.39	2.0	403.0	DB08359	experimental	2-PHENYLAMINO-4-METHYL-5-ACETYL THIAZOLE	CC(=O)c1c(C)nc(s1)Nc2ccccc2
17916	sp|P9WQD9|FAB1_MYC	P0A953	96.39	2.0	403.0	DB08627	experimental	(5R)-4-HYDROXY-3,5-DIMETHYL-5-[(1E,3E)-2-METHYLPENTA-1,3-DIENYL]THIOPHEN-2(5H)-ONE	C/C=C/C(C)=C/[C@@]1(C)SC(=O)C(C)=C1O
17917	sp|P9WQD9|FAB1_MYC	P0A953	96.39	2.0	403.0	DB08628	experimental	(5R)-5-[(1E)-BUTA-1,3-DIENYL]-4-HYDROXY-3,5-DIMETHYLTHIOPHEN-2(5H)-ONE	OC1=C(C)C(=O)S[C@]1(C)/C=C/C=C
17919	sp|P9WQD9|FAB1_MYC	Q9ZGI2	81.49	121.0	460.0	DB07703	experimental	(3R,4S,5S,7R,9E,11R,12R)-12-ETHYL-4-HYDROXY-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE	C[C@@H]1C[C@H](C)[C@H](O)[C@@H](C)C(=O)O[C@H](CC)[C@H](C)/C=C/C1=O
17920	sp|P9WQD9|FAB1_MYC	Q9ZGI2	81.49	121.0	460.0	DB08431	experimental	[(3R,4S)-4-HYDROXY-3-METHYL-2-OXOHEXYL]PHOSPHONIC ACID	CC[C@H](O)[C@@H](C)C(=O)C[P@@H](=O)O
17921	sp|P9WQD9|FAB1_MYC	Q9ZGI2	81.49	121.0	460.0	DB08759	experimental	[(3R,4S,5S,7R)-4,8-DIHYDROXY-3,5,7-TRIMETHYL-2-OXOOCTYL]PHOSPHONIC ACID	OC[C@H](C)C[C@H](C)[C@H](O)[C@@H](C)C(=O)C[P@H](=O)O
17922	sp|P9WQD9|FAB1_MYC	P49327	96.39	4.0	405.0	DB01034	experimental	Cerulenin	NC(=O)[C@@H]1O[C@@H]1C(=O)CC/C=C/C/C=C/C
17923	sp|P9WQD9|FAB1_MYC	P49327	96.39	4.0	405.0	DB01083	approved; investigational	Orlistat	CCCCCCCCCCC[C@H](OC(=O)[C@@H](NC=O)CC(C)C)C[C@@H]1OC(=O)[C@H]1CCCCCC
17924	sp|Q79FV4|CYSK2_MY	P35520	86.29	83.0	404.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
17925	sp|Q79FV4|CYSK2_MY	P35520	86.29	83.0	404.0	DB00118	approved; investigational; nutraceutical	Ademetionine	[O-]C(=O)[C@@H](N)CC[S+](C)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
17926	sp|Q79FV4|CYSK2_MY	P35520	86.29	83.0	404.0	DB00133	investigational; nutraceutical	Serine	OC(=O)[C@@H](N)CO
17927	sp|Q79FV4|CYSK2_MY	P35520	86.29	83.0	404.0	DB00151	approved; nutraceutical	Cysteine	OC(=O)[C@@H](N)CS
17928	sp|Q79FV4|CYSK2_MY	Q96GA7	72.31	25.0	294.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
17929	sp|Q79FV4|CYSK2_MY	P20132	75.81	10.0	292.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
17930	sp|Q79FV4|CYSK2_MY	P20132	75.81	10.0	292.0	DB00133	investigational; nutraceutical	Serine	OC(=O)[C@@H](N)CO
17931	sp|Q79FV4|CYSK2_MY	Q9GZT4	73.66	38.0	312.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
17932	sp|Q79FV4|CYSK2_MY	Q9GZT4	73.66	38.0	312.0	DB00133	investigational; nutraceutical	Serine	OC(=O)[C@@H](N)CO
17933	sp|Q79FV4|CYSK2_MY	Q00740	76.08	8.0	291.0	DB01735	experimental	3-Chloroalaninate	[O-]C(=O)[C@H]([NH3+])CCl
17934	sp|Q79FV4|CYSK2_MY	Q00740	76.08	8.0	291.0	DB01804	experimental	2-Ammoniobut-3-Enoate, 2-Amino-3-Butenoate	[O-]C(=O)[C@H]([NH3+])C=C
17935	sp|Q79FV4|CYSK2_MY	Q00740	76.08	8.0	291.0	DB02085	experimental	1-Aminocyclopropanecarboxylic Acid	OC(=O)C1(N)CC1
17936	sp|Q79FV4|CYSK2_MY	Q00740	76.08	8.0	291.0	DB03053	experimental	1-Aminocyclopropylphosphonate	OP([O-])(=O)C1(N)CC1
17937	sp|Q79FV4|CYSK2_MY	Q00740	76.08	8.0	291.0	DB04212	experimental	2-Iminiopropanoate	CC(=[NH2+])C([O-])=O
17938	sp|Q79FV4|CYSK2_MY	Q00740	76.08	8.0	291.0	DB04553	experimental	2-Oxobutanoic Acid	CCC(=O)C(=O)O
17939	sp|Q79FV4|CYSK2_MY	P0A2K1	81.99	66.0	371.0	DB03171	experimental	Indole-3-Propanol Phosphate	OP(=O)(O)OCCCc1c[nH]c(c12)cccc2
17940	sp|Q79FV4|CYSK2_MY	P0A2K1	81.99	66.0	371.0	DB04143	experimental	Indole-3-Glycerol Phosphate	OP(=O)(O)OC[C@@H](O)[C@@H](O)c1c[nH]c(c12)cccc2
17941	sp|Q79FV4|CYSK2_MY	P0A2K1	81.99	66.0	371.0	DB07732	experimental	2-[(2-NAPHTHYLSULFONYL)AMINO]ETHYL DIHYDROGEN PHOSPHATE	OP(=O)(O)OCCNS(=O)(=O)c(cc1)cc(c12)cccc2
17942	sp|Q79FV4|CYSK2_MY	P0A2K1	81.99	66.0	371.0	DB07745	experimental	2-{[4-(TRIFLUOROMETHOXY)BENZOYL]AMINO}ETHYL DIHYDROGEN PHOSPHATE	OP(=O)(O)OCCNC(=O)c1ccc(OC(F)(F)F)cc1
17943	sp|Q79FV4|CYSK2_MY	P0A2K1	81.99	66.0	371.0	DB07748	experimental	2-({[4-(TRIFLUOROMETHOXY)PHENYL]SULFONYL}AMINO)ETHYL DIHYDROGEN PHOSPHATE	OP(=O)(O)OCCNS(=O)(=O)c1ccc(OC(F)(F)F)cc1
17944	sp|Q79FV4|CYSK2_MY	P0A2K1	81.99	66.0	371.0	DB07773	experimental	5-FLUOROINDOLE PROPANOL PHOSPHATE	OP(=O)(O)OCCCc1c[nH]c(c12)ccc(F)c2
17945	sp|Q79FV4|CYSK2_MY	P0A2K1	81.99	66.0	371.0	DB07890	experimental	4-(2-HYDROXYPHENYLTHIO)-1-BUTENYLPHOSPHONIC ACID	Oc1ccccc1SCC/C=C/P(=O)(O)O
17946	sp|Q79FV4|CYSK2_MY	P0A2K1	81.99	66.0	371.0	DB07894	experimental	4-(2-HYDROXY-4-FLUOROPHENYLTHIO)-BUTYLPHOSPHONIC ACID	Oc1ccc(F)cc1SCC/C=C/P(=O)(O)O
17947	sp|Q79FV4|CYSK2_MY	P0A2K1	81.99	66.0	371.0	DB07925	experimental	4-(2-HYDROXYPHENYLSULFINYL)-BUTYLPHOSPHONIC ACID	Oc1ccccc1[S@](=O)CCCCP(=O)(O)O
17948	sp|Q79FV4|CYSK2_MY	P0A2K1	81.99	66.0	371.0	DB07951	experimental	N-(indole-3-acetyl)-L-aspartic acid	OC(=O)C[C@@H](C(=O)O)NC(=O)Cc1c[nH]c(c12)cccc2
17949	sp|Q79FV4|CYSK2_MY	P0A2K1	81.99	66.0	371.0	DB07952	experimental	N-[1H-INDOL-3-YL-ACETYL]GLYCINE ACID	OC(=O)CNC(=O)Cc1c[nH]c(c12)cccc2
17950	sp|Q79FV4|CYSK2_MY	P0A2K1	81.99	66.0	371.0	DB07953	experimental	N-[1H-INDOL-3-YL-ACETYL]VALINE ACID	CC(C)[C@@H](C(=O)O)NC(=O)Cc1c[nH]c(c12)cccc2
17951	sp|P9WQ61|FAA22_MY	Q9NUB1	74.04	138.0	660.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
17952	sp|P9WQ61|FAA22_MY	Q8ZKF6	73.05	105.0	620.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
17953	sp|P9WQ61|FAA22_MY	Q8ZKF6	73.05	105.0	620.0	DB03230	experimental	Adenosine-5'-Propylphosphate	CCCOP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
17954	sp|P9WQ61|FAA22_MY	P40871	71.21	28.0	530.0	DB01672	experimental	2,3-Dihydroxy-Benzoic Acid	OC(=O)c1cccc(O)c1O
17955	sp|P9WQ61|FAA22_MY	Q8GN86	70.21	7.0	502.0	DB03728	experimental	p-Chlorobenzoic acid	OC(=O)c1ccc(Cl)cc1
17956	sp|P9WQJ3|FATRP_MY	O95342	83.52	127.0	654.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
17957	sp|P9WQJ3|FATRP_MY	O95342	83.52	127.0	654.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
17958	sp|P9WQJ3|FATRP_MY	O95342	84.47	781.0	1314.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
17959	sp|P9WQJ3|FATRP_MY	O95342	84.47	781.0	1314.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
17960	sp|P9WQJ3|FATRP_MY	P08183	80.35	119.0	626.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
17961	sp|P9WQJ3|FATRP_MY	P08183	80.35	119.0	626.0	DB00603	approved; investigational	Medroxyprogesterone acetate	CC(=O)O[C@]1(C(=O)C)CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C([C@H](C3)C)=CC(=O)CC4
17962	sp|P9WQJ3|FATRP_MY	P08183	80.35	119.0	626.0	DB00778	approved; investigational; withdrawn	Roxithromycin	COCCOCO/N=C([C@H](C)[C@@H](O)[C@]1(C)O)/[C@H](C)C[C@@](C)(O)[C@@H]([C@@H](C)[C@@H]([C@@H](C)C(=O)O[C@@H]1CC)O[C@@H](C[C@@]2(C)OC)O[C@@H](C)[C@@H]2O)O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C
17963	sp|P9WQJ3|FATRP_MY	P08183	80.35	119.0	626.0	DB00813	approved; illicit; investigational; vet_approved	Fentanyl	c1ccccc1N(C(=O)CC)C2CCN(CC2)CCc3ccccc3
17964	sp|P9WQJ3|FATRP_MY	P08183	80.35	119.0	626.0	DB04877	experimental	Voacamine	CC[C@H]1C[C@@H](C2)CN([C@@H]1[C@@]23C(=O)OC)CCc4c3[nH]c5c4cc(OC)c(c5)[C@@H](C[C@H]67)c8c(c9c([nH]8)cccc9)C[C@H](C6C(=O)OC)N(C)CC\7=C\C
17965	sp|P9WQJ3|FATRP_MY	P08183	80.35	119.0	626.0	DB04881	investigational	Elacridar	COc1cccc(c12)c(=O)c3c([nH]2)c(ccc3)C(=O)Nc4ccc(cc4)CCN(C5)CCc(c56)cc(OC)c(c6)OC
17966	sp|P9WQJ3|FATRP_MY	P08183	80.35	119.0	626.0	DB04905	investigational	Tesmilifene	CCN(CC)CCOc1ccc(cc1)Cc2ccccc2
17967	sp|P9WQJ3|FATRP_MY	P08183	80.35	119.0	626.0	DB05449	investigational	FM-VP4	 
17968	sp|P9WQJ3|FATRP_MY	P08183	80.35	119.0	626.0	DB06191	investigational	Zosuquidar	FC1(F)[C@H]2[C@@H]1c(cccc3)c3[C@@H](c(c24)cccc4)N5CCN(CC5)C[C@@H](O)COc6cccc(c67)nccc7
17969	sp|P9WQJ3|FATRP_MY	P08183	80.35	119.0	626.0	DB06240	investigational	Tariquidar	COc(c1)c(OC)cc(c12)CCN(C2)CCc3ccc(cc3)NC(=O)c4cc(OC)c(OC)cc4NC(=O)c(c5)cnc(c56)cccc6
17970	sp|P9WQJ3|FATRP_MY	P08183	80.35	119.0	626.0	DB09031	approved; investigational	Miltefosine	CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C
17971	sp|P9WQJ3|FATRP_MY	P08183	80.35	119.0	626.0	DB11635	approved	Tocofersolan	 
17972	sp|P9WQJ3|FATRP_MY	P08183	80.35	119.0	626.0	DB14061	experimental	Hycanthone	CCN(CC)CCNc(ccc1CO)c(c12)c(=O)c3c(s2)cccc3
17973	sp|P9WQJ3|FATRP_MY	P08183	80.35	119.0	626.0	DB14062	experimental	Concanamycin A	NC(=O)O[C@@H]1[C@@H](C)O[C@H](C[C@H]1O)O[C@H](C2)[C@H](C)[C@@H](/C=C/C)O[C@@]2(O)[C@@H](C)[C@H](O)[C@H](C)[C@H]3OC(=O)/C(OC)=C/C(C)=C/[C@@H](C)[C@@H](O)[C@@H](CC)[C@@H](O)[C@H](C)C/C(C)=C/C=C/[C@@H]3OC
17974	sp|P9WQJ3|FATRP_MY	P08183	80.35	119.0	626.0	DB14063	experimental	Dexverapamil	COc1ccc(cc1OC)CCN(C)CCC[C@@](C#N)(C(C)C)c2cc(OC)c(OC)cc2
17975	sp|P9WQJ3|FATRP_MY	P08183	80.35	119.0	626.0	DB14064	experimental	Emopamil	c1ccccc1C(C#N)(C(C)C)CCCN(C)CCc2ccccc2
17976	sp|P9WQJ3|FATRP_MY	P08183	80.35	119.0	626.0	DB14065	experimental	Lomerizine	COc1ccc(c(OC)c1OC)CN2CCN(CC2)C(c3ccc(F)cc3)c4ccc(F)cc4
17977	sp|P9WQJ3|FATRP_MY	P08183	80.35	119.0	626.0	DB14066	experimental	Tetrandrine	c12ccc(OC)c(c1)Oc3ccc(cc3)C[C@H]4c5c(CCN4C)cc(OC)c(c5)Oc6c7c(CCN(C)[C@H]7C2)cc(OC)c6OC
17978	sp|P9WQJ3|FATRP_MY	P08183	80.35	119.0	626.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
17979	sp|P9WQJ3|FATRP_MY	P08183	80.35	119.0	626.0	DB14068	experimental	Dexniguldipine	[O-][N+](=O)c1cccc(c1)[C@@H]2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCCN(CC3)CCC3(c4ccccc4)c5ccccc5
17980	sp|P9WQJ3|FATRP_MY	P08183	80.35	119.0	626.0	DB14069	investigational	ONT-093	CCOC/C=C/c1ccc(cc1)-c2nc(-c3ccc(cc3)NC(C)C)c([nH]2)-c4ccc(cc4)NC(C)C
17981	sp|P9WQJ3|FATRP_MY	P08183	80.35	119.0	626.0	DB14070	experimental	HM-30181	c1cccc(c12)c(=O)cc(o2)C(=O)Nc3cc(OC)c(OC)cc3-c4nn(nn4)-c5ccc(cc5)CCN(C6)CCc(c67)cc(OC)c(c7)OC
17982	sp|P9WQJ3|FATRP_MY	P08183	80.35	119.0	626.0	DB14071	experimental	Desmethylsertraline	c1cccc(c12)[C@@H](CC[C@@H]2N)c3cc(Cl)c(Cl)cc3
17983	sp|P9WQJ3|FATRP_MY	P08183	80.35	119.0	626.0	DB14072	experimental	Reversin 121	c1ccccc1COC(=O)C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@H](C(=O)OC(C)(C)C)CCCCNC(=O)OCc2ccccc2
17984	sp|P9WQJ3|FATRP_MY	P08183	81.62	756.0	1271.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
17985	sp|P9WQJ3|FATRP_MY	P08183	81.62	756.0	1271.0	DB00603	approved; investigational	Medroxyprogesterone acetate	CC(=O)O[C@]1(C(=O)C)CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C([C@H](C3)C)=CC(=O)CC4
17986	sp|P9WQJ3|FATRP_MY	P08183	81.62	756.0	1271.0	DB00778	approved; investigational; withdrawn	Roxithromycin	COCCOCO/N=C([C@H](C)[C@@H](O)[C@]1(C)O)/[C@H](C)C[C@@](C)(O)[C@@H]([C@@H](C)[C@@H]([C@@H](C)C(=O)O[C@@H]1CC)O[C@@H](C[C@@]2(C)OC)O[C@@H](C)[C@@H]2O)O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C
17987	sp|P9WQJ3|FATRP_MY	P08183	81.62	756.0	1271.0	DB00813	approved; illicit; investigational; vet_approved	Fentanyl	c1ccccc1N(C(=O)CC)C2CCN(CC2)CCc3ccccc3
17988	sp|P9WQJ3|FATRP_MY	P08183	81.62	756.0	1271.0	DB04877	experimental	Voacamine	CC[C@H]1C[C@@H](C2)CN([C@@H]1[C@@]23C(=O)OC)CCc4c3[nH]c5c4cc(OC)c(c5)[C@@H](C[C@H]67)c8c(c9c([nH]8)cccc9)C[C@H](C6C(=O)OC)N(C)CC\7=C\C
17989	sp|P9WQJ3|FATRP_MY	P08183	81.62	756.0	1271.0	DB04881	investigational	Elacridar	COc1cccc(c12)c(=O)c3c([nH]2)c(ccc3)C(=O)Nc4ccc(cc4)CCN(C5)CCc(c56)cc(OC)c(c6)OC
17990	sp|P9WQJ3|FATRP_MY	P08183	81.62	756.0	1271.0	DB04905	investigational	Tesmilifene	CCN(CC)CCOc1ccc(cc1)Cc2ccccc2
17991	sp|P9WQJ3|FATRP_MY	P08183	81.62	756.0	1271.0	DB05449	investigational	FM-VP4	 
17992	sp|P9WQJ3|FATRP_MY	P08183	81.62	756.0	1271.0	DB06191	investigational	Zosuquidar	FC1(F)[C@H]2[C@@H]1c(cccc3)c3[C@@H](c(c24)cccc4)N5CCN(CC5)C[C@@H](O)COc6cccc(c67)nccc7
17993	sp|P9WQJ3|FATRP_MY	P08183	81.62	756.0	1271.0	DB06240	investigational	Tariquidar	COc(c1)c(OC)cc(c12)CCN(C2)CCc3ccc(cc3)NC(=O)c4cc(OC)c(OC)cc4NC(=O)c(c5)cnc(c56)cccc6
17994	sp|P9WQJ3|FATRP_MY	P08183	81.62	756.0	1271.0	DB09031	approved; investigational	Miltefosine	CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C
17995	sp|P9WQJ3|FATRP_MY	P08183	81.62	756.0	1271.0	DB11635	approved	Tocofersolan	 
17996	sp|P9WQJ3|FATRP_MY	P08183	81.62	756.0	1271.0	DB14061	experimental	Hycanthone	CCN(CC)CCNc(ccc1CO)c(c12)c(=O)c3c(s2)cccc3
17997	sp|P9WQJ3|FATRP_MY	P08183	81.62	756.0	1271.0	DB14062	experimental	Concanamycin A	NC(=O)O[C@@H]1[C@@H](C)O[C@H](C[C@H]1O)O[C@H](C2)[C@H](C)[C@@H](/C=C/C)O[C@@]2(O)[C@@H](C)[C@H](O)[C@H](C)[C@H]3OC(=O)/C(OC)=C/C(C)=C/[C@@H](C)[C@@H](O)[C@@H](CC)[C@@H](O)[C@H](C)C/C(C)=C/C=C/[C@@H]3OC
17998	sp|P9WQJ3|FATRP_MY	P08183	81.62	756.0	1271.0	DB14063	experimental	Dexverapamil	COc1ccc(cc1OC)CCN(C)CCC[C@@](C#N)(C(C)C)c2cc(OC)c(OC)cc2
17999	sp|P9WQJ3|FATRP_MY	P08183	81.62	756.0	1271.0	DB14064	experimental	Emopamil	c1ccccc1C(C#N)(C(C)C)CCCN(C)CCc2ccccc2
18000	sp|P9WQJ3|FATRP_MY	P08183	81.62	756.0	1271.0	DB14065	experimental	Lomerizine	COc1ccc(c(OC)c1OC)CN2CCN(CC2)C(c3ccc(F)cc3)c4ccc(F)cc4
18001	sp|P9WQJ3|FATRP_MY	P08183	81.62	756.0	1271.0	DB14066	experimental	Tetrandrine	c12ccc(OC)c(c1)Oc3ccc(cc3)C[C@H]4c5c(CCN4C)cc(OC)c(c5)Oc6c7c(CCN(C)[C@H]7C2)cc(OC)c6OC
18002	sp|P9WQJ3|FATRP_MY	P08183	81.62	756.0	1271.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
18003	sp|P9WQJ3|FATRP_MY	P08183	81.62	756.0	1271.0	DB14068	experimental	Dexniguldipine	[O-][N+](=O)c1cccc(c1)[C@@H]2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCCN(CC3)CCC3(c4ccccc4)c5ccccc5
18004	sp|P9WQJ3|FATRP_MY	P08183	81.62	756.0	1271.0	DB14069	investigational	ONT-093	CCOC/C=C/c1ccc(cc1)-c2nc(-c3ccc(cc3)NC(C)C)c([nH]2)-c4ccc(cc4)NC(C)C
18005	sp|P9WQJ3|FATRP_MY	P08183	81.62	756.0	1271.0	DB14070	experimental	HM-30181	c1cccc(c12)c(=O)cc(o2)C(=O)Nc3cc(OC)c(OC)cc3-c4nn(nn4)-c5ccc(cc5)CCN(C6)CCc(c67)cc(OC)c(c7)OC
18006	sp|P9WQJ3|FATRP_MY	P08183	81.62	756.0	1271.0	DB14071	experimental	Desmethylsertraline	c1cccc(c12)[C@@H](CC[C@@H]2N)c3cc(Cl)c(Cl)cc3
18007	sp|P9WQJ3|FATRP_MY	P08183	81.62	756.0	1271.0	DB14072	experimental	Reversin 121	c1ccccc1COC(=O)C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@H](C(=O)OC(C)(C)C)CCCCNC(=O)OCc2ccccc2
18008	sp|P9WQJ3|FATRP_MY	Q2M3G0	81.14	108.0	620.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
18009	sp|P9WQJ3|FATRP_MY	Q2M3G0	81.14	108.0	620.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
18010	sp|P9WQJ3|FATRP_MY	Q2M3G0	81.77	737.0	1253.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
18011	sp|P9WQJ3|FATRP_MY	Q2M3G0	81.77	737.0	1253.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
18012	sp|P9WQJ3|FATRP_MY	P33527	79.87	363.0	867.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
18013	sp|P9WQJ3|FATRP_MY	P33527	79.87	363.0	867.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
18014	sp|P9WQJ3|FATRP_MY	P33527	79.87	363.0	867.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
18015	sp|P9WQJ3|FATRP_MY	P33527	79.87	363.0	867.0	DB06176	approved; investigational	Romidepsin	O=C([C@H]12)N/C(=C\C)C(=O)N[C@@H](C(C)C)C(=O)O[C@@H](CC(=O)N[C@H](C(C)C)C(=O)N1)/C=C/CCSSC2
18016	sp|P9WQJ3|FATRP_MY	P33527	79.87	363.0	867.0	DB08855	experimental; investigational	Leukotriene C4	CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@@H](O)CCCC(=O)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@H](N)C(=O)O
18017	sp|P9WQJ3|FATRP_MY	P33527	80.82	1016.0	1526.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
18018	sp|P9WQJ3|FATRP_MY	P33527	80.82	1016.0	1526.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
18019	sp|P9WQJ3|FATRP_MY	P33527	80.82	1016.0	1526.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
18020	sp|P9WQJ3|FATRP_MY	P33527	80.82	1016.0	1526.0	DB06176	approved; investigational	Romidepsin	O=C([C@H]12)N/C(=C\C)C(=O)N[C@@H](C(C)C)C(=O)O[C@@H](CC(=O)N[C@H](C(C)C)C(=O)N1)/C=C/CCSSC2
18021	sp|P9WQJ3|FATRP_MY	P33527	80.82	1016.0	1526.0	DB08855	experimental; investigational	Leukotriene C4	CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@@H](O)CCCC(=O)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@H](N)C(=O)O
18022	sp|P9WQJ3|FATRP_MY	Q92887	78.76	360.0	857.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
18023	sp|P9WQJ3|FATRP_MY	Q92887	78.76	360.0	857.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
18024	sp|P9WQJ3|FATRP_MY	Q92887	82.57	1012.0	1533.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
18025	sp|P9WQJ3|FATRP_MY	Q92887	82.57	1012.0	1533.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
18026	sp|P9WQJ3|FATRP_MY	Q09428	89.7	353.0	919.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
18027	sp|P9WQJ3|FATRP_MY	Q09428	89.7	353.0	919.0	DB00222	approved	Glimepiride	CCC1=C(C)CN(C1=O)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3
18028	sp|P9WQJ3|FATRP_MY	Q09428	89.7	353.0	919.0	DB00672	approved; investigational	Chlorpropamide	CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1
18029	sp|P9WQJ3|FATRP_MY	Q09428	89.7	353.0	919.0	DB00731	approved; investigational	Nateglinide	CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](C(=O)O)Cc2ccccc2
18030	sp|P9WQJ3|FATRP_MY	Q09428	89.7	353.0	919.0	DB00912	approved; investigational	Repaglinide	CCOc1c(C(=O)O)ccc(c1)CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3
18031	sp|P9WQJ3|FATRP_MY	Q09428	89.7	353.0	919.0	DB01067	approved; investigational	Glipizide	Cc1ncc(nc1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
18032	sp|P9WQJ3|FATRP_MY	Q09428	89.7	353.0	919.0	DB01120	approved	Gliclazide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN(C2)CC(C23)CCC3
18033	sp|P9WQJ3|FATRP_MY	Q09428	89.7	353.0	919.0	DB01124	approved; investigational	Tolbutamide	CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1
18034	sp|P9WQJ3|FATRP_MY	Q09428	89.7	353.0	919.0	DB01251	approved; investigational	Gliquidone	COc(cc1)cc(c12)C(=O)N(C(=O)C2(C)C)CCc3ccc(cc3)S(=O)(=O)NC(=O)NC4CCCCC4
18035	sp|P9WQJ3|FATRP_MY	Q09428	89.7	353.0	919.0	DB01252	investigational	Mitiglinide	c1ccccc1C[C@H](C(=O)O)CC(=O)N(C2)C[C@H]([C@H]23)CCCC3
18036	sp|P9WQJ3|FATRP_MY	Q09428	89.7	353.0	919.0	DB01382	approved; investigational	Glymidine	COCCOc1cnc(nc1)NS(=O)(=O)c2ccccc2
18037	sp|P9WQJ3|FATRP_MY	Q09428	81.77	1063.0	1579.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
18038	sp|P9WQJ3|FATRP_MY	Q09428	81.77	1063.0	1579.0	DB00222	approved	Glimepiride	CCC1=C(C)CN(C1=O)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3
18039	sp|P9WQJ3|FATRP_MY	Q09428	81.77	1063.0	1579.0	DB00672	approved; investigational	Chlorpropamide	CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1
18040	sp|P9WQJ3|FATRP_MY	Q09428	81.77	1063.0	1579.0	DB00731	approved; investigational	Nateglinide	CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](C(=O)O)Cc2ccccc2
18041	sp|P9WQJ3|FATRP_MY	Q09428	81.77	1063.0	1579.0	DB00912	approved; investigational	Repaglinide	CCOc1c(C(=O)O)ccc(c1)CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3
18042	sp|P9WQJ3|FATRP_MY	Q09428	81.77	1063.0	1579.0	DB01067	approved; investigational	Glipizide	Cc1ncc(nc1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
18043	sp|P9WQJ3|FATRP_MY	Q09428	81.77	1063.0	1579.0	DB01120	approved	Gliclazide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN(C2)CC(C23)CCC3
18044	sp|P9WQJ3|FATRP_MY	Q09428	81.77	1063.0	1579.0	DB01124	approved; investigational	Tolbutamide	CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1
18045	sp|P9WQJ3|FATRP_MY	Q09428	81.77	1063.0	1579.0	DB01251	approved; investigational	Gliquidone	COc(cc1)cc(c12)C(=O)N(C(=O)C2(C)C)CCc3ccc(cc3)S(=O)(=O)NC(=O)NC4CCCCC4
18046	sp|P9WQJ3|FATRP_MY	Q09428	81.77	1063.0	1579.0	DB01252	investigational	Mitiglinide	c1ccccc1C[C@H](C(=O)O)CC(=O)N(C2)C[C@H]([C@H]23)CCCC3
18047	sp|P9WQJ3|FATRP_MY	Q09428	81.77	1063.0	1579.0	DB01382	approved; investigational	Glymidine	COCCOc1cnc(nc1)NS(=O)(=O)c2ccccc2
18048	sp|P9WQJ3|FATRP_MY	Q09428	89.7	353.0	919.0	DB00839	approved; investigational	Tolazamide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2
18049	sp|P9WQJ3|FATRP_MY	Q09428	89.7	353.0	919.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
18050	sp|P9WQJ3|FATRP_MY	Q09428	81.77	1063.0	1579.0	DB00839	approved; investigational	Tolazamide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2
18051	sp|P9WQJ3|FATRP_MY	Q09428	81.77	1063.0	1579.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
18052	sp|P9WQJ3|FATRP_MY	O15439	78.92	126.0	624.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
18053	sp|P9WQJ3|FATRP_MY	O15439	80.67	765.0	1274.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
18054	sp|P9WQJ3|FATRP_MY	O60706	88.11	348.0	904.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
18055	sp|P9WQJ3|FATRP_MY	O60706	88.11	348.0	904.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
18056	sp|P9WQJ3|FATRP_MY	O60706	88.11	348.0	904.0	DB09220	approved; investigational	Nicorandil	[O-][N+](=O)OCCNC(=O)c1cccnc1
18057	sp|P9WQJ3|FATRP_MY	O60706	79.87	1041.0	1545.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
18058	sp|P9WQJ3|FATRP_MY	O60706	79.87	1041.0	1545.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
18059	sp|P9WQJ3|FATRP_MY	O60706	79.87	1041.0	1545.0	DB09220	approved; investigational	Nicorandil	[O-][N+](=O)OCCNC(=O)c1cccnc1
18060	sp|P9WQJ3|FATRP_MY	O15440	81.46	912.0	1426.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
18061	sp|P9WQJ3|FATRP_MY	O15440	81.46	912.0	1426.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
18062	sp|P9WQJ3|FATRP_MY	O95255	79.4	348.0	849.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
18063	sp|P9WQJ3|FATRP_MY	O95255	79.87	993.0	1497.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
18064	sp|P9WQJ3|FATRP_MY	P13569	82.73	118.0	640.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
18065	sp|P9WQJ3|FATRP_MY	P13569	82.73	118.0	640.0	DB00887	approved	Bumetanide	CCCCNc1c(c(S(=O)(=O)N)cc(c1)C(=O)O)Oc2ccccc2
18066	sp|P9WQJ3|FATRP_MY	P13569	82.73	118.0	640.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
18067	sp|P9WQJ3|FATRP_MY	P13569	82.73	118.0	640.0	DB01050	approved	Ibuprofen	CC(C)Cc1ccc(cc1)C(C)C(=O)O
18068	sp|P9WQJ3|FATRP_MY	P13569	82.73	118.0	640.0	DB02587	experimental; investigational	Colforsin	O[C@H]1CCC(C)(C)[C@@H]([C@]12C)[C@H](O)[C@H](OC(=O)C)[C@]3(C)[C@]2(O)C(=O)C[C@](O3)(C)C=C
18069	sp|P9WQJ3|FATRP_MY	P13569	82.73	118.0	640.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
18070	sp|P9WQJ3|FATRP_MY	P13569	82.73	118.0	640.0	DB04522	experimental	Dexfosfoserine	OC(=O)[C@@H](N)COP(=O)(O)O
18071	sp|P9WQJ3|FATRP_MY	P13569	82.73	118.0	640.0	DB04941	approved	Crofelemer	 
18072	sp|P9WQJ3|FATRP_MY	P13569	82.73	118.0	640.0	DB06266	investigational	Lonidamine	c1cccc(c12)n(nc2C(=O)O)Cc3c(Cl)cc(Cl)cc3
18073	sp|P9WQJ3|FATRP_MY	P13569	82.73	118.0	640.0	DB08820	approved	Ivacaftor	CC(C)(C)c1cc(C(C)(C)C)c(O)cc1NC(=O)c(c2=O)c[nH]c(c23)cccc3
18074	sp|P9WQJ3|FATRP_MY	P13569	82.73	118.0	640.0	DB09213	approved; investigational	Dexibuprofen	CC(C)Cc1ccc(cc1)[C@H](C)C(=O)O
18075	sp|P9WQJ3|FATRP_MY	P13569	82.73	118.0	640.0	DB09280	approved	Lumacaftor	O=C(O)c1cccc(c1)-c2nc(ccc2C)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
18076	sp|P9WQJ3|FATRP_MY	P13569	82.73	118.0	640.0	DB11712	approved; investigational	Tezacaftor	OC[C@H](O)Cn1c(C(C)(C)CO)cc(c12)cc(c(F)c2)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
18077	sp|P9WQJ3|FATRP_MY	P13569	82.73	118.0	640.0	DB15444	approved; investigational	Elexacaftor	FC(F)(F)C(C)(C)COc1nn(cc1)-c2nc(N(C3(C)C)C[C@@H](C)C3)c(cc2)C(=O)NS(=O)(=O)c4cn(C)nc4C
18078	sp|P9WQJ3|FATRP_MY	P13569	84.15	908.0	1439.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
18079	sp|P9WQJ3|FATRP_MY	P13569	84.15	908.0	1439.0	DB00887	approved	Bumetanide	CCCCNc1c(c(S(=O)(=O)N)cc(c1)C(=O)O)Oc2ccccc2
18080	sp|P9WQJ3|FATRP_MY	P13569	84.15	908.0	1439.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
18081	sp|P9WQJ3|FATRP_MY	P13569	84.15	908.0	1439.0	DB01050	approved	Ibuprofen	CC(C)Cc1ccc(cc1)C(C)C(=O)O
18082	sp|P9WQJ3|FATRP_MY	P13569	84.15	908.0	1439.0	DB02587	experimental; investigational	Colforsin	O[C@H]1CCC(C)(C)[C@@H]([C@]12C)[C@H](O)[C@H](OC(=O)C)[C@]3(C)[C@]2(O)C(=O)C[C@](O3)(C)C=C
18083	sp|P9WQJ3|FATRP_MY	P13569	84.15	908.0	1439.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
18084	sp|P9WQJ3|FATRP_MY	P13569	84.15	908.0	1439.0	DB04522	experimental	Dexfosfoserine	OC(=O)[C@@H](N)COP(=O)(O)O
18085	sp|P9WQJ3|FATRP_MY	P13569	84.15	908.0	1439.0	DB04941	approved	Crofelemer	 
18086	sp|P9WQJ3|FATRP_MY	P13569	84.15	908.0	1439.0	DB06266	investigational	Lonidamine	c1cccc(c12)n(nc2C(=O)O)Cc3c(Cl)cc(Cl)cc3
18087	sp|P9WQJ3|FATRP_MY	P13569	84.15	908.0	1439.0	DB08820	approved	Ivacaftor	CC(C)(C)c1cc(C(C)(C)C)c(O)cc1NC(=O)c(c2=O)c[nH]c(c23)cccc3
18088	sp|P9WQJ3|FATRP_MY	P13569	84.15	908.0	1439.0	DB09213	approved; investigational	Dexibuprofen	CC(C)Cc1ccc(cc1)[C@H](C)C(=O)O
18089	sp|P9WQJ3|FATRP_MY	P13569	84.15	908.0	1439.0	DB09280	approved	Lumacaftor	O=C(O)c1cccc(c1)-c2nc(ccc2C)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
18090	sp|P9WQJ3|FATRP_MY	P13569	84.15	908.0	1439.0	DB11712	approved; investigational	Tezacaftor	OC[C@H](O)Cn1c(C(C)(C)CO)cc(c12)cc(c(F)c2)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
18091	sp|P9WQJ3|FATRP_MY	P13569	84.15	908.0	1439.0	DB15444	approved; investigational	Elexacaftor	FC(F)(F)C(C)(C)COc1nn(cc1)-c2nc(N(C3(C)C)C[C@@H](C)C3)c(cc2)C(=O)NS(=O)(=O)c4cn(C)nc4C
18092	sp|P96218|GLTB_MYC	P55038	98.69	31.0	1538.0	DB03247	approved; investigational	Flavin mononucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)COP(=O)(O)O
18093	sp|P9WND9|HSAB_MYC	Q9LAG2	81.82	1.0	154.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
18094	sp|P9WJA1|HSAA_MYC	P45954	86.29	74.0	414.0	DB00167	investigational; nutraceutical	Isoleucine	CC[C@H](C)[C@H](N)C(=O)O
18095	sp|P9WJA1|HSAA_MYC	P45954	86.29	74.0	414.0	DB00313	approved; investigational	Valproic acid	CCCC(C(=O)O)CCC
18096	sp|P9WJA1|HSAA_MYC	Q06319	87.82	23.0	369.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
18097	sp|P9WJA1|HSAA_MYC	Q06319	87.82	23.0	369.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
18098	sp|P9WJA1|HSAA_MYC	P16219	89.34	51.0	403.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
18099	sp|P9WJA1|HSAA_MYC	P16219	89.34	51.0	403.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
18100	sp|P9WJA1|HSAA_MYC	P16219	89.34	51.0	403.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
18101	sp|P9WJA1|HSAA_MYC	Q72JJ3	87.06	23.0	366.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
18102	sp|P9WJA1|HSAA_MYC	P11310	87.31	58.0	402.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
18103	sp|P9WJA1|HSAA_MYC	P11310	87.31	58.0	402.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
18104	sp|P9WJA1|HSAA_MYC	P11310	87.31	58.0	402.0	DB03415	experimental	3-thiaoctanoyl-CoA	CCCCCSCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
18105	sp|P9WJA1|HSAA_MYC	Q9UKU7	87.56	52.0	397.0	DB01675	experimental	Methacrylyl-Coenzyme A	CC(=C)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
18106	sp|P9WJA1|HSAA_MYC	Q9UKU7	87.56	52.0	397.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
18107	sp|P9WJA1|HSAA_MYC	P26440	91.37	54.0	414.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
18108	sp|P9WJA1|HSAA_MYC	P26440	91.37	54.0	414.0	DB04036	experimental	Coenzyme A persulfide	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSS
18109	sp|P9WJA1|HSAA_MYC	Q9KIE5	91.37	5.0	365.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
18110	sp|P9WKE3|KPRS_MYC	P14193	95.09	6.0	316.0	DB02798	experimental	Alpha-Methylene Adenosine Monophosphate	CP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
18111	sp|P9WKE3|KPRS_MYC	P14193	95.09	6.0	316.0	DB03148	experimental	Adenosine 5'-methylenediphosphate	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)CP(=O)(O)O
18112	sp|P9WKE3|KPRS_MYC	Q8IE67	99.08	111.0	434.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
18113	sp|P9WPV1|ATPE_MYC	P30049	72.73	57.0	145.0	DB00753	approved; vet_approved	Isoflurane	FC(F)OC(Cl)C(F)(F)F
18114	sp|P9WPV1|ATPE_MYC	P30049	72.73	57.0	145.0	DB01189	approved	Desflurane	FC(F)OC(F)C(F)(F)F
18115	sp|P9WNC7|HPPK_MYC	P53848	81.91	299.0	453.0	DB00634	approved	Sulfacetamide	CC(=O)NS(=O)(=O)c1ccc(N)cc1
18116	sp|P9WNC7|HPPK_MYC	P26281	71.28	1.0	135.0	DB02119	experimental	6-Hydroxymethyl-7,8-Dihydropterin	O=c1[nH]c(N)nc(c12)NCC(=N2)CO
18117	sp|P9WNC7|HPPK_MYC	P26281	71.28	1.0	135.0	DB02596	experimental	alpha,beta-Methyleneadenosine 5'-triphosphate	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)CP(=O)(O)OP(=O)(O)O
18118	sp|P9WNC7|HPPK_MYC	P26281	71.28	1.0	135.0	DB03197	experimental	6-Hydroxymethylpterin	Nc([nH]1)nc(=O)c(c12)nc(cn2)CO
18119	sp|P9WNC7|HPPK_MYC	P26281	71.28	1.0	135.0	DB04047	experimental	6-hydroxymethylpterin diphosphate	Nc([nH]1)nc(=O)c(c12)nc(cn2)COP(=O)(O)OP(=O)(O)O
18120	sp|P9WNC7|HPPK_MYC	P26281	71.28	1.0	135.0	DB04158	experimental	6-(adenosine tetraphosphate-methyl)-7,8-dihydropterin	Nc([nH]1)nc(=O)c(c12)N=C(CN2)COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
18121	sp|P9WNC7|HPPK_MYC	P26281	71.28	1.0	135.0	DB04610	experimental	7,8-dihydro-6-hydroxymethyl-7-methyl-7-[2-phenylethyl]-pterin	O=c1[nH]c(N)nc(c12)N[C@](C)(C(=N2)CO)CCc3ccccc3
18122	sp|P9WNC7|HPPK_MYC	P43777	71.81	1.0	136.0	DB02278	experimental	7,8-dihydro-7,7-dimethyl-6-hydroxypterin	Nc([nH]1)nc(=O)c(c12)NC(=O)C(N2)(C)C
18123	sp|P9WKG5|ISPF_MYC	P62617	96.86	2.0	156.0	DB02552	experimental	Geranyl Diphosphate	CC(C)=CCC/C(C)=C/CO[P@@](=O)(O)OP(=O)(O)O
18124	sp|P9WKG5|ISPF_MYC	P62619	96.86	2.0	156.0	DB01859	experimental	4-CDP-2-C-methyl-D-erythritol 2-phosphate	OP(=O)(O)O[C@@](C)(CO)[C@H](O)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2ccc(N)nc2=O
18125	sp|P9WKG5|ISPF_MYC	P62619	96.86	2.0	156.0	DB02552	experimental	Geranyl Diphosphate	CC(C)=CCC/C(C)=C/CO[P@@](=O)(O)OP(=O)(O)O
18126	sp|P9WKG5|ISPF_MYC	P62619	96.86	2.0	156.0	DB03403	experimental	Cytidine-5'-Monophosphate	Nc1nc(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)O
18127	sp|P9WKG5|ISPF_MYC	P62619	96.86	2.0	156.0	DB03687	experimental	4-(Cytidine 5'-diphospho)-2-C-methyl-D-erythritol	OC[C@](C)(O)[C@H](O)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2ccc(N)nc2=O
18128	sp|P9WKG5|ISPF_MYC	P62619	96.86	2.0	156.0	DB03961	experimental	2c-Methyl-D-Erythritol 2,4-Cyclodiphosphate	O=P1(O)OP(=O)(O)OC[C@@H](O)[C@](O1)(C)CO
18129	sp|P9WKG5|ISPF_MYC	P62619	96.86	2.0	156.0	DB04555	experimental	Cytidine-5'-Diphosphate	Nc1nc(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O
18130	sp|P9WKG5|ISPF_MYC	Q8EBR3	96.86	3.0	157.0	DB07780	experimental	Farnesyl diphosphate	CC(C)=CCC/C(C)=C/CC/C(C)=C/COP(=O)(O)OP(=O)(O)O
18131	sp|P9WKG5|ISPF_MYC	A0R559	96.23	2.0	155.0	DB04714	experimental	ISOPENTENYL PYROPHOSPHATE	CC(=C)CCO[P@@](=O)(O)OP(=O)(O)O
18132	sp|P9WKG5|ISPF_MYC	Q9PM68	93.08	213.0	361.0	DB02552	experimental	Geranyl Diphosphate	CC(C)=CCC/C(C)=C/CO[P@@](=O)(O)OP(=O)(O)O
18133	sp|P9WKG5|ISPF_MYC	Q9PM68	93.08	213.0	361.0	DB03403	experimental	Cytidine-5'-Monophosphate	Nc1nc(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)O
18134	sp|P9WKG5|ISPF_MYC	Q8RQP5	84.91	2.0	137.0	DB03403	experimental	Cytidine-5'-Monophosphate	Nc1nc(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)O
18135	sp|P9WKG5|ISPF_MYC	Q8RQP5	84.91	2.0	137.0	DB04555	experimental	Cytidine-5'-Diphosphate	Nc1nc(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O
18136	sp|P9WN69|G6PI_MYC	P06744	99.28	4.0	553.0	DB02007	experimental	alpha-D-glucose 6-phosphate	O[C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O)COP(=O)(O)O
18137	sp|P9WN69|G6PI_MYC	P06744	99.28	4.0	553.0	DB02076	experimental	6-phospho-D-gluconic acid	OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(=O)O
18138	sp|P9WN69|G6PI_MYC	P06744	99.28	4.0	553.0	DB02093	experimental	5-phospho-D-arabinohydroxamic acid	ONC(=O)[C@@H](O)[C@H](O)[C@H](O)COP(=O)(O)O
18139	sp|P9WN69|G6PI_MYC	P06744	99.28	4.0	553.0	DB02548	experimental	D-glucitol 6-phosphate	OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)COP(=O)(O)O
18140	sp|P9WN69|G6PI_MYC	P06744	99.28	4.0	553.0	DB03042	experimental	5-Phosphoarabinonic Acid	OC(=O)[C@@H](O)[C@H](O)[C@H](O)COP(=O)(O)O
18141	sp|P9WN69|G6PI_MYC	P06744	99.28	4.0	553.0	DB03581	experimental	Glucose-6-Phosphate	OP(=O)(O)OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C=O
18142	sp|P9WN69|G6PI_MYC	P06744	99.28	4.0	553.0	DB03937	experimental	D-erythrose 4-phosphate	O=C[C@H](O)[C@H](O)COP(=O)(O)O
18143	sp|P9WN69|G6PI_MYC	P06744	99.28	4.0	553.0	DB04493	experimental	Fructose-6-phosphate	OCC(=O)[C@@H](O)[C@H](O)[C@H](O)COP(=O)(O)O
18144	sp|P9WN69|G6PI_MYC	P06744	99.28	4.0	553.0	DB09130	approved; investigational	Copper	[Cu]
18145	sp|P9WN69|G6PI_MYC	P06744	99.28	4.0	553.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
18146	sp|P9WN41|GLMM_MYC	P26276	85.49	12.0	395.0	DB02007	experimental	alpha-D-glucose 6-phosphate	O[C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O)COP(=O)(O)O
18147	sp|P9WN41|GLMM_MYC	P26276	85.49	12.0	395.0	DB02843	experimental	alpha-D-glucose-1-phosphate	OC[C@H]1O[C@H](OP(=O)(O)O)[C@H](O)[C@@H](O)[C@@H]1O
18148	sp|P9WN41|GLMM_MYC	P26276	85.49	12.0	395.0	DB02867	experimental	D-Mannose 1-Phosphate	OC[C@H]1OC(OP(=O)(O)O)[C@@H](O)[C@@H](O)[C@@H]1O
18149	sp|P9WN41|GLMM_MYC	P26276	85.49	12.0	395.0	DB02900	experimental	alpha-D-mannose 6-phosphate	O[C@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O)COP(=O)(O)O
18150	sp|P9WN41|GLMM_MYC	P26276	85.49	12.0	395.0	DB04522	experimental	Dexfosfoserine	OC(=O)[C@@H](N)COP(=O)(O)O
18151	sp|P9WN41|GLMM_MYC	P36871	81.03	49.0	412.0	DB02835	experimental	Alpha-D-Glucose 1,6-Bisphosphate	OP(=O)(O)OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O1)OP(=O)(O)O
18152	sp|P9WN41|GLMM_MYC	P36871	81.03	49.0	412.0	DB04397	experimental	Alpha-D-Glucose-1-Phosphate-6-Vanadate	O[V](=O)(=O)OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O1)OP(=O)(O)O
18153	sp|P9WKG1|ISPH2_MY	P62623	91.64	2.0	309.0	DB01785	experimental	Dimethylallyl Diphosphate	CC(C)=CCO[P@@](=O)(O)OP(=O)(O)O
18154	sp|P9WKG1|ISPH2_MY	P62623	91.64	2.0	309.0	DB04714	experimental	ISOPENTENYL PYROPHOSPHATE	CC(=C)CCO[P@@](=O)(O)OP(=O)(O)O
18155	sp|P9WQ51|FAC19_MY	Q8ZKF6	98.54	79.0	619.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
18156	sp|P9WQ51|FAC19_MY	Q8ZKF6	98.54	79.0	619.0	DB03230	experimental	Adenosine-5'-Propylphosphate	CCCOP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
18157	sp|P9WQ51|FAC19_MY	Q9NUB1	98.91	112.0	654.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
18158	sp|P9WQ51|FAC19_MY	Q9NR19	103.47	106.0	673.0	DB00131	approved; investigational; nutraceutical	Adenosine phosphate	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
18159	sp|P9WQ51|FAC19_MY	Q9NR19	103.47	106.0	673.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
18160	sp|P9WQ51|FAC19_MY	P40871	91.42	28.0	529.0	DB01672	experimental	2,3-Dihydroxy-Benzoic Acid	OC(=O)c1cccc(O)c1O
18161	sp|P9WQ51|FAC19_MY	Q8GN86	91.06	3.0	502.0	DB03728	experimental	p-Chlorobenzoic acid	OC(=O)c1ccc(Cl)cc1
18162	sp|P9WQ51|FAC19_MY	O60488	91.61	119.0	621.0	DB00159	approved; nutraceutical	Icosapent	CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O
18163	sp|P9WQ51|FAC19_MY	O60488	91.61	119.0	621.0	DB00197	approved; investigational; withdrawn	Troglitazone	Cc1c(O)c(C)c(C)c(c12)OC(C)(CC2)COc3ccc(cc3)CC4SC(=O)NC4=O
18164	sp|P9WQ51|FAC19_MY	O60488	91.61	119.0	621.0	DB00412	approved; investigational	Rosiglitazone	c1cccnc1N(C)CCOc2ccc(cc2)CC3SC(=O)NC3=O
18165	sp|O53521|FAC15_MY	O60488	102.0	97.0	709.0	DB00159	approved; nutraceutical	Icosapent	CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O
18166	sp|O53521|FAC15_MY	O60488	102.0	97.0	709.0	DB00197	approved; investigational; withdrawn	Troglitazone	Cc1c(O)c(C)c(C)c(c12)OC(C)(CC2)COc3ccc(cc3)CC4SC(=O)NC4=O
18167	sp|O53521|FAC15_MY	O60488	102.0	97.0	709.0	DB00412	approved; investigational	Rosiglitazone	c1cccnc1N(C)CCOc2ccc(cc2)CC3SC(=O)NC3=O
18168	sp|O53521|FAC15_MY	P33121	97.0	112.0	694.0	DB00131	approved; investigational; nutraceutical	Adenosine phosphate	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
18169	sp|O53521|FAC15_MY	P33121	97.0	112.0	694.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
18170	sp|O53521|FAC15_MY	Q96GR2	101.67	111.0	721.0	DB08326	experimental	2-(6-HYDROXY-1,3-BENZOTHIAZOL-2-YL)-1,3-THIAZOL-4(5H)-ONE	c1cc(O)cc(c12)sc(n2)C3=NC(=O)CS3
18171	sp|O53521|FAC15_MY	Q8I0X2	101.33	133.0	741.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
18172	sp|P9WJI1|FPRB_MYC	P22570	79.48	30.0	487.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
18173	sp|P9WJI1|FPRB_MYC	P22570	79.48	30.0	487.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
18174	sp|P9WJI1|FPRB_MYC	P9WIQ3	78.26	2.0	452.0	DB01753	experimental	4-oxo-nicotinamide-adenine dinucleotide phosphate	NC(=O)[C@H]1C=[N+](C=CC1=O)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
18175	sp|P9WJI1|FPRB_MYC	P9WIQ3	78.26	2.0	452.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
18176	sp|P9WKF5|KAD_MYCT	Q96MA6	70.17	59.0	186.0	DB01717	experimental	Bis(Adenosine)-5'-Pentaphosphate	n1cnc(N)c(c12)ncn2[C@H]3[C@H](O)[C@H](O)[C@H](O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
18177	sp|P9WKF5|KAD_MYCT	P27142	70.17	1.0	128.0	DB01717	experimental	Bis(Adenosine)-5'-Pentaphosphate	n1cnc(N)c(c12)ncn2[C@H]3[C@H](O)[C@H](O)[C@H](O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
18178	sp|P9WKF5|KAD_MYCT	P16304	70.17	1.0	128.0	DB01717	experimental	Bis(Adenosine)-5'-Pentaphosphate	n1cnc(N)c(c12)ncn2[C@H]3[C@H](O)[C@H](O)[C@H](O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
18179	sp|P9WKF5|KAD_MYCT	P84139	70.17	1.0	128.0	DB01717	experimental	Bis(Adenosine)-5'-Pentaphosphate	n1cnc(N)c(c12)ncn2[C@H]3[C@H](O)[C@H](O)[C@H](O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
18180	sp|P9WKF5|KAD_MYCT	P30085	103.87	6.0	194.0	DB00441	approved	Gemcitabine	Nc1nc(=O)n(cc1)[C@@H](C2(F)F)O[C@H](CO)[C@H]2O
18181	sp|P9WKF5|KAD_MYCT	P30085	103.87	6.0	194.0	DB03403	experimental	Cytidine-5'-Monophosphate	Nc1nc(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)O
18182	sp|P9WKF5|KAD_MYCT	P30085	103.87	6.0	194.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
18183	sp|P9WKF5|KAD_MYCT	P30085	103.87	6.0	194.0	DB03664	experimental	P1-(adenosine-5'-P5-(uridine-5')pentaphosphate	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5ccc(=O)[nH]c5=O
18184	sp|P9WKF5|KAD_MYCT	P30085	103.87	6.0	194.0	DB04444	experimental	Tetrafluoroaluminate Ion	F[Al-](F)(F)F
18185	sp|P9WKF5|KAD_MYCT	P00568	99.45	11.0	191.0	DB01717	experimental	Bis(Adenosine)-5'-Pentaphosphate	n1cnc(N)c(c12)ncn2[C@H]3[C@H](O)[C@H](O)[C@H](O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
18186	sp|P9WKF5|KAD_MYCT	P0A6I9	86.74	5.0	162.0	DB01690	experimental	Bis(Adenosine)-5'-Triphosphate	n1cnc(N)c(c12)ncn2[C@H]3[C@H](O)[C@H](O)[C@H](O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
18187	sp|P9WG89|EMRB_MYC	P9WJY5	79.26	33.0	461.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
18188	sp|O33194|G3PP_MYC	Q96GD0	70.54	19.0	268.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
18189	sp|P9WP71|COX1_MYC	P98002	92.67	19.0	550.0	DB04147	experimental	Dodecyldimethylamine N-oxide	CCCCCCCCCCCC[N+]([O-])(C)C
18190	sp|P9WP71|COX1_MYC	P33517	94.59	16.0	558.0	DB03619	approved	Deoxycholic acid	C1C[C@@H](O)C[C@H]([C@]12C)CC[C@@H]3[C@@H]2C[C@H](O)[C@@]4(C)[C@H]3CC[C@@H]4[C@H](C)CCC(=O)O
18191	sp|P9WP71|COX1_MYC	P00395	87.96	5.0	509.0	DB02659	approved	Cholic Acid	OC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](C[C@@H]2O)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
18192	sp|P9WP71|COX1_MYC	P00395	87.96	5.0	509.0	DB04464	experimental	N-Formylmethionine	O=CN[C@H](C(=O)O)CCSC
18193	sp|P9WP71|COX1_MYC	P00395	87.96	5.0	509.0	DB09140	approved; vet_approved	Oxygen	O=O
18194	sp|P9WHS9|DAPE_MYC	Q03154	91.24	72.0	395.0	DB00128	approved; nutraceutical	Aspartic acid	OC(=O)[C@@H](N)CC(=O)O
18195	sp|P9WHS9|DAPE_MYC	Q03154	91.24	72.0	395.0	DB06151	approved; investigational	Acetylcysteine	CC(=O)N[C@@H](CS)C(=O)O
18196	sp|P9WHS9|DAPE_MYC	Q03154	91.24	72.0	395.0	DB09130	approved; investigational	Copper	[Cu]
18197	sp|P9WNS5|DUT_MYCT	P9WNS5	99.35	1.0	154.0	DB01965	experimental	2'-Deoxyuridine 5'-alpha,beta-imido-triphosphate	OP(=O)(O)OP(=O)(O)NP(=O)(O)OC[C@H]1O[C@H](C[C@@H]1O)n2ccc(=O)[nH]c2=O
18198	sp|P9WNS5|DUT_MYCT	P9WNS5	99.35	1.0	154.0	DB02333	experimental	Deoxyuridine-5'-Triphosphate	O=c1[nH]c(=O)ccn1[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
18199	sp|P9WNS5|DUT_MYCT	P9WNS5	99.35	1.0	154.0	DB03413	experimental	Deoxyuridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
18200	sp|P9WNS5|DUT_MYCT	P9WNS5	99.35	1.0	154.0	DB03800	experimental	Deoxyuridine monophosphate	OP(=O)(O)OC[C@H]1O[C@H](C[C@@H]1O)n2ccc(=O)[nH]c2=O
18201	sp|P9WNS5|DUT_MYCT	P33316	88.96	113.0	250.0	DB03413	experimental	Deoxyuridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
18202	sp|P9WNS5|DUT_MYCT	P33316	88.96	113.0	250.0	DB04685	experimental	1-{(2S,5S)-4-FLUORO-5-[(TRITYLOXY)METHYL]TETRAHYDROFURAN-2-YL}PYRIMIDINE-2,4(1H,3H)-DIONE	O=c1[nH]c(=O)ccn1[C@H]2C[C@H](F)[C@H](O2)COC(c3ccccc3)(c4ccccc4)c5ccccc5
18203	sp|P9WNS5|DUT_MYCT	P06968	88.96	12.0	149.0	DB01965	experimental	2'-Deoxyuridine 5'-alpha,beta-imido-triphosphate	OP(=O)(O)OP(=O)(O)NP(=O)(O)OC[C@H]1O[C@H](C[C@@H]1O)n2ccc(=O)[nH]c2=O
18204	sp|P9WNS5|DUT_MYCT	P06968	88.96	12.0	149.0	DB02333	experimental	Deoxyuridine-5'-Triphosphate	O=c1[nH]c(=O)ccn1[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
18205	sp|P9WNS5|DUT_MYCT	P06968	88.96	12.0	149.0	DB03413	experimental	Deoxyuridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
18206	sp|P9WNS5|DUT_MYCT	P06968	88.96	12.0	149.0	DB03800	experimental	Deoxyuridine monophosphate	OP(=O)(O)OC[C@H]1O[C@H](C[C@@H]1O)n2ccc(=O)[nH]c2=O
18207	sp|P9WNS5|DUT_MYCT	P03371	79.87	751.0	874.0	DB03413	experimental	Deoxyuridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
18208	sp|P9WNS5|DUT_MYCT	P16088	80.52	721.0	845.0	DB01891	experimental	Tl-3-093	c1ccccc1C[C@@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)OCc2ccccc2
18209	sp|P9WNS5|DUT_MYCT	P16088	80.52	721.0	845.0	DB02333	experimental	Deoxyuridine-5'-Triphosphate	O=c1[nH]c(=O)ccn1[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
18210	sp|P9WNS5|DUT_MYCT	P16088	80.52	721.0	845.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
18211	sp|P9WNS5|DUT_MYCT	P16088	80.52	721.0	845.0	DB03800	experimental	Deoxyuridine monophosphate	OP(=O)(O)OC[C@H]1O[C@H](C[C@@H]1O)n2ccc(=O)[nH]c2=O
18212	sp|P9WNS5|DUT_MYCT	P16088	80.52	721.0	845.0	DB07365	experimental	1-Naphthyl-L-alanine	OC(=O)[C@@H](N)Cc1cccc(c12)cccc2
18213	sp|P9WNS5|DUT_MYCT	P16088	80.52	721.0	845.0	DB08253	experimental	NAM NAPTHYLAMINOALANINE	NC(=O)[C@@H](N)Cc1cccc(c12)cccc2
18214	sp|P9WQ01|ARGB_MYC	Q9HTN2	96.94	10.0	295.0	DB04075	experimental	N-Acetyl-L-Glutamate	CC(=O)N[C@H](C(=O)O)CCC(=O)O
18215	sp|P9WQ01|ARGB_MYC	P0A6C8	85.37	5.0	256.0	DB04075	experimental	N-Acetyl-L-Glutamate	CC(=O)N[C@H](C(=O)O)CCC(=O)O
18216	sp|P9WQ01|ARGB_MYC	P0A6C8	85.37	5.0	256.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
18217	sp|P9WQ01|ARGB_MYC	P0A6C8	85.37	5.0	256.0	DB04444	experimental	Tetrafluoroaluminate Ion	F[Al-](F)(F)F
18218	sp|P9WNX7|GABD2_MY	P00352	90.73	26.0	496.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
18219	sp|P9WNX7|GABD2_MY	P00352	90.73	26.0	496.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
18220	sp|P9WNX7|GABD2_MY	P00352	90.73	26.0	496.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
18221	sp|P9WNX7|GABD2_MY	P00352	90.73	26.0	496.0	DB04447	experimental	1,4-Dithiothreitol	SC[C@H](O)[C@@H](O)CS
18222	sp|P9WNX7|GABD2_MY	O94788	90.93	40.0	511.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
18223	sp|P9WNX7|GABD2_MY	O94788	90.93	40.0	511.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
18224	sp|P9WNX7|GABD2_MY	O94788	90.93	40.0	511.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
18225	sp|P9WNX7|GABD2_MY	P30837	90.54	40.0	509.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
18226	sp|P9WNX7|GABD2_MY	P05091	91.31	38.0	511.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
18227	sp|P9WNX7|GABD2_MY	P05091	91.31	38.0	511.0	DB00536	approved	Guanidine	NC(N)=N
18228	sp|P9WNX7|GABD2_MY	P05091	91.31	38.0	511.0	DB00822	approved	Disulfiram	CCN(CC)C(=S)SSC(=S)N(CC)CC
18229	sp|P9WNX7|GABD2_MY	P05091	91.31	38.0	511.0	DB02115	experimental	Daidzin	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)Oc(c2)ccc(c23)c(=O)c(co3)-c4ccc(O)cc4
18230	sp|P9WNX7|GABD2_MY	P05091	91.31	38.0	511.0	DB04381	experimental	Crotonaldehyde	O=C/C=C/C
18231	sp|P9WNX7|GABD2_MY	P47895	90.93	33.0	504.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
18232	sp|P9WNX7|GABD2_MY	P47895	90.93	33.0	504.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
18233	sp|P9WNX7|GABD2_MY	P49189	91.12	14.0	486.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
18234	sp|P9WNX7|GABD2_MY	O75891	90.73	429.0	899.0	DB00116	nutraceutical	Tetrahydrofolic acid	Nc([nH]1)nc(=O)c(c12)NC(CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
18235	sp|P9WNX7|GABD2_MY	P25553	88.03	20.0	476.0	DB03619	approved	Deoxycholic acid	C1C[C@@H](O)C[C@H]([C@]12C)CC[C@@H]3[C@@H]2C[C@H](O)[C@@]4(C)[C@H]3CC[C@@H]4[C@H](C)CCC(=O)O
18236	sp|P9WNX7|GABD2_MY	P51649	88.61	72.0	531.0	DB00139	approved; nutraceutical	Succinic acid	OC(=O)CCC(=O)O
18237	sp|P9WNX7|GABD2_MY	P51649	88.61	72.0	531.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
18238	sp|P9WNX7|GABD2_MY	P51649	88.61	72.0	531.0	DB00313	approved; investigational	Valproic acid	CCCC(C(=O)O)CCC
18239	sp|P9WNX7|GABD2_MY	P51649	88.61	72.0	531.0	DB00534	approved; withdrawn	Chlormerodrin	Cl[Hg]CC(OC)CNC(=O)N
18240	sp|P9WNX7|GABD2_MY	P77674	87.84	16.0	471.0	DB04401	experimental	Betaine aldehyde	C[N+](C)(C)CC=O
18241	sp|P9WNX7|GABD2_MY	P30838	82.24	3.0	429.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
18242	sp|P9WNX7|GABD2_MY	Q02252	93.05	47.0	529.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
18243	sp|P9WNX7|GABD2_MY	P43353	85.52	7.0	450.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
18244	sp|P9WNX7|GABD2_MY	P51648	84.94	2.0	442.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
18245	sp|P9WNX7|GABD2_MY	Q59931	87.84	16.0	471.0	DB02263	experimental	Glyceraldehyde-3-Phosphate	O=C[C@H](O)COP(=O)(O)O
18246	sp|P9WNX7|GABD2_MY	Q59931	87.84	16.0	471.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
18247	sp|P9WNX7|GABD2_MY	P83849	89.0	52.0	513.0	DB03564	experimental	(4r)-2-Methylpentane-2,4-Diol	C[C@H](O)CC(C)(C)O
18248	sp|P9WNX7|GABD2_MY	P49419	88.61	64.0	523.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
18249	sp|P9WNX7|GABD2_MY	P49419	88.61	64.0	523.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
18250	sp|P9WNX7|GABD2_MY	P48448	70.85	6.0	373.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
18251	sp|P9WNX7|GABD2_MY	P48448	70.85	6.0	373.0	DB09116	approved; withdrawn	Calcium carbimide	[N-]=C=[N-]
18252	sp|P9WNX7|GABD2_MY	P09546	86.49	653.0	1101.0	DB03051	experimental	(S)-2-Tetrahydrofuroic acid	OC(=O)[C@H]1CCCO1
18253	sp|P9WNX7|GABD2_MY	P09546	86.49	653.0	1101.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
18254	sp|P9WNX7|GABD2_MY	P09546	86.49	653.0	1101.0	DB04398	approved; vet_approved	Lactic acid	CC(O)C(=O)O
18255	sp|P9WNX7|GABD2_MY	P30038	92.86	77.0	558.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
18256	sp|P9WNX7|GABD2_MY	Q56694	86.29	5.0	452.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
18257	sp|P9WPA7|COAA_MYC	P0A6I3	98.72	8.0	316.0	DB01783	approved; nutraceutical; vet_approved	Pantothenic acid	OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)O
18258	sp|P9WPA7|COAA_MYC	P0A6I3	98.72	8.0	316.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
18259	sp|P9WPA7|COAA_MYC	P0A6I3	98.72	8.0	316.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
18260	sp|P9WPL7|CP141_MY	P53554	96.5	8.0	394.0	DB04450	experimental	Heptyl 1-Thiohexopyranoside	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)SCCCCCCC
18261	sp|P9WPL7|CP141_MY	Q83WG3	102.5	1.0	411.0	DB06955	experimental	3,4-bis(7-chloro-1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid	c1ccc(Cl)c(c12)[nH]cc2-c3c(C(=O)O)[nH]c(C(=O)O)c3-c4c[nH]c(c45)c(Cl)ccc5
18262	sp|P9WPL7|CP141_MY	Q83WG3	102.5	1.0	411.0	DB07588	experimental	3,4-DI-1H-INDOL-3-YL-1H-PYRROLE-2,5-DICARBOXYLIC ACID	c1cccc(c12)[nH]cc2-c3c(C(=O)O)[nH]c(C(=O)O)c3-c4c[nH]c(c45)cccc5
18263	sp|P9WPL7|CP141_MY	Q00441	96.75	13.0	400.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
18264	sp|P9WPL7|CP141_MY	Q00441	96.75	13.0	400.0	DB03369	experimental	9-Aminophenanthrene	c1cccc(c12)c3c(cc2N)cccc3
18265	sp|P9WPL7|CP141_MY	Q00441	96.75	13.0	400.0	DB04070	experimental	6-Deoxyerythronolide B	C[C@@H]1C[C@H](C)[C@H](O)[C@@H](C)[C@H](O)[C@@H](C)C(=O)O[C@H](CC)[C@H](C)[C@H](O)[C@@H](C)C1=O
18266	sp|P9WPL7|CP141_MY	P9WPN5	98.25	1.0	394.0	DB07705	experimental	(S)-econazole	Clc1ccc(cc1)CO[C@H](Cn2ccnc2)c3c(Cl)cc(Cl)cc3
18267	sp|P9WPL7|CP141_MY	P9WPN5	98.25	1.0	394.0	DB07971	experimental	5-AMINO-2-{4-[(4-AMINOPHENYL)SULFANYL]PHENYL}-1H-ISOINDOLE-1,3(2H)-DIONE	Nc1ccc(cc1)Sc2ccc(cc2)N(C3=O)C(=O)c(c34)ccc(c4)N
18268	sp|P9WPL7|CP141_MY	P9WPN5	98.25	1.0	394.0	DB07972	experimental	1-(3-METHYLPHENYL)-1H-BENZIMIDAZOL-5-AMINE	Cc1cccc(c1)-n2cnc(c23)cc(N)cc3
18269	sp|P9WPL7|CP141_MY	P9WPP7	98.75	1.0	396.0	DB02721	experimental	4-Iodopyrazole	Ic1c[nH]nc1
18270	sp|P9WPL7|CP141_MY	P9WPP7	98.75	1.0	396.0	DB08761	experimental	(3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine-2,5-dione	Oc1ccc(cc1)C[C@@H]2NC(=O)[C@@H](NC2=O)Cc3ccc(O)cc3
18271	sp|P9WPL7|CP141_MY	Q9FCA6	95.0	24.0	404.0	DB02175	experimental	Malonic acid	OC(=O)CC(=O)O
18272	sp|P9WPL7|CP141_MY	Q9FCA6	95.0	24.0	404.0	DB02521	experimental	Flaviolin	Oc1cc(O)cc(c12)C(=O)C(O)=CC2=O
18273	sp|P9WPL7|CP141_MY	Q9FCA6	95.0	24.0	404.0	DB03254	experimental	4-Phenyl-1h-Imidazole	[nH]1cncc1-c2ccccc2
18274	sp|P9WPL7|CP141_MY	Q9FCA6	95.0	24.0	404.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
18275	sp|P9WPL7|CP141_MY	P00183	86.25	62.0	407.0	DB01011	approved; investigational	Metyrapone	c1ccncc1C(C)(C)C(=O)c2cnccc2
18276	sp|P9WPL7|CP141_MY	P00183	86.25	62.0	407.0	DB01663	experimental	lambda-bis(2,2'-bipyridine)-(5-methyl-2-2'-bipyridine)-C9-adamantane ruthenium (II)	C1=CC=CN2C1=C(C=CC=C3)N3[Ru+2]245(N6C(C=CC=C6)=C7N4C=CC=C7)N8C(=C9N5C=CC(C)=C9)C=C(C=C8)CCCCCCCCC(=O)N[C@@H]([C@H]12)[C@H]3C[C@@H](C1)C[C@@H](C2)C3
18277	sp|P9WPL7|CP141_MY	P00183	86.25	62.0	407.0	DB01703	experimental	N-(2-ferrocenylethyl)maleimide	O=C1C=CC(=O)N1CCC2(C3C4C5C26)[Fe]13456789C2C7C8C9C12
18278	sp|P9WPL7|CP141_MY	P00183	86.25	62.0	407.0	DB01744	approved	Camphor	C[C@]12C(=O)C[C@H](C1(C)C)CC2
18279	sp|P9WPL7|CP141_MY	P00183	86.25	62.0	407.0	DB01826	experimental	N-Butyl Isocyanide	CCCC[N+]#[C-]
18280	sp|P9WPL7|CP141_MY	P00183	86.25	62.0	407.0	DB02125	experimental	Adamantanone	O=C([C@H]12)[C@H]3C[C@@H](C1)C[C@@H](C2)C3
18281	sp|P9WPL7|CP141_MY	P00183	86.25	62.0	407.0	DB02617	experimental	1-(N-Imidazolyl)-2-Hydroxy-2-(2,3-Dichlorophenyl)Octane	CCCCCC[C@](O)(Cn1ccnc1)c2ccc(Cl)cc2Cl
18282	sp|P9WPL7|CP141_MY	P00183	86.25	62.0	407.0	DB02817	experimental	5-Exo-Hydroxycamphor	C[C@]12C[C@@H](O)[C@H](CC1=O)C2(C)C
18283	sp|P9WPL7|CP141_MY	P00183	86.25	62.0	407.0	DB02851	experimental	Thiocamphor	C[C@]12C(=S)C[C@H](C1(C)C)CC2
18284	sp|P9WPL7|CP141_MY	P00183	86.25	62.0	407.0	DB03031	experimental	Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Octyl-Amide	CN(C)c1cccc(c12)c(ccc2)S(=O)(=O)NCCCCCCCCNC(=O)C34CC5CC(C3)CC(C5)C4
18285	sp|P9WPL7|CP141_MY	P00183	86.25	62.0	407.0	DB03540	experimental	Norcamphor	[C@H]12CC[C@H](C1)C(=O)C2
18286	sp|P9WPL7|CP141_MY	P00183	86.25	62.0	407.0	DB03627	experimental	Adamantane	C12CC3CC(C1)CC(C3)C2
18287	sp|P9WPL7|CP141_MY	P00183	86.25	62.0	407.0	DB03836	experimental	1,3,5-trichlorobenzene	Clc1cc(Cl)cc(Cl)c1
18288	sp|P9WPL7|CP141_MY	P00183	86.25	62.0	407.0	DB04032	experimental	Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Butyl-Amide	CN(C)c1cccc(c12)c(ccc2)S(=O)(=O)NCCCCNC(=O)C34CC5CC(C3)CC(C5)C4
18289	sp|P9WPL7|CP141_MY	P00183	86.25	62.0	407.0	DB04501	experimental	Camphane	C[C@@]12CCC(C1(C)C)CC2
18290	sp|P9WPL7|CP141_MY	O31440	85.25	44.0	385.0	DB04257	experimental	Palmitoleic Acid	CCCCCC/C=C\CCCCCCCC(=O)O
18291	sp|P9WPL7|CP141_MY	Q9NR63	87.75	117.0	468.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
18292	sp|P9WPL7|CP141_MY	Q6V0L0	90.75	124.0	487.0	DB00523	approved; investigational	Alitretinoin	OC(=O)/C=C(\C)/C=C/C=C(/C)\C=C\C(C1(C)C)=C(C)CCC1
18293	sp|P9WPL7|CP141_MY	Q6V0L0	90.75	124.0	487.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
18294	sp|P9WPL7|CP141_MY	P08684	90.25	115.0	476.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
18295	sp|P9WPL7|CP141_MY	P08684	90.25	115.0	476.0	DB00143	approved; investigational; nutraceutical	Glutathione	OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(=O)O
18296	sp|P9WPL7|CP141_MY	P08684	90.25	115.0	476.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
18297	sp|P9WPL7|CP141_MY	P08684	90.25	115.0	476.0	DB05478	investigational	Pradefovir mesylate	n1cnc(N)c(c12)ncn2CCOC[P@@]3(=O)OCC[C@H](O3)c4cc(Cl)ccc4
18298	sp|P9WPL7|CP141_MY	P08684	90.25	115.0	476.0	DB06634	investigational	Casopitant	FC(F)(F)c1cc(cc(c1)C(F)(F)F)[C@@H](C)N(C)C(=O)N2CC[C@H](N3CCN(CC3)C(=O)C)C[C@@H]2c4ccc(F)cc4C
18299	sp|P9WPL7|CP141_MY	Q9HB55	91.5	114.0	480.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
18300	sp|P9WPL7|CP141_MY	P10632	92.0	112.0	480.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
18301	sp|P9WPL7|CP141_MY	P10632	92.0	112.0	480.0	DB03796	approved	Palmitic Acid	CCCCCCCCCCCCCCCC(=O)O
18302	sp|P9WPL7|CP141_MY	P10632	92.0	112.0	480.0	DB08607	experimental	(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE	O=C1NC(=O)S[C@@H]1Cc2ccc(cc2)OC[C@@](O3)(C)CCc(c34)c(C)c(O)c(C)c4C
18303	sp|P9WPL7|CP141_MY	P33261	89.5	112.0	470.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
18304	sp|P9WPL7|CP141_MY	P33261	89.5	112.0	470.0	DB12319	investigational; withdrawn	Benzbromarone	c1cccc(c12)c(c(o2)CC)C(=O)c3cc(Br)c(O)c(Br)c3
18305	sp|P9WPL7|CP141_MY	P11712	89.5	112.0	470.0	DB03317	experimental	Ferroheme C	[Fe-2]123[N+]4=C5C=C6[N+]1=C(C(C)=C6C(C)S)C=C7[N+]2=C(C(=C7C)CCC(=O)O)C=C8[N+]3=C(C=C4C(=C5C)C(C)S)C(C)=C8CCC(=O)O
18306	sp|P9WPL7|CP141_MY	P11712	89.5	112.0	470.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
18307	sp|P9WPL7|CP141_MY	P11712	89.5	112.0	470.0	DB12319	investigational; withdrawn	Benzbromarone	c1cccc(c12)c(c(o2)CC)C(=O)c3cc(Br)c(O)c(Br)c3
18308	sp|P9WPL7|CP141_MY	P33260	98.75	75.0	470.0	DB07670	experimental	N,4-Dimethyl-N-(1-phenyl-1H-pyrazol-5-yl)benzenesulfonamide	Cc1ccc(cc1)S(=O)(=O)N(C)c2ccnn2-c3ccccc3
18309	sp|P9WPL7|CP141_MY	P20813	89.5	113.0	471.0	DB02974	experimental	4-(4-Chlorophenyl)Imidazole	Clc1ccc(cc1)-c2cnc[nH]2
18310	sp|P9WPL7|CP141_MY	P20813	89.5	113.0	471.0	DB04664	experimental	Cyclohexyl-pentyl-maltoside	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@@H]2CO)OCCCCCC3CCCCC3
18311	sp|P9WPL7|CP141_MY	P20813	89.5	113.0	471.0	DB04794	approved; investigational	Bifonazole	c1ccccc1C(n2ccnc2)c3ccc(cc3)-c4ccccc4
18312	sp|P9WPL7|CP141_MY	P20813	89.5	113.0	471.0	DB08369	experimental	1-(biphenyl-4-ylmethyl)-1H-imidazole	c1cncn1Cc2ccc(cc2)-c3ccccc3
18313	sp|P9WPL7|CP141_MY	O43174	87.0	120.0	468.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
18314	sp|P9WPL7|CP141_MY	O43174	87.0	120.0	468.0	DB13083	investigational	Talarozole	c1ncnn1C(C(CC)CC)c2ccc(cc2)Nc(s3)nc(c34)cccc4
18315	sp|P9WPL7|CP141_MY	P08686	85.0	116.0	456.0	DB01026	approved; investigational	Ketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OCC(CO3)OC3(Cn4ccnc4)c5ccc(Cl)cc5Cl
18316	sp|P9WPL7|CP141_MY	O15528	88.0	126.0	478.0	DB01436	approved; nutraceutical	Alfacalcidol	CC(C)CCC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)/C(CCC2)=C/C=C3/C[C@@H](O)C[C@H](O)C3=C
18318	sp|P9WPL7|CP141_MY	P14779	83.5	93.0	427.0	DB03440	experimental	N-hexadecanoylglycine	CCCCCCCCCCCCCCCC(=O)NCC(=O)O
18319	sp|P9WPL7|CP141_MY	P14779	83.5	93.0	427.0	DB04257	experimental	Palmitoleic Acid	CCCCCC/C=C\CCCCCCCC(=O)O
18320	sp|P9WPL7|CP141_MY	P14779	83.5	93.0	427.0	DB08086	experimental	N-[12-(1H-imidazol-1-yl)dodecanoyl]-L-leucine	CC(C)C[C@@H](C(=O)O)NC(=O)CCCCCCCCCCCn1ccnc1
18321	sp|P9WPL7|CP141_MY	Q16850	80.5	153.0	475.0	DB01007	approved	Tioconazole	c1nccn1CC(c(c(Cl)c2)ccc2Cl)OCc3c(Cl)scc3
18322	sp|P9WPL7|CP141_MY	Q16850	80.5	153.0	475.0	DB01167	approved; investigational	Itraconazole	CCC(C)n1ncn(c1=O)-c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@@H](CO5)O[C@@]5(Cn6cncn6)c7ccc(Cl)cc7Cl
18323	sp|P9WPL7|CP141_MY	Q16850	80.5	153.0	475.0	DB05667	investigational	Levoketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OC[C@H](CO3)O[C@]3(Cn4ccnc4)c5ccc(Cl)cc5Cl
18324	sp|P9WPL7|CP141_MY	Q16850	80.5	153.0	475.0	DB07705	experimental	(S)-econazole	Clc1ccc(cc1)CO[C@H](Cn2ccnc2)c3c(Cl)cc(Cl)cc3
18325	sp|P9WPL7|CP141_MY	P10614	85.25	148.0	489.0	DB06890	experimental	(2R)-2-PHENYL-N-PYRIDIN-4-YLBUTANAMIDE	c1ccccc1[C@@H](CC)C(=O)Nc2ccncc2
18326	sp|P9WPL7|CP141_MY	P10614	85.25	148.0	489.0	DB07560	experimental	N-[(1S)-2-methyl-1-(pyridin-4-ylcarbamoyl)propyl]cyclohexanecarboxamide	c1cnccc1NC(=O)[C@H](C(C)C)NC(=O)C2CCCCC2
18327	sp|P9WPL7|CP141_MY	P10614	85.25	148.0	489.0	DB07568	experimental	(2S)-2-[(2,1,3-BENZOTHIADIAZOL-4-YLSULFONYL)AMINO]-2-PHENYL-N-PYRIDIN-4-YLACETAMIDE	n1snc(c12)cccc2S(=O)(=O)N[C@@H](c3ccccc3)C(=O)Nc4ccncc4
18328	sp|P9WPL7|CP141_MY	P10614	85.25	148.0	489.0	DB07569	experimental	CIS-4-METHYL-N-[(1S)-3-(METHYLSULFANYL)-1-(PYRIDIN-4-YLCARBAMOYL)PROPYL]CYCLOHEXANECARBOXAMIDE	c1cnccc1NC(=O)[C@H](CCSC)NC(=O)[C@@H]2CC[C@H](C)CC2
18329	sp|P9WPL7|CP141_MY	P10614	85.25	148.0	489.0	DB07572	experimental	3-{[(4-methylphenyl)sulfonyl]amino}propyl pyridin-4-ylcarbamate	Cc1ccc(cc1)S(=O)(=O)NCCCOC(=O)Nc2ccncc2
18330	sp|P9WPL7|CP141_MY	P10614	85.25	148.0	489.0	DB07635	experimental	4,4'-Dihydroxybenzophenone	Oc1ccc(cc1)C(=O)c2ccc(O)cc2
18331	sp|P9WPL7|CP141_MY	P50859	86.25	149.0	494.0	DB01026	approved; investigational	Ketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OCC(CO3)OC3(Cn4ccnc4)c5ccc(Cl)cc5Cl
18332	sp|P9WPL7|CP141_MY	P50859	86.25	149.0	494.0	DB01167	approved; investigational	Itraconazole	CCC(C)n1ncn(c1=O)-c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@@H](CO5)O[C@@]5(Cn6cncn6)c7ccc(Cl)cc7Cl
18333	sp|P9WPL7|CP141_MY	P50859	86.25	149.0	494.0	DB09040	approved	Efinaconazole	C=C1CCN(CC1)[C@H](C)[C@](O)(Cn2cncn2)c3c(F)cc(F)cc3
18334	sp|P9WPL7|CP141_MY	P50859	86.25	149.0	494.0	DB11633	approved; investigational	Isavuconazole	c1ncnn1C[C@](O)(c2c(F)ccc(F)c2)[C@@H](C)c3nc(cs3)-c4ccc(C#N)cc4
18335	sp|P9WPL7|CP141_MY	P11511	83.0	132.0	464.0	DB00184	approved	Nicotine	CN1CCC[C@H]1c2cnccc2
18336	sp|P9WPL7|CP141_MY	P11511	83.0	132.0	464.0	DB00357	approved; investigational	Aminoglutethimide	Nc1ccc(cc1)C2(CC)CCC(=O)NC2=O
18337	sp|P9WPL7|CP141_MY	P11511	83.0	132.0	464.0	DB00655	approved	Estrone	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)cc4
18338	sp|P9WPL7|CP141_MY	P11511	83.0	132.0	464.0	DB00894	approved; investigational	Testolactone	C1=CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2CC[C@@]4(C)[C@H]3CCC(O4)=O
18339	sp|P9WPL7|CP141_MY	P11511	83.0	132.0	464.0	DB00990	approved; investigational	Exemestane	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(C(C3)=C)=CC(=O)C=C4
18340	sp|P9WPL7|CP141_MY	P11511	83.0	132.0	464.0	DB01006	approved; investigational	Letrozole	N#Cc1ccc(cc1)C(n2cncn2)c3ccc(C#N)cc3
18341	sp|P9WPL7|CP141_MY	P11511	83.0	132.0	464.0	DB01217	approved; investigational	Anastrozole	N#CC(C)(C)c1cc(C(C)(C)C#N)cc(c1)Cn2cncn2
18342	sp|P9WPL7|CP141_MY	P11511	83.0	132.0	464.0	DB02342	investigational	2-Methoxyestradiol	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)c(c4)OC
18343	sp|P9WPL7|CP141_MY	P11511	83.0	132.0	464.0	DB03467	experimental	Naringenin	Oc1ccc(cc1)[C@@H](O2)CC(=O)c(c23)c(O)cc(c3)O
18344	sp|P9WPL7|CP141_MY	P11511	83.0	132.0	464.0	DB04539	experimental	Glyphosate	OC(=O)C[NH2+]CP(=O)(O)O
18345	sp|P9WPL7|CP141_MY	P11511	83.0	132.0	464.0	DB05749	investigational	MPI-674	 
18346	sp|P9WNE3|CPFC_MYC	P32396	86.05	8.0	304.0	DB01911	experimental	N-Methylmesoporphyrin	CCc(c(c12)C)c(n1)cc3[nH]c(c(c3C)CCC(=O)O)cc4nc(c(C)c4CCC(=O)O)cc5c(C)c(CC)c(c2)n5C
18347	sp|P9WNE3|CPFC_MYC	P32396	86.05	8.0	304.0	DB02188	experimental	N-Methylmesoporphyrin Containing Copper	CCC1=C(C2=CC3=C(C(=C(N3C)C=C4C(=C(C(=N4)C=C5C(=C(C(=CC1=N2)[N-]5)C)CCC(=O)O)CCC(=O)O)C)C)CC)C.[Cu+]
18348	sp|P9WNE3|CPFC_MYC	Q7KZA3	91.86	64.0	380.0	DB02659	approved	Cholic Acid	OC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](C[C@@H]2O)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
18349	sp|P9WNE3|CPFC_MYC	P22830	91.86	71.0	387.0	DB02659	approved	Cholic Acid	OC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](C[C@@H]2O)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
18350	sp|P9WJA3|HRP1_MYC	Q9UGI9	83.92	210.0	330.0	DB00131	approved; investigational; nutraceutical	Adenosine phosphate	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
18351	sp|P9WJA3|HRP1_MYC	Q9UGI9	83.92	210.0	330.0	DB00945	approved; vet_approved	Acetylsalicylic acid	CC(=O)Oc1ccccc1C(=O)O
18352	sp|P9WJA3|HRP1_MYC	Q9UGI9	83.92	210.0	330.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
18353	sp|P9WJA3|HRP1_MYC	Q9UGI9	81.82	360.0	477.0	DB00131	approved; investigational; nutraceutical	Adenosine phosphate	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
18354	sp|P9WJA3|HRP1_MYC	Q9UGI9	81.82	360.0	477.0	DB00945	approved; vet_approved	Acetylsalicylic acid	CC(=O)Oc1ccccc1C(=O)O
18355	sp|P9WJA3|HRP1_MYC	Q9UGI9	81.82	360.0	477.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
18356	sp|P9WJA3|HRP1_MYC	Q9UGJ0	85.31	286.0	408.0	DB00131	approved; investigational; nutraceutical	Adenosine phosphate	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
18357	sp|P9WJA3|HRP1_MYC	Q9UGJ0	85.31	286.0	408.0	DB00945	approved; vet_approved	Acetylsalicylic acid	CC(=O)Oc1ccccc1C(=O)O
18358	sp|P9WJA3|HRP1_MYC	Q9UGJ0	85.31	286.0	408.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
18359	sp|P9WJA3|HRP1_MYC	Q9UGJ0	78.32	442.0	554.0	DB00131	approved; investigational; nutraceutical	Adenosine phosphate	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
18360	sp|P9WJA3|HRP1_MYC	Q9UGJ0	78.32	442.0	554.0	DB00945	approved; vet_approved	Acetylsalicylic acid	CC(=O)Oc1ccccc1C(=O)O
18361	sp|P9WJA3|HRP1_MYC	Q9UGJ0	78.32	442.0	554.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
18362	sp|P9WJA3|HRP1_MYC	P54619	83.92	56.0	176.0	DB00131	approved; investigational; nutraceutical	Adenosine phosphate	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
18363	sp|P9WJA3|HRP1_MYC	P54619	83.92	56.0	176.0	DB00945	approved; vet_approved	Acetylsalicylic acid	CC(=O)Oc1ccccc1C(=O)O
18364	sp|P9WJA3|HRP1_MYC	P54619	83.92	56.0	176.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
18365	sp|P9WJA3|HRP1_MYC	P54619	83.92	202.0	322.0	DB00131	approved; investigational; nutraceutical	Adenosine phosphate	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
18366	sp|P9WJA3|HRP1_MYC	P54619	83.92	202.0	322.0	DB00945	approved; vet_approved	Acetylsalicylic acid	CC(=O)Oc1ccccc1C(=O)O
18367	sp|P9WJA3|HRP1_MYC	P54619	83.92	202.0	322.0	DB12010	approved; investigational	Fostamatinib	COc1c(OC)cc(cc1OC)Nc2ncc(F)c(n2)Nc(cc3)nc(c34)N(C(=O)C(O4)(C)C)COP(=O)(O)O
18368	sp|P9WJA3|HRP1_MYC	P35520	81.82	424.0	541.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
18369	sp|P9WJA3|HRP1_MYC	P35520	81.82	424.0	541.0	DB00118	approved; investigational; nutraceutical	Ademetionine	[O-]C(=O)[C@@H](N)CC[S+](C)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
18370	sp|P9WJA3|HRP1_MYC	P35520	81.82	424.0	541.0	DB00133	investigational; nutraceutical	Serine	OC(=O)[C@@H](N)CO
18371	sp|P9WJA3|HRP1_MYC	P35520	81.82	424.0	541.0	DB00151	approved; nutraceutical	Cysteine	OC(=O)[C@@H](N)CS
18372	sp|P9WNG3|FABH_MYC	P9WNG3	99.7	1.0	335.0	DB03017	approved; experimental	Lauric acid	CCCCCCCCCCCC(=O)O
18373	sp|P9WNG3|FABH_MYC	P9WNG3	99.7	1.0	335.0	DB03264	experimental	Dodecyl-Coa	CCCCCCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
18374	sp|P9WNG3|FABH_MYC	P9WNG3	99.7	1.0	335.0	DB07611	experimental	DECANE-1-THIOL	CCCCCCCCCCS
18375	sp|P9WNG3|FABH_MYC	P9WNG3	99.7	1.0	335.0	DB07650	experimental	Decyl formate	CCCCCCCCCCOC=O
18376	sp|P9WNG3|FABH_MYC	P9WNG3	99.7	1.0	335.0	DB08171	experimental	11-MERCAPTOUNDECANOIC ACID	OC(=O)CCCCCCCCCCS
18377	sp|P9WNG3|FABH_MYC	P9WNG3	99.7	1.0	335.0	DB08684	experimental	O-Decyl Hydrogen Thiocarbonate	CCCCCCCCCCOC(=O)S
18378	sp|P9WNG3|FABH_MYC	P9WNG3	99.7	1.0	335.0	DB08712	experimental	11-[(MERCAPTOCARBONYL)OXY]UNDECANOIC ACID	OC(=O)CCCCCCCCCCOC(=O)S
18379	sp|P9WNG3|FABH_MYC	Q9F6D4	96.42	9.0	332.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
18380	sp|P9WNG3|FABH_MYC	P0A6R0	93.43	3.0	316.0	DB01034	experimental	Cerulenin	NC(=O)[C@@H]1O[C@@H]1C(=O)CC/C=C/C/C=C/C
18381	sp|P9WNG3|FABH_MYC	P0A6R0	93.43	3.0	316.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
18382	sp|P9WNG3|FABH_MYC	P0A6R0	93.43	3.0	316.0	DB02039	experimental	S-Acetyl-Cysteine	OC(=O)[C@@H](N)CSC(=O)C
18383	sp|P9WNG3|FABH_MYC	P0A6R0	93.43	3.0	316.0	DB02316	experimental	1-(5-Carboxypentyl)-5-[(2,6-Dichlorobenzyl)Oxy]-1 H-Indole-2-Carboxylic Acid	OC(=O)CCCCCn1c(C(=O)O)cc(c12)cc(cc2)OCc3c(Cl)cccc3Cl
18384	sp|P9WNG3|FABH_MYC	P0A6R0	93.43	3.0	316.0	DB03661	experimental	L-cysteic acid	OC(=O)[C@@H](N)CS(=O)(=O)O
18385	sp|P9WNG3|FABH_MYC	P0A6R0	93.43	3.0	316.0	DB04524	experimental	Malonyl-CoA	OC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
18386	sp|P9WNG3|FABH_MYC	Q820T1	94.03	5.0	320.0	DB07429	experimental	2-({[4-bromo-3-(diethylsulfamoyl)phenyl]carbonyl}amino)benzoic acid	CCN(CC)S(=O)(=O)c1cc(ccc1Br)C(=O)Nc2ccccc2C(=O)O
18387	sp|P9WNG3|FABH_MYC	P9WPF1	94.33	72.0	388.0	DB08231	experimental	Myristic acid	CCCCCCCCCCCCCC(=O)O
18388	sp|I6YC53|ESXT_MYC	P13647	76.0	284.0	360.0	DB01593	approved; investigational	Zinc	[Zn]
18389	sp|I6YC53|ESXT_MYC	P13647	76.0	284.0	360.0	DB14487	approved; investigational	Zinc acetate	CC([O-])=O
18390	sp|I6YC53|ESXT_MYC	P13647	72.0	380.0	452.0	DB01593	approved; investigational	Zinc	[Zn]
18391	sp|I6YC53|ESXT_MYC	P13647	72.0	380.0	452.0	DB14487	approved; investigational	Zinc acetate	CC([O-])=O
18392	sp|I6YC53|ESXT_MYC	P13645	82.0	257.0	339.0	DB01593	approved; investigational	Zinc	[Zn]
18393	sp|I6YC53|ESXT_MYC	P13645	82.0	257.0	339.0	DB09130	approved; investigational	Copper	[Cu]
18394	sp|I6YC53|ESXT_MYC	P13645	82.0	257.0	339.0	DB14487	approved; investigational	Zinc acetate	CC([O-])=O
18395	sp|I6YC53|ESXT_MYC	P02538	78.0	149.0	227.0	DB01593	approved; investigational	Zinc	[Zn]
18396	sp|I6YC53|ESXT_MYC	P02538	78.0	149.0	227.0	DB14487	approved; investigational	Zinc acetate	CC([O-])=O
18397	sp|I6YC53|ESXT_MYC	P02538	76.0	279.0	355.0	DB01593	approved; investigational	Zinc	[Zn]
18398	sp|I6YC53|ESXT_MYC	P02538	76.0	279.0	355.0	DB14487	approved; investigational	Zinc acetate	CC([O-])=O
18399	sp|I6YC53|ESXT_MYC	P04264	75.0	295.0	370.0	DB01593	approved; investigational	Zinc	[Zn]
18400	sp|I6YC53|ESXT_MYC	P04264	75.0	295.0	370.0	DB09130	approved; investigational	Copper	[Cu]
18401	sp|I6YC53|ESXT_MYC	P04264	75.0	295.0	370.0	DB14487	approved; investigational	Zinc acetate	CC([O-])=O
18402	sp|I6YC53|ESXT_MYC	P04264	71.0	392.0	463.0	DB01593	approved; investigational	Zinc	[Zn]
18403	sp|I6YC53|ESXT_MYC	P04264	71.0	392.0	463.0	DB09130	approved; investigational	Copper	[Cu]
18404	sp|I6YC53|ESXT_MYC	P04264	71.0	392.0	463.0	DB14487	approved; investigational	Zinc acetate	CC([O-])=O
18405	sp|I6YC53|ESXT_MYC	P35908	79.0	290.0	369.0	DB01593	approved; investigational	Zinc	[Zn]
18406	sp|I6YC53|ESXT_MYC	P35908	79.0	290.0	369.0	DB09130	approved; investigational	Copper	[Cu]
18407	sp|I6YC53|ESXT_MYC	P35908	79.0	290.0	369.0	DB11157	approved	Anthralin	Oc1cccc(c12)Cc3c(C2=O)c(O)ccc3
18408	sp|I6YC53|ESXT_MYC	P35908	79.0	290.0	369.0	DB14487	approved; investigational	Zinc acetate	CC([O-])=O
18409	sp|I6YC53|ESXT_MYC	P35908	72.0	389.0	461.0	DB01593	approved; investigational	Zinc	[Zn]
18410	sp|I6YC53|ESXT_MYC	P35908	72.0	389.0	461.0	DB09130	approved; investigational	Copper	[Cu]
18411	sp|I6YC53|ESXT_MYC	P35908	72.0	389.0	461.0	DB11157	approved	Anthralin	Oc1cccc(c12)Cc3c(C2=O)c(O)ccc3
18412	sp|I6YC53|ESXT_MYC	P35908	72.0	389.0	461.0	DB14487	approved; investigational	Zinc acetate	CC([O-])=O
18413	sp|I6YC53|ESXT_MYC	P08729	75.0	207.0	282.0	DB01087	approved	Primaquine	c1ccnc(c12)c(cc(c2)OC)NC(C)CCCN
18415	sp|I6YC53|ESXT_MYC	P08729	73.0	301.0	374.0	DB01087	approved	Primaquine	c1ccnc(c12)c(cc(c2)OC)NC(C)CCCN
18419	sp|I6YC53|ESXT_MYC	P05787	78.0	202.0	280.0	DB09130	approved; investigational	Copper	[Cu]
18422	sp|I6YC53|ESXT_MYC	P05787	72.0	301.0	373.0	DB09130	approved; investigational	Copper	[Cu]
18423	sp|I6YC53|ESXT_MYC	P02533	82.0	223.0	305.0	DB01593	approved; investigational	Zinc	[Zn]
18424	sp|I6YC53|ESXT_MYC	P02533	82.0	223.0	305.0	DB14487	approved; investigational	Zinc acetate	CC([O-])=O
18425	sp|I6YC53|ESXT_MYC	P08779	82.0	225.0	307.0	DB01593	approved; investigational	Zinc	[Zn]
18426	sp|I6YC53|ESXT_MYC	P08779	82.0	225.0	307.0	DB14487	approved; investigational	Zinc acetate	CC([O-])=O
18427	sp|I6YC53|ESXT_MYC	Q99456	82.0	237.0	319.0	DB00400	approved; investigational; vet_approved	Griseofulvin	COc(c1Cl)cc(OC)c(C2=O)c1O[C@]23[C@H](C)CC(=O)C=C3OC
18428	sp|I6YC53|ESXT_MYC	Q99456	82.0	237.0	319.0	DB11157	approved	Anthralin	Oc1cccc(c12)Cc3c(C2=O)c(O)ccc3
18429	sp|I6YC53|ESXT_MYC	P35527	80.0	262.0	342.0	DB01593	approved; investigational	Zinc	[Zn]
18430	sp|I6YC53|ESXT_MYC	P35527	80.0	262.0	342.0	DB09130	approved; investigational	Copper	[Cu]
18431	sp|I6YC53|ESXT_MYC	P35527	80.0	262.0	342.0	DB14487	approved; investigational	Zinc acetate	CC([O-])=O
18432	sp|I6YC53|ESXT_MYC	P35527	80.0	262.0	342.0	DB14533	approved; investigational	Zinc chloride	[Cl-]
18433	sp|I6YC53|ESXT_MYC	P35527	80.0	262.0	342.0	DB14548	approved; experimental	Zinc sulfate, unspecified form	 
18434	sp|I6YC53|ESXT_MYC	P08670	72.0	91.0	163.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
18435	sp|I6YC53|ESXT_MYC	P08670	72.0	91.0	163.0	DB12695	investigational	Phenethyl Isothiocyanate	S=C=NCCc1ccccc1
18436	sp|I6YC53|ESXT_MYC	P08670	78.0	212.0	290.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
18437	sp|I6YC53|ESXT_MYC	P08670	78.0	212.0	290.0	DB12695	investigational	Phenethyl Isothiocyanate	S=C=NCCc1ccccc1
18438	sp|I6YC53|ESXT_MYC	P08670	73.0	309.0	382.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
18439	sp|I6YC53|ESXT_MYC	P08670	73.0	309.0	382.0	DB12695	investigational	Phenethyl Isothiocyanate	S=C=NCCc1ccccc1
18440	sp|P9WGG1|GMHA_MYC	Q9HVZ0	79.59	39.0	195.0	DB02470	experimental	D-Glycero-D-Mannopyranose-7-Phosphate	OP(=O)(O)OC[C@@H](O)[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O
18441	sp|I6YBZ8|HTDY_MYC	P51659	92.07	326.0	593.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
18442	sp|I6YBZ8|HTDY_MYC	P51659	92.07	326.0	593.0	DB03192	experimental	(R)-3-hydroxydecanoyl-CoA	CCCCCCC[C@@H](O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
18443	sp|P9WQC3|ADH_MYCT	P00325	79.56	12.0	304.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
18444	sp|P9WQC3|ADH_MYCT	P00325	79.56	12.0	304.0	DB01213	approved; vet_approved	Fomepizole	Cc1c[nH]nc1
18445	sp|P9WQC3|ADH_MYCT	P00325	79.56	12.0	304.0	DB02481	experimental	N-Benzylformamide	O=CNCc1ccccc1
18446	sp|P9WQC3|ADH_MYCT	P00325	79.56	12.0	304.0	DB02721	experimental	4-Iodopyrazole	Ic1c[nH]nc1
18447	sp|P9WQC3|ADH_MYCT	P00325	79.56	12.0	304.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
18448	sp|P9WQC3|ADH_MYCT	P00325	79.56	12.0	304.0	DB03703	experimental	Cyclohexanol	OC1CCCCC1
18449	sp|P9WQC3|ADH_MYCT	P00325	79.56	12.0	304.0	DB04105	experimental	N-Heptylformamide	CCCCCCCNC=O
18450	sp|P9WQC3|ADH_MYCT	P00325	79.56	12.0	304.0	DB09462	approved; investigational	Glycerin	OCC(O)CO
18451	sp|P9WQC3|ADH_MYCT	P07327	79.56	12.0	304.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
18452	sp|P9WQC3|ADH_MYCT	P07327	79.56	12.0	304.0	DB01213	approved; vet_approved	Fomepizole	Cc1c[nH]nc1
18453	sp|P9WQC3|ADH_MYCT	P07327	79.56	12.0	304.0	DB02721	experimental	4-Iodopyrazole	Ic1c[nH]nc1
18454	sp|P9WQC3|ADH_MYCT	P07327	79.56	12.0	304.0	DB04065	experimental	N-Cyclopentyl-N-Cyclobutylformamide	C1CCC1N(C=O)C2CCCC2
18455	sp|P9WQC3|ADH_MYCT	P00326	80.11	12.0	306.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
18456	sp|P9WQC3|ADH_MYCT	P00326	80.11	12.0	306.0	DB01213	approved; vet_approved	Fomepizole	Cc1c[nH]nc1
18457	sp|P9WQC3|ADH_MYCT	P00326	80.11	12.0	306.0	DB01711	experimental	2,3,4,5,6-Pentafluorobenzyl Alcohol	OCc1c(F)c(F)c(F)c(F)c1F
18458	sp|P9WQC3|ADH_MYCT	P00326	80.11	12.0	306.0	DB02131	experimental	N-1-methylheptylformamide	O=CN[C@H](C)CCCCCC
18459	sp|P9WQC3|ADH_MYCT	P00326	80.11	12.0	306.0	DB02249	experimental	2-Ethoxyethanol	CCOCCO
18460	sp|P9WQC3|ADH_MYCT	P00326	80.11	12.0	306.0	DB02659	approved	Cholic Acid	OC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](C[C@@H]2O)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
18461	sp|P9WQC3|ADH_MYCT	P00326	80.11	12.0	306.0	DB02721	experimental	4-Iodopyrazole	Ic1c[nH]nc1
18462	sp|P9WQC3|ADH_MYCT	P00326	80.11	12.0	306.0	DB02757	experimental	Pyrazole	[nH]1cccn1
18463	sp|P9WQC3|ADH_MYCT	P00326	80.11	12.0	306.0	DB02822	experimental	Para-Bromobenzyl Alcohol	OCc1ccc(Br)cc1
18464	sp|P9WQC3|ADH_MYCT	P00326	80.11	12.0	306.0	DB02871	experimental	3-Butylthiolane 1-Oxide	O=[S@@]1C[C@H](CC1)CCCC
18465	sp|P9WQC3|ADH_MYCT	P00326	80.11	12.0	306.0	DB03020	experimental	5-beta-D-ribofuranosylnicotinamide adenine dinucleotide	NC(=O)c1c[nH+]cc(c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
18466	sp|P9WQC3|ADH_MYCT	P00326	80.11	12.0	306.0	DB03061	experimental	(R)-N-(1-Methyl-Hexyl)-Formamide	CCCCC[C@H](C)NC=O
18467	sp|P9WQC3|ADH_MYCT	P00326	80.11	12.0	306.0	DB03226	experimental	Trifluoroethanol	OCC(F)(F)F
18468	sp|P9WQC3|ADH_MYCT	P00326	80.11	12.0	306.0	DB03559	experimental	Cyclohexylformamide	O=CNC1CCCCC1
18469	sp|P9WQC3|ADH_MYCT	P00326	80.11	12.0	306.0	DB04071	experimental	Cpad	NC(=O)c1nc(ccc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
18470	sp|P9WQC3|ADH_MYCT	P00326	80.11	12.0	306.0	DB04113	experimental	N-Formylpiperidine	O=CN1CCCCC1
18471	sp|P9WQC3|ADH_MYCT	P00326	80.11	12.0	306.0	DB04312	experimental	2,3-Difluorobenzyl Alcohol	OCc1cccc(F)c1F
18472	sp|P9WQC3|ADH_MYCT	P00326	80.11	12.0	306.0	DB04448	experimental	2,4-Difluorobenzyl Alcohol 2,4-Difluoro-1-(Hydroxymethyl)Benzene	OCc1ccc(F)cc1F
18473	sp|P9WQC3|ADH_MYCT	P40394	79.02	24.0	314.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
18474	sp|P9WQC3|ADH_MYCT	P08319	84.2	12.0	321.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
18475	sp|P9WQC3|ADH_MYCT	P08319	84.2	12.0	321.0	DB03559	experimental	Cyclohexylformamide	O=CNC1CCCCC1
18476	sp|P9WQC3|ADH_MYCT	P42328	81.74	3.0	303.0	DB03226	experimental	Trifluoroethanol	OCC(F)(F)F
18477	sp|P9WQC3|ADH_MYCT	P11766	80.11	10.0	304.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
18478	sp|P9WQC3|ADH_MYCT	P11766	80.11	10.0	304.0	DB03017	approved; experimental	Lauric acid	CCCCCCCCCCCC(=O)O
18479	sp|P9WQC3|ADH_MYCT	P11766	80.11	10.0	304.0	DB03704	experimental	12-Hydroxydodecanoic Acid	OCCCCCCCCCCCC(=O)O
18480	sp|P9WQC3|ADH_MYCT	P11766	80.11	10.0	304.0	DB04153	experimental	S-Hydroxymethyl Glutathione	OC(=O)[C@@H](N)CCC(=O)N[C@@H](CSCO)C(=O)NCC(=O)O
18481	sp|P9WQC3|ADH_MYCT	Q00796	80.93	11.0	308.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
18482	sp|P9WQC3|ADH_MYCT	Q00796	80.93	11.0	308.0	DB04478	experimental	Cp-166572, 2-Hydroxymethyl-4-(4-N,N-Dimethylaminosulfonyl-1-Piperazino)-Pyrimidine	CN(C)S(=O)(=O)N1CCN(CC1)c2ccnc(n2)CO
18483	sp|P9WQC3|ADH_MYCT	P14941	71.12	16.0	277.0	DB02606	experimental; investigational	2-Butanol	CC[C@@H](C)O
18484	sp|P9WQC3|ADH_MYCT	P14941	71.12	16.0	277.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
18485	sp|P9WNX5|DHAS_MYC	P44801	106.67	3.0	371.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
18486	sp|P9WNX5|DHAS_MYC	P44801	106.67	3.0	371.0	DB03502	experimental	(4s)-4-{[(2s)-2-Amino-3-Oxopropyl]Sulfanyl}-L-Homoserinate	OC(=O)[C@@H](N)C[C@H](O)SC[C@H](N)C(=O)O
18487	sp|P9WNX5|DHAS_MYC	P44801	106.67	3.0	371.0	DB04498	experimental	Aspartate Semialdehyde	OC(=O)[C@H](N)CC=O
18488	sp|O33283|EPHG_MYC	Q9ZAG3	83.22	15.0	139.0	DB02641	experimental	Heptanamide	CCCCCCC(=O)N
18489	sp|O33283|EPHG_MYC	Q9ZAG3	83.22	15.0	139.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
18490	sp|O33283|EPHG_MYC	Q9ZAG3	83.22	15.0	139.0	DB04165	experimental	Valpromide	CCCC(C(=O)N)CCC
18491	sp|I6Y0R5|FOLC_MYC	P15925	78.64	21.0	404.0	DB02301	experimental	5,10-Methylene-6-Hydrofolic Acid	Nc([nH]1)nc(=O)c(c12)N3[C@H](C=N2)CN(C3)c4ccc(cc4)C(=O)N[C@@H](C(=O)O)CCC(=O)O
18492	sp|I6Y0R5|FOLC_MYC	P15925	78.64	21.0	404.0	DB03755	experimental	Adenosine-5'-[Beta, Gamma-Methylene]Tetraphosphate	n1cnc(N)c(c12)ncn2[C@H]3[C@H](O)[C@H](O)[C@H](O3)COP(=O)(O)OP(=O)(O)CP(=O)(O)OP(=O)(O)O
18493	sp|I6Y0R5|FOLC_MYC	P15925	78.64	21.0	404.0	DB03801	experimental	Lysine Nz-Carboxylic Acid	OC(=O)[C@@H](N)CCCCNC(=O)O
18494	sp|I6Y0R5|FOLC_MYC	P15925	78.64	21.0	404.0	DB03909	experimental	Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate	OP(=O)(O)CP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
18495	sp|I6Y0R5|FOLC_MYC	P08192	75.56	22.0	390.0	DB02437	experimental	(5r)-5-Amino-6-Hydroxyhexylcarbamic Acid	OC[C@@H](N)CCCCNC(=O)O
18496	sp|I6Y0R5|FOLC_MYC	P08192	75.56	22.0	390.0	DB03830	experimental	Phosphorylated Dihydropteroate	O=c1[nH]c(N)nc(c12)ncc(n2)CNc3ccc(cc3)C(=O)OP(=O)(O)O
18497	sp|P9WN63|GAL1_MYC	P51570	92.56	31.0	367.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
18498	sp|P9WNB7|FRDC_MYC	P0A8Q0	96.83	7.0	129.0	DB07490	experimental	2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL	Clc1ccc(cc1)[C@@H](C)c2cc([N+]([O-])=O)cc([N+]([O-])=O)c2O
18499	sp|P9WNB7|FRDC_MYC	P0A8Q0	96.83	7.0	129.0	DB07918	experimental	2-heptyl-4-hydroxyquinoline N-oxide	CCCCCCCc(cc1O)[n+]([O-])c(c12)cccc2
18500	sp|P9WPU7|ATPA_MYC	P25705	92.17	47.0	553.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
18501	sp|P9WPU7|ATPA_MYC	P25705	92.17	47.0	553.0	DB07384	experimental	1-ACETYL-2-CARBOXYPIPERIDINE	OC(=O)[C@@H]1CCCCN1C(=O)C
18502	sp|P9WPU7|ATPA_MYC	P25705	92.17	47.0	553.0	DB07394	experimental	AUROVERTIN B	C[C@@]12O[C@H](CC)[C@@](C)([C@H]1OC(=O)C)O[C@H]([C@@H]2O)/C=C/C=C/C=C/c3c(C)c(OC)cc(=O)o3
18503	sp|P9WPU7|ATPA_MYC	P25705	92.17	47.0	553.0	DB08399	experimental	Piceatannol	Oc1cc(cc(O)c1)/C=C/c2ccc(O)c(O)c2
18504	sp|P9WPU7|ATPA_MYC	P25705	92.17	47.0	553.0	DB08629	experimental	N1-(2-AMINO-4-METHYLPENTYL)OCTAHYDRO-PYRROLO[1,2-A] PYRIMIDINE	CC(C)C[C@H](N)CN1CCCN([C@H]12)CCC2
18505	sp|P9WPU7|ATPA_MYC	P25705	92.17	47.0	553.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
18506	sp|P9WPU7|ATPA_MYC	P15313	77.78	42.0	469.0	DB01133	approved; investigational; vet_approved	Tiludronic acid	OP(=O)(O)C(P(=O)(O)O)Sc1ccc(Cl)cc1
18507	sp|P9WPU7|ATPA_MYC	P21281	77.6	49.0	475.0	DB05260	approved; investigational	Gallium nitrate	[O-][N+]([O-])=O
18508	sp|P9WPU7|ATPA_MYC	P21281	77.6	49.0	475.0	DB07347	experimental	4-(2-Aminoethyl)Benzenesulfonyl Fluoride	NCCc1ccc(S(F)(=O)=O)cc1
18509	sp|P9WPU7|ATPA_MYC	P21281	77.6	49.0	475.0	DB01133	approved; investigational; vet_approved	Tiludronic acid	OP(=O)(O)C(P(=O)(O)O)Sc1ccc(Cl)cc1
18510	sp|P9WPU7|ATPA_MYC	P06576	82.33	65.0	517.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
18511	sp|P9WPU7|ATPA_MYC	P06576	82.33	65.0	517.0	DB07384	experimental	1-ACETYL-2-CARBOXYPIPERIDINE	OC(=O)[C@@H]1CCCCN1C(=O)C
18512	sp|P9WPU7|ATPA_MYC	P06576	82.33	65.0	517.0	DB07394	experimental	AUROVERTIN B	C[C@@]12O[C@H](CC)[C@@](C)([C@H]1OC(=O)C)O[C@H]([C@@H]2O)/C=C/C=C/C=C/c3c(C)c(OC)cc(=O)o3
18513	sp|P9WPU7|ATPA_MYC	P06576	82.33	65.0	517.0	DB08399	experimental	Piceatannol	Oc1cc(cc(O)c1)/C=C/c2ccc(O)c(O)c2
18514	sp|P9WPU7|ATPA_MYC	P06576	82.33	65.0	517.0	DB08629	experimental	N1-(2-AMINO-4-METHYLPENTYL)OCTAHYDRO-PYRROLO[1,2-A] PYRIMIDINE	CC(C)C[C@H](N)CN1CCCN([C@H]12)CCC2
18515	sp|P9WPU7|ATPA_MYC	P06576	82.33	65.0	517.0	DB12695	investigational	Phenethyl Isothiocyanate	S=C=NCCc1ccccc1
18516	sp|P9WPN1|C135A_MY	P08684	101.34	39.0	494.0	DB00143	approved; investigational; nutraceutical	Glutathione	OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(=O)O
18517	sp|P9WPN1|C135A_MY	P08684	101.34	39.0	494.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
18518	sp|P9WPN1|C135A_MY	P08684	101.34	39.0	494.0	DB05478	investigational	Pradefovir mesylate	n1cnc(N)c(c12)ncn2CCOC[P@@]3(=O)OCC[C@H](O3)c4cc(Cl)ccc4
18519	sp|P9WPN1|C135A_MY	P08684	101.34	39.0	494.0	DB06634	investigational	Casopitant	FC(F)(F)c1cc(cc(c1)C(F)(F)F)[C@@H](C)N(C)C(=O)N2CC[C@H](N3CCN(CC3)C(=O)C)C[C@@H]2c4ccc(F)cc4C
18520	sp|P9WPN1|C135A_MY	P08684	101.34	39.0	494.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
18521	sp|P9WPN1|C135A_MY	P20815	101.78	39.0	496.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
18522	sp|P9WPN1|C135A_MY	P20815	101.78	39.0	496.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
18523	sp|P9WPN1|C135A_MY	P20815	101.78	39.0	496.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
18524	sp|P9WPN1|C135A_MY	P24462	101.11	39.0	493.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
18525	sp|P9WPN1|C135A_MY	P24462	101.11	39.0	493.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
18526	sp|P9WPN1|C135A_MY	P24462	101.11	39.0	493.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
18527	sp|P9WPN1|C135A_MY	P33261	100.89	27.0	480.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
18528	sp|P9WPN1|C135A_MY	P33261	100.89	27.0	480.0	DB12319	investigational; withdrawn	Benzbromarone	c1cccc(c12)c(c(o2)CC)C(=O)c3cc(Br)c(O)c(Br)c3
18529	sp|P9WPN1|C135A_MY	P11712	100.89	27.0	480.0	DB03317	experimental	Ferroheme C	[Fe-2]123[N+]4=C5C=C6[N+]1=C(C(C)=C6C(C)S)C=C7[N+]2=C(C(=C7C)CCC(=O)O)C=C8[N+]3=C(C=C4C(=C5C)C(C)S)C(C)=C8CCC(=O)O
18530	sp|P9WPN1|C135A_MY	P11712	100.89	27.0	480.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
18531	sp|P9WPN1|C135A_MY	P11712	100.89	27.0	480.0	DB12319	investigational; withdrawn	Benzbromarone	c1cccc(c12)c(c(o2)CC)C(=O)c3cc(Br)c(O)c(Br)c3
18532	sp|P9WPN1|C135A_MY	Q9HB55	101.11	39.0	493.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
18533	sp|P9WPN1|C135A_MY	P33260	100.89	27.0	480.0	DB07670	experimental	N,4-Dimethyl-N-(1-phenyl-1H-pyrazol-5-yl)benzenesulfonamide	Cc1ccc(cc1)S(=O)(=O)N(C)c2ccnn2-c3ccccc3
18534	sp|P9WPN1|C135A_MY	P10632	100.89	27.0	480.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
18535	sp|P9WPN1|C135A_MY	P10632	100.89	27.0	480.0	DB03796	approved	Palmitic Acid	CCCCCCCCCCCCCCCC(=O)O
18536	sp|P9WPN1|C135A_MY	P10632	100.89	27.0	480.0	DB08607	experimental	(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE	O=C1NC(=O)S[C@@H]1Cc2ccc(cc2)OC[C@@](O3)(C)CCc(c34)c(C)c(O)c(C)c4C
18537	sp|P9WPN1|C135A_MY	P20813	98.22	28.0	469.0	DB02974	experimental	4-(4-Chlorophenyl)Imidazole	Clc1ccc(cc1)-c2cnc[nH]2
18538	sp|P9WPN1|C135A_MY	P20813	98.22	28.0	469.0	DB04664	experimental	Cyclohexyl-pentyl-maltoside	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@@H]2CO)OCCCCCC3CCCCC3
18539	sp|P9WPN1|C135A_MY	P20813	98.22	28.0	469.0	DB04794	approved; investigational	Bifonazole	c1ccccc1C(n2ccnc2)c3ccc(cc3)-c4ccccc4
18540	sp|P9WPN1|C135A_MY	P20813	98.22	28.0	469.0	DB08369	experimental	1-(biphenyl-4-ylmethyl)-1H-imidazole	c1cncn1Cc2ccc(cc2)-c3ccccc3
18541	sp|P9WPN1|C135A_MY	P11509	101.78	31.0	488.0	DB04665	experimental	Coumarin	c1cc(=O)oc(c12)cccc2
18542	sp|P9WPN1|C135A_MY	P11509	101.78	31.0	488.0	DB07609	experimental	N,N-DIMETHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	CN(C)Cc1ccc(o1)-c2cccnc2
18543	sp|P9WPN1|C135A_MY	P11509	101.78	31.0	488.0	DB07617	experimental	N-METHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	CNCc1ccc(o1)-c2cccnc2
18544	sp|P9WPN1|C135A_MY	P11509	101.78	31.0	488.0	DB07621	experimental	(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	NCc1ccc(o1)-c2cccnc2
18545	sp|P9WPN1|C135A_MY	P11509	101.78	31.0	488.0	DB07623	experimental	4,4'-DIPYRIDYL DISULFIDE	c1cnccc1SSc2ccncc2
18546	sp|P9WPN1|C135A_MY	P05181	99.33	31.0	477.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
18547	sp|P9WPN1|C135A_MY	P04798	104.9	38.0	509.0	DB02342	investigational	2-Methoxyestradiol	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)c(c4)OC
18548	sp|P9WPN1|C135A_MY	P04798	104.9	38.0	509.0	DB12379	investigational	Indirubin	c1cccc(c12)NC(=O)C\2=C(C3=O)\Nc(c34)cccc4
18549	sp|P9WPN1|C135A_MY	P04798	104.9	38.0	509.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
18550	sp|P9WPN1|C135A_MY	P05177	104.68	40.0	510.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
18551	sp|P9WPN1|C135A_MY	P05177	104.68	40.0	510.0	DB07453	experimental	alpha-Naphthoflavone	c1ccccc1-c(cc2=O)oc(c23)c4c(cc3)cccc4
18552	sp|P9WPN1|C135A_MY	P05177	104.68	40.0	510.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
18553	sp|P9WPN1|C135A_MY	P05177	104.68	40.0	510.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
18554	sp|P9WPN1|C135A_MY	P05177	104.68	40.0	510.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
18555	sp|P9WPN1|C135A_MY	O43174	100.45	42.0	493.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
18556	sp|P9WPN1|C135A_MY	O43174	100.45	42.0	493.0	DB13083	investigational	Talarozole	c1ncnn1C(C(CC)CC)c2ccc(cc2)Nc(s3)nc(c34)cccc4
18557	sp|P9WPN1|C135A_MY	P24557	107.8	47.0	531.0	DB00795	approved	Sulfasalazine	OC(=O)c1cc(ccc1O)/N=N/c2ccc(cc2)S(=O)(=O)Nc3ncccc3
18558	sp|P9WPN1|C135A_MY	P24557	107.8	47.0	531.0	DB01207	experimental	Ridogrel	OC(=O)CCCCO/N=C(/c1cnccc1)c2cc(C(F)(F)F)ccc2
18559	sp|P9WPN1|C135A_MY	P24557	107.8	47.0	531.0	DB03052	experimental	Dazoxiben	OC(=O)c1ccc(cc1)OCCn2ccnc2
18560	sp|P9WPN1|C135A_MY	P24557	107.8	47.0	531.0	DB05505	investigational	NM-702	 
18561	sp|P9WPN1|C135A_MY	P10635	100.0	31.0	480.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
18562	sp|P9WPN1|C135A_MY	P10635	100.0	31.0	480.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
18563	sp|P9WPN1|C135A_MY	P10635	100.0	31.0	480.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
18564	sp|P9WPN1|C135A_MY	Q16678	104.01	49.0	516.0	DB01645	investigational	Genistein	Oc1ccc(cc1)-c(c2=O)coc(c23)cc(O)cc3O
18565	sp|P9WPN1|C135A_MY	Q16678	104.01	49.0	516.0	DB02342	investigational	2-Methoxyestradiol	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)c(c4)OC
18566	sp|P9WPN1|C135A_MY	Q16678	104.01	49.0	516.0	DB03467	experimental	Naringenin	Oc1ccc(cc1)[C@@H](O2)CC(=O)c(c23)c(O)cc(c3)O
18567	sp|P9WPN1|C135A_MY	Q16678	104.01	49.0	516.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
18568	sp|P9WPN1|C135A_MY	Q16678	104.01	49.0	516.0	DB06732	experimental	beta-Naphthoflavone	c1cccc(c12)c3c(cc2)oc(cc3=O)-c4ccccc4
18569	sp|P9WPN1|C135A_MY	Q16678	104.01	49.0	516.0	DB07776	approved; experimental	Flavone	c1cccc(c12)oc(cc2=O)-c3ccccc3
18570	sp|P9WPN1|C135A_MY	Q16678	104.01	49.0	516.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
18571	sp|P9WPN1|C135A_MY	Q16678	104.01	49.0	516.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
18572	sp|P9WPN1|C135A_MY	P10614	100.45	62.0	513.0	DB06890	experimental	(2R)-2-PHENYL-N-PYRIDIN-4-YLBUTANAMIDE	c1ccccc1[C@@H](CC)C(=O)Nc2ccncc2
18573	sp|P9WPN1|C135A_MY	P10614	100.45	62.0	513.0	DB07560	experimental	N-[(1S)-2-methyl-1-(pyridin-4-ylcarbamoyl)propyl]cyclohexanecarboxamide	c1cnccc1NC(=O)[C@H](C(C)C)NC(=O)C2CCCCC2
18574	sp|P9WPN1|C135A_MY	P10614	100.45	62.0	513.0	DB07568	experimental	(2S)-2-[(2,1,3-BENZOTHIADIAZOL-4-YLSULFONYL)AMINO]-2-PHENYL-N-PYRIDIN-4-YLACETAMIDE	n1snc(c12)cccc2S(=O)(=O)N[C@@H](c3ccccc3)C(=O)Nc4ccncc4
18575	sp|P9WPN1|C135A_MY	P10614	100.45	62.0	513.0	DB07569	experimental	CIS-4-METHYL-N-[(1S)-3-(METHYLSULFANYL)-1-(PYRIDIN-4-YLCARBAMOYL)PROPYL]CYCLOHEXANECARBOXAMIDE	c1cnccc1NC(=O)[C@H](CCSC)NC(=O)[C@@H]2CC[C@H](C)CC2
18576	sp|P9WPN1|C135A_MY	P10614	100.45	62.0	513.0	DB07572	experimental	3-{[(4-methylphenyl)sulfonyl]amino}propyl pyridin-4-ylcarbamate	Cc1ccc(cc1)S(=O)(=O)NCCCOC(=O)Nc2ccncc2
18577	sp|P9WPN1|C135A_MY	P10614	100.45	62.0	513.0	DB07635	experimental	4,4'-Dihydroxybenzophenone	Oc1ccc(cc1)C(=O)c2ccc(O)cc2
18578	sp|P9WPN1|C135A_MY	P50859	99.55	63.0	510.0	DB01026	approved; investigational	Ketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OCC(CO3)OC3(Cn4ccnc4)c5ccc(Cl)cc5Cl
18579	sp|P9WPN1|C135A_MY	P50859	99.55	63.0	510.0	DB01167	approved; investigational	Itraconazole	CCC(C)n1ncn(c1=O)-c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@@H](CO5)O[C@@]5(Cn6cncn6)c7ccc(Cl)cc7Cl
18580	sp|P9WPN1|C135A_MY	P50859	99.55	63.0	510.0	DB09040	approved	Efinaconazole	C=C1CCN(CC1)[C@H](C)[C@](O)(Cn2cncn2)c3c(F)cc(F)cc3
18581	sp|P9WPN1|C135A_MY	P50859	99.55	63.0	510.0	DB11633	approved; investigational	Isavuconazole	c1ncnn1C[C@](O)(c2c(F)ccc(F)c2)[C@@H](C)c3nc(cs3)-c4ccc(C#N)cc4
18582	sp|P9WPN1|C135A_MY	O15528	103.56	41.0	506.0	DB01436	approved; nutraceutical	Alfacalcidol	CC(C)CCC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)/C(CCC2)=C/C=C3/C[C@@H](O)C[C@H](O)C3=C
18583	sp|P9WPN1|C135A_MY	P10613	103.12	54.0	517.0	DB00196	approved; investigational	Fluconazole	c1ncnn1CC(O)(Cn2cncn2)c3c(F)cc(F)cc3
18584	sp|P9WPN1|C135A_MY	P10613	103.12	54.0	517.0	DB00239	approved	Oxiconazole	Clc1cc(Cl)c(cc1)CO/N=C(\Cn2ccnc2)c3ccc(Cl)cc3Cl
18585	sp|P9WPN1|C135A_MY	P10613	103.12	54.0	517.0	DB00251	approved	Terconazole	CC(C)N1CCN(CC1)c2ccc(cc2)OC[C@@H](CO3)O[C@@]3(Cn4cncn4)c5c(Cl)cc(Cl)cc5
18586	sp|P9WPN1|C135A_MY	P10613	103.12	54.0	517.0	DB00257	approved; vet_approved	Clotrimazole	Clc1ccccc1C(n2ccnc2)(c3ccccc3)c4ccccc4
18587	sp|P9WPN1|C135A_MY	P10613	103.12	54.0	517.0	DB00582	approved	Voriconazole	c1ncnn1C[C@](O)(c2c(F)cc(F)cc2)[C@@H](C)c3ncncc3F
18588	sp|P9WPN1|C135A_MY	P10613	103.12	54.0	517.0	DB01007	approved	Tioconazole	c1nccn1CC(c(c(Cl)c2)ccc2Cl)OCc3c(Cl)scc3
18589	sp|P9WPN1|C135A_MY	P10613	103.12	54.0	517.0	DB01110	approved; investigational; vet_approved	Miconazole	Clc1cc(Cl)c(cc1)COC(Cn2ccnc2)c3c(Cl)cc(Cl)cc3
18590	sp|P9WPN1|C135A_MY	P10613	103.12	54.0	517.0	DB01127	approved	Econazole	Clc1ccc(cc1)COC(Cn2ccnc2)c3c(Cl)cc(Cl)cc3
18591	sp|P9WPN1|C135A_MY	P10613	103.12	54.0	517.0	DB01153	approved; investigational	Sertaconazole	Clc1cc(Cl)ccc1C(Cn2cncc2)OCc3csc(c34)c(Cl)ccc4
18592	sp|P9WPN1|C135A_MY	P10613	103.12	54.0	517.0	DB01263	approved; investigational; vet_approved	Posaconazole	C[C@H](O)[C@H](CC)n1ncn(c1=O)-c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@H](CO5)C[C@]5(Cn6cncn6)c7c(F)cc(F)cc7
18593	sp|P9WPN1|C135A_MY	P10613	103.12	54.0	517.0	DB04794	approved; investigational	Bifonazole	c1ccccc1C(n2ccnc2)c3ccc(cc3)-c4ccccc4
18594	sp|P9WPN1|C135A_MY	P10613	103.12	54.0	517.0	DB08933	approved	Luliconazole	Clc1cc(Cl)c(cc1)[C@@H]2CS/C(S2)=C(/C#N)n3ccnc3
18596	sp|P9WPN1|C135A_MY	Q6V0L0	101.56	46.0	502.0	DB00523	approved; investigational	Alitretinoin	OC(=O)/C=C(\C)/C=C/C=C(/C)\C=C\C(C1(C)C)=C(C)CCC1
18597	sp|P9WPN1|C135A_MY	Q6V0L0	101.56	46.0	502.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
18598	sp|P9WPN1|C135A_MY	Q9NR63	95.1	47.0	474.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
18599	sp|P9WPN1|C135A_MY	P15538	100.45	45.0	496.0	DB00648	approved	Mitotane	Clc1ccc(cc1)C(C(Cl)Cl)c2ccccc2Cl
18600	sp|P9WPN1|C135A_MY	P15538	100.45	45.0	496.0	DB01011	approved; investigational	Metyrapone	c1ccncc1C(C)(C)C(=O)c2cnccc2
18601	sp|P9WPN1|C135A_MY	P15538	100.45	45.0	496.0	DB05667	investigational	Levoketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OC[C@H](CO3)O[C@]3(Cn4ccnc4)c5ccc(Cl)cc5Cl
18602	sp|P9WPN1|C135A_MY	P15538	100.45	45.0	496.0	DB11837	approved; investigational	Osilodrostat	c1ncc(n12)CC[C@@H]2c3c(F)cc(C#N)cc3
18603	sp|P9WPN1|C135A_MY	Q16850	95.32	67.0	495.0	DB01007	approved	Tioconazole	c1nccn1CC(c(c(Cl)c2)ccc2Cl)OCc3c(Cl)scc3
18604	sp|P9WPN1|C135A_MY	Q16850	95.32	67.0	495.0	DB01167	approved; investigational	Itraconazole	CCC(C)n1ncn(c1=O)-c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@@H](CO5)O[C@@]5(Cn6cncn6)c7ccc(Cl)cc7Cl
18605	sp|P9WPN1|C135A_MY	Q16850	95.32	67.0	495.0	DB05667	investigational	Levoketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OC[C@H](CO3)O[C@]3(Cn4ccnc4)c5ccc(Cl)cc5Cl
18606	sp|P9WPN1|C135A_MY	Q16850	95.32	67.0	495.0	DB07705	experimental	(S)-econazole	Clc1ccc(cc1)CO[C@H](Cn2ccnc2)c3c(Cl)cc(Cl)cc3
18607	sp|P9WPN1|C135A_MY	P08686	98.0	40.0	480.0	DB01026	approved; investigational	Ketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OCC(CO3)OC3(Cn4ccnc4)c5ccc(Cl)cc5Cl
18608	sp|P9WPN1|C135A_MY	P19099	100.0	45.0	494.0	DB00421	approved	Spironolactone	C1CC(=O)O[C@@]12[C@]3(C)[C@@H](CC2)[C@H]4[C@H](CC3)[C@]5(C)C(=CC(=O)CC5)C[C@H]4SC(=O)C
18609	sp|P9WPN1|C135A_MY	P19099	100.0	45.0	494.0	DB11837	approved; investigational	Osilodrostat	c1ncc(n12)CC[C@@H]2c3c(F)cc(C#N)cc3
18610	sp|P9WPN1|C135A_MY	Q02928	92.87	92.0	509.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
18611	sp|P9WPN1|C135A_MY	P05093	100.89	26.0	479.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
18612	sp|P9WPN1|C135A_MY	P05093	100.89	26.0	479.0	DB00396	approved; vet_approved	Progesterone	CC(=O)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
18613	sp|P9WPN1|C135A_MY	P05093	100.89	26.0	479.0	DB00421	approved	Spironolactone	C1CC(=O)O[C@@]12[C@]3(C)[C@@H](CC2)[C@H]4[C@H](CC3)[C@]5(C)C(=CC(=O)CC5)C[C@H]4SC(=O)C
18614	sp|P9WPN1|C135A_MY	P05093	100.89	26.0	479.0	DB01026	approved; investigational	Ketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OCC(CO3)OC3(Cn4ccnc4)c5ccc(Cl)cc5Cl
18615	sp|P9WPN1|C135A_MY	P05093	100.89	26.0	479.0	DB05812	approved	Abiraterone	C1C[C@H](O)CC([C@]12C)=CC[C@@H]3[C@@H]2CC[C@@]4(C)[C@H]3CC=C4c5cccnc5
18616	sp|P9WPN1|C135A_MY	P05093	100.89	26.0	479.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
18618	sp|P9WPN1|C135A_MY	P05093	100.89	26.0	479.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
18619	sp|P9WPN1|C135A_MY	P14779	94.21	24.0	447.0	DB03440	experimental	N-hexadecanoylglycine	CCCCCCCCCCCCCCCC(=O)NCC(=O)O
18620	sp|P9WPN1|C135A_MY	P14779	94.21	24.0	447.0	DB04257	experimental	Palmitoleic Acid	CCCCCC/C=C\CCCCCCCC(=O)O
18621	sp|P9WPN1|C135A_MY	P14779	94.21	24.0	447.0	DB08086	experimental	N-[12-(1H-imidazol-1-yl)dodecanoyl]-L-leucine	CC(C)C[C@@H](C(=O)O)NC(=O)CCCCCCCCCCCn1ccnc1
18622	sp|P9WPN1|C135A_MY	P05108	98.22	72.0	513.0	DB00357	approved; investigational	Aminoglutethimide	Nc1ccc(cc1)C2(CC)CCC(=O)NC2=O
18623	sp|P9WPN1|C135A_MY	P11511	97.33	48.0	485.0	DB00184	approved	Nicotine	CN1CCC[C@H]1c2cnccc2
18624	sp|P9WPN1|C135A_MY	P11511	97.33	48.0	485.0	DB00357	approved; investigational	Aminoglutethimide	Nc1ccc(cc1)C2(CC)CCC(=O)NC2=O
18625	sp|P9WPN1|C135A_MY	P11511	97.33	48.0	485.0	DB00655	approved	Estrone	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)cc4
18626	sp|P9WPN1|C135A_MY	P11511	97.33	48.0	485.0	DB00894	approved; investigational	Testolactone	C1=CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2CC[C@@]4(C)[C@H]3CCC(O4)=O
18627	sp|P9WPN1|C135A_MY	P11511	97.33	48.0	485.0	DB00990	approved; investigational	Exemestane	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(C(C3)=C)=CC(=O)C=C4
18628	sp|P9WPN1|C135A_MY	P11511	97.33	48.0	485.0	DB01006	approved; investigational	Letrozole	N#Cc1ccc(cc1)C(n2cncn2)c3ccc(C#N)cc3
18629	sp|P9WPN1|C135A_MY	P11511	97.33	48.0	485.0	DB01217	approved; investigational	Anastrozole	N#CC(C)(C)c1cc(C(C)(C)C#N)cc(c1)Cn2cncn2
18630	sp|P9WPN1|C135A_MY	P11511	97.33	48.0	485.0	DB02342	investigational	2-Methoxyestradiol	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)c(c4)OC
18631	sp|P9WPN1|C135A_MY	P11511	97.33	48.0	485.0	DB03467	experimental	Naringenin	Oc1ccc(cc1)[C@@H](O2)CC(=O)c(c23)c(O)cc(c3)O
18632	sp|P9WPN1|C135A_MY	P11511	97.33	48.0	485.0	DB04539	experimental	Glyphosate	OC(=O)C[NH2+]CP(=O)(O)O
18633	sp|P9WPN1|C135A_MY	P11511	97.33	48.0	485.0	DB05749	investigational	MPI-674	 
18634	sp|P9WPN1|C135A_MY	O31440	84.19	14.0	392.0	DB04257	experimental	Palmitoleic Acid	CCCCCC/C=C\CCCCCCCC(=O)O
18635	sp|P9WPN1|C135A_MY	P53554	75.28	28.0	366.0	DB04450	experimental	Heptyl 1-Thiohexopyranoside	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)SCCCCCCC
18636	sp|P9WPN1|C135A_MY	Q16647	96.44	36.0	469.0	DB00812	approved; vet_approved	Phenylbutazone	CCCCC1C(=O)N(c2ccccc2)N(C1=O)c3ccccc3
18637	sp|P9WPN1|C135A_MY	Q16647	96.44	36.0	469.0	DB01240	approved	Epoprostenol	OC(=O)CCC/C=C(C1)\O[C@H]([C@H]12)C[C@@H](O)[C@@H]2/C=C/[C@@H](O)CCCCC
18638	sp|P9WPN1|C135A_MY	Q16647	96.44	36.0	469.0	DB08675	experimental	(5Z)-7-{(1R,4S,5R,6R)-6-[(1E)-1-Octen-1-yl]-2,3-diazabicyclo[2.2.1]hept-2-en-5-yl}-5-heptenoic acid	OC(=O)CCC/C=C\C[C@@H]([C@H]12)[C@H]([C@@H](C1)N=N2)/C=C/CCCCCC
18639	sp|P9WPN1|C135A_MY	Q9FCA6	75.28	37.0	375.0	DB02175	experimental	Malonic acid	OC(=O)CC(=O)O
18640	sp|P9WPN1|C135A_MY	Q9FCA6	75.28	37.0	375.0	DB02521	experimental	Flaviolin	Oc1cc(O)cc(c12)C(=O)C(O)=CC2=O
18641	sp|P9WPN1|C135A_MY	Q9FCA6	75.28	37.0	375.0	DB03254	experimental	4-Phenyl-1h-Imidazole	[nH]1cncc1-c2ccccc2
18642	sp|P9WPN1|C135A_MY	Q9FCA6	75.28	37.0	375.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
18643	sp|P9WPT7|CTPJ_MYC	P03960	80.91	47.0	581.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
18644	sp|P9WMS3|DHMA1_MY	P51698	91.33	15.0	289.0	DB01701	experimental	1,2-Dichloro-Propane	C[C@@H](Cl)CCl
18645	sp|P9WMS3|DHMA1_MY	P51698	91.33	15.0	289.0	DB02145	experimental	Butyl alcohol	CCCCO
18646	sp|P9WMS3|DHMA1_MY	P51698	91.33	15.0	289.0	DB02302	experimental	Symmetric dimethylarginine	CN/C(=N/C)NCCC[C@H](N)C(=O)O
18647	sp|P9WMS3|DHMA1_MY	P51698	91.33	15.0	289.0	DB02774	experimental	1,3-Propanediol	OCCCO
18648	sp|P9WMS3|DHMA1_MY	P51698	91.33	15.0	289.0	DB03335	experimental	(+)-1-bromo-2-propanol	C[C@H](O)CBr
18649	sp|P9WMS3|DHMA1_MY	P51698	91.33	15.0	289.0	DB03733	experimental	Ethylene Dichloride	ClCCCl
18650	sp|P9WMS3|DHMA1_MY	P51698	91.33	15.0	289.0	DB04320	experimental	2-Bromo-2-Propene-1-Ol	OCC(Br)=C
18651	sp|P9WMS3|DHMA1_MY	O07732	80.67	3.0	245.0	DB02596	experimental	alpha,beta-Methyleneadenosine 5'-triphosphate	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)CP(=O)(O)OP(=O)(O)O
18652	sp|P9WMS3|DHMA1_MY	P13001	72.33	3.0	220.0	DB03688	experimental	Hydracrylic acid	OCCC(=O)O
18653	sp|P9WPP7|CP121_MY	P9WPP7	99.75	1.0	396.0	DB02721	experimental	4-Iodopyrazole	Ic1c[nH]nc1
18654	sp|P9WPP7|CP121_MY	P9WPP7	99.75	1.0	396.0	DB08761	experimental	(3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine-2,5-dione	Oc1ccc(cc1)C[C@@H]2NC(=O)[C@@H](NC2=O)Cc3ccc(O)cc3
18655	sp|P9WPP7|CP121_MY	P53554	94.44	19.0	393.0	DB04450	experimental	Heptyl 1-Thiohexopyranoside	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)SCCCCCCC
18656	sp|P9WPP7|CP121_MY	Q9FCA6	96.21	23.0	404.0	DB02175	experimental	Malonic acid	OC(=O)CC(=O)O
18657	sp|P9WPP7|CP121_MY	Q9FCA6	96.21	23.0	404.0	DB02521	experimental	Flaviolin	Oc1cc(O)cc(c12)C(=O)C(O)=CC2=O
18658	sp|P9WPP7|CP121_MY	Q9FCA6	96.21	23.0	404.0	DB03254	experimental	4-Phenyl-1h-Imidazole	[nH]1cncc1-c2ccccc2
18659	sp|P9WPP7|CP121_MY	Q9FCA6	96.21	23.0	404.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
18660	sp|P9WPP7|CP121_MY	Q00441	96.46	18.0	400.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
18661	sp|P9WPP7|CP121_MY	Q00441	96.46	18.0	400.0	DB03369	experimental	9-Aminophenanthrene	c1cccc(c12)c3c(cc2N)cccc3
18662	sp|P9WPP7|CP121_MY	Q00441	96.46	18.0	400.0	DB04070	experimental	6-Deoxyerythronolide B	C[C@@H]1C[C@H](C)[C@H](O)[C@@H](C)[C@H](O)[C@@H](C)C(=O)O[C@H](CC)[C@H](C)[C@H](O)[C@@H](C)C1=O
18663	sp|P9WPP7|CP121_MY	Q83WG3	97.22	24.0	409.0	DB06955	experimental	3,4-bis(7-chloro-1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid	c1ccc(Cl)c(c12)[nH]cc2-c3c(C(=O)O)[nH]c(C(=O)O)c3-c4c[nH]c(c45)c(Cl)ccc5
18664	sp|P9WPP7|CP121_MY	Q83WG3	97.22	24.0	409.0	DB07588	experimental	3,4-DI-1H-INDOL-3-YL-1H-PYRROLE-2,5-DICARBOXYLIC ACID	c1cccc(c12)[nH]cc2-c3c(C(=O)O)[nH]c(C(=O)O)c3-c4c[nH]c(c45)cccc5
18665	sp|P9WPP7|CP121_MY	P9WPN5	95.45	22.0	400.0	DB07705	experimental	(S)-econazole	Clc1ccc(cc1)CO[C@H](Cn2ccnc2)c3c(Cl)cc(Cl)cc3
18666	sp|P9WPP7|CP121_MY	P9WPN5	95.45	22.0	400.0	DB07971	experimental	5-AMINO-2-{4-[(4-AMINOPHENYL)SULFANYL]PHENYL}-1H-ISOINDOLE-1,3(2H)-DIONE	Nc1ccc(cc1)Sc2ccc(cc2)N(C3=O)C(=O)c(c34)ccc(c4)N
18667	sp|P9WPP7|CP121_MY	P9WPN5	95.45	22.0	400.0	DB07972	experimental	1-(3-METHYLPHENYL)-1H-BENZIMIDAZOL-5-AMINE	Cc1cccc(c1)-n2cnc(c23)cc(N)cc3
18668	sp|P9WPP7|CP121_MY	P00183	77.53	100.0	407.0	DB01011	approved; investigational	Metyrapone	c1ccncc1C(C)(C)C(=O)c2cnccc2
18669	sp|P9WPP7|CP121_MY	P00183	77.53	100.0	407.0	DB01663	experimental	lambda-bis(2,2'-bipyridine)-(5-methyl-2-2'-bipyridine)-C9-adamantane ruthenium (II)	C1=CC=CN2C1=C(C=CC=C3)N3[Ru+2]245(N6C(C=CC=C6)=C7N4C=CC=C7)N8C(=C9N5C=CC(C)=C9)C=C(C=C8)CCCCCCCCC(=O)N[C@@H]([C@H]12)[C@H]3C[C@@H](C1)C[C@@H](C2)C3
18670	sp|P9WPP7|CP121_MY	P00183	77.53	100.0	407.0	DB01703	experimental	N-(2-ferrocenylethyl)maleimide	O=C1C=CC(=O)N1CCC2(C3C4C5C26)[Fe]13456789C2C7C8C9C12
18671	sp|P9WPP7|CP121_MY	P00183	77.53	100.0	407.0	DB01744	approved	Camphor	C[C@]12C(=O)C[C@H](C1(C)C)CC2
18672	sp|P9WPP7|CP121_MY	P00183	77.53	100.0	407.0	DB01826	experimental	N-Butyl Isocyanide	CCCC[N+]#[C-]
18673	sp|P9WPP7|CP121_MY	P00183	77.53	100.0	407.0	DB02125	experimental	Adamantanone	O=C([C@H]12)[C@H]3C[C@@H](C1)C[C@@H](C2)C3
18674	sp|P9WPP7|CP121_MY	P00183	77.53	100.0	407.0	DB02617	experimental	1-(N-Imidazolyl)-2-Hydroxy-2-(2,3-Dichlorophenyl)Octane	CCCCCC[C@](O)(Cn1ccnc1)c2ccc(Cl)cc2Cl
18675	sp|P9WPP7|CP121_MY	P00183	77.53	100.0	407.0	DB02817	experimental	5-Exo-Hydroxycamphor	C[C@]12C[C@@H](O)[C@H](CC1=O)C2(C)C
18676	sp|P9WPP7|CP121_MY	P00183	77.53	100.0	407.0	DB02851	experimental	Thiocamphor	C[C@]12C(=S)C[C@H](C1(C)C)CC2
18677	sp|P9WPP7|CP121_MY	P00183	77.53	100.0	407.0	DB03031	experimental	Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Octyl-Amide	CN(C)c1cccc(c12)c(ccc2)S(=O)(=O)NCCCCCCCCNC(=O)C34CC5CC(C3)CC(C5)C4
18678	sp|P9WPP7|CP121_MY	P00183	77.53	100.0	407.0	DB03540	experimental	Norcamphor	[C@H]12CC[C@H](C1)C(=O)C2
18679	sp|P9WPP7|CP121_MY	P00183	77.53	100.0	407.0	DB03627	experimental	Adamantane	C12CC3CC(C1)CC(C3)C2
18680	sp|P9WPP7|CP121_MY	P00183	77.53	100.0	407.0	DB03836	experimental	1,3,5-trichlorobenzene	Clc1cc(Cl)cc(Cl)c1
18681	sp|P9WPP7|CP121_MY	P00183	77.53	100.0	407.0	DB04032	experimental	Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Butyl-Amide	CN(C)c1cccc(c12)c(ccc2)S(=O)(=O)NCCCCNC(=O)C34CC5CC(C3)CC(C5)C4
18682	sp|P9WPP7|CP121_MY	P00183	77.53	100.0	407.0	DB04501	experimental	Camphane	C[C@@]12CCC(C1(C)C)CC2
18683	sp|P9WPP7|CP121_MY	O31440	88.38	48.0	398.0	DB04257	experimental	Palmitoleic Acid	CCCCCC/C=C\CCCCCCCC(=O)O
18684	sp|P9WPP7|CP121_MY	Q9NR63	88.13	109.0	458.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
18685	sp|P9WPP7|CP121_MY	Q6V0L0	93.69	108.0	479.0	DB00523	approved; investigational	Alitretinoin	OC(=O)/C=C(\C)/C=C/C=C(/C)\C=C\C(C1(C)C)=C(C)CCC1
18686	sp|P9WPP7|CP121_MY	Q6V0L0	93.69	108.0	479.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
18687	sp|P9WPP7|CP121_MY	O43174	89.39	108.0	462.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
18688	sp|P9WPP7|CP121_MY	O43174	89.39	108.0	462.0	DB13083	investigational	Talarozole	c1ncnn1C(C(CC)CC)c2ccc(cc2)Nc(s3)nc(c34)cccc4
18689	sp|P9WPP7|CP121_MY	P11509	99.24	67.0	460.0	DB04665	experimental	Coumarin	c1cc(=O)oc(c12)cccc2
18690	sp|P9WPP7|CP121_MY	P11509	99.24	67.0	460.0	DB07609	experimental	N,N-DIMETHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	CN(C)Cc1ccc(o1)-c2cccnc2
18691	sp|P9WPP7|CP121_MY	P11509	99.24	67.0	460.0	DB07617	experimental	N-METHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	CNCc1ccc(o1)-c2cccnc2
18692	sp|P9WPP7|CP121_MY	P11509	99.24	67.0	460.0	DB07621	experimental	(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	NCc1ccc(o1)-c2cccnc2
18693	sp|P9WPP7|CP121_MY	P11509	99.24	67.0	460.0	DB07623	experimental	4,4'-DIPYRIDYL DISULFIDE	c1cnccc1SSc2ccncc2
18694	sp|P9WPP7|CP121_MY	P20813	82.83	130.0	458.0	DB02974	experimental	4-(4-Chlorophenyl)Imidazole	Clc1ccc(cc1)-c2cnc[nH]2
18695	sp|P9WPP7|CP121_MY	P20813	82.83	130.0	458.0	DB04664	experimental	Cyclohexyl-pentyl-maltoside	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@@H]2CO)OCCCCCC3CCCCC3
18696	sp|P9WPP7|CP121_MY	P20813	82.83	130.0	458.0	DB04794	approved; investigational	Bifonazole	c1ccccc1C(n2ccnc2)c3ccc(cc3)-c4ccccc4
18697	sp|P9WPP7|CP121_MY	P20813	82.83	130.0	458.0	DB08369	experimental	1-(biphenyl-4-ylmethyl)-1H-imidazole	c1cncn1Cc2ccc(cc2)-c3ccccc3
18698	sp|P9WPP7|CP121_MY	P08686	80.05	132.0	449.0	DB01026	approved; investigational	Ketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OCC(CO3)OC3(Cn4ccnc4)c5ccc(Cl)cc5Cl
18699	sp|P9WPP7|CP121_MY	Q16850	84.6	133.0	468.0	DB01007	approved	Tioconazole	c1nccn1CC(c(c(Cl)c2)ccc2Cl)OCc3c(Cl)scc3
18700	sp|P9WPP7|CP121_MY	Q16850	84.6	133.0	468.0	DB01167	approved; investigational	Itraconazole	CCC(C)n1ncn(c1=O)-c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@@H](CO5)O[C@@]5(Cn6cncn6)c7ccc(Cl)cc7Cl
18701	sp|P9WPP7|CP121_MY	Q16850	84.6	133.0	468.0	DB05667	investigational	Levoketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OC[C@H](CO3)O[C@]3(Cn4ccnc4)c5ccc(Cl)cc5Cl
18702	sp|P9WPP7|CP121_MY	Q16850	84.6	133.0	468.0	DB07705	experimental	(S)-econazole	Clc1ccc(cc1)CO[C@H](Cn2ccnc2)c3c(Cl)cc(Cl)cc3
18703	sp|P9WPN7|CP128_MY	P9WPN5	79.14	17.0	404.0	DB07705	experimental	(S)-econazole	Clc1ccc(cc1)CO[C@H](Cn2ccnc2)c3c(Cl)cc(Cl)cc3
18704	sp|P9WPN7|CP128_MY	P9WPN5	79.14	17.0	404.0	DB07971	experimental	5-AMINO-2-{4-[(4-AMINOPHENYL)SULFANYL]PHENYL}-1H-ISOINDOLE-1,3(2H)-DIONE	Nc1ccc(cc1)Sc2ccc(cc2)N(C3=O)C(=O)c(c34)ccc(c4)N
18705	sp|P9WPN7|CP128_MY	P9WPN5	79.14	17.0	404.0	DB07972	experimental	1-(3-METHYLPHENYL)-1H-BENZIMIDAZOL-5-AMINE	Cc1cccc(c1)-n2cnc(c23)cc(N)cc3
18706	sp|P9WPN7|CP128_MY	Q83WG3	81.8	10.0	410.0	DB06955	experimental	3,4-bis(7-chloro-1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid	c1ccc(Cl)c(c12)[nH]cc2-c3c(C(=O)O)[nH]c(C(=O)O)c3-c4c[nH]c(c45)c(Cl)ccc5
18707	sp|P9WPN7|CP128_MY	Q83WG3	81.8	10.0	410.0	DB07588	experimental	3,4-DI-1H-INDOL-3-YL-1H-PYRROLE-2,5-DICARBOXYLIC ACID	c1cccc(c12)[nH]cc2-c3c(C(=O)O)[nH]c(C(=O)O)c3-c4c[nH]c(c45)cccc5
18708	sp|P9WPN7|CP128_MY	P00183	78.53	25.0	409.0	DB01011	approved; investigational	Metyrapone	c1ccncc1C(C)(C)C(=O)c2cnccc2
18709	sp|P9WPN7|CP128_MY	P00183	78.53	25.0	409.0	DB01663	experimental	lambda-bis(2,2'-bipyridine)-(5-methyl-2-2'-bipyridine)-C9-adamantane ruthenium (II)	C1=CC=CN2C1=C(C=CC=C3)N3[Ru+2]245(N6C(C=CC=C6)=C7N4C=CC=C7)N8C(=C9N5C=CC(C)=C9)C=C(C=C8)CCCCCCCCC(=O)N[C@@H]([C@H]12)[C@H]3C[C@@H](C1)C[C@@H](C2)C3
18710	sp|P9WPN7|CP128_MY	P00183	78.53	25.0	409.0	DB01703	experimental	N-(2-ferrocenylethyl)maleimide	O=C1C=CC(=O)N1CCC2(C3C4C5C26)[Fe]13456789C2C7C8C9C12
18711	sp|P9WPN7|CP128_MY	P00183	78.53	25.0	409.0	DB01744	approved	Camphor	C[C@]12C(=O)C[C@H](C1(C)C)CC2
18712	sp|P9WPN7|CP128_MY	P00183	78.53	25.0	409.0	DB01826	experimental	N-Butyl Isocyanide	CCCC[N+]#[C-]
18713	sp|P9WPN7|CP128_MY	P00183	78.53	25.0	409.0	DB02125	experimental	Adamantanone	O=C([C@H]12)[C@H]3C[C@@H](C1)C[C@@H](C2)C3
18714	sp|P9WPN7|CP128_MY	P00183	78.53	25.0	409.0	DB02617	experimental	1-(N-Imidazolyl)-2-Hydroxy-2-(2,3-Dichlorophenyl)Octane	CCCCCC[C@](O)(Cn1ccnc1)c2ccc(Cl)cc2Cl
18715	sp|P9WPN7|CP128_MY	P00183	78.53	25.0	409.0	DB02817	experimental	5-Exo-Hydroxycamphor	C[C@]12C[C@@H](O)[C@H](CC1=O)C2(C)C
18716	sp|P9WPN7|CP128_MY	P00183	78.53	25.0	409.0	DB02851	experimental	Thiocamphor	C[C@]12C(=S)C[C@H](C1(C)C)CC2
18717	sp|P9WPN7|CP128_MY	P00183	78.53	25.0	409.0	DB03031	experimental	Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Octyl-Amide	CN(C)c1cccc(c12)c(ccc2)S(=O)(=O)NCCCCCCCCNC(=O)C34CC5CC(C3)CC(C5)C4
18718	sp|P9WPN7|CP128_MY	P00183	78.53	25.0	409.0	DB03540	experimental	Norcamphor	[C@H]12CC[C@H](C1)C(=O)C2
18719	sp|P9WPN7|CP128_MY	P00183	78.53	25.0	409.0	DB03627	experimental	Adamantane	C12CC3CC(C1)CC(C3)C2
18720	sp|P9WPN7|CP128_MY	P00183	78.53	25.0	409.0	DB03836	experimental	1,3,5-trichlorobenzene	Clc1cc(Cl)cc(Cl)c1
18721	sp|P9WPN7|CP128_MY	P00183	78.53	25.0	409.0	DB04032	experimental	Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Butyl-Amide	CN(C)c1cccc(c12)c(ccc2)S(=O)(=O)NCCCCNC(=O)C34CC5CC(C3)CC(C5)C4
18722	sp|P9WPN7|CP128_MY	P00183	78.53	25.0	409.0	DB04501	experimental	Camphane	C[C@@]12CCC(C1(C)C)CC2
18723	sp|P9WPN7|CP128_MY	P53554	77.71	13.0	393.0	DB04450	experimental	Heptyl 1-Thiohexopyranoside	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)SCCCCCCC
18724	sp|P9WPN7|CP128_MY	Q00441	78.94	15.0	401.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
18725	sp|P9WPN7|CP128_MY	Q00441	78.94	15.0	401.0	DB03369	experimental	9-Aminophenanthrene	c1cccc(c12)c3c(cc2N)cccc3
18726	sp|P9WPN7|CP128_MY	Q00441	78.94	15.0	401.0	DB04070	experimental	6-Deoxyerythronolide B	C[C@@H]1C[C@H](C)[C@H](O)[C@@H](C)[C@H](O)[C@@H](C)C(=O)O[C@H](CC)[C@H](C)[C@H](O)[C@@H](C)C1=O
18727	sp|P9WPN7|CP128_MY	Q9FCA6	76.69	28.0	403.0	DB02175	experimental	Malonic acid	OC(=O)CC(=O)O
18728	sp|P9WPN7|CP128_MY	Q9FCA6	76.69	28.0	403.0	DB02521	experimental	Flaviolin	Oc1cc(O)cc(c12)C(=O)C(O)=CC2=O
18729	sp|P9WPN7|CP128_MY	Q9FCA6	76.69	28.0	403.0	DB03254	experimental	4-Phenyl-1h-Imidazole	[nH]1cncc1-c2ccccc2
18730	sp|P9WPN7|CP128_MY	Q9FCA6	76.69	28.0	403.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
18731	sp|P9WPN7|CP128_MY	P08684	71.17	118.0	466.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
18732	sp|P9WPN7|CP128_MY	P08684	71.17	118.0	466.0	DB00143	approved; investigational; nutraceutical	Glutathione	OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(=O)O
18733	sp|P9WPN7|CP128_MY	P08684	71.17	118.0	466.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
18734	sp|P9WPN7|CP128_MY	P08684	71.17	118.0	466.0	DB05478	investigational	Pradefovir mesylate	n1cnc(N)c(c12)ncn2CCOC[P@@]3(=O)OCC[C@H](O3)c4cc(Cl)ccc4
18735	sp|P9WPN7|CP128_MY	P08684	71.17	118.0	466.0	DB06634	investigational	Casopitant	FC(F)(F)c1cc(cc(c1)C(F)(F)F)[C@@H](C)N(C)C(=O)N2CC[C@H](N3CCN(CC3)C(=O)C)C[C@@H]2c4ccc(F)cc4C
18736	sp|P9WPN7|CP128_MY	P20815	71.17	118.0	466.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
18737	sp|P9WPN7|CP128_MY	P20815	71.17	118.0	466.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
18738	sp|P9WPN7|CP128_MY	P20815	71.17	118.0	466.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
18739	sp|P9WPN7|CP128_MY	P24462	71.17	118.0	466.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
18740	sp|P9WPN7|CP128_MY	P24462	71.17	118.0	466.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
18741	sp|P9WPN7|CP128_MY	P24462	71.17	118.0	466.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
18742	sp|P9WPN7|CP128_MY	P9WPP7	76.89	18.0	394.0	DB02721	experimental	4-Iodopyrazole	Ic1c[nH]nc1
18743	sp|P9WPN7|CP128_MY	P9WPP7	76.89	18.0	394.0	DB08761	experimental	(3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine-2,5-dione	Oc1ccc(cc1)C[C@@H]2NC(=O)[C@@H](NC2=O)Cc3ccc(O)cc3
18744	sp|P9WPN7|CP128_MY	Q9NR63	71.98	136.0	488.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
18745	sp|P9WPN7|CP128_MY	Q6V0L0	76.89	134.0	510.0	DB00523	approved; investigational	Alitretinoin	OC(=O)/C=C(\C)/C=C/C=C(/C)\C=C\C(C1(C)C)=C(C)CCC1
18746	sp|P9WPN7|CP128_MY	Q6V0L0	76.89	134.0	510.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
18747	sp|P9WPN7|CP128_MY	Q9HB55	71.17	118.0	466.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
18748	sp|P9WPN7|CP128_MY	P33261	82.41	76.0	479.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
18749	sp|P9WPN7|CP128_MY	P33261	82.41	76.0	479.0	DB12319	investigational; withdrawn	Benzbromarone	c1cccc(c12)c(c(o2)CC)C(=O)c3cc(Br)c(O)c(Br)c3
18750	sp|P9WPN7|CP128_MY	P11712	82.41	76.0	479.0	DB03317	experimental	Ferroheme C	[Fe-2]123[N+]4=C5C=C6[N+]1=C(C(C)=C6C(C)S)C=C7[N+]2=C(C(=C7C)CCC(=O)O)C=C8[N+]3=C(C=C4C(=C5C)C(C)S)C(C)=C8CCC(=O)O
18751	sp|P9WPN7|CP128_MY	P11712	82.41	76.0	479.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
18752	sp|P9WPN7|CP128_MY	P11712	82.41	76.0	479.0	DB12319	investigational; withdrawn	Benzbromarone	c1cccc(c12)c(c(o2)CC)C(=O)c3cc(Br)c(O)c(Br)c3
18753	sp|P9WPN7|CP128_MY	P33260	82.0	76.0	477.0	DB07670	experimental	N,4-Dimethyl-N-(1-phenyl-1H-pyrazol-5-yl)benzenesulfonamide	Cc1ccc(cc1)S(=O)(=O)N(C)c2ccnn2-c3ccccc3
18754	sp|P9WPN7|CP128_MY	O43174	73.62	129.0	489.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
18755	sp|P9WPN7|CP128_MY	O43174	73.62	129.0	489.0	DB13083	investigational	Talarozole	c1ncnn1C(C(CC)CC)c2ccc(cc2)Nc(s3)nc(c34)cccc4
18756	sp|P9WPN7|CP128_MY	P10632	81.8	80.0	480.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
18757	sp|P9WPN7|CP128_MY	P10632	81.8	80.0	480.0	DB03796	approved	Palmitic Acid	CCCCCCCCCCCCCCCC(=O)O
18758	sp|P9WPN7|CP128_MY	P10632	81.8	80.0	480.0	DB08607	experimental	(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE	O=C1NC(=O)S[C@@H]1Cc2ccc(cc2)OC[C@@](O3)(C)CCc(c34)c(C)c(O)c(C)c4C
18759	sp|P9WPN7|CP128_MY	O15528	71.98	126.0	478.0	DB01436	approved; nutraceutical	Alfacalcidol	CC(C)CCC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)/C(CCC2)=C/C=C3/C[C@@H](O)C[C@H](O)C3=C
18760	sp|P9WPN7|CP128_MY	P20813	82.41	78.0	481.0	DB02974	experimental	4-(4-Chlorophenyl)Imidazole	Clc1ccc(cc1)-c2cnc[nH]2
18761	sp|P9WPN7|CP128_MY	P20813	82.41	78.0	481.0	DB04664	experimental	Cyclohexyl-pentyl-maltoside	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@@H]2CO)OCCCCCC3CCCCC3
18762	sp|P9WPN7|CP128_MY	P20813	82.41	78.0	481.0	DB04794	approved; investigational	Bifonazole	c1ccccc1C(n2ccnc2)c3ccc(cc3)-c4ccccc4
18763	sp|P9WPN7|CP128_MY	P20813	82.41	78.0	481.0	DB08369	experimental	1-(biphenyl-4-ylmethyl)-1H-imidazole	c1cncn1Cc2ccc(cc2)-c3ccccc3
18764	sp|P9WPN7|CP128_MY	P11509	82.82	77.0	482.0	DB04665	experimental	Coumarin	c1cc(=O)oc(c12)cccc2
18765	sp|P9WPN7|CP128_MY	P11509	82.82	77.0	482.0	DB07609	experimental	N,N-DIMETHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	CN(C)Cc1ccc(o1)-c2cccnc2
18766	sp|P9WPN7|CP128_MY	P11509	82.82	77.0	482.0	DB07617	experimental	N-METHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	CNCc1ccc(o1)-c2cccnc2
18767	sp|P9WPN7|CP128_MY	P11509	82.82	77.0	482.0	DB07621	experimental	(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	NCc1ccc(o1)-c2cccnc2
18768	sp|P9WPN7|CP128_MY	P11509	82.82	77.0	482.0	DB07623	experimental	4,4'-DIPYRIDYL DISULFIDE	c1cnccc1SSc2ccncc2
18769	sp|P9WPN7|CP128_MY	P05181	81.19	78.0	475.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
18771	sp|P9WPN7|CP128_MY	P14779	76.48	52.0	426.0	DB03440	experimental	N-hexadecanoylglycine	CCCCCCCCCCCCCCCC(=O)NCC(=O)O
18772	sp|P9WPN7|CP128_MY	P14779	76.48	52.0	426.0	DB04257	experimental	Palmitoleic Acid	CCCCCC/C=C\CCCCCCCC(=O)O
18773	sp|P9WPN7|CP128_MY	P14779	76.48	52.0	426.0	DB08086	experimental	N-[12-(1H-imidazol-1-yl)dodecanoyl]-L-leucine	CC(C)C[C@@H](C(=O)O)NC(=O)CCCCCCCCCCCn1ccnc1
18774	sp|P9WPN7|CP128_MY	Q02928	70.35	135.0	479.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
18775	sp|P9WPT9|CTPB_MYC	P03960	71.14	75.0	610.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
18776	sp|P9WNL3|DER_MYCT	Q9X1F8	93.74	2.0	436.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
18777	sp|P9WHH9|DLDH_MYC	P14218	100.65	4.0	471.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
18778	sp|P9WHH9|DLDH_MYC	P18925	100.65	4.0	471.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
18779	sp|P9WHH9|DLDH_MYC	P09622	100.43	43.0	509.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
18780	sp|P9WHH9|DLDH_MYC	P09622	100.43	43.0	509.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
18781	sp|P9WHH9|DLDH_MYC	P06715	95.47	3.0	446.0	DB00336	approved; investigational; vet_approved	Nitrofural	NC(=O)N/N=C/c1ccc(o1)[N+]([O-])=O
18782	sp|P9WHH9|DLDH_MYC	P06715	95.47	3.0	446.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
18783	sp|P9WHH9|DLDH_MYC	Q51225	100.65	117.0	584.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
18784	sp|P9WHH9|DLDH_MYC	P00390	97.84	64.0	518.0	DB00143	approved; investigational; nutraceutical	Glutathione	OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(=O)O
18785	sp|P9WHH9|DLDH_MYC	P00390	97.84	64.0	518.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
18786	sp|P9WHH9|DLDH_MYC	P00390	97.84	64.0	518.0	DB00262	approved; investigational	Carmustine	ClCCNC(=O)N(N=O)CCCl
18787	sp|P9WHH9|DLDH_MYC	P00390	97.84	64.0	518.0	DB01644	experimental	3,6-dihydroxy-xanthene-9-propionic acid	OC(=O)CCC1c(ccc(c2)O)c2Oc(c13)cc(O)cc3
18788	sp|P9WHH9|DLDH_MYC	P00390	97.84	64.0	518.0	DB02153	experimental	3-sulfino-L-alanine	OC(=O)[C@@H](N)C[S@](=O)O
18789	sp|P9WHH9|DLDH_MYC	P00390	97.84	64.0	518.0	DB02553	experimental	Glutathionylspermidine disulfide	NCCCCNCCCNC(=O)CNC(=O)[C@@H](NC(=O)CC[C@@H](N)C(=O)O)CSSC[C@H](NC(=O)CC[C@@H](N)C(=O)O)C(=O)NCC(=O)NCCCNCCCCN
18790	sp|P9WHH9|DLDH_MYC	P00390	97.84	64.0	518.0	DB02895	experimental	3-(Prop-2-Ene-1-Sulfinyl)-Propene-1-Thiol	S/C=C/C[S@](=O)CC=C
18791	sp|P9WHH9|DLDH_MYC	P00390	97.84	64.0	518.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
18792	sp|P9WHH9|DLDH_MYC	P00390	97.84	64.0	518.0	DB03310	approved; experimental; investigational	Glutathione disulfide	OC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)NCC(=O)O)CSSC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@H](N)C(=O)O
18793	sp|P9WHH9|DLDH_MYC	P00390	97.84	64.0	518.0	DB03867	experimental	3-nitro-L-tyrosine	OC(=O)[C@@H](N)Cc1cc([N+]([O-])=O)c(O)cc1
18794	sp|P9WHH9|DLDH_MYC	P00390	97.84	64.0	518.0	DB07393	experimental	2-(2-PHENYL-3-PYRIDIN-2-YL-4,5,6,7-TETRAHYDRO-2H-ISOPHOSPHINDOL-1-YL)PYRIDINE	n1ccccc1-c2p(-c3ccccc3)c(c(c24)CCCC4)-c5ncccc5
18795	sp|P9WHH9|DLDH_MYC	P00390	97.84	64.0	518.0	DB07714	experimental	6-(3-METHYL-1,4-DIOXO-1,4-DIHYDRONAPHTHALEN-2-YL)HEXANOIC ACID	c1cccc(c12)C(=O)C(=C(C2=O)C)CCCCCC(=O)O
18796	sp|P9WHH9|DLDH_MYC	P00390	97.84	64.0	518.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
18797	sp|P9WHH9|DLDH_MYC	P00390	97.84	64.0	518.0	DB09130	approved; investigational	Copper	[Cu]
18799	sp|P9WHH9|DLDH_MYC	P00390	97.84	64.0	518.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
18800	sp|P9WHH9|DLDH_MYC	P09063	96.77	9.0	458.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
18801	sp|P9WHH9|DLDH_MYC	Q16881	101.08	162.0	631.0	DB01169	approved; investigational	Arsenic trioxide	O=[As]O[As]=O
18802	sp|P9WHH9|DLDH_MYC	Q16881	101.08	162.0	631.0	DB02338	experimental	NADPH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
18803	sp|P9WHH9|DLDH_MYC	Q16881	101.08	162.0	631.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
18804	sp|P9WHH9|DLDH_MYC	Q16881	101.08	162.0	631.0	DB03566	experimental	Spermidine	NCCCCNCCCN
18805	sp|P9WHH9|DLDH_MYC	Q16881	101.08	162.0	631.0	DB04106	investigational	Fotemustine	CCOP(=O)(OCC)[C@@H](C)NC(=O)N(N=O)CCCl
18806	sp|P9WHH9|DLDH_MYC	Q16881	101.08	162.0	631.0	DB05428	investigational	Motexafin gadolinium	CCc(c12)c(CC)c([n-]1)cc3nc(c(C)c3CCCO)cnc4c(ncc5nc(c2)c(c5C)CCCO)cc(OCCOCCOCCOC)c(c4)OCCOCCOCCOC
18807	sp|P9WHH9|DLDH_MYC	Q16881	101.08	162.0	631.0	DB05448	investigational	PX-12	CCC(C)SSc1ncc[nH]1
18808	sp|P9WHH9|DLDH_MYC	Q9NNW7	100.22	39.0	504.0	DB05428	investigational	Motexafin gadolinium	CCc(c12)c(CC)c([n-]1)cc3nc(c(C)c3CCCO)cnc4c(ncc5nc(c2)c(c5C)CCCO)cc(OCCOCCOCCOC)c(c4)OCCOCCOCCOC
18809	sp|P9WHH9|DLDH_MYC	Q94655	105.39	3.0	492.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
18810	sp|P9WHH9|DLDH_MYC	P28593	100.0	6.0	470.0	DB02240	experimental	Quinacrine mustard	c1cc(Cl)cc(n2)c1c(c(c23)cc(OC)cc3)NC(C)CCCN(CCCl)CCCl
18811	sp|P9WHH9|DLDH_MYC	P28593	100.0	6.0	470.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
18812	sp|P9WHH9|DLDH_MYC	P28593	100.0	6.0	470.0	DB03470	experimental	Trypanothione	OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(=O)NCCCCNCCCNC(=O)CNC(=O)[C@H](CS)NC(=O)CC[C@H](N)C(=O)O
18813	sp|P9WHH9|DLDH_MYC	P28593	100.0	6.0	470.0	DB04299	experimental	Maleic Acid	OC(=O)/C=C\C(=O)O
18815	sp|P9WHH9|DLDH_MYC	Q56839	97.84	43.0	497.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
18816	sp|P9WHH9|DLDH_MYC	Q56839	97.84	43.0	497.0	DB03163	experimental	2-oxopropyl-CoM	CC(=O)CSCCS(=O)(=O)O
18817	sp|P95279|ECH13_MY	P9WNP5	73.9	37.0	272.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
18818	sp|P95279|ECH13_MY	P9WNP5	73.9	37.0	272.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
18819	sp|P95279|ECH13_MY	O75521	71.07	131.0	357.0	DB08231	experimental	Myristic acid	CCCCCCCCCCCCCC(=O)O
18820	sp|P95279|ECH13_MY	P42126	74.21	26.0	262.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
18821	sp|P95279|ECH13_MY	P42126	74.21	26.0	262.0	DB03127	experimental	Benzamidine	NC(=[NH2+])c1ccccc1
18822	sp|P95279|ECH13_MY	P28793	72.33	7.0	237.0	DB08249	experimental	3,6,9,12,15-PENTAOXATRICOSAN-1-OL	CCCCCCCCOCCOCCOCCOCCOCCO
18823	sp|P9WNN1|EFTU_MYC	Q01698	102.02	1.0	405.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
18824	sp|P9WNN1|EFTU_MYC	Q01698	102.02	1.0	405.0	DB08185	experimental	2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE	OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(nc(n3)SC)NCCC(C)C
18825	sp|P9WNN1|EFTU_MYC	P60339	102.02	1.0	405.0	DB04124	experimental	Aurodox	O=c1n(C)ccc(O)c1C(=O)/C(C)=C/C=C/C=C/[C@H]2O[C@H]([C@@H](O)[C@H]2O)[C@H](C)[C@H](OC)/C(C)=C/C=C/CNC(=O)[C@@H](CC)[C@@]3(O)O[C@H](C(C)(C)[C@@H](O)[C@H]3O)/C=C/C=C\C
18826	sp|P9WNN1|EFTU_MYC	P60339	102.02	1.0	405.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
18827	sp|P9WNN1|EFTU_MYC	Q83JC4	98.99	1.0	393.0	DB02975	experimental	GE-2270A	NC(=O)[C@@H]1CCCN1C(=O)[C@@H]2COC(=N2)c3csc(n3)-c(n4)ccc5c(sc6)nc6C(=O)N[C@@H](CC(=O)NC)c(sc7C)nc7C(=O)N[C@@H](C(C)C)c(sc8COC)nc8C(=O)NCC(=O)N[C@@H]([C@@H](O)c9ccccc9)c(n1)scc1c(n1)scc1c45
18828	sp|P9WNN1|EFTU_MYC	Q83JC4	98.99	1.0	393.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
18829	sp|P9WNN1|EFTU_MYC	P49411	99.24	47.0	440.0	DB01593	approved; investigational	Zinc	[Zn]
18830	sp|P9WNN1|EFTU_MYC	P49411	99.24	47.0	440.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
18831	sp|P9WNN1|EFTU_MYC	P49411	99.24	47.0	440.0	DB14487	approved; investigational	Zinc acetate	CC([O-])=O
18832	sp|P9WNN1|EFTU_MYC	P49411	99.24	47.0	440.0	DB14533	approved; investigational	Zinc chloride	[Cl-]
18833	sp|P9WNN1|EFTU_MYC	P49411	99.24	47.0	440.0	DB14548	approved; experimental	Zinc sulfate, unspecified form	 
18834	sp|P9WNN1|EFTU_MYC	P68104	110.86	2.0	441.0	DB01593	approved; investigational	Zinc	[Zn]
18835	sp|P9WNN1|EFTU_MYC	P68104	110.86	2.0	441.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
18836	sp|P9WNN1|EFTU_MYC	P68104	110.86	2.0	441.0	DB09130	approved; investigational	Copper	[Cu]
18837	sp|P9WNN1|EFTU_MYC	P68104	110.86	2.0	441.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
18838	sp|P9WNN1|EFTU_MYC	P68104	110.86	2.0	441.0	DB14487	approved; investigational	Zinc acetate	CC([O-])=O
18839	sp|P9WNN1|EFTU_MYC	P68104	110.86	2.0	441.0	DB14533	approved; investigational	Zinc chloride	[Cl-]
18840	sp|P9WNN1|EFTU_MYC	P68104	110.86	2.0	441.0	DB14548	approved; experimental	Zinc sulfate, unspecified form	 
18841	sp|P9WNN1|EFTU_MYC	Q00080	107.32	2.0	427.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
18842	sp|P9WNN1|EFTU_MYC	P15170	106.82	71.0	494.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
18843	sp|P9WNN1|EFTU_MYC	Q96RE1	94.44	3.0	377.0	DB09130	approved; investigational	Copper	[Cu]
18844	sp|P9WN71|G6PD1_MY	P11413	101.29	30.0	502.0	DB03085	approved; investigational	Glycolic acid	OCC(=O)O
18845	sp|P9WN71|G6PD1_MY	P11413	101.29	30.0	502.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
18846	sp|P9WN71|G6PD1_MY	P11413	101.29	30.0	502.0	DB05107	investigational	16-Bromoepiandrosterone	O=C1[C@H](Br)C[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)C[C@@H](O)CC4
18847	sp|P9WN71|G6PD1_MY	P11413	101.29	30.0	502.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
18848	sp|P9WN71|G6PD1_MY	P11411	101.5	6.0	479.0	DB02338	experimental	NADPH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
18849	sp|P9WN71|G6PD1_MY	P11411	101.5	6.0	479.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
18850	sp|P9WN71|G6PD1_MY	P11411	101.5	6.0	479.0	DB04122	experimental	beta-D-glucose 6-phosphate	O[C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@H]1O)COP(=O)(O)O
18851	sp|P9WN71|G6PD1_MY	O95479	99.36	28.0	491.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
18852	sp|P9WIQ3|FPRA_MYC	P9WIQ3	99.78	1.0	456.0	DB01753	experimental	4-oxo-nicotinamide-adenine dinucleotide phosphate	NC(=O)[C@H]1C=[N+](C=CC1=O)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
18853	sp|P9WIQ3|FPRA_MYC	P9WIQ3	99.78	1.0	456.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
18854	sp|P9WIQ3|FPRA_MYC	P22570	98.46	40.0	489.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
18855	sp|P9WIQ3|FPRA_MYC	P22570	98.46	40.0	489.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
18856	sp|P9WJP7|3MGH_MYC	P29372	89.66	111.0	293.0	DB00515	approved	Cisplatin	[NH3+][Pt](Cl)(Cl)[NH3+]
18857	sp|P9WJP7|3MGH_MYC	P29372	89.66	111.0	293.0	DB01593	approved; investigational	Zinc	[Zn]
18858	sp|P9WJP7|3MGH_MYC	P29372	89.66	111.0	293.0	DB14487	approved; investigational	Zinc acetate	CC([O-])=O
18859	sp|P9WJP7|3MGH_MYC	P29372	89.66	111.0	293.0	DB14533	approved; investigational	Zinc chloride	[Cl-]
18860	sp|P9WJP7|3MGH_MYC	P29372	89.66	111.0	293.0	DB14548	approved; experimental	Zinc sulfate, unspecified form	 
18861	sp|P9WIE3|AHPE_MYC	P9WG35	95.42	19.0	165.0	DB03382	experimental	S-oxy-L-cysteine	OC(=O)[C@@H](N)CS=O
18862	sp|P9WIE3|AHPE_MYC	Q06830	90.85	7.0	146.0	DB01593	approved; investigational	Zinc	[Zn]
18863	sp|P9WIE3|AHPE_MYC	Q06830	90.85	7.0	146.0	DB09130	approved; investigational	Copper	[Cu]
18864	sp|P9WIE3|AHPE_MYC	Q06830	90.85	7.0	146.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
18865	sp|P9WIE3|AHPE_MYC	Q06830	90.85	7.0	146.0	DB14487	approved; investigational	Zinc acetate	CC([O-])=O
18866	sp|P9WIE3|AHPE_MYC	Q06830	90.85	7.0	146.0	DB14533	approved; investigational	Zinc chloride	[Cl-]
18867	sp|P9WIE3|AHPE_MYC	Q06830	90.85	7.0	146.0	DB14548	approved; experimental	Zinc sulfate, unspecified form	 
18868	sp|P9WIE3|AHPE_MYC	P32119	90.2	7.0	145.0	DB02153	experimental	3-sulfino-L-alanine	OC(=O)[C@@H](N)C[S@](=O)O
18869	sp|P9WIE3|AHPE_MYC	P32119	90.2	7.0	145.0	DB04048	experimental	N-Carbamoyl-Alanine	OC(=O)[C@@H](C)NC(=O)N
18870	sp|P9WIE3|AHPE_MYC	P32119	90.2	7.0	145.0	DB09130	approved; investigational	Copper	[Cu]
18871	sp|P9WIE3|AHPE_MYC	Q8IL80	89.54	5.0	142.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
18872	sp|P9WIE3|AHPE_MYC	Q8P9V9	81.7	10.0	135.0	DB04640	experimental	Naphthalene-2,6-disulfonic acid	OS(=O)(=O)c(cc1)cc(c12)ccc(c2)S(=O)(=O)O
18873	sp|P9WIE3|AHPE_MYC	P30044	90.2	56.0	194.0	DB00995	approved; investigational	Auranofin	CCP(CC)(CC)=[Au]S[C@@H]1O[C@H](COC(=O)C)[C@@H](OC(=O)C)[C@H](OC(=O)C)[C@H]1OC(=O)C
18874	sp|P9WIE3|AHPE_MYC	P30044	90.2	56.0	194.0	DB03608	experimental	Diminazene	NC(=N)c1ccc(cc1)N/N=N/c2ccc(cc2)C(N)=N
18875	sp|P9WIE3|AHPE_MYC	P30041	77.78	7.0	126.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
18876	sp|P9WIE3|AHPE_MYC	P30041	77.78	7.0	126.0	DB09130	approved; investigational	Copper	[Cu]
18877	sp|P9WN93|FUMC_MYC	P05042	95.57	2.0	455.0	DB02749	experimental	Pyromellitic Acid	OC(=O)c1cc(C(=O)O)c(C(=O)O)cc1C(=O)O
18878	sp|P9WN93|FUMC_MYC	P05042	95.57	2.0	455.0	DB03452	experimental	3-Trimethylsilylsuccinic Acid	C[Si](C)(C)C(C(=O)O)CC(=O)O
18879	sp|P9WN93|FUMC_MYC	P05042	95.57	2.0	455.0	DB03499	experimental	D-Malic acid	OC(=O)[C@H](O)CC(=O)O
18880	sp|P9WN93|FUMC_MYC	P05042	95.57	2.0	455.0	DB04272	approved; nutraceutical; vet_approved	Citric acid	OC(=O)CC(O)(C(=O)O)CC(=O)O
18881	sp|P9WN93|FUMC_MYC	P0AC38	96.41	2.0	459.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
18882	sp|P9WGI9|GLYA1_MY	Q5KUI2	92.92	4.0	411.0	DB03256	experimental	(6R)-Folinic acid	Nc([nH]1)nc(=O)c(c12)N(C=O)[C@@H](CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
18883	sp|P9WGI9|GLYA1_MY	P0A827	93.38	7.0	416.0	DB02824	experimental	N-Pyridoxyl-Glycine-5-Monophosphate	Cc1ncc(COP(=O)(O)O)c(c1O)CNCC(=O)O
18884	sp|P9WGI9|GLYA1_MY	P0A827	93.38	7.0	416.0	DB11596	approved; investigational	Levoleucovorin	Nc([nH]1)nc(=O)c(c12)N(C=O)[C@H](CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
18885	sp|P9WGI9|GLYA1_MY	Q53ET4	95.43	46.0	464.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
18886	sp|P9WGI9|GLYA1_MY	Q53ET4	95.43	46.0	464.0	DB00116	nutraceutical	Tetrahydrofolic acid	Nc([nH]1)nc(=O)c(c12)NC(CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
18887	sp|P9WGI9|GLYA1_MY	Q53ET4	95.43	46.0	464.0	DB00145	approved; nutraceutical; vet_approved	Glycine	NCC(=O)O
18888	sp|P9WGI9|GLYA1_MY	P34897	95.43	46.0	464.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
18889	sp|P9WGI9|GLYA1_MY	P34897	95.43	46.0	464.0	DB00116	nutraceutical	Tetrahydrofolic acid	Nc([nH]1)nc(=O)c(c12)NC(CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
18890	sp|P9WGI9|GLYA1_MY	P34897	95.43	46.0	464.0	DB00145	approved; nutraceutical; vet_approved	Glycine	NCC(=O)O
18891	sp|P9WGI9|GLYA1_MY	P34897	95.43	46.0	464.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
18892	sp|P9WGI9|GLYA1_MY	P34896	95.21	19.0	436.0	DB00114	approved; investigational; nutraceutical	Pyridoxal phosphate	Cc1ncc(c(C=O)c1O)COP(=O)(O)O
18893	sp|P9WGI9|GLYA1_MY	P34896	95.21	19.0	436.0	DB00116	nutraceutical	Tetrahydrofolic acid	Nc([nH]1)nc(=O)c(c12)NC(CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
18894	sp|P9WGI9|GLYA1_MY	P34896	95.21	19.0	436.0	DB00145	approved; nutraceutical; vet_approved	Glycine	NCC(=O)O
18895	sp|P9WGI9|GLYA1_MY	P34896	95.21	19.0	436.0	DB01055	experimental	Mimosine	OC(=O)[C@@H](N)Cn1ccc(=O)c(O)c1
18896	sp|P9WGI9|GLYA1_MY	P34896	95.21	19.0	436.0	DB02067	experimental	Triglu-5-formyl-tetrahydrofolate	Nc([nH]1)nc(=O)c(c12)N(C=O)[C@H](CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)N[C@H](C(=O)O)CCC(=O)N[C@H](C(=O)O)CCC(=O)O
18897	sp|P9WGI9|GLYA1_MY	P34896	95.21	19.0	436.0	DB02800	experimental	5-hydroxymethyl-5,6-dihydrofolic acid	O=c1[nH]c(N)nc(c12)N=C[C@@H](N2CO)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
18898	sp|P9WGI9|GLYA1_MY	P34896	95.21	19.0	436.0	DB02824	experimental	N-Pyridoxyl-Glycine-5-Monophosphate	Cc1ncc(COP(=O)(O)O)c(c1O)CNCC(=O)O
18899	sp|P9WMS7|GUAA_MYC	P04079	99.05	5.0	525.0	DB04272	approved; nutraceutical; vet_approved	Citric acid	OC(=O)CC(O)(C(=O)O)CC(=O)O
18900	sp|P9WMS7|GUAA_MYC	P49915	90.86	26.0	503.0	DB00142	approved; nutraceutical	Glutamic acid	OC(=O)[C@@H](N)CCC(=O)O
18901	sp|P9WPC3|CLPP2_MY	P0A6G7	90.19	13.0	206.0	DB07571	experimental	N~2~-[(BENZYLOXY)CARBONYL]-N-[(1S,2S)-2-HYDROXY-1-(4-HYDROXYBENZYL)PROPYL]-L-LEUCINAMIDE	Oc1ccc(cc1)C[C@@H]([C@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)OCc2ccccc2
18902	sp|P9WPC3|CLPP2_MY	Q16740	91.12	52.0	247.0	DB04464	experimental	N-Formylmethionine	O=CN[C@H](C(=O)O)CCSC
18903	sp|P9WIJ3|DEF_MYCT	P9WIJ3	99.49	1.0	197.0	DB08310	experimental	N-[(2R)-2-{[(2S)-2-(1,3-benzoxazol-2-yl)pyrrolidin-1-yl]carbonyl}hexyl]-N-hydroxyformamide	CCCC[C@H](CN(O)C=O)C(=O)N1CCC[C@H]1c(o2)nc(c23)cccc3
18904	sp|P9WIJ3|DEF_MYCT	Q93LE9	80.71	1.0	160.0	DB04310	experimental	2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide	CCCCC[C@H](CC(=O)NO)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1CO
18905	sp|P9WIJ3|DEF_MYCT	Q9I7A8	77.16	1.0	153.0	DB02036	experimental	2-(3,4-Dihydro-3-Oxo-2h-Benzo[B][1,4]Thiazin-2-Yl)-N-Hydroxyacetamide	ONC(=O)C[C@H](C(=O)N1)Sc(c12)cccc2
18906	sp|P9WIJ3|DEF_MYCT	Q9I7A8	77.16	1.0	153.0	DB02810	experimental	N-(2-Acetamido)Iminodiacetic Acid	NC(=O)CN(CC(=O)O)CC(=O)O
18907	sp|P9WIJ3|DEF_MYCT	Q9I7A8	77.16	1.0	153.0	DB04310	experimental	2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide	CCCCC[C@H](CC(=O)NO)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1CO
18908	sp|P9WIJ3|DEF_MYCT	P96113	72.59	2.0	145.0	DB03661	experimental	L-cysteic acid	OC(=O)[C@@H](N)CS(=O)(=O)O
18909	sp|P9WIJ3|DEF_MYCT	P0A6K3	78.68	1.0	156.0	DB01942	experimental; investigational	Formic acid	OC=O
18910	sp|P9WIJ3|DEF_MYCT	P0A6K3	78.68	1.0	156.0	DB02276	experimental	(S)-2-(Phosphonoxy)Caproyl-L-Leucyl-P-Nitroanilide	CCCC[C@H](OP(=O)(O)O)C(=O)N[C@@H](CC(C)C)C(=O)Nc1ccc([N+]([O-])=O)cc1
18911	sp|P9WIJ3|DEF_MYCT	P0A6K3	78.68	1.0	156.0	DB04310	experimental	2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide	CCCCC[C@H](CC(=O)NO)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1CO
18912	sp|P9WIJ3|DEF_MYCT	P0A6K3	78.68	1.0	156.0	DB04368	experimental	Bb-3497	CCCC[C@H](CN(O)C=O)C(=O)N[C@@H](C(C)(C)C)C(=O)N(C)C
18913	sp|P9WIJ3|DEF_MYCT	P0A6K3	78.68	1.0	156.0	DB08523	experimental	[HYDROXY(3-PHENYLPROPYL)AMINO]METHANOL	OCN(O)CCCc1ccccc1
18914	sp|P9WIJ3|DEF_MYCT	Q8I372	76.14	66.0	216.0	DB02625	experimental	(2r)-2-{[Formyl(Hydroxy)Amino]Methyl}Hexanoic Acid	O=CN(O)C[C@H](C(=O)O)CCCC
18915	sp|P9WIJ3|DEF_MYCT	Q8I372	76.14	66.0	216.0	DB03648	experimental	(2S,2'S)-2,2'-(1,2-Hydrazinediylbis{methylene[(2S)-1-oxo-2,1-hexanediyl]imino})bis(6-amino-N-phenylhexanamide)	c1ccccc1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CCCC)CNNC[C@@H](CCCC)C(=O)N[C@@H](CCCCN)C(=O)Nc2ccccc2
18916	sp|P9WIJ3|DEF_MYCT	P43522	80.71	2.0	161.0	DB03661	experimental	L-cysteic acid	OC(=O)[C@@H](N)CS(=O)(=O)O
18917	sp|P9WIJ3|DEF_MYCT	Q819K2	82.74	6.0	169.0	DB04310	experimental	2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide	CCCCC[C@H](CC(=O)NO)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1CO
18918	sp|P9WIJ3|DEF_MYCT	Q82ZJ0	85.28	5.0	173.0	DB04310	experimental	2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide	CCCCC[C@H](CC(=O)NO)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1CO
18919	sp|P9WIJ3|DEF_MYCT	Q9HBH1	85.79	67.0	236.0	DB04310	experimental	2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide	CCCCC[C@H](CC(=O)NO)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1CO
18920	sp|P9WIJ3|DEF_MYCT	Q9HBH1	85.79	67.0	236.0	DB04368	experimental	Bb-3497	CCCC[C@H](CN(O)C=O)C(=O)N[C@@H](C(C)(C)C)C(=O)N(C)C
18921	sp|P9WIJ3|DEF_MYCT	P68826	83.76	5.0	170.0	DB04310	experimental	2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide	CCCCC[C@H](CC(=O)NO)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1CO
18922	sp|P9WIJ3|DEF_MYCT	Q8NX78	83.76	5.0	170.0	DB02153	experimental	3-sulfino-L-alanine	OC(=O)[C@@H](N)C[S@](=O)O
18923	sp|P9WIJ3|DEF_MYCT	Q8NX78	83.76	5.0	170.0	DB04310	experimental	2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide	CCCCC[C@H](CC(=O)NO)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1CO
18924	sp|P9WIJ3|DEF_MYCT	Q672W7	78.17	1.0	155.0	DB08753	experimental	4-{(1E)-3-OXO-3-[(2-PHENYLETHYL)AMINO]PROP-1-EN-1-YL}-1,2-PHENYLENE DIACETATE	CC(=O)Oc1ccc(cc1OC(=O)C)/C=C/C(=O)NCCc2ccccc2
18925	sp|P9WIJ3|DEF_MYCT	Q672W7	78.17	1.0	155.0	DB08754	experimental	N-Caffeoyltyramine	Oc1ccc(cc1)CCNC(=O)/C=C/c2cc(O)c(O)cc2
18926	sp|P9WIJ3|DEF_MYCT	Q8DP79	87.31	18.0	190.0	DB08523	experimental	[HYDROXY(3-PHENYLPROPYL)AMINO]METHANOL	OCN(O)CCCc1ccccc1
18927	sp|P9WIJ3|DEF_MYCT	Q8DP79	87.31	18.0	190.0	DB08524	experimental	2-(3-BENZOYLPHENOXY)ETHYL(HYDROXY)FORMAMIDE	O=CN(O)CCOc1cccc(c1)C(=O)c2ccccc2
18928	sp|P9WIJ3|DEF_MYCT	Q8DP79	87.31	18.0	190.0	DB08525	experimental	HYDROXY[3-(6-METHYLPYRIDIN-2-YL)PROPYL]FORMAMIDE	Cc1nc(ccc1)CCCN(O)C=O
18929	sp|P9WIJ3|DEF_MYCT	P68771	88.32	18.0	192.0	DB04310	experimental	2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide	CCCCC[C@H](CC(=O)NO)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1CO
18930	sp|P9WIJ3|DEF_MYCT	O31410	82.74	5.0	168.0	DB04310	experimental	2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide	CCCCC[C@H](CC(=O)NO)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1CO
18931	sp|P9WIJ3|DEF_MYCT	Q819U0	77.16	1.0	153.0	DB04310	experimental	2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide	CCCCC[C@H](CC(=O)NO)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1CO
18932	sp|P9WN91|FRDA_MYC	P00363	99.31	3.0	582.0	DB00730	approved; vet_approved	Thiabendazole	c1scnc1-c(n2)[nH]c(c23)cccc3
18933	sp|P9WN91|FRDA_MYC	P00363	99.31	3.0	582.0	DB07490	experimental	2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL	Clc1ccc(cc1)[C@@H](C)c2cc([N+]([O-])=O)cc([N+]([O-])=O)c2O
18934	sp|P9WN91|FRDA_MYC	P00363	99.31	3.0	582.0	DB07918	experimental	2-heptyl-4-hydroxyquinoline N-oxide	CCCCCCCc(cc1O)[n+]([O-])c(c12)cccc2
18935	sp|P9WN91|FRDA_MYC	P0AC41	99.66	7.0	588.0	DB04631	experimental	Atpenin A5	ClC[C@H](Cl)[C@@H](C)C[C@H](C)C(=O)c1c(O)c(OC)c([nH]c1=O)OC
18936	sp|P9WN91|FRDA_MYC	P0AC41	99.66	7.0	588.0	DB07671	experimental	2-[1-METHYLHEXYL]-4,6-DINITROPHENOL	CCCCCC(C)c1c(O)c(N(=O)=O)cc(c1)N(=O)=O
18937	sp|P9WN91|FRDA_MYC	P0AC41	99.66	7.0	588.0	DB08690	experimental	Ubiquinone Q2	COC1=C(OC)C(=O)C(=C(C)C1=O)C/C=C(\C)CCC=C(C)C
18938	sp|P9WN91|FRDA_MYC	P17412	101.72	5.0	598.0	DB07669	experimental	2,3-Dimethyl-1,4-naphthoquinone	O=C1C(C)=C(C)C(=O)c(c12)cccc2
18939	sp|P9WN91|FRDA_MYC	P31040	95.88	60.0	619.0	DB04141	experimental	2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol	O[C@H]1[C@@H](O)[C@@H](CO)O[C@H]([C@@H]1O)OCCCCCC
18940	sp|P9WN91|FRDA_MYC	P31040	95.88	60.0	619.0	DB04657	approved; experimental	Carboxin	S1CCOC(C)=C1C(=O)Nc2ccccc2
18941	sp|P9WN91|FRDA_MYC	P31040	95.88	60.0	619.0	DB04795	experimental	Thenoyltrifluoroacetone	FC(F)(F)C(=O)CC(=O)c1cccs1
18942	sp|P9WN91|FRDA_MYC	P31040	95.88	60.0	619.0	DB08689	experimental	Ubiquinone Q1	COC1=C(OC)C(=O)C(=C(C)C1=O)CC=C(C)C
18943	sp|P9WN91|FRDA_MYC	P31040	95.88	60.0	619.0	DB09270	approved; investigational; nutraceutical	Ubidecarenone	COC1=C(OC)C(=O)C(=C(C)C1=O)C/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CCC=C(C)C
18944	sp|P9WN91|FRDA_MYC	P10902	87.99	8.0	521.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
18945	sp|P9WN39|GLN1B_MY	P9WN38	99.79	1.0	478.0	DB04272	approved; nutraceutical; vet_approved	Citric acid	OC(=O)CC(O)(C(=O)O)CC(=O)O
18946	sp|P9WN39|GLN1B_MY	P9WN39	99.79	1.0	478.0	DB04272	approved; nutraceutical; vet_approved	Citric acid	OC(=O)CC(O)(C(=O)O)CC(=O)O
18947	sp|P9WN39|GLN1B_MY	P0A1P6	97.49	3.0	469.0	DB02663	experimental	2-Amino-4-(Hydroxymethyl-Phosphinyl)Butanoic Acid	C[P@](=O)(O)CC[C@@H](N)C(=O)O
18948	sp|P9WN39|GLN1B_MY	C0H551	85.98	19.0	430.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
18950	sp|P9WN19|GLTD_MYC	Q16881	75.61	138.0	507.0	DB01169	approved; investigational	Arsenic trioxide	O=[As]O[As]=O
18951	sp|P9WN19|GLTD_MYC	Q16881	75.61	138.0	507.0	DB02338	experimental	NADPH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
18952	sp|P9WN19|GLTD_MYC	Q16881	75.61	138.0	507.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
18953	sp|P9WN19|GLTD_MYC	Q16881	75.61	138.0	507.0	DB03566	experimental	Spermidine	NCCCCNCCCN
18954	sp|P9WN19|GLTD_MYC	Q16881	75.61	138.0	507.0	DB04106	investigational	Fotemustine	CCOP(=O)(OCC)[C@@H](C)NC(=O)N(N=O)CCCl
18955	sp|P9WN19|GLTD_MYC	Q16881	75.61	138.0	507.0	DB05428	investigational	Motexafin gadolinium	CCc(c12)c(CC)c([n-]1)cc3nc(c(C)c3CCCO)cnc4c(ncc5nc(c2)c(c5C)CCCO)cc(OCCOCCOCCOC)c(c4)OCCOCCOCCOC
18956	sp|P9WN19|GLTD_MYC	Q16881	75.61	138.0	507.0	DB05448	investigational	PX-12	CCC(C)SSc1ncc[nH]1
18957	sp|P9WPD3|CISY2_MY	O34002	99.46	5.0	376.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
18958	sp|P9WPD3|CISY2_MY	O34002	99.46	5.0	376.0	DB04272	approved; nutraceutical; vet_approved	Citric acid	OC(=O)CC(O)(C(=O)O)CC(=O)O
18959	sp|P9WPD3|CISY2_MY	Q9LCX9	96.78	3.0	364.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
18960	sp|P9WPD3|CISY2_MY	Q9LCX9	96.78	3.0	364.0	DB04272	approved; nutraceutical; vet_approved	Citric acid	OC(=O)CC(O)(C(=O)O)CC(=O)O
18961	sp|P9WN95|FTSZ_MYC	P9WN95	99.74	1.0	379.0	DB01864	experimental	5'-Guanosine-Diphosphate-Monothiophosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=S)(O)O
18962	sp|P9WN95|FTSZ_MYC	P9WN95	99.74	1.0	379.0	DB04315	experimental	Guanosine-5'-Diphosphate	O=c1[nH]c(N)nc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)O
18963	sp|P9WN95|FTSZ_MYC	O08398	81.79	16.0	326.0	DB03532	experimental	Phosphomethylphosphonic acid guanylate ester	Nc([nH]1)nc(=O)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)CP(=O)(O)OP(=O)(O)O
18964	sp|P9WNX9|GABD1_MY	O94788	99.78	55.0	511.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
18965	sp|P9WNX9|GABD1_MY	O94788	99.78	55.0	511.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
18966	sp|P9WNX9|GABD1_MY	O94788	99.78	55.0	511.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
18967	sp|P9WNX9|GABD1_MY	P47895	99.78	49.0	505.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
18968	sp|P9WNX9|GABD1_MY	P47895	99.78	49.0	505.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
18969	sp|P9WNX9|GABD1_MY	P00352	99.78	38.0	494.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
18970	sp|P9WNX9|GABD1_MY	P00352	99.78	38.0	494.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
18971	sp|P9WNX9|GABD1_MY	P00352	99.78	38.0	494.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
18972	sp|P9WNX9|GABD1_MY	P00352	99.78	38.0	494.0	DB04447	experimental	1,4-Dithiothreitol	SC[C@H](O)[C@@H](O)CS
18973	sp|P9WNX9|GABD1_MY	P05091	99.78	54.0	510.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
18974	sp|P9WNX9|GABD1_MY	P05091	99.78	54.0	510.0	DB00536	approved	Guanidine	NC(N)=N
18975	sp|P9WNX9|GABD1_MY	P05091	99.78	54.0	510.0	DB00822	approved	Disulfiram	CCN(CC)C(=S)SSC(=S)N(CC)CC
18976	sp|P9WNX9|GABD1_MY	P05091	99.78	54.0	510.0	DB02115	experimental	Daidzin	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)Oc(c2)ccc(c23)c(=O)c(co3)-c4ccc(O)cc4
18977	sp|P9WNX9|GABD1_MY	P05091	99.78	54.0	510.0	DB04381	experimental	Crotonaldehyde	O=C/C=C/C
18978	sp|P9WNX9|GABD1_MY	P30837	99.78	54.0	510.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
18979	sp|P9WNX9|GABD1_MY	P49189	99.34	31.0	485.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
18980	sp|P9WNX9|GABD1_MY	O75891	100.44	440.0	899.0	DB00116	nutraceutical	Tetrahydrofolic acid	Nc([nH]1)nc(=O)c(c12)NC(CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
18981	sp|P9WNX9|GABD1_MY	P25553	98.91	24.0	476.0	DB03619	approved	Deoxycholic acid	C1C[C@@H](O)C[C@H]([C@]12C)CC[C@@H]3[C@@H]2C[C@H](O)[C@@]4(C)[C@H]3CC[C@@H]4[C@H](C)CCC(=O)O
18982	sp|P9WNX9|GABD1_MY	P51649	99.56	76.0	531.0	DB00139	approved; nutraceutical	Succinic acid	OC(=O)CCC(=O)O
18983	sp|P9WNX9|GABD1_MY	P51649	99.56	76.0	531.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
18984	sp|P9WNX9|GABD1_MY	P51649	99.56	76.0	531.0	DB00313	approved; investigational	Valproic acid	CCCC(C(=O)O)CCC
18985	sp|P9WNX9|GABD1_MY	P51649	99.56	76.0	531.0	DB00534	approved; withdrawn	Chlormerodrin	Cl[Hg]CC(OC)CNC(=O)N
18986	sp|P9WNX9|GABD1_MY	P77674	98.91	20.0	472.0	DB04401	experimental	Betaine aldehyde	C[N+](C)(C)CC=O
18987	sp|P9WNX9|GABD1_MY	P30838	93.44	3.0	430.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
18988	sp|P9WNX9|GABD1_MY	Q59931	98.69	20.0	471.0	DB02263	experimental	Glyceraldehyde-3-Phosphate	O=C[C@H](O)COP(=O)(O)O
18989	sp|P9WNX9|GABD1_MY	Q59931	98.69	20.0	471.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
18990	sp|P9WNX9|GABD1_MY	P83849	99.78	56.0	512.0	DB03564	experimental	(4r)-2-Methylpentane-2,4-Diol	C[C@H](O)CC(C)(C)O
18991	sp|P9WNX9|GABD1_MY	Q02252	99.78	57.0	513.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
18992	sp|P9WNX9|GABD1_MY	P49419	100.22	66.0	524.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
18993	sp|P9WNX9|GABD1_MY	P49419	100.22	66.0	524.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
18994	sp|P9WNX9|GABD1_MY	P51648	91.9	5.0	425.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
18995	sp|P9WNX9|GABD1_MY	P43353	92.34	7.0	429.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
18996	sp|P9WNX9|GABD1_MY	P09546	96.06	662.0	1101.0	DB03051	experimental	(S)-2-Tetrahydrofuroic acid	OC(=O)[C@H]1CCCO1
18997	sp|P9WNX9|GABD1_MY	P09546	96.06	662.0	1101.0	DB03147	approved	Flavin adenine dinucleotide	O=c1[nH]c(=O)nc(c12)n(c3c(n2)cc(C)c(c3)C)C[C@H](O)[C@H](O)[C@H](O)CO[P@@](=O)(O)O[P@](=O)(O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)n5cnc(c56)c(N)ncn6
18998	sp|P9WNX9|GABD1_MY	P09546	96.06	662.0	1101.0	DB04398	approved; vet_approved	Lactic acid	CC(O)C(=O)O
18999	sp|P9WNX9|GABD1_MY	P30038	98.03	86.0	534.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
19000	sp|P9WNX9|GABD1_MY	P48448	73.74	12.0	349.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
19001	sp|P9WNX9|GABD1_MY	P48448	73.74	12.0	349.0	DB09116	approved; withdrawn	Calcium carbimide	[N-]=C=[N-]
19002	sp|P9WNX9|GABD1_MY	Q56694	96.5	11.0	452.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
19003	sp|P9WNB5|FRDD_MYC	P0A8Q3	79.2	5.0	104.0	DB07490	experimental	2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL	Clc1ccc(cc1)[C@@H](C)c2cc([N+]([O-])=O)cc([N+]([O-])=O)c2O
19004	sp|P9WNB5|FRDD_MYC	P0A8Q3	79.2	5.0	104.0	DB07918	experimental	2-heptyl-4-hydroxyquinoline N-oxide	CCCCCCCc(cc1O)[n+]([O-])c(c12)cccc2
19005	sp|P9WNB5|FRDD_MYC	P9WNX3	72.0	7.0	97.0	DB01694	experimental	D-tartaric acid	OC(=O)[C@@H](O)[C@H](O)C(=O)O
19006	sp|P9WPE1|CITEL_MY	P9WPE1	99.63	1.0	273.0	DB01942	experimental; investigational	Formic acid	OC=O
19007	sp|P9WPE1|CITEL_MY	Q9RUZ0	99.27	10.0	281.0	DB02637	experimental	Oxaloacetate Ion	OC(=O)C(=O)CC([O-])=O
19008	sp|P9WPD5|CISY1_MY	Q9LCX9	86.31	4.0	376.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
19009	sp|P9WPD5|CISY1_MY	Q9LCX9	86.31	4.0	376.0	DB04272	approved; nutraceutical; vet_approved	Citric acid	OC(=O)CC(O)(C(=O)O)CC(=O)O
19010	sp|P9WPD5|CISY1_MY	O34002	86.54	4.0	377.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
19011	sp|P9WPD5|CISY1_MY	O34002	86.54	4.0	377.0	DB04272	approved; nutraceutical; vet_approved	Citric acid	OC(=O)CC(O)(C(=O)O)CC(=O)O
19012	sp|P9WPD5|CISY1_MY	O75390	87.94	71.0	450.0	DB01969	experimental	Trifluoroacetonyl coenzyme A	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSCC(=O)C(F)(F)F
19013	sp|P9WPD5|CISY1_MY	O75390	87.94	71.0	450.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
19014	sp|P9WPD5|CISY1_MY	O75390	87.94	71.0	450.0	DB02637	experimental	Oxaloacetate Ion	OC(=O)C(=O)CC([O-])=O
19015	sp|P9WPD5|CISY1_MY	O75390	87.94	71.0	450.0	DB03182	experimental	alpha-Fluoro-carboxymethyldethia coenzyme A complex	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCC[C@@H](F)C(=O)O
19016	sp|P9WPD5|CISY1_MY	O75390	87.94	71.0	450.0	DB03499	experimental	D-Malic acid	OC(=O)[C@H](O)CC(=O)O
19017	sp|P9WPD5|CISY1_MY	O75390	87.94	71.0	450.0	DB04230	experimental	Nitromethyldethia coenzyme A	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCC[N+]([O-])=O
19018	sp|P9WPD5|CISY1_MY	O75390	87.94	71.0	450.0	DB04272	approved; nutraceutical; vet_approved	Citric acid	OC(=O)CC(O)(C(=O)O)CC(=O)O
19019	sp|P9WPP3|CP124_MY	P53554	87.38	20.0	394.0	DB04450	experimental	Heptyl 1-Thiohexopyranoside	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)SCCCCCCC
19020	sp|P9WPP3|CP124_MY	Q83WG3	91.59	17.0	409.0	DB06955	experimental	3,4-bis(7-chloro-1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid	c1ccc(Cl)c(c12)[nH]cc2-c3c(C(=O)O)[nH]c(C(=O)O)c3-c4c[nH]c(c45)c(Cl)ccc5
19021	sp|P9WPP3|CP124_MY	Q83WG3	91.59	17.0	409.0	DB07588	experimental	3,4-DI-1H-INDOL-3-YL-1H-PYRROLE-2,5-DICARBOXYLIC ACID	c1cccc(c12)[nH]cc2-c3c(C(=O)O)[nH]c(C(=O)O)c3-c4c[nH]c(c45)cccc5
19022	sp|P9WPP3|CP124_MY	Q9FCA6	88.32	26.0	404.0	DB02175	experimental	Malonic acid	OC(=O)CC(=O)O
19023	sp|P9WPP3|CP124_MY	Q9FCA6	88.32	26.0	404.0	DB02521	experimental	Flaviolin	Oc1cc(O)cc(c12)C(=O)C(O)=CC2=O
19024	sp|P9WPP3|CP124_MY	Q9FCA6	88.32	26.0	404.0	DB03254	experimental	4-Phenyl-1h-Imidazole	[nH]1cncc1-c2ccccc2
19025	sp|P9WPP3|CP124_MY	Q9FCA6	88.32	26.0	404.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
19026	sp|P9WPP3|CP124_MY	Q00441	89.25	19.0	401.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
19027	sp|P9WPP3|CP124_MY	Q00441	89.25	19.0	401.0	DB03369	experimental	9-Aminophenanthrene	c1cccc(c12)c3c(cc2N)cccc3
19028	sp|P9WPP3|CP124_MY	Q00441	89.25	19.0	401.0	DB04070	experimental	6-Deoxyerythronolide B	C[C@@H]1C[C@H](C)[C@H](O)[C@@H](C)[C@H](O)[C@@H](C)C(=O)O[C@H](CC)[C@H](C)[C@H](O)[C@@H](C)C1=O
19029	sp|P9WPP3|CP124_MY	P9WPN5	87.38	22.0	396.0	DB07705	experimental	(S)-econazole	Clc1ccc(cc1)CO[C@H](Cn2ccnc2)c3c(Cl)cc(Cl)cc3
19030	sp|P9WPP3|CP124_MY	P9WPN5	87.38	22.0	396.0	DB07971	experimental	5-AMINO-2-{4-[(4-AMINOPHENYL)SULFANYL]PHENYL}-1H-ISOINDOLE-1,3(2H)-DIONE	Nc1ccc(cc1)Sc2ccc(cc2)N(C3=O)C(=O)c(c34)ccc(c4)N
19031	sp|P9WPP3|CP124_MY	P9WPN5	87.38	22.0	396.0	DB07972	experimental	1-(3-METHYLPHENYL)-1H-BENZIMIDAZOL-5-AMINE	Cc1cccc(c1)-n2cnc(c23)cc(N)cc3
19032	sp|P9WPP3|CP124_MY	P9WPP7	90.42	9.0	396.0	DB02721	experimental	4-Iodopyrazole	Ic1c[nH]nc1
19033	sp|P9WPP3|CP124_MY	P9WPP7	90.42	9.0	396.0	DB08761	experimental	(3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine-2,5-dione	Oc1ccc(cc1)C[C@@H]2NC(=O)[C@@H](NC2=O)Cc3ccc(O)cc3
19034	sp|P9WPP3|CP124_MY	P00183	81.31	59.0	407.0	DB01011	approved; investigational	Metyrapone	c1ccncc1C(C)(C)C(=O)c2cnccc2
19035	sp|P9WPP3|CP124_MY	P00183	81.31	59.0	407.0	DB01663	experimental	lambda-bis(2,2'-bipyridine)-(5-methyl-2-2'-bipyridine)-C9-adamantane ruthenium (II)	C1=CC=CN2C1=C(C=CC=C3)N3[Ru+2]245(N6C(C=CC=C6)=C7N4C=CC=C7)N8C(=C9N5C=CC(C)=C9)C=C(C=C8)CCCCCCCCC(=O)N[C@@H]([C@H]12)[C@H]3C[C@@H](C1)C[C@@H](C2)C3
19036	sp|P9WPP3|CP124_MY	P00183	81.31	59.0	407.0	DB01703	experimental	N-(2-ferrocenylethyl)maleimide	O=C1C=CC(=O)N1CCC2(C3C4C5C26)[Fe]13456789C2C7C8C9C12
19037	sp|P9WPP3|CP124_MY	P00183	81.31	59.0	407.0	DB01744	approved	Camphor	C[C@]12C(=O)C[C@H](C1(C)C)CC2
19038	sp|P9WPP3|CP124_MY	P00183	81.31	59.0	407.0	DB01826	experimental	N-Butyl Isocyanide	CCCC[N+]#[C-]
19039	sp|P9WPP3|CP124_MY	P00183	81.31	59.0	407.0	DB02125	experimental	Adamantanone	O=C([C@H]12)[C@H]3C[C@@H](C1)C[C@@H](C2)C3
19040	sp|P9WPP3|CP124_MY	P00183	81.31	59.0	407.0	DB02617	experimental	1-(N-Imidazolyl)-2-Hydroxy-2-(2,3-Dichlorophenyl)Octane	CCCCCC[C@](O)(Cn1ccnc1)c2ccc(Cl)cc2Cl
19041	sp|P9WPP3|CP124_MY	P00183	81.31	59.0	407.0	DB02817	experimental	5-Exo-Hydroxycamphor	C[C@]12C[C@@H](O)[C@H](CC1=O)C2(C)C
19042	sp|P9WPP3|CP124_MY	P00183	81.31	59.0	407.0	DB02851	experimental	Thiocamphor	C[C@]12C(=S)C[C@H](C1(C)C)CC2
19043	sp|P9WPP3|CP124_MY	P00183	81.31	59.0	407.0	DB03031	experimental	Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Octyl-Amide	CN(C)c1cccc(c12)c(ccc2)S(=O)(=O)NCCCCCCCCNC(=O)C34CC5CC(C3)CC(C5)C4
19044	sp|P9WPP3|CP124_MY	P00183	81.31	59.0	407.0	DB03540	experimental	Norcamphor	[C@H]12CC[C@H](C1)C(=O)C2
19045	sp|P9WPP3|CP124_MY	P00183	81.31	59.0	407.0	DB03627	experimental	Adamantane	C12CC3CC(C1)CC(C3)C2
19046	sp|P9WPP3|CP124_MY	P00183	81.31	59.0	407.0	DB03836	experimental	1,3,5-trichlorobenzene	Clc1cc(Cl)cc(Cl)c1
19047	sp|P9WPP3|CP124_MY	P00183	81.31	59.0	407.0	DB04032	experimental	Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Butyl-Amide	CN(C)c1cccc(c12)c(ccc2)S(=O)(=O)NCCCCNC(=O)C34CC5CC(C3)CC(C5)C4
19048	sp|P9WPP3|CP124_MY	P00183	81.31	59.0	407.0	DB04501	experimental	Camphane	C[C@@]12CCC(C1(C)C)CC2
19049	sp|P9WPP3|CP124_MY	Q6V0L0	88.79	128.0	508.0	DB00523	approved; investigational	Alitretinoin	OC(=O)/C=C(\C)/C=C/C=C(/C)\C=C\C(C1(C)C)=C(C)CCC1
19050	sp|P9WPP3|CP124_MY	Q6V0L0	88.79	128.0	508.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
19051	sp|P9WPP3|CP124_MY	Q9NR63	83.88	131.0	490.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
19052	sp|P9WPP3|CP124_MY	O43174	87.15	117.0	490.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
19053	sp|P9WPP3|CP124_MY	O43174	87.15	117.0	490.0	DB13083	investigational	Talarozole	c1ncnn1C(C(CC)CC)c2ccc(cc2)Nc(s3)nc(c34)cccc4
19054	sp|P9WPP3|CP124_MY	P08684	83.41	119.0	476.0	DB00143	approved; investigational; nutraceutical	Glutathione	OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(=O)O
19055	sp|P9WPP3|CP124_MY	P08684	83.41	119.0	476.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
19056	sp|P9WPP3|CP124_MY	P08684	83.41	119.0	476.0	DB05478	investigational	Pradefovir mesylate	n1cnc(N)c(c12)ncn2CCOC[P@@]3(=O)OCC[C@H](O3)c4cc(Cl)ccc4
19057	sp|P9WPP3|CP124_MY	P08684	83.41	119.0	476.0	DB06634	investigational	Casopitant	FC(F)(F)c1cc(cc(c1)C(F)(F)F)[C@@H](C)N(C)C(=O)N2CC[C@H](N3CCN(CC3)C(=O)C)C[C@@H]2c4ccc(F)cc4C
19058	sp|P9WPP3|CP124_MY	P08684	83.41	119.0	476.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
19059	sp|P9WPP3|CP124_MY	P20815	83.41	118.0	475.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
19060	sp|P9WPP3|CP124_MY	P20815	83.41	118.0	475.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
19061	sp|P9WPP3|CP124_MY	P20815	83.41	118.0	475.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
19062	sp|P9WPP3|CP124_MY	Q9HB55	84.35	114.0	475.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
19063	sp|P9WPP3|CP124_MY	P10632	79.44	140.0	480.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
19064	sp|P9WPP3|CP124_MY	P10632	79.44	140.0	480.0	DB03796	approved	Palmitic Acid	CCCCCCCCCCCCCCCC(=O)O
19065	sp|P9WPP3|CP124_MY	P10632	79.44	140.0	480.0	DB08607	experimental	(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE	O=C1NC(=O)S[C@@H]1Cc2ccc(cc2)OC[C@@](O3)(C)CCc(c34)c(C)c(O)c(C)c4C
19066	sp|P9WPP3|CP124_MY	P24462	83.64	118.0	476.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
19067	sp|P9WPP3|CP124_MY	P24462	83.64	118.0	476.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
19068	sp|P9WPP3|CP124_MY	P24462	83.64	118.0	476.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
19069	sp|P9WPP3|CP124_MY	P11712	79.21	139.0	478.0	DB03317	experimental	Ferroheme C	[Fe-2]123[N+]4=C5C=C6[N+]1=C(C(C)=C6C(C)S)C=C7[N+]2=C(C(=C7C)CCC(=O)O)C=C8[N+]3=C(C=C4C(=C5C)C(C)S)C(C)=C8CCC(=O)O
19070	sp|P9WPP3|CP124_MY	P11712	79.21	139.0	478.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
19071	sp|P9WPP3|CP124_MY	P11712	79.21	139.0	478.0	DB12319	investigational; withdrawn	Benzbromarone	c1cccc(c12)c(c(o2)CC)C(=O)c3cc(Br)c(O)c(Br)c3
19072	sp|P9WPP3|CP124_MY	P33261	78.04	140.0	474.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
19073	sp|P9WPP3|CP124_MY	P33261	78.04	140.0	474.0	DB12319	investigational; withdrawn	Benzbromarone	c1cccc(c12)c(c(o2)CC)C(=O)c3cc(Br)c(O)c(Br)c3
19074	sp|P9WPP3|CP124_MY	P33260	75.0	140.0	461.0	DB07670	experimental	N,4-Dimethyl-N-(1-phenyl-1H-pyrazol-5-yl)benzenesulfonamide	Cc1ccc(cc1)S(=O)(=O)N(C)c2ccnn2-c3ccccc3
19075	sp|P9WPP3|CP124_MY	P20813	77.57	133.0	465.0	DB02974	experimental	4-(4-Chlorophenyl)Imidazole	Clc1ccc(cc1)-c2cnc[nH]2
19076	sp|P9WPP3|CP124_MY	P20813	77.57	133.0	465.0	DB04664	experimental	Cyclohexyl-pentyl-maltoside	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@@H]2CO)OCCCCCC3CCCCC3
19077	sp|P9WPP3|CP124_MY	P20813	77.57	133.0	465.0	DB04794	approved; investigational	Bifonazole	c1ccccc1C(n2ccnc2)c3ccc(cc3)-c4ccccc4
19078	sp|P9WPP3|CP124_MY	P20813	77.57	133.0	465.0	DB08369	experimental	1-(biphenyl-4-ylmethyl)-1H-imidazole	c1cncn1Cc2ccc(cc2)-c3ccccc3
19079	sp|P9WPP3|CP124_MY	O15528	84.35	135.0	496.0	DB01436	approved; nutraceutical	Alfacalcidol	CC(C)CCC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)/C(CCC2)=C/C=C3/C[C@@H](O)C[C@H](O)C3=C
19080	sp|P9WPP3|CP124_MY	O31440	80.84	46.0	392.0	DB04257	experimental	Palmitoleic Acid	CCCCCC/C=C\CCCCCCCC(=O)O
19081	sp|P9WPP3|CP124_MY	P14779	79.91	105.0	447.0	DB03440	experimental	N-hexadecanoylglycine	CCCCCCCCCCCCCCCC(=O)NCC(=O)O
19082	sp|P9WPP3|CP124_MY	P14779	79.91	105.0	447.0	DB04257	experimental	Palmitoleic Acid	CCCCCC/C=C\CCCCCCCC(=O)O
19083	sp|P9WPP3|CP124_MY	P14779	79.91	105.0	447.0	DB08086	experimental	N-[12-(1H-imidazol-1-yl)dodecanoyl]-L-leucine	CC(C)C[C@@H](C(=O)O)NC(=O)CCCCCCCCCCCn1ccnc1
19084	sp|P9WPP3|CP124_MY	P08686	74.53	133.0	452.0	DB01026	approved; investigational	Ketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OCC(CO3)OC3(Cn4ccnc4)c5ccc(Cl)cc5Cl
19085	sp|P9WPP3|CP124_MY	P11511	88.79	89.0	469.0	DB00184	approved	Nicotine	CN1CCC[C@H]1c2cnccc2
19086	sp|P9WPP3|CP124_MY	P11511	88.79	89.0	469.0	DB00357	approved; investigational	Aminoglutethimide	Nc1ccc(cc1)C2(CC)CCC(=O)NC2=O
19087	sp|P9WPP3|CP124_MY	P11511	88.79	89.0	469.0	DB00655	approved	Estrone	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)cc4
19088	sp|P9WPP3|CP124_MY	P11511	88.79	89.0	469.0	DB00894	approved; investigational	Testolactone	C1=CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2CC[C@@]4(C)[C@H]3CCC(O4)=O
19089	sp|P9WPP3|CP124_MY	P11511	88.79	89.0	469.0	DB00990	approved; investigational	Exemestane	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(C(C3)=C)=CC(=O)C=C4
19090	sp|P9WPP3|CP124_MY	P11511	88.79	89.0	469.0	DB01006	approved; investigational	Letrozole	N#Cc1ccc(cc1)C(n2cncn2)c3ccc(C#N)cc3
19091	sp|P9WPP3|CP124_MY	P11511	88.79	89.0	469.0	DB01217	approved; investigational	Anastrozole	N#CC(C)(C)c1cc(C(C)(C)C#N)cc(c1)Cn2cncn2
19092	sp|P9WPP3|CP124_MY	P11511	88.79	89.0	469.0	DB02342	investigational	2-Methoxyestradiol	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)c(c4)OC
19093	sp|P9WPP3|CP124_MY	P11511	88.79	89.0	469.0	DB03467	experimental	Naringenin	Oc1ccc(cc1)[C@@H](O2)CC(=O)c(c23)c(O)cc(c3)O
19094	sp|P9WPP3|CP124_MY	P11511	88.79	89.0	469.0	DB04539	experimental	Glyphosate	OC(=O)C[NH2+]CP(=O)(O)O
19095	sp|P9WPP3|CP124_MY	P11511	88.79	89.0	469.0	DB05749	investigational	MPI-674	 
19096	sp|P9WQ35|CYA1_MYC	Q08462	89.39	49.0	445.0	DB02587	experimental; investigational	Colforsin	O[C@H]1CCC(C)(C)[C@@H]([C@]12C)[C@H](O)[C@H](OC(=O)C)[C@]3(C)[C@]2(O)C(=O)C[C@](O3)(C)C=C
19097	sp|P9WQ35|CYA1_MYC	Q08462	89.39	49.0	445.0	DB06843	experimental	2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE	OP(=O)(O)O[C@H]1C[C@@H](O[C@@H]1C)n2cnc(c23)c(N)ncn3
19098	sp|P9WQ35|CYA1_MYC	Q08462	89.39	49.0	445.0	DB09121	approved; withdrawn	Aurothioglucose	OC[C@H]1O[C@H](S[Au])[C@H](O)[C@@H](O)[C@@H]1O
19099	sp|P9WQ35|CYA1_MYC	Q08828	79.68	102.0	455.0	DB00131	approved; investigational; nutraceutical	Adenosine phosphate	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
19100	sp|P9WQ35|CYA1_MYC	Q08828	79.68	102.0	455.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
19101	sp|P9WQ35|CYA1_MYC	Q08828	79.68	102.0	455.0	DB09121	approved; withdrawn	Aurothioglucose	OC[C@H]1O[C@H](S[Au])[C@H](O)[C@@H](O)[C@@H]1O
19102	sp|P9WQ35|CYA1_MYC	O95622	71.33	940.0	1256.0	DB02587	experimental; investigational	Colforsin	O[C@H]1CCC(C)(C)[C@@H]([C@]12C)[C@H](O)[C@H](OC(=O)C)[C@]3(C)[C@]2(O)C(=O)C[C@](O3)(C)C=C
19103	sp|P9WQ35|CYA1_MYC	O95622	71.33	940.0	1256.0	DB06843	experimental	2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE	OP(=O)(O)O[C@H]1C[C@@H](O[C@@H]1C)n2cnc(c23)c(N)ncn3
19104	sp|P9WQ35|CYA1_MYC	O95622	71.33	940.0	1256.0	DB09121	approved; withdrawn	Aurothioglucose	OC[C@H]1O[C@H](S[Au])[C@H](O)[C@@H](O)[C@@H]1O
19105	sp|P9WND1|DHPS1_MY	P9WND1	99.64	1.0	280.0	DB03592	experimental	Pterin-6-Yl-Methyl-Monophosphate	O=c1[nH]c(N)nc(c12)ncc(n2)COP(=O)(O)O
19106	sp|P9WND1|DHPS1_MY	P0C0X1	97.14	1.0	273.0	DB00250	approved; investigational	Dapsone	Nc1ccc(cc1)S(=O)(=O)c2ccc(N)cc2
19107	sp|P9WND1|DHPS1_MY	P0AC13	95.71	12.0	280.0	DB00259	approved	Sulfanilamide	Nc1ccc(cc1)S(=O)(=O)N
19108	sp|P9WND1|DHPS1_MY	P0AC13	95.71	12.0	280.0	DB00263	approved; vet_approved	Sulfisoxazole	Cc1noc(c1C)NS(=O)(=O)c2ccc(N)cc2
19109	sp|P9WND1|DHPS1_MY	P0AC13	95.71	12.0	280.0	DB00576	approved; investigational; vet_approved	Sulfamethizole	Cc1nnc(s1)NS(=O)(=O)c2ccc(N)cc2
19110	sp|P9WND1|DHPS1_MY	P0AC13	95.71	12.0	280.0	DB00634	approved	Sulfacetamide	CC(=O)NS(=O)(=O)c1ccc(N)cc1
19111	sp|P9WND1|DHPS1_MY	P0AC13	95.71	12.0	280.0	DB01015	approved	Sulfamethoxazole	Cc1cc(no1)NS(=O)(=O)c2ccc(N)cc2
19112	sp|P9WND1|DHPS1_MY	P0AC13	95.71	12.0	280.0	DB01298	approved	Sulfacytine	CCn1ccc(nc1=O)NS(=O)(=O)c2ccc(N)cc2
19113	sp|P9WND1|DHPS1_MY	P0AC13	95.71	12.0	280.0	DB01581	approved; vet_approved	Sulfamerazine	Cc1nc(ncc1)NS(=O)(=O)c2ccc(N)cc2
19114	sp|P9WND1|DHPS1_MY	P0AC13	95.71	12.0	280.0	DB01582	approved; investigational; vet_approved	Sulfamethazine	Cc1cc(C)nc(n1)NS(=O)(=O)c2ccc(N)cc2
19115	sp|P9WND1|DHPS1_MY	P0AC13	95.71	12.0	280.0	DB06729	approved	Sulfaphenazole	Nc1ccc(cc1)S(=O)(=O)Nc2ccnn2-c3ccccc3
19116	sp|P9WND1|DHPS1_MY	P0AC13	95.71	12.0	280.0	DB06821	approved	Sulfameter	COc1cnc(nc1)NS(=O)(=O)c2ccc(N)cc2
19117	sp|P9WND1|DHPS1_MY	P0AC13	95.71	12.0	280.0	DB14033	approved; vet_approved	Acetyl sulfisoxazole	Cc1noc(c1C)N(C(=O)C)S(=O)(=O)c2ccc(N)cc2
19118	sp|P9WND1|DHPS1_MY	Q81VW8	90.71	22.0	276.0	DB03592	experimental	Pterin-6-Yl-Methyl-Monophosphate	O=c1[nH]c(N)nc(c12)ncc(n2)COP(=O)(O)O
19119	sp|P9WND1|DHPS1_MY	Q81VW8	90.71	22.0	276.0	DB03705	experimental	6-Methylamino-5-Nitroisocytosine	CNc1c([N+]([O-])=O)c(=O)[nH]c(n1)N
19120	sp|P9WND1|DHPS1_MY	Q81VW8	90.71	22.0	276.0	DB04047	experimental	6-hydroxymethylpterin diphosphate	Nc([nH]1)nc(=O)c(c12)nc(cn2)COP(=O)(O)OP(=O)(O)O
19121	sp|P9WND1|DHPS1_MY	Q81VW8	90.71	22.0	276.0	DB04196	experimental	Pteroic acid	O=c1[nH]c(N)nc(c12)ncc(n2)CNc3ccc(cc3)C(=O)O
19122	sp|P9WND1|DHPS1_MY	Q49184	95.36	2.0	269.0	DB00891	approved	Sulfapyridine	Nc1ccc(cc1)S(=O)(=O)Nc2ccccn2
19123	sp|P9WND1|DHPS1_MY	P0C002	93.93	2.0	265.0	DB00634	approved	Sulfacetamide	CC(=O)NS(=O)(=O)c1ccc(N)cc1
19124	sp|P9WND1|DHPS1_MY	Q27738	85.71	52.0	292.0	DB00359	approved; investigational; vet_approved	Sulfadiazine	Nc1ccc(cc1)S(=O)(=O)Nc2ncccn2
19125	sp|P9WND1|DHPS1_MY	Q27738	85.71	52.0	292.0	DB00664	approved; withdrawn	Sulfametopyrazine	COc1nccnc1NS(=O)(=O)c2ccc(N)cc2
19126	sp|P9WND1|DHPS1_MY	Q27738	85.71	52.0	292.0	DB01145	approved	Sulfoxone	OS(=O)CNc1ccc(cc1)S(=O)(=O)c2ccc(cc2)NCS(=O)O
19127	sp|P9WND1|DHPS1_MY	Q27738	85.71	52.0	292.0	DB01299	approved; investigational	Sulfadoxine	COc1ncnc(c1OC)NS(=O)(=O)c2ccc(N)cc2
19128	sp|P9WND1|DHPS1_MY	Q27738	85.71	52.0	292.0	DB06147	approved; vet_approved	Sulfathiazole	Nc1ccc(cc1)S(=O)(=O)Nc2nccs2
19129	sp|P9WND1|DHPS1_MY	Q27738	85.71	52.0	292.0	DB08798	experimental	Sulfamoxole	Cc1c(C)nc(o1)NS(=O)(=O)c2ccc(N)cc2
19130	sp|P9WND1|DHPS1_MY	P0C0X2	95.71	13.0	281.0	DB00250	approved; investigational	Dapsone	Nc1ccc(cc1)S(=O)(=O)c2ccc(N)cc2
19131	sp|P9WNT9|DPO3X_MY	P06710	73.36	6.0	430.0	DB02930	experimental	Adenosine 5'-[gamma-thio]triphosphate	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=S)(O)O
19132	sp|P9WN73|G6PD2_MY	P11413	91.25	34.0	503.0	DB03085	approved; investigational	Glycolic acid	OCC(=O)O
19133	sp|P9WN73|G6PD2_MY	P11413	91.25	34.0	503.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
19134	sp|P9WN73|G6PD2_MY	P11413	91.25	34.0	503.0	DB05107	investigational	16-Bromoepiandrosterone	O=C1[C@H](Br)C[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)C[C@@H](O)CC4
19135	sp|P9WN73|G6PD2_MY	P11413	91.25	34.0	503.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
19136	sp|P9WN73|G6PD2_MY	P11411	92.02	9.0	482.0	DB02338	experimental	NADPH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
19137	sp|P9WN73|G6PD2_MY	P11411	92.02	9.0	482.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
19138	sp|P9WN73|G6PD2_MY	P11411	92.02	9.0	482.0	DB04122	experimental	beta-D-glucose 6-phosphate	O[C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@H]1O)COP(=O)(O)O
19139	sp|P9WN73|G6PD2_MY	O95479	70.23	20.0	381.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
19140	sp|P9WPU5|ATPB_MYC	P06576	97.74	49.0	524.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
19141	sp|P9WPU5|ATPB_MYC	P06576	97.74	49.0	524.0	DB07384	experimental	1-ACETYL-2-CARBOXYPIPERIDINE	OC(=O)[C@@H]1CCCCN1C(=O)C
19142	sp|P9WPU5|ATPB_MYC	P06576	97.74	49.0	524.0	DB07394	experimental	AUROVERTIN B	C[C@@]12O[C@H](CC)[C@@](C)([C@H]1OC(=O)C)O[C@H]([C@@H]2O)/C=C/C=C/C=C/c3c(C)c(OC)cc(=O)o3
19143	sp|P9WPU5|ATPB_MYC	P06576	97.74	49.0	524.0	DB08399	experimental	Piceatannol	Oc1cc(cc(O)c1)/C=C/c2ccc(O)c(O)c2
19144	sp|P9WPU5|ATPB_MYC	P06576	97.74	49.0	524.0	DB08629	experimental	N1-(2-AMINO-4-METHYLPENTYL)OCTAHYDRO-PYRROLO[1,2-A] PYRIMIDINE	CC(C)C[C@H](N)CN1CCCN([C@H]12)CCC2
19145	sp|P9WPU5|ATPB_MYC	P06576	97.74	49.0	524.0	DB12695	investigational	Phenethyl Isothiocyanate	S=C=NCCc1ccccc1
19146	sp|P9WPU5|ATPB_MYC	P21281	88.07	45.0	473.0	DB05260	approved; investigational	Gallium nitrate	[O-][N+]([O-])=O
19147	sp|P9WPU5|ATPB_MYC	P21281	88.07	45.0	473.0	DB07347	experimental	4-(2-Aminoethyl)Benzenesulfonyl Fluoride	NCCc1ccc(S(F)(=O)=O)cc1
19148	sp|P9WPU5|ATPB_MYC	P21281	88.07	45.0	473.0	DB01133	approved; investigational; vet_approved	Tiludronic acid	OP(=O)(O)C(P(=O)(O)O)Sc1ccc(Cl)cc1
19149	sp|P9WPU5|ATPB_MYC	P38606	73.46	194.0	551.0	DB00630	approved	Alendronic acid	NCCCC(O)(P(=O)(O)O)P(=O)(O)O
19150	sp|P9WPU5|ATPB_MYC	P38606	73.46	194.0	551.0	DB01077	approved	Etidronic acid	OP(=O)(O)C(C)(O)P(=O)(O)O
19151	sp|P9WPU5|ATPB_MYC	P38606	73.46	194.0	551.0	DB06733	experimental	Bafilomycin A1	CO[C@H]1/C=C/C=C(\C)C[C@H](C)[C@H](O)[C@H](C)/C=C(\C)/C=C(\OC)C(=O)O[C@@H]1[C@@H](C)[C@@H](O)[C@H](C)[C@@]2(O)C[C@@H](O)[C@H](C)[C@H](O2)C(C)C
19152	sp|P9WPU5|ATPB_MYC	P38606	73.46	194.0	551.0	DB06734	experimental	Bafilomycin B1	CO[C@H]1/C=C\C=C(\C)C[C@H](C)[C@H](O)[C@H](C)/C=C(/C)\C=C(\OC)C(=O)OC1[C@@H](C)[C@@H](O)[C@H](C)[C@@]2(O)C[C@H]([C@H](C)[C@H](O2)C(C)C)OC(=O)/C=C/C(=O)NC3=C(O)CCC3=O
19153	sp|P9WPU5|ATPB_MYC	P38606	73.46	194.0	551.0	DB01133	approved; investigational; vet_approved	Tiludronic acid	OP(=O)(O)C(P(=O)(O)O)Sc1ccc(Cl)cc1
19154	sp|P9WPU5|ATPB_MYC	P15313	88.27	39.0	468.0	DB01133	approved; investigational; vet_approved	Tiludronic acid	OP(=O)(O)C(P(=O)(O)O)Sc1ccc(Cl)cc1
19155	sp|P9WPU5|ATPB_MYC	Q76NM6	70.99	200.0	545.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
19156	sp|P9WPU5|ATPB_MYC	P25705	79.01	100.0	484.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
19157	sp|P9WPU5|ATPB_MYC	P25705	79.01	100.0	484.0	DB07384	experimental	1-ACETYL-2-CARBOXYPIPERIDINE	OC(=O)[C@@H]1CCCCN1C(=O)C
19158	sp|P9WPU5|ATPB_MYC	P25705	79.01	100.0	484.0	DB07394	experimental	AUROVERTIN B	C[C@@]12O[C@H](CC)[C@@](C)([C@H]1OC(=O)C)O[C@H]([C@@H]2O)/C=C/C=C/C=C/c3c(C)c(OC)cc(=O)o3
19159	sp|P9WPU5|ATPB_MYC	P25705	79.01	100.0	484.0	DB08399	experimental	Piceatannol	Oc1cc(cc(O)c1)/C=C/c2ccc(O)c(O)c2
19160	sp|P9WPU5|ATPB_MYC	P25705	79.01	100.0	484.0	DB08629	experimental	N1-(2-AMINO-4-METHYLPENTYL)OCTAHYDRO-PYRROLO[1,2-A] PYRIMIDINE	CC(C)C[C@H](N)CN1CCCN([C@H]12)CCC2
19161	sp|P9WPU5|ATPB_MYC	P25705	79.01	100.0	484.0	DB11638	experimental; investigational	Artenimol	[C@]123[C@H]4CC[C@@H](C)[C@@H]1CC[C@@](C)(OO2)O[C@H]3OC(O)[C@@H]4C
19162	sp|P9WPN5|CP130_MY	P9WPN5	99.75	1.0	405.0	DB07705	experimental	(S)-econazole	Clc1ccc(cc1)CO[C@H](Cn2ccnc2)c3c(Cl)cc(Cl)cc3
19163	sp|P9WPN5|CP130_MY	P9WPN5	99.75	1.0	405.0	DB07971	experimental	5-AMINO-2-{4-[(4-AMINOPHENYL)SULFANYL]PHENYL}-1H-ISOINDOLE-1,3(2H)-DIONE	Nc1ccc(cc1)Sc2ccc(cc2)N(C3=O)C(=O)c(c34)ccc(c4)N
19164	sp|P9WPN5|CP130_MY	P9WPN5	99.75	1.0	405.0	DB07972	experimental	1-(3-METHYLPHENYL)-1H-BENZIMIDAZOL-5-AMINE	Cc1cccc(c1)-n2cnc(c23)cc(N)cc3
19165	sp|P9WPN5|CP130_MY	P53554	95.56	5.0	392.0	DB04450	experimental	Heptyl 1-Thiohexopyranoside	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)SCCCCCCC
19166	sp|P9WPN5|CP130_MY	Q00441	97.78	6.0	402.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
19167	sp|P9WPN5|CP130_MY	Q00441	97.78	6.0	402.0	DB03369	experimental	9-Aminophenanthrene	c1cccc(c12)c3c(cc2N)cccc3
19168	sp|P9WPN5|CP130_MY	Q00441	97.78	6.0	402.0	DB04070	experimental	6-Deoxyerythronolide B	C[C@@H]1C[C@H](C)[C@H](O)[C@@H](C)[C@H](O)[C@@H](C)C(=O)O[C@H](CC)[C@H](C)[C@H](O)[C@@H](C)C1=O
19169	sp|P9WPN5|CP130_MY	Q83WG3	96.3	19.0	409.0	DB06955	experimental	3,4-bis(7-chloro-1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid	c1ccc(Cl)c(c12)[nH]cc2-c3c(C(=O)O)[nH]c(C(=O)O)c3-c4c[nH]c(c45)c(Cl)ccc5
19170	sp|P9WPN5|CP130_MY	Q83WG3	96.3	19.0	409.0	DB07588	experimental	3,4-DI-1H-INDOL-3-YL-1H-PYRROLE-2,5-DICARBOXYLIC ACID	c1cccc(c12)[nH]cc2-c3c(C(=O)O)[nH]c(C(=O)O)c3-c4c[nH]c(c45)cccc5
19171	sp|P9WPN5|CP130_MY	Q9FCA6	92.35	28.0	402.0	DB02175	experimental	Malonic acid	OC(=O)CC(=O)O
19172	sp|P9WPN5|CP130_MY	Q9FCA6	92.35	28.0	402.0	DB02521	experimental	Flaviolin	Oc1cc(O)cc(c12)C(=O)C(O)=CC2=O
19173	sp|P9WPN5|CP130_MY	Q9FCA6	92.35	28.0	402.0	DB03254	experimental	4-Phenyl-1h-Imidazole	[nH]1cncc1-c2ccccc2
19174	sp|P9WPN5|CP130_MY	Q9FCA6	92.35	28.0	402.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
19175	sp|P9WPN5|CP130_MY	P00183	84.69	62.0	405.0	DB01011	approved; investigational	Metyrapone	c1ccncc1C(C)(C)C(=O)c2cnccc2
19176	sp|P9WPN5|CP130_MY	P00183	84.69	62.0	405.0	DB01663	experimental	lambda-bis(2,2'-bipyridine)-(5-methyl-2-2'-bipyridine)-C9-adamantane ruthenium (II)	C1=CC=CN2C1=C(C=CC=C3)N3[Ru+2]245(N6C(C=CC=C6)=C7N4C=CC=C7)N8C(=C9N5C=CC(C)=C9)C=C(C=C8)CCCCCCCCC(=O)N[C@@H]([C@H]12)[C@H]3C[C@@H](C1)C[C@@H](C2)C3
19177	sp|P9WPN5|CP130_MY	P00183	84.69	62.0	405.0	DB01703	experimental	N-(2-ferrocenylethyl)maleimide	O=C1C=CC(=O)N1CCC2(C3C4C5C26)[Fe]13456789C2C7C8C9C12
19178	sp|P9WPN5|CP130_MY	P00183	84.69	62.0	405.0	DB01744	approved	Camphor	C[C@]12C(=O)C[C@H](C1(C)C)CC2
19179	sp|P9WPN5|CP130_MY	P00183	84.69	62.0	405.0	DB01826	experimental	N-Butyl Isocyanide	CCCC[N+]#[C-]
19180	sp|P9WPN5|CP130_MY	P00183	84.69	62.0	405.0	DB02125	experimental	Adamantanone	O=C([C@H]12)[C@H]3C[C@@H](C1)C[C@@H](C2)C3
19181	sp|P9WPN5|CP130_MY	P00183	84.69	62.0	405.0	DB02617	experimental	1-(N-Imidazolyl)-2-Hydroxy-2-(2,3-Dichlorophenyl)Octane	CCCCCC[C@](O)(Cn1ccnc1)c2ccc(Cl)cc2Cl
19182	sp|P9WPN5|CP130_MY	P00183	84.69	62.0	405.0	DB02817	experimental	5-Exo-Hydroxycamphor	C[C@]12C[C@@H](O)[C@H](CC1=O)C2(C)C
19183	sp|P9WPN5|CP130_MY	P00183	84.69	62.0	405.0	DB02851	experimental	Thiocamphor	C[C@]12C(=S)C[C@H](C1(C)C)CC2
19184	sp|P9WPN5|CP130_MY	P00183	84.69	62.0	405.0	DB03031	experimental	Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Octyl-Amide	CN(C)c1cccc(c12)c(ccc2)S(=O)(=O)NCCCCCCCCNC(=O)C34CC5CC(C3)CC(C5)C4
19185	sp|P9WPN5|CP130_MY	P00183	84.69	62.0	405.0	DB03540	experimental	Norcamphor	[C@H]12CC[C@H](C1)C(=O)C2
19186	sp|P9WPN5|CP130_MY	P00183	84.69	62.0	405.0	DB03627	experimental	Adamantane	C12CC3CC(C1)CC(C3)C2
19187	sp|P9WPN5|CP130_MY	P00183	84.69	62.0	405.0	DB03836	experimental	1,3,5-trichlorobenzene	Clc1cc(Cl)cc(Cl)c1
19188	sp|P9WPN5|CP130_MY	P00183	84.69	62.0	405.0	DB04032	experimental	Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Butyl-Amide	CN(C)c1cccc(c12)c(ccc2)S(=O)(=O)NCCCCNC(=O)C34CC5CC(C3)CC(C5)C4
19189	sp|P9WPN5|CP130_MY	P00183	84.69	62.0	405.0	DB04501	experimental	Camphane	C[C@@]12CCC(C1(C)C)CC2
19190	sp|P9WPN5|CP130_MY	P9WPP7	91.6	23.0	394.0	DB02721	experimental	4-Iodopyrazole	Ic1c[nH]nc1
19191	sp|P9WPN5|CP130_MY	P9WPP7	91.6	23.0	394.0	DB08761	experimental	(3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine-2,5-dione	Oc1ccc(cc1)C[C@@H]2NC(=O)[C@@H](NC2=O)Cc3ccc(O)cc3
19192	sp|P9WPN5|CP130_MY	Q9NR63	81.98	136.0	468.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
19193	sp|P9WPN5|CP130_MY	Q6V0L0	85.93	137.0	485.0	DB00523	approved; investigational	Alitretinoin	OC(=O)/C=C(\C)/C=C/C=C(/C)\C=C\C(C1(C)C)=C(C)CCC1
19194	sp|P9WPN5|CP130_MY	Q6V0L0	85.93	137.0	485.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
19195	sp|P9WPN5|CP130_MY	P20813	84.69	126.0	469.0	DB02974	experimental	4-(4-Chlorophenyl)Imidazole	Clc1ccc(cc1)-c2cnc[nH]2
19196	sp|P9WPN5|CP130_MY	P20813	84.69	126.0	469.0	DB04664	experimental	Cyclohexyl-pentyl-maltoside	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@@H]2CO)OCCCCCC3CCCCC3
19197	sp|P9WPN5|CP130_MY	P20813	84.69	126.0	469.0	DB04794	approved; investigational	Bifonazole	c1ccccc1C(n2ccnc2)c3ccc(cc3)-c4ccccc4
19198	sp|P9WPN5|CP130_MY	P20813	84.69	126.0	469.0	DB08369	experimental	1-(biphenyl-4-ylmethyl)-1H-imidazole	c1cncn1Cc2ccc(cc2)-c3ccccc3
19199	sp|P9WPN5|CP130_MY	O31440	86.17	46.0	395.0	DB04257	experimental	Palmitoleic Acid	CCCCCC/C=C\CCCCCCCC(=O)O
19200	sp|P9WPN5|CP130_MY	P11712	82.96	124.0	460.0	DB03317	experimental	Ferroheme C	[Fe-2]123[N+]4=C5C=C6[N+]1=C(C(C)=C6C(C)S)C=C7[N+]2=C(C(=C7C)CCC(=O)O)C=C8[N+]3=C(C=C4C(=C5C)C(C)S)C(C)=C8CCC(=O)O
19201	sp|P9WPN5|CP130_MY	P11712	82.96	124.0	460.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
19202	sp|P9WPN5|CP130_MY	P11712	82.96	124.0	460.0	DB12319	investigational; withdrawn	Benzbromarone	c1cccc(c12)c(c(o2)CC)C(=O)c3cc(Br)c(O)c(Br)c3
19203	sp|P9WPN5|CP130_MY	P10632	86.91	128.0	480.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
19204	sp|P9WPN5|CP130_MY	P10632	86.91	128.0	480.0	DB03796	approved	Palmitic Acid	CCCCCCCCCCCCCCCC(=O)O
19205	sp|P9WPN5|CP130_MY	P10632	86.91	128.0	480.0	DB08607	experimental	(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE	O=C1NC(=O)S[C@@H]1Cc2ccc(cc2)OC[C@@](O3)(C)CCc(c34)c(C)c(O)c(C)c4C
19206	sp|P9WPN5|CP130_MY	P08684	83.7	125.0	464.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
19207	sp|P9WPN5|CP130_MY	P08684	83.7	125.0	464.0	DB00143	approved; investigational; nutraceutical	Glutathione	OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(=O)O
19208	sp|P9WPN5|CP130_MY	P08684	83.7	125.0	464.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
19209	sp|P9WPN5|CP130_MY	P08684	83.7	125.0	464.0	DB05478	investigational	Pradefovir mesylate	n1cnc(N)c(c12)ncn2CCOC[P@@]3(=O)OCC[C@H](O3)c4cc(Cl)ccc4
19210	sp|P9WPN5|CP130_MY	P08684	83.7	125.0	464.0	DB06634	investigational	Casopitant	FC(F)(F)c1cc(cc(c1)C(F)(F)F)[C@@H](C)N(C)C(=O)N2CC[C@H](N3CCN(CC3)C(=O)C)C[C@@H]2c4ccc(F)cc4C
19211	sp|P9WPN5|CP130_MY	P33261	82.47	125.0	459.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
19212	sp|P9WPN5|CP130_MY	P33261	82.47	125.0	459.0	DB12319	investigational; withdrawn	Benzbromarone	c1cccc(c12)c(c(o2)CC)C(=O)c3cc(Br)c(O)c(Br)c3
19213	sp|P9WPN5|CP130_MY	P20815	83.46	125.0	463.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
19214	sp|P9WPN5|CP130_MY	P20815	83.46	125.0	463.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
19215	sp|P9WPN5|CP130_MY	P20815	83.46	125.0	463.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
19216	sp|P9WPN5|CP130_MY	P33260	81.98	125.0	457.0	DB07670	experimental	N,4-Dimethyl-N-(1-phenyl-1H-pyrazol-5-yl)benzenesulfonamide	Cc1ccc(cc1)S(=O)(=O)N(C)c2ccnn2-c3ccccc3
19217	sp|P9WPN5|CP130_MY	O43174	89.14	130.0	491.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
19218	sp|P9WPN5|CP130_MY	O43174	89.14	130.0	491.0	DB13083	investigational	Talarozole	c1ncnn1C(C(CC)CC)c2ccc(cc2)Nc(s3)nc(c34)cccc4
19219	sp|P9WPN5|CP130_MY	P24462	84.69	121.0	464.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
19220	sp|P9WPN5|CP130_MY	P24462	84.69	121.0	464.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
19221	sp|P9WPN5|CP130_MY	P24462	84.69	121.0	464.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
19222	sp|P9WPN5|CP130_MY	P11509	97.53	66.0	461.0	DB04665	experimental	Coumarin	c1cc(=O)oc(c12)cccc2
19223	sp|P9WPN5|CP130_MY	P11509	97.53	66.0	461.0	DB07609	experimental	N,N-DIMETHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	CN(C)Cc1ccc(o1)-c2cccnc2
19224	sp|P9WPN5|CP130_MY	P11509	97.53	66.0	461.0	DB07617	experimental	N-METHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	CNCc1ccc(o1)-c2cccnc2
19225	sp|P9WPN5|CP130_MY	P11509	97.53	66.0	461.0	DB07621	experimental	(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	NCc1ccc(o1)-c2cccnc2
19226	sp|P9WPN5|CP130_MY	P11509	97.53	66.0	461.0	DB07623	experimental	4,4'-DIPYRIDYL DISULFIDE	c1cnccc1SSc2ccncc2
19227	sp|P9WPN5|CP130_MY	Q9HB55	84.44	122.0	464.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
19228	sp|P9WPN5|CP130_MY	Q16850	80.25	151.0	476.0	DB01007	approved	Tioconazole	c1nccn1CC(c(c(Cl)c2)ccc2Cl)OCc3c(Cl)scc3
19229	sp|P9WPN5|CP130_MY	Q16850	80.25	151.0	476.0	DB01167	approved; investigational	Itraconazole	CCC(C)n1ncn(c1=O)-c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@@H](CO5)O[C@@]5(Cn6cncn6)c7ccc(Cl)cc7Cl
19230	sp|P9WPN5|CP130_MY	Q16850	80.25	151.0	476.0	DB05667	investigational	Levoketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OC[C@H](CO3)O[C@]3(Cn4ccnc4)c5ccc(Cl)cc5Cl
19231	sp|P9WPN5|CP130_MY	Q16850	80.25	151.0	476.0	DB07705	experimental	(S)-econazole	Clc1ccc(cc1)CO[C@H](Cn2ccnc2)c3c(Cl)cc(Cl)cc3
19232	sp|P9WPN5|CP130_MY	P05181	93.83	79.0	459.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
19233	sp|P9WPN5|CP130_MY	P10614	83.46	148.0	486.0	DB06890	experimental	(2R)-2-PHENYL-N-PYRIDIN-4-YLBUTANAMIDE	c1ccccc1[C@@H](CC)C(=O)Nc2ccncc2
19234	sp|P9WPN5|CP130_MY	P10614	83.46	148.0	486.0	DB07560	experimental	N-[(1S)-2-methyl-1-(pyridin-4-ylcarbamoyl)propyl]cyclohexanecarboxamide	c1cnccc1NC(=O)[C@H](C(C)C)NC(=O)C2CCCCC2
19235	sp|P9WPN5|CP130_MY	P10614	83.46	148.0	486.0	DB07568	experimental	(2S)-2-[(2,1,3-BENZOTHIADIAZOL-4-YLSULFONYL)AMINO]-2-PHENYL-N-PYRIDIN-4-YLACETAMIDE	n1snc(c12)cccc2S(=O)(=O)N[C@@H](c3ccccc3)C(=O)Nc4ccncc4
19236	sp|P9WPN5|CP130_MY	P10614	83.46	148.0	486.0	DB07569	experimental	CIS-4-METHYL-N-[(1S)-3-(METHYLSULFANYL)-1-(PYRIDIN-4-YLCARBAMOYL)PROPYL]CYCLOHEXANECARBOXAMIDE	c1cnccc1NC(=O)[C@H](CCSC)NC(=O)[C@@H]2CC[C@H](C)CC2
19237	sp|P9WPN5|CP130_MY	P10614	83.46	148.0	486.0	DB07572	experimental	3-{[(4-methylphenyl)sulfonyl]amino}propyl pyridin-4-ylcarbamate	Cc1ccc(cc1)S(=O)(=O)NCCCOC(=O)Nc2ccncc2
19238	sp|P9WPN5|CP130_MY	P10614	83.46	148.0	486.0	DB07635	experimental	4,4'-Dihydroxybenzophenone	Oc1ccc(cc1)C(=O)c2ccc(O)cc2
19239	sp|P9WPN5|CP130_MY	P50859	87.16	137.0	490.0	DB01026	approved; investigational	Ketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OCC(CO3)OC3(Cn4ccnc4)c5ccc(Cl)cc5Cl
19240	sp|P9WPN5|CP130_MY	P50859	87.16	137.0	490.0	DB01167	approved; investigational	Itraconazole	CCC(C)n1ncn(c1=O)-c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@@H](CO5)O[C@@]5(Cn6cncn6)c7ccc(Cl)cc7Cl
19241	sp|P9WPN5|CP130_MY	P50859	87.16	137.0	490.0	DB09040	approved	Efinaconazole	C=C1CCN(CC1)[C@H](C)[C@](O)(Cn2cncn2)c3c(F)cc(F)cc3
19242	sp|P9WPN5|CP130_MY	P50859	87.16	137.0	490.0	DB11633	approved; investigational	Isavuconazole	c1ncnn1C[C@](O)(c2c(F)ccc(F)c2)[C@@H](C)c3nc(cs3)-c4ccc(C#N)cc4
19243	sp|P9WPN5|CP130_MY	P08686	81.48	120.0	450.0	DB01026	approved; investigational	Ketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OCC(CO3)OC3(Cn4ccnc4)c5ccc(Cl)cc5Cl
19244	sp|P9WPN5|CP130_MY	P05093	100.74	58.0	466.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
19245	sp|P9WPN5|CP130_MY	P05093	100.74	58.0	466.0	DB00396	approved; vet_approved	Progesterone	CC(=O)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
19246	sp|P9WPN5|CP130_MY	P05093	100.74	58.0	466.0	DB00421	approved	Spironolactone	C1CC(=O)O[C@@]12[C@]3(C)[C@@H](CC2)[C@H]4[C@H](CC3)[C@]5(C)C(=CC(=O)CC5)C[C@H]4SC(=O)C
19247	sp|P9WPN5|CP130_MY	P05093	100.74	58.0	466.0	DB01026	approved; investigational	Ketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OCC(CO3)OC3(Cn4ccnc4)c5ccc(Cl)cc5Cl
19248	sp|P9WPN5|CP130_MY	P05093	100.74	58.0	466.0	DB05812	approved	Abiraterone	C1C[C@H](O)CC([C@]12C)=CC[C@@H]3[C@@H]2CC[C@@]4(C)[C@H]3CC=C4c5cccnc5
19249	sp|P9WPN5|CP130_MY	P05093	100.74	58.0	466.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
19251	sp|P9WPN5|CP130_MY	P05093	100.74	58.0	466.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
19252	sp|P9WPN5|CP130_MY	P05177	78.27	162.0	479.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
19253	sp|P9WPN5|CP130_MY	P05177	78.27	162.0	479.0	DB07453	experimental	alpha-Naphthoflavone	c1ccccc1-c(cc2=O)oc(c23)c4c(cc3)cccc4
19254	sp|P9WPN5|CP130_MY	P05177	78.27	162.0	479.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
19255	sp|P9WPN5|CP130_MY	P05177	78.27	162.0	479.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
19256	sp|P9WPN5|CP130_MY	P05177	78.27	162.0	479.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
19257	sp|P9WPL3|CP143_MY	Q00441	98.98	12.0	401.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
19258	sp|P9WPL3|CP143_MY	Q00441	98.98	12.0	401.0	DB03369	experimental	9-Aminophenanthrene	c1cccc(c12)c3c(cc2N)cccc3
19259	sp|P9WPL3|CP143_MY	Q00441	98.98	12.0	401.0	DB04070	experimental	6-Deoxyerythronolide B	C[C@@H]1C[C@H](C)[C@H](O)[C@@H](C)[C@H](O)[C@@H](C)C(=O)O[C@H](CC)[C@H](C)[C@H](O)[C@@H](C)C1=O
19260	sp|P9WPL3|CP143_MY	P53554	95.42	18.0	393.0	DB04450	experimental	Heptyl 1-Thiohexopyranoside	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)SCCCCCCC
19261	sp|P9WPL3|CP143_MY	P00183	93.38	40.0	407.0	DB01011	approved; investigational	Metyrapone	c1ccncc1C(C)(C)C(=O)c2cnccc2
19262	sp|P9WPL3|CP143_MY	P00183	93.38	40.0	407.0	DB01663	experimental	lambda-bis(2,2'-bipyridine)-(5-methyl-2-2'-bipyridine)-C9-adamantane ruthenium (II)	C1=CC=CN2C1=C(C=CC=C3)N3[Ru+2]245(N6C(C=CC=C6)=C7N4C=CC=C7)N8C(=C9N5C=CC(C)=C9)C=C(C=C8)CCCCCCCCC(=O)N[C@@H]([C@H]12)[C@H]3C[C@@H](C1)C[C@@H](C2)C3
19263	sp|P9WPL3|CP143_MY	P00183	93.38	40.0	407.0	DB01703	experimental	N-(2-ferrocenylethyl)maleimide	O=C1C=CC(=O)N1CCC2(C3C4C5C26)[Fe]13456789C2C7C8C9C12
19264	sp|P9WPL3|CP143_MY	P00183	93.38	40.0	407.0	DB01744	approved	Camphor	C[C@]12C(=O)C[C@H](C1(C)C)CC2
19265	sp|P9WPL3|CP143_MY	P00183	93.38	40.0	407.0	DB01826	experimental	N-Butyl Isocyanide	CCCC[N+]#[C-]
19266	sp|P9WPL3|CP143_MY	P00183	93.38	40.0	407.0	DB02125	experimental	Adamantanone	O=C([C@H]12)[C@H]3C[C@@H](C1)C[C@@H](C2)C3
19267	sp|P9WPL3|CP143_MY	P00183	93.38	40.0	407.0	DB02617	experimental	1-(N-Imidazolyl)-2-Hydroxy-2-(2,3-Dichlorophenyl)Octane	CCCCCC[C@](O)(Cn1ccnc1)c2ccc(Cl)cc2Cl
19268	sp|P9WPL3|CP143_MY	P00183	93.38	40.0	407.0	DB02817	experimental	5-Exo-Hydroxycamphor	C[C@]12C[C@@H](O)[C@H](CC1=O)C2(C)C
19269	sp|P9WPL3|CP143_MY	P00183	93.38	40.0	407.0	DB02851	experimental	Thiocamphor	C[C@]12C(=S)C[C@H](C1(C)C)CC2
19270	sp|P9WPL3|CP143_MY	P00183	93.38	40.0	407.0	DB03031	experimental	Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Octyl-Amide	CN(C)c1cccc(c12)c(ccc2)S(=O)(=O)NCCCCCCCCNC(=O)C34CC5CC(C3)CC(C5)C4
19271	sp|P9WPL3|CP143_MY	P00183	93.38	40.0	407.0	DB03540	experimental	Norcamphor	[C@H]12CC[C@H](C1)C(=O)C2
19272	sp|P9WPL3|CP143_MY	P00183	93.38	40.0	407.0	DB03627	experimental	Adamantane	C12CC3CC(C1)CC(C3)C2
19273	sp|P9WPL3|CP143_MY	P00183	93.38	40.0	407.0	DB03836	experimental	1,3,5-trichlorobenzene	Clc1cc(Cl)cc(Cl)c1
19274	sp|P9WPL3|CP143_MY	P00183	93.38	40.0	407.0	DB04032	experimental	Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Butyl-Amide	CN(C)c1cccc(c12)c(ccc2)S(=O)(=O)NCCCCNC(=O)C34CC5CC(C3)CC(C5)C4
19275	sp|P9WPL3|CP143_MY	P00183	93.38	40.0	407.0	DB04501	experimental	Camphane	C[C@@]12CCC(C1(C)C)CC2
19276	sp|P9WPL3|CP143_MY	P9WPN5	91.35	24.0	383.0	DB07705	experimental	(S)-econazole	Clc1ccc(cc1)CO[C@H](Cn2ccnc2)c3c(Cl)cc(Cl)cc3
19277	sp|P9WPL3|CP143_MY	P9WPN5	91.35	24.0	383.0	DB07971	experimental	5-AMINO-2-{4-[(4-AMINOPHENYL)SULFANYL]PHENYL}-1H-ISOINDOLE-1,3(2H)-DIONE	Nc1ccc(cc1)Sc2ccc(cc2)N(C3=O)C(=O)c(c34)ccc(c4)N
19278	sp|P9WPL3|CP143_MY	P9WPN5	91.35	24.0	383.0	DB07972	experimental	1-(3-METHYLPHENYL)-1H-BENZIMIDAZOL-5-AMINE	Cc1cccc(c1)-n2cnc(c23)cc(N)cc3
19279	sp|P9WPL3|CP143_MY	Q9FCA6	93.64	36.0	404.0	DB02175	experimental	Malonic acid	OC(=O)CC(=O)O
19280	sp|P9WPL3|CP143_MY	Q9FCA6	93.64	36.0	404.0	DB02521	experimental	Flaviolin	Oc1cc(O)cc(c12)C(=O)C(O)=CC2=O
19281	sp|P9WPL3|CP143_MY	Q9FCA6	93.64	36.0	404.0	DB03254	experimental	4-Phenyl-1h-Imidazole	[nH]1cncc1-c2ccccc2
19282	sp|P9WPL3|CP143_MY	Q9FCA6	93.64	36.0	404.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
19283	sp|P9WPL3|CP143_MY	Q83WG3	98.47	20.0	407.0	DB06955	experimental	3,4-bis(7-chloro-1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid	c1ccc(Cl)c(c12)[nH]cc2-c3c(C(=O)O)[nH]c(C(=O)O)c3-c4c[nH]c(c45)c(Cl)ccc5
19284	sp|P9WPL3|CP143_MY	Q83WG3	98.47	20.0	407.0	DB07588	experimental	3,4-DI-1H-INDOL-3-YL-1H-PYRROLE-2,5-DICARBOXYLIC ACID	c1cccc(c12)[nH]cc2-c3c(C(=O)O)[nH]c(C(=O)O)c3-c4c[nH]c(c45)cccc5
19285	sp|P9WPL3|CP143_MY	P08684	98.47	92.0	479.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
19286	sp|P9WPL3|CP143_MY	P08684	98.47	92.0	479.0	DB00143	approved; investigational; nutraceutical	Glutathione	OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(=O)O
19287	sp|P9WPL3|CP143_MY	P08684	98.47	92.0	479.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
19288	sp|P9WPL3|CP143_MY	P08684	98.47	92.0	479.0	DB05478	investigational	Pradefovir mesylate	n1cnc(N)c(c12)ncn2CCOC[P@@]3(=O)OCC[C@H](O3)c4cc(Cl)ccc4
19289	sp|P9WPL3|CP143_MY	P08684	98.47	92.0	479.0	DB06634	investigational	Casopitant	FC(F)(F)c1cc(cc(c1)C(F)(F)F)[C@@H](C)N(C)C(=O)N2CC[C@H](N3CCN(CC3)C(=O)C)C[C@@H]2c4ccc(F)cc4C
19290	sp|P9WPL3|CP143_MY	P20815	98.47	92.0	479.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
19291	sp|P9WPL3|CP143_MY	P20815	98.47	92.0	479.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
19292	sp|P9WPL3|CP143_MY	P20815	98.47	92.0	479.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
19293	sp|P9WPL3|CP143_MY	P24462	98.98	92.0	481.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
19294	sp|P9WPL3|CP143_MY	P24462	98.98	92.0	481.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
19295	sp|P9WPL3|CP143_MY	P24462	98.98	92.0	481.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
19296	sp|P9WPL3|CP143_MY	Q9HB55	97.71	93.0	477.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
19297	sp|P9WPL3|CP143_MY	P9WPP7	95.67	20.0	396.0	DB02721	experimental	4-Iodopyrazole	Ic1c[nH]nc1
19298	sp|P9WPL3|CP143_MY	P9WPP7	95.67	20.0	396.0	DB08761	experimental	(3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine-2,5-dione	Oc1ccc(cc1)C[C@@H]2NC(=O)[C@@H](NC2=O)Cc3ccc(O)cc3
19299	sp|P9WPL3|CP143_MY	Q9NR63	99.75	97.0	489.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
19300	sp|P9WPL3|CP143_MY	Q6V0L0	95.93	129.0	506.0	DB00523	approved; investigational	Alitretinoin	OC(=O)/C=C(\C)/C=C/C=C(/C)\C=C\C(C1(C)C)=C(C)CCC1
19301	sp|P9WPL3|CP143_MY	Q6V0L0	95.93	129.0	506.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
19302	sp|P9WPL3|CP143_MY	P24557	70.48	243.0	520.0	DB00795	approved	Sulfasalazine	OC(=O)c1cc(ccc1O)/N=N/c2ccc(cc2)S(=O)(=O)Nc3ncccc3
19303	sp|P9WPL3|CP143_MY	P24557	70.48	243.0	520.0	DB01207	experimental	Ridogrel	OC(=O)CCCCO/N=C(/c1cnccc1)c2cc(C(F)(F)F)ccc2
19304	sp|P9WPL3|CP143_MY	P24557	70.48	243.0	520.0	DB03052	experimental	Dazoxiben	OC(=O)c1ccc(cc1)OCCn2ccnc2
19305	sp|P9WPL3|CP143_MY	P24557	70.48	243.0	520.0	DB05505	investigational	NM-702	 
19306	sp|P9WPL3|CP143_MY	O43174	94.91	116.0	489.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
19307	sp|P9WPL3|CP143_MY	O43174	94.91	116.0	489.0	DB13083	investigational	Talarozole	c1ncnn1C(C(CC)CC)c2ccc(cc2)Nc(s3)nc(c34)cccc4
19308	sp|P9WPL3|CP143_MY	O15528	102.29	86.0	488.0	DB01436	approved; nutraceutical	Alfacalcidol	CC(C)CCC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)/C(CCC2)=C/C=C3/C[C@@H](O)C[C@H](O)C3=C
19309	sp|P9WPL3|CP143_MY	P33260	100.76	75.0	471.0	DB07670	experimental	N,4-Dimethyl-N-(1-phenyl-1H-pyrazol-5-yl)benzenesulfonamide	Cc1ccc(cc1)S(=O)(=O)N(C)c2ccnn2-c3ccccc3
19310	sp|P9WPL3|CP143_MY	P11712	101.78	76.0	476.0	DB03317	experimental	Ferroheme C	[Fe-2]123[N+]4=C5C=C6[N+]1=C(C(C)=C6C(C)S)C=C7[N+]2=C(C(=C7C)CCC(=O)O)C=C8[N+]3=C(C=C4C(=C5C)C(C)S)C(C)=C8CCC(=O)O
19311	sp|P9WPL3|CP143_MY	P11712	101.78	76.0	476.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
19312	sp|P9WPL3|CP143_MY	P11712	101.78	76.0	476.0	DB12319	investigational; withdrawn	Benzbromarone	c1cccc(c12)c(c(o2)CC)C(=O)c3cc(Br)c(O)c(Br)c3
19313	sp|P9WPL3|CP143_MY	P33261	102.04	75.0	476.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
19314	sp|P9WPL3|CP143_MY	P33261	102.04	75.0	476.0	DB12319	investigational; withdrawn	Benzbromarone	c1cccc(c12)c(c(o2)CC)C(=O)c3cc(Br)c(O)c(Br)c3
19315	sp|P9WPL3|CP143_MY	P10632	93.13	113.0	479.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
19316	sp|P9WPL3|CP143_MY	P10632	93.13	113.0	479.0	DB03796	approved	Palmitic Acid	CCCCCCCCCCCCCCCC(=O)O
19317	sp|P9WPL3|CP143_MY	P10632	93.13	113.0	479.0	DB08607	experimental	(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE	O=C1NC(=O)S[C@@H]1Cc2ccc(cc2)OC[C@@](O3)(C)CCc(c34)c(C)c(O)c(C)c4C
19318	sp|P9WPL3|CP143_MY	P20813	101.78	81.0	481.0	DB02974	experimental	4-(4-Chlorophenyl)Imidazole	Clc1ccc(cc1)-c2cnc[nH]2
19319	sp|P9WPL3|CP143_MY	P20813	101.78	81.0	481.0	DB04664	experimental	Cyclohexyl-pentyl-maltoside	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@@H]2CO)OCCCCCC3CCCCC3
19320	sp|P9WPL3|CP143_MY	P20813	101.78	81.0	481.0	DB04794	approved; investigational	Bifonazole	c1ccccc1C(n2ccnc2)c3ccc(cc3)-c4ccccc4
19321	sp|P9WPL3|CP143_MY	P20813	101.78	81.0	481.0	DB08369	experimental	1-(biphenyl-4-ylmethyl)-1H-imidazole	c1cncn1Cc2ccc(cc2)-c3ccccc3
19322	sp|P9WPL3|CP143_MY	P05181	101.27	77.0	475.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
19323	sp|P9WPL3|CP143_MY	Q16850	86.51	157.0	497.0	DB01007	approved	Tioconazole	c1nccn1CC(c(c(Cl)c2)ccc2Cl)OCc3c(Cl)scc3
19324	sp|P9WPL3|CP143_MY	Q16850	86.51	157.0	497.0	DB01167	approved; investigational	Itraconazole	CCC(C)n1ncn(c1=O)-c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@@H](CO5)O[C@@]5(Cn6cncn6)c7ccc(Cl)cc7Cl
19325	sp|P9WPL3|CP143_MY	Q16850	86.51	157.0	497.0	DB05667	investigational	Levoketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OC[C@H](CO3)O[C@]3(Cn4ccnc4)c5ccc(Cl)cc5Cl
19326	sp|P9WPL3|CP143_MY	Q16850	86.51	157.0	497.0	DB07705	experimental	(S)-econazole	Clc1ccc(cc1)CO[C@H](Cn2ccnc2)c3c(Cl)cc(Cl)cc3
19328	sp|P9WPL3|CP143_MY	P14779	89.06	89.0	439.0	DB03440	experimental	N-hexadecanoylglycine	CCCCCCCCCCCCCCCC(=O)NCC(=O)O
19329	sp|P9WPL3|CP143_MY	P14779	89.06	89.0	439.0	DB04257	experimental	Palmitoleic Acid	CCCCCC/C=C\CCCCCCCC(=O)O
19330	sp|P9WPL3|CP143_MY	P14779	89.06	89.0	439.0	DB08086	experimental	N-[12-(1H-imidazol-1-yl)dodecanoyl]-L-leucine	CC(C)C[C@@H](C(=O)O)NC(=O)CCCCCCCCCCCn1ccnc1
19331	sp|P9WPL3|CP143_MY	P11511	89.06	115.0	465.0	DB00184	approved	Nicotine	CN1CCC[C@H]1c2cnccc2
19332	sp|P9WPL3|CP143_MY	P11511	89.06	115.0	465.0	DB00357	approved; investigational	Aminoglutethimide	Nc1ccc(cc1)C2(CC)CCC(=O)NC2=O
19333	sp|P9WPL3|CP143_MY	P11511	89.06	115.0	465.0	DB00655	approved	Estrone	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)cc4
19334	sp|P9WPL3|CP143_MY	P11511	89.06	115.0	465.0	DB00894	approved; investigational	Testolactone	C1=CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2CC[C@@]4(C)[C@H]3CCC(O4)=O
19335	sp|P9WPL3|CP143_MY	P11511	89.06	115.0	465.0	DB00990	approved; investigational	Exemestane	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(C(C3)=C)=CC(=O)C=C4
19336	sp|P9WPL3|CP143_MY	P11511	89.06	115.0	465.0	DB01006	approved; investigational	Letrozole	N#Cc1ccc(cc1)C(n2cncn2)c3ccc(C#N)cc3
19337	sp|P9WPL3|CP143_MY	P11511	89.06	115.0	465.0	DB01217	approved; investigational	Anastrozole	N#CC(C)(C)c1cc(C(C)(C)C#N)cc(c1)Cn2cncn2
19338	sp|P9WPL3|CP143_MY	P11511	89.06	115.0	465.0	DB02342	investigational	2-Methoxyestradiol	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)c(c4)OC
19339	sp|P9WPL3|CP143_MY	P11511	89.06	115.0	465.0	DB03467	experimental	Naringenin	Oc1ccc(cc1)[C@@H](O2)CC(=O)c(c23)c(O)cc(c3)O
19340	sp|P9WPL3|CP143_MY	P11511	89.06	115.0	465.0	DB04539	experimental	Glyphosate	OC(=O)C[NH2+]CP(=O)(O)O
19341	sp|P9WPL3|CP143_MY	P11511	89.06	115.0	465.0	DB05749	investigational	MPI-674	 
19342	sp|P9WPL3|CP143_MY	O31440	86.01	52.0	390.0	DB04257	experimental	Palmitoleic Acid	CCCCCC/C=C\CCCCCCCC(=O)O
19343	sp|I6YGS0|EPHA_MYC	P34913	94.1	239.0	542.0	DB02029	experimental	N-Cyclohexyl-N'-(4-Iodophenyl)Urea	Ic1ccc(cc1)NC(=O)NC2CCCCC2
19344	sp|I6YGS0|EPHA_MYC	P34913	94.1	239.0	542.0	DB03677	experimental	N-Cyclohexyl-N'-Decylurea	CCCCCCCCCCNC(=O)NC1CCCCC1
19345	sp|I6YGS0|EPHA_MYC	P34913	94.1	239.0	542.0	DB04213	experimental	N-Cyclohexyl-N'-(Propyl)Phenyl Urea	C1CCCCC1NC(=O)NCCCc2ccccc2
19346	sp|I6YGS0|EPHA_MYC	P34913	94.1	239.0	542.0	DB06345	investigational	AR-9281	CC(=O)N1CCC(CC1)NC(=O)NC23CC4CC(C2)CC(C4)C3
19347	sp|I6YGS0|EPHA_MYC	P34913	94.1	239.0	542.0	DB08256	experimental	N-[(CYCLOHEXYLAMINO)CARBONYL]GLYCINE	OC(=O)CNC(=O)NC1CCCCC1
19348	sp|I6YGS0|EPHA_MYC	P34913	94.1	239.0	542.0	DB08257	experimental	4-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}BUTANOIC ACID	OC(=O)CCCNC(=O)NC1CCCCC1
19349	sp|I6YGS0|EPHA_MYC	P34913	94.1	239.0	542.0	DB08258	experimental	6-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEXANOIC ACID	OC(=O)CCCCCNC(=O)NC1CCCCC1
19350	sp|I6YGS0|EPHA_MYC	P34913	94.1	239.0	542.0	DB08259	experimental	7-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEPTANOIC ACID	OC(=O)CCCCCCNC(=O)NC1CCCCC1
19351	sp|I6YGS0|EPHA_MYC	P34913	94.1	239.0	542.0	DB12610	investigational	Ebselen	c1cccc(c12)[se]n(c2=O)-c3ccccc3
19352	sp|O05779|FTSE_MYC	P08183	94.35	393.0	610.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
19353	sp|O05779|FTSE_MYC	P08183	94.35	393.0	610.0	DB00603	approved; investigational	Medroxyprogesterone acetate	CC(=O)O[C@]1(C(=O)C)CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C([C@H](C3)C)=CC(=O)CC4
19354	sp|O05779|FTSE_MYC	P08183	94.35	393.0	610.0	DB00778	approved; investigational; withdrawn	Roxithromycin	COCCOCO/N=C([C@H](C)[C@@H](O)[C@]1(C)O)/[C@H](C)C[C@@](C)(O)[C@@H]([C@@H](C)[C@@H]([C@@H](C)C(=O)O[C@@H]1CC)O[C@@H](C[C@@]2(C)OC)O[C@@H](C)[C@@H]2O)O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C
19355	sp|O05779|FTSE_MYC	P08183	94.35	393.0	610.0	DB00813	approved; illicit; investigational; vet_approved	Fentanyl	c1ccccc1N(C(=O)CC)C2CCN(CC2)CCc3ccccc3
19356	sp|O05779|FTSE_MYC	P08183	94.35	393.0	610.0	DB04877	experimental	Voacamine	CC[C@H]1C[C@@H](C2)CN([C@@H]1[C@@]23C(=O)OC)CCc4c3[nH]c5c4cc(OC)c(c5)[C@@H](C[C@H]67)c8c(c9c([nH]8)cccc9)C[C@H](C6C(=O)OC)N(C)CC\7=C\C
19357	sp|O05779|FTSE_MYC	P08183	94.35	393.0	610.0	DB04881	investigational	Elacridar	COc1cccc(c12)c(=O)c3c([nH]2)c(ccc3)C(=O)Nc4ccc(cc4)CCN(C5)CCc(c56)cc(OC)c(c6)OC
19358	sp|O05779|FTSE_MYC	P08183	94.35	393.0	610.0	DB04905	investigational	Tesmilifene	CCN(CC)CCOc1ccc(cc1)Cc2ccccc2
19359	sp|O05779|FTSE_MYC	P08183	94.35	393.0	610.0	DB05449	investigational	FM-VP4	 
19360	sp|O05779|FTSE_MYC	P08183	94.35	393.0	610.0	DB06191	investigational	Zosuquidar	FC1(F)[C@H]2[C@@H]1c(cccc3)c3[C@@H](c(c24)cccc4)N5CCN(CC5)C[C@@H](O)COc6cccc(c67)nccc7
19361	sp|O05779|FTSE_MYC	P08183	94.35	393.0	610.0	DB06240	investigational	Tariquidar	COc(c1)c(OC)cc(c12)CCN(C2)CCc3ccc(cc3)NC(=O)c4cc(OC)c(OC)cc4NC(=O)c(c5)cnc(c56)cccc6
19362	sp|O05779|FTSE_MYC	P08183	94.35	393.0	610.0	DB09031	approved; investigational	Miltefosine	CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C
19363	sp|O05779|FTSE_MYC	P08183	94.35	393.0	610.0	DB11635	approved	Tocofersolan	 
19364	sp|O05779|FTSE_MYC	P08183	94.35	393.0	610.0	DB14061	experimental	Hycanthone	CCN(CC)CCNc(ccc1CO)c(c12)c(=O)c3c(s2)cccc3
19365	sp|O05779|FTSE_MYC	P08183	94.35	393.0	610.0	DB14062	experimental	Concanamycin A	NC(=O)O[C@@H]1[C@@H](C)O[C@H](C[C@H]1O)O[C@H](C2)[C@H](C)[C@@H](/C=C/C)O[C@@]2(O)[C@@H](C)[C@H](O)[C@H](C)[C@H]3OC(=O)/C(OC)=C/C(C)=C/[C@@H](C)[C@@H](O)[C@@H](CC)[C@@H](O)[C@H](C)C/C(C)=C/C=C/[C@@H]3OC
19366	sp|O05779|FTSE_MYC	P08183	94.35	393.0	610.0	DB14063	experimental	Dexverapamil	COc1ccc(cc1OC)CCN(C)CCC[C@@](C#N)(C(C)C)c2cc(OC)c(OC)cc2
19367	sp|O05779|FTSE_MYC	P08183	94.35	393.0	610.0	DB14064	experimental	Emopamil	c1ccccc1C(C#N)(C(C)C)CCCN(C)CCc2ccccc2
19368	sp|O05779|FTSE_MYC	P08183	94.35	393.0	610.0	DB14065	experimental	Lomerizine	COc1ccc(c(OC)c1OC)CN2CCN(CC2)C(c3ccc(F)cc3)c4ccc(F)cc4
19369	sp|O05779|FTSE_MYC	P08183	94.35	393.0	610.0	DB14066	experimental	Tetrandrine	c12ccc(OC)c(c1)Oc3ccc(cc3)C[C@H]4c5c(CCN4C)cc(OC)c(c5)Oc6c7c(CCN(C)[C@H]7C2)cc(OC)c6OC
19370	sp|O05779|FTSE_MYC	P08183	94.35	393.0	610.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
19371	sp|O05779|FTSE_MYC	P08183	94.35	393.0	610.0	DB14068	experimental	Dexniguldipine	[O-][N+](=O)c1cccc(c1)[C@@H]2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCCN(CC3)CCC3(c4ccccc4)c5ccccc5
19372	sp|O05779|FTSE_MYC	P08183	94.35	393.0	610.0	DB14069	investigational	ONT-093	CCOC/C=C/c1ccc(cc1)-c2nc(-c3ccc(cc3)NC(C)C)c([nH]2)-c4ccc(cc4)NC(C)C
19373	sp|O05779|FTSE_MYC	P08183	94.35	393.0	610.0	DB14070	experimental	HM-30181	c1cccc(c12)c(=O)cc(o2)C(=O)Nc3cc(OC)c(OC)cc3-c4nn(nn4)-c5ccc(cc5)CCN(C6)CCc(c67)cc(OC)c(c7)OC
19374	sp|O05779|FTSE_MYC	P08183	94.35	393.0	610.0	DB14071	experimental	Desmethylsertraline	c1cccc(c12)[C@@H](CC[C@@H]2N)c3cc(Cl)c(Cl)cc3
19375	sp|O05779|FTSE_MYC	P08183	94.35	393.0	610.0	DB14072	experimental	Reversin 121	c1ccccc1COC(=O)C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@H](C(=O)OC(C)(C)C)CCCCNC(=O)OCc2ccccc2
19376	sp|O05779|FTSE_MYC	P08183	96.52	1035.0	1257.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
19377	sp|O05779|FTSE_MYC	P08183	96.52	1035.0	1257.0	DB00603	approved; investigational	Medroxyprogesterone acetate	CC(=O)O[C@]1(C(=O)C)CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C([C@H](C3)C)=CC(=O)CC4
19378	sp|O05779|FTSE_MYC	P08183	96.52	1035.0	1257.0	DB00778	approved; investigational; withdrawn	Roxithromycin	COCCOCO/N=C([C@H](C)[C@@H](O)[C@]1(C)O)/[C@H](C)C[C@@](C)(O)[C@@H]([C@@H](C)[C@@H]([C@@H](C)C(=O)O[C@@H]1CC)O[C@@H](C[C@@]2(C)OC)O[C@@H](C)[C@@H]2O)O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C
19379	sp|O05779|FTSE_MYC	P08183	96.52	1035.0	1257.0	DB00813	approved; illicit; investigational; vet_approved	Fentanyl	c1ccccc1N(C(=O)CC)C2CCN(CC2)CCc3ccccc3
19380	sp|O05779|FTSE_MYC	P08183	96.52	1035.0	1257.0	DB04877	experimental	Voacamine	CC[C@H]1C[C@@H](C2)CN([C@@H]1[C@@]23C(=O)OC)CCc4c3[nH]c5c4cc(OC)c(c5)[C@@H](C[C@H]67)c8c(c9c([nH]8)cccc9)C[C@H](C6C(=O)OC)N(C)CC\7=C\C
19381	sp|O05779|FTSE_MYC	P08183	96.52	1035.0	1257.0	DB04881	investigational	Elacridar	COc1cccc(c12)c(=O)c3c([nH]2)c(ccc3)C(=O)Nc4ccc(cc4)CCN(C5)CCc(c56)cc(OC)c(c6)OC
19382	sp|O05779|FTSE_MYC	P08183	96.52	1035.0	1257.0	DB04905	investigational	Tesmilifene	CCN(CC)CCOc1ccc(cc1)Cc2ccccc2
19383	sp|O05779|FTSE_MYC	P08183	96.52	1035.0	1257.0	DB05449	investigational	FM-VP4	 
19384	sp|O05779|FTSE_MYC	P08183	96.52	1035.0	1257.0	DB06191	investigational	Zosuquidar	FC1(F)[C@H]2[C@@H]1c(cccc3)c3[C@@H](c(c24)cccc4)N5CCN(CC5)C[C@@H](O)COc6cccc(c67)nccc7
19385	sp|O05779|FTSE_MYC	P08183	96.52	1035.0	1257.0	DB06240	investigational	Tariquidar	COc(c1)c(OC)cc(c12)CCN(C2)CCc3ccc(cc3)NC(=O)c4cc(OC)c(OC)cc4NC(=O)c(c5)cnc(c56)cccc6
19386	sp|O05779|FTSE_MYC	P08183	96.52	1035.0	1257.0	DB09031	approved; investigational	Miltefosine	CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C
19387	sp|O05779|FTSE_MYC	P08183	96.52	1035.0	1257.0	DB11635	approved	Tocofersolan	 
19388	sp|O05779|FTSE_MYC	P08183	96.52	1035.0	1257.0	DB14061	experimental	Hycanthone	CCN(CC)CCNc(ccc1CO)c(c12)c(=O)c3c(s2)cccc3
19389	sp|O05779|FTSE_MYC	P08183	96.52	1035.0	1257.0	DB14062	experimental	Concanamycin A	NC(=O)O[C@@H]1[C@@H](C)O[C@H](C[C@H]1O)O[C@H](C2)[C@H](C)[C@@H](/C=C/C)O[C@@]2(O)[C@@H](C)[C@H](O)[C@H](C)[C@H]3OC(=O)/C(OC)=C/C(C)=C/[C@@H](C)[C@@H](O)[C@@H](CC)[C@@H](O)[C@H](C)C/C(C)=C/C=C/[C@@H]3OC
19390	sp|O05779|FTSE_MYC	P08183	96.52	1035.0	1257.0	DB14063	experimental	Dexverapamil	COc1ccc(cc1OC)CCN(C)CCC[C@@](C#N)(C(C)C)c2cc(OC)c(OC)cc2
19391	sp|O05779|FTSE_MYC	P08183	96.52	1035.0	1257.0	DB14064	experimental	Emopamil	c1ccccc1C(C#N)(C(C)C)CCCN(C)CCc2ccccc2
19392	sp|O05779|FTSE_MYC	P08183	96.52	1035.0	1257.0	DB14065	experimental	Lomerizine	COc1ccc(c(OC)c1OC)CN2CCN(CC2)C(c3ccc(F)cc3)c4ccc(F)cc4
19393	sp|O05779|FTSE_MYC	P08183	96.52	1035.0	1257.0	DB14066	experimental	Tetrandrine	c12ccc(OC)c(c1)Oc3ccc(cc3)C[C@H]4c5c(CCN4C)cc(OC)c(c5)Oc6c7c(CCN(C)[C@H]7C2)cc(OC)c6OC
19394	sp|O05779|FTSE_MYC	P08183	96.52	1035.0	1257.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
19395	sp|O05779|FTSE_MYC	P08183	96.52	1035.0	1257.0	DB14068	experimental	Dexniguldipine	[O-][N+](=O)c1cccc(c1)[C@@H]2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCCN(CC3)CCC3(c4ccccc4)c5ccccc5
19396	sp|O05779|FTSE_MYC	P08183	96.52	1035.0	1257.0	DB14069	investigational	ONT-093	CCOC/C=C/c1ccc(cc1)-c2nc(-c3ccc(cc3)NC(C)C)c([nH]2)-c4ccc(cc4)NC(C)C
19397	sp|O05779|FTSE_MYC	P08183	96.52	1035.0	1257.0	DB14070	experimental	HM-30181	c1cccc(c12)c(=O)cc(o2)C(=O)Nc3cc(OC)c(OC)cc3-c4nn(nn4)-c5ccc(cc5)CCN(C6)CCc(c67)cc(OC)c(c7)OC
19398	sp|O05779|FTSE_MYC	P08183	96.52	1035.0	1257.0	DB14071	experimental	Desmethylsertraline	c1cccc(c12)[C@@H](CC[C@@H]2N)c3cc(Cl)c(Cl)cc3
19399	sp|O05779|FTSE_MYC	P08183	96.52	1035.0	1257.0	DB14072	experimental	Reversin 121	c1ccccc1COC(=O)C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@H](C(=O)OC(C)(C)C)CCCCNC(=O)OCc2ccccc2
19400	sp|O05779|FTSE_MYC	Q2M3G0	95.22	386.0	605.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
19401	sp|O05779|FTSE_MYC	Q2M3G0	95.22	386.0	605.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
19402	sp|O05779|FTSE_MYC	Q2M3G0	96.09	1016.0	1237.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
19403	sp|O05779|FTSE_MYC	Q2M3G0	96.09	1016.0	1237.0	DB14067	experimental; investigational	Dofequidar	c1ccnc(c12)cccc2OCC(O)CN3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5
19404	sp|O05779|FTSE_MYC	O95342	95.65	420.0	640.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
19405	sp|O05779|FTSE_MYC	O95342	95.65	420.0	640.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
19406	sp|O05779|FTSE_MYC	O95342	96.52	1078.0	1300.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
19407	sp|O05779|FTSE_MYC	O95342	96.52	1078.0	1300.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
19408	sp|O05779|FTSE_MYC	Q09428	100.87	680.0	912.0	DB00839	approved; investigational	Tolazamide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2
19409	sp|O05779|FTSE_MYC	Q09428	100.87	680.0	912.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
19410	sp|O05779|FTSE_MYC	Q09428	93.04	1344.0	1558.0	DB00839	approved; investigational	Tolazamide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2
19411	sp|O05779|FTSE_MYC	Q09428	93.04	1344.0	1558.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
19412	sp|O05779|FTSE_MYC	Q09428	100.87	680.0	912.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
19413	sp|O05779|FTSE_MYC	Q09428	100.87	680.0	912.0	DB00222	approved	Glimepiride	CCC1=C(C)CN(C1=O)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3
19414	sp|O05779|FTSE_MYC	Q09428	100.87	680.0	912.0	DB00672	approved; investigational	Chlorpropamide	CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1
19415	sp|O05779|FTSE_MYC	Q09428	100.87	680.0	912.0	DB00731	approved; investigational	Nateglinide	CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](C(=O)O)Cc2ccccc2
19416	sp|O05779|FTSE_MYC	Q09428	100.87	680.0	912.0	DB00912	approved; investigational	Repaglinide	CCOc1c(C(=O)O)ccc(c1)CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3
19417	sp|O05779|FTSE_MYC	Q09428	100.87	680.0	912.0	DB01067	approved; investigational	Glipizide	Cc1ncc(nc1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
19418	sp|O05779|FTSE_MYC	Q09428	100.87	680.0	912.0	DB01120	approved	Gliclazide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN(C2)CC(C23)CCC3
19419	sp|O05779|FTSE_MYC	Q09428	100.87	680.0	912.0	DB01124	approved; investigational	Tolbutamide	CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1
19420	sp|O05779|FTSE_MYC	Q09428	100.87	680.0	912.0	DB01251	approved; investigational	Gliquidone	COc(cc1)cc(c12)C(=O)N(C(=O)C2(C)C)CCc3ccc(cc3)S(=O)(=O)NC(=O)NC4CCCCC4
19421	sp|O05779|FTSE_MYC	Q09428	100.87	680.0	912.0	DB01252	investigational	Mitiglinide	c1ccccc1C[C@H](C(=O)O)CC(=O)N(C2)C[C@H]([C@H]23)CCCC3
19422	sp|O05779|FTSE_MYC	Q09428	100.87	680.0	912.0	DB01382	approved; investigational	Glymidine	COCCOc1cnc(nc1)NS(=O)(=O)c2ccccc2
19423	sp|O05779|FTSE_MYC	Q09428	93.04	1344.0	1558.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
19424	sp|O05779|FTSE_MYC	Q09428	93.04	1344.0	1558.0	DB00222	approved	Glimepiride	CCC1=C(C)CN(C1=O)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3
19425	sp|O05779|FTSE_MYC	Q09428	93.04	1344.0	1558.0	DB00672	approved; investigational	Chlorpropamide	CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1
19426	sp|O05779|FTSE_MYC	Q09428	93.04	1344.0	1558.0	DB00731	approved; investigational	Nateglinide	CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](C(=O)O)Cc2ccccc2
19427	sp|O05779|FTSE_MYC	Q09428	93.04	1344.0	1558.0	DB00912	approved; investigational	Repaglinide	CCOc1c(C(=O)O)ccc(c1)CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3
19428	sp|O05779|FTSE_MYC	Q09428	93.04	1344.0	1558.0	DB01067	approved; investigational	Glipizide	Cc1ncc(nc1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
19429	sp|O05779|FTSE_MYC	Q09428	93.04	1344.0	1558.0	DB01120	approved	Gliclazide	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN(C2)CC(C23)CCC3
19430	sp|O05779|FTSE_MYC	Q09428	93.04	1344.0	1558.0	DB01124	approved; investigational	Tolbutamide	CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1
19431	sp|O05779|FTSE_MYC	Q09428	93.04	1344.0	1558.0	DB01251	approved; investigational	Gliquidone	COc(cc1)cc(c12)C(=O)N(C(=O)C2(C)C)CCc3ccc(cc3)S(=O)(=O)NC(=O)NC4CCCCC4
19432	sp|O05779|FTSE_MYC	Q09428	93.04	1344.0	1558.0	DB01252	investigational	Mitiglinide	c1ccccc1C[C@H](C(=O)O)CC(=O)N(C2)C[C@H]([C@H]23)CCCC3
19433	sp|O05779|FTSE_MYC	Q09428	93.04	1344.0	1558.0	DB01382	approved; investigational	Glymidine	COCCOc1cnc(nc1)NS(=O)(=O)c2ccccc2
19434	sp|O05779|FTSE_MYC	O60706	96.96	672.0	895.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
19435	sp|O05779|FTSE_MYC	O60706	96.96	672.0	895.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
19436	sp|O05779|FTSE_MYC	O60706	96.96	672.0	895.0	DB09220	approved; investigational	Nicorandil	[O-][N+](=O)OCCNC(=O)c1cccnc1
19437	sp|O05779|FTSE_MYC	O60706	93.91	1312.0	1528.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
19438	sp|O05779|FTSE_MYC	O60706	93.91	1312.0	1528.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
19439	sp|O05779|FTSE_MYC	O60706	93.91	1312.0	1528.0	DB09220	approved; investigational	Nicorandil	[O-][N+](=O)OCCNC(=O)c1cccnc1
19440	sp|O05779|FTSE_MYC	P33527	89.57	644.0	850.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
19441	sp|O05779|FTSE_MYC	P33527	89.57	644.0	850.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
19442	sp|O05779|FTSE_MYC	P33527	89.57	644.0	850.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
19443	sp|O05779|FTSE_MYC	P33527	89.57	644.0	850.0	DB06176	approved; investigational	Romidepsin	O=C([C@H]12)N/C(=C\C)C(=O)N[C@@H](C(C)C)C(=O)O[C@@H](CC(=O)N[C@H](C(C)C)C(=O)N1)/C=C/CCSSC2
19444	sp|O05779|FTSE_MYC	P33527	89.57	644.0	850.0	DB08855	experimental; investigational	Leukotriene C4	CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@@H](O)CCCC(=O)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@H](N)C(=O)O
19445	sp|O05779|FTSE_MYC	P33527	93.04	1293.0	1507.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
19446	sp|O05779|FTSE_MYC	P33527	93.04	1293.0	1507.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
19447	sp|O05779|FTSE_MYC	P33527	93.04	1293.0	1507.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
19448	sp|O05779|FTSE_MYC	P33527	93.04	1293.0	1507.0	DB06176	approved; investigational	Romidepsin	O=C([C@H]12)N/C(=C\C)C(=O)N[C@@H](C(C)C)C(=O)O[C@@H](CC(=O)N[C@H](C(C)C)C(=O)N1)/C=C/CCSSC2
19449	sp|O05779|FTSE_MYC	P33527	93.04	1293.0	1507.0	DB08855	experimental; investigational	Leukotriene C4	CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@@H](O)CCCC(=O)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@H](N)C(=O)O
19450	sp|O05779|FTSE_MYC	Q92887	90.87	637.0	846.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
19451	sp|O05779|FTSE_MYC	Q92887	90.87	637.0	846.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
19452	sp|O05779|FTSE_MYC	Q92887	93.48	1300.0	1515.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
19453	sp|O05779|FTSE_MYC	Q92887	93.48	1300.0	1515.0	DB01138	approved	Sulfinpyrazone	c1ccccc1N2N(c3ccccc3)C(=O)C(C2=O)CCS(=O)c4ccccc4
19454	sp|O05779|FTSE_MYC	O15440	83.91	574.0	767.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
19455	sp|O05779|FTSE_MYC	O15440	83.91	574.0	767.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
19456	sp|O05779|FTSE_MYC	O15440	93.04	1193.0	1407.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
19457	sp|O05779|FTSE_MYC	O15440	93.04	1193.0	1407.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
19458	sp|O05779|FTSE_MYC	O15439	90.87	409.0	618.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
19459	sp|O05779|FTSE_MYC	O15439	92.61	1041.0	1254.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
19460	sp|O05779|FTSE_MYC	O95255	89.57	629.0	835.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
19461	sp|O05779|FTSE_MYC	O95255	93.04	1265.0	1479.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
19462	sp|O05779|FTSE_MYC	P13569	81.3	437.0	624.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
19463	sp|O05779|FTSE_MYC	P13569	81.3	437.0	624.0	DB00887	approved	Bumetanide	CCCCNc1c(c(S(=O)(=O)N)cc(c1)C(=O)O)Oc2ccccc2
19464	sp|O05779|FTSE_MYC	P13569	81.3	437.0	624.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
19465	sp|O05779|FTSE_MYC	P13569	81.3	437.0	624.0	DB01050	approved	Ibuprofen	CC(C)Cc1ccc(cc1)C(C)C(=O)O
19466	sp|O05779|FTSE_MYC	P13569	81.3	437.0	624.0	DB02587	experimental; investigational	Colforsin	O[C@H]1CCC(C)(C)[C@@H]([C@]12C)[C@H](O)[C@H](OC(=O)C)[C@]3(C)[C@]2(O)C(=O)C[C@](O3)(C)C=C
19467	sp|O05779|FTSE_MYC	P13569	81.3	437.0	624.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
19468	sp|O05779|FTSE_MYC	P13569	81.3	437.0	624.0	DB04522	experimental	Dexfosfoserine	OC(=O)[C@@H](N)COP(=O)(O)O
19469	sp|O05779|FTSE_MYC	P13569	81.3	437.0	624.0	DB04941	approved	Crofelemer	 
19470	sp|O05779|FTSE_MYC	P13569	81.3	437.0	624.0	DB06266	investigational	Lonidamine	c1cccc(c12)n(nc2C(=O)O)Cc3c(Cl)cc(Cl)cc3
19471	sp|O05779|FTSE_MYC	P13569	81.3	437.0	624.0	DB08820	approved	Ivacaftor	CC(C)(C)c1cc(C(C)(C)C)c(O)cc1NC(=O)c(c2=O)c[nH]c(c23)cccc3
19472	sp|O05779|FTSE_MYC	P13569	81.3	437.0	624.0	DB09213	approved; investigational	Dexibuprofen	CC(C)Cc1ccc(cc1)[C@H](C)C(=O)O
19473	sp|O05779|FTSE_MYC	P13569	81.3	437.0	624.0	DB09280	approved	Lumacaftor	O=C(O)c1cccc(c1)-c2nc(ccc2C)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
19474	sp|O05779|FTSE_MYC	P13569	81.3	437.0	624.0	DB11712	approved; investigational	Tezacaftor	OC[C@H](O)Cn1c(C(C)(C)CO)cc(c12)cc(c(F)c2)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
19475	sp|O05779|FTSE_MYC	P13569	81.3	437.0	624.0	DB15444	approved; investigational	Elexacaftor	FC(F)(F)C(C)(C)COc1nn(cc1)-c2nc(N(C3(C)C)C[C@@H](C)C3)c(cc2)C(=O)NS(=O)(=O)c4cn(C)nc4C
19476	sp|O05779|FTSE_MYC	P13569	92.61	1210.0	1423.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
19477	sp|O05779|FTSE_MYC	P13569	92.61	1210.0	1423.0	DB00887	approved	Bumetanide	CCCCNc1c(c(S(=O)(=O)N)cc(c1)C(=O)O)Oc2ccccc2
19478	sp|O05779|FTSE_MYC	P13569	92.61	1210.0	1423.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
19479	sp|O05779|FTSE_MYC	P13569	92.61	1210.0	1423.0	DB01050	approved	Ibuprofen	CC(C)Cc1ccc(cc1)C(C)C(=O)O
19480	sp|O05779|FTSE_MYC	P13569	92.61	1210.0	1423.0	DB02587	experimental; investigational	Colforsin	O[C@H]1CCC(C)(C)[C@@H]([C@]12C)[C@H](O)[C@H](OC(=O)C)[C@]3(C)[C@]2(O)C(=O)C[C@](O3)(C)C=C
19481	sp|O05779|FTSE_MYC	P13569	92.61	1210.0	1423.0	DB04395	experimental	Phosphoaminophosphonic Acid-Adenylate Ester	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@H]([C@H](O)[C@H]3O)CO[P@@](=O)(O)O[P@](=O)(O)NP(=O)(O)O
19482	sp|O05779|FTSE_MYC	P13569	92.61	1210.0	1423.0	DB04522	experimental	Dexfosfoserine	OC(=O)[C@@H](N)COP(=O)(O)O
19483	sp|O05779|FTSE_MYC	P13569	92.61	1210.0	1423.0	DB04941	approved	Crofelemer	 
19484	sp|O05779|FTSE_MYC	P13569	92.61	1210.0	1423.0	DB06266	investigational	Lonidamine	c1cccc(c12)n(nc2C(=O)O)Cc3c(Cl)cc(Cl)cc3
19485	sp|O05779|FTSE_MYC	P13569	92.61	1210.0	1423.0	DB08820	approved	Ivacaftor	CC(C)(C)c1cc(C(C)(C)C)c(O)cc1NC(=O)c(c2=O)c[nH]c(c23)cccc3
19486	sp|O05779|FTSE_MYC	P13569	92.61	1210.0	1423.0	DB09213	approved; investigational	Dexibuprofen	CC(C)Cc1ccc(cc1)[C@H](C)C(=O)O
19487	sp|O05779|FTSE_MYC	P13569	92.61	1210.0	1423.0	DB09280	approved	Lumacaftor	O=C(O)c1cccc(c1)-c2nc(ccc2C)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
19488	sp|O05779|FTSE_MYC	P13569	92.61	1210.0	1423.0	DB11712	approved; investigational	Tezacaftor	OC[C@H](O)Cn1c(C(C)(C)CO)cc(c12)cc(c(F)c2)NC(=O)C3(CC3)c(c4)ccc(c45)OC(O5)(F)F
19489	sp|O05779|FTSE_MYC	P13569	92.61	1210.0	1423.0	DB15444	approved; investigational	Elexacaftor	FC(F)(F)C(C)(C)COc1nn(cc1)-c2nc(N(C3(C)C)C[C@@H](C)C3)c(cc2)C(=O)NS(=O)(=O)c4cn(C)nc4C
19490	sp|O05779|FTSE_MYC	O95477	91.74	899.0	1110.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
19491	sp|O05779|FTSE_MYC	O95477	91.74	899.0	1110.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
19492	sp|O05779|FTSE_MYC	O95477	91.74	899.0	1110.0	DB01599	approved; investigational	Probucol	CC(C)(C)c1cc(cc(c1O)C(C)(C)C)SC(C)(C)Sc2cc(C(C)(C)C)c(O)c(c2)C(C)(C)C
19493	sp|O05779|FTSE_MYC	O95477	91.74	1912.0	2123.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
19494	sp|O05779|FTSE_MYC	O95477	91.74	1912.0	2123.0	DB01016	approved	Glyburide	Clc1ccc(OC)c(c1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
19495	sp|O05779|FTSE_MYC	O95477	91.74	1912.0	2123.0	DB01599	approved; investigational	Probucol	CC(C)(C)c1cc(cc(c1O)C(C)(C)C)SC(C)(C)Sc2cc(C(C)(C)C)c(O)c(c2)C(C)(C)C
19496	sp|O05779|FTSE_MYC	P45844	88.7	95.0	299.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
19497	sp|O05779|FTSE_MYC	Q9UNQ0	89.13	60.0	265.0	DB04851	investigational	Biricodar	COc1c(OC)cc(cc1OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc3cnccc3)CCCc4cnccc4
19498	sp|O05779|FTSE_MYC	Q9UNQ0	89.13	60.0	265.0	DB11995	approved; investigational	Avatrombopag	OC(=O)C1CCN(CC1)c2c(Cl)cc(cn2)C(=O)Nc3nc(-c4cc(Cl)cs4)c(s3)N5CCN(CC5)C6CCCCC6
19499	sp|O05779|FTSE_MYC	A0A0T9AZ62	90.0	222.0	429.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
19500	sp|P9WN55|GCSH_MYC	P23434	87.31	48.0	165.0	DB03187	experimental	6-(Hydroxyethyldithio)-8-(Aminomethylthio)Octanoic Acid	NCSCC[C@@H](SSCCO)CCCCC(=O)O
19501	sp|P9WN55|GCSH_MYC	P23434	87.31	48.0	165.0	DB03760	experimental	Dihydrolipoic Acid	SCC[C@H](S)CCCCC(=O)O
19502	sp|P9WP67|COX3_MYC	P00414	88.67	78.0	258.0	DB02659	approved	Cholic Acid	OC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](C[C@@H]2O)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
19503	sp|P9WP67|COX3_MYC	P00414	88.67	78.0	258.0	DB04464	experimental	N-Formylmethionine	O=CN[C@H](C(=O)O)CCSC
19504	sp|P9WPL5|CP142_MY	P9WPN5	88.94	48.0	402.0	DB07705	experimental	(S)-econazole	Clc1ccc(cc1)CO[C@H](Cn2ccnc2)c3c(Cl)cc(Cl)cc3
19505	sp|P9WPL5|CP142_MY	P9WPN5	88.94	48.0	402.0	DB07971	experimental	5-AMINO-2-{4-[(4-AMINOPHENYL)SULFANYL]PHENYL}-1H-ISOINDOLE-1,3(2H)-DIONE	Nc1ccc(cc1)Sc2ccc(cc2)N(C3=O)C(=O)c(c34)ccc(c4)N
19506	sp|P9WPL5|CP142_MY	P9WPN5	88.94	48.0	402.0	DB07972	experimental	1-(3-METHYLPHENYL)-1H-BENZIMIDAZOL-5-AMINE	Cc1cccc(c1)-n2cnc(c23)cc(N)cc3
19507	sp|P9WPL5|CP142_MY	P53554	79.65	77.0	394.0	DB04450	experimental	Heptyl 1-Thiohexopyranoside	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)SCCCCCCC
19508	sp|P9WPL5|CP142_MY	Q00441	78.64	88.0	401.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
19509	sp|P9WPL5|CP142_MY	Q00441	78.64	88.0	401.0	DB03369	experimental	9-Aminophenanthrene	c1cccc(c12)c3c(cc2N)cccc3
19510	sp|P9WPL5|CP142_MY	Q00441	78.64	88.0	401.0	DB04070	experimental	6-Deoxyerythronolide B	C[C@@H]1C[C@H](C)[C@H](O)[C@@H](C)[C@H](O)[C@@H](C)C(=O)O[C@H](CC)[C@H](C)[C@H](O)[C@@H](C)C1=O
19511	sp|P9WPL5|CP142_MY	Q83WG3	89.7	52.0	409.0	DB06955	experimental	3,4-bis(7-chloro-1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid	c1ccc(Cl)c(c12)[nH]cc2-c3c(C(=O)O)[nH]c(C(=O)O)c3-c4c[nH]c(c45)c(Cl)ccc5
19512	sp|P9WPL5|CP142_MY	Q83WG3	89.7	52.0	409.0	DB07588	experimental	3,4-DI-1H-INDOL-3-YL-1H-PYRROLE-2,5-DICARBOXYLIC ACID	c1cccc(c12)[nH]cc2-c3c(C(=O)O)[nH]c(C(=O)O)c3-c4c[nH]c(c45)cccc5
19513	sp|P9WPL5|CP142_MY	Q9FCA6	79.4	88.0	404.0	DB02175	experimental	Malonic acid	OC(=O)CC(=O)O
19514	sp|P9WPL5|CP142_MY	Q9FCA6	79.4	88.0	404.0	DB02521	experimental	Flaviolin	Oc1cc(O)cc(c12)C(=O)C(O)=CC2=O
19515	sp|P9WPL5|CP142_MY	Q9FCA6	79.4	88.0	404.0	DB03254	experimental	4-Phenyl-1h-Imidazole	[nH]1cncc1-c2ccccc2
19516	sp|P9WPL5|CP142_MY	Q9FCA6	79.4	88.0	404.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
19517	sp|P9WPL5|CP142_MY	P00183	77.64	102.0	411.0	DB01011	approved; investigational	Metyrapone	c1ccncc1C(C)(C)C(=O)c2cnccc2
19518	sp|P9WPL5|CP142_MY	P00183	77.64	102.0	411.0	DB01663	experimental	lambda-bis(2,2'-bipyridine)-(5-methyl-2-2'-bipyridine)-C9-adamantane ruthenium (II)	C1=CC=CN2C1=C(C=CC=C3)N3[Ru+2]245(N6C(C=CC=C6)=C7N4C=CC=C7)N8C(=C9N5C=CC(C)=C9)C=C(C=C8)CCCCCCCCC(=O)N[C@@H]([C@H]12)[C@H]3C[C@@H](C1)C[C@@H](C2)C3
19519	sp|P9WPL5|CP142_MY	P00183	77.64	102.0	411.0	DB01703	experimental	N-(2-ferrocenylethyl)maleimide	O=C1C=CC(=O)N1CCC2(C3C4C5C26)[Fe]13456789C2C7C8C9C12
19520	sp|P9WPL5|CP142_MY	P00183	77.64	102.0	411.0	DB01744	approved	Camphor	C[C@]12C(=O)C[C@H](C1(C)C)CC2
19521	sp|P9WPL5|CP142_MY	P00183	77.64	102.0	411.0	DB01826	experimental	N-Butyl Isocyanide	CCCC[N+]#[C-]
19522	sp|P9WPL5|CP142_MY	P00183	77.64	102.0	411.0	DB02125	experimental	Adamantanone	O=C([C@H]12)[C@H]3C[C@@H](C1)C[C@@H](C2)C3
19523	sp|P9WPL5|CP142_MY	P00183	77.64	102.0	411.0	DB02617	experimental	1-(N-Imidazolyl)-2-Hydroxy-2-(2,3-Dichlorophenyl)Octane	CCCCCC[C@](O)(Cn1ccnc1)c2ccc(Cl)cc2Cl
19524	sp|P9WPL5|CP142_MY	P00183	77.64	102.0	411.0	DB02817	experimental	5-Exo-Hydroxycamphor	C[C@]12C[C@@H](O)[C@H](CC1=O)C2(C)C
19525	sp|P9WPL5|CP142_MY	P00183	77.64	102.0	411.0	DB02851	experimental	Thiocamphor	C[C@]12C(=S)C[C@H](C1(C)C)CC2
19526	sp|P9WPL5|CP142_MY	P00183	77.64	102.0	411.0	DB03031	experimental	Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Octyl-Amide	CN(C)c1cccc(c12)c(ccc2)S(=O)(=O)NCCCCCCCCNC(=O)C34CC5CC(C3)CC(C5)C4
19527	sp|P9WPL5|CP142_MY	P00183	77.64	102.0	411.0	DB03540	experimental	Norcamphor	[C@H]12CC[C@H](C1)C(=O)C2
19528	sp|P9WPL5|CP142_MY	P00183	77.64	102.0	411.0	DB03627	experimental	Adamantane	C12CC3CC(C1)CC(C3)C2
19529	sp|P9WPL5|CP142_MY	P00183	77.64	102.0	411.0	DB03836	experimental	1,3,5-trichlorobenzene	Clc1cc(Cl)cc(Cl)c1
19530	sp|P9WPL5|CP142_MY	P00183	77.64	102.0	411.0	DB04032	experimental	Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Butyl-Amide	CN(C)c1cccc(c12)c(ccc2)S(=O)(=O)NCCCCNC(=O)C34CC5CC(C3)CC(C5)C4
19531	sp|P9WPL5|CP142_MY	P00183	77.64	102.0	411.0	DB04501	experimental	Camphane	C[C@@]12CCC(C1(C)C)CC2
19532	sp|P9WPL5|CP142_MY	Q6V0L0	94.47	137.0	513.0	DB00523	approved; investigational	Alitretinoin	OC(=O)/C=C(\C)/C=C/C=C(/C)\C=C\C(C1(C)C)=C(C)CCC1
19533	sp|P9WPL5|CP142_MY	Q6V0L0	94.47	137.0	513.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
19534	sp|P9WPL5|CP142_MY	Q9NR63	88.44	138.0	490.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
19535	sp|P9WPL5|CP142_MY	P9WPP7	78.89	82.0	396.0	DB02721	experimental	4-Iodopyrazole	Ic1c[nH]nc1
19536	sp|P9WPL5|CP142_MY	P9WPP7	78.89	82.0	396.0	DB08761	experimental	(3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine-2,5-dione	Oc1ccc(cc1)C[C@@H]2NC(=O)[C@@H](NC2=O)Cc3ccc(O)cc3
19537	sp|P9WPL5|CP142_MY	O43174	91.71	126.0	491.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
19538	sp|P9WPL5|CP142_MY	O43174	91.71	126.0	491.0	DB13083	investigational	Talarozole	c1ncnn1C(C(CC)CC)c2ccc(cc2)Nc(s3)nc(c34)cccc4
19539	sp|P9WPL5|CP142_MY	O31440	78.14	82.0	393.0	DB04257	experimental	Palmitoleic Acid	CCCCCC/C=C\CCCCCCCC(=O)O
19540	sp|P9WPL5|CP142_MY	P11509	71.11	205.0	488.0	DB04665	experimental	Coumarin	c1cc(=O)oc(c12)cccc2
19541	sp|P9WPL5|CP142_MY	P11509	71.11	205.0	488.0	DB07609	experimental	N,N-DIMETHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	CN(C)Cc1ccc(o1)-c2cccnc2
19542	sp|P9WPL5|CP142_MY	P11509	71.11	205.0	488.0	DB07617	experimental	N-METHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	CNCc1ccc(o1)-c2cccnc2
19543	sp|P9WPL5|CP142_MY	P11509	71.11	205.0	488.0	DB07621	experimental	(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	NCc1ccc(o1)-c2cccnc2
19544	sp|P9WPL5|CP142_MY	P11509	71.11	205.0	488.0	DB07623	experimental	4,4'-DIPYRIDYL DISULFIDE	c1cnccc1SSc2ccncc2
19545	sp|P9WPL5|CP142_MY	P20813	86.68	139.0	484.0	DB02974	experimental	4-(4-Chlorophenyl)Imidazole	Clc1ccc(cc1)-c2cnc[nH]2
19546	sp|P9WPL5|CP142_MY	P20813	86.68	139.0	484.0	DB04664	experimental	Cyclohexyl-pentyl-maltoside	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@@H]2CO)OCCCCCC3CCCCC3
19547	sp|P9WPL5|CP142_MY	P20813	86.68	139.0	484.0	DB04794	approved; investigational	Bifonazole	c1ccccc1C(n2ccnc2)c3ccc(cc3)-c4ccccc4
19548	sp|P9WPL5|CP142_MY	P20813	86.68	139.0	484.0	DB08369	experimental	1-(biphenyl-4-ylmethyl)-1H-imidazole	c1cncn1Cc2ccc(cc2)-c3ccccc3
19549	sp|P9WPL5|CP142_MY	Q16850	82.66	148.0	477.0	DB01007	approved	Tioconazole	c1nccn1CC(c(c(Cl)c2)ccc2Cl)OCc3c(Cl)scc3
19550	sp|P9WPL5|CP142_MY	Q16850	82.66	148.0	477.0	DB01167	approved; investigational	Itraconazole	CCC(C)n1ncn(c1=O)-c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@@H](CO5)O[C@@]5(Cn6cncn6)c7ccc(Cl)cc7Cl
19551	sp|P9WPL5|CP142_MY	Q16850	82.66	148.0	477.0	DB05667	investigational	Levoketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OC[C@H](CO3)O[C@]3(Cn4ccnc4)c5ccc(Cl)cc5Cl
19552	sp|P9WPL5|CP142_MY	Q16850	82.66	148.0	477.0	DB07705	experimental	(S)-econazole	Clc1ccc(cc1)CO[C@H](Cn2ccnc2)c3c(Cl)cc(Cl)cc3
19553	sp|P9WPL5|CP142_MY	P08686	81.91	131.0	457.0	DB01026	approved; investigational	Ketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OCC(CO3)OC3(Cn4ccnc4)c5ccc(Cl)cc5Cl
19554	sp|P9WFE1|DCUP_MYC	P06132	96.64	13.0	358.0	DB03727	experimental	Coproporphyrin I	OC(=O)CCc(c12)c(C)c([nH]1)cc3nc(c(C)c3CCC(=O)O)cc4c(CCC(=O)O)c(C)c([nH]4)cc5nc(c2)c(C)c5CCC(=O)O
19555	sp|P9WFE1|DCUP_MYC	P06132	96.64	13.0	358.0	DB04461	experimental	Coproporphyrinogen III	OC(=O)CCc(c(c12)C)c([nH]1)Cc3c(C)c(CCC(=O)O)c([nH]3)Cc4c(C)c(CCC(=O)O)c([nH]4)Cc5c(c(C)c(C2)[nH]5)CCC(=O)O
19556	sp|P9WFF7|DPDS_MYC	P9WFF7	99.66	1.0	296.0	DB02552	experimental	Geranyl Diphosphate	CC(C)=CCC/C(C)=C/CO[P@@](=O)(O)OP(=O)(O)O
19557	sp|P9WFF7|DPDS_MYC	P9WFF7	99.66	1.0	296.0	DB04714	experimental	ISOPENTENYL PYROPHOSPHATE	CC(=C)CCO[P@@](=O)(O)OP(=O)(O)O
19558	sp|P9WFF7|DPDS_MYC	P60472	79.73	9.0	245.0	DB15690	approved	Fluoroestradiol F-18	O[C@H]1[C@H]([18F])C[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)cc4
19560	sp|P9WNN9|ECHA8_MY	P30084	95.33	42.0	287.0	DB02563	experimental	Hexanoyl-CoA	CCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
19561	sp|P9WNN9|ECHA8_MY	P30084	95.33	42.0	287.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
19562	sp|P9WNN9|ECHA8_MY	P30084	95.33	42.0	287.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
19563	sp|P9WNN9|ECHA8_MY	P30084	95.33	42.0	287.0	DB04117	experimental	4-(N,N-Dimethylamino)cinnamoyl-CoA	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)/C=C/c4ccc(cc4)N(C)C
19564	sp|P9WNN9|ECHA8_MY	P30084	95.33	42.0	287.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
19565	sp|P9WNN9|ECHA8_MY	P52045	100.39	1.0	259.0	DB03117	experimental	2-carboxypropyl-coenzyme A	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC[C@H](C)C(=O)O
19566	sp|P9WNN9|ECHA8_MY	O75521	98.05	139.0	391.0	DB08231	experimental	Myristic acid	CCCCCCCCCCCCCC(=O)O
19567	sp|P9WNN9|ECHA8_MY	O68600	98.05	2.0	254.0	DB01652	experimental	4-hydroxybenzoyl-CoA	Oc1ccc(cc1)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2OP(=O)(O)O)n3cnc(c34)c(N)ncn4
19568	sp|P9WNN9|ECHA8_MY	P42126	97.67	45.0	296.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
19569	sp|P9WNN9|ECHA8_MY	P42126	97.67	45.0	296.0	DB03127	experimental	Benzamidine	NC(=[NH2+])c1ccccc1
19570	sp|P9WNN9|ECHA8_MY	P9WNP5	103.11	42.0	307.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
19571	sp|P9WNN9|ECHA8_MY	P9WNP5	103.11	42.0	307.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
19572	sp|P9WNN9|ECHA8_MY	Q6NVY1	74.71	36.0	228.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
19573	sp|P9WNN9|ECHA8_MY	Q08426	91.05	8.0	242.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
19574	sp|P9WNN9|ECHA8_MY	Q93TU6	89.88	14.0	245.0	DB02906	experimental	(2s,4s)-Alpha-Campholinic Acid	CC1(C)[C@H](C)C(=O)C[C@H]1CC(O)O
19575	sp|P9WNN9|ECHA8_MY	P40939	85.6	41.0	261.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
19576	sp|P9WNN9|ECHA8_MY	P28793	75.88	14.0	209.0	DB08249	experimental	3,6,9,12,15-PENTAOXATRICOSAN-1-OL	CCCCCCCCOCCOCCOCCOCCOCCO
19577	sp|I6YC03|EPHB_MYC	P95276	99.72	1.0	356.0	DB07496	experimental	1,3-diphenylurea	c1ccccc1NC(=O)Nc2ccccc2
19578	sp|P9WQ11|END3_MYC	P17802	74.29	28.0	210.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
19579	sp|P9WQ11|END3_MYC	P17802	74.29	28.0	210.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
19580	sp|P9WQ11|END3_MYC	P17802	74.29	28.0	210.0	DB03366	experimental; investigational	Imidazole	[nH]1ccnc1
19581	sp|P9WQ11|END3_MYC	P17802	74.29	28.0	210.0	DB09462	approved; investigational	Glycerin	OCC(O)CO
19582	sp|P9WGT3|FABG_MYC	Q9BTZ2	103.24	20.0	275.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
19583	sp|P9WGT3|FABG_MYC	P0AEK2	97.57	2.0	243.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
19584	sp|P9WGT3|FABG_MYC	Q9WYS2	100.4	6.0	254.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
19585	sp|P9WGT3|FABG_MYC	Q92506	103.64	4.0	260.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
19586	sp|P9WGT3|FABG_MYC	Q92506	103.64	4.0	260.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
19590	sp|P9WGT3|FABG_MYC	Q84EX5	100.4	3.0	251.0	DB04619	experimental	Acetophenone	CC(=O)c1ccccc1
19591	sp|P9WGT3|FABG_MYC	Q84EX5	100.4	3.0	251.0	DB04784	experimental	(R)-1-phenylethanol	C[C@@H](O)c1ccccc1
19592	sp|P9WGT3|FABG_MYC	P0CG22	104.45	20.0	278.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
19593	sp|P9WGT3|FABG_MYC	P0CG22	104.45	20.0	278.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
19594	sp|P9WGT3|FABG_MYC	P0CG22	104.45	20.0	278.0	DB03541	experimental	10-Propargyl-5,8-Dideazafolic Acid	OC(=O)CC[C@@H](C(=O)O)NC(=O)c1ccc(cc1)N(CC#C)Cc(c2)ccc(c23)[nH]c(N)nc3=O
19595	sp|P9WGT3|FABG_MYC	P0CG22	104.45	20.0	278.0	DB07689	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)NCc(cn3)nc(c34)c(N)nc(n4)N
19596	sp|P9WGT3|FABG_MYC	P0CG22	104.45	20.0	278.0	DB07765	experimental	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)N(C)Cc(cn3)nc(c34)c(N)nc(n4)N
19597	sp|P9WGT3|FABG_MYC	P0AET8	98.38	6.0	249.0	DB02123	experimental	Glycochenodeoxycholic Acid	OC(=O)CNC(=O)CC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](C[C@H]3O)C[C@H](O)CC4
19598	sp|P9WGT3|FABG_MYC	P16544	102.83	5.0	259.0	DB01942	experimental; investigational	Formic acid	OC=O
19599	sp|P9WGT3|FABG_MYC	P16544	102.83	5.0	259.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
19600	sp|P9WGT3|FABG_MYC	P16544	102.83	5.0	259.0	DB07715	investigational	Emodin	Cc(c1)cc(O)c(c12)C(=O)c3c(C2=O)cc(O)cc3O
19601	sp|P9WGT3|FABG_MYC	Q9BY49	101.21	16.0	266.0	DB00173	approved; nutraceutical	Adenine	n1cnc(N)c(c12)[nH]cn2
19602	sp|P9WGT3|FABG_MYC	Q7Z4W1	95.95	5.0	242.0	DB02831	experimental	Dihydrogenphosphate	OP([O-])(=O)O
19603	sp|P9WGT3|FABG_MYC	Q7Z4W1	95.95	5.0	242.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
19604	sp|P9WGT3|FABG_MYC	Q16698	100.4	55.0	303.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
19605	sp|P9WGT3|FABG_MYC	Q16698	100.4	55.0	303.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
19606	sp|P9WGT3|FABG_MYC	Q6GI75	101.62	3.0	254.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
19607	sp|P9WGT3|FABG_MYC	Q6GI75	101.62	3.0	254.0	DB11155	approved	Triclocarban	Clc1ccc(cc1)NC(=O)Nc2cc(Cl)c(Cl)cc2
19608	sp|P9WGT3|FABG_MYC	Q99714	102.43	6.0	259.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
19609	sp|P9WGT3|FABG_MYC	Q99714	102.43	6.0	259.0	DB02820	experimental	1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct	C1CCCCCN1C(=O)[C@H](c2ccccc2)n(c3=S)cnc(c34)nn(c4)[C@H]5C=CN(C=C5C([O-])=N)[C@@H]6O[C@@H]([C@@H](O)[C@H]6O)COP([O-])(=O)OP(=O)(O)OC[C@H]7O[C@H]([C@H]([O-])[C@@H]7[O-])n8cnc(c89)c(N)ncn9
19610	sp|P9WGT3|FABG_MYC	Q99714	102.43	6.0	259.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
19611	sp|P9WGT3|FABG_MYC	A0A348A0U3	101.62	3.0	254.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
19612	sp|P9WGT3|FABG_MYC	Q6UWP2	97.98	7.0	249.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
19613	sp|P9WGT3|FABG_MYC	Q6PKH6	77.73	18.0	210.0	DB04200	experimental	Matairesinol	COc1cc(ccc1O)C[C@H]2COC(=O)[C@@H]2Cc3ccc(O)c(c3)OC
19614	sp|P9WGT3|FABG_MYC	P0AEK4	100.81	4.0	253.0	DB01691	experimental	Indole Naphthyridinone	c1cccc(c12)n(C)cc2CN(C)C(=O)/C=C/c(c3)cnc(c34)NC(=O)CC4
19615	sp|P9WGT3|FABG_MYC	P0AEK4	100.81	4.0	253.0	DB01865	experimental	3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide	c1cccc(c12)cc(n2C)CN(C)C(=O)/C=C/c3cnc(N)cc3
19616	sp|P9WGT3|FABG_MYC	P0AEK4	100.81	4.0	253.0	DB02379	experimental	Beta-D-Glucose	OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
19617	sp|P9WGT3|FABG_MYC	P0AEK4	100.81	4.0	253.0	DB03030	experimental	4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole	Cc1ccc(cc1)Cn2cnc(c2)-c3cccs3
19618	sp|P9WGT3|FABG_MYC	P0AEK4	100.81	4.0	253.0	DB03534	experimental	3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide	CC(=O)N(C)Cc1c(N)ccc(c1)C(=O)N(C)Cc(n2C)cc(c23)cccc3
19619	sp|P9WGT3|FABG_MYC	P0AEK4	100.81	4.0	253.0	DB04030	experimental	1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole	Oc1ccc(cc1)Cn2c(c3c(c24)cccc4)CN(CC3)C(=O)c5ccc(O)cc5
19620	sp|P9WGT3|FABG_MYC	P0AEK4	100.81	4.0	253.0	DB08265	experimental	2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL	Cc1ccc(cc1)S(=O)(=O)n(b2O)ncc(c23)cccc3
19621	sp|P9WGT3|FABG_MYC	P0AEK4	100.81	4.0	253.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
19622	sp|P9WGT3|FABG_MYC	P0AEK4	100.81	4.0	253.0	DB08605	experimental	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	CCCS(=O)(=O)n(b1O)ncc(c12)sc(c2)C
19623	sp|P9WGT3|FABG_MYC	Q7AUG5	97.98	3.0	245.0	DB04782	experimental	(S)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@H]2CO2
19624	sp|P9WGT3|FABG_MYC	Q93D82	97.98	3.0	245.0	DB04472	experimental	(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol	[N-]=[N+]=NC[C@H](O)c1ccc([N+]([O-])=O)cc1
19625	sp|P9WGT3|FABG_MYC	Q93D82	97.98	3.0	245.0	DB04499	experimental	(R)-styrene oxide	C1O[C@@H]1c2ccccc2
19626	sp|P9WGT3|FABG_MYC	Q93D82	97.98	3.0	245.0	DB04777	experimental	(R)-4-Nitrostyrene oxide	[O-][N+](=O)c1ccc(cc1)[C@@H]2CO2
19627	sp|P9WGT3|FABG_MYC	Q8I814	107.69	6.0	272.0	DB02015	experimental	Dihydrofolic Acid	O=c1[nH]c(N)nc(c12)NCC(=N2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
19628	sp|P9WGT3|FABG_MYC	Q8I814	107.69	6.0	272.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
19629	sp|P9WGT3|FABG_MYC	Q9HBH5	105.67	41.0	302.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
19630	sp|P9WGT3|FABG_MYC	O24990	100.4	4.0	252.0	DB04393	experimental	Soneclosan	Clc1cc(O)c(cc1)Oc2ccc(Cl)cc2
19631	sp|P9WGT3|FABG_MYC	O24990	100.4	4.0	252.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
19632	sp|P9WGT3|FABG_MYC	Q01782	112.15	8.0	285.0	DB02338	experimental	NADPH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
19633	sp|P9WGT3|FABG_MYC	Q01782	112.15	8.0	285.0	DB02532	experimental	2,4,6-Triaminoquinazoline	Nc(c1)ccc(c12)nc(N)nc2N
19634	sp|P9WGT3|FABG_MYC	Q01782	112.15	8.0	285.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
19635	sp|P9WGT3|FABG_MYC	Q01782	112.15	8.0	285.0	DB04400	experimental	L-erythro-7,8-dihydrobiopterin	C[C@H](O)[C@H](O)C(CN1)=Nc(c12)c(=O)nc([nH]2)N
19637	sp|P9WGT3|FABG_MYC	Q8NBQ5	82.19	29.0	232.0	DB02854	experimental	Aetiocholanolone	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@H](CC3)C[C@H](O)CC4
19638	sp|P9WGT3|FABG_MYC	Q8NBN7	85.83	32.0	244.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
19639	sp|P9WGT3|FABG_MYC	Q8TC12	85.02	34.0	244.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
19640	sp|P9WGT3|FABG_MYC	O75911	92.31	34.0	262.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
19641	sp|P9WGT3|FABG_MYC	Q9NYR8	78.54	6.0	200.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
19642	sp|P9WGT3|FABG_MYC	P14061	84.62	2.0	211.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
19643	sp|P9WGT3|FABG_MYC	P14061	84.62	2.0	211.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
19644	sp|P9WGT3|FABG_MYC	P14061	84.62	2.0	211.0	DB01561	experimental; illicit	Androstanedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
19645	sp|P9WGT3|FABG_MYC	P14061	84.62	2.0	211.0	DB02187	experimental	Equilin	O=C1CC[C@H]([C@@]12C)C=3[C@H](CC2)c4c(CC3)cc(O)cc4
19646	sp|P9WGT3|FABG_MYC	P14061	84.62	2.0	211.0	DB02323	experimental	EM-1745	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)C[C@@H]([C@@H]4O)CCCCCCCCC(=O)OC[C@H]5O[C@H]([C@H](O)[C@@H]5O)n6cnc(c67)c(N)ncn7
19647	sp|P9WGT3|FABG_MYC	P14061	84.62	2.0	211.0	DB02901	illicit; investigational	Stanolone	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
19648	sp|P9WGT3|FABG_MYC	P14061	84.62	2.0	211.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
19649	sp|P9WGT3|FABG_MYC	P14061	84.62	2.0	211.0	DB13951	experimental	Stanolone acetate	CC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)[C@@H](CC3)CC(=O)CC4
19650	sp|P9WGT3|FABG_MYC	Q02338	85.02	48.0	258.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
19651	sp|P9WGT3|FABG_MYC	Q96NR8	83.4	34.0	240.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
19652	sp|P9WGT3|FABG_MYC	P51659	84.62	5.0	214.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
19653	sp|P9WGT3|FABG_MYC	P51659	84.62	5.0	214.0	DB03192	experimental	(R)-3-hydroxydecanoyl-CoA	CCCCCCC[C@@H](O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
19654	sp|P9WGT3|FABG_MYC	P28845	82.59	23.0	227.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
19655	sp|P9WGT3|FABG_MYC	P28845	82.59	23.0	227.0	DB02329	experimental	Carbenoxolone	OC(=O)CCC(=O)O[C@@H](CC1)C(C)(C)[C@@H]([C@]12C)CC[C@]3(C)[C@@H]2C(=O)C=C4[C@H]5[C@@](C)(CC[C@@]34C)CC[C@](C5)(C)C(=O)O
19656	sp|P9WGT3|FABG_MYC	P28845	82.59	23.0	227.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
19657	sp|P9WGT3|FABG_MYC	P28845	82.59	23.0	227.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
19658	sp|P9WGT3|FABG_MYC	P28845	82.59	23.0	227.0	DB04652	experimental	Corticosterone	OCC(=O)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H]([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
19659	sp|P9WGT3|FABG_MYC	P28845	82.59	23.0	227.0	DB05064	investigational	INCB13739	 
19660	sp|P9WGT3|FABG_MYC	P28845	82.59	23.0	227.0	DB06992	experimental	(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone	Cc1ccc(cc1F)-c2nc(ccc2)C(=O)N(CC3(C)C)CCC3
19661	sp|P9WGT3|FABG_MYC	P28845	82.59	23.0	227.0	DB07017	experimental	(5S)-2-{[(1S)-1-(4-Fluorophenyl)ethyl]amino}-5-(2-hydroxy-2-propanyl)-5-methyl-1,3-thiazol-4(5H)-one	Fc1ccc(cc1)[C@H](C)NC(=NC2=O)S[C@@]2(C)C(C)(C)O
19662	sp|P9WGT3|FABG_MYC	P28845	82.59	23.0	227.0	DB07049	experimental	(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine	[O-][N+](=O)c1ccc(cc1)N2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)C(C)(C)C
19663	sp|P9WGT3|FABG_MYC	P28845	82.59	23.0	227.0	DB07056	experimental	2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide	CCN(CC)C(=O)Cc1cccc(n1)NS(=O)(=O)c2c(C)c(Cl)ccc2
19664	sp|P9WGT3|FABG_MYC	P28845	82.59	23.0	227.0	DB07310	experimental	(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one	Fc1ccccc1[C@H](C)NC(=NC2=O)S[C@]2(C)C(F)(F)F
19665	sp|P9WGT3|FABG_MYC	P28845	82.59	23.0	227.0	DB07316	experimental	N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)C3CCN(CC3)CC4(CC4)C(=O)N
19666	sp|P9WGT3|FABG_MYC	P28845	82.59	23.0	227.0	DB07619	experimental	N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	FC(F)(F)[C@@](C)(O)c1ccc(cc1)C(=O)N(C2CC2)[C@H]3CC[C@@H](CC3)c4cccnc4
19667	sp|P9WGT3|FABG_MYC	P28845	82.59	23.0	227.0	DB07624	experimental	1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide	C1CC1(C(=O)N)CN2C[C@@H](C)N(CC2)S(=O)(=O)c3ccc(cc3)[C@](C)(O)C(F)(F)F
19668	sp|P9WGT3|FABG_MYC	P28845	82.59	23.0	227.0	DB07866	experimental	(5S)-2-(Cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one	CCC[C@]1(C)SC(=NC1=O)NC2CCCCCCC2
19669	sp|P9WGT3|FABG_MYC	P28845	82.59	23.0	227.0	DB08277	experimental	2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE	CS(=O)(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4c(Cl)cc(F)cc4
19670	sp|P9WGT3|FABG_MYC	P28845	82.59	23.0	227.0	DB08280	experimental	(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE	NC(=O)[C@]12C[C@@H]3C[C@H](C1)C[C@H](C2)[C@H]3NC(=O)C(C)(C)Oc4ccc(OC)cc4
19671	sp|P9WGT3|FABG_MYC	P28845	82.59	23.0	227.0	DB08771	experimental	(5R)-2-[(2-Fluorophenyl)amino]-5-isopropyl-1,3-thiazol-4(5H)-one	CC(C)[C@H]1SC(=NC1=O)Nc2c(F)cccc2
19672	sp|P9WGT3|FABG_MYC	P28845	82.59	23.0	227.0	DB13751	approved; experimental	Glycyrrhizic acid	C1C[C@](C)(C(=O)O)C[C@H]([C@]12C)C=3[C@@](C)(CC2)[C@@]4(C)[C@H](C(=O)C3)[C@]5(C)[C@@H](CC4)C(C)(C)[C@H](CC5)O[C@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O[C@@H]7O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]7O
19673	sp|P9WGT3|FABG_MYC	P9WGR1	105.67	5.0	266.0	DB00609	approved	Ethionamide	CCc1nccc(c1)C(=S)N
19674	sp|P9WGT3|FABG_MYC	P9WGR1	105.67	5.0	266.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
19675	sp|P9WGT3|FABG_MYC	P9WGR1	105.67	5.0	266.0	DB02990	experimental	S-(2-Acetamidoethyl) hexadecanethioate	CCCCCCCCCCCCCCCC(=O)SCCNC(=O)C
19676	sp|P9WGT3|FABG_MYC	P9WGR1	105.67	5.0	266.0	DB04289	experimental	Genz-10850	[nH]1ccc(c12)cc(cc2)C(=O)N3CCN(CC3)C4c(cccc5)c5c(c46)cccc6
19677	sp|P9WGT3|FABG_MYC	P9WGR1	105.67	5.0	266.0	DB05154	approved	Pretomanid	[O-][N+](=O)c(n1)cn(c12)C[C@@H](CO2)OCc3ccc(OC(F)(F)F)cc3
19678	sp|P9WGT3|FABG_MYC	P9WGR1	105.67	5.0	266.0	DB07090	experimental	(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cccc(c1C)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
19679	sp|P9WGT3|FABG_MYC	P9WGR1	105.67	5.0	266.0	DB07123	experimental	N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE	Cc1ccc(cc1)C(=O)N2CCC(CC2)Cc3ccccc3
19680	sp|P9WGT3|FABG_MYC	P9WGR1	105.67	5.0	266.0	DB07155	experimental	(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE	c1ccccc1NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
19681	sp|P9WGT3|FABG_MYC	P9WGR1	105.67	5.0	266.0	DB07178	experimental	5-PENTYL-2-PHENOXYPHENOL	CCCCCc1cc(O)c(cc1)Oc2ccccc2
19682	sp|P9WGT3|FABG_MYC	P9WGR1	105.67	5.0	266.0	DB07188	experimental	(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(cc(Cl)c1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
19683	sp|P9WGT3|FABG_MYC	P9WGR1	105.67	5.0	266.0	DB07192	experimental	(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Brc1cc(ccc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
19684	sp|P9WGT3|FABG_MYC	P9WGR1	105.67	5.0	266.0	DB07222	experimental	(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Clc1cc(c(C)cc1)NC(=O)[C@@H]2CN(C(=O)C2)C3CCCCC3
19685	sp|P9WGT3|FABG_MYC	P9WGR1	105.67	5.0	266.0	DB07287	experimental	2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL	c1cccnc1Cc2cc(O)c(cc2)Oc3ccc(Cl)cc3Cl
19686	sp|P9WGT3|FABG_MYC	P9WGR1	105.67	5.0	266.0	DB08604	approved; investigational	Triclosan	Oc1cc(Cl)ccc1Oc2c(Cl)cc(Cl)cc2
19687	sp|P9WGT3|FABG_MYC	Q92781	80.57	23.0	222.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
19688	sp|P9WGT3|FABG_MYC	Q92781	80.57	23.0	222.0	DB00162	approved; nutraceutical; vet_approved	Vitamin A	OC/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
19689	sp|P9WGT3|FABG_MYC	P80365	83.0	76.0	281.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
19690	sp|P9WGT3|FABG_MYC	P80365	83.0	76.0	281.0	DB01185	approved; illicit	Fluoxymesterone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@](F)([C@H](C2)O)[C@]4(C)C(CC3)=CC(=O)CC4
19691	sp|P9WGT3|FABG_MYC	P80365	83.0	76.0	281.0	DB01569	experimental; illicit	Formebolone	C[C@]1(O)CC[C@H]([C@@]12C)[C@H]3[C@H]([C@@H](C2)O)[C@]4(C)C(CC3)=CC(=O)C(C=O)=C4
19692	sp|P9WGT3|FABG_MYC	P80365	83.0	76.0	281.0	DB14538	experimental; vet_approved	Hydrocortisone aceponate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CC)C(=O)COC(=O)C
19693	sp|P9WGT3|FABG_MYC	P80365	83.0	76.0	281.0	DB14539	approved; vet_approved	Hydrocortisone acetate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)C
19694	sp|P9WGT3|FABG_MYC	P80365	83.0	76.0	281.0	DB14540	approved; vet_approved	Hydrocortisone butyrate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCC
19695	sp|P9WGT3|FABG_MYC	P80365	83.0	76.0	281.0	DB14541	approved; investigational; vet_approved	Hydrocortisone cypionate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COC(=O)CCC5CCCC5
19696	sp|P9WGT3|FABG_MYC	P80365	83.0	76.0	281.0	DB14542	approved; vet_approved	Hydrocortisone phosphate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(O)C(=O)COP(=O)(O)O
19697	sp|P9WGT3|FABG_MYC	P80365	83.0	76.0	281.0	DB14543	approved; vet_approved	Hydrocortisone probutate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@]4(OC(=O)CCC)C(=O)COC(=O)CC
19698	sp|P9WGT3|FABG_MYC	P80365	83.0	76.0	281.0	DB14544	approved; vet_approved	Hydrocortisone valerate	C1CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2[C@@H](O)C[C@@]4(C)[C@H]3CC[C@@]4(C(=O)CO)OC(=O)CCCC
19699	sp|P9WGT3|FABG_MYC	P37059	85.43	79.0	290.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
19700	sp|P9WGT3|FABG_MYC	P37059	85.43	79.0	290.0	DB13952	approved; investigational; vet_approved	Estradiol acetate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)C
19701	sp|P9WGT3|FABG_MYC	P37059	85.43	79.0	290.0	DB13953	approved; investigational; vet_approved	Estradiol benzoate	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)c5ccccc5
19702	sp|P9WGT3|FABG_MYC	P37059	85.43	79.0	290.0	DB13954	approved; investigational; vet_approved	Estradiol cypionate	C1CCCC1CCC(=O)O[C@H]2CC[C@H]([C@@]23C)[C@H]4[C@H](CC3)c5c(CC4)cc(O)cc5
19703	sp|P9WGT3|FABG_MYC	P37059	85.43	79.0	290.0	DB13955	approved; investigational; vet_approved	Estradiol dienanthate	CCCCCCC(=O)O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(cc4)OC(=O)CCCCCC
19704	sp|P9WGT3|FABG_MYC	P37059	85.43	79.0	290.0	DB13956	approved; investigational; vet_approved	Estradiol valerate	c1cc(O)cc(CC2)c1[C@@H](CC3)[C@@H]2[C@@H]([C@]34C)CC[C@@H]4OC(=O)CCCC
19705	sp|P9WGT3|FABG_MYC	P37058	81.38	48.0	249.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
19706	sp|P9WGT3|FABG_MYC	P35270	100.4	6.0	254.0	DB02637	experimental	Oxaloacetate Ion	OC(=O)C(=O)CC([O-])=O
19707	sp|P9WGT3|FABG_MYC	P35270	100.4	6.0	254.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
19708	sp|P9WGT3|FABG_MYC	P35270	100.4	6.0	254.0	DB03886	experimental	Biopterin	C[C@@H](O)[C@@H](O)c(n1)cnc(c12)nc(N)[nH]c2=O
19709	sp|P9WGT3|FABG_MYC	P35270	100.4	6.0	254.0	DB04275	experimental	N-acetylserotonin	CC(=O)NCCc1c[nH]c(c12)ccc(c2)O
19710	sp|P9WGT3|FABG_MYC	P56937	93.93	2.0	234.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
19711	sp|P9WGT3|FABG_MYC	P16152	93.52	7.0	238.0	DB01698	approved; experimental; investigational	Rutin	O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O[C@H]1C)OC[C@H]2O[C@H]([C@H](O)[C@@H](O)[C@@H]2O)Oc(c3=O)c(-c4cc(O)c(O)cc4)oc(c35)cc(O)cc5O
19712	sp|P9WGT3|FABG_MYC	P16152	93.52	7.0	238.0	DB02709	investigational	Resveratrol	Oc1ccc(cc1)/C=C/c2cc(O)cc(O)c2
19713	sp|P9WGT3|FABG_MYC	P16152	93.52	7.0	238.0	DB03394	experimental	Heptaethylene glycol	OCCOCCOCCOCCOCCOCCOCCO
19714	sp|P9WGT3|FABG_MYC	P16152	93.52	7.0	238.0	DB03556	experimental	2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400	CCOCCOCCOCCOCCOCCOCCOCCOCCO
19715	sp|P9WGT3|FABG_MYC	P16152	93.52	7.0	238.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
19716	sp|P9WGT3|FABG_MYC	P16152	93.52	7.0	238.0	DB04463	experimental	3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol	n1cnc(N)c(c12)c(nn2C(C)(C)C)-c3cccc(O)c3
19717	sp|P9WGT3|FABG_MYC	P16152	93.52	7.0	238.0	DB11672	approved; experimental; investigational	Curcumin	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2cc(OC)c(O)cc2
19718	sp|P9WGT3|FABG_MYC	P16152	93.52	7.0	238.0	DB14635	experimental	Curcumin sulfate	COc1cc(ccc1O)/C=C/C(=O)CC(=O)/C=C/c2ccc(OS(=O)(=O)O)c(c2)OC
19719	sp|P9WGT3|FABG_MYC	P09417	76.52	9.0	198.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
19720	sp|P9WGT3|FABG_MYC	P09417	76.52	9.0	198.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
19721	sp|P9WGT3|FABG_MYC	Q8T8E9	78.54	2.0	196.0	DB03435	experimental	Uridine-5'-Diphosphate	O=c1[nH]c(=O)ccn1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O
19722	sp|P9WGT3|FABG_MYC	P26391	77.33	3.0	194.0	DB03751	experimental	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	O=c1[nH]c(=O)n(cc1C)[C@H]2C[C@H](O)[C@H](O2)COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
19723	sp|P9WGT3|FABG_MYC	P14169	70.85	4.0	179.0	DB04555	experimental	Cytidine-5'-Diphosphate	Nc1nc(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)O
19724	sp|P9WPM7|CP136_MY	P08684	92.68	36.0	492.0	DB00143	approved; investigational; nutraceutical	Glutathione	OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(=O)O
19725	sp|P9WPM7|CP136_MY	P08684	92.68	36.0	492.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
19726	sp|P9WPM7|CP136_MY	P08684	92.68	36.0	492.0	DB05478	investigational	Pradefovir mesylate	n1cnc(N)c(c12)ncn2CCOC[P@@]3(=O)OCC[C@H](O3)c4cc(Cl)ccc4
19727	sp|P9WPM7|CP136_MY	P08684	92.68	36.0	492.0	DB06634	investigational	Casopitant	FC(F)(F)c1cc(cc(c1)C(F)(F)F)[C@@H](C)N(C)C(=O)N2CC[C@H](N3CCN(CC3)C(=O)C)C[C@@H]2c4ccc(F)cc4C
19728	sp|P9WPM7|CP136_MY	P08684	92.68	36.0	492.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
19729	sp|P9WPM7|CP136_MY	P20815	92.28	37.0	491.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
19730	sp|P9WPM7|CP136_MY	P20815	92.28	37.0	491.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
19731	sp|P9WPM7|CP136_MY	P20815	92.28	37.0	491.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
19732	sp|P9WPM7|CP136_MY	P24462	92.68	36.0	492.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
19733	sp|P9WPM7|CP136_MY	P24462	92.68	36.0	492.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
19734	sp|P9WPM7|CP136_MY	P24462	92.68	36.0	492.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
19735	sp|P9WPM7|CP136_MY	Q9HB55	92.89	35.0	492.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
19736	sp|P9WPM7|CP136_MY	Q16850	92.28	44.0	498.0	DB01007	approved	Tioconazole	c1nccn1CC(c(c(Cl)c2)ccc2Cl)OCc3c(Cl)scc3
19737	sp|P9WPM7|CP136_MY	Q16850	92.28	44.0	498.0	DB01167	approved; investigational	Itraconazole	CCC(C)n1ncn(c1=O)-c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@@H](CO5)O[C@@]5(Cn6cncn6)c7ccc(Cl)cc7Cl
19738	sp|P9WPM7|CP136_MY	Q16850	92.28	44.0	498.0	DB05667	investigational	Levoketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OC[C@H](CO3)O[C@]3(Cn4ccnc4)c5ccc(Cl)cc5Cl
19739	sp|P9WPM7|CP136_MY	Q16850	92.28	44.0	498.0	DB07705	experimental	(S)-econazole	Clc1ccc(cc1)CO[C@H](Cn2ccnc2)c3c(Cl)cc(Cl)cc3
19740	sp|P9WPM7|CP136_MY	O43174	91.46	39.0	489.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
19741	sp|P9WPM7|CP136_MY	O43174	91.46	39.0	489.0	DB13083	investigational	Talarozole	c1ncnn1C(C(CC)CC)c2ccc(cc2)Nc(s3)nc(c34)cccc4
19742	sp|P9WPM7|CP136_MY	P10632	91.26	27.0	476.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
19743	sp|P9WPM7|CP136_MY	P10632	91.26	27.0	476.0	DB03796	approved	Palmitic Acid	CCCCCCCCCCCCCCCC(=O)O
19744	sp|P9WPM7|CP136_MY	P10632	91.26	27.0	476.0	DB08607	experimental	(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE	O=C1NC(=O)S[C@@H]1Cc2ccc(cc2)OC[C@@](O3)(C)CCc(c34)c(C)c(O)c(C)c4C
19745	sp|P9WPM7|CP136_MY	P11712	91.46	27.0	477.0	DB03317	experimental	Ferroheme C	[Fe-2]123[N+]4=C5C=C6[N+]1=C(C(C)=C6C(C)S)C=C7[N+]2=C(C(=C7C)CCC(=O)O)C=C8[N+]3=C(C=C4C(=C5C)C(C)S)C(C)=C8CCC(=O)O
19746	sp|P9WPM7|CP136_MY	P11712	91.46	27.0	477.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
19747	sp|P9WPM7|CP136_MY	P11712	91.46	27.0	477.0	DB12319	investigational; withdrawn	Benzbromarone	c1cccc(c12)c(c(o2)CC)C(=O)c3cc(Br)c(O)c(Br)c3
19748	sp|P9WPM7|CP136_MY	Q9NR63	90.85	42.0	489.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
19749	sp|P9WPM7|CP136_MY	P04798	91.67	32.0	483.0	DB02342	investigational	2-Methoxyestradiol	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)c(c4)OC
19750	sp|P9WPM7|CP136_MY	P04798	91.67	32.0	483.0	DB12379	investigational	Indirubin	c1cccc(c12)NC(=O)C\2=C(C3=O)\Nc(c34)cccc4
19751	sp|P9WPM7|CP136_MY	P04798	91.67	32.0	483.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
19752	sp|P9WPM7|CP136_MY	P33260	89.43	29.0	469.0	DB07670	experimental	N,4-Dimethyl-N-(1-phenyl-1H-pyrazol-5-yl)benzenesulfonamide	Cc1ccc(cc1)S(=O)(=O)N(C)c2ccnn2-c3ccccc3
19753	sp|P9WPM7|CP136_MY	P50859	95.33	56.0	525.0	DB01026	approved; investigational	Ketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OCC(CO3)OC3(Cn4ccnc4)c5ccc(Cl)cc5Cl
19754	sp|P9WPM7|CP136_MY	P50859	95.33	56.0	525.0	DB01167	approved; investigational	Itraconazole	CCC(C)n1ncn(c1=O)-c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@@H](CO5)O[C@@]5(Cn6cncn6)c7ccc(Cl)cc7Cl
19755	sp|P9WPM7|CP136_MY	P50859	95.33	56.0	525.0	DB09040	approved	Efinaconazole	C=C1CCN(CC1)[C@H](C)[C@](O)(Cn2cncn2)c3c(F)cc(F)cc3
19756	sp|P9WPM7|CP136_MY	P50859	95.33	56.0	525.0	DB11633	approved; investigational	Isavuconazole	c1ncnn1C[C@](O)(c2c(F)ccc(F)c2)[C@@H](C)c3nc(cs3)-c4ccc(C#N)cc4
19757	sp|P9WPM7|CP136_MY	P10614	94.92	55.0	522.0	DB06890	experimental	(2R)-2-PHENYL-N-PYRIDIN-4-YLBUTANAMIDE	c1ccccc1[C@@H](CC)C(=O)Nc2ccncc2
19758	sp|P9WPM7|CP136_MY	P10614	94.92	55.0	522.0	DB07560	experimental	N-[(1S)-2-methyl-1-(pyridin-4-ylcarbamoyl)propyl]cyclohexanecarboxamide	c1cnccc1NC(=O)[C@H](C(C)C)NC(=O)C2CCCCC2
19759	sp|P9WPM7|CP136_MY	P10614	94.92	55.0	522.0	DB07568	experimental	(2S)-2-[(2,1,3-BENZOTHIADIAZOL-4-YLSULFONYL)AMINO]-2-PHENYL-N-PYRIDIN-4-YLACETAMIDE	n1snc(c12)cccc2S(=O)(=O)N[C@@H](c3ccccc3)C(=O)Nc4ccncc4
19760	sp|P9WPM7|CP136_MY	P10614	94.92	55.0	522.0	DB07569	experimental	CIS-4-METHYL-N-[(1S)-3-(METHYLSULFANYL)-1-(PYRIDIN-4-YLCARBAMOYL)PROPYL]CYCLOHEXANECARBOXAMIDE	c1cnccc1NC(=O)[C@H](CCSC)NC(=O)[C@@H]2CC[C@H](C)CC2
19761	sp|P9WPM7|CP136_MY	P10614	94.92	55.0	522.0	DB07572	experimental	3-{[(4-methylphenyl)sulfonyl]amino}propyl pyridin-4-ylcarbamate	Cc1ccc(cc1)S(=O)(=O)NCCCOC(=O)Nc2ccncc2
19762	sp|P9WPM7|CP136_MY	P10614	94.92	55.0	522.0	DB07635	experimental	4,4'-Dihydroxybenzophenone	Oc1ccc(cc1)C(=O)c2ccc(O)cc2
19763	sp|P9WPM7|CP136_MY	P33261	91.46	27.0	477.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
19764	sp|P9WPM7|CP136_MY	P33261	91.46	27.0	477.0	DB12319	investigational; withdrawn	Benzbromarone	c1cccc(c12)c(c(o2)CC)C(=O)c3cc(Br)c(O)c(Br)c3
19765	sp|P9WPM7|CP136_MY	P11509	90.45	28.0	473.0	DB04665	experimental	Coumarin	c1cc(=O)oc(c12)cccc2
19766	sp|P9WPM7|CP136_MY	P11509	90.45	28.0	473.0	DB07609	experimental	N,N-DIMETHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	CN(C)Cc1ccc(o1)-c2cccnc2
19767	sp|P9WPM7|CP136_MY	P11509	90.45	28.0	473.0	DB07617	experimental	N-METHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	CNCc1ccc(o1)-c2cccnc2
19768	sp|P9WPM7|CP136_MY	P11509	90.45	28.0	473.0	DB07621	experimental	(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	NCc1ccc(o1)-c2cccnc2
19769	sp|P9WPM7|CP136_MY	P11509	90.45	28.0	473.0	DB07623	experimental	4,4'-DIPYRIDYL DISULFIDE	c1cnccc1SSc2ccncc2
19770	sp|P9WPM7|CP136_MY	P10613	96.34	48.0	522.0	DB00196	approved; investigational	Fluconazole	c1ncnn1CC(O)(Cn2cncn2)c3c(F)cc(F)cc3
19771	sp|P9WPM7|CP136_MY	P10613	96.34	48.0	522.0	DB00239	approved	Oxiconazole	Clc1cc(Cl)c(cc1)CO/N=C(\Cn2ccnc2)c3ccc(Cl)cc3Cl
19772	sp|P9WPM7|CP136_MY	P10613	96.34	48.0	522.0	DB00251	approved	Terconazole	CC(C)N1CCN(CC1)c2ccc(cc2)OC[C@@H](CO3)O[C@@]3(Cn4cncn4)c5c(Cl)cc(Cl)cc5
19773	sp|P9WPM7|CP136_MY	P10613	96.34	48.0	522.0	DB00257	approved; vet_approved	Clotrimazole	Clc1ccccc1C(n2ccnc2)(c3ccccc3)c4ccccc4
19774	sp|P9WPM7|CP136_MY	P10613	96.34	48.0	522.0	DB00582	approved	Voriconazole	c1ncnn1C[C@](O)(c2c(F)cc(F)cc2)[C@@H](C)c3ncncc3F
19775	sp|P9WPM7|CP136_MY	P10613	96.34	48.0	522.0	DB01007	approved	Tioconazole	c1nccn1CC(c(c(Cl)c2)ccc2Cl)OCc3c(Cl)scc3
19776	sp|P9WPM7|CP136_MY	P10613	96.34	48.0	522.0	DB01110	approved; investigational; vet_approved	Miconazole	Clc1cc(Cl)c(cc1)COC(Cn2ccnc2)c3c(Cl)cc(Cl)cc3
19777	sp|P9WPM7|CP136_MY	P10613	96.34	48.0	522.0	DB01127	approved	Econazole	Clc1ccc(cc1)COC(Cn2ccnc2)c3c(Cl)cc(Cl)cc3
19778	sp|P9WPM7|CP136_MY	P10613	96.34	48.0	522.0	DB01153	approved; investigational	Sertaconazole	Clc1cc(Cl)ccc1C(Cn2cncc2)OCc3csc(c34)c(Cl)ccc4
19779	sp|P9WPM7|CP136_MY	P10613	96.34	48.0	522.0	DB01263	approved; investigational; vet_approved	Posaconazole	C[C@H](O)[C@H](CC)n1ncn(c1=O)-c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@H](CO5)C[C@]5(Cn6cncn6)c7c(F)cc(F)cc7
19780	sp|P9WPM7|CP136_MY	P10613	96.34	48.0	522.0	DB04794	approved; investigational	Bifonazole	c1ccccc1C(n2ccnc2)c3ccc(cc3)-c4ccccc4
19781	sp|P9WPM7|CP136_MY	P10613	96.34	48.0	522.0	DB08933	approved	Luliconazole	Clc1cc(Cl)c(cc1)[C@@H]2CS/C(S2)=C(/C#N)n3ccnc3
19782	sp|P9WPM7|CP136_MY	Q6V0L0	94.92	43.0	510.0	DB00523	approved; investigational	Alitretinoin	OC(=O)/C=C(\C)/C=C/C=C(/C)\C=C\C(C1(C)C)=C(C)CCC1
19783	sp|P9WPM7|CP136_MY	Q6V0L0	94.92	43.0	510.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
19784	sp|P9WPM7|CP136_MY	P20813	91.67	20.0	471.0	DB02974	experimental	4-(4-Chlorophenyl)Imidazole	Clc1ccc(cc1)-c2cnc[nH]2
19785	sp|P9WPM7|CP136_MY	P20813	91.67	20.0	471.0	DB04664	experimental	Cyclohexyl-pentyl-maltoside	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@@H]2CO)OCCCCCC3CCCCC3
19786	sp|P9WPM7|CP136_MY	P20813	91.67	20.0	471.0	DB04794	approved; investigational	Bifonazole	c1ccccc1C(n2ccnc2)c3ccc(cc3)-c4ccccc4
19787	sp|P9WPM7|CP136_MY	P20813	91.67	20.0	471.0	DB08369	experimental	1-(biphenyl-4-ylmethyl)-1H-imidazole	c1cncn1Cc2ccc(cc2)-c3ccccc3
19788	sp|P9WPM7|CP136_MY	P05177	93.29	34.0	493.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
19789	sp|P9WPM7|CP136_MY	P05177	93.29	34.0	493.0	DB07453	experimental	alpha-Naphthoflavone	c1ccccc1-c(cc2=O)oc(c23)c4c(cc3)cccc4
19790	sp|P9WPM7|CP136_MY	P05177	93.29	34.0	493.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
19791	sp|P9WPM7|CP136_MY	P05177	93.29	34.0	493.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
19792	sp|P9WPM7|CP136_MY	P05177	93.29	34.0	493.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
19793	sp|P9WPM7|CP136_MY	P05181	90.04	31.0	474.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
19795	sp|P9WPM7|CP136_MY	P24557	97.76	47.0	528.0	DB00795	approved	Sulfasalazine	OC(=O)c1cc(ccc1O)/N=N/c2ccc(cc2)S(=O)(=O)Nc3ncccc3
19796	sp|P9WPM7|CP136_MY	P24557	97.76	47.0	528.0	DB01207	experimental	Ridogrel	OC(=O)CCCCO/N=C(/c1cnccc1)c2cc(C(F)(F)F)ccc2
19797	sp|P9WPM7|CP136_MY	P24557	97.76	47.0	528.0	DB03052	experimental	Dazoxiben	OC(=O)c1ccc(cc1)OCCn2ccnc2
19798	sp|P9WPM7|CP136_MY	P24557	97.76	47.0	528.0	DB05505	investigational	NM-702	 
19799	sp|P9WPM7|CP136_MY	P05093	91.87	25.0	477.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
19800	sp|P9WPM7|CP136_MY	P05093	91.87	25.0	477.0	DB00396	approved; vet_approved	Progesterone	CC(=O)[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
19801	sp|P9WPM7|CP136_MY	P05093	91.87	25.0	477.0	DB00421	approved	Spironolactone	C1CC(=O)O[C@@]12[C@]3(C)[C@@H](CC2)[C@H]4[C@H](CC3)[C@]5(C)C(=CC(=O)CC5)C[C@H]4SC(=O)C
19802	sp|P9WPM7|CP136_MY	P05093	91.87	25.0	477.0	DB01026	approved; investigational	Ketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OCC(CO3)OC3(Cn4ccnc4)c5ccc(Cl)cc5Cl
19803	sp|P9WPM7|CP136_MY	P05093	91.87	25.0	477.0	DB05812	approved	Abiraterone	C1C[C@H](O)CC([C@]12C)=CC[C@@H]3[C@@H]2CC[C@@]4(C)[C@H]3CC=C4c5cccnc5
19804	sp|P9WPM7|CP136_MY	P05093	91.87	25.0	477.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
19806	sp|P9WPM7|CP136_MY	P05093	91.87	25.0	477.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
19807	sp|P9WPM7|CP136_MY	Q16678	96.34	36.0	510.0	DB01645	investigational	Genistein	Oc1ccc(cc1)-c(c2=O)coc(c23)cc(O)cc3O
19808	sp|P9WPM7|CP136_MY	Q16678	96.34	36.0	510.0	DB02342	investigational	2-Methoxyestradiol	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)c(c4)OC
19809	sp|P9WPM7|CP136_MY	Q16678	96.34	36.0	510.0	DB03467	experimental	Naringenin	Oc1ccc(cc1)[C@@H](O2)CC(=O)c(c23)c(O)cc(c3)O
19810	sp|P9WPM7|CP136_MY	Q16678	96.34	36.0	510.0	DB04216	experimental; investigational	Quercetin	Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(O)c3
19811	sp|P9WPM7|CP136_MY	Q16678	96.34	36.0	510.0	DB06732	experimental	beta-Naphthoflavone	c1cccc(c12)c3c(cc2)oc(cc3=O)-c4ccccc4
19812	sp|P9WPM7|CP136_MY	Q16678	96.34	36.0	510.0	DB07776	approved; experimental	Flavone	c1cccc(c12)oc(cc2=O)-c3ccccc3
19813	sp|P9WPM7|CP136_MY	Q16678	96.34	36.0	510.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
19814	sp|P9WPM7|CP136_MY	Q16678	96.34	36.0	510.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
19815	sp|P9WPM7|CP136_MY	Q02928	83.54	92.0	503.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
19816	sp|P9WPM7|CP136_MY	P14779	84.96	25.0	443.0	DB03440	experimental	N-hexadecanoylglycine	CCCCCCCCCCCCCCCC(=O)NCC(=O)O
19817	sp|P9WPM7|CP136_MY	P14779	84.96	25.0	443.0	DB04257	experimental	Palmitoleic Acid	CCCCCC/C=C\CCCCCCCC(=O)O
19818	sp|P9WPM7|CP136_MY	P14779	84.96	25.0	443.0	DB08086	experimental	N-[12-(1H-imidazol-1-yl)dodecanoyl]-L-leucine	CC(C)C[C@@H](C(=O)O)NC(=O)CCCCCCCCCCCn1ccnc1
19819	sp|P9WPM7|CP136_MY	P15538	86.18	68.0	492.0	DB00648	approved	Mitotane	Clc1ccc(cc1)C(C(Cl)Cl)c2ccccc2Cl
19820	sp|P9WPM7|CP136_MY	P15538	86.18	68.0	492.0	DB01011	approved; investigational	Metyrapone	c1ccncc1C(C)(C)C(=O)c2cnccc2
19821	sp|P9WPM7|CP136_MY	P15538	86.18	68.0	492.0	DB05667	investigational	Levoketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OC[C@H](CO3)O[C@]3(Cn4ccnc4)c5ccc(Cl)cc5Cl
19822	sp|P9WPM7|CP136_MY	P15538	86.18	68.0	492.0	DB11837	approved; investigational	Osilodrostat	c1ncc(n12)CC[C@@H]2c3c(F)cc(C#N)cc3
19823	sp|P9WPM7|CP136_MY	P19099	86.38	68.0	493.0	DB00421	approved	Spironolactone	C1CC(=O)O[C@@]12[C@]3(C)[C@@H](CC2)[C@H]4[C@H](CC3)[C@]5(C)C(=CC(=O)CC5)C[C@H]4SC(=O)C
19824	sp|P9WPM7|CP136_MY	P19099	86.38	68.0	493.0	DB11837	approved; investigational	Osilodrostat	c1ncc(n12)CC[C@@H]2c3c(F)cc(C#N)cc3
19825	sp|P9WPM7|CP136_MY	P10635	90.65	32.0	478.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
19826	sp|P9WPM7|CP136_MY	P10635	90.65	32.0	478.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
19827	sp|P9WPM7|CP136_MY	P10635	90.65	32.0	478.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
19828	sp|P9WPM7|CP136_MY	P08686	88.82	45.0	482.0	DB01026	approved; investigational	Ketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OCC(CO3)OC3(Cn4ccnc4)c5ccc(Cl)cc5Cl
19829	sp|P9WPM7|CP136_MY	O15528	88.41	69.0	504.0	DB01436	approved; nutraceutical	Alfacalcidol	CC(C)CCC[C@@H](C)[C@H]1CC[C@H]([C@@]12C)/C(CCC2)=C/C=C3/C[C@@H](O)C[C@H](O)C3=C
19830	sp|P9WPM7|CP136_MY	P05108	88.21	75.0	509.0	DB00357	approved; investigational	Aminoglutethimide	Nc1ccc(cc1)C2(CC)CCC(=O)NC2=O
19831	sp|P9WPM7|CP136_MY	P53554	77.64	11.0	393.0	DB04450	experimental	Heptyl 1-Thiohexopyranoside	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)SCCCCCCC
19832	sp|P9WPM7|CP136_MY	P11511	79.88	72.0	465.0	DB00184	approved	Nicotine	CN1CCC[C@H]1c2cnccc2
19833	sp|P9WPM7|CP136_MY	P11511	79.88	72.0	465.0	DB00357	approved; investigational	Aminoglutethimide	Nc1ccc(cc1)C2(CC)CCC(=O)NC2=O
19834	sp|P9WPM7|CP136_MY	P11511	79.88	72.0	465.0	DB00655	approved	Estrone	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)cc4
19835	sp|P9WPM7|CP136_MY	P11511	79.88	72.0	465.0	DB00894	approved; investigational	Testolactone	C1=CC(=O)C=C([C@]12C)CC[C@@H]3[C@@H]2CC[C@@]4(C)[C@H]3CCC(O4)=O
19836	sp|P9WPM7|CP136_MY	P11511	79.88	72.0	465.0	DB00990	approved; investigational	Exemestane	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(C(C3)=C)=CC(=O)C=C4
19837	sp|P9WPM7|CP136_MY	P11511	79.88	72.0	465.0	DB01006	approved; investigational	Letrozole	N#Cc1ccc(cc1)C(n2cncn2)c3ccc(C#N)cc3
19838	sp|P9WPM7|CP136_MY	P11511	79.88	72.0	465.0	DB01217	approved; investigational	Anastrozole	N#CC(C)(C)c1cc(C(C)(C)C#N)cc(c1)Cn2cncn2
19839	sp|P9WPM7|CP136_MY	P11511	79.88	72.0	465.0	DB02342	investigational	2-Methoxyestradiol	O[C@H]1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)c4c(CC3)cc(O)c(c4)OC
19840	sp|P9WPM7|CP136_MY	P11511	79.88	72.0	465.0	DB03467	experimental	Naringenin	Oc1ccc(cc1)[C@@H](O2)CC(=O)c(c23)c(O)cc(c3)O
19841	sp|P9WPM7|CP136_MY	P11511	79.88	72.0	465.0	DB04539	experimental	Glyphosate	OC(=O)C[NH2+]CP(=O)(O)O
19842	sp|P9WPM7|CP136_MY	P11511	79.88	72.0	465.0	DB05749	investigational	MPI-674	 
19843	sp|P9WPM7|CP136_MY	Q16647	90.85	34.0	481.0	DB00812	approved; vet_approved	Phenylbutazone	CCCCC1C(=O)N(c2ccccc2)N(C1=O)c3ccccc3
19844	sp|P9WPM7|CP136_MY	Q16647	90.85	34.0	481.0	DB01240	approved	Epoprostenol	OC(=O)CCC/C=C(C1)\O[C@H]([C@H]12)C[C@@H](O)[C@@H]2/C=C/[C@@H](O)CCCCC
19845	sp|P9WPM7|CP136_MY	Q16647	90.85	34.0	481.0	DB08675	experimental	(5Z)-7-{(1R,4S,5R,6R)-6-[(1E)-1-Octen-1-yl]-2,3-diazabicyclo[2.2.1]hept-2-en-5-yl}-5-heptenoic acid	OC(=O)CCC/C=C\C[C@@H]([C@H]12)[C@H]([C@@H](C1)N=N2)/C=C/CCCCCC
19846	sp|P9WPM7|CP136_MY	O31440	79.27	13.0	403.0	DB04257	experimental	Palmitoleic Acid	CCCCCC/C=C\CCCCCCCC(=O)O
19847	sp|P9WPM7|CP136_MY	Q00441	77.64	20.0	402.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
19848	sp|P9WPM7|CP136_MY	Q00441	77.64	20.0	402.0	DB03369	experimental	9-Aminophenanthrene	c1cccc(c12)c3c(cc2N)cccc3
19849	sp|P9WPM7|CP136_MY	Q00441	77.64	20.0	402.0	DB04070	experimental	6-Deoxyerythronolide B	C[C@@H]1C[C@H](C)[C@H](O)[C@@H](C)[C@H](O)[C@@H](C)C(=O)O[C@H](CC)[C@H](C)[C@H](O)[C@@H](C)C1=O
19850	sp|P9WPM7|CP136_MY	Q9FCA6	74.8	36.0	404.0	DB02175	experimental	Malonic acid	OC(=O)CC(=O)O
19851	sp|P9WPM7|CP136_MY	Q9FCA6	74.8	36.0	404.0	DB02521	experimental	Flaviolin	Oc1cc(O)cc(c12)C(=O)C(O)=CC2=O
19852	sp|P9WPM7|CP136_MY	Q9FCA6	74.8	36.0	404.0	DB03254	experimental	4-Phenyl-1h-Imidazole	[nH]1cncc1-c2ccccc2
19853	sp|P9WPM7|CP136_MY	Q9FCA6	74.8	36.0	404.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
19854	sp|P9WNN7|ECH12_MY	P9WNP5	99.3	24.0	307.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
19855	sp|P9WNN7|ECH12_MY	P9WNP5	99.3	24.0	307.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
19856	sp|P9WNN7|ECH12_MY	P30084	87.37	40.0	289.0	DB02563	experimental	Hexanoyl-CoA	CCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
19857	sp|P9WNN7|ECH12_MY	P30084	87.37	40.0	289.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
19858	sp|P9WNN7|ECH12_MY	P30084	87.37	40.0	289.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
19859	sp|P9WNN7|ECH12_MY	P30084	87.37	40.0	289.0	DB04117	experimental	4-(N,N-Dimethylamino)cinnamoyl-CoA	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)/C=C/c4ccc(cc4)N(C)C
19860	sp|P9WNN7|ECH12_MY	P30084	87.37	40.0	289.0	DB09568	approved; investigational	Omega-3-carboxylic acids	 
19861	sp|P9WNN7|ECH12_MY	O75521	89.82	135.0	391.0	DB08231	experimental	Myristic acid	CCCCCCCCCCCCCC(=O)O
19862	sp|P9WNN7|ECH12_MY	P52045	87.02	11.0	259.0	DB03117	experimental	2-carboxypropyl-coenzyme A	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@H]([C@H]3O)OP(=O)(O)O)COP(=O)(O)OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC[C@H](C)C(=O)O
19863	sp|P9WNN7|ECH12_MY	O68600	77.19	7.0	227.0	DB01652	experimental	4-hydroxybenzoyl-CoA	Oc1ccc(cc1)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2OP(=O)(O)O)n3cnc(c34)c(N)ncn4
19864	sp|P9WNN7|ECH12_MY	P42126	87.72	45.0	295.0	DB02910	experimental	Octanoyl-Coenzyme A	CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
19865	sp|P9WNN7|ECH12_MY	P42126	87.72	45.0	295.0	DB03127	experimental	Benzamidine	NC(=[NH2+])c1ccccc1
19866	sp|P9WNN7|ECH12_MY	P28793	80.35	8.0	237.0	DB08249	experimental	3,6,9,12,15-PENTAOXATRICOSAN-1-OL	CCCCCCCCOCCOCCOCCOCCOCCO
19867	sp|P9WNN7|ECH12_MY	Q08426	82.81	6.0	242.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
19868	sp|P9WPP1|CP125_MY	P9WPN5	87.3	7.0	385.0	DB07705	experimental	(S)-econazole	Clc1ccc(cc1)CO[C@H](Cn2ccnc2)c3c(Cl)cc(Cl)cc3
19869	sp|P9WPP1|CP125_MY	P9WPN5	87.3	7.0	385.0	DB07971	experimental	5-AMINO-2-{4-[(4-AMINOPHENYL)SULFANYL]PHENYL}-1H-ISOINDOLE-1,3(2H)-DIONE	Nc1ccc(cc1)Sc2ccc(cc2)N(C3=O)C(=O)c(c34)ccc(c4)N
19870	sp|P9WPP1|CP125_MY	P9WPN5	87.3	7.0	385.0	DB07972	experimental	1-(3-METHYLPHENYL)-1H-BENZIMIDAZOL-5-AMINE	Cc1cccc(c1)-n2cnc(c23)cc(N)cc3
19871	sp|P9WPP1|CP125_MY	Q83WG3	88.68	7.0	391.0	DB06955	experimental	3,4-bis(7-chloro-1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid	c1ccc(Cl)c(c12)[nH]cc2-c3c(C(=O)O)[nH]c(C(=O)O)c3-c4c[nH]c(c45)c(Cl)ccc5
19872	sp|P9WPP1|CP125_MY	Q83WG3	88.68	7.0	391.0	DB07588	experimental	3,4-DI-1H-INDOL-3-YL-1H-PYRROLE-2,5-DICARBOXYLIC ACID	c1cccc(c12)[nH]cc2-c3c(C(=O)O)[nH]c(C(=O)O)c3-c4c[nH]c(c45)cccc5
19873	sp|P9WPP1|CP125_MY	P53554	87.53	13.0	392.0	DB04450	experimental	Heptyl 1-Thiohexopyranoside	OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)SCCCCCCC
19874	sp|P9WPP1|CP125_MY	Q00441	88.45	19.0	402.0	DB01536	experimental; illicit	Androstenedione	O=C1CC[C@H]([C@@]12C)[C@H]3[C@H](CC2)[C@]4(C)C(CC3)=CC(=O)CC4
19875	sp|P9WPP1|CP125_MY	Q00441	88.45	19.0	402.0	DB03369	experimental	9-Aminophenanthrene	c1cccc(c12)c3c(cc2N)cccc3
19876	sp|P9WPP1|CP125_MY	Q00441	88.45	19.0	402.0	DB04070	experimental	6-Deoxyerythronolide B	C[C@@H]1C[C@H](C)[C@H](O)[C@@H](C)[C@H](O)[C@@H](C)C(=O)O[C@H](CC)[C@H](C)[C@H](O)[C@@H](C)C1=O
19877	sp|P9WPP1|CP125_MY	P00183	85.22	36.0	405.0	DB01011	approved; investigational	Metyrapone	c1ccncc1C(C)(C)C(=O)c2cnccc2
19878	sp|P9WPP1|CP125_MY	P00183	85.22	36.0	405.0	DB01663	experimental	lambda-bis(2,2'-bipyridine)-(5-methyl-2-2'-bipyridine)-C9-adamantane ruthenium (II)	C1=CC=CN2C1=C(C=CC=C3)N3[Ru+2]245(N6C(C=CC=C6)=C7N4C=CC=C7)N8C(=C9N5C=CC(C)=C9)C=C(C=C8)CCCCCCCCC(=O)N[C@@H]([C@H]12)[C@H]3C[C@@H](C1)C[C@@H](C2)C3
19879	sp|P9WPP1|CP125_MY	P00183	85.22	36.0	405.0	DB01703	experimental	N-(2-ferrocenylethyl)maleimide	O=C1C=CC(=O)N1CCC2(C3C4C5C26)[Fe]13456789C2C7C8C9C12
19880	sp|P9WPP1|CP125_MY	P00183	85.22	36.0	405.0	DB01744	approved	Camphor	C[C@]12C(=O)C[C@H](C1(C)C)CC2
19881	sp|P9WPP1|CP125_MY	P00183	85.22	36.0	405.0	DB01826	experimental	N-Butyl Isocyanide	CCCC[N+]#[C-]
19882	sp|P9WPP1|CP125_MY	P00183	85.22	36.0	405.0	DB02125	experimental	Adamantanone	O=C([C@H]12)[C@H]3C[C@@H](C1)C[C@@H](C2)C3
19883	sp|P9WPP1|CP125_MY	P00183	85.22	36.0	405.0	DB02617	experimental	1-(N-Imidazolyl)-2-Hydroxy-2-(2,3-Dichlorophenyl)Octane	CCCCCC[C@](O)(Cn1ccnc1)c2ccc(Cl)cc2Cl
19884	sp|P9WPP1|CP125_MY	P00183	85.22	36.0	405.0	DB02817	experimental	5-Exo-Hydroxycamphor	C[C@]12C[C@@H](O)[C@H](CC1=O)C2(C)C
19885	sp|P9WPP1|CP125_MY	P00183	85.22	36.0	405.0	DB02851	experimental	Thiocamphor	C[C@]12C(=S)C[C@H](C1(C)C)CC2
19886	sp|P9WPP1|CP125_MY	P00183	85.22	36.0	405.0	DB03031	experimental	Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Octyl-Amide	CN(C)c1cccc(c12)c(ccc2)S(=O)(=O)NCCCCCCCCNC(=O)C34CC5CC(C3)CC(C5)C4
19887	sp|P9WPP1|CP125_MY	P00183	85.22	36.0	405.0	DB03540	experimental	Norcamphor	[C@H]12CC[C@H](C1)C(=O)C2
19888	sp|P9WPP1|CP125_MY	P00183	85.22	36.0	405.0	DB03627	experimental	Adamantane	C12CC3CC(C1)CC(C3)C2
19889	sp|P9WPP1|CP125_MY	P00183	85.22	36.0	405.0	DB03836	experimental	1,3,5-trichlorobenzene	Clc1cc(Cl)cc(Cl)c1
19890	sp|P9WPP1|CP125_MY	P00183	85.22	36.0	405.0	DB04032	experimental	Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Butyl-Amide	CN(C)c1cccc(c12)c(ccc2)S(=O)(=O)NCCCCNC(=O)C34CC5CC(C3)CC(C5)C4
19891	sp|P9WPP1|CP125_MY	P00183	85.22	36.0	405.0	DB04501	experimental	Camphane	C[C@@]12CCC(C1(C)C)CC2
19892	sp|P9WPP1|CP125_MY	Q9FCA6	82.22	47.0	403.0	DB02175	experimental	Malonic acid	OC(=O)CC(=O)O
19893	sp|P9WPP1|CP125_MY	Q9FCA6	82.22	47.0	403.0	DB02521	experimental	Flaviolin	Oc1cc(O)cc(c12)C(=O)C(O)=CC2=O
19894	sp|P9WPP1|CP125_MY	Q9FCA6	82.22	47.0	403.0	DB03254	experimental	4-Phenyl-1h-Imidazole	[nH]1cncc1-c2ccccc2
19895	sp|P9WPP1|CP125_MY	Q9FCA6	82.22	47.0	403.0	DB03814	experimental	2-(N-morpholino)ethanesulfonic acid	OS(=O)(=O)CCN1CCOCC1
19896	sp|P9WPP1|CP125_MY	P9WPP7	83.14	16.0	376.0	DB02721	experimental	4-Iodopyrazole	Ic1c[nH]nc1
19897	sp|P9WPP1|CP125_MY	P9WPP7	83.14	16.0	376.0	DB08761	experimental	(3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine-2,5-dione	Oc1ccc(cc1)C[C@@H]2NC(=O)[C@@H](NC2=O)Cc3ccc(O)cc3
19898	sp|P9WPP1|CP125_MY	Q9NR63	90.99	97.0	491.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
19899	sp|P9WPP1|CP125_MY	Q6V0L0	84.99	138.0	506.0	DB00523	approved; investigational	Alitretinoin	OC(=O)/C=C(\C)/C=C/C=C(/C)\C=C\C(C1(C)C)=C(C)CCC1
19900	sp|P9WPP1|CP125_MY	Q6V0L0	84.99	138.0	506.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
19901	sp|P9WPP1|CP125_MY	O43174	84.3	126.0	491.0	DB00755	approved; investigational; nutraceutical	Tretinoin	OC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C(C1(C)C)=C(C)CCC1
19902	sp|P9WPP1|CP125_MY	O43174	84.3	126.0	491.0	DB13083	investigational	Talarozole	c1ncnn1C(C(CC)CC)c2ccc(cc2)Nc(s3)nc(c34)cccc4
19903	sp|P9WPP1|CP125_MY	P08686	74.36	130.0	452.0	DB01026	approved; investigational	Ketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OCC(CO3)OC3(Cn4ccnc4)c5ccc(Cl)cc5Cl
19904	sp|P9WPP1|CP125_MY	O31440	78.52	44.0	384.0	DB04257	experimental	Palmitoleic Acid	CCCCCC/C=C\CCCCCCCC(=O)O
19905	sp|P9WPP1|CP125_MY	P08684	79.21	127.0	470.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
19906	sp|P9WPP1|CP125_MY	P08684	79.21	127.0	470.0	DB00143	approved; investigational; nutraceutical	Glutathione	OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(=O)O
19907	sp|P9WPP1|CP125_MY	P08684	79.21	127.0	470.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
19908	sp|P9WPP1|CP125_MY	P08684	79.21	127.0	470.0	DB05478	investigational	Pradefovir mesylate	n1cnc(N)c(c12)ncn2CCOC[P@@]3(=O)OCC[C@H](O3)c4cc(Cl)ccc4
19909	sp|P9WPP1|CP125_MY	P08684	79.21	127.0	470.0	DB06634	investigational	Casopitant	FC(F)(F)c1cc(cc(c1)C(F)(F)F)[C@@H](C)N(C)C(=O)N2CC[C@H](N3CCN(CC3)C(=O)C)C[C@@H]2c4ccc(F)cc4C
19910	sp|P9WPP1|CP125_MY	P11712	78.75	139.0	480.0	DB03317	experimental	Ferroheme C	[Fe-2]123[N+]4=C5C=C6[N+]1=C(C(C)=C6C(C)S)C=C7[N+]2=C(C(=C7C)CCC(=O)O)C=C8[N+]3=C(C=C4C(=C5C)C(C)S)C(C)=C8CCC(=O)O
19911	sp|P9WPP1|CP125_MY	P11712	78.75	139.0	480.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
19912	sp|P9WPP1|CP125_MY	P11712	78.75	139.0	480.0	DB12319	investigational; withdrawn	Benzbromarone	c1cccc(c12)c(c(o2)CC)C(=O)c3cc(Br)c(O)c(Br)c3
19913	sp|P9WPP1|CP125_MY	P20815	78.98	127.0	469.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
19914	sp|P9WPP1|CP125_MY	P20815	78.98	127.0	469.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
19915	sp|P9WPP1|CP125_MY	P20815	78.98	127.0	469.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
19916	sp|P9WPP1|CP125_MY	P10632	79.21	140.0	483.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
19917	sp|P9WPP1|CP125_MY	P10632	79.21	140.0	483.0	DB03796	approved	Palmitic Acid	CCCCCCCCCCCCCCCC(=O)O
19918	sp|P9WPP1|CP125_MY	P10632	79.21	140.0	483.0	DB08607	experimental	(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE	O=C1NC(=O)S[C@@H]1Cc2ccc(cc2)OC[C@@](O3)(C)CCc(c34)c(C)c(O)c(C)c4C
19919	sp|P9WPP1|CP125_MY	P33261	78.52	140.0	480.0	DB00951	approved; investigational	Isoniazid	NNC(=O)c1ccncc1
19920	sp|P9WPP1|CP125_MY	P33261	78.52	140.0	480.0	DB12319	investigational; withdrawn	Benzbromarone	c1cccc(c12)c(c(o2)CC)C(=O)c3cc(Br)c(O)c(Br)c3
19921	sp|P9WPP1|CP125_MY	Q9HB55	79.21	127.0	470.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
19922	sp|P9WPP1|CP125_MY	P24462	79.21	127.0	470.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
19923	sp|P9WPP1|CP125_MY	P24462	79.21	127.0	470.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
19924	sp|P9WPP1|CP125_MY	P24462	79.21	127.0	470.0	DB11994	approved; investigational	Diacerein	CC(=O)Oc1cccc(c12)C(=O)c3c(C2=O)c(OC(=O)C)cc(c3)C(=O)O
19925	sp|P9WPP1|CP125_MY	P33260	75.52	140.0	467.0	DB07670	experimental	N,4-Dimethyl-N-(1-phenyl-1H-pyrazol-5-yl)benzenesulfonamide	Cc1ccc(cc1)S(=O)(=O)N(C)c2ccnn2-c3ccccc3
19926	sp|P9WPP1|CP125_MY	P20813	76.44	137.0	468.0	DB02974	experimental	4-(4-Chlorophenyl)Imidazole	Clc1ccc(cc1)-c2cnc[nH]2
19927	sp|P9WPP1|CP125_MY	P20813	76.44	137.0	468.0	DB04664	experimental	Cyclohexyl-pentyl-maltoside	OC[C@H]1O[C@@H]([C@H](O)[C@@H](O)[C@@H]1O)O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@@H]2CO)OCCCCCC3CCCCC3
19928	sp|P9WPP1|CP125_MY	P20813	76.44	137.0	468.0	DB04794	approved; investigational	Bifonazole	c1ccccc1C(n2ccnc2)c3ccc(cc3)-c4ccccc4
19929	sp|P9WPP1|CP125_MY	P20813	76.44	137.0	468.0	DB08369	experimental	1-(biphenyl-4-ylmethyl)-1H-imidazole	c1cncn1Cc2ccc(cc2)-c3ccccc3
19930	sp|P9WPP1|CP125_MY	P11509	79.21	145.0	488.0	DB04665	experimental	Coumarin	c1cc(=O)oc(c12)cccc2
19931	sp|P9WPP1|CP125_MY	P11509	79.21	145.0	488.0	DB07609	experimental	N,N-DIMETHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	CN(C)Cc1ccc(o1)-c2cccnc2
19932	sp|P9WPP1|CP125_MY	P11509	79.21	145.0	488.0	DB07617	experimental	N-METHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	CNCc1ccc(o1)-c2cccnc2
19933	sp|P9WPP1|CP125_MY	P11509	79.21	145.0	488.0	DB07621	experimental	(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	NCc1ccc(o1)-c2cccnc2
19934	sp|P9WPP1|CP125_MY	P11509	79.21	145.0	488.0	DB07623	experimental	4,4'-DIPYRIDYL DISULFIDE	c1cnccc1SSc2ccncc2
19935	sp|P9WPP1|CP125_MY	Q16850	75.29	150.0	476.0	DB01007	approved	Tioconazole	c1nccn1CC(c(c(Cl)c2)ccc2Cl)OCc3c(Cl)scc3
19936	sp|P9WPP1|CP125_MY	Q16850	75.29	150.0	476.0	DB01167	approved; investigational	Itraconazole	CCC(C)n1ncn(c1=O)-c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@@H](CO5)O[C@@]5(Cn6cncn6)c7ccc(Cl)cc7Cl
19937	sp|P9WPP1|CP125_MY	Q16850	75.29	150.0	476.0	DB05667	investigational	Levoketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OC[C@H](CO3)O[C@]3(Cn4ccnc4)c5ccc(Cl)cc5Cl
19938	sp|P9WPP1|CP125_MY	Q16850	75.29	150.0	476.0	DB07705	experimental	(S)-econazole	Clc1ccc(cc1)CO[C@H](Cn2ccnc2)c3c(Cl)cc(Cl)cc3
19939	sp|P9WPP1|CP125_MY	P50859	81.52	141.0	494.0	DB01026	approved; investigational	Ketoconazole	CC(=O)N1CCN(CC1)c2ccc(cc2)OCC(CO3)OC3(Cn4ccnc4)c5ccc(Cl)cc5Cl
19940	sp|P9WPP1|CP125_MY	P50859	81.52	141.0	494.0	DB01167	approved; investigational	Itraconazole	CCC(C)n1ncn(c1=O)-c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@@H](CO5)O[C@@]5(Cn6cncn6)c7ccc(Cl)cc7Cl
19941	sp|P9WPP1|CP125_MY	P50859	81.52	141.0	494.0	DB09040	approved	Efinaconazole	C=C1CCN(CC1)[C@H](C)[C@](O)(Cn2cncn2)c3c(F)cc(F)cc3
19942	sp|P9WPP1|CP125_MY	P50859	81.52	141.0	494.0	DB11633	approved; investigational	Isavuconazole	c1ncnn1C[C@](O)(c2c(F)ccc(F)c2)[C@@H](C)c3nc(cs3)-c4ccc(C#N)cc4
19943	sp|P9WPP1|CP125_MY	P24557	91.45	109.0	505.0	DB00795	approved	Sulfasalazine	OC(=O)c1cc(ccc1O)/N=N/c2ccc(cc2)S(=O)(=O)Nc3ncccc3
19944	sp|P9WPP1|CP125_MY	P24557	91.45	109.0	505.0	DB01207	experimental	Ridogrel	OC(=O)CCCCO/N=C(/c1cnccc1)c2cc(C(F)(F)F)ccc2
19945	sp|P9WPP1|CP125_MY	P24557	91.45	109.0	505.0	DB03052	experimental	Dazoxiben	OC(=O)c1ccc(cc1)OCCn2ccnc2
19946	sp|P9WPP1|CP125_MY	P24557	91.45	109.0	505.0	DB05505	investigational	NM-702	 
19947	sp|P9WPP1|CP125_MY	P10614	78.75	149.0	490.0	DB06890	experimental	(2R)-2-PHENYL-N-PYRIDIN-4-YLBUTANAMIDE	c1ccccc1[C@@H](CC)C(=O)Nc2ccncc2
19948	sp|P9WPP1|CP125_MY	P10614	78.75	149.0	490.0	DB07560	experimental	N-[(1S)-2-methyl-1-(pyridin-4-ylcarbamoyl)propyl]cyclohexanecarboxamide	c1cnccc1NC(=O)[C@H](C(C)C)NC(=O)C2CCCCC2
19949	sp|P9WPP1|CP125_MY	P10614	78.75	149.0	490.0	DB07568	experimental	(2S)-2-[(2,1,3-BENZOTHIADIAZOL-4-YLSULFONYL)AMINO]-2-PHENYL-N-PYRIDIN-4-YLACETAMIDE	n1snc(c12)cccc2S(=O)(=O)N[C@@H](c3ccccc3)C(=O)Nc4ccncc4
19950	sp|P9WPP1|CP125_MY	P10614	78.75	149.0	490.0	DB07569	experimental	CIS-4-METHYL-N-[(1S)-3-(METHYLSULFANYL)-1-(PYRIDIN-4-YLCARBAMOYL)PROPYL]CYCLOHEXANECARBOXAMIDE	c1cnccc1NC(=O)[C@H](CCSC)NC(=O)[C@@H]2CC[C@H](C)CC2
19951	sp|P9WPP1|CP125_MY	P10614	78.75	149.0	490.0	DB07572	experimental	3-{[(4-methylphenyl)sulfonyl]amino}propyl pyridin-4-ylcarbamate	Cc1ccc(cc1)S(=O)(=O)NCCCOC(=O)Nc2ccncc2
19952	sp|P9WPP1|CP125_MY	P10614	78.75	149.0	490.0	DB07635	experimental	4,4'-Dihydroxybenzophenone	Oc1ccc(cc1)C(=O)c2ccc(O)cc2
19953	sp|P9WPP1|CP125_MY	P10613	80.37	143.0	491.0	DB00196	approved; investigational	Fluconazole	c1ncnn1CC(O)(Cn2cncn2)c3c(F)cc(F)cc3
19954	sp|P9WPP1|CP125_MY	P10613	80.37	143.0	491.0	DB00239	approved	Oxiconazole	Clc1cc(Cl)c(cc1)CO/N=C(\Cn2ccnc2)c3ccc(Cl)cc3Cl
19955	sp|P9WPP1|CP125_MY	P10613	80.37	143.0	491.0	DB00251	approved	Terconazole	CC(C)N1CCN(CC1)c2ccc(cc2)OC[C@@H](CO3)O[C@@]3(Cn4cncn4)c5c(Cl)cc(Cl)cc5
19956	sp|P9WPP1|CP125_MY	P10613	80.37	143.0	491.0	DB00257	approved; vet_approved	Clotrimazole	Clc1ccccc1C(n2ccnc2)(c3ccccc3)c4ccccc4
19957	sp|P9WPP1|CP125_MY	P10613	80.37	143.0	491.0	DB00582	approved	Voriconazole	c1ncnn1C[C@](O)(c2c(F)cc(F)cc2)[C@@H](C)c3ncncc3F
19958	sp|P9WPP1|CP125_MY	P10613	80.37	143.0	491.0	DB01007	approved	Tioconazole	c1nccn1CC(c(c(Cl)c2)ccc2Cl)OCc3c(Cl)scc3
19959	sp|P9WPP1|CP125_MY	P10613	80.37	143.0	491.0	DB01110	approved; investigational; vet_approved	Miconazole	Clc1cc(Cl)c(cc1)COC(Cn2ccnc2)c3c(Cl)cc(Cl)cc3
19960	sp|P9WPP1|CP125_MY	P10613	80.37	143.0	491.0	DB01127	approved	Econazole	Clc1ccc(cc1)COC(Cn2ccnc2)c3c(Cl)cc(Cl)cc3
19961	sp|P9WPP1|CP125_MY	P10613	80.37	143.0	491.0	DB01153	approved; investigational	Sertaconazole	Clc1cc(Cl)ccc1C(Cn2cncc2)OCc3csc(c34)c(Cl)ccc4
19962	sp|P9WPP1|CP125_MY	P10613	80.37	143.0	491.0	DB01263	approved; investigational; vet_approved	Posaconazole	C[C@H](O)[C@H](CC)n1ncn(c1=O)-c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@H](CO5)C[C@]5(Cn6cncn6)c7c(F)cc(F)cc7
19963	sp|P9WPP1|CP125_MY	P10613	80.37	143.0	491.0	DB04794	approved; investigational	Bifonazole	c1ccccc1C(n2ccnc2)c3ccc(cc3)-c4ccccc4
19964	sp|P9WPP1|CP125_MY	P10613	80.37	143.0	491.0	DB08933	approved	Luliconazole	Clc1cc(Cl)c(cc1)[C@@H]2CS/C(S2)=C(/C#N)n3ccnc3
19965	sp|P9WNV5|DNLI_MYC	P18858	72.39	530.0	897.0	DB00290	approved; investigational	Bleomycin	NC(=O)OC1C(O)C(OC(C1O)CO)OC2C(O)C(O)C(CO)OC2O[C@@H](c3c[nH]cn3)[C@H](NC(=O)c4nc(nc(N)c4C)[C@H](CC(=O)N)NC[C@H](N)C(=O)N)C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCc5nc(cs5)-c6nc(cs6)C(=O)NCCC[S+](C)C
19966	sp|P9WNV5|DNLI_MYC	P49916	93.89	353.0	829.0	DB00290	approved; investigational	Bleomycin	NC(=O)OC1C(O)C(OC(C1O)CO)OC2C(O)C(O)C(CO)OC2O[C@@H](c3c[nH]cn3)[C@H](NC(=O)c4nc(nc(N)c4C)[C@H](CC(=O)N)NC[C@H](N)C(=O)N)C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCc5nc(cs5)-c6nc(cs6)C(=O)NCCC[S+](C)C
19967	sp|I6XHI4|FADA5_MY	P07097	98.47	5.0	390.0	DB01915	experimental	S-Hydroxycysteine	OC(=O)[C@@H](N)CSO
19968	sp|I6XHI4|FADA5_MY	P07097	98.47	5.0	390.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
19969	sp|I6XHI4|FADA5_MY	P07097	98.47	5.0	390.0	DB02039	experimental	S-Acetyl-Cysteine	OC(=O)[C@@H](N)CSC(=O)C
19970	sp|I6XHI4|FADA5_MY	P07097	98.47	5.0	390.0	DB02160	experimental	S-Butyryl-Cystein	OC(=O)[C@@H](N)CSC(=O)CCC
19971	sp|I6XHI4|FADA5_MY	P07097	98.47	5.0	390.0	DB03045	experimental	Pantothenyl-Aminoethanol-Acetate Pivalic Acid	CC(=O)OCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COC(=O)C(C)(C)C
19972	sp|I6XHI4|FADA5_MY	P07097	98.47	5.0	390.0	DB03059	experimental	Acetoacetyl-CoA	CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
19973	sp|I6XHI4|FADA5_MY	P07097	98.47	5.0	390.0	DB08328	experimental	PANTOTHENYL-AMINOETHANOL-11-PIVALIC ACID	CC(C)(C)C(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCO
19974	sp|I6XHI4|FADA5_MY	P07097	98.47	5.0	390.0	DB08408	experimental	(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-({3-oxo-3-[(2-sulfanylethyl)amino]propyl}amino)butyl 2,2-dimethylpropanoate	CC(C)(C)C(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS
19975	sp|I6XHI4|FADA5_MY	Q9BWD1	99.23	8.0	396.0	DB01915	experimental	S-Hydroxycysteine	OC(=O)[C@@H](N)CSO
19976	sp|I6XHI4|FADA5_MY	Q9BWD1	99.23	8.0	396.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
19977	sp|I6XHI4|FADA5_MY	P28790	97.95	8.0	391.0	DB08249	experimental	3,6,9,12,15-PENTAOXATRICOSAN-1-OL	CCCCCCCCOCCOCCOCCOCCOCCO
19978	sp|I6XHI4|FADA5_MY	P09110	97.7	38.0	420.0	DB09069	approved; investigational	Trimetazidine	COc1c(OC)c(OC)c(cc1)CN2CCNCC2
19979	sp|I6XHI4|FADA5_MY	P24752	98.21	42.0	426.0	DB00795	approved	Sulfasalazine	OC(=O)c1cc(ccc1O)/N=N/c2ccc(cc2)S(=O)(=O)Nc3ncccc3
19980	sp|I6XHI4|FADA5_MY	P24752	98.21	42.0	426.0	DB09061	approved; investigational	Cannabidiol	CCCCCc1cc(O)c(c(O)c1)[C@@H]2C=C(C)CC[C@H]2C(C)=C
19982	sp|I6XHI4|FADA5_MY	P24752	98.21	42.0	426.0	DB14011	investigational	Nabiximols	CC(=C)[C@@H]1CCC(C)=C[C@H]1c2c(O)cc(cc2O)CCCCC
19983	sp|P9WQG9|AAC2_MYC	P9WQG9	99.45	1.0	181.0	DB01842	experimental	3'-Phosphate-Adenosine-5'-Diphosphate	OP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
19984	sp|P9WQG9|AAC2_MYC	P9WQG9	99.45	1.0	181.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
19985	sp|P9WQG9|AAC2_MYC	P9WQG9	99.45	1.0	181.0	DB03615	approved; experimental	Ribostamycin	O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]2[C@@H](O)[C@H](N)C[C@H](N)[C@H]2O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N
19986	sp|P9WNC9|DHPS2_MY	P0C0X2	90.88	2.0	291.0	DB00250	approved; investigational	Dapsone	Nc1ccc(cc1)S(=O)(=O)c2ccc(N)cc2
19987	sp|P9WNC9|DHPS2_MY	Q81VW8	80.82	19.0	276.0	DB03592	experimental	Pterin-6-Yl-Methyl-Monophosphate	O=c1[nH]c(N)nc(c12)ncc(n2)COP(=O)(O)O
19988	sp|P9WNC9|DHPS2_MY	Q81VW8	80.82	19.0	276.0	DB03705	experimental	6-Methylamino-5-Nitroisocytosine	CNc1c([N+]([O-])=O)c(=O)[nH]c(n1)N
19989	sp|P9WNC9|DHPS2_MY	Q81VW8	80.82	19.0	276.0	DB04047	experimental	6-hydroxymethylpterin diphosphate	Nc([nH]1)nc(=O)c(c12)nc(cn2)COP(=O)(O)OP(=O)(O)O
19990	sp|P9WNC9|DHPS2_MY	Q81VW8	80.82	19.0	276.0	DB04196	experimental	Pteroic acid	O=c1[nH]c(N)nc(c12)ncc(n2)CNc3ccc(cc3)C(=O)O
19991	sp|P9WNC9|DHPS2_MY	P0AC13	83.02	13.0	277.0	DB00259	approved	Sulfanilamide	Nc1ccc(cc1)S(=O)(=O)N
19992	sp|P9WNC9|DHPS2_MY	P0AC13	83.02	13.0	277.0	DB00263	approved; vet_approved	Sulfisoxazole	Cc1noc(c1C)NS(=O)(=O)c2ccc(N)cc2
19993	sp|P9WNC9|DHPS2_MY	P0AC13	83.02	13.0	277.0	DB00576	approved; investigational; vet_approved	Sulfamethizole	Cc1nnc(s1)NS(=O)(=O)c2ccc(N)cc2
19994	sp|P9WNC9|DHPS2_MY	P0AC13	83.02	13.0	277.0	DB00634	approved	Sulfacetamide	CC(=O)NS(=O)(=O)c1ccc(N)cc1
19995	sp|P9WNC9|DHPS2_MY	P0AC13	83.02	13.0	277.0	DB01015	approved	Sulfamethoxazole	Cc1cc(no1)NS(=O)(=O)c2ccc(N)cc2
19996	sp|P9WNC9|DHPS2_MY	P0AC13	83.02	13.0	277.0	DB01298	approved	Sulfacytine	CCn1ccc(nc1=O)NS(=O)(=O)c2ccc(N)cc2
19997	sp|P9WNC9|DHPS2_MY	P0AC13	83.02	13.0	277.0	DB01581	approved; vet_approved	Sulfamerazine	Cc1nc(ncc1)NS(=O)(=O)c2ccc(N)cc2
19998	sp|P9WNC9|DHPS2_MY	P0AC13	83.02	13.0	277.0	DB01582	approved; investigational; vet_approved	Sulfamethazine	Cc1cc(C)nc(n1)NS(=O)(=O)c2ccc(N)cc2
19999	sp|P9WNC9|DHPS2_MY	P0AC13	83.02	13.0	277.0	DB06729	approved	Sulfaphenazole	Nc1ccc(cc1)S(=O)(=O)Nc2ccnn2-c3ccccc3
20000	sp|P9WNC9|DHPS2_MY	P0AC13	83.02	13.0	277.0	DB06821	approved	Sulfameter	COc1cnc(nc1)NS(=O)(=O)c2ccc(N)cc2
20001	sp|P9WNC9|DHPS2_MY	P0AC13	83.02	13.0	277.0	DB14033	approved; vet_approved	Acetyl sulfisoxazole	Cc1noc(c1C)N(C(=O)C)S(=O)(=O)c2ccc(N)cc2
20002	sp|P9WNC9|DHPS2_MY	P9WND1	84.28	6.0	274.0	DB03592	experimental	Pterin-6-Yl-Methyl-Monophosphate	O=c1[nH]c(N)nc(c12)ncc(n2)COP(=O)(O)O
20003	sp|P9WNC9|DHPS2_MY	P0C0X1	86.16	7.0	281.0	DB00250	approved; investigational	Dapsone	Nc1ccc(cc1)S(=O)(=O)c2ccc(N)cc2
20004	sp|P9WNC9|DHPS2_MY	Q49184	86.48	4.0	279.0	DB00891	approved	Sulfapyridine	Nc1ccc(cc1)S(=O)(=O)Nc2ccccn2
20005	sp|P9WNC9|DHPS2_MY	P0C002	85.53	3.0	275.0	DB00634	approved	Sulfacetamide	CC(=O)NS(=O)(=O)c1ccc(N)cc1
20006	sp|P9WNC9|DHPS2_MY	P53848	100.94	499.0	820.0	DB00634	approved	Sulfacetamide	CC(=O)NS(=O)(=O)c1ccc(N)cc1
20007	sp|P9WNC9|DHPS2_MY	Q27738	72.64	50.0	281.0	DB00359	approved; investigational; vet_approved	Sulfadiazine	Nc1ccc(cc1)S(=O)(=O)Nc2ncccn2
20008	sp|P9WNC9|DHPS2_MY	Q27738	72.64	50.0	281.0	DB00664	approved; withdrawn	Sulfametopyrazine	COc1nccnc1NS(=O)(=O)c2ccc(N)cc2
20009	sp|P9WNC9|DHPS2_MY	Q27738	72.64	50.0	281.0	DB01145	approved	Sulfoxone	OS(=O)CNc1ccc(cc1)S(=O)(=O)c2ccc(cc2)NCS(=O)O
20010	sp|P9WNC9|DHPS2_MY	Q27738	72.64	50.0	281.0	DB01299	approved; investigational	Sulfadoxine	COc1ncnc(c1OC)NS(=O)(=O)c2ccc(N)cc2
20011	sp|P9WNC9|DHPS2_MY	Q27738	72.64	50.0	281.0	DB06147	approved; vet_approved	Sulfathiazole	Nc1ccc(cc1)S(=O)(=O)Nc2nccs2
20012	sp|P9WNC9|DHPS2_MY	Q27738	72.64	50.0	281.0	DB08798	experimental	Sulfamoxole	Cc1c(C)nc(o1)NS(=O)(=O)c2ccc(N)cc2
20013	sp|P9WNU1|DPO3B_MY	P0A988	85.07	2.0	344.0	DB06998	experimental	[(5R)-5-(2,3-dibromo-5-ethoxy-4-hydroxybenzyl)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]acetic acid	OC(=O)CN1C(=O)[C@H](SC1=S)Cc2c(Br)c(Br)c(O)c(c2)OCC
20014	sp|P9WQ55|FAD10_MY	P40871	92.96	28.0	530.0	DB01672	experimental	2,3-Dihydroxy-Benzoic Acid	OC(=O)c1cccc(O)c1O
20015	sp|P9WQ55|FAD10_MY	Q8GN86	92.41	3.0	502.0	DB03728	experimental	p-Chlorobenzoic acid	OC(=O)c1ccc(Cl)cc1
20016	sp|P9WQ55|FAD10_MY	Q8ZKF6	100.93	79.0	624.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
20017	sp|P9WQ55|FAD10_MY	Q8ZKF6	100.93	79.0	624.0	DB03230	experimental	Adenosine-5'-Propylphosphate	CCCOP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
20018	sp|P9WQ55|FAD10_MY	Q9NUB1	100.37	114.0	656.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
20019	sp|P9WQ55|FAD10_MY	Q9NR19	106.11	102.0	675.0	DB00131	approved; investigational; nutraceutical	Adenosine phosphate	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
20020	sp|P9WQ55|FAD10_MY	Q9NR19	106.11	102.0	675.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
20021	sp|P9WG81|FOLD_MYC	P13995	104.27	37.0	330.0	DB00116	nutraceutical	Tetrahydrofolic acid	Nc([nH]1)nc(=O)c(c12)NC(CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
20022	sp|P9WG81|FOLD_MYC	P13995	104.27	37.0	330.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
20023	sp|P9WG81|FOLD_MYC	P11586	102.85	4.0	293.0	DB00116	nutraceutical	Tetrahydrofolic acid	Nc([nH]1)nc(=O)c(c12)NC(CN2)CNc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
20024	sp|P9WG81|FOLD_MYC	P11586	102.85	4.0	293.0	DB00157	approved; nutraceutical	NADH	NC(=O)C1=CN(C=CC1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc(c45)c(N)ncn5
20025	sp|P9WG81|FOLD_MYC	P11586	102.85	4.0	293.0	DB02358	experimental	LY374571	Nc1nc(=O)c(N)c([nH]1)NC(=O)Nc2ccc(cc2)C(=O)N[C@H](C(=O)O)CCC(=O)O
20026	sp|P9WG81|FOLD_MYC	P11586	102.85	4.0	293.0	DB03461	experimental	Nicotinamide adenine dinucleotide phosphate	NC(=O)c1ccc[n+](c1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP([O-])(=O)OP(=O)(O)OC[C@H]3O[C@H]([C@@H]([C@@H]3O)OP(=O)(O)O)n4cnc(c45)c(N)ncn5
20027	sp|P9WG81|FOLD_MYC	P11586	102.85	4.0	293.0	DB04322	experimental	LY249543	Nc([nH]1)nc(=O)c(c12)C[C@@H](CN2)CCc3ccc(cc3)C(=O)N[C@H](C(=O)O)CCC(=O)O
20028	sp|P9WNZ1|COABC_MY	P0ABQ0	94.02	5.0	398.0	DB02431	experimental	Cytidine-5'-Triphosphate	Nc1nc(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
20029	sp|P9WNZ1|COABC_MY	P0ABQ0	94.02	5.0	398.0	DB03403	experimental	Cytidine-5'-Monophosphate	Nc1nc(=O)n(cc1)[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)O
20030	sp|P9WNL5|EMBC_MYC	P9WNL5	99.91	1.0	1094.0	DB00330	approved	Ethambutol	CC[C@@H](CO)NCCN[C@@H](CC)CO
20031	sp|P9WNL5|EMBC_MYC	P9WNL7	99.36	10.0	1097.0	DB00330	approved	Ethambutol	CC[C@@H](CO)NCCN[C@@H](CC)CO
20032	sp|P9WNL5|EMBC_MYC	P9WNL9	98.99	8.0	1091.0	DB00330	approved	Ethambutol	CC[C@@H](CO)NCCN[C@@H](CC)CO
20033	sp|O53551|FAC17_MY	Q8ZKF6	102.59	107.0	622.0	DB01992	investigational; nutraceutical	Coenzyme A	SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(=O)(O)O)n2cnc(c23)c(N)ncn3
20034	sp|O53551|FAC17_MY	Q8ZKF6	102.59	107.0	622.0	DB03230	experimental	Adenosine-5'-Propylphosphate	CCCOP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc(c23)c(N)ncn3
20035	sp|O53551|FAC17_MY	Q9NUB1	101.39	142.0	651.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
20036	sp|O53551|FAC17_MY	Q8GN86	92.03	39.0	501.0	DB03728	experimental	p-Chlorobenzoic acid	OC(=O)c1ccc(Cl)cc1
20037	sp|O53551|FAC17_MY	Q9NR19	105.98	142.0	674.0	DB00131	approved; investigational; nutraceutical	Adenosine phosphate	n1cnc(N)c(c12)ncn2[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)O
20038	sp|O53551|FAC17_MY	Q9NR19	105.98	142.0	674.0	DB00171	investigational; nutraceutical	ATP	Nc1ncnc(c12)n(cn2)[C@@H]3O[C@@H]([C@@H](O)[C@H]3O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O
20039	sp|O53551|FAC17_MY	P40871	95.02	52.0	529.0	DB01672	experimental	2,3-Dihydroxy-Benzoic Acid	OC(=O)c1cccc(O)c1O
